PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Kramer, K; Wu, J; Crowe, DL				Kramer, K.; Wu, J.; Crowe, D. L.			Tumor suppressor control of the cancer stem cell niche	ONCOGENE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HUMAN BREAST-CANCER; PPAR-GAMMA; MAMMARY-GLAND; NUCLEAR-ENVELOPE; PROGENITOR CELLS; ANGIOGENESIS; EXPRESSION; VEGF; MOUSE	Mammary stem cells (MSCs) expansion is associated with aggressive human breast cancer. The nuclear receptor peroxisome proliferator activated receptor. (PPAR gamma) is a breast cancer tumor suppressor, but the mechanisms of this suppression are not completely characterized. To determine whether PPAR gamma regulates MSC expansion in mammary cancer, we deleted PPAR gamma expression in the mammary epithelium of an in vivo model of basal breast cancer. Loss of PPAR gamma expression reduced tumor latency, and expanded the CD24+/CD49f(hi) MSC population. PPAR gamma-null mammary tumors exhibited increased angiogenesis, which was detected in human breast cancer. In vivo inhibition of a PPAR gamma-regulated miR-15a/angiopoietin-1 pathway blocked increased angiogenesis and MSC expansion. PPAR gamma bound and activated a canonical response element in the miR-15a gene. PPAR gamma-null tumors were sensitive to the targeted anti-angiogenic drug sunitinib but resistant to cytotoxic chemotherapy. Normalization of tumor vasculature with sunitinib resulted in objective response to cytotoxic chemotherapy. Chemotherapy-treated PPAR gamma-null mammary tumors exhibited luminal phenotype and expansion of unipotent CD61+ luminal progenitor cells. Transplantation of chemotherapy-treated luminal progenitor cells recapitulated the luminal phenotype. These results have important implications for anti-angiogenic therapy in breast cancer patients.	[Kramer, K.; Wu, J.; Crowe, D. L.] Univ Illinois, Ctr Canc, 801 S Paulina St, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Crowe, DL (corresponding author), Univ Illinois, Ctr Canc, 801 S Paulina St, Chicago, IL 60612 USA.	dlcrowe@uic.edu	Wu, Jianchun/AAX-3533-2020	Wu, Jianchun/0000-0002-8473-9368	NIH National Research Service award [DE18381]; Department of Defense Breast Cancer Research Program award [W81XWH-10-1-0081]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T32DE018381, T32DE007057] Funding Source: NIH RePORTER	NIH National Research Service award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program award; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We thank Dr Ke Ma and Jewell Graves (University of Illinois Research Resources Center) for assistance with microscopy and flow cytometry. KK was supported by NIH National Research Service award DE18381. This study was supported by Department of Defense Breast Cancer Research Program award W81XWH-10-1-0081.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Asano A, 2001, MOL CELL ENDOCRINOL, V174, P71, DOI 10.1016/S0303-7207(00)00450-0; Bensinger SJ, 2008, NATURE, V454, P470, DOI 10.1038/nature07202; Bronisz A, 2012, NAT CELL BIOL, V14, P159, DOI 10.1038/ncb2396; Caine GJ, 2004, ANN MED, V36, P273, DOI 10.1080/07853890410026098; Chekhonin VP, 2013, CURR CANCER DRUG TAR, V13, P423, DOI 10.2174/15680096113139990074; Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170; Chou J, 2013, NAT CELL BIOL, V15, P201, DOI 10.1038/ncb2672; Conley SJ, 2012, P NATL ACAD SCI USA, V109, P2784, DOI 10.1073/pnas.1018866109; Crowe DL, 2004, HISTOL HISTOPATHOL, V19, P505, DOI 10.14670/HH-19.505; Danza K, 2013, EUR J HUM GENET, V21, P824, DOI 10.1038/ejhg.2012.273; Fantozzi A, 2014, CANCER RES, V74, P1566, DOI 10.1158/0008-5472.CAN-13-1641; Fauconnet S, 2002, J BIOL CHEM, V277, P23534, DOI 10.1074/jbc.M200172200; Golembesky AK, 2008, CARCINOGENESIS, V29, P1944, DOI 10.1093/carcin/bgn154; Harfouche R, 2011, J STEROID BIOCHEM, V123, P17, DOI 10.1016/j.jsbmb.2010.09.005; He T, 2014, J PATHOL, V232, P499, DOI 10.1002/path.4324; Heessen S, 2007, EMBO REP, V8, P914, DOI 10.1038/sj.embor.7401075; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jiang WG, 2003, INT J CANCER, V106, P752, DOI 10.1002/ijc.11302; Kong W, 2014, ONCOGENE, V33, P679, DOI 10.1038/onc.2012.636; Lacroix L, 2005, AM J PATHOL, V167, P223, DOI 10.1016/S0002-9440(10)62967-7; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu BY, 2004, P NATL ACAD SCI USA, V101, P4158, DOI 10.1073/pnas.0400699101; Liu Yu-hua, 2011, Zhonghua Zhong Liu Za Zhi, V33, P827; Luo QF, 2013, INT J ONCOL, V43, P1212, DOI 10.3892/ijo.2013.2034; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Nieto Y, 2007, BRIT J CANCER, V97, P391, DOI 10.1038/sj.bjc.6603875; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Panigrahy D, 2002, J CLIN INVEST, V110, P923, DOI 10.1172/JCI200215634; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Png KJ, 2012, NATURE, V481, P190, DOI 10.1038/nature10661; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Reddi HV, 2013, CANCER GENE THER, V20, P267, DOI 10.1038/cgt.2013.16; Reiss Y, 2009, J PATHOL, V217, P571, DOI 10.1002/path.2484; Roth C, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2766; Saez E, 2004, GENE DEV, V18, P528, DOI 10.1101/gad.1167804; Schmidt SF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-152; Siragam V, 2012, ONCOTARGET, V3, P1370, DOI 10.18632/oncotarget.717; Sleeman KE, 2007, J CELL BIOL, V176, P19, DOI 10.1083/jcb.200604065; Steglich B, 2013, NUCLEUS-PHILA, V4, P379, DOI 10.4161/nucl.26394; Tian LF, 2009, CANCER RES, V69, P9236, DOI 10.1158/0008-5472.CAN-09-2067; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; Van Keymeulen A, 2011, NATURE, V479, P189, DOI 10.1038/nature10573; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Watkins G, 2004, ONCOL REP, V12, P483; Yu J, 2011, J BIOMED RES, V25, P170, DOI 10.1016/S1674-8301(11)60022-5; Zhu N, 2011, MOL CELL BIOCHEM, V351, P157, DOI 10.1007/s11010-011-0723-7; Zou C, 2012, CELL CYCLE, V11, P2137, DOI 10.4161/cc.20598	50	7	7	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2016	35	32					4165	4178		10.1038/onc.2015.475	http://dx.doi.org/10.1038/onc.2015.475			14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU3YY	26686086	Green Accepted			2022-12-26	WOS:000382149800002
J	Kushwaha, P; Khedgikar, V; Sharma, D; Yuen, T; Gautam, J; Ahmad, N; Karvande, A; Mishra, PR; Trivedi, PK; Sun, L; Bhadada, SK; Zaidi, M; Trivedi, R				Kushwaha, Priyanka; Khedgikar, Vikram; Sharma, Deepika; Yuen, Tony; Gautam, Jyoti; Ahmad, Naseer; Karvande, Anirudha; Mishra, Prabhat R.; Trivedi, Prabodh K.; Sun, Li; Bhadada, Sanjay K.; Zaidi, Mone; Trivedi, Ritu			MicroRNA 874-3p Exerts Skeletal Anabolic Effects Epigenetically during Weaning by Suppressing Hdac1 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						animal model; bone; bone morphogenetic protein (BMP); cell differentiation; drug discovery; gene silencing; histone deacetylase 1 (HDAC1); microRNA (miRNA); osteoblast; osteoporosis	CELL-PROLIFERATION; BONE-FORMATION; DIFFERENTIATION; LACTATION; OXYTOCIN	Embryonic skeletogenesis and postnatal bone development require the transfer of calcium from the mother to the offspring during pregnancy and lactation. Therefore, bone resorption in the mother becomes elevated during these periods, resulting in significant maternal skeletal loss. There follows an anabolic phase around weaning during which there is a remarkable recovery of the maternal skeleton. However, the mechanism(s) of this anabolic response remain(s) largely unknown. We identified eight differentially expressed miRNAs by array profiling, of which miR-874-3p was highly expressed at weaning, a time when bone loss was noted to recover. We report that this weaning-associated miRNA is an anabolic target. Therefore, an agomir of miR-874-3p induced osteoblast differentiation and mineralization. These actions were mediated through the inhibition of Hdac1 expression and enhanced Runx2 transcriptional activation. When injected in vivo, the agomir significantly increased osteoblastogenesis and mineralization, reversed bone loss caused by ovariectomy, and increased bone strength. We speculate that elevated miR-874-3p expression during weaning enhances bone formation and that this miRNA may become a therapeutic target for conditions of bone loss.	[Kushwaha, Priyanka; Khedgikar, Vikram; Gautam, Jyoti; Ahmad, Naseer; Karvande, Anirudha; Trivedi, Ritu] CSIR, Cent Drug Res Inst, Div Endocrinol, Lucknow 226031, Uttar Pradesh, India; [Kushwaha, Priyanka] CSIR, Cent Drug Res Inst, Acad Sci & Innovat Res, Lucknow 226031, Uttar Pradesh, India; [Mishra, Prabhat R.] CSIR, Cent Drug Res Inst, Div Pharmaceut, Lucknow 226031, Uttar Pradesh, India; [Sharma, Deepika] Natl Bot Res Inst, Council Sci & Ind Res, Lucknow 226001, Uttar Pradesh, India; [Yuen, Tony; Sun, Li; Zaidi, Mone] Mt Sinai Sch Med, Dept Med, Mt Sinai Bone Program, New York, NY 10029 USA; [Bhadada, Sanjay K.] Postgrad Inst Med Educ & Res, Dept Endocrinol & Metab, Chandigarh 160012, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - National Botanical Research Institute (NBRI); Icahn School of Medicine at Mount Sinai; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	Trivedi, R (corresponding author), CSIR, Cent Drug Res Inst, Div Endocrinol, Lucknow 226031, Uttar Pradesh, India.; Zaidi, M (corresponding author), Mt Sinai Sch Med, Dept Med, Mt Sinai Bone Program, New York, NY 10029 USA.	mone.zaidi@mountsinai.org; ritu_trivedi@cdri.res.in	Mishra, Prabhat Ranjan/C-3814-2009	Gautam, Jyoti/0000-0003-2961-9547	CSIR [BSC0201]; Department of Biotechnology [DBT-GAP0127]; National Institutes of Health [DK80459, AG40132, AR06592, AR06066]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR065932, R01AR067066] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080459] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG040132] Funding Source: NIH RePORTER	CSIR(Council of Scientific & Industrial Research (CSIR) - India); Department of Biotechnology; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by CSIR Grant BSC0201 and Department of Biotechnology Grant DBT-GAP0127 (to R. T.); National Institutes of Health Grants DK80459 (to M. Z. and L. S.), AG40132 (to M. Z.), AR06592 (to M. Z.), and AR06066 (to M. Z). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ardeshirpour L, 2007, ENDOCRINOLOGY, V148, P3875, DOI 10.1210/en.2006-1467; Bolzetta F, 2014, BONE, V68, P41, DOI 10.1016/j.bone.2014.08.001; Di Benedetto A, 2014, P NATL ACAD SCI USA, V111, P16502, DOI 10.1073/pnas.1419349111; Eguchi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058796; Eskildsen T, 2011, P NATL ACAD SCI USA, V108, P6139, DOI 10.1073/pnas.1016758108; Gamez B, 2013, J BIOL CHEM, V288, P14264, DOI 10.1074/jbc.M112.432104; Gautam J, 2014, BRIT J NUTR, V111, P1811, DOI 10.1017/S0007114514000051; Goettsch C, 2011, AM J PATHOL, V179, P1594, DOI 10.1016/j.ajpath.2011.06.016; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hassan MQ, 2010, P NATL ACAD SCI USA, V107, P19879, DOI 10.1073/pnas.1007698107; Hornstein E, 2005, NATURE, V438, P671, DOI 10.1038/nature04138; Hu R, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.176099; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Khedgikar V, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.294; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Kureel J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.4; Kushwaha P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.350; Lebel E, 2014, J OSTEOPOROS, V2014, DOI 10.1155/2014/897182; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Lian JB, 2012, NAT REV ENDOCRINOL, V8, P212, DOI 10.1038/nrendo.2011.234; Lin EA, 2009, J BIOL CHEM, V284, P11326, DOI 10.1074/jbc.M807709200; Liu XS, 2012, J BONE MINER RES, V27, P865, DOI 10.1002/jbmr.1503; Liu X, 2009, BIOCHEM BIOPH RES CO, V388, P161, DOI 10.1016/j.bbrc.2009.07.148; Mann M, 2010, P NATL ACAD SCI USA, V107, P15804, DOI 10.1073/pnas.0915022107; Miller SC, 1998, ANAT REC, V251, P265, DOI 10.1002/(SICI)1097-0185(199806)251:2<265::AID-AR16>3.0.CO;2-M; Mizoguchi F, 2010, J CELL BIOCHEM, V109, P866, DOI 10.1002/jcb.22228; Nohata N, 2013, BRIT J CANCER, V108, P1648, DOI 10.1038/bjc.2013.122; Sashidhara KV, 2013, J MED CHEM, V56, P109, DOI 10.1021/jm301281e; Sugatani T, 2011, BLOOD, V117, P3648, DOI 10.1182/blood-2010-10-311415; Sugatani T, 2009, J BIOL CHEM, V284, P4667, DOI 10.1074/jbc.M805777200; Tamma R, 2009, P NATL ACAD SCI USA, V106, P7149, DOI 10.1073/pnas.0901890106; Yang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021679; Zhang JF, 2011, MOL BIOL CELL, V22, P3955, DOI 10.1091/mbc.E11-04-0356; Zhang M, 2002, J BIOL CHEM, V277, P44005, DOI 10.1074/jbc.M208265200; Zhao X, 2014, J BONE MINER METAB, V32, P221, DOI 10.1007/s00774-013-0537-7	35	27	28	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3959	3966		10.1074/jbc.M115.687152	http://dx.doi.org/10.1074/jbc.M115.687152			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26663087	Green Published, hybrid			2022-12-26	WOS:000371338400023
J	Shakerley, NL; Chandrasekaran, A; Trebak, M; Miller, BA; Melendez, JA				Shakerley, Nicole L.; Chandrasekaran, Akshaya; Trebak, Mohamed; Miller, Barbara A.; Melendez, J. Andres			Francisella tularensis Catalase Restricts Immune Function by Impairing TRPM2 Channel Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antioxidant; bacterial pathogenesis; calcium channel; catalase; cellular immune response; hydrogen peroxide; infection; macrophage; Francisella	2-AMINOETHOXYDIPHENYL BORATE 2-APB; BLOOD MONONUCLEAR-CELLS; MELASTATIN 2 TRPM2; HYDROGEN-PEROXIDE; HUMAN MACROPHAGES; OXIDATIVE STRESS; CALCIUM-ENTRY; MYCOBACTERIUM-TUBERCULOSIS; LISTERIA-MONOCYTOGENES; PERITONEAL-MACROPHAGES	As an innate defense mechanism, macrophages produce reactive oxygen species that weaken pathogens and serve as secondary messengers involved in immune function. The Gram-negative bacterium Francisella tularensis utilizes its antioxidant armature to limit the host immune response, but the mechanism behind this suppression is not defined. Here we establish that F. tularensis limits Ca2+ entry in macrophages, thereby limiting actin reorganization and IL-6 production in a redox-dependent fashion. Wild type (live vaccine strain) or catalase-deficient F. tularensis (katG) show distinct profiles in their H2O2 scavenging rates, 1 and 0.015 pm/s, respectively. Murine alveolar macrophages infected with katG display abnormally high basal intracellular Ca2+ concentration that did not increase further in response to H2O2. Additionally, katG-infected macrophages displayed limited Ca2+ influx in response to ionomycin, as a result of ionophore H2O2 sensitivity. Exogenously added H2O2 or H2O2 generated by katG likely oxidizes ionomycin and alters its ability to transport Ca2+. Basal increases in cytosolic Ca2+ and insensitivity to H2O2-mediated Ca2+ entry in katG-infected cells are reversed by the Ca2+ channel inhibitors 2-aminoethyl diphenylborinate and SKF-96365. 2-Aminoethyl diphenylborinate but not SKF-96365 abrogated katG-dependent increases in macrophage actin remodeling and IL-6 secretion, suggesting a role for H2O2-mediated Ca2+ entry through the transient receptor potential melastatin 2 (TRPM2) channel in macrophages. Indeed, increases in basal Ca2+, actin polymerization, and IL-6 production are reversed in TRPM2-null macrophages infected with katG. Together, our findings provide compelling evidence that F. tularensis catalase restricts reactive oxygen species to temper macrophage TRPM2-mediated Ca2+ signaling and limit host immune function.	[Shakerley, Nicole L.; Chandrasekaran, Akshaya; Trebak, Mohamed; Melendez, J. Andres] SUNY Albany, Polytech Inst, Coll Nanoscale Sci, Albany, NY 12203 USA; [Trebak, Mohamed] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Miller, Barbara A.] Penn State Univ, Coll Med, Dept Pediat, Hershey, PA 17033 USA; [Miller, Barbara A.] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Melendez, JA (corresponding author), Coll Nanoscale Sci, 257 Fuller Rd, Albany, NY 12203 USA.; Melendez, JA (corresponding author), Coll Engn, 257 Fuller Rd, Albany, NY 12203 USA.	jmelendez@sunypoly.edu	Shakerley, Nicole L/C-1245-2015; Chandrasekaran, Akshaya/AAB-5252-2020	Shakerley, Nicole L/0000-0002-7880-3343; Chandrasekaran, Akshaya/0000-0003-0535-6623; Melendez, Juan/0000-0001-8021-3097	NIAID, National Institutes of Health [PO1AI056320]; National Institutes of Health [R01HL097111, R01HL123364]; American Heart Association [14GRNT18880008]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097111, R01HL123364] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI056320] Funding Source: NIH RePORTER	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by funded by NIAID, National Institutes of Health Grant PO1AI056320 (to J. A. M.). This study was also supported in part by National Institutes of Health Grants R01HL097111 and R01HL123364 and American Heart Association Grant 14GRNT18880008 (to M. T.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Khodor S, 2010, CELL MICROBIOL, V12, P1604, DOI 10.1111/j.1462-5822.2010.01494.x; Andersson H, 2006, J MED MICROBIOL, V55, P263, DOI 10.1099/jmm.0.46313-0; Asare R, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2010.00145; Asare R, 2010, ENVIRON MICROBIOL, V12, P2559, DOI 10.1111/j.1462-2920.2010.02229.x; Azenabor AA, 2009, IMMUNOBIOLOGY, V214, P143, DOI 10.1016/j.imbio.2008.06.001; Bosio CM, 2007, J IMMUNOL, V178, P4538, DOI 10.4049/jimmunol.178.7.4538; Bosio CM, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00009; Braun FJ, 2001, J BIOL CHEM, V276, P1063, DOI 10.1074/jbc.M008348200; Chen SJ, 2013, AM J PHYSIOL-CELL PH, V304, pC548, DOI 10.1152/ajpcell.00069.2012; Clemens DL, 2007, ANN NY ACAD SCI, V1105, P160, DOI 10.1196/annals.1409.001; Clemens DL, 2004, INFECT IMMUN, V72, P3204, DOI 10.1128/IAI.72.6.3204-3217.2004; Cremer TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008508; Cremer TJ, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00013; Day AM, 2012, MOL CELL, V45, P398, DOI 10.1016/j.molcel.2011.11.027; Di AK, 2012, NAT IMMUNOL, V13, P29, DOI 10.1038/ni.2171; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; Ernst RK, 1999, J INFECT DIS, V179, pS326, DOI 10.1086/513850; Evans JH, 2007, P NATL ACAD SCI USA, V104, P16176, DOI 10.1073/pnas.0707719104; Forestal CA, 2007, J INFECT DIS, V196, P134, DOI 10.1086/518611; Gao GF, 2014, J CLIN INVEST, V124, P4989, DOI 10.1172/JCI76042; Gees M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003962; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Jones CL, 2012, MICROBIOL MOL BIOL R, V76, P383, DOI 10.1128/MMBR.05027-11; Kashio M, 2012, P NATL ACAD SCI USA, V109, P6745, DOI 10.1073/pnas.1114193109; KIM E, 1992, INFECT IMMUN, V60, P1244, DOI 10.1128/IAI.60.3.1244-1248.1992; KNOWLES GC, 1992, J HISTOCHEM CYTOCHEM, V40, P1605, DOI 10.1177/40.10.1527379; Knowles H, 2013, IMMUNOL RES, V55, P241, DOI 10.1007/s12026-012-8373-8; Knowles H, 2011, P NATL ACAD SCI USA, V108, P11578, DOI 10.1073/pnas.1010678108; Kolisek M, 2005, MOL CELL, V18, P61, DOI 10.1016/j.molcel.2005.02.033; Lindgren H, 2007, INFECT IMMUN, V75, P1303, DOI 10.1128/IAI.01717-06; Lindgren H, 2011, INFECT IMMUN, V79, P1218, DOI 10.1128/IAI.01116-10; LIPP P, 1993, CELL CALCIUM, V14, P359, DOI 10.1016/0143-4160(93)90040-D; Lischke T, 2013, INFECT IMMUN, V81, P4091, DOI 10.1128/IAI.00340-13; Mahawar M, 2012, J BIOL CHEM, V287, P25216, DOI 10.1074/jbc.M112.367672; Malik ZA, 2000, J EXP MED, V191, P287, DOI 10.1084/jem.191.2.287; Maruyama T, 1997, J BIOCHEM-TOKYO, V122, P498; Massullo P, 2006, SEMIN CELL DEV BIOL, V17, P654, DOI 10.1016/j.semcdb.2006.11.006; Melillo AA, 2010, J BIOL CHEM, V285, P27553, DOI 10.1074/jbc.M110.144394; Melillo AA, 2009, J BACTERIOL, V191, P6447, DOI 10.1128/JB.00534-09; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Miller BA, 2006, J MEMBRANE BIOL, V209, P31, DOI 10.1007/s00232-005-0839-3; Miller BA, 2013, AM J PHYSIOL-HEART C, V304, pH1010, DOI 10.1152/ajpheart.00906.2012; Miller BA, 2011, ADV EXP MED BIOL, V704, P531, DOI 10.1007/978-94-007-0265-3_29; Mohapatra NP, 2010, J IMMUNOL, V184, P5141, DOI 10.4049/jimmunol.0903413; Motiani RK, 2013, FASEB J, V27, P63, DOI 10.1096/fj.12-213801; Nhieu GT, 2004, BIOL CELL, V96, P93, DOI 10.1016/j.biocel.2003.10.006; Nunes P, 2013, TRAFFIC, V14, P1118, DOI 10.1111/tra.12115; Nunes P, 2010, J LEUKOCYTE BIOL, V88, P57, DOI 10.1189/jlb.0110028; Oyston PCF, 2004, NAT REV MICROBIOL, V2, P967, DOI 10.1038/nrmicro1045; Oyston PCF, 2008, J MED MICROBIOL, V57, P921, DOI 10.1099/jmm.0.2008/000653-0; Paranavitana C, 2008, FEMS IMMUNOL MED MIC, V54, P92, DOI 10.1111/j.1574-695X.2008.00456.x; Parsa KVL, 2008, MOL IMMUNOL, V45, P3012, DOI 10.1016/j.molimm.2008.01.011; Parsonage D, 2008, P NATL ACAD SCI USA, V105, P8209, DOI 10.1073/pnas.0708308105; Pedersen SF, 2005, CELL CALCIUM, V38, P233, DOI 10.1016/j.ceca.2005.06.028; Peng KT, 2011, CELL MICROBIOL, V13, P1586, DOI 10.1111/j.1462-5822.2011.01643.x; Peppiatt CM, 2003, CELL CALCIUM, V34, P97, DOI 10.1016/S0143-4160(03)00026-5; Perraud AL, 2004, MOL IMMUNOL, V41, P657, DOI 10.1016/j.molimm.2004.04.013; Potier M, 2008, PFLUG ARCH EUR J PHY, V457, P405, DOI 10.1007/s00424-008-0533-2; RADDASSI K, 1994, CELL IMMUNOL, V153, P443, DOI 10.1006/cimm.1994.1041; Santic M, 2008, INFECT IMMUN, V76, P2671, DOI 10.1128/IAI.00185-08; Seaver LC, 2001, J BACTERIOL, V183, P7173, DOI 10.1128/JB.183.24.7173-7181.2001; Song MY, 2011, ANTIOXID REDOX SIGN, V15, P1549, DOI 10.1089/ars.2010.3648; Su JL, 2007, INFECT IMMUN, V75, P3089, DOI 10.1128/IAI.01865-06; Tano JY, 2011, BIOCHEM BIOPH RES CO, V407, P432, DOI 10.1016/j.bbrc.2011.03.048; Telepnev M, 2005, MICROB PATHOGENESIS, V38, P239, DOI 10.1016/j.micpath.2005.02.003; Telepnev M, 2003, CELL MICROBIOL, V5, P41, DOI 10.1046/j.1462-5822.2003.00251.x; Togashi K, 2008, BRIT J PHARMACOL, V153, P1324, DOI 10.1038/sj.bjp.0707675; Trebak M, 2002, J BIOL CHEM, V277, P21617, DOI 10.1074/jbc.M202549200; Trebak M, 2010, ANTIOXID REDOX SIGN, V12, P657, DOI 10.1089/ars.2009.2842; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691; Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220; Vonkavaara M, 2008, CELL MICROBIOL, V10, P1327, DOI 10.1111/j.1462-5822.2008.01129.x; Wilson JE, 2009, INFECT IMMUN, V77, P4953, DOI 10.1128/IAI.00844-09; Yang RL, 2014, PATHOG DIS, V70, P51, DOI 10.1111/2049-632X.12075; Ye YX, 2012, INT IMMUNOPHARMACOL, V12, P384, DOI 10.1016/j.intimp.2011.12.011; Zou J, 2013, AM J PHYSIOL-CELL PH, V305, pC61, DOI 10.1152/ajpcell.00390.2012	77	12	12	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3871	3881		10.1074/jbc.M115.706879	http://dx.doi.org/10.1074/jbc.M115.706879			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26679996	hybrid, Green Published			2022-12-26	WOS:000371338400016
J	Abd Alla, J; Graemer, M; Fu, XB; Quitterer, U				Abd Alla, Joshua; Graemer, Muriel; Fu, Xuebin; Quitterer, Ursula			Inhibition of G-protein-coupled Receptor Kinase 2 Prevents the Dysfunctional Cardiac Substrate Metabolism in Fatty Acid Synthase Transgenic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNCOUPLING PROTEIN-2; PPAR-GAMMA; LIPID-METABOLISM; GENE-EXPRESSION; HEART-FAILURE; ADIPONECTIN; ALPHA; PHOSPHORYLATION; DIFFERENTIATION; IDENTIFICATION	Impairment of myocardial fatty acid substrate metabolism is characteristic of late-stage heart failure and has limited treatment options. Here, we investigated whether inhibition of G-protein-coupled receptor kinase 2 (GRK2) could counteract the disturbed substrate metabolism of late-stage heart failure. The heart failure-like substrate metabolism was reproduced in a novel transgenic model of myocardium-specific expression of fatty acid synthase (FASN), the major palmitate-synthesizing enzyme. The increased fatty acid utilization of FASN transgenic neonatal cardiomyocytes rapidly switched to a heart failure phenotype in an adult-like lipogenic milieu. Similarly, adult FASN transgenic mice developed signs of heart failure. The development of disturbed substrate utilization of FASN transgenic cardiomyocytes and signs of heart failure were retarded by the transgenic expression of GRKInh, a peptide inhibitor of GRK2. Cardioprotective GRK2 inhibition required an intact ERK axis, which blunted the induction of cardiotoxic transcripts, in part by enhanced serine 273 phosphorylation of Pparg (peroxisome proliferator-activated receptor gamma). Conversely, the dual-specific GRK2 and ERK cascade inhibitor, RKIP (Raf kinase inhibitor protein), triggered dysfunctional cardiomyocyte energetics and the expression of heart failure-promoting Pparg-regulated genes. Thus, GRK2 inhibition is a novel approach that targets the dysfunctional substrate metabolism of the failing heart.	[Abd Alla, Joshua; Graemer, Muriel; Fu, Xuebin; Quitterer, Ursula] ETH, Mol Pharmacol Unit, Swiss Fed Inst Technol, Dept Chem & Appl Biosci, CH-8057 Zurich, Switzerland; [Fu, Xuebin] Univ Bern, Dept Clin Res, CH-3010 Bern, Switzerland; [Quitterer, Ursula] Univ Zurich, Inst Pharmacol & Toxicol, Dept Med, CH-8057 Zurich, Switzerland	ETH Zurich; University of Bern; University of Zurich	Quitterer, U (corresponding author), ETH, Mol Pharmacol Unit, Winterthurerstr 190, CH-8057 Zurich, Switzerland.	ursula.quitterer@pharma.ethz.ch	Fu, Xuebin/B-6591-2018; Fu, Xuebin/AAH-9622-2019	Fu, Xuebin/0000-0002-7232-3576; Fu, Xuebin/0000-0002-1281-2466	Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung Grant [31-140679]	Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung Grant	This work was supported in part by Schweizerischer Nationalfonds zur Forderung der Wissenschaftlichen Forschung Grant 31-140679 (to U. Q.). The authors declare that they have no conflicts of interest with the contents of this article.	Abd Alla J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00148; Abd Alla J, 2010, INTEGR BIOL-UK, V2, P209, DOI 10.1039/b922592g; AbdAlla Said, 2011, Cardiovascular & Hematological Agents in Medicinal Chemistry, V9, P190; AbdAlla S, 2009, J BIOL CHEM, V284, P6554, DOI 10.1074/jbc.M807746200; Banks AS, 2015, NATURE, V517, P391, DOI 10.1038/nature13887; Berthiaume JM, 2010, AM J PHYSIOL-HEART C, V299, pH410, DOI 10.1152/ajpheart.00270.2010; Biagi PL, 1999, MECH AGEING DEV, V107, P181, DOI 10.1016/S0047-6374(98)00148-1; BISHOP SP, 1970, AM J PHYSIOL, V218, P153, DOI 10.1152/ajplegacy.1970.218.1.153; Bodyak N, 2007, AM J PHYSIOL-HEART C, V293, pH829, DOI 10.1152/ajpheart.01409.2006; Brinks Henriette, 2010, Drug Discov Today Dis Mech, V7, pe129, DOI 10.1016/j.ddmec.2010.07.007; Bui AL, 2011, NAT REV CARDIOL, V8, P30, DOI 10.1038/nrcardio.2010.165; Chatham JC, 2012, CIRC RES, V111, P666, DOI 10.1161/CIRCRESAHA.112.277392; Chemaly ER, 2011, J MOL CELL CARDIOL, V51, P144, DOI 10.1016/j.yjmcc.2011.04.006; Chirala SS, 2003, P NATL ACAD SCI USA, V100, P6358, DOI 10.1073/pnas.0931394100; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Chou IP, 2014, EUR J NUTR, V53, P907, DOI 10.1007/s00394-013-0594-7; Dadson K, 2015, J MOL CELL CARDIOL, V86, P102, DOI 10.1016/j.yjmcc.2015.06.020; Dy GK, 2013, CA-CANCER J CLIN, V63, P249, DOI 10.3322/caac.21184; Frankel DS, 2009, J AM COLL CARDIOL, V53, P754, DOI 10.1016/j.jacc.2008.07.073; Fu XB, 2013, J BIOL CHEM, V288, P7738, DOI 10.1074/jbc.M112.428078; George J, 2006, HEART, V92, P1420, DOI 10.1136/hrt.2005.083345; Graham DJ, 2010, JAMA-J AM MED ASSOC, V304, P411, DOI 10.1001/jama.2010.920; Hamza MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004907; Hansmann G, 2007, CIRCULATION, V115, P1275, DOI 10.1161/CIRCULATIONAHA.106.663120; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Joseph JW, 2004, J BIOL CHEM, V279, P51049, DOI 10.1074/jbc.M409189200; Kim C, 2013, NATURE, V494, P105, DOI 10.1038/nature11799; Kim JE, 2008, BONE, V43, P394, DOI 10.1016/j.bone.2008.03.021; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Knobloch M, 2013, NATURE, V493, P226, DOI 10.1038/nature11689; Kujiraoka T, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000361; Lahey R, 2014, CIRCULATION, V130, P1790, DOI 10.1161/CIRCULATIONAHA.114.011687; Lee HJ, 2015, STEM CELLS, V33, P2182, DOI 10.1002/stem.2020; Li N, 2010, J CARDIOVASC PHARM, V55, P161, DOI 10.1097/01.fjc.0000365898.92719.f0; Lips DJ, 2004, CIRCULATION, V109, P1938, DOI 10.1161/01.CIR.0000127126.73759.23; Liu C, 2015, SCI REP-UK, V5, DOI 10.1038/srep09530; Liu L, 2014, J BIOL CHEM, V289, P29881, DOI 10.1074/jbc.M114.601864; Liu QH, 2011, J MOL CELL CARDIOL, V51, P474, DOI 10.1016/j.yjmcc.2010.10.004; Lopaschuk GD, 2010, J CARDIOVASC PHARM, V56, P130, DOI 10.1097/FJC.0b013e3181e74a14; Lorenz K, 2003, NATURE, V426, P574, DOI 10.1038/nature02158; Lucas E, 2014, BBA-MOL BASIS DIS, V1842, P2448, DOI 10.1016/j.bbadis.2014.09.004; Marfella R, 2009, J LIPID RES, V50, P2314, DOI 10.1194/jlr.P900032-JLR200; Mochly-Rosen D, 2012, NAT REV DRUG DISCOV, V11, P937, DOI 10.1038/nrd3871; Murholm M, 2010, BBA-GEN SUBJECTS, V1800, P619, DOI 10.1016/j.bbagen.2010.03.008; Nakou ES, 2013, INT J CARDIOL, V170, P96, DOI 10.1016/j.ijcard.2013.10.038; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; O'Shea KM, 2010, AM J PHYSIOL-HEART C, V298, pH1639, DOI 10.1152/ajpheart.00957.2009; Park TS, 2012, HEART FAIL CLIN, V8, P633, DOI 10.1016/j.hfc.2012.06.003; Piguet AC, 2010, CLIN SCI, V118, P401, DOI 10.1042/CS20090313; Quitterer U, 2011, BIOCHEM BIOPH RES CO, V409, P544, DOI 10.1016/j.bbrc.2011.05.041; Razani B, 2011, J BIOL CHEM, V286, P30949, DOI 10.1074/jbc.M111.230508; Son NH, 2010, J CLIN INVEST, V120, P3443, DOI 10.1172/JCI40905; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Taegtmeyer H, 2011, J MOL CELL CARDIOL, V50, P2, DOI 10.1016/j.yjmcc.2010.09.014; UNGERER M, 1993, CIRCULATION, V87, P454, DOI 10.1161/01.CIR.87.2.454; Wang YJ, 2015, CIRCULATION, V131, P1392, DOI 10.1161/CIRCULATIONAHA.114.015248; WITTELS B, 1968, J CLIN INVEST, V47, P1787, DOI 10.1172/JCI105868; Woodall MC, 2014, CIRC RES, V114, P1661, DOI 10.1161/CIRCRESAHA.114.300513; Zheng HY, 2012, P NATL ACAD SCI USA, V109, P7055, DOI 10.1073/pnas.1118359109	59	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2583	2600		10.1074/jbc.M115.702688	http://dx.doi.org/10.1074/jbc.M115.702688			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26670611	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000369626900005
J	Romani, B; Baygloo, NS; Hamidi-Fard, M; Aghasadeghi, MR; Allahbakhshi, E				Romani, Bizhan; Baygloo, Nima Shaykh; Hamidi-Fard, Mojtaba; Aghasadeghi, Mohammad Reza; Allahbakhshi, Elham			HIV-1 Vpr Protein Induces Proteasomal Degradation of Chromatin-associated Class I HDACs to Overcome Latent Infection of Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; E3 UBIQUITIN LIGASE; HISTONE DEACETYLASES; REPLICATION; TRANSCRIPTION; INHIBITION; ACTIVATION; PROMOTER; MODULATE; TARGETS	Mechanisms underlying HIV-1 latency remain among the most crucial questions that need to be answered to adopt strategies for purging the latent viral reservoirs. Here we show that HIV-1 accessory protein Vpr induces depletion of class I HDACs, including HDAC1, 2, 3, and 8, to overcome latency in macrophages. We found that Vpr binds and depletes chromatin-associated class I HDACs through a VprBP-dependent mechanism, with HDAC3 as the most affected class I HDAC. De novo expression of Vpr in infected macrophages induced depletion of HDAC1 and 3 on the HIV-1 LTR that was associated with hyperacetylation of histones on the HIV-1 LTR. As a result of hyperacetylation of histones on HIV-1 promotor, the virus established an active promotor and this contributed to the acute infection of macrophages. Collectively, HIV-1 Vpr down-regulates class I HDACs on chromatin to counteract latent infections of macrophages.	[Romani, Bizhan; Baygloo, Nima Shaykh] Univ Isfahan, Dept Biol, Fac Sci, Esfahan 8174673441, Iran; [Romani, Bizhan; Allahbakhshi, Elham] Ahvaz Jundishapur Univ Med Sci, Fac Med, Cellular & Mol Res Ctr, Ahvaz 6135715794, Iran; [Hamidi-Fard, Mojtaba; Aghasadeghi, Mohammad Reza] Pasteur Inst Iran, Hepatitis & AIDS Dept, Tehran 1316943551, Iran	University of Isfahan; Ahvaz Jundishapur University of Medical Sciences (AJUMS); Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran	Allahbakhshi, E (corresponding author), Ahvaz Jundishapur Univ Med Sci, Fac Med, Cellular & Mol Res Ctr, Ahvaz 6135715794, Iran.; Aghasadeghi, MR (corresponding author), Pasteur Inst Iran, Hepatitis & AIDS Dept, Tehran 1316943551, Iran.	mrasadeghi@pasteur.ac.ir; abakhshi_e@ajums.ac.ir	/J-9114-2017; aghasadeghi, mohammad reza/K-9497-2017	/0000-0003-3399-3590; aghasadeghi, mohammad reza/0000-0003-2186-0774	Ahvaz Jundishapur University of Medical Sciences	Ahvaz Jundishapur University of Medical Sciences	This work was supported by research grants from Ahvaz Jundishapur University of Medical Sciences. The authors declare that they have no conflicts of interest with the contents of this article.	Ahn J, 2010, J BIOL CHEM, V285, P37333, DOI 10.1074/jbc.M110.133181; Archin NM, 2012, NATURE, V487, P482, DOI 10.1038/nature11286; Barton KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102684; Belzile JP, 2010, J VIROL, V84, P3320, DOI 10.1128/JVI.02590-09; Chen RX, 2004, J BIOL CHEM, V279, P28419, DOI 10.1074/jbc.M403875200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Delcuve GP, 2012, CLIN EPIGENETICS, V4, DOI 10.1186/1868-7083-4-5; Edelstein LC, 2009, AIDS RES HUM RETROV, V25, P883, DOI 10.1089/aid.2008.0294; Gallinari P, 2007, CELL RES, V17, P195, DOI 10.1038/sj.cr.7310149; Hoshino S, 2010, J LEUKOCYTE BIOL, V87, P1133, DOI 10.1189/jlb.0809547; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Iijima K, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-83; Jones RB, 2013, J VIROL, V87, P13307, DOI 10.1128/JVI.02257-13; Kaur M, 2012, NUCLEIC ACIDS RES, V40, P7332, DOI 10.1093/nar/gks366; Kim K, 2012, MOL CELL BIOL, V32, P783, DOI 10.1128/MCB.06037-11; Klockow LC, 2013, VIROLOGY, V444, P191, DOI 10.1016/j.virol.2013.06.010; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lai MY, 2005, J VIROL, V79, P15443, DOI 10.1128/JVI.79.24.15443-15451.2005; Lehrman G, 2005, LANCET, V366, P549, DOI 10.1016/S0140-6736(05)67098-5; LEVY DN, 1995, J VIROL, V69, P1243, DOI 10.1128/JVI.69.2.1243-1252.1995; LEVY DN, 1994, P NATL ACAD SCI USA, V91, P10873, DOI 10.1073/pnas.91.23.10873; Lezin A, 2007, BLOOD, V110, P3722, DOI 10.1182/blood-2007-04-085076; Liu BD, 2005, J VIROL, V79, P9579, DOI 10.1128/JVI.79.15.9579-9587.2005; Mangasarian A, 1999, J VIROL, V73, P1964, DOI 10.1128/JVI.73.3.1964-1973.1999; Pickering S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003895; Romani B, 2015, J BIOL CHEM, V290, P17380, DOI 10.1074/jbc.M115.641522; Romani B, 2009, J GEN VIROL, V90, P1795, DOI 10.1099/vir.0.011726-0; Ropero S, 2007, MOL ONCOL, V1, P19, DOI 10.1016/j.molonc.2007.01.001; Sorin M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000463; Tan L, 2007, J VIROL, V81, P10822, DOI 10.1128/JVI.01380-07; VanLint C, 1996, EMBO J, V15, P1112, DOI 10.1002/j.1460-2075.1996.tb00449.x; VERDIN E, 1993, EMBO J, V12, P3249, DOI 10.1002/j.1460-2075.1993.tb05994.x; Wang X, 2013, J BIOL CHEM, V288, P15474, DOI 10.1074/jbc.M112.416735; Wang ZB, 2009, CELL, V138, P1019, DOI 10.1016/j.cell.2009.06.049; Wen XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030939; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Ylisastigui L, 2004, AIDS, V18, P1101, DOI 10.1097/00002030-200405210-00003	39	27	29	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2696	2711		10.1074/jbc.M115.689018	http://dx.doi.org/10.1074/jbc.M115.689018			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26679995	hybrid, Green Published			2022-12-26	WOS:000369626900013
J	Leon, LAA; de Almeida, AJ; de Paula, VS; Tourinho, RS; Villela, DAM; Gaspar, AMC; Lewis-Ximenez, LL; Pinto, MA				Amado Leon, Luciane Almeida; de Almeida, Adilson Jose; de Paula, Vanessa Salete; Tourinho, Renata Santos; Maciel Villela, Daniel Antunes; Coimbra Gaspar, Ana Maria; Lewis-Ximenez, Lia Laura; Pinto, Marcelo Alves			Longitudinal Study of Hepatitis A Infection by Saliva Sampling: The Kinetics of HAV Markers in Saliva Revealed the Application of Saliva Tests for Hepatitis A Study	PLOS ONE			English	Article							TIME RT-PCR; ORAL FLUID; RAPID TEST; VIRUS; VIREMIA; QUANTIFICATION; ANTIBODIES; DURATION; BLOOD; SERUM	Despite the increasing numbers of studies investigating hepatitis A diagnostic through saliva, the frequency and the pattern of hepatitis A virus (HAV) markers in this fluid still remains unknown. To address this issue, we carried on a longitudinal study to examine the kinetics of HAV markers in saliva, in comparison with serum samples. The present study followed-up ten patients with acute hepatitis A infection during 180 days post diagnosis (dpd). Total anti-HAV was detected in paired serum and saliva samples until the end of the follow-up, showing a peak titer at 90th. However, total anti-HAV level was higher in serum than in saliva samples. This HAV marker showed a probability of 100% to be detected in both serum and saliva during 180 dpd. The IgM anti-HAV could be detected in saliva up to 150 dpd, showing the highest frequency at 30th, when it was detected in all individuals. During the first month of HAV infection, this acute HAV marker showed a detection probability of 100% in paired samples. The detection of IgM anti-HAV in saliva was not dependent on its level in serum, HAV-RNA detection and/or viral load, since no association was found between IgM anti-HAV positivity in saliva and any of these parameter (p > 0.05). Most of the patients (80%) were found to contain HAV-RNA in saliva, mainly at early acute phase (30th day). However, it was possible to demonstrate the HAV RNA presence in paired samples for more than 90 days, even after seroconversion. No significant relationship was observed between salivary HAV-RNA positivity and serum viral load, demonstrating that serum viral load is not predictive of HAV-RNA detection in saliva. Similar viral load was seen in paired samples (on average 104 copies/mL). These data demonstrate that the best diagnostic coverage can be achieved by salivary anti-HAV antibodies and HAV-RNA tests during 30-90 dpd. The long detection and high probability of specific-HAV antibodies positivity in saliva samples make the assessment of salivary antibodies a useful tool for diagnosis and epidemiological studies. The high frequency of HAV-RNA in saliva and the probability of detection of about 50%, during the first 30 dpd, demonstrate that saliva is also useful for molecular investigation of hepatitis A cases, mainly during the early course of infection. Therefore, the collection of saliva may provide a simple, cheap and non-invasive means of diagnosis, epidemiological surveys and monitoring of hepatitis A infection purposes.	[Amado Leon, Luciane Almeida; de Paula, Vanessa Salete; Tourinho, Renata Santos; Coimbra Gaspar, Ana Maria; Pinto, Marcelo Alves] Oswaldo Cruz Inst Fdn, Lab Technol Dev Virol, Rio De Janeiro, RJ, Brazil; [de Almeida, Adilson Jose; Lewis-Ximenez, Lia Laura] Oswaldo Cruz Inst Fdn, Lab Viral Hepatitis, Rio De Janeiro, RJ, Brazil; [Maciel Villela, Daniel Antunes] Oswaldo Cruz Inst Fdn, Sci Comp Program Dept, PROCC, Rio De Janeiro, RJ, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz	Leon, LAA (corresponding author), Oswaldo Cruz Inst Fdn, Lab Technol Dev Virol, Rio De Janeiro, RJ, Brazil.	l_amado@ioc.fiocruz	Amado, Luciane/AAI-9442-2021; de Paula, Vanessa S/I-8037-2016; Villela, Daniel/AAG-6445-2019; Pinto, Marcelo/G-7503-2012; Pinto, Marcelo Alves/ABA-3312-2020	de Paula, Vanessa S/0000-0002-6314-754X; Villela, Daniel/0000-0001-8371-2959; Pinto, Marcelo/0000-0003-3462-7277; Lewis-Ximenez, Lia Laura/0000-0002-3447-4621	Fundacao de Amparo a pesquisa do Estado do Rio de Janeiro [E-26/112.097/2013]	Fundacao de Amparo a pesquisa do Estado do Rio de Janeiro(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	Support was provided by the Fundacao de Amparo a pesquisa do Estado do Rio de Janeiro [www.faperj.br], grant number: E-26/112.097/2013 to author: LAAL.	Ahmed M, 2011, INDIAN J MED MICROBI, V29, P72, DOI 10.4103/0255-0857.76532; Amado LA, 2006, MEM I OSWALDO CRUZ, V101, P149, DOI 10.1590/S0074-02762006000200006; Amado LA, 2010, INT J EXP PATHOL, V91, P87, DOI 10.1111/j.1365-2613.2009.00699.x; Arnado LA, 2008, J VIROL METHODS, V148, P74, DOI 10.1016/j.jviromet.2007.10.020; Belza MJ, 2012, SEX TRANSM INFECT, V88, P218, DOI 10.1136/sextrans-2011-050131; Bower WA, 2000, J INFECT DIS, V182, P12, DOI 10.1086/315701; BRANDTZAEG P, 1970, SCAND J HAEMAT     S, V12, P1; Costa-Mattioli M, 2002, J VIRAL HEPATITIS, V9, P101, DOI 10.1046/j.1365-2893.2002.00336.x; Cruz HM, 2011, J CLIN LAB ANAL, V25, P134, DOI 10.1002/jcla.20447; Ximenes RAD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094622; De Paula VS, 2007, WATER RES, V41, P1169, DOI 10.1016/j.watres.2006.11.029; Donnell-Fink LA, 2012, JAIDS-J ACQ IMM DEF, V61, P588, DOI [10.1097/QAI.0b013e31826a6d67., 10.1097/QAI.0b013e31826a6d67]; Drobnik A, 2011, AM J PUBLIC HEALTH, V101, P2151, DOI 10.2105/AJPH.2011.300251; FitzSimons David, 2010, Vaccine, V28, P583, DOI 10.1016/j.vaccine.2009.10.136; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hussain Z, 2006, WORLD J GASTROENTERO, V12, P4683, DOI 10.3748/wjg.v12.i29.4683; Joshi MS, 2014, DIAGN MICR INFEC DIS, V78, P379, DOI 10.1016/j.diagmicrobio.2013.12.013; Kwon OS, 2000, J GASTROEN HEPATOL, V15, P1043, DOI 10.1046/j.1440-1746.2000.02291.x; Lackner A, 2010, J MED VIROL, V82, P1582, DOI 10.1002/jmv.21849; Lima LR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102925; Menezes GBL, 2012, MEM I OSWALDO CRUZ, V107, P680, DOI 10.1590/S0074-02762012000500016; Mackiewicz V, 2004, J CLIN MICROBIOL, V42, P4329, DOI 10.1128/JCM.42.9.4329-4331.2004; Matheson K, 2010, VACCINE, V28, P8105, DOI 10.1016/j.vaccine.2010.09.107; Morris-Cunnington MC, 2004, AM J EPIDEMIOL, V159, P786, DOI 10.1093/aje/kwh107; Mortimer P P, 1994, Clin Diagn Virol, V2, P231, DOI 10.1016/0928-0197(94)90048-5; Normann A, 2004, J MED VIROL, V72, P10, DOI 10.1002/jmv.10532; Oba Isabel Takano, 2000, Revista do Instituto de Medicina Tropical de Sao Paulo, V42, P197, DOI 10.1590/S0036-46652000000400004; Ochnio JJ, 1997, J CLIN MICROBIOL, V35, P98, DOI 10.1128/JCM.35.1.98-101.1997; PARRY JV, 1989, J MED VIROL, V28, P255, DOI 10.1002/jmv.1890280410; Poovorawan Y, 2005, J CLIN VIROL, V32, P24, DOI 10.1016/j.jcv.2004.04.008; R Core Team, 2013, R LANG ENV STAT COMP; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Tourinho RS, 2012, VACCINE, V30, P6421, DOI 10.1016/j.vaccine.2012.08.015; Tourinho RS, 2011, J VIROL METHODS, V173, P169, DOI 10.1016/j.jviromet.2011.01.014; Vitral CL, 2012, MEM I OSWALDO CRUZ, V107, P652, DOI 10.1590/S0074-02762012000500012; Wood S, 2013, GAMMA4 GEN ADDITIVE; [No title captured]	37	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145454	10.1371/journal.pone.0145454	http://dx.doi.org/10.1371/journal.pone.0145454			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690904	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092300077
J	Arthur, GK; Duffy, SM; Roach, KM; Hirst, RA; Shikotra, A; Gaillard, EA; Bradding, P				Arthur, Greer K.; Duffy, S. Mark; Roach, Katy M.; Hirst, Rob A.; Shikotra, Aarti; Gaillard, Erol A.; Bradding, Peter			K(Ca)3.1 K+ Channel Expression and Function in Human Bronchial Epithelial Cells	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; CHLORIDE SECRETION; MAST-CELLS; IN-VITRO; AIRWAY; ASTHMA; FIBROSIS; ACTIVATION; MIGRATION; GROWTH	The K(Ca)3.1 K+ channel has been proposed as a novel target for pulmonary diseases such as asthma and pulmonary fibrosis. It is expressed in epithelia but its expression and function in primary human bronchial epithelial cells (HBECs) has not been described. Due to its proposed roles in the regulation of cell proliferation, migration, and epithelial fluid secretion, inhibiting this channel might have either beneficial or adverse effects on HBEC function. The aim of this study was to assess whether primary HBECs express the K(Ca)3.1 channel and its role in HBEC function. Primary HBECs from the airways of healthy and asthmatic subjects, SV-transformed BEAS-2B cells and the neoplastic H292 epithelial cell line were studied. Primary HBECs, BEAS-2B and H292 cells expressed K(Ca)3.1 mRNA and protein, and robust K(Ca)3.1 ion currents. K(Ca)3.1 protein expression was increased in asthmatic compared to healthy airway epithelium in situ, and K(Ca)3.1 currents were larger in asthmatic compared to healthy HBECs cultured in vitro. Selective K(Ca)3.1 blockers (TRAM-34, ICA-17043) had no effect on epithelial cell proliferation, wound closure, ciliary beat frequency, or mucus secretion. However, several features of TGF beta 1-dependent epithelial-mesenchymal transition (EMT) were inhibited by K(Ca)3.1 blockade. Treatment with K(Ca)3.1 blockers is likely to be safe with respect to airway epithelial biology, and may potentially inhibit airway remodelling through the inhibition of EMT.	[Arthur, Greer K.; Duffy, S. Mark; Roach, Katy M.; Hirst, Rob A.; Shikotra, Aarti; Gaillard, Erol A.; Bradding, Peter] Univ Leicester, Dept Infect Immun & Inflammat, Inst Lung Hlth, Leicester, Leics, England	University of Leicester	Arthur, GK (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, Inst Lung Hlth, Leicester, Leics, England.	gka12@le.ac.uk	Hirst, Robert/AAD-1649-2022	Roach, Katy M/0000-0002-4825-8719; Gaillard, Erol/0000-0003-0996-8133; Arthur, Greer/0000-0002-4849-4076; Bradding, Peter/0000-0001-8403-0319	Medical Research Council; Dunhill Medical Trust [R270/1112]; National Institute for Health Research Leicester Respiratory Biomedical Research Unit; The Dunhill Medical Trust [R270/1112] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Dunhill Medical Trust(Dunhill Medical Trust); National Institute for Health Research Leicester Respiratory Biomedical Research Unit; The Dunhill Medical Trust(Dunhill Medical Trust)	This work was supported in part by a Medical Research Council PhD studentship for GKA, a project grant from The Dunhill Medical Trust (project grant R270/1112), and was also supported in part by the National Institute for Health Research Leicester Respiratory Biomedical Research Unit. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albaqumi M, 2008, KIDNEY INT, V74, P740, DOI 10.1038/ki.2008.246; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Avasarala S, 2015, J BIOL CHEM; British Thoracic Society Scottish Intercollegiate Guidelines Network, 2008, Thorax, V63 Suppl 4, piv1, DOI 10.1136/thx.2008.097741; BRADDING P, 1992, J EXP MED, V176, P1381, DOI 10.1084/jem.176.5.1381; Bradding P, 2009, BRIT J PHARMACOL, V157, P1330, DOI 10.1111/j.1476-5381.2009.00362.x; Brooks SA, 2000, HISTOL HISTOPATHOL, V15, P143, DOI 10.14670/HH-15.143; Cruse G, 2006, THORAX, V61, P880, DOI 10.1136/thx.2006.060319; Cruse G, 2011, J ALLERGY CLIN IMMUN, V128, P1303, DOI 10.1016/j.jaci.2011.07.047; Devor DC, 1999, J GEN PHYSIOL, V113, P743, DOI 10.1085/jgp.113.5.743; Duffy SM, 2005, FASEB J, V19, P1006, DOI 10.1096/fj.04-3439fje; Duffy SM, 2004, J ALLERGY CLIN IMMUN, V114, P66, DOI 10.1016/j.jaci.2004.04.005; Duffy SM, 2003, J ALLERGY CLIN IMMUN, V112, P965, DOI 10.1016/j.jaci.2003.07.004; Duffy SM, 2001, J IMMUNOL, V167, P4261, DOI 10.4049/jimmunol.167.8.4261; Enomoto Y, 2009, J ALLERGY CLIN IMMUN, V124, P913, DOI 10.1016/j.jaci.2009.08.044; Fischer KD, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0146-6; Girodet PO, 2013, AM J RESP CELL MOL, V48, P212, DOI 10.1165/rcmb.2012-0103OC; Gras D, 2012, J ALLERGY CLIN IMMUN, V129, P1259, DOI 10.1016/j.jaci.2012.01.073; Green RH, 2002, LANCET, V360, P1715, DOI 10.1016/S0140-6736(02)11679-5; Grgic I, 2009, P NATL ACAD SCI USA, V106, P14518, DOI 10.1073/pnas.0903458106; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Harron SA, 2009, CAN J PHYSIOL PHARM, V87, P337, DOI [10.1139/Y09-009, 10.1139/y09-009]; Hewson CA, 2004, J MOL BIOL, V344, P683, DOI 10.1016/j.jmb.2004.09.059; Hirst RA, 2010, CHEST, V138, P1441, DOI 10.1378/chest.10-0175; Holgate ST, 1998, CLIN EXP ALLERGY, V28, P97; Holgate ST, 1999, CLIN EXP ALLERGY, V29, P90, DOI 10.1046/j.1365-2222.1999.00016.x; Holgate Stephen T, 2009, Proc Am Thorac Soc, V6, P655, DOI 10.1513/pats.200907-072DP; Hollins F, 2008, J IMMUNOL, V181, P2772, DOI 10.4049/jimmunol.181.4.2772; Jensen BS, 1999, P NATL ACAD SCI USA, V96, P10917, DOI 10.1073/pnas.96.19.10917; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Klein H, 2009, AM J PHYSIOL-CELL PH, V296, pC285, DOI 10.1152/ajpcell.00418.2008; Latella G, 1996, INT J COLORECTAL DIS, V11, P76; Nowrin K, 2014, EXPERT REV RESP MED, V8, P547, DOI 10.1586/17476348.2014.948853; Ohya S, 2011, J BIOL CHEM, V286, P16940, DOI 10.1074/jbc.M110.184192; Okumura S, 2005, J ALLERGY CLIN IMMUN, V115, P272, DOI 10.1016/j.jaci.2004.10.004; Pedersen KA, 1999, BBA-BIOMEMBRANES, V1420, P231, DOI 10.1016/S0005-2736(99)00110-8; Roach KM, 2015, FIBROGENESIS TISSUE, V8, DOI 10.1186/s13069-015-0022-0; Roach KM, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0155-5; Roach KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085244; ROCHE WR, 1989, LANCET, V1, P520; Schilling T, 2004, EUR J NEUROSCI, V19, P1469, DOI 10.1111/j.1460-9568.2004.03265.x; Schilling T, 2009, PFLUG ARCH EUR J PHY, V459, P71, DOI 10.1007/s00424-009-0710-y; Schwab A, 1999, PFLUG ARCH EUR J PHY, V438, P330, DOI 10.1007/s004240050917; SCHWAB A, 1995, PFLUG ARCH EUR J PHY, V430, P802, DOI 10.1007/BF00386179; Schwab A, 1999, CELL PHYSIOL BIOCHEM, V9, P126, DOI 10.1159/000016309; Shepherd MC, 2007, AM J RESP CELL MOL, V37, P525, DOI 10.1165/rcmb.2006-0358OC; Shikotra A, 2012, J ALLERGY CLIN IMMUN, V129, P104, DOI 10.1016/j.jaci.2011.08.031; Shumilina E, 2008, J IMMUNOL, V180, P8040, DOI 10.4049/jimmunol.180.12.8040; Singh AK, 2000, J PHARMACOL EXP THER, V292, P778; Sohal Sukhwinder S, 2011, Respir Res, V12, P130, DOI 10.1186/1465-9921-12-130; Sohal SS, 2010, RESPIROLOGY, V15, P930, DOI 10.1111/j.1440-1843.2010.01808.x; Stewart CE, 2012, THORAX, V67, P477, DOI 10.1136/thoraxjnl-2011-200508; Stocker JW, 2003, BLOOD, V101, P2412, DOI 10.1182/blood-2002-05-1433; Su LT, 2006, J BIOL CHEM, V281, P11260, DOI 10.1074/jbc.M512885200; Tharp DL, 2006, AM J PHYSIOL-HEART C, V291, pH2493, DOI 10.1152/ajpheart.01254.2005; Thomas B, 2009, EUR RESPIR J, V34, P401, DOI 10.1183/09031936.00153308; Trinh NTN, 2008, AM J PHYSIOL-LUNG C, V295, pL866, DOI 10.1152/ajplung.90224.2008; Van Der Velden J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066886; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Willis Brigham C, 2006, Proc Am Thorac Soc, V3, P377, DOI 10.1513/pats.200601-004TK; Wulff H, 2000, P NATL ACAD SCI USA, V97, P8151, DOI 10.1073/pnas.97.14.8151	62	13	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145259	10.1371/journal.pone.0145259	http://dx.doi.org/10.1371/journal.pone.0145259			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689552	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092300049
J	Avau, B; Bauters, D; Steensels, S; Vancleef, L; Laermans, J; Lesuisse, J; Buyse, J; Lijnen, HR; Tack, J; Depoortere, I				Avau, Bert; Bauters, Dries; Steensels, Sandra; Vancleef, Laurien; Laermans, Jorien; Lesuisse, Jens; Buyse, Johan; Lijnen, H. Roger; Tack, Jan; Depoortere, Inge			The Gustatory Signaling Pathway and Bitter Taste Receptors Affect the Development of Obesity and Adipocyte Metabolism in Mice	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; NORMAL-WEIGHT; SECRETION; TOXICITY; GHRELIN; ABSORPTION; GUSTDUCIN; BENZOATE	Intestinal chemosensory signaling pathways involving the gustatory G-protein, gustducin, and bitter taste receptors (TAS2R) have been implicated in gut hormone release. Alterations in gut hormone profiles may contribute to the success of bariatric surgery. This study investigated the involvement of the gustatory signaling pathway in the development of diet-induced obesity and the therapeutic potential of targeting TAS2Rs to induce body weight loss. alpha-gustducin-deficient (alpha-gust(-/-)) mice became less obese than wild type (WT) mice when fed a highfat diet (HFD). White adipose tissue (WAT) mass was lower in alpha-gust(-/-) mice due to increased heat production as a result of increases in brown adipose tissue (BAT) thermogenic activity, involving increased protein expression of uncoupling protein 1. Intra-gastric treatment of obese WT and alpha-gust(-/-) mice with the bitter agonists denatonium benzoate (DB) or quinine (Q) during 4 weeks resulted in an alpha-gustducin-dependent decrease in body weight gain associated with a decrease in food intake (DB), but not involving major changes in gut peptide release. Both WAT and 3T3-F442A pre-adipocytes express TAS2Rs. Treatment of pre-adipocytes with DB or Q decreased differentiation into mature adipocytes. In conclusion, interfering with the gustatory signaling pathway protects against the development of HFD-induced obesity presumably through promoting BAT activity. Intra-gastric bitter treatment inhibits weight gain, possibly by directly affecting adipocyte metabolism.	[Avau, Bert; Steensels, Sandra; Vancleef, Laurien; Laermans, Jorien; Tack, Jan; Depoortere, Inge] Univ Leuven, Gut Peptide Res Lab, Translat Res Ctr Gastrointestinal Disorders, B-3000 Leuven, Belgium; [Bauters, Dries; Lijnen, H. Roger] Univ Leuven, Ctr Mol & Vasc Biol, B-3000 Leuven, Belgium; [Lesuisse, Jens; Buyse, Johan] Univ Leuven, Dept Biosyst, Lab Livestock Physiol, B-3001 Leuven, Belgium	KU Leuven; KU Leuven; KU Leuven	Depoortere, I (corresponding author), Univ Leuven, Gut Peptide Res Lab, Translat Res Ctr Gastrointestinal Disorders, Gasthuisberg O&N1,Box 701, B-3000 Leuven, Belgium.	inge.depoortere@med.kuleuven.be	Lijnen, Roger/AAA-4085-2020; Depoortere, Inge/I-5019-2013	Tack, Jan/0000-0002-3206-6704; Steensels, Sandra/0000-0001-6544-1884; Depoortere, Inge/0000-0002-0289-2175; Laermans, Jorien/0000-0002-6695-6019	University of Leuven; Flemish Foundation for Scientific Research [FWO G073615N]	University of Leuven(KU Leuven); Flemish Foundation for Scientific Research(FWO)	This work was supported in part by a Methusalem grant from the University of Leuven (www.kuleuven.be) and by a grant from the Flemish Foundation for Scientific Research (http://www.fwo.be, FWO G073615N). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avau B, 2015, ACTA PHYSL OXF; Avau B, 2015, SCI REP-UK, V5, DOI 10.1038/srep15985; Barja-Fernandez S, 2015, GASTROENT RES PRACT, V2015, DOI 10.1155/2015/560938; Bauters D, 2015, BBA-GEN SUBJECTS, V1850, P1449, DOI 10.1016/j.bbagen.2015.04.003; Behrens M, 2011, PHYSIOL BEHAV, V105, P4, DOI 10.1016/j.physbeh.2011.02.010; Biere A, 2004, OECOLOGIA, V140, P430, DOI 10.1007/s00442-004-1603-6; BOTTGER WM, 1990, J PHARMACOKINET BIOP, V18, P1, DOI 10.1007/BF01063619; Buyse J, 1998, BRIT POULTRY SCI, V39, P264, DOI 10.1080/00071669889231; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Cettour-Rose Philippe, 2013, BMC Physiology, V13, P5, DOI 10.1186/1472-6793-13-5; Chaudhari N, 2010, J CELL BIOL, V190, P285, DOI 10.1083/jcb.201003144; COLLEY JC, 1989, TOXICOLOGY, V54, P219, DOI 10.1016/0300-483X(89)90047-4; Cummings DE, 2007, J CLIN INVEST, V117, P13, DOI 10.1172/JCI30227; Depoortere I, 2014, GUT, V63, P179, DOI 10.1136/gutjnl-2013-305112; DREWITT PN, 1993, FOOD CHEM TOXICOL, V31, P235, DOI 10.1016/0278-6915(93)90073-8; Fruhbeck G, 2015, NAT REV ENDOCRINOL, V11, P465, DOI 10.1038/nrendo.2015.84; Glendinning JI, 2008, PHYSIOL BEHAV, V93, P757, DOI 10.1016/j.physbeh.2007.11.029; GREEN H, 1974, CELL, V3, P127, DOI 10.1016/0092-8674(74)90116-0; HANSEN SR, 1993, VET HUM TOXICOL, V35, P234; Hass N, 2010, CELL TISSUE RES, V339, P493, DOI 10.1007/s00441-009-0907-6; HURWITZ A, 1971, J PHARMACOL EXP THER, V179, P485; Jang HJ, 2007, P NATL ACAD SCI USA, V104, P15069, DOI 10.1073/pnas.0706890104; Janssen P, 2011, ALIMENT PHARM THER, V33, P880, DOI 10.1111/j.1365-2036.2011.04609.x; Janssen S, 2011, P NATL ACAD SCI USA, V108, P2094, DOI 10.1073/pnas.1011508108; Janssen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040168; Jeon TI, 2008, J CLIN INVEST, V118, P3693, DOI 10.1172/JCI36461; Kakkar AK, 2015, EUR J INTERN MED, V26, P89, DOI 10.1016/j.ejim.2015.01.005; Kim KS, 2014, DIABETOLOGIA, V57, P2117, DOI 10.1007/s00125-014-3326-5; KLAUS S, 1991, INT J BIOCHEM, V23, P791, DOI 10.1016/0020-711X(91)90062-R; KREYMANN B, 1987, LANCET, V2, P1300; le Roux CW, 2005, J CLIN ENDOCR METAB, V90, P1068, DOI 10.1210/jc.2004-1216; Lee RJ, 2014, J CLIN INVEST, V124, P1393, DOI 10.1172/JCI72094; Li Y, 2013, AM J PHYSIOL-ENDOC M, V304, pE651, DOI 10.1152/ajpendo.00471.2012; Masubuchi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054500; Meyer-Gerspach AC, 2014, PHYSIOL BEHAV, V129, P265, DOI 10.1016/j.physbeh.2014.02.043; Meyerhof W, 2010, CHEM SENSES, V35, P157, DOI 10.1093/chemse/bjp092; Poher AL, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00004; Romijn CaL W, 1961, 2 S EN MET EUR ASS A, V10, P49; RUIZAVILA L, 1995, NATURE, V376, P80, DOI 10.1038/376080a0; Sampath H, 2009, J BIOL CHEM, V284, P19961, DOI 10.1074/jbc.M109.014225; Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943; Schulz TJ, 2011, P NATL ACAD SCI USA, V108, P143, DOI 10.1073/pnas.1010929108; Simon BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086454; Simon BR, 2013, J BIOL CHEM, V288, P32475, DOI 10.1074/jbc.M113.514034; Singh N, 2011, BIOCHEM BIOPH RES CO, V406, P146, DOI 10.1016/j.bbrc.2011.02.016; Steinert RE, 2011, CLIN NUTR, V30, P524, DOI 10.1016/j.clnu.2011.01.007; Sundberg JP, 2000, AM J PATHOL, V156, P2067, DOI 10.1016/S0002-9440(10)65078-X; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Talavera K, 2008, FASEB J, V22, P1343, DOI 10.1096/fj.07-9591com; Tschop M, 2001, J ENDOCRINOL INVEST, V24, pRC19, DOI 10.1007/BF03351037; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Vegezzi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107732; Verhulst PJ, 2008, GASTROENTEROLOGY, V135, P1267, DOI 10.1053/j.gastro.2008.06.044; Westerberg R, 2004, J BIOL CHEM, V279, P5621, DOI 10.1074/jbc.M310529200; Widmayer P, 2012, INT J OBESITY, V36, P1353, DOI 10.1038/ijo.2011.216; Zagrobelny M, 2004, PHYTOCHEMISTRY, V65, P293, DOI 10.1016/j.phytochem.2003.10.016	56	41	42	3	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145538	10.1371/journal.pone.0145538	http://dx.doi.org/10.1371/journal.pone.0145538			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26692363	Green Submitted, Green Published, gold			2022-12-26	WOS:000367092300086
J	Chang, TH; Hsu, HH; Chou, YC; Yu, JC; Hsu, GC; Huang, GS; Liao, GS				Chang, Tsun-Hou; Hsu, Hsian-He; Chou, Yu-Ching; Yu, Jyh-Cherng; Hsu, Giu-Cheng; Huang, Guo-Shu; Liao, Guo-Shiou			The Values of Combined and Sub-Stratified Imaging Scores with Ultrasonography and Mammography in Breast Cancer Subtypes	PLOS ONE			English	Article							NEGATIVE MAMMOGRAPHY; MOLECULAR SUBTYPE; SCORING SYSTEM; ULTRASOUND; WOMEN; RECEPTOR; THERAPY; PERFORMANCE; SURVIVAL; FEATURES	Background and Objectives The Breast Imaging Reporting and Data System (BI-RADS) of Mammography (MG) and Ultrasonography (US) were equivalent to the "5-point score" and applied for combined and sub-stratified imaging assessments. This study evaluated the value of combined and sub-stratified imaging assessments with MG and US over breast cancer subtypes (BCS). Materials and Methods Medical records of 5,037 cases having imaging-guided core biopsy, performed from 2009 to 2012, were retrospectively reviewed. This study selected 1,995 cases (1,457 benign and 538 invasive cancer) having both MG and US before biopsy. These cases were categorized with the "5-point score" for their MG and US, and applied for combined and sub-stratified imaging assessments. Invasive cancers were classified on the basis of BCS, and correlated with combined and sub-stratified imaging assessments. Results These selected cases were evaluated by the "5-point score." MG, US, and combined and sub-stratified imaging assessments all revealed statistically significant (P < 0.001) incidence of malignancy. The sensitivity was increased in the combined imaging score (99.8%), and the specificity was increased in the sub-stratified combined score (75.4%). In the sub-stratified combined imaging assessment, all BCS can be classified with higher scores (abnormality hierarchy), and luminal B subtype showed the most salient result (hierarchy: higher, 95%; lower, 5%). Conclusions Combined and sub-stratified imaging assessments can increase sensitivity and specificity of breast cancer diagnosis, respectively, and Luminal B subtype shows the best identification by sub-stratified combined imaging scoring.	[Chang, Tsun-Hou] Tri Serv Gen Hosp, Dept Radiol, Taipei, Taiwan; [Hsu, Hsian-He; Huang, Guo-Shu] Natl Def Med Ctr, Dept Radiol, Taipei, Taiwan; [Chou, Yu-Ching] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Yu, Jyh-Cherng; Liao, Guo-Shiou] Natl Def Med Ctr, Tri Serv Gen Hosp, Div Gen Surg, Dept Surg, Taipei, Taiwan; [Hsu, Giu-Cheng] Kang Ning Gen Hosp, Breast Med Ctr, Taipei, Taiwan	Tri-Service General Hospital; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Tri-Service General Hospital	Liao, GS (corresponding author), Natl Def Med Ctr, Tri Serv Gen Hosp, Div Gen Surg, Dept Surg, Taipei, Taiwan.	guoshiou@ndmctsgh.edu.tw			 [TSGH-C104-050];  [TSGH-C105-046];  [TSGH-C105-017]	; ; 	We would like to thank the sources of the funding, TSGH-C104-050, TSGH-C105-046, and TSGH-C105-017, which support our study.	Ben T, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2904; Berg WA, 2012, JAMA-J AM MED ASSOC, V307, P1394, DOI 10.1001/jama.2012.388; Blows FM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000279; Chae EY, 2013, J ULTRAS MED, V32, P1573, DOI 10.7863/ultra.32.9.1573; Chan SWW, 2008, WORLD J SURG, V32, P2593, DOI 10.1007/s00268-007-9273-2; Crispo A, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-15; Dogan BE, 2012, ANN ONCOL, V23, P23, DOI 10.1093/annonc/mds191; [EA S EB M EA M CJ DO], 2013, ACR BI RADS ATLAS BR; Fernandez-Morales LA, 2007, CLIN BREAST CANCER, V7, P559, DOI 10.3816/CBC.2007.n.012; Girardi V, 2013, BREAST, V22, P806, DOI 10.1016/j.breast.2013.02.010; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Grimm LJ, 2015, RADIOLOGY, V274, P352, DOI 10.1148/radiol.14140594; Ha R, 2015, AM J ROENTGENOL, V204, P1354, DOI 10.2214/AJR.14.13666; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Kelly KM, 2010, EUR RADIOL, V20, P2557, DOI 10.1007/s00330-010-1844-1; Kim MY, 2013, ACTA RADIOL, V54, P889, DOI 10.1177/0284185113488580; Kolb TM, 2002, RADIOLOGY, V225, P165, DOI 10.1148/radiol.2251011667; Li B, 2014, ASIAN PAC J CANCER P, V15, P3555, DOI 10.7314/APJCP.2014.15.8.3555; Li CI, 2009, CANCER RES, V69, P6865, DOI 10.1158/0008-5472.CAN-09-1355; Li JG, 2014, BREAST CANCER RES TR, V144, P391, DOI 10.1007/s10549-014-2863-4; Maxwell AJ, 2009, CLIN RADIOL, V64, P624, DOI 10.1016/j.crad.2009.01.010; Minicozzi P, 2013, J CANCER RES CLIN, V139, P1569, DOI 10.1007/s00432-013-1478-1; Murphy IG, 2007, J SURG ONCOL, V96, P457, DOI 10.1002/jso.20801; Puig-Vives M, 2013, GYNECOL ONCOL, V130, P609, DOI 10.1016/j.ygyno.2013.05.039; Roche NA, 1998, BRIT J SURG, V85, P669; Skaane P, 2015, ACTA RADIOL, V56, P404, DOI 10.1177/0284185114528835; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Taylor K, 2011, BRIT J RADIOL, V84, P1005, DOI 10.1259/bjr/48490964; Wilkinson LS, 2011, BRIT J RADIOL, V84, P965, DOI 10.1259/bjr/51580547; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Wong FY, 2011, ANN ACAD MED SINGAP, V40, P90; Zhang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep11085	32	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145390	10.1371/journal.pone.0145390	http://dx.doi.org/10.1371/journal.pone.0145390			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689198	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092300067
J	Kilari, S; Cossette, S; Pooya, S; Bordas, M; Huang, YW; Ramchandran, R; Wilkinson, GA				Kilari, Sreenivasulu; Cossette, Stephanie; Pooya, Shabnam; Bordas, Michelle; Huang, Yi-Wen; Ramchandran, Ramani; Wilkinson, George A.			Endothelial Cell Surface Expressed Chemotaxis and Apoptosis Regulator (ECSCR) Regulates Lipolysis in White Adipocytes via the PTEN/AKT Signaling Pathway	PLOS ONE			English	Article							INSULIN; MECHANISMS; PROTEIN	Elevated plasma triglycerides are associated with increased susceptibility to heart disease and stroke, but the mechanisms behind this relationship are unclear. A clearer understanding of gene products which influence plasma triglycerides might help identify new therapeutic targets for these diseases. The Endothelial Cell Surface expressed Chemotaxis and apoptosis Regulator (ECSCR) was initially studied as an endothelial cell marker, but has recently been identified in white adipocytes, the primary storage cell type for triglycerides. Here we confirm ECSCR expression in white adipocytes and show that Ecscr knockout mice show elevated fasting plasma triglycerides. At a cellular level, cultured 3T3-L1 adipocytes silenced for Ecscr show a blunted Akt phosphorylation response. Additionally we show that the phosphatase and tensin homology containing (PTEN) lipid phosphatase association with ECSCR is increased by insulin stimulation. These data suggest a scenario by which ECSCR contributes to control of white adipocyte lipolysis. In this scenario, white adipocytes lacking Ecscr display elevated PTEN activity, thereby reducing AKT activation and impairing insulin-mediated suppression of lipolysis. Collectively, these results suggest that ECSCR plays a critical function in regulating lipolysis in white adipose tissue.	[Kilari, Sreenivasulu; Cossette, Stephanie; Pooya, Shabnam; Bordas, Michelle; Ramchandran, Ramani; Wilkinson, George A.] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Kilari, Sreenivasulu; Cossette, Stephanie; Pooya, Shabnam; Bordas, Michelle; Ramchandran, Ramani; Wilkinson, George A.] Med Coll Wisconsin, Dev Vasc Biol Program, Milwaukee, WI 53226 USA; [Kilari, Sreenivasulu; Cossette, Stephanie; Pooya, Shabnam; Bordas, Michelle; Huang, Yi-Wen; Ramchandran, Ramani; Wilkinson, George A.] Childrens Res Inst, Milwaukee, WI USA; [Huang, Yi-Wen; Ramchandran, Ramani] Med Coll Wisconsin, Dept Obstet & Gynecol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Ramchandran, R (corresponding author), Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	rramchan@mcw.edu; gwilkinson@cuw.edu		Kilari, Sreenivasulu/0000-0002-9149-7360	National Institutes of Health Heart, Lung and Blood Institute [1R01 HL09712, 1R01HL102745-01, 1R01HL112639-01]; NIH; Women's Health Research Fund; Concordia University of Wisconsin funds; Children's Research Institute of the Medical College of Wisconsin; American Heart Association Scientist Development [11SDG5310020]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL112639, R01HL102745] Funding Source: NIH RePORTER	National Institutes of Health Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Women's Health Research Fund; Concordia University of Wisconsin funds; Children's Research Institute of the Medical College of Wisconsin; American Heart Association Scientist Development(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by grants from National Institutes of Health Heart, Lung and Blood Institute (1R01 HL09712, 1R01HL102745-01 & 1R01HL112639-01 to RR, http://www.nhlbi.nih.gov/). SC & SB are partially supported from NIH grants to RR. SK, MB, are supported by funds from Women's Health Research Fund. GAW was supported by Concordia University of Wisconsin funds, the Children's Research Institute of the Medical College of Wisconsin, and American Heart Association Scientist Development Grant 11SDG5310020 (http://research.americanheart.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian M, 2009, TRENDS ENDOCRIN MET, V20, P424, DOI 10.1016/j.tem.2009.06.002; Akakabe Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3389; Armstrong LJ, 2008, ARTERIOSCL THROM VAS, V28, P1640, DOI 10.1161/ATVBAHA.108.162511; Austin CP, 2004, NAT GENET, V36, P921, DOI 10.1038/ng0904-921; BERHANU P, 1983, J CLIN INVEST, V72, P1958, DOI 10.1172/JCI111160; Carmen GY, 2006, CELL SIGNAL, V18, P401, DOI 10.1016/j.cellsig.2005.08.009; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; Fang K, 2011, PHYSIOL GENOMICS, V43, P43, DOI 10.1152/physiolgenomics.00138.2010; Gao XX, 2011, P NATL ACAD SCI USA, V108, P14509, DOI 10.1073/pnas.1019386108; Herbert TP, 2000, J BIOL CHEM, V275, P11249, DOI 10.1074/jbc.275.15.11249; Jiang GQ, 2002, FRONT BIOSCI-LANDMRK, V7, pD904; Kersten S, 2001, EMBO REP, V2, P282, DOI 10.1093/embo-reports/kve071; Kilari S, 2013, J BIOL CHEM, V288, P10265, DOI 10.1074/jbc.M112.413542; Kim J, 2007, J BIOL CHEM, V282, P11038, DOI 10.1074/jbc.M606197200; KLIP A, 1990, DIABETES CARE, V13, P228, DOI 10.2337/diacare.13.3.228; Koide M, 2011, P NATL ACAD SCI USA, V108, P9472, DOI 10.1073/pnas.1101296108; Koren S, 2015, DIABETOLOGIA, V58, P1063, DOI 10.1007/s00125-015-3532-9; Lopez MJ, 2011, METHODS MOL BIOL, V702, P37, DOI 10.1007/978-1-61737-960-4_4; Lu J, 2012, COMPUT BIOL CHEM, V41, P41, DOI 10.1016/j.compbiolchem.2012.10.003; Madsen L, 2003, BIOCHEM J, V375, P539, DOI 10.1042/BJ20030503; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Rask-Madsen C, 2012, ARTERIOSCL THROM VAS, V32, P2052, DOI 10.1161/ATVBAHA.111.241919; Rask-Madsen C, 2010, CELL METAB, V11, P379, DOI 10.1016/j.cmet.2010.03.013; Shi CW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021482; Sierra-Filardi E, 2011, BLOOD, V117, P5092, DOI 10.1182/blood-2010-09-306993; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Verma A, 2010, BLOOD, V115, P4614, DOI 10.1182/blood-2009-10-248856	27	8	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144185	10.1371/journal.pone.0144185	http://dx.doi.org/10.1371/journal.pone.0144185			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26692198	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092300005
J	Wang, ZW; Chen, ST; Nie, ZL; Zhang, JW; Zhou, Z; Deng, T; Sun, H				Wang, Zhi-Wei; Chen, Shao-Tian; Nie, Ze-Long; Zhang, Jian-Wen; Zhou, Zhuo; Deng, Tao; Sun, Hang			Climatic Factors Drive Population Divergence and Demography: Insights Based on the Phylogeography of a Riparian Plant Species Endemic to the Hengduan Mountains and Adjacent Regions	PLOS ONE			English	Article							QINGHAI-TIBETAN PLATEAU; EAST-ASIAN MONSOON; SOUTH CHINA SEA; GENETIC CONSEQUENCES; CHLOROPLAST; EVOLUTION; FOREST; MITOCHONDRIAL; SEQUENCES; EXPANSION	Quaternary climatic factors have played a significant role in population divergence and demography. Here we investigated the phylogeography of Osteomeles schwerinae, a dominant riparian plant species of the hot/warm-dry river valleys of the Hengduan Mountains (HDM), Qinling Mountains (QLM) and Yunnan-Guizhou Plateau (YGP). Three chloroplast DNA (cpDNA) regions (trnD-trnT, psbD-trnT, petL-psbE), one single copy nuclear gene (glyceraldehyde 3-phosphate dehydrogenase; G3pdh), and climatic data during the Last Interglacial (LIG; c. 120-140 ka), Last Glacial Maximum (LGM; c. 21 ka), and Current (c. 1950-2000) periods were used in this study. Six cpDNA haplotypes and 15 nuclear DNA (nDNA) haplotypes were identified in the 40 populations of O. schwerinae. Spatial Analysis of Molecular Variance, median-joining networks, and Bayesian phylogenetic trees based on the cpDNA and nDNA datasets, all suggested population divergence between the QLM and HDM-YGP regions. Our climatic analysis identified significant heterogeneity of the climatic factors in the QLM and HDM-YGP regions during the aforementioned three periods. The divergence times based on cpDNA and nDNA haplotypes were estimated to be 466.4-159.4 ka and 315.8-160.3 ka, respectively, which coincide with the time of the weakening of the Asian monsoons in these regions. In addition, unimodal pairwise mismatch distribution curves, expansion times, and Ecological Niche Modeling suggested a history of population expansion (rather than contraction) during the last glaciation. Interestingly, the expansion times were found being well consistent with the intensification of the Asian monsoons during this period. We inferred that the divergence between the two main lineages is probably caused by disruption of more continuous distribution because of weakening of monsoons/less precipitation, whilst subsequent intensification of the Asian monsoons during the last glaciation facilitated the expansion of O. schwerinae populations.	[Wang, Zhi-Wei; Chen, Shao-Tian; Nie, Ze-Long; Zhang, Jian-Wen; Zhou, Zhuo; Deng, Tao; Sun, Hang] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Div & Biogeog East Asia, Kunming 650201, Peoples R China; [Wang, Zhi-Wei] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Sun, H (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Div & Biogeog East Asia, Kunming 650201, Peoples R China.	hsun@mail.kib.ac.cn	ZHANG, Jianwen/AAG-7743-2020; , wenzi/ABB-4126-2021	ZHANG, Jianwen/0000-0002-4735-168X; 	Strategic Priority Research Program (B) of the Chinese Academy of Sciences [XDB03030112]; NSFC-Yunnan Natural Science Foundation Combining Program [U1136601]; Hundred Talents Program of the Chinese Academy of Sciences [2011312D11022]; CAS/SAFEA International Partnership Program for Creative Teams	Strategic Priority Research Program (B) of the Chinese Academy of Sciences(Chinese Academy of Sciences); NSFC-Yunnan Natural Science Foundation Combining Program; Hundred Talents Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); CAS/SAFEA International Partnership Program for Creative Teams	The study was supported by the Strategic Priority Research Program (B) of the Chinese Academy of Sciences (XDB03030112 to HS), NSFC-Yunnan Natural Science Foundation Combining Program (U1136601 to HS), the Hundred Talents Program of the Chinese Academy of Sciences (2011312D11022 to HS) and the CAS/SAFEA International Partnership Program for Creative Teams. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An Z.S., 1990, QUATERN INT, V7, P91, DOI DOI 10.1016/1040-6182(90)90042-3; Andrew RL, 2010, ANN BOT-LONDON, V105, P707, DOI 10.1093/aob/mcq034; Ao H, 2012, GLOBAL PLANET CHANGE, V80-81, P51, DOI 10.1016/j.gloplacha.2011.09.012; Ao H, 2011, QUATERNARY SCI REV, V30, P1560, DOI 10.1016/j.quascirev.2011.04.009; Avise J. C., 2000, PHYLOGEOGRAPHY HIST; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Boulay S, 2005, PALAEOGEOGR PALAEOCL, V228, P260, DOI 10.1016/j.palaeo.2005.06.005; Bush ABG, 1999, J GEOPHYS RES-ATMOS, V104, P24509, DOI 10.1029/1999JD900447; Caicedo AL, 2004, MOL ECOL, V13, P1871, DOI 10.1111/j.1365-294X.2004.02191.x; Chen SY, 2008, BOT J LINN SOC, V157, P125, DOI 10.1111/j.1095-8339.2008.00785.x; Clark MK, 2005, GEOLOGY, V33, P525, DOI 10.1130/G21265.1; Clift PD, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL027772; Cun YZ, 2010, MOL PHYLOGENET EVOL, V56, P972, DOI 10.1016/j.ympev.2010.05.007; DING ZL, 1995, QUATERNARY RES, V44, P149, DOI 10.1006/qres.1995.1059; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fan DM, 2013, MOL ECOL, V22, P4270, DOI 10.1111/mec.12388; Funk DJ, 2006, P NATL ACAD SCI USA, V103, P3209, DOI 10.1073/pnas.0508653103; Garfin GM, 2005, TREE-RING RES, V61, P59, DOI 10.3959/1536-1098-61.2.59; Hao QZ, 2005, J GEOPHYS RES-SOL EA, V110, DOI 10.1029/2005JB003765; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hijmans RJ, 2001, PLANT GENETIC RESOUR, P15, DOI DOI 10.1007/s10344-011-0563-5; Jaramillo-Correa JP, 2008, MOL ECOL, V17, P2476, DOI 10.1111/j.1365-294X.2008.03762.x; Jaramillo-Correa JP, 2006, MOL ECOL, V15, P2787, DOI 10.1111/j.1365-294X.2006.02974.x; Jin Z, 1993, ACTA BOT YUNNANICA, V16, P1; Jin Z, 1998, GUIHAIA, V18, P313; Li FL, 2014, J ARID ENVIRON, V108, P1, DOI 10.1016/j.jaridenv.2014.04.011; Li Y, 2011, MOL PHYLOGENET EVOL, V59, P412, DOI 10.1016/j.ympev.2011.01.009; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu J, 2013, NEW PHYTOL, V199, P1093, DOI 10.1111/nph.12336; Olsen KM, 1999, P NATL ACAD SCI USA, V96, P5586, DOI 10.1073/pnas.96.10.5586; Opgenoorth L, 2010, NEW PHYTOL, V185, P332, DOI 10.1111/j.1469-8137.2009.03007.x; Peppe DJ, 2011, NEW PHYTOL, V190, P724, DOI 10.1111/j.1469-8137.2010.03615.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Qian H, 2000, NATURE, V407, P180, DOI 10.1038/35025052; Rambaut A, 2009, TRACER VERSION 1 5 0; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schaal BA, 1998, MOL ECOL, V7, P465, DOI 10.1046/j.1365-294x.1998.00318.x; Schneider von Deimling T, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026484; Schoenbohm LM, 2006, GEOL SOC AM BULL, V118, P672, DOI 10.1130/B25816.1; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Shui Y. M., 2003, SEED PLANTS HONGHE R; Statistics P, 2009, STAT PROGR SOC SCI V; Steinhoff DF, 2013, Q J ROY METEOR SOC, V139, P1615, DOI 10.1002/qj.2038; Tang Y., 2004, J MT SCI-ENGL, V1, P38, DOI DOI 10.1007/BF02919358; Tian S, 2010, PLANT SYST EVOL, V284, P219, DOI 10.1007/s00606-009-0246-9; [万云霞 WAN Yunxia], 2008, [自然资源学报, Journal of Natural Resources], V23, P657; Wang FY, 2008, J SYST EVOL, V46, P13, DOI 10.3724/SP.J.1002.2008.07049; Wang IJ, 2013, ECOL LETT, V16, P175, DOI 10.1111/ele.12025; Wang LY, 2009, MOL ECOL, V18, P709, DOI 10.1111/j.1365-294X.2008.04055.x; Wang R, 2011, NEW PHYTOL, V191, P828, DOI 10.1111/j.1469-8137.2011.03720.x; Wang YH, 2015, NEW PHYTOL, V206, P852, DOI 10.1111/nph.13261; Wang YJ, 2008, NATURE, V451, P1090, DOI 10.1038/nature06692; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wright S, 1978, VARIABILITY NATURAL; Wu ZY, 2001, FLORA CHINA, P28; Xia K, 2009, PALAEOGEOGR PALAEOCL, V276, P80, DOI 10.1016/j.palaeo.2009.02.024; [肖霞云 XIAO Xia-yun], 2009, [古生物学报, Acta Palaeontologica Sinica], V48, P185; Yang FM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057638; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; Yue LL, 2012, AM J BOT, V99, P1726, DOI 10.3732/ajb.1100506; Zhang TC, 2011, MOL PHYLOGENET EVOL, V60, P1, DOI 10.1016/j.ympev.2011.04.009	70	15	19	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145014	10.1371/journal.pone.0145014	http://dx.doi.org/10.1371/journal.pone.0145014			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689776	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092300031
J	Espindola, MS; Lima, LJG; Soares, LS; Cacemiro, MC; Zambuzi, FA; Gomes, MD; Amaral, LR; Bollela, VR; Martins, OA; Frantz, FG				Espindola, Milena S.; Lima, Leonardo J. G.; Soares, Luana S.; Cacemiro, Maira C.; Zambuzi, Fabiana A.; Gomes, Matheus de Souza; Amaral, Laurence R.; Bollela, Valdes R.; Martins-Filho, Olindo A.; Frantz, Fabiani G.			Dysregulated Immune Activation in Second-Line HAART HIV plus Patients Is Similar to That of Untreated Patients	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; DISEASE PROGRESSION; INDEPENDENT PREDICTORS; SOLUBLE CD163; CELL COUNT; INFECTION; INFLAMMATION; REPLICATION; MARKERS; SUPPRESSION	Background Successful highly active antiretroviral therapy (HAART) has changed the outcome of AIDS patients worldwide because the complete suppression of viremia improves health and prolongs life expectancy of HIV-1+ patients. However, little attention has been given to the immunological profile of patients under distinct HAART regimens. This work aimed to investigate the differences in the immunological pattern of HIV-1+ patients under the first- or second-line HAART in Brazil. Methods CD4+ T cell counts, Viral load, and plasma concentration of sCD14, sCD163, MCP-1, RANTES, IP-10, IL-1 beta, IL-6, TNF-alpha, IL-12, IFN-alpha, IFN-gamma, IL-4, IL-5, and IL-10 were assessed for immunological characterization of the following clinical groups: Non-infected individuals (NI; n = 66), HIV-1+ untreated (HIV; n = 46), HIV-1+ treated with first-line HAART (HAART 1; n = 15); and HIV-1+ treated with second-line HAART (HAART 2; n = 15). Results We found that the immunological biosignature pattern of HAART 1 is similar to that of NI individuals, especially in patients presenting slow progression of the disease, while patients under HAART 2 remain in a moderate inflammatory state, which is similar to that of untreated HIV patients pattern. Network correlations revealed that differences in IP-10, TNF-alpha, IL-6, IFN-alpha, and IL-10 interactions were primordial in HIV disease and treatment. Heat map and decision tree analysis identified that IP-10> TNF-alpha > IFN-alpha were the best respective HAART segregation biomarkers. Conclusion HIV patients in different HAART regimens develop distinct immunological biosignature, introducing a novel perspective into disease outcome and potential new therapies that consider HAART patients as a heterogeneous group.	[Espindola, Milena S.; Lima, Leonardo J. G.; Soares, Luana S.; Cacemiro, Maira C.; Zambuzi, Fabiana A.; Frantz, Fabiani G.] Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, BR-14041903 Ribeirao Preto, SP, Brazil; [Gomes, Matheus de Souza; Amaral, Laurence R.] Univ Fed Uberlandia, FACOM, INGEB, Lab Bioinformat & Anal Mol, Patos De Minas, MG, Brazil; [Bollela, Valdes R.] Univ Sao Paulo, Fac Med Ribeirao Preto, BR-14041903 Ribeirao Preto, SP, Brazil; [Martins-Filho, Olindo A.] Fiocruz MS, Ctr Pesquisas Rene Rachou, Lab Biomarcadores Diagnost & Monitoramento, Belo Horizonte, MG, Brazil	Universidade de Sao Paulo; Universidade Federal de Uberlandia; Universidade de Sao Paulo; Fundacao Oswaldo Cruz	Frantz, FG (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut Ribeirao Preto, DACTB, BR-14041903 Ribeirao Preto, SP, Brazil.	frantz@usp.br	Soares, Luana/AAL-1909-2020; Frantz, Fabiani Gai/B-9204-2016; Cacemiro, Maira C/S-4458-2017; Martins-Filho, Olindo Assis/ABE-6278-2021; de Souza Gomes, Matheus/G-3480-2012; Amaral, Laurence/G-5905-2012; Amaral, Laurence Rodrigues do/R-2209-2019	Soares, Luana/0000-0001-5924-1691; Frantz, Fabiani Gai/0000-0001-6960-2438; Cacemiro, Maira C/0000-0002-4170-2063; Martins-Filho, Olindo Assis/0000-0002-5494-4889; de Souza Gomes, Matheus/0000-0001-7352-3089; Amaral, Laurence/0000-0003-4681-5451; Amaral, Laurence Rodrigues do/0000-0003-4681-5451	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/12512-0, 2011/12199-0, 2011/24026-3, 2012/02799-3]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, grants: MSE #2011/12512-0; FGF #2011/12199-0; LSS #2011/24026-3; LJGL #2012/02799-3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiuti F, 2006, AIDS REV, V8, P88; Coelho-dos-Reis JGA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002328; Badley AD, 2005, CELL DEATH DIFFER, V12, P924, DOI 10.1038/sj.cdd.4401580; Brenchley JM, 2004, J EXP MED, V200, P749, DOI 10.1084/jem.20040874; Burdo TH, 2011, J INFECT DIS, V204, P1227, DOI 10.1093/infdis/jir520; Burdo TH, 2011, J INFECT DIS, V204, P154, DOI 10.1093/infdis/jir214; Cha L, 2014, CLIN TRANSL IMMUNOL, V3, DOI 10.1038/cti.2014.1; Coetzee D, 2004, AIDS, V18, P887, DOI 10.1097/00002030-200404090-00006; Danaher RJ, 2010, AIDS, V24, P2578, DOI 10.1097/QAD.0b013e32833f4022; Deeks SG, 2013, IMMUNITY, V39, P633, DOI 10.1016/j.immuni.2013.10.001; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; French MA, 2015, AIDS; French MA, 2009, J INFECT DIS, V200, P1212, DOI 10.1086/605890; Funderburg NT, 2014, CURR OPIN HIV AIDS, V9, P80, DOI 10.1097/COH.0000000000000019; Goujard C, 2006, CLIN INFECT DIS, V42, P709, DOI 10.1086/500213; Guimaraes AGDP, 2015, JAIDS-J ACQ IMM DEF, V68, P112, DOI 10.1097/QAI.0000000000000412; Hall M., 2009, SIGKDD EXPLORATIONS, V11, P10, DOI [10.1145/1656274.1656278, DOI 10.1145/1656274.1656278]; Hattab S, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-122; Hayes TL, 2013, AIDS, V27, P867, DOI 10.1097/QAD.0b013e32835d85b4; Hazenberg MD, 2003, AIDS, V17, P1881, DOI 10.1097/00002030-200309050-00006; Ivers LC, 2005, CLIN INFECT DIS, V41, P217, DOI 10.1086/431199; Johnson LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001418; Juompan LY, 2008, AIDS RES HUM RETROV, V24, P573, DOI 10.1089/aid.2007.0182; Kalayjian RC, 2010, J INFECT DIS, V201, P1796, DOI 10.1086/652750; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kuller LH, 2008, PLOS MED, V5, P1496, DOI 10.1371/journal.pmed.0050203; Lapadula G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124741; Latronico T, 2007, AIDS, V21, P677, DOI 10.1097/QAD.0b013e328018751d; Lau B, 2007, JAIDS-J ACQ IMM DEF, V44, P179, DOI 10.1097/01.qai.0000247229.68246.c5; Laurent C, 2005, JAIDS-J ACQ IMM DEF, V38, P14, DOI 10.1097/00126334-200501010-00003; Leeansyah E, 2013, CURR OPIN HIV AIDS, V8, P117, DOI 10.1097/COH.0b013e32835c7134; Lepri AC, 1998, AIDS, V12, P1639, DOI 10.1097/00002030-199813000-00011; Li QS, 2005, NATURE, V434, P1148, DOI 10.1038/nature03513; Lichtfuss GF, 2011, BIOMARK MED, V5, P171, DOI [10.2217/bmm.11.15, 10.2217/BMM.11.15]; Liovat AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046143; Luiza-Silva M, 2011, J INFECT DIS, V204, P873, DOI 10.1093/infdis/jir439; Marchetti G, 2011, AIDS, V25, P1385, DOI 10.1097/QAD.0b013e3283471d10; Marin B, 2009, AIDS, V23, P1743, DOI 10.1097/QAD.0b013e32832e9b78; Mastroianni CM, 2007, TRENDS MOL MED, V13, P449, DOI 10.1016/j.molmed.2007.09.001; Ministerio da Saude. Secretaria de Vigilancia em Saude. Departamento de DST AIDS e Hepatites Virais, 2013, PROTOCOLO CLINICO E; Mocroft A, 2010, JAIDS-J ACQ IMM DEF, V55, P262, DOI 10.1097/QAI.0b013e3181e9be6b; Nakagawa F, 2013, CURR OPIN INFECT DIS, V26, P17, DOI 10.1097/QCO.0b013e32835ba6b1; Neuhaus J, 2010, J INFECT DIS, V201, P1788, DOI 10.1086/652749; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN, P302; Regidor DL, 2011, AIDS, V25, P303, DOI 10.1097/QAD.0b013e32834273ad; Alves EAR, 2015, INT IMMUNOPHARMACOL, V24, P314, DOI 10.1016/j.intimp.2014.12.025; Rodger AJ, 2009, J INFECT DIS, V200, P973, DOI 10.1086/605447; Sandler NG, 2011, J INFECT DIS, V203, P780, DOI 10.1093/infdis/jiq118; Sankaran S, 2008, J VIROL, V82, P538, DOI 10.1128/JVI.01449-07; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Starling AL, 2015, BIOMARKERS, P1; TAYLOR R, 1990, J DIAGN MED SONOG, V6, P35, DOI 10.1177/875647939000600106; UNIAIDS, 2013, GLOBAL REPORT UNAIDS; Valdez H, 2002, AIDS, V16, P1859, DOI 10.1097/00002030-200209270-00002	54	13	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145261	10.1371/journal.pone.0145261	http://dx.doi.org/10.1371/journal.pone.0145261			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684789	Green Submitted, Green Published, gold			2022-12-26	WOS:000366725800054
J	Liu, TT; You, HL; Weng, SW; Wei, YC; Eng, HL; Huang, WT				Liu, Ting-Ting; You, Huey-Ling; Weng, Shao-Wen; Wei, Yu-Ching; Eng, Hock-Liew; Huang, Wan-Ting			Recurrent Amplification at 13q34 Targets at CUL4A, IRS2, and TFDP1 As an Independent Adverse Prognosticator in Intrahepatic Cholangiocarcinoma	PLOS ONE			English	Article							HUMAN BREAST-CANCER; POLYMORPHISM ARRAY ANALYSIS; GENE AMPLIFICATION; COLORECTAL-CANCER; HEPATOCELLULAR CARCINOMAS; LUNG-CANCER; OVEREXPRESSION; METASTASIS; EXPRESSION; PATTERNS	Amplification of genes at 13q34 has been reported to be associated with tumor proliferation and progression in diverse types of cancers. However, its role in intrahepatic cholangiocarcinoma (iCCA) has yet to be explored. We examined two iCCA cell lines and 86 cases of intrahepatic cholangiocarcinoma to analyze copy number of three target genes, including cullin 4A (CUL4A), insulin receptor substrate 2 (IRS2), and transcription factor Dp-1 (TFDP1) at 13q34 by quantitative real-time polymerase chain reaction. The cell lines and all tumor samples were used to test the relationship between copy number (CN) alterations and protein expression by western blotting and immunohistochemical assays, respectively. IRS2 was introduced, and each target gene was silenced in cell lines. The mobility potential of cells was compared in the basal condition and after manipulation using cell migration and invasion assays. CN alterations correlated with protein expression levels. The SNU1079 cell line containing deletions of the target genes demonstrated decreased protein expression levels and significantly lower numbers of migratory and invasive cells, as opposed to the RBE cell line, which does not contain CN alterations. Overexpression of IRS2 by introducing IRS2 in SUN1079 cells increased the mobility potential. In contrast, silencing each target gene showed a trend or statistical significance toward inhibition of migratory and invasive capacities in RBE cells. In tumor samples, the amplification of each of these genes was associated with poor disease-free survival. Twelve cases (13.9%) demonstrated copy numbers > 4 for all three genes tested (CUL4A, IRS2, and TFDP1), and showed a significant difference in disease-free survival by both univariate and multivariate survival analyses (hazard ratio, 2.69; 95% confidence interval, 1.23 to 5.88; P = 0.013). Our data demonstrate that amplification of genes at 13q34 plays an oncogenic role in iCCA featuring adverse disease-free survival, which may provide new directions for targeted therapy.	[Liu, Ting-Ting; Eng, Hock-Liew; Huang, Wan-Ting] Kaohsiung Chang Gung Mem Hosp, Dept Pathol, Kaohsiung, Taiwan; [Liu, Ting-Ting; You, Huey-Ling; Weng, Shao-Wen; Eng, Hock-Liew; Huang, Wan-Ting] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Liu, Ting-Ting; You, Huey-Ling; Huang, Wan-Ting] Kaohsiung Chang Gung Mem Hosp, Dept Lab Med, Kaohsiung, Taiwan; [Weng, Shao-Wen] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Kaohsiung, Taiwan; [You, Huey-Ling] Fooyin Univ, Dept Med Lab Sci & Biotechnol, Kaohsiung, Taiwan; [Wei, Yu-Ching] Kaohsiung Med Univ Hosp, Kaohsiung Municipal Ta Tung Hosp, Dept Pathol, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Fooyin University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Municipal Ta-Tung Hospital	Huang, WT (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Pathol, Kaohsiung, Taiwan.	huangwanting5@gmail.com	Weng, Shao wen/GYU-9746-2022		Chang Gung Memorial Hospital [CMRPG8A1162, CMRPG8D1321]; National Science Council, Taiwan [NSC 104-2320-B-182A-004]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported in part by grants from Chang Gung Memorial Hospital (CMRPG8A1162, CMRPG8D1321) and National Science Council, Taiwan (NSC 104-2320-B-182A-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba MC, 2007, CANCER RES, V67, P4104, DOI 10.1158/0008-5472.CAN-06-4672; Andersen JB, 2012, CURR OPIN GASTROEN, V28, P266, DOI 10.1097/MOG.0b013e3283523c7e; Bondar T, 2006, MOL CELL BIOL, V26, P2531, DOI 10.1128/MCB.26.7.2531-2539.2006; Castillo SD, 2010, J PATHOL, V222, P89, DOI 10.1002/path.2732; Day E, 2013, INT J EXP PATHOL, V94, P203, DOI 10.1111/iep.12021; Dearth RK, 2007, CELL CYCLE, V6, P705, DOI 10.4161/cc.6.6.4035; Garcia MJ, 2013, MOL CANCER THER, V12, P530, DOI 10.1158/1535-7163.MCT-12-0768; Gibson SL, 2007, CELL CYCLE, V6, P631, DOI 10.4161/cc.6.6.3987; Gupta A, 2002, INT J RADIAT ONCOL, V52, P822, DOI 10.1016/S0360-3016(01)02739-0; Huang HY, 2010, ANN SURG ONCOL, V17, P3212, DOI 10.1245/s10434-010-1185-y; Huang WT, 2014, INT J CLIN EXP PATHO, V7, P6841; Huang WT, 2012, APMIS, V120, P872, DOI 10.1111/j.1600-0463.2012.02915.x; Jackson JG, 2001, ONCOGENE, V20, P7318, DOI 10.1038/sj.onc.1204920; Jacquemier J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-351; Lips EH, 2007, J PATHOL, V212, P269, DOI 10.1002/path.2180; Liu G, 2015, TUMOUR BIOL; Martin ES, 2007, CANCER RES, V67, P10736, DOI 10.1158/0008-5472.CAN-07-2742; Melchor L, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2456; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; Ren SC, 2012, J MOL MED, V90, P1121, DOI 10.1007/s00109-012-0885-0; Shan B, 1996, CELL GROWTH DIFFER, V7, P689; Sia D, 2013, ONCOGENE, V32, P4861, DOI 10.1038/onc.2012.617; Sia D, 2013, GASTROENTEROLOGY, V144, P829, DOI 10.1053/j.gastro.2013.01.001; Sugimachi K, 2001, J HEPATOL, V35, P74, DOI 10.1016/S0168-8278(01)00079-4; Temam S, 2007, J CLIN ONCOL, V25, P2164, DOI 10.1200/JCO.2006.06.6605; Ukita Y, 2002, J HEPATOL, V36, P780, DOI 10.1016/S0168-8278(02)00057-0; Wang YS, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-252; Wang YS, 2014, CANCER RES, V74, P520, DOI 10.1158/0008-5472.CAN-13-2182; Yasui K, 2003, J HUM GENET, V48, P609, DOI 10.1007/s10038-003-0086-3; Yasui K, 2002, HEPATOLOGY, V35, P1476, DOI 10.1053/jhep.2002.33683; You HL, 2012, EXP MOL PATHOL, V92, P281, DOI 10.1016/j.yexmp.2012.01.009; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	32	4	5	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145388	10.1371/journal.pone.0145388	http://dx.doi.org/10.1371/journal.pone.0145388			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684807	gold, Green Published, Green Submitted			2022-12-26	WOS:000366725800072
J	Dhaliwal, AK; Mohan, A; Sidhu, G; Maqbool, R; Gill, KS				Dhaliwal, Amandeep K.; Mohan, Amita; Sidhu, Gaganjot; Maqbool, Rizwana; Gill, Kulvinder S.			An Ethylmethane Sulfonate Mutant Resource in Pre-Green Revolution Hexaploid Wheat	PLOS ONE			English	Article							INDUCED MUTATIONS; GENES	Mutagenesis is a powerful tool used for studying gene function as well as for crop improvement. It is regaining popularity because of the development of effective and cost efficient methods for high-throughput mutation detection. Selection for semi-dwarf phenotype during green revolution has reduced genetic diversity including that for agronomically desirable traits. Most of the available mutant populations in wheat (Triticum aestivum L.) were developed in post-green revolution cultivars. Besides the identification and isolation of agronomically important alleles in the mutant population of pre-green revolution cultivar, this population can be a vital resource for expanding the genetic diversity for wheat breeding. Here we report an Ethylmethane Sulfonate (EMS) generated mutant population consisting of 4,180 unique mutant plants in a pre-green revolution spring wheat cultivar 'Indian'. Released in early 1900s, 'Indian' is devoid of any known height-reducing mutations. Unique mutations were captured by proceeding with single M-2 seed from each of the 4,180 M-1 plants. Mutants for various phenotypic traits were identified by detailed phenotyping for altered morphological and agronomic traits on M-2 plants in the greenhouse and M-3 plants in the field. Of the 86 identified mutants, 75 (87%) were phenotypically stable at the M-4 generation. Among the observed phenotypes, variation in plant height was the most frequent followed by the leaf morphology. Several mutant phenotypes including looped peduncle, crooked plant morphology, 'gritty' coleoptiles, looped lower internodes, and burnt leaf tips are not reported in other plant species. Considering the extent and diversity of the observed mutant phenotypes, this population appears to be a useful resource for the forward and reverse genetic studies. This resource is available to the scientific community.	[Dhaliwal, Amandeep K.; Mohan, Amita; Sidhu, Gaganjot; Maqbool, Rizwana; Gill, Kulvinder S.] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA	Washington State University	Gill, KS (corresponding author), Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA.	ksgill@wsu.edu	Sidhu, Gaganjot/O-7667-2019; Dhaliwal, Amandeep Kaur/R-9254-2017		National Science Foundation-Basic Research to Enable Agriculture Development (NSF-BREAD) [0965533]	National Science Foundation-Basic Research to Enable Agriculture Development (NSF-BREAD)(National Science Foundation (NSF)NSF - Office of the Director (OD))	This research was funded by National Science Foundation-Basic Research to Enable Agriculture Development (NSF-BREAD) grant # 0965533 (http://www.nsf.gov/funding/pgm_summ.jsp? pims_id=503285). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen L, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031005, 10.1371/journal.pone.0046239, 10.1371/journal.pone.0041570, 10.1371/journal.pone.0035254]; Clark JA, 1926, AGRONJ, V18, P920; Dong CM, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-143; Dong CM, 2009, PLANT GENOME-US, V2, P39, DOI 10.3835/plantgenome2008.10.0012; Feiz L, 2009, THEOR APPL GENET, V118, P247, DOI 10.1007/s00122-008-0893-1; Friml J, 2003, CURR OPIN PLANT BIOL, V6, P7, DOI 10.1016/S1369526602000031; GOUD JV, 1967, CURR SCI INDIA, V36, P557; Greb T, 2003, GENE DEV, V17, P1175, DOI 10.1101/gad.260703; Greene EA, 2003, GENETICS, V164, P731; Howard TP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087053; Kuraparthy V, 2007, THEOR APPL GENET, V114, P1379, DOI 10.1007/s00122-007-0524-2; Li PJ, 2007, CELL RES, V17, P402, DOI 10.1038/cr.2007.38; Li XY, 2003, NATURE, V422, P618, DOI 10.1038/nature01518; Mohan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073314; Mutti J, 2007, TARGETED IMPROVEMENT; NEWHOUSE KE, 1992, PLANT PHYSIOL, V100, P882, DOI 10.1104/pp.100.2.882; Ordonio RL, 2014, SCI REP-UK, V4, DOI 10.1038/srep05287; Pepper GE, 1974, THESIS; RICHARDS RA, 1992, AUST J AGR RES, V43, P517, DOI 10.1071/AR9920517; Sakamoto T, 2006, NAT BIOTECHNOL, V24, P105, DOI 10.1038/nbt1173; Schumacher K, 1999, P NATL ACAD SCI USA, V96, P290, DOI 10.1073/pnas.96.1.290; Sestili F, 2010, MOL BREEDING, V25, P145, DOI 10.1007/s11032-009-9314-7; Sidhu G, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2112-1; Slade AJ, 2005, NAT BIOTECHNOL, V23, P75, DOI 10.1038/nbt1043; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Uauy C, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-115; Waines JG, 2007, ANN BOT-LONDON, V100, P991, DOI 10.1093/aob/mcm180; Zaccai M, 2009, PLANT SCI, V176, P736, DOI 10.1016/j.plantsci.2009.02.014	28	22	23	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145227	10.1371/journal.pone.0145227	http://dx.doi.org/10.1371/journal.pone.0145227			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678261	gold, Green Published, Green Submitted			2022-12-26	WOS:000366723400059
J	Jahromi, GP; Ghanei, M; Hosseini, SK; Shamsaei, A; Gholipourmalekabadi, M; Koochaki, A; Osguei, NK; Samadikuchaksaraei, A				Jahromi, Gila Pirzad; Ghanei, Mostafa; Hosseini, Seyed Kazem; Shamsaei, Alireza; Gholipourmalekabadi, Mazaher; Koochaki, Ameneh; Osguei, Nushin Karkuki; Samadikuchaksaraei, Ali			Characterization of Lung Fibroblasts More than Two Decades after Mustard Gas Exposure	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; SULFUR MUSTARD; BRONCHOALVEOLAR LAVAGE; BRONCHIOLITIS OBLITERANS; EPITHELIAL-CELLS; MILD ASTHMA; APOPTOSIS; DIFFER; DIFFERENTIATION; PROLIFERATION	Purpose In patients with short-term exposure to the sulfur mustard gas, the delayed cellular effects on lungs have not been well understood yet. The lung pathology shows a dominant feature consistent with obliterative bronchiolitis, in which fibroblasts play a central role. This study aims to characterize alterations to lung fibroblasts, at the cellular level, in patients with delayed respiratory complications after short-term exposure to the sulfur mustard gas. Methods Fibroblasts were isolated from the transbronchial biopsies of patients with documented history of exposure to single high-dose sulfur mustard during 1985-7 and compared with the fibroblasts of control subjects. Results Compared with controls, patients' fibroblasts were thinner and shorter, and showed a higher population doubling level, migration capacity and number of filopodia. Sulfur mustard decreased the in vitro viability of fibroblasts and increased their sensitivity to induction of apoptosis, but did not change the rate of spontaneous apoptosis. In addition, higher expression of alpha smooth muscle actin showed that the lung's microenvironment in these patients is permissive for myofibroblastic differentiation. Conclusions These findings suggest that in patients under the study, the delayed pulmonary complications of sulfur mustard should be considered as a unique pathology, which might need a specific management by manipulation of cellular components.	[Jahromi, Gila Pirzad] Baqiyatallah Univ Med Sci, Neurosci Res Ctr, Tehran, Iran; [Ghanei, Mostafa] Baqiyatallah Univ Med Sci, Chem Injury Res Ctr, Tehran, Iran; [Ghanei, Mostafa] Baqiyatallah Univ Med Sci, Fac Med, Dept Resp Med, Tehran, Iran; [Hosseini, Seyed Kazem] Univ Tehran Med Sci, Tissue Bank, Tehran, Iran; [Hosseini, Seyed Kazem] Univ Tehran Med Sci, Preparat Res Ctr, Tehran, Iran; [Shamsaei, Alireza] Baqiyatallah Univ Med Sci, Fac Med, Dept Pathol, Tehran, Iran; [Gholipourmalekabadi, Mazaher] Shahid Beheshti Univ Med Sci, Sch Adv Technol Med, Dept Biotechnol, Tehran, Iran; [Koochaki, Ameneh] Shahid Beheshti Univ Med Sci, Cellular & Mol Biol Res Ctr, Tehran, Iran; [Osguei, Nushin Karkuki] Eposci Millennium Inst, Tehran, Iran; [Samadikuchaksaraei, Ali] Iran Univ Med Sci, Cellular & Mol Res Ctr, Tehran, Iran; [Samadikuchaksaraei, Ali] Iran Univ Med Sci, Fac Adv Technol Med, Dept Tissue Engn & Regenerat Med, Tehran, Iran; [Samadikuchaksaraei, Ali] Iran Univ Med Sci, Fac Allied Med, Dept Med Biotechnol, Tehran, Iran	Baqiyatallah University of Medical Sciences (BMSU); Baqiyatallah University of Medical Sciences (BMSU); Baqiyatallah University of Medical Sciences (BMSU); Tehran University of Medical Sciences; Tehran University of Medical Sciences; Baqiyatallah University of Medical Sciences (BMSU); Shahid Beheshti University Medical Sciences; Shahid Beheshti University Medical Sciences; Iran University of Medical Sciences; Iran University of Medical Sciences; Iran University of Medical Sciences	Samadikuchaksaraei, A (corresponding author), Iran Univ Med Sci, Cellular & Mol Res Ctr, Tehran, Iran.	samadikuchaksaraei@yahoo.com	Samadikuchaksaraei, Ali/H-6402-2019; Ghanei, Mostafa/V-1975-2019; jahromi, gila pirzad/X-5341-2019; Gholipourmalekabadi, Mazaher/P-3019-2018	Samadikuchaksaraei, Ali/0000-0002-2108-9927; Ghanei, Mostafa/0000-0001-9372-0928; Gholipourmalekabadi, Mazaher/0000-0001-6287-6831; pirzad jahromi, gila/0000-0002-2683-1625; Karkuki Osguei, Nushin/0000-0001-9585-2908	Ministry of Health and Medical Education of Iran	Ministry of Health and Medical Education of Iran	This project was supported with a research grant from the Ministry of Health and Medical Education of Iran. Other than the named authors, no one employed or contracted by the funder played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghanouri R, 2004, AM J PHYSIOL-LUNG C, V287, pL1160, DOI 10.1152/ajplung.00169.2003; Andersson-Sjoland A, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-76; Andersson-Sjoland A, 2011, J HEART LUNG TRANSPL, V30, P945, DOI 10.1016/j.healun.2011.04.006; Balali-Mood M, 2006, BASIC CLIN PHARMACOL, V99, P273, DOI 10.1111/j.1742-7843.2006.pto_429.x; BALALIMOOD M, 2005, J MED CHEM BIOL RADI, V3, P1; Barker AF, 2014, NEW ENGL J MED, V370, P1820, DOI 10.1056/NEJMra1204664; Barman SA, 2014, ARTERIOSCL THROM VAS, V34, P1704, DOI 10.1161/ATVBAHA.114.303848; Beheshti J, 2006, PATHOL RES PRACT, V202, P739, DOI 10.1016/j.prp.2006.04.008; Bermudez O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063226; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Dompeling E, 2004, EUR RESPIR J, V23, P343, DOI 10.1183/09031936.04.00100004; Ekstrand-Hammarstrom B, 2011, TOXICOLOGY, V280, P88, DOI 10.1016/j.tox.2010.11.012; Gao X, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-17; Ghabili K, 2011, CRIT REV TOXICOL, V41, P384, DOI 10.3109/10408444.2010.541224; Ghabili K, 2010, J APPL TOXICOL, V30, P627, DOI 10.1002/jat.1581; Ghanei M, 2008, RESP MED, V102, P825, DOI 10.1016/j.rmed.2008.01.016; Ghanei M, 2011, INHAL TOXICOL, V23, P363, DOI 10.3109/08958378.2011.576278; Harris DA, 2013, J THORAC CARDIOV SUR, V145, P854, DOI 10.1016/j.jtcvs.2012.03.079; Holz O, 2004, EUR RESPIR J, V24, P575, DOI 10.1183/09031936.04.00143703; Jia N, 2014, J FUNCT FOODS, V11, P142, DOI 10.1016/j.jff.2014.09.011; Johnson JR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016175; Kehe K, 2005, TOXICOLOGY, V214, P198, DOI 10.1016/j.tox.2005.06.014; Kehe K, 2009, TOXICOLOGY, V263, P3, DOI 10.1016/j.tox.2009.04.060; Khateri S, 2003, J OCCUP ENVIRON MED, V45, P1136, DOI 10.1097/01.jom.0000094993.20914.d1; Lama Vibha N, 2006, Proc Am Thorac Soc, V3, P373, DOI 10.1513/pats.200512-133TK; Larsen K, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-11; Larsen K, 2004, AM J RESP CRIT CARE, V170, P1049, DOI 10.1164/rccm.200404-507OC; Maher TM, 2010, AM J RESP CRIT CARE, V182, P73, DOI 10.1164/rccm.200905-0674OC; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; McAteer J., 2002, BASIC CELL CULTURE; MIO T, 1992, CHEST, V102, P832, DOI 10.1378/chest.102.3.832; Mishra NC, 2012, INT IMMUNOPHARMACOL, V13, P101, DOI 10.1016/j.intimp.2012.03.010; Moodley YP, 2003, AM J PATHOL, V163, P345, DOI 10.1016/S0002-9440(10)63658-9; Nowrouzi Azin, 2010, Iran Biomed J, V14, P23; Panahi Y, 2005, IRAN J ALLERGY ASTHM, V4; Poursaleh Z, 2012, DARU, V20, DOI 10.1186/2008-2231-20-27; Ramos C, 2001, AM J RESP CELL MOL, V24, P591, DOI 10.1165/ajrcmb.24.5.4333; Ray R, 2008, DRUG CHEM TOXICOL, V31, P137, DOI 10.1080/01480540701688840; Ruff Albert L, 2007, Eplasty, V8, pe2; Saki M, 2009, YAKHTEH, V11, P55; Scheja A, 2007, EUR RESPIR J, V29, P446, DOI 10.1183/09031936.00135205; Sheridan JA, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0214-6; Sohal SS, 2010, RESPIROLOGY, V15, P930, DOI 10.1111/j.1440-1843.2010.01808.x; Thomason JWW, 2003, JAMA-J AM MED ASSOC, V290, P598, DOI 10.1001/jama.290.5.598; Tufvesson E, 2003, J CELL SCI, V116, P4857, DOI 10.1242/jcs.00808; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551	46	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145148	10.1371/journal.pone.0145148	http://dx.doi.org/10.1371/journal.pone.0145148			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26679937	Green Submitted, Green Published, gold			2022-12-26	WOS:000366723400050
J	Ranglack, DH; Dobson, LK; du Toit, JT; Derr, J				Ranglack, Dustin H.; Dobson, Lauren K.; du Toit, Johan T.; Derr, James			Genetic Analysis of the Henry Mountains Bison Herd	PLOS ONE			English	Article							NORTH-AMERICAN BISON; MITOCHONDRIAL-DNA; CATTLE; CONSERVATION; IDENTIFICATION; INTROGRESSION; SCIENCE; RANGE	Wild American plains bison (Bison bison) populations virtually disappeared in the late 1800s, with some remnant animals retained in what would become Yellowstone National Park and on private ranches. Some of these private bison were intentionally crossbred with cattle for commercial purposes. This forced hybridization resulted in both mitochondrial and nuclear introgression of cattle genes into some of the extant bison genome. As the private populations grew, excess animals, along with their history of cattle genetics, provided founders for newly established public bison populations. Of the US public bison herds, only those in Yellowstone and Wind Cave National Parks (YNP and WCNP) appear to be free of detectable levels of cattle introgression. However, a small free-ranging population (similar to 350 animals) exists on public land, along with domestic cattle, in the Henry Mountains (HM) of southern Utah. This isolated bison herd originated from a founder group translocated from YNP in the 1940s. Using genetic samples from 129 individuals, we examined the genetic status of the HM population and found no evidence of mitochondrial or nuclear introgression of cattle genes. This new information confirms it is highly unlikely for free-living bison to crossbreed with cattle, and this disease-free HM bison herd is valuable for the long-term conservation of the species. This bison herd is a subpopulation of the YNP/WCNP/HM metapopulation, within which it can contribute significantly to national efforts to restore the American plains bison to more of its native range.	[Ranglack, Dustin H.; du Toit, Johan T.] Utah State Univ, Dept Wildland Resources, Logan, UT 84322 USA; [Ranglack, Dustin H.] Utah State Univ, Ctr Ecol, Logan, UT 84322 USA; [Dobson, Lauren K.; Derr, James] Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX USA	Utah System of Higher Education; Utah State University; Utah System of Higher Education; Utah State University; Texas A&M University System; Texas A&M University College Station	Ranglack, DH (corresponding author), Montana State Univ, Dept Ecol, Bozeman, MT 59717 USA.	dhranglack@gmail.com	Ranglack, Dustin/AAU-6451-2020; du Toit, Johan T./D-3390-2009	Ranglack, Dustin/0000-0003-4534-9487; du Toit, Johan T./0000-0003-0705-7117; Dobson, Lauren/0000-0001-8111-8542	Utah Division of Wildlife Resources	Utah Division of Wildlife Resources	The work was funded by the Utah Division of Wildlife Resources. The funder had no role in study design, analysis, decision to publish, or preparation of the manuscript.	Boyd DP, 2006, J WEST, V45, P15; BOYD DP, 2003, CONSERVATION N AM BI; Coder G. D., 1975, NATL MOVEMENT PRESER; CRONIN MA, 1991, WILDLIFE SOC B, V19, P94; Cronin MA, 2013, J HERED, V104, P500, DOI 10.1093/jhered/est030; Department of the Interior, 2014, DOI BIS REP LOOK FOR; Derr JN, 2012, CONSERV BIOL, V26, P1130, DOI 10.1111/j.1523-1739.2012.01905.x; Dickson BG, 2014, BIOL CONSERV, V178, P117, DOI 10.1016/j.biocon.2014.08.001; Dobson LK, 2015, SEQUENCING GENOME N; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Freese CH, 2007, BIOL CONSERV, V136, P175, DOI 10.1016/j.biocon.2006.11.019; Gates C, 2010, AM BISON STATUS SURV, P55; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Halbert ND, 2007, J HERED, V98, P1, DOI 10.1093/jhered/esl051; Halbert ND, 2008, MOL ECOL, V17, P4963, DOI 10.1111/j.1365-294X.2008.03973.x; Halbert ND, 2005, MOL ECOL, V14, P2343, DOI 10.1111/j.1365-294X.2005.02591.x; Halbert ND, 2004, J MAMMAL, V85, P924, DOI 10.1644/BER-029; Hedrick PW, 2013, MOL ECOL, V22, P4606, DOI 10.1111/mec.12415; Hedrick PW, 2009, J HERED, V100, P411, DOI 10.1093/jhered/esp024; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Koons DN, 2012, J MAMMAL, V93, P475, DOI 10.1644/11-MAMM-A-281.1; Meagher M, 2008, WILDLIFE SOC B, V17, P15; Nelson K, 1965, STATUS HABITS AM BUF; Park SDE, 2001, THESIS; Popov B, 1950, GAME ANIMALS FISH IN; Pritchard JK, 2000, GENETICS, V155, P945; Ranglack DH, 2015, ORYX, P1; Ranglack DH, 2015, RANGELAND ECOL MANAG, V68, P349, DOI 10.1016/j.rama.2015.05.008; Ranglack DH, 2015, ECOL INDIC, V56, P145, DOI 10.1016/j.ecolind.2015.04.009; Ranglack DH, 2015, J APPL ECOL, V52, P467, DOI 10.1111/1365-2664.12386; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sanderson EW, 2008, CONSERV BIOL, V22, P252, DOI 10.1111/j.1523-1739.2008.00899.x; Schnabel RD, 2000, ANIM GENET, V31, P360, DOI 10.1046/j.1365-2052.2000.00685.x; Van Vuren D. H., 2001, Animal Biodiversity and Conservation, V24, P117; VANVUREN D, 1983, J RANGE MANAGE, V36, P499, DOI 10.2307/3897952; VANVUREN D, 1986, J MAMMAL, V67, P503, DOI 10.2307/1381282; Ward TJ, 1999, ANIM CONSERV, V2, P51, DOI 10.1111/j.1469-1795.1999.tb00048.x	37	4	4	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144239	10.1371/journal.pone.0144239	http://dx.doi.org/10.1371/journal.pone.0144239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673758	gold, Green Published, Green Submitted			2022-12-26	WOS:000366722700031
J	Affo, S; Rodrigo-Torres, D; Blaya, D; Morales-Ibanez, O; Coll, M; Millan, C; Altamirano, J; Arroyo, V; Caballeria, J; Bataller, R; Gines, P; Sancho-Bru, P				Affo, Silvia; Rodrigo-Torres, Daniel; Blaya, Delia; Morales-Ibanez, Oriol; Coll, Mar; Millan, Cristina; Altamirano, Jose; Arroyo, Vicente; Caballeria, Joan; Bataller, Ramon; Gines, Pere; Sancho-Bru, Pau			Chemokine Receptor Ccr6 Deficiency Alters Hepatic Inflammatory Cell Recruitment and Promotes Liver Inflammation and Fibrosis	PLOS ONE			English	Article							DELTA-T-CELLS; DISEASE PATHOGENESIS; ALCOHOLIC HEPATITIS; EXPRESSION; DIFFERENTIATION; REGENERATION; MIGRATION; SUBSETS; TARGETS; INJURY	Chronic liver diseases are characterized by a sustained inflammatory response in which chemokines and chemokine-receptors orchestrate inflammatory cell recruitment. In this study we investigated the role of the chemokine receptor CCR6 in acute and chronic liver injury. In the absence of liver injury Ccr6(-/-) mice presented a higher number of hepatic macrophages and increased expression of pro-inflammatory cytokines and M1 markers Tnf-alpha, II6 and Mcp1. Inflammation and cell recruitment were increased after carbon tetrachloride-induced acute liver injury in Ccr6(-/-) mice. Moreover, chronic liver injury by carbon tetrachloride in Ccr6(-/-) mice was associated with enhanced inflammation and fibrosis, altered macrophage recruitment, enhanced CD4(+) cells and a reduction in Th17 (CD4(+)IL17(+)) and mature dendritic (MHCII(+)CD11c(+)) cells recruitment. Clodronate depletion of macrophages in Ccr6(-/-) mice resulted in a reduction of hepatic pro-inflammatory and pro-fibrogenic markers in the absence and after liver injury. Finally, increased CCR6 hepatic expression in patients with alcoholic hepatitis was found to correlate with liver expression of CCL20 and severity of liver disease. In conclusion, CCR6 deficiency affects hepatic inflammatory cell recruitment resulting in the promotion of hepatic inflammation and fibrosis.	[Affo, Silvia; Rodrigo-Torres, Daniel; Blaya, Delia; Morales-Ibanez, Oriol; Coll, Mar; Millan, Cristina; Altamirano, Jose; Arroyo, Vicente; Caballeria, Joan; Gines, Pere; Sancho-Bru, Pau] Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain; [Altamirano, Jose] VHIR, Barcelona, Spain; [Arroyo, Vicente; Caballeria, Joan; Gines, Pere; Sancho-Bru, Pau] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Barcelona, Spain; [Arroyo, Vicente; Caballeria, Joan; Gines, Pere] Univ Barcelona, Fac Med, Hosp Clin, Liver Unit, Barcelona 7, Spain; [Bataller, Ramon] Univ N Carolina, Dept Med, Div Gastroenterol & Hepatol, Chapel Hill, NC USA; [Bataller, Ramon] Univ N Carolina, Dept Nutr, Div Gastroenterol & Hepatol, Chapel Hill, NC USA	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Sancho-Bru, P (corresponding author), Inst Invest Biomed August Pi & Sunyer IDIBAPS, Barcelona, Spain.	psancho@clinic.ub.es	Coll, Mar/N-1957-2014; Gines, Pere/B-6646-2009; Rodrigo, Teresa/F-6183-2018; Affo, Silvia/AAX-1492-2021; Ginès, Pere/C-7730-2014; Sancho-Bru, Pau/D-4900-2014; Arroyo, Vicente/F-9189-2015	Coll, Mar/0000-0003-3726-0087; Gines, Pere/0000-0003-4657-4504; Ginès, Pere/0000-0003-4657-4504; Sancho-Bru, Pau/0000-0001-5569-9259; Arroyo, Vicente/0000-0002-2728-1848; Affo, Silvia/0000-0002-9731-3913; Bataller, Ramon/0000-0002-1119-7799	Instituto de Salud Carlos III: FIS-Fondo de Investigacion Sanitaria Carlos III; ISCIII Subdirecion General de evaluacion; European Regional Development Fund [FIS PI14/ 00330, PI13/080126, PI12/01274, PI12/042380, PI11/041538]; National Institutes of Health (NIH)-National Institute on Alcohol Abuse and Alcoholism (NIAAA) [1U01AA021908-01-33490, 1U01AA021908]; Instituto de Salud Carlos III; Miguel Servet; Fondo Europeo de Desarrollo Europeo (FEDER); Union Europea, "Una manera de hacer Europa" [CP11/00071]; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Ministerio de Educacion, Cultura y Deporte, FPU program; Instituto de Salud Carlos III, Sara Borrell; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [U01AA020821, U01AA021908] Funding Source: NIH RePORTER	Instituto de Salud Carlos III: FIS-Fondo de Investigacion Sanitaria Carlos III(Instituto de Salud Carlos III); ISCIII Subdirecion General de evaluacion; European Regional Development Fund(European Commission); National Institutes of Health (NIH)-National Institute on Alcohol Abuse and Alcoholism (NIAAA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Miguel Servet; Fondo Europeo de Desarrollo Europeo (FEDER); Union Europea, "Una manera de hacer Europa"; Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); Ministerio de Educacion, Cultura y Deporte, FPU program(German Research Foundation (DFG)); Instituto de Salud Carlos III, Sara Borrell(Instituto de Salud Carlos III); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by grants from Instituto de Salud Carlos III: FIS-Fondo de Investigacion Sanitaria Carlos III, which is part of the Spanish National Plan of I<SUP>+</SUP>D<SUP>+</SUP>I, co-financed by the ISCIII Subdirecion General de evaluacion and the European Regional Development Fund (FIS PI14/ 00330, PI13/080126, PI12/01274, PI12/042380 and PI11/041538 to PS-B, PG, VA, JC, and RB, respectively); National Institutes of Health (NIH)-National Institute on Alcohol Abuse and Alcoholism (NIAAA)(1U01AA021908-01-33490 to PS-B and 1U01AA021908 to RB); a grant to PS-B from the Instituto de Salud Carlos III, Miguel Servet and co-financed by Fondo Europeo de Desarrollo Europeo (FEDER), Union Europea, "Una manera de hacer Europa" (CP11/00071); a grant to SA from Institut d'Investigacions Biomediques August Pi i Sunyer (IDIBAPS); and a grant to DR-T from the Ministerio de Educacion, Cultura y Deporte, FPU program. MC was funded by Instituto de Salud Carlos III, Sara Borrell. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affo S, 2014, GUT, V63, P1782, DOI 10.1136/gutjnl-2013-306098; Affo S, 2013, GUT, V62, P452, DOI 10.1136/gutjnl-2011-301146; Altamirano J, 2011, NAT REV GASTRO HEPAT, V8, P491, DOI 10.1038/nrgastro.2011.134; Colmenero J, 2007, GASTROENTEROLOGY, V132, P687, DOI 10.1053/j.gastro.2006.12.036; Dominguez M, 2009, GASTROENTEROLOGY, V136, P1639, DOI 10.1053/j.gastro.2009.01.056; Ehling J, 2014, GUT, V63, P1960, DOI 10.1136/gutjnl-2013-306294; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Gao B, 2014, GUT, V63, P1683, DOI 10.1136/gutjnl-2013-306603; Gao B, 2011, GASTROENTEROLOGY, V141, P1572, DOI 10.1053/j.gastro.2011.09.002; Gieling RG, 2008, CLIN LIVER DIS, V12, P915, DOI 10.1016/j.cld.2008.07.001; Gosselin A, 2010, J IMMUNOL, V184, P1604, DOI 10.4049/jimmunol.0903058; Haas JD, 2009, EUR J IMMUNOL, V39, P3488, DOI 10.1002/eji.200939922; Hammerich L, 2014, HEPATOLOGY, V59, P630, DOI 10.1002/hep.26697; Heymann F, 2012, HEPATOLOGY, V55, P898, DOI 10.1002/hep.24764; Ito T, 2011, EXP CELL RES, V317, P613, DOI 10.1016/j.yexcr.2010.12.018; Karlmark KR, 2010, HEPATOLOGY, V52, P1769, DOI 10.1002/hep.23894; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Karlmark Karlin Raja, 2008, Expert Rev Gastroenterol Hepatol, V2, P233, DOI 10.1586/17474124.2.2.233; Kucharzik T, 2002, EUR J IMMUNOL, V32, P104, DOI 10.1002/1521-4141(200201)32:1<104::AID-IMMU104>3.0.CO;2-C; Liao F, 1999, J IMMUNOL, V162, P186; Lloyd CM, 2008, J IMMUNOL METHODS, V334, P70, DOI 10.1016/j.jim.2008.02.005; Marra F, 2014, GASTROENTEROLOGY, V147, P577, DOI 10.1053/j.gastro.2014.06.043; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623; Rahman AH, 2013, BBA-MOL BASIS DIS, V1832, P998, DOI 10.1016/j.bbadis.2013.01.005; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Rao R, 2014, GASTROENTEROLOGY, V147, P473, DOI 10.1053/j.gastro.2014.04.042; Shu SA, 2007, CLIN EXP IMMUNOL, V149, P335, DOI 10.1111/j.1365-2249.2007.03419.x; Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025; Thomas JA, 2011, HEPATOLOGY, V53, P2003, DOI 10.1002/hep.24315; Wang C, 2009, MUCOSAL IMMUNOL, V2, P173, DOI 10.1038/mi.2008.84; Wasmuth HE, 2010, SEMIN LIVER DIS, V30, P215, DOI 10.1055/s-0030-1255351; Wasmuth HE, 2009, GASTROENTEROLOGY, V137, P309, DOI 10.1053/j.gastro.2009.03.053; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Yamazaki T, 2008, J IMMUNOL, V181, P8391, DOI 10.4049/jimmunol.181.12.8391; Zimmermann Henning W., 2011, Inflammation & Allergy Drug Targets, V10, P509	36	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145147	10.1371/journal.pone.0145147	http://dx.doi.org/10.1371/journal.pone.0145147			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691857	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092300043
J	Jang, JW; Park, YH; Park, SY; Wang, MJ; Lim, JS; Kim, SH; Chun, IK; Yang, Y; Kim, S				Jang, Jae-Won; Park, Young Ho; Park, So Young; Wang, Min Jeong; Lim, Jae-Sung; Kim, Sung-Hun; Chun, In Kook; Yang, Youngsoon; Kim, SangYun			Longitudinal Cerebral Perfusion Change in Transient Global Amnesia Related to Left Posterior Medial Network Disruption	PLOS ONE			English	Article							JUGULAR VALVE INCOMPETENCE; TEMPORAL-LOBE; RISK-FACTORS; HIPPOCAMPAL; SPECT; HYPOPERFUSION; CONNECTIVITY; EVOLUTION; ACETAZOLAMIDE; ACTIVATION	Background The pathophysiology of transient global amnesia (TGA) is not fully understood. Previous studies using single photon emission computed tomography (SPECT) have reported inconclusive results regarding cerebral perfusion. This study was conducted to identify the patterns of regional cerebral blood flow (rCBF) in TGA patients via longitudinal SPECT analysis. An association between the observed SPECT patterns and a pathophysiological mechanism was considered. Methods Based on the TGA registry database of Seoul National University Bundang Hospital, 22 TGA patients were retrospectively identified. The subjects underwent initial Tc-99m-ethyl cysteinate dimer (ECD) SPECT within 4 days of an amnestic event and underwent follow-up scans approximately 6 months later. The difference in ECD uptake between the two scans was measured via voxel-based whole brain analysis, and the quantified ECD uptake was tested using a paired t-test. Results The TGA patients had significantly decreased cerebral perfusion at the left precuneus (P<0.001, uncorrected) and at the left superior parietal and inferior temporal gyrus according to the voxel-based whole brain analysis (P<0.005, uncorrected). A difference in the quantified ECD uptake between the 2 scans was also found at the left precuneus among the 62 cortical volumes of interest (P = 0.018, Cohen's d = -0.25). Conclusion We identified left hemispheric lateralized hypoperfusion that may be related to posterior medial network disruption. These findings may be a contributing factor to the pathophysiology of TGA.	[Jang, Jae-Won; Kim, Sung-Hun] Kangwon Natl Univ Hosp, Dept Neurol, Chunchon, South Korea; [Park, Young Ho; Park, So Young; Wang, Min Jeong; Kim, SangYun] Seoul Natl Univ, Bundang Hosp, Clin Neurosci Ctr, Seongnam, South Korea; [Park, Young Ho; Park, So Young; Wang, Min Jeong; Lim, Jae-Sung; Kim, SangYun] Seoul Natl Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Lim, Jae-Sung] Seoul Natl Univ, Boramae Med Ctr, Dept Neurol, Seoul, South Korea; [Chun, In Kook] Kangwon Natl Univ Hosp, Dept Nucl Med, Chunchon, South Korea; [Yang, Youngsoon] Seoul Vet Hosp, Dept Neurol, Seoul, South Korea	Kangwon National University; Kangwon National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Kangwon National University; Kangwon National University Hospital; Seoul Veterans Hospital	Kim, S (corresponding author), Seoul Natl Univ, Bundang Hosp, Clin Neurosci Ctr, Seongnam, South Korea.	neuroksy@snu.ac.kr	Chun, In Kook/V-9034-2019; Lim, Jae-Sung/D-5555-2012	Chun, In Kook/0000-0002-4144-3647; Lim, Jae-Sung/0000-0001-6157-2908				Agosti C, 2010, EUR NEUROL, V63, P291, DOI 10.1159/000292502; Akkawi NM, 2001, LANCET, V357, P957, DOI 10.1016/S0140-6736(05)71655-X; Baracchini C, 2015, J NEUROIMAGING, V25, P92, DOI 10.1111/jon.12090; Baracchini C, 2012, STROKE, V43, P2289, DOI 10.1161/STROKEAHA.112.654087; Bartsch T, 2007, ANN NEUROL, V62, P475, DOI 10.1002/ana.21189; Bartsch T, 2015, J CEREBR BLOOD F MET, V35, P1836, DOI 10.1038/jcbfm.2015.137; Caffarra P, 2009, BEHAV NEUROL, V22, P131, DOI [10.3233/BEN-2009-0253, 10.3233/ben-2009-0253]; Caplan L, 1985, TRANSIENT GLOBAL AMN, P205; Caplan LR, 2010, STROKE, V41, pE568, DOI 10.1161/STROKEAHA.110.579789; Caplan LR, 2010, STROKE, V41, pe9, DOI [10.1161/strokeaha.110.579789, DOI 10.1161/STR0KEAHA.110.579789]; Cejas C, 2010, STROKE, V41, P67, DOI 10.1161/STROKEAHA.109.566315; Chung YA, 2009, NEUROIMAGE, V47, P50, DOI 10.1016/j.neuroimage.2008.11.011; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Donnet A, 2015, HEADACHE, V55, P853, DOI 10.1111/head.12545; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Enzinger C, 2008, STROKE, V39, P2219, DOI 10.1161/STROKEAHA.107.508655; EVANS J, 1993, J NEUROL NEUROSUR PS, V56, P1227, DOI 10.1136/jnnp.56.11.1227; FISHER CM, 1964, ACTA NEUROL SCAND, V40, P7; Forster A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122537; FORMAN SD, 1995, MAGNET RESON MED, V33, P636, DOI 10.1002/mrm.1910330508; GOLDENBERG G, 1991, NEUROLOGY, V41, P1748, DOI 10.1212/WNL.41.11.1748; Han K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132893; HODGES JR, 1990, J NEUROL NEUROSUR PS, V53, P834, DOI 10.1136/jnnp.53.10.834; HODGES JR, 1990, BRAIN, V113, P639, DOI 10.1093/brain/113.3.639; Jovin TG, 2000, J NEUROIMAGING, V10, P238, DOI 10.1111/jon2000104238; Jung HH, 1996, J NEUROL NEUROSUR PS, V61, P654, DOI 10.1136/jnnp.61.6.654-a; Kang Y, 2015, EUR RADIOL, V25, P703, DOI 10.1007/s00330-014-3448-7; Kapucu OL, 2009, EUR J NUCL MED MOL I, V36, P2093, DOI 10.1007/s00259-009-1266-y; Kim J, 2013, J NEUROIMAGING OFFIC, DOI [10.1111/jon.12021, DOI 10.1111/J0N.12021]; Kwon Y, 2014, SEIZURE-EUR J EPILEP, V23, P825, DOI 10.1016/j.seizure.2014.06.014; La Joie R, 2014, NEURON, V81, P1417, DOI 10.1016/j.neuron.2014.01.026; LALOUX P, 1992, ARCH NEUROL-CHICAGO, V49, P543, DOI 10.1001/archneur.1992.00530290131022; Lewis SL, 1998, LANCET, V352, P397, DOI 10.1016/S0140-6736(98)01442-1; Libby LA, 2012, J NEUROSCI, V32, P6550, DOI 10.1523/JNEUROSCI.3711-11.2012; Lin KH, 2014, EUR J NEUROL, V21, P718, DOI 10.1111/ene.12346; LIN KN, 1993, STROKE, V24, P1093, DOI 10.1161/01.STR.24.7.1093; Lochner P, 2014, J NEUROIMAGING, V24, P479, DOI 10.1111/jon.12042; MATSUDA H, 1993, CLIN NUCL MED, V18, P46, DOI 10.1097/00003072-199301000-00011; MELO TP, 1992, BRAIN, V115, P261, DOI 10.1093/brain/115.1.261; Modabbernia A, 2012, ACTA NEUROL BELG, V112, P237, DOI 10.1007/s13760-012-0072-7; Moon Y, 2016, ACTA NEUROL SCAND, V134, P160, DOI 10.1111/ane.12518; Nardone R, 2004, J NEUROL, V251, P42, DOI 10.1007/s00415-004-0270-1; Pantoni L, 2005, EUR J NEUROL, V12, P350, DOI 10.1111/j.1468-1331.2004.00982.x; Park YH, 2016, CLIN EEG NEUROSCI, V47, P69, DOI 10.1177/1550059414543684; Park YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067447; Peer M, 2014, ANN NEUROL, V75, P634, DOI 10.1002/ana.24137; Ranganath C, 2012, NAT REV NEUROSCI, V13, P713, DOI 10.1038/nrn3338; Ritchey M, 2015, PROG BRAIN RES, V219, P45, DOI 10.1016/bs.pbr.2015.04.001; Ryoo I, 2012, NEURORADIOLOGY, V54, P329, DOI 10.1007/s00234-011-0889-4; Sakashita Y, 1997, J NEUROL NEUROSUR PS, V63, P605, DOI 10.1136/jnnp.63.5.605; Sander K, 2005, LANCET NEUROL, V4, P437, DOI 10.1016/S1474-4422(05)70121-6; Schmidtke K, 1998, J NUCL MED, V39, P155; Spaniol J, 2009, NEUROPSYCHOLOGIA, V47, P1765, DOI 10.1016/j.neuropsychologia.2009.02.028; Spreng RN, 2009, J COGNITIVE NEUROSCI, V21, P489, DOI 10.1162/jocn.2008.21029; STILLHARD G, 1990, J NEUROL NEUROSUR PS, V53, P339, DOI 10.1136/jnnp.53.4.339; Takeuchi R, 1998, J NUCL MED, V39, P1360; Warren JD, 2000, J CLIN NEUROSCI, V7, P57, DOI 10.1054/jocn.1998.0129; Winbeck K, 2005, J NEUROL NEUROSUR PS, V76, P438, DOI 10.1136/jnnp.2004.042432; Yamane Y, 2008, J COMPUT ASSIST TOMO, V32, P415, DOI 10.1097/RCT.0b013e3180de5b9b; Yang Y, 2008, J CLIN NEUROL, V4, P59, DOI 10.3988/jcn.2008.4.2.59; Yang Y, 2009, J CLIN NEUROL, V5, P74, DOI 10.3988/jcn.2009.5.2.74; ZORZON M, 1995, STROKE, V26, P1536, DOI 10.1161/01.STR.26.9.1536	62	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145658	10.1371/journal.pone.0145658	http://dx.doi.org/10.1371/journal.pone.0145658			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690067	Green Submitted, Green Published, gold			2022-12-26	WOS:000367092300093
J	Lee, SY; Park, HJ; Best-Popescu, C; Jang, S; Park, YK				Lee, Sang Yun; Park, Hyun Joo; Best-Popescu, Catherine; Jang, Seongsoo; Park, Yong Keun			The Effects of Ethanol on the Morphological and Biochemical Properties of Individual Human Red Blood Cells	PLOS ONE			English	Article							OPTICAL DIFFRACTION TOMOGRAPHY; ERYTHROCYTE-MEMBRANE FLUIDITY; PLASMODIUM-FALCIPARUM; PHASE MICROSCOPY; REFRACTIVE-INDEX; ALCOHOL; DYNAMICS; DEFORMABILITY; VISUALIZATION; HEMOGLOBIN	Here, we report the results of a study on the effects of ethanol exposure on human red blood cells (RBCs) using quantitative phase imaging techniques at the level of individual cells. Three-dimensional refractive index tomograms and dynamic membrane fluctuations of RBCs were measured using common-path diffraction optical tomography, from which morphological (volume, surface area, and sphericity); biochemical (hemoglobin (Hb) concentration and Hb content); and biomechanical (membrane fluctuation) parameters were retrieved at various concentrations of ethanol. RBCs exposed to the ethanol concentration of 0.1 and 0.3% v/v exhibited cell sphericities higher than those of normal cells. However, mean surface area and sphericity of RBCs in a lethal alcoholic condition (0.5% v/v) are not statistically different with those of healthy RBCs. Meanwhile, significant decreases of Hb content and concentration in RBC cytoplasm at the lethal condition were observed. Furthermore, dynamic fluctuation of RBC membranes increased significantly upon ethanol treatments, indicating ethanol-induced membrane fluidization.	[Lee, Sang Yun; Park, Hyun Joo; Park, Yong Keun] Korea Adv Inst Sci & Technol, Dept Phys, Daejeon, South Korea; [Best-Popescu, Catherine] Univ Illinois, Dept Bioengn, Urbana, IL USA; [Jang, Seongsoo] Univ Ulsan, Coll Med, Dept Lab Med, Seoul, South Korea; [Jang, Seongsoo] Univ Ulsan, Asan Med Ctr, Seoul, South Korea	Korea Advanced Institute of Science & Technology (KAIST); University of Illinois System; University of Illinois Urbana-Champaign; University of Ulsan; University of Ulsan	Park, YK (corresponding author), Korea Adv Inst Sci & Technol, Dept Phys, Daejeon, South Korea.	yk.park@kaist.ac.kr	Park, YongKeun/B-9017-2009	Park, YongKeun/0000-0003-0528-6661; Best-Popescu, Catherine/0000-0003-3857-5953	Korea Advanced Institute of Science and Technology (KAIST); National Research Foundation (NRF) of Korea [2014K1A3A1A09063027, 2013M3C1A3063046, 2012-M3C1A1-048860, 2014M3C1A3052537]; Asia Pacific Center for Theoretical Physics (APCTP); KAIST-Khalifa University; KAIST Endrun-project	Korea Advanced Institute of Science and Technology (KAIST); National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Asia Pacific Center for Theoretical Physics (APCTP); KAIST-Khalifa University; KAIST Endrun-project	This work was supported by Korea Advanced Institute of Science and Technology (KAIST), National Research Foundation (NRF) of Korea (2014K1A3A1A09063027, 2013M3C1A3063046, 2012-M3C1A1-048860, 2014M3C1A3052537), Asia Pacific Center for Theoretical Physics (APCTP), KAIST-Khalifa University, KAIST Endrun-project.	Ballard HS, 1997, ALCOHOL HEALTH RES W, V21, P42; BARER R, 1953, NATURE, V172, P1097, DOI 10.1038/1721097a0; BEAUGE F, 1985, ALCOHOL CLIN EXP RES, V9, P322, DOI 10.1111/j.1530-0277.1985.tb05552.x; BEAUGE F, 1988, BIOCHEM PHARMACOL, V37, P3823, DOI 10.1016/0006-2952(88)90062-7; Beauge F, 1986, ALCOHOL ALCOHOLISM S, V1, P561; Ben-Isaac E, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.238103; BENEDETTI A, 1986, PHARMACOL RES, V18, P1003, DOI 10.1016/0031-6989(86)90018-4; Byun H, 2012, ACTA BIOMATER, V8, P4130, DOI 10.1016/j.actbio.2012.07.011; Chandramohanadas R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020869; CHI LM, 1991, BIOCHIM BIOPHYS ACTA, V1062, P46, DOI 10.1016/0005-2736(91)90333-4; CHIEN S, 1987, ANNU REV PHYSIOL, V49, P177, DOI 10.1146/annurev.ph.49.030187.001141; CHIN JH, 1977, MOL PHARMACOL, V13, P435; CRANSTON HA, 1984, SCIENCE, V223, P400, DOI 10.1126/science.6362007; Debnath SK, 2011, OPT LETT, V36, P4677, DOI 10.1364/OL.36.004677; Deng JL, 2005, J RAMAN SPECTROSC, V36, P257, DOI 10.1002/jrs.1301; Diez-Silva M, 2012, SCI REPORTS, V2; Fehr M, 2008, CLIN HEMORHEOL MICRO, V39, P351, DOI 10.3233/CH-2008-1102; Friebel M, 2006, APPL OPTICS, V45, P2838, DOI 10.1364/AO.45.002838; GOLDSTEIN DB, 1986, ANN EMERG MED, V15, P1013, DOI 10.1016/S0196-0644(86)80120-2; Halsted CH, 2002, J NUTR, V132, p2367S, DOI 10.1093/jn/132.8.2367S; HARRIS RA, 1981, MOL PHARMACOL, V20, P128; HERBERT V, 1963, ANN INTERN MED, V58, P977, DOI 10.7326/0003-4819-58-6-977; HILLBOM ME, 1983, EUR J CLIN INVEST, V13, P45, DOI 10.1111/j.1365-2362.1983.tb00063.x; HRELIA S, 1986, BIOCHEM INT, V12, P741; Ioannou GN, 2004, GASTROENTEROLOGY, V126, P1293, DOI 10.1053/j.gastro.2004.01.020; Jensen T, 2006, BLOOD COAGUL FIBRIN, V17, P471, DOI 10.1097/01.mbc.0000240920.72930.63; Kim K, 2015, OPTICA, V2, P343, DOI 10.1364/OPTICA.2.000343; Kim K, 2014, OPT LETT, V39, P6935, DOI 10.1364/OL.39.006935; Kim K, 2013, OPT EXPRESS, V21, P32269, DOI 10.1364/OE.21.032269; Kim Y., 2012, MEASUREMENT TECHNIQU; Kim Y, 2014, STUDY EFFECT LEADERS, P4; Kim Y, 2014, OPT EXPRESS, V22, P10398, DOI 10.1364/OE.22.010398; Lauer V, 2002, J MICROSC-OXFORD, V205, P165, DOI 10.1046/j.0022-2720.2001.00980.x; Lee K, 2014, OPT LETT, V39, P3630, DOI 10.1364/OL.39.003630; Lee K, 2013, SENSORS-BASEL, V13, P4170, DOI 10.3390/s130404170; Lim J, 2015, OPT EXPRESS, V23, P16933, DOI 10.1364/OE.23.016933; MCLAWHON RW, 1987, J MEMBRANE BIOL, V99, P73, DOI 10.1007/BF01870623; Mohandas N, 1993, SEMINARS HEMATOLOGY; Oonishi T, 2000, ALCOHOL CLIN EXP RES, V24, P352, DOI 10.1097/00000374-200003000-00017; Palmieri VO, 2006, ADV EXP MED BIOL, V578, P125; Park H, 2015, ARXIV150500832; Park H., 2015, ARXIV150504232; Park YK, 2008, P NATL ACAD SCI USA, V105, P13730, DOI 10.1073/pnas.0806100105; Park YK, 2006, OPT EXPRESS, V14, P8263, DOI 10.1364/OE.14.008263; Park Y, 2011, MECHANOBIOLOGY OF CELL-CELL AND CELL-MATRIX INTERACTIONS, P279, DOI 10.1007/978-1-4419-8083-0_13; Park YK, 2010, P NATL ACAD SCI USA, V107, P1289, DOI 10.1073/pnas.0910785107; Park Y, 2009, OPT LETT, V34, P3668, DOI 10.1364/OL.34.003668; Popescu G, 2006, OPT LETT, V31, P775, DOI 10.1364/OL.31.000775; Popescu G., 2011, QUANTITATIVE PHASE I; Popescu G, 2008, BLOOD CELL MOL DIS, V41, P10, DOI 10.1016/j.bcmd.2008.01.010; Rabai M, 2010, CLIN HEMORHEOL MICRO, V44, P227, DOI 10.3233/CH-2010-1267; Ruef P, 1999, PEDIATR RES, V45, P114, DOI 10.1203/00006450-199901000-00019; Shaked NT, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3556717; Shin S, 2015, SPIE BIOS; Shin S., 2015, ARXIV150606237; Sonmez M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076579; STIBLER H, 1991, SCAND J CLIN LAB INV, V51, P309, DOI 10.3109/00365519109091621; Sung YJ, 2009, OPT EXPRESS, V17, P266, DOI 10.1364/OE.17.000266; TAKEDA M, 1982, J OPT SOC AM, V72, P156, DOI 10.1364/JOSA.72.000156; Tomaiuolo G, 2012, CYTOM PART A, V81A, P1040, DOI 10.1002/cyto.a.22215; Toth A, 2014, CLIN HEMORHEOL MICRO, V56, P13, DOI 10.3233/CH-2012-1640; Tyulina OV, 2002, ALCOHOL ALCOHOLISM, V37, P179, DOI 10.1093/alcalc/37.2.179; Tyulina OV, 2000, BBA-MOL BASIS DIS, V1535, P69, DOI 10.1016/S0925-4439(00)00086-7; Vent-Schmidt J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114412; WAUGH RE, 1992, BLOOD, V79, P1351; Wolf E., 1969, Optics Communications, V1, P153, DOI 10.1016/0030-4018(69)90052-2; WOOD WG, 1987, ALCOHOL CLIN EXP RES, V11, P332, DOI 10.1111/j.1530-0277.1987.tb01320.x; Yoo M, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.128005	68	26	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145327	10.1371/journal.pone.0145327	http://dx.doi.org/10.1371/journal.pone.0145327			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690915	Green Submitted, Green Published, gold			2022-12-26	WOS:000367092300057
J	Briffa, R; Um, I; Faratian, D; Zhou, Y; Turnbull, AK; Langdon, SP; Harrison, DJ				Briffa, Romina; Um, Inhwa; Faratian, Dana; Zhou, Ying; Turnbull, Arran K.; Langdon, Simon P.; Harrison, David J.			Multi-Scale Genomic, Transcriptomic and Proteomic Analysis of Colorectal Cancer Cell Lines to Identify Novel Biomarkers	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; DNA MISMATCH-REPAIR; COPY NUMBER ALTERATIONS; GENE-EXPRESSION; PROTEIN EXPRESSION; PROMOTER HYPERMETHYLATION; MICROARRAY ANALYSIS; CARCINOMA-CELLS; DEATH 6; MUTATIONS	Selecting colorectal cancer (CRC) patients likely to respond to therapy remains a clinical challenge. The objectives of this study were to establish which genes were differentially expressed with respect to treatment sensitivity and relate this to copy number in a panel of 15 CRC cell lines. Copy number variations of the identified genes were assessed in a cohort of CRCs. IC50's were measured for 5-fluorouracil, oxaliplatin, and BEZ-235, a PI3K/mTOR inhibitor. Cell lines were profiled using array comparative genomic hybridisation, Illumina gene expression analysis, reverse phase protein arrays, and targeted sequencing of KRAS hotspot mutations. Frequent gains were observed at 2p, 3q, 5p, 7p, 7q, 8q, 12p, 13q, 14q, and 17q and losses at 2q, 3p, 5q, 8p, 9p, 9q, 14q, 18q, and 20p. Frequently gained regions contained EGFR, PIK3CA, MYC, SMO, TRIB1, FZD1, and BRCA2, while frequently lost regions contained FHIT and MACROD2. TRIB1 was selected for further study. Gene enrichment analysis showed that differentially expressed genes with respect to treatment response were involved in Wnt signalling, EGF receptor signalling, apoptosis, cell cycle, and angiogenesis. Stepwise integration of copy number and gene expression data yielded 47 candidate genes that were significantly correlated. PDCD6 was differentially expressed in all three treatment responses. Tissue microarrays were constructed for a cohort of 118 CRC patients and TRIB1 and MYC amplifications were measured using fluorescence in situ hybridisation. TRIB1 and MYC were amplified in 14.5% and 7.4% of the cohort, respectively, and these amplifications were significantly correlated (p <= 0.0001). TRIB1 protein expression in the patient cohort was significantly correlated with pERK, Akt, and Caspase 3 expression. In conclusion, a set of candidate predictive biomarkers for 5-fluorouracil, oxaliplatin, and BEZ235 are described that warrant further study. Amplification of the putative oncogene TRIB1 has been described for the first time in a cohort of CRC patients.	[Briffa, Romina; Faratian, Dana; Zhou, Ying; Turnbull, Arran K.; Langdon, Simon P.] Univ Edinburgh, Inst Genet & Mol Med, Div Pathol, Edinburgh EH4 2XU, Midlothian, Scotland; [Um, Inhwa; Harrison, David J.] Univ St Andrews, Sch Med, St Andrews KY16 9TF, Fife, Scotland	University of Edinburgh; University of St Andrews	Langdon, SP (corresponding author), Univ Edinburgh, Inst Genet & Mol Med, Div Pathol, Crewe Rd South, Edinburgh EH4 2XU, Midlothian, Scotland.	simon.langdon@ed.ac.uk		Briffa, Romina/0000-0002-2223-1403; harrison, david/0000-0001-9041-9988; Turnbull, Arran/0000-0002-2287-0889	Strategic Educational Pathways Scholarship (Malta); European Union - European Social Fund (ESF) under Operational Programme II - Cohesion Policy "Empowering People for More Jobs and a Better Quality of Life"; Medical Research Scotland	Strategic Educational Pathways Scholarship (Malta); European Union - European Social Fund (ESF) under Operational Programme II - Cohesion Policy "Empowering People for More Jobs and a Better Quality of Life"; Medical Research Scotland	This work was partially funded by the Strategic Educational Pathways Scholarship (Malta). The scholarship is part-financed by the European Union - European Social Fund (ESF) under Operational Programme II - Cohesion Policy 2007-2013, "Empowering People for More Jobs and a Better Quality of Life". This project was additionally funded by Medical Research Scotland.	American Cancer Society, 2011, GLOB CANC FACTS FIG; Arnold CN, 2003, INT J CANCER, V106, P66, DOI 10.1002/ijc.11176; Barnetson RA, 2006, NEW ENGL J MED, V354, P2751, DOI 10.1056/NEJMoa053493; Barsotti AM, 2012, J BIOL CHEM, V287, P2509, DOI 10.1074/jbc.M111.322875; Baselga J, 2002, ONCOLOGIST, V7, P2; Bertrand FE, 2012, CELL CYCLE, V11, P4344, DOI 10.4161/cc.22134; Bhushan L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022484; Boyer J, 2004, CLIN CANCER RES, V10, P2158, DOI 10.1158/1078-0432.CCR-03-0362; Bracht K, 2010, BRIT J CANCER, V103, P340, DOI 10.1038/sj.bjc.6605780; Brough R, 2012, EMBO J, V31, P1160, DOI 10.1038/emboj.2011.490; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Camps J, 2009, GENE CHROMOSOME CANC, V48, P1002, DOI 10.1002/gcc.20699; Cervigne NK, 2014, HUM MOL GENET, V23, P2618, DOI 10.1093/hmg/ddt657; Chu E, 2012, CLIN COLORECTAL CANC, V11, P1, DOI 10.1016/j.clcc.2011.05.005; Colussi D, 2013, INT J MOL SCI, V14, P16365, DOI 10.3390/ijms140816365; Correia JD, 2007, CELL DEATH DIFFER, V14, P830, DOI 10.1038/sj.cdd.4402070; Custodio A, 2013, CRIT REV ONCOL HEMAT, V85, P45, DOI 10.1016/j.critrevonc.2012.05.001; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Drosten M, 2010, EMBO J, V29, P1091, DOI 10.1038/emboj.2010.7; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Edwards MC, 1997, GENETICS, V147, P1063; Ellison V, 1998, J BIOL CHEM, V273, P5979, DOI 10.1074/jbc.273.10.5979; Faratian D, 2011, JOVE-J VIS EXP, DOI 10.3791/3334; Faratian D, 2009, CANCER RES, V69, P6713, DOI 10.1158/0008-5472.CAN-09-0777; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Ferlay J, 2010, GLOBOCAN 2008 CANC I; Fink D, 1996, CANCER RES, V56, P4881; Fritsche-Guenther R, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.27; Ghoussaini M, 2008, JNCI-J NATL CANCER I, V100, P962, DOI 10.1093/jnci/djn190; Glaab E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-358; Goel A, 2004, CANCER RES, V64, P3014, DOI 10.1158/0008-5472.CAN-2401-2; Goga A, 2007, NAT MED, V13, P820, DOI 10.1038/nm1606; Heiser LM, 2012, P NATL ACAD SCI USA, V109, P2724, DOI 10.1073/pnas.1018854108; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huppi Konrad, 2012, Frontiers in Genetics, V3, P69, DOI 10.3389/fgene.2012.00069; Ilic N, 2011, P NATL ACAD SCI USA, V108, pE699, DOI 10.1073/pnas.1108237108; Jones AM, 2005, ONCOGENE, V24, P118, DOI 10.1038/sj.onc.1208194; Jung JJ, 2007, ONCOL REP, V18, P593; Kim H, 2009, NUCLEIC ACIDS RES, V37, P2940, DOI 10.1093/nar/gkp149; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Knutsen T, 2010, GENE CHROMOSOME CANC, V49, P204, DOI 10.1002/gcc.20730; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Kurisaki A, 2006, MOL CELL BIOL, V26, P1318, DOI 10.1128/MCB.26.4.1318-1332.2006; la Cour JM, 2003, AM J PATHOL, V163, P81, DOI 10.1016/S0002-9440(10)63632-2; Lagerstedt KK, 2010, CANCER INFORM, V9, P79; Lassmann S, 2007, J MOL MED-JMM, V85, P289, DOI 10.1007/s00109-006-0126-5; Li WT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033653; Linnebacher M, 2013, ONCOL LETT, V5, P173, DOI 10.3892/ol.2012.1006; Lockwood WW, 2012, CLIN CANCER RES, V18, P1936, DOI 10.1158/1078-0432.CCR-11-1431; Longley DB, 2007, 5 FLUOROURACIL APOPT, P263; Loo LWM, 2013, GENE CHROMOSOME CANC, V52, P450, DOI 10.1002/gcc.22043; Mackay A, 2009, BREAST CANCER RES TR, V118, P481, DOI 10.1007/s10549-008-0296-7; Mady HH, 2002, CLIN EXP METASTAS, V19, P351, DOI 10.1023/A:1015594702522; Mariadason JM, 2003, CANCER RES, V63, P8791; McCabe A, 2005, JNCI-J NATL CANCER I, V97, P1808, DOI 10.1093/jnci/dji427; Meyer C, 2013, ENDOCR-RELAT CANCER, V20, P123, DOI 10.1530/ERC-12-0192; Mojica W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-5; Moser R, 2012, MOL CANCER RES, V10, P535, DOI 10.1158/1541-7786.MCR-11-0508; Naccarati A, 2012, MUTAGENESIS, V27, P211, DOI 10.1093/mutage/ger067; National Comprehensive Cancer Network (NCCN), 2013, CLIN PRACT GUID ONC; Park SH, 2012, CELL SIGNAL, V24, P726, DOI 10.1016/j.cellsig.2011.11.006; Peng XW, 2015, CANCER BIOL THER, V16, P261, DOI 10.1080/15384047.2014.1001287; Pietrantonio F, 2014, ONCOLOGY, V86, P89; Raghavan Arvind, 2004, Briefings in Functional Genomics & Proteomics, V3, P112, DOI 10.1093/bfgp/3.2.112; Reed JC, 1997, NATURE, V387, P773, DOI 10.1038/42867; Rho SB, 2012, CELL SIGNAL, V24, P131, DOI 10.1016/j.cellsig.2011.08.013; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rochette PJ, 2002, ONCOGENE, V21, P5743, DOI 10.1038/sj.onc.1205641; Sadanandam A, 2013, NAT MED, V19, P619, DOI 10.1038/nm.3175; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Samuels Y, 2004, CELL CYCLE, V3, P1221, DOI 10.4161/cc.3.10.1164; Scartozzi M, 2011, BRIT J CANCER, V104, P1786, DOI 10.1038/bjc.2011.161; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Serra V, 2008, CANCER RES, V68, P8022, DOI 10.1158/0008-5472.CAN-08-1385; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Shi ZZ, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-52; Shortt J, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a009829; Smith G, 2002, P NATL ACAD SCI USA, V99, P9433, DOI 10.1073/pnas.122612899; Spitzner M, 2010, INT J RADIAT ONCOL, V78, P1184, DOI 10.1016/j.ijrobp.2010.06.023; Spurrier B, 2008, NAT PROTOC, V3, P1796, DOI 10.1038/nprot.2008.179; Su D, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-31; Suzuki K, 2012, CANCER SCI, V103, P1788, DOI 10.1111/j.1349-7006.2012.02362.x; Tan J, 2013, CHIN J CANCER, V32, P376, DOI 10.5732/cjc.012.10287; Toyoshima M, 2012, P NATL ACAD SCI USA, V109, P9545, DOI 10.1073/pnas.1121119109; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; Varella-Garcia M, 2009, J CLIN PATHOL, V62, P970, DOI 10.1136/jcp.2009.066548; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Wang Huixia, 2006, BMC Genomics, V7, P166; Weidlich S, 2011, BRIT J CANCER, V105, P246, DOI 10.1038/bjc.2011.197; Weinstein M, 1998, P NATL ACAD SCI USA, V95, P9378, DOI 10.1073/pnas.95.16.9378; Williams JR, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-71; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Xie T, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0042001, 10.1371/journal.pone.0047577]; Yang D, 2010, P NATL ACAD SCI USA, V107, P13836, DOI 10.1073/pnas.1008366107; Yao Y, 2009, BBA-PROTEINS PROTEOM, V1794, P1433, DOI 10.1016/j.bbapap.2009.06.005; Yokoyama T, 2011, CANCER SCI, V102, P1115, DOI 10.1111/j.1349-7006.2011.01914.x; Zhang C.J., 2011, DYE FINISH, V8, P1, DOI DOI 10.1371/J0URNAL.P0NE.0023849	102	33	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144708	10.1371/journal.pone.0144708	http://dx.doi.org/10.1371/journal.pone.0144708			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678268	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000366723400019
J	Cameron, SJ; Morrell, CN; Bao, C; Swaim, AF; Rodriguez, A; Lowenstein, CJ				Cameron, Scott J.; Morrell, Craig N.; Bao, Clare; Swaim, AnneMarie F.; Rodriguez, Annabelle; Lowenstein, Charles J.			A Novel Anti-Inflammatory Effect for High Density Lipoprotein	PLOS ONE			English	Article							APOLIPOPROTEIN-A-I; B TYPE-I; SCAVENGER RECEPTOR; SR-BI; HDL RECEPTOR; CHOLESTEROL; EXPRESSION; MYELOPEROXIDASE; PROTEIN; CELLS	High density lipoprotein has anti-inflammatory effects in addition to mediating reverse cholesterol transport. While many of the chronic anti-inflammatory effects of high density lipoprotein (HDL) are attributed to changes in cell adhesion molecules, little is known about acute signal transduction events elicited by HDL in endothelial cells. We now show that high density lipoprotein decreases endothelial cell exocytosis, the first step in leukocyte trafficking. ApoA-I, a major apolipoprotein of HDL, mediates inhibition of endothelial cell exocytosis by interacting with endothelial scavenger receptor-BI which triggers an intracellular protective signaling cascade involving protein kinase C (PKC). Other apolipoproteins within the HDL particle have only modest effects upon endothelial exocytosis. Using a human primary culture of endothelial cells and murine apo-AI knockout mice, we show that apo-AI prevents endothelial cell exocytosis which limits leukocyte recruitment. These data suggest that high density lipoprotein may inhibit diseases associated with vascular inflammation in part by blocking endothelial exocytosis.	[Cameron, Scott J.; Lowenstein, Charles J.] Univ Rochester, Sch Med, Div Cardiol, Dept Med, Rochester, NY 14652 USA; [Cameron, Scott J.; Morrell, Craig N.; Lowenstein, Charles J.] Univ Rochester, Sch Med, Aab Cardiovasc Res Inst, Rochester, NY 14652 USA; [Bao, Clare] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Morrell, Craig N.; Swaim, AnneMarie F.] Johns Hopkins Univ, Sch Med, Dept Comparat Med, Baltimore, MD 21205 USA; [Rodriguez, Annabelle] Univ Connecticut, Sch Med, Dept Cell Biol, Farmington, CT 06030 USA	University of Rochester; University of Rochester; Johns Hopkins University; Johns Hopkins University; University of Connecticut	Cameron, SJ (corresponding author), Univ Rochester, Sch Med, Div Cardiol, Dept Med, Box 679,601 Elmwood Ave, Rochester, NY 14652 USA.	scott_cameron@urmc.rochester.edu	Cameron, Scott/AAW-8429-2021	Cameron, Scott/0000-0002-9616-1540; Lowenstein, Charles/0000-0003-0485-7514	NIH/NHLBI [R21 HL108372]; Pfizer; American Heart Association [14GRNT19020033, 13EIA14250023]; NIH training grant [5T32HL066988-1]; Sable Heart Fund, Independent Order of Oddfellows; Bayer Diagnostics; National Institutes of Health [R01HL124018]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL108372, R01HL124018, T32HL066988] Funding Source: NIH RePORTER	NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Pfizer(Pfizer); American Heart Association(American Heart Association); NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sable Heart Fund, Independent Order of Oddfellows; Bayer Diagnostics(Bayer AG); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH/NHLBI grant R21 HL108372 (to CJL); an International HDL Research Awards Program from Pfizer (to CJL); American Heart Association grants 14GRNT19020033 (to CJL); NIH training grant 5T32HL066988-1 (to SJC); by Sable Heart Fund, Independent Order of Oddfellows (to SJC); by Bayer Diagnostics (to SJC); and by American Heart Association 13EIA14250023 and National Institutes of Health R01HL124018 (to CNM).; This study was supported by the following grants: NIH/NHLBI grant R21 HL108372 (to CJL); an International HDL Research Awards Program from Pfizer (to CJL); American Heart Association grants 14GRNT19020033 (to CJL); NIH training grant 5T32HL066988-1(to SJC); by Sable Heart Fund, Independent Order of Oddfellows (to SJC); by Bayer Diagnostics (to SJC); by American Heart Association 13EIA14250023 and National Institutes of Health R01HL124018 (to CNM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We are indebted to the late Dr. Peter O. Kwiterovich Jr as well as to Donna Virgil for isolation of HDL fractions and for some helpful discussions during the early part of this study.	ACTON SL, 1994, J BIOL CHEM, V269, P21003; Al-Jarallah A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106487; Ansell BJ, 2007, AM J CARDIOL, V100, p3N, DOI 10.1016/j.amjcard.2007.08.006; Ansell BJ, 2003, CIRCULATION, V108, P2751, DOI 10.1161/01.CIR.0000103624.14436.4B; Barragan M, 2006, J LEUKOCYTE BIOL, V80, P1473, DOI 10.1189/jlb.0106041; Barter Philip J, 2007, Curr Cardiol Rep, V9, P493, DOI 10.1007/BF02938394; Bergt C, 2004, P NATL ACAD SCI USA, V101, P13032, DOI 10.1073/pnas.0405292101; BODEN WE, 2000, AM J CARDIOL, V86, P19, DOI DOI 10.1016/S0002-9149(00)01464-8; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; COCKERILL GW, 1995, ARTERIOSCL THROM VAS, V15, P1987, DOI 10.1161/01.ATV.15.11.1987; Dorfman SE, 2005, J NUTR, V135, P492, DOI 10.1093/jn/135.3.492; FREEMAN M, 1991, P NATL ACAD SCI USA, V88, P4931, DOI 10.1073/pnas.88.11.4931; Gomaraschi M, 2008, J PHARMACOL EXP THER, V324, P776, DOI 10.1124/jpet.107.129411; Gong M, 2003, J CLIN INVEST, V111, P1579, DOI 10.1172/JCI200316777; GORDON DJ, 1989, NEW ENGL J MED, V321, P1311; HABERLAND ME, 1985, P NATL ACAD SCI USA, V82, P2693, DOI 10.1073/pnas.82.9.2693; Huby T, 2006, J CLIN INVEST, V116, P2767, DOI 10.1172/JCI26893; Krieger M, 2001, J CLIN INVEST, V108, P793, DOI 10.1172/JCI200114011; KRIEGER M, 1994, ANNU REV BIOCHEM, V63, P601, DOI 10.1146/annurev.bi.63.070194.003125; LAAKSO M, 1993, CIRCULATION, V88, P1421, DOI 10.1161/01.CIR.88.4.1421; LEES RS, 1963, J LAB CLIN MED, V61, P518; Li XM, 2002, J BIOL CHEM, V277, P27256, DOI 10.1074/jbc.M203267200; Linsel-Nitschke P, 2005, NAT REV DRUG DISCOV, V4, P193, DOI 10.1038/nrd1658; Martin SS, 2015, EUR HEART J, V36, P22, DOI 10.1093/eurheartj/ehu264; Matsushita K, 2003, CELL, V115, P139, DOI 10.1016/S0092-8674(03)00803-1; McDonald MC, 2003, SHOCK, V20, P551, DOI 10.1097/01.shk.0000097249.97298.a3; Navab M, 2005, TRENDS CARDIOVAS MED, V15, P158, DOI 10.1016/j.tcm.2005.05.008; Navab M, 2004, CURR OPIN LIPIDOL, V15, P645, DOI 10.1097/00041433-200412000-00004; NAVAB M, 1991, J CLIN INVEST, V88, P2039, DOI 10.1172/JCI115532; Nicholls SJ, 2007, JAMA-J AM MED ASSOC, V297, P499, DOI 10.1001/jama.297.5.499; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Nofer JR, 2004, J CLIN INVEST, V113, P569, DOI 10.1172/JCI200418004; Parastatidis I, 2007, CIRC RES, V101, P368, DOI 10.1161/CIRCRESAHA.107.157537; Rader DJ, 2003, AM J CARDIOL, V92, p42J, DOI 10.1016/S0002-9149(03)00615-5; Reddy ST, 2006, EXPERT OPIN INV DRUG, V15, P13, DOI 10.1517/13543784.15.1.13; Rigotti A, 1997, P NATL ACAD SCI USA, V94, P12610, DOI 10.1073/pnas.94.23.12610; Rodriguez C, 2009, THROMB HAEMOSTASIS, V101, P665, DOI 10.1160/TH08-10-0675; Seetharam D, 2006, CIRC RES, V98, P63, DOI 10.1161/01.RES.0000199272.59432.5b; Shao BH, 2005, J BIOL CHEM, V280, P5983, DOI 10.1074/jbc.M411484200; Shaul PW, 2004, J CLIN INVEST, V113, P509, DOI 10.1172/JCI200421072; Silver DL, 2001, CURR OPIN LIPIDOL, V12, P497, DOI 10.1097/00041433-200110000-00004; Simons K, 2000, SCIENCE, V290, P1721, DOI 10.1126/science.290.5497.1721; Subramaniam M, 1996, BLOOD, V87, P1238, DOI 10.1182/blood.V87.4.1238.bloodjournal8741238; Tall AR, 2002, J CLIN INVEST, V110, P899, DOI 10.1172/JCI200216391; Tedgui A, 2001, CIRC RES, V88, P877, DOI 10.1161/hh0901.090440; Teiber JF, 2004, J LIPID RES, V45, P2260, DOI 10.1194/jlr.M400213-JLR200; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; van der Veen JN, 2005, J LIPID RES, V46, P526, DOI 10.1194/jlr.M400400-JLR200; Van Lenten BJ, 2002, CIRCULATION, V106, P1127, DOI 10.1161/01.CIR.0000030182.35880.3E; WAGNER DD, 1993, THROMB HAEMOSTASIS, V70, P105; Walldius G, 2004, CLIN CHEM LAB MED, V42, P1355, DOI 10.1515/CCLM.2004.254; Watson AD, 1995, J CLIN INVEST, V96, P2882, DOI 10.1172/JCI118359; Wiejak J, 2012, MOL PHARMACOL, V81, P657, DOI 10.1124/mol.111.076976; Williams PT, 2011, ATHEROSCLEROSIS, V214, P196, DOI 10.1016/j.atherosclerosis.2010.10.024; Xia P, 1999, J BIOL CHEM, V274, P33143, DOI 10.1074/jbc.274.46.33143; Xu SZ, 1997, J LIPID RES, V38, P1289; Yamakuchi M, 2005, CIRC RES, V96, P1185, DOI 10.1161/01.RES.0000170229.49776.81; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986; Zheng L, 2005, J BIOL CHEM, V280, P38, DOI 10.1074/jbc.M407019200; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109; Zhu QY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118737; ZHU W, 2008, CIRCRESAHA AHA, V107, DOI DOI 10.1161/CIRCRESAHA.107.159079	62	11	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144372	10.1371/journal.pone.0144372	http://dx.doi.org/10.1371/journal.pone.0144372			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26680360	Green Submitted, Green Published, gold			2022-12-26	WOS:000366723400012
J	Chen, HY; Sun, MN; Liu, J; Tong, CX; Meng, T				Chen, Haiying; Sun, Manni; Liu, Jing; Tong, Chunxiao; Meng, Tao			Silencing of Paternally Expressed Gene 10 Inhibits Trophoblast Proliferation and Invasion	PLOS ONE			English	Article							IMPRINTED GENES; HUMAN PLACENTAS; PEG10; METALLOPROTEINASES; RETROTRANSPOSON; COLLAGENASE; MIGRATION; CELLS	Paternally expressed gene 10 (PEG10) is an imprinted and monoallelic expressed gene. Previous study using a knockout mouse model revealed a crucial role of PEG10 in placental development, yet the exact function of PEG10 during placentation remains to be elucidated. In this study, denuded chorionic villi were prepared from first trimester human placentas, and transduced with PEG10 small interference RNA (siRNA) or non-targeting control sequence by lentiviral infection. Immunohistochemical staining revealed that silencing of PEG10 in the chorionic villous explants resulted in reduced immune-reactivity to CK7, Ki67 and integrin alpha 5, implying that silencing of PEG10 impaired the proliferation of villous trophoblasts and may interfere with the activity of extravillous trophoblasts. We further investigated the role of PEG10 in the proliferation, migration and invasion of JEG-3 trophoblast cell line and the primary chorionic villous cells. PEG10-silenced JEG-3 cells and primary chorionic villous cells displayed a reduced proliferation rate and impaired invasiveness in vitro. Silencing of PEG10 in trophoblast cells led to upregulated expression of tissue inhibitor of metalloproteinase-1 (TIMP-1) as well as downregulated expression of matrix metalloproteinase (MMP)-2 and MMP-9. Furthermore, knockdown of TIMP-1 reversed the suppressed invasiveness of PEG10 siRNA-transduced JEG-3 cells. In conclusion, our study demonstrates that PEG10 plays an important role in trophoblast proliferation and promotes trophoblast invasion through TIMP-1.	[Chen, Haiying; Sun, Manni; Liu, Jing; Tong, Chunxiao; Meng, Tao] China Med Univ, Affiliated Hosp 1, Dept Obstet, Shenyang 110001, Peoples R China	China Medical University	Meng, T (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Obstet, Shenyang 110001, Peoples R China.	mengtao1995@163.com			National Natural Science Foundation of China [81270711]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from the National Natural Science Foundation of China (http://www.nsfc.gov.cn): No. 81270711. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apps R, 2011, PLACENTA, V32, P33, DOI 10.1016/j.placenta.2010.10.010; AUTIOHARMAINEN H, 1992, LAB INVEST, V67, P191; Baczyk D, 2006, PLACENTA, V27, P367, DOI 10.1016/j.placenta.2005.03.006; BIRKEDALHANSEN H, 1993, CRIT REV ORAL BIOL M, V4, P197, DOI 10.1177/10454411930040020401; Bischof P, 1995, Early Pregnancy, V1, P263; Chen HY, 2012, ACTA HISTOCHEM, V114, P589, DOI 10.1016/j.acthis.2011.11.003; Cohen M, 2007, GYNECOL OBSTET INVES, V64, P126, DOI 10.1159/000101734; Deng XZ, 2014, ONCOL REP, V32, P2159, DOI 10.3892/or.2014.3469; Diplas AI, 2009, EPIGENETICS-US, V4, P235, DOI 10.4161/epi.9019; Doria S, 2010, EPIGENETICS-US, V5, P444, DOI 10.4161/epi.5.5.12118; Gomez DE, 1997, EUR J CELL BIOL, V74, P111; Hunt JS, 2009, CURR OPIN PHARMACOL, V9, P462, DOI 10.1016/j.coph.2009.05.007; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Liang Xiao-Yan, 2008, Yichuan, V30, P735, DOI 10.3724/SP.J.1005.2008.00735; Metsalu T, 2014, EPIGENETICS-US, V9, P1397, DOI 10.4161/15592294.2014.970052; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Ono R, 2006, NAT GENET, V38, P101, DOI 10.1038/ng1699; Ono R, 2003, GENOME RES, V13, P1696, DOI 10.1101/gr.906803; Ono R, 2001, GENOMICS, V73, P232, DOI 10.1006/geno.2001.6494; PUISTOLA U, 1989, HUM REPROD, V4, P309, DOI 10.1093/oxfordjournals.humrep.a136894; Smallwood A, 2003, BIOL REPROD, V69, P286, DOI 10.1095/biolreprod.102.013078; WOOLLEY DE, 1975, BIOCHEM BIOPH RES CO, V66, P747, DOI 10.1016/0006-291X(75)90573-2; Xiong J, 2012, CLIN INVEST MED, V35, pE117; Zhang L, 2011, HUM REPROD, V26, P2146, DOI 10.1093/humrep/der153	24	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144845	10.1371/journal.pone.0144845	http://dx.doi.org/10.1371/journal.pone.0144845			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26680220	Green Published, gold, Green Submitted			2022-12-26	WOS:000366723400031
J	Milford, D; Rosbach, N; Bendszus, M; Heiland, S				Milford, David; Rosbach, Nicolas; Bendszus, Martin; Heiland, Sabine			Mono-Exponential Fitting in T2-Relaxometry: Relevance of Offset and First Echo	PLOS ONE			English	Article							TRANSVERSE RELAXOMETRY; ARTICULAR-CARTILAGE; SPATIAL VARIATION; T2 RELAXOMETRY; HIPPOCAMPAL T2; MRI; RELAXATION	Introduction T2 relaxometry has become an important tool in quantitative MRI. Little focus has been put on the effect of the refocusing flip angle upon the offset parameter, which was introduced to account for a signal floor due to noise or to long T2 components. The aim of this study was to show that B1 imperfections contribute significantly to the offset. We further introduce a simple method to reduce the systematic error in T2 by discarding the first echo and using the offset fitting approach. Materials and Methods Signal curves of T2 relaxometry were simulated based on extended phase graph theory and evaluated for 4 different methods (inclusion and exclusion of the first echo, while fitting with and without the offset). We further performed T2 relaxometry in a phantom at 9.4T magnetic resonance imaging scanner and used the same methods for post-processing as in the extended phase graph simulated data. Single spin echo sequences were used to determine the correct T2 time. Results The simulation data showed that the systematic error in T2 and the offset depends on the refocusing pulse, the echo spacing and the echo train length. The systematic error could be reduced by discarding the first echo. Further reduction of the systematic T2 error was reached by using the offset as fitting parameter. The phantom experiments confirmed these findings. Conclusion The fitted offset parameter in T2 relaxometry is influenced by imperfect refocusing pulses. Using the offset as a fitting parameter and discarding the first echo is a fast and easy method to minimize the error in T2, particularly for low to intermediate echo train length.	[Milford, David; Rosbach, Nicolas; Bendszus, Martin; Heiland, Sabine] Univ Heidelberg Hosp, Dept Neuroradiol, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Milford, D (corresponding author), Univ Heidelberg Hosp, Dept Neuroradiol, Heidelberg, Germany.	David.Milford@med.uni-heidelberg.de			Deutsche Forschungsgemeinschaft (DFG) [SFB 1118]; Dietmar-Hopp-Stiftung	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Dietmar-Hopp-Stiftung	This research was supported by grants of the Deutsche Forschungsgemeinschaft (DFG, SFB 1118) and of the Dietmar-Hopp-Stiftung.	Akhondi-Asl A, 2014, LECT NOTES COMPUT SC, V8675, P145, DOI 10.1007/978-3-319-10443-0_19; Andreychenko A, 2013, MAGN RESON MED, V70, P885, DOI 10.1002/mrm.24512; ARMSPACH JP, 1991, MAGN RESON IMAGING, V9, P107, DOI 10.1016/0730-725X(91)90104-T; Bevington P. R., 2003, DATA REDUCTION ERROR, DOI 10.2307/2284752; Carneiro AAO, 2006, BRAZ J PHYS, V36, P9, DOI 10.1590/S0103-97332006000100005; DAMADIAN R, 1971, SCIENCE, V171, P1151, DOI 10.1126/science.171.3976.1151; Dietrich O, 2008, EUR J RADIOL, V65, P29, DOI 10.1016/j.ejrad.2007.11.005; Duncan JS, 1997, AM J NEURORADIOL, V18, P1791; Duncan JS, 1996, AM J NEURORADIOL, V17, P1805; Feng YQ, 2013, MAGN RESON MED, V70, P1765, DOI 10.1002/mrm.24607; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Harms S E, 1986, Radiographics, V6, P117; HENNIG J, 1988, J MAGN RESON, V78, P397, DOI 10.1016/0022-2364(88)90128-X; Hennig J., 1991, CONCEPT MAGNETIC RES, V3, P179, DOI 10.1002/cmr.1820030402; Hennig J., 1991, CONCEPT MAGNETIC RES, V3, P125, DOI [10.1002/cmr.1820030302, DOI 10.1002/CMR.1820030302]; Kanzow C, 2004, J COMPUT APPL MATH, V172, P375, DOI 10.1016/j.cam.2004.02.013; Kosior RK, 2011, NEUROIMAGE, V58, P189, DOI 10.1016/j.neuroimage.2011.06.002; Lebel RM, 2010, MAGN RESON MED, V64, P1005, DOI 10.1002/mrm.22487; Lourakis M. I., LEVENBERG MARQUARDT; Maier CF, 2003, J MAGN RESON IMAGING, V17, P358, DOI 10.1002/jmri.10263; MAJUMDAR S, 1987, MAGNET RESON MED, V4, P203, DOI 10.1002/mrm.1910040302; MAJUMDAR S, 1986, MAGNET RESON MED, V3, P397, DOI 10.1002/mrm.1910030305; MAUDSLEY AA, 1986, J MAGN RESON, V69, P488, DOI 10.1016/0022-2364(86)90160-5; MEIBOOM S, 1958, REV SCI INSTRUM, V29, P688, DOI 10.1063/1.1716296; Mosher TJ, 2000, RADIOLOGY, V214, P259, DOI 10.1148/radiology.214.1.r00ja15259; Neumann D, 2014, MAGN RESON MATER PHY, V27, P567, DOI 10.1007/s10334-014-0438-3; Pell GS, 2006, J MAGN RESON IMAGING, V23, P248, DOI 10.1002/jmri.20490; Pell GS, 2004, NEUROIMAGE, V21, P707, DOI 10.1016/j.neuroimage.2003.09.059; Pell GS, 2003, P ISMRM 11 ANN M; Petrovic A, 2015, MAGN RESON MED, V73, P818, DOI 10.1002/mrm.25170; Prasloski T, 2012, MAGN RESON MED, V67, P1803, DOI 10.1002/mrm.23157; Schar M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139859; Smith HE, 2001, J MAGN RESON IMAGING, V14, P50, DOI 10.1002/jmri.1150; St Pierre TG, 2004, NMR BIOMED, V17, P446, DOI 10.1002/nbm.905; THORPE JW, 1995, J NEUROL NEUROSUR PS, V59, P487, DOI 10.1136/jnnp.59.5.487; Tofts P., 2005, QUANTITATIVE MRI BRA, P143; Weigel M., 2014, J MAGN RESON IMAGING; Whittall KP, 1999, MAGNET RESON MED, V41, P1255, DOI 10.1002/(SICI)1522-2594(199906)41:6<1255::AID-MRM23>3.0.CO;2-I; Wood JC, 2005, BLOOD, V106, P1460, DOI 10.1182/blood-2004-10-3982; Zelaya FO, 1997, MAGN RESON IMAGING, V15, P497, DOI 10.1016/S0730-725X(96)00396-7	41	60	60	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145255	10.1371/journal.pone.0145255	http://dx.doi.org/10.1371/journal.pone.0145255			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678918	gold, Green Published, Green Submitted			2022-12-26	WOS:000366723400064
J	Richards, CL; Lawrence, KA; Su, H; Yang, YY; Yang, XF; Dulebohn, DP; Gherardini, FC				Richards, Crystal L.; Lawrence, Kevin A.; Su, Hua; Yang, Youyun; Yang, X. Frank; Dulebohn, Daniel P.; Gherardini, Frank C.			Acetyl-Phosphate Is Not a Global Regulatory Bridge between Virulence and Central Metabolism in Borrelia burgdorferi	PLOS ONE			English	Article							RESPONSE REGULATOR; ESCHERICHIA-COLI; LYME-DISEASE; GENE-EXPRESSION; IN-VITRO; LIPID-II; RPOS; PHOSPHORYLATION; SPIROCHETE; RESISTANCE	In B. burgdorferi, the Rrp2-RpoN-RpoS signaling cascade is a distinctive system that coordinates the expression of virulence factors required for successful transition between its arthropod vector and mammalian hosts. Rrp2 (BB0763), an RpoN specific response regulator, is essential to activate this regulatory pathway. Previous investigations have attempted to identify the phosphate donor of Rrp2, including the cognate histidine kinase, Hk2 (BB0764), non-cognate histidine kinases such as Hk1, CheA1, and CheA2, and small molecular weight P-donors such as carbamoyl-phosphate and acetyl-phosphate (AcP). In a report by Xu et al., exogenous sodium acetate led to increased expression of RpoS and OspC and it was hypothesized this effect was due to increased levels of AcP via the enzyme AckA (BB0622). Genome analyses identified only one pathway that could generate AcP in B. burgdorferi: the acetate/mevalonate pathway that synthesizes the lipid, undecaprenyl phosphate (C-55-P, lipid I), which is essential for cell wall biogenesis. To assess the role of AcP in Rrp2-dependent regulation of RpoS and OspC, we used a unique selection strategy to generate mutants that lacked ackA (bb0622: acetate to AcP) or pta (bb0589: AcP to acetyl-CoA). These mutants have an absolute requirement for mevalonate and demonstrate that ackA and pta are required for cell viability. When the Delta ackA or Delta pta mutant was exposed to conditions (i.e., increased temperature or cell density) that up-regulate the expression of RpoS and OspC, normal induction of those proteins was observed. In addition, adding 20mM acetate or 20mM benzoate to the growth media of B. burgdorferi strain B31 Delta ackA induced the expression of RpoS and OspC. These data suggest that AcP (generated by AckA) is not directly involved in modulating the Rrp2-RpoN-RpoS regulatory pathway and that exogenous acetate or benzoate are triggering an acid stress response in B. burgdorferi.	[Richards, Crystal L.; Lawrence, Kevin A.; Su, Hua; Dulebohn, Daniel P.; Gherardini, Frank C.] NIH, Lab Zoonot Pathogens, Rocky Mt Labs, Hamilton, MT 59840 USA; [Yang, Youyun; Yang, X. Frank] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	National Institutes of Health (NIH) - USA; Indiana University System; Indiana University Bloomington	Gherardini, FC (corresponding author), NIH, Lab Zoonot Pathogens, Rocky Mt Labs, Hamilton, MT 59840 USA.	Fgherardini@niaid.nih.gov			Intramural Research Program of the NIAID (National Institute of Allergy and Infectious Diseases (US)), NIH (National Institutes of Health (US)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000905] Funding Source: NIH RePORTER	Intramural Research Program of the NIAID (National Institute of Allergy and Infectious Diseases (US)), NIH (National Institutes of Health (US)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the NIAID (National Institute of Allergy and Infectious Diseases (US)), NIH (National Institutes of Health (US)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbieri CM, 2008, ANAL BIOCHEM, V376, P73, DOI 10.1016/j.ab.2008.02.004; BARBOUR AG, 1986, INFECT IMMUN, V52, P549, DOI 10.1128/IAI.52.2.549-554.1986; Blevins JS, 2009, J BACTERIOL, V191, P2902, DOI 10.1128/JB.01721-08; Boardman BK, 2008, INFECT IMMUN, V76, P3844, DOI 10.1128/IAI.00467-08; Bouche S, 1998, MOL MICROBIOL, V27, P787, DOI 10.1046/j.1365-2958.1998.00725.x; Brooks CS, 2003, INFECT IMMUN, V71, P3371, DOI 10.1128/IAI.71.6.3371-3383.2003; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Burtnick MN, 2007, MOL MICROBIOL, V65, P277, DOI 10.1111/j.1365-2958.2007.05813.x; Caimano MJ, 2004, INFECT IMMUN, V72, P6433, DOI 10.1128/IAI.72.11.6433-6445.2004; Calmano MJ, 2007, MOL MICROBIOL, V65, P1193, DOI 10.1111/j.1365-2958.2007.05860.x; DEVER LL, 1993, ANTIMICROB AGENTS CH, V37, P1115, DOI 10.1128/AAC.37.5.1115; Dulebohn DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093141; Elias AF, 2003, J MOL MICROB BIOTECH, V6, P29, DOI 10.1159/000073406; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; Ferry James G., 2015, Life-Basel, V5, P1454, DOI 10.3390/life5021454; Frank KL, 2003, J BACTERIOL, V185, P6723, DOI 10.1128/JB.185.22.6723-6727.2003; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Gherardini F., 2010, BORRELIA MOL BIOL HO, P103; Honda M, 2000, J INHERIT METAB DIS, V23, P464, DOI 10.1023/A:1005660130109; Hubner A, 2001, P NATL ACAD SCI USA, V98, P12724, DOI 10.1073/pnas.231442498; Kazragis RJ, 1996, ANTIMICROB AGENTS CH, V40, P2632, DOI 10.1128/AAC.40.11.2632; Kim SB, 2001, FEMS MICROBIOL LETT, V195, P179, DOI 10.1111/j.1574-6968.2001.tb10518.x; Klein AH, 2007, J BACTERIOL, V189, P5574, DOI 10.1128/JB.00564-07; Kramer NE, 2004, FEMS MICROBIOL LETT, V239, P157, DOI 10.1016/j.femsle.2004.08.033; LANE RS, 1991, ANNU REV ENTOMOL, V36, P587, DOI 10.1146/annurev.en.36.010191.003103; Lange BM, 2000, P NATL ACAD SCI USA, V97, P13172, DOI 10.1073/pnas.240454797; Liu XQ, 2009, J MICROBIOL, V47, P657, DOI 10.1007/s12275-009-0087-9; LUKAT GS, 1992, P NATL ACAD SCI USA, V89, P718, DOI 10.1073/pnas.89.2.718; Lybecker MC, 2007, MOL MICROBIOL, V64, P1075, DOI 10.1111/j.1365-2958.2007.05716.x; Martin NI, 2007, FUTURE MICROBIOL, V2, P513, DOI 10.2217/17460913.2.5.513; Muller M, 2012, MICROBIOL MOL BIOL R, V76, P444, DOI 10.1128/MMBR.05024-11; Ojaimi C, 2003, INFECT IMMUN, V71, P1689, DOI 10.1128/IAI.71.4.1689-1705.2003; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Schwan TG, 2000, J CLIN MICROBIOL, V38, P382; SMITH PJC, 1960, BIOCHEM J, V76, P514, DOI 10.1042/bj0760514; STORM DR, 1974, J BIOL CHEM, V249, P1823; Sze CW, 2011, INFECT IMMUN, V79, P1270, DOI 10.1128/IAI.00871-10; Van Laar TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038171; von Lackum K, 2005, FEMS MICROBIOL LETT, V243, P173, DOI 10.1016/j.femsle.2004.12.002; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07; Wolfe AJ, 2010, CURR OPIN MICROBIOL, V13, P204, DOI 10.1016/j.mib.2010.01.002; Xu HJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001104; Yang XF, 2000, MOL MICROBIOL, V37, P1470, DOI 10.1046/j.1365-2958.2000.02104.x; Zhao YS, 2005, APPL ENVIRON MICROB, V71, P530, DOI 10.1128/AEM.71.1.530-537.2005	45	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144472	10.1371/journal.pone.0144472	http://dx.doi.org/10.1371/journal.pone.0144472			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26681317	gold, Green Published			2022-12-26	WOS:000366723400016
J	Lorenzo, JR; Alonso, LG; Sanchez, IE				Lorenzo, J. Ramiro; Alonso, Leonardo G.; Sanchez, Ignacio E.			Prediction of Spontaneous Protein Deamidation from Sequence-Derived Secondary Structure and Intrinsic Disorder	PLOS ONE			English	Article							ISOASPARTATE; PEPTIDES; RESIDUES; SERVER; DAMAGE; RATES	Asparagine residues in proteins undergo spontaneous deamidation, a post-translational modification that may act as a molecular clock for the regulation of protein function and turnover. Asparagine deamidation is modulated by protein local sequence, secondary structure and hydrogen bonding. We present NGOME, an algorithm able to predict non-enzymatic deamidation of internal asparagine residues in proteins in the absence of structural data, using sequence-based predictions of secondary structure and intrinsic disorder. Compared to previous algorithms, NGOME does not require three-dimensional structures yet yields better predictions than available sequence-only methods. Four case studies of specific proteins show how NGOME may help the user identify deamidation-prone asparagine residues, often related to protein gain of function, protein degradation or protein misfolding in pathological processes. A fifth case study applies NGOME at a proteomic scale and unveils a correlation between asparagine deamidation and protein degradation in yeast. NGOME is freely available as a webserver at the National EMBnet node Argentina, URL: http://www.embnet.qb.fcen.uba.ar/in the subpage "Protein and nucleic acid structure and sequence analysis".	[Lorenzo, J. Ramiro] Consejo Nacl Invest Cient & Tecn, Inst Invest Ingn Genet & Biol Mol, Buenos Aires, DF, Argentina; [Alonso, Leonardo G.] Fdn Inst Leloir, Prot Struct Funct & Engn Lab, Buenos Aires, DF, Argentina; [Alonso, Leonardo G.] IIBBA CONICET, Buenos Aires, DF, Argentina; [Sanchez, Ignacio E.] Univ Buenos Aires, Prot Physiol Lab, Dept Quim Biol, Fac Ciencias Exactas & Nat, Buenos Aires, DF, Argentina; [Sanchez, Ignacio E.] Univ Buenos Aires, IQUIBICEN CONICET, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires	Alonso, LG (corresponding author), Fdn Inst Leloir, Prot Struct Funct & Engn Lab, Buenos Aires, DF, Argentina.	leonardoe7@gmail.com; isanchez@qb.fcen.uba.ar		Sanchez, Ignacio Enrique/0000-0003-4284-9013; Alonso, Leonardo Gabriel/0000-0002-0596-703X; Lorenzo Lopez, Juan Ramiro/0000-0002-1860-9418	Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina) [PICT 2012-2550]; CONICET graduate fellowship	Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina)(ANPCyT); CONICET graduate fellowship	Funding was provided by Agencia Nacional de Promocion Cientifica y Tecnologica (Argentina, www.agencia.mincyt.gob.ar), grant number PICT 2012-2550 to IES. Funding was also provided by CONICET graduate fellowship to RL; IES and LGA are career investigators from CONICET. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Curnis F, 2006, J BIOL CHEM, V281, P36466, DOI 10.1074/jbc.M604812200; Daughdrill GW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029207; Deverman BE, 2002, CELL, V111, P51, DOI 10.1016/S0092-8674(02)00972-8; Diepold K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030295; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Furuya K, 2009, DEAMIDATED INTERFERO; GEIGER T, 1987, J BIOL CHEM, V262, P785; Harris RJ, 2001, J CHROMATOGR B, V752, P233, DOI 10.1016/S0378-4347(00)00548-X; Kosky AA, 1999, PROTEIN SCI, V8, P2519; Kosky AA, 2009, PHARM RES-DORDR, V26, P2417, DOI 10.1007/s11095-009-9953-8; Lowenson JD, 2001, J BIOL CHEM, V276, P20695, DOI 10.1074/jbc.M100987200; Patananan AN, 2014, J BIOL CHEM, V289, P16936, DOI 10.1074/jbc.M114.564385; Reissner KJ, 2003, CELL MOL LIFE SCI, V60, P1281, DOI 10.1007/s00018-003-2287-5; Robinson NE, 2002, P NATL ACAD SCI USA, V99, P5283, DOI 10.1073/pnas.082102799; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P4367, DOI 10.1073/pnas.071066498; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P944, DOI 10.1073/pnas.98.3.944; Shi YH, 2013, J AM CHEM SOC, V135, P15897, DOI 10.1021/ja407801x; Sydow JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100736; Vergara IA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-265	21	20	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145186	10.1371/journal.pone.0145186	http://dx.doi.org/10.1371/journal.pone.0145186			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674530	Green Published, Green Submitted, gold			2022-12-26	WOS:000366722700113
J	Minarik, G; Repiska, G; Hyblova, M; Nagyova, E; Soltys, K; Budis, J; Duris, F; Sysak, R; Bujalkova, MG; Vlkova-Izrael, B; Biro, O; Nagy, B; Szemes, T				Minarik, Gabriel; Repiska, Gabriela; Hyblova, Michaela; Nagyova, Emilia; Soltys, Katarina; Budis, Jaroslav; Duris, Frantisek; Sysak, Rastislav; Bujalkova, Maria Gerykova; Vlkova-Izrael, Barbora; Biro, Orsolya; Nagy, Balint; Szemes, Tomas			Utilization of Benchtop Next Generation Sequencing Platforms Ion Torrent PGM and MiSeq in Noninvasive Prenatal Testing for Chromosome 21 Trisomy and Testing of Impact of In Silico and Physical Size Selection on Its Analytical Performance	PLOS ONE			English	Article							FREE FETAL DNA; MATERNAL PLASMA; ANEUPLOIDIES; DIAGNOSIS; BLOOD	Objectives The aims of this study were to test the utility of benchtop NGS platforms for NIPT for trisomy 21 using previously published z score calculation methods and to optimize the sample preparation and data analysis with use of in silico and physical size selection methods. Methods Samples from 130 pregnant women were analyzed by whole genome sequencing on benchtop NGS systems Ion Torrent PGM and MiSeq. The targeted yield of 3 million raw reads on each platform was used for z score calculation. The impact of in silico and physical size selection on analytical performance of the test was studied. Results Using a z score value of 3 as the cut-off, 98.11% - 100% (104-106/106) specificity and 100% (24/24) sensitivity and 99.06% - 100% (105-106/106) specificity and 100% (24/24) sensitivity were observed for Ion Torrent PGM and MiSeq, respectively. After in silico based size selection both platforms reached 100% specificity and sensitivity. Following the physical size selection z scores of tested trisomic samples increased significantly-p = 0.0141 and p = 0.025 for Ion Torrent PGM and MiSeq, respectively. Conclusions Noninvasive prenatal testing for chromosome 21 trisomy with the utilization of benchtop NGS systems led to results equivalent to previously published studies performed on high-to-ultrahigh throughput NGS systems. The in silico size selection led to higher specificity of the test. Physical size selection performed on isolated DNA led to significant increase in z scores. The observed results could represent a basis for increasing of cost effectiveness of the test and thus help with its penetration worldwide.	[Minarik, Gabriel; Repiska, Gabriela; Vlkova-Izrael, Barbora] Comenius Univ, Fac Med, Inst Mol Biomed, Bratislava, Slovakia; [Minarik, Gabriel; Hyblova, Michaela; Nagyova, Emilia; Soltys, Katarina; Duris, Frantisek; Szemes, Tomas] Comenius Univ, Fac Nat Sci, Dept Mol Biol, Bratislava, Slovakia; [Minarik, Gabriel; Vlkova-Izrael, Barbora; Szemes, Tomas] Geneton Ltd, Bratislava, Slovakia; [Budis, Jaroslav; Duris, Frantisek] Comenius Univ, Fac Math Phys & Informat, Dept Comp Sci, Bratislava, Slovakia; [Sysak, Rastislav] Comenius Univ, Fac Med, Dept Gynaecol & Obstet 1, Bratislava, Slovakia; [Bujalkova, Maria Gerykova] Medirex Inc, Dept Clin Genet, Bratislava, Slovakia; [Bujalkova, Maria Gerykova] Nemocnicna Inc, Outpatient Clin Med Genet, Malacky, Slovakia; [Biro, Orsolya; Nagy, Balint] Semmelweis Univ, Dept Obstet & Gynecol 1, H-1085 Budapest, Hungary	Comenius University Bratislava; Comenius University Bratislava; Comenius University Bratislava; Comenius University Bratislava; Semmelweis University	Minarik, G (corresponding author), Comenius Univ, Fac Med, Inst Mol Biomed, Bratislava, Slovakia.	gabriel.minarik@gmail.com	Hyblova, Michaela/GPW-9833-2022; Budis, Jaroslav/N-8117-2019; Soltys, Katarina/Q-6592-2018; hyblova, Michaela/AAS-5147-2020; Soltys, Katarina/W-1265-2017	Hyblova, Michaela/0000-0001-6519-4967; Budis, Jaroslav/0000-0002-8667-6655; Soltys, Katarina/0000-0003-3862-3329; Duris, Frantisek/0000-0001-8985-4122; Gerykova Bujalkova, Maria/0000-0001-6840-1802; Repiska, Gabriela/0000-0003-2069-8859; Szemes, Tomas/0000-0002-0900-2534	Slovak Research and Development Agency [VMSP-II-0030-09, APVV-0720-10]; Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic [VEGA-1/0285/11]; Research & Development Operational Programme - ERDF project REVOGENE - Research centre for molecular genetics - Geneton Ltd. [ITMS 26240220067]; Geneton Ltd.; Medirex Inc.; Nemocnicna Inc.	Slovak Research and Development Agency(Slovak Research and Development Agency); Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic; Research & Development Operational Programme - ERDF project REVOGENE - Research centre for molecular genetics - Geneton Ltd.; Geneton Ltd.; Medirex Inc.; Nemocnicna Inc.	The project was supported by Slovak Research and Development Agency - projects VMSP-II-0030-09 and APVV-0720-10 - GM; Grant Agency of the Ministry of Education, Science, Research and Sport of the Slovak Republic - project VEGA-1/0285/11 - GM and Research & Development Operational Programme funded by the ERDF project REVOGENE - Research centre for molecular genetics - ITMS 26240220067 - Geneton Ltd. The funders Geneton Ltd., Medirex Inc. and Nemocnicna Inc. provided support in the form of salaries for authors GM, TS and MGB, respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ashoor G, 2012, AM J OBSTET GYNECOL, V206, P322, DOI DOI 10.1016/j.ajog.2012.01.029; Bianchi DW, 2012, OBSTET GYNECOL, V119, P890, DOI 10.1097/AOG.0b013e31824fb482; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chiu RWK, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7401; Ehrich M, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.060; Faas BHW, 2012, EXPERT OPIN BIOL TH, V12, pS19, DOI 10.1517/14712598.2012.670632; Fan HC, 2008, P NATL ACAD SCI USA, V105, P16266, DOI 10.1073/pnas.0808319105; Hiromadnikova I, 2006, DNA CELL BIOL, V25, P635, DOI 10.1089/dna.2006.25.635; Jeon YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110240; Jiang FM, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-57; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lau TK, 2012, J MATERN-FETAL NEO M, V25, P1370, DOI 10.3109/14767058.2011.635730; Li Y, 2004, CLIN CHEM, V50, P1002, DOI 10.1373/clinchem.2003.029835; Liao C, 2014, P NATL ACAD SCI USA, V111, P7415, DOI 10.1073/pnas.1321997111; Lo KK, 2014, BIOINFORMATICS, V30, P2965, DOI 10.1093/bioinformatics/btu419; Lo YMD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001720; Lo YMD, 1998, AM J HUM GENET, V62, P768, DOI 10.1086/301800; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Lo YMD, 1998, NEW ENGL J MED, V339, P1734, DOI 10.1056/NEJM199812103392402; Nicolaides KH, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.08.033; Palomaki GE, 2012, GENET MED, V14, P296, DOI 10.1038/gim.2011.73; Palomaki GE, 2011, GENET MED, V13, P913, DOI 10.1097/GIM.0b013e3182368a0e; Quail MA, 2012, ELECTROPHORESIS, V33, P3521, DOI 10.1002/elps.201200128; Rava RP, 2014, CLIN CHEM, V60, P243, DOI 10.1373/clinchem.2013.207951; Sehnert AJ, 2011, CLIN CHEM, V57, P1042, DOI 10.1373/clinchem.2011.165910; Stumm M, 2012, PRENATAL DIAG, V32, P569, DOI 10.1002/pd.3862; Wang YL, 2014, J HUM GENET, V59, P393, DOI 10.1038/jhg.2014.40; Yuan Y, 2013, CLIN CHEM, V59, P846, DOI 10.1373/clinchem.2012.196725	28	24	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144811	10.1371/journal.pone.0144811	http://dx.doi.org/10.1371/journal.pone.0144811			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26669558	Green Published, gold, Green Submitted			2022-12-26	WOS:000366719300023
J	Niknazar, M; Krishnan, GP; Bazhenov, M; Mednick, SC				Niknazar, Mohammad; Krishnan, Giri P.; Bazhenov, Maxim; Mednick, Sara C.			Coupling of Thalamocortical Sleep Oscillations Are Important for Memory Consolidation in Humans	PLOS ONE			English	Article							SLOW-WAVE SLEEP; SPINDLES; MECHANISMS; ZOLPIDEM; OXYBATE; IMPACT; MODEL	Sleep, specifically non-rapid eye movement (NREM) sleep, is thought to play a critical role in the consolidation of recent memories. Two main oscillatory activities observed during NREM, cortical slow oscillations (SO, 0.5-1.0Hz) and thalamic spindles (12-15Hz), have been shown to independently correlate with memory improvement. Yet, it is not known how these thalamocortical events interact, or the significance of this interaction, during the consolidation process. Here, we found that systemic administration of the GABAergic drug (zolpidem) increased both the phase-amplitude coupling between SO and spindles, and verbal memory improvement in humans. These results suggest that thalamic spindles that occur during transitions to the cortical SO Up state are optimal for memory consolidation. Our study predicts that the timely interactions between cortical and thalamic events during consolidation, contribute to memory improvement and is mediated by the level of inhibitory neurotransmission.	[Niknazar, Mohammad; Krishnan, Giri P.; Bazhenov, Maxim] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA; [Niknazar, Mohammad; Mednick, Sara C.] Univ Calif Riverside, Dept Psychol, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside	Bazhenov, M (corresponding author), Univ Calif Riverside, Dept Cell Biol & Neurosci, 900 Univ Ave, Riverside, CA 92521 USA.	bazhenov@salk.edu; sara.mednick@ucr.edu		mednick, sara/0000-0002-0906-3097	HHS \ NIH \ National Institute on Aging (U.S. National Institute on Aging) [R01AG046646]; DOD \ ONR \ Office of Naval Research Global (ONR Global) [MURI: N000141310672]; NIH [R01AG046646]; ONR [MURI: N000141310672]; NATIONAL INSTITUTE ON AGING [R01AG046646] Funding Source: NIH RePORTER	HHS \ NIH \ National Institute on Aging (U.S. National Institute on Aging); DOD \ ONR \ Office of Naval Research Global (ONR Global); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ONR(Office of Naval Research); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by HHS vertical bar NIH vertical bar National Institute on Aging (U.S. National Institute on Aging) - R01AG046646 [Bazhenov], DOD vertical bar ONR vertical bar Office of Naval Research Global (ONR Global) MURI: N000141310672 [Bazhenov], and HHS vertical bar NIH vertical bar National Institute on Aging (U.S. National Institute on Aging) - R01AG046646 [Mednick].; This work was supported by grants from NIH (R01AG046646) and ONR (MURI: N000141310672).	Battaglia FP, 2004, LEARN MEMORY, V11, P697, DOI 10.1101/lm.73504; Bazhenov M, 2000, J NEUROPHYSIOL, V84, P1076, DOI 10.1152/jn.2000.84.2.1076; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Chen JY, 2012, J PHYSIOL-LONDON, V590, P3987, DOI 10.1113/jphysiol.2012.227462; Crestani F, 2000, BRIT J PHARMACOL, V131, P1251, DOI 10.1038/sj.bjp.0703717; De Gennaro L, 2003, SLEEP MED REV, V7, P423, DOI 10.1053/smrv.2002.0252; Destexhe A, 1996, J NEUROPHYSIOL, V76, P2049, DOI 10.1152/jn.1996.76.3.2049; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; Lakatos P, 2005, J NEUROPHYSIOL, V94, P1904, DOI 10.1152/jn.00263.2005; Manoach DS, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.021.2009; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; McCormick L, 1997, SLEEP, V20, P939, DOI 10.1093/sleep/20.11.939; Mednick SC, 2013, J NEUROSCI, V33, P4494, DOI 10.1523/JNEUROSCI.3127-12.2013; Mednick SC, 2011, TRENDS NEUROSCI, V34, P504, DOI 10.1016/j.tins.2011.06.003; Molle M, 2004, P NATL ACAD SCI USA, V101, P13963, DOI 10.1073/pnas.0402820101; Molle M, 2002, J NEUROSCI, V22, P10941; Nir Y, 2011, NEURON, V70, P153, DOI 10.1016/j.neuron.2011.02.043; Oyanedel CN, 2014, BEHAV BRAIN RES, V275, P126, DOI 10.1016/j.bbr.2014.09.008; Pardi D, 2006, CNS DRUGS, V20, P993, DOI 10.2165/00023210-200620120-00004; Penny WD, 2008, J NEUROSCI METH, V174, P50, DOI 10.1016/j.jneumeth.2008.06.035; Phillips KG, 2012, NEURON, V76, P526, DOI 10.1016/j.neuron.2012.09.016; Poe GR, 2000, BRAIN RES, V855, P176, DOI 10.1016/S0006-8993(99)02310-0; Rasch B, 2013, PHYSIOL REV, V93, P681, DOI 10.1152/physrev.00032.2012; SALVA P, 1995, CLIN PHARMACOKINET, V29, P142, DOI 10.2165/00003088-199529030-00002; Sanchez-Vives MV, 2010, J NEUROPHYSIOL, V104, P1314, DOI 10.1152/jn.00178.2010; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Siegle JH, 2014, ELIFE, V3, DOI 10.7554/eLife.03061; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M, 2001, J NEUROPHYSIOL, V85, P1969, DOI 10.1152/jn.2001.85.5.1969; Timofeev I, 2005, TRENDS CHRONOBIOLOGY, P1; VONKROSIGK M, 1993, SCIENCE, V261, P361, DOI 10.1126/science.8392750; Walker MP, 2009, ANN NY ACAD SCI, V1156, P168, DOI 10.1111/j.1749-6632.2009.04416.x; Walsh JK, 2010, SLEEP, V33, P1217, DOI 10.1093/sleep/33.9.1217; Ward LM, 2003, TRENDS COGN SCI, V7, P553, DOI 10.1016/j.tics.2003.10.012; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555	36	74	76	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144720	10.1371/journal.pone.0144720	http://dx.doi.org/10.1371/journal.pone.0144720			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671283	Green Published, Green Submitted, gold			2022-12-26	WOS:000366719300017
J	Silva, VP; Moreira-Santos, M; Mateus, C; Teixeira, T; Ribeiro, R; Viegas, CA				Silva, Vera P.; Moreira-Santos, Matilde; Mateus, Carla; Teixeira, Tania; Ribeiro, Rui; Viegas, Cristina A.			Evaluation of Arthrobacter aurescens Strain TC1 as Bioaugmentation Bacterium in Soils Contaminated with the Herbicidal Substance Terbuthylazine	PLOS ONE			English	Article							TRIAZINE HERBICIDES; BIOREMEDIATION TOOL; ATRAZINE; BIODEGRADATION; TEMPERATURE; EVOLUTION; COMMUNITY; TRZN	In the last years the chloro-s-triazine active substance terbuthylazine has been increasingly used as an herbicide and may leave residues in the environment which can be of concern. The present study aimed at developing a bioaugmentation tool based on the soil bacterium Arthrobacter aurescens strain TC1 for the remediation of terbuthylazine contaminated soils and at examining its efficacy for both soil and aquatic compartments. First, the feasibility of growing the bioaugmentation bacterium inocula on simple sole nitrogen sources (ammonium and nitrate) instead of atrazine, while still maintaining its efficiency to biodegrade terbuthylazine was shown. In sequence, the successful and quick (3 days) bioremediation efficacy of ammonium-grown A. aurescens TC1 cells was proven in a natural soil freshly spiked or four-months aged with commercial terbuthylazine at a dose 10x higher than the recommended in corn cultivation, to mimic spill situations. Ecotoxicity assessment of the soil eluates towards a freshwater microalga supported the effectiveness of the bioaugmentation tool. Obtained results highlight the potential to decontaminate soil while minimizing terbuthylazine from reaching aquatic compartments via the soil-water pathway. The usefulness of this bioaugmentation tool to provide rapid environment decontamination is particularly relevant in the event of accidental high herbicide contamination. Its limitations and advantages are discussed.	[Silva, Vera P.; Mateus, Carla; Viegas, Cristina A.] Univ Lisbon, Inst Super Tecn, iBB Inst Bioengn & Biosci, P-1699 Lisbon, Portugal; [Viegas, Cristina A.] Univ Lisbon, Inst Super Tecn, Dept Bioengn, P-1699 Lisbon, Portugal; [Moreira-Santos, Matilde; Teixeira, Tania; Ribeiro, Rui] Univ Coimbra, Dept Life Sci, CFE, Coimbra, Portugal	Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Lisboa; Instituto Superior Tecnico; Universidade de Coimbra	Viegas, CA (corresponding author), Univ Lisbon, Inst Super Tecn, iBB Inst Bioengn & Biosci, P-1699 Lisbon, Portugal.	cristina.viegas@tecnico.ulisboa.pt	Ribeiro, Rui/C-7788-2012; Viegas, Cristina A/C-7815-2011; Moreira-Santos, Matilde/J-2609-2013	Ribeiro, Rui/0000-0002-0883-1939; Viegas, Cristina A/0000-0003-1394-0731; Moreira-Santos, Matilde/0000-0001-7067-5028	iBB-Institute for Bioengineering and Biosciences [UID/BIO/04565/2013]; European Funds for Economic and Regional Development - FEDER-through the Competitiveness Factors Operational Programme - COMPETE [PTDC/AAC-AMB/111317/2009, Pest-OE/EQB/LA0023/2011]; National Funds through the Portuguese Foundation of Science and Technology (FCT) [PTDC/AAC-AMB/111317/2009, Pest-OE/EQB/LA0023/2011]; FCT [SFRH/BPD/99800/2014]; Programa Operacional Potencial Humano of QREN Portugal; Portuguese budget through the Ministry of Education and Science	iBB-Institute for Bioengineering and Biosciences; European Funds for Economic and Regional Development - FEDER-through the Competitiveness Factors Operational Programme - COMPETE; National Funds through the Portuguese Foundation of Science and Technology (FCT); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Programa Operacional Potencial Humano of QREN Portugal; Portuguese budget through the Ministry of Education and Science(Portuguese Foundation for Science and Technology)	This work was supported by funding received by iBB-Institute for Bioengineering and Biosciences (UID/BIO/04565/2013) and other funding (Contracts PTDC/AAC-AMB/111317/2009, Pest-OE/EQB/LA0023/2011) from European Funds for Economic and Regional Development - FEDER-through the Competitiveness Factors Operational Programme - COMPETE and National Funds through the Portuguese Foundation of Science and Technology (FCT). M Moreira-Santos thanks to FCT for a postdoctoral fellowship (reference SFRH/BPD/99800/2014), funded by Programa Operacional Potencial Humano of QREN Portugal (2014-2020) and by the Portuguese budget through the Ministry of Education and Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, EFSA J, V9, DOI 10.2903/j.efsa.2011.2481; Caracciolo AB, 2010, FEMS MICROBIOL ECOL, V71, P127, DOI 10.1111/j.1574-6941.2009.00787.x; Barriuso E, 2004, J AGR FOOD CHEM, V52, P6552, DOI 10.1021/jf040245l; Carafa R, 2007, CHEMOSPHERE, V69, P1625, DOI 10.1016/j.chemosphere.2007.05.060; Changey F, 2011, GENE, V490, P18, DOI 10.1016/j.gene.2011.09.005; Chelinho S, 2012, ENVIRON TOXICOL CHEM, V31, P1564, DOI 10.1002/etc.1840; Chelinho S, 2010, J SOIL SEDIMENT, V10, P568, DOI 10.1007/s11368-009-0145-2; Chirnside AEM, 2009, SOIL BIOL BIOCHEM, V41, P2484, DOI 10.1016/j.soilbio.2009.09.005; Fiori E, 2013, AQUAT TOXICOL, V128, P79, DOI 10.1016/j.aquatox.2012.12.001; Forgacs AL, 2013, TOXICOL SCI, V134, P155, DOI 10.1093/toxsci/kft096; Fruchey I, 2003, APPL ENVIRON MICROB, V69, P3653, DOI 10.1128/AEM.69.6.3653-3657.2003; Garcia-Gonzalez V, 2003, APPL ENVIRON MICROB, V69, P6987, DOI 10.1128/AEM.69.12.6987-6993.2003; Giger W, 2009, ENVIRON SCI POLLUT R, V16, P98, DOI 10.1007/s11356-009-0156-y; Govantes F, 2009, MICROB BIOTECHNOL, V2, P178, DOI 10.1111/j.1751-7915.2008.00073.x; Jablonowski ND, 2011, ENVIRON SCI POLLUT R, V18, P328, DOI 10.1007/s11356-010-0431-y; Johannesen H, 2003, ENVIRON TOXICOL CHEM, V22, P722, DOI [10.1897/1551-5028(2003)022&lt;0722:MOAATD&gt;2.0.CO;2, 10.1002/etc.5620220407]; Jurina T, 2014, APPL MICROBIOL BIOT, V98, P7223, DOI 10.1007/s00253-014-5774-8; Kjeldsen LS, 2013, TOXICOL APPL PHARM, V272, P453, DOI 10.1016/j.taap.2013.06.028; Kolic NU, 2007, INT BIODETER BIODEGR, V60, P299, DOI 10.1016/j.ibiod.2007.05.004; Lima D, 2009, CHEMOSPHERE, V74, P187, DOI 10.1016/j.chemosphere.2008.09.083; Navarro S, 2004, CHEMOSPHERE, V57, P51, DOI 10.1016/j.chemosphere.2004.05.016; OECD, 1984, GUID TEST CHEM; Perez J, 2013, ENVIRON SCI POLLUT R, V20, P4671, DOI 10.1007/s11356-012-1443-6; PPDB, 2013, GEN INF TERB DAT PES; Shapir N, 2007, J BACTERIOL, V189, P674, DOI 10.1128/JB.01257-06; Shapir N, 2005, APPL ENVIRON MICROB, V71, P2214, DOI 10.1128/AEM.71.5.2214-2220.2005; Shapir N, 2006, J BACTERIOL, V188, P5859, DOI 10.1128/JB.00517-06; Silva E, 2011, ENVIRON MONIT ASSESS, V176, P331, DOI 10.1007/s10661-010-1586-1; Strong LC, 2002, APPL ENVIRON MICROB, V68, P5973, DOI 10.1128/AEM.68.12.5973-5980.2002; STURMAN PJ, 1995, J CONTAM HYDROL, V19, P171, DOI 10.1016/0169-7722(95)00017-P; USEPA (United States Environmental Protection Agency), 2011, TERB FIN WORK PLAN R; Wackett LP, 2002, APPL MICROBIOL BIOT, V58, P39, DOI 10.1007/s00253-001-0862-y; Wang QF, 2013, INT BIODETER BIODEGR, V77, P63, DOI 10.1016/j.ibiod.2012.11.003; Wang QF, 2012, INT BIODETER BIODEGR, V71, P61, DOI 10.1016/j.ibiod.2012.04.005	34	17	22	4	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144978	10.1371/journal.pone.0144978	http://dx.doi.org/10.1371/journal.pone.0144978			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26662024	gold, Green Submitted, Green Published			2022-12-26	WOS:000366715900161
J	Hofer, J; Forster, F; Isenman, DE; Wahrmann, M; Leitner, J; Holzl, MA; Kovarik, JJ; Stockinger, H; Bohmig, GA; Steinberger, P; Zlabinger, GJ				Hofer, Johannes; Forster, Florian; Isenman, David E.; Wahrmann, Markus; Leitner, Judith; Hoelzl, Markus A.; Kovarik, Johannes J.; Stockinger, Hannes; Boehmig, Georg A.; Steinberger, Peter; Zlabinger, Gerhard J.			Ig-like transcript 4 as a cellular receptor for soluble complement fragment C4d	FASEB JOURNAL			English	Article						homeostasis; autoimmunity; scavenger receptor; complement receptor; antibody-mediated rejection	IMMUNOGLOBULIN-LIKE RECEPTORS; RAY CRYSTAL-STRUCTURE; CELLS; ACTIVATION; DISEASE; BINDING; FAMILY; DEPOSITION; COMPONENTS; REJECTION	Complement regulation leads to the generation of complement split products (CSPs) such as complement component (C)4d, a marker for disease activity in autoimmune syndromes or antibody-mediated allograft rejection. However, the physiologic role of C4d has been unknown. By screening murine thymoma BW5147 cells expressing a cDNA library generated from human monocyte-derived dendritic cells with recombinant human C4d, we identified Ig-like transcript (ILT)4 and ILT5v2 as cellular receptors for C4d. Both receptors, expressed on monocytes, macrophages, and dendritic cells, also interacted with the CSPs C3d, C4b, C3b, and iC3b. However, C4d did not bind to classic complement receptors (CRs). Interaction between cell surface-resident ILT4 and soluble monomeric C4d resulted in endocytosis of C4d. Surprisingly, binding of soluble ILT4 to C4d covalently immobilized to a cellular surface following classic complement activation could not be detected. Remarkably, C4d immobilized to a solid phase via its intrinsic thioester conferred a dose-dependent inhibition of TNF-alpha and IL-6 secretion in monocytes activated via Fc-cross-linking of up to 50% as compared to baseline. Similarly, C4d conferred an attenuation of intracellular Ca2+ flux in monocytes activated via Fc-cross-linking. In conclusion, ILT4 represents a scavenger-type endocytotic CR for soluble monomeric C4d, whereas attenuation of monocyte activation by physiologically oriented C4d on a surface appears to be dependent on a yet to be identified C4d receptor.-Hofer, J., Forster, F., Isenman, D. E., Wahrmann, M., Leitner, J., Holzl, M. A., Kovarik, J. K., Stockinger, H., Bohmig, G. A., Steinberger, P., Zlabinger, G. J. Ig-like transcript 4 as a cellular receptor for soluble complement fragment C4d. FASEB J. 30, 1492-1503 (2016). www.fasebj.org	[Hofer, Johannes; Hoelzl, Markus A.; Kovarik, Johannes J.; Zlabinger, Gerhard J.] Med Univ Vienna, Div Clin Expt Immunol, Vienna, Austria; [Leitner, Judith; Steinberger, Peter] Med Univ Vienna, Div Immune Receptors & T Cell Activat, Inst Immunol, Vienna, Austria; [Forster, Florian; Stockinger, Hannes] Med Univ Vienna, Mol Immunol Unit, Inst Hyg & Appl Immunol, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Hofer, Johannes; Wahrmann, Markus; Kovarik, Johannes J.; Boehmig, Georg A.] Med Univ Vienna, Div Nephrol & Dialysis, Dept Internal Med 3, Vienna, Austria; [Isenman, David E.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Isenman, David E.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Hoelzl, Markus A.] Columbia Univ, Coll Phys & Surg, Columbia Ctr Translat Immunol, Dept Med Surg & Microbiol Immunol, New York, NY USA	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; University of Toronto; University of Toronto; Columbia University	Steinberger, P; Zlabinger, GJ (corresponding author), Med Univ Vienna, Inst Immunol, Ctr Pathophysiol Infectiol & Immunol, Lazarettgasse 19, A-1090 Vienna, Austria.	peter.steinberger@meduniwien.ac.at; gerhard.zlabinger@meduniwien.ac.at	Stockinger, Hannes/E-5173-2011	Stockinger, Hannes/0000-0001-6404-4430; Steinberger, Peter/0000-0001-6848-4097; Wahrmann, Markus/0000-0002-1301-8694; Zlabinger, Gerhard/0000-0002-7478-4173; Kovarik, Johannes/0000-0002-0206-082X; Leitner, Judith/0000-0002-7156-1759	Else-Kroner-Fresenius Stiftung [P07/08//A88/07]; Jubilaumsfonds der Osterreichischen Nationalbank [10521]; Fonds zur Forderung der Wissenschaftlichen Forschung/Austrian Science Fund [21964-B20]; Austrian Science Fund (FWF) [P 21964] Funding Source: researchfish	Else-Kroner-Fresenius Stiftung; Jubilaumsfonds der Osterreichischen Nationalbank; Fonds zur Forderung der Wissenschaftlichen Forschung/Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	The authors thank Margarethe Merio and Claus Wenhart (Institute of Immunology, Medical University of Vienna) for excellent technical assistance. The authors also thank Gunther Hofbauer (Core Unit Cell Sorting, Medical University of Vienna), as well as Dieter Printz (St. Anna Children's Cancer Research Institute, Vienna, Austria) for cell sorting. This project was supported by grants from the Else-Kroner-Fresenius Stiftung (Project Number P07/08//A88/07; to G.J.Z. and J.H.), Jubilaumsfonds der Osterreichischen Nationalbank (Project Number 10521; to G.A.B.), and the Fonds zur Forderung der Wissenschaftlichen Forschung/Austrian Science Fund (Project Number 21964-B20; to P.S., J.H., F.F., D.E.I., M.W., J.L., MA.H., J.J.K., GAB., P.S., GJ.Z.), who with Margarethe Merio are mentioned as inventors regarding the New European patent application on "Complement split product C4d for the treatment of inflammatory conditions" filed by the Medical University of Vienna at the European Patent Office (Application Number: EP12174644.0). J.H., P.S., and G.J.Z. conceived and designed experiments; J.H. performed most experiments; F.F. participated in Ca<SUP>2+</SUP> flux and Western blot experiments; D.E.I. generated recombinant complement split products; M.W. generated C4d from human plasma; P.S. and J.L. performed experiments; JJ.K. and M.A.H. participated in experiments; F.F., D.E.I., M.W., G.A.B., J.L., M.A.H., J.J.K., and H.S. analyzed data, provided suggestions, and critically reviewed the manuscript; and J.H., P.S., and GJ.Z. analyzed data and wrote the paper. The authors declare no conflicts of interest.	Anderson KJ, 2009, IMMUNOLOGY, V127, P8, DOI 10.1111/j.1365-2567.2009.03097.x; Blom AM, 2009, MOL IMMUNOL, V46, P2808, DOI 10.1016/j.molimm.2009.04.025; Bohmig GA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V1341091; Borges L, 2000, CYTOKINE GROWTH F R, V11, P209, DOI 10.1016/S1359-6101(00)00007-1; Botto M, 2009, MOL IMMUNOL, V46, P2774, DOI 10.1016/j.molimm.2009.04.029; Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515; Chen ZB, 2000, J EXP MED, V192, P1339, DOI 10.1084/jem.192.9.1339; Clemenza L, 2004, J IMMUNOL, V172, P1670, DOI 10.4049/jimmunol.172.3.1670; Colonna M, 1999, J LEUKOCYTE BIOL, V66, P375, DOI 10.1002/jlb.66.3.375; Colonna M, 1998, J IMMUNOL, V160, P3096; Fanger NA, 1998, EUR J IMMUNOL, V28, P3423, DOI 10.1002/(SICI)1521-4141(199811)28:11<3423::AID-IMMU3423>3.0.CO;2-2; Gregori S, 2010, BLOOD, V116, P935, DOI 10.1182/blood-2009-07-234872; Gullstrand B, 2009, CLIN EXP IMMUNOL, V156, P303, DOI 10.1111/j.1365-2249.2009.03896.x; Haas M, 2009, J AM SOC NEPHROL, V20, P197, DOI 10.1681/ASN.2008030279; Holzl MA, 2011, CELL IMMUNOL, V267, P88, DOI 10.1016/j.cellimm.2010.12.001; Hunt JS, 2005, FASEB J, V19, P681, DOI 10.1096/fj.04-2078rev; Kao AH, 2010, ARTHRITIS RHEUM-US, V62, P837, DOI 10.1002/art.27267; Khera R, 2009, MOL IMMUNOL, V46, P761, DOI 10.1016/j.molimm.2008.09.026; Kober J, 2008, EUR J IMMUNOL, V38, P2678, DOI 10.1002/eji.200838250; Kubo T, 2009, J EXP MED, V206, P1971, DOI 10.1084/jem.20082392; LAW SK, 1980, J IMMUNOL, V125, P634; Leitner J, 2010, J IMMUNOL METHODS, V362, P131, DOI 10.1016/j.jim.2010.09.020; Leitner J, 2009, EUR J IMMUNOL, V39, P1754, DOI 10.1002/eji.200839028; Lepin EJM, 2000, EUR J IMMUNOL, V30, P3552, DOI 10.1002/1521-4141(200012)30:12<3552::AID-IMMU3552>3.0.CO;2-L; Liu CC, 2009, CTS-CLIN TRANSL SCI, V2, P300, DOI 10.1111/j.1752-8062.2009.00135.x; Munoz LE, 2010, AUTOIMMUNITY, V43, P232, DOI 10.3109/08916930903510930; Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277; Nakamura A, 2004, NAT IMMUNOL, V5, P623, DOI 10.1038/ni1074; Nozaki M, 2006, P NATL ACAD SCI USA, V103, P2328, DOI 10.1073/pnas.0408835103; Pfistershammer K, 2009, BLOOD, V114, P2323, DOI 10.1182/blood-2008-10-183814; Racusen LC, 2003, AM J TRANSPLANT, V3, P708, DOI 10.1034/j.1600-6143.2003.00072.x; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Ristich V, 2007, HUM IMMUNOL, V68, P264, DOI 10.1016/j.humimm.2006.11.008; Steinberger P, 2004, J IMMUNOL, V172, P2352, DOI 10.4049/jimmunol.172.4.2352; Takai T, 2005, IMMUNOLOGY, V115, P433, DOI 10.1111/j.1365-2567.2005.02177.x; van den Elsen JMH, 2002, J MOL BIOL, V322, P1103, DOI 10.1016/S0022-2836(02)00854-9; Yang Y, 2007, AM J HUM GENET, V80, P1037, DOI 10.1086/518257; Zhang ZH, 2005, LANCET, V366, P556, DOI 10.1016/S0140-6736(05)67099-7; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	39	15	17	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1492	1503		10.1096/fj.15-275594	http://dx.doi.org/10.1096/fj.15-275594			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26678451				2022-12-26	WOS:000372629100011
J	Horsman, JW; Miller, DL				Horsman, Joseph W.; Miller, Dana L.			Mitochondrial Sulfide Quinone Oxidoreductase Prevents Activation of the Unfolded Protein Response in Hydrogen Sulfide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Caenorhabditis elegans (C; elegans); eukaryotic initiation factor 2 (eIF2); hydrogen sulfide; proteostasis; translation initiation	MOLECULAR-MECHANISMS; DIETARY RESTRICTION; TRANSLATION; PROTEOSTASIS; EUKARYOTES; INITIATION; OXIDATION; HYPOXIA; ELEGANS; CYCLE	Hydrogen sulfide (H2S) is an endogenously produced gaseous molecule with important roles in cellular signaling. In mammals, exogenous H2S improves survival of ischemia/reperfusion. We have previously shown that exposure to H2S increases the lifespan and thermotolerance in Caenorhabditis elegans, and improves protein homeostasis in low oxygen. The mitochondrial SQRD-1 (sulfide quinone oxidoreductase) protein is a highly conserved enzyme involved in H2S metabolism. SQRD-1 is generally considered important to detoxify H2S. Here, we show that SQRD-1 is also required to maintain protein translation in H2S. In sqrd-1 mutant animals, exposure to H2S leads to phosphorylation of eIF2 and inhibition of protein synthesis. In contrast, global protein translation is not altered in wild-type animals exposed to lethally high H2S or in hif-1(ia04) mutants that die when exposed to low H2S. We demonstrate that both gcn-2 and pek-1 kinases are involved in the H2S-induced phosphorylation of eIF2. Both ER and mitochondrial stress responses are activated in sqrd-1 mutant animals exposed to H2S, but not in wild-type animals. We speculate that SQRD-1 activity in H2S may coordinate proteostasis responses in multiple cellular compartments.	[Horsman, Joseph W.; Miller, Dana L.] Univ Washington, Dept Biochem, Sch Med, UW Mailbox 357350, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Miller, DL (corresponding author), Univ Washington, Dept Biochem, Sch Med, UW Mailbox 357350, Seattle, WA 98195 USA.	DLM16@uw.edu		Miller, Dana/0000-0003-3983-0493	NIH Office of Research Infrastructure Programs [P40 OD010440]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES024958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [T32AG000057, R00AG033050, R01AG044378] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH Office of Research Infrastructure Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr. Vivien McKay for expert advice that was essential for us to complete polysome profiling experiments, and Dr. Kate Stoll, who performed initial polysome profile experiments. Dr. Malene Hansen (Sanford Burnham Institute) provided valuable advice for metabolic labeling experiments. We would like to thank the Miller lab for insightful comments on the manuscript. Some strains were provided by the Caenorhabditis Genetic Stock Center, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440).	Baker BM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002760; Bos EM, 2015, BRIT J PHARMACOL, V172, P1479, DOI 10.1111/bph.12869; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Donnelly N, 2013, CELL MOL LIFE SCI, V70, P3493, DOI 10.1007/s00018-012-1252-6; Fawcett EM, 2015, AGING CELL, V14, P92, DOI 10.1111/acel.12301; Fawcett EM, 2012, JOVE-J VIS EXP, DOI 10.3791/4088; Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488; Goubern M, 2007, FASEB J, V21, P1699, DOI 10.1096/fj.06-7407com; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Hine C, 2015, CELL, V160, P132, DOI 10.1016/j.cell.2014.11.048; Jackson MR, 2012, BIOCHEMISTRY-US, V51, P6804, DOI 10.1021/bi300778t; Kabil H, 2011, P NATL ACAD SCI USA, V108, P16831, DOI 10.1073/pnas.1102008108; Kennedy BK, 2009, AGING CELL, V8, P617, DOI 10.1111/j.1474-9726.2009.00522.x; Kim H, 2013, AM J PHYSIOL-CELL PH, V305, pC1257, DOI 10.1152/ajpcell.00176.2013; Kimura H, 2014, MOLECULES, V19, P16146, DOI 10.3390/molecules191016146; Lagoutte E, 2010, BBA-BIOENERGETICS, V1797, P1500, DOI 10.1016/j.bbabio.2010.04.004; Lee HJ, 2012, J BIOL CHEM, V287, P4451, DOI 10.1074/jbc.M111.278325; LEROUX A, 1982, P NATL ACAD SCI-BIOL, V79, P2147, DOI 10.1073/pnas.79.7.2147; Libiad M, 2014, J BIOL CHEM, V289, P30901, DOI 10.1074/jbc.M114.602664; MARTIN TE, 1973, EXP CELL RES, V80, P496, DOI 10.1016/0014-4827(73)90333-9; Milby TH, 1999, AM J IND MED, V35, P192, DOI 10.1002/(SICI)1097-0274(199902)35:2<192::AID-AJIM11>3.3.CO;2-3; Miller DL, 2007, P NATL ACAD SCI USA, V104, P20618, DOI 10.1073/pnas.0710191104; Miller DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025476; Mishanina AV, 2015, NAT CHEM BIOL, V11, P457, DOI 10.1038/nchembio.1834; NICHOLLS P, 1982, CAN J BIOCHEM CELL B, V60, P613, DOI 10.1139/o82-076; Nicholson CK, 2010, PHARMACOL RES, V62, P289, DOI 10.1016/j.phrs.2010.06.002; Olson KR, 2014, NITRIC OXIDE-BIOL CH, V41, P11, DOI 10.1016/j.niox.2014.05.012; Padilla PA, 2002, MOL BIOL CELL, V13, P1473, DOI 10.1091/mbc.01-12-0594; Patil CK, 2004, PLOS BIOL, V2, P1208, DOI 10.1371/journal.pbio.0020246; Paul BD, 2012, NAT REV MOL CELL BIO, V13, P499, DOI 10.1038/nrm3391; Riddle D. L., 1998, TRENDS CELL BIOL, V8, P92; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Sherman MY, 2013, TRENDS BIOCHEM SCI, V38, P585, DOI 10.1016/j.tibs.2013.09.003; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Talaei F, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-1; Theissen U, 2003, MOL BIOL EVOL, V20, P1564, DOI 10.1093/molbev/msg174; Truong DH, 2006, DRUG METAB REV, V38, P733, DOI 10.1080/03602530600959607; Tu BP, 2002, MOL CELL, V10, P983, DOI 10.1016/S1097-2765(02)00696-2; Uthus EO, 2006, MECH AGEING DEV, V127, P444, DOI 10.1016/j.mad.2006.01.001; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275	40	13	14	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					5320	5325		10.1074/jbc.M115.697102	http://dx.doi.org/10.1074/jbc.M115.697102			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26677221	Green Published, hybrid			2022-12-26	WOS:000371640600041
J	Hafver, TL; Hodne, K; Wanichawan, P; Aronsen, JM; Dalhus, B; Lunde, PK; Lunde, M; Martinsen, M; Enger, UH; Fuller, W; Sjaastad, I; Louch, WE; Sejersted, OM; Carlson, CR				Hafver, Tandekile Lubelwana; Hodne, Kjetil; Wanichawan, Pimthanya; Aronsen, Jan Magnus; Dalhus, Bjorn; Lunde, Per Kristian; Lunde, Marianne; Martinsen, Marita; Enger, Ulla Helene; Fuller, William; Sjaastad, Ivar; Louch, William Edward; Sejersted, Ole Mathias; Carlson, Cathrine Rein			Protein Phosphatase 1c Associated with the Cardiac Sodium Calcium Exchanger 1 Regulates Its Activity by Dephosphorylating Serine 68-phosphorylatedPhospholemman	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+/CA2+ EXCHANGER; NA+-CA2+ EXCHANGER; STRUCTURAL BASIS; DEPENDENT REGULATION; MOLECULAR-BASIS; CA2+ REGULATION; ION-TRANSPORT; PHOSPHOLEMMAN; PHOSPHORYLATION; BINDING	The sodium (Na+)-calcium (Ca2+) exchanger 1 (NCX1) is an important regulator of intracellular Ca2+ homeostasis. Serine 68-phosphorylated phospholemman (pSer-68-PLM) inhibits NCX1 activity. In the context of Na+/K+-ATPase (NKA) regulation, pSer-68-PLM is dephosphorylated by protein phosphatase 1 (PP1). PP1 also associates with NCX1; however, the molecular basis of this association is unknown. In this study, we aimed to analyze the mechanisms of PP1 targeting to the NCX1-pSer-68-PLM complex and hypothesized that a direct and functional NCX1-PP1 interaction is a prerequisite for pSer-68-PLM dephosphorylation. Using a variety of molecular techniques, we show that PP1 catalytic subunit (PP1c) co-localized, co-fractionated, and co-immunoprecipitated with NCX1 in rat cardiomyocytes, left ventricle lysates, and HEK293 cells. Bioinformatic analysis, immunoprecipitations, mutagenesis, pulldown experiments, and peptide arrays constrained PP1c anchoring to the K(I/V) FF motif in the first Ca2+ binding domain (CBD) 1 in NCX1. This binding site is also partially in agreement with the extended PP1-binding motif K(V/I) FF-X5-8 Phi(1)Phi(2)-X8-9-R. The cytosolic loop of NCX1, containing the K(I/V) FF motif, had no effect on PP1 activity in an in vitro assay. Dephosphorylation of pSer-68-PLM in HEK293 cells was not observed when NCX1 was absent, when the K(I/V) FF motif was mutated, or when the PLM-and PP1c-binding sites were separated (mimicking calpain cleavage of NCX1). Co-expression of PLM and NCX1 inhibited NCX1 current (both modes). Moreover, co-expression of PLM with NCX1(F407P) (mutated K(I/V) FF motif) resulted in the current being completely abolished. In conclusion, NCX1 is a substrate-specifying PP1c regulator protein, indirectly regulating NCX1 activity through pSer-68-PLM dephosphorylation.	[Hafver, Tandekile Lubelwana; Hodne, Kjetil; Wanichawan, Pimthanya; Aronsen, Jan Magnus; Lunde, Per Kristian; Lunde, Marianne; Martinsen, Marita; Enger, Ulla Helene; Sjaastad, Ivar; Louch, William Edward; Sejersted, Ole Mathias; Carlson, Cathrine Rein] Oslo Univ Hosp, Expt Med Res Inst, Kirkeveien 166, N-0450 Oslo, Norway; [Hafver, Tandekile Lubelwana; Hodne, Kjetil; Wanichawan, Pimthanya; Aronsen, Jan Magnus; Lunde, Per Kristian; Lunde, Marianne; Martinsen, Marita; Enger, Ulla Helene; Sjaastad, Ivar; Louch, William Edward; Sejersted, Ole Mathias; Carlson, Cathrine Rein] Univ Oslo, N-0450 Oslo, Norway; [Hafver, Tandekile Lubelwana; Hodne, Kjetil; Wanichawan, Pimthanya; Lunde, Per Kristian; Lunde, Marianne; Martinsen, Marita; Enger, Ulla Helene; Sjaastad, Ivar; Louch, William Edward; Sejersted, Ole Mathias; Carlson, Cathrine Rein] Univ Oslo, KG Jebsen Cardiac Res Ctr, N-0316 Oslo, Norway; [Hafver, Tandekile Lubelwana; Hodne, Kjetil; Wanichawan, Pimthanya; Lunde, Per Kristian; Lunde, Marianne; Martinsen, Marita; Enger, Ulla Helene; Sjaastad, Ivar; Louch, William Edward; Sejersted, Ole Mathias; Carlson, Cathrine Rein] Univ Oslo, Ctr Heart Failure Res, N-0316 Oslo, Norway; [Hodne, Kjetil] Norwegian Univ Life Sci NMBU, Dept Basic Sci & Aquat Med, N-0454 Oslo, Norway; [Aronsen, Jan Magnus] Bjorknes Coll, Oslo, Norway; [Dalhus, Bjorn] Oslo Univ Hosp, Rikshosp, Dept Microbiol, N-0424 Oslo, Norway; [Dalhus, Bjorn] Univ Oslo, Inst Clin Med, Dept Med Biochem, N-0424 Oslo, Norway; [Fuller, William] Univ Dundee, Cardiovasc & Diabet Med, Sch Med, Dundee DD1 9SY, Scotland	University of Oslo; University of Oslo; University of Oslo; University of Oslo; Norwegian University of Life Sciences; University of Oslo; National Hospital Norway; University of Oslo; University of Dundee	Carlson, CR (corresponding author), Oslo Univ Hosp, Expt Med Res Inst, Kirkeveien 166, N-0450 Oslo, Norway.	c.r.carlson@medisin.uio.no	Dalhus, Bjørn/AAK-2895-2020	Hodne, Kjetil/0000-0001-8528-9728; Fuller, William/0000-0002-5883-4433	South-Eastern Norway Regional Health Authority; Norwegian National Health Association; Research Council of Norway; Stiftelsen Kristian Gerhard Jebsen; Simon Fougner Hartmann's Family Fund, Denmark; Anders Jahre's Fund; South-Eastern Regional Health Authorities' Technology Platform for Structural Biology and Bioinformatics Grants [2012085, 2015095]; British Heart Foundation [PG/12/6/29366, PG/10/93/28650, FS/13/22/30126] Funding Source: researchfish; Medical Research Council [1218481] Funding Source: researchfish	South-Eastern Norway Regional Health Authority; Norwegian National Health Association; Research Council of Norway(Research Council of Norway); Stiftelsen Kristian Gerhard Jebsen; Simon Fougner Hartmann's Family Fund, Denmark; Anders Jahre's Fund; South-Eastern Regional Health Authorities' Technology Platform for Structural Biology and Bioinformatics Grants; British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by the South-Eastern Norway Regional Health Authority, the Norwegian National Health Association, Research Council of Norway, Stiftelsen Kristian Gerhard Jebsen, the Simon Fougner Hartmann's Family Fund, Denmark, and Anders Jahre's Fund for the promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the South-Eastern Regional Health Authorities' Technology Platform for Structural Biology and Bioinformatics Grants 2012085 and 2015095.	Ahlers BA, 2005, J BIOL CHEM, V280, P19875, DOI 10.1074/jbc.M414703200; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Beullens M, 1999, J BIOL CHEM, V274, P14053, DOI 10.1074/jbc.274.20.14053; Blaustein MP, 1999, PHYSIOL REV, V79, P763, DOI 10.1152/physrev.1999.79.3.763; Boens S, 2013, METHODS MOL BIOL, V1053, P271, DOI 10.1007/978-1-62703-562-0_16; Bollen M, 2001, TRENDS BIOCHEM SCI, V26, P426, DOI 10.1016/S0968-0004(01)01836-9; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Bossuyt J, 2005, CIRC RES, V97, P558, DOI 10.1161/01.RES.0000181172.27931.c3; Bossuyt J, 2006, J BIOL CHEM, V281, P32765, DOI 10.1074/jbc.M606254200; Brattelid T, 2007, J MOL CELL CARDIOL, V43, P767, DOI 10.1016/j.yjmcc.2007.08.019; Carr AN, 2002, MOL CELL BIOL, V22, P4124, DOI 10.1128/MCB.22.12.4124-4135.2002; Choy MS, 2014, P NATL ACAD SCI USA, V111, P4097, DOI 10.1073/pnas.1317395111; Choy MS, 2012, BIOCHEM SOC T, V40, P969, DOI 10.1042/BST20120094; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; Egloff MP, 1997, EMBO J, V16, P1876, DOI 10.1093/emboj/16.8.1876; El-Armouche A, 2011, FASEB J, V25, P4467, DOI 10.1096/fj.11-184903; Frank R, 1996, Methods Mol Biol, V66, P149; Fuller W, 2009, AM J PHYSIOL-CELL PH, V296, pC1346, DOI 10.1152/ajpcell.00523.2008; Han F, 2010, AM J PHYSIOL-CELL PH, V299, pC1363, DOI 10.1152/ajpcell.00027.2010; Hasenfuss G, 1999, CIRCULATION, V99, P641, DOI 10.1161/01.CIR.99.5.641; Hasenfuss G, 1998, CARDIOVASC RES, V37, P279, DOI 10.1016/S0008-6363(97)00277-0; Heroes E, 2013, FEBS J, V280, P584, DOI 10.1111/j.1742-4658.2012.08547.x; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hilge M, 2012, J BIOL CHEM, V287, P31641, DOI 10.1074/jbc.R112.353573; Hurley TD, 2007, J BIOL CHEM, V282, P28874, DOI 10.1074/jbc.M703472200; Johnson LS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-431; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Khananshvili D, 2014, PFLUG ARCH EUR J PHY, V466, P43, DOI 10.1007/s00424-013-1405-y; LEE SL, 1994, J BIOL CHEM, V269, P14849; Lesage B, 2004, J BIOL CHEM, V279, P55978, DOI 10.1074/jbc.M411911200; Linck B, 1998, AM J PHYSIOL-CELL PH, V274, pC415, DOI 10.1152/ajpcell.1998.274.2.C415; Lu YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024724; Lunde IG, 2012, PHYSIOL GENOMICS, V44, P162, DOI 10.1152/physiolgenomics.00016.2011; MATSUOKA S, 1993, P NATL ACAD SCI USA, V90, P3870, DOI 10.1073/pnas.90.9.3870; McAvoy Thomas, 2010, Curr Protoc Mol Biol, VChapter 18, DOI 10.1002/0471142727.mb1818s92; Meiselbach H, 2006, CHEM BIOL, V13, P49, DOI 10.1016/j.chembiol.2005.10.009; Nicolaou P, 2009, J MOL CELL CARDIOL, V47, P365, DOI 10.1016/j.yjmcc.2009.05.010; Nicoll DA, 2006, J BIOL CHEM, V281, P21577, DOI 10.1074/jbc.C600117200; O'Connell N, 2012, STRUCTURE, V20, P1746, DOI 10.1016/j.str.2012.08.003; Ottolia M, 2009, J BIOL CHEM, V284, P32735, DOI 10.1074/jbc.M109.055434; Panigrahi AK, 2011, MOL CELL BIOL, V31, P4335, DOI 10.1128/MCB.06075-11; Peti W, 2013, FEBS J, V280, P596, DOI 10.1111/j.1742-4658.2012.08509.x; Philipson KD, 2000, ANNU REV PHYSIOL, V62, P111, DOI 10.1146/annurev.physiol.62.1.111; Pogwizd SM, 1999, CIRC RES, V85, P1009; Ragusa MJ, 2010, NAT STRUCT MOL BIOL, V17, P459, DOI 10.1038/nsmb.1786; Ren XY, 2008, BIOCHEMISTRY-US, V47, P6081, DOI 10.1021/bi800177t; Ren XY, 2013, J MOL CELL CARDIOL, V57, P68, DOI 10.1016/j.yjmcc.2013.01.010; Ruknudin AM, 2007, ANN NY ACAD SCI, V1099, P103, DOI 10.1196/annals.1387.036; Schulze DH, 2003, J BIOL CHEM, V278, P28849, DOI 10.1074/jbc.M300754200; Shattock MJ, 2015, J PHYSIOL-LONDON, V593, P1361, DOI 10.1113/jphysiol.2014.282319; Sipido KR, 2002, CARDIOVASC RES, V53, P782, DOI 10.1016/S0008-6363(01)00470-9; Song JL, 2005, AM J PHYSIOL-HEART C, V288, pH2342, DOI 10.1152/ajpheart.01133.2004; STUDER R, 1994, CIRC RES, V75, P443, DOI 10.1161/01.RES.75.3.443; Sweadner KJ, 2000, GENOMICS, V68, P41, DOI 10.1006/geno.2000.6274; Terrak M, 2004, NATURE, V429, P780, DOI 10.1038/nature02582; Wakula P, 2003, J BIOL CHEM, V278, P18817, DOI 10.1074/jbc.M300175200; Wanichawan P, 2014, J BIOL CHEM, V289, P33984, DOI 10.1074/jbc.M114.602581; Wanichawan P, 2011, AM J PHYSIOL-CELL PH, V300, pC989, DOI 10.1152/ajpcell.00196.2010; Wypijewski KJ, 2013, J BIOL CHEM, V288, P13808, DOI 10.1074/jbc.M113.460956; Zhang XQ, 2006, J BIOL CHEM, V281, P15694, DOI 10.1074/jbc.M601252200; Zhang XQ, 2006, J APPL PHYSIOL, V100, P212, DOI 10.1152/japplphysiol.00757.2005; Zhang XQ, 2003, AM J PHYSIOL-HEART C, V284, pH225, DOI 10.1152/ajpheart.00698.2002; Zhang XQ, 2011, AM J PHYSIOL-CELL PH, V301, pC833, DOI 10.1152/ajpcell.00069.2011; Zhang XQ, 2009, AM J PHYSIOL-CELL PH, V296, pC911, DOI 10.1152/ajpcell.00196.2008	64	11	11	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4561	4579		10.1074/jbc.M115.677898	http://dx.doi.org/10.1074/jbc.M115.677898			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26668322	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000371604600025
J	Kastrati, I; Siklos, MI; Calderon-Gierszal, EL; El-Shennawy, L; Georgieva, G; Thayer, EN; Thatcher, GRJ; Frasor, J				Kastrati, Irida; Siklos, Marton I.; Calderon-Gierszal, Esther L.; El-Shennawy, Lamiaa; Georgieva, Gergana; Thayer, Emily N.; Thatcher, Gregory R. J.; Frasor, Jonna			Dimethyl Fumarate Inhibits the Nuclear Factor B Pathway in Breast Cancer Cells by Covalent Modification of p65 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						breast cancer; chemical modification; drug action; inflammation; inhibitor; NFB; covalent modification; cysteine; dimethyl fumarate; mammosphere	NF-KAPPA-B; STEM-CELLS; ACID ESTERS; DNA-BINDING; TNF-ALPHA; ACTIVATION; EXPRESSION; SUBUNIT; KINASE; IKK	In breast tumors, activation of the nuclear factor B (NFB) pathway promotes survival, migration, invasion, angiogenesis, stem cell-like properties, and resistance to therapyall phenotypes of aggressive disease where therapy options remain limited. Adding an anti-inflammatory/anti-NFB agent to breast cancer treatment would be beneficial, but no such drug is approved as either a monotherapy or adjuvant therapy. To address this need, we examined whether dimethyl fumarate (DMF), an anti-inflammatory drug already in clinical use for multiple sclerosis, can inhibit the NFB pathway. We found that DMF effectively blocks NFB activity in multiple breast cancer cell lines and abrogates NFB-dependent mammosphere formation, indicating that DMF has anti-cancer stem cell properties. In addition, DMF inhibits cell proliferation and significantly impairs xenograft tumor growth. Mechanistically, DMF prevents p65 nuclear translocation and attenuates its DNA binding activity but has no effect on upstream proteins in the NFB pathway. Dimethyl succinate, the inactive analog of DMF that lacks the electrophilic double bond of fumarate, is unable to inhibit NFB activity. Also, the cell-permeable thiol N-acetyl l-cysteine, reverses DMF inhibition of the NFB pathway, supporting the notion that the electrophile, DMF, acts via covalent modification. To determine whether DMF interacts directly with p65, we synthesized and used a novel chemical probe of DMF by incorporating an alkyne functionality and found that DMF covalently modifies p65, with cysteine 38 being essential for the activity of DMF. These results establish DMF as an NFB inhibitor with anti-tumor activity that may add therapeutic value in the treatment of aggressive breast cancers.	[Kastrati, Irida; Calderon-Gierszal, Esther L.; El-Shennawy, Lamiaa; Georgieva, Gergana; Frasor, Jonna] Univ Illinois, Dept Physiol & Biophys, 835 S Wolcott Ave,E202 MSB,MC901, Chicago, IL 60612 USA; [Siklos, Marton I.; Thayer, Emily N.; Thatcher, Gregory R. J.] Univ Illinois, Dept Med Chem & Pharmacognosy, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Kastrati, I (corresponding author), Univ Illinois, Dept Physiol & Biophys, 835 S Wolcott Ave,E202 MSB,MC901, Chicago, IL 60612 USA.	ikastr2@uic.edu	Kastrati, Irida/L-4641-2019	Kastrati, Irida/0000-0002-8086-1411	National Institutes of Health [R01 CA130932, R01 CA200669, R01 CA121107]; Susan G. Komen for the Cure [PDF12229484]; NATIONAL CANCER INSTITUTE [R01CA200669, R01CA121107, R01CA130932] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grants R01 CA130932 and R01 CA200669 (to J. F.) and R01 CA121107 (to G. R. J. T.) and by Postdoctoral Fellowship Grant PDF12229484 from Susan G. Komen for the Cure (to I. K.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Anand P, 2008, CANCER RES, V68, P8861, DOI 10.1158/0008-5472.CAN-08-1902; Baumgarten SC, 2012, MOL ENDOCRINOL, V26, P360, DOI 10.1210/me.2011-1302; Cao YX, 2007, P NATL ACAD SCI USA, V104, P15852, DOI 10.1073/pnas.0706728104; Charafe-Jauffret E, 2008, PATHOBIOLOGY, V75, P75, DOI 10.1159/000123845; Chen FE, 1998, NATURE, V391, P410, DOI 10.1038/34956; Croker AK, 2008, J CELL MOL MED, V12, P374, DOI 10.1111/j.1582-4934.2007.00211.x; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Garber K, 2006, NAT BIOTECHNOL, V24, P127, DOI 10.1038/nbt0206-127; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; Gilmore TD, 2006, ONCOGENE, V25, P6887, DOI 10.1038/sj.onc.1209982; GILMORE TD, 1990, CELL, V62, P841, DOI 10.1016/0092-8674(90)90257-F; Gotz MG, 2008, J MED CHEM, V51, P2816, DOI 10.1021/jm701311r; Greten FR, 2007, CELL, V130, P918, DOI 10.1016/j.cell.2007.07.009; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Herschkowitz JI, 2012, P NATL ACAD SCI USA, V109, P2778, DOI 10.1073/pnas.1018862108; Hinohara K, 2012, P NATL ACAD SCI USA, V109, P6584, DOI 10.1073/pnas.1113271109; Hoefnagel JJ, 2003, BRIT J DERMATOL, V149, P363, DOI 10.1046/j.1365-2133.2003.05433.x; Hollier BG, 2009, J MAMMARY GLAND BIOL, V14, P29, DOI 10.1007/s10911-009-9110-3; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Johnstone PAS, 2002, CURR PROB CANCER, V26, P282, DOI 10.1067/mcn.2002.129997; Jones RL, 2011, J CLIN PATHOL, V64, P130, DOI 10.1136/jcp.2010.082966; Karin M, 2002, NAT REV CANCER, V2, P301, DOI 10.1038/nrc780; Kastrati I, 2015, ONCOGENE, V34, P2309, DOI 10.1038/onc.2014.180; Kastrati I, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1868-7; Kim HJ, 2006, CELL DEATH DIFFER, V13, P738, DOI 10.1038/sj.cdd.4401877; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liang MC, 2006, BIOCHEM PHARMACOL, V71, P634, DOI 10.1016/j.bcp.2005.11.013; Linker RA, 2011, BRAIN, V134, P678, DOI 10.1093/brain/awq386; Loewe R, 2002, J IMMUNOL, V168, P4781, DOI 10.4049/jimmunol.168.9.4781; Mah R, 2014, BIOORG MED CHEM LETT, V24, P33, DOI 10.1016/j.bmcl.2013.10.003; Marcotte D, 2013, BIOORGAN MED CHEM, V21, P4011, DOI 10.1016/j.bmc.2013.04.019; Mercurio F, 1997, SCIENCE, V278, P860, DOI 10.1126/science.278.5339.860; Nakshatri H, 1997, MOL CELL BIOL, V17, P3629, DOI 10.1128/MCB.17.7.3629; Peng HY, 2012, J BIOL CHEM, V287, P28017, DOI 10.1074/jbc.M112.383380; Pradhan M, 2012, MOL CELL BIOL, V32, P569, DOI 10.1128/MCB.05869-11; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; RUBEN SM, 1991, SCIENCE, V251, P1490, DOI 10.1126/science.2006423; Seidel P, 2009, AM J PHYSIOL-LUNG C, V297, pL326, DOI 10.1152/ajplung.90624.2008; Sovak MA, 1997, J CLIN INVEST, V100, P2952, DOI 10.1172/JCI119848; Speers AE, 2003, J AM CHEM SOC, V125, P4686, DOI 10.1021/ja034490h; Stender JD, 2010, MOL CELL BIOL, V30, P3943, DOI 10.1128/MCB.00118-10; Sullivan LB, 2013, MOL CELL, V51, P236, DOI 10.1016/j.molcel.2013.05.003; Tamura R, 2012, BIOSCI BIOTECH BIOCH, V76, P2360, DOI 10.1271/bbb.120619; Vandermeeren M, 2001, J INVEST DERMATOL, V116, P124, DOI 10.1046/j.1523-1747.2001.00211.x; Velasco-Velazquez MA, 2011, AM J PATHOL, V179, P2, DOI 10.1016/j.ajpath.2011.03.005; Wilms H, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-30; Yamamoto M, 2008, J MED CHEM, V51, P5780, DOI 10.1021/jm8006245; Zhou YM, 2005, INT J BIOCHEM CELL B, V37, P1130, DOI 10.1016/j.biocel.2004.09.006	52	83	84	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3639	3647		10.1074/jbc.M115.679704	http://dx.doi.org/10.1074/jbc.M115.679704			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26683377	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000370854500041
J	Monian, P; Jiang, XJ				Monian, Prashant; Jiang, Xuejun			The Cellular Apoptosis Susceptibility Protein ( CAS) Promotes Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis and Cell Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOCHROME-C RELEASE; SEGREGATION GENE CSE1; CASPASE ACTIVATION; CHROMOSOME SEGREGATION; MUSCLE DIFFERENTIATION; NUCLEOTIDE EXCHANGE; DEATH RECEPTORS; CANCER GENOMICS; NEURONAL DEATH; HUMAN HOMOLOG	A signature event during the cell intrinsic apoptotic pathway is mitochondrial outer membrane permeabilization, leading to formation of the apoptosome, a caspase activation complex. The cellular apoptosis susceptibility protein (CAS) can facilitate apoptosome assembly by stimulating nucleotide exchange on Apaf-1 following binding of cytochrome c. We report here that CAS expression itself is up-regulated during tumor necrosis factor-related apoptosis-inducing ligand(TRAIL)-induced apoptosis, and knockdown of CAS renders cells resistant to TRAIL. We find that TRAIL induces up-regulation of CAS in a posttranscriptional, caspase-8-dependent manner through degradation of cIAP1, an E3 ligase that targets CAS for ubiquitin-dependent proteasomal degradation. We identified a novel signaling pathway whereby caspase-8 engages a feedforward cascade that leads to CAS up-regulation and amplifies the apoptotic signal. Furthermore, in silico analysis revealed that expression of CAS is up-regulated at both the mRNA and DNA levels in human breast tumors, consistent with its role in promoting cell proliferation. Overexpression of various oncogenes led to CAS upregulation in non-transformed cells. Intriguingly, oncogene-induced CAS up-regulation also resulted in greater susceptibility to TRAIL-induced cell death, consistent with its proapoptotic function. These findings suggest that CAS plays contrasting roles in proliferation and apoptosis and that overexpression of CAS in tumors could serve as a potential biomarker to guide therapeutic choices.	Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA; Mem Sloan Kettering Canc Ctr, Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Jiang, XJ (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.	jiangx@mskcc.org	Monian, Prashant/J-7414-2019		William H. and Alice Goodwin and the Commonwealth Foundation for Cancer Research of the Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center; National Institutes of Health [P30 CA008748, R01GM113013, R01CA166413]; NATIONAL CANCER INSTITUTE [P30CA008748, R01CA166413] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM113013] Funding Source: NIH RePORTER	William H. and Alice Goodwin and the Commonwealth Foundation for Cancer Research of the Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by William H. and Alice Goodwin and the Commonwealth Foundation for Cancer Research of the Experimental Therapeutics Center of Memorial Sloan Kettering Cancer Center; a Cycle for Survival grant; National Institutes of Health Cancer Center Core Grant P30 CA008748; and National Institutes of Health Grants R01GM113013 and R01CA166413 (to X. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bar-Shira A, 2002, CANCER RES, V62, P6803; Bera TK, 2001, MOL CELL BIOL, V21, P7020, DOI 10.1128/MCB.21.20.7020-7024.2001; Boni R, 1999, AM J DERMATOPATH, V21, P125, DOI 10.1097/00000372-199904000-00003; BRINKMANN U, 1995, P NATL ACAD SCI USA, V92, P10427, DOI 10.1073/pnas.92.22.10427; Brustmann H, 2004, GYNECOL ONCOL, V92, P268, DOI 10.1016/j.ygyno.2003.10.029; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Cecconi F, 1998, CELL, V94, P727, DOI 10.1016/S0092-8674(00)81732-8; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Deshmukh M, 2000, J CELL BIOL, V150, P131, DOI 10.1083/jcb.150.1.131; Deshmukh M, 1998, NEURON, V21, P695, DOI 10.1016/S0896-6273(00)80587-5; Devarajan E, 2002, ONCOGENE, V21, P8843, DOI 10.1038/sj.onc.1206044; Fernando P, 2005, FASEB J, V19, P1671, DOI 10.1096/fj.04-2981fje; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Ferreira CG, 2001, CLIN CANCER RES, V7, P2468; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Guicciardi ME, 2011, EXP CELL RES, V317, P107, DOI 10.1016/j.yexcr.2010.10.005; Hakem R, 1998, CELL, V94, P339, DOI 10.1016/S0092-8674(00)81477-4; Huesmann GR, 2006, NEURON, V52, P1061, DOI 10.1016/j.neuron.2006.10.033; Ichim G, 2015, MOL CELL, V57, P860, DOI 10.1016/j.molcel.2015.01.018; Ishizaki Y, 1998, J CELL BIOL, V140, P153, DOI 10.1083/jcb.140.1.153; Jia L, 2001, BLOOD, V98, P414, DOI 10.1182/blood.V98.2.414; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; Jost PJ, 2009, NATURE, V460, P1035, DOI 10.1038/nature08229; Kim HE, 2005, P NATL ACAD SCI USA, V102, P17545, DOI 10.1073/pnas.0507900102; Kim HE, 2008, MOL CELL, V30, P239, DOI 10.1016/j.molcel.2008.03.014; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuida K, 1998, CELL, V94, P325, DOI 10.1016/S0092-8674(00)81476-2; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Liu XJ, 2015, MOL CELL, V58, P284, DOI 10.1016/j.molcel.2015.03.003; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Martinou I, 1999, J CELL BIOL, V144, P883, DOI 10.1083/jcb.144.5.883; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Murray TVA, 2008, J CELL SCI, V121, P3786, DOI 10.1242/jcs.024547; Neame SJ, 1998, J CELL BIOL, V142, P1583, DOI 10.1083/jcb.142.6.1583; O'Donnell MA, 2011, NAT CELL BIOL, V13, P1437, DOI 10.1038/ncb2362; Ogryzko VV, 1997, BIOCHEMISTRY-US, V36, P9493, DOI 10.1021/bi970236o; Potts MB, 2005, J CELL BIOL, V171, P925, DOI 10.1083/jcb.200504082; Rongvaux A, 2014, CELL, V159, P1563, DOI 10.1016/j.cell.2014.11.037; Santambrogio L, 2005, NAT IMMUNOL, V6, P1020, DOI 10.1038/ni1250; Soengas MS, 1999, SCIENCE, V284, P156, DOI 10.1126/science.284.5411.156; Soengas MS, 2001, NATURE, V409, P207, DOI 10.1038/35051606; Srinivasula SM, 1998, MOL CELL, V1, P949, DOI 10.1016/S1097-2765(00)80095-7; Tait SWG, 2010, DEV CELL, V18, P802, DOI [10.1016/j.devcel.2010.03.014, 10.1016/j.devce1.2010.03.014]; Tamm I, 2000, CLIN CANCER RES, V6, P1796; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Weil M, 1999, CURR BIOL, V9, P361, DOI 10.1016/S0960-9822(99)80162-6; Wellmann A, 2001, INT J MOL MED, V7, P489; White MJ, 2014, CELL, V159, P1549, DOI 10.1016/j.cell.2014.11.036; Wolf BB, 2001, J BIOL CHEM, V276, P34244, DOI 10.1074/jbc.M011778200; Woo M, 2003, NAT IMMUNOL, V4, P1016, DOI 10.1038/ni976; XIAO ZX, 1993, MOL CELL BIOL, V13, P4691, DOI 10.1128/MCB.13.8.4691; Yin XM, 1999, NATURE, V400, P886, DOI 10.1038/23730; Yoshida H, 1998, CELL, V94, P739, DOI 10.1016/S0092-8674(00)81733-X; Zou H, 1997, CELL, V90, P405, DOI 10.1016/S0092-8674(00)80501-2; Zou H, 1999, J BIOL CHEM, V274, P11549, DOI 10.1074/jbc.274.17.11549	60	9	10	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2379	2388		10.1074/jbc.M115.685008	http://dx.doi.org/10.1074/jbc.M115.685008			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26668314	hybrid, Green Published			2022-12-26	WOS:000369610400027
J	Hernandez-Pliego, J; Rodriguez, C; Bustamante, J				Hernandez-Pliego, Jesus; Rodriguez, Carlos; Bustamante, Javier			Why Do Kestrels Soar?	PLOS ONE			English	Article							FALCO-NAUMANNI; FLIGHT STRATEGIES; ECOLOGICAL ENERGETICS; THERMAL-CONVECTION; ENERGY LANDSCAPES; MIGRATING RAPTORS; LESSER KESTRELS; GLIDING FLIGHT; BIRDS; MOVEMENT	Individuals allocate considerable amounts of energy to movement, which ultimately affects their ability to survive and reproduce. Birds fly by flapping their wings, which is dependent on the chemical energy produced by muscle work, or use soaring-gliding flight, in which chemical energy is replaced with energy harvested from moving air masses, such as thermals. Flapping flight requires more energy than soaring-gliding flight, and this difference in the use of energy increases with body mass. However, soaring-gliding results in lower speeds than flapping, especially for small species. Birds therefore face a trade-off between energy and time costs when deciding which flight strategy to use. Raptors are a group of large birds that typically soar. As relatively light weight raptors, falcons can either soar on weak thermals or fly by flapping with low energy costs. In this paper, we study the flight behavior of the insectivorous lesser kestrel (Falco naumanni) during foraging trips and the influence of solar radiation, which we have adopted as a proxy for thermal formation, on kestrel flight variables. We tracked 35 individuals from two colonies using high frequency GPS-dataloggers over four consecutive breeding seasons. Contrary to expectations, kestrels relied heavily on thermal soaring when foraging, especially during periods of high solar radiation. This produced a circadian pattern in the kestrel flight strategy that led to a spatial segregation of foraging areas. Kestrels flapped towards foraging areas close to the colony when thermals were not available. However, as soon as thermals were formed, they soared on them towards foraging areas far from the colony, especially when they were surrounded by poor foraging habitats. This reduced the chick provisioning rate at the colony. Given that lesser kestrels have a preference for feeding on large insects, and considering the average distance they cover to capture them during foraging trips, to commute using flapping flight would result in a negative energy balance for the family group. Our results show that lesser kestrels prioritize saving energy when foraging, suggesting that kestrels are more energy than time-constrained during the breeding season.	[Hernandez-Pliego, Jesus; Bustamante, Javier] EBD CSIC, Dept Wetland Ecol, Seville 41092, Spain; [Rodriguez, Carlos] EBD CSIC, Dept Conservat Biol, Seville 41092, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD)	Hernandez-Pliego, J (corresponding author), EBD CSIC, Dept Wetland Ecol, C Americo Vespucio S-N, Seville 41092, Spain.	jhpliego@ebd.csic.es	Bustamante, Javier/C-2735-2008; Bustamante, Javier/AAA-7273-2019; Hernández-Pliego, Jesús/M-4067-2015	Bustamante, Javier/0000-0001-7515-0677; Bustamante, Javier/0000-0001-7515-0677; Hernández-Pliego, Jesús/0000-0002-7343-4518	Consejeria de Innovacion, Ciencia y Empresa of the Junta de Andalucia [P09-RNM-04588]; FEDER funds from the European Union; JAE; Spanish National Research Council; European Social Fund	Consejeria de Innovacion, Ciencia y Empresa of the Junta de Andalucia(Junta de Andalucia); FEDER funds from the European Union(European Commission); JAE; Spanish National Research Council; European Social Fund(European Social Fund (ESF))	This study was funded by the "HORUS" project (ref: P09-RNM-04588) financed by the Consejeria de Innovacion, Ciencia y Empresa of the Junta de Andalucia and FEDER funds from the European Union. J. Hernandez-Pliego and C. Rodriguez were supported by JAE-predoc and a JAE-doc fellowships, respectively, co-funded by the Spanish National Research Council and the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank J.A. Bellas, E. Munoz, I. Piudo, and A. Quilez for their support during field work. We are also grateful to G. Anastasiou and C. Morrison for revising the English. Sergio A. Lambertucci, Zsuzsa Akos, Todd Katzner, and Judy Shamoun-Baranes made useful comments on an early draft of this manuscript. This study was funded by the "HORUS" project (ref: P09-RNM-04588) financed by the Consejeria de Innovacion, Ciencia y Empresa of the Junta de Andalucia and FEDER funds from the European Union. J. Hernandez-Pliego and C. Rodriguez were supported by JAE-predoc and a JAE-doc fellowships, respectively, co-funded by the Spanish National Research Council and the European Social Fund.	Agostini N, 2015, ITAL J ZOOL, V82, P186, DOI 10.1080/11250003.2015.1009404; Agostini N, 2015, CURR ZOOL IN PRESS, V61; Akos Z, 2010, BIOINSPIR BIOMIM, V5, DOI 10.1088/1748-3182/5/4/045003; Alerstam T, 2001, J THEOR BIOL, V209, P319, DOI 10.1006/jtbi.2001.2266; ALES RF, 1992, LANDSCAPE ECOL, V7, P3, DOI 10.1007/BF02573953; ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; Barron DG, 2010, METHODS ECOL EVOL, V1, P180, DOI 10.1111/j.2041-210X.2010.00013.x; BAUDINETTE RV, 1974, NATURE, V248, P83, DOI 10.1038/248083b0; Bishop CM, 2015, SCIENCE, V347, P250, DOI 10.1126/science.1258732; Bohrer G, 2012, ECOL LETT, V15, P96, DOI 10.1111/j.1461-0248.2011.01713.x; Bonal R, 2008, J AVIAN BIOL, V39, P189, DOI 10.1111/j.2008.0908-8857.04125.x; Bustamante J, 1997, BIOL CONSERV, V80, P153, DOI 10.1016/S0006-3207(96)00136-X; Catry I, 2014, BIRD STUDY, V61, P447, DOI 10.1080/00063657.2014.953031; Cramp S, 1980, THE BIRDS OF THE WES, VII; Dodge S, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-3; Duerr AE, 2015, FUNCT ECOL, V29, P779, DOI 10.1111/1365-2435.12381; Duerr AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035548; Duriez O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084887; ELLINGTON CP, 1991, J EXP BIOL, V160, P71; Fagan WF, 2013, ECOL LETT, V16, P1316, DOI 10.1111/ele.12165; GARRATT JR, 1994, EARTH-SCI REV, V37, P89, DOI 10.1016/0012-8252(94)90026-4; GITTLEMAN JL, 1988, AM ZOOL, V28, P863, DOI 10.1093/icb/28.3.863; Gleiss AC, 2011, METHODS ECOL EVOL, V2, P23, DOI 10.1111/j.2041-210X.2010.00057.x; HEDENSTROM A, 1993, PHILOS T ROY SOC B, V342, P353, DOI 10.1098/rstb.1993.0164; Hedenstrom A, 2008, PHILOS T R SOC B, V363, P287, DOI 10.1098/rstb.2007.2140; Hernandez-Pliego J, 2014, CURR ZOOL, V60, P604, DOI 10.1093/czoolo/60.5.604; Kumar RS, 2014, MISTNESY, V15, P14; Lanzone MJ, 2012, BIOL LETTERS, V8, P710, DOI 10.1098/rsbl.2012.0359; LASIEWSKI RC, 1967, CONDOR, V69, P13, DOI 10.2307/1366368; Liminana R, 2013, BEHAV ECOL SOCIOBIOL, V67, P823, DOI 10.1007/s00265-013-1506-9; Liminana R, 2012, IBIS, V154, P389, DOI 10.1111/j.1474-919X.2011.01210.x; Lopez-Lopez P, 2010, LANDSCAPE ECOL, V25, P803, DOI 10.1007/s10980-010-9460-7; MASMAN D, 1986, ARDEA, V74, P24; MASMAN D, 1988, ARDEA, V76, P64; Mateos-Rodriguez M, 2012, BEHAV ECOL, V23, P403, DOI 10.1093/beheco/arr204; Mellone U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039833; MENDELSOHN JM, 1989, OSTRICH, V60, P35, DOI 10.1080/00306525.1989.9634503; Norberg Ulla M., 1996, P199; Pennycuick CJ, 2008, THEOR ECOL SER, P1; PENNYCUICK CJ, 1972, IBIS, V114, P178, DOI 10.1111/j.1474-919X.1972.tb02603.x; PENNYCUICK CJ, 1971, J EXP BIOL, V55, P13; Portugal SJ, 2014, NATURE, V505, P399, DOI 10.1038/nature12939; R Core Team, 2014, LANG ENV STAT COMP; Rodriguez A, 2014, J EXP ZOOL PART A, V321, P376, DOI 10.1002/jez.1868; Rodriguez C, 2008, BIODIVERS CONSERV, V17, P1753, DOI 10.1007/s10531-008-9381-9; Rodriguez C, 2014, BIRD CONSERV INT, V24, P438, DOI 10.1017/S0959270913000129; Rodriguez C, 2010, J RAPTOR RES, V44, P120, DOI 10.3356/JRR-09-34.1; RUDOLPH SG, 1982, ECOLOGY, V63, P1268, DOI 10.2307/1938854; Ruppert D, 2003, SEMIPARAMETRIC REGRE; Sachs G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041449; Sapir N, 2011, P ROY SOC B-BIOL SCI, V278, P3380, DOI 10.1098/rspb.2011.0358; Sapir N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013956; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schmidt-Nielsen K, 1997, ANIMAL PHYSIOLOGY; SCHOENER TW, 1968, ECOLOGY, V49, P123, DOI 10.2307/1933567; Shamoun-Baranes J, 2003, CONDOR, V105, P208, DOI 10.1650/0010-5422(2003)105[0208:DUOTCB]2.0.CO;2; Shannon HD, 2002, CONDOR, V104, P679, DOI 10.1650/0010-5422(2002)104[0679:AWPSFT]2.0.CO;2; Shepard ELC, 2013, AM NAT, V182, P298, DOI 10.1086/671257; Spaar R, 1997, IBIS, V139, P523, DOI 10.1111/j.1474-919X.1997.tb04669.x; Spaar R, 1997, CONDOR, V99, P458, DOI 10.2307/1369952; Strandberg R, 2009, ARDEA, V97, P287, DOI 10.5253/078.097.0304; Telia J, 1996, THESIS; Valone TJ, 2002, PHILOS T R SOC B, V357, P1549, DOI 10.1098/rstb.2002.1064; Van Huis A., 2013, EDIBLE INSECTS FUTUR, P67; Vansteelant WMG, 2014, J FIELD ORNITHOL, V85, P40, DOI 10.1111/jofo.12048; VISCOR G, 1987, COMP BIOCHEM PHYS A, V87, P231, DOI 10.1016/0300-9629(87)90118-6; Wall J, 2006, CURR BIOL, V16, pR527, DOI 10.1016/j.cub.2006.06.049; Wilson RP, 2012, P ROY SOC B-BIOL SCI, V279, P975, DOI 10.1098/rspb.2011.1544; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x; YOUNG GS, 1988, EARTH-SCI REV, V25, P179, DOI 10.1016/0012-8252(88)90020-7	70	15	15	2	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145402	10.1371/journal.pone.0145402	http://dx.doi.org/10.1371/journal.pone.0145402			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689780	Green Submitted, gold, Green Published			2022-12-26	WOS:000367092300071
J	Hurtado, R; Fabrizio, T; Vanstreels, RET; Krauss, S; Webby, RJ; Webster, RG; Durigon, EL				Hurtado, Renata; Fabrizio, Thomas; Vanstreels, Ralph Eric Thijl; Krauss, Scott; Webby, Richard J.; Webster, Robert G.; Durigon, Edison Luiz			Molecular Characterization of Subtype H11N9 Avian Influenza Virus Isolated from Shorebirds in Brazil	PLOS ONE			English	Article							CONTAINS GENES; WILD BIRDS; SEQUENCE; WATERFOWL; OUTBREAK; EQUINE; DUCK	Migratory aquatic birds play an important role in the maintenance and spread of avian influenza viruses (AIV). Many species of aquatic migratory birds tend to use similar migration routes, also known as flyways, which serve as important circuits for the dissemination of AIV. In recent years there has been extensive surveillance of the virus in aquatic birds in the Northern Hemisphere; however in contrast only a few studies have been attempted to detect AIV in wild birds in South America. There are major flyways connecting South America to Central and North America, whereas avian migration routes between South America and the remaining continents are uncommon. As a result, it has been hypothesized that South American AIV strains would be most closely related to the strains from North America than to those from other regions in the world. We characterized the full genome of three AIV subtype H11N9 isolates obtained from ruddy turnstones (Arenaria interpres) on the Amazon coast of Brazil. For all gene segments, all three strains consistently clustered together within evolutionary lineages of AIV that had been previously described from aquatic birds in North America. In particular, the H11N9 isolates were remarkably closely related to AIV strains from shorebirds sampled at the Delaware Bay region, on the Northeastern coast of the USA, more than 5000 km away from where the isolates were retrieved. Additionally, there was also evidence of genetic similarity to AIV strains from ducks and teals from interior USA and Canada. These findings corroborate that migratory flyways of aquatic birds play an important role in determining the genetic structure of AIV in the Western hemisphere, with a strong epidemiological connectivity between North and South America.	[Hurtado, Renata] Univ Sao Paulo, Sch Vet Med, Dept Prevent Vet Med & Anim Hlth, Sao Paulo, Brazil; [Fabrizio, Thomas; Krauss, Scott; Webby, Richard J.; Webster, Robert G.] St Jude Childrens Res Hosp, Dept Infect Dis, Div Virol, Memphis, TN 38105 USA; [Vanstreels, Ralph Eric Thijl] Univ Sao Paulo, Sch Vet Med, Dept Pathol, Lab Wildlife Comparat Pathol, Sao Paulo, Brazil; [Hurtado, Renata; Durigon, Edison Luiz] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Lab Biosafety Level 3, Sao Paulo, Brazil	Universidade de Sao Paulo; St Jude Children's Research Hospital; Universidade de Sao Paulo; Universidade de Sao Paulo	Hurtado, R (corresponding author), Univ Sao Paulo, Sch Vet Med, Dept Prevent Vet Med & Anim Hlth, Sao Paulo, Brazil.	renata_fh@yahoo.com.br	Fabrizio, Thomas/J-9935-2013; Webby, Richard J/N-5657-2018	Fabrizio, Thomas/0000-0002-8960-0728; Durigon, Edison/0000-0003-4898-6553	Sao Paulo Research Foundation; National Counsel of Technological and Scientific Development, and Coordination for the Improvement of Higher Education Personnel	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Counsel of Technological and Scientific Development, and Coordination for the Improvement of Higher Education Personnel	This research was funded by Sao Paulo Research Foundation, National Counsel of Technological and Scientific Development, and Coordination for the Improvement of Higher Education Personnel. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANTAS P. T. Z., 1983, WADER STUDY GROUP B, V39, P52; Bahl J, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003570; BECKER WB, 1966, J HYG-CAMB, V64, P309, DOI 10.1017/S0022172400040596; BirdLife International, 2012, IUCN RED LIST THREAT, V2012, DOI [http://dx.doi.org/10.2305/lUCN.UK.2012-1.RLTS, DOI 10.2305/IUCN.UK.2012-1.RLTS.]; Blanco DE, 2008, MAPPING WATERBIRD DI; Boere CG, 2006, WATERBIRDS WORLD, P40; Chen CY, 2012, J VIROL, V86, P11950, DOI 10.1128/JVI.02167-12; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Ellis TM, 2004, AVIAN PATHOL, V33, P492, DOI 10.1080/03079450400003601; Gill JS, 2006, EMERG INFECT DIS, V12, P1284, DOI 10.3201/eid1708.060492; Hallgrimsson Gunnar Thor, 2011, Marine Ornithology, V39, P137; Hanson BA, 2008, J WILDLIFE DIS, V44, P351, DOI 10.7589/0090-3558-44.2.351; Hay AJ, 1998, TXB INFLUENZA, P43; Hurt AC, 2014, MBIO, V5, DOI 10.1128/mBio.01098-14; Karlsson EA, 2013, EMERG MICROBES INFEC, V2, DOI 10.1038/emi.2013.20; KAWAOKA Y, 1988, VIROLOGY, V163, P247, DOI 10.1016/0042-6822(88)90260-7; Kayali G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026818; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Krauss S, 2010, P ROY SOC B-BIOL SCI, V277, P3373, DOI 10.1098/rspb.2010.1090; Mathieu C, 2015, VIRUS RES, V199, P42, DOI 10.1016/j.virusres.2015.01.008; Maximino C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103943; Minton C, 2010, EXCITING RESULTS GEO; Morgulis A, 2008, BIOINFORMATICS, V24, P1757, DOI 10.1093/bioinformatics/btn322; Obenauer JC, 2006, SCIENCE, V311, P1576, DOI 10.1126/science.1121586; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pasick J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09484; Pawar SD, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-251; Ramey AM, 2010, VIROLOGY, V401, P179, DOI 10.1016/j.virol.2010.02.006; Rimondi A, 2011, J VIROL, V85, P13354, DOI 10.1128/JVI.05946-11; Spackman E, 2007, AVIAN DIS, V51, P273, DOI 10.1637/7529-032106R.1; Spackman E, 2006, J VIROL, V80, P7760, DOI 10.1128/JVI.00445-06; Stailknecht DE, 2007, J WILDLIFE DIS, V43, pS15; Stallknecht DE, 2012, J WILDLIFE DIS, V48, P382, DOI 10.7589/0090-3558-48.2.382; Stallknecht D. E., 2008, AVIAN INFLUENZA, V1, P43, DOI DOI 10.1002/9780813818634.ch3; Suarez D. L., 2008, AVIAN INFLUENZA, P3; Suarez DL, 2004, EMERG INFECT DIS, V10, P693, DOI 10.3201/eid1004.030396; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; World Health Organization, 2014, AV INFL FACT SHEET; Wu HB, 2015, ARCH VIROL, V160, P2595, DOI 10.1007/s00705-015-2528-6; Wu Y, 2014, TRENDS MICROBIOL, V22, P183, DOI 10.1016/j.tim.2014.01.010; Xu KM, 2012, VIRUS RES, V168, P41, DOI 10.1016/j.virusres.2012.06.010; Zhang Y, 2012, J VIROL, V86, P12443, DOI 10.1128/JVI.02236-12	45	7	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145627	10.1371/journal.pone.0145627	http://dx.doi.org/10.1371/journal.pone.0145627			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689791	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092300091
J	Vancova, M; Nebesarova, J				Vancova, Marie; Nebesarova, Jana			Correlative Fluorescence and Scanning Electron Microscopy of Labelled Core Fucosylated Glycans Using Cryosections Mounted on Carbon-Patterned Glass Slides	PLOS ONE			English	Article							SALIVARY-GLAND; N-GLYCANS; TICK; GLYCOSYLATION; FUCOSE	The aim of the study is co-localization of N-glycans with fucose attached to N-acetylglucosamine in alpha 1,3 linkage, that belong to immunogenic carbohydrate epitopes in humans, and N-glycans with alpha 1,6-core fucose typical for mammalian type of N-linked glycosylation. Both glycan epitopes were labelled in cryosections of salivary glands isolated from the tick Ixodes ricinus. Salivary glands secrete during feeding many bioactive molecules and influence both successful feeding and transmission of tick-borne pathogens. For accurate and reliable localization of labelled glycans in both fluorescence and scanning electron microscopes, we used carbon imprints of finder or indexed EM grids on glass slides. We discuss if the topographical images can provide information about labelled structures, the working setting of the field-emission scanning electron microscope and the influence of the detector selection (a below-the-lens Autrata improved YAG detector of back-scattered electrons; in-lens and conventional Everhart-Thornley detectors of secondary electrons) on the imaging of gold nanoparticles, quantum dots and osmium-stained membranes.	[Vancova, Marie; Nebesarova, Jana] Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Vvi, CR-37005 Ceske Budejovice, Czech Republic; [Vancova, Marie] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Nebesarova, Jana] Charles Univ Prague, Fac Sci, Prague, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; University of South Bohemia Ceske Budejovice; Charles University Prague	Vancova, M (corresponding author), Acad Sci Czech Republ, Inst Parasitol, Ctr Biol, Vvi, Branisovska 31, CR-37005 Ceske Budejovice, Czech Republic.	vancova@paru.cas.cz	Vancova, Marie/G-8347-2014; Nebesarova, Jana/G-7351-2014	Vancova, Marie/0000-0003-0678-8268; Nebesarova, Jana/0000-0002-0897-7487	Biology Centre of the ASCR [TTE01020118]; EU-FP7 ANTIGONE, Biology Centre of the ASCR [278976]	Biology Centre of the ASCR; EU-FP7 ANTIGONE, Biology Centre of the ASCR	This work was supported by TTE01020118 - Biology Centre of the ASCR (JN); EU-FP7 ANTIGONE, project number 278976 Biology Centre of the ASCR (MV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht RM, 2013, ADV MICROS MICROANAL, P83; Altmann F, 2007, INT ARCH ALLERGY IMM, V142, P99, DOI 10.1159/000096114; Benedetti L, 2014, SCI REP-UK, V4, DOI 10.1038/srep07033; BINNINGTON KC, 1978, INT J PARASITOL, V8, P97, DOI 10.1016/0020-7519(78)90004-8; Brown E, 2009, SEMIN CELL DEV BIOL, V20, P910, DOI 10.1016/j.semcdb.2009.07.006; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Dupejova J, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-4; Erlandsen SL, 1999, SCANNING MICROSCOPY, V13, P43; FAWCETT DW, 1981, TISSUE CELL, V13, P231, DOI 10.1016/0040-8166(81)90003-3; Hermann R, 1996, HISTOCHEM CELL BIOL, V106, P31; Intra J, 2015, INSECT BIOCHEM MOLEC, V63, P133, DOI 10.1016/j.ibmb.2015.06.011; Kaufman W.R., 1982, PHYSL TICKS, P213; Kopek BG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077209; Kopek BG, 2012, P NATL ACAD SCI USA, V109, P6136, DOI 10.1073/pnas.1121558109; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; Liv N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055707; Ma B, 2006, GLYCOBIOLOGY, V16, p158R, DOI 10.1093/glycob/cwl040; Man P, 2008, EUR J MASS SPECTROM, V14, P345, DOI 10.1255/ejms.979; Morandi V, 2007, J APPL PHYS, V101, DOI 10.1063/1.2745333; Nebesarova J, 2015, NANOMED-NANOTECHNOL, DOI [10.1016/j.nano.2015.09.008, DOI 10.1016/J.NAN0.2015.09.008]; Nisman R, 2004, J HISTOCHEM CYTOCHEM, V52, P13, DOI 10.1177/002215540405200102; Pedra JHF, 2010, CELL MICROBIOL, V12, P1222, DOI 10.1111/j.1462-5822.2010.01464.x; Reimer L., 1998, SCAN ELECTRON MICROS, V2nd ed, DOI [10.1007/978-3-540-38967-5, DOI 10.1007/978-3-540-38967-5]; Seiter J, 2014, J MICROSC-OXFORD, V254, P75, DOI 10.1111/jmi.12120; Staudacher E, 1999, BBA-GEN SUBJECTS, V1473, P216, DOI 10.1016/S0304-4165(99)00181-6; Sterba J, 2014, CARBOHYD RES, V389, P93, DOI 10.1016/j.carres.2014.02.017; TOKUYASU KT, 1973, J CELL BIOL, V57, P551, DOI 10.1083/jcb.57.2.551; TOKUYASU KT, 1978, J ULTRA MOL STRUCT R, V63, P287, DOI 10.1016/S0022-5320(78)80053-7; van Die I, 1999, FEBS LETT, V463, P189, DOI 10.1016/S0014-5793(99)01508-2; Vancova M, 2011, MICROSC MICROANAL, V17, P810, DOI 10.1017/S1431927611000547; Wandrol P, 2014, MICROSC MICROANAL S3, V20, P1266; Watanabe S, 2012, METHOD CELL BIOL, V111, P283, DOI 10.1016/B978-0-12-416026-2.00015-7; Zonnevylle AC, 2013, J MICROSC-OXFORD, V252, P58, DOI 10.1111/jmi.12071	33	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145034	10.1371/journal.pone.0145034	http://dx.doi.org/10.1371/journal.pone.0145034			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690057	Green Submitted, Green Published, gold			2022-12-26	WOS:000367092300033
J	Agnarson, AM; Stromdahl, S; Levira, F; Masanja, H; Thorson, AE				Agnarson, Abela Mpobela; Stromdahl, Susanne; Levira, Francis; Masanja, Honorati; Thorson, Anna Ekeus			Female-Driven Multiple Concurrent Sexual Partnership Systems in a Rural Part of a Southern Tanzanian Province	PLOS ONE			English	Article							HIV EPIDEMICS; AFRICA	Background Multiple concurrent sexual relationships are one of the major challenges to HIV prevention in Tanzania. This study aims to explore sexual behaviour patterns including the practice of multiple concurrent sexual partnerships in a rural Tanzanian setting. Methods This qualitative study used focus group discussions and in-depth interviews with men and women from the community as well as ethnographic participant observations. The data was collected during 16 months of fieldwork in 2007, 2008, and 2009. The focus group discussions and in-depth interviews were transcribed verbatim and translated into English. The data was analysed through the process of latent content analysis. An open coding coding process was applied to create categories and assign themes. Findings Mafiga matatu was an expression used in this society to describe women's multiple concurrent sexual partners, usually three partners, which was described as a way to ensure social and financial security for their families as well as to achieve sexual pleasure. Adolescent initiation ceremonies initiated and conducted by grand mothers taught young women why and how to engage successfully in multiple concurrent sexual relationships. Some men expressed support for their female partners to behave according to mafiga matatu, while other men were hesitant around this behaviour. Our findings indicate that having multiple concurrent sexual partners is common and a normative behaviour in this setting. Economical factors and sexual pleasure were identified as drivers and viewed as legitimate reason for women to have multiple concurrent sexual partnerships. Conclusions Structural changes improving women's financial opportunities and increasing gender equality will be important to enable women to not depend on multiple concurrent sexual partnerships for financial security. Future research should explore how normative sexual behaviour changes as these structural changes take place.	[Agnarson, Abela Mpobela; Stromdahl, Susanne; Thorson, Anna Ekeus] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Levira, Francis; Masanja, Honorati] Ifakara Hlth Inst, Dar Es Salaam, Tanzania	Karolinska Institutet; Ifakara Health Institute	Agnarson, AM (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.	abela.agnarson@ki.se		Thorson, Anna/0000-0002-8703-6561; Levira, Francis/0000-0002-7063-2447; Stromdahl, Susanne/0000-0002-6706-0177	Swedish Medical Research Council (Vetenskapsradet, VR)	Swedish Medical Research Council (Vetenskapsradet, VR)	This research project was part of a project financed by the Swedish Medical Research Council (Vetenskapsradet, VR), (http://www.vr.se). AA SS AT received funding. The funders of this project did not play a role in the analysis of the data, preparation of the manuscript, or decision to publish the results.	[Anonymous], 2007, QUALITATIVE METHODOL; Baird S, 2010, HEALTH ECON, V19, P55, DOI 10.1002/hec.1569; Beidelman T., 1967, MATRILINEAL PEOPLES; Caplan A, 1976, BOYS CIRCUMCISION GI; Chen SX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000147; Dahlgren LE, 2014, QUALITATIVE METHODOL; Dewalt K., 2002, PARTICIPANT OBSERVAT; Doyle AM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000287; Halley Meghan., 2012, THESIS; Helle-Valle J, 2005, UNDERSTANDING SEXUAL; Hennink MM, 2007, INTERNATIONAL FOCUS GROUP RESEARCH: A HANDBOOK FOR THE HEALTH AND SOCIAL SCIENCES, P1, DOI 10.1017/CBO9780511619458; Hobbs D., 2001, HDB ETHNOGRAPHY, P204; Huygens P, 1996, SOC SCI MED, V42, P221, DOI 10.1016/0277-9536(95)00088-7; Kinsman J, 2000, Cult Health Sex, V2, P151, DOI 10.1080/136910500300778; Larsen Kjersti., 1990, OCCASIONAL PAPERS SO; Leclerc-Madlala S, 2009, SEX HEALTH, V6, P103, DOI 10.1071/SH08032; Liv H, 2015, AFR TODAY, V51, P57; Mah TL, 2010, AIDS BEHAV, V14, P11, DOI 10.1007/s10461-008-9433-x; Mah TL, 2010, AIDS BEHAV, V14, P25, DOI 10.1007/s10461-009-9617-z; Malisha L, 2008, HEALTH RISK SOC, V10, P585, DOI 10.1080/13698570802533713; Mamuya S, 1972, JANDO UNYAGO; Morris M, 1997, AIDS, V11, P641, DOI 10.1097/00002030-199705000-00012; Morris M, 2011, LANCET, V378, P1843, DOI 10.1016/S0140-6736(11)61803-5; National AIDS Control Program, 2011, HIV AIDS STI SURV RE; Patton MQ, 2002, QUALITATIVE METHODS; Philemon MN, 2007, FACTORS CONTRIBUTING; Plotkin M, 2011, UNPEELED MANGO QUALI; Schneider D. M., 1961, MATRILINEAL KINSHIP; Stoebenau Kirsten, 2011, Global Health, V7, P34, DOI 10.1186/1744-8603-7-34; Stovall James G., 2005, JOURNALISM WHO WHAT; Swantz M, 1969, RELIG MAGICAL RITES; Tanzania Commission for AIDS, 2012, COUNTRY PROGRESS REP; UNAIDS, 2009, CONS HELD DEF MEAS C; UNICEF, 2001, EQ GIRLS BOYS BAS ED; United Nations Educational Scientific and Cultural Organization and The United Republic of Tanzania Ministry of Education and Vocational Training, 2011, TANZ ED SECT AN; Van de Walle E, 1995, SEXUAL INITIATION TR; Wamoyi J, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-742; WEMBAH-RASHID J.A., 1975, ETHNO HIST MATRILINE; Wembah-Rashid JAR, 1994, AFRICAN ANTHR, V1, P49; Zembe YZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051998	40	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145297	10.1371/journal.pone.0145297	http://dx.doi.org/10.1371/journal.pone.0145297			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9KM	26683189	Green Published, Green Submitted, gold			2022-12-26	WOS:000366725800060
J	Ge, CM; Che, LX; Du, CY				Ge, Chunmin; Che, Lixiao; Du, Chunying			The UBC Domain Is Required for BRUCE to Promote BRIT1/MCPH1 Function in DSB Signaling and Repair Post Formation of BRUCE-USP8-BRIT1 Complex	PLOS ONE			English	Article							DAMAGE RESPONSIVE PROTEIN; DOUBLE-STRAND BREAKS; FANCONI-ANEMIA; UBIQUITIN LIGASE; DNA; RNF168; IAP; APOPTOSIS; RNF8; CYTOKINESIS	BRUCE is implicated in the regulation of DNA double-strand break response to preserve genome stability. It acts as a scaffold to tether USP8 and BRIT1, together they form a nuclear BRUCE-USP8-BRIT1 complex, where BRUCE holds K63-ubiquitinated BRIT1 from access to DSB in unstressed cells. Following DSB induction, BRUCE promotes USP8 mediated deubiquitination of BRIT1, a prerequisite for BRIT1 to be released from the complex and recruited to DSB by binding to gamma-H2AX. BRUCE contains UBC and BIR domains, but neither is required for the scaffolding function of BRUCE mentioned above. Therefore, it remains to be determined whether they are required for BRUCE in DSB response. Here we show that the UBC domain, not the BIR domain, is required for BRUCE to promote DNA repair at a step post the formation of BRUCE-USP8-BRIT1 complex. Mutation or deletion of the BRUCE UBC domain did not disrupt the BRUCE-USP8-BRIT1 complex, but impaired deubiquitination and consequent recruitment of BRIT1 to DSB. This leads to impaired chromatin relaxation, decreased accumulation of MDC1, NBS1, pATM and RAD51 at DSB, and compromised homologous recombination repair of DNA DSB. These results demonstrate that in addition to the scaffolding function in complex formation, BRUCE has an E3 ligase function to promote BRIT1 deubiquitination by USP8 leading to accumulation of BRIT1 at DNA double-strand break. These data support a crucial role for BRUCE UBC activity in the early stage of DSB response.	[Ge, Chunmin; Che, Lixiao; Du, Chunying] Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH 45267 USA	University System of Ohio; University of Cincinnati	Du, CY (corresponding author), Univ Cincinnati, Coll Med, Dept Canc & Cell Biol, Cincinnati, OH 45267 USA.	ducg@ucmail.uc.edu			National Institutes of Health [CA158323]; NATIONAL CANCER INSTITUTE [R01CA158323] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health Grants CA158323 (to C.D.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Rachid Drissi at Cincinnati Children Hospital Medical Center for MNase protocol; Dr. Jeremy Stark at City of Hope for HR reporter; Karen Domenico at Shiners Hospitals for Children for flow cytometric analysis of HR repair; Glenn Doerman for figure preparation; and Du lab members for helpful discussion. This work was supported by the National Institutes of Health Grant CA158323 (to C. D.).	Barr FA, 2007, CELL, V131, P847, DOI 10.1016/j.cell.2007.11.011; Bartke T, 2004, MOL CELL, V14, P801, DOI 10.1016/j.molcel.2004.05.018; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Chen ZH, 1999, BIOCHEM BIOPH RES CO, V264, P847, DOI 10.1006/bbrc.1999.1585; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Cohn MA, 2008, MOL CELL, V32, P306, DOI 10.1016/j.molcel.2008.10.009; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Garcia-Higuera I, 2001, MOL CELL, V7, P249, DOI 10.1016/S1097-2765(01)00173-3; Gatti M, 2015, CELL REP, V10, P226, DOI 10.1016/j.celrep.2014.12.021; Ge C, 2015, P NATL ACAD SCI US; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Gunn Amanda, 2012, Methods Mol Biol, V920, P379, DOI 10.1007/978-1-61779-998-3_27; Hauser HP, 1998, J CELL BIOL, V141, P1415, DOI 10.1083/jcb.141.6.1415; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Jackson SP, 2013, MOL CELL, V49, P795, DOI 10.1016/j.molcel.2013.01.017; Jasin M, 1996, TRENDS GENET, V12, P224, DOI 10.1016/0168-9525(96)10019-6; Jensen RB, 2010, NATURE, V467, P678, DOI 10.1038/nature09399; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Lin SY, 2005, P NATL ACAD SCI USA, V102, P15105, DOI 10.1073/pnas.0507722102; Liu J, 2010, NAT STRUCT MOL BIOL, V17, P1260, DOI 10.1038/nsmb.1904; Lotz K, 2004, MOL CELL BIOL, V24, P9339, DOI 10.1128/MCB.24.21.9339-9350.2004; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mattiroli F, 2012, CELL, V150, P1182, DOI 10.1016/j.cell.2012.08.005; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Mosbech A, 2013, J BIOL CHEM, V288, P16579, DOI 10.1074/jbc.M113.459917; Naito Mikihiko, 2006, Tanpakushitsu Kakusan Koso, V51, P1391; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Nishi R, 2014, NAT CELL BIOL, V16, P1016, DOI 10.1038/ncb3028; Peng G, 2009, CELL CYCLE, V8, P3071, DOI 10.4161/cc.8.19.9411; Pinato S, 2011, MOL CELL BIOL, V31, P118, DOI 10.1128/MCB.00818-10; Pohl C, 2008, CELL, V132, P832, DOI 10.1016/j.cell.2008.01.012; Price BD, 2013, CELL, V152, P1344, DOI 10.1016/j.cell.2013.02.011; Rajendra E, 2014, MOL CELL, V54, P858, DOI 10.1016/j.molcel.2014.05.001; Ren JY, 2005, P NATL ACAD SCI USA, V102, P565, DOI 10.1073/pnas.0408744102; Sharma N, 2014, CELL CYCLE, V13, P106, DOI 10.4161/cc.26814; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Thorslund T, 2010, NAT STRUCT MOL BIOL, V17, P1263, DOI 10.1038/nsmb.1905; Trimborn M, 2004, AM J HUM GENET, V75, P261, DOI 10.1086/422855; Verhagen AM, 2000, CELL, V102, P43, DOI 10.1016/S0092-8674(00)00009-X; Wang XZ, 2004, MOL CELL BIOL, V24, P5850, DOI 10.1128/MCB.24.13.5850-5862.2004; Xu Y, 2011, CELL CYCLE, V10, P261, DOI 10.4161/cc.10.2.14543; Zhang Z, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.599605	46	7	7	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144957	10.1371/journal.pone.0144957	http://dx.doi.org/10.1371/journal.pone.0144957			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683461	Green Published, Green Submitted, gold			2022-12-26	WOS:000366725800026
J	He, ZW; Zhang, Z; Guo, WX; Zhang, Y; Zhou, RC; Shi, SH				He, Ziwen; Zhang, Zhang; Guo, Wuxia; Zhang, Ying; Zhou, Renchao; Shi, Suhua			De Novo Assembly of Coding Sequences of the Mangrove Palm (Nypa fruticans) Using RNA-Seq and Discovery of Whole-Genome Duplications in the Ancestor of Palms	PLOS ONE			English	Article							ANNOTATION; EVOLUTION; SELECTION; ALIGNMENT; RESOURCE; TOOL	Nypa fruticans (Arecaceae) is the only monocot species of true mangroves. This species represents the earliest mangrove fossil recorded. How N. fruticans adapts to the harsh and unstable intertidal zone is an interesting question. However, the 60 gene segments deposited in NCBI are insufficient for solving this question. In this study, we sequenced, assembled and annotated the transcriptome of N. fruticans using next-generation sequencing technology. A total of 19,918,800 clean paired-end reads were de novo assembled into 45,368 unigenes with a N50 length of 1,096 bp. A total of 41.35% unigenes were functionally annotated using Blast2GO. Many genes annotated to "response to stress" and 15 putative positively selected genes were identified. Simple sequence repeats were identified and compared with other palms. The divergence time between N. fruticans and other palms was estimated at 75 million years ago using the genomic data, which is consistent with the fossil record. After calculating the synonymous substitution rate between paralogs, we found that two whole-genome duplication events were shared by N. fruticans and other palms. These duplication events provided a large amount of raw material for the more than 2,000 later speciation events in Arecaceae. This study provides a high quality resource for further functional and evolutionary studies of N. fruticans and palms in general.	[He, Ziwen; Zhang, Zhang; Guo, Wuxia; Zhou, Renchao; Shi, Suhua] Sun Yat Sen Univ, Guangdong Prov Key Lab Plant Resources, Key Lab Biodivers Dynam & Conservat, State Key Lab Biocontrol,Guangdong Higher Educ In, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Ying] Hainan Normal Univ, Coll Life Sci, Haikou 571158, Hainan, Peoples R China	Sun Yat Sen University; Hainan Normal University	Shi, SH (corresponding author), Sun Yat Sen Univ, Guangdong Prov Key Lab Plant Resources, Key Lab Biodivers Dynam & Conservat, State Key Lab Biocontrol,Guangdong Higher Educ In, Guangzhou 510275, Guangdong, Peoples R China.	lssssh@mail.sysu.edu.cn			National Natural Science Foundation of China [91331202, 41130208, 31170213]; Science Foundation of State Key Laboratory of Biocontrol [SKLBC13A03]; China Postdoctoral Science Foundation [2014M552264, 2015T80931]; Chang Hungta Science Foundation of Sun Yat-Sen University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of State Key Laboratory of Biocontrol; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Chang Hungta Science Foundation of Sun Yat-Sen University	SS and RZ were supported by grants from the National Natural Science Foundation of China 91331202, 41130208 and 31170213, http://www.nsfc.gov.cn/) and the Science Foundation of State Key Laboratory of Biocontrol (SKLBC13A03). ZH was supported by grants from China Postdoctoral Science Foundation (2014M552264 and 2015T80931, http://jj.chinapostdoctor.org.cn/). This work was also supported by the Chang Hungta Science Foundation of Sun Yat-Sen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants 91331202, 41130208 and 31170213 from the National Natural Science Foundation of China (NSFC), grant SKLBC13A03 from the Science Foundation of State Key Laboratory of Biocontrol and the project funded by China Postdoctoral Science Foundation (2014M552264 and 2015T80931). We would also like to acknowledge the Chang Hungta Science Foundation of Sun Yat-Sen University.	Al-Dous EK, 2011, NAT BIOTECHNOL, V29, P521, DOI 10.1038/nbt.1860; Al-Mssallem IS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3274; Asmussen CB, 2006, BOT J LINN SOC, V151, P15, DOI 10.1111/j.1095-8339.2006.00521.x; Baud S, 2009, PLANT CELL PHYSIOL, V50, P1463, DOI 10.1093/pcp/pcp092; Beick S, 2008, MOL CELL BIOL, V28, P5337, DOI 10.1128/MCB.00563-08; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; Cushing DA, 2005, PLANTA, V221, P424, DOI 10.1007/s00425-004-1452-x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; De Paolo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102155; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fan HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059997; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Gao F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124382; Gee Carole T., 2001, Wetlands Ecology and Management, V9, P181, DOI 10.1023/A:1011148522181; Gong QQ, 2005, PLANT J, V44, P826, DOI 10.1111/j.1365-313X.2005.02587.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Harley MM, 2006, BOT J LINN SOC, V151, P39, DOI 10.1111/j.1095-8339.2006.00522.x; Janssen T, 2004, BOT J LINN SOC, V146, P385, DOI 10.1111/j.1095-8339.2004.00345.x; Jian SG, 2010, AQUAT BOT, V92, P23, DOI 10.1016/j.aquabot.2009.09.003; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li FL, 2007, PLANT PHYSIOL, V145, P87, DOI 10.1104/pp.107.100560; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; McKain MR, 2012, AM J BOT, V99, P397, DOI 10.3732/ajb.1100537; O'Neill CM, 2012, HEREDITY, V108, P115, DOI 10.1038/hdy.2011.54; Ouyang S, 2007, NUCLEIC ACIDS RES, V35, pD883, DOI 10.1093/nar/gkl976; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Schrank E, 1987, BERLINER GEOWISS ABH, V75, P249; Shi T, 2010, ANN BOT-LONDON, V106, P497, DOI 10.1093/aob/mcq129; Singh R, 2013, NATURE, V500, P335, DOI 10.1038/nature12309; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Sunderland Terry C. H., 2002, Palms, V46, P154; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Tomlinson P, 1986, THE BOTANY OF MANGRO, p[147, 295]; Van de Peer Y, 2009, TRENDS PLANT SCI, V14, P680, DOI 10.1016/j.tplants.2009.09.001; Vanneste K, 2014, GENOME RES, V24, P1334, DOI 10.1101/gr.168997.113; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang JZ, 2005, MOL BIOL EVOL, V22, P2472, DOI 10.1093/molbev/msi237; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2	46	17	17	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145385	10.1371/journal.pone.0145385	http://dx.doi.org/10.1371/journal.pone.0145385			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684618	gold, Green Submitted, Green Published			2022-12-26	WOS:000366725800070
J	de Sandes-Freitas, TV; Felipe, CR; Aguiar, WF; Cristelli, MP; Tedesco-Silva, H; Medina-Pestana, JO				de Sandes-Freitas, Taina Veras; Felipe, Claudia Rosso; Aguiar, Wilson Ferreira; Cristelli, Marina Pontello; Tedesco-Silva, Helio; Medina-Pestana, Jose Osmar			Prolonged Delayed Graft Function Is Associated with Inferior Patient and Kidney Allograft Survivals	PLOS ONE			English	Article							BEATING DONOR KIDNEYS; RENAL-TRANSPLANTATION; ACUTE REJECTION; IMPACT	It is unclear if there is an association between the duration of delayed graft function (DGF) and kidney transplant (KT) outcomes. This study investigated the impact of prolonged DGF on patient and graft survivals, and renal function one year after KT. This single center retrospective analysis included all deceased donor KT performed between Jan/1998 and Dec/2008 (n = 1412). Patients were grouped in quartiles according to duration of DGF (1-5, 6-10, 1115, and > 15 days, designated as prolonged DGF). The overall incidence of DGF was 54.2%. Prolonged DGF was associated with retransplantation (OR 2.110, CI95% 1.064-4.184, p = 0.033) andmore than 3 HLAmismatches (OR 1.819, CI95% 1.117-2.962, p = 0.016). The incidence of acute rejection was higher in patients with DGF compared with those without DGF (36.2% vs. 12.2%, p<0.001). Compared to patients without DGF, DGF(1-5), DGF(6-10), and DGF(11-15), patients with prolonged DGF showed inferior one year patient survival (95.2% vs. 95.4% vs. 95.5% vs. 93.4% vs. 88.86%, p = 0.003), graft survival (91% vs. 91.4% vs. 92% vs. 88.7% vs. 70.5%, p<0.001), death-censored graft survival (95.7% vs. 95.4% vs. 96.4% vs. 94% vs. 79.3%, p<0.001), and creatinine clearance (58.0 +/- 24.6 vs. 55.8 +/- 22.2 vs. 53.8 +/- 24.1 vs. 53.0 +/- 27.2 vs. 36.8 +/- 27.0mL/min, p<0.001), respectively. Multivariable analysis showed that prolonged DGF was an independent risk factor for graft loss (OR 3.876, CI95% 2.270-6.618, p<0.001), death censored graft loss (OR 4.103, CI95% 2.055-8.193, p<0.001), and death (OR 3.065, CI95% 1.536-6.117, p = 0.001). Prolonged DGF, determined by retransplantation and higher HLA mismatches, was associated with inferior renal function, and patient and graft survivals at one year.	[de Sandes-Freitas, Taina Veras; Felipe, Claudia Rosso; Cristelli, Marina Pontello; Tedesco-Silva, Helio; Medina-Pestana, Jose Osmar] Univ Fed Sao Paulo UNIFESP, Hosp Rim, Div Nephrol, Sao Paulo, Brazil; [Aguiar, Wilson Ferreira] Univ Fed Sao Paulo UNIFESP, Hosp Rim, Div Urol, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Universidade Federal de Sao Paulo (UNIFESP)	de Sandes-Freitas, TV (corresponding author), Univ Fed Sao Paulo UNIFESP, Hosp Rim, Div Nephrol, Sao Paulo, Brazil.	taina.sandes@gmail.com	Aguiar, Wilson/I-3876-2016	Aguiar, Wilson/0000-0002-7581-096X; Medina Pestana, Jose/0000-0003-3912-2980				Arias M, 2003, TRANSPLANT P, V35, P1655, DOI 10.1016/S0041-1345(03)00564-5; Azevedo LS, 2005, TRANSPLANT P, V37, P2746, DOI 10.1016/j.transproceed.2005.05.005; Baptista Ana Paula Maia, 2013, Braz. J. Nephrol., V35, P289, DOI 10.5935/0101-2800.20130048; Brook NR, 2003, AM J TRANSPLANT, V3, P614, DOI 10.1034/j.1600-6143.2003.00113.x; Butala NM, 2013, TRANSPLANTATION, V95, P1008, DOI 10.1097/TP.0b013e3182855544; Chawla LS, 2014, NEW ENGL J MED, V371, P58, DOI 10.1056/NEJMra1214243; Fernandez-Juarez G, 2002, TRANSPLANT P, V34, P338, DOI 10.1016/S0041-1345(01)02789-0; Fontan MP, 1996, TRANSPLANTATION, V62, P42, DOI 10.1097/00007890-199607150-00009; Johnston O, 2006, NEPHROL DIAL TRANSPL, V21, P2270, DOI 10.1093/ndt/gfl103; Klein R, 2013, TRANSPLANTATION, V95, P611, DOI 10.1097/TP.0b013e318279153c; Malinoski DJ, 2013, AM J TRANSPLANT, V13, P993, DOI 10.1111/ajt.12090; Mallon DH, 2013, TRANSPLANTATION, V96, P885, DOI 10.1097/TP.0b013e3182a19348; Organ Procurement and Transplantation Network (OPTN) and Scientic Registry of Transplant Recipients (SRTR), 2014, OPTN SRTR 2012 ANN D; Qureshi F, 2002, TRANSPLANTATION, V74, P1400, DOI 10.1097/00007890-200211270-00010; Renkens JJM, 2005, AM J TRANSPLANT, V5, P2704, DOI 10.1111/j.1600-6143.2005.01072.x; Salamzadeh J, 2012, ANN TRANSPL, V17, P69; SHOSKES DA, 1990, TRANSPLANTATION, V49, P201, DOI 10.1097/00007890-199001000-00045; TROPPMANN C, 1995, TRANSPLANTATION, V59, P962, DOI 10.1097/00007890-199504150-00007; Yarlagadda SG, 2009, NEPHROL DIAL TRANSPL, V24, P1039, DOI 10.1093/ndt/gfn667; YOKOYAMA I, 1994, CLIN TRANSPLANT, V8, P101	20	47	50	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144188	10.1371/journal.pone.0144188	http://dx.doi.org/10.1371/journal.pone.0144188			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26679933	gold, Green Published, Green Submitted			2022-12-26	WOS:000366723400010
J	Mulley, G; Beeton, ML; Wilkinson, P; Vlisidou, I; Ockendon-Powell, N; Hapeshi, A; Tobias, NJ; Nollmann, FI; Bode, HB; van den Elsen, J; Ffrench-Constant, RH; Waterfield, NR				Mulley, Geraldine; Beeton, Michael L.; Wilkinson, Paul; Vlisidou, Isabella; Ockendon-Powell, Nina; Hapeshi, Alexia; Tobias, Nick J.; Nollmann, Friederike I.; Bode, Helge B.; van den Elsen, Jean; Ffrench-Constant, Richard H.; Waterfield, Nicholas R.			From Insect to Man: Photorhabdus Sheds Light on the Emergence of Human Pathogenicity	PLOS ONE			English	Article							SP NOV.; YERSINIA-PSEUDOTUBERCULOSIS; FUNCTIONAL-ANALYSIS; VIRULENCE FACTORS; SUBSP NOV.; PMRA-PMRB; LUMINESCENS; EXPRESSION; ASYMBIOTICA; IDENTIFICATION	Photorhabdus are highly effective insect pathogenic bacteria that exist in a mutualistic relationship with Heterorhabditid nematodes. Unlike other members of the genus, Photorhabdus asymbiotica can also infect humans. Most Photorhabdus cannot replicate above 34 degrees C, limiting their host-range to poikilothermic invertebrates. In contrast, P. asymbiotica must necessarily be able to replicate at 37 degrees C or above. Many well-studied mammalian pathogens use the elevated temperature of their host as a signal to regulate the necessary changes in gene expression required for infection. Here we use RNA-seq, proteomics and phenotype microarrays to examine temperature dependent differences in transcription, translation and phenotype of P. asymbiotica at 28 degrees C versus 37 degrees C, relevant to the insect or human hosts respectively. Our findings reveal relatively few temperature dependant differences in gene expression. There is however a striking difference in metabolism at 37 degrees C, with a significant reduction in the range of carbon and nitrogen sources that otherwise support respiration at 28 degrees C. We propose that the key adaptation that enables P. asymbiotica to infect humans is to aggressively acquire amino acids, peptides and other nutrients from the human host, employing a so called "nutritional virulence" strategy. This would simultaneously cripple the host immune response while providing nutrients sufficient for reproduction. This might explain the severity of ulcerated lesions observed in clinical cases of Photorhabdosis. Furthermore, while P. asymbiotica can invade mammalian cells they must also resist immediate killing by humoral immunity components in serum. We observed an increase in the production of the insect Phenol-oxidase inhibitor Rhabduscin normally deployed to inhibit the melanisation immune cascade. Crucially we demonstrated this molecule also facilitates protection against killing by the alternative human complement pathway.	[Mulley, Geraldine] Univ Reading, Sch Biol Sci, Reading RG6 6AJ, Berks, England; [Beeton, Michael L.] Cardiff Metropolitan Univ, Cardiff Sch Hlth Sci, Cardiff CF5 2YB, S Glam, Wales; [Wilkinson, Paul; Vlisidou, Isabella] Univ Bristol, Bristol BS8 1TQ, Avon, England; [Ockendon-Powell, Nina] Gloucester Royal Hosp, Publ Hlth England, Dept Microbiol, Primary Care Unit, Gloucester GL1 3NN, England; [Hapeshi, Alexia; Waterfield, Nicholas R.] Univ Warwick, Warwick Med Sch, Div Biomed Sci, Coventry CV4 7AL, W Midlands, England; [Tobias, Nick J.; Nollmann, Friederike I.; Bode, Helge B.] Goethe Univ Frankfurt, Fachbereich Biowissensch, Buchmann Ctr Life Sci BMLS, D-60438 Frankfurt, Germany; [van den Elsen, Jean] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Ffrench-Constant, Richard H.] Univ Exeter, Biosci, Penryn TR10 9EZ, England	University of Reading; Cardiff Metropolitan University; Cardiff University; University of Bristol; Public Health England; University of Warwick; Goethe University Frankfurt; University of Bath; University of Exeter	Waterfield, NR (corresponding author), Univ Warwick, Warwick Med Sch, Div Biomed Sci, Med Sch Bldg,Gibbet Hill Rd, Coventry CV4 7AL, W Midlands, England.	N.R.Waterfield@warwick.ac.uk	Bode, Helge B/F-7022-2014	Bode, Helge B/0000-0001-6048-5909; Hapeshi, Alexia/0000-0002-5717-0532; ffrench-Constant, Richard/0000-0001-5385-9888; Waterfield, Nicholas/0000-0002-8044-7763; Beeton, Michael/0000-0002-6292-0772; Tobias, Nicholas/0000-0003-2725-3043; van den Elsen, Jean/0000-0002-0367-1956; Ockendon-Powell, Nina/0000-0001-5809-5397	BBSRC [BBE0213281]; EU [211436, 223328]; Warwick University Medical School; BBSRC [BB/E021328/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU(European Commission); Warwick University Medical School; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the BBSRC (grant number BBE0213281), EU FP7 consortium grant EMBEK1 (number 211436), EU FP7 consortium grant GAMEXP (number 223328), and Warwick University Medical School.	Abu Kwaik Y, 2013, CELL MICROBIOL, V15, P882, DOI 10.1111/cmi.12138; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bishop AH, 2014, J INVERTEBR PATHOL, V121, P85, DOI 10.1016/j.jip.2014.07.001; Bode HB, 2009, CURR OPIN CHEM BIOL, V13, P224, DOI 10.1016/j.cbpa.2009.02.037; Brachmann AO, 2013, NAT CHEM BIOL, V9, P573, DOI [10.1038/NCHEMBIO.1295, 10.1038/nchembio.1295]; Brameyer S, 2015, P NATL ACAD SCI USA, V112, P572, DOI 10.1073/pnas.1417685112; Brameyer S, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00166; Costa SCP, 2009, INFECT IMMUN, V77, P1022, DOI 10.1128/IAI.01064-08; Crawford JM, 2012, P NATL ACAD SCI USA, V109, P10821, DOI 10.1073/pnas.1201160109; Croucher NJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp811; Daborn PJ, 2002, P NATL ACAD SCI USA, V99, P10742, DOI 10.1073/pnas.102068099; Daborn PJ, 2001, J BACTERIOL, V183, P5834, DOI 10.1128/JB.183.20.5834-5839.2001; Dowling AJ, 2007, CELL MICROBIOL, V9, P2470, DOI 10.1111/j.1462-5822.2007.00974.x; Fan J, 2014, NATURE, V510, P298, DOI 10.1038/nature13236; Felfoldi G, 2009, APPL ENVIRON MICROB, V75, P3120, DOI 10.1128/AEM.02271-08; Feret R., 2014, CURR PROTOC PROTEIN, V75; Ferreira T, 2014, INT J SYST EVOL MICR, V64, P1540, DOI 10.1099/ijs.0.059840-0; Fischer-Le Saux M, 1999, INT J SYST BACTERIOL, V49, P1645, DOI 10.1099/00207713-49-4-1645; Fuchs SW, 2013, ANGEW CHEM INT EDIT, V52, P4108, DOI 10.1002/anie.201210116; Gerrard J, 2004, MICROBES INFECT, V6, P229, DOI 10.1016/j.micinf.2003.10.018; Gerrard JG, 2003, EMERG INFECT DIS, V9, P251; Gerrard JG, 2006, EMERG INFECT DIS, V12, P1562, DOI 10.3201/eid1210.060464; Gunn JS, 2000, INFECT IMMUN, V68, P6139, DOI 10.1128/IAI.68.11.6139-6146.2000; Herbst K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000435; Heroven AK, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00158; Hu K, 2000, FEMS MICROBIOL LETT, V189, P219, DOI 10.1111/j.1574-6968.2000.tb09234.x; HULTMARK D, 1993, TRENDS GENET, V9, P178, DOI 10.1016/0168-9525(93)90165-E; Jones RT, 2010, BMC MICROBIOL, P10; Joyce SA, 2011, ADV APPL MICROBIOL, V76, P1, DOI 10.1016/B978-0-12-387048-3.00001-5; Konkel ME, 2000, MICROBES INFECT, V2, P157, DOI 10.1016/S1286-4579(00)00272-0; Krin E, 2008, ENVIRON MICROBIOL, V10, P1118, DOI 10.1111/j.1462-2920.2007.01528.x; Krin E, 2006, APPL ENVIRON MICROB, V72, P6439, DOI 10.1128/AEM.00398-06; Kronenwerth M, 2014, CHEMBIOCHEM, V15, P2689, DOI 10.1002/cbic.201402447; Kullas AL, 2012, CELL HOST MICROBE, V12, P791, DOI 10.1016/j.chom.2012.10.018; KURASHIGE S, 1985, SCAND J IMMUNOL, V22, P1, DOI 10.1111/j.1365-3083.1985.tb01853.x; la Buscato E, 2013, CHEMMEDCHEM, V8, P919, DOI 10.1002/cmdc.201300057; Lee KM, 2012, INFECT IMMUN, V80, P1639, DOI 10.1128/IAI.06161-11; LI JX, 1995, APPL ENVIRON MICROB, V61, P4329, DOI 10.1128/AEM.61.12.4329-4333.1995; Lilley KS, 2004, EXPERT REV PROTEOMIC, V1, P401, DOI 10.1586/14789450.1.4.401; Marceau M, 2005, CURR ISSUES MOL BIOL, V7, P151; Marceau M, 2004, MICROBIOL-SGM, V150, P3947, DOI 10.1099/mic.0.27426-0; Martin B, ANGELS GLOW BATTLE S; Medzhitov R, 2002, SCIENCE, V296, P298, DOI 10.1126/science.1068883; Meibom KL, 2005, SCIENCE, V310, P1824, DOI 10.1126/science.1120096; Meylaers K, 2003, CURR PHARM DESIGN, V9, P159, DOI 10.2174/1381612033392279; Mignot T, 2001, MOL MICROBIOL, V42, P1189, DOI 10.1046/j.1365-2958.2001.02692.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Mouammine A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110060; Mulley G, 2010, J BACTERIOL, V192, P4944, DOI 10.1128/JB.00294-10; Ning ZM, 2001, GENOME RES, V11, P1725, DOI 10.1101/gr.194201; Nollmann FI, 2015, CHEMBIOCHEM, V16, P205, DOI 10.1002/cbic.201402603; Nuss AM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005087; Orozco RA, 2013, CURR MICROBIOL, V66, P30, DOI 10.1007/s00284-012-0220-6; Plichta KL, 2009, J HELMINTHOL, V83, P309, DOI 10.1017/S0022149X09222942; Read TD, 2003, NATURE, V423, P81, DOI 10.1038/nature01586; Reichenbach B, 2008, NUCLEIC ACIDS RES, V36, P2570, DOI 10.1093/nar/gkn091; REYNOLDS SE, 1985, J INSECT PHYSIOL, V31, P119, DOI 10.1016/0022-1910(85)90016-2; RICHARDSON WH, 1988, APPL ENVIRON MICROB, V54, P1602, DOI 10.1128/AEM.54.6.1602-1605.1988; ROTH JR, 1993, J BACTERIOL, V175, P3303, DOI 10.1128/jb.175.11.3303-3316.1993; Sandberg TE, 2014, MOL BIOL EVOL, V31, P2647, DOI 10.1093/molbev/msu209; Scotti C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013892; Seelen MA, 2005, J IMMUNOL METHODS, V296, P187, DOI 10.1016/j.jim.2004.11.016; Sharma V, 2014, BIOCHEM BIOPH RES CO, V453, P220, DOI 10.1016/j.bbrc.2014.06.021; Silva CP, 2002, CELL MICROBIOL, V4, P329, DOI 10.1046/j.1462-5822.2002.00194.x; Smith KS, 2000, FEMS MICROBIOL REV, V24, P335, DOI 10.1016/S0168-6445(00)00030-9; Stark RM, 1997, J MED MICROBIOL, V46, P793, DOI 10.1099/00222615-46-9-793; Tailliez P, 2010, INT J SYST EVOL MICR, V60, P1921, DOI 10.1099/ijs.0.014308-0; Tala A, 2011, MOL MICROBIOL, V81, P1330, DOI 10.1111/j.1365-2958.2011.07766.x; Theopold U, 2014, DEV COMP IMMUNOL, V42, P42, DOI 10.1016/j.dci.2013.03.014; Urbanowski ML, 2000, MOL MICROBIOL, V37, P856, DOI 10.1046/j.1365-2958.2000.02051.x; Grosso-Becera MV, 2015, TRENDS MICROBIOL, V23, P509, DOI 10.1016/j.tim.2015.04.004; Vilcinskas A, 2013, J INSECT PHYSIOL, V59, P123, DOI 10.1016/j.jinsphys.2012.08.018; Waterfield N, 2005, FEMS MICROBIOL LETT, V245, P47, DOI 10.1016/j.femsle.2005.02.018; Waterfield NR, 2008, P NATL ACAD SCI USA, V105, P15967, DOI 10.1073/pnas.0711114105; Waterfield NR, 2009, ANNU REV MICROBIOL, V63, P557, DOI 10.1146/annurev.micro.091208.073507; Watson RJ, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-177; Weissfeld AS, 2005, J CLIN MICROBIOL, V43, P4152, DOI 10.1128/JCM.43.8.4152-4155.2005; Wilkinson P, 2010, FEMS MICROBIOL LETT, V309, P136, DOI 10.1111/j.1574-6968.2010.02030.x; Wilkinson P, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-302; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005; Yang G, 2006, J BACTERIOL, V188, P2254, DOI 10.1128/JB.188.6.2254-2261.2006; Zhang YJJ, 2013, CELL MICROBIOL, V15, P1079, DOI 10.1111/cmi.12140; Zhao LB, 2012, J CHROMATOGR B, V885, P160, DOI 10.1016/j.jchromb.2011.12.026	84	22	22	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144937	10.1371/journal.pone.0144937	http://dx.doi.org/10.1371/journal.pone.0144937			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26681201	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000366723400035
J	Humphries, AT; McQuaid, CD; McClanahan, TR				Humphries, Austin T.; McQuaid, Christopher D.; McClanahan, Tim R.			Context-Dependent Diversity-Effects of Seaweed Consumption on Coral Reefs in Kenya	PLOS ONE			English	Article							GREAT-BARRIER-REEF; FEEDING-PREFERENCE EXPERIMENTS; PHASE-SHIFTS; HERBIVOROUS FISHES; ALGAL SUCCESSION; COMPETITION; CLOSURES; RECOVERY; RESILIENCE; MANAGEMENT	Consumers and prey diversity, their interactions, and subsequent effects on ecosystem function are important for ecological processes but not well understood in high diversity ecosystems such as coral reefs. Consequently, we tested the potential for diversity-effects with a series of surveys and experiments evaluating the influence of browsing herbivores on macroalgae in Kenya's fringing reef ecosystem. We surveyed sites and undertook experiments in reefs subject to three levels of human fishing influence: open access fished reefs, small and recently established community-managed marine reserves, and larger, older government-managed marine reserves. Older marine reserves had a greater overall diversity of herbivores and browsers but this was not clearly associated with reduced macroalgal diversity or abundance. Experiments studying succession on hard substrata also found no effects of consumer diversity. Instead, overall browser abundance of either sea urchins or fishes was correlated with declines in macroalgal cover. An exception was that the absence of a key fish browser genus, Naso, which was correlated with the persistence of Sargassum in a marine reserve. Algal selectivity assays showed that macroalgae were consumed at variable rates, a product of strong species-specific feeding and low overlap in the selectivity of browsing fishes. We conclude that the effects of browser and herbivore diversity are less than the influences of key species, whose impacts emerge in different contexts that are influenced by fisheries management. Consequently, identifying key herbivore species and managing to protect them may assist protecting reef functions.	[Humphries, Austin T.; McQuaid, Christopher D.] Rhodes Univ, Dept Zool & Entomol, Coastal Res Grp, ZA-6140 Grahamstown, South Africa; [Humphries, Austin T.] Wildlife Conservat Soc, Coral Reef Conservat Project, Mombasa, Kenya; [McClanahan, Tim R.] Wildlife Conservat Soc, Marine Programs, Bronx, NY USA	Rhodes University; Wildlife Conservation Society	Humphries, AT (corresponding author), Univ Rhode Isl, Dept Fisheries Anim & Vet Sci, Coll Environm & Life Sci, Kingston, RI 02881 USA.	humphries@uri.edu	McClanahan, Tim/K-4998-2019; McQuaid, Christopher/AAT-3725-2020	McQuaid, Christopher/0000-0002-3473-8308	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; Wildlife Conservation Society from the Western Indian Ocean Marine Science Association; Tiffany Foundation; McBean Foundation; John D. and Catherine T. MacArthur Foundation	South African Research Chairs Initiative of the Department of Science and Technology; National Research Foundation; Wildlife Conservation Society from the Western Indian Ocean Marine Science Association; Tiffany Foundation; McBean Foundation; John D. and Catherine T. MacArthur Foundation	This work is based upon research supported by the South African Research Chairs Initiative of the Department of Science and Technology and the National Research Foundation to C. McQuaid. T. McClanahan was supported by grants to the Wildlife Conservation Society from the Western Indian Ocean Marine Science Association, the Tiffany, McBean, and John D. and Catherine T. MacArthur Foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam TC, 2015, MAR ECOL PROG SER, V520, P1, DOI 10.3354/meps11170; Bellwood DR, 2006, CURR BIOL, V16, P2434, DOI 10.1016/j.cub.2006.10.030; BELLWOOD DR, 1990, ENVIRON BIOL FISH, V28, P189, DOI 10.1007/BF00751035; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Bellwood DR, 1994, RECORDS AUSTR MUSEUM; Bennett S, 2011, MAR ECOL PROG SER, V426, P241, DOI 10.3354/meps09016; Brandl SJ, 2014, J ANIM ECOL, V83, P661, DOI 10.1111/1365-2656.12171; Burkepile DE, 2008, P NATL ACAD SCI USA, V105, P16201, DOI 10.1073/pnas.0801946105; Burkepile DE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008963; Byrnes JEK, 2013, ECOLOGY, V94, P1636, DOI 10.1890/11-2310.1; Cheal AJ, 2010, CORAL REEFS, V29, P1005, DOI 10.1007/s00338-010-0661-y; Choat JH, 2002, MAR BIOL, V140, P613, DOI 10.1007/s00227-001-0715-3; Chong-Seng KM, 2014, CORAL REEFS, V33, P409, DOI 10.1007/s00338-014-1134-5; Clements KD, 2009, FUNCT ECOL, V23, P79, DOI 10.1111/j.1365-2435.2008.01524.x; Condy M, 2015, AQUAT CONSERV, V25, P396, DOI 10.1002/aqc.2482; Cvitanovic C, 2009, CORAL REEFS, V28, P127, DOI 10.1007/s00338-008-0433-0; Dixson DL, 2014, SCIENCE, V345, P892, DOI 10.1126/science.1255057; Edwards CB, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.1835; Fox RJ, 2007, MAR ECOL PROG SER, V339, P49, DOI 10.3354/meps339049; Green A.L., 2009, MONITORING FUNCTIONA; Hay ME, 1997, CORAL REEFS, V16, pS67, DOI 10.1007/s003380050243; HAY ME, 1994, ECOLOGY, V75, P1714, DOI 10.2307/1939631; Hixon MA, 1996, ECOL MONOGR, V66, P67, DOI 10.2307/2963481; Hoey AS, 2010, MAR BIOL, V157, P189, DOI 10.1007/s00227-009-1309-8; Hoey AS, 2009, ECOSYSTEMS, P1; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Humphries AT, 2014, MAR ECOL PROG SER, V504, P119, DOI 10.3354/meps10744; LESSIOS HA, 1984, CORAL REEFS, V3, P173, DOI 10.1007/BF00288252; Letourneur Y, 1998, NAGA, V21, P39; Lockwood JR, 1998, OECOLOGIA, V116, P475, DOI 10.1007/s004420050612; Mantyka CS, 2007, MAR ECOL PROG SER, V352, P177, DOI 10.3354/meps07055; Marshell A, 2015, J EXP MAR BIOL ECOL, V473, P152, DOI 10.1016/j.jembe.2015.09.002; Mbaru EK, 2013, FISH RES, V148, P90, DOI 10.1016/j.fishres.2013.08.011; McClanahan TR, 2012, MAR ECOL PROG SER, V469, P121, DOI 10.3354/meps10009; McClanahan TR, 2011, AQUAT CONSERV, V21, P658, DOI 10.1002/aqc.1225; McClanahan TR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042884; McClanahan TR, 2014, MAR ECOL PROG SER, V497, P13, DOI 10.3354/meps10605; MCCLANAHAN TR, 1990, OECOLOGIA, V83, P362, DOI 10.1007/BF00317561; MCCLANAHAN TR, 1994, J EXP MAR BIOL ECOL, V184, P237, DOI 10.1016/0022-0981(94)90007-8; MCCLANAHAN TR, 1988, MAR ECOL PROG SER, V44, P191, DOI 10.3354/meps044191; McClanahan TR, 1997, ENVIRON CONSERV, V24, P105, DOI 10.1017/S0376892997000179; McCook LJ, 2001, CORAL REEFS, V19, P400, DOI 10.1007/s003380000129; Micheli F, 2005, ECOL LETT, V8, P391, DOI 10.1111/j.1461-0248.2005.00731.x; Mumby PJ, 2009, CORAL REEFS, V28, P761, DOI 10.1007/s00338-009-0506-8; Nakamura Y, 2003, ICHTHYOL RES, V50, P15, DOI 10.1007/s102280300002; OGDEN J C, 1978, Environmental Biology of Fishes, V3, P49, DOI 10.1007/BF00006308; Persson A, 1999, CAN J FISH AQUAT SCI, V56, P70, DOI 10.1139/cjfas-56-1-70; Petchey OL, 2008, P NATL ACAD SCI USA, V105, P4191, DOI 10.1073/pnas.0710672105; Rasher DB, 2013, ECOLOGY, V94, P1347, DOI 10.1890/12-0389.1; ROA R, 1992, OECOLOGIA, V89, P509, DOI 10.1007/BF00317157; Sandin SA, 2012, OECOLOGIA, V168, P1079, DOI 10.1007/s00442-011-2156-0; SCOTT FJ, 1987, MAR ECOL PROG SER, V39, P293, DOI 10.3354/meps039293; Team RDC, 2013, LANG ENV STAT COMP; Thibaut LM, 2013, ECOL LETT, V16, P140, DOI 10.1111/ele.12019; Verges A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045543; Wilson SK, 2012, CONSERVATION BIOL	57	9	9	3	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144204	10.1371/journal.pone.0144204	http://dx.doi.org/10.1371/journal.pone.0144204			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673609	Green Submitted, gold, Green Published			2022-12-26	WOS:000366722700030
J	Gasulla, JM; Escaso, F; Narvaez, I; Ortega, F; Sanz, JL				Miguel Gasulla, Jose; Escaso, Fernando; Narvaez, Ivan; Ortega, Francisco; Luis Sanz, Jose			A New Sail-Backed Styracosternan (Dinosauria: Ornithopoda) from the Early Cretaceous of Morella, Spain	PLOS ONE			English	Article							BASAL IGUANODONT DINOSAURIA; DELAPPARENTIA-TUROLENSIS; ORNITHISCHIA ORNITHOPODA; TERUEL; ARCILLAS; POSITION	A new styracosternan ornithopod genus and species is here described based on a partial postcranial skeleton and an associated dentary tooth of a single specimen from the Arcillas de Morella Formation (Early Cretaceous, late Barremian) at the Morella locality, (Castellen Spain). Morelladon beltrani gen. et sp. nov. is diagnosed by eight autapomorphic features. The set of autapomorphies includes: very elongated and vertical neural spines of the dorsal vertebrae, midline keel on ventral surface of the second to fourth sacral vertebrae restricted to the anterior half of the centrum, a posterodorsally inclined medial ridge on the postacetabular process of the ilium that meets its dorsal margin and distal end of the straight ischial shaft laterally expanded, among others. Phylogenetic analyses reveal that the new Iberian form is more closely related to its synchronic and sympatric contemporary European taxa Iguanodon bernissartensis and Mantellisaurus atherfieldensis, known from Western Europe, than to other Early Cretaceous Iberian styracosternans (Delapparentia turolensis and Proa valdearinnoensis). The recognition of Morelladon beltrani gen. et sp. nov. indicates that the Iberian Peninsula was home to a highly diverse medium to large bodied styracosternan assemblage during the Early Cretaceous.	[Miguel Gasulla, Jose; Luis Sanz, Jose] Univ Autonoma Madrid, Unidad Paleontol, Madrid, Spain; [Escaso, Fernando; Narvaez, Ivan; Ortega, Francisco] Univ Nacl Educ Distancia, Grp Biol Evolut, E-28040 Madrid, Spain	Autonomous University of Madrid; Universidad Nacional de Educacion a Distancia (UNED)	Escaso, F (corresponding author), Univ Nacl Educ Distancia, Grp Biol Evolut, E-28040 Madrid, Spain.	fescaso@ccia.uned.es	Sanz, Jose Luis/O-1421-2019; Ortega, Francisco/K-3255-2015; Narvaez, Ivan/D-8147-2018; Ortega, Francisco/B-5760-2009; Escaso, Fernando/H-9782-2015	Ortega, Francisco/0000-0002-7431-354X; Narvaez, Ivan/0000-0003-0114-7058; Ortega, Francisco/0000-0002-7431-354X; Escaso, Fernando/0000-0001-7642-1555; Sanz, Jose Luis/0000-0002-5214-5725				Chabli S., 1988, THESIS; DOLLO L, 1888, CR HEBD ACAD SCI, V106, P775; Gasca JM, 2015, J IBER GEOL, V41, P57, DOI 10.5209/rev_JIGE.2015.v41.n1.48655; Gasulla J.M., 2009, P PROGR ABSTR FIELD, P44; Gasulla JM, 2014, CRETACEOUS RES, V47, P19, DOI 10.1016/j.cretres.2013.10.004; Goloboff PA, 2008, CLADISTICS, V24, P774, DOI 10.1111/j.1096-0031.2008.00217.x; Hooley R. W., 1925, Quarterly Journal of the Geological Society of London, V81, P1; Gasca JM, 2014, CRETACEOUS RES, V50, P264, DOI 10.1016/j.cretres.2014.05.009; Marsh O.C., 1881, AM J SCI, V21, P417, DOI DOI 10.2475/AJS.S3-21.125.417; Mcdonald AT, 2011, ZOOTAXA, P52, DOI 10.11646/zootaxa.2783.1.4; Mcdonald AT, 2012, ZOOTAXA, P61; McDonald AT, 2012, CRETACEOUS RES, V33, P1, DOI 10.1016/j.cretres.2011.03.002; McDonald AT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014075; Norman D.B., 1986, Bulletin de l'Institut Royal des Sciences Naturelles de Belgique Sciences de la Terre, V56, P281; Norman David B., 2011, Palaeontological Association Field Guides to Fossils, V14, P407; Norman DB, 2015, ZOOL J LINN SOC-LOND, V173, P92, DOI 10.1111/zoj.12193; Norman David B., 2012, P174; Norman DB, 2011, SPEC PAP PALAEONTOL, P165, DOI 10.1111/j.1475-4983.2011.01082.x; Norman DB., 1980, MEMOIRES I ROYAL SCI, V178, P1; Owen R., 1842, REPORTS BRIT ASS ADV, V11, P60; Pereda-Suberbiola X, 2011, CR PALEVOL, V10, P551, DOI 10.1016/j.crpv.2011.04.003; Ruiz-Omenaca JI, 2011, ESTUD GEOL-MADRID, V67, P83, DOI 10.3989/egeol.40276.124; SALAS R, 2005, GEOGACETA, V38, P15; Sanz JL., 1982, GEOLOGIA PALEONTOLOG, P69; Seeley H.G., 1887, P R SOC LONDON, V43, P165, DOI [10.1098/rspl.1887.0117, DOI 10.1098/RSPL.1887.0117]; Sereno Paul C., 1998, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V210, P41; SERENO PC, 1986, NATL GEOGR RES, V2, P234; Serrano ML, 2013, GEOL MAG, V150, P572, DOI 10.1017/S0016756813000095; Shibata M, 2015, ZOOTAXA, V3914, P421, DOI 10.11646/zootaxa.3914.4.3; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Taquet Philippe, 1999, Annales de Paleontologie, V85, P85, DOI 10.1016/S0753-3969(99)80009-3; Taquet R, 1976, CHAPITRE, P57; Verdu FJ, 2015, CRETACEOUS RES, V56, P250, DOI 10.1016/j.cretres.2015.05.010; Villanueva-Amadoz U, 2015, HIST BIOL, V27, P389, DOI 10.1080/08912963.2013.874422; Wang XL, 2010, EARTH ENV SCI T R SO, V101, P135, DOI 10.1017/S1755691010009266; Wu W-H, 2012, BERNISSART DINOSAURS, P174; [You Hailu 尤海鲁], 2005, [地质通报, Geological Bulletin of China], V24, P785	37	21	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144167	10.1371/journal.pone.0144167	http://dx.doi.org/10.1371/journal.pone.0144167			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673161	Green Published, Green Submitted, gold			2022-12-26	WOS:000366722700027
J	Sutton, GJ; Hoskins, AJ; Arnould, JPY				Sutton, Grace J.; Hoskins, Andrew J.; Arnould, John P. Y.			Benefits of Group Foraging Depend on Prey Type in a Small Marine Predator, the Little Penguin	PLOS ONE			English	Article							EUDYPTULA-MINOR; BASS STRAIT; BEHAVIOR; ENVIRONMENTS; CONSUMPTION; JELLYFISH; ENERGY; FOOD	Group foraging provides predators with advantages in over-powering prey larger than themselves or in aggregating small prey for efficient exploitation. For group-living predatory species, cooperative hunting strategies provide inclusive fitness benefits. However, for colonial-breeding predators, the benefit pay-offs of group foraging are less clear due to the potential for intra-specific competition. We used animal-borne cameras to determine the prey types, hunting strategies, and success of little penguins (Eudyptula minor), a small, colonial breeding air-breathing marine predator that has recently been shown to display extensive at-sea foraging associations with conspecifics. Regardless of prey type, little penguins had a higher probability of associating with conspecifics when hunting prey that were aggregated than when prey were solitary. In addition, success was greater when individuals hunted schooling rather than solitary prey. Surprisingly, however, success on schooling prey was similar or greater when individuals hunted on their own than when with conspecifics. These findings suggest individuals may be trading-off the energetic gains of solitary hunting for an increased probability of detecting prey within a spatially and temporally variable prey field by associating with conspecifics.	[Sutton, Grace J.; Arnould, John P. Y.] Deakin Univ, Sch Life & Environm Sci, Geelong, Vic 3217, Australia; [Hoskins, Andrew J.] CSIRO Land & Water, Canberra, ACT, Australia	Deakin University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Sutton, GJ (corresponding author), Deakin Univ, Sch Life & Environm Sci, Burwood Campus, Geelong, Vic 3217, Australia.	gsutton@deakin.edu.au	Hoskins, Andrew/T-2694-2019	Hoskins, Andrew/0000-0001-8907-6682	Deakin University internal funds	Deakin University internal funds	This project was supported by Deakin University internal funds.	Agnew P, 2013, MAR BIOL, V160, P2375, DOI 10.1007/s00227-013-2231-7; Akaike H., 1973, P 2 INT S INF THEOR, P267, DOI 10.1007/978-1-4612-1694-0; [Anonymous], 2014, R LANG ENV STAT COMP; Arnould JPY, 2004, EMU, V104, P261, DOI 10.1071/MU04035; Bates D, IME4 LINEAR MIXED EF; Beauchamp Guy, 2013, SOCIAL PREDATION GRO; BELOVSKY GE, 1989, THEOR POPUL BIOL, V36, P144, DOI 10.1016/0040-5809(89)90026-9; Berlincourt M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105065; Bunce A, 2001, ICES J MAR SCI, V58, P904, DOI 10.1006/jmsc.2001.1083; CLARK CW, 1986, THEOR POPUL BIOL, V30, P45, DOI 10.1016/0040-5809(86)90024-9; CULLEN JM, 1992, EMU, V91, P318, DOI 10.1071/MU9910318; Daniel TA, 2007, ANIM BEHAV, V74, P1241, DOI 10.1016/j.anbehav.2007.01.029; Doyle TK, 2007, J EXP MAR BIOL ECOL, V343, P239, DOI 10.1016/j.jembe.2006.12.010; Fauchald P, 2009, MAR ECOL PROG SER, V391, P139, DOI 10.3354/meps07818; GREEN B, 1989, PHYSIOL ZOOL, V62, P702, DOI 10.1086/physzool.62.3.30157922; HARRISON NM, 1984, LIMNOL OCEANOGR, V29, P1335, DOI 10.4319/lo.1984.29.6.1335; Hoese D.F., 1994, FISHES AUSTR S COAST, P781; Hoskins AJ, 2008, MAR ECOL PROG SER, V366, P293, DOI 10.3354/meps07507; HOUSTON AI, 1993, PHILOS T ROY SOC B, V341, P375, DOI 10.1098/rstb.1993.0123; KLOMP NI, 1991, EMU, V91, P32, DOI 10.1071/MU9910032; OBRIEN DP, 1988, MAR ECOL PROG SER, V42, P219, DOI 10.3354/meps042219; PACKER C, 1990, AM NAT, V136, P1, DOI 10.1086/285079; Pinheiro J., 2006, MIXED EFFECTS MODELS; Pinheiro J, 2015, NLME LINEAR NONLINEA; Ponganis PJ, 2000, J EXP BIOL, V203, P3275; POYSA H, 1992, ORNIS SCAND, V23, P159, DOI 10.2307/3676444; Preston Tiana J., 2008, Endangered Species Research, V4, P95, DOI 10.3354/esr00069; RYPSTRA AL, 1991, OECOLOGIA, V86, P25, DOI 10.1007/BF00317384; Scantlebury DM, 2014, SCIENCE, V346, P79, DOI 10.1126/science.1256424; Schrimpf MB, 2012, MAR ECOL PROG SER, V460, P247, DOI 10.3354/meps09750; Takahashi A, 2008, POLAR BIOL, V31, P1291, DOI 10.1007/s00300-008-0502-4; Thiebault A, 2014, BEHAV ECOL, V25, P1302, DOI 10.1093/beheco/aru132; Wakefield ED, 2009, MAR ECOL PROG SER, V391, P165, DOI 10.3354/meps08203; Watanabe YY, 2013, P NATL ACAD SCI USA, V110, P2199, DOI 10.1073/pnas.1216244110; Wiley D, 2011, BEHAVIOUR, V148, P575, DOI 10.1163/000579511X570893; Wilson RP, 2007, DEEP-SEA RES PT II, V54, P193, DOI 10.1016/j.dsr2.2006.11.017; Zuur Alain F., 2009, P1	37	38	39	1	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144297	10.1371/journal.pone.0144297	http://dx.doi.org/10.1371/journal.pone.0144297			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674073	Green Submitted, Green Published, gold			2022-12-26	WOS:000366722700033
J	Muraoka, Y; Tsujikawa, A; Takahashi, A; Iida, Y; Murakami, T; Ooto, S; Suzuma, K; Uji, A; Yoshimura, N				Muraoka, Yuki; Tsujikawa, Akitaka; Takahashi, Ayako; Iida, Yuto; Murakami, Tomoaki; Ooto, Sotaro; Suzuma, Kiyoshi; Uji, Akihito; Yoshimura, Nagahisa			Foveal Damage Due to Subfoveal Hemorrhage Associated with Branch Retinal Vein Occlusion	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; MACULAR EDEMA; SUBRETINAL HEMORRHAGE; SUBMACULAR HEMORRHAGE; NATURAL-HISTORY; VISUAL-ACUITY; DEGENERATION; RANIBIZUMAB; DETACHMENT; MANAGEMENT	To investigate the functional and morphologic prognoses of eyes with subfoveal hemorrhage from acute branch retinal vein occlusion (BRVO), and to examine the effect of intravitreal ranibizumab injection (IVR) on these prognoses, we assessed 81 eyes with acute BRVO, of which 38 did not receive IVR [IVR(-) group], and 43 were treated with IVR [IVR(+) group] for macular edema. The foveal morphologic changes were examined via optical coherence tomography (OCT). At initial examination, 63 eyes exhibited subfoveal hemorrhage. At final examination, the defect lengths in the foveal external limiting membrane (ELM) and ellipsoid lines in these eyes were longer, and final VA was significantly poorer, compared with eyes without subfoveal hemorrhage. In comparisons between the final measurements in eyes with subfoveal hemorrhage in the IVR(-) and IVR(+) groups, while there were no differences in initial ocular conditions, final VA was significantly better in the IVR(+) group. The defects in the ELM and ellipsoid lines in the IVR(+) group were shorter than those of the IVR(-) group (p = 0.002 in both). Final VA was correlated with the defect lengths of foveal ELM and ellipsoid lines in both the IVR(-) and IVR(+) groups (both p < 0.001). In addition, the defect lengths of foveal ELM and ellipsoid lines were closely correlated with the duration of subfoveal hemorrhage (both p < 0.001). BRVO-associated subfoveal hemorrhage caused damage to the foveal photoreceptors, and visual dysfunction. However, IVR improved these prognoses, by accelerating the absorption of the subfoveal hemorrhage.	[Muraoka, Yuki; Takahashi, Ayako; Iida, Yuto; Murakami, Tomoaki; Ooto, Sotaro; Suzuma, Kiyoshi; Uji, Akihito; Yoshimura, Nagahisa] Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan; [Tsujikawa, Akitaka] Kagawa Univ, Fac Med, Dept Ophthalmol, Takamatsu, Kagawa 760, Japan	Kyoto University; Kagawa University	Muraoka, Y (corresponding author), Kyoto Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Kyoto, Japan.	muraoka@kuhp.kyoto-u.ac.jp		Tsujikawa, Akitaka/0000-0003-0779-7799	Japan Society for the Promotion of Science (JSPS), Tokyo, Japan [21592256]; Japan National Society for the Prevention of Blindness, Tokyo, Japan; Novartis Pharma K.K., Tokyo, Japan; Innovative Techno-Hub for Integrated Medical Bio-Imaging of the Project for Developing Innovation Systems; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan	Japan Society for the Promotion of Science (JSPS), Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Japan National Society for the Prevention of Blindness, Tokyo, Japan(Japan National Society for the Prevention of Blindness); Novartis Pharma K.K., Tokyo, Japan; Innovative Techno-Hub for Integrated Medical Bio-Imaging of the Project for Developing Innovation Systems; Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported in part by the Japan Society for the Promotion of Science (JSPS), Tokyo, Japan (Grant-in-Aid for Scientific Research, no. 21592256), the Japan National Society for the Prevention of Blindness, Tokyo, Japan, Novartis Pharma K.K., Tokyo, Japan, the Innovative Techno-Hub for Integrated Medical Bio-Imaging of the Project for Developing Innovation Systems, from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avery RL, 1996, RETINA-J RET VIT DIS, V16, P183, DOI 10.1097/00006982-199616030-00001; Berrocal MH, 1996, AM J OPHTHALMOL, V122, P486, DOI 10.1016/S0002-9394(14)72107-5; Brown DM, 2011, OPHTHALMOLOGY, V118, P1594, DOI 10.1016/j.ophtha.2011.02.022; Campochiaro PA, 2014, OPHTHALMOLOGY, V121, P209, DOI 10.1016/j.ophtha.2013.08.038; Campochiaro PA, 2012, OPHTHALMOLOGICA, V227, P30, DOI 10.1159/000337157; Chang W, 2014, AM J OPHTHALMOL, V157, P1250, DOI 10.1016/j.ajo.2014.02.007; FINKELSTEIN D, 1992, ARCH OPHTHALMOL-CHIC, V110, P1427, DOI 10.1001/archopht.1992.01080220089028; FRANGIEH GT, 1982, ARCH OPHTHALMOL-CHIC, V100, P1132; GLATT H, 1982, AM J OPHTHALMOL, V94, P762, DOI 10.1016/0002-9394(82)90301-4; Green WR, 1996, OPHTHALMIC PATHOLOGY, V2, P733; Hayreh SS, 2014, PROG RETIN EYE RES, V41, P1, DOI 10.1016/j.preteyeres.2014.04.001; Hayreh SS, 2014, JAMA OPHTHALMOL, V132, P13, DOI 10.1001/jamaophthalmol.2013.5515; Heier JS, 2012, OPHTHALMOLOGY, V119, P802, DOI 10.1016/j.ophtha.2011.12.005; Humayun M, 1998, AM J OPHTHALMOL, V126, P358, DOI 10.1016/S0002-9394(98)00090-7; Kurashige Y, 2012, RETINA-J RET VIT DIS, V32, P792, DOI 10.1097/IAE.0b013e3182278b98; Lerche RC, 2001, OPHTHALMIC SURG LAS, V32, P272; Murakami T, 2012, RETINA-J RET VIT DIS, V32, P1853, DOI 10.1097/IAE.0b013e31824b824c; Muraoka Y, 2013, JPN J OPHTHALMOL, V57, P275, DOI 10.1007/s10384-013-0236-x; Notomi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053338; Ohashi H, 2004, OPHTHALMOLOGY, V111, P2050, DOI 10.1016/j.ophtha.2004.04.031; Ota M, 2007, BRIT J OPHTHALMOL, V91, P1644, DOI 10.1136/bjo.2007.118497; Rao H., 2014, CURR EYE RES, P1; Scupola A, 1999, OPHTHALMOLOGICA, V213, P97, DOI 10.1159/000027400; SHILLING JS, 1984, BRIT J OPHTHALMOL, V68, P196, DOI 10.1136/bjo.68.3.196; Spaide RF, 2003, RETINA-J RET VIT DIS, V23, P343, DOI 10.1097/00006982-200306000-00009; TOTH CA, 1992, AM J OPHTHALMOL, V113, P175, DOI 10.1016/S0002-9394(14)71530-2; TOTH CA, 1991, ARCH OPHTHALMOL-CHIC, V109, P723, DOI 10.1001/archopht.1991.01080050139046; Tsujikawa A, 2010, AM J OPHTHALMOL, V149, P291, DOI 10.1016/j.ajo.2009.09.007; Ueda-Arakawa N, 2012, JPN J OPHTHALMOL, V56, P589, DOI 10.1007/s10384-012-0191-y; Zhao XR, 2009, STROKE, V40, pS92, DOI 10.1161/STROKEAHA.108.533158	30	12	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144894	10.1371/journal.pone.0144894	http://dx.doi.org/10.1371/journal.pone.0144894			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26661582	Green Submitted, gold, Green Published			2022-12-26	WOS:000366715900139
J	Yang, LH; Gao, ZX; Hu, LP; Wu, GR; Yang, XW; Zhang, LH; Zhu, Y; Wong, BS; Xin, W; Sy, MS; Li, CY				Yang, Liheng; Gao, Zhenxing; Hu, Lipeng; Wu, Guiru; Yang, Xiaowen; Zhang, Lihua; Zhu, Ying; Wong, Boon-Seng; Xin, Wei; Sy, Man-Sun; Li, Chaoyang			Glycosylphosphatidylinositol Anchor Modification Machinery Deficiency Is Responsible for the Formation of Pro-Prion Protein (PrP) in BxPC-3 Protein and Increases Cancer Cell Motility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell migration; cell surface; glycosylphosphatidylinositol (GPI anchor); pancreatic cancer; prion; GPI anchor synthesis; cancer cell motility; pancreatic ductal adenocarcinoma cell; prion protein	MENTAL-RETARDATION SYNDROME; GPI-ANCHOR; GASTRIC-CANCER; INTELLECTUAL DISABILITY; CAUSE HYPERPHOSPHATASIA; PANCREATIC-CANCER; SYNTHESIS PATHWAY; PIGV MUTATIONS; POOR-PROGNOSIS; BREAST-CANCER	The normal cellular prion protein (PrP) is a glycosylphosphatidylinositol (GPI)-anchored cell surface glycoprotein. However, in pancreatic ductal adenocarcinoma cell lines, such as BxPC-3, PrP exists as a pro-PrP retaining its glycosylphosphatidylinositol (GPI) peptide signaling sequence. Here, we report the identification of another pancreatic ductal adenocarcinoma cell line, AsPC-1, which expresses a mature GPI-anchored PrP. Comparison of the 24 genes involved in the GPI anchor modification pathway between AsPC-1 and BxPC-3 revealed 15 of the 24 genes, including PGAP1 and PIG-F, were down-regulated in the latter cells. We also identified six missense mutations in DPM2, PIG-C, PIG-N, and PIG-P alongside eight silent mutations. When BxPC-3 cells were fused with Chinese hamster ovary (CHO) cells, which lack endogenous PrP, pro-PrP was successfully converted into mature GPI-anchored PrP. Expression of the individual gene, such as PGAP1, PIG-F, or PIG-C, into BxPC-3 cells does not result in phosphoinositide-specific phospholipase C sensitivity of PrP. However, when PIG-F but not PIG-P is expressed in PGAP1-expressing BxPC-3 cells, PrP on the surface of the cells becomes phosphoinositide-specific phospholipase C-sensitive. Thus, low expression of PIG-F and PGAP1 is the major factor contributing to the accumulation of pro-PrP. More importantly, BxPC-3 cells expressing GPI-anchored PrP migrate much slower than BxPC-3 cells bearing pro-PrP. In addition, GPI-anchored PrP-bearing AsPC-1 cells also migrate slower than pro-PrP bearing BxPC-3 cells, although both cells express filamin A. Knocking out PRNP in BxPC-3 cell drastically reduces its migration. Collectively, these results show that multiple gene irregularity in BxPC-3 cells is responsible for the formation of pro-PrP, and binding of pro-PrP to filamin A contributes to enhanced tumor cell motility.	[Yang, Liheng; Gao, Zhenxing; Hu, Lipeng; Wu, Guiru] Chinese Acad Sci, Univ Chinese Acad Sci, Wuhan Inst Virol, 44 Xiao Hong Shan Zhong Qu, Wuhan 430071, Peoples R China; [Yang, Xiaowen] Jiangxi Tumor Hosp, Dept Abdominal Surg 1, Nanchang 330029, Peoples R China; [Zhang, Lihua] Southeast Univ, Zhongda Hosp, Dept Pathol, Nanjing 210009, Jiangsu, Peoples R China; [Zhu, Ying] Wuhan Univ, State Key Lab Virol, Sch Life Sci, Dept Virol, Wuhan, Peoples R China; [Wong, Boon-Seng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore; [Xin, Wei; Sy, Man-Sun] Case Western Reserve Univ, Sch Med, Dept Pathol, Cleveland, OH 44102 USA; [Li, Chaoyang] Chinese Acad Sci, Hubei Collaborat Innovat Ctr Ind Fermentat, Wuhan Inst Virol, State Key Lab Virol, 44 Xiao Hong Shan Zhong Qu, Wuhan 430071, Peoples R China	Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Wuhan Institute of Virology, CAS; Southeast University - China; Wuhan University; National University of Singapore; Case Western Reserve University; Chinese Academy of Sciences; Wuhan Institute of Virology, CAS	Li, CY (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, Xiao Hong Shan 44, Wuhan 430071, Hubei, Peoples R China.	cyli@wh.iov.cn	Gao, Zhenxing/AAL-8244-2020; Wong, Boon-Seng/G-2759-2012	Wong, Boon-Seng/0000-0002-7118-8077	Chinese National Science Foundation [81172376, 31270209]; Nature Science Foundation of Hubei Province [2015CFA087]; Chinese Academy of Sciences 100-Talents Program; State Key Laboratory of Virology of China [2015IOV005]; WIV "One-Three-Five" Strategic Programs	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province); Chinese Academy of Sciences 100-Talents Program(Chinese Academy of Sciences); State Key Laboratory of Virology of China; WIV "One-Three-Five" Strategic Programs	This work was supported by Chinese National Science Foundation Grants 81172376 and 31270209, Nature Science Foundation of Hubei Province Grant 2015CFA087, Chinese Academy of Sciences 100-Talents Program, State Key Laboratory of Virology of China Grant 2015IOV005, and WIV "One-Three-Five" Strategic Programs. The authors declare that they have no conflicts of interest with the contents of this article.	Antonacopoulou AG, 2008, ANTICANCER RES, V28, P1221; Belet S, 2014, HUM MUTAT, V35, P350, DOI 10.1002/humu.22498; Benestad SL, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-87; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; Chen R, 2002, J CELL BIOCHEM, V84, P68, DOI 10.1002/jcb.1267; Dery MA, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3398; Diep DB, 1998, J BIOL CHEM, V273, P2355, DOI 10.1074/jbc.273.4.2355; Fujita M, 2012, BBA-MOL CELL BIOL L, V1821, P1050, DOI 10.1016/j.bbalip.2012.01.004; Fujita M, 2010, FEBS LETT, V584, P1670, DOI 10.1016/j.febslet.2009.10.079; Hansen L, 2013, AM J HUM GENET, V92, P575, DOI 10.1016/j.ajhg.2013.03.008; Ho JC, 2006, INT J CANCER, V119, P1330, DOI 10.1002/ijc.22005; Hong Y, 2000, J BIOL CHEM, V275, P20911, DOI 10.1074/jbc.M001913200; Horn D, 2011, AM J MED GENET A, V155A, P1917, DOI 10.1002/ajmg.a.34102; Howard MF, 2014, AM J HUM GENET, V94, P278, DOI 10.1016/j.ajhg.2013.12.012; Hu R, 2009, EXP HEMATOL, V37, P423, DOI 10.1016/j.exphem.2009.01.003; Jiang WW, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-74; Kato M, 2014, NEUROLOGY, V82, P1587, DOI 10.1212/WNL.0000000000000389; Krawitz PM, 2013, AM J HUM GENET, V92, P584, DOI 10.1016/j.ajhg.2013.03.011; Krawitz PM, 2012, AM J HUM GENET, V91, P146, DOI 10.1016/j.ajhg.2012.05.004; Krawitz PM, 2010, NAT GENET, V42, P827, DOI 10.1038/ng.653; Kvarnung M, 2013, J MED GENET, V50, P521, DOI 10.1136/jmedgenet-2013-101654; LEHMANN S, 1995, J BIOL CHEM, V270, P24589, DOI 10.1074/jbc.270.41.24589; Li CY, 2010, J BIOL CHEM, V285, P30328, DOI 10.1074/jbc.M110.147413; Li CY, 2009, J CLIN INVEST, V119, P2725, DOI 10.1172/JCI39542; Liang J, 2009, FEBS J, V276, P685, DOI 10.1111/j.1742-4658.2008.06816.x; Maeda Y, 2006, METHOD ENZYMOL, V416, P182, DOI 10.1016/S0076-6879(06)16012-7; Maydan G, 2011, J MED GENET, V48, P383, DOI 10.1136/jmg.2010.087114; Meslin F, 2007, ANN ONCOL, V18, P1793, DOI 10.1093/annonc/mdm406; Meslin F, 2007, CANCER RES, V67, P10910, DOI 10.1158/0008-5472.CAN-07-0512; Miller MW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004019; Moss J, 1999, MOL CELL BIOCHEM, V193, P109, DOI 10.1023/A:1006924514074; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Murakami Y, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004320; Nagpal JK, 2008, MODERN PATHOL, V21, P979, DOI 10.1038/modpathol.2008.76; Ng BG, 2012, AM J HUM GENET, V90, P685, DOI 10.1016/j.ajhg.2012.02.010; Pan YL, 2006, FASEB J, V20, P1886, DOI 10.1096/fj.06-6138fje; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; PRUSINER SB, 1993, P NATL ACAD SCI USA, V90, P10608, DOI 10.1073/pnas.90.22.10608; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Richt JA, 2007, NAT BIOTECHNOL, V25, P132, DOI 10.1038/nbt1271; SAILER A, 1994, CELL, V77, P967, DOI 10.1016/0092-8674(94)90436-7; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Stossel TP, 2003, DEV CELL, V4, P444, DOI 10.1016/S1534-5807(03)00098-4; Swoboda KJ, 2014, AM J MED GENET A, V164, P17, DOI 10.1002/ajmg.a.36189; TAKEDA J, 1993, CELL, V73, P703, DOI 10.1016/0092-8674(93)90250-T; Yang Liheng, 2014, Virologica Sinica, V29, P228, DOI 10.1007/s12250-014-3480-4; Yang XW, 2014, ACTA BIOCH BIOPH SIN, V46, P431, DOI 10.1093/abbs/gmu019; Zanusso G, 1998, P NATL ACAD SCI USA, V95, P8812, DOI 10.1073/pnas.95.15.8812; Zhang L, 2010, GASTROENTEROLOGY, V138, P949, DOI 10.1053/j.gastro.2009.11.010; Zhou L, 2014, INT J CANCER, V135, P2329, DOI 10.1002/ijc.28883	50	12	12	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3905	3917		10.1074/jbc.M115.705830	http://dx.doi.org/10.1074/jbc.M115.705830			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26683373	Green Published, hybrid			2022-12-26	WOS:000371338400019
J	Azage, M; Kumie, A; Worku, A; Bagtzoglou, AC				Azage, Muluken; Kumie, Abera; Worku, Alemayehu; Bagtzoglou, Amvrossios C.			Childhood Diarrhea Exhibits Spatiotemporal Variation in Northwest Ethiopia: A SaTScan Spatial Statistical Analysis	PLOS ONE			English	Article							RISK-FACTORS; CLIMATE VARIABILITY; UNDER-5 CHILDREN; DISEASE; CHOLERA; EPIDEMIOLOGY; PREVALENCE; HOUSEHOLD; COMMUNITY; PATTERNS	Background Childhood diarrhea continues to be a public health problem in developing countries, including Ethiopia. Detecting clusters and trends of childhood diarrhea is important to designing effective interventions. Therefore, this study aimed to investigate spatiotemporal clustering and seasonal variability of childhood diarrhea in northwest Ethiopia. Methods Retrospective record review of childhood diarrhea was conducted using quarterly reported data to the district health office for the seven years period beginning July 1, 2007. Thirty three districts were included and geo-coded in this study. Spatial, temporal and space-time scan spatial statistics were employed to identify clusters of childhood diarrhea. Smoothing using a moving average was applied to visualize the trends and seasonal pattern of childhood diarrhea. Statistical analyses were performed using Excel (R) and SaTScan programs. The maps were plotted using ArcGIS 10.0. Results Childhood diarrhea in northwest Ethiopia exhibits statistical evidence of spatial, temporal, and spatiotemporal clustering, with seasonal patterns and decreasing temporal trends observed in the study area. A most likely purely spatial cluster was found in the East Gojjam administrative zone of Gozamin district (LLR = 7123.89, p < 0.001). The most likely spatiotemporal cluster was detected in all districts of East Gojjam zone and a few districts of the West Gojjam zone (LLR = 24929.90, p<0.001), appearing from July 1, 2009 to June 30, 2011. One high risk period from July 1, 2008 to June 30, 2010 (LLR = 9655.86, p = 0.001) was observed in all districts. Peak childhood diarrhea cases showed a seasonal trend, occurring more frequently from January to March and April to June. Conclusion Childhood diarrhea did not occur at random. It has spatiotemporal variation and seasonal patterns with a decreasing temporal trend. Accounting for the spatiotemporal variation identified in the study areas is advised for the prevention and control of diarrhea.	[Azage, Muluken] Univ Addis Ababa, Ethiopian Inst Water Resources, Addis Ababa, Ethiopia; [Kumie, Abera; Worku, Alemayehu] Univ Addis Ababa, Sch Publ Hlth, Coll Hlth Sci, Addis Ababa, Ethiopia; [Bagtzoglou, Amvrossios C.] Univ Connecticut, Sch Engn, Dept Civil & Environm Engn, Storrs, CT 06269 USA	Addis Ababa University; Addis Ababa University; University of Connecticut	Azage, M (corresponding author), Univ Addis Ababa, Ethiopian Inst Water Resources, Addis Ababa, Ethiopia.	mulukenag@yahoo.com	Kumie, Abera/AAC-8537-2022; Azage, Muluken/AAF-6515-2020; Bagtzoglou, Amvrossios/AAG-6598-2019	Azage, Muluken/0000-0003-3222-0158; Bagtzoglou, Amvrossios/0000-0002-4707-4336	Addis Ababa University; Bahir Dar University; University of Connecticut; USAID	Addis Ababa University; Bahir Dar University; University of Connecticut; USAID(United States Agency for International Development (USAID))	The Addis Ababa University, Bahir Dar University, the University of Connecticut and USAID provided funding to collect data for the study by covering expenses during field visits and for software to analyze the data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alebachew A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001696; Alexander KA, 2013, INT J ENV RES PUB HE, V10, P1202, DOI 10.3390/ijerph10041202; Amare Deribew, 2007, Ethiopian Journal of Health Development, V21, P117; Bentham G, 2001, INT J BIOMETEOROL, V45, P22, DOI 10.1007/s004840000083; Berhe F, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-187; Bezatu Mengistie, 2013, Open Journal of Preventive Medicine, V3, P446, DOI 10.4236/ojpm.2013.37060; Bhandari G P, 2012, J Nepal Health Res Counc, V10, P181; Borroto RJ, 2000, INT J EPIDEMIOL, V29, P764, DOI 10.1093/ije/29.4.764; Brooks JT, 2003, AM J TROP MED HYG, V68, P671, DOI 10.4269/ajtmh.2003.68.671; Bums JM, 2007, HIST SUB SAHARAN AFR; Caimcross S, 2010, INT J EPIDEMIOL, V39; Chaikaew N, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-36; Checkley W, 2000, LANCET, V355, P442, DOI 10.1016/S0140-6736(00)82010-3; Checkley W, 2003, AM J EPIDEMIOL, V157, P166, DOI 10.1093/aje/kwf179; Cheng YJ, 2013, GEOSPATIAL HEALTH, V7, P279, DOI 10.4081/gh.2013.86; Chou WC, 2010, SCI TOTAL ENVIRON, V409, P43, DOI 10.1016/j.scitotenv.2010.09.001; Clasen TF, 2010, COCHRANE DB SYST REV, V16; D'Souza RM, 2008, EPIDEMIOL INFECT, V136, P56, DOI 10.1017/S0950268807008229; Dereje Ayalew, 2012, Agricultural Sciences, V3, P608, DOI 10.4236/as.2012.34074; Dessalegn M, 2011, ETHIOP J HEALTH DEV, V25, P192; Development BoFaE, 2014, POPULATION SIZE OF A; El-Fadel M, 2013, ENVIRON MONIT ASSESS, V29, P29; Elliott P, 2004, ENVIRON HEALTH PERSP, V112, P998, DOI 10.1289/ehp.6735; Emch M, 2001, ENVIRON PLANN A, V33, P339, DOI 10.1068/a33132; Eshete Wondwossen Birke, 2008, East Afr J Public Health, V5, P193; ESRI, 2011, ARCGIS DESKT REL 10; FDRE/MoH, 2011, HEALTH AND HEALTH RE; FDRE/MoH, 2010, HEALTH AND HEALTH RE; FMOH, 2013, HEALTH SECTOR DEVELO; FMOH, 2005, HEALTH SECTOR STRATE; Galan DI, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-527; Gebru T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-395; Godana W, 2013, RURAL REMOTE HEALTH, V13; Hasan KZ, 2006, J HEALTH POPUL NUTR, V24, P25; Hashizume M, 2007, INT J EPIDEMIOL, V36, P1030, DOI 10.1093/ije/dym148; Hickman D, 2014, MBIO, V5, DOI 10.1128/mBio.01032-13; Hoque BA, 2006, INT J HYG ENVIR HEAL, V209, P451, DOI 10.1016/j.ijheh.2006.04.008; Huang DS, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-130; International CSAEal, 2012, ETHIOPIA DEMOGRAPHIC; Islam MS, 2009, T ROY SOC TROP MED H, V103, P1165, DOI 10.1016/j.trstmh.2009.04.016; Jackson MC, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-55; Jagai JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038168; Jenkins G., 1994, TIME SERIES ANAL FOR; Kelly-Hope LA, 2007, AM J TROP MED HYG, V76, P706, DOI 10.4269/ajtmh.2007.76.706; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; KULLDORFF M, 1995, STAT MED, V14, P799, DOI 10.1002/sim.4780140809; Kulldorff M, 2003, COMPUT STAT DATA AN, V42, P665, DOI 10.1016/S0167-9473(02)00160-3; Kulldorff M, 2013, SATSCAN TMSER GUIDE; Kulldorff M., 1999, J NATL I PUBLIC HLTH, V48, P94; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luquero FJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019005; Macro CSAEaO, 2006, ETHIOPIA DEMOGRAPHIC; Macro CSAEaO, 2001, ETHIOPIAN DEMOGRAPHI; Mediratta RP, 2010, J HEALTH POPUL NUTR, V28, P253; Mekasha A, 2003, East Afr Med J, V80, P77; Mellander PE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068461; Mitike G, 2001, East Afr Med J, V78, P433; Nkoko DB, 2011, EMERG INFECT DIS, V17, P2026, DOI 10.3201/eid1711.110170; Nykiforuk JC, 2008, TECHNICAL REPORT 08; Odoi Agricola, 2004, Int J Health Geogr, V3, P11, DOI 10.1186/1476-072X-3-11; Osei FB, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-62; Pardhan-Ali A, 2012, INT J HEALTH GEOGR, V11, DOI 10.1186/1476-072X-11-17; Pruss-Ustun A CC, 2006, PREVENTING DISEASE T; Shikur M, 2013, SCI J PUBLIC HLTH, V1, P102, DOI DOI 10.11648/J.SJPH.20130102.19; Song C, 2003, INT J HEALTH GEOGR, V2, P9, DOI [10.1186/1476-072X-2-9, DOI 10.1186/1476-072X-2-9]; Tang FY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083487; Teklemariam S, 2000, ETHIOPIAN MED J, V38, P27; Thomas MK, 2006, INT J ENVIRON HEAL R, V16, P167, DOI 10.1080/09603120600641326; [UNICEF WHO], 2014, PROGRESS ON SANITATI; Walker CLF, 2013, LANCET, V381, P1405, DOI 10.1016/S0140-6736(13)60222-6; Walker CLF, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-220; Walker CLF, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000768; [WHO UNICEF], 2009, DIARRHOEAWHY CHILDRE; [WHO UNICEF FMOH], 2007, RAPID ASSESSMENT OF	75	26	27	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144690	10.1371/journal.pone.0144690	http://dx.doi.org/10.1371/journal.pone.0144690			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690058	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092300013
J	Jwa, E; Shin, KH; Lim, HW; Jung, SY; Lee, S; Kang, HS; Lee, E; Park, YH				Jwa, Eunjin; Shin, Kyung Hwan; Lim, Hyeon Woo; Jung, So-Youn; Lee, Seeyoun; Kang, Han-Sung; Lee, EunSook; Park, Young Hee			Identification of Risk Factors for Locoregional Recurrence in Breast Cancer Patients with Nodal Stage N0 and N1: Who Could Benefit from Post-Mastectomy Radiotherapy?	PLOS ONE			English	Article							INTERNATIONAL EXPERT CONSENSUS; POSITIVE LYMPH-NODES; POSTOPERATIVE RADIOTHERAPY; ADJUVANT CHEMOTHERAPY; COOPERATIVE-GROUP; AMERICAN-SOCIETY; PRIMARY THERAPY; MASTECTOMY; WOMEN; HIGHLIGHTS	Introduction The locoregional recurrence (LRR) rate was reported as high as approximately 20% in stage I-II breast cancer following mastectomy. To investigate the risk factors for LRR in pT1-2N0-1 breast cancer patients treated with mastectomy but not radiation, and to define a subgroup of patients at high risk of LRR who may benefit from postmastectomy radiotherapy (PMRT). Methods and Materials In total, 390 patients with pT1-2N0M0 (n = 307) and pT1-2N1M0 (n = 83) breast cancer who underwent total mastectomy without adjuvant radiotherapy from 2002 to 2011 were enrolled in the study. Results After a median follow-up period of 5.6 years (range, 0.6-11.3 years), 21 patients had 18 systemic relapses and 12 LRRs including six in the chest wall and eight in the regional nodal area. The 5-year LRR-free survival (LRRFS) rates were 97.0% in pN0, 98.8% in pN1, and 97.4% in all patients. Multivariate analysis revealed that age < 50 years (Hazard Ratio, 11.4; p = 0.01) and no adjuvant chemotherapy (Hazard Ratio, 10.2; p = 0.04) were independent risk factors for LRR in pN0 patients. Using these factors, the 5-year LRRFS rates were 100% without any risk factors, 96.4% with one risk factor, and 86.7% with two risk factors. In pN1 patients, multivariate analysis revealed that having a hormone receptor negative tumor (Hazard Ratio, 18.3; p = 0.03) was the only independent risk factor for LRR. The 5-year LRRFS rates were 100.0% for luminal type, and 92.3% for non-luminal type cancer. Conclusion Patients with pT1-2N0-1 breast cancer who underwent total mastectomy without PMRT could be stratified by nodal stage and risk factors for LRR. PMRT may have of value for node negative patients aged less than 50 years and who are not treated with adjuvant chemotherapy, and for non-luminal type patients with one to three positive nodes.	[Jwa, Eunjin; Shin, Kyung Hwan; Lim, Hyeon Woo; Jung, So-Youn; Lee, Seeyoun; Kang, Han-Sung; Lee, EunSook; Park, Young Hee] Natl Canc Ctr, Ctr Breast Canc, Res Inst & Hosp, Goyang, South Korea; [Jwa, Eunjin] Soonchunhyang Univ, Dept Radiat Oncol, Coll Med, Cheonan, South Korea; [Shin, Kyung Hwan] Seoul Natl Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea; [Park, Young Hee] Soonchunhyang Univ, Coll Med, Dept Radiat Oncol, Seoul, South Korea	National Cancer Center - Korea (NCC); Soonchunhyang University; Seoul National University (SNU); Soonchunhyang University	Shin, KH (corresponding author), Natl Canc Ctr, Ctr Breast Canc, Res Inst & Hosp, Goyang, South Korea.	radiat@snu.ac.kr						Abi-Raad R, 2011, INT J RADIAT ONCOL, V81, P21; Allred DC, 1998, MODERN PATHOL, V11, P155; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Fodor J, 2003, STRAHLENTHER ONKOL, V179, P197, DOI 10.1007/s00066-003-1010-7; Goldhirsch A, 1998, J NATL CANCER I, V90, P1601, DOI 10.1093/jnci/90.21.1601; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Gradishar WJ, 2015, J NATL COMPR CANC NE, V13, P448, DOI 10.6004/jnccn.2015.0060; Jagsi R, 2004, INTERNATIONAL JOURNA, V62, P1035, DOI [10.1016/i.iifobp.2004.12.014, DOI 10.1016/J.IJR0BP.2004.12.014]; Karlsson P, 2007, J CLIN ONCOL, V25, P2019, DOI 10.1200/JCO.2006.09.8152; Kyndi M, 2008, J CLIN ONCOL, V26, P1419, DOI 10.1200/JCO.2007.14.5565; McGale P, 2014, LANCET, V383, P2127, DOI 10.1016/S0140-6736(14)60488-8; Moo TA, 2014, ANN SURG ONCOL, V21, P1569, DOI 10.1245/s10434-014-3488-x; Olivotto LA, 2004, J CLIN ONCOL, V22, P4237, DOI 10.1200/JCO.2004.06.974; Overgaard M, 1999, LANCET, V353, P1641, DOI 10.1016/S0140-6736(98)09201-0; Overgaard M, 1997, NEW ENGL J MED, V337, P949, DOI 10.1056/NEJM199710023371401; Recht A, 2001, J CLIN ONCOL, V19, P1539, DOI 10.1200/JCO.2001.19.5.1539; Selz J, 2012, INT J RADIAT ONCOL, V84, P1123, DOI 10.1016/j.ijrobp.2012.02.047; Sharma R, 2010, ANN SURG ONCOL, V17, P2899, DOI 10.1245/s10434-010-1089-x; Stuart-Harris R, 2008, BREAST, V17, P323, DOI 10.1016/j.breast.2008.02.002; Tendulkar RD, 2012, INT J RADIAT ONCOL, V83, pE577, DOI 10.1016/j.ijrobp.2012.01.076; Truong PT, 2014, INT J RADIAT ONCOL, V88, P57, DOI 10.1016/j.ijrobp.2013.09.024; Truong PT, 2005, INT J RADIAT ONCOL, V62, P175, DOI 10.1016/j.ijrobp.2004.09.013; Truong PT, 2005, J AM COLL SURGEONS, V200, P912, DOI 10.1016/j.jamcollsurg.2005.02.010; Truong PT, 2004, INT J RADIAT ONCOL, V58, P797, DOI 10.1016/S0360-3016(03)01626-2; Wallgren A, 2003, J CLIN ONCOL, V21, P1205, DOI 10.1200/JCO.2003.03.130; Wang JH, 2011, RADIOTHER ONCOL, V100, P200, DOI 10.1016/j.radonc.2011.07.007; Wolff AC, 2013, J CLIN ONCOL, V31, P3997, DOI 10.1200/JCO.2013.50.9984; Yang TJ, 2015, ANN SURG ONCOL, V22, pS495, DOI 10.1245/s10434-015-4697-7; Yu JI, 2013, ONCOLOGY-BASEL, V85, P14, DOI 10.1159/000352002	30	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145463	10.1371/journal.pone.0145463	http://dx.doi.org/10.1371/journal.pone.0145463			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691445	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092300080
J	Zilian, E; Saragih, H; Vijayan, V; Hiller, O; Figueiredo, C; Aljabri, A; Blasczyk, R; Theilmeier, G; Becker, JU; Larmann, J; Immenschuh, S				Zilian, Eva; Saragih, Hendry; Vijayan, Vijith; Hiller, Oliver; Figueiredo, Constanca; Aljabri, Abid; Blasczyk, Rainer; Theilmeier, Gregor; Becker, Jan Ulrich; Larmann, Jan; Immenschuh, Stephan			Heme Oxygenase-1 Inhibits HLA Class I Antibody-Dependent Endothelial Cell Activation	PLOS ONE			English	Article							NF-KAPPA-B; MEDIATED ALLOGRAFT-REJECTION; INTRAVENOUS IMMUNE GLOBULIN; CARBON-MONOXIDE; TRANSPLANT VASCULOPATHY; CARDIAC ALLOGRAFTS; OXIDATIVE STRESS; COMPLEMENT; MECHANISMS; EXPRESSION	Antibody-mediated rejection (AMR) is a key limiting factor for long-term graft survival in solid organ transplantation. Human leukocyte antigen (HLA) class I (HLA I) antibodies (Abs) play a major role in the pathogenesis of AMR via their interactions with HLA molecules on vascular endothelial cells (ECs). The antioxidant enzyme heme oxygenase (HO)-1 has anti-inflammatory functions in the endothelium. As complement-independent effects of HLA I Abs can activate ECs, it was the goal of the current study to investigate the role of HO-1 on activation of human ECs by HLA I Abs. In cell cultures of various primary humanmacro- and microvascular ECs treatment with monoclonal pan-and allele-specific HLA I Abs up-regulated the expression of inducible proinflammatory adhesion molecules and chemokines (vascular cell adhesion molecule-1 [VCAM-1], intercellular cell adhesion molecule-1 [ICAM-1], interleukin-8 [IL-8] and monocyte chemotactic protein 1 [MCP-1]). Pharmacological induction of HO-1 with cobalt-protoporphyrin IX reduced, whereas inhibition of HO-1 with either zinc-protoporphyrin IX or siRNA-mediated knockdown increased HLA I Ab-dependent up-regulation of VCAM-1. Treatment with two carbon monoxide (CO)-releasing molecules, which liberate the gaseous HO product CO, blocked HLA I Ab-dependent EC activation. Finally, in an in vitro adhesion assay exposure of ECs to HLA I Abs led to increased monocyte binding, which was counteracted by up-regulation of HO-1. In conclusion, HLA I Ab-dependent EC activation is modulated by endothelial HO-1 and targeted induction of this enzyme may be a novel therapeutic approach for the treatment of AMR in solid organ transplantation.	[Zilian, Eva; Saragih, Hendry; Vijayan, Vijith; Hiller, Oliver; Figueiredo, Constanca; Aljabri, Abid; Blasczyk, Rainer; Immenschuh, Stephan] Hannover Med Sch, Inst Transfus Med, Hannover, Germany; [Saragih, Hendry] Gadjah Mada Univ, Fac Biol, Yogyakarta, Indonesia; [Theilmeier, Gregor; Larmann, Jan] Hannover Med Sch, Dept Anesthesiol & Intens Care Med, Hannover, Germany; [Becker, Jan Ulrich] Univ Hosp Cologne, Inst Pathol, Cologne, Germany	Hannover Medical School; Gadjah Mada University; Hannover Medical School; University of Cologne	Immenschuh, S (corresponding author), Hannover Med Sch, Inst Transfus Med, Hannover, Germany.	immenschuh.stephan@mh-hannover.de	Vijayan, Vijith/AAP-9913-2020; Immenschuh, Stephan/AAM-9181-2020; Larmann, Jan/ABI-3699-2020; Larmann, Jan/B-4034-2011; Saragih, Hendry Tri Sakti/AAZ-9800-2021	Immenschuh, Stephan/0000-0003-3722-5791; Larmann, Jan/0000-0003-3365-4572; Larmann, Jan/0000-0003-3365-4572; Saragih, Hendry Tri Sakti/0000-0003-0696-6191; Blasczyk, Rainer/0000-0003-3875-3190; Becker, Jan Ulrich/0000-0003-2929-8085	Else Kroner-Fresenius-Stiftung [EKFS A309_2012]; Deutsche Forschungsgemeinschaft [IM 20/4-1, LA 2343/7-1]	Else Kroner-Fresenius-Stiftung; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The work was supported by the following: Else Kroner-Fresenius-Stiftung, http://www.ekfs.de/de/start.html, grant number EKFS A309_2012 (to SI and JUB); and Deutsche Forschungsgemeinschaft, http://www.dfg.de/, grant number IM 20/4-1 (to SI), grant number LA 2343/7-1 (to JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; Bian H, 2001, TRANSPLANT P, V33, P311, DOI 10.1016/S0041-1345(00)02022-4; Bieri M, 2009, INT J BIOCHEM CELL B, V41, P2422, DOI 10.1016/j.biocel.2009.06.009; Calay D, 2014, ANTIOXID REDOX SIGN, V20, P1789, DOI 10.1089/ars.2013.5659; Chauveau C, 2002, AM J TRANSPLANT, V2, P581, DOI 10.1034/j.1600-6143.2002.20702.x; Clark JE, 2003, CIRC RES, V93, pE2, DOI 10.1161/01.RES.0000084381.86567.08; Colvin RB, 2005, NAT REV IMMUNOL, V5, P807, DOI 10.1038/nri1702; Djamali A, 2014, AM J TRANSPLANT, V14, P255, DOI 10.1111/ajt.12589; Galvani S, 2011, CIRCULATION, V124, P2725, DOI 10.1161/CIRCULATIONAHA.111.021790; Greenwood J, 2007, TRENDS IMMUNOL, V28, P88, DOI 10.1016/j.it.2006.12.003; Grosser N, 2004, FREE RADICAL BIO MED, V37, P2064, DOI 10.1016/j.freeradbiomed.2004.09.009; Hirohashi T, 2010, AM J TRANSPLANT, V10, P510, DOI 10.1111/j.1600-6143.2009.02958.x; Immenschuh S, 2006, HISTOL HISTOPATHOL, V21, P679, DOI 10.14670/HH-21.679; Immenschuh S, 2013, FREE RADICAL BIO MED, V54, P85, DOI 10.1016/j.freeradbiomed.2012.10.551; Jane-wit D, 2013, CIRCULATION, V128, P2504, DOI 10.1161/CIRCULATIONAHA.113.002972; Jindra PT, 2008, J IMMUNOL, V180, P2214, DOI 10.4049/jimmunol.180.4.2214; Jindra PT, 2008, J IMMUNOL, V180, P2357, DOI 10.4049/jimmunol.180.4.2357; Kittleson MM, 2012, CURR OPIN ORGAN TRAN, V17, P551, DOI 10.1097/MOT.0b013e3283577fef; Koh KK, 2009, CARDIOVASC RES, V81, P649, DOI 10.1093/cvr/cvn354; Larmann J, 2010, ANESTHESIOLOGY, V113, P610, DOI 10.1097/ALN.0b013e3181e99bfc; Lee CY, 2007, TRANSPLANTATION, V84, P1324, DOI 10.1097/01.tp.0000287457.54761.53; Lee TS, 2004, CIRCULATION, V110, P1296, DOI 10.1161/01.CIR.0000140694.67251.9C; Lucchiari N, 2000, HUM IMMUNOL, V61, P518, DOI 10.1016/S0198-8859(00)00109-9; Mark KS, 2001, J PHARMACOL EXP THER, V297, P1051; Mitchell RN, 2009, ANNU REV PATHOL-MECH, V4, P19, DOI 10.1146/annurev.pathol.3.121806.151449; Montgomery RA, 2000, TRANSPLANTATION, V70, P887, DOI 10.1097/00007890-200009270-00006; Motterlini R, 2010, NAT REV DRUG DISCOV, V9, P728, DOI 10.1038/nrd3228; Muller WA, 2011, ANNU REV PATHOL-MECH, V6, P323, DOI 10.1146/annurev-pathol-011110-130224; Naemi FMA, 2013, TRANSPLANTATION, V96, P258, DOI 10.1097/TP.0b013e3182985504; Nankivell BJ, 2010, NEW ENGL J MED, V363, P1451, DOI 10.1056/NEJMra0902927; Narayanan K, 2006, TRANSPL IMMUNOL, V15, P187, DOI 10.1016/j.trim.2005.09.005; Narayanan K, 2004, EUR J IMMUNOL, V34, P2303, DOI 10.1002/eji.200324843; Nourshargh S, 2014, IMMUNITY, V41, P694, DOI 10.1016/j.immuni.2014.10.008; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Rahimi S, 2004, AM J TRANSPLANT, V4, P326, DOI 10.1111/j.1600-6143.2004.00334.x; Saragih H, 2014, THROMB HAEMOSTASIS, V111, P1077, DOI 10.1160/TH13-11-0923; Sato K, 2001, J IMMUNOL, V166, P4185, DOI 10.4049/jimmunol.166.6.4185; Sehnert B, 2013, P NATL ACAD SCI USA, V110, P16556, DOI 10.1073/pnas.1218219110; Seldon MP, 2007, J IMMUNOL, V179, P7840, DOI 10.4049/jimmunol.179.11.7840; Sis B, 2009, AM J TRANSPLANT, V9, P2312, DOI 10.1111/j.1600-6143.2009.02761.x; Smith JD, 2000, INT IMMUNOL, V12, P563, DOI 10.1093/intimm/12.4.563; Soares MP, 2004, J IMMUNOL, V172, P3553, DOI 10.4049/jimmunol.172.6.3553; Soares MP, 1998, NAT MED, V4, P1073, DOI 10.1038/2063; Stocker R, 2006, CIRCULATION, V114, P2178, DOI 10.1161/CIRCULATIONAHA.105.598698; Sumitran-Holgersson S, 2008, CURR OPIN IMMUNOL, V20, P607, DOI 10.1016/j.coi.2008.07.005; Taflin C, 2011, IMMUNOL LETT, V139, P1, DOI 10.1016/j.imlet.2011.04.014; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; True AL, 2007, CIRC RES, V101, P893, DOI 10.1161/CIRCRESAHA.107.158998; Valenzuela NM, 2014, CURR OPIN ORGAN TRAN, V19, P33, DOI 10.1097/MOT.0000000000000040; Valenzuela NM, 2013, J IMMUNOL, V190, P6635, DOI 10.4049/jimmunol.1201434; Vo AA, 2008, NEW ENGL J MED, V359, P242, DOI 10.1056/NEJMoa0707894; Wasowska BA, 2010, IMMUNOL RES, V47, P25, DOI 10.1007/s12026-009-8136-3; Wehner J, 2007, CIRC RES, V100, P191, DOI 10.1161/01.RES.0000255032.33661.88; Wood KJ, 2012, TRANSPLANTATION, V93, P1, DOI 10.1097/TP.0b013e31823cab44; Wu ML, 2011, ANTIOXID REDOX SIGN, V15, P1835, DOI 10.1089/ars.2010.3726; Xiao L, 2014, AM J PHYSIOL-HEART C, V306, pH317, DOI 10.1152/ajpheart.00182.2013; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165; Yamakuchi M, 2007, P NATL ACAD SCI USA, V104, P1301, DOI 10.1073/pnas.0602035104; Zhang X, 2009, AM J TRANSPLANT, V9, P2459, DOI 10.1111/j.1600-6143.2009.02819.x; Zhang XH, 2012, CURR OPIN ORGAN TRAN, V17, P446, DOI 10.1097/MOT.0b013e328355f1c2	60	6	6	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145306	10.1371/journal.pone.0145306	http://dx.doi.org/10.1371/journal.pone.0145306			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690352	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092300054
J	Gu, Y; Chen, C; Yi, S; Wang, SS; Gong, LL; Liu, J; Gu, XS; Zhao, Q; Li, SY				Gu, Yun; Chen, Chu; Yi, Sheng; Wang, Shanshan; Gong, Leilei; Liu, Jie; Gu, Xiaosong; Zhao, Qing; Li, Shiying			miR-sc8 Inhibits Schwann Cell Proliferation and Migration by Targeting Egfr	PLOS ONE			English	Article							PERIPHERAL-NERVE REGENERATION; SCIATIC-NERVE; GROWTH-FACTOR; ESOPHAGOGASTRIC CANCER; BREAST-CANCER; MICRORNAS; FAMILY; INJURY; IDENTIFICATION; PARTNERSHIP	MicroRNAs (miRNAs) negatively regulate the expression of target genes at the post-transcriptional level in diverse biological processes. We have previously identified a group of novel miRNAs in proximal nerve following rat sciatic nerve transection by Solexa sequencing. In this study, the biological function and action mode of miR-sc8, one of the above identified miRNAs, were investigated. An increased expression of miR-sc8 inhibited cell proliferation and migration of Schwann cells (SCs), and inversely, silencing of the miR-sc8 expression promoted cell proliferation and migration of SCs. The epidermal growth factor receptor (Egfr) was identified as the target gene of miR-sc8, which exerted negative regulation of Egfr by translational suppression. The temporal change profile of the miR-sc8 expression was negatively correlated with that of the Egfr expression in proximal nerve following sciatic nerve transection. Moreover, Knockdown of Egfr attenuated the promoting effects of miR-sc8 inhibitor on SC proliferation and migration. Overall, our data indicate that miR-sc8 affects phenotype modulation of SCs by targeting Egfr, providing further insights into the regulatory role of miRNAs in peripheral nerve regeneration.	[Gu, Yun; Chen, Chu; Yi, Sheng; Gong, Leilei; Liu, Jie; Gu, Xiaosong; Li, Shiying] Nantong Univ, Coinnovat Ctr Neuroregenerat, Jiangsu Key Lab Neuroregenerat, Nantong, Jiangsu, Peoples R China; [Wang, Shanshan] Nantong Univ, Affiliated Hosp, Dept Obstet & Gynecol, Nantong, Jiangsu, Peoples R China; [Zhao, Qing] Chinese Peoples Liberat Army Gen Hosp, Inst Orthopaed, Peoples Liberat Army, Key Lab, Beijing, Peoples R China	Nantong University; Nantong University; Chinese People's Liberation Army General Hospital	Zhao, Q (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Inst Orthopaed, Peoples Liberat Army, Key Lab, Beijing, Peoples R China.	drzhaoqing@sina.com; lisy0379@ntu.edu.cn	Yi, Sheng/AAA-6017-2020	Yi, Sheng/0000-0003-1316-3370	National Key Basic Research Program of China (973 and 863 programs) [2014CB542202, 2012AA020502]; National Natural Science Foundation of China [81130080, 31170946, 31300879]; Jiangsu Provincial Natural Science Foundation [BK2012230]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Key Basic Research Program of China (973 and 863 programs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Provincial Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This study was supported by National Key Basic Research Program of China (973 and 863 programs, Grant Nos. 2014CB542202, 2012AA020502), National Natural Science Foundation of China (Grant No. 81130080, 31170946, 31300879), Jiangsu Provincial Natural Science Foundation (BK2012230), and Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Acunzo M, 2013, P NATL ACAD SCI USA, V110, P8573, DOI 10.1073/pnas.1302107110; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Atalay G, 2003, ANN ONCOL, V14, P1346, DOI 10.1093/annonc/mdg365; Ayyappan S, 2013, ANTICANCER RES, V33, P4139; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bremer J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012450; Chen YY, 2005, J NEUROPATH EXP NEUR, V64, P613, DOI 10.1097/01.jnen.0000171650.94341.46; Cho WCS, 2011, RNA BIOL, V8, P125, DOI 10.4161/rna.8.1.14259; Frostick SP, 1998, MICROSURG, V18, P397, DOI 10.1002/(SICI)1098-2752(1998)18:7<397::AID-MICR2>3.0.CO;2-F; Howe LR, 2011, CANCER PREV RES, V4, P1149, DOI 10.1158/1940-6207.CAPR-11-0334; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Lee S K, 2000, J Am Acad Orthop Surg, V8, P243; Li SY, 2015, MOL THER, V23, P423, DOI 10.1038/mt.2014.220; Li SY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057000; Li SY, 2012, J NEUROSCI RES, V90, P791, DOI 10.1002/jnr.22814; Li SY, 2011, SCI CHINA LIFE SCI, V54, P806, DOI 10.1007/s11427-011-4213-7; Liu KL, 2011, NUCLEIC ACIDS RES, V39, P2869, DOI 10.1093/nar/gkq904; Okines A, 2011, NAT REV CLIN ONCOL, V8, P492, DOI 10.1038/nrclinonc.2011.45; Pereira JA, 2010, J NEUROSCI, V30, P6763, DOI 10.1523/JNEUROSCI.0801-10.2010; Suto T, 2015, CARCINOGENESIS, V36, P338, DOI 10.1093/carcin/bgu242; Viader A, 2011, J NEUROSCI, V31, P17358, DOI 10.1523/JNEUROSCI.3931-11.2011; Webber C, 2010, EXP NEUROL, V223, P51, DOI 10.1016/j.expneurol.2009.05.037; Xie J, 2014, ONCOL REP, V31, P1715, DOI 10.3892/or.2014.3052; Xu B, 2012, PROSTATE, V72, P1171, DOI 10.1002/pros.22466; Yu B, 2012, NUCLEIC ACIDS RES, V40, P10356, DOI 10.1093/nar/gks750; Yu B, 2012, J CELL SCI, V125, P2675, DOI 10.1242/jcs.098996; Yun B, 2010, J NEUROSCI, V30, P7722, DOI 10.1523/JNEUROSCI.0876-10.2010; Zhou X, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-22	29	21	21	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145185	10.1371/journal.pone.0145185	http://dx.doi.org/10.1371/journal.pone.0145185			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683191	Green Published, Green Submitted, gold			2022-12-26	WOS:000366725800042
J	Hall, JS; Russell, RE; Franson, JC; Soos, C; Dusek, RJ; Allen, RB; Nashold, SW; TeSlaa, JL; Jonsson, JE; Ballard, JR; Harms, NJ; Brown, JD				Hall, Jeffrey S.; Russell, Robin E.; Franson, J. Christian; Soos, Catherine; Dusek, Robert J.; Allen, R. Bradford; Nashold, Sean W.; TeSlaa, Joshua L.; Jonsson, Jon Einar; Ballard, Jennifer R.; Harms, Naomi Jane; Brown, Justin D.			Avian Influenza Ecology in North Atlantic Sea Ducks: Not All Ducks Are Created Equal	PLOS ONE			English	Article							MIGRATORY BIRDS; A VIRUSES; EVOLUTION; AMERICAN; REASSORTMENT; PERSISTENCE; INFECTION; WATERFOWL; DYNAMICS; PATTERNS	Wild waterfowl are primary reservoirs of avian influenza viruses (AIV). However the role of sea ducks in the ecology of avian influenza, and how that role differs from freshwater ducks, has not been examined. We obtained and analyzed sera from North Atlantic sea ducks and determined the seroprevalence in those populations. We also tested swab samples from North Atlantic sea ducks for the presence of AIV. We found relatively high serological prevalence (61%) in these sea duck populations but low virus prevalence (0.3%). Using these data we estimated that an antibody half-life of 141 weeks (3.2 years) would be required to attain these prevalences. These findings are much different than what is known in freshwater waterfowl and have implications for surveillance efforts, AIV in marine environments, and the roles of sea ducks and other long-lived waterfowl in avian influenza ecology.	[Hall, Jeffrey S.; Russell, Robin E.; Franson, J. Christian; Dusek, Robert J.; Nashold, Sean W.; TeSlaa, Joshua L.] USGS Natl Wildlife Hlth Ctr, Madison, WI 53711 USA; [Soos, Catherine] Environm Canada, Sci & Technol Branch, Saskatoon, SK S7N 5B4, Canada; [Allen, R. Bradford] Maine Dept Inland Fisheries & Wildlife, Bangor, ME 04401 USA; [Jonsson, Jon Einar] Univ Iceland, Snaefellsnes Res Ctr, IS-245 Stykkisholmur, Iceland; [Ballard, Jennifer R.; Brown, Justin D.] Univ Georgia, Southeastern Cooperat Wildlife Dis Study, Athens, GA 30602 USA; [Harms, Naomi Jane] Univ Saskatchewan, Western Coll Vet Med, Dept Vet Pathol, Saskatoon, SK S7N 5B4, Canada	United States Department of the Interior; United States Geological Survey; Environment & Climate Change Canada; University of Iceland; University System of Georgia; University of Georgia; University of Saskatchewan	Hall, JS (corresponding author), USGS Natl Wildlife Hlth Ctr, Madison, WI 53711 USA.	jshall@usgs.gov	Soos, Catherine/Q-4983-2019; Jónsson, Jón Einar/K-7482-2015	Soos, Catherine/0000-0003-4610-3614; Jónsson, Jón Einar/0000-0003-1198-786X; Franson, J/0000-0002-0251-4238; Hall, Jeffrey/0000-0001-5599-2826; TeSlaa, Joshua/0000-0001-7802-3454; Dusek, Robert/0000-0001-6177-7479; Nashold, Sean/0000-0002-8869-6633; Russell, Robin/0000-0001-8726-7303	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services [HHSN266200400041C, HHSN266200700007C]	National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this work was provided by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, Department of Health and Human Services, under Contract Nos. HHSN266200400041C and HHSN266200700007C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, AVIAN DIS, V51, P161, DOI 10.1637/7602-041306R.1; [Anonymous], 2014, R LANG ENV STAT COMP; [Anonymous], 1926, P EDINBURGH MATH SOC, V1, P98, DOI 10.1017/S0013091500034428; [Anonymous], 2006, US INTERAGENCY STRAT; Anthony SJ, 2012, MBIO, V3, DOI 10.1128/mBio.00166-12; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Dusek RJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092075; Fereidouni SR, 2010, AVIAN DIS, V54, P79, DOI 10.1637/9005-073109-Reg.1; Fouchier RAM, 2003, AVIAN DIS, V47, P857, DOI 10.1637/0005-2086-47.s3.857; Hall JS, 2014, INFECT GENET EVOL, V28, P130, DOI 10.1016/j.meegid.2014.09.013; Hall JS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-179; HINSHAW VS, 1980, CAN J MICROBIOL, V26, P622, DOI 10.1139/m80-108; Hosmer Jr DW, 2004, APPL LOGISTIC REGRES; Hoye BJ, 2011, OIKOS, V120, P748, DOI 10.1111/j.1600-0706.2010.18961.x; Ip HS, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-71; Karlsson EA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5791; Keeler SP, 2014, APPL ENVIRON MICROB, V80, P2910, DOI 10.1128/AEM.03790-13; Koehler AV, 2008, MOL ECOL, V17, P4754, DOI 10.1111/j.1365-294X.2008.03953.x; Krauss S, 2004, VECTOR-BORNE ZOONOT, V4, P177, DOI 10.1089/vbz.2004.4.177; Krauss S, 2007, PLOS PATHOG, V3, P1684, DOI 10.1371/journal.ppat.0030167; Krementz DG, 1996, J WILDLIFE MANAGE, V60, P855, DOI 10.2307/3802386; Miller MR, 2007, EVOLUTION, V61, P2, DOI 10.1111/j.1558-5646.2007.00001.x; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Ramey AM, J WILDL DIS IN PRESS; Ramey AM, 2011, ARCH VIROL, V156, P1813, DOI 10.1007/s00705-011-1059-z; REED L. J., 1938, AMER JOUR HYG, V27, P493; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; Stailknecht DE, 2007, J WILDLIFE DIS, V43, pS15; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; Tolf C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061201; Wahlgren J, 2008, VECTOR-BORNE ZOONOT, V8, P783, DOI 10.1089/vbz.2007.0274; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Wille M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020664; Wille M, 2011, ARCH VIROL, V156, P107, DOI 10.1007/s00705-010-0839-1; Wilson HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058308; Woolcock P.R., 2008, AVIAN INFLUENZA VIRU	37	11	11	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144524	10.1371/journal.pone.0144524	http://dx.doi.org/10.1371/journal.pone.0144524			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26677841	Green Published, Green Submitted, gold			2022-12-26	WOS:000366723400017
J	Houska, T; Kraft, P; Chamorro-Chavez, A; Breuer, L				Houska, Tobias; Kraft, Philipp; Chamorro-Chavez, Alejandro; Breuer, Lutz			SPOTting Model Parameters Using a Ready-Made Python Package	PLOS ONE			English	Article							PARTICLE SWARM OPTIMIZATION; RAINFALL-RUNOFF MODELS; UNCERTAINTY ANALYSIS; GLOBAL OPTIMIZATION; EFFICIENT ALGORITHM; HYDROLOGIC-MODELS; CALIBRATION; RELIABILITY; QUANTIFICATION; IDENTIFICATION	The choice for specific parameter estimation methods is often more dependent on its availability than its performance. We developed SPOTPY (Statistical Parameter Optimization Tool), an open source python package containing a comprehensive set of methods typically used to calibrate, analyze and optimize parameters for a wide range of ecological models. SPOTPY currently contains eight widely used algorithms, 11 objective functions, and can sample from eight parameter distributions. SPOTPY has a model-independent structure and can be run in parallel from the workstation to large computation clusters using the Message Passing Interface (MPI). We tested SPOTPY in five different case studies to parameterize the Rosenbrock, Griewank and Ackley functions, a one-dimensional physically based soil moisture routine, where we searched for parameters of the van Genuchten-Mualem function and a calibration of a biogeochemistry model with different objective functions. The case studies reveal that the implemented SPOTPY methods can be used for any model with just a minimal amount of code for maximal power of parameter optimization. They further show the benefit of having one package at hand that includes number of well performing parameter search methods, since not every case study can be solved sufficiently with every algorithm or every objective function.	[Houska, Tobias; Kraft, Philipp; Chamorro-Chavez, Alejandro; Breuer, Lutz] Univ Giessen, Inst Landscape Ecol & Resources Management, Res Ctr BioSyst Land Use & Nutr IFZ, D-35390 Giessen, Germany; [Breuer, Lutz] Univ Giessen, Ctr Int Dev & Environm Res, D-35390 Giessen, Germany	Justus Liebig University Giessen	Houska, T (corresponding author), Univ Giessen, Inst Landscape Ecol & Resources Management, Res Ctr BioSyst Land Use & Nutr IFZ, D-35390 Giessen, Germany.	tobias.houska@umwelt.uni-giessen.de	Kraft, Philipp/Q-6051-2019; Griewank, Klaus G/A-9097-2017; Houska, Tobias/AAG-2276-2020; Breuer, Lutz/C-6652-2013	Kraft, Philipp/0000-0002-0991-8366; Griewank, Klaus G/0000-0003-3899-9449; Houska, Tobias/0000-0001-7780-2376; Breuer, Lutz/0000-0001-9720-1076	LOEWE excellence cluster FACE2FACE of the Hessen State Ministry of Higher Education, Research and the Arts; DFG [BR2238/13-1, BR2238/5 2]; Marie Curie Training Network: Quantifying Uncertainty in Integrated Catchment Studies (QUICS) [PITN-GA-2013-607000]	LOEWE excellence cluster FACE2FACE of the Hessen State Ministry of Higher Education, Research and the Arts; DFG(German Research Foundation (DFG)); Marie Curie Training Network: Quantifying Uncertainty in Integrated Catchment Studies (QUICS)	This work was funded by the LOEWE excellence cluster FACE2FACE of the Hessen State Ministry of Higher Education, Research and the Arts. Further support was received by the DFG for Tobias Houska (BR2238/13-1) and Alejandro Chamorro-Chavez (BR2238/5 2). Lutz Breuer would like to acknowledge funding of the Marie Curie Training Network: Quantifying Uncertainty in Integrated Catchment Studies (QUICS), PITN-GA-2013-607000. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Ackley D. H., 1987, GENETIC ALGORITHMS S, P170; Alireza Alfi, 2011, Acta Automatica Sinica, V37, P541, DOI 10.3724/SP.J.1004.2011.00541; Bardossy A, 2008, HYDROL EARTH SYST SC, V12, P1273, DOI 10.5194/hess-12-1273-2008; Behrangi A, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006429; Bergstrom S., 1995, Computer models of watershed hydrology., P443; Beven K, 2006, J HYDROL, V320, P18, DOI 10.1016/j.jhydrol.2005.07.007; BEVEN K, 1992, HYDROL PROCESS, V6, P279, DOI 10.1002/hyp.3360060305; Beven K, 2001, J HYDROL, V249, P11, DOI 10.1016/S0022-1694(01)00421-8; Buytaert W, 2008, HYDROL PROCESS, V22, P4175, DOI 10.1002/hyp.7125; Clark MP, 2015, WATER RESOUR RES, V51, P2498, DOI 10.1002/2015WR017198; Dalcin L, 2008, J PARALLEL DISTR COM, V68, P655, DOI 10.1016/j.jpdc.2007.09.005; Doherty J, 2003, J AM WATER RESOUR AS, V39, P251, DOI 10.1111/j.1752-1688.2003.tb04381.x; DUAN QY, 1994, J HYDROL, V158, P265, DOI 10.1016/0022-1694(94)90057-4; Efstratiadis A, 2010, HYDROLOG SCI J, V55, P58, DOI 10.1080/02626660903526292; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Geweke J., 1992, BAYESIAN STAT, V4, P169, DOI DOI 10.21034/SR.148; Gong ZJ, 2006, RELIAB ENG SYST SAFE, V91, P915, DOI 10.1016/j.ress.2005.09.007; Goodman J, 2010, COMM APP MATH COM SC, V5, P65, DOI 10.2140/camcos.2010.5.65; Guinot V, 2011, J HYDROL, V401, P1, DOI 10.1016/j.jhydrol.2011.02.004; Haan CT, 1998, T ASAE, V41, P65, DOI 10.13031/2013.17158; Haas E, 2013, LANDSCAPE ECOL, V28, P615, DOI 10.1007/s10980-012-9772-x; Harp DR, 2012, COMPUT GEOSCI-UK, V40, P19, DOI 10.1016/j.cageo.2011.06.025; Hoffman M.D., 2011, ARXIV11114246CSSTAT; Hossain F, 2006, COMPUT GEOSCI-UK, V32, P776, DOI 10.1016/j.cageo.2005.10.006; Houska T, 2014, BIOGEOSCIENCES, V11, P2069, DOI 10.5194/bg-11-2069-2014; Huang MY, 2006, J HYDROL, V320, P37, DOI 10.1016/j.jhydrol.2005.07.010; Jager HJ, 2003, J APPL BOT-ANGEW BOT, V77, P117; Jung BS, 2006, J ENVIRON INFORM, V7, P24, DOI 10.3808/jei.200600064; Kammann C, 2001, EUR J SOIL SCI, V52, P297, DOI 10.1046/j.1365-2389.2001.00380.x; Kammann C, 2008, SOIL BIOL BIOCHEM, V40, P2194, DOI 10.1016/j.soilbio.2008.04.012; Karaboga D, 2007, J GLOBAL OPTIM, V39, P459, DOI 10.1007/s10898-007-9149-x; Kavetski D, 2006, WATER RESOUR RES, V42, DOI 10.1029/2005WR004368; KIRKPATRICK S, 1983, SCIENCE, V220, P671, DOI 10.1126/science.220.4598.671; KITANIDIS PK, 1985, J HYDROL, V79, P53, DOI 10.1016/0022-1694(85)90181-7; Kraft P, 2012, AGU FALL M, P0688; Kraft P, 2011, ENVIRON MODELL SOFTW, V26, P828, DOI 10.1016/j.envsoft.2010.12.009; Krausse T, 2012, HYDROL EARTH SYST SC, V16, P603, DOI 10.5194/hess-16-603-2012; Legates DR, 1999, WATER RESOUR RES, V35, P233, DOI 10.1029/1998WR900018; Li L, 2010, J HYDROL, V390, P210, DOI 10.1016/j.jhydrol.2010.06.044; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Madsen H, 2002, J HYDROL, V261, P48, DOI 10.1016/S0022-1694(01)00619-9; Matott LS, 2013, COMPUT GEOSCI-UK, V60, P156, DOI 10.1016/j.cageo.2013.07.023; Matott LS, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007301; MCKAY MD, 1979, TECHNOMETRICS, V21, P239, DOI 10.2307/1268522; METROPOLIS N, 1953, J CHEM PHYS, V21, P1087, DOI 10.1063/1.1699114; Moeck C, 2015, ENVIRON MODELL SOFTW, V66, P78, DOI 10.1016/j.envsoft.2014.12.018; Montanari A, 2009, WATER RESOUR RES, V45, DOI 10.1029/2009WR008471; Moriasi DN, 2007, T ASABE, V50, P885, DOI 10.13031/2013.23153; Murphy C, 2006, AREA, V38, P65, DOI 10.1111/j.1475-4762.2006.00656.x; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Oliphant T.E., 2006, A GUIDE TO NUMPY, V1; Ortiz C, 2011, ECOL MODEL, V222, P3020, DOI 10.1016/j.ecolmodel.2011.05.034; Over MW, 2015, WATER RESOUR RES, V51, P861, DOI 10.1002/2014WR015252; Patil A, 2010, J STAT SOFTW, V35, P1; Perkel JM, 2015, NATURE, V518, P125, DOI 10.1038/518125a; Potter MA, 1994, LECT NOTES COMPUT SC, V866, P249; ROSENBROCK HH, 1960, COMPUT J, V3, P175, DOI 10.1093/comjnl/3.3.175; Santos CA, 2000, ANN J HYDRAUL ENG, P705; Schuller GI, 2007, STRUCT SAF, V29, P167, DOI 10.1016/j.strusafe.2006.07.010; Scott RL, 2000, WATER RESOUR RES, V36, P2233, DOI 10.1029/2000WR900116; Shafii M, 2015, J HYDROL, V523, P693, DOI 10.1016/j.jhydrol.2015.01.051; Smith T, 2015, J HYDROL, V528, P29, DOI 10.1016/j.jhydrol.2015.05.051; Smith T, 2010, WATER RESOUR RES, V46, DOI 10.1029/2010WR009514; Smith TJ, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006705; SOROOSHIAN S, 1993, WATER RESOUR RES, V29, P1185, DOI 10.1029/92WR02617; Stacey A, 2003, IEEE C EVOL COMPUTAT, P1425; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; ter Braak CJF, 2008, STAT COMPUT, V18, P435, DOI 10.1007/s11222-008-9104-9; Thyer M, 1999, WATER RESOUR RES, V35, P767, DOI 10.1029/1998WR900058; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Vrugt JA, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001746; Vrugt JA, 2009, STOCH ENV RES RISK A, V23, P1011, DOI 10.1007/s00477-008-0274-y; Wagener T, 2005, STOCH ENV RES RISK A, V19, P378, DOI 10.1007/s00477-005-0006-5; Wallach D., 2006, WORKING DYNAMIC CROP; Wang S, 2014, J INF COMPUT SCI, V11, P5631, DOI [10. 12733/ jics20104829, DOI 10.12733/jics20104829]; Weise T, 2008, GLOBAL OPTIMIZATION; Willmott C.J., 1981, PHYS GEOGR, V2, P184, DOI [10.1080/02723646.1981.10642213, DOI 10.1080/02723646.1981.10642213]; Windhorst D, 2014, HYDROL EARTH SYST SC, V18, P4113, DOI 10.5194/hess-18-4113-2014; Yang J, 2008, J HYDROL, V358, P1, DOI 10.1016/j.jhydrol.2008.05.012; Zhu GP, 2010, APPL MATH COMPUT, V217, P3166, DOI 10.1016/j.amc.2010.08.049	81	82	82	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145180	10.1371/journal.pone.0145180	http://dx.doi.org/10.1371/journal.pone.0145180			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26680783	Green Published, Green Submitted, gold			2022-12-26	WOS:000366723400054
J	Shiozawa, S; Hirata, RP; Graven-Nielsen, T				Shiozawa, Shinichiro; Hirata, Rogerio Pessoto; Graven-Nielsen, Thomas			Center of Pressure Displacement of Standing Posture during Rapid Movements Is Reorganised Due to Experimental Lower Extremity Muscle Pain	PLOS ONE			English	Article							CONCURRENT COGNITIVE TASK; LOW-BACK-PAIN; KNEE OSTEOARTHRITIS; OLDER-ADULTS; QUIET STANCE; BALANCE; ADJUSTMENTS; STABILITY; GAIT; RISK	Background Postural control during rapid movements may be impaired due to musculoskeletal pain. The purpose of this study was to investigate the effect of experimental knee-related muscle pain on the center of pressure (CoP) displacement in a reaction time task condition. Methods Nine healthy males performed two reaction time tasks (dominant side shoulder flexion and bilateral heel lift) before, during, and after experimental pain induced in the dominant side vastus medialis or the tibialis anterior muscles by hypertonic saline injections. The CoP displacement was extracted from the ipsilateral and contralateral side by two force plates and the net CoP displacement was calculated. Results Compared with non-painful sessions, tibialis anterior muscle pain during the peak and peak-to-peak displacement for the CoP during anticipatory postural adjustments (APAs) of the shoulder task reduced the peak-to-peak displacement of the net CoP in the medial-lateral direction (P < 0.05). Tibialis anterior and vastus medialis muscle pain during shoulder flexion task reduced the anterior-posterior peak-to-peak displacement in the ipsilateral side (P < 0.05). Conclusions The central nervous system in healthy individuals was sufficiently robust in maintaining the APA characteristics during pain, although the displacement of net and ipsilateral CoP in the medial-lateral and anterior-posterior directions during unilateral fast shoulder movement was altered.	[Shiozawa, Shinichiro; Hirata, Rogerio Pessoto; Graven-Nielsen, Thomas] Aalborg Univ, Lab Musculoskeletal Pain & Motor Control, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact SMI,Fac Med, Aalborg, Denmark	Aalborg University	Graven-Nielsen, T (corresponding author), Aalborg Univ, Lab Musculoskeletal Pain & Motor Control, Dept Hlth Sci & Technol, Ctr Sensory Motor Interact SMI,Fac Med, Aalborg, Denmark.	tgn@hst.aau.dk	; Hirata, Rogerio/G-8371-2011	Graven-Nielsen, Thomas/0000-0002-7787-4860; Hirata, Rogerio/0000-0002-9943-2713	Danish Agency for Science, Technology and Innovation; Japanese Science and Technology Agency; Japanese Society for the Promotion of Rehabilitation	Danish Agency for Science, Technology and Innovation; Japanese Science and Technology Agency(Japan Science & Technology Agency (JST)); Japanese Society for the Promotion of Rehabilitation	This work was supported by a collaboration grant between the Danish Agency for Science, Technology and Innovation and the Japanese Science and Technology Agency (2009-2012). The first author received a grant from Japanese Society for the Promotion of Rehabilitation.	Aliberti S, 2011, CLINICS, V66, P367, DOI 10.1590/S1807-59322011000300001; ArendtNielsen L, 1996, PAIN, V64, P231, DOI 10.1016/0304-3959(95)00115-8; ARUIN AS, 1995, EXP BRAIN RES, V106, P291; Aruin AS, 1996, ELECTROMYOGR MOTOR C, V101, P497, DOI 10.1016/S0013-4694(96)95219-4; Astephen JL, 2008, J BIOMECH, V41, P868, DOI 10.1016/j.jbiomech.2007.10.016; Bank PJM, 2013, EUR J PAIN, V17, P145, DOI 10.1002/j.1532-2149.2012.00186.x; Bouisset S, 2008, NEUROPHYSIOL CLIN, V38, P345, DOI 10.1016/j.neucli.2008.10.001; BOUISSET S, 1981, NEUROSCI LETT, V22, P263, DOI 10.1016/0304-3940(81)90117-8; BOUISSET S, 1987, J BIOMECH, V20, P735, DOI 10.1016/0021-9290(87)90052-2; Brauer SG, 2002, GAIT POSTURE, V15, P83, DOI 10.1016/S0966-6362(01)00163-1; Brown LA, 1999, J GERONTOL A-BIOL, V54, pM165, DOI 10.1093/gerona/54.4.M165; Creaby MW, 2012, ARCH PHYS MED REHAB, V93, P822, DOI 10.1016/j.apmr.2011.11.029; Foley SJ, 2006, OSTEOARTHR CARTILAGE, V14, P533, DOI 10.1016/j.joca.2005.12.007; Freitas SMSF, 2005, GAIT POSTURE, V22, P322, DOI 10.1016/j.gaitpost.2004.11.001; Graven-Nielsen T, 2006, SCAND J RHEUMATOL, V35, P1, DOI 10.1080/03009740600865980; Graven-Nielsen T, 2002, MUSCLE NERVE, V26, P708, DOI 10.1002/mus.10225; Hassan BS, 2001, ANN RHEUM DIS, V60, P612, DOI 10.1136/ard.60.6.612; Henriksen M, 2009, BRIT J SPORT MED, V43, P503, DOI 10.1136/bjsm.2008.050393; Henriksen M, 2007, J APPL PHYSIOL, V103, P132, DOI 10.1152/japplphysiol.01105.2006; Henriksen M, 2011, J PAIN, V12, P460, DOI 10.1016/j.jpain.2010.10.004; Hirata RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071253; Hirata RP, 2012, EUR J APPL PHYSIOL, V112, P2511, DOI 10.1007/s00421-011-2226-3; Hirata RP, 2011, J PAIN, V12, P911, DOI 10.1016/j.jpain.2011.02.356; Hirata RP, 2010, CLIN BIOMECH, V25, P931, DOI 10.1016/j.clinbiomech.2010.06.001; Hodges PW, 2009, ARTHRIT RHEUM-ARTHR, V61, P70, DOI 10.1002/art.24089; Hodges PW, 2003, EXP BRAIN RES, V151, P262, DOI 10.1007/s00221-003-1457-x; Hunt MA, 2010, ARTHRIT CARE RES, V62, P496, DOI 10.1002/acr.20046; Jacobs JV, 2009, EXP NEUROL, V215, P334, DOI 10.1016/j.expneurol.2008.10.019; Jadelis K, 2001, J AM GERIATR SOC, V49, P884, DOI 10.1046/j.1532-5415.2001.49178.x; Jover M, 2010, DEV MED CHILD NEUROL, V52, P850, DOI 10.1111/j.1469-8749.2009.03611.x; Karayannis NV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067779; Kelly VE, 2008, J GERONTOL A-BIOL, V63, P1329, DOI 10.1093/gerona/63.12.1329; King LA, 2010, ARCH PHYS MED REHAB, V91, P1332, DOI 10.1016/j.apmr.2010.05.013; Leveille SG, 2002, J AM GERIATR SOC, V50, P671, DOI 10.1046/j.1532-5415.2002.50161.x; Lin SI, 2002, J MOTOR BEHAV, V34, P37, DOI 10.1080/00222890209601929; Messier SP, 2002, ARTHRIT RHEUM-ARTHR, V47, P141, DOI 10.1002/art.10339; Mouchnino L, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-21; Nagai K, 2011, ARCH GERONTOL GERIAT, V53, P338, DOI 10.1016/j.archger.2011.01.003; Pua YH, 2011, ARTHRIT CARE RES, V63, P1706, DOI 10.1002/acr.20615; Rankin JK, 2000, J GERONTOL A-BIOL, V55, pM112, DOI 10.1093/gerona/55.3.M112; Rathleff MS, 2013, MED SCI SPORT EXER, V45, P1730, DOI 10.1249/MSS.0b013e318292be30; Rocchi L, 2006, NEUROSCI LETT, V406, P128, DOI 10.1016/j.neulet.2006.07.027; Saito H, 2014, HUM MOVEMENT SCI, V37, P69, DOI 10.1016/j.humov.2014.07.001; Salomoni SE, 2012, EUR J APPL PHYSIOL, V112, P3607, DOI 10.1007/s00421-012-2343-7; Santos MJ, 2010, J ELECTROMYOGR KINES, V20, P398, DOI 10.1016/j.jelekin.2010.01.002; Schrager MA, 2008, GAIT POSTURE, V28, P466, DOI 10.1016/j.gaitpost.2008.02.009; Shiozawa S, 2015, EUR J PAIN; Shiozawa S, 2013, HUM MOVEMENT SCI, V32, P1239, DOI 10.1016/j.humov.2013.01.009; Smith M, 2005, EXP BRAIN RES, V166, P109, DOI 10.1007/s00221-005-2352-4; Suzuki S, 2010, MED BIOL ENG COMPUT, V48, P845, DOI 10.1007/s11517-010-0664-4; Szabo SM, 2008, J AM GERIATR SOC, V56, P800, DOI 10.1111/j.1532-5415.2008.01666.x; Tsao H, 2010, PAIN, V150, P167, DOI 10.1016/j.pain.2010.04.023; Tucker KJ, 2009, PAIN, V141, P151, DOI 10.1016/j.pain.2008.10.029; Uemura K, 2011, J GERONTOL A-BIOL, V66, P904, DOI 10.1093/gerona/glr081; VOIGHT ML, 1991, AM J SPORT MED, V19, P131, DOI 10.1177/036354659101900207; WHIPPLE R, 1993, J GERONTOL, V48, P71, DOI 10.1093/geronj/48.Special_Issue.71; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9; Winter DA, 2003, J ELECTROMYOGR KINES, V13, P49, DOI 10.1016/S1050-6411(02)00085-8; Winter DA, 1996, J NEUROPHYSIOL, V75, P2334, DOI 10.1152/jn.1996.75.6.2334; Winter DA, 1995, WATERLOO BIOMECHANIC, P3; WOOLLACOTT MH, 1986, INT J AGING HUM DEV, V23, P97, DOI 10.2190/VXN3-N3RT-54JB-X16X	61	4	5	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144933	10.1371/journal.pone.0144933	http://dx.doi.org/10.1371/journal.pone.0144933			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26680777	Green Published, gold, Green Submitted			2022-12-26	WOS:000366723400034
J	Yabe, R; Miura, A; Usui, T; Mudrak, I; Ogris, E; Ohama, T; Sato, K				Yabe, Ryotaro; Miura, Akane; Usui, Tatsuya; Mudrak, Ingrid; Ogris, Egon; Ohama, Takashi; Sato, Koichi			Protein Phosphatase Methyl-Esterase PME-1 Protects Protein Phosphatase 2A from Ubiquitin/Proteasome Degradation	PLOS ONE			English	Article							CATALYTIC SUBUNIT; KINASE PATHWAY; PP2A; PHOSPHORYLATION; BINDING; ALPHA; SET; METHYLESTERASE; INACTIVATION; ASSOCIATION	Protein phosphatase 2A (PP2A) is a conserved essential enzyme that is implicated as a tumor suppressor based on its central role in phosphorylation-dependent signaling pathways. Protein phosphatase methyl esterase (PME-1) catalyzes specifically the demethylation of the C-terminal Leu309 residue of PP2A catalytic subunit (PP2Ac). It has been shown that PME-1 affects the activity of PP2A by demethylating PP2Ac, but also by directly binding to the phosphatase active site, suggesting loss of PME-1 in cells would enhance PP2A activity. However, here we show that PME-1 knockout mouse embryonic fibroblasts (MEFs) exhibit lower PP2A activity than wild type MEFs. Loss of PME-1 enhanced poly-ubiquitination of PP2Ac and shortened the half-life of PP2Ac protein resulting in reduced PP2Ac levels. Chemical inhibition of PME-1 and rescue experiments with wild type and mutated PME-1 revealed methyl-esterase activity was necessary to maintain PP2Ac protein levels. Our data demonstrate that PME-1 methyl-esterase activity protects PP2Ac from ubiquitin/proteasome degradation.	[Yabe, Ryotaro; Miura, Akane; Ohama, Takashi; Sato, Koichi] Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Pharmacol, Yamaguchi 7538515, Japan; [Usui, Tatsuya] Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Toxicol, Yamaguchi 7538515, Japan; [Mudrak, Ingrid; Ogris, Egon] Med Univ Vienna, Max F Perutz Labs, Dept Med Biochem, A-1030 Vienna, Austria	Yamaguchi University; Yamaguchi University; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Ohama, T (corresponding author), Yamaguchi Univ, Joint Fac Vet Med, Lab Vet Pharmacol, Yamaguchi 7538515, Japan.	t.ohama@yamaguchi-u.ac.jp	Usui, Tatsuya/Q-5170-2017	Usui, Tatsuya/0000-0002-1818-2127; Ogris, Egon/0000-0001-5950-9264	Japan Society for the Promotion of Science (JSPS);  [25660227];  [15K14856];  [15J07273]; Grants-in-Aid for Scientific Research [15J07273] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Thus study was supported by Japan Society for the Promotion of Science (JSPS); Grant number and the funder's URLs are: (https://www.jsps.go.jp/english/index.html) Grant Number 25660227: TO, 15K14856: TO, 15J07273: RY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachovchin DA, 2011, P NATL ACAD SCI USA, V108, P6811, DOI 10.1073/pnas.1015248108; Baharians Z, 1998, J BIOL CHEM, V273, P19019, DOI 10.1074/jbc.273.30.19019; Brautigan DL, 2013, FEBS J, V280, P324, DOI 10.1111/j.1742-4658.2012.08609.x; Bryant JC, 1999, BIOCHEM J, V339, P241, DOI 10.1042/0264-6021:3390241; CHEN J, 1994, J BIOL CHEM, V269, P7957; CHEN J, 1992, SCIENCE, V257, P1261, DOI 10.1126/science.1325671; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Chung HY, 1999, BIOCHEMISTRY-US, V38, P10371, DOI 10.1021/bi990902g; Colella S, 2001, INT J CANCER, V93, P798, DOI 10.1002/ijc.1423; De Baere I, 1999, BIOCHEMISTRY-US, V38, P16539, DOI 10.1021/bi991646a; Eichhorn PJA, 2009, BBA-REV CANCER, V1795, P1, DOI 10.1016/j.bbcan.2008.05.005; Enjoji S, 2015, J VET MED SCI, V77, P1451, DOI 10.1292/jvms.15-0193; Hombauer H, 2007, PLOS BIOL, V5, P1355, DOI 10.1371/journal.pbio.0050155; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Junttila MR, 2007, CELL, V130, P51, DOI 10.1016/j.cell.2007.04.044; Katsiari CG, 2005, J CLIN INVEST, V115, P3193, DOI 10.1172/JCI24895; Kong M, 2009, MOL CELL, V36, P51, DOI 10.1016/j.molcel.2009.09.025; Kremmer E, 1997, MOL CELL BIOL, V17, P1692, DOI 10.1128/MCB.17.3.1692; Kuo YC, 2008, J BIOL CHEM, V283, P1882, DOI 10.1074/jbc.M709585200; LeNoue-Newton M, 2011, J BIOL CHEM, V286, P17665, DOI 10.1074/jbc.M111.222414; Li M, 1996, J BIOL CHEM, V271, P11059, DOI 10.1074/jbc.271.19.11059; Li XH, 2002, MOL CELL BIOL, V22, P3674, DOI 10.1128/MCB.22.11.3674-3684.2002; Longin S, 2004, BIOCHEM J, V380, P111, DOI 10.1042/BJ20031643; Mazur PK, 2014, NATURE, V510, P283, DOI 10.1038/nature13320; McConnell JL, 2010, BIOCHEMISTRY-US, V49, P1713, DOI 10.1021/bi901837h; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Murata K, 1997, P NATL ACAD SCI USA, V94, P10624, DOI 10.1073/pnas.94.20.10624; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Ogris E, 1999, J BIOL CHEM, V274, P14382, DOI 10.1074/jbc.274.20.14382; Ohama T, 2010, J BIOL CHEM, V285, P8711, DOI 10.1074/jbc.M109.099788; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ortega-Gutierrez S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002486; Puustinen P, 2009, CANCER RES, V69, P2870, DOI 10.1158/0008-5472.CAN-08-2760; Silverstein AM, 2002, P NATL ACAD SCI USA, V99, P4221, DOI 10.1073/pnas.072071699; Slupe Andrew M, 2011, Enzyme Res, V2011, P398751, DOI 10.4061/2011/398751; Stefansson B, 2006, J BIOL CHEM, V281, P22624, DOI 10.1074/jbc.M601772200; Strack S, 2004, J BIOL CHEM, V279, P47732, DOI 10.1074/jbc.M408015200; Tolstykh T, 2000, EMBO J, V19, P5682, DOI 10.1093/emboj/19.21.5682; Trotta R, 2007, J EXP MED, V204, P2397, DOI 10.1084/jem.20070419; Wandzioch E, 2014, CANCER RES, V74, P4295, DOI 10.1158/0008-5472.CAN-13-3130; Xing YN, 2008, CELL, V133, P154, DOI 10.1016/j.cell.2008.02.041	41	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145226	10.1371/journal.pone.0145226	http://dx.doi.org/10.1371/journal.pone.0145226			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678046	gold, Green Submitted, Green Published			2022-12-26	WOS:000366723400058
J	Berthelot, CC; Kamita, SG; Sacchi, R; Yang, J; Nording, ML; Georgi, K; Karbowski, CH; German, JB; Weiss, RH; Hogg, RJ; Hammock, BD; Zivkovic, AM				Berthelot, Claire C.; Kamita, Shizuo George; Sacchi, Romina; Yang, Jun; Nording, Malin L.; Georgi, Katrin; Karbowski, Christine Hegedus; German, J. Bruce; Weiss, Robert H.; Hogg, Ronald J.; Hammock, Bruce D.; Zivkovic, Angela M.			Changes in PTGS1 and ALOX12 Gene Expression in Peripheral Blood Mononuclear Cells Are Associated with Changes in Arachidonic Acid, Oxylipins, and Oxylipin/Fatty Acid Ratios in Response to Omega-3 Fatty Acid Supplementation	PLOS ONE			English	Article							CARDIOVASCULAR-DISEASE; FATTY-ACIDS; PROSTAGLANDIN	Introduction There is a high degree of inter-individual variability among people in response to intervention with omega-3 fatty acids (FA), which may partly explain conflicting results on the effectiveness of omega-3 FA for the treatment and prevention of chronic inflammatory diseases. In this study we sought to evaluate whether part of this inter-individual variability in response is related to the regulation of key oxylipin metabolic genes in circulating peripheral blood mononuclear cells (PBMCs). Methods Plasma FA and oxylipin profiles from 12 healthy individuals were compared to PBMC gene expression profiles following six weeks of supplementation with fish oil, which delivered 1.9 g/d eicosapentaenoic acid (EPA) and 1.5 g/d docosahexaenoic acid (DHA). Fold changes in gene expression were measured by a quantitative polymerase chain reaction (qPCR). Results Healthy individuals supplemented with omega-3 FA had differential responses in prostaglandin-endoperoxide synthase 1 (PTGS1), prostaglandin-endoperoxide synthase 2 (PTGS2), arachidonate 12-lipoxygenase (ALOX12), and interleukin 8 (IL-8) gene expression in isolated PBMCs. In those individuals for whom plasma arachidonic acid (ARA) in the phosphatidylethanolamine (PE) lipid class decreased in response to omega-3 intervention, there was a corresponding decrease in gene expression for PTGS1 and ALOX12. Several oxylipin product/FA precursor ratios (e.g. prostaglandin E-2 (PGE(2))/ARA for PTGS1 and 12-hydroxyeicosatetraenoic acid (12-HETE)/ARA for ALOX12) were also associated with fold change in gene expression, suggesting an association between enzyme activity and gene expression. The fold-change in PTGS1 gene expression was highly positively correlated with ALOX12 gene expression but not with PTGS2, whereas IL-8 and PTGS2 were positively correlated. Conclusions The regulation of important oxylipin metabolic genes in PBMCs varied with the extent of change in ARA concentrations in the case of PTGS1 and ALOX12 regulation. PBMC gene expression changes in response to omega-3 supplementation varied among healthy individuals, and were associated with changes in plasma FA and oxylipin composition to different degrees in different individuals.	[Berthelot, Claire C.] Univ Picardie Jules Verne, Amiens, France; [Berthelot, Claire C.] Univ Technol Compiegne, Compiegne, France; [Berthelot, Claire C.; Sacchi, Romina; Zivkovic, Angela M.] Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA; [Kamita, Shizuo George; Yang, Jun; Nording, Malin L.; Georgi, Katrin; Karbowski, Christine Hegedus; Hammock, Bruce D.] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA; [Nording, Malin L.] Umea Univ, Dept Chem, Umea, Sweden; [Yang, Jun; Hammock, Bruce D.] Univ Calif Davis, Ctr Comprehens Canc, Davis, CA 95616 USA; [German, J. Bruce] Univ Calif Davis, Dept Food Sci & Technol, Davis, CA 95616 USA; [German, J. Bruce; Zivkovic, Angela M.] Univ Calif Davis, Foods Hlth Inst, Davis, CA 95616 USA; [Weiss, Robert H.] Univ Calif Davis, Div Nephrol, Dept Med, Davis, CA 95616 USA; [Weiss, Robert H.] Sacramento VA Med Ctr, Med Serv, Sacramento, CA USA; [Hogg, Ronald J.] Scott & White Mem Hosp & Clin, Temple, TX USA	Picardie Universites; Universite de Picardie Jules Verne (UPJV); Picardie Universites; Universite de Technologie de Compiegne; University of California System; University of California Davis; University of California System; University of California Davis; Umea University; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Scott & White Medical Center	Zivkovic, AM (corresponding author), Univ Calif Davis, Dept Nutr, Davis, CA 95616 USA.	amzivkovic@ucdavis.edu	Yang, Jun/B-2262-2010	Yang, Jun/0000-0001-8126-1728; Zivkovic, Angela/0000-0002-2828-7862	Center for Health and Nutrition Research (CHNR) Pilot Grant Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [R01 DK49368]; University of California Discovery Program [05GEB01NHB]; National Institute of Environmental Health Sciences (NIEHS) [P42ES004699]; NIEHS [R01 ES002710]; NIEHS Superfund Research Program [P42 ES011269]; California Dairy Research Foundation; American Asthma Association [09-0269]; Cystic Fibrosis Research Inc.; Swedish Research Councils VR [2011-6044]; Formas [2010-303]; Vinnova [2010-02070]; West Coast Comprehensive Metabolomics Center National Institutes of Health/NIDDK [U24 DK097154]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK049368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011269, P42ES004699, R01ES002710] Funding Source: NIH RePORTER	Center for Health and Nutrition Research (CHNR) Pilot Grant Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); University of California Discovery Program; National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS Superfund Research Program; California Dairy Research Foundation; American Asthma Association; Cystic Fibrosis Research Inc.; Swedish Research Councils VR(Swedish Research Council); Formas(Swedish Research Council Formas); Vinnova(Vinnova); West Coast Comprehensive Metabolomics Center National Institutes of Health/NIDDK; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was provided in part by The Center for Health and Nutrition Research (CHNR) Pilot Grant Program, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) grant R01 DK49368; The University of California Discovery Program (05GEB01NHB); the National Institute of Environmental Health Sciences (NIEHS) P42ES004699, NIEHS R01 ES002710, and NIEHS Superfund Research Program P42 ES011269; the California Dairy Research Foundation; the American Asthma Association #09-0269; JY was supported by the Elizabeth Nash Memorial fellowship from the Cystic Fibrosis Research Inc.; BDH is a George and Judy Marcus Senior Fellow of the American Asthma Foundation; the Swedish Research Councils VR (#2011-6044), Formas (#2010-303), and Vinnova (#2010-02070); West Coast Comprehensive Metabolomics Center National Institutes of Health/NIDDK U24 DK097154. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouwens M, 2009, AM J CLIN NUTR, V90, P415, DOI 10.3945/ajcn.2009.27680; Bryan DL, 2005, LIPIDS, V40, P1007, DOI 10.1007/s11745-005-1463-4; Deckelbaum RJ, 2006, AM J CLIN NUTR, V83, p1520S, DOI 10.1093/ajcn/83.6.1520S; Fahy E, 2009, J LIPID RES, V50, pS9, DOI 10.1194/jlr.R800095-JLR200; FOLCH J, 1957, J BIOL CHEM, V226, P497; Hogg RJ, 2006, CLIN J AM SOC NEPHRO, V1, P1167, DOI 10.2215/CJN.02300606; Maldve RE, 2000, J LIPID RES, V41, P873; Nording ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076575; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rizos EC, 2012, JAMA-J AM MED ASSOC, V308, P1024, DOI 10.1001/2012.jama.11374; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Smith WL, 1996, J BIOL CHEM, V271, P33157, DOI 10.1074/jbc.271.52.33157; Vichai V, 2005, INFLAMM RES, V54, P163, DOI 10.1007/s00011-004-1338-1; Warensjo E, 2008, NUTR METAB CARDIOVAS; Watkins SM, 2002, J LIPID RES, V43, P1809, DOI 10.1194/jlr.M200169-JLR200; Yang J, 2009, ANAL CHEM, V81, P8085, DOI 10.1021/ac901282n; Zivkovic AM, 2009, METABOLOMICS, V5, P507, DOI 10.1007/s11306-009-0174-2	18	11	11	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144996	10.1371/journal.pone.0144996	http://dx.doi.org/10.1371/journal.pone.0144996			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26672987	gold, Green Published, Green Submitted			2022-12-26	WOS:000366722700083
J	Chen, QJ; Tao, J; Hei, HY; Li, FP; Wang, YM; Peng, W; Zhang, XM				Chen, Qijing; Tao, Jie; Hei, Hongya; Li, Fangping; Wang, Yunman; Peng, Wen; Zhang, Xuemei			Up-Regulatory Effects of Curcumin on Large Conductance Ca2+-Activated K+ Channels	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; ION CHANNELS; MAPK; DEGRADATION; INHIBITION; BETA(1)-SUBUNIT; UBIQUITINATION; MODULATION; ACTIVATION; EXPRESSION	Large conductance Ca2+-activated potassium channels (BK) are targets for research that explores therapeutic means to various diseases, owing to the roles of the channels in mediating multiple physiological processes in various cells and tissues. We investigated the pharmacological effects of curcumin, a compound isolated from the herb Curcuma longa, on BK channels. As recorded by whole-cell patch-clamp, curcumin increased BK (a) and BK (alpha+beta 1) currents in transfected HEK293 cells as well as the current density of BK in A7r5 smooth muscle cells in a dose-dependent manner. By incubating with curcumin for 24 hours, the current density of exogenous BK (a) in HEK293 cells and the endogenous BK in A7r5 cells were both enhanced notably, though the steady-state activation of the channels did not shift significantly, except for BK (alpha+beta 1). Curcumin up-regulated the BK protein expression without changing its mRNA level in A7r5 cells. The surface expression and the half-life of BK channels were also increased by curcumin in HEK293 cells. These effects of curcumin were abolished by MG-132, a proteasome inhibitor. Curcumin also increased ERK 1/2 phosphorylation, while inhibiting ERK by U0126 attenuated the curcumin-induced up-regulation of BK protein expression. We also observed that the curcumin-induced relaxation in the isolated rat aortic rings was significantly attenuated by paxilline, a BK channel specific blocker. These results show that curcumin enhances the activity of the BK channels by interacting with BK directly as well as enhancing BK protein expression through inhibiting proteasomal degradation and activating ERK signaling pathway. The findings suggest that curcumin is a potential BK channel activator and provide novel insight into its complicated pharmacological effects and the underlying mechanisms.	[Chen, Qijing; Tao, Jie; Hei, Hongya; Li, Fangping; Zhang, Xuemei] Fudan Univ, Sch Pharm, Dept Pharmacol, Shanghai 201203, Peoples R China; [Tao, Jie; Wang, Yunman; Peng, Wen] Shanghai Univ Tradit Chinese Med, Putuo Hosp, Dept Nephrol, Shanghai 200062, Peoples R China	Fudan University; Shanghai University of Traditional Chinese Medicine	Peng, W (corresponding author), Shanghai Univ Tradit Chinese Med, Putuo Hosp, Dept Nephrol, 164 Lanxi Rd, Shanghai 200062, Peoples R China.	pengwen01@vip.sina.com; xuemzhang@fudan.edu.cn	Tao, Jie/AAF-7766-2020		National Science Foundation of China [81370979, 81573478]; Shanghai Science and Technology Innovation [14140903202]; Key Medical Discipline project of Shanghai Municipal Health Bureau [ZK2012A34]; Shanghai Municipal Education Commission [15ZZ063]; Putuo Hospital, Shanghai University of Traditional Chinese Medicine [2014YJ002]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Innovation; Key Medical Discipline project of Shanghai Municipal Health Bureau; Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Putuo Hospital, Shanghai University of Traditional Chinese Medicine	Funding provided by National Science Foundation of China No 81370979 and 81573478 (X. Zhang)(http://www.nsfc.gov.cn/): data collection and decision to publish, Shanghai Science and Technology Innovation Grant NO. 14140903202 (X. Zhang) (http://www.stcsm.gov.cn/): study design and data collection, Leading Academic Discipline Project of SATC (W. Peng)(http://www.satcm.gov.cn/): data collection and analysis, decision to publish, the Key Medical Discipline project of Shanghai Municipal Health Bureau (NO. ZK2012A34) (W. Peng) (http://www.wsjsw.gov.cn/wsj/): preparation of the manuscript, Innovation Program of Shanghai Municipal Education Commission (NO. 15ZZ063) (J. Tao) (http://www.shmec.gov.cn/): preparation of the manuscript and Research Project of Putuo Hospital, Shanghai University of Traditional Chinese Medicine (NO. 2014YJ002) (J. Tao) (http://www.sptdch.cn/): data collection and analysis and preparation of the manuscript.	Ahluwalia J, 2004, NATURE, V427, P853, DOI 10.1038/nature02356; Brondello JM, 1999, SCIENCE, V286, P2514, DOI 10.1126/science.286.5449.2514; Choi SW, 2013, PFLUG ARCH EUR J PHY, V465, P1121, DOI 10.1007/s00424-013-1239-7; Darvesh AS, 2012, EXPERT OPIN INV DRUG, V21, P1123, DOI 10.1517/13543784.2012.693479; Dutta K, 2009, J NEUROIMMUNE PHARM, V4, P328, DOI 10.1007/s11481-009-9158-2; Foutz RM, 2008, AM J PHYSIOL-RENAL, V294, pF1465, DOI 10.1152/ajprenal.00012.2008; Hasima N, 2013, CURR MED CHEM; Hong DH, 2013, BIOCHEM BIOPH RES CO, V430, P307, DOI 10.1016/j.bbrc.2012.10.132; Jordan WC, 1996, J NATL MED ASSOC, V88, P333; Kunzelmann K, 2005, J MEMBRANE BIOL, V205, P159, DOI 10.1007/s00232-005-0781-4; Leamy AW, 2011, NEUROSCI LETT, V503, P157, DOI 10.1016/j.neulet.2011.07.054; Lee US, 2010, TRENDS NEUROSCI, V33, P415, DOI 10.1016/j.tins.2010.06.004; Li DM, 2006, P NATL ACAD SCI USA, V103, P19569, DOI 10.1073/pnas.0609555104; Li M, 2013, J BIOL CHEM, V288, P3668, DOI 10.1074/jbc.M112.426585; Lian YT, 2013, PHYTOTHER RES, V27, P1321, DOI 10.1002/ptr.4863; Liu YL, 2015, J AM SOC NEPHROL, V26, P844, DOI 10.1681/ASN.2014020186; Liu Z, 2014, ONCOGENE, V33, P65, DOI 10.1038/onc.2012.544; Maheshwari RK, 2006, LIFE SCI, V78, P2081, DOI 10.1016/j.lfs.2005.12.007; Nardi A, 2008, CURR MED CHEM, V15, P1126, DOI 10.2174/092986708784221412; Navarro-Antolin J, 2005, CIRCULATION, V112, P1309, DOI 10.1161/CIRCULATIONAHA.104.529404; Novakovic A, 2006, BASIC CLIN PHARMACOL, V99, P360, DOI 10.1111/j.1742-7843.2006.pto_531.x; O'Malley D, 2007, EUR J NEUROSCI, V25, P673, DOI 10.1111/j.1460-9568.2007.05347.x; Park SY, 2008, FOOD CHEM TOXICOL, V46, P2881, DOI 10.1016/j.fct.2008.05.030; Pietrzykowski AZ, 2008, NEURON, V59, P274, DOI 10.1016/j.neuron.2008.05.032; Ster J, 2007, P NATL ACAD SCI USA, V104, P2519, DOI 10.1073/pnas.0611031104; Tao J, 2014, TOXINS, V6, P1419, DOI 10.3390/toxins6041419; Tao J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015896; Vial E, 2003, J CELL SCI, V116, P4957, DOI 10.1242/jcs.00812; Wan SB, 2010, INT J MOL MED, V26, P447, DOI 10.3892/ijmm_00000484; Wang M, 2011, EUR J PHARMACOL, V650, P41, DOI 10.1016/j.ejphar.2010.09.049; Xu PH, 2007, VASC PHARMACOL, V47, P25, DOI 10.1016/j.vph.2007.03.003; Yamashita M, 2005, J BIOL CHEM, V280, P29409, DOI 10.1074/jbc.M502333200; Zhang DM, 2010, CIRC RES, V107, P1454, DOI 10.1161/CIRCRESAHA.110.228361; Zhang XM, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00094; Zhao J, 2012, J BIOL CHEM, V287, P19105, DOI 10.1074/jbc.M112.339507; Zheng YM, 2013, AM J PHYSIOL-CELL PH, V304, pC780, DOI 10.1152/ajpcell.00006.2012; Zhou HY, 2011, CURR DRUG TARGETS, V12, P332, DOI 10.2174/138945011794815356; Zhou XB, 2010, P NATL ACAD SCI USA, V107, P8005, DOI 10.1073/pnas.0912029107; Zhu MM, 2009, BRIT J PHARMACOL, V158, P1895, DOI 10.1111/j.1476-5381.2009.00471.x; Zhuang JQ, 2011, AM J PHYSIOL-RENAL, V301, pF410, DOI 10.1152/ajprenal.00518.2010	40	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144800	10.1371/journal.pone.0144800	http://dx.doi.org/10.1371/journal.pone.0144800			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26672753	Green Published, gold, Green Submitted			2022-12-26	WOS:000366722700063
J	Santos, ESL; Cerqueira-Silva, CBM; Mori, GM; Ahnert, D; Mello, DLN; Pires, JL; Correa, RX; de Souza, AP				Santos, Elisa S. L.; Cerqueira-Silva, Carlos Bernard M.; Mori, Gustavo M.; Ahnert, Dario; Mello, Durval L. N.; Pires, Jose Luis; Correa, Ronan X.; de Souza, Anete P.			Genetic Structure and Molecular Diversity of Cacao Plants Established as Local Varieties for More than Two Centuries: The Genetic History of Cacao Plantations in Bahia, Brazil	PLOS ONE			English	Article							WITCH-BROOM DISEASE; POPULATION-STRUCTURE; MICROSATELLITES; DOMESTICATION; L.; SOFTWARE; PROGRAM; ORIGIN; AMAZON	Bahia is the most important cacao-producing state in Brazil, which is currently the sixth-largest country worldwide to produce cacao seeds. In the eighteenth century, the Comum, Para and Maranhao varieties of cacao were introduced into southern Bahia, and their descendants, which are called 'Bahian cacao' or local Bahian varieties, have been cultivated for over 200 years. Comum plants have been used to start plantations in African countries and extended as far as countries in South Asia and Oceania. In Brazil, two sets of clones selected from Bahian varieties and their mutants, the Agronomic Institute of East (SIAL) and Bahian Cacao Institute (SIC) series, represent the diversity of Bahian cacao in germplasm banks. Because the genetic diversity of Bahian varieties, which is essential for breeding programs, remains unknown, the objective of this work was to assess the genetic structure and diversity of local Bahian varieties collected from farms and germplasm banks. To this end, 30 simple sequence repeat (SSR) markers were used to genotype 279 cacao plants from germplasm and local farms. The results facilitated the identification of 219 cacao plants of Bahian origin, and 51 of these were SIAL or SIC clones. Bahian cacao showed low genetic diversity. It could be verified that SIC and SIAL clones do not represent the true diversity of Bahian cacao, with the greatest amount of diversity found in cacao trees on the farms. Thus, a core collection to aid in prioritizing the plants to be sampled for Bahian cacao diversity is suggested. These results provide information that can be used to conserve Bahian cacao plants and applied in breeding programs to obtain more productive Bahian cacao with superior quality and tolerance to major diseases in tropical cacao plantations worldwide.	[Santos, Elisa S. L.; Cerqueira-Silva, Carlos Bernard M.] State Univ Southwest Bahia, Lab Appl Mol Genet, Dept Exact & Nat Sci, Itapetinga, BA, Brazil; [Santos, Elisa S. L.; Cerqueira-Silva, Carlos Bernard M.; Mori, Gustavo M.; de Souza, Anete P.] Univ Estadual Campinas, Ctr Mol Biol & Genet Engn, Campinas, SP, Brazil; [Ahnert, Dario; Correa, Ronan X.] Univ Estadual Santa Cruz, Dept Biol Sci, Genet & Biotechnol Ctr, Ilheus, BA, Brazil; [Mello, Durval L. N.] Bahian Fed Inst Educ Sci & Technol, Urucuca, BA, Brazil; [Pires, Jose Luis] Execut Comm Plan Cacao Farming, Cocoa Res Ctr, Itabuna, BA, Brazil; [de Souza, Anete P.] Univ Estadual Campinas, Inst Biol, Dept Plant Biol, Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Santa Cruz; Universidade de Sao Paulo; Universidade Estadual de Campinas	de Souza, AP (corresponding author), Univ Estadual Campinas, Ctr Mol Biol & Genet Engn, Campinas, SP, Brazil.	anete@unicamp.br	Mori, Gustavo Maruyama/D-5700-2013; DE SOUZA, ANETE PEREIRA/B-8663-2012; Corrêa, Ronan X/K-7976-2012	Mori, Gustavo Maruyama/0000-0003-2308-2224; DE SOUZA, ANETE PEREIRA/0000-0003-3831-9829; Corrêa, Ronan X/0000-0002-4010-1565	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2008/52197-4, 2010/50033-4, 2013/08086-1]; Conselho de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, PROCAD-NF); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [620239/2008-5, 555432/2009-2]; Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) [DTE0035/2013]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, PROCAD-NF); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB))	The authors gratefully acknowledge the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (2008/52197-4) for financial support and scholarships to GMM (2010/50033-4, 2013/08086-1); Conselho de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, PROCAD-NF2008); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq process 620239/2008-5 and 555432/2009-2) for financial support and the graduate fellowship to ESLS and research fellowships to APS; Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB) (DTE0035/2013) for financial support.	Ahnert D, 2013, GUIA DE MANEJO DO AG, P24; Aikpokpodion PO, 2009, TREE GENET GENOMES, V5, P699, DOI 10.1007/s11295-009-0221-1; Araujo M, 1998, RESERVA DA BIOSFERA; Bartley BGD, 2005, THE GENETIC DIVERSIT; Bennett AB, 2003, TRENDS PLANT SCI, V8, P561, DOI 10.1016/j.tplants.2003.10.004; Caldas MM, 2013, GEOFORUM, V47, P147, DOI 10.1016/j.geoforum.2013.01.006; Cascardo JC, 1993, ANNALS OF THE BRAZIL, P47; Cheesman E. E., 1944, TROP AGRIC [TRINIDAD], V21, P144; Cipriani G, 2010, THEOR APPL GENET, V121, P1569, DOI 10.1007/s00122-010-1411-9; Clement C. R., 2010, Diversity, V2, P72; Creste S, 2001, PLANT MOL BIOL REP, V19, P299, DOI 10.1007/BF02772828; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Faleiro FG, AGROTROPICA, V14, P31; Faria D, 2007, BIODIVERS CONSERV, V16, P2335, DOI 10.1007/s10531-007-9189-z; Figueiredo GSF, 2008, THESIS; Instituto Brasileiro de Geografia e Estatistica, 2013, COORDENACAO DE AGROP; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Lanaud C, 1999, MOL ECOL, V8, P2141, DOI 10.1046/j.1365-294x.1999.00802.x; Lanaud C, 1897, CAFE CACAO THE, V31, P267; Leite PB, 2013, CIENC AGROTEC, V37, P244, DOI 10.1590/S1413-70542013000300007; Lima LS, 2008, MOL BREEDING, V22, P315, DOI 10.1007/s11032-008-9174-6; Loor Solorzano RG, 2009, TREE GENET GENOMES, V5, P421, DOI [10.1007/s11295-008-0196-3, DOI 10.1007/S11295-008-0196-3]; Lopes UV, 2011, CROP BREED APPL BIOT, V11, P73, DOI 10.1590/S1984-70332011000500011; Monteiro Wilson Reis, 2009, P589, DOI 10.1007/978-0-387-71201-7_16; Motamayor JC, 2003, HEREDITY, V91, P322, DOI 10.1038/sj.hdy.6800298; Motamayor JC, 2002, HEREDITY, V89, P380, DOI 10.1038/sj.hdy.6800156; Motamayor JC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003311; Motilal LA, 2013, TREE GENET GENOMES, V9, P1395, DOI 10.1007/s11295-013-0645-5; N'Goran JAK, 2000, EUPHYTICA, V115, P83, DOI 10.1023/A:1003980411485; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pereira MG, 1987, THEOBROMA, V17, P209; Pires JL, 2003, THESIS U VICOSA BRAZ; Pritchard JK, 2000, GENETICS, V155, P945; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sambuichi Regina Helena Rosa, 2006, Acta Bot. Bras., V20, P943, DOI 10.1590/S0102-33062006000400018; SANTOS E. S., 2014, THESIS; Santos ESL, 2012, BIOL PLANTARUM, V56, P789, DOI 10.1007/s10535-012-0134-y; Sereno ML, 2006, CONSERV GENET, V7, P13, DOI 10.1007/s10592-005-7568-0; Silva A., 2013, THESIS; Solorzano RGL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048438; Valle, 2007, CIENCIA TECNOLOGIA E, P1; Vello F, 1972, THEOBROMA, V2, P15; Vello F., 1971, THEOBROMA, V1, P3; Yamada M. M., 2001, Crop Breeding and Applied Biotechnology, V1, P377; Young AM, 2007, THE CHOCOLATE TREE A	46	14	15	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145276	10.1371/journal.pone.0145276	http://dx.doi.org/10.1371/journal.pone.0145276			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675449	Green Submitted, gold, Green Published			2022-12-26	WOS:000366722700119
J	Su, XW; Chan, AHY; Lu, G; Lin, M; Sze, J; Zhou, JY; Poon, WS; Liu, Q; Zheng, VZY; Wong, GKC				Su, Xian Wei; Chan, Anna Ho Yin; Lu, Gang; Lin, Marie; Sze, Johnny; Zhou, Jing Ye; Poon, Wai Sang; Liu, Qiang; Zheng, Vera Zhi Yuan; Wong, George Kwok Chu			Circulating microRNA 132-3p and 324-3p Profiles in Patients after Acute Aneurysmal Subarachnoid Hemorrhage	PLOS ONE			English	Article							TRANSIENT FOCAL ISCHEMIA; MYOCARDIAL-INFARCTION; POTENTIAL BIOMARKER; CEREBRAL INFARCTION; EARLY-DIAGNOSIS; EXPRESSION; BRAIN; REGION; ANGIOGENESIS; HYPERTENSION	Background Aneurysmal subarachnoid hemorrhage (SAH) is a highly morbid and fatal condition with high rate of cognitive impairment and negative impact in quality of life among survivors. Delayed cerebral infarction (DCI) is one the major factors for these negative outcomes. In this study we compared the circulating microRNA profiles of SAH patients and healthy individuals, and the circulating microRNA profiles of SAH patients with and without DCI. Methods Peripheral blood samples on Day 7 after the onset of SAH were subjected to microarray analysis with Affymetrix miRNA 3.0 array and quantitative PCR analysis. SAH patients with (N = 20) and without DCI (N = 20) and Healthy controls (N = 20) were included for analyses. Results We demonstrated that 99 miRNAs were found to be dysregulated in the SAH patient group with DCI. 81 miRNAs were upregulated and 18 were downregulated. Findings from KEGG pathway analysis showed that miRNAs and target genes for axon guidance and TGF-beta signaling were involved, implying that the resulted differential miRNA expression pattern reflect the results of SAH instead of etiology of the disease. miR-132-3p and miR-324-3p showed distinctive upregulations in qPCR [miR-132: 9.5 fold (95% CI: 2.3 to 16.7) in DCI group and 3.4 fold (95% CI: 1.0 to 5.8) in Non-DCI group; miR-324: 4924 fold (95% CI: 2620 to 7228) in DCI group and 4545 fold (95% CI: 2408 to 6683) in non-DCI group]. However, there were no significant differences in fold changes between SAH patients with and without DCI [fold change ratios (mean+/-SD): 2.7+/-4.2 and 1.1+/-1.1 for miRNA-132 and miRNA-324]. Conclusion Our study demonstrated that as compared to healthy control, miR-132 and miR-324 showed a upregulation in both SAH DCI and Non-DCI groups. However, the differences between the SAH DCI and non-DCI groups were not statistically significant.	[Su, Xian Wei; Chan, Anna Ho Yin; Lu, Gang; Lin, Marie; Sze, Johnny; Poon, Wai Sang; Zheng, Vera Zhi Yuan; Wong, George Kwok Chu] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Div Neurosurg, Hong Kong, Hong Kong, Peoples R China; [Lu, Gang; Zhou, Jing Ye; Liu, Qiang] Chinese Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong	Wong, GKC (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Div Neurosurg, Hong Kong, Hong Kong, Peoples R China.	georgewong@surgery.cuhk.edu.hk	Poon, Wai S/HGD-3084-2022; Poon, Wai Sang/F-1558-2011; Wong, George Kwok Chu/L-4344-2016; Wong, George KC/A-6378-2011	Wong, George KC/0000-0002-6078-2548	Chinese University of Hong Kong Direct Grant for Research [MD11782]	Chinese University of Hong Kong Direct Grant for Research	This work was supported by a Chinese University of Hong Kong Direct Grant for Research (MD11782). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by a Chinese University of Hong Kong Direct Grant for Research (MD11782).	Adlakha YK, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-33; *AFF, EX ARR BACKGR CORR; Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; Araldi E, 2015, CURR VASC PHARMACOL, V13, P291, DOI 10.2174/15701611113119990012; Chen S, 2014, PROG NEUROBIOL, V115, P64, DOI 10.1016/j.pneurobio.2013.09.002; Cui LB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027071; de Rooij NK, 2007, J NEUROL NEUROSUR PS, V78, P1365, DOI 10.1136/jnnp.2007.117655; Dharap A, 2009, J CEREBR BLOOD F MET, V29, P675, DOI 10.1038/jcbfm.2008.157; Ding Q, 2014, NEUROSCI BULL, V30, P683, DOI 10.1007/s12264-013-1441-9; Dodel R, 2010, STROKE, V41, P2918, DOI 10.1161/STROKEAHA.110.586826; Ertekin S, 2014, MOL VIS, V20, P1057; Fiedler SD, 2010, METHODS MOL BIOL, V630, P49, DOI 10.1007/978-1-60761-629-0_4; Gaal EI, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002563; Heggermont WA, 2012, HYPERTENSION, V60, P1088, DOI 10.1161/HYPERTENSIONAHA.111.187104; Huang JK, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/364316; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Jiang YG, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-36; Jin HW, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-296; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; KASSELL NF, 1990, J NEUROSURG, V73, P37, DOI 10.3171/jns.1990.73.1.0037; Koch W, 2011, ATHEROSCLEROSIS, V217, P220, DOI 10.1016/j.atherosclerosis.2011.03.014; Krupinski J, 1996, STROKE, V27, P852, DOI 10.1161/01.STR.27.5.852; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Lei ZY, 2015, J CELL MOL MED, V19, P1994, DOI 10.1111/jcmm.12586; Li CC, 2015, EUR J MED RES, V20, DOI 10.1186/s40001-015-0148-y; Li PX, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000972; Li SQ, 2011, CIRCULATION, V124, P175, DOI 10.1161/CIRCULATIONAHA.110.012237; Liu DH, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0188-x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magill ST, 2010, P NATL ACAD SCI USA, V107, P20382, DOI 10.1073/pnas.1015691107; Rabinstein AA, 2004, STROKE, V35, P1862, DOI 10.1161/01.STR.0000133132.76983.8e; Sanders I, 2012, INT J UROL, V19, P1017, DOI 10.1111/j.1442-2042.2012.03082.x; Sano H, 2015, WORLD NEUROSURG, V83, P801, DOI 10.1016/j.wneu.2014.12.032; Schmidt JM, 2007, NEUROCRIT CARE, V7, P10, DOI 10.1007/s12028-007-0003-2; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; TEASDALE G, 1974, LANCET, V2, P81; van Rooij E, 2011, CIRC RES, V108, P219, DOI 10.1161/CIRCRESAHA.110.227496; Vlachos IS, 2012, NUCLEIC ACIDS RES, V40, pW498, DOI 10.1093/nar/gks494; Vucic EA, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-778; Wang GK, 2010, EUR HEART J, V31, P659, DOI 10.1093/eurheartj/ehq013; Wei YQ, 2014, J VASC SURG, V59, P879, DOI 10.1016/j.jvs.2013.10.095; Wong GKC, 2011, NEUROSURGERY, V68, P1556, DOI 10.1227/NEU.0b013e31820cd40d; Wong GKC, 2014, WORLD NEUROSURG, V81, P552, DOI 10.1016/j.wneu.2013.07.128; Wong GKC, 2012, J NEUROL NEUROSUR PS, V83, P1112, DOI 10.1136/jnnp-2012-302217; Wong HKA, 2013, HUM MOL GENET, V22, P3077, DOI 10.1093/hmg/ddt164; Yasuno K, 2011, P NATL ACAD SCI USA, V108, P19707, DOI 10.1073/pnas.1117137108; Yasuno K, 2010, NAT GENET, V42, P420, DOI 10.1038/ng.563; Yu HC, 2015, PROG NEURO-PSYCHOPH, V63, P23, DOI 10.1016/j.pnpbp.2015.05.007	50	41	43	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144724	10.1371/journal.pone.0144724	http://dx.doi.org/10.1371/journal.pone.0144724			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675167	Green Submitted, Green Published, gold			2022-12-26	WOS:000366722700058
J	Vladimirskiy, B; Urbanczik, R; Senn, W				Vladimirskiy, Boris; Urbanczik, Robert; Senn, Walter			Hierarchical Novelty-Familiarity Representation in the Visual System by Modular Predictive Coding	PLOS ONE			English	Article							CLASSICAL RECEPTIVE-FIELD; MODELS; V1; SUPPRESSION; SELECTIVITY; COMPETITION; EMERGENCE; ALGORITHM; CORTEX; CELLS	Predictive coding has been previously introduced as a hierarchical coding framework for the visual system. At each level, activity predicted by the higher level is dynamically subtracted from the input, while the difference in activity continuously propagates further. Here we introduce modular predictive coding as a feedforward hierarchy of prediction modules without back-projections from higher to lower levels. Within each level, recurrent dynamics optimally segregates the input into novelty and familiarity components. Although the anatomical feedforward connectivity passes through the novelty-representing neurons, it is nevertheless the familiarity information which is propagated to higher levels. This modularity results in a twofold advantage compared to the original predictive coding scheme: the familiarity-novelty representation forms quickly, and at each level the full representational power is exploited for an optimized readout. As we show, natural images are successfully compressed and can be reconstructed by the familiarity neurons at each level. Missing information on different spatial scales is identified by novelty neurons and complements the familiarity representation. Furthermore, by virtue of the recurrent connectivity within each level, non-classical receptive field properties still emerge. Hence, modular predictive coding is a biologically realistic metaphor for the visual system that dynamically extracts novelty at various scales while propagating the familiarity information.	[Vladimirskiy, Boris; Urbanczik, Robert; Senn, Walter] Univ Bern, Dept Physiol, CH-3012 Bern, Switzerland	University of Bern	Senn, W (corresponding author), Univ Bern, Dept Physiol, Buhlpl 5, CH-3012 Bern, Switzerland.	Senn@cns.physio.unibe.ch	Senn, Walter/D-6308-2014	Senn, Walter/0000-0003-3622-0497	Swiss National Science Foundation (SNSF) [31003A-133094, 310030L-156863]	Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	This work was supported by the Swiss National Science Foundation (SNSF, personal grants No. 31003A-133094 and 310030L-156863 of WS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Swiss National Science Foundation (SNSF, personal grants No. 31003A-133094 and 310030L-156863 of WS).	ADELSON EH, 1985, J OPT SOC AM A, V2, P284, DOI 10.1364/JOSAA.2.000284; Angelucci A, 2003, J PHYSIOL-PARIS, V97, P141, DOI 10.1016/j.jphysparis.2003.09.001; Barlow H, 2001, NETWORK-COMP NEURAL, V12, P241, DOI 10.1088/0954-898X/12/3/301; Barlow H. B., 1961, SENS COMMUN, P217, DOI DOI 10.7551/MITPRESS/9780262518420.003.0013; Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; BOLZ J, 1986, NATURE, V320, P362, DOI 10.1038/320362a0; Cadieu C, 2007, J NEUROPHYSIOL, V98, P1733, DOI 10.1152/jn.01265.2006; Carandini M, 2005, J NEUROSCI, V25, P10577, DOI 10.1523/JNEUROSCI.3726-05.2005; Chavane F, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00004; Clark A, 2013, BEHAV BRAIN SCI, V36, P181, DOI 10.1017/S0140525X12000477; Cohen MR, 2011, NEURON, V70, P1192, DOI 10.1016/j.neuron.2011.04.029; DAYAN P, 1995, NEURAL COMPUT, V7, P889, DOI 10.1162/neco.1995.7.5.889; Durand S, 2007, VISUAL NEUROSCI, V24, P679, DOI 10.1017/S0952523807070563; Foldiak P., 1989, IJCNN: International Joint Conference on Neural Networks (Cat. No.89CH2765-6), P401, DOI 10.1109/IJCNN.1989.118615; Fournier J, 2011, NAT NEUROSCI, V14, P1053, DOI 10.1038/nn.2861; Friston Karl J., 1994, Human Brain Mapping, V2, P56, DOI 10.1002/hbm.460020107; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Friston KJ, 2009, PHILOS T R SOC B, V364, P1211, DOI 10.1098/rstb.2008.0300; Friston KJ, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000211; Fyfe C, 1997, NEURAL PROCESS LETT, V6, P33, DOI 10.1023/A:1009606706736; Garrido MI, 2009, NEUROIMAGE, V48, P269, DOI 10.1016/j.neuroimage.2009.06.034; Haykin S. O., 2008, NEURAL NETWORKS LEAR; HINTON GE, 1995, SCIENCE, V268, P1158, DOI 10.1126/science.7761831; Hoyer PO, 2003, NEUROCOMPUTING, V52-4, P547, DOI 10.1016/S0925-2312(02)00782-8; Johnson RR, 1997, J NEUROSCI, V17, P7129; Karklin Y, 2009, NATURE, V457, P83, DOI 10.1038/nature07481; Koch C, 1999, NAT NEUROSCI, V2, P9, DOI 10.1038/4511; Koch MA, 2002, NEUROIMAGE, V16, P241, DOI 10.1006/nimg.2001.1052; Larkum ME, 2004, CEREB CORTEX, V14, P1059, DOI 10.1093/cercor/bhh065; Lee H., 2006, ADV NEURAL INFORM PR, P801, DOI DOI 10.1371/J0URNAL.P0NE.0006098; Lichtman JW, 2008, NAT REV NEUROSCI, V9, P417, DOI 10.1038/nrn2391; Lieder F, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003288; MILLER KD, 1994, J NEUROSCI, V14, P409; Nyberg L, 2000, P NATL ACAD SCI USA, V97, P11120, DOI 10.1073/pnas.97.20.11120; Ohzawa I, 1997, J NEUROPHYSIOL, V77, P2879, DOI 10.1152/jn.1997.77.6.2879; Oja E, 1997, NEUROCOMPUTING, V17, P25, DOI 10.1016/S0925-2312(97)00045-3; Olshausen BA, 1997, VISION RES, V37, P3311, DOI 10.1016/S0042-6989(97)00169-7; Olshausen BA, 1996, NATURE, V381, P607, DOI 10.1038/381607a0; Plumbley MD, 2004, IEEE T NEURAL NETWOR, V15, P66, DOI 10.1109/TNN.2003.820672; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Riesenhuber M, 1999, NAT NEUROSCI, V2, P1019, DOI 10.1038/14819; Seung HS, 2009, NEURON, V62, P17, DOI 10.1016/j.neuron.2009.03.020; Spratling MW, 2010, J NEUROSCI, V30, P3531, DOI 10.1523/JNEUROSCI.4911-09.2010; Spratling MW, 2008, FRONT COMPUT NEUROSC, V2, P1, DOI 10.3389/neuro.10.004.2008; Stanford TR, 2010, NAT NEUROSCI, V13, P379, DOI 10.1038/nn.2485; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; Thorpe SJ, 2009, NEURON, V62, P168, DOI 10.1016/j.neuron.2009.04.012; Urbanczik R, 2014, NEURON, V81, P521, DOI 10.1016/j.neuron.2013.11.030; van Hateren JH, 1998, P ROY SOC B-BIOL SCI, V265, P359, DOI 10.1098/rspb.1998.0303; Victor JD, 2009, J NEUROPHYSIOL, V102, P3414, DOI 10.1152/jn.00086.2009; Yeh CI, 2009, P NATL ACAD SCI USA, V106, P14652, DOI 10.1073/pnas.0907406106	51	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144636	10.1371/journal.pone.0144636	http://dx.doi.org/10.1371/journal.pone.0144636			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670700	Green Submitted, gold, Green Published			2022-12-26	WOS:000366719300013
J	Zhang, JY; Braun, MY				Zhang, Jinyu; Braun, Michel Y.			Protoporphyrin Treatment Modulates Susceptibility to Experimental Autoimmune Encephalomyelitis in miR-155-Deficient Mice	PLOS ONE			English	Article							HEME OXYGENASE-1; INFLAMMATION; INHIBITION	We previously identified heme oxygenase 1 (HO-1) as a specific target of miR-155, and inhibition of HO-1 activity restored the capacity of miR-155(-/-)CD4(+) T cells to promote antigendriven inflammation after adoptive transfer in antigen-expressing recipients. Protoporphyrins are molecules recognized for their modulatory effect on HO-1 expression and function. In the present study, we investigated the effect of protoporphyrin treatment on the development of autoimmunity in miR-155-deficient mice. MiR-155-mediated control of HO-1 expression in promoting T cell-driven chronic autoimmunity was confirmed since HO-1 inhibition restored susceptibility to experimental autoimmune encephalomyelitis (EAE) in miR-155deficient mice. The increased severity of the disease was accompanied by an enhanced T cell infiltration into the brain. Taken together, these results underline the importance of miR155-mediated control of HO-1 expression in regulating the function of chronically-stimulated T cells in EAE.	[Zhang, Jinyu] Third Mil Med Univ, Coll Pharm, Natl Engn Res Ctr Immunol Prod, Dept Microbiol & Biochem Pharm, Chongqing, Peoples R China; [Braun, Michel Y.] Univ Libre Bruxelles, Fac Med, Inst Med Immunol, Gosselies, Belgium	Army Medical University; Universite Libre de Bruxelles	Zhang, JY (corresponding author), Third Mil Med Univ, Coll Pharm, Natl Engn Res Ctr Immunol Prod, Dept Microbiol & Biochem Pharm, Chongqing, Peoples R China.	zhangjinyu_syd@163.com			Fonds de la Recherche Scientifique (FRS-FNRS) [3.4590.11F]; Interuniversity Attraction Poles (IAP) [P7/39]; China Scholarship Council (CSC); Alice and David Van Buuren Foundation; Rose and Jean Hoguet Foundation; Institute for Medical Immunology	Fonds de la Recherche Scientifique (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Poles (IAP)(Belgian Federal Science Policy Office); China Scholarship Council (CSC)(China Scholarship Council); Alice and David Van Buuren Foundation; Rose and Jean Hoguet Foundation; Institute for Medical Immunology	This work was supported by Fonds de la Recherche Scientifique (FRS-FNRS; grant number: 3.4590.11F), an Interuniversity Attraction Poles (IAP) (Contract P7/39), the Alice and David Van Buuren Foundation and The Rose and Jean Hoguet Foundation. JZ was supported by The China Scholarship Council (CSC) and an intramural PhD fellowship of the Institute for Medical Immunology.; This work was supported by Fonds de la Recherche Scientifique (FRS-FNRS; grant number: 3.4590.11F), an Interuniversity Attraction Poles (IAP) (Contract P7/39), the Alice and David Van Buuren Foundation and The Rose and Jean Hoguet Foundation. J.Z. was supported by The China Scholarship Council (CSC) and an intramural PhD fellowship of the Institute for Medical Immunology.	Banerjee A, 2010, EUR J IMMUNOL, V40, P225, DOI 10.1002/eji.200939381; Chora AA, 2007, J CLIN INVEST, V117, P438, DOI 10.1172/JCI28844; Dutra FF, 2014, P NATL ACAD SCI USA, V111, pE4110, DOI 10.1073/pnas.1405023111; Hegazi RAF, 2005, J EXP MED, V202, P1703, DOI 10.1084/jem.20051047; Jinek M, 2009, NATURE, V457, P405, DOI 10.1038/nature07755; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Louafi F, 2010, J BIOL CHEM, V285, P41328, DOI 10.1074/jbc.M110.146852; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Maines MD, 1997, ANNU REV PHARMACOL, V37, P517, DOI 10.1146/annurev.pharmtox.37.1.517; Mathonnet G, 2007, SCIENCE, V317, P1764, DOI 10.1126/science.1146067; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; Murugaiyan G, 2011, J IMMUNOL, V187, P2213, DOI 10.4049/jimmunol.1003952; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Pae HO, 2004, J IMMUNOL, V172, P4744, DOI 10.4049/jimmunol.172.8.4744; Pino PA, 2011, JOVE-J VIS EXP, DOI 10.3791/2348; Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Wang P, 2010, J IMMUNOL, V185, P6226, DOI 10.4049/jimmunol.1000491; Zhang J, 2015, INTERNATIONAL CONFERENCE ON ADVANCES IN MANAGEMENT SCIENCE AND ENGINEERING (AMSE 2015), P155; Zhang JY, 2014, INT IMMUNOL, V26, P407, DOI 10.1093/intimm/dxu043	22	7	7	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145237	10.1371/journal.pone.0145237	http://dx.doi.org/10.1371/journal.pone.0145237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670809	Green Published, Green Submitted, gold			2022-12-26	WOS:000366719300054
J	Munoz-Barrera, M; Aguilar, I; Monje-Casas, F				Munoz-Barrera, Marta; Aguilar, Isabel; Monje-Casas, Fernando			Dispensability of the SAC Depends on the Time Window Required by Aurora B to Ensure Chromosome Biorientation	PLOS ONE			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; PROTEIN-KINASE; MITOTIC SPINDLE; BUDDING YEAST; KINETOCHORE; COMPLEX; DISRUPTION; MICE; MISSEGREGATION; ORIENTATION	Aurora B and the spindle assembly checkpoint (SAC) collaborate to ensure the proper biorientation of chromosomes during mitosis. However, lack of Aurora B activity and inactivation of the SAC have a very different impact on chromosome segregation. This is most evident in Saccharomyces cerevisiae, since in this organism the lack of Aurora B is lethal and leads to severe aneuploidy problems, while the SAC is dispensable under normal growth conditions and mutants in this checkpoint do not show evident chromosome segregation defects. We demonstrate that the efficient repair of incorrect chromosome attachments by Aurora B during the initial stages of spindle assembly in budding yeast determines the lack of chromosome segregation defects in SAC mutants, and propose that the differential time window that Aurora B kinase requires to establish chromosome biorientation is the key factor that determines why some cells are more dependent on a functional SAC than others.	[Munoz-Barrera, Marta; Monje-Casas, Fernando] CSIC, CABIMER, E-41080 Seville, Spain; [Aguilar, Isabel; Monje-Casas, Fernando] Univ Seville, Dept Genet, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); University of Sevilla	Monje-Casas, F (corresponding author), CSIC, CABIMER, E-41080 Seville, Spain.	fernando.monje@cabimer.es	Monje-Casas, Fernando/M-3062-2014	Monje-Casas, Fernando/0000-0002-3587-2373	Junta de Andalucia [CVI-5806]; Spanish Ministry of Economy and Competitiveness [BFU2013-43718-P]; European Union (FEDER); V Research Programme (VPPI) of the University of Seville; JAE-Predoc fellowship from the Spanish National Research Council (CSIC)	Junta de Andalucia(Junta de Andalucia); Spanish Ministry of Economy and Competitiveness(Spanish Government); European Union (FEDER)(European Commission); V Research Programme (VPPI) of the University of Seville; JAE-Predoc fellowship from the Spanish National Research Council (CSIC)	This work was supported by Junta de Andalucia (CVI-5806), the Spanish Ministry of Economy and Competitiveness (BFU2013-43718-P) and the European Union (FEDER). F.M.-C was recipient of a contract from the V Research Programme (VPPI) of the University of Seville. M.M.-B. was recipient of a JAE-Predoc fellowship from the Spanish National Research Council (CSIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu J, 1999, J CELL BIOL, V146, P13, DOI 10.1083/jcb.146.1.13; Burds AA, 2005, P NATL ACAD SCI USA, V102, P11296, DOI 10.1073/pnas.0505053102; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Cutts SM, 1999, HUM MOL GENET, V8, P1145, DOI 10.1093/hmg/8.7.1145; D'Aquino KE, 2005, MOL CELL, V19, P223, DOI 10.1016/j.molcel.2005.06.005; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; DOHMEN RJ, 1994, SCIENCE, V263, P1273, DOI 10.1126/science.8122109; Farruggio DC, 1999, P NATL ACAD SCI USA, V96, P7306, DOI 10.1073/pnas.96.13.7306; Fernandez-Miranda G, 2011, DEVELOPMENT, V138, P2661, DOI 10.1242/dev.066381; Foijer F, 2013, P NATL ACAD SCI USA, V110, P2928, DOI 10.1073/pnas.1217388110; Hogan B, 1994, MANIPULATING MOUSE E; Jin FZ, 2013, P NATL ACAD SCI USA, V110, P21036, DOI 10.1073/pnas.1307595111; Kalitsis P, 2000, GENE DEV, V14, P2277, DOI 10.1101/gad.827500; Kitagawa R, 1999, NAT CELL BIOL, V1, P514, DOI 10.1038/70309; Kotwaliwale CV, 2007, DEV CELL, V13, P433, DOI 10.1016/j.devcel.2007.07.003; Lew DJ, 2003, ANNU REV GENET, V37, P251, DOI 10.1146/annurev.genet.37.042203.120656; McAinsh AD, 2003, ANNU REV CELL DEV BI, V19, P519, DOI 10.1146/annurev.cellbio.19.111301.155607; Mirchenko L, 2010, CURR BIOL, V20, P1396, DOI 10.1016/j.cub.2010.06.023; Monje-Casas F, 2007, CELL, V128, P477, DOI 10.1016/j.cell.2006.12.040; Munoz-Barrera M, 2014, P NATL ACAD SCI USA, V111, pE3996, DOI 10.1073/pnas.1408017111; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nezi LG, 2009, CURR OPIN CELL BIOL, V21, P785, DOI 10.1016/j.ceb.2009.09.007; Nguyen HG, 2005, MOL CELL BIOL, V25, P4977, DOI 10.1128/MCB.25.12.4977-4992.2005; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; Ramaswamy V, 2003, MOL CELL BIOL, V23, P9136, DOI 10.1128/MCB.23.24.9136-9149.2003; Ross KE, 2003, GENETICS, V165, P489; Snow MHL, 1977, J EMBRYOL EXP MORPH, V42, P293; Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5; Uren AG, 2000, CURR BIOL, V10, P1319, DOI 10.1016/S0960-9822(00)00769-7; Valerio-Santiago M, 2011, J CELL BIOL, V192, P599, DOI 10.1083/jcb.201007044; Vazquez-Novelle MD, 2010, CURR BIOL, V20, P1402, DOI 10.1016/j.cub.2010.06.036; Welburn JPI, 2008, DEV CELL, V15, P645, DOI 10.1016/j.devcel.2008.10.011; Wong J, 2007, MOL BIOL CELL, V18, P3800, DOI 10.1091/mbc.E07-06-0536; Yamanaka Y, 2008, MECH DEVELOP, V125, P441, DOI 10.1016/j.mod.2008.01.011	35	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144972	10.1371/journal.pone.0144972	http://dx.doi.org/10.1371/journal.pone.0144972			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26661752	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900160
J	Somaiah, C; Kumar, A; Mawrie, D; Sharma, A; Patil, SD; Bhattacharyya, J; Swaminathan, R; Jaganathan, BG				Somaiah, Chinnapaka; Kumar, Atul; Mawrie, Darilang; Sharma, Amit; Patil, Suraj Dasharath; Bhattacharyya, Jina; Swaminathan, Rajaram; Jaganathan, Bithiah Grace			Collagen Promotes Higher Adhesion, Survival and Proliferation of Mesenchymal Stem Cells	PLOS ONE			English	Article							OSTEOGENIC DIFFERENTIATION; EXTRACELLULAR-MATRIX; BONE-MARROW; FIBRONECTIN; MIGRATION; CYTOSKELETAL; VITRONECTIN; INHIBITION; SCAFFOLD; SHAPE	Mesenchymal stem cells (MSC) can differentiate into several cell types and are desirable candidates for cell therapy and tissue engineering. However, due to poor cell survival, proliferation and differentiation in the patient, the therapy outcomes have not been satisfactory. Although several studies have been done to understand the conditions that promote proliferation, differentiation and migration of MSC in vitro and in vivo, still there is no clear understanding on the effect of non-cellular bio molecules. Of the many factors that influence the cell behavior, the immediate cell microenvironment plays a major role. In this context, we studied the effect of extracellular matrix (ECM) proteins in controlling cell survival, proliferation, migration and directed MSC differentiation. We found that collagen promoted cell proliferation, cell survival under stress and promoted high cell adhesion to the cell culture surface. Increased osteogenic differentiation accompanied by high active RHOA (Ras homology gene family member A) levels was exhibited by MSC cultured on collagen. In conclusion, our study shows that collagen will be a suitable matrix for large scale production of MSC with high survival rate and to obtain high osteogenic differentiation for therapy.	[Somaiah, Chinnapaka; Kumar, Atul; Mawrie, Darilang; Sharma, Amit; Patil, Suraj Dasharath; Jaganathan, Bithiah Grace] Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Stem Cell Biol Lab, Gauhati, Assam, India; [Swaminathan, Rajaram] Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Gauhati, Assam, India; [Bhattacharyya, Jina] Gauhati Med Coll Hosp, Dept Hematol, Gauhati, Assam, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Guwahati; Gauhati Medical College & Hospital	Jaganathan, BG (corresponding author), Indian Inst Technol Guwahati, Dept Biosci & Bioengn, Stem Cell Biol Lab, Gauhati, Assam, India.	bithiahgj@iitg.ernet.in	Swaminathan, Rajaram/I-2250-2019	Swaminathan, Rajaram/0000-0003-1294-8379; Kumar, Atul/0000-0001-9682-5725	Ministry of Human Resource Development, Govt. of India.; Department of Science and Technology (DST), Govt. of India [SR/FT/LS-97/2009]; Department of Biotechnology (DBT), Govt. of India under RGYI (Rapid Grant for Young Investigator) scheme [BT/PRI/5091/GBD/27/310/2011]	Ministry of Human Resource Development, Govt. of India.; Department of Science and Technology (DST), Govt. of India(Department of Science & Technology (India)); Department of Biotechnology (DBT), Govt. of India under RGYI (Rapid Grant for Young Investigator) scheme	CS, AK, DM are supported by fellowship from Ministry of Human Resource Development, Govt. of India. This work was supported by funds from Department of Science and Technology SR/FT/LS-97/2009 (DST), Govt. of India and Department of Biotechnology (DBT), Govt. of India under RGYI (Rapid Grant for Young Investigator) scheme BT/PRI/5091/GBD/27/310/2011 to BGJ (http://www.dbtindia.nic.in/). TIRF measurement was performed in facility supported by DBT to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CS, AK, DM are supported by fellowship from Ministry of Human Resource Development, Govt. of India. This work was supported by funds from Department of Science and Technology SR/FT/LS-97/2009 (DST), Govt. of India and Department of Biotechnology (DBT), Govt. of India under RGYI (Rapid Grant for Young Investigator) scheme BT/PRI/5091/GBD/27/310/2011 to BGJ (http://www.dbtindia.nic.in/). TIRF measurement was performed in facility supported by DBT to RS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Bernhardt A, 2008, J MATER SCI-MATER M, V19, P269, DOI 10.1007/s10856-006-0059-0; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Chazotte Brad, 2011, Cold Spring Harb Protoc, V2011, P990, DOI 10.1101/pdb.prot5648; Chen Shaoliang, 2006, J Invasive Cardiol, V18, P552; CLYMAN RI, 1990, CIRC RES, V67, P175, DOI 10.1161/01.RES.67.1.175; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; Deng JH, 2006, MOL CELL BIOL, V26, P1077, DOI 10.1128/MCB.26.3.1077-1086.2006; Donzelli E, 2007, ARCH ORAL BIOL, V52, P64, DOI 10.1016/j.archoralbio.2006.07.007; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Hare JM, 2009, J AM COLL CARDIOL, V54, P2277, DOI 10.1016/j.jacc.2009.06.055; Hayakawa Kimihide, 2012, Commun Integr Biol, V5, P572, DOI 10.4161/cib.21891; Huang Y, 2013, J NANOMATER, V2013, DOI 10.1155/2013/343909; Jaganathan BG, 2010, LEUKEMIA, V24, P1791, DOI 10.1038/leu.2010.164; Jaganathan BG, 2007, STEM CELLS, V25, P1966, DOI 10.1634/stemcells.2007-0167; Kang BJ, 2013, J BIOMAT SCI-POLYM E, V24, P1233, DOI 10.1080/09205063.2012.745717; Kang YY, 2017, J TISSUE ENG REGEN M, V11, P1929, DOI 10.1002/term.2090; Kilian KA, 2010, P NATL ACAD SCI USA, V107, P4872, DOI 10.1073/pnas.0903269107; Kim HJ, 2012, J BIOMED MATER RES B, V100B, P1645, DOI 10.1002/jbm.b.32733; Li BJ, 2013, SCI REP-UK, V3, DOI 10.1038/srep02425; Li J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/786475; Lim SM, 2010, EXP CELL RES, V316, P2833, DOI 10.1016/j.yexcr.2010.06.010; Linhares-Lacerda L, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S5-S2; Linsley C, 2013, TISSUE ENG PT A, V19, P1416, DOI [10.1089/ten.tea.2012.0523, 10.1089/ten.TEA.2012.0523]; Mathieu PS, 2012, TISSUE ENG PART B-RE, V18, P436, DOI [10.1089/ten.teb.2012.0014, 10.1089/ten.TEB.2012.0014]; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Ogura Naomi, 2004, J Oral Sci, V46, P207, DOI 10.2334/josnusd.46.207; Oh S, 2009, P NATL ACAD SCI USA, V106, P2130, DOI 10.1073/pnas.0813200106; Park JH, 2012, NEUROSURGERY, V70, P1238, DOI 10.1227/NEU.0b013e31824387f9; Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009; Reyes M, 2002, J CLIN INVEST, V109, P337, DOI 10.1172/JCI200214327; Rodrigo R, 2013, DIS MARKERS, V2013, P773, DOI 10.1155/2013/974358; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Ruster B, 2005, STEM CELLS DEV, V14, P231, DOI 10.1089/scd.2005.14.231; Sahin AO, 2012, CELL ADHES MIGR, V6, P39, DOI 10.4161/cam.18975; Salasznyk RM, 2004, J BIOMED BIOTECHNOL, P24, DOI 10.1155/S1110724304306017; Sanchez-Ramos J, 2000, EXP NEUROL, V164, P247, DOI 10.1006/exnr.2000.7389; Schneider RK, 2010, BIOMATERIALS, V31, P467, DOI 10.1016/j.biomaterials.2009.09.059; Sonowal H, 2013, J BIOMED SCI, V20, DOI 10.1186/1423-0127-20-71; Thibault MM, 2007, STEM CELLS DEV, V16, P489, DOI 10.1089/scd.2006.0100; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Trappmann B, 2013, CURR OPIN BIOTECH, V24, P948, DOI 10.1016/j.copbio.2013.03.020; Trappmann B, 2012, NAT MATER, V11, P642, DOI [10.1038/nmat3339, 10.1038/NMAT3339]; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Varum S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020914; Wang JL, 2012, J BIOMED MATER RES A, V100A, P2929, DOI 10.1002/jbm.a.34236; Xu JF, 2012, INT J MOL SCI, V13, P17104, DOI 10.3390/ijms131217104; Zhang WH, 2015, J BIOMATER TISS ENG, V5, P257, DOI 10.1166/jbt.2015.1314	49	143	147	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145068	10.1371/journal.pone.0145068	http://dx.doi.org/10.1371/journal.pone.0145068			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26661657	gold, Green Submitted, Green Published			2022-12-26	WOS:000366715900179
J	Rai, R; Zhang, F; Colavita, K; Leu, NA; Kurosaka, S; Kumar, A; Birnbaum, MD; Gyorffy, B; Dong, DW; Shtutman, M; Kashina, A				Rai, R.; Zhang, F.; Colavita, K.; Leu, N. A.; Kurosaka, S.; Kumar, A.; Birnbaum, M. D.; Gyorffy, B.; Dong, D. W.; Shtutman, M.; Kashina, A.			Arginyltransferase suppresses cell tumorigenic potential and inversely correlates with metastases in human cancers	ONCOGENE			English	Article							RNA-PROTEIN TRANSFERASE; END RULE PATHWAY; IN-VIVO; ARGINYLATION; EXPRESSION; FORMS; ATE1	Arginylation is an emerging post-translational modification mediated by arginyltransferase (ATE1) that is essential for mammalian embryogenesis and regulation of the cytoskeleton. Here, we discovered that Ate1-knockout (KO) embryonic fibroblasts exhibit tumorigenic properties, including abnormally rapid contact-independent growth, reduced ability to form cell-cell contacts and chromosomal aberrations. Ate1-KO fibroblasts can form large colonies in Matrigel and exhibit invasive behavior, unlike wild-type fibroblasts. Furthermore, Ate1-KO cells form tumors in subcutaneous xenograft assays in immunocompromised mice. Abnormal growth in these cells can be partially rescued by reintroduction of stably expressed specific Ate1 isoforms, which also reduce the ability of these cells to form tumors. Tumor array studies and bioinformatics analysis show that Ate1 is downregulated in several types of human cancer samples at the protein level, and that its transcription level inversely correlates with metastatic progression and patient survival. We conclude that Ate1-KO results in carcinogenic transformation of cultured fibroblasts, suggesting that in addition to its previously known activities Ate1 gene is essential for tumor suppression and also likely participates in suppression of metastatic growth.	[Rai, R.; Zhang, F.; Colavita, K.; Leu, N. A.; Kurosaka, S.; Kashina, A.] Univ Penn, Sch Vet Med, Philadelphia, PA 19104 USA; [Zhang, F.; Kumar, A.; Birnbaum, M. D.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Dept Mol & Cellular Pharmacol, Miami, FL 33136 USA; [Gyorffy, B.] MTA TTK Lendulet Canc Biomarker Res Grp, Budapest, Hungary; [Gyorffy, B.] Semmelweis Univ, Dept Pediat 2, Budapest, Hungary; [Dong, D. W.] Univ Penn, Perelman Sch Med, Inst Biomed Informat, Philadelphia, PA 19104 USA; [Shtutman, M.] Univ South Carolina, Columbia, SC 29208 USA	University of Pennsylvania; University of Miami; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Semmelweis University; University of Pennsylvania; Pennsylvania Medicine; University of South Carolina System; University of South Carolina Columbia	Kashina, A (corresponding author), Univ Penn, Sch Vet Med, Dept Anim Biol, Philadelphia, PA 19104 USA.	akashina@vet.upenn.edu	Gyorffy, Balazs/AAA-9135-2021; Shtutman, Michael/AAB-8391-2020	Gyorffy, Balazs/0000-0002-5772-3766; Shtutman, Michael/0000-0002-2458-3226	NIH [GM104003, GM117984, GM109091]; Pilot Grant from the Mari Lowe Center for Comparative Oncology; OTKA grant [K108655]; Developmental Grant from Sylvester Comprehensive Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM109091, R01GM104003, R01GM108744] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pilot Grant from the Mari Lowe Center for Comparative Oncology; OTKA grant(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Developmental Grant from Sylvester Comprehensive Cancer Center; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH grants GM104003 and GM117984 and the Pilot Grant from the Mari Lowe Center for Comparative Oncology to AK. BG was supported by the OTKA K108655 grant. MS was supported by NIH grant GM109091. FZ, MDB and A Kumar were partly supported by a Developmental Grant from Sylvester Comprehensive Cancer Center.	BALZI E, 1990, J BIOL CHEM, V265, P7464; Eisenach PA, 2014, J BIOL CHEM, V289, P35376, DOI 10.1074/jbc.M114.578674; Gyorffy B, 2015, ONCOTARGET, V6, P13334; KAJI H, 1963, BIOCHIM BIOPHYS ACTA, V76, P477; Karakozova M, 2006, SCIENCE, V313, P192, DOI 10.1126/science.1129344; Kurosaka S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000878; Kwon YT, 1999, MOL CELL BIOL, V19, P182; Kwon YT, 2002, SCIENCE, V297, P96, DOI 10.1126/science.1069531; Mihaly Z, 2013, BREAST CANCER RES TR, V140, P219, DOI 10.1007/s10549-013-2622-y; Piatkov KI, 2012, P NATL ACAD SCI USA, V109, pE1839, DOI 10.1073/pnas.1207786109; Rai R, 2005, P NATL ACAD SCI USA, V102, P10123, DOI 10.1073/pnas.0504500102; Rai R, 2006, EMBO REP, V7, P800, DOI 10.1038/sj.embor.7400747; Saha S, 2011, CHEM BIOL, V18, P1369, DOI 10.1016/j.chembiol.2011.08.019; Saha S, 2011, DEV BIOL, V358, P1, DOI 10.1016/j.ydbio.2011.06.043; Wang JL, 2014, CHEM BIOL, V21, P331, DOI 10.1016/j.chembiol.2013.12.017; Wang JL, 2011, CHEM BIOL, V18, P121, DOI 10.1016/j.chembiol.2010.10.016; Wong CCL, 2007, PLOS BIOL, V5, P2231, DOI 10.1371/journal.pbio.0050258; Zhang FL, 2012, J CELL BIOL, V197, P819, DOI 10.1083/jcb.201112129	18	20	20	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 4	2016	35	31					4058	4068		10.1038/onc.2015.473	http://dx.doi.org/10.1038/onc.2015.473			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS8GG	26686093	Green Accepted, Green Submitted			2022-12-26	WOS:000381020900004
J	Magi, T; Kuehni, CE; Torchetti, L; Wengenroth, L; Luer, S; Frei-Erb, M				Magi, Tatjana; Kuehni, Claudia E.; Torchetti, Loredana; Wengenroth, Laura; Lueer, Sonja; Frei-Erb, Martin			Use of Complementary and Alternative Medicine in Children with Cancer: A Study at a Swiss University Hospital	PLOS ONE			English	Article							PEDIATRIC ONCOLOGY PATIENTS; HERB-DRUG INTERACTIONS; CHILDHOOD-CANCER; PREVALENCE; POPULATION; CHEMOTHERAPY; THERAPIES; GERMANY	Background Though complementary and alternative medicine (CAM) are frequently used by children and adolescents with cancer, there is little information on how and why they use it. This study examined prevalence and methods of CAM, the therapists who applied it, reasons for and against using CAM and its perceived effectiveness. Parent-perceived communication was also evaluated. Parents were asked if medical staff provided information on CAM to patients, if parents reported use of CAM to physicians, and what attitude they thought physicians had toward CAM. Study Design All childhood cancer patients treated at the University Children's Hospital Bern between 2002-2011 were retrospectively surveyed about their use of CAM. Results Data was collected from 133 patients (response rate: 52%). Of those, 53% had used CAM (mostly classical homeopathy) and 25% of patients received information about CAM from medical staff. Those diagnosed more recently were more likely to be informed about CAM options. The most frequent reason for choosing CAM was that parents thought it would improve the patient's general condition. The most frequent reason for not using CAM was lack of information. Of those who used CAM, 87% perceived positive effects. Conclusions Since many pediatric oncology patients use CAM, patients' needs should be addressed by open communication between families, treating oncologists and CAM therapists, which will allow parents to make informed and safe choices about using CAM.	[Magi, Tatjana; Kuehni, Claudia E.; Wengenroth, Laura] Univ Bern, Inst Social & Prevent Med, Swiss Childhood Canc Registry, Bern, Switzerland; [Magi, Tatjana; Torchetti, Loredana; Frei-Erb, Martin] Univ Bern, Inst Complementary Med, Bern, Switzerland; [Lueer, Sonja] Univ Bern, Inselspital, Univ Childrens Hosp Bern, Div Pediat Hematol Oncol, CH-3010 Bern, Switzerland	University of Bern; University of Bern; University of Bern; University Hospital of Bern	Frei-Erb, M (corresponding author), Univ Bern, Inst Complementary Med, Bern, Switzerland.	martin.frei@ikom.unibe.ch		Kuehni, Claudia E./0000-0001-8957-2002; Frei-Erb, Martin/0000-0002-7923-3741	Swiss Paediatric Oncology Group; Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren; Swiss Cancer Research; Kinderkrebshilfe Schweiz; Ernst-Gohner Stiftung; Stiftung Domarena; CSL Behring; National Institute of Cancer Epidemiology and Registration	Swiss Paediatric Oncology Group; Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren; Swiss Cancer Research; Kinderkrebshilfe Schweiz; Ernst-Gohner Stiftung; Stiftung Domarena; CSL Behring; National Institute of Cancer Epidemiology and Registration	The work of the Swiss Childhood Cancer Registry is supported by the Swiss Paediatric Oncology Group (www.spog.ch), Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren (www.gdk-cds.ch), Swiss Cancer Research (www.krebsforschung.ch), Kinderkrebshilfe Schweiz (www.kinderkrebshilfe.ch), Ernst-Gohner Stiftung (http://www.ernst-goehner-stiftung.ch), Stiftung Domarena, CSL Behring (www.cslbehring.ch) and National Institute of Cancer Epidemiology and Registration (www.nicer.ch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Arush M, 2006, J PEDIAT HEMATOL ONC, V28, P141; Bishop FL, 2010, PEDIATRICS, V125, P768, DOI 10.1542/peds.2009-1775; Clerici CA, 2009, PEDIATR BLOOD CANCER, V53, P599, DOI 10.1002/pbc.22093; ErfahrungsMedizinisches Register (EMR), BAS SWITZ EMR REG QU; Falkenberg T, 2012, FORSCH KOMPLEMENTMED, V19, P6, DOI 10.1159/000343812; Fernandez CV, 1998, J CLIN ONCOL, V16, P1279, DOI 10.1200/JCO.1998.16.4.1279; Gozum S, 2007, CANCER NURS, V30, P38, DOI 10.1097/00002820-200701000-00007; Gomez-Martinez R, 2007, PEDIATR BLOOD CANCER, V49, P820, DOI 10.1002/pbc.21101; Hamidah A, 2009, PEDIATR BLOOD CANCER, V52, P70, DOI 10.1002/pbc.21798; Hu ZP, 2005, PHARM RES-DORDR, V22, P902, DOI 10.1007/s11095-005-4585-0; Izzo AA, 2005, FUND CLIN PHARMACOL, V19, P1, DOI 10.1111/j.1472-8206.2004.00301.x; Klein SD, 2012, SWISS MED WKLY, V142, DOI 10.4414/smw.2012.13666; Laengler A, 2008, EUR J CANCER, V44, P2233, DOI 10.1016/j.ejca.2008.07.020; Langler A, 2005, KLIN PADIATR, V217, P357, DOI 10.1055/s-2005-872522; Martel D, 2005, PEDIATR BLOOD CANCER, V44, P660, DOI 10.1002/pbc.20205; McCune JS, 2004, SUPPORT CARE CANCER, V12, P454, DOI 10.1007/s00520-004-0598-1; Meijerman I, 2006, ONCOLOGIST, V11, P742, DOI 10.1634/theoncologist.11-7-742; Michel G, 2007, SWISS MED WKLY, V137, P502; National Center for Complementary and Integrative Health (NCCIH). Bethesda (MD), 2014, NCCIH PUBL D, VD156; Roth M, 2009, J PEDIAT HEMATOL ONC, V31, P177, DOI 10.1097/MPH.0b013e3181984f5a; Seely D, 2007, J PEDIAT HEMATOL ONC, V29, P32, DOI 10.1097/MPH.0b013e3180310521; Singendonk M, 2013, EUR J PEDIATR, V172, P31, DOI 10.1007/s00431-012-1821-6; Steliarova-Foucher E, 2005, CANCER-AM CANCER SOC, V103, P1457, DOI 10.1002/cncr.20910; Zuzak TJ, 2009, EUR J PEDIATR, V168, P431, DOI 10.1007/s00431-008-0765-3	24	23	23	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145787	10.1371/journal.pone.0145787	http://dx.doi.org/10.1371/journal.pone.0145787			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694320	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092500076
J	Mendes, JS; Santiago, AD; Toledo, MAS; Rosselli-Murai, LK; Favaro, MTP; Santos, CA; Horta, MAC; Crucello, A; Beloti, LL; Romero, F; Tasic, L; de Souza, AA; de Souza, AP				Mendes, Juliano S.; Santiago, Andre da S.; Toledo, Marcelo A. S.; Rosselli-Murai, Luciana K.; Favaro, Marianna T. P.; Santos, Clelton A.; Horta, Maria Augusta C.; Crucello, Aline; Beloti, Lilian L.; Romero, Fabian; Tasic, Ljubica; de Souza, Alessandra A.; de Souza, Anete P.			VapD in Xylella fastidiosa Is a Thermostable Protein with Ribonuclease Activity	PLOS ONE			English	Article							BIOFILM FORMATION; STRUCTURE PREDICTION; ANTISENSE RNAS; VIRULENCE; PLANT; EXPRESSION; BACTERIA; SEQUENCE; STRAIN	Xylella fastidiosa strain 9a5c is a gram-negative phytopathogen that is the causal agent of citrus variegated chlorosis (CVC), a disease that is responsible for economic losses in Brazilian agriculture. The most well-known mechanism of pathogenicity for this bacterial pathogen is xylem vessel occlusion, which results from bacterial movement and the formation of biofilms. The molecular mechanisms underlying the virulence caused by biofilm formation are unknown. Here, we provide evidence showing that virulence-associated protein D in X. fastidiosa (Xf-VapD) is a thermostable protein with ribonuclease activity. Moreover, protein expression analyses in two X. fastidiosa strains, including virulent (Xf9a5c) and nonpathogenic (XfJ1a12) strains, showed that Xf-VapD was expressed during all phases of development in both strains and that increased expression was observed in Xf9a5c during biofilm growth. This study is an important step toward characterizing and improving our understanding of the biological significance of Xf-VapD and its potential functions in the CVC pathosystem.	[Mendes, Juliano S.; Santiago, Andre da S.; Toledo, Marcelo A. S.; Rosselli-Murai, Luciana K.; Favaro, Marianna T. P.; Santos, Clelton A.; Horta, Maria Augusta C.; Crucello, Aline; Beloti, Lilian L.; de Souza, Anete P.] Univ Estadual Campinas, Ctr Biol Mol & Engn Genet, BR-13083875 Campinas, SP, Brazil; [Romero, Fabian; Tasic, Ljubica] Univ Estadual Campinas, Inst Quim, Dept Quim Organ, BR-13083970 Campinas, SP, Brazil; [de Souza, Alessandra A.] Ctr APTA Citros Sylvio Moreira IAC, BR-13490970 Cordeiropolis, SP, Brazil; [de Souza, Anete P.] Univ Estadual Campinas, Inst Biol, Dept Biol Vegetal, BR-13083862 Campinas, SP, Brazil	Universidade Estadual de Campinas; Universidade Estadual de Campinas; Instituto Agronomico de Campinas (IAC); Universidade Estadual de Campinas	de Souza, AP (corresponding author), Univ Estadual Campinas, Ctr Biol Mol & Engn Genet, BR-13083875 Campinas, SP, Brazil.	anete@unicamp.br	Favaro, Marianna/G-5011-2018; Crucello, Aline/AHD-3584-2022; Santos, Clelton A/I-2202-2012; Horta, Maria/N-5051-2016; Mendes, Juliano/S-8023-2016; Tasic, Ljubica/C-3760-2013; Horta, Maria/Q-6194-2019; DE SOUZA, ANETE PEREIRA/B-8663-2012	Favaro, Marianna/0000-0003-2942-247X; Santos, Clelton A/0000-0002-6725-8925; Horta, Maria/0000-0003-2159-5296; Mendes, Juliano/0000-0001-7249-2292; Tasic, Ljubica/0000-0003-2930-7332; Horta, Maria/0000-0003-2159-5296; DE SOUZA, ANETE PEREIRA/0000-0003-3831-9829	CAPES; FAPESP [2011/50268-4]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); CNPq; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/51580-4, 2001/07533-7]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors gratefully acknowledge the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, Process 2012/51580-4 and 2001/07533-7) and Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES, Computational Biology Program). JSM received a Ph.D. fellowship from CAPES, ASS was partially supported by a Ph.D. fellowship from FAPESP (Process 2011/50268-4) and CAPES (Computational Biology Program); CAS is the recipient of a post-doctoral fellowship from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq). APS and AAS are the recipients of a research fellowship from CNPq.	Abascal F, 2010, NUCLEIC ACIDS RES, V38, pW7, DOI 10.1093/nar/gkq291; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beloglazova N, 2008, J BIOL CHEM, V283, P20361, DOI 10.1074/jbc.M803225200; Benjwal S, 2006, PROTEIN SCI, V15, P635, DOI 10.1110/ps.051917406; Bove JM, 2007, IUBMB LIFE, V59, P346, DOI 10.1080/15216540701299326; BRANDTS JF, 1965, J AM CHEM SOC, V87, P2759, DOI 10.1021/ja01090a043; Caserta R, 2014, MOL PLANT MICROBE IN, V27, P1241, DOI 10.1094/MPMI-03-14-0090-R; Caserta R, 2010, APPL ENVIRON MICROB, V76, P4250, DOI 10.1128/AEM.02114-09; Catani CF, 2004, PROTEIN EXPRES PURIF, V37, P320, DOI 10.1016/j.pep.2004.07.002; Chatterjee S, 2008, ANNU REV PHYTOPATHOL, V46, P243, DOI 10.1146/annurev.phyto.45.062806.094342; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; DAVIS MJ, 1981, CURR MICROBIOL, V6, P309, DOI 10.1007/BF01566883; de Souza AA, 2004, FEMS MICROBIOL LETT, V237, P341, DOI [10.1016/j.femsle.2004.06.055, 10.1111/j.1574-6968.2004.tb09716.x]; Gunderson FF, 2015, INFECT IMMUN, V83, P1008, DOI 10.1128/IAI.03102-14; Haddad N, 2014, J BIOL CHEM, V289, P27814, DOI 10.1074/jbc.M114.561795; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hopkins DL, 2002, PLANT DIS, V86, P1056, DOI 10.1094/PDIS.2002.86.10.1056; Janissen R, 2015, SCI REP-UK, V5, DOI 10.1038/srep09856; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Koide T, 2004, J BACTERIOL, V186, P5442, DOI 10.1128/JB.186.16.5442-5449.2004; Kumar L, 2015, FITOTERAPIA, V102, P84, DOI 10.1016/j.fitote.2015.02.002; Kumwenda B, 2013, EVOL BIOINFORM, V9, P327, DOI 10.4137/EBO.S12539; Kwon AR, 2012, NUCLEIC ACIDS RES, V40, P4216, DOI 10.1093/nar/gkr1305; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambais MR, 2000, CURR OPIN MICROBIOL, V3, P459, DOI 10.1016/S1369-5274(00)00121-1; LaSarre B, 2013, MICROBIOL MOL BIOL R, V77, P73, DOI 10.1128/MMBR.00046-12; Machado Edduardo Caruso, 1994, Revista Brasileira de Fisiologia Vegetal, V6, P53; Marques LLR, 2002, PLANT DIS, V86, P633, DOI 10.1094/PDIS.2002.86.6.633; Marques MV, 2001, PLASMID, V45, P184, DOI 10.1006/plas.2000.1514; Matos RG, 2014, FRONT CELL INFECT MI, V4, P1; Nylander JAA, 2004, PROGRAM DISTRIBUTED; Purcell AH, 2012, ADV DIS VECTOR RES, P243; Rahmati S, 2002, MOL MICROBIOL, V43, P677, DOI 10.1046/j.1365-2958.2002.02773.x; Ren D, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-263; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Santos CA, 2013, MICROB PATHOGENESIS, V59-60, P1, DOI 10.1016/j.micpath.2013.02.007; Saramago M, 2015, PLASMID, V78, P26, DOI 10.1016/j.plasmid.2014.09.003; Saramago M, 2014, CURR OPIN MICROBIOL, V18, P105, DOI 10.1016/j.mib.2014.02.009; Sauer K, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-6-219; Simpson AJG, 2000, NATURE, V406, P151, DOI 10.1038/35018003; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tan CJ, 2007, LANGMUIR, V23, P2722, DOI 10.1021/la062178q; Teixeira DD, 2004, CURR MICROBIOL, V49, P396, DOI 10.1007/s00284-004-4363-y; Toledo MAS, 2013, BBA-PROTEINS PROTEOM, V1834, P697, DOI 10.1016/j.bbapap.2012.12.017; Toledo MAS, 2011, PROTEIN EXPRES PURIF, V75, P204, DOI 10.1016/j.pep.2010.10.004; Trivedi S, 2006, GENET MOL RES, V5, P816; Vercruysse M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004175; Viegas SC, 2008, RNA BIOL, V5, P230, DOI 10.4161/rna.6915; Vieille C, 2001, MICROBIOL MOL BIOL R, V65, P1, DOI 10.1128/MMBR.65.1.1-43.2001; WAGNER EGH, 1994, ANNU REV MICROBIOL, V48, P713, DOI 10.1146/annurev.mi.48.100194.003433; Wagner EGH, 2002, ADV GENET, V46, P361; Wassenaar TM, 2001, FEMS MICROBIOL LETT, V201, P1; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whittingham JL, 2014, ACTA CRYSTALLOGR D, V70, P2139, DOI 10.1107/S1399004714012632; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; ZALE SE, 1986, BIOCHEMISTRY-US, V25, P5432, DOI 10.1021/bi00367a014	58	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145765	10.1371/journal.pone.0145765	http://dx.doi.org/10.1371/journal.pone.0145765			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694028	Green Submitted, gold, Green Published			2022-12-26	WOS:000367092500074
J	Gaydos, JK; Thixton, S; Donatuto, J				Gaydos, Joseph K.; Thixton, Sofie; Donatuto, Jamie			Evaluating Threats in Multinational Marine Ecosystems: A Coast Salish First Nations and Tribal Perspective	PLOS ONE			English	Article							POLYCYCLIC AROMATIC-HYDROCARBONS; PRINCE-WILLIAM-SOUND; PETROLEUM-HYDROCARBONS; RISK-ASSESSMENT; OIL-SPILL; EMBRYOS; POPULATION; EXPOSURE; COLUMBIA; IMPACTS	Despite the merit of managing natural resources on the scale of ecosystems, evaluating threats and managing risk in ecosystems that span multiple countries or jurisdictions can be challenging. This requires each government involved to consider actions in concert with actions being taken in other countries by co-managing entities. Multiple proposed fossil fuel-related and port development projects in the Salish Sea, a 16,925 km(2) inland sea shared by Washington State (USA), British Columbia (Canada), and Indigenous Coast Salish governments, have the potential to increase marine vessel traffic and negatively impact natural resources. There is no legal mandate or management mechanism requiring a comprehensive review of the potential cumulative impacts of these development activities throughout the Salish Sea and across the international border. This project identifies ongoing and proposed energy-related development projects that will increase marine vessel traffic in the Salish Sea and evaluates the threats each project poses to natural resources important to the Coast Salish. While recognizing that Coast Salish traditions identify all species as important and connected, we used expert elicitation to identify 50 species upon which we could evaluate impact. These species were chosen because Coast Salish depend upon them heavily for harvest revenue or as a staple food source, they were particularly culturally or spiritually significant, or they were historically part of Coast Salish lifeways. We identified six development projects, each of which had three potential impacts (pressures) associated with increased marine vessel traffic: oil spill, vessel noise and vessel strike. Projects varied in their potential for localized impacts (pressures) including shoreline development, harbor oil spill, pipeline spill, coal dust accumulation and nearshore LNG explosion. Based on available published data, impact for each pressure/species interaction was rated as likely, possible or unlikely. Impacts are likely to occur in 23 to 28% of the possible pressure/species scenarios and are possible in another 15 to 28% additional pressure/species interactions. While it is not clear which impacts will be additive, synergistic, or potentially antagonistic, studies that manipulate multiple stressors in marine ecosystems suggest that threats associated with these six projects are likely to have an overall additive or even synergistic interaction and therefore impact species of major cultural importance to the Coast Salish, an important concept that would be lost by merely evaluating each project independently. Failure to address multiple impacts will affect the Coast Salish and the 7 million other people that also depend on this ecosystem. These findings show the value of evaluating multiple threats, and ultimately conducting risk assessments at the scale of ecosystems and highlight the serious need for managers of multinational ecosystems to actively collaborate on evaluating threats, assessing risk, and managing resources.	[Gaydos, Joseph K.; Thixton, Sofie] UC Davis Karen C Drayer Wildlife Hlth Ctr, Orcas Isl Off, SeaDoc Soc, Eastsound, WA 98245 USA; [Donatuto, Jamie] Swinomish Indian Tribal Community, La Conner, WA USA		Gaydos, JK (corresponding author), UC Davis Karen C Drayer Wildlife Hlth Ctr, Orcas Isl Off, SeaDoc Soc, Eastsound, WA 98245 USA.	jkgaydos@ucdavis.edu			U.S. EPA sub-award via the Northwest Indian Fish Commission (NWIFC) [EPA320-438(2)]; UC Davis School of Veterinary Medicine's Karen C. Drayer Wildlife Health Center	U.S. EPA sub-award via the Northwest Indian Fish Commission (NWIFC); UC Davis School of Veterinary Medicine's Karen C. Drayer Wildlife Health Center	This project was supported by funds from a U.S. EPA sub-award to the Swinomish Indian Tribal Community via the Northwest Indian Fish Commission (NWIFC EPA320-438(2)), with a sub award to the SeaDoc Society, a program of the UC Davis School of Veterinary Medicine's Karen C. Drayer Wildlife Health Center (www.seadocsociety.org). The U.S. EPA was not involved in any aspect of this study design, data collection or analysis, or writing of this manuscript. The SeaDoc Society and the Coast Salish Gathering (www.coastsalishgathering.com) also provided in-kind support.	Ahrens MJ, 2005, OCEANOGR MAR BIOL, V43, P69; ANTRIM LD, 1995, MAR BIOL, V122, P23, DOI 10.1007/BF00349274; Arquette M, 2002, ENVIRON HEALTH PERSP, V110, P259, DOI 10.1289/ehp.02110s2259; Ayres KL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036842; Bounds WJ, 2007, WATER AIR SOIL POLL, V185, P195, DOI 10.1007/s11270-007-9442-9; Bowman TD, 1997, J WILDLIFE MANAGE, V61, P962, DOI 10.2307/3802206; Buscaino G, 2010, MAR ENVIRON RES, V69, P136, DOI 10.1016/j.marenvres.2009.09.004; Buscher B., 2009, J INT WILDL LAW POLI, V12, P33, DOI [10.1080/13880290902938138, DOI 10.1080/13880290902938138]; Carls MG, 2010, MAR ENVIRON RES, V69, P318, DOI 10.1016/j.marenvres.2009.12.006; Carro N, 2005, ENV RES J, V100, P339; Carvalho FP, 1999, TRAC-TREND ANAL CHEM, V18, P656, DOI 10.1016/S0165-9936(99)00148-X; Chang SE, 2014, ECOL SOC, V19, DOI 10.5751/ES-06406-190226; Codarin A, 2009, MAR POLLUT BULL, V58, P1880, DOI 10.1016/j.marpolbul.2009.07.011; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Dean TA, 1998, MAR POLLUT BULL, V36, P201, DOI 10.1016/S0025-326X(97)00184-7; Donatuto JL, 2011, HEALTH RISK SOC, V13, P103, DOI 10.1080/13698575.2011.556186; Dunlop RA, 2010, P ROY SOC B-BIOL SCI, V277, P2521, DOI 10.1098/rspb.2009.2319; Etkin DS, 2014, WASHINGTON STATE DEP; Frittelli J, 2014, C RES SERVICE, P25; GARIBALDI A, 2004, ECOLOGY SOC, V9, pR2; Gaydos JK, 2014, P SAL SEA C SEATTL W; Gaydos Joseph K., 2011, Northwestern Naturalist, V92, P79; Gaydos JK, 2008, ECOHEALTH, V5, P460, DOI 10.1007/s10393-009-0209-1; Gregory R., 2012, STRUCTURED DECISION, DOI [DOI 10.1002/9781444398557, 10.1002/9781444398557]; Guzman HM, 2013, MAR MAMMAL SCI, V29, P629, DOI 10.1111/j.1748-7692.2012.00605.x; Harris SG, 1997, RISK ANAL, V17, P789, DOI 10.1111/j.1539-6924.1997.tb01284.x; Harris SG, 2000, ENVIRON SCI POLLUT R, P91; Henkel LA, 2014, MAR POLLUT BULL, V79, P155, DOI 10.1016/j.marpolbul.2013.12.023; Incardona JP, 2012, P NATL ACAD SCI USA, V109, pE51, DOI 10.1073/pnas.1108884109; Johnson R, 2006, INT J COAL GEOL, V68, P57, DOI 10.1016/j.coal.2005.10.003; Lackey RT, 1998, LANDSCAPE URBAN PLAN, V40, P21, DOI 10.1016/S0169-2046(97)00095-9; Lage-Yusty MA, 2009, B ENVIRON CONTAM TOX, V82, P158, DOI 10.1007/s00128-008-9503-9; Lee RF, 1997, MAR POLLUT BULL, V34, P928, DOI 10.1016/S0025-326X(97)00078-7; Maccarone AD, 2000, WATERBIRDS, V23, P246; Matkin CO, 2008, MAR ECOL PROG SER, V356, P269, DOI 10.3354/meps07273; Merrick, 2014, PREVENTING OIL SPILL; Morrow JE, 1974, EPA660373019, P37; Northwest Clean Air Agency, 2014, 1179 NOC NW CLEAN AI, V1179, P8; Northwest Indian Fisheries Commission, 2011, TREAT RIGHTS RISK ON, P35; Pacific International Terminals, 2012, GAT PAC TERM MAJ PRO, P312; Parihar A, 2011, SAFETY SCI, V49, P686, DOI 10.1016/j.ssci.2011.01.004; Pasquevich MY, 2013, COMP BIOCHEM PHYS C, V157, P390, DOI 10.1016/j.cbpc.2013.03.006; Pietsch T.W., 2015, NOAA PROFESSIONAL PA, DOI [10.7755/PP.18, DOI 10.7755/PZRP.18]; RailWorks Corporation, 2014, TES CRUD OIL UNL FAC; Ritter L, 2013, SNC LAVALIN INT REFE; Short FT, 1996, ENVIRON CONSERV, V23, P17, DOI 10.1017/S0376892900038212; Slabbekoorn H, 2010, TRENDS ECOL EVOL, V25, P419, DOI 10.1016/j.tree.2010.04.005; Tengberg A, 2013, MAR POLICY, V38, P355, DOI 10.1016/j.marpol.2012.06.013; Vancouver Port Metro, 2014, 2012072 EAP PORT MET, P35; Vancouver Port Metro, 2014, EAP 2012 072, P19; Vancouver Port Metro, 2013, ROB BANK TERM 2 PROJ, P105; Von Ziegesar Olga, 1994, P173; West JE, 2014, SCI TOTAL ENVIRON, V499, P114, DOI 10.1016/j.scitotenv.2014.08.042; Williams R, 2014, ANIM CONSERV, V17, P174, DOI 10.1111/acv.12076; Wolfley J, 1998, AM INDIAN CULT RES J, V22, P151, DOI 10.17953/aicr.22.2.gn5w81421k243111; Woodfibre LNG Limited, 2014, UPD PROJ DESCR, P34; Yanagida GK, 2012, ARCH ENVIRON CON TOX, V62, P282, DOI 10.1007/s00244-011-9704-9; Zimmerman JR, 2004, ENVIRON SCI TECHNOL, V38, P5458, DOI 10.1021/es034992v	59	9	9	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144861	10.1371/journal.pone.0144861	http://dx.doi.org/10.1371/journal.pone.0144861			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SF	26691860	Green Submitted, Green Published, gold			2022-12-26	WOS:000367092300023
J	Just, PA; Poncy, A; Charawi, S; Dahmani, R; Traore, M; Dumontet, T; Drouet, V; Dumont, F; Gilgenkrantz, H; Colnot, S; Terris, B; Coulouarn, C; Lemaigre, F; Perret, C				Just, Pierre-Alexandre; Poncy, Alexis; Charawi, Sara; Dahmani, Rajae; Traore, Massire; Dumontet, Typhanie; Drouet, Valerie; Dumont, Florent; Gilgenkrantz, Helene; Colnot, Sabine; Terris, Benoit; Coulouarn, Cedric; Lemaigre, Frederic; Perret, Christine			LKB1 and Notch Pathways Interact and Control Biliary Morphogenesis	PLOS ONE			English	Article							INTRAHEPATIC BILE-DUCTS; ALAGILLE-SYNDROME; LIVER DEVELOPMENT; SIGNALING PATHWAYS; HUMAN JAGGED1; MICE; ACTIVATION; KINASE; GENE; DIFFERENTIATION	Background LKB1 is an evolutionary conserved kinase implicated in a wide range of cellular functions including inhibition of cell proliferation, regulation of cell polarity and metabolism. When Lkb1 is inactivated in the liver, glucose homeostasis is perturbed, cellular polarity is affected and cholestasis develops. Cholestasis occurs as a result from deficient bile duct development, yet how LKB1 impacts on biliary morphogenesis is unknown. Methodology/Principal Findings We characterized the phenotype of mice in which deletion of the Lkb1 gene has been specifically targeted to the hepatoblasts. Our results confirmed that lack of LKB1 in the liver results in bile duct paucity leading to cholestasis. Immunostaining analysis at a prenatal stage showed that LKB1 is not required for differentiation of hepatoblasts to cholangiocyte precursors but promotes maturation of the primitive ductal structures to mature bile ducts. This phenotype is similar to that obtained upon inactivation of Notch signaling in the liver. We tested the hypothesis of a functional overlap between the LKB1 and Notch pathways by gene expression profiling of livers deficient in Lkb1 or in the Notch mediator RbpJ. and identified a mutual cross-talk between LKB1 and Notch signaling. In vitro experiments confirmed that Notch activity was deficient upon LKB1 loss. Conclusion LKB1 and Notch share a common genetic program in the liver, and regulate bile duct morphogenesis.	[Just, Pierre-Alexandre; Charawi, Sara; Dahmani, Rajae; Traore, Massire; Dumontet, Typhanie; Drouet, Valerie; Dumont, Florent; Gilgenkrantz, Helene; Colnot, Sabine; Terris, Benoit; Perret, Christine] INSERM, Inst Cochin, U1016, F-75014 Paris, France; [Just, Pierre-Alexandre; Charawi, Sara; Dahmani, Rajae; Traore, Massire; Dumontet, Typhanie; Drouet, Valerie; Dumont, Florent; Gilgenkrantz, Helene; Colnot, Sabine; Terris, Benoit; Perret, Christine] CNRS, UMR8104, F-75014 Paris, France; [Just, Pierre-Alexandre; Charawi, Sara; Dahmani, Rajae; Traore, Massire; Dumontet, Typhanie; Drouet, Valerie; Dumont, Florent; Gilgenkrantz, Helene; Colnot, Sabine; Terris, Benoit; Perret, Christine] Univ Paris 05, F-75014 Paris, France; [Just, Pierre-Alexandre; Charawi, Sara; Dahmani, Rajae; Traore, Massire; Dumontet, Typhanie; Drouet, Valerie; Gilgenkrantz, Helene; Colnot, Sabine; Terris, Benoit; Perret, Christine] Equipe Labellisee LNCC Paris, Paris, France; [Just, Pierre-Alexandre; Terris, Benoit] Hop Cochin, AP HP, Hop Univ Paris Ctr, Dept Pathol, F-75014 Paris, France; [Poncy, Alexis; Lemaigre, Frederic] de Duve Inst, B-1200 Brussels, Belgium; [Poncy, Alexis; Lemaigre, Frederic] Catholic Univ Louvain, B-1200 Brussels, Belgium; [Coulouarn, Cedric] Univ Rennes 1, INSERM, UMR991, F-35033 Rennes, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Universite Catholique Louvain; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes	Perret, C (corresponding author), INSERM, Inst Cochin, U1016, F-75014 Paris, France.	christine.perret@inserm.fr	Perret-Mayeux, Christine/L-3297-2017; JUST, Pierre-Alexandre/P-1972-2017; Gilgenkrantz, Helene/G-5534-2017; Coulouarn, Cedric/E-5472-2011; Terris, Benoit/P-1497-2017; Colnot, Sabine/A-9169-2008	Coulouarn, Cedric/0000-0002-5692-9586; Colnot, Sabine/0000-0002-3949-9107; perret, christine/0000-0003-4710-7051; gilgenkrantz, helene/0000-0001-6770-4561	INSERM; CNRS; Ligue Nationale Contre le Cancer LNCC (France) "Equipe labelisee Ligue Nationale Contre le Cancer"; INCA; ANR; LABEX Who am I? grants; Poste d'accueil AP-HP-CNRS/CEA; Interuniversity Attraction Pole Programme (Belgian Science Policy (BELSPO)) [PVII-47]; D.G. Higher Education and Scientific Research of the French Community of Belgium [10/15-029]; Alphonse and Jean Forton Fund [2011-R10150-004]; Fonds de la Recherche Scientifique Medicale [3.4536.10F]	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Ligue Nationale Contre le Cancer LNCC (France) "Equipe labelisee Ligue Nationale Contre le Cancer"; INCA(Institut National du Cancer (INCA) France); ANR(French National Research Agency (ANR)); LABEX Who am I? grants; Poste d'accueil AP-HP-CNRS/CEA; Interuniversity Attraction Pole Programme (Belgian Science Policy (BELSPO)); D.G. Higher Education and Scientific Research of the French Community of Belgium; Alphonse and Jean Forton Fund; Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS)	Core fundings came from INSERM, CNRS, grants from Ligue Nationale Contre le Cancer LNCC (France) "Equipe labelisee Ligue Nationale Contre le Cancer" (CP), INCA, ANR and LABEX Who am I? grants (CP). PAJ was a recipient of Poste d'accueil AP-HP-CNRS/CEA. This work was also supported by the Interuniversity Attraction Pole Programme (Belgian Science Policy (BELSPO), grant PVII-47; http://www.belspo.be/) (FL), the D.G. Higher Education and Scientific Research of the French Community of Belgium (grant 10/15-029) (FL), the Alphonse and Jean Forton Fund (grant 2011-R10150-004; http://www.kbs.frb.be/fund.aspxid=293586&langtype=2060) (FL), and the Fonds de la Recherche Scientifique Medicale (grant 3.4536.10F; http://www.fnrs.be/) (FL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Antoniou A, 2009, GASTROENTEROLOGY, V136, P2325, DOI 10.1053/j.gastro.2009.02.051; Baas AF, 2004, CELL, V116, P457, DOI 10.1016/S0092-8674(04)00114-X; Bardeesy N, 2002, NATURE, V419, P162, DOI 10.1038/nature01045; Carpentier R, 2011, GASTROENTEROLOGY, V141, P1432, DOI 10.1053/j.gastro.2011.06.049; Clotman F, 2002, DEVELOPMENT, V129, P1819; Coffinier C, 2002, DEVELOPMENT, V129, P1829; Coulouarn C, 2006, HEPATOLOGY, V44, P1003, DOI 10.1002/hep.21293; Coulouarn C, 2012, CARCINOGENESIS, V33, P1791, DOI 10.1093/carcin/bgs208; Emerick KM, 1999, HEPATOLOGY, V29, P822, DOI 10.1002/hep.510290331; Fu D, 2010, J CELL SCI, V123, P3294, DOI 10.1242/jcs.068098; Geisler F, 2008, HEPATOLOGY, V48, P607, DOI 10.1002/hep.22381; Geisler F, 2015, HEPATOLOGY, V61, P382, DOI 10.1002/hep.27268; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hofmann JJ, 2010, DEVELOPMENT, V137, P4061, DOI 10.1242/dev.052118; Jansen M, 2009, PHYSIOL REV, V89, P777, DOI 10.1152/physrev.00026.2008; Jungermann K, 1996, ANNU REV NUTR, V16, P179, DOI 10.1146/annurev.nu.16.070196.001143; Kellendonk C, 2000, GENESIS, V26, P151, DOI 10.1002/(SICI)1526-968X(200002)26:2<151::AID-GENE17>3.0.CO;2-E; KNUTH A, 1985, J HEPATOL, V1, P579, DOI 10.1016/S0168-8278(85)80002-7; Kodama Y, 2004, GASTROENTEROLOGY, V127, P1775, DOI 10.1053/j.gastro.2004.09.004; Lahmar M, 2008, STEM CELLS, V26, P621, DOI 10.1634/stemcells.2007-0428; Lemaigre F, 2004, CURR OPIN GENET DEV, V14, P582, DOI 10.1016/j.gde.2004.08.004; Li LH, 1997, NAT GENET, V16, P243, DOI 10.1038/ng0797-243; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lo B, 2012, J CELL BIOL, V199, P1117, DOI 10.1083/jcb.201208080; Loomes KM, 2007, HEPATOLOGY, V45, P323, DOI 10.1002/hep.21460; Lozier J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001851; McCright B, 2002, DEVELOPMENT, V129, P1075; McDaniell R, 2006, AM J HUM GENET, V79, P169, DOI 10.1086/505332; Mirouse V, 2011, FEBS LETT, V585, P981, DOI 10.1016/j.febslet.2010.12.025; Noah TK, 2013, ANNU REV PHYSIOL, V75, P263, DOI 10.1146/annurev-physiol-030212-183741; Oda T, 1997, NAT GENET, V16, P235, DOI 10.1038/ng0797-235; Pajvani UB, 2013, NAT MED, V19, P1055, DOI 10.1038/nm.3259; Pajvani UB, 2011, NAT MED, V17, P961, DOI 10.1038/nm.2378; Patel K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5535; Raynaud P, 2011, HEPATOLOGY, V53, P1959, DOI 10.1002/hep.24292; Raynaud P, 2011, INT J BIOCHEM CELL B, V43, P245, DOI 10.1016/j.biocel.2009.07.020; Sakamoto K, 2006, AM J PHYSIOL-ENDOC M, V290, pE780, DOI 10.1152/ajpendo.00443.2005; Sebbagh M, 2009, CURR BIOL, V19, P37, DOI 10.1016/j.cub.2008.11.033; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shorning BY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004264; Sparks EE, 2010, HEPATOLOGY, V51, P1391, DOI 10.1002/hep.23431; Takashima Y, 2015, HEPATOLOGY, V61, P1003, DOI 10.1002/hep.27436; Woods A, 2011, BIOCHEM J, V434, P49, DOI 10.1042/BJ20101721; Xiao SY, 2001, AM J PATHOL, V159, P1415, DOI 10.1016/S0002-9440(10)62528-X; Zong YW, 2009, DEVELOPMENT, V136, P1727, DOI 10.1242/dev.029140	47	13	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145400	10.1371/journal.pone.0145400	http://dx.doi.org/10.1371/journal.pone.0145400			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689699	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092300070
J	McCabe, KL; Kunzevitzky, NJ; Chiswell, BP; Xia, X; Goldberg, JL; Lanza, R				McCabe, Kathryn L.; Kunzevitzky, Noelia J.; Chiswell, Brian P.; Xia, Xin; Goldberg, Jeffrey L.; Lanza, Robert			Efficient Generation of Human Embryonic Stem Cell-Derived Corneal Endothelial Cells by Directed Differentiation	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; IN-VITRO; SURFACE MARKERS; GENE-EXPRESSION; OCULAR SURFACE; NEURAL CREST; TRANSPLANTATION; FATE; PLURIPOTENT; PHENOTYPE	Aim To generate human embryonic stem cell derived corneal endothelial cells (hESC-CECs) for transplantation in patients with corneal endothelial dystrophies. Materials and Methods Feeder-free hESC-CECs were generated by a directed differentiation protocol. hESC-CECs were characterized by morphology, expression of corneal endothelial markers, and microarray analysis of gene expression. Results hESC-CECs were nearly identical morphologically to primary human corneal endothelial cells, expressed Zona Occludens 1 (ZO-1) and Na+/K+ ATPase alpha 1 (ATPA1) on the apical surface in monolayer culture, and produced the key proteins of Descemet's membrane, Collagen VIII alpha 1 and VIII alpha 2 (COL8A1 and 8A2). Quantitative PCR analysis revealed expression of all corneal endothelial pump transcripts. hESC-CECs were 96% similar to primary human adult CECs by microarray analysis. Conclusion hESC-CECs are morphologically similar, express corneal endothelial cell markers and express a nearly identical complement of genes compared to human adult corneal endothelial cells. hESC-CECs may be a suitable alternative to donor-derived corneal endothelium.	[McCabe, Kathryn L.; Chiswell, Brian P.; Lanza, Robert] Ocata Therapeut, Marlborough, MA 01752 USA; [Kunzevitzky, Noelia J.; Goldberg, Jeffrey L.] Univ Miami, Sch Med, Bascom Palmer Eye Inst, Miami, FL 33136 USA; [Kunzevitzky, Noelia J.] Emmecell, Key Biscayne, FL 33149 USA; [Kunzevitzky, Noelia J.; Xia, Xin; Goldberg, Jeffrey L.] Univ Calif San Diego, Shiley Eye Inst, La Jolla, CA 92093 USA; [Goldberg, Jeffrey L.] Stanford Univ, Sch Med, Byers Eye Inst, Palo Alto, CA 94303 USA	Bascom Palmer Eye Institute; University of Miami; University of California System; University of California San Diego; Stanford University	Lanza, R (corresponding author), Ocata Therapeut, Marlborough, MA 01752 USA.	rlanza@ocata.com		Kunzevitzky, Noelia/0000-0002-8993-6520; Goldberg, Jeffrey/0000-0002-1390-7360; Lanza, Robert/0000-0002-3047-3074	Ocata Therapeutics	Ocata Therapeutics	The study was funded by Ocata Therapeutics and associated collaborators (listed as authors). All had a role in the above. The funders had a role in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Bartakova Alena, 2014, Curr Ophthalmol Rep, V2, P81; Busin M, 2014, CURR OPIN OPHTHALMOL, V25, P312, DOI 10.1097/ICU.0000000000000071; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Cheong YK, 2013, INVEST OPHTH VIS SCI, V54, P4538, DOI 10.1167/iovs.13-11754; Chng ZZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067546; Chung Y, 2008, CELL STEM CELL, V2, P113, DOI 10.1016/j.stem.2007.12.013; CONSIGLI SA, 1993, INVEST OPHTH VIS SCI, V34, P559; Doane KJ, 1998, INVEST OPHTH VIS SCI, V39, P263; Du ZW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7626; Feizi S, 2014, EXP EYE RES, V122, P132, DOI 10.1016/j.exer.2014.04.002; Figueira EC, 2007, INVEST OPHTH VIS SCI, V48, P144, DOI 10.1167/iovs.06-0346; Gage PJ, 2005, INVEST OPHTH VIS SCI, V46, P4200, DOI 10.1167/iovs.05-0691; GOSPODAROWICZ D, 1979, P NATL ACAD SCI USA, V76, P464, DOI 10.1073/pnas.76.1.464; Gottsch JD, 2003, ARCH OPHTHALMOL-CHIC, V121, P252; Greenhill NS, 2000, MATRIX BIOL, V19, P19, DOI 10.1016/S0945-053X(99)00053-0; Grossniklaus HE, 2012, INVESTIG OPHTHALMOL, V54; GrushkinLerner LS, 1997, EXP EYE RES, V64, P323, DOI 10.1006/exer.1996.0207; Hamann S, 1998, AM J PHYSIOL-CELL PH, V274, pC1332, DOI 10.1152/ajpcell.1998.274.5.C1332; Hara S, 2014, STEM CELLS DEV, V23, P2190, DOI 10.1089/scd.2013.0387; Hirata-Tominaga K, 2013, STEM CELLS, V31, P1396, DOI 10.1002/stem.1390; Huang L, 2010, INVEST OPHTH VIS SCI, V51, P3943, DOI 10.1167/iovs.09-4970; Inagaki E, 2013, INVEST OPHTH VIS SCI, V54, P7258, DOI 10.1167/iovs.13-12022; JUMBLATT MM, 1978, INVEST OPHTH VIS SCI, V17, P1135; Kim E, 2014, INVEST OPHTH VIS SCI, V55, P5099, DOI 10.1167/iovs.14-14564; Klimanskaya I, 2007, NAT PROTOC, V2, P1963, DOI 10.1038/nprot.2007.274; Koizumi N, 2008, CORNEA, V27, pS48, DOI 10.1097/ICO.0b013e31817f2298; Larsson P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031573; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ljubimov AV, 1996, INVEST OPHTH VIS SCI, V37, P997; LOVICU FJ, 1993, INVEST OPHTH VIS SCI, V34, P3355; Lwigale PY, 2009, DEV BIOL, V336, P257, DOI 10.1016/j.ydbio.2009.10.008; Masur SK, 1999, INVEST OPHTH VIS SCI, V40, P904; McCabe KL, 2014, PRINCIPLES OF TISSUE ENGINEERING, 4TH EDITION, P1413, DOI 10.1016/B978-0-12-398358-9.00067-7; Mohan R, 1995, CURR EYE RES, V14, P1135, DOI 10.3109/02713689508995820; Moysidis SN, 2015, NANOMED-NANOTECHNOL, V11, P499, DOI 10.1016/j.nano.2014.12.002; Mukhopadhyay M, 2006, DEVELOPMENT, V133, P2149, DOI 10.1242/dev.02381; Nakahara M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069009; Narsinh KH, 2011, MOL THER, V19, P635, DOI 10.1038/mt.2011.41; Neumann LC, 2012, HUM MOL GENET, V21, P4038, DOI 10.1093/hmg/dds228; Nguyen TT, 2012, INVEST OPHTH VIS SCI, V53, P2020, DOI 10.1167/iovs.12-9475; Numata R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088169; Okumura N, 2014, INVEST OPHTH VIS SCI, V55, P7610, DOI 10.1167/iovs.14-14980; Okumura N, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0058000, 10.1371/journal.pone.0075961]; Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634; Peh GSL, 2011, TRANSPLANTATION, V91, P811, DOI 10.1097/TP.0b013e3182111f01; Piao JH, 2015, CELL STEM CELL, V16, P198, DOI 10.1016/j.stem.2015.01.004; Qin P, 1997, DEV DYNAM, V209, P367, DOI 10.1002/(SICI)1097-0177(199708)209:4<367::AID-AJA4>3.0.CO;2-G; Reh TA, 2010, METHODS MOL BIOL, V636, P139, DOI 10.1007/978-1-60761-691-7_9; Russ HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025566; Schwartz SD, 2015, LANCET, V385, P509, DOI 10.1016/S0140-6736(14)61376-3; Schwartz SD, 2012, LANCET, V379, P713, DOI 10.1016/S0140-6736(12)60028-2; Sha XY, 2013, EXP EYE RES, V116, P36, DOI 10.1016/j.exer.2013.08.008; Simoes-Costa M, 2013, GENOME RES, V23, P1069, DOI 10.1101/gr.157586.113; Song WK, 2015, STEM CELL REPORTS, P4; SPEEDWELL L, 1988, ARCH OPHTHALMOL-CHIC, V106, P771; Stephan S, 2004, J BIOL CHEM, V279, P21469, DOI 10.1074/jbc.M305805200; Sugino IK, 2011, INVEST OPHTH VIS SCI, V52, P1345, DOI 10.1167/iovs.10-6112; Sun TT, 2004, J INVEST DERM SYMP P, V9, P202, DOI 10.1111/j.1087-0024.2004.09311.x; Sun XC, 2001, CURR EYE RES, V22, P1; Sun XC, 2008, INVEST OPHTH VIS SCI, V49, P1048, DOI 10.1167/iovs.07-1188; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Umeda K, 2015, STEM CELL REP, V4, P712, DOI 10.1016/j.stemcr.2015.02.012; Unger RE, 2002, MICROVASC RES, V64, P384, DOI 10.1006/mvre.2002.2434; Wallace DF, 2010, AM J PHYSIOL-CELL PH, V298, pC75, DOI 10.1152/ajpcell.00621.2008; Woodward MA, 2013, CORNEA, V32, P737, DOI 10.1097/ICO.0b013e3182685cb2; World Health Organization, 2010, GLOB DAT VIS IMP 201; Yoshihara M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117581; Zhang K, 2014, STEM CELLS DEV, V23, P1340, DOI 10.1089/scd.2013.0510; Zhu C, 2004, INVEST OPHTH VIS SCI, V45, P1743, DOI 10.1167/iovs.03-0814; Zhu YT, 2008, INVEST OPHTH VIS SCI, V49, P3879, DOI 10.1167/iovs.08-1693; Zhu YT, 2014, J CELL BIOL, V206, P799, DOI 10.1083/jcb.201404032; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	72	56	60	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145266	10.1371/journal.pone.0145266	http://dx.doi.org/10.1371/journal.pone.0145266			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689688	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092300050
J	Wiberg, R; Jonsson, S; Novikova, LN; Kingham, PJ				Wiberg, Rebecca; Jonsson, Samuel; Novikova, Liudmila N.; Kingham, Paul J.			Investigation of the Expression of Myogenic Transcription Factors, microRNAs and Muscle-Specific E3 Ubiquitin Ligases in the Medial Gastrocnemius and Soleus Muscles following Peripheral Nerve Injury	PLOS ONE			English	Article							POOR FUNCTIONAL RECOVERY; CHAIN ISOFORM EXPRESSION; ADULT SKELETAL-MUSCLE; SWI/SNF ATPASE BRG1; CONTRIBUTING FACTORS; GENE-EXPRESSION; SATELLITE CELLS; MESSENGER-RNA; MYOD FAMILY; DIFFERENTIATION	Despite surgical innovation, the sensory and motor outcome after a peripheral nerve injury remains incomplete. One contributing factor to the poor outcome is prolonged denervation of the target organ, leading to apoptosis of both mature myofibres and satellite cells with subsequent replacement of the muscle tissue with fibrotic scar and adipose tissue. In this study, we investigated the expression of myogenic transcription factors, muscle specific microRNAs and muscle-specific E3 ubiquitin ligases at several time points following denervation in two different muscles, the gastrocnemius (containing predominantly fast type fibres) and soleus (slow type) muscles, since these molecules may influence the degree of atrophy following denervation. Both muscles exhibited significant atrophy (compared with the contra-lateral sides) at 7 days following either a nerve transection or crush injury. In the crush model, the soleus muscle showed significantly increased muscle weights at days 14 and 28 which was not the case for the gastrocnemius muscle which continued to atrophy. There was a significantly more pronounced up-regulation of MyoD expression in the denervated soleus muscle compared with the gastrocnemius muscle. Conversely, myogenin was more markedly elevated in the gastrocnemius versus soleus muscles. The muscles also showed significantly contrasting transcriptional regulation of the microRNAs miR-1 and miR-206. MuRF1 and Atrogin-1 showed the highest levels of expression in the denervated gastrocnemius muscle. This study provides further insights regarding the intracellular regulatory molecules that generate and maintain distinct patterns of gene expression in different fibre types following peripheral nerve injury.	[Wiberg, Rebecca; Jonsson, Samuel; Novikova, Liudmila N.; Kingham, Paul J.] Umea Univ, Dept Integrat Med Biol, Sect Anat, Umea, Sweden; [Wiberg, Rebecca; Jonsson, Samuel] Umea Univ, Dept Surg & Perioperat Sci, Sect Hand & Plast Surg, Umea, Sweden	Umea University; Umea University	Kingham, PJ (corresponding author), Umea Univ, Dept Integrat Med Biol, Sect Anat, Umea, Sweden.	paul.kingham@umu.se		Kingham, Paul/0000-0003-2596-5936	Swedish Research Council; Umea University/Insamlingsstiftelsen	Swedish Research Council(Swedish Research CouncilEuropean Commission); Umea University/Insamlingsstiftelsen	Funding was from the Swedish Research Council (LN) and Umea University/Insamlingsstiftelsen (LN, PK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARANY M, 1967, J GEN PHYSIOL, V50, P197, DOI 10.1085/jgp.50.6.197; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bergstrom DA, 2001, MOL CELL BIOL, V21, P2404, DOI 10.1128/MCB.21.7.2404-2412.2001; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Borisov AB, 2005, ANAT EMBRYOL, V209, P269, DOI 10.1007/s00429-004-0429-7; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; BUONANNO A, 1992, NUCLEIC ACIDS RES, V20, P539, DOI 10.1093/nar/20.3.539; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Chen DH, 2010, ACTA OTO-LARYNGOL, V130, P1411, DOI 10.3109/00016489.2010.496464; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cohen TJ, 2007, J BIOL CHEM, V282, P33752, DOI 10.1074/jbc.M706268200; Davie JK, 2007, DEV BIOL, V311, P650, DOI 10.1016/j.ydbio.2007.08.014; Egawa T, 2014, AM J PHYSIOL-ENDOC M, V306, pE344, DOI 10.1152/ajpendo.00495.2013; Ekmark M, 2007, J PHYSIOL-LONDON, V584, P637, DOI 10.1113/jphysiol.2007.141457; FU SY, 1995, J NEUROSCI, V15, P3876; FU SY, 1995, J NEUROSCI, V15, P3886; HUGHES SM, 1993, DEVELOPMENT, V118, P1137; Jeng SF, 2009, J NEUROTRAUM, V26, P2345, DOI 10.1089/neu.2009.0960; Jonsson S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056484; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Krawiec BJ, 2007, AM J PHYSIOL-ENDOC M, V292, pE1555, DOI 10.1152/ajpendo.00622.2006; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Krichevsky Anna M, 2007, ScientificWorldJournal, V7, P155; Kukreti H, 2013, J BIOL CHEM, V288, P6663, DOI 10.1074/jbc.M112.390369; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Maves L, 2007, DEVELOPMENT, V134, P3371, DOI 10.1242/dev.003905; Megeney LA, 1995, BIOCHEM CELL BIOL, V73, P723, DOI 10.1139/o95-080; MERLIE JP, 1994, J BIOL CHEM, V269, P2461; Moresi V, 2010, CELL, V143, P35, DOI 10.1016/j.cell.2010.09.004; Nystrom GJ, 2008, INT J CLIN EXP MED, V1, P50; Obernosterer G, 2006, RNA, V12, P1161, DOI 10.1261/rna.2322506; Ohkawa Y, 2006, EMBO J, V25, P490, DOI 10.1038/sj.emboj.7600943; Ohkawa Y, 2007, J BIOL CHEM, V282, P6564, DOI 10.1074/jbc.M608898200; Park KHJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3906; Perry RLS, 2000, FRONT BIOSCI, V5, pD750, DOI 10.2741/Perry; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; SCHIAFFINO S, 1989, J MUSCLE RES CELL M, V10, P197, DOI 10.1007/BF01739810; Senf SM, 2010, AM J PHYSIOL-CELL PH, V298, pC38, DOI 10.1152/ajpcell.00315.2009; Soares RJ, 2014, J BIOL CHEM, V289, P21909, DOI 10.1074/jbc.M114.561845; SUGIURA T, 1993, INT J BIOCHEM, V25, P1609, DOI 10.1016/0020-711X(93)90519-K; Talmadge RJ, 2000, MUSCLE NERVE, V23, P661, DOI 10.1002/(SICI)1097-4598(200005)23:5<661::AID-MUS3>3.0.CO;2-J; Tang HB, 2006, P NATL ACAD SCI USA, V103, P16977, DOI 10.1073/pnas.0601565103; Tawa NE, 1997, J CLIN INVEST, V100, P197, DOI 10.1172/JCI119513; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046	48	15	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0142699	10.1371/journal.pone.0142699	http://dx.doi.org/10.1371/journal.pone.0142699			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691660	gold, Green Submitted, Green Published			2022-12-26	WOS:000367092300002
J	Yang, ZH; Augustin, J; Hu, J; Jiang, H				Yang, Zhenhua; Augustin, Jonathan; Hu, Jing; Jiang, Hao			Physical Interactions and Functional Coordination between the Core Subunits of Set1/MII Complexes and the Reprogramming Factors	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HUMAN SOMATIC-CELLS; C-MYC; BINDING PROTEIN; METHYLTRANSFERASE ACTIVITY; HUMAN FIBROBLASTS; H3K4 METHYLATION; OPEN CHROMATIN; SELF-RENEWAL; HISTONE H3	Differentiated cells can be reprogrammed to the pluripotent state by overexpression of defined factors, and this process is profoundly influenced by epigenetic mechanisms including dynamic histone modifications. Changes in H3K4 methylation have been shown to be the predominant activating response in the early stage of cellular reprogramming. Mechanisms underlying such epigenetic priming, however, are not well understood. Here we show that the expression of the reprogramming factors (Yamanaka factors, Oct4, Sox2, Klf4 and Myc), especially Myc, directly promotes the expression of certain core subunits of the Set1/MII family of H3K4 methyltransferase complexes. A dynamic recruitment of the Set1/MII complexes largely, though not sufficiently in its own, explains the dynamics of the H3K4 methylation during cellular reprogramming. We then demonstrate that the core subunits of the Set1/MII complexes physically interact with mainly Sox2 and Myc among the Yamanaka factors. We further show that Sox2 directly binds the Ash2l subunit in the Set1/MII complexes and this binding is mediated by the HMG domain of Sox2. Functionally, we show that the Set1/MII complex core subunits are required for efficient cellular reprogramming. We also show that Dpy30, one of the core subunits in the complexes, is required for the efficient target binding of the reprogramming factors. Interestingly, such requirement is not necessarily dependent on locus-specific H3K4 methylation. Our work provides a better understanding of how the reprogramming factors physically interact and functionally coordinate with a key group of epigenetic modulators to mediate transitions of the chromatin state involved in cellular reprogramming.	[Jiang, Hao] Univ Alabama Birmingham, Med Sch Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; Univ Alabama Birmingham, Med Sch Birmingham, UAB Stem Cell Inst, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Jiang, H (corresponding author), Univ Alabama Birmingham, Med Sch Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA.	haojiang@uab.edu		Augustin, Jonathan/0000-0002-3302-4426	University of Alabama at Birmingham Start-up fund	University of Alabama at Birmingham Start-up fund	This work was supported by the University of Alabama at Birmingham Start-up fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Ang YS, 2011, CELL, V145, P183, DOI 10.1016/j.cell.2011.03.003; Barrero MJ, 2010, CELL STEM CELL, V7, P565, DOI 10.1016/j.stem.2010.10.009; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Bledau AS, 2014, DEVELOPMENT, V141, P1022, DOI 10.1242/dev.098152; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cai Y, 2010, J BIOL CHEM, V285, P4268, DOI 10.1074/jbc.C109.087981; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Demers C, 2007, MOL CELL, V27, P573, DOI 10.1016/j.molcel.2007.06.022; Doege CA, 2012, NATURE, V488, P652, DOI 10.1038/nature11333; Dou YL, 2006, NAT STRUCT MOL BIOL, V13, P713, DOI 10.1038/nsmb1128; Dou YL, 2005, CELL, V121, P873, DOI 10.1016/j.cell.2005.04.031; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Hussein SMI, 2014, NATURE, V516, P198, DOI 10.1038/nature14046; Jiang H, 2011, CELL, V144, P513, DOI 10.1016/j.cell.2011.01.020; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Koche RP, 2011, CELL STEM CELL, V8, P96, DOI 10.1016/j.stem.2010.12.001; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Li XZ, 2009, MOL CELL, V36, P290, DOI 10.1016/j.molcel.2009.07.031; Lin CY, 2012, CELL, V151, P56, DOI 10.1016/j.cell.2012.08.026; Lin CH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007839; Mansour AA, 2012, NATURE, V488, P409, DOI 10.1038/nature11272; Menssen A, 2002, P NATL ACAD SCI USA, V99, P6274, DOI 10.1073/pnas.082005599; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nie ZQ, 2012, CELL, V151, P68, DOI 10.1016/j.cell.2012.08.033; Pajic A, 2000, INT J CANCER, V87, P787, DOI 10.1002/1097-0215(20000915)87:6<787::AID-IJC4>3.0.CO;2-6; Papp B, 2013, CELL, V152, P1324, DOI 10.1016/j.cell.2013.02.043; Plath K, 2011, NAT REV GENET, V12, P253, DOI 10.1038/nrg2955; Polo JM, 2012, CELL, V151, P1617, DOI 10.1016/j.cell.2012.11.039; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sabo A, 2014, NATURE, V511, P488, DOI 10.1038/nature13537; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Sindhu C, 2012, J BIOL CHEM, V287, P30922, DOI 10.1074/jbc.R111.319046; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Smith E, 2010, MOL CELL, V40, P689, DOI 10.1016/j.molcel.2010.11.031; Soufi A, 2012, CELL, V151, P994, DOI 10.1016/j.cell.2012.09.045; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Suganuma T, 2008, NAT STRUCT MOL BIOL, V15, P364, DOI 10.1038/nsmb.1397; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JP, 2010, NATURE, V464, P1082, DOI 10.1038/nature08924; Ullius A, 2014, NUCLEIC ACIDS RES, V42, P6901, DOI 10.1093/nar/gku312; Walz S, 2014, NATURE, V511, P483, DOI 10.1038/nature13473; Wan M, 2013, J BIOL CHEM, V288, P5039, DOI 10.1074/jbc.M112.424515; Wang YL, 2008, J BIOL CHEM, V283, P33808, DOI 10.1074/jbc.M806936200; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Xu YY, 2013, J BIOL CHEM, V288, P9767, DOI 10.1074/jbc.M112.403881; Yang ZH, 2014, BLOOD, V124, P2025, DOI 10.1182/blood-2014-01-549220; Zhang Z, 2011, STEM CELLS, V29, P229, DOI 10.1002/stem.578; Zhao W, 2013, CELL, V152, P1037, DOI 10.1016/j.cell.2013.02.006; Zuryn S, 2014, SCIENCE, V345, P826, DOI 10.1126/science.1255885	63	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145336	10.1371/journal.pone.0145336	http://dx.doi.org/10.1371/journal.pone.0145336			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691508	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092300060
J	Youkee, D; Brown, CS; Lilburn, P; Shetty, N; Brooks, T; Simpson, A; Bentley, N; Lado, M; Kamara, TB; Walker, NF; Johnson, O				Youkee, Daniel; Brown, Colin S.; Lilburn, Paul; Shetty, Nandini; Brooks, Tim; Simpson, Andrew; Bentley, Neil; Lado, Marta; Kamara, Thaim B.; Walker, Naomi F.; Johnson, Oliver			Assessment of Environmental Contamination and Environmental Decontamination Practices within an Ebola Holding Unit, Freetown, Sierra Leone	PLOS ONE			English	Article							TRANSMISSION; FILOVIRUSES; FLUIDS; FEVER; RISK	Evidence to inform decontamination practices at Ebola holding units (EHUs) and treatment centres is lacking. We conducted an audit of decontamination procedures inside Connaught Hospital EHU in Freetown, Sierra Leone, by assessing environmental swab specimens for evidence of contamination with Ebola virus by RT-PCR. Swabs were collected following discharge of Ebola Virus Disease (EVD) patients before and after routine decontamination. Prior to decontamination, Ebola virus RNA was detected within a limited area at all bedside sites tested, but not at any sites distant to the bedside. Following decontamination, few areas contained detectable Ebola virus RNA. In areas beneath the bed there was evidence of transfer of Ebola virus material during cleaning. Retraining of cleaning staff reduced evidence of environmental contamination after decontamination. Current decontamination procedures appear to be effective in eradicating persistence of viral RNA. This study supports the use of viral swabs to assess Ebola viral contamination within the clinical setting. We recommend that regular refresher training of cleaning staff and audit of environmental contamination become standard practice at all Ebola care facilities during EVD outbreaks.	[Youkee, Daniel; Brown, Colin S.; Lilburn, Paul; Lado, Marta; Walker, Naomi F.; Johnson, Oliver] Kings Coll London, Kings Ctr Global Hlth, Kings Sierra Leone Partnership, London WC2R 2LS, England; [Youkee, Daniel; Brown, Colin S.; Lilburn, Paul; Lado, Marta; Walker, Naomi F.; Johnson, Oliver] Kings Hlth Partners, London, England; [Brown, Colin S.] UCL, Hosp Trop Dis, London, England; [Shetty, Nandini; Brooks, Tim; Simpson, Andrew; Bentley, Neil] Publ Hlth England, Salisbury, Wilts, England; [Kamara, Thaim B.] Connaught Hosp, Freetown, Sierra Leone; [Walker, Naomi F.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis & Immun, London, England; [Walker, Naomi F.] Univ Cape Town, Inst Infect Dis & Mol Med, Clin Infect Dis Res Initiat, ZA-7925 Cape Town, South Africa	University of London; King's College London; University of London; King's College London; University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; University College London; Public Health England; Connaught Hospital; Imperial College London; University of Cape Town	Youkee, D (corresponding author), Kings Coll London, Kings Ctr Global Hlth, Kings Sierra Leone Partnership, London WC2R 2LS, England.	daniel.youkee@kcl.ac.uk	Brown, Colin/AAF-9597-2021	Brown, Colin/0000-0003-4776-3403; Johnson, Oliver/0000-0001-8698-0553; Lilburn, Paul/0000-0001-7449-3854; Youkee, Daniel/0000-0002-2383-4425; Walker, Naomi/0000-0002-3345-7694				[Aip PED Hse WHO], 2014, CLIN MAN PAT VHF POC; Alfson K. J., 2015, J VIROL; Arkell P, QUANTIFYING RISK NOS; Bausch DG, 2007, J INFECT DIS, V196, pS142, DOI 10.1086/520545; Bibby K, 2015, AM CHEM SOC, V2, P2; Cook BWM, 2015, VIRUSES-BASEL, V7, P1975, DOI 10.3390/v7041975; Fischer R, 2015, EMERG INFECT DIS, V21, P1243, DOI 10.3201/eid2107.150253; FISHERHOCH SP, 1995, BRIT MED J, V311, P857, DOI 10.1136/bmj.311.7009.857; Fitzpatrick G, 2014, DESCRIBING READMISSI, V2014, P1; Francesconi P, 2003, EMERG INFECT DIS, V9, P1430, DOI 10.3201/eid0911.030339; Ftika L, 2013, J HOSP INFECT, V83, P185, DOI 10.1016/j.jhin.2012.10.013; Lado M, 2015, LANCET INFECT DIS, V3099, P1; Paweska JT, 2009, EMERG INFECT DIS, V15, P1598, DOI 10.3201/eid1510.090211; Piercy TJ, 2010, J APPL MICROBIOL, V109, P1531, DOI 10.1111/j.1365-2672.2010.04778.x; Sagripanti JL, 2011, ARCH VIROL, V156, P489, DOI 10.1007/s00705-010-0847-1; Shears P, 2015, J HOSP INFECT, V90, P1, DOI 10.1016/j.jhin.2015.01.002; Trombley AR, 2010, AM J TROP MED HYG, V82, P954, DOI 10.4269/ajtmh.2010.09-0636	17	19	19	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145167	10.1371/journal.pone.0145167	http://dx.doi.org/10.1371/journal.pone.0145167			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26692018	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092300044
J	Buijsse, B; Jacobs, DR; Steffen, LM; Kromhout, D; Gross, MD				Buijsse, Brian; Jacobs, David R., Jr.; Steffen, Lyn M.; Kromhout, Daan; Gross, Myron D.			Plasma Ascorbic Acid, A Priori Diet Quality Score, and Incident Hypertension: A Prospective Cohort Study	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; ARTERY RISK DEVELOPMENT; BLOOD-PRESSURE; VITAMIN-C; METAANALYSIS; SUPPLEMENTATION; ASSOCIATIONS; STROKE; MORTALITY; CARDIA	Vitamin C may reduce risk of hypertension, either in itself or by marking a healthy diet pattern. We assessed whether plasma ascorbic acid and the a priori diet quality score relate to incident hypertension and whether they explain each other's predictive abilities. Data were from 2884 black and white adults (43% black, mean age 35 years) initially hypertensionfree in the Coronary Artery Risk Development in Young Adults Study (study year 10, 19951996). Plasma ascorbic acid was assessed at year 10 and the diet quality score at year 7. Eight-hundred-and-forty cases of hypertension were documented between years 10 and 25. After multiple adjustments, each 12-point (1 SD) higher diet quality score at year 7 related to mean 3.7 mu mol/L (95% CI 2.9 to 4.6) higher plasma ascorbic acid at year 10. In separate multiple-adjusted Cox regression models, the hazard ratio of hypertension per 19.6- mu mol/L (1 SD) higher ascorbic acid was 0.85 (95% CI 0.79-0.92) and per 12-points higher diet score 0.86 (95% CI 0.79-0.94). These hazard ratios changed little with mutual adjustment of ascorbic acid and diet quality score for each other, or when adjusted for anthropometric variables, diabetes, and systolic blood pressure at year 10. Intake of dietary vitamin C and several food groups high in vitamin C content were inversely related to hypertension, whereas supplemental vitamin C was not. In conclusion, plasma ascorbic acid and the a priori diet quality score independently predict hypertension. This suggests that hypertension risk is reduced by improving overall diet quality and/or vitamin C status. The inverse association seen for dietary but not for supplemental vitamin C suggests that vitamin C status is preferably improved by eating foods rich in vitamin C, in addition to not smoking and other dietary habits that prevent ascorbic acid from depletion.	[Buijsse, Brian; Jacobs, David R., Jr.; Steffen, Lyn M.; Kromhout, Daan] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Buijsse, Brian] German Inst Human Nutr Potsdam Rehbrucke, Dept Epidemiol, Nuthetal, Germany; [Kromhout, Daan] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands; [Gross, Myron D.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); Wageningen University & Research; University of Minnesota System; University of Minnesota Twin Cities	Jacobs, DR (corresponding author), Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA.	jacob004@umn.edu		Jacobs, David/0000-0002-7232-0543; Steffen, Lyn M/0000-0002-4053-6729	National Heart, Lung, and Blood Institute [HHSN268201300025C, HHSN268201300026C, HHSN268201300027C, HHSN268201300028C, HHSN268201300029C, HHSN268200900041C]; Intramural Research Program of the National Institute on Aging; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053560] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Coronary Artery Risk Development in Young Adults Study (CARDIA) is supported by contracts HHSN268201300025C, HHSN268201300026C, HHSN268201300027C, HHSN268201300028C, HHSN268201300029C, and HHSN268200900041C from the National Heart, Lung, and Blood Institute and the Intramural Research Program of the National Institute on Aging. Ascorbic acid was assessed as part of an ancillary study to CARDIA called Young Adult Longitudinal Trends in Antioxidants (YALTA), R01 HL 053560 (DRJ and MG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrogue HJ, 2007, NEW ENGL J MED, V356, P1966, DOI 10.1056/NEJMra064486; Bach-Faig A, 2006, PUBLIC HEALTH NUTR, V9, P1110, DOI 10.1017/S1368980007668499; Block G, 2001, AM J EPIDEMIOL, V154, P1113, DOI 10.1093/aje/154.12.1113; Block G, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-35; Conlin PR, 2000, AM J HYPERTENS, V13, P949, DOI 10.1016/S0895-7061(99)00284-8; d'Uscio LV, 2003, CIRC RES, V92, P88, DOI 10.1161/01.RES.0000049166.33035.62; Dinh QN, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/406960; FRIEDMAN GD, 1988, J CLIN EPIDEMIOL, V41, P1105, DOI 10.1016/0895-4356(88)90080-7; GALE CR, 1995, BRIT MED J, V310, P1563, DOI 10.1136/bmj.310.6994.1563; Genuth S, 2003, DIABETES CARE, V26, P3160; GEY KF, 1993, CLIN INVESTIGATOR, V71, P3, DOI 10.1007/BF00210955; Hertog MGL, 1997, LANCET, V349, P699, DOI 10.1016/S0140-6736(05)60135-3; Jacobs David R Jr, 1989, J Cardiopulm Rehabil, V9, P448, DOI 10.1097/00008483-198911000-00003; Jee SH, 2002, AM J HYPERTENS, V15, P691, DOI 10.1016/S0895-7061(02)02964-3; Juraschek SP, 2012, AM J CLIN NUTR, V95, P1079, DOI 10.3945/ajcn.111.027995; Khaw KT, 2001, LANCET, V357, P657, DOI 10.1016/S0140-6736(00)04128-3; Larsson SC, 2011, STROKE, V42, P2746, DOI 10.1161/STROKEAHA.111.622142; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MCDONALD A, 1991, J AM DIET ASSOC, V91, P1104; Myung SK, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f10; Ness AR, 1999, PUBLIC HEALTH NUTR, V2, P51, DOI 10.1017/S1368980099000063; Pereira MA, 2004, ARCH INTERN MED, V164, P370, DOI 10.1001/archinte.164.4.370; Pfister R, 2011, AM HEART J, V162, P246, DOI 10.1016/j.ahj.2011.05.007; Royston P., 2008, MULTIVARIABLE MODEL; Sijtsma FPC, 2012, AM J CLIN NUTR, V95, P580, DOI 10.3945/ajcn.111.020719; Steffen LM, 2005, AM J CLIN NUTR, V82, P1169, DOI 10.1093/ajcn/82.6.1169; Steinberg D, 2002, CIRCULATION, V105, P2107, DOI 10.1161/01.CIR.0000014762.06201.06; Streppel MT, 2005, ARCH INTERN MED, V165, P150, DOI 10.1001/archinte.165.2.150; van Mierlo LAJ, 2006, J HUM HYPERTENS, V20, P571, DOI 10.1038/sj.jhh.1002038; Wannamethee SG, 2013, CIRC-HEART FAIL, V6, P647, DOI 10.1161/CIRCHEARTFAILURE.112.000281; Wannamethee SG, 2006, AM J CLIN NUTR, V83, P567, DOI 10.1093/ajcn.83.3.567; Xin X, 2001, HYPERTENSION, V38, P1112, DOI 10.1161/hy1101.093424	32	17	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144920	10.1371/journal.pone.0144920	http://dx.doi.org/10.1371/journal.pone.0144920			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683190	Green Published, gold			2022-12-26	WOS:000366725800024
J	Dave, KK; Punekar, NS				Dave, Khyati K.; Punekar, Narayan S.			Expression of Lactate Dehydrogenase in Aspergillus niger for L-Lactic Acid Production	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; EFFICIENT PRODUCTION; RENEWABLE MATERIALS; ENGINEERED YEASTS; GENE; RHIZOPUS; FERMENTATION; ENZYME; CITRATE; GENOME	Different engineered organisms have been used to produce L-lactate. Poor yields of lactate at low pH and expensive downstream processing remain as bottlenecks. Aspergillus niger is a prolific citrate producer and a remarkably acid tolerant fungus. Neither a functional lactate dehydrogenase (LDH) from nor lactate production by A. niger is reported. Its genome was also investigated for the presence of a functional ldh. The endogenous A. niger citrate synthase promoter relevant to A. niger acidogenic metabolism was employed to drive constitutive expression of mouse lactate dehydrogenase (mldhA). An appraisal of different branches of the A. niger pyruvate node guided the choice of mldhA for heterologous expression. A high copy number transformant C12 strain, displaying highest LDH specific activity, was analyzed under different growth conditions. The C12 strain produced 7.7 g/l of extracellular L-lactate from 60 g/l of glucose, in non-neutralizing minimal media. Significantly, lactate and citrate accumulated under two different growth conditions. Already an established acidogenic platform, A. niger now promises to be a valuable host for lactate production.	[Dave, Khyati K.; Punekar, Narayan S.] Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Punekar, NS (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Bombay 400076, Maharashtra, India.	nsp@iitb.ac.in			Council of Scientific and Industrial Research (CSIR) research fellowship	Council of Scientific and Industrial Research (CSIR) research fellowship	Khyati Dave received Council of Scientific and Industrial Research (CSIR) research fellowship.	Andersen MR, 2011, GENOME RES, V21, P885, DOI 10.1101/gr.112169.110; Andersen MR, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.12; Bianchi MM, 2001, APPL ENVIRON MICROB, V67, P5621, DOI 10.1128/AEM.67.12.5621-5625.2001; Blumhoff ML, 2013, METAB ENG, V19, P26, DOI 10.1016/j.ymben.2013.05.003; Branduardi P, 2006, MICROB CELL FACT, V5, DOI 10.1186/1475-2859-5-4; CLARKE AR, 1988, BIOCHEMISTRY-US, V27, P1617, DOI 10.1021/bi00405a034; Dave K, 2011, J BIOTECHNOL, V155, P173, DOI 10.1016/j.jbiotec.2011.06.012; FEIR HA, 1969, CAN J BIOCHEM CELL B, V47, P697, DOI 10.1139/o69-107; Flipphi M, 2009, FUNGAL GENET BIOL, V46, pS19, DOI 10.1016/j.fgb.2008.07.018; HAWTREY CO, 1970, J EXP ZOOL, V174, P451, DOI 10.1002/jez.1401740408; Hynes MJ, 2010, CELLULAR AND MOLECULAR BIOLOGY OF FILAMENTOUS FUNGI, P312; Ikushima S, 2009, BIOSCI BIOTECH BIOCH, V73, P1818, DOI 10.1271/bbb.90186; Ilmen M, 2007, APPL ENVIRON MICROB, V73, P117, DOI 10.1128/AEM.01311-06; Ilmen M, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-53; Ishida N, 2005, APPL ENVIRON MICROB, V71, P1964, DOI 10.1128/AEM.71.4.1964-1970.2005; Ishida N, 2006, BIOSCI BIOTECH BIOCH, V70, P1148, DOI 10.1271/bbb.70.1148; Jernejc K, 2002, FEMS MICROBIOL LETT, V217, P185, DOI 10.1111/j.1574-6968.2002.tb11473.x; Kobayashi K, 2014, J IND MICROBIOL BIOT, V41, P749, DOI 10.1007/s10295-014-1419-2; Kumar S, 2015, APPL ENV MICROBIOL, V81; LEGISA M, 1989, APPL MICROBIOL BIOT, V31, P453, DOI 10.1007/BF00270775; Li A, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-57; Li A, 2011, FUNGAL GENET BIOL, V48, P602, DOI 10.1016/j.fgb.2011.01.013; Liaud N, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0249-x; Magnuson J.K., 2004, ADV FUNGAL BIOTECHNO, P307, DOI DOI 10.1007/978-1-4419-8859-1_12; Meijer S, 2009, METAB ENG, V11, P107, DOI 10.1016/j.ymben.2008.12.002; MEIXNERMONORI B, 1984, CAN J MICROBIOL, V30, P16, DOI 10.1139/m84-003; Noor S, 2005, MICROBIOL-SGM, V151, P1409, DOI 10.1099/mic.0.27751-0; Okano K, 2010, APPL MICROBIOL BIOT, V85, P413, DOI 10.1007/s00253-009-2280-5; Ookubo A, 2008, BIOSCI BIOTECH BIOCH, V72, P3063, DOI 10.1271/bbb.80493; Pacheco A, 2012, FEMS YEAST RES, V12, P375, DOI 10.1111/j.1567-1364.2012.00790.x; Papagianni M, 2007, BIOTECHNOL ADV, V25, P244, DOI 10.1016/j.biotechadv.2007.01.002; PETRARULO M, 1995, CLIN CHEM, V41, P1518; Porro D, 1999, APPL ENVIRON MICROB, V65, P4211; Punekar NS, 2009, India patent, Patent No. [2542/MUM/2009, 2542MUM2009]; Ruijter GJG, 1996, J MICROBIOL METH, V25, P295, DOI 10.1016/0167-7012(95)00104-2; Saitoh S, 2005, APPL ENVIRON MICROB, V71, P2789, DOI 10.1128/AEM.71.5.2789-2792.2005; Sambrook J., 2001, MOL CLONING LAB MANU; Skory CD, 2003, J IND MICROBIOL BIOT, V30, P22, DOI 10.1007/s10295-002-0004-2; Skory CD, 2007, CURR GENET, V52, P23, DOI 10.1007/s00294-007-0135-0; Skory CD, 2010, ENZYME MICROB TECH, V46, P43, DOI 10.1016/j.enzmictec.2009.08.014; Skulj M, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-6; SOCCOL CR, 1994, WORLD J MICROB BIOT, V10, P433, DOI 10.1007/BF00144467; Terabayashi Y, 2012, APPL MICROBIOL BIOT, V93, P305, DOI 10.1007/s00253-011-3767-4; Tokuhiro K, 2009, APPL MICROBIOL BIOT, V82, P883, DOI 10.1007/s00253-008-1831-5; van der Straat L, 2014, MICROB CELL FACT, V13, DOI 10.1186/1475-2859-13-11; Wakai S, 2014, BIORESOURCE TECHNOL, V173, P376, DOI 10.1016/j.biortech.2014.09.094; Wang Y, 2015, J BIOSCI BIOENG, V119, P10, DOI 10.1016/j.jbiosc.2014.06.003; Zhang ZY, 2007, BIOCHEM ENG J, V35, P251, DOI 10.1016/j.bej.2007.01.028	48	19	19	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145459	10.1371/journal.pone.0145459	http://dx.doi.org/10.1371/journal.pone.0145459			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683313	gold, Green Submitted, Green Published			2022-12-26	WOS:000366725800079
J	Jin, XC; Steinbach, JH				Jin, Xiaochun; Steinbach, Joe Henry			Potentiation of Neuronal Nicotinic Receptors by 17 beta-Estradiol: Roles of the Carboxy-Terminal and the Amino-Terminal Extracellular Domains	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTORS; ALPHA-4-BETA-2 RECEPTOR; NERVOUS-SYSTEM; BINDING; PROTEINS; SUBTYPES; SUBUNIT; REGIONS; SITE	The endogenous steroid 17 beta-estradiol (beta EST) potentiates activation of neuronal nicotinic receptors containing alpha 4 subunits. Previous work has shown that the final 4 residues of the alpha 4 subunit are required for potentiation. However, receptors containing the alpha 2 subunit are not potentiated although it has these 4 residues, and only one amino acid difference in the C-terminal tail (FLAGMI vs. WLAGMI). Previous work had indicated that the tryptophan residue was involved in binding an analog of beta EST, but not in potentiation by beta EST. To determine the structural basis for the loss of potentiation we analyzed data from chimeric subunits, which indicated that the major factor underlying the difference between alpha 2 and alpha 4 is the tryptophan/phenylalanine difference, while the N-terminal extracellular domain is a less significant factor. When the tryptophan in alpha 4 was mutated, both phenylalanine and tyrosine conferred lower potentiation while lysine and leucine did not. The reduction reflected a reduced maximal magnitude of potentiation, indicating that the tryptophan is involved in transduction of steroid effects. The regions of the alpha 4 N-terminal extracellular domain involved in potentiation lie near the agonist-binding pocket, rather than close to the membrane or the C-terminal tail, and appear to be involved in transduction rather than binding. These observations indicate that the C-terminal region is involved in both steroid binding (AGMI residues) and transduction (W). The role of the N-terminus appears to be independent of the C-terminal tryptophan and likely reflects an influence on conformational changes caused during channel activation by agonist and potentiation by estradiol.	[Jin, Xiaochun; Steinbach, Joe Henry] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Steinbach, Joe Henry] Washington Univ, Sch Med, Taylor Family Inst Innovat Psychiat Res, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Steinbach, JH (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.	jhs@morpheus.wustl.edu			National Institute of Neurological Disorders and Stroke [NS22356]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022356] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Institute of Neurological Disorders and Stroke grant NS22356 (JHS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARGOS P, 1987, J MOL BIOL, V193, P385, DOI 10.1016/0022-2836(87)90226-9; CHOTHIA C, 1976, J MOL BIOL, V105, P1, DOI 10.1016/0022-2836(76)90191-1; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P211, DOI 10.1021/bi00699a001; Curtis L, 2002, MOL PHARMACOL, V61, P127, DOI 10.1124/mol.61.1.127; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Dash B, 2014, NEUROPHARMACOLOGY, V79, P715, DOI 10.1016/j.neuropharm.2014.01.021; Dash B, 2012, J NEUROCHEM, V121, P349, DOI 10.1111/j.1471-4159.2012.07685.x; Dayhoff MO, 1983, SEQUENCE DETERMINATI; Di Resta C, 2010, EUR J PHARMACOL, V643, P13, DOI 10.1016/j.ejphar.2010.05.063; Dwyer Donard S, 2005, BMC Chem Biol, V5, P2, DOI 10.1186/1472-6769-5-2; Gotti C, 2007, BIOCHEM PHARMACOL, V74, P1102, DOI 10.1016/j.bcp.2007.05.023; Gotti C, 2006, TRENDS PHARMACOL SCI, V27, P482, DOI 10.1016/j.tips.2006.07.004; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Higley MJ, 2014, CURR OPIN NEUROBIOL, V29, P88, DOI 10.1016/j.conb.2014.06.004; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Jin XC, 2014, MOL PHARMACOL, V85, P11, DOI 10.1124/mol.113.089979; Jin XC, 2011, J NEUROSCI, V31, P5045, DOI 10.1523/JNEUROSCI.4802-10.2011; Jin XC, 2009, J PHYSIOL-LONDON, V587, P981, DOI 10.1113/jphysiol.2008.159343; Ke L, 1996, J NEUROCHEM, V67, P1100; Khiroug SS, 2004, NEUROSCIENCE, V124, P817, DOI 10.1016/j.neuroscience.2004.01.017; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lee WY, 2009, J NEUROSCI, V29, P3189, DOI 10.1523/JNEUROSCI.6185-08.2009; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Ley CKK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103244; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; Paradiso K, 2000, MOL PHARMACOL, V58, P341, DOI 10.1124/mol.58.2.341; Paradiso K, 2001, J NEUROSCI, V21, P6561, DOI 10.1523/JNEUROSCI.21-17-06561.2001; PERSSON B, 1994, J MOL BIOL, V237, P182, DOI 10.1006/jmbi.1994.1220; Picciotto MR, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a012112; Picciotto MR, 2012, NEURON, V76, P116, DOI 10.1016/j.neuron.2012.08.036; Wang J, 2015, NEUROPHARMACOLOGY, V96, P194, DOI 10.1016/j.neuropharm.2014.10.009; Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842; Zamyatnin A A, 1972, Prog Biophys Mol Biol, V24, P107, DOI 10.1016/0079-6107(72)90005-3	34	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144631	10.1371/journal.pone.0144631	http://dx.doi.org/10.1371/journal.pone.0144631			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684647	gold, Green Submitted, Green Published			2022-12-26	WOS:000366725800016
J	Khan, MAH; Sharma, A; Rarick, KR; Roman, RJ; Harder, DR; Imig, JD				Khan, Md Abdul Hye; Sharma, Amit; Rarick, Kevin R.; Roman, Richard J.; Harder, David R.; Imig, John D.			Elevated Aminopeptidase P Attenuates Cerebral Arterial Responses to Bradykinin in Fawn-Hooded Hypertensive Rats	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME; MYOGENIC RESPONSE; PHOSPHORYLATION; IDENTIFICATION; DEGRADATION; INHIBITION; PROTEIN; AUTOREGULATION; INACTIVATION; DYSFUNCTION	Cerebral arterial myogenic and autoregulatory responses are impaired in Fawn Hooded hypertensive (FHH) rats. Cerebral autoregulatory responses are restored in the congenic rat strain in which a segment of chromosome 1 from the Brown Norway (BN) rat was transferred into the FHH genetic background (FHH. 1BN). The impact of this region on cerebral arterial dilator responses remains unknown. Aminopeptidase is a gene that was transferred into the FHH genetic background to generate the FHH. 1BN rats and is responsible for degradation of the vasodilator bradykinin. Thus, we hypothesized that FHH rats will have increased aminopeptidase P levels with impaired cerebral arterial responses to bradykinin compared to BN and FHH. 1BN rats. We demonstrated higher cerebral arterial expression of aminopeptidase P in FHH compared to BN rats. Accordingly, we demonstrated markedly impaired cerebral arterial dilation to bradykinin in FHH compared to BN rats. Interestingly, aminopeptidase P expression was lower in FHH. 1BN compared to FHH rats. Decreased aminopeptidase P levels in FHH. 1BN rats were associated with increased cerebral arterial bradykinin-induced dilator responses. Aminopeptidase P inhibition by apstatin improved cerebral arterial bradykinin dilator responses in FHH rats to a level similar to FHH. 1BN rats. Unlike bradykinin, cerebral arterial responses to acetylcholine were similar between FHH and FHH. 1BN groups. These findings indicate decreased bradykinin bioavailability contributes to impaired cerebral arterial dilation in FHH rats. Overall, these data indicate an important role of aminopeptidase P in the impaired cerebral arterial function in FHH rat.	[Khan, Md Abdul Hye; Sharma, Amit; Imig, John D.] Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA; [Rarick, Kevin R.; Harder, David R.; Imig, John D.] Med Coll Wisconsin, Ctr Cardiovasc, Milwaukee, WI 53226 USA; [Roman, Richard J.] Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA; [Harder, David R.] Med Coll Wisconsin, Dept Physiol, Milwaukee, WI 53226 USA	Medical College of Wisconsin; Medical College of Wisconsin; University of Mississippi; University of Mississippi Medical Center; Medical College of Wisconsin	Imig, JD (corresponding author), Med Coll Wisconsin, Dept Pharmacol & Toxicol, Milwaukee, WI 53226 USA.	jdimig@mcw.edu	sharma, amit/L-8162-2019	sharma, amit/0000-0002-4492-2248; Imig, John/0000-0002-9668-2899; Khan, Md Abdul Hye/0000-0001-5940-9300	National Heart, Lung, and Blood Institute [R01 HL033833, HL105997]; Veterans Administration Research Career Scientist Award; American Heart Association Midwest Affiliate; Midwest Affiliate of the American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL033833, R01HL105997] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK104184] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Veterans Administration Research Career Scientist Award; American Heart Association Midwest Affiliate(American Heart Association); Midwest Affiliate of the American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Heart, Lung, and Blood Institute Grants R01 HL033833 and HL105997 and the Veterans Administration Research Career Scientist Award (DRH), an American Heart Association Midwest Affiliate Grant-in-Aid (JDI), and a postdoctoral fellowship from the Midwest Affiliate of the American Heart Association (Md. AHK) supported this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagate K, 2000, EUR J PHARMACOL, V407, P317, DOI 10.1016/S0014-2999(00)00744-5; BIANCHI G, 1994, P NATL ACAD SCI USA, V91, P3999, DOI 10.1073/pnas.91.9.3999; Burke M, 2013, AM J PHYSIOL-RENAL, V304, pF565, DOI 10.1152/ajprenal.00404.2012; Efendiev R, 2004, CIRC RES, V95, P1100, DOI 10.1161/01.RES.0000149570.20845.89; Ersahin C, 1997, J CARDIOVASC PHARM, V30, P96, DOI 10.1097/00005344-199707000-00014; Fagan SC, 2004, STROKE, V35, P2220, DOI 10.1161/01.STR.0000138023.60272.9e; Fan F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112878; GARDNER K, 1986, J BIOL CHEM, V261, P1339; Halcox JPJ, 2002, CIRCULATION, V106, P653, DOI 10.1161/01.CIR.0000025404.78001.D8; Heitzer T, 2001, CIRCULATION, V104, P2673, DOI 10.1161/hc4601.099485; JOSHI R, 1990, J BIOL CHEM, V265, P13130; Kim KS, 2000, J PHARMACOL EXP THER, V292, P295; Kitamura S, 1999, AM J PHYSIOL-HEART C, V276, pH1664, DOI 10.1152/ajpheart.1999.276.5.H1664; KITAMURA S, 1995, BRIT J PHARMACOL, V114, P6, DOI 10.1111/j.1476-5381.1995.tb14897.x; La Corte AIC, 2008, J RENIN-ANGIO-ALDO S, V9, P221, DOI 10.1177/1470320308096405; Lopez B, 2006, AM J PHYSIOL-RENAL, V290, pF1213, DOI 10.1152/ajprenal.00335.2005; Matsuoka Y, 1996, J BIOL CHEM, V271, P25157, DOI 10.1074/jbc.271.41.25157; Murphy TV, 2002, CLIN EXP PHARMACOL P, V29, P612, DOI 10.1046/j.1440-1681.2002.03698.x; Nowak W, 2011, EUR J PHARMACOL, V667, P271, DOI 10.1016/j.ejphar.2011.05.045; Ochodnicky P, 2010, AM J PHYSIOL-RENAL, V298, pF625, DOI 10.1152/ajprenal.00289.2009; Pabbidi MR, 2014, AM J PHYSIOL-HEART C, V306, pH989, DOI 10.1152/ajpheart.00636.2013; Pabbidi MR, 2013, AM J PHYSIOL-HEART C, V304, pH311, DOI 10.1152/ajpheart.00622.2012; Peterson EC, 2011, INT J VASC MED, V2011, DOI 10.1155/2011/823525; Prechel MM, 1995, J PHARMACOL EXP THER, V275, P1136; Rodriguez-Yanez Manuel, 2006, Cerebrovasc Dis, V21 Suppl 2, P21, DOI 10.1159/000091700; RYAN JW, 1994, J PHARMACOL EXP THER, V269, P941; SIMMONS WH, 1992, J BIOL CHEM, V267, P4897; Tibbles LA, 1999, CELL MOL LIFE SCI, V55, P1230, DOI 10.1007/s000180050369; Tripodi G, 1997, BIOCHEM BIOPH RES CO, V237, P685, DOI 10.1006/bbrc.1997.7173; VANHOUTTE PM, 1989, HYPERTENSION, V13, P658, DOI 10.1161/01.HYP.13.6.658; Widlansky ME, 2003, J AM COLL CARDIOL, V42, P1149, DOI 10.1016/S0735-1097(03)00994-X; Williams JM, 2011, AM J PHYSIOL-RENAL, V300, pF330, DOI 10.1152/ajprenal.00261.2010; YARON A, 1993, CRIT REV BIOCHEM MOL, V28, P31, DOI 10.3109/10409239309082572; Zagato L, 2000, HYPERTENSION, V36, P734, DOI 10.1161/01.HYP.36.5.734	34	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145335	10.1371/journal.pone.0145335	http://dx.doi.org/10.1371/journal.pone.0145335			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683993	Green Submitted, Green Published, gold			2022-12-26	WOS:000366725800066
J	Pereira, BD; Bouillet, LEM; Dorigo, NA; Fraefel, C; Bruna-Romero, O				Pereira, Bruna de Andrade; Maduro Bouillet, Leoneide E.; Dorigo, Natalia A.; Fraefel, Cornel; Bruna-Romero, Oscar			Adenovirus Specific Pre-Immunity Induced by Natural Route of Infection Does Not Impair Transduction by Adenoviral Vaccine Vectors in Mice	PLOS ONE			English	Article							T-CELL RESPONSES; NEUTRALIZING ANTIBODIES; PROTECTIVE IMMUNITY; PREEXISTING IMMUNITY; ANTI-AD5 IMMUNITY; GENE-THERAPY; IMMUNOGENICITY; TYPE-5; SEROPREVALENCE; SEROTYPE-35	Recombinant human adenovirus serotype 5 (HAd5V) vectors are gold standards of T-cell immunogenicity as they efficiently induce also humoral responses to exogenous antigens, in particular when used in prime-boost protocols. Some investigators have shown that preexisting immunity to adenoviruses interferes with transduction by adenoviral vectors, but the actual extent of this interference is not known since it has been mostly studied in mice using unnatural routes of infection and virus doses. Here we studied the effects of HAd5V-specific immune responses induced by intranasal infection on the transduction efficiency of recombinant adenovirus vectors. Of interest, when HAd5V immunity was induced in mice by the natural respiratory route, the pre-existing immunity against HAd5V did not significantly interfere with the B and T-cell immune responses against the transgene products induced after a prime/boost inoculation protocol with a recombinant HAd5V-vector, as measured by ELISA and in vivo cytotoxic T-cell assays, respectively. We also correlated the levels of HAd5V-specific neutralizing antibodies (Ad5NAbs) induced in mice with the levels of Ad5NAb titers found in humans. The data indicate that approximately 60% of the human serum samples tested displayed Ad5NAb levels that could be overcome with a prime-boost vaccination protocol. These results suggest that recombinant HAd5V vectors are potentially useful for prime-boost vaccination strategies, at least when pre-existing immunity against HAd5V is at low or medium levels.	[Pereira, Bruna de Andrade; Maduro Bouillet, Leoneide E.; Dorigo, Natalia A.; Bruna-Romero, Oscar] Univ Fed Minas Gerais, Dept Microbiol, Belo Horizonte, MG, Brazil; [Pereira, Bruna de Andrade; Fraefel, Cornel] Univ Zurich, Inst Virol, Zurich, Switzerland	Universidade Federal de Minas Gerais; University of Zurich	Pereira, BD (corresponding author), Univ Zurich, Inst Virol, Zurich, Switzerland.	brunap@vetvir.uzh.ch	Bouillet, Leoneide/GRO-4340-2022; BRUNA-ROMERO, OSCAR/B-3918-2010	BRUNA-ROMERO, OSCAR/0000-0002-8855-4969; Fraefel, Cornel/0000-0001-7221-6706	Brazilian agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [482029/2007-2]; CNPq productivity fellowship	Brazilian agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq productivity fellowship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This project was funded by the Brazilian agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq project 482029/2007-2). OBR was also granted with a CNPq productivity fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors declare to have no competing interests. This project was funded by the Brazilian agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq project 482029/2007-2). OBR was also granted with a CNPq productivity fellowship.	Barbosa RPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061795; Andrade BP de, 2007, INT MICROBIOL, V10, P261; Appaiahgari MB, 2007, CLIN VACCINE IMMUNOL, V14, P1053, DOI 10.1128/CVI.00173-07; Barouch DH, 2004, J IMMUNOL, V172, P6290, DOI 10.4049/jimmunol.172.10.6290; Bruna-Romera O, 2001, P NATL ACAD SCI USA, V98, P11491, DOI 10.1073/pnas.191380898; Caetano BC, 2006, HUM GENE THER, V17, P415, DOI 10.1089/hum.2006.17.415; Chuang I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055571; Croyle MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003548; Curlin ME, 2011, AIDS, V25, P153, DOI 10.1097/QAD.0b013e328342115c; Ersching J, 2010, VIROLOGY, V407, P1, DOI 10.1016/j.virol.2010.07.043; Gabitzsch ES, 2009, VACCINE, V27, P6394, DOI 10.1016/j.vaccine.2009.06.028; Grimaldi G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002853; Guan M, 2008, CANCER GENE THER, V15, P371, DOI 10.1038/cgt.2008.13; Haut LH, 2011, J INFECT DIS, V203, P1073, DOI 10.1093/infdis/jiq161; Holst PJ, 2010, J IMMUNOL, V184, P4431, DOI 10.4049/jimmunol.0900537; Lemckert AAC, 2005, J VIROL, V79, P9694, DOI 10.1128/JVI.79.15.9694-9701.2005; Lemckert AAC, 2006, J GEN VIROL, V87, P2891, DOI 10.1099/vir.0.82079-0; Machado AV, 2006, HUM GENE THER, V17, P898, DOI 10.1089/hum.2006.17.898; Mast TC, 2010, VACCINE, V28, P950, DOI 10.1016/j.vaccine.2009.10.145; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Mendes EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063201; Morse MA, 2013, CANCER IMMUNOL IMMUN, V62, P1293, DOI 10.1007/s00262-013-1400-3; Nanda A, 2005, J VIROL, V79, P14161, DOI 10.1128/JVI.79.22.14161-14168.2005; Nwanegbo E, 2004, CLIN DIAGN LAB IMMUN, V11, P351, DOI 10.1128/CDLI.11.2.351-357.2004; Osada T, 2009, CANCER GENE THER, V16, P673, DOI 10.1038/cgt.2009.17; Pandey A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033428; Ramshaw IA, 2000, IMMUNOL TODAY, V21, P163, DOI 10.1016/S0167-5699(00)01612-1; Resende DM, 2008, VACCINE, V26, P4585, DOI 10.1016/j.vaccine.2008.05.091; Smaill F, 2014, EXPERT REV VACCINES, V13, P927, DOI 10.1586/14760584.2014.929947; Tazawa H, 2013, EXPERT OPIN BIOL TH, V13, P1569, DOI 10.1517/14712598.2013.845662; Thorner AR, 2006, J CLIN MICROBIOL, V44, P3781, DOI 10.1128/JCM.01249-06; Tian G, 2009, ANTI-CANCER DRUG, V20, P389, DOI 10.1097/CAD.0b013e32832a2df9; Zeng MT, 2007, VACCINE, V25, P7540, DOI 10.1016/j.vaccine.2007.08.035; Zhang SJ, 2013, J MED VIROL, V85, P1077, DOI 10.1002/jmv.23546	34	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145260	10.1371/journal.pone.0145260	http://dx.doi.org/10.1371/journal.pone.0145260			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26679149	Green Published, gold, Green Submitted			2022-12-26	WOS:000366723400065
J	Ying, JM; Lin, C; Wu, J; Guo, L; Qiu, T; Ling, Y; Shan, L; Zhou, HT; Zhao, DB; Wang, J; Liang, JW; Zhao, JJ; Jiao, YC; Lu, N; Zhao, H				Ying, Jianming; Lin, Chen; Wu, Jian; Guo, Lei; Qiu, Tian; Ling, Yun; Shan, Ling; Zhou, Haitao; Zhao, Dongbing; Wang, Jian; Liang, Jianwei; Zhao, Jianjun; Jiao, Yuchen; Lu, Ning; Zhao, Hong			Anaplastic Lymphoma Kinase Rearrangement in Digestive Tract Cancer: Implication for Targeted Therapy in Chinese Population	PLOS ONE			English	Article							CELL LUNG-CANCER; ALK; GENE; CRIZOTINIB; SPECTRIN; EXPRESSION; FUSION; IDENTIFICATION; CHEMOTHERAPY; PROTEINS	Background Anaplastic lymphoma kinase (ALK) rearrangements define a subgroup of lung cancer which is eligible to targeted kinase inhibition. The aim of this study is to observe the incidence rate of ALK fusion in a large cohort of Chinese digestive tract cancer patients. Patients and Methods Tissue microarray (TMA) was constructed from 808 digestive tract cancer cases, including 169 esophageal squamous cell carcinoma, 182 gastric cancer and 457 colorectal cancer (CRC) cases. We tested all cases for ALK expression via a fully automated immunohistochemistry (IHC) assay. The IHC-positive cases were subjected to fluorescence in situ hybridization (FISH), real-time polymerase chain reaction (qRT-PCR), target gene enrichment and sequencing for confirmation of ALK gene rearrangement and discovery of novel fusion partner. Results Among the tested cases, 2 (0.44%) CRC cases showed positive both by IHC and FISH. By qRT-PCR, EML4-ALK fusion was found in one IHC-positive CRC case. In another IHC-positive CRC case, target gene enrichment and sequencing revealed ALK was fused to a novel partner, spectrin beta non-erythrocytic 1 (SPTBN1). One gastric cancer case showed partially positive IHC result, but no fusion was found by FISH and gene sequencing. Conclusions The incidence rate of ALK gene fusion in Chinese CRC patients was 0.44%, but not detectable in gastric and esophageal cancers. The novel SPTBN1-ALK fusion, together with other ALK fusion genes, may become a potential target for anti-ALK therapy.	[Ying, Jianming; Guo, Lei; Qiu, Tian; Ling, Yun; Shan, Ling; Lu, Ning] Chinese Acad Med Sci, Canc Hosp, Dept Pathol, Beijing 100730, Peoples R China; [Lin, Chen; Zhou, Haitao; Zhao, Dongbing; Wang, Jian; Liang, Jianwei; Zhao, Jianjun; Zhao, Hong] Chinese Acad Med Sci, Canc Hosp, Dept Abdominal Surg Oncol, Beijing 100730, Peoples R China; [Wu, Jian] MyGenostics Inc, Baltimore, MD USA; [Jiao, Yuchen] Chinese Acad Med Sci, Lab Cell & Mol Biol, Canc Inst, Beijing 100730, Peoples R China; [Jiao, Yuchen] Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst, Beijing 100730, Peoples R China; [Jiao, Yuchen] Chinese Acad Med Sci, Canc Hosp, Beijing 100730, Peoples R China; [Jiao, Yuchen] Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Zhao, H (corresponding author), Chinese Acad Med Sci, Canc Hosp, Dept Abdominal Surg Oncol, Beijing 100730, Peoples R China.	jiaoyuchen@cicams.ac.cn; nlu03@126.com; zhaohong9@sina.com	Guo, Lei/AEU-0178-2022		Natural Basic Research Program of China [2014CB542002]; National Natural Science Foundation of China [31470073, 81201967]; Beijing Natural Science Foundation [7144238]; Beijing Nova PrograM [2009A69]	Natural Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Nova PrograM(Beijing Municipal Science & Technology Commission)	This study was supported by grants from the Natural Basic Research Program of China (973 program 2014CB542002) and the National Natural Science Foundation of China (31470073), National Natural Science Foundation of China (81201967), the Beijing Natural Science Foundation (7144238) and Beijing Nova Program (No. 2009A69). MyGenostics Inc., provided support in the form of salaries for author Jian Wu, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author is articulated in the 'author contributions' section.; This study was supported by grants from the Natural Basic Research Program of China (973 program 2014CB542002) and the National Natural Science Foundation of China (31470073), National Natural Science Foundation of China (81201967), the Beijing Natural Science Foundation (7144238) and Beijing Nova Program (No. 2009A69).	Aisner DL, 2013, MOL CANC RES; An XL, 2005, BIOCHEM BIOPH RES CO, V327, P794, DOI 10.1016/j.bbrc.2004.12.063; Bai RY, 2000, BLOOD, V96, P4319, DOI 10.1182/blood.V96.13.4319; Bang YJ, 2010, LANCET, V376, P1302; Bang YJ, 2012, ARCH PATHOL LAB MED, V136, P1201, DOI 10.5858/arpa.2012-0246-RA; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Butrynski JE, 2010, NEW ENGL J MED, V363, P1727, DOI 10.1056/NEJMoa1007056; Chiarle R, 2005, NAT MED, V11, P623, DOI 10.1038/nm1249; Coffin CM, 2001, MODERN PATHOL, V14, P569, DOI 10.1038/modpathol.3880352; Curran MP, 2012, DRUGS, V72, P99, DOI 10.2165/11207680-000000000-00000; Demetri GD, 2002, NEW ENGL J MED, V347, P472, DOI 10.1056/NEJMoa020461; Gallagher G, 2008, CANCER GENET CYTOGEN, V181, P46, DOI 10.1016/j.cancergencyto.2007.10.021; GOODMAN SR, 1995, BRAIN RES BULL, V36, P593, DOI 10.1016/0361-9230(94)00264-2; Grand FH, 2007, EXP HEMATOL, V35, P1723, DOI 10.1016/j.exphem.2007.07.002; Inoue A, 2006, J CLIN ONCOL, V24, P3340, DOI 10.1200/JCO.2005.05.4692; Jazii FR, 2006, WORLD J GASTROENTERO, V12, P7104, DOI 10.3748/wjg.v12.i44.7104; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Lipson D, 2012, NAT MED, V18, P382, DOI 10.1038/nm.2673; McDermott U, 2008, CANCER RES, V68, P3389, DOI 10.1158/0008-5472.CAN-07-6186; MORRIS SW, 1994, SCIENCE, V263, P1281, DOI 10.1126/science.8122112; Nakamura H, 2013, J CLIN PATHOL, V66, P705, DOI 10.1136/jclinpath-2012-201329; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Shaw AT, 2011, LANCET ONCOL, V12, P1004, DOI 10.1016/S1470-2045(11)70232-7; Siena S, 2009, JNCI-J NATL CANCER I, V101, P1308, DOI 10.1093/jnci/djp280; Stransky N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5846; WATKINS PC, 1989, CYTOGENET CELL GENET, V51, P1103; YAN Y, 1993, SCIENCE, V262, P2027, DOI 10.1126/science.8266097; Ying J, 2013, ANN ONCOL, V24, P2589, DOI 10.1093/annonc/mdt295; Zou HY, 2007, CANCER RES, V67, P4408, DOI 10.1158/0008-5472.CAN-06-4443	30	17	18	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144731	10.1371/journal.pone.0144731	http://dx.doi.org/10.1371/journal.pone.0144731			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678488	Green Published, gold, Green Submitted			2022-12-26	WOS:000366723400021
J	Dong, CJ; Jiang, LK; Peng, WZ; Xu, J; Mahboob, S; Al-Ghanim, KA; Sun, XW; Xu, P				Dong, Chuanju; Jiang, Likun; Peng, Wenzhu; Xu, Jian; Mahboob, Shahid; Al-Ghanim, Khalid A.; Sun, Xiaowen; Xu, Peng			Phylogenetic and Evolutionary Analyses of the Frizzled Gene Family in Common Carp (Cyprinus carpio) Provide Insights into Gene Expansion from Whole-Genome Duplications	PLOS ONE			English	Article							EXPRESSION; IDENTIFICATION; ZEBRAFISH; RECEPTOR; LOCALIZATION; GUIDANCE; SEQUENCE; GROWTH; OVARY; FATE	In humans, the frizzled (FZD) gene family encodes 10 homologous proteins that commonly localize to the plasma membrane. Besides being associated with three main signaling pathways for cell development, most FZDs have different physiological effects and are major determinants in the development process of vertebrates and. Here, we identified and annotated the FZD genes in the whole-genome of common carp (Cyprinus carpio), a teleost fish, and determined their phylogenetic relationships to FZDs in other vertebrates. Our analyses revealed extensive gene duplications in the common carp that have led to the 26 FZD genes that we detected in the common carp genome. All 26 FZD genes were assigned orthology to the 10 FZD genes of on-land vertebrates, with none of genes being specific to the fish lineage. We postulated that the expansion of the FZD gene family in common carp was the result of an additional whole genome duplication event and that the FZD gene family in other teleosts has been lost in their evolution history with the reason that the functions of genes are redundant and conservation. Through the expression profiling of FZD genes in common carp, we speculate that the ancestral gene was likely capable of performing all functions and was expressed broadly, while some descendant duplicate genes only performed partial functions and were specifically expressed at certain stages of development.	[Dong, Chuanju; Jiang, Likun; Peng, Wenzhu; Xu, Jian; Sun, Xiaowen; Xu, Peng] Chinese Acad Fishery Sci, CAFS Key Lab Aquat Genom, Beijing, Peoples R China; [Dong, Chuanju; Jiang, Likun; Peng, Wenzhu; Xu, Jian; Sun, Xiaowen; Xu, Peng] Chinese Acad Fishery Sci, Beijing Key Lab Fishery Biotechnol, Ctr Appl Aquat Genom, Beijing, Peoples R China; [Dong, Chuanju; Jiang, Likun; Peng, Wenzhu] Shanghai Ocean Univ, Coll Fisheries & Life Sci, Shanghai, Peoples R China; [Mahboob, Shahid; Al-Ghanim, Khalid A.] King Saud Univ, Coll Sci, Dept Zool, Riyadh 11451, Saudi Arabia; [Mahboob, Shahid] GC Univ, Dept Zool, Faisalabad, Pakistan	Chinese Academy of Fishery Sciences; Chinese Academy of Fishery Sciences; Shanghai Ocean University; King Saud University; Government College University Faisalabad	Xu, P (corresponding author), Chinese Acad Fishery Sci, CAFS Key Lab Aquat Genom, Beijing, Peoples R China.	xupeng@cafs.ac.cn	Rana, Shahid Mahboob/P-1131-2014; Xu, Peng/J-4018-2012	Rana, Shahid Mahboob/0000-0003-4969-5387; Xu, Peng/0000-0002-1531-5078	National Natural Science Foundation of China [31422057]; National High-Technology Research and Development Program of China ( 863 program) [2011AA100401]; Central Non-profit Institutes of Chinese Academy of Fishery Sciences [2014A03YQ01]; agricultural science and technology key projects [2011-G12]; Deanship of Scientific Research at King Saud University [RG 1435-012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Technology Research and Development Program of China ( 863 program)(National High Technology Research and Development Program of China); Central Non-profit Institutes of Chinese Academy of Fishery Sciences; agricultural science and technology key projects; Deanship of Scientific Research at King Saud University(King Saud University)	The authors acknowledge grant support from the National Natural Science Foundation of China (No. 31422057), National High-Technology Research and Development Program of China (863 program; 2011AA100401), Special Scientific Research Funds for Central Non-profit Institutes of Chinese Academy of Fishery Sciences (2014A03YQ01) and the introduction of advanced agricultural science and technology key projects (2011-G12). The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for funding this research (No. RG 1435-012).; We acknowledge grant support from the National Natural Science Foundation of China (No. 31422057), National High-Technology Research and Development Program of China (863 program; 2011AA100401), Special Scientific Research Funds for Central Non-profit Institutes of Chinese Academy of Fishery Sciences (2014A03YQ01) and the introduction of advanced agricultural science and technology key projects (2011-G12). The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for funding this Research (No. RG 1435-012).	Adell T, 2003, FEBS LETT, V554, P363, DOI 10.1016/S0014-5793(03)01190-6; Adler PN, 2002, DEV CELL, V2, P525, DOI 10.1016/S1534-5807(02)00176-4; Allendorf F.W., 1984, P1; Bhanot P, 1996, NEW MEMBER FRIZZLED; Blomme T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r43; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Christoffels A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S2; Davis JC, 2004, PLOS BIOL, V2, P318, DOI 10.1371/journal.pbio.0020055; Dubois L, 2001, CELL, V105, P613, DOI 10.1016/S0092-8674(01)00375-0; Edger PP, 2009, CHROMOSOME RES, V17, P699, DOI 10.1007/s10577-009-9055-9; Freeling M, 2009, ANNU REV PLANT BIOL, V60, P433, DOI 10.1146/annurev.arplant.043008.092122; Gates MA, 1999, GENOME RES, V9, P334; Gradl D, 1999, MECH DEVELOP, V86, P3, DOI 10.1016/S0925-4773(99)00129-X; Guo N, 2004, P NATL ACAD SCI USA, V101, P9277, DOI 10.1073/pnas.0402802101; Hahn MW, 2009, J HERED, V100, P605, DOI 10.1093/jhered/esp047; Hasan MR, 2007, STUDY ANAL FEEDS FER; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Hsieh M, 2005, BIOL REPROD, V73, P1135, DOI 10.1095/biolreprod.105.042739; Hsieh M, 2002, ENDOCRINOLOGY, V143, P898, DOI 10.1210/en.143.3.898; Ishikawa T, 2001, DEVELOPMENT, V128, P25; Ji PF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035152; Ji PF, 2012, PLOS ONE, V7; Jiang YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108200; Jiang YH, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0091609, 10.1371/journal.pone.0093563, 10.1371/journal.pone.0105989]; Kettleborough RNW, 2013, NATURE, V496, P494, DOI 10.1038/nature11992; Kirikoshi H, 2001, INT J ONCOL, V19, P111; Liu C, 2008, J NEUROSCI, V28, P5641, DOI 10.1523/JNEUROSCI.1056-08.2008; Liu SQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0048156; Lyuksyutova AI, 2003, SCIENCE, V302, P1984, DOI 10.1126/science.1089610; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Minobe S, 2000, DEV GENES EVOL, V210, P258, DOI 10.1007/s004270050312; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; OHNO S, 1967, CHROMOSOMA, V23, P1, DOI 10.1007/BF00293307; Phillips R, 2001, BIOL REV, V76, P1, DOI 10.1017/S1464793100005613; Ricken A, 2002, ENDOCRINOLOGY, V143, P2741, DOI 10.1210/en.143.7.2741; Schenkelaars Q, 2015, EVOL DEV, V17, P160, DOI 10.1111/ede.12115; Semon M, 2007, CURR OPIN GENET DEV, V17, P505, DOI 10.1016/j.gde.2007.09.007; Sundfeldt K, 2000, J REPROD FERTIL, V118, P375, DOI 10.1530/reprod/118.2.375; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thorpe CJ, 2000, TRENDS CELL BIOL, V10, P10, DOI 10.1016/S0962-8924(99)01672-4; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wang HY, 2006, CELL SIGNAL, V18, P934, DOI 10.1016/j.cellsig.2005.12.008; Wang YS, 2006, J NEUROSCI, V26, P355, DOI 10.1523/JNEUROSCI.3221-05.2006; Wang YS, 2002, J NEUROSCI, V22, P8563; Welcomme RL., 1988, FAO FISHERIES TECHNI; WOLF U, 1969, HUMANGENETIK, V7, P240, DOI 10.1007/BF00273173; Xu J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-307; Xu J, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0048140, 10.1371/journal.pone.0029552]; Xu P, 2014, NAT GENET, V46, P1212, DOI 10.1038/ng.3098; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-537; Xu P, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-188; Ye X, 2011, DEVELOPMENT, V138, P1161, DOI 10.1242/dev.057620; Yu HM, 2010, DEVELOPMENT, V137, P3707, DOI 10.1242/dev.052001; Zhao L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063928	55	10	14	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144037	10.1371/journal.pone.0144037	http://dx.doi.org/10.1371/journal.pone.0144037			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675214	Green Published, gold, Green Submitted			2022-12-26	WOS:000366722700020
J	Laitinen, A; Bockelman, C; Hagstrom, J; Kokkola, A; Fermer, C; Nilsson, O; Haglund, C				Laitinen, Alli; Bockelman, Camilla; Hagstrom, Jaana; Kokkola, Arto; Fermer, Christian; Nilsson, Olle; Haglund, Caj			Podocalyxin as a Prognostic Marker in Gastric Cancer	PLOS ONE			English	Article							POOR-PROGNOSIS; INDEPENDENT FACTOR; PROTEIN; OVEREXPRESSION; METASTASIS	Background Podocalyxin-like 1 (PODXL) is a cell-adhesion glycoprotein associated with aggressive tumor phenotype and poor prognosis in several forms of cancer. The aim of this study was to investigate PODXL expression in gastric cancer by use of two different antibodies. Methods By tumor-tissue microarrays and immunohistochemistry we evaluated PODXL expression in tumor specimens from 337 patients who underwent surgery for gastric adenocarcinoma at Helsinki University Hospital. We used two different antibodies: HPA2110, which is a polyclonal antibody and an in-house monoclonal antibody called HES9, to investigate the association of PODXL expression with clinicopathologic variables and patient survival. Results PODXL staining was positive by the polyclonal antibody in 153 (57.5%) cases and by the monoclonal antibody in 212 (76%). Polyclonal antibody expression was associated with intestinal cancer type (p<0.001). Monoclonal antibody staining was associated with age over 66 (p = 0.001), with intestinal cancer (p< 0.001), and with small tumor size (<= 5 cm; p = 0.024). Both antibodies were associated with high S-phase fraction (p = 0.022; p = 0.010), and high tumor proliferation index (Ki-67; p = 0.003; p = 0.001). PODXL positivity by the polyclonal antibody indicated reduced gastric-cancer-specific 5-year survival of 24.0% (95% CI 16.9-31.1), compared to 43.3% (95% CI 33.7-52.9) for patients with PODXL negativity (p = 0.001). The result remained significant in multivariable analysis (HR = 3.17; 95% CI 1.37-7.34, p = 0.007). Conclusion In gastric cancer, PODXL expression by the polyclonal antibody HPA2110 is an independent marker of poor prognosis.	[Laitinen, Alli; Bockelman, Camilla; Kokkola, Arto; Haglund, Caj] Univ Helsinki, Dept Surg, Helsinki, Finland; [Laitinen, Alli; Bockelman, Camilla; Hagstrom, Jaana; Kokkola, Arto; Haglund, Caj] Helsinki Univ Hosp, Helsinki, Finland; [Laitinen, Alli; Bockelman, Camilla; Hagstrom, Jaana; Haglund, Caj] Univ Helsinki, Res Programs Unit, Translat Canc Biol, Helsinki, Finland; [Hagstrom, Jaana] Univ Helsinki, Dept Pathol & Oral Pathol, Helsinki, Finland; [Fermer, Christian] Fujirebio Diagnost AB, Gothenburg, Sweden; [Nilsson, Olle] Onson Consulting, Gothenburg, Sweden	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; University of Helsinki; H.U. Group Holdings Inc	Laitinen, A (corresponding author), Univ Helsinki, Dept Surg, Helsinki, Finland.	alli.laitinen@helsinki.fi	Böckelman, Camilla/AFX-4447-2022; Hagström, Jaana/G-1468-2018; Haglund, Caj/N-1240-2019	Hagström, Jaana/0000-0001-6079-7881; Bockelman, Camilla/0000-0002-1628-0305	Finska Lakaresallskapet; Kurt och Doris Palander Foundation; Sigrid Juselius Foundation; Medicinska understodsforeningen Liv och Halsa; Fujirebio Diagnostics AB; Onson Consulting	Finska Lakaresallskapet; Kurt och Doris Palander Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Medicinska understodsforeningen Liv och Halsa; Fujirebio Diagnostics AB; Onson Consulting	This study was supported by grants from Finska Lakaresallskapet, the Kurt och Doris Palander Foundation, the Sigrid Juselius Foundation, and Medicinska understodsforeningen Liv och Halsa. Fujirebio Diagnostics AB and Onson Consulting provided support in the form of salaries for authors CF and ON, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archie V, 2006, CRIT REV ONCOL HEMAT, V57, P123, DOI 10.1016/j.critrevonc.2005.09.004; Boman K, 2013, BRIT J CANCER, V108, P2321, DOI 10.1038/bjc.2013.215; Casey G, 2006, HUM MOL GENET, V15, P735, DOI 10.1093/hmg/ddi487; Cipollone JA, 2012, CLIN EXP METASTAS, V29, P239, DOI 10.1007/s10585-011-9446-0; Dicken BJ, 2005, ANN SURG, V241, P27, DOI 10.1097/01.sla.0000149300.28588.23; Doyonnas R, 2005, BLOOD, V105, P4170, DOI 10.1182/blood-2004-10-4077; Heby M, 2015, BMC CLIN PATHOL, V15, DOI 10.1186/s12907-015-0009-1; HORVAT R, 1986, J CELL BIOL, V102, P484, DOI 10.1083/jcb.102.2.484; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kaprio T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-493; Kaprio T, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-494; KERJASCHKI D, 1984, J CELL BIOL, V98, P1505, DOI 10.1083/jcb.98.4.1505; Larsson A, 2011, BRIT J CANCER, V105, P666, DOI 10.1038/bjc.2011.295; Larsson A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-282; Larsson AH, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-109; Mrena J, 2010, TUMOR BIOL, V31, P1, DOI 10.1007/s13277-009-0001-4; Ponnusamy MP, 2010, ONCOGENE, V29, P5741, DOI 10.1038/onc.2010.309; Ponnusamy MP, 2013, CURR CANCER DRUG TAR, V13, P945, DOI 10.2174/15680096113136660100; Ponten F, 2008, J PATHOL, V216, P387, DOI 10.1002/path.2440; Saukkonen K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129012; Schopperle WM, 2003, BIOCHEM BIOPH RES CO, V300, P285; Somasiri A, 2004, CANCER RES, V64, P5068, DOI 10.1158/0008-5472.CAN-04-0240; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; Wiksten JP, 2008, ANTICANCER RES, V28, P2279	24	20	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145079	10.1371/journal.pone.0145079	http://dx.doi.org/10.1371/journal.pone.0145079			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674770	gold, Green Published, Green Submitted			2022-12-26	WOS:000366722700095
J	Linhares, DCL; Johnson, C; Morrison, RB				Linhares, Daniel C. L.; Johnson, Clayton; Morrison, Robert B.			Economic Analysis of Vaccination Strategies for PRRS Control	PLOS ONE			English	Article							RESPIRATORY SYNDROME VIRUS; SOW HERDS; UNITED-STATES; PERFORMANCE; IMPACT	Porcine reproductive and respiratory syndrome virus (PRRSv) is a swine-specific pathogen that causes significant increases in production costs. When a breeding herd becomes infected, in an attempt to hasten control and elimination of PRRSv, some veterinarians have adopted a strategy called load-close-expose which consists of interrupting replacement pig introductions into the herd for several weeks (herd closure) and exposing the whole herd to a replicating PRRSv to boost herd immunity. Either modified-live virus (MLV) vaccine or live field-virus inoculation (FVI) is used. This study consisted of partial budget analyses to compare MLV to FVI as the exposure method of load-close-expose program to control and eliminate PRRSv from infected breeding herds, and secondly to estimate benefit/cost of vaccinating sow herds preventatively. Under the assumptions used in this study, MLV held economic advantage over FVI. However, sensitivity analysis revealed that decreasing margin over variable costs below $47.32, or increasing PRRSv-attributed cost above $18.89 or achieving time-to-stability before 25 weeks resulted in advantage of FVI over MLV. Preventive vaccination of sow herds was beneficial when the frequency of PRRSv infection was at least every 2.1 years. The economics of preventative vaccination was minimally affected by cost attributed to field-type PRRSv infection on growing pigs or by the breeding herd productivity level. The models developed and described in this paper provide valuable tools to assist veterinarians in their efforts to control PRRSv.	[Linhares, Daniel C. L.] Iowa State Univ, Coll Vet Med, Vet Diagnost & Prod Anim Med Dept, Ames, IA 50011 USA; [Johnson, Clayton] Maschhoffs LLC, Swine Hlth Dept, Carlyle, IL USA; [Morrison, Robert B.] Univ Minnesota, Coll Vet Med, Dept Vet Populat Med, St Paul, MN 55108 USA	Iowa State University; University of Minnesota System; University of Minnesota Twin Cities	Linhares, DCL (corresponding author), Iowa State Univ, Coll Vet Med, Vet Diagnost & Prod Anim Med Dept, Ames, IA 50011 USA.	Linhares@IAstate.edu		Correia Lima Linhares, Daniel/0000-0001-7788-9942	Maschhoffs, LLC (Carlyle, IL)	Maschhoffs, LLC (Carlyle, IL)	The Maschhoffs, LLC (Carlyle, IL) provided support in the form of salary for CJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abbitt B, 1979, CITRUS VEGETABLE MAG, V42; Arruda AG, 2015, TRANSBOUND IN PRESS, DOI [10.1111/tbed.12343, DOI 10.1111/TBED.12343]; Botner A, 1997, VET REC, V141, P497, DOI 10.1136/vr.141.19.497; Chaminuka P, 2012, SOC NATUR RESOUR, V25, P235, DOI 10.1080/08941920.2011.580417; Corzo CA, 2010, VIRUS RES, V154, P185, DOI 10.1016/j.virusres.2010.08.016; Desrosiers R, 2002, J SWINE HEALTH PROD, V10, P23; Dewey CE, 2004, PREV VET MED, V62, P299, DOI 10.1016/j.prevetmed.2003.11.007; Dewey CE, 1999, PREV VET MED, V40, P233, DOI 10.1016/S0167-5877(99)00025-2; Holtkamp DJ, 2013, J SWINE HEALTH PROD, V21, P72; Li MHH, 2012, N AM J AQUACULT, V74, P142, DOI 10.1080/15222055.2012.672373; Linhares D., 2013, THESIS; Linhares DCL, 2014, PREV VET MED, V116, P111, DOI 10.1016/j.prevetmed.2014.05.010; METROPOLIS N, 1949, J AM STAT ASSOC, V44, P335, DOI 10.2307/2280232; Murtaugh MP, 2011, VACCINE, V29, P8192, DOI 10.1016/j.vaccine.2011.09.013; Neumann EJ, 2005, JAVMA-J AM VET MED A, V227, P385, DOI 10.2460/javma.2005.227.385; Nielsen J, 2002, VET MICROBIOL, V84, P1, DOI 10.1016/S0378-1135(01)00450-3; Nieuwenhuis N, 2012, VET REC, V170, P225, DOI 10.1136/vr.100101; Rodgers JC, 2012, J ANIM SCI, V90, P4055, DOI 10.2527/jas.2011-4836; Sami AS, 2012, J ANIM VET ADV, V11, P803, DOI 10.3923/javaa.2012.803.808; Torremorell M., 2003, PORK CHECKOFF, P157; Velayudhan DE, 2015, ASIAN AUSTRAL J ANIM, V28, P1, DOI 10.5713/ajas.14.0001R	21	22	22	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144265	10.1371/journal.pone.0144265	http://dx.doi.org/10.1371/journal.pone.0144265			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673898	Green Published, Green Submitted, gold			2022-12-26	WOS:000366722700032
J	Otero, O; Pinton, A; Cappetta, H; Adnet, S; Valentin, X; Salem, M; Jaeger, JJ				Otero, Olga; Pinton, Aurelie; Cappetta, Henri; Adnet, Sylvain; Valentin, Xavier; Salem, Mustapha; Jaeger, Jean-Jacques			A Fish Assemblage from the Middle Eocene from Libya (Dur At-Talah) and the Earliest Record of Modern African Fish Genera	PLOS ONE			English	Article							LATE MIOCENE; FAYUM; OLIGOCENE; ICHTHYOFAUNA; TELEOSTEI; TERTIARY	In the early nineteen sixties, Arambourg and Magnier found some freshwater fish (i.e., Polypterus sp., Siluriformes indet. and Lates sp.) mixed with marine members in an Eocene vertebrate assemblage at Gebel Coquin, in the southern Libyan Desert. This locality, aged ca 37-39Ma and now known under the name of Dur At-Talah, has been recently excavated. A new fish assemblage, mostly composed of teeth, was collected by the Mission Paleontologique Franco-Libyenne. In this paper, we describe freshwater fish members including a dipnoan (Protopterus sp.), and several actinopterygians: bichir (Polypterus sp.), aba fish (Gymnarchus sp.), several catfishes (Chrysichthys sp. and a mochokid indet.), several characiforms (including the tiger fish Hydrocynus sp., and one or two alestin-like fish), and perciforms (including the snake-head fish Parachanna sp. and at least one cichlid). Together with the fossiliferous outcrops at Birket Qarun in Egypt, the Libyan site at Dur At-Talah reduces a 10-Ma chronological gap in the fossil record of African freshwater fish. Their fish assemblages overlap in their composition and thus constitute a rather homogenous, original and significant amount of new elements regarding the Paleogene African ichthyofauna. This supports the establishment of the modern African freshwater fish fauna during this time period because these sites mostly contain the earliest members known in modern genera.	[Otero, Olga; Pinton, Aurelie; Valentin, Xavier; Jaeger, Jean-Jacques] Univ Poitiers, CNRS, Inst Paleoprimatol Paleontol Humaine Evolut & Pa, UMR 7262, Poitiers, France; [Cappetta, Henri; Adnet, Sylvain] Univ Montpellier 2, Inst Sci Evolut Montpellier ISE M, UMR5554, Montpellier, France; [Salem, Mustapha] Univ Al Fatah, Dept Geol, Tripoli, Libya	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite de Montpellier; Al Fateh University	Otero, O (corresponding author), Univ Poitiers, CNRS, Inst Paleoprimatol Paleontol Humaine Evolut & Pa, UMR 7262, Poitiers, France.	olga.otero@univ-poitiers.fr	Otero, Olga/T-5467-2018	Otero, Olga/0000-0002-8129-2054	Agence Nationale pour la Recherche programme EVAH [ANR05-blan-0235]; Agence National pour la Recherche (program EVAH) [ANR05-blan-0235]	Agence Nationale pour la Recherche programme EVAH(French National Research Agency (ANR)); Agence National pour la Recherche (program EVAH)(French National Research Agency (ANR))	This research was funded by the Agence Nationale pour la Recherche (http://www.agence-nationale-recherche.fr/) programme EVAH, number ANR05-blan-0235.; We thank all of the members of the French-Libyan Paleontological Mission, notably Awad A. Bilal (Benghazi), Mouloud Benammi, Yaowalak Chaimanee and Olivier Chavasseau (Poitiers), Pauline Coster (Kansas), Bernard Marandat and Laurent Marivaux (Montpellier). The MPFL research project is a scientific collaboration between the University of Poitiers (France) and the University of Tripoli (Libya). The MPFL fieldwork and research is supported by the Agence National pour la Recherche (program EVAH, number ANR05-BLAN-0235). We extend gratitude to the editor who handled the manuscript and to the anonymous reviewer and to Alison Murray (Canada) for their comments.	ARAMBOURG C, 1961, CR HEBD ACAD SCI, V252, P1181; Arambourg C., 1963, Publications in Anthropology Viking Fund, V36, P55; Ashour A, 2012, J AFR EARTH SCI, V65, P72, DOI 10.1016/j.jafrearsci.2012.02.004; BELLAIR P, 1954, CR HEBD ACAD SCI, V239, P1822; Bleeker P, 1858, ACTA SOC REGIAE SCIE, V4; Churcher CS, 2001, PALAEONTOLOGY, V44, P305, DOI 10.1111/1475-4983.00181; Cocchi I, 1824, ANNALI MUSEO FIRENZE, V4, P63; Cuvier G., 1829, REGNE ANIMAL DISTRIB; Cuvier G J L r., 1816, POISSONS MOLLUSQUESE; ESTES R, 1969, COPEIA, P317; GINGERICH PD, 1992, U MICHIGAN PAPERS PA, V30, P1; Jaeger JJ, 2010, NATURE, V467, P1096, DOI 10.1038/nature09425; Jaeger JJ, 2010, ZOOL J LINN SOC-LOND, V160, P195, DOI 10.1111/j.1096-3642.2009.00600.x; Jordan DS, 1923, STANFORD U PUBL U BS, V3, P77, DOI [10.5962/bhl.title.161386, DOI 10.5962/BHL.TITLE.161386]; Kner R, 1855, MATH NATURWISSENSCHA, V17, P313; Lacepede B. G. E., 1803, HIST NATURELLE POISS, V5; Longbottom A, 2010, PALAEONTOLOGY, V53, P571, DOI 10.1111/j.1475-4983.2010.00946.x; Martin M., 1997, EARTH PLANETARY S 2A, V325, P635; Martin Michel, 1995, Geobios Memoire Special (Villeurbanne), V19, P275; Murray AM, 2010, J VERTEBR PALEONTOL, V30, P665, DOI 10.1080/02724631003758060; Murray AM, 2006, J PALEONTOL, V80, P1172, DOI 10.1666/0022-3360(2006)80[1172:ANCTCF]2.0.CO;2; Murray AM, 2003, CAN J EARTH SCI, V40, P983, DOI 10.1139/E03-031; Murray AM, 2002, J VERTEBR PALEONTOL, V22, P453, DOI 10.1671/0272-4634(2002)022[0453:LPJOAC]2.0.CO;2; Murray AM, 2004, J VERTEBR PALEONTOL, V24, P299, DOI 10.1671/1948; Murray AM, 2004, PALAEONTOLOGY, V47, P711, DOI 10.1111/j.0031-0239.2004.00384.x; Otero O, 1999, NEUES JAHRB GEOL P-M, P81; Otero O, 2008, GEOL SOC SPEC PUBL, V295, P155, DOI 10.1144/SP295.10; Otero O, 2011, FISH FISH, V12, P235, DOI 10.1111/j.1467-2979.2010.00389.x; Otero O, 2010, PALAEONTOGR ABT A, V292, P21, DOI 10.1127/pala/292/2010/21; Otero O, 2010, CYBIUM, V34, P93; Otero O, 2009, J AFR EARTH SCI, V54, P62, DOI 10.1016/j.jafrearsci.2009.03.004; Owen R., 1839, P LINN SOC LONDON, V1, P27; Paugy D, 2008, FAUNAFRI VERSION; Pinton A, 2011, J VERTEBR PALEONTOL, V31, P22, DOI 10.1080/02724634.2011.539648; Rasmussen DT, 2008, DEV PRIMATOL-PROG PR, P181, DOI 10.1007/978-0-387-73896-3_13; Regan C. T., 1920, Annals & Magazine of Natural History Series 9, V5; Risch Luc M., 1992, Faune Tropicale, V28, P395; Savage R. J. G., 1969, Proceedings of the Geological Society London, V1969, P167; Savage R. J. G., 1971, S GEOL LIB U LIB TRI, P215; Seiffert ER, 2008, DEV PRIMATOL-PROG PR, P71, DOI 10.1007/978-0-387-73896-3_8; Stewart KM, 2001, FISH FISH, V2, P177, DOI 10.1046/j.1467-2960.2001.00052.x; STEWART KM, 2003, LOTHAGAM DAWN HUMANI, P79; STIASSNY M L J, 1987, Bulletin of the Museum of Comparative Zoology, V151, P269; Stiassny M.L.J., 1989, ANN SCI ZOOL MARC TE, V258, P1; TEUGELS G G, 1984, Cybium, V8, P1; Wright AWR, 1980, GEOLOGY LIBYA, V1, P309	46	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144358	10.1371/journal.pone.0144358	http://dx.doi.org/10.1371/journal.pone.0144358			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674637	Green Published, gold			2022-12-26	WOS:000366722700037
J	Schoene, D; Valenzuela, T; Toson, B; Delbaere, K; Severino, C; Garcia, J; Davies, TA; Russell, F; Smith, ST; Lord, SR				Schoene, Daniel; Valenzuela, Trinidad; Toson, Barbara; Delbaere, Kim; Severino, Connie; Garcia, Jaime; Davies, Thomas A.; Russell, Frances; Smith, Stuart T.; Lord, Stephen R.			Interactive Cognitive-Motor Step Training Improves Cognitive Risk Factors of Falling in Older Adults - A Randomized Controlled Trial	PLOS ONE			English	Article							DUAL-TASK CONDITIONS; VIDEO-GAME; DEPRESSION SEVERITY; EXERCISE; PEOPLE; SINGLE; GAIT; INTERVENTION; METAANALYSIS; PERFORMANCE	Purpose Interactive cognitive-motor training (ICMT) requires individuals to perform both gross motor movements and complex information processing. This study investigated the effectiveness of ICMT on cognitive functions associated with falls in older adults. Methods A single-blinded randomized controlled trial was conducted in community-dwelling older adults (N = 90, mean age 81.5 +/- 7) without major cognitive impairment. Participants in the intervention group (IG) played four stepping games that required them to divide attention, inhibit irrelevant stimuli, switch between tasks, rotate objects and make rapid decisions. The recommended minimum dose was three 20-minute sessions per week over a period of 16 weeks unsupervised at home. Participants in the control group (CG) received an evidence- based brochure on fall prevention. Measures of processing speed, attention/executive function (EF), visuo-spatial ability, concerns about falling and depression were assessed before and after the intervention. Results Eighty-one participants (90%) attended re-assessment. There were no improvements with respect to the Stroop Stepping Test (primary outcome) in the intervention group. Compared to the CG, the IG improved significantly in measures of processing speed, visuo-spatial ability and concern about falling. Significant interactions were observed for measures of EF and divided attention, indicating group differences varied for different levels of the covariate with larger improvements in IG participants with poorer baseline performance. The interaction for depression showed no change for the IG but an increase in the CG for those with low depressive symptoms at baseline. Additionally, low and high-adherer groups differed in their baseline performance and responded differently to the intervention. Compared to high adherers, low adherers improved more in processing speed and visual scanning while high-adherers improved more in tasks related to EF. Conclusions This study shows that unsupervised stepping ICMT led to improvements in specific cognitive functions associated with falls in older people. Low adherers improved in less complex functions while high-adherers improved in EF.	[Schoene, Daniel; Valenzuela, Trinidad; Toson, Barbara; Delbaere, Kim; Severino, Connie; Davies, Thomas A.; Smith, Stuart T.; Lord, Stephen R.] Univ New S Wales, Neurosci Res Australia, Sydney, NSW, Australia; [Schoene, Daniel] Univ Erlangen Nurnberg, Inst Biomed Aging, Nurnberg, Germany; [Valenzuela, Trinidad] Univ Finis Terrae, Fac Med, Sch Kinesiol, Exercise Sci Lab, Santiago, Chile; [Garcia, Jaime] Univ Technol Sydney, iNEXT, mHlth Lab, Sydney, NSW 2007, Australia; [Russell, Frances] Australian Catholic Univ, RSL LifeCare Chair Ageing, Sydney, NSW, Australia; [Smith, Stuart T.] Univ Sunshine Coast, Fac Arts & Business, Sippy Downs, Qld 4556, Australia	Neuroscience Research Australia; University of New South Wales Sydney; University of Erlangen Nuremberg; Universidad Finis Terrae; University of Technology Sydney; Australian Catholic University; University of the Sunshine Coast	Lord, SR (corresponding author), Univ New S Wales, Neurosci Res Australia, Sydney, NSW, Australia.	s.lord@neura.edu.au	Valenzuela, Trinidad/AAE-7451-2022; Schoene, Daniel/H-8861-2019; Delbaere, Kim/D-6370-2011; Toson, Barbara/M-4534-2019	Schoene, Daniel/0000-0003-0717-5746; Delbaere, Kim/0000-0002-5655-0234; Toson, Barbara/0000-0001-6661-9971; Lord, Stephen R/0000-0002-7111-8802; Garcia, Jaime/0000-0001-5718-1605; Valenzuela, Trinidad/0000-0001-7764-0223; Smith, Stuart/0000-0002-4735-6026	National Health and Medical Research Council [568975]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council Partnership Grant (568975)-SRL, STS, KD; International Postgraduate Research Scholarship-DS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson-Hanley C, 2012, AM J PREV MED, V42, P109, DOI 10.1016/j.amepre.2011.10.016; Anstey KJ, 2009, NEUROPSYCHOLOGY, V23, P500, DOI 10.1037/a0015389; Arbuthnott K, 2000, J CLIN EXP NEUROPSYC, V22, P518, DOI 10.1076/1380-3395(200008)22:4;1-0;FT518; Berteau-Pavy D, 2011, PEBL TECHNICAL REPOR; Best JR, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00353; Borson S, 2000, INT J GERIATR PSYCH, V15, P1021, DOI 10.1002/1099-1166(200011)15:11<1021::AID-GPS234>3.0.CO;2-6; Brach JS, 2013, J AM GERIATR SOC, V61, P1879, DOI 10.1111/jgs.12506; Bridle C, 2012, BRIT J PSYCHIAT, V201, P180, DOI 10.1192/bjp.bp.111.095174; Bula CJ, 2011, GERONTOLOGY, V57, P276, DOI 10.1159/000322241; Chatfield MD, 2005, J CLIN EPIDEMIOL, V58, P13, DOI 10.1016/j.jclinepi.2004.05.006; Colcombe SJ, 2004, P NATL ACAD SCI USA, V101, P3316, DOI 10.1073/pnas.0400266101; DEBRUIN ED, 2011, J NOV PHYSIOTHER, V1, P104, DOI DOI 10.4172/2165-7025.1000104; Delbaere K, 2011, J GERONTOLOGY A; Fabre C, 2002, INT J SPORTS MED, V23, P415, DOI 10.1055/s-2002-33735; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Fan J, 2009, BRAIN COGNITION, V70, P209, DOI 10.1016/j.bandc.2009.02.002; Fischer J.S., 2012, NEUROPSYCHOLOGICAL A, V5th; Foley L. S., 2008, MENTAL HLTH PHYS ACT, V1, P69, DOI DOI 10.1016/J.MHPA.2008.07.001; Fraser SA, 2014, GAMES HEALTH J, V3, P172, DOI 10.1089/g4h.2013.0095; Gillespie L.D., 2012, COCHRANE DATABASE SY; Green CS, 2008, PSYCHOL AGING, V23, P692, DOI 10.1037/a0014345; Gregory MA, 2013, CURR SPORT MED REP, V12, P256, DOI 10.1249/JSR.0b013e31829a74fd; Groll DL, 2005, J CLIN EPIDEMIOL, V58, P595, DOI 10.1016/j.jclinepi.2004.10.018; Hsu CL, 2012, OSTEOPOROSIS INT, V23, P2409, DOI 10.1007/s00198-012-1992-z; Kayama H, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.3108; Kelly ME, 2014, AGEING RES REV, V16, P12, DOI 10.1016/j.arr.2014.05.002; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kueider AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040588; Kvelde T, 2013, J AM GERIATR SOC, V61, P694, DOI 10.1111/jgs.12209; Laver K, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-64; Lord SR, 2003, PHYS THER, V83, P237, DOI 10.1093/ptj/83.3.237; Lord SR, 2001, J GERONTOL A-BIOL, V56, pM627, DOI 10.1093/gerona/56.10.M627; Maillot P, 2012, PSYCHOL AGING, V27, P589, DOI 10.1037/a0026268; Martin K, 2009, DEMENT GERIATR COGN, V27, P451, DOI 10.1159/000216840; Martin KL, 2013, J GERONTOL A-BIOL, V68, P1091, DOI 10.1093/gerona/glt010; Martin M, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006220.pub2; Mueller ST, 2014, J NEUROSCI METH, V222, P250, DOI 10.1016/j.jneumeth.2013.10.024; Oei AC, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00054; Oswald Wolf D, 2006, Eur J Ageing, V3, P179, DOI 10.1007/s10433-006-0035-z; Peng W, 2011, CYBERPSYCH BEH SOC N, V14, P681, DOI 10.1089/cyber.2010.0578; Pichierri G, 2012, BMC GERIATR, V12, DOI 10.1186/1471-2318-12-74; Pichierri G, 2012, CLIN INTERV AGING, V7, P175, DOI 10.2147/CIA.S32558; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Raz A, 2006, NAT REV NEUROSCI, V7, P367, DOI 10.1038/nrn1903; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Schoene D, 2014, BMC GERIATR, V14, DOI 10.1186/1471-2318-14-107; Schoene D, 2014, AGE AGEING, V43, P285, DOI 10.1093/ageing/aft157; Schoene D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057734; Schoene D, 2011, ARCH PHYS MED REHAB, V92, P947, DOI 10.1016/j.apmr.2011.01.012; Silsupadol P, 2009, ARCH PHYS MED REHAB, V90, P381, DOI 10.1016/j.apmr.2008.09.559; Smith ST, 2013, IEEE ENG MED BIO, P7033, DOI 10.1109/EMBC.2013.6611177; Spreen O, 1998, COMPENDIUM NEUROPSYC; Studenski S, 2010, J NUTR HEALTH AGING, V14, P850, DOI 10.1007/s12603-010-0119-5; Theill N, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-103; Van Breukelen GJP, 2006, J CLIN EPIDEMIOL, V59, P920, DOI 10.1016/j.jclinepi.2006.02.007; Wolf SL, 2003, J AM GERIATR SOC, V51, P1693, DOI 10.1046/j.1532-5415.2003.51552.x; Zhou SS, 2011, BRAIN COGNITION, V75, P205, DOI 10.1016/j.bandc.2010.12.003	57	73	74	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145161	10.1371/journal.pone.0145161	http://dx.doi.org/10.1371/journal.pone.0145161			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9JH	26673919	Green Submitted, Green Published, gold			2022-12-26	WOS:000366722700109
J	Shan, HD; Ni, YQ; Xue, K; Yu, J; Huang, X				Shan, Haidong; Ni, Yinqing; Xue, Kang; Yu, Jia; Huang, Xin			Type 1 Retinopathy of Prematurity and Its Laser Treatment of Large Preterm Infants in East China	PLOS ONE			English	Article							AGGRESSIVE POSTERIOR RETINOPATHY; BIRTH-WEIGHT; RISK-FACTORS; DISEASE; BABIES; ROLES; GRAMS; UNITS	Purpose To describe Type 1 retinopathy of prematurity (ROP) and its laser treatment outcomes in premature infants with birth weight > 1250 g in Eastern China. Methods A retrospective review of 3175 ROP records was conducted at Shanghai Eye & ENT Hospital of Fudan University. The records were collected at the ROP clinic from 2006 to 2014, including their demographic and medical information such as gestational age, birth weight, supplemental oxygen therapy, systemic complications, ROP stage, location, presence of plus disease. All infants were examined by RetCam fundus camera. Those with Type 1 ROP were also examined by indirect ophthalmoscope before undergoing transpupillary laser treatment. Results A total of 12 infants (24 eyes) with Type 1 ROP and birth weight > 1250 g were enrolled. All infants enrolled had plus disease and ROP in zone II retina. Specifically, 16 eyes (67%) had stage 2 ROP. 8 eyes (33%) had stage 3 ROP. ROP regressed in 23 eyes (96%) following laser treatment. Partial retinal detachment developed in one eye (4%). No severe involution sequelaes or laser-related complications were recorded. Mean follow-up was 30 +/- 6 weeks. Conclusion Type 1 ROP may occur in large premature infants who have undergone supplemental oxygen therapy. This Type 1 ROP is mainly located in zone II retina. Laser treatment is a safe and effective intervention for these infants.	[Shan, Haidong; Ni, Yinqing; Xue, Kang; Yu, Jia; Huang, Xin] Fudan Univ, Dept Ophthalmol & Visual Sci, Eye & ENT Hosp, Shanghai 200031, Peoples R China; [Shan, Haidong; Ni, Yinqing; Xue, Kang; Yu, Jia; Huang, Xin] Fudan Univ, Shanghai Key Lab Visual Impairment & Restorat, Shanghai 200031, Peoples R China; [Shan, Haidong] Kashgar Prefecture Second Peoples Hosp, Dept Ophthalmol, Xinjiang 844000, Peoples R China	Fudan University; Fudan University	Huang, X (corresponding author), Fudan Univ, Dept Ophthalmol & Visual Sci, Eye & ENT Hosp, Shanghai 200031, Peoples R China.	shanghaieent@yahoo.com			National Natural Science Foundation of China; Natural Science Foundation of Shanghai Municipality; Young Fellow Grant of Shanghai Health Bureau; Young Fellow Grant of Fudan University; China State Scholarship; Winkler Award of China Oxford Scholarship; Henry Lester Fund; Wing Yip Bursary	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shanghai Municipality(Natural Science Foundation of Shanghai); Young Fellow Grant of Shanghai Health Bureau; Young Fellow Grant of Fudan University; China State Scholarship; Winkler Award of China Oxford Scholarship; Henry Lester Fund; Wing Yip Bursary	The authors thank support from National Natural Science Foundation of China, Natural Science Foundation of Shanghai Municipality, Young Fellow Grant of Shanghai Health Bureau, Young Fellow Grant of Fudan University, China State Scholarship, Winkler Award of China Oxford Scholarship, Henry Lester Fund and Wing Yip Bursary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Lu Ruan and Dr. Cheng Jiang for their help in data collection. The authors thank supports from National Natural Science Foundation of China, Natural Science Foundation of Shanghai Municipality, Young Fellow Grant of Shanghai Health Bureau, Young Fellow Grant of Fudan University, China State Scholarship, Winkler Award of China Oxford Scholarship, Henry Lester Fund and Wing Yip Bursary.	Azuma N, 2006, AM J OPHTHALMOL, V142, P636, DOI 10.1016/j.ajo.2006.05.048; Chan-Ling T, 2004, INVEST OPHTH VIS SCI, V45, P2020, DOI 10.1167/iovs.03-1169; Chen Y, 2008, BRIT J OPHTHALMOL, V92, P326, DOI 10.1136/bjo.2007.131813; Chen Y, 2006, BRIT J OPHTHALMOL, V90, P268, DOI 10.1136/bjo.2005.078063; Chen Y, 2015, RETINA-J RET VIT DIS, V35, P1674, DOI 10.1097/IAE.0000000000000512; Chen Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116669; Chen Yi-Hsing, 2013, Biomed J, V36, P84, DOI 10.4103/2319-4170.110399; Flynn JT, 2006, AM J OPHTHALMOL, V142, P46, DOI 10.1016/j.ajo.2006.02.018; Gole GA, 2005, ARCH OPHTHALMOL-CHIC, V123, P991, DOI 10.1001/archopht.123.7.991; Good William V, 2004, Trans Am Ophthalmol Soc, V102, P233; Good WV, 2003, ARCH OPHTHALMOL-CHIC, V121, P1684; Gu MH, 2011, MED PRIN PRACT, V20, P244, DOI 10.1159/000323764; Hughes S, 2000, INVEST OPHTH VIS SCI, V41, P1217; Hutchinson AK, 2003, J AAPOS, V7, P190, DOI 10.1016/S1091-8531(02)42018-6; Jandeck C, 1996, BRIT J OPHTHALMOL, V80, P728, DOI 10.1136/bjo.80.8.728; Lichtenstein SJ, 2006, PEDIATRICS, V117, P572, DOI 10.1542/peds.2005-2749; Murakami Y, 2008, BRIT J OPHTHALMOL, V92, P1456, DOI 10.1136/bjo.2008.138867; Nishina S, 2009, OPHTHALMOLOGY, V116, P2442, DOI 10.1016/j.ophtha.2009.05.011; Sanghi G, 2014, INDIAN J OPHTHALMOL, V62, DOI 10.4103/0301-4738.128639; Sanghi G, 2009, RETINA-J RET VIT DIS, V29, P1335, DOI 10.1097/IAE.0b013e3181a68f3a; Shah PK, 2012, ARCH DIS CHILD-FETAL, V97, pF371, DOI 10.1136/fetalneonatal-2011-301121; Stone J, 1996, INVEST OPHTH VIS SCI, V37, P290; Travassos A, 2007, OPHTHAL SURG LAS IM, V38, P233, DOI 10.3928/15428877-20070501-09; Wilkinson AR, 2009, EYE, V23, P2137, DOI 10.1038/eye.2008.128; Xu Y, 2013, INVEST OPHTH VIS SCI, V54, P8229, DOI 10.1167/iovs.13-12297; Yanovitch TL, 2006, J AAPOS, V10, P128, DOI 10.1016/j.jaapos.2005.08.005	26	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144313	10.1371/journal.pone.0144313	http://dx.doi.org/10.1371/journal.pone.0144313			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674190	Green Submitted, Green Published, gold			2022-12-26	WOS:000366722700034
J	Ding, YM; Li, YY; Lu, LC; Zhang, RY; Zeng, LH; Wang, LL; Zhang, X				Ding, Yuemin; Li, Yuying; Lu, Lingchao; Zhang, Ruyi; Zeng, Linghui; Wang, Linlin; Zhang, Xiong			Inhibition of Nischarin Expression Promotes Neurite Outgrowth through Regulation of PAK Activity	PLOS ONE			English	Article							BINDING PROTEIN; RHO-GTPASES; CELL-MIGRATION; GROWTH CONE; PC12 CELLS; P21-ACTIVATED-KINASE-1 PAK1; NEURONAL MORPHOLOGY; EPITHELIAL-CELLS; P35/CDK5 KINASE; RAC	Nischarin is a cytoplasmic protein expressed in various organs that plays an inhibitory role in cell migration and invasion and the carcinogenesis of breast cancer cells. We previously reported that Nischarin is highly expressed in neuronal cell lines and is differentially expressed in the brain tissue of adult rats. However, the physiological function of Nischarin in neural cells remains unknown. Here, we show that Nischarin is expressed in rat primary cortical neurons but not in astrocytes. Nischarin is localized around the nucleus and dendrites. Using shRNA to knockdown the expression of endogenous Nischarin significantly increases the percentage of neurite-bearing cells, remarkably increases neurite length, and accelerates neurite extension in neuronal cells. Silencing Nischarin expression also promotes dendrite elongation in rat cortical neurons where Nischarin interacts with p21-activated kinase 1/2 (PAK1/2) and negatively regulates phosphorylation of both PAK1 and PAK2. The stimulation of neurite growth observed in cells with decreased levels of Nischarin is partially abolished by IPA3-mediated inhibition of PAK1 activity. Our findings indicate that endogenous Nischarin inhibits neurite outgrowth by blocking PAK1 activation in neurons.	[Ding, Yuemin; Lu, Lingchao; Zeng, Linghui] Zhejiang Univ City Coll, Sch Med, Dept Clin Med, Hangzhou 310015, Zhejiang, Peoples R China; [Li, Yuying] Quzhou Coll Technol, Dept Physiol, Sch Med, Quzhou 324000, Peoples R China; [Zhang, Ruyi] Jiaxing Second Hosp, Dept Pathol, Jiaxing 314000, Peoples R China; [Wang, Linlin; Zhang, Xiong] Zhejiang Univ, Sch Med, Dept Basic Med Sci, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University City College; Zhejiang University	Wang, LL (corresponding author), Zhejiang Univ, Sch Med, Dept Basic Med Sci, Hangzhou 310058, Zhejiang, Peoples R China.	wanglinlin@zju.edu.cn; xiongzhang@zju.edu.cn			National Natural Science Foundation of China [81000535, 81371953]; Natural Science Foundation of Zhejiang Province [LY14H090002, LY15H250001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province)	This work was supported by a National Natural Science Foundation of China (no. 81000535) to YD, by a Natural Science Foundation of Zhejiang Province (no. LY14H090002) to YD, by a National Natural Science Foundation of China (no. 81371953) to LW, and by a Natural Science Foundation of Zhejiang Province (no. LY15H250001) to XZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alahari SK, 2004, EMBO J, V23, P2777, DOI 10.1038/sj.emboj.7600291; Alahari SK, 2004, BIOCHEM J, V377, P449, DOI 10.1042/BJ20030411; Alahari SK, 2003, EXP CELL RES, V288, P415, DOI 10.1016/S0014-4827(03)00233-7; Alahari SK, 2000, J CELL BIOL, V151, P1141, DOI 10.1083/jcb.151.6.1141; Auer M, 2011, ANN ANAT, V193, P259, DOI 10.1016/j.aanat.2011.02.015; Baranwal S, 2011, J NATL CANCER I, V103, P1513, DOI 10.1093/jnci/djr350; Bokoch GM, 2003, ANNU REV BIOCHEM, V72, P743, DOI 10.1146/annurev.biochem.72.121801.161742; Bouquet C, 2007, ADV EXP MED BIOL, V621, P1, DOI 10.1007/978-0-387-76715-4_1; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; Daniels RH, 1998, EMBO J, V17, P754, DOI 10.1093/emboj/17.3.754; Dent EW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a001800; Ding YM, 2008, MOL CELL BIOL, V28, P3742, DOI 10.1128/MCB.01832-07; Ding YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054563; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Hall A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001818; Hayashi K, 2002, MOL CELL NEUROSCI, V20, P579, DOI 10.1006/mcne.2002.1144; Jain P, 2013, J BIOL CHEM, V288, P15495, DOI 10.1074/jbc.M112.418103; Kozma R, 1997, MOL CELL BIOL, V17, P1201, DOI 10.1128/MCB.17.3.1201; Kreis P, 2009, CELL SIGNAL, V21, P384, DOI 10.1016/j.cellsig.2008.11.001; Kuijl C, 2013, EMBO J, V32, P713, DOI 10.1038/emboj.2013.10; Langhammer CG, 2010, CYTOM PART A, V77A, P1160, DOI 10.1002/cyto.a.20954; Li F, 2012, ADDICT BIOL, V17, P392, DOI 10.1111/j.1369-1600.2011.00373.x; Li S, 2013, J NEUROSCI, V33, P790, DOI 10.1523/JNEUROSCI.1238-12.2013; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; MANSER E, 1994, NATURE, V367, P40, DOI 10.1038/367040a0; Marler KJM, 2005, MOL CELL BIOL, V25, P5226, DOI 10.1128/MCB.25.12.5226-5241.2005; Nikolic M, 1998, NATURE, V395, P194, DOI 10.1038/26034; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Rashid T, 2001, J BIOL CHEM, V276, P49043, DOI 10.1074/jbc.M105599200; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; Saha RN, 2009, J IMMUNOL, V183, P2068, DOI 10.4049/jimmunol.0801892; Schaefer AW, 2008, DEV CELL, V15, P146, DOI 10.1016/j.devcel.2008.05.003; Schwieger J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133680; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Sebok A, 1999, J NEUROCHEM, V73, P949, DOI 10.1046/j.1471-4159.1999.0730949.x; Shin EY, 2009, BIOCHEM BIOPH RES CO, V379, P384, DOI 10.1016/j.bbrc.2008.12.066; Shin EY, 2002, J BIOL CHEM, V277, P44417, DOI 10.1074/jbc.M203754200; Thies E, 2003, J NEUROBIOL, V54, P358, DOI 10.1002/neu.10135; Wu XH, 2013, INFLAMM RES, V62, P929, DOI 10.1007/s00011-013-0631-2; Zhu PM, 2005, J NEUROSCI RES, V81, P817, DOI 10.1002/jnr.20597	40	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144948	10.1371/journal.pone.0144948	http://dx.doi.org/10.1371/journal.pone.0144948			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670864	Green Published, Green Submitted, gold			2022-12-26	WOS:000366719300034
J	McClelland, D; Murray, GI				McClelland, David; Murray, Graeme I.			A Comprehensive Study of Extramural Venous Invasion in Colorectal Cancer	PLOS ONE			English	Article							VASCULAR INVASION; LYMPHOVASCULAR INVASION; PROGNOSTIC-SIGNIFICANCE; ADJUVANT CHEMOTHERAPY; CARCINOMA; SURVIVAL; STAIN; ELASTICA; RECTUM	Colorectal cancer is a common malignancy and a leading cause of cancer related death. Cancer staging following resection is key to determining any adjuvant therapy in those patients with high risk disease. In colorectal cancer, tumour stage and lymph node stage are the main pathological factors which have been considered to influence outcome. Increasing emphasis is now being placed on other factors, especially the presence of extramural venous invasion (EMVI). It is important to understand the relationship of EMVI with other pathological factors and to confirm that in an individual centre that EMVI is being detected at an appropriate rate and is of prognostic significance. This comprehensive study assesses the reporting and prognostic significance of EMVI in a single centre, using prospectively collected data from histopathology reports of a cohort of 2405 patients who underwent surgery for colorectal cancer over a nine year period. Overall, EMVI was reported in 27.9% of colorectal cancer excision specimens. In tumours (n = 1928) that had not received neoadjuvant therapy, the presence of EMVI varied significantly depending on tumour site (chi(2) = 12.03, p < 0.005), tumour stage (chi(2) = 268.188, p < 0.001), lymph node stage (chi(2) = 294.368, p < 0.001) and Dukes' stage (chi(2) = 253.753, p < 0.001). Multivariate analysis confirmed EMVI as a significant independent prognostic indicator (p < 0.001). In conclusion, the presence of EMVI as an independent prognostic indicator is shown and is related to other pathological and prognostic factors. This study emphasises the requirement for the accurate identification of EMVI in colorectal cancer excision specimens and also understanding the relationship of EMVI with other prognostic factors.	[McClelland, David] NHS Grampian, Aberdeen Royal Infirm, Dept Pathol, Aberdeen, Scotland; [Murray, Graeme I.] Univ Aberdeen, Sch Med Med Sci & Nutr, Div Appl Med, Pathol, Aberdeen, Scotland	University of Aberdeen; University of Aberdeen	Murray, GI (corresponding author), Univ Aberdeen, Sch Med Med Sci & Nutr, Div Appl Med, Pathol, Aberdeen, Scotland.	g.i.murray@abdn.ac.uk						Abdulkader M, 2006, HISTOPATHOLOGY, V49, P487, DOI 10.1111/j.1365-2559.2006.02533.x; Barresi V, 2012, AM J SURG PATHOL, V36, P66, DOI 10.1097/PAS.0b013e31822d3008; Benson AB, 2004, J CLIN ONCOL, V22, P3408, DOI 10.1200/JCO.2004.05.063; Betge J, 2012, CANCER-AM CANCER SOC, V118, P628, DOI 10.1002/cncr.26310; Brown GT, 2016, HISTOPATHOLOGY, V68, P556, DOI 10.1111/his.12780; Coghlin C, 2015, PROTEOM CLIN APPL, V9, P64, DOI 10.1002/prca.201400082; Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979; Dawson H, 2014, FRONT ONCOL, V4, P354, DOI DOI 10.3389/fonc.2014.00354; Dirschmid K, 2012, J CLIN PATHOL, V65, P619, DOI 10.1136/jclinpath-2011-200552; Gibson KM, 2014, DIS COLON RECTUM, V57, P916, DOI 10.1097/DCR.0000000000000162; Gray R, 2007, LANCET, V370, P2020, DOI 10.1016/s0140-6736(07)61866-2; HORN A, 1991, DIS COLON RECTUM, V34, P798, DOI 10.1007/BF02051074; Howlett CJ, 2009, J CLIN PATHOL, V62, P1021, DOI 10.1136/jcp.2009.065615; Hyslop T, 2013, J CANCER, V4, P193, DOI 10.7150/jca.5830; Kingston EF, 2007, DIS COLON RECTUM, V50, P1867, DOI 10.1007/s10350-007-9021-6; Kirsch R, 2013, AM J SURG PATHOL, V37, P200, DOI 10.1097/PAS.0b013e31826a92cd; Loughrey MB, 2014, STANDARDS DATASETS R; Meguerditchian AN, 2005, AM J SURG, V189, P707, DOI 10.1016/j.amjsurg.2005.03.012; Messenger DE, 2012, HUM PATHOL, V43, P965, DOI 10.1016/j.humpath.2011.11.015; Messenger DE, 2011, J CLIN PATHOL, V64, P983, DOI 10.1136/jclinpath-2011-200156; MINSKY BD, 1988, CANCER, V61, P1417, DOI 10.1002/1097-0142(19880401)61:7<1417::AID-CNCR2820610723>3.0.CO;2-9; Nagtegaal ID, 2015, HISTOPATHOLOGY, V66, P102, DOI 10.1111/his.12563; O'Dwyer D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027718; O'Shea A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104991; Parnaby CN, 2015, BRIT J CANCER, V113, P212, DOI 10.1038/bjc.2015.211; Petersen VC, 2002, GUT, V51, P65, DOI 10.1136/gut.51.1.65; Roxburgh CSD, 2011, J CLIN PATHOL, V64, P1142, DOI 10.1136/jclinpath-2011-200284; Roxburgh CSD, 2010, ANN SURG, V252, P989, DOI 10.1097/SLA.0b013e3181f1c60d; Signguideline. Scottish Intercollegiate Guidelines Network (SIGN), 2011, SCOTT INT GUID NETW; Sternberg A, 2002, J CLIN PATHOL, V55, P17, DOI 10.1136/jcp.55.1.17; TALBOT IC, 1981, HISTOPATHOLOGY, V5, P141, DOI 10.1111/j.1365-2559.1981.tb01774.x; van Wyk HC, 2014, CRIT REV ONCOL HEMAT, V90, P77, DOI 10.1016/j.critrevonc.2013.11.004; Vass DG, 2004, J CLIN PATHOL, V57, P769, DOI 10.1136/jcp.2003.015826; Williams G, 2007, DATASET COLORECTAL C; Woods YL, 2014, J CLIN PATHOL, V67, P499, DOI 10.1136/jclinpath-2013-202060; Young PE, 2014, J CANCER, V5, P262, DOI 10.7150/jca.7988	36	27	29	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144987	10.1371/journal.pone.0144987	http://dx.doi.org/10.1371/journal.pone.0144987			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671331	Green Published, Green Submitted, gold			2022-12-26	WOS:000366719300037
J	Vered, O; Simon-Tuval, T; Yagupsky, P; Malul, M; Cicurel, A; Davidovitch, N				Vered, Oded; Simon-Tuval, Tzahit; Yagupsky, Pablo; Malul, Miki; Cicurel, Assi; Davidovitch, Nadav			The Price of a Neglected Zoonosis: Case-Control Study to Estimate Healthcare Utilization Costs of Human Brucellosis	PLOS ONE			English	Article							BENEFIT-ANALYSIS; CONTROL STRATEGIES; VACCINATION; DIAGNOSIS	Human brucellosis has reemerged as a serious public health threat to the Bedouin population of southern Israel in recent years. Little is known about its economic implications derived from elevated healthcare utilization (HCU). Our objective was to estimate the HCU costs associated with human brucellosis from the insurer perspective. A case-control retrospective study was conducted among Clalit Health Services (CHS) enrollees. Brucellosis cases were defined as individuals that were diagnosed with brucellosis at the Clinical Microbiology Laboratory of Soroka University Medical Center in the 2010-2012 period (n = 470). Control subjects were randomly selected and matched 1: 3 by age, sex, clinic, and primary physician (n = 1,410). HCU data, demographic characteristics and comorbidities were obtained from CHS computerized database. Mean +/- SD age of the brucellosis cases was 26.6 +/- 17.6 years. 63% were male and 85% were Bedouins. No significant difference in Charlson comorbidity index was found between brucellosis cases and controls (0.41 vs. 0.45, respectively, P = 0.391). Before diagnosis (baseline), the average total annual HCU cost of brucellosis cases was slightly yet significantly higher than that of the control group ($439 vs. $382, P<0.05), however, no significant differences were found at baseline in the predominant components of HCU, i.e. hospitalizations, diagnostic procedures, and medications. At the year following diagnosis, the average total annual HCU costs of brucellosis cases was significantly higher than that of controls ($1,327 vs. $380, respectively, P<0.001). Most of the difference stems from 7.9 times higher hospitalization costs (p<0.001). Additional elevated costs were 3.6 times higher laboratory tests (P<0.001), 2.8 times higher emergency room visits (P<0.001), 1.8 times higher medication (P<0.001) and 1.3 times higher diagnostic procedures (P<0.001). We conclude that human brucellosis is associated with elevated HCU costs. Considering these results in cost-effective analyses may be crucial for both reducing health inequities and optimal allocation of health systems' scarce resources.	[Vered, Oded; Malul, Miki] Ben Gurion Univ Negev, Guilford Glazer Fac Business & Management, Dept Publ Policy & Adm, IL-84105 Beer Sheva, Israel; [Simon-Tuval, Tzahit; Davidovitch, Nadav] Ben Gurion Univ Negev, Dept Hlth Syst Management, Guilford Glazer Fac Business & Management, IL-84105 Beer Sheva, Israel; [Simon-Tuval, Tzahit; Cicurel, Assi; Davidovitch, Nadav] Ben Gurion Univ Negev, Fac Hlth Sci, Beer Sheva, Israel; [Yagupsky, Pablo] Ben Gurion Univ Negev, Soroka Univ Med Ctr, Clin Microbiol Lab, IL-84105 Beer Sheva, Israel; [Cicurel, Assi] Ben Gurion Univ Negev, Clalit Hlth Serv, Southern Dist, IL-84105 Beer Sheva, Israel	Ben Gurion University; Ben Gurion University; Ben Gurion University; Ben Gurion University; Soroka Medical Center; Ben Gurion University; Clalit Health Services	Simon-Tuval, T (corresponding author), Ben Gurion Univ Negev, Dept Hlth Syst Management, Guilford Glazer Fac Business & Management, IL-84105 Beer Sheva, Israel.	simont@bgu.ac.il	Tuval, Tzahit Simon/E-6328-2011	Tuval, Tzahit Simon/0000-0003-4518-7828; malul, miki/0000-0001-9985-8303				Anis E, 2011, ISR MED ASSOC J, V13, P359; [Anonymous], 2015, GUID ATC CLASS DDD A; Banai M, 2010, Prilozi, V31, P167; Blasco J M, 2010, Prilozi, V31, P145; Can MF, 2014, KAFKAS UNIV VET FAK, V20, P107, DOI 10.9775/kvfd.2013.9585; Can MF, 2011, KAFKAS UNIV VET FAK, V17, P601; Center for Disease Control and Prevention, 2010, CAS DEF NAT NOT DIS; Coelho AM, 2011, ARQ BRAS MED VET ZOO, V63, P1, DOI 10.1590/S0102-09352011000100001; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; Dean AS, 2012, PLOS NEGLECT TROP D, V6, DOI [10.1371/journal.pntd.0001929, 10.1371/journal.pntd.0001865]; DEYO RA, 1992, J CLIN EPIDEMIOL, V45, P613, DOI 10.1016/0895-4356(92)90133-8; del Pozo JSG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032090; Kumar A, 2010, Prilozi, V31, P219; Narrod C, 2012, ECOHEALTH, V9, P150, DOI 10.1007/s10393-012-0747-9; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Pappas G, 2005, NEW ENGL J MED, V352, P2325, DOI 10.1056/NEJMra050570; Perez-Avraham G, 2001, T ROY SOC TROP MED H, V95, P301, DOI 10.1016/S0035-9203(01)90241-X; Roth F, 2003, B WORLD HEALTH ORGAN, V81, P867; Rubach MP, 2013, CURR OPIN INFECT DIS, V26, P404, DOI 10.1097/QCO.0b013e3283638104; Ruiz-Mesa JD, 2005, CLIN MICROBIOL INFEC, V11, P221, DOI 10.1111/j.1469-0691.2004.01063.x; Shemesh AA, 2013, AIR WATER BORNE DIS, V2; Yousefi-Nooraie R, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007179.pub2; Zhen Q, 2013, CLIN MICROBIOL INFEC, V19, pE395, DOI 10.1111/1469-0691.12250; Zinsstag J, 2007, EMERG INFECT DIS, V13, P527, DOI 10.3201/eid1304.060381	24	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145086	10.1371/journal.pone.0145086	http://dx.doi.org/10.1371/journal.pone.0145086			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26669738	gold, Green Submitted, Green Published			2022-12-26	WOS:000366719300045
J	Zhu, B; Zhang, M; Williams, EM; Keller, C; Mansoor, A; Davie, JK				Zhu, B.; Zhang, M.; Williams, E. M.; Keller, C.; Mansoor, A.; Davie, J. K.			TBX2 represses PTEN in rhabdomyosarcoma and skeletal muscle	ONCOGENE			English	Article							CELL-CYCLE ARREST; EGR-1 TRANSCRIPTION FACTOR; BREAST-CANCER; MYOGENIC DIFFERENTIATION; SIGNALING PATHWAY; TUMOR SUPPRESSION; MUTANT MICE; KINASE-B; IN-VIVO; EXPRESSION	Rhabdomyosarcoma (RMS) is the most frequent soft tissue sarcoma in children that shares many features of developing skeletal muscle. TBX2, a T-box family member, is highly upregulated in tumor cells of both major RMS subtypes where it functions as an oncogene. TBX2 is a repressor that is often overexpressed in cancer cells and functions in bypassing cell growth control, including the repression of the cell cycle regulators p14 and p21. We have found that TBX2 directly represses the tumor-suppressor phosphatase and tensin homolog (PTEN) in both RMS and normal muscle. Exogenous expression of TBX2 in normal muscle cells downregulates PTEN, and depletion or interference with TBX2 in RMS cells upregulates PTEN. Human RMS tumors show high levels of TBX2 and correspondingly low levels of PTEN. The expression of PTEN in clinical RMS samples is relatively uncharacterized, and we establish that suppression of PTEN is a frequent event in both subtypes of RMS. TBX2 represses PTEN by directly binding to the promoter and recruiting the histone deacetylase, HDAC1. RMS cells have high levels of activated AKT owing to the deregulation of phosphoinositide-3 kinase (PI3K) signaling, and depletion or interference with TBX2, which upregulates PTEN, results in a reduction of phospho-AKT. We have also found that the highly related T-box family member TBX3 does not repress PTEN in the muscle lineage. This work suggests that TBX2 is a central component of the PTEN/PI3K/AKT signaling pathway deregulation in RMS cells and that targeting TBX2 in RMS tumors may offer a novel therapeutic approach for RMS.	[Zhu, B.; Zhang, M.; Davie, J. K.] Southern Illinois Univ, Sch Med, Dept Biochem & Mol Biol, 229 Neckers Bldg,1245 Lincoln Dr, Carbondale, IL 62901 USA; [Zhu, B.; Zhang, M.; Davie, J. K.] Southern Illinois Univ, Sch Med, Simmons Canc Inst, 229 Neckers Bldg,1245 Lincoln Dr, Carbondale, IL 62901 USA; [Williams, E. M.; Mansoor, A.] Oregon Hlth & Sci Univ, Dept Pathol, Portland, OR 97201 USA; [Keller, C.] Childrens Canc Therapy Dev Inst, Ft Collins, CO USA; [Zhu, B.] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA; [Zhang, M.] Yale Univ, Dept Pathol, New Haven, CT 06520 USA	Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; Oregon Health & Science University; Yale University; Yale University	Davie, JK (corresponding author), Southern Illinois Univ, Sch Med, Dept Biochem & Mol Biol, 229 Neckers Bldg,1245 Lincoln Dr, Carbondale, IL 62901 USA.; Davie, JK (corresponding author), Southern Illinois Univ, Sch Med, Simmons Canc Inst, 229 Neckers Bldg,1245 Lincoln Dr, Carbondale, IL 62901 USA.	jdavie@siumed.edu		Keller, Charles/0000-0003-2505-7487	American Cancer Society, Illinois Division [159609]; National Institute of Health, NIAMS division [RAR 060017A]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R15AR060017, R15AR068622] Funding Source: NIH RePORTER	American Cancer Society, Illinois Division(American Cancer Society); National Institute of Health, NIAMS division; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Terry Morgan, MD, PhD, Oregon Health and Sciences University for help with the statistical analysis of the archival RMS tumor samples. We thank Steven Verhulst, PhD, Southern Illinois University School of Medicine for help with the statistical analysis of the primary RMS tumor samples. This work was supported by grant 159609 from the American Cancer Society, Illinois Division to JD and by grant RAR 060017A from the National Institute of Health, NIAMS division.	Burgucu D, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-481; Carlson H, 2002, ONCOGENE, V21, P3827, DOI 10.1038/sj.onc.1205476; Castellino RC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010849; Chalhoub N, 2009, ANNU REV PATHOL-MECH, V4, P127, DOI 10.1146/annurev.pathol.4.110807.092311; Chung JH, 2005, CANCER RES, V65, P8096, DOI 10.1158/0008-5472.CAN-05-1888; Ciccarelli C, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-41; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Di Cristofano A, 1998, NAT GENET, V19, P348, DOI 10.1038/1235; Di Cristofano A, 2001, NAT GENET, V27, P222, DOI 10.1038/84879; Douglas NC, 2013, J MAMMARY GLAND BIOL, V18, P143, DOI 10.1007/s10911-013-9282-8; Fan WW, 2004, CANCER RES, V64, P5132, DOI 10.1158/0008-5472.CAN-04-0615; Hollenbach AD, 1999, EMBO J, V18, P3702, DOI 10.1093/emboj/18.13.3702; Huang W, 2007, ONCOGENE, V26, P2471, DOI 10.1038/sj.onc.1210033; Jacobs JJL, 2000, NAT GENET, V26, P291, DOI 10.1038/81583; Jonsson G, 2007, ONCOGENE, V26, P4738, DOI 10.1038/sj.onc.1210252; Leevers SJ, 1999, CURR OPIN CELL BIOL, V11, P219, DOI 10.1016/S0955-0674(99)80029-5; Li DM, 1998, P NATL ACAD SCI USA, V95, P15406, DOI 10.1073/pnas.95.26.15406; Li HG, 2007, CANCER LETT, V253, P215, DOI 10.1016/j.canlet.2007.01.020; Li J, 2014, J BIOL CHEM, V289, P35633, DOI 10.1074/jbc.M114.596411; Liu F, 2013, PIGM CELL MELANOMA R, V26, P67, DOI 10.1111/pcmr.12029; Lomnytska M, 2006, INT J CANCER, V118, P412, DOI 10.1002/ijc.21332; Londhe P, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-14; Londhe P, 2011, MOL CELL BIOL, V31, P2854, DOI 10.1128/MCB.05397-11; Lyng H, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-268; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mahlamaki EH, 2002, GENE CHROMOSOME CANC, V35, P353, DOI 10.1002/gcc.10122; Mandl A, 2007, MOL CELL BIOL, V27, P8098, DOI 10.1128/MCB.00756-07; Okamura H, 2005, J CELL BIOCHEM, V94, P117, DOI 10.1002/jcb.20283; Peres J, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-117; Peres Jade, 2010, Genes Cancer, V1, P272, DOI 10.1177/1947601910365160; Prince S, 2004, CANCER RES, V64, P1669, DOI 10.1158/0008-5472.CAN-03-3286; Radu A, 2003, MOL CELL BIOL, V23, P6139, DOI 10.1128/MCB.23.17.6139-6149.2003; Redmond KL, 2010, ONCOGENE, V29, P3252, DOI 10.1038/onc.2010.84; Relaix F, 2003, GENE DEV, V17, P2950, DOI 10.1101/gad.281203; Renshaw J, 2013, CLIN CANCER RES, V19, P5940, DOI 10.1158/1078-0432.CCR-13-0850; Rodriguez M, 2008, CANCER RES, V68, P7872, DOI 10.1158/0008-5472.CAN-08-0301; Ross AH, 2009, P NATL ACAD SCI USA, V106, P1297, DOI 10.1073/pnas.0812473106; Rowley M, 2004, J MAMMARY GLAND BIOL, V9, P109, DOI 10.1023/B:JOMG.0000037156.64331.3f; Sarver AL, 2010, CANCER RES, V70, P9570, DOI 10.1158/0008-5472.CAN-10-2074; Shao J, 2007, CARCINOGENESIS, V28, P2476, DOI 10.1093/carcin/bgm186; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Shern JF, 2014, CANCER DISCOV, V4, P216, DOI 10.1158/2159-8290.CD-13-0639; Sinclair CS, 2002, CANCER RES, V62, P3587; Singh S, 2010, AM J PATHOL, V177, P2055, DOI 10.2353/ajpath.2010.091195; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Toker A, 2000, J BIOL CHEM, V275, P8271, DOI 10.1074/jbc.275.12.8271; Vance KW, 2005, CANCER RES, V65, P2260, DOI 10.1158/0008-5472.CAN-04-3045; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Wan XL, 2003, ONCOGENE, V22, P8205, DOI 10.1038/sj.onc.1206878; Weng LP, 2002, HUM MOL GENET, V11, P1687, DOI 10.1093/hmg/11.15.1687; Weng LP, 2001, HUM MOL GENET, V10, P599, DOI 10.1093/hmg/10.6.599; Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005; Zhu B, 2014, INT J CANCER, V135, P785, DOI 10.1002/ijc.28721; Zhu XY, 2001, CANCER RES, V61, P4569; 2005, SCIENCE, V307, P1098, DOI DOI 10.1126/SCIENCE.1106148	55	25	26	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2016	35	32					4212	4224		10.1038/onc.2015.486	http://dx.doi.org/10.1038/onc.2015.486			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU3YY	26686089	Green Accepted, Green Submitted			2022-12-26	WOS:000382149800006
J	Rienzo, M; Rocchi, AR; Threatt, SD; Dougherty, DA; Lummis, SCR				Rienzo, Matthew; Rocchi, Angela R.; Threatt, Stephanie D.; Dougherty, Dennis A.; Lummis, Sarah C. R.			Perturbation of Critical Prolines in Gloeobacter violaceus Ligand-gated Ion Channel (GLIC) Supports Conserved Gating Motions among Cys-loop Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cys-loop receptor; electrophysiology; non-standard mutagenesis; protein conformation; structure-function; Gloeobacter violaceus; proline analogs; non-canonical amino acid; nonsense suppression; mutagenesis	X-RAY-STRUCTURE; NICOTINIC ACETYLCHOLINE-RECEPTORS; TRANSMEMBRANE ALPHA-HELIX; ALLOSTERIC MODULATION; STRUCTURAL INSIGHTS; MECHANISM; CONFORMATION; ISOMERIZATION; TRAFFICKING; ANESTHETICS	Gloeobacter violaceus ligand-gated ion channel (GLIC) has served as a valuable structural and functional model for the eukaryotic Cys-loop receptor superfamily. In Cys-loop and other receptors, we have previously demonstrated the crucial roles played by several conserved prolines. Here we explore the role of prolines in the gating transitions of GLIC. As conventional substitutions at some positions resulted in nonfunctional proteins, we used in vivo non-canonical amino acid mutagenesis to determine the specific structural requirements at these sites. Receptors were expressed heterologously in Xenopus laevis oocytes, and whole-cell electrophysiology was used to monitor channel activity. Pro-119 in the Cys-loop, Pro-198 and Pro-203 in the M1 helix, and Pro-299 in the M4 helix were sensitive to substitution, and distinct roles in receptor activity were revealed for each. In the context of the available structural data for GLIC, the behaviors of Pro-119, Pro-203, and Pro-299 mutants are consistent with earlier proline mutagenesis work. However, the Pro-198 site displays a unique phenotype that gives evidence of the importance of the region surrounding this residue for the correct functioning of GLIC.	[Rienzo, Matthew; Threatt, Stephanie D.; Dougherty, Dennis A.] CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd, Pasadena, CA 91125 USA; [Rocchi, Angela R.; Lummis, Sarah C. R.] Univ Cambridge, Dept Biochem, Tennis Court Rd, Cambridge CB2 1GA, England	California Institute of Technology; University of Cambridge	Dougherty, DA (corresponding author), CALTECH, Div Chem & Chem Engn, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	dadougherty@caltech.edu		Rienzo, Matthew/0000-0002-9389-1310	National Institutes of Health [NS 34407]; Wellcome Trust [WT 81925]; National Institutes of Health/National Research Service Award Training [GM07616]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS034407, R01NS034407] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health/National Research Service Award Training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants NS 34407 (to D. A. D.) and the Wellcome Trust Grant WT 81925 (to S. C. R. L.) and by National Institutes of Health/National Research Service Award Training Grant GM07616 (to M. R.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Alqazzaz M, 2011, BIOPHYS J, V101, P2912, DOI 10.1016/j.bpj.2011.10.055; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bouzat C, 2004, NATURE, V430, P896, DOI 10.1038/nature02753; Bretscher LE, 2001, J AM CHEM SOC, V123, P777, DOI 10.1021/ja005542v; Carswell CL, 2015, STRUCTURE, V23, P1655, DOI 10.1016/j.str.2015.06.020; Dacosta CJB, 2013, STRUCTURE, V21, P1271, DOI 10.1016/j.str.2013.06.019; Dang H, 2000, MOL PHARMACOL, V57, P1114; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; England PM, 1999, CELL, V96, P89, DOI 10.1016/S0092-8674(00)80962-9; England PM, 1999, TETRAHEDRON LETT, V40, P6189, DOI 10.1016/S0040-4039(99)01300-3; Gonzalez-Gutierrez G, 2013, P NATL ACAD SCI USA, V110, P18716, DOI 10.1073/pnas.1313156110; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Henault CM, 2015, J BIOL CHEM, V290, P25118, DOI 10.1074/jbc.M115.676833; Henault CM, 2015, NEUROPHARMACOLOGY, V96, P157, DOI 10.1016/j.neuropharm.2014.11.011; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Jha A, 2007, J GEN PHYSIOL, V130, P547, DOI 10.1085/jgp.200709856; Kao C, 1999, RNA, V5, P1268, DOI 10.1017/S1355838299991033; Limapichat W, 2010, J BIOL CHEM, V285, P8976, DOI 10.1074/jbc.M109.060939; Lummis SCR, 2005, NATURE, V438, P248, DOI 10.1038/nature04130; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Nowak MW, 1998, METHOD ENZYMOL, V293, P504; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; Nys M, 2013, BIOCHEM PHARMACOL, V86, P1042, DOI 10.1016/j.bcp.2013.07.001; Pandey AK, 2013, J AM CHEM SOC, V135, P4333, DOI 10.1021/ja3109664; Prevost MS, 2012, NAT STRUCT MOL BIOL, V19, P642, DOI 10.1038/nsmb.2307; Reimer U, 1998, J MOL BIOL, V279, P449, DOI 10.1006/jmbi.1998.1770; Rienzo M, 2014, CHEM BIOL, V21, P1700, DOI 10.1016/j.chembiol.2014.10.019; Sauguet L, 2014, P NATL ACAD SCI USA, V111, P966, DOI 10.1073/pnas.1314997111; Sauguet L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2682; Sauguet L, 2013, EMBO J, V32, P728, DOI 10.1038/emboj.2013.17; Tasneem A, 2005, GENOME BIOL, V6; Van Arnam EB, 2011, ACS CHEM BIOL, V6, P1063, DOI 10.1021/cb200153g; Wang JM, 2002, NAT NEUROSCI, V5, P963, DOI 10.1038/nn918	35	11	11	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 18	2016	291	12					6272	6280		10.1074/jbc.M115.694372	http://dx.doi.org/10.1074/jbc.M115.694372			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DH6IM	26668320	Green Published, hybrid, Green Accepted			2022-12-26	WOS:000372894200018
J	Shabrova, E; Hoyos, B; Vinogradov, V; Kim, YK; Wassef, L; Leitges, M; Quadro, L; Hammerling, U				Shabrova, Elena; Hoyos, Beatrice; Vinogradov, Valerie; Kim, Youn-Kyung; Wassef, Lesley; Leitges, Michael; Quadro, Loredana; Hammerling, Ulrich			Retinol as a cofactor for PKC delta-mediated impairment of insulin sensitivity in a mouse model of diet-induced obesity	FASEB JOURNAL			English	Article						vitamin A; PKC delta signalosome; metabolic syndrome	PROTEIN-KINASE-C; ADIPOSE-TISSUE INFLAMMATION; NECROSIS-FACTOR-ALPHA; BINDING-PROTEIN; VITAMIN-A; OXIDATIVE STRESS; GENE-EXPRESSION; SERUM RETINOL-BINDING-PROTEIN-4; MITOCHONDRIAL DYSFUNCTION; RESISTANCE	We previously defined that the mitochondria-localized PKC delta signaling complex stimulates the conversion of pyruvate to acetyl-coenzyme A by the pyruvate dehydrogenase complex. We demonstrated in vitro and ex vivo that retinol supplementation enhances ATP synthesis in the presence of the PKC delta signalosome. Here, we tested in vivo if a persistent oversupply of retinol would further impair glucose metabolism in a mouse model of diet-induced insulin resistance. We crossed mice overexpressing human retinol-binding protein (hRBP) under the muscle creatine kinase (MCK) promoter (MCKhRBP) with the PKC delta(-/-) strain to generate mice with a different status of the PKC delta signalosome and retinoid levels. Mice with a functional PKC delta signalosome and elevated retinoid levels (PKC delta(+/+)hRBP) developed the most advanced stage of insulin resistance. In contrast, elevation of retinoid levels in mice with inactive PKC delta did not affect remarkably their metabolism, resulting in phenotypic similarity between PKC delta(-/-)hRBP and PKC delta(-/-) mice. Therefore, in addition to the well-defined role of PKC delta in the etiology of metabolic syndrome, we present a novel PKC delta signaling pathway that requires retinol as a metabolic cofactor and is involved in the regulation of fuel utilization in mitochondria. The distinct role in whole-body energy homeostasis establishes the PKC delta signalosome as a promising target for therapeutic intervention in metabolic disorders.	[Shabrova, Elena; Hoyos, Beatrice; Vinogradov, Valerie; Hammerling, Ulrich] Mem Sloan Kettering Canc Ctr, Program Immunol, 425 East 68th St, New York, NY 10065 USA; [Kim, Youn-Kyung; Wassef, Lesley; Quadro, Loredana; Hammerling, Ulrich] Rutgers State Univ, Dept Food Sci, Rutgers Ctr Lipid Res, POB 231, New Brunswick, NJ 08903 USA; [Leitges, Michael] Univ Oslo, Biotechnol Ctr Oslo, Oslo, Norway	Memorial Sloan Kettering Cancer Center; Rutgers State University New Brunswick; University of Oslo	Hammerling, U (corresponding author), Mem Sloan Kettering Canc Ctr, Program Immunol, 425 East 68th St, New York, NY 10065 USA.	uhammerling@gmail.com	Leitges, Michael/AAN-1953-2021	Leitges, Michael/0000-0003-4203-6995	Memorial Sloan-Kettering Cancer Center; U.S. National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01HD057493, R01HD057493-02S1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD057493] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Memorial Sloan-Kettering Cancer Center; U.S. National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors acknowledge intellectual and material support by the members of the Weill-Cornell Pharmacology Department (New York, NY, USA), Drs. Lorraine Gudas, Jochen Buck, and Lonny Levine. The authors also thank Drs. Giovanni Manfredi and Anatoly Starkov (Cornell Medical College, New York, NY, USA) for manyfold advice and Dr. Malcolm Watford (Rutgers University, Piscataway, NY, USA) for critical reading of the manuscript. The authors are indebted to Dr. J. Friedman (Rockefeller University, New York, NY, USA) for help in PIXImus measurements. U.H. was supported by a grant from Memorial Sloan-Kettering Cancer Center, and L.Q. by grants from the U.S. National Institutes of Health/Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD057493 and R01HD057493-02S1). E.S., L.Q., B.H., and U.H. were responsible for planning, oversight, and execution of the experiments, as well as of interpretation and validation of results. V.V., Y.-K.K., and L.W. carried out mouse breeding, maintenance and genotyping experiments, and assisted with various analytic procedures. M.L. provided breeding pairs of protein kinase C delta knockout mice. The authors declare no conflicts of interest.	Acin-Perez R, 2010, FASEB J, V24, P5033, DOI 10.1096/fj.10-166934; Acin-Perez R, 2010, FASEB J, V24, P627, DOI 10.1096/fj.09-142281; Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Almind K, 2004, DIABETES, V53, P3274, DOI 10.2337/diabetes.53.12.3274; [Anonymous], [No title captured], DOI DOI 10.1016/j.febslet.2007.11.051; Avogaro A, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000262; Berniakovich I, 2008, J BIOL CHEM, V283, P34283, DOI 10.1074/jbc.M804362200; Berry DC, 2013, J BIOL CHEM, V288, P24528, DOI 10.1074/jbc.M113.484014; Berry DC, 2012, BBA-MOL CELL BIOL L, V1821, P168, DOI 10.1016/j.bbalip.2011.07.002; Berry DC, 2011, P NATL ACAD SCI USA, V108, P4340, DOI 10.1073/pnas.1011115108; Bezy O, 2011, J CLIN INVEST, V121, P2504, DOI 10.1172/JCI46045; BOUSSIOTIS VA, 1994, P NATL ACAD SCI USA, V91, P7007, DOI 10.1073/pnas.91.15.7007; Braiman L, 1999, MOL ENDOCRINOL, V13, P2002, DOI 10.1210/me.13.12.2002; Braiman L, 2001, MOL ENDOCRINOL, V15, P565, DOI 10.1210/me.15.4.565; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Brun PJ, 2013, BIOFACTORS, V39, P151, DOI 10.1002/biof.1056; BUCK J, 1990, J EXP MED, V171, P1613, DOI 10.1084/jem.171.5.1613; BUCK J, 1991, SCIENCE, V254, P1654, DOI 10.1126/science.1749937; Bullen JW, 2007, AM J PHYSIOL-ENDOC M, V292, pE1079, DOI 10.1152/ajpendo.00245.2006; Chiu HJ, 2008, FASEB J, V22, P3878, DOI 10.1096/fj.08-112375; Cho YM, 2006, DIABETES CARE, V29, P2457, DOI 10.2337/dc06-0360; Colombo C, 2003, J BIOL CHEM, V278, P3992, DOI 10.1074/jbc.M207665200; D'Ambrosio DN, 2011, NUTRIENTS, V3, P63, DOI 10.3390/nu3010063; de Oliveira MR, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/140267; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; FARESE RV, 1992, BIOCHEM J, V288, P319, DOI 10.1042/bj2880319; Fisher-Wellman KH, 2013, FREE RADICAL BIO MED, V65, P1201, DOI 10.1016/j.freeradbiomed.2013.09.008; Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008; FOLCH J, 1957, J BIOL CHEM, V226, P497; Franckhauser S, 2002, DIABETES, V51, P624, DOI 10.2337/diabetes.51.3.624; Gavi S, 2007, J CLIN ENDOCR METAB, V92, P1886, DOI 10.1210/jc.2006-1815; Giorgio M, 2005, CELL, V122, P221, DOI 10.1016/j.cell.2005.05.011; Gong JL, 2012, FASEB J, V26, P3537, DOI 10.1096/fj.11-197376; Goodman E, 2005, CIRCULATION, V111, P1970, DOI 10.1161/01.CIR.0000161957.34198.2B; Goodpaster BH, 2013, DIABETES, V62, P1032, DOI 10.2337/db12-1612; Graham TE, 2006, NEW ENGL J MED, V354, P2552, DOI 10.1056/NEJMoa054862; Greene MW, 2006, BIOCHEM BIOPH RES CO, V349, P976, DOI 10.1016/j.bbrc.2006.08.158; Halse R, 2001, DIABETES, V50, P720, DOI 10.2337/diabetes.50.4.720; Hammerling U, 2013, FASEB J, V27, P3887, DOI 10.1096/fj.13-1001ufm; Hartman HB, 2002, J BIOL CHEM, V277, P19754, DOI 10.1074/jbc.M201451200; Haugen BR, 2004, ENDOCRINOLOGY, V145, P3679, DOI 10.1210/en.2003-1401; Hennige AM, 2010, DIABETES, V59, P119, DOI 10.2337/db09-0512; Houmard JA, 2008, AM J PHYSIOL-REG I, V294, pR1111, DOI 10.1152/ajpregu.00396.2007; Hoyos B, 2012, BBA-MOL CELL BIOL L, V1821, P241, DOI 10.1016/j.bbalip.2011.06.014; Hu C, 2008, DIABETIC MED, V25, P11, DOI 10.1111/j.1464-5491.2007.02314.x; Imam A, 2001, FASEB J, V15, P28; Janke J, 2006, DIABETES, V55, P2805, DOI 10.2337/db06-0616; Jia WP, 2007, J CLIN ENDOCR METAB, V92, P3224, DOI 10.1210/jc.2007-0209; Johansson H, 2008, CANCER RES, V68, P9512, DOI 10.1158/0008-5472.CAN-08-0553; Jolliffe I.T., 2002, SPRINGER SERIES STAT; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; Kholodenko BN, 2000, TRENDS CELL BIOL, V10, P173, DOI 10.1016/S0962-8924(00)01741-4; Kieffer TJ, 2000, AM J PHYSIOL-ENDOC M, V278, pE1, DOI 10.1152/ajpendo.2000.278.1.E1; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; Korichneva I, 2002, J BIOL CHEM, V277, P44327, DOI 10.1074/jbc.M205634200; Krssak M, 2004, DIABETES, V53, P3048, DOI 10.2337/diabetes.53.12.3048; Kuehn HS, 2013, BLOOD, V121, P3117, DOI 10.1182/blood-2012-12-469544; Leitges M, 2001, J CLIN INVEST, V108, P1505; Li JP, 2002, AM J PHYSIOL-ENDOC M, V282, pE1334, DOI 10.1152/ajpendo.00516.2001; Li Y, 2008, DIABETES, V57, P817, DOI 10.2337/db07-0617; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Majumder PK, 2001, CELL GROWTH DIFFER, V12, P465; Manolescu DC, 2010, J NUTR, V140, P311, DOI 10.3945/jn.109.115147; Mayr M, 2004, AM J PHYSIOL-HEART C, V287, pH937, DOI 10.1152/ajpheart.00877.2003; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; McTernan PG, 2007, J CLIN ENDOCR METAB, V92, P2430, DOI 10.1210/jc.2007-1054; Miyamoto A, 2002, NATURE, V416, P865, DOI 10.1038/416865a; Mobbs Charles V., 2007, V35, P39; Moraes-Vieira PM, 2014, CELL METAB, V19, P512, DOI 10.1016/j.cmet.2014.01.018; Motani A, 2009, J BIOL CHEM, V284, P7673, DOI 10.1074/jbc.M809654200; Munkhtulga L, 2007, HUM GENET, V120, P879, DOI 10.1007/s00439-006-0264-4; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; Norseen J, 2012, MOL CELL BIOL, V32, P2010, DOI 10.1128/MCB.06193-11; Noy N, 2000, BIOCHEM J, V348, P481, DOI 10.1042/0264-6021:3480481; NOY N, 1991, BIOCHEMISTRY-US, V30, P6380, DOI 10.1021/bi00240a005; Obrochta KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099435; Opalinska M, 2014, MICROB CELL, V1, P51, DOI 10.15698/mic2014.01.127; Pagliarini DJ, 2006, TRENDS BIOCHEM SCI, V31, P26, DOI 10.1016/j.tibs.2005.11.005; Pagnin E, 2005, J CLIN ENDOCR METAB, V90, P1130, DOI 10.1210/jc.2004-1283; Pederson BA, 2004, MOL CELL BIOL, V24, P7179, DOI 10.1128/MCB.24.16.7179-7187.2004; Penniston KL, 2006, AM J CLIN NUTR, V83, P191; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Preitner F, 2009, AM J PHYSIOL-ENDOC M, V297, pE1420, DOI 10.1152/ajpendo.00362.2009; Quadro L, 2002, J BIOL CHEM, V277, P30191, DOI 10.1074/jbc.M205046200; Quinn P. G., 2005, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V5, P423, DOI 10.2174/156800805774912962; Rahimi Y, 2014, P NATL ACAD SCI USA, V111, P16508, DOI 10.1073/pnas.1419104111; Ranieri SC, 2010, P NATL ACAD SCI USA, V107, P13420, DOI 10.1073/pnas.1008647107; Rosenzweig T, 2002, DIABETES, V51, P1921, DOI 10.2337/diabetes.51.6.1921; Schmitz-Peiffer C, 2008, DIABETES, V57, P1774, DOI 10.2337/db07-1769; Sommer A., 1996, VITAMIN A DEFICIENCY, P62; Sorriento D., 2014, SCI WORLD J, V2014, DOI DOI 10.1155/2014/604685; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Sugii S, 2009, P NATL ACAD SCI USA, V106, P22504, DOI 10.1073/pnas.0912487106; SUTHERLAND TM, 1974, GENETICS, V78, P525; Talior I, 2005, AM J PHYSIOL-ENDOC M, V288, pE405, DOI 10.1152/ajpendo.00378.2004; Tamori Y, 2006, NAT MED, V12, P30, DOI 10.1038/nm0106-30; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Uchida T, 2007, J BIOL CHEM, V282, P2707, DOI 10.1074/jbc.M610482200; Valsecchi F, 2013, PHYSIOLOGY, V28, P199, DOI 10.1152/physiol.00004.2013; Vogel S, 2001, J BIOL CHEM, V276, P1353, DOI 10.1074/jbc.M005118200; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; West KP, 2002, J NUTR, V132, p2857S, DOI 10.1093/jn/132.9.2857S; Xie YS, 1998, PROTEIN EXPRES PURIF, V14, P31, DOI 10.1006/prep.1998.0944; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Zemany L, 2015, DIABETES, V64, P1603, DOI 10.2337/db14-0970; Zhao F, 2011, ANTIOXID REDOX SIGN, V14, P757, DOI 10.1089/ars.2010.3773	108	8	9	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1339	1355		10.1096/fj.15-281543	http://dx.doi.org/10.1096/fj.15-281543			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26671999	Green Published			2022-12-26	WOS:000370387800029
J	Giri, J; Srivastav, S; Basu, M; Palit, S; Gupta, P; Ukil, A				Giri, Jayeeta; Srivastav, Supriya; Basu, Moumita; Palit, Shreyasi; Gupta, Purnima; Ukil, Anindita			Leishmania donovani Exploits Myeloid Cell Leukemia 1 (MCL-1) Protein to Prevent Mitochondria-dependent Host Cell Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; B-cell lymphoma 2 (Bcl-2) family; cytochrome c; Leishmania; macrophage	TOXOPLASMA-GONDII; SIGNALING PATHWAY; CYTOCHROME-C; MACROPHAGES; ACTIVATION; INHIBITION; BCL-2; TRANSCRIPTION; INVOLVEMENT; RESISTANCE	Apoptosis is one of the mechanisms used by host cells to remove unwanted intracellular organisms, and often found to be subverted by pathogens through use of host anti-apoptotic proteins. In the present study, with the help of in vitro and in vivo approaches, we documented that the macrophage anti-apoptotic protein myeloid cell leukemia 1 (MCL-1) is exploited by the intra-macrophage parasite Leishmania donovani to protect their home from actinomycin D-induced mitochondria-dependent apoptosis. Among all the anti-apoptotic BCL-2 family members, infection preferentially up-regulated expression of MCL-1 at both the mRNA and protein levels and compared with infected control, MCL-1-silenced infected macrophages documented enhanced caspase activity and increased apoptosis when subjected to actinomycin D treatment. Phosphorylation kinetics and ChIP assay demonstrated that infection-induced MCL-1 expression was regulated by transcription factor CREB (cAMP-response element-binding protein) and silencing of CREB resulted in reduced expression of MCL-1 and increased apoptosis. During infection, MCL-1 was found to be localized in mitochondria and this was significantly reduced in Tom70-silenced macrophages, suggesting the active role of TOM70 in MCL-1 transport. In the mitochondria, MCL-1 interacts with the major pro-apoptotic protein BAK and prevents BAK-BAK homo-oligomer formation thereby preventing cytochrome c release-mediated mitochondrial dysfunction. Silencing of MCL-1 in the spleen of infected mice showed decreased parasite burden and increased induction of splenocyte apoptosis. Collectively our results showed that L. donovani exploited the macrophage anti-apoptotic protein MCL-1 to prevent BAK-mediated mitochondria-dependent apoptosis thereby protecting its niche, which is essential for disease progression.	[Giri, Jayeeta; Basu, Moumita; Gupta, Purnima; Ukil, Anindita] Univ Calcutta, Dept Biochem, Kolkata, India; [Srivastav, Supriya; Palit, Shreyasi] CSIR, Indian Inst Chem Biol, Infect Dis & Immunol Div, Kolkata 700032, India	University of Calcutta; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB)	Ukil, A (corresponding author), Dept Biochem, 35 Ballygunge Circular Rd, Kolkata 700019, W Bengal, India.	aninditau@yahoo.com	Gupta, Purnima/AAP-8717-2020; Basu, Moumita/AAP-8728-2020	GIRI, JAYEETA/0000-0002-2688-7274; BASU, MOUMITA/0000-0001-6691-5279; Gupta, Purnima/0000-0003-4389-3024	Department of Science and Technology [SB/WEA-013/2013, SB/SO/BB-0055/2013]; Council of Scientific and Industrial Research (CSIR); University Grants Commission (UGC); Indian Council of Medical Research (ICMR), Government of India	Department of Science and Technology(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (UGC)(University Grants Commission, India); Indian Council of Medical Research (ICMR), Government of India(Indian Council of Medical Research (ICMR))	This work was supported by the Department of Science and Technology Grants SB/WEA-013/2013 and SB/SO/BB-0055/2013, the Council of Scientific and Industrial Research (CSIR), University Grants Commission (UGC), and Indian Council of Medical Research (ICMR), Government of India. The authors declare that they have no conflicts of interest with the contents of this article.	Akarid K, 2004, J LEUKOCYTE BIOL, V76, P95, DOI 10.1189/jlb.1001877; Alli OAT, 2000, INFECT IMMUN, V68, P6431, DOI 10.1128/IAI.68.11.6431-6440.2000; Avni D, 2010, MOL IMMUNOL, V47, P1396, DOI 10.1016/j.molimm.2010.02.015; AYALA A, 1991, J IMMUNOL, V147, P4147; Bhattacharya P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024141; Bleicken S, 2010, J BIOL CHEM, V285, P6636, DOI 10.1074/jbc.M109.081539; Cahir-McFarland ED, 2000, P NATL ACAD SCI USA, V97, P6055, DOI 10.1073/pnas.100119497; Carl VS, 2004, J LEUKOCYTE BIOL, V76, P735, DOI 10.1189/jlb.1003526; CHANG KP, 1976, SCIENCE, V193, P678, DOI 10.1126/science.948742; Chao JR, 1998, MOL CELL BIOL, V18, P4883, DOI 10.1128/MCB.18.8.4883; Chou CH, 2006, MOL BIOL CELL, V17, P3952, DOI 10.1091/mbc.E06-04-0319; Dewson G, 2009, MOL CELL, V36, P696, DOI 10.1016/j.molcel.2009.11.008; Donovan MJ, 2009, EXP PARASITOL, V123, P58, DOI 10.1016/j.exppara.2009.05.012; Epling-Burnette PK, 2001, J CLIN INVEST, V107, P351, DOI 10.1172/JCI9940; Fujise K, 2000, J BIOL CHEM, V275, P39458, DOI 10.1074/jbc.M006626200; Goebel S, 2001, J CELL SCI, V114, P3495; Griffin DE, 1999, TRENDS MICROBIOL, V7, P155, DOI 10.1016/S0966-842X(99)01470-5; Handman E, 2002, TRENDS PARASITOL, V18, P332, DOI 10.1016/S1471-4922(02)02352-8; Heussler VT, 2001, INT J PARASITOL, V31, P1166, DOI 10.1016/S0020-7519(01)00271-5; Jamil S, 2005, BIOCHEM J, V387, P659, DOI 10.1042/BJ20041596; Kar S, 2010, J LEUKOCYTE BIOL, V88, P9, DOI 10.1189/jlb.0909644; Kausalya S, 2001, J IMMUNOL, V166, P4721, DOI 10.4049/jimmunol.166.7.4721; Koziel J, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/427021; Leu JIJ, 2004, NAT CELL BIOL, V6, P443, DOI 10.1038/ncb1123; Lisi S, 2005, J EUKARYOT MICROBIOL, V52, P211, DOI 10.1111/j.1550-7408.2005.00026.x; Liu HT, 2001, J EXP MED, V194, P113, DOI 10.1084/jem.194.2.113; McIlwain DR, 2015, CSH PERSPECT BIOL, V7; Mellett M, 2011, J IMMUNOL, V186, P4925, DOI 10.4049/jimmunol.1002739; Milot E, 2011, THESCIENTIFICWORLDJO, V11, P1948, DOI 10.1100/2011/131539; MOORE KJ, 1994, J IMMUNOL, V152, P2930; Moshynska O, 2004, JNCI-J NATL CANCER I, V96, P673, DOI 10.1093/jnci/djh122; Nandan D, 2012, J IMMUNOL, V188, P367, DOI 10.4049/jimmunol.1100076; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Quan JH, 2013, EXP PARASITOL, V133, P462, DOI 10.1016/j.exppara.2013.01.005; Rajalingam K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003102; Ruhland A, 2007, CELL MICROBIOL, V9, P84, DOI 10.1111/j.1462-5822.2006.00769.x; Samavati L, 2009, MOL IMMUNOL, V46, P1867, DOI 10.1016/j.molimm.2009.02.018; Shadab Md, 2011, Mol Biol Int, V2011, P343961, DOI 10.4061/2011/343961; Single B, 1998, CELL DEATH DIFFER, V5, P1001, DOI 10.1038/sj.cdd.4400462; Sly LM, 2003, J IMMUNOL, V170, P430, DOI 10.4049/jimmunol.170.1.430; Srivastav S, 2014, J BIOL CHEM, V289, P1092, DOI 10.1074/jbc.M113.496323; Srivastav S, 2012, J IMMUNOL, V189, P924, DOI 10.4049/jimmunol.1102845; Thomas LW, 2010, FEBS LETT, V584, P2981, DOI 10.1016/j.febslet.2010.05.061; Wang JM, 1999, MOL CELL BIOL, V19, P6195; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Williams G T, 1994, Trends Microbiol, V2, P463, DOI 10.1016/0966-842X(94)90648-3; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; Yamamoto H, 2009, J BIOL CHEM, V284, P31635, DOI 10.1074/jbc.M109.041756; Yang J, 1997, SCIENCE, V275, P1129, DOI 10.1126/science.275.5303.1129	54	19	19	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3496	3507		10.1074/jbc.M115.672873	http://dx.doi.org/10.1074/jbc.M115.672873			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26670606	Green Published, hybrid			2022-12-26	WOS:000370854500030
J	Yan, KZ; You, LY; Degerny, C; Ghorbani, M; Liu, X; Chen, LL; Li, L; Miao, DS; Yang, XJ				Yan, Kezhi; You, Linya; Degerny, Cindy; Ghorbani, Mohammad; Liu, Xin; Chen, Lulu; Li, Lin; Miao, Dengshun; Yang, Xiang-Jiao			The Chromatin Regulator BRPF3 Preferentially Activates the HBO1 Acetyltransferase but Is Dispensable for Mouse Development and Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAUSE GENITOPATELLAR SYNDROME; ACUTE MYELOID-LEUKEMIA; DE-NOVO MUTATIONS; HISTONE ACETYLTRANSFERASE; PHD FINGER; CAENORHABDITIS-ELEGANS; CELL-PROLIFERATION; SEGMENTAL IDENTITY; GENE-EXPRESSION; HAT COMPLEXES	To interpret epigenetic information, chromatin readers utilize various protein domains for recognition of DNA and histone modifications. Some readers possess multidomains for modification recognition and are thus multivalent. Bromodomain- and plant homeodomain-linked finger-containing protein 3 (BRPF3) is such a chromatin reader, containing two plant homeodomain-linked fingers, one bromodomain and a PWWP domain. However, its molecular and biological functions remain to be investigated. Here, we report that endogenous BRPF3 preferentially forms a tetrameric complex with HBO1 (also known as KAT7) and two other subunits but not with related acetyltransferases such as MOZ, MORF, TIP60, and MOF(also known as KAT6A, KAT6B, KAT5, and KAT8, respectively). We have also characterized a mutant mouse strain with a lacZ reporter inserted at the Brpf3 locus. Systematic analysis of beta-galactosidase activity revealed dynamic spatiotemporal expression of Brpf3 during mouse embryogenesis and high expression in the adult brain and testis. Brpf3 disruption, however, resulted in no obvious gross phenotypes. This is in stark contrast to Brpf1 and Brpf2, whose loss causes lethality at E9.5 and E15.5, respectively. In Brpf3-null mice and embryonic fibroblasts, RT-quantitative PCR uncovered no changes in levels of Brpf1 and Brpf2 transcripts, confirming no compensation from them. These results indicate that BRPF3 forms a functional tetrameric complex with HBO1 but is not required for mouse development and survival, thereby distinguishing BRPF3 from its paralogs, BRPF1 and BRPF2.	[Yan, Kezhi; You, Linya; Degerny, Cindy; Ghorbani, Mohammad; Liu, Xin; Li, Lin; Yang, Xiang-Jiao] McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada; [Yan, Kezhi; Yang, Xiang-Jiao] McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada; [Yan, Kezhi; You, Linya; Ghorbani, Mohammad; Li, Lin; Yang, Xiang-Jiao] McGill Univ, Dept Med, Montreal, PQ H3A 1A3, Canada; [Chen, Lulu; Miao, Dengshun] Nanjing Med Univ, Dept Human Anat, Res Ctr Bone & Stem Cells, State Key Lab Reprod Med, Nanjing 210029, Jiangsu, Peoples R China; [Yang, Xiang-Jiao] McGill Univ, Ctr Hlth, Montreal, PQ H3A 1A3, Canada; [You, Linya] Stanford Univ, 1201 Welch Rd,MSLS P151, Stanford, CA 94305 USA; [Degerny, Cindy] Maitre Conf Univ Paris Sud, CEA Saclay, Batiment 144,Porte 65,Point Courrier 22, F-91191 Gif Sur Yvette, France	McGill University; McGill University; McGill University; Nanjing Medical University; McGill University; Stanford University; CEA; UDICE-French Research Universities; Universite Paris Saclay	Yang, XJ (corresponding author), McGill Univ, Rosalind & Morris Goodman Canc Res Ctr, Montreal, PQ H3A 1A3, Canada.; Yang, XJ (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ H3A 1A3, Canada.; Yang, XJ (corresponding author), McGill Univ, Dept Med, Montreal, PQ H3A 1A3, Canada.; Yang, XJ (corresponding author), McGill Univ, Ctr Hlth, Montreal, PQ H3A 1A3, Canada.	xiang-jiao.yang@mcgill.ca		Miao, Dengshun/0000-0002-2682-3502; You, Linya/0000-0002-2569-0269	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research-National Science Foundation of China; Fonds de Recherche Sante-National Science Foundation of China	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canadian Institutes of Health Research-National Science Foundation of China(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche Sante-National Science Foundation of China	This work was supported by grants from Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada (to X.-J. Y.), Canadian Institutes of Health Research-National Science Foundation of China, and Fonds de Recherche Sante-National Science Foundation of China joint research initiatives (to D. M. and X.-J. Y.). The authors declare that they have no conflicts of interest with the contents of this article.	Arboleda VA, 2015, AM J HUM GENET, V96, P498, DOI 10.1016/j.ajhg.2015.01.017; Avvakumov N, 2012, MOL CELL BIOL, V32, P689, DOI 10.1128/MCB.06455-11; Borrow J, 1996, NAT GENET, V14, P33, DOI 10.1038/ng0996-33; Campeau PM, 2012, AM J HUM GENET, V90, P282, DOI 10.1016/j.ajhg.2011.11.023; Chamberlin HM, 2000, DEVELOPMENT, V127, P713; Chan-on W, 2013, NAT GENET, V45, P1474, DOI 10.1038/ng.2806; Chang S, 2003, GENE DEV, V17, P2123, DOI 10.1101/gad.1117903; Chinen Y, 2014, GENE CHROMOSOME CANC, V53, P299, DOI 10.1002/gcc.22140; Clayton-Smith J, 2011, AM J HUM GENET, V89, P675, DOI 10.1016/j.ajhg.2011.10.008; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Deacon RMJ, 2006, NAT PROTOC, V1, P1117, DOI 10.1038/nprot.2006.170; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Dulak AM, 2013, NAT GENET, V45, P478, DOI 10.1038/ng.2591; Feng Y., 2015, EMBO J, DOI 10.15252/embj.201591293; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Foy RL, 2008, J BIOL CHEM, V283, P28817, DOI 10.1074/jbc.M801407200; Grasso CS, 2012, NATURE, V487, P239, DOI 10.1038/nature11125; Hibiya K, 2009, DEV BIOL, V329, P176, DOI 10.1016/j.ydbio.2009.02.021; Huether R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4630; Kaufmann M. H., 1994, ATLAS MOUSE DEV; Kim GW, 2013, J BIOL CHEM, V288, P20334, DOI 10.1074/jbc.M113.464792; Klein BJ, 2016, NUCLEIC ACIDS RES, V44, P472, DOI 10.1093/nar/gkv1321; Klein BJ, 2014, EPIGENETICS-US, V9, P186, DOI 10.4161/epi.26792; Kool M, 2014, CANCER CELL, V25, P393, DOI 10.1016/j.ccr.2014.02.004; Kraft M, 2011, J CLIN INVEST, V121, P3479, DOI 10.1172/JCI43428; Kranz A, 2010, GENESIS, V48, P512, DOI 10.1002/dvg.20641; Kueh AJ, 2011, MOL CELL BIOL, V31, P845, DOI 10.1128/MCB.00159-10; Lafon A, 2007, ONCOGENE, V26, P5373, DOI 10.1038/sj.onc.1210606; Lakso M, 1996, P NATL ACAD SCI USA, V93, P5860, DOI 10.1073/pnas.93.12.5860; Lalonde ME, 2014, GENE DEV, V28, P1029, DOI 10.1101/gad.236331.113; Lalonde ME, 2013, GENE DEV, V27, P2009, DOI 10.1101/gad.223396.113; Latham JA, 2007, NAT STRUCT MOL BIOL, V14, P1017, DOI 10.1038/nsmb1307; Laue K, 2008, DEVELOPMENT, V135, P1935, DOI 10.1242/dev.017160; Liu L, 2012, J STRUCT BIOL, V180, P165, DOI 10.1016/j.jsb.2012.06.014; Lubula MY, 2014, FEBS LETT, V588, P3844, DOI 10.1016/j.febslet.2014.09.028; Lynch H, 2013, BREAST J, V19, P520, DOI 10.1111/tbj.12145; Miller CT, 2004, DEVELOPMENT, V131, P2443, DOI 10.1242/dev.01134; Mishima Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6872; Mishima Y, 2011, BLOOD, V118, P2443, DOI 10.1182/blood-2011-01-331892; Moore SDP, 2004, CANCER RES, V64, P5570, DOI 10.1158/0008-5472.CAN-04-0050; O'Meara MM, 2010, GENETICS, V186, P1497, DOI 10.1534/genetics.110.123661; Olauson H, 2012, J AM SOC NEPHROL, V23, P1641, DOI 10.1681/ASN.2012010048; Panagopoulos I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117010; Perry J, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-6; Pettitt SJ, 2009, NAT METHODS, V6, P493, DOI 10.1038/nmeth.1342; Poplawski A, 2014, J MOL BIOL, V426, P1661, DOI 10.1016/j.jmb.2013.12.007; Qin S, 2011, J BIOL CHEM, V286, P36944, DOI 10.1074/jbc.M111.244400; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Saksouk N, 2009, MOL CELL, V33, P257, DOI 10.1016/j.molcel.2009.01.007; Sanchez R, 2014, BBA-GENE REGUL MECH, V1839, P676, DOI 10.1016/j.bbagrm.2014.03.011; Sansom OJ, 2007, NAT CLIN PRACT ONCOL, V4, P305, DOI 10.1038/ncponc0812; Simo-Riudalbas L, 2015, CANCER RES, V75, P3936, DOI 10.1158/0008-5472.CAN-14-3702; Simpson MA, 2012, AM J HUM GENET, V90, P290, DOI 10.1016/j.ajhg.2011.11.024; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Suganuma T, 2011, ANNU REV BIOCHEM, V80, P473, DOI 10.1146/annurev-biochem-061809-175347; Szakszon K, 2013, AM J MED GENET A, V161A, P884, DOI 10.1002/ajmg.a.35848; Tahmasebi S, 2013, J BIOL CHEM, V288, P12791, DOI 10.1074/jbc.M113.465443; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; Testa G, 2004, GENESIS, V38, P151, DOI 10.1002/gene.20012; Tham E, 2015, AM J HUM GENET, V96, P507, DOI 10.1016/j.ajhg.2015.01.016; Ullah M, 2008, MOL CELL BIOL, V28, P6828, DOI 10.1128/MCB.01297-08; Vezzoli A, 2010, NAT STRUCT MOL BIOL, V17, P617, DOI 10.1038/nsmb.1797; Wu H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018919; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Yan KZ, 2012, METHODS MOL BIOL, V809, P445, DOI 10.1007/978-1-61779-376-9_29; Yang XJ, 2007, ONCOGENE, V26, P5408, DOI 10.1038/sj.onc.1210609; Yang XJ, 2015, BBA-MOL CELL RES, V1853, P1818, DOI 10.1016/j.bbamcr.2015.04.014; You JS, 2012, CANCER CELL, V22, P9, DOI 10.1016/j.ccr.2012.06.008; You LY, 2015, J BIOL CHEM, V290, P11349, DOI 10.1074/jbc.M115.643189; You LY, 2015, J BIOL CHEM, V290, P7114, DOI 10.1074/jbc.M114.635250; You LY, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005034; You LY, 2014, EPIGENETICS-US, V9, P860, DOI 10.4161/epi.28530; Yu HC, 2014, AM J MED GENET A, V164, P950, DOI 10.1002/ajmg.a.36379; Zack TI, 2013, NAT GENET, V45, P1134, DOI 10.1038/ng.2760	75	18	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2647	2663		10.1074/jbc.M115.703041	http://dx.doi.org/10.1074/jbc.M115.703041			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26677226	Green Published, hybrid			2022-12-26	WOS:000369626900010
J	Lohr, B; Vasquez-Ordonez, AA; Lopez-Lavalle, LAB				Loehr, Bernhard; Andres Vasquez-Ordonez, Aymer; Becerra Lopez-Lavalle, Luis Augusto			Rhynchophorus palmarum in Disguise: Undescribed Polymorphism in the "Black" Palm Weevil	PLOS ONE			English	Article							FERRUGINEUS OLIVIER; COLOR POLYMORPHISM; COLEOPTERA; CURCULIONIDAE; APHIDIDAE; PATTERNS; REGION; PCR	During studies to adapt pheromone trapping of Rhynchophorus palmarum to the special coconut growing conditions at the Colombian Pacific coast, 152 atypically-colored specimens were captured in a total collection of 53,802 of the normally completely black weevil. Five specimens had the typical coloration of Rhynchophorus ferrugineus, an invasive species recently introduced to Aruba and Curacao. A regional expansion of this invasion to the South American continent was feared and all atypical specimens were submitted to taxonomic analysis. Both conventional and molecular methods were employed. Conventional taxonomics confirmed the samples as belonging to R. palmarum but registered undescribed and species-atypical morphological variability in the subgular suture (wide vs. narrow), the ratio between intraocular distance and width of antennal scrobes (> 0.35 vs. < 0.29) and the indentation of the mandibles (up to three mandibular teeth vs. bilobed). Molecular analysis placed all samples inspected, black and reddish alike, firmly within the R. palmarum group and the hypothesis of having inter-specific hybrids was rejected using co-dominant single sequence repeat markers with allelic specificity for both species.	[Loehr, Bernhard] Ctr Invest Palmira, Corp Colombiana Invest Agr, Palmira, Valle Del Cauca, Colombia; [Andres Vasquez-Ordonez, Aymer] Ctr Int Agr Trop, Entomol Program, Cali 6713, Valle Del Cauca, Colombia; [Becerra Lopez-Lavalle, Luis Augusto] Ctr Int Agr Trop, Cassava Program, Cali 6713, Valle Del Cauca, Colombia	Corporacion Colombiana de Investigacion Agropecuaria, AGROSAVIA; Alliance; International Center for Tropical Agriculture - CIAT; Alliance; International Center for Tropical Agriculture - CIAT	Lohr, B (corresponding author), Ctr Invest Palmira, Corp Colombiana Invest Agr, Palmira, Valle Del Cauca, Colombia.	blohr55@gmail.com	Vásquez-Ordóñez, Aymer Andrés/AGH-6088-2022; Lopez-Lavalle, Luis Augusto Becerra/H-4678-2019	Vásquez-Ordóñez, Aymer Andrés/0000-0002-4970-9067; Lopez-Lavalle, Luis Augusto Becerra/0000-0003-3520-2270	Colciencias [2236-502-27543]	Colciencias(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This work was partially funded by Colciencias (www.colciencias.gov.co) grant no. 2236-502-27543 to Centro International de Agricultura Tropical (BL). The remaining costs were covered through CIAT core funds (BL, AAV, LABL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham V. A., 1998, Sultan Qaboos University Journal for Scientific Research - Agricultural Sciences, V3, P77; Abraham V. A., 1989, Journal of Plantation Crops, V16, P159; ANDERSON RS, 1986, J NAT HIST, V20, P283, DOI 10.1080/00222938600770241; [Anonymous], 2007, Bulletin OEPP/EPPO Bulletin, V37, P571, DOI 10.1111/j.1365-2338.2007.01165.x; Barranco P, 1995, B ASOC ESP ENT, V20, P257; Bond AB, 2007, 52 LINC U; Cabello T, 2007, 1 JORN INT PIC ROJ P; Capdevielle-Dulac C, MOL EOLO RES; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Drosopoulos S, 2008, B INSECTOL, V61, P99; El-Mergawy RAAM, 2011, INT J AGRIC BIOL, V13, P227; EPPO, 2009, EPPO REP SERV, P01; Forsman A, 2002, EVOLUTION, V56, P349, DOI 10.1111/j.0014-3820.2002.tb01345.x; Giblin-Davis RM, 2013, CABI INVASIVE SER, P1, DOI 10.1079/9781845938291.0001; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Gray SM, 2007, TRENDS ECOL EVOL, V22, P71, DOI 10.1016/j.tree.2006.10.005; HAGLEY EAC, 1963, J ECON ENTOMOL, V56, P375, DOI 10.1093/jee/56.3.375; Hallett RH, 2004, J NAT HIST, V38, P2863, DOI 10.1080/00222930310001657874; Hochkirch A, 2008, EVOL DEV, V10, P350, DOI 10.1111/j.1525-142X.2008.00243.x; Johnson CW, 1920, J HERED, V11, P84, DOI 10.1093/oxfordjournals.jhered.a101975; Kairo MT, 2010, P CAR FOOD CROPS SOC, V46, P87; LAMBERS DHR, 1966, ANNU REV ENTOMOL, V11, P47, DOI 10.1146/annurev.en.11.010166.000403; Lohr B, 2014, MANUAL TRAMPEO PICUD; Lohr B, 2013, BIOCONT NEWS INF, V34, p19N; Machado Vilmar, 2001, Revista Brasileira de Zoologia, V18, P711, DOI 10.1590/S0101-81752001000300007; Moulton MJ, 2010, MOL ECOL RESOUR, V10, P615, DOI 10.1111/j.1755-0998.2009.02823.x; Mozcek AP, 1999, ANIM BEHAV, V59, P459; Murphy ST, 1999, BIOCONTROL NEWS INF, V20, P35; Nilsson AN., 2012, DNA BARCODES, V1, P1, DOI DOI 10.2478/DNA-2012-0001; Oelschlager AC, 2002, ENTOMOL, V85, P507; Ovalle TM, 2014, ECOL EVOL, V4, P3778, DOI 10.1002/ece3.1204; Rampling LR, 2001, AUST J AGR RES, V52, P1131, DOI 10.1071/AR01027; Roda A., 2011, Bulletin OEPP, V41, P116, DOI 10.1111/j.1365-2338.2011.02446.x; Rugman-Jones PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078379; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; SEPÚLVEDA-CANO PAULA A, 2009, Acta biol.Colomb., V14, P49; Svensson EI, 2007, EVOL ECOL; Sword GA, 2000, P ROY SOC B-BIOL SCI, V267, P63, DOI 10.1098/rspb.2000.0967; Tambe JT, 2013, B INSECTOL, V66, P153; Thery M, 2008, BEHAV ECOL, V19, P627, DOI 10.1093/beheco/arn024; Vanderplanck KFL, 1960, J ANIM ECOL, V29, P15; WATTANAPONGSIRI A, 1966, DEP AGR SCI B, V1; WEBER G, 1985, Z ANGEW ENTOMOL, V100, P100	43	10	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0143210	10.1371/journal.pone.0143210	http://dx.doi.org/10.1371/journal.pone.0143210			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683205	Green Published, gold, Green Submitted			2022-12-26	WOS:000366725800006
J	Igietseme, JU; Omosun, Y; Stuchlik, O; Reed, MS; Partin, J; He, Q; Joseph, K; Ellerson, D; Bollweg, B; George, Z; Eko, FO; Bandea, C; Liu, H; Yang, GY; Shieh, WJ; Pohl, J; Karem, K; Black, CM				Igietseme, Joseph U.; Omosun, Yusuf; Stuchlik, Olga; Reed, Matthew S.; Partin, James; He, Qing; Joseph, Kahaliah; Ellerson, Debra; Bollweg, Brigid; George, Zenas; Eko, Francis O.; Bandea, Claudiu; Liu, Hsi; Yang, Genyan; Shieh, Wun-Ju; Pohl, Jan; Karem, Kevin; Black, Carolyn M.			Role of Epithelial-Mesenchyme Transition in Chlamydia Pathogenesis	PLOS ONE			English	Article							FEMALE REPRODUCTIVE-TRACT; CANCER-CELL MIGRATION; HUMAN BREAST-CANCER; OXIDASE-LIKE 2; GENITAL-TRACT; MOUSE MODEL; CERVICAL-CANCER; DIFFERENTIAL EXPRESSION; MURIDARUM INFECTION; EMBRYO IMPLANTATION	Chlamydia trachomatis genital infection in women causes serious adverse reproductive complications, and is a strong co-factor for human papilloma virus (HPV)-associated cervical epithelial carcinoma. We tested the hypothesis that Chlamydia induces epithelial-mesenchyme transition (EMT) involving T cell-derived TNF-alpha signaling, caspase activation, cleavage inactivation of dicer and dysregulation of micro-RNA (miRNA) in the reproductive epithelium; the pathologic process of EMT causes fibrosis and fertility-related epithelial dysfunction, and also provides the co-factor function for HPV-related cervical epithelial carcinoma. Using a combination of microarrays, immunohistochemistry and proteomics, we showed that chlamydia altered the expression of crucial miRNAs that control EMT, fibrosis and tumorigenesis; specifically, miR-15a, miR-29b, miR-382 and MiR-429 that maintain epithelial integrity were down-regulated, while miR-9, mi-R-19a, miR-22 and miR-205 that promote EMT, fibrosis and tumorigenesis were up-regulated. Chlamydia induced EMT in vitro and in vivo, marked by the suppression of normal epithelial cell markers especially E-cadherin but up-regulation of mesenchymal markers of pathological EMT, including T-cadherin, MMP9, and fibronectin. Also, Chlamydia upregulated pro-EMT regulators, including the zinc finger E-box binding homeobox protein, ZEB1, Snail1/2, and thrombospondin1 (Thbs1), but down-regulated anti-EMT and fertility promoting proteins (i.e., the major gap junction protein connexin 43 (Cx43), Mets1, Add1Scarb1 and MARCKSL1). T cell-derived TNF-alpha signaling was required for chlamydial-induced infertility and caspase inhibitors prevented both infertility and EMT. Thus, chlamydial-induced T cell-derived TNF-alpha activated caspases that inactivated dicer, causing alteration in the expression of reproductive epithelial miRNAs and induction of EMT. EMT causes epithelial malfunction, fibrosis, infertility, and the enhancement of tumorigenesis of HPV oncogene-transformed epithelial cells. These findings provide a novel understanding of the molecular pathogenesis of chlamydia-associated diseases, which may guide a rational prevention strategy.	[Igietseme, Joseph U.; Omosun, Yusuf; Stuchlik, Olga; Reed, Matthew S.; Partin, James; He, Qing; Joseph, Kahaliah; Ellerson, Debra; Bollweg, Brigid; George, Zenas; Bandea, Claudiu; Liu, Hsi; Yang, Genyan; Shieh, Wun-Ju; Pohl, Jan; Karem, Kevin; Black, Carolyn M.] Ctr Dis Control & Prevent CDC Atlanta, Natl Ctr Emerging Zoonot & Infect Dis, Atlanta, GA 30333 USA; [Igietseme, Joseph U.; Omosun, Yusuf; He, Qing; Eko, Francis O.] Morehouse Sch Med, Dept Microbiol Biochem & Immunol, Atlanta, GA 30310 USA	Centers for Disease Control & Prevention - USA; Morehouse School of Medicine	Igietseme, JU (corresponding author), Ctr Dis Control & Prevent CDC Atlanta, Natl Ctr Emerging Zoonot & Infect Dis, Atlanta, GA 30333 USA.	jigietseme@cdc.gov	Omosun, Yusuf/P-9944-2019	Omosun, Yusuf/0000-0003-4759-6254	National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention; National Institutes of Health [AI41231, GM 08248, RR03034, 1SC1GM098197]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [SC1AI103041, R01AI041231] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [S21MD000101] Funding Source: NIH RePORTER	National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	1. National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention. Internal research support to: JUI. 2. National Institutes of Health Grant #s: AI41231, GM 08248, RR03034 and 1SC1GM098197 to: JUI, FOE and QH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbeit JM, 1996, P NATL ACAD SCI USA, V93, P2930, DOI 10.1073/pnas.93.7.2930; Arigoni M, 2013, AM J PATHOL, V182, P2058, DOI 10.1016/j.ajpath.2013.02.046; Ashida H, 2006, J BIOL CHEM, V281, P896, DOI 10.1074/jbc.M511311200; Boini KM, 2012, J CELL MOL MED, V16, P1674, DOI 10.1111/j.1582-4934.2011.01462.x; Brake T, 2005, P NATL ACAD SCI USA, V102, P2490, DOI 10.1073/pnas.0409883102; Bujak E, 2014, EXP CELL RES, V327, P135, DOI 10.1016/j.yexcr.2014.05.024; Butterworth MB, 2007, J BIOL CHEM, V282, P37885, DOI 10.1074/jbc.M707989200; Byrne A, 2010, EXP CELL RES, V316, P258, DOI 10.1016/j.yexcr.2009.08.018; Cano A, 2012, FUTURE ONCOL, V8, P1095, DOI [10.2217/FON.12.105, 10.2217/fon.12.105]; Castellano P, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00122; Catalano RD, 2005, P NATL ACAD SCI USA, V102, P8585, DOI 10.1073/pnas.0502343102; Chang CC, 2012, J IMMUNOL, V188, P3042, DOI 10.4049/jimmunol.1102899; Chen Q, 2013, MOL ASPECTS MED, V34, P1024, DOI 10.1016/j.mam.2012.07.017; Chinnadurai G, 2009, CANCER RES, V69, P731, DOI 10.1158/0008-5472.CAN-08-3349; Christianson MS, 2012, CURR OPIN ENDOCRINOL, V19, P115, DOI 10.1097/MED.0b013e3283505771; Citi Sandra, 2014, Small GTPases, V5, P1, DOI 10.4161/21541248.2014.973760; Crowley JL, 2009, MOL BIOL CELL, V20, P948, DOI 10.1091/mbc.E08-08-0867; Darville T, 2010, J INFECT DIS, V201, pS114, DOI 10.1086/652397; DeAngelis AM, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.119883; Debattista J, 2003, FERTIL STERIL, V79, P1273, DOI 10.1016/S0015-0282(03)00396-0; Diaz-Lopez A, 2014, CANCER MANAG RES, V6, P205, DOI 10.2147/CMAR.S38156; Elgamal OA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076402; Fang ZY, 2013, J BIOL CHEM, V288, P7918, DOI 10.1074/jbc.M112.416842; Feng Y, 2014, INT J CLIN EXP PATHO, V7, P64; Feng Z, 2014, LAB INVEST, V94, P439, DOI 10.1038/labinvest.2014.4; Friso S, 2015, TRANSL RES, V165, P154, DOI 10.1016/j.trsl.2014.06.007; Grange C, 2014, FRONTIERS ONCOLOGY, V4, P1; Gupta R, 2015, AM J REPROD IMMUNOL, V73, P126, DOI 10.1111/aji.12281; Havelange V, 2014, BLOOD, V123, P2412, DOI 10.1182/blood-2013-10-532374; He Y, 2013, BIOCHIMIE, V95, P1355, DOI 10.1016/j.biochi.2013.03.010; Herrero AB, 2011, EMBO J, V30, P2008, DOI 10.1038/emboj.2011.117; Huang QH, 2015, CIRCULATION, V131, P1082, DOI 10.1161/CIRCULATIONAHA.114.012725; Igietseme JU, 2013, J INFECT DIS, V207, P1095, DOI 10.1093/infdis/jit009; Igietseme JU, 2009, J INFECT DIS, V200, P926, DOI 10.1086/605411; Jayachandran A, 2014, ONCOTARGET, V5, P5782, DOI 10.18632/oncotarget.2164; Jimenez-Salazar JE, 2014, HORM CANCER-US, V5, P161, DOI 10.1007/s12672-014-0180-3; Jonsdottir K, 2012, BREAST CANCER RES TR, V135, P381, DOI 10.1007/s10549-012-2155-9; Kang H, 2009, INT J ONCOL, V35, P205, DOI 10.3892/ijo_00000330; Kawahara H, 2013, J BIOCHEM, V153, P147, DOI 10.1093/jb/mvs149; Kim BR, 2014, CELL SIGNAL, V26, P1765, DOI 10.1016/j.cellsig.2014.05.010; Kim T, 2009, EMBO J, V28, P1612, DOI 10.1038/emboj.2009.118; Kiyamova R, 2012, BIOMARKERS, V17, P362, DOI 10.3109/1354750X.2012.677476; Kothari AN, 2014, CLIN TRANSL MED, V3, DOI 10.1186/s40169-014-0035-0; Kramann R, 2013, J PATHOL, V231, P273, DOI 10.1002/path.4253; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Laws MJ, 2008, DEVELOPMENT, V135, P2659, DOI 10.1242/dev.019810; Lee K, 2012, INT REV CEL MOL BIO, V294, P171, DOI 10.1016/B978-0-12-394305-7.00004-5; Lee M. H., 2011, CELL CYCLE, V10, P3057, DOI [DOI 10.4161/CC.10.18, 10.4161/cc.10.18.17320, DOI 10.4161/CC.10.18.17320]; Legare C, 2014, J PROTEOME RES, V13, P5403, DOI 10.1021/pr501031x; Lin WY, 2015, J HEPATOL, V62, P1024, DOI 10.1016/j.jhep.2014.11.038; Liu Y, 2013, CANCER DISCOV, V3, P870, DOI 10.1158/2159-8290.CD-13-0015; Lykke-Andersen K, 2003, MOL CELL BIOL, V23, P6790, DOI 10.1128/MCB.23.19.6790-6797.2003; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Moon HJ, 2014, BIOORG CHEM, V57, P231, DOI 10.1016/j.bioorg.2014.07.003; Moore R, 2013, BMC DEV BIOL, V13, DOI 10.1186/1471-213X-13-39; Mtango NR, 2014, ADV EXP MED BIOL, V759, P89, DOI 10.1007/978-1-4939-0817-2_5; Muhlen S, 2010, INT J ONCOL, V37, P337, DOI 10.3892/ijo_00000682; Murthy AK, 2011, INFECT IMMUN, V79, P2928, DOI 10.1128/IAI.05022-11; Nagaraja AK, 2008, MOL ENDOCRINOL, V22, P2336, DOI 10.1210/me.2008-0142; Nishikawa R, 2014, INT J ONCOL, V45, P401, DOI 10.3892/ijo.2014.2437; Nothnick WB, 2012, REPRODUCTION, V143, P559, DOI 10.1530/REP-11-0240; Oikonomou N, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000108; Pal S, 1998, J MED MICROBIOL, V47, P599, DOI 10.1099/00222615-47-7-599; Pei XH, 2014, BIOCHEM BIOPH RES CO, V446, P322, DOI 10.1016/j.bbrc.2014.02.109; Prins JR, 2012, J REPROD IMMUNOL, V95, P1, DOI 10.1016/j.jri.2012.05.004; Ramon LA, 2012, HUM REPROD, V27, P3036, DOI 10.1093/humrep/des292; Ren LF, 2013, BIOCHEM BIOPH RES CO, V436, P192, DOI 10.1016/j.bbrc.2013.05.072; Renthal NE, 2010, P NATL ACAD SCI USA, V107, P20828, DOI 10.1073/pnas.1008301107; Rubina KA, 2015, CANCERS, V7, P1349, DOI 10.3390/cancers7030840; Rylski M, 2008, J BIOL CHEM, V283, P35140, DOI 10.1074/jbc.M804540200; Schiffman M, 2011, JNCI-J NATL CANCER I, V103, P368, DOI 10.1093/jnci/djq562; Shao R, 2014, PROSTATE, V74, P970, DOI 10.1002/pros.22814; Shen YH, 2013, CELL BIOCHEM BIOPHYS, V66, P139, DOI 10.1007/s12013-012-9462-y; Shi ZQ, 2014, CRIT REV EUKAR GENE, V24, P55, DOI 10.1615/CritRevEukaryotGeneExpr.2014007798; Shieh WJ, 2010, AM J PATHOL, V177, P166, DOI 10.2353/ajpath.2010.100115; Shyu AB, 2008, EMBO J, V27, P471, DOI 10.1038/sj.emboj.7601977; Simonetti AC, 2009, MICROBES INFECT, V11, P435, DOI 10.1016/j.micinf.2009.01.004; Song SJ, 2014, CELL CYCLE, V13, P11, DOI 10.4161/cc.27027; Song SJ, 2013, CELL, V154, P311, DOI 10.1016/j.cell.2013.06.026; Song SJ, 2013, CELL STEM CELL, V13, P87, DOI 10.1016/j.stem.2013.06.003; Streicher KL, 2007, ONCOGENE, V26, P2104, DOI 10.1038/sj.onc.1210002; Su LX, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054237; Sweetwyne MT, 2012, MATRIX BIOL, V31, P178, DOI 10.1016/j.matbio.2012.01.006; Takahashi R, 2014, FRONT GENET, V4, DOI 10.3389/fgene.2013.00295; TUFFREY M, 1981, FEMS MICROBIOL LETT, V12, P111; TUFFREY M, 1992, J REPROD FERTIL, V95, P31, DOI 10.1530/jrf.0.0950031; Veresov VG, 2014, CELL SIGNAL, V26, P370, DOI 10.1016/j.cellsig.2013.11.016; Wang RJ, 2015, CANCER LETT, V356, P568, DOI 10.1016/j.canlet.2014.10.003; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Xiong GF, 2011, MOL CELL ENDOCRINOL, V331, P23, DOI 10.1016/j.mce.2010.06.003; Yamamoto N, 2013, INT J ONCOL, V43, P1855, DOI 10.3892/ijo.2013.2145; Yan JC, 2013, CURR CANCER DRUG TAR, V13, P930, DOI 10.2174/15680096113136660098; Yang DH, 2007, J BIOL CHEM, V282, P13114, DOI 10.1074/jbc.M611356200; Yeruva L, 2014, MBIO, V5, P01241; Yu JW, 2014, LAB INVEST, V94, P978, DOI 10.1038/labinvest.2014.91; Yu J, 2014, MOL HUM REPROD, V20, P260, DOI 10.1093/molehr/gat087; Yu J, 2011, MOL CELL ENDOCRINOL, V344, P25, DOI 10.1016/j.mce.2011.04.011; Yun UJ, 2012, CANCER LETT, V323, P155, DOI 10.1016/j.canlet.2012.04.003; Yuva-Aydemir Y, 2011, RNA BIOL, V8, P557, DOI 10.4161/rna.8.4.16019; Zarnescu DC, 2013, TRENDS CARDIOVAS MED, V23, P275, DOI 10.1016/j.tcm.2013.03.003; Zhang C, 2009, CELL BIOL INT, V33, P632, DOI 10.1016/j.cellbi.2009.02.017; Zhang SN, 2013, CELL DIV, V8, DOI 10.1186/1747-1028-8-14; Zhang S, 2013, MOL ASPECTS MED, V34, P939, DOI 10.1016/j.mam.2012.12.011; Zhang Y, 2014, MOL THER, V22, P974, DOI 10.1038/mt.2014.25; Zhang ZY, 2014, PAK J MED SCI, V30, P432	105	30	35	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145198	10.1371/journal.pone.0145198	http://dx.doi.org/10.1371/journal.pone.0145198			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26681200	Green Published, Green Submitted, gold			2022-12-26	WOS:000366723400055
J	Moorthy, AS; Brooks, SPJ; Kalmokoff, M; Eberl, HJ				Moorthy, Arun S.; Brooks, Stephen P. J.; Kalmokoff, Martin; Eberl, Hermann J.			A Spatially Continuous Model of Carbohydrate Digestion and Transport Processes in the Colon	PLOS ONE			English	Article							GUT MICROBIOTA; LARGE-INTESTINE; SURFACE-AREA; FERMENTATION; HEALTH; IMPACT; TRACT; PERSPECTIVES; DEGRADATION; RESPONSES	A spatially continuous mathematical model of transport processes, anaerobic digestion and microbial complexity as would be expected in the human colon is presented. The model is a system of first-order partial differential equations with context determined number of dependent variables, and stiff, non-linear source terms. Numerical simulation of the model is used to elucidate information about the colon-microbiota complex. It is found that the composition of materials on outflow of the model does not well-describe the composition of material in other model locations, and inferences using outflow data varies according to model reactor representation. Additionally, increased microbial complexity allows the total microbial community to withstand major system perturbations in diet and community structure. However, distribution of strains and functional groups within the microbial community can be modified depending on perturbation length and microbial kinetic parameters. Preliminary model extensions and potential investigative opportunities using the computational model are discussed.	[Moorthy, Arun S.; Eberl, Hermann J.] Univ Guelph, Biophys Interdept Grp, Guelph, ON N1G 2W1, Canada; [Moorthy, Arun S.; Eberl, Hermann J.] Univ Guelph, Dept Math & Stat, Guelph, ON N1G 2W1, Canada; [Brooks, Stephen P. J.] Hlth Canada, Food Directorate, Bur Nutr, Ottawa, ON K1A 0L2, Canada; [Kalmokoff, Martin] Agr & Agri Food Canada, Atlantic Food & Hort Res Stn, Kentville, NS, Canada	University of Guelph; University of Guelph; Health Canada; Agriculture & Agri Food Canada	Moorthy, AS (corresponding author), Univ Guelph, Biophys Interdept Grp, Guelph, ON N1G 2W1, Canada.	amoorthy@uoguelph.ca	Moorthy, Arun/AAS-2064-2021	Moorthy, Arun/0000-0002-5988-1389; Eberl, Hermann/0000-0001-5558-0872; Brooks, Stephen/0000-0002-1169-6221	Ontario Ministry of Agriculture Food and Rural Affairs [200130]; Ontario Ministry of Agriculture and Rural Affairs (OMAFRA) grant	Ontario Ministry of Agriculture Food and Rural Affairs; Ontario Ministry of Agriculture and Rural Affairs (OMAFRA) grant	This research was funded by an Ontario Ministry of Agriculture Food and Rural Affairs (grant no. 200130) received by HJE.; This research was funded by an Ontario Ministry of Agriculture and Rural Affairs (OMAFRA) grant. The authors would like to express their gratitude to Jesse Knight, Kathleen Songin and Richard Yam for their assistance developing compuGUT software tools.	Batstone Damien J., 2006, Reviews in Environmental Science and Bio/Technology, V5, P57, DOI 10.1007/s11157-005-7191-z; Batstone DJ, 2002, WATER SCI TECHNOL, V45, P65; Bonfrate L, 2013, SCAND J GASTROENTERO, V48, P995, DOI 10.3109/00365521.2013.799220; Brooks SPJ, 2011, COMPREHENSIVE BIOTECHNOLOGY, VOL 4: AGRICULTURAL AND RELATED BIOTECHNOLOGIES, 2ND EDITION, P575; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Edlund C, 2000, J ANTIMICROB CHEMOTH, V46, P41, DOI 10.1093/jac/46.suppl_1.41; Faith JJ, 2011, SCIENCE, V333, P101, DOI 10.1126/science.1206025; Fontana L, 2015, CELL, V161, P106, DOI 10.1016/j.cell.2015.02.020; Gesmann M, 2011, R J, V3, P40; Green-Johnson JM, 2012, J AOAC INT, V95, P35, DOI 10.5740/jaoacint.SGE_Green-Johnson; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Hamady M, 2009, GENOME RES, V19, P1141, DOI 10.1101/gr.085464.108; Helander HF, 2014, SCAND J GASTROENTERO, V49, P681, DOI 10.3109/00365521.2014.898326; Hester RL, 2011, J PHYSIOL-LONDON, V589, P1053, DOI 10.1113/jphysiol.2010.201558; Hindmarsh AC, 2005, ACM T MATH SOFTWARE, V31, P363, DOI 10.1145/1089014.1089020; Iida N, 2013, SCIENCE, V342, P967, DOI 10.1126/science.1240527; Kettle H, 2014, ENV MICROBIOLOGY; Kovatchev Boris P, 2009, J Diabetes Sci Technol, V3, P44; Liotta SF, 2000, SIAM J NUMER ANAL, V38, P1337, DOI 10.1137/S0036142999363061; Macfarlane GT, 2007, CURR OPIN BIOTECH, V18, P156, DOI 10.1016/j.copbio.2007.01.011; Macia L, 2012, IMMUNOL REV, V245, P164, DOI 10.1111/j.1600-065X.2011.01080.x; Maqbool S, 2009, DIGEST DIS SCI, V54, P2167, DOI 10.1007/s10620-009-0899-9; Mc Caffrey C, 2008, IEEE PERVAS COMPUT, V7, P23, DOI 10.1109/MPRV.2008.17; Minekus M, 1999, APPL MICROBIOL BIOT, V53, P108, DOI 10.1007/s002530051622; MOLLY K, 1993, APPL MICROBIOL BIOT, V39, P254, DOI 10.1007/BF00228615; Moorthy AS, 2014, J BIOSCI BIOENG, V117, P478, DOI 10.1016/j.jbiosc.2013.09.015; Munoz-Tamayo R, 2010, J THEOR BIOL, V266, P189, DOI 10.1016/j.jtbi.2010.05.040; Payne AN, 2012, TRENDS BIOTECHNOL, V30, P17, DOI 10.1016/j.tibtech.2011.06.011; Ramirez I, 2009, WATER RES, V43, P2787, DOI 10.1016/j.watres.2009.03.034; Rostami-Hodjegan Amin, 2004, Drug Discov Today Technol, V1, P441, DOI 10.1016/j.ddtec.2004.10.002; Rubio R, 2014, FOOD MICROBIOL, V38, P303, DOI 10.1016/j.fm.2013.07.015; SADAHIRO S, 1992, SURG RADIOL ANAT, V14, P251, DOI 10.1007/BF01794949; SCHEPPACH W, 1994, GUT, V35, pS35, DOI 10.1136/gut.35.1_Suppl.S35; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Sommer F, 2013, NAT REV MICROBIOL, V11, P227, DOI 10.1038/nrmicro2974; Taghipoor M, 2014, MATH BIOSCI, V258, P101, DOI 10.1016/j.mbs.2014.09.011; Taghipoor M, 2012, J THEOR BIOL, V294, P114, DOI 10.1016/j.jtbi.2011.10.024; Tortora GJ, 2008, PRINCIPLES ANATOMY P; Vardakou M, 2007, INT J BIOL MACROMOL, V41, P584, DOI 10.1016/j.ijbiomac.2007.07.017; Williams CF, 2015, ANNU REV FOOD SCI T, V6, P329, DOI 10.1146/annurev-food-022814-015429	42	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145309	10.1371/journal.pone.0145309	http://dx.doi.org/10.1371/journal.pone.0145309			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26680208	Green Submitted, Green Published, gold			2022-12-26	WOS:000366723400070
J	Ruegsegger, GN; Company, JM; Toedebusch, RG; Roberts, CK; Roberts, MD; Booth, FW				Ruegsegger, Gregory N.; Company, Joseph M.; Toedebusch, Ryan G.; Roberts, Christian K.; Roberts, Michael D.; Booth, Frank W.			Rapid Alterations in Perirenal Adipose Tissue Transcriptomic Networks with Cessation of Voluntary Running	PLOS ONE			English	Article							GENE-EXPRESSION; ADIPOCYTE HYPERPLASIA; INSULIN-RESISTANCE; CHILDHOOD OBESITY; WEIGHT-REDUCTION; EPIDIDYMAL FAT; CELL-CYCLE; INFLAMMATION; PROTEIN; RATS	In maturing rats, the growth of abdominal fat is attenuated by voluntary wheel running. After the cessation of running by wheel locking, a rapid increase in adipose tissue growth to a size that is similar to rats that have never run (i.e. catch-up growth) has been previously reported by our lab. In contrast, diet-induced increases in adiposity have a slower onset with relatively delayed transcriptomic responses. The purpose of the present study was to identify molecular pathways associated with the rapid increase in adipose tissue after ending 6 wks of voluntary running at the time of puberty. Age-matched, male Wistar rats were given access to running wheels from 4 to 10 weeks of age. From the 10th to 11th week of age, one group of rats had continued wheel access, while the other group had one week of wheel locking. Perirenal adipose tissue was extracted, RNA sequencing was performed, and bioinformatics analyses were executed using Ingenuity Pathway Analysis (IPA). IPA was chosen to assist in the understanding of complex ` omics data by integrating data into networks and pathways. Wheel locked rats gained significantly more fat mass and significantly increased body fat percentage between weeks 10-11 despite having decreased food intake, as compared to rats with continued wheel access. IPA identified 646 known transcripts differentially expressed (p < 0.05) between continued wheel access and wheel locking. In wheel locked rats, IPA revealed enrichment of transcripts for the following functions: extracellular matrix, macrophage infiltration, immunity, and pro-inflammatory. These findings suggest that increases in visceral adipose tissue that accompanies the cessation of pubertal physical activity are associated with the alteration of multiple pathways, some of which may potentiate the development of pubertal obesity and obesity-associated systemic low-grade inflammation that occurs later in life.	[Ruegsegger, Gregory N.; Company, Joseph M.; Toedebusch, Ryan G.; Roberts, Michael D.; Booth, Frank W.] Univ Missouri, Coll Vet Med, Dept Biomed Sci, Columbia, MO 65211 USA; [Roberts, Christian K.] VA Greater Los Angeles Healthcare Syst, Geriatr Res Educ & Clin Ctr, Los Angeles, CA USA; [Booth, Frank W.] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO USA; [Booth, Frank W.] Univ Missouri, Dept Nutr & Exercise Physiol, Columbia, MO USA; [Booth, Frank W.] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Booth, FW (corresponding author), Univ Missouri, Coll Vet Med, Dept Biomed Sci, Columbia, MO 65211 USA.	boothf@missouri.edu		Ruegsegger, Gregory/0000-0002-8018-0456				Adapala VJ, 2012, J NUTR BIOCHEM, V23, P567, DOI 10.1016/j.jnutbio.2011.02.013; Aydin S, 2014, NUTRITION, V30, P1, DOI 10.1016/j.nut.2013.05.013; Bragina O, 2015, J BIOENERG BIOMEMBR, V47, P209, DOI 10.1007/s10863-015-9609-9; Carobbio S, 2013, DIABETES, V62, P3697, DOI 10.2337/db12-1748; Cho KW, 2014, CELL REP, V9, P605, DOI 10.1016/j.celrep.2014.09.004; Company JM, 2013, AM J PHYSIOL-REG I, V305, pR1465, DOI 10.1152/ajpregu.00139.2013; Dankel SN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011033; Flintoff KA, 2014, J CELL PHYSIOL, V229, P1538, DOI 10.1002/jcp.24597; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; Jackman MR, 2008, AM J PHYSIOL-REG I, V294, pR1117, DOI 10.1152/ajpregu.00808.2007; Keller MP, 2008, GENOME RES, V18, P706, DOI 10.1101/gr.074914.107; Keophiphath M, 2009, MOL ENDOCRINOL, V23, P11, DOI 10.1210/me.2008-0183; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Kim DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083363; Kless C, 2015, MOL NUTR FOOD RES, V59, P968, DOI 10.1002/mnfr.201400840; Kump DS, 2006, AM J PHYSIOL-ENDOC M, V290, pE480, DOI 10.1152/ajpendo.00321.2005; Kump DS, 2005, J PHYSIOL-LONDON, V565, P911, DOI 10.1113/jphysiol.2005.084525; Kump DS, 2005, J PHYSIOL-LONDON, V562, P829, DOI 10.1113/jphysiol.2004.073593; Laye MJ, 2007, J APPL PHYSIOL, V102, P1341, DOI 10.1152/japplphysiol.01018.2006; Li JP, 2002, AM J PHYSIOL-ENDOC M, V282, pE1334, DOI 10.1152/ajpendo.00516.2001; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041610; MacLean PS, 2006, AM J PHYSIOL-REG I, V290, pR1577, DOI 10.1152/ajpregu.00810.2005; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; McQuaid SE, 2011, DIABETES, V60, P47, DOI 10.2337/db10-0867; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Munoz A, 2013, J CLIN ENDOCR METAB, V98, pE1360, DOI 10.1210/jc.2012-3841; NEEL JV, 1962, AM J HUM GENET, V14, P353; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Okada-Iwabu M, 2013, NATURE, V503, P493, DOI 10.1038/nature12656; Roberts MD, 2013, AM J PHYSIOL-REG I, V304, pR1024, DOI 10.1152/ajpregu.00581.2012; Roberts MD, 2012, AM J PHYSIOL-REG I, V303, pR247, DOI 10.1152/ajpregu.00167.2012; Rosini TC, 2012, REV ASSOC MED BRAS, V58, P383; Rustemeyer SM, 2011, J ANIM SCI, V89, P916, DOI 10.2527/jas.2010-3473; Schafer N, 2014, METABOLOMICS, V10, P461, DOI 10.1007/s11306-013-0590-1; Song HK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035552; St-Amand J, 2001, FASEB J, V15, P684, DOI 10.1096/fj.00-0150com; Sumimoto H, 2008, FEBS J, V275, P3249, DOI 10.1111/j.1742-4658.2008.06488.x; Tam CS, 2011, INT J PEDIATR OBES, V6, pE360, DOI 10.3109/17477166.2011.575152; Toedebusch RG, 2014, PHYSIOL GENOMICS, V46, P362, DOI 10.1152/physiolgenomics.00172.2013; Turaga RVN, 2009, CELL CYCLE, V8, P2080, DOI 10.4161/cc.8.13.8925; Urruticoechea A, 2005, J CLIN ONCOL, V23, P7212, DOI 10.1200/JCO.2005.07.501; Vadiveloo PK, 1998, J BIOL CHEM, V273, P23104, DOI 10.1074/jbc.273.36.23104; van Dijk A, 2008, CELL TISSUE RES, V332, P289, DOI 10.1007/s00441-008-0573-0; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zhang W, 2015, COMP BIOCHEM PHYS A, V181, P62, DOI 10.1016/j.cbpa.2014.11.012; Zhang YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096997	47	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145229	10.1371/journal.pone.0145229	http://dx.doi.org/10.1371/journal.pone.0145229			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678390	gold, Green Submitted, Green Published			2022-12-26	WOS:000366723400060
J	Bennitt, E; Bonyongo, MC; Harris, S				Bennitt, Emily; Bonyongo, Mpaphi Casper; Harris, Stephen			Behaviour-Related Scalar Habitat Use by Cape Buffalo (Syncerus caffer caffer)	PLOS ONE			English	Article							AFRICAN BUFFALO; OKAVANGO DELTA; NATIONAL-PARK; LARGE HERBIVORE; MOVEMENT PATTERNS; SPECIES-DIVERSITY; ANIMAL MOVEMENTS; SPATIAL SCALES; TRADE-OFF; SELECTION	Studies of habitat use by animals must consider behavioural resource requirements at different scales, which could influence the functional value of different sites. Using Cape buffalo (Syncerus caffer caffer) in the Okavango Delta, Botswana, we tested the hypotheses that behaviour affected use between and within habitats, hereafter referred to as macro-and microhabitats, respectively. We fitted GPS-enabled collars to fifteen buffalo and used the distances and turning angles between consecutive fixes to cluster the resulting data into resting, grazing, walking and relocating behaviours. Distance to water and six vegetation characteristic variables were recorded in sites used for each behaviour, except for relocating, which occurred too infrequently. We used multilevel binomial and multinomial logistic regressions to identify variables that characterised seasonally-preferred macrohabitats and microhabitats used for different behaviours. Our results showed that macrohabitat use was linked to behaviour, although this was least apparent during the rainy season, when resources were most abundant. Behaviour-related microhabitat use was less significant, but variation in forage characteristics could predict some behaviour within all macrohabitats. The variables predicting behaviour were not consistent, but resting and grazing sites were more readily identifiable than walking sites. These results highlight the significance of resting, as well as foraging, site availability in buffalo spatial processes. Our results emphasise the importance of considering several behaviours and scales in studies of habitat use to understand the links between environmental resources and animal behavioural and spatial ecology.	[Bennitt, Emily; Harris, Stephen] Univ Bristol, Sch Biol Sci, Bristol, Avon, England; [Bonyongo, Mpaphi Casper] Okavango Res Inst, Maun, Botswana	University of Bristol	Bennitt, E (corresponding author), Univ Bristol, Sch Biol Sci, Bristol, Avon, England.	ebennitt@ori.ub.bw	Bennitt, Emily/AAB-6032-2020; Bonyongo, Mpaphi Casper/AAS-1423-2021		Dulverton Trust; North of England Zoological Society; Idea Wild; Roberts Fund; Wilderness Safaris Wildlife Trust	Dulverton Trust; North of England Zoological Society; Idea Wild; Roberts Fund; Wilderness Safaris Wildlife Trust	Support was provided by the Dulverton Trust [http://www.dulverton.org/] to SH; the North of England Zoological Society [http://www.chesterzoo.org/global/north-of-england-zoological-society] to EB; Idea Wild [http://www.ideawild.org/] to EB; the Roberts Fund [https://www.cs.bris.ac.uk/Teaching/learning/roberts.html] to EB; the Wilderness Safaris Wildlife Trust [http://www.wildernesstrust.com/] to EB; Mr Rodney Fuhr to EB; Mr Ian Fuhr to EB; Mr Martin and Mrs Jenny Bennitt tp EB; Mr Harry Ferguson to EB; and Dr Dane Hawk to EB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Alldredge JR, 2006, J WILDLIFE MANAGE, V70, P337, DOI 10.2193/0022-541X(2006)70[337:DAAORS]2.0.CO;2; Bailey DW, 1996, J RANGE MANAGE, V49, P386, DOI 10.2307/4002919; Barraquand F, 2008, ECOLOGY, V89, P3336, DOI 10.1890/08-0162.1; Bartlam H. L. A., 2010, THESIS; Basille M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065493; Bennitt E., 2012, THESIS; Bennitt E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101346; Beyer HL, 2010, PHILOS T R SOC B, V365, P2245, DOI 10.1098/rstb.2010.0083; Bonyongo MC, 2007, AFR J ECOL, V45, P527, DOI 10.1111/j.1365-2028.2007.00764.x; Bowne DR, 1999, LANDSCAPE ECOL, V14, P53, DOI 10.1023/A:1008025827895; BRANSBY DI, 1977, AGRON J, V69, P393, DOI 10.2134/agronj1977.00021962006900030016x; Burkepile DE, 2013, ECOSPHERE, V4, DOI 10.1890/ES13-00078.1; Buxton DR, 1996, ANIM FEED SCI TECH, V59, P37, DOI 10.1016/0377-8401(95)00885-3; Chirima GJ, 2012, KOEDOE, V54, DOI 10.4102/koedoe.v54i1.1009; Cornelis D, 2011, J MAMMAL, V92, P1287, DOI 10.1644/10-MAMM-A-397.1; de Knegt HJ, 2007, BEHAV ECOL, V18, P1065, DOI 10.1093/beheco/arm080; de Omena PM, 2010, BEHAV ECOL, V21, P690, DOI 10.1093/beheco/arq040; Devereux CL, 2006, BEHAV ECOL, V17, P303, DOI 10.1093/beheco/arj032; Fortin D, 2003, OECOLOGIA, V134, P219, DOI 10.1007/s00442-002-1112-4; Fortin D, 2009, ECOLOGY, V90, P2480, DOI 10.1890/08-0345.1; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; Fynn RWS, 2014, S AFR J WILDL RES, V44, P1, DOI 10.3957/056.044.0103; Gaillard JM, 2010, PHILOS T R SOC B, V365, P2255, DOI 10.1098/rstb.2010.0085; Ganskopp DC, 2007, RANGELAND ECOL MANAG, V60, P350, DOI 10.2111/1551-5028(2007)60[350:GEISAA]2.0.CO;2; GEORGIADIS NJ, 1989, J TROP ECOL, V5, P93, DOI 10.1017/S0266467400003254; Haby NA, 2013, J MAMMAL, V94, P801, DOI 10.1644/12-MAMM-A-220.1; Hardy M. B., 1993, African Journal of Range and Forage Science, V10, P77, DOI 10.1080/10220119.1993.9638327; Heinl M, 2006, LANDSCAPE ECOL, V21, P699, DOI 10.1007/s10980-005-5243-y; Knight TW, 1996, ECOLOGY, V77, P1756, DOI 10.2307/2265781; Korte LM, 2008, J MAMMAL, V89, P115, DOI 10.1644/06-MAMM-A-423.1; Laca EA, 2010, ECOL LETT, V13, P311, DOI 10.1111/j.1461-0248.2009.01423.x; Leblond M, 2010, ECOGRAPHY, V33, P1102, DOI 10.1111/j.1600-0587.2009.06104.x; Lewis JS, 2007, J APPL ECOL, V44, P663, DOI 10.1111/j.1365-2664.2007.01286.x; Lima SL, 2005, ANIM BEHAV, V70, P723, DOI 10.1016/j.anbehav.2005.01.008; Ludwig F, 2004, PLANT ECOL, V170, P93, DOI 10.1023/B:VEGE.0000019023.29636.92; Macandza VA, 2012, J ZOOL, V287, P175, DOI 10.1111/j.1469-7998.2012.00900.x; Macandza VA, 2004, S AFR J WILDL RES, V34, P113; Masse A, 2009, J MAMMAL, V90, P961, DOI 10.1644/08-MAMM-A-148.1; Matawa F, 2012, ECOL MODEL, V242, P189, DOI 10.1016/j.ecolmodel.2012.05.010; Matson TK, 2005, J WILDLIFE MANAGE, V69, P1708, DOI 10.2193/0022-541X(2005)69[1708:MUBBII]2.0.CO;2; Mayor SJ, 2009, ECOSCIENCE, V16, P238, DOI 10.2980/16-2-3238; McCann NP, 2014, J MAMMAL, V95, P369, DOI 10.1644/13-MAMM-A-110; Megaze A, 2013, AFR J ECOL, V51, P393, DOI 10.1111/aje.12049; Melletti M, 2007, J ZOOL, V271, P178, DOI 10.1111/j.1469-7998.2006.00196.x; Melletti M, 2009, AFR J ECOL, V47, P121, DOI 10.1111/j.1365-2028.2008.00965.x; Morales JM, 2010, PHILOS T R SOC B, V365, P2289, DOI 10.1098/rstb.2010.0082; Mugangu TE, 1995, MAMMALIA, V59, P349, DOI 10.1515/mamm.1995.59.3.349; Muposhi VK, 2014, TROP CONSERV SCI, V7, P440, DOI 10.1177/194008291400700306; Mysterud A, 1998, ECOLOGY, V79, P1435, DOI 10.1890/0012-9658(1998)079[1435:FRIHUA]2.0.CO;2; Omphile UJ, 2002, J RANGE MANAGE, V55, P341, DOI 10.2307/4003470; Owen-Smith N, 2004, LANDSCAPE ECOL, V19, P761, DOI 10.1007/s10980-005-0247-2; Owen-Smith N, 2010, PHILOS T R SOC B, V365, P2267, DOI 10.1098/rstb.2010.0095; Perrin MR, 1999, S AFR J WILDL RES, V29, P72; Peterson DW, 2008, PLANT ECOL, V194, P5, DOI 10.1007/s11258-007-9270-4; Prins HHT, 2014, ECOLOGY, EVOLUTION AND BEHAVIOUR OF WILD CATTLE: IMPLICATIONS FOR CONSERVATION, P21; Prins HHT, 1996, ECOLOGY BEHAV AFRICA; Quinn GP, 2003, EXPT DESIGN DATA ANA; Ramberg L, 2006, AQUAT SCI, V68, P310, DOI 10.1007/s00027-006-0857-y; Rasbash J., 2015, MLWIN VERSION 2 33; Russell RE, 2003, OIKOS, V103, P142, DOI 10.1034/j.1600-0706.2003.12418.x; Ryan SJ, 2006, J WILDLIFE MANAGE, V70, P764, DOI 10.2193/0022-541X(2006)70[764:RAHSOA]2.0.CO;2; Ryan SJ, 2012, J WILDLIFE MANAGE, V76, P1499, DOI 10.1002/jwmg.407; Schneider TC, 2013, MAMM BIOL, V78, P438, DOI 10.1016/j.mambio.2013.06.002; Semeniuk CAD, 2005, BEHAV ECOL, V16, P417, DOI 10.1093/beheco/ari005; SENFT RL, 1987, BIOSCIENCE, V37, P789, DOI 10.2307/1310545; Shrader AM, 2007, BEHAV ECOL, V18, P103, DOI 10.1093/beheco/arl057; Sikes RS, 2011, J MAMMAL, V92, P235, DOI 10.1644/10-MAMM-F-355.1; Sinclair A.R.E., 1977, AFRICAN BUFFALO STUD; Siziba N, 2012, AFR J ECOL, V50, P43, DOI 10.1111/j.1365-2028.2011.01289.x; Smit IPJ, 2011, ECOGRAPHY, V34, P67, DOI 10.1111/j.1600-0587.2010.06029.x; Taolo C., 2003, THESIS; Thornton A, 2009, BEHAV ECOL, V20, P103, DOI 10.1093/beheco/arn120; Thorson JM, 1998, BEHAV ECOL, V9, P151, DOI 10.1093/beheco/9.2.151; Valeix M, 2011, BIOL CONSERV, V144, P902, DOI 10.1016/j.biocon.2010.10.029; Van der Boogaart KG, 2006, GEOL SOC SPEC PUBL, V264, P119, DOI 10.1144/GSL.SP.2006.264.01.09; Van Moorter B, 2010, J WILDLIFE MANAGE, V74, P588, DOI 10.2193/2009-155; Venter JA, 2008, S AFR J WILDL RES, V38, P42, DOI 10.3957/0379-4369-38.1.42; WallisDeVries MF, 1999, OECOLOGIA, V121, P355, DOI 10.1007/s004420050939; Wilmshurst JF, 2000, P ROY SOC B-BIOL SCI, V267, P345, DOI 10.1098/rspb.2000.1007; Wilson RR, 2012, WILDLIFE BIOL, V18, P424, DOI 10.2981/12-044; Winnie JA, 2008, ECOLOGY, V89, P1457, DOI 10.1890/07-0772.1; Zollner PA, 2000, WILDLIFE SOC B, V28, P1003	83	9	9	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145145	10.1371/journal.pone.0145145	http://dx.doi.org/10.1371/journal.pone.0145145			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673623	Green Published, gold, Green Submitted			2022-12-26	WOS:000366722700107
J	Ardizzoni, E; Fajardo, E; Saranchuk, P; Casenghi, M; Page, AL; Varaine, F; Kosack, CS; Hepple, P				Ardizzoni, Elisa; Fajardo, Emmanuel; Saranchuk, Peter; Casenghi, Martina; Page, Anne-Laure; Varaine, Francis; Kosack, Cara S.; Hepple, Pamela			Implementing the Xpert (R) MTB/RIF Diagnostic Test for Tuberculosis and Rifampicin Resistance: Outcomes and Lessons Learned in 18 Countries	PLOS ONE			English	Article							ASSAY	Background The Xpert (R) MTB/RIF (Xpert) is an automated molecular test for simultaneous detection of tuberculosis (TB) and rifampicin resistance, recommended by the World Health Organization as the preferred diagnostic method for individuals presumed to have multi-drug resistant TB (MDR-TB) or HIV-associated TB. We describe the performance of Xpert and key lessons learned during two years of implementation under routine conditions in 33 projects located in 18 countries supported by Medecins Sans Frontieres across varied geographic, epidemiological and clinical settings. Methods Xpert was used following three strategies: the first being as the initial test, with microscopy in parallel, for all presumptive TB cases; the second being only for patients at risk of MDR-TB, or with HIV-associated TB, or presumptive paediatric TB; and the third being as the initial test for these high-risk patients plus as an add-on test to microscopy in others. Routine laboratory data were collected, using laboratory registers. Qualitative data such as logistic aspects, human resources, and tool acceptance were collected using a questionnaire. Findings In total, 52,863 samples underwent Xpert testing from April 2011 to December 2012. The average MTB detection rate was 18.5%, 22.3%, and 11.6% for the three different strategies respectively. Analysis of the results on samples tested in parallel showed that using Xpert as add-on test to microscopy would have increased laboratory TB confirmation by 49.7%, versus 42.3% for Xpert replacing microscopy. The main limitation of the test was the high rate of inconclusive results, which correlated with factors such as defective modules, cartridge version (G3 vs. G4) and staff experience. Operational and logistical hurdles included infrastructure renovation, basic computer training, regular instrument troubleshooting and maintenance, all of which required substantial and continuous support. Conclusion The implementation of Xpert was feasible and significantly increased TB detection compared to microscopy, despite the high rate of inconclusive results. Xpert implementation was accompanied by considerable operational and logistical challenges. To further decentralize diagnosis, simpler, low-cost TB technologies well-suited to low-resource settings are still urgently needed.	[Ardizzoni, Elisa] Med Sans Frontieres, Inst Trop Med, Antwerp, Belgium; [Fajardo, Emmanuel; Saranchuk, Peter] Med Sans Frontieres, Southern Africa Med Unit, Cape Town, South Africa; [Casenghi, Martina] Med Sans Frontieres, Geneva, Switzerland; [Page, Anne-Laure] Med Sans Frontieres, Epictr, Paris, France; [Ardizzoni, Elisa; Varaine, Francis] Med Sans Frontieres, Paris, France; [Kosack, Cara S.] Med Sans Frontieres, Amsterdam, Netherlands; [Hepple, Pamela] Med Sans Frontieres, Manson Unit, London, England	Doctors Without Borders; Institute of Tropical Medicine (ITM); Doctors Without Borders; Doctors Without Borders; Doctors Without Borders; Doctors Without Borders; Doctors Without Borders	Ardizzoni, E (corresponding author), Med Sans Frontieres, Inst Trop Med, Antwerp, Belgium.	eardizzoni@itg.be			Medecins Sans Frontieres, a nonprofit medical humanitarian organization	Medecins Sans Frontieres, a nonprofit medical humanitarian organization	The work described in this paper was funded by Medecins Sans Frontieres, a nonprofit medical humanitarian organization. No outside funding was used in the production of this article.	[Anonymous], 2011, AUT REAL TIM NUCL AC; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; Cepheid, 2008, GENEXPERT DX SYST OP; Cepheid, 2012, CEPHEID XPERT MTB RI; Chang K, 2012, J INFECTION, V64, P580, DOI 10.1016/j.jinf.2012.02.012; Creswell J, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-2; FIND, 2011, FIND REP PERF XPERT; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hillemann D, 2011, J CLIN MICROBIOL, V49, P1202, DOI 10.1128/JCM.02268-10; Human I, 2009, PLOS MED, V6, DOI [10.1371/journal, DOI 10.1371/JOURNAL]; Oberhelman RA, 2010, LANCET INFECT DIS, V10, P612, DOI 10.1016/S1473-3099(10)70141-9; Rachow A, 2012, CLIN INFECT DIS, V54, P1388, DOI 10.1093/cid/cis190; Raizada N, EXPERIENCE IMPLEMENT; Schnippel K, 2013, SAMJ S AFR MED J, V103, P101, DOI [10.7196/SAMJ.6182, 10.7196/samj.6182]; Steingart KR, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009593.pub2; Stevens W, S AFRICAS REALITY CH, P205; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; Weyer K, 1998, LAB SERVICES TUBER 2, VWHO/TB/98.258; WHO, 2014, GLOB TUB REP 2014; WHO, 2008, PROP RED NUMB SMEARS; World Health Organization, 2013, CONGUID UANT DRU, P2013; World Health Organization, 2008, MOL LIN PROB ASS RAP; World Health Organization, 2011, RAP IMPL XPERT MTB R; World Health Organization, 2013, US XPERT MTB RIF ASS; World Health Organization, 2011, ROADM PREV COMB DRUG	26	44	46	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144656	10.1371/journal.pone.0144656	http://dx.doi.org/10.1371/journal.pone.0144656			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670929	Green Published, gold			2022-12-26	WOS:000366719300015
J	Yin, KF; Lei, YJ; Wen, X; Lacruz, RS; Soleimani, M; Kurtz, I; Snead, ML; White, SN; Paine, ML				Yin, Kaifeng; Lei, Yuejuan; Wen, Xin; Lacruz, Rodrigo S.; Soleimani, Manoocher; Kurtz, Ira; Snead, Malcolm L.; White, Shane N.; Paine, Michael L.			SLC26A Gene Family Participate in pH Regulation during Enamel Maturation	PLOS ONE			English	Article							CARBONIC-ANHYDRASE-II; MEDULLARY COLLECTING DUCT; DEVELOPING HAMSTER MOLARS; ANION-EXCHANGER AE2; CL-/HCO3-EXCHANGER; CYSTIC-FIBROSIS; INTRACELLULAR PH; DEVELOPING TEETH; HCO3-SECRETION; DENTAL ENAMEL	The bicarbonate transport activities of Slc26a1, Slc26a6 and Slc26a7 are essential to physiological processes in multiple organs. Although mutations of Slc26a1, Slc26a6 and Slc26a7 have not been linked to any human diseases, disruption of Slc26a1, Slc26a6 or Slc26a7 expression in animals causes severe dysregulation of acid-base balance and disorder of anion homeostasis. Amelogenesis, especially the enamel formation during maturation stage, requires complex pH regulation mechanisms based on ion transport. The disruption of stage-specific ion transporters frequently results in enamel pathosis in animals. Here we present evidence that Slc26a1, Slc26a6 and Slc26a7 are highly expressed in rodent incisor ameloblasts during maturation-stage tooth development. In maturation-stage ameloblasts, Slc26a1, Slc26a6 and Slc26a7 show a similar cellular distribution as the cystic fibrosis transmembrane conductance regulator (Cftr) to the apical region of cytoplasmic membrane, and the distribution of Slc26a7 is also seen in the cytoplasmic/subapical region, presumably on the lysosomal membrane. We have also examined Slc26a1 and Slc26a7 null mice, and although no overt abnormal enamel phenotypes were observed in Slc26a1(-/-) or Slc26a7(-/-) animals, absence of Slc26a1 or Slc26a7 results in up-regulation of Cftr, Ca2, Slc4a4, Slc4a9 and Slc26a9, all of which are involved in pH homeostasis, indicating that this might be a compensatory mechanism used by ameloblasts cells in the absence of Slc26 genes. Together, our data show that Slc26a1, Slc26a6 and Slc26a7 are novel participants in the extracellular transport of bicarbonate during enamel maturation, and that their functional roles may be achieved by forming interaction units with Cftr.	[Yin, Kaifeng; Wen, Xin; Snead, Malcolm L.; Paine, Michael L.] Univ So Calif, Herman Ostrow Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA USA; [Lei, Yuejuan] Guangxi Med Univ, Affiliated Stomatol Hosp, Dept Operat & Endodont, Nanning, Guangxi, Peoples R China; [Lacruz, Rodrigo S.] NYU, Coll Dent, Basic Sci & Craniofacial Biol, New York, NY USA; [Soleimani, Manoocher] Univ Cincinnati, Dept Med, Res Serv, Vet Affairs Med Ctr, Cincinnati, OH USA; [Kurtz, Ira] Univ Calif Los Angeles, David Geffen Sch Med, Div Nephrol, Los Angeles, CA 90095 USA; [White, Shane N.] Univ Calif Los Angeles, Sch Dent, Los Angeles, CA 90024 USA	University of Southern California; Guangxi Medical University; New York University; University System of Ohio; University of Cincinnati; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Cincinnati VA Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Paine, ML (corresponding author), Univ So Calif, Herman Ostrow Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA USA.	paine@usc.edu	soleimani, m/U-6889-2017; Lacruz, Rodrigo/AGY-8090-2022	soleimani, m/0000-0002-3446-8870; 	 [DE019629];  [DE013045];  [DK077162]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R00DE022799, R01DE019629, R01DE013045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R37DE013045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK077162] Funding Source: NIH RePORTER	; ; ; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding provided to MLP, DE019629, http://www.nidcr.nih.gov/, MLP designed the experiments and prepared the manuscript, MLS, DE013045, http://www.nidcr.nih.gov/, MLS prepared the manuscript and IK, DK077162, http://www.niddk.nih.gov/Pages/default.aspx, IK prepared the manuscript.	Alper SL, 2013, MOL ASPECTS MED, V34, P494, DOI 10.1016/j.mam.2012.07.009; Andrejewski N, 1999, J BIOL CHEM, V274, P12692, DOI 10.1074/jbc.274.18.12692; Arquitt CK, 2002, J DENT RES, V81, P492, DOI 10.1177/154405910208100712; Bertrand CA, 2009, J GEN PHYSIOL, V133, P421, DOI 10.1085/jgp.200810097; Bronckers A, 2010, BONE, V46, P1188, DOI 10.1016/j.bone.2009.12.002; Bronckers ALJJ, 2011, EUR J ORAL SCI, V119, P185, DOI 10.1111/j.1600-0722.2011.00901.x; Bronckers ALJJ, 2009, J EXP ZOOL PART B, V312B, P375, DOI 10.1002/jez.b.21267; Chang EH, 2011, CELLS TISSUES ORGANS, V194, P249, DOI 10.1159/000324248; Chavez JC, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094037; Dawson PA, 2010, J CLIN INVEST, V120, P706, DOI 10.1172/JCI31474; DEDUVE C, 1966, ANNU REV PHYSIOL, V28, P435, DOI 10.1146/annurev.ph.28.030166.002251; DOGTEROM AA, 1983, J BIOL BUCCALE, V11, P15; DOGTEROM AA, 1983, J DENT RES, V62, P789, DOI 10.1177/00220345830620070201; Duan X, 2014, J DENT RES, V93, P117, DOI 10.1177/0022034513507066; Duan X, 2011, J DENT RES, V90, P175, DOI 10.1177/0022034510385687; Freel RW, 2006, AM J PHYSIOL-GASTR L, V290, pG719, DOI 10.1152/ajpgi.00481.2005; Hayashi H, 2009, AM J PHYSIOL-CELL PH, V296, pC1279, DOI 10.1152/ajpcell.00638.2008; Hihnala S, 2006, MOL HUM REPROD, V12, P107, DOI 10.1093/molehr/gal009; Homma K, 2010, BBA-BIOMEMBRANES, V1798, P1029, DOI 10.1016/j.bbamem.2010.02.001; Hu JCC, 2007, ORTHOD CRANIOFAC RES, V10, P45, DOI 10.1111/j.1601-6343.2007.00384.x; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Jalali R., 2014, CELL TISSUE RES; Jiang ZR, 2006, NAT GENET, V38, P474, DOI 10.1038/ng1762; Josephsen K, 2010, AM J PHYSIOL-CELL PH, V299, pC1299, DOI 10.1152/ajpcell.00218.2010; Lacruz RS, 2013, J BONE MINER RES, V28, P672, DOI 10.1002/jbmr.1779; Lacruz RS, 2011, EUR J ORAL SCI, V119, P149, DOI 10.1111/j.1600-0722.2011.00881.x; Lacruz RS, 2012, J CELL PHYSIOL, V227, P2264, DOI 10.1002/jcp.22965; Lacruz RS, 2012, J CELL PHYSIOL, V227, P1776, DOI 10.1002/jcp.22911; Lacruz RS, 2010, J BIOL CHEM, V285, P24432, DOI 10.1074/jbc.M110.115188; Lacruz RS, 2010, BIOCHEM BIOPH RES CO, V393, P883, DOI 10.1016/j.bbrc.2010.02.116; Lacruz RS, 2010, CALCIFIED TISSUE INT, V86, P91, DOI 10.1007/s00223-009-9326-7; LIN HM, 1994, CALCIFIED TISSUE INT, V55, P38, DOI 10.1007/BF00310167; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lloyd J B, 1996, Subcell Biochem, V27, P361; Lyaruu DM, 2008, MATRIX BIOL, V27, P119, DOI 10.1016/j.matbio.2007.09.006; LYMAN GE, 1977, AM J PHYSIOL, V232, pF364, DOI 10.1152/ajprenal.1977.232.4.F364; McKee MD, 2013, J DENT RES, V92, P721, DOI 10.1177/0022034513490958; Nanci A, 2008, TEN CATE S ORAL HIST; Paine ML, 2008, J DENT RES, V87, P391, DOI 10.1177/154405910808700415; Petrovic S, 2004, AM J PHYSIOL-RENAL, V286, pF161, DOI 10.1152/ajprenal.00219.2003; Petrovic S, 2003, AM J PHYSIOL-CELL PH, V285, pC608, DOI 10.1152/ajpcell.00084.2003; Petrovic S, 2003, AM J PHYSIOL-GASTR L, V284, pG1093, DOI 10.1152/ajpgi.00454.2002; Reibring CG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096007; SASAKI S, 1991, ARCH ORAL BIOL, V36, P227, DOI 10.1016/0003-9969(91)90090-H; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shapiro JL, 2007, CELL MOL LIFE SCI, V64, P244, DOI 10.1007/s00018-006-6429-4; Simmer JP, 2002, CONNECT TISSUE RES, V43, P441, DOI 10.1080/03008200290001159; SIMMER JP, 1995, CRIT REV ORAL BIOL M, V6, P84, DOI 10.1177/10454411950060020701; Singh AK, 2008, ACTA PHYSIOL, V193, P357, DOI 10.1111/j.1748-1716.2008.01854.x; Smith C E, 1996, Adv Dent Res, V10, P159; Smith CE, 1998, CRIT REV ORAL BIOL M, V9, P128, DOI 10.1177/10454411980090020101; Smith CE, 1996, ANAT REC, V245, P186, DOI 10.1002/(SICI)1097-0185(199606)245:2<186::AID-AR7>3.0.CO;2-V; Smith CE, 2006, EUR J ORAL SCI, V114, P147, DOI 10.1111/j.1600-0722.2006.00273.x; Snead CM, 2011, EUR J ORAL SCI, V119, P136, DOI 10.1111/j.1600-0722.2011.00867.x; Sui W, 2003, J DENT RES, V82, P388, DOI 10.1177/154405910308200512; Sun XM, 2008, CELL PHYSIOL BIOCHEM, V21, P95, DOI 10.1159/000113751; Takagi T, 1998, CONNECT TISSUE RES, V38, P181, DOI 10.3109/03008209809017035; Toyosawa S, 1996, CELL TISSUE RES, V285, P217, DOI 10.1007/s004410050639; Wang XG, 2010, J CELL PHYSIOL, V225, P709, DOI 10.1002/jcp.22267; Wang YX, 2006, EMBO J, V25, P5049, DOI 10.1038/sj.emboj.7601387; Wen X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097318; Wright J T, 1996, Adv Dent Res, V10, P270; Wright JT, 1996, J DENT RES, V75, P966, DOI 10.1177/00220345960750041101; Xie QH, 2002, AM J PHYSIOL-RENAL, V283, pF826, DOI 10.1152/ajprenal.00079.2002; Xu J, 2006, J AM SOC NEPHROL, V17, P956, DOI 10.1681/ASN.2005111174; Xu J, 2009, J BIOL CHEM, V284, P29470, DOI 10.1074/jbc.M109.044396; Yadav MC, 2012, J BONE MINER RES, V27, P1722, DOI 10.1002/jbmr.1619; Yin KF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-998; Zou Y, 2007, BIOCHEM J, V408, P347, DOI 10.1042/BJ20070881	69	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144703	10.1371/journal.pone.0144703	http://dx.doi.org/10.1371/journal.pone.0144703			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671068	gold, Green Submitted, Green Published			2022-12-26	WOS:000366719300016
J	Dinardo, CL; Santos, HC; Vaquero, AR; Martelini, AR; Dallan, LAO; Alencar, AM; Krieger, JE; Pereira, AC				Dinardo, Carla Luana; Santos, Hadassa Campos; Vaquero, Andre Ramos; Martelini, Andre Ricardo; Oliveira Dallan, Luis Alberto; Alencar, Adriano Mesquita; Krieger, Jose Eduardo; Pereira, Alexandre Costa			Smoking and Female Sex: Independent Predictors of Human Vascular Smooth Muscle Cells Stiffening	PLOS ONE			English	Article							PULSE-WAVE VELOCITY; ARTERIAL STIFFNESS; AORTIC STIFFNESS; CARDIOVASCULAR RISK; DIABETES-MELLITUS; WOMEN; HYPERTENSION; HYPERTROPHY; EXPRESSION; MECHANISM	Aims Recent evidence shows the rigidity of vascular smooth muscle cells (VSMC) contributes to vascular mechanics. Arterial rigidity is an independent cardiovascular risk factor whose associated modifications in VSMC viscoelasticity have never been investigated. This study's objective was to evaluate if the arterial rigidity risk factors aging, African ancestry, female sex, smoking and diabetes mellitus are associated with VMSC stiffening in an experimental model using a human derived vascular smooth muscle primary cell line repository. Methods Eighty patients subjected to coronary artery bypass surgery were enrolled. VSMCs were extracted from internal thoracic artery fragments and mechanically evaluated using Optical Magnetic Twisting Cytometry assay. The obtained mechanical variables were correlated with the clinical variables: age, gender, African ancestry, smoking and diabetes mellitus. Results The mechanical variables Gr, G'r and G"r had a normal distribution, demonstrating an inter-individual variability of VSMC viscoelasticity, which has never been reported before. Female sex and smoking were independently associated with VSMC stiffening: Gr (apparent cell stiffness) p = 0.022 and p = 0.018, R-2 0.164; G'r (elastic modulus) p = 0.019 and p = 0.009, R-2 0.184 and G"r (dissipative modulus) p = 0.011 and p = 0.66, R-2 0.141. Conclusion Female sex and smoking are independent predictors of VSMC stiffening. This pro-rigidity effect represents an important element for understanding the vascular rigidity observed in post-menopausal females and smokers, as well as a potential therapeutic target to be explored in the future. There is a significant inter-individual variation of VSMC viscoelasticity, which is slightly modulated by clinical variables and probably relies on molecular factors.	[Dinardo, Carla Luana; Santos, Hadassa Campos; Vaquero, Andre Ramos; Martelini, Andre Ricardo; Krieger, Jose Eduardo; Pereira, Alexandre Costa] Univ Sao Paulo, Sch Med, Heart Inst InCor, Lab Genet & Mol Cardiol, Sao Paulo, Brazil; [Alencar, Adriano Mesquita] Univ Sao Paulo, Inst Phys, Lab Microrheol & Mol Physiol, Sao Paulo, Brazil; [Oliveira Dallan, Luis Alberto] Univ Sao Paulo, Sch Med, Heart Inst InCor, Coronary Surg Unit, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo	Dinardo, CL (corresponding author), Univ Sao Paulo, Sch Med, Heart Inst InCor, Lab Genet & Mol Cardiol, Sao Paulo, Brazil.	caludinardo@gmail.com	Alencar, Adriano M/L-5071-2013; Stefanadis, Christodoulos/ABH-2232-2020; Pereira, Alexandre/HHN-1038-2022	Alencar, Adriano M/0000-0001-9324-2698; Stefanadis, Christodoulos/0000-0001-5974-6454; dallan, luis alberto/0000-0002-8655-8966	 [2012/21103-0]		This work was supported by Grant #2012/21103-0, Sao Paulo Research Foundation (FAPESP).	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Atef ME, 2014, AM J PHYSIOL-CELL PH, V307, pC97, DOI 10.1152/ajpcell.00337.2013; Barua RS, 2003, CIRCULATION, V107, P2342, DOI 10.1161/01.CIR.0000066691.52789.BE; Blacher J, 1999, HYPERTENSION, V33, P1111, DOI 10.1161/01.HYP.33.5.1111; Cardena MMSG, 2014, INT J CARDIOL, V176, P527, DOI 10.1016/j.ijcard.2014.07.039; Center SHG, 2014, HUM GEN DIV PROJ; Coutinho T, 2013, J AM COLL CARDIOL, V61, P96, DOI 10.1016/j.jacc.2012.08.997; Cucina A, 2000, SURGERY, V127, P72, DOI 10.1067/msy.2000.102422; Dinardo CL, 2014, AM J PHYSIOL-HEART C, V306, pH505, DOI 10.1152/ajpheart.00655.2013; Dinardo CL, 2012, BIORHEOLOGY, V49, P365, DOI 10.3233/BIR-120621; Durier S, 2003, CIRCULATION, V108, P1845, DOI 10.1161/01.CIR.0000091407.86925.7A; Fabry B, 2001, J APPL PHYSIOL, V91, P986, DOI 10.1152/jappl.2001.91.2.986; Galmiche G, 2014, HYPERTENSION, V63, P520, DOI 10.1161/HYPERTENSIONAHA.113.01967; Giannattasio C, 1996, ATHEROSCLEROSIS, V124, P249, DOI 10.1016/0021-9150(96)05834-0; Hata K, 2012, TOB INDUC DIS, V10, DOI 10.1186/1617-9625-10-11; Ichihara A, 2002, NEPHROL DIAL TRANSPL, V17, P1513, DOI 10.1093/ndt/17.8.1513; Jacob-Ferreira ALB, 2010, EUR J PHARMACOL, V627, P216, DOI 10.1016/j.ejphar.2009.10.057; Santos PCJD, 2011, AM J HYPERTENS, V24, P278, DOI 10.1038/ajh.2010.244; LEVENSON J, 1987, ARTERIOSCLEROSIS, V7, P572, DOI 10.1161/01.ATV.7.6.572; Liu WF, 2012, CARDIOVASC RES, V95, P215, DOI 10.1093/cvr/cvs168; Louis H, 2007, AM J PHYSIOL-HEART C, V293, pH2597, DOI 10.1152/ajpheart.00299.2007; Mitchell GF, 2008, HYPERTENSION, V51, P1123, DOI 10.1161/HYPERTENSIONAHA.107.108175; Mullick AE, 2001, AM J PHYSIOL-HEART C, V281, pH2204, DOI 10.1152/ajpheart.2001.281.5.H2204; Osborne-Pellegrin M, 2010, AM J PHYSIOL-HEART C, V299, pH144, DOI 10.1152/ajpheart.00040.2010; Park CY, 2010, AM J PHYSIOL-CELL PH, V298, pC1245, DOI 10.1152/ajpcell.00417.2009; Qiu HY, 2010, CIRC RES, V107, P615, DOI 10.1161/CIRCRESAHA.110.221846; Regnault V, 2012, J AM COLL CARDIOL, V59, P1771, DOI 10.1016/j.jacc.2012.01.044; SALOMAA V, 1995, CIRCULATION, V91, P1432, DOI 10.1161/01.CIR.91.5.1432; Segers P, 2007, HYPERTENSION, V49, P1248, DOI 10.1161/HYPERTENSIONAHA.106.085480; Sehgel NL, 2013, AM J PHYSIOL-HEART C, V305, pH1281, DOI 10.1152/ajpheart.00232.2013; Stefanadis C, 1999, AM J PHYSIOL-HEART C, V276, pH658, DOI 10.1152/ajpheart.1999.276.2.H658; Takami T, 2011, VASC HEALTH RISK MAN, V7, P633, DOI 10.2147/VHRM.S25798; Tarnoki A, 2015, J HYPERTENS, V33, pE29, DOI 10.1097/01.hjh.0000467426.41935.74; Tomiyama H, 2010, J AM COLL CARDIOL, V55, P1979, DOI 10.1016/j.jacc.2009.12.042; Waddell TK, 2001, J HYPERTENS, V19, P2205, DOI 10.1097/00004872-200112000-00014; Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008; Zhou EH, 2012, J R SOC INTERFACE, V9, P1144, DOI 10.1098/rsif.2011.0733	38	7	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145062	10.1371/journal.pone.0145062	http://dx.doi.org/10.1371/journal.pone.0145062			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26661469	Green Published, gold, Green Submitted			2022-12-26	WOS:000366715900178
J	Fleskens, V; Mokry, M; van der Leun, AM; Huppelschoten, S; Pals, CEM; Peeters, J; Coenen, S; Cardoso, BA; Barata, JT; van Loosdregt, J; Coffer, PJ				Fleskens, V.; Mokry, M.; van der Leun, A. M.; Huppelschoten, S.; Pals, C. E. G. M.; Peeters, J.; Coenen, S.; Cardoso, B. A.; Barata, J. T.; van Loosdregt, J.; Coffer, P. J.			FOXP3 can modulate TAL1 transcriptional activity through interaction with LMO2	ONCOGENE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; REGULATORY T-CELLS; GENE-EXPRESSION; TUMOR-SUPPRESSOR; TRANSGENIC MICE; PROTEIN LMO2; CANCER-CELLS; COMPLEX; DIFFERENTIATION; SCL	T-cell acute lymphoblastic leukemia (T-ALL) frequently involves aberrant expression of TAL1 (T-cell acute lymphocytic leukemia 1) and LMO2, oncogenic members of the TAL1 transcriptional complex. Transcriptional activity of the TAL1-complex is thought to have a pivotal role in the transformation of thymocytes and is associated with a differentiation block and self-renewal. The transcription factor Forkhead Box P3 (FOXP3) was recently described to be expressed in a variety of malignancies including T-ALL. Here we show that increased FOXP3 levels negatively correlate with expression of genes regulated by the oncogenic TAL1-complex in human T-ALL patient samples as well as a T-ALL cell line ectopically expressing FOXP3. In these cells, FOXP3 expression results in altered regulation of cell cycle progression and reduced cell viability. Finally, we demonstrate that FOXP3 binds LMO2 in vitro, resulting in decreased interaction between LMO2 and TAL1, providing a molecular mechanism for FOXP3-mediated transcriptional modulation in T-ALL. Collectively, our findings provide initial evidence for a novel role of FOXP3 as a tumor suppressor in T-ALL through modulation of TAL1 transcriptional activity.	[Fleskens, V.; van der Leun, A. M.; Huppelschoten, S.; Pals, C. E. G. M.; Peeters, J.; Coenen, S.; van Loosdregt, J.; Coffer, P. J.] Univ Med Ctr Utrecht, Ctr Mol Med, Dept Cell Biol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands; [Mokry, M.; van Loosdregt, J.; Coffer, P. J.] Wilhelmina Childrens Hosp, Div Pediat, Utrecht, Netherlands; [Cardoso, B. A.; Barata, J. T.] Univ Lisbon, Fac Med, Inst Mol Med, Lisbon, Portugal	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Universidade de Lisboa	Coffer, PJ (corresponding author), Univ Med Ctr Utrecht, Ctr Mol Med, Dept Cell Biol, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	p.j.coffer@umcutrecht.nl	Barata, João T./D-9181-2015; Mokry, Michal/AAN-3809-2021; Coffer, Paul/AAF-7970-2020	Barata, João T./0000-0002-4826-8976; Mokry, Michal/0000-0002-5298-4852; Cardoso, Bruno/0000-0002-6521-7257; Peeters, Janneke/0000-0002-5777-4352	Dutch Arthritis Foundation (Rheumafonds); Fundacao para a Ciencia e a Tecnologia	Dutch Arthritis Foundation (Rheumafonds); Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission)	We thank S Sakaguchi and T Mutis for providing us with plasmids and T Radstake for providing us with cells. VF and JvL were supported by a grant from the Dutch Arthritis Foundation (Rheumafonds), and BAC was supported by a fellowship from Fundacao para a Ciencia e a Tecnologia. This work was supported by grant from the Dutch Arthritis Foundation (Rheumafonds), and a fellowship from Fundacao para a Ciencia e a Tecnologia.	Aarts-Riemens T, 2008, EUR J IMMUNOL, V38, P1381, DOI 10.1002/eji.200737590; Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Atak ZK, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003997; Barata JT, 2004, BLOOD, V103, P1891, DOI 10.1182/blood-2002-12-3861; Brunkow ME, 2001, NAT GENET, V27, P68, DOI 10.1038/83784; Cardoso BA, 2011, LEUKEMIA, V25, P1578, DOI 10.1038/leu.2011.140; Chen GY, 2008, J IMMUNOL, V180, P5163, DOI 10.4049/jimmunol.180.8.5163; Condorelli GL, 1996, CANCER RES, V56, P5113; Correia NC, 2013, LEUKEMIA, V27, P1603, DOI 10.1038/leu.2013.63; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Fleskens V, 2014, INT REV IMMUNOL, V33, P94, DOI 10.3109/08830185.2013.816698; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Gavin MA, 2006, P NATL ACAD SCI USA, V103, P6659, DOI 10.1073/pnas.0509484103; Grutz GG, 1998, EMBO J, V17, P4594, DOI 10.1093/emboj/17.16.4594; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Hansson A, 2003, BIOCHEM BIOPH RES CO, V312, P1073, DOI 10.1016/j.bbrc.2003.11.030; Herblot S, 2000, NAT IMMUNOL, V1, P138, DOI 10.1038/77819; Hinz S, 2007, CANCER RES, V67, P8344, DOI 10.1158/0008-5472.CAN-06-3304; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Karanikas V, 2008, J TRANSL MED, V6, DOI 10.1186/1479-5876-6-19; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Larson RC, 1996, EMBO J, V15, P1021, DOI 10.1002/j.1460-2075.1996.tb00439.x; Lecuyer E, 2002, BLOOD, V100, P2430, DOI 10.1182/blood-2002-02-0568; Liu RH, 2009, CANCER RES, V69, P2252, DOI 10.1158/0008-5472.CAN-08-3717; Luo XD, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-34; Ma GF, 2013, BIOCHEM BIOPH RES CO, V430, P804, DOI 10.1016/j.bbrc.2012.11.065; Mansour MR, 2013, J EXP MED, V210, P1545, DOI 10.1084/jem.20122516; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Martin F, 2010, ONCOGENE, V29, P4121, DOI 10.1038/onc.2010.174; Matsubara Y, 2005, LEUKEMIA, V19, P482, DOI 10.1038/sj.leu.2403628; McCormack MP, 2010, SCIENCE, V327, P879, DOI 10.1126/science.1182378; McMurchy AN, 2013, BLOOD, V121, P1265, DOI 10.1182/blood-2012-05-431023; Palomero T, 2006, BLOOD, V108, P986, DOI 10.1182/blood-2005-08-3482; Roncador G, 2005, LEUKEMIA, V19, P2247, DOI 10.1038/sj.leu.2403965; Rudra D, 2012, NAT IMMUNOL, V13, P1010, DOI 10.1038/ni.2402; Samon JB, 2008, BLOOD, V112, P1813, DOI 10.1182/blood-2008-03-144980; Sanda T, 2012, CANCER CELL, V22, P209, DOI 10.1016/j.ccr.2012.06.007; Shi XZ, 2010, STEM CELLS, V28, P462, DOI 10.1002/stem.274; Tremblay M, 2003, J BIOL CHEM, V278, P12680, DOI 10.1074/jbc.M209870200; Tremblay M, 2010, GENE DEV, V24, P1093, DOI 10.1101/gad.1897910; Tuovinen H, 2008, IMMUNOL CELL BIOL, V86, P523, DOI 10.1038/icb.2008.36; van Loosdregt J, 2013, IMMUNITY, V39, P259, DOI 10.1016/j.immuni.2013.05.018; van Loosdregt J, 2013, IMMUNITY, V39, P298, DOI 10.1016/j.immuni.2013.07.019; van Loosdregt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019047; Van Vlierberghe P, 2012, J CLIN INVEST, V122, P3398, DOI 10.1172/JCI61269; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Wang J, 2007, EUR J IMMUNOL, V37, P129, DOI 10.1002/eji.200636435; Wang LZ, 2009, CANCER CELL, V16, P336, DOI 10.1016/j.ccr.2009.08.016; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Xu ZX, 2003, MOL CELL BIOL, V23, P7585, DOI 10.1128/MCB.23.21.7585-7599.2003; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zuo T, 2007, CELL, V129, P1275, DOI 10.1016/j.cell.2007.04.034	57	7	7	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 4	2016	35	31					4141	4148		10.1038/onc.2015.481	http://dx.doi.org/10.1038/onc.2015.481			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS8GG	26686090				2022-12-26	WOS:000381020900012
J	Warne, J; Pryce, G; Hill, JM; Shi, X; Lenneras, F; Puentes, F; Kip, M; Hilditch, L; Walker, P; Simone, MI; Chan, AWE; Towers, GJ; Coker, AR; Duchen, MR; Szabadkai, G; Baker, D; Selwood, DL				Warne, Justin; Pryce, Gareth; Hill, Julia M.; Shi, Xiao; Lenneras, Felicia; Puentes, Fabiola; Kip, Maarten; Hilditch, Laura; Walker, Paul; Simone, Michela I.; Chan, A. W. Edith; Towers, Greg J.; Coker, Alun R.; Duchen, Michael R.; Szabadkai, Gyorgy; Baker, David; Selwood, David L.			Selective Inhibition of the Mitochondrial Permeability Transition Pore Protects against Neurodegeneration in Experimental Multiple Sclerosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; TRAUMATIC BRAIN-INJURY; HUMAN CYCLOPHILIN-D; CYCLOSPORINE-A; AXONAL DEGENERATION; ATP SYNTHASE; TRIPHENYLPHOSPHONIUM CATIONS; LENTIVIRAL VECTOR; P-GLYCOPROTEIN	The mitochondrial permeability transition pore is a recognized drug target for neurodegenerative conditions such as multiple sclerosis and for ischemia-reperfusion injury in the brain and heart. The peptidylprolyl isomerase, cyclophilin D (CypD, PPIF), is a positive regulator of the pore, and genetic down-regulation or knock-out improves outcomes in disease models. Current inhibitors of peptidylprolyl isomerases show no selectivity between the tightly conserved cyclophilin paralogs and exhibit significant off-target effects, immunosuppression, and toxicity. We therefore designed and synthesized a new mitochondrially targeted CypD inhibitor, JW47, using a quinolinium cation tethered to cyclosporine. X-ray analysis was used to validate the design concept, and biological evaluation revealed selective cellular inhibition of CypD and the permeability transition pore with reduced cellular toxicity compared with cyclosporine. In an experimental autoimmune encephalomyelitis disease model of neurodegeneration in multiple sclerosis, JW47 demonstrated significant protection of axons and improved motor assessments with minimal immunosuppression. These findings suggest that selective CypD inhibition may represent a viable therapeutic strategy for MS and identify quinolinium as a mitochondrial targeting group for in vivo use.	[Warne, Justin; Pryce, Gareth; Shi, Xiao; Kip, Maarten; Simone, Michela I.; Chan, A. W. Edith; Coker, Alun R.; Selwood, David L.] UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England; [Pryce, Gareth; Lenneras, Felicia; Puentes, Fabiola; Baker, David] Queen Mary Univ London, Barts & London Sch Med & Dent, Neuroimmunol Unit, Blizard Inst, 4 Newark St, London E1 2AT, England; [Hill, Julia M.; Duchen, Michael R.; Szabadkai, Gyorgy] UCL, Dept Cell & Dev Biol, Mortimer St, London WC1E 6BT, England; [Hilditch, Laura; Towers, Greg J.] UCL, Med Res Council, Ctr Med Mol Biol, Div Infect & Immun, Mortimer St, London WC1E 6BT, England; [Walker, Paul] Cyprotex Discovery Ltd, 100 Barbirolli Sq, Manchester M2 3AB, Lancs, England; [Szabadkai, Gyorgy] Univ Padua, Dept Biomed Sci, I-35122 Padua, Italy; [Simone, Michela I.] Univ Newcastle, Sch Environm & Life Sci, Discipline Chem, Callaghan, NSW 2308, Australia	University of London; University College London; University of London; Queen Mary University London; University of London; University College London; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of London; University College London; University of Padua; University of Newcastle	Selwood, DL (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.; Baker, D (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Neuroimmunol Unit, Blizard Inst, 4 Newark St, London E1 2AT, England.	david.baker@qmul.ac.uk; d.selwood@ucl.ac.uk	Simone, Michela I./A-6887-2011; duchen, michael/A-2116-2009; Simone, Michela/AAS-7878-2020	Simone, Michela I./0000-0002-1339-8236; duchen, michael/0000-0003-2548-4294; Simone, Michela/0000-0002-1339-8236; Coker, Alun/0000-0001-7385-0143; Szabadkai, Gyorgy/0000-0002-3006-3577; Selwood, David/0000-0002-6817-5064; Towers, Gregory/0000-0002-7707-0264; Walker, Paul/0000-0002-7840-9709	FastForward; National Multiple Sclerosis Society; Wellcome Trust [090940]; Medical Research Council, a Medical Research Council Confidence in Concept Award; National Institute for Health Research University College London Hospitals Biomedical Research Centre; Eisai UK Ltd.; British Heart Foundation; Telethon Italy; Italian Association for Cancer Research (AIRC); MRC [G0801172] Funding Source: UKRI; Medical Research Council [G0801172] Funding Source: researchfish; Wellcome Trust [108183/Z/15/Z] Funding Source: researchfish	FastForward; National Multiple Sclerosis Society(National Multiple Sclerosis Society); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council, a Medical Research Council Confidence in Concept Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research University College London Hospitals Biomedical Research Centre(General Electric); Eisai UK Ltd.(Eisai Co Ltd); British Heart Foundation(British Heart Foundation); Telethon Italy(Fondazione Telethon); Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by FastForward, National Multiple Sclerosis Society, Wellcome Trust Senior Fellowship 090940 (to G. J. T.), the Medical Research Council, a Medical Research Council Confidence in Concept Award (to G. J. T. and D. S.), and the National Institute for Health Research University College London Hospitals Biomedical Research Centre. Three authors (G. S., D. B., and D. L. S.) are inventors on a patent filed by the university. Through the university revenue sharing scheme, inventors may, should the invention be commercialized and in the fullness of time, receive some financial benefit.; Supported by a studentship from Eisai UK Ltd.; Supported by the British Heart Foundation, Wellcome Trust, Telethon Italy, and the Italian Association for Cancer Research (AIRC).	Al-Izki S, 2014, BRAIN, V137, P92, DOI 10.1093/brain/awt324; Al-Izki S, 2012, MULT SCLER RELAT DIS, V1, P29, DOI 10.1016/j.msard.2011.09.001; Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111; ALLEN SJ, 1993, CELL IMMUNOL, V146, P335, DOI 10.1006/cimm.1993.1031; AMOR S, 1994, J IMMUNOL, V153, P4349; Astin R, 2013, SCI REP-UK, V3, DOI 10.1038/srep02467; Bainbridge JWB, 2001, GENE THER, V8, P1665, DOI 10.1038/sj.gt.3301574; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Baker D, 2011, MULT SCLER J, V17, P647, DOI 10.1177/1352458511398885; Barbarino JM, 2013, PHARMACOGENET GENOM, V23, P563, DOI 10.1097/FPC.0b013e328364db84; Barrientos SA, 2011, J NEUROSCI, V31, P966, DOI 10.1523/JNEUROSCI.4065-10.2011; Bart J, 2000, CANCER TREAT REV, V26, P449, DOI 10.1053/ctrv.2000.0194; Basso E, 2008, J BIOL CHEM, V283, P26307, DOI 10.1074/jbc.C800132200; Bonora M, 2013, CELL CYCLE, V12, P674, DOI 10.4161/cc.23599; Campbell GR, 2014, MULT SCLER J, V20, P1806, DOI 10.1177/1352458514544537; Chinopoulos C, 2011, FEBS J, V278, P1112, DOI 10.1111/j.1742-4658.2011.08026.x; Chung NS, 2004, ADV DRUG DELIVER REV, V56, P1315, DOI 10.1016/j.addr.2003.12.003; Coles AJ, 1999, ANN NEUROL, V46, P296, DOI 10.1002/1531-8249(199909)46:3<296::AID-ANA4>3.0.CO;2-#; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Davis TL, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000439; Du H, 2011, NEUROBIOL AGING, V32, P398, DOI 10.1016/j.neurobiolaging.2009.03.003; Dube H, 2012, BIOCHEM J, V441, P901, DOI 10.1042/BJ20111301; Dutta R, 2006, ANN NEUROL, V59, P478, DOI 10.1002/ana.20736; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Forte M, 2007, P NATL ACAD SCI USA, V104, P7558, DOI 10.1073/pnas.0702228104; Gaali S, 2010, ACS MED CHEM LETT, V1, P536, DOI 10.1021/ml1001272; Gallay PA, 2013, DRUG DES DEV THER, V7, P105, DOI 10.2147/DDDT.S30946; Gane EJ, 2010, LIVER INT, V30, P1019, DOI 10.1111/j.1478-3231.2010.02250.x; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Giorgio V, 2009, J BIOL CHEM, V284, P33982, DOI 10.1074/jbc.M109.020115; Gogarten W, 1998, J NEUROSURG ANESTH, V10, P101, DOI 10.1097/00008506-199804000-00006; Guo L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054914; Halestrap AP, 2015, J MOL CELL CARDIOL, V78, P129, DOI 10.1016/j.yjmcc.2014.08.018; Hampton DW, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-84; Hanell A, 2015, ACTA NEUROPATHOL, V129, P317, DOI 10.1007/s00401-014-1376-x; Hazelton JL, 2009, J NEUROSCI RES, V87, P1250, DOI 10.1002/jnr.21921; Hecking M, 2008, TRANSPL INT, V21, P223, DOI 10.1111/j.1432-2277.2007.00563.x; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Hoye AT, 2008, ACCOUNTS CHEM RES, V41, P87, DOI 10.1021/ar700135m; Jackson SJ, 2009, J NEUROPATH EXP NEUR, V68, P616, DOI 10.1097/NEN.0b013e3181a41d23; Jackson SJ, 2005, NEUROSCIENCE, V134, P261, DOI 10.1016/j.neuroscience.2005.02.045; Kageyama T, 2013, J NEUROL, V260, P627, DOI 10.1007/s00415-012-6692-2; Kajitani K, 2008, PROTEINS, V70, P1635, DOI 10.1002/prot.21855; Kapoor R, 2003, ANN NEUROL, V53, P174, DOI 10.1002/ana.10443; KAPPOS L, 1988, ANN NEUROL, V23, P56, DOI 10.1002/ana.410230110; Kato M, 2009, CARDIOVASC RES, V83, P335, DOI 10.1093/cvr/cvp094; Kutzelnigg A, 2014, HAND CLINIC, V122, P15, DOI 10.1016/B978-0-444-52001-2.00002-9; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lemasters JJ, 2007, METHOD CELL BIOL, V80, P283, DOI 10.1016/S0091-679X(06)80014-2; Leo S, 2008, ANN NY ACAD SCI, V1147, P264, DOI 10.1196/annals.1427.019; Lim SY, 2011, J CELL MOL MED, V15, P2443, DOI 10.1111/j.1582-4934.2010.01235.x; Liu YY, 2006, ANAL BIOCHEM, V356, P100, DOI 10.1016/j.ab.2006.04.040; Macarron R, 2011, FUTURE MED CHEM, V3, P505, DOI [10.4155/FMC.11.19, 10.4155/fmc.11.19]; Mahad D, 2008, BRAIN, V131, P1722, DOI 10.1093/brain/awn105; MAKLER MT, 1990, Patent No. 4946849; Malouitre S, 2010, BIOCHEM J, V425, P137, DOI 10.1042/BJ20090332; Marta M, 2012, CNS NEUROL DISORD-DR, V11, P610, DOI 10.2174/187152712801661301; Martin LJ, 2014, NEUROBIOL AGING, V35, P1132, DOI 10.1016/j.neurobiolaging.2013.11.008; Martin LJ, 2009, EXP NEUROL, V218, P333, DOI 10.1016/j.expneurol.2009.02.015; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McEwan WA, 2009, J VIROL, V83, P8270, DOI 10.1128/JVI.00670-09; Millard M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013131; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nikolovska-Coleska Z, 2004, ANAL BIOCHEM, V332, P261, DOI 10.1016/j.ab.2004.05.055; Ohno N, 2014, P NATL ACAD SCI USA, V111, P9953, DOI 10.1073/pnas.1401155111; ONEILL JK, 1992, J NEUROIMMUNOL, V38, P53, DOI 10.1016/0165-5728(92)90090-8; Porteous CM, 2013, BBA-GEN SUBJECTS, V1830, P3458, DOI 10.1016/j.bbagen.2013.02.005; Pryce G, 2005, J NEUROIMMUNOL, V165, P41, DOI 10.1016/j.jneuroim.2005.04.009; Pryce G, 2014, FASEB J, V28, P117, DOI 10.1096/fj.13-239442; Quintanilla RA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-45; Raftopoulos R, 2015, MULT SCLER J, V21, P273; Rasaiyaah J, 2013, NATURE, V503, P402, DOI 10.1038/nature12769; Readnower RD, 2011, J NEUROTRAUM, V28, P1845, DOI 10.1089/neu.2011.1755; Reddy PH, 2012, BBA-MOL BASIS DIS, V1822, P639, DOI 10.1016/j.bbadis.2011.10.011; Reily C, 2013, REDOX BIOL, V1, P86, DOI 10.1016/j.redox.2012.11.009; Rodrigues JR, 2007, EXP PARASITOL, V115, P19, DOI 10.1016/j.exppara.2006.05.002; Ross MF, 2005, BIOCHEMISTRY-MOSCOW+, V70, P222, DOI 10.1007/s10541-005-0104-5; Savino C, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/719407; SCHINKEL AH, 1995, J CLIN INVEST, V96, P1698, DOI 10.1172/JCI118214; Schlatter D, 2005, ACTA CRYSTALLOGR D, V61, P513, DOI 10.1107/S0907444905003070; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sharma Pradeep, 2005, Farmaco (Lausanne), V60, P870, DOI 10.1016/j.farmac.2005.08.006; Smulik JA, 2002, ORG LETT, V4, P2051, DOI 10.1021/ol0258987; Starr R, 1996, J NEUROSCI RES, V44, P328; Su K, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00169; Su KG, 2012, EUR J NEUROSCI, V35, P562, DOI 10.1111/j.1460-9568.2011.07972.x; Templeton I, 2014, METHODS MOL BIOL, V1113, P471, DOI 10.1007/978-1-62703-758-7_22; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Valasani KR, 2014, ACTA CRYSTALLOGR F, V70, P717, DOI 10.1107/S2053230X14009480; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WOLINSKY JS, 1990, ANN NEUROL, V27, P591; Wu N, 2015, EUR REV MED PHARMACO, V19, P446; Ylinen LMJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001062; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	99	46	50	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4356	4373		10.1074/jbc.M115.700385	http://dx.doi.org/10.1074/jbc.M115.700385			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26679998	hybrid, Green Published			2022-12-26	WOS:000371604600009
J	Shobair, M; Dagliyan, O; Kota, P; Dang, YL; He, H; Stutts, MJ; Dokholyan, NV				Shobair, Mahmoud; Dagliyan, Onur; Kota, Pradeep; Dang, Yan L.; He, Hong; Stutts, M. Jackson; Dokholyan, Nikolay V.			Gain-of-Function Mutation W493R in the Epithelial Sodium Channel Allosterically Reconfigures Intersubunit Coupling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						electrophysiology; ion channel; molecular docking; molecular dynamics; protein-protein interaction; allosteric activation; channelopathies; tetramer model	NA+ CHANNEL; ION-CHANNEL; GENETIC-VARIATION; ENAC; ACTIVATION; REVEALS; SUBUNIT; ARCHITECTURE; CHOLESTEROL; INHIBITION	Sodium absorption in epithelial cells is rate-limited by the epithelial sodium channel (ENaC) activity in lung, kidney, and the distal colon. Pathophysiological conditions, such as cystic fibrosis and Liddle syndrome, result from water-electrolyte imbalance partly due to malfunction of ENaC regulation. Because the quaternary structure of ENaC is yet undetermined, the bases of pathologically linked mutations in ENaC subunits , , and are largely unknown. Here, we present a structural model of heterotetrameric ENaC (12) that is consistent with previous cross-linking results and site-directed mutagenesis experiments. By using this model, we show that the disease-causing mutation W493R rewires structural dynamics of the intersubunit interfaces (1) and (2). Changes in dynamics can allosterically propagate to the channel gate. We demonstrate that cleavage of the -subunit, which is critical for full channel activation, does not mediate activation of ENaC by W493R. Our molecular dynamics simulations led us to identify a channel-activating electrostatic interaction between (2)Arg-493 and Glu-348 at the (2) interface. By neutralizing a sodium-binding acidic patch at the (1) interface, we reduced ENaC activation of W493R by more than 2-fold. By combining homology modeling, molecular dynamics, cysteine cross-linking, and voltage clamp experiments, we propose a dynamics-driven model for the gain-of-function in ENaC by W493R. Our integrated computational and experimental approach advances our understanding of structure, dynamics, and function of ENaC in its disease-causing state.	[Shobair, Mahmoud; Dagliyan, Onur; Kota, Pradeep; Dokholyan, Nikolay V.] Univ N Carolina, Program Mol & Cellular Biophys, Chapel Hill, NC 27599 USA; [Shobair, Mahmoud; Dokholyan, Nikolay V.] Univ N Carolina, Curriculum Bioinformat & Computat Biol, Chapel Hill, NC 27599 USA; [Shobair, Mahmoud; Dagliyan, Onur; Kota, Pradeep; Dokholyan, Nikolay V.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Dang, Yan L.; He, Hong; Stutts, M. Jackson; Dokholyan, Nikolay V.] Univ N Carolina, Cyst Fibrosis & Pulm Dis Res & Treatment Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Dokholyan, NV (corresponding author), Univ N Carolina, Biochem & Biophys, Chapel Hill, NC 27599 USA.	dokh@unc.edu	Dagliyan, Onur/N-5683-2019; Dokholyan, Nikolay/D-8081-2018	Dagliyan, Onur/0000-0003-1825-1011; Dokholyan, Nikolay/0000-0002-8225-4025; Shobair, Mahmoud/0000-0003-1684-9677	National Institutes of Health [P01 HL 110873-04]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110873] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067553] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Program Project Grant P01 HL 110873-04. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abi-Antoun T, 2011, AM J PHYSIOL-RENAL, V300, pF1089, DOI 10.1152/ajprenal.00610.2010; Azad AK, 2009, HUM MUTAT, V30, P1093, DOI 10.1002/humu.21011; Babini E, 2003, J BIOL CHEM, V278, P28418, DOI 10.1074/jbc.M301315200; Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; Baker SE, 2011, RESP PHYSIOL NEUROBI, V179, P212, DOI 10.1016/j.resp.2011.08.007; Bartoi T, 2014, P NATL ACAD SCI USA, V111, P8281, DOI 10.1073/pnas.1324060111; Bhalla V, 2008, J AM SOC NEPHROL, V19, P1845, DOI 10.1681/ASN.2008020225; Butterworth MB, 2008, J BIOL CHEM, V283, P35305, DOI 10.1074/jbc.R800044200; Collier DM, 2014, J GEN PHYSIOL, V144, P337, DOI 10.1085/jgp.201411208; Coscoy S, 1998, J BIOL CHEM, V273, P8317, DOI 10.1074/jbc.273.14.8317; Dagliyan O, 2013, P NATL ACAD SCI USA, V110, P6800, DOI 10.1073/pnas.1218319110; Dagliyan O, 2011, STRUCTURE, V19, P1837, DOI 10.1016/j.str.2011.09.014; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; Dijkink L, 2002, PFLUG ARCH EUR J PHY, V444, P549, DOI 10.1007/s00424-002-0855-4; Ding F., 2012, COMPUTATIONAL MODELI, P55, DOI [10.1007/978-1-4614-2146-7_3, DOI 10.1007/978-1-4614-2146-7_3]; Ding F, 2008, STRUCTURE, V16, P1010, DOI 10.1016/j.str.2008.03.013; Ding F, 2006, PLOS COMPUT BIOL, V2, P725, DOI 10.1371/journal.pcbi.0020085; Edelheit O, 2014, FEBS J, V281, P2097, DOI 10.1111/febs.12765; Firsov D, 1998, EMBO J, V17, P344, DOI 10.1093/emboj/17.2.344; Foxx-Lupo WT, 2011, RESP PHYSIOL NEUROBI, V179, P205, DOI 10.1016/j.resp.2011.08.008; Gao Y, 2007, BIOCHEM BIOPH RES CO, V359, P143, DOI 10.1016/j.bbrc.2007.05.077; Garty H, 1997, PHYSIOL REV, V77, P359, DOI 10.1152/physrev.1997.77.2.359; Gentzsch M, 2010, J BIOL CHEM, V285, P32227, DOI 10.1074/jbc.M110.155259; Gwiazda K, 2015, J BIOL CHEM, V290, P17956, DOI 10.1074/jbc.M115.641688; Handschick M, 2012, J CYST FIBROS, V11, P53, DOI 10.1016/j.jcf.2011.08.008; Harris M, 2008, J BIOL CHEM, V283, P7455, DOI 10.1074/jbc.M707399200; Haselwandter CA, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003055; Howsham C., 2014, ION CHANNEL DRUG DIS, P135; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Ji HL, 2012, AM J PHYSIOL-LUNG C, V303, pL1013, DOI 10.1152/ajplung.00206.2012; Kashlan OB, 2015, J BIOL CHEM, V290, P568, DOI 10.1074/jbc.M114.606152; Kashlan OB, 2010, J BIOL CHEM, V285, P35216, DOI 10.1074/jbc.M110.167064; Kota P, 2014, J BIOL CHEM, V289, P23029, DOI 10.1074/jbc.M114.570952; Kota P, 2012, BIOCHEMISTRY-US, V51, P3460, DOI 10.1021/bi2014773; Krueger B, 2009, CELL PHYSIOL BIOCHEM, V24, P605, DOI 10.1159/000257516; Kucher V, 2011, BIOPHYS J, V100, P1930, DOI 10.1016/j.bpj.2011.02.046; Li TB, 2009, J BIOL CHEM, V284, P4689, DOI 10.1074/jbc.M805302200; Liu ZF, 2009, NATURE, V461, P120, DOI 10.1038/nature08277; Meltzer RH, 2007, J BIOL CHEM, V282, P25548, DOI 10.1074/jbc.M703825200; Nury H, 2010, J MOL BIOL, V395, P1114, DOI 10.1016/j.jmb.2009.11.024; Proctor EA, 2015, CHEM SCI, V6, P1237, DOI 10.1039/c4sc01320d; Proctor EA, 2011, WIRES COMPUT MOL SCI, V1, P80, DOI 10.1002/wcms.4; Ramachandran S, 2011, PROTEINS, V79, P261, DOI 10.1002/prot.22879; Rauh R, 2010, J PHYSIOL-LONDON, V588, P1211, DOI 10.1113/jphysiol.2009.180224; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Shehata Marlene F, 2009, Int Arch Med, V2, P28, DOI 10.1186/1755-7682-2-28; Sheng S, 2006, AM J PHYSIOL-RENAL, V290, pF1488, DOI 10.1152/ajprenal.00439.2005; Sherwood TW, 2011, J NEUROSCI, V31, P9723, DOI 10.1523/JNEUROSCI.1665-11.2011; Shirvanyants D, 2012, J PHYS CHEM B, V116, P8375, DOI 10.1021/jp2114576; Simonetti FL, 2013, NUCLEIC ACIDS RES, V41, pW8, DOI 10.1093/nar/gkt427; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Stadler T, 2015, J BIOL CHEM, V290, P6316, DOI 10.1074/jbc.M114.605899; Stewart AP, 2011, J BIOL CHEM, V286, P31944, DOI 10.1074/jbc.M111.275289; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Wei SP, 2007, J MEMBRANE BIOL, V220, P21, DOI 10.1007/s00232-007-9071-7; Xu Q, 2009, PROTEIN SCI, V18, P2100, DOI 10.1002/pro.224; Yang HY, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000151; Yin S., 2010, INTRO PROTEIN STRUCT, P453, DOI [10.1002/9780470882207.ch20, DOI 10.1002/9780470882207.CH20]; Yin SY, 2007, NAT METHODS, V4, P466, DOI 10.1038/nmeth0607-466	60	6	6	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3682	3692		10.1074/jbc.M115.678052	http://dx.doi.org/10.1074/jbc.M115.678052			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26668308	Green Published, hybrid			2022-12-26	WOS:000371338400001
J	Cardinali, A; Pizzeghello, D; Zanin, G				Cardinali, Alessandra; Pizzeghello, Diego; Zanin, Giuseppe			Fatty Acid Methyl Ester (FAME) Succession in Different Substrates as Affected by the Co-Application of Three Pesticides	PLOS ONE			English	Article							SOIL MICROBIAL COMMUNITIES; DEGRADATION; PROFILES; COMPOST; CARBON; AZOXYSTROBIN; FUNGICIDES; IMPACT; HERBICIDES; STABILITY	Introduction In intensive agriculture areas the use of pesticides can alter soil properties and microbial community structure with the risk of reducing soil quality. Materials and Methods In this study the fatty acid methyl esters (FAMEs) evolution has been studied in a factorial lab experiment combining five substrates (a soil, two aged composts and their mixtures) treated with a co-application of three pesticides (azoxystrobin, chlorotoluron and epoxiconazole), with two extraction methods, and two incubation times (0 and 58 days). FAMEs extraction followed the microbial identification system (MIDI) and ester-linked method (EL). Results and Discussion The pesticides showed high persistence, as revealed by half-life (t(1/2)) values ranging from 168 to 298 days, which confirms their recalcitrance to degradation. However, t(1/2) values were affected by substrate and compost age down to 8 days for chlorotoluron in S and up to 453 days for epoxiconazole in 12M. Fifty-six FAMEs were detected. Analysis of variance (ANOVA) showed that the EL method detected a higher number of FAMEs and unique FAMEs than the MIDI one, whereas principal component analysis (PCA) highlighted that the monosaturated 18:1 omega 9c and cyclopropane 19:0 omega 10c/19 omega 6 were the most significant FAMEs grouping by extraction method. The cyclopropyl to monoenoic acids ratio evidenced higher stress conditions when pesticides were applied to compost and compost+soil than solely soil, as well as with final time. Conclusion Overall, FAMEs profiles showed the importance of the extraction method for both substrate and incubation time, the t(1/2) values highlighted the effectiveness of solely soil and the less mature compost in reducing the persistence of pesticides.	[Cardinali, Alessandra; Pizzeghello, Diego; Zanin, Giuseppe] Univ Padua, DAFNAE, Dept Agron Food Nat Resources Anim & Environm, I-35020 Legnaro, PD, Italy	University of Padua	Pizzeghello, D (corresponding author), Univ Padua, DAFNAE, Dept Agron Food Nat Resources Anim & Environm, Viale Univ 16, I-35020 Legnaro, PD, Italy.	diego.pizzeghello@unipd.it	Pizzeghello, Diego/H-7173-2019	Pizzeghello, Diego/0000-0002-2455-8733				Andreu V, 2004, TRAC-TREND ANAL CHEM, V23, P772, DOI 10.1016/j.trac.2004.07.008; Arias-Estevez M, 2008, AGR ECOSYST ENVIRON, V123, P247, DOI 10.1016/j.agee.2007.07.011; Banks ML, 2014, APPL SOIL ECOL, V74, P12, DOI 10.1016/j.apsoil.2013.08.018; Bernard E, 2012, APPL SOIL ECOL, V52, P29, DOI 10.1016/j.apsoil.2011.10.002; Bossio DA, 1998, MICROBIAL ECOL, V36, P1, DOI 10.1007/s002489900087; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; Boulter-Bitzer JI, 2006, APPL SOIL ECOL, V34, P65, DOI 10.1016/j.apsoil.2005.12.007; Bowles TM, 2014, SOIL BIOL BIOCHEM, V68, P252, DOI 10.1016/j.soilbio.2013.10.004; Cardinali A, 2010, APPL ENVIRON MICROB, V76, P6600, DOI 10.1128/AEM.00824-10; Coppola L, 2011, NEW BIOTECHNOL, V29, P99, DOI 10.1016/j.nbt.2011.03.005; Daniel DW, 2015, SCI TOTAL ENVIRON, V514, P290, DOI 10.1016/j.scitotenv.2015.01.066; Feld L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126080; Feng Y, 2003, SOIL BIOL BIOCHEM, V35, P1693, DOI 10.1016/j.soilbio.2003.08.016; Fenoll J, 2015, ENVIRON SCI POLLUT R, V22, P4336, DOI 10.1007/s11356-014-3652-7; Frostegard A, 1996, BIOL FERT SOILS, V22, P59, DOI 10.1007/BF00384433; Garcia-Orenes F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080522; Ghafoor A, 2011, ENVIRON SCI TECHNOL, V45, P6411, DOI 10.1021/es2012353; Ghosh RK, 2009, J AGR FOOD CHEM, V57, P632, DOI 10.1021/jf802716f; Glucksman AM, 2000, J APPL MICROBIOL, V88, P711, DOI 10.1046/j.1365-2672.2000.01058.x; HAACK SK, 1994, APPL ENVIRON MICROB, V60, P2483, DOI 10.1128/AEM.60.7.2483-2493.1994; Imfeld G, 2012, EUR J SOIL BIOL, V49, P22, DOI 10.1016/j.ejsobi.2011.11.010; IUSS Working Group, 2006, WORLD REF BAS SOIL R, V103; Jorgensen LF, 2012, CHEMOSPHERE, V88, P554, DOI 10.1016/j.chemosphere.2012.03.027; Karanasios EC, 2013, CHEMOSPHERE, V93, P20, DOI 10.1016/j.chemosphere.2013.04.049; KIEFT TL, 1994, APPL ENVIRON MICROB, V60, P3292, DOI 10.1128/AEM.60.9.3292-3299.1994; Lopes FM, 2010, WORLD J MICROB BIOT, V26, P1155, DOI 10.1007/s11274-009-0283-0; Marinozzi M, 2013, ENVIRON SCI POLLUT R, V20, P2546, DOI 10.1007/s11356-012-1165-9; Navarro S, 2012, J AGR FOOD CHEM, V60, P5279, DOI 10.1021/jf301094c; Petersen SO, 2002, SOIL SCI SOC AM J, V66, P826, DOI 10.2136/sssaj2002.0826; Rodrigues ET, 2013, ENVIRON INT, V53, P18, DOI 10.1016/j.envint.2012.12.005; Roldan ML, 2011, ANAL CHIM ACTA, V699, P87, DOI 10.1016/j.aca.2011.05.001; Schutter ME, 2000, SOIL SCI SOC AM J, V64, P1659, DOI 10.2136/sssaj2000.6451659x; Steger K, 2005, MICROB ECOL, V50, P163, DOI 10.1007/s00248-004-0139-y; Steger K, 2003, J MICROBIOL METH, V55, P371, DOI 10.1016/S0167-7012(03)00187-8; Stromberger ME, 2012, SOIL BIOL BIOCHEM, V46, P155, DOI 10.1016/j.soilbio.2011.11.024; Verdenelli RA, 2012, SCI TOTAL ENVIRON, V414, P210, DOI 10.1016/j.scitotenv.2011.10.066; Vischetti C, 2008, CHEMOSPHERE, V72, P1739, DOI 10.1016/j.chemosphere.2008.04.065; Wu L, 2002, J ENVIRON QUAL, V31, P1323, DOI 10.2134/jeq2002.1323; Zelles L, 1997, CHEMOSPHERE, V35, P275, DOI 10.1016/S0045-6535(97)00155-0; Zhen Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108555	40	7	7	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145501	10.1371/journal.pone.0145501	http://dx.doi.org/10.1371/journal.pone.0145501			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694029	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092500054
J	Byrom, AE; Anderson, DP; Coleman, M; Thomson, C; Cross, ML; Pech, RP				Byrom, Andrea E.; Anderson, Dean P.; Coleman, Morgan; Thomson, Caroline; Cross, Martin L.; Pech, Roger P.			Assessing Movements of Brushtail Possums (Trichosurus vulpecula) in Relation to Depopulated Buffer Zones for the Management of Wildlife Tuberculosis in New Zealand	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS INFECTION; SPATIAL-DISTRIBUTION; DISPERSAL; PATTERNS; CATTLE; TB; CONTACT; FOREST; ERADICATION; POPULATIONS	In New Zealand, managing the threat of bovine tuberculosis (TB) to livestock includes population reduction of potentially infectious wildlife, primarily the brushtail possum (Trichosurus vulpecula). Population control is often targeted on forested buffer zones adjacent to farmland, in order to limit movements of possums across the buffer and reduce the risk of disease transmission to livestock. To assess the effectiveness of buffers in protecting livestock we analysed GPS telemetry data from possums located in untreated forest adjacent to buffers, and used these data to characterise patterns of movement that could lead to possums reaching farmland during the season when most dispersal occurs. Analyses of movement data showed that the direction of dispersal by sub-adult and adult possums and the extent of long exploratory movements were not biased toward forest buffers, even though these provided vacant habitat as suitable for possums as untreated forest. Instead, dispersal and exploratory movements were uncommon even for sub-adult possums and such events typically lasted < 10 days. Dispersing possums settled predominantly in river valleys. A simulation model was developed for the 3-6-month dispersal season; it demonstrated a probability of <0.001 that an infected possum, originating from a low-density population with low disease prevalence in untreated forest, would move across 3 km of recently controlled forest buffer to reach farmland. Our results indicate short-term reduction in the risk of TB transmission from possums to livestock in New Zealand by the use of depopulated buffer zones, while acknowledging that the threat of disease spread from untreated forest is likely to increase over time as possum population density and, potentially, TB prevalence among those possums, increase in the buffer zone.	[Byrom, Andrea E.; Anderson, Dean P.; Coleman, Morgan; Thomson, Caroline; Cross, Martin L.; Pech, Roger P.] Landcare Res, POB 69040, Lincoln 7640, New Zealand	Landcare Research - New Zealand	Byrom, AE (corresponding author), Landcare Res, POB 69040, Lincoln 7640, New Zealand.	byroma@landcareresearch.co.nz			TBfree New Zealand [R-10720, 795204-0022]; TBfree Ltd, New Zealand	TBfree New Zealand; TBfree Ltd, New Zealand	The research reported in this manuscript was supported by research grant number R-10720 awarded from TBfree New Zealand (www.tbfree.org.nz, formerly the Animal Health Board of New Zealand) to support Landcare Research project number 795204-0022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r P Livingstone, G Knowles, C Pullen and S Peters (TB Free NZ) helped with selection of study sites. The Greymouth Mawheranui Area Office and the Franz Josef Waiau Area Office of the West Coast Tai Poutini Conservancy of the Department of Conservation (DOC) gave permission to work on DOC land. Permission was obtained from the Greymouth Community and Public Health Office to use cyanide to retrieve collared possums. Te Runanga o Ngati Waewae gave consent to work at all sites. Landowners near the Upper Ahaura study sites (Waikiti Downs Station and Gloriavale Christian Community) and D Friend, who had grazing rights adjacent to the Whataroa study site, allowed access across their land. C Barnes and K Cohen (Vector Control Services) and J Mead, J Pari, N Fea, D Hurst and H de Meringo helped with fieldwork. Coastwide Helicopters and Alpine Adventures / Fox and Franz Josef Heliservices provided transport and tracked possums by helicopter. Ivor Yockney (Landcare Research) tracked possums from a fixed-wing aircraft. We thank Dr Phil Cowan (Landcare Research) for providing constructive comments on an earlier draft of this manuscript. Dave Latham and Cecilia Arienti-Latham (Landcare Research) provided helpful input during manuscript revision. This work was funded by TBfree Ltd, New Zealand.	[Anonymous], 2005, HDB NZ MAMMALS; Arthur A, 2002, LC0102102 AN HLTH BO, P1; BARLOW ND, 1991, J APPL ECOL, V28, P794, DOI 10.2307/2404208; BARLOW ND, 1993, J APPL ECOL, V30, P156, DOI 10.2307/2404279; Bielby J, 2014, P NATL ACAD SCI USA, V111, P9193, DOI 10.1073/pnas.1401503111; Byrom AE, 2002, J APPL ECOL, V39, P67, DOI 10.1046/j.1365-2664.2002.00689.x; Caley P, 1999, NEW ZEAL VET J, V47, P133, DOI 10.1080/00480169.1999.36130; Carter SP, 2007, P ROY SOC B-BIOL SCI, V274, P2769, DOI 10.1098/rspb.2007.0998; Clinchy M, 2001, J ANIM ECOL, V70, P515, DOI 10.1046/j.1365-2656.2001.00510.x; Coleman JD, 1999, NEW ZEAL VET J, V47, P119, DOI 10.1080/00480169.1999.36127; COLEMAN JD, 1994, NEW ZEAL VET J, V42, P128, DOI 10.1080/00480169.1994.35802; Coleman Jim, 2000, P92; Cowan PE, 1997, WILDLIFE RES, V24, P279, DOI 10.1071/WR96005; Cowan PE, 1996, WILDLIFE RES, V23, P237, DOI 10.1071/WR9960237; Cowan PE, 2000, SCI CONSERVATION PUB, V144, P1; Cowan Phil, 2000, P24; Delgado MD, 2008, AM NAT, V172, P475, DOI 10.1086/590964; Efford M, 2000, WILDLIFE RES, V27, P117, DOI 10.1071/WR99005; Efford M., 1991, 9173 AN HLTH BOARD, P1; Efford Murray, 2000, P47; Etherington TR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088293; Glen AS, 2012, NEW ZEAL J ECOL, V36, P29; KAREIVA PM, 1983, OECOLOGIA, V56, P234, DOI 10.1007/BF00379695; Livingstone PG, 2015, NEW ZEAL VET J, V63, P98, DOI 10.1080/00480169.2015.1013581; Morales JM, 2004, ECOLOGY, V85, P2436, DOI 10.1890/03-0269; NPCA, 2008, POSS POP MON US TRAP, P1; Nugent G, 2015, NEW ZEAL VET J, V63, P28, DOI 10.1080/00480169.2014.963791; Nugent G, 1997, OPTIMAL BUFFER WIDTH; Nugent G, 2013, PREV VET MED, V109, P168, DOI 10.1016/j.prevetmed.2012.09.008; Nugent G, 2011, WILDLIFE RES, V38, P249, DOI 10.1071/WR10198; Palmer MV, 2013, TRANSBOUND EMERG DIS, V60, P1, DOI 10.1111/tbed.12115; Paterson BM, 1995, NEW ZEAL VET J, V43, P281, DOI 10.1080/00480169./1995.35907; Pech R, 2010, WILDLIFE RES, V37, P283, DOI 10.1071/WR09161; Polo G, 2013, PREV VET MED, V111, P10, DOI 10.1016/j.prevetmed.2013.03.010; Porphyre T, 2011, PREV VET MED, V100, P221, DOI 10.1016/j.prevetmed.2011.03.014; Porphyre T, 2008, VET RES, V39, DOI 10.1051/vetres:2008007; Python Software Foundation, 2013, PYTH PROGR LANG; Ramsey D, 2005, WILDLIFE RES, V32, P229, DOI 10.1071/WR03119; Ramsey DSL, 2010, J APPL ECOL, V47, P911, DOI 10.1111/j.1365-2664.2010.01839.x; Recio MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028225; Rosatte R, 2001, J WILDLIFE DIS, V37, P265, DOI 10.7589/0090-3558-37.2.265; Sarre SD, 2014, MOL ECOL, V23, P3419, DOI 10.1111/mec.12834; Smouse PE, 2010, PHILOS T R SOC B, V365, P2201, DOI 10.1098/rstb.2010.0078; Tompkins DM, 2013, VACCINE, V31, P893, DOI 10.1016/j.vaccine.2012.12.003; Turchin Peter, 1998; Warburton B, 2015, NEW ZEAL VET J, V63, P77, DOI 10.1080/00480169.2014.981315; Warburton B, 2014, POSSUM COST CONTROL; WARD GD, 1985, AUST WILDLIFE RES, V12, P145; Windsor PA, 2011, TRANSBOUND EMERG DIS, V58, P421, DOI 10.1111/j.1865-1682.2011.01225.x; Wiser SK, 2011, APPL VEG SCI, V14, P506, DOI 10.1111/j.1654-109X.2011.01146.x; Yockney IJ, 2013, EPIDEMIOL INFECT, V141, P1407, DOI 10.1017/S0950268813000289; Yockney IJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121865	52	7	7	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145636	10.1371/journal.pone.0145636	http://dx.doi.org/10.1371/journal.pone.0145636			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689918	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092300092
J	Delaplane, KS; Pietravalle, S; Brown, MA; Budge, GE				Delaplane, Keith S.; Pietravalle, Stephane; Brown, Mike A.; Budge, Giles E.			Honey Bee Colonies Headed by Hyperpolyandrous Queens Have Improved Brood Rearing Efficiency and Lower Infestation Rates of Parasitic Varroa Mites	PLOS ONE			English	Article							APIS-MELLIFERA; GENETIC DIVERSITY; EXTREME POLYANDRY; EVOLUTION; BEHAVIOR; HYMENOPTERA; INFECTIONS; DESTRUCTOR; DISEASE; NUMBER	A honey bee queen mates on wing with an average of 12 males and stores their sperm to produce progeny of mixed paternity. The degree of a queen's polyandry is positively associated with measures of her colony's fitness, and observed distributions of mating number are evolutionary optima balancing risks of mating flights against benefits to the colony. Effective mating numbers as high as 40 have been documented, begging the question of the upper bounds of this behavior that can be expected to confer colony benefit. In this study we used instrumental insemination to create three classes of queens with exaggerated range of polyandry- 15, 30, or 60 drones. Colonies headed by queens inseminated with 30 or 60 drones produced more brood per bee and had a lower proportion of samples positive for Varroa destructor mites than colonies whose queens were inseminated with 15 drones, suggesting benefits of polyandry at rates higher than those normally obtaining in nature. Our results are consistent with two hypotheses that posit conditions that reward such high expressions of polyandry: (1) a queen may mate with many males in order to promote beneficial non-additive genetic interactions among subfamilies, and (2) a queen may mate with many males in order to capture a large number of rare alleles that regulate resistance to pathogens and parasites in a breeding population. Our results are unique for identifying the highest levels of polyandry yet detected that confer colony-level benefit and for showing a benefit of polyandry in particular toward the parasitic mite V. destructor.	[Delaplane, Keith S.] Univ Georgia, Dept Entomol, Athens, GA 30602 USA; [Pietravalle, Stephane; Budge, Giles E.] Food & Environm Res Agcy, York YO41 1LZ, N Yorkshire, England; [Brown, Mike A.] Anim & Plant Hlth Agcy, York YO41 1LZ, N Yorkshire, England	University System of Georgia; University of Georgia; Food & Environment Research Agency; Animal & Plant Health Agency UK	Delaplane, KS (corresponding author), Univ Georgia, Dept Entomol, Athens, GA 30602 USA.	ksd@uga.edu	Delaplane, Keith/AAN-5197-2021	Delaplane, Keith/0000-0001-9323-441X	Trans-Atlantic exchange program of the Biotechnology and Biological Sciences Research Council; USDA Managed Pollinator Coordinated Agricultural Project; C.B. Dennis British Beekeepers Research Trust; BBSRC [BB/I025220/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/I025220/1] Funding Source: researchfish	Trans-Atlantic exchange program of the Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); USDA Managed Pollinator Coordinated Agricultural Project; C.B. Dennis British Beekeepers Research Trust; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Funding was provided by the Trans-Atlantic exchange program of the Biotechnology and Biological Sciences Research Council, the USDA Managed Pollinator Coordinated Agricultural Project, and the C.B. Dennis British Beekeepers Research Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arechavaleta-Velasco ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047269; Behrens D, 2011, ECOL EVOL, V1, DOI 10.1002/ece3.17; Belloy L, 2007, APIDOLOGIE, V38, P136, DOI [10.1051/apido:2006069, 10.1051/apido:2007039]; BURGETT M, 1985, J ECON ENTOMOL, V78, P1154, DOI 10.1093/jee/78.5.1154; Cobey SW, 2007, APIDOLOGIE, V38, P390, DOI 10.1051/apido:2007029; COLE BJ, 1983, BEHAV ECOL SOCIOBIOL, V12, P191, DOI 10.1007/BF00290771; CROZIER RH, 1976, THEOR POPUL BIOL, V10, P1, DOI 10.1016/0040-5809(76)90002-2; Delaplane KS, 2012, J APICULT RES, V51, DOI [http://dx.doi.org/10.3896/IBRA.1.51.5, DOI 10.3896/IBRA.1.51.5]; Dietemann V, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.09; Estroup A, 1994, P ROY SOC B, V258, P1; Fuchs S, 1999, BEHAV ECOL SOCIOBIOL, V45, P269, DOI 10.1007/s002650050561; HALLIDAY T, 1987, ANIM BEHAV, V35, P939, DOI 10.1016/S0003-3472(87)80138-0; HARBO JR, 1985, AM BEE J, V125, P197; Ingold T., 2011, REDRAWING ANTHR MAT, P1; KELLER L, 1994, EVOLUTION, V48, P694, DOI [10.2307/2410479, 10.1111/j.1558-5646.1994.tb01354.x]; Kraus FB, 2004, BEHAV ECOL SOCIOBIOL, V55, P494, DOI 10.1007/s00265-003-0706-0; Lapidge KL, 2002, NATURWISSENSCHAFTEN, V89, P565, DOI 10.1007/s00114-002-0371-6; Liersch S, 1998, P ROY SOC B-BIOL SCI, V265, P221, DOI 10.1098/rspb.1998.0285; MACKENSEN O, 1947, J ECON ENTOMOL, V40, P344, DOI 10.1093/jee/40.3.344; Mattila HR, 2007, SCIENCE, V317, P362, DOI 10.1126/science.1143046; Neumann P, 2000, INSECT SOC, V47, P271, DOI 10.1007/PL00001714; Oldroyd BP, 2007, TRENDS ECOL EVOL, V22, P408, DOI 10.1016/j.tree.2007.06.001; PAGE RE, 1995, BEHAV ECOL SOCIOBIOL, V36, P387, DOI 10.1007/BF00177334; PAGE RE, 1980, GENETICS, V96, P263; Palmer KA, 2000, APIDOLOGIE, V31, P235, DOI 10.1051/apido:2000119; Rinderer TE, 2001, APIDOLOGIE, V32, P381, DOI 10.1051/apido:2001138; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Seeley TD, 2007, P ROY SOC B-BIOL SCI, V274, P67, DOI 10.1098/rspb.2006.3702; SHERMAN PW, 1988, AM NAT, V131, P602, DOI 10.1086/284809; SHYKOFF JA, 1991, P ROY SOC B-BIOL SCI, V243, P55, DOI 10.1098/rspb.1991.0009; Tarpy DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118734; Tarpy DR, 2013, NATURWISSENSCHAFTEN, V100, P723, DOI 10.1007/s00114-013-1065-y; Tarpy DR, 2006, NATURWISSENSCHAFTEN, V93, P195, DOI 10.1007/s00114-006-0091-4; Tarpy DR, 2003, P ROY SOC B-BIOL SCI, V270, P99, DOI 10.1098/rspb.2002.2199; Tarpy DR, 2004, INSECT SOC, V51, P203, DOI 10.1007/s00040-004-0734-4; VSN INTERNATIONAL, 2014, GENSTAT WINDOWS; Yue C, 2006, J INVERTEBR PATHOL, V92, P105, DOI 10.1016/j.jip.2006.03.001	37	21	21	0	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0142985	10.1371/journal.pone.0142985	http://dx.doi.org/10.1371/journal.pone.0142985			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691845	Green Submitted, gold, Green Published			2022-12-26	WOS:000367092300003
J	Yang, C; Zhang, DM; Song, ZB; Hou, YQ; Bao, YL; Sun, LG; Yu, CL; Li, YX				Yang, Cheng; Zhang, Dong-Mei; Song, Zhen-Bo; Hou, Ya-Qin; Bao, Yong-Li; Sun, Lu-Guo; Yu, Chun-Lei; Li, Yu-Xin			Protumoral TSP50 Regulates Macrophage Activities and Polarization via Production of TNF-alpha and IL-1 beta, and Activation of the NF-kappa B Signaling Pathway	PLOS ONE			English	Article							CELL-PROLIFERATION; CANCER; EXPRESSION; PROTEASE; CYTOKINES; RESPONSES; SYSTEM; GROWTH; TESTES; CCL1	Testes-specific protease 50 (TSP50) is abnormally overexpressed in many kinds of cancers and promotes cell proliferation and migration. However, whether TSP50 can influence the tumor microenvironment, especially the function of immune cells in the microenvironment, remains largely unknown. We demonstrated that exposure to the conditioned medium from TSP50-overexpressing cells, or co-culture with TSP50-overexpressing cells, enhanced the cytokine production and phagocytic activities of macrophages, and induced M2b polarization. Further investigation showed that production of TNF-alpha and IL-1 beta was strongly induced by TSP50 in TSP50-overexpressing cells. TSP50-induced TNF-alpha and IL-1 beta were main factors that mediated the effects of TSP50-overexpressing cells on macrophages. The NF-kappa B pathway could be activated in macrophages upon the treatment of conditioned medium of TSP50-overexpressing cells and its activation is necessary for the observed effects on macrophages. Taken together, our results suggested that oncogenic TSP50 expressed in cells could activate surrounding macrophages and induce M2b polarization, partly through inducing TNF-alpha/IL-1 beta secretion and subsequent NF-kappa B pathway activation. This implies a potential mechanism by which oncogene TSP50 regulates tumor microenvironment to support tumor development.	[Yang, Cheng; Zhang, Dong-Mei; Hou, Ya-Qin; Bao, Yong-Li] NE Normal Univ, Natl Engn Lab Druggable Gene & Prot Screening, Changchun 130024, Peoples R China; [Song, Zhen-Bo; Sun, Lu-Guo; Yu, Chun-Lei; Li, Yu-Xin] NE Normal Univ, Inst Genet & Cytol, Changchun 130024, Peoples R China	Northeast Normal University - China; Northeast Normal University - China	Bao, YL (corresponding author), NE Normal Univ, Natl Engn Lab Druggable Gene & Prot Screening, Changchun 130024, Peoples R China.	baoyl800@nenu.edu.cn; sunlg388@nenu.edu.cn	Li, yu/HHZ-5236-2022; li, yu/HGL-9518-2022; li, Yu/HCI-9086-2022; Li, yuxin/GSD-1668-2022		National Natural Science Foundation of China [81272919, 81272242]; National High Technology Research and Development Program of China [2012AA02A407]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	The work was supported by National Natural Science Foundation of China (Grant No. 81272919 and 81272242), and National High Technology Research and Development Program of China (No. 2012AA02A407).	Asai A, 2012, J LEUKOCYTE BIOL, V92, P859, DOI 10.1189/jlb.0212107; Bachireddy P, 2012, CLIN EXP IMMUNOL, V167, P188, DOI 10.1111/j.1365-2249.2011.04514.x; Bai J, 2015, ONCOTARGET; Balkwill F, 2010, FUTURE ONCOL, V6, P1833, DOI [10.2217/fon.10.155, 10.2217/FON.10.155]; Borrello MG, 2005, P NATL ACAD SCI USA, V102, P14825, DOI 10.1073/pnas.0503039102; Ortiz MC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130713; Dalrymple H, 2013, BMC IMMUNOL, V14, DOI 10.1186/1471-2172-14-41; David S, 2011, NAT REV NEUROSCI, V12, P388, DOI 10.1038/nrn3053; Dinarello CA, 2006, CANCER METAST REV, V25, P307, DOI 10.1007/s10555-006-9000-8; Gattinoni L, 2006, NAT REV IMMUNOL, V6, P383, DOI 10.1038/nri1842; Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098; HEUFF G, 1993, CANCER IMMUNOL IMMUN, V37, P125, DOI 10.1007/BF01517045; Keophiphath M, 2010, ARTERIOSCL THROM VAS, V30, P39, DOI 10.1161/ATVBAHA.109.197442; Kerkar SP, 2012, CANCER RES, V72, P3125, DOI 10.1158/0008-5472.CAN-11-4094; Kida Y, 2005, CYTOKINE, V29, P159, DOI 10.1016/j.cyto.2004.10.009; Lei Zheng GX, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0022203.g001, DOI 10.1371/JOURNAL.PONE.0022203.G001]; Leidi M, 2009, J IMMUNOL, V182, P4415, DOI 10.4049/jimmunol.0713732; Li Y, 2014, J INTERN MED, V276, P52, DOI 10.1111/joim.12237; Li YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035030; Liu F, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/498246; Liu J, 2011, WORLD J GASTROENTERO, V17, P1362, DOI 10.3748/wjg.v17.i10.1362; Liu YC, 2014, INT J BIOL SCI, V10, P520, DOI 10.7150/ijbs.8879; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Ngo AN, 2014, J ANAL BIOANALYTICAL, V5, DOI [10.4172/2155-9872.1000198, DOI 10.4172/2155-9872.1000198]; Ning BT, 2012, ONCOL LETT, V3, P871, DOI 10.3892/ol.2012.557; Pagliari LJ, 2000, MOL CELL BIOL, V20, P8855, DOI 10.1128/MCB.20.23.8855-8865.2000; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Rakhra K, 2010, CANCER CELL, V18, P485, DOI 10.1016/j.ccr.2010.10.002; Saperstein S, 2009, J INTERF CYTOK RES, V29, P273, DOI 10.1089/jir.2008.0076; Sato T, 2011, IMMUNOL RES, V51, P170, DOI 10.1007/s12026-011-8262-6; Shan JD, 2002, CANCER RES, V62, P290; Sironi M, 2006, J LEUKOCYTE BIOL, V80, P342, DOI 10.1189/jlb.1005586; Song ZB, 2011, BIOCHEM J, V436, P457, DOI 10.1042/BJ20101780; Sousa S, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0621-0; Takei Y, 2004, CANCER RES, V64, P3365, DOI 10.1158/0008-5472.CAN-03-2682; Xie XF, 2015, CARBOHYD POLYM, V132, P323, DOI 10.1016/j.carbpol.2015.06.046; Xu HP, 2007, CANCER RES, V67, P1239, DOI 10.1158/0008-5472.CAN-06-3688; Xu HP, 2004, UROLOGY, V64, P826, DOI 10.1016/j.urology.2004.05.012; Yuan LM, 1999, CANCER RES, V59, P3215; Zhang B, 2015, EXP NEUROL, V273, P83, DOI 10.1016/j.expneurol.2015.08.001; Zhang XP, 2014, TUMOR BIOL, V35, P10781, DOI 10.1007/s13277-014-2090-y; Zhou LA, 2010, IUBMB LIFE, V62, P825, DOI 10.1002/iub.390	44	12	17	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145095	10.1371/journal.pone.0145095	http://dx.doi.org/10.1371/journal.pone.0145095			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684869	Green Submitted, gold, Green Published			2022-12-26	WOS:000366725800037
J	Lessard, CB; Cottrell, BA; Maruyama, H; Suresh, S; Golde, TE; Koo, EH				Lessard, Christian B.; Cottrell, Barbara A.; Maruyama, Hiroko; Suresh, Suraj; Golde, Todd E.; Koo, Edward H.			gamma-Secretase Modulators and APH1 Isoforms Modulate gamma-Secretase Cleavage but Not Position of epsilon-Cleavage of the Amyloid Precursor Protein (APP)	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ALZHEIMERS-DISEASE; BETA-SECRETASE; TRANSMEMBRANE DOMAIN; TERMINAL FRAGMENT; PRESENILIN-1; MUTATIONS; A-BETA-42; PURIFICATION; GENERATION	The relative increase in A beta 42 peptides from familial Alzheimer disease (FAD) linked APP and PSEN mutations can be related to changes in both epsilon-cleavage site utilization and subsequent step-wise cleavage. Cleavage at the epsilon-site releases the amyloid precursor protein (APP) intracellular domain (AICD), and perturbations in the position of epsilon-cleavage are closely associated with changes in the profile of amyloid beta-protein (A beta) species that are produced and secreted. The mechanisms by which gamma-secretase modulators (GSMs) or FAD mutations affect the various gamma-secretase cleavages to alter the generation of A beta peptides have not been fully elucidated. Recent studies suggested that GSMs do not modulate epsilon-cleavage of APP, but the data were derived principally from recombinant truncated epitope tagged APP substrate. Here, using full length APP from transfected cells, we investigated whether GSMs modify the epsilon-cleavage of APP under more native conditions. Our results confirmed the previous findings that epsilon-cleavage is insensitive to GSMs. In addition, fenofibrate, an inverse GSM (iGSM), did not alter the position or kinetics of epsilon-cleavage position in vitro. APH1A and APH1B, a subunit of the gamma-secretase complex, also modulated A beta 42/A beta 40 ratio without any alterations in epsilon-cleavage, a result in contrast to what has been observed with PS1 and APP FAD mutations. Consequently, GSMs and APH1 appear to modulate gamma-secretase activity and A beta 42 generation by altering processivity but not epsilon-cleavage site utilization.	[Lessard, Christian B.; Cottrell, Barbara A.; Maruyama, Hiroko; Suresh, Suraj; Koo, Edward H.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Golde, Todd E.] Univ Florida, Coll Med, Dept Neurosci, Ctr Translat Res Neurodegenerat Dis, Gainesville, FL 32611 USA; [Koo, Edward H.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 117595, Singapore; [Koo, Edward H.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117595, Singapore	University of California System; University of California San Diego; State University System of Florida; University of Florida; National University of Singapore; National University of Singapore	Koo, EH (corresponding author), Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA.	edkoo@ucsd.edu			NIH [AG 20206]; NATIONAL CANCER INSTITUTE [P01CA166009] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG020206] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH Grants AG 20206 to T.E.G. and E.H.K.	Ahn K, 2010, P NATL ACAD SCI USA, V107, P21435, DOI 10.1073/pnas.1013246107; Beher D, 2004, J BIOL CHEM, V279, P43419, DOI 10.1074/jbc.M404937200; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Chavez-Gutierrez L, 2012, EMBO J, V31, P2261, DOI 10.1038/emboj.2012.79; Czirr E, 2008, J BIOL CHEM, V283, P17049, DOI 10.1074/jbc.M802912200; Czirr E, 2007, J BIOL CHEM, V282, P24504, DOI 10.1074/jbc.M700618200; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; Dimitrov M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3246; Ebke A, 2011, J BIOL CHEM, V286, P37181, DOI 10.1074/jbc.C111.276972; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Fraering PC, 2004, BIOCHEMISTRY-US, V43, P9774, DOI 10.1021/bi0494976; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Gu YJ, 2001, J BIOL CHEM, V276, P35235, DOI 10.1074/jbc.C100357200; Hahn S, 2011, J NEUROCHEM, V116, P385, DOI 10.1111/j.1471-4159.2010.07118.x; Jung JI, 2013, FASEB J, V27, P3775, DOI 10.1096/fj.12-225649; Kakuda N, 2006, J BIOL CHEM, V281, P14776, DOI 10.1074/jbc.M513453200; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Koo EH, 2004, NAT MED, V10, pS26, DOI 10.1038/nm1065; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Kounnas MZ, 2010, NEURON, V67, P769, DOI 10.1016/j.neuron.2010.08.018; Kretner B, 2011, J BIOL CHEM, V286, P15240, DOI 10.1074/jbc.M110.213587; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; McLendon C, 2000, FASEB J, V14, P2383; Mori K, 2010, PSYCHOGERIATRICS, V10, P117, DOI 10.1111/j.1479-8301.2010.00330.x; Okochi M, 2013, CELL REP, V3, P42, DOI 10.1016/j.celrep.2012.11.028; Olsson F, 2014, J BIOL CHEM, V289, P1540, DOI 10.1074/jbc.M113.498246; PODLISNY MB, 1995, J BIOL CHEM, V270, P9564, DOI 10.1074/jbc.270.16.9564; Ran Y, 2014, J BIOL CHEM, V289, P3276, DOI 10.1074/jbc.M113.512921; Sagi SA, 2011, J BIOL CHEM; Sastre M, 2001, EMBO REP, V2, P835, DOI 10.1093/embo-reports/kve180; Sato T, 2005, FEBS LETT, V579, P2907, DOI 10.1016/j.febslet.2005.04.037; Sato T, 2003, J BIOL CHEM, V278, P24294, DOI 10.1074/jbc.M211161200; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Scheuner D, 1996, NAT MED, V2, P864, DOI 10.1038/nm0896-864; Searfoss GH, 2003, J BIOL CHEM, V278, P46107, DOI 10.1074/jbc.M307757200; Serneels L, 2009, SCIENCE, V324, P639, DOI 10.1126/science.1171176; Singh R, 2009, J PHYS CHEM B, V113, P2990, DOI 10.1021/jp811154w; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; SISODIA SS, 1993, J NEUROSCI, V13, P3136; Takahashi Y, 2003, J BIOL CHEM, V278, P18664, DOI 10.1074/jbc.M301619200; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Uemura K, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1129; Uemura K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007893; Uljon SN, 2000, METH MOL B, V146, P439, DOI 10.1385/1-59259-045-4:439; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vetrivel KS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-4; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Weidemann A, 2002, BIOCHEMISTRY-US, V41, P2825, DOI 10.1021/bi015794o; Wong GT, 2004, J BIOL CHEM, V279, P12876, DOI 10.1074/jbc.M311652200; Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107; Zhang LL, 2001, BIOCHEMISTRY-US, V40, P5049, DOI 10.1021/bi0028800	52	9	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144758	10.1371/journal.pone.0144758	http://dx.doi.org/10.1371/journal.pone.0144758			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678856	Green Published, gold, Green Submitted			2022-12-26	WOS:000366723400024
J	Jansen, SJ; Gho, JMIH; Koudstaal, S; van Hout, GPJ; Zwetsloot, PPM; van Oorschot, JWM; van Eeuwijk, ECM; Leiner, T; Hoefer, IE; Goumans, MJ; Doevendans, PA; Sluijter, JPG; Chamuleau, SAJ				Sanne J. Jansen of Lorkeers; Gho, Johannes M. I. H.; Koudstaal, Stefan; van Hout, Gerardus P. J.; Zwetsloot, Peter Paul M.; van Oorschot, Joep W. M.; van Eeuwijk, Esther C. M.; Leiner, Tim; Hoefer, Imo E.; Goumans, Marie-Jose; Doevendans, Pieter A.; Sluijter, Joost P. G.; Chamuleau, Steven A. J.			Xenotransplantation of Human Cardiomyocyte Progenitor Cells Does Not Improve Cardiac Function in a Porcine Model of Chronic Ischemic Heart Failure. Results from a Randomized, Blinded, Placebo Controlled Trial	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; STEM-CELLS; THERAPY; DELIVERY; INJECTION; DIFFERENTIATION; TRANSPLANTATION; REPERFUSION; MECHANISMS; SAFETY	Background Recently cardiomyocyte progenitor cells (CMPCs) were successfully isolated from fetal and adult human hearts. Direct intramyocardial injection of human CMPCs (hCMPCs) in experimental mouse models of acute myocardial infarction significantly improved cardiac function compared to controls. Aim Here, our aim was to investigate whether xenotransplantation via intracoronary infusion of fetal hCMPCs in a pig model of chronic myocardial infarction is safe and efficacious, in view of translation purposes. Methods & Results We performed a randomized, blinded, placebo controlled trial. Four weeks after ischemia/reperfusion injury by 90 minutes of percutaneous left anterior descending artery occlusion, pigs (n = 16, 68.5 +/- 5.4 kg) received intracoronary infusion of 10 million fetal hCMPCs or placebo. All animals were immunosuppressed by cyclosporin (CsA). Four weeks after infusion, endpoint analysis by MRI displayed no difference in left ventricular ejection fraction, left ventricular end diastolic and left ventricular end systolic volumes between both groups. Serial pressure volume (PV-)loop and echocardiography showed no differences in functional parameters between groups at any timepoint. Infarct size at follow-up, measured by late gadolinium enhancement MRI showed no difference between groups. Intracoronary pressure and flow measurements showed no signs of coronary obstruction 30 minutes after cell infusion. No premature death occurred in cell treated animals. Conclusion Xenotransplantation via intracoronary infusion of hCMPCs is feasible and safe, but not associated with improved left ventricular performance and infarct size compared to placebo in a porcine model of chronic myocardial infarction.	[Sanne J. Jansen of Lorkeers; Gho, Johannes M. I. H.; Koudstaal, Stefan; Zwetsloot, Peter Paul M.; Doevendans, Pieter A.; Chamuleau, Steven A. J.] Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands; [Koudstaal, Stefan; Doevendans, Pieter A.; Sluijter, Joost P. G.; Chamuleau, Steven A. J.] ICIN Netherlands Heart Inst, Utrecht, Netherlands; [van Hout, Gerardus P. J.; van Eeuwijk, Esther C. M.; Hoefer, Imo E.; Sluijter, Joost P. G.] Univ Med Ctr Utrecht, Expt Cardiol Lab, Utrecht, Netherlands; [van Oorschot, Joep W. M.; Leiner, Tim] Univ Med Ctr Utrecht, Dept Radiol, Utrecht, Netherlands; [Goumans, Marie-Jose] Leiden Univ, Med Ctr, Dept Mol Cell Biol, Leiden, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Chamuleau, SAJ (corresponding author), Univ Med Ctr Utrecht, Dept Cardiol, Utrecht, Netherlands.	s.a.j.chamuleau@umcutrecht.nl	Goumans, Marie-José/AAG-4994-2021; Zwetsloot, Peter-Paul/N-8846-2019; Goumans, Marie Jose/U-1455-2019	Zwetsloot, Peter-Paul/0000-0002-2634-4667; Goumans, Marie Jose/0000-0001-9344-6746; Sluijter, Joost/0000-0003-2088-9102; Chamuleau, Steven/0000-0002-9952-6701	BioMedical Materials Institute [P1.04]; Dutch Ministry of Economic Affairs, Agriculture and Innovation; Nederlandse Hartstichting; Alexandre Suerman program; Netherlands CardioVascular Research Initiative (CVON): the Dutch Heart Foundation; Netherlands CardioVascular Research Initiative (CVON): Dutch Federation of University Medical Centers; Netherlands CardioVascular Research Initiative (CVON): the Netherlands Organization for Health Research and Development; Netherlands CardioVascular Research Initiative (CVON): the Royal Netherlands Academy of Sciences; NOW Clinical Fellowship [90700432]	BioMedical Materials Institute; Dutch Ministry of Economic Affairs, Agriculture and Innovation; Nederlandse Hartstichting; Alexandre Suerman program; Netherlands CardioVascular Research Initiative (CVON): the Dutch Heart Foundation; Netherlands CardioVascular Research Initiative (CVON): Dutch Federation of University Medical Centers; Netherlands CardioVascular Research Initiative (CVON): the Netherlands Organization for Health Research and Development; Netherlands CardioVascular Research Initiative (CVON): the Royal Netherlands Academy of Sciences; NOW Clinical Fellowship	This research forms part of the Project P1.04 SMARTCARE of the research program of the BioMedical Materials Institute, co-funded by the Dutch Ministry of Economic Affairs, Agriculture and Innovation. The financial contribution of the Nederlandse Hartstichting is gratefully acknowledged. This project is co-funded by a grant from the Alexandre Suerman program for MD/PhD students of the University Medical Center Utrecht, the Netherlands. This work is also funded by the Netherlands CardioVascular Research Initiative (CVON): the Dutch Heart Foundation, Dutch Federation of University Medical Centers, the Netherlands Organization for Health Research and Development and the Royal Netherlands Academy of Sciences. Professor Leiner is recipient of a NOW Clinical Fellowship (90700432).	Ang KL, 2008, NAT CLIN PRACT CARD, V5, P663, DOI 10.1038/ncpcardio1321; Bearzi C, 2009, P NATL ACAD SCI USA, V106, P15885, DOI 10.1073/pnas.0907622106; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bolli R, 2013, CIRCULATION, V128, P122, DOI 10.1161/CIRCULATIONAHA.112.001075; Chong JJH, 2014, NATURE, V510, P273, DOI 10.1038/nature13233; De Rosa S, 2013, CIRC-CARDIOVASC INTE, V6, P44, DOI 10.1161/CIRCINTERVENTIONS.112.971705; Delewi R, 2014, EUR HEART J, V35, P989, DOI 10.1093/eurheartj/eht372; Eding JEC, 2015, CIRC RES, V116, P80, DOI 10.1161/CIRCRESAHA.116.304872; Felix NJ, 2007, NAT REV IMMUNOL, V7, P942, DOI 10.1038/nri2200; Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818; Fukushima S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003071; Gaetani Roberto, 2014, J Cell Mol Med, V18, P2147, DOI 10.1111/jcmm.12458; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Goumans MJ, 2014, HEART, V100, P1153, DOI 10.1136/heartjnl-2014-305646; Goumans MJ, 2008, STEM CELL RES, V1, P138, DOI 10.1016/j.scr.2008.02.003; Jansen Lorkeers SJ, 2014, J CARDIOVASC TRANSL, V7, P475, DOI 10.1007/s12265-014-9570-8; Jeevanantham V, 2012, CIRCULATION, V126, P551, DOI 10.1161/CIRCULATIONAHA.111.086074; Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058; Kanazawa H, 2015, CIRC-HEART FAIL, V8, P322, DOI 10.1161/CIRCHEARTFAILURE.114.001484; Koudstaal S, 2014, JOVE-J VIS EXP, DOI 10.3791/51269; Koudstaal S, 2013, J CELL MOL MED, V17, P1128, DOI 10.1111/jcmm.12089; Koudstaal S, 2013, STEM CELL TRANSL MED, V2, P434, DOI 10.5966/sctm.2013-0001; Lee ST, 2011, J AM COLL CARDIOL, V57, P455, DOI 10.1016/j.jacc.2010.07.049; Malliaras Konstantinos, 2012, Circulation, V125, P100, DOI 10.1161/CIRCULATIONAHA.111.042598; Matsuda S, 2000, IMMUNOPHARMACOLOGY, V47, P119, DOI 10.1016/S0162-3109(00)00192-2; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Penn EC, 2008, J MOL CELL CARDIOL, V44, P486, DOI 10.1016/j.yjmcc.2007.09.012; Piot C, 2008, NEW ENGL J MED, V359, P473, DOI 10.1056/NEJMoa071142; Sanganalmath SK, 2013, CIRC RES, V113, P810, DOI 10.1161/CIRCRESAHA.113.300219; Schachinger V, 2006, EUR HEART J, V27, P2775, DOI 10.1093/eurheartj/ehl388; Sena E, 2007, TRENDS NEUROSCI, V30, P433, DOI 10.1016/j.tins.2007.06.009; Smits AM, 2009, NAT PROTOC, V4, P232, DOI 10.1038/nprot.2008.229; Smits AM, 2009, CARDIOVASC RES, V83, P527, DOI 10.1093/cvr/cvp146; van der Spoel TIG, 2012, J CELL MOL MED, V16, P2768, DOI 10.1111/j.1582-4934.2012.01594.x; van der Spoel TIG, 2011, CARDIOVASC RES, V91, P649, DOI 10.1093/cvr/cvr113; van Hout GPJ, 2013, EXP PHYSIOL, V98, P1565, DOI 10.1113/expphysiol.2013.074179; van Vliet P, 2010, J CELL MOL MED, V14, P861, DOI 10.1111/j.1582-4934.2010.01053.x; Williams AR, 2013, CIRCULATION, V127, P213, DOI 10.1161/CIRCULATIONAHA.112.131110; Ye L, 2014, CELL STEM CELL, V15, P750, DOI 10.1016/j.stem.2014.11.009; Yee K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113805; Zorginstituut Nederland, 2013, FARMACOTHERAPEUTISCH	42	5	5	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0143953	10.1371/journal.pone.0143953	http://dx.doi.org/10.1371/journal.pone.0143953			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678993	Green Published, Green Submitted, gold			2022-12-26	WOS:000366723400005
J	Daly, EA; Brodeur, RD				Daly, Elizabeth A.; Brodeur, Richard D.			Warming Ocean Conditions Relate to Increased Trophic Requirements of Threatened and Endangered Salmon	PLOS ONE			English	Article							COLUMBIA RIVER PLUME; EARLY MARINE RESIDENCE; CHINOOK SALMON; PACIFIC SALMON; NORTH PACIFIC; ONCORHYNCHUS-KISUTCH; SOCKEYE-SALMON; ENERGY DENSITY; CLIMATE-CHANGE; INTERDECADAL VARIABILITY	The trophic habits, size and condition of yearling Chinook salmon (Oncorhynchus tshawytscha) caught early in their marine residence were examined during 19 survey years (1981-1985; 1998-2011). Juvenile salmon consumed distinct highly piscivorous diets in cold and warm ocean regimes with major differences between ocean regimes driven by changes in consumption of juvenile rockfishes, followed by several other fish prey, adult euphausiids and decapod larvae. Notable, Chinook salmon consumed 30% more food in the warm versus cold ocean regime in both May and June. Additionally, there were about 30% fewer empty stomachs in the warm ocean regime in May, and 10% fewer in warm June periods. The total prey energy density consumed during the warmer ocean regime was also significantly higher than in cold. Chinook salmon had lower condition factor and were smaller in fork length during the warm ocean regime, and were longer and heavier for their size during the cold ocean regime. The significant increase in foraging during the warm ocean regime occurred concurrently with lower available prey biomass. Adult return rates of juvenile Chinook salmon that entered the ocean during a warm ocean regime were lower. Notably, our long term data set contradicts the long held assertion that juvenile salmon eat less in a warm ocean regime when low growth and survival is observed, and when available prey are reduced. Comparing diet changes between decades under variable ocean conditions may assist us in understanding the effects of projected warming ocean regimes on juvenile Chinook salmon and their survival in the ocean environment. Bioenergetically, the salmon appear to require more food resources during warm ocean regimes.	[Daly, Elizabeth A.] Oregon State Univ, Cooperat Inst Marine Resources Studies, Newport, OR 97365 USA; [Brodeur, Richard D.] NOAA, Fish Ecol Div, NW Fisheries Sci Ctr, Natl Marine Fisheries Serv, Newport, OR USA	Oregon State University; National Aeronautics & Space Administration (NASA); National Oceanic Atmospheric Admin (NOAA) - USA	Daly, EA (corresponding author), Oregon State Univ, Cooperat Inst Marine Resources Studies, Newport, OR 97365 USA.	Elizabeth.daly@oregonstate.edu		Brodeur, Richard/0000-0002-6629-5564	Bonneville Power Administration [1998-014-00]	Bonneville Power Administration	This work was supported by the Bonneville Power Administration, project #1998-014-00 (http://www.bpa.gov/).	Anthony JA, 2000, J EXP MAR BIOL ECOL, V248, P53, DOI 10.1016/S0022-0981(00)00159-3; Atcheson ME, 2012, T AM FISH SOC, V141, P1081, DOI 10.1080/00028487.2012.675914; Auad G, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003219; Auth TD, 2015, PROG OCEANOGR, V137, P103, DOI 10.1016/j.pocean.2015.05.025; Aydin KY, 2005, DEEP-SEA RES PT II, V52, P757, DOI 10.1016/j.dsr2.2004.12.017; Beaubier Jessica, 2013, Marine Ornithology, V41, P35; Beauchamp David A., 2007, North Pacific Anadromous Fish Commission Bulletin, V4, P257; Beauchamp David A., 2009, V70, P53; Belkin IM, 2009, PROG OCEANOGR, V81, P207, DOI 10.1016/j.pocean.2009.04.011; Benkwitt CE, 2009, T AM FISH SOC, V138, P111, DOI 10.1577/T08-060.1; Biro PA, 2005, P ROY SOC B-BIOL SCI, V272, P1443, DOI 10.1098/rspb.2005.3096; BRETT JR, 1969, J FISH RES BOARD CAN, V26, P2363, DOI 10.1139/f69-230; BRETT JR, 1971, AM ZOOL, V11, P99; BRODEUR RD, 1985, ESTUAR COAST SHELF S, V21, P365, DOI 10.1016/0272-7714(85)90017-4; BRODEUR RD, 1990, FISH B-NOAA, V88, P617; BRODEUR RD, 1992, MAR ECOL PROG SER, V84, P101, DOI 10.3354/meps084101; BRODEUR RD, 1992, CAN J FISH AQUAT SCI, V49, P1670, DOI 10.1139/f92-186; Brodeur RD, 2008, MAR ECOL PROG SER, V366, P187, DOI 10.3354/meps07539; Brodeur RD, 2007, FISH OCEANOGR, V16, P395, DOI 10.1111/j.1365-2419.2007.00438.x; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Burke BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054134; Burla M, 2010, CAN J FISH AQUAT SCI, V67, P1671, DOI 10.1139/F10-083; Cheung WWL, 2015, PROG OCEANOGR, V130, P19, DOI 10.1016/j.pocean.2014.09.003; Chittaro PM, 2014, ENVIRON BIOL FISH, V97, P1397, DOI 10.1007/s10641-014-0230-2; Chust G, 2014, GLOBAL CHANGE BIOL, V20, P2124, DOI 10.1111/gcb.12562; Cole J, 2000, FISH OCEANOGR, V9, P1, DOI 10.1046/j.1365-2419.2000.00118.x; Cummins K.W., 1971, INT ASS THEORETICAL, V18, P1, DOI [DOI 10.1080/05384680.1971.11903918, 10. 1080/05384680. 1971. 11903918]; Daly EA, 2014, MAR COAST FISH, V6, P62, DOI 10.1080/19425120.2013.869284; Daly EA, 2013, MAR ECOL PROG SER, V484, P203, DOI 10.3354/meps10320; Daly EA, 2012, ENVIRON BIOL FISH, V94, P117, DOI 10.1007/s10641-011-9857-4; Daly EA, 2010, MAR BIOL, V157, P1975, DOI 10.1007/s00227-010-1466-9; Davis N.D., 1998, North Pacific Anadromous Fish Commission Bulletin, V1, P146; Doney SC, 2012, ANNU REV MAR SCI, V4, P11, DOI 10.1146/annurev-marine-041911-111611; Fergusson EA, 2013, N PAC ANADR FISH COM, V9, P112; Glaser SM, 2010, MAR ECOL PROG SER, V414, P209, DOI 10.3354/meps08723; Gorley C.K., 2006, GETTING STARTED PRIM; Guraslan C, 2014, FISH OCEANOGR, V23, P436, DOI 10.1111/fog.12080; Handeland SO, 2008, AQUACULTURE, V283, P36, DOI 10.1016/j.aquaculture.2008.06.042; Hannah RW, 2010, CAL COOP OCEAN FISH, V51, P119; Hare S. R., 1995, Canadian Special Publication of Fisheries and Aquatic Sciences, V121, P357; Hickey BM, 1998, J GEOPHYS RES-OCEANS, V103, P10339, DOI 10.1029/97JC03290; Kaeriyama M, 2004, FISH OCEANOGR, V13, P197, DOI 10.1111/j.1365-2419.2004.00286.x; Koslow JA, 2002, FISH OCEANOGR, V11, P65, DOI 10.1046/j.1365-2419.2002.00187.x; Lienart GDH, 2014, ANIM BEHAV, V89, P199, DOI 10.1016/j.anbehav.2013.12.031; Litz MNC, 2010, MAR ECOL PROG SER, V405, P71, DOI 10.3354/meps08479; Logerwell EA, 2003, FISH OCEANOGR, V12, P554, DOI 10.1046/j.1365-2419.2003.00238.x; Mantua NJ, 1997, B AM METEOROL SOC, V78, P1069, DOI 10.1175/1520-0477(1997)078<1069:APICOW>2.0.CO;2; Miller JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099814; Mills KE, 2013, GLOBAL CHANGE BIOL, V19, P3046, DOI 10.1111/gcb.12298; Morgan CA, 2005, MAR ECOL PROG SER, V299, P19, DOI 10.3354/meps299019; Morrison KW, 2014, MAR BIOL, V161, P2243, DOI 10.1007/s00227-014-2502-y; Mueter FJ, 2002, CAN J FISH AQUAT SCI, V59, P456, DOI 10.1139/f02-020; Nishiyama T., RES I N PAC FISH SPE, V1977, P289; Pearcy W. G., 1992, OCEAN ECOLOGY N PACI; Pearcy WG, 1990, NOAA TECH REP NMFS, V93, P1; Peterson JO, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004965; Pyper BJ, 2005, T AM FISH SOC, V134, P86, DOI 10.1577/T04-034.1; Renkawitz MD, 2015, MAR ECOL PROG SER, V538, P197, DOI 10.3354/meps11470; Roegner GC, 2013, CONT SHELF RES, V60, P70, DOI 10.1016/j.csr.2013.04.007; Rosa R, 2010, MAR ECOL PROG SER, V410, P205, DOI 10.3354/meps08635; Ryding KE, 1999, CAN J FISH AQUAT SCI, V56, P2374, DOI 10.1139/cjfas-56-12-2374; Schwing FB, 2010, J MARINE SYST, V79, P245, DOI 10.1016/j.jmarsys.2008.11.027; Shanks AL, 2013, FISH OCEANOGR, V22, P263, DOI 10.1111/fog.12020; Sharma R, 2013, FISH OCEANOGR, V22, P14, DOI 10.1111/fog.12001; Siddon EC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084526; Sidwell VD., 1981, FSEC11 NOAA NMFS; SPEAR LB, 1993, J ANIM ECOL, V62, P399, DOI 10.2307/5190; Stachura MM, 2014, CAN J FISH AQUAT SCI, V71, P226, DOI 10.1139/cjfas-2013-0367; Sydeman WJ, 2014, SCIENCE, V345, P77, DOI [10.1126/science.1251635, 10.1126/science.1250830]; Sydeman WJ, 2014, PROG OCEANOGR, V120, P352, DOI 10.1016/j.pocean.2013.10.017; Tanasichuk RW, 2011, FISH OCEANOGR, V20, P462, DOI 10.1111/j.1365-2419.2011.00596.x; THAYER GW, 1973, FISH B-NOAA, V71, P289; Thayer JA, 2014, MAR ECOL PROG SER, V498, P249, DOI 10.3354/meps10608; Tomaro LM, 2012, MAR ECOL PROG SER, V452, P237, DOI 10.3354/meps09620; Van Pelt TI, 1997, COMP BIOCHEM PHYS A, V118, P1393, DOI 10.1016/S0300-9629(97)00240-5; Wainwright TC, 2013, NORTHWEST SCI, V87, P219, DOI 10.3955/046.087.0305; Wang DW, 2015, NATURE, V518, P390, DOI 10.1038/nature14235; Weitkamp LA, 2012, FISH B-NOAA, V110, P426; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Woodworth-Jefcoats PA, 2013, GLOBAL CHANGE BIOL, V19, P724, DOI 10.1111/gcb.12076	80	28	28	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144066	10.1371/journal.pone.0144066	http://dx.doi.org/10.1371/journal.pone.0144066			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675673	gold, Green Submitted, Green Published			2022-12-26	WOS:000366722700023
J	Garcia-Cossio, E; Severens, M; Nienhuis, B; Duysens, J; Desain, P; Keijsers, N; Farquhar, J				Garcia-Cossio, Eliana; Severens, Marianne; Nienhuis, Bart; Duysens, Jacques; Desain, Peter; Keijsers, Noel; Farquhar, Jason			Decoding Sensorimotor Rhythms during Robotic-Assisted Treadmill Walking for Brain Computer Interface (BCI) Applications	PLOS ONE			English	Article							MOTOR RECOVERY; STROKE; GAIT; HAND; IMAGERY; REHABILITATION; CLASSIFICATION; OSCILLATIONS; INDIVIDUALS; SIGNALS	Locomotor malfunction represents a major problem in some neurological disorders like stroke and spinal cord injury. Robot-assisted walking devices have been used during rehabilitation of patients with these ailments for regaining and improving walking ability. Previous studies showed the advantage of brain-computer interface (BCI) based robot-assisted training combined with physical therapy in the rehabilitation of the upper limb after stroke. Therefore, stroke patients with walking disorders might also benefit from using BCI robot-assisted training protocols. In order to develop such BCI, it is necessary to evaluate the feasibility to decode walking intention from cortical patterns during robot-assisted gait training. Spectral patterns in the electroencephalogram (EEG) related to robot-assisted active and passive walking were investigated in 10 healthy volunteers (mean age 32.3 +/- 10.8, six female) and in three acute stroke patients (all male, mean age 46.7 +/- 16.9, Berg Balance Scale 20 +/- 12.8). A logistic regression classifier was used to distinguish walking from baseline in these spectral EEG patterns. Mean classification accuracies of 94.0 +/- 5.4% and 93.1 +/- 7.9%, respectively, were reached when active and passive walking were compared against baseline. The classification performance between passive and active walking was 83.4 +/- 7.4%. A classification accuracy of 89.9 +/- 5.7% was achieved in the stroke patients when comparing walking and baseline. Furthermore, in the healthy volunteers modulation of low gamma activity in central midline areas was found to be associated with the gait cycle phases, but not in the stroke patients. Our results demonstrate the feasibility of BCI-based robotic-assisted training devices for gait rehabilitation.	[Garcia-Cossio, Eliana; Severens, Marianne; Desain, Peter; Farquhar, Jason] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands; [Severens, Marianne; Nienhuis, Bart; Duysens, Jacques; Keijsers, Noel] Sint Maartensklin, Res Dev & Educ Dept, Nijmegen, Netherlands; [Duysens, Jacques] Katholieke Univ Leuven, Dept Kinesiol, Leuven, Belgium	Radboud University Nijmegen; Sint Maartens Clinic; KU Leuven	Garcia-Cossio, E (corresponding author), Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, NL-6525 ED Nijmegen, Netherlands.	e.garciacossio@donders.ru.nl	Desain, Peter/D-1267-2012	Duysens, Jacques/0000-0002-0043-8817	BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs; Netherlands Ministry of Education, Culture and Science	BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Ministry of Education, Culture and Science	This study was supported by the BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors acknowledge the support of the BrainGain Smart Mix Programme of the Netherlands Ministry of Economic Affairs and the Netherlands Ministry of Education, Culture and Science.	Ang KK, 2010, IEEE ENG MED BIO, P5549, DOI 10.1109/IEMBS.2010.5626782; Antelis JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061976; Arya KN, 2011, J BODYW MOV THER, V15, P528, DOI 10.1016/j.jbmt.2011.01.023; Au SK, 2005, INT C REHAB ROBOT, P375; Billinger M., 2012, PRACTICAL BRAIN COMP, P333, DOI [10.1007/978-3-642-29746-5_17, DOI 10.1007/978-3-642-29746-5_17]; Birbaumer N, 2008, CURR OPIN NEUROL, V21, P634, DOI 10.1097/WCO.0b013e328315ee2d; Bishop C, 2006, PATTERN RECOGN; Bradberry TJ, 2010, J NEUROSCI, V30, P3432, DOI 10.1523/JNEUROSCI.6107-09.2010; Buch ER, 2012, BRAIN, V135, P596, DOI 10.1093/brain/awr331; Canolty RT, 2006, SCIENCE, V313, P1626, DOI 10.1126/science.1128115; Castermans T, 2014, BRAIN SCI, V4, P1, DOI 10.3390/brainsci4010001; Castermans T, 2014, NEUROSCI LETT, V561, P166, DOI 10.1016/j.neulet.2013.12.059; Cipriani C, 2008, IEEE T ROBOT, V24, P170, DOI 10.1109/TRO.2007.910708; Collinger J, 2012, LANCET, V381, P347; Daly JJ, 2008, LANCET NEUROL, V7, P1032, DOI 10.1016/S1474-4422(08)70223-0; Daly JJ, 2009, J NEUROL PHYS THER, V33, P203, DOI 10.1097/NPT.0b013e3181c1fc0b; Do AH, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-111; Do AH, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-49; Englehart K, 2003, IEEE T BIO-MED ENG, V50, P848, DOI 10.1109/TBME.2003.813539; Farquhar J, 2013, NEUROINFORMATICS, V11, P175, DOI 10.1007/s12021-012-9171-0; Fitzsimmons NA, 2009, FRONT INTEGR NEUROSC, V3, DOI 10.3389/neuro.07.003.2009; Fleerkotte BM, 2014, J NEUROENG REHABIL, V11, DOI 10.1186/1743-0003-11-26; Fries P, 2005, TRENDS COGN SCI, V9, P474, DOI 10.1016/j.tics.2005.08.011; Gomez-Rodriguez M, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036005; Gu Y, 2009, CLIN NEUROPHYSIOL, V120, P1596, DOI 10.1016/j.clinph.2009.05.006; Gwin JT, 2011, NEUROIMAGE, V54, P1289, DOI 10.1016/j.neuroimage.2010.08.066; Hesse S, 2008, DTSCH ARZTEBL INT, V105, P330, DOI 10.3238/arztebl.2008.0330; Hidler J, 2008, CLIN BIOMECH, V23, P1251, DOI 10.1016/j.clinbiomech.2008.08.004; Hochberg LR, 2012, NATURE, V485, P372, DOI 10.1038/nature11076; Ivanenko YP, 2002, J NEUROPHYSIOL, V87, P3070, DOI 10.1152/jn.2002.87.6.3070; Johansson BB, 2011, ACTA NEUROL SCAND, V123, P147, DOI 10.1111/j.1600-0404.2010.01417.x; Kamibayashi K, 2010, EXP BRAIN RES, V202, P385, DOI 10.1007/s00221-009-2145-2; King CE, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-77; Koenraadt KLM, 2014, NEUROIMAGE, V85, P415, DOI 10.1016/j.neuroimage.2013.04.070; Kotlowski Wojciech, 2011, P 28 INT C MACH LEAR, P1113; Krzanowski W., 1988, PRINCIPLES OF MULTIV; Langhorne P, 2009, LANCET NEUROL, V8, P741, DOI 10.1016/S1474-4422(09)70150-4; Lotze M, 2003, BRAIN, V126, P866, DOI 10.1093/brain/awg079; Magee DJ, 2014, ORTHOPEDIC PHYSICAL; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Mehrholz J, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006185.pub2; Miyai I, 2001, NEUROIMAGE, V14, P1186, DOI 10.1006/nimg.2001.0905; Murguialday AR, 2007, INT C REHAB ROBOT, P609, DOI 10.1109/ICORR.2007.4428487; Omlor W, 2007, NEUROIMAGE, V34, P1191, DOI 10.1016/j.neuroimage.2006.10.018; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Petersen TH, 2012, J PHYSIOL-LONDON, V590, P2443, DOI 10.1113/jphysiol.2012.227397; Pfurtscheller G, 2000, NEUROSCI LETT, V292, P211, DOI 10.1016/S0304-3940(00)01471-3; Ramos-Murguialday A, 2015, ANN CLIN TRANSL NEUR, V2, P1, DOI 10.1002/acn3.122; Ramos-Murguialday A, 2013, ANN NEUROL, V74, P100, DOI 10.1002/ana.23879; Ramos-Murguialday A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047048; Sale P, 2012, EUR J PHYS REHAB MED, V48, P313; Seeber M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00485; Severens M, 2012, IEEE ENG MED BIO, P2764, DOI 10.1109/EMBC.2012.6346537; Severens M, 2013, THESIS; Severens M, 2014, IEEE T NEUR SYS REH, VPP, P1, DOI DOI 10.1109/TNSRE.2014.2371391; Sitaram R, 2007, NEUROIMAGE, V34, P1416, DOI 10.1016/j.neuroimage.2006.11.005; Takeuchi N, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/128641; Takeuchi N, 2012, STROKE RES TREAT, V2012, DOI 10.1155/2012/584727; Tenore FVG, 2009, IEEE T BIO-MED ENG, V56, P1427, DOI 10.1109/TBME.2008.2005485; Vos DM, 2010, NEUROINFORMATICS, V8, P135, DOI [10.1007/s12021-010-9076-8, 10.1007/s12021-010-9071-0]; Wagner J, 2012, NEUROIMAGE, V63, P1203, DOI 10.1016/j.neuroimage.2012.08.019; Waldert S, 2008, J NEUROSCI, V28, P1000, DOI 10.1523/JNEUROSCI.5171-07.2008	63	33	34	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0137910	10.1371/journal.pone.0137910	http://dx.doi.org/10.1371/journal.pone.0137910			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675472	Green Submitted, Green Published, gold			2022-12-26	WOS:000366722700001
J	Sun, CC; Chiu, HT; Lin, YF; Lee, KY; Pang, JHS				Sun, Chi-Chin; Chiu, Hsiao-Ting; Lin, Yi-Fang; Lee, Kuo-Ying; Pang, Jong-Hwei Su			Y-27632, a ROCK Inhibitor, Promoted Limbal Epithelial Cell Proliferation and Corneal Wound Healing	PLOS ONE			English	Article							RHO-ASSOCIATED KINASE; EMBRYONIC STEM-CELLS; PROTEIN-KINASE; IN-VITRO; DEFICIENCY; TRANSPLANTATION; APOPTOSIS; PATHWAY; GTPASES; TISSUE	Transplantation of ex vivo cultured limbal epithelial cells is proven effective in restoring limbal stem cell deficiency. The present study aimed to investigate the promoting effect of Y-27632 on limbal epithelial cell proliferation. Limbal explants isolated from human donor eyes were expanded three weeks on culture dishes and outgrowth of epithelial cells was subsequently subcultured for in vitro experiments. In the presence of Y-27632, the ex vivo limbal outgrowth was accelerated, particularly the cells with epithelial cell-like morphology. Y-27632 dose-dependently promoted the proliferation of in vitro cultured human limbal epithelial cells as examined by phase contrast microscopy and luminescent cell-viability assay 30 hours after the treatment. The colony forming efficacy determined 7 days after the treatment was enhanced by Y-27632 also in a dose-dependent manner. The number of p63- or Ki67-positive cells was dose-dependently increased in Y-27632-treated cultures as detected by immunofluorescent staining and western blotanalysis. Cell cycle analysis by flow cytometric method revealed an increase in S-phase proliferating cells. The epithelial woundclosure rate was shown to be faster in experimental group received topical treatment withY-27632 than the sham control using a rat corneal wounding model. These resultsdemonstrate that Y-27632 can promote both the ex vivo and in vitro proliferation oflimbal epithelial cell proliferation. The in vivo enhanced epithelial wound healingfurther implies that the Y-27632 may act as a new strategy for treating limbal stem cell deficiency.	[Sun, Chi-Chin; Chiu, Hsiao-Ting; Lin, Yi-Fang; Lee, Kuo-Ying] Chang Gung Mem Hosp, Dept Ophthalmol, Keelung, Taiwan; [Sun, Chi-Chin] Chang Gung Univ, Coll Med, Dept Chinese Med, Taoyuan, Taiwan; [Pang, Jong-Hwei Su] Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University	Pang, JHS (corresponding author), Chang Gung Univ, Grad Inst Clin Med Sci, Coll Med, Taoyuan, Taiwan.	jonghwei@mail.cgu.edu.tw			Chang Gung Medical Research Foundation [CMRPG2A0271, CMRPG2A0272, CMRPG2A0273, CMRPG2C0181, CMRPG270403, CMRPG2C0182]; Ministry of Science and Technology, Taiwan [102-2314-B-182A-089-MY2]	Chang Gung Medical Research Foundation; Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan)	Funding was provided by CMRPG2A0271, CMRPG2A0272, CMRPG2A0273, CMRPG2C0181, CMRPG270403 and CMRPG2C0182 from the Chang Gung Medical Research Foundation (CCS), and the Ministry of Science and Technology, Taiwan (grant number 102-2314-B-182A-089-MY2) (CCS).	Amano M, 2000, EXP CELL RES, V261, P44, DOI 10.1006/excr.2000.5046; Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Chidambaranathan GP, 2015, CORNEA, V34, P1478, DOI 10.1097/ICO.0000000000000593; Coleman ML, 2002, CELL DEATH DIFFER, V9, P493, DOI 10.1038/sj.cdd.4400987; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Del Debbio CB, 2014, INVEST OPHTH VIS SCI, V55, P2631, DOI 10.1167/iovs.13-13162; Echevarria TJ, 2011, STEM CELL REV REP, V7, P256, DOI 10.1007/s12015-010-9199-1; Emre N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012148; Gauthaman K, 2010, STEM CELL REV REP, V6, P86, DOI [10.1007/s12015-010-9166-x, 10.1007/s12015-009-9107-8]; Gomes JAP, 2003, OPHTHALMOLOGY, V110, P466, DOI 10.1016/S0161-6420(02)01888-2; Hall A, 2000, PHILOS T R SOC B, V355, P965, DOI 10.1098/rstb.2000.0632; Han ES, 2011, GRAEF ARCH CLIN EXP, V249, P1697, DOI 10.1007/s00417-011-1760-3; Holland EJ, 2015, CORNEA, V34, pS9, DOI 10.1097/ICO.0000000000000534; Kamai T, 2003, CLIN CANCER RES, V9, P2632; Kamai T, 2002, BJU INT, V89, P449, DOI 10.1046/j.1464-4096.2001.01920.x; Kaneko K, 2002, PANCREAS, V24, P251, DOI 10.1097/00006676-200204000-00007; Kurosawa H, 2012, J BIOSCI BIOENG, V114, P577, DOI 10.1016/j.jbiosc.2012.07.013; Minambres R, 2006, J CELL SCI, V119, P271, DOI 10.1242/jcs.02723; Nakamura K, 2014, J PERIODONTAL RES, V49, P363, DOI 10.1111/jre.12114; Nishida K, 2004, NEW ENGL J MED, V351, P1187, DOI 10.1056/NEJMoa040455; O'Callaghan AR, 2011, STEM CELLS, V29, P1923, DOI 10.1002/stem.756; Okumura N, 2014, INVEST OPHTH VIS SCI, V55, P318, DOI 10.1167/iovs.13-12225; Okumura N, 2013, INVEST OPHTH VIS SCI, V54, P2493, DOI 10.1167/iovs.12-11320; Okumura N, 2012, AM J PATHOL, V181, P268, DOI 10.1016/j.ajpath.2012.03.033; Okumura N, 2011, BRIT J OPHTHALMOL, V95, P1006, DOI 10.1136/bjo.2010.194571; Okumura N, 2009, INVEST OPHTH VIS SCI, V50, P3680, DOI 10.1167/iovs.08-2634; Olson MF, 2008, CURR OPIN CELL BIOL, V20, P242, DOI 10.1016/j.ceb.2008.01.002; Peerani R, 2007, EMBO J, V26, P4744, DOI 10.1038/sj.emboj.7601896; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Poli M, 2015, CORNEA, V34, P817, DOI 10.1097/ICO.0000000000000457; Puetz S, 2009, PHYSIOLOGY, V24, P342, DOI 10.1152/physiol.00023.2009; Quiros M, 2014, SEMIN CELL DEV BIOL, V36, P194, DOI 10.1016/j.semcdb.2014.09.003; Rama P, 2010, NEW ENGL J MED, V363, P147, DOI 10.1056/NEJMoa0905955; Sakisaka T, 2004, J CELL BIOL, V166, P17, DOI 10.1083/jcb.200405002; Sangwan VS, 2011, BRIT J OPHTHALMOL, V95, P1525, DOI 10.1136/bjophthalmol-2011-300352; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Shortt AJ, 2014, STEM CELL TRANSL MED, V3, P265, DOI 10.5966/sctm.2013-0025; SundarRaj N, 1998, INVEST OPHTH VIS SCI, V39, P1266; Svoboda KKH, 2004, DEV DYNAM, V229, P579, DOI 10.1002/dvdy.20008; Terunuma A, 2010, TISSUE ENG PT A, V16, P1363, DOI [10.1089/ten.tea.2009.0339, 10.1089/ten.TEA.2009.0339]; Tsai RJ, 2000, NEW ENGL J MED, V343, P86, DOI 10.1056/NEJM200007133430202; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wright B, 2013, DRUG DISCOV TODAY, V18, P79, DOI 10.1016/j.drudis.2012.07.012; Yin J, 2008, AM J PHYSIOL-CELL PH, V295, pC378, DOI 10.1152/ajpcell.90624.2007; Zhao ZY, 2003, DEV DYNAM, V226, P24, DOI 10.1002/dvdy.10212; Zhou QJ, 2013, TISSUE ENG PART C-ME, V19, P531, DOI [10.1089/ten.tec.2012.0429, 10.1089/ten.TEC.2012.0429]	46	35	36	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144571	10.1371/journal.pone.0144571	http://dx.doi.org/10.1371/journal.pone.0144571			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673160	gold, Green Published, Green Submitted			2022-12-26	WOS:000366722700045
J	Arrabal, S; Lucena, MA; Canduela, MJ; Ramos-Uriarte, A; Rivera, P; Serrano, A; Pavon, FJ; Decara, J; Vargas, A; Baixeras, E; Martin-Rufian, M; Marquez, J; Fernandez-Llebrez, P; De Roos, B; Grandes, P; de Fonseca, FR; Suarez, J				Arrabal, Sergio; Angel Lucena, Miguel; Josune Canduela, Miren; Ramos-Uriarte, Almudena; Rivera, Patricia; Serrano, Antonia; Javier Pavon, Francisco; Decara, Juan; Vargas, Antonio; Baixeras, Elena; Martin-Rufian, Mercedes; Marquez, Javier; Fernandez-Llebrez, Pedro; De Roos, Baukje; Grandes, Pedro; Rodriguez de Fonseca, Fernando; Suarez, Juan			Pharmacological Blockade of Cannabinoid CB1 Receptors in Diet-Induced Obesity Regulates Mitochondrial Dihydrolipoamide Dehydrogenase in Muscle	PLOS ONE			English	Article							ENDOCANNABINOID SYSTEM; CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; ADIPOSE-TISSUE; ANTAGONIST; RIMONABANT; OVERWEIGHT; EXPRESSION; WEIGHT; BIOENERGETICS	Cannabinoid CB1 receptors peripherally modulate energy metabolism. Here, we investigated the role of CB1 receptors in the expression of glucose/pyruvate/tricarboxylic acid (TCA) metabolism in rat abdominal muscle. Dihydrolipoamide dehydrogenase (DLD), a flavoprotein component (E3) of alpha-ketoacid dehydrogenase complexes with diaphorase activity in mitochondria, was specifically analyzed. After assessing the effectiveness of the CB1 receptor antagonist AM251 (3 mg kg(-1), 14 days) on food intake and body weight, we could identified seven key enzymes from either glycolytic pathway or TCA cycle-regulated by both diet and CB1 receptor activity-through comprehensive proteomic approaches involving two-dimensional electrophoresis and MALDI-TOF/LC-ESI trap mass spectrometry. These enzymes were glucose 6-phosphate isomerase (GPI), triosephosphate isomerase (TPI), enolase (Eno3), lactate dehydrogenase (LDHa), glyoxalase-1 (Glo1) and the mitochondrial DLD, whose expressions were modified by AM251 in hypercaloric diet-induced obesity. Specifically, AM251 blocked high-carbohydrate diet (HCD)-induced expression of GPI, TPI, Eno3 and LDHa, suggesting a down-regulation of glucose/pyruvate/lactate pathways under glucose availability. AM251 reversed the HCD-inhibited expression of Glo1 and DLD in the muscle, and the DLD and CB1 receptor expression in the mitochondrial fraction. Interestingly, we identified the presence of CB1 receptors at the membrane of striate muscle mitochondria. DLD over-expression was confirmed in muscle of CB1-/- mice. AM251 increased the pyruvate dehydrogenase and glutathione reductase activity in C2C12 myotubes, and the diaphorase/oxidative activity in the mitochondria fraction. These results indicated an up-regulation of methylglyoxal and TCA cycle activity. Findings suggest that CB1 receptors in muscle modulate glucose/pyruvate/lactate pathways and mitochondrial oxidative activity by targeting DLD.	[Arrabal, Sergio; Angel Lucena, Miguel; Rivera, Patricia; Serrano, Antonia; Javier Pavon, Francisco; Decara, Juan; Vargas, Antonio; Baixeras, Elena; Rodriguez de Fonseca, Fernando; Suarez, Juan] Univ Malaga, UGC Salud Mental, Inst Invest Biomed Malaga IBIMA, Hosp Univ Reg Malaga, E-29071 Malaga, Spain; [Arrabal, Sergio; Rivera, Patricia; Serrano, Antonia; Javier Pavon, Francisco; Decara, Juan; Vargas, Antonio; Baixeras, Elena; Rodriguez de Fonseca, Fernando; Suarez, Juan] Inst Salud Carlos III, CIBER OBN, Madrid, Spain; [Josune Canduela, Miren; Ramos-Uriarte, Almudena; Grandes, Pedro] Univ Basque Country UPV EHU, Dept Neurosci, Leioa, Spain; [Martin-Rufian, Mercedes] Univ Malaga, ECAI Prote, Inst Invest Biomed Malaga IBIMA, E-29071 Malaga, Spain; [Marquez, Javier] Univ Malaga, Dept Biol Mol & Bioquim, Inst Invest Biomed Malaga IBIMA, E-29071 Malaga, Spain; [Fernandez-Llebrez, Pedro] Univ Malaga, Dept Biol Celular Genet & Fisiol, Inst Invest Biomed Malaga IBIMA, E-29071 Malaga, Spain; [De Roos, Baukje] Univ Aberdeen, Rowett Inst Nutr & Hlth, Aberdeen, Scotland	Universidad de Malaga; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; University of Basque Country; Universidad de Malaga; Universidad de Malaga; Universidad de Malaga; University of Aberdeen	de Fonseca, FR (corresponding author), Univ Malaga, UGC Salud Mental, Inst Invest Biomed Malaga IBIMA, Hosp Univ Reg Malaga, E-29071 Malaga, Spain.	fernando.rodriguez@ibima.eu; juan.suarez@ibima.eu	marquez, javier/K-3289-2012; Grandes, Pedro/AAA-1627-2019; Suarez, Juan/I-5188-2015; Ramos, Almudena/AAS-1563-2020; Pavón Morón, Francisco Javier/AAG-9721-2020; Grandes, Pedro/H-7494-2015; Decara Del Olmo, Juan Manuel/I-1931-2015	marquez, javier/0000-0003-3317-3963; Suarez, Juan/0000-0001-5254-9802; Ramos, Almudena/0000-0002-2632-1625; Pavón Morón, Francisco Javier/0000-0002-5256-8904; RODRIGUEZ DE FONSECA, FERNANDO/0000-0002-4516-5795; Grandes, Pedro/0000-0003-3947-4230; Alonso-Alconada, Daniel/0000-0002-9874-2947; Arrabal Nunez, Sergio/0000-0002-0600-9634; Rivera, Patricia/0000-0002-0478-6667; Decara Del Olmo, Juan Manuel/0000-0002-9868-015X; BAIXERAS, ELENA/0000-0001-6955-2434	CIBERobn [CB06/03/1008)]; Ministerio de Economia y Competitividad (MINECO) [BFU2012-33334]; Instituto de Salud Carlos III (ISCIII); UE-ERDF [CP12/03109, CTS-8221, CVI-6656, SAS111224, CP14/00173]; Red de Trastornos Adictivos [RD12/0028/0001, RD12/0028/0004, RD12/0028/0013]; Basque Country Government [BCG IT764-13]; Consejeria de Economia, Innovaciin y Ciencia; Junta de Andalucia; Consejeria de Salud; University of the Basque Country UPV/EHU [UFI11/41]; National System of Health [CP12/03109]; ISCIII [CP14/00212]	CIBERobn; Ministerio de Economia y Competitividad (MINECO); Instituto de Salud Carlos III (ISCIII)(Instituto de Salud Carlos IIIEuropean Commission); UE-ERDF; Red de Trastornos Adictivos(Instituto de Salud Carlos III); Basque Country Government(Basque Government); Consejeria de Economia, Innovaciin y Ciencia; Junta de Andalucia(Junta de Andalucia); Consejeria de Salud; University of the Basque Country UPV/EHU; National System of Health; ISCIII(Instituto de Salud Carlos III)	This work was supported by CIBERobn (CB06/03/1008), Ministerio de Economia y Competitividad (MINECO) (PG: BFU2012-33334), Instituto de Salud Carlos III (ISCIII), MINECO, cofunded by UE-ERDF program (JS: CP12/03109), Red de Trastornos Adictivos (FRF: RD12/0028/0001, PG: RD12/0028/0004, JM: RD12/0028/0013), The Basque Country Government (PG: BCG IT764-13), Consejeria de Economia, Innovaciin y Ciencia, Junta de Andalucia, UE-ERDF (FRF: CTS-8221, JM: CVI-6656), Consejeria de Salud, Junta de Andalucia, UE-ERDF (FRF: SAS111224), and University of the Basque Country UPV/EHU (PG: UFI11/41). JS, FJP and AS hold "Miguel Servet" research contracts from the National System of Health, ISCIII, UE-ERDF (CP12/03109, CP14/00212, and CP14/00173 respectively).	Alonso M, 2012, BRIT J PHARMACOL, V165, P2274, DOI 10.1111/j.1476-5381.2011.01698.x; Athanasiou A, 2007, BIOCHEM BIOPH RES CO, V364, P131, DOI 10.1016/j.bbrc.2007.09.107; Bae N, 2012, ANAL BIOCHEM, V428, P1, DOI 10.1016/j.ab.2012.05.016; BARTOVA A, 1976, J BIOL CHEM, V251, P5002; Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Benard G, 2012, NAT NEUROSCI, V15, P558, DOI 10.1038/nn.3053; Bermudez-Silva FJ, 2007, EUR J PHARMACOL, V565, P207, DOI 10.1016/j.ejphar.2007.02.066; Cavuoto P, 2007, MOL CELL ENDOCRINOL, V267, P63, DOI 10.1016/j.mce.2006.12.038; Christensen R, 2007, LANCET, V370, P1706, DOI 10.1016/S0140-6736(07)61721-8; Christopoulou FD, 2011, J CLIN PHARM THER, V36, P10, DOI 10.1111/j.1365-2710.2010.01164.x; Constantin-Teodosiu D, 2013, DIABETES METAB J, V37, P301, DOI 10.4093/dmj.2013.37.5.301; Crespillo A, 2011, BIOCHEM J, V433, P175, DOI 10.1042/BJ20100751; de Roos B, 2005, FASEB J, V19, P813, DOI 10.1096/fj.04-2974fje; Di Marzo V, 2008, DIABETOLOGIA, V51, P1356, DOI 10.1007/s00125-008-1048-2; Di Marzo V, 2011, HANDB EXP PHARMACOL, V203, P75, DOI 10.1007/978-3-642-17214-4_4; Engeli S, 2008, J NEUROENDOCRINOL, V20, P110, DOI 10.1111/j.1365-2826.2008.01683.x; Hebert-Chatelain E, 2014, MOL METAB, V3, P495, DOI 10.1016/j.molmet.2014.03.007; Hebert-Chatelain E, 2014, MOL METAB, V3, P339, DOI 10.1016/j.molmet.2014.03.008; Hojlund K, 2008, ENDOCRIN METAB CLIN, V37, P713, DOI 10.1016/j.ecl.2008.06.006; Iannotti FA, 2014, P NATL ACAD SCI USA, V111, pE2472, DOI 10.1073/pnas.1406728111; Klyachko NL, 2005, J BIOL CHEM, V280, P16106, DOI 10.1074/jbc.M414285200; Lipina C, 2014, AM J PHYSIOL-ENDOC M, V307, pE1, DOI 10.1152/ajpendo.00100.2014; Liu YL, 2005, INT J OBESITY, V29, P183, DOI 10.1038/sj.ijo.0802847; Mailloux RJ, 2015, REDOX BIOL, V4, P381, DOI 10.1016/j.redox.2015.02.001; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Matias I, 2008, MOL CELL ENDOCRINOL, V286, pS66, DOI 10.1016/j.mce.2008.01.026; Pagano C, 2008, J NEUROENDOCRINOL, V20, P124, DOI 10.1111/j.1365-2826.2008.01690.x; Pagotto U, 2006, ENDOCR REV, V27, P73, DOI 10.1210/er.2005-0009; Patti ME, 2010, ENDOCR REV, V31, P364, DOI 10.1210/er.2009-0027; Pavon FJ, 2008, J NEUROENDOCRINOL, V20, P116, DOI 10.1111/j.1365-2826.2008.01693.x; Pi-Sunyer F, 2006, JAMA-J AM MED ASSOC, V295, P761, DOI 10.1001/jama.295.7.761; Riedel G, 2009, BRIT J PHARMACOL, V156, P1154, DOI 10.1111/j.1476-5381.2008.00107.x; Rivera P, 2013, EUR J NEUROSCI, V37, P105, DOI 10.1111/ejn.12012; Sivitz WI, 2010, ANTIOXID REDOX SIGN, V12, P537, DOI 10.1089/ars.2009.2531; Tam J, 2010, J CLIN INVEST, V120, P2953, DOI 10.1172/JCI42551; Tedesco L, 2008, DIABETES, V57, P2028, DOI 10.2337/db07-1623; Tedesco L, 2010, DIABETES, V59, P2826, DOI 10.2337/db09-1881; Tiyerili V, 2010, BASIC RES CARDIOL, V105, P465, DOI 10.1007/s00395-010-0090-7; Tuomilehto J, 2001, NEW ENGL J MED, V344, P1343, DOI 10.1056/NEJM200105033441801; Van Gaal LF, 2005, LANCET, V365, P1389, DOI 10.1016/S0140-6736(05)66374-X; Vida M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090016; Wilson PWF, 2002, ARCH INTERN MED, V162, P1867, DOI 10.1001/archinte.162.16.1867; Yu J, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0115167, 10.1371/journal.pone.0112628]	44	21	22	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145244	10.1371/journal.pone.0145244	http://dx.doi.org/10.1371/journal.pone.0145244			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671069	Green Published, gold, Green Submitted			2022-12-26	WOS:000366719300056
J	Behmenburg, F; Dorsch, M; Huhn, R; Mally, D; Heinen, A; Hollmann, MW; Berger, MM				Behmenburg, Friederike; Dorsch, Marianne; Huhn, Ragnar; Mally, David; Heinen, Andre; Hollmann, Markus W.; Berger, Marc M.			Impact of Mitochondrial Ca2+-Sensitive Potassium (mBK(Ca)) Channels in Sildenafil-Induced Cardioprotection in Rats	PLOS ONE			English	Article							CA2+-ACTIVATED K+ CHANNELS; ISCHEMIA-REPERFUSION INJURY; INDUCED RELAXATION; BKCA CHANNELS; HUMAN BLADDER; NITRIC-OXIDE; ACTIVATION; MECHANISM; PHOSPHORYLATION; PHOSPHODIESTERASE	Background Mitochondrial large-conductance Ca2+-sensitive potassium (mBK(Ca)) channels are involved in myocardial ischemic preconditioning. Their role in sildenafil-induced cardioprotection is unknown. We investigated whether sildenafil-induced acute cardioprotection is mediated by activation of mBKCa channels in the rat heart in vitro. Methods Male Wistar rats (n = 8 per group) were randomized and anesthetized with pentobarbital (90 mg/kg). Hearts were isolated, mounted on a Langendorff system and perfused with Krebs-Henseleit buffer at a constant pressure of 80 mmHg. Hearts underwent 30 min of global ischemia followed by 60 min of reperfusion. At the end of the experiments infarct size was determined by TTC staining. In the control group rats were not further treated. Sildenafil (3 mu M) was administered over 10 min before the beginning of ischemia. The mBKCa channel inhibitor paxilline (1 mu M) was administered with and without sildenafil before the onset of ischemia. The pathway underlying sildenafil-induced cardioprotection was further investigated with the protein kinase G blocker KT5823 (1 mu M). Myocardial cGMP concentration was measured by ELISA. Data (mean +/- SD) were analysed with a one and two-way analysis of variance as appropriate. Results In control animals infarct size was 52 +/- 8%. Sildenafil increased cGMP concentration and reduced infarct size to 35 +/- 6% (P<0.05 vs. control). Paxilline and KT5823 completely blocked sildenafil-induced cardioprotection (paxilline+sildenafil: 50 +/- 8%, KT5823+sildenafil: 45 +/- 8%; both P<0.05 vs. sildenafil). Functional heart parameters and coronary flow were not different between the study groups. Conclusion This study shows that in male rats protein kinase G-dependent opening of mBK(Ca) channels plays a pivotal role in sildenafil-induced cardioprotection.	[Behmenburg, Friederike; Dorsch, Marianne; Huhn, Ragnar; Mally, David] Univ Hosp Dusseldorf, Dept Anesthesiol, Dusseldorf, Germany; [Heinen, Andre] Univ Dusseldorf, Dept Cardiovasc Physiol, Dusseldorf, Germany; [Hollmann, Markus W.] Univ Amsterdam, Acad Med Ctr, Dept Anesthesiol, LEICA, NL-1105 AZ Amsterdam, Netherlands; [Berger, Marc M.] Paracelsus Med Univ, Salzburg Gen Hosp, Dept Anesthesiol Perioperat & Gen Crit Care Med, Salzburg, Austria	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf Hospital; Heinrich Heine University Dusseldorf; University of Amsterdam; Academic Medical Center Amsterdam; Paracelsus Private Medical University	Huhn, R (corresponding author), Univ Hosp Dusseldorf, Dept Anesthesiol, Dusseldorf, Germany.	Ragnar.Huhn@med.uni-duesseldorf.de	Berger, Marc/AAN-2887-2020; Huhn, Ragnar/X-6466-2018	Huhn, Ragnar/0000-0002-3114-7190; Berger, Marc Moritz/0000-0001-6771-3193				Balderas E, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00104; Bentzen BH, 2009, PFLUG ARCH EUR J PHY, V457, P979, DOI 10.1007/s00424-008-0583-5; Borchert GH, 2013, EXP BIOL MED, V238, P233, DOI 10.1177/1535370212474596; Cattaneo MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029680; Clements RT, 2015, CIRC J, V79, P455, DOI 10.1253/circj.CJ-15-0015; Das A, 2014, PHARM THER; Das A, 2008, J BIOL CHEM, V283, P29572, DOI 10.1074/jbc.M801547200; Das A, 2009, AM J PHYSIOL-HEART C, V296, pH1236, DOI 10.1152/ajpheart.00100.2009; Das S, 2002, DRUG EXP CLIN RES, V28, P213; Deenadayalu V, 2012, AM J PHYSIOL-HEART C, V302, pH115, DOI 10.1152/ajpheart.00046.2011; Dikmen A, 2013, NITRIC OXIDE-BIOL CH, V31, pS38, DOI 10.1016/j.niox.2013.06.072; Frassdorf J, 2010, CAN J ANESTH, V57, P767, DOI 10.1007/s12630-010-9325-1; Fusco F, 2012, EUR UROL, V62, P1174, DOI 10.1016/j.eururo.2012.07.025; Galie N, 2005, NEW ENGL J MED, V353, P2148, DOI 10.1056/NEJMoa050010; Goldstein I, 1998, NEW ENGL J MED, V338, P1397, DOI 10.1056/NEJM199805143382001; Gragasin FS, 2004, FASEB J, V18, P1382, DOI 10.1096/fj.04-1978com; Heinen A, 2014, EXP GERONTOL, V56, P99, DOI 10.1016/j.exger.2014.03.029; Huhn R, 2010, BRIT J ANAESTH, V105, P589, DOI 10.1093/bja/aeq213; Huhn R, 2012, EXP GERONTOL, V47, P116, DOI 10.1016/j.exger.2011.11.003; Koneru S, 2008, J CELL MOL MED, V12, P2651, DOI 10.1111/j.1582-4934.2008.00319.x; Kukreja RC, 2011, EXP CLIN CARDIOL, V16, pE30; Lai MH, 2014, AM J PHYSIOL-HEART C, V307, pH1327, DOI 10.1152/ajpheart.00354.2014; Lee KH, 2014, CLIN EXP PHARMACOL P, V41, P763, DOI 10.1111/1440-1681.12290; Madhani M, 2010, AM J PHYSIOL-HEART C, V299, pH827, DOI 10.1152/ajpheart.00129.2010; Milano G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027910; Ockaili R, 2002, AM J PHYSIOL-HEART C, V283, pH1263, DOI 10.1152/ajpheart.00324.2002; Oger S, 2010, BRIT J PHARMACOL, V160, P1135, DOI 10.1111/j.1476-5381.2010.00748.x; Reffelmann T, 2003, CARDIOVASC RES, V59, P441, DOI 10.1016/S0008-6363(03)00435-8; Salloum F, 2003, CIRC RES, V92, P595, DOI 10.1161/01.RES.0000066853.09821.98; Salloum FN, 2008, AM J PHYSIOL-HEART C, V294, pH1398, DOI [10.1152/ajpheart.ajpheart.91438.2007, 10.1152/ajpheart.91438.2007]; Sanchez M, 1996, NEUROPHARMACOLOGY, V35, P963, DOI 10.1016/0028-3908(96)00137-2; Schmitt N, 2014, PHYSIOL REV, V94, P609, DOI 10.1152/physrev.00022.2013; Shintani Y, 2004, J MOL CELL CARDIOL, V37, P1213, DOI 10.1016/j.yjmcc.2004.09.012; Tantini B, 2005, BASIC RES CARDIOL, V100, P131, DOI 10.1007/s00395-004-0504-5; Thebaud B, 2002, PEDIATR RES, V52, P19, DOI 10.1203/00006450-200207000-00006; Wang XY, 2008, J MOL CELL CARDIOL, V44, P105, DOI 10.1016/j.yjmcc.2007.10.006; World Health Organization (WHO), 2013, TOP 10 CAUS DEATH; Xu WH, 2002, SCIENCE, V298, P1029, DOI 10.1126/science.1074360; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667	39	36	36	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144737	10.1371/journal.pone.0144737	http://dx.doi.org/10.1371/journal.pone.0144737			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671662	Green Published, Green Submitted, gold			2022-12-26	WOS:000366719300020
J	Halford, WP; Geltz, J; Messer, RJ; Hasenkrug, KJ				Halford, William P.; Geltz, Joshua; Messer, Ronald J.; Hasenkrug, Kim J.			Antibodies Are Required for Complete Vaccine-Induced Protection against Herpes Simplex Virus 2	PLOS ONE			English	Article							CD8(+) T-CELLS; GENITAL HERPES; ADENOVIRUS VECTORS; TRIGEMINAL GANGLIA; GLYCOPROTEIN-B; SAFETY PROFILE; NERVOUS-SYSTEM; DEFICIENT MICE; CD43 FUNCTIONS; E-SELECTIN	Herpes simplex virus 2 (HSV-2) 0 Delta NLS is a live HSV-2 ICP0(-) mutant vaccine strain that is profoundly attenuated in vivo due to its interferon-hypersensitivity. Recipients of the HSV-2 0.NLS vaccine are resistant to high-dose HSV-2 challenge as evidenced by profound reductions in challenge virus spread, shedding, disease and mortality. In the current study, we investigated the requirements for HSV-2 0 Delta NLS vaccine-induced protection. Studies using (UV)-inactivated HSV-2 0 Delta NLS revealed that self-limited replication of the attenuated virus was required for effective protection from vaginal or ocular HSV-2 challenge. Diminished antibody responses in recipients of the UV-killed HSV-2 vaccine suggested that antibodies might be playing a critical role in early protection. This hypothesis was investigated in B-cell-deficient mu MT mice. Vaccination with live HSV-2 0 Delta NLS induced equivalent CD8(+) T cell responses in wild-type and mu MT mice. Vaccinated mu MT mice shed similar to 40-fold more infectious HSV-2 at 24 hours post-challenge relative to vaccinated wild-type (B-cell(+)) mice, and most vaccinated mu MT mice eventually succumbed to a slowly progressing HSV-2 challenge. Importantly, passive transfer of HSV-2 antiserum restored full protection to HSV-2 0 Delta NLS-vaccinated mu MT mice. The results demonstrate that B cells are required for complete vaccine-induced protection against HSV-2, and indicate that virus-specific antibodies are the dominant mediators of early vaccine-induced protection against HSV-2.	[Halford, William P.; Geltz, Joshua] So Illinois Univ, Sch Med, Dept Microbiol & Immunol, Springfield, IL 62702 USA; [Messer, Ronald J.; Hasenkrug, Kim J.] NIAID, Persistent Viral Dis Lab, Rocky Mt Labs, NIH, Hamilton, MT 59840 USA	Southern Illinois University System; Southern Illinois University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Halford, WP (corresponding author), So Illinois Univ, Sch Med, Dept Microbiol & Immunol, Springfield, IL 62702 USA.	halford@siumed.edu			National Institutes of Health [R21 AI081072]; SIU School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000753, R21AI081072] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SIU School of Medicine; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this study was provided by the National Institutes of Health grant R21 AI081072 and startup funds to William Halford from the SIU School of Medicine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide P, 2007, J INVEST DERMATOL, V127, P1964, DOI 10.1038/sj.jid.5700805; Allen UD, 2014, PAED CHILD HEALT-CAN, V19, P201, DOI 10.1093/pch/19.4.201; Bedoui S, 2009, NAT IMMUNOL, V10, P488, DOI 10.1038/ni.1724; Belshe RB, 2012, NEW ENGL J MED, V366, P34, DOI 10.1056/NEJMoa1103151; Bergmann CC, 2001, J IMMUNOL, V167, P1575, DOI 10.4049/jimmunol.167.3.1575; Butler NS, 2011, CELL HOST MICROBE, V9, P451, DOI 10.1016/j.chom.2011.05.008; Chentoufi AA, 2010, J IMMUNOL, V184, P2561, DOI 10.4049/jimmunol.0902322; Coleman JL, 2013, HUM VACC IMMUNOTHER, V9, P729, DOI 10.4161/hv.23289; Crucian B, 2006, CLIN VACCINE IMMUNOL, V13, P403, DOI 10.1128/CVI.13.3.403-408.2006; Dervillez X, 2013, J IMMUNOL, V191, P5124, DOI 10.4049/jimmunol.1301415; Dervillez X, 2012, FUTURE VIROL, V7, P371, DOI 10.2217/FVL.12.22; Dittmer U, 1999, NAT MED, V5, P189, DOI 10.1038/5550; Divito S, 2006, IMMUNOL RES, V36, P119, DOI 10.1385/IR:36:1:119; Dolan BP, 2011, CELL MOL LIFE SCI, V68, P1481, DOI 10.1007/s00018-011-0656-z; Doll Katherine L, 2013, Methods Mol Biol, V923, P493; Dudley KL, 2000, VIROLOGY, V270, P454, DOI 10.1006/viro.2000.0298; Duley AK, 2012, J IMMUNOL, V189, P2521, DOI 10.4049/jimmunol.1201125; Dunkelberger JR, 2010, MOL IMMUNOL, V47, P2176, DOI 10.1016/j.molimm.2010.05.008; Dutton JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076407; ELLIS WD, 1975, PREP BIOCHEM, V5, P179, DOI 10.1080/00327487508061569; EVERETT RD, 1984, EMBO J, V3, P3135, DOI 10.1002/j.1460-2075.1984.tb02270.x; Everett RD, 2000, BIOESSAYS, V22, P761, DOI 10.1002/1521-1878(200008)22:8<761::AID-BIES10>3.0.CO;2-A; Flagg EW, 2011, PEDIATRICS, V127, pE1, DOI 10.1542/peds.2010-0134; Freeman EE, 2006, AIDS, V20, P73, DOI 10.1097/01.aids.0000198081.09337.a7; Galea SA, 2008, J INFECT DIS, V197, pS165, DOI 10.1086/522125; GEBHARDT BM, 1988, INVEST OPHTH VIS SCI, V29, P1683; Gebhardt T, 2011, NATURE, V477, P216, DOI 10.1038/nature10339; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Geltz JJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116091; Goulleret N, 2010, VACCINE, V28, P5878, DOI 10.1016/j.vaccine.2010.06.056; Halford WP, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-44; Halford WP, 2014, EXPERT REV VACCINES, V13, P691, DOI 10.1586/14760584.2014.910121; Halford WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065523; Halford WP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017748; Halford WP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012251; Halford WP, 2001, J VIROL, V75, P6143, DOI 10.1128/JVI.75.13.6143-6153.2001; Halford WP, 2001, J VIROL, V75, P3240, DOI 10.1128/JVI.75.7.3240-3249.2001; HANKE T, 1991, J VIROL, V65, P1177, DOI 10.1128/JVI.65.3.1177-1186.1991; Harle P, 2002, VIROLOGY, V293, P295, DOI 10.1006/viro.2001.1280; Homann D, 1998, J VIROL, V72, P9208, DOI 10.1128/JVI.72.11.9208-9216.1998; Iijima N, 2014, SCIENCE, V346, P93, DOI 10.1126/science.1257530; Khan AA, 2015, J VIROL, V89, P6619, DOI 10.1128/JVI.00788-15; Khanna KM, 2003, IMMUNITY, V18, P593, DOI 10.1016/S1074-7613(03)00112-2; Koelle DM, 2008, CLIN VACCINE IMMUNOL, V15, P773, DOI 10.1128/CVI.00020-08; Koelle DM, 1998, J CLIN INVEST, V101, P1500, DOI 10.1172/JCI1758; Konno H, 2014, MICROBES INFECT, V16, P998, DOI 10.1016/j.micinf.2014.10.002; Laing KJ, 2012, CLIN EXP IMMUNOL, V167, P47, DOI 10.1111/j.1365-2249.2011.04502.x; Lester SN, 2014, J MOL BIOL, V426, P1246, DOI 10.1016/j.jmb.2013.11.024; Lingappa JR, 2007, DRUGS, V67, P155, DOI 10.2165/00003495-200767020-00001; Liu T, 2000, J EXP MED, V191, P1459, DOI 10.1084/jem.191.9.1459; Looker KJ, 2015, PLOS ONE, V10, DOI [10.1371/journal.pone.0114989, 10.1371/journal.pone.0140765]; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Matsumoto M, 2005, J IMMUNOL, V175, P8042, DOI 10.4049/jimmunol.175.12.8042; Messer RJ, 2004, P NATL ACAD SCI USA, V101, P12260, DOI 10.1073/pnas.0404769101; Mo A, 2011, VACCINE, V29, P8530, DOI 10.1016/j.vaccine.2011.07.011; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; NAGAFUCHI S, 1979, J GEN VIROL, V44, P715, DOI 10.1099/0022-1317-44-3-715; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; OAKES JE, 1975, INFECT IMMUN, V12, P166, DOI 10.1128/IAI.12.1.166-172.1975; Orr MT, 2007, J IMMUNOL, V178, P4731, DOI 10.4049/jimmunol.178.8.4731; PARR MB, 1994, LAB INVEST, V70, P369; Pascual A, 2011, CLIN MICROBIOL INFEC, V17, P1907, DOI 10.1111/j.1469-0691.2011.03641.x; Preacher K. J., 2001, CALCULATION FISHERS; Rai D, 2009, J IMMUNOL, V183, P7672, DOI 10.4049/jimmunol.0902874; Richardus JH, 2013, VACCINE, V31, P6136, DOI 10.1016/j.vaccine.2013.06.081; RIEDMANN EM, 2014, HUM VACC IMMUNOTHER, V10, P255; Rivera A, 2001, INT IMMUNOL, V13, P1583, DOI 10.1093/intimm/13.12.1583; Rupp R, 2008, EXPERT OPIN EMERG DR, V13, P41, DOI 10.1517/14728214.13.1.41 ; Sarma JV, 2011, CELL TISSUE RES, V343, P227, DOI 10.1007/s00441-010-1034-0; Schiffer JT, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00209; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Shlapobersky M, 2012, J GEN VIROL, V93, P1305, DOI 10.1099/vir.0.040055-0; SIMMONS A, 1992, J EXP MED, V175, P1337, DOI 10.1084/jem.175.5.1337; Skoberne M, 2013, J VIROL, V87, P3930, DOI 10.1128/JVI.02745-12; Speck P, 1998, J GEN VIROL, V79, P561, DOI 10.1099/0022-1317-79-3-561; St Leger AJ, 2011, J IMMUNOL, V186, P3927, DOI 10.4049/jimmunol.1003735; Sudfeld CR, 2013, SEX TRANSM INFECT, V89, P561, DOI 10.1136/sextrans-2012-050869; TELLEZ A, 1970, TRANSFUSION, V10, P223, DOI 10.1111/j.1537-2995.1970.tb00733.x; Theil D, 2003, AM J PATHOL, V163, P2179, DOI 10.1016/S0002-9440(10)63575-4; Thompson MR, 2014, J BIOL CHEM, V289, P23568, DOI 10.1074/jbc.M114.554147; Tronstein E, 2011, JAMA-J AM MED ASSOC, V305, P1441, DOI 10.1001/jama.2011.420; Wald A, 1997, J CLIN INVEST, V99, P1092, DOI 10.1172/JCI119237; Wald A, 2011, VACCINE, V29, P8520, DOI 10.1016/j.vaccine.2011.09.046; Yewdell JW, 2001, J CELL SCI, V114, P845; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792	86	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145228	10.1371/journal.pone.0145228	http://dx.doi.org/10.1371/journal.pone.0145228			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670699	Green Published, Green Submitted, gold			2022-12-26	WOS:000366719300053
J	Pegan, TM; Rumelt, RB; Dzielski, SA; Ferraro, MM; Flesher, LE; Young, N; Freeman, AC; Freeman, BG				Pegan, Teresa M.; Rumelt, Reid B.; Dzielski, Sarah A.; Ferraro, Mary Margaret; Flesher, Lauren E.; Young, Nathaniel; Freeman, Alexandra Class; Freeman, Benjamin G.			Asymmetric Response of Costa Rican White-Breasted Wood-Wrens (Henicorhina leucosticta) to Vocalizations from Allopatric Populations	PLOS ONE			English	Article							SPECIES RECOGNITION; TERRITORIAL RESPONSES; SPARROWS RESPOND; SONG; SPECIATION; LIMITS; FEMALE; DIVERGENCE; BIRDS	Divergence in song between allopatric populations can contribute to premating reproductive isolation in territorial birds. Song divergence is typically measured by quantifying divergence in vocal traits using audio recordings, but field playback experiments provide a more direct way to behaviorally measure song divergence between allopatric populations. The White-breasted Wood-Wren (Henicorhina leucosticta; hereafter WBWW) is an abundant Neotropical species with four mitochondrial clades (in Central America, the Darien, the Choco and the Amazon) that are deeply divergent (similar to 5-16% sequence divergence). We assessed the possibility that the WBWWas currently defined may represent multiple biological species by conducting both statistical analysis of vocal characters and field playback experiments within three clades (Central America, Choco and Amazon). Our analysis of vocal traits revealed that Central American songs overlapped in acoustic space with Choco songs, indicating vocal similarity between these two populations, but that Central American songs were largely divergent from Amazonian songs. Playback experiments in the Caribbean lowlands of Costa Rica revealed that Central American WBWWs typically responded aggressively to songs from the Choco population but did not respond to playback of songs from the Amazonian population, echoing the results of the vocal trait analysis. This marked difference in behavioral response demonstrates that the songs of Central American and Amazonian WBWWs (but not Central American and Choco WBWWs) have diverged sufficiently that Central American WBWWs no longer recognize song from Amazonian WBWWs as a signal to elicit territorial defense. This suggests that significant premating reproductive isolation has evolved between these two populations, at least from the perspective of the Central American population, and is consistent with the possibility that Central American and Amazonian populations represent distinct biological species. We conclude by advocating for the further use of field playback experiments to assess premating reproductive isolation (and species limits) between allopatric songbird populations, a situation where behavioral systematics can answer questions that phylogenetic systematics cannot.	[Pegan, Teresa M.; Dzielski, Sarah A.; Ferraro, Mary Margaret; Flesher, Lauren E.; Young, Nathaniel; Freeman, Benjamin G.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA; [Freeman, Alexandra Class; Freeman, Benjamin G.] Cornell Lab Ornithol, Ithaca, NY USA	Cornell University; Cornell University	Freeman, BG (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14850 USA.	bgf27@cornell.edu	Pegan, Teresa/AAF-8612-2021		National Science Foundation [2011083591]; Cornell Lab of Ornithology	National Science Foundation(National Science Foundation (NSF)); Cornell Lab of Ornithology	This work was funded by National Science Foundation Graduate Research Fellowship Grant 2011083591 to BGF (http://www.nsf.gov), and Cornell Lab of Ornithology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank La Selva staff, particularly K. A. Gonzalez, for facilitating field research, Macaulay Library staff for providing song recordings, and I. Lovette, J. Fitzpatrick and the Lab of Ornithology for supporting the field course during which we conducted playback experiments. D. Toews and two anonymous reviewers provided valuable comments. This material is based upon work supported by the National Science Foundation Graduate Research Fellowship under Grant No. 2011083591.	Aguilar C, 2016, MITOCHONDRIAL DNA A, V27, P956, DOI 10.3109/19401736.2014.926503; Areta JI, 2013, CONDOR, V115, P131, DOI 10.1525/cond.2012.120039; Barraclough TG, 2000, AM NAT, V155, P419, DOI 10.1086/303332; Benites P, 2015, J AVIAN BIOL, V46, P55, DOI 10.1111/jav.00447; BirdLife International & NatureServe, 2014, BIRD SPEC DISTR MAPS; Block NL, 2015, ECOL EVOL, V5, P3743, DOI 10.1002/ece3.1639; Boyle WA, 2015, BIOL CONSERV, V188, P11, DOI 10.1016/j.biocon.2015.01.004; Brewer D., 2001, WRENS DIPPERS THRASH; Chaves JC, 2010, CONDOR, V112, P718, DOI 10.1525/cond.2010.100098; Class AM, 2011, CONDOR, V113, P438, DOI 10.1525/cond.2011.100068; Colbeck GJ, 2010, ANIM BEHAV, V80, P311, DOI 10.1016/j.anbehav.2010.05.013; Coyne J.A., 2004, SPECIATION; Cure C, 2012, ANIM BEHAV, V84, DOI 10.1016/j.anbehav.2012.04.039; Danner JE, 2011, AM NAT, V178, P53, DOI 10.1086/660283; Dingle C, 2006, AUK, V123, P119, DOI 10.1642/0004-8038(2006)123[0119:EZATPR]2.0.CO;2; Lara CE, 2012, AUK, V129, P537, DOI 10.1525/auk.2012.12028; Vargas LE, 2011, J TROP ECOL, V27, P65, DOI 10.1017/S026646741000060X; Feo TJ, 2015, AUK, V132, P248, DOI 10.1642/AUK-14-108.1; Flesher L, 2015, NEOTROPICAL BIRDS ON; Gill FB, 2014, AUK, V131, P150, DOI 10.1642/AUK-13-206.1; Hudson EJ, 2014, J HERED, V105, P821, DOI 10.1093/jhered/esu041; Irwin DE, 2001, IBIS, V143, P233, DOI 10.1111/j.1474-919X.2001.tb04479.x; Isler ML, 1998, AUK, V115, P577, DOI 10.2307/4089407; Jankowski JE, 2010, ECOLOGY, V91, P1877, DOI 10.1890/09-2063.1; Lelevier M, 2008, THESIS; Mason NA, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0967; McEntee JP, 2014, BEHAV ECOL, V25, P1380, DOI 10.1093/beheco/aru136; Mortega KG, 2014, FRONT ZOOL, V11, DOI 10.1186/s12983-014-0085-6; Nelson DA, 2004, BEHAVIOUR, V141, P53, DOI 10.1163/156853904772746600; Pigot AL, 2013, ECOL LETT, V16, P330, DOI 10.1111/ele.12043; PRESCOTT DRC, 1987, WILSON BULL, V99, P611; Price T, 2008, SPECIATION BIRDS; R Development Core Team, 2014, R LANG ENV STAT COMP; Reif J, 2015, ANIM BEHAV, V104, P131, DOI 10.1016/j.anbehav.2015.03.016; SEARCY WA, 1990, ANIM BEHAV, V40, P1119, DOI 10.1016/S0003-3472(05)80178-2; SEARCY WA, 1988, NATURE, V332, P152, DOI 10.1038/332152a0; Seddon N, 2010, P ROY SOC B-BIOL SCI, V277, P2475, DOI 10.1098/rspb.2010.0210; Slabbekoorn H, 2002, PHILOS T R SOC B, V357, P493, DOI 10.1098/rstb.2001.1056; Sosa-Lopez JR, 2014, AUK, V131, P41, DOI 10.1642/AUK-13-161.1; Stouffer PC, 2013, AUK, V130, P529, DOI 10.1525/auk.2013.12179; Stutchbury B.J.M., 2001, BEHAV ECOLOGY TROPIC; The Cornell Lab of Ornithology, 2014, BIOAC RES PROGR RAV; Tobias JA, 2010, IBIS, V152, P724, DOI 10.1111/j.1474-919X.2010.01051.x; Toews DPL, 2008, MOL ECOL, V17, P2691, DOI 10.1111/j.1365-294X.2008.03769.x; Toews DPL, 2015, AUK, V132, P78, DOI 10.1642/AUK-14-138.1; Uy JAC, 2009, EVOLUTION, V63, P153, DOI 10.1111/j.1558-5646.2008.00530.x; Weir JT, 2007, SCIENCE, V315, P1574, DOI 10.1126/science.1135590; Weir JT, 2011, AM NAT, V177, P462, DOI 10.1086/658910	48	11	12	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144949	10.1371/journal.pone.0144949	http://dx.doi.org/10.1371/journal.pone.0144949			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671001	gold, Green Submitted, Green Published			2022-12-26	WOS:000366719300035
J	Paula, DP; Souza, LM; Andow, DA				Paula, Debora P.; Souza, Lucas M.; Andow, David A.			Sequestration and Transfer of Cry Entomotoxin to the Eggs of a Predaceous Ladybird Beetle	PLOS ONE			English	Article							BT RICE; PYRROLIZIDINE ALKALOIDS; ARTHROPOD PREDATORS; TOXIN; EXPOSURE; PLANTS; MAIZE	In the past 10 years, sequestration of Cry toxins and transfer to offspring has been indicated in three insect species in laboratory studies. This work directly demonstrates the sequestration and intergenerational transfer of Cry1F by the parents of the aphidophagous coccinellid predator, Harmonia axyridis, to its offspring. Recently emerged adults (10 individual couples/cage/treatment) were exposed during 20 days to aphids (100 Myzus persicae each day) that fed on a holidic diet containing 20 mu g/mL Cry1F (and a control-group). Egg batches and neonate larvae were monitored daily, and counted and weighed for immunodetection of Cry1F by ELISA. At the end of the bioassay, the parents were weighed and analyzed by ELISA. Cry1F was detected in the offspring, both eggs and neonate larvae, of exposed H. axyridis adults. On average the neonate larvae had 60% of the Cry1F concentration of the eggs from the same egg batch. The Cry1F concentration in the adults was positively correlated with the concentration in their eggs. These three results provided independent evidence of transfer to offspring. No detrimental effects of Cry1F were observed on the age of first reproduction, total number of eggs laid per female, age-specific fecundity, egg development time, hatching rate, or fertility rate. The occurrence and generality of intergenerational transfer of Cry toxins should be investigated in the field to determine its potential ecological implications.	[Paula, Debora P.; Souza, Lucas M.] Embrapa Genet Resources & Biotechnol, BR-70770917 Brasilia, DF, Brazil; [Andow, David A.] Univ Minnesota, Dept Entomol, St Paul, MN 55108 USA	Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of Minnesota System; University of Minnesota Twin Cities	Paula, DP (corresponding author), Embrapa Genet Resources & Biotechnol, Parque Estacao Biol,W5 Norte,POB 02372, BR-70770917 Brasilia, DF, Brazil.	debora.pires@embrapa.br	de Souza, Lucas Machado/J-8621-2012	Machado de Souza, Lucas/0000-0001-8589-9534	USDA Regional Research Project [NC205]	USDA Regional Research Project	The work was supported by USDA Regional Research Project NC205. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, SAS 9 4 TS LEV 1M2 X; Arpaia S, 2010, COLLECTION BIOSAFETY, V5, P2; BENN M, 1979, EXPERIENTIA, V35, P731, DOI 10.1007/BF01968208; Carey JR, 2001, ANNU REV ENTOMOL, V46, P79, DOI 10.1146/annurev.ento.46.1.79; Chen M, 2009, ECOTOXICOLOGY, V18, P230, DOI 10.1007/s10646-008-0276-z; DADD RH, 1966, EXPERIENTIA, V22, P832, DOI 10.1007/BF01897447; Douglas AE, 2007, APHIDS AS CROP PESTS, P115, DOI 10.1079/9780851998190.0115; DUFFEY SS, 1980, ANNU REV ENTOMOL, V25, P447, DOI 10.1146/annurev.en.25.010180.002311; Gao MQ, 2010, ENVIRON ENTOMOL, V39, P2039, DOI 10.1603/EN10035; Harwood JD, 2005, MOL ECOL, V14, P2815, DOI 10.1111/j.1365-294X.2005.02611.x; James C., 2014, GLOBAL STATUS COMMER; Koch RL, 2003, J INSECT SCI, V3, DOI 10.1093/jis/3.1.32; Lovei GL, 2009, ENVIRON ENTOMOL, V38, P293, DOI 10.1603/022.038.0201; Nakasu EYT, 2013, ENTOMOL EXP APPL, V148, P105, DOI 10.1111/eea.12082; Obrist LB, 2006, ECOL ENTOMOL, V31, P143, DOI 10.1111/j.0307-6946.2006.00762.x; Paula D.P., 2015, ENTOMOL EXP IN PRESS; Paula DP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095422; Paula DP, 2015, ENVIRON POLLUT; Reudler Talsma JH, 2007, THESIS; ROTHSCHILD M, 1973, J ENTOMOL SER A, V48, P89; Siebert MW, 2009, J ECON ENTOMOL, V102, P1301, DOI 10.1603/029.102.0357; Stephens EJ, 2012, AGR ECOSYST ENVIRON, V156, P72, DOI 10.1016/j.agee.2012.05.002; Torres JB, 2006, AGR FOREST ENTOMOL, V8, P191, DOI 10.1111/j.1461-9563.2006.00298.x; USEPA, 2013, HLTH EFF GLOSS GLOSS; WITTE L, 1990, NATURWISSENSCHAFTEN, V77, P540, DOI 10.1007/BF01139268; Yu HG, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0093710, 10.1371/journal.pone.0103973]; Zhang GF, 2006, ENVIRON ENTOMOL, V35, P143, DOI 10.1603/0046-225X-35.1.143; Zhang Qing-ling, 2013, Yingyong Shengtai Xuebao, V24, P1647; Zwahlen Claudia, 2005, Environmental Biosafety Research, V4, P113, DOI 10.1051/ebr:2005014	29	5	5	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144895	10.1371/journal.pone.0144895	http://dx.doi.org/10.1371/journal.pone.0144895			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26661738	Green Published, gold, Green Submitted			2022-12-26	WOS:000366715900140
J	Zavalkoff, S; Korah, N; Quach, C				Zavalkoff, Samara; Korah, Nadine; Quach, Caroline			Presence of a Physician Safety Champion Is Associated with a Reduction in Urinary Catheter Utilization in the Pediatric Intensive Care Unit	PLOS ONE			English	Article							CLINICAL-PRACTICE; SURVEILLANCE; PREVENTION	Background Safety champions are effective in a variety of safety initiatives; however, there are no reports of their role in hospital-acquired infections prevention. Objective We aimed to describe the association of the presence of a physician safety champion with our urinary catheter device utilization ratios (DUR) in the Pediatric Intensive Care Unit (PICU). Methods Our PICU has incidence rates of catheter-associated urinary tract infections (CAUTI) and urinary catheter DUR above the 90th percentile. Using a quasi-experimental design, we compared our DUR when the PICU team was exposed and unexposed (champion's maternity leaves) to a physician safety champion. Hospital acquired infection (HAI) surveillance of all PICU admissions between April 1st 2009 and June 29th 2013 was done prospectively. To ensure stable acuity of the patient population over time, we used the central venous catheter (CVC) DUR as a control. Results The urinary catheter DUR was 0.44 (95% confidence interval [CI] 0.42-0.45) during the unexposed period versus 0.39 (95% CI 0.38-0.40) during the exposed period, for an absolute difference of 0.05 (95% CI 0.03-0.06; p<0.0001). The overall CVC DUR increased from 0.57 (95% CI 0.55-0.58) during the unexposed period to 0.63 (95% CI 0.61-0.64) during the exposed period, an absolute increase of 0.06 (95% CI 0.04-0.08; p<0.0001). Comparing the exposed and unexposed periods, adjusting for time trend, we observed a 17% decrease in the urinary catheter DUR when the safety champion was present (odds ratio [OR] 0.83; 95% CI 0.77-0.90). The rate of catheter-associated urinary tract infections did not change. Conclusions The presence of a unit-based safety champion can have a positive impact on urinary catheter DUR in a PICU.	[Zavalkoff, Samara] McGill Univ, Montreal Childrens Hosp, Dept Pediat, Div Crit Care,Hlth Ctr, Montreal, PQ H3H 1P3, Canada; [Korah, Nadine] McGill Univ, Montreal Childrens Hosp, Dept Pediat, Div Gen Pediat,Hlth Ctr, Montreal, PQ H3H 1P3, Canada; [Quach, Caroline] McGill Univ, Montreal Childrens Hosp, Dept Pediat, Infect Control,Hlth Ctr, Montreal, PQ H3H 1P3, Canada; [Quach, Caroline] McGill Univ, Dept Pediat, Div Infect Dis, Montreal, PQ H3A 2T5, Canada; [Quach, Caroline] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada	McGill University; McGill University; McGill University; McGill University; McGill University	Zavalkoff, S (corresponding author), McGill Univ, Montreal Childrens Hosp, Dept Pediat, Div Crit Care,Hlth Ctr, Montreal, PQ H3H 1P3, Canada.	samara.zavalkoff@mcgill.ca	Quach, Caroline/AAT-6987-2021	Quach, Caroline/0000-0002-1170-9475				Ash JS, 2003, INT J MED INFORM, V69, P235, DOI 10.1016/S1386-5056(02)00107-7; Campbell J, 2008, CRIT CARE NURS Q, V31, P251, DOI 10.1097/01.CNQ.0000325050.91473.0b; Dodek P, 2004, ANN INTERN MED, V141, P305, DOI 10.7326/0003-4819-141-4-200408170-00011; Dopson S, 2002, HEALTH CARE MANAGE R, V27, P35, DOI 10.1097/00004010-200207000-00005; Doumit G, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000125.pub3; Dudeck MA, 2013, AM J INFECT CONTROL, V41, P286, DOI 10.1016/j.ajic.2013.01.002; Frank JR, 2008, SAFETY COMPETENCIES; Graham ID, 2002, CAN J SURG, V45, P132; Grenny J, 2008, INFLUENCER POWER CHA; Hendy J, 2012, SOC SCI MED, V74, P348, DOI 10.1016/j.socscimed.2011.02.009; Horan TC, 1997, AM J INFECT CONTROL, V25, P112, DOI 10.1016/S0196-6553(97)90037-7; Horan TC, 1997, AM J INFECT CONTROL, V25, P73, DOI 10.1016/S0196-6553(97)90031-6; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Horan TC, 2011, INFECT CONT HOSP EP, V32, P1143, DOI 10.1086/662588; Klevens RM, 2002, PUBLIC HLTH REP, V122, P160; Kohn LT, 2000, ERR IS HUMAN BUILDIN; Lo E, 2014, INFECT CONT HOSP EP, V35, pS32, DOI DOI 10.1086/675718; Maher L, 2010, SUSTAINABILITY MODEL; Muething SE, 2012, PEDIATRICS, V130, pE423, DOI 10.1542/peds.2011-3566; Pittet D, 2000, LANCET, V356, P1307, DOI 10.1016/S0140-6736(00)02814-2; Quach C, 2014, INFECT CONT HOSP EP, V35, P158, DOI 10.1086/674862; Shaw EK, 2012, J AM BOARD FAM MED, V25, P676, DOI 10.3122/jabfm.2012.05.110281; Solomon DH, 1998, JAMA-J AM MED ASSOC, V280, P2020, DOI 10.1001/jama.280.23.2020; Soo Stephanie, 2009, Healthc Q, V12 Spec No Patient, P123; Thompson GN, 2006, J ADV NURS, V53, P691, DOI 10.1111/j.1365-2648.2006.03775.x; Weingart SN, 2009, J NURS CARE QUAL, V24, P203, DOI 10.1097/NCQ.0b013e318195168d	26	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144222	10.1371/journal.pone.0144222	http://dx.doi.org/10.1371/journal.pone.0144222			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26666216	Green Published, gold			2022-12-26	WOS:000366715900033
J	Ren, JQ; Huo, L; Wang, WJ; Zhang, Y; Li, W; Lou, JZ; Xu, T; Feng, W				Ren, Jinqi; Huo, Lin; Wang, Wenjuan; Zhang, Yong; Li, Wei; Lou, Jizhong; Xu, Tao; Feng, Wei			Structural Correlation of the Neck Coil with the Coiled-coil (CC1)-Forkhead-associated (FHA) Tandem for Active Kinesin-3 KIF13A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						intracellular trafficking; kinesin; molecular motor; structural biology; x-ray crystallography; KIF13A; neck coil	MOLECULAR-DYNAMICS; MOTOR PROTEIN; DOMAIN; DIMERIZATION; BINDING; CONFORMATIONS; PROCESSIVITY; TRANSPORT; MOTILITY; STRAIN	Processive kinesin motors often contain a coiled-coil neck that controls the directionality and processivity. However, the neck coil (NC) of kinesin-3 is too short to form a stable coiled-coil dimer. Here, we found that the coiled-coil (CC1)-forkhead-associated (FHA) tandem (that is connected to NC by Pro-390) of kinesin-3 KIF13A assembles as an extended dimer. With the removal of Pro-390, the NC-CC1 tandem of KIF13A unexpectedly forms a continuous coiled-coil dimer that can be well aligned into the CC1-FHA dimer. The reverse introduction of Pro-390 breaks the NC-CC1 coiled-coil dimer but provides the intrinsic flexibility to couple NC with the CC1-FHA tandem. Mutations of either NC, CC1, or the FHA domain all significantly impaired the motor activity. Thus, the three elements within the NC-CC1-FHA tandem of KIF13A are structurally interrelated to form a stable dimer for activating the motor. This work also provides the first direct structural evidence to support the formation of a coiled-coil neck by the short characteristic neck domain of kinesin-3.	[Ren, Jinqi; Huo, Lin; Wang, Wenjuan; Li, Wei; Xu, Tao; Feng, Wei] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China; [Zhang, Yong; Lou, Jizhong] Chinese Acad Sci, Inst Biophys, Key Lab RNA Biol, 15 Datun Rd, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Feng, W (corresponding author), Chinese Acad Sci, Inst Biophys, 15 Datun Rd, Beijing 100101, Peoples R China.	wfeng@ibp.ac.cn	Li, Wei/AAI-3871-2020	Ren, Jinqi/0000-0002-5109-2828	National Major Basic Research Program of China [2011CB910503, 2014CB910202]; National Natural Science Foundation of China [31300611, 31190062, 31470746, 31200577]	National Major Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Major Basic Research Program of China Grants 2011CB910503 and 2014CB910202 and National Natural Science Foundation of China Grants 31300611, 31190062, 31470746, and 31200577. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Al-Bassam J, 2003, J CELL BIOL, V163, P743, DOI 10.1083/jcb.200308020; Asenjo AB, 2006, NAT STRUCT MOL BIOL, V13, P648, DOI 10.1038/nsmb1109; Atherton J, 2014, ELIFE, V3, DOI 10.7554/eLife.03680; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Brown JH, 1996, PROTEINS, V26, P134; Crevenna AH, 2008, BIOPHYS J, V95, P5216, DOI 10.1529/biophysj.108.132449; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endow SA, 1999, NAT CELL BIOL, V1, pE163, DOI 10.1038/14113; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Grummt M, 1998, EMBO J, V17, P5536, DOI 10.1093/emboj/17.19.5536; Hammond JW, 2009, PLOS BIOL, V7, P650, DOI 10.1371/journal.pbio.1000072; Hirokawa N, 2010, NEURON, V68, P610, DOI 10.1016/j.neuron.2010.09.039; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Huckaba TM, 2011, J BIOL CHEM, V286, P7457, DOI 10.1074/jbc.M110.167023; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huo L, 2012, STRUCTURE, V20, P1550, DOI 10.1016/j.str.2012.07.002; Jaud J, 2006, BIOPHYS J, V91, P1407, DOI 10.1529/biophysj.105.076265; Kozielski F, 1997, CELL, V91, P985, DOI 10.1016/S0092-8674(00)80489-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liang XY, 2008, ACCOUNTS CHEM RES, V41, P991, DOI 10.1021/ar700148u; Liu B, 2014, PROG BIOCHEM BIOPHYS, V41, P870, DOI 10.3724/SP.J.1206.2014.00073; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mahajan A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.151re12; Martin DS, 2010, P NATL ACAD SCI USA, V107, P5453, DOI 10.1073/pnas.0914924107; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Miyazono Y, 2010, EMBO J, V29, P93, DOI 10.1038/emboj.2009.319; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rashid DJ, 2005, J PEPT RES, V65, P538, DOI 10.1111/j.1399-3011.2005.00255.x; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Shastry S, 2011, P NATL ACAD SCI USA, V108, P16253, DOI 10.1073/pnas.1102628108; Sindelar CV, 2002, NAT STRUCT BIOL, V9, P844, DOI 10.1038/nsb852; Soldati T, 2006, NAT REV MOL CELL BIO, V7, P897, DOI 10.1038/nrm2060; Soppina V, 2014, P NATL ACAD SCI USA, V111, P5562, DOI 10.1073/pnas.1400759111; Thormahlen M, 1998, J STRUCT BIOL, V122, P30, DOI 10.1006/jsbi.1998.3986; Tomishige M, 2002, SCIENCE, V297, P2263, DOI 10.1126/science.1073386; Tong YF, 2010, P NATL ACAD SCI USA, V107, P20346, DOI 10.1073/pnas.1009008107; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Vale RD, 1997, ANNU REV CELL DEV BI, V13, P745, DOI 10.1146/annurev.cellbio.13.1.745; Vale RD, 2000, PHILOS T ROY SOC B, V355, P449, DOI 10.1098/rstb.2000.0586; Verhey KJ, 2011, ANNU REV BIOPHYS, V40, P267, DOI 10.1146/annurev-biophys-042910-155310; Woehlke G, 2000, NAT REV MOL CELL BIO, V1, P50, DOI 10.1038/35036069; Yildiz A, 2008, CELL, V134, P1030, DOI 10.1016/j.cell.2008.07.018	47	8	9	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3581	3594		10.1074/jbc.M115.689091	http://dx.doi.org/10.1074/jbc.M115.689091			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26680000	Green Published, hybrid			2022-12-26	WOS:000370854500037
J	Takegahara, N; Kim, H; Mizuno, H; Sakaue-Sawano, A; Miyawaki, A; Tomura, M; Kanagawa, O; Ishii, M; Choi, Y				Takegahara, Noriko; Kim, Hyunsoo; Mizuno, Hiroki; Sakaue-Sawano, Asako; Miyawaki, Atsushi; Tomura, Michio; Kanagawa, Osami; Ishii, Masaru; Choi, Yongwon			Involvement of Receptor Activator of Nuclear Factor-B Ligand (RANKL)-induced Incomplete Cytokinesis in the Polyploidization of Osteoclasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell biology; cell division; cell proliferation; flow cytometry; imaging; osteoclast; incomplete cytokinesis; polyploidy	CELL-CELL FUSION; CYCLE; DIFFERENTIATION; ENDOREPLICATION; PRECURSORS; IDENTIFICATION	Osteoclasts are specialized polyploid cells that resorb bone. Upon stimulation with receptor activator of nuclear factor-B ligand (RANKL), myeloid precursors commit to becoming polyploid, largely via cell fusion. Polyploidization of osteoclasts is necessary for their bone-resorbing activity, but the mechanisms by which polyploidization is controlled remain to be determined. Here, we demonstrated that in addition to cell fusion, incomplete cytokinesis also plays a role in osteoclast polyploidization. In in vitro cultured osteoclasts derived from mice expressing the fluorescent ubiquitin-based cell cycle indicator (Fucci), RANKL induced polyploidy by incomplete cytokinesis as well as cell fusion. Polyploid cells generated by incomplete cytokinesis had the potential to subsequently undergo cell fusion. Nuclear polyploidy was also observed in osteoclasts in vivo, suggesting the involvement of incomplete cytokinesis in physiological polyploidization. Furthermore, RANKL-induced incomplete cytokinesis was reduced by inhibition of Akt, resulting in impaired multinucleated osteoclast formation. Taken together, these results reveal that RANKL-induced incomplete cytokinesis contributes to polyploidization of osteoclasts via Akt activation.	[Takegahara, Noriko] Osaka Univ, WPI Immunol Frontier Res Ctr, Next Generat Opt Immune imaging, Suita, Osaka 5650871, Japan; [Takegahara, Noriko; Kim, Hyunsoo; Choi, Yongwon] Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA; [Mizuno, Hiroki; Ishii, Masaru] Osaka Univ, Grad Sch Med & Frontier Biosci, Dept Immunol & Cell Biol, WPI Immunol Frontier Res Ctr, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan; [Mizuno, Hiroki; Ishii, Masaru] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, 5 Sanban Cho, Tokyo 1020075, Japan; [Sakaue-Sawano, Asako; Miyawaki, Atsushi] RIKEN, Brain Sci Inst, Adv Technol Dev Grp, Lab Cell Funct & Dynam, Wako, Saitama 3510198, Japan; [Tomura, Michio] RIKEN, Lab Autoimmune Regulat, Res Ctr Allergy & Immunol, Yokohama, Kanagawa 2300045, Japan; [Tomura, Michio] Osaka Ohtani Univ, Immunol Lab, Fac Pharm, 3-11-1 Nishikiorikita, Tondabayashi, Osaka 5848540, Japan; [Kanagawa, Osami] Univ Tokyo, Grad Sch Med, Dept Mol Prevent Med, Bunkyo Ku, 7-3-1 Hongo, Tokyo 113033, Japan	Osaka University; University of Pennsylvania; Pennsylvania Medicine; Osaka University; Japan Science & Technology Agency (JST); RIKEN; RIKEN; University of Tokyo	Choi, Y (corresponding author), Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA 19104 USA.; Takegahara, N (corresponding author), Osaka Univ, Suita, Osaka 5650871, Japan.	takegaharanor@gmail.com; ychoi3@mail.med.upenn.edu	Kim, Hyunsoo/AAP-1689-2021; Miyawaki, Atsushi/K-3569-2014; Takegahara, Noriko/AAP-1694-2021	Miyawaki, Atsushi/0000-0002-2329-3235; Sakaue-Sawano, Asako/0000-0002-6975-0390	Uehara Memorial Foundation; Nakatomi Foundation; Tomizawa Jun-ichi and Keiko Fund of the Molecular Biology Society of Japan for Young Scientists; Takeda Science Foundation; National Institutes of Health [AR055903, AR067726]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055903, R01AR067726] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15H01156] Funding Source: KAKEN	Uehara Memorial Foundation(Uehara Memorial Foundation); Nakatomi Foundation; Tomizawa Jun-ichi and Keiko Fund of the Molecular Biology Society of Japan for Young Scientists; Takeda Science Foundation(Takeda Science Foundation (TSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Uehara Memorial Foundation, the Nakatomi Foundation, Tomizawa Jun-ichi and Keiko Fund of the Molecular Biology Society of Japan for Young Scientists, the Pharma-link between Academia and Shionogi, the Takeda Science Foundation (to N. T.), and in part by National Institutes of Health Grants AR055903 and AR067726 (to Y. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe T, 2013, DEVELOPMENT, V140, P237, DOI 10.1242/dev.084111; Abu-Amer Y, 2008, AUTOIMMUNITY, V41, P204, DOI 10.1080/08916930701694543; Aguilar PS, 2013, TRENDS GENET, V29, P427, DOI 10.1016/j.tig.2013.01.011; Aiba Y, 2010, P NATL ACAD SCI USA, V107, P12192, DOI 10.1073/pnas.1005443107; Brodbeck WG, 2009, CURR OPIN HEMATOL, V16, P53, DOI 10.1097/MOH.0b013e32831ac52e; Celton-Morizur S, 2009, J CLIN INVEST, V119, P1880, DOI 10.1172/JCI38677; Comai L, 2005, NAT REV GENET, V6, P836, DOI 10.1038/nrg1711; Edgar BA, 2014, NAT REV MOL CELL BIO, V15, P197, DOI 10.1038/nrm3756; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Fox DT, 2013, DEVELOPMENT, V140, P3, DOI 10.1242/dev.080531; Gentric G, 2012, CLIN RES HEPATOL GAS, V36, P29, DOI 10.1016/j.clinre.2011.05.011; Gentric G, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/282430; Glotzer M, 2005, SCIENCE, V307, P1735, DOI 10.1126/science.1096896; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Greenblatt MB, 2015, J EXP MED, V212, P1283, DOI 10.1084/jem.20150407; Hixon ML, 2000, J CLIN INVEST, V106, P1011, DOI 10.1172/JCI8252; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; Jacome-Galarza CE, 2013, J BONE MINER RES, V28, P1203, DOI 10.1002/jbmr.1822; Kikuta J, 2013, J CLIN INVEST, V123, P866, DOI 10.1172/JCI65054; Kim NS, 2006, MOL CELL BIOL, V26, P1002, DOI 10.1128/MCB.26.3.1002-1013.2006; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Leevers SJ, 2005, CURR OPIN CELL BIOL, V17, P604, DOI 10.1016/j.ceb.2005.09.008; Machlus KR, 2013, J CELL BIOL, V201, P785, DOI 10.1083/jcb.201304054; Meiyanto E, 2001, BIOCHEM BIOPH RES CO, V282, P278, DOI 10.1006/bbrc.2001.4564; Miyamoto H, 2012, J BONE MINER RES, V27, P1289, DOI 10.1002/jbmr.1575; Mizoguchi T, 2009, J CELL BIOL, V184, P541, DOI 10.1083/jcb.200806139; Moon JB, 2012, J IMMUNOL, V188, P163, DOI 10.4049/jimmunol.1101254; Oikawa T, 2012, J CELL BIOL, V197, P553, DOI 10.1083/jcb.201111116; Oren-Suissa M, 2007, TRENDS CELL BIOL, V17, P537, DOI 10.1016/j.tcb.2007.09.004; Otto SP, 2007, CELL, V131, P452, DOI 10.1016/j.cell.2007.10.022; Pandit SK, 2013, TRENDS CELL BIOL, V23, P556, DOI 10.1016/j.tcb.2013.06.002; Peng QS, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000500; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sakaue-Sawano A, 2013, DEVELOPMENT, V140, P4624, DOI 10.1242/dev.099226; Sankar U, 2004, J BONE MINER RES, V19, P1339, DOI 10.1359/JBMR.040321; Scimeca JC, 2000, BONE, V26, P207, DOI 10.1016/S8756-3282(99)00278-1; Srinivas BP, 2007, NAT GENET, V39, P781, DOI 10.1038/ng2055; Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276; TAKAHASHI N, 1994, DEV BIOL, V163, P212, DOI 10.1006/dbio.1994.1137; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Tomura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073801; Vignery A, 2005, TRENDS CELL BIOL, V15, P188, DOI 10.1016/j.tcb.2005.02.008; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yamaguchi H, 2011, J CELL BIOL, V193, P1275, DOI 10.1083/jcb.201009126	47	19	21	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3439	3454		10.1074/jbc.M115.677427	http://dx.doi.org/10.1074/jbc.M115.677427			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26670608	hybrid, Green Published			2022-12-26	WOS:000370854500026
J	Zhang, YF; French, SL; Beyer, AL; Schneider, DA				Zhang, Yinfeng; French, Sarah L.; Beyer, Ann L.; Schneider, David A.			The Transcription Factor THO Promotes Transcription Initiation and Elongation by RNA Polymerase I	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; MOLECULAR EVIDENCE; YEAST GENE; COMPLEX; HPR1; EXPORT; RDNA; CELLS; SPT5; RECOMBINATION	Although ribosomal RNA represents the majority of cellular RNA, and ribosome synthesis is closely connected to cell growth and proliferation rates, a complete understanding of the factors that influence transcription of ribosomal DNA is lacking. Here, we show that the THO complex positively affects transcription by RNA polymerase I (Pol I). We found that THO physically associates with the rDNA repeat and interacts genetically with Pol I transcription initiation factors. Pol I transcription in hpr1 or tho2 null mutants is dramatically reduced to less than 20% of the WT level. Pol I occupancy of the coding region of the rDNA in THO mutants is decreased to similar to 50% of WT level. Furthermore, although the percentage of active rDNA repeats remains unaffected in the mutant cells, the overall rDNA copy number increases similar to 2-fold compared with WT. Together, these data show that perturbation of THO function impairs transcription initiation and elongation by Pol I, identifying a new cellular target for the conserved THO complex.	[Zhang, Yinfeng; Schneider, David A.] Univ Alabama Birmingham, Dept Biochem & Mol Human Genet, Kaul Human Genet Bldg,Rm 442,720 20th St S, Birmingham, AL 35294 USA; [French, Sarah L.; Beyer, Ann L.] Univ Virginia, Dept Microbiol, Charlottesville, VA 22908 USA	University of Alabama System; University of Alabama Birmingham; University of Virginia	Schneider, DA (corresponding author), Univ Alabama Birmingham, Dept Biochem & Mol Human Genet, Kaul Human Genet Bldg,Rm 442,720 20th St S, Birmingham, AL 35294 USA.	dschneid@uab.edu		Schneider, David/0000-0003-0635-5091	National Institutes of Health [GM063952, GM084946]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063952, R01GM084946] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants GM063952 (to A. L. B.) and GM084946 (to D. A. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AGUILERA A, 1990, MOL CELL BIOL, V10, P1439, DOI 10.1128/MCB.10.4.1439; Anderson SJ, 2011, J BIOL CHEM, V286, P18816, DOI 10.1074/jbc.M110.202101; Bryk M, 2002, CURR BIOL, V12, P165, DOI 10.1016/S0960-9822(01)00652-2; Chang MP, 1999, MOL CELL BIOL, V19, P1056; Chavez S, 2000, EMBO J, V19, P5824, DOI 10.1093/emboj/19.21.5824; Chavez S, 1997, GENE DEV, V11, P3459, DOI 10.1101/gad.11.24.3459; Chavez S, 2001, MOL CELL BIOL, V21, P7054, DOI 10.1128/MCB.21.20.7054-7064.2001; Cioci F, 2003, MOL CELL, V12, P135, DOI 10.1016/S1097-2765(03)00262-4; Claypool JA, 2004, MOL BIOL CELL, V15, P946, DOI 10.1091/mbc.E03-08-0594; Dominguez-Sanchez MS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002386; Dominguez-Sanchez MS, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-77; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; El Hage A, 2010, GENE DEV, V24, P1546, DOI 10.1101/gad.573310; French SL, 2003, MOL CELL BIOL, V23, P1558, DOI 10.1128/MCB.23.5.1558-1568.2003; Gomez-Gonzalez B, 2011, EMBO J, V30, P3106, DOI 10.1038/emboj.2011.206; Gwizdek C, 2006, P NATL ACAD SCI USA, V103, P16376, DOI 10.1073/pnas.0607941103; Hartzog GA, 1998, GENE DEV, V12, P357, DOI 10.1101/gad.12.3.357; Hobeika M, 2007, MOL BIOL CELL, V18, P2561, DOI 10.1091/mbc.E07-02-0153; Huertas P, 2003, MOL CELL, V12, P711, DOI 10.1016/j.molcel.2003.08.010; Jimeno S, 2002, EMBO J, V21, P3526, DOI 10.1093/emboj/cdf335; Kim YH, 2006, NUCLEIC ACIDS RES, V34, P2914, DOI 10.1093/nar/gkl293; Li YL, 2007, CANCER RES, V67, P6657, DOI 10.1158/0008-5472.CAN-06-3234; Masayasu Nomura Y. N., 2004, TRANSCRIPTION RDNA; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; Pena A, 2012, EMBO J, V31, P1605, DOI 10.1038/emboj.2012.10; Piruat JI, 1998, EMBO J, V17, P4859, DOI 10.1093/emboj/17.16.4859; Prado F, 1997, EMBO J, V16, P2826, DOI 10.1093/emboj/16.10.2826; RIGGS DL, 1990, J BIOL CHEM, V265, P7596; Rondon AG, 2003, J BIOL CHEM, V278, P39037, DOI 10.1074/jbc.M305718200; Rondon AG, 2003, EMBO J, V22, P612, DOI 10.1093/emboj/cdg047; Schneider DA, 2006, P NATL ACAD SCI USA, V103, P12707, DOI 10.1073/pnas.0605686103; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Viktorovskaya OV, 2013, CELL REP, V4, P974, DOI 10.1016/j.celrep.2013.07.044; Viktorovskaya OV, 2011, J BIOL CHEM, V286, P18825, DOI 10.1074/jbc.M110.202119; WARNER JR, 1991, METHOD ENZYMOL, V194, P423; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Williamson K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057974; Yao W, 2007, MOL CELL, V26, P51, DOI 10.1016/j.molcel.2007.02.018; Zhang YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056793; Zhang YF, 2010, J BIOL CHEM, V285, P14152, DOI 10.1074/jbc.M110.115220; Zhang YF, 2009, P NATL ACAD SCI USA, V106, P2153, DOI 10.1073/pnas.0812939106	42	7	7	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					3010	3018		10.1074/jbc.M115.673442	http://dx.doi.org/10.1074/jbc.M115.673442			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26663077	Green Published, hybrid			2022-12-26	WOS:000369626900037
J	Schnoder, L; Hao, WL; Qin, YR; Liu, SR; Tomic, I; Liu, X; Fassbender, K; Liu, Y				Schnoeder, Laura; Hao, Wenlin; Qin, Yiren; Liu, Shirong; Tomic, Inge; Liu, Xu; Fassbender, Klaus; Liu, Yang			Deficiency of Neuronal p38 alpha MAPK Attenuates Amyloid Pathology in Alzheimer Disease Mouse and Cell Models through Facilitating Lysosomal Degradation of BACE1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOKINE UP-REGULATION; BETA-SECRETASE; PRECURSOR PROTEIN; MEMORY DEFICITS; TRANSGENIC MICE; A-BETA; TAU PHOSPHORYLATION; OXIDATIVE STRESS; P38 KINASE; AUTOPHAGY	Amyloid beta (A beta) damages neurons and triggers microglial inflammatory activation in the Alzheimer disease (AD) brain. BACE1 is the primary enzyme in A beta generation. Neuroinflammation potentially up-regulates BACE1 expression and increases A beta production. In Alzheimer amyloid precursor protein-transgenic mice and SH-SY5Y cell models, we specifically knocked out or knocked down gene expression of mapk14, which encodes p38 alpha MAPK, a kinase sensitive to inflammatory and oxidative stimuli. Using immunological and biochemical methods, we observed that reduction of p38 alpha MAPK expression facilitated the lysosomal degradation of BACE1, decreased BACE1 protein and activity, and subsequently attenuated A beta generation in the AD mouse brain. Inhibition of p38 alpha MAPK also enhanced autophagy. Blocking autophagy by treating cells with 3-methyladenine or overexpressing dominant-negative ATG5 abolished the deficiency of the p38 alpha MAPK-induced BACE1 protein reduction in cultured cells. Thus, our study demonstrates that p38 alpha MAPK plays a critical role in the regulation of BACE1 degradation and A beta generation in AD pathogenesis.	[Schnoeder, Laura; Hao, Wenlin; Qin, Yiren; Tomic, Inge; Liu, Xu; Fassbender, Klaus; Liu, Yang] Univ Saarland, Dept Neurol, D-66421 Homburg, Germany; [Schnoeder, Laura; Hao, Wenlin; Qin, Yiren; Tomic, Inge; Liu, Xu; Fassbender, Klaus; Liu, Yang] Univ Saarland, German Inst Dementia Prevent DIDP, D-66421 Homburg, Germany; [Liu, Shirong] Brigham & Womens Hosp, Harvard Inst Med, Ctr Neurol Dis, Boston, MA 02115 USA	Saarland University; Saarland University; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Liu, Y (corresponding author), Univ Saarland, Dept Neurol, D-66421 Homburg, Germany.; Liu, Y (corresponding author), Univ Saarland, German Inst Dementia Prevent DIDP, D-66421 Homburg, Germany.	a.liu@mx.uni-saarland.de	Liu, Shirong/AAB-7300-2021; Liu, Yang/GSD-5476-2022	Liu, Shirong/0000-0002-3821-9134; Liu, Yang/0000-0002-7614-4233; Fassbender, Klaus/0000-0003-3596-868X	Deutsche Forschungsgemeinschaft [LI1725/2-1]; Else Kroner-Fresenius-Stiftung [2012_A247]; Prof. Dr. Peter Theiss Wissenschaftspreis grant	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Else Kroner-Fresenius-Stiftung; Prof. Dr. Peter Theiss Wissenschaftspreis grant	This work was supported by the Deutsche Forschungsgemeinschaft Grant LI1725/2-1 (to Y. L.), Else Kroner-Fresenius-Stiftung 2012_A247 (to Y. L. and K. F.), and a Prof. Dr. Peter Theiss Wissenschaftspreis 2015 grant (to X. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Alam JJ, 2015, J ALZHEIMERS DIS, V48, P219, DOI 10.3233/JAD-150277; Bachstetter AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-79; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Cagnin A, 2001, LANCET, V358, P461, DOI 10.1016/S0140-6736(01)05625-2; Chami L, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-52; Chang KH, 2010, J NEUROCHEM, V113, P1221, DOI 10.1111/j.1471-4159.2010.06687.x; Chishti MA, 2001, J BIOL CHEM, V276, P21562, DOI 10.1074/jbc.M100710200; Christensen MA, 2004, MOL CELL BIOL, V24, P865, DOI 10.1128/MCB.24.2.865-874.2004; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Criscuolo C, 2015, NEUROBIOL AGING, V36, P1303, DOI 10.1016/j.neurobiolaging.2014.11.016; Fukumoto H, 2004, AM J PATHOL, V164, P719, DOI 10.1016/S0002-9440(10)63159-8; Ge YW, 2004, FASEB J, V18, P1037, DOI 10.1096/fj.03-1379fje; Ghosh S, 2013, J NEUROSCI, V33, P5053, DOI 10.1523/JNEUROSCI.4361-12.2013; Goebbels S, 2006, GENESIS, V44, P611, DOI 10.1002/dvg.20256; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; He P, 2007, J CELL BIOL, V178, P829, DOI 10.1083/jcb.200705042; Hensley K, 1999, J NEUROCHEM, V72, P2053, DOI 10.1046/j.1471-4159.1999.0722053.x; Jo C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4496; Kang EL, 2010, J BIOL CHEM, V285, P24108, DOI 10.1074/jbc.M109.092742; Karaca I, 2014, J BIOL CHEM, V289, P16761, DOI 10.1074/jbc.M113.535500; Kato Y, 2002, NAT STRUCT BIOL, V9, P532, DOI 10.1038/nsb807; Keil E, 2013, CELL DEATH DIFFER, V20, P321, DOI 10.1038/cdd.2012.129; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kizuka Y, 2015, EMBO MOL MED, V7, P175, DOI 10.15252/emmm.201404438; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Koh YH, 2005, J BIOL CHEM, V280, P32499, DOI 10.1074/jbc.M506199200; Li SM, 2011, J NEUROSCI, V31, P6627, DOI 10.1523/JNEUROSCI.0203-11.2011; Li YK, 2003, J NEUROSCI, V23, P1605; Liu RQ, 2010, J BIOL CHEM, V285, P19986, DOI 10.1074/jbc.M109.036798; Liu Y, 2014, J NEUROSCI, V34, P12982, DOI 10.1523/JNEUROSCI.1348-14.2014; Liu Y, 2009, J BIOL CHEM, V284, P3691, DOI 10.1074/jbc.M804446200; Matsuzawa T, 2012, J IMMUNOL, V189, P813, DOI 10.4049/jimmunol.1102041; May PC, 2011, J NEUROSCI, V31, P16507, DOI 10.1523/JNEUROSCI.3647-11.2011; McConlogue L, 2007, J BIOL CHEM, V282, P26326, DOI 10.1074/jbc.M611687200; Mizushima N, 1998, J BIOL CHEM, V273, P33889, DOI 10.1074/jbc.273.51.33889; Mucke L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006338; Munoz L, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-21; Nilsson P, 2013, CELL REP, V5, P61, DOI 10.1016/j.celrep.2013.08.042; Nishida K, 2004, MOL CELL BIOL, V24, P10611, DOI 10.1128/MCB.24.24.10611-10620.2004; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; Ohno M, 2004, NEURON, V41, P27, DOI 10.1016/S0896-6273(03)00810-9; Parr C, 2012, MOL CELL BIOL, V32, P4410, DOI 10.1128/MCB.00930-12; Peric A, 2015, ACTA NEUROPATHOL, V129, P363, DOI 10.1007/s00401-014-1379-7; Polito VA, 2014, EMBO MOL MED, V6, P1142, DOI 10.15252/emmm.201303671; Radde R, 2006, EMBO REP, V7, P940, DOI 10.1038/sj.embor.7400784; Reynolds CH, 1997, J NEUROCHEM, V69, P191; Sastre M, 2006, P NATL ACAD SCI USA, V103, P443, DOI 10.1073/pnas.0503839103; Song WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136950; Sun AY, 2003, EXP NEUROL, V183, P394, DOI 10.1016/S0014-4886(03)00180-8; Taguchi T, 2000, Environ Health Prev Med, V4, P217, DOI 10.1007/BF02931261; Tan JG, 2012, J NEUROCHEM, V120, P869, DOI 10.1111/j.1471-4159.2011.07623.x; Vassar R, 2014, J NEUROCHEM, V130, P4, DOI 10.1111/jnc.12715; von Arnim CAF, 2004, J CELL SCI, V117, P5437, DOI 10.1242/jcs.01422; Wahle T, 2005, MOL CELL NEUROSCI, V29, P453, DOI 10.1016/j.mcn.2005.03.014; Walter J, 2001, J BIOL CHEM, V276, P14634, DOI 10.1074/jbc.M011116200; Webber JL, 2010, EMBO J, V29, P27, DOI 10.1038/emboj.2009.321; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346; Xie K, 2013, NEUROBIOL AGING, V34, P2389, DOI 10.1016/j.neurobiolaging.2013.04.013; Xing B, 2015, J MOL NEUROSCI, V55, P509, DOI 10.1007/s12031-014-0372-x; Yang DS, 2011, BRAIN, V134, P258, DOI 10.1093/brain/awq341; Yang LB, 2003, NAT MED, V9, P3, DOI 10.1038/nm0103-3; Yu WH, 2005, J CELL BIOL, V171, P87, DOI 10.1083/jcb.200505082; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhong W, 2014, AUTOPHAGY, V10, P1285, DOI 10.4161/auto.28789; Zhu XW, 2000, J NEUROPATH EXP NEUR, V59, P880, DOI 10.1093/jnen/59.10.880	68	77	80	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2067	2079		10.1074/jbc.M115.695916	http://dx.doi.org/10.1074/jbc.M115.695916			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26663083	Green Published, hybrid			2022-12-26	WOS:000369610400003
J	Janiszewska, J; Szaumkessel, M; Kostrzewska-Poczekaj, M; Bednarek, K; Paczkowska, J; Jackowska, J; Grenman, R; Szyfter, K; Wierzbicka, M; Giefing, M; Jarmuz-Szymczak, M				Janiszewska, Joanna; Szaumkessel, Marcin; Kostrzewska-Poczekaj, Magdalena; Bednarek, Kinga; Paczkowska, Julia; Jackowska, Joanna; Grenman, Reidar; Szyfter, Krzysztof; Wierzbicka, Malgorzata; Giefing, Maciej; Jarmuz-Szymczak, Malgorzata			Global miRNA Expression Profiling Identifies miR-1290 as Novel Potential oncomiR in Laryngeal Carcinoma	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; LASER-CAPTURE MICRODISSECTION; NECK-CANCER; TUMOR-SUPPRESSOR; HEAD; APOPTOSIS; TISSUE; GENES; MICRORNAS; BIOMARKER	Background Laryngeal squamous cell carcinoma (LSCC) is the most common group among head and neck cancers. LSCC is characterized by a high incidence in Europe. With the aim of better understanding its genetic background we performed global miRNA expression profiling of LSCC cell lines and primary specimens. By this approach we identified a cohort of 33 upregulated and 9 downregulated miRNA genes in LSCC as compared to epithelial no tumor controls. Results Within this group we identified overexpression of the novel miR-1290 gene not reported in the context of LSCC before. Using a combined bioinformatical approach in connection with functional analysis we delineated two putative target genes of miR-1290 namely ITPR2 and MAF which are significantly downregulated in LSCC. They are interesting candidates for tumor suppressor genes as they are implicated in apoptosis and other processes deregulated in cancer. Conclusion Taken together, we propose miR-1290 as the new oncomiR involved in LSCC pathogenesis. Additionally, we suggest that the oncogenic potential of miR-1290 might be expressed by the involvement in downregulation of its target genes MAF and ITPR2.	[Janiszewska, Joanna; Szaumkessel, Marcin; Kostrzewska-Poczekaj, Magdalena; Bednarek, Kinga; Paczkowska, Julia; Szyfter, Krzysztof; Giefing, Maciej; Jarmuz-Szymczak, Malgorzata] Polish Acad Sci, Inst Human Genet, Dept Canc Genet, PL-60479 Poznan, Poland; [Jackowska, Joanna; Wierzbicka, Malgorzata; Giefing, Maciej] Univ Med Sci, Dept Otolaryngol & Laryngol Oncol, Poznan, Poland; [Grenman, Reidar] Turku Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, FIN-20520 Turku, Finland; [Grenman, Reidar] Turku Univ Hosp, Dept Med Biochem, FIN-20520 Turku, Finland; [Grenman, Reidar] Univ Turku, Turku, Finland; [Szyfter, Krzysztof] Univ Med Sci, Dept Audiol & Phoniatry, Poznan, Poland; [Jarmuz-Szymczak, Malgorzata] Poznan Univ Med Sci, Dept Hematol, Poznan, Poland	Polish Academy of Sciences; Institute of Human Genetics of the Polish Academy of Sciences; University of Turku; University of Turku; University of Turku; Poznan University of Medical Sciences	Janiszewska, J (corresponding author), Polish Acad Sci, Inst Human Genet, Dept Canc Genet, PL-60479 Poznan, Poland.	jjanisz@man.poznan.pl	Bednarek, Kinga/HGF-0045-2022; Giefing, Maciej/D-2568-2009	Wierzbicka, Malgorzata/0000-0003-0006-6352; Bednarek, Kinga/0000-0003-0135-4663; Paczkowska, Julia/0000-0002-3976-4353; Jackowska, Joanna/0000-0002-5189-5823; Janiszewska, Joanna/0000-0002-1765-0152; Szyfter, Krzysztof/0000-0003-2631-6399; Kostrzewska-Poczekaj, Magdalena/0000-0001-8099-3839; Giefing, Maciej/0000-0002-4760-8246; Jarmuz-Szymczak, Malgorzata/0000-0003-0437-5806	Polish National Science Center [N N401 195839]	Polish National Science Center	The study was financed by the Polish National Science Center grant number N N401 195839 (https://www.ncn.gov.pl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker H, 2005, ORAL ONCOL, V41, P183, DOI 10.1016/j.oraloncology.2004.08.009; Baraniskin A, 2013, INT J CANCER, V132, pE48, DOI 10.1002/ijc.27791; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Cao PY, 2013, HEAD NECK-J SCI SPEC, V35, P720, DOI 10.1002/hed.23011; Cervigne NK, 2009, HUM MOL GENET, V18, P4818, DOI 10.1093/hmg/ddp446; Childs G, 2009, AM J PATHOL, V174, P736, DOI 10.2353/ajpath.2009.080731; CHOMCZYNSKI P, 1993, BIOTECHNIQUES, V15, P532; Chuang HC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104821; Dequanter D, 2012, ACTA CHIR BELG, V112, P423, DOI 10.1080/00015458.2012.11680866; DONALDSON KL, 1994, INT J CANCER, V57, P847, DOI 10.1002/ijc.2910570614; Dweep H, 2011, J BIOMED INFORM, V44, P839, DOI 10.1016/j.jbi.2011.05.002; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Fletcher AM, 2008, TRANSL ONCOL, V1, P202, DOI 10.1593/tlo.08163; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Giefing M, 2011, GENE CHROMOSOME CANC, V50, P154, DOI 10.1002/gcc.20840; Ha PK, 2009, ORAL ONCOL, V45, P335, DOI 10.1016/j.oraloncology.2008.05.015; Hale TK, 2000, J BIOL CHEM, V275, P17991, DOI 10.1074/jbc.M000921200; Harris T, 2012, AM J PATHOL, V180, P917, DOI 10.1016/j.ajpath.2011.12.004; Hsu CM, 2012, TUMOR BIOL, V33, P1933, DOI 10.1007/s13277-012-0454-8; Huang XY, 2015, EUR UROL, V67, P33, DOI 10.1016/j.eururo.2014.07.035; Hui ABY, 2010, CLIN CANCER RES, V16, P1129, DOI 10.1158/1078-0432.CCR-09-2166; Jarmuz M, 2005, CANCER GENET CYTOGEN, V160, P82, DOI 10.1016/j.cancergencyto.2004.12.006; Jarvinen AK, 2006, ONCOGENE, V25, P6997, DOI 10.1038/sj.onc.1209690; Kostrzewska-Poczekaj M, 2010, CANCER BIOMARK, V8, P11, DOI 10.3233/DMA-2011-0814; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Leethanakul C, 2000, ONCOGENE, V19, P3220, DOI 10.1038/sj.onc.1203703; Lencesova L, 2013, ACTA PHYSIOL, V208, P350, DOI 10.1111/apha.12105; Long XB, 2009, ONCOL REP, V22, P1189, DOI 10.3892/or_00000554; MacFarlane LA, 2010, CURR GENOMICS, V11, P537, DOI 10.2174/138920210793175895; Peng SP, 2009, IMMUNOLOGY, V127, P267, DOI 10.1111/j.1365-2567.2008.03014.x; Perri F, 2015, HEAD NECK-J SCI SPEC, V37, P763, DOI 10.1002/hed.23837; Ramdas L, 2009, HEAD NECK-J SCI SPEC, V31, P642, DOI 10.1002/hed.21017; Ren JY, 2010, EUR J CANCER, V46, P3409, DOI 10.1016/j.ejca.2010.07.047; Salazar C, 2014, EXPERT REV MOL DIAGN, V14, P1033, DOI 10.1586/14737159.2014.960519; Salazar C, 2014, CELL ONCOL, V37, P331, DOI 10.1007/s13402-014-0188-2; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Smith IM, 2009, ARCH OTOLARYNGOL, V135, P487, DOI 10.1001/archoto.2009.43; Song J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011456; Sun X, 2013, BIOMED REP, V1, P743, DOI 10.3892/br.2013.143; Tran N, 2007, BIOCHEM BIOPH RES CO, V358, P12, DOI 10.1016/j.bbrc.2007.03.201; Wanebo HJ, 2014, ANN ONCOL, V25, P2036, DOI 10.1093/annonc/mdu248; Wang XW, 2008, RNA, V14, P1012, DOI 10.1261/rna.965408; Wiel C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4792; Wu XL, 2013, ONCOTARGET, V4, P1388, DOI 10.18632/oncotarget.1239; Wulfken LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025787; Yan B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073656; Yang Ying, 2007, Einstein J Biol Med, V23, P2; Zhang B, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-118; Zhao XD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056395; Zheng J, 2011, J CELL BIOCHEM, V112, P872, DOI 10.1002/jcb.22995	51	28	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0144924	10.1371/journal.pone.0144924	http://dx.doi.org/10.1371/journal.pone.0144924			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694163	Green Submitted, Green Published, gold			2022-12-26	WOS:000367092500015
J	Ma, Y; Ma, N; Liu, QB; Qi, Y; Manabe, R; Furuyashiki, T				Ma, Yan; Ma, Ning; Liu, Qingbin; Qi, Yao; Manabe, Ri-ichiroh; Furuyashiki, Tomoyuki			Tor Signaling Regulates Transcription of Amino Acid Permeases through a GATA Transcription Factor Gaf1 in Fission Yeast	PLOS ONE			English	Article							GENE-EXPRESSION; CELL INTEGRITY; KINASE; PROTEIN; GROWTH; ACTIVATION; NUTRIENT; PATHWAY; PHOSPHORYLATION; IDENTIFICATION	In the fission yeast, two Tor isoforms, Tor1 and Tor2, oppositely regulate gene expression of amino acid permeases. To elucidate the transcriptional machinery for these regulations, here we have employed the cap analysis of gene expression (CAGE), a method of analyzing expression profiles and identifying transcriptional start sites (TSSs). The loss of Tor1 decreased, and Tor2 inhibition by its temperature sensitive mutation increased, mRNA expression of isp5(+), per1(+), put4(+) and SPBPB2B2.01. In contrast, the loss of Tor1 increased, and Tor2 inhibition decreased, the expression of cat1(+). These changes were confirmed by semi-quantitative RT-PCR. These opposite effects by the loss of Tor1 and Tor2 inhibition appeared to occur evenly across multiple TSSs for the respective genes. The motif discovery analysis based on the CAGE results identified the GATA motifs as a potential cis-regulatory element for Tor-mediated regulation. In the luciferase reporter assay, the loss of Tor1 reduced, and Tor2 inhibition and nitrogen depletion increased, the activity of isp5(+) promoter as well as that of a GATAAG reporter. One of the GATAAG motifs in isp5(+) promoter was critical for its transcriptional activity, and a GATA transcription factor Gaf1 was critical for the activities of isp5(+) promoter and the GATAAG reporter. Furthermore, Tor2 inhibition and nitrogen depletion induced nuclear localization of Gaf1 from the cytosol and its dephosphorylation. These results suggest that Tor2 inhibition, which is known to be induced by nitrogen depletion, promotes nuclear localization of Gaf1, thereby inducing isp5(+) transcription through Gaf1 binding to the GATAAG motif in its promoter. Since Gaf1 was also critical for transcription of per1(+) and put4(+), Tor-Gaf1 signaling may coordinate transcription of multiple amino acid permeases according to nutrient availability.	[Ma, Yan; Ma, Ning; Liu, Qingbin; Qi, Yao; Furuyashiki, Tomoyuki] Kobe Univ, Grad Sch Med, Div Pharmacol, Kobe, Hyogo 657, Japan; [Manabe, Ri-ichiroh] RIKEN Ctr Life Sci Technol, Div Genom Technol, Yokohama, Kanagawa, Japan	Kobe University; RIKEN	Ma, Y (corresponding author), Kobe Univ, Grad Sch Med, Div Pharmacol, Kobe, Hyogo 657, Japan.	mayan@med.kobe-u.ac.jp	Furuyashiki, Tomoyuki/AAG-5283-2019; Furuyashiki, Tomoyuki/B-8760-2014	Furuyashiki, Tomoyuki/0000-0001-8089-8399; Furuyashiki, Tomoyuki/0000-0001-8089-8399	Japan Society for the Promotion of Science [26460339]; MEXT; Platform Project for Supporting in Drug Discovery and Life Science Research from Japan Agency for Medical Research and Development; Innovative Cell Biology by Innovative Technology from MEXT; Grants-in-Aid for Scientific Research [15H01289, 24689015] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Platform Project for Supporting in Drug Discovery and Life Science Research from Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Innovative Cell Biology by Innovative Technology from MEXT; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid for Scientific Research (C) from Japan Society for the Promotion of Science to Y.M. (No. 26460339), a Research Grant from MEXT to the RIKEN Center for Life Science Technologies, a Grant of the Innovative Cell Biology by Innovative Technology from MEXT to Yoshihide Hayashizaki, and the Platform Project for Supporting in Drug Discovery and Life Science Research from Japan Agency for Medical Research and Development. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Atkin J, 2014, J CELL SCI, V127, P1346, DOI 10.1242/jcs.146373; Beck T, 1999, NATURE, V402, P689, DOI 10.1038/45287; Coffman JA, 1996, MOL CELL BIOL, V16, P847; Cox KH, 2004, J BIOL CHEM, V279, P10270, DOI 10.1074/jbc.M312023200; Deng L, 2006, MOL BIOL CELL, V17, P4790, DOI 10.1091/mbc.E06-06-0526; Fingar DC, 2004, ONCOGENE, V23, P3151, DOI 10.1038/sj.onc.1207542; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x; HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0; Hirayama S, 2003, J BIOL CHEM, V278, P18078, DOI 10.1074/jbc.M212900200; Hoskins RA, 2011, GENOME RES, V21, P182, DOI 10.1101/gr.112466.110; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Laor D, 2015, MBIO, V6, DOI 10.1128/mBio.00959-15; Laor D, 2014, MOL CELL BIOL, V34, P794, DOI 10.1128/MCB.01473-13; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Ma N, 2013, GENETICS, V195, P457, DOI 10.1534/genetics.113.154674; Matsuo T, 2007, MOL CELL BIOL, V27, P3154, DOI 10.1128/MCB.01039-06; Murata M, 2014, METHODS MOL BIOL, V1164, P67, DOI 10.1007/978-1-4939-0805-9_7; Nakashima A, 2012, J CELL SCI, V125, P5840, DOI 10.1242/jcs.111146; Nakashima A, 2010, J CELL SCI, V123, P777, DOI 10.1242/jcs.060319; Ohmiya H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-269; Rallis C, 2013, AGING CELL; Rhind N, 2011, SCIENCE, V332, P930, DOI 10.1126/science.1203357; ROTHSTEIN RJ, 1983, METHOD ENZYMOL, V101, P202; Rowen DW, 1997, J BACTERIOL, V179, P3761, DOI 10.1128/jb.179.11.3761-3766.1997; Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100; Stanbrough M, 1996, J BACTERIOL, V178, P2465, DOI 10.1128/jb.178.8.2465-2468.1996; Toda T, 1996, MOL CELL BIOL, V16, P6752; Uritani M, 2006, GENES CELLS, V11, P1367, DOI 10.1111/j.1365-2443.2006.01025.x; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zheng X, 2014, INT J MOL SCI, V15, P20753, DOI 10.3390/ijms151120753; Zhou X, 2012, J BIOL CHEM, V287, P23434, DOI 10.1074/jbc.C111.338715	34	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144677	10.1371/journal.pone.0144677	http://dx.doi.org/10.1371/journal.pone.0144677			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689777	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092300011
J	Wang, XB; Qiao, C; Wei, L; Han, YD; Cui, NH; Huang, ZL; Li, ZH; Zheng, F; Yan, M				Wang, Xue-bin; Qiao, Chen; Wei, Li; Han, Ya-di; Cui, Ning-hua; Huang, Zhu-liang; Li, Zu-hua; Zheng, Fang; Yan, Ming			Associations of Polymorphisms in MTHFR Gene with the Risk of Age-Related Cataract in Chinese Han Population: A Genotype-Phenotype Analysis	PLOS ONE			English	Article							METHYLENETETRAHYDROFOLATE REDUCTASE GENE; ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; PLASMA HOMOCYSTEINE; COMMON MUTATION; FOLATE; EXPRESSION; PREVALENCE; VARIANTS; DISEASE	Homocysteine (Hcy) is a potential risk factor for age-related cataract (ARC). Methylenetetrahydrofolate reductase (MTHFR) is the key enzyme for Hcy metabolism, and variants of MTHFR may affect MTHFR enzyme activity. This study mainly evaluated the associations between variants in MTHFR gene, plasma MTHFR enzyme activity, total Hcy (tHcy) levels and ARC risk in Chinese population. Four single nucleotide polymorphisms (SNPs) in MTHFR gene were genotyped using the high-resolution melting (HRM) method in 502 ARC patients (mean age, 70.2 [SD, 9.0], 46.0% male) and 890 healthy controls (mean age, 67.1 [SD, 11.1], 47.6% male). The plasma MTHFR activity, folic acid (FA), vitamins B12 and B6 levels were detected by enzyme-linked immunosorbent assays (ELISA). The plasma tHcy levels were measured by an automated enzymatic assay. After the Bonferroni correction, the minor allele T of SNP rs1801133 showed a significant association with an increased risk of overall ARC (OR = 1.26, P = 0.003). Consistent association was also found between SNP rs1801133 and cortical ARC risk (OR = 1.44, P = 0.003). Haplotype analyses revealed an adverse effect of the haplotype "C-A-T-C" (alleles in order of SNPs rs3737967, rs1801131, rs1801133 and rs9651118) on ARC risk (OR = 1.55, P = 0.003). Moreover, in a joint analysis of SNPs rs9651118 and rs1801133, subjects with two unfavorable genotypes had a 1.76-fold increased risk of ARC compared with the reference group, and a statistically significant dose-response trend (P-trend=0.001) was also observed. Further, in healthy controls and patients with cortical ARC, the allele T of SNP rs1801133 and the increasing number of unfavorable genotypes were significantly correlated with decreased MTHFR activity as well as increased tHcy levels. However, there was no significant association between FA, vitamins B12, B6 levels and MTHFR variants. Our data indicated that variants in MTHFR gene might individually and jointly influence susceptibility to ARC by affecting MTHFR enzyme activity and tHcy levels.	[Wang, Xue-bin; Qiao, Chen; Han, Ya-di; Huang, Zhu-liang; Li, Zu-hua; Zheng, Fang; Yan, Ming] Wuhan Univ, Zhongnan Hosp, Ctr Gene Diag, Wuhan 430072, Hubei, Peoples R China; [Wei, Li; Yan, Ming] Wuhan Univ, Zhongnan Hosp, Dept Ophthalmol, Wuhan 430072, Hubei, Peoples R China; [Cui, Ning-hua] Childrens Hosp Zhengzhou, Dept Clin Lab, Zhengzhou, Henan, Peoples R China	Wuhan University; Wuhan University	Zheng, F (corresponding author), Wuhan Univ, Zhongnan Hosp, Ctr Gene Diag, Wuhan 430072, Hubei, Peoples R China.	zhengfang@whu.edu.cn; yanming72@whu.edu.cn			Health and Family Planning Commission of Hubei Province [WJ2015MB1-10]; National Basic Research Program of China (973 Program) [2012CB720600]	Health and Family Planning Commission of Hubei Province; National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This study was supported by grants from Health and Family Planning Commission of Hubei Province (WJ2015MB1-10) (http://www.hbwsjs.gov.cn/) and the National Basic Research Program of China (973 Program, 2012CB720600) (http://www.most.gov.cn/bszn/new/973/jbxx/index.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asbell PA, 2005, LANCET, V365, P599; Ates O, 2010, ACTA OPHTHALMOL, V88, P891, DOI 10.1111/j.1755-3768.2009.01583.x; Benke K, 2015, THROMB HAEMOSTASIS, V114, P748, DOI 10.1160/TH15-02-0096; Bhagyalaxmi SG, 2009, BBA-MOL BASIS DIS, V1792, P974, DOI 10.1016/j.bbadis.2009.06.011; Burda P, 2015, HUM MUTAT; Cao SS, 2015, INFLAMM BOWEL DIS, V21, P636, DOI 10.1097/MIB.0000000000000238; Chen JX, 2014, BRIT J DERMATOL, V170, P1092, DOI 10.1111/bjd.12845; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Congdon N, 2005, OPHTHALMOLOGY, V112, P73, DOI 10.1016/j.ophtha.2004.07.012; Cotlarciuc I, 2014, STROKE, V45, P1920, DOI 10.1161/STROKEAHA.114.005208; Elanchezhian R, 2012, CHEM-BIOL INTERACT, V200, P1, DOI 10.1016/j.cbi.2012.08.017; Gong Y, 2015, OPTOM VIS SCI; Hammond CJ, 2001, INVEST OPHTH VIS SCI, V42, P601; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; HEIBA IM, 1995, INVEST OPHTH VIS SCI, V36, P227; Holmes MV, 2011, LANCET, V378, P584, DOI 10.1016/S0140-6736(11)60872-6; Huang PR, 2015, SCI REP-UK, V5, DOI 10.1038/srep10585; Ikesugi K, 2006, EXP EYE RES, V83, P508, DOI 10.1016/j.exer.2006.01.033; Jacques PF, 1996, CIRCULATION, V93, P7, DOI 10.1161/01.CIR.93.1.7; Klerk M, 2002, JAMA-J AM MED ASSOC, V288, P2023, DOI 10.1001/jama.288.16.2023; Liew M, 2004, CLIN CHEM, V50, P1156, DOI 10.1373/clinchem.2004.032136; Luo XQ, 2014, NUTR METAB, V11, DOI 10.1186/1743-7075-11-55; MacQuarrie KL, 2011, TRENDS GENET, V27, P141, DOI 10.1016/j.tig.2011.01.001; MAGNO BV, 1993, INVEST OPHTH VIS SCI, V34, P2138; Marini NJ, 2008, P NATL ACAD SCI USA, V105, P8055, DOI 10.1073/pnas.0802813105; McGimpsey SJ, 2009, OPHTHALMOLOGY, V116, P1778, DOI 10.1016/j.ophtha.2009.02.033; Outinen PA, 1999, BLOOD, V94, P959, DOI 10.1182/blood.V94.3.959.415k20_959_967; Pascolini D, 2010, BR J OPHTHALMOL, V96, P614, DOI DOI 10.1136/BJ0PHTHALM0L-2011-300539; Pejchal R, 2006, BIOCHEMISTRY-US, V45, P4808, DOI 10.1021/bi052294c; Qin XH, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000563; Roy SW, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-208; Rozen R, 1997, THROMB HAEMOSTASIS, V78, P523; Schaid DJ, 2002, AM J HUM GENET, V70, P425, DOI 10.1086/338688; Sen SK, 2008, INDIAN J CLIN BIOCHE, V23, P255, DOI 10.1007/s12291-008-0057-8; Tan AG, 2015, INVEST OPHTH VIS SCI, V56, P216, DOI 10.1167/iovs.14-15531; Tan YY, 2003, CLIN CHEM, V49, P1029, DOI 10.1373/49.6.1029; Truscott RJW, 2005, EXP EYE RES, V80, P709, DOI 10.1016/j.exer.2004.12.007; van der Put NMJ, 1998, AM J HUM GENET, V62, P1044, DOI 10.1086/301825; Wang X, 2012, J MOL CELL CARDIOL, V52, P753, DOI 10.1016/j.yjmcc.2011.12.009; Weisberg IS, 2001, ATHEROSCLEROSIS, V156, P409, DOI 10.1016/S0021-9150(00)00671-7; Weiss N, 2001, P NATL ACAD SCI USA, V98, P12503, DOI 10.1073/pnas.231428998; Westra HJ, 2013, NAT GENET, V45, P1238, DOI 10.1038/ng.2756; Wu H, 2014, INVEST OPHTH VIS SCI, V55, P3660, DOI 10.1167/iovs.13-13695; Xu F, 2012, OPHTHALMOLOGY, V119, P2493, DOI 10.1016/j.ophtha.2012.06.025; Xu ZL, 2009, NUCLEIC ACIDS RES, V37, pW600, DOI 10.1093/nar/gkp290; Ye J, 2012, INVEST OPHTH VIS SCI, V53, P3885, DOI 10.1167/iovs.12-9820; Yu XN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114012; Zetterberg M, 2005, AM J OPHTHALMOL, V140, P932, DOI 10.1016/j.ajo.2005.05.026; Zhang DQ, 2012, CIRC RES, V111, P37, DOI [10.1161/CIRCRESAHA.112.269472, 10.1161/circresaha.112.269472]; Zhang DH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123423; Zhao JL, 2010, OPHTHALMOLOGY, V117, P409, DOI 10.1016/j.ophtha.2009.11.023	51	5	5	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145581	10.1371/journal.pone.0145581	http://dx.doi.org/10.1371/journal.pone.0145581			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689687	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092300090
J	Krembel, A; Colin, R; Sourjik, V				Krembel, Anna; Colin, Remy; Sourjik, Victor			Importance of Multiple Methylation Sites in Escherichia coli Chemotaxis	PLOS ONE			English	Article							BACILLUS-SUBTILIS CHEMOTAXIS; BACTERIAL CHEMOTAXIS; ASPARTATE RECEPTOR; PROTEIN METHYLATION; ADAPTATION; COMPLEX; ATTRACTANT; METHYLTRANSFERASE; CHEMORECEPTORS; TRANSDUCTION	Bacteria navigate within inhomogeneous environments by temporally comparing concentrations of chemoeffectors over the course of a few seconds and biasing their rate of reorientations accordingly, thereby drifting towards more favorable conditions. This navigation requires a short-term memory achieved through the sequential methylations and demethylations of several specific glutamate residues on the chemotaxis receptors, which progressively adjusts the receptors' activity to track the levels of stimulation encountered by the cell with a delay. Such adaptation also tunes the receptors' sensitivity according to the background ligand concentration, enabling the cells to respond to fractional rather than absolute concentration changes, i.e. to perform logarithmic sensing. Despite the adaptation system being principally well understood, the need for a specific number of methylation sites remains relatively unclear. Here we systematically substituted the four glutamate residues of the Tar receptor of Escherichia coli by non-methylated alanine, creating a set of 16 modified receptors with a varying number of available methylation sites and explored the effect of these substitutions on the performance of the chemotaxis system. Alanine substitutions were found to desensitize the receptors, similarly but to a lesser extent than glutamate methylation, and to affect the methylation and demethylation rates of the remaining sites in a site-specific manner. Each substitution reduces the dynamic range of chemotaxis, by one order of magnitude on average. The substitution of up to two sites could be partly compensated by the adaptation system, but the full set of methylation sites was necessary to achieve efficient logarithmic sensing.	[Krembel, Anna; Sourjik, Victor] Heidelberg Univ, DKFZ ZMBH Alliance, Zentrum Mol Biol, D-69120 Heidelberg, Germany; [Colin, Remy; Sourjik, Victor] Max Planck Inst Terr Microbiol, D-35043 Marburg, Germany; [Colin, Remy; Sourjik, Victor] LOEWE Ctr Synthet Microbiol SYNMIKRO, D-35043 Marburg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Max Planck Society	Sourjik, V (corresponding author), Heidelberg Univ, DKFZ ZMBH Alliance, Zentrum Mol Biol, Neuenheimer Feld 282, D-69120 Heidelberg, Germany.	victor.sourjik@synmikro.mpi-marburg.mpg.de		Colin, Remy/0000-0001-9051-8003	European Research Council [294761-MicRobE]; National Institutes of Health [R01 GM082938]; Deutsche Forschungsgemeinschaft [SO 421/11-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082938] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant 294761-MicRobE from the European Research Council, by grant R01 GM082938 from the National Institutes of Health and by grant SO 421/11-1 from the Deutsche Forschungsgemeinschaft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; BERG HC, 1975, P NATL ACAD SCI USA, V72, P3235, DOI 10.1073/pnas.72.8.3235; BERG HC, 1972, NATURE, V239, P500, DOI 10.1038/239500a0; Bornhorst JA, 2000, BIOCHEMISTRY-US, V39, P9486, DOI 10.1021/bi0002737; Bornhorst JA, 2001, J GEN PHYSIOL, V118, P693, DOI 10.1085/jgp.118.6.693; Colin R, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0486; Dufour YS, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003694; Endres RG, 2006, P NATL ACAD SCI USA, V103, P13040, DOI 10.1073/pnas.0603101103; Endres RG, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.49; Glekas GD, 2011, MICROBIOL-SGM, V157, P56, DOI 10.1099/mic.0.044685-0; GOY MF, 1977, P NATL ACAD SCI USA, V74, P4964, DOI 10.1073/pnas.74.11.4964; Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014; Hazelbauer GL, 2010, CURR OPIN MICROBIOL, V13, P124, DOI 10.1016/j.mib.2009.12.014; Johnson KO, 2002, NEUROSCIENTIST, V8, P111, DOI 10.1177/107385840200800207; Kalinin YV, 2009, BIOPHYS J, V96, P2439, DOI 10.1016/j.bpj.2008.10.027; KEHRY MR, 1983, P NATL ACAD SCI-BIOL, V80, P3599, DOI 10.1073/pnas.80.12.3599; KEHRY MR, 1982, J BIOL CHEM, V257, P378; Lazova MD, 2011, P NATL ACAD SCI USA, V108, P13870, DOI 10.1073/pnas.1108608108; MACNAB RM, 1972, P NATL ACAD SCI USA, V69, P2509, DOI 10.1073/pnas.69.9.2509; Mello BA, 2003, BIOPHYS J, V84, P2943, DOI 10.1016/S0006-3495(03)70021-6; MESIBOV R, 1973, J GEN PHYSIOL, V62, P203, DOI 10.1085/jgp.62.2.203; Morton-Firth CJ, 1999, J MOL BIOL, V286, P1059, DOI 10.1006/jmbi.1999.2535; Neumann S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084904; Neumann S, 2012, P NATL ACAD SCI USA, V109, P12159, DOI 10.1073/pnas.1205307109; Neumann S, 2010, EMBO J, V29, P3484, DOI 10.1038/emboj.2010.224; Nishiyama S, 1999, MOL MICROBIOL, V32, P357, DOI 10.1046/j.1365-2958.1999.01355.x; Nishiyama SI, 1997, J BACTERIOL, V179, P6573, DOI 10.1128/jb.179.21.6573-6580.1997; NOWLIN DM, 1987, J BIOL CHEM, V262, P6039; Oleksiuk O, 2011, CELL, V145, P312, DOI 10.1016/j.cell.2011.03.013; Porter SL, 2011, NAT REV MICROBIOL, V9, P153, DOI 10.1038/nrmicro2505; SHAPIRO MJ, 1995, P NATL ACAD SCI USA, V92, P1053, DOI 10.1073/pnas.92.4.1053; SHAPIRO MJ, 1995, J BIOL CHEM, V270, P751, DOI 10.1074/jbc.270.2.751; SHAPIRO MJ, 1994, J BIOL CHEM, V269, P11054; Shoval O, 2010, P NATL ACAD SCI USA, V107, P15995, DOI 10.1073/pnas.1002352107; Sourjik V, 2004, NATURE, V428, P437, DOI 10.1038/nature02406; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998; Sourjik V, 2007, METHOD ENZYMOL, V423, P365, DOI 10.1016/S0076-6879(07)23017-4; Sourjik V, 2012, CURR OPIN CELL BIOL, V24, P262, DOI 10.1016/j.ceb.2011.11.008; SPRINGER MS, 1979, NATURE, V280, P279, DOI 10.1038/280279a0; TERWILLIGER TC, 1984, J BIOL CHEM, V259, P7719; Tu YH, 2008, P NATL ACAD SCI USA, V105, P14855, DOI 10.1073/pnas.0807569105; Vladimirov N, 2009, BIOL CHEM, V390, P1097, DOI 10.1515/BC.2009.130; Vladimirov N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000242; Wadhams GH, 2004, NAT REV MOL CELL BIO, V5, P1024, DOI 10.1038/nrm1524; Walukiewicz HE, 2014, MOL MICROBIOL, V93, P1104, DOI 10.1111/mmi.12721; Wilson LG, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.018101	46	11	11	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145582	10.1371/journal.pone.0145582	http://dx.doi.org/10.1371/journal.pone.0145582			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683829	Green Submitted, Green Published, gold			2022-12-26	WOS:000366725800083
J	Beck, EN; Martens, KAE; Almeida, QJ				Beck, Eric N.; Martens, Kaylena A. Ehgoetz; Almeida, Quincy J.			Freezing of Gait in Parkinson's Disease: An Overload Problem?	PLOS ONE			English	Article							GENERATED LIMB MOVEMENTS; PRIMATE MOTOR THALAMUS; BILATERAL COORDINATION; VISUAL-ATTENTION; BASAL GANGLIA; AUDITORY CUES; DUAL TASKING; LOCOMOTION; ANXIETY; INFORMATION	Freezing of gait (FOG) is arguably the most severe symptom associated with Parkinson's disease (PD), and often occurs while performing dual tasks or approaching narrowed and cluttered spaces. While it is well known that visual cues alleviate FOG, it is not clear if this effect may be the result of cognitive or sensorimotor mechanisms. Nevertheless, the role of vision may be a critical link that might allow us to disentangle this question. Gaze behaviour has yet to be carefully investigated while freezers approach narrow spaces, thus the overall objective of this study was to explore the interaction between cognitive and sensory-perceptual influences on FOG. In experiment #1, if cognitive load is the underlying factor leading to FOG, then one might expect that a dual-task would elicit FOG episodes even in the presence of visual cues, since the load on attention would interfere with utilization of visual cues. Alternatively, if visual cues alleviate gait despite performance of a dual-task, then it may be more probable that sensory mechanisms are at play. In compliment to this, the aim of experiment#2 was to further challenge the sensory systems, by removing vision of the lowerlimbs and thereby forcing participants to rely on other forms of sensory feedback rather than vision while walking toward the narrow space. Spatiotemporal aspects of gait, percentage of gaze fixation frequency and duration, as well as skin conductance levels were measured in freezers and non-freezers across both experiments. Results from experiment#1 indicated that although freezers and non-freezers both walked with worse gait while performing the dual-task, in freezers, gait was relieved by visual cues regardless of whether the cognitive demands of the dual-task were present. At baseline and while dual-tasking, freezers demonstrated a gaze behaviour that neglected the doorway and instead focused primarily on the pathway, a strategy that non-freezers adopted only when performing the dual-task. Interestingly, with the combination of visual cues and dual-task, freezers increased the frequency and duration of fixations toward the doorway, compared to non-freezers. These results suggest that although increasing demand on attention does significantly deteriorate gait in freezers, an increase in cognitive demand is not exclusively responsible for freezing (since visual cues were able to overcome any interference elicited by the dual-task). When vision of the lower limbs was removed in experiment#2, only the freezers' gait was affected. However, when visual cues were present, freezers' gait improved regardless of the dualtask. This gait behaviour was accompanied by greater amount of time spent looking at the visual cues irrespective of the dual-task. Since removing vision of the lower-limbs hindered gait even under low attentional demand, restricted sensory feedback may be an important factor to the mechanisms underlying FOG.	[Beck, Eric N.; Martens, Kaylena A. Ehgoetz; Almeida, Quincy J.] Wilfrid Laurier Univ, Sun Life Movement Disorders Res & Rehabil Ctr, Waterloo, ON N2L 3C5, Canada; [Beck, Eric N.; Almeida, Quincy J.] Wilfrid Laurier Univ, Dept Kinesiol & Phys Educ, Waterloo, ON N2L 3C5, Canada; [Martens, Kaylena A. Ehgoetz] Univ Waterloo, Dept Psychol, Waterloo, ON N2L 3G1, Canada	Wilfrid Laurier University; Wilfrid Laurier University; University of Waterloo	Almeida, QJ (corresponding author), Wilfrid Laurier Univ, Sun Life Movement Disorders Res & Rehabil Ctr, Waterloo, ON N2L 3C5, Canada.	qalmeida@wlu.ca	Ehgoetz Martens, Kaylena/G-9997-2016	Ehgoetz Martens, Kaylena/0000-0002-8488-2295	Canadian Institutes of Health Research; Parkinson Society Canada; North American Society for Psychology of Sport and Physical Activity; Canadian Foundation for Innovation [20774]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Parkinson Society Canada; North American Society for Psychology of Sport and Physical Activity; Canadian Foundation for Innovation(Canada Foundation for Innovation)	This work has been funded by the Canadian Institutes of Health Research (KEM), Parkinson Society Canada (KEM), North American Society for Psychology of Sport and Physical Activity (KEM), and Canadian Foundation for Innovation (QJA #20774). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamovich SV, 2001, NEUROSCIENCE, V104, P1027, DOI 10.1016/S0306-4522(01)00099-9; Almeida QJ, 2010, J NEUROL NEUROSUR PS, V81, P513, DOI 10.1136/jnnp.2008.160580; Almeida QJ, 2005, NEUROSCIENCE, V134, P283, DOI 10.1016/j.neuroscience.2005.02.050; Azulay JP, 1999, BRAIN, V122, P111, DOI 10.1093/brain/122.1.111; Baker K, 2008, PARKINSONISM RELAT D, V14, P314, DOI 10.1016/j.parkreldis.2007.09.008; Baker K, 2007, ARCH PHYS MED REHAB, V88, P1593, DOI 10.1016/j.apmr.2007.07.026; Boucsein W, 2012, ELECTRODERMAL ACTIVITY, SECOND EDITION, P1, DOI 10.1007/978-1-4614-1126-0; Bucci MP, 2014, RES DEV DISABIL, V35, P1292, DOI 10.1016/j.ridd.2014.03.029; Cerasa A, 2006, BRAIN RES BULL, V71, P259, DOI 10.1016/j.brainresbull.2006.09.014; Chee R, 2009, BRAIN, V132, P2151, DOI 10.1093/brain/awp053; Cowie D, 2012, MOVEMENT DISORD, V27, P492, DOI 10.1002/mds.23990; Ehgoetz Martens K.A., 2015, NEUROPSYCHOLOGIA, P1; Fox E, 2002, COGNITION EMOTION, V16, P355, DOI 10.1080/02699930143000527; Fox E, 2001, J EXP PSYCHOL GEN, V130, P681, DOI 10.1037/0096-3445.130.4.681; GLICKSTEIN M, 1991, TRENDS NEUROSCI, V14, P480, DOI 10.1016/0166-2236(91)90055-Y; Hackney ME, 2010, NEUROREHAB NEURAL RE, V24, P97, DOI 10.1177/1545968309341061; Hausdorff JM, 2003, EXP BRAIN RES, V149, P187, DOI 10.1007/s00221-002-1354-8; Iansek R, 2006, MOVEMENT DISORD, V21, P1419, DOI 10.1002/mds.20998; Jueptner M, 1998, BRAIN, V121, P1437, DOI 10.1093/brain/121.8.1437; Keijsers NLW, 2005, EUR J NEUROSCI, V21, P239, DOI 10.1111/j.1460-9568.2004.03840.x; Knobl P, 2012, J NEUROL NEUROSUR PS, V83, P98, DOI 10.1136/jnnp-2011-300869; LADER MH, 1967, J PSYCHOSOM RES, V11, P271, DOI 10.1016/0022-3999(67)90021-9; Lazzaro I, 1999, INT J PSYCHOPHYSIOL, V34, P123, DOI 10.1016/S0167-8760(99)00068-9; Lebold CA, 2010, PARKINSONS DIS-US, V2010, DOI 10.4061/2010/732508; Lebold CA, 2011, J CLIN NEUROSCI, V18, P798, DOI 10.1016/j.jocn.2010.07.151; Lee SJ, 2012, AM J PHYS MED REHAB, V91, P2, DOI 10.1097/PHM.0b013e31823c7507; Lewis SJG, 2009, PARKINSONISM RELAT D, V15, P333, DOI 10.1016/j.parkreldis.2008.08.006; Maidan I, 2015, J NEUROL, V262, P899, DOI 10.1007/s00415-015-7650-6; Martens KAE, 2015, EUR J NEUROSCI, V42, P2028, DOI 10.1111/ejn.12928; Martens KAE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062602; Matar E, 2013, PARKINSONISM RELAT D, V19, P937, DOI 10.1016/j.parkreldis.2013.06.002; Morris ME, 1996, BRAIN, V119, P551, DOI 10.1093/brain/119.2.551; Nieuwboer A, 2001, MOVEMENT DISORD, V16, P1066, DOI 10.1002/mds.1206; Nieuwboer A, 2013, MOVEMENT DISORD, V28, P1509, DOI 10.1002/mds.25683; Patla AE, 1997, NEUROREPORT, V8, P3661, DOI 10.1097/00001756-199712010-00002; Patla AE, 2004, EXP BRAIN RES, V155, P173, DOI 10.1007/s00221-003-1714-z; Pieruccini-Faria F, 2013, J MOTOR BEHAV, V45, P369, DOI 10.1080/00222895.2013.810139; Pieruccini-Faria F, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0250-8; Pieruccini-Faria F, 2014, BRAIN COGNITION, V87, P76, DOI 10.1016/j.bandc.2014.03.005; Plotnik M, 2005, ANN NEUROL, V57, P656, DOI 10.1002/ana.20452; Plotnik M, 2009, J NEUROL NEUROSUR PS, V80, P347, DOI 10.1136/jnnp.2008.157362; Plotnik M, 2008, EUR J NEUROSCI, V27, P1999, DOI 10.1111/j.1460-9568.2008.06167.x; Rochester L, 2007, J NEURAL TRANSM, V114, P1243, DOI 10.1007/s00702-007-0756-y; Shine JM, 2013, BRAIN, V136, P3671, DOI 10.1093/brain/awt272; Shine JM, 2013, BRAIN, V136, P1204, DOI 10.1093/brain/awt049; Shine JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052602; Suteerawattananon M, 2004, J NEUROL SCI, V219, P63, DOI 10.1016/j.jns.2003.12.007; Tan T, 2011, NEUROSCIENCE, V192, P746, DOI 10.1016/j.neuroscience.2011.06.071; van Donkelaar P, 1999, J NEUROPHYSIOL, V82, P934, DOI 10.1152/jn.1999.82.2.934; van Donkelaar P, 2000, J NEUROPHYSIOL, V83, P2780, DOI 10.1152/jn.2000.83.5.2780; Velik R, 2012, IEEE ENG MED BIO, P4656, DOI 10.1109/EMBC.2012.6347005; Vitorio R, 2014, NEUROSCIENCE, V277, P273, DOI 10.1016/j.neuroscience.2014.07.024; Vitorio R, 2013, GAIT POSTURE, V38, P330, DOI 10.1016/j.gaitpost.2012.12.019; Yogev G, 2005, EUR J NEUROSCI, V22, P1248, DOI 10.1111/j.1460-9568.2005.04298.x; Yogev-Seligmann G, 2012, GAIT POSTURE, V35, P641, DOI 10.1016/j.gaitpost.2011.12.016; Young WR, 2012, J GERONTOL B-PSYCHOL, V67, P43, DOI 10.1093/geronb/gbr074	56	37	38	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144986	10.1371/journal.pone.0144986	http://dx.doi.org/10.1371/journal.pone.0144986			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678262	Green Published, Green Submitted, gold			2022-12-26	WOS:000366723400039
J	Kullberg, P; Toivonen, T; Pouzols, FM; Lehtomaki, J; Di Minin, E; Moilanen, A				Kullberg, Peter; Toivonen, Tuuli; Pouzols, Federico Montesino; Lehtomaki, Joona; Di Minin, Enrico; Moilanen, Atte			Complementarity and Area-Efficiency in the Prioritization of the Global Protected Area Network	PLOS ONE			English	Article							CONSERVATION PRIORITIES; BIODIVERSITY; EXPANSION; DIVERSITY; PERFORMANCE; RESOLUTION; TARGETS; COSTS	Complementarity and cost-efficiency are widely used principles for protected area network design. Despite the wide use and robust theoretical underpinnings, their effects on the performance and patterns of priority areas are rarely studied in detail. Here we compare two approaches for identifying the management priority areas inside the global protected area network: 1) a scoring-based approach, used in recently published analysis and 2) a spatial prioritization method, which accounts for complementarity and area-efficiency. Using the same IUCN species distribution data the complementarity method found an equal-area set of priority areas with double the mean species ranges covered compared to the scoringbased approach. The complementarity set also had 72% more species with full ranges covered, and lacked any coverage only for half of the species compared to the scoring approach. Protected areas in our complementarity-based solution were on average smaller and geographically more scattered. The large difference between the two solutions highlights the need for critical thinking about the selected prioritization method. According to our analysis, accounting for complementarity and area-efficiency can lead to considerable improvements when setting management priorities for the global protected area network.	[Kullberg, Peter; Pouzols, Federico Montesino; Lehtomaki, Joona; Di Minin, Enrico; Moilanen, Atte] Univ Helsinki, Dept Biosci, Helsinki, Finland; [Toivonen, Tuuli] Univ Helsinki, Dept Geosci & Geog, Helsinki, Finland; [Di Minin, Enrico] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa	University of Helsinki; University of Helsinki; University of Kwazulu Natal	Kullberg, P (corresponding author), Univ Helsinki, Dept Biosci, Helsinki, Finland.	peter.kullberg@helsinki.fi	Di Minin, Enrico/J-6904-2013; Moilanen, Atte/A-5005-2011; Montesino Pouzols, Federico/D-7995-2014	Di Minin, Enrico/0000-0002-5562-318X; Montesino Pouzols, Federico/0000-0002-2981-5612; Toivonen, Tuuli/0000-0002-6625-4922	European research council (ERC) project Global Environmental Decision Analysis (GEDA) (ERC-StG) [260393]; Academy of Finland's Finnish Centre of Excellence Program	European research council (ERC) project Global Environmental Decision Analysis (GEDA) (ERC-StG); Academy of Finland's Finnish Centre of Excellence Program	Support was provided by the European research council (ERC, [erc.europa.eu/]) project Global Environmental Decision Analysis (GEDA) (ERC-StG grant #260393) and the Academy of Finland's [www.aka.fi] Finnish Centre of Excellence Program 2012-2017. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abellan P, 2005, BIODIVERS CONSERV, V14, P3457, DOI 10.1007/s10531-004-0550-1; Arponen A, 2012, CONSERV BIOL, V26, P294, DOI 10.1111/j.1523-1739.2011.01814.x; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; Bertzky B, 2012, PROTECTED PLATET REP; Cantu-Salazar L, 2010, BIOSCIENCE, V60, P808, DOI 10.1525/bio.2010.60.10.7; Ceballos G, 2007, ECOL APPL, V17, P569, DOI 10.1890/06-0134; Chape S, 2005, PHILOS T R SOC B, V360, P443, DOI 10.1098/rstb.2004.1592; Di Minin E, 2015, BIOSCIENCE, V65, P637, DOI 10.1093/biosci/biv064; Di Minin E, 2013, CONSERV BIOL, V27, P808, DOI 10.1111/cobi.12048; Di Minin E, 2012, BIOL CONSERV, V153, P187, DOI 10.1016/j.biocon.2012.04.015; Eklund J, 2011, PHILOS T R SOC B, V366, P2661, DOI 10.1098/rstb.2011.0114; FERRIER S, 2009, SPATIAL CONSERVATION, P1; Gaston KJ, 2006, BIOL CONSERV, V132, P76, DOI 10.1016/j.biocon.2006.03.013; Gaston KJ, 2008, ANNU REV ECOL EVOL S, V39, P93, DOI 10.1146/annurev.ecolsys.39.110707.173529; Harrop SR, 2011, GLOBAL ENVIRON CHANG, V21, P474, DOI 10.1016/j.gloenvcha.2011.01.014; Hockings M., 2006, EVALUATION EFFECTIVE; IUCN, 2013, IUCN RED LIST THREAT; Jenkins CN, 2008, CONSERV BIOL, V22, P1037, DOI 10.1111/j.1523-1739.2008.00974.x; Klein CJ, 2014, MAR POLICY, V48, P204, DOI 10.1016/j.marpol.2014.03.008; Knight A. T., 2009, SPATIAL CONSERVATION, P249; Kremen C, 2008, SCIENCE, V320, P222, DOI 10.1126/science.1155193; Kujala H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053315; Kukkala AS, 2013, BIOL REV, V88, P443, DOI 10.1111/brv.12008; Laitila J, 2012, ECOL MODEL, V247, P40, DOI 10.1016/j.ecolmodel.2012.08.010; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; Le Saout S, 2013, SCIENCE, V342, P803, DOI 10.1126/science.1239268; Lehtomaki J, 2013, ENVIRON MODELL SOFTW, V47, P128, DOI 10.1016/j.envsoft.2013.05.001; Margules CR, 2007, ECOL BIODIVERS CONS, P1; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Marignani M, 2012, BIODIVERS CONSERV, V21, P1853, DOI 10.1007/s10531-012-0283-5; McCreless E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080893; Moilanen A., 2014, SPATIAL CONSERVATION; Moilanen A, 2013, DIVERS DISTRIB, V19, P171, DOI 10.1111/ddi.12000; Moilanen A, 2011, ECOL APPL, V21, P1419, DOI 10.1890/10-1865.1; Moilanen A, 2008, CONSERV BIOL, V22, P1655, DOI 10.1111/j.1523-1739.2008.01043.x; Naidoo R, 2006, TRENDS ECOL EVOL, V21, P681, DOI 10.1016/j.tree.2006.10.003; Possingham HP, 2006, PRINCIPLES CONSERVAT, P516; Pouzols FM, 2014, NATURE, V516, P383, DOI 10.1038/nature14032; PRESSEY RL, 1989, BIOL CONSERV, V50, P199, DOI 10.1016/0006-3207(89)90010-4; Ripple WJ, 2014, SCIENCE, V343, P151, DOI 10.1126/science.1241484; Soutullo A, 2008, DIVERS DISTRIB, V14, P604, DOI 10.1111/j.1472-4642.2007.00445.x; Traba J, 2007, BIODIVERS CONSERV, V16, P3255, DOI 10.1007/s10531-006-9138-2; UNEP WCMC, 2013, WORLD DAT PROT AR WD; VANEWRIGHT RI, 1991, BIOL CONSERV, V55, P235, DOI 10.1016/0006-3207(91)90030-D; Williams P, 1996, CONSERV BIOL, V10, P155, DOI 10.1046/j.1523-1739.1996.10010155.x; Wilson KA, 2007, PLOS BIOL, V5, P1850, DOI 10.1371/journal.pbio.0050223	46	10	10	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145231	10.1371/journal.pone.0145231	http://dx.doi.org/10.1371/journal.pone.0145231			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678497	Green Submitted, gold, Green Published			2022-12-26	WOS:000366723400061
J	Caruso, F; Sciacca, V; Bellia, G; De Domenico, E; Larosa, G; Papale, E; Pellegrino, C; Pulvirenti, S; Riccobene, G; Simeone, F; Speziale, F; Viola, S; Pavan, G				Caruso, Francesco; Sciacca, Virginia; Bellia, Giorgio; De Domenico, Emilio; Larosa, Giuseppina; Papale, Elena; Pellegrino, Carmelo; Pulvirenti, Sara; Riccobene, Giorgio; Simeone, Francesco; Speziale, Fabrizio; Viola, Salvatore; Pavan, Gianni			Size Distribution of Sperm Whales Acoustically Identified during Long Term Deep-Sea Monitoring in the Ionian Sea	PLOS ONE			English	Article							INTER-PULSE INTERVALS; PHYSETER-MACROCEPHALUS; MEDITERRANEAN SEA; POPULATION-STRUCTURE; SOUND PRODUCTION; CLICKS; LENGTH; MOVEMENTS; ABUNDANCE; NEUTRINO	The sperm whale (Physeter macrocephalus) emits a typical short acoustic signal, defined as a "click", almost continuously while diving. It is produced in different time patterns to acoustically explore the environment and communicate with conspecifics. Each emitted click has a multi-pulse structure, resulting from the production of the sound within the sperm whale's head. A Stable Inter Pulse Interval (Stable IPI) can be identified among the pulses that compose a single click. Applying specific algorithms, the measurement of this interval provides useful information to assess the total length of the animal recorded. In January 2005, a cabled hydrophone array was deployed at a depth of 2,100 m in the Central Mediterranean Sea, 25 km offshore Catania (Ionian Sea). The acoustic antenna, named OvDE (Ocean noise Detection Experiment), was in operation until November 2006. OvDE provided real time acoustic data used to perform Passive Acoustic Monitoring (PAM) of cetacean sound emissions. In this work, an innovative approach was applied to automatically measure the Stable IPI of the clicks, performing a cepstrum analysis to the energy (square amplitude) of the signals. About 2,100 five-minute recordings were processed to study the size distribution of the sperm whales detected during the OvDE long term deep-sea acoustic monitoring. Stable IPIs were measured in the range between 2.1 ms and 6.4 ms. The equations of Gordon (1991) and of Growcott (2011) were used to convert the IPIs into measures of size. The results revealed that the sperm whales recorded were distributed in length from about 7.5 m to 14 m. The size category most represented was from 9 m to 12 m (adult females or juvenile males) and specimens longer than 14 m (old males) seemed to be absent.	[Caruso, Francesco; Sciacca, Virginia; De Domenico, Emilio] Univ Messina, Dipartimento Sci Biol & Ambientali, Messina, Italy; [Caruso, Francesco; Sciacca, Virginia; Bellia, Giorgio; Larosa, Giuseppina; Pulvirenti, Sara; Riccobene, Giorgio; Speziale, Fabrizio; Viola, Salvatore] Ist Nazl Fis Nucl INFN, Lab Nazl Sud, Catania, Italy; [Bellia, Giorgio] Univ Catania, Dipartimento Fis & Astron, Catania, Italy; [Papale, Elena] CNR, Bioacoust Lab, IAMC Capo Granitola, Torretta Granitola, TP, Italy; [Pellegrino, Carmelo] Ist Nazl Fis Nucl INFN Bologna, Bologna, Italy; [Pellegrino, Carmelo] Univ Bologna, Dipartimento Fis & Astron, Bologna, Italy; [Simeone, Francesco] Ist Nazl Fis Nucl INFN Roma1, Rome, Italy; [Pavan, Gianni] Univ Pavia, Dipartimento Sci Terra & Ambiente, Ctr Interdisciplinare Bioacust & Ric Ambientali C, I-27100 Pavia, Italy	University of Messina; Istituto Nazionale di Fisica Nucleare (INFN); University of Catania; Consiglio Nazionale delle Ricerche (CNR); L'Istituto per l'Ambiente Marino Costiero (IAMC-CNR); Istituto Nazionale di Fisica Nucleare (INFN); University of Bologna; Istituto Nazionale di Fisica Nucleare (INFN); University of Pavia	Caruso, F (corresponding author), Univ Messina, Dipartimento Sci Biol & Ambientali, Messina, Italy.	fcaruso@unime.it	viola, Salvatore/C-1002-2014; Caruso, Francesco/AAB-4845-2019; Riccobene, Giorgio/A-4502-2010; Sciacca, Virginia/N-7205-2015; Sciacca, Virginia/AAD-1528-2022; Pulvirenti, Sara Rita/AAE-1289-2019; Simeone, Francesco/L-1057-2016; Pavan, Gianni/M-4619-2015; Bellia, Giorgio/A-5684-2008	viola, Salvatore/0000-0001-9511-8279; Caruso, Francesco/0000-0001-6881-3786; Riccobene, Giorgio/0000-0002-0600-2774; Sciacca, Virginia/0000-0002-7711-1249; Sciacca, Virginia/0000-0002-7711-1249; Pulvirenti, Sara Rita/0000-0003-3017-512X; Pavan, Gianni/0000-0002-4599-9028; Bellia, Giorgio/0000-0003-3063-5739; Pellegrino, Carmelo/0000-0003-1530-4595; papale, elena/0000-0002-5150-9240	Italian Ministry of Education, Universities and Research [RBFR08NRZE]; Italian Ministry of the Environment [DPN/2008/28401]	Italian Ministry of Education, Universities and Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of the Environment	This work was conducted under the SMO (Submarine Multidisciplinary Observatory) FIRB 2008 activities, funded by the Italian Ministry of Education, Universities and Research (No. RBFR08NRZE) (GR) (https://web2.infn.it/smo/). The work of one of the authors (GP) was supported by a grant of the Italian Ministry of the Environment (DPN/2008/28401) (http://www.unipv.it/cibra/progettocetacei.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLERFENCHEL HS, 1980, CAN J FISH AQUAT SCI, V37, P2358, DOI 10.1139/f80-283; Aiello S, 2015, ASTROPART PHYS, V66, P1, DOI 10.1016/j.astropartphys.2014.12.010; Aiello S, 2010, ASTROPART PHYS, V33, P263, DOI 10.1016/j.astropartphys.2010.02.009; Antunes R, 2010, J ACOUST SOC AM, V127, P3239, DOI 10.1121/1.3327509; Backus R. H., 1966, WHALES DOLPHINS PORP, P510; Bolognari A., 1951, Bollettino di Zoologia, V18, P253; Bolognari A, 1950, ITALIAN J ZOOLOGY, V17, P29; Caruso F., 2014, Biologia Marina Mediterranea, V21, P393; CLARKE MR, 1978, J MAR BIOL ASSOC UK, V58, P1, DOI 10.1017/S0025315400024371; Cranford TW, 1999, MAR MAMMAL SCI, V15, P1133, DOI 10.1111/j.1748-7692.1999.tb00882.x; DISCIARA GN, 2006, STATUS DISTRIBUTION, P48; Drouot V, 2004, J MAR BIOL ASSOC UK, V84, P675, DOI 10.1017/S0025315404009749h; Drouot Violaine, 2004, Journal of Cetacean Research and Management, V6, P29; Favali P, 2013, IEEE J OCEANIC ENG, V38, P358, DOI 10.1109/JOE.2012.2224536; Frantzis A, 2011, DEEP-SEA RES PT I, V58, P454, DOI 10.1016/j.dsr.2011.02.005; Frantzis A, 2008, CAN J ZOOL, V86, P62, DOI 10.1139/Z07-114; Frantzis A, 2014, AQUAT CONSERV, V24, P83, DOI 10.1002/aqc.2435; Gannier A, 2002, MAR ECOL PROG SER, V243, P281, DOI 10.3354/meps243281; Gillespie D., 2009, J ACOUST SOC AM, V125, P2547, DOI [10.1121/1.4808713, DOI 10.1121/1.4808713]; Goold JC, 1996, DEEP-SEA RES PT I, V43, P961, DOI 10.1016/0967-0637(96)00066-0; Goold JC, 1996, J ACOUST SOC AM, V100, P3431, DOI 10.1121/1.416984; Gordon J. C. D, 1987, BEHAV ECOLOGY SPERM; GORDON JCD, 1991, J ZOOL, V224, P301, DOI 10.1111/j.1469-7998.1991.tb04807.x; Growcott A, 2011, J ACOUST SOC AM, V130, P568, DOI 10.1121/1.3578455; Klinck H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036128; Laplanche C, 2006, J ACOUST SOC AM, V119, P4074, DOI 10.1121/1.2184987; Lewis T, 2007, J MAR BIOL ASSOC UK, V87, P353, DOI 10.1017/S0025315407054896; Madsen PT, 2002, J EXP BIOL, V205, P1899; Madsen PT, 2012, J AM CETACEAN SOC, V41, P9; Mathias D, 2009, J ACOUST SOC AM, V125, P3444, DOI 10.1121/1.3097758; Mazzariol S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019417; Miller BS, 2013, J ACOUST SOC AM, V134, P2438, DOI 10.1121/1.4816564; Mohl B, 2003, J ACOUST SOC AM, V114, P1143, DOI 10.1121/1.1586258; Mohl B., 1981, MAMM SEAS, V3, P327; Norris K.S., 1972, ANIMAL ORIENTATION N, P397; Nosengo N, 2009, NATURE, V462, P560, DOI 10.1038/462560a; Notarbartolo-Di-Sciara G, 2014, AQUAT CONSERV, V24, P4, DOI 10.1002/aqc.2409; Pace DS, 2014, AQUAT CONSERV, V24, P1, DOI 10.1002/aqc.2457; Pavan G., 1999, European Research on Cetaceans, V12, P254; Pavan G, 2000, J ACOUST SOC AM, V107, P3487, DOI 10.1121/1.429419; Pavan G., 1997, P I ACOUST, V19, P157; Pavan G., 2008, COMPUTATIONAL BIOACO, P7; Rhinelander MQ, 2004, J ACOUST SOC AM, V115, P1826, DOI 10.1121/1.1689346; Riccobene G, 2009, NUCL INSTRUM METH A, V604, pS149, DOI 10.1016/j.nima.2009.03.195; Riccobene G, 2008, J PHYS CONF SER, V136, DOI 10.1088/1742-6596/136/2/022053; Rice D.W., 1989, P177; Sciacca V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141838; Teloni Valeria, 2007, Journal of Cetacean Research and Management, V9, P127; Viola S, 2013, NUCL INSTRUM METH A, V725, P207, DOI 10.1016/j.nima.2012.11.150; Zimmer WMX, 2003, IEEE J OCEANIC ENG, V28, P13, DOI 10.1109/JOE.2002.808209; Zimmer WMX, 2005, J ACOUST SOC AM, V118, P3337, DOI 10.1121/1.2082707; Zimmer WMX, 2005, J ACOUST SOC AM, V117, P1473, DOI 10.1121/1.1828501	52	22	22	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144503	10.1371/journal.pone.0144503	http://dx.doi.org/10.1371/journal.pone.0144503			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675588	gold, Green Published, Green Submitted			2022-12-26	WOS:000366722700041
J	Hovik, KT; Plessen, KJ; Cavanna, AE; Skogli, EW; Andersen, PN; Oie, M				Hovik, Kjell Tore; Plessen, Kerstin J.; Cavanna, Andrea E.; Skogli, Erik Winther; Andersen, Per Normann; Oie, Merete			Cognition, Emotion and Behavior in Children with Tourette's Syndrome and Children with ADHD-Combined Subtype-A Two-Year Follow-Up Study	PLOS ONE			English	Article							MANIFEST ANXIETY SCALE; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; SOMATIC MARKER HYPOTHESIS; IOWA GAMBLING TASK; DECISION-MAKING; EXECUTIVE FUNCTIONS; RATING INVENTORY; TIC SEVERITY; I THINK; DSM-IV	Objective This two-year follow-up study investigates the course of and association among measures of cognitive control, focused attention, decision-making and symptom severity (anxiety, depression and behavior)in children and adolescents with Tourette's Syndrome (TS) or Attention-Deficit/Hyperactivity Disorder-Combined subtype (ADHD-C). Method 19 children with TS, 33 with ADHD-C, and 50 typically developing children (TDC) were examined with a battery of psychometric measures and rating forms at baseline and two years later. Results All three groups improved likewise in measures of cognitive control over time, whereas only the TDC improved in focused attention. The group of children with TS with comorbidities performed more similar to the children with ADHD-C in cognitive control at T1 and T2, whereas the children with TS without comorbidities performed more similar to the TDC in cognitive control at T1 and T2. In the decision-making task, the children with TS (with or without comorbidities) preferred a safer strategy in selecting advantageous choices than the children with ADHD-C and the TDC at T2. Children with TS and children with ADHD-C showed higher symptoms of anxiety and depression and more problems with emotional control compared with TDC at both time points. Finally, children with ADHD-C self-reported more depression symptoms than those with TS at both assessments. For the TS group, safer decision-making was related to better emotional control, and this relationship was stronger for the TS subgroup without comorbidities. Conclusion This study emphasizes the importance of addressing symptoms of anxiety and depression in children with TS or ADHD-C, identifying the effect of comorbidities in children with TS, and that children with TS or ADHD-C likely differ in their sensitivity to reinforcement contingencies.	[Hovik, Kjell Tore; Skogli, Erik Winther; Andersen, Per Normann; Oie, Merete] Innlandet Hosp Trust, Div Mental Hlth Care, Lillehammer, Norway; [Hovik, Kjell Tore; Oie, Merete] Univ Oslo, Inst Psychol, Oslo, Norway; [Plessen, Kerstin J.] Univ Copenhagen, Child & Adolescent Mental Hlth Ctr, Capital Reg Psychiat, Copenhagen, Denmark; [Plessen, Kerstin J.] Univ Copenhagen, Inst Clin Med, Copenhagen, Denmark; [Cavanna, Andrea E.] Univ Birmingham, Dept Neuropsychiat, Birmingham, W Midlands, England; [Cavanna, Andrea E.] BSMHFT, Birmingham, W Midlands, England; [Cavanna, Andrea E.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England; [Cavanna, Andrea E.] Inst Neurol, Sobell Dept Movement Disorders, London WC1N 3BG, England; [Andersen, Per Normann] Lillehammer Univ Coll, Dept Educ & Social Work, Lillehammer, Norway	Innlandet Hospital Trust; University of Oslo; University of Copenhagen; University of Copenhagen; University of Birmingham; Aston University; University of London; University College London; Inland Norway University of Applied Sciences	Hovik, KT (corresponding author), Innlandet Hosp Trust, Div Mental Hlth Care, Lillehammer, Norway.	kjell.tore.hovik@sykehuset-innlandet.no	Andersen, Per Normann/I-1531-2013	Andersen, Per Normann/0000-0002-0242-7230; Skogli, Erik Winther/0000-0002-8450-2176	Innlandet Hospital Trust [150170]; Regional Resource Center for Autism, ADHD, Tourette's Syndrome and Narcolepsy, Oslo University Hospital [150182]	Innlandet Hospital Trust; Regional Resource Center for Autism, ADHD, Tourette's Syndrome and Narcolepsy, Oslo University Hospital	The work was supported by grants from Innlandet Hospital Trust (grant number 150170) and from Regional Resource Center for Autism, ADHD, Tourette's Syndrome and Narcolepsy, Oslo University Hospital (grant number 150182). The authors declare no conflict of interest with respect to authorship or publication of this article.	Aase H, 2006, J CHILD PSYCHOL PSYC, V47, P457, DOI 10.1111/j.1469-7610.2005.01468.x; Achenbach T.M., 2001, MANUAL ASEBA SCH AGE; American Psychiatric Association, 2000, DIAGN STAT MAN MENT, V4th; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Angold A, 1995, INT J METHOD PSYCH, V5, P237; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Barkley R.A., 2012, BARKLEY DEFICITS EXE; Baumeister RF, 2007, HDB EMOTION REGULATI; Bechara A, 2005, TRENDS COGN SCI, V9, P159, DOI 10.1016/j.tics.2005.02.002; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Berger A, 2007, PROG NEUROBIOL, V82, P256, DOI 10.1016/j.pneurobio.2007.06.004; Best JR, 2010, CHILD DEV, V81, P1641, DOI 10.1111/j.1467-8624.2010.01499.x; BOEHNKE K, 1986, PERS INDIV DIFFER, V7, P553, DOI 10.1016/0191-8869(86)90132-7; Brand M, 2007, J CLIN EXP NEUROPSYC, V29, P86, DOI 10.1080/13803390500507196; Brown T.E., 2006, INT J DISABIL DEV ED, V53, P35, DOI [10.1080/10349120500510024, DOI 10.1080/10349120500510024]; Cavanna AE, 2013, NEUROSCI BIOBEHAV R, V37, P1008, DOI 10.1016/j.neubiorev.2012.10.011; Chan RCK, 2008, ARCH CLIN NEUROPSYCH, V23, P201, DOI 10.1016/j.acn.2007.08.010; Clarke RA, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.75; Coghill DR, 2014, PSYCHOL MED, V44, P1989, DOI 10.1017/S0033291713002547; Cohen J.E., 1988, STAT POWER ANAL BEHA; Conners C.K., 2004, CONNERS CONTINUOUS P; COSTELLO EJ, 1988, J AM ACAD CHILD PSY, V27, P726, DOI 10.1097/00004583-198811000-00011; COSTELLO EJ, 1991, J AFFECT DISORDERS, V23, P199, DOI 10.1016/0165-0327(91)90101-W; Crone EA, 2004, DEV NEUROPSYCHOL, V25, P251, DOI 10.1207/s15326942dn2503_2; Daviss WB, 2006, J CHILD PSYCHOL PSYC, V47, P927, DOI 10.1111/j.1469-7610.2006.01646.x; Delis D.C., 2001, DELIS KAPLAN EXECUTI; Denckla MB, 2002, CHILD NEUROPSYCHOL, V8, P304, DOI 10.1076/chin.8.4.304.13512; DeVito EE, 2008, BIOL PSYCHIAT, V64, P636, DOI 10.1016/j.biopsych.2008.04.017; DuPaul G. J., 1998, ADHD RATING SCALE 4; Eddy CM, 2012, PSYCHIAT RES, V200, P46, DOI 10.1016/j.psychres.2012.05.023; Egeland J, 2010, CHILD NEUROPSYCHOL, V16, P326, DOI 10.1080/09297041003601462; Egeland J, 2010, J ATTEN DISORD, V13, P339, DOI 10.1177/1087054708323019; Ehlers S, 1999, J AUTISM DEV DISORD, V29, P129, DOI 10.1023/A:1023040610384; Elliott R, 2000, J NEUROSCI, V20, P6159, DOI 10.1523/JNEUROSCI.20-16-06159.2000; Fallmyr O., 2011, TIDSSKRIFT NORSK PSY, V48, P339; FERRANDO PJ, 1994, PERS INDIV DIFFER, V16, P693, DOI 10.1016/0191-8869(94)90211-9; Freeman RD, 2007, EUR CHILD ADOLES PSY, V16, P15, DOI 10.1007/s00787-007-1003-7; Gaub M, 1997, J ABNORM CHILD PSYCH, V25, P103, DOI 10.1023/A:1025775311259; Geurts HM, 2006, J ABNORM CHILD PSYCH, V34, P813, DOI 10.1007/s10802-006-9059-2; Gioia GA, 2000, BEHAV RATING INVENTO; Gorman DA, 2010, BRIT J PSYCHIAT, V197, P36, DOI 10.1192/bjp.bp.109.071050; Goudriaan AE, 2006, ADDICTION, V101, P534, DOI 10.1111/j.1360-0443.2006.01380.x; Goudriaan AE, 2005, COGNITIVE BRAIN RES, V23, P137, DOI 10.1016/j.cogbrainres.2005.01.017; Greenberg G, 2013, ADV CHILD DEV BEHAV, V44, P95, DOI 10.1016/B978-0-12-397947-6.00004-0; Greimel E, 2008, J NEURAL TRANSM, V115, P191, DOI 10.1007/s00702-007-0815-4; Groen Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074909; Heilman RM, 2010, EMOTION, V10, P257, DOI 10.1037/a0018489; Hirschtritt ME, 2015, JAMA PSYCHIAT, V72, P325, DOI 10.1001/jamapsychiatry.2014.2650; Hoekstra PJ, 2013, EUR CHILD ADOLES PSY, V22, P185, DOI 10.1007/s00787-012-0337-y; Hofmann W, 2012, TRENDS COGN SCI, V16, P174, DOI 10.1016/j.tics.2012.01.006; HOLM S, 1979, SCAND J STAT, V6, P65; Hovik KT, 2016, J ATTEN DISORD, V20, P825, DOI 10.1177/1087054713512371; Hovik KT, 2017, J ATTEN DISORD, V21, P811, DOI 10.1177/1087054714550336; Jackson GM, 2007, EXP BRAIN RES, V182, P357, DOI 10.1007/s00221-007-0999-8; Jackson SR, 2011, CURR BIOL, V21, P580, DOI 10.1016/j.cub.2011.02.047; JOHNSON CA, 1973, J CHILD PSYCHOL PSYC, V14, P181, DOI 10.1111/j.1469-7610.1973.tb01186.x; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Kovacs, 1983, CHILDRENS DEPRESSION; Lavin P., 2008, CLIN DEPRESSION OVER; Leckman JF, 2003, BRAIN DEV-JPN, V25, pS24, DOI 10.1016/S0387-7604(03)90004-0; LECKMAN JF, 1989, J AM ACAD CHILD PSY, V28, P566, DOI 10.1097/00004583-198907000-00015; Lewin AB, 2011, J ANXIETY DISORD, V25, P164, DOI 10.1016/j.janxdis.2010.08.016; Luman M, 2005, CLIN PSYCHOL REV, V25, P183, DOI 10.1016/j.cpr.2004.11.001; Luman M, 2008, J CHILD PSYCHOL PSYC, V49, P712, DOI 10.1111/j.1469-7610.2008.01910.x; Maia TV, 2004, P NATL ACAD SCI USA, V101, P16075, DOI 10.1073/pnas.0406666101; Mathews CA, 2004, J NEUROL NEUROSUR PS, V75, P1149, DOI 10.1136/jnnp.2003.020693; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Mueller SC, 2006, CURR BIOL, V16, P570, DOI 10.1016/j.cub.2006.01.064; O'Connor K, 2002, BEHAV RES THER, V40, P1113, DOI 10.1016/S0005-7967(02)00048-7; Overton WF, 2013, APPL DEV SCI, V17, P94, DOI 10.1080/10888691.2013.778717; Palminteri S, 2009, P NATL ACAD SCI USA, V106, P19179, DOI 10.1073/pnas.0904035106; Pashler H, 2001, ANNU REV PSYCHOL, V52, P629, DOI 10.1146/annurev.psych.52.1.629; PELA OA, 1982, PSYCHOL REP, V51, P1135, DOI 10.2466/pr0.1982.51.3f.1135; Pessoa L, 2008, NAT REV NEUROSCI, V9, P148, DOI 10.1038/nrn2317; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Pine DS, 1999, AM J PSYCHIAT, V156, P133, DOI 10.1176/ajp.156.1.133; Power TJ, 2004, J ABNORM CHILD PSYCH, V32, P27, DOI 10.1023/B:JACP.0000007578.30863.93; Reynolds C.R., 1985, REVISED CHILDRENS MA; REYNOLDS CR, 1981, J CONSULT CLIN PSYCH, V49, P352, DOI 10.1037/0022-006X.49.3.352; REYNOLDS CR, 1981, PERCEPT MOTOR SKILL, V53, P702, DOI 10.2466/pms.1981.53.3.702; REYNOLDS CR, 1980, J CONSULT CLIN PSYCH, V48, P774, DOI 10.1037/0022-006X.48.6.774; REYNOLDS CR, 1982, EDUC PSYCHOL MEAS, V42, P1205, DOI 10.1177/001316448204200429; Robertson MM, 2009, J PSYCHOSOM RES, V67, P475, DOI 10.1016/j.jpsychores.2009.07.010; Robertson MM, 2000, BRAIN, V123, P425, DOI 10.1093/brain/123.3.425; Roessner V, 2007, EUR CHILD ADOLES PSY, V16, P24, DOI 10.1007/s00787-007-1004-6; SCHOLWINSKI E, 1985, GIFTED CHILD QUART, V29, P125, DOI 10.1177/001698628502900305; Seidman LJ, 2006, CLIN PSYCHOL REV, V26, P466, DOI 10.1016/j.cpr.2006.01.004; Sergeant JA, 2002, BEHAV BRAIN RES, V130, P3, DOI 10.1016/S0166-4328(01)00430-2; Singer HS, 2005, LANCET NEUROL, V4, P149, DOI 10.1016/S1474-4422(05)01012-4; Skogli EW, 2017, J ATTEN DISORD, V21, P305, DOI 10.1177/1087054714524984; Skogli EW, 2014, CHILD NEUROPSYCHOL, V20, P162, DOI 10.1080/09297049.2012.753998; Smith DG, 2012, DEV PSYCHOL, V48, P1180, DOI 10.1037/a0026342; Solanto MV, 2002, BEHAV BRAIN RES, V130, P65, DOI 10.1016/S0166-4328(01)00431-4; Sonuga-Barke EJS, 2003, NEUROSCI BIOBEHAV R, V27, P593, DOI 10.1016/j.neubiorev.2003.08.005; Spencer T, 1998, J CHILD PSYCHOL PSYC, V39, P1037, DOI 10.1017/S0021963098002984; Toplak ME, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-8; Turgeon L, 2003, PSYCHOL ASSESSMENT, V15, P378, DOI 10.1037/1040-3590.15.3.378; Vohs KD, 2004, HDB SELF REGULATION, P1; Volkow ND, 2009, JAMA-J AM MED ASSOC, V302, P1084, DOI 10.1001/jama.2009.1308; Watkins LH, 2005, PSYCHOL MED, V35, P571, DOI 10.1017/S0033291704003691; Wechsler D., 1991, WISC 3 WECHSLER INTE; Willcutt EG, 2005, BIOL PSYCHIAT, V57, P1336, DOI 10.1016/j.biopsych.2005.02.006	103	12	12	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144874	10.1371/journal.pone.0144874	http://dx.doi.org/10.1371/journal.pone.0144874			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9JH	26673612	Green Published, gold			2022-12-26	WOS:000366722700068
J	Nim, HT; Furtado, MB; Costa, MW; Kitano, H; Rosenthal, NA; Boyd, SE				Nim, Hieu T.; Furtado, Milena B.; Costa, Mauro W.; Kitano, Hiroaki; Rosenthal, Nadia A.; Boyd, Sarah E.			CARFMAP: A Curated Pathway Map of Cardiac Fibroblasts	PLOS ONE			English	Article							SYSTEMS BIOLOGY; SIGNALING-NETWORK; GENE-EXPRESSION; REPAIR; HEART; REGENERATION; CELL; PATHOPHYSIOLOGY; SOFTWARE; PROMOTER	The adult mammalian heart contains multiple cell types that work in unison under tightly regulated conditions to maintain homeostasis. Cardiac fibroblasts are a significant and unique population of non-muscle cells in the heart that have recently gained substantial interest in the cardiac biology community. To better understand this renaissance cell, it is essential to systematically survey what has been known in the literature about the cellular and molecular processes involved. We have built CARFMAP (http://visionet.erc.monash.edu.au/CARFMAP), an interactive cardiac fibroblast pathway map derived from the biomedical literature using a software-assisted manual data collection approach. CARFMAP is an information-rich interactive tool that enables cardiac biologists to explore the large body of literature in various creative ways. There is surprisingly little overlap between the cardiac fibroblast pathway map, a foreskin fibroblast pathway map, and a whole mouse organism signalling pathway map from the REACTOME database. Among the use cases of CARFMAP is a common task in our cardiac biology laboratory of identifying new genes that are (1) relevant to cardiac literature, and (2) differentially regulated in high-throughput assays. From the expression profiles of mouse cardiac and tail fibroblasts, we employed CARFMAP to characterise cardiac fibroblast pathways. Using CARFMAP in conjunction with transcriptomic data, we generated a stringent list of six genes that would not have been singled out using bioinformatics analyses alone. Experimental validation showed that five genes (Mmp3, Il6, Edn1, Pdgfc and Fgf10) are differentially regulated in the cardiac fibroblast. CARFMAP is a powerful tool for systems analyses of cardiac fibroblasts, facilitating systems-level cardiovascular research.	[Nim, Hieu T.; Furtado, Milena B.; Costa, Mauro W.; Kitano, Hiroaki; Rosenthal, Nadia A.; Boyd, Sarah E.] Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia; [Nim, Hieu T.; Boyd, Sarah E.] Monash Univ, Fac Informat Technol, Clayton, Vic 3800, Australia; [Kitano, Hiroaki] RIKEN Ctr Integrat Med Sci, Lab Dis Syst Modeling, Yokohama, Kanagawa, Japan; [Kitano, Hiroaki] Okinawa Inst Sci & Technol, Kunigami, Okinawa, Japan; [Rosenthal, Nadia A.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London W12 0NN, England; [Rosenthal, Nadia A.] Jackson Lab, Bar Harbor, ME 04609 USA	Australian Regenerative Medicine Institute; Monash University; Monash University; RIKEN; Okinawa Institute of Science & Technology Graduate University; Imperial College London; Jackson Laboratory	Nim, HT (corresponding author), Monash Univ, Australian Regenerat Med Inst, Clayton, Vic 3800, Australia.	hieu.nim@monash.edu; sarah.boyd@monash.edu	Boyd, Sarah E/I-9047-2012; Costa, Mauro W/S-9219-2018	Costa, Mauro W/0000-0003-3579-8625; Boyd, Sarah/0000-0002-7264-8602; Rosenthal, Nadia/0000-0002-7599-7365	ARC Discovery Grant [DP130104792]; NHMRC Australia Fellowship; NHRMC Project Grant [AP1069710]; State Government of Victoria; Australian Government	ARC Discovery Grant(Australian Research Council); NHMRC Australia Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHRMC Project Grant; State Government of Victoria; Australian Government(Australian GovernmentCGIAR)	ARC Discovery Grant DP130104792 to SEB and HK; NHMRC Australia Fellowship to NR. NHRMC Project Grant AP1069710 to NAR and MWC. The Australian Regenerative Medicine Institute is supported by grants from the State Government of Victoria and the Australian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anversa P, 2013, MAYO CLIN PROC, V88, P871, DOI 10.1016/j.mayocp.2013.04.001; Banerjee I, 2007, AM J PHYSIOL-HEART C, V293, pH1883, DOI 10.1152/ajpheart.00514.2007; Bassingthwaighte J, 2009, EXP PHYSIOL, V94, P597, DOI 10.1113/expphysiol.2008.044099; Baum J, 2011, J CARDIOVASC PHARM, V57, P376, DOI 10.1097/FJC.0b013e3182116e39; Bruno CM, 2003, PANMINERVA MED, V45, P151; Bujak M, 2008, J AM COLL CARDIOL, V51, P1384, DOI 10.1016/j.jacc.2008.01.011; Camelliti P, 2006, ADV CARDIOL, V42, P132, DOI 10.1159/000092566; Caron E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.108; Chen W, 2013, BBA-MOL CELL RES, V1833, P945, DOI 10.1016/j.bbamcr.2012.08.023; Choi SJ, 2009, EUR J HUM GENET, V17, P774, DOI 10.1038/ejhg.2008.245; de Jong HJI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041289; Fu JD, 2013, STEM CELL REP, V1, P235, DOI 10.1016/j.stemcr.2013.07.005; Furtado MB, 2014, GENOM DATA, V2, P345, DOI 10.1016/j.gdata.2014.10.006; Furtado MB, 2014, CIRC RES, V114, P1422, DOI 10.1161/CIRCRESAHA.114.302530; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Ghosh S, 2011, NAT REV GENET, V12, P821, DOI 10.1038/nrg3096; Gu CH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074050; Gupta MK, 2013, OMICS, V17, P584, DOI 10.1089/omi.2013.0007; Hunter P, 2005, PHYSIOLOGY, V20, P316, DOI 10.1152/physiol.00022.2005; Hyduke DR, 2010, NAT REV GENET, V11, P297, DOI 10.1038/nrg2750; Ito N, 2007, AM J HYPERTENS, V20, P792, DOI 10.1016/j.amjhyper.2007.02.004; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Karr JR, 2012, CELL, V150, P389, DOI 10.1016/j.cell.2012.05.044; Kohl P, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.51; Krenning G, 2010, J CELL PHYSIOL, V225, P631, DOI 10.1002/jcp.22322; Ma LP, 2012, INT J CARDIOL, V155, P20, DOI 10.1016/j.ijcard.2011.01.085; Moore-Morris T, 2014, CIRC RES, V115, P602, DOI 10.1161/CIRCRESAHA.114.304854; Ng A, 2006, BRIEF BIOINFORM, V7, P318, DOI 10.1093/bib/bbl036; Nim HT, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0578-0; Nim HT, 2015, PROG BIOPHYS MOL BIO, V117, P69, DOI 10.1016/j.pbiomolbio.2014.11.006; Padwal MK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092481; Plichta JK, 2012, J BURN CARE RES, V33, P299, DOI 10.1097/BCR.0b013e318240540a; Poux S, 2014, J BIOL DATABASES CUR, V2014, P10; Qian L, 2013, CIRC RES, V113, P915, DOI 10.1161/CIRCRESAHA.112.300625; Rando TA, 2013, NEW ENGL J MED, V369, P575, DOI 10.1056/NEJMcibr1306063; Rebholz-Schuhmann D, 2012, NAT REV GENET, V13, P829, DOI 10.1038/nrg3337; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Snider P, 2009, CIRC RES, V105, P934, DOI 10.1161/CIRCRESAHA.109.201400; Souders CA, 2009, CIRC RES, V105, P1164, DOI 10.1161/CIRCRESAHA.109.209809; Stennard FA, 2003, DEV BIOL, V262, P206, DOI 10.1016/S0012-1606(03)00385-3; Van Landeghem S, 2013, PLANT CELL, V25, P794, DOI 10.1105/tpc.112.108753; Wagner JA, 1996, J EXP MED, V183, P2417, DOI 10.1084/jem.183.6.2417; Xin M, 2013, NAT REV MOL CELL BIO, V14, P529, DOI 10.1038/nrm3619; Ye S, 1996, J BIOL CHEM, V271, P13055, DOI 10.1074/jbc.271.22.13055	44	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0143274	10.1371/journal.pone.0143274	http://dx.doi.org/10.1371/journal.pone.0143274			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673252	Green Submitted, gold, Green Published			2022-12-26	WOS:000366722700008
J	Smit, R; Postma, MJ				Smit, Renata; Postma, Maarten J.			The Burden of Tick-Borne Encephalitis in Disability-Adjusted Life Years (DALYs) for Slovenia	PLOS ONE			English	Article							GLOBAL BURDEN; COST-EFFECTIVENESS; CLINICAL-COURSE; VACCINATION; TBE; EPIDEMIOLOGY; DISEASE; AGE; AWARENESS; PREVENTION	Background Tick-borne encephalitis (TBE) presents an increasing burden in many parts of Europe, Asian Russia, Siberia, Asian former USSR and Far East. Incidence can be considered as one way to express the burden. A more comprehensive measure concerns disability-adjusted life years (DALYs), better characterizing the full burden of TBE. TBE burden in DALYs has not yet been estimated, nor has it been specified by the Global Burden of Disease (GBD) studies. Objective The purpose of the present study is to estimate the burden of TBE in Slovenia, expressed in DALYs, both from the population and individual perspectives. We discuss the impact of TBE burden on public health and potential strategies to reduce this burden in Slovenia. Methods The burden of TBE is estimated by using the updated DALYs' methodology first introduced in the GBD project. The DALYs. calculations are based on the health outcomes of the natural course of the disease being modelled. Corrections for under-reporting and under-ascertainment are applied. The impact of uncertainty in parameters in the model was assessed using sensitivity analyses. Results From the population perspective, total DALYs amount to 3,450 (167.8 per 100,000 population), while from the individual perspective they amount to 3.1 per case in 2011. Notably, the consequences of TBE present a larger burden than TBE itself. Conclusions TBE presents a relatively high burden expressed in DALYs compared with estimates for other infectious diseases from the GBD 2010 study for Slovenia. Raising awareness and increasing vaccination coverage are needed to reduce TBE and its consequences.	[Smit, Renata; Postma, Maarten J.] Univ Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon PE2, Groningen, Netherlands; [Smit, Renata; Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Inst Sci Hlth Aging & healthcaRE SHARE, Groningen, Netherlands; [Postma, Maarten J.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Smit, R (corresponding author), Univ Groningen, Dept Pharm, Unit PharmacoEpidemiol & PharmacoEcon PE2, Groningen, Netherlands.	renata_smit@t-2.net		Postma, Maarten/0000-0002-6306-3653; Smit, Dr. Renata/0000-0002-2175-3648				Airoldi M, 2009, HEALTH ECON, V18, P1237, DOI 10.1002/hec.1424; Amicizia D, 2013, HUM VACC IMMUNOTHER, V9, P1163, DOI 10.4161/hv.23802; Anand S, 1997, J HEALTH ECON, V16, P685, DOI 10.1016/S0167-6296(97)00005-2; Arnesen T, 2004, HEALTH POLICY, V70, P137, DOI 10.1016/j.healthpol.2003.08.004; Barendregt JJ, 1996, B WORLD HEALTH ORGAN, V74, P439; Bognar G, 2008, ECON PHILOS, V24, P167, DOI 10.1017/S026626710800179X; Broker Michael, 2003, Travel Med Infect Dis, V1, P181, DOI 10.1016/j.tmaid.2003.07.001; Cizman M, 1999, WIEN KLIN WOCHENSCHR, V111, P484; Demicheli V, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000977.pub2; Dumpis U, 1999, CLIN INFECT DIS, V28, P882, DOI 10.1086/515195; European Centre for Disease Prevention and Control, 2012, EP SIT TICK BORN ENC; Gibbons CL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-147; Grgic-Vitek M, 2014, VACCINE, V32, P2944, DOI 10.1016/j.vaccine.2013.05.093; Grgic-Vitek M, 2011, VACCINE, V29, P5178, DOI 10.1016/j.vaccine.2011.05.033; Haglund M, 2003, VACCINE, V21, pS11, DOI 10.1016/S0264-410X(02)00811-3; Hansmann Y, 2004, MED MALADIES INFECT, V34, pS28, DOI 10.1016/S0399-077X(04)90009-1; Heinz FX, 2007, VACCINE, V25, P7559, DOI 10.1016/j.vaccine.2007.08.024; Institute for Health Metrics and Evaluation, 2019, GBD DAT, DOI DOI 10.6069/VFWJ-JF14; International Scientific Working Group on Tick-Borne Encephalitis (ISW-TBE), 2015, ECDC PRES TICK BORN; Jereb M, 2006, WIEN KLIN WOCHENSCHR, V118, P765, DOI 10.1007/s00508-006-0728-5; Kaiser R, 1999, BRAIN, V122, P2067, DOI 10.1093/brain/122.11.2067; Kaiser R, 2002, INT J MED MICROBIOL, V291, P58, DOI 10.1016/S1438-4221(02)80012-1; Kaiser R, 2008, INFECT DIS CLIN N AM, V22, P561, DOI 10.1016/j.idc.2008.03.013; Kelly TA, 2013, EMERG INFECT DIS, V19, P1428, DOI 10.3201/eid1909.130201; Kollaritsch H, BACKGROUND DOCUMENT; Kollaritsch H, 2011, VACCINE, V29, P4556, DOI 10.1016/j.vaccine.2011.04.061; Kretzschmar M, 2012, NEW METHODOLOGY ESTI, V9, DOI [10.1371/journal.pmed.1001205, DOI 10.1371/JOURNAL.PMED.1001205]; Kunz C., 1992, Acta Leidensia, V60, P1; Kunz C, 2003, VACCINE, V21, pS50, DOI 10.1016/S0264-410X(02)00813-7; Kunze U, 2005, WIEN MED WOCHENSCHR, V155, P289, DOI 10.1007/s10354-005-0178-0; Kunze U, 2010, WIEN MED WOCHENSCHR, V160, P252, DOI 10.1007/s10354-010-0798-x; Kunze Ursula, 2010, Vaccine, V28, P875, DOI 10.1016/j.vaccine.2009.11.032; Lesnicar G, 2003, PEDIATR INFECT DIS J, V22, P612, DOI 10.1097/00006454-200307000-00009; Lindenbach B.D., 2001, FIELDS VIROLOGY, V1, P991, DOI DOI 10.1016/J.JMB.2013.11.024; Lindquist L, 2008, LANCET, V371, P1861, DOI 10.1016/S0140-6736(08)60800-4; Livartowski A, 1996, VACCINE, V14, P495, DOI 10.1016/0264-410X(95)00223-N; Logar M, 2000, INFECTION, V28, P74, DOI 10.1007/s150100050050; Logar M, 2006, WIEN KLIN WOCHENSCHR, V118, P702, DOI 10.1007/s00508-006-0699-6; Lyttkens Carl Hampus, 2003, Eur J Health Econ, V4, P195, DOI 10.1007/s10198-003-0169-2; Mangen M, 2011, METHODOLOGY PROTOCOL; Mangen MJJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079740; Mansfield KL, 2009, J GEN VIROL, V90, P1781, DOI 10.1099/vir.0.011437-0; Mantke OD, 2008, SURVEY CASES TICK BO; Maximova OA, 2009, J HISTOCHEM CYTOCHEM, V57, P973, DOI 10.1369/jhc.2009.954180; Mickiene A, 2002, CLIN INFECT DIS, V35, P650, DOI 10.1086/342059; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Murray CJL, 2012, LANCET, V380, P2063, DOI 10.1016/S0140-6736(12)61899-6; Murray CJ, 2010, LANCET, V380, P2055; Murray CJ, 2010, COMPREHENSIVE SYSTEM, P2063; Murray CJL, 1997, J HEALTH ECON, V16, P703, DOI 10.1016/S0167-6296(97)00004-0; Murray CJL, 2003, POP STUD-J DEMOG, V57, P165, DOI 10.1080/0032472032000097083; Murray CJL, 1997, LANCET, V349, P1347, DOI 10.1016/S0140-6736(96)07494-6; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; MURRAY CJL, 1994, B WORLD HEALTH ORGAN, V72, P429; Murray CJL, 1997, LANCET, V349, P1436, DOI 10.1016/S0140-6736(96)07495-8; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nacionalni institut za javno zdravje (NIJZ), 2014, EP SPREM NAL ZLIJ BO; Nacionalni institut za javno zdravje (NIJZ), 2014, NAV IZV PROGR CEPLJ; Nacionalni institut za javno zdravje (NIJZ), PRIP CEPLJ PROT KLOP; Radsel-Medvescek A, 1980, ARBOVIRUSES MEDITERR, V9, P281; Rakar R, BEDJ S TICK BORN MEN, P37; Randolph SE, 2010, VET PARASITOL, V167, P92, DOI 10.1016/j.vetpar.2009.09.011; Salomon JA, 2004, BMJ-BRIT MED J, V328, P258, DOI 10.1136/bmj.37963.691632.44; Salomon JA, 2002, POPUL DEV REV, V28, P205, DOI 10.1111/j.1728-4457.2002.00205.x; Smit R, 2014, REV TICK BORNE ENCEP, P1; Smit R, 2012, VACCINE, V30, P6301, DOI 10.1016/j.vaccine.2012.07.083; Statistical Office of the Republic of Slovenia, 2014, POP LARG 5 YEAR AG G; Suss J, 2011, TICKS TICK-BORNE DIS, V2, P2, DOI 10.1016/j.ttbdis.2010.10.007; Suss J, 2010, WIEN MED WOCHENSCHR, V160, P94, DOI 10.1007/s10354-010-0756-7; Suss J, 2008, Euro Surveill, V13; Suss J, 2003, VACCINE, V21, pS19, DOI 10.1016/S0264-410X(02)00812-5; van Lier E A, 2007, Euro Surveill, V12, pE3; van Lier EA, DIS BURDEN INFECT DI; WHO, METH DAT SOURC GLOB; WHO, DISABILITY WEIGHTS D; World Health Organization, GLOB BURD DIS CONC; World Health Organization, WORLD HLTH REP 2000; World Health Organization, GLOB BURD DIS GBD; World Health Organization, 2004, GLOB BURD DIS 2004 U; World Health Organization (WHO), DEFINITION; Zavadska D, 2013, HUM VACC IMMUNOTHER, V9, P362, DOI 10.4161/hv.22766; Zent O, 2005, EXPERT REV VACCINES, V4, P747, DOI 10.1586/14760584.4.5.747	82	18	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144988	10.1371/journal.pone.0144988	http://dx.doi.org/10.1371/journal.pone.0144988			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26672751	Green Published, gold, Green Submitted			2022-12-26	WOS:000366722700082
J	Xing, HY; Cai, YQ; Wang, XF; Wang, LL; Li, P; Wang, GY; Chen, JH				Xing, Hai-Yan; Cai, Yong-Qing; Wang, Xian-Feng; Wang, Lin-Li; Li, Pan; Wang, Guan-Ying; Chen, Jian-Hong			The Cytoprotective Effect of Hyperoside against Oxidative Stress Is Mediated by the Nrf2-ARE Signaling Pathway through GSK-3 beta Inactivation	PLOS ONE			English	Article							TRANSCRIPTION FACTOR NRF2; HYDROGEN-PEROXIDE; HEME OXYGENASE-1; ANTIOXIDANT RESPONSE; UP-REGULATION; CELL-DAMAGE; QUERCETIN; INVOLVEMENT; ACTIVATION; EXPRESSION	Glycogen synthase kinase-3 beta (GSK-3 beta) acts as a negative regulator of NF-E2 related factor 2 (Nrf2) by inducing Nrf2 degradation and nuclear export. Our previous study demonstrated that the flavonoid hyperoside elicits cytoprotection against oxidative stress by activating the Keap1-Nrf2-ARE signaling pathway, thus increasing the expression of antioxidant enzymes, such as heme oxygenase-1 (HO-1), superoxide dismutase (SOD) and catalase. However, the role of GSK-3 beta in hyperoside-mediated Nrf2 activation is unclear. Here, we demonstrate that in a normal human hepatocyte cell line, (L02), hyperoside is capable of inducing the phosphorylation of GSK-3 beta at Ser9 without affecting the protein levels of GSK-3 beta and its phosphorylation at Thr390. Lithium chloride (LiCl) and short interfering RNA (siRNA)-mediated inhibition of GSK-3 beta significantly enhanced the ability of hyperoside to protect L02 liver cells from H2O2-induced oxidative damage, leading to increased cell survival shown by the maintenance of cell membrane integrity and elevated levels of glutathione (GSH), one of the endogenous antioxidant biomarkers. Further study showed that LiCl and siRNA-mediated inhibition of GSK-3 beta increased hyperoside-induced HO-1 expression, and the effect was dependent upon enhanced Nrf2 nuclear translocation and gene expression. These activities were followed by ARE-mediated transcriptional activation in the presence of hyperoside, which was abolished by the transfection of the cells with Nrf2 siRNA. Furthermore, the siRNA-mediated inhibition of Keap1 also enhanced hyperoside-induced Nrf2 nuclear accumulation and HO-1 expression, which was relatively smaller than the effects obtained from GSK-3 beta siRNA administration. Moreover, Keap1 siRNA administration alone had no significant effect on the phosphorylation and protein expression of GSK-3 beta. Collectively, our data provide evidence that hyperoside attenuates H2O2 -induced L02 cell damage by activating the Nrf2-ARE signaling pathway through both an increase in GSK-3 beta inhibitory phosphorylation at Ser9 and an inhibition of Keap1 and that hyperoside-mediated GSK-3 beta inhibition exhibits more significant effects.	[Chen, Jian-Hong] Third Mil Med Univ, Daping Hosp, Dept Pharm, Chongqing 400042, Peoples R China; Third Mil Med Univ, Inst Surg Res, Chongqing 400042, Peoples R China	Army Medical University; Army Medical University	Chen, JH (corresponding author), Third Mil Med Univ, Daping Hosp, Dept Pharm, Chongqing 400042, Peoples R China.	chenjh-110@263.net			National Natural Science Foundation of China [81302867, 81273608]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the grants from the National Natural Science Foundation of China (Grant No. 81302867 and 81273608) http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Martin MA, 2010, J NUTR BIOCHEM, V21, P196, DOI 10.1016/j.jnutbio.2008.10.009; Granado-Serrano AB, 2012, CHEM-BIOL INTERACT, V195, P154, DOI 10.1016/j.cbi.2011.12.005; Bitar MS, 2012, ADIPOCYTE, V1, P161, DOI 10.4161/adip.20235; Choi JH, 2011, J NAT PROD, V74, P1055, DOI 10.1021/np200001x; Dinkova-Kostova AT, 2010, J BIOL CHEM, V285, P33747, DOI 10.1074/jbc.M110.163485; Guo Y, 2015, FREE RADICAL BIO MED, V88, P337, DOI 10.1016/j.freeradbiomed.2015.06.013; Huang CS, 2013, ARCH TOXICOL, V87, P167, DOI 10.1007/s00204-012-0913-4; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Jiang YF, 2015, GUT, V64, P168, DOI 10.1136/gutjnl-2013-306043; Kaspar JW, 2011, FASEB J, V25, P1076, DOI 10.1096/fj.10-171553; Khan RA, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-114; Kim JS, 2010, FITOTERAPIA, V81, P85, DOI 10.1016/j.fitote.2009.08.008; Kronke G, 2003, J BIOL CHEM, V278, P51006, DOI 10.1074/jbc.M304103200; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; Lee KH, 2013, AM J PHYSIOL-LUNG C, V304, pL782, DOI 10.1152/ajplung.00348.2012; Li CC, 2014, NEUROTOXICOL TERATOL, V46, P1, DOI 10.1016/j.ntt.2014.08.007; Li LR, 2014, CHEM-BIOL INTERACT, V209, P56, DOI 10.1016/j.cbi.2013.12.005; Li ZL, 2013, FREE RADICAL BIO MED, V57, P132, DOI 10.1016/j.freeradbiomed.2012.12.023; Li ZL, 2012, J ETHNOPHARMACOL, V139, P388, DOI 10.1016/j.jep.2011.11.020; Mari M, 2010, ANTIOXID REDOX SIGN, V12, P1295, DOI 10.1089/ars.2009.2634; Morse D, 2002, AM J RESP CELL MOL, V27, P8, DOI 10.1165/ajrcmb.27.1.4862; Narasimhan M, 2014, TOXICOL LETT, V228, P179, DOI 10.1016/j.toxlet.2014.05.020; Narasimhan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051111; Piao MJ, 2008, BBA-GEN SUBJECTS, V1780, P1448, DOI 10.1016/j.bbagen.2008.07.012; Qiu LX, 2015, WORLD J GASTROENTERO, V21, P1099, DOI 10.3748/wjg.v21.i4.1099; Rada P, 2012, MOL CELL BIOL, V32, P3486, DOI 10.1128/MCB.00180-12; Rada P, 2011, MOL CELL BIOL, V31, P1121, DOI 10.1128/MCB.01204-10; Rojo AI, 2008, MOL CELL NEUROSCI, V39, P125, DOI 10.1016/j.mcn.2008.06.007; Rojo AI, 2014, ANTIOXID REDOX SIGN, V21, P2498, DOI 10.1089/ars.2014.5843; Rojo AI, 2012, FREE RADICAL BIO MED, V52, P473, DOI 10.1016/j.freeradbiomed.2011.11.003; Serviddio G, 2010, CURR MED CHEM, V17, P2325, DOI 10.2174/092986710791698530; Shang GG, 2015, J NUTR BIOCHEM, V26, P596, DOI 10.1016/j.jnutbio.2014.12.008; Sun GB, 2012, TOXICOL APPL PHARM, V265, P229, DOI 10.1016/j.taap.2012.10.002; Thornton TM, 2008, SCIENCE, V320, P667, DOI 10.1126/science.1156037; Weng CJ, 2011, NEW BIOTECHNOL, V28, P767, DOI 10.1016/j.nbt.2011.05.003; Xi YD, 2012, CURR NEUROVASC RES, V9, P32, DOI 10.2174/156720212799297092; Xia SF, 2015, PHYSIOL BEHAV, V138, P325, DOI 10.1016/j.physbeh.2014.09.008; Xing HY, 2011, BIOCHEM BIOPH RES CO, V410, P759, DOI 10.1016/j.bbrc.2011.06.046; Yang HP, 2015, ANTIOXID REDOX SIGN, V22, P259, DOI 10.1089/ars.2014.6027; Zenkov NK, 2013, BIOCHEMISTRY-MOSCOW+, V78, P19, DOI 10.1134/S0006297913010033; Zhou J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101668; Zhou L, 2012, J MED FOOD, V15, P461, DOI 10.1089/jmf.2011.1921; Zhou YY, 2014, INT J NEUROPSYCHOPH, V17, P635, DOI 10.1017/S146114571300148X; Zou Y, 2013, FREE RADICAL RES, V47, P55, DOI 10.3109/10715762.2012.742518	44	51	55	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145183	10.1371/journal.pone.0145183	http://dx.doi.org/10.1371/journal.pone.0145183			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674355	Green Submitted, Green Published, gold			2022-12-26	WOS:000366722700112
J	Balvan, J; Gumulec, J; Raudenska, M; Krizova, A; Stepka, P; Babula, P; Kizek, R; Adam, V; Masarik, M				Balvan, Jan; Gumulec, Jaromir; Raudenska, Martina; Krizova, Aneta; Stepka, Petr; Babula, Petr; Kizek, Rene; Adam, Vojtech; Masarik, Michal			Oxidative Stress Resistance in Metastatic Prostate Cancer: Renewal by Self-Eating	PLOS ONE			English	Article							NF-KAPPA-B; CELL-DEATH; INDUCED MITOPHAGY; FLOW-CYTOMETRY; SOMATIC-CELLS; UP-REGULATION; AUTOPHAGY; PLURIPOTENCY; SENESCENCE; APOPTOSIS	Resistant cancer phenotype is a key obstacle in the successful therapy of prostate cancer. The primary aim of our study was to explore resistance mechanisms in the advanced type of prostate cancer cells (PC-3) and to clarify the role of autophagy in these processes. We performed time-lapse experiment (48 hours) with ROS generating plumbagin by using multimodal holographic microscope. Furthermore, we also performed the flow-cytometric analysis and the qRT-PCR gene expression analysis at 12 selected time points. TEM and confocal microscopy were used to verify the results. We found out that autophagy (namely mitophagy) is an important resistance mechanism. The major ROS producing mitochondria were coated by an autophagic membrane derived from endoplasmic reticulum and degraded. According to our results, increasing ROS resistance may be also accompanied by increased average cell size and polyploidization, which seems to be key resistance mechanism when connected with an escape from senescence. Many different types of cellcell interactions were recorded including entosis, vesicular transfer, eating of dead or dying cells, and engulfment and cannibalism of living cells. Entosis was disclosed as a possible mechanism of polyploidization and enabled the long-term survival of cancer cells. Significantly reduced cell motility was found after the plumbagin treatment. We also found an extensive induction of pluripotency genes expression (NANOG, SOX2, and POU5F1) at the time-point of 20 hours. We suppose, that overexpression of pluripotency genes in the portion of prostate tumour cell population exposed to ROS leads to higher developmental plasticity and capability to faster respond to changes in the extracellular environment that could ultimately lead to an alteration of cell fate.	[Balvan, Jan; Gumulec, Jaromir; Raudenska, Martina; Masarik, Michal] Masaryk Univ, Fac Med, Dept Pathol Physiol, CZ-62500 Brno, Czech Republic; [Balvan, Jan; Gumulec, Jaromir; Raudenska, Martina; Krizova, Aneta; Kizek, Rene; Adam, Vojtech] Brno Univ Technol, Cent European Inst Technol, CZ-61600 Brno, Czech Republic; [Krizova, Aneta] TESCAN Brno Sro, Brno, Czech Republic; [Stepka, Petr; Babula, Petr] Masaryk Univ, Fac Med, Dept Physiol, CZ-62500 Brno, Czech Republic; [Kizek, Rene; Adam, Vojtech] Mendel Univ Brno, Dept Chem & Biochem, CZ-61300 Brno, Czech Republic	Masaryk University Brno; Brno University of Technology; Masaryk University Brno; Mendel University in Brno	Masarik, M (corresponding author), Masaryk Univ, Fac Med, Dept Pathol Physiol, Kamenice 5, CZ-62500 Brno, Czech Republic.	masarik@med.muni.cz	Křížová, Aneta/G-8475-2014; Gumulec, Jaromir/D-7638-2012; Adam, Vojtech/D-7686-2012; Raudenska, Martina/F-9187-2012; Křížová, Aneta/ABC-9504-2021; Masarik, Michal/D-9920-2012; Babula, Petr/AAL-6510-2020; Balvan, Jan/I-2945-2012; Stepka, Petr/AAX-5425-2020	Gumulec, Jaromir/0000-0002-9658-3444; Adam, Vojtech/0000-0002-8527-286X; Raudenska, Martina/0000-0001-8258-6671; Křížová, Aneta/0000-0002-9919-6204; Masarik, Michal/0000-0003-1172-7195; Stepka, Petr/0000-0003-4918-3103; Kizek, Rene/0000-0002-0467-6169	Faculty of Medicine, Masaryk University; Specific University Research Grant [MUNI/A/1549/2014, MUNI/A/1326/2014]; Ministry of Education, Youth and Sports of the Czech Republic; commercial company (TESCAN)	Faculty of Medicine, Masaryk University; Specific University Research Grant; Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); commercial company (TESCAN)	This work was supported by funds from the Faculty of Medicine, Masaryk University to junior researcher (Michal Masarik) and by the project MUNI/A/1549/2014 and MUNI/A/1326/2014 with the support of the Specific University Research Grant, as provided by the Ministry of Education, Youth and Sports of the Czech Republic in the year 2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The commercial company (TESCAN) provided support in the form of salary for author Aneta Krizova, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abreu M, 2012, PLOS ONE, P7; Aitken RJ, 2012, J BIOL CHEM, V287, P33048, DOI 10.1074/jbc.M112.366690; Ashrafi G, 2013, CELL DEATH DIFFER, V20, P31, DOI 10.1038/cdd.2012.81; Balvan J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121674; Barbieri CE, 2013, EUR UROL, V64, P567, DOI 10.1016/j.eururo.2013.05.029; BARER R, 1957, J OPT SOC AM, V47, P545, DOI 10.1364/JOSA.47.000545; Basu HS, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.AM2015-2899; Beausejour CM, 2003, EMBO J, V22, P4212, DOI 10.1093/emboj/cdg417; Bertram J, 2006, PROSTATE, V66, P895, DOI 10.1002/pros.20411; Bockler S, 2014, DEV CELL, V28, P450, DOI 10.1016/j.devcel.2014.01.012; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buchheit CL, 2014, NAT REV CANCER, V14, P632, DOI 10.1038/nrc3789; CARROLL AG, 1993, PROSTATE, V23, P123, DOI 10.1002/pros.2990230206; Castro FAV, 2008, PLOS ONE, P3; Chan LLY, 2012, AUTOPHAGY, V8, P1371, DOI 10.4161/auto.21028; Choucair K, 2012, BMC CANCER, P12; DAVIES HG, 1952, NATURE, V169, P541, DOI 10.1038/169541a0; Degenhardt K, 2006, CANCER CELL, V10, P51, DOI 10.1016/j.ccr.2006.06.001; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Erenpreisa J, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-92; Florey O, 2011, NAT CELL BIOL, V13, P1335, DOI 10.1038/ncb2363; Gumulec J, 2014, INT J ONCOL, V44, P923, DOI 10.3892/ijo.2013.2223; Gustin JA, 2001, J BIOL CHEM, V276, P27740, DOI 10.1074/jbc.M102559200; Howe EN, 2012, PLOS ONE, P7; Ibrahim P, 1997, LETT APPL MICROBIOL, V25, P437, DOI 10.1111/j.1472-765X.1997.tb00013.x; Karantza-Wadsworth V, 2007, GENE DEV, V21, P1621, DOI 10.1101/gad.1565707; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Kohsaka S, 2011, BIOCHEM BIOPH RES CO, V410, P878, DOI 10.1016/j.bbrc.2011.06.082; Kolman P, 2010, OPT EXPRESS, V18, P21990, DOI 10.1364/OE.18.021990; Krajcovic M, 2013, MOL BIOL CELL, V24, P3736, DOI 10.1091/mbc.E13-07-0408; Krajcovic M, 2011, NAT CELL BIOL, V13, P324, DOI 10.1038/ncb2174; Kroemer G, 2014, CELL RES, V24, P1280, DOI 10.1038/cr.2014.133; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; Lim LY, 2009, BRIT J CANCER, V101, P1606, DOI 10.1038/sj.bjc.6605335; Ling GQ, 2012, ONCOL LETT, V4, P1264, DOI 10.3892/ol.2012.916; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Liu YQ, 2013, ACTA PHARMACOL SIN, V34, P1183, DOI 10.1038/aps.2013.68; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mali P, 2008, STEM CELLS, V26, P1998, DOI 10.1634/stemcells.2008-0346; Mancuso P, 2009, CLIN CANCER RES, V15, P3640, DOI 10.1158/1078-0432.CCR-09-0591; Marullo R, 2013, PLOS ONE, P8; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Menendez JA, 2011, CELL CYCLE, V10, P3658, DOI 10.4161/cc.10.21.18128; Mitchell R, 2014, STEM CELLS, V32, P2178, DOI 10.1002/stem.1721; Nakajima S, 2011, FEBS LETT, V585, P2249, DOI 10.1016/j.febslet.2011.05.047; Panov A, 2013, PLOS ONE, P8; Parganlija D, 2014, PLOS ONE, P9; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Powolny AA, 2008, PHARM RES-DORDR, V25, P2171, DOI 10.1007/s11095-008-9533-3; Qian W, 2005, AM J PHYSIOL-CELL PH, V289, pC1466, DOI 10.1152/ajpcell.00265.2005; Roca H, 2008, J BIOL CHEM, V283, P25057, DOI 10.1074/jbc.M801073200; Roca H, 2008, AUTOPHAGY, V4, P969, DOI 10.4161/auto.6822; RUBIN SJ, 1991, J SURG ONCOL, V46, P31, DOI 10.1002/jso.2930460108; Rufini A, 2013, ONCOGENE, V32, P5129, DOI 10.1038/onc.2012.640; Salmina K, 2010, EXP CELL RES, V316, P2099, DOI 10.1016/j.yexcr.2010.04.030; Sandur SK, 2006, J BIOL CHEM, V281, P17023, DOI 10.1074/jbc.M601595200; Saunders A, 2013, STEM CELLS, V31, P1227, DOI 10.1002/stem.1384; Sedletska Yuliya, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P251, DOI 10.2174/1568011053765967; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Slaby T, 2013, OPT EXPRESS, V21, P14747, DOI 10.1364/OE.21.014747; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Sun Q, 2014, CELL RES, V24, P1299, DOI 10.1038/cr.2014.138; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan AS, 2015, CELL METAB, V21, P81, DOI 10.1016/j.cmet.2014.12.003; Udovich JA, 2009, J MICROSC-OXFORD, V234, P124, DOI 10.1111/j.1365-2818.2009.03153.x; Wlodkowic D, 2011, METHODS MOL BIOL, V740, P81, DOI 10.1007/978-1-61779-108-6_10; Wu Z, 2006, PROSTATE, V66, P1114, DOI 10.1002/pros.20447; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zemskova M, 2010, MOL CANCER RES, V8, P1126, DOI 10.1158/1541-7786.MCR-10-0174; Zhang HF, 2008, J BIOL CHEM, V283, P10892, DOI 10.1074/jbc.M800102200; Zhang H, 2015, J BIOL CHEM, V290, P1129, DOI 10.1074/jbc.M114.590943; Zhang L, 2014, BIOMED RES INT; Zhang S, 2014, ONCOGENE, V33, P116, DOI 10.1038/onc.2013.96; Zhang SW, 2014, INT J CANCER, V134, P508, DOI 10.1002/ijc.28319	77	17	17	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145016	10.1371/journal.pone.0145016	http://dx.doi.org/10.1371/journal.pone.0145016			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671576	Green Submitted, Green Published, gold			2022-12-26	WOS:000366719300039
J	Seboxa, T; Amogne, W; Abebe, W; Tsegaye, T; Azazh, A; Hailu, W; Fufa, K; Grude, N; Henriksen, TH				Seboxa, Teshale; Amogne, Wondwossen; Abebe, Workeabeba; Tsegaye, Tewodros; Azazh, Aklilu; Hailu, Workagegnehu; Fufa, Kebede; Grude, Nils; Henriksen, Thor-Henrik			High Mortality from Blood Stream Infection in Addis Ababa, Ethiopia, Is Due to Antimicrobial Resistance	PLOS ONE			English	Article							BETA-LACTAMASE PRODUCTION; ESCHERICHIA-COLI; EPIDEMIOLOGY; SEPSIS; PNEUMONIAE; BACTEREMIA; SEPTICEMIA; MORBIDITY; OUTCOMES; PATIENT	Background Managing blood stream infection in Africa is hampered by lack of bacteriological support needed for antimicrobial stewardship, and background data needed for empirical treatment. A combined pro-and retrospective approach was used to overcome thresholds in clinical research in Africa. Methods Outcome and characteristics including age, HIV infection, pancytopenia and bacteriological results were studied in 292 adult patients with two or more SIRS criteria using univariate and confirming multivariate logistic regression models. Expected randomly distributed resistance covariation was compared with observed co-resistance among gram-negative enteric bacteria in 92 paediatric blood culture isolates that had been harvested in the same hospital during the same period of time. Results Mortality was fivefold increased among patients with positive blood culture results [50.0% vs. 9.8%; OR 11.24 (4.38-25.88), p < 0.0001], and for this group of patients mortality was significantly associated with antimicrobial resistance [OR 23.28 (3.3-164.4), p = 0.002]. All 11 patients with Enterobacteriaceae resistant to 3rd. generation cephalosporins died. Eighty-nine patients had pancytopenia grade 3-4. Among patients with negative blood culture results, mortality was significantly associated with pancytopenia [OR 3.12 (1.32-7.39), p = 0.01]. HIV positivity was not associated with increased mortality. Antimicrobial resistance that concerned gram-negative enteric bacteria, regardless of species, was characterized by co-resistance between third generation cephalosporins, gentamicin, chloramphenicol, and co-trimoxazole. Conclusion Mortality was strongly associated with growth of bacteria resistant to empirical treatment, and these patients were dead or dying when bacteriological reports arrived. Because of coresistance, alternative efficient antibiotics would not have been available in Ethiopia for 8/11 Enterobacteriaceae-infected patients with isolates resistant to third generation cephalosporins. Strong and significant resistance covariation between 3rd. generation cephalosporins, chloramphenicol, gentamicin, and co-trimoxazole was identified. Pronounced pancytopenia was common and associated with increased mortality. HIV positive patients had no excess mortality.	[Seboxa, Teshale; Amogne, Wondwossen; Tsegaye, Tewodros; Hailu, Workagegnehu; Henriksen, Thor-Henrik] Univ Addis Ababa, Sch Med, Dept Internal Med, Addis Ababa, Ethiopia; [Abebe, Workeabeba] Univ Addis Ababa, Sch Med, Dept Pediat & Child Hlth, Addis Ababa, Ethiopia; [Azazh, Aklilu] Univ Addis Ababa, Sch Med, Dept Emergency & Crit Care Med, Addis Ababa, Ethiopia; [Fufa, Kebede] Black Lion Hosp, Dept Microbiol, Addis Ababa, Ethiopia; [Grude, Nils] Vestfold Hosp Trust, Dept Microbiol, Tonsberg, Norway; [Henriksen, Thor-Henrik] Vestfold Hosp Trust, Dept Med, Tonsberg, Norway	Addis Ababa University; Addis Ababa University; Addis Ababa University	Henriksen, TH (corresponding author), Univ Addis Ababa, Sch Med, Dept Internal Med, Addis Ababa, Ethiopia.	thor-henrik.henriksen@siv.no	Amogne, Wondwossen/AGM-9855-2022; Degu, Wondwossen Amogne/GON-3590-2022	Ayele, Tewodros/0000-0003-0705-0222	Vestfold Hospital Trust, Norway	Vestfold Hospital Trust, Norway	The project was financed by research grants from Vestfold Hospital Trust, Norway. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu Agersew, 2012, BMC Res Notes, V5, P197, DOI 10.1186/1756-0500-5-197; Ani C, 2015, CRIT CARE MED, V43, P65, DOI 10.1097/CCM.0000000000000555; [Anonymous], 2005, PRINCIPLES PRACTICE; Ashley EA, 2011, TROP MED INT HEALTH, V16, P1167, DOI 10.1111/j.1365-3156.2011.02822.x; Biadgilign S, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-15; Blomberg B, 2005, J CLIN MICROBIOL, V43, P745, DOI 10.1128/JCM.43.2.745-749.2005; Blomberg B, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-43; CHARLSON ME, 1987, J CHRON DIS, V40, P705, DOI 10.1016/0021-9681(87)90107-X; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen CJ, 2014, CLIN MICROBIOL INFEC, V20, P605, DOI 10.1111/1469-0691.12705; Cheng WL, 2016, J MICROBIOL IMMUNOL, V49, P208, DOI 10.1016/j.jmii.2014.05.003; Feasey NA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092226; FRIEDLAND IR, 1992, ANTIMICROB AGENTS CH, V36, P1596, DOI 10.1128/AAC.36.8.1596; Cuervo SI, 2014, BIOMEDICA, V34, P170, DOI [10.7705/biomedica.v34i0.1680, 10.1590/S0120-41572014000500020]; Ito S, 2006, INTERNAL MED, V45, P303, DOI 10.2169/internalmedicine.45.1535; Kindie AD DM, 2014, 31 WORLD C BIOM LAB; Kuenzli E, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-528; Kumar A, 2006, J INFECT DIS, V193, P251, DOI 10.1086/498909; Laupland KB, 2004, CRIT CARE MED, V32, P992, DOI 10.1097/01.CCM.0000119424.31648.1E; LAW BJ, 1984, PEDIATR RES, V18, P314, DOI 10.1203/00006450-198404000-00002; Laxminarayan R, 2013, LANCET INFECT DIS, V13, P1057, DOI 10.1016/S1473-3099(13)70318-9; Leistner R, 2014, INFECTION, V42, P991, DOI 10.1007/s15010-014-0670-9; Leistner R, 2014, INFECT DRUG RESIST, V7, P57, DOI 10.2147/IDR.S56984; LINDTJORN B, 1989, ETHIOPIAN MED J, V27, P27; MacVane SH, 2014, J HOSP MED, V9, P232, DOI 10.1002/jhm.2157; McGregor JC, 2005, AM J EPIDEMIOL, V161, P483, DOI 10.1093/aje/kwi068; MOSS W, 1992, ETHIOPIAN MED J, V30, P197; NORM-VET, NORM NORM VET CONS A; OLI K, 1990, CENT AFR J MED, V36, P68; OSLER W, 1892, PRINCIPLES PRACTICE, P114; Rothman KJ, 1986, MODERN EPIDEMIOLOGY, V1, P77; Schrag SJ, 2012, PEDIATR INFECT DIS J, V31, P821, DOI 10.1097/INF.0b013e31825c4b5a; Shallcross LJ, 2014, J ANTIMICROB CHEMOTH, V69, P2883, DOI 10.1093/jac/dku346; Shitaye Demissie, 2010, Ethiop Med J, V48, P11; STEINBIGLER P, 1995, INTERNIST, V36, P608; Tham Johan, 2013, Infect Drug Resist, V6, P93, DOI 10.2147/IDR.S46290; US Department of Health and Human Servies, 2010, COMMON TERMINOLOGY C; Velaphi S, 2009, ANN TROP PAEDIATR, V29, P101, DOI 10.1179/146532809X440716; Vlieghe E, 2009, INT J ANTIMICROB AG, V34, P295, DOI 10.1016/j.ijantimicag.2009.04.015; WHO, 2014, DRUG THER B, V52, P77; Willems E, 2013, INT J ANTIMICROB AG, V41, P99, DOI 10.1016/j.ijantimicag.2012.07.006; Willmann M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-515; World Health Organization, 2014, ANT RES GLOB REP SUR	43	35	38	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144944	10.1371/journal.pone.0144944	http://dx.doi.org/10.1371/journal.pone.0144944			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670718	Green Published, Green Submitted, gold			2022-12-26	WOS:000366719300033
J	Stivers, PJ; Harmonay, L; Hicks, A; Mehmet, H; Morris, M; Robinson, GM; Strack, PR; Savage, MJ; Zaller, DM; Zwierzynski, I; Brandish, PE				Stivers, Peter J.; Harmonay, Lauren; Hicks, Alexandra; Mehmet, Huseyin; Morris, Melody; Robinson, Gain M.; Strack, Peter R.; Savage, Mary J.; Zaller, Dennis M.; Zwierzynski, Izabela; Brandish, Philip E.			Pharmacological Inhibition of O-GlcNAcase Does Not Increase Sensitivity of Glucocorticoid Receptor-Mediated Transrepression	PLOS ONE			English	Article							RNA-POLYMERASE-II; NF-KAPPA-B; TERMINAL DOMAIN; INSENSITIVE ASTHMA; IN-VIVO; C-MYC; PHOSPHORYLATION; GLCNACYLATION; CELLS; TRANSCRIPTION	Glucocorticoid signaling regulates target genes by multiple mechanisms, including the repression of transcriptional activities of nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) though direct protein-protein interactions and subsequent O-GlcNAcylation of RNA polymerase II (pol II). Recent studies have shown that overexpression of O-linked beta-N-acetylglucosamine transferase (OGT), which adds an O-linked beta-N-acetylglucosamine (O-GlcNAc) group to the C-terminal domain of RNA pol II, increases the transrepression effects of glucocorticoids (GC). As O-GlcNAcase (OGA) is an enzyme that removes O-GlcNAc from O-GlcNAcylated proteins, we hypothesized that the potentiation of GC effects following OGT overexpression could be similarly observed via the direct inhibition of OGA, inhibiting O-GlcNAc removal from pol II. Here we show that despite pharmacological evidence of target engagement by a selective small molecule inhibitor of OGA, there is no evidence for a sensitizing effect on glucocorticoid-mediated effects on TNF-alpha promoter activity, or gene expression generally, in human cells. Furthermore, inhibition of OGA did not potentiate glucocorticoid-induced apoptosis in several cancer cell lines. Thus, despite evidence for O-GlcNAc modification of RNA pol II in GR-mediated transrepression, our data indicate that pharmacological inhibition of OGA does not potentiate or enhance glucocorticoid-mediated transrepression.	[Stivers, Peter J.; Harmonay, Lauren; Hicks, Alexandra; Mehmet, Huseyin; Morris, Melody; Robinson, Gain M.; Strack, Peter R.; Zaller, Dennis M.; Brandish, Philip E.] Merck & Co Inc, Boston, MA 02115 USA; [Savage, Mary J.; Zwierzynski, Izabela] Merck & Co Inc, Rahway, NJ 07065 USA	Merck & Company; Merck & Company	Stivers, PJ (corresponding author), Merck & Co Inc, Boston, MA 02115 USA.	peter.stivers@merck.com			Merck Co., Inc.	Merck Co., Inc.(Merck & Company)	The work was funded entirely by Merck & Co., Inc. The funder provided support in the form of salaries for authors PS, LH, AH, HM, MM, PS, MS, DZ, IZ, PB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adcock IM, 2008, CURR ALLERGY ASTHM R, V8, P171, DOI 10.1007/s11882-008-0028-4; Adcock IM, 2003, J ENDOCRINOL, V178, P347, DOI 10.1677/joe.0.1780347; Bachmaier R, 2009, ONCOGENE, V28, P1280, DOI 10.1038/onc.2008.484; Chan MTS, 1998, J ALLERGY CLIN IMMUN, V101, P594, DOI 10.1016/S0091-6749(98)70165-4; CHOU TY, 1995, J BIOL CHEM, V270, P18961, DOI 10.1074/jbc.270.32.18961; Comer FI, 2001, BIOCHEMISTRY-US, V40, P7845, DOI 10.1021/bi0027480; Gao Y, 2001, J BIOL CHEM, V276, P9838, DOI 10.1074/jbc.M010420200; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Gu L, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-150; Gu YC, 2010, CANCER RES, V70, P6344, DOI 10.1158/0008-5472.CAN-09-1887; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Herr I, 2009, RESULTS PROBL CELL D, V49, P191, DOI 10.1007/400_2008_20; Hilgers RHP, 2012, AM J PHYSIOL-HEART C, V303, pH513, DOI 10.1152/ajpheart.01175.2011; Inaba H, 2010, LANCET ONCOL, V11, P1096, DOI 10.1016/S1470-2045(10)70114-5; KELLY WG, 1993, J BIOL CHEM, V268, P10416; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Li MD, 2012, J BIOL CHEM, V287, P12904, DOI 10.1074/jbc.M111.303792; Luecke HF, 2005, GENE DEV, V19, P1116, DOI 10.1101/gad.1297105; Marwick JA, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-33; Marwick JA, 2009, AM J RESP CRIT CARE, V179, P542, DOI 10.1164/rccm.200810-1570OC; Medh RD, 1998, CANCER RES, V58, P3684; Mercado N, 2011, J PHARMACOL EXP THER, V337, P465, DOI 10.1124/jpet.110.175950; Mi WY, 2011, BBA-MOL BASIS DIS, V1812, P514, DOI 10.1016/j.bbadis.2011.01.009; Nissen RM, 2000, GENE DEV, V14, P2314, DOI 10.1101/gad.827900; Ranuncolo SM, 2012, J BIOL CHEM, V287, P23549, DOI 10.1074/jbc.M111.330910; Uhlen M, 2010, NAT BIOTECHNOL, V28, P1248, DOI 10.1038/nbt1210-1248; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035277; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Yuzwa SA, 2012, NAT CHEM BIOL, V8, P393, DOI [10.1038/NCHEMBIO.797, 10.1038/nchembio.797]; Zachara NE, 2006, BBA-MOL CELL BIOL L, V1761, P599, DOI 10.1016/j.bbalip.2006.04.007; Zijlstra GJ, 2012, EUR RESPIR J, V39, P439, DOI 10.1183/09031936.00017911	32	2	2	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145151	10.1371/journal.pone.0145151	http://dx.doi.org/10.1371/journal.pone.0145151			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670328	Green Published, Green Submitted, gold			2022-12-26	WOS:000366719300050
J	Meiser, J; Kramer, L; Sapcariu, SC; Battello, N; Ghelfi, J; D'Herouel, AF; Skupin, A; Hiller, K				Meiser, Johannes; Kraemer, Lisa; Sapcariu, Sean C.; Battello, Nadia; Ghelfi, Jenny; D'Herouel, Aymeric Fouquier; Skupin, Alexander; Hiller, Karsten			Pro-inflammatory Macrophages Sustain Pyruvate Oxidation through Pyruvate Dehydrogenase for the Synthesis of Itaconate and to Enable Cytokine Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						immunology; inflammation; macrophage; metabolic regulation; metabolism; mitochondrial metabolism; pyruvate; Itaconate	REDUCTIVE GLUTAMINE-METABOLISM; DENDRITIC CELL ACTIVATION; TUMOR-NECROSIS-FACTOR; ALPHA-KETOGLUTARATE; CANCER-CELLS; TCA CYCLE; MURINE MACROPHAGES; GLUCOSE-METABOLISM; HYPOXIA; CARBOXYLATION	Upon stimulation with Th1 cytokines or bacterial lipopolysaccharides, resting macrophages shift their phenotype toward a pro-inflammatory state as part of the innate immune response. LPS-activated macrophages undergo profound metabolic changes to adapt to these new physiological requirements. One key step to mediate this metabolic adaptation is the stabilization of HIF1, which leads to increased glycolysis and lactate release, as well as decreased oxygen consumption. HIF1 abundance can result in the induction of the gene encoding pyruvate dehydrogenase kinase 1 (PDK1), which inhibits pyruvate dehydrogenase (PDH) via phosphorylation. Therefore, it has been speculated that pyruvate oxidation through PDH is decreased in pro-inflammatory macrophages. However, to answer this open question, an in-depth analysis of this metabolic branching point was so far lacking. In this work, we applied stable isotope-assisted metabolomics techniques and demonstrate that pyruvate oxidation is maintained in mature pro-inflammatory macrophages. Glucose-derived pyruvate is oxidized via PDH to generate citrate in the mitochondria. Citrate is used for the synthesis of the antimicrobial metabolite itaconate and for lipogenesis. An increased demand for these metabolites decreases citrate oxidation through the tricarboxylic acid cycle, whereas increased glutamine uptake serves to replenish the TCA cycle. Furthermore, we found that the PDH flux is maintained by unchanged PDK1 abundance, despite the presence of HIF1. By pharmacological intervention, we demonstrate that the PDH flux is an important node for M(LPS) macrophage activation. Therefore, PDH represents a metabolic intervention point that might become a research target for translational medicine to treat chronic inflammatory diseases.	[Meiser, Johannes; Kraemer, Lisa; Sapcariu, Sean C.; Battello, Nadia; Ghelfi, Jenny; D'Herouel, Aymeric Fouquier; Skupin, Alexander; Hiller, Karsten] Univ Luxembourg, Luxembourg Ctr Syst Biomed, 6 Ave Swing, L-4367 Belvaux, Luxembourg	University of Luxembourg	Hiller, K (corresponding author), Univ Luxembourg, Luxembourg Ctr Syst Biomed, Metabol Grp, 6 Ave Swing, L-4367 Belvaux, Luxembourg.	karsten.hiller@uni.lu	meiser, johannes/S-7571-2018	meiser, johannes/0000-0002-9093-6210; Hiller, Karsten/0000-0001-9322-5820; SKUPIN, Alexander/0000-0002-8955-8304	Fonds National de la Recherche Luxembourg Grant ATTRACT [A10/03]; AFR [3973022]; Helmholtz Virtual Institute of Complex Molecular Systems in Environmental Health	Fonds National de la Recherche Luxembourg Grant ATTRACT(Luxembourg National Research Fund); AFR(Luxembourg National Research Fund); Helmholtz Virtual Institute of Complex Molecular Systems in Environmental Health	This work was supported in part by the Fonds National de la Recherche Luxembourg Grant ATTRACT A10/03 (to K. H.) and AFR-Postdoc-3973022 (to J. M.). The authors declare that they have no conflicts of interest with the contents of this article.; Recipient of financial support from the Helmholtz Virtual Institute of Complex Molecular Systems in Environmental Health.	Basler T, 2006, J LEUKOCYTE BIOL, V79, P628, DOI 10.1189/jlb.0905520; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; Clementi E, 1998, P NATL ACAD SCI USA, V95, P7631, DOI 10.1073/pnas.95.13.7631; Degrandi D, 2009, J INTERF CYTOK RES, V29, P55, DOI 10.1089/jir.2008.0013; Demaria M, 2010, AGING-US, V2, P823, DOI 10.18632/aging.100232; Denko NC, 2008, NAT REV CANCER, V8, P705, DOI 10.1038/nrc2468; DRAPIER JC, 1988, J IMMUNOL, V140, P2829; Everts B, 2014, NAT IMMUNOL, V15, P323, DOI 10.1038/ni.2833; Fendt SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3236; Filipp FV, 2012, PIGM CELL MELANOMA R, V25, P375, DOI 10.1111/j.1755-148X.2012.00989.x; Gameiro PA, 2013, J BIOL CHEM, V288, P12967, DOI 10.1074/jbc.M112.396796; Garzetti L, 2014, J LEUKOCYTE BIOL, V95, P817, DOI 10.1189/jlb.0913485; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hellwig-Burgel T, 1999, BLOOD, V94, P1561, DOI 10.1182/blood.V94.5.1561.417a06_1561_1567; Hiller K, 2009, ANAL CHEM, V81, P3429, DOI 10.1021/ac802689c; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Imtiyaz HZ, 2010, CURR TOP MICROBIOL, V345, P105, DOI 10.1007/82_2010_74; Infantino V, 2011, BIOCHEM J, V438, P433, DOI 10.1042/BJ20111275; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Jung YJ, 2003, BIOCHEM J, V370, P1011, DOI 10.1042/BJ20021279; Kelly B, 2015, CELL RES, V25, P771, DOI 10.1038/cr.2015.68; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; King A, 2006, ONCOGENE, V25, P4675, DOI 10.1038/sj.onc.1209594; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Leek RD, 2002, J MAMMARY GLAND BIOL, V7, P177, DOI 10.1023/A:1020304003704; Lewis JS, 1999, J LEUKOCYTE BIOL, V66, P889, DOI 10.1002/jlb.66.6.889; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Metallo CM, 2009, J BIOTECHNOL, V144, P167, DOI 10.1016/j.jbiotec.2009.07.010; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Mullen AR, 2014, CELL REP, V7, P1679, DOI 10.1016/j.celrep.2014.04.037; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Newsholme F, 1999, J NUTR BIOCHEM, V10, P316; Nishi K, 2008, ANTIOXID REDOX SIGN, V10, P983, DOI 10.1089/ars.2007.1825; O'Neill LAJ, 2013, NATURE, V493, P346, DOI 10.1038/nature11862; Palsson-McDermott EM, 2015, CELL METAB, V21, P65, DOI [10.1016/j.cmet.2014.12.005, 10.1016/j.cmet.2015.01.017]; Patel MS, 2006, BIOCHEM SOC T, V34, P217, DOI 10.1042/BST0340217; Sapcariu SC, 2014, METHODSX, V1, P74, DOI 10.1016/j.mex.2014.07.002; Strelko CL, 2011, J AM CHEM SOC, V133, P16386, DOI 10.1021/ja2070889; Tan Z, 2015, J IMMUNOL, V194, P6082, DOI 10.4049/jimmunol.1402469; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; Vazquez A, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-58; Walther JL, 2012, METAB ENG, V14, P162, DOI 10.1016/j.ymben.2011.12.004; Warburg O, 1924, NATURWISSENSCHAFTEN, V12, P1131, DOI 10.1007/BF01504608; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Wise DR, 2010, TRENDS BIOCHEM SCI, V35, P427, DOI 10.1016/j.tibs.2010.05.003; Yang CD, 2014, MOL CELL, V56, P414, DOI 10.1016/j.molcel.2014.09.025	51	136	141	2	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3932	3946		10.1074/jbc.M115.676817	http://dx.doi.org/10.1074/jbc.M115.676817			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26679997	Green Published, hybrid			2022-12-26	WOS:000371338400021
J	Evans-Roberts, KM; Mitchenall, LA; Wall, MK; Leroux, J; Mylne, JS; Maxwell, A				Evans-Roberts, Katherine M.; Mitchenall, Lesley A.; Wall, Melisa K.; Leroux, Julie; Mylne, Joshua S.; Maxwell, Anthony			DNA Gyrase Is the Target for the Quinolone Drug Ciprofloxacin in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chloroplast; DNA gyrase; DNA replication; DNA topoisomerase; plant biochemistry; quinolones	RESISTANCE-DETERMINING REGION; ESCHERICHIA-COLI; A-PROTEIN; TRANSGENIC PLANTS; NALIDIXIC-ACID; GENE; CLONING; EXPRESSION; SUBUNIT; MUTATIONS	The Arabidopsis thaliana genome contains four genes that were originally annotated as potentially encoding DNA gyrase: ATGYRA, ATGYRB1, ATGYRB2, and ATGYRB3. Although we subsequently showed that ATGYRB3 does not encode a gyrase subunit, the other three genes potentially encode subunits of a plant gyrase. We also showed evidence for the existence of supercoiling activity in A. thaliana and that the plant is sensitive to quinolone and aminocoumarin antibiotics, compounds that target DNA gyrase in bacteria. However, it was not possible at that time to show whether the A. thaliana genes encoded an active gyrase enzyme, nor whether that enzyme is indeed the target for the quinolone and aminocoumarin antibiotics. Here we show that an A. thaliana mutant resistant to the quinolone drug ciprofloxacin has a point mutation in ATGYRA. Moreover we show that, as in bacteria, the quinolone-sensitive (wild-type) allele is dominant to the resistant gene. Further we have heterologously expressed ATGYRA and ATGYRB2 in a baculovirus expression system and shown supercoiling activity of the partially purified enzyme. Expression/purification of the quinolone-resistant A. thaliana gyrase yields active enzyme that is resistant to ciprofloxacin. Taken together these experiments now show unequivocally that A. thaliana encodes an organelle-targeted DNA gyrase that is the target of the quinolone drug ciprofloxacin; this has important consequences for plant physiology and the development of herbicides.	[Evans-Roberts, Katherine M.; Mitchenall, Lesley A.; Wall, Melisa K.; Maxwell, Anthony] John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Leroux, Julie; Mylne, Joshua S.] Univ Western Australia, Sch Chem & Biochem, 35 Stirling Highway, Perth, WA 6009, Australia; [Leroux, Julie; Mylne, Joshua S.] Australian Res Council Ctr Excellence Plant Energ, 35 Stirling Highway, Perth, WA 6009, Australia; [Evans-Roberts, Katherine M.] Babraham Inst Enterprise Ltd, Babraham Res Campus, Cambridge CB22 3AT, England; [Wall, Melisa K.] Princess Alexandra Hosp, Dept Emergency Med, Brisbane, Qld 4102, Australia	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Western Australia; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Maxwell, A (corresponding author), John Innes Ctr, Dept Biol Chem, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England.	tony.maxwell@jic.ac.uk	Mylne, Joshua S/A-5581-2009; Mylne, Josh/GMX-4544-2022	Mylne, Joshua S/0000-0003-4957-6388; Mylne, Josh/0000-0003-4957-6388; Maxwell, Anthony/0000-0002-5756-6430; Mitchenall, Lesley/0000-0002-0063-1991	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/J004561/1]; John Innes Foundation; BBSRC; Syngenta (UK); Australian Research Council [FT120100013]; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000201] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); John Innes Foundation; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Syngenta (UK)(Syngenta); Australian Research Council(Australian Research Council); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Grant BB/J004561/1 from the Biotechnology and Biological Sciences Research Council (BBSRC) and the John Innes Foundation. This work was also was supported by a Ph.D. studentship from the BBSRC and Syngenta (UK) (to K. M. E. R.) and an Australian Research Council Future Fellowship (FT120100013) (to J. S. M.). The authors declare that they have no conflicts of interest with the contents of this article.	Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Bebear CM, 2000, ANTIMICROB AGENTS CH, V44, P2719, DOI 10.1128/AAC.44.10.2719-2727.2000; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Berrow NS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm047; Burlison JA, 2006, J AM CHEM SOC, V128, P15529, DOI 10.1021/ja065793p; Bush N. G., 2015, ECOSAL PLUS, V6, DOI [10.1128/ecosalplus.ESP-0010-2014, DOI 10.1128/ECOSALPLUS.ESP-0010-2014]; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; Chapple SDJ, 2002, J BIOTECHNOL, V95, P269, DOI 10.1016/S0168-1656(02)00023-8; Cho HS, 2004, PLANT CELL, V16, P2665, DOI 10.1105/tpc.104.024281; Collin F, 2011, APPL MICROBIOL BIOT, V92, P479, DOI 10.1007/s00253-011-3557-z; Dar MA, 2007, EUKARYOT CELL, V6, P398, DOI 10.1128/EC.00357-06; Evans-Roberts K. M., 2007, THESIS U E ANGLIA NO; Evans-Roberts KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009899; Friedman SM, 2001, ANTIMICROB AGENTS CH, V45, P2378, DOI 10.1128/AAC.45.8.2378-2380.2001; GELLERT M, 1976, P NATL ACAD SCI USA, V73, P3872, DOI 10.1073/pnas.73.11.3872; GELLERT M, 1977, P NATL ACAD SCI USA, V74, P4772, DOI 10.1073/pnas.74.11.4772; Griggs DJ, 1996, ANTIMICROB AGENTS CH, V40, P1009, DOI 10.1128/AAC.40.4.1009; HALLETT P, 1990, GENE, V93, P139, DOI 10.1016/0378-1119(90)90148-K; HALLETT P, 1991, ANTIMICROB AGENTS CH, V35, P335, DOI 10.1128/AAC.35.2.335; HANE MW, 1969, J BACTERIOL, V99, P238, DOI 10.1128/JB.99.1.238-241.1969; Jones Jonathan D. G., 1992, Transgenic Research, V1, P285, DOI 10.1007/BF02525170; KREUZER KN, 1979, J BACTERIOL, V140, P424, DOI 10.1128/JB.140.2.424-435.1979; Neff MM, 2002, TRENDS GENET, V18, P613, DOI 10.1016/S0168-9525(02)02820-2; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; REECE RJ, 1989, J BIOL CHEM, V264, P19648; ROBINSON MJ, 1991, J BIOL CHEM, V266, P14585; SNYDER M, 1979, J MOL BIOL, V131, P287, DOI 10.1016/0022-2836(79)90077-9; Vos SM, 2011, NAT REV MOL CELL BIO, V12, P827, DOI 10.1038/nrm3228; Wall MK, 2004, P NATL ACAD SCI USA, V101, P7821, DOI 10.1073/pnas.0400836101; Waterhouse PM, 1998, P NATL ACAD SCI USA, V95, P13959, DOI 10.1073/pnas.95.23.13959; WILLMOTT CJR, 1993, ANTIMICROB AGENTS CH, V37, P126, DOI 10.1128/AAC.37.1.126; YOSHIDA H, 1990, ANTIMICROB AGENTS CH, V34, P1271, DOI 10.1128/AAC.34.6.1271; Zhao YG, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng006	33	37	37	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3136	3144		10.1074/jbc.M115.689554	http://dx.doi.org/10.1074/jbc.M115.689554			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26663076	hybrid, Green Published			2022-12-26	WOS:000370854500002
J	Patil, H; Wilks, C; Gonzalez, RW; Dhanireddy, S; Conrad-Webb, H; Bergel, M				Patil, Hemangi; Wilks, Carrie; Gonzalez, Rhiannon W.; Dhanireddy, Sudheer; Conrad-Webb, Heather; Bergel, Michael			Mitotic Activation of a Novel Histone Deacetylase 3-Linker Histone H1.3 Protein Complex by Protein Kinase CK2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						chromatin; histone deacetylase 3 (HDAC3); mitosis; mitotic spindle; protein kinase; linker histone H1; 3; protein kinase CK2	CELL-CYCLE PROGRESSION; N-COR; PHOSPHORYLATION SITE; OVARIAN-CANCER; BETA-SUBUNIT; AURORA-B; IN-VIVO; HDAC3; CHROMATIN; MITOSIS	Histone deacetylase 3 (HDAC3) and linker histone H1 are involved in both chromatin compaction and the regulation of mitotic progression. However, the mechanisms by which HDAC3 and H1 regulate mitosis and the factors controlling HDAC3 and H1 activity during mitosis are unclear. Furthermore, as of now, no association between class I, II, or IV (non-sirtuin) HDACs and linker histones has been reported. Here we describe a novel HDAC3-H1.3 complex containing silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) and nuclear receptor corepressor 1 (N-CoR) that accumulated in synchronized HeLa cells in late G(2) phase and mitosis. Nonetheless, the deacetylation activity by HDAC3 in the complex was evident only in mitotic complexes. HDAC3 associated with H1.3 was highly phosphorylated on Ser-424 only during mitosis. Isolation of inactive HDAC3-H1.3 complexes from late G(2) phase cells, and phosphorylation of HDAC3 in the complexes at serine 424 by protein kinase CK2 (also known as casein kinase 2) activated the HDAC3 in vitro. In vivo, CK2 and CK2' double knockdown cells demonstrated a significant decrease in HDAC3 Ser-424 phosphorylation during mitosis. HDAC3 and H1.3 co-localized in between the chromosomes, with polar microtubules and spindle poles during metaphase through telophase, and partially co-localized with chromatin during prophase and interphase. H1 has been reported previously to associate with microtubules and, therefore, could potentially function in targeting HDAC3 to the microtubules. We suggest that phosphorylation of HDAC3 in the complex by CK2 during mitosis activates the complex for a dual role: compaction of the mitotic chromatin and regulation of polar microtubules dynamic instability.	[Patil, Hemangi; Wilks, Carrie; Gonzalez, Rhiannon W.; Dhanireddy, Sudheer; Conrad-Webb, Heather; Bergel, Michael] Texas Womans Univ, Dept Biol, 304 Adm Dr, Denton, TX 76204 USA	Texas Womans University	Bergel, M (corresponding author), Texas Womans Univ, Dept Biol, 304 Adm Dr, Denton, TX 76204 USA.	MBergel@twu.edu			Texas Woman's University Research Enhancement Program; Department of Biology	Texas Woman's University Research Enhancement Program; Department of Biology	This work was supported by grants from the Texas Woman's University Research Enhancement Program and Department of Biology. The authors declare that they have no conflicts of interest with the contents of this article.	Alami R, 2003, P NATL ACAD SCI USA, V100, P5920, DOI 10.1073/pnas.0736105100; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bhaskara S, 2008, MOL CELL, V30, P61, DOI 10.1016/j.molcel.2008.02.030; Blagosklonny MV, 2002, MOL CANCER THER, V1, P937; Bosc DG, 1999, MOL CELL BIOCHEM, V191, P213, DOI 10.1023/A:1006840329973; Bustin M, 2005, MOL CELL, V17, P617, DOI 10.1016/j.molcel.2005.02.019; CHEN JD, 1995, NATURE, V377, P454, DOI 10.1038/377454a0; Clausell J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007243; Cowger JJM, 2006, BIOCHEMISTRY-US, V45, P13150, DOI 10.1021/bi060562g; Eot-Houllier G, 2008, GENE DEV, V22, P2639, DOI 10.1101/gad.484108; Fadri-Moskwik M, 2012, FASEB J, V26, P4057, DOI 10.1096/fj.12-206656; Fu MF, 2005, J BIOL CHEM, V280, P16934, DOI 10.1074/jbc.M500403200; Gallinari P, 2007, CELL RES, V17, P195, DOI 10.1038/sj.cr.7310149; Goldstein LSB, 1999, ANNU REV CELL DEV BI, V15, P141, DOI 10.1146/annurev.cellbio.15.1.141; Goodson ML, 2014, MOL CELL BIOL, V34, P4104, DOI 10.1128/MCB.00554-14; Gregoire S, 2007, MOL CELL BIOL, V27, P1280, DOI 10.1128/MCB.00882-06; Guenther MG, 2001, MOL CELL BIOL, V21, P6091, DOI 10.1128/MCB.21.18.6091-6101.2001; GURLEY LR, 1995, J BIOL CHEM, V270, P27653, DOI 10.1074/jbc.270.46.27653; HANNA DE, 1995, J BIOL CHEM, V270, P25905, DOI 10.1074/jbc.270.43.25905; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; Harshman SW, 2013, NUCLEIC ACIDS RES, V41, P9593, DOI 10.1093/nar/gkt700; Herrera JE, 2000, MOL CELL BIOL, V20, P523, DOI 10.1128/MCB.20.2.523-529.2000; Ishii S, 2008, P NATL ACAD SCI USA, V105, P4179, DOI 10.1073/pnas.0710140105; Jiang YD, 2014, P NATL ACAD SCI USA, V111, P13541, DOI 10.1073/pnas.1411939111; Karagianni P, 2007, ONCOGENE, V26, P5439, DOI 10.1038/sj.onc.1210612; Kruhlak MJ, 2001, J BIOL CHEM, V276, P38307; Li JW, 2000, EMBO J, V19, P4342, DOI 10.1093/emboj/19.16.4342; Li Y, 2006, GENE DEV, V20, P2566, DOI 10.1101/gad.1455006; LITCHFIELD DW, 1995, BBA-MOL CELL RES, V1269, P69, DOI 10.1016/0167-4889(95)00100-7; Magnaghi-Jaulin L, 2007, CANCER RES, V67, P6360, DOI 10.1158/0008-5472.CAN-06-3012; Maresca TJ, 2005, J CELL BIOL, V169, P859, DOI 10.1083/jcb.200503031; McQuown SC, 2011, NEUROBIOL LEARN MEM, V96, P27, DOI [10.1016/j.nlm.2011.04.005, 10.1016/j.nlm.2011.04.002]; Medrzycki M, 2014, CANCER RES, V74, P6463, DOI 10.1158/0008-5472.CAN-13-2922; Medrzycki M, 2012, FRONT BIOSCI-LANDMRK, V17, P396, DOI 10.2741/3934; Nakayama T, 2008, J BIOL CHEM, V283, P16632, DOI 10.1074/jbc.M705764200; Ozawa Y, 2001, BLOOD, V98, P2116, DOI 10.1182/blood.V98.7.2116; Parseghian MH, 2000, CHROMOSOME RES, V8, P405, DOI 10.1023/A:1009262819961; Reichert N, 2012, CELL MOL LIFE SCI, V69, P2173, DOI 10.1007/s00018-012-0921-9; Rougeulle C, 2004, MOL CELL BIOL, V24, P5475, DOI 10.1128/MCB.24.12.5475-5484.2004; Sarg B, 2006, J BIOL CHEM, V281, P6573, DOI 10.1074/jbc.M508957200; SAWIN KE, 1995, P NATL ACAD SCI USA, V92, P4289, DOI 10.1073/pnas.92.10.4289; Schemies J, 2009, CANCER LETT, V280, P222, DOI 10.1016/j.canlet.2009.01.040; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Stevens FE, 2008, ONCOGENE, V27, P1345, DOI 10.1038/sj.onc.1210779; Talasz H, 1996, BIOCHEMISTRY-US, V35, P1761, DOI 10.1021/bi951914e; Terme JM, 2011, J BIOL CHEM, V286, P35347, DOI 10.1074/jbc.M111.281923; van den Wildenberg SMJL, 2008, CURR BIOL, V18, P1860, DOI 10.1016/j.cub.2008.10.026; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Wen YD, 2000, P NATL ACAD SCI USA, V97, P7202, DOI 10.1073/pnas.97.13.7202; Wen YD, 2003, J BIOL CHEM, V278, P1841, DOI 10.1074/jbc.M206528200; Wilson AJ, 2006, J BIOL CHEM, V281, P13548, DOI 10.1074/jbc.M510023200; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; Yde CW, 2008, ONCOGENE, V27, P4986, DOI 10.1038/onc.2008.146; Yoon HG, 2003, EMBO J, V22, P1336, DOI 10.1093/emboj/cdg120; Zhang CJ, 2002, ONCOGENE, V21, P3754, DOI 10.1038/sj.onc.1205467; Zhang XH, 2005, GENE DEV, V19, P827, DOI 10.1101/gad.1286005	57	11	11	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3158	3172		10.1074/jbc.M115.643874	http://dx.doi.org/10.1074/jbc.M115.643874			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26663086	Green Published, hybrid			2022-12-26	WOS:000370854500004
J	Buffet, C; Catelli, MG; Hecale-Perlemoine, K; Bricaire, L; Garcia, C; Gallet-Dierick, A; Rodriguez, S; Cormier, F; Groussin, L				Buffet, Camille; Catelli, Maria-Grazia; Hecale-Perlemoine, Karine; Bricaire, Leopoldine; Garcia, Camille; Gallet-Dierick, Anne; Rodriguez, Stephanie; Cormier, Francoise; Groussin, Lionel			Dual Specificity Phosphatase 5, a Specific Negative Regulator of ERK Signaling, Is Induced by Serum Response Factor and EIk-1 Transcription Factor	PLOS ONE			English	Article							PROTEIN-KINASE PHOSPHATASE-3; TERNARY COMPLEX FACTORS; DNA-BINDING ACTIVITY; C-FOS PROMOTER; MAP KINASE; GENE-EXPRESSION; PHOSPHORYLATION SITES; CATALYTIC ACTIVATION; FEEDBACK-REGULATION; THYROID-CANCER	Serum stimulation of mammalian cells induces, via the MAPK pathway, the nuclear protein DUSP5 (dual-specificity phosphatase 5), which specifically interacts with and inactivates the ERK1/2 MAP kinases. However, molecular mechanisms underlying DUSP5 induction are not well known. Here, we found that the DUSP5 mRNA induction depends on a transcriptional regulation by the MAPK pathway, without any modification of the mRNA stability. Two contiguous CArG boxes that bind serum response factor (SRF) were found in a 1 Kb promoter region, as well as several E twenty-six transcription factor family binding sites (EBS). These sites potentially bind EIk-1, a transcription factor activated by ERK1/2. Using wild type or mutated DUSP5 promoter reporters, we demonstrated that SRF plays a crucial role in serum induction of DUSP5 promoter activity, the proximal CArG box being important for SRF binding in vitro and in living cells. Moreover, in vitro and in vivo binding data of EIk-1 to the same promoter region further demonstrate a role for EIk-1 in the transcriptional regulation of DUSP5. SRF and EIk-1 form a ternary complex (EIk-1-SRF-DNA) on DUSP5 promoter, consequently providing a link to an important negative feedback tightly regulating phosphorylated ERK levels.	[Buffet, Camille; Catelli, Maria-Grazia; Hecale-Perlemoine, Karine; Bricaire, Leopoldine; Garcia, Camille; Gallet-Dierick, Anne; Rodriguez, Stephanie; Cormier, Francoise; Groussin, Lionel] Univ Paris 05, Inst Cochin, Endocrinol Metabolism Diabet Dept, CNRS UMR8104,INSERM U1016, Paris, France; [Groussin, Lionel] Cochin Hosp, Dept Endocrinol, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite	Groussin, L (corresponding author), Univ Paris 05, Inst Cochin, Endocrinol Metabolism Diabet Dept, CNRS UMR8104,INSERM U1016, Paris, France.	lionel.groussin@aphp.fr		Cormier, Francoise/0000-0002-6904-5122; Groussin, Lionel/0000-0003-1476-475X; Rodriguez, Stephanie/0000-0003-4520-144X	American Thyroid Association (ATA) [R06059KK]; French Fondation pour la recherche sur le cancer (ARC); French National Academy of Medicine; Ile de France Regional Health Agency	American Thyroid Association (ATA); French Fondation pour la recherche sur le cancer (ARC); French National Academy of Medicine; Ile de France Regional Health Agency	This work was supported by: the American Thyroid Association [ATA R06059KK], a predoctoral fellowship from the French Fondation pour la recherche sur le cancer (ARC), the French National Academy of Medicine, and a predoctoral and doctoral fellowship from the Ile de France Regional Health Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2014, CELL, V159, P676, DOI 10.1016/j.cell.2014.09.050; Arkell RS, 2008, CELL SIGNAL, V20, P836, DOI 10.1016/j.cellsig.2007.12.014; Bermudez O, 2010, AM J PHYSIOL-CELL PH, V299, pC189, DOI 10.1152/ajpcell.00347.2009; Bermudez O, 2011, J CELL PHYSIOL, V226, P276, DOI 10.1002/jcp.22339; Blanchette M, 2004, GENOME RES, V14, P708, DOI 10.1101/gr.1933104; Boros J, 2009, GENOME RES, V19, P1963, DOI 10.1101/gr.093047.109; BUCHER P, 1990, J MOL BIOL, V212, P563, DOI 10.1016/0022-2836(90)90223-9; Chai J, 2002, J PHYSIOL PHARMACOL, V53, P147; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; DALTON S, 1992, CELL, V68, P597, DOI 10.1016/0092-8674(92)90194-H; Dowd S, 1998, J CELL SCI, V111, P3389; Ekerot M, 2008, BIOCHEM J, V412, P287, DOI 10.1042/BJ20071512; Fjeld CC, 2000, J BIOL CHEM, V275, P6749, DOI 10.1074/jbc.275.10.6749; Foulds CE, 2004, MOL CELL BIOL, V24, P10954, DOI 10.1128/MCB.24.24.10954-10964.2004; Furukawa T, 2008, BIOCHEM BIOPH RES CO, V377, P317, DOI 10.1016/j.bbrc.2008.10.003; GILLE H, 1992, NATURE, V358, P414, DOI 10.1038/358414a0; Griffith OL, 2006, J CLIN ONCOL, V24, P5043, DOI 10.1200/JCO.2006.06.7330; Groom LA, 1996, EMBO J, V15, P3621, DOI 10.1002/j.1460-2075.1996.tb00731.x; Guerci A, 2012, CELL METAB, V15, P25, DOI 10.1016/j.cmet.2011.12.001; Hassler M, 2001, EMBO J, V20, P3018, DOI 10.1093/emboj/20.12.3018; HILL CS, 1993, CELL, V73, P395, DOI 10.1016/0092-8674(93)90238-L; HILL CS, 1994, EMBO J, V13, P5421, DOI 10.1002/j.1460-2075.1994.tb06877.x; HIPSKIND RA, 1991, NATURE, V354, P531, DOI 10.1038/354531a0; Hollenhorst PC, 2011, ANNU REV BIOCHEM, V80, P437, DOI 10.1146/annurev.biochem.79.081507.103945; ISHIBASHI T, 1994, J BIOL CHEM, V269, P29897; Iyer D, 2006, P NATL ACAD SCI USA, V103, P4516, DOI 10.1073/pnas.0505338103; JANKNECHT R, 1992, EMBO J, V11, P1045, DOI 10.1002/j.1460-2075.1992.tb05143.x; JANKNECHT R, 1992, NUCLEIC ACIDS RES, V20, P3317, DOI 10.1093/nar/20.13.3317; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; KABNICK KS, 1988, MOL CELL BIOL, V8, P3244, DOI 10.1128/MCB.8.8.3244; Karlsson M, 2004, J BIOL CHEM, V279, P41882, DOI 10.1074/jbc.M406720200; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Knauf JA, 2009, CURR OPIN CELL BIOL, V21, P296, DOI 10.1016/j.ceb.2009.01.013; KONIG H, 1989, EMBO J, V8, P2559, DOI 10.1002/j.1460-2075.1989.tb08394.x; Kucharska A, 2009, CELL SIGNAL, V21, P1794, DOI 10.1016/j.cellsig.2009.07.015; KWAK SP, 1995, J BIOL CHEM, V270, P1156, DOI 10.1074/jbc.270.3.1156; Lee JU, 2012, EUR J ENDOCRINOL, V167, P93, DOI 10.1530/EJE-12-0010; Ling Y, 1997, EMBO J, V16, P2431, DOI 10.1093/emboj/16.9.2431; MANAK JR, 1993, ONCOGENE, V8, P703; MANAK JR, 1991, MOL CELL BIOL, V11, P3652, DOI 10.1128/MCB.11.7.3652; Mandl M, 2005, MOL CELL BIOL, V25, P1830, DOI 10.1128/MCB.25.5.1830-1845.2005; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; McCarthy SA, 1997, MOL CELL BIOL, V17, P2401, DOI 10.1128/MCB.17.5.2401; Mendoza MC, 2011, TRENDS BIOCHEM SCI, V36, P320, DOI 10.1016/j.tibs.2011.03.006; Mo Y, 2001, J MOL BIOL, V314, P495, DOI 10.1006/jmbi.2001.5138; Muda M, 1998, J BIOL CHEM, V273, P9323, DOI 10.1074/jbc.273.15.9323; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Nunes-Xavier CE, 2010, J BIOL CHEM, V285, P26417, DOI 10.1074/jbc.M110.121830; Odrowaz Z, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002694; PELLEGRINI L, 1995, NATURE, V376, P490, DOI 10.1038/376490a0; Plani-Lam JHC, 2015, INT J BIOCHEM CELL B, V61, P53, DOI 10.1016/j.biocel.2015.02.003; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; PRICE MA, 1995, EMBO J, V14, P2589, DOI 10.1002/j.1460-2075.1995.tb07257.x; RIVERA VM, 1993, MOL CELL BIOL, V13, P6260, DOI 10.1128/MCB.13.10.6260; Schratt G, 2004, EMBO J, V23, P1834, DOI 10.1038/sj.emboj.7600188; Sharrocks AD, 2002, BIOCHEM SOC T, V30, P1; Shaw PE, 2003, INT J BIOCHEM CELL B, V35, P1210, DOI 10.1016/S1357-2725(03)00031-1; SHAW PE, 1989, CELL, V56, P563, DOI 10.1016/0092-8674(89)90579-5; SHORE P, 1994, MOL CELL BIOL, V14, P3283, DOI 10.1128/MCB.14.5.3283; Stritt C, 2009, NAT NEUROSCI, V12, P418, DOI 10.1038/nn.2280; Sun Q, 2006, GENOME RES, V16, P197, DOI 10.1101/gr.4108706; TREISMAN R, 1992, EMBO J, V11, P4631, DOI 10.1002/j.1460-2075.1992.tb05565.x; Tullai JW, 2004, J BIOL CHEM, V279, P20167, DOI 10.1074/jbc.M309260200; Ueda K, 2003, ONCOGENE, V22, P5586, DOI 10.1038/sj.onc.1206845; Vanhoutte P, 2001, J BIOL CHEM, V276, P5189, DOI 10.1074/jbc.M006678200; Vickers ER, 2004, MOL CELL BIOL, V24, P10340, DOI 10.1128/MCB.24.23.10340-10351.2004; Withers DA, 2000, J BIOL CHEM, V275, P40588, DOI 10.1074/jbc.M007262200; Yang BS, 1996, MOL CELL BIOL, V16, P538; Zeliadt NA, 2008, TOXICOL APPL PHARM, V232, P408, DOI 10.1016/j.taap.2008.08.007; Zhang ZF, 2010, CARCINOGENESIS, V31, P577, DOI 10.1093/carcin/bgq020	70	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145484	10.1371/journal.pone.0145484	http://dx.doi.org/10.1371/journal.pone.0145484			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691724	Green Submitted, Green Published, gold			2022-12-26	WOS:000367092300082
J	Qureshi, O; Cho, H; Choudhary, M; Seeling, JM				Qureshi, Osama; Cho, Hyuk; Choudhary, Madhusudan; Seeling, Joni M.			A Nonsynonymous/Synonymous Substitution Analysis of the B56 Gene Family Aids in Understanding B56 Isoform Diversity	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; REGULATORY SUBUNIT; CODON BIAS; DUPLICATE GENES; BETA; HOLOENZYME; EVOLUTION; GENOME; IDENTIFICATION; COMPLEX	Gene duplication leads to the formation of gene families, wherein purifying or neutral selection maintains the original gene function, while diversifying selection confers new functions onto duplicated genes. The B56 gene family is highly conserved; it is encoded by one gene in protists and fungi, and five genes in vertebrates. B56 regulates protein phosphatase 2A (PP2A), an abundant heterotrimeric serine/threonine phosphatase that functions as a tumor suppressor and consists of a scaffolding "A" and catalytic "C" subunit heterodimer bound to a regulatory "B" subunit. Individual regulatory B56 subunits confer disparate functions onto PP2A in various cell-cell signaling pathways. B56 proteins share a conserved central core domain, but have divergent N- and C-termini which play a role in isoform specificity. We carried out a nonsynonymous/synonymous substitution analysis to better understand the divergence of vertebrate B56 genes. When five B56 paralogs from ten vertebrate species were analyzed, the gene family displayed purifying selection; stronger purifying selection was revealed when individual B56 isoforms were analyzed separately. The B56 core experienced stronger purifying selection than the N- and C-termini, which correlates with the presence of several contacts between the core and the AC heterodimer. Indeed, the majority of the contact points that we analyzed between B56 and the AC heterodimer experienced strong purifying selection. B56 subfamilies showed distinct patterns of selection in their Nand C-termini. The C-terminus of the B56-1 subfamily and the N-terminus of the B56-2 subfamily exhibited strong purifying selection, suggesting that these termini carry out subfamily-specific functions, while the opposite termini exhibited diversifying selection and likely carry out isoform-specific functions. We also found reduced synonymous substitutions at the N- and C-termini when grouping B56 genes by species but not by isoform, suggesting species-specific codon bias may have a role in regulating B56 gene expression.	[Qureshi, Osama; Choudhary, Madhusudan; Seeling, Joni M.] Sam Houston State Univ, Dept Biol Sci, Huntsville, TX 77340 USA; [Cho, Hyuk] Sam Houston State Univ, Dept Comp Sci, Huntsville, TX 77340 USA	Texas State University System; Sam Houston State University; Texas State University System; Sam Houston State University	Seeling, JM (corresponding author), Sam Houston State Univ, Dept Biol Sci, Huntsville, TX 77340 USA.	jms120@shsu.edu			JMS Sam Houston State University Enhancement Research Grant Program	JMS Sam Houston State University Enhancement Research Grant Program	This work was funded by JMS Sam Houston State University Enhancement Research Grant Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi AA, 2009, EVOL BIOINFORM, V5, P5; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arnold HK, 2006, MOL CELL BIOL, V26, P2832, DOI 10.1128/MCB.26.7.2832-2844.2006; Baek S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-139; Chen W, 2004, CANCER CELL, V5, P127, DOI 10.1016/S1535-6108(04)00026-1; Cho US, 2007, NATURE, V445, P53, DOI 10.1038/nature05351; Conant GC, 2003, GENOME RES, V13, P2052, DOI 10.1101/gr.1252603; Gao ZH, 2002, P NATL ACAD SCI USA, V99, P1182, DOI 10.1073/pnas.032468199; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Hershberg R, 2008, ANNU REV GENET, V42, P287, DOI 10.1146/annurev.genet.42.110807.091442; Huerta-Cepas J, 2011, BIOINFORMATICS, V27, P38, DOI 10.1093/bioinformatics/btq609; Hunt RC, 2014, TRENDS GENET, V30, P308, DOI 10.1016/j.tig.2014.04.006; Ito A, 2000, EMBO J, V19, P562, DOI 10.1093/emboj/19.4.562; Li XH, 2001, EMBO J, V20, P4122, DOI 10.1093/emboj/20.15.4122; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; Magnusdottir A, 2009, PROTEINS, V74, P212, DOI 10.1002/prot.22150; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Moore RC, 2003, P NATL ACAD SCI USA, V100, P15682, DOI 10.1073/pnas.2535513100; Nabiyouni M, 2013, GENE, V519, P113, DOI 10.1016/j.gene.2013.01.033; NEI M, 1986, MOL BIOL EVOL, V3, P418; Novichkov PS, 2009, J BACTERIOL, V191, P65, DOI 10.1128/JB.01237-08; Ohno S, 1970, EVOLUTION BY GENE DU; Pais FSM, 2014, ALGORITHM MOL BIOL, V9, DOI 10.1186/1748-7188-9-4; Park M, 2014, BBA-MOL CELL BIOL L, V1841, P1608, DOI 10.1016/j.bbalip.2014.08.008; Peters Anne E, 2012, BMC Res Notes, V5, P192, DOI 10.1186/1756-0500-5-192; Quax TEF, 2015, MOL CELL, V59, P149, DOI 10.1016/j.molcel.2015.05.035; Robinson-Rechavi M, 2001, MOL BIOL EVOL, V18, P681, DOI 10.1093/oxfordjournals.molbev.a003849; Rodgers JT, 2011, MOL CELL, V41, P471, DOI 10.1016/j.molcel.2011.02.007; Rorick AM, 2007, DEV BIOL, V302, P477, DOI 10.1016/j.ydbio.2006.10.011; Seeling JM, 1999, SCIENCE, V283, P2089, DOI 10.1126/science.283.5410.2089; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Sommer LM, 2015, INT J MOL SCI, V16, P10134, DOI 10.3390/ijms160510134; Van Kanegan MJ, 2009, MOL CELL BIOL, V29, P662, DOI 10.1128/MCB.01242-08; Varadkar P, 2014, DEV DYNAM, V243, P778, DOI 10.1002/dvdy.24111; Wang DP, 2011, BIOL DIRECT, V6, DOI 10.1186/1745-6150-6-13; Wang MC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-266; Xu YH, 2006, CELL, V127, P1239, DOI 10.1016/j.cell.2006.11.033; Yang J, 2003, DEVELOPMENT, V130, P5569, DOI 10.1242/dev.00762; Yang J, 2010, LIFE SCI, V87, P659, DOI 10.1016/j.lfs.2010.10.003	39	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145529	10.1371/journal.pone.0145529	http://dx.doi.org/10.1371/journal.pone.0145529			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26692027	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092300084
J	Steins, A; Dik, P; Muller, WH; Vervoort, SJ; Reimers, K; Kuhbier, JW; Vogt, PM; van Apeldoorn, AA; Coffer, PJ; Schepers, K				Steins, Anne; Dik, Pieter; Muller, Wally H.; Vervoort, Stephin J.; Reimers, Kerstin; Kuhbier, Joern W.; Vogt, Peter M.; van Apeldoorn, Aart A.; Coffer, Paul J.; Schepers, Koen			In Vitro Evaluation of Spider Silk Meshes as a Potential Biomaterial for Bladder Reconstruction	PLOS ONE			English	Article							SMALL-INTESTINAL SUBMUCOSA; AUGMENTATION CYSTOPLASTY; UROTHELIAL CELLS; URINARY-BLADDER; DRAGLINE SILK; STEM-CELLS; SPINA-BIFIDA; RESPONSES; BIOCOMPATIBILITY; DIFFERENTIATION	Reconstruction of the bladder by means of both natural and synthetic materials remains a challenge due to severe adverse effects such as mechanical failure. Here we investigate the application of spider major ampullate gland-derived dragline silk from the Nephila edulis spider, a natural biomaterial with outstanding mechanical properties and a slow degradation rate, as a potential scaffold for bladder reconstruction by studying the cellular response of primary bladder cells to this biomaterial. We demonstrate that spider silk without any additional biological coating supports adhesion and growth of primary human urothelial cells (HUCs), which are multipotent bladder cells able to differentiate into the various epithelial layers of the bladder. HUCs cultured on spider silk did not show significant changes in the expression of various epithelial-to-mesenchymal transition and fibrosis associated genes, and demonstrated only slight reduction in the expression of adhesion and cellular differentiation genes. Furthermore, flow cytometric analysis showed that most of the silk-exposed HUCs maintain an undifferentiated immunophenotype. These results demonstrate that spider silk from the Nephila edulis spider supports adhesion, survival and growth of HUCs without significantly altering their cellular properties making this type of material a suitable candidate for being tested in pre-clinical models for bladder reconstruction.	[Steins, Anne; Dik, Pieter; Coffer, Paul J.] Univ Med Ctr Utrecht, Wilhelmina Childrens Hosp, Div Pediat, Utrecht, Netherlands; [Muller, Wally H.] Univ Utrecht, Dept Chem, NL-3584 CH Utrecht, Netherlands; [Steins, Anne; Vervoort, Stephin J.; Coffer, Paul J.; Schepers, Koen] Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands; [Reimers, Kerstin; Kuhbier, Joern W.; Vogt, Peter M.] Hannover Med Sch, Dept Plast Hand & Reconstruct Surg, Hannover, Germany; [van Apeldoorn, Aart A.] Univ Twente, MIRA Inst Biomed Technol & Tech Med, Dept Dev Bioengn, NL-7500 AE Enschede, Netherlands	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University; Utrecht University Medical Center; Hannover Medical School; University of Twente	Schepers, K (corresponding author), Univ Med Ctr Utrecht, Dept Cell Biol, Utrecht, Netherlands.	k.schepers@lumc.nl	Vervoort, Stephin/AAP-7854-2020; Coffer, Paul/AAF-7970-2020; Vogt, Peter M./AAL-1332-2020; van Apeldoorn, Aart/AAP-5433-2021; Schepers, Koen/H-7108-2013	van Apeldoorn, Aart/0000-0002-2940-5699; Schepers, Koen/0000-0003-2442-242X; Vervoort, Stephin/0000-0001-7459-126X				Allmeling C, 2008, CELL PROLIFERAT, V41, P408, DOI 10.1111/j.1365-2184.2008.00534.x; Altman GH, 2003, BIOMATERIALS, V24, P401, DOI 10.1016/S0142-9612(02)00353-8; Apodaca G, 2004, TRAFFIC, V5, P117, DOI 10.1046/j.1600-0854.2003.00156.x; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Atala A, 2011, BRIT MED BULL, V97, P81, DOI 10.1093/bmb/ldr003; BARRERA DA, 1993, J AM CHEM SOC, V115, P11010, DOI 10.1021/ja00076a077; Birder LA, 2004, SCAND J UROL NEPHROL, V38, P48, DOI 10.1080/03008880410015165; Blackledge TA, 2009, J EXP BIOL, V212, P1980, DOI 10.1242/jeb.028944; Brown CP, 2015, J MATER RES, V30, P108, DOI 10.1557/jmr.2014.365; BUBENIK J, 1970, INT J CANCER, V5, P310, DOI 10.1002/ijc.2910050303; Caione P, 2012, PEDIATR SURG INT, V28, P421, DOI 10.1007/s00383-012-3063-0; Campodonico F, 2004, EUR UROL, V46, P531, DOI 10.1016/j.eururo.2004.04.019; Cunniff P.M., 1994, POLYM ADVAN TECHNOL, V5, P401; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Feil G, 2006, EUR UROL, V50, P1330, DOI 10.1016/j.eururo.2006.05.041; Foo CWP, 2002, ADV DRUG DELIVER REV, V54, P1131; Franck D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056237; Frimberger D, 2012, PEDIATR CLIN N AM, V59, P757, DOI 10.1016/j.pcl.2012.05.006; Gellynck K, 2008, J MATER SCI-MATER M, V19, P3399, DOI 10.1007/s10856-008-3474-6; Gellynck K, 2008, J MATER SCI-MATER M, V19, P2963, DOI 10.1007/s10856-007-3330-0; Gilbert SM, 2005, J UROLOGY, V173, P1080, DOI 10.1097/01.ju.0000155248.57049.4e; Gomes S, 2012, J TISSUE ENG REGEN M, V6, P356, DOI 10.1002/term.437; Gosline JM, 1999, J EXP BIOL, V202, P3295; Hakimi O, 2007, COMPOS PART B-ENG, V38, P324, DOI 10.1016/j.compositesb.2006.06.012; Ho PL, 2012, NAT REV UROL, V9, P583, DOI 10.1038/nrurol.2012.142; Kawakami S, 2002, J CELL PHYSIOL, V191, P310, DOI 10.1002/jcp.10099; Kearns V, 2008, TOP TISSUE ENG, V4; Kuhbier JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012032; Lazzeri M, 2006, UROL INT, V76, P289, DOI 10.1159/000092049; Liberio MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112122; MARSHALL CJ, 1977, J NATL CANCER I, V58, P1743, DOI 10.1093/jnci/58.6.1743; Meinel L, 2005, BIOMATERIALS, V26, P147, DOI 10.1016/j.biomaterials.2004.02.047; MULLER LL, 1975, J HISTOCHEM CYTOCHEM, V23, P107, DOI 10.1177/23.2.1117127; Oberpenning F, 1999, NAT BIOTECHNOL, V17, P149, DOI 10.1038/6146; Ortlepp CS, 2004, BIOMACROMOLECULES, V5, P727, DOI 10.1021/bm034269x; Pariente JL, 2001, J BIOMED MATER RES, V55, P33, DOI 10.1002/1097-4636(200104)55:1<33::AID-JBM50>3.0.CO;2-7; Partridge MA, 2006, MOL BIOL CELL, V17, P4237, DOI 10.1091/mbc.E06-06-0496; Perez-Rigueiro J, 2005, J EXP BIOL, V208, P2633, DOI 10.1242/jeb.01701; Radtke C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016990; Ram-Liebig G, 2004, BJU INT, V94, P922, DOI 10.1111/j.1464-410X.2004.05061.x; Rising A, 2005, ZOOL SCI, V22, P273, DOI 10.2108/zsj.22.273; Rohrmann D, 1996, J UROLOGY, V156, P2094, DOI 10.1016/S0022-5347(01)65442-9; Romih R, 2005, CELL TISSUE RES, V320, P259, DOI 10.1007/s00441-004-1005-4; Sakakibara R, 2003, NEUROUROL URODYNAM, V22, P328, DOI 10.1002/nau.2150; Schafer-Nolte F, 2014, ANN SURG, V259, P781, DOI 10.1097/SLA.0b013e3182917677; Seth A, 2013, BIOMATERIALS, V34, P4758, DOI 10.1016/j.biomaterials.2013.03.038; Slotta U, 2012, CHEM ENG PROG; Soergel TM, 2004, J UROLOGY, V172, P1649, DOI 10.1097/01.ju.0000140194.87974.56; Sponner A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000998; Strand W, 2004, J UROLOGY, V172, P1651; Tian H, 2010, TISSUE ENG PT A, V16, P1769, DOI [10.1089/ten.tea.2009.0625, 10.1089/ten.TEA.2009.0625]; Vollrath F, 2002, IN VIVO, V16, P229; Vollrath F, 2001, NATURE, V410, P541, DOI 10.1038/35069000; Wang DS, 2007, BJU INT, V99, P628, DOI 10.1111/j.1464-410X.2006.06662.x; WEN CM, 1990, ANN ALLERGY, V65, P375; Wen ZM, 1996, J INVEST ALLERG CLIN, V6, P237; Wendt H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021833; Zhang YY, 2000, J UROLOGY, V164, P928, DOI 10.1016/S0022-5347(05)67220-5; Zhu YT, 2013, BMC UROL, V13, DOI 10.1186/1471-2490-13-57	60	20	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145240	10.1371/journal.pone.0145240	http://dx.doi.org/10.1371/journal.pone.0145240			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689371	Green Submitted, Green Published, gold			2022-12-26	WOS:000367092300048
J	Giovannoni, I; Callea, F; Bellacchio, E; Torre, G; De Goyet, JD; Francalanci, P				Giovannoni, Isabella; Callea, Francesco; Bellacchio, Emanuele; Torre, Giuliano; De Goyet, Jean De Ville; Francalanci, Paola			Genetics and Molecular Modeling of New Mutations of Familial Intrahepatic Cholestasis in a Single Italian Center	PLOS ONE			English	Article							SALT EXPORT PUMP; MDCK-II CELLS; ABCB11 MUTATIONS; HEREDITARY CHOLESTASIS; PHENOTYPIC DIFFERENCES; DEFICIENCY; EXPRESSION; CHILDREN; PFIC2; SECRETION	Familial intrahepatic cholestases (FICs) are a heterogeneous group of autosomal recessive disorders of childhood that disrupt bile formation and present with cholestasis of hepatocellular origin. Three distinct forms are described: FIC1 and FIC2, associated with low/normal GGT level in serum, which are caused by impaired bile salt secretion due to defects in ATP8B1 encoding the FIC1 protein and defects in ABCB11 encoding bile salt export pump protein, respectively; FIC3, linked to high GGT level, involves impaired biliary phospholipid secretion due to defects in ABCB4, encoding multidrug resistance 3 protein. Different mutations in these genes may cause either a progressive familial intrahepatic cholestasis (PFIC) or a benign recurrent intrahepatic cholestasis (BRIC). For the purposes of the present study we genotyped 27 children with intrahepatic cholestasis, diagnosed on either a clinical or histological basis. Two BRIC, 23 PFIC and 2 BRIC/PFIC were identified. Thirty-four different mutations were found of which 11 were novel. One was a 2Mb deletion (5'UTR-exon 18) in ATP8B1. In another case microsatellite analysis of chromosome 2, including ABCB11, showed uniparental disomy. Two cases were compound heterozygous for BRIC/PFIC2 mutations. Our results highlight the importance of the pathogenic role of novel mutations in the three genes and unusual modes of their transmission.	[Giovannoni, Isabella; Callea, Francesco; Francalanci, Paola] Bambino Gesu Pediat Hosp, IRCCS, Dept Pathol & Mol Histopathol, Rome, Italy; [Bellacchio, Emanuele] Bambino Gesu Pediat Hosp, IRCCS, Res Labs, Rome, Italy; [Torre, Giuliano] Bambino Gesu Pediat Hosp, IRCCS, Dept Hepatol, Gastroenterol & Nutr Unit, Rome, Italy; [De Goyet, Jean De Ville] Bambino Gesu Pediat Hosp, IRCCS, Dept Pediat Surg & Transplantat, Rome, Italy	IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu	Francalanci, P (corresponding author), Bambino Gesu Pediat Hosp, IRCCS, Dept Pathol & Mol Histopathol, Rome, Italy.	paola.francalanci@opbg.net	Francalanci, Paola/AAA-4908-2020; Giovannoni, Isabella/AAH-9206-2019; Goyet, Jean de Ville de/A-1708-2014; Goyet, Jean de Ville de/I-6913-2019; Bellacchio, Emanuele/AAH-9255-2019	Giovannoni, Isabella/0000-0002-9980-6594; Goyet, Jean de Ville de/0000-0001-7681-6178; Goyet, Jean de Ville de/0000-0001-7681-6178; Bellacchio, Emanuele/0000-0002-2757-849X				Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Byrne JA, 2009, HEPATOLOGY, V49, P553, DOI 10.1002/hep.22683; Chen HL, 2002, J PEDIATR-US, V140, P119, DOI 10.1067/mpd.2002.119993; Crawford AR, 1997, J CLIN INVEST, V100, P2562, DOI 10.1172/JCI119799; Davit-Spraul A, 2010, HEPATOLOGY, V51, P1645, DOI 10.1002/hep.23539; Francalanci P, 2013, HEPATOL RES, V43, P315, DOI 10.1111/j.1872-034X.2012.01061.x; Giovannoni I, 2012, HEPATOL RES, V42, P327, DOI 10.1111/j.1872-034X.2011.00925.x; Giovannoni I, 2011, DIGEST LIVER DIS, V43, P567, DOI 10.1016/j.dld.2011.03.004; Gonzales E, 2009, FRONT BIOSCI-LANDMRK, V14, P4242, DOI 10.2741/3526; Jacquemin E, 2012, CLIN RES HEPATOL GAS, V36, pS26, DOI 10.1016/S2210-7401(12)70018-9; Kagawa T, 2008, AM J PHYSIOL-GASTR L, V294, pG58, DOI 10.1152/ajpgi.00367.2007; Klomp LWJ, 2004, HEPATOLOGY, V40, P27, DOI 10.1002/hep.20285; Lam CW, 2006, J HEPATOL, V44, P240, DOI 10.1016/j.jhep.2005.09.013; Lam P, 2007, AM J PHYSIOL-CELL PH, V293, pC1709, DOI 10.1152/ajpcell.00327.2007; Lam P, 2010, SEMIN LIVER DIS, V30, P125, DOI 10.1055/s-0030-1253222; Liu C, 2007, GASTROENTEROLOGY, V132, P119, DOI 10.1053/j.gastro.2006.10.034; Lykavieris P, 2003, J HEPATOL, V39, P447, DOI 10.1016/S0168-8278(03)00286-1; Mochizuki K, 2007, AM J PHYSIOL-GASTR L, V292, pG818, DOI 10.1152/ajpgi.00415.2006; Nobili V, 2006, J GASTROENTEROL, V41, P598, DOI 10.1007/s00535-006-1816-z; Noe J, 2005, J HEPATOL, V43, P536, DOI 10.1016/j.jhep.2005.05.020; Strautnieks SS, 2008, GASTROENTEROLOGY, V134, P1203, DOI 10.1053/j.gastro.2008.01.038; Strautnieks SS, 1998, NAT GENET, V20, P233, DOI 10.1038/3034; van der Woerd WL, 2010, BEST PRACT RES CL GA, V24, P541, DOI 10.1016/j.bpg.2010.07.010; Van Mil SWC, 2004, GASTROENTEROLOGY, V127, P379, DOI 10.1053/j.gastro.2004.04.065; van Mil SWC, 2001, SEMIN LIVER DIS, V21, P535, DOI 10.1055/s-2001-19034; Wagner SA, 2012, MOL CELL PROTEOMICS, V11, P1578, DOI 10.1074/mcp.M112.017905; Xu D, 2011, BIOPHYS J, V101, P2525, DOI 10.1016/j.bpj.2011.10.024	27	12	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145021	10.1371/journal.pone.0145021	http://dx.doi.org/10.1371/journal.pone.0145021			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678486	gold, Green Published, Green Submitted			2022-12-26	WOS:000366723400041
J	Jenkins, CN; Alves, MAS; Uezu, A; Vale, MM				Jenkins, Clinton N.; Alves, Maria Alice S.; Uezu, Alexandre; Vale, Mariana M.			Patterns of Vertebrate Diversity and Protection in Brazil	PLOS ONE			English	Article							SPATIAL CONSERVATION PRIORITIES; ATLANTIC FOREST; AREAS; FUTURE	Most conservation decisions take place at national or finer spatial scales. Providing useful information at such decision-making scales is essential for guiding the practice of conservation. Brazil is one of the world's megadiverse countries, and consequently decisions about conservation in the country have a disproportionate impact on the survival of global biodiversity. For three groups of terrestrial vertebrates (birds, mammals, and amphibians), we examined geographic patterns of diversity and protection in Brazil, including that of endemic, small-ranged, and threatened species. To understand potential limitations of the data, we also explored how spatial bias in collection localities may influence the perceived patterns of diversity. The highest overall species richness is in the Amazon and Atlantic Forests, while the Atlantic Forest dominates in terms of country endemics and small-ranged species. Globally threatened species do not present a consistent pattern. Patterns for birds were similar to overall species richness, with higher concentrations of threatened species in the Atlantic Forest, while mammals show a more generalized pattern across the country and a high concentration in the Amazon. Few amphibians are listed as threatened, mostly in the Atlantic Forest. Data deficient mammals occur across the country, concentrating in the Amazon and southeast Atlantic Forest, and there are no data deficient birds in Brazil. In contrast, nearly a third of amphibians are data deficient, widespread across the country, but with a high concentration in the far southeast. Spatial biases in species locality data, however, possibly influence the perceived patterns of biodiversity. Regions with low sampling density need more biological studies, as do the many data deficient species. All biomes except the Amazon have less than 3% of their area under full protection. Reassuringly though, rates of protection do correlate with higher biodiversity, including higher levels of threatened and small-ranged species. Our results indicate a need for expanded formal protection in Brazil, especially in the Atlantic forest, and with an emphasis on fully protected areas.	[Jenkins, Clinton N.; Uezu, Alexandre] Inst Pesquisas Ecol, Sao Paulo, Brazil; [Alves, Maria Alice S.] Univ Estado Rio de Janeiro, Dept Ecol, BR-20550011 Rio De Janeiro, Brazil; [Vale, Mariana M.] Univ Fed Rio de Janeiro, Dept Ecol, Rio De Janeiro, Brazil	Instituto de Pesquisas Ecologicas; Universidade do Estado do Rio de Janeiro; Universidade Federal do Rio de Janeiro	Jenkins, CN (corresponding author), Inst Pesquisas Ecol, Sao Paulo, Brazil.	Clinton.Jenkins@gmail.com	Jenkins, Clinton/D-6134-2011; Uezu, Alexandre/G-5435-2014; Alves, Maria Alice S./B-3548-2013; Vale, Mariana M./I-9408-2012	Jenkins, Clinton/0000-0003-2198-0637; Alves, Maria Alice S./0000-0002-0622-270X; Vale, Mariana M./0000-0003-0734-4925	Ciencia Sem Fronteiras program [A025_2013]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [08792/2009-2]; Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ) [E-26/102.837868/2012]; CNPq [444704/2014-0]; MCTI/CNPq/FAPs PELD [34/2012]; CNPq PPBio/Rede BioM.A. [477524/2012-2]; FAPERJ [E-26/111.577/2014]; RedeCLIMA Program [01.0405.01]	Ciencia Sem Fronteiras program; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); MCTI/CNPq/FAPs PELD; CNPq PPBio/Rede BioM.A.(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); RedeCLIMA Program	CNJ received support from the Ciencia Sem Fronteiras program (A025_2013), MASA received support from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, process 08792/2009-2), and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ, process E-26/102.837868/2012). MMV received support from CNPq (grant no. 444704/2014-0), MCTI/CNPq/FAPs PELD (Grant No. 34/2012), CNPq PPBio/Rede BioM.A. (Grant No. 477524/2012-2), FAPERJ (grant no. E-26/111.577/2014) and RedeCLIMA Program (grant no. 01.0405.01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABSABER Aziz, 2003, DOMINIOS NATUREZA BR; ANDRADE-LIMA D., 1982, BIOL DIVERSIFICATION, P245; Becker CG, 2010, DIVERS DISTRIB, V16, P10, DOI 10.1111/j.1472-4642.2009.00625.x; BirdLife International, 2014, NATURESERVE BIRD SPE; Bland LM, 2015, CONSERV BIOL, V29, P250, DOI 10.1111/cobi.12372; Canhos DAL, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002204; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Convention on Biological Diversity, 2011, C PART DEC X 2 STRAT; Crouzeilles R, 2013, ENVIRON CONSERV, V40, P209, DOI 10.1017/S0376892912000367; Da Silva JMC, 2002, BIOSCIENCE, V52, P225, DOI 10.1641/0006-3568(2002)052[0225:BPACIT]2.0.CO;2; De Marques AAB, 2015, ORYX, V49, P25, DOI 10.1017/S0030605314000726; de Oliveira G, 2009, ACTA OECOL, V35, P630, DOI 10.1016/j.actao.2009.05.011; Diniz Filho J.A.F., 2009, OECOLOGIA BRAS, V13, P470, DOI DOI 10.4257/0EC0.2009.1303.05; Diniz JAF, 2004, AMPHIBIA-REPTILIA, V25, P63, DOI 10.1163/156853804322992841; Diniz JAF, 2008, ORYX, V42, P567, DOI 10.1017/S0030605308001129; ICMBio, 2014, ESP AM LIST 2014; IUCN, 2012, IUCN RED LIST CATEGO, VSecond edition; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; Jenkins CN, 2008, CONSERV BIOL, V22, P1037, DOI 10.1111/j.1523-1739.2008.00974.x; Jenkins CN, 2013, P NATL ACAD SCI USA, V110, pE2602, DOI 10.1073/pnas.1302251110; Jenkins CN, 2010, BIOL CONSERV, V143, P992, DOI 10.1016/j.biocon.2010.01.014; Joppa LN, 2013, SCIENCE, V341, P1100, DOI 10.1126/science.1241706; Loyola RD, 2013, BIODIVERS CONSERV, V22, P483, DOI 10.1007/s10531-012-0424-x; Maldonado C, 2015, GLOBAL ECOL BIOGEOGR, V24, P973, DOI 10.1111/geb.12326; Marini MA, 2005, CONSERV BIOL, V19, P665, DOI 10.1111/j.1523-1739.2005.00706.x; Mello De PLH, 2015, CONSERVING BIOGEOGRA, P1, DOI [10.1371/journal.pone.0133995, DOI 10.1371/JOURNAL.PONE.0133995]; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Ocampo-Penuela N, 2014, CONSERV BIOL, V28, P1260, DOI 10.1111/cobi.12312; Peres CA, 2000, CONSERV BIOL, V14, P240, DOI 10.1046/j.1523-1739.2000.98485.x; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Pinto MP, 2008, DIVERS DISTRIB, V14, P78, DOI 10.1111/j.1472-4642.2007.00421.x; Pinto MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105205; Pinto MP, 2012, ENVIRON CONSERV, V39, P30, DOI 10.1017/S0376892911000440; Pinto MP, 2009, BIODIVERS CONSERV, V18, P957, DOI 10.1007/s10531-008-9513-2; Por FD, 1992, ATLANTIC FOREST BRAZ; Pouzols FM, 2014, NATURE, V516, P383, DOI 10.1038/nature14032; Prado D.E., 2003, ECOLOGIA CONSERVACA; Rangel TF, 2010, ECOGRAPHY, V33, P46, DOI 10.1111/j.1600-0587.2009.06299.x; Rizzini C.T., 1976, TRATADO FITOGEOGRAFI; Silva da JMC, 2004, BIODIVERSIDADE CAATI; Sobral FL, 2014, NAT CONSERVACAO, V12, P150, DOI 10.1016/j.ncon.2014.09.008; Trindade J, 2012, BIODIVERS CONSERV, V21, P2709, DOI 10.1007/s10531-012-0326-y; Uezu A, 2011, BIODIVERS CONSERV, V20, P3627, DOI 10.1007/s10531-011-0154-5; Vale MM, 2008, CONSERV BIOL, V22, P1006, DOI 10.1111/j.1523-1739.2008.00939.x; Vale Mariana M., 2015, Oecologia Australis, V19, P63; Vale MM, 2012, J BIOGEOGR, V39, P1744, DOI 10.1111/j.1365-2699.2012.02750.x	47	39	40	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145064	10.1371/journal.pone.0145064	http://dx.doi.org/10.1371/journal.pone.0145064			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26679348	Green Submitted, Green Published, gold			2022-12-26	WOS:000366723400047
J	Kaptijn, R; Thomese, F; Liefbroer, AC; Van Poppel, F; Van Bodegom, D; Westendorp, RGJ				Kaptijn, Ralf; Thomese, Fleur; Liefbroer, Aart C.; Van Poppel, Frans; Van Bodegom, David; Westendorp, Rudi G. J.			The Trade-Off between Female Fertility and Longevity during the Epidemiological Transition in the Netherlands	PLOS ONE			English	Article							HUMAN LIFE-HISTORIES; MORTALITY; REPRODUCTION; POPULATION; SELECTION; CHILDBEARING; MOTHERS; ENGLAND; EUROPE; NUMBER	Several hypotheses have been put forward to explain the relationship between women's fertility and their post-reproductive longevity. In this study, we focus on the disposable soma theory, which posits that a negative relationship between women's fertility and longevity can be understood as an evolutionary trade-off between reproduction and survival. We examine the relationship between fertility and longevity during the epidemiological transition in the Netherlands. This period of rapid decline in mortality from infectious diseases offers a good opportunity to study the relationship between fertility and longevity, using registry data from 6,359 women born in The Netherlands between 1850 and 1910. We hypothesize that an initially negative relationship between women's fertility and their longevity gradually turns less negative during the epidemiological transition, because of decreasing costs of higher parities. An initially inversed U-shaped association between fertility and longevity changes to zero during the epidemiological transition. This does suggest a diminishing environmental pressure on fertility. However, we find no evidence of an initial linear trade-off between fertility and post-reproductive survival.	[Kaptijn, Ralf; Thomese, Fleur; Liefbroer, Aart C.] Vrije Univ Amsterdam, Amsterdam, Netherlands; [Liefbroer, Aart C.; Van Poppel, Frans] Netherlands Interdisciplinary Demog Inst, The Hague, Netherlands; [Liefbroer, Aart C.] Univ Groningen, Univ Med Ctr Groningen, NL-9713 AV Groningen, Netherlands; [Van Bodegom, David; Westendorp, Rudi G. J.] Leyden Acad Vital & Aging, Leiden, Netherlands; [Westendorp, Rudi G. J.] Univ Copenhagen, Copenhagen, Denmark	Vrije Universiteit Amsterdam; Royal Netherlands Academy of Arts & Sciences; Netherlands Interdisciplinary Demographic Institute (NIDI-KNAW); University of Groningen; University of Copenhagen	Thomese, F (corresponding author), Vrije Univ Amsterdam, Amsterdam, Netherlands.	fleur.thomese@vu.nl		Liefbroer, Aart/0000-0002-7884-3150; van Bodegom, David/0000-0002-5691-8342	Dutch Scientific Foundation NWO [051-14-050]	Dutch Scientific Foundation NWO(Netherlands Organization for Scientific Research (NWO))	This paper is part of the project Aging Societies, funded of the Dutch Scientific Foundation NWO (grant number 051-14-050).	Alter G, 2007, DEMOGRAPHY, V44, P785, DOI 10.1353/dem.2007.0037; Ansart S, 2009, INFLUENZA OTHER RESP, V3, P99, DOI 10.1111/j.1750-2659.2009.00080.x; COX DR, 1972, J R STAT SOC B, V34, P187; Dior UR, 2013, ANN EPIDEMIOL, V23, P13, DOI 10.1016/j.annepidem.2012.10.005; Doblhammer G, 2003, P ROY SOC B-BIOL SCI, V270, P1541, DOI 10.1098/rspb.2003.2400; Dribe M, 2004, POP STUD-J DEMOG, V58, P297, DOI 10.1080/0032472042000272357; Gagnon A, 2015, FERTIL STERIL, V103, P1109, DOI 10.1016/j.fertnstert.2015.03.030; Gagnon A, 2009, AM J HUM BIOL, V21, P533, DOI 10.1002/ajhb.20893; Gogele M, 2011, J GERONTOL A-BIOL, V66, P26, DOI 10.1093/gerona/glq163; Grundy E, 2005, SOC SCI MED, V61, P217, DOI 10.1016/j.socscimed.2004.11.046; Holt-Lunstad J, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000316; Hurt LS, 2006, POP STUD-J DEMOG, V60, P55, DOI 10.1080/00324720500436011; Jasienska G, 2006, AM J HUM BIOL, V18, P422, DOI 10.1002/ajhb.20497; Jasienska G, 2009, AM J HUM BIOL, V21, P524, DOI 10.1002/ajhb.20931; Joyner K, 2012, DEMOGRAPHY, V49, P101, DOI 10.1007/s13524-011-0073-9; Kirkwood TBL, 2000, NATURE, V408, P233, DOI 10.1038/35041682; Korpelainen H, 2003, AM J PHYS ANTHROPOL, V120, P384, DOI 10.1002/ajpa.10191; Kuningas M, 2011, AGE, V33, P615, DOI 10.1007/s11357-010-9202-4; Le Bourg E, 2007, AGEING RES REV, V6, P141, DOI 10.1016/j.arr.2007.04.002; Lycett JE, 2000, P ROY SOC B-BIOL SCI, V267, P31, DOI 10.1098/rspb.2000.0962; Meij JJ, 2009, J EVOLUTION BIOL, V22, P1014, DOI 10.1111/j.1420-9101.2009.01713.x; Mostafa G, 2000, SOC SCI MED, V50, P763, DOI 10.1016/S0277-9536(99)00295-6; Omran AR, 2005, MILBANK Q, V83, P731, DOI 10.1111/j.1468-0009.2005.00398.x; Ronsmans C, 2001, INT J EPIDEMIOL, V30, P467, DOI 10.1093/ije/30.3.467; Smith KR, 2009, J GERONTOL A-BIOL, V64, P740, DOI 10.1093/gerona/glp055; Spence NJ, 2009, SOC SCI MED, V68, P1625, DOI 10.1016/j.socscimed.2009.02.018; Van Bodegom D, 2007, ANN NY ACAD SCI, V1100, P84, DOI 10.1196/annals.1395.007; Van De Putte BV, 2005, HIST METHOD, V38, P61, DOI 10.3200/HMTS.38.2.61-94; Wang Xiaofei, 2013, Evolution Medicine and Public Health, P241, DOI 10.1093/emph/eot013; Westendorp RGJ, 2004, EMBO REP, V5, P2, DOI 10.1038/sj.embor.7400059; Westendorp RGJ, 2001, NAT MED, V7, P873, DOI 10.1038/90868; WolleswinkelVandenBosch JH, 1997, INT J EPIDEMIOL, V26, P772, DOI 10.1093/ije/26.4.772; ZANDEN J. L, 2013, 4 MADD PROJ	33	15	15	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144353	10.1371/journal.pone.0144353	http://dx.doi.org/10.1371/journal.pone.0144353			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9JO	26680211	gold, Green Published, Green Submitted			2022-12-26	WOS:000366723400011
J	Sarkisyan, KS; Zlobovskaya, OA; Gorbachev, DA; Bozhanova, NG; Sharonov, GV; Staroverov, DB; Egorov, ES; Ryabova, AV; Solntsev, KM; Mishin, AS; Lukyanov, KA				Sarkisyan, Karen S.; Zlobovskaya, Olga A.; Gorbachev, Dmitry A.; Bozhanova, Nina G.; Sharonov, George V.; Staroverov, Dmitriy B.; Egorov, Evgeny S.; Ryabova, Anastasia V.; Solntsev, Kyril M.; Mishin, Alexander S.; Lukyanov, Konstantin A.			KillerOrange, a Genetically Encoded Photosensitizer Activated by Blue and Green Light	PLOS ONE			English	Article							FLUORESCENT PROTEIN; CHROMOPHORE; CELLS; REGULATOR; ABLATION; OXYGEN	Genetically encoded photosensitizers, proteins that produce reactive oxygen species when illuminated with visible light, are increasingly used as optogenetic tools. Their applications range from ablation of specific cell populations to precise optical inactivation of cellular proteins. Here, we report an orange mutant of red fluorescent protein KillerRed that becomes toxic when illuminated with blue or green light. This new protein, KillerOrange, carries a tryptophan-based chromophore that is novel for photosensitizers. We show that KillerOrange can be used simultaneously and independently from KillerRed in both bacterial and mammalian cells offering chromatic orthogonality for light-activated toxicity.	[Sarkisyan, Karen S.; Zlobovskaya, Olga A.; Gorbachev, Dmitry A.; Bozhanova, Nina G.; Sharonov, George V.; Staroverov, Dmitriy B.; Egorov, Evgeny S.; Mishin, Alexander S.; Lukyanov, Konstantin A.] Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Gorbachev, Dmitry A.] Moscow MV Lomonosov State Univ, Fac Biol, Moscow, Russia; [Sharonov, George V.] Moscow MV Lomonosov State Univ, Fac Med, Moscow, Russia; [Egorov, Evgeny S.] Pirogov Russian Natl Res Med Univ, Moscow, Russia; [Ryabova, Anastasia V.] Prokhorov Gen Phys Inst, Laser Biospect Lab, Moscow, Russia; [Solntsev, Kyril M.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Mishin, Alexander S.; Lukyanov, Konstantin A.] Nizhny Novgorod State Med Acad, Nizhnii Novgorod, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Lomonosov Moscow State University; Lomonosov Moscow State University; Pirogov Russian National Research Medical University; Russian Academy of Sciences; Prokhorov General Physics Institute of the Russian Academy of Sciences; University System of Georgia; Georgia Institute of Technology; Privolzhsky Research Medical University	Sarkisyan, KS (corresponding author), Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia.	karen.s.sarkisyan@gmail.com	Sarkisyan, Karen/AAA-5784-2021; Staroverov, Dmitry/AAN-7359-2020; Lukyanov, Konstantin A/D-4030-2013; Ryabova, Anastasia V/I-7911-2014; Zlobovskaya, Olga/AAM-4307-2021; Sharonov, George V/B-1323-2014; Sarkisyan, Karen S/M-6821-2015; Mishin, Alexander/L-9420-2014	Sarkisyan, Karen/0000-0002-5375-6341; Staroverov, Dmitry/0000-0001-6789-9442; Lukyanov, Konstantin A/0000-0001-9845-2088; Ryabova, Anastasia V/0000-0003-3488-1128; Sharonov, George V/0000-0001-8610-5054; Sarkisyan, Karen S/0000-0002-5375-6341; Mishin, Alexander/0000-0002-4935-7030; Bozhanova, Nina/0000-0002-2164-5698; Gorbachev, Dmitry/0000-0001-6124-2511; Solntsev, Kyril/0000-0002-6855-462X; Zlobovskaya, Olga/0000-0002-9068-6768	Russian Science Foundation [14-25-00129]; OPTEC grant for young scientists [21/2014/51-Msk]; Science and Innovation Youth Contest Participant grant (UMNIK) [3616Gammay2/2014]; National Science Foundation [CHE-1213047]; Direct For Mathematical & Physical Scien [1213047] Funding Source: National Science Foundation	Russian Science Foundation(Russian Science Foundation (RSF)); OPTEC grant for young scientists; Science and Innovation Youth Contest Participant grant (UMNIK); National Science Foundation(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The work was supported by Russian Science Foundation (14-25-00129). KSS was supported by OPTEC grant for young scientists (21/2014/51-Msk) and Science and Innovation Youth Contest Participant grant (UMNIK, 3616 Gamma y2/2014). Experiments were partially carried out using the equipment provided by the IBCH core facility (CKP IBCH). KMS acknowledges generous support from the National Science Foundation (CHE-1213047).; We would like to thank J.T. Ripper (Department of Surgery, Whitechapel District Institute, London, UK) for fruitful discussions and technical assistance. The work was supported by Russian Science Foundation (14-25-00129). KSS was supported by OPTEC grant for young scientists (21/2014/51-Msk) and Science and Innovation Youth Contest Participant grant (UMNIK, 3616 Gamma y2/2014). Experiments were partially carried out using the equipment provided by the IBCH core facility (CKP IBCH). KMS acknowledges generous support from the National Science Foundation (CHE-1213047).	Ai HW, 2007, BIOCHEMISTRY-US, V46, P5904, DOI 10.1021/bi700199g; Bulina ME, 2006, NAT BIOTECHNOL, V24, P95, DOI 10.1038/nbt1175; Byrne LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076075; Carpentier P, 2009, FEBS LETT, V583, P2839, DOI 10.1016/j.febslet.2009.07.041; Chudakov DM, 2010, PHYSIOL REV, V90, P1103, DOI 10.1152/physrev.00038.2009; Del Bene F, 2010, SCIENCE, V330, P669, DOI 10.1126/science.1192949; Destaing O, 2010, MOL BIOL CELL, V21, P4108, DOI 10.1091/mbc.E10-07-0580; Hansen MJ, 2015, CHEM SOC REV, V44, P3358, DOI 10.1039/c5cs00118h; Ivashchenko O, 2011, MOL BIOL CELL, V22, P1440, DOI 10.1091/mbc.E10-11-0919; Jarvela T, 2014, MOL BIOL CELL, V25, P133, DOI 10.1091/mbc.E13-07-0395; Jewhurst Kyle, 2014, J Cell Death, V7, P25, DOI 10.4137/JCD.S18368; Kobayashi J, 2013, NEUROSCI LETT, V548, P261, DOI 10.1016/j.neulet.2013.05.053; Kuznetsova DS, 2015, J BIOPHOTONICS, V8, P952, DOI 10.1002/jbio.201400130; Lan L, 2014, NUCLEIC ACIDS RES, V42, P2330, DOI 10.1093/nar/gkt1233; Lelimousin M, 2009, BIOCHEMISTRY-US, V48, P10038, DOI 10.1021/bi901093w; Levin E., 2015, ANGEW CHEM, V127, P12561, DOI [10.1002/ange.201500740, DOI 10.1002/ANGE.201500740]; Liao ZX, 2014, BIOMATERIALS, V35, P500, DOI 10.1016/j.biomaterials.2013.09.075; Lin JY, 2013, NEURON, V79, P241, DOI 10.1016/j.neuron.2013.05.022; Lukyanov KA, 2010, PHOTOCH PHOTOBIO SCI, V9, P1301, DOI 10.1039/c0pp00114g; Matsumoto A, 2011, BIOTECHNIQUES, V51, P55, DOI 10.2144/000113705; Matsunaga S, 2012, CELL REP, V1, P299, DOI 10.1016/j.celrep.2012.02.005; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Mishin AS, 2015, CURR OPIN CHEM BIOL, V27, P1, DOI 10.1016/j.cbpa.2015.05.002; Pletnev S, 2009, J BIOL CHEM, V284, P32028, DOI 10.1074/jbc.M109.054973; Qi YCB, 2012, P NATL ACAD SCI USA, V109, P7499, DOI 10.1073/pnas.1204096109; Ryumina AP, 2013, BBA-GEN SUBJECTS, V1830, P5059, DOI 10.1016/j.bbagen.2013.07.015; Sarkisyan KS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00608; Serebrovskaya EO, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.7.071403; Serebrovskaya EO, 2011, BIOCHEM J, V435, P65, DOI 10.1042/BJ20101217; Shibuya T, 2012, J PHOTOCH PHOTOBIO B, V117, P1, DOI 10.1016/j.jphotobiol.2012.08.005; Shirmanova MV, 2013, J BIOPHOTONICS, V6, P283, DOI 10.1002/jbio.201200056; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Takemoto K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02629; Torra J, 2015, PHOTOCH PHOTOBIO SCI, V14, P280, DOI 10.1039/c4pp00338a; Vartanian JP, 1996, NUCLEIC ACIDS RES, V24, P2627, DOI 10.1093/nar/24.14.2627; Vegh RB, 2014, J PHYS CHEM B, V118, P4527, DOI 10.1021/jp500919a; Vegh RB, 2011, CHEM COMMUN, V47, P4887, DOI 10.1039/c0cc05713d; Williams DC, 2013, CELL REP, V5, P553, DOI 10.1016/j.celrep.2013.09.023; Yan LB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131518	39	46	49	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145287	10.1371/journal.pone.0145287	http://dx.doi.org/10.1371/journal.pone.0145287			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26679300	Green Published, Green Submitted, gold			2022-12-26	WOS:000366723400066
J	Zhao, P; Wang, QH; Tian, CM; Kakishima, M				Zhao, Peng; Wang, Qing-Hong; Tian, Cheng-Ming; Kakishima, Makoto			Integrating a Numerical Taxonomic Method and Molecular Phylogeny for Species Delimitation of Melampsora Species (Melampsoraceae, Pucciniales) on Willows in China	PLOS ONE			English	Article							RUST FUNGUS; SALIX; GENERA; LEVEL; NEED	The species in genus Melampsora are the causal agents of leaf rust diseases on willows in natural habitats and plantations. However, the classification and recognition of species diversity are challenging because morphological characteristics are scant and morphological variation in Melampsora on willows has not been thoroughly evaluated. Thus, the taxonomy of Melampsora species on willows remains confused, especially in China where 31 species were reported based on either European or Japanese taxonomic systems. To clarify the species boundaries of Melampsora species on willows in China, we tested two approaches for species delimitation inferred from morphological and molecular variations. Morphological species boundaries were determined based on numerical taxonomic analyses of morphological characteristics in the uredinial and telial stages by cluster analysis and one-way analysis of variance. Phylogenetic species boundaries were delineated based on the generalized mixed Yule-coalescent (GMYC) model analysis of the sequences of the internal transcribed spacer (ITS1 and ITS2) regions including the 5.8S and D1/D2 regions of the large nuclear subunit of the ribosomal RNA gene. Numerical taxonomic analyses of 14 morphological characteristics recognized in the uredinial-telial stages revealed 22 morphological species, whereas the GMYC results recovered 29 phylogenetic species. In total, 17 morphological species were in concordance with the phylogenetic species and 5 morphological species were in concordance with 12 phylogenetic species. Both the morphological and molecular data supported 14 morphological characteristics, including 5 newly recognized characteristics and 9 traditionally emphasized characteristics, as effective for the differentiation of Melampsora species on willows in China. Based on the concordance and discordance of the two species delimitation approaches, we concluded that integrative taxonomy by using both morphological and molecular variations was an effective approach for delimitating Melampsora species on willows in China.	[Zhao, Peng] Univ Tsukuba, Grad Sch Life & Environm Sci, Ibaraki 3058572, Japan; [Wang, Qing-Hong] China Univ Petr, Beijing Key Lab Oil & Gas Pollut Control, State Key Lab Heavy Oil Proc, Beijing 102249, Peoples R China; [Tian, Cheng-Ming] Beijing Forestry Univ, Minist Educ, Key Lab Silviculture & Conservat, Beijing 100083, Peoples R China; [Kakishima, Makoto] Univ Tsukuba, Fac Life & Environm Sci, Ibaraki 3058572, Japan; [Kakishima, Makoto] Jilin Agr Univ, Chinese Minist Educ Edible & Med Fungi, Engn Res Ctr, Changchun 130118, Jilin Province, Peoples R China	University of Tsukuba; China University of Petroleum; Beijing Forestry University; University of Tsukuba; Jilin Agricultural University	Wang, QH (corresponding author), China Univ Petr, Beijing Key Lab Oil & Gas Pollut Control, State Key Lab Heavy Oil Proc, Beijing 102249, Peoples R China.	wangqhqh@163.com	, peng/AAE-4583-2020		National Natural Science Foundation of China [21306229]; Research Fund for the Doctoral Program of Higher Education of China [20130007120007]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by National Natural Science Foundation of China (21306229) and Research Fund for the Doctoral Program of Higher Education of China (20130007120007). Qinghong Wang received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aime M. Catherine, 2006, Mycoscience, V47, P112, DOI 10.1007/s10267-006-0281-0; [Anonymous], 2014, TRACER V1 6; Arthur J.C., 1920, B TORREY BOT CLUB, V47, P480, DOI 10.2307/2480199; Bagyanarayana G, 2005, RUST DISEASES OF WILLOW AND POPLAR, P29, DOI 10.1079/9780851999999.0029; Bennett C, 2011, MYCOLOGIA, V103, P1004, DOI 10.3852/10-289; Cao ZM, 1999, RUST FUNGI OF QINLIN; Carstens BC, 2010, SYST BIOL, V59, P400, DOI 10.1093/sysbio/syq024; Chatasiri S, 2008, MYCOSCIENCE, V49, P66, DOI 10.1007/s10267-007-0390-4; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Cummins GB, 2003, ILLUSTRATED GENERA O; DABINETT PE, 1978, CAN J BOT, V56, P2031, DOI 10.1139/b78-244; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Ezard T, 2009, SPECIES LIMITS BY TH; Fujisawa T, 2013, SYST BIOL, V62, P707, DOI 10.1093/sysbio/syt033; Gonzalez-Garcia S, 2012, SCI TOTAL ENVIRON, V421, P210, DOI 10.1016/j.scitotenv.2012.01.041; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hiratsuka N, 1982, TAXONOMIC REVISION M, V20, P1; Huelsenbeck JP, 1996, TRENDS ECOL EVOL, V11, P152, DOI 10.1016/0169-5347(96)10006-9; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hylander N., 1953, OPERA BOT, V1, P1; Ito S, 1938, MYCOLOGICAL FLORA OF; KAMPFER P, 1991, J GEN MICROBIOL, V137, P1831, DOI 10.1099/00221287-137-8-1831; KIRK PM, 2001, DICT FUNGI; Klebahn H, 1897, Z PFLANZEN KRANKHIET, V7, P129; Klebahn H, 1902, Z PFLANZENKRANKHREIT, V12, P17; Klebahn H, 1914, UREDINEAE, P69; Kubatko LS, 2009, BIOINFORMATICS, V25, P971, DOI 10.1093/bioinformatics/btp079; Kuprevich VF., 1957, CRYPTOGAMIC PLANTS U, P1; Kuzovkina YA, 2005, WATER AIR SOIL POLL, V162, P183, DOI 10.1007/s11270-005-6272-5; Lee Seung Kyu, 1999, Mycoscience, V40, P121, DOI 10.1007/BF02464290; Liang YM., 2006, THESIS U TSUKUBA JAP; Liro J.I., 1908, UREDINEAE FENNICAE F; Liu W., 2005, THESIS; Matsumoto T, 1915, T SAPPORO NATURAL HI, V6, P22; Miyake I., 1913, BOT MAG TOKYO, V27, P37; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Padial JM, 2009, ZOOL SCR, V38, P431, DOI 10.1111/j.1463-6409.2008.00381.x; Pei MH, 2005, MYCOL RES, V109, P401, DOI 10.1017/S0953756205002479; Pei MH, 2005, RUST DISEASES OF WILLOW AND POPLAR, P1, DOI 10.1079/9780851999999.0000; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; ROYLE DJ, 1992, BIOMASS BIOENERG, V2, P45, DOI 10.1016/0961-9534(92)90087-7; Schlick-Steiner BC, 2010, ANNU REV ENTOMOL, V55, P421, DOI 10.1146/annurev-ento-112408-085432; Schneider O, 1905, WEITERE VERSUCHE SCH, V15, P232; Smith JA, 2004, MYCOLOGIA, V96, P1330, DOI 10.2307/3762149; Spiers AG, 1996, MYCOL RES, V100, P1163, DOI 10.1016/S0953-7562(96)80176-6; Swofford DL, 2001, SYST BIOL, V50, P525, DOI 10.1080/106351501750435086; Sydow P, 1915, MONOGRAPHIA UREDINEA; Tai FL, 1979, SYLLOGE FUNGORUM SIN; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian Cheng-Ming, 2004, Mycoscience, V45, P56, DOI 10.1007/s10267-003-0150-z; Verwijst T, 1996, SCAND J FOREST RES, V11, P104, DOI 10.1080/02827589609382917; Virtudazo EV, 2001, J GEN PLANT PATHOL, V67, P28, DOI DOI 10.1007/PL00012983; Wahyuno Dono, 2001, Mycoscience, V42, P519, DOI 10.1007/BF02460950; Wang Y.-Z., 1980, Acta Microbiologica Sinica, V20, P16; Wieclaw H, 2013, NORD J BOT, V31, P464, DOI 10.1111/j.1756-1051.2013.00095.x; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Wilson M, 1966, THE BRITISH RUST FUN; ZAMBINO PJ, 1993, MYCOLOGIA, V85, P401, DOI 10.2307/3760702; Zhao P, 2015, MYCOL PROG, V14, DOI 10.1007/s11557-015-1091-6; Zhao P, 2014, MYCOSCIENCE, V55, P390, DOI 10.1016/j.myc.2013.12.005; Zhao P, 2013, MYCOTAXON, V123, P81, DOI 10.5248/123.81; Zheng W., 1983, SYLVA SINICA; Zhuang J. Y., 1989, Acta Mycologica Sinica, V8, P259; Zhuang J. Y., 1994, Mycosystema, V7, P37; Zhuang J. Y., 1986, Acta Mycologica Sinica, V5, P75; Zhuang J. Y., 1983, Acta Mycologica Sinica, V2, P146; Zhuang Jian-yun, 2006, Journal of Fungal Research, V4, P1; Zhuang JianYun, 2002, Journal of Jilin Agricultural University, V24, P5; Zhuang JY, 2003, MYCOSYSTEMA, V22, P107; Zhuang WY, 2005, FUNGI OF NORTHWESTER; Ziller WG, 1974, THE TREE RUSTS OF WE	73	13	13	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144883	10.1371/journal.pone.0144883	http://dx.doi.org/10.1371/journal.pone.0144883			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26680416	Green Published, gold, Green Submitted			2022-12-26	WOS:000366723400032
J	Chen, QY; Deeb, RS; Ma, YL; Staudt, MR; Crystal, RG; Gross, SS				Chen, Qiuying; Deeb, Ruba S.; Ma, Yuliang; Staudt, Michelle R.; Crystal, Ronald G.; Gross, Steven S.			Serum Metabolite Biomarkers Discriminate Healthy Smokers from COPD Smokers	PLOS ONE			English	Article							OBSTRUCTIVE-PULMONARY-DISEASE; SURFACTANT PROTEIN-D; EXHALED BREATH CONDENSATE; INFLAMMATORY BIOMARKERS; LUNG-FUNCTION; POTENTIAL BIOMARKER; ACUTE EXACERBATIONS; PLASMA-FIBRINOGEN; OXIDATIVE STRESS; GENE-EXPRESSION	COPD (chronic obstructive pulmonary disease) is defined by a fixed expiratory airflow obstruction associated with disordered airways and alveolar destruction. COPD is caused by cigarette smoking and is the third greatest cause of mortality in the US. Forced expiratory volume in 1 second (FEV1) is the only validated clinical marker of COPD, but it correlates poorly with clinical features and is not sensitive enough to predict the early onset of disease. Using LC/MS global untargeted metabolite profiling of serum samples from a well-defined cohort of healthy smokers (n = 37), COPD smokers (n = 41) and non-smokers (n = 37), we sought to discover serum metabolic markers with known and/or unknown molecular identities that are associated with early-onset COPD. A total of 1,181 distinct molecular ions were detected in 95% of sera from all study subjects and 23 were found to be differentially-expressed in COPD-smokers vs. healthy-smokers. These 23 putative biomarkers were differentially-correlated with lung function parameters and used to generate a COPD prediction model possessing 87.8% sensitivity and 86.5% specificity. In an independent validation set, this model correctly predicted COPD in 8/10 individuals. These serum biomarkers included myoinositol, glycerophopshoinositol, fumarate, cysteinesulfonic acid, a modified version of fibrinogen peptide B (mFBP), and three doubly-charged peptides with undefined sequence that significantly and positively correlate with mFBP levels. Together, elevated levels of serum mFBP and additional disease-associated biomarkers point to a role for chronic inflammation, thrombosis, and oxidative stress in remodeling of the COPD airways. Serum metabolite biomarkers offer a promising and accessible window for recognition of early-stage COPD.	[Chen, Qiuying; Ma, Yuliang; Gross, Steven S.] Weill Cornell Med, Dept Pharmacol, New York, NY 10065 USA; [Deeb, Ruba S.; Staudt, Michelle R.; Crystal, Ronald G.] Weill Cornell Med, Dept Med Genet, New York, NY 10065 USA	Cornell University; Cornell University	Crystal, RG (corresponding author), Weill Cornell Med, Dept Med Genet, 1300 York Ave, New York, NY 10065 USA.	ssgross@med.cornell.edu; geneticmedicine@med.cornell.edu		Staudt, Michelle/0000-0002-3364-0894	NIH [R01HL107882, R01HL1189541, R37HL087062, P20 HL113443]; Family Smoking Prevention and Tobacco Control Act; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P20HL113443, R37HL087062, R01HL107882] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Family Smoking Prevention and Tobacco Control Act; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported, in part, by NIH R01HL107882, R01HL1189541, R37HL087062 and P20 HL113443. Research reported in this publication was supported in part by the Family Smoking Prevention and Tobacco Control Act. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Food and Drug Administration.; We thank C. Hollmann and S. Hyde in the Department of Genetic Medicine for help with the clinical regulatory aspects of these studies. These studies were supported, in part, by NIH R01HL107882, R01HL1189541, R37HL087062 and P20 HL113443. Research reported in this publication was supported in part by the Family Smoking Prevention and Tobacco Control Act. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Food and Drug Administration.	Akbas F, 2012, EXP LUNG RES, V38, P286, DOI 10.3109/01902148.2012.689088; Allred KF, 2009, J NUTR, V139, P1833, DOI 10.3945/jn.109.108001; Antczak A, 2012, ARCH MED SCI, V8, P277, DOI 10.5114/aoms.2012.28555; Barouchos N, 2015, SCAND J CLIN LAB INV, V75, P126, DOI 10.3109/00365513.2014.992944; Begas E, 2007, BIOMED CHROMATOGR, V21, P190, DOI 10.1002/bmc.736; Bentley AR, 2008, THORAX, V63, P956, DOI 10.1136/thx.2007.086199; BLOMBACK B, 1978, NATURE, V275, P501, DOI 10.1038/275501a0; Bowler RP, 2015, AM J RESP CRIT CARE, V191, P275, DOI 10.1164/rccm.201410-1771OC; Bowler RP, 2012, COPD, V9, P651, DOI 10.3109/15412555.2012.736317; Carolan BJ, 2013, AM J RESP CRIT CARE, V188, P561, DOI 10.1164/rccm.201212-2299OC; Chan KH, 2010, INT J TUBERC LUNG D, V14, P1193; Chen QY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037149, 10.1371/journal.pone.0042971]; Csanky E, 2009, ELECTROPHORESIS, V30, P1228, DOI 10.1002/elps.200800722; Dahl M, 2001, AM J RESP CRIT CARE, V164, P1008, DOI 10.1164/ajrccm.164.6.2010067; Dahl M, 2008, AM J RESP CRIT CARE, V177, P1177, DOI 10.1164/rccm.200802-225ED; Deja S, 2014, J PHARMACEUT BIOMED, V100, P369, DOI 10.1016/j.jpba.2014.08.020; Dessi A, 2013, J OBSTET GYNAECOL, V33, P776, DOI 10.3109/01443615.2013.831046; Diaz AA, 2010, CHEST, V138, P880, DOI 10.1378/chest.10-0542; Dickens JA, 2012, COPD, V9, P574, DOI 10.3109/15412555.2012.718926; Dinavahi S S, 2014, Drug Res (Stuttg), V64, P214, DOI 10.1055/s-0033-1355411; Pastor MD, 2013, INT J MOL SCI, V14, P3440, DOI 10.3390/ijms14023440; Duvoix A, 2013, THORAX, V68, P670, DOI 10.1136/thoraxjnl-2012-201871; ECKHARDT T, 1981, J CLIN INVEST, V67, P809, DOI 10.1172/JCI110098; Eickmeier O, 2010, CYTOKINE, V50, P152, DOI 10.1016/j.cyto.2010.02.004; El-Deek SE, 2013, MED PRIN PRACT, V22, P469, DOI 10.1159/000349934; Fruchter O, 2015, AM J MED SCI, V349, P29, DOI 10.1097/MAJ.0000000000000332; Fuster Antonia, 2008, Int J Chron Obstruct Pulmon Dis, V3, P149; GIROD S, 1992, PEDIATR PULM, V13, P22, DOI 10.1002/ppul.1950130107; GRYGIEL JJ, 1981, CLIN PHARMACOL THER, V30, P491, DOI 10.1038/clpt.1981.193; Han W, 2009, CANCER PREV RES, V2, P370, DOI 10.1158/1940-6207.CAPR-08-0209; He HY, 2014, CHINESE MED J-PEKING, V127, P1608, DOI 10.3760/cma.j.issn.0366-6999.20132502; Heo JS, 2014, COPD, V11, P152, DOI 10.3109/15412555.2013.828028; Higashimoto Y, 2009, RESP MED, V103, P1231, DOI 10.1016/j.rmed.2009.01.021; Ismailoglu I, 2014, DEV BIOL, V391, P230, DOI 10.1016/j.ydbio.2014.04.005; Jetter A, 2009, EUR J CLIN PHARMACOL, V65, P411, DOI 10.1007/s00228-008-0597-0; Johansson SL, 2014, RESP MED, V108, P1336, DOI 10.1016/j.rmed.2014.06.003; Kirdar S, 2009, SCAND J CLIN LAB INV, V69, P219, DOI 10.1080/00365510802474400; Koutsokera A, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-111; Kurt OK, 2015, INFLAMMATION, V38, P89, DOI 10.1007/s10753-014-0010-3; Liang R, 2013, MOL MED REP, V7, P1470, DOI 10.3892/mmr.2013.1377; Lopez-Campos JL, 2015, PATIENT PREFER ADHER, V9, P95, DOI 10.2147/PPA.S55009; MacNee W, 2013, ANN MED, V45, P291, DOI 10.3109/07853890.2012.732703; Malerba M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/271918; Mannino DM, 2015, CHRON OBSTR PULM DIS, V2, P23, DOI 10.15326/jcopdf.2.1.2014.0138; Markoulis N, 2006, PANMINERVA MED, V48, P209; Marwick John A, 2010, Ther Adv Respir Dis, V4, P19, DOI 10.1177/1753465809352792; Musharraf SG, 2015, SCI REP-UK, V5, DOI 10.1038/srep08607; Ning Wen, 2006, Proc Am Thorac Soc, V3, P466, DOI 10.1513/pats.200603-031MS; Nobakht BF, 2015, BIOMARKERS, V20, P5, DOI 10.3109/1354750X.2014.983167; Paige M, 2011, BIOCHEM BIOPH RES CO, V413, P588, DOI 10.1016/j.bbrc.2011.09.006; Papaioannou AI, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-67; Petersen AMW, 2007, LUNG, V185, P161, DOI 10.1007/s00408-007-9000-7; Pinto-Plata Victor, 2006, Proc Am Thorac Soc, V3, P465, DOI 10.1513/pats.200603-030MS; Polosa R, 2013, INTERN EMERG MED, V8, P567, DOI 10.1007/s11739-011-0636-1; Qaseem A, 2011, ANN INTERN MED, V155, P179, DOI 10.7326/0003-4819-155-3-201108020-00008; Rana GSJB, 2010, ANAL BIOANAL CHEM, V397, P1809, DOI 10.1007/s00216-010-3742-4; Rosenberg SR, 2012, TRANSL RES, V159, P228, DOI 10.1016/j.trsl.2012.01.019; Rothwell JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093474; Schuetz P, 2015, CLIN CHEM LAB MED, V53, P521, DOI 10.1515/cclm-2014-0748; Scott JA, 2014, INT J MOL SCI, V15, P6062, DOI 10.3390/ijms15046062; SENIOR RM, 1986, J CLIN INVEST, V77, P1014, DOI 10.1172/JCI112353; Shaw JG, 2014, J THORAC DIS, V6, P1532, DOI 10.3978/j.issn.2072-1439.2014.11.33; Sriskantharajah S, 2013, ANN NY ACAD SCI, V1280, P35, DOI 10.1111/nyas.12039; Stockley RA, 2014, INT J CHRONIC OBSTR, V9, P163, DOI 10.2147/COPD.S42362; Suzuki Masaru, 2014, Ann Am Thorac Soc, V11, P1511, DOI 10.1513/AnnalsATS.201408-351OC; TANG BK, 1991, CLIN PHARMACOL THER, V49, P648, DOI 10.1038/clpt.1991.82; Tapson Victor F, 2005, Proc Am Thorac Soc, V2, P71, DOI 10.1513/pats.200407-038MS; Ten Hoeve Arne Lucas, 2012, Tanaffos, V11, P12; Thomsen M, 2013, JAMA-J AM MED ASSOC, V309, P2353, DOI 10.1001/jama.2013.5732; Turino GM, 2011, AM J RESP CRIT CARE, V184, P637, DOI 10.1164/rccm.201103-0450PP; Ubhi BK, 2012, MOL BIOSYST, V8, P3125, DOI 10.1039/c2mb25194a; Undas A, 2009, THROMB HAEMOSTASIS, V102, P1176, DOI 10.1160/TH09-02-0118; Verrills NM, 2011, AM J RESP CRIT CARE, V183, P1633, DOI 10.1164/rccm.201010-1623OC; Vestbo J, 2014, RESP MED, V108, P729, DOI 10.1016/j.rmed.2014.03.002; Wang MY, 2016, CLIN RESPIR J, V10, P104, DOI 10.1111/crj.12194; Wedzicha JA, 2000, THROMB HAEMOSTASIS, V84, P210; Westwood M, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-40; Wu HX, 2014, BIOCHEM BIOPH RES CO, V450, P110, DOI 10.1016/j.bbrc.2014.05.073; Zhang J, 2015, RESP CARE, V60, P251, DOI 10.4187/respcare.03519	79	31	33	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0143937	10.1371/journal.pone.0143937	http://dx.doi.org/10.1371/journal.pone.0143937			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674646	Green Published, gold, Green Submitted			2022-12-26	WOS:000366722700017
J	Choi, HJ; Kim, YJ; Choi, DK; Kim, YS				Choi, Hye-Ji; Kim, Ye-Jin; Choi, Dong-Ki; Kim, Yong-Sung			Engineering of Immunoglobulin Fc Heterodimers Using Yeast Surface-Displayed Combinatorial Fc Library Screening	PLOS ONE			English	Article							BISPECIFIC ANTIBODY; DIRECTED EVOLUTION; IGG ANTIBODIES; CELL-SURFACE; BINDING; GENERATION; EXPRESSION; REVEAL; ALPHA	Immunoglobulin Fc heterodimers, which are useful scaffolds for the generation of bispecific antibodies, have been mostly generated through structure-based rational design methods that introduce asymmetric mutations into the CH3 homodimeric interface to favor heterodimeric Fc formation. Here, we report an approach to generate heterodimeric Fc variants through directed evolution combined with yeast surface display. We developed a combinatorial heterodimeric Fc library display system by mating two haploid yeast cell lines, one haploid cell line displayed an Fc chain library (displayed Fc(CH3A)) with mutations in one CH3 domain (CH3A) on the yeast cell surface, and the other cell line secreted an Fc chain library (secreted Fc(CH3B)) with mutations in the other CH3 domain (CH3B). In the mated cells, secreted Fc(CH3B) is displayed on the cell surface through heterodimerization with the displayed Fc(CH3A), the detection of which enabled us to screen the library for heterodimeric Fc variants. We constructed combinatorial heterodimeric Fc libraries with simultaneous mutations in the homodimer-favoring electrostatic interaction pairs K370-E357/S364 or D399K392/K409 at the CH3 domain interface. High-throughput screening of the libraries using flow cytometry yielded heterodimeric Fc variants with heterodimer-favoring CH3 domain interface mutation pairs, some of them showed high heterodimerization yields (similar to 80-90%) with previously unidentified CH3 domain interface mutation pairs, such as hydrogen bonds and cation-pi interactions. Our study provides a new approach for engineering Fc heterodimers that could be used to engineer other heterodimeric protein-protein interactions through directed evolution combined with yeast surface display.	[Choi, Hye-Ji; Kim, Ye-Jin; Choi, Dong-Ki; Kim, Yong-Sung] Ajou Univ, Dept Mol Sci & Technol, Suwon 16499, South Korea	Ajou University	Kim, YS (corresponding author), Ajou Univ, Dept Mol Sci & Technol, Suwon 16499, South Korea.	kimys@ajou.ac.kr		Kim, Yong-Sung/0000-0003-2673-1509	National Research Foundation - Korean government [2014M3C1A3051470, 2013M3A6A4043874, 2013R1A2A2A01005817, 2012-0006687]	National Research Foundation - Korean government(Korean Government)	This work was supported by grants from the Pioneer Research Center Program (2014M3C1A3051470), the Global Frontier Project (2013M3A6A4043874), the Mid-career Researcher Program (2013R1A2A2A01005817), and the Priority Research Center Program (2012-0006687) from the National Research Foundation funded by the Korean government.	Angelini A, 2015, METHODS MOL BIOL, V1319, P3, DOI 10.1007/978-1-4939-2748-7_1; Atwell S, 1997, J MOL BIOL, V270, P26, DOI 10.1006/jmbi.1997.1116; Baek DS, 2015, BIOCHEM BIOPH RES CO, V463, P414, DOI 10.1016/j.bbrc.2015.05.086; Baek DS, 2014, J MICROBIOL BIOTECHN, V24, P408, DOI 10.4014/jmb.1401.01002; Benatuil L, 2010, PROTEIN ENG DES SEL, V23, P155, DOI 10.1093/protein/gzq002; Boder ET, 2000, METHOD ENZYMOL, V328, P430, DOI 10.1016/S0076-6879(00)28410-3; Choi DK, 2014, MABS-AUSTIN, V6, P1402, DOI 10.4161/mabs.36389; Choi HJ, 2015, MOL IMMUNOL, V65, P377, DOI 10.1016/j.molimm.2015.02.017; Choi HJ, 2013, MOL CANCER THER, V12, P2748, DOI 10.1158/1535-7163.MCT-13-0628; Davis JH, 2010, PROTEIN ENG DES SEL, V23, P195, DOI 10.1093/protein/gzp094; EDELMAN GM, 1969, P NATL ACAD SCI USA, V63, P78, DOI 10.1073/pnas.63.1.78; Elliott JM, 2014, J MOL BIOL, V426, P1947, DOI 10.1016/j.jmb.2014.02.015; Gunasekaran K, 2010, J BIOL CHEM, V285, P19637, DOI 10.1074/jbc.M110.117382; Hu XB, 2009, J BIOL CHEM, V284, P16369, DOI 10.1074/jbc.M109.001743; Jiang W, 2010, P NATL ACAD SCI USA, V107, P13258, DOI 10.1073/pnas.1006344107; Kim MS, 2007, J MOL BIOL, V374, P1374, DOI 10.1016/j.jmb.2007.10.034; Kitazawa T, 2012, NAT MED, V18, P1570, DOI 10.1038/nm.2942; Klein C, 2012, MABS-AUSTIN, V4, P653, DOI 10.4161/mabs.21379; Kontermann RE, 2012, MABS-AUSTIN, V4, P182, DOI 10.4161/mabs.4.2.19000; Lee CH, 2010, PROTEIN EXPRES PURIF, V71, P42, DOI 10.1016/j.pep.2009.12.004; LIPKE PN, 1989, MOL CELL BIOL, V9, P3155, DOI 10.1128/MCB.9.8.3155; Merchant AM, 1998, NAT BIOTECHNOL, V16, P677, DOI 10.1038/nbt0798-677; Moore GL, 2011, MABS-AUSTIN, V3, P546, DOI 10.4161/mabs.3.6.18123; Ridgway JBB, 1996, PROTEIN ENG, V9, P617, DOI 10.1093/protein/9.7.617; Sampei Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057479; Saphire EO, 2002, J MOL BIOL, V319, P9, DOI 10.1016/S0022-2836(02)00244-9; Spiess C, 2015, MOL IMMUNOL, V67, P95, DOI 10.1016/j.molimm.2015.01.003; Strop P, 2012, J MOL BIOL, V420, P204, DOI 10.1016/j.jmb.2012.04.020; Traxlmayr MW, 2012, BBA-PROTEINS PROTEOM, V1824, P542, DOI 10.1016/j.bbapap.2012.01.006; Von Kreudenstein TS, 2014, METHODS, V65, P77, DOI 10.1016/j.ymeth.2013.10.016; Von Kreudenstein TS, 2013, MABS-AUSTIN, V5, P646, DOI 10.4161/mabs.25632; Wang KC, 2010, J IMMUNOL METHODS, V354, P11, DOI 10.1016/j.jim.2010.01.006; Watt MM, 2013, ACCOUNTS CHEM RES, V46, P955, DOI 10.1021/ar300100g; Weaver-Feldhaus JM, 2004, FEBS LETT, V564, P24, DOI 10.1016/S0014-5793(04)00309-6	34	13	37	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145349	10.1371/journal.pone.0145349	http://dx.doi.org/10.1371/journal.pone.0145349			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675656	Green Published, Green Submitted, gold			2022-12-26	WOS:000366722700120
J	Strumylaite, L; Sharp, SJ; Kregzdyte, R; Poskiene, L; Bogusevicius, A; Pranys, D				Strumylaite, Loreta; Sharp, Stephen J.; Kregzdyte, Rima; Poskiene, Lina; Bogusevicius, Algirdas; Pranys, Darius			The Association of Low-To-Moderate Alcohol Consumption with Breast Cancer Subtypes Defined by Hormone Receptor Status	PLOS ONE			English	Article							RISK-FACTORS; ESTROGEN; ETHANOL; WOMEN; PROLIFERATION; METAANALYSIS; EXPRESSION; ESTRADIOL; ALPHA	Background Alcohol is a well-established risk factor for breast cancer, but pathways involved in alcohol-related breast carcinogenesis are not clearly defined. We examined the association between low-to-moderate alcohol intake and breast cancer subtypes by tumor hormone receptor status. Materials and Methods A hospital-based case-control study was performed in 585 cases and 1,170 controls. Information on alcohol intake and other risk factors was collected via a questionnaire. Logistic regression was used for analyses. All statistical tests were two-sided. Results The odds ratio of breast cancer was 1.75 (95% confidence interval [CI]: 1.21-2.53) in women who consumed <= 5 drinks/week, and 3.13 (95% CI: 1.81-5.43) in women who consumed >5 drinks/week, both compared with non-drinkers for >= 10 years, after adjustment for age and other confounders. The association of alcohol intake with estrogen receptor-positive breast cancer was stronger than with estrogen receptor-negative: the odds ratio per 1 category increase was 2.05 (95% CI: 1.49-2.82) and 1.29 (95% CI: 0.85-1.94) (P-heterogeneity = 0.07). There was no evidence of an interaction between alcohol intake and menopausal status (P = 0.19) in overall group; however, it was significant in estrogen receptor-positive breast cancer (P = 0.04). Conclusions Low-to-moderate alcohol intake is associated with the risk of estrogen receptor-positive breast cancer with the strongest association in postmenopausal women. Since alcohol intake is a modifiable risk factor of breast cancer, every woman should be informed and advised to control alcohol use.	[Strumylaite, Loreta; Kregzdyte, Rima] Lithuanian Univ Hlth Sci, Med Acad, Neurosci Inst, Kaunas, Lithuania; [Sharp, Stephen J.] Univ Cambridge, Inst Metab Sci, Sch Clin Med, MRC Epidemiol Unit, Cambridge, England; [Poskiene, Lina; Pranys, Darius] Lithuanian Univ Hlth Sci, Med Acad, Dept Pathol Anat, Kaunas, Lithuania; [Bogusevicius, Algirdas] Lithuanian Univ Hlth Sci, Dept Surg, Med Acad, Kaunas, Lithuania	Lithuanian University of Health Sciences; University of Cambridge; Lithuanian University of Health Sciences; Lithuanian University of Health Sciences	Strumylaite, L (corresponding author), Lithuanian Univ Hlth Sci, Med Acad, Neurosci Inst, Kaunas, Lithuania.	loreta.strumylaite@lsmuni.lt			Lithuanian State Science and Studies Foundation (at present the Research Council of Lithuania) [T-64/09]	Lithuanian State Science and Studies Foundation (at present the Research Council of Lithuania)(Research Council of Lithuania (LMTLT))	The work was supported by the following: No. T-64/09; The Lithuanian State Science and Studies Foundation (at present the Research Council of Lithuania). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen NE, 2009, JNCI-J NATL CANCER I, V101, P296, DOI 10.1093/jnci/djn514; Beral V, 2002, BRIT J CANCER, V87, P1234, DOI 10.1038/sj.bjc.6600596; Brown LM, 2010, BREAST CANCER RES TR, V120, P203, DOI 10.1007/s10549-009-0464-4; Cao Y, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4238; Chen WY, 2011, JAMA-J AM MED ASSOC, V306, P1884, DOI 10.1001/jama.2011.1590; DAKO, 1996, REF IMM BREAST CANC, P9; Dallal CM, 2014, CARCINOGENESIS, V35, P346, DOI 10.1093/carcin/bgt367; Deandrea S, 2008, CANCER EPIDEM BIOMAR, V17, P2025, DOI 10.1158/1055-9965.EPI-08-0157; Dorgan JF, 2001, JNCI-J NATL CANCER I, V93, P710, DOI 10.1093/jnci/93.9.710; Etique N, 2004, INT J MOL MED, V13, P149; Fan SJ, 2000, CANCER RES, V60, P5635; Feunekes GIJ, 1999, AM J EPIDEMIOL, V150, P105; FRIEDENREICH CM, 1993, AM J EPIDEMIOL, V137, P512, DOI 10.1093/oxfordjournals.aje.a116704; GAVALER JS, 1987, J STUD ALCOHOL, V48, P295, DOI 10.15288/jsa.1987.48.295; GINSBURG ES, 1995, FERTIL STERIL, V63, P1227, DOI 10.1016/S0015-0282(16)57602-X; Hammond MEH, 2010, ARCH PATHOL LAB MED, V134, P907, DOI [10.1043/1543-2165-134.6.907, 10.1200/JCO.2009.25.6529, 10.1200/JOP.777003]; IARC (International Agency for Research on Cancer), 2010, ALC CONS ETH CARB; Kabat GC, 2011, CANCER CAUSE CONTROL, V22, P775, DOI 10.1007/s10552-011-9750-7; Key J, 2006, CANCER CAUSE CONTROL, V17, P759, DOI 10.1007/s10552-006-0011-0; Key T, 2002, JNCI-J NATL CANCER I, V94, P606, DOI DOI 10.1093/JNCI/94.8.606; Kropp S, 2001, AM J EPIDEMIOL, V154, P624, DOI 10.1093/aje/154.7.624; Lew JQ, 2009, AM J EPIDEMIOL, V170, P308, DOI 10.1093/aje/kwp120; Li CI, 2010, J NATL CANCER I, V102, P1422, DOI 10.1093/jnci/djq316; Li Y, 2009, EUR J CANCER, V45, P843, DOI 10.1016/j.ejca.2008.11.001; Miller TW, 2010, J CLIN INVEST, V120, P2406, DOI 10.1172/JCI41680; Park SY, 2014, INT J CANCER, V134, P1504, DOI 10.1002/ijc.28476; REICHMAN ME, 1993, J NATL CANCER I, V85, P722, DOI 10.1093/jnci/85.9.722; Romieu I, 2015, INT J CANCER, V137, P1921, DOI 10.1002/ijc.29469; Rosenberg LU, 2006, CANCER EPIDEM BIOMAR, V15, P2482, DOI 10.1158/1055-9965.EPI-06-0489; Sarkola T, 2001, J CLIN ENDOCR METAB, V86, P1981, DOI 10.1210/jc.86.5.1981; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; Setiawan VW, 2009, AM J EPIDEMIOL, V169, P1251, DOI 10.1093/aje/kwp036; Singletary KW, 2001, CANCER LETT, V165, P131, DOI 10.1016/S0304-3835(01)00419-0; Strumylaite L, 2013, ASIAN PAC J CANCER P, V14, P2777, DOI 10.7314/APJCP.2013.14.5.2777; Suzuki R, 2005, JNCI-J NATL CANCER I, V97, P1601, DOI 10.1093/jnci/dji341; Suzuki R, 2008, INT J CANCER, V122, P1832, DOI 10.1002/ijc.23184; Suzuki R, 2010, INT J CANCER, V127, P685, DOI 10.1002/ijc.25079; Visvanathan K, 2007, ALCOHOL CLIN EXP RES, V31, P467, DOI 10.1111/j.1530-0277.2006.00334.x; World Health Organization, 2000, INT GUID MON ALC CON; Zhang M, 2011, BRIT J CANCER, V105, P1089, DOI 10.1038/bjc.2011.302; Zhang SMM, 2007, AM J EPIDEMIOL, V165, P667, DOI 10.1093/aje/kwk054	41	8	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144680	10.1371/journal.pone.0144680	http://dx.doi.org/10.1371/journal.pone.0144680			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674340	Green Published, Green Submitted, gold			2022-12-26	WOS:000366722700053
J	Wang, LY; Murk, W; DeWan, AT				Wang, Leyao; Murk, William; DeWan, Andrew T.			Genome-Wide Gene by Environment Interaction Analysis Identifies Common SNPs at 17q21.2 that Are Associated with Increased Body Mass Index Only among Asthmatics	PLOS ONE			English	Article							CHILDHOOD ASTHMA; OBESITY; EXPRESSION; KERATIN; RISK; DIFFERENTIATION; POPULATION; DISEASES; CANCER; ORMDL3	Asthmatics have an increased risk of being overweight/obese. Although the underlying mechanisms of this are unclear, genetic factors are believed to play an essential role. To identify common genetic variants that are associated with asthma-related BMI increase, we performed a genome-wide gene by environment (asthma) interaction analysis for the outcome of BMI in the Multi-Ethnic Study of Atherosclerosis (MESA) study (N = 2474 Caucasians, 257 asthmatics), and replicated findings in the Framingham Heart Study (FHS) offspring cohort (N = 1408 Caucasians, 382 asthmatics). The replicable tagging SNP, rs2107212, was further examined in stratified analyses. Seven SNPs clustered in 17q21.2 were identified to be associated with higher BMI among asthmatics (interaction p < 5x10(-7) in MESA and p < 0.05 in FHS). In both MESA and FHS asthmatics, subjects carrying the A allele on rs2107212 had significantly higher odds of obesity than non-carriers, which was not the case for non-asthmatics. We further examined BMI change subsequent to asthma diagnosis over a period of 26 years in FHS and demonstrated greater BMI increase among asthmatics compared to non-asthmatics. Asthmatics carrying the A allele at rs2107212 had significantly greater net BMI increase over the 26-year period compared to non-asthmatics. In this study, we found that common genetic variants on 17q21.2 are associated with postasthma BMI increase among Caucasians. This finding will help elucidate pathways involved in the comorbidity of asthma and obesity.	[Wang, Leyao; Murk, William; DeWan, Andrew T.] Yale Univ, Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT 06520 USA	Yale University	DeWan, AT (corresponding author), Yale Univ, Sch Publ Hlth, Dept Chron Dis Epidemiol, New Haven, CT 06520 USA.	andrew.dewan@yale.edu		DeWan, Andrew/0000-0002-7679-8704	United States Air Force/AFMC [FA8650-13-2-6371]; NIH/NIAID Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) [1F32AI114097-01A1]; Canadian Institutes of Health Research [DFS - 129311]; National Heart, Lung, and Blood Institute (NHLBI); CTSA [UL1-RR-024156]; U.S. Environmental Protection Agency (EPA) under Science to Achieve Results (STAR) Program [RD831697]; Boston University [N01-HC-25195]; NHLBI [N02-HL-64278];  [N01-HC-95159];  [N01-HC-95160];  [N01-HC-95161];  [N01-HC-95162];  [N01-HC-95163];  [N01-HC-95164];  [N01-HC-95165];  [N01-HC-95166];  [N01-HC-95167];  [N01-HC-95168];  [N01-HC-95169]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F32AI114097] Funding Source: NIH RePORTER	United States Air Force/AFMC; NIH/NIAID Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); U.S. Environmental Protection Agency (EPA) under Science to Achieve Results (STAR) Program; Boston University; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); ; ; ; ; ; ; ; ; ; ; ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a cooperative agreement from the United States Air Force/AFMC [Award No. FA8650-13-2-6371]. http://www.afmc.af.mil/. Dr. Leyao Wang is supported by the NIH/NIAID Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (F32) [Award No. 1F32AI114097-01A1]. http://www.niaid.nih.gov/. William Murk is supported by a Doctoral Foreign Study Award from the Canadian Institutes of Health Research [Award No. DFS - 129311]. http://www.cihr-irsc.gc.ca/e/37788.html/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. MESA and the MESA SHARe project are conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with MESA investigators. Support for MESA is provided by contracts N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, N01-HC-95169 and CTSA UL1-RR-024156. The Multi-Ethnic Study of Atherosclerosis and Air Pollution (MESA Air) is supported by the U.S. Environmental Protection Agency (EPA) under Science to Achieve Results (STAR) Program Grant # RD831697. The Framingham Heart Study is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University (Contract No. N01-HC-25195). Funding for SHARe genotyping was provided by NHLBI Contract N02-HL-64278. SHARe Illumina genotyping was provided under an agreement between Illumina and Boston University. This manuscript was not prepared in collaboration with investigators of the MESA, MESA Air or Framingham Heart Study and does not necessarily reflect the opinions or views of those studies and funding agencies and no official endorsement should be inferred.	Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Birkenkamp-Demtroder K, 2002, CANCER RES, V62, P4352; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279, DOI DOI 10.2105/AJPH.41.3.279; Egan KB, 2015, PEDIATR OBES, V10, P345, DOI 10.1111/ijpo.271; Ford ES, 2005, J ALLERGY CLIN IMMUN, V115, P897, DOI 10.1016/j.jaci.2004.11.050; Gonzalez JR, 2014, AM J HUM GENET, V94, P361, DOI 10.1016/j.ajhg.2014.01.015; Hallstrand TS, 2005, J ALLERGY CLIN IMMUN, V116, P1235, DOI 10.1016/j.jaci.2005.09.016; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Irvine AD, 2011, NEW ENGL J MED, V365, P1315, DOI 10.1056/NEJMra1011040; Kim SH, 2014, ALLERGY ASTHMA IMMUN, V6, P189, DOI 10.4168/aair.2014.6.3.189; Langbein L, 2007, J INVEST DERMATOL, V127, P1532, DOI 10.1038/sj.jid.5700734; Laprise C, 2014, GENES IMMUN, V15, P247, DOI 10.1038/gene.2014.12; Liffers ST, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-137; Melen E, 2013, CLIN EXP ALLERGY, V43, P463, DOI 10.1111/cea.12054; Melen E, 2010, J ALLERGY CLIN IMMUN, V126, P631, DOI 10.1016/j.jaci.2010.06.030; Meyers DA, 2014, LANCET RESP MED, V2, P405, DOI 10.1016/S2213-2600(14)70012-8; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Nahm DH, 2002, AM J RESP CRIT CARE, V165, P1536, DOI 10.1164/rccm.200201-009OC; Nayak AP, 2014, TOXICOL SCI, V140, P327, DOI 10.1093/toxsci/kfu079; Nystad W, 2004, AM J EPIDEMIOL, V160, P969, DOI 10.1093/aje/kwh303; Ono JG, 2014, PEDIATR RES, V75, P165, DOI 10.1038/pr.2013.186; Park JE, 2011, PROTEOMICS, V11, P2777, DOI 10.1002/pmic.201000544; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Schwarzer G, 2014, METAMETA ANAL R R PA; Stukus DR, 2015, J ALLERGY CLIN IMMUN, V135, P894, DOI 10.1016/j.jaci.2014.11.002; von Kries R, 2001, ALLERGY, V56, P318, DOI 10.1034/j.1398-9995.2001.00727.x; Wang KJ, 2009, CANCER LETT, V281, P144, DOI 10.1016/j.canlet.2009.02.037; Watanabe Tsuneo, 2013, Rinsho Byori, V61, P19; Winter Y, 2013, VITAM HORM, V91, P29, DOI 10.1016/B978-0-12-407766-9.00002-X; Zhang JS, 2001, GENE CHROMOSOME CANC, V30, P123, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1070>3.0.CO;2-W	33	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144114	10.1371/journal.pone.0144114	http://dx.doi.org/10.1371/journal.pone.0144114			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26672748	gold, Green Published, Green Submitted			2022-12-26	WOS:000366722700025
J	Barniv, D; Nelken, I				Barniv, Dana; Nelken, Israel			Auditory Streaming as an Online Classification Process with Evidence Accumulation	PLOS ONE			English	Article							PERCEPTUAL ORGANIZATION; MODEL; ADAPTATION; SEGREGATION; DYNAMICS; CORTEX; COMMON; NOISE	When human subjects hear a sequence of two alternating pure tones, they often perceive it in one of two ways: as one integrated sequence (a single "stream" consisting of the two tones), or as two segregated sequences, one sequence of low tones perceived separately from another sequence of high tones (two "streams"). Perception of this stimulus is thus bistable. Moreover, subjects report on-going switching between the two percepts: unless the frequency separation is large, initial perception tends to be of integration, followed by toggling between integration and segregation phases. The process of stream formation is loosely named "auditory streaming". Auditory streaming is believed to be a manifestation of human ability to analyze an auditory scene, i.e. to attribute portions of the incoming sound sequence to distinct sound generating entities. Previous studies suggested that the durations of the successive integration and segregation phases are statistically independent. This independence plays an important role in current models of bistability. Contrary to this, we show here, by analyzing a large set of data, that subsequent phase durations are positively correlated. To account together for bistability and positive correlation between subsequent durations, we suggest that streaming is a consequence of an evidence accumulation process. Evidence for segregation is accumulated during the integration phase and vice versa; a switch to the opposite percept occurs stochastically based on this evidence. During a long phase, a large amount of evidence for the opposite percept is accumulated, resulting in a long subsequent phase. In contrast, a short phase is followed by another short phase. We implement these concepts using a probabilistic model that shows both bistability and correlations similar to those observed experimentally.	[Barniv, Dana; Nelken, Israel] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel; [Nelken, Israel] Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Neurobiol, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Barniv, D (corresponding author), Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel.	dana.barniv@mail.huji.ac.il	Nelken, Israel/B-7753-2011	Nelken, Israel/0000-0002-6645-107X	Israel Science Foundation [72/2009, 390/2013]; Israel Ministry of Science [3-8674]; Laboratoire Internationale Associee (LEA) FINNEPS	Israel Science Foundation(Israel Science Foundation); Israel Ministry of Science(Ministry of Science, Technology and Space (MOST), Israel); Laboratoire Internationale Associee (LEA) FINNEPS	IN was supported by grants 72/2009 and 390/2013 from the Israel Science Foundation, by grant 3-8674 from the Israel Ministry of Science in the framework of the collaboration France-Israel, and by the Laboratoire Internationale Associee (LEA) FINNEPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreou LV, 2011, HEARING RES, V280, P228, DOI 10.1016/j.heares.2011.06.001; Beauvois MW, 1996, J ACOUST SOC AM, V99, P2270, DOI 10.1121/1.415414; Bregman A. S., 1990, AUDITORY SCENE ANALY; BREGMAN AS, 1978, J EXP PSYCHOL HUMAN, V4, P380, DOI 10.1037/0096-1523.4.3.380; Deike S, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00461; Denham S.L., 2013, LEARN PERCEPT, V5, P73, DOI [10.1556/LP.5.2013.Suppl2.6, DOI 10.1556/LP.5.2013.SUPPL2.6]; Elhilali M, 2009, NEURON, V61, P317, DOI 10.1016/j.neuron.2008.12.005; Elhilali M, 2008, J ACOUST SOC AM, V124, P3751, DOI 10.1121/1.3001672; Fishman YI, 2001, HEARING RES, V151, P167, DOI 10.1016/S0378-5955(00)00224-0; Gigante G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000430; HARTMANN WM, 1991, MUSIC PERCEPT, V9, P155; Hupe JM, 2008, J VISION, V8, DOI 10.1167/8.7.1; Kaelbling LP, 1996, J ARTIF INTELL RES, V4, P237, DOI 10.1613/jair.301; Kuznetsova A., 2015, LMERTEST TESTS LINEA; Marti D, 2013, NEURAL COMPUT, V25, P1, DOI 10.1162/NECO_a_00383; McCabe SL, 1997, J ACOUST SOC AM, V101, P1611, DOI 10.1121/1.418176; McVay JC, 2012, J EXP PSYCHOL LEARN, V38, P525, DOI 10.1037/a0025896; Micheyl C, 2005, NEURON, V48, P139, DOI 10.1016/j.neuron.2005.08.039; Mill RW, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002925; Moreno-Bote R, 2007, J NEUROPHYSIOL, V98, P1125, DOI 10.1152/jn.00116.2007; Pastukhov A, 2011, J VISION, V11, DOI 10.1167/11.10.12; Pressnitzer D, 2008, CURR BIOL, V18, P1124, DOI 10.1016/j.cub.2008.06.053; Pressnitzer D, 2006, CURR BIOL, V16, P1351, DOI 10.1016/j.cub.2006.05.054; R Core Team, 2015, LANG ENV STAT COMP I; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Shpiro A, 2007, J NEUROPHYSIOL, V97, P462, DOI 10.1152/jn.00604.2006; Shpiro A, 2009, J COMPUT NEUROSCI, V27, P37, DOI 10.1007/s10827-008-0125-3; van Ee R, 2009, J OPT SOC AM A, V26, P2612, DOI 10.1364/JOSAA.26.002612; van Noorden L., 1975, TEMPORAL COHERENCE I; WALKER P, 1978, PSYCHOL BULL, V85, P376, DOI 10.1037/0033-2909.85.2.376; Wang DL, 2008, COGN NEURODYNAMICS, V2, P7, DOI 10.1007/s11571-007-9035-8; Wrigley SN, 2004, IEEE T NEURAL NETWOR, V15, P1151, DOI 10.1109/TNN.2004.832710	32	19	19	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144788	10.1371/journal.pone.0144788	http://dx.doi.org/10.1371/journal.pone.0144788			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9HZ	26671774	Green Published, gold, Green Submitted			2022-12-26	WOS:000366719300021
J	Willems, C; Herdzin, J; Martens, S				Willems, Charlotte; Herdzin, Johannes; Martens, Sander			Individual Differences in Temporal Selective Attention as Reflected in Pupil Dilation	PLOS ONE			English	Article							WORKING-MEMORY; BLINK; TASK; MAGNITUDE	Background Attention is restricted for the second of two targets when it is presented within 200-500 ms of the first target. This attentional blink (AB) phenomenon allows one to study the dynamics of temporal selective attention by varying the interval between the two targets (T1 and T2). Whereas the AB has long been considered as a robust and universal cognitive limitation, several studies have demonstrated that AB task performance greatly differs between individuals, with some individuals showing no AB whatsoever. Methodology/Principal Findings Here, we studied these individual differences in AB task performance in relation to differences in attentional timing. Furthermore, we investigated whether AB magnitude is predictive for the amount of attention allocated to T1. For both these purposes pupil dilation was measured, and analyzed with our recently developed deconvolution method. We found that the dynamics of temporal attention in small versus large blinkers differ in a number of ways. Individuals with a relatively small AB magnitude seem better able to preserve temporal order information. In addition, they are quicker to allocate attention to both T1 and T2 than large blinkers. Although a popular explanation of the AB is that it is caused by an unnecessary overinvestment of attention allocated to T1, a more complex picture emerged from our data, suggesting that this may depend on whether one is a small or a large blinker. Conclusion The use of pupil dilation deconvolution seems to be a powerful approach to study the temporal dynamics of attention, bringing us a step closer to understanding the elusive nature of the AB. We conclude that the timing of attention to targets may be more important than the amount of allocated attention in accounting for individual differences.	[Willems, Charlotte; Herdzin, Johannes; Martens, Sander] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NL-9713 AV Groningen, Netherlands; [Willems, Charlotte; Herdzin, Johannes; Martens, Sander] Univ Groningen, Univ Med Ctr Groningen, Neuroimaging Ctr, Groningen, Netherlands	University of Groningen; University of Groningen	Willems, C (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NL-9713 AV Groningen, Netherlands.	charlot.willems@gmail.com		Martens, Sander/0000-0001-8237-7984	Research School of Behavioral and Cognitive Neurosciences	Research School of Behavioral and Cognitive Neurosciences	This work was supported by the Research School of Behavioral and Cognitive Neurosciences - CW/SM, http://www.rug.nl/research/behavioural-cognitive-neurosciences/?lang = en. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, V19; Akyurek EG, 2012, J EXP PSYCHOL HUMAN, V38, P1448, DOI 10.1037/a0027610; Arnell KM, 2006, MEM COGNITION, V34, P1472, DOI 10.3758/BF03195912; Arnell KM, 2010, PSYCHOL RES-PSYCH FO, V74, P1, DOI 10.1007/s00426-008-0200-4; Colzato LS, 2007, PSYCHON B REV, V14, P1051, DOI 10.3758/BF03193090; Di Lollo V, 2005, PSYCHOL RES-PSYCH FO, V69, P191, DOI 10.1007/s00426-004-0173-x; DUX PE, 2008, PLOS ONE, V3; Feinstein JS, 2004, CONSCIOUS COGN, V13, P323, DOI 10.1016/j.concog.2003.10.004; Green CS, 2003, NATURE, V423, P534, DOI 10.1038/nature01647; HOEKS B, 1993, BEHAV RES METH INSTR, V25, P16, DOI 10.3758/BF03204445; Klein C, 2011, INTELLIGENCE, V39, P27, DOI 10.1016/j.intell.2010.11.004; Kuznetsova A., 2013, LMERTEST TESTS RANDO; MacLean MH, 2012, ATTEN PERCEPT PSYCHO, V74, P1080, DOI 10.3758/s13414-012-0338-4; MacLean MH, 2012, BRAIN COGNITION, V78, P218, DOI 10.1016/j.bandc.2011.12.010; MacLean MH, 2010, COGNITION EMOTION, V24, P1431, DOI 10.1080/02699930903417897; Martens S, 2006, ACTA PSYCHOL, V123, P204, DOI 10.1016/j.actpsy.2006.01.001; Martens S, 2006, J COGNITIVE NEUROSCI, V18, P1423, DOI 10.1162/jocn.2006.18.9.1423; Martens S, 2009, EXP PSYCHOL, V56, P33, DOI 10.1027/1618-3169.56.1.33; McArthur G, 1999, NEUROREPORT, V10, P3691, DOI 10.1097/00001756-199911260-00042; McLaughlin EN, 2001, Q J EXP PSYCHOL-A, V54, P169, DOI 10.1080/02724980042000075; McLean GMT, 2009, SCI STUD READ, V13, P334, DOI 10.1080/10888430903001365; Olivers CNL, 2007, PSYCHOL RES-PSYCH FO, V71, P126, DOI 10.1007/s00426-005-0029-z; Olivers CNL, 2006, J EXP PSYCHOL HUMAN, V32, P364, DOI 10.1037/0096-1523.32.2.364; Olivers CNL, 2005, PSYCHOL SCI, V16, P265, DOI 10.1111/j.0956-7976.2005.01526.x; Preacher KJ, 2005, PSYCHOL METHODS, V10, P178, DOI 10.1037/1082-989X.10.2.178; R Development Core Team, 2012, R LANG ENV STAT COMP; RAYMOND JE, 1992, J EXP PSYCHOL HUMAN, V18, P849, DOI 10.1037/0096-1523.18.3.849; Sarkar D., 2019, NLME LINEAR NONLINEA; Shapiro K, 2006, NEUROREPORT, V17, P163, DOI 10.1097/01.wnr.0000195670.37892.1a; Slagter HA, 2012, J COGNITIVE NEUROSCI, V24, P1932, DOI 10.1162/jocn_a_00255; Slagter HA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010556; Taatgen NA, 2009, COGNITIVE PSYCHOL, V59, P1, DOI 10.1016/j.cogpsych.2008.12.002; Troche SJ, 2013, COGN PROCESS, V14, P273, DOI 10.1007/s10339-013-0553-5; van Vugt MK, 2014, CONSCIOUS COGN, V23, P32, DOI 10.1016/j.concog.2013.11.001; Visser TAW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033265; Vogel EK, 2002, PSYCHON B REV, V9, P739, DOI 10.3758/BF03196329; Wierda SM, 2012, P NATL ACAD SCI USA, V109, P8456, DOI 10.1073/pnas.1201858109; Wierda SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015024; Willems C, 2015, J COGN NEUROSCI ACCE; Willems C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066185; Wyble B, 2009, J EXP PSYCHOL HUMAN, V35, P787, DOI 10.1037/a0013902	41	7	7	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145056	10.1371/journal.pone.0145056	http://dx.doi.org/10.1371/journal.pone.0145056			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26660976	Green Published, gold, Green Submitted			2022-12-26	WOS:000366715900176
J	Ingthorsson, S; Andersen, K; Hilmarsdottir, B; Maelandsmo, GM; Magnusson, MK; Gudjonsson, T				Ingthorsson, S.; Andersen, K.; Hilmarsdottir, B.; Maelandsmo, G. M.; Magnusson, M. K.; Gudjonsson, T.			HER2 induced EMT and tumorigenicity in breast epithelial progenitor cells is inhibited by coexpression of EGFR	ONCOGENE			English	Article							TO-MESENCHYMAL TRANSITION; MYOEPITHELIAL CELLS; ERBB RECEPTORS; CLAUDIN-LOW; CANCER; DIFFERENTIATION; EXPRESSION; TRANSFORMATION; ENDOCYTOSIS; HIERARCHY	The members of the epidermal growth factor receptor (EGFR) kinase family are important players in breast morphogenesis and cancer. EGFR2/HER2 and EGFR expression have a prognostic value in certain subtypes of breast cancer such as HER2-amplified, basal-like and luminal type B. Many clinically approved small molecular inhibitors and monoclonal antibodies have been designed to target HER2, EGFR or both. There is, however, still limited knowledge on how the two receptors are expressed in normal breast epithelium, what effects they have on cellular differentiation and how they participate in neoplastic transformation. D492 is a breast epithelial cell line with stem cell properties that can undergo epithelial to mesenchyme transition (EMT), generate luminal-and myoepithelial cells and form complex branching structures in three-dimensional (3D) culture. Here, we show that overexpression of HER2 in D492 (D492(HER2)) resulted in EMT, loss of contact growth inhibition and increased oncogenic potential in vivo. HER2 overexpression, furthermore, inhibited endogenous EGFR expression. Re-introducing EGFR in D492(HER2) (D492(HER2/EGFR)) partially reversed the mesenchymal state of the cells, as an epithelial phenotype reappeared both in 3D cultures and in vivo. The D492(HER2/EGFR) xenografts grow slower than the D492HER2 tumors, while overexpression of EGFR alone (D492(EGFR)) was not oncogenic in vivo. Consistent with the EGFR-mediated epithelial phenotype, overexpression of EGFR drove the cells toward a myoepithelial phenotype in 3D culture. The effect of two clinically approved anti-HER2 and EGFR therapies, trastuzumab and cetuximab, was tested alone and in combination on D492HER2 xenografts. While trastuzumab had a growth inhibitory effect compared with untreated control, the effect of cetuximab was limited. When administered in combination, the growth inhibitory effect of trastuzumab was less pronounced. Collectively, our data indicate that in HER2-overexpressing D492 cells, EGFR can behave as a tumor suppressor, by pushing the cells towards epithelial differentiation.	[Ingthorsson, S.; Hilmarsdottir, B.; Magnusson, M. K.; Gudjonsson, T.] Univ Iceland, Biomed Ctr, Stem Cell Res Unit, Vatnsmyrarvegur 16, IS-101 Reykjavik, Iceland; [Ingthorsson, S.; Hilmarsdottir, B.; Magnusson, M. K.; Gudjonsson, T.] Landspitali Univ Hosp, Dept Haematol Lab, Reykjavik, Iceland; [Andersen, K.; Maelandsmo, G. M.] Norwegian Radium Hosp, Oslo Univ Hosp, Inst Canc Res, Dept Tumor Biol, Oslo, Norway; [Andersen, K.; Maelandsmo, G. M.] Norwegian Radium Hosp, Oslo Univ Hosp, Canc Stem Cell Innovat Ctr, Oslo, Norway; [Maelandsmo, G. M.] Univ Oslo, Inst Clin Med, KG Jebsen Ctr Breast Canc Res, Oslo, Norway; [Magnusson, M. K.] Univ Iceland, Dept Pharmacol & Toxicol, Reykjavik, Iceland	University of Iceland; Landspitali National University Hospital; University of Oslo; University of Oslo; University of Oslo; University of Iceland	Gudjonsson, T (corresponding author), Univ Iceland, Biomed Ctr, Stem Cell Res Unit, Vatnsmyrarvegur 16, IS-101 Reykjavik, Iceland.	tgudjons@hi.is	Mælandsmo, Gunhild Mari/AFV-4446-2022; Hilmarsdottir, Bylgja/AAV-7406-2020	Gudjonsson, Thorarinn/0000-0001-9645-9665; Hilmarsdottir, Bylgja/0000-0001-8693-5541; Ingthorsson, Saevar/0000-0001-8480-9680	Landspitali University Hospital Science Fund; University of Iceland Research Fund; Science and Technology Policy Council Research Fund; Grant of Excellence, 'Gongum saman'	Landspitali University Hospital Science Fund; University of Iceland Research Fund; Science and Technology Policy Council Research Fund; Grant of Excellence, 'Gongum saman'	This work was supported from Landspitali University Hospital Science Fund, University of Iceland Research Fund, Science and Technology Policy Council Research Fund and Grant of Excellence, 'Gongum saman', a supporting group for breast cancer research in Iceland. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript. We are grateful to Petros Gebregziabher and Alexandr Kristian for advicing on and performing the in vivo experiments.	Balk-Moller E, 2014, AM J PATHOL, V184, P1198, DOI 10.1016/j.ajpath.2013.12.013; Barsky SH, 2005, J MAMMARY GLAND BIOL, V10, P249, DOI 10.1007/s10911-005-9585-5; Baulida J, 1996, J BIOL CHEM, V271, P5251; Carpenter RL, 2014, ONCOGENE, V34, P546; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Davis NM, 2014, ONCOTARGET, V5, P4603, DOI 10.18632/oncotarget.2209; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Flageng MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074618; Forster N, 2014, DEV CELL, V28, P147, DOI 10.1016/j.devcel.2013.11.019; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Greulich H, 2005, PLOS MED, V2, P1167, DOI 10.1371/journal.pmed.0020313; Gudjonsson T, 2002, GENE DEV, V16, P693, DOI 10.1101/gad.952602; Gudjonsson T, 2002, J CELL SCI, V115, P39; Guth U, 2014, BREAST, V23, P26, DOI 10.1016/j.breast.2013.10.007; Gupta P, 2014, MOL ONCOL, V8, P1532, DOI 10.1016/j.molonc.2014.06.006; Haglund K, 2012, J CELL SCI, V125, P265, DOI 10.1242/jcs.091280; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hartman Z, 2013, ONCOGENE, V32, P4169, DOI 10.1038/onc.2012.418; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Hilmarsdottir B, 2015, DEV BIOL, V403, P150, DOI 10.1016/j.ydbio.2015.05.007; Hilmarsdottir B, 2014, GENES-BASEL, V5, P804, DOI 10.3390/genes5030804; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Ingthorsson Saevar, 2010, BMC Res Notes, V3, P184, DOI 10.1186/1756-0500-3-184; Jenndahl LE, 2005, INT J ONCOL, V27, P439; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lee K, 2011, EMBO J, V30, P2662, DOI 10.1038/emboj.2011.159; Li YM, 2004, CANCER CELL, V6, P459, DOI 10.1016/j.ccr.2004.09.027; Moyret-Lalle C, 2014, WORLD J CLIN ONCOL, V5, P311, DOI 10.5306/wjco.v5.i3.311; Nakagawa M, 2012, BREAST CANCER-TOKYO, V19, P54, DOI 10.1007/s12282-011-0265-6; Oakes SR, 2014, CELL MOL LIFE SCI, V71, P4301, DOI 10.1007/s00018-014-1674-4; Ortega-Cava Cesar F, 2011, J Carcinog, V10, P29, DOI 10.4103/1477-3163.90443; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pinhel I, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3145; PinkasKramarski R, 1996, EMBO J, V15, P2452, DOI 10.1002/j.1460-2075.1996.tb00603.x; Sabatier R, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-228; Schneider MR, 2016, ONCOGENE, V35, P2949, DOI 10.1038/onc.2015.372; Sigurdsson V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023833; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; Sobande Folakemi, 2015, Cesk Patol, V51, P80; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sternlicht MD, 2006, DIFFERENTIATION, V74, P365, DOI 10.1111/j.1432-0436.2006.00105.x; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Taube JH, 2010, P NATL ACAD SCI USA, V107, P15449, DOI 10.1073/pnas.1004900107; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Vidi Pierre-Alexandre, 2013, Methods Mol Biol, V945, P193, DOI 10.1007/978-1-62703-125-7_13; Visvader JE, 2014, GENE DEV, V28, P1143, DOI 10.1101/gad.242511.114; Zhan LX, 2006, CANCER RES, V66, P5201, DOI 10.1158/0008-5472.CAN-05-4081; Zhang MH, 2014, BIOMED REP, V2, P41, DOI 10.3892/br.2013.187; Zwang Yaara, 2009, Traffic, V10, P349, DOI 10.1111/j.1600-0854.2008.00870.x	49	47	48	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG	2016	35	32					4244	4255		10.1038/onc.2015.489	http://dx.doi.org/10.1038/onc.2015.489			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DU3YY	26686087	hybrid, Green Published			2022-12-26	WOS:000382149800009
J	Li, N; Mruk, DD; Mok, KW; Li, MWM; Wong, CKC; Lee, WM; Han, DS; Silvestrini, B; Cheng, CY				Li, Nan; Mruk, Dolores D.; Mok, Ka-Wai; Li, Michelle W. M.; Wong, Chris K. C.; Lee, Will M.; Han, Daishu; Silvestrini, Bruno; Cheng, C. Yan			Connexin 43 reboots meiosis and reseals blood-testis barrier following toxicant-mediated aspermatogenesis and barrier disruption	FASEB JOURNAL			English	Article						gap junction; spermatogenesis; actin microfilaments; seminiferous epithelial cycle; tight junction	F-ACTIN ORGANIZATION; CELL-SPECIFIC KNOCKOUT; ECTOPLASMIC SPECIALIZATION; SEMINIFEROUS EPITHELIUM; SERTOLI-CELLS; GAP-JUNCTION; RAT TESTIS; PROTEIN COMPLEX; SPERMATOGENESIS; ADHESION	Earlier studies have shown that rats treated with an acute dose of 1-(2,4-dichlorobenzyl)-1H-indazole-3-carbohydrazide (adjudin, a male contraceptive under development) causes permanent infertility due to irreversible blood-testis barrier (BTB) disruption even though the population of undifferentiated spermatogonia remains similar to normal rat testes, because spermatogonia fail to differentiate into spermatocytes to enter meiosis. Since other studies have illustrated the significance of connexin 43 (Cx43)-based gap junction in maintaining the homeostasis of BTB in the rat testis and the phenotypes of Sertoli cell-conditional Cx43 knockout mice share many of the similarities of the adjudin-treated rats, we sought to examine if overexpression of Cx43 in these adjudin-treated rats would reseal the disrupted BTB and reinitiate spermatogenesis. A full-length Cx43 cloned into mammalian expression vector pCI-neo was used to transfect testes of adjudin-treated rats versus empty vector. It was found that overexpression of Cx43 indeed resealed the Sertoli cell tight junction-permeability barrier based on a functional in vivo assay in tubules displaying signs of meiosis as noted by the presence of round spermatids. Thus, these findings suggest that overexpression of Cx43 reinitiated spermatogenesis at least through the steps ofmeiosis to generate round spermatids in testes of rats treated with an acute dose of adjudin that led to aspermatogenesis. It was also noted that the round spermatids underwent eventual degeneration with the formation of multinucleated cells following Cx43 overexpression due to the failure of spermiogenesis because no elongating/elongated spermatids were detected in any of the tubules examined. The mechanism by which overexpression of Cx43 reboots meiosis and rescues BTB function was also examined. In summary, overexpression of Cx43 in the testis with aspermatogenesis reboots meiosis and reseals toxicant-induced BTB disruption, even though it fails to support round spermatids to enter spermiogenesis.-Li, N., Mruk, D. D., Mok, K.-W., Li, M. W. M., Wong, C. K. C., Lee, W. M., Han, D., Silvestrini, B., Cheng, C. Y. Connexin 43 reboots meiosis and reseals blood-testis barrier following toxicant-mediated aspermatogenesis and barrier disruption. FASEB J. 30, 1436-1452 (2016). www.fasebj.org	[Li, Nan; Mruk, Dolores D.; Mok, Ka-Wai; Li, Michelle W. M.; Cheng, C. Yan] Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, 1230 York Ave, New York, NY 10065 USA; [Wong, Chris K. C.] Hong Kong Baptist Univ, Dept Biol, Hong Kong, Hong Kong, Peoples R China; [Lee, Will M.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Han, Daishu] Chinese Acad Med Sci, Inst Basic Med Sci, Dept Cell Biol, Peking Union Med Coll, Beijing 100730, Peoples R China; [Silvestrini, Bruno] SBM Srl Pharmaceut, Rome, Italy	Population Council; Hong Kong Baptist University; University of Hong Kong; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Institute of Basic Medical Sciences - CAMS	Cheng, CY (corresponding author), Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, 1230 York Ave, New York, NY 10065 USA.	y-cheng@popcbr.rockefeller.edu	Lee, Will M/D-2357-2009; wong, chris/GSN-0962-2022; Li, Michelle W M/N-4914-2019; Li, Wing Man Michelle/B-8295-2008	Li, Michelle W M/0000-0002-9778-984X; Li, Wing Man Michelle/0000-0002-9778-984X; Cheng, C Yan/0000-0003-3117-3791	U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development [U54-HD029990, R01-HD056034]; National Natural Science Foundation of China/Hong Kong Research Grants Council Joint Research Scheme [N_HKU 717/12]; Hong Kong Research Grants Council General Research Fund [771513]; Committee for Research and Conference Grants of the University of Hong Kong Seed Funding Grant; Hong Kong Lee Siu Kee Foundation [LSK/14-15/P06]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD056034, U54HD029990] Funding Source: NIH RePORTER	U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Natural Science Foundation of China/Hong Kong Research Grants Council Joint Research Scheme; Hong Kong Research Grants Council General Research Fund(Hong Kong Research Grants Council); Committee for Research and Conference Grants of the University of Hong Kong Seed Funding Grant; Hong Kong Lee Siu Kee Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development Grants U54-HD029990 (Project 5 to C.Y.C.) and R01-HD056034 (to C.Y.C.); National Natural Science Foundation of China/Hong Kong Research Grants Council Joint Research Scheme Grant N_HKU 717/12 (to W.M.L.); Hong Kong Research Grants Council General Research Fund Grant 771513 (to W.M.L.); and the Committee for Research and Conference Grants of the University of Hong Kong Seed Funding Grant (to W.M.L.); and The Hong Kong Lee Siu Kee Foundation Grant LSK/14-15/P06 (to C.K.C.W.). The authors declare no conflicts of interest.	Bao BA, 2012, J BIOL CHEM, V287, P8407, DOI 10.1074/jbc.M111.306522; BERGMANN M, 1983, ANAT EMBRYOL, V168, P269, DOI 10.1007/BF00315821; Brehm R, 2007, AM J PATHOL, V171, P19, DOI 10.2353/ajpath.2007.061171; Breitsprecher D, 2013, J CELL SCI, V126, P1, DOI 10.1242/jcs.107250; Carette D, 2010, DEV BIOL, V346, P54, DOI 10.1016/j.ydbio.2010.07.014; CHAPIN RE, 1983, EXP MOL PATHOL, V38, P149, DOI 10.1016/0014-4800(83)90082-5; Cheng C.Y., 2014, SPERMATOGENESIS, V4, pe981485, DOI [10.4161/21565562.2014.9814895, DOI 10.4161/21565562.2014.9814895, 10.4161/21565562.2014.981485, DOI 10.4161/21565562.2014.981485]; Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790; Cheng CY, 2005, CONTRACEPTION, V72, P251, DOI 10.1016/j.contraception.2005.03.008; CLERMONT Y, 1957, AM J ANAT, V100, P241, DOI 10.1002/aja.1001000205; Edwards M, 2014, NAT REV MOL CELL BIO, V15, P677, DOI 10.1038/nrm3869; Fukuda R, 2000, J Toxicol Sci, V25 Spec No, P233; Gerner L, 2013, EXP DERMATOL, V22, P754, DOI 10.1111/exd.12234; Greco Steven J, 2013, Methods Mol Biol, V1024, P87, DOI 10.1007/978-1-62703-453-1_7; Gunther S, 2013, TRANSGENIC RES, V22, P631, DOI 10.1007/s11248-012-9668-1; HEW KW, 1993, BIOL REPROD, V49, P840, DOI 10.1095/biolreprod49.4.840; Johnson KJ., 2014, SPERMATOGENESIS, V4, DOI [10.4161/21565562.2014.979106, DOI 10.4161/21565562.2014.979106]; Kaneko Y, 2015, J PHARMACOL EXP THER, V353, P192, DOI 10.1124/jpet.114.220210; Krause M, 2014, NAT REV MOL CELL BIO, V15, P577, DOI 10.1038/nrm3861; Li MWM, 2006, J ENDOCRINOL, V190, P313, DOI 10.1677/joe.1.06781; Li MWM, 2013, ADV EXP MED BIOL, V763, P260; Li MWM, 2010, P NATL ACAD SCI USA, V107, P17998, DOI 10.1073/pnas.1007047107; Li MWM, 2009, P NATL ACAD SCI USA, V106, P10213, DOI 10.1073/pnas.0901700106; Li N, 2015, ENDOCRINOLOGY, V156, P2969, DOI 10.1210/en.2015-1161; Lie PPY, 2012, P NATL ACAD SCI USA, V109, P12562, DOI 10.1073/pnas.1202316109; Lie PPY, 2009, FASEB J, V23, P2555, DOI 10.1096/fj.06-070573; Machtaler S, 2014, FEBS LETT, V588, P1249, DOI 10.1016/j.febslet.2014.01.027; Mok KW, 2012, INT J ANDROL, V35, P86, DOI 10.1111/j.1365-2605.2011.01183.x; Mok Ka-Wai, 2011, Spermatogenesis, V1, P270; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Mruk Dolores D, 2011, Spermatogenesis, V1, P121; MUSIL LS, 1990, J CELL BIOL, V111, P2077, DOI 10.1083/jcb.111.5.2077; Narayana K., 2007, Morphologie, V91, P173; Pointis Georges, 2011, Spermatogenesis, V1, P303; Pointis G, 2010, PHILOS T R SOC B, V365, P1607, DOI 10.1098/rstb.2009.0114; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Risley MS, 2000, BIOL REPROD, V62, P748, DOI 10.1095/biolreprod62.3.748; Ro S, 2007, DEV BIOL, V311, P592, DOI 10.1016/j.ydbio.2007.09.009; RUSSELL LD, 1989, AM J ANAT, V184, P179, DOI 10.1002/aja.1001840302; SETCHELL BP, 1970, J ENDOCRINOL, V47, P81, DOI 10.1677/joe.0.0470081; Siu ER, 2009, ENDOCRINOLOGY, V150, P3336, DOI 10.1210/en.2008-1741; Song R, 2011, P NATL ACAD SCI USA, V108, P13159, DOI 10.1073/pnas.1108567108; Sosinsky GE, 2007, BIOCHEM J, V408, P375, DOI 10.1042/BJ20070550; Sridharan S, 2007, BIOL REPROD, V76, P804, DOI 10.1095/biolreprod.106.059212; Toyama Y, 2001, J ANDROL, V22, P413; Valiunas V, 2005, J PHYSIOL-LONDON, V568, P459, DOI 10.1113/jphysiol.2005.090985; Valiunas V, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12286; Higa GSV, 2014, MOL NEUROBIOL, V49, P1309, DOI 10.1007/s12035-013-8603-7; Wan HT, 2014, ENDOCRINOLOGY, V155, P249, DOI 10.1210/en.2013-1657; Wan HT, 2013, AM J PHYSIOL-ENDOC M, V305, pE687, DOI 10.1152/ajpendo.00254.2013; Wiebe JP, 2000, J ANDROL, V21, P625; WIEBE JP, 1984, CONTRACEPTION, V29, P291, DOI 10.1016/S0010-7824(84)80009-8; Wong EWP, 2008, BBA-BIOMEMBRANES, V1778, P692, DOI 10.1016/j.bbamem.2007.11.006; Wu JW, 2014, P NATL ACAD SCI USA, V111, pE2851, DOI 10.1073/pnas.1407777111; Xia WL, 2006, J BIOL CHEM, V281, P16799, DOI 10.1074/jbc.M601618200; Xiao X, 2014, HUM REPROD, V29, P1279, DOI 10.1093/humrep/deu011; Zhang SS, 2014, FEBS LETT, V588, P1439, DOI 10.1016/j.febslet.2014.01.002; Zhang SZ, 2015, J CELL PHYSIOL, V230, P2476, DOI 10.1002/jcp.24982	58	30	30	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1436	1452		10.1096/fj.15-276527	http://dx.doi.org/10.1096/fj.15-276527			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26678449	Green Published			2022-12-26	WOS:000372629100007
J	Du, JH; Rountree, A; Cleghorn, WM; Contreras, L; Lindsay, KJ; Sadilek, M; Gu, HW; Djukovic, D; Raftery, D; Satrustegui, J; Kanow, M; Chan, L; Tsang, SH; Sweet, IR; Hurley, JB				Du, Jianhai; Rountree, Austin; Cleghorn, Whitney M.; Contreras, Laura; Lindsay, Ken J.; Sadilek, Martin; Gu, Haiwei; Djukovic, Danijel; Raftery, Dan; Satrustegui, Jorgina; Kanow, Mark; Chan, Lawrence; Tsang, Stephen H.; Sweet, Ian R.; Hurley, James B.			Phototransduction Influences Metabolic Flux and Nucleotide Metabolism in Mouse Retina	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-CONSUMPTION; ASPARTATE-GLUTAMATE; MITOCHONDRIAL TRANSPORTER; CALCIUM-REGULATION; INNER RETINA; OUTER RETINA; LIGHT; ROD; VERTEBRATE; GLUCOSE	Production of energy in a cell must keep pace with demand. Photoreceptors use ATP to maintain ion gradients in darkness, whereas in light they use it to support phototransduction. Matching production with consumption can be accomplished by coupling production directly to consumption. Alternatively, production can be set by a signal that anticipates demand. In this report we investigate the hypothesis that signaling through phototransduction controls production of energy in mouse retinas. We found that respiration in mouse retinas is not coupled tightly to ATP consumption. By analyzing metabolic flux in mouse retinas, we also found that phototransduction slows metabolic flux through glycolysis and through intermediates of the citric acid cycle. We also evaluated the relative contributions of regulation of the activities of alpha-ketoglutarate dehydrogenase and the aspartate-glutamate carrier 1. In addition, a comprehensive analysis of the retinal metabolome showed that phototransduction also influences steady-state concentrations of 5'-GMP, ribose-5-phosphate, ketone bodies, and purines.	[Du, Jianhai; Cleghorn, Whitney M.; Lindsay, Ken J.; Kanow, Mark; Hurley, James B.] Univ Washington, Dept Biochem, Seattle, WA 98109 USA; [Rountree, Austin; Sweet, Ian R.] Univ Washington, Diabet & Obes Ctr Excellence, Seattle, WA 98109 USA; [Sadilek, Martin] Univ Washington, Dept Chem, Seattle, WA 98109 USA; [Gu, Haiwei; Djukovic, Danijel; Raftery, Dan] Univ Washington, Northwest Metabol Res Ctr, Dept Anesthesiol & Pain Med, Seattle, WA 98109 USA; [Du, Jianhai; Hurley, James B.] Univ Washington, Dept Ophthalmol, Seattle, WA 98109 USA; [Contreras, Laura; Satrustegui, Jorgina] Univ Autonoma Madrid, Consejo Super Invest Cient, Ctr Mol Biol Severo Ochoa, Dept Mol Biol,CIBER Rare Dis CIBERER, E-28049 Madrid, Spain; [Contreras, Laura; Satrustegui, Jorgina] Autonomous Univ Madrid, Hlth Res Inst, Fdn Jimenez Diaz, E-28049 Madrid, Spain; [Chan, Lawrence; Tsang, Stephen H.] Columbia Univ, Dept Ophthalmol, Bernard & Shirlee Brown Glaucoma Lab, New York, NY 10027 USA; [Chan, Lawrence; Tsang, Stephen H.] Columbia Univ, Dept Ophthalmol, Barbara & Donald Jonas Stem Cell Lab, New York, NY 10027 USA; [Tsang, Stephen H.] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Tsang, Stephen H.] Columbia Univ, Inst Human Nutr, New York, NY 10032 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid; Columbia University; Columbia University; Columbia University; Columbia University	Hurley, JB (corresponding author), Univ Washington, Dept Chem, UW Box 357350,1705 NE Pacific St, Seattle, WA 98195 USA.	jbhhh@uw.edu	Contreras, Laura/A-2296-2015; Satrustegui, Jorgina/R-6732-2019; Contreras, Laura/ABG-7620-2021	Contreras, Laura/0000-0003-1157-4942; Satrustegui Gil Delgado, Jorgina/0000-0003-3377-2667	National Institutes of Health [EY06641, EY017863, EY001730]; NATIONAL EYE INSTITUTE [R01EY017863, R01EY006641, F32EY006641, P30EY001730] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK017047] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants EY06641 and EY017863 (to J. B. H.) and EY001730 (NEI Center Core). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors declare that they have no conflicts of interest with the contents of this article.	Adler L, 2014, J BIOL CHEM, V289, P1519, DOI 10.1074/jbc.M113.511295; AHMED J, 1993, INVEST OPHTH VIS SCI, V34, P516; Ahn CS, 2015, CANCER METAB, V3, DOI 10.1186/s40170-015-0128-2; Alarcon CR, 2015, NATURE, V519, P482, DOI 10.1038/nature14281; AMES A, 1992, J NEUROSCI, V12, P840, DOI 10.1523/jneurosci.12-03-00840.1992; Arshavsky VY, 2012, J BIOL CHEM, V287, P1620, DOI 10.1074/jbc.R111.305243; Barnes S, 2002, ADV EXP MED BIOL, V514, P465; Becker MA, 2001, PROG NUCLEIC ACID RE, V69, P115, DOI 10.1016/S0079-6603(01)69046-9; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; BRAUN RD, 1995, INVEST OPHTH VIS SCI, V36, P542; Calvert PD, 2000, P NATL ACAD SCI USA, V97, P13913, DOI 10.1073/pnas.250478897; Carroll PA, 2015, CANCER CELL, V27, P271, DOI 10.1016/j.ccell.2014.11.024; Chandel N. S., 2015, NAVIGATING METABOLIS, P49; Chang B, 2006, INVEST OPHTH VIS SCI, V47, P5017, DOI 10.1167/iovs.05-1468; Chertov AO, 2011, J BIOL CHEM, V286, P34700, DOI 10.1074/jbc.M111.279752; Contreras L, 2015, NEUROCHEM INT, V88, P38, DOI 10.1016/j.neuint.2015.04.001; Contreras L, 2009, J BIOL CHEM, V284, P7091, DOI 10.1074/jbc.M808066200; Daiger SP, 2003, ADV EXP MED BIOL, V533, P1; DAWIS SM, 1989, BIOPHYS J, V55, P79, DOI 10.1016/S0006-3495(89)82782-1; DENTON RM, 1990, ANNU REV PHYSIOL, V52, P451, DOI 10.1146/annurev.ph.52.030190.002315; Du JH, 2015, METHOD ENZYMOL, V561, P149, DOI 10.1016/bs.mie.2015.04.002; Du JH, 2013, J BIOL CHEM, V288, P36129, DOI 10.1074/jbc.M113.507285; Du JH, 2013, P NATL ACAD SCI USA, V110, P18501, DOI 10.1073/pnas.1311193110; FAIN GL, 1990, TRENDS NEUROSCI, V13, P378, DOI 10.1016/0166-2236(90)90023-4; Finkel T, 2015, CIRC RES, V116, P1810, DOI 10.1161/CIRCRESAHA.116.305484; Gellerich FN, 2010, BBA-BIOENERGETICS, V1797, P1018, DOI 10.1016/j.bbabio.2010.02.005; Gellerich FN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008181; Glancy B, 2012, BIOCHEMISTRY-US, V51, P2959, DOI 10.1021/bi2018909; Gu HW, 2015, ANALYST, V140, P2726, DOI 10.1039/c4an02386b; Hartong DT, 2008, NAT GENET, V40, P1230, DOI 10.1038/ng.223; Hedstrom L, 2009, CHEM REV, V109, P2903, DOI 10.1021/cr900021w; Hurley JB, 2015, J NEUROSCI RES, V93, P1079, DOI 10.1002/jnr.23583; Hurley JB, 2014, VERTEBRATE PHOTORECE, P91; Jalil MA, 2005, J BIOL CHEM, V280, P31333, DOI 10.1074/jbc.M505286200; KIMBLE EA, 1980, EXP EYE RES, V31, P271, DOI 10.1016/S0014-4835(80)80037-6; Krebs HA, 1927, BIOCHEM Z, V189, P57; Krizaj D, 2002, FRONT BIOSCI-LANDMRK, V7, pD2023, DOI 10.2741/krizaj; Krol J, 2010, CELL, V141, P618, DOI 10.1016/j.cell.2010.03.039; Lau JCM, 2012, EXP EYE RES, V102, P50, DOI 10.1016/j.exer.2012.07.004; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; Lee M, 2014, CELL, V158, P980, DOI 10.1016/j.cell.2014.08.005; Lindsay KJ, 2014, P NATL ACAD SCI USA, V111, P15579, DOI 10.1073/pnas.1412441111; LINSENMEIER RA, 1986, J GEN PHYSIOL, V88, P521, DOI 10.1085/jgp.88.4.521; Linton JD, 2010, P NATL ACAD SCI USA, V107, P8599, DOI 10.1073/pnas.1002471107; Llorente-Folch I, 2015, J PHYSIOL-LONDON, V593, P3447, DOI 10.1113/JP270254; Llorente-Folch I, 2013, J NEUROSCI, V33, P13957, DOI 10.1523/JNEUROSCI.0929-13.2013; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Mayers JR, 2015, TRENDS BIOCHEM SCI, V40, P130, DOI 10.1016/j.tibs.2015.01.004; MEDRANO CJ, 1995, EXP EYE RES, V61, P273, DOI 10.1016/S0014-4835(05)80122-8; Millard P, 2012, BIOINFORMATICS, V28, P1294, DOI 10.1093/bioinformatics/bts127; Murgia M, 2015, CELL CALCIUM, V58, P11, DOI 10.1016/j.ceca.2014.11.001; MURPHY MP, 1988, EUR J BIOCHEM, V173, P637, DOI 10.1111/j.1432-1033.1988.tb14046.x; Nathan J, 2006, PHOTOCHEM PHOTOBIOL, V82, P1489, DOI 10.1562/2006-02-27-RA-818; Okawa H, 2008, CURR BIOL, V18, P1917, DOI 10.1016/j.cub.2008.10.029; Poitry S, 1996, J GEN PHYSIOL, V108, P75, DOI 10.1085/jgp.108.2.75; Ramos M, 2011, J NEUROSCI RES, V89, P2008, DOI 10.1002/jnr.22639; Satrustegui J, 2007, J NEUROSCI RES, V85, P3359, DOI 10.1002/jnr.21299; Schoors S, 2015, NATURE, V520, P192, DOI 10.1038/nature14362; Sickel W, 1972, Adv Exp Med Biol, V24, P101; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Sweet Ian R, 2002, Diabetes Technol Ther, V4, P67, DOI 10.1089/15209150252924111; Tarboush R, 2012, TISSUE CELL, V44, P264, DOI 10.1016/j.tice.2012.04.004; Wang L, 1997, ACTA PHYSIOL SCAND, V160, P71, DOI 10.1046/j.1365-201X.1997.00203.x; Warburg O, 1924, BIOCHEM Z, V152, P309; WATTS RWE, 1983, ADV ENZYME REGUL, V21, P33, DOI 10.1016/0065-2571(83)90007-9; Winkler BS, 2008, INVEST OPHTH VIS SCI, V49, P4613, DOI 10.1167/iovs.08-2004; WINKLER BS, 1981, J GEN PHYSIOL, V77, P667, DOI 10.1085/jgp.77.6.667; WINKLER BS, 1986, EXP EYE RES, V43, P829, DOI 10.1016/S0014-4835(86)80013-6; Woodruff ML, 2002, J PHYSIOL-LONDON, V542, P843, DOI 10.1113/jphysiol.2001.013987; Xu Y, 2007, J NEUROCHEM, V101, P120, DOI 10.1111/j.1471-4159.2006.04349.x; YARFITZ S, 1994, J BIOL CHEM, V269, P14329; YOUNG RW, 1971, J CELL BIOL, V49, P303, DOI 10.1083/jcb.49.2.303; Zhang J, 2014, MOL CELL, V56, P205, DOI 10.1016/j.molcel.2014.08.018; Zhao H, 2013, CHEM COMMUN, V49, P4444, DOI 10.1039/c3cc41437j; Zhu JJ, 2014, J PROTEOME RES, V13, P4120, DOI 10.1021/pr500494u; ZUCKERMAN R, 1980, EXP EYE RES, V30, P117, DOI 10.1016/0014-4835(80)90106-2	77	61	61	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 26	2016	291	9					4698	4710		10.1074/jbc.M115.698985	http://dx.doi.org/10.1074/jbc.M115.698985			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8JT	26677218	hybrid, Green Published			2022-12-26	WOS:000371604600036
J	Lee, S; Ye, A; Kim, J				Lee, Suman; Ye, An; Kim, Joomyeong			DNA-Binding Motif of the Imprinted Transcription Factor PEG3	PLOS ONE			English	Article							AMINO-ACID TRANSPORTER; GENE; PIK3C3/VPS34; SYSTEM; CELLS; MICE	Peg3 is an imprinted gene that is predicted to encode a DNA-binding zinc finger protein. This was previously demonstrated through Chromatin Immuno Precipitation-based Sequencing experiments. In the current study, we reanalyzed the previous ChIP-Seq results and further characterized the DNA-binding motif of PEG3. According to the results, PEG3 binds to the promoters and enhancers of a subset of genes that are closely associated with the known functions of Peg3. Some of these identified targets include Tufm, Mrpl45, Cry2, Per1, Slc25a29 and Slc38a2. With this set of targets, we derived a DNA-binding motif of PEG3, 5'-GTGGCAGT-3', which also provides a tabulated matrix that can be used for predicting other unknown genomic targets. Among the newly identified targets, we analyzed in detail the two loci, Slc38a2 and Slc38a4, which are known to be involved in neutral amino acid transport. The results indicated that PEG3 likely functions as a transcriptional repressor for these two loci. Overall, the current study provides a set of genomic targets and also redefines the DNA-binding motif for the imprinted transcription factor PEG3.	[Lee, Suman; Ye, An; Kim, Joomyeong] Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA	Louisiana State University System; Louisiana State University	Kim, J (corresponding author), Louisiana State Univ, Dept Biol Sci, Baton Rouge, LA 70803 USA.	jkim@lsu.edu			National Institutes of Health [R01-GM066225, R01-GM097074]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097074, R01GM066225] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by National Institutes of Health (J.K. R01-GM066225 and R01-GM097074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Buraschi S, 2013, P NATL ACAD SCI USA, V110, pE2582, DOI 10.1073/pnas.1305732110; Curley JP, 2005, FASEB J, V19, P1302, DOI 10.1096/fj.04-3216fje; Desforges M, 2006, AM J PHYSIOL-CELL PH, V290, pC305, DOI 10.1152/ajpcell.00258.2005; Doi M, 2012, BIOL PHARM BULL, V35, P1385, DOI 10.1248/bpb.b12-00364; Dowdy SC, 2005, GYNECOL ONCOL, V99, P126, DOI 10.1016/j.ygyno.2005.05.036; Ezer D, 2014, COMPUT STRUCT BIOTEC, V10, P63, DOI 10.1016/j.csbj.2014.07.005; Feng WW, 2008, CANCER-AM CANCER SOC, V112, P1489, DOI 10.1002/cncr.23323; Gotea V, 2010, GENOME RES, V20, P565, DOI 10.1101/gr.104471.109; Gupta S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r24; He Hongzhi, 2014, Genomics & Informatics, V12, P105, DOI 10.5808/GI.2014.12.3.105; Jaber N, 2012, AUTOPHAGY, V8, P707, DOI 10.4161/auto.19627; Kim J, 1997, GENOME RES, V7, P532, DOI 10.1101/gr.7.5.532; Kim J, 2008, HUM MOL GENET, V17, P391, DOI 10.1093/hmg/ddm316; Kim J, 2007, GENOMICS, V90, P85, DOI 10.1016/j.ygeno.2007.03.012; Kim J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083359; Kuroiwa Y, 1996, NAT GENET, V12, P186, DOI 10.1038/ng0296-186; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; LaSalle JM, 2015, HUM MOL GENET; Li LL, 1999, SCIENCE, V284, P330, DOI 10.1126/science.284.5412.330; Lincoln GA, 2003, J ENDOCRINOL, V179, P1, DOI 10.1677/joe.0.1790001; Perera BPU, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119493; Schioth HB, 2013, MOL ASPECTS MED, V34, P571, DOI 10.1016/j.mam.2012.07.012; Smith RJ, 2003, GENOME RES, V13, P558, DOI 10.1101/gr.781503; Thiaville MM, 2013, GENE, V512, P314, DOI 10.1016/j.gene.2012.10.005; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Ye A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108596; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou XA, 2010, AUTOPHAGY, V6, P798, DOI 10.4161/auto.6.6.12511	32	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145531	10.1371/journal.pone.0145531	http://dx.doi.org/10.1371/journal.pone.0145531			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26692216	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092300085
J	Li, YX; Wu, X; Jaqueth, J; Zhang, DF; Cui, DH; Li, CH; Hu, GH; Dong, HY; Song, YC; Shi, YS; Wang, TY; Li, BL; Li, Y				Li, Yong-xiang; Wu, Xun; Jaqueth, Jennifer; Zhang, Dengfeng; Cui, Donghui; Li, Chunhui; Hu, Guanghui; Dong, Huaiyu; Song, Yan-chun; Shi, Yun-su; Wang, Tianyu; Li, Bailin; Li, Yu			The Identification of Two Head Smut Resistance-Related QTL in Maize by the Joint Approach of Linkage Mapping and Association Analysis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; TRAIT LOCUS QHS2.09; QUANTITATIVE RESISTANCE; SPORISORIUM-REILIANA; LEAF-BLIGHT; MAJOR QTL; PATHOGENS; MARKERS; WEIGHT; TASSEL	Head smut, caused by the fungus Sphacelotheca reiliana (Kuhn) Clint, is a devastating threat to maize production. In this study, QTL mapping of head smut resistance was performed using a recombinant inbred line (RIL) population from a cross between a resistant line "QI319" and a susceptible line "Huangzaosi" (HZS) with a genetic map constructed from genotyping-by-sequencing (GBS) data and composed of 1638 bin markers. Two head smut resistance QTL were identified, located on Chromosome 2 (q2.09HR) and Chromosome 5 (q5.03HR), q2.09HR is co-localized with a previously reported QTL for head smut resistance, and the effect of q5.03HR has been validated in backcross populations. It was also observed that pyramiding the resistant alleles of both QTL enhanced the level of resistance to head smut. A genome-wide association study (GWAS) using 277 diverse inbred lines was processed to validate the mapped QTL and to identify additional head smut resistance associations. A total of 58 associated SNPs were detected, which were distributed in 31 independent regions. SNPs with significant association to head smut resistance were detected within the q2.09HR and q5.03HR regions, confirming the linkage mapping results. It was also observed that both additive and epistastic effects determine the genetic architecture of head smut resistance in maize. As shown in this study, the combined strategy of linkage mapping and association analysis is a powerful approach in QTL dissection for disease resistance in maize.	[Li, Yong-xiang; Wu, Xun; Zhang, Dengfeng; Li, Chunhui; Song, Yan-chun; Shi, Yun-su; Wang, Tianyu; Li, Yu] Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100081, Peoples R China; [Jaqueth, Jennifer; Li, Bailin] DuPont Pioneer, Wilmington, DE 19803 USA; [Cui, Donghui] DuPont Pioneer, Beijing 101309, Peoples R China; [Hu, Guanghui] Heilongjiang Acad Agr Sci, Maize Res Inst, Harbin 150086, Peoples R China; [Dong, Huaiyu] Liaoning Acad Agr Sci, Inst Plant Protect, Shenyang 110161, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; DuPont; Heilongjiang Academy of Agricultural Sciences	Wang, TY (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Beijing 100081, Peoples R China.	wangtianyu@263.net; liyu03@caas.cn	li, yong/HDN-3885-2022; li, bai/GRJ-4913-2022; li, yongxiang/GPW-6930-2022; li, bz/GVR-7133-2022		DuPont Pioneer; Program of MOST of China; Program of MOA of China [2011CB100105, 201303007, 2013BAD01B02, 2014CB138200, 2014NWB030]; CAAS (Innovation Program)	DuPont Pioneer; Program of MOST of China; Program of MOA of China; CAAS (Innovation Program)	This research was supported by DuPont Pioneer and the Programs of MOST and MOA of China (2011CB100105, 201303007, 2013BAD01B02, 2014CB138200, 2014NWB030) and CAAS (Innovation Program). The funders provided support in the form of salaries for authors but did not have any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALI A, 1990, J AM SOC HORTIC SCI, V115, P668, DOI 10.21273/JASHS.115.4.668; Bai JK, 1994, J MAIZE SCI, V2, P67; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BERNARDO R, 1992, AGRONOMIE, V12, P303, DOI 10.1051/agro:19920403; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Brown PJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002383; Chen YS, 2008, THEOR APPL GENET, V117, P1241, DOI 10.1007/s00122-008-0858-4; Di H, 2015, EUPHYTICA, V202, P69, DOI 10.1007/s10681-014-1219-9; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Fan CH, 2006, THEOR APPL GENET, V112, P1164, DOI 10.1007/s00122-006-0218-1; Hallauer A.R., 1988, QUANTITATIVE GENETIC; Herzog E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092429; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; [吉海莲 JI Hailian], 2007, [植物遗传资源学报, Journal of Plant Genetic Resources], V8, P132; Jin QiMing, 2003, Journal of Maize Sciences, V11, P86; Jin QM, 2000, J MAIZE SCI, V8, P84; Kump KL, 2011, NAT GENET, V43, P163, DOI 10.1038/ng.747; Li CH, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0187-4; Li CH, 2013, EUPHYTICA, V193, P303, DOI 10.1007/s10681-013-0901-7; Li H, 2013, NAT GENET, V45, P43, DOI 10.1038/ng.2484; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Li XH, 2008, FIELD CROP RES, V106, P148, DOI 10.1016/j.fcr.2007.11.008; Liu HJ, 2014, BMC GENOMICS, V15, DOI [10.1186/1471-2164-15-433, 10.1186/1471-2164-15-25]; Liu RX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049836; Liu ZhiZhai, 2012, Scientia Agricultura Sinica, V45, P2107; Lu YL, 2009, THEOR APPL GENET, V120, P93, DOI 10.1007/s00122-009-1162-7; Lubberstedt T, 1999, THEOR APPL GENET, V99, P593, DOI 10.1007/s001220051273; Ma BY, 1983, CHIN AGRIC SIN, V4, P12; Mei Z. B., 1982, Shanxi Nongye Kexue (Shanxi Agricultural Sciences), P10; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Parlevliet JE, 2002, EUPHYTICA, V124, P147, DOI 10.1023/A:1015601731446; Platt A, 2010, GENETICS, V186, P1045, DOI 10.1534/genetics.110.121665; Poland JA, 2011, P NATL ACAD SCI USA, V108, P6893, DOI 10.1073/pnas.1010894108; SAS Institute, 2009, SAS SYSTEM FOR WINDO; Shi HL, 2005, CHIN AGRON SIN, V3, P481; Teng WenTao, 2004, Scientia Agricultura Sinica, V37, P1804; Wang L, 2011, THEOR APPL GENET, V122, P327, DOI 10.1007/s00122-010-1449-8; Wang M, 2012, PLANT SCI, V196, P125, DOI 10.1016/j.plantsci.2012.08.004; Wang SK, 2012, NAT GENET, V44, P950, DOI 10.1038/ng.2327; Weng JF, 2012, PHYTOPATHOLOGY, V102, P692, DOI 10.1094/PHYTO-12-11-0330; Wu X, 2014, THEOR APPL GENET, V127, P621, DOI 10.1007/s00122-013-2246-y; Xie WB, 2010, P NATL ACAD SCI USA, V107, P10578, DOI 10.1073/pnas.1005931107; Xu ML, 1999, PLANT DIS, V83, P390, DOI 10.1094/PDIS.1999.83.4.390; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Yu HH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017595; Zuo WL, 2015, NAT GENET, V47, P151, DOI 10.1038/ng.3170	47	7	10	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145549	10.1371/journal.pone.0145549	http://dx.doi.org/10.1371/journal.pone.0145549			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689370	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092300088
J	Teichenne, J; Morro, M; Casellas, A; Jimenez, V; Tellez, N; Leger, A; Bosch, F; Ayuso, E				Teichenne, Joan; Morro, Meritxell; Casellas, Alba; Jimenez, Veronica; Tellez, Noelia; Leger, Adrien; Bosch, Fatima; Ayuso, Eduard			Identification of miRNAs Involved in Reprogramming Acinar Cells into Insulin Producing Cells	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PANCREATIC EXOCRINE CELLS; TRANSCRIPTION FACTORS; AR42J CELLS; MICRORNA EXPRESSION; SECRETING DUCTS; BETA-CELLS; IN-VITRO; DIFFERENTIATION; LIVER	Reprogramming acinar cells into insulin producing cells using adenoviral (Ad)-mediated delivery of Pdx1, Ngn3 and MafA (PNM) is an innovative approach for the treatment of diabetes. Here, we aimed to investigate the molecular mechanisms involved in this process and in particular, the role of microRNAs. To this end, we performed a comparative study of acinar-to-beta cell reprogramming efficiency in the rat acinar cell line AR42J and its subclone B13 after transduction with Ad-PNM. B13 cells were more efficiently reprogrammed than AR42J cells, which was demonstrated by a strong activation of beta cell markers (Ins1, Ins2, IAPP, NeuroD1 and Pax4). miRNome panels were used to analyze differentially expressed miRNAs in acinar cells under four experimental conditions (i) non-transduced AR42J cells, (ii) non-transduced B13 cells, (iii) B13 cells transduced with Ad-GFP vectors and (iv) B13 cells transduced with Ad-PNM vectors. A total of 59 miRNAs were found to be differentially expressed between non-transduced AR42J and B13 cells. Specifically, the miR-200 family was completely repressed in B13 cells, suggesting that these cells exist in a less differentiated state than AR42J cells and as a consequence they present a greater plasticity. Adeno-viral transduction per se induced dedifferentiation of acinar cells and 11 miRNAs were putatively involved in this process, whereas 8 miRNAs were found to be associated with PNM expression. Of note, Ad-PNM reprogrammed B13 cells presented the same levels of miR-137-3p, miR-135a-5p, miR-204-5p and miR-210-3p of those detected in islets, highlighting their role in the process. In conclusion, this study led to the identification of miRNAs that might be of compelling importance to improve acinar-to-beta cell conversion for the future treatment of diabetes.	[Teichenne, Joan; Morro, Meritxell; Casellas, Alba; Jimenez, Veronica; Bosch, Fatima; Ayuso, Eduard] Univ Autonoma Barcelona, Ctr Anim Biotechnol & Gene Therapy, Bellaterra, Spain; [Teichenne, Joan; Morro, Meritxell; Casellas, Alba; Jimenez, Veronica; Bosch, Fatima; Ayuso, Eduard] Univ Autonoma Barcelona, Sch Vet Med, Dept Biochem & Mol Biol, Bellaterra, Spain; [Morro, Meritxell; Casellas, Alba; Jimenez, Veronica; Tellez, Noelia; Bosch, Fatima; Ayuso, Eduard] CIBER Diabet & Enfermedades Metab Asociadas CIBER, Madrid, Spain; [Tellez, Noelia] IDIBELL, Bellvitge Biomed Res Inst, Barcelona, Spain; [Leger, Adrien; Ayuso, Eduard] Univ Nantes, Lab Therapie Gen, INSERM, UMR1089, Nantes, France; [Leger, Adrien; Ayuso, Eduard] Atlantic Gene Therapies, Nantes, France	Autonomous University of Barcelona; Autonomous University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERES; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); University of Barcelona; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Ayuso, E (corresponding author), Univ Autonoma Barcelona, Ctr Anim Biotechnol & Gene Therapy, Bellaterra, Spain.	eduard.ayuso@univ-nantes.fr	AYUSO LOPEZ, Eduardo/I-7686-2017; JIMENEZ, VERONICA/AAL-2626-2021; Tellez, Noelia/C-1029-2008; CASELLAS, ALBA/AAG-6719-2020; Morró Larrubia, Meritxell/L-3345-2017	JIMENEZ, VERONICA/0000-0001-9145-9877; Tellez, Noelia/0000-0001-7879-3256; Morró Larrubia, Meritxell/0000-0003-1725-9599; BOSCH, FATIMA/0000-0002-7705-5515; Ayuso, Eduard/0000-0003-0811-2229; CASELLAS, ALBA/0000-0003-0203-4733; Leger, Adrien/0000-0001-8772-6776; Teichenne, Joan/0000-0002-3455-5923	European Foundation for the Study of Diabetes ("Young Investigator Award Innovative Therapies for Type 1 Diabetes" - EFSD/JDRF/Roche); Ministerio de Economia y Competitividad [SAF 2014-54866-R]; Generalitat de Catalunya [2014SGR-1669]; Direccio General de Recerca, Generalitat de Catalunya; Ministerio de Educacion, Cultura y Deporte, Spain; ICREA Academia Award	European Foundation for the Study of Diabetes ("Young Investigator Award Innovative Therapies for Type 1 Diabetes" - EFSD/JDRF/Roche); Ministerio de Economia y Competitividad(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Direccio General de Recerca, Generalitat de Catalunya(Generalitat de Catalunya); Ministerio de Educacion, Cultura y Deporte, Spain(Spanish Government); ICREA Academia Award(ICREA)	This work was supported by grants from the European Foundation for the Study of Diabetes ("Young Investigator Award Innovative Therapies for Type 1 Diabetes" sponsored by EFSD/JDRF/Roche) to EA and "Ministerio de Economia y Competitividad (SAF 2014-54866-R) and Generalitat de Catalunya (2014SGR-1669 and ICREA Academia Award) to FB. JT and MM were recipients of predoctoral fellowships from Direccio General de Recerca, Generalitat de Catalunya, and from Ministerio de Educacion, Cultura y Deporte, Spain, respectively.	Akinci E, 2012, BIOCHEM J, V442, P539, DOI 10.1042/BJ20111678; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Banga A, 2014, GENE THER, V21, P19, DOI 10.1038/gt.2013.50; Banga A, 2012, P NATL ACAD SCI USA, V109, P15336, DOI 10.1073/pnas.1201701109; Chen YJ, 2014, CELL REP, V6, P1046, DOI 10.1016/j.celrep.2014.02.013; Choi PS, 2008, NEURON, V57, P41, DOI 10.1016/j.neuron.2007.11.018; Christoffersen NR, 2007, RNA, V13, P1172, DOI 10.1261/rna.586807; CHRISTOPHE J, 1994, AM J PHYSIOL, V266, pG963, DOI 10.1152/ajpgi.1994.266.6.G963; Darnell DK, 2006, DEV DYNAM, V235, P3156, DOI 10.1002/dvdy.20956; Fairhall EA, 2013, TOXICOL RES-UK, V2, P308, DOI 10.1039/c3tx50030f; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; Francis Natalie, 2014, Microrna, V3, P54; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; International Diabetes Federation, DIABETES ATLAS, V9th; Jayawardena TM, 2012, CIRC RES, V110, P1465, DOI 10.1161/CIRCRESAHA.112.269035; Jimenez V, 2011, DIABETOLOGIA, V54, P1075, DOI 10.1007/s00125-011-2070-3; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kaneto H, 2005, DIABETES, V54, P1009, DOI 10.2337/diabetes.54.4.1009; Kay MA, 2011, NAT REV GENET, V12, P316, DOI 10.1038/nrg2971; Klein D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055064; Lahmy R, 2014, MOL BIOL REP, V41, P2055, DOI 10.1007/s11033-014-3054-4; Lan MS, 2014, LIFE SCI, V114, P45, DOI 10.1016/j.lfs.2014.08.001; Li H, 2008, J BIOMED SCI, V15, P487, DOI 10.1007/s11373-008-9233-3; Li WD, 2014, NAT BIOTECHNOL, V32, P1223, DOI 10.1038/nbt.3082; Lima MJ, 2013, DIABETES, V62, P2821, DOI 10.2337/db12-1256; Lima MJ, 2012, MOL CELL ENDOCRINOL, V358, P69, DOI 10.1016/j.mce.2012.02.024; LONGNECKER DS, 1979, CANCER LETT, V7, P197, DOI 10.1016/S0304-3835(79)80080-4; Lu J, 2014, BIOCHEM BIOPH RES CO, V453, P405, DOI 10.1016/j.bbrc.2014.09.095; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; Marek CJ, 2003, BIOCHEM J, V370, P763, DOI 10.1042/BJ20021545; Mashima H, 1996, J CLIN INVEST, V97, P1647, DOI 10.1172/JCI118591; Matsuoka TA, 2007, MOL ENDOCRINOL, V21, P2764, DOI 10.1210/me.2007-0028; Medici D, 2008, MOL BIOL CELL, V19, P4875, DOI 10.1091/mbc.E08-05-0506; Miravet S, 2014, METHODS MOL BIOL, V1089, P159, DOI 10.1007/978-1-62703-679-5_12; Morro M, 2014, HUM GENE THER, V25, P824, DOI 10.1089/hum.2013.182; Ogihara T, 2008, ENDOCR J, V55, P691, DOI 10.1507/endocrj.K07E-169; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Strauss WM, 2006, MAMM GENOME, V17, P833, DOI 10.1007/s00335-006-0025-7; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tellez N, 2007, DIABETOLOGIA, V50, P602, DOI 10.1007/s00125-006-0548-1; Wahid F, 2010, BBA-MOL CELL RES, V1803, P1231, DOI 10.1016/j.bbamcr.2010.06.013; Wang AY, 2007, MOL THER, V15, P255, DOI 10.1038/sj.mt.6300032; Xu GL, 2013, NAT MED, V19, P1141, DOI 10.1038/nm.3287; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Zaldumbide A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048093; Zhang YQ, 2001, DIABETES, V50, pS10, DOI 10.2337/diabetes.50.2007.S10; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	49	4	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145116	10.1371/journal.pone.0145116	http://dx.doi.org/10.1371/journal.pone.0145116			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690959	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092300038
J	Xie, SJ; Zhang, XJ; Zhang, JQ; Li, FH; Xiang, JH				Xie, Shijun; Zhang, Xiaojun; Zhang, Jiquan; Li, Fuhua; Xiang, Jianhai			Envelope Proteins of White Spot Syndrome Virus (WSSV) Interact with Litopenaeus vannamei Peritrophin-Like Protein (LvPT)	PLOS ONE			English	Article							STRUCTURAL PROTEINS; PROTEOMIC ANALYSIS; MEMBRANE; WSBV; GENE	White spot syndrome virus (WSSV) is a major pathogen in shrimp cultures. The interactions between viral proteins and their receptors on the surface of cells in a frontier target tissue are crucial for triggering an infection. In this study, a yeast two-hybrid (Y2H) library was constructed using cDNA obtained from the stomach and gut of Litopenaeus vannamei, to ascertain the role of envelope proteins in WSSV infection. For this purpose, VP37 was used as the bait in the Y2H library screening. Forty positive clones were detected after screening. The positive clones were analyzed and discriminated, and two clones belonging to the peritrophin family were subsequently confirmed as genuine positive clones. Sequence analysis revealed that both clones could be considered as the same gene, LV-peritrophin (LvPT). Co-immunoprecipitation confirmed the interaction between LvPT and VP37. Further studies in the Y2H system revealed that LvPT could also interact with other WSSV envelope proteins such as VP32, VP38A, VP39B, and VP41A. The distribution of LvPT in tissues revealed that LvPT was mainly expressed in the stomach than in other tissues. In addition, LvPT was found to be a secretory protein, and its chitin-binding ability was also confirmed.	[Xie, Shijun; Zhang, Xiaojun; Zhang, Jiquan; Li, Fuhua; Xiang, Jianhai] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao 266071, Peoples R China; [Xie, Shijun] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Xiang, JH (corresponding author), Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao 266071, Peoples R China.	jhxiang@qdio.ac.cn	zhang, jin/GXV-9154-2022	zhang, Jiquan/0000-0001-5063-339X	National Major Fundamental Research Program (973 program) [2012CB114403]; National High-Tech Research and Development Program (863 program) [2012AA10A404]	National Major Fundamental Research Program (973 program)(National Basic Research Program of China); National High-Tech Research and Development Program (863 program)	This work was financially supported by the National Major Fundamental Research Program (973 program 2012CB114403) and the National High-Tech Research and Development Program (863 program 2012AA10A404).	Bao YY, 2013, FEBS J, V280, P939, DOI 10.1111/febs.12088; Chang YS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010718; Chen KY, 2009, FISH SHELLFISH IMMUN, V27, P460, DOI 10.1016/j.fsi.2009.06.018; Chou HY, 1998, AQUACULTURE, V164, P263, DOI 10.1016/S0044-8486(98)00192-6; Di Leonardo VA, 2005, J FISH DIS, V28, P565, DOI 10.1111/j.1365-2761.2005.00659.x; EISEMAN CH, 1994, INT J PARASITOL, V24, P15, DOI 10.1016/0020-7519(94)90055-8; Escobedo-Bonilla CM, 2008, J FISH DIS, V31, P1, DOI 10.1111/j.1365-2761.2007.00877.x; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Huang CH, 2002, MOL CELL PROTEOMICS, V1, P223, DOI 10.1074/mcp.M100035-MCP200; Kang WK, 2003, ARCH VIROL, V148, P99, DOI 10.1007/s00705-002-0902-7; Liu QH, 2009, LETT APPL MICROBIOL, V48, P44, DOI 10.1111/j.1472-765X.2008.02482.x; Marsh M, 2006, CELL, V124, P729, DOI 10.1016/j.cell.2006.02.007; Martin GG, 2006, BIOL BULL-US, V211, P275, DOI 10.2307/4134549; Oidtmann B, 2011, TRANSBOUND EMERG DIS, V58, P469, DOI 10.1111/j.1865-1682.2011.01231.x; Sangsuriya P, 2014, MOL CELL PROTEOMICS, V13, P269, DOI 10.1074/mcp.M113.029199; Tellam RL, 1999, INSECT BIOCHEM MOLEC, V29, P87, DOI 10.1016/S0965-1748(98)00123-4; Tsai JM, 2004, J VIROL, V78, P11360, DOI 10.1128/JVI.78.20.11360-11370.2004; van Hulten MCW, 2000, J GEN VIROL, V81, P2525, DOI 10.1099/0022-1317-81-10-2525; van Hulten MCW, 2001, VIROLOGY, V286, P7, DOI 10.1006/viro.2001.1002; Wang CH, 1995, DIS AQUAT ORGAN, V23, P239, DOI 10.3354/dao023239; Wang LY, 2013, FISH SHELLFISH IMMUN, V35, P840, DOI 10.1016/j.fsi.2013.06.018; Wang LY, 2012, FISH SHELLFISH IMMUN, V33, P1285, DOI 10.1016/j.fsi.2012.09.014; Wu WL, 2005, VIROLOGY, V332, P578, DOI 10.1016/j.virol.2004.12.011; Yang F, 2001, J VIROL, V75, P11811, DOI 10.1128/JVI.75.23.11811-11820.2001; Yu Y, 2015, CHIN J OCEANOL LIMN, V33, P1, DOI 10.1007/s00343-014-3232-1; Zhang CC, 2014, J BIOSCIENCES, V39, P63, DOI 10.1007/s12038-013-9411-y	26	30	32	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144922	10.1371/journal.pone.0144922	http://dx.doi.org/10.1371/journal.pone.0144922			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26692362	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092300026
J	Jomoui, W; Fucharoen, G; Sanchaisuriya, K; Nguyen, VH; Fucharoen, S				Jomoui, Wittaya; Fucharoen, Goonnapa; Sanchaisuriya, Kanokwan; Van Hoa Nguyen; Fucharoen, Supan			Hemoglobin Constant Spring among Southeast Asian Populations: Haplotypic Heterogeneities and Phylogenetic Analysis	PLOS ONE			English	Article							NORTHEAST THAILAND; H-DISEASE; HEMATOLOGICAL CHARACTERIZATION; ALPHA-THALASSEMIA; MOLECULAR-BASIS; FEATURES; GENE; VIETNAM; ORIGINS	Background Hemoglobin Constant Spring (Hb CS) is an abnormal Hb caused by a mutation at the termination codon of alpha 2-globin gene found commonly among Southeast Asian and Chinese people. Association of Hb CS with alpha(0)-thalassemia leads to a thalassemia intermedia syndrome commonly encountered in the region. We report chromosome background and addressed genetic origins of Hb CS observed in a large cohort of Hb CS among Southeast Asian populations. Materials and Methods A study was done on 102 Vietnamese (aged 15-49 year-old) and 40 Laotian (aged 18-39 year-old) subjects with Hb CS and results compared with 120 Hb CS genes in Thailand. Hematological parameters were recorded and Hb analysis was performed using capillary electrophoresis. Hb CS mutation and thalassemia genotypes were defined by DNA analysis. Six DNA polymorphisms within a-globin gene cluster including 5' Xba I, Bgl I, Inter-zeta HVR, AccI, RsaI and aPstI 3', were determined using PCR-RFLP assay. Results Nine different genotypes of Hb CS were observed. In contrast to the Thai Hb CS alleles which are mostly linked to haplotype (+-S + + -), most of the Vietnamese and the Laotian Hb CS genes were associated with haplotype (+-M + + -), both of which are different from that of the European Hb CS. Conclusions Hb CS is commonly found in combination with other thalassemias among Southeast Asian populations. Accurate genotyping of the cases requires both hematologic and DNA analyses. At least two independent origins are associated with the Hb CS gene which could indirectly explain the high prevalence of this Hb variant in the region.	[Jomoui, Wittaya] Khon Kaen Univ, Grad Sch, Program Biomed Sci, Khon Kaen, Thailand; [Jomoui, Wittaya; Fucharoen, Goonnapa; Sanchaisuriya, Kanokwan; Fucharoen, Supan] Khon Kaen Univ, Fac Associated Med Sci, Med Diagnost Labs, Ctr Res & Dev, Khon Kaen, Thailand; [Van Hoa Nguyen] Hue Coll Med, Hue, Vietnam; [Van Hoa Nguyen] Hue Coll Pharm, Hue, Vietnam	Khon Kaen University; Khon Kaen University; Hue University; Hue University	Fucharoen, S (corresponding author), Khon Kaen Univ, Fac Associated Med Sci, Med Diagnost Labs, Ctr Res & Dev, Khon Kaen, Thailand.	supan@kku.ac.th	Jomoui, Wittaya/AEU-0406-2022		National Research University Program of Khon Kaen University; Royal Golden Jubilee PhD Program of the Thailand Research Fund (TRF), Thailand [PHD/0210/2553]	National Research University Program of Khon Kaen University; Royal Golden Jubilee PhD Program of the Thailand Research Fund (TRF), Thailand	This work was supported by the National Research University Program of Khon Kaen University and the Office of the Higher Education Commission, Ministry of Education to SF. WJ is supported by the Royal Golden Jubilee PhD Program (PHD/0210/2553) of the Thailand Research Fund (TRF), Thailand.	Boonsa S, 2004, ACTA HAEMATOL-BASEL, V111, P149, DOI 10.1159/000076523; Bunn HF, 1986, HEMOGLOBIN MOL GENET; Chen FE, 2000, NEW ENGL J MED, V343, P544, DOI 10.1056/NEJM200008243430804; Chui DHK, 2003, BLOOD, V101, P791, DOI 10.1182/blood-2002-07-1975; CLEGG JB, 1971, NATURE, V234, P337, DOI 10.1038/234337a0; El-Kalla S, 1998, ACTA HAEMATOL-BASEL, V100, P49, DOI 10.1159/000040863; Flint J, 1998, BAILLIERE CLIN HAEM, V11, P1, DOI 10.1016/S0950-3536(98)80069-3; Fucharoen G, 2002, HUM HERED, V53, P18, DOI 10.1159/000048600; Fucharoen S, 2003, HAEMATOLOGICA, V88, P1092; FUCHAROEN S, 1987, HEMOGLOBIN, V11, P65, DOI 10.3109/03630268709036587; FUCHAROEN S, 1990, LANCET, V335, P1527, DOI 10.1016/0140-6736(90)93065-W; Harteveld CL, 2001, HAEMATOLOGICA, V86, P36; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; Nguyen HV, 2013, HEMOGLOBIN, V37, P333, DOI 10.3109/03630269.2013.790829; HUNT DM, 1982, BRIT J HAEMATOL, V51, P405, DOI 10.1111/j.1365-2141.1982.tb02796.x; Krause MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037214; Krishnamurti L, 1998, ANN NY ACAD SCI, V850, P415, DOI 10.1111/j.1749-6632.1998.tb10508.x; LAIG M, 1990, HUM GENET, V84, P188; LIU TC, 1994, AM J HEMATOL, V45, P293, DOI 10.1002/ajh.2830450405; Miles KL, 2001, BRIT J HAEMATOL, V113, P694, DOI 10.1046/j.1365-2141.2001.02823.x; Noguera NI, 2000, HAEMATOLOGICA, V85, P667; Sae-Ung N, 2007, ACTA HAEMATOL-BASEL, V117, P78, DOI 10.1159/000096857; Schrier SL, 1997, BLOOD, V89, P1762, DOI 10.1182/blood.V89.5.1762.1762_1762_1769; Singsanan S, 2007, ANN HEMATOL, V86, P665, DOI 10.1007/s00277-007-0310-x; Tritipsombut J, 2012, HEMOGLOBIN, V36, P47, DOI 10.3109/03630269.2011.637149; Nguyen VH, 2014, BLOOD CELL MOL DIS, V52, P161, DOI 10.1016/j.bcmd.2013.12.002; Yamsri S, 2010, PRENATAL DIAG, V30, P540, DOI 10.1002/pd.2514	27	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145230	10.1371/journal.pone.0145230	http://dx.doi.org/10.1371/journal.pone.0145230			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683994	Green Published, Green Submitted, gold			2022-12-26	WOS:000366725800048
J	Myers, JS; von Lersner, AK; Robbins, CJ; Sang, QXA				Myers, Jennifer S.; von Lersner, Ariana K.; Robbins, Charles J.; Sang, Qing-Xiang Amy			Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; IN-SITU HYBRIDIZATION; C-MYC ONCOGENE; TGF-BETA; PROTEIN EXPRESSION; SIGNALING PATHWAY; BREAST-CANCER; RAN-GTPASE; TRANSFORMING GROWTH-FACTOR-BETA-1; RADICAL PROSTATECTOMY	Genomic technologies including microarrays and next-generation sequencing have enabled the generation of molecular signatures of prostate cancer. Lists of differentially expressed genes between malignant and non-malignant states are thought to be fertile sources of putative prostate cancer biomarkers. However such lists of differentially expressed genes can be highly variable for multiple reasons. As such, looking at differential expression in the context of gene sets and pathways has been more robust. Using next-generation genome sequencing data from The Cancer Genome Atlas, differential gene expression between age- and stage- matched human prostate tumors and non-malignant samples was assessed and used to craft a pathway signature of prostate cancer. Up- and down-regulated genes were assigned to pathways composed of curated groups of related genes from multiple databases. The significance of these pathways was then evaluated according to the number of differentially expressed genes found in the pathway and their position within the pathway using Gene Set Enrichment Analysis and Signaling Pathway Impact Analysis. The "transforming growth factor-beta signaling" and "Ran regulation of mitotic spindle formation" pathways were strongly associated with prostate cancer. Several other significant pathways confirm reported findings from microarray data that suggest actin cytoskeleton regulation, cell cycle, mitogen-activated protein kinase signaling, and calcium signaling are also altered in prostate cancer. Thus we have demonstrated feasibility of pathway analysis and identified an underexplored area (Ran) for investigation in prostate cancer pathogenesis.	[Myers, Jennifer S.; von Lersner, Ariana K.; Robbins, Charles J.; Sang, Qing-Xiang Amy] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Sang, Qing-Xiang Amy] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University	Sang, QXA (corresponding author), Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA.	qxsang@chem.fsu.edu		Robbins, Charles/0000-0002-3130-7107	Leslie N. Wilson-Delores Auzenne Graduate Assistantship for Minorities; Florida State University Graduate School; Research Experience Program of Women in Math, Science, and Engineering of Florida State University; Florida State University; Endowed Chair Professorship in Cancer Research	Leslie N. Wilson-Delores Auzenne Graduate Assistantship for Minorities; Florida State University Graduate School; Research Experience Program of Women in Math, Science, and Engineering of Florida State University; Florida State University; Endowed Chair Professorship in Cancer Research	This work was in part supported by the Leslie N. Wilson-Delores Auzenne Graduate Assistantship for Minorities awarded to JSM by the Florida State University Graduate School, the Research Experience Program of Women in Math, Science, and Engineering of Florida State University to AKVL, and grants from the Florida State University and an Endowed Chair Professorship in Cancer Research from anonymous donors to QXAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Dr. Jinfeng Zhang and Mr. Kaixian Yu in the Departments of Statistics at Florida State University for helpful discussions. This work was in part supported by the Leslie N. Wilson-Delores Auzenne Graduate Assistantship for Minorities awarded to JSM by the Florida State University Graduate School, the Research Experience Program of Women in Math, Science, and Engineering of Florida State University to AKVL, and grants from the Florida State University and an Endowed Chair Professorship in Cancer Research from anonymous donors to QXAS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalinkeel R, 2004, CANCER RES, V64, P5311, DOI 10.1158/0008-5472.CAN-2506-2; Aaltomaa S, 1999, PROSTATE, V39, P8; Abe H, 2008, INT J CANCER, V122, P2391, DOI 10.1002/ijc.23400; Abraham G, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-277; Adler HL, 1999, J UROLOGY, V161, P182, DOI 10.1016/S0022-5347(01)62092-5; Ahram M, 2002, MOL CARCINOGEN, V33, P9, DOI 10.1002/mc.10019; Aitchison AA, 2008, PROSTATE, V68, P661, DOI 10.1002/pros.20730; Ajiboye S, 2010, BJU INT, V105, P913, DOI 10.1111/j.1464-410X.2009.08999.x; Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Akimoto S, 1998, ENDOCR J, V45, P183, DOI 10.1507/endocrj.45.183; Alaiya AA, 2011, INT J ONCOL, V38, P1047, DOI 10.3892/ijo.2011.937; Anees M, 2011, CANCER-AM CANCER SOC, V117, P1172, DOI 10.1002/cncr.25504; Apakama I, 1996, BRIT J CANCER, V74, P1258, DOI 10.1038/bjc.1996.526; Arora R, 2004, CANCER-AM CANCER SOC, V100, P2362, DOI 10.1002/cncr.20243; Azuma K, 2004, CLIN CANCER RES, V10, P6695, DOI 10.1158/1078-0432.CCR-04-0818; Barres V, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-272; Basu A, 2012, PROSTATE, V72, P597, DOI 10.1002/pros.21463; Bettuzzi S, 2000, CANCER RES, V60, P1472; Bettuzzi S, 2003, CANCER RES, V63, P3469; Bibikova M, 2007, GENOMICS, V89, P666, DOI 10.1016/j.ygeno.2007.02.005; BISCHOFF FR, 1995, EMBO J, V14, P705, DOI 10.1002/j.1460-2075.1995.tb07049.x; Black AR, 2001, J CELL PHYSIOL, V188, P143, DOI 10.1002/jcp.1111; Blobe GC, 2000, NEW ENGL J MED, V342, P1350, DOI 10.1056/NEJM200005043421807; Blume-Jensen P, 2015, CLIN CANCER RES, V21, P2591, DOI 10.1158/1078-0432.CCR-14-2603; Bouraoui Y, 2008, CANCER DETECT PREV, V32, P23, DOI 10.1016/j.cdp.2008.02.007; Bubendorf L, 1999, CANCER RES, V59, P803; Bubendorf L, 1996, AM J PATHOL, V148, P1557; BUTTYAN R, 1987, PROSTATE, V11, P327, DOI 10.1002/pros.2990110405; Campa D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016914; Cardillo MR, 2000, ANAL QUANT CYTOL, V22, P1; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Cazares LH, 2002, CLIN CANCER RES, V8, P2541; Chaux A, 2012, MODERN PATHOL, V25, P1543, DOI 10.1038/modpathol.2012.104; Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2; Chen JJ, 2013, COMPUT MATH METHOD M, V2013, DOI 10.1155/2013/909525; Chetcuti A, 2001, PROSTATE, V47, P132, DOI 10.1002/pros.1056; Chuang HY, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100180; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; COLOMBEL M, 1993, AM J PATHOL, V143, P390; Coppola V, 2010, ENDOCR-RELAT CANCER, V17, pF1, DOI 10.1677/ERC-09-0172; Creighton CJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001816; Cuzick J, 2011, LANCET ONCOL, V12, P245, DOI 10.1016/S1470-2045(10)70295-3; Dallas SL, 2005, J CELL PHYSIOL, V202, P361, DOI 10.1002/jcp.20147; Dang CV, 2012, GENE DEV, V26, P877, DOI 10.1101/gad.189365.112; Davalieva K, 2015, PROSTATE, V75, P1586, DOI 10.1002/pros.23034; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Diamandis EP, 2014, CLIN CHEM LAB MED, V52, P791, DOI 10.1515/cclm-2014-0317; Diamandis EP, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-87; Dijkstra S, 2014, CLIN BIOCHEM, V47, P889, DOI 10.1016/j.clinbiochem.2013.10.023; Ding ZH, 2011, NATURE, V470, P269, DOI 10.1038/nature09677; Djonov V, 1997, PROSTATE, V31, P103; Drachenberg DE, 1999, PROSTATE, V41, P127, DOI 10.1002/(SICI)1097-0045(19991001)41:2<127::AID-PROS7>3.0.CO;2-H; Draisma G, 2009, JNCI-J NATL CANCER I, V101, P374, DOI 10.1093/jnci/djp001; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Ems-McClung SC, 2004, MOL BIOL CELL, V15, P46, DOI 10.1091/mbc.E03-07-0454; Ernst T, 2002, AM J PATHOL, V160, P2169, DOI 10.1016/S0002-9440(10)61165-0; Feng XH, 2000, EMBO J, V19, P5178, DOI 10.1093/emboj/19.19.5178; FLEMING WH, 1986, CANCER RES, V46, P1535; Fukuchi M, 2001, MOL BIOL CELL, V12, P1431, DOI 10.1091/mbc.12.5.1431; Furuta E, 2010, BBA-REV CANCER, V1805, P141, DOI 10.1016/j.bbcan.2010.01.005; George DJ, 2005, CLIN CANCER RES, V11, P1815, DOI 10.1158/1078-0432.CCR-04-1560; Gerdes MJ, 1998, J HISTOCHEM CYTOCHEM, V46, P379, DOI 10.1177/002215549804600312; Glinsky GV, 2004, J CLIN INVEST, V113, P913, DOI 10.1172/JCI200420032; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Gordanpour A, 2012, PROSTATE CANCER P D, V15, P314, DOI 10.1038/pcan.2012.3; Gotoh A, 1997, J UROLOGY, V158, P636, DOI 10.1016/S0022-5347(01)64574-9; Green MML, 2007, INT J RADIAT ONCOL, V67, P84, DOI 10.1016/j.ijrobp.2006.08.077; Gregg JL, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-165; Grover SK, 2015, PATHOL ONCOL RES, V21, P651, DOI 10.1007/s12253-014-9870-y; Gruss OJ, 2004, J CELL BIOL, V166, P949, DOI 10.1083/jcb.200312112; Gurel B, 2008, MODERN PATHOL, V21, P1156, DOI 10.1038/modpathol.2008.111; Harada N, 2008, BIOCHEM BIOPH RES CO, V373, P373, DOI 10.1016/j.bbrc.2008.06.024; Hawksworth D, 2010, PROSTATE CANCER P D, V13, P311, DOI 10.1038/pcan.2010.31; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Hobisch A, 2000, J PATHOL, V191, P239, DOI 10.1002/1096-9896(2000)9999:9999<::AID-PATH633>3.0.CO;2-X; Hoffman RM, 2011, NEW ENGL J MED, V365, P2013, DOI 10.1056/NEJMcp1103642; Hoque MO, 2005, J CLIN ONCOL, V23, P6569, DOI 10.1200/JCO.2005.07.009; Hsiao PW, 1999, J BIOL CHEM, V274, P20229, DOI 10.1074/jbc.274.29.20229; Hu J, 2013, NAT BIOTECHNOL, V31, P522, DOI 10.1038/nbt.2530; Hung KE, 2009, CANCER PREV RES, V2, P224, DOI 10.1158/1940-6207.CAPR-08-0153; Hyytiainen M, 2004, CRIT REV CL LAB SCI, V41, P233, DOI 10.1080/10408360490460933; Jenkins RB, 1997, CANCER RES, V57, P524; Jia PL, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S3-S13; Johnson MI, 1998, PROSTATE, V37, P223, DOI 10.1002/(SICI)1097-0045(19981201)37:4<223::AID-PROS3>3.0.CO;2-O; Kalab P, 2008, J CELL SCI, V121, P1577, DOI 10.1242/jcs.005959; Kanehisa M, 2010, NUCLEIC ACIDS RES, V38, pD355, DOI 10.1093/nar/gkp896; Karnes RJ, 2013, J UROLOGY, V190, P2047, DOI 10.1016/j.juro.2013.06.017; Katayama H, 2008, CELL CYCLE, V7, P2691, DOI 10.4161/cc.7.17.6460; Katayama Hiroshi, 2003, Cancer and Metastasis Reviews, V22, P451, DOI 10.1023/A:1023789416385; Khan AP, 2010, MOL CELL PROTEOMICS, V9, P298, DOI 10.1074/mcp.M900159-MCP200; Kim IY, 1996, CLIN CANCER RES, V2, P1255; Kim IY, 1998, CLIN CANCER RES, V4, P1625; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kiprijanovska Sanja, 2014, Int J Proteomics, V2014, P594761, DOI 10.1155/2014/594761; Knezevic D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-690; Koh Cheryl M, 2010, Genes Cancer, V1, P617, DOI 10.1177/1947601910379132; Kremer CL, 2006, PROSTATE, V66, P1203, DOI 10.1002/pros.20410; Kress TR, 2015, NAT REV CANCER, V15, P593, DOI 10.1038/nrc3984; Kurisetty VV, 2008, ONCOGENE, V27, P7139, DOI 10.1038/onc.2008.325; Lapointe J, 2004, P NATL ACAD SCI USA, V101, P811, DOI 10.1073/pnas.0304146101; Latil A, 2003, CLIN CANCER RES, V9, P5477; LaTulippe E, 2002, CANCER RES, V62, P4499; Lee E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000217; Lee SO, 2003, CLIN CANCER RES, V9, P370; Li P, 2002, AM J PATHOL, V161, P1467, DOI 10.1016/S0002-9440(10)64422-7; Lin BY, 1999, CANCER RES, V59, P4180; Lin JF, 2007, INT J CANCER, V121, P2596, DOI 10.1002/ijc.23016; LIU AJ, 2007, QUANTITATIVE ANAL PA, V8, P853; Liu F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-153; Liu QX, 2013, CANCER RES, V73, P3297, DOI 10.1158/0008-5472.CAN-12-3970; Lotan TL, 2011, CLIN CANCER RES, V17, P6563, DOI 10.1158/1078-0432.CCR-11-1244; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lucas JM, 2014, CANCER DISCOV, V4, P1310, DOI 10.1158/2159-8290.CD-13-1010; Lucas SM, 2012, PROSTATE CANCER, V2012, DOI 10.1155/2012/640968; Lucia MS, 1998, J CELL PHYSIOL, V175, P184, DOI 10.1002/(SICI)1097-4652(199805)175:2<184::AID-JCP8>3.0.CO;2-K; Luo J, 2001, CANCER RES, V61, P4683; Luo JH, 2002, MOL CARCINOGEN, V33, P25, DOI 10.1002/mc.10018; Mack D, 1997, EUR J CANCER, V33, P317, DOI 10.1016/S0959-8049(96)00402-9; Mahapatra S, 2012, CLIN CANCER RES, V18, P2882, DOI 10.1158/1078-0432.CCR-11-2090; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; MCDONNELL TJ, 1992, CANCER RES, V52, P6940; Mechergui YB, 2009, INFLAMMATION, V32, P202, DOI 10.1007/s10753-009-9121-7; Meehan KL, 2002, PROSTATE, V50, P54, DOI 10.1002/pros.10032; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Michaelis M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019705; Michalaki V, 2004, BRIT J CANCER, V90, P2312, DOI 10.1038/sj.bjc.6601814; Moore JD, 2001, BIOESSAYS, V23, P77, DOI 10.1002/1521-1878(200101)23:1<77::AID-BIES1010>3.3.CO;2-5; Mori R, 2010, PROSTATE, V70, P1692, DOI 10.1002/pros.21204; Moul JW, 1996, SURGERY, V120, P159, DOI 10.1016/S0039-6060(96)80283-2; Moyer VA, 2012, ANN INTERN MED, V157, P120, DOI 10.7326/0003-4819-157-2-201207170-00459; Mucci NR, 2000, J NATL CANCER I, V92, P1941, DOI 10.1093/jnci/92.23.1941; Mukherjee R, 2011, BRIT J CANCER, V104, P1920, DOI 10.1038/bjc.2011.163; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Nakashima J, 2000, CLIN CANCER RES, V6, P2702; Neumayer G, 2014, CELL MOL LIFE SCI, V71, P3027, DOI 10.1007/s00018-014-1582-7; Nunez C, 2008, HISTOPATHOLOGY, V53, P166, DOI 10.1111/j.1365-2559.2008.03092.x; Omar EA, 2001, PROSTATE, V49, P191, DOI 10.1002/pros.1134; Ouellet V, 2005, ONCOGENE, V24, P4672, DOI 10.1038/sj.onc.1208214; Ouellet V, 2006, INT J CANCER, V119, P599, DOI 10.1002/ijc.21902; Ozen M, 2008, ONCOGENE, V27, P1788, DOI 10.1038/sj.onc.1210809; Pannu V, 2015, ONCOTARGET, V6, P6076, DOI 10.18632/oncotarget.3475; Park JI, 2003, ONCOGENE, V22, P4314, DOI 10.1038/sj.onc.1206478; Perry KT, 1997, PROSTATE, V33, P133, DOI 10.1002/(SICI)1097-0045(19971001)33:2<133::AID-PROS7>3.0.CO;2-L; Qian DZ, 2009, CLIN CANCER RES, V15, P3135, DOI 10.1158/1078-0432.CCR-08-1982; R Core Team, 2021, R LANGUAGE ENV STAT; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Ravitz MJ, 1997, ADV CANCER RES, V71, P165, DOI 10.1016/S0065-230X(08)60099-8; Reis ST, 2013, CLINICS, V68, P652, DOI 10.6061/clinics/2013(05)12; Remo A, 2016, APPL IMMUNOHISTO M M, V24, P201, DOI 10.1097/PAI.0000000000000171; Revelos K, 2005, IN VIVO, V19, P911; Ricote M, 2004, CANCER-AM CANCER SOC, V100, P1388, DOI 10.1002/cncr.20142; Rigaud J, 2004, PROSTATE, V58, P269, DOI 10.1002/pros.10329; Robey RB, 2015, CARCINOGENESIS, V36, pS203, DOI 10.1093/carcin/bgv037; Royuela M, 1998, GROWTH FACTORS, V16, P101, DOI 10.3109/08977199809002121; Royuela M, 2000, GROWTH FACTORS, V18, P135, DOI 10.3109/08977190009003239; Ruscica M, 2006, ENDOCRINOLOGY, V147, P1466, DOI 10.1210/en.2005-0925; Sanlioglu AD, 2007, J UROLOGY, V177, P359, DOI 10.1016/j.juro.2006.08.087; Sato H, 2006, INT J UROL, V13, P761, DOI 10.1111/j.1442-2042.2006.01399.x; Savli H, 2008, EXP MOL MED, V40, P176, DOI 10.3858/emm.2008.40.2.176; Schroten C, 2012, CANCER IMMUNOL IMMUN, V61, P905, DOI 10.1007/s00262-011-1159-3; Shariat SF, 2004, UROLOGY, V63, P1191, DOI 10.1016/j.urology.2003.12.015; Shariat SF, 2004, CLIN CANCER RES, V10, P1992, DOI 10.1158/1078-0432.CCR-0768-03; Shariat SF, 2001, UROLOGY, V58, P1008, DOI 10.1016/S0090-4295(01)01405-4; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Silk AD, 2009, J CELL BIOL, V184, P677, DOI 10.1083/jcb.200810091; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Song CJ, 2015, PROSTATE, V75, P500, DOI 10.1002/pros.22936; Stamey TA, 2001, J UROLOGY, V166, P2171, DOI 10.1016/S0022-5347(05)65528-0; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tamboli P, 1996, MODERN PATHOL, V9, P1015; Tanenbaum ME, 2009, CURR BIOL, V19, P1703, DOI 10.1016/j.cub.2009.08.027; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Tarca AL, 2013, SPIA SIGNALING PATHW; THOMPSON SJ, 1992, BRIT J UROL, V69, P609, DOI 10.1111/j.1464-410X.1992.tb15632.x; Tian L, 2005, P NATL ACAD SCI USA, V102, P13544, DOI 10.1073/pnas.0506577102; Trieselmann N, 2003, J CELL SCI, V116, P4791, DOI 10.1242/jcs.00798; TRUONG LD, 1993, HUM PATHOL, V24, P4, DOI 10.1016/0046-8177(93)90055-L; TWILLIE DA, 1995, UROLOGY, V45, P542, DOI 10.1016/S0090-4295(99)80034-X; Ueda K, 2013, J PROTEOME RES, V12, P4497, DOI 10.1021/pr400547s; Vaarala MH, 2001, INT J CANCER, V94, P705, DOI 10.1002/ijc.1526; Vainio Paula, 2012, PLoS One, V7, pe39801, DOI 10.1371/journal.pone.0039801; Vainio P, 2011, ONCOTARGET, V2, P1176; Vainio P, 2011, AM J PATHOL, V178, P525, DOI 10.1016/j.ajpath.2010.10.002; Van der Kwast TH, 2014, VIRCHOWS ARCH, V464, P293, DOI 10.1007/s00428-014-1540-7; Varambally S, 2005, CANCER CELL, V8, P393, DOI 10.1016/j.ccr.2005.10.001; Waalkes S, 2010, ONCOL REP, V23, P1257, DOI 10.3892/or_00000758; Wan YZ, 2010, J INTERF CYTOK RES, V30, P677, DOI 10.1089/jir.2009.0117; Wang Y, 2011, COMPUT BIOL CHEM, V35, P151, DOI 10.1016/j.compbiolchem.2011.04.003; Welsh JB, 2001, CANCER RES, V61, P5974; Wiese C, 2001, SCIENCE, V291, P653, DOI 10.1126/science.1057661; Wikstrom P, 1998, PROSTATE, V37, P19, DOI 10.1002/(SICI)1097-0045(19980915)37:1<19::AID-PROS4>3.0.CO;2-3; Wise GJ, 2000, J UROLOGY, V164, P722, DOI 10.1016/S0022-5347(05)67289-8; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Xia F, 2008, CANCER RES, V68, P1826, DOI 10.1158/0008-5472.CAN-07-5279; Xu JC, 2000, CANCER RES, V60, P1677; Xu JF, 2005, CANCER EPIDEM BIOMAR, V14, P2563, DOI 10.1158/1055-9965.EPI-05-0356; Yu YP, 2004, J CLIN ONCOL, V22, P2790, DOI 10.1200/JCO.2004.05.158; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zeng L, 2004, HUM PATHOL, V35, P290, DOI 10.1016/j.humpath.2003.11.001; Zhang MS, 2014, DEV CELL, V31, P393, DOI 10.1016/j.devcel.2014.10.014; Zhang M, 2008, BIOINFORMATICS, V24, P2057, DOI 10.1093/bioinformatics/btn365; Zhang M, 2009, BIOINFORMATICS, V25, P1662, DOI 10.1093/bioinformatics/btp295; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhao HJ, 2007, J CELL PHYSIOL, V210, P111, DOI 10.1002/jcp.20828; Zhong WD, 2008, CLIN INVEST MED, V31, pE8, DOI 10.25011/cim.v31i1.3136	209	28	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145322	10.1371/journal.pone.0145322	http://dx.doi.org/10.1371/journal.pone.0145322			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683658	gold, Green Published, Green Submitted			2022-12-26	WOS:000366725800064
J	Mynhardt, S; Maree, S; Pelser, I; Bennett, NC; Bronner, GN; Wilson, JW; Bloomer, P				Mynhardt, Samantha; Maree, Sarita; Pelser, Illona; Bennett, Nigel C.; Bronner, Gary N.; Wilson, John W.; Bloomer, Paulette			Phylogeography of a Morphologically Cryptic Golden Mole Assemblage from South-Eastern Africa	PLOS ONE			English	Article							CHROMOSOMAL EVOLUTION; SPECIES DELIMITATION; GEOGRAPHIC-VARIATION; GENETIC-DIVERGENCE; MITOCHONDRIAL-DNA; DIVERSITY; SEQUENCES; DIVERSIFICATION; LANDSCAPE; CLIMATE	The Greater Maputaland-Pondoland-Albany (GMPA) region of southern Africa was recently designated as a centre of vertebrate endemism. The phylogeography of the vertebrate taxa occupying this region may provide insights into the evolution of faunal endemism in southeastern Africa. Here we investigate the phylogeographic patterns of an understudied small mammal species assemblage (Amblysomus) endemic to the GMPA, to test for cryptic diversity within the genus, and to better understand diversification across the region. We sampled specimens from 50 sites across the distributional range of Amblysomus, with emphasis on the widespread A. hottentotus, to analyse geographic patterns of genetic diversity using mitochondrial DNA (mtDNA) and nuclear intron data. Molecular dating was used to elucidate the evolutionary and phylogeographic history of Amblysomus. Our phylogenetic reconstructions show that A. hottentotus comprises several distinct lineages, or evolutionarily significant units (ESUs), some with restricted geographic ranges and thus worthy of conservation attention. Divergence of the major lineages dated to the early Pliocene, with later radiations in the GMPA during the late-Pliocene to early-Pleistocene. Evolutionary diversification within Amblysomus may have been driven by uplift of the Great Escarpment c. 5-3 million years ago (Ma), habitat changes associated with intensification of the east-west rainfall gradient across South Africa and the influence of subsequent global climatic cycles. These drivers possibly facilitated geographic spread of ancestral lineages, local adaptation and vicariant isolation. Our study adds to growing empirical evidence identifying East and southern Africa as cradles of vertebrate diversity.	[Mynhardt, Samantha; Maree, Sarita; Pelser, Illona; Bloomer, Paulette] Univ Pretoria, Dept Genet, Mol Ecol & Evolut Programme, ZA-0002 Pretoria, South Africa; [Mynhardt, Samantha; Maree, Sarita; Bennett, Nigel C.; Wilson, John W.] Univ Pretoria, Dept Zool & Entomol, ZA-0002 Pretoria, South Africa; [Bronner, Gary N.] Univ Cape Town, Dept Biol Sci, ZA-7925 Cape Town, South Africa	University of Pretoria; University of Pretoria; University of Cape Town	Bloomer, P (corresponding author), Univ Pretoria, Dept Genet, Mol Ecol & Evolut Programme, ZA-0002 Pretoria, South Africa.	paulette.bloomer@up.ac.za	Mynhardt, Samantha/N-3213-2019; Wilson, John W./E-9601-2011; Bloomer, Paulette/F-5501-2010; Bennett, Nigel/E-4238-2010; Bronner, Gary/E-9107-2010	Mynhardt, Samantha/0000-0001-9276-8700; Wilson, John W./0000-0002-7230-1449; Bloomer, Paulette/0000-0002-6357-0153; Bennett, Nigel/0000-0001-9748-2947; Bronner, Gary/0000-0002-2279-3094	National Research Foundation [46995]; Department of Science and Technology via the National Research Foundation funds the South African Research Chairs Initiative Chair for Mammal Behavioural Ecology and Physiology	National Research Foundation; Department of Science and Technology via the National Research Foundation funds the South African Research Chairs Initiative Chair for Mammal Behavioural Ecology and Physiology	This work was supported by National Research Foundation unique grant number 46995 to PB for running expenses and bursary support; Department of Science and Technology via the National Research Foundation funds the South African Research Chairs Initiative Chair for Mammal Behavioural Ecology and Physiology held by NCB (running costs and PhD scholarship to S. Mynhardt, postdoctoral scholarship to S. Maree); www.nrf.ac.za. This work is based upon research supported by the National Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken N, 2004, MOL ECOL, V13, P1423, DOI 10.1111/j.1365-294X.2004.02159.x; [Anonymous], 2005, TERR VERT SPEC DAT; Asher RJ, 2010, PALAEONTOL ELECTRON, V13; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Bennett N.C., 2000, AFRICAN MOLE RATS EC; Berthier K, 2005, MOL ECOL, V14, P2861, DOI 10.1111/j.1365-294X.2005.02636.x; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Bininda-Emonds ORP, 2007, EVOL BIOINFORM, V3, P59; Bowie RCK, 2006, MOL PHYLOGENET EVOL, V38, P171, DOI 10.1016/j.ympev.2005.06.001; Bronner GN, 2000, MAMMALIA, V64, P41, DOI 10.1515/mamm.2000.64.1.41; Bronner GN, 1996, MAMMALIA, V60, P707, DOI 10.1515/mamm.1996.60.4.707; Bronner GN, 2015, IUCN RED LIST THREAT; Bronner GN, 2005, MAMMAL SPECIES WORLD, P71; Bronner GN, 1995, SYSTEMATIC REVISION; Bronner GN, 2013, MAMMALS AFRICA, P226; Brooks T, 2001, BIOSCIENCE, V51, P613, DOI 10.1641/0006-3568(2001)051[0613:TABFCI]2.0.CO;2; Broom R., 1941, ANN TRANSVAAL MUS, V20, P215; Burgess ND, 2007, BIOL CONSERV, V134, P209, DOI 10.1016/j.biocon.2006.08.015; C.E.P.F. Ecosystem Profile, 2010, EC PROF MAP POND ALB; Carr AS, 2012, SO AFRICAN GEOMORPHO, P269; Castillo JA, 2014, MOL ECOL, V23, P843, DOI 10.1111/mec.12650; Ceccarelli FS, 2014, MOL PHYLOGENET EVOL, V80, P125, DOI 10.1016/j.ympev.2014.07.023; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; Coetzee J. A., 1978, Palaeoecology of Africa; Volume 10, P13; Coulon A, 2006, MOL ECOL, V15, P1669, DOI 10.1111/j.1365-294X.2006.02861.x; Cowling RM, 2009, MOL PHYLOGENET EVOL, V51, P64, DOI 10.1016/j.ympev.2008.05.034; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; DEMENOCAL PB, 1995, SCIENCE, V270, P53, DOI 10.1126/science.270.5233.53; Demos TC, 2014, MOL PHYLOGENET EVOL, V71, P41, DOI 10.1016/j.ympev.2013.10.014; Diedericks G, 2014, MOL PHYLOGENET EVOL, V71, P234, DOI 10.1016/j.ympev.2013.10.015; Donoghue PCJ, 2007, TRENDS ECOL EVOL, V22, P424, DOI 10.1016/j.tree.2007.05.005; Driver A, 2012, SYNTHESIS REPORT; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, TRACER V 1 5; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Dulvy NK, 2009, NATURE, V462, P417, DOI 10.1038/462417a; Ellis J., 2015, IUCN RED LIST 2017 2, pe.T63100A48908629; Ence DD, 2011, MOL ECOL RESOUR, V11, P473, DOI 10.1111/j.1755-0998.2010.02947.x; ESRI, 2011, ARCMAP V 10; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Faulkes CG, 2004, MOL ECOL, V13, P613, DOI 10.1046/j.1365-294X.2004.02099.x; FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fjeldsa J, 1997, BIODIVERS CONSERV, V6, P325, DOI 10.1023/A:1018356506390; Fjeldsa J, 2012, ANNU REV ECOL EVOL S, V43, P249, DOI 10.1146/annurev-ecolsys-102710-145113; Gilbert C, 2008, CYTOGENET GENOME RES, V121, P110, DOI 10.1159/000125836; Gilbert C, 2006, CHROMOSOME RES, V14, P793, DOI 10.1007/s10577-006-1091-0; GLOBE, 1999, TOP MAP AFR BAS GLOB; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Harmse HJ, 1978, BIOGEOGRAPHY ECOLOGY, P71; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HICKMAN GC, 1979, S AFR J ZOOL, V14, P9; Huhndorf MH, 2007, MOL ECOL, V16, P663, DOI 10.1111/j.1365-294X.2007.03153.x; IRWIN DM, 1991, J MOL EVOL, V32, P128, DOI 10.1007/BF02515385; KOCHER TD, 1989, P NATL ACAD SCI USA, V86, P6196, DOI 10.1073/pnas.86.16.6196; LAWES MJ, 1990, J BIOGEOGR, V17, P669, DOI 10.2307/2845148; Linder HP, 2012, J BIOGEOGR, V39, P1189, DOI 10.1111/j.1365-2699.2012.02728.x; Linder HP, 2003, BIOL REV, V78, P597, DOI 10.1017/S1464793103006171; Lohman DJ, 2010, BIOL CONSERV, V143, P1885, DOI 10.1016/j.biocon.2010.04.042; Lorenzen ED, 2012, MOL ECOL, V21, P3656, DOI 10.1111/j.1365-294X.2012.05650.x; Luyt J, 2004, DEV MICROSATEL UNPUB; Lyons LA, 1997, NAT GENET, V15, P47, DOI 10.1038/ng0197-47; Mace GM, 2004, PHILOS T R SOC B, V359, P711, DOI 10.1098/rstb.2003.1454; Maud RR, 2012, SO AFRICAN GEOMORPHO, P7; McCarthy T., 2005, STORY EARTH LIFE SO; Mittermeier Russell A., 2004, P1; Montgelard C, 2012, ACTA OECOL, V42, P50, DOI 10.1016/j.actao.2012.02.001; MORITZ C, 1987, ANNU REV ECOL SYST, V18, P269, DOI 10.1146/annurev.ecolsys.18.1.269; Mucina I., 2006, STRELITZIA, V19; Mucina L., 2006, VEGETATION S AFRICA, P349; Nascimento FF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061924; Nei M., 2000, MOL EVOLUTION PHYLOG; Nicolas V, 2011, J BIOGEOGR, V38, P191, DOI 10.1111/j.1365-2699.2010.02399.x; Olson LE, 2004, BIOL J LINN SOC, V83, P1, DOI 10.1111/j.1095-8312.2004.00366.x; PALUMBI SR, 1994, MOL BIOL EVOL, V11, P426; Parker PG, 1998, ECOLOGY, V79, P361, DOI 10.1890/0012-9658(1998)079[0361:WMCTUA]2.0.CO;2; Partridge T. C., 1997, VEGETATION SO AFRICA, P5; Partridge TC, 2000, OXFORD MGR GEOL GEOP, P3; Perera SJ, 2011, S AFR J SCI, V107, P49, DOI 10.4102/sajs.v107i7/8.462; Pio DV, 2014, GLOBAL CHANGE BIOL, V20, P1538, DOI 10.1111/gcb.12524; Porat N, 2008, QUATERNARY SCI REV, V27, P1024, DOI 10.1016/j.quascirev.2008.01.017; Rambaut A, 2006, FIGTREE V1 4 2; Roberts A., 1951, MAMMALS S AFRICA; Roberts Austin, 1946, ANN TRANSVAAL MUS, V20, P303; Sambrook J., 2006, COMMONLY USED TECHNI, DOI 10.1101/pdb.prot4455; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seiffert ER, 2010, ACTA PAL POL; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Steenkamp Y., 2004, HOTSPOTS REVISITED E; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TEMPLETON AR, 1992, GENETICS, V132, P619; Tolley KA, 2010, AFR J HERPETOL, V59, P17, DOI 10.1080/04416651003744943; Tyson PD, 2000, OXFORD MGR GEOL GEOP, P371; van Wyk AE., 2001, REGIONS FLORISTIC EN; Venta PJ, 1996, BIOCHEM GENET, V34, P321, DOI 10.1007/BF02399951; Voje KL, 2009, MOL ECOL, V18, P93, DOI 10.1111/j.1365-294X.2008.04002.x; Vrba ES, 2000, OXFORD MGR GEOL GEOP, P277; Waples R. S., 1991, DEFINITION SPECIES E; White F., 1978, Monographiae Biologicae, V31, P463; WILLOWS-MUNRO s, 2008, MOL EVOLUTION AFRICA; Willows-Munro S, 2011, J BIOGEOGR, V38, P1976, DOI 10.1111/j.1365-2699.2011.02543.x; YANG ZB, 1994, J MOL EVOL, V39, P105; YANG ZH, 1994, J MOL EVOL, V39, P306, DOI 10.1007/BF00160154; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107; Zou FH, 2007, MOL PHYLOGENET EVOL, V44, P165, DOI 10.1016/j.ympev.2006.12.004	106	12	13	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144995	10.1371/journal.pone.0144995	http://dx.doi.org/10.1371/journal.pone.0144995			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683828	Green Published, Green Submitted, gold			2022-12-26	WOS:000366725800029
J	Smilg, JS; Berger, LR				Smilg, Jacqueline S.; Berger, Lee R.			Discovering Hominins - Application of Medical Computed Tomography (CT) to Fossil-Bearing Rocks from the Site of Malapa, South Africa	PLOS ONE			English	Article							TOOTH ENAMEL THICKNESS; BONE DISTRIBUTION; CORTICAL BONE; MORPHOLOGY; PALEOANTHROPOLOGY; COMMUNICATION; VALIDATION; FEATURES; CRANIUM; BRAIN	In the South African context, computed tomography (CT) has been used applied to individually prepared fossils and small rocks containing fossils, but has not been utilized on large breccia blocks as a means of discovering fossils, and particularly fossil hominins. Previous attempts at CT imaging of rocks from other South African sites for this purpose yielded disappointing results. For this study, 109 fossil-bearing rocks from the site of Malapa, South Africa were scanned with medical CT prior to manual preparation. The resultant images were assessed for accuracy of fossil identification and characterization against the standard of manual preparation. The accurate identification of fossils, including those of early hominins, that were not visible on the surface of individual blocks, is shown to be possible. The discovery of unexpected fossils is reduced, thus lowering the potential that fossils could be damaged through accidental encounter during routine preparation, or even entirely missed. This study should significantly change the way fossil discovery, recovery and preparation is done in the South African context and has potential for application in other palaeontological situations. Medical CT imaging is shown to be reliable, readily available, cost effective and accurate in finding fossils within matrix conglomerates. Improvements in CT equipment and in CT image quality are such that medical CT is now a viable imaging modality for this palaeontological application.	[Smilg, Jacqueline S.] Charlotte Maxeke Johannesburg Acad Hosp, Dept Diagnost Radiol, Johannesburg, South Africa; [Smilg, Jacqueline S.; Berger, Lee R.] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [Berger, Lee R.] Univ Witwatersrand, Natl Res Fdn, Ctr Excellence Palaeosci, Dept Sci & Technol, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand; National Research Foundation - South Africa; University of Witwatersrand	Smilg, JS (corresponding author), Charlotte Maxeke Johannesburg Acad Hosp, Dept Diagnost Radiol, Johannesburg, South Africa.	jsmilg@yahoo.com	Berger, Lee Rogers/AAC-3484-2020	Berger, Lee Rogers/0000-0002-0367-7629				Adcock D, 2002, DIGITAL IMAGING; Badawi-Fayad J, 2005, SURG RADIOL ANAT, V27, P536, DOI 10.1007/s00276-005-0041-4; Balzeau A, 2005, J HUM EVOL, V48, P535, DOI 10.1016/j.jhevol.2005.01.002; Balzeau A, 2010, CR PALEVOL, V9, P265, DOI 10.1016/j.crpv.2010.07.006; Barrett JF, 2004, RADIOGRAPHICS, V24, P1679, DOI 10.1148/rg.246045065; Berger L.R., 2005, HIST MAKULEKA CONCES; Bolliger SA, 2012, RADIOGRAPHICS, V32, P1553, DOI 10.1148/rg.325115742; Bruhl, 1896, ARCH ANAT PHYSL 547, P547; Carpenter K, 2001, J PALEONTOLOGICAL SC, V07, P1; Coleman MN, 2007, AM J PHYS ANTHROPOL, V133, P723, DOI 10.1002/ajpa.20583; CONROY G C, 1991, Palaeontologia Africana, V28, P53; CONROY GC, 1984, SCIENCE, V226, P456, DOI 10.1126/science.226.4673.456; CONROY GC, 1990, SCIENCE, V247, P838, DOI 10.1126/science.2305255; Conroy GC, 1998, SCIENCE, V280, P1730, DOI 10.1126/science.280.5370.1730; Croker SL, 2009, HOMO, V60, P551, DOI 10.1016/j.jchb.2009.07.003; Cunningham JA, 2014, TRENDS ECOL EVOL, V29, P347, DOI 10.1016/j.tree.2014.04.004; DAEGLING DJ, 1991, AM J PHYS ANTHROPOL, V86, P321, DOI 10.1002/ajpa.1330860302; Daniels R, 2011, TECHNLOGIES USED INV; Dirks PHGM, 2010, SCIENCE, V328, P205, DOI 10.1126/science.1184950; du Plessis A, 2013, J ARCHAEOL SCI, V40, P4607, DOI 10.1016/j.jas.2013.07.024; Fairdough I, 2010, CT SCANS OFFER NEW W; Falk D, 2005, SCIENCE, V308, P242, DOI 10.1126/science.1109727; Falk D, 2007, AM J PHYS ANTHROPOL, V134, P529, DOI 10.1002/ajpa.20697; Galik K, 2004, SCIENCE, V305, P1450, DOI 10.1126/science.1098807; GRINE F E, 1991, Palaeontologia Africana, V28, P61; Grine FE, 2004, S AFR J SCI, V100, P389; HAUBITZ B, 1988, PALEOBIOLOGY, V14, P206, DOI 10.1017/S0094837300011921; Hoffmann R, 2014, BIOGEOSCIENCES, V11, P2721, DOI 10.5194/bg-11-2721-2014; Hohenstein P, 2004, BRIT J RADIOL, V77, P420, DOI 10.1259/bjr/27832269; HOUNDFIELD GN, 1973, BRIT J RADIOL, V46, P1016, DOI 10.1259/0007-1285-46-552-1016; JUNGERS WL, 1979, AM J PHYS ANTHROPOL, V50, P285, DOI 10.1002/ajpa.1330500219; Ketcham RA, 2001, COMPUT GEOSCI-UK, V27, P381, DOI 10.1016/S0098-3004(00)00116-3; Kimpe T, 2007, J DIGIT IMAGING, V20, P422, DOI 10.1007/s10278-006-1052-3; Lemoine M, 1896, CR HEBD ACAD SCI, V123, P764; MANZI G, 2001, RIV ANTROPOL, V79, P61; McLean D, 2001, RADIAT PHYS CHEM, V61, P723, DOI 10.1016/S0969-806X(01)00387-5; Ohman JC, 1997, AM J PHYS ANTHROPOL, V104, P117, DOI 10.1002/(SICI)1096-8644(199709)104:1<117::AID-AJPA8>3.0.CO;2-O; Olejniczak AJ, 2005, S AFR J SCI, V101, P219; PEYTON RL, 1992, GEODERMA, V53, P329, DOI 10.1016/0016-7061(92)90062-C; Plotino G, 2006, J AM DENT ASSOC, V137, P1555, DOI 10.14219/jada.archive.2006.0091; Prossinger Hermann, 2003, Anatomical Record, V273B, P132, DOI 10.1002/ar.b.10022; Rahman Imran A., 2012, Evolution Education and Outreach, V5, P635; RICHTSMEIER JT, 1995, CLEFT PALATE-CRAN J, V32, P217, DOI 10.1597/1545-1569(1995)032<0217:PRAVOT>2.3.CO;2; Ruff Christopher B., 1994, Yearbook of Physical Anthropology, V37, P65; Schoenemann PT, 2007, AM J PHYS ANTHROPOL, V132, P183, DOI 10.1002/ajpa.20499; Schwartz GT, 1996, AM J PHYS ANTHROPOL, V99, P613; Schwartz GT, 1998, J HUM EVOL, V35, P523, DOI 10.1006/jhev.1998.0239; Selden P., 2011, EVOLUTION FOSSIL ECO; Smilg JS, 2010, SHANGH WORLD EXP SEM; SPOOR CF, 1993, AM J PHYS ANTHROPOL, V91, P469, DOI 10.1002/ajpa.1330910405; Spoor CF, 1993, THESIS; SPOOR F, 1994, NATURE, V369, P645, DOI 10.1038/369645a0; SPOOR F, 1995, J ANAT, V186, P271; Spoor Fred, 1994, Courier Forschungsinstitut Senckenberg, V171, P251; Stewart K, 2009, FAMOUS FOSSIL LUCY S; UNESCO, 2012, WORLD HER LIST; VANNIER MW, 1985, AM J PHYS ANTHROPOL, V67, P299, DOI 10.1002/ajpa.1330670402; Weber GW, 2011, VIRTUAL ANTHROPOLOGY: GUIDE TO A NEW INTERDISCIPLINARY FIELD, P1, DOI 10.1007/978-3-211-49347-2; Willis Paul M.A., 1995, Memoir of the Association of Australasian Palaeontologists, V18, P203; Wu XJ, 2008, CHINESE SCI BULL, V53, P2513, DOI 10.1007/s11434-008-0263-z; Wu XJ, 2009, PROG NAT SCI, V19, P913, DOI 10.1016/j.pnsc.2008.10.009; Zatz LM, 1981, TECHNICAL ASPECTS CO, P3853; Zollikofer C.P.E., 2005, VIRTUAL RECONSTRUCTI	63	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145340	10.1371/journal.pone.0145340	http://dx.doi.org/10.1371/journal.pone.0145340			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684299	Green Published, gold, Green Submitted			2022-12-26	WOS:000366725800068
J	Wang, HP; Zhang, YJ; Zhang, ZL; Mahadevan, S; Deng, Y				Wang, Hongping; Zhang, Yajuan; Zhang, Zili; Mahadevan, Sankaran; Deng, Yong			Physarum Spreader: A New Bio-Inspired Methodology for Identifying Influential Spreaders in Complex Networks	PLOS ONE			English	Article							NODE CENTRALITY; IDENTIFICATION; ALGORITHM	Identifying influential spreaders in networks, which contributes to optimizing the use of available resources and efficient spreading of information, is of great theoretical significance and practical value. A random-walk-based algorithm LeaderRank has been shown as an effective and efficient method in recognizing leaders in social network, which even outperforms the well-known PageRank method. As LeaderRank is initially developed for binary directed networks, further extensions should be studied in weighted networks. In this paper, a generalized algorithm PhysarumSpreader is proposed by combining LeaderRank with a positive feedback mechanism inspired from an amoeboid organism called Physarum Polycephalum. By taking edge weights into consideration and adding the positive feedback mechanism, PhysarumSpreader is applicable in both directed and undirected networks with weights. By taking two real networks for examples, the effectiveness of the proposed method is demonstrated by comparing with other standard centrality measures.	[Wang, Hongping; Zhang, Yajuan; Zhang, Zili; Deng, Yong] Southwest Univ, Sch Comp & Informat Sci, Chongqing, Peoples R China; [Zhang, Zili] Deakin Univ, Sch Informat Technol, Geelong, Vic 3217, Australia; [Mahadevan, Sankaran] Vanderbilt Univ, Civil & Environm Engn Dept, Nashville, TN 37235 USA	Southwest University - China; Deakin University; Vanderbilt University	Deng, Y (corresponding author), Southwest Univ, Sch Comp & Informat Sci, Chongqing, Peoples R China.	ydeng@swu.edu.cn	Wang, Hongping/ABA-6158-2020; Deng, Yong/A-9193-2015	Wang, Hongping/0000-0002-3413-0597; Deng, Yong/0000-0001-9286-2123	National Natural Science Foundation of China [61174022, 61573290, 61503237]; Specialized Research Fund for the Doctoral Program of Higher Education [20131102130002]; R&D Program of China [2012BAH07B01]; National High Technology Research and Development Program of China (863 Program) [2013AA013801]; China State Key Laboratory of Virtual Reality Technology and Systems, Beihang University [BUAA-VR-14KF-02]; General Research Program of the Science - Sichuan Provincial Department of Education [14ZB0322]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); R&D Program of China; National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); China State Key Laboratory of Virtual Reality Technology and Systems, Beihang University; General Research Program of the Science - Sichuan Provincial Department of Education	The work is partially supported by National Natural Science Foundation of China (Grant Nos. 61174022, 61573290, 61503237), Specialized Research Fund for the Doctoral Program of Higher Education (Grant No. 20131102130002), R&D Program of China (2012BAH07B01), National High Technology Research and Development Program of China (863 Program) (Grant No. 2013AA013801), China State Key Laboratory of Virtual Reality Technology and Systems, Beihang University (Grant No. BUAA-VR-14KF-02), the General Research Program of the Science Supported by Sichuan Provincial Department of Education (Grant No. 14ZB0322).; The authors greatly appreciate the reviews' suggestions and the editor's encouragement. The work is partially supported by National High Technology Research and Development Program of China (863 Program) (Grant No. 2013AA013801), National Natural Science Foundation of China (Grant Nos. 61174022, 61573290, 61503237), China State Key Laboratory of Virtual Reality Technology and Systems, Beihang University (Grant No. BUAA-VR-14KF-02).	[Anonymous], 2012, J INFORM COMPUTATION; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Baumgarten W, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/2/026003; Baumgarten W, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.046113; Bonacich P, 2001, SOC NETWORKS, V23, P191, DOI 10.1016/S0378-8733(01)00038-7; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Brin S, 1998, COMPUT NETWORKS ISDN, V30, P107, DOI 10.1016/S0169-7552(98)00110-X; Chen DB, 2012, PHYSICA A, V391, P1777, DOI 10.1016/j.physa.2011.09.017; Colizza V, 2007, NAT PHYS, V3, P276, DOI 10.1038/nphys560; Deng XY, 2014, EXPERT SYST APPL, V41, P156, DOI 10.1016/j.eswa.2013.07.018; Deng Y, 2015, MATH PROBL ENG, V2015, DOI 10.1155/2015/878024; Deng Y, 2015, APPL INTELL, V43, P530, DOI 10.1007/s10489-015-0661-2; Dijkstra E. W., 1959, NUMERISCHE MATH, V1, P269, DOI [DOI 10.1007/BF01386390, 10.1007/BF01386390]; Douceur JR, 2002, LECT NOTES COMPUT SC, V2429, P251, DOI 10.1007/3-540-45748-8_24; Du YX, 2014, PHYSICA A, V399, P57, DOI 10.1016/j.physa.2013.12.031; Estrada E, 2010, PHYSICA A, V389, P3648, DOI 10.1016/j.physa.2010.03.030; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; FREEMAN LC, 1991, SOC NETWORKS, V13, P141, DOI 10.1016/0378-8733(91)90017-N; Gao C, 2013, PHYSICA A, V392, P5490, DOI 10.1016/j.physa.2013.06.059; Jiang W, 2015, J INTELL FUZZY SYST, V28, P2343, DOI 10.3233/IFS-151639; Katz L., 1953, PSYCHOMETRIKA, V18, P39, DOI [DOI 10.1007/BF02289026, 10.1007/BF02289026]; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Kolaczyk ED, 2009, SOC NETWORKS, V31, P190, DOI 10.1016/j.socnet.2009.02.003; Landherr A, 2010, BUS INFORM SYST ENG+, V2, P371, DOI 10.1007/s12599-010-0127-3; Li Q, 2014, PHYSICA A, V404, P47, DOI 10.1016/j.physa.2014.02.041; Lu LY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021202; Miyaji T., 2008, INT J PURE APPL MATH, V47, P353; Nakagaki T, 2000, NATURE, V407, P470, DOI 10.1038/35035159; Nakagaki T, 2001, BIOPHYS CHEM, V92, P47, DOI 10.1016/S0301-4622(01)00179-X; Nakagaki T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.068104; Newman MEJ, 2005, SOC NETWORKS, V27, P39, DOI 10.1016/j.socnet.2004.11.009; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Opsahl T, 2010, SOC NETWORKS, V32, P245, DOI 10.1016/j.socnet.2010.03.006; Pathak PH, 2012, COMPUT COMMUN, V35, P1074, DOI 10.1016/j.comcom.2012.01.023; Pei S, 2014, SCI REP-UK, V4, DOI 10.1038/srep05547; Pei S, 2013, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2013/12/P12002; Qi XQ, 2012, INFORM SCIENCES, V194, P240, DOI 10.1016/j.ins.2011.12.027; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Su XY, 2015, RISK ANAL, V35, P1296, DOI 10.1111/risa.12347; Tero A, 2006, PHYSICA A, V363, P115, DOI 10.1016/j.physa.2006.01.053; Tero A, 2007, J THEOR BIOL, V244, P553, DOI 10.1016/j.jtbi.2006.07.015; Tero A, 2010, SCIENCE, V327, P439, DOI 10.1126/science.1177894; Wang FH, 2011, J TRANSP GEOGR, V19, P285, DOI 10.1016/j.jtrangeo.2010.01.004; Wang GX, 2008, PROG NAT SCI-MATER, V18, P1043, DOI 10.1016/j.pnsc.2008.03.015; WANG H, 2014, MEDIAT INFLAMM, DOI DOI 10.1155/2014/; Wang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106132; Wang P, 2014, IEEE T BIOMED CIRC S, V8, P87, DOI 10.1109/TBCAS.2014.2303160; Watanabe S, 2011, BIOSYSTEMS, V105, P225, DOI 10.1016/j.biosystems.2011.05.001; Wei DJ, 2013, PHYSICA A, V392, P2564, DOI 10.1016/j.physa.2013.01.054; Yan G, 2005, CHINESE PHYS LETT, V22, P510, DOI 10.1088/0256-307X/22/2/068; Yang R, 2007, PHYS LETT A, V364, P189, DOI 10.1016/j.physleta.2006.12.021; Yong Deng, 2015, Mathematical Problems in Engineering, V2015, DOI 10.1155/2015/212794; Zhang H, 2011, J BIOMED INFORM, V44, P830, DOI 10.1016/j.jbi.2011.05.001; Zhang YJ, 2011, CHIN CONT DECIS CONF, P1440, DOI 10.1109/CCDC.2011.5968418; Zhou T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020648; Zio E, 2011, RISK ANAL, V31, P1196, DOI 10.1111/j.1539-6924.2011.01584.x	57	2	2	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145028	10.1371/journal.pone.0145028	http://dx.doi.org/10.1371/journal.pone.0145028			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684194	Green Published, Green Submitted, gold			2022-12-26	WOS:000366725800031
J	Jatulan, EO; Rabajante, JF; Banaay, CGB; Fajardo, AC; Jose, EC				Jatulan, Eduardo O.; Rabajante, Jomar F.; Banaay, Charina Gracia B.; Fajardo, Alejandro C., Jr.; Jose, Editha C.			A Mathematical Model of Intra-Colony Spread of American Foulbrood in European Honeybees (Apis mellifera L.)	PLOS ONE			English	Article							LARVAE SUBSP LARVAE; PAENIBACILLUS-LARVAE; BEES	American foulbrood (AFB) is one of the severe infectious diseases of European honeybees (Apis mellifera L.) and other Apis species. This disease is caused by a gram-positive, spore-forming bacterium Paenibacillus larvae. In this paper, a compartmental (SI framework) model is constructed to represent the spread of AFB within a colony. The model is analyzed to determine the long-term fate of the colony once exposed to AFB spores. It was found out that without effective and efficient treatment, AFB infection eventually leads to colony collapse. Furthermore, infection thresholds were predicted based on the stability of the equilibrium states. The number of infected cell combs is one of the factors that drive disease spread. Our results can be used to forecast the transmission timeline of AFB infection and to evaluate the control strategies for minimizing a possible epidemic.	[Jatulan, Eduardo O.; Rabajante, Jomar F.; Jose, Editha C.] Univ Philippines Los Banos, Inst Math Sci & Phys, Laguna, Philippines; [Banaay, Charina Gracia B.; Fajardo, Alejandro C., Jr.] Univ Philippines Los Banos, Inst Biol Sci, Laguna, Philippines; [Jatulan, Eduardo O.; Rabajante, Jomar F.; Banaay, Charina Gracia B.; Fajardo, Alejandro C., Jr.; Jose, Editha C.] Univ Philippines Los Banos, UPLB Bee Program, Laguna, Philippines	University of the Philippines System; University of the Philippines Los Banos; University of the Philippines System; University of the Philippines Los Banos; University of the Philippines System; University of the Philippines Los Banos	Jatulan, EO (corresponding author), Univ Philippines Los Banos, Inst Math Sci & Phys, Laguna, Philippines.	eojatulan@up.edu.ph	Rabajante, Jomar Fajardo/K-3502-2014; Jatulan, Eduardo/ABF-5206-2021; Banaay, Charina Gracia B./AAA-6985-2020	Rabajante, Jomar Fajardo/0000-0002-0655-0893; Jatulan, Eduardo/0000-0003-3558-0757				Alvarado I, 2013, J BACTERIOL, V195, P1005, DOI 10.1128/JB.01958-12; Cervancia C. R., 2013, Philippine Entomologist, V27, P75; Datta S, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0650; Fries I, 2001, APIDOLOGIE, V32, P199, DOI 10.1051/apido:2001122; Fries I, 2006, VET MICROBIOL, V114, P269, DOI 10.1016/j.vetmic.2005.11.068; Gavina M, 2014, B MATH BIOL, V76, P997, DOI 10.1007/s11538-014-9943-9; Genersch E, 2006, INT J SYST EVOL MICR, V56, P501, DOI 10.1099/ijs.0.63928-0; Genersch E, 2010, J INVERTEBR PATHOL, V103, pS10, DOI 10.1016/j.jip.2009.06.015; GOODWIN RM, 1994, J APICULT RES, V33, P209, DOI 10.1080/00218839.1994.11100873; Hansen H, 1999, BEE WORLD, V80, P5, DOI 10.1080/0005772X.1999.11099415; Khoury DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018491; Neuendorf S, 2004, MICROBIOL-SGM, V150, P2381, DOI 10.1099/mic.0.27125-0; Perko L, 2001, DIFFER EQUAT DYN SYS; Sastry S., 1999, NONLINEAR SYSTEM ANA; von der Ohe W., 2003, APIACTA, V38, P137	15	9	10	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0143805	10.1371/journal.pone.0143805	http://dx.doi.org/10.1371/journal.pone.0143805			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674357	gold, Green Published, Green Submitted			2022-12-26	WOS:000366722700015
J	Murayama, Y; Yoshioka, M; Okada, H; Takata, E; Masujin, K; Iwamaru, Y; Shimozaki, N; Yamamura, T; Yokoyama, T; Mohri, S; Tsutsumi, Y				Murayama, Yuichi; Yoshioka, Miyako; Okada, Hiroyuki; Takata, Eri; Masujin, Kentaro; Iwamaru, Yoshifumi; Shimozaki, Noriko; Yamamura, Tomoaki; Yokoyama, Takashi; Mohri, Shirou; Tsutsumi, Yuji			Subcritical Water Hydrolysis Effectively Reduces the In Vitro Seeding Activity of PrPSc but Fails to Inactivate the Infectivity of Bovine Spongiform Encephalopathy Prions	PLOS ONE			English	Article							MISFOLDING CYCLIC AMPLIFICATION; SUPERCRITICAL WATER; ORGANIC-ACIDS; AMINO-ACIDS; PROTEIN; MEAT; REPLICATION; DISEASE; AGENTS	The global outbreak of bovine spongiform encephalopathy (BSE) has been attributed to the recycling of contaminated meat and bone meals (MBMs) as feed supplements. The use of MBMs has been prohibited in many countries; however, the development of a method for inactivating BSE prions could enable the efficient and safe use of these products as an organic resource. Subcritical water (SCW), which is water heated under pressure to maintain a liquid state at temperatures below the critical temperature (374 degrees C), exhibits strong hydrolytic activity against organic compounds. In this study, we examined the residual in vitro seeding activity of protease-resistant prion protein (PrPSc) and the infectivity of BSE prions after SCW treatments. Spinal cord homogenates prepared from BSE-infected cows were treated with SCW at 230-280 degrees C for 5-7.5 min and used to intracerebrally inoculate transgenic mice overexpressing bovine prion protein. Serial protein misfolding cyclic amplification (sPMCA) analysis detected no PrPSc in the SCW-treated homogenates, and the mice treated with these samples survived for more than 700 days without any signs of disease. However, sPMCA analyses detected PrPSc accumulation in the brains of all inoculated mice. Furthermore, secondary passage mice, which inoculated with brain homogenates derived from a western blotting (WB)-positive primary passage mouse, died after an average of 240 days, similar to mice inoculated with untreated BSE-infected spinal cord homogenates. The PrPSc accumulation and vacuolation typically observed in the brains of BSE-infected mice were confirmed in these secondary passage mice, suggesting that the BSE prions maintained their infectivity after SCW treatment. One late-onset case, as well as asymptomatic but sPMCA-positive cases, were also recognized in secondary passage mice inoculated with brain homogenates from WB-negative but sPMCA-positive primary passage mice. These results indicated that SCW-mediated hydrolysis was insufficient to eliminate the infectivity of BSE prions under the conditions tested.	[Murayama, Yuichi; Yoshioka, Miyako; Okada, Hiroyuki; Masujin, Kentaro; Iwamaru, Yoshifumi; Shimozaki, Noriko; Yamamura, Tomoaki; Yokoyama, Takashi; Mohri, Shirou] Natl Inst Anim Hlth, Influenza Prion Dis Res Ctr, Tsukuba, Ibaraki 305, Japan; [Yoshioka, Miyako] Natl Inst Anim Hlth, Res Area Pathol & Pathophysiol, Tsukuba, Ibaraki 305, Japan; [Takata, Eri; Tsutsumi, Yuji] Kyushu Univ, Fac Agr, Dept Agroenvironm Sci, Fukuoka, Fukuoka, Japan; [Takata, Eri] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 305, Japan; [Mohri, Shirou] Tohoku Univ, Grad Sch Med, Dept Neurol Sci, Sendai, Miyagi 980, Japan	National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; National Agriculture & Food Research Organization - Japan; National Institute of Animal Health - Japan; Kyushu University; Forestry & Forest Products Research Institute - Japan; Tohoku University	Murayama, Y (corresponding author), Natl Inst Anim Hlth, Influenza Prion Dis Res Ctr, Tsukuba, Ibaraki 305, Japan.	ymura@affrc.go.jp	Mohri, Shirou/AAK-1281-2020		BSE and other Prion Disease Control Project; Recycling of Bovine Meat and Bone Meal and Inactivation of BSE prion by Sub-critical Water Treatment of the Ministry of Agriculture, Forestry and Fisheries of Japan	BSE and other Prion Disease Control Project; Recycling of Bovine Meat and Bone Meal and Inactivation of BSE prion by Sub-critical Water Treatment of the Ministry of Agriculture, Forestry and Fisheries of Japan	This study was supported by a Grant-in-Aid from the BSE and other Prion Disease Control Project (YM, no grant number) and Recycling of Bovine Meat and Bone Meal and Inactivation of BSE prion by Sub-critical Water Treatment (YT, no grant number) of the Ministry of Agriculture, Forestry and Fisheries of Japan (http://www.maff.go.jp/e/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmoez W, 2013, INT J CHEM REACT ENG, V11, P369, DOI 10.1515/ijcre-2013-0017; de Vos CJ, 2009, RISK ANAL, V29, P541, DOI 10.1111/j.1539-6924.2008.01177.x; Doherr MG, 2007, VACCINE, V25, P5619, DOI 10.1016/j.vaccine.2006.10.059; Fukuda S, 2012, JPN J INFECT DIS, V65, P37; Giles K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000206; Goto M, 1999, IND ENG CHEM RES, V38, P1863, DOI 10.1021/ie980479s; Hayashi HK, 2005, BIOCHEM BIOPH RES CO, V328, P1024, DOI 10.1016/j.bbrc.2005.01.065; Hill AF, 2000, P NATL ACAD SCI USA, V97, P10248, DOI 10.1073/pnas.97.18.10248; Johnson CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019836; Kabyemela BM, 1999, IND ENG CHEM RES, V38, P2888, DOI 10.1021/ie9806390; Khuwijitjaru P, 2004, CHEM ENG J, V99, P1, DOI 10.1016/j.cej.2003.08.002; Liang X., 2013, J MAT SCI CHEM ENG, V1, P1, DOI [DOI 10.4236/MSCE.2013.15001, 10.4236/msce.2013.15001]; Matsuura Y, 2013, BIOCHEM BIOPH RES CO, V432, P86, DOI 10.1016/j.bbrc.2013.01.081; McLeod AH, 2004, BIOCHEM BIOPH RES CO, V317, P1165, DOI 10.1016/j.bbrc.2004.03.168; Mekonnen TH, 2015, J CHEM TECHNOL BIOT, V90, P476, DOI 10.1002/jctb.4333; Murayama Y, 2006, BIOCHEM BIOPH RES CO, V348, P758, DOI 10.1016/j.bbrc.2006.07.130; Murayama Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013152; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Race R, 1998, NATURE, V392, P770, DOI 10.1038/33834; Race R, 2001, J VIROL, V75, P10106, DOI 10.1128/JVI.75.21.10106-10112.2001; Race RE, 2004, J VIROL, V78, P2164, DOI 10.1128/JVI.78.4.2164-2165.2004; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Sakudo A, 2011, INT J MOL MED, V27, P483, DOI 10.3892/ijmm.2011.605; Scott MR, 1997, P NATL ACAD SCI USA, V94, P14279, DOI 10.1073/pnas.94.26.14279; Shimizu Y, 2010, MICROBIOL IMMUNOL, V54, P112, DOI 10.1111/j.1348-0421.2009.00190.x; Suyama K, 2007, BIOSCI BIOTECH BIOCH, V71, P2069, DOI 10.1271/bbb.70085; Suyama K, 2007, BIOCHEM BIOPH RES CO, V356, P245, DOI 10.1016/j.bbrc.2007.02.113; Tavakoli O, 2008, SCI TOTAL ENVIRON, V398, P175, DOI 10.1016/j.scitotenv.2008.03.019; Taylor DM, 2001, CONTRIB MICROBIOL, V7, P58; Taylor DM, 2000, VET J, V159, P10, DOI 10.1053/tvjl.1999.0406; Wahyudiono, 2013, ENG J-THAIL, V17, P1, DOI 10.4186/ej.2013.17.1.1; WELLS GAH, 1987, VET REC, V121, P419, DOI 10.1136/vr.121.18.419; Yoshida H, 2004, J CHEM ENG JPN, V37, P253, DOI 10.1252/jcej.37.253; Yoshida H, 1999, BIOTECHNOL PROGR, V15, P1090, DOI 10.1021/bp9900920; Yoshida H, 2007, WASTE REFINERY SUBCR; Yoshioka M, 2007, J APPL MICROBIOL, V102, P509, DOI 10.1111/j.165-2672.2006.03080.x; Yoshioka M, 2007, BIOSCI BIOTECH BIOCH, V71, P2565, DOI 10.1271/bbb.70257; Yoshioka M, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-134; Yoshioka M, 2011, MICROBIOL IMMUNOL, V55, P331, DOI 10.1111/j.1348-0421.2011.00328.x	39	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144761	10.1371/journal.pone.0144761	http://dx.doi.org/10.1371/journal.pone.0144761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675475	Green Submitted, Green Published, gold			2022-12-26	WOS:000366722700060
J	Petta, S; Marrone, O; Torres, D; Buttacavoli, M; Camma, C; Di Marco, V; Licata, A; Lo Bue, A; Parrinello, G; Pinto, A; Salvaggio, A; Tuttolomondo, A; Craxi, A; Bonsignore, MR				Petta, Salvatore; Marrone, Oreste; Torres, Daniele; Buttacavoli, Maria; Camma, Calogero; Di Marco, Vito; Licata, Anna; Lo Bue, Anna; Parrinello, Gaspare; Pinto, Antonio; Salvaggio, Adriana; Tuttolomondo, Antonino; Craxi, Antonio; Bonsignore, Maria Rosaria			Obstructive Sleep Apnea Is Associated with Liver Damage and Atherosclerosis in Patients with Non-Alcoholic Fatty Liver Disease	PLOS ONE			English	Article							CHRONIC INTERMITTENT HYPOXIA; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; OBESE-PATIENTS; CAROTID-BODY; RISK-FACTORS; STEATOHEPATITIS; SEVERITY; HISTOLOGY; INJURY	Background/Aims We assessed whether obstructive sleep apnea (OSA) and nocturnal hypoxemia are associated with severity of liver fibrosis and carotid atherosclerosis in patients with biopsy-proven NAFLD and low prevalence of morbid obesity. Secondary aim was to explore the association of OSA and hypoxemia with NASH and severity of liver pathological changes. Methods Consecutive patients (n = 126) with chronically elevated ALT and NAFLD underwent STOP-BANG questionnaire to estimate OSA risk and ultrasonographic carotid assessment. In patients accepting to perform cardiorespiratory polygraphy (PG, n = 50), OSA was defined as an apnea/hypopnea index >= 5. A carotid atherosclerotic plaque was defined as a focal thickening > 1.3 mm. Results Prevalence of high OSA risk was similar in patients refusing or accepting PG (76% vs 68%, p = 0.17). Among those accepting PG, overall OSA prevalence was significantly higher in patients with F2-F4 fibrosis compared to those without (72% vs 44%; p = 0.04). Significant fibrosis was independently associated with mean nocturnal oxygen saturation (SaO(2))<95% (OR 3.21, 95%C.I. 1.02-7.34; p = 0.04). Prevalence of OSA tended to be higher in patients with, than in those without, carotid plaques (64% vs 40%; p = 0.08). Carotid plaques were independently associated with % time at SaO2<90% > 1 (OR 6.30, 95% C. I. 1.02-12.3; p = 0.01). Conclusions In NAFLD patients with chronically elevated ALT at low prevalence of morbid obesity, OSA was highly prevalent and indexes of SaO(2) resulted independently associated with severity of liver fibrosis and carotid atherosclerosis. These data suggest to consider sleep disordered breathing as a potential additional therapeutic target in severe NAFLD patients.	[Petta, Salvatore; Camma, Calogero; Di Marco, Vito; Licata, Anna; Craxi, Antonio] Univ Palermo, DiBiMIS, Sez Gastroenterol & Epatol, Palermo, Italy; [Marrone, Oreste; Lo Bue, Anna; Salvaggio, Adriana] CNR, Inst Biomed & Mol Immunol, Palermo, Italy; [Torres, Daniele; Parrinello, Gaspare; Pinto, Antonio; Tuttolomondo, Antonino] Univ Palermo, DiBiMIS, Sez Med Interna, Palermo, Italy; [Buttacavoli, Maria; Bonsignore, Maria Rosaria] Univ Palermo, DiBiMIS, Sez Malattie Cardio Resp & Endocrino Metabol, Palermo, Italy	University of Palermo; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biomedicina e di Immunologia Molecolare "Alberto Monroy" (IBIM-CNR); University of Palermo; University of Palermo	Petta, S (corresponding author), Univ Palermo, DiBiMIS, Sez Gastroenterol & Epatol, Palermo, Italy.	petsa@inwind.it	Marrone, Oreste/ABB-6945-2020; Di Marco, Vito/AAC-4612-2022; Bonsignore, Maria/U-6440-2017	Marrone, Oreste/0000-0001-6819-7928; Bonsignore, Maria/0000-0002-4875-7796; Pinto, Antonio/0000-0002-8083-3699	PRIN [2010C4JJWB_001]	PRIN(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN))	This study was funded by grants from the PRIN 2010-2011 (Prot. N. 2010C4JJWB_001).; This study was funded by grants from the PRIN 2010-2011 (Prot. N. 2010C4JJWB_001). The authors are grateful to Mr Fabio Artisi, who was recipient of some of the funds for this research, for technical help for polygraphic recordings.	Abdelmalek MF, 2010, HEPATOLOGY, V51, P1961, DOI 10.1002/hep.23535; Ali SS, 2014, SLEEP MED REV, V18, P379, DOI 10.1016/j.smrv.2014.01.004; Amer Diabet Assoc, 2014, DIABETES CARE, V37, pS14, DOI 10.2337/dc14-S014; [Anonymous], 1992, SAS TECHNICAL REPORT; Argo CK, 2009, J HEPATOL, V51, P371, DOI 10.1016/j.jhep.2009.03.019; Aron-Wisnewsky J, 2012, J HEPATOL, V56, P225, DOI 10.1016/j.jhep.2011.04.022; Baguet JP, 2005, CHEST, V128, P3407, DOI 10.1378/chest.128.5.3407; Bedogni G, 2005, HEPATOLOGY, V42, P44, DOI 10.1002/hep.20734; Buttacavoli M, 2016, ULTRASOUND MED BIOL, V42, P104, DOI 10.1016/j.ultrasmedbio.2015.08.009; Campos GM, 2008, HEPATOLOGY, V47, P1916, DOI 10.1002/hep.22241; Chesson Jr A. L., 2007, THE AASM MANUAL FOR; Chou TC, 2015, SLEEP MED, V16, P955, DOI 10.1016/j.sleep.2015.02.542; Chung F, 2012, BRIT J ANAESTH, V108, P768, DOI 10.1093/bja/aes022; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Colloredo G, 2003, J HEPATOL, V39, P239, DOI 10.1016/S0168-8278(03)00191-0; Conde SV, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00418; Corey KE, 2015, DIGEST DIS SCI, V60, P2523, DOI 10.1007/s10620-015-3650-8; Daltro C, 2010, OBES SURG, V20, P1536, DOI 10.1007/s11695-010-0212-1; Dongiovanni P, 2013, CURR PHARM DESIGN, V19, P5219, DOI 10.2174/13816128113199990381; Epstein LJ, 2009, J CLIN SLEEP MED, V5, P263; Fracanzani AL, 2008, HEPATOLOGY, V48, P792, DOI 10.1002/hep.22429; Fracanzani AL, 2008, AM J MED, V121, P72, DOI 10.1016/j.amjmed.2007.08.041; Gunnarsson SI, 2014, ARTERIOSCL THROM VAS, V34, P2338, DOI 10.1161/ATVBAHA.114.303965; Jablonski KL, 2013, NUTR METAB CARDIOVAS, V23, P792, DOI 10.1016/j.numecd.2012.12.006; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Jouet P, 2007, OBES SURG, V17, P478, DOI 10.1007/s11695-007-9085-3; Kallivitz ER, 2007, J CLIN GASTROENTEROL, V41, P918, DOI 10.1097/01.mcg.0000225692.62121.55; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Lin QC, 2015, SLEEP BREATH, V19, P273, DOI 10.1007/s11325-014-1008-7; Marchesini G, 2003, HEPATOLOGY, V37, P917, DOI 10.1053/jhep.2003.50161; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Mishra P, 2008, LIVER INT, V28, P1080, DOI 10.1111/j.1478-3231.2008.01822.x; Nobili V, 2015, THORAX, V70, P769, DOI 10.1136/thoraxjnl-2015-206782; Nobili V, 2014, AM J RESP CRIT CARE, V189, P66, DOI 10.1164/rccm.201307-1339OC; Petta S, 2011, ALIMENT PHARM THER, V34, P757, DOI 10.1111/j.1365-2036.2011.04788.x; Petta S, 2010, CURR PHARM DESIGN, V16, P741, DOI 10.2174/138161210790883787; Petta S, 2009, DIGEST LIVER DIS, V41, P615, DOI 10.1016/j.dld.2009.01.004; Petta S, 2015, J HEPATOL, V62, P928, DOI 10.1016/j.jhep.2014.11.030; Petta S, 2011, DIGEST LIVER DIS, V43, P404, DOI 10.1016/j.dld.2010.12.013; Polotsky VY, 2009, AM J RESP CRIT CARE, V179, P228, DOI 10.1164/rccm.200804-608OC; Pulixi EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096349; Qi JC, 2015, SLEEP BREATH; Savransky V, 2008, CIRC RES, V103, P1173, DOI 10.1161/CIRCRESAHA.108.178533; Savransky V, 2007, AM J PHYSIOL-GASTR L, V293, pG871, DOI 10.1152/ajpgi.00145.2007; Savransky V, 2007, HEPATOLOGY, V45, P1007, DOI 10.1002/hep.21593; Savransky V, 2009, EXP PHYSIOL, V94, P228, DOI 10.1113/expphysiol.2008.044883; Singh H, 2005, DIGEST DIS SCI, V50, P2338, DOI 10.1007/s10620-005-3058-y; Sundaram SS, 2014, J PEDIATR-US, V164, P699, DOI 10.1016/j.jpeds.2013.10.072; Suzuki T, 2004, SLEEP, V27, P129, DOI 10.1093/sleep/27.1.129; Tanne F, 2005, HEPATOLOGY, V41, P1290, DOI 10.1002/hep.20725; Targher G, 2008, DIABETOLOGIA, V51, P444, DOI 10.1007/s00125-007-0897-4; Targher G, 2010, NEW ENGL J MED, V363, P1341, DOI 10.1056/NEJMra0912063; van der Poorten D, 2008, HEPATOLOGY, V48, P449, DOI 10.1002/hep.22350	54	31	34	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0142210	10.1371/journal.pone.0142210	http://dx.doi.org/10.1371/journal.pone.0142210			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26672595	Green Published, gold, Green Submitted			2022-12-26	WOS:000366722700004
J	Ghosh, C; Manjunath, GB; Konai, MM; Uppu, DSSM; Hoque, J; Paramanandham, K; Shome, BR; Haldar, J				Ghosh, Chandradhish; Manjunath, Goutham B.; Konai, Mohini M.; Uppu, Divakara S. S. M.; Hoque, Jiaul; Paramanandham, Krishnamoorthy; Shome, Bibek R.; Haldar, Jayanta			Aryl-Alkyl-Lysines: Agents That Kill Planktonic Cells, Persister Cells, Biofilms of MRSA and Protect Mice from Skin-Infection	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; COMBAT BACTERIAL-RESISTANCE; ANTIMICROBIAL PEPTIDES; ANTIBACTERIAL ACTIVITY; SMALL MOLECULES; ERADICATE BIOFILMS; BARRIER FUNCTION; CYSTIC-FIBROSIS; HOST-DEFENSE; MEMBRANE	Development of synthetic strategies to combat Staphylococcal infections, especially those caused by methicillin resistant Staphyloccus aureus (MRSA), needs immediate attention. In this manuscript we report the ability of aryl-alkyl-lysines, simple membrane active small molecules, to treat infections caused by planktonic cells, persister cells and biofilms of MRSA. A representative compound, NCK-10, did not induce development of resistance in planktonic cells in multiple passages and retained activity in varying environments of pH and salinity. At low concentrations the compound was able to depolarize and permeabilize the membranes of S. aureus persister cells rapidly. Treatment with the compound not only eradicated pre-formed MRSA biofilms, but also brought down viable counts in bacterial biofilms. In a murine model of MRSA skin infection, the compound was more effective than fusidic acid in bringing down the bacterial burden. Overall, this class of molecules bears potential as antibacterial agents against skin-infections.	[Ghosh, Chandradhish; Manjunath, Goutham B.; Konai, Mohini M.; Uppu, Divakara S. S. M.; Hoque, Jiaul; Haldar, Jayanta] Jawaharlal Nehru Ctr Adv Sci Res, New Chem Unit, Chem Biol & Med Chem Lab, Bengaluru 560064, Karnataka, India; [Paramanandham, Krishnamoorthy; Shome, Bibek R.] Natl Inst Vet Epidemiol & Dis Informat NIVEDI Ram, Yelahanka, Bengaluru 560064, Karnataka, India	Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Council of Agricultural Research (ICAR); ICAR - National Institute of Veterinary Epidemiology & Disease Informatics	Haldar, J (corresponding author), Jawaharlal Nehru Ctr Adv Sci Res, New Chem Unit, Chem Biol & Med Chem Lab, Bengaluru 560064, Karnataka, India.	jayanta@jncasr.ac.in	Uppu, Divakara SSM/U-1848-2019	Uppu, Divakara SSM/0000-0002-7271-9538; Shome, Bibek/0000-0003-4741-7076; PARAMANANDHAM, KRISHNAMOORTHY/0000-0001-7495-1333	grant "Ramanujan Fellowship" from the Department of Science and Technology (DST), Govt. of India [SR/S2/RJN-43/2009]	grant "Ramanujan Fellowship" from the Department of Science and Technology (DST), Govt. of India	This work was supported by the grant "Ramanujan Fellowship" [SR/S2/RJN-43/2009] from the Department of Science and Technology (DST), Govt. of India.	Barraud N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084220; Bayer AS, 2013, ANN NY ACAD SCI, V1277, P139, DOI 10.1111/j.1749-6632.2012.06819.x; Bremner JB, 2010, ANGEW CHEM INT EDIT, V49, P537, DOI 10.1002/anie.200904392; Chen CM, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-98; Chen X, 2011, APPL ENVIRON MICROB, V77, P4878, DOI 10.1128/AEM.02440-10; Chiller K, 2001, J INVEST DERM SYMP P, V6, P170, DOI 10.1046/j.0022-202x.2001.00043.x; Friedrich C, 1999, ANTIMICROB AGENTS CH, V43, P1542, DOI 10.1128/AAC.43.7.1542; Ghosh C, 2015, CHEMMEDCHEM, V10, P1606, DOI 10.1002/cmdc.201500299; Ghosh C, 2014, J MED CHEM, V57, P1428, DOI 10.1021/jm401680a; Goldfeder Y, 2010, ANTIMICROB AGENTS CH, V54, P2590, DOI 10.1128/AAC.01656-09; Goldman MJ, 1997, CELL, V88, P553, DOI 10.1016/S0092-8674(00)81895-4; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Haug BE, 2008, J MED CHEM, V51, P4306, DOI 10.1021/jm701600a; Hoque J, 2015, CHEM COMMUN, V51, P13670, DOI 10.1039/c5cc05159b; Hoque J, 2015, J MED CHEM, V58, P5486, DOI 10.1021/acs.jmedchem.5b00443; Hu YM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011818; Hurdle JG, 2011, NAT REV MICROBIOL, V9, P62, DOI 10.1038/nrmicro2474; Huynh KK, 2007, MICROBIOL MOL BIOL R, V71, P452, DOI 10.1128/MMBR.00003-07; Isaksson J, 2011, J MED CHEM, V54, P5786, DOI 10.1021/jm200450h; Jantsch J, 2015, CELL METAB, V21, P493, DOI 10.1016/j.cmet.2015.02.003; Keren I, 2004, FEMS MICROBIOL LETT, V230, P13, DOI 10.1016/S0378-1097(03)00856-5; Kim JS, 2011, ANTIMICROB AGENTS CH, V55, P5380, DOI 10.1128/AAC.00708-11; Koh JJ, 2015, J MED CHEM, V58, P739, DOI 10.1021/jm501285x; Konai MM, 2015, BIOCONJUGATE CHEM, V26, P2442, DOI 10.1021/acs.bioconjchem.5b00494; Konai MM, 2014, J MED CHEM, V57, P9409, DOI 10.1021/jm5013566; Kumar K, 2013, J ANTIMICROB CHEMOTH, V68, P1465, DOI 10.1093/jac/dkt045; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Lundberg CV, 2013, INT J ANTIMICROB AG, V42, P272, DOI 10.1016/j.ijantimicag.2013.05.008; Mascio CTM, 2007, ANTIMICROB AGENTS CH, V51, P4255, DOI 10.1128/AAC.00824-07; Mensa B, 2014, ANTIMICROB AGENTS CH, V58, P5136, DOI 10.1128/AAC.02955-14; Mohamed MF, 2014, DRUG DES DEV THER, V8, P1979, DOI 10.2147/DDDT.S72129; Nardis C, 2013, Ann Ig, V25, P443, DOI 10.7416/ai.2013.1946; Ooi N, 2010, J ANTIMICROB CHEMOTH, V65, P72, DOI 10.1093/jac/dkp409; Pan JC, 2013, BIOORG MED CHEM LETT, V23, P4648, DOI 10.1016/j.bmcl.2013.06.011; Patel JB, 2009, CLIN INFECT DIS, V49, P935, DOI 10.1086/605495; Pezzulo AA, 2012, NATURE, V487, P109, DOI 10.1038/nature11130; Roche ED, 2012, ANTIMICROB AGENTS CH, V56, P4508, DOI 10.1128/AAC.00467-12; Savage VJ, 2013, ANTIMICROB AGENTS CH, V57, P1968, DOI 10.1128/AAC.02008-12; Schmid-Wendtner MH, 2006, SKIN PHARMACOL PHYS, V19, P296, DOI 10.1159/000094670; Schmidt NW, 2014, ACS NANO, V8, P8786, DOI 10.1021/nn502201a; Siberry GK, 2003, CLIN INFECT DIS, V37, P1257, DOI 10.1086/377501; Thati Venubabu, 2011, Indian J Med Res, V134, P704, DOI 10.4103/0971-5916.91001; Uppu DSSM, 2016, BIOMATERIALS, V74, P131, DOI 10.1016/j.biomaterials.2015.09.042; Wilson P, 2003, J ANTIMICROB CHEMOTH, V51, P186, DOI 10.1093/jac/dkg104; Yarlagadda V, 2015, INT J ANTIMICROB AG, V45, P627, DOI 10.1016/j.ijantimicag.2015.02.013; Yarlagadda V, 2014, J MED CHEM, V57, P4558, DOI 10.1021/jm500270w	46	30	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144094	10.1371/journal.pone.0144094	http://dx.doi.org/10.1371/journal.pone.0144094			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26669634	Green Published, Green Submitted, gold			2022-12-26	WOS:000366719300004
J	Lim, Y; Han, SW; Yoon, JH; Lee, JM; Lee, JM; Paeng, JC; Won, JK; Kang, GH; Jeong, SY; Park, KJ; Lee, KH; Kim, JH; Kim, TY				Lim, Yoojoo; Han, Sae-Won; Yoon, Jeong Hee; Lee, Jeong Min; Lee, Jung Min; Paeng, Jin Chul; Won, Jae-Kyung; Kang, Gyeong Hoon; Jeong, Seung-Yong; Park, Kyu Joo; Lee, Kyung-Hun; Kim, Jee Hyun; Kim, Tae-You			Clinical Implication of Anti-Angiogenic Effect of Regorafenib in Metastatic Colorectal Cancer	PLOS ONE			English	Article							RESPONSE EVALUATION CRITERIA; RENAL-CELL CARCINOMA; PHASE-3 TRIAL; LUNG-CANCER; HEPATOCELLULAR-CARCINOMA; COMPUTED-TOMOGRAPHY; TARGETED THERAPY; TUMOR CAVITATION; MODIFIED RECIST; BAY 73-4506	Background Regorafenib induces distinct radiological changes that represent its anti-angiogenic effect. However, clinical implication of the changes is unclear. Methods Tumor attenuation as measured by Hounsfield units (HU) in contrast-enhanced computed tomography (CT) and cavitary changes of lung metastases were analyzed in association with treatment outcome of metastatic colorectal cancer patients (N = 80) treated with regorafenib in a prospective study. Results 141 lesions in 72 patients were analyzed with HU. After 2 cycles of regorafenib, 87.5% of patients showed decrease of HU (Median change -23.9%, range -61.5%-20.7%). Lesional attenuation change was modestly associated with metabolic changes of 18-fluoro-deoxyglucose positron emission tomography-CT (Pearson's r = 0.37, p = 0.002). Among 53 patients with lung metastases, 17 (32.1%) developed cavitary changes. There were no differences in disease control rate, progression-free survival, or overall survival according to the radiological changes. At the time of progressive disease (PD) according to RECIST 1.1, HU was lower than baseline in 86.0% (43/50) and cavitary change of lung metastasis persisted without refilling in 84.6% (11/13). Conclusion Regorafenib showed prominent anti-angiogenic effect in colorectal cancer, but the changes were not associated with treatment outcome. However, the anti-angiogenic effects persisted at the time of PD, which suggests that we may need to develop new treatment strategies.	[Lim, Yoojoo; Han, Sae-Won; Lee, Kyung-Hun; Kim, Tae-You] Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea; [Han, Sae-Won; Kim, Tae-You] Seoul Natl Univ, Coll Med, Canc Res Inst, Seoul, South Korea; [Yoon, Jeong Hee; Lee, Jeong Min] Seoul Natl Univ Hosp, Dept Radiol, Seoul 110744, South Korea; [Lee, Jung Min; Paeng, Jin Chul] Seoul Natl Univ Hosp, Dept Nucl Med, Seoul 110744, South Korea; [Won, Jae-Kyung; Kang, Gyeong Hoon] Seoul Natl Univ Hosp, Dept Pathol, Seoul 110744, South Korea; [Jeong, Seung-Yong; Park, Kyu Joo] Seoul Natl Univ Hosp, Dept Surg, Seoul 110744, South Korea; [Kim, Jee Hyun] Seoul Natl Univ, Bundang Hosp, Dept Internal Med, Songnam, Geyonggi Do, South Korea; [Kim, Tae-You] Seoul Natl Univ, Grad Sch Convergence Sci & Technol, Dept Mol Med & Biopharmaceut Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kim, TY (corresponding author), Seoul Natl Univ Hosp, Dept Internal Med, Seoul 110744, South Korea.	kimty@snu.ac.kr	Kang, Gyeong Hoon/F-1051-2010; Lee, Jeong Min/V-3429-2019; Yoon, Jeong Hee/ABA-5127-2021	Kang, Gyeong Hoon/0000-0003-2380-6675; Lee, Jeong Min/0000-0003-0561-8777; Yoon, Jeong Hee/0000-0002-9925-9973; Won, Jae-Kyung/0000-0003-1459-8093; Lim, Yoojoo/0000-0002-4181-2916	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI); Ministry of Health & Welfare, Republic of Korea [HI14C1277]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health & Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI, http://www.khidi.or.kr), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1277), to TYK. Regorafenib was provided by Bayer Pharma AG (http://pharma.bayer.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Elkacem L, 2013, MOL CANCER THER, V12, P1322, DOI 10.1158/1535-7163.MCT-12-1162; Bennouna J, 2013, LANCET ONCOL, V14, P29, DOI 10.1016/S1470-2045(12)70477-1; Choi H, 2007, J CLIN ONCOL, V25, P1753, DOI 10.1200/JCO.2006.07.3049; Chun YS, 2009, JAMA-J AM MED ASSOC, V302, P2338, DOI 10.1001/jama.2009.1755; Crabb SJ, 2009, J CLIN ONCOL, V27, P404, DOI 10.1200/JCO.2008.16.2545; Cyran CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076009; Demetri GD, 2013, LANCET, V381, P295, DOI 10.1016/S0140-6736(12)61857-1; Edeline J, 2012, CANCER-AM CANCER SOC, V118, P147, DOI 10.1002/cncr.26255; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Jeffers M, 2013, ASCO M S, V31, P381; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; Lenz HJ, 2013, ASCO M, V31, P3514; Li J, 2015, LANCET ONCOL, V16, P619, DOI 10.1016/S1470-2045(15)70156-7; Marom EM, 2008, J THORAC ONCOL, V3, P351, DOI 10.1097/JTO.0b013e318168c7e9; Nishino M, 2012, CANCER IMAGING, V12, P225, DOI 10.1102/1470-7330.2012.0027; O'Connor JPB, 2012, CLIN CANCER RES, V18, P6588, DOI 10.1158/1078-0432.CCR-12-1501; Ricotta R, 2013, LANCET, V381, P1537, DOI 10.1016/S0140-6736(13)60976-9; Schmieder R, 2014, INT J CANCER, V135, P1487, DOI 10.1002/ijc.28669; Shinagare AB, 2014, EUR J CANCER, V50, P981, DOI 10.1016/j.ejca.2013.11.037; Smith AD, 2010, AM J ROENTGENOL, V194, P1470, DOI 10.2214/AJR.09.3456; Smith AD, 2010, AM J ROENTGENOL, V194, P157, DOI 10.2214/AJR.09.2941; Strumberg D, 2012, BRIT J CANCER, V106, P1722, DOI 10.1038/bjc.2012.153; Wilhelm SM, 2011, INT J CANCER, V129, P245, DOI 10.1002/ijc.25864	24	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145004	10.1371/journal.pone.0145004	http://dx.doi.org/10.1371/journal.pone.0145004			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671465	Green Published, gold, Green Submitted			2022-12-26	WOS:000366719300038
J	Bueno-Silva, B; Kawamoto, D; Ando-Suguimoto, ES; Alencar, SM; Rosalen, PL; Mayer, MPA				Bueno-Silva, Bruno; Kawamoto, Dione; Ando-Suguimoto, Ellen S.; Alencar, Severino M.; Rosalen, Pedro L.; Mayer, Marcia P. A.			Brazilian Red Propolis Attenuates Inflammatory Signaling Cascade in LPS-Activated Macrophages	PLOS ONE			English	Article							NF-KAPPA-B; CHEMICAL-COMPOSITION; CYTOKINE PRODUCTION; ETHANOL EXTRACTS; INTERFERON-GAMMA; BOTANICAL ORIGIN; DOWN-REGULATION; GREEN PROPOLIS; IN-VITRO; PROTEIN	Although previous studies suggested an anti-inflammatory property of Brazilian red propolis (BRP), the mechanisms involved in the anti-inflammatory effects of BRP and its activity on macrophages were still not elucidated. This study aimed to evaluate whether BRP attenuates the inflammatory effect of LPS on macrophages and to investigate its underlying mechanisms. BRP was added to RAW 264.7 murine macrophages after activation with LPS. NO production, cell viability, cytokines profile were evaluated. Activation of inflammatory signaling pathways and macrophage polarization were determined by RT-qPCR and Western blot. BRP at 50 mu g/ml inhibited NO production by 78% without affecting cell viability. Cd80 and Cd86 were upregulated whereas mrc1 was down regulated by BRP indicating macrophage polarization at M1. BRP attenuated the production of pro-inflammatory mediators IL-12, GM-CSF, IFN-gamma, IL-1 beta in cell supernatants although levels of TNF-alpha and IL-6 were slightly increased after BRP treatment. Levels of IL-4, IL-10 and TGF-beta were also reduced by BRP. BRP significantly reduced the up-regulation promoted by LPS of transcription of genes in inflammatory signaling (Pdk1, Pak1, Nfkb1, Mtcp1, Gsk3b, Fos and Elk1) and of Il1 beta and Il1f9 (fold-change rate >5), which were further confirmed by the inhibition of NF-kappa B and MAPK signaling pathways. Furthermore, the upstream adaptor MyD88 adaptor-like (Mal), also known as TIRAP, involved in TLR2 and TLR4 signaling, was down-regulated in BRP treated LPS-activated macrophages. Given that BRP inhibited multiple signaling pathways in macrophages involved in the inflammatory process activated by LPS, our data indicated that BRP is a noteworthy food-source for the discovery of new bioactive compounds and a potential candidate to attenuate exhacerbated inflammatory diseases.	[Bueno-Silva, Bruno; Kawamoto, Dione; Ando-Suguimoto, Ellen S.; Mayer, Marcia P. A.] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, SP, Brazil; [Alencar, Severino M.] ESALQ USP, Coll Agr Luiz de Queiroz, Piracicaba, SP, Brazil; [Rosalen, Pedro L.] Univ Campinas UNICAMP, Piracicaba Dent Sch, Dept Physiol Sci, Piracicaba, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas	Mayer, MPA (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, SP, Brazil.	mpamayer@icb.usp.br	Rosalen, Pedro Luiz/I-3718-2012; Bueno-Silva, Bruno/J-3097-2012; Alencar, Severino Matias/B-7743-2012; Mayer, Marcia/D-4645-2012	Rosalen, Pedro Luiz/0000-0003-0812-4027; Bueno-Silva, Bruno/0000-0003-3275-5910; Alencar, Severino Matias/0000-0002-6637-7973; Mayer, Marcia/0000-0002-5910-8433; Kawamoto, Dione/0000-0002-6702-7000	Sao Paulo Research Foundation (FAPESP) [2012/14323-3, 2012/01500-4]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Grant #2012/14323-3 and Grant #2012/01500-4 from Sao Paulo Research Foundation (FAPESP). URL: http://www.fapesp.br/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando-Suguimoto ES, 2014, CYTOKINE, V66, P46, DOI 10.1016/j.cyto.2013.12.014; Bandara M, 2010, IMMUNOL CELL BIOL, V88, P727, DOI 10.1038/icb.2010.26; Barberis L, 2008, THROMB HAEMOSTASIS, V99, P279, DOI 10.1160/TH07-10-0632; Bernard NJ, 2013, IUBMB LIFE, V65, P777, DOI 10.1002/iub.1201; Besnard A, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00035; Bonham KS, 2014, CELL, V156, P705, DOI 10.1016/j.cell.2014.01.019; Bueno-Silva B, 2013, BIOFOULING, V29, P1233, DOI 10.1080/08927014.2013.834050; Bueno-Silva B, 2013, J AGR FOOD CHEM, V61, P4546, DOI 10.1021/jf305468f; Burgermeister E, 2007, MOL CELL BIOL, V27, P803, DOI 10.1128/MCB.00601-06; Burkly LC, 2011, CYTOKINE, V56, P109, DOI 10.1016/j.cyto.2011.07.425; BUTCHER C, 1994, J IMMUNOL, V153, P701; Chan ED, 2001, INFECT IMMUN, V69, P2001, DOI 10.1128/IAI.69.4.2001-2010.2001; Cragg GM, 2013, BBA-GEN SUBJECTS, V1830, P3670, DOI 10.1016/j.bbagen.2013.02.008; da Cunha MG, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/256287; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; Davoodi J, 2010, INT J BIOCHEM CELL B, V42, P958, DOI 10.1016/j.biocel.2010.02.008; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Epelman S, 2014, IMMUNITY, V41, P21, DOI 10.1016/j.immuni.2014.06.013; Fialka I, 1996, J CELL BIOL, V132, P1115, DOI 10.1083/jcb.132.6.1115; Foster AM, 2014, J IMMUNOL, V192, P6053, DOI 10.4049/jimmunol.1301481; Franchin M, 2012, J ETHNOPHARMACOL, V143, P709, DOI 10.1016/j.jep.2012.07.040; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Gresnigt MS, 2013, SEMIN IMMUNOL, V25, P458, DOI 10.1016/j.smim.2013.11.003; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Gupta Charu, 2014, J Complement Integr Med, V11, P151; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; HEWETT SJ, 1993, NEUROSCI LETT, V164, P229, DOI 10.1016/0304-3940(93)90898-U; Hodgkinson CP, 2008, ARTERIOSCL THROM VAS, V28, P2275, DOI 10.1161/ATVBAHA.108.175992; Inui S, 2014, NAT PROD RES, V28, P1293, DOI 10.1080/14786419.2014.898146; Ishihara M, 2009, ONCOL REP, V22, P349, DOI 10.3892/or_00000444; Italiani P, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00514; Janssens S, 2002, CURR BIOL, V12, P467, DOI 10.1016/S0960-9822(02)00712-1; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kelley SL, 2013, J IMMUNOL, V190, P1304, DOI 10.4049/jimmunol.1202446; Kim DI, 2012, J CLIN IMMUNOL, V32, P340, DOI 10.1007/s10875-011-9628-1; Kim S, 2011, BIOCHEM PHARMACOL, V81, P1343, DOI 10.1016/j.bcp.2011.03.012; Labonte AC, 2014, MOL CELLS, V37, P275, DOI 10.14348/molcells.2014.2374; Laine J, 2002, J BIOL CHEM, V277, P3743, DOI 10.1074/jbc.M107069200; Lee SM, 2011, INFLAMM RES, V60, P807, DOI 10.1007/s00011-011-0336-3; Lepri SR, 2014, HUM CELL, V27, P78, DOI 10.1007/s13577-012-0051-6; Lima LDC, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-177; Lopez BGC, 2014, FOOD CHEM, V146, P174, DOI 10.1016/j.foodchem.2013.09.063; Machado J. L, 2012, EVID-BASED COMPL ALT, V2012, P10, DOI [10.1155/2012/157652, DOI 10.1155/2012/157652]; Mackova A, 2013, NAT PROD COMMUN, V8, P1509; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Matsumoto H, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-68; Miranda MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125101; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nakayama M, 2000, J EXP MED, V192, P1373, DOI 10.1084/jem.192.9.1373; Okabe Y, 2014, CELL, V157, P832, DOI 10.1016/j.cell.2014.04.016; Oldoni TLC, 2011, SEP PURIF TECHNOL, V77, P208, DOI 10.1016/j.seppur.2010.12.007; Park YK, 2002, J AGR FOOD CHEM, V50, P2502, DOI 10.1021/jf011432b; Paulino N, 2008, EUR J PHARMACOL, V587, P296, DOI 10.1016/j.ejphar.2008.02.067; Paulino N, 2006, PLANTA MED, V72, P899, DOI 10.1055/s-2006-947185; Qiu CL, 2014, CELL PHYSIOL BIOCHEM, V33, P784, DOI 10.1159/000358652; Rankin CT, 2000, NAT GENET, V24, P262, DOI 10.1038/73472; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Saravanan S, 2014, EUR J PHARM SCI, V56, P70, DOI 10.1016/j.ejps.2014.02.005; Sathaliyawala T, 2010, IMMUNITY, V33, P597, DOI 10.1016/j.immuni.2010.09.012; Silva BB, 2008, EVID-BASED COMPL ALT, V5, P313, DOI 10.1093/ecam/nem059; Smolen JS, 2014, ANN RHEUM DIS, V73, P1616, DOI 10.1136/annrheumdis-2013-205137; St-Denis A, 1998, J BIOL CHEM, V273, P32787, DOI 10.1074/jbc.273.49.32787; Stein RC, 2001, ENDOCR-RELAT CANCER, V8, P237, DOI 10.1677/erc.0.0080237; Takeda K, 2004, SEMIN IMMUNOL, V16, P3, DOI 10.1016/j.smim.2003.10.003; Tang Y, 1998, P NATL ACAD SCI USA, V95, P5139, DOI 10.1073/pnas.95.9.5139; Wei Q, 2005, J BIOL CHEM, V280, P18081, DOI 10.1074/jbc.M413607200; Wiley SR, 2003, CYTOKINE GROWTH F R, V14, P241, DOI 10.1016/S1359-6101(03)00019-4; Williams LM, 2004, IMMUNOLOGY, V113, P281, DOI 10.1111/j.1365-2567.2004.01988.x; Wu SQ, 2002, BLOOD, V100, P4454, DOI 10.1182/blood-2002-02-0415	69	46	47	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144954	10.1371/journal.pone.0144954	http://dx.doi.org/10.1371/journal.pone.0144954			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660901	gold, Green Published, Green Submitted			2022-12-26	WOS:000366715900155
J	Candelaria, NR; Weldon, R; Muthusamy, S; Nguyen-Vu, T; Addanki, S; Yoffou, PH; Karaboga, H; Blessing, AM; Bollu, LR; Miranda, RC; Lin, CY				Candelaria, Nicholes R.; Weldon, Ryan; Muthusamy, Selvaraj; Trang Nguyen-Vu; Addanki, Sridevi; Yoffou, Paule-Helena; Karaboga, Husna; Blessing, Alicia M.; Bollu, Lakshmi Reddy; Miranda, Rajesh C.; Lin, Chin-Yo			Alcohol Regulates Genes that Are Associated with Response to Endocrine Therapy and Attenuates the Actions of Tamoxifen in Breast Cancer Cells	PLOS ONE			English	Article							ESTROGEN-RECEPTOR; PREMENOPAUSAL WOMEN; TUMOR PROGRESSION; RISK-FACTORS; IN-VITRO; CONSUMPTION; EXPRESSION; ERK1/2; TRANSCRIPTION; TRANSDUCTION	Hereditary, hormonal, and behavioral factors contribute to the development of breast cancer. Alcohol consumption is a modifiable behavior that is linked to increased breast cancer risks and is associated with the development of hormone-dependent breast cancers as well as disease progression and recurrence following endocrine treatment. In this study we examined the molecular mechanisms of action of alcohol by applying molecular, genetic, and genomic approaches in characterizing its effects on estrogen receptor (ER)-positive breast cancer cells. Treatments with alcohol promoted cell proliferation, increased growth factor signaling, and up-regulated the transcription of the ER target gene GREB1 but not the canonical target TFF1/pS2. Microarray analysis following alcohol treatment identified a large number of alcohol-responsive genes, including those which function in apoptotic and cell proliferation pathways. Furthermore, expression profiles of the responsive gene sets in tumors were strongly associated with clinical outcomes in patients who received endocrine therapy. Correspondingly, alcohol treatment attenuated the anti-proliferative effects of the endocrine therapeutic drug tamoxifen in ER-positive breast cancer cells. To determine the contribution and functions of responsive genes, their differential expression in tumors were assessed between outcome groups. The proto-oncogene BRAF was identified as a novel alcohol-and estrogen-induced gene that showed higher expression in patients with poor outcomes. Knock-down of BRAF, moreover, prevented the proliferation of breast cancer cells. These findings not only highlight the mechanistic basis of the effects of alcohol on breast cancer cells and increased risks for disease incidents and recurrence, but may facilitate the discovery and characterization of novel oncogenic pathways and markers in breast cancer research and therapeutics.	[Candelaria, Nicholes R.; Weldon, Ryan; Muthusamy, Selvaraj; Trang Nguyen-Vu; Addanki, Sridevi; Yoffou, Paule-Helena; Karaboga, Husna; Blessing, Alicia M.; Lin, Chin-Yo] Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77004 USA; [Bollu, Lakshmi Reddy] Univ Houston, Dept Biol & Biochem, Houston, TX USA; [Miranda, Rajesh C.] Texas A&M Hlth Sci Ctr, Coll Med, Dept Neurosci & Expt Therapeut, Bryan, TX USA; [Miranda, Rajesh C.] Texas A&M Hlth Sci Ctr, Coll Med, Womens Hlth Neurosci Program, Bryan, TX USA	University of Houston System; University of Houston; University of Houston System; University of Houston; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	Lin, CY (corresponding author), Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77004 USA.	clin23@central.uh.edu		Blessing, Alicia/0000-0002-3083-049X; Miranda, Rajesh/0000-0002-8359-892X; Muthusamy, Selvaraj/0000-0003-4498-848X	State of Texas Emerging Technologies Fund [300-9-1958]	State of Texas Emerging Technologies Fund	The Center for Nuclear Receptors and Cell Signaling at the University of Houston is supported by the State of Texas Emerging Technologies Fund (grant number 300-9-1958). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ADACHI J, 1991, J STUD ALCOHOL, V52, P448, DOI 10.15288/jsa.1991.52.448; Banerjee S, 2008, CANCER RES, V68, P7606, DOI 10.1158/0008-5472.CAN-08-1461; Barrett WC, 1999, J BIOL CHEM, V274, P34543, DOI 10.1074/jbc.274.49.34543; BOYD NF, 1995, CANCER EPIDEM BIOMAR, V4, P727; Castiel A, 2011, J CELL SCI, V124, P532, DOI 10.1242/jcs.079731; CAVIGELLI M, 1995, EMBO J, V14, P5957, DOI 10.1002/j.1460-2075.1995.tb00284.x; Chen WY, 2011, JAMA-J AM MED ASSOC, V306, P1884, DOI 10.1001/jama.2011.1590; Chumsri S, 2011, J STEROID BIOCHEM, V125, P13, DOI 10.1016/j.jsbmb.2011.02.001; Clemons M, 2001, NEW ENGL J MED, V344, P276, DOI 10.1056/NEJM200101253440407; Das SK, 2007, LIFE SCI, V81, P177, DOI 10.1016/j.lfs.2007.05.005; DORGAN JF, 1994, CANCER CAUSE CONTROL, V5, P53, DOI 10.1007/BF01830726; Egan KM, 1998, CANCER EPIDEM BIOMAR, V7, P359; Enger SM, 1999, BRIT J CANCER, V79, P1308, DOI 10.1038/sj.bjc.6690210; Erez A, 2007, CANCER RES, V67, P4022, DOI 10.1158/0008-5472.CAN-07-0064; Etique N, 2006, BREAST CANC, V15, P17; Etique N, 2007, INT J ONCOL, V31, P1509; Fan SJ, 2000, CANCER RES, V60, P5635; Farmer P, 2005, BREAST CANC RES S2, V7, p[P2, 11], DOI DOI 10.1186/BCR1122; Fillmore MT, 2011, AM J ADDICTION, V20, P468, DOI 10.1111/j.1521-0391.2011.00156.x; FORMAN MR, 1995, AM J CLIN NUTR, V62, P131, DOI 10.1093/ajcn/62.1.131; GAPSTUR SM, 1995, CANCER EPIDEM BIOMAR, V4, P313; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Graves LM, 2000, NATURE, V403, P328, DOI 10.1038/35002111; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; HERRINTON LJ, 1993, CANCER, V71, P3029, DOI 10.1002/1097-0142(19930515)71:10<3029::AID-CNCR2820711024>3.0.CO;2-K; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Keshamouni VG, 2002, J BIOL CHEM, V277, P22558, DOI 10.1074/jbc.M202351200; Key J, 2006, CANCER CAUSE CONTROL, V17, P759, DOI 10.1007/s10552-006-0011-0; Kim-Kaneyama JR, 2000, J BIOL CHEM, V275, P20685, DOI 10.1074/jbc.M908723199; Kirschner RD, 2010, CELL CYCLE, V9, P2177, DOI 10.4161/cc.9.11.11844; Kwan ML, 2010, J CLIN ONCOL, V28, P4410, DOI 10.1200/JCO.2010.29.2730; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Li CI, 2010, J NATL CANC I; Lin CY, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r66; Long GV, 2011, J CLIN ONCOL, V29, P1239, DOI 10.1200/JCO.2010.32.4327; Massarweh S, 2008, CANCER RES, V68, P826, DOI 10.1158/0008-5472.CAN-07-2707; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; Meng QH, 2000, BIOCHEM BIOPH RES CO, V273, P448, DOI 10.1006/bbrc.2000.2942; Mill CP, 2009, BREAST CANCER-TARGET, V1, P31; Miller LD, 2005, P NATL ACAD SCI USA, V102, P13550, DOI 10.1073/pnas.0506230102; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; NASCA PC, 1994, AM J EPIDEMIOL, V140, P980, DOI 10.1093/oxfordjournals.aje.a117205; Park SK, 2000, PHARMACOGENETICS, V10, P301, DOI 10.1097/00008571-200006000-00004; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Seitz HK, 2012, ALCOHOL ALCOHOLISM, V47, P204, DOI 10.1093/alcalc/ags011; Singletary KW, 2001, JAMA-J AM MED ASSOC, V286, P2143, DOI 10.1001/jama.286.17.2143; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun L, 2014, BIOCHEM BIOPH RES CO, V449, P444, DOI 10.1016/j.bbrc.2014.05.048; Trentham-Dietz A, 2000, CANCER EPIDEM BIOMAR, V9, P697; Vorderstrasse BA, 2012, BREAST CANCER RES TR, V136, P729, DOI 10.1007/s10549-012-2275-2; Wen GY, 2011, CANCER LETT, V308, P23, DOI 10.1016/j.canlet.2011.04.010; Wen J, 2009, ONCOGENE, V28, P575, DOI 10.1038/onc.2008.405; YIRMIYA R, 1992, BRAIN BEHAV IMMUN, V6, P74, DOI 10.1016/0889-1591(92)90061-R; Zhang QS, 2013, CARCINOGENESIS, V34, P28, DOI 10.1093/carcin/bgs316; Zhang SMM, 2007, AM J EPIDEMIOL, V165, P667, DOI 10.1093/aje/kwk054; Zhong Q, 2014, ONCOTARGET, V5, P12410, DOI 10.18632/oncotarget.2678; Zolfaghari R, 2012, AM J PHYSIOL-GASTR L, V303, pG578, DOI 10.1152/ajpgi.00234.2012	59	11	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145061	10.1371/journal.pone.0145061	http://dx.doi.org/10.1371/journal.pone.0145061			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26661278	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900177
J	Majdoul, S; Seye, AK; Kichler, A; Holic, N; Galy, A; Bechinger, B; Fenard, D				Majdoul, Saliha; Seye, Ababacar K.; Kichler, Antoine; Holic, Nathalie; Galy, Anne; Bechinger, Burkhard; Fenard, David			Molecular Determinants of Vectofusin-1 and Its Derivatives for the Enhancement of Lentivirally Mediated Gene Transfer into Hematopoietic Stem/Progenitor Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APE LEUKEMIA-VIRUS; HISTIDINE-RICH PEPTIDES; VESICULAR STOMATITIS-VIRUS; AVIAN SARCOMA VIRUSES; RETROVIRAL TRANSDUCTION; HYDROPHOBIC MOMENT; MAMMALIAN-CELLS; LDL RECEPTOR; STEM-CELLS; T-CELLS	Gene delivery into hCD34+ hematopoietic stem/progenitor cells (HSPCs) using human immunodeficiency virus, type 1-derived lentiviral vectors (LVs) has several promising therapeutic applications. Numerous clinical trials are currently underway. However, the efficiency, safety, and cost of LV gene therapy could be ameliorated by enhancing target cell transduction levels and reducing the amount of LV used on the cells. Several transduction enhancers already exist, such as fibronectin fragments or cationic compounds. Recently, we discovered Vectofusin-1, a new transduction enhancer, also called LAH4-A4, a short histidine-rich amphipathic peptide derived from the LAH4 family of DNA transfection agents. Vectofusin-1 enhances the infectivity of lentiviral and gamma-retroviral vectors pseudotyped with various envelope glycoproteins. In this study, we compared a family of Vectofusin-1 isomers and showed that Vectofusin-1 remains the lead peptide for HSPC transduction enhancement with LVs pseudotyped with vesicular stomatitis virus glycoproteins and also with modified gibbon ape leukemia virus glycoproteins. By comparing the capacity of numerous Vectofusin-1 variants to promote the modified gibbon ape leukemia virus glycoprotein-pseudotyped lentiviral vector infectivity of HSPCs, the lysine residues on the N-terminal extremity of Vectofusin-1, a hydrophilic angle of 140 degrees formed by the histidine residues in the Schiffer-Edmundson helical wheel representation, hydrophobic residues consisting of leucine were all found to be essential and helped to define a minimal active sequence. The data also show that the critical determinants necessary for lentiviral transduction enhancement are partially different from those necessary for efficient antibiotic or DNA transfection activity of LAH4 derivatives. In conclusion, these results help to decipher the action mechanism of Vectofusin-1 in the context of hCD34+ cell-based gene therapy.	[Majdoul, Saliha; Seye, Ababacar K.; Holic, Nathalie; Galy, Anne; Fenard, David] Genethon, F-91000 Evry, France; [Majdoul, Saliha; Seye, Ababacar K.; Holic, Nathalie; Galy, Anne; Fenard, David] INSERM, UMR S951, F-91000 Evry, France; [Majdoul, Saliha; Holic, Nathalie; Galy, Anne; Fenard, David] Univ Evry, F-91000 Evry, France; [Kichler, Antoine] CNRS, UMR 7199, F-67401 Illkirch Graffenstaden, France; [Kichler, Antoine; Bechinger, Burkhard] Univ Strasbourg, F-67000 Strasbourg, France; [Bechinger, Burkhard] Inst Chim, CNRS, UMR 7177, F-67401 Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Galy, A; Fenard, D (corresponding author), INSERM, UMR S951, Genethon, 1 Bis Rue Int, F-91000 Evry, France.	galy@genethon.fr; dfenard@genethon.fr	Galy, Anne HM/J-4439-2013; Holic, Nathalie/U-8979-2018; Fenard, David/D-9533-2011	Galy, Anne HM/0000-0002-0153-4392; Holic, Nathalie/0000-0001-9869-1388; Fenard, David/0000-0003-0242-386X	Association Francaise contre les Myopathies; Fondation pour la Recherche Medicale [DCM2012-1225742]; Agence Nationale de la Recherche Project TRANSPEP [07-PCV-0018]; Agence Nationale de la Recherche Project LabEx Chemistry of Complex Systems [10-LABX-0026_CSC]; RTRA International Center of Frontier Research in Chemistry	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale de la Recherche Project TRANSPEP(French National Research Agency (ANR)); Agence Nationale de la Recherche Project LabEx Chemistry of Complex Systems(French National Research Agency (ANR)); RTRA International Center of Frontier Research in Chemistry	This work was supported by the Association Francaise contre les Myopathies (to A. G. and D. F.) and Fondation pour la Recherche Medicale Grant DCM2012-1225742 (to A. G., B. B., and D. F.). This work was also supported by Agence Nationale de la Recherche Projects TRANSPEP 07-PCV-0018 and LabEx Chemistry of Complex Systems 10-LABX-0026_CSC and the RTRA International Center of Frontier Research in Chemistry (to B. B.). The authors declare that they have no conflicts of interest with the contents of this article.	Aiken C, 1997, J VIROL, V71, P5871, DOI 10.1128/JVI.71.8.5871-5877.1997; Amirache F, 2014, BLOOD, V123, P1422, DOI 10.1182/blood-2013-11-540641; Bechinger B, 1996, J MOL BIOL, V263, P768, DOI 10.1006/jmbi.1996.0614; Bechinger B, 1999, BIOPOLYMERS, V51, P174, DOI 10.1002/(SICI)1097-0282(1999)51:3<174::AID-BIP2>3.0.CO;2-7; Christodoulopoulos I, 2001, J VIROL, V75, P4129, DOI 10.1128/JVI.75.9.4129-4138.2001; CORNETTA K, 1989, J VIROL METHODS, V23, P187, DOI 10.1016/0166-0934(89)90132-8; Dathe M, 1997, FEBS LETT, V403, P208, DOI 10.1016/S0014-5793(97)00055-0; Davis HE, 2004, BIOPHYS J, V86, P1234, DOI 10.1016/S0006-3495(04)74197-1; EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0; Fenard D, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.17; Fenard D, 2013, J VIROL METHODS, V189, P375, DOI 10.1016/j.jviromet.2013.02.005; Finkelshtein D, 2013, P NATL ACAD SCI USA, V110, P7306, DOI 10.1073/pnas.1214441110; Gaspar HB, 2011, SCI TRANSL MED, V3, DOI [10.1126/scitranslmed.3002716, 10.1126/scitranslmed.3002715]; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Georgescu J, 2010, BIOPHYS J, V99, P2507, DOI 10.1016/j.bpj.2010.05.038; Hanenberg H, 1996, NAT MED, V2, P876, DOI 10.1038/nm0896-876; Hodgson CP, 1996, NAT BIOTECHNOL, V14, P339, DOI 10.1038/nbt0396-339; Hoefig I, 2012, J GENE MED, V14, P549, DOI 10.1002/jgm.2653; Ingrao D, 2014, HUM GENE THER METHOD, V25, P48, DOI 10.1089/hgtb.2013.090; INNES CL, 1990, J VIROL, V64, P957, DOI 10.1128/JVI.64.2.957-961.1990; KAVANAUGH MP, 1994, P NATL ACAD SCI USA, V91, P7071, DOI 10.1073/pnas.91.15.7071; Kichler A, 2003, P NATL ACAD SCI USA, V100, P1564, DOI 10.1073/pnas.0337677100; Kichler A, 2007, J MOL MED, V85, P191, DOI 10.1007/s00109-006-0119-4; Kichler A, 2006, BBA-BIOMEMBRANES, V1758, P301, DOI 10.1016/j.bbamem.2006.02.005; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Lamers CHJ, 2008, CYTOTHERAPY, V10, P406, DOI 10.1080/14653240801982961; Langlet-Bertin B, 2010, PHARM RES-DORDR, V27, P1426, DOI 10.1007/s11095-010-0138-2; Liang M, 2009, J VIROL, V83, P13026, DOI 10.1128/JVI.01530-09; Marin V, 2015, MOL THER, V23, pS217, DOI 10.1016/S1525-0016(16)34149-1; Mason AJ, 2006, FASEB J, V20, P320, DOI 10.1096/fj.05-4293fje; Mason AJ, 2006, ANTIMICROB AGENTS CH, V50, P3305, DOI 10.1128/AAC.00490-06; Mason AJ, 2009, J BIOL CHEM, V284, P119, DOI 10.1074/jbc.M806201200; Meier C, 2014, WIRES NANOMED NANOBI, V6, P438, DOI 10.1002/wnan.1275; Merten OW, 2011, HUM GENE THER, V22, P343, DOI 10.1089/hum.2010.060; MORITZ T, 1994, J CLIN INVEST, V93, P1451, DOI 10.1172/JCI117122; Moritz T, 1996, BLOOD, V88, P855, DOI 10.1182/blood.V88.3.855.bloodjournal883855; OHARA B, 1990, CELL GROWTH DIFFER, V1, P119; OLAH Z, 1994, J BIOL CHEM, V269, P25426; Sakuma T, 2012, BIOCHEM J, V443, P603, DOI 10.1042/BJ20120146; Sandrin V, 2002, BLOOD, V100, P823, DOI 10.1182/blood-2001-11-0042; SCHIFFER M, 1967, BIOPHYS J, V7, P121, DOI 10.1016/S0006-3495(67)86579-2; Senes A, 2000, J MOL BIOL, V296, P921, DOI 10.1006/jmbi.1999.3488; TOYOSHIMA K, 1969, VIROLOGY, V38, P414, DOI 10.1016/0042-6822(69)90154-8; Uematsu N, 2000, BIOPHYS J, V79, P2075, DOI 10.1016/S0006-3495(00)76455-1; VOGT PK, 1967, VIROLOGY, V33, P175, DOI 10.1016/0042-6822(67)90109-2; Vogt TCB, 1999, J BIOL CHEM, V274, P29115, DOI 10.1074/jbc.274.41.29115; Wieprecht T, 1997, BIOCHEMISTRY-US, V36, P12869, DOI 10.1021/bi971398n; Wurm M, 2010, J GENE MED, V12, P137, DOI 10.1002/jgm.1429; Yolamanova M, 2013, NAT NANOTECHNOL, V8, P130, DOI [10.1038/nnano.2012.248, 10.1038/NNANO.2012.248]; Zhan H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077106; Zhang LS, 2014, J PEPT SCI, V20, P46, DOI 10.1002/psc.2587	51	24	24	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2161	2169		10.1074/jbc.M115.675033	http://dx.doi.org/10.1074/jbc.M115.675033			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26668323	hybrid, Green Published			2022-12-26	WOS:000369610400010
J	Demir, AB; Koc, A				Demir, Ayse Banu; Koc, Ahmet			High-Copy Overexpression Screening Reveals PDR5 as the Main Doxorubicin Resistance Gene in Yeast	PLOS ONE			English	Article							BINDING CASSETTE TRANSPORTER; SACCHAROMYCES-CEREVISIAE; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; PLASMA-MEMBRANE; KINASE PRK1P; CELL-LINE; ADRIAMYCIN; TRANSCRIPTION; AMPLIFICATION	Doxorubicin is one of the most potent anticancer drugs used in the treatment of various cancer types. The efficacy of doxorubicin is influenced by the drug resistance mechanisms and its cytotoxicity. In this study, we performed a high-copy screening analysis to find genes that play a role in doxorubicin resistance and found several genes (CUE5, AKL1, CAN1, YHR177W and PDR5) that provide resistance. Among these genes, overexpression of PDR5 provided a remarkable resistance, and deletion of it significantly rendered the tolerance level for the drug. Q-PCR analyses suggested that transcriptional regulation of these genes was not dependent on doxorubicin treatment. Additionally, we profiled the global expression pattern of cells in response to doxorubicin treatment and highlighted the genes and pathways that are important in doxorubicin tolerance/toxicity. Our results suggest that many efflux pumps and DNA metabolism genes are upregulated by the drug and required for doxorubicin tolerance.	[Demir, Ayse Banu; Koc, Ahmet] Izmir Inst Technol, Dept Mol Biol & Genet, Izmir, Turkey; [Demir, Ayse Banu] Dokuz Eylul Univ, Inst Oncol, Dept Basic Oncol, Izmir, Turkey	Izmir Institute of Technology; Dokuz Eylul University	Koc, A (corresponding author), Izmir Inst Technol, Dept Mol Biol & Genet, Izmir, Turkey.	ahmetkoc@iyte.edu.tr	Demir, Ayse Banu/AAP-8530-2020; KOÇ, AHMET/ABI-3322-2020	Demir, Ayse Banu/0000-0003-4616-8151; KOÇ, AHMET/0000-0003-3484-2137	TUBITAK (Turkey) [114Z701]	TUBITAK (Turkey)(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	This work was supported by TUBITAK (Turkey) Grand No. 114Z701 to Ahmet Koc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen JD, 1999, CANCER RES, V59, P4237; BALZI E, 1994, J BIOL CHEM, V269, P2206; Bauer BE, 1999, BBA-BIOMEMBRANES, V1461, P217, DOI 10.1016/S0005-2736(99)00160-1; Brown JA, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100043; Cabrito TR, 2011, BIOCHEM J, V440, P195, DOI 10.1042/BJ20110876; COLE SPC, 1992, SCIENCE, V258, P1650, DOI 10.1126/science.1360704; DECOTTIGNIES A, 1995, J BIOL CHEM, V270, P18150, DOI 10.1074/jbc.270.30.18150; DeRisi J, 2000, FEBS LETT, V470, P156, DOI 10.1016/S0014-5793(00)01294-1; EGNER R, 1995, MOL CELL BIOL, V15, P5879; Furuchi T, 2004, NUCLEIC ACIDS RES, V32, P2578, DOI 10.1093/nar/gkh582; Gao C, 2004, J BIOL CHEM, V279, P42677, DOI 10.1074/jbc.M406363200; Gewirtz DA, 1999, BIOCHEM PHARMACOL, V57, P727, DOI 10.1016/S0006-2952(98)00307-4; Golin J, 2003, J BIOL CHEM, V278, P5963, DOI 10.1074/jbc.M210908200; Gottesman MM, 2002, ANNU REV MED, V53, P615, DOI 10.1146/annurev.med.53.082901.103929; Henry KR, 2003, CURR BIOL, V13, P1564, DOI 10.1016/S0960-9822(03)00579-7; Huang RY, 2007, CANCER RES, V67, P765, DOI 10.1158/0008-5472.CAN-06-2839; Ichikawa Y, 2014, J CLIN INVEST, V124, P617, DOI 10.1172/JCI72931; JOHZUKA K, 1995, GENETICS, V139, P1521; KATZMANN DJ, 1995, MOL CELL BIOL, V15, P6875; Katzmann DJ, 1996, J BIOL CHEM, V271, P23049, DOI 10.1074/jbc.271.38.23049; Kihara A, 2004, MOL BIOL CELL, V15, P4949, DOI 10.1091/mbc.E04-06-0458; Kolaczkowski M, 1996, J BIOL CHEM, V271, P31543, DOI 10.1074/jbc.271.49.31543; KULE C, 1994, MOL PHARMACOL, V46, P1234; LEPPERT G, 1990, GENETICS, V125, P13; Lohse MB, 2014, P NATL ACAD SCI USA, V111, P10404, DOI 10.1073/pnas.1410110111; Longhurst TJ, 1996, BRIT J CANCER, V74, P1331, DOI 10.1038/bjc.1996.545; Longley DB, 2005, J PATHOL, V205, P275, DOI 10.1002/path.1706; Lu KF, 2014, CELL, V158, P549, DOI 10.1016/j.cell.2014.05.048; Malinska K, 2003, MOL BIOL CELL, V14, P4427, DOI 10.1091/mbc.E03-04-0221; Maresova L, 2005, MOL MICROBIOL, V55, P588, DOI 10.1111/j.1365-2958.2004.04410.x; Miyahara K, 1996, FEBS LETT, V399, P317, DOI 10.1016/S0014-5793(96)01353-1; Omura S, 1981, Methods Enzymol, V72, P520; Philpott CC, 2002, BIOCHEM SOC T, V30, P698, DOI 10.1042/bst0300698; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Rogers B, 2001, J MOL MICROB BIOTECH, V3, P207; Schenk PW, 2003, MOL PHARMACOL, V64, P259, DOI 10.1124/mol.64.2.259; Shih SC, 2003, EMBO J, V22, P1273, DOI 10.1093/emboj/cdg140; Shively CA, 2013, GENETICS, V193, P1297, DOI 10.1534/genetics.112.147876; Shukla A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-314; Simunek T, 2009, PHARMACOL REP, V61, P154; SINGH SV, 1989, BIOCHEM PHARMACOL, V38, P3505, DOI 10.1016/0006-2952(89)90121-4; SLOVAK ML, 1995, CANCER RES, V55, P4214; Song Qingxuan, 2012, Cells, V1, P263, DOI 10.3390/cells1030263; SZYBALSKI W, 1952, J BACTERIOL, V64, P489, DOI 10.1128/JB.64.4.489-499.1952; Takahashi T, 2005, J CELL PHYSIOL, V202, P100, DOI 10.1002/jcp.20082; Takahashi T, 2006, CANCER RES, V66, P11932, DOI 10.1158/0008-5472.CAN-06-3220; Takahashi T, 2011, J TOXICOL SCI, V36, P855, DOI 10.2131/jts.36.855; Takahashi T, 2009, J TOXICOL SCI, V34, P703, DOI 10.2131/jts.34.703; Teixeira MC, 2014, NUCLEIC ACIDS RES, V42, pD161, DOI 10.1093/nar/gkt1015; UEDA K, 1987, J BIOL CHEM, V262, P505; Vachova L, 2005, J CELL BIOL, V169, P711, DOI 10.1083/jcb.200410064; Westmoreland TJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005830; Withoff S, 1996, ANTICANCER RES, V16, P1867; Xia L, 2007, CANCER RES, V67, P11411, DOI 10.1158/0008-5472.CAN-07-2399; Xiao W, 1998, MOL GEN GENET, V257, P614, DOI 10.1007/s004380050689; YOSHIDA Y, 1991, BIOCHEM SOC T, V19, P778, DOI 10.1042/bst0190778; Zeng GH, 2001, MOL BIOL CELL, V12, P3759, DOI 10.1091/mbc.12.12.3759; Zhu KC, 1999, BIOCHEM BIOPH RES CO, V266, P361, DOI 10.1006/bbrc.1999.1815	58	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145108	10.1371/journal.pone.0145108	http://dx.doi.org/10.1371/journal.pone.0145108			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690737	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092300036
J	He, JR; Zheng, LM; Zhang, WJ; Lin, YS				He, Jinru; Zheng, Lianming; Zhang, Wenjing; Lin, Yuanshao			Life Cycle Reversal in Aurelia sp.1 (Cnidaria, Scyphozoa)	PLOS ONE			English	Article							ASEXUAL REPRODUCTION RATES; JELLYFISH BLOOMS; GELATINOUS ZOOPLANKTON; TURRITOPSIS-NUTRICULA; COMMON JELLYFISH; AURITA; HYDROZOA; POLYPS; DIFFERENTIATION; METAMORPHOSIS	The genus Aurelia is one of the major contributors to jellyfish blooms in coastal waters, possibly due in part to hydroclimatic and anthropogenic causes, as well as their highly adaptive reproductive traits. Despite the wide plasticity of cnidarian life cycles, especially those recognized in certain Hydroza species, the known modifications of Aurelia life history were mostly restricted to its polyp stage. In this study, we document the formation of polyps directly from the ectoderm of degenerating juvenile medusae, cell masses from medusa tissue fragments, and subumbrella of living medusae. This is the first evidence for back-transformation of sexually mature medusae into polyps in Aurelia sp.1. The resulting reconstruction of the schematic life cycle of Aurelia reveals the underestimated potential of life cycle reversal in scyphozoan medusae, with possible implications for biological and ecological studies.	[He, Jinru; Zheng, Lianming; Zhang, Wenjing] Xiamen Univ, Marine Biodivers & Global Change Res Ctr MBiGC, Xiamen, Peoples R China; [Zheng, Lianming] Xiamen Univ, Fujian Prov Key Lab Coastal Ecol & Environm Studi, Xiamen, Peoples R China; [Zheng, Lianming; Zhang, Wenjing; Lin, Yuanshao] Xiamen Univ, Coll Ocean & Earth Sci, Xiamen, Peoples R China; [He, Jinru] Zhejiang Prov Zhoushan Marine Ecol Environm Monit, Zhoushan, Peoples R China	Xiamen University; Xiamen University; Xiamen University	Zheng, LM (corresponding author), Xiamen Univ, Marine Biodivers & Global Change Res Ctr MBiGC, Xiamen, Peoples R China.	zhlm@xmu.edu.cn	Zhang, Wenjing/H-5057-2012; 郑, 连明/GZL-5449-2022; He, Jinru/A-3908-2016	Zhang, Wenjing/0000-0002-2600-5040; He, Jinru/0000-0002-4985-6737	National Natural Science Foundation of China [41006078, J1210050, J1310037]; Public Science and Technology Research Funds Projects of Ocean [201505034]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Public Science and Technology Research Funds Projects of Ocean	This work was supported by the National Natural Science Foundation of China under contract No. 41006078 (LZ), No. J1210050 (LZ) and No. J1310037 (LZ); the Public Science and Technology Research Funds Projects of Ocean under contract No. 201505034 (LZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarado AS, 2014, CELL, V157, P110, DOI 10.1016/j.cell.2014.02.041; Arai MN, 1997, FUNCTIONAL BIOL SCYP; Bavestrello Giorgio, 1992, Scientia Marina, V56, P137; Boero F, 2008, MAR ECOL PROG SER, V356, P299, DOI 10.3354/meps07368; Boero F, 2002, REPRO BIOL, V11, P141; Boero F., 1997, P53; Boero F., 1992, SEX ORIGIN EVOL, V6, P59; Bouillon Jean, 2000, Thalassia Salentina, V24, P1; Brodeur RD, 2002, MAR ECOL PROG SER, V233, P89, DOI 10.3354/meps233089; Brotz L, 2012, HYDROBIOLOGIA, V690, P3, DOI 10.1007/s10750-012-1039-7; Carla' EC, 2003, TISSUE CELL, V35, P213, DOI 10.1016/S0040-8166(03)00028-4; CARRE D, 1995, SCI MAR, V59, P193; CHAPMAN DM, 1968, J MAR BIOL ASSOC UK, V48, P187, DOI 10.1017/S0025315400032537; CHAPMAN DM, 1970, J MAR BIOL ASSOC UK, V50, P107, DOI 10.1017/S0025315400000631; Collins AG, 2002, J EVOLUTION BIOL, V15, P418, DOI 10.1046/j.1420-9101.2002.00403.x; Condon RH, 2013, P NATL ACAD SCI USA, V110, P1000, DOI 10.1073/pnas.1210920110; Condon RH, 2012, BIOSCIENCE, V62, P160, DOI 10.1525/bio.2012.62.2.9; Condon RH, 2011, P NATL ACAD SCI USA, V108, P10225, DOI 10.1073/pnas.1015782108; COSTELLO JH, 1994, MAR BIOL, V121, P327, DOI 10.1007/BF00346741; Daly M, 2007, ZOOTAXA, P127, DOI 10.11646/zootaxa.1668.1.11; Dawson MN, 2001, BIOL BULL, V200, P92, DOI 10.2307/1543089; Dawson MN, 2005, P NATL ACAD SCI USA, V102, P11968, DOI 10.1073/pnas.0503811102; De Vito D, 2006, MAR BIOL, V149, P339, DOI 10.1007/s00227-005-0182-3; Dong ZJ, 2010, MAR POLLUT BULL, V60, P954, DOI 10.1016/j.marpolbul.2010.04.022; Duarte CM, 2013, FRONT ECOL ENVIRON, V11, P91, DOI 10.1890/110246; Ender A, 2003, MOL BIOL EVOL, V20, P130, DOI 10.1093/molbev/msg018; Fautin DG, 2002, CAN J ZOOL, V80, P1735, DOI 10.1139/Z02-133; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Gibbons MJ, 2013, J PLANKTON RES, V35, P929, DOI 10.1093/plankt/fbt063; Gold DA, 2013, DEV GENES EVOL, V223, P53, DOI 10.1007/s00427-012-0429-1; Hadzi Jovan, 1909, Zoologischer Anzeiger Leipzig, V34; HAMNER WM, 1974, AM ZOOL, V14, P833; He JR, 2015, J MAR BIOL ASSOC UK, V95, P289, DOI 10.1017/S0025315414000836; HIRAI ETURO, 1958, BULL MARINE BIOL STA ASAMUSHI TOHOKU UNIV, V9, P81; Holstein TW, 2014, CURR BIOL, V24, pR159, DOI 10.1016/j.cub.2014.01.003; Jarms G., 1997, P271; Kakinuma Y., 1975, Bulletin Mar Biol Stn Asamushi, V15, P101; Ki JS, 2008, ICES J MAR SCI, V65, P443, DOI 10.1093/icesjms/fsn018; Kubota Shin, 2005, Bulletin of the Biogeographical Society of Japan, V60, P31; Kubota Shin, 2006, Bulletin of the Biogeographical Society of Japan, V61, P85; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; 김동훈, 2013, [The Journal of Korea Robotics Society, 로봇학회 논문지], V8, P51, DOI 10.7746/jkros.2013.8.1.051; Lucas CH, 2014, GLOBAL ECOL BIOGEOGR, V23, P701, DOI 10.1111/geb.12169; Lucas CH, 2012, ADV MAR BIOL, V63, P133, DOI 10.1016/B978-0-12-394282-1.00003-X; Lucas CH, 2001, HYDROBIOLOGIA, V451, P229, DOI 10.1023/A:1011836326717; Makabe R, 2014, J OCEANOGR, V70, P447, DOI 10.1007/s10872-014-0249-1; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; Miglietta MP, 2007, J ZOOL SYST EVOL RES, V45, P11, DOI 10.1111/j.1439-0469.2006.00379.x; Miller MEC, 2012, J EXP MAR BIOL ECOL, V432, P113, DOI 10.1016/j.jembe.2012.07.015; Mills CE, 2001, HYDROBIOLOGIA, V451, P55, DOI 10.1023/A:1011888006302; Miranda LS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010182; MOLLER H, 1980, MAR BIOL, V60, P123, DOI 10.1007/BF00389155; Piraino S, 1996, BIOL BULL-US, V190, P302, DOI 10.2307/1543022; Piraino S, 2004, CAN J ZOOL, V82, P1748, DOI 10.1139/Z04-174; Purcell JE, 2005, J MAR BIOL ASSOC UK, V85, P461, DOI 10.1017/S0025315405011409; Purcell JE, 2001, HYDROBIOLOGIA, V451, P27, DOI 10.1023/A:1011883905394; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Purcell JE, 2007, MAR ECOL PROG SER, V348, P183, DOI 10.3354/meps07056; Purcell JE, 2012, HYDROBIOLOGIA, V690, P169, DOI 10.1007/s10750-012-1047-7; Richardson AJ, 2009, TRENDS ECOL EVOL, V24, P312, DOI 10.1016/j.tree.2009.01.010; RICHMOND RH, 1985, MAR ECOL PROG SER, V22, P181, DOI 10.3354/meps022181; Schiariti A, 2014, MAR ECOL PROG SER, V510, P241, DOI 10.3354/meps10798; Schmich J, 2007, INT J DEV BIOL, V51, P45, DOI 10.1387/ijdb.062152js; Sigerfoos C. P., 1893, Johns Hopkins University Circulars, Vxii, P106; Straehler-Pohl I, 2005, MAR BIOL, V147, P1271, DOI 10.1007/s00227-005-0031-4; Straehler-Pohl Ilka, 2011, Zootaxa, V2755, P36; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thein H, 2012, HYDROBIOLOGIA, V690, P157, DOI 10.1007/s10750-012-1045-9; Uye Siain-Icth, 2008, Plankton & Benthos Research, V3, P125, DOI 10.3800/pbr.3.125; [Вагелли А.А. Vagelli Alejandro A.], 2007, [Зоология беспозвоночных, Invertebrate Zoology, Zoologiya bespozvonochnykh], V4, P111; Xian WW, 2005, SCIENCE, V307, P41	71	17	20	2	91	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145314	10.1371/journal.pone.0145314	http://dx.doi.org/10.1371/journal.pone.0145314			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690755	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092300056
J	Nkuize, M; De Wit, S; Muls, V; Delforge, M; Deyi, VYM; Cadiere, GB; Buset, M				Nkuize, Marcel; De Wit, Stephane; Muls, Vinciane; Delforge, Marc; Deyi, Veronique Y. Miendje; Cadiere, Guy B.; Buset, Michel			HIV-Helicobacter pylori Co-Infection: Antibiotic Resistance, Prevalence, and Risk Factors	PLOS ONE			English	Article							ERADICATION THERAPY; INFECTION; AMOXICILLIN; MANAGEMENT; ENDOSCOPY; PNEUMONIA; DISEASE; ERA	Background Patients infected with human immunodeficiency virus (HIV) are living longer due to the availability of more potent treatments. However, prescription of antibiotics to treat or prevent infections in these patients may increase the likelihood of co-infection with antibiotic-resistant species. Aim To compare antimicrobial susceptibility of Helicobacter pylori (H. pylori) in HIV-positive and HIV-negative patients and assess risk-factors for resistance. Methods We prospectively collected data from consecutive HIV-positive and HIV-negative patients undergoing upper gastrointestinal endoscopy. Patients with H. pylori-positive gastric biopsies who had never received H. pylori treatment were included. Results Of the 353 patients included, 93 were HIV-positive and 260 HIV-negative. Among the HIV-positive patients, 56 (60%) had been infected for < 10 years, the median CD4+ count was 493 cells/mu l and median viral load was 61 copies/mL; 66 (71%) were receiving antiretroviral therapy. HIV-positive patients were more often male (p = 0.009), had a lower body mass index (p<0.0001), and had less frequently received antibiotics during the 12-months prior to the endoscopy (p<0.0001) than HIV-negative patients. HIV-positive patients were more likely to have H. pylori resistant to levofloxacin (p = 0.0004), metronidazole (p = 0.01), or multiple antibiotics (p = 0.006). HIV-positive Black Africans were more likely to have resistant strains than were HIV-negative Black Africans (p = 0.04). Ethnicity and HIV status were independent risk factors for H. pylori resistance in all patients and acquired immune deficiency syndrome (AIDS) and sex were risk factors in HIV-positive patients. Conclusions There was a higher prevalence of primary H. pylori-resistant strains in HIV-positive than in HIV-negative patients. AIDS and sex were predictors of H. pylori resistance in HIV-positive patients.	[Nkuize, Marcel; Muls, Vinciane; Buset, Michel] Univ Libre Bruxelles, CHU St Pierre, Dept Gastroenterol & Hepatol, Brussels, Belgium; [De Wit, Stephane; Delforge, Marc] Univ Libre Bruxelles, CHU St Pierre, Div Infect Dis, Brussels, Belgium; [Deyi, Veronique Y. Miendje] Univ Libre Bruxelles, CHU Brugmann, Dept Microbiol, Brussels, Belgium; [Cadiere, Guy B.] Univ Libre Bruxelles, CHU St Pierre, Dept Digest Surg, Brussels, Belgium	Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Vrije Universiteit Brussel	Nkuize, M (corresponding author), Univ Libre Bruxelles, CHU St Pierre, Dept Gastroenterol & Hepatol, Brussels, Belgium.	marcelnkuize@hotmail.com		nkuize, marcel/0000-0002-7708-050X				AliMohamed F, 2002, East Afr Med J, V79, P226; Chiu HM, 2004, J GASTROEN HEPATOL, V19, P423, DOI 10.1111/j.1440-1746.2003.03278.x; Clinical and Laboratory Standards Institute, 2009, M100S19 CLSI S, V29, pM100; Collini PJ, 2013, CURR HIV-AIDS REP, V10, P273, DOI 10.1007/s11904-013-0162-z; Collini PJ, 2012, J INFECTION, V64, P131, DOI 10.1016/j.jinf.2011.12.003; De Francesco V, 2010, J GASTROINTEST LIVER, V19, P409; Desroches JJ, 1997, J NUCL MED, V38, P1141; Deyi VYM, 2011, J CLIN MICROBIOL, V49, P2200, DOI 10.1128/JCM.02642-10; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Feikin DR, 2004, LANCET INFECT DIS, V4, P445, DOI 10.1016/S1473-3099(04)01060-6; Fialho ABC, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-13; Figura N, 2012, NEW MICROBIOL, V35, P335; Furuta T, 2001, CLIN PHARMACOL THER, V69, P158, DOI 10.1067/mcp.2001.113959; Graham DY, 2008, NAT CLIN PRACT GASTR, V5, P321, DOI 10.1038/ncpgasthep1138; Graham DY, 2010, GUT, V59, P1143, DOI 10.1136/gut.2009.192757; Haggerty CL, 2007, CLIN INFECT DIS, V44, P953, DOI 10.1086/512191; Houben MHMG, 1999, ALIMENT PHARM THER, V13, P1047; Malfertheiner P, 2007, GUT, V56, P772, DOI 10.1136/gut.2006.101634; Malfertheiner P, 2012, GUT, V61, P646, DOI 10.1136/gutjnl-2012-302084; MARANO BJ, 1993, AM J GASTROENTEROL, V88, P687; Megraud F, 2013, GUT, V62, P34, DOI 10.1136/gutjnl-2012-302254; Morris AM, 2000, AM J RESP CRIT CARE, V162, P612, DOI 10.1164/ajrccm.162.2.9912058; Nachega Jean B, 2012, AIDS, V26 Suppl 1, pS39; Ndip RN, 2008, TROP MED INT HEALTH, V13, P848, DOI 10.1111/j.1365-3156.2008.02062.x; Nkuize M, 2010, HIV MED, V11, P412, DOI 10.1111/j.1468-1293.2009.00807.x; Nkuize M, 2012, HELICOBACTER, V17, P153, DOI 10.1111/j.1523-5378.2011.00929.x; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Sachs George, 2011, Curr Gastroenterol Rep, V13, P540, DOI 10.1007/s11894-011-0226-4; Sachs George, 2009, Curr Gastroenterol Rep, V11, P455, DOI 10.1007/s11894-009-0070-y; Saruc M, 2001, BRAZ J MED BIOL RES, V34, P1435, DOI 10.1590/S0100-879X2001001100010; Tanih NF, 2010, SAMJ S AFR MED J, V100, P49; Zuckerman JM, 2004, INFECT DIS CLIN N AM, V18, P621, DOI 10.1016/j.idc.2004.04.010	32	5	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145119	10.1371/journal.pone.0145119	http://dx.doi.org/10.1371/journal.pone.0145119			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691198	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092300039
J	Valero, Y; Arizcun, M; Esteban, MA; Bandin, I; Olveira, JG; Patel, S; Cuesta, A; Chaves-Pozo, E				Valero, Yulema; Arizcun, Marta; Angeles Esteban, M.; Bandin, Isabel; Olveira, Jose G.; Patel, Sonal; Cuesta, Alberto; Chaves-Pozo, Elena			Nodavirus Colonizes and Replicates in the Testis of Gilthead Seabream and European Sea Bass Modulating Its Immune and Reproductive Functions	PLOS ONE			English	Article							NERVOUS-NECROSIS-VIRUS; SPARUS-AURATA L.; DICENTRARCHUS-LABRAX; TELEOST FISH; HORIZONTAL TRANSMISSION; VIRAL ENCEPHALOPATHY; SUBGENOMIC RNA3; STAR PROTEIN; BETANODAVIRUS; TESTOSTERONE	Viruses are threatening pathogens for fish aquaculture. Some of them are transmitted through gonad fluids or gametes as occurs with nervous necrosis virus (NNV). In order to be transmitted through the gonad, the virus should colonize and replicate inside some cell types of this tissue and avoid the subsequent immune response locally. However, whether NNV colonizes the gonad, the cell types that are infected, and how the immune response in the gonad is regulated has never been studied. We have demonstrated for the first time the presence and localization of NNV into the testis after an experimental infection in the European sea bass (Dicentrarchus labrax), and in the gilthead seabream (Sparus aurata), a very susceptible and an asymptomatic host fish species, respectively. Thus, we localized in the testis viral RNA in both species using in situ PCR and viral proteins in gilthead seabream by immunohistochemistry, suggesting that males might also transmit the virus. In addition, we were able to isolate infective particles from the testis of both species demonstrating that NNV colonizes and replicates into the testis of both species. Blood contamination of the tissues sampled was discarded by completely fish bleeding, furthermore the in situ PCR and immunocytochemistry techniques never showed staining in blood vessels or cells. Moreover, we also determined how the immune and reproductive functions are affected comparing the effects in the testis with those found in the brain, the main target tissue of the virus. Interestingly, NNV triggered the immune response in the European sea bass but not in the gilthead seabream testis. Regarding reproductive functions, NNV infection alters 17 beta-estradiol and 11-ketotestosterone production and the potential sensitivity of brain and testis to these hormones, whereas there is no disruption of testicular functions according to several reproductive parameters. Moreover, we have also studied the NNV infection of the testis in vitro to assess local responses. Our in vitro results show that the changes observed on the expression of immune and reproductive genes in the testis of both species are different to those observed upon in vivo infections in most of the cases.	[Valero, Yulema; Arizcun, Marta; Chaves-Pozo, Elena] IEO, Ctr Oceanog Murcia, Murcia, Spain; [Angeles Esteban, M.; Cuesta, Alberto] Univ Murcia, Fac Biol, Dept Cell Biol & Histol, Murcia, Spain; [Bandin, Isabel; Olveira, Jose G.] Univ Santiago de Compostela, Inst Acuicultura, Dept Microbiol & Parasitol, Unidad Ictiopatol Patol Viral, Santiago De Compostela, Spain; [Patel, Sonal] Inst Marine Res, N-5024 Bergen, Norway	Spanish Institute of Oceanography; University of Murcia; Universidade de Santiago de Compostela; Institute of Marine Research - Norway	Chaves-Pozo, E (corresponding author), IEO, Ctr Oceanog Murcia, Carretera Azohia S-N, Murcia, Spain.	elena.chaves@mu.ieo.es	Esteban, MA/D-6709-2011; Cuesta, Alberto/B-6372-2008; Arizcun, Marta/ABE-5713-2020; Cuesta, Yulema Valero/H-6694-2015; Bandin, Isabel/K-6542-2014; Chaves-Pozo, Elena/H-5325-2015	Esteban, MA/0000-0002-6264-1458; Cuesta, Alberto/0000-0002-0906-7995; Arizcun, Marta/0000-0001-8514-1854; Cuesta, Yulema Valero/0000-0002-5432-4903; Bandin, Isabel/0000-0002-1947-5933; Chaves-Pozo, Elena/0000-0003-4030-1273	Ministerio de Economia y Competitividad; Instituto Espanol de Ocenaografia; FEDER [AGL2010-20801-C02-01, AGL2010-20801-C02-02, AGL2013-43588-P]; Fundacion Seneca (Grupo de Excelencia de la Region de Murcia) [04538/GERM/06]; Xunta de Galicia [EM2012/005]	Ministerio de Economia y Competitividad(Spanish Government); Instituto Espanol de Ocenaografia; FEDER(European Commission); Fundacion Seneca (Grupo de Excelencia de la Region de Murcia)(Fundacion Seneca); Xunta de Galicia(Xunta de GaliciaEuropean Commission)	Elena Chaves-Pozo thanks the Ministerio de Economia y Competitividad for her Ramon y Cajal's research contract and Yulema Valero thanks the Instituto Espanol de Ocenaografia for her PhD grant. This work was supported by grants of the Ministerio de Economia y Competitividad and FEDER (AGL2010-20801-C02-01, AGL2010-20801-C02-02, AGL2013-43588-P) and Fundacion Seneca (Grupo de Excelencia de la Region de Murcia 04538/GERM/06) and partially by Grant EM2012/005 from Xunta de Galicia.	Aguila S, 2013, MOL IMMUNOL, V53, P218, DOI 10.1016/j.molimm.2012.08.002; Aranguren R, 2002, J FISH DIS, V25, P317, DOI 10.1046/j.1365-2761.2002.00368.x; Arukwe A, 2008, CELL BIOL TOXICOL, V24, P527, DOI 10.1007/s10565-008-9069-7; Blazquez M, 2009, J EXP ZOOL PART B, V312B, P686, DOI 10.1002/jez.b.21286; Breuil G, 2002, J FISH DIS, V25, P697, DOI 10.1046/j.1365-2761.2002.00406.x; BREUIL G, 1991, AQUACULTURE, V97, P109, DOI 10.1016/0044-8486(91)90258-9; Cabas I, 2011, MOL IMMUNOL, V48, P2079, DOI 10.1016/j.molimm.2011.07.001; Castric J, 2001, DIS AQUAT ORGAN, V47, P33, DOI 10.3354/dao047033; Chang YT, 2011, FISH SHELLFISH IMMUN, V30, P1283, DOI 10.1016/j.fsi.2011.03.018; Chaves-Pozo E, 2008, GEN COMP ENDOCR, V156, P531, DOI 10.1016/j.ygcen.2008.03.004; Chaves-Pozo E, 2005, BIOL REPROD, V72, P593, DOI 10.1095/biolreprod.104.036103; Chaves-Pozo E, 2005, J LEUKOCYTE BIOL, V78, P345, DOI 10.1189/jlb.0205120; Chaves-Pozo E, 2007, BIOL REPROD, V76, P142, DOI 10.1095/biolreprod.106.056036; Chaves-Pozo E, 2011, SEX STEROIDS, P199; Chaves-Pozo E, 2012, FISH SHELLFISH IMMUN, V33, P1159, DOI 10.1016/j.fsi.2012.09.002; Chaves-Pozo E, 2010, DEV COMP IMMUNOL, V34, P648, DOI 10.1016/j.dci.2010.01.009; Chen NC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005203; Cuesta A, 2007, FISH SHELLFISH IMMUN, V23, P693, DOI 10.1016/j.fsi.2007.01.015; Deane EE, 2001, COMP BIOCHEM PHYS B, V129, P687, DOI 10.1016/S1096-4959(01)00369-4; Delsert C, 1997, ARCH VIROL, V142, P2359, DOI 10.1007/s007050050248; Diotel N, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00137; Fenner BJ, 2006, J VIROL, V80, P85, DOI 10.1128/JVI.80.1.85-94.2006; Frerichs GN, 1996, J GEN VIROL, V77, P2067, DOI 10.1099/0022-1317-77-9-2067; Garcia-Segura LM, 2001, PROG NEUROBIOL, V63, P29, DOI 10.1016/S0301-0082(00)00025-3; Gomez DK, 2004, J FISH DIS, V27, P603, DOI 10.1111/j.1365-2761.2004.00577.x; Gomez Y, 2000, J STEROID BIOCHEM, V74, P143, DOI 10.1016/S0960-0760(00)00099-6; Grotmol S, 1999, DIS AQUAT ORGAN, V36, P95, DOI 10.3354/dao036095; Hedger MP, 2002, J REPROD IMMUNOL, V57, P19, DOI 10.1016/S0165-0378(02)00016-5; Hodneland K, 2011, J FISH DIS, V34, P189, DOI 10.1111/j.1365-2761.2010.01227.x; Hou Y, 1999, FISHERIES SCI, V65, P850, DOI 10.2331/fishsci.65.850; Inoue R, 2003, FEMS MICROBIOL ECOL, V46, P213, DOI 10.1016/S0168-6496(03)00215-0; Iwamoto T, 2005, J GEN VIROL, V86, P2807, DOI 10.1099/vir.0.80902-0; Iwamoto T, 2000, DIS AQUAT ORGAN, V43, P81, DOI 10.3354/dao043081; Kocan RM, 2001, DIS AQUAT ORGAN, V44, P75, DOI 10.3354/dao044075; Korsnes K, 2012, DIS AQUAT ORGAN, V99, P13, DOI 10.3354/dao02454; Kuo HC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036183; Liarte S, 2011, DEV COMP IMMUNOL, V35, P840, DOI 10.1016/j.dci.2011.03.015; Liarte S, 2011, DEV COMP IMMUNOL, V35, P19, DOI 10.1016/j.dci.2010.07.007; Liarte S, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-20; Maltese Chiara, 2007, Ittiopatologia, V4, P93; Mezeth KB, 2009, DIS AQUAT ORGAN, V83, P97, DOI 10.3354/dao02015; Migaud H, 2012, GEN COMP ENDOCR, V179, P384, DOI 10.1016/j.ygcen.2012.07.033; Munday BL, 2002, J FISH DIS, V25, P127, DOI 10.1046/j.1365-2761.2002.00350.x; Munoz-Cruz S, 2011, CURR TOP MED CHEM, V11, P1714; Nagai T, 1999, J GEN VIROL, V80, P3019, DOI 10.1099/0022-1317-80-11-3019; NISHIZAWA T, 1994, DIS AQUAT ORGAN, V18, P103, DOI 10.3354/dao018103; NUOVO GJ, 1995, PCR METH APPL, V4, pS151; Olveira JG, 2013, AQUACULTURE, V406, P125, DOI 10.1016/j.aquaculture.2013.05.007; Olveira JG, 2009, J GEN VIROL, V90, P2940, DOI 10.1099/vir.0.013912-0; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rodriguez L, 2000, FISH PHYSIOL BIOCHEM, V23, P141, DOI 10.1023/A:1007871604795; Sanchez-Hernandez M, 2013, J STEROID BIOCHEM, V138, P183, DOI 10.1016/j.jsbmb.2013.05.014; Schulz RW, 2010, GEN COMP ENDOCR, V165, P390, DOI 10.1016/j.ygcen.2009.02.013; Sinyakov MS, 2011, VIROLOGY, V410, P228, DOI 10.1016/j.virol.2010.11.004; Smail DA, 2008, J FISH DIS, V31, P49, DOI 10.1111/j.1365-2761.2007.00866.x; Sommerset I, 2004, DIS AQUAT ORGAN, V58, P117, DOI 10.3354/dao058117; Stocco DM, 2001, ANNU REV PHYSIOL, V63, P193, DOI 10.1146/annurev.physiol.63.1.193; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Tan C, 2001, J GEN VIROL, V82, P647, DOI 10.1099/0022-1317-82-3-647; Valero Y, 2015, CELL TISSUE RES, V362, P215, DOI 10.1007/s00441-015-2172-1; Valero Y, 2015, J GEN VIROL, V96, P2176, DOI 10.1099/vir.0.000164; Valero Y, 2015, FISH SHELLFISH IMMUN, V44, P203, DOI 10.1016/j.fsi.2015.02.015; Weltzien FA, 2004, COMP BIOCHEM PHYS A, V137, P447, DOI 10.1016/j.cbpb.2003.11.007	63	35	35	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145131	10.1371/journal.pone.0145131	http://dx.doi.org/10.1371/journal.pone.0145131			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691348	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000367092300040
J	Dietrich, M; Finocchiaro, N; Olszweski, S; Arens, J; Schmitz-Rode, T; Sachweh, J; Jockenhoevel, S; Cornelissen, CG				Dietrich, Maren; Finocchiaro, Nicole; Olszweski, Sebastian; Arens, Jutta; Schmitz-Rode, Thomas; Sachweh, Joerg; Jockenhoevel, Stefan; Cornelissen, Christian G.			ENDOXY - Development of a Biomimetic Oxygenator-Test-Device	PLOS ONE			English	Article							ENDOTHELIAL-CELL CULTURE; FLUID SHEAR-STRESS; VASCULAR GRAFT; BIOMATERIALS; PROTOCOL; PECAM-1; FLOW	Objective This study focusses on the development of a biomimetic oxygenator test device. Due to limited biocompatibility, current oxygenators do not allow mid- to long-term therapy. Tissue engineering uses autologous cell sources to overcome the immunogenic barriers of biomaterials. Surface coating with endothelial cells might improve hemocompatibility and thus prevent immunogenic reactions of the body. In this study this concept is applied to endothelialise a gas-permeable membrane to develop a biomimetic oxygenator test-device (ENDOXY). Methods ENDOXY-a multifunctional test-system was developed to endothelialise a gas-permeable membrane suitable for cell culture and to test the cell retention under shear stress and to measure gas transfer through it. Results Successful endothelialisation of the membrane was achieved and cells showed characteristic endothelial morphologies. They stained positive for endothelial markers. The number of cells aligned with shear stress and cell retention after blood perfusing experiments was high. Gas transfer is observed via uncoated and endothelialised membranes. Conclusion The study showed promising results with regard to system design, endothelialisation, and cell retention under shear stress conditions. It strongly encourages further research into the system by testing different membrane materials to design a biomimetic membrane surface and pave way for a fully hemocompatible oxygenator.	[Dietrich, Maren; Finocchiaro, Nicole; Olszweski, Sebastian; Schmitz-Rode, Thomas; Sachweh, Joerg; Jockenhoevel, Stefan; Cornelissen, Christian G.] Rhein Westfal TH Aachen, Helmholtz Inst Aachen, Inst Appl Med Engn, Dept Tissue Engn & Text Implants, Aachen, Germany; [Arens, Jutta; Schmitz-Rode, Thomas] Rhein Westfal TH Aachen, Helmholtz Inst Aachen, Inst Appl Med Engn, Dept Cardiovasc Engn, Aachen, Germany; [Cornelissen, Christian G.] RWTH Aachen Univ Hosp, Sect Pneumol, Dept Internal Med, Aachen, Germany	Helmholtz Association; RWTH Aachen University; Helmholtz Association; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University Hospital	Jockenhoevel, S (corresponding author), Rhein Westfal TH Aachen, Helmholtz Inst Aachen, Inst Appl Med Engn, Dept Tissue Engn & Text Implants, Aachen, Germany.	jockenhoevel@hia.rwth-aachen.de		Arens, Jutta/0000-0002-9115-0519; Schmitz-Rode, Thomas/0000-0002-1181-2165; Jockenhoevel, Stefan/0000-0003-0584-9444	START research program of the medical faculty of the RWTH Aachen University	START research program of the medical faculty of the RWTH Aachen University	This research was financed by the START research program of the medical faculty of the RWTH Aachen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DEJ, 2011, ANN BIOMED ENG, V39, P2329, DOI 10.1007/s10439-011-0352-z; Ando J, 2009, CIRC J, V73, P1983, DOI 10.1253/circj.CJ-09-0583; [Anonymous], European Patent, Patent No. [EP0231572A2, 0231572]; Baudin B, 2007, NAT PROTOC, V2, P481, DOI 10.1038/nprot.2007.54; de Mel A, 2008, BIOMACROMOLECULES, V9, P2969, DOI 10.1021/bm800681k; Dusserre N, 2004, ARTERIOSCL THROM VAS, V24, P1796, DOI 10.1161/01.ATV.0000141133.32496.41; Fischer WBH CA HS, 2009, Z HERZ THORAX GEFASS, V23, P293; Flanagan TC., 2009, TISSUE ENG A; Hess C, 2010, TISSUE ENG PT A, V16, P3043, DOI [10.1089/ten.tea.2010.0131, 10.1089/ten.TEA.2010.0131]; HEWETT PW, 1993, IN VITRO CELL DEV-AN, V29A, P823; Howell GJ, 2004, MOL MEMBR BIOL, V21, P413, DOI 10.1080/09687860400011571; IVES CL, 1986, IN VITRO CELL DEV B, V22, P500; Jones CI, 2008, AM J PHYSIOL-CELL PH, V295, pC180, DOI 10.1152/ajpcell.00549.2007; Koch S, 2010, BIOMATERIALS, V31, P4731, DOI 10.1016/j.biomaterials.2010.02.051; LIU SQ, 1994, P NATL ACAD SCI USA, V91, P8782, DOI 10.1073/pnas.91.19.8782; Marin V, 2001, J IMMUNOL METHODS, V254, P183, DOI 10.1016/S0022-1759(01)00408-2; McGuigan AP, 2007, BIOMATERIALS, V28, P2547, DOI 10.1016/j.biomaterials.2007.01.039; Michiels C, 2003, J CELL PHYSIOL, V196, P430, DOI 10.1002/jcp.10333; Montoya JP, 1992, ASAIO J, V38, P399; Pearson JD, 1999, BEST PRACT RES CL HA, V12, P329, DOI 10.1053/beha.1999.0028; Polk AA, 2010, BIOTECHNOL BIOENG, V106, P490, DOI 10.1002/bit.22675; Pusztaszeri MP, 2006, J HISTOCHEM CYTOCHEM, V54, P385, DOI 10.1369/jhc.4A6514.2005; Resnick N, 2003, PROG BIOPHYS MOL BIO, V81, P177, DOI 10.1016/S0079-6107(02)00052-4; Silbernagel S, 2001, TASCHENATLAS PHYSL, P120; SMEETS EF, 1992, BIOTECH HISTOCHEM, V67, P241, DOI 10.3109/10520299209110072; Sumpio BE, 2002, INT J BIOCHEM CELL B, V34, P1508, DOI 10.1016/S1357-2725(02)00075-4; Tschoeke B, 2009, TISSUE ENG PT A, V15, P1909, DOI 10.1089/ten.tea.2008.0499; Wegner JA, 1997, J CARDIOTHOR VASC AN, V11, P275, DOI 10.1016/S1053-0770(97)90096-3; West JB, 2003, AM J PHYSIOL-LUNG C, V285, pL501, DOI 10.1152/ajplung.00117.2003; Woodfin A, 2007, ARTERIOSCL THROM VAS, V27, P2514, DOI 10.1161/ATVBAHA.107.151456; Yalcin O, 2008, AM J PHYSIOL-HEART C, V294, pH2098, DOI 10.1152/ajpheart.00015.2008; Yazdani SK, 2010, J VASC SURG, V51, P174, DOI 10.1016/j.jvs.2009.08.074	32	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0142961	10.1371/journal.pone.0142961	http://dx.doi.org/10.1371/journal.pone.0142961			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26682907	Green Submitted, Green Published, gold			2022-12-26	WOS:000366725800004
J	Strzala, T; Kowalczyk, A; Lukaszewicz, E				Strzala, Tomasz; Kowalczyk, Artur; Lukaszewicz, Ewa			Reintroduction of the European Capercaillie from the Capercaillie Breeding Centre in Wisla Forest District: Genetic Assessments of Captive and Reintroduced Populations	PLOS ONE			English	Article							TETRAO-UROGALLUS L.; INFERENCE; SOFTWARE; SEMEN; DIFFERENTIATION; FRAGMENTATION; CONSEQUENCES; PRESERVATION; PHYLOGENIES; DIVERSITY	The Western capercaillie (Tetrao urogallus) is a specific bird species, which, despite its very broad distribution and large global population size, is highly endangered in many Western and Central European countries. According to the species situation, in many countries (including Poland), breeding and reintroduction programmes have been started. One of the most complex and large-scale reintroduction programmes was started in Bory Dolnoslaskie Forest, and the Capercaillie Breeding Centre in Wisla Forest District was used as one of the sources of individuals for reintroduction. As genetic tools provide essential knowledge about species biodiversity, which is crucially important during the breeding process and reintroduction, both captive and reintroduced grouse populations were genetically analysed. We were particularly interested in genetic diversity of the individuals in both populations and the genetic relationship between them, as well as between them and other capercaillie representatives from their current range. To fulfil these goals we determined nine microsatellite loci along with a fragment of the mitochondrial control region. Genetic diversity parameters were moderate to high compared to populations from other Central and Western European countries. Both populations were clustered into three distinct genetic clades based on microsatellites. Phylogenetic analysis placed all mitochondrial haplotypes we revealed in the Eurasian clade. The present results will play an important role as they will help to preserve and maximize genetic diversity in captive populations, and will provide a basis for future monitoring of the reintroduction process.	[Strzala, Tomasz] Wroclaw Univ Environm & Life Sci, Fac Biol, Dept Genet, Wroclaw, Poland; [Kowalczyk, Artur; Lukaszewicz, Ewa] Wroclaw Univ Environm & Life Sci, Fac Biol, Inst Anim Breeding, Div Poultry Breeding, Wroclaw, Poland	Wroclaw University of Environmental & Life Sciences; Wroclaw University of Environmental & Life Sciences	Strzala, T (corresponding author), Wroclaw Univ Environm & Life Sci, Fac Biol, Dept Genet, Wroclaw, Poland.	tomasz.strzala@up.wroc.pl	ŁUKASZEWICZ, EWA T./B-4114-2017; Strzała, Tomasz/P-3357-2019; Kowalczyk, Artur/B-5721-2017; Strzała, Tomasz/F-4578-2011	ŁUKASZEWICZ, EWA T./0000-0002-9505-0056; Strzała, Tomasz/0000-0002-7761-1630; Kowalczyk, Artur/0000-0001-7446-0147; Strzała, Tomasz/0000-0002-7761-1630	National Research Centre [NN 311 081040]; Wroclaw Centre of Biotechnology, programme "The Leading National Research Centre (KNOW) of Wroclaw University of Environmental and Life Sciences"	National Research Centre(National Research Centre (NRC)); Wroclaw Centre of Biotechnology, programme "The Leading National Research Centre (KNOW) of Wroclaw University of Environmental and Life Sciences"	The experiment was supported financially by the National Research Centre, NN 311 081040. The publication was supported by Wroclaw Centre of Biotechnology, programme "The Leading National Research Centre (KNOW) of Wroclaw University of Environmental and Life Sciences for years 2014-2018".	Alda F, 2011, ANIM CONSERV, V14, P249, DOI 10.1111/j.1469-1795.2010.00425.x; [Anonymous], 2001, POLSKA CZERWONA KSIE; Bajc M, 2011, PLOS ONE, P6; Benjamini Y, 1995, J R STAT SOC B; CHAKRABORTY R, 1992, ANN HUM GENET, V56, P45, DOI 10.1111/j.1469-1809.1992.tb01128.x; Criscuolo A, 2011, MOL PHYLOGENET EVOL, V61, P944, DOI 10.1016/j.ympev.2011.08.029; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Olivier D, 2007, CONSERV GENET, V8, P513, DOI 10.1007/s10592-006-9165-2; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Frankham R., 2010, INTRO CONSERVATION G, DOI DOI 10.1017/CBO9780511809002; Glowacinski Z, 1992, POLSKA CZERWONA KSIE, P173; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kalinowski ST, 2006, CONSERV GENET, V7, P991, DOI 10.1007/s10592-006-9134-9; Kowalczyk A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116797; Kowalczyk A, 2012, THERIOGENOLOGY, V77, P899, DOI 10.1016/j.theriogenology.2011.09.015; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liukkonen-Anttila T, 2004, ANN ZOOL FENN, V41, P619; Lukaszewicz ET, 2015, REPROD DOMEST ANIM, V50, P452, DOI 10.1111/rda.12512; Lukaszewicz E, 2011, ORNIS FENNICA, V88, P110; Merta D, 2008, P 1 C PROT FOR GROUS, P224; Merta D, 2013, CZYNNA OCHRONA GLUSZ, P195; Merta Dorota, 2013, Vogelwelt, V134, P65; Moran-Luis M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099799; Morin PA, 2010, J HERED, V101, P1, DOI 10.1093/jhered/esp107; Park S, 2008, EXCEL MICROSATELLITE; Piertney SB, 2001, MOL ECOL NOTES, V1, P303, DOI 10.1046/j.1471-8278.2001.00118.x; Pritchard JK, 2000, GENETICS, V155, P945; Regnaut S, 2006, CONSERV GENET, V7, P449, DOI 10.1007/s10592-005-9023-7; Rodriguez-Munoz R, 2007, CONSERV GENET, V8, P659, DOI 10.1007/s10592-006-9212-z; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rutkowski R, 2005, ACTA ORNITHOL, V40, P27, DOI 10.3161/068.040.0108; Rzonca Zenon, 2012, Grouse News, V43, P17; Segelbacher G, 2000, MOL ECOL, V9, P1934, DOI 10.1046/j.1365-294x.2000.0090111934.x; Segelbacher G, 2003, MOL ECOL, V12, P1773, DOI 10.1046/j.1365-294X.2003.01873.x; Segelbacher G, 2002, MOL ECOL, V11, P1669, DOI 10.1046/j.1365-294X.2002.01565.x; Segelbacher G, 2007, J ORNITHOL, P148; Segelbacher G, 2002, THESIS; Segelbacher G, 2008, MOL ECOL, V17, P2356, DOI 10.1111/j.1365-294X.2008.03767.x; Storch I., 2007, GROUSE STATUS SURVEY; Storch Ilse, 2001, BWP Update, V3, P1; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Vazquez JF, 2012, J WILDLIFE MANAGE, V76, P957, DOI 10.1002/jwmg.346; Zurek Z, 2011, STUDIA MAT CENTRUM E, P229; [No title captured]	53	7	8	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145433	10.1371/journal.pone.0145433	http://dx.doi.org/10.1371/journal.pone.0145433			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26682897	Green Submitted, Green Published, gold			2022-12-26	WOS:000366725800076
J	Yu, RX; Miyamura, N; Okamoto-Uchida, Y; Arima, N; Ishigami-Yuasa, M; Kagechika, H; Nishina, H				Yu, Ruoxing; Miyamura, Norio; Okamoto-Uchida, Yoshimi; Arima, Norie; Ishigami-Yuasa, Mari; Kagechika, Hiroyuki; Nishina, Hiroshi			A Modified Murine Embryonic Stem Cell Test for Evaluating the Teratogenic Effects of Drugs on Early Embryogenesis	PLOS ONE			English	Article							BENZODIAZEPINE USE; IN-VITRO; DEVELOPMENTAL TOXICITY; PRIMITIVE STREAK; PREGNANCY; EMBRYOTOXICITY; MALFORMATIONS; RECEPTORS; BODIES; ASSAY	Mammalian fetal development is easily disrupted by exogenous agents, making it essential to test new drug candidates for embryotoxicity and teratogenicity. To standardize the testing of drugs that might be used to treat pregnant women, the U.S. Food and Drug Administration (FDA) formulated special grade categories, labeled A, B, C, D and X, that define the level of risk associated with the use of a specific drug during pregnancy. Drugs in categories (Cat.) D and X are those with embryotoxic and/ or teratogenic effects on humans and animals. However, which stages of pregnancy are affected by these agents and their molecular mechanisms are unknown. We describe here an embryonic stem cell test (EST) that classifies FDA pregnancy Cat. D and Cat. X drugs into 4 classes based on their differing effects on primitive streak formation. We show that similar to 84% of Cat. D and Cat. X drugs target this period of embryogenesis. Our results demonstrate that our modified EST can identify how a drug affects early embryogenesis, when it acts, and its molecular mechanism. Our test may thus be a useful addition to the drug safety testing armamentarium.	[Yu, Ruoxing; Miyamura, Norio; Okamoto-Uchida, Yoshimi; Arima, Norie; Nishina, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Dev & Regenerat Biol, Tokyo 1138510, Japan; [Ishigami-Yuasa, Mari; Kagechika, Hiroyuki] TMDU, Chem Biol Screening Ctr, Tokyo 1010062, Japan; [Ishigami-Yuasa, Mari; Kagechika, Hiroyuki] TMDU, Inst Biomat & Bioengn, Dept Organ & Med Chem, Tokyo 1010062, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Nishina, H (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Dev & Regenerat Biol, Tokyo 1138510, Japan.	nishina.dbio@mri.tmd.ac.jp		Kagechika, Hiroyuki/0000-0002-6747-1013	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Ministry of Health, Labor and Welfare of Japan; Joint Usage/Research Program of MRI, TMDU; JSPS; A. Advanced Research Networks; MEXT Platform for Drug Discovery, Informatics, and Structural Life Science, Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Joint Usage/Research Program of MRI, TMDU; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); A. Advanced Research Networks; MEXT Platform for Drug Discovery, Informatics, and Structural Life Science, Japan	This work was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, a Grant-in-Aid from the Ministry of Health, Labor and Welfare of Japan, and a Joint Usage/Research Program of MRI, TMDU. This work was partly supported by JSPS Core-to-Core Program, A. Advanced Research Networks, and MEXT Platform for Drug Discovery, Informatics, and Structural Life Science, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank numerous members of the Nishina laboratories for their helpful discussions and critical comments on the manuscript. This work was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, a Grant-in-Aid from the Ministry of Health, Labor and Welfare of Japan, and funding by the Joint Usage/Research Program of MRI, TMDU. This work was partly supported by the JSPS Core-to-Core Program, A. Advanced Research Networks, and the MEXT Platform for Drug Discovery, Informatics, and Structural Life Science, Japan.	Arima N, 2013, BIOCHEM BIOPH RES CO, V435, P447, DOI 10.1016/j.bbrc.2013.05.006; Bain PA, 2009, EFFECTIVE MIGRAINE T; Doering PL, 2002, AM J OBSTET GYNECOL, V187, P333, DOI 10.1067/mob.2002.125740; Dolovich LR, 1998, BMJ-BRIT MED J, V317, P839, DOI 10.1136/bmj.317.7162.839; Enato E, 2011, J OBSTET GYNAECOL CA, V33, P46, DOI 10.1016/S1701-2163(16)34772-7; Feibus KB, 2008, J MED TOXICOL, V4, P284, DOI 10.1007/BF03161214; Festag M, 2007, TOXICOL IN VITRO, V21, P1631, DOI 10.1016/j.tiv.2007.06.014; Gilbert-Barness E, 2010, ANN CLIN LAB SCI, V40, P99; Hadjal Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.246; Henderson E, 2011, POSTGRAD MED J, V87, P349, DOI 10.1136/pgmj.2010.103606; Hong EJ, 2013, TOX RESEARCH, V29, P221, DOI 10.5487/TR.2013.29.4.221; Hyoun SC, 2012, BIRTH DEFECTS RES A, V94, P187, DOI 10.1002/bdra.23003; LAEGREID L, 1989, J PEDIATR-US, V114, P126, DOI 10.1016/S0022-3476(89)80619-5; Law R, 2010, CAN FAM PHYSICIAN, V56, P239; Luscher B, 2004, PHARMACOL THERAPEUT, V102, P195, DOI 10.1016/j.pharmthera.2004.04.003; MCELHATTON PR, 1994, REPROD TOXICOL, V8, P461, DOI 10.1016/0890-6238(94)90029-9; Mikawa T, 2004, DEV DYNAM, V229, P422, DOI 10.1002/dvdy.10458; Nishina H, 1997, NATURE, V385, P350, DOI 10.1038/385350a0; Palmer Jessica A, 2013, Birth Defects Res B Dev Reprod Toxicol, V98, P343, DOI 10.1002/bdrb.21078; Panzica-Kelly JM, 2013, TOXICOL SCI, V131, P447, DOI 10.1093/toxsci/kfs293; Piette D, 2008, NAT PROTOC, V3, P1194, DOI 10.1038/nprot.2008.103; ROSENBERG L, 1983, NEW ENGL J MED, V309, P1282, DOI 10.1056/NEJM198311243092103; Seiler AEM, 2011, NAT PROTOC, V6, P961, DOI 10.1038/nprot.2011.348; Sevene E, 2012, PEDIATR DRUGS, V14, P43, DOI 10.2165/11591270-000000000-00000; SIEBER SM, 1978, TERATOLOGY, V18, P31, DOI 10.1002/tera.1420180107; Sigel E, 2012, J BIOL CHEM, V287, P40224, DOI 10.1074/jbc.R112.386664; Sogorb MA, 2014, TOXICOL LETT, V230, P356, DOI 10.1016/j.toxlet.2014.01.037; Tan O, 2013, REPROD SCI, V20, P16, DOI 10.1177/1933719112459244; Uhl K, 2002, DRUG SAFETY, V25, P885, DOI 10.2165/00002018-200225120-00006; Wu JZ, 2010, STEM CELLS DEV, V19, P1723, DOI 10.1089/scd.2010.0066; Yap C, 2014, J CELL SCI, V127, P2204, DOI 10.1242/jcs.134502; Zhanel GG, 2004, DRUGS, V64, P63, DOI 10.2165/00003495-200464010-00005	32	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145286	10.1371/journal.pone.0145286	http://dx.doi.org/10.1371/journal.pone.0145286			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26682887	Green Submitted, Green Published, gold			2022-12-26	WOS:000366725800058
J	Yan, Z; Liang, HX; Deng, L; Long, H; Chen, H; Chai, WR; Suo, L; Xu, C; Kuang, YP; Wu, LQ; Lu, SS; Lyu, QF				Yan, Zheng; Liang, Hongxing; Deng, Li; Long, Hui; Chen, Hong; Chai, Weiran; Suo, Lun; Xu, Chen; Kuang, Yanping; Wu, Lingqian; Lu, Shengsheng; Lyu, Qifeng			Eight-Shaped Hatching Increases the Risk of Inner Cell Mass Splitting in Extended Mouse Embryo Culture	PLOS ONE			English	Article							MONOZYGOTIC TWINNING RATE; BLASTOCYST STAGE; TWINS; PREGNANCIES; FERTILIZATION	Increased risk of monozygotic twinning (MZT) has been shown to be associated with assisted reproduction techniques, particularly blastocyst culture. Interestingly, inner cell mass (ICM) splitting in human '8'-shaped hatching blastocysts that resulted in MZT was reported. However, the underlying cause of MZT is not known. In this study, we investigated in a mouse model whether in vitro culture leads to ICM splitting and its association with hatching types. Blastocyst hatching was observed in: (i) in vivo developed blastocysts and (ii-iii) in vitro cultured blastocysts following in vivo or in vitro fertilization. We found that '8'-shaped hatching occurred with significantly higher frequency in the two groups of in vitro cultured blastocysts than in the group of in vivo developed blastocysts (24.4% and 20.4% versus 0.8%, respectively; n = 805, P < 0.01). Moreover, Oct4 immunofluorescence staining was performed to identify the ICM in the hatching and hatched blastocysts. Scattered and split distribution of ICM cells was observed around the small zona opening of '8'-shaped hatching blastocysts. This occurred at a high frequency in the in vitro cultured groups. Furthermore, we found more double OCT4-positive masses, suggestive of increased ICM splitting in '8'-shaped hatching and hatched blastocysts than in 'U'-shaped hatching and hatched blastocysts (12.5% versus 1.9%, respectively; n = 838, P < 0.01). Therefore, our results demonstrate that extended in vitro culture can cause high frequencies of '8'-shaped hatching, and '8'-shaped hatching that may disturb ICM herniation leading to increased risk of ICM splitting in mouse blastocysts. These results may provide insights into the increased risk of human MZT after in vitro fertilization and blastocyst transfer.	[Yan, Zheng; Long, Hui; Chen, Hong; Chai, Weiran; Suo, Lun; Kuang, Yanping; Lyu, Qifeng] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 9, Dept Assisted Reprod, Shanghai 200011, Peoples R China; [Liang, Hongxing; Lu, Shengsheng] Guangxi Univ, Guangxi High Educ Key Lab Anim Reprod & Biotechno, State Key Lab Conservat & Utilizat Subtrop Agrobi, Nanning 530004, Peoples R China; [Deng, Li; Wu, Lingqian] Cent S Univ, Xiangya Hosp, Natl Lab Med Genet, Changsha 410078, Hunan, Peoples R China; [Xu, Chen; Kuang, Yanping] Shanghai Key Lab Reprod Med, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University; Guangxi University; Central South University	Wu, LQ (corresponding author), Cent S Univ, Xiangya Hosp, Natl Lab Med Genet, Changsha 410078, Hunan, Peoples R China.	lyuqifeng@126.com; shengshenglu@sina.com; wulingqian@sklmg.edu.cn	Wu, Ling/GZN-2235-2022		Natural Science Foundation of Shanghai, China [15ZR1424900]; National Natural Science Foundation for the Youth of China [81300485]; National Natural Science Foundation of China [31071275, 81571486]	Natural Science Foundation of Shanghai, China(Natural Science Foundation of Shanghai); National Natural Science Foundation for the Youth of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by the Natural Science Foundation of Shanghai, China (15ZR1424900) URL: http://www.stcsm.gov.cn/, role: design the study, decision to publish, and preparation of the manuscript, the National Natural Science Foundation for the Youth of China (81300485) URL: http://www.nsfc.gov.cn/, role: perform the study, decision to publish, and preparation of the manuscript, and the National Natural Science Foundation of China (31071275, 81571486), URL: http://www.nsfc.gov.cn/, role: design the study, data collection and analysis and preparation of the manuscript.	ALIKANI M, 1994, HUM REPROD, V9, P1318, DOI 10.1093/oxfordjournals.humrep.a138701; Alikani M, 2003, HUM REPROD, V18, P1937, DOI 10.1093/humrep/deg369; Aston KI, 2008, REPRODUCTION, V136, P377, DOI 10.1530/REP-08-0206; Behr B, 2003, FERTIL STERIL, V80, P1502, DOI 10.1016/j.fertnstert.2003.07.001; Behr B, 2000, J ASSIST REPROD GEN, V17, P349, DOI 10.1023/A:1009461213139; Blickstein I, 1999, NEW ENGL J MED, V340, P738, DOI 10.1056/NEJM199903043400916; Blickstein I, 2007, TWIN RES HUM GENET, V10, P394, DOI 10.1375/twin.10.2.394; Bruce AW, 2010, CURR OPIN GENET DEV, V20, P485, DOI 10.1016/j.gde.2010.05.006; CHIDA S, 1990, J IN VITRO FERTIL EM, V7, P177, DOI 10.1007/BF01135685; da Costa ALE, 2001, HUM REPROD, V16, P333, DOI 10.1093/humrep/16.2.333; Derom C, 2006, FERTIL STERIL, V85, P755, DOI 10.1016/j.fertnstert.2005.08.034; DEROM C, 1987, LANCET, V1, P1236; Frankfurter D, 2004, FERTIL STERIL, V82, P483, DOI 10.1016/j.fertnstert.2004.02.105; Haimov-Kochman R, 2009, FERTIL STERIL, V92, DOI 10.1016/j.fertnstert.2009.04.054; Hall JG, 2003, LANCET, V362, P735, DOI 10.1016/S0140-6736(03)14237-7; Harkness UF, 2005, SEMIN PERINATOL, V29, P296, DOI 10.1053/j.semperi.2005.10.001; Hershlag A, 1999, FERTIL STERIL, V71, P144, DOI 10.1016/S0015-0282(98)00402-6; HSU YC, 1980, SCIENCE, V209, P605, DOI 10.1126/science.7190325; Jain JK, 2004, J ASSIST REPROD GEN, V21, P103, DOI 10.1023/B:JARG.0000029493.54929.be; Kawachiya S, 2011, FERTIL STERIL, V95, P2140, DOI 10.1016/j.fertnstert.2010.12.018; Knopman J, 2010, FERTIL STERIL, V94, P502, DOI 10.1016/j.fertnstert.2009.03.064; Landim-Alvarenga FC, 2002, ANIM REPROD SCI, V71, P181, DOI 10.1016/S0378-4320(02)00045-3; MACGILLIVRAY I, 1986, SEMIN PERINATOL, V10, P4; McLaren A, 1995, GENET RES, V66, P195, DOI 10.1017/S0016672300034649; Menezo YJR, 2002, HUM REPROD, V17, P247, DOI 10.1093/humrep/17.1.247; Milki AA, 2003, FERTIL STERIL, V79, P503, DOI 10.1016/S0015-0282(02)04754-4; SCHINZEL AAGL, 1979, J PEDIATR-US, V95, P921, DOI 10.1016/S0022-3476(79)80278-4; Sills E S, 2000, Twin Res, V3, P217, DOI 10.1375/twin.3.4.217; Skiadas CC, 2008, HUM REPROD, V23, P1366, DOI 10.1093/humrep/den045; Slotnick RN, 1996, J ASSIST REPROD GEN, V13, P381, DOI 10.1007/BF02066168; Sparks Amy E, 2012, Methods Mol Biol, V912, P387, DOI 10.1007/978-1-61779-971-6_22; Tarlatzis BC, 2002, FERTIL STERIL, V77, P196, DOI 10.1016/S0015-0282(01)02958-2; Van Langendonckt A, 2000, FERTIL STERIL, V74, P1047, DOI 10.1016/S0015-0282(00)01554-5; Vitthala S, 2009, HUM REPROD UPDATE, V15, P45, DOI 10.1093/humupd/dmn045; Yakin K, 2003, FERTIL STERIL, V79, P1044, DOI 10.1016/S0015-0282(02)04941-5	35	12	12	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145172	10.1371/journal.pone.0145172	http://dx.doi.org/10.1371/journal.pone.0145172			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26680631	Green Submitted, Green Published, gold			2022-12-26	WOS:000366723400053
J	Gaiko-Shcherbak, A; Fabris, G; Dreissen, G; Merkel, R; Hoffmann, B; Noetzel, E				Gaiko-Shcherbak, Aljona; Fabris, Gloria; Dreissen, Georg; Merkel, Rudolf; Hoffmann, Bernd; Noetzel, Erik			The Acinar Cage: Basement Membranes Determine Molecule Exchange and Mechanical Stability of Human Breast Cell Acini	PLOS ONE			English	Article							INTERSTITIAL FLUID PRESSURE; EPITHELIAL ACINI; FILTRATION BARRIER; IN-VITRO; IV; MORPHOGENESIS; COLLAGEN; BENIGN; MODELS; PERMEABILITY	The biophysical properties of the basement membrane that surrounds human breast glands are poorly understood, but are thought to be decisive for normal organ function and malignancy. Here, we characterize the breast gland basement membrane with a focus on molecule permeation and mechanical stability, both crucial for organ function. We used well-established and nature-mimicking MCF10A acini as 3D cell model for human breast glands, with ether low- or highly-developed basement membrane scaffolds. Semi-quantitative dextran tracer (3 to 40 kDa) experiments allowed us to investigate the basement membrane scaffold as a molecule diffusion barrier in human breast acini in vitro. We demonstrated that molecule permeation correlated positively with macromolecule size and intriguingly also with basement membrane development state, revealing a pore size of at least 9 nm. Notably, an intact collagen IV mesh proved to be essential for this permeation function. Furthermore, we performed ultra-sensitive atomic force microscopy to quantify the response of native breast acini and of decellularized basement membrane shells against mechanical indentation. We found a clear correlation between increasing acinar force resistance and basement membrane formation stage. Most important native acini with highly-developed basement membranes as well as cell-free basement membrane shells could both withstand physiologically relevant loads (<= 20 nN) without loss of structural integrity. In contrast, low-developed basement membranes were significantly softer and more fragile. In conclusion, our study emphasizes the key role of the basement membrane as conductor of acinar molecule influx and mechanical stability of human breast glands, which are fundamental for normal organ function.	[Gaiko-Shcherbak, Aljona; Fabris, Gloria; Dreissen, Georg; Merkel, Rudolf; Hoffmann, Bernd; Noetzel, Erik] Forschungszentrum Julich, Inst Complex Syst ICS7 Biomech, D-52425 Julich, Germany	Helmholtz Association; Research Center Julich	Noetzel, E (corresponding author), Forschungszentrum Julich, Inst Complex Syst ICS7 Biomech, D-52425 Julich, Germany.	e.noetzel@fz-juelich.de	Hoffmann, Bernd/I-7237-2013; Merkel, Rudolf/G-3647-2013; Noetzel-Reiss, Erik/GYV-0999-2022	Merkel, Rudolf/0000-0003-3178-3282; Noetzel-Reiss, Erik/0000-0003-3163-6848; Gaiko-Shcherbak, Aljona/0000-0001-9097-0825; Hoffmann, Bernd/0000-0002-3803-8835; Dreissen, Georg/0000-0003-2720-660X				Abrams GA, 2000, CELL TISSUE RES, V299, P39, DOI 10.1007/s004410050004; Amsden B, 1998, MACROMOLECULES, V31, P8382, DOI 10.1021/ma980765f; Bole-Feysot C, 1998, ENDOCR REV, V19, P225, DOI 10.1210/edrv.19.3.0334; Brandner JM, 2002, EUR J CELL BIOL, V81, P253, DOI 10.1078/0171-9335-00244; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003; CAULFIEL.JP, 1974, J CELL BIOL, V63, P883, DOI 10.1083/jcb.63.3.883; Chipman SD, 2006, INT J NANOMED, V1, P375, DOI 10.2147/nano.2006.1.4.375; DAVIES B, 1993, BRIT J CANCER, V67, P1126, DOI 10.1038/bjc.1993.207; Debnath J, 2005, NAT REV CANCER, V5, P675, DOI 10.1038/nrc1695; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Debnath J, 2002, CELL, V111, P29, DOI 10.1016/S0092-8674(02)01001-2; Dong JM, 2013, J SURG RES, V183, P56, DOI 10.1016/j.jss.2012.11.047; FARQUHAR MG, 1975, KIDNEY INT, V8, P197, DOI 10.1038/ki.1975.103; Ferrell N, 2013, BIOPHYS J, V104, P1476, DOI 10.1016/j.bpj.2013.01.062; Gajewska M, 2013, AUTOPHAGY DEV REMODE; Gehrke SH, 1997, ANN NY ACAD SCI, V831, P179; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Halfter W, 2013, CELL ADHES MIGR, V7, P64, DOI 10.4161/cam.22479; Hassiotou F, 2013, CLIN ANAT, V26, P29, DOI 10.1002/ca.22165; Hebner C, 2008, ANNU REV PATHOL-MECH, V3, P313, DOI 10.1146/annurev.pathmechdis.3.121806.151526; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Ikeda K, 2006, AM J PATHOL, V168, P856, DOI 10.2353/ajpath.2006.050384; Iozzo RV, 2005, NAT REV MOL CELL BIO, V6, P646, DOI 10.1038/nrm1702; Kalluri R, 2003, NAT REV CANCER, V3, P422, DOI 10.1038/nrc1094; Lance A., 2013, J TISSUE ENG REGEN M; LeBleu VS, 2007, EXP BIOL MED, V232, P1121, DOI 10.3181/0703-MR-72; Lee GY, 2007, NAT METHODS, V4, P359, DOI 10.1038/NMETH1015; Lin DC, 2009, BIOMECH MODEL MECHAN, V8, P345, DOI 10.1007/s10237-008-0139-9; Mailleux AA, 2008, CELL CYCLE, V7, P57, DOI 10.4161/cc.7.1.5150; McKee TD, 2006, CANCER RES, V66, P2509, DOI 10.1158/0008-5472.CAN-05-2242; MONTEAGUDO C, 1990, AM J PATHOL, V136, P585; Muschler J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003202; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Nakano S, 1999, LAB INVEST, V79, P281; NATHANSON SD, 1994, ANN SURG ONCOL, V1, P333, DOI 10.1007/BF03187139; OSTROM KM, 1990, PROG FOOD NUTR SCI, V14, P1; PARISH CR, 1992, INT J CANCER, V52, P378, DOI 10.1002/ijc.2910520309; Polyak K, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003244; Poschl E, 2004, DEVELOPMENT, V131, P1619, DOI 10.1242/dev.01037; Reginato MJ, 2003, NAT CELL BIOL, V5, P733, DOI 10.1038/ncb1026; SCHNEEBERGER EE, 1992, AM J PHYSIOL, V262, pL647, DOI 10.1152/ajplung.1992.262.6.L647; Singer JW, 2005, J CONTROL RELEASE, V109, P120, DOI 10.1016/j.jconrel.2005.09.033; Taddei I, 2003, J MAMMARY GLAND BIOL, V8, P383, DOI 10.1023/B:JOMG.0000017426.74915.b9; Tang WYY, 2014, CELL REP, V8, P1722, DOI 10.1016/j.celrep.2014.08.026; Underwood JM, 2006, J CELL PHYSIOL, V208, P141, DOI 10.1002/jcp.20639; van Zijl F, 2011, MUTAT RES-REV MUTAT, V728, P23, DOI 10.1016/j.mrrev.2011.05.002; Vidi Pierre-Alexandre, 2013, Methods Mol Biol, V945, P193, DOI 10.1007/978-1-62703-125-7_13; Wang H, 2013, P NATL ACAD SCI USA, V110, P163, DOI 10.1073/pnas.1201141110; WELLING LW, 1995, NEWS PHYSIOL SCI, V10, P30; YURCHENCO PD, 1992, J CELL BIOL, V117, P1119, DOI 10.1083/jcb.117.5.1119	51	22	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145174	10.1371/journal.pone.0145174	http://dx.doi.org/10.1371/journal.pone.0145174			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674091	Green Submitted, Green Published, gold			2022-12-26	WOS:000366722700110
J	Sharma, G; Johal, AS; Liversidge, HM				Sharma, Geetanjali; Johal, Ama S.; Liversidge, Helen M.			Predicting Agenesis of the Mandibular Second Premolar from Adjacent Teeth	PLOS ONE			English	Article							PERMANENT TEETH; LONDON ATLAS; MINERALIZATION; CHILDREN	Early diagnosis of agenesis of the mandibular second premolar (P2) enhances management of the dental arch in the growing child. The aim of this study was to explore the relationship in the development of the mandibular first molar (M1) and first premolar (P1) at early stages of P2 (second premolar). Specifically, we ask if the likelihood of P2 agenesis can be predicted from adjacent developing teeth. We selected archived dental panoramic radiographs with P2 at crown formation stages (N = 212) and calculated the likelihood of P2 at initial mineralisation stage 'Ci' given the tooth stage of adjacent teeth. Our results show that the probability of observing mandibular P2 at initial mineralisation stage 'Ci' decreased as both the adjacent P1 and M1 matured. The modal stage at P2 'Ci' was P1 'Coc' (cusp outline complete) and M1 'Crc' (crown complete). Initial mineralisation of P2 was observed up to P1 'Crc' and M1 stage 'R1/2' (root half). The chance of observing P2 at least 'Coc' (coalescence of cusps) was considerably greater prior to these threshold stages compared to later stages of P1 and M1. These findings suggest that P2 is highly unlikely to develop if P1 is beyond 'Crc' and M1 is beyond 'R1/2'.	[Sharma, Geetanjali; Johal, Ama S.; Liversidge, Helen M.] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, London, England	University of London; Queen Mary University London	Liversidge, HM (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Dent, London, England.	h.m.liversidge@qmul.ac.uk		Liversidge, Helen/0000-0002-7056-9337				AlQahtani SJ, 2014, AM J PHYS ANTHROPOL, V154, P70, DOI 10.1002/ajpa.22473; AlQahtani SJ, 2010, AM J PHYS ANTHROPOL, V142, P481, DOI 10.1002/ajpa.21258; Bicakci AA, 2012, KOREAN J ORTHOD, V42, P94, DOI 10.4041/kjod.2012.42.2.94; CUNAT JJ, 1973, J AM DENT ASSOC, V87, P183, DOI 10.14219/jada.archive.1973.0364; Fass EN, 1971, J DENT CHILD, V37, P494; GARN STANLEY M., 1958, JOUR DENTAL RES, V37, P561, DOI 10.1177/00220345580370032801; Liversidge HM, 2008, ACTA STOMATOL CROAT, V42, P311; Liversidge HM, 2011, ANN HUM BIOL, V38, P702, DOI 10.3109/03014460.2011.609565; LOGAN WILLIAM H. G., 1933, JOUR AMER DENTAL ASSOC, V20, P379; Moorrees CF, 1963, J DENT RES, V42, P490; NIELSEN HG, 1976, SCAND J DENT RES, V84, P109; Nystrom ME, 2007, ACTA ODONTOL SCAND, V65, P36, DOI 10.1080/00016350600965900; Polder BJ, 2004, COMMUNITY DENT ORAL, V32, P217, DOI 10.1111/j.1600-0528.2004.00158.x; Rakhshan V, 2013, PROG ORTHOD, V14, DOI 10.1186/2196-1042-14-33; RAVN JJ, 1977, SCAND J DENT RES, V85, P232; Reinquist M, 1969, SWED DENT J, V62, P535; Shackelford LL, 2012, AM J PHYS ANTHROPOL, V147, P227, DOI 10.1002/ajpa.21639; Simpson SW, 1998, J HUM EVOL, V35, P479, DOI 10.1006/jhev.1998.0235	18	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144180	10.1371/journal.pone.0144180	http://dx.doi.org/10.1371/journal.pone.0144180			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673218	Green Submitted, Green Published, gold			2022-12-26	WOS:000366722700028
J	Chakraborty, P; Bjork, P; Kallberg, E; Olsson, A; Riva, M; Morgelin, M; Liberg, D; Ivars, F; Leanderson, T				Chakraborty, Paramita; Bjork, Per; Kallberg, Eva; Olsson, Anders; Riva, Matteo; Morgelin, Matthias; Liberg, David; Ivars, Fredrik; Leanderson, Tomas			Vesicular Location and Transport of S100A8 and S100A9 Proteins in Monocytoid Cells	PLOS ONE			English	Article							MYELOID-RELATED PROTEIN-14; CALCIUM-BINDING PROTEINS; MRP14; DIFFERENTIATION; INTERLEUKIN-1-BETA; IDENTIFICATION; TRANSLOCATION; NEUTROPHILS; MIGRATION; MEMBRANE	We show here, by using surface biotinylation, followed by Western blotting or surface plasmon resonance analysis, that very low levels of S100A8 and/or S100A9 can be detected on the surface of THP-1 cells or freshly isolated human monocytes. This was supported by immune-electron microscopy where we observed membrane-associated expression of the proteins restricted to small patches. By using confocal microscopy we could determine that S100A8 and S100A9 protein in THP-1 cells or freshly isolated human monocytes was mostly present in vesicular structures. This finding was confirmed using immune-electron microscopy. Subcellular fractionation and confocal microscopy showed that these vesicular structures are mainly early endosomes and endolysosomes. Our subsequent studies showed that accumulation of S100A8 and S100A9 in the endolysosomal compartment is associated with induction of their release from the cells. Furthermore, an inhibitor of lysosomal activity could modulate the release of S100A8 and S100A9 in the extracellular milieu. Our current results suggest that the S100A8 and S100A9 proteins are primarily associated with certain kinds of cytosolic vesicles and may be secreted via an endolysosomal pathway.	[Chakraborty, Paramita; Kallberg, Eva; Ivars, Fredrik; Leanderson, Tomas] Lund Univ, Immunol Grp, Lund, Sweden; [Bjork, Per; Olsson, Anders; Riva, Matteo; Liberg, David; Leanderson, Tomas] Act Biotech AB, Lund, Sweden; [Morgelin, Matthias] Lund Univ, Div Infect Med, Lund, Sweden	Lund University; Lund University	Leanderson, T (corresponding author), Lund Univ, Immunol Grp, Lund, Sweden.	tomas.leanderson@med.lu.se	Chakraborty, Paramita/AAL-9606-2020	Chakraborty, Paramita/0000-0002-0320-8697; Riva, Matteo/0000-0003-2697-6717	Swedish Cancer Foundation [140520]; Kocks Foundation; Osterlund Foundation; Active Biotech AB	Swedish Cancer Foundation; Kocks Foundation; Osterlund Foundation; Active Biotech AB	This work was supported by the Swedish Cancer Foundation (Grant # 140520), Kocks Foundation and Osterlund Foundation. Active Biotech AB provided support in the form of salaries for authors TL, PB, DL, AO and MR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributors" section.	Andrei C, 1999, MOL BIOL CELL, V10, P1463, DOI 10.1091/mbc.10.5.1463; Benoit S, 2006, BRIT J DERMATOL, V155, P62, DOI 10.1111/j.1365-2133.2006.07198.x; Bjork P, 2009, PLOS BIOL, V7, P800, DOI 10.1371/journal.pbio.1000097; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Bober M, 2010, J INNATE IMMUN, V2, P160, DOI 10.1159/000232587; Bode G, 2008, J BIOL CHEM, V283, P31776, DOI 10.1074/jbc.M803908200; Burke M, 2014, J PROTEOME RES, V13, P836, DOI 10.1021/pr400879c; DALE I, 1985, AM J CLIN PATHOL, V84, P24, DOI 10.1093/ajcp/84.1.24; Daniels GM, 1998, METHOD ENZYMOL, V296, P307; de Araujo Mariana Eca Guimaraes, 2008, V424, P317, DOI 10.1007/978-1-60327-064-9_25; Diercks BP, 2013, SCAND J IMMUNOL, V77, P169, DOI 10.1111/sji.12015; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Fialka I, 1999, J BIOL CHEM, V274, P26233, DOI 10.1074/jbc.274.37.26233; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Gardella S, 2002, EMBO REP, V3, P995, DOI 10.1093/embo-reports/kvf198; Glass MJ, 2006, NEUROSCIENCE, V143, P547, DOI 10.1016/j.neuroscience.2006.08.051; GOEBELER M, 1995, BIOCHEM J, V309, P419, DOI 10.1042/bj3090419; Healy AM, 2006, CIRCULATION, V113, P2278, DOI 10.1161/CIRCULATIONAHA.105.607333; HESSIAN PA, 1993, J LEUKOCYTE BIOL, V53, P197, DOI 10.1002/jlb.53.2.197; Huh KH, 1999, J BIOL CHEM, V274, P151, DOI 10.1074/jbc.274.1.151; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Jia J, 2014, CELL, V159, P623, DOI 10.1016/j.cell.2014.09.032; Kerkhoff C, 2005, FASEB J, V19, P467, DOI 10.1096/fj.04-2377fje; Lominadze G, 2005, J IMMUNOL, V174, P7257, DOI 10.4049/jimmunol.174.11.7257; Lood C, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3314; Mambula SS, 2006, J IMMUNOL, V177, P7849, DOI 10.4049/jimmunol.177.11.7849; Marty V, 2005, GLIA, V49, P511, DOI 10.1002/glia.20138; McCormick MM, 2005, J BIOL CHEM, V280, P41521, DOI 10.1074/jbc.M509442200; Nacken W, 2004, FEBS LETT, V572, P289, DOI 10.1016/j.febslet.2004.07.024; New SEP, 2013, CIRC RES, V113, P72, DOI 10.1161/CIRCRESAHA.113.301036; Pasquali C, 1999, J CHROMATOGR B, V722, P89, DOI 10.1016/S0378-4347(98)00314-4; Rammes A, 1997, J BIOL CHEM, V272, P9496; Riva M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061832; ROTH J, 1993, BLOOD, V82, P1875; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Stroncek DF, 2005, J TRANSL MED, V3, P1, DOI 10.1186/1479-5876-3-36; Trischler M, 1999, J CELL SCI, V112, P4773; vandenBos C, 1996, J IMMUNOL, V156, P1247; VODOVOTZ Y, 1995, J IMMUNOL, V154, P2914; Vogl T, 2004, BLOOD, V104, P4260, DOI 10.1182/blood-2004-02-0446; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Vogl T, 2012, INT J MOL SCI, V13, P2893, DOI 10.3390/ijms13032893	43	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145217	10.1371/journal.pone.0145217	http://dx.doi.org/10.1371/journal.pone.0145217			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26661255	gold, Green Published			2022-12-26	WOS:000366715900193
J	Chen, JC; Hoey, DA; Chua, M; Bellon, R; Jacobs, CR				Chen, Julia C.; Hoey, David A.; Chua, Mardonn; Bellon, Raymond; Jacobs, Christopher R.			Mechanical signals promote osteogenic fate through a primary cilia-mediated mechanism	FASEB JOURNAL			English	Article						mesenchymal stem cell; ulna loading; primary cilium; bone; homing	DIRECTIONAL CELL-MIGRATION; BONE-MARROW; STROMAL CELLS; MECHANOTRANSDUCTION; DIFFERENTIATION; PROLIFERATION; RECRUITMENT; OSTEOCYTES; KIF3A	It has long been suspected, but never directly shown, that bone formed to accommodate an increase in mechanical loading is related to the creation of osteoblasts from skeletal stem cells. Indeed, biophysical stimuli potently regulate osteogenic lineage commitment in vitro. In this study, we transplanted bone marrow cells expressing green fluorescent protein, to enable lineage tracing, and subjected mice to a biophysical stimulus, to elicit a bone-forming response. We detected cells derived from transplanted progenitors embedded within the bone matrix near active bone-forming surfaces in response to loading, demonstrating for thefirst time, that mechanical signals enhance the homing and attachment of bone marrow cells to bone surfaces and the commitment to an osteogenic lineage of these cells in vivo. Furthermore, we used an inducible Cre/Lox recombination system to delete kinesin family member 3A (Kif3a), a gene that is essential for primary cilia formation, at will in transplanted cells and their progeny, regardless of which tissue may have incorporated them. Disruption of the mechanosensing organelle, the primary cilium in a progenitor population, significantly decreased the amount of bone formed in response to mechanical stimulation. The collective results of our study directly demonstrate that, in a novel experimental stem cell mechanobiology model, mechanical signals enhance osteogenic lineage commitment in vivo and that the primary cilium contributes to this process.-Chen, J. C., Hoey, D. A., Chua, M., Bellon, R., Jacobs, C. R. Mechanical signals promote osteogenic fate through a primary cilia-mediated mechanism. FASEB J. 30, 1504-1511 (2016). www.fasebj.org	[Chen, Julia C.; Hoey, David A.; Jacobs, Christopher R.] Columbia Univ, Dept Biomed Engn, New York, NY USA; [Bellon, Raymond] Columbia Univ, Dept Chem Engn, New York, NY USA; [Hoey, David A.] Trinity Coll Dublin, Trinity Ctr Bioengn, Trin Biomed Sci Inst, 152-160 Pearse St, Dublin 2, Ireland; [Hoey, David A.] Trinity Coll Dublin, Dept Mech & Mfg Engn, Sch Engn, Dublin, Ireland; [Hoey, David A.] Univ Limerick, Dept Mech Aeronaut & Biomed Engn, Ctr Appl Biomed Engn Res, Mat & Surface Sci Inst, Limerick, Ireland; [Chua, Mardonn] Univ British Columbia, Dept Biotechnol, Vancouver, BC V5Z 1M9, Canada	Columbia University; Columbia University; Trinity College Dublin; Trinity College Dublin; University of Limerick; University of British Columbia	Hoey, DA (corresponding author), Trinity Coll Dublin, Trinity Ctr Bioengn, Trin Biomed Sci Inst, 152-160 Pearse St, Dublin 2, Ireland.	david.hoey@ul.ie	Hoey, David/A-7587-2012; Hoey, David/X-9231-2019	Hoey, David/0000-0001-5898-0409; 	New York State Stem Cell Grant [N089-210]; U.S. National Institutes of Health, Institute of Arthritis and Musculoskeletal and Skin Disease [AR054156, AR062177, AR059038]; European Research Council [336882]; Science Foundation Ireland European Research Council (ERC) [SFI 13/ERC/L2864]; Irish Reseach Council (IRCSET)-Marie Curie International Mobility Fellowship in Science, Engineering and Technology; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062177, T32AR059038, R21AR054156] Funding Source: NIH RePORTER	New York State Stem Cell Grant; U.S. National Institutes of Health, Institute of Arthritis and Musculoskeletal and Skin Disease; European Research Council(European Research Council (ERC)European Commission); Science Foundation Ireland European Research Council (ERC)(Science Foundation Ireland); Irish Reseach Council (IRCSET)-Marie Curie International Mobility Fellowship in Science, Engineering and Technology; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank K. Lee, A. Nguyen, H. Li, B. Shelton, S. Bhumiratana, C. Hue, K. Yamada, and K. Prestia for technical assistance, and K. Lee and A. Nguyen for helpful discussions (all from Columbia University). This work was supported by New York State Stem Cell Grant N089-210 (to C. R. J.); U.S. National Institutes of Health, Institute of Arthritis and Musculoskeletal and Skin Disease Grants AR054156, AR062177, and AR059038 (to C. R. J.); European Research Council Grant 336882 (to D.A.H.); Science Foundation Ireland European Research Council (ERC) Support Grant SFI 13/ERC/L2864 (to D.A.H.); and an Irish Reseach Council (IRCSET)-Marie Curie International Mobility Fellowship in Science, Engineering and Technology (to D.A.H). J.C.C. and D.A.H. designed and performed experiments, interpreted the data, and wrote the manuscript; M.C. and R.B. performed experiments; and C.R.J. designed experiments, interpreted the data, and wrote the manuscript. The authors declare no conflicts of interest.	Arnsdorf EJ, 2010, J BIOMECH, V43, P2881, DOI 10.1016/j.jbiomech.2010.07.033; Birmingham E, 2012, EUR CELLS MATER, V23, P13, DOI 10.22203/eCM.v023a02; Bodle JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062554; Brady RT, 2015, BIOCHEM BIOPH RES CO, V459, P118, DOI 10.1016/j.bbrc.2015.02.080; Castillo Alesha B, 2010, Curr Osteoporos Rep, V8, P98, DOI 10.1007/s11914-010-0015-2; Chen JC, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt318; Christensen ST, 2013, METHOD ENZYMOL, V525, P45, DOI 10.1016/B978-0-12-397944-5.00003-1; Corral DA, 1998, P NATL ACAD SCI USA, V95, P13835, DOI 10.1073/pnas.95.23.13835; Coughlin TR, 2015, CALCIFIED TISSUE INT, V96, P65, DOI 10.1007/s00223-014-9928-6; Cui YZ, 2002, BONE MARROW TRANSPL, V30, P843, DOI 10.1038/sj.bmt.1703766; David V, 2007, ENDOCRINOLOGY, V148, P2553, DOI 10.1210/en.2006-1704; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Everts V, 2002, J BONE MINER RES, V17, P77, DOI 10.1359/jbmr.2002.17.1.77; Hoey DA, 2012, STEM CELLS, V30, P2561, DOI 10.1002/stem.1235; Hoey DA, 2011, BIOCHEM BIOPH RES CO, V412, P182, DOI 10.1016/j.bbrc.2011.07.072; Kuhn NZ, 2010, J CELL PHYSIOL, V222, P268, DOI 10.1002/jcp.21940; Li YJ, 2004, J ORTHOP RES, V22, P1283, DOI 10.1016/j.orthres.2004.04.002; Marszalek JR, 1999, P NATL ACAD SCI USA, V96, P5043, DOI 10.1073/pnas.96.9.5043; Nachury MV, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0465; Paridaen JTML, 2013, CELL, V155, P333, DOI 10.1016/j.cell.2013.08.060; Park D, 2012, CELL STEM CELL, V10, P259, DOI 10.1016/j.stem.2012.02.003; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Qiu N, 2012, J CELL SCI, V125, P1945, DOI 10.1242/jcs.095893; Robling AG, 2002, BONE, V31, P562, DOI 10.1016/S8756-3282(02)00871-2; Rombouts WJC, 2003, LEUKEMIA, V17, P160, DOI 10.1038/sj.leu.2402763; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; Schneider L, 2010, CELL PHYSIOL BIOCHEM, V25, P279, DOI 10.1159/000276562; Scholey JM, 2003, ANNU REV CELL DEV BI, V19, P423, DOI 10.1146/annurev.cellbio.19.111401.091318; Taguchi K, 2005, BIOCHEM BIOPH RES CO, V331, P31, DOI 10.1016/j.bbrc.2005.03.119; Takeda S, 1999, J CELL BIOL, V145, P825, DOI 10.1083/jcb.145.4.825; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Temiyasathit S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033368; Tummala P, 2010, CELL MOL BIOENG, V3, P207, DOI 10.1007/s12195-010-0127-x; Turner CH, 1998, BONE, V22, P463, DOI 10.1016/S8756-3282(98)00041-6; Wang LP, 2005, BLOOD, V106, P3650, DOI 10.1182/blood-2005-02-0582	35	60	60	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1504	1511		10.1096/fj.15-276402	http://dx.doi.org/10.1096/fj.15-276402			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26675708	Green Published, Green Submitted			2022-12-26	WOS:000372629100012
J	Finelli, MJ; Sanchez-Pulido, L; Liu, KX; Davies, KE; Oliver, PL				Finelli, Mattea J.; Sanchez-Pulido, Luis; Liu, Kevin X.; Davies, Kay E.; Oliver, Peter L.			The Evolutionarily Conserved Tre2/Bub2/Cdc16 (TBC), Lysin Motif (LysM), Domain Catalytic (TLDc) Domain Is Neuroprotective against Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOZYGOUS TBC1D24 MUTATION; RESISTANCE 1; OXR1 PROTEIN; 2 SIBLINGS; EXPRESSION; SEQUENCE; EPILEPSY; IDENTIFICATION; PROTECTION; REVEALS	Oxidative stress is a pathological feature of many neurological disorders; therefore, utilizing proteins that are protective against such cellular insults is a potentially valuable therapeutic approach. Oxidation resistance 1 (OXR1) has been shown previously to be critical for oxidative stress resistance in neuronal cells; deletion of this gene causes neurodegeneration in mice, yet conversely, overexpression of OXR1 is protective in cellular and mouse models of amyotrophic lateral sclerosis. However, the molecular mechanisms involved are unclear. OXR1 contains the Tre2/Bub2/Cdc16 (TBC), lysin motif (LysM), domain catalytic (TLDc) domain, a motif present in a family of proteins including TBC1 domain family member 24 (TBC1D24), a protein mutated in a range of disorders characterized by seizures, hearing loss, and neurodegeneration. The TLDc domain is highly conserved across species, although the structure-function relationship is unknown. To understand the role of this domain in the stress response, we carried out systematic analysis of all mammalian TLDc domain-containing proteins, investigating their expression and neuroprotective properties in parallel. In addition, we performed a detailed structural and functional study of this domain in which we identified key residues required for its activity. Finally, we present a new mouse insertional mutant of Oxr1, confirming that specific disruption of the TLDc domain in vivo is sufficient to cause neurodegeneration. Our data demonstrate that the integrity of the TLDc domain is essential for conferring neuroprotection, an important step in understanding the functional significance of all TLDc domain-containing proteins in the cellular stress response and disease.	[Finelli, Mattea J.; Sanchez-Pulido, Luis; Liu, Kevin X.; Davies, Kay E.; Oliver, Peter L.] Univ Oxford, Dept Physiol Anat & Genet, MRC, Funct Genom Unit, Parks Rd, Oxford OX1 3PT, England	University of Oxford	Oliver, PL (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, MRC, Funct Genom Unit, Parks Rd, Oxford OX1 3PT, England.	peter.oliver@dpag.ox.ac.uk	Finelli, Mattea/AAD-5783-2022; Oliver, Peter/AAS-4022-2020; Liu, Kevin X/E-4319-2015	Liu, Kevin X/0000-0003-2071-5137; Oliver, Peter/0000-0003-3347-2461; Sanchez Pulido, Luis/0000-0002-2300-8502; Finelli, Mattea/0000-0002-0152-3642	United Kingdom Medical Research Council; European Research Council under the European Union [311394]; MRC [MC_U137761449, MC_UU_12021/2, MC_UU_12021/1, MC_U137761446] Funding Source: UKRI; Medical Research Council [MC_UU_12021/1, MC_U137761449, MC_U137761446, MC_UU_12021/2] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Research Council under the European Union(European Research Council (ERC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a United Kingdom Medical Research Council Programme grant (to K. E. D.) and funding from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC Grant 311394 (to P. L. O.). The authors declare that they have no conflicts of interest with the contents of this article.	Afawi Z, 2013, EPILEPSY RES, V105, P240, DOI 10.1016/j.eplepsyres.2013.02.005; Alasoo K, 2015, SCI REP-UK, V5, DOI 10.1038/srep12524; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Araii H, 2008, ONCOL REP, V19, P1381; Azaiez H, 2014, HUM MUTAT, V35, P819, DOI 10.1002/humu.22557; Barzilai A, 2004, DNA REPAIR, V3, P1109, DOI 10.1016/j.dnarep.2004.03.002; Blaise M, 2012, PROTEINS, V80, P1694, DOI 10.1002/prot.24050; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; Campeau PM, 2014, LANCET NEUROL, V13, P44, DOI 10.1016/S1474-4422(13)70265-5; Cardon A., 2015, NEUROLOGY, V84, pS271; Cho SH, 2015, TUBERC RESPIR DIS, V78, P99, DOI 10.4046/trd.2015.78.2.99; Chodroff RA, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-7-r72; Corbett MA, 2010, AM J HUM GENET, V87, P371, DOI 10.1016/j.ajhg.2010.08.001; Dobrowolny G, 2005, J CELL BIOL, V168, P193, DOI 10.1083/jcb.200407021; Doerks T, 2002, GENOME RES, V12, P47, DOI 10.1101/gr.203201; Doummar D, 2015, MOVEMENT DISORD, V30, P1431, DOI 10.1002/mds.26303; Durand M, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-13; Elliott NA, 2004, MOL CELL BIOL, V24, P3180, DOI 10.1128/MCB.24.8.3180-3187.2004; Endo S, 2014, DRUG METAB DISPOS, V42, P803, DOI 10.1124/dmd.113.056044; Falace A, 2014, P NATL ACAD SCI USA, V111, P2337, DOI 10.1073/pnas.1316294111; Falace A, 2010, AM J HUM GENET, V87, P365, DOI 10.1016/j.ajhg.2010.07.020; Fernandes AC, 2014, J CELL BIOL, V207, P453, DOI 10.1083/jcb.201406026; Finelli MJ, 2015, HUM MOL GENET, V24, P3529, DOI 10.1093/hmg/ddv104; Gandhi S, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/428010; Guven A, 2013, J MED GENET, V50, P199, DOI 10.1136/jmedgenet-2012-101313; Jaramillo-Gutierrez G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011168; Kobayashi N, 2014, J INSECT PHYSIOL, V68, P58, DOI 10.1016/j.jinsphys.2014.06.020; Li Y, 2014, SCI REP, V4, P1, DOI DOI 10.1038/SREP07186; Liu KX, 2015, BRAIN, V138, P1167, DOI 10.1093/brain/awv039; Melo A, 2011, OXID MED CELL LONGEV, V2011, DOI 10.1155/2011/467180; Milh M, 2013, HUM MUTAT, V34, P869, DOI 10.1002/humu.22318; Murphy KC, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-26; Murray AR, 2013, INVEST OPHTH VIS SCI, V54, P1689, DOI 10.1167/iovs.12-10921; Musaro A, 2007, EXP GERONTOL, V42, P76, DOI 10.1016/j.exger.2006.05.004; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Oliver PL, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002338; Poulat AL, 2015, EPILEPSY RES, V111, P72, DOI 10.1016/j.eplepsyres.2015.01.008; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rehman AU, 2014, AM J HUM GENET, V94, P144, DOI 10.1016/j.ajhg.2013.12.004; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanada Y, 2014, FREE RADICAL RES, V48, P919, DOI 10.3109/10715762.2014.927063; SERRANO L, 1989, NATURE, V342, P296, DOI 10.1038/342296a0; Shao WL, 2002, MOL CELL BIOL, V22, P3358, DOI 10.1128/MCB.22.10.3358-3372.2002; Shkolnik K, 2008, REPRODUCTION, V135, P321, DOI 10.1530/REP-07-0402; Shukla V, 2011, ADV PHARMACOL SCI, V2011, DOI 10.1155/2011/572634; Skarnes WC, 2011, NATURE, V474, P337, DOI 10.1038/nature10163; Sonnhammer ELL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-108; Stamper C, 2008, MOVEMENT DISORD, V23, P1588, DOI 10.1002/mds.22184; Strazisar BG, 2015, EUR J PAEDIATR NEURO, V19, P251, DOI 10.1016/j.ejpn.2014.12.011; Uttara B, 2009, CURR NEUROPHARMACOL, V7, P65, DOI 10.2174/157015909787602823; Uytterhoeven V, 2011, CELL, V145, P117, DOI 10.1016/j.cell.2011.02.039; Vinciguerra M, 2010, AGING-US, V2, P43; Volkert MR, 2000, P NATL ACAD SCI USA, V97, P14530, DOI 10.1073/pnas.260495897; Wang ZP, 2012, J IMMUNOL, V188, P3993, DOI 10.4049/jimmunol.1103301; West DB, 2015, GENOME RES, V25, P598, DOI 10.1101/gr.184184.114; Yang MY, 2014, FREE RADICAL BIO MED, V77, P41, DOI 10.1016/j.freeradbiomed.2014.09.003; Yu LA, 2015, FINANC INNOV, V1, DOI 10.1186/s40854-015-0005-6	57	39	40	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2751	2763		10.1074/jbc.M115.685222	http://dx.doi.org/10.1074/jbc.M115.685222			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26668325	Green Published, hybrid			2022-12-26	WOS:000369626900016
J	Altman, R; Lim, S; Steen, RG; Dasa, V				Altman, Roy; Lim, Sooyeol; Steen, R. Grant; Dasa, Vinod			Hyaluronic Acid Injections Are Associated with Delay of Total Knee Replacement Surgery in Patients with Knee Osteoarthritis: Evidence from a Large US Health Claims Database	PLOS ONE			English	Article							TOTAL JOINT ARTHROPLASTY; INTRAARTICULAR HYALURONAN; TASK-FORCE; MANAGEMENT; RECOMMENDATIONS; HIP; EFFICACY; SAFETY; VISCOSUPPLEMENTATION; GUIDELINES	Background The growing prevalence of osteoarthritis (OA) and the medical costs associated with total knee replacement (TKR) surgery for end-stage OA motivate a search for agents that can delay OA progression. We test a hypothesis that hyaluronic acid (HA) injection is associated with delay of TKR in a dose-dependent manner. Methods and Findings We retrospectively evaluated records in an administrative claims database of similar to 79 million patients, to identify all patients with knee OA who received TKR during a 6-year period. Only patients with continuous plan enrollment from diagnosis until TKR were included, so that complete medical records were available. OA diagnosis was the index event and we evaluated time-to-TKR as a function of the number of HA injections. The database included 182,022 patients with knee OA who had TKR; 50,349 (27.7%) of these patients were classified as HA Users, receiving >= 1 courses of HA prior to TKR, while 131,673 patients (72.3%) were HA Non-users prior to TKR, receiving no HA. Cox proportional hazards modelling shows that TKR risk decreases as a function of the number of HA injection courses, if patient age, gender, and disease comorbidity are used as background covariates. Multiple HA injections are therefore associated with delay of TKR (all, P < 0.0001). Half of HA Non-users had a TKR by 114 days post-diagnosis of knee OA, whereas half of HA Users had a TKR by 484 days post-diagnosis (chi(2) = 19,769; p < 0.0001). Patients who received no HA had a mean time-to-TKR of 0.7 years; with one course of HA, the mean time to TKR was 1.4 years (chi(2) = 13,725; p < 0.0001); patients who received >= 5 courses delayed TKR by 3.6 years (chi(2) = 19,935; p < 0.0001). Conclusions HA injection in patients with knee OA is associated with a dose-dependent increase in time-to-TKR.	[Altman, Roy] Univ Calif Los Angeles, Dept Rheumatol, Los Angeles, CA USA; [Lim, Sooyeol] Seikagaku Corp, North Amer Business Unit, Tokyo, Japan; [Steen, R. Grant] Bioventus LLC, Dept Med Affairs, Durham, NC 27703 USA; [Dasa, Vinod] Louisiana State Univ, Hlth Sci Ctr, Dept Orthopaed, New Orleans, LA USA	University of California System; University of California Los Angeles; Seikagaku Corporation; Smith & Nephew; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Steen, RG (corresponding author), Bioventus LLC, Dept Med Affairs, Durham, NC 27703 USA.	Grant.Steen@bioventusglobal.com		Steen, R. Grant/0000-0003-3386-6575; dasa, vinod/0000-0001-5282-4026	Seikagaku Corporation of Tokyo, Japan; Seikagaku Corporation; Bioventus LLC	Seikagaku Corporation of Tokyo, Japan; Seikagaku Corporation; Bioventus LLC	This research was sponsored by the Seikagaku Corporation of Tokyo, Japan. Sooyeol Lim is employed by Seikagaku Corporation. Seikagaku Corporation provided support in the form of salary for author SL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. R. Grant Steen is employed by Bioventus LLC. Bioventus LLC provided support in the form of salary for author RGS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Abbott T, 2013, ARTHRITIS RHEUM-US, V65, pS910; Altman R, 2015, J KNEE SURG, V26; Bagga H, 2006, J RHEUMATOL, V33, P946; Bannuru RR, 2015, ANN INTERN MED, V162, P46, DOI 10.7326/M14-1231; Bannuru RR, 2014, ARTHROSCOPY, V30, P86, DOI 10.1016/j.arthro.2013.10.007; Barrett JP, 2002, CLIN DRUG INVEST, V22, P87, DOI 10.2165/00044011-200222020-00003; Brooks DE, 2014, VETERANS AFFAIRS DEP, P1; Bruyere O, 2014, SEMIN ARTHRITIS RHEU, V44, P253, DOI 10.1016/j.semarthrit.2014.05.014; Charlson ME, 2014, CHARLSON COMORBIDITY; Cianflocco AJ, 2013, POSTGRAD MED, V125, P97, DOI 10.3810/pgm.2013.01.2618; Cram P, 2012, JAMA-J AM MED ASSOC, V308, P1227, DOI 10.1001/2012.jama.11153; Cross M, 2014, ANN RHEUM DIS, V73, P1323, DOI 10.1136/annrheumdis-2013-204763; Das Anirban, 2009, J Fam Pract, V58, p281c; Fam H, 2007, BIORHEOLOGY, V44, P59; Fraenkel L, 2014, J RHEUMATOL, V41, P47, DOI 10.3899/jrheum.130762; George LK, 2014, VALUE HEALTH, V17, P605, DOI 10.1016/j.jval.2014.04.004; Ghosh P, 2002, SEMIN ARTHRITIS RHEU, V32, P10, DOI 10.1053/sarh.2002.33720; Health Economics and Outcomes Research, 2013, DAT STAT AN PLAN; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Hochberg MC, 2012, ARTHRIT CARE RES, V64, P465, DOI 10.1002/acr.21596; Huddleston JI, 2009, J ARTHROPLASTY, V24, P95, DOI 10.1016/j.arth.2009.05.001; Jevsevar DS, 2013, J AM ACAD ORTHOP SUR, V21, P571, DOI 10.5435/JAAOS-21-09-571; Jordan KM, 2003, ANN RHEUM DIS, V62, P1145, DOI 10.1136/ard.2003.011742; Khan T, 2014, ACMP NEXUS; Kirksey M, 2012, ANESTH ANALG, V115, P321, DOI 10.1213/ANE.0b013e31825b6824; Kleinberg S, 2011, J BIOMED INFORM, V44, P1102, DOI 10.1016/j.jbi.2011.07.001; Lalmohamed A, 2014, ARTHRITIS RHEUMATOL, V66, P311, DOI 10.1002/art.38232; Losina E, 2015, ARTHRIT CARE RES, V67, P203, DOI 10.1002/acr.22412; Lu N, 2015, ARTHRITIS RHEUMATOL; Malinzak RA, 2009, J ARTHROPLASTY, V24, P84, DOI 10.1016/j.arth.2009.05.016; Mar J, 2013, Rev Esp Cir Ortop Traumatol, V57, P6, DOI 10.1016/j.recot.2012.08.006; McAlindon TE, 2014, OSTEOARTHR CARTILAGE, V22, P363, DOI 10.1016/j.joca.2014.01.003; McArthur BA, 2012, PATIENT PREFER ADHER, V6, P905, DOI 10.2147/PPA.S27783; Meding JB, 2013, BONE JOINT J, V95B, P1484, DOI 10.1302/0301-620X.95B11.32467; Memtsoudis SG, 2013, CLIN ORTHOP RELAT R, V471, P17, DOI [10.1007/s11999-012-2608-9, 10.1007/s11999-012-2682-z]; Moreland LW, 2003, ARTHRITIS RES THER, V5, P54, DOI 10.1186/ar623; MQIC MD, 2013, MED MAN AD OST; National Collaborating Centre for Chronic Conditions N-C, 2008, PHARM MAN OST; Nelson AE, 2014, SEMIN ARTHRITIS RHEU, V43, P701, DOI 10.1016/j.semarthrit.2013.11.012; Neustadt DH, 2003, CLIN EXP RHEUMATOL, V21, P307; Newberry SJ, 2014, SYSTEMATIC REV EFFEC, V14; Rasouli MR, 2013, CLIN ORTHOP RELAT R, V471, P3102, DOI 10.1007/s11999-013-2949-z; Ravi B, 2014, BRIT J SPORT MED, V48, P1580, DOI 10.1136/bjsports-2014-f6187rep; Rutjes AWS, 2012, ANN INTERN MED, V157, P180, DOI 10.7326/0003-4819-157-3-201208070-00473; Schairer WW, 2014, CLIN ORTHOP RELAT R, V472, P181, DOI 10.1007/s11999-013-3030-7; Skou ST, 2015, NEW ENGL J MED, V373, P1597, DOI 10.1056/NEJMoa1505467; Slover J, 2012, JAMA-J AM MED ASSOC, V308, P1266, DOI 10.1001/jama.2012.12644; Strand V, 2015, J PAIN RES, V8, P217, DOI 10.2147/JPR.S83076; Turajane Thana, 2009, J Med Assoc Thai, V92 Suppl 6, pS63; Waddell DD, 2007, J MANAGE CARE PHARM, V13, P113, DOI 10.18553/jmcp.2007.13.2.113; Waddell DD, 2014, J KNEE SURG; WILLISOWEN CA, 2010, CLIN ORTHOP RELAT R, V92, P1128, DOI DOI 10.1302/0301-620X.92B8.24333; Zhang W, 2008, OSTEOARTHR CARTILAGE, V16, P137, DOI 10.1016/j.joca.2007.12.013	53	71	73	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145776	10.1371/journal.pone.0145776	http://dx.doi.org/10.1371/journal.pone.0145776			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694145	Green Published, gold			2022-12-26	WOS:000367092500075
J	Kovacs, L; Kezer, FL; Bakony, M; Hufnagel, L; Tozser, J; Jurkovich, V				Kovacs, Levente; Kezer, Fruzsina Luca; Bakony, Mikolt; Hufnagel, Levente; Tozser, Janos; Jurkovich, Viktor			Associations between Heart Rate Variability Parameters and Housing- and Individual-Related Variables in Dairy Cows Using Canonical Correspondence Analysis	PLOS ONE			English	Article							CATTLE; MILKING; WELFARE; STRESS; TEMPERAMENT; BEHAVIOR; HABITAT; POSTURE; HUMANS; SYSTEM	We investigated the associations between heart rate variability (HRV) parameters and some housing-and individual-related variables using the canonical correspondence analysis (CCOA) method in lactating Holstein-Friesian dairy cows. We collected a total of 5200 5-min interbeat interval (IBI) samples from 260 animals on five commercial dairy farms [smaller-scale farms with 70 (Farm 1, n = 50) and 80 cows per farm (Farm 2, n = 40), and larger-scale farms with 850 (Farm 3, n = 66), 1900 (Farm 4, n = 60) and 1200 (Farm 5, n = 45) cows. Dependent variables included HRV parameters, which reflect the activity of the autonomic nervous system: heart rate (HR), the root mean square of successive differences (RMSSD) in IBIs, the standard deviation 1 (SD1), the high frequency (HF) component of HRV and the ratio between the low frequency (LF) and the HF parameter (LF/HF). Explanatory variables were group size, space allowance, milking frequency, parity, daily milk yield, body condition score, locomotion score, farm, season and physical activity (lying, lying and rumination, standing, standing and rumination and feeding). Physical activity involved in standing, feeding and in rumination was associated with HRV parameters, indicating a decreasing sympathetic and an increasing vagal tone in the following order: feeding, standing, standing and rumination, lying and rumination, lying. Objects representing summer positioned close to HR and LF and far from SD1, RMSSD and HF indicate a higher sympathetic and a lower vagal activity. Objects representing autumn, spring and winter associated with increasing vagal activity, in this order. Time-domain measures of HRV were associated with most of the housing-and individual-related explanatory variables. Higher HR and lower RMSSD and SD1 were associated with higher group size, milking frequency, parity and milk yield, and low space allowance. Higher parity and milk yield were associated with higher sympathetic activity as well (higher LF/HF), while individuals with lower locomotion scores (lower degree of lameness) were characterized with a higher sympathetic and a lower vagal tone (higher HR and LF/HF and lower RMSSD and SD1). Our findings indicate that the CCOA method is useful in demonstrating associations between HRV and selected explanatory variables. We consider physical activity, space allowance, group size, milking frequency, parity, daily milk yield, locomotion score and season to be the most important variables in further HRV studies on dairy cows.	[Kovacs, Levente; Kezer, Fruzsina Luca] MTA SZIE Large Anim Clin Res Grp, H-2225 Ullo Dora Major, Hungary; [Kovacs, Levente; Kezer, Fruzsina Luca; Tozser, Janos] Szent Istvan Univ, Inst Anim Husb, Fac Agr & Environm Sci, H-2100 Godollo, Hungary; [Bakony, Mikolt] Rumino Vet Bt, H-2030 Erd, Hungary; [Hufnagel, Levente] Szent Istvan Univ, Inst Crop Prod, Fac Agr & Environm Sci, H-2100 Godollo, Hungary; [Jurkovich, Viktor] Szent Istvan Univ, Fac Vet Sci, Dept Anim Hyg Herd Hlth & Vet Ethol, H-1078 Budapest, Hungary	Hungarian University of Agriculture & Life Sciences; Hungarian University of Agriculture & Life Sciences; Hungarian University of Agriculture & Life Sciences	Kovacs, L (corresponding author), MTA SZIE Large Anim Clin Res Grp, H-2225 Ullo Dora Major, Hungary.	Kovacs.Levente@mkk.szie.hu	Jurkovich, Viktor/AAJ-2114-2020	Bakony, Mikolt/0000-0002-4801-8459; Jurkovich, Viktor/0000-0002-6019-3508	Research Centre of Excellence [9878/2015/FEKUT]	Research Centre of Excellence	This study was supported by the Research Centre of Excellence, grant number: 9878/2015/FEKUT, http://www.nemzetikivalosag.hu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Angers B, 1999, MOL ECOL, V8, P1043, DOI 10.1046/j.1365-294x.1999.00669.x; Boddugari K, 2001, J DAIRY SCI, V84, P873, DOI 10.3168/jds.S0022-0302(01)70210-X; Breuer K, 2000, APPL ANIM BEHAV SCI, V66, P273, DOI 10.1016/S0168-1591(99)00097-0; Buck M, 2013, LIVEST SCI, V158, P129, DOI 10.1016/j.livsci.2013.10.011; Camm AJ, 1996, CIRCULATION, V93, P1043; Cooper A, 2005, PLANT ECOL, V181, P255, DOI 10.1007/s11258-005-7149-9; D'Ambrosio JL, 2014, ECOL ENG, V68, P32, DOI 10.1016/j.ecoleng.2014.03.037; Faye B, 1997, PREV VET MED, V32, P171, DOI 10.1016/S0167-5877(97)00017-2; Frondelius L, 2015, PHYSIOL BEHAV, V139, P437, DOI 10.1016/j.physbeh.2014.12.002; Gomes PIA, 2014, J HYDROL, V519, P3615, DOI 10.1016/j.jhydrol.2014.11.009; Greenacre M, 2013, ECOLOGY, V94, P241, DOI 10.1890/11-1730.1; HADY PJ, 1994, J DAIRY SCI, V77, P1543, DOI 10.3168/jds.S0022-0302(94)77095-8; Hagen K, 2005, PHYSIOL BEHAV, V85, P195, DOI 10.1016/j.physbeh.2005.03.019; Hammer O, 2006, PALEONTOLOGICAL DATA ANALYSIS, P1; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Jurkovich V, 2012, MAGY ALLATORVOSOK, V134, P605; Kleiger RE, 2005, ANN NONINVAS ELECTRO, V10, P88, DOI 10.1111/j.1542-474X.2005.10101.x; Koolhaas JM, 2011, NEUROSCI BIOBEHAV R, V35, P1291, DOI 10.1016/j.neubiorev.2011.02.003; Kovacs L, 2015, PHYSIOL BEHAV, V139, P281, DOI 10.1016/j.physbeh.2014.11.039; Kovacs L, 2014, J DAIRY SCI, V97, P6955, DOI 10.3168/jds.2014-8327; Kovacs L, 2014, ANIMAL, V8, P316, DOI 10.1017/S1751731113002140; Kovacs L, 2013, J DAIRY SCI, V96, P7743, DOI 10.3168/jds.2013-7030; Kovacs L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134792; LEBRETON JD, 1991, EURO CH ENV, V2, P85; Legendre P., 2012, NUMERICAL ECOLOGY; Lunardi VO, 2012, ESTUAR COAST SHELF S, V96, P179, DOI 10.1016/j.ecss.2011.11.001; Marler Thomas E, 2013, Commun Integr Biol, V6, pe25924, DOI 10.4161/cib.25924; Mialon MM, 2012, VET J, V194, P55, DOI 10.1016/j.tvjl.2012.02.019; Minero M, 2001, VET REC, V149, P772, DOI 10.1136/vr.149.25.772; Moctezuma C, 2014, J CHEM ECOL, V40, P458, DOI 10.1007/s10886-014-0431-3; Mohr E, 2002, PHYSIOL BEHAV, V75, P251, DOI 10.1016/S0031-9384(01)00651-5; Piccione G, 2005, RES VET SCI, V79, P155, DOI 10.1016/j.rvsc.2004.11.010; Porges SW, 2003, PHYSIOL BEHAV, V79, P503, DOI 10.1016/S0031-9384(03)00156-2; Rao C.R., 1964, SANKHYA A, V26, P329, DOI DOI 10.1214/AOMS/1177704248; Raussi S, 2003, APPL ANIM BEHAV SCI, V80, P245, DOI 10.1016/S0168-1591(02)00213-7; ROBERT P, 1976, ROY STAT SOC C-APP, V25, P257; Rushen J, 1999, J DAIRY SCI, V82, P720, DOI 10.3168/jds.S0022-0302(99)75289-6; Sourial N, 2010, J CLIN EPIDEMIOL, V63, P638, DOI 10.1016/j.jclinepi.2009.08.008; Sprecher DJ, 1997, THERIOGENOLOGY, V47, P1179, DOI 10.1016/S0093-691X(97)00098-8; Sutherland MA, 2012, PHYSIOL BEHAV, V107, P329, DOI 10.1016/j.physbeh.2012.07.013; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Telezhenko E, 2012, J DAIRY SCI, V95, P3064, DOI 10.3168/jds.2011-4953; TERBRAAK CJF, 1986, ECOLOGY, V67, P1167; TERBRAAK CJF, 1998, CANOCO 4; Thayer JF, 1999, ELECTROEN CLIN NEURO, V79, P358; VANDENWOLLENBERG AL, 1977, PSYCHOMETRIKA, V42, P207, DOI 10.1007/BF02294050; von Borell E, 2007, PHYSIOL BEHAV, V92, P293, DOI 10.1016/j.physbeh.2007.01.007; von Keyserlingk MAG, 2008, J DAIRY SCI, V91, P1011, DOI 10.3168/jds.2007-0532; Welfare Quality&REG;, 2009, ASS PROT CATTL	51	9	9	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145313	10.1371/journal.pone.0145313	http://dx.doi.org/10.1371/journal.pone.0145313			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690578	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092300055
J	Eryilmaz, U; Demirci, B; Aksun, S; Boyacioglu, M; Akgullu, C; Ilgenli, TF; Yalinkilinc, HS; Bilgen, M				Eryilmaz, Ufuk; Demirci, Buket; Aksun, Saliha; Boyacioglu, Murat; Akgullu, Cagdas; Ilgenli, Tevfik Fikret; Yalinkilinc, Hande Sultan; Bilgen, Mehmet			S100A1 as a Potential Diagnostic Biomarker for Assessing Cardiotoxicity and Implications for the Chemotherapy of Certain Cancers	PLOS ONE			English	Article							HEART-FAILURE; TROPONIN-I; PREDICTION; MANAGEMENT; THERAPY; FAMILY; DAMAGE; ASSAY	This study examined the value of blood marker S100A1 in detecting cardiotoxicity induced by chemotherapy agents; trastuzumab and lapatinib, in normal rat heart. The rats were divided into three groups: control (n = 8, no treatment), T (n = 8, one time ip treatment with 10mg/kg trastuzumab) and L (n = 8, oral treatment with 100 mg/kg/day lapatinib for 7 days). The activities of oxidative stress parameters Malondialdehyde (MDA), Superoxide dismutase (SOD), Catalase (CAT) and Glutathione (GSH) were measured from the extracted cardiac tissues. The levels of troponinI and S100A1 expressions were measured from blood samples. All biomarkers responded to the treatments as they exhibited alterations from their normative values, validating the chemically induced cardiotoxicity. S100A1 expression attenuated significantly (75%), which made the sensitive detection of cardiotoxicity feasible. Assessment of cardiotoxicity with S100A1 may be a valuable alternative in clinical oncology of cancers in some organs such as breast and prostate, as they do not overexpress it to compete against.	[Eryilmaz, Ufuk; Akgullu, Cagdas] Adnan Menderes Univ, Fac Med, Dept Cardiol, Aydin, Turkey; [Demirci, Buket] Adnan Menderes Univ, Fac Med, Dept Med Pharmacol, Aydin, Turkey; [Aksun, Saliha] Katip Celebi Univ, Fac Med, Dept Med Biochem, Izmir, Turkey; [Boyacioglu, Murat; Yalinkilinc, Hande Sultan] Adnan Menderes Univ, Fac Vet Med, Dept Pharmacol & Toxicol, Aydin, Turkey; [Ilgenli, Tevfik Fikret] Konya Selcuklu Private Hosp, Dept Cardiol, Konya, Turkey; [Bilgen, Mehmet] Adnan Menderes Univ, Fac Med, Dept Biophys, Aydin, Turkey	Adnan Menderes University; Adnan Menderes University; Izmir Katip Celebi University; Adnan Menderes University; Private Konya Hospital; Selcuklu Hospital; Adnan Menderes University	Eryilmaz, U (corresponding author), Adnan Menderes Univ, Fac Med, Dept Cardiol, Aydin, Turkey.	drufukeryilmaz@gmail.com	DEMIRCI, BUKET/C-1006-2018; aksun, saliha/S-1742-2019; SAHINER, Hande Sultan/GOK-0902-2022; Sahiner, Hande Sultan/O-9777-2015	DEMIRCI, BUKET/0000-0002-3442-5061; SAHINER, Hande Sultan/0000-0003-2811-3579; Sahiner, Hande Sultan/0000-0003-2811-3579; AKSUN, SALIHA/0000-0002-7991-1645	Scientific and Technological Research Council of Turkey [TUBITAK 1001-113E177]	Scientific and Technological Research Council of Turkey(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK))	M. Bilgen is funded by the Scientific and Technological Research Council of Turkey (Research Grant TUBITAK 1001-113E177). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Babar T, 2014, CURR PHARM DESIGN, V20, P4911; Babuin L, 2005, CAN MED ASSOC J, V173, P1191, DOI 10.1503/cmaj/051291; Baykara M, 2015, DIAGN INTERV RADIOL, V21, P317, DOI 10.5152/dir.2015.14075; Bielecka-Dabrowa A, 2015, INT J MOL SCI, V16, P10715, DOI 10.3390/ijms160510715; Cardinale D, 2002, ANN ONCOL, V13, P710, DOI 10.1093/annonc/mdf170; Chen HY, 2014, AM J CANCER RES, V4, P89; Willis BC, 2015, AM J PHYSIOL-HEART C, V308, pH467, DOI 10.1152/ajpheart.00734.2013; Conway A, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1407-6; de Boer RA, 2015, EUR J HEART FAIL, V17, P559, DOI 10.1002/ejhf.273; De Buyzere M, 2015, CLIN CHIM ACTA, V443, P1, DOI 10.1016/j.cca.2015.01.015; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Duarte-Costa S, 2014, PHYSIOL RES, V63, P669, DOI 10.33549/physiolres.932712; Ewer MS, 2010, J CLIN ONCOL, V28, P3901, DOI 10.1200/JCO.2010.30.6274; Gimenez MR, 2015, EXPERT REV MOL DIAGN, V15, P547, DOI 10.1586/14737159.2015.1010519; Gupta S, 2007, PROG CARDIOVASC DIS, V50, P151, DOI 10.1016/j.pcad.2007.01.002; Ji YF, 2014, INT J MOL MED, V33, P769, DOI 10.3892/ijmm.2014.1633; Lazo M, 2015, J HEPATOL, V62, P841, DOI 10.1016/j.jhep.2014.11.024; Li YB, 2015, J PROTEOME RES, V14, P2437, DOI 10.1021/pr501116c; Mallick A, 2015, REV ESP CARDIOL, V68, P514, DOI 10.1016/j.rec.2015.02.009; Morris PG, 2013, CANCER-AM CANCER SOC, V119, P3943, DOI 10.1002/cncr.28284; Morris PG, 2011, CLIN CANCER RES, V17, P3490, DOI 10.1158/1078-0432.CCR-10-1359; Most P, 2001, P NATL ACAD SCI USA, V98, P13889, DOI 10.1073/pnas.241393598; Most P, 2006, CIRCULATION, V114, P1258, DOI 10.1161/CIRCULATIONAHA.106.622415; OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3; Omland T, 2015, CLIN CHIM ACTA, V443, P78, DOI 10.1016/j.cca.2014.08.016; Pouleur AC, 2015, CLIN CHIM ACTA, V443, P9, DOI 10.1016/j.cca.2014.10.046; Salama SM, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/137083; Salama SM, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-279; Sawaya H, 2012, CIRC-CARDIOVASC IMAG, V5, P596, DOI 10.1161/CIRCIMAGING.112.973321; Sendur MAN, 2013, CURR MED RES OPIN, V29, P1015, DOI 10.1185/03007995.2013.807232; Singh Dhssraj, 2015, Curr Heart Fail Rep, V12, P255, DOI 10.1007/s11897-015-0258-4; Stevens PL, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-015-0603-y; SUN Y, 1988, CLIN CHEM, V34, P497; Tian S, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00277; TIETZE F, 1969, ANAL BIOCHEM, V27, P502, DOI 10.1016/0003-2697(69)90064-5; van Boxtel W, 2015, BIOMARKERS, V20, P143, DOI 10.3109/1354750X.2015.1040839; van Hasselt JGC, 2011, CLIN PHARMACOL THER, V90, P126, DOI 10.1038/clpt.2011.74; Wright Nathan T, 2009, Curr Chem Biol, V3, P138; Wu AHB, 2015, AM HEART J, V169, P674, DOI 10.1016/j.ahj.2015.01.016	40	10	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145418	10.1371/journal.pone.0145418	http://dx.doi.org/10.1371/journal.pone.0145418			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26682543	Green Submitted, gold, Green Published			2022-12-26	WOS:000366725800074
J	Kanobe, C; McCarville, MT; O'Neal, ME; Tylka, GL; MacIntosh, GC				Kanobe, Charles; McCarville, Michael T.; O'Neal, Matthew E.; Tylka, Gregory L.; MacIntosh, Gustavo C.			Soybean Aphid Infestation Induces Changes in Fatty Acid Metabolism in Soybean	PLOS ONE			English	Article							HETERODERA-GLYCINES; HYDROPEROXIDE LYASE; DESATURASE GENES; PLANT DEFENSES; HOST-PLANT; ARABIDOPSIS; HEMIPTERA; EXPRESSION; RESPONSES; NEMATODE	The soybean aphid (Aphis glycines Matsumura) is one of the most important insect pests of soybeans in the North- central region of the US. It has been hypothesized that aphids avoid effective defenses by inhibition of jasmonate- regulated plant responses. Given the role fatty acids play in jasmonate- induced plant defenses, we analyzed the fatty acid profile of soybean leaves and seeds from aphid-infested plants. Aphid infestation reduced levels of polyunsaturated fatty acids in leaves with a concomitant increase in palmitic acid. In seeds, a reduction in polyunsaturated fatty acids was associated with an increase in stearic acid and oleic acid. Soybean plants challenged with the brown stem rot fungus or with soybean cyst nematodes did not present changes in fatty acid levels in leaves or seeds, indicating that the changes induced by aphids are not a general response to pests. One of the polyunsaturated fatty acids, linolenic acid, is the precursor of jasmonate; thus, these changes in fatty acid metabolism may be examples of " metabolic hijacking" by the aphid to avoid the induction of effective defenses. Based on the changes in fatty acid levels observed in seeds and leaves, we hypothesize that aphids potentially induce interference in the fatty acid desaturation pathway, likely reducing FAD2 and FAD6 activity that leads to a reduction in polyunsaturated fatty acids. Our data support the idea that aphids block jasmonate- dependent defenses by reduction of the hormone precursor.	[Kanobe, Charles; MacIntosh, Gustavo C.] Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA; [McCarville, Michael T.; O'Neal, Matthew E.] Iowa State Univ, Dept Entomol, Ames, IA USA; [Tylka, Gregory L.] Iowa State Univ, Dept Plant Pathol & Microbiol, Ames, IA USA	Iowa State University; Iowa State University; Iowa State University	MacIntosh, GC (corresponding author), Iowa State Univ, Roy J Carver Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA.	gustavo@iastate.edu		MacIntosh, Gustavo/0000-0003-1350-1229	Iowa Soybean Association; soybean checkoff	Iowa Soybean Association; soybean checkoff	This research was supported in part by the Iowa Soybean Association and the soybean checkoff through a grant to GCM, MEO and GLT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghoram K, 2006, CROP SCI, V46, P2453, DOI 10.2135/cropsci2006.04.0218; Arimura G, 2009, PLANT CELL PHYSIOL, V50, P911, DOI 10.1093/pcp/pcp030; Avila CA, 2013, MOL PLANT MICROBE IN, V26, P977, DOI 10.1094/MPMI-01-13-0031-R; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Bate NJ, 1998, PLANT PHYSIOL, V117, P1393, DOI 10.1104/pp.117.4.1393; Bilyeu KD, 2003, CROP SCI, V43, P1833, DOI 10.2135/cropsci2003.1833; Botella MA, 1996, PLANT PHYSIOL, V112, P1201, DOI 10.1104/pp.112.3.1201; BROWSE J, 1989, PLANT PHYSIOL, V90, P522, DOI 10.1104/pp.90.2.522; Chehab EW, 2007, J INTEGR PLANT BIOL, V49, P43, DOI 10.1111/j.1744-7909.2006.00405.x; Chi XY, 2011, PLANT MOL BIOL REP, V29, P769, DOI 10.1007/s11105-010-0284-z; Chiozza MV, 2010, ENVIRON ENTOMOL, V39, P856, DOI 10.1603/EN09338; Clemente TE, 2009, PLANT PHYSIOL, V151, P1030, DOI 10.1104/pp.109.146282; Conconi A, 1996, PLANT PHYSIOL, V111, P797, DOI 10.1104/pp.111.3.797; Creelman Robert A, 2002, Arabidopsis Book, V1, pe0012, DOI 10.1199/tab.0012; De Vos M, 2005, MOL PLANT MICROBE IN, V18, P923, DOI 10.1094/MPMI-18-0923; Dixon AF G, 1998, APHID ECOLOGY; Elzinga DA, 2013, CURR OPIN PLANT BIOL, V16, P451, DOI 10.1016/j.pbi.2013.06.018; ERICKSON EA, 1988, J HERED, V79, P465, DOI 10.1093/oxfordjournals.jhered.a110552; FEHR W. R., 1977, STAGES SOYBEAN DEV; Fehr WR, 2007, CROP SCI, V47, pS72, DOI 10.2135/cropsci2007.04.0004IPBS; Gheysen G, 2011, CURR OPIN PLANT BIOL, V14, P415, DOI 10.1016/j.pbi.2011.03.012; Grant M, 2006, CURR OPIN PLANT BIOL, V9, P414, DOI 10.1016/j.pbi.2006.05.013; Hammond E. G., 1991, MOD METHOD PLANT, V12, P321, DOI DOI 10.1007/978-3-642-84023-4_; HAMMOND EG, 1984, BIOTECHNOLOGY OILS F, P89; Heil M, 2008, NEW PHYTOL, V178, P41, DOI 10.1111/j.1469-8137.2007.02330.x; Heldt H.-W., 2005, PLANT BIOCH; Heppard EP, 1996, PLANT PHYSIOL, V110, P311, DOI 10.1104/pp.110.1.311; Hildebrand D., 2011, PLANT METABOLISM BIO, P27, DOI DOI 10.1002/9781119991311.CH2; Hill CB, 2009, CROP SCI, V49, P1193, DOI 10.2135/cropsci2008.09.0561; Hill J. H., 2001, Plant Disease, V85, P561, DOI 10.1094/PDIS.2001.85.5.561C; Howe GA, 2004, J PLANT GROWTH REGUL, V23, P223, DOI 10.1007/s00344-004-0030-6; Impullitti AE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098311; Li Y, 2008, NEW PHYTOL, V179, P185, DOI 10.1111/j.1469-8137.2008.02443.x; Louis J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00213; Louis J, 2010, PLANT J, V64, P800, DOI 10.1111/j.1365-313X.2010.04378.x; Louis J, 2010, MOL PLANT MICROBE IN, V23, P618, DOI 10.1094/MPMI-23-5-0618; Lygin AV, 2010, PHYTOPATHOLOGY, V100, P897, DOI 10.1094/PHYTO-100-9-0897; Mantelin S, 2015, ADV BOT RES, V73, P325, DOI 10.1016/bs.abr.2014.12.011; McCarville MT, 2012, ENTOMOL EXP APPL, V143, P55, DOI 10.1111/j.1570-7458.2012.01227.x; McCarville MT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086415; McCarville MT, 2012, CROP PROT, V42, P210, DOI 10.1016/j.cropro.2012.05.022; McConn M, 1997, P NATL ACAD SCI USA, V94, P5473, DOI 10.1073/pnas.94.10.5473; Miyara SB, 2015, ADV BOT RES, V73, P139, DOI 10.1016/bs.abr.2014.12.004; Moran PJ, 2001, PLANT PHYSIOL, V125, P1074, DOI 10.1104/pp.125.2.1074; Myers SW, 2005, J ECON ENTOMOL, V98, P113, DOI 10.1603/0022-0493-98.1.113; Nafie E., 2008, J APPL SCI RES, V4, P2046; Niblack TL, 2006, ANNU REV PHYTOPATHOL, V44, P283, DOI 10.1146/annurev.phyto.43.040204.140218; Ragsdale DW, 2007, J ECON ENTOMOL, V100, P1258, DOI 10.1603/0022-0493(2007)100[1258:ETFSAH]2.0.CO;2; Ragsdale DW, 2011, ANNU REV ENTOMOL, V56, P375, DOI 10.1146/annurev-ento-120709-144755; Ragsdale DW, 2004, ANN ENTOMOL SOC AM, V97, P204, DOI 10.1603/0013-8746(2004)097[0204:SABINA]2.0.CO;2; Sandhu D, 2007, J AM OIL CHEM SOC, V84, P229, DOI 10.1007/s11746-007-1037-5; Schmid KM., 2002, BIOCH LIPIDS LIPOPRO, P93; Studham ME, 2013, MOL PLANT MICROBE IN, V26, P116, DOI 10.1094/MPMI-05-12-0124-FI; Studham Matthew E, 2012, BMC Res Notes, V5, P392; Thiex NJ, 2003, J AOAC INT, V86, P899; Tooker JF, 2009, MOL PLANT MICROBE IN, V22, P551, DOI 10.1094/MPMI-22-5-0551; Upchurch RG, 2010, J AM OIL CHEM SOC, V87, P857, DOI 10.1007/s11746-010-1576-z; Vancanneyt G, 2001, P NATL ACAD SCI USA, V98, P8139, DOI 10.1073/pnas.141079498; Varenhorst AJ, 2015, ENVIRON ENTOMOL, V44, P658, DOI 10.1093/ee/nvv051; Varenhorst AJ, 2015, ARTHROPOD-PLANT INTE, V9, P457, DOI 10.1007/s11829-015-9395-7; Wallis JG, 2002, PROG LIPID RES, V41, P254, DOI 10.1016/S0163-7827(01)00027-3; Will T, 2007, P NATL ACAD SCI USA, V104, P10536, DOI 10.1073/pnas.0703535104; Workneh F, 1999, PHYTOPATHOLOGY, V89, P204, DOI 10.1094/PHYTO.1999.89.3.204; Wrather JA, 2006, J NEMATOL, V38, P173; YADAV NS, 1993, PLANT PHYSIOL, V103, P467, DOI 10.1104/pp.103.2.467; Zarate SI, 2007, PLANT PHYSIOL, V143, P866, DOI 10.1104/pp.106.090035; Zhu JW, 2005, J CHEM ECOL, V31, P1733, DOI 10.1007/s10886-005-5923-8; Zhuang H, 1996, PLANT PHYSIOL, V111, P805, DOI 10.1104/pp.111.3.805	68	13	13	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145660	10.1371/journal.pone.0145660	http://dx.doi.org/10.1371/journal.pone.0145660			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684003	gold, Green Published, Green Submitted			2022-12-26	WOS:000366725800084
J	Watanabe, A; Gold, MEL; Brusatte, SL; Benson, RBJ; Choiniere, J; Davidson, A; Norell, MA				Watanabe, Akinobu; Gold, Maria Eugenia Leone; Brusatte, Stephen L.; Benson, Roger B. J.; Choiniere, Jonah; Davidson, Amy; Norell, Mark A.			Vertebral Pneumaticity in the Ornithomimosaur Archaeornithomimus (Dinosauria: Theropoda) Revealed by Computed Tomography Imaging and Reappraisal of Axial Pneumaticity in Ornithomimosauria	PLOS ONE			English	Article							POSTCRANIAL SKELETAL PNEUMATICITY; AIR-SACS; GIANT ORNITHOMIMOSAUR; PNEUMATIZATION; EVOLUTION; RECONSTRUCTION; ORIGIN	Among extant vertebrates, pneumatization of postcranial bones is unique to birds, with few known exceptions in other groups. Through reduction in bone mass, this feature is thought to benefit flight capacity in modern birds, but its prevalence in non-avian dinosaurs of variable sizes has generated competing hypotheses on the initial adaptive significance of postcranial pneumaticity. To better understand the evolutionary history of postcranial pneumaticity, studies have surveyed its distribution among non-avian dinosaurs. Nevertheless, the degree of pneumaticity in the basal coelurosaurian group Ornithomimosauria remains poorly known, despite their potential to greatly enhance our understanding of the early evolution of pneumatic bones along the lineage leading to birds. Historically, the identification of postcranial pneumaticity in non-avian dinosaurs has been based on examination of external morphology, and few studies thus far have focused on the internal architecture of pneumatic structures inside the bones. Here, we describe the vertebral pneumaticity of the ornithomimosaur Archaeornithomimus with the aid of X-ray computed tomography (CT) imaging. Complementary examination of external and internal osteology reveals (1) highly pneumatized cervical vertebrae with an elaborate configuration of interconnected chambers within the neural arch and the centrum; (2) anterior dorsal vertebrae with pneumatic chambers inside the neural arch; (3) apneumatic sacral vertebrae; and (4) a subset of proximal caudal vertebrae with limited pneumatic invasion into the neural arch. Comparisons with other theropod dinosaurs suggest that ornithomimosaurs primitively exhibited a plesio-morphic theropod condition for axial pneumaticity that was extended among later taxa, such as Archaeornithomimus and large bodied Deinocheirus. This finding corroborates the notion that evolutionary increases in vertebral pneumaticity occurred in parallel among independent lineages of bird-line archosaurs. Beyond providing a comprehensive view of vertebral pneumaticity in a non-avian coelurosaur, this study demonstrates the utility and need of CT imaging for further clarifying the early evolutionary history of postcranial pneumaticity.	[Watanabe, Akinobu; Gold, Maria Eugenia Leone; Davidson, Amy; Norell, Mark A.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Watanabe, Akinobu; Gold, Maria Eugenia Leone; Norell, Mark A.] Amer Museum Nat Hist, Richard Gilder Grad Sch, New York, NY 10024 USA; [Brusatte, Stephen L.] Univ Edinburgh, Sch GeoSci, Edinburgh EH8 9YL, Midlothian, Scotland; [Benson, Roger B. J.] Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; [Benson, Roger B. J.; Choiniere, Jonah] Univ Witwatersrand, Evolutionary Studies Inst, Johannesburg, South Africa; [Benson, Roger B. J.; Choiniere, Jonah] Univ Witwatersrand, DST NRF Ctr Excellence Palaeosci, Johannesburg, South Africa	American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); University of Edinburgh; University of Oxford; University of Witwatersrand; University of Witwatersrand	Watanabe, A (corresponding author), Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA.	awatanabe@amnh.org	Watanabe, Akinobu/ABE-2244-2021		Richard Gilder Graduate School at the American Museum of Natural History; NSF Graduate Research Fellowship; NSF [DEB 1110357]; Columbia University; Royal Society Research Grant [RG130018]; Marie Curie Career Integration Grant [FP7-PEOPLE-2013-CIG 630652]; Department of Science and Technology and National Research Foundation of South Africa Centre of Excellence in Palaeosciences; Friedel Sellschop Award through the University of the Witwatersrand; Palaeontological Scientific Trust; Scatterlings of Africa Programmes; National Research Foundation of South Africa Incentive Funding for Rated Researchers; American Museum of Natural History Division of Paleontology	Richard Gilder Graduate School at the American Museum of Natural History; NSF Graduate Research Fellowship(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Columbia University; Royal Society Research Grant(Royal Society of London); Marie Curie Career Integration Grant; Department of Science and Technology and National Research Foundation of South Africa Centre of Excellence in Palaeosciences; Friedel Sellschop Award through the University of the Witwatersrand; Palaeontological Scientific Trust; Scatterlings of Africa Programmes; National Research Foundation of South Africa Incentive Funding for Rated Researchers; American Museum of Natural History Division of Paleontology	This study was funded by the Richard Gilder Graduate School at the American Museum of Natural History (AW, MELG), Kalbfleisch Fellowship and Gerstner Scholarship (JNC) administered by the Richard Gilder Graduate School at the American Museum of Natural History; NSF Graduate Research Fellowship (SLB, AW), NSF DEB 1110357 (SLB), Columbia University (SLB), Royal Society Research Grant RG130018 (SLB), Marie Curie Career Integration Grant FP7-PEOPLE-2013-CIG 630652 (SLB), Department of Science and Technology and National Research Foundation of South Africa Centre of Excellence in Palaeosciences grants in aid of research (JNC), Friedel Sellschop Award through the University of the Witwatersrand (JNC), Palaeontological Scientific Trust (PAST) and its Scatterlings of Africa Programmes (JNC), National Research Foundation of South Africa Incentive Funding for Rated Researchers (JNC), and the American Museum of Natural History Division of Paleontology (AW, MELG, SLB, JC, AD, MAN).	Bellairs A.D., 1960, BIOL COMP PHYSL BIRD, V1, P241, DOI DOI 10.1016/B978-1-4832-3142-6.50012-4; Benson RBJ, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001853; Benson RBJ, 2012, BIOL REV, V87, P168, DOI 10.1111/j.1469-185X.2011.00190.x; Britt B., 1997, ENCY DINOSAURS, P590; Britt BB, 1998, NATURE, V395, P374, DOI 10.1038/26469; Britt BB, 1993, THESIS; Brusatte SL, 2014, CURR BIOL, V24, P2386, DOI 10.1016/j.cub.2014.08.034; Butler RJ, 2009, BIOL LETTERS, V5, P557, DOI 10.1098/rsbl.2009.0139; Choiniere JN, 2012, J AFR EARTH SCI, V71-72, P1, DOI 10.1016/j.jafrearsci.2012.05.005; Christiansen P, 2000, P ROY SOC B-BIOL SCI, V267, P2501, DOI 10.1098/rspb.2000.1311; Claessens LPAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004497; Crisp E., 1857, P ZOOL SOC LOND, V25, P215, DOI [10.1111/j.1096-3642.1857.tb01229.x, DOI 10.1111/J.1096-3642.1857.TB01229.X]; CURREY JD, 1985, J ZOOL, V206, P453; CURRIE PJ, 1993, CRETACEOUS RES, V14, P127, DOI 10.1006/cres.1993.1011; De Klerk WJ, 2000, J VERTEBR PALEONTOL, V20, P324, DOI 10.1671/0272-4634(2000)020[0324:ANCDFT]2.0.CO;2; Duncker H.-R., 1971, ADV ANAT EMBRYOL CEL, V45, P1; DUNCKER HR, 1989, LIFE SCI R, V45, P147; Fajardo RJ, 2007, J ANAT, V211, P138, DOI 10.1111/j.1469-7580.2007.00749.x; Farmer CG, 2006, RESP PHYSIOL NEUROBI, V154, P89, DOI 10.1016/j.resp.2006.04.014; Gauthier J., 1986, Memoirs of the California Academy of Sciences, P1; Gold MEL, 2013, AM MUS NOVIT, P1; HOGG DA, 1984, J ANAT, V139, P105; HOGG DA, 1984, J ANAT, V138, P617; Hunter J, 1774, PHILOS T ROY SOC LON, V64, P205; Janensch W., 1947, PALAEONTOGRAPHICA S, V7, P1; Ji Q, 2003, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2003)420<0001:AEODAI>2.0.CO;2; King A. S., 1966, International Review of General and Experimental Zoology, V2, P171; KING A. S., 1956, BRIT VET JOUR, V112, P279; KING A. S., 1957, ACTA ANAT, V31, P220; KING AS, 1979, FORM FUNCTION BIRDS; Kobayashi Y, 2005, CAN J EARTH SCI, V42, P1501, DOI 10.1139/E05-044; Kobayashi Y, 2003, ACTA PALAEONTOL POL, V48, P235; Lee YN, 2014, NATURE, V515, P257, DOI 10.1038/nature13874; MAGNUSSEN H, 1979, RESP PHYSL, V27, P129; Makovicky P. J., 2011, LIVING DINOSAURS EVO, P9, DOI DOI 10.1002/9781119990475.CH1; Makovicky PJ, 2004, DINOSAURIA, 2ND EDITION, P137; Makovicky PJ, 2010, P ROY SOC B-BIOL SCI, V277, P191, DOI 10.1098/rspb.2009.0236; Martin EG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097159; McLelland J., 1989, P221; Nysten M., 1962, ANN MUSEE ROYAL AFRI, V8, P187; O'Connor PM, 2007, J VERTEBR PALEONTOL, V27, P127; O'Connor PM, 2006, J MORPHOL, V267, P1199, DOI 10.1002/jmor.10470; O'Connor PM, 2004, J MORPHOL, V261, P141, DOI 10.1002/jmor.10190; O'Connor PM, 2005, NATURE, V436, P253, DOI 10.1038/nature03716; O'Connor PM, 2009, J EXPT ZOOLOGY A, V311A, P504, DOI [10.1002/jez.548, DOI 10.1002/JEZ.548]; Osmolska H., 1972, Palaeontologia Polonica, VNo. 27, P103; PEREZMORENO BP, 1994, NATURE, V370, P363, DOI 10.1038/370363a0; Ruben JA, 2003, PHYSIOL BIOCHEM ZOOL, V76, P141, DOI 10.1086/375425; Scheid P., 1989, P369; Scheid P., 1982, MODEL COMP GAS EXCHA; Sereno PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003303; Smith D., 1990, Journal of Vertebrate Paleontology, V10, P255; Taylor MP, 2007, PALAEONTOLOGY, V50, P1547, DOI 10.1111/j.1475-4983.2007.00728.x; Watanabe A, 2013, J VERTEBR PALEONTOL, V33, P1169, DOI 10.1080/02724634.2013.770750; Wedel MJ, 2005, SAUROPODS: EVOLUTION AND PALEOBIOLOGY, P201; Wedel MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078213; Wedel MJ, 2006, INTEGR ZOOL, V1, P80, DOI 10.1111/j.1749-4877.2006.00019.x; Wedel MJ, 2009, J EXP ZOOL PART A, V311A, P611, DOI 10.1002/jez.513; Wedel MJ, 2000, ACTA PALAEONTOL POL, V45, P343; Wedel MJ, 2003, PALEOBIOLOGY, V29, P243, DOI 10.1666/0094-8373(2003)029<0243:VPASAT>2.0.CO;2; Welty J. C., 1982, LIFE BIRDS; Wilson JA, 1999, J VERTEBR PALEONTOL, V19, P639, DOI 10.1080/02724634.1999.10011178; Wilson JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017114; Witmer LM, 1997, J VERTEBR PALEONTOL, V17, P1, DOI 10.1080/02724634.1997.10011027; Xu X, 2014, SCIENCE, V346, P1341, DOI 10.1126/science.1253293	65	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145168	10.1371/journal.pone.0145168	http://dx.doi.org/10.1371/journal.pone.0145168			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26682888	Green Published, gold, Green Submitted			2022-12-26	WOS:000366725800040
J	Soleymani, A; Pennekamp, F; Petchey, OL; Weibel, R				Soleymani, Ali; Pennekamp, Frank; Petchey, Owen L.; Weibel, Robert			Developing and Integrating Advanced Movement Features Improves Automated Classification of Ciliate Species	PLOS ONE			English	Article							CROSS-SCALE ANALYSIS; IMAGE-ANALYSIS; BEHAVIOR; PROTOZOA; SYSTEM; TAXONOMY; ECOLOGY; MODELS; TIME; FOOD	Recent advances in tracking technologies such as GPS or video tracking systems describe the movement paths of individuals in unprecedented details and are increasingly used in different fields, including ecology. However, extracting information from raw movement data requires advanced analysis techniques, for instance to infer behaviors expressed during a certain period of the recorded trajectory, or gender or species identity in case data is obtained from remote tracking. In this paper, we address how different movement features affect the ability to automatically classify the species identity, using a dataset of unicellular microbes (i.e., ciliates). Previously, morphological attributes and simple movement metrics, such as speed, were used for classifying ciliate species. Here, we demonstrate that adding advanced movement features, in particular such based on discrete wavelet transform, to morphological features can improve classification. These results may have practical applications in automated monitoring of waste water facilities as well as environmental monitoring of aquatic systems.	[Soleymani, Ali; Weibel, Robert] Univ Zurich, Dept Geog, Zurich, Switzerland; [Pennekamp, Frank; Petchey, Owen L.] Univ Zurich, Inst Evolutionary Biol & Environm Studies, Zurich, Switzerland; [Petchey, Owen L.] Eawag Swiss Fed Inst Aquat Sci & Technol, Dept Aquat Ecol, Dubendorf, Switzerland	University of Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute of Aquatic Science & Technology (EAWAG)	Soleymani, A (corresponding author), Univ Zurich, Dept Geog, Zurich, Switzerland.	ali.soleymani@geo.uzh.ch	Pennekamp, Frank/ABD-3597-2020; Petchey, Owen/D-8851-2011	Pennekamp, Frank/0000-0003-0679-1045; Petchey, Owen/0000-0002-7724-1633; Weibel, Robert/0000-0002-2425-0077	University of Zurich; University of Zurich Research Priority Program on 'Global Change and Biodiversity' (URPP GCB)	University of Zurich; University of Zurich Research Priority Program on 'Global Change and Biodiversity' (URPP GCB)	AS and FP were supported by the University of Zurich. Contributions of OLP were supported by the University of Zurich Research Priority Program on 'Global Change and Biodiversity' (URPP GCB).	Altermatt F, 2015, METHODS ECOL EVOL, V6, P218, DOI 10.1111/2041-210X.12312; Amaral AL, 2008, ANAL BIOANAL CHEM, V391, P1321, DOI 10.1007/s00216-008-1845-y; Amaral AL, 2004, ENVIRONMETRICS, V15, P381, DOI 10.1002/env.652; Amer M., 2011, 2011 IEEE International Conference on Computer Vision Workshops (ICCV Workshops), P1488, DOI 10.1109/ICCVW.2011.6130426; Bell JL, 2008, J PLANKTON RES, V30, P1351, DOI 10.1093/plankt/fbn092; Beyer HL, 2013, METHODS ECOL EVOL, V4, P433, DOI 10.1111/2041-210X.12026; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Cagnacci F, 2010, PHILOS T R SOC B, V365, P2157, DOI 10.1098/rstb.2010.0107; Chang YC, 2011, HYDROBIOLOGIA, V666, P223, DOI 10.1007/s10750-010-0548-5; Chen MR, 2012, J EXP MAR BIOL ECOL, V422, P14, DOI 10.1016/j.jembe.2012.04.005; Conradt L, 2000, P ROY SOC B-BIOL SCI, V267, P1505, DOI 10.1098/rspb.2000.1171; DAUBECHIES I, 1990, IEEE T INFORM THEORY, V36, P961, DOI 10.1109/18.57199; de Weerd N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129030; Dell AI, 2014, TRENDS ECOL EVOL, V29, P417, DOI 10.1016/j.tree.2014.05.004; Demsar U, 2015, MOV ECOL, V3, DOI 10.1186/s40462-015-0032-y; Dodge S, 2009, COMPUT ENVIRON URBAN, V33, P419, DOI 10.1016/j.compenvurbsys.2009.07.008; Dodge S, 2008, INFORM VISUAL, V7, P240, DOI 10.1057/palgrave.ivs.9500182; Dray S, 2010, ECOL RES, V25, P673, DOI 10.1007/s11284-010-0701-7; Fagan WF, 2013, ECOL LETT, V16, P1316, DOI 10.1111/ele.12165; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Fenchel T, 1999, PROTIST, V150, P325, DOI 10.1016/S1434-4610(99)70033-7; Finlay BJ, 2004, PHILOS T R SOC B, V359, P599, DOI 10.1098/rstb.2003.1450; Gaucherel C., 2011, Computational Ecology and Software, V1, P69; Ginoris YP, 2007, WATER RES, V41, P2581, DOI 10.1016/j.watres.2007.02.006; Guler I, 2005, J NEUROSCI METH, V148, P113, DOI 10.1016/j.jneumeth.2005.04.013; Gurarie E, 2015, J ANIM ECOL; Gurarie E, 2009, ECOL LETT, V12, P395, DOI 10.1111/j.1461-0248.2009.01293.x; Hennessey TM, 2012, METHOD CELL BIOL, V109, P393, DOI [10.1016/B978-0-12-395967-9.00015-3, 10.1016/B978-0-12-385967-9.00015-3]; Joo D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077686; Jordan D, 2013, P NATL ACAD SCI USA, V110, P14018, DOI 10.1073/pnas.1308282110; Kuhn M, 2008, J STAT SOFTW, V28, P1, DOI 10.18637/jss.v028.i05; Laube P, 2011, T GIS, V15, P401, DOI 10.1111/j.1467-9671.2011.01256.x; Li X., 2014, AM J GEOGR INF SYST, V3, P63; Long JA, 2013, INT J GEOGR INF SCI, V27, P292, DOI 10.1080/13658816.2012.682578; Lynn D., 2011, CILIATED PROTOZOA CH; MALLAT SG, 1989, IEEE T ACOUST SPEECH, V37, P2091, DOI 10.1109/29.45554; Mallat SG, 1989, IEEE T PATTERN ANAL, VI, P1604; March D, 2010, MAR ECOL PROG SER, V400, P195, DOI 10.3354/meps08410; Mesquita DP, 2013, ANAL CHIM ACTA, V802, P14, DOI 10.1016/j.aca.2013.09.016; Nams VO, 2014, ECOL LETT, V17, P1228, DOI 10.1111/ele.12328; Nathan R, 2012, J EXP BIOL, V215, P986, DOI 10.1242/jeb.058602; Pennekamp F, 2015, ECOL EVOL, V5, P2584, DOI 10.1002/ece3.1529; Pernthaler J, 2005, NAT REV MICROBIOL, V3, P537, DOI 10.1038/nrmicro1180; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Relyea RA, 2001, ECOLOGY, V82, P523, DOI 10.1890/0012-9658(2001)082[0523:MABPOL]2.0.CO;2; Riotte-Lambert L, 2013, J THEOR BIOL, V317, P238, DOI 10.1016/j.jtbi.2012.10.026; Soleymani A, 2014, J SPAT INT SCI, P1, DOI 10.5311/JOSIS.2014.8.162; Subasi A, 2007, EXPERT SYST APPL, V32, P1084, DOI 10.1016/j.eswa.2006.02.005; Sur M, 2014, ECOL INFORM, V20, P47, DOI 10.1016/j.ecoinf.2014.01.007; Webb SL, 2009, J MAMMAL, V90, P1210, DOI 10.1644/08-MAMM-A-278.1; Wittemyer G, 2008, P NATL ACAD SCI USA, V105, P19108, DOI 10.1073/pnas.0801744105	51	8	8	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145345	10.1371/journal.pone.0145345	http://dx.doi.org/10.1371/journal.pone.0145345			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26680591	Green Accepted, Green Published, gold			2022-12-26	WOS:000366723400072
J	Sapey-Triomphe, LA; Heckemann, RA; Boublay, N; Dorey, JM; Henaff, MA; Rouch, I; Padovan, C; Hammers, A; Krolak-Salmon, P				Sapey-Triomphe, Laurie-Anne; Heckemann, Rolf A.; Boublay, Nawele; Dorey, Jean-Michel; Henaff, Marie-Anne; Rouch, Isabelle; Padovan, Catherine; Hammers, Alexander; Krolak-Salmon, Pierre		Alzheimers Dis Neuroimaging Initia	Neuroanatomical Correlates of Recognizing Face Expressions in Mild Stages of Alzheimer's Disease	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; EMOTION RECOGNITION; FACIAL EXPRESSIONS; ELDERLY SUBJECTS; UP-REGULATION; HUMAN BRAIN; DISGUST; DIAGNOSIS; MEMORY; REGIONS	Early Alzheimer's disease can involve social disinvestment, possibly as a consequence of impairment of nonverbal communication skills. This study explores whether patients with Alzheimer's disease at the mild cognitive impairment or mild dementia stage have impaired recognition of emotions in facial expressions, and describes neuroanatomical correlates of emotion processing impairment. As part of the ongoing PACO study (personality, Alzheimer's disease and behaviour), 39 patients with Alzheimer's disease at the mild cognitive impairment or mild dementia stage and 39 matched controls completed tests involving discrimination of four basic emotions-happiness, fear, anger, and disgust-on photographs of faces. In patients, automatic volumetry of 83 brain regions was performed on structural magnetic resonance images using MAPER (multi-atlas propagation with enhanced registration). From the literature, we identified for each of the four basic emotions one brain region thought to be primarily associated with the function of recognizing that emotion. We hypothesized that the volume of each of these regions would be correlated with subjects' performance in recognizing the associated emotion. Patients showed deficits of basic emotion recognition, and these impairments were correlated with the volumes of the expected regions of interest. Unexpectedly, most of these correlations were negative: better emotional facial recognition was associated with lower brain volume. In particular, recognition of fear was negatively correlated with the volume of amygdala, disgust with pallidum, and happiness with fusiform gyrus. Recognition impairment in mild stages of Alzheimer's disease for a given emotion was thus associated with less visible atrophy of functionally responsible brain structures within the patient group. Possible explanations for this counterintuitive result include neuroinflammation, regional beta-amyloid deposition, or transient overcompensation during early stages of Alzheimer's disease.	[Sapey-Triomphe, Laurie-Anne; Heckemann, Rolf A.; Hammers, Alexander] CERMEP Imagerie Vivant, Neurodis Fdn, Lyon, France; [Sapey-Triomphe, Laurie-Anne; Henaff, Marie-Anne; Padovan, Catherine; Krolak-Salmon, Pierre] CNRS, UMR 5292, Lyon Neurosci Res Ctr, Brain Dynam & Cognit,INSERM,U1028, Lyon, France; [Sapey-Triomphe, Laurie-Anne] Ecole Normale Super Lyon, F-69364 Lyon, France; [Heckemann, Rolf A.] Univ Gothenburg, Sahlgrenska Univ Hosp, MedTech West, Gothenburg, Sweden; [Heckemann, Rolf A.] Univ London Imperial Coll Sci Technol & Med, Div Brain Sci, London, England; [Boublay, Nawele; Dorey, Jean-Michel; Rouch, Isabelle; Krolak-Salmon, Pierre] Hosp Civils Lyon, Clin & Res Memory Ctr Lyon, Hop Charpennes, Lyon, France; [Boublay, Nawele] Hosp Civils Lyon, Dept Med Informat & Res Evaluat, Lyon, France; [Boublay, Nawele; Krolak-Salmon, Pierre] Univ Lyon 1, F-69000 Lyon, France; [Dorey, Jean-Michel; Padovan, Catherine] Ctr Hosp Le Vinatier, Pole Est, Bron, France; [Hammers, Alexander] Kings Coll London, Div Imaging Sci & Biomed Engn, London WC2R 2LS, England	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Jean Monnet; Ecole Normale Superieure de Lyon (ENS de LYON); Sahlgrenska University Hospital; University of Gothenburg; Imperial College London; CHU Lyon; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of London; King's College London	Heckemann, RA (corresponding author), MedTech West, Roda Straket 10B, S-41345 Gothenburg, Sweden.	rolf.heckemann@medtechwest.se	krolak-salmon, pierre/AAV-2152-2020; Heckemann, Rolf Andreas/H-9022-2019; Hammers, Alexander/D-9982-2015	Heckemann, Rolf Andreas/0000-0003-3582-3683; Hammers, Alexander/0000-0001-9530-4848	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; DOD ADNI (Department of Defense) [W81XWH-12-2-0012]; National Institute on Aging; National Institute of Biomedical Imaging and Bioengineering; Canadian Institutes of Health Research; National Hospital-Based Clinical Research Program (PHRC); AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd.; Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; Transition Therapeutics; NATIONAL INSTITUTE ON AGING [U01AG024904] Funding Source: NIH RePORTER	Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DOD ADNI (Department of Defense); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Hospital-Based Clinical Research Program (PHRC); AbbVie, Alzheimer's Association(AbbVie); Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen(Biogen); Bristol-Myers Squibb Company(Bristol-Myers Squibb); CereSpir, Inc.; Eisai Inc.(Eisai Co Ltd); Elan Pharmaceuticals, Inc.; Eli Lilly and Company(Eli Lilly); EuroImmun; F. Hoffmann-La Roche Ltd.(Hoffmann-La Roche); Genentech, Inc.(Roche HoldingGenentech); Fujirebio; GE Healthcare(General ElectricGE Healthcare); IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.(Johnson & JohnsonJohnson & Johnson USA); Lumosity; Lundbeck(Lundbeck Corporation); Merck Co., Inc.(Merck & Company); Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation(Novartis); Pfizer Inc.(Pfizer); Piramal Imaging; Servier(Servier); Takeda Pharmaceutical Company(Takeda Pharmaceutical Company Ltd); Transition Therapeutics; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The PACO project (PI: Prof. Pierre Krolak-Salmon) was financed by a grant from the French Ministry of Health via the Hospital Programme for Clinicial Research (Le programme hospitalier de recherche clinique). Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-2-0012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd. and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosi ty; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; PACO is financed by the National Hospital-Based Clinical Research Program (PHRC). We would like to thank all study participants and their carers for their time.; One part of the data used in preparation of this article was obtained from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database (adni.loni.usc.edu). As such, the investigators within the ADNI contributed to the design and implementation of ADNI and/or provided data but did not participate in analysis or writing of this report. A complete listing of ADNI investigators can be found at: http://adni.loni.usc.edu/wpcontent/uploads/how_to_apply/ADNI_Acknowledgement_List.pdf. Datacollection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) and DOD ADNI (Department of Defense award number W81XWH-12-20012). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: AbbVie, Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Araclon Biotech; BioClinica, Inc.; Biogen; Bristol-Myers Squibb Company; CereSpir, Inc.; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; EuroImmun; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; Fujirebio; GE Healthcare; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Lumosity; Lundbeck; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Neurotrack Technologies; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Takeda Pharmaceutical Company; and Transition Therapeutics. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of Southern California.	Adalbert R, 2013, NEUROPATH APPL NEURO, V39, P90, DOI 10.1111/j.1365-2990.2012.01308.x; Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Adolphs Ralph, 2002, Behav Cogn Neurosci Rev, V1, P21, DOI 10.1177/1534582302001001003; Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Albert MS, 2011, NEUROBIOL AGING, V32, pS58, DOI 10.1016/j.neurobiolaging.2011.09.010; Alexander-Bloch A, 2013, NAT REV NEUROSCI, V14, P322, DOI 10.1038/nrn3465; Amieva H, 2008, ANN NEUROL, V64, P492, DOI 10.1002/ana.21509; Bediou B, 2005, CAN J PSYCHIAT, V50, P525, DOI 10.1177/070674370505000905; Bediou B, 2009, J GERIATR PSYCH NEUR, V22, P130, DOI 10.1177/0891988709332939; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blair RJR, 1999, BRAIN, V122, P883, DOI 10.1093/brain/122.5.883; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bussiere T, 2002, NEUROSCIENCE, V112, P75, DOI 10.1016/S0306-4522(02)00056-8; Calder AJ, 2000, NAT NEUROSCI, V3, P1077, DOI 10.1038/80586; Chetelat G, 2003, NEUROIMAGE, V18, P525, DOI 10.1016/S1053-8119(02)00026-5; DeKosky ST, 2002, ANN NEUROL, V51, P145, DOI 10.1002/ana.10069; Dickerson BC, 2005, NEUROLOGY, V65, P404, DOI 10.1212/01.wnl.0000171450.97464.49; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Edison P, 2008, NEUROBIOL DIS, V32, P412, DOI 10.1016/j.nbd.2008.08.001; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gousias IS, 2008, NEUROIMAGE, V40, P672, DOI 10.1016/j.neuroimage.2007.11.034; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; Hargrave R, 2002, J NEUROPSYCH CLIN N, V14, P64, DOI 10.1176/jnp.14.1.64; Heckemann RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129211; Heckemann RA, 2011, NEUROIMAGE, V56, P2024, DOI 10.1016/j.neuroimage.2011.03.014; Heckemann RA, 2010, NEUROIMAGE, V51, P221, DOI 10.1016/j.neuroimage.2010.01.072; Henry JD, 2008, NEUROPSYCHOLOGIA, V46, P1363, DOI 10.1016/j.neuropsychologia.2007.12.012; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; Keihaninejad S, 2010, NEUROIMAGE, V50, P1427, DOI 10.1016/j.neuroimage.2010.01.064; Kohler CG, 2005, AM J GERIAT PSYCHIAT, V13, P926, DOI 10.1176/appi.ajgp.13.11.926; Krolak-Salmon P, 2006, REV NEUROL-FRANCE, V162, P1047, DOI 10.1016/S0035-3787(06)75117-7; Krolak-Salmon P, 2003, ANN NEUROL, V53, P446, DOI 10.1002/ana.10502; Kumfor F, 2014, BRAIN, V137, P3061, DOI 10.1093/brain/awu246; LAAKSO MP, 1995, J NEURAL TRANSM-PARK, V9, P73, DOI 10.1007/BF02252964; LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629; Lindquist KA, 2012, BEHAV BRAIN SCI, V35, P121, DOI 10.1017/S0140525X11000446; McCade D, 2011, DEMENT GERIATR COGN, V32, P257, DOI 10.1159/000335009; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mormino EC, 2009, BRAIN, V132, P1310, DOI 10.1093/brain/awn320; Perrin M, 2012, J ALZHEIMERS DIS, V29, P817, DOI 10.3233/JAD-2012-111490; Petersen RC, 2000, NEUROLOGY, V54, P581, DOI 10.1212/WNL.54.3.581; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Putcha D, 2011, J NEUROSCI, V31, P17680, DOI 10.1523/JNEUROSCI.4740-11.2011; Sapey-Triomphe LA, 2015, PACO BASELINE MR BRA, DOI [10.6084/m9.figshare.1534657, DOI 10.6084/M9.FIGSHARE.1534657]; Spoletini I, 2008, AM J GERIAT PSYCHIAT, V16, P389, DOI 10.1097/JGP.0b013e318165dbce; Sprengelmeyer R, 1996, BRAIN, V119, P1647, DOI 10.1093/brain/119.5.1647; Teng E, 2007, DEMENT GERIATR COGN, V23, P271, DOI 10.1159/000100829; Truchot L, 2007, NEUROLOGY, V69, P1012, DOI 10.1212/01.wnl.0000271377.52421.4a; Vuilleumier P, 2007, NEUROPSYCHOLOGIA, V45, P174, DOI 10.1016/j.neuropsychologia.2006.06.003; Weiss EM, 2008, AM J GERIAT PSYCHIAT, V16, P974, DOI 10.1097/JGP.0b013e318186bd53; Whitwell JL, 2007, ARCH NEUROL-CHICAGO, V64, P1130, DOI 10.1001/archneur.64.8.1130; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Willis M, 2011, J NEURAL TRANSM, V118, P727, DOI 10.1007/s00702-011-0648-z	54	29	31	3	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0143586	10.1371/journal.pone.0143586	http://dx.doi.org/10.1371/journal.pone.0143586			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673928	Green Submitted, gold, Green Published			2022-12-26	WOS:000366722700012
J	Azzoni, L; Barbour, R; Papasavvas, E; Glencross, DK; Stevens, WS; Cotton, MF; Violari, A; Montaner, LJ				Azzoni, Livio; Barbour, Russell; Papasavvas, Emmanouil; Glencross, Deborah K.; Stevens, Wendy S.; Cotton, Mark F.; Violari, Avy; Montaner, Luis J.			Early ART Results in Greater Immune Reconstitution Benefits in HIV-Infected Infants: Working with Data Missingness in a Longitudinal Dataset	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; T-CELL-ACTIVATION; MICROBIAL TRANSLOCATION; INTERLEUKIN-7 LEVELS; PLASMA-LEVELS; CHILDREN; RECOVERY; SUBSETS; RESPONSES; PREDICT	Background Early initiation of anti-retroviral treatment (ART) decreases mortality as compared to deferred treatment, but whether it preserves immune cells from early loss or promotes their recovery remains undefined. Determination of complex immunological endpoints in infants is often marred by missing data due to missed visits and/or inadequate sampling. Specialized methods are required to address missingness and facilitate data analysis. Methods We characterized the changes in cellular and humoral immune parameters over the first year of life in 66 HIV-infected infants (0-1 year of age) enrolled in the CHER study starting therapy within 12 weeks of birth (n = 42) or upon disease progression (n = 24). A convenience cohort of 23 uninfected infants aged 0-6 months born to mothers with HIV-1 infection was used as controls. Flow cytometry and ELISA were used to evaluate changes in natural killer (NK) cells, plasmacytoid dendritic cells (pDC), and CD4(+) or CD8(+) T-cell frequencies. Data missingness was assessed using Little's test. Complete datasets for analysis were created using Multiple Imputation (MI) or Bayesian modeling and multivariate analysis was conducted on the imputed datasets. Results HIV-1-infected infants had greater frequency of CD4(+) T cells with naive phenotype, as well as higher serum IL-7 levels than HIV exposed/uninfected infants. The elevated data missingness was completely at random, allowing the use of both MI and Bayesian modeling. Both methods indicate that early ART initiation results in higher CD4(+) T cell frequency, lower expression of CD95 in CD8(+) T cell, and preservation of naive T cell subsets. In contrast, innate immune effectors appeared to be similar independently of the timing of ART initiation. Conclusions Early ART initiation in infants with perinatal HIV infection reduces immune activation and preserves an early expansion of naive T-cells with undiminished innate cell numbers, giving greater immune reconstitution than achieved with deferred ART. Both statistical approaches concurred in this finding.	[Azzoni, Livio; Papasavvas, Emmanouil; Montaner, Luis J.] Wistar Inst Anat & Biol, Philadelphia, PA 19104 USA; [Barbour, Russell] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT USA; [Glencross, Deborah K.; Stevens, Wendy S.] Univ Witwatersrand, Dept Mol Med & Hematol, Johannesburg, South Africa; [Glencross, Deborah K.; Stevens, Wendy S.] Natl Hlth Lab Serv, Johannesburg, South Africa; [Cotton, Mark F.] Univ Stellenbosch, Dept Paediat & Child Hlth, Childrens Infect Dis Clin Res Unit, Cape Town, South Africa; [Violari, Avy] Univ Witwatersrand, Perinatal HIV Res Unit, Johannesburg, South Africa	The Wistar Institute; Yale University; University of Witwatersrand; National Health Laboratory Service; Stellenbosch University; University of Witwatersrand	Montaner, LJ (corresponding author), Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA.	Montaner@wistar.org	Cotton, Mark/AAQ-9936-2020	Cotton, Mark/0000-0003-2559-6034; Glencross, Deborah/0000-0001-7106-769X	National Institute of Allergy and Infectious Disease (NIAID) [AI062512]; Philadelphia Foundation (Robert I. Jacobs Fund); Stengel-Miller family; Commonwealth of Pennsylvania; Commonwealth Universal Research Enhancement Program; Pennsylvania Department of Health; National Cancer Institute Wistar Cancer Center [P30 CA10815]; NIMH [5P30MH062294-12]; Center for Interdisciplinary Research on AIDS; National Institute of Allergy and Infectious Diseases (NIAID) of the US National Institutes for Health (NIH), through the Comprehensive International Program of Research on AIDS (CIPRA) network [U19 AI53217]; Departments of Health of the Western Cape; Gauteng, South Africa; GlaxoSmithKline plc; Dean of Yale's School of Public Health; NATIONAL CANCER INSTITUTE [P30CA010815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI053217] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062294] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Disease (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Philadelphia Foundation (Robert I. Jacobs Fund); Stengel-Miller family; Commonwealth of Pennsylvania; Commonwealth Universal Research Enhancement Program; Pennsylvania Department of Health; National Cancer Institute Wistar Cancer Center; NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Center for Interdisciplinary Research on AIDS; National Institute of Allergy and Infectious Diseases (NIAID) of the US National Institutes for Health (NIH), through the Comprehensive International Program of Research on AIDS (CIPRA) network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Departments of Health of the Western Cape; Gauteng, South Africa; GlaxoSmithKline plc(GlaxoSmithKline); Dean of Yale's School of Public Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was primarily supported by a grant to L.J. Montaner by the National Institute of Allergy and Infectious Disease (NIAID AI062512, www.niaid.nih.gov). Additional support was provided by The Philadelphia Foundation (Robert I. Jacobs Fund), https://www.philafound.org; The Stengel-Miller family, AIDS funds from the Commonwealth of Pennsylvania and from the Commonwealth Universal Research Enhancement Program (www.portal.state.pa.us/portal/server.pt/community/health_research_program_cure/14189), Pennsylvania Department of Health (www.health.pa.gov), as well as by the National Cancer Institute Wistar Cancer Center Grant (P30 CA10815, www.cancer.gov/). Dr. Barbour's work was supported by NIMH grant 5P30MH062294-12 (https://www.nimh.nih.gov) to Paul Cleary, Dean of Yale's School of Public Health. This grant supports the Center for Interdisciplinary Research on AIDS. Support for the CIPRA-SA CHER study was provided by the National Institute of Allergy and Infectious Diseases (NIAID, www.niaid.nih.gov) of the US National Institutes for Health (NIH), through the Comprehensive International Program of Research on AIDS (CIPRA) network, grant number U19 AI53217. The Departments of Health of the Western Cape (https://www.westerncape.gov.za/dept/health) and Gauteng (www.health.gpg.gov.za), South Africa and GlaxoSmithKline plc (www.gsk.com) provided additional support. The CIPRA-SA CHER study was conducted under the supervision of the USA Food and Drug Administration (IND n. 71494). The content of this publication does not necessarily reflect the views or policies of NIAID, nor does mention of trade names, commercial projects, or organizations imply endorsement by the US Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter G, 2005, BLOOD, V106, P3366, DOI 10.1182/blood-2005-03-1100; Anselmi A, 2007, CLIN EXP IMMUNOL, V150, P442, DOI 10.1111/j.1365-2249.2007.03526.x; Azzoni L, 2005, J INFECT DIS, V191, P1451, DOI 10.1086/429300; Azzoni L, 2002, J IMMUNOL, V168, P5764, DOI 10.4049/jimmunol.168.11.5764; Azzoni L, 2007, AIDS, V21, P293, DOI 10.1097/QAD.0b013e328012b85f; Blackwell M, 2017, SOCIOL METHOD RES, V46, P342, DOI 10.1177/0049124115589052; Blanco A, 2008, J IMMUNOL, V180, P530, DOI 10.4049/jimmunol.180.1.530; BONAGURA VR, 1992, J PEDIATR-US, V121, P195, DOI 10.1016/S0022-3476(05)81187-4; Boulassel MR, 2007, VIRAL IMMUNOL, V20, P649, DOI 10.1089/vim.2007.0047; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Cagigi A, 2014, PEDIATR INFECT DIS J, V33, pE126, DOI 10.1097/INF.0000000000000144; Chehimi J, 2002, J IMMUNOL, V168, P4796, DOI 10.4049/jimmunol.168.9.4796; Chiappini E, 2003, JAIDS-J ACQ IMM DEF, V33, P601, DOI 10.1097/00126334-200308150-00008; Coetzee LM, 2009, CYTOM PART B-CLIN CY, V76B, P375, DOI 10.1002/cyto.b.20478; Correa R, 2003, J CLIN IMMUNOL, V23, P401, DOI 10.1023/A:1025325718213; Cotton MF, 2013, LANCET, V382, P1555, DOI 10.1016/S0140-6736(13)61409-9; Crawly M., 2005, STAT INTRO USING R; DeSouza CM, 2009, J BIOPHARM STAT, V19, P1055, DOI 10.1080/10543400903242795; Gelman A., 2007, DATA ANAL USING REGR; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Gorelick MH, 2006, J CLIN EPIDEMIOL, V59, P1115, DOI 10.1016/j.jclinepi.2004.11.029; Holmes TH, 2014, J IMMUNOL METHODS, V414, P32, DOI 10.1016/j.jim.2014.08.001; Honaker J, 2011, J STAT SOFTW, V45, P1; Honaker J, 2010, AM J POLIT SCI, V54, P561, DOI 10.1111/j.1540-5907.2010.00447.x; Imai K, 2008, J COMPUT GRAPH STAT, V17, P892, DOI 10.1198/106186008X384898; Jordan KA, 2006, VIROLOGY, V347, P117, DOI 10.1016/j.virol.2005.12.002; Kaambwa Billingsley, 2012, BMC Res Notes, V5, P330, DOI 10.1186/1756-0500-5-330; Kopka J, 2005, J CLIN VIROL, V33, P237, DOI 10.1016/j.jcv.2004.11.014; Le J, 2014, THER DRUG MONIT, V36, P510, DOI 10.1097/FTD.0000000000000039; Little R. J. A., 1987, STAT ANAL MISSING DA; LITTLE RJA, 1988, J AM STAT ASSOC, V83, P1198, DOI 10.2307/2290157; Little TD, 2014, J PEDIATR PSYCHOL, V39, P151, DOI 10.1093/jpepsy/jst048; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Madhi SA, 2010, J INFECT DIS, V202, P355, DOI 10.1086/653704; Mansoor N, 2009, CLIN IMMUNOL, V130, P280, DOI 10.1016/j.clim.2008.09.006; Mansourian M, 2014, J TROP PEDIATRICS, V60, P61, DOI 10.1093/tropej/fmt078; Mason A, 2012, BAYESIAN ANAL, V7, P109, DOI 10.1214/12-BA704; Newell M-L, 1994, PEDIATRICS, V94, P815; Owen MJ, 2013, EVERYONES STAT SOFTW; Papasavvas E, 2011, PEDIATR INFECT DIS J, V30, P877, DOI 10.1097/INF.0b013e31821d141e; Pensierosoa S, 2009, P NATL ACAD SCI USA, V106, P7939, DOI 10.1073/pnas.0901702106; PLAEGERMARSHALL S, 1994, CLIN IMMUNOL IMMUNOP, V71, P19, DOI 10.1006/clin.1994.1046; Rainwater-Lovett K, 2014, JAIDS-J ACQ IMM DEF, V67, P455, DOI 10.1097/QAI.0000000000000342; Resino S, 2006, J ANTIMICROB CHEMOTH, V57, P798, DOI 10.1093/jac/dkl032; Resino S, 2001, CLIN EXP IMMUNOL, V125, P266, DOI 10.1046/j.1365-2249.2001.01612.x; Roberts L, 2010, AIDS, V24, P819, DOI 10.1097/QAD.0b013e3283367836; Rosso R, 2010, SCAND J IMMUNOL, V71, P45, DOI 10.1111/j.1365-3083.2009.02345.x; Rubin D, 2008, MULTIPLE IMPUTATION; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; Ruel T, 2009, CLIN IMMUNOL, V131, P410, DOI 10.1016/j.clim.2009.01.016; Sharland M, 2002, HIV Med, V3, P215, DOI 10.1046/j.1468-1293.2002.00120.x; Simani OE, 2014, AIDS, V28, P531, DOI 10.1097/QAD.0000000000000127; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Ssewanyana I, 2009, AIDS RES HUM RETROV, V25, P65, DOI 10.1089/aid.2008.0138; Steyerberg EW, 2007, J CLIN EPIDEMIOL, V60, P979, DOI 10.1016/j.jclinepi.2007.03.003; Tobin NH, 2014, CURR HIV-AIDS REP, V11, P1, DOI 10.1007/s11904-013-0189-1; VOICULESCU C, 1994, FEMS IMMUNOL MED MIC, V9, P217, DOI 10.1111/j.1574-695X.1994.tb00496.x; Wallet MA, 2010, AIDS, V24, P1281, DOI 10.1097/QAD.0b013e328339e228; White IR, 2010, STAT MED, V29, P2920, DOI 10.1002/sim.3944; Wiens JJ, 2008, J SYST EVOL, V46, P307, DOI 10.3724/SP.J.1002.2008.08040; Woodward P, 2005, J STAT SOFTW, V14; Woodward P, 2011, BAYESIAN ANAL MADE S; Xiao L, 2014, J AM STAT ASSOC, V109, P1, DOI 10.1080/01621459.2013.830070; Ye P, 2004, CURR HIV RES, V2, P177, DOI 10.2174/1570162043484898; Ziegner U, 1999, CLIN DIAGN LAB IMMUN, V6, P718, DOI 10.1128/CDLI.6.5.718-724.1999	65	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145320	10.1371/journal.pone.0145320	http://dx.doi.org/10.1371/journal.pone.0145320			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671450	Green Published, gold			2022-12-26	WOS:000366719300058
J	Hayden, B; Soto, DX; Jardine, TD; Graham, BS; Cunjak, RA; Romakkaniemi, A; Linnansaari, T				Hayden, Brian; Soto, David X.; Jardine, Tim D.; Graham, Brittany S.; Cunjak, Richard A.; Romakkaniemi, Atso; Linnansaari, Tommi			Small Tails Tell Tall Tales - Intra-Individual Variation in the Stable Isotope Values of Fish Fin	PLOS ONE			English	Article							AQUATIC FOOD WEBS; CARBON; NITROGEN; DELTA-C-13; HYDROGEN; RATIOS; SCALES; DIET; GROWTH; TISSUE	Background Fish fin is a widely used, non-lethal sample material in studies using stable isotopes to assess the ecology of fishes. However, fish fin is composed of two distinct tissues (ray and membrane) which may have different stable isotope values and are not homogeneously distributed within a fin. As such, estimates of the stable isotope values of a fish may vary according to the section of fin sampled. Methods To assess the magnitude of this variation, we analysed carbon (delta C-13), nitrogen (delta N-15), hydrogen (delta H-2) and oxygen (delta O-18) stable isotopes of caudal fin fromjuvenile, riverine stages of Atlantic salmon (Salmo salar) and brown trout (Salmo trutta). Individual fins were sub-sectioned into tip, mid and base, of which a further subset were divided into ray and membrane. Findings Isotope variation between fin sections, evident in all four elements, was primarily related to differences between ray and membrane. Base sections were(13)C depleted relative to tip (similar to 1 %) with equivalent variation evident between ray and membrane. A similar trend was evident in delta H-2, though the degree of variation was far greater (similar to 10%). Base and ray sections were O-18 enriched (similar to 2%) relative to tip and membrane, respectively. Ray and membrane sections displayed longitudinal variation in N-15 mirroring that of composite fin (similar to 1%), indicating that variation in(15)N values was likely related to ontogenetic variation. Conclusions To account for the effects of intra-fin variability in stable isotope analyses we suggest that researchers sampling fish fin, in increasing priority, 1) also analyse muscle (or liver) tissue from a subsample of fish to calibrate their data, or 2) standardize sampling by selecting tissue only from the extreme tip of a fin, or 3) homogenize fins prior to analysis.	[Hayden, Brian; Soto, David X.; Jardine, Tim D.; Graham, Brittany S.; Cunjak, Richard A.; Linnansaari, Tommi] Univ New Brunswick, Dept Biol, New Brunswick, NB E3B 5A3, Canada; [Soto, David X.] Environm Canada, Saskatoon, SK, Canada; [Jardine, Tim D.] Univ Saskatchewan, Toxicol Ctr, Sch Environm & Sustainabil, Saskatoon, SK, Canada; [Graham, Brittany S.] Natl Inst Water & Atmospher Res NIWA, Wellington, New Zealand; [Romakkaniemi, Atso] Nat Resources Inst Finland, Oulu, Finland	University of New Brunswick; Environment & Climate Change Canada; University of Saskatchewan; National Institute of Water & Atmospheric Research (NIWA) - New Zealand; Natural Resources Institute Finland (Luke)	Hayden, B (corresponding author), Univ New Brunswick, Dept Biol, New Brunswick, NB E3B 5A3, Canada.	brian.hayden@unb.ca	Soto, David X./B-2017-2018; Jardine, Timothy Donald/AFZ-4837-2022	Soto, David X./0000-0003-4210-293X; Jardine, Timothy/0000-0002-5917-9792	Finnish-Swedish Transboundary River Commission [A 13/7]; Canadian Research Chair [1-132477-45-01]; NSERC [1-50006-40-01]	Finnish-Swedish Transboundary River Commission; Canadian Research Chair(Canada Research Chairs); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by the Finnish-Swedish Transboundary River Commission (grant number: A 13/7) to AR and TL and by Canadian Research Chair (grant number: 1-132477-45-01) and NSERC Discovery (grant number: 1-50006-40-01) grants to RAC. The authors are indebted to the technical staff of the Natural Resources Institute Finland who assisted during field sampling, and the technical staff of the Stable Isotopes in Nature Laboratory who prepared and analysed the samples.; This work was funded by the Finnish-Swedish Transboundary River Commission (grant number: A 13/7) to AR and TL and by Canadian Research Chair (grant number: 1-132477-45-01) and NSERC Discovery (grant number: 1-550006-40-01) grants to RAC. The authors are indebted to the technical staff of the Natural Resources Institute Finland who assisted during field sampling, and the technical staff of the Stable Isotopes in Nature Laboratory who prepared and analysed the samples.	[Anonymous], 2014, R LANG ENV STAT COMP; Boecklen WJ, 2011, ANNU REV ECOL EVOL S, V42, P411, DOI 10.1146/annurev-ecolsys-102209-144726; Cable J, 2011, HYDROL PROCESS, V25, P2228, DOI 10.1002/hyp.7982; Cano-Rocabayera O, 2015, ENVIRON BIOL FISH, V98, P925, DOI 10.1007/s10641-014-0328-6; Cherel Y, 2009, BIOL LETTERS, V5, P830, DOI 10.1098/rsbl.2009.0552; Cole JJ, 2011, P NATL ACAD SCI USA, V108, P1975, DOI 10.1073/pnas.1012807108; Darimont CT, 2002, CAN J ZOOL, V80, P1638, DOI 10.1139/Z02-149; Doucett RR, 2007, ECOLOGY, V88, P1587, DOI 10.1890/06-1184; Doucett RR, 1996, CAN J FISH AQUAT SCI, V53, P2058, DOI 10.1139/cjfas-53-9-2058; Dutton A, 2005, HYDROL PROCESS, V19, P4121, DOI 10.1002/hyp.5876; Fincel MJ, 2012, FISHERIES MANAG ECOL, V19, P283, DOI 10.1111/j.1365-2400.2011.00830.x; Finlay JC, 2001, ECOLOGY, V82, P1052, DOI 10.2307/2679902; Flammang BE, 2014, ZOOLOGY, V117, P86, DOI 10.1016/j.zool.2013.10.001; Freyhof J., 2007, HDB EUROPEAN FRESHWA; Fry B., 2006, STABLE ISOTOPE ECOLO; Graham CT, 2014, HYDROBIOLOGIA, V721, P45, DOI 10.1007/s10750-013-1636-0; Graham CT, 2013, ISOT ENVIRON HEALT S, V49, P555, DOI 10.1080/10256016.2013.808635; Grey J, 2009, FRESHWATER BIOL, V54, P1663, DOI 10.1111/j.1365-2427.2009.02215.x; Hayden B, 2014, J ANIM ECOL, V83, P1501, DOI 10.1111/1365-2656.12233; Hette-Tronquart N, 2012, RAPID COMMUN MASS SP, V26, P1603, DOI 10.1002/rcm.6265; Hobson KA, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00018.1; HOBSON KA, 1992, CONDOR, V94, P181, DOI 10.2307/1368807; Hobson KA, 2008, TERR ECOL SER, V2, P1; Hutchinson JJ, 2006, J FISH BIOL, V69, P1874, DOI 10.1111/j.1095-8649.2006.01234.x; ICES, 2015, REP BALT SALM TROUT; Jardine TD, 2011, MAR FRESHWATER RES, V62, P83, DOI 10.1071/MF10211; Kelly MH, 2006, N AM J FISH MANAGE, V26, P921, DOI 10.1577/M05-084.1; Kiljunen M, 2006, J APPL ECOL, V43, P1213, DOI 10.1111/j.1365-2664.2006.01224.x; Larsson S, 2011, ENVIRON BIOL FISH, V92, P361, DOI 10.1007/s10641-011-9846-7; Merritt R. W., 2008, INTRO AQUATIC INSECT; Newsome SD, 2009, ECOLOGY, V90, P961, DOI 10.1890/07-1812.1; Parris KM, 2010, J APPL ECOL, V47, P227, DOI 10.1111/j.1365-2664.2009.01755.x; Persson ME, 2007, ENVIRON POLLUT, V145, P131, DOI 10.1016/j.envpol.2006.03.036; Phillips DL, 2006, OECOLOGIA, V147, P195, DOI 10.1007/s00442-005-0292-0; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Reitsema LJ, 2013, AM J HUM BIOL, V25, P445, DOI 10.1002/ajhb.22398; Roussel JM, 2014, GLOBAL CHANGE BIOL, V20, P523, DOI 10.1111/gcb.12293; SODERBERG RW, 1987, PROG FISH CULT, V49, P280, DOI 10.1577/1548-8640(1987)49<280:EORDOG>2.0.CO;2; Soto DX, 2013, FUNCT ECOL, V27, P535, DOI 10.1111/1365-2435.12054; Suzuki KW, 2005, CAN J FISH AQUAT SCI, V62, P671, DOI 10.1139/F04-231; Thomas SM, 2015, J ANIM ECOL, V84, P861, DOI 10.1111/1365-2656.12326; Trueman CN, 2012, J FISH BIOL, V81, P826, DOI 10.1111/j.1095-8649.2012.03361.x; Valladares S, 2012, AQUAT ECOL, V46, P363, DOI 10.1007/s10452-012-9407-y; Vander Zanden MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116182; Vander Zanden MJ, 1999, NATURE, V401, P464, DOI 10.1038/46762; Wassenaar LI, 2003, ISOT ENVIRON HEALT S, V39, P211, DOI 10.1080/1025601031000096781; Wassenaar LI, 2000, ENVIRON SCI TECHNOL, V34, P2354, DOI 10.1021/es990804i; Willis TJ, 2013, MAR BIOL, V160, P1633, DOI 10.1007/s00227-013-2216-6	48	22	22	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145154	10.1371/journal.pone.0145154	http://dx.doi.org/10.1371/journal.pone.0145154			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670464	gold, Green Published, Green Submitted			2022-12-26	WOS:000366719300051
J	Hsueh, YH; Lin, KS; Ke, WJ; Hsieh, CT; Chiang, CL; Tzou, DY; Liu, ST				Hsueh, Yi-Huang; Lin, Kuen-Song; Ke, Wan-Ju; Hsieh, Chien-Te; Chiang, Chao-Lung; Tzou, Dong-Ying; Liu, Shih-Tung			The Antimicrobial Properties of Silver Nanoparticles in Bacillus subtilis Are Mediated by Released Ag+ Ions	PLOS ONE			English	Article							ESCHERICHIA-COLI; ANTIBACTERIAL ACTIVITY; TOXICITY; MECHANISM; CYTOTOXICITY; BIOCONTROL; MICROSCOPY; STABILITY; EXPOSURE; MATRIX	The superior antimicrobial properties of silver nanoparticles (Ag NPs) are well-documented, but the exact mechanisms underlying Ag-NP microbial toxicity remain the subject of intense debate. Here, we show that Ag-NP concentrations as low as 10 ppm exert significant toxicity against Bacillus subtilis, a beneficial bacterium ubiquitous in the soil. Growth arrest and chromosomal DNA degradation were observed, and flow cytometric quantification of propidium iodide (PI) staining also revealed that Ag-NP concentrations of 25 ppm and above increased membrane permeability. RedoxSensor content analysis and Phag-GFP expression analysis further indicated that reductase activity and cytosolic protein expression decreased in B. subtilis cells treated with 10-50 ppm of Ag NPs. We conducted X-ray absorption near-edge structure (XANES) and extended X-ray absorption fine structure (EXAFS) analyses to directly clarify the valence and fine structure of Ag atoms in B. subtilis cells placed in contact with Ag NPs. The results confirmed the Ag species in Ag NP-treated B. subtilis cells as Ag2O, indicating that Ag-NP toxicity is likely mediated by released Ag+ ions from Ag NPs, which penetrate bacterial cells and are subsequently oxidized intracellularly to Ag2O. These findings provide conclusive evidence for the role of Ag+ ions in Ag-NP microbial toxicity, and suggest that the impact of inappropriately disposed Ag NPs to soil and water ecosystems may warrant further investigation.	[Hsueh, Yi-Huang] Yuan Ze Univ, Grad Sch Biotechnol & Bioengn, Taoyuan, Taiwan; [Lin, Kuen-Song; Hsieh, Chien-Te; Chiang, Chao-Lung; Tzou, Dong-Ying] Yuan Ze Univ, Dept Chem Engn & Mat Sci, Taoyuan, Taiwan; [Ke, Wan-Ju; Liu, Shih-Tung] Chang Gung Univ, Grad Inst Biomed Sci, Taoyuan, Taiwan; [Ke, Wan-Ju; Liu, Shih-Tung] Chang Gung Univ, Res Ctr Bacterial Pathogenesis, Taoyuan, Taiwan	Yuan Ze University; Yuan Ze University; Chang Gung University; Chang Gung University	Hsueh, YH (corresponding author), Yuan Ze Univ, Grad Sch Biotechnol & Bioengn, Taoyuan, Taiwan.	yihhsueh@saturn.yzu.edu.tw	Chiang, Chao-Lung/AAF-1568-2019		Yuan Ze University, Taiwan [3070111]	Yuan Ze University, Taiwan	This work was supported by Grant 3070111 from Yuan Ze University, Taiwan, to Yi-Huang Hsueh.	Bais HP, 2004, PLANT PHYSIOL, V134, P307, DOI 10.1104/pp.103.028712; Biswas A, 2012, ADV COLLOID INTERFAC, V170, P2, DOI 10.1016/j.cis.2011.11.001; Bloemberg GV, 2001, CURR OPIN PLANT BIOL, V4, P343, DOI 10.1016/S1369-5266(00)00183-7; Branda SS, 2001, P NATL ACAD SCI USA, V98, P11621, DOI 10.1073/pnas.191384198; Chaloupka K, 2010, TRENDS BIOTECHNOL, V28, P580, DOI 10.1016/j.tibtech.2010.07.006; Chowdhury S, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-365; Christy A. Jegatha, 2012, Advances in Natural Sciences: Nanoscience & Nanotechnology, V3, DOI 10.1088/2043-6262/3/3/035013; Colman BP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057189; de Lima R, 2012, J APPL TOXICOL, V32, P867, DOI 10.1002/jat.2780; Dibrov P, 2002, ANTIMICROB AGENTS CH, V46, P2668, DOI 10.1128/AAC.46.8.2668-2670.2002; Dobias J, 2013, ENVIRON SCI TECHNOL, V47, P4140, DOI 10.1021/es304023p; Docter D, 2014, BEILSTEIN J NANOTECH, V5, P1380, DOI 10.3762/bjnano.5.151; Dubas ST, 2006, COLLOID SURFACE A, V289, P105, DOI 10.1016/j.colsurfa.2006.04.012; Duncan TV, 2011, J COLLOID INTERF SCI, V363, P1, DOI 10.1016/j.jcis.2011.07.017; Earl AM, 2008, TRENDS MICROBIOL, V16, P269, DOI 10.1016/j.tim.2008.03.004; El Badawy AM, 2011, ENVIRON SCI TECHNOL, V45, P283, DOI 10.1021/es1034188; Fabrega J, 2011, ENVIRON INT, V37, P517, DOI 10.1016/j.envint.2010.10.012; Fabrega J, 2009, ENVIRON SCI TECHNOL, V43, P7285, DOI 10.1021/es803259g; Gajbhiye A, 2010, WORLD J MICROB BIOT, V26, P1187, DOI 10.1007/s11274-009-0287-9; Gambino M, 2015, J APPL MICROBIOL, V118, P1103, DOI 10.1111/jam.12779; Holt KB, 2005, BIOCHEMISTRY-US, V44, P13214, DOI 10.1021/bi0508542; Hsueh YH, 2007, APPL ENVIRON MICROB, V73, P7225, DOI 10.1128/AEM.00690-07; Hsueh YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128457; Iravani S, 2014, RES PHARM SCI, V9, P385; Ivask A, 2014, ACS NANO, V8, P374, DOI 10.1021/nn4044047; Kalyuzhnaya MG, 2008, ISME J, V2, P696, DOI 10.1038/ismej.2008.32; Kawata K, 2009, ENVIRON SCI TECHNOL, V43, P6046, DOI 10.1021/es900754q; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Kim SW, 2011, APPL MICROBIOL BIOT, V92, P1045, DOI 10.1007/s00253-011-3611-x; Kumar M, 2015, PLASMONICS IN PRESS; Kumar M, 2011, J APPL PHYS, V109, DOI 10.1063/1.3555593; Kumar M, 2010, PHYSICA E, V42, P1940, DOI 10.1016/j.physe.2010.03.002; Kvitek L, 2008, J PHYS CHEM C, V112, P5825, DOI 10.1021/jp711616v; Levard C, 2012, ENVIRON SCI TECHNOL, V46, P6900, DOI 10.1021/es2037405; Lytle FW, 1999, J SYNCHROTRON RADIAT, V6, P123, DOI 10.1107/S0909049599001260; Ma J, 2003, NANOTECHNOLOGY, V14, P619, DOI 10.1088/0957-4484/14/6/310; Mader U, 2012, NUCLEIC ACIDS RES, V40, pD1278, DOI 10.1093/nar/gkr923; McFarland AD, 2003, NANO LETT, V3, P1057, DOI 10.1021/nl034372s; MEITZNER G, 1992, J PHYS CHEM-US, V96, P4960, DOI 10.1021/j100191a043; Miao AJ, 2009, ENVIRON POLLUT, V157, P3034, DOI 10.1016/j.envpol.2009.05.047; Mishra YK, 2008, NUCL INSTRUM METH B, V266, P1804, DOI 10.1016/j.nimb.2008.01.040; Mishra YK, 2007, SCRIPTA MATER, V56, P629, DOI 10.1016/j.scriptamat.2006.12.008; Mueller NC, 2008, ENVIRON SCI TECHNOL, V42, P4447, DOI 10.1021/es7029637; Navarro E, 2008, ENVIRON SCI TECHNOL, V42, P8959, DOI 10.1021/es801785m; Nesvizhskii AI, 1999, J SYNCHROTRON RADIAT, V6, P315, DOI 10.1107/S0909049599001697; Pal S, 2007, APPL ENVIRON MICROB, V73, P1712, DOI 10.1128/AEM.02218-06; Prabhu S, 2012, INT NANO LETT, V2, DOI 10.1186/2228-5326-2-32; Raffi M, 2008, J MATER SCI TECHNOL, V24, P192; Ravel B, 2005, PHYS SCRIPTA, VT115, P1007; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Ravel B, 2012, J SYNCHROTRON RADIAT, V19, P869, DOI 10.1107/S0909049512036886; Ruparelia JP, 2008, ACTA BIOMATER, V4, P707, DOI 10.1016/j.actbio.2007.11.006; Salata OV, 2004, J Nanobiotechnology, V2, P3, DOI 10.1186/1477-3155-2-3; Suresh AK, 2012, LANGMUIR, V28, P2727, DOI 10.1021/la2042058; Tankhiwale R, 2009, COLLOID SURFACE B, V69, P164, DOI 10.1016/j.colsurfb.2008.11.004; Tenzer S, 2013, NAT NANOTECHNOL, V8, P772, DOI 10.1038/nnano.2013.181; Tiwari V., 2014, J NANOMED NANOTECHNO, V5, P246, DOI [10.4172/2157-7439.1000246, DOI 10.4172/2157-7439.1000246]; Xiu ZM, 2012, NANO LETT, V12, P4271, DOI 10.1021/nl301934w; Yamanaka M, 2005, APPL ENVIRON MICROB, V71, P7589, DOI 10.1128/AEM.71.11.7589-7593.2005; Youssef AM, 2014, INT J BIOL MACROMOL, V69, P185, DOI 10.1016/j.ijbiomac.2014.05.047; ZABINSKY SI, 1995, PHYS REV B, V52, P2995, DOI 10.1103/PhysRevB.52.2995; Zhang N, 2011, PLANT SOIL, V344, P87, DOI 10.1007/s11104-011-0729-7	62	95	97	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144306	10.1371/journal.pone.0144306	http://dx.doi.org/10.1371/journal.pone.0144306			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26669836	gold, Green Submitted, Green Published			2022-12-26	WOS:000366719300006
J	Maijer, KI; Neumann, E; Muller-Ladner, U; Drop, DACAD; Ramwadhdoebe, TH; Choi, IYK; Gerlag, DM; de Hair, MJH; Tak, PP				Maijer, Karen I.; Neumann, Elena; Mueller-Ladner, Ulf; Drop, Daniel A. C. A. D.; Ramwadhdoebe, Tamara H.; Choi, Ivy Y. K.; Gerlag, Danielle M.; de Hair, Maria J. H.; Tak, Paul P.			Serum Vaspin Levels Are Associated with the Development of Clinically Manifest Arthritis in Autoantibody-Positive Individuals	PLOS ONE			English	Article							NF-KAPPA-B; RHEUMATOID-ARTHRITIS; RISK-FACTORS; SYNOVIAL INFLAMMATION; AMERICAN-COLLEGE; DISEASE-ACTIVITY; LEPTIN LEVELS; ADIPONECTIN; ADIPOKINES; RESISTIN	Objectives We have previously shown that overweight may increase the risk of developing rheumatoid arthritis (RA) in autoantibody positive individuals. Adipose tissue could contribute to the development of RA by production of various bioactive peptides. Therefore, we examined levels of adipokines in serum and synovial tissue of subjects at risk of RA. Methods Fifty-one individuals positive for immunoglobulin M rheumatoid factor (IgM-RF) and/or anticitrullinated protein antibodies (ACPA), without arthritis, were included in this prospective study. Levels of adiponectin, vaspin, resistin, leptin, chemerin and omentin were determined in baseline fasting serum samples (n = 27). Synovial tissue was obtained by arthroscopy at baseline and we examined the expression of adiponectin, resistin and visfatin by immunohistochemistry. Results The development of clinically manifest arthritis after follow-up was associated with baseline serum vaspin levels (HR1.5 (95% CI 1.1 to 2.2); p = 0.020), also after adjustment for overweight (HR1.7 (95% CI 1.1 to 2.5); p = 0.016). This association was not seen for other adipokines. Various serum adipokine levels correlated with BMI (adiponectin r = -0.538, leptin r = 0.664; chemerin r = 0.529) and systemic markers of inflammation such as CRP levels at baseline (adiponectin r = -0.449, omentin r = -0.557, leptin r = 0.635, chemerin r = 0.619, resistin r = 0.520) and ESR (leptin r = 0.512, chemerin r = 0.708), p-value < 0.05. Synovial expression of adiponectin, resistin and visfatin was not associated with development of clinically manifest arthritis. Conclusions In this exploratory study, serum adipokines were associated with an increased inflammatory state in autoantibody-positive individuals at risk of developing RA. Furthermore, serum vaspin levels may assist in predicting the development of arthritis in these individuals.	[Maijer, Karen I.; Drop, Daniel A. C. A. D.; Ramwadhdoebe, Tamara H.; Choi, Ivy Y. K.; Gerlag, Danielle M.; de Hair, Maria J. H.; Tak, Paul P.] Univ Amsterdam, Acad Med Ctr, Div Clin Immunol & Rheumatol, NL-1105 AZ Amsterdam, Netherlands; [Neumann, Elena; Mueller-Ladner, Ulf] Univ Giessen, Dept Internal Med & Rheumatol, Kerckhoff Klin, Bad Nauheim, Germany	University of Amsterdam; Academic Medical Center Amsterdam; Justus Liebig University Giessen; Kerckhoff Clinic	Tak, PP (corresponding author), Univ Cambridge, Cambridge, England.	paul-peter.x.tak@gsk.com	Neumann, Elena/A-1418-2011		Dutch Arthritis Foundation [06-1-303, 11-1-407]; Netherlands Organisation for Health Research and Development (ZonMw) [200310003]; Innovative Medicines Initiative (IMI) EU [115142]; Seventh Framework Programme (FP7) Euro-TEAM consortium [305549]; Bundesministerium fur Bildung und Forschung (BMBF) [01EC1002C]; Deutsche Forschungsgemeinschaft (DFG) [NE1174/5.1]	Dutch Arthritis Foundation; Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development); Innovative Medicines Initiative (IMI) EU; Seventh Framework Programme (FP7) Euro-TEAM consortium; Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Dutch Arthritis Foundation [grant numbers 06-1-303, 11-1-407 for DMG], the Netherlands Organisation for Health Research and Development (ZonMw) [grant number 200310003 for DMG], the Innovative Medicines Initiative (IMI) EU funded project BeTheCure [grant number 115142 for DMG], the Seventh Framework Programme (FP7) Euro-TEAM consortium [grant number 305549 for DMG], Bundesministerium fur Bildung und Forschung (BMBF) [grant number 01EC1002C for EN], and Deutsche Forschungsgemeinschaft (DFG) [grant number NE1174/5.1 for EN]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; ALTMAN R, 1990, ARTHRITIS RHEUM, V33, P1601, DOI 10.1002/art.1780331101; Bigaard J, 2005, INT J OBESITY, V29, P778, DOI 10.1038/sj.ijo.0802976; Bokarewa M, 2005, J IMMUNOL, V174, P5789, DOI 10.4049/jimmunol.174.9.5789; Bokarewa M, 2003, ANN RHEUM DIS, V62, P952, DOI 10.1136/ard.62.10.952; Buckley CD, 2013, NAT REV IMMUNOL, V13, P59, DOI 10.1038/nri3362; Crowson CS, 2013, ARTHRIT CARE RES, V65, P71, DOI 10.1002/acr.21660; de Boer TN, 2012, OSTEOARTHR CARTILAGE, V20, P846, DOI 10.1016/j.joca.2012.05.002; de Hair MJH, 2014, ARTHRITIS RHEUMATOL, V66, P513, DOI 10.1002/art.38273; de Hair MJH, 2013, ANN RHEUM DIS, V72, P1654, DOI 10.1136/annrheumdis-2012-202254; Flegal KM, 2010, JAMA-J AM MED ASSOC, V303, P235, DOI 10.1001/jama.2009.2014; Galic S, 2010, MOL CELL ENDOCRINOL, V316, P129, DOI 10.1016/j.mce.2009.08.018; Gerlag D, 2005, BEST PRACT RES CL RH, V19, P387, DOI 10.1016/j.berh.2005.01.005; Gerlag DM, 2012, ANN RHEUM DIS, V71, P638, DOI 10.1136/annrheumdis-2011-200990; Gunaydin R, 2006, SOUTH MED J, V99, P1078, DOI 10.1097/01.smj.0000240625.27772.79; Hizmetli S, 2007, RHEUMATOL INT, V27, P335, DOI 10.1007/s00296-006-0264-7; Jung CH, 2011, BIOCHEM BIOPH RES CO, V413, P264, DOI 10.1016/j.bbrc.2011.08.083; Kaneko K, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3475; Kontny E, 2012, ANN RHEUM DIS, V71, P262, DOI 10.1136/annrheumdis-2011-200123; Kraan MC, 1998, ARTHRITIS RHEUM, V41, P1481, DOI 10.1002/1529-0131(199808)41:8<1481::AID-ART19>3.0.CO;2-O; Lahiri M, 2012, RHEUMATOLOGY, V51, P499, DOI 10.1093/rheumatology/ker299; Lee SW, 2007, RHEUMATOL INT, V27, P537, DOI 10.1007/s00296-006-0253-x; Lehrke M, 2009, EUR J ENDOCRINOL, V161, P339, DOI 10.1530/EJE-09-0380; Li HL, 2013, ATHEROSCLEROSIS, V228, P61, DOI 10.1016/j.atherosclerosis.2013.02.013; Lu B, 2014, ANN RHEUM DIS, V73, P1914, DOI 10.1136/annrheumdis-2014-205459; Migita K, 2006, CLIN EXP RHEUMATOL, V24, P698; Myasoedova E, 2010, ARTHRITIS RHEUM-US, V62, P1576, DOI 10.1002/art.27425; Neumeier M, 2006, J LEUKOCYTE BIOL, V79, P803, DOI 10.1189/jlb.0905521; Otero M, 2006, RHEUMATOLOGY, V45, P944, DOI 10.1093/rheumatology/kel157; Otero M, 2006, ANN RHEUM DIS, V65, P1198, DOI 10.1136/ard.2005.046540; Otero M, 2006, DRUG NEWS PERSPECT, V19, P21, DOI 10.1358/dnp.2006.19.1.966243; Ouchi N, 2003, CURR OPIN LIPIDOL, V14, P561, DOI 10.1097/00041433-200312000-00003; Ouchi N, 2003, CIRCULATION, V107, P671, DOI 10.1161/01.CIR.0000055188.83694.B3; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Ozgen M, 2010, ARCH MED RES, V41, P457, DOI 10.1016/j.arcmed.2010.08.012; Pedersen Jens K, 2007, Open Rheumatol J, V1, P18, DOI 10.2174/1874312900701010018; Pedersen M, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar2022; Phalitakul S, 2011, PHARMACOL RES, V64, P493, DOI 10.1016/j.phrs.2011.06.001; Schaffler A, 2003, JAMA-J AM MED ASSOC, V290, P1709, DOI 10.1001/jama.290.13.1709-c; Scotece M, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/125458; Senolt L, 2007, ANN RHEUM DIS, V66, P458, DOI 10.1136/ard.2006.054734; Senolt L, 2010, ANN RHEUM DIS, V69, P1410, DOI 10.1136/ard.2009.119735; Stofkova A, 2009, Endocr Regul, V43, P157; TAK PP, 1995, ARTHRITIS RHEUM, V38, P1457, DOI 10.1002/art.1780381012; TAK PP, 1995, CLIN IMMUNOL IMMUNOP, V77, P236, DOI 10.1006/clin.1995.1149; Tan WF, 2009, SEMIN ARTHRITIS RHEU, V38, P420, DOI 10.1016/j.semarthrit.2008.01.017; Tsao TS, 2002, J BIOL CHEM, V277, P29359, DOI 10.1074/jbc.C200312200; van de Sande MGH, 2011, ANN RHEUM DIS, V70, P423, DOI 10.1136/ard.2010.139550; Wulster-Radcliffe MC, 2004, BIOCHEM BIOPH RES CO, V316, P924, DOI 10.1016/j.bbrc.2004.02.130	49	23	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144932	10.1371/journal.pone.0144932	http://dx.doi.org/10.1371/journal.pone.0144932			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670468	gold, Green Published, Green Submitted			2022-12-26	WOS:000366719300031
J	Xue, H; Wang, JL; Hou, JH; Li, JJ; Gao, JS; Chen, SH; Zhu, H; Wu, SL				Xue, Hao; Wang, Jianli; Hou, Jinhong; Li, Junjuan; Gao, Jingsheng; Chen, Shuohua; Zhu, Hang; Wu, Shouling			Prehypertension and Chronic Kidney Disease in Chinese Population: Four-Year Follow-Up Study	PLOS ONE			English	Article							RISK-FACTORS; BLOOD-PRESSURE; PREVALENCE; HYPERTENSION; ADULTS; PARTICIPANTS; ASSOCIATION	Hypertension is a well established cause of chronic kidney disease (CKD). However, the effect of prehypertension on risk of CKD is controversial. The aim of this study is to determine whether prehypertension increases the risk of CKD events in the Chinese population. We enrolled 20,034 with prehypertension and 12,351 with ideal blood pressure in this prospective study. CKD was defined as an estimated glomerular filtration rate (eGFR) <60 ml/min 1.73m(2). The new occurrences of CKD events were collected during follow-up. Cumulative survival and freedom for the occurrence of new CKD events was analyzed using the Kaplan-Meier approach. Multivariate Cox Regression was used to analyze the effect of prehypertension on CKD. The median follow-up time was 47 (interquartile range 44-51) months. 601 new onset CKD events occurred during the follow-up period. The cumulative incidence of new CKD events was higher in the prehypertensive population than that in the ideal blood pressure population (2.10% vs 1.46%, P = 0.0001). Multivariate Cox Regression showed that relative risks (RRs) for the new onset CKD events in the prehypertensive population were 1.69 (95% confidence intervals (CI): 1.41 similar to 2.04, P = 0.001) higher than those in the ideal blood pressure population. Similarly, the risks were 1.68 (95% CI: 1.33 similar to 2.13 P = 0.001) times higher in females and 2.14 (95% CI: 1.58 similar to 2.91 P = 0.001) times higher in males by adjustment for traditional CV risk factors. Our findings demonstrated prehypertension is an independent risk factor for the occurrence of new CKD events in the Chinese population.	[Xue, Hao; Zhu, Hang] Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, Beijing 100853, Peoples R China; [Wang, Jianli; Hou, Jinhong; Li, Junjuan; Gao, Jingsheng; Chen, Shuohua; Wu, Shouling] Hebei United Univ, Kailuan Hosp, Dept Cardiol, Tangshan, Peoples R China	Chinese People's Liberation Army General Hospital; North China University of Science & Technology	Zhu, H (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, 28 Fuxing Rd, Beijing 100853, Peoples R China.	zhuhang301@126.com; drwusl@163.com	wang, jian/GVS-0711-2022; Xue, Hao/GXV-4717-2022		Chinese PLA General Hospital Clinical Sustaining Project [2012FC-TSYS-4003]; Capital Public Health Cultivation Project [Z141100002114029]	Chinese PLA General Hospital Clinical Sustaining Project; Capital Public Health Cultivation Project	This work was supported by Chinese PLA General Hospital Clinical Sustaining Project (NO. 2012FC-TSYS-4003) and the Capital Public Health Cultivation Project (NO. Z141100002114029).	Altun B, 2012, KIDNEY BLOOD PRESS R, V36, P36, DOI 10.1159/000339025; [Anonymous], 2012, AM J KIDNEY DIS, V39, pS1; Chen W, 2009, NEPHROL DIAL TRANSPL, V24, P1205, DOI 10.1093/ndt/gfn604; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Guo XF, 2013, CURR HYPERTENS REP, V15, P703, DOI 10.1007/s11906-013-0403-y; Holmes David, 2013, Nat Rev Nephrol, V9, P695, DOI 10.1038/nrneph.2013.215; Huang YL, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-177; Huang YL, 2014, AM J KIDNEY DIS, V63, P76, DOI 10.1053/j.ajkd.2013.07.024; Kanno A, 2012, NEPHROL DIAL TRANSPL, V27, P3218, DOI 10.1093/ndt/gfs054; Kim MJ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-960; Kubo M, 2003, KIDNEY INT, V63, P1508, DOI 10.1046/j.1523-1755.2003.00886.x; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lin B, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-36; Liu Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102000; Mahmoodi BK, 2012, LANCET, V380, P1649, DOI 10.1016/S0140-6736(12)61272-0; Meng XJ, 2012, CIRC J, V76, P900, DOI 10.1253/circj.CJ-11-1118; Munkhaugen J, 2009, AM J KIDNEY DIS, V54, P638, DOI 10.1053/j.ajkd.2009.03.023; Ninomiya T, 2007, J AM SOC NEPHROL, V18, P2135, DOI 10.1681/ASN.2007010067; O'Seaghdha CM, 2009, HYPERTENSION, V54, P509, DOI 10.1161/HYPERTENSIONAHA.108.128413; Tohidi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045304; Vasan RS, 2002, JAMA-J AM MED ASSOC, V287, P1003, DOI 10.1001/jama.287.8.1003; Wu SL, 2012, CIRC-CARDIOVASC QUAL, V5, P487, DOI 10.1161/CIRCOUTCOMES.111.963694; Yano Y, 2012, KIDNEY INT, V81, P293, DOI 10.1038/ki.2011.346; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zheng LQ, 2010, J HYPERTENS, V28, P1158, DOI 10.1097/HJH.0b013e3283378568	25	18	20	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144438	10.1371/journal.pone.0144438	http://dx.doi.org/10.1371/journal.pone.0144438			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670101	Green Submitted, Green Published, gold			2022-12-26	WOS:000366719300008
J	Sun, XF; Park, CB; Deng, WB; Potter, SS; Dey, SK				Sun, Xiaofei; Park, Craig B.; Deng, Wenbo; Potter, S. Steven; Dey, Sudhansu K.			Uterine inactivation of muscle segment homeobox (Msx) genes alters epithelial cell junction proteins during embryo implantation	FASEB JOURNAL			English	Article						uterus; receptivity; adhesion; claudin; Sprr2	BLASTOCYST IMPLANTATION; EXTRACELLULAR-MATRIX; EXPRESSION ANALYSIS; BINDING-PROTEIN; MOUSE; RECEPTIVITY; UTERUS; FAMILY; MICE; DYNAMICS	Embryo implantation requires that the uterus differentiate into the receptive state. Failure to attain uterine receptivity will impede blastocyst attachment and result in a compromised pregnancy. The molecular mechanism by which the uterus transitions from the pre-receptive to the receptive stage is complex, involving an intricate interplay of various molecules. We recently found that mice with uterine deletion of Msx genes (Msx1(d/d/)Msx2(d/d)) are infertile because of implantation failure associated with heightened apicobasal polarity of luminal epithelial cells during the receptive period. However, information on Msx's roles in regulating epithelial polarity remains limited. To gain further insight, we analyzed cell-type-specific gene expression by RNA sequencing of separated luminal epithelial and stromal cells by laser capture microdissection from Msx1(d/d)/Msx2(d/d) and floxed mouse uteri on d 4 of pseudopregnancy. We found that claudin-1, a tight junction protein, and small proline-rich (Sprr2) protein, a major component of cornified envelopes in keratinized epidermis, were substantially up-regulated in Msx1(d/d)/Msx2(d/d) uterine epithelia. These factors also exhibited unique epithelial expression patterns at the implantation chamber (crypt) in Msx1(f/f)/Msx2(f/f) females; the patterns were lost in Msx1(d/d)/Msx2(d/d) epithelia on d 5, suggesting important roles during implantation. The results suggest that Msx genes play important roles during uterine receptivity including modulation of epithelial junctional activity.-Sun, X., Park, C. B., Deng, W., Potter, S. S., Dey, S. K. Uterine inactivation of muscle segment homeobox (Msx) genes alters epithelial cell junction proteins during embryo implantation. FASEB J. 30, 1425-1435 (2016). www.fasebj.org	[Sun, Xiaofei; Park, Craig B.; Deng, Wenbo; Dey, Sudhansu K.] Cincinnati Childrens Hosp Med Ctr, Div Reprod Sci, Cincinnati, OH 45229 USA; [Potter, S. Steven; Dey, Sudhansu K.] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center	Dey, SK (corresponding author), Cincinnati Childrens Hosp Med Ctr, MLC 7045,3333 Burnet Ave, Cincinnati, OH 45229 USA.	sk.dey@cchmc.org			U.S. National Institutes of Health (NIH) National Institute of Child Health and Human Development [HD068524]; NIH National Cancer Institute [P01-CA77839]; March of Dimes [3-FY12-127, 3-FY13-543]; Canadian Institutes of Health Research; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD068524] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P01CA077839] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Child Health and Human Development; NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); March of Dimes(March of Dimes); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank J. Lydon and F. DeMayo (Baylor College of Medicine, Houston, TX, USA) for initially providing the Pgr<SUP>Cre/+</SUP> mice, and R. Maxson (University of Southern California, Los Angeles, CA, USA) for the Msx1<SUP>loxP/loxP</SUP>/Msx2<SUP>loxP/loxP</SUP> mice. This study was supported in part by U.S. National Institutes of Health (NIH) National Institute of Child Health and Human Development Grant HD068524, NIH National Cancer Institute Grant P01-CA77839, and March of Dimes Grants 3-FY12-127 and 3-FY13-543 (to S.K.D). C.B.P. was supported by a fellowship from the Canadian Institutes of Health Research. The authors declare no conflicts of interest.	Alappat S, 2003, CELL RES, V13, P429, DOI 10.1038/sj.cr.7290185; BORTH W, 1992, FASEB J, V6, P3345, DOI 10.1096/fasebj.6.15.1281457; Candi E, 2005, NAT REV MOL CELL BIO, V6, P328, DOI 10.1038/nrm1619; Carson DD, 2000, DEV BIOL, V223, P217, DOI 10.1006/dbio.2000.9767; Catron KM, 1996, MECH DEVELOP, V55, P185, DOI 10.1016/0925-4773(96)00503-5; Cha J, 2014, CELL REP, V8, P381, DOI 10.1016/j.celrep.2014.06.027; Cha J, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130035; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Daikoku T, 2004, MOL ENDOCRINOL, V18, P1238, DOI 10.1210/me.2003-0403; Daikoku T, 2011, DEV CELL, V21, P1014, DOI 10.1016/j.devcel.2011.09.010; Das SK, 1997, DEV GENET, V21, P44, DOI 10.1002/(SICI)1520-6408(1997)21:1&lt;44::AID-DVG5&gt;3.0.CO;2-8; Dey SK, 2004, REPRODUCTION, V128, P655, DOI 10.1530/rep.1.00537; ENDERS AC, 1975, ANAT REC, V182, P137, DOI 10.1002/ar.1091820202; Finnerty JR, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-18; Franco HL, 2010, BIOL REPROD, V82, P991, DOI 10.1095/biolreprod.109.081513; Frantz C, 2010, J CELL SCI, V123, P4195, DOI 10.1242/jcs.023820; Furuse M, 1998, J CELL BIOL, V143, P391, DOI 10.1083/jcb.143.2.391; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Furuse M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002907; GUMBINER BM, 1993, J CELL BIOL, V123, P1631, DOI 10.1083/jcb.123.6.1631; Hong SH, 2010, REPROD TOXICOL, V30, P469, DOI 10.1016/j.reprotox.2010.04.009; Hong SH, 2004, MOL CELLS, V17, P477; KARTASOVA T, 1988, MOL CELL BIOL, V8, P2195, DOI 10.1128/MCB.8.5.2195; MADARA JL, 1988, CELL, V53, P497, DOI 10.1016/0092-8674(88)90562-4; Maier S, 2008, EXP CELL RES, V314, P2477, DOI 10.1016/j.yexcr.2008.05.020; Murphy CR, 2004, CELL RES, V14, P259, DOI 10.1038/sj.cr.7290227; Paria BC, 2002, SCIENCE, V296, P2185, DOI 10.1126/science.1071601; Reese J, 2001, J BIOL CHEM, V276, P44137, DOI 10.1074/jbc.M107563200; SATOKATA I, 1994, NAT GENET, V6, P348, DOI 10.1038/ng0494-348; Satokata I, 2000, NAT GENET, V24, P391, DOI 10.1038/74231; Simmons DG, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-352; Song H, 2002, DEVELOPMENT, V129, P2879; Soyal SM, 2005, GENESIS, V41, P58, DOI 10.1002/gene.20098; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Sun XF, 2013, MOL ENDOCRINOL, V27, P1492, DOI 10.1210/me.2013-1086; Sun XF, 2012, P NATL ACAD SCI USA, V109, P1145, DOI 10.1073/pnas.1118411109; Tan YF, 2006, REPROD NUTR DEV, V46, P641, DOI 10.1051/rnd:2006037; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Wang JQ, 2011, DEV CELL, V21, P575, DOI 10.1016/j.devcel.2011.07.003; Zhang HL, 1996, P NATL ACAD SCI USA, V93, P1764, DOI 10.1073/pnas.93.5.1764; Zhong YF, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-169	43	15	18	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1425	1435		10.1096/fj.15-282798	http://dx.doi.org/10.1096/fj.15-282798			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26667042	Green Published			2022-12-26	WOS:000372629100006
J	Kienast, Y; Jucknischke, U; Scheiblich, S; Thier, M; de Wouters, M; Haas, A; Lehmann, C; Brand, V; Bernicke, D; Honold, K; Lorenz, S				Kienast, Yvonne; Jucknischke, Ute; Scheiblich, Stefan; Thier, Martina; de Wouters, Mariana; Haas, Alexander; Lehmann, Christian; Brand, Verena; Bernicke, Dirk; Honold, Konrad; Lorenz, Stefan			Rapid Activation of Bone Morphogenic Protein 9 by Receptor-mediated Displacement of Pro-domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bone morphogenetic protein (BMP); homeostasis; protein complex; surface plasmon resonance (SPR); transforming growth factor (TGF-B)	HEREDITARY HEMORRHAGIC TELANGIECTASIA; SUPPRESSES TUMOR-GROWTH; MESENCHYMAL STEM-CELLS; KINASE 1 ALK1; BMP9; ANGIOGENESIS; TGF-BETA-1; IDENTIFICATION; MUTATIONS; PRODOMAIN	By non-covalent association after proteolytic cleavage, the pro-domains modulate the activities of the mature growth factor domains across the transforming growth factor- family. In the case of bone morphogenic protein 9 (BMP9), however, the pro-domains do not inhibit the bioactivity of the growth factor, and the BMP9pro-domain complexes have equivalent biological activities as the BMP9 mature ligand dimers. By using real-time surface plasmon resonance, we could demonstrate that either binding of pro-domain-complexed BMP9 to type I receptor activin receptor-like kinase 1 (ALK1), type II receptors, co-receptor endoglin, or to mature BMP9 domain targeting antibodies leads to immediate and complete displacement of the pro-domains from the complex. Vice versa, pro-domain binding by an anti-pro-domain antibody results in release of the mature BMP9 growth factor. Based on these findings, we adjusted ELISA assays to measure the protein levels of different BMP9 variants. Although mature BMP9 and inactive precursor BMP9 protein were directly detectable by ELISA, BMP9pro-domain complex could only be measured indirectly as dissociated fragments due to displacement of mature growth factor and pro-domains after antibody binding. Our studies provide a model in which BMP9 can be readily activated upon getting into contact with its receptors. This increases the understanding of the underlying biology of BMP9 activation and also provides guidance for ELISA development for the detection of circulating BMP9 variants.	[Kienast, Yvonne; Jucknischke, Ute; Scheiblich, Stefan; Thier, Martina; de Wouters, Mariana; Haas, Alexander; Lehmann, Christian; Brand, Verena; Bernicke, Dirk; Honold, Konrad; Lorenz, Stefan] Roche Innovat Ctr Penzberg, Roche Pharma Res & Early Dev pRED, D-82377 Penzberg, Germany; [Kienast, Yvonne; Jucknischke, Ute; Scheiblich, Stefan; Lehmann, Christian; Bernicke, Dirk; Honold, Konrad] Roche Innovat Ctr Penzberg, Discovery Oncol, D-82377 Penzberg, Germany; [Thier, Martina; de Wouters, Mariana] Roche Innovat Ctr, Translat Technol & Bioinformat, CH-4070 Basel, Switzerland; [Haas, Alexander; Lorenz, Stefan] Roche Innovat Ctr Penzberg, Large Mol Res, D-82377 Penzberg, Germany	Roche Holding	Kienast, Y (corresponding author), Roche Diagnost GmbH, Roche Innovat Ctr Penzberg, Roche Pharma Res & Early Dev, Discovery Oncol, Nonnenwald 2, D-82377 Penzberg, Germany.	yvonne.kienast@roche.com						Bidart M, 2012, CELL MOL LIFE SCI, V69, P313, DOI 10.1007/s00018-011-0751-1; Brown MA, 2005, J BIOL CHEM, V280, P25111, DOI 10.1074/jbc.M503328200; Burke RM, 2013, P NATL ACAD SCI USA, V110, P19567, DOI 10.1073/pnas.1319297110; Castonguay R, 2011, J BIOL CHEM, V286, P30034, DOI 10.1074/jbc.M111.260133; Chen H, 2013, P NATL ACAD SCI USA, V110, P11887, DOI 10.1073/pnas.1306074110; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Crawford SE, 1998, CELL, V93, P1159, DOI 10.1016/S0092-8674(00)81460-9; Cunha SI, 2010, J EXP MED, V207, P85, DOI 10.1084/jem.20091309; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Gregory KE, 2005, J BIOL CHEM, V280, P27970, DOI 10.1074/jbc.M504270200; Hauburger A, 2009, FEBS J, V276, P6386, DOI 10.1111/j.1742-4658.2009.07361.x; Herrera B, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-20; Hintze V, 2012, ACTA BIOMATER, V8, P2144, DOI 10.1016/j.actbio.2012.03.021; Hintze V, 2014, BIOMACROMOLECULES, V15, P3083, DOI 10.1021/bm5006855; Hu-Lowe DD, 2011, CANCER RES, V71, P1362, DOI 10.1158/0008-5472.CAN-10-1451; Jiang H., 2015, J BIOL CHEM IN PRESS, V290; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Kang Q, 2009, STEM CELLS DEV, V18, P545, DOI 10.1089/scd.2008.0130; Lopez-Coviella I, 2000, SCIENCE, V289, P313, DOI 10.1126/science.289.5477.313; Luo JY, 2010, J BIOL CHEM, V285, P29588, DOI 10.1074/jbc.M110.130518; Luther G, 2011, CURR GENE THER, V11, P229; LYONS RM, 1988, J CELL BIOL, V106, P1659, DOI 10.1083/jcb.106.5.1659; Mi LZ, 2015, P NATL ACAD SCI USA, V112, P3710, DOI 10.1073/pnas.1501303112; Mitchell D, 2010, MOL CANCER THER, V9, P379, DOI 10.1158/1535-7163.MCT-09-0650; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; Oh SP, 2000, P NATL ACAD SCI USA, V97, P2626, DOI 10.1073/pnas.97.6.2626; Ramirez F, 2010, CELL TISSUE RES, V339, P71, DOI 10.1007/s00441-009-0822-x; Ramirez F, 2009, CURR OPIN CELL BIOL, V21, P616, DOI 10.1016/j.ceb.2009.05.005; Ricard N, 2012, BLOOD, V119, P6162, DOI 10.1182/blood-2012-01-407593; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Sengle G, 2008, J MOL BIOL, V381, P1025, DOI 10.1016/j.jmb.2008.06.074; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Sengle G, 2011, J BIOL CHEM, V286, P5087, DOI 10.1074/jbc.M110.188615; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Townson SA, 2012, J BIOL CHEM, V287, P27313, DOI 10.1074/jbc.M112.377960; Wei ZQ, 2014, J BIOL CHEM, V289, P31150, DOI 10.1074/jbc.M114.579771; Wooderchak-Donahue WL, 2013, AM J HUM GENET, V93, P530, DOI 10.1016/j.ajhg.2013.07.004	38	29	32	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3395	3410		10.1074/jbc.M115.680009	http://dx.doi.org/10.1074/jbc.M115.680009			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26677222	Green Published, hybrid			2022-12-26	WOS:000370854500023
J	Kosasih, HJ; Last, K; Rogerson, FM; Golub, SB; Gauci, SJ; Russo, VC; Stanton, H; Wilson, R; Lamande, SR; Holden, P; Fosang, AJ				Kosasih, Hansen J.; Last, Karena; Rogerson, Fraser M.; Golub, Suzanne B.; Gauci, Stephanie J.; Russo, Vincenzo C.; Stanton, Heather; Wilson, Richard; Lamande, Shireen R.; Holden, Paul; Fosang, Amanda J.			A Disintegrin and Metalloproteinase with Thrombospondin Motifs-5 (ADAMTS-5) Forms Catalytically Active Oligomers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cartilage; cartilage biology; metalloprotease; oligomer; oligomerization; ADAMTS; ADAMTS5; aggrecan	AGGRECAN INTERGLOBULAR DOMAIN; PROCOLLAGEN N-PROTEINASE; VON-WILLEBRAND-FACTOR; ARTICULAR-CARTILAGE; IN-VIVO; SYNOVIAL-FLUID; OSTEOARTHRITIC CARTILAGE; PROTEOLYTIC ACTIVITIES; FUNCTIONAL DIFFERENCES; NONCATALYTIC DOMAINS	The metalloproteinase ADAMTS-5 (A disintegrin and metalloproteinase with thrombospondin motifs) degrades aggrecan, a proteoglycan essential for cartilage structure and function. ADAMTS-5 is the major aggrecanase in mouse cartilage, and is also likely to be the major aggrecanase in humans. ADAMTS-5 is a multidomain enzyme, but the function of the C-terminal ancillary domains is poorly understood. We show that mutant ADAMTS-5 lacking the catalytic domain, but with a full suite of ancillary domains inhibits wild type ADAMTS activity, in vitro and in vivo, in a dominant-negative manner. The data suggest that mutant ADAMTS-5 binds to wild type ADAMTS-5; thus we tested the hypothesis that ADAMTS-5 associates to form oligomers. Co-elution, competition, and in situ PLA experiments using full-length and truncated recombinant ADAMTS-5 confirmed that ADAMTS-5 molecules interact, and showed that the catalytic and disintegrin-like domains support these intermolecular interactions. Cross-linking experiments revealed that recombinant ADAMTS-5 formed large, reduction-sensitive oligomers with a nominal molecular mass of approximate to 400 kDa. The oligomers were unimolecular and proteolytically active. ADAMTS-5 truncates comprising the disintegrin and/or catalytic domains were able to competitively block full-length ADAMTS-5-mediated aggrecan cleavage, measured by production of the G1-EGE(373) neoepitope. These results show that ADAMTS-5 oligomerization is required for full aggrecanase activity, and they provide evidence that blocking oligomerization inhibits ADAMTS-5 activity. The data identify the surface provided by the catalytic and disintegrin-like domains of ADAMTS-5 as a legitimate target for the design of aggrecanase inhibitors.	[Kosasih, Hansen J.; Last, Karena; Rogerson, Fraser M.; Golub, Suzanne B.; Stanton, Heather; Fosang, Amanda J.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Kosasih, Hansen J.; Last, Karena; Rogerson, Fraser M.; Golub, Suzanne B.; Gauci, Stephanie J.; Russo, Vincenzo C.; Stanton, Heather; Lamande, Shireen R.; Fosang, Amanda J.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Holden, Paul] Oregon Hlth & Sci Univ, Dept Orthopaed & Rehabil, Portland, OR 97239 USA; [Wilson, Richard] Univ Tasmania, Hobart, Tas 7000, Australia	University of Melbourne; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; Oregon Health & Science University; University of Tasmania	Fosang, AJ (corresponding author), Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia.; Fosang, AJ (corresponding author), Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.	amanda.fosang@mcri.edu.au	Wilson, Richard/H-8429-2012	Wilson, Richard/0000-0003-0152-4394; Fosang, Amanda/0000-0002-5523-5427; STANTON, HEATHER/0000-0002-3427-5614; Last, Karena/0000-0002-4396-8404; Lamande, Shireen/0000-0003-2938-2711; Kosasih, Hansen/0000-0002-0428-6195	National Health & Medical Research Council (Australia); Murdoch Childrens Research Institute; Victorian State Government's Operational Infrastructure Support Program	National Health & Medical Research Council (Australia)(National Health and Medical Research Council (NHMRC) of Australia); Murdoch Childrens Research Institute; Victorian State Government's Operational Infrastructure Support Program	This work was supported by the National Health & Medical Research Council (Australia), the Murdoch Childrens Research Institute, and the Victorian State Government's Operational Infrastructure Support Program. The authors declare that they have no conflicts of interest with the contents of this article.	Abbaszade I, 1999, J BIOL CHEM, V274, P23443, DOI 10.1074/jbc.274.33.23443; BRACKERTZ D, 1977, ARTHRITIS RHEUM, V20, P841, DOI 10.1002/art.1780200314; Cha HJ, 2002, J MOL BIOL, V320, P1065, DOI 10.1016/S0022-2836(02)00558-2; Chockalingam PS, 2011, OSTEOARTHR CARTILAGE, V19, P315, DOI 10.1016/j.joca.2010.12.004; COLIGE A, 1995, J BIOL CHEM, V270, P16724, DOI 10.1074/jbc.270.28.16724; Dufour A, 2010, J BIOL CHEM, V285, P35944, DOI 10.1074/jbc.M109.091769; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; Flannery CR, 2002, J BIOL CHEM, V277, P42775, DOI 10.1074/jbc.M205309200; Fosang AJ, 2008, EUR CELLS MATER, V15, P11, DOI 10.22203/eCM.v015a02; Fujikawa K, 2001, BLOOD, V98, P1662, DOI 10.1182/blood.V98.6.1662; Furlan M, 1996, BLOOD, V87, P4223, DOI 10.1182/blood.V87.10.4223.bloodjournal87104223; Fushimi K, 2008, J BIOL CHEM, V283, P6706, DOI 10.1074/jbc.M708647200; Gao G, 2002, J BIOL CHEM, V277, P11034, DOI 10.1074/jbc.M107443200; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; GOLDBERG GI, 1992, J BIOL CHEM, V267, P4583; Hashimoto G, 2004, J BIOL CHEM, V279, P32483, DOI 10.1074/jbc.M314216200; HOJIMA Y, 1989, J BIOL CHEM, V264, P11336; HOJIMA Y, 1994, J BIOL CHEM, V269, P11381; HUGHES CE, 1992, J BIOL CHEM, V267, P16011; ILIC MZ, 1992, ARCH BIOCHEM BIOPHYS, V294, P115, DOI 10.1016/0003-9861(92)90144-L; Itoh Y, 2008, J BIOL CHEM, V283, P13053, DOI 10.1074/jbc.M709327200; Itoh Y, 2006, MOL BIOL CELL, V17, P5390, DOI 10.1091/mbc.e06-08-0740; Jones GC, 2005, ARTHRITIS RES THER, V7, P160, DOI 10.1186/ar1783; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Kelwick R, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0676-3; Koo BH, 2012, J BIOL CHEM, V287, P22643, DOI 10.1074/jbc.M111.337949; Larkin J, 2015, OSTEOARTHR CARTILAGE, V23, P1254, DOI 10.1016/j.joca.2015.02.778; Little CB, 2005, ARTHRITIS RHEUM-US, V52, P1461, DOI 10.1002/art.21022; Little CB, 2007, J CLIN INVEST, V117, P1627, DOI 10.1172/JCI30765; Longpre JM, 2009, INT J BIOCHEM CELL B, V41, P1116, DOI 10.1016/j.biocel.2008.10.008; Lorenzen I, 2011, BIOCHEM BIOPH RES CO, V415, P330, DOI 10.1016/j.bbrc.2011.10.056; LOULAKIS P, 1992, BIOCHEM J, V284, P589, DOI 10.1042/bj2840589; Malfait AM, 2002, J BIOL CHEM, V277, P22201, DOI 10.1074/jbc.M200431200; Malfait AM, 2008, ARCH BIOCHEM BIOPHYS, V478, P43, DOI 10.1016/j.abb.2008.07.012; McCulloch DR, 2009, GENE EXPR PATTERNS, V9, P314, DOI 10.1016/j.gep.2009.02.006; Mosyak L, 2008, PROTEIN SCI, V17, P16, DOI 10.1110/ps.073287008; Naito S, 2007, PATHOL INT, V57, P703, DOI 10.1111/j.1440-1827.2007.02167.x; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Olson MW, 2000, J BIOL CHEM, V275, P2661, DOI 10.1074/jbc.275.4.2661; Plaas A, 2007, OSTEOARTHR CARTILAGE, V15, P719, DOI 10.1016/j.joca.2006.12.008; Powell AJ, 2007, ARTHRITIS RHEUM-US, V56, P3010, DOI 10.1002/art.22818; Rauch A, 2006, J PROTEOME RES, V5, P112, DOI 10.1021/pr0503533; Rogerson FM, 2008, ARTHRITIS RHEUM-US, V58, P1664, DOI 10.1002/art.23458; Sandy JD, 2001, BIOCHEM J, V358, P615, DOI 10.1042/0264-6021:3580615; Sohail A, 2011, J BIOL CHEM, V286, P33178, DOI 10.1074/jbc.M111.253369; Song RH, 2007, ARTHRITIS RHEUM-US, V56, P575, DOI 10.1002/art.22334; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Stanton H, 2011, NAT PROTOC, V6, DOI 10.1038/nprot.2010.179; Sterchi EE, 2008, MOL ASPECTS MED, V29, P309, DOI 10.1016/j.mam.2008.08.002; Struglics A, 2006, OSTEOARTHR CARTILAGE, V14, P101, DOI 10.1016/j.joca.2005.07.018; Struglics A, 2011, OSTEOARTHR CARTILAGE, V19, P1047, DOI 10.1016/j.joca.2011.05.006; Struglics A, 2012, ARTHRITIS RHEUM-US, V64, P4151, DOI 10.1002/art.34665; Vankemmelbeke MN, 2001, EUR J BIOCHEM, V268, P1259, DOI 10.1046/j.1432-1327.2001.01990.x; Wilson R, 2008, METHODS, V45, P22, DOI 10.1016/j.ymeth.2008.01.008; Yamamoto K, 2014, J BIOL CHEM, V289, P6462, DOI 10.1074/jbc.M113.545376; Yamamoto K, 2013, FASEB J, V27, P511, DOI 10.1096/fj.12-216671; Zeng WL, 2006, BBA-GEN SUBJECTS, V1760, P517, DOI 10.1016/j.bbagen.2006.01.013; Zhao HR, 2008, J BIOL CHEM, V283, P35023, DOI 10.1074/jbc.M806553200	59	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3197	3208		10.1074/jbc.M115.704817	http://dx.doi.org/10.1074/jbc.M115.704817			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26668318	Green Published, hybrid			2022-12-26	WOS:000370854500008
J	Keravis, T; Favot, L; Abusnina, AA; Anton, A; Justiniano, H; Soleti, R; Alibrahim, EA; Simard, G; Andriantsitohaina, R; Lugnier, C				Keravis, Therese; Favot, Laure; Abusnina, Abdurrazag A.; Anton, Anita; Justiniano, Helene; Soleti, Raffaella; Alibrahim, Eid Alabed; Simard, Gilles; Andriantsitohaina, Ramaroson; Lugnier, Claire			Delphinidin Inhibits Tumor Growth by Acting on VEGF Signalling in Endothelial Cells	PLOS ONE			English	Article							RED WINE POLYPHENOLS; CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; PROTEIN-KINASE-C; DIETARY ANTHOCYANIDIN; RAT AORTA; ACTIVATION; PDE4; ANGIOGENESIS; MECHANISMS; PATHWAY	The vasculoprotective properties of delphinidin are driven mainly by its action on endothelial cells. Moreover, delphinidin displays anti-angiogenic properties in both in vitro and in vivo angiogenesis models and thereby might prevent the development of tumors associated with excessive vascularization. This study was aimed to test the effect of delphinidin on melanoma-induced tumor growth with emphasis on its molecular mechanism on endothelial cells. Delphinidin treatment significantly decreased in vivo tumor growth induced by B16-F10 melanoma cell xenograft in mice. In vitro, delphinidin was not able to inhibit VEGFR2-mediated B16-F10 melanoma cell proliferation but it specifically reduced basal and VEGFR2-mediated endothelial cell proliferation. The anti-proliferative effect of delphinidin was reversed either by the MEK1/2 MAP kinase inhibitor, U-0126, or the PI3K inhibitor, LY-294002. VEGF-induced proliferation was reduced either by U-0126 or LY-294002. Under these conditions, delphinidin failed to decrease further endothelial cell proliferation. Delphinidin prevented VEGF-induced phosphorylation of ERK1/2 and p38 MAPK and decreased the expression of the transcription factors, CREB and ATF1. Finally, delphinidin was more potent in inhibiting in vitro cyclic nucleotide phosphodiesterases (PDEs), PDE1 and PDE2, compared to PDE3-PDE5. Altogether delphinidin reduced tumor growth of melanoma cell in vivo by acting specifically on endothelial cell proliferation. The mechanism implies an association between inhibition of VEGF-induced proliferation via VEGFR2 signalling, MAPK, PI3K and at transcription level on CREB/ATF1 factors, and the inhibition of PDE2. In conjunction with our previous studies, we demonstrate that delphinidin is a promising compound to prevent pathologies associated with generation of vascular network in tumorigenesis.	[Keravis, Therese; Favot, Laure; Abusnina, Abdurrazag A.; Anton, Anita; Justiniano, Helene; Lugnier, Claire] Univ Strasbourg, Lab Biophoton & Pharmacol, CNRS, UMR 7213, Illkirch Graffenstaden, France; [Soleti, Raffaella; Alibrahim, Eid Alabed; Simard, Gilles; Andriantsitohaina, Ramaroson] Univ Angers, INSERM, LUNAM, U1063, Angers, France; [Simard, Gilles; Andriantsitohaina, Ramaroson] CHU Angers, Angers, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Lugnier, C (corresponding author), Univ Strasbourg, Lab Biophoton & Pharmacol, CNRS, UMR 7213, Illkirch Graffenstaden, France.	claire.lugnier@unistra.fr	SOLETI, RAFFAELLA/ABB-5455-2020; ANDRIANTSITOHAINA, Ramaroson/H-5286-2018; lugnier, claire/AAF-3911-2020; Laforge, Laure Favot/AGW-2729-2022; soleti, raffaella/AAC-1678-2021	SOLETI, RAFFAELLA/0000-0002-0271-0490; andriantsitohaina, ramaroson/0000-0002-4770-3585; Lugnier, Claire/0000-0002-0850-1331	French Centre National de la Recherche Scientifique; INSERM; University of Strasbourg; University of Angers; APRIFEL/Ligue Contre le Cancer, France; Libyan Higher Education Ministry	French Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); University of Strasbourg; University of Angers; APRIFEL/Ligue Contre le Cancer, France; Libyan Higher Education Ministry	This work was supported in part by the French Centre National de la Recherche Scientifique, the INSERM, the University of Strasbourg, the University of Angers and APRIFEL/Ligue Contre le Cancer, France. Dr. Abdurazzag Abusnina was supported by a fellowship from the Libyan Higher Education Ministry. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abusnina A, 2015, THROMB HAEMOSTASIS, V113, P319, DOI 10.1160/TH14-05-0454; Abusnina A, 2011, MOL NUTR FOOD RES, V55, P1677, DOI 10.1002/mnfr.201100307; Alvarez E, 2006, BRIT J PHARMACOL, V147, P269, DOI 10.1038/sj.bjp.0706507; Andriambeloson E, 1998, J NUTR, V128, P2324, DOI 10.1093/jn/128.12.2324; Andriantsitohaina R, 2012, BRIT J NUTR, V108, P1532, DOI 10.1017/S0007114512003406; Arranz S, 2012, NUTRIENTS, V4, P759, DOI 10.3390/nu4070759; Baron-Menguy C, 2007, FASEB J, V21, P3511, DOI 10.1096/fj.06-7782com; Campos-Toimil M, 2008, BRIT J PHARMACOL, V154, P82, DOI 10.1038/bjp.2008.56; Chalopin M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008554; Clere Nicolas, 2011, Cardiovascular & Hematological Agents in Medicinal Chemistry, V9, P62; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Dent Paul, 2014, Cancer Biol Ther, V15, P245, DOI 10.4161/cbt.27541; Duluc L, 2014, INT J BIOCHEM CELL B, V53, P9, DOI 10.1016/j.biocel.2014.03.030; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Favot L, 2004, THROMB HAEMOSTASIS, V92, P634, DOI 10.1160/TH03-12-0768; Favot L, 2003, CARDIOVASC RES, V59, P479, DOI 10.1016/S0008-6363(03)00433-4; Favot L, 2003, THROMB HAEMOSTASIS, V90, P334, DOI 10.1160/TH03-02-0084; Geoffroy V, 1999, EUR J BIOCHEM, V259, P892, DOI 10.1046/j.1432-1327.1999.00123.x; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Goncalves RL, 2009, EUR J PHARMACOL, V620, P78, DOI 10.1016/j.ejphar.2009.08.008; Gustin JA, 2004, AM J PHYSIOL-CELL PH, V286, pC547, DOI 10.1152/ajpcell.00332.2002; Ilan N, 1998, J CELL SCI, V111, P3621; Keravis T., 2006, CYCLIC NUCLEOTIDE PH, P417; Keravis Therese, 2005, V307, P63; Keravis T, 2012, BRIT J PHARMACOL, V165, P1288, DOI 10.1111/j.1476-5381.2011.01729.x; Kubo K, 2005, J MED CHEM, V48, P1359, DOI 10.1021/jm030427r; Lamy S, 2006, CARCINOGENESIS, V27, P989, DOI 10.1093/carcin/bgi279; Lamy S, 2008, CARCINOGENESIS, V29, P1033, DOI 10.1093/carcin/bgn070; Lugnier C, 2006, PHARMACOL THERAPEUT, V109, P366, DOI 10.1016/j.pharmthera.2005.07.003; Lugnier C, 2001, FASEB J, V15, pA211; LUGNIER C, 1986, BIOCHEM PHARMACOL, V35, P1743, DOI 10.1016/0006-2952(86)90333-3; Martin S, 2003, BIOCHEM PHARMACOL, V65, P669, DOI 10.1016/S0006-2952(02)01568-X; Martin S, 2002, BRIT J PHARMACOL, V135, P1579, DOI 10.1038/sj.bjp.0704603; Maurice DH, 2014, NAT REV DRUG DISCOV, V13, P290, DOI 10.1038/nrd4228; Pal HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077270; Sassone-Corsi P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011148; Soleti R, 2009, CARCINOGENESIS, V30, P580, DOI 10.1093/carcin/bgp030; Tcheudji JFK, 2001, J MOL BIOL, V310, P781, DOI 10.1006/jmbi.2001.4813; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Wang Z, 2015, SEM CANC BI IN PRESS; Xu CS, 2013, SCI WORLD J, DOI 10.1155/2013/417413; Xu H, 2008, CARDIOVASC RES, V78, P349, DOI 10.1093/cvr/cvm085; Zachary I, 2001, CARDIOVASC RES, V49, P568, DOI 10.1016/S0008-6363(00)00268-6	43	20	25	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145291	10.1371/journal.pone.0145291	http://dx.doi.org/10.1371/journal.pone.0145291			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694325	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092500036
J	Dobbins, GC; Ugai, H; Curiel, DT; Gillespie, GY				Dobbins, G. Clement; Ugai, Hideyo; Curiel, David T.; Gillespie, G. Yancey			A Multi Targeting Conditionally Replicating Adenovirus Displays Enhanced Oncolysis while Maintaining Expression of Immunotherapeutic Agents	PLOS ONE			English	Article							GENE-TRANSFER EFFICIENCY; MALIGNANT GLIOMA; OVARIAN-CANCER; IN-VIVO; CELLS; PROTEIN; VIROTHERAPY; GENERATION; INFECTION; RECEPTOR	Studies have demonstrated that oncolytic adenoviruses based on a 24 base pair deletion in the viral E1A gene (D24) may be promising therapeutics for treating a number of cancer types. In order to increase the therapeutic potential of these oncolytic viruses, a novel conditionally replicating adenovirus targeting multiple receptors upregulated on tumors was generated by incorporating an Ad5/3 fiber with a carboxyl terminus RGD ligand. The virus displayed full cytopathic effect in all tumor lines assayed at low titers with improved cytotoxicity over Ad5-RGD D24, Ad5/3 D24 and an HSV oncolytic virus. The virus was then engineered to deliver immunotherapeutic agents such as GM-CSF while maintaining enhanced heterogenic oncolysis.	[Dobbins, G. Clement] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA; [Dobbins, G. Clement; Gillespie, G. Yancey] Univ Alabama Birmingham, Dept Neurosurg, Birmingham, AL USA; [Ugai, Hideyo] Washington Univ, Sch Med, Dept Radiat Oncol, Div Canc Biol, St Louis, MO USA; [Curiel, David T.] Washington Univ, Sch Med, Dept Radiat Oncol, Biol Therapeut Ctr, St Louis, MO USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Washington University (WUSTL); Washington University (WUSTL)	Dobbins, GC (corresponding author), Univ Alabama Birmingham, Dept Pediat, Birmingham, AL 35294 USA.	gclemd@uab.edu; yancey@uab.edu	Ugai, Hideyo/K-4920-2017	Ugai, Hideyo/0000-0002-9121-8480; Gillespie, George/0000-0001-6436-9542	National Institutes of Health [T32-NS048039]; American Cancer Society [PF-12-143-01-CCE]; Susan G. Komen for the Cure [KG100194]; UAB/UMN SPORE in Pancreatic Cancer [5P50 CA101955-07]; UAB Brain Tumor SPORE [5P20 CA151129-03, P01 CA071933]; NATIONAL CANCER INSTITUTE [P50CA101955, P01CA071933, P20CA151129] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS048039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); UAB/UMN SPORE in Pancreatic Cancer; UAB Brain Tumor SPORE; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the following grants: T32-NS048039 from the National Institutes of Health and PF-12-143-01-CCE from the American Cancer Society (G.C.D); Susan G. Komen for the Cure KG100194 (D.T.C., H.U.); UAB/UMN SPORE in Pancreatic Cancer 5P50 CA101955-07 (D.T.C.); UAB Brain Tumor SPORE 5P20 CA151129-03 (G.Y.G.) and P01 CA071933 (G.Y.G.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arellano M, 2008, BIOL-TARGETS THER, V2, P13; Bauerschmitz GJ, 2002, INT J ONCOL, V21, P1161; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; BERK AJ, 1986, ANNU REV GENET, V20, P45, DOI 10.1146/annurev.ge.20.120186.000401; BIGNER DD, 1981, J NEUROPATH EXP NEUR, V40, P201, DOI 10.1097/00005072-198105000-00001; Chartier C, 1996, J VIROL, V70, P4805, DOI 10.1128/JVI.70.7.4805-4810.1996; Fueyo J, 2000, ONCOGENE, V19, P2, DOI 10.1038/sj.onc.1203251; Fukuda K, 2003, CANCER RES, V63, P4434; Gill BJ, 2014, P NATL ACAD SCI USA, V111, P12550, DOI 10.1073/pnas.1405839111; Heise C, 2000, NAT MED, V6, P1134, DOI 10.1038/80474; Horwitz MS, 2004, J GENE MED, V6, pS172, DOI 10.1002/jgm.495; Jiang H, 2011, J VIROL, V85, P4720, DOI 10.1128/JVI.02032-10; Kanerva A, 2002, CLIN CANCER RES, V8, P275; Kim KH, 2011, HUM GENE THER, V22, P821, DOI 10.1089/hum.2010.180; Kimball KJ, 2010, CLIN CANCER RES, V16, P5277, DOI 10.1158/1078-0432.CCR-10-0791; Kimball KJ, 2009, MOL IMAGING, V8, P264, DOI 10.2310/7290.2009.00025; Koski A, 2015, MOL THER, V23, P1641, DOI 10.1038/mt.2015.125; Koski A, 2010, MOL THER, V18, P1874, DOI 10.1038/mt.2010.161; Krasnykh VN, 1996, J VIROL, V70, P6839, DOI 10.1128/JVI.70.10.6839-6846.1996; Lenaerts L, 2008, REV MED VIROL, V18, P357, DOI 10.1002/rmv.589; Li EG, 1998, J VIROL, V72, P2055, DOI 10.1128/JVI.72.3.2055-2061.1998; Liu YP, 2014, GYNECOL ONCOL, V132, P722, DOI 10.1016/j.ygyno.2014.01.009; Lu ZZ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003718; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; Matzinger P, 2002, SCIENCE, V296, P301, DOI 10.1126/science.1071059; Megison ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086843; Meulenbroek RA, 2004, MOL THER, V9, P617, DOI 10.1016/j.ymthe.2004.01.012; Miller CR, 1998, CANCER RES, V58, P5738; Parker JN, 2000, P NATL ACAD SCI USA, V97, P2208, DOI 10.1073/pnas.040557897; Pesonen S, 2011, MOL PHARMACEUT, V8, P12, DOI 10.1021/mp100219n; Pol J, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.28694; Rein Daniel T, 2006, Future Oncol, V2, P137, DOI 10.2217/14796694.2.1.137; Russell SJ, 2012, NAT BIOTECHNOL, V30, P658, DOI 10.1038/nbt.2287; Sauthoff H, 2004, MOL THER, V10, P749, DOI 10.1016/j.ymthe.2004.07.014; Senzer NN, 2009, J CLIN ONCOL, V27, P5763, DOI 10.1200/JCO.2009.24.3675; Soria C, 2010, NATURE, V466, P1076, DOI 10.1038/nature09307; Suzuki K, 2001, CLIN CANCER RES, V7, P120; Tollefson AE, 1996, J VIROL, V70, P2296, DOI 10.1128/JVI.70.4.2296-2306.1996; Tyler MA, 2006, MOL CANCER THER, V5, P2408, DOI 10.1158/1535-7163.MCT-06-0187; Ugai H, 2005, BIOCHEM BIOPH RES CO, V331, P1053, DOI 10.1016/j.bbrc.2005.03.227; Ugai H, 2007, J MOL BIOL, V366, P1142, DOI 10.1016/j.jmb.2006.11.090; Ugai H, 2010, J MOL BIOL, V395, P55, DOI 10.1016/j.jmb.2009.10.034; Ulasov IV, 2007, J NEUROSURG, V107, P617, DOI 10.3171/JNS-07/09/0617; Volk AL, 2003, CANCER BIOL THER, V2, P511, DOI 10.4161/cbt.2.5.440; Wang HJ, 2011, NAT MED, V17, P96, DOI 10.1038/nm.2270; Young AM, 2012, MOL THER, V20, P1676, DOI 10.1038/mt.2012.116; Zheng CY, 2000, NAT BIOTECHNOL, V18, P176, DOI 10.1038/72628; Zhu ZB, 2007, INT J ONCOL, V31, P1213	48	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145272	10.1371/journal.pone.0145272	http://dx.doi.org/10.1371/journal.pone.0145272			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689910	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092300052
J	Silal, SP; Little, F; Barnes, KI; White, LJ				Silal, Sheetal Prakash; Little, Francesca; Barnes, Karen Irma; White, Lisa Jane			Hitting a Moving Target: A Model for Malaria Elimination in the Presence of Population Movement	PLOS ONE			English	Article							SOUTH-AFRICA; PLASMODIUM-FALCIPARUM; MPUMALANGA PROVINCE; MATHEMATICAL-MODELS; TRANSMISSION; MOZAMBIQUE; SPREAD	South Africa is committed to eliminating malaria with a goal of zero local transmission by 2018. Malaria elimination strategies may be unsuccessful if they focus only on vector biology, and ignore the mobility patterns of humans, particularly where the majority of infections are imported. In the first study in Mpumalanga Province in South Africa designed for this purpose, a metapopulation model is developed to assess the impact of their proposed elimination-focused policy interventions. A stochastic, non-linear, ordinary-differential equation model is fitted to malaria data from Mpumalanga and neighbouring Maputo Province in Mozambique. Further scaling-up of vector control is predicted to lead to a minimal reduction in local infections, while mass drug administration and focal screening and treatment at the Mpumalanga-Maputo border are predicted to have only a short-lived impact. Source reduction in Maputo Province is predicted to generate large reductions in local infections through stemming imported infections. The mathematical model predicts malaria elimination to be possible only when imported infections are treated before entry or eliminated at the source suggesting that a regionally focused strategy appears needed, for achieving malaria elimination in Mpumalanga and South Africa.	[Silal, Sheetal Prakash; Little, Francesca] Univ Cape Town, Dept Stat Sci, ZA-7700 Rondebosch, South Africa; [Barnes, Karen Irma] Univ Cape Town, Dept Med, Div Clin Pharmacol, ZA-7925 Observatory, South Africa; [White, Lisa Jane] Mahidol Univ, Mahidol Oxford Trop Med Res Unit, Bangkok 10700, Thailand; [White, Lisa Jane] Univ Oxford, Nuffield Dept Clin Med, Churchill Hosp, Ctr Trop Med, Oxford, England	University of Cape Town; University of Cape Town; Mahidol Oxford Tropical Medicine Research Unit (MORU); Mahidol University; University of Oxford	Silal, SP (corresponding author), Univ Cape Town, Dept Stat Sci, ZA-7700 Rondebosch, South Africa.	Sheetal.Silal@uct.ac.za	White, Lisa/AAC-9396-2020; Silal, Sheetal/AAB-1873-2020	White, Lisa/0000-0002-6523-185X; Silal, Sheetal/0000-0002-3007-5383; Little, Francesca/0000-0002-5917-9928	National Research Foundation of South Africa under the Thuthuka Grant Programme [80617]; National Research Foundation in South Africa; Wellcome Trust	National Research Foundation of South Africa under the Thuthuka Grant Programme; National Research Foundation in South Africa(National Research Foundation - South Africa); Wellcome Trust(Wellcome TrustEuropean Commission)	This work was funded by the National Research Foundation of South Africa under the Thuthuka Grant Programme (Grant number: 80617; http://www.nrf.ac.za). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to the Malaria Elimination Programme of the Department of Health in Mpumalanga, South Africa for the provision of data and are particularly grateful to Aaron Mabuza and Gerdalize Kok from the Malaria Elimination Programme for their valuable input. This material is based upon work supported financially by the National Research Foundation in South Africa. We are grateful to the National Research Foundation in South Africa for financial support. Any opinion, findings and conclusions or recommendations expressed in this material are those of the authors and therefore the NRF does not accept any liability in regard thereto. Mahidol-Oxford Tropical Medicine Research Unit is funded by the Wellcome Trust.	ANDERSON R M, 1991; [Anonymous], 2011, TECHNICAL REPORT; [Anonymous], 2014, LUBOMBO SPATIAL DEV; Ariey F, 2003, INFECT GENET EVOL, V2, P185, DOI 10.1016/S1567-1348(02)00099-0; Arino J, 2012, J MATH BIOL, V64, P423, DOI 10.1007/s00285-011-0418-4; Auger P, 2008, MATH BIOSCI, V216, P123, DOI 10.1016/j.mbs.2008.08.010; Blumberg L, 2007, SAMJ S AFR MED J, V97, P1193; Castillo-Riquelme M, 2008, TROP MED INT HEALTH, V13, P108, DOI 10.1111/j.1365-3156.2007.01979.x; Chitnis N, 2008, B MATH BIOL, V70, P1272, DOI 10.1007/s11538-008-9299-0; Cleveland R.B., 1990, J OFF STAT, V6; Coleman M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-68; Collins WE, 1999, AM J TROP MED HYG, V61, P4, DOI 10.4269/tropmed.1999.61-04; Craig MH, 1999, PARASITOL TODAY, V15, P105, DOI 10.1016/S0169-4758(99)01396-4; Crowell V, 2012, EPIDEMICS-NETH, V4, P1, DOI 10.1016/j.epidem.2011.10.003; Department of Home Affairs, 2005, TECHNICAL REPORT; Eberhart R., 1995, P 6 INT S MICR MACH, P39; Espinal C, 1992, ENFOQUE INTEGRAL SAL, P429; Executive Office of the President, 2013, TECHNICAL REPORT; EYLES DON E., 1951, JOUR NATL MALARIA SOC, V10, P327; Govere JM, 2001, S AFR J SCI, V97, P55; Griffin JT, 2014, NAT COMMUN, V5, DOI [10.1038/ncomms4136, DOI 10.1038/NC0MMS4136]; Hall BF, 2009, J INFECT DIS, V200, P1639, DOI 10.1086/646611; Hlongwana KW, 2011, AFRICAN J PRIMARY HL, V3; JEFFERY GM, 1955, AM J TROP MED HYG, V4, P781, DOI 10.4269/ajtmh.1955.4.781; Kennedy J., 1995, P ICNN 95 INT C NEUR, V4, P1942; Koella JC, 2003, MALARIA J, V2, DOI 10.1186/1475-2875-2-3; Le Menach A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-23; Makanga M, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-S1-S5; Mandal S, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-202; MILLER M. J., 1958, TRANS ROY SOC TROP MED AND HYG, V52, P152, DOI 10.1016/0035-9203(58)90036-1; Montosi E, 2012, HYDROL EARTH SYST SC, V16, P2759, DOI 10.5194/hess-16-2759-2012; Moonasar D, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-294; Moonen B, 2010, LANCET, V376, P1592, DOI 10.1016/S0140-6736(10)61269-X; Ngomane L, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-19; Oluwagbemi OO, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0068040, DOI 10.1371/J0URNAL.P0NE.0068040]; President&rsquo;s Malaria Initiative, 2013, TECHNICAL REPORT; Roberts L, 2007, SCIENCE, V318, P1544, DOI 10.1126/science.318.5856.1544; Rodriguez DJ, 2001, B MATH BIOL, V63, P547, DOI 10.1006/bulm.2001.0231; Sharp B, 2001, TECHNICAL REPORT; Sharp BL, 1996, S AFR MED J, V86, P83; Sharp BL, 2007, AM J TROP MED HYG, V76, P42, DOI 10.4269/ajtmh.2007.76.42; Silal SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076640; Smith DL, 2004, PLOS BIOL, V2, P1957, DOI 10.1371/journal.pbio.0020368; Statistics South Africa, 2012, CENS 2011 MUN REP MP; Tatem AJ, 2010, P NATL ACAD SCI USA, V107, P12222, DOI 10.1073/pnas.1002971107; Thomson D, 1911, THE LEUCOCYTES IN MA; White LJ, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-212; World Health Organization, 2007, TECHNICAL REPORT; Zacarias OP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-79; Zambrano-Bigiarini M, 2013, HYDROPSO PARTICLE SW; Zambrano-Bigiarini M, 2013, ENVIRON MODELL SOFTW, V43, P5, DOI 10.1016/j.envsoft.2013.01.004; Zorom M, 2012, J APPL MATH, DOI 10.1155/2012/854723	52	24	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144990	10.1371/journal.pone.0144990	http://dx.doi.org/10.1371/journal.pone.0144990			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689547	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092300029
J	Wan, M; Huang, W; Zhang, JM; Zhao, XD; Tan, RS; Wan, XF; Zhong, L				Wan, Min; Huang, Wei; Zhang, Jun-Mei; Zhao, Xiaodan; Tan, Ru San; Wan, Xiaofeng; Zhong, Liang			Variational Reconstruction of Left Cardiac Structure from CMR Images	PLOS ONE			English	Article							REGIONAL WALL CURVEDNESS; SURFACE RECONSTRUCTION; SHAPE RECONSTRUCTION; VENTRICULAR-FUNCTION; HEART; MODEL; SEGMENTATION; RESTORATION; SIMULATION; STRESS	Cardiovascular Disease (CVD), accounting for 17% of overall deaths in the USA, is the leading cause of death over the world. Advances in medical imaging techniques make the quantitative assessment of both the anatomy and function of heart possible. The cardiac modeling is an invariable prerequisite for quantitative analysis. In this study, a novel method is proposed to reconstruct the left cardiac structure from multi-planed cardiac magnetic resonance (CMR) images and contours. Routine CMR examination was performed to acquire both long axis and short axis images. Trained technologists delineated the endocardial contours. Multiple sets of two dimensional contours were projected into the three dimensional patient-based coordinate system and registered to each other. The union of the registered point sets was applied a variational surface reconstruction algorithm based on Delaunay triangulation and graph-cuts. The resulting triangulated surfaces were further post-processed. Quantitative evaluation on our method was performed via computing the overlapping ratio between the reconstructed model and the manually delineated long axis contours, which validates our method. We envisage that this method could be used by radiographers and cardiologists to diagnose and assess cardiac function in patients with diverse heart diseases.	[Wan, Min; Huang, Wei; Wan, Xiaofeng] Nanchang Univ, Nanchang 330031, Jiangxi, Peoples R China; [Zhang, Jun-Mei; Zhao, Xiaodan; Tan, Ru San; Zhong, Liang] Natl Heart Ctr Singapore, Singapore 169609, Singapore; [Zhang, Jun-Mei; Tan, Ru San; Zhong, Liang] Duke NUS Grad Med Sch Singapore, Singapore 169857, Singapore	Nanchang University; National Heart Centre Singapore; National University of Singapore	Wan, M (corresponding author), Nanchang Univ, Nanchang 330031, Jiangxi, Peoples R China.	wanmin1983@gmail.com; zhong.liang@nhcs.com.sg		Tan, Ru San/0000-0003-2086-6517; Zhang, Jun-Mei/0000-0002-2257-1803; zhao, xiaodan/0000-0003-1469-8027; ZHONG, LIANG/0000-0003-3608-4173	National Natural Science Foundation of China [NSFC 61562060]; National Research Foundation [NRF2011NRF-POC001-068]; National Medical Research Council [NMRC/EDG/1037/2011]; Biomedical Research Council Research Grant [14/1/32/24/002]; Goh Cardiovascular Research Grant [Duke-NUS-GCR/2013/0009]; SERC Biomedical Engineering Programme [1211480003, 1321480012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Research Foundation; National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biomedical Research Council Research Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Goh Cardiovascular Research Grant; SERC Biomedical Engineering Programme	This work was supported by National Natural Science Foundation of China (NSFC 61562060), http://www.nsfc.gov.cn, M.W., study design; National Research Foundation (NRF2011NRF-POC001-068), http://www.nrf.gov.sg, R.S.T., study design; the National Medical Research Council (NMRC/EDG/1037/2011), http://www.nmrc.gov.sg, L.Z., data collection; Biomedical Research Council Research Grant (14/1/32/24/002), http://www.a-star.edu.sg/About-A-STAR/Biomedical-Research-Council.aspx, L.Z., data collection; the Goh Cardiovascular Research Grant (Duke-NUS-GCR/2013/0009), https://www.nhcs.com.sg/aboutnhc/awards/Pages/Home.aspx, L.Z., data analysis; and SERC Biomedical Engineering Programme Grants 1211480003 and 1321480012, http://www.a-star.edu.sg/Research/Funding-Opportunities/Grants-Sponsorship/SERC-Biomedical-Engineering-Programme-BEP.aspx, R.S.T, preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (NSFC 61562060), National Research Foundation (NRF2011NRF-POC001-068), the National Medical Research Council (NMRC/EDG/1037/2011), Biomedical Research Council Research Grant (14/1/32/24/002), the Goh Cardiovascular Research Grant (Duke-NUS-GCR/2013/0009) and SERC Biomedical Engineering Programme Grants 1211480003 and 1321480012. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajaj CL, 1996, GRAPH MODEL IM PROC, V58, P524, DOI 10.1006/gmip.1996.0044; Bardinet E, 1996, Med Image Anal, V1, P129, DOI 10.1016/S1361-8415(96)80009-0; Barr A. H., 1981, IEEE Computer Graphics and Applications, V1, P11, DOI 10.1109/MCG.1981.1673799; Bereg S, 2004, P 9 ACM S SOL MOD AP, P303; BESL PJ, 1992, IEEE T PATTERN ANAL, V14, P239, DOI 10.1109/34.121791; BOISSONNAT JD, 1988, COMPUT VISION GRAPH, V44, P1, DOI 10.1016/S0734-189X(88)80028-8; Boykov Y, 2004, IEEE T PATTERN ANAL, V26, P1124, DOI 10.1109/TPAMI.2004.60; CAUVIN JC, 1993, COMPUT MED IMAG GRAP, V17, P345, DOI 10.1016/0895-6111(93)90027-K; CHEN CW, 1995, COMPUT MED IMAG GRAP, V19, P85, DOI 10.1016/0895-6111(94)00041-7; Ecabert O, 2006, PROC SPIE, V6144, DOI 10.1117/12.652105; Ector J, 2005, CIRCULATION, V112, P3769, DOI 10.1161/CIRCULATIONAHA.105.565002; Frangi AF, 2002, IEEE T MED IMAGING, V21, P1151, DOI 10.1109/TMI.2002.804426; Frangi AF, 2001, IEEE T MED IMAGING, V20, P2, DOI 10.1109/42.906421; Khalafvand SS, 2014, INT J NUMER METH BIO, V30, P1044, DOI 10.1002/cnm.2643; Khalafvand SS, 2012, COMPUT BIOL MED, V42, P863, DOI 10.1016/j.compbiomed.2012.06.010; Khalafvand SS, 2011, COMPUT METHOD BIOMEC, V14, P113, DOI 10.1080/10255842.2010.493515; Khalafvand SS, 2015, SUBMITTED TO COMP MA; Lim CW, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0093747, DOI 10.1371/J0URNAL.P0NE.0093747]; Lorenz C, 2006, MED IMAGE ANAL, V10, P657, DOI 10.1016/j.media.2006.03.004; Lotjonen J, 2004, MED IMAGE ANAL, V8, P371, DOI 10.1016/j.media.2004.06.013; METAXAS D, 1993, IEEE T PATTERN ANAL, V15, P580, DOI 10.1109/34.216727; Oliva JM, 1996, COMPUT GRAPH FORUM, V15, pC397, DOI 10.1111/1467-8659.1530397; Su B, 2015, NUMERICAL MODELING O; Su BY, 2014, COMPUT METH PROG BIO, V113, P474, DOI 10.1016/j.cmpb.2013.11.009; Swingen C, 2003, INT J CARDIOVAS IMAG, V19, P325, DOI 10.1023/A:1025450211508; Tan ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068615; Teo SK, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0006; Vadakkumpadan F, 2010, WIRES SYST BIOL MED, V2, P489, DOI 10.1002/wsbm.76; van Assen HC, 2006, MED IMAGE ANAL, V10, P286, DOI 10.1016/j.media.2005.12.001; Nguyen VT, 2015, COMPUT METHOD BIOMEC, V18, P401, DOI 10.1080/10255842.2013.803534; Vollmer J, 1999, COMPUT GRAPH FORUM, V18, pC131, DOI 10.1111/1467-8659.00334; Wan M, 2011, INT J NUMER METH ENG, V85, P206, DOI 10.1002/nme.2965; Wang DS, 2006, COMPUT METHOD APPL M, V195, P5621, DOI 10.1016/j.cma.2005.10.028; Wang DS, 2006, INT J NUMER METH ENG, V65, P734, DOI 10.1002/nme.1465; Zhao HK, 2001, IEEE WORKSHOP ON VARIATIONAL AND LEVEL SET METHODS IN COMPUTER VISION, PROCEEDINGS, P194, DOI 10.1109/VLSM.2001.938900; Zheng YF, 2008, IEEE T MED IMAGING, V27, P1668, DOI 10.1109/TMI.2008.2004421; Zhong L, 2011, AM J PHYSIOL-HEART C, V300, pH1653, DOI 10.1152/ajpheart.00021.2011; Zhong L, 2012, AM J PHYSIOL-HEART C, V302, pH1306, DOI 10.1152/ajpheart.00679.2011; Zhong L, 2011, MED ENG PHYS, V33, P1120, DOI 10.1016/j.medengphy.2011.05.003; Zhong L, 2009, AM J PHYSIOL-HEART C, V296, pH573, DOI 10.1152/ajpheart.00525.2008	40	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145570	10.1371/journal.pone.0145570	http://dx.doi.org/10.1371/journal.pone.0145570			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689551	Green Submitted, Green Published, gold			2022-12-26	WOS:000367092300089
J	Akther, H; Agersted, MD; Olesen, J				Akther, Hasna; Agersted, Mette Dalgaard; Olesen, Jorgen			Naupliar and Metanaupliar Development of Thysanoessa raschii (Malacostraca, Euphausiacea) from Godthabsfjord, Greenland, with a Reinstatement of the Ancestral Status of the Free-Living Nauplius in Malacostracan Evolution	PLOS ONE			English	Article							SCANNING-ELECTRON-MICROSCOPY; LARVAL DEVELOPMENT; JAPANESE CONCHOSTRACANS; POSTEMBRYONIC DEVELOPMENT; CRUSTACEA; BRANCHIOPODA; PHYLOGENY; LAEVICAUDATA; SPINICAUDATA; CIRRIPEDIA	The presence of a characteristic crustacean larval type, the nauplius, in many crustacean taxa has often been considered one of the few uniting characters of the Crustacea. WithinMalacostraca, the largest crustacean group, nauplii are only present in two taxa, Euphauciacea (krill) and Decapoda Dendrobranchiata. The presence of nauplii in these two taxa has traditionally been considered a retained primitive characteristic, but free-living nauplii have also been suggested to have reappeared a couple of times from direct developing ancestors duringmalacostracan evolution. Based on a re-study of Thysanoessa raschii (Euphausiacea) using preserved material collected in Greenland, we readdress this important controversy in crustacean evolution, and, in the process, redescribe the naupliar and metanaupliar development of T. raschii. In contrast tomost previous studies of euphausiid development, we recognize three (not two) naupliar (= ortho-naupliar) stages (N1-N3) followed by a metanauplius (MN). While there are many morphological changes between nauplius 1 and 2 (e.g., appearance of long caudal setae), the changes between nauplius 2 and 3 are few but distinct. They involve the size of some caudal spines (largest in N3) and the setation of the antennal endopod (an extra seta in N3). A wider comparison between free-living nauplii of both Malacostraca and nonMalacostraca revealed similarities between nauplii in many taxa both at the general level (e.g., the gradual development and number of appendages) and at the more detailed level (e.g., unclear segmentation of naupliar appendages, caudal setation, presence of frontal filaments). We recognize these similarities as homologies and therefore suggest that free-living nauplii were part of the ancestral malacostracan type of development. The derived morphology (e.g., lack of feeding structures, no fully formed gut, high content of yolk) of both euphausiid and dendrobranchiate nauplii is evidently related to their non-feeding (lecithotrophic) status.	[Akther, Hasna; Olesen, Jorgen] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen, Denmark; [Akther, Hasna; Agersted, Mette Dalgaard] Tech Univ Denmark, Sect Oceanog & Climate, Natl Inst Aquat Resources, Charlottenlund, Denmark	University of Copenhagen; Technical University of Denmark	Olesen, J (corresponding author), Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen, Denmark.	jolesen@snm.ku.dk	Agersted, Mette Dalgaard/AFW-0709-2022; Illife, Thomas/R-2252-2017; Olesen, Jørgen/A-3353-2013	Illife, Thomas/0000-0002-4342-5960; Olesen, Jørgen/0000-0001-9582-7083; Olesen, Jes/0000-0002-6712-2702	Danish Centre for Marine Research, DCH; European Union [ENV.2010.2.2.1-1, 264933]; Greenland Climate Research Centre [6505]; Carlsberg grant	Danish Centre for Marine Research, DCH; European Union(European Commission); Greenland Climate Research Centre; Carlsberg grant	Field work of the project BOFYGO was funded by a grant from the Danish Centre for Marine Research, DCH to Torkel Gissel Nielsen; the research received funding from the European Union Seventh Framework Programme project EURO-BASIN (ENV.2010.2.2.1-1) under grant agreement no 264933; support was provided by the Greenland Climate Research Centre (project 6505); microscopic equipment was supported by a Carlsberg grant to JO.; Torkel Gissel Nielsen (DTU Aqua) is thanked for donating the samples used in the work to the Natural History Museum of Denmark. Russell Hopcroft (University of Alaska Fairbanks) is thanked for permission to use his photo of an adult Thysanoessa raschii in Fig 1. The field work of the project BOFYGO was funded by a grant from the Danish Centre for Marine Research, DCH to Torkel Gissel Nielsen. The research leading to these results has received funding from the European Union Seventh Framework Programme project EURO-BASIN (ENV.2010.2.2.1-1) under grant agreement no 264933 and the Greenland Climate Research Centre (project 6505). Light microscopy equipment used in the project was supported by a Carlsberg grant to JO.	Agersted MD, 2014, J PLANKTON RES, V36, P800, DOI 10.1093/plankt/fbt139; ANDERSON D. T., 1967, AUST J ZOOL, V15, P47, DOI 10.1071/ZO9670047; Anderson D. T., 1973, EMBRYOLOGY PHYLOGENY; Chan BKK, 2014, ATLAS OF CRUSTACEAN LARVAE, P116; Choi JH, 2001, FISH B-NOAA, V99, P275; COLLIS SA, 1994, ACTA ZOOL-STOCKHOLM, V75, P297, DOI 10.1111/j.1463-6395.1994.tb00966.x; DAHMS HU, 1989, POLAR BIOL, V10, P221; Dahms HU, 2000, HYDROBIOLOGIA, V417, P91, DOI 10.1023/A:1003886818724; Dunger W., 1993, LEHRBUCH SPEZIELLEN, P1031; Einarsson Hermann, 1945, DANA REPT, V27, P1; Ferrari FD, 2013, CRUSTACEANA, V86, P632, DOI 10.1163/15685403-00003190; Ferrari FD, 2011, CRUSTACEANA, V84, P869, DOI 10.1163/001121611X579745; Fraser F. C., 1936, Discovery Reports Cambridge, V14, P1; Fritsch M, 2013, ZOOMORPHOLOGY, V132, P163, DOI 10.1007/s00435-012-0173-0; Glenner H, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-21; Gomez-Gutierrez J, 2002, J PLANKTON RES, V24, P1265, DOI 10.1093/plankt/24.12.1265; GURNEY R, 1942, LARVAE DECAPOD CRUST; Haug C, 2012, PALAEONTOL ELECTRON, V15, P1; Haug C, 2014, CONTRIB ZOOL, V83, P185, DOI 10.1163/18759866-08303003; Haug JT, 2011, J CRUSTACEAN BIOL, V31, P668, DOI 10.1651/11-3481.1; Haug JT, 2010, EARTH ENV SCI T R SO, V100, P311, DOI 10.1017/S1755691010008145; Heath H, 1924, J MORPHOL, V38, P453, DOI 10.1002/jmor.1050380402; HIROTA Y, 1984, MAR BIOL, V81, P311, DOI 10.1007/BF00393226; Jenner RA, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-21; Jia ZN, 2014, POLAR BIOL, V37, P165, DOI 10.1007/s00300-013-1420-7; Jirikowski GJ, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-76; Kiernan DA, 2006, EVOL DEV, V8, P537, DOI 10.1111/j.1525-142X.2006.00126.x; KNIGHT MD, 1975, FISH B-NOAA, V73, P145; Koenemann S, 2009, DEV GENES EVOL, V219, P131, DOI 10.1007/s00427-009-0273-0; Lebour M. V., 1924, Journal of the Marine Biol Society Plymouth, V13, P402; LEBOUR MARIE V., 1926, JOUR MARINE BIOL ASSOC, V14, P1; Maas Andreas, 2003, Fossils and Strata, V49, P1; MACDONALD R9DERICK, 1928, JOUR MARINE BIOL ASSOC, V15, P57; MACDONALD RODERICK, 1927, JOUR MARINE BIOL ASSOC, V14, P785; MARSCHALL HP, 1984, POLAR BIOL, V2, P245, DOI 10.1007/BF00263631; Martin JW, 2014, ATLAS OF CRUSTACEAN LARVAE, P220; Martin JW, 2014, ATLAS OF CRUSTACEAN LARVAE, P8; Martin JW, 2014, ATLAS OF CRUSTACEAN LARVAE, P1; Maruzzo D, 2009, ARTHROPOD STRUCT DEV, V38, P163, DOI 10.1016/j.asd.2008.09.001; Mauchline J., 1971, Fiches Ident Zooplancton, VNo. 135/137,1971, P1; Mauchline J, 1969, Adv. mar. Biol., V7, P1; Mauchline J., 1980, ADV MAR BIOL, P3; Misof B, 2014, SCIENCE, V346, P763, DOI 10.1126/science.1257570; Moller OS, 2008, ARTHROPOD STRUCT DEV, V37, P333, DOI 10.1016/j.asd.2007.12.002; Moller OS, 2004, ZOOMORPHOLOGY, V123, P107, DOI 10.1007/s00435-003-0093-0; MULLER KJ, 1988, FOSSILS STRATA, V23, P1; Nijhout H.F., 1994, INSECT HORMONES; Olesen, 2001, BIOL SKRIFTER, V53, P1; Olesen J, 2005, J MORPHOL, V264, P131, DOI 10.1002/jmor.10202; Olesen J, 2004, ARTHROPOD STRUCT DEV, V33, P453, DOI 10.1016/j.asd.2004.07.001; Olesen J, 2003, J MORPHOL, V256, P235, DOI 10.1002/jmor.10043; Olesen J, 2003, ACTA ZOOL-STOCKHOLM, V84, P41, DOI 10.1046/j.1463-6395.2003.00129.x; Olesen J, 2000, ZOOMORPHOLOGY, V120, P47, DOI 10.1007/s004350000024; Olesen J, 2015, PLOS ONE, P1; Olesen J., 2013, FUNCTIONAL MORPHOLOG, P103; Olesen J, 2014, ATLAS OF CRUSTACEAN LARVAE, P138; Olesen J, 2014, ATLAS OF CRUSTACEAN LARVAE, P90; Olesen J, 2014, ATLAS OF CRUSTACEAN LARVAE, P84; Olesen J, 2013, J MORPHOL, V274, P229, DOI 10.1002/jmor.20101; Olesen J, 2011, ARTHROPOD STRUCT DEV, V40, P449, DOI 10.1016/j.asd.2011.04.002; RCore Team, 2020, R LANG ENV STAT COMP; Regier JC, 2010, NATURE, V463, P1079, DOI 10.1038/nature08742; Richter S, 2001, J ZOOL SYST EVOL RES, V39, P113; Riisgaard K, 2014, MAR ECOL PROG SER, V500, P67, DOI 10.3354/meps10706; Sars GO, 1898, ARCH MATH NATURVID, V20, P1; Scholtz G, 2000, J ZOOL SYST EVOL RES, V38, P175, DOI 10.1046/j.1439-0469.2000.383151.x; Scholtz Gerhard, 2013, P63; Scourfield D. J., 1940, Proceedings of the Linnean Society of London, V152, P290; Semmler H, 2009, ARTHROPOD STRUCT DEV, V38, P135, DOI 10.1016/j.asd.2008.09.003; Shen X, 2015, ACTA OCEANOL SIN, V34, P84, DOI 10.1007/s13131-015-0583-1; Siegel Volker, 2000, Fish and Aquatic Resources Series, V6, P103; Stegner MEJ, 2015, ZOOMORPHOLOGY; STRATHMANN RR, 1994, AM ZOOL, V34, P502; SUH HL, 1993, MAR BIOL, V115, P625, DOI 10.1007/BF00349370; Swalethorp R, 2014, J PLANKTON RES; Tarling GT, 2010, ADV MAR BIOL, P57; Teglhus F, DISTRIBUTION S UNPUB; Vicente CS, 2014, ATLAS OF CRUSTACEAN LARVAE, P199; WALOSSEK D, 1990, LETHAIA, V23, P409, DOI 10.1111/j.1502-3931.1990.tb01373.x; Walossek D., 1998, Systematics Association Special Volume Series, V55, P139; WALOSSEK D, 1993, LETHAIA, V26, P7, DOI 10.1111/j.1502-3931.1993.tb01504.x; Zhang XG, 2007, NATURE, V449, P595, DOI 10.1038/nature06138; Zhang XG, 2010, CURR BIOL, V20, P1075, DOI 10.1016/j.cub.2010.04.026	83	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0141955	10.1371/journal.pone.0141955	http://dx.doi.org/10.1371/journal.pone.0141955			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26682744	Green Published, Green Submitted, gold			2022-12-26	WOS:000366725800003
J	He, DL; Wang, Q; Wang, K; Yang, PF				He, Dongli; Wang, Qiong; Wang, Kun; Yang, Pingfang			Genome-Wide Dissection of the MicroRNA Expression Profile in Rice Embryo during Early Stages of Seed Germination	PLOS ONE			English	Article							ARABIDOPSIS-THALIANA; COMPUTATIONAL IDENTIFICATION; TRANSCRIPTION FACTORS; PROTEOMIC ANALYSIS; STRESS CONDITIONS; ALEURONE CELLS; MESSENGER-RNA; PROTEIN; GENES; REVEALS	The first 24 hours after imbibition (HAI) is pivotal for rice seed germination, during which embryo cells switch from a quiescent state to a metabolically active state rapidly. MicroRNAs (miRNAs) have increasingly been shown to play important roles in rice development. Nevertheless, limited knowledge about miRNA regulation has been obtained in the early stages of rice seed germination. In this study, the small RNAs (sRNAs) from embryos of 0, 12, and 24 HAI rice seeds were sequenced to investigate the composition and expression patterns of miRNAs. The bioinformatics analysis identified 289 miRNA loci, including 59 known and 230 novel miRNAs, and 35 selected miRNAs were confirmed by stem-loop real-time RT-PCR. Expression analysis revealed that the dry and imbibed seeds have unique miRNA expression patterns compared with other tissues, particularly for the dry seeds. Using three methods, Mireap, psRNATarget and degradome analyses, 1197 potential target genes of identified miRNAs involved in various molecular functions were predicted. Among these target genes, 39 had significantly negative correlations with their corresponding miRNAs as inferred from published transcriptome data, and 6 inversely expressed miRNA-target pairs were confirmed by 5'-RACE assay. Our work provides an inventory of miRNA expression profiles and miRNA-target interactions in rice embryos, and lays a foundation for further studies of miRNA-mediated regulation in initial seed germination.	[He, Dongli; Wang, Qiong; Yang, Pingfang] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Special Agr, Wuhan 430074, Peoples R China; [Wang, Qiong] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Wang, Kun] Wuhan Univ, Coll Iife Sci, Wuhan 430072, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Wuhan University	Yang, PF (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Special Agr, Wuhan 430074, Peoples R China.	yangpf@wbgcas.cn		He, Dongli/0000-0002-5510-7556	National Science Foundation of China [31101213, 31271805]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the the National Science Foundation of China (31101213 and 31271805), http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo-Quaye C, 2009, BIOINFORMATICS, V25, P130, DOI 10.1093/bioinformatics/btn604; Azevedo C, 2006, EMBO J, V25, P2007, DOI 10.1038/sj.emboj.7601084; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Braun JE, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012328; Curaba J, 2014, J EXP BOT, V65, P1425, DOI 10.1093/jxb/eru002; Dai XB, 2011, NUCLEIC ACIDS RES, V39, pW155, DOI 10.1093/nar/gkr319; Eckardt NA, 2013, PLANT CELL, V25, P2382, DOI 10.1105/tpc.113.250713; Gallagher M, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01281; Galland M, 2014, MOL CELL PROTEOMICS, V13, P252, DOI 10.1074/mcp.M113.032227; Groszmann M, 2011, P NATL ACAD SCI USA, V108, P2617, DOI 10.1073/pnas.1019217108; Han C, 2014, PLANT CELL PHYSIOL, V55, P1826, DOI 10.1093/pcp/pcu114; Han C, 2014, J PROTEOME RES, V13, P1766, DOI 10.1021/pr401295c; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; He DL, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00246; He DL, 2011, J INTEGR PLANT BIOL, V53, P835, DOI 10.1111/j.1744-7909.2011.01074.x; He DL, 2011, PROTEOMICS, V11, P2693, DOI 10.1002/pmic.201000598; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Holdsworth MJ, 2008, TRENDS PLANT SCI, V13, P7, DOI 10.1016/j.tplants.2007.11.002; Howell KA, 2006, PLANT MOL BIOL, V60, P201, DOI 10.1007/s11103-005-3688-7; Howell KA, 2007, J BIOL CHEM, V282, P15619, DOI 10.1074/jbc.M609866200; Howell KA, 2009, PLANT PHYSIOL, V149, P961, DOI 10.1104/pp.108.129874; Iwakawa H, 2013, MOL CELL, V52, P591, DOI 10.1016/j.molcel.2013.10.033; Jones-Rhoades MW, 2004, MOL CELL, V14, P787, DOI 10.1016/j.molcel.2004.05.027; Jossier M, 2009, PLANT J, V59, P316, DOI 10.1111/j.1365-313X.2009.03871.x; Kanegae H, 2005, PLANT PHYSIOL BIOCH, V43, P669, DOI 10.1016/j.plaphy.2005.06.004; Kim JY, 2010, PLANT CELL PHYSIOL, V51, P1079, DOI 10.1093/pcp/pcq072; Klein J, 1996, MOL GEN GENET, V250, P7, DOI 10.1007/BF02191820; Koyama T, 2010, PLANT CELL, V22, P3574, DOI 10.1105/tpc.110.075598; Lewis SM, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni189; Liu PP, 2007, PLANT J, V52, P133, DOI 10.1111/j.1365-313X.2007.03218.x; Ma XX, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-510; Meyers BC, 2007, CONSTRUCTION SMALL R, V43, P110; Mi SJ, 2008, CELL, V133, P116, DOI 10.1016/j.cell.2008.02.034; Millar AA, 2005, PLANT CELL, V17, P705, DOI 10.1105/tpc.104.027920; Nobuta K, 2007, NAT BIOTECHNOL, V25, P473, DOI 10.1038/nbt1291; Nonogaki H, 2010, PLANT CELL PHYSIOL, V51, P1840, DOI 10.1093/pcp/pcq154; Palatnik JF, 2007, DEV CELL, V13, P115, DOI 10.1016/j.devcel.2007.04.012; Raghavendra AS, 2010, TRENDS PLANT SCI, V15, P395, DOI 10.1016/j.tplants.2010.04.006; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Reyes JL, 2007, PLANT J, V49, P592, DOI 10.1111/j.1365-313X.2006.02980.x; Rodriguez RE, 2010, DEVELOPMENT, V137, P103, DOI 10.1242/dev.043067; Singh A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-435; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Tsuji H, 2006, PLANT J, V47, P427, DOI 10.1111/j.1365-313X.2006.02795.x; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Wang HJ, 2013, SHOCK, V39, P480, DOI 10.1097/SHK.0b013e3182940cb8; WANG L, 2011, INT SYST APPL ISA 20, V2011, P1, DOI DOI 10.1145/2072298.2071964; Wang XF, 2009, PLANT CELL, V21, P1053, DOI 10.1105/tpc.109.065714; Watanabe KA, 2014, GENOMICS, V103, P122, DOI 10.1016/j.ygeno.2013.10.007; Wei LQ, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r53; Wu L, 2010, MOL CELL, V38, P465, DOI 10.1016/j.molcel.2010.03.008; Wu L, 2009, PLANT CELL, V21, P3421, DOI 10.1105/tpc.109.070938; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xie KB, 2012, PLANT PHYSIOL, V158, P1382, DOI 10.1104/pp.111.190488; Xu XH, 2009, THEOR APPL GENET, V119, P75, DOI 10.1007/s00122-009-1018-1; Xue LJ, 2009, NUCLEIC ACIDS RES, V37, P916, DOI 10.1093/nar/gkn998; Yang GD, 2012, J GENET, V91, P313, DOI 10.1007/s12041-012-0199-6; Yang PF, 2007, PROTEOMICS, V7, P3358, DOI 10.1002/pmic.200700207; Zhang BH, 2006, COMPUT BIOL CHEM, V30, P395, DOI 10.1016/j.compbiolchem.2006.08.006; Zhang BH, 2006, CELL MOL LIFE SCI, V63, P246, DOI 10.1007/s00018-005-5467-7	60	22	23	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145424	10.1371/journal.pone.0145424	http://dx.doi.org/10.1371/journal.pone.0145424			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26681181	Green Published, Green Submitted, gold			2022-12-26	WOS:000366723400074
J	Sarr, FD; Niang, M; Thiam, D; Dia, N; Badiane, A; Ndao, AB; Sokhna, C; Spiegel, A; Richard, V				Sarr, Fatoumata Diene; Niang, Mbayame; Thiam, Diamilatou; Dia, Ndongo; Badiane, Abdoulaye; Ndao, A. B.; Sokhna, Cheikh; Spiegel, Andre; Richard, Vincent			Acute Febrile Illness and Influenza Disease Burden in a Rural Cohort Dedicated to Malaria in Senegal, 2012-2013	PLOS ONE			English	Article							SENTINEL SURVEILLANCE; SEASONAL INFLUENZA; VIRAL ETIOLOGY; GLOBAL BURDEN; EPIDEMIOLOGY; CHILDREN; AFRICA; PNEUMONIA; MORTALITY; KENYA	Background African populations are considered to be particularly vulnerable to fever illnesses, including malaria, and acute respiratory disease, owing to limited resources and overcrowding. However, the overall burden of influenza in this context is poorly defined and incidence data for African countries are scarce. We therefore studied the fever syndrome incidence and more specifically influenza incidence in a cohort of inhabitants of Dielmo and Ndiop in Sokone district, Senegal. Methods Daily febrile-illness data were prospectively obtained from January 2012 to December 2013 from the cohort of the villages of Dielmo and Ndiop, initially dedicated to the study of malaria. Nasopharyngeal swabs were collected from, and malaria diagnosis tests (thick blood smears) carried out on, every febrile individual during clinical visits; reverse transcriptase- polymerase chain reaction was used to identify influenza viruses in the samples. Binomial negative regression analysis was used to study the relationship between the monthly incidence rate and various covariates. Results In Dielmo and Ndiop, the incidence ofmalaria has decreased, but fever syndromes remain frequent. Among the 1036 inhabitants included in the cohort, a total of 1,129 episodes of fever were reported. Influenza was present all year round with peaks in October-December 2012 and August 2013. The fever, ILI and influenza incidence density rates differed significantly between age groups. At both sites, the adjusted incidence relative risks for fever syndromes and ILI were significantly higher in the [6-24 months) than other age groups: 7.3 (95% CI: [5.7-9.3]) and 16.1 (95% CI: [11.1-23.3]) respectively. The adjusted incidence relative risk for influenza was significantly higher for the [0-6 months) than other age groups: 9.9 (95% CI: [2.9-33.6]). At both sites, incidence density rates were lowest among adults > = 50 years. Conclusions In this rural setting in Senegal, influenza was most frequent among the youngest children. Preventive strategies targeting this population should be implemented.	[Sarr, Fatoumata Diene; Thiam, Diamilatou; Badiane, Abdoulaye; Spiegel, Andre; Richard, Vincent] Inst Pasteur, Epidemiol Unit, Dakar, Senegal; [Niang, Mbayame; Dia, Ndongo] Inst Pasteur, Virol Unit, Dakar, Senegal; [Ndao, A. B.] Minist Hlth, Hlth Dist Sokone, Sokone, Senegal; [Sokhna, Cheikh] Inst Rech Dev, Dakar, Senegal	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; Institut de Recherche pour le Developpement (IRD)	Richard, V (corresponding author), Inst Pasteur, Epidemiol Unit, Dakar, Senegal.	vrichard@pasteur.sn		Vincent, RICHARD/0000-0002-6961-1753	Department of Health and Human Service via the International Network of Pasteur Institutes [IDSEP 110011-01-00]; Pasteur Institute of Dakar; Institut pour la recherche et le developpement (IRD)	Department of Health and Human Service via the International Network of Pasteur Institutes; Pasteur Institute of Dakar; Institut pour la recherche et le developpement (IRD)	This work was supported by the Department of Health and Human Service (Grant Number: IDSEP 110011-01-00) via the International Network of Pasteur Institutes, the Pasteur Institute of Dakar and the Institut pour la recherche et le developpement (IRD) via the support of the Dielmo and Ndiop research programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	[Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], MALARIA J; Dia N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093227; Dosseh A, 2000, AM J TROP MED HYG, V62, P639, DOI 10.4269/ajtmh.2000.62.639; Freitas FTM, 2013, EPIDEMIOL INFECT, V141, P1731, DOI 10.1017/S0950268812002221; Gessner BD, 2011, LANCET INFECT DIS, V11, P223, DOI 10.1016/S1473-3099(11)70008-1; Guinovart C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-36; Katz MA, 2012, J INFECT DIS, V206, pS53, DOI 10.1093/infdis/jis530; Katz MA, 2012, J INFECT DIS, V206, pS1, DOI 10.1093/infdis/jis548; Lekana-Douki SE, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-373; Li CK, 2006, PUBLIC HEALTH, V120, P517, DOI 10.1016/j.puhe.2006.03.004; Monto AS, 2004, INT CONGR SER, V1263, P3, DOI 10.1016/j.ics.2004.02.049; Moura FEA, 2009, AM J TROP MED HYG, V81, P180, DOI 10.4269/ajtmh.2009.81.180; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Niang MN, 2012, J INFECT DIS, V206, pS129, DOI 10.1093/infdis/jis576; Njouom R, 2012, J INFECT DIS, V206, pS29, DOI 10.1093/infdis/jis573; Nyatanyi T, 2012, J INFECT DIS, V206, pS74, DOI 10.1093/infdis/jis574; Onyango CO, 2012, J INFECT DIS, V206, pS61, DOI 10.1093/infdis/jis536; Radin JM, 2012, J INFECT DIS, V206, pS14, DOI 10.1093/infdis/jis606; Rajatonirina S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072839; Rajatonirina S, 2012, B WORLD HEALTH ORGAN, V90, P385, DOI 10.2471/BLT.11.097816; Randrianasolo L, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-31; Schoub Barry D, 2010, Expert Rev Respir Med, V4, P167, DOI 10.1586/ers.10.10; Shek Lynette Pei-Chi, 2003, Paediatr Respir Rev, V4, P105, DOI 10.1016/S1526-0542(03)00024-1; Simmerman JM, 2009, PLOS ONE, V4, pA107, DOI 10.1371/journal.pone.0007776; Steffen C, 2011, VACCINE, V29, P363, DOI 10.1016/j.vaccine.2010.11.029; Trape JF, 2014, LANCET INFECT DIS, V14, P476, DOI 10.1016/S1473-3099(14)70712-1; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Yazdanbakhsh M, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000182; [No title captured]	30	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0143999	10.1371/journal.pone.0143999	http://dx.doi.org/10.1371/journal.pone.0143999			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26679177	gold, Green Published, Green Submitted			2022-12-26	WOS:000366723400006
J	Au, HK; Chang, JH; Wu, YC; Kuo, YC; Chen, YH; Lee, WC; Chang, TS; Lan, PC; Kuo, HC; Lee, KL; Lee, MT; Tzeng, CR; Huang, YH				Au, Heng-Kien; Chang, Jui-Hung; Wu, Yu-Chih; Kuo, Yung-Che; Chen, Yu-Hsi; Lee, Wei-Chin; Chang, Te-Sheng; Lan, Pei-Chi; Kuo, Hung-Chih; Lee, Kha-Liang; Lee, Mei-Tsu; Tzeng, Chii-Ruey; Huang, Yen-Hua			TGF-beta I Regulates Cell Migration through Pluripotent Transcription Factor OCT4 in Endometriosis	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR-BETA; STEM-CELLS; MENSTRUAL DISSEMINATION; SIGNALING PATHWAY; PERITONEAL-FLUID; EXPRESSION; CANCER; WOMEN; EMT	Transforming growth factor (TGF-beta)/TGF-beta receptor signal is known to promote cell migration. Up-regulation of TGF-beta in serum/peritoneal fluid and increased levels of pluripotent transcription factor OCT4 in endometriotic tissues are frequently observed in patients with endometriosis. However, the mechanisms underlying how TGF-beta/TGF-beta receptor and OCT4 affect endometriotic cell migration still remain largely unknown. Therefore, endometriotic tissue with high cell migratory capacity were collected from patients with adenomyotic myometrium (n = 23) and chocolate cyst (n = 24); and endometrial tissue with low cell migratory capacity in normal endometrium or hyperplastic endometrium (n = 8) were collected as the controls. We found the mRNA levels of TGF-beta receptor I (TGF-beta RI) and OCT4 were significantly higher in the high-migratory ectopic endometriotic tissues than those of the low-migratory normal or hyperplastic endometrium. Positive correlations between TGF-beta RI and OCT4, and either TGF-beta RI or OCT4 with migration-related genes (SNAIL, SLUG and TWIST) regarding the mRNA levels were observed in human endometriotic tissues. TGF-beta I dose-dependently increased the gene and protein levels of OCT4, SNAIL and N-Cadherin (N-CAD) and silencing of endogenous OCT4 significantly suppressed the TGF-beta I-induced expressions of N-CAD and SNAIL in primary human endometriotic stromal cells and human endometrial carcinoma cell lines RL95-2 and HEC1A. Furthermore, TGF-beta I significantly increased the migration ability of endometriotic cells and silencing of OCT4 dramatically suppressed the TGF-beta I-induced cell migration activity evidenced by wound-closure assay, transwell assay, and confocal image of F-actin cellular distribution. In conclusion, the present findings demonstrate that the niche TGF-beta plays a critical role in initiating expressions of pluripotent transcription factor OCT4 which may contribute to the ectopic endometrial growth by stimulating endometrial cell migration. These findings would be useful for developing therapeutic strategies targeting TGF-beta-OCT4 signaling to prevent endometriosis in the future.	[Chang, Jui-Hung; Wu, Yu-Chih; Kuo, Yung-Che; Chen, Yu-Hsi; Lee, Wei-Chin; Chang, Te-Sheng; Lan, Pei-Chi; Lee, Kha-Liang; Lee, Mei-Tsu; Huang, Yen-Hua] Taipei Med Univ, Dept Biochem & Mol Cell Biol, Sch Med, Coll Med, Taipei, Taiwan; [Lee, Wei-Chin; Lee, Kha-Liang; Huang, Yen-Hua] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan; [Wu, Yu-Chih; Lan, Pei-Chi; Huang, Yen-Hua] Taipei Med Univ, Ctr Cell Therapy & Regenerat Med, Taipei, Taiwan; [Au, Heng-Kien] Taipei Med Univ, Sch Med, Dept Obstet & Gynecol, Coll Med, Taipei, Taiwan; [Au, Heng-Kien; Tzeng, Chii-Ruey] Taipei Med Univ, Taipei Med Univ Hosp, Ctr Reprod Med, Taipei, Taiwan; [Au, Heng-Kien; Tzeng, Chii-Ruey] Taipei Med Univ Hosp, Dept Obstet & Gynecol, Taipei, Taiwan; [Chang, Te-Sheng] Chang Gung Mem Hosp, Dept Gastroenterol & Hepatol, Chiayi, Taiwan; [Kuo, Hung-Chih] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan; [Huang, Yen-Hua] Taipei Med Univ, Ctr Comprehens Canc, Taipei, Taiwan; [Huang, Yen-Hua] Taipei Med Univ, PhD Program Translat Med, Taipei, Taiwan	Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; Taipei Medical University; Taipei Medical University Hospital; Chang Gung Memorial Hospital; Academia Sinica - Taiwan; Taipei Medical University; Taipei Medical University	Huang, YH (corresponding author), Taipei Med Univ, Dept Biochem & Mol Cell Biol, Sch Med, Coll Med, Taipei, Taiwan.	rita1204@tmu.edu.tw	Kuo, Hung-Chih/H-7810-2014	Kuo, Hung-Chih/0000-0003-1336-1203; Kuo, Yung-Che/0000-0002-9425-7389; Wu, Yu-Chih/0000-0001-5781-2665; Huang, Yen-Hua/0000-0001-6020-9998	National Science Council, Taiwan [NSC (100-102)-2321-B-038-003, NSC101-2314-B-182A-028, NSC102-2628-B-038-008-MY3]; Ministry of Science and Technology, Taiwan [MOST 103-2321-B-038-011]; Health and Welfare Surcharge of Tobacco Products [MOHW104-TDU-B-212-124-001]; Taipei Medical University [TMUTOP103002-9]; Taipei Medical University Hospital [100TMU-TMUH-13, 102TMU-TMUH-13, 103TMU-TMUH-05]; Chang Gung Memorial Hospital [CMRPG680311, CMRPG690411, CMRPG6A0471, CMRPG6B0381, CMRPG6B0382]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Health and Welfare Surcharge of Tobacco Products; Taipei Medical University; Taipei Medical University Hospital; Chang Gung Memorial Hospital(Chang Gung Memorial Hospital)	This work was supported by grants from the National Science Council, Taiwan (NSC (100-102)-2321-B-038-003, NSC101-2314-B-182A-028, and NSC102-2628-B-038-008-MY3) (http://www.most.gov.tw/), Ministry of Science and Technology, Taiwan (MOST 103-2321-B-038-011) (http://www.most.gov.tw/), Health and Welfare Surcharge of Tobacco Products (MOHW104-TDU-B-212-124-001) (http://www.mohw.gov.tw/EN/Ministry/Index.aspx), Taipei Medical University (TMUTOP103002-9) (http://www.tmu.edu.tw/english/main.php), and Taipei Medical University Hospital (100TMU-TMUH-13, 102TMU-TMUH-13, 103TMU-TMUH-05) (http://www.tmuh.org.tw/tmuh_en/index.php), and Chang Gung Memorial Hospital (CMRPG680311, CMRPG690411, CMRPG6A0471, CMRPG6B0381 and CMRPG6B0382) (https://www.cgmh.org.tw/eng2002/index.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acloque H, 2009, J CLIN INVEST, V119, P1438, DOI 10.1172/JCI38019; Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Chan RWS, 2011, AM J PATHOL, V178, P2832, DOI 10.1016/j.ajpath.2011.02.025; Chang JH, 2013, FERTIL STERIL, V99, P1332, DOI 10.1016/j.fertnstert.2012.11.033; Chang TS, 2015, CLIN CANCER RES, V21, P201, DOI 10.1158/1078-0432.CCR-13-3274; Chen YJ, 2010, J PATHOL, V222, P261, DOI 10.1002/path.2761; Chiou SH, 2010, CANCER RES, V70, P10433, DOI 10.1158/0008-5472.CAN-10-2638; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Duangkumpha K, 2014, TUMOR BIOL, V35, P9667, DOI 10.1007/s13277-014-2246-9; Elliott RL, 2005, J CLIN ONCOL, V23, P2078, DOI 10.1200/JCO.2005.02.047; Forte A, 2009, MOL MED, V15, P392, DOI 10.2119/molmed.2009.00068; Fuxe J, 2012, SEMIN CANCER BIOL, V22, P455, DOI 10.1016/j.semcancer.2012.05.004; Gargett CE, 2007, HUM REPROD UPDATE, V13, P87, DOI 10.1093/humupd/dml045; Gargett CE, 2012, FERTIL STERIL, V98, DOI 10.1016/j.fertnstert.2012.05.004; Gotte M, 2011, FERTIL STERIL, V95, P338, DOI 10.1016/j.fertnstert.2010.08.006; Gruenwald P, 1942, AM J OBSTET GYNECOL, V44, P470, DOI 10.1016/S0002-9378(42)90484-8; Heldin CH, 2012, FEBS LETT, V586, P1959, DOI 10.1016/j.febslet.2012.02.037; Huang HP, 2011, J BIOL CHEM, V286, P33520, DOI 10.1074/jbc.M111.256164; Huang YH, 2014, MOL HUM REPROD, V20, P1, DOI 10.1093/molehr/gau016; Huang YH, 2009, FASEB J, V23, P2076, DOI 10.1096/fj.08-121939; Hull ML, 2012, AM J PATHOL, V180, P880, DOI 10.1016/j.ajpath.2011.11.013; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Jung JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028068; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Karoubi G, 2010, J SURG ONCOL, V102, P689, DOI 10.1002/jso.21665; Kristensen DM, 2010, MOL HUM REPROD, V16, P835, DOI 10.1093/molehr/gaq008; Kupker W, 1998, HUM REPROD UPDATE, V4, P719, DOI 10.1093/humupd/4.5.719; Lebovic DI, 2001, FERTIL STERIL, V75, P1, DOI 10.1016/S0015-0282(00)01630-7; Ling TY, 2006, P NATL ACAD SCI USA, V103, P9530, DOI 10.1073/pnas.0510232103; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Figueira PGM, 2011, ANN NY ACAD SCI, V1221, P10, DOI 10.1111/j.1749-6632.2011.05969.x; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Moustakas A, 2012, SEMIN CANCER BIOL, V22, P446, DOI 10.1016/j.semcancer.2012.04.002; Nilsson Eric E, 2002, Reprod Biomed Online, V5, P254; Omwandho COA, 2010, HUM REPROD, V25, P101, DOI 10.1093/humrep/dep382; OOSTERLYNCK DJ, 1994, OBSTET GYNECOL, V83, P287; Pacchiarotti A, 2011, FERTIL STERIL, V95, P1171, DOI 10.1016/j.fertnstert.2010.10.029; Padykula HA, 1991, ANN N Y ACAD SCI, V622, P47, DOI 10.1111/j.1749-6632.1991.tb37849.x; Peng S, 2010, ONCOGENE, V29, P2153, DOI 10.1038/onc.2009.500; Pizzo A, 2002, GYNECOL OBSTET INVES, V54, P82, DOI 10.1159/000067717; Russell WW, 1899, J HOPKINS HOSP B, V10, P8; Sampson JA, 1927, AM J OBSTET GYNECOL, V14, P422, DOI 10.1016/S0002-9378(15)30003-X; Sampson JA, 1927, AM J PATHOL, V3, P93; Sampson JA, 1925, AM J OBSTET GYNECOL, V10, P649, DOI 10.1016/S0002-9378(25)90629-1; Sasson IE, 2008, ANN NY ACAD SCI, V1127, P106, DOI 10.1196/annals.1434.014; Silveira CGT, 2012, HUM REPROD, V27, P3187, DOI 10.1093/humrep/des282; Simoens S, 2012, HUM REPROD, V27, P1292, DOI 10.1093/humrep/des073; Sotomayor P, 2009, PROSTATE, V69, P401, DOI 10.1002/pros.20895; Valcourt U, 2005, MOL BIOL CELL, V16, P1987, DOI 10.1091/mbc.e04-08-0658; Vassiliadis S, 2005, Clin Dev Immunol, V12, P125, DOI 10.1080/17402520500125484; Wu YJ, 2011, CANCER-AM CANCER SOC, V117, P3989, DOI 10.1002/cncr.25944; Xu J, 2009, CELL RES, V19, P156, DOI 10.1038/cr.2009.5; Yang WCV, 2004, BEST PRACT RES CL OB, V18, P305, DOI 10.1016/j.bpobgyn.2004.03.003	55	25	27	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145256	10.1371/journal.pone.0145256	http://dx.doi.org/10.1371/journal.pone.0145256			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675296	Green Submitted, gold, Green Published			2022-12-26	WOS:000366722700118
J	Levy, E; Kornowski, R; Gavrieli, R; Fratty, I; Greenberg, G; Waldman, M; Birk, E; Shainberg, A; Akirov, A; Miskin, R; Hochhauser, E				Levy, Esther; Kornowski, Ran; Gavrieli, Reut; Fratty, Ilana; Greenberg, Gabriel; Waldman, Maayan; Birk, Einat; Shainberg, Asher; Akirov, Amit; Miskin, Ruth; Hochhauser, Edith			Long-Lived alpha MUPA Mice Show Attenuation of Cardiac Aging and Leptin-Dependent Cardioprotection	PLOS ONE			English	Article							TERM CALORIC RESTRICTION; CIRCADIAN-RHYTHMS; NITRIC-OXIDE; BODY-WEIGHT; HEART; ADIPONECTIN; DYSFUNCTION; PROTECTS; EXPRESSION; APOPTOSIS	alpha MUPA transgenic mice spontaneously consume less food compared with their wild type (WT) ancestors due to endogenously increased levels of the satiety hormone leptin. aMUPA mice share many benefits with mice under caloric restriction (CR) including an extended life span. To understand mechanisms linked to cardiac aging, we explored the response of aMUPA hearts to ischemic conditions at the age of 6, 18, or 24 months. Mice were subjected to myocardial infarction (MI) in vivo and to ischemia/reperfusion ex vivo. Compared to WT mice, aMUPA showed functional and histological advantages under all experimental conditions. At 24 months, none of the WT mice survived the first ischemic day while aMUPA mice demonstrated 50% survival after 7 ischemic days. Leptin, an adipokine decreasing under CR, was consistently similar to 60% higher in aMUPA sera at baseline. Leptin levels gradually increased in both genotypes 24h post MI but were doubled in aMUPA. Pretreatment with leptin neutralizing antibodies or with inhibitors of leptin signaling (AG-490 and Wortmannin) abrogated the aMUPA benefits. The antibodies also reduced phosphorylation of the leptin signaling components STAT3 and AKT specifically in the aMUPA myocardium. aMUPA mice did not show elevation in adiponectin, an adipokine previously implicated in CR-induced cardioprotection. WT mice treated for short-term CR exhibited cardioprotection similar to that of aMUPA, however, along with increased adiponectin at baseline. Collectively, the results demonstrate a life-long increased ischemic tolerance in aMUPA mice, indicating the attenuation of cardiac aging. aMUPA cardioprotection is mediated through endogenous leptin, suggesting a protective pathway distinct from that elicited under CR.	[Levy, Esther; Gavrieli, Reut; Fratty, Ilana; Waldman, Maayan; Akirov, Amit; Hochhauser, Edith] Tel Aviv Univ, Felsenstein Med Res Ctr, Cardiac Res Lab, Petah Tiqwa, Israel; [Kornowski, Ran; Greenberg, Gabriel] Rabin Med Ctr, Dept Cardiol, Petah Tiqwa, Israel; [Gavrieli, Reut; Fratty, Ilana; Shainberg, Asher] Bar Ilan Univ, Fac Life Sci, Ramat Gan, Israel; [Birk, Einat] Tel Aviv Univ, Dept Cardiol, Petah Tiqwa, Israel; [Birk, Einat] Tel Aviv Univ, Schneider Childrens Med Ctr, Petah Tiqwa, Israel; [Miskin, Ruth] Weizmann Inst Sci, IL-76100 Rehovot, Israel	Tel Aviv University; Rabin Medical Center; Bar Ilan University; Tel Aviv University; Tel Aviv University; Weizmann Institute of Science	Hochhauser, E (corresponding author), Tel Aviv Univ, Felsenstein Med Res Ctr, Cardiac Res Lab, Petah Tiqwa, Israel.	hochhaus@post.tau.ac.il	Akirov, Amit/GYV-5697-2022; Waldman, Maayan/G-5369-2015	Waldman, Maayan/0000-0002-6204-6974	Israel Science Foundation (ISF) [834/09]; Young Investigator Support Grant at Rabin Medical Center to Amit Akirov	Israel Science Foundation (ISF)(Israel Science Foundation); Young Investigator Support Grant at Rabin Medical Center to Amit Akirov	This study was supported by the Israel Science Foundation (ISF) grant No. 834/09, awarded to me and The Young Investigator Support Grant at Rabin Medical Center to Amit Akirov.	Ahmet I, 2011, J MOL CELL CARDIOL, V51, P263, DOI 10.1016/j.yjmcc.2011.04.015; Barouch LA, 2003, CIRCULATION, V108, P754, DOI 10.1161/01.CIR.0000083716.82622.FD; Berg AH, 2005, CIRC RES, V96, P939, DOI 10.1161/01.RES.0000163635.62927.34; Boengler K, 2008, CIRC RES, V102, P131, DOI 10.1161/CIRCRESAHA.107.164699; Boengler K, 2011, ANTIOXID REDOX SIGN, V14, P863, DOI 10.1089/ars.2010.3309; Boengler K, 2009, CARDIOVASC RES, V83, P247, DOI 10.1093/cvr/cvp033; Broderick TL, 2002, MOL CELL BIOCHEM, V233, P119, DOI 10.1023/A:1015506327849; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Chandrasekar B, 2001, AM J PHYSIOL-HEART C, V280, pH2094, DOI 10.1152/ajpheart.2001.280.5.H2094; Chapnik N, 2013, J ENDOCRINOL, V217, P283, DOI 10.1530/JOE-13-0033; Chatham JC, 2013, J MOL CELL CARDIOL, V55, P139, DOI 10.1016/j.yjmcc.2012.06.016; Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455; Coppari R, 2012, NAT REV DRUG DISCOV, V11, P692, DOI 10.1038/nrd3757; Edwards AG, 2010, MECH AGEING DEV, V131, P739, DOI 10.1016/j.mad.2010.09.007; Fallach R, 2010, J MOL CELL CARDIOL, V48, P1236, DOI 10.1016/j.yjmcc.2010.02.020; Froy O, 2010, INT J OBES LOND, V35, P226; Froy O, 2007, PROG NEUROBIOL, V82, P142, DOI 10.1016/j.pneurobio.2007.03.002; Froy O, 2010, AGING-US, V2, P7, DOI 10.18632/aging.100116; Fruhbeck G, 2006, BIOCHEM J, V393, P7, DOI 10.1042/BJ20051578; Gonzalez AA, 2004, AM J PHYSIOL-ENDOC M, V287, pE1032, DOI 10.1152/ajpendo.00172.2004; Gutman R, 2011, EXP GERONTOL, V46, P606, DOI 10.1016/j.exger.2011.02.015; Han XF, 2012, J NUTR BIOCHEM, V23, P1592, DOI 10.1016/j.jnutbio.2011.11.002; Harlan SM, 2013, MOL METAB, V2, P69, DOI 10.1016/j.molmet.2013.03.004; Heusch G, 2008, CIRCULATION, V118, P1915, DOI 10.1161/CIRCULATIONAHA.108.805242; Hochhauser E, 2003, AM J PHYSIOL-HEART C, V284, pH2351, DOI 10.1152/ajpheart.00783.2002; Karmazyn M, 2008, CARDIOVASC RES, V79, P279, DOI 10.1093/cvr/cvn115; Konstantinides S, 2004, ARTERIOSCL THROM VAS, V24, P2196, DOI 10.1161/01.ATV.0000146531.79402.9a; Lee B, 2014, REV ENDOCR METAB DIS, V15, P149, DOI 10.1007/s11154-013-9283-3; Long PG, 2002, MECH AGEING DEV, V123, P1411, DOI 10.1016/S0047-6374(02)00068-4; Matsui H, 2007, LIFE SCI, V80, P672, DOI 10.1016/j.lfs.2006.10.027; McGaffin KR, 2008, CARDIOVASC RES, V77, P54, DOI 10.1093/cvr/cvm023; McGaffin KR, 2011, CARDIOVASC RES, V89, P60, DOI 10.1093/cvr/cvq288; McGaffin KR, 2009, CARDIOVASC RES, V83, P313, DOI 10.1093/cvr/cvp071; Miskin R, 2005, MECH AGEING DEV, V126, P255, DOI 10.1016/j.mad.2004.08.018; Miskin R, 1997, J GERONTOL A-BIOL, V52, pB118, DOI 10.1093/gerona/52A.2.B118; MISKIN R, 1990, EUR J BIOCHEM, V190, P31, DOI 10.1111/j.1432-1033.1990.tb15541.x; Rico L, 2005, ENDOCRINOLOGY, V146, P4167, DOI 10.1210/en.2005-0156; Roger VL, 2011, CIRCULATION, V123, pE18, DOI 10.1161/CIR.0b013e3182009701; Shibata R, 2007, J MOL CELL CARDIOL, V42, P1065, DOI 10.1016/j.yjmcc.2007.03.808; Shinmura K, 2005, J MOL CELL CARDIOL, V39, P285, DOI 10.1016/j.yjmcc.2005.03.010; Shinmura K, 2007, CIRCULATION, V116, P2809, DOI 10.1161/CIRCULATIONAHA.107.725697; Shinmura K, 2008, AM J PHYSIOL-HEART C, V295, pH2348, DOI 10.1152/ajpheart.00602.2008; Smith CCT, 2006, BRIT J PHARMACOL, V149, P5, DOI 10.1038/sj.bjp.0706834; Smith CCT, 2011, PHARMACOL THERAPEUT, V129, P206, DOI 10.1016/j.pharmthera.2010.09.003; Smith CCT, 2010, AM J PHYSIOL-HEART C, V299, pH1265, DOI 10.1152/ajpheart.00092.2010; Smith RM, 2004, CARDIOVASC RES, V63, P611, DOI 10.1016/j.cardiores.2004.06.019; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Steckler R, 2015, J GERONOTOL IN PRESS; Tahergorabi Zoya, 2015, Adv Biomed Res, V4, P79, DOI 10.4103/2277-9175.156526; Tirosh O, 2005, MECH AGEING DEV, V126, P1262, DOI 10.1016/j.mad.2005.07.003; van den Borne SWM, 2009, CARDIOVASC RES, V84, P273, DOI 10.1093/cvr/cvp207; Waldman M, 2013, BIOCHEM PHARMACOL, V85, P1626, DOI 10.1016/j.bcp.2013.03.014; Weiss EP, 2011, AM J PHYSIOL-HEART C, V301, pH1205, DOI 10.1152/ajpheart.00685.2011; Wojtovich AP, 2012, EXP GERONTOL, V47, P1, DOI 10.1016/j.exger.2011.11.001; Yanai H, 2015, AGING-US, V7, P167, DOI 10.18632/aging.100726; Zhu M, 2004, EXP GERONTOL, V39, P1049, DOI 10.1016/j.exger.2004.03.024	56	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144593	10.1371/journal.pone.0144593	http://dx.doi.org/10.1371/journal.pone.0144593			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673217	Green Published, Green Submitted, gold			2022-12-26	WOS:000366722700046
J	Naro, A; Russo, M; Leo, A; Rifici, C; Pollicino, P; Bramanti, P; Calabro, RS				Naro, Antonino; Russo, Margherita; Leo, Antonino; Rifici, Carmela; Pollicino, Patrizia; Bramanti, Placido; Calabro, Rocco Salvatore			Cortical Responsiveness to Nociceptive Stimuli in Patients with Chronic Disorders of Consciousness: Do C-Fiber Laser Evoked Potentials Have a Role?	PLOS ONE			English	Article							COMA RECOVERY SCALE; BRAIN POTENTIALS; A-DELTA; SURFACE-AREAS; PAIN; HYPERALGESIA; GUIDELINES; RESPONSES; PATHWAYS; NOVELTY	It has been shown that the presence of Ad-fiber laser evoked potentials (Ad-LEP) in patients suffering from chronic disorders of consciousness (DOC), such as vegetative state (VS) and minimally conscious state (MCS), may be the expression of a residual cortical pain arousal. Interestingly, the study of C-fiber LEP (C-LEP) could be useful in the assessment of cortical pain arousal in the DOC individuals who lack of A delta-LEP. To this end, we enrolled 38 DOC patients following post-anoxic or post-traumatic brain injury, who met the international criteria for VS and MCS diagnosis. Each subject was clinically evaluated, through the coma recovery scale-revised (CRS-R) and the nociceptive coma scale-revised (NCS-R), and electrophysiologically tested by means of a solid-state laser for A delta-LEP and C-LEP. VS individuals showed increased latencies and reduced amplitudes of both the A delta-LEP and C-LEP components in comparison to MCS patients. Although nearly all of the patients had both the LEP components, some VS individuals showed only the C-LEP ones. Notably, such patients had a similar NCS-R score to those having both the LEP components. Hence, we could hypothesize that C-LEP generators may be rearranged or partially spared in order to still guarantee cortical pain arousal when A delta-LEP generators are damaged. Therefore, the residual presence of C-LEP should be assessed when A delta-LEP are missing, since a potential pain experience should be still present in some patients, so to properly initiate, or adapt, the most appropriate pain treatment.	[Naro, Antonino; Russo, Margherita; Leo, Antonino; Rifici, Carmela; Pollicino, Patrizia; Bramanti, Placido; Calabro, Rocco Salvatore] IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy	IRCCS Bonino Pulejo	Calabro, RS (corresponding author), IRCCS Ctr Neurolesi Bonino Pulejo, Messina, Italy.	salbro77@tiscali.it	calabro, rocco salvatore/L-9570-2019; Calabrò, Rocco S/K-7520-2016; Bramanti, Placido/K-5117-2016; Leo, Antonino/K-7529-2016; Leo, Antonino/ABI-7198-2020; Rifici, Carmela/ABH-4398-2020	calabro, rocco salvatore/0000-0002-8566-3166; Leo, Antonino/0000-0003-4163-5830; Leo, Antonino/0000-0003-4163-5830; 				ASHWAL S, 1994, NEW ENGL J MED, V330, P1499; BENNETT GJ, 1994, TXB PAIN; Boly M, 2005, NEUROPSYCHOL REHABIL, V15, P283, DOI 10.1080/09602010443000371; Bragard D, 1996, NEUROSCI LETT, V209, P81, DOI 10.1016/0304-3940(96)12604-5; BROMM B, 1983, PFLUG ARCH EUR J PHY, V399, P155, DOI 10.1007/BF00663913; CAMPBELL JN, 1983, J NEUROPHYSIOL, V49, P98, DOI 10.1152/jn.1983.49.1.98; Chatelle C, 2012, J NEUROL NEUROSUR PS, V83, P1233, DOI 10.1136/jnnp-2012-302987; Cruccu G, 2008, CLIN NEUROPHYSIOL, V119, P1705, DOI 10.1016/j.clinph.2008.03.016; Cruccu G, 2003, BRAIN, V126, P2246, DOI 10.1093/brain/awg227; Cruccu G, 2010, EUR J NEUROL, V17, P1010, DOI 10.1111/j.1468-1331.2010.02969.x; de Tommaso M, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00017; de Tommaso M, 2013, BRAIN INJURY, V27, P962, DOI 10.3109/02699052.2013.775507; Di Perri C, 2013, NEUROLOGY, V81, P1417, DOI 10.1212/WNL.0b013e3182a43b78; Garcia-Larrea L, 2003, NEUROPHYSIOL CLIN, V33, P279, DOI 10.1016/j.neucli.2003.10.008; Garcia-Larrea L, 2002, BRAIN, V125, P2766, DOI 10.1093/brain/awf275; GEISSER S, 1958, ANN MATH STAT, V29, P885, DOI 10.1214/aoms/1177706545; Gerrard P, 2014, ARCH PHYS MED REHAB, V95, P2335, DOI 10.1016/j.apmr.2014.06.018; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Haanpaa M, 2011, PAIN, V152, P14, DOI 10.1016/j.pain.2010.07.031; Hu L, 2014, J NEUROSCI, V34, P11439, DOI 10.1523/JNEUROSCI.1355-14.2014; Iannetti GD, 2008, J NEUROPHYSIOL, V100, P815, DOI 10.1152/jn.00097.2008; Iannetti GD, 2004, CLIN NEUROPHYSIOL, V115, P2629, DOI 10.1016/j.clinph.2004.05.023; Iannetti GD, 2003, J NEUROPHYSIOL, V89, P562, DOI 10.1152/jn.00393.2002; Kalmar K, 2005, NEUROPSYCHOL REHABIL, V15, P454, DOI 10.1080/09602010443000425; Kassubek J, 2003, J NEUROL SCI, V212, P85, DOI 10.1016/S0022-510X(03)00106-0; LAMOTTE RH, 1983, J NEUROPHYSIOL, V50, P1; Laureys S, 2002, NEUROIMAGE, V17, P732, DOI 10.1006/nimg.2002.1236; Lenz FA, 1991, PAIN CENTRAL NERVOU; Letham B, 2011, J NEUROSCI METH, V194, P374, DOI 10.1016/j.jneumeth.2010.10.016; Magerl W, 1999, PAIN, V82, P127, DOI 10.1016/S0304-3959(99)00061-5; Montagna W, 1959, P BROWN U S BIOL SKI; Mouraux A, 2006, Suppl Clin Neurophysiol, V59, P197; Mouraux A, 2009, J NEUROPHYSIOL, V101, P3258, DOI 10.1152/jn.91181.2008; Opsommer E, 2001, CLIN NEUROPHYSIOL, V112, P1868, DOI 10.1016/S1388-2457(01)00622-8; Opsommer E, 1999, NEUROPHYSIOL CLIN, V29, P411, DOI 10.1016/S0987-7053(00)87265-2; Perchet C, 2008, CLIN NEUROPHYSIOL, V119, P2615, DOI 10.1016/j.clinph.2008.06.021; Plaghki L, 2003, NEUROPHYSIOL CLIN, V33, P269, DOI 10.1016/j.neucli.2003.10.003; Ronga I, 2013, J NEUROPHYSIOL, V109, P692, DOI 10.1152/jn.00464.2012; Spiegel J, 2000, CLIN NEUROPHYSIOL, V111, P725, DOI 10.1016/S1388-2457(99)00297-7; Treede RD, 2003, NEUROPHYSIOL CLIN, V33, P303, DOI 10.1016/j.neucli.2003.10.009; Treede RD, 1998, PAIN FORUM, V7, P191, DOI 10.1016/S1082-3174(98)80005-6; Truini A, 2008, PAIN, V140, P405, DOI 10.1016/j.pain.2008.08.018; Valeriani M, 2002, NEUROSCI LETT, V329, P329, DOI 10.1016/S0304-3940(02)00671-7; Vogt BA, 2000, PROG BRAIN RES, V122, P223; Wang AL, 2010, J NEUROPHYSIOL, V104, P2116, DOI 10.1152/jn.01088.2009; Weng HR, 2000, NEUROSCIENCE, V101, P393, DOI 10.1016/S0306-4522(00)00368-7; Wu Q, 1999, PAIN, V80, P209, DOI 10.1016/S0304-3959(98)00206-1; Zanatta P, 2012, MINERVA ANESTESIOL, V78, P749	48	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144713	10.1371/journal.pone.0144713	http://dx.doi.org/10.1371/journal.pone.0144713			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674634	Green Published, gold, Green Submitted			2022-12-26	WOS:000366722700055
J	Wang, DC; Shanina, I; Toyofuku, WM; Horwitz, MS; Scott, MD				Wang, Duncheng; Shanina, Iryna; Toyofuku, Wendy M.; Horwitz, Marc S.; Scott, Mark D.			Inhibition of Autoimmune Diabetes in NOD Mice by miRNA Therapy	PLOS ONE			English	Article							REGULATORY T-CELLS; METHOXYPOLY(ETHYLENE GLYCOL); ISLET TRANSPLANTATION; DENDRITIC CELLS; TH17 CELLS; IMMUNOCAMOUFLAGE; PREVENTION; INDUCTION; RECOGNITION; EFFICACY	Autoimmune destruction of the pancreatic islets in Type 1 diabetes is mediated by both increased proinflammatory (Teff) and decreased regulatory (Treg) T lymphocytes resulting in a significant decrease in the Treg: Teff ratio. The non-obese diabetic (NOD) mouse is an excellent in vivo model for testing potential therapeutics for attenuating the decrease in the Treg: Teff ratio and inhibiting disease pathogenesis. Here we show for the first time that a bioreactor manufactured therapeutic consisting of a complex of miRNA species (denoted as TA1) can effectively reset the NOD immune system from a proinflammatory to a tolerogenic state thus preventing or delaying autoimmune diabetes. Treatment of NOD mice with TA1 resulted in a systemic broad-spectrum upregulation of tolerogenic T cell subsets with a parallel downregulation of Teff subsets yielding a dramatic increase in the Treg: Teff ratio. Moreover, the murine-derived TA1 was highly effective in the inhibition of allorecognition of HLA-disparate human PBMC. TA1 demonstrated dose-responsiveness and exhibited equivalent or better inhibition of allorecognition driven proliferation than etanercept (a soluble TNF receptor). These findings demonstrate that miRNA-based therapeutics can effectively attenuate or arrest autoimmune disease processes and may be of significant utility in a broad range of autoimmune diseases including Type 1 diabetes.	[Wang, Duncheng; Toyofuku, Wendy M.; Scott, Mark D.] Canadian Blood Serv, Ctr Innovat, Ottawa, ON, Canada; [Wang, Duncheng; Toyofuku, Wendy M.; Scott, Mark D.] Univ British Columbia, Ctr Blood Res, Vancouver, BC V5Z 1M9, Canada; [Shanina, Iryna; Horwitz, Marc S.] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V5Z 1M9, Canada; [Scott, Mark D.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada	Canadian Blood Services; University of British Columbia; University of British Columbia; University of British Columbia	Scott, MD (corresponding author), Canadian Blood Serv, Ctr Innovat, Ottawa, ON, Canada.	mdscott@mail.ubc.ca		Wang, Duncheng/0000-0002-2085-9512	Canadian Institutes of Health Research [123317]; Canadian Blood Services; Health Canada; Canada Foundation for Innovation; Michael Smith Foundation for Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Blood Services; Health Canada; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This work was supported by grants from the Canadian Institutes of Health Research (Grant No. 123317; MDS), Canadian Blood Services (MDS) and Health Canada (MDS). The views expressed herein do not necessarily represent the view of the federal government of Canada. We thank the Canada Foundation for Innovation and the Michael Smith Foundation for Health Research for infrastructure funding at the University of British Columbia Centre for Blood Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Atkinson MA, 1999, NAT MED, V5, P601, DOI 10.1038/9442; Balasa B, 1997, J IMMUNOL, V159, P4620; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Bhardwaj Arun, 2010, Mol Cell Pharmacol, V2, P213; Braicu C, 2013, CURR MED CHEM; Chen AM, 2003, J BIOMED MATER RES A, V67A, P626, DOI 10.1002/jbm.a.10146; Chen AM, 2001, BIODRUGS, V15, P833, DOI 10.2165/00063030-200115120-00005; Chen AM, 2006, ARTIF CELL BLOOD SUB, V34, P305, DOI 10.1080/10731190600683845; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Cortes JR, 2014, J AUTOIMMUN, V55, P51, DOI 10.1016/j.jaut.2014.05.007; Creusot RJ, 2010, MOL THER, V18, P2112, DOI 10.1038/mt.2010.146; D'Alise AM, 2008, P NATL ACAD SCI USA, V105, P19857, DOI 10.1073/pnas.0810713105; Feuerer M, 2009, IMMUNITY, V31, P654, DOI 10.1016/j.immuni.2009.08.023; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gaudreau S, 2007, J IMMUNOL, V179, P3638, DOI 10.4049/jimmunol.179.6.3638; Gregori S, 2003, J IMMUNOL, V171, P4040, DOI 10.4049/jimmunol.171.8.4040; Grewal IS, 1998, ANNU REV IMMUNOL, V16, P111, DOI 10.1146/annurev.immunol.16.1.111; Guay C, 2011, TRANSL RES, V157, P253, DOI 10.1016/j.trsl.2011.01.009; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Korn T, 2007, SEMIN IMMUNOL, V19, P362, DOI 10.1016/j.smim.2007.10.007; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Korn T, 2008, P NATL ACAD SCI USA, V105, P18460, DOI 10.1073/pnas.0809850105; Kriegel MA, 2012, P NATL ACAD SCI USA, V109, P3457, DOI 10.1073/pnas.1115308109; Kyluik-Price DL, 2014, BIOMATERIALS, V35, P412, DOI 10.1016/j.biomaterials.2013.09.016; Le Y, 2010, ACTA BIOMATER, V6, P2631, DOI 10.1016/j.actbio.2010.01.031; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin MS, 2011, IMMUNOL RES, V50, P213, DOI 10.1007/s12026-011-8215-0; Lindley S, 2005, DIABETES, V54, P92, DOI 10.2337/diabetes.54.1.92; Liu C, 2011, NAT MED, V17, P211, DOI 10.1038/nm.2284; Luo XR, 2010, IMMUNITY, V32, P488, DOI 10.1016/j.immuni.2010.04.002; MONTANA E, 1993, J CLIN INVEST, V91, P780, DOI 10.1172/JCI116297; Murad KL, 1999, BLOOD, V94, P2135; Nielsen LB, 2012, EXP DIABETES RES, V2012, DOI DOI 10.1155/2012/896362; Nishio J, 2010, J EXP MED, V207, P1879, DOI 10.1084/jem.20100205; Noorchashm H, 1997, DIABETOLOGIA, V40, pB50, DOI 10.1007/BF03168187; Richer MJ, 2008, DIABETES, V57, P1302, DOI 10.2337/db07-1460; Richer MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031153; Roep BO, 2003, DIABETOLOGIA, V46, P305, DOI 10.1007/s00125-003-1089-5; Ryan EA, 2001, DIABETES, V50, P710, DOI 10.2337/diabetes.50.4.710; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Shapiro AMJ, 2000, NEW ENGL J MED, V343, P230, DOI 10.1056/NEJM200007273430401; Shen EX, 2011, CELL BIOL INT, V35, P705, DOI 10.1042/CBI20100528; Tang XY, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/345347; Thayer TC, 2010, ENDOCRIN METAB CLIN, V39, P541, DOI 10.1016/j.ecl.2010.05.001; Thomas David, 2005, Rev Diabet Stud, V2, P9, DOI 10.1900/RDS.2005.2.9; Tritt M, 2008, DIABETES, V57, P113, DOI 10.2337/db06-1700; Wang DC, 2012, BIOMATERIALS, V33, P3002, DOI 10.1016/j.biomaterials.2011.12.041; Wang DC, 2011, BIOMATERIALS, V32, P9494, DOI 10.1016/j.biomaterials.2011.08.061; Wei B, 2010, CELL MOL IMMUNOL, V7, P175, DOI 10.1038/cmi.2010.19; Yang H, 2012, TRANSPLANTATION, V93, P580, DOI 10.1097/TP.0b013e318244dd67; You S, 2005, DIABETES, V54, P1415, DOI 10.2337/diabetes.54.5.1415	53	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145179	10.1371/journal.pone.0145179	http://dx.doi.org/10.1371/journal.pone.0145179			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674203	Green Published, gold, Green Submitted			2022-12-26	WOS:000366722700111
J	Weijerman, M; Fulton, EA; Kaplan, IC; Gorton, R; Leemans, R; Mooij, WM; Brainard, RE				Weijerman, Mariska; Fulton, Elizabeth A.; Kaplan, Isaac C.; Gorton, Rebecca; Leemans, Rik; Mooij, Wolf M.; Brainard, Russell E.			An Integrated Coral Reef Ecosystem Model to Support Resource Management under a Changing Climate	PLOS ONE			English	Article							GREAT-BARRIER-REEF; REGION-WIDE DECLINES; OCEAN ACIDIFICATION; MARINE ECOSYSTEMS; FISHES; IMPACTS; RECOVERY; FUTURE; DISTURBANCE; RESPONSES	Millions of people rely on the ecosystem services provided by coral reefs, but sustaining these benefits requires an understanding of how reefs and their biotic communities are affected by local human-induced disturbances and global climate change. Ecosystembased management that explicitly considers the indirect and cumulative effects of multiple disturbances has been recommended and adopted in policies in many places around the globe. Ecosystem models give insight into complex reef dynamics and their responses to multiple disturbances and are useful tools to support planning and implementation of ecosystem-based management. We adapted the Atlantis Ecosystem Model to incorporate key dynamics for a coral reef ecosystem around Guam in the tropical western Pacific. We used this model to quantify the effects of predicted climate and ocean changes and current levels of current land-based sources of pollution (LBSP) and fishing. We used the following six ecosystem metrics as indicators of ecosystem state, resilience and harvest potential: 1) ratio of calcifying to non-calcifying benthic groups, 2) trophic level of the community, 3) biomass of apex predators, 4) biomass of herbivorous fishes, 5) total biomass of living groups and 6) the end-to-start ratio of exploited fish groups. Simulation tests of the effects of each of the three drivers separately suggest that by mid-century climate change will have the largest overall effect on this suite of ecosystem metrics due to substantial negative effects on coral cover. The effects of fishing were also important, negatively influencing five out of the six metrics. Moreover, LBSP exacerbates this effect for all metrics but not quite as badly as would be expected under additive assumptions, although the magnitude of the effects of LBSP are sensitive to uncertainty associated with primary productivity. Over longer time spans (i.e., 65 year simulations), climate change impacts have a slight positive interaction with other drivers, generally meaning that declines in ecosystem metrics are not as steep as the sum of individual effects of the drivers. These analyses offer one way to quantify impacts and interactions of particular stressors in an ecosystem context and so provide guidance to managers. For example, the model showed that improving water quality, rather than prohibiting fishing, extended the timescales over which corals can maintain high abundance by at least 5-8 years. This result, in turn, provides more scope for corals to adapt or for resilient species to become established and for local and global management efforts to reduce or reverse stressors.	[Weijerman, Mariska] Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA; [Weijerman, Mariska; Leemans, Rik] Wageningen Univ, Environm Syst Anal Grp, NL-6700 AP Wageningen, Netherlands; [Weijerman, Mariska; Brainard, Russell E.] NOAA Fisheries, Pacific Isl Fisheries Sci Ctr, Honolulu, HI USA; [Fulton, Elizabeth A.; Gorton, Rebecca] CSIRO, Oceans & Atmosphere Flagship, Hobart, Tas, Australia; [Kaplan, Isaac C.] NOAA Fisheries, NW Fisheries Sci Ctr, Seattle, WA USA; [Mooij, Wolf M.] Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands; [Mooij, Wolf M.] Wageningen Univ, Aquat Ecol & Water Qual Management Grp, NL-6700 AP Wageningen, Netherlands	University of Hawaii System; University of Hawaii Manoa; Wageningen University & Research; National Oceanic Atmospheric Admin (NOAA) - USA; Commonwealth Scientific & Industrial Research Organisation (CSIRO); National Oceanic Atmospheric Admin (NOAA) - USA; Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research	Weijerman, M (corresponding author), Univ Hawaii Manoa, Joint Inst Marine & Atmospher Res, Honolulu, HI 96822 USA.	mariska.weijerman@noaa.gov	Mooij, Wolf M/C-2677-2008; Leemans, Rik/A-1548-2009; Fulton, Beth/AAJ-1398-2021; Fulton, Beth/A-2871-2008; KNAW, NIOO-KNAW/A-4320-2012	Mooij, Wolf M/0000-0001-5586-8200; Leemans, Rik/0000-0002-4001-6301; Fulton, Beth/0000-0002-5904-7917; Fulton, Beth/0000-0002-5904-7917; KNAW, NIOO-KNAW/0000-0002-3835-159X; Gorton, Rebecca/0000-0002-5290-3506	NOAA Coral Reef Conservation Program; NOAA Office of Habitat	NOAA Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); NOAA Office of Habitat	MW received funding from the NOAA Coral Reef Conservation Program (http://coralreef.noaa.gov/) and from NOAA Office of Habitat (http://www.habitat.noaa.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding was provided to MW by the NOAA Coral Reef Conservation Program and NOAA Office of Habitat. We would like to thank Ivor Williams, John Rooney, Jeff Polovina and anonymous reviewers for their improvements to the manuscript. The scientific results and conclusions, and any views or opinions expressed herein, are those of the authors and do not necessarily reflect those of NOAA or the Department of Commerce.	Aeby GS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016887; Ainsworth CH, 2008, ECOL MODEL, V214, P361, DOI 10.1016/j.ecolmodel.2008.02.039; Ainsworth CH, 2011, ICES J MAR SCI, V68, P1217, DOI 10.1093/icesjms/fsr043; Ainsworth CH, 2014, GLOBAL CHANGE BIOLOG; Ainsworth CH, 2011, ATLANTIS MODEL DEVEL; Alvarez-Filip L, 2009, P ROY SOC B-BIOL SCI, V276, P3019, DOI 10.1098/rspb.2009.0339; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Balmford A, 2005, ECOL LETT, V8, P1218, DOI 10.1111/j.1461-0248.2005.00814.x; Ban SS, 2014, GLOBAL CHANGE BIOL, V20, P681, DOI 10.1111/gcb.12453; Bascompte J, 2005, P NATL ACAD SCI USA, V102, P5443, DOI 10.1073/pnas.0501562102; Baskett ML, 2009, ECOL APPL, V19, P3, DOI 10.1890/08-0139.1; BELLWOOD DR, 1990, ENVIRON BIOL FISH, V28, P189, DOI 10.1007/BF00751035; Bellwood DR, 2011, PROCEEDINGS OF THE R; Brand E, 2007, NOAA TECHNICAL MEMOR; Carriger JF, 2013, COAST MANAGE, V41, P19, DOI 10.1080/08920753.2012.747814; Castruccio FS, 2013, J GEOPHYS RES-OCEANS, V118, P6123, DOI 10.1002/2013JC009196; Christensen V., 2008, LEN OCE FUTS PROJ, P235; Coker DJ, 2014, REV FISH BIOL FISHER, V24, P89, DOI 10.1007/s11160-013-9319-5; DeMartini EE, 2007, B MAR SCI, V81, P139; Edwards HJ, 2011, GLOBAL CHANGE BIOL, V17, P2033, DOI 10.1111/j.1365-2486.2010.02366.x; Enochs I, 2008, PROCEEDINGS 11TH INT; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Fulton EA, 2005, ICES J MAR SCI, V62, P540, DOI 10.1016/j.icesjms.2004.12.012; Fulton EA, 2007, ALTERNATIVE MANAGEME; Fulton EA, 2001, THE EFFECTS OF MODEL; Fulton EA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084242; Fulton EA, 2011, FISH FISH, V12, P171, DOI 10.1111/j.1467-2979.2011.00412.x; Fulton EA, 2010, J MARINE SYST, V81, P171, DOI 10.1016/j.jmarsys.2009.12.012; Fung T, 2009, LOCAL SCALE MODELS O; Gesch D., 2007, DIGITAL ELEVATION MO, P99; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; Green A.L., 2009, MONITORING FUNCTIONA; Griffith GP, 2012, CONSERV BIOL, V26, P1145, DOI 10.1111/j.1523-1739.2012.01937.x; Heenan A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079604; Hoeke RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018038; Hoey AS, 2011, ECOL LETT, V14, P267, DOI 10.1111/j.1461-0248.2010.01581.x; Horne P, 2010, TECHNICAL MEMO NMFS, P140; Hughes TP, 2010, TRENDS ECOL EVOL, V25, P633, DOI 10.1016/j.tree.2010.07.011; Jackson JBC, 2014, STATUS AND TRENDS OF; Jennings S, 1996, AMBIO, V25, P44; Kaplan IC, 2013, FISH FISH, V14, P515, DOI 10.1111/j.1467-2979.2012.00484.x; Kaplan IC, 2012, PROG OCEANOGR, V102, P5, DOI 10.1016/j.pocean.2012.03.009; Kaplan IC, 2010, CAN J FISH AQUAT SCI, V67, P1968, DOI 10.1139/F10-118; Kennedy EV, 2013, CURR BIOL, V23, P912, DOI 10.1016/j.cub.2013.04.020; Kirby RR, 2009, ECOSYSTEMS, V12, P548, DOI 10.1007/s10021-009-9241-9; Link JS, 2010, PROG OCEANOGR, V87, P214, DOI 10.1016/j.pocean.2010.09.020; Logan CA, 2014, GLOBAL CHANGE BIOL, V20, P125, DOI 10.1111/gcb.12390; Loh T-L, 2015, PEERJ PREPRINTS, P2167; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; McClanahan TR, 2007, MAR ECOL PROG SER, V337, P1, DOI 10.3354/meps337001; McClanahan TR, 2014, CURR OPIN ENV SUST, V7, P59, DOI 10.1016/j.cosust.2013.11.028; McClanahan TR, 2014, MAR ECOL PROG SER, V497, P13, DOI 10.3354/meps10605; Melbourne-Thomas J, 2011, ECOL SOC, V16, DOI 10.5751/ES-04208-160323; Mumby PJ, 2007, P NATL ACAD SCI USA, V104, P8362, DOI 10.1073/pnas.0702602104; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Mumby PJ, 2006, ECOL APPL, V16, P747, DOI 10.1890/1051-0761(2006)016[0747:TIOEGS]2.0.CO;2; Nystrom M, 2012, ECOSYSTEMS, V15, P695, DOI 10.1007/s10021-012-9530-6; Ortiz JC, 2014, NAT CLIM CHANGE, V4, P1090, DOI 10.1038/NCLIMATE2439; Paddack MJ, 2006, CORAL REEFS, V25, P461, DOI 10.1007/s00338-006-0112-y; Paddack MJ, 2009, CURR BIOL, V19, P590, DOI 10.1016/j.cub.2009.02.041; Paine RT, 1998, ECOSYSTEMS, V1, P535, DOI 10.1007/s100219900049; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Pequignet AC, 2011, CORAL REEFS, V30, P71, DOI 10.1007/s00338-011-0719-5; Plaganyi EE, 2007, FAO FISHERIES TECHNI, V477, P126; Principe P., 2012, QUANTIFYING CORAL RE; Riegl B, 2013, ECOL EVOL, V3, P1050, DOI 10.1002/ece3.519; Rowan R, 2004, NATURE, V430, P742, DOI 10.1038/430742a; Sebastian CR, 2013, ECOL MODEL, V263, P326, DOI 10.1016/j.ecolmodel.2013.05.012; Selig ER, 2012, GLOBAL CHANGE BIOL, V18, P1561, DOI 10.1111/j.1365-2486.2012.02658.x; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Stocker T. F., 2013, CONTRIBUTION OF WORK; Storlazzi CD, 2014, 20141130 US GEOL SUR, DOI [10.3133/ofr20141130, DOI 10.3133/OFR20141130:]; Stow CA, 2009, J MARINE SYST, V76, P4, DOI 10.1016/j.jmarsys.2008.03.011; Thompson AA, 2010, CORAL REEFS, V29, P637, DOI 10.1007/s00338-009-0562-0; Travers M, 2007, PROG OCEANOGR, V75, P751, DOI 10.1016/j.pocean.2007.08.001; Vetter O, 2010, JOURNAL OF GEOPHYSIC, V115; Wang X, 2008, BIOGEOSCIENCES, V5, P3869; Weijerman M, 2014, NOAA TECH MEMO NOAA; Weijerman M, FISHERIES BULLETIN I; Weijerman M, 2015, PROGRESS IN OCEANOGR; Weijerman M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063797; Williams GJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2013.3069; Williams I, 2011, NOAA TECH MEMO NOAA; Williams ID, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120516; Wilson SK, 2006, GLOBAL CHANGE BIOL, V12, P2220, DOI 10.1111/j.1365-2486.2006.01252.x; Wolanski E, 2004, J MARINE SYST, V46, P133, DOI 10.1016/j.jmarsys.2003.11.018; Yee SH, 2014, ECOLOGICAL EC	87	30	30	1	106	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144165	10.1371/journal.pone.0144165	http://dx.doi.org/10.1371/journal.pone.0144165			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26672983	gold, Green Submitted, Green Published			2022-12-26	WOS:000366722700026
J	About, F; Oudot-Mellakh, T; Niay, J; Rabiega, P; Pedergnana, V; Duffy, D; Sultanik, P; Cagnot, C; Carrat, F; Marcellin, P; Zoulim, F; Larrey, D; Hezode, C; Fontaine, H; Bronowicki, JP; Pol, S; Albert, ML; Theodorou, I; Cobat, A; Abel, L				About, Fredegonde; Oudot-Mellakh, Tiphaine; Niay, Jonathan; Rabiega, Pascaline; Pedergnana, Vincent; Duffy, Darragh; Sultanik, Philippe; Cagnot, Carole; Carrat, Fabrice; Marcellin, Patrick; Zoulim, Fabien; Larrey, Dominique; Hezode, Christophe; Fontaine, Helene; Bronowicki, Jean-Pierre; Pol, Stanislas; Albert, Matthew L.; Theodorou, Ioannis; Cobat, Aurelie; Abel, Laurent		ANRS CO20-CUPIC Study Grp	Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study	PLOS ONE			English	Article							HEPATITIS-C VIRUS; INDUCED HEMOLYTIC-ANEMIA; GENOTYPE 1 INFECTION; GENETIC-VARIATION; PLUS RIBAVIRIN; DOSE REDUCTION; TELAPREVIR; VARIANTS; BOCEPREVIR; PROTECT	Background Human genetic factors influence the outcome of pegylated interferon and ribavirin hepatitis C therapy. We explored the role of IL28B, APOH and ITPA SNPs on the outcomes of triple therapy including telaprevir or boceprevir in patients with compensated cirrhosis chronically infected with HCV-1. Patients and Methods A total of 256 HCV-1 Caucasian treatment-experienced patients with compensated cirrhosis from the ANRS CO20-CUPIC cohort were genotyped for a total of 10 candidate SNPs in IL28B (rs12979860 and rs368234815), APOH (rs8178822, rs12944940, rs10048158, rs52797880, rs1801689 and rs1801690) and ITPA (rs1127354 and rs7270101). We tested the association of IL28B and APOH SNPs with sustained virological response and of ITPA SNPs with anemia related phenotypes by means of logistic regression assuming an additive genetic model. Results None of the six APOH SNPs were associated with sustained virological response. The favorable alleles of the IL28B SNPs rs12979860 and rs368234815 were associated with sustained virological response (rs12979860: OR = 2.35[1.50-3.70], P = 2x10(-4)). Refined analysis showed that the effect of IL28B SNPs on sustained virological response was restricted to prior PegIFN/RBV relapse (OR = 3.80[1.82-8.92], P = 8x10(-4)). We also confirmed the association between ITPA low activity alleles and protection against early hemoglobin decline in triple therapy (P = 2x10(-5)). Conclusion Our results suggest that the screening of rs12979860 may remain interesting for decision making in prior relapse HCV-1 Caucasian patients with compensated cirrhosis eligible for a telaprevir-or boceprevir-based therapy.	[About, Fredegonde; Pedergnana, Vincent; Cobat, Aurelie] Inst Natl Sante & Rech Med INSERM U1163, Necker Branch, Lab Human Genet Infect Dis, Paris, France; [About, Fredegonde; Pedergnana, Vincent; Cobat, Aurelie; Abel, Laurent] Paris Descartes Univ, Imagine Inst, Paris, France; [Oudot-Mellakh, Tiphaine; Niay, Jonathan; Theodorou, Ioannis] INSERM U1135, Grp Hosp Pitie Salpetriere, AP HP, Ctr Immunol & Malad Infectieuses Paris CIMI,Lab I, Paris, France; [Oudot-Mellakh, Tiphaine; Niay, Jonathan] Univ Paris 06, Grp Hosp Pitie Salpetriere, AP HP, Plateforme Genom Inserm ANRS, Paris, France; [Rabiega, Pascaline; Carrat, Fabrice] Univ Paris 06, INSERM, Univ Sorbonne, Inst Pierre Louis Epidemiol & Sante Publ IPLESP U, Paris, France; [Pedergnana, Vincent] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Duffy, Darragh; Albert, Matthew L.] Inst Pasteur, Dept Immunol, Ctr Human Immunol, F-75724 Paris, France; [Duffy, Darragh; Albert, Matthew L.] INSERM, U818, Inst Pasteur, Dept Immunol,Lab Dendrit Cell, Paris, France; [Sultanik, Philippe; Fontaine, Helene] Univ Paris 05, Hop Cochin, AP HP, Dept Hepatol, Paris, France; [Sultanik, Philippe; Fontaine, Helene; Pol, Stanislas; Albert, Matthew L.] INSERM, UMS20, Inst Pasteur, Paris, France; [Cagnot, Carole] Inserm ANRS France Rech Nord & Sud Sida HIV Hepat, Unit Basic & Clin Res Viral Hepatitis, Paris, France; [Carrat, Fabrice] Hop St Antoine, AP HP, Serv Sante Publ, F-75571 Paris, France; [Marcellin, Patrick] Hop Beaujon, Serv Hepatol, Clichy, France; [Zoulim, Fabien] CNRS 5286, INSERM, UMR 11052, CRCL, Lyon 03, France; [Zoulim, Fabien] Univ Lyon 1, F-69622 Villeurbanne, France; [Zoulim, Fabien] Hop Croix Rousse, Serv Hepatol & Gastroenterol, Hosp Civils Lyon, F-69317 Lyon, France; [Larrey, Dominique] CHU St Eloi Hosp, Liver Unit, Montpellier, France; [Hezode, Christophe] UPEC, Hop Henri Mondor, AP HP, Dept Gastroenterol & Hepatol, Creteil, France; [Hezode, Christophe] UPEC, INSERM U955, IMRB, Creteil, France; [Bronowicki, Jean-Pierre] Univ Lorraine, CHU Nancy, INSERM U954, Dept Hepatogastroenterol, Vandoeuvre Les Nancy, France; [Abel, Laurent] Rockefeller Univ, Rockefeller Branch, St Giles Lab Human Genet Infect Dis, New York, NY 10021 USA	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Oxford; Wellcome Centre for Human Genetics; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Leon Berard; Centre de Recherche en cancerologie (CRCL); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Universite de Montpellier; CHU de Montpellier; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); CHU de Nancy; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; Rockefeller University	Cobat, A (corresponding author), Inst Natl Sante & Rech Med INSERM U1163, Necker Branch, Lab Human Genet Infect Dis, Paris, France.	aurelie.cobat@inserm.fr; laurent.abel@inserm.fr	Hezode, Christophe/U-4659-2018; Abel, Laurent/H-8888-2017; Cobat, Aurélie/H-4722-2017; Carrat, Fabrice/AAU-8480-2020; Zoulim, Fabien/ABD-5594-2021; Dubuisson, Jean/E-6813-2016	Abel, Laurent/0000-0001-7016-6493; Cobat, Aurélie/0000-0001-7209-6257; Carrat, Fabrice/0000-0002-8672-7918; Zoulim, Fabien/0000-0002-2245-0083; Pedergnana, Vincent/0000-0002-7852-5339; Paradis, Valerie/0000-0003-3142-3762; Pawlotsky, Jean-Michel/0000-0003-0745-7559; Albert, TRAN/0000-0003-0003-5361; cyrille, feray/0000-0002-8627-9676; rosa, isabelle/0000-0001-6879-3148; Dubuisson, Jean/0000-0003-1626-7693; Bedossa, Pierre/0000-0002-8487-7322; Cacoub, Patrice/0000-0002-6727-4992; Cales, Paul/0000-0003-4866-5274; Di Martino, Vincent/0000-0002-2022-690X; , Poynard/0000-0002-3726-7230; About, Fredegonde/0000-0002-3561-8041	INSERM-ANRS (France REcherche Nord & sud Sida-HIV Hepatites-FRENSH) [2010-A01273-36]; Institut National de la Sante et de la Recherche Medicale (INSERM); University Paris Descartes; French National Research Agency (ANR) under the "Investments for the future" program [ANR-10-IAHU-01]; Association Francaise pour l'Etude du Foie (AFEF); Fondation pour la Recherche Medicale (FRM) [FDM20140630671]	INSERM-ANRS (France REcherche Nord & sud Sida-HIV Hepatites-FRENSH)(French National Research Agency (ANR)); Institut National de la Sante et de la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); University Paris Descartes; French National Research Agency (ANR) under the "Investments for the future" program(French National Research Agency (ANR)); Association Francaise pour l'Etude du Foie (AFEF); Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale)	This work was supported by INSERM-ANRS (France REcherche Nord & sud Sida-HIV Hepatites-FRENSH, Grant no 2010-A01273-36, http://www.anrs.fr), Institut National de la Sante et de la Recherche Medicale (INSERM, http://www.inserm.fr), University Paris Descartes (http://www.parisdescartes.fr), the French National Research Agency (ANR, http://www.agence-nationale-recherche.fr) under the "Investments for the future" program (grant noANR-10-IAHU-01), and in part by the Association Francaise pour l'Etude du Foie (AFEF, http://www.afef.asso.fr). FA is the recipient of a fellowship from Fondation pour la Recherche Medicale (FRM, Grant no FDM20140630671, http://www.frm.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghemo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095881; Ahmed WH, 2013, WORLD J GASTROENTERO, V19, P1387, DOI 10.3748/wjg.v19.i9.1387; Akuta N, 2013, J CLIN MICROBIOL, V51, P2862, DOI 10.1128/JCM.01129-13; Athanasiadis G, 2013, J THROMB HAEMOST, V11, P521, DOI 10.1111/jth.12120; Bacon BR, 2011, NEW ENGL J MED, V364, P1207, DOI 10.1056/NEJMoa1009482; Casanova JL, 2013, ANNU REV GENOM HUM G, V14, P215, DOI 10.1146/annurev-genom-091212-153448; CASSADER M, 1994, ATHEROSCLEROSIS, V110, P45, DOI 10.1016/0021-9150(94)90066-3; Chayama K, 2011, J INFECT DIS, V204, P84, DOI 10.1093/infdis/jir210; Clark PJ, 2013, J VIRAL HEPATITIS, V20, P858, DOI 10.1111/jvh.12113; Eskesen AN, 2012, EUR J GASTROEN HEPAT, V24, P890, DOI 10.1097/MEG.0b013e3283546efd; Fellay J, 2010, NATURE, V464, P405, DOI 10.1038/nature08825; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Hezode C, 2014, GASTROENTEROLOGY, V147, P132, DOI 10.1053/j.gastro.2014.03.051; Hezode C, 2013, J HEPATOL, V59, P434, DOI 10.1016/j.jhep.2013.04.035; Holmes JA, 2012, J VIRAL HEPATITIS, V19, P677, DOI 10.1111/jvh.12003; Jacobson IM, 2011, J HEPATOL, V54, pS542, DOI 10.1016/S0168-8278(11)61371-8; Leduc MS, 2008, J LIPID RES, V49, P2648, DOI 10.1194/jlr.M800155-JLR200; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Mehdi H, 1999, HUM GENET, V105, P63, DOI 10.1007/s004390051065; Mehdi H, 2003, EUR J BIOCHEM, V270, P230, DOI 10.1046/j.1432-1033.2003.03379.x; Pol S, 2013, J HEPATOL, V58, P883, DOI 10.1016/j.jhep.2012.12.023; Poordad F, 2012, GASTROENTEROLOGY, V143, P608, DOI 10.1053/j.gastro.2012.05.011; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Rau M, 2013, J HEPATOL, V58, P669, DOI 10.1016/j.jhep.2012.11.027; Shimada N, 2014, HEPATOL RES OFF 0310; Shipkova M, 2006, CLIN CHEM, V52, P240, DOI 10.1373/clinchem.2005.059501; Sterling RK, 2015, ALIMENT PHARM THER, V41, P671, DOI 10.1111/apt.13095; Sultanik P, 2015, LIVER INT; Suresh S, 2009, J RHEUMATOL, V36, P315, DOI 10.3899/jrheum.080482; Suzuki F, 2011, HEPATOLOGY, V53, P415, DOI 10.1002/hep.24058; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P1181, DOI 10.1053/j.gastro.2010.06.016; Tsubota A, 2014, J GASTROEN HEPATOL, V29, P144, DOI 10.1111/jgh.12402; Zeuzem S, 2014, NEW ENGL J MED, V370, P1604, DOI 10.1056/NEJMoa1401561; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	36	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145105	10.1371/journal.pone.0145105	http://dx.doi.org/10.1371/journal.pone.0145105			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670100	Green Submitted, gold, Green Published			2022-12-26	WOS:000366719300048
J	Kawano, S; Kakehashi, M				Kawano, Shoko; Kakehashi, Masayuki			Substantial Impact of School Closure on the Transmission Dynamics during the Pandemic Flu H1N1-2009 in Oita, Japan	PLOS ONE			English	Article							ABSOLUTE-HUMIDITY; INFLUENZA; INTERVENTIONS; SURVIVAL	Background School closure is considered as an effective measure to prevent pandemic influenza. Although Japan has implemented many class, grade, and whole school closures during the early stage of the pandemic 2009, the effectiveness of such a school closure has not been analysed appropriately. In addition, analysis based on evidence or data from a large population has yet to be performed. We evaluated the preventive effect of school closure against the pandemic (H1N1) 2009 and examined efficient strategies of reactive school closure. Materials and Methods Data included daily reports of reactive school closures and the number of infected students in the pandemic in Oita City, Japan. We used a regression model that incorporated a time delay to analyse the daily data of school closure based on a time continuous susceptible-exposed- infected-removed model of infectious disease spread. The delay was due to the time-lag from transmission to case reporting. We simulated the number of students infected daily with and without school closure and evaluated the effectiveness. Results The model with a 3-day delay from transmission to reporting yielded the best fit using R-2 (the coefficient of determination). This result suggests that the recommended period of school closure is more than 4 days. Moreover, the effect of school closure in the simulation of school closure showed the following: the number of infected students decreased by about 24% at its peak, and the number of cumulative infected students decreased by about 8.0%. Conclusions School closure was an effective intervention for mitigating the spread of influenza and should be implemented for more than 4 days. School closure has a remarkable impact on decreasing the number of infected students at the peak, but it does not substantially decrease the total number of infected students.	[Kawano, Shoko] Hiroshima Univ, Grad Sch Hlth Sci, Hiroshima, Japan; [Kakehashi, Masayuki] Hiroshima Univ, Inst Biomed & Hlth Sci, Hiroshima, Japan	Hiroshima University; Hiroshima University	Kawano, S (corresponding author), Hiroshima Univ, Grad Sch Hlth Sci, Hiroshima, Japan.	kawanoshoko@hiroshima-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [23390133]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid for Scientific Research "Scientific Research (B) (General)" of the Ministry of Education, Culture, Sports, Science and Technology, Japan (grant 23390133) https://www.jsps.go.jp/j-grantsinaid/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], INFECT AGENTS SURVEI; Bell D, 2006, EMERG INFECT DIS, V12, P88; Cabinet Secretariat, NAT ACT PLAN PAND IN; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; Centers for Disease Control and Prevention, 2009, H1N1 OV PAND; Earn DJD, 2012, ANN INTERN MED, V156, P173, DOI 10.7326/0003-4819-156-3-201202070-00005; Eda Kunio, 2012, Kansenshogaku Zasshi, V86, P274; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Halder N, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-221; HARPER GJ, 1961, J HYG-CAMBRIDGE, V59, P479, DOI 10.1017/S0022172400039176; Hasui M, 2012, J AMBULATORY GEN PED, V15, P13; He DH, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1345; Infectious Disease Surveillance Center, INC INFL ILLN NUMB A; Jackson C, 2011, EMERG INFECT DIS, V17, P245, DOI 10.3201/eid1702.100458; Kawaguchi R, 2009, EMERG INFECT DIS, V15, P1685, DOI 10.3201/eid1510.091029; Markel H, 2007, JAMA-J AM MED ASSOC, V298, P644, DOI 10.1001/jama.298.6.644; Miller JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010425; Milne GJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004005; Ministry of Education Culture Sports Science and Technology, 2009, CURR SIT EACH PREF P; Ministry of Health Labour and Welfare, 2009, GUID SCH CLOS BAS ID; Ministry of Health Labour and Welfare, IMPL BAS MEAS PAND F; Morimoto Tomoko, 2010, Environmental Health and Preventive Medicine, V15, P151, DOI 10.1007/s12199-009-0122-9; Neuzil KM, 2002, ARCH PEDIAT ADOL MED, V156, P986, DOI 10.1001/archpedi.156.10.986; Nishiura H, 2009, EUROSURVEILLANCE, V14; Shaman J, 2011, AM J EPIDEMIOL, V173, P127, DOI 10.1093/aje/kwq347; Shaman J, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000316; Shaman J, 2009, P NATL ACAD SCI USA, V106, P3243, DOI 10.1073/pnas.0806852106; Shiino T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011057; Shimizu N, 2012, NIHON KANSENKANKYO G, V27, P96; Shoji M, 1985, J TUBERCULOSIS LEPRO, V37, P327; Shoji M, 2009, JPN J CLIN EXP MED, V86, P1517; Shoji M, 1988, J TUBERCULOSIS LEPRO, V40, P95; Shoji M, 2011, TOHOKU J EXP MED, V224, P251, DOI 10.1620/tjem.224.251; Statistics Japan, CENS 2009; Sugisaki K, 2008, J JPN PEDIAT SOC, V112, P696; Sugisaki K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074716; Sugiura H, 2010, JAPANESE J SCH HLTH, V52, P214; Vynnycky E, 2008, EPIDEMIOL INFECT, V136, P166, DOI 10.1017/S0950268807008369; World Health Organization, MEAS SCH STT; Yamamoto S, 2012, J HLTH WELFARE STAT, V59, P9	41	24	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144839	10.1371/journal.pone.0144839	http://dx.doi.org/10.1371/journal.pone.0144839			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26669757	Green Submitted, Green Published, gold			2022-12-26	WOS:000366719300025
J	Moon, HG; Kim, N; Jeong, S; Lee, M; Moon, H; Kim, J; Yoo, TK; Lee, HB; Kim, J; Noh, DY; Han, W				Moon, Hyeong-Gon; Kim, Namshin; Jeong, Seongmun; Lee, Minju; Moon, HyunHye; Kim, Jongjin; Yoo, Tae-Kyung; Lee, Han-Byoel; Kim, Jisun; Noh, Dong-Young; Han, Wonshik			The Clinical Significance and Molecular Features of the Spatial Tumor Shapes in Breast Cancers	PLOS ONE			English	Article							METASTASIS; SUBTYPES; MORPHOLOGY; INTERFACE; INVASION; SIZE	Each breast cancer has its unique spatial shape, but the clinical importance and the underlying mechanism for the three-dimensional tumor shapes are mostly unknown. We collected the data on the three-dimensional tumor size and tumor volume data of invasive breast cancers from 2,250 patients who underwent surgery between Jan 2000 and Jul 2007. The degree of tumor eccentricity was estimated by using the difference between the spheroid tumor volume and ellipsoid tumor volume (spheroid-ellipsoid discrepancy, SED). In 41 patients, transcriptome and exome sequencing data obtained. Estimation of more accurate tumor burden by calculating ellipsoid tumor volumes did not improve the outcome prediction when compared to the traditional longest diameter measurement. However, the spatial tumor eccentricity, which was measured by SED, showed significant variation between the molecular subtypes of breast cancer. Additionally, the degree of tumor eccentricity was associated with well-known prognostic factors of breast cancer such as tumor size and lymph node metastasis. Transcriptome data from 41 patients showed significant association between MMP13 and spatial tumor shapes. Network analysis and analysis of TCGA gene expression data suggest that MMP13 is regulated by ERBB2 and S100A7A. The present study validates the usefulness of the current tumor size method in determining tumor stages. Furthermore, we show that the tumors with high eccentricity are more likely to have aggressive tumor characteristics. Genes involved in the extracellular matrix remodeling can be candidate regulators of the spatial tumor shapes in breast cancer.	[Moon, Hyeong-Gon; Kim, Jongjin; Yoo, Tae-Kyung; Lee, Han-Byoel; Kim, Jisun; Noh, Dong-Young; Han, Wonshik] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea; [Moon, Hyeong-Gon; Lee, Minju; Moon, HyunHye; Kim, Jongjin; Yoo, Tae-Kyung; Lee, Han-Byoel; Kim, Jisun; Noh, Dong-Young; Han, Wonshik] Seoul Natl Univ, Coll Med, Canc Res Inst, Lab Breast Canc Biol, Seoul, South Korea; [Moon, Hyeong-Gon; Moon, HyunHye; Han, Wonshik] Seoul Natl Univ, Coll Med, Genome Med Inst, Seoul, South Korea; [Kim, Namshin; Jeong, Seongmun] Korea Res Inst Biosci & Biotechnol, Genome Inst, Epigen Res Ctr, Daejeon, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Han, W (corresponding author), Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea.	hanw@snu.ac.kr	Kim, Namshin/Q-6491-2017; Han, Wonshik/B-3699-2008	Kim, Namshin/0000-0001-6361-274X; Han, Wonshik/0000-0001-7310-0764; Jeong, Seongmun/0000-0002-0038-461X; Moon, Hyeong-Gon/0000-0002-9981-0286; KIM, JISUN/0000-0002-4884-6107	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2012R1A1A2005929, 2015R1D1A1A02061904]; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea [A1220200]; grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C3405, HI14C1277]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea; grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This study was supported by (MHG) Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2012R1A1A2005929 and 2015R1D1A1A02061904), by the grant from the National R&D Program for Cancer Control, Ministry for Health and Welfare, Republic of Korea (A1220200); (WH) the grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI14C3405); (DYN) the grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI14C1277).	Anderson ARA, 2006, CELL, V127, P905, DOI 10.1016/j.cell.2006.09.042; Bae MS, 2015, ACTA RADIOL, V56, P269, DOI 10.1177/0284185114524197; Bao L, 2014, BIOINFORMATICS; Bearer EL, 2009, CANCER RES, V69, P4493, DOI 10.1158/0008-5472.CAN-08-3834; CARTER CL, 1989, CANCER-AM CANCER SOC, V63, P181, DOI 10.1002/1097-0142(19890101)63:1<181::AID-CNCR2820630129>3.0.CO;2-H; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen MK, 2004, CANCER-AM CANCER SOC, V100, P2160, DOI 10.1002/cncr.20210; Harari D, 2000, ONCOGENE, V19, P6102, DOI 10.1038/sj.onc.1203973; Ichikawa Y, 2014, ONCOL LETT, V8, P977, DOI 10.3892/ol.2014.2271; Jiang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058329; Kim J, 2015, GENE CHROMOSOME CANC, V54, P681, DOI 10.1002/gcc.22279; Miller CA, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003665; Moon HG, 2013, ANN ONCOL, V24, P2298, DOI 10.1093/annonc/mdt187; Moon HG, 2009, J CLIN ONCOL, V27, P5899, DOI 10.1200/JCO.2009.22.4436; MORRISON SD, 1983, J NATL CANCER I, V71, P407; Nannuru KC, 2010, CANCER RES, V70, P3494, DOI 10.1158/0008-5472.CAN-09-3251; Nasser MW, 2015, CANCER RES, V75, P974, DOI 10.1158/0008-5472.CAN-14-2161; Nikitin A, 2003, BIOINFORMATICS, V19, P2155, DOI 10.1093/bioinformatics/btg290; Perry SW, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-411; Salz T, 2015, MOL CANCER RES, V13, P461, DOI 10.1158/1541-7786.MCR-14-0389; Singletary SE, 2006, CA-CANCER J CLIN, V56, P37, DOI 10.3322/canjclin.56.1.37; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Szabo A, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00087; Thompson EW, 2005, CANCER RES, V65, P5991, DOI 10.1158/0008-5472.CAN-05-0616; Uematsu T, 2009, RADIOLOGY, V250, P638, DOI 10.1148/radiol.2503081054; Vizoso FJ, 2007, BRIT J CANCER, V96, P903, DOI 10.1038/sj.bjc.6603666; Wapnir IL, 1996, BREAST CANCER RES TR, V41, P15, DOI 10.1007/BF01807032; Wolf R, 2009, CANCER LETT, V277, P101, DOI 10.1016/j.canlet.2008.11.032; Yeo EJ, 2014, CANCER RES, V74, P2962, DOI 10.1158/0008-5472.CAN-13-2421	29	15	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0143811	10.1371/journal.pone.0143811	http://dx.doi.org/10.1371/journal.pone.0143811			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26669540	Green Published, gold			2022-12-26	WOS:000366719300003
J	Sorrentino, D; Marino, M; Dassopoulos, T; Zarifi, D; Del Bianco, T				Sorrentino, Dario; Marino, Marco; Dassopoulos, Themistocles; Zarifi, Dimitra; Del Bianco, Tiziana			Low Dose Infliximab for Prevention of Postoperative Recurrence of Crohn's Disease: Long Term Follow-Up and Impact of Infliximab Trough Levels and Antibodies to Infliximab	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; THERAPY; MAINTENANCE; SERUM; REMISSION; OUTCOMES; COHORT; AGENTS	Objective In patients with postoperative recurrence of Crohn's disease endoscopic and clinical remission can be maintained for up to 1 year with low infliximab doses (3 mg/Kg). However, in theory low-dose infliximab treated patients could develop subtherapeutic trough levels, infiximab antibodies, and might loose response to therapy. To verify this hypothesis infliximab pharmacokinetics and clinical/endoscopic response were checked in a group of patients treated in the long term with low infliximab doses. Design Infliximab antibodies, infliximab levels, highly-sensitive CRP and fecal calprotectin were measured during the 8-week interval in 5 consecutive patients in clinical (Crohn's Disease Activity Index < 150) and endoscopic (Rutgeerts scores 0-1) remission after one year of therapy with infliximab 3 mg/Kg. For comparison with reported standards, infliximab pharmacokinetics and inflammatory parameters were also tested in 6 Crohn's disease patients who did not undergo surgery and who were in clinical remission while on infliximab 5 mg/Kg. Patients on low infliximab dose also underwent colonoscopy after 18 additional months of therapy. Results Highly sensitive CRP and fecal calprotectin increased in all patients during the 8-week interval. Infliximab trough levels were lower in patients treated with the low dose compared to controls (mean +/- SE: 2.0 +/- 0.3 vs 4.75 +/- 0.83 mu g/mL respectively p<0.05). Infliximab antibodies were present in two of the subjects treated with low infliximab dose and in none of the controls. However, in low dose-treated patients after 18 additional months of therapy endoscopy continued to show mucosal remission and none of them developed clinical recurrence or side effects. Conclusions Patients treated with low infliximab doses had lower trough levels compared to patients treated with 5 mg/Kg and some developed antibodies to infliximab. However, low infliximab doses sustained clinical and endoscopic remission for a total of 30 months of treatment.	[Sorrentino, Dario] Virginia Tech, Caril Sch Med, Div Gastroenterol, IBD Ctr, Roanoke, VA USA; [Sorrentino, Dario; Marino, Marco; Zarifi, Dimitra; Del Bianco, Tiziana] Univ Udine, Sch Med, Dept Clin & Expt Med Sci, I-33100 Udine, Italy; [Dassopoulos, Themistocles] Baylor Univ, Med Ctr, Baylor Ctr IBD, Dallas, TX USA	Virginia Polytechnic Institute & State University; University of Udine; Baylor University; Baylor University Medical Center	Sorrentino, D (corresponding author), Virginia Tech, Caril Sch Med, Div Gastroenterol, IBD Ctr, Roanoke, VA USA.	drsorrentino@carilionclinic.org	Sorrentino, Dario/K-7253-2019					BEST WR, 1976, GASTROENTEROLOGY, V70, P439; Cassinotti A, 2009, INFLAMM BOWEL DIS, V15, P1264, DOI 10.1002/ibd.20899; Casteele NV, 2015, GUT, V64, P1539, DOI 10.1136/gutjnl-2014-307883; Hanauer SB, 2007, GUT, V56, P1181, DOI 10.1136/gut.2006.115980; Hashash JG, 2013, EXPERT REV GASTROENT, V7, P501, DOI 10.1586/17474124.2013.814933; Imaeda H, 2014, J GASTROENTEROL, V49, P674, DOI 10.1007/s00535-013-0829-7; Levesque BG, 2014, ALIMENT PHARM THER, V39, P1126, DOI 10.1111/apt.12733; Louis E, 2012, GASTROENTEROLOGY, V142, P63, DOI 10.1053/j.gastro.2011.09.034; Lowenberg M, 2014, GASTROENTEROLOGY, V146, pS450; Nanda KS, 2013, AM J GASTROENTEROL, V108, P40, DOI 10.1038/ajg.2012.363; O'Meara S, 2014, INFLAMM BOWEL DIS, V20, P1, DOI 10.1097/01.MIB.0000436951.80898.6d; Ordas I, 2012, CLIN GASTROENTEROL H, V10, P1079, DOI 10.1016/j.cgh.2012.06.032; Peyrin-Biroulet L, 2012, INFLAMM BOWEL DIS, V18, P2201, DOI 10.1002/ibd.23016; Pittet V, 2013, J CROHNS COLITIS, V7, P820, DOI 10.1016/j.crohns.2013.04.013; Regueiro M, 2014, CLIN GASTROENTEROL H, V12, P1494, DOI 10.1016/j.cgh.2013.12.035; RUTGEERTS P, 1984, GUT, V25, P665, DOI 10.1136/gut.25.6.665; Smart C, 2014, EXPERT REV PHARM OUT, V14, P589, DOI 10.1586/14737167.2014.950235; Sorrentino D, 2014, INFLAMM BOWEL DIS, V20, P757, DOI 10.1097/01.MIB.0000442680.47427.bf; Sorrentino D, 2013, NAT REV GASTRO HEPAT, V10, P413, DOI 10.1038/nrgastro.2013.69; Sorrentino D, 2010, CLIN GASTROENTEROL H, V8, P591, DOI 10.1016/j.cgh.2010.01.016; Steenholdt C, 2014, AM J GASTROENTEROL, V109, P1055, DOI 10.1038/ajg.2014.106; Steenholdt C, 2014, GUT, V63, P919, DOI 10.1136/gutjnl-2013-305279; Vande Casteele N, 2013, AM J GASTROENTEROL, V108, P962, DOI 10.1038/ajg.2013.12; Vaughn BP, 2014, INFLAMM BOWEL DIS, V20, P1996, DOI 10.1097/MIB.0000000000000156; Wang SL, 2012, J IMMUNOL METHODS, V382, P177, DOI 10.1016/j.jim.2012.06.002; Waugh AWG, 2010, ALIMENT PHARM THER, V32, P1129, DOI 10.1111/j.1365-2036.2010.04446.x	26	19	20	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144900	10.1371/journal.pone.0144900	http://dx.doi.org/10.1371/journal.pone.0144900			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670274	Green Published, gold, Green Submitted			2022-12-26	WOS:000366719300029
J	Schmid, F; Wang, Q; Huska, MR; Andrade-Navarro, MA; Lemm, M; Fichtner, I; Dahlmann, M; Kobelt, D; Walther, W; Smith, J; Schlag, PM; Stein, U				Schmid, F.; Wang, Q.; Huska, M. R.; Andrade-Navarro, M. A.; Lemm, M.; Fichtner, I.; Dahlmann, M.; Kobelt, D.; Walther, W.; Smith, J.; Schlag, P. M.; Stein, U.			SPON2, a newly identified target gene of MACC1, drives colorectal cancer metastasis in mice and is prognostic for colorectal cancer patient survival	ONCOGENE			English	Article							EXTRACELLULAR-MATRIX PROTEIN; EXPRESSION ANALYSIS; MET; SPONDIN-2; MARKER; HGF	MACC1 (metastasis associated in colon cancer 1) is a prognostic biomarker for tumor progression, metastasis and survival of a variety of solid cancers including colorectal cancer (CRC). Here we aimed to identify the MACC1-induced transcriptome and key players mediating the MACC1-induced effects in CRC. We performed microarray analyses using CRC cells ectopically overexpressing MACC1. We identified more than 1300 genes at least twofold differentially expressed, including the gene SPON2 (Spondin 2) as 90-fold upregulated transcriptional target of MACC1. MACC1-dependent SPON2 expression regulation was validated on mRNA and protein levels in MACC1 high (endogenously or ectopically) and low (endogenously or by knockdown) expressing cells. Chromatin immunoprecipitation analysis demonstrated the binding of MACC1 to the gene promoter of SPON2. In cell culture, ectopic SPON2 overexpression induced cell viability, migration, invasion and colony formation in endogenously MACC1 and SPON2 low expressing cells, whereas SPON2 knockdown reduced proliferative, migratory and invasive abilities in CRC cells with high endogenous MACC1 and SPON2 expression. In intrasplenically transplanted NOD/SCID mice, metastasis induction was analyzed with control or SPON2-overexpressing CRC cells. Tumors with SPON2 overexpression induced liver metastasis (vs control animals without any metastases, P = 0.0036). In CRC patients, SPON2 expression was determined in primary tumors (stages I-III), and survival time was analyzed by Kaplan-Meier method. CRC patients with high SPON2 expressing primary tumors demonstrated 8 months shorter metastasis-free survival (MFS) compared with patients with low SPON2 levels (P = 0.053). Combining high levels of SPON2 and MACC1 improved the identification of high-risk patients with a 20-month shorter MFS vs patients with low biomarker expression. In summary, SPON2 is a transcriptional target of the metastasis gene MACC1. SPON2 induces cell motility in vitro and CRC metastasis in mice. In patients, SPON2 serves as prognostic indicator for CRC metastasis and survival, and might represent a promising target for therapeutic approaches.	[Schmid, F.; Wang, Q.; Dahlmann, M.; Kobelt, D.; Walther, W.; Smith, J.; Stein, U.] Charite, Expt & Clin Res Ctr, Robert Rossle Str 10, D-13125 Berlin, Germany; [Schmid, F.; Wang, Q.; Huska, M. R.; Andrade-Navarro, M. A.; Lemm, M.; Fichtner, I.; Dahlmann, M.; Kobelt, D.; Walther, W.; Smith, J.; Stein, U.] Helmholtz Assoc, Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany; [Schlag, P. M.] Charite Comprehens Canc Ctr, Berlin, Germany; [Stein, U.] German Canc Consortium DKTK, Heidelberg, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; German Cancer Research Center (DKFZ)	Stein, U (corresponding author), Charite, Expt & Clin Res Ctr, Robert Rossle Str 10, D-13125 Berlin, Germany.; Stein, U (corresponding author), Helmholtz Assoc, Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	ustein@mdc-berlin.de		Stein, Ulrike/0000-0001-7006-282X; Dahlmann, Mathias/0000-0002-0036-5283; Huska, Matthew/0000-0002-0912-745X; Walther, Wolfgang/0000-0003-2360-1370	German Cancer Consortium (DKTK)	German Cancer Consortium (DKTK)	We are thankful to Wolfgang Kemmner and his laboratory for the help with the microarray experiments. We thank Maria Stecklum and Nadine Basler for support with the in vivo bioluminescence imaging, and Jutta Aumann for assistance on expression analyses. We thank Manisha Juneja and Katharina Ilm for help with the combinatorial biomarker analysis in the CRC patients. We are grateful to Markus Niederstrasser for statistical advice. This work was supported by the German Cancer Consortium (DKTK).	Anderson GL, 2010, JNCI-J NATL CANCER I, V102, P26, DOI 10.1093/jnci/djp438; Arlt F, 2009, INT J BIOCHEM CELL B, V41, P2356, DOI 10.1016/j.biocel.2009.08.001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burock S, 2015, WORLD J GASTROENTERO, V21, P333, DOI 10.3748/wjg.v21.i1.333; Carvalho B, 2012, CELL ONCOL, V35, P53, DOI 10.1007/s13402-011-0065-1; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Edwards S, 2005, BRIT J CANCER, V92, P376, DOI 10.1038/sj.bjc.6602261; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Galimi F, 2011, CLIN CANCER RES, V17, P3146, DOI 10.1158/1078-0432.CCR-10-3377; Gao CF, 2005, CELL RES, V15, P49, DOI 10.1038/sj.cr.7290264; Gherardi E, 2012, NAT REV CANCER, V12, P89, DOI 10.1038/nrc3205; Hagemann C, 2013, NEURO-ONCOLOGY, V15, P1696, DOI 10.1093/neuonc/not136; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ilm K, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0316-2; Jia W, 2005, BLOOD, V106, P3854, DOI 10.1182/blood-2005-04-1658; Juneja M, 2013, MOL ONCOL, V7, P929, DOI 10.1016/j.molonc.2013.05.003; Koelzer VH, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1150-z; Li H, 2006, EMBO J, V25, P4097, DOI 10.1038/sj.emboj.7601289; Lucarelli G, 2013, J UROLOGY, V190, P2271, DOI 10.1016/j.juro.2013.05.004; Manda R, 1999, GENOMICS, V61, P5, DOI 10.1006/geno.1999.5939; Neufeld G, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006718; Nitsche U, 2012, ANN SURG, V256, P763, DOI 10.1097/SLA.0b013e318272de87; Parry R, 2005, CANCER RES, V65, P8397, DOI 10.1158/0008-5472.CAN-05-1203; Pichorner A, 2012, CLIN EXP METASTAS, V29, P573, DOI 10.1007/s10585-012-9472-6; Qian XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037225; Rajkumar T, 2010, CANCER CELL INT, V10, DOI 10.1186/1475-2867-10-45; Ridley AJ, 2001, J CELL SCI, V114, P2713; Romanuik TL, 2009, AM J PATHOL, V175, P2264, DOI 10.2353/ajpath.2009.080868; Sakurai A, 2012, CELL RES, V22, P23, DOI 10.1038/cr.2011.198; Schmid F, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-49; Simon I, 2007, GYNECOL ONCOL, V106, P112, DOI 10.1016/j.ygyno.2007.03.007; Stein Ulrike, 2007, V176, P61; Stein U, 2013, EXPERT OPIN THER TAR, V17, P1039, DOI 10.1517/14728222.2013.815727; Stein U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049249; Stein U, 2011, NEOPLASIA, V13, P131, DOI 10.1593/neo.101172; Stein U, 2010, J MOL MED, V88, P11, DOI 10.1007/s00109-009-0537-1; Stein U, 2009, CELL CYCLE, V8, P2467, DOI 10.4161/cc.8.15.9018; Stein U, 2009, NAT MED, V15, P59, DOI 10.1038/nm.1889; Wagstaff L, 2011, FRONT BIOSCI-LANDMRK, V16, P1861, DOI 10.2741/3827; Wang Nina, 2012, Nan Fang Yi Ke Da Xue Xue Bao, V32, P312; Zhang Q, 2015, ONCOTARGET, V6, P15095, DOI 10.18632/oncotarget.3822	42	40	43	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 17	2016	35	46					5942	5952		10.1038/onc.2015.451	http://dx.doi.org/10.1038/onc.2015.451			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	ED0CA	26686083				2022-12-26	WOS:000388509400002
J	Tischer, A; Campbell, JC; Machha, VR; Moon-Tasson, L; Benson, LM; Sankaran, B; Kim, C; Auton, M				Tischer, Alexander; Campbell, James C.; Machha, Venkata R.; Moon-Tasson, Laurie; Benson, Linda M.; Sankaran, Banumathi; Kim, Choel; Auton, Matthew			Mutational Constraints on Local Unfolding Inhibit the Rheological Adaptation of von Willebrand Factor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mass spectrometry (MS); platelet glycoprotein Ib; protein denaturation; protein stability; protein structure; structural biology; surface plasmon resonance; trypsin; von Willebrand factor; x-ray crystallography	FACTOR A1 DOMAIN; PLATELET GLYCOPROTEIN-IB; DISEASE TYPE-B; CRYSTAL-STRUCTURE; CONFORMATIONAL FLEXIBILITY; ADENYLATE KINASE; STRUCTURAL BASIS; FACTOR BINDING; SNAKE-VENOM; ALPHA	Unusually large von Willebrand factor (VWF), the first responder to vascular injury in primary hemostasis, is designed to capture platelets under the high shear stress of rheological blood flow. In type 2M von Willebrand disease, two rare mutations (G1324A and G1324S) within the platelet GPIb binding interface of the VWF A1 domain impair the hemostatic function of VWF. We investigate structural and conformational effects of these mutations on the A1 domain's efficacy to bind collagen and adhere platelets under shear flow. These mutations enhance the thermodynamic stability, reduce the rate of unfolding, and enhance the A1 domain's resistance to limited proteolysis. Collagen binding affinity is not significantly affected indicating that the primary stabilizing effect of these mutations is to diminish the platelet binding efficiency under shear flow. The enhanced stability stems from the steric consequences of adding a side chain (G1324A) and additionally a hydrogen bond (G1324S) to His(1322) across the 2-3 hairpin in the GPIb binding interface, which restrains the conformational degrees of freedom and the overall flexibility of the native state. These studies reveal a novel rheological strategy in which the incorporation of a single glycine within the GPIb binding interface of normal VWF enhances the probability of local unfolding that enables the A1 domain to conformationally adapt to shear flow while maintaining its overall native structure.	[Tischer, Alexander; Machha, Venkata R.; Moon-Tasson, Laurie; Auton, Matthew] Mayo Clin, Div Hematol, Dept Internal Med, Rochester, MN 55905 USA; [Tischer, Alexander; Machha, Venkata R.; Moon-Tasson, Laurie; Auton, Matthew] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Campbell, James C.; Kim, Choel] Baylor Coll Med, Struct & Computat Biol & Mol Biophys Program, Houston, TX 77030 USA; [Kim, Choel] Baylor Coll Med, Dept Pharmacol, Houston, TX 77030 USA; [Kim, Choel] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Benson, Linda M.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Sankaran, Banumathi] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Berkeley Ctr Struct Biol, Berkeley, CA 94720 USA	Mayo Clinic; Mayo Clinic; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Mayo Clinic; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Auton, M (corresponding author), Mayo Clin, Div Hematol, Dept Internal Med, Rochester, MN 55906 USA.; Auton, M (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55906 USA.	auton.matthew@mayo.edu		Auton, Matthew/0000-0002-4446-6932	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL109109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM056929] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy DE-AC02-05CH11231.	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Ajzenberg N, 2000, BLOOD, V95, P3796; Arya M, 2002, BLOOD, V99, P3971, DOI 10.1182/blood-2001-11-0060; Auton M, 2007, J MOL BIOL, V366, P986, DOI 10.1016/j.jmb.2006.10.067; Auton M, 2009, BIOPHYS J, V97, P618, DOI 10.1016/j.bpj.2009.05.009; Blenner MA, 2014, J BIOL CHEM, V289, P5565, DOI 10.1074/jbc.M113.511220; Bonnefoy A, 2006, J THROMB HAEMOST, V4, P2151, DOI 10.1111/j.1538-7836.2006.02111.x; Celikel R, 1998, NAT STRUCT BIOL, V5, P189, DOI 10.1038/nsb0398-189; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Dumas JJ, 2004, J BIOL CHEM, V279, P23327, DOI 10.1074/jbc.M401659200; Emsley J, 1998, J BIOL CHEM, V273, P10396, DOI 10.1074/jbc.273.17.10396; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fields PA, 1998, P NATL ACAD SCI USA, V95, P11476, DOI 10.1073/pnas.95.19.11476; FIRKIN B, 1973, AUST NZ J MED, V3, P225, DOI 10.1111/j.1445-5994.1973.tb03086.x; Fukuda K, 2005, NAT STRUCT MOL BIOL, V12, P152, DOI 10.1038/nsmb892; Fukuda K, 2002, STRUCTURE, V10, P943, DOI 10.1016/S0969-2126(02)00787-6; Hilbert L, 2002, THROMB HAEMOSTASIS, V87, P635; HOLMBERG L, 1972, BMJ-BRIT MED J, V3, P317, DOI 10.1136/bmj.3.5822.317; HOWARD MA, 1984, BRIT J HAEMATOL, V57, P25, DOI 10.1111/j.1365-2141.1984.tb02862.x; HOWARD MA, 1982, BLOOD, V60, P1420; Huang RH, 2009, STRUCTURE, V17, P1476, DOI 10.1016/j.str.2009.09.011; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Ju LN, 2015, THROMB RES, V136, P606, DOI 10.1016/j.thromres.2015.06.019; Kitchen S, 2006, SEMIN THROMB HEMOST, V32, P492, DOI 10.1055/s-2006-947863; KOSHLAND DE, 1959, J CELL COMPAR PHYSL, V54, P245, DOI 10.1002/jcp.1030540420; Lopez JA, 2005, BLOOD COAGUL FIBRIN, V16, pS11, DOI 10.1097/01.mbc.0000167657.85143.ad; Maita N, 2003, J BIOL CHEM, V278, P37777, DOI 10.1074/jbc.M305566200; Morales LD, 2006, J THROMB HAEMOST, V4, P417, DOI 10.1111/j.1538-7836.2006.01742.x; RABINOWITZ I, 1992, P NATL ACAD SCI USA, V89, P9846, DOI 10.1073/pnas.89.20.9846; Schneider SW, 2007, P NATL ACAD SCI USA, V104, P7899, DOI 10.1073/pnas.0608422104; Schrank TP, 2009, P NATL ACAD SCI USA, V106, P16984, DOI 10.1073/pnas.0906510106; Tischer A, 2014, BIOPHYS J, V107, P1185, DOI 10.1016/j.bpj.2014.07.026; Tischer A, 2014, PROTEINS, V82, P867, DOI 10.1002/prot.24464; Tischer A, 2013, PROTEIN SCI, V22, P1147, DOI 10.1002/pro.2301; Tischer A, 2013, PROTEIN SCI, V22, P1049, DOI 10.1002/pro.2294; WEISS HJ, 1973, J CLIN INVEST, V52, P2708, DOI 10.1172/JCI107465; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zavodszky P, 1998, P NATL ACAD SCI USA, V95, P7406, DOI 10.1073/pnas.95.13.7406; Zhang HJ, 1997, BIOCHEM BIOPH RES CO, V238, P382, DOI 10.1006/bbrc.1997.7301; Zimmermann MT, 2015, BIOPHYS J, V109, P398, DOI 10.1016/j.bpj.2015.06.008; Zoldak G, 2004, EUR J BIOCHEM, V271, P48, DOI 10.1046/j.1432-1033.2003.03900.x	41	18	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					3848	3859		10.1074/jbc.M115.703850	http://dx.doi.org/10.1074/jbc.M115.703850			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26677223	hybrid, Green Published, Green Submitted			2022-12-26	WOS:000371338400014
J	Hien, TT; Turczynska, KM; Dahan, D; Ekman, M; Grossi, M; Sjogren, J; Nilsson, J; Braun, T; Boettger, T; Garcia-Vaz, E; Stenkula, K; Sward, K; Gomez, MF; Albinsson, S				Tran Thi Hien; Turczynska, Karolina M.; Dahan, Diana; Ekman, Mari; Grossi, Mario; Sjogren, Johan; Nilsson, Johan; Braun, Thomas; Boettger, Thomas; Garcia-Vaz, Eliana; Stenkula, Karin; Sward, Karl; Gomez, Maria F.; Albinsson, Sebastian			Elevated Glucose Levels Promote Contractile and Cytoskeletal Gene Expression in Vascular Smooth Muscle via Rho/Protein Kinase C and Actin Polymerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell differentiation; diabetes; glucose; microRNA (miRNA); Rho (Rho GTPase); vascular smooth muscle cells; actin polymerization	STRETCH-DEPENDENT GROWTH; GLYCATION END-PRODUCTS; RHO-KINASE; UP-REGULATION; INDUCED ACTIVATION; DOWN-REGULATION; BLOOD-GLUCOSE; DIABETIC-RATS; CA2+ CHANNELS; DIFFERENTIATION	Both type 1 and type 2 diabetes are associated with increased risk of cardiovascular disease. This is in part attributed to the effects of hyperglycemia on vascular endothelial and smooth muscle cells, but the underlying mechanisms are not fully understood. In diabetic animal models, hyperglycemia results in hypercontractility of vascular smooth muscle possibly due to increased activation of Rho-kinase. The aim of the present study was to investigate the regulation of contractile smooth muscle markers by glucose and to determine the signaling pathways that are activated by hyperglycemia in smooth muscle cells. Microarray, quantitative PCR, and Western blot analyses revealed that both mRNA and protein expression of contractile smooth muscle markers were increased in isolated smooth muscle cells cultured under high compared with low glucose conditions. This effect was also observed in hyperglycemic Akita mice and in diabetic patients. Elevated glucose activated the protein kinase C and Rho/Rho-kinase signaling pathways and stimulated actin polymerization. Glucose-induced expression of contractile smooth muscle markers in cultured cells could be partially or completely repressed by inhibitors of advanced glycation end products, L-type calcium channels, protein kinase C, Rho-kinase, actin polymerization, and myocardin-related transcription factors. Furthermore, genetic ablation of the miR-143/145 cluster prevented the effects of glucose on smooth muscle marker expression. In conclusion, these data demonstrate a possible link between hyperglycemia and vascular disease states associated with smooth muscle contractility.	[Tran Thi Hien; Turczynska, Karolina M.; Dahan, Diana; Ekman, Mari; Grossi, Mario; Stenkula, Karin; Sward, Karl; Albinsson, Sebastian] Lund Univ, Dept Expt Med Sci, BMC D12, SE-22184 Lund, Sweden; [Sjogren, Johan; Nilsson, Johan] Lund Univ, Dept Clin Sci, BMC D12, SE-22184 Lund, Sweden; [Braun, Thomas; Boettger, Thomas] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany; [Garcia-Vaz, Eliana; Gomez, Maria F.] Lund Univ, Dept Clin Sci Malmo, S-20502 Malmo, Sweden	Lund University; Lund University; Max Planck Society; Lund University	Albinsson, S (corresponding author), Lund Univ, Dept Expt Med Sci, BMC D12, SE-22184 Lund, Sweden.	sebastian.albinsson@med.lu.se	Boettger, Thomas/E-3406-2012; Nilsson, Johan/A-4742-2011; Gomez, Maria F/D-3696-2014; Sjögren, Johan/AAZ-6448-2021; Braun, Thomas/B-2310-2008; Albinsson, Sebastian/B-4105-2010	Boettger, Thomas/0000-0003-4280-8449; Nilsson, Johan/0000-0001-6860-6090; Gomez, Maria F/0000-0001-6210-3142; Sjögren, Johan/0000-0001-7965-7491; Stenkula, Karin/0000-0002-0739-1150; Albinsson, Sebastian/0000-0001-6936-3967; Braun, Thomas/0000-0002-6165-4804	Novo Nordisk Foundation; Per-Eric and Ulla Schyberg Foundation; Albert Pahlsson Foundation; Swedish Heart and Lung Foundation [HLF 20130700]; Swedish Research Council [2014-3352]; Swedish Diabetes Association (Diabetesfonden); Innovative Medicines Initiative Joint Undertaking [115006]; European Union; Novo Nordisk Fonden [NNF15OC0016144, NNF12OC1016299] Funding Source: researchfish	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Per-Eric and Ulla Schyberg Foundation; Albert Pahlsson Foundation; Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association (Diabetesfonden); Innovative Medicines Initiative Joint Undertaking; European Union(European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the Novo Nordisk Foundation, the Per-Eric and Ulla Schyberg Foundation, and the Albert Pahlsson Foundation (to S. A.). This work was also supported by Swedish Heart and Lung Foundation Grant HLF 20130700, Swedish Research Council Grant 2014-3352, and Swedish Diabetes Association (Diabetesfonden) (to M. F. G. and K. Stenkula). This work was also supported by Innovative Medicines Initiative Joint Undertaking 115006, comprising funds from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution. The authors declare that they have no conflicts of interest with the contents of this article.	ABEBE W, 1990, J CARDIOVASC PHARM, V16, P239, DOI 10.1097/00005344-199008000-00010; Albinsson S, 2004, J BIOL CHEM, V279, P34849, DOI 10.1074/jbc.M403370200; Albinsson S, 2007, AM J PHYSIOL-CELL PH, V293, pC772, DOI 10.1152/ajpcell.00622.2006; Albinsson S, 2010, ARTERIOSCL THROM VAS, V30, P1118, DOI 10.1161/ATVBAHA.109.200873; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Arita R, 2009, DIABETES, V58, P215, DOI 10.2337/db08-0762; BARBAGALLO M, 1995, J CLIN INVEST, V95, P763, DOI 10.1172/JCI117724; Bhattachariya A, 2015, ACTA PHYSIOL, V215, P133, DOI 10.1111/apha.12536; Boettger T, 2009, J CLIN INVEST, V119, P2634, DOI 10.1172/JCI38864; Bu DX, 2010, CIRC RES, V106, P1040, DOI 10.1161/CIRCRESAHA.109.201103; Cazzola M, 2012, AM J RESP CELL MOL, V47, P509, DOI 10.1165/rcmb.2011-0449OC; Chang SH, 2006, AM J PHYSIOL-RENAL, V290, pF650, DOI 10.1152/ajprenal.00235.2005; Cicek FA, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-51; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Cosentino F, 2003, CIRCULATION, V107, P1017, DOI 10.1161/01.CIR.0000051367.92927.07; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Creager MA, 2003, CIRCULATION, V108, P1527, DOI 10.1161/01.CIR.0000091257.27563.32; Dahan D, 2014, AM J PHYSIOL-CELL PH, V307, pC1093, DOI 10.1152/ajpcell.00250.2014; Fleischhacker E, 1999, DIABETES, V48, P1323, DOI 10.2337/diabetes.48.6.1323; Goldberg IJ, 2004, J CLIN INVEST, V114, P613, DOI 10.1172/JCI200422826; Goldin A, 2006, CIRCULATION, V114, P597, DOI 10.1161/CIRCULATIONAHA.106.621854; Guo ZH, 2005, CARDIOVASC RES, V67, P723, DOI 10.1016/j.cardiores.2005.04.008; Hellstrand P, 2005, CAN J PHYSIOL PHARM, V83, P869, DOI 10.1139/Y05-061; Hirose A, 2010, FEBS LETT, V584, P61, DOI 10.1016/j.febslet.2009.11.082; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Howard RL, 1996, J LAB CLIN MED, V127, P504, DOI 10.1016/S0022-2143(96)90068-2; KAISER N, 1993, DIABETES, V42, P80, DOI 10.2337/diabetes.42.1.80; Kandabashi T, 2003, ARTERIOSCL THROM VAS, V23, P2209, DOI 10.1161/01.ATV.0000104010.87348.26; Kawamura H, 2004, ARTERIOSCL THROM VAS, V24, P276, DOI 10.1161/01.ATV.0000112012.33770.2a; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Kizub IV, 2010, BRIT J PHARMACOL, V159, P1724, DOI 10.1111/j.1476-5381.2010.00666.x; Lawes CMM, 2004, DIABETES CARE, V27, P2836; LEE TS, 1989, P NATL ACAD SCI USA, V86, P5141, DOI 10.1073/pnas.86.13.5141; Li CH, 2003, FASEB J, V17, P2106, DOI 10.1096/fj.03-0150fje; Lin GR, 2007, CARDIOVASC RES, V75, P51, DOI 10.1016/j.cardiores.2007.03.009; Liu Y, 2005, J BIOL CHEM, V280, P9719, DOI 10.1074/jbc.M412862200; LUO JH, 1993, J BIOL CHEM, V268, P23580; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; MASUO M, 1994, J GEN PHYSIOL, V104, P265, DOI 10.1085/jgp.104.2.265; Matsumoto T, 2010, BRIT J PHARMACOL, V160, P1092, DOI 10.1111/j.1476-5381.2010.00753.x; Mehta D, 1999, J PHYSIOL-LONDON, V519, P829, DOI 10.1111/j.1469-7793.1999.0829n.x; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Moreno-Dominguez A, 2013, J PHYSIOL-LONDON, V591, P1235, DOI 10.1113/jphysiol.2012.243576; Navedo MF, 2010, AM J PHYSIOL-CELL PH, V298, pC211, DOI 10.1152/ajpcell.00267.2009; Navedo MF, 2005, P NATL ACAD SCI USA, V102, P11112, DOI 10.1073/pnas.0500360102; Nilsson-Berglund LM, 2010, ARTERIOSCL THROM VAS, V30, P218, DOI 10.1161/ATVBAHA.109.199299; Nobe K, 2002, BRIT J PHARMACOL, V136, P441, DOI 10.1038/sj.bjp.0704722; Nystoriak MA, 2014, CIRC RES, V114, P607, DOI 10.1161/CIRCRESAHA.114.302168; Pyla R, 2013, AM J PHYSIOL-CELL PH, V304, pC574, DOI 10.1152/ajpcell.00275.2012; Rama A, 2006, EUR J CELL BIOL, V85, P375, DOI 10.1016/j.ejcb.2005.11.007; Ren JL, 2010, J BIOL CHEM, V285, P31829, DOI 10.1074/jbc.M109.097576; Ronkainen JJ, 2011, J PHYSIOL-LONDON, V589, P2669, DOI 10.1113/jphysiol.2010.201400; Sadegh MK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035882; Sakurada S, 2003, CIRC RES, V93, P548, DOI 10.1161/01.RES.0000090998.08629.60; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Shi N, 2014, J BIOMED RES, V28, P40, DOI 10.7555/JBR.28.20130130; Singh R, 2001, DIABETOLOGIA, V44, P129, DOI 10.1007/s001250051591; Staiculescu MC, 2013, CARDIOVASC RES, V98, P428, DOI 10.1093/cvr/cvt034; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thallas-Bonke V, 2004, DIABETES, V53, P2921, DOI 10.2337/diabetes.53.11.2921; Thomas MC, 2014, ADV CHRONIC KIDNEY D, V21, P311, DOI 10.1053/j.ackd.2014.03.004; Turczynska KM, 2015, ARTERIOSCL THROM VAS, V35, P1489, DOI 10.1161/ATVBAHA.114.305065; Turczynska Karolina M, 2013, Commun Integr Biol, V6, pe22278, DOI 10.4161/cib.22278; Turczynska KM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065135; Turczynska KM, 2012, J BIOL CHEM, V287, P19199, DOI 10.1074/jbc.M112.341073; Uenishi E, 2013, J BIOL CHEM, V288, P25851, DOI 10.1074/jbc.M113.464420; Ungvari Z, 1999, CARDIOVASC RES, V43, P1018, DOI 10.1016/S0008-6363(99)00106-6; Wamhoff BR, 2004, CIRC RES, V95, P406, DOI 10.1161/01.RES.0000138582.36921.9e; WHITE RE, 1988, AM J PHYSIOL, V255, pH1036, DOI 10.1152/ajpheart.1988.255.5.H1036; Xie ZW, 2010, J BIOL CHEM, V285, P8628, DOI 10.1074/jbc.M109.057711; Xie ZW, 2006, CARDIOVASC RES, V69, P491, DOI 10.1016/j.cardiores.2005.11.002; Xin M, 2009, GENE DEV, V23, P2166, DOI 10.1101/gad.1842409; Yang XQ, 2008, CLIN EXP PHARMACOL P, V35, P1097, DOI 10.1111/j.1440-1681.2007.04756.x; Yao L, 2013, CARDIOVASC RES, V97, P509, DOI 10.1093/cvr/cvs371; Ying ZK, 2009, ARTERIOSCL THROM VAS, V29, P1657, DOI 10.1161/ATVBAHA.109.190892; Yoshida T, 2008, CIRC RES, V102, P1548, DOI 10.1161/CIRCRESAHA.108.176974; Zeidan A, 2003, AM J PHYSIOL-CELL PH, V284, pC1387, DOI 10.1152/ajpcell.00508.2002; Zetterqvist AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065020	79	43	44	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3552	3568		10.1074/jbc.M115.654384	http://dx.doi.org/10.1074/jbc.M115.654384			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26683376	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000370854500035
J	Barnoud, T; Donninger, H; Clark, GJ				Barnoud, Thibaut; Donninger, Howard; Clark, Geoffrey J.			Ras Regulates Rb via NORE1A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINOBLASTOMA PROTEIN; TUMOR-SUPPRESSOR; ONCOGENIC RAS; EFFECTOR NORE1; P53; PHOSPHATASE; SENESCENCE; GROWTH; GENE; EXPRESSION	Mutations in the Ras oncogene are one of the most frequent events in human cancer. Although Ras regulates numerous growth-promoting pathways to drive transformation, it can paradoxically promote an irreversible cell cycle arrest known as oncogene-induced senescence. Although senescence has clearly been implicated as a major defense mechanism against tumorigenesis, the mechanisms by which Ras can promote such a senescent phenotype remain poorly defined. We have shown recently that the Ras death effector NORE1A plays a critical role in promoting Ras-induced senescence and connects Ras to the regulation of the p53 tumor suppressor. We now show that NORE1A also connects Ras to the regulation of a second major prosenescent tumor suppressor, the retinoblastoma (Rb) protein. We show that Ras induces the formation of a complex between NORE1A and the phosphatase PP1A, promoting the activation of the Rb tumor suppressor by dephosphorylation. Furthermore, suppression of Rb reduces NORE1A senescence activity. These results, together with our previous findings, suggest that NORE1A acts as a critical tumor suppressor node, linking Ras to both the p53 and the Rb pathways to drive senescence.	[Barnoud, Thibaut] Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Dept Biochem & Mol Genet, Louisville, KY 40202 USA; [Donninger, Howard] Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Dept Med, Louisville, KY 40202 USA; [Clark, Geoffrey J.] Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Dept Pharmacol & Toxicol, 505 S Hancock St, Louisville, KY 40202 USA	University of Louisville; University of Louisville; University of Louisville	Clark, GJ (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Dept Pharmacol & Toxicol, 505 S Hancock St, Louisville, KY 40202 USA.	gjclar01@louisville.edu	Donninger, Howard/I-9874-2019	Donninger, Howard/0000-0002-8589-1660; Barnoud, Thibaut/0000-0001-5588-6281	National Institutes of Health [R01 CA133171-01A2]; NATIONAL CANCER INSTITUTE [R01CA133171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant R01 CA133171-01A2 (to G. J. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALBERTS AS, 1993, P NATL ACAD SCI USA, V90, P388, DOI 10.1073/pnas.90.2.388; Aoyama Y, 2004, ONCOGENE, V23, P3426, DOI 10.1038/sj.onc.1207486; Ayllon V, 2000, EMBO J, V19, P2237, DOI 10.1093/emboj/19.10.2237; Barr FA, 2011, J CELL SCI, V124, P2323, DOI 10.1242/jcs.087106; Ben-Porath I, 2005, INT J BIOCHEM CELL B, V37, P961, DOI 10.1016/j.biocel.2004.10.013; Benavente CA, 2015, ANNU REV PATHOL-MECH, V10, P547, DOI 10.1146/annurev-pathol-012414-040259; Bollen M, 2010, TRENDS BIOCHEM SCI, V35, P450, DOI 10.1016/j.tibs.2010.03.002; Bollen M, 2009, TRENDS CELL BIOL, V19, P531, DOI 10.1016/j.tcb.2009.06.005; Calvisi DF, 2008, INT J CANCER, V123, P2057, DOI 10.1002/ijc.23720; Calvisi DF, 2009, CANCER RES, V69, P4629, DOI 10.1158/0008-5472.CAN-08-3672; Campbell PM, 2004, SEMIN CANCER BIOL, V14, P105, DOI 10.1016/j.semcancer.2003.09.015; Carriere C, 2011, GASTROENTEROLOGY, V141, P1091, DOI 10.1053/j.gastro.2011.05.041; Castro ME, 2008, CARCINOGENESIS, V29, P491, DOI 10.1093/carcin/bgm246; Chen JD, 2003, CANCER CELL, V4, P405, DOI 10.1016/S1535-6108(03)00269-1; Chen QM, 1998, BIOCHEM J, V332, P43, DOI 10.1042/bj3320043; Chen X, 2009, P NATL ACAD SCI USA, V106, P7979, DOI 10.1073/pnas.0900343106; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Contente Sara, 2011, Genes Cancer, V2, P166, DOI 10.1177/1947601911405042; Cox AD, 2003, ONCOGENE, V22, P8999, DOI 10.1038/sj.onc.1207111; Dannenberg Jan-Hermen, 2006, V42, P183, DOI 10.1007/002; De Leon G, 2008, CANCER BIOL THER, V7, P833, DOI 10.4161/cbt.7.6.5839; DeNicola Gina M, 2009, Eur J Cancer, V45 Suppl 1, P211, DOI 10.1016/S0959-8049(09)70036-X; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; Donninger H, 2007, J CELL SCI, V120, P3163, DOI 10.1242/jcs.010389; Donninger H, 2015, J CELL BIOL, V208, P777, DOI 10.1083/jcb.201408087; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; DURFEE T, 1993, GENE DEV, V7, P555, DOI 10.1101/gad.7.4.555; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FUTREAL PA, 1991, ONCOGENE, V6, P1109; Gao J, 2004, ONCOGENE, V23, P687, DOI 10.1038/sj.onc.1207169; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Khokhlatchev A, 2002, CURR BIOL, V12, P253, DOI 10.1016/S0960-9822(02)00683-8; Klumpers F, 2014, SENSOR ACTUAT B-CHEM, V203, P904, DOI 10.1016/j.snb.2014.07.064; Kolupaeva V, 2013, FEBS J, V280, P627, DOI 10.1111/j.1742-4658.2012.08511.x; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Kurnari G, 2007, J MOL BIOL, V367, P1294, DOI 10.1016/j.jmb.2007.01.026; Lee D, 2012, EMBO REP, V13, P163, DOI 10.1038/embor.2011.235; Lee SJ, 2007, CELL DEATH DIFFER, V14, P1106, DOI 10.1038/sj.cdd.4402111; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; Meuwissen R, 2003, CANCER CELL, V4, P181, DOI 10.1016/S1535-6108(03)00220-4; Michaud K, 2010, CANCER RES, V70, P3228, DOI 10.1158/0008-5472.CAN-09-4559; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; Overmeyer JH, 2011, FRONT BIOSCI-LANDMRK, V16, P1693, DOI 10.2741/3814; Park J, 2010, J BIOL CHEM, V285, P35029, DOI 10.1074/jbc.M110.165506; Pearson M, 2000, NATURE, V406, P207, DOI 10.1038/35018127; Praskova M, 2004, BIOCHEM J, V381, P453, DOI 10.1042/BJ20040025; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; RICHARDS CA, 1990, CANCER RES, V50, P1521; Schmidt ML, 2014, J BIOL CHEM, V289, P31102, DOI 10.1074/jbc.M114.594283; Schwarz D., 2002, THESIS RUHR U BOCHUM; Sdek P, 2005, MOL CELL, V20, P699, DOI 10.1016/j.molcel.2005.10.017; Sellers WR, 1998, GENE DEV, V12, P95, DOI 10.1101/gad.12.1.95; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SHAY JW, 1991, EXP CELL RES, V196, P33, DOI 10.1016/0014-4827(91)90453-2; Shinmura K, 2011, LUNG CANCER, V71, P19, DOI 10.1016/j.lungcan.2010.04.006; Smogorzewska A, 2002, EMBO J, V21, P4338, DOI 10.1093/emboj/cdf433; Suryaraja R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.91; Tamrakar S, 1999, ONCOGENE, V18, P7803, DOI 10.1038/sj.onc.1203211; Tamrakar S, 2000, J BIOL CHEM, V275, P27784; Trinkle-Mulcahy L, 2001, J CELL SCI, V114, P4219; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Vos MD, 2003, J BIOL CHEM, V278, P21938, DOI 10.1074/jbc.M211019200; Wang RH, 2001, ONCOGENE, V20, P6111, DOI 10.1038/sj.onc.1204829; Wurzenberger C, 2011, NAT REV MOL CELL BIO, V12, P469, DOI 10.1038/nrm3149; Wurzer G, 2001, J CELL BIOCHEM, P1; Yamamoto T, 1999, J BIOCHEM-TOKYO, V126, P799, DOI 10.1093/oxfordjournals.jbchem.a022519; Zheng L, 2001, EXP CELL RES, V264, P2, DOI 10.1006/excr.2000.5129	69	19	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					3114	3123		10.1074/jbc.M115.697557	http://dx.doi.org/10.1074/jbc.M115.697557			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26677227	Green Published, hybrid			2022-12-26	WOS:000369626900046
J	Kunze, G; Kohling, S; Vogel, A; Rademann, J; Huster, D				Kuenze, Georg; Koehling, Sebastian; Vogel, Alexander; Rademann, Joerg; Huster, Daniel			Identification of the Glycosaminoglycan Binding Site of Interleukin-10 by NMR Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; CYTOKINE PRODUCTION; CELL-PROLIFERATION; DERMATAN SULFATE; FORCE-FIELD; B-CELLS; PROTEIN; IL-10; MECHANISM; DYNAMICS	The biological function of interleukin-10 (IL-10), a pleiotropic cytokine with an essential role in inflammatory processes, is known to be affected by glycosaminoglycans (GAGs). GAGs are highly negatively charged polysaccharides and integral components of the extracellular matrix with important functions in the biology of many growth factors and cytokines. The molecular mechanism of the IL-10/GAG interaction is unclear. In particular, experimental evidence about IL-10/GAG binding sites is lacking, despite its importance for understanding the biological role of the interaction. Here, we report the experimental determination of a GAG binding site of IL-10. Although no co-crystal structure of the IL-10.GAG complex could be obtained, its structural characterization was possible by NMR spectroscopy. Chemical shift perturbations of IL-10 induced by GAG binding were used to narrow down the location of the binding site and to assess the affinity for different GAG molecules. Subsequent observation of NMR pseudocontact shifts of IL-10 and its heparin ligand, as induced by a protein-attached lanthanide spin label, provided structural restraints for the protein.ligand complex. Using these restraints, pseudocontact shift-based rigid body docking together with molecular dynamics simulations yielded a GAG binding model. The heparin binding site is located at the C-terminal end of helix D and the adjacent DE loop and coincides with a patch of positively charged residues involving arginines 102, 104, 106, and 107 and lysines 117 and 119. This study represents the first experimental characterization of the IL-10.GAG complex structure and provides the starting point for revealing the biological significance of the interaction of IL-10 with GAGs.	[Kuenze, Georg; Koehling, Sebastian; Vogel, Alexander; Rademann, Joerg; Huster, Daniel] Univ Leipzig, Inst Med Phys & Biophys, Hartelstr 16-18, D-04107 Leipzig, Germany; [Koehling, Sebastian; Rademann, Joerg] Free Univ Berlin, Inst Pharm, Med Chem, Konigin Luise Str 2 4, D-14195 Berlin, Germany	Leipzig University; Free University of Berlin	Huster, D (corresponding author), Univ Leipzig, Inst Med Phys & Biophys, Hartelstr 16-18, D-04107 Leipzig, Germany.	daniel.huster@medizin.uni-leipzig.de	Rademann, Jörg/F-4893-2017	Rademann, Jörg/0000-0001-6678-3165	Deutsche Forschungsgemeinschaft [Transregio-SFB 67]; Verband der Chemischen Industrie e.V. [Do 187/11]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Verband der Chemischen Industrie e.V.	This work was supported by Deutsche Forschungsgemeinschaft Grants Transregio-SFB 67, A6, and A8 and Grant Do 187/11 from the Verband der Chemischen Industrie e.V. (to G. K.). The authors declare that they have no conflicts of interest with the contents of this article.	Angulo J, 2010, CHEM-EUR J, V16, P7803, DOI 10.1002/chem.200903528; Barthelmes K, 2011, J AM CHEM SOC, V133, P808, DOI 10.1021/ja104983t; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bertini I, 2001, J AM CHEM SOC, V123, P4181, DOI 10.1021/ja0028626; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; BRUNO E, 1995, EXP HEMATOL, V23, P1212; Cai GF, 1999, EUR J IMMUNOL, V29, P2658, DOI 10.1002/(SICI)1521-4141(199909)29:09<2658::AID-IMMU2658>3.3.CO;2-7; Canales A, 2014, J AM CHEM SOC, V136, P8011, DOI 10.1021/ja502406x; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; CAVANAGH J, 1991, J MAGN RESON, V91, P429, DOI 10.1016/0022-2364(91)90209-C; Chautard E, 2009, BIOINFORMATICS, V25, P690, DOI 10.1093/bioinformatics/btp025; Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610; DING L, 1992, J IMMUNOL, V148, P3133; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esko JD, 2009, ESSENTIALS GLYCOBIOL, P501; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FIORENTINO DF, 1989, J EXP MED, V170, P2081, DOI 10.1084/jem.170.6.2081; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; Garcia-Mayoral MF, 2013, ACS CHEM BIOL, V8, P144, DOI 10.1021/cb300386v; Gehrcke JP, 2015, J MOL GRAPH MODEL, V62, P97, DOI 10.1016/j.jmgm.2015.09.003; Grunig G, 1997, J EXP MED, V185, P1089, DOI 10.1084/jem.185.6.1089; Guan JY, 2013, J AM CHEM SOC, V135, P5859, DOI 10.1021/ja401323m; Gupta M, 2012, BLOOD, V119, P2844, DOI 10.1182/blood-2011-10-388538; Gupta P, 1998, BLOOD, V92, P4641, DOI 10.1182/blood.V92.12.4641.424k10_4641_4651; Guvench O, 2008, J COMPUT CHEM, V29, P2543, DOI 10.1002/jcc.21004; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Handel TM, 2005, ANNU REV BIOCHEM, V74, P385, DOI 10.1146/annurev.biochem.72.121801.161747; HUIGE CJM, 1995, J COMPUT CHEM, V16, P56, DOI 10.1002/jcc.540160106; Imberty A, 2007, CARBOHYD RES, V342, P430, DOI 10.1016/j.carres.2006.12.019; ISHIDA H, 1992, J EXP MED, V175, P1213, DOI 10.1084/jem.175.5.1213; Josephson K, 2000, J BIOL CHEM, V275, P13552, DOI 10.1074/jbc.275.18.13552; KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088; Kleywegt GJ, 1998, ACTA CRYSTALLOGR D, V54, P1119, DOI 10.1107/S0907444998007100; Kunze G, 2014, GLYCOBIOLOGY, V24, P1036, DOI 10.1093/glycob/cwu069; Kunze G, 2014, BIOMOL NMR ASSIGN, V8, P375, DOI 10.1007/s12104-013-9521-3; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; LEVY Y, 1994, J CLIN INVEST, V93, P424, DOI 10.1172/JCI116977; LLORENTE L, 1995, J EXP MED, V181, P839, DOI 10.1084/jem.181.3.839; Logsdon NJ, 2012, P NATL ACAD SCI USA, V109, P12704, DOI 10.1073/pnas.1117551109; MacKerell AD, 2004, J AM CHEM SOC, V126, P698, DOI 10.1021/ja036959e; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mallajosyula SS, 2012, J CHEM THEORY COMPUT, V8, P759, DOI 10.1021/ct200792v; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; MORI S, 1995, J MAGN RESON SER B, V108, P94, DOI 10.1006/jmrb.1995.1109; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Mulloy B, 2008, MOL SIMULAT, V34, P481, DOI 10.1080/08927020701784754; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagelkerken L, 1997, INT IMMUNOL, V9, P1243, DOI 10.1093/intimm/9.9.1243; Nitz M, 2003, CHEMBIOCHEM, V4, P272, DOI 10.1002/cbic.200390047; Otting G, 2010, ANNU REV BIOPHYS, V39, P387, DOI 10.1146/annurev.biophys.093008.131321; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Pestka S, 2004, ANNU REV IMMUNOL, V22, P929, DOI 10.1146/annurev.immunol.22.012703.104622; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Pichert A, 2012, GLYCOBIOLOGY, V22, P134, DOI 10.1093/glycob/cwr120; ROBERTS R, 1988, NATURE, V332, P376, DOI 10.1038/332376a0; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P315, DOI 10.1016/j.cytogfr.2010.11.001; Saio T, 2011, J BIOMOL NMR, V51, P395, DOI 10.1007/s10858-011-9566-5; Salek-Ardakani S, 2000, BLOOD, V96, P1879, DOI 10.1182/blood.V96.5.1879.h8001879_1879_1888; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Schmitz C, 2008, J BIOMOL NMR, V41, P179, DOI 10.1007/s10858-008-9249-z; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; SHAKA AJ, 1985, J MAGN RESON, V64, P547, DOI 10.1016/0022-2364(85)90122-2; Shinmyouzu K, 2007, BIOCHEM BIOPH RES CO, V354, P447, DOI 10.1016/j.bbrc.2006.12.221; SKLENAR V, 1993, J MAGN RESON SER A, V102, P241, DOI 10.1006/jmra.1993.1098; Tournoy KG, 2000, CLIN EXP ALLERGY, V30, P775; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; VANGUNSTEREN WF, 1977, MOL PHYS, V34, P1311, DOI 10.1080/00268977700102571; WALTER MR, 1995, BIOCHEMISTRY-US, V34, P12118, DOI 10.1021/bi00038a004; ZDANOV A, 1995, STRUCTURE, V3, P591, DOI 10.1016/S0969-2126(01)00193-9; Zdanov A, 2010, CYTOKINE GROWTH F R, V21, P325, DOI 10.1016/j.cytogfr.2010.08.003; Zhuang TD, 2008, PROTEIN SCI, V17, P1220, DOI 10.1110/ps.034561.108	74	29	28	0	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					3100	3113		10.1074/jbc.M115.681759	http://dx.doi.org/10.1074/jbc.M115.681759			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26677224	hybrid, Green Published			2022-12-26	WOS:000369626900045
J	Muller, A; Stellmacher, A; Freitag, CE; Landgraf, P; Dieterich, DC				Mueller, Anke; Stellmacher, Anne; Freitag, Christine E.; Landgraf, Peter; Dieterich, Daniela C.			Monitoring Astrocytic Proteome Dynamics by Cell Type-Specific Protein Labeling	PLOS ONE			English	Article							TRANSFER-RNA SYNTHETASE; NEWLY SYNTHESIZED PROTEINS; ACID TAGGING BONCAT; SYNAPTIC PLASTICITY; TRANSLATIONAL CONTROL; CALCIUM OSCILLATIONS; ESCHERICHIA-COLI; MAMMALIAN-CELLS; IN-VIVO; BRAIN	The ability of the nervous system to undergo long-term plasticity is based on changes in cellular and synaptic proteomes. While many studies have explored dynamic alterations in neuronal proteomes during plasticity, there has been less attention paid to the astrocytic counterpart. Indeed, progress in identifying cell type-specific proteomes is limited owing to technical difficulties. Here, we present a cell type-specific metabolic tagging technique for a mammalian coculture model based on the bioorthogonal amino acid azidonorleucine and the mutated Mus musculus methionyl-tRNA synthetase(L274G) enabling azidonorleucine introduction into de novo synthesized proteins. Azidonorleucine incorporation resulted in cell type-specific protein labeling and retained neuronal or astrocytic cell viability. Furthermore, we were able to label astrocytic de novo synthesized proteins and identified both Connexin-43 and 60S ribosomal protein L10a upregulated upon treatment with Brain-derived neurotrophic factor in astrocytes of a neuron-glia coculture. Taken together, we demonstrate the successful dissociation of astrocytic from neuronal proteomes by cell type-specific metabolic labeling offering new possibilities for the analyses of cell type-specific proteome dynamics.	[Mueller, Anke; Stellmacher, Anne; Landgraf, Peter; Dieterich, Daniela C.] Univ Magdeburg, Inst Pharmacol & Toxicol, Neural Plast & Commun, D-39106 Magdeburg, Germany; [Freitag, Christine E.; Dieterich, Daniela C.] Leibniz Inst Neurobiol, Res Grp Neural, Magdeburg, Germany; [Dieterich, Daniela C.] Ctr Behav Brain Sci, Magdeburg, Germany	Otto von Guericke University; Leibniz Institut fur Neurobiologie (LIN)	Dieterich, DC (corresponding author), Univ Magdeburg, Inst Pharmacol & Toxicol, Neural Plast & Commun, D-39106 Magdeburg, Germany.	daniela.dieterich@med.ovgu.de		Dieterich, Daniela C./0000-0002-9880-1214	German Research Foundation (DFG) [DI 1512/1-1, SPP 1172/1757, DI 1512/2-1, DI 1512/5-1, GU230/6-1, SFB 779 TPB09]; Leibniz Society PAKT grant (LGS SynaptoGenetics)	German Research Foundation (DFG)(German Research Foundation (DFG)); Leibniz Society PAKT grant (LGS SynaptoGenetics)	This work was supported by the German Research Foundation (DFG; Emmy Noether Program (DI 1512/1-1), SPP 1172/1757 (DI 1512/2-1 & 5-1, German-Israeli DIP grant (GU230/6-1), SFB 779 TPB09 to D.C.D), a Leibniz Society PAKT grant (LGS SynaptoGenetics) to D.C.D.	Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Buffington SA, 2014, ANNU REV NEUROSCI, V37, P17, DOI 10.1146/annurev-neuro-071013-014100; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cajigas IJ, 2012, NEURON, V74, P453, DOI 10.1016/j.neuron.2012.02.036; Chever O, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0596; Costa-Mattioli M, 2009, NEURON, V61, P10, DOI 10.1016/j.neuron.2008.10.055; DERMIETZEL R, 1989, P NATL ACAD SCI USA, V86, P10148, DOI 10.1073/pnas.86.24.10148; Dieck ST, 2015, NAT METHODS, V12, P411, DOI [10.1038/nmeth.3319, 10.1038/NMETH.3319]; Dieterich DC, 2007, NAT PROTOC, V2, P532, DOI 10.1038/nprot.2007.52; Dieterich DC, 2006, P NATL ACAD SCI USA, V103, P9482, DOI 10.1073/pnas.0601637103; Dieterich DC, 2010, CURR OPIN NEUROBIOL, V20, P623, DOI 10.1016/j.conb.2010.06.011; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Erdmann I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8521; Goudriaan A, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00012; Greco TM, 2010, J PROTEOME RES, V9, P2764, DOI 10.1021/pr100134n; Habas A, 2013, P NATL ACAD SCI USA, V110, P18291, DOI 10.1073/pnas.1208764110; Han D, 2014, PROTEOMICS, V14, P1604, DOI 10.1002/pmic.201300495; Harada C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1190; Hinz FI, 2012, ACS CHEM NEUROSCI, V3, P40, DOI 10.1021/cn2000876; Hodas JJL, 2012, PROTEOMICS, V12, P2464, DOI 10.1002/pmic.201200112; Jones EV, 2011, J NEUROSCI, V31, P4154, DOI 10.1523/JNEUROSCI.4757-10.2011; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kawamura M, 2011, CELL CALCIUM, V49, P249, DOI 10.1016/j.ceca.2011.02.009; Koulakoff A, 2008, GLIA, V56, P1299, DOI 10.1002/glia.20698; Lang K, 2014, CHEM REV, V114, P4764, DOI 10.1021/cr400355w; Lange SC, 2012, NEUROCHEM RES, V37, P2569, DOI 10.1007/s11064-012-0868-0; Leal G, 2015, BRAIN RES, V1621, P82, DOI 10.1016/j.brainres.2014.10.019; Lee Y, 2008, GLIA, V56, P481, DOI 10.1002/glia.20622; Link AJ, 2006, P NATL ACAD SCI USA, V103, P10180, DOI 10.1073/pnas.0601167103; Link AJ, 2003, J AM CHEM SOC, V125, P11164, DOI 10.1021/ja036765z; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Ngo JT, 2013, P NATL ACAD SCI USA, V110, P4992, DOI 10.1073/pnas.1216375110; Ngo JT, 2009, NAT CHEM BIOL, V5, P715, DOI 10.1038/nchembio.200; Niehues S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8520; Ohira K, 2007, EUR J NEUROSCI, V25, P406, DOI 10.1111/j.1460-9568.2007.05282.x; Oliet SHR, 2001, SCIENCE, V292, P923, DOI 10.1126/science.1059162; PASTI L, 1995, J BIOL CHEM, V270, P15203, DOI 10.1074/jbc.270.25.15203; Perea G, 2014, FRONT CELL NEUROSCI, V8, DOI [10.3389/1ncel.2014.00378, 10.3389/fncel.2014.00378]; Pfrieger FW, 2012, GLIA, V60, P681, DOI 10.1002/glia.22283; Pirttimaki TM, 2011, J NEUROSCI, V31, P7637, DOI 10.1523/JNEUROSCI.5783-10.2011; Rose CR, 2003, NATURE, V426, P74, DOI 10.1038/nature01983; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Rouach N, 2000, J CELL BIOL, V149, P1513, DOI 10.1083/jcb.149.7.1513; Santello M, 2012, ADV EXP MED BIOL, V970, P307, DOI 10.1007/978-3-7091-0932-8_14; Sutton MA, 2006, CELL, V127, P49, DOI 10.1016/j.cell.2006.09.014; Tanrikulu IC, 2009, P NATL ACAD SCI USA, V106, P15285, DOI 10.1073/pnas.0905735106; Tcherkezian J, 2010, CELL, V141, P632, DOI 10.1016/j.cell.2010.04.008; Xie AX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049637; Yang YJ, 2009, NEURON, V61, P880, DOI 10.1016/j.neuron.2009.02.010; Ye YY, 2011, NEUROSCI LETT, V503, P15, DOI 10.1016/j.neulet.2011.07.055; Yoon BC, 2012, CELL, V148, P752, DOI 10.1016/j.cell.2011.11.064; Yuet KP, 2015, P NATL ACAD SCI USA, V112, P2705, DOI 10.1073/pnas.1421567112	52	16	16	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145451	10.1371/journal.pone.0145451	http://dx.doi.org/10.1371/journal.pone.0145451			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690742	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092300076
J	Vidovic, MMC; Gornitz, N; Muller, KR; Ratsch, G; Kloft, M				Vidovic, Marina M. -C.; Goernitz, Nico; Mueller, Klaus-Robert; Raetsch, Gunnar; Kloft, Marius			SVM2Motif-Reconstructing Overlapping DNA Sequence Motifs by Mimicking an SVM Predictor	PLOS ONE			English	Article								Identifying discriminative motifs underlying the functionality and evolution of organisms is a major challenge in computational biology. Machine learning approaches such as support vector machines (SVMs) achieve state-of-the-art performances in genomic discrimination tasks, but-due to its black-box character-motifs underlying its decision function are largely unknown. As a remedy, positional oligomer importance matrices (POIMs) allow us to visualize the significance of position-specific subsequences. Although being a major step towards the explanation of trained SVM models, they suffer from the fact that their size grows exponentially in the length of the motif, which renders their manual inspection feasible only for comparably small motif sizes, typically k <= 5. In this work, we extend the work on positional oligomer importance matrices, by presenting a new machine-learning methodology, entitled motifPOIM, to extract the truly relevant motifs-regardless of their length and complexity-underlying the predictions of a trained SVM model. Our framework thereby considers the motifs as free parameters in a probabilistic model, a task which can be phrased as a non-convex optimization problem. The exponential dependence of the POIM size on the oligomer length poses a major numerical challenge, which we address by an efficient optimization framework that allows us to find possibly overlapping motifs consisting of up to hundreds of nucleotides. We demonstrate the efficacy of our approach on a synthetic data set as well as a real-world human splice site data set.	[Vidovic, Marina M. -C.; Goernitz, Nico; Mueller, Klaus-Robert] Tech Univ Berlin, Machine Learning Grp, Berlin, Germany; [Mueller, Klaus-Robert] Korea Univ, Dept Brain & Cognit Engn, Seoul 136713, South Korea; [Raetsch, Gunnar] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Kloft, Marius] Humboldt Univ, Dept Comp Sci, D-10099 Berlin, Germany	Technical University of Berlin; Korea University; Memorial Sloan Kettering Cancer Center; Humboldt University of Berlin	Vidovic, MMC (corresponding author), Tech Univ Berlin, Machine Learning Grp, Berlin, Germany.	marina.vidovic@tu-berlin.de; klaus-robert.mueller@tu-berlin.de; ratschg@mskcc.org; kloft@hu-berlin.de	Mueller, Klaus-Robert/Y-3547-2019; Rätsch, Gunnar/O-5914-2017	Mueller, Klaus-Robert/0000-0002-3861-7685; Rätsch, Gunnar/0000-0001-5486-8532	German Research Foundation [KL 2698/1-1, KL 2698/2-1]; BMBF ALICE II grant [01IB15001B]; German Research Foundation through the grant DFG [MU 987/6-1, RA 1894/1-1]; National Research Foundation of Korea - Ministry of Education, Science, and Technology in the BK21 program; German Ministry for Education and Research as Berlin Big Data Center BBDC [01IS14013A]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	German Research Foundation(German Research Foundation (DFG)); BMBF ALICE II grant(Federal Ministry of Education & Research (BMBF)); German Research Foundation through the grant DFG(German Research Foundation (DFG)); National Research Foundation of Korea - Ministry of Education, Science, and Technology in the BK21 program; German Ministry for Education and Research as Berlin Big Data Center BBDC; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	MK acknowledges support by the German Research Foundation (http://www.dfg.de/en/) through the grant KL 2698/1-1 and KL 2698/2-1. MMCV and NG were supported by BMBF (http://www.bmbf.de) ALICE II grant 01IB15001B. The authors also acknowledge the support by the German Research Foundation through the grant DFG MU 987/6-1 and RA 1894/1-1. KRM is thankful for partial funding by the National Research Foundation of Korea (http://www.nrf.re.kr/nrf_eng_cms/) funded by the Ministry of Education, Science, and Technology in the BK21 program and the German Ministry for Education and Research (http://www.bmbf.de/en/) as Berlin Big Data Center BBDC, funding mark 01IS14013A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We greatly thank Sebastian Schultheiss, Soren Sonnenburg, Christian Widmer, Manu Setty, Alexander Zien and Christina Leslie for interesting discussions and helpful comments. MK acknowledges support by the German Research Foundation through the grant KL 2698/1-1 and KL 2698/2-1. MMCV and NG were supported by BMBF ALICE II grant 01IB15001B. We also acknowledge the support by the German Research Foundation through the grant DFG MU 987/6-1 and RA 1894/1-1. KRM thanks for partial funding by the National Research Foundation of Korea funded by the Ministry of Education, Science, and Technology in the BK21 program and the German Ministry for Education and Research as Berlin Big Data Center BBDC, funding mark 01IS14013A.	Abeel T, 2009, BIOINFORMATICS, DOI [10.1093/bioinformatics/btp191, DOI 10.1093/BI0INF0RMATICS/BTP191]; Bach S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130140; Baehrens D, 2010, J MACH LEARN RES, V11, P1803; Bailey T.L., 1994, FITTING A MIXTURE MO; Ben-Hur A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000173; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Cortes C., 2013, ADV NEURAL INFORM PR, P2760; Gornitz N, 2009, LECT NOTES ARTIF INT, V5781, P407, DOI 10.1007/978-3-642-04180-8_44; Gorntiz N, 2015, PR MACH LEARN RES, V37, P1833; Gornitz N., 2009, P 2 ACM WORKSH SEC A, P47, DOI 10.1145/1654988.1655002; Hansen K, 2011, MOL INFORM, V30, P817, DOI 10.1002/minf.201100059; Kloft M., 2011, ADV NEURAL INFORM PR, V24, P2438; Kloft M., 2008, P 1 ACM WORKSH WORKS, P71; Kloft M, 2011, J MACH LEARN RES, V12, P953; Kloft M, 2010, LECT NOTES ARTIF INT, V6322, P66, DOI 10.1007/978-3-642-15883-4_5; LESLIE C, 2002, P PSB, V7, P566; LIU DC, 1989, MATH PROGRAM, V45, P503, DOI 10.1007/BF01589116; Marius K., 2009, NIPS, P997; Montavon G, 2013, IEEE SIGNAL PROC MAG, V30, P62, DOI 10.1109/MSP.2013.2249294; Muller KR, 2001, IEEE T NEURAL NETWOR, V12, P181, DOI 10.1109/72.914517; Nakajima S, 2009, PROCEEDINGS OF THE 1, V24; Ratsch G, 2007, PLOS COMPUT BIOL, V3, P313, DOI 10.1371/journal.pcbi.0030020; Ratsch G., 2004, KERNEL METHODS COMPU, P277; Sandelin A, 2004, NUCLEIC ACIDS RES, V32, pD91, DOI 10.1093/nar/gkh012; Sandelin Albin, 2003, Functional & Integrative Genomics, V3, P125, DOI 10.1007/s10142-003-0086-6; Scholkopf B., 2002, LEARNING WITH KERNEL; Sonnenburg S, 2002, LECT NOTES COMPUT SC, V2415, P329; Sonnenburg S, 2010, P 27 INT C MACH LEAR, P999; Sonnenburg S, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S10-S7; Sonnenburg S, 2008, BIOINFORMATICS, V24, pI6, DOI 10.1093/bioinformatics/btn170; Sonnenburg S, 2006, BIOINFORMATICS, V22, pE472, DOI 10.1093/bioinformatics/btl250; Sonnenburg S, 2006, J MACH LEARN RES, V7, P1531; Sonnenburg S, 2010, J MACH LEARN RES, V11, P1799; Zeller G, 2013, ARXIV PREPRINT ARXIV; Zien A, 2000, BIOINFORMATICS, V16, P799, DOI 10.1093/bioinformatics/16.9.799; Zien A, 2007, COMPUTING POSITIONAL, P2	38	3	3	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144782	10.1371/journal.pone.0144782	http://dx.doi.org/10.1371/journal.pone.0144782			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690911	Green Submitted, Green Published, gold			2022-12-26	WOS:000367092300017
J	Xia, ZQ; Zhang, J; Xue, YK; Sun, GQ; Jin, Z				Xia, Zhi-Qiang; Zhang, Juan; Xue, Ya-Kui; Sun, Gui-Quan; Jin, Zhen			Modeling the Transmission of Middle East Respirator Syndrome Corona Virus in the Republic of Korea	PLOS ONE			English	Article							MERS-COV; DYNAMICS; OUTBREAK; LESSONS; DISEASE	The 2015 epidemic of Middle East respiratory syndrome (MERS) in the Republic of Korea has been the largest outbreak outside Middle East. This epidemic had caused 185 laboratory-confirmed cases and 36 deaths in the Republic of Korea until September 2, 2015, which attracted public's attention. Based on the detailed data of patients released by World Health Organization (WHO) and actual propagation of the epidemic, we construct two dynamical models to simulate the propagation processes from May 20 to June 8 and from June 9 to July 10, 2015, respectively and find that the basic reproduction number R-0 reaches up to 4.422. The numerical analysis shows that the reasons of the outbreak spread quickly are lack of self-protection sense and targeted control measures. Through partial correction analysis, the parameters a1 and. have strong correlations with R-0, i.e., the infectivity and proportion of the asymptomatic infected cases have much influence on the spread of disease. By sensitivity analysis, strengthening self-protection ability of susceptible and quickly isolating or monitoring close contacts are effective measures to control the disease.	[Xia, Zhi-Qiang; Xue, Ya-Kui] North Univ China, Dept Math, Taiyuan 030051, Shanxi, Peoples R China; [Xia, Zhi-Qiang; Zhang, Juan; Sun, Gui-Quan; Jin, Zhen] Shanxi Univ, Complex Syst Res Ctr, Taiyuan 030006, Shanxi, Peoples R China	North University of China; Shanxi University	Xue, YK (corresponding author), North Univ China, Dept Math, Taiyuan 030051, Shanxi, Peoples R China.	xyk5152@163.com; gquansun@126.com; jinzhn@263.net	jin, zhen/B-6563-2015; Sun, Gui-Quan/Y-3606-2019; Sun, Gui-Quan/AAE-7769-2019	jin, zhen/0000-0002-9763-707X; Sun, Gui-Quan/0000-0002-1831-1603; 	National Natural Science Foundation of China [11501338, 11171314, 11331009, 11301490]; 131 Talents of Shanxi University; Top Young Academic Leaders of Higher Learning Institutions of Shanxi Province; International Exchange Program of Postdoctor in Fudan University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 131 Talents of Shanxi University; Top Young Academic Leaders of Higher Learning Institutions of Shanxi Province; International Exchange Program of Postdoctor in Fudan University	The research is funded by the National Natural Science Foundation of China (under grants 11501338, 11171314, 11331009, and 11301490), 131 Talents of Shanxi University, Top Young Academic Leaders of Higher Learning Institutions of Shanxi Province, and International Exchange Program of Postdoctor in Fudan University.	Altizer S, 2006, ECOL LETT, V9, P467, DOI 10.1111/j.1461-0248.2005.00879.x; Assiri A, 2013, LANCET INFECT DIS, V13, P752, DOI 10.1016/S1473-3099(13)70204-4; Cauchemez S, 2013, EUROSURVEILLANCE, V18, P18; Chowell G, 2014, EPIDEMICS-NETH, V9, P40, DOI 10.1016/j.epidem.2014.09.011; Cowling BJ, 2015, EUROPEAN COMMUNICABL, V20; Drosten C, 2013, LANCET INFECT DIS, V13, P727, DOI 10.1016/S1473-3099(13)70159-2; Drosten C, 2013, LANCET INFECT DIS, V13, P745, DOI 10.1016/S1473-3099(13)70154-3; Ferguson NM, 2014, LANCET INFECT DIS, V14, P93, DOI 10.1016/S1473-3099(13)70691-1; Jansen A, 2015, WEST PAC SURVEILL RE, V6, P68, DOI [10.5365/WPSAR.2015.6.3.002, 10.5365/wpsar.2015.6.3.002]; Khan A, 2015, J INFECT DEV COUNTR, V9, P543, DOI 10.3855/jidc.7278; Lee SS, 2015, INT J INFECT DIS, V38, P65, DOI 10.1016/j.ijid.2015.07.014; Li MT, 2014, MATH BIOSCI ENG, V11, P1115, DOI 10.3934/mbe.2014.11.1115; Lim PL, 2015, T ROY SOC TROP MED H, V109, P541, DOI 10.1093/trstmh/trv064; Lovecraft H P, 2013, LANCET, V382, P694; Memish ZA, 2015, TRAVEL MED INFECT DI, V13, P311, DOI 10.1016/j.tmaid.2015.06.012; Mizumoto K, 2015, INT J INFECT DIS, V39, P7, DOI 10.1016/j.ijid.2015.08.005; Nishiura H, 2015, EUROSURVEILLANCE, V20, P6, DOI 10.2807/1560-7917.ES2015.20.27.21181; Rivers C, MODELING EMERGING IN; Sharif-Yakan A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004457; Su S, 2015, LANCET, V385, P2349, DOI 10.1016/S0140-6736(15)60859-5; Wang Z, 2015, PHYS LIFE REV, V15, P1, DOI 10.1016/j.plrev.2015.07.006; Wang Z, 2015, PHYS LIFE REV, V14, P1, DOI 10.1016/j.plrev.2015.04.033; Wang Z, 2015, EUR PHYS J B, V88, DOI 10.1140/epjb/e2015-60270-7; World Health Organization, 2015, INVESTIGATION OF CAS; World Health Organization, 2015, CLINICAL MANAGEMENT; Xia S, 2014, VIRUS RES, V194, P200, DOI 10.1016/j.virusres.2014.10.007; Xia ZQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13857; Zhang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108592; Zhang RongHua, 2015, Journal of Applied Virology, V4, P30	29	32	32	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144778	10.1371/journal.pone.0144778	http://dx.doi.org/10.1371/journal.pone.0144778			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690750	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092300016
J	Sanabria-Urban, S; Song, HJ; Oyama, K; Gonzalez-Rodriguez, A; Serrano-Meneses, MA; del Castillo, RC				Sanabria-Urban, Salomon; Song, Hojun; Oyama, Ken; Gonzalez-Rodriguez, Antonio; Serrano-Meneses, Martin A.; Cueva del Castillo, Raul			Body Size Adaptations to Altitudinal Climatic Variation in Neotropical Grasshoppers of the Genus Sphenarium (Orthoptera: Pyrgomorphidae)	PLOS ONE			English	Article							LIFE-HISTORY VARIATION; SEXUAL SELECTION; PURPURASCENS ORTHOPTERA; ONTOGENIC PERSPECTIVE; CORRELATED RESPONSE; RENSCHS RULE; DIMORPHISM; INSECTS; EVOLUTION; INFERENCE	Altitudinal clines in body size can result from the effects of natural and sexual selection on growth rates and developing times in seasonal environments. Short growing and reproductive seasons constrain the body size that adults can attain and their reproductive success. Little is known about the effects of altitudinal climatic variation on the diversification of Neotropical insects. In central Mexico, in addition to altitude, highly heterogeneous topography generates diverse climates that can occur even at the same latitude. Altitudinal variation and heterogeneous topography open an opportunity to test the relative impact of climatic variation on body size adaptations. In this study, we investigated the relationship between altitudinal climatic variation and body size, and the divergence rates of sexual size dimorphism (SSD) in Neotropical grasshoppers of the genus Sphenarium using a phylogenetic comparative approach. In order to distinguish the relative impact of natural and sexual selection on the diversification of the group, we also tracked the altitudinal distribution of the species and trends of both body size and SSD on the phylogeny of Sphenarium. The correlative evidence suggests no relationship between altitude and body size. However, larger species were associated with places having a warmer winter season in which the temporal window for development and reproduction can be longer. Nonetheless, the largest species were also associated with highly seasonal environments. Moreover, large body size and high levels of SSD have evolved independently several times throughout the history of the group and male body size has experienced a greater evolutionary divergence than females. These lines of evidence suggest that natural selection, associated with seasonality and sexual selection, on maturation time and body size could have enhanced the diversification of this insect group.	[Sanabria-Urban, Salomon; Cueva del Castillo, Raul] Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, UBIPRO, Lab Ecol, AP 314, Mexico City 54090, DF, Mexico; [Song, Hojun] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Oyama, Ken; Gonzalez-Rodriguez, Antonio] UNAM, Inst Invest Ecosistemas & Sustentabilidad, Morelia 58190, Michoacan, Mexico; [Serrano-Meneses, Martin A.] Univ Autonoma Tlaxcala, Ctr Tlaxcala Biol Conducta, Lab Biol Evolut, Tlaxcala 90062, Mexico	Universidad Nacional Autonoma de Mexico; Texas A&M University System; Texas A&M University College Station; Universidad Nacional Autonoma de Mexico	del Castillo, RC (corresponding author), Univ Nacl Autonoma Mexico, Fac Estudios Super Iztacala, UBIPRO, Lab Ecol, AP 314, Mexico City 54090, DF, Mexico.	rcueva@ecologia.unam.mx	Cueva del Castillo, Raul/D-3800-2018; Serrano-Meneses, Martin Alejandro/V-6601-2019	Cueva del Castillo, Raul/0000-0002-6385-0729; Serrano-Meneses, Martin Alejandro/0000-0002-0163-4983; Sanabria-Urban, Salomon/0000-0002-4079-498X	Universidad Nacional Autonoma de Mexico, Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica [IN 220214]; Consejo Nacional de Ciencia y Tecnologia, Ciencia Basica [57009]; PAPIIT-UNAM [IN220214]; CONACyT [57009, 262893]; NSF [IOS-1253493]	Universidad Nacional Autonoma de Mexico, Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica; Consejo Nacional de Ciencia y Tecnologia, Ciencia Basica; PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NSF(National Science Foundation (NSF))	This work was supported by the following sources of funding: Universidad Nacional Autonoma de Mexico, Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica: IN 220214; Consejo Nacional de Ciencia y Tecnologia, Ciencia Basica 57009.r We thank O. Tellez-Valdez, M. Arenas-Navarro and W. Ramirez-Toro for their support with the geographic information systems, E. Aguilar for her support in the laboratory and A. Blanco, A. Diaz-De la Vega, A. Pingarroni, F. A. Rivera-Ortiz, P. Gomez-Ruiz, R. Marino-Perez, P. Fontana and V. Jimenez-Arcos for their support in the field work. We thank E. Marino-Pedraza, M. F. O'brien and J. D. Weintraub for the facilities provided to review the museum type specimens. We thank Enio Cano for the facilities provided to obtain samples from Guatemala. Thanks also to Derek A. Woller for reviewing and editing the English of this manuscript. Matthias Foellmer, Matjaz Kuntner and an anonymous reviewer made valuable suggestions to improve the quality of the manuscript. This research was partially supported by the following projects: PAPIIT-UNAM IN220214, CONACyT-57009, and NSF IOS-1253493. S. Sanabria-Urban is a doctoral student from Programa de Doctorado en Ciencias Biomedicas, Universidad Nacional Autonoma de Mexico (UNAM) and received fellowship 262893 from CONACYT.	Abrams PA, 1996, AM NAT, V147, P381, DOI 10.1086/285857; [Anonymous], 2014, TRACER V1 6; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Badyaev AV, 2002, TRENDS ECOL EVOL, V17, P369, DOI 10.1016/S0169-5347(02)02569-7; Berner D, 2007, FUNCT ECOL, V21, P505, DOI 10.1111/j.1365-2435.2007.01253.x; Berner D, 2006, J ANIM ECOL, V75, P130, DOI 10.1111/j.1365-2656.2005.01028.x; Berner D, 2004, ECOGRAPHY, V27, P733, DOI 10.1111/j.0906-7590.2005.04012.x; Blanckenhorn WU, 2007, AM NAT, V169, P245, DOI 10.1086/510597; Blanckenhorn WU, 2004, INTEGR COMP BIOL, V44, P413, DOI 10.1093/icb/44.6.413; Blanckenhorn WU, 1997, OECOLOGIA, V109, P342, DOI 10.1007/s004420050092; Blanckenhorn WU, 2007, SEX SIZE GENDER ROLE, P278; Boyle WK, 1974, REVISION GENUS SPHEN; Bradshaw WE, 2008, MOL ECOL, V17, P157, DOI 10.1111/j.1365-294X.2007.03509.x; Brandt R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020040; Cano-Santana Z., 2009, BIODIVERSIDAD ECOSIS, P337; CHEVERUD JM, 1985, EVOLUTION, V39, P1335, DOI 10.1111/j.1558-5646.1985.tb05699.x; Chown SL, 2010, BIOL REV, V85, P139, DOI 10.1111/j.1469-185X.2009.00097.x; Cuervo-Robayo AP, 2014, INT J CLIMATOL, V34, P2427, DOI 10.1002/joc.3848; CUEVA D, 2003, J INSECT BEHAV, V16, P503, DOI DOI 10.1023/A:1027303323242; Dale J, 2007, P ROY SOC B-BIOL SCI, V274, P2971, DOI 10.1098/rspb.2007.1043; del Castillo RC, 1999, ECOL ENTOMOL, V24, P146, DOI 10.1046/j.1365-2311.1999.00188.x; del Castillo RC, 2002, OIKOS, V96, P217, DOI 10.1034/j.1600-0706.2002.960203.x; Del Castillo RC, 1999, EVOLUTION, V53, P209, DOI 10.1111/j.1558-5646.1999.tb05346.x; Descamps M., 1975, Folia Ent Mex, VNo. 31-32, P3; DINGLE H, 1990, OECOLOGIA, V84, P199, DOI 10.1007/BF00318272; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Eades DC, 2015, ORTHOPTERA SPECIES F; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659; Fairburn Daphne J., 2007, P1; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Foellmer MW, 2007, SEX SIZE GENDER ROLE, P278; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; Hadfield JD, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i02; Hagen SB, 2007, ECOGRAPHY, V30, P299, DOI [10.1111/j.2007.0906-7590.04981.x, 10.1111/j.0906-7590.2007.04981.x]; Harvey P, 1991, OXFORD SERIES ECOLOG; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Heled J, 2010, MOL BIOL EVOL, V27, P570, DOI 10.1093/molbev/msp274; Hodkinson ID, 2005, BIOL REV, V80, P489, DOI 10.1017/S1464793105006767; HONEK A, 1993, OIKOS, V66, P483, DOI 10.2307/3544943; Horne CR, 2015, ECOL LETT, V18, P327, DOI 10.1111/ele.12413; Ji YJ, 2003, MOL ECOL NOTES, V3, P581, DOI 10.1046/j.1471-8286.2003.00519.x; Jones KE, 1997, FUNCT ECOL, V11, P751, DOI 10.1046/j.1365-2435.1997.00149.x; Karl I, 2008, OIKOS, V117, P778, DOI 10.1111/j.0030-1299.2008.16522.x; Kevan D.K.M., 1978, Revista de la Sociedad Entomologica Argentina, V36, P3; KEVAN D. KEITH McE., 1964, PROC ACAD NATUR SCI PHILA, V116, P231; Krasnov B, 1996, J ARID ENVIRON, V34, P477, DOI 10.1006/jare.1996.0126; Laiolo P, 2013, J EVOLUTION BIOL, V26, P2171, DOI 10.1111/jeb.12213; Lanfear R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-82; Lehmann Gerund U. C., 2008, Journal of Orthoptera Research, V17, P165, DOI 10.1665/1082-6467-17.2.165; LOVICH JE, 1992, GROWTH DEVELOP AGING, V56, P269; Lugo-Olguin SD, 2007, ANN ENTOMOL SOC AM, V100, P591, DOI 10.1603/0013-8746(2007)100[591:MMFFAA]2.0.CO;2; Maddison, 2018, MESQUITE MODULAR SYS; Marques-Mayaudon C, 1962, AN I BIOL U MEX, V33, P247; Marquez C., 1965, AN I BIOL UNAM Z, V39, P107; Marquez M C., 1965, Anales del Instituto de Biologia Universidad de Mexico, V35, P87; McLean MJ, 2013, EVOL BIOL, V40, P141, DOI 10.1007/s11692-012-9197-0; Morbey YE, 2013, J THEOR BIOL, V339, P93, DOI 10.1016/j.jtbi.2013.05.009; MOUSSEAU TA, 1987, HEREDITY, V59, P181, DOI 10.1038/hdy.1987.113; Moya-Larano J, 2002, EVOLUTION, V56, P420, DOI 10.1111/j.0014-3820.2002.tb01351.x; Nylin S, 1998, ANNU REV ENTOMOL, V43, P63, DOI 10.1146/annurev.ento.43.1.63; O'Donnell M.S., 2012, US GEOLOGICAL SURVEY, V691, P10, DOI [DOI 10.3133/DS691, 10.1016/j.mimet.2011.04.001]; Orme D, 2013, R PACKAGE VERSION 0; Oyama K, 1994, ESTUDIOS INTERACCION, P301; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; PEREZ DE, 1995, ANN ENTOMOL SOC AM, V88, P31, DOI 10.1093/aesa/88.1.31; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Poissant J, 2010, EVOLUTION, V64, P97, DOI 10.1111/j.1558-5646.2009.00793.x; R Core Team, 2021, R LANGUAGE ENV STAT; Raihani G, 2006, ANIM BEHAV, V71, P833, DOI 10.1016/j.anbehav.2005.06.013; Reeve JP, 1996, EVOLUTION, V50, P1927, DOI [10.2307/2410751, 10.1111/j.1558-5646.1996.tb03580.x]; Rensch B., 1950, Bonner Zoologische Beitraege, V1, P58; ROFF D, 1980, OECOLOGIA, V45, P202, DOI 10.1007/BF00346461; Serrano Limon G., 1989, Anales del Instituto de Biologia Universidad Nacional Autonoma de Mexico Serie Zoologia, V59, P139; Serrano-Meneses MA, 2007, ANIM BEHAV, V73, P987, DOI 10.1016/j.anbehav.2006.08.012; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Sokal R. R., 1981, BIOMETRY; Sol D, 2014, P NATL ACAD SCI USA, V111, pE534, DOI 10.1073/pnas.1320729111; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Song HJ, 2009, INSECT SYST EVOL, V40, P159, DOI 10.1163/187631209X424571; Sorensen JG, 2005, J EVOLUTION BIOL, V18, P829, DOI 10.1111/j.1420-9101.2004.00876.x; Stillwell RC, 2010, ANNU REV ENTOMOL, V55, P227, DOI 10.1146/annurev-ento-112408-085500; Svenson GJ, 2004, SYST ENTOMOL, V29, P359, DOI 10.1111/j.0307-6970.2004.00240.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatarnic NJ, 2013, INVERTEBR SYST, V27, P307, DOI 10.1071/IS12072; Thornhill R., 1983, pi; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x; Webb TJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000897; Whitman Douglas W., 2008, Journal of Orthoptera Research, V17, P117, DOI 10.1665/1082-6467-17.2.117; WIKLUND C, 1991, OIKOS, V60, P373, DOI 10.2307/3545080; Wiklund C, 1988, AM NATURALIST, P132, DOI 10.1086/284779; Yom-Tov Y, 2006, OECOLOGIA, V148, P213, DOI 10.1007/s00442-006-0364-9	93	16	16	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145248	10.1371/journal.pone.0145248	http://dx.doi.org/10.1371/journal.pone.0145248			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684616	Green Published, gold, Green Submitted			2022-12-26	WOS:000366725800052
J	Agossa, FR; Gnanguenon, V; Anagonou, R; Azondekon, R; Aizoun, N; Sovi, A; Oke-Agbo, F; Sezonlin, M; Akogbeto, MC				Agossa, Fiacre R.; Gnanguenon, Virgile; Anagonou, Rodrigue; Azondekon, Roseric; Aizoun, Nazaire; Sovi, Arthur; Oke-Agbo, Frederic; Sezonlin, Michel; Akogbeto, Martin C.			Impact of Insecticide Resistance on the Effectiveness of Pyrethroid-Based Malaria Vectors Control Tools in Benin: Decreased Toxicity and Repellent Effect	PLOS ONE			English	Article							ANOPHELES-GAMBIAE-S.L.; TREATED NETS; BENDIOCARB; TRANSMISSION; POPULATIONS; EFFICACY	Since the first evidence of pyrethroids resistance in 1999 in Benin, mutations have rapidly increased in mosquitoes and it is now difficult to design a study including a control area where malaria vectors are fully susceptible. Few studies have assessed the after effect of resistance on the success of pyrethroid based prevention methods in mosquito populations. We therefore assessed the impact of resistance on the effectiveness of pyrethroids based indoor residual spraying (IRS) in semi-field conditions and long lasting insecticidal nets (LLINs) in laboratory conditions. The results observed showed low repulsion and low toxicity of pyrethroids compounds in the test populations. The toxicity of pyrethroids used in IRS was significantly low with An. gambiae s.l (< 46%) but high for other predominant species such as Mansonia africana (93% to 97%). There were significant differences in terms of the repellent effect expressed as exophily and deterrence compared to the untreated huts (P<0.001). Furthermore, mortality was 23.71% for OlyseNet (R) and 39.06% for PermaNet (R). However, with laboratory susceptible "Kisumu", mortality was 100% for both nets suggesting a resistance within the wild mosquito populations. Thus treatment with pyrethroids at World Health Organization recommended dose will not be effective at reducing malaria in the coming years. Therefore it is necessary to study how insecticide resistance decreases the efficacy of particular pyrethroids used in pyrethroid-based vector control so that a targeted approach can be adopted.	[Agossa, Fiacre R.; Gnanguenon, Virgile; Anagonou, Rodrigue; Azondekon, Roseric; Aizoun, Nazaire; Sovi, Arthur; Oke-Agbo, Frederic; Akogbeto, Martin C.] CREC, Cotonou, Benin; [Sezonlin, Michel; Akogbeto, Martin C.] FAST UAC, Lab Evolut Biodiversite Arthropodes & Assainissem, Abomey Calavi, Benin	Entomological Research Center of Cotonou (CREC); University of Abomey Calavi	Agossa, FR (corresponding author), CREC, Cotonou, Benin.	rofargossa@yahoo.fr		SOVI, ARTHUR/0000-0003-1294-2129; Azondekon, Roseric/0000-0001-9155-4153	Tagros under grant Tagros/CREC/; Tagros	Tagros under grant Tagros/CREC/; Tagros	The research leading to these results was financially supported by Tagros under grant Tagros/CREC/June 12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Tagros which funded this study. We acknowledge all volunteers from Malanville for participating and facilitating this study. We are also grateful to Simon MCollins for language editing.	Agossa FR, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-193; Agossa FR, 2014, T ROY SOC TROP MED H, V108, P84, DOI 10.1093/trstmh/trt117; Aikpon R, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-192; Akogbeto M, 1999, B SOC PATHOL EXOT, V92, P123; Akogbeto M, 2011, AM J TROP MED HYG, V85, P586, DOI 10.4269/ajtmh.2011.10-0668; Akogbeto MC, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-22; Akogbeto MC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-204; Alonso PL, 2011, PLOS MED, V8, DOI DOI 10.1371/J0URNA; [Anonymous], 2010, TECHNICAL REPORT; [Anonymous], 2010, VCC DEV NEW PUBL HLT; [Anonymous], 1985, INT GUIDING PRINCIPL; Corbel V, 2007, ACTA TROP, V101, P207, DOI 10.1016/j.actatropica.2007.01.005; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; Djegbe I, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-409; Djegbe I, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-261; Djouaka RF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-538; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Gnanguenon V, 2013, BMC PUBLIC HEALTH, V13, P1; Killeen GF, 2007, PLOS MED, V4, P1246, DOI 10.1371/journal.pmed.0040229; LAURENCE B. R., 1960, BULL ENT RES, V51, P491, DOI 10.1017/S0007485300055127; Malima RC, 2008, MALARIA J, V7, P6; Moore SJ, 2007, TROP MED INT HEALTH, V12, P532, DOI 10.1111/j.1365-3156.2006.01811.x; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Padonou GG, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-72; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Sovi A, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-319; Stanczyk NM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054438; Ughasi J, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-89; WHO, 2013, TEST PROC INS RES MA	29	15	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145207	10.1371/journal.pone.0145207	http://dx.doi.org/10.1371/journal.pone.0145207			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674643	gold, Green Published, Green Submitted			2022-12-26	WOS:000366722700114
J	Alves, J; Madureira, P; Baltazar, MT; Barros, L; Oliveira, L; Dinis-Oliveira, RJ; Andrade, EB; Ribeiro, A; Vieira, LM; Trieu-Cuot, P; Duarte, JA; Carvalho, F; Ferreira, P				Alves, Joana; Madureira, Pedro; Baltazar, Maria Teresa; Barros, Leandro; Oliveira, Liliana; Dinis-Oliveira, Ricardo Jorge; Andrade, Elva Bonifacio; Ribeiro, Adlia; Vieira, Luis Mira; Trieu-Cuot, Patrick; Duarte, Jose Alberto; Carvalho, Felix; Ferreira, Paula			A Safe and Stable Neonatal Vaccine Targeting GAPDH Confers Protection against Group B Streptococcus Infections in Adult Susceptible Mice	PLOS ONE			English	Article							NONPREGNANT ADULTS; DISEASE; PROTEINS; SURFACE; PREVENTION; SEROTYPES; TOXICITY; MARKERS; HUMANS; RATS	Group B Streptococcus (GBS), a commensal organism, can turn into a life-threatening pathogen in neonates and elderly, or in adults with severe underlying diseases such as diabetes. We developed a vaccine targeting the GBS glyceraldehyde-3-phosphate dehydrogenase (GAPDH), a glycolytic enzyme detected at the bacterial surface, which was proven to be effective in a neonatal mouse model of infection. Since this bacterium has emerged as an important pathogen in non-pregnant adults, here we investigated whether this vaccine also confers protection in an adult susceptible and in a diabetic mouse model of infection. For immunoprotection studies, sham or immunized adult mice were infected with GBS serotype Ia and V strains, the two most prevalent serotypes isolated in adults. Sham and vaccinated mice were also rendered diabetic and infected with a serotype V GBS strain. For toxicological (pre-clinical) studies, adult mice were vaccinated three times, with three concentrations of recombinant GAPDH adjuvanted with Allydrogel, and the toxicity parameters were evaluated twenty-four hours after the last immunization. For the stability tests, the vaccine formulations were maintained at 4 degrees C for 6 and 12 months prior immunization. The results showed that all tested doses of the vaccine, including the stability study formulations, were immunogenic and that the vaccine was innocuous. The organs (brain, blood, heart, and liver) of vaccinated susceptible or diabetic adult mice were significantly less colonized compared to those of control mice. Altogether, these results demonstrate that the GAPDH-based vaccine is safe and stable and protects susceptible and diabetic adult mice against GBS infections. It is therefore a promising candidate as a global vaccine to prevent GBS-induced neonatal and adult diseases.	[Alves, Joana; Madureira, Pedro; Barros, Leandro; Oliveira, Liliana; Andrade, Elva Bonifacio; Ribeiro, Adlia; Vieira, Luis Mira; Ferreira, Paula] Univ Porto, ICBAS, P-4100 Porto, Portugal; [Alves, Joana; Madureira, Pedro; Oliveira, Liliana; Andrade, Elva Bonifacio; Ribeiro, Adlia; Ferreira, Paula] Univ Porto, Inst Invest & Inovacao Saude, P-4100 Porto, Portugal; [Alves, Joana; Madureira, Pedro; Oliveira, Liliana; Andrade, Elva Bonifacio; Ribeiro, Adlia; Ferreira, Paula] Univ Porto, IBMC, P-4100 Porto, Portugal; [Baltazar, Maria Teresa; Dinis-Oliveira, Ricardo Jorge; Carvalho, Felix] Univ Porto, Fac Farm, REQUIMTE, Toxicol Lab, P-4100 Porto, Portugal; [Dinis-Oliveira, Ricardo Jorge] Univ Porto, Fac Med, Dept Legal Med & Forens Sci, P-4100 Porto, Portugal; [Dinis-Oliveira, Ricardo Jorge] CRL, Inst Res & Adv Training Hlth Sci & Technol, Adv Inst Hlth Sci, IINFACTS,Dept Sci,North ISCS N,CESPU, Gandra, Portugal; [Trieu-Cuot, Patrick] Inst Pasteur, Unite Biol Bacteries Pathogenes Gram Positif, CNRS, ERL 3526, Paris, France; [Duarte, Jose Alberto] Univ Porto, Fac Desporto, CIAFEL, P-4100 Porto, Portugal	Universidade do Porto; Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; Universidade do Porto; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Universidade do Porto	Ferreira, P (corresponding author), Univ Porto, ICBAS, Rua Campo Alegre 823, P-4100 Porto, Portugal.	pauferr@icbas.up.pt	Duarte, Jose Alberto/F-1443-2013; Oliveira, Liliana/AAX-9115-2021; Andrade, Elva Bonifácio/K-3096-2013; Carvalho, Félix/D-4914-2013; Oliveira, Liliana/K-5859-2013; Dinis-Oliveira, Ricardo Jorge/D-9186-2013; Madureira, Pedro/D-2174-2013; Alves, Joana EV/J-6866-2013; Ferreira da Silva, Paula/J-6149-2013	Duarte, Jose Alberto/0000-0003-4756-5917; Oliveira, Liliana/0000-0001-5222-7600; Andrade, Elva Bonifácio/0000-0002-1941-580X; Carvalho, Félix/0000-0003-3858-3494; Oliveira, Liliana/0000-0001-5222-7600; Dinis-Oliveira, Ricardo Jorge/0000-0001-7430-6297; Madureira, Pedro/0000-0003-4078-800X; Alves, Joana EV/0000-0003-3131-9834; TRIEU-CUOT, Patrick/0000-0002-2768-9587; Barros, Leandro/0000-0002-7339-9994; Ferreira da Silva, Paula/0000-0001-8639-9224	European Regional Development Fund (FEDER) through the Operational Competitiveness Program (COMPETE) under Project FCOMP [01-0124-FEDER-015841]; National funds from the Foundation for Science and Technology (FCT) [PTDC/SAU - MIC/111387/2009, RFH/BD/77232/2011, SFRH/BPD/88137/2012]	European Regional Development Fund (FEDER) through the Operational Competitiveness Program (COMPETE) under Project FCOMP; National funds from the Foundation for Science and Technology (FCT)	This work was supported by funds from European Regional Development Fund (FEDER) through the Operational Competitiveness Program (COMPETE) under Project FCOMP [01-0124-FEDER-015841] and National funds from the Foundation for Science and Technology (FCT) [PTDC/SAU - MIC/111387/2009, RFH/BD/77232/2011 to JA and SFRH/BPD/88137/2012 to PM].	BAKER CJ, 1976, NEW ENGL J MED, V294, P753, DOI 10.1056/NEJM197604012941404; BAKER CJ, 1985, REV INFECT DIS, V7, P458; Barrow P, 2012, J PHARMACOL TOX MET, V65, P58, DOI 10.1016/j.vascn.2011.12.001; Bellais S, 2012, J INFECT DIS, V206, P1745, DOI 10.1093/infdis/jis605; Bergseng H, 2008, EUR J CLIN MICROBIOL, V27, P1193, DOI 10.1007/s10096-008-0565-8; BERNARD A, 1995, TOXICOL LETT, V77, P145, DOI 10.1016/0378-4274(95)03284-3; Black S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005451; Blancas D, 2004, EUR J CLIN MICROBIOL, V23, P168, DOI 10.1007/s10096-003-1098-9; Bozbas H, 2006, CLIN MED RES, V4, P79, DOI 10.3121/cmr.4.1.79; Chen DX, 2013, J PHARM SCI-US, V102, P29, DOI 10.1002/jps.23352; Da Cunha V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5544; Dinis M, 2009, J INFECT DIS, V199, P116, DOI 10.1086/594372; Dinis-Oliveira RJ, 2007, FREE RADICAL BIO MED, V42, P1017, DOI 10.1016/j.freeradbiomed.2006.12.031; Domingo P, 1997, CLIN INFECT DIS, V25, P1180, DOI 10.1086/516094; Edwards MS, 2008, HUM VACCINES, V4, P444, DOI 10.4161/hv.4.6.6507; FABINY DL, 1971, CLIN CHEM, V17, P696; Farley MM, 2001, CLIN INFECT DIS, V33, P556, DOI 10.1086/322696; Feng YJ, 2009, J INFECT DIS, V200, P1583, DOI 10.1086/644602; Forster R, 2012, J PHARMACOL TOX MET, V66, P1, DOI 10.1016/j.vascn.2012.04.003; Hayashi K, 2006, BIOL PHARM BULL, V29, P1110, DOI 10.1248/bpb.29.1110; Henningham A, 2012, J MOL MED, V90, P1197, DOI 10.1007/s00109-012-0897-9; Hill SA, 2009, FEMS MICROBIOL REV, V33, P521, DOI 10.1111/j.1574-6976.2009.00171.x; JACKSON LA, 1995, ANN INTERN MED, V123, P415, DOI 10.7326/0003-4819-123-6-199509150-00003; Jeffery CJ, 2009, MOL BIOSYST, V5, P345, DOI 10.1039/b900658n; Johri AK, 2006, NAT REV MICROBIOL, V4, P932, DOI 10.1038/nrmicro1552; Jordan HT, 2008, PEDIATR INFECT DIS J, V27, P1057, DOI 10.1097/INF.0b013e318180b3b9; Kim SB, 1998, NEPHROL DIAL TRANSPL, V13, P2053, DOI 10.1093/ndt/13.8.2053; Knezevic I, 2009, BIOLOGICALS, V37, P357, DOI 10.1016/j.biologicals.2009.08.004; Lachenauer CS, 1999, J INFECT DIS, V179, P1030, DOI 10.1086/314666; Ling E, 2004, CLIN EXP IMMUNOL, V138, P290, DOI 10.1111/j.1365-2249.2004.02628.x; Madureira P, 2007, J IMMUNOL, V178, P1379, DOI 10.4049/jimmunol.178.3.1379; Madureira P, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002363; Magalhaes V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063244; Margarit I, 2009, J INFECT DIS, V199, P108, DOI 10.1086/595564; Martins ER, 2012, J CLIN MICROBIOL, V50, P1219, DOI 10.1128/JCM.05488-11; Matull WR, 2006, J CLIN PATHOL, V59, P340, DOI 10.1136/jcp.2002.002923; Obianime A W, 2009, Niger J Physiol Sci, V24, P177; Oliveira L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029963; Palmeira P, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/985646; Palmeiro JK, 2011, VACCINE, V29, P3729, DOI 10.1016/j.vaccine.2011.02.102; Persson E, 2004, CLIN MICROBIOL INFEC, V10, P791, DOI 10.1111/j.1469-0691.2004.00931.x; Sambola A, 2002, CLIN INFECT DIS, V34, P1576, DOI 10.1086/340538; Schrag SJ, 2000, NEW ENGL J MED, V342, P15, DOI 10.1056/NEJM200001063420103; Seifert KN, 2003, CAN J MICROBIOL, V49, P350, DOI 10.1139/W03-042; Skoff TH, 2009, CLIN INFECT DIS, V49, P85, DOI 10.1086/599369; TALKE H, 1965, KLIN WOCHENSCHR, V43, P174, DOI 10.1007/BF01484513; Tazi A, 2011, CLIN MICROBIOL INFEC, V17, P1587, DOI 10.1111/j.1469-0691.2011.03628.x; Watterson C, 2009, TOXICOL PATHOL, V37, P28, DOI 10.1177/0192623308329286; Zeissig S, 2014, NAT IMMUNOL, V15, P307, DOI 10.1038/ni.2847	49	9	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144196	10.1371/journal.pone.0144196	http://dx.doi.org/10.1371/journal.pone.0144196			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673420	Green Published, gold			2022-12-26	WOS:000366722700029
J	Fan, GX; Guan, XF; Sun, Q; Hu, AN; Zhu, YJ; Gu, GF; Zhang, HL; He, SS				Fan, Guoxin; Guan, Xiaofei; Sun, Qi; Hu, Annan; Zhu, Yanjie; Gu, Guangfei; Zhang, Hailong; He, Shisheng			Puncture Reduction in Percutaneous Transforaminal Endoscopic Discectomy with HE's Lumbar LOcation (HELLO) System: A Cadaver Study	PLOS ONE			English	Article							OPERATING-ROOM PERSONNEL; RADIATION-EXPOSURE; INTERBODY FUSION; SPINAL SURGERY; STENOSIS	Background Percutaneous transforaminal endoscopic discectomy (PTED) usually requires numerous punctures under X-ray fluoroscopy. Repeated puncture will lead to more radiation exposure and reduce the beginners' confidence. Objective This cadaver study aimed to investigate the efficacy of HE's Lumbar Location (HELLO) system in puncture reduction of PTED. Study design Cadaver study. Setting Comparative groups. Methods HELLO system consists of self-made surface locator and puncture locator. One senior surgeon conducted the puncture procedure of PTED on the left side of 20 cadavers at L4/L5 and L5/S1 level with the assistance of HELLO system (Group A). Additionally, the senior surgeon conducted the puncture procedure of PTED on the right side of the cadavers at L4/L5 and L5/S1 level with traditional methods (Group B). On the other hand, an inexperienced surgeon conducted the puncture procedure of PTED on the left side of the cadavers at L4/L5 and L5/S1 level with the assistance of our HELLO system (Group C). Results At L4/L5 level, there was significant difference in puncture times between Group A and Group B (P<0.001), but no significant difference was observed between Group A and Group C (P = 0.811). Similarly at L5/S1 level, there was significant difference in puncture times between Group A and Group B (P<0.001), but no significant difference was observed between Group A and Group C (P = 0.981). At L4/L5 level, there was significant difference in fluoroscopy time between Group A and Group B (P<0.001), but no significant difference was observed between Group A and Group C (P = 0.290). Similarly at L5/S1 level, there was significant difference in fluoroscopy time between Group A and Group B (P<0.001), but no significant difference was observed between Group A and Group C (P = 0.523). As for radiation exposure, HELLO system reduced 39%-45% radiation dosage when comparing Group A and Group B, but there was no significant difference in radiation exposure between Group A and Group C whatever at L4/L5 level or L5/S1 level (P>0.05). There was no difference in location time between Group A and Group B or Group A and Group C either at L4/L5 level or L5/S1 level (P>0.05). Limitations Small-sample preclinical study. Conclusion HELLO system was effective in reducing puncture times, fluoroscopy time and radiation exposure, as well as the difficulty of learning PTED. (2015-RES-127)	[Fan, Guoxin; Guan, Xiaofei; Sun, Qi; Hu, Annan; Zhu, Yanjie; Gu, Guangfei; Zhang, Hailong; He, Shisheng] Tongji Univ, Sch Med, Dept Orthoped, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China	Tongji University	He, SS (corresponding author), Tongji Univ, Sch Med, Dept Orthoped, Shanghai Peoples Hosp 10, Shanghai 200092, Peoples R China.	tjhss7418@foxmail.com			National College Students' Innovative Project-Tongji University [1500107108]	National College Students' Innovative Project-Tongji University	This study was supported by the National College Students' Innovative Project-Tongji University (1500107108).	Abdullah KG, 2012, SPINE, V37, pE1074, DOI 10.1097/BRS.0b013e31825786d8; Ahn Y, 2014, EXPERT REV MED DEVIC, V11, P605, DOI 10.1586/17434440.2014.940314; Ahn Y, 2013, SPINE, V38, P617, DOI 10.1097/BRS.0b013e318275ca58; Ahn Y, 2012, EXPERT REV MED DEVIC, V9, P361, DOI [10.1586/erd.12.23, 10.1586/ERD.12.23]; Fan GX, 2015, J PEDIATR ORTHOPED, V35, pE37, DOI 10.1097/BPO.0000000000000279; Fan GX, 2015, J SPINAL DISORD TECH, V28, pE173, DOI 10.1097/BSD.0000000000000210; Fan GX, 2015, SPINE J, V15, P797, DOI 10.1016/j.spinee.2014.09.034; Fan GX, 2014, J SPINAL DISORD TECH, V27, P448, DOI 10.1097/BSD.0000000000000083; Gu G, 2013, J SPINAL DISORD TECH; Gu GF, 2013, J SPINAL DISORD TECH, V26, pE277, DOI 10.1097/BSD.0b013e31828677d8; Kafadar A, 2006, MINIM INVAS NEUROSUR, V49, P74, DOI 10.1055/s-2006-932184; Moses ZB, 2013, NEUROSURG FOCUS, V35, DOI 10.3171/2013.5.FOCUS13150; Mulconrey DS, 2013, J SPINAL DISORD TECH; Nellensteijn J, 2010, EUR SPINE J, V19, P879, DOI 10.1007/s00586-009-1272-6; Nellensteijn J, 2010, EUR SPINE J, V19, P181, DOI 10.1007/s00586-009-1155-x; Tabaraee E, 2013, SPINE, V38, P1953, DOI 10.1097/BRS.0b013e3182a51d1e; Taher F, 2013, SPINE, V38, P1386, DOI 10.1097/BRS.0b013e31828705ad; Zhang L, 2014, MINIM INVASIV THER, V23, P173, DOI 10.3109/13645706.2013.870914	18	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144939	10.1371/journal.pone.0144939	http://dx.doi.org/10.1371/journal.pone.0144939			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674640	Green Submitted, Green Published, gold			2022-12-26	WOS:000366722700075
J	Boa, ISF; Porto, ML; Pereira, ACH; Ramos, JPL; Scherer, R; Oliveira, JP; Nogueira, BV; Meyrelles, SS; Vasquez, EC; Endringer, DC; Pereira, TMC				Fonte Boa, Igor Santos; Porto, Marcella Leite; Hertel Pereira, Ana Claudia; Louzada Ramos, Jean Pierre; Scherer, Rodrigo; Oliveira, Jairo Pinto; Nogueira, Breno Valentim; Meyrelles, Silvana Santos; Vasquez, Elisardo Corral; Endringer, Denise Coutinho; Costa Pereira, Thiago Melo			Resin from Virola oleifera Protects Against Radiocontrast-Induced Nephropathy in Mice	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; CONTRAST-INDUCED NEPHROPATHY; OXIDATIVE STRESS; RENOVASCULAR HYPERTENSION; ASCORBIC-ACID; NITRIC-OXIDE; RISK-FACTORS; DNA-DAMAGE; PREVENTION; MEDIA	Contrast-induced nephropathy (CIN) is an iatrogenic medical event for which there is not yet a successful therapy. Increasing evidence in rodents has suggested that this disease is associated with renal tubular and vascular injury that is triggered directly by oxidative stress. In the present study, we evaluated whether the antioxidant resin from Virola oleifera (RV) could attenuate renal damage in an experimental mouse model of CIN. Adult male Swiss mice were divided into six groups and pre-treated orally with RV (10, 100 and 300 mg/kg), N-acetylcysteine (200 mg/kg) or vehicle for 5 days before the induction of CIN and Control group. Renal function was assessed by measuring plasma creatinine and urea levels. Additionally, renal oxidative stress and apoptosis/cell viability were determined with flow cytometry. Finally, kidney tissues were sectioned for histopathological examination. In this CIN model, pre-treatment with RV improved renal function, lowered the mortality rate, and reduced oxidative stress and apoptosis in both the medulla and cortex renal cells in a dose-dependent manner. Moreover, the RV treatment had beneficial effects on kidney histopathology that were superior to the standard treatment with N-acetylcysteine. These data suggest that because of its antioxidative and antiapoptotic effects and its ability to preserve renal function, resin from Virola oleifera may have potential as a new therapeutic approach for preventing CIN.	[Fonte Boa, Igor Santos; Hertel Pereira, Ana Claudia; Louzada Ramos, Jean Pierre; Scherer, Rodrigo; Vasquez, Elisardo Corral; Endringer, Denise Coutinho; Costa Pereira, Thiago Melo] Vila Velha Univ UVV, Pharmaceut Sci Grad Program, Vila Velha, ES, Brazil; [Porto, Marcella Leite; Meyrelles, Silvana Santos; Vasquez, Elisardo Corral] Univ Fed Espirito Santo, Hlth Sci Ctr, Lab Translat Physiol, Vitoria, Brazil; [Oliveira, Jairo Pinto; Nogueira, Breno Valentim] Univ Fed Espirito Santo, Dept Morphol, Hlth Sci Ctr, Vitoria, Brazil; [Endringer, Denise Coutinho; Costa Pereira, Thiago Melo] Fed Inst Educ Sci & Technol IFES, Vila Velha, ES, Brazil	Centro Universitario Vila Velha; Universidade Federal do Espirito Santo; Universidade Federal do Espirito Santo; Instituto Federal do Espirito Santo (IFES)	Pereira, TMC (corresponding author), Vila Velha Univ UVV, Pharmaceut Sci Grad Program, Vila Velha, ES, Brazil.	pereiratmc@gmail.com	Endringer, Denise C/N-7520-2017; OLIVEIRA, JAIRO/I-7147-2019; Meyrelles, Silvana/GPW-5312-2022; Endringer, Denise/AAB-5156-2021; Scherer, Rodrigo/J-8594-2012; NOGUEIRA, BRENO/X-7418-2019; Vasquez, Elisardo C/D-5885-2012; NOGUEIRA, BRENO VALENTIM/O-7459-2016	Endringer, Denise C/0000-0001-9396-2097; OLIVEIRA, JAIRO/0000-0001-7595-1183; Meyrelles, Silvana/0000-0003-0167-4093; Endringer, Denise/0000-0001-9396-2097; Scherer, Rodrigo/0000-0001-7656-0248; NOGUEIRA, BRENO/0000-0002-2199-0635; Vasquez, Elisardo C/0000-0002-7169-5634; NOGUEIRA, BRENO VALENTIM/0000-0002-2199-0635	National Council for the Development of Science and Technology (CNPq) [445080/2014-0]; State Agency for the Development of Science and Technology (FAPES) [60619392/2012, 61581321/2013]	National Council for the Development of Science and Technology (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); State Agency for the Development of Science and Technology (FAPES)	This study was supported by the National Council for the Development of Science and Technology (CNPq, 445080/2014-0 Grant, http://carloschagas.cnpq.br/) and the State Agency for the Development of Science and Technology (FAPES, 60619392/2012 and 61581321/2013 Grants, http://www.fapes.es.gov.br/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the National Council for the Development of Science and Technology (CNPq, 445080/2014-0 Grant) and the State Agency for the Development of Science and Technology (FAPES- 60619392/2012 and 61581321/2013 Grants). We are grateful to Dr. Rogerio Piontkowski, Arthur Lourensute Porto and Tommasi Laboratory analysis for use of their facilities and the Laboratory of Cellular Ultrastructure Carlos Alberto Redins (LUCCAR) for technical assistance and use of the microscope.	AGMON Y, 1994, J CLIN INVEST, V94, P1069, DOI 10.1172/JCI117421; Andreucci M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/362725; Baliano A. P., 2015, Ethnobotany Research and Applications, V14, P155; Barrett BJ, 2006, NEW ENGL J MED, V354, P379, DOI 10.1056/NEJMcp050801; BECKMAN JS, 1993, BIOCHEM SOC T, V21, P330, DOI 10.1042/bst0210330; Billings FT, 2008, AM J PHYSIOL-RENAL, V295, pF741, DOI 10.1152/ajprenal.90244.2008; Brune B, 2003, KIDNEY INT, V63, pS22; Bunel V, 2015, TOXICOL IN VITRO, V29, P458, DOI 10.1016/j.tiv.2014.12.017; Carvalho AAV, 2010, PHYTOTHER RES, V24, P113, DOI 10.1002/ptr.2882; Cheng CW, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/161235; Colbay M, 2010, EXP TOXICOL PATHOL, V62, P81, DOI 10.1016/j.etp.2009.02.119; Colombo AF, 2010, BRAZ J BIOL, V70, P697, DOI 10.1590/S1519-69842010000400002; Curtis LM, 2007, KIDNEY INT, V72, P907, DOI 10.1038/sj.ki.5002530; Dias AT, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-35; Domitrovic R, 2014, FOOD CHEM TOXICOL, V66, P321, DOI 10.1016/j.fct.2014.02.002; Duan SB, 2013, RENAL FAILURE, V35, P150, DOI 10.3109/0886022X.2012.741650; FERNANDES AMAP, 1993, PHYTOCHEMISTRY, V32, P1567, DOI 10.1016/0031-9422(93)85181-P; Goldenberg I, 2005, CAN MED ASSOC J, V172, P1461, DOI 10.1503/cmaj.1040847; Goldfarb S, 2009, MAYO CLIN PROC, V84, P170, DOI 10.1016/S0025-6196(11)60825-2; Gomes IBS, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00247; Gomes IBS, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-184; Grassi D, 2010, NUTRIENTS, V2, P889, DOI 10.3390/nu2080889; Gurm HS, 2012, JACC-CARDIOVASC INTE, V5, P98, DOI 10.1016/j.jcin.2011.09.019; Heyman SN, 2010, INVEST RADIOL, V45, P188, DOI 10.1097/RLI.0b013e3181d2eed8; Hizoh I, 2002, INVEST RADIOL, V37, P428, DOI 10.1097/00004424-200208000-00003; Itoh Y, 2005, J PHARMACOL SCI, V97, P473, DOI 10.1254/jphs.CRJ05002X; Kalyanaraman B, 2013, REDOX BIOL, V1, P244, DOI 10.1016/j.redox.2013.01.014; Karami M, 2014, IRAN J BASIC MED SCI, V17, P69; Khan AM, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.163; Kinaci MK, 2012, EXP THER MED, V3, P249, DOI 10.3892/etm.2011.382; Kongkham S, 2013, NEFROLOGIA, V33, P116, DOI 10.3265/Nefrologia.pre2012.Nov.11736; Kwak KH, 2014, EXP THER MED, V7, P508, DOI 10.3892/etm.2013.1440; Lauver DA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113598; Lee HT, 2006, AM J PHYSIOL-RENAL, V290, pF1367, DOI 10.1152/ajprenal.00347.2005; Liu SS, 2013, AM J PHYSIOL-RENAL, V305, pF1533, DOI 10.1152/ajprenal.00656.2012; Lopez-Novoa JM, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-13; McCullough PA, 2013, J AM COLL CARDIOL, V62, P2176, DOI 10.1016/j.jacc.2013.07.066; Michael A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/249810; Milaneze B., 2014, BMC P, V8, pP29, DOI [10.1186/1753-6561-8-S4-P29, DOI 10.1186/1753-6561-8-S4-P29]; Nogueira BV, 2012, CELL PHYSIOL BIOCHEM, V29, P143, DOI 10.1159/000337595; Rua EDO, 2014, J BIOMED SCI, V21, DOI 10.1186/s12929-014-0105-z; Osthoff M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/962695; Pashkow FJ, 2011, INT J INFLAMM, V2011, DOI 10.4061/2011/514623; Pattharanitima P, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/236930; Persson PB, 2005, KIDNEY INT, V68, P14, DOI 10.1111/j.1523-1755.2005.00377.x; Poljsak B, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/956792; Scherer R, 2009, FOOD CHEM, V112, P654, DOI 10.1016/j.foodchem.2008.06.026; Seeliger E, 2012, EUR HEART J, V33, P2007, DOI 10.1093/eurheartj/ehr494; Setsukinai K, 2003, J BIOL CHEM, V278, P3170, DOI 10.1074/jbc.M209264200; Singh JP, 2014, J SURG RES, V187, P631, DOI 10.1016/j.jss.2013.11.1088; Spargias K, 2004, CIRCULATION, V110, P2837, DOI 10.1161/01.CIR.0000146396.19081.73; Tepel M, 2000, NEW ENGL J MED, V343, P180, DOI 10.1056/NEJM200007203430304; Tonini CL, 2013, INT J MOL SCI, V14, P3325, DOI 10.3390/ijms14023325; Wu HL, 2007, J AM SOC NEPHROL, V18, P1180, DOI 10.1681/ASN.2006060622; Yokomaku Y, 2008, J AM SOC NEPHROL, V19, P321, DOI 10.1681/ASN.2007040481; Zager RA, 2003, KIDNEY INT, V64, P128, DOI 10.1046/j.1523-1755.2003.00059.x	56	13	14	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144329	10.1371/journal.pone.0144329	http://dx.doi.org/10.1371/journal.pone.0144329			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674346	Green Published, Green Submitted, gold			2022-12-26	WOS:000366722700035
J	Luo, WM; Kong, J; Gong, Y; Liu, XQ; Yang, RX; Zhao, YX				Luo, Wei-min; Kong, Jing; Gong, Yan; Liu, Xiao-qiong; Yang, Rui-xue; Zhao, Yu-xia			Tongxinluo Protects against Hypertensive Kidney Injury in Spontaneously-Hypertensive Rats by Inhibiting Oxidative Stress and Activating Forkhead Box O1 Signaling	PLOS ONE			English	Article							GINSENOSIDE RG1; MESENCHYMAL TRANSITION; RENAL STRUCTURE; BLOOD-PRESSURE; TRANSCRIPTION; PODOCYTES; DISEASE; INFLAMMATION; MARKERS; DAMAGE	Hypertension is an independent risk factor for the progression of chronic renal failure, and oxidative stress plays a critical role in hypertensive renal damage. Forkbox O1(FoxO1) signaling protects cells against oxidative stress and may be a useful target for treating oxidative stress-induced hypertension. Tongxinluo is a traditional Chinese medicine with cardioprotective and renoprotective functions. Therefore, this study aimed to determine the effects of Tongxinluo in hypertensive renal damage in spontaneously hypertensive rats (SHRs) and elucidate the possible involvement of oxidative stress and FoxO1 signaling in its molecular mechanisms. SHRs treated with Tongxinluo for 12 weeks showed a reduction in systolic blood pressure. In addition to increasing creatinine clearance, Tongxinluo decreased urinary albumin excretion, oxidative stress injury markers including malondialdehyde and protein carbonyls, and expression of nicotinamide adenine dinucleotide phosphate oxidase subunits and its activity in SHR kidneys. While decreasing phosphorylation of FoxO1, Tongxinluo also inhibited the phosphorylation of extracellular signal-regulated kinase1/2 and p38 and enhanced manganese superoxide dismutase and catalase activities in SHR kidneys. Furthermore, histology revealed attenuation of glomerulosclerosis and renal podocyte injury, while Tongxinluo decreased the expression of alpha-smooth muscle actin, extracellular matrixprotein, transforming growth factor beta 1 and small mothers against decapentaplegic homolog 3, and improved tubulointerstitial fibrosis in SHR kidneys. Finally, Tongxinluo inhibited inflammatory cell infiltration as well as expression of tumor necrosis factor-a and interleukin-6. In conclusion, Tongxinluo protected SHRs against hypertension-induced renal injury by exerting antioxidant, antifibrotic, and anti-inflammatory activities. Moreover, the underlying mechanisms of these effects may involve inhibition of oxidative stress and functional activation of FoxO1 signaling.	[Luo, Wei-min; Kong, Jing] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Jinan, Shandong, Peoples R China; [Luo, Wei-min; Zhao, Yu-xia] Shandong Univ, Qilu Hosp, Dept Tradit Chinese Med, Jinan, Shandong, Peoples R China; [Gong, Yan] Jinan Hosp Infect Dis, Dept Magnet Resonance Imaging, Jinan, Shandong, Peoples R China; [Liu, Xiao-qiong; Yang, Rui-xue] Shandong Univ, Qilu Hosp, Dept Cardiol, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University	Zhao, YX (corresponding author), Shandong Univ, Qilu Hosp, Dept Tradit Chinese Med, Jinan, Shandong, Peoples R China.	yxzhao@sdu.edu.cn		Luo, Weimin/0000-0002-3403-4183	National 973 Basic Research Program of China [2012CB518603]; National Natural Science Foundation of China [30873325, 81100103, 81173251, 81302939]; Shandong Province Medical Science and Technology Development Plan [2014WS0147]	National 973 Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Medical Science and Technology Development Plan	This work was supported by the National 973 Basic Research Program of China, www.973.gov.cn (no. 2012CB518603 to YXZ), the National Natural Science Foundation of China, www.nsfc.gov.cn (30873325, 81100103, 81173251, 81302939 to YXZ), and the Shandong Province Medical Science and Technology Development Plan, www.sdwsjs.gov.cn (2014WS0147 to RXY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal D, 2012, ANTIOXID REDOX SIGN, V16, P139, DOI 10.1089/ars.2011.3967; Ambrogini E, 2010, CELL METAB, V11, P136, DOI 10.1016/j.cmet.2009.12.009; Asada S, 2007, CELL SIGNAL, V19, P519, DOI 10.1016/j.cellsig.2006.08.015; Biswas SK, 2007, FREE RADICAL RES, V41, P216, DOI 10.1080/10715760601059672; Boccitto M, 2011, CURR DRUG TARGETS, V12, P1303, DOI 10.2174/138945011796150316; Cao HB, 2014, TRIALS, V15, DOI 10.1186/1745-6215-15-84; Chandran G, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/608512; Cifarelli V, 2012, MOL ENDOCRINOL, V26, P1213, DOI 10.1210/me.2011-1276; Crews DC, 2010, HYPERTENSION, V55, P1102, DOI 10.1161/HYPERTENSIONAHA.110.150722; Daehn I, 2014, J CLIN INVEST, V124, P1608, DOI 10.1172/JCI71195; Doggrell SA, 1998, CARDIOVASC RES, V39, P89, DOI 10.1016/S0008-6363(98)00076-5; Dounousi E, 2006, AM J KIDNEY DIS, V48, P752, DOI 10.1053/j.ajkd.2006.08.015; Eddy AA, 2000, PEDIATR NEPHROL, V15, P290, DOI 10.1007/s004670000461; Erejuwa OO, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/374037; Guo F, 2016, J CELL BIOCHEM, V117, P74, DOI 10.1002/jcb.25249; HASSENKHODJA R, 1992, J CARDIOVASC SURG, V33, P199; Heijnen BFJ, 2014, HYPERTENS RES, V37, P100, DOI 10.1038/hr.2013.99; Joshi S, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/462361; Jung YA, 2009, BIOCHEM BIOPH RES CO, V386, P757, DOI 10.1016/j.bbrc.2009.06.124; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; LEE LK, 1995, J CLIN INVEST, V96, P953, DOI 10.1172/JCI118143; Liu C, 2015, DIAGN PATHOL, V10, DOI 10.1186/s13000-015-0347-4; Ludikhuize J, 2007, ARTHRITIS RHEUM-US, V56, P2180, DOI 10.1002/art.22653; Ma LY, 2015, EUR HEART J SUPPL, V17, pB5, DOI 10.1093/eurheartj/suv020; Ma LJ, 2005, J AM SOC NEPHROL, V16, P966, DOI 10.1681/ASN.2004060492; Maiese K, 2009, CLIN SCI, V116, P191, DOI 10.1042/CS20080113; Mao N, 2014, ACTA PHARMACOL SIN, V35, P513, DOI 10.1038/aps.2013.187; Olzinski AR, 2005, CARDIOVASC RES, V66, P170, DOI 10.1016/j.cardiores.2004.12.021; Palm F, 2011, AM J PHYSIOL-REG I, V301, pR1229, DOI 10.1152/ajpregu.00720.2010; Palmer SC, 2015, LANCET, V385, P2047, DOI 10.1016/S0140-6736(14)62459-4; Paravicini TM, 2008, DIABETES CARE, V31, pS170, DOI 10.2337/dc08-s247; Ponugoti B, 2012, EXP DIABETES RES, DOI 10.1155/2012/939751; Reiser J, 2014, NAT REV NEPHROL, V10, P104, DOI 10.1038/nrneph.2013.274; Ruiz S, 2013, KIDNEY INT, V83, P1029, DOI 10.1038/ki.2012.439; Shao D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4315; Sun Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080859; Wang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098047; Wang J, 2014, EVID-BASED COMPL ALT, V2014, DOI 10.1155/2014/187979; Wang JY, 2014, AM J PHYSIOL-RENAL, V306, pF486, DOI 10.1152/ajprenal.00528.2013; Xie XS, 2010, PHYTOTHER RES, V24, P1581, DOI 10.1002/ptr.3190; Xie XS, 2009, CHIN J INTEGR MED, V15, P133, DOI 10.1007/s11655-009-0133-9; Xie XS, 2009, J ETHNOPHARMACOL, V122, P35, DOI 10.1016/j.jep.2008.11.020; Zhang L, 2009, AM J PHYSIOL-HEART C, V297, pH2004, DOI 10.1152/ajpheart.00208.2009; Zhang MH, 2013, PLANTA MED, V79, P1319, DOI 10.1055/s-0033-1350649; Zhang MH, 2011, J ETHNOPHARMACOL, V137, P99, DOI 10.1016/j.jep.2011.04.045; Zhang WR, 2012, HYPERTENSION, V59, P136, DOI 10.1161/HYPERTENSIONAHA.111.173328	46	22	24	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145130	10.1371/journal.pone.0145130	http://dx.doi.org/10.1371/journal.pone.0145130			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673167	gold, Green Published, Green Submitted			2022-12-26	WOS:000366722700104
J	Sircar, G; Saha, B; Mandal, RS; Pandey, N; Saha, S; Bhattacharya, SG				Sircar, Gaurab; Saha, Bodhisattwa; Mandal, Rahul Shubhra; Pandey, Naren; Saha, Sudipto; Bhattacharya, Swati Gupta			Purification, Cloning and Immuno-Biochemical Characterization of a Fungal Aspartic Protease Allergen Rhi o 1 from the Airborne Mold Rhizopus oryzae	PLOS ONE			English	Article							ASPERGILLUS-FUMIGATUS; SEQUENCES; PROTEINS; BLA-G-2; MODEL	Background Fungal allergy is considered as serious health problem worldwide and is increasing at an alarming rate in the industrialized areas. Rhizopus oyzae is a ubiquitously present airborne pathogenic mold and an important source of inhalant allergens for the atopic population of India. Here, we report the biochemical and immunological features of its 44 kDa sero-reactive aspartic protease allergen, which is given the official designation 'Rhi o 1'. Method The natural Rhi o 1 was purified by sequential column chromatography and its amino acid sequence was determined by mass spectrometry and N-terminal sequencing. Based on its amino acid sequence, the cDNA sequence was identified, cloned and expressed to produce recombinant Rhi o 1. The allergenic activity of rRhi o 1 was assessed by means of its IgE reactivity and histamine release ability. The biochemical property of Rhi o 1 was studied by enzyme assay. IgE-inhibition experiments were performed to identify its cross-reactivity with the German cockroach aspartic protease allergen Bla g 2. For precise characterization of the cross-reactive epitope, we used anti-Bla g 2 monoclonal antibodies for their antigenic specificity towards Rhi o 1. A homology based model of Rhi o 1 was built and mapping of the cross-reactive conformational epitope was done using certain in silico structural studies. Results The purified natural nRhi o 1 was identified as an endopeptidase. The full length allergen cDNA was expressed and purified as recombinant rRhi o 1. Purified rRhi o 1 displayed complete allergenicity similar to the native nRhi o 1. It was recognized by the serum IgE of the selected mold allergy patients and efficiently induced histamine release from the sensitized PBMC cells. This allergen was identified as an active aspartic protease functional in low pH. The Rhi o 1 showed cross reactivity with the cockroach allergen Bla g 2, as it can inhibit IgE binding to rBla g 2 up to certain level. The rBla g 2 was also found to cross-stimulate histamine release from the effector cells sensitized with anti-Rhi o 1 serum IgE. This cross-reactivity was found to be mediated by a common mAb4C3 recognizable conformational epitope. Bioinformatic studies revealed high degree of structural resemblances between the 4C3 binding sites of both the allergens. Conclusion/Significance The present study reports for the first time anew fungal aspartic protease allergen designated as Rhi o 1, which triggers IgE-mediated sensitization leading to various allergic diseases. Here we have characterized the recombinant Rhi o 1 and its immunological features including cross-reactive epitope information that will facilitate the component-resolved diagnosis of mold allergy.	[Sircar, Gaurab; Saha, Bodhisattwa; Bhattacharya, Swati Gupta] Bose Inst, Div Plant Biol, Kolkata 700009, W Bengal, India; [Mandal, Rahul Shubhra] Natl Inst Cholera & Enter Dis, Biomed Informat Ctr, Kolkata 700010, W Bengal, India; [Pandey, Naren] Belle Vue Clin, Dept Allergy & Asthma, Kolkata 700001, W Bengal, India; [Saha, Sudipto] Bose Inst, Bioinformat Ctr, Kolkata 700054, W Bengal, India	Department of Science & Technology (India); Bose Institute; Indian Council of Medical Research (ICMR); ICMR - National Institute of Cholera & Enteric Diseases (NICED); Department of Science & Technology (India); Bose Institute	Bhattacharya, SG (corresponding author), Bose Inst, Div Plant Biol, Main Campus,93-1 Acharya Prafulla Chandra Rd, Kolkata 700009, W Bengal, India.	swati@jcbose.ac.in	Saha, Sudipto/AAF-1034-2020	Mandal, Rahul/0000-0001-8939-3362; Sircar, Gaurab/0000-0002-9067-4564	Council of Scientific and Industrial Research [03/015(0414)/2011-EMR-I]; University Grant Commission [F.2-8/2002 (SA-I)]; Indian Council of Medical Research [2013-1551G]; DBT [BT/RLF/Re-entry/11/2011]; Dept. of Science and Technology, Govt. of India	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); University Grant Commission(University Grants Commission, India); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); DBT(Department of Biotechnology (DBT) India); Dept. of Science and Technology, Govt. of India(Department of Science & Technology (India))	GS, BS and RSM recieved PhD fellowships from Council of Scientific and Industrial Research (Grant No. 03/015(0414)/2011-EMR-I), University Grant Commission (Grant No. F.2-8/2002 (SA-I)) and Indian Council of Medical Research (extramural project grant number - IRIS ID: 2013-1551G), respectively. SS is a recipient of Ramalingaswamy re-entry scientist fellow from DBT (BT/RLF/Re-entry/11/2011). Dept. of Science and Technology, Govt. of India has provided financial support for infrastructural facility to pursue this research in Bose Institute.	Ahmad S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-51; ARRUDA LK, 1995, J BIOL CHEM, V270, P19563, DOI 10.1074/jbc.270.33.19563; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; Brenke R, 2012, BIOINFORMATICS, V28, P2608, DOI 10.1093/bioinformatics/bts493; Chapman MD, 2007, J ALLERGY CLIN IMMUN, V119, P414, DOI 10.1016/j.jaci.2006.11.001; Chen JC, 2011, J BIOL CHEM, V286, P26667, DOI 10.1074/jbc.M110.193987; Chowdhary A, 2014, CRIT REV MICROBIOL, V40, P30, DOI 10.3109/1040841X.2012.754401; Crameri R, 1998, INT ARCH ALLERGY IMM, V115, P99, DOI 10.1159/000023889; Devars du Mayne Marie, 2015, Ear Nose Throat J, V94, pE17; Glesner J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022223; Green B. J., 2011, J ALLERGY; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; HEYMANN PW, 1986, J IMMUNOL, V137, P2841; Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0; HORNER WE, 1995, CLIN MICROBIOL REV, V8, P161, DOI 10.1128/CMR.8.2.161; Hox V, 2014, ALLERGY, V69, P282, DOI 10.1111/all.12347; Kasera R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063063; Kauffman Henk F, 2006, Clin Mol Allergy, V4, P5, DOI 10.1186/1476-7961-4-5; Larche M, 2006, NAT REV IMMUNOL, V6, P761, DOI 10.1038/nri1934; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee MF, 2012, ANN ALLERG ASTHMA IM, V108, P243, DOI 10.1016/j.anai.2012.01.014; Li M, 2008, J BIOL CHEM, V283, P22806, DOI 10.1074/jbc.M800937200; Li M, 2011, J IMMUNOL, V186, P333, DOI 10.4049/jimmunol.1002318; Ma LJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000549; Mayerhofer M., 2014, ACID PROTEASE PRODUC; Nawange SR, 2012, MYCOPATHOLOGIA, V174, P171, DOI 10.1007/s11046-012-9532-0; Norbaeck D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088303; Pomes A, 2014, METHODS, V66, P75, DOI 10.1016/j.ymeth.2013.07.036; Pomes A, 2010, INT ARCH ALLERGY IMM, V152, P1, DOI 10.1159/000260078; Radauer C, 2008, J ALLERGY CLIN IMMUN, V121, P847, DOI 10.1016/j.jaci.2008.01.025; Sharma R, 2011, ALLERGY RHINOL, V2, P21, DOI 10.2500/ar.2011.2.0005; Shen HD, 1999, CLIN EXP ALLERGY, V29, P642, DOI 10.1046/j.1365-2222.1999.00509.x; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sicherer SH, 2001, J ALLERGY CLIN IMMUN, V108, P881, DOI 10.1067/mai.2001.118515; Singh B, 2010, J PROTEOME RES, V9, P5517, DOI 10.1021/pr100604x; Sircar G, 2012, J PROTEOMICS, V77, P455, DOI 10.1016/j.jprot.2012.09.023; Smolenski G, 1997, MICROBIOL-SGM, V143, P349, DOI 10.1099/00221287-143-2-349; Sun G, 2001, J IMMUNOL, V167, P1014, DOI 10.4049/jimmunol.167.2.1014; Valenta R, 2010, ANNU REV IMMUNOL, V28, P211, DOI 10.1146/annurev-immunol-030409-101218; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Wunschmann S, 2005, J ALLERGY CLIN IMMUN, V116, P140, DOI 10.1016/j.jaci.2005.04.024	42	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144547	10.1371/journal.pone.0144547	http://dx.doi.org/10.1371/journal.pone.0144547			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26672984	gold, Green Submitted, Green Published			2022-12-26	WOS:000366722700044
J	Wang, M; Xie, TT; Chang, ZY; Wang, L; Xie, XY; Kou, YH; Xu, HX; Gao, XL				Wang, Mei; Xie, Tingting; Chang, Zhanying; Wang, Ling; Xie, Xiangyun; Kou, Yaohong; Xu, Hongxia; Gao, Xiaoli			A New Type of Liquid Silymarin Proliposome Containing Bile Salts: Its Preparation and Improved Hepatoprotective Effects	PLOS ONE			English	Article							IMPROVED ORAL DELIVERY; IN-VITRO EVALUATION; LIPOSOMES; BIOAVAILABILITY; SYSTEM; FORMULATION; LIPIDS; MODEL	Silymarin, a known extract, is used in the treatment of liver diseases with various origins, but its current administration form cannot target the liver because of its poor oral bioavailability. A new type of oral silymarin proliposome aimed at improving silymarin's poor bioavailability and hepatoprotective effects, is introduced in this work. Silymarin-loaded liquid proliposome were prepared using a simple dissolving process. The morphology, particle size, zeta potential, and entrapment efficiency of the silymarin liposomes were analysed. The everted gut sac transport model was used to measure the intestinal transport of liposomes. The liposomal hepatoprotective activity was evaluated in three types of experimental hepatitis animal models. After staining with haematoxylin and eosin, the livers were microscopically examined to analyse any pathological changes. The prepared silymarin proliposome formed silymarin liposomes with a multilayer liposome structure and improved intestinal transport. In an injured liver, the silymarin liposomes produced a stronger hepatoprotective effect through a significant decrease in both the aminotransferase and MDA levels and a significant increase in the SOD and GSH-PX levels compared to orally administered silymarin tablets. This effect was also confirmed histopathologically. In a word, incorporation of silymarin into a liposomal carrier system increased intestinal absorption and showed better hepatoprotective effects compared to silymarin tablets.	[Wang, Mei; Chang, Zhanying; Wang, Ling; Xie, Xiangyun; Kou, Yaohong; Xu, Hongxia; Gao, Xiaoli] Xinjiang Med Univ, Coll Pharm, Dept Pharmaceut, Urumqi, Peoples R China; [Xie, Tingting] Peoples Liberat Army Gen Hosp, Dept Pharmaceut Care, Beijing, Peoples R China	Xinjiang Medical University; Chinese People's Liberation Army General Hospital	Gao, XL (corresponding author), Xinjiang Med Univ, Coll Pharm, Dept Pharmaceut, Urumqi, Peoples R China.	Xli_g@sina.com						Alam MA, 2012, J PHARM PHARMACOL, V64, P326, DOI 10.1111/j.2042-7158.2011.01391.x; BARZAGHI N, 1990, EUR J DRUG METAB PH, V15, P333, DOI 10.1007/BF03190223; Cao X, 2012, ACTA BIOMATER, V8, P2104, DOI 10.1016/j.actbio.2012.02.011; Chen YP, 2009, INT J PHARMACEUT, V376, P153, DOI 10.1016/j.ijpharm.2009.04.022; Chu C, 2011, ACTA PHARMACOL SIN, V32, P973, DOI 10.1038/aps.2011.25; El-Samaligy MS, 2006, INT J PHARMACEUT, V319, P121, DOI 10.1016/j.ijpharm.2006.04.023; Elmowafy M, 2013, EUR J PHARM SCI, V50, P161, DOI 10.1016/j.ejps.2013.06.012; Gao Xiao-li, 2005, Yaoxue Xuebao, V40, P1139; Ghosh A, 2012, J PHARM SCI TECHNOL, V2, P348; Hildebrand A, 2003, COLLOID SURFACE B, V32, P335, DOI 10.1016/j.colsurfb.2003.08.001; Hiremath PS, 2009, INT J PHARMACEUT, V380, P96, DOI 10.1016/j.ijpharm.2009.07.008; Karn PR, 2013, NANOMEDICINE-UK, V8, P1529, DOI [10.2217/NNM.13.131, 10.2217/nnm.13.131]; Kossena GA, 2003, J PHARM SCI-US, V92, P634, DOI 10.1002/jps.10329; Kumar N, 2014, PHARMACOL REP, V66, P788, DOI 10.1016/j.pharep.2014.04.007; Li XR, 2010, AAPS PHARMSCITECH, V11, P672, DOI 10.1208/s12249-010-9432-x; Liu L., 2007, ASIAN J PHARM SCI, V2, P150; Maherani B, 2011, CURR NANOSCI, V7, P436, DOI 10.2174/157341311795542453; Niu M, 2011, EUR J PHARM BIOPHARM, V81, P265; Parveen R, 2011, INT J PHARMACEUT, V413, P245, DOI 10.1016/j.ijpharm.2011.04.041; Porter CJH, 2007, NAT REV DRUG DISCOV, V6, P231, DOI 10.1038/nrd2197; Potluri P, 2006, DRUG DELIV, V13, P227, DOI 10.1080/10717540500395007; Rao S, 2014, J CONTROL RELEASE, V193, P174, DOI 10.1016/j.jconrel.2014.05.013; Shaji J, 2013, INT J PHARM BIO SCI, V4, P150; Sonali D, 2010, ACTA PHARMACEUT, V60, P427, DOI 10.2478/v10007-010-0038-3; Sun CD, 2013, AAPS PHARMSCITECH, V14, P332, DOI 10.1208/s12249-013-9924-6; Theodosiou E, 2014, PHYTOCHEM REV, V13, P1, DOI 10.1007/s11101-013-9285-5; Wagner A, 2011, LIPOSOME TECHNOLOGY; Wang J, 2005, J CHIN MED IND, V36, P707; Wang M, 2011, CHIN J NEW DRUGS, V20, P75; Wu W, 2006, EUR J PHARM BIOPHARM, V63, P288, DOI 10.1016/j.ejpb.2005.12.005; Zhang Y, 2010, RESOURCES, V18, P239	31	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0143625	10.1371/journal.pone.0143625	http://dx.doi.org/10.1371/journal.pone.0143625			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674103	Green Published, Green Submitted, gold			2022-12-26	WOS:000366722700013
J	Zhang, QB; Zhang, BH; Zhang, KZ; Meng, XT; Jia, QA; Zhang, QB; Bu, Y; Zhu, XD; Ma, DN; Ye, BG; Zhang, N; Ren, ZG; Sun, HC; Tang, ZY				Zhang, Q-B; Zhang, B-H; Zhang, K-Z; Meng, X-T; Jia, Q-A; Zhang, Q-B; Bu, Y.; Zhu, X-D; Ma, D-N; Ye, B-G; Zhang, N.; Ren, Z-G; Sun, H-C; Tang, Z-Y			Moderate swimming suppressed the growth and metastasis of the transplanted liver cancer in mice model: with reference to nervous system	ONCOGENE			English	Article							PHYSICAL-ACTIVITY; HEPATOCELLULAR-CARCINOMA; CELL-PROLIFERATION; TUMOR-GROWTH; TGF-BETA; EXERCISE INTERVENTION; PREFRONTAL CORTEX; DOWN-REGULATION; GASTRIC-CANCER; T-CELLS	Physical activity has been shown to suppress tumor initiation and progression. The neurotransmitter dopamine (DA) is closely related to movement and exhibits antitumor properties. However, whether the suppressive effects of physical activity on tumors was mediated by the nervous system via increased DA level remains unknowns. Here we show that regular moderate swimming (8 min/day, 9 weeks) raised DA levels in the prefrontal cortex, serum and tumor tissue, suppressed growth, reduced lung metastasis of transplanted liver cancer, and prolonged survival in a C57BL/6 mouse model, while overload swimming (16 and 32 min/day, 9 weeks) had the opposite effect. In nude mice that were orthotopically implanted with human liver cancer cell lines, DA treatment significantly suppressed growth and lung metastasis by acting on the D2 receptor (DR2). Furthermore, DR2 blockade attenuated the suppressive effect of moderate swimming on liver cancer. Both moderate swimming and DA treatment suppressed the transforming growth factor-beta (TGF-beta 1)-induced epithelial-mesenchymal transition of transplanted liver cancer cells. At the molecular level, DR2 signaling inhibited extracellular signal-regulated kinase phosphorylation and expression of TGF-beta 1 in vitro. Together, these findings demonstrated a novel mechanism by which the moderate exercise suppressed liver cancer through boosting DR2 activity, while overload exercise had the opposite effect, highlighting the possible importance of the dopaminergic system in tumor growth and metastasis of liver cancer.	[Zhang, Q-B; Zhang, B-H; Zhang, K-Z; Jia, Q-A; Zhang, Q-B; Bu, Y.; Zhu, X-D; Ma, D-N; Ye, B-G; Zhang, N.; Ren, Z-G; Sun, H-C; Tang, Z-Y] Fudan Univ, Zhongshan Hosp, Liver Canc Inst, Shanghai, Peoples R China; [Zhang, Q-B; Jia, Q-A] Minist Educ, Key Lab Carcinogenesis & Canc Invas, Shanghai, Peoples R China; [Zhang, K-Z] Fudan Univ, Huashan Hosp, Canc Metastasis Inst, Shanghai, Peoples R China; [Meng, X-T] Peoples Hosp Taizhou City, Dept Gen Surg, Taizhou, Peoples R China; [Zhang, Q-B] Xuzhou Med Coll, Sch Anesthesiol, Xuzhou, Peoples R China; [Zhang, Q-B] Shandong Univ, Qilu Hosp, Dept Gen Surg, Jinan, Peoples R China	Fudan University; Fudan University; Xuzhou Medical University; Shandong University	Tang, ZY (corresponding author), Fudan Univ, Liver Canc Inst, 180 Fenglin Rd, Shanghai 200032, Peoples R China.; Tang, ZY (corresponding author), Fudan Univ, Zhongshan Hosp, 180 Fenglin Rd, Shanghai 200032, Peoples R China.	tang.zhaoyou@zs-hospital.sh.cn	Zhu, Xiao-Dong/A-8197-2010	Zhu, Xiao-Dong/0000-0001-9864-6763; Sun, Hui-Chuan/0000-0003-3761-7058	National Natural Science Foundation of China [81372314]; National Key Project for Infectious Diseases of China [2012ZX10002012-004]; Shanghai Natural Science Fund for Youth Scholars [12ZR1442300]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Project for Infectious Diseases of China; Shanghai Natural Science Fund for Youth Scholars	This project was supported by the National Natural Science Foundation of China (grant number: 81372314), the National Key Project for Infectious Diseases of China (2012ZX10002012-004) and the Shanghai Natural Science Fund for Youth Scholars (12ZR1442300). The authors appreciate the instruction in writing of the manuscript provided by Professor Hong Tu and Assistant Professor Yu Gan (State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, China).	Aguirre-Ghiso JA, 2003, CANCER RES, V63, P1684; Almeida PWM, 2009, J APPL PHYSIOL, V107, P261, DOI 10.1152/japplphysiol.00249.2009; Ballard-Barbash R, 2012, JNCI-J NATL CANCER I, V104, P815, DOI 10.1093/jnci/djs207; Chakroborty D, 2004, CLIN CANCER RES, V10, P4349, DOI 10.1158/1078-0432.CCR-04-0059; Chakroborty D, 2008, J CLIN INVEST, V118, P1380, DOI 10.1172/JCI33125; Demarzo MMP, 2004, CANCER LETT, V216, P31, DOI 10.1016/j.canlet.2004.06.002; Friedenreich CM, 2010, J CLIN ONCOL, V28, P1458, DOI 10.1200/JCO.2009.24.9557; Ganguly S, 2010, AM J PATHOL, V177, P2701, DOI 10.2353/ajpath.2010.100617; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Giovannucci EL, 2012, JNCI-J NATL CANCER I, V104, P797, DOI 10.1093/jnci/djs229; Goldacre MJ, 2005, BRIT J PSYCHIAT, V187, P334, DOI 10.1192/bjp.187.4.334; Gray JR, 2002, P NATL ACAD SCI USA, V99, P4115, DOI 10.1073/pnas.062381899; He SB, 2012, INT J SPORTS MED, V33, P525, DOI 10.1055/s-0032-1306325; Heinen MM, 2011, AM J CLIN NUTR, V94, P1314, DOI 10.3945/ajcn.110.007542; Herz DM, 2014, NEUROIMAGE, V90, P15, DOI 10.1016/j.neuroimage.2013.11.023; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; ISHIBASHI M, 1994, CANCER RES, V54, P3442; Jia QA, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-89; Klaissle P, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-132; Lee J, 2012, J NUTR BIOCHEM, V23, P1341, DOI 10.1016/j.jnutbio.2011.08.003; Li Y, 2003, J CANCER RES CLIN, V129, P43, DOI 10.1007/s00432-002-0396-4; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Moderate exercise may reduce ovarian cancer risk, 2006, MAYO CLIN WOMENS HLT, V10, P3; Moreno-Smith M, 2011, CLIN CANCER RES, V17, P3649, DOI 10.1158/1078-0432.CCR-10-2441; Mulder KM, 2000, CYTOKINE GROWTH F R, V11, P23, DOI 10.1016/S1359-6101(99)00026-X; Muller HK, 2011, BRAIN RES, V1385, P26, DOI 10.1016/j.brainres.2011.02.048; Murphy EA, 2004, J APPL PHYSIOL, V97, P955, DOI 10.1152/japplphysiol.00252.2004; Pacheco R, 2009, J NEUROIMMUNOL, V216, P8, DOI 10.1016/j.jneuroim.2009.07.018; Padua D, 2008, CELL, V133, P66, DOI 10.1016/j.cell.2008.01.046; Peng H, 2013, HEPATOLOGY, V57, P2299, DOI 10.1002/hep.26258; Pickett M, 2002, CANCER PRACT, V10, P284, DOI 10.1046/j.1523-5394.2002.106006.x; Saez MD, 2007, MOL CELL BIOCHEM, V294, P19, DOI 10.1007/s11010-005-9067-5; Sasvari M, 2011, J SPORT SCI MED, V10, P93; Tang ZY, 2012, CHIN J INTEGR MED, V18, P323, DOI 10.1007/s11655-012-1103-1; Tang ZY, 2004, J CANCER RES CLIN, V130, P187, DOI 10.1007/s00432-003-0511-1; THOMPSON HJ, 1994, CANCER RES, V54, pS1960; Tian F, 2003, CANCER RES, V63, P8284; Wan DF, 2004, P NATL ACAD SCI USA, V101, P15724, DOI 10.1073/pnas.0404089101; Wang J, 2012, SCAND J MED SCI SPOR, V22, P643, DOI 10.1111/j.1600-0838.2010.01288.x; Wise RA, 2008, NEUROTOX RES, V14, P169, DOI 10.1007/BF03033808; World Health Organization, 2010, GLOB REC PHYS ACT HL, P10; Zhang Q, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054250, 10.1371/journal.pone.0059667]; Zhang W, 2012, GASTROENTEROLOGY, V143, P1641, DOI 10.1053/j.gastro.2012.08.032; Zhang W, 2010, CLIN CANCER RES, V16, P3420, DOI 10.1158/1078-0432.CCR-09-2904	45	33	39	3	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 4	2016	35	31					4122	4131		10.1038/onc.2015.484	http://dx.doi.org/10.1038/onc.2015.484			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS8GG	26686088				2022-12-26	WOS:000381020900010
J	Dayde, D; Guerard, M; Perron, P; Hatat, AS; Barrial, C; Eymin, B; Gazzeri, S				Dayde, D.; Guerard, M.; Perron, P.; Hatat, A-S; Barrial, C.; Eymin, B.; Gazzeri, S.			Nuclear trafficking of EGFR by Vps34 represses Arf expression to promote lung tumor cell survival	ONCOGENE			English	Article							GROWTH-FACTOR RECEPTOR; SIGNALING NETWORK; PROGNOSTIC VALUE; P14(ARF) EXPRESSION; IONIZING-RADIATION; PROTEIN EXPRESSION; CANCER; MUTATIONS; MECHANISMS; GEFITINIB	Epidermal growth factor receptor (EGFR) is a cell surface receptor that has an essential role in cell proliferation and survival, and overexpression of EGFR is a common feature of human cancers. In Non-small-cell lung cancer (NSCLC), activating mutations of EGFR have also been described. We recently showed that mutant EGFR-L858R inhibits the expression of the p14ARF tumor-suppressor protein to promote cell survival. In this study, we defined the molecular bases by which EGFR controls Arf expression. Using various lung tumor models, we showed that EGF stimulation inhibits Arf transcription by a mechanism involving the nuclear transport and recruitment of EGFR to the Arf promoter. We unraveled the vesicular trafficking protein Vps34 as a mediator of EGFR nuclear trafficking and showed that its neutralization prevents the accumulation of EGFR to the Arf promoter in response to ligand activation. Finally, in lung tumor cells that carry mutant EGFR-L858R, we demonstrated that inhibition of Vps34 using small interfering RNA restrains nuclear EGFR location and restores Arf expression leading to apoptosis. These findings identify the Arf tumor suppressor as a new transcriptional target of nuclear EGFR and highlight Vps34 as an important regulator of the nuclear EGFR/Arf survival pathway. As a whole, they provide a mechanistic explanation to the inverse correlation between nuclear expression of EGFR and overall survival in NSCLC patients.	[Dayde, D.; Guerard, M.; Perron, P.; Hatat, A-S; Barrial, C.; Eymin, B.; Gazzeri, S.] INSERM, Ctr Rech, Equipe Bases Mol Progress Canc Poumo, U823, Grenoble, France; [Dayde, D.; Guerard, M.; Perron, P.; Hatat, A-S; Barrial, C.; Eymin, B.; Gazzeri, S.] Univ Grenoble 1, Inst Albert Bonniot, Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Gazzeri, S (corresponding author), Inst Albert Bonniot, INSERM, Ctr Rech, Equipe Bases Mol Progress Canc Poumon,U823, F-38042 Grenoble, France.	Sylvie.Gazzeri@ujf-grenoble.fr	eymin, beatrice/U-4670-2019; Eymin, Beatrice/M-1962-2013; gazzeri, sylvie/U-4669-2019; gazzeri, sylvie/M-1961-2013	eymin, beatrice/0000-0002-7311-3810; Eymin, Beatrice/0000-0002-7311-3810; gazzeri, sylvie/0000-0001-5817-1839; gazzeri, sylvie/0000-0001-5817-1839	Institut National de la Sante et de la Recherche Medicale [U823]; Fondation ARC pour la recherche sur le cancer [20131200109]; Fondation de France; Ligue Nationale contre Le Cancer Comite de Savoie; Fond de Dotation pour la Recherche en Sante Respiratoire; Fondation ARC pour la recherche sur le cancer; le Fonds Agir pour les Maladies Chroniques; French Research Ministry	Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Fondation ARC pour la recherche sur le cancer(Fondation ARC pour la Recherche sur le Cancer); Fondation de France(Fondation de France); Ligue Nationale contre Le Cancer Comite de Savoie; Fond de Dotation pour la Recherche en Sante Respiratoire; Fondation ARC pour la recherche sur le cancer(Fondation ARC pour la Recherche sur le Cancer); le Fonds Agir pour les Maladies Chroniques; French Research Ministry(Ministry of Research, France)	We thank Professor A Gazdar for providing us with the H1719, HCC827 and H1975 cellular models and Dr MC Hung for the CHO-EGFR and CHO-EGFR-pNLS cells. This work was supported by Institut National de la Sante et de la Recherche Medicale U823, the Fondation ARC pour la recherche sur le cancer (grant no. 20131200109), the Fondation de France and the Ligue Nationale contre Le Cancer Comite de Savoie. DD was supported by the Fond de Dotation pour la Recherche en Sante Respiratoire 2010 and the Fondation ARC pour la recherche sur le cancer. MG was supported by le Fonds Agir pour les Maladies Chroniques. A-SH was supported by the French Research Ministry.	Abhold EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032459; Aggarwal H, 2011, EXP MOL PATHOL, V91, P496, DOI 10.1016/j.yexmp.2011.05.006; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Brand TM, 2011, DISCOV MED, V12, P419; Burda P, 2002, J CELL SCI, V115, P3889, DOI 10.1242/jcs.00090; Carpenter G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008979; Chen DJ, 2007, CLIN CANCER RES, V13, P6555, DOI 10.1158/1078-0432.CCR-07-1610; Cortot AB, 2014, CLIN LUNG CANCER, V15, P124, DOI 10.1016/j.cllc.2013.08.003; Dittmann K, 2010, FEBS LETT, V584, P3878, DOI 10.1016/j.febslet.2010.08.005; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Eymin B, 2003, ONCOGENE, V22, P1822, DOI 10.1038/sj.onc.1206303; Giri DK, 2005, MOL CELL BIOL, V25, P11005, DOI 10.1128/MCB.25.24.11005-11018.2005; Huang WC, 2011, J BIOL CHEM, V286, P20558, DOI 10.1074/jbc.M111.240796; Hung LY, 2008, NUCLEIC ACIDS RES, V36, P4337, DOI 10.1093/nar/gkn417; Jaganathan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019605; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Li C, 2009, ONCOGENE, V28, P3801, DOI 10.1038/onc.2009.234; Liccardi G, 2011, CANCER RES, V71, P1103, DOI 10.1158/0008-5472.CAN-10-2384; Lill NL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2003341; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Lo HW, 2010, DISCOV MED, V10, P44; Lo HW, 2010, MOL CANCER RES, V8, P232, DOI 10.1158/1541-7786.MCR-09-0391; Lo HW, 2005, CANCER CELL, V7, P575, DOI 10.1016/j.ccr.2005.05.007; Lo HW, 2005, CANCER RES, V65, P338; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maggi LB, 2014, BBA-MOL BASIS DIS, V1842, P831, DOI 10.1016/j.bbadis.2014.01.016; MAO L, 1995, CANCER RES, V55, P2995; Marsh T, 2015, NAT CELL BIOL, V17, P1, DOI 10.1038/ncb3089; Massie C, 2006, NAT REV CANCER, V6, P403, DOI 10.1038/nrc1882; Meng XX, 2012, LUNG CANCER, V77, P24, DOI 10.1016/j.lungcan.2012.02.015; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Mounawar M, 2007, CANCER RES, V67, P5667, DOI 10.1158/0008-5472.CAN-06-4229; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Ozenne P, 2013, ONCOGENE, V32, P1050, DOI 10.1038/onc.2012.107; Ozenne P, 2010, INT J CANCER, V127, P2239, DOI 10.1002/ijc.25511; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Psyrri A, 2005, CLIN CANCER RES, V11, P5856, DOI 10.1158/1078-0432.CCR-05-0420; QUELLE DE, 1995, CELL, V83, P993; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Simonsen A, 2009, J CELL BIOL, V186, P773, DOI 10.1083/jcb.200907014; Tao YG, 2005, EXP CELL RES, V303, P240, DOI 10.1016/j.yexcr.2004.09.030; Traynor AM, 2013, LUNG CANCER, V81, P138, DOI 10.1016/j.lungcan.2013.03.020; Vanhaesebroeck B, 2010, NAT REV MOL CELL BIO, V11, P329, DOI 10.1038/nrm2882; Vonlanthen S, 2001, BRIT J CANCER, V84, P1372, DOI 10.1054/bjoc.2001.1791; Wang YN, 2010, ONCOGENE, V29, P3997, DOI 10.1038/onc.2010.157; Wang YN, 2012, CELL BIOSCI, V2, DOI 10.1186/2045-3701-2-13; Xia WY, 2009, MOL CARCINOGEN, V48, P610, DOI 10.1002/mc.20504; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhao ZH, 2008, LUNG CANCER, V62, P113, DOI 10.1016/j.lungcan.2008.02.014	54	23	24	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 28	2016	35	30					3986	3994		10.1038/onc.2015.480	http://dx.doi.org/10.1038/onc.2015.480			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS8DJ	26686095	Green Submitted			2022-12-26	WOS:000381013100010
J	Fan, MH; Zhu, Q; Li, HH; Ra, HJ; Majumdar, S; Gulick, DL; Jerome, JA; Madsen, DH; Christofidou-Solomidou, M; Speicher, DW; Bachovchin, WW; Feghali-Bostwick, C; Pure, E				Fan, Ming-Hui; Zhu, Qiang; Li, Hui-Hua; Ra, Hyun-Jeong; Majumdar, Sonali; Gulick, Dexter L.; Jerome, Jacob A.; Madsen, Daniel H.; Christofidou-Solomidou, Melpo; Speicher, David W.; Bachovchin, William W.; Feghali-Bostwick, Carol; Pure, Ellen			Fibroblast Activation Protein (FAP) Accelerates Collagen Degradation and Clearance from Lungs in Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						collagen; extracellular matrix; fibroblast; pulmonary fibrosis; serine protease; gelatinase; interstitial lung disease	SERINE-PROTEASE; PULMONARY-FIBROSIS; MATRIX-METALLOPROTEINASE; EXTRACELLULAR-MATRIX; PROTEOLYTIC ACTIVATION; PROCOLLAGEN PRODUCTION; REMODELING INTERFACE; NEUTROPHIL ELASTASE; STROMAL FIBROBLASTS; TISSUE INHIBITORS	Idiopathic pulmonary fibrosis is a disease characterized by progressive, unrelenting lung scarring, with death from respiratory failure within 2-4 years unless lung transplantation is performed. New effective therapies are clearly needed. Fibroblast activation protein (FAP) is a cell surface-associated serine protease up-regulated in the lungs of patients with idiopathic pulmonary fibrosis as well as in wound healing and cancer. We postulate that FAP is not only a marker of disease but influences the development of pulmonary fibrosis after lung injury. In two different models of pulmonary fibrosis, intratracheal bleomycin instillation and thoracic irradiation, we find increased mortality and increased lung fibrosis in FAP-deficient mice compared with wild-type mice. Lung extracellular matrix analysis reveals accumulation of intermediate-sized collagen fragments in FAP-deficient mouse lungs, consistent with in vitro studies showing that FAP mediates ordered proteolytic processing of matrix metalloproteinase (MMP)-derived collagen cleavage products. FAP-mediated collagen processing leads to increased collagen internalization without altering expression of the endocytic collagen receptor, Endo180. Pharmacologic FAP inhibition decreases collagen internalization as expected. Conversely, restoration of FAP expression in the lungs of FAP-deficient mice decreases lung hydroxyproline content after intratracheal bleomycin to levels comparable with that of wild-type controls. Our findings indicate that FAP participates directly, in concert with MMPs, in collagen catabolism and clearance and is an important factor in resolving scar after injury and restoring lung homeostasis. Our study identifies FAP as a novel endogenous regulator of fibrosis and is the first to show FAP's protective effects in the lung.	[Fan, Ming-Hui; Li, Hui-Hua; Gulick, Dexter L.; Jerome, Jacob A.] Univ Pittsburgh, Dept Med, Pulm Allergy & Crit Care Div, 930 Scaife Hall, Pittsburgh, PA 15213 USA; [Zhu, Qiang] Univ N Carolina, Mol & Cellular Pathol Grad Program, Chapel Hill, NC 27599 USA; [Ra, Hyun-Jeong; Christofidou-Solomidou, Melpo] Univ Penn, Dept Hematol & Oncol, Philadelphia, PA 19104 USA; [Pure, Ellen] Univ Penn, Dept Biomed Sci, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA; [Pure, Ellen] Univ Penn, Dept Med, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA; [Majumdar, Sonali; Speicher, David W.] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA; [Madsen, Daniel H.] NIDCR, Proteases & Tissue Remodeling Sect, Oral & Pharyngeal Canc Branch, Ctr Canc Immune Therapy,NIH, Bethesda, MD 20892 USA; [Bachovchin, William W.] Tufts Univ, Sackler Sch Biomed Grad Sci, Boston, MA 02111 USA; [Feghali-Bostwick, Carol] Med Univ S Carolina, Div Rheumatol & Immunol, Dept Med, Charleston, SC 29425 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; University of North Carolina Chapel Hill; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; The Wistar Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); Tufts University; Medical University of South Carolina	Fan, MH (corresponding author), Univ Pittsburgh, Dept Med, Pulm Allergy & Crit Care Div, 930 Scaife Hall, Pittsburgh, PA 15213 USA.	fanm@upmc.edu	william.bachovchin@tufts.edu/AAA-3538-2022	Madsen, Daniel Hargboel/0000-0002-3183-6201	National Institutes of Health [R01 CA141144, R01 CA133470, K08HL102266, P30AR05891, K24 AR060297, R01 CA131582]; Dalsemer Research Award from the American Lung Association [DA167003]; Intramural Research Program of the National Institutes of Health from NIDCR; NCI [P30 CA010815]; The Danish Cancer Society [R124-A7599] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [R01CA131582, R01CA141144, P30CA010815, R01CA133470] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL102266] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K24AR060297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dalsemer Research Award from the American Lung Association; Intramural Research Program of the National Institutes of Health from NIDCR; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); The Danish Cancer Society(Danish Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health Grants R01 CA141144 (to E. P.), R01 CA133470 (to M. C. S.), K08HL102266 (to M. H. F.), P30AR05891 (to PI Mark Gladwin; funding provided to M. H. F.), and K24 AR060297 (to C. F. B.), Dalsemer Research Award DA167003 (M. H. F.) from the American Lung Association, and in part by the Intramural Research Program of the National Institutes of Health from NIDCR (to D. H. M.), National Institutes of Health Grant R01 CA131582 (to D. W. S.), and Core Grant P30 CA010815 from NCI (to The Wistar Institute). M. C. S. has patents PCT/US14/41636 and PCT/US15/22501 pending and has a founder's equity position in LignaMed, LLC, but these have no connection to the data reported in this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acharya PS, 2008, J CELL SCI, V121, P1393, DOI 10.1242/jcs.021683; Acharya PS, 2006, HUM PATHOL, V37, P352, DOI 10.1016/j.humpath.2005.11.020; Aggarwal S, 2008, BIOCHEMISTRY-US, V47, P1076, DOI 10.1021/bi701921b; Arnold JN, 2014, CANCER IMMUNOL RES, V2, P121, DOI 10.1158/2326-6066.CIR-13-0150; Bae S, 2008, BRIT J HAEMATOL, V142, P827, DOI 10.1111/j.1365-2141.2008.07241.x; Blanc-Brude OP, 2005, EXP CELL RES, V304, P16, DOI 10.1016/j.yexcr.2004.10.021; Bras LED, 2013, J PROTEOMICS, V86, P43, DOI 10.1016/j.jprot.2013.05.004; Brokopp CE, 2011, EUR HEART J, V32, P2713, DOI 10.1093/eurheartj/ehq519; Bundesmann MM, 2012, AM J RESP CELL MOL, V46, P233, DOI 10.1165/rcmb.2010-0485OC; Chambers RC, 1998, BIOCHEM J, V333, P121, DOI 10.1042/bj3330121; Chambers RC, 2000, J BIOL CHEM, V275, P35584, DOI 10.1074/jbc.M003188200; Checa M, 2008, HUM GENET, V124, P465, DOI 10.1007/s00439-008-0571-z; Cheng JD, 2002, CANCER RES, V62, P4767; Christiansen VJ, 2007, ARCH BIOCHEM BIOPHYS, V457, P177, DOI 10.1016/j.abb.2006.11.006; Chua F, 2007, AM J PATHOL, V170, P65, DOI 10.2353/ajpath.2007.060352; Chung KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088772; Cohen SJ, 2008, PANCREAS, V37, P154, DOI 10.1097/MPA.0b013e31816618ce; Curino AC, 2005, J CELL BIOL, V169, P977, DOI 10.1083/jcb.200411153; Dabbagh K, 1998, EUR RESPIR J, V11, P1002, DOI 10.1183/09031936.98.11051002; DeQuach JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013039; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Engelholm LH, 2003, J CELL BIOL, V160, P1009, DOI 10.1083/jcb.200211091; Everts V, 1996, HISTOCHEM J, V28, P229, DOI 10.1007/BF02409011; Gogly B, 1998, ANAL BIOCHEM, V255, P211, DOI 10.1006/abio.1997.2318; Han SJ, 2010, J BIOL CHEM, V285, P22276, DOI 10.1074/jbc.M110.102079; Henry LR, 2007, CLIN CANCER RES, V13, P1736, DOI 10.1158/1078-0432.CCR-06-1746; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Howell DCJ, 2001, AM J PATHOL, V159, P1383, DOI 10.1016/S0002-9440(10)62525-4; Huber MA, 2003, J INVEST DERMATOL, V120, P182, DOI 10.1046/j.1523-1747.2003.12035.x; Iwasa S, 2005, CANCER LETT, V227, P227, DOI 10.1016/j.canlet.2004.06.031; Karimi-Shah BA, 2015, NEW ENGL J MED, V372, P1189, DOI 10.1056/NEJMp1500526; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Lee HJ, 2006, MOL BIOL CELL, V17, P4812, DOI 10.1091/mbc.E06-06-0486; Lee TH, 2014, MOL BIOL CELL, V25, P583, DOI 10.1091/mbc.E13-07-0382; Lee W, 1996, J CELL PHYSIOL, V168, P695, DOI 10.1002/(SICI)1097-4652(199609)168:3<695::AID-JCP22>3.0.CO;2-X; Levy MT, 1999, HEPATOLOGY, V29, P1768, DOI 10.1002/hep.510290631; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Li YJ, 2011, J EXP MED, V208, P1459, DOI 10.1084/jem.20102510; Liu SQ, 2012, AM J PHYSIOL-HEART C, V303, pH1446, DOI 10.1152/ajpheart.00362.2012; Machtay M, 2006, RADIOTHER ONCOL, V81, P196, DOI 10.1016/j.radonc.2006.09.013; Madsen DH, 2007, J BIOL CHEM, V282, P27037, DOI 10.1074/jbc.M701088200; Madsen DH, 2012, J PATHOL, V227, P94, DOI 10.1002/path.3981; Madsen DH, 2011, J BIOL CHEM, V286, P26996, DOI 10.1074/jbc.M110.208033; MATHEW S, 1995, GENOMICS, V25, P335, DOI 10.1016/0888-7543(95)80157-H; Meadows SA, 2007, BIOCHEMISTRY-US, V46, P4598, DOI 10.1021/bi062227y; Messaritou G, 2009, J CELL SCI, V122, P4042, DOI 10.1242/jcs.044305; MONSKY WL, 1994, CANCER RES, V54, P5702; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Moraes TJ, 2003, CRIT CARE MED, V31, pS189, DOI 10.1097/01.CCM.0000057842.90746.1E; National Research Council Committee for the Update of the Guide for the Care and Use of Laboratory Animals, 2011, GUIDE CARE USE LAB A, V8th, P1, DOI DOI 10.17226/12910; Niedermeyer J, 2000, MOL CELL BIOL, V20, P1089, DOI 10.1128/MCB.20.3.1089-1094.2000; Niedermeyer J, 2001, INT J DEV BIOL, V45, P445; Olson AL, 2007, AM J RESP CRIT CARE, V176, P277, DOI 10.1164/rccm.200701-044OC; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Park JE, 1999, J BIOL CHEM, V274, P36505, DOI 10.1074/jbc.274.51.36505; Peretti D, 2015, NATURE, V518, P236, DOI 10.1038/nature14142; PineiroSanchez ML, 1997, J BIOL CHEM, V272, P7595, DOI 10.1074/jbc.272.12.7595; Radisky Derek C, 2008, Proc Am Thorac Soc, V5, P316, DOI 10.1513/pats.200711-166DR; Richards TJ, 2012, AM J RESP CRIT CARE, V185, P67, DOI 10.1164/rccm.201101-0058OC; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; RILEY DJ, 1988, EXP LUNG RES, V14, P549, DOI 10.3109/01902148809087827; Santos AM, 2009, J CLIN INVEST, V119, P3613, DOI 10.1172/JCI38988; SCANLAN MJ, 1994, P NATL ACAD SCI USA, V91, P5657, DOI 10.1073/pnas.91.12.5657; Shapiro SD, 1998, CURR OPIN CELL BIOL, V10, P602, DOI 10.1016/S0955-0674(98)80035-5; Strieter Robert M, 2008, Proc Am Thorac Soc, V5, P305, DOI 10.1513/pats.200710-160DR; Sulek J, 2007, J HISTOCHEM CYTOCHEM, V55, P347, DOI 10.1369/jhc.6A7133.2006; Taooka Y, 1997, AM J RESP CRIT CARE, V156, P260, DOI 10.1164/ajrccm.156.1.9612077; Tchou J, 2013, HUM PATHOL, V44, P2549, DOI 10.1016/j.humpath.2013.06.016; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang LCS, 2014, CANCER IMMUNOL RES, V2, P154, DOI 10.1158/2326-6066.CIR-13-0027; Wang XM, 2008, FRONT BIOSCI-LANDMRK, V13, P3168, DOI 10.2741/2918; Weathington NM, 2006, NAT MED, V12, P317, DOI 10.1038/nm1361; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Yamaguchi Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003421; Yang K, 2007, INT J RADIAT BIOL, V83, P665, DOI 10.1080/09553000701558977	75	49	49	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 8	2016	291	15					8070	8089		10.1074/jbc.M115.701433	http://dx.doi.org/10.1074/jbc.M115.701433			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DJ2SZ	26663085	Green Published, hybrid			2022-12-26	WOS:000374056700026
J	Jung, G; Fajardo, G; Ribeiro, AJS; Kooiker, KB; Coronado, M; Zhao, MM; Hu, DQ; Reddy, S; Kodo, K; Sriram, K; Insel, PA; Wu, JC; Pruitt, BL; Bernstein, D				Jung, Gwanghyun; Fajardo, Giovanni; Ribeiro, Alexandre J. S.; Kooiker, Kristina Bezold; Coronado, Michael; Zhao, Mingming; Hu, Dong-Qing; Reddy, Sushma; Kodo, Kazuki; Sriram, Krishna; Insel, Paul A.; Wu, Joseph C.; Pruitt, Beth L.; Bernstein, Daniel			Time-dependent evolution of functional vs. remodeling signaling in induced pluripotent stem cell-derived cardiomyocytes and induced maturation with biomechanical stimulation	FASEB JOURNAL			English	Article						beta-adrenergic receptor; cell signaling maturation; cardiotoxicity testing	PROTEIN-COUPLED RECEPTORS; RAT VENTRICULAR MYOCYTES; CHRONIC HEART-FAILURE; CARDIAC MYOCYTES; KINASE-II; BETA(1)-ADRENERGIC STIMULATION; BETA(2)-ADRENERGIC RECEPTORS; DILATED CARDIOMYOPATHY; BETA-ARRESTINS; CA2+ LEAK	Human induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are a powerful platform for uncovering disease mechanisms and assessing drugs for efficacy/toxicity. However, the accuracy with which hiPSC-CMs recapitulate the contractile and remodeling signaling of adult cardiomyocytes is not fully known. We used beta-adrenergic receptor (beta-AR) signaling as a prototype to determine the evolution of signaling component expression and function during hiPSC-CM maturation. In "early" hiPSC-CMs (less than or equal to d 30), beta 2-ARs are a primary source of cAMP/PKA signaling. With longer culture, beta 1-AR signaling increases: from 0% of cAMP generation at d 30 to 56.8 +/- 6.6% by d 60. PKA signaling shows a similar increase: 15.7+/-5.2%(d 30), 49.8+/-0.5%(d 60), and 71.0+/-6.1% (d 90). cAMP generation increases 9-fold from d 30 to 60, with enhanced coupling to remodeling pathways (e.g., Akt and Ca2+/calmodulin-dependent protein kinase type II) and development of caveolin-mediated signaling compartmentalization. By contrast, cardiotoxicity induced by chronic beta-AR stimulation, a major component of heart failure, develops much later: 5% cell death at d 30 vs. 55% at d 90. Moreover, beta-AR maturation can be accelerated by biomechanical stimulation. The differential maturation of beta-AR functional vs. remodeling signaling in hiPSC-CMs has important implications for their use in disease modeling and drug testing. We propose that assessment of signaling be added to the indices of phenotypic maturation of hiPSC-CMs.-Jung, G., Fajardo, G., Ribeiro, A. J. S., Kooiker, K. B., Coronado, M., Zhao, M., Hu, D.-Q., Reddy, S., Kodo, K., Sriram, K., Insel, P. A., Wu, J. C., Pruitt, B. L., Bernstein, D. Time-dependent evolution of functional vs. remodeling signaling in induced pluripotent stem cell-derived cardiomyocytes and induced maturation with biomechanical stimulation. FASEB J. 30, 1464-1479 (2016). www.fasebj.org	[Jung, Gwanghyun; Fajardo, Giovanni; Kooiker, Kristina Bezold; Coronado, Michael; Zhao, Mingming; Hu, Dong-Qing; Reddy, Sushma; Bernstein, Daniel] Stanford Univ, Dept Pediat, Div Cardiol, Sch Med, Stanford, CA 94305 USA; [Jung, Gwanghyun; Fajardo, Giovanni; Kooiker, Kristina Bezold; Coronado, Michael; Zhao, Mingming; Hu, Dong-Qing; Reddy, Sushma; Kodo, Kazuki; Wu, Joseph C.; Bernstein, Daniel] Stanford Univ, Stanford Cardiovasc Inst, Sch Med, Stanford, CA 94305 USA; [Kodo, Kazuki; Wu, Joseph C.] Stanford Univ, Dept Med, Div Cardiovasc Med, Sch Med, Stanford, CA 94305 USA; [Wu, Joseph C.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA; [Ribeiro, Alexandre J. S.; Pruitt, Beth L.] Stanford Univ, Dept Mech Engn, Sch Engn, Stanford, CA 94305 USA; [Sriram, Krishna; Insel, Paul A.] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92103 USA; [Sriram, Krishna; Insel, Paul A.] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; University of California System; University of California San Diego; University of California System; University of California San Diego	Bernstein, D (corresponding author), 750 Welch Rd,Suite 325, Palo Alto, CA 94304 USA.	danb@stanford.edu	; Wu, Joseph/H-1067-2013	Bernstein, Daniel/0000-0001-7761-5853; Pruitt, Beth L./0000-0002-4861-2124; Wu, Joseph/0000-0002-6068-8041	U.S. National Institutes of Health/National Heart, Lung, and Blood Institute [HL123655, HL11708301, HL11300604, F32 HL126348]; Stanford Child Health Research Institute; American Heart Association [14POST18360018]; National Science Foundation Emerging Frontiers in Research and Innovation Multicellular and Inter-kingdom Signaling [1136790]; Department of Defense [W81XWH-14-1-0372]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL123655, R21HL123655, T32HL094274, F32HL126348] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Stanford Child Health Research Institute; American Heart Association(American Heart Association); National Science Foundation Emerging Frontiers in Research and Innovation Multicellular and Inter-kingdom Signaling; Department of Defense(United States Department of Defense); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Jared Chunko (Division of Cardiovascular Medicine, Department of Medicine, Stanford Cardiovascular Institute) and Euan Ashley (Division of Cardiovascular Medicine and Genetics, Department of Medicine, Stanford Cardiovascular Institute) who assisted in obtaining human heart samples. They are grateful for the support of the Neuroscience Microscopy Service at the Institute for Stem Cell Biology and Regenerative Medicine, Stanford University. This work was supported by U.S. National Institutes of Health/National Heart, Lung, and Blood Institute Grants HL123655 and HL11708301 (to D.B.), HL11300604 (to J.C.W.), and F32 HL126348 (to G.J.); Stanford Child Health Research Institute postdoctoral grant (to G.J.); American Heart Association postdoctoral fellowship 14POST18360018 (to A.J.S.R.); National Science Foundation Emerging Frontiers in Research and Innovation Multicellular and Inter-kingdom Signaling 1136790 (to B.L.P.); and Department of Defense Award W81XWH-14-1-0372 (to P.A.I.).	Bastiani M, 2009, J CELL BIOL, V185, P1259, DOI 10.1083/jcb.200903053; Bernstein D, 2011, PROG PEDIATR CARDIOL, V31, P35, DOI 10.1016/j.ppedcard.2010.11.007; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; BRODDE OE, 1991, PHARMACOL REV, V43, P203; Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]; Butler J, 2007, CARDIOVASC RES, V74, P114, DOI 10.1016/j.cardiores.2007.01.006; Communal C, 1998, CIRCULATION, V98, P1329, DOI 10.1161/01.CIR.98.13.1329; DELMONTE F, 1993, CIRCULATION, V88, P854, DOI 10.1161/01.CIR.88.3.854; Engelhardt S, 2004, CIRCULATION, V109, P1154, DOI 10.1161/01.CIR.0000117254.68497.39; Germanguz I, 2011, J CELL MOL MED, V15, P38, DOI 10.1111/j.1582-4934.2009.00996.x; Godier-Furnemont AFG, 2015, BIOMATERIALS, V60, P82, DOI 10.1016/j.biomaterials.2015.03.055; Grimm M, 2010, J MOL CELL CARDIOL, V48, P322, DOI 10.1016/j.yjmcc.2009.10.016; Grisanti LA, 2014, J MOL CELL CARDIOL, V72, P39, DOI 10.1016/j.yjmcc.2014.02.009; Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892; Hirt MN, 2014, J MOL CELL CARDIOL, V74, P151, DOI 10.1016/j.yjmcc.2014.05.009; Huang NF, 2013, BIOMATERIALS, V34, P2928, DOI 10.1016/j.biomaterials.2013.01.017; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Kamakura T, 2013, CIRC J, V77, P1307, DOI 10.1253/circj.CJ-12-0987; Kaumann A, 1999, CIRCULATION, V99, P65, DOI 10.1161/01.CIR.99.1.65; KUZNETSOV V, 1995, CIRC RES, V76, P40, DOI 10.1161/01.RES.76.1.40; Lan F, 2013, CELL STEM CELL, V12, P101, DOI 10.1016/j.stem.2012.10.010; Lefkowitz RJ, 1998, J BIOL CHEM, V273, P18677, DOI 10.1074/jbc.273.30.18677; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Lundy SD, 2013, STEM CELLS DEV, V22, P1991, DOI 10.1089/scd.2012.0490; Mangmool S, 2010, J CELL BIOL, V189, P573, DOI 10.1083/jcb.200911047; MANN DL, 1992, CIRCULATION, V85, P790, DOI 10.1161/01.CIR.85.2.790; Metrich M, 2008, CIRC RES, V102, P959, DOI 10.1161/CIRCRESAHA.107.164947; Neef S, 2010, CIRC RES, V106, P1134, DOI 10.1161/CIRCRESAHA.109.203836; Nikolaev VO, 2006, CIRC RES, V99, P1084, DOI 10.1161/01.RES.0000250046.69918.d5; Nikolaev VO, 2010, SCIENCE, V327, P1653, DOI 10.1126/science.1185988; Ogata T, 2008, MOL CELL BIOL, V28, P3424, DOI 10.1128/MCB.02186-07; Patel H. H., 2008, V186, P167, DOI 10.1007/978-3-540-72843-6_7; Pereira L, 2007, J PHYSIOL-LONDON, V583, P685, DOI 10.1113/jphysiol.2007.133066; Pereira L, 2013, CIRCULATION, V127, P913, DOI 10.1161/CIRCULATIONAHA.12.148619; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Qin D, 2010, NAT PROTOC, V5, P491, DOI 10.1038/nprot.2009.234; Rao C, 2013, BIOMATERIALS, V34, P2399, DOI 10.1016/j.biomaterials.2012.11.055; Rapacciuolo A, 2003, J BIOL CHEM, V278, P35403, DOI 10.1074/jbc.M305675200; Rosenbaum DM, 2009, NATURE, V459, P356, DOI 10.1038/nature08144; Schefe JH, 2006, J MOL MED, V84, P901, DOI 10.1007/s00109-006-0097-6; SLOTKIN TA, 1995, TOXICOL APPL PHARM, V133, P188, DOI 10.1006/taap.1995.1141; SLOTKIN TA, 1994, TOXICOL APPL PHARM, V129, P223, DOI 10.1006/taap.1994.1247; Sossalla S, 2010, CIRC RES, V107, P1150, DOI 10.1161/CIRCRESAHA.110.220418; Sun N, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003552; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Wang G, 2014, NAT MED, V20, P616, DOI 10.1038/nm.3545; Wang W, 2004, CIRC RES, V95, P798, DOI 10.1161/01.RES.0000145361.50017.aa; Wu HD, 2015, CELL STEM CELL, V17, P89, DOI 10.1016/j.stem.2015.04.020; Xiang Y, 2002, J BIOL CHEM, V277, P33783, DOI 10.1074/jbc.M204136200; XIAO RP, 1994, J BIOL CHEM, V269, P19151; Xu L, 2010, CIRC RES, V107, P398, DOI 10.1161/CIRCRESAHA.110.222562; Yang XL, 2014, CIRC RES, V114, P511, DOI 10.1161/CIRCRESAHA.114.300558; Yazawa M, 2011, NATURE, V471, P230, DOI 10.1038/nature09855; Yoo B, 2009, AM J PHYSIOL-HEART C, V297, pH1377, DOI 10.1152/ajpheart.00504.2009; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhang SJ, 2000, J BIOL CHEM, V275, P21773, DOI 10.1074/jbc.M909484199; Zhu WZ, 2003, J CLIN INVEST, V111, P617, DOI 10.1172/JCI200316326	59	43	44	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1464	1479		10.1096/fj.15-280982	http://dx.doi.org/10.1096/fj.15-280982			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26675706	Green Published, Green Submitted			2022-12-26	WOS:000372629100009
J	Owings, JP; Kuiper, EG; Prezioso, SM; Meisner, J; Varga, JJ; Zelinskaya, N; Dammer, EB; Duong, DM; Seyfried, NT; Alberti, S; Conn, GL; Goldberg, JB				Owings, Joshua P.; Kuiper, Emily G.; Prezioso, Samantha M.; Meisner, Jeffrey; Varga, John J.; Zelinskaya, Natalia; Dammer, Eric B.; Duong, Duc M.; Seyfried, Nicholas T.; Alberti, Sebastian; Conn, Graeme L.; Goldberg, Joanna B.			Pseudomonas aeruginosa EftM Is a Thermoregulated Methyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						circular dichroism (CD); homology modeling; mass spectrometry (MS); Pseudomonas aeruginosa (P; aeruginosa); S-adenosylmethionine (SAM); translation elongation factor; EF-Tu; lysine methyltransferase	ELONGATION-FACTOR TU; PROTEIN; METHYLATION; LYSINE; IDENTIFICATION; TEMPERATURE; SPECIFICITY; INTERACTS; GROWTH; REGION	Pseudomonas aeruginosa is a Gram-negative opportunistic pathogen that trimethylates elongation factor-thermo-unstable (EF-Tu) on lysine 5. Lysine 5 methylation occurs in a temperature-dependent manner and is generally only seen when P. aeruginosa is grown at temperatures close to ambient (25 degrees C) but not at higher temperatures (37 degrees C). We have previously identified the gene, eftM (for EF-Tu-modifying enzyme), responsible for this modification and shown its activity to be associated with increased bacterial adhesion to and invasion of respiratory epithelial cells. Bioinformatic analyses predicted EftM to be a Class I S-adenosyl-l-methionine (SAM)-dependent methyltransferase. An in vitro methyltransferase assay was employed to show that, in the presence of SAM, EftM directly trimethylates EF-Tu. A natural variant of EftM, with a glycine to arginine substitution at position 50 in the predicted SAM-binding domain, lacks both SAM binding and enzyme activity. Mass spectrometry analysis of the in vitro methyltransferase reaction products revealed that EftM exclusively methylates at lysine 5 of EF-Tu in a distributive manner. Consistent with the in vivo temperature dependence of methylation of EF-Tu, preincubation of EftM at 37 degrees C abolished methyltransferase activity, whereas this activity was retained when EftM was preincubated at 25 degrees C. Irreversible protein unfolding at 37 degrees C was observed, and we propose that this instability is the molecular basis for the temperature dependence of EftM activity. Collectively, our results show that EftM is a thermolabile, SAM-dependent methyltransferase that directly trimethylates lysine 5 of EF-Tu in P. aeruginosa.	[Owings, Joshua P.; Prezioso, Samantha M.; Meisner, Jeffrey; Varga, John J.; Goldberg, Joanna B.] Emory Univ, Dept Pediat, Div Pulmonol Allergy Immunol Cyst Fibrosis & Slee, Atlanta, GA 30322 USA; [Owings, Joshua P.; Prezioso, Samantha M.; Meisner, Jeffrey; Varga, John J.; Goldberg, Joanna B.] Emory Univ, Emory Childrens Ctr Cyst Fibrosis Res, Atlanta, GA 30322 USA; [Owings, Joshua P.; Prezioso, Samantha M.; Meisner, Jeffrey; Varga, John J.; Goldberg, Joanna B.] Childrens Healthcare Atlanta, Atlanta, GA 30322 USA; [Owings, Joshua P.; Varga, John J.; Goldberg, Joanna B.] Univ Virginia, Dept Microbiol Immunol & Canc Biol, Charlottesville, VA 22908 USA; [Kuiper, Emily G.; Zelinskaya, Natalia; Dammer, Eric B.; Duong, Duc M.; Seyfried, Nicholas T.; Conn, Graeme L.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Kuiper, Emily G.] Emory Univ, Sch Med, Biochem Cell & Dev Biol Program, Atlanta, GA 30322 USA; [Prezioso, Samantha M.] Emory Univ, Sch Med, Microbiol & Mol Genet Program, Grad Div Biol & Biomed Sci, Atlanta, GA 30322 USA; [Alberti, Sebastian] Univ Islas Baleares, Inst Univ Invest Ciencias Salud, Palma De Mallorca 07122, Spain	Emory University; Emory University; Children's Healthcare of Atlanta (CHOA); University of Virginia; Emory University; Emory University; Emory University; Universitat de les Illes Balears	Goldberg, JB (corresponding author), Emory Univ, Sch Med, Dept Pediat, Div Pulmonol Allergy Immunol Cyst Fibrosis & Cyst, 1510 Clifton Rd NE,Suite 3009, Atlanta, GA 30322 USA.	joanna.goldberg@emory.edu	Alberti, Sebastian/H-2490-2013; Dammer, Eric B/V-8652-2019; Varga, John J/I-8130-2012	Alberti, Sebastian/0000-0003-0020-6861; Dammer, Eric B/0000-0003-2947-7606; Varga, John J/0000-0002-4868-1971; Duong, Duc/0000-0001-5880-1888	Cystic Fibrosis Foundation [GOLDBE10G0, GOLDBE14P0]; National Institutes of Health [R21AI103651]; Ministerio de Economia y Competitividad of Spain - European Development Regional Fund [SAF2012-38426]; Spanish Network for Research in Infectious Diseases from the Instituto de Salud Carlos III - European Development Regional Fund [REIPI RD12/0015]; Emory Neuroscience NINDS, National Institutes of Health [P30NS055077]; National Science Foundation MRI program [1040177]; NIAID, National Institutes of Health [T32AI007046, T32AI106699]; Agriculture and Food Research Initiative from the United States Department of Agriculture National Institute of Food and Agriculture [2013-67011-21133]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055432, R21AI103651, T32AI007046, T32AI106699] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS055077] Funding Source: NIH RePORTER	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministerio de Economia y Competitividad of Spain - European Development Regional Fund; Spanish Network for Research in Infectious Diseases from the Instituto de Salud Carlos III - European Development Regional Fund; Emory Neuroscience NINDS, National Institutes of Health; National Science Foundation MRI program(National Science Foundation (NSF)); NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Agriculture and Food Research Initiative from the United States Department of Agriculture National Institute of Food and Agriculture; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported in part through Cystic Fibrosis Foundation Grants GOLDBE10G0 and GOLDBE14P0 (to J. B. G.), National Institutes of Health Grant R21AI103651 (to J. B. G.), and Ministerio de Economia y Competitividad of Spain Grant SAF2012-38426 and Spanish Network for Research in Infectious Diseases Grant REIPI RD12/0015 from the Instituto de Salud Carlos III (both co-financed by the European Development Regional Fund) (to S. A.). Mass spectrometry was supported by Emory Neuroscience NINDS, National Institutes of Health, Core Facilities Grant P30NS055077. The Auto-iTC<INF>200</INF> instrument was purchased with support National Science Foundation MRI program Grant 1040177, the Winship Cancer Institute's shared resource program, and the Biochemistry Department of Emory University. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; Supported in part by NIAID, National Institutes of Health, Training Grant T32AI007046 (to the University of Virginia).; Supported by Agriculture and Food Research Initiative Competitive Grant 2013-67011-21133 from the United States Department of Agriculture National Institute of Food and Agriculture.; Supported in part by NIAID, National Institutes of Health, Training Grant T32AI106699 (to Emory University).	Abeykoon A, 2014, J BIOL CHEM, V289, P7691, DOI 10.1074/jbc.M113.535567; AMBLER RP, 1959, NATURE, V184, P56, DOI 10.1038/184056b0; Azevedo Cristina, 2015, Advances in Biological Regulation, V60, P144, DOI 10.1016/j.jbior.2015.09.008; Balasubramanian S, 2008, INFECT IMMUN, V76, P3116, DOI 10.1128/IAI.00173-08; Barbier M, 2008, J INFECT DIS, V197, P465, DOI 10.1086/525048; Barbier M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089941; Barbier M, 2013, MBIO, V4, DOI 10.1128/mBio.00207-13; Burgie ES, 2008, BIOCHEMISTRY-US, V47, P3982, DOI 10.1021/bi800063j; Caldas TD, 1998, J BIOL CHEM, V273, P11478, DOI 10.1074/jbc.273.19.11478; CHANG FN, 1974, J BACTERIOL, V120, P651, DOI 10.1128/JB.120.2.651-656.1974; Clark SE, 2013, INFECT IMMUN, V81, P392, DOI 10.1128/IAI.01168-12; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Garcia-Fontana C, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004849; Garcia-Fontana C, 2013, J BIOL CHEM, V288, P18987, DOI 10.1074/jbc.M113.472605; Gozal YM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-82; Granato D, 2004, INFECT IMMUN, V72, P2160, DOI 10.1128/IAI.72.4.2160-2169.2004; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Kraal B, 1999, FOLIA MICROBIOL, V44, P131, DOI 10.1007/BF02816232; KROPINSKI AMB, 1987, J BACTERIOL, V169, P1960, DOI 10.1128/jb.169.5.1960-1966.1987; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Lam O, 2014, VIRULENCE, V5, P852, DOI 10.4161/21505594.2014.970949; Lanouette S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134974; Laurberg M, 1998, J BIOL CHEM, V273, P4387, DOI 10.1074/jbc.273.8.4387; LITALIEN JJ, 1979, FEBS LETT, V107, P359, DOI 10.1016/0014-5793(79)80407-X; Marques MAM, 1998, INFECT IMMUN, V66, P2625, DOI 10.1128/IAI.66.6.2625-2631.1998; Martin JL, 2002, CURR OPIN STRUC BIOL, V12, P783, DOI 10.1016/S0959-440X(02)00391-3; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Porcella SF, 1996, MICROBIOL-SGM, V142, P2481, DOI 10.1099/00221287-142-9-2481; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schaumburg J, 2004, PROTEOMICS, V4, P2991, DOI 10.1002/pmic.200400928; Schmidt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018184; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Seyfried NT, 2012, J PROTEOME RES, V11, P2721, DOI 10.1021/pr2010814; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; TSUJI A, 1982, MICROBIOL IMMUNOL, V26, P15, DOI 10.1111/j.1348-0421.1982.tb00149.x; VANNOORT JM, 1986, EUR J BIOCHEM, V160, P557; Weiser JN, 1998, INFECT IMMUN, V66, P4263; Witek MA, 2014, BBA-PROTEINS PROTEOM, V1844, P1648, DOI 10.1016/j.bbapap.2014.06.012; Wuichet K, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000724; Wurtzel O, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002945; Xu P, 2009, J PROTEOME RES, V8, P3944, DOI 10.1021/pr900251d	42	9	9	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3280	3290		10.1074/jbc.M115.706853	http://dx.doi.org/10.1074/jbc.M115.706853			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26677219	Green Published, hybrid			2022-12-26	WOS:000370854500014
J	de Oliveira, DN; Christofoletti, RA; Barreto, RE				de Oliveira, Diogo Nunes; Christofoletti, Ronaldo Adriano; Barreto, Rodrigo Egydio			Feeding Behavior of a Crab According to Cheliped Number	PLOS ONE			English	Article							CALLINECTES-SAPIDUS RATHBUN; BLUE-CRAB; CARCINUS-MAENAS; PORCELAIN CRABS; CAUDAL AUTOTOMY; CANCER-PAGURUS; FIDDLER-CRAB; REGENERATION; COSTS; MECHANISM	Cheliped loss through autotomy is a common reflexive response in decapod crustaceans. Cheliped loss has direct and indirect effects on feeding behavior which can affect population dynamics and the role of species in the community. In this study, we assessed the impact of autotomy (0, 1, or 2 cheliped loss) on feeding behavior in the crab Pachygrapsus transversus, an omnivorous and abundant species that inhabits subtropical intertidal rocky shores along the South Atlantic Ocean. Autotomy altered crab feeding patterns and foraging behavior; however, the time spent foraging on animal prey or algae was not affected. These results indicate a plasticity of feeding behavior in P. transversus, allowing them to maintain feeding when injured.	[de Oliveira, Diogo Nunes] Univ Estadual Paulista, Inst Biociencias IBB UNESP, BR-18618970 Sao Paulo, Brazil; [Christofoletti, Ronaldo Adriano] Univ Fed Sao Paulo, Inst Mar, Santos, SP, Brazil; [Barreto, Rodrigo Egydio] Univ Estadual Paulista, Inst Biociencias, Dept Fisiol, BR-18618970 Sao Paulo, Brazil	Universidade Estadual Paulista; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Universidade Estadual Paulista	Barreto, RE (corresponding author), Univ Estadual Paulista, Inst Biociencias, Dept Fisiol, Rubiao Jr S-N, BR-18618970 Sao Paulo, Brazil.	rebarreto@yahoo.com	Christofoletti, Ronaldo A./D-3266-2012; Barreto, Rodrigo E/A-3440-2013	Christofoletti, Ronaldo A./0000-0002-2168-9527; Barreto, Rodrigo E/0000-0002-4611-0059	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [07/58436-8, 06/00559-4, 06/60237-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) due scholarship to DNO (07/58436-8) and research funds granted to RAC (06/00559-4 and 06/60237-0). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen BJ, 2007, FUNCT ECOL, V21, P154, DOI 10.1111/j.1365-2435.2006.01219.x; ARNOLD EN, 1984, J NAT HIST, V18, P127, DOI 10.1080/00222938400770131; Bateman PW, 2009, J ZOOL, V277, P1, DOI 10.1111/j.1469-7998.2008.00484.x; BENNETT D B, 1973, Journal of Experimental Marine Biology and Ecology, V13, P45, DOI 10.1016/0022-0981(73)90045-2; Brock RE, 1998, BIOL BULL, V194, P53, DOI 10.2307/1542513; Christofoletti RA, 2010, MAR ECOL PROG SER, V420, P125, DOI 10.3354/meps08880; COEN LD, 1988, OECOLOGIA, V75, P198, DOI 10.1007/BF00378597; Davis JLD, 2005, J CRUSTACEAN BIOL, V25, P655, DOI 10.1651/C-2586.1; Endler J.A., 1986, P109; Fleming PA, 2007, BIOL REV, V82, P481, DOI 10.1111/j.1469-185X.2007.00020.x; Flynn PST, 2015, J SEA RES, V103, P113, DOI 10.1016/j.seares.2015.07.002; FORMANOWICZ DR, 1990, ANIM BEHAV, V40, P400, DOI 10.1016/S0003-3472(05)80936-4; HARRIS RN, 1989, AM NAT, V134, P835, DOI 10.1086/285016; Hiatt R. W., 1948, Pacific Science, V2, P135; HINES AH, 1990, MAR ECOL PROG SER, V67, P105, DOI 10.3354/meps067105; JUANES F, 1990, ECOLOGY, V71, P744, DOI 10.2307/1940327; Juanes F, 1995, J EXP MAR BIOL ECOL, V193, P197, DOI 10.1016/0022-0981(95)00118-2; Knope ML, 2014, MAR ECOL-EVOL PERSP, V35, P471, DOI 10.1111/maec.12103; LAWTON P, 1989, MAR ECOL PROG SER, V52, P169, DOI 10.3354/meps052169; Maginnis TL, 2015, MAR FRESHW BEHAV PHY, V48, P241, DOI 10.1080/10236244.2015.1041241; Maginnis TL, 2006, BEHAV ECOL, V17, P857, DOI 10.1093/beheco/arl010; MCVEAN A, 1974, J EXP BIOL, V60, P423; McVean A, 1982, BIOL CRUSTACEA, P107; Naya DE, 2007, COMP BIOCHEM PHYS A, V146, P189, DOI 10.1016/j.cbpa.2006.10.014; Patterson L, 2009, APPL ANIM BEHAV SCI, V116, P302, DOI 10.1016/j.applanim.2008.08.007; Reaney LT, 2008, ANIM BEHAV, V75, P1473, DOI 10.1016/j.anbehav.2007.09.021; Savage T, 1978, FLA MAR RES PUBL, V32, P23; SKINNER DM, 1970, SCIENCE, V169, P383, DOI 10.1126/science.169.3943.383; SMITH LD, 1991, BIOL BULL, V180, P416, DOI 10.2307/1542342; SMITH LD, 1991, J EXP MAR BIOL ECOL, V151, P245; SMITH LD, 1990, B MAR SCI, V46, P23; SMITH LD, 1992, OECOLOGIA, V89, P494, DOI 10.1007/BF00317155; Wasson K, 2002, BEHAV ECOL, V13, P481, DOI 10.1093/beheco/13.4.481; Wood FD, 1932, J EXP ZOOL, V62, P1, DOI 10.1002/jez.1400620102; Woodland WNF, 1920, Q J MICROSC SCI, V65, P63	35	15	16	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145121	10.1371/journal.pone.0145121	http://dx.doi.org/10.1371/journal.pone.0145121			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26682546	Green Published, Green Submitted, gold			2022-12-26	WOS:000366725800038
J	Podleschny, M; Grund, A; Berger, H; Rollwitz, E; Borchers, A				Podleschny, Martina; Grund, Anita; Berger, Hanna; Rollwitz, Erik; Borchers, Annette			A PTK7/Ror2 Co-Receptor Complex Affects Xenopus Neural Crest Migration	PLOS ONE			English	Article							TYROSINE KINASE ROR2; PLANAR CELL POLARITY; SIGNALING ACTIVITY; RECEPTOR; PTK7; EXPRESSION; CANCER; ACTIVATION; PATHWAY; GROWTH	Neural crest cells are a highly migratory pluripotent cell population that generates a wide array of different cell types and failure in their migration can result in severe birth defects and malformation syndromes. Neural crest migration is controlled by various means including chemotaxis, repellent guidance cues and cell-cell interaction. Non-canonical Wnt PCP (planar cell polarity) signaling has previously been shown to control cell-contact mediated neural crest cell guidance. PTK7 (protein tyrosine kinase 7) is a transmembrane pseudokinase and a known regulator of Wnt/PCP signaling, which is expressed in Xenopus neural crest cells and required for their migration. PTK7 functions as a Wnt co-receptor; however, it remains unclear by which means PTK7 affects neural crest migration. Expressing fluorescently labeled proteins in Xenopus neural crest cells we find that PTK7 co-localizes with the Ror2 Wnt-receptor. Further, co-immunoprecipitation experiments demonstrate that PTK7 interacts with Ror2. The PTK7/Ror2 interaction is likely relevant for neural crest migration, because Ror2 expression can rescue the PTK7 loss of function migration defect. Live cell imaging of explanted neural crest cells shows that PTK7 loss of function affects the formation of cell protrusions as well as cell motility. Co-expression of Ror2 can rescue these defects. In vivo analysis demonstrates that a kinase dead Ror2 mutant cannot rescue PTK7 loss of function. Thus, our data suggest that Ror2 can substitute for PTK7 and that the signaling function of its kinase domain is required for this effect.	[Podleschny, Martina; Grund, Anita; Berger, Hanna; Rollwitz, Erik; Borchers, Annette] Univ Marburg, Fac Biol, Mol Embryol, D-35043 Marburg, Germany	Philipps University Marburg	Borchers, A (corresponding author), Univ Marburg, Fac Biol, Mol Embryol, D-35043 Marburg, Germany.	borchers@uni-marburg.de	Borchers, Annette/AAF-8126-2021	Borchers, Annette/0000-0002-2524-5384	Deutsche Forschungsgemeinschaft [BO 1978/42]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded by Deutsche Forschungsgemeinschaft, grant number BO 1978/42. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABERCROMBIE M, 1953, EXP CELL RES, V5, P111, DOI 10.1016/0014-4827(53)90098-6; ABERCROMBIE M, 1954, EXP CELL RES, V6, P293, DOI 10.1016/0014-4827(54)90176-7; Andreeva A, 2014, DEV CELL, V29, P20, DOI 10.1016/j.devcel.2014.02.008; Ataseven B, 2014, ONCOTARGETS THER, V7, P1723, DOI 10.2147/OTT.S62676; Axelrod Jeffrey D, 2002, ScientificWorldJournal, V2, P434; Banerjee S, 2011, DEVELOPMENT, V138, P3287, DOI 10.1242/dev.067306; Barclay AN, 2003, SEMIN IMMUNOL, V15, P215, DOI 10.1016/S1044-5323(03)00047-2; Becker SFS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085717; Billiard J, 2005, MOL ENDOCRINOL, V19, P90, DOI 10.1210/me.2004-0153; Bin-Nun N, 2014, DEVELOPMENT, V141, P410, DOI 10.1242/dev.095984; Bolande RP, 1997, PEDIATR PATHOL LAB M, V17, P1, DOI 10.1080/107710497174994; Borchers A, 2001, DEVELOPMENT, V128, P3049; Borchers A, 2000, DEV GENES EVOL, V210, P217, DOI 10.1007/s004270050307; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Carmona-Fontaine C, 2011, DEV CELL, V21, P1026, DOI 10.1016/j.devcel.2011.10.012; Carmona-Fontaine C, 2008, NATURE, V456, P957, DOI 10.1038/nature07441; Carter RE, 1998, J BIOL CHEM, V273, P35000, DOI 10.1074/jbc.273.52.35000; Chen R, 2014, CANCER RES, V74, P2892, DOI 10.1158/0008-5472.CAN-13-2775; Clay MR, 2013, DEVELOPMENT, V140, P3198, DOI 10.1242/dev.095448; de Melker AA, 2004, DEV DYNAM, V230, P708, DOI 10.1002/dvdy.20091; Easty DJ, 1997, INT J CANCER, V71, P1061, DOI 10.1002/(SICI)1097-0215(19970611)71:6<1061::AID-IJC24>3.0.CO;2-F; Endoh H, 2004, J CLIN ONCOL, V22, P811, DOI 10.1200/JCO.2004.04.109; Enomoto M, 2009, ONCOGENE, V28, P3197, DOI 10.1038/onc.2009.175; Feike AC, 2010, BIOCH BIOPHYS RES CO; Gartner S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084472; Gao B, 2011, DEV CELL, V20, P163, DOI 10.1016/j.devcel.2011.01.001; Golubkov VS, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-15; Golubkov VS, 2010, J BIOL CHEM; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Hayes M, 2013, DEVELOPMENT, V140, P1807, DOI 10.1242/dev.090183; He FL, 2008, DEVELOPMENT, V135, P3871, DOI 10.1242/dev.025767; Hikasa H, 2002, DEVELOPMENT, V129, P5227; Jin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090247; Kani S, 2004, J BIOL CHEM, V279, P50102, DOI 10.1074/jbc.M409039200; Kashef J, 2009, GENE DEV, V23, P1393, DOI 10.1101/gad.519409; Kim SH, 1998, DEVELOPMENT, V125, P4681; Klein TJ, 2005, ANNU REV CELL DEV BI, V21, P155, DOI 10.1146/annurev.cellbio.21.012704.132806; Kobayashi M, 2009, ORAL SURG ORAL MED O, V107, P398, DOI 10.1016/j.tripleo.2008.08.018; Kroiher M, 2001, BIOESSAYS, V23, P69, DOI 10.1002/1521-1878(200101)23:1<69::AID-BIES1009>3.3.CO;2-B; Kuriyama S, 2008, PHILOS T R SOC LON B; Lara E, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-170; Linnemannstons K, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004443; Liu Q, 2014, NEUROONCOLOGY; Liu Y, 2008, J CELL BIOCHEM, V105, P497, DOI 10.1002/jcb.21848; Lopez-Bergami P, 2005, MOL CELL, V19, P309, DOI 10.1016/j.molcel.2005.06.025; Lu XW, 2004, NATURE, V430, P93, DOI 10.1038/nature02677; Matthews HK, 2008, DEVELOPMENT, V135, P1771, DOI 10.1242/dev.017350; Mayor R, 2014, BIOCHEM J, V457, P19, DOI 10.1042/BJ20131182; Mayor R, 2010, TRENDS CELL BIOL, V20, P319, DOI 10.1016/j.tcb.2010.03.005; Medina A, 2000, MECH DEVELOP, V92, P227, DOI 10.1016/S0925-4773(00)00240-9; Meijering E, 2012, METHOD ENZYMOL, V504, P183, DOI 10.1016/B978-0-12-391857-4.00009-4; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mikels A, 2009, J BIOL CHEM, V284, P30167, DOI 10.1074/jbc.M109.041715; Miller MA, 2000, DEV BIOL, V224, P286, DOI 10.1006/dbio.2000.9786; Morioka K, 2009, CANCER SCI, V100, P1227, DOI 10.1111/j.1349-7006.2009.01165.x; Muller-Tidow C, 2004, CLIN CANCER RES, V10, P1241, DOI 10.1158/1078-0432.CCR-0954-03; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Nishita M, 2006, J CELL BIOL, V175, P555, DOI 10.1083/jcb.200607127; Nomachi A, 2008, J BIOL CHEM, V283, P27973, DOI 10.1074/jbc.M802325200; O'Connell MP, 2010, ONCOGENE, V29, P34, DOI 10.1038/onc.2009.305; Ohkawara B, 2011, DEV DYNAM, V240, P188, DOI 10.1002/dvdy.22500; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Ossipova O, 2011, DEVELOPMENT, V138, P5441, DOI 10.1242/dev.067280; Paudyal A, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-87; Peradziryi H, 2012, ARCH BIOCHEM BIOPHYS, V524, P71, DOI 10.1016/j.abb.2011.12.019; Peradziryi H, 2011, EMBO J, V30, P3729, DOI 10.1038/emboj.2011.236; Powell DR, 2013, WIRES SYST BIOL MED, V5, P511, DOI 10.1002/wsbm.1224; Prebet T, 2010, BLOOD; Puppo F, 2011, EMBO REP, V12, P43, DOI 10.1038/embor.2010.185; Saha S, 2001, SCIENCE, V294, P1343, DOI 10.1126/science.1065817; Sammar M, 2004, GENES CELLS, V9, P1227, DOI 10.1111/j.1365-2443.2004.00799.x; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; Shnitsar I, 2008, DEVELOPMENT, V135, P4015, DOI 10.1242/dev.023556; SMITH WC, 1991, CELL, V67, P753, DOI 10.1016/0092-8674(91)90070-F; Snider TN, 2014, BIRTH DEFECTS RES C, V102, P324, DOI 10.1002/bdrc.21075; Theveneau E, 2013, CELL MOL LIFE SCI, V70, P3481, DOI 10.1007/s00018-012-1251-7; Theveneau E, 2013, NAT CELL BIOL, V15, P763, DOI 10.1038/ncb2772; Theveneau E, 2012, DEV BIOL, V366, P34, DOI 10.1016/j.ydbio.2011.12.041; Theveneau Eric, 2010, Small GTPases, V1, P113, DOI 10.4161/sgtp.1.2.13673; Theveneau E, 2011, GENESIS, V49, P164, DOI 10.1002/dvg.20700; Theveneau E, 2010, DEV CELL, V19, P39, DOI 10.1016/j.devcel.2010.06.012; Ulmer B, 2013, CELL REP, V3, P615, DOI 10.1016/j.celrep.2013.02.015; Vladar EK, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002964; Wallingford JB, 2012, ANNU REV CELL DEV BI, V28, P627, DOI 10.1146/annurev-cellbio-092910-154208; Wehner P, 2011, DEVELOPMENT, V138, P1321, DOI 10.1242/dev.056291; Weston CR, 2002, CURR OPIN GENET DEV, V12, P14, DOI 10.1016/S0959-437X(01)00258-1; Winkel A, 2008, CELL SIGNAL, V20, P2134, DOI 10.1016/j.cellsig.2008.08.009; Witte F, 2010, FASEB J, V24, P2417, DOI 10.1096/fj.09-150615; Wright TM, 2009, ONCOGENE, V28, P2513, DOI 10.1038/onc.2009.116; Yamada M, 2010, DEV DYNAM, V239, P941, DOI 10.1002/dvdy.22212; Yamamoto H, 2007, GENES CELLS, V12, P1215, DOI 10.1111/j.1365-2443.2007.01128.x; Yamamoto S, 2008, DEV CELL, V15, P23, DOI 10.1016/j.devcel.2008.05.007; Yen WW, 2009, DEVELOPMENT, V136, P2039, DOI 10.1242/dev.030601; Zhang DC, 2014, BIRTH DEFECTS RES C, V102, P275, DOI 10.1002/bdrc.21081; Zhang HT, 2014, INT J MOL SCI, V15, P11665, DOI 10.3390/ijms150711665	95	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145169	10.1371/journal.pone.0145169	http://dx.doi.org/10.1371/journal.pone.0145169			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26680417	gold, Green Published, Green Submitted			2022-12-26	WOS:000366723400052
J	Xue, P; Gao, L; Xiao, S; Zhang, GP; Xiao, MY; Zhang, QY; Zheng, X; Cai, Y; Jin, CH; Yang, JH; Wu, SW; Lu, XB				Xue, Ping; Gao, Lin; Xiao, Sha; Zhang, Guopei; Xiao, Mingyang; Zhang, Qianye; Zheng, Xiao; Cai, Yuan; Jin, Cuihong; Yang, Jinghua; Wu, Shengwen; Lu, Xiaobo			Genetic Polymorphisms in XRCC1, CD3EAP, PPP1R13L, XPB, XPC, and XPF and the Risk of Chronic Benzene Poisoning in a Chinese Occupational Population	PLOS ONE			English	Article							SINGLE NUCLEOTIDE POLYMORPHISMS; OXIDATIVE DNA-DAMAGE; BONE-MARROW; CHROMOSOME 19Q13.2-3; BREAST-CANCER; LUNG-CANCER; REPAIR; ERCC1; SUSCEPTIBILITY; ASSOCIATION	Objectives Individual variations in the capacity of DNA repair machinery to relieve benzene-induced DNA damage may be the key to developing chronic benzene poisoning (CBP), an increasingly prevalent occupational disease in China. ERCC1 (Excision repair cross complementation group 1) is located on chromosome 19q13.2-3 and participates in the crucial steps of Nucleotide Excision Repair (NER); moreover, we determined that one of its polymorphisms, ERCC1 rs11615, is a biomarker for CBP susceptibility in our previous report. Our aim is to further explore the deeper association between some genetic variations related to ERCC1 polymorphisms and CBP risk. Methods Nine single nucleotide polymorphisms (SNPs) of XRCC1 (X-ray repair cross-complementing 1), CD3EAP (CD3e molecule, epsilon associated protein), PPP1R13L (protein phosphatase 1, regulatory subunit 13 like), XPB (Xeroderma pigmentosum group B), XPC (Xeroderma pigmentosum group C) and XPF (Xeroderma pigmentosum group F) were genotyped by the Snapshot and TaqMan-MGB (R) probe techniques, in a study involving 102 CBP patients and 204 controls. The potential interactions between these SNPs and lifestyle factors, such as smoking and drinking, were assessed using a stratified analysis. Results An XRCC1 allele, rs25487, was related to a higher risk of CBP (P<0.001) even after stratifying for potential confounders. Carriers of the TT genotype of XRCC1 rs1799782 who were alcohol drinkers (OR = 8.000; 95% CI: 1.316-48.645; P = 0.022), male (OR = 9.333; 95% CI: 1.593-54.672; P = 0.019), and had an exposure of <= 12 years (OR = 2.612; 95% CI: 1.048-6.510; P = 0.035) had an increased risk of CBP. However, the T allele in PPP1R13L rs1005165 (P<0.05) and the GA allele in CD3EAP rs967591 (OR = 0.162; 95% CI: 0039 +/- 0.666; P = 0.037) decreased the risk of CBP in men. The haplotype analysis of XRCC1 indicated that XRCC1 rs25487(A), rs25489(G) and rs1799782(T) (OR = 15.469; 95% CI: 5.536-43.225; P<0.001) were associated with a high risk of CBP. Conclusions The findings showed that the rs25487 and rs1799782 polymorphisms of XRCC1 may contribute to an individual's susceptibility to CBP and may be used as valid biomarkers. Overall, the genes on chromosome 19q13.2-3 may have a special significance in the development of CBP in occupationally exposed Chinese populations.	[Xue, Ping; Gao, Lin; Xiao, Sha; Zhang, Guopei; Xiao, Mingyang; Zhang, Qianye; Zheng, Xiao; Cai, Yuan; Jin, Cuihong; Yang, Jinghua; Wu, Shengwen; Lu, Xiaobo] China Med Univ, Sch Publ Hlth, Dept Toxicol, Shenyang 110001, Liaoning, Peoples R China; [Gao, Lin] Shenyang Ninth Peoples Hosp, Poisoning Dept, Shenyang 110001, Liaoning, Peoples R China	China Medical University	Lu, XB (corresponding author), China Med Univ, Sch Publ Hlth, Dept Toxicol, Shenyang 110001, Liaoning, Peoples R China.	xiaobo-lu@163.com			National Natural Science Foundation of China [81273118]; Shenyang Technology Specific Foundation [F12-193-9-17]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shenyang Technology Specific Foundation	This study was supported by National Natural Science Foundation of China (No. 81273118) and Shenyang Technology Specific Foundation (No. F12-193-9-17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin DP, 2001, INT J TOXICOL, V20, P69; Andreoli C, 1997, MUTAT RES-FUND MOL M, V377, P95, DOI 10.1016/S0027-5107(97)00065-1; Bergamaschi D, 2003, NAT GENET, V33, P162, DOI 10.1038/ng1070; Capleton AC, 2005, CHEM-BIOL INTERACT, V153, P43, DOI 10.1016/j.cbi.2005.03.007; Chae YS, 2013, J CANCER RES CLIN, V139, P465, DOI 10.1007/s00432-012-1346-4; Chanvaivit S, 2007, MUTAT RES-GEN TOX EN, V626, P79, DOI 10.1016/j.mrgentox.2006.09.007; Chen SQ, 2002, CARCINOGENESIS, V23, P1321, DOI 10.1093/CARCIN/23.8.1321; Ding PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092083; Faiola B, 2004, MUTAT RES-FUND MOL M, V549, P195, DOI 10.1016/j.mrfmmm.2003.12.022; Fracasso ME, 2010, TOXICOL LETT, V192, P22, DOI 10.1016/j.toxlet.2009.04.028; Hosgood HD, 2009, OCCUP ENVIRON MED, V66, P848, DOI 10.1136/oem.2008.044024; Huang J, 2007, INT J GYNECOL CANCER, V17, P668, DOI 10.1111/j.1525-1438.2007.00840.x; Jeon HS, 2013, CLIN CANCER RES, V19, P4185, DOI 10.1158/1078-0432.CCR-12-2792; Jiang HL, 2013, TUMOR BIOL, V34, P3417, DOI 10.1007/s13277-013-0914-9; Kim SY, 2004, PHARMACOGENETICS, V14, P453, DOI 10.1097/01.fpc.0000114751.08559.7b; KOLACHANA P, 1993, CANCER RES, V53, P1023; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Lan Q, 2004, SCIENCE, V306, P1774, DOI 10.1126/science.1102443; Lee EB, 2010, ANN SURG ONCOL, V17, P2608, DOI 10.1245/s10434-010-1082-4; Leng SG, 2005, CANCER EPIDEM BIOMAR, V14, P1295, DOI 10.1158/1055-9965.EPI-04-0690; LI YB, 1995, CHEM-BIOL INTERACT, V94, P101, DOI 10.1016/0009-2797(94)03326-4; Lu AL, 2001, CELL BIOCHEM BIOPHYS, V35, P141, DOI 10.1385/CBB:35:2:141; Maffei F, 2009, MUTAT RES, V583, P1; Nexo BA, 2003, CARCINOGENESIS, V24, P899, DOI 10.1093/carcin/bgg043; Nexo BA, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-56; Recio L, 2005, CHEM-BIOL INTERACT, V153, P159, DOI 10.1016/j.cbi.2005.03.020; Rodriguez B, 2010, TOXICOL LETT, V193, P26, DOI 10.1016/j.toxlet.2009.12.005; SEATON MJ, 1994, CARCINOGENESIS, V15, P1799, DOI 10.1093/carcin/15.9.1799; Shen M, 2006, CARCINOGENESIS, V27, P2083, DOI 10.1093/carcin/bgl061; Skjelbred CF, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-175; Stern MC, 2001, CANCER EPIDEM BIOMAR, V10, P125; Vidal AE, 2001, EMBO J, V20, P6530, DOI 10.1093/emboj/20.22.6530; Vogel U, 2004, MUTAT RES-FUND MOL M, V546, P65, DOI 10.1016/j.mrfmmm.2003.11.001; Vogel U, 2007, CANCER LETT, V247, P159, DOI 10.1016/j.canlet.2006.04.001; Vousden KH, 2006, J CELL SCI, V119, P5015, DOI 10.1242/jcs.03293; Xiao S, 2013, MUTAT RES-GEN TOX EN, V751, P52, DOI 10.1016/j.mrgentox.2012.11.002; Xing DY, 2002, INT J CANCER, V100, P600, DOI 10.1002/ijc.10528; Yin JY, 2012, LUNG CANCER, V76, P286, DOI 10.1016/j.lungcan.2012.01.001; Yin JY, 2002, CANCER EPIDEM BIOMAR, V11, P1449; Zhang ZB, 2005, CANCER EPIDEM BIOMAR, V14, P2614, DOI 10.1158/1055-9965.EPI-05-0143	40	6	7	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144458	10.1371/journal.pone.0144458	http://dx.doi.org/10.1371/journal.pone.0144458			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26681190	Green Published, Green Submitted, gold			2022-12-26	WOS:000366723400015
J	Hashimoto, Y; Kondo, C; Katunuma, N				Hashimoto, Yoko; Kondo, Chihiro; Katunuma, Nobuhiko			An Active 32-kDa Cathepsin L Is Secreted Directly from HT 1080 Fibrosarcoma Cells and Not via Lysosomal Exocytosis	PLOS ONE			English	Article							MANNOSE 6-PHOSPHATE RECEPTOR; DIPLOCOCCUS-PNEUMONIAE; TUMOR MICROENVIRONMENT; CARBOHYDRATE MOIETIES; MOLECULAR-MASS; PROCATHEPSIN-L; CANCER-CELLS; ENZYMES; INHIBITION; ACTIVATION	Cathepsin L [EC 3.4.22.15] is secreted via lysosomal exocytosis by several types of cancer cells, including prostate and breast cancer cells. We previously reported that human cultured fibrosarcoma ( HT 1080) cells secrete cathepsin L into the medium; this secreted cathepsin is 10-times more active than intracellular cathepsin. This increased activity was attributed to the presence of a 32-kDa cathepsin L in the medium. The aim of this study was to examine how this active 32-kDa cathepsin L is secreted into the medium. To this end, we compared the secreted active 32-kDa cathepsin L with lysosomal cathepsin L by using a novel gelatin zymography technique that employs leupeptin. We also examined the glycosylation and phosphorylation status of the proteins by using the enzymes endoglycosidase H [EC 3.2.1.96] and alkaline phosphatase [EC 3.1.3.1]. Strong active bands corresponding to the 32-kDa and 34-kDa cathepsin L forms were detected in the medium and lysosomes, respectively. The cell extract exhibited strong active bands for both forms. Moreover, both forms were adsorbed onto a concanavalin A-agarose column. The core protein domain of both forms had the same molecular mass of 30 kDa. The 32-kDa cathepsin L was phosphorylated, while the 34-kDa lysosomal form was dephosphorylated, perhaps because of the lysosomal marker enzyme, acid phosphatase. These results suggest that the active 32-kDa form does not enter the lysosomes. In conclusion, our results indicate that the active 32-kDa cathepsin L is secreted directly from the HT 1080 cells and not via lysosomal exocytosis.	[Hashimoto, Yoko; Kondo, Chihiro] Aichi Gakuin Univ, Sch Dent, Dept Biochem, Nagoya, Aichi 464, Japan; [Katunuma, Nobuhiko] Tokushima Bunri Univ, Inst Hlth Sci, Tokushima, Japan	Aichi Gakuin University; Tokushima Bunri University	Hashimoto, Y (corresponding author), Aichi Gakuin Univ, Sch Dent, Dept Biochem, 1-100 Kusumoto Cho, Nagoya, Aichi 464, Japan.	yokuteku@dpc.agu.ac.jp			Aichi-Gakuin University Annual Fund	Aichi-Gakuin University Annual Fund	This work was supported by Aichi-Gakuin University Annual Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews NW, 2000, TRENDS CELL BIOL, V10, P316, DOI 10.1016/S0962-8924(00)01794-3; Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; ARAKAWA M, 1974, J BIOCHEM, V76, P307, DOI 10.1093/oxfordjournals.jbchem.a130572; Castino R, 2003, J MOL RECOGNIT, V16, P337, DOI 10.1002/jmr.643; DONG JM, 1990, J BIOL CHEM, V265, P4210; DUVE CD, 1955, BIOCHEM J, V60, P604, DOI 10.1042/bj0600604; Ghosh P, 2003, J CELL BIOL, V163, P755, DOI 10.1083/jcb.200308038; Gillies Robert J., 1999, Neoplasia (New York), V1, P197, DOI 10.1038/sj.neo.7900037; HARA K, 1988, FEBS LETT, V231, P229, DOI 10.1016/0014-5793(88)80737-3; Hashimoto Y, 2001, BIOCHEM BIOPH RES CO, V283, P334, DOI 10.1006/bbrc.2001.4787; Hashimoto Y, 2006, CANCER BIOTHER RADIO, V21, P217, DOI 10.1089/cbr.2006.21.217; INUBUSHI T, 1994, J BIOCHEM-TOKYO, V116, P282, DOI 10.1093/oxfordjournals.jbchem.a124520; ISHIDOH K, 1987, FEBS LETT, V223, P69, DOI 10.1016/0014-5793(87)80511-2; Jaiswal JK, 2002, J CELL BIOL, V159, P625, DOI 10.1083/jcb.200208154; Katunuma N, 1999, FEBS LETT, V458, P6, DOI 10.1016/S0014-5793(99)01107-2; KOIDE N, 1974, J BIOL CHEM, V249, P4897; KORNFELD S, 1986, J CLIN INVEST, V77, P1, DOI 10.1172/JCI112262; Kuliawat R, 1997, J CELL BIOL, V137, P595, DOI 10.1083/jcb.137.3.595; Lakka SS, 2004, ONCOGENE, V23, P4681, DOI 10.1038/sj.onc.1207616; LANG L, 1984, J BIOL CHEM, V259, P4663; LAZZARINO D, 1990, J BIOL CHEM, V265, P11864; Linebaugh BE, 1999, EUR J BIOCHEM, V264, P100, DOI 10.1046/j.1432-1327.1999.00582.x; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045910; Lunt SJ, 2009, CLIN EXP METASTAS, V26, P19, DOI 10.1007/s10585-008-9182-2; MASON RW, 1992, BIOCHEM BIOPH RES CO, V189, P1659, DOI 10.1016/0006-291X(92)90268-P; Medina DL, 2011, DEV CELL, V21, P421, DOI 10.1016/j.devcel.2011.07.016; MURAMATS.T, 1971, J BIOL CHEM, V246, P5534; NISHIMURA Y, 1988, ARCH BIOCHEM BIOPHYS, V261, P64, DOI 10.1016/0003-9861(88)90104-X; NOVIKOFF ALEX B., 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P179, DOI 10.1083/jcb.2.4.179; Ohkubo K, 2003, ENDOCR J, V50, P9, DOI 10.1507/endocrj.50.9; Podgorski I, 2003, BIOCHEM SOC SYMP, V70, P263, DOI 10.1042/bss0700263; Reddy A, 2001, CELL, V106, P157, DOI 10.1016/S0092-8674(01)00421-4; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Rohn WM, 2000, J CELL SCI, V113, P2093; ROTHMAN JE, 1987, CELL, V50, P521, DOI 10.1016/0092-8674(87)90024-9; Samie MA, 2014, J LIPID RES, V55, P995, DOI 10.1194/jlr.R046896; SMITH SM, 1989, BIOCHEM J, V262, P931, DOI 10.1042/bj2620931; Sudhan DR, 2013, CLIN EXP METASTAS, V30, P891, DOI 10.1007/s10585-013-9590-9; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; TURK B, 1993, BIOCHEMISTRY-US, V32, P375, DOI 10.1021/bi00052a046; UMEZAWA H, 1970, J ANTIBIOT, V23, P425, DOI 10.7164/antibiotics.23.425	41	14	14	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145067	10.1371/journal.pone.0145067	http://dx.doi.org/10.1371/journal.pone.0145067			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674348	Green Submitted, gold, Green Published			2022-12-26	WOS:000366722700092
J	Huang, RE; Ye, WM; Ren, XL; Zhao, ZY				Huang, Ren-E; Ye, Weimin; Ren, Xiaoliang; Zhao, Zhongying			Morphological and Molecular Characterization of Phasmarhabditis huizhouensis sp nov (Nematoda: Rhabditidae), a New Rhabditid Nematode from South China	PLOS ONE			English	Article							BIOLOGICAL-CONTROL; HERMAPHRODITA NEMATODA; TERRESTRIAL MOLLUSKS; PARASITE; DNA; ANGIOSTOMATIDAE; PHYLOGENY; SLUGS; SECERNENTEA; AGENT	The genus Phasmarhabditis is an economically important group of rhabditid nematodes, to which the well-known slug-parasite P. hermaphrodita belongs. Despite the commercial use of Phasmarhabditis species as an attractive and promising approach for pest control, the taxonomy and systematics of this group of rhabditids are poorly understood, largely because of the lack of diagnostic morphological features and DNA sequences for distinguishing species or inferring phylogenetic relationship. During a nematode sampling effort for identifying free-living relatives of Caenorhabditis elegans in Huizhou City, Guangdong, China, a novel species belonging to the genus Phasmarhabditis was isolated from rotting leaves. Detailed morphology of the gonochoristic P. huizhouensis sp. nov. was described and illustrated. The adult female has a robust body, a relatively short and wide buccal capsule conjoined by a rhabditiform pharynx. Females are characterized by a short cupola-shaped tail end bearing a slender pointed tip, with the junction flanked by a pair of 'rod-like' phasmids. Males have an open peloderan bursa that is supported by 9 pairs of genital papillae and 1 terminal pair of phasmids. P. huizhouensis sp. nov. is morphologically very similar to the type species Phasmarhabditis papillosa but is distinguishable by its male caudal traits. The new species is readily differentiated from other taxa in the genus by its female tail shape. Molecular phylogenetic inferences based on small subunit (SSU) and the D2-D3 domain of large subunit (LSU) ribosomal DNA genes reveal that P. huizhouensis sp. nov. forms a unique branch in both phylogenies which is genetically related to P. hermaphrodita and other parasites such as Angiostoma spp. The host associations of P. huizhouensis sp. nov. and its ability to parasitize slugs are unknown.	[Huang, Ren-E] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Huang, Ren-E; Ren, Xiaoliang; Zhao, Zhongying] Hong Kong Baptist Univ, Dept Biol, Fac Sci, Hong Kong, Hong Kong, Peoples R China; [Ye, Weimin] North Carolina Dept Agr & Consumer Serv, Div Agron, Nematode Assay Sect, Raleigh, NC USA	Tsinghua University; Hong Kong Baptist University	Huang, RE (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China.	renehuang2014@126.com; zyzhao@hkbu.edu.hk	Zhao, Zhongying/C-3261-2015		National Natural Science Foundation of China [31201700]; Early Career Scheme (ECS) of the Research Grants Council (RGC) of Hong Kong [HKBU263512]; General Research Fund (GRF) of the Research Grants Council (RGC) of Hong Kong [HKBU12103314]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Early Career Scheme (ECS) of the Research Grants Council (RGC) of Hong Kong; General Research Fund (GRF) of the Research Grants Council (RGC) of Hong Kong	This study was funded by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) (Grant No. 31201700) to REH, and by the Early Career Scheme (ECS) and General Research Fund (GRF) of the Research Grants Council (RGC) of Hong Kong (http://www.ugc.edu.hk/eng/rgc/) (Grant No. HKBU263512 and HKBU12103314 respectively) to ZZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrassy I., 1976, EVOLUTION BASIS SYST; Andrassy I., 1983, TAXONOMIC REV SUBORD; Azzam Karima M., 2003, Journal of the Egyptian German Society of Zoology, V42, P79; Barriere Antoine, 2006, WormBook, P1; Blaxter ML, 1998, NATURE, V392, P71, DOI 10.1038/32160; Bonaparte CLJL, 1838, ICONOGRAPHIA TAUNA I, VII; De Ley IT, 2014, NEMATOLOGY, V16, P1129, DOI 10.1163/15685411-00002838; deMan J.G, 1880, TIJDSCHRIFT NEDERLAN, V5, P1; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Haber M, 2005, MOL BIOL EVOL, V22, P160, DOI 10.1093/molbev/msh264; Hooper DJ, 1999, NEMATOLOGY, V1, P173, DOI 10.1163/156854199508144; Huang RE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110957; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Ivanova ES, 2010, J HELMINTHOL, V84, P297, DOI 10.1017/S0022149X09990678; Ivanova ES, 2013, RUSS J NEMATOL, V21, P41; Ivanova ES, 2009, SYST PARASITOL, V74, P113, DOI 10.1007/s11230-009-9200-z; Larget B, 1999, MOL BIOL EVOL, V16, P750, DOI 10.1093/oxfordjournals.molbev.a026160; Mengert H., 1953, Zeitschrift fuer Morphologie und Oekologie der Tiere, V41, P311, DOI 10.1007/BF00407426; MORAND S, 1990, SYST PARASITOL, V15, P127, DOI 10.1007/BF00009990; Nadler SA, 1998, MOL PHYLOGENET EVOL, V10, P221, DOI 10.1006/mpev.1998.0514; Nadler SA, 2003, INT J PARASITOL, V33, P1115, DOI 10.1016/S0020-7519(03)00134-6; POINAR GO, 1993, FUND APPL NEMATOL, V16, P333; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Rae R. G., 2006, Aspects of Applied Biology, P211; Rae R, 2007, PEST MANAG SCI, V63, P1153, DOI 10.1002/ps.1424; da Silva NRR, 2010, NEMATOLOGY, V12, P661, DOI 10.1163/138855410X500073; Ross JL, 2012, J HELMINTHOL, V86, P215, DOI 10.1017/S0022149X11000277; Ross JL, 2011, SYST PARASITOL, V79, P71, DOI 10.1007/s11230-011-9294-y; Ross JL, 2010, MOL PHYLOGENET EVOL, V55, P738, DOI 10.1016/j.ympev.2010.01.026; Ross JL, 2010, BIOL INVASIONS, V12, P603, DOI 10.1007/s10530-009-9467-7; Ryss AY, 2003, ZOOSYSTEMATICA ROSSI, V11, P257; Sanchez-Herraiz MJ, 2000, HERPETOLOGICA, V56, P105; STOCK SP, 1991, MEM I OSWALDO CRUZ, V86, P219, DOI 10.1590/S0074-02761991000200011; Sudhaus W., 2011, Journal of Nematode Morphology and Systematics, V14, P113; Sudhaus W, 2001, J NEMATOL, V33, P1; Sudhaus W., 1976, Zoologica Stuttg, V43, P1; Thomas WK, 1997, J NEMATOL, V29, P250; WILSON MJ, 1993, BIOCONTROL SCI TECHN, V3, P503, DOI 10.1080/09583159309355306; Wilson MJ, 2004, APPL SOIL ECOL, V26, P179, DOI 10.1016/j.apsoil.2004.01.005; WILSON MJ, 1995, FUND APPL NEMATOL, V18, P159; Zaborski ER, 2001, J INVERTEBR PATHOL, V77, P284, DOI 10.1006/jipa.2001.5024	41	23	25	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144386	10.1371/journal.pone.0144386	http://dx.doi.org/10.1371/journal.pone.0144386			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674768	gold, Green Published, Green Submitted			2022-12-26	WOS:000366722700038
J	Sandrock, I; Zietara, N; Lyszkiewicz, M; Oberdorfer, L; Witzlau, K; Krueger, A; Prinz, I				Sandrock, Inga; Zietara, Natalia; Lyszkiewicz, Marcin; Oberdoerfer, Linda; Witzlau, Katrin; Krueger, Andreas; Prinz, Immo			MicroRNA-181a/b-1 Is Not Required for Innate gamma delta NKT Effector Cell Development	PLOS ONE			English	Article							T-CELLS; ALPHA-BETA; LIMITED DIVERSITY; SELECTION; REPERTOIRE; EXPRESSION; STRENGTH; SUBSET; TRANSCRIPTION; IL-17A	Thymic development of alpha beta T lymphocytes into invariant natural killer (NK) T cells depends on their selection via agonistic lipid antigen presented by CD1d. If successful, newly selected NKT cells gain effector functions already in the thymus. Some gamma delta T cell subsets also acquire effector functions in the thymus. However, it is not clear whether agonistic TCR stimulation is involved in thymic gamma delta T cell selection and development. Here we combine two genetic models to address this question. MiR-181a/b-1(-/-) mice, which show impaired agonistic T cell selection of invariant alpha beta NKT cells, were crossed to Tcrd-H2BeGFP reporter mice to monitor selection, intra-thymic expansion and differentiation of gamma delta T cells. We found that miR-181a/b-1-deficiency had no effect on numbers of thymic gamma delta T cell or on their differentiation towards an IL-17- or IFN-gamma-producing effector phenotype. Also, the composition of peripheral lymph node gamma delta T cells was not affected by miR-181a/b-1-deficiency. Dendritic epidermal gamma delta T cells were normally present in knock-out animals. However, we observed elevated frequencies and numbers of gamma delta NKT cells in the liver, possibly because gamma delta NKT cells can expand and replace missing alpha beta NKT cells in peripheral niches. In summary, we investigated the role of miR-181a/b-1 for selection, intrathymic development and homeostasis of gamma delta T cells. We conclude that miR-181a/b-1-dependent modulation of T cell selection is not critically required for innate development of gamma delta NKT cells or of any other gamma delta T cell subtypes.	[Sandrock, Inga; Zietara, Natalia; Lyszkiewicz, Marcin; Oberdoerfer, Linda; Witzlau, Katrin; Krueger, Andreas; Prinz, Immo] Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany	Hannover Medical School	Sandrock, I (corresponding author), Hannover Med Sch, Inst Immunol, D-30625 Hannover, Germany.	Sandrock.Inga@mh-hannover.de	Prinz, Immo/A-3026-2010; Krueger, Andreas/M-9769-2019; Krueger, Andreas/B-9427-2009	Prinz, Immo/0000-0002-8789-9578; Krueger, Andreas/0000-0001-7873-7334; Krueger, Andreas/0000-0001-7873-7334; Zietara, Natalia/0000-0002-4597-6731	Braukmann-Wittenberg-Herz-Stiftung; German Research Foundation (DFG); DFG [PR727/4-1, PR727/5-1, SFB900-B8, KR2320/3-1, SFB738-A7]; Ministry For Science and Culture of Lower Saxony through the Georg-Christoph-Lichtenberg Scholarship scheme	Braukmann-Wittenberg-Herz-Stiftung; German Research Foundation (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); Ministry For Science and Culture of Lower Saxony through the Georg-Christoph-Lichtenberg Scholarship scheme	Assistance was provided by the Cell Sorting Core Facility of the Hannover Medical School, supported in part by Braukmann-Wittenberg-Herz-Stiftung and German Research Foundation (DFG). The work was supported by grants from the DFG (PR727/4-1; PR727/5-1; and SFB900-B8 to I.P. and cluster of excellence EXC62-2 "REBIRTH", KR2320/3-1 and SFB738-A7 to A.K.). I.S. was supported in part by the Ministry For Science and Culture of Lower Saxony through the Georg-Christoph-Lichtenberg Scholarship scheme.; Assistance was provided by the Cell Sorting Core Facility of the Hannover Medical School, supported in part by Braukmann-Wittenberg-Herz-Stiftung and German Research Foundation (DFG). The allophycocyanin-conjugated CD1d tetramer loaded with PBS-57, an analog of alpha GalCer, as well as unloaded CD1d tetramer were kindly provided by the National Institutes of Health Tetramer Facility at Emory University. The work was supported by grants from the DFG (PR727/4-1; PR727/5-1; and SFB900-B8 to I.P. and cluster of excellence EXC62-2 "REBIRTH", KR2320/3-1 and SFB738-A7 to A.K.). I.S. was a scholar of Hannover Biomedical Research School (HBRS/DEWIN).	Alonzo ES, 2010, J IMMUNOL, V184, P1268, DOI 10.4049/jimmunol.0903218; ARASE H, 1995, J EXP MED, V182, P891, DOI 10.1084/jem.182.3.891; ASARNOW DM, 1988, CELL, V55, P837, DOI 10.1016/0092-8674(88)90139-0; Azuara V, 1998, EUR J IMMUNOL, V28, P3456, DOI 10.1002/(SICI)1521-4141(199811)28:11&lt;3456::AID-IMMU3456&gt;3.0.CO;2-F; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chennupati V, 2010, J IMMUNOL, V185, P5160, DOI 10.4049/jimmunol.1001652; Chien YH, 2014, ANNU REV IMMUNOL, V32, P121, DOI 10.1146/annurev-immunol-032713-120216; Ciofani M, 2006, IMMUNITY, V25, P105, DOI 10.1016/j.immuni.2006.05.010; Fragoso R, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002855; Garbe AI, 2006, J EXP MED, V203, P1579, DOI 10.1084/jem.20060474; Gerber DJ, 1999, J IMMUNOL, V163, P3076; Grigoriadou K, 2002, J IMMUNOL, V169, P3736, DOI 10.4049/jimmunol.169.7.3736; Haas JD, 2012, IMMUNITY, V37, P48, DOI 10.1016/j.immuni.2012.06.003; Haas JD, 2009, EUR J IMMUNOL, V39, P3488, DOI 10.1002/eji.200939922; Haks MC, 2005, IMMUNITY, V22, P595, DOI 10.1016/j.immuni.2005.04.003; Hamada S, 2008, J IMMUNOL, V181, P3456, DOI 10.4049/jimmunol.181.5.3456; HAVRAN WL, 1989, P NATL ACAD SCI USA, V86, P4185, DOI 10.1073/pnas.86.11.4185; Hayes SM, 2005, IMMUNITY, V22, P583, DOI 10.1016/j.immuni.2005.03.014; Henao-Mejia J, 2013, IMMUNITY, V38, P984, DOI 10.1016/j.immuni.2013.02.021; ITOHARA S, 1990, NATURE, V343, P754, DOI 10.1038/343754a0; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Kirigin FF, 2012, J IMMUNOL, V188, P3257, DOI 10.4049/jimmunol.1103175; Kreslavsky T, 2008, J EXP MED, V205, P1173, DOI 10.1084/jem.20072425; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; Lewis JM, 2006, NAT IMMUNOL, V7, P843, DOI 10.1038/ni1363; Li J, 2013, J IMMUNOL, V191, P5052, DOI 10.4049/jimmunol.1301252; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; LIVAK F, 1995, IMMUNITY, V2, P617, DOI 10.1016/1074-7613(95)90006-3; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Pang DJ, 2012, IMMUNOLOGY, V136, P283, DOI 10.1111/j.1365-2567.2012.03582.x; Passoni L, 1997, IMMUNITY, V7, P83, DOI 10.1016/S1074-7613(00)80512-9; Pereira P, 2013, J IMMUNOL, V191, P1716, DOI 10.4049/jimmunol.1203168; Pereira P, 2012, EUR J IMMUNOL, V42, P1272, DOI 10.1002/eji.201142109; Prinz I, 2006, NAT IMMUNOL, V7, P995, DOI 10.1038/ni1371; Prinz I, 2013, EUR J IMMUNOL, V43, P1988, DOI 10.1002/eji.201343759; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Roark CL, 2004, J LEUKOCYTE BIOL, V75, P68, DOI 10.1189/jlb.0703326; Shibata K, 2008, J IMMUNOL, V181, P5940, DOI 10.4049/jimmunol.181.9.5940; Shibata K, 2014, J IMMUNOL, V192, P2210, DOI 10.4049/jimmunol.1302145; Shibata K, 2011, BLOOD, V118, P586, DOI 10.1182/blood-2011-02-334995; Simonian PL, 2009, J IMMUNOL, V182, P6540, DOI 10.4049/jimmunol.0900013; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Turchinovich G, 2011, TRENDS IMMUNOL, V32, P567, DOI 10.1016/j.it.2011.09.005; Turchinovich G, 2011, IMMUNITY, V35, P59, DOI 10.1016/j.immuni.2011.04.018; Wencker M, 2014, NAT IMMUNOL, V15, P80, DOI 10.1038/ni.2773; Xiong N, 2004, IMMUNITY, V21, P121, DOI 10.1016/j.immuni.2004.06.008; Zietara N, 2013, P NATL ACAD SCI USA, V110, P7407, DOI 10.1073/pnas.1221984110	49	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145010	10.1371/journal.pone.0145010	http://dx.doi.org/10.1371/journal.pone.0145010			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673421	gold, Green Submitted, Green Published			2022-12-26	WOS:000366722700086
J	Orlhac, F; Soussan, M; Chouahnia, K; Martinod, E; Buvat, I				Orlhac, Fanny; Soussan, Michael; Chouahnia, Kader; Martinod, Emmanuel; Buvat, Irene			18F-FDG PET-Derived Textural Indices Reflect Tissue-Specific Uptake Pattern in Non-Small Cell Lung Cancer	PLOS ONE			English	Article							PATHOLOGICAL RESPONSE; ESOPHAGEAL CANCER; FEATURES; HETEROGENEITY; IMAGES; RADIOTHERAPY; PARAMETERS; RADIOMICS; SURVIVAL; VOLUMES	Purpose Texture indices (TI) calculated from 18F-FDG PET tumor images show promise for predicting response to therapy and survival. Their calculation involves a resampling of standardized uptake values (SUV) within the tumor. This resampling can be performed differently and significantly impacts the TI values. Our aim was to investigate how the resampling approach affects the ability of TI to reflect tissue-specific pattern of metabolic activity. Methods 18F-FDG PET were acquired for 48 naive-treatment patients with non-small cell lung cancer and for a uniform phantom. We studied 7 TI, SUVmax and metabolic volume (MV) in the phantom, tumors and healthy tissue using the usual relative resampling (RR) method and an absolute resampling (AR) method. The differences in TI values between tissue types and cancer subtypes were investigated using Wilcoxon's tests. Results Most RR-based TI were highly correlated with MV for tumors less than 60 mL (Spearman correlation coefficient r between 0.74 and 1), while this correlation was reduced for ARbased TI (r between 0.06 and 0.27 except for RLNU where r = 0.91). Most AR-based TI were significantly different between tumor and healthy tissues (pvalues < 0.01 for all 7 TI) and between cancer subtypes (pvalues<0.05 for 6 TI). Healthy tissue and adenocarcinomas exhibited more homogeneous texture than tumor tissue and squamous cell carcinomas respectively. Conclusion TI computed using an AR method vary as a function of the tissue type and cancer subtype more than the TI involving the usual RR method. AR-based TI might be useful for tumor characterization.	[Orlhac, Fanny; Soussan, Michael; Buvat, Irene] Univ Paris Saclay, Univ Paris 11, Imagerie Mol Vivo, IMIV,CEA,Inserm,CNRS,CEA,SHFJ, Orsay, France; [Soussan, Michael] Avicenne Hosp, AP HP, Dept Nucl Med, Bobigny, France; [Chouahnia, Kader] Avicenne Hosp, AP HP, Dept Oncol, Bobigny, France; [Martinod, Emmanuel] Avicenne Hosp, AP HP, Dept Thorac Surg, Bobigny, France	CEA; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP	Orlhac, F (corresponding author), Univ Paris Saclay, Univ Paris 11, Imagerie Mol Vivo, IMIV,CEA,Inserm,CNRS,CEA,SHFJ, Orsay, France.	orlhacf@gmail.com	Buvat, Irene/U-8447-2018; Orlhac, Fanny/AAC-6428-2019	Buvat, Irene/0000-0002-7053-6471; Orlhac, Fanny/0000-0002-5588-1867; Soussan, Michael/0000-0002-0798-4749; Martinod, Emmanuel/0000-0001-8465-4498				Asamura H, 2008, J THORAC ONCOL, V3, P46, DOI 10.1097/JTO.0b013e31815e8577; Brooks FJ, 2014, J NUCL MED, V55, P37, DOI 10.2967/jnumed.112.116715; Brooks FJ, 2013, EUR J NUCL MED MOL I, V40, P1292, DOI 10.1007/s00259-013-2430-y; Buvat I, 2002, PHYS MED BIOL, V47, P1761, DOI 10.1088/0031-9155/47/10/311; Buvat I, 2015, J NUCL MED, V56, P1642, DOI 10.2967/jnumed.115.163469; Chalkidou A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124165; Cheng NM, 2015, EUR J NUCL MED MOL I, V42, P419, DOI 10.1007/s00259-014-2933-1; Cheng NM, 2013, J NUCL MED, V54, P1703, DOI 10.2967/jnumed.112.119289; Cook GJR, 2013, J NUCL MED, V54, P19, DOI 10.2967/jnumed.112.107375; Dong XZ, 2013, NUCL MED COMMUN, V34, P40, DOI 10.1097/MNM.0b013e32835ae50c; El Naqa I, 2009, PATTERN RECOGN, V42, P1162, DOI 10.1016/j.patcog.2008.08.011; Galavis PE, 2010, ACTA ONCOL, V49, P1012, DOI 10.3109/0284186X.2010.498437; Kumar V, 2012, MAGN RESON IMAGING, V30, P1234, DOI 10.1016/j.mri.2012.06.010; Leijenaar RTH, 2013, ACTA ONCOL, V52, P1391, DOI 10.3109/0284186X.2013.812798; Mangili E, 1998, EUR J HISTOCHEM, V42, P287; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; Nestle U, 2005, J NUCL MED, V46, P1342; Orlhac F, 2014, J NUCL MED, V56, P430; Orlhac F, 2014, J NUCL MED, V55, P414, DOI 10.2967/jnumed.113.129858; Soussan M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094017; Tan S, 2013, INT J RADIAT ONCOL, V85, P1375, DOI 10.1016/j.ijrobp.2012.10.017; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; Vaidya M, 2012, RADIOTHER ONCOL, V102, P239, DOI 10.1016/j.radonc.2011.10.014; Willaime JMY, 2013, PHYS MED BIOL, V58, P187, DOI 10.1088/0031-9155/58/2/187; Xu R, 2014, ANN NUCL MED, V28, P926, DOI 10.1007/s12149-014-0895-9; Yang F, 2013, EUR J NUCL MED MOL I, V40, P716, DOI 10.1007/s00259-012-2332-4; Zhang H, 2014, INT J RADIAT ONCOL, V88, P195, DOI 10.1016/j.ijrobp.2013.09.037	27	99	99	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145063	10.1371/journal.pone.0145063	http://dx.doi.org/10.1371/journal.pone.0145063			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26669541	gold, Green Published, Green Submitted			2022-12-26	WOS:000366719300043
J	Szarek, D; Marycz, K; Lis, A; Zawada, Z; Tabakow, P; Laska, J; Jarmundowicz, W				Szarek, Dariusz; Marycz, Krzysztof; Lis, Anna; Zawada, Zbigniew; Tabakow, Pawel; Laska, Jadwiga; Jarmundowicz, Wlodzimierz			Lizard tail spinal cord: a new experimental model of spinal cord injury without limb paralysis	FASEB JOURNAL			English	Article						gecko; animal laboratory model; rat; SCI; implant	PERIPHERAL-NERVE REGENERATION; GLIAL-CELLS; ENHANCES ELONGATION; ALGINATE; AXONS; TRANSLATION; SYSTEM; GECKO	Spinal cord injury (SCI) is a well-known devastating lesion that sadly is very resistant to all treatment attempts. This fact has stimulated the exploration of multiple regenerative strategies that are examined at both the basic and clinical level. For laboratory research, different in vivo models are used, but each has many important limitations. The main limitation of these models is the high level of animal suffering related to the inflicted neurologic injury. It has caused a growing tendency to limit the injury, but this, in turn, produces incomplete SCI models and uncertainties in the neuroregeneration interpretation. To overcome such limitations, a new experimental SCI model is proposed. Geckos have been extensively examined as a potential animal model of SCI. Their spinal cord extends into the tail and can be transected without causing the typical neurologic consequences observed in rat models. In this study, we compared the gecko tail SCI model with the rat model of thoracic SCI. Anatomic and histologic analyses showed comparability between the gecko and rat in diameter of spinal canal and spinal cord, as well as applicability of multiple staining techniques (hematoxylin and eosin, immunostaining, and scanning and transmission electron microscopy). We tested the suitability of in vivo study with 3 prototype implants for the reconstruction of SCI: a multichannel sponge, a multilaminar tube, and a gel cylinder. These were compared with a spinal cord excision (control). A 20-wk observation revealed no adverse effects of SCI on the animals' well-being. The animals were easily housed and observed. Histologic analysis showed growth of nervous tissue elements on implant surface and implant cellular colonization. The study showed that the gecko SCI model can be used as a primary model for the assessment of SCI treatment methods. It provides a platform for testing multiple solutions with limited animal suffering before performing tests on mammals. Detailed results of the experimental conditions and testing techniques are provided.-Szarek, D., Marycz, K., Lis, A., Zawada, Z., Tabakow, P., Laska, J., Jarmundowicz, W. Lizard tail spinal cord: a new experimental model of spinal cord injury without limb paralysis. FASEB J. 30, 1391-1403 (2016). www.fasebj.org	[Szarek, Dariusz] Lower Silesia Specialist Hosp T Marciniak, Dept Neurosurg, Ctr Emergency Med, Gen AE Fieldorfa 2, PL-54049 Wroclaw, Poland; [Marycz, Krzysztof] Univ Environm & Life Sci, Dept Electron Microscopy, Wroclaw, Poland; [Lis, Anna; Laska, Jadwiga] AGH Akad Gorniczo Hutnicza Univ Sci & Technol, Dept Biomat, Krakow, Poland; [Zawada, Zbigniew] Univ Zielona Gora, Dept Biol, Zielona Gora, Poland; [Tabakow, Pawel; Jarmundowicz, Wlodzimierz] Wroclaw Med Univ, Dept Neurosurg, Wroclaw, Poland	Wroclaw University of Environmental & Life Sciences; AGH University of Science & Technology; University of Zielona Gora; Wroclaw Medical University	Szarek, D (corresponding author), Lower Silesia Specialist Hosp T Marciniak, Dept Neurosurg, Ctr Emergency Med, Gen AE Fieldorfa 2, PL-54049 Wroclaw, Poland.	szarekdariusz@gmail.com	Laska, Jadwiga/AAI-7319-2021; Tabakow, Pawel/AAY-1039-2020; Lis, Anna/X-8139-2018; Marycz, Krzysztof/A-2249-2017; Szarek, Dariusz/ABB-2655-2020	Laska, Jadwiga/0000-0002-7230-3882; Lis, Anna/0000-0001-7775-3981; Tabakow, Pawel/0000-0001-8638-3871	Polish National Center for Science (Narodowe Cetrum Nauki) Grant [NN403 176540]; Medical University Wroclaw Grant [GR 756]; Wroclaw Centre of Biotechnology Programme; Leading National Research Centre (KNOW)	Polish National Center for Science (Narodowe Cetrum Nauki) Grant; Medical University Wroclaw Grant; Wroclaw Centre of Biotechnology Programme; Leading National Research Centre (KNOW)	This study was supported by Polish National Center for Science (Narodowe Cetrum Nauki) Grant NN403 176540, Medical University Wroclaw Grant GR 756, and Wroclaw Centre of Biotechnology Programme, the Leading National Research Centre (KNOW) for years 2014-2018.	Basso DM, 2000, PHYS THER, V80, P808, DOI 10.1093/ptj/80.8.808; Chernoff EAG, 2003, DEV DYNAM, V226, P295, DOI 10.1002/dvdy.10240; Clancy B, 2007, NEUROTOXICOLOGY, V28, P931, DOI 10.1016/j.neuro.2007.01.014; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Cristino L, 2000, BRAIN RES, V871, P83, DOI 10.1016/S0006-8993(00)02445-8; Grzesiak J, 2015, MAT SCI ENG C-MATER, V52, P163, DOI 10.1016/j.msec.2015.03.050; Grzesiak J, 2015, INT J POLYM SCI, V2015, DOI 10.1155/2015/908328; Grzesiak J, 2013, INT J MORPHOL, V31, P826, DOI 10.4067/S0717-95022013000300008; Kataoka K, 2004, TISSUE ENG, V10, P493, DOI 10.1089/107632704323061852; Kataoka K, 2001, J BIOMED MATER RES, V54, P373, DOI 10.1002/1097-4636(20010305)54:3<373::AID-JBM90>3.3.CO;2-H; Kwon BK, 2010, J NEUROTRAUM, V27, P21, DOI 10.1089/neu.2009.1048; Marycz K, 2014, BIO-MED MATER ENG, V24, P1625, DOI 10.3233/BME-140966; McLean KE, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-50; Metz GAS, 2000, J NEUROTRAUM, V17, P1, DOI 10.1089/neu.2000.17.1; Meyer V, 2002, HERPETOLOGICA, V58, P75, DOI 10.1655/0018-0831(2002)058[0075:POOARL]2.0.CO;2; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Santos-Benito FF, 2006, J NEUROTRAUM, V23, P521, DOI 10.1089/neu.2006.23.521; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Sharif-Alhoseini M., 2014, TOPICS IN PARAPLEGIA, P209; SIMPSON SB, 1994, PROG BRAIN RES, V103, P229; Stephan K, 2015, SPINE J, V15, P1994, DOI 10.1016/j.spinee.2015.04.041; Stokols S, 2006, TISSUE ENG, V12, P2777, DOI 10.1089/ten.2006.12.2777; STOLL G, 1989, J NEUROCYTOL, V18, P671, DOI 10.1007/BF01187086; Suzuki Y, 1999, NEUROSCI LETT, V259, P75, DOI 10.1016/S0304-3940(98)00924-0; Szarek D., 2012, J BIOMATER NANOBIOTE, V3, P20, DOI DOI 10.4236/JBNB.2012.31004; Szarek D, 2013, BIOTECHNOL APPL BIOC, V60, P547, DOI 10.1002/bab.1096; Takeda A, 2015, NEUROSCIENCE, V284, P134, DOI 10.1016/j.neuroscience.2014.09.066; Webber C, 2010, EXP NEUROL, V223, P51, DOI 10.1016/j.expneurol.2009.05.037; Young W, 2002, PROG BRAIN RES, V137, P231	29	14	14	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1391	1403		10.1096/fj.15-272468	http://dx.doi.org/10.1096/fj.15-272468			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26667043				2022-12-26	WOS:000372629100003
J	Bae, YU; Choi, JH; Nagy, A; Sung, HK; Kim, JR				Bae, Yun-Ui; Choi, Joon-Hyuk; Nagy, Andras; Sung, Hoon-Ki; Kim, Jae-Ryong			Antisenescence effect of mouse embryonic stem cell conditioned medium through a PDGF/FGF pathway	FASEB JOURNAL			English	Article						cellular senescence; conditioned medium; embryonic stem cells; PDGF-BB	PLASMINOGEN-ACTIVATOR INHIBITOR-1; GROWTH-FACTOR BB; REPLICATIVE SENESCENCE; LIFE-SPAN; ENDOTHELIAL-CELLS; PROGENITOR CELLS; IN-VITRO; ANGIOGENESIS; MICE; FIBROBLASTS	Cellular senescence, an irreversible state of growth arrest, underlies organismal aging and age-related diseases. Recent evidence suggests that aging intervention based on inhibition of cellular senescence might be a promising strategy for treatment of aging and age-related diseases. Embryonic stem cells (ESCs) and ESC conditioned medium (CM) have been suggested as a desirable source for regenerative medicine. However, effects of ESC-CM on cellular senescence remain to be determined. We found that treatment of senescent human dermal fibroblasts with CM from mouse ESCs (mESCs) decreases senescence phenotypes. We found that platelet-derived growth factor BB in mESC-CM plays a critical role in antisenescence effect of mESC-CM through up-regulation of fibroblast growth factor 2. We confirmed that mESC-CM treatment accelerates the wound-healing process by down-regulating senescence-associated p53 expression in in vivo models. Taken together, our results suggest that mESC-CM has the ability to suppress cellular senescence and maintain proliferative capacity. Therefore, this strategy might emerge as a novel therapeutic strategy for aging and age-related diseases.	[Bae, Yun-Ui; Kim, Jae-Ryong] Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, 170 Hyunchung Ro, Daegu 705717, South Korea; [Bae, Yun-Ui; Kim, Jae-Ryong] Yeungnam Univ, Coll Med, Smart Aging Convergence Res Ctr, Daegu 705717, South Korea; [Choi, Joon-Hyuk] Yeungnam Univ, Coll Med, Dept Pathol, Daegu 705717, South Korea; [Nagy, Andras; Sung, Hoon-Ki] Mt Sinai Hosp, Lunenfeld Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada; [Sung, Hoon-Ki] Hosp Sick Children, Res Inst, Physiol & Expt Med Program, Toronto, ON M5G 0A4, Canada	Yeungnam University; Yeungnam University; Yeungnam University; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Kim, JR (corresponding author), Yeungnam Univ, Coll Med, Dept Biochem & Mol Biol, 170 Hyunchung Ro, Daegu 705717, South Korea.; Sung, HK (corresponding author), Hosp Sick Children, Res Inst, Peter Gilgan Ctr Res & Learning, Physiol & Expt Med Program, 686 Bay St,Room 10-9710, Toronto, ON M5G 0A4, Canada.	hoon-ki.sung@sickkids.ca; kimjr@ynu.ac.kr	Nagy, Andras/G-6465-2013; Sung, Hoon-Ki/A-1922-2016; Choi, Joon Hyuk/AFK-3005-2022; Choi, Joon Hyuk/AAG-1437-2022	Nagy, Andras/0000-0003-4311-0413; Sung, Hoon-Ki/0000-0001-6677-9385; 	Basic Science Research Program [2013R1A1A2060930]; Bio and Medical Technology Development Program [2013M3A9B6076413]; Medical Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [2015R1A5A2009124]	Basic Science Research Program; Bio and Medical Technology Development Program; Medical Research Center Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning	This work was supported by Basic Science Research Program (2013R1A1A2060930), Bio and Medical Technology Development Program (2013M3A9B6076413), and Medical Research Center Program (2015R1A5A2009124) through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning.	Alexander PB, 2015, CELL RES, V25, P135, DOI 10.1038/cr.2014.141; Cao RH, 2003, NAT MED, V9, P604, DOI 10.1038/nm848; Cao YH, 2008, J MOL MED, V86, P785, DOI 10.1007/s00109-008-0337-z; Chen HN, 2011, NATURE, V478, P349, DOI 10.1038/nature10502; Cho SC, 2010, P NATL ACAD SCI USA, V107, P19326, DOI 10.1073/pnas.1005078107; Choi HR, 2011, AGING CELL, V10, P148, DOI 10.1111/j.1474-9726.2010.00654.x; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2011, AGING-US, V3, P555, DOI 10.18632/aging.100333; Di Santo S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005643; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Elzi DJ, 2012, P NATL ACAD SCI USA, V109, P12052, DOI 10.1073/pnas.1120437109; Gruber HE, 2012, BIOTECH HISTOCHEM, V87, P303, DOI 10.3109/10520295.2011.649785; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Kim JM, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2313; Kim KS, 2007, MOL BIOL CELL, V18, P4543, DOI 10.1091/mbc.E07-03-0280; Kim KS, 2007, AGING CELL, V6, P535, DOI 10.1111/j.1474-9726.2007.00315.x; Kim KS, 2009, MECH AGEING DEV, V130, P179, DOI 10.1016/j.mad.2008.11.004; Kim YM, 2013, AGING CELL, V12, P622, DOI 10.1111/acel.12087; Kim YM, 2010, J BIOL CHEM, V285, P29069, DOI 10.1074/jbc.M110.120386; Komi-Kuramochi A, 2005, J ENDOCRINOL, V186, P273, DOI 10.1677/joe.1.06055; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Landgren E, 1996, EXP CELL RES, V223, P405, DOI 10.1006/excr.1996.0095; Lavasani M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1611; Lee AS, 2013, NAT MED, V19, P998, DOI 10.1038/nm.3267; Lee MJ, 2011, CYTOTHERAPY, V13, P165, DOI 10.3109/14653249.2010.512632; Li XY, 2007, CELL TISSUE RES, V327, P607, DOI 10.1007/s00441-006-0354-6; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Loffredo FS, 2013, CELL, V153, P828, DOI 10.1016/j.cell.2013.04.015; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Makridakis M, 2010, J PROTEOMICS, V73, P2291, DOI 10.1016/j.jprot.2010.07.001; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Michael IP, 2014, EMBO MOL MED, V6, P604, DOI 10.1002/emmm.201303708; Moon SH, 2011, BIOMATERIALS, V32, P6445, DOI 10.1016/j.biomaterials.2011.05.026; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Pallante BA, 2007, CIRC RES, V100, pE1, DOI 10.1161/01.RES.0000253487.02398.85; Park JS, 2001, FASEB J, V15, P1625, DOI 10.1096/fj.00-0723fje; Park SJ, 2013, BIOMATERIALS, V34, P995, DOI 10.1016/j.biomaterials.2012.10.039; Rando TA, 2012, CELL, V148, P46, DOI 10.1016/j.cell.2012.01.003; Ranganath SH, 2012, CELL STEM CELL, V10, P244, DOI 10.1016/j.stem.2012.02.005; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Scherping SC, 1997, CONNECT TISSUE RES, V36, P1, DOI 10.3109/03008209709160209; Telgenhoff D, 2005, CELL DEATH DIFFER, V12, P695, DOI 10.1038/sj.cdd.4401632; Tomishima M., 2012, STEMBOOK; Vande Berg JS, 2005, WOUND REPAIR REGEN, V13, P76, DOI 10.1111/j.1067-1927.2005.130110.x; Villeda SA, 2011, NATURE, V477, P90, DOI 10.1038/nature10357; Woo DH, 2012, GASTROENTEROLOGY, V142, P602, DOI 10.1053/j.gastro.2011.11.030; Wu LC, 1997, PLAST RECONSTR SURG, V99, P815, DOI 10.1097/00006534-199703000-00030; Yamamoto S, 2008, J BIOL CHEM, V283, P23139, DOI 10.1074/jbc.M710308200	49	21	22	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2016	30	3					1276	1286		10.1096/fj.15-278846	http://dx.doi.org/10.1096/fj.15-278846			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DE1LF	26675707				2022-12-26	WOS:000370387800023
J	Ames, JJ; Contois, L; Caron, JM; Tweedie, E; Yang, XH; Friesel, R; Vary, C; Brooks, PC				Ames, Jacquelyn J.; Contois, Liangru; Caron, Jennifer M.; Tweedie, Eric; Yang, Xuehui; Friesel, Robert; Vary, Calvin; Brooks, Peter C.			Identification of an Endogenously Generated Cryptic Collagen Epitope (XL313) That May Selectively Regulate Angiogenesis by an Integrin Yes-associated Protein (YAP) Mechano-transduction Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACELLULAR-MATRIX; TUMOR-GROWTH; CHORIOALLANTOIC MEMBRANE; CELL-MIGRATION; OUTSIDE-IN; ALPHA-V-BETA-3 INTEGRIN; BETA(3) INTEGRIN; CHICK-EMBRYO; ARG; BINDING	Extracellular matrix (ECM) remodeling regulates angiogenesis. However, the precise mechanisms by which structural changes in ECM proteins contribute to angiogenesis are not fully understood. Integrins are molecules with the ability to detect compositional and structural changes within the ECM and integrate this information into a network of signaling circuits that coordinate context-dependent cell behavior. The role of integrin alpha v beta 3 in angiogenesis is complex, as evidence exists for both positive and negative functions. The precise downstream signaling events initiated by alpha v beta 3 may depend on the molecular characteristics of its ligands. Here, we identified an RGD-containing cryptic collagen epitope that is generated in vivo. Surprisingly, rather than inhibiting alpha v beta 3 signaling, this collagen epitope promoted alpha v beta 3 activation and stimulated angiogenesis and inflammation. An antibody directed to this RGDKGE epitope but not other RGD collagen epitopes inhibited angiogenesis and inflammation in vivo. The selective ability of this RGD epitope to promote angiogenesis and inflammation depends in part on its flanking KGE motif. Interestingly, a subset of macrophages may represent a physiologically relevant source of this collagen epitope. Here, we define an endothelial cell mechano-signaling pathway in which a cryptic collagen epitope activates alpha v beta 3 leading to an Src and p38 MAPK-dependent cascade that leads to nuclear accumulation of Yes-associated protein (YAP) and stimulation of endothelial cell growth. Collectively, our findings not only provide evidence for a novel mechano-signaling pathway, but also define a possible therapeutic strategy to control alpha v beta 3 signaling by targeting a proangiogenic and inflammatory ligand of alpha v beta 3 rather than the receptor itself.	[Ames, Jacquelyn J.; Contois, Liangru; Caron, Jennifer M.; Tweedie, Eric; Yang, Xuehui; Friesel, Robert; Vary, Calvin; Brooks, Peter C.] Maine Med Ctr Res Inst, Ctr Mol Med, 81 Res Dr, Scarborough, ME 04074 USA	Maine Medical Center	Brooks, PC (corresponding author), Maine Med Ctr Res Inst, Ctr Mol Med, 81 Res Dr, Scarborough, ME 04074 USA.	brookp1@mmc.org			National Institutes of Health [CA91645, HL65301, HL083151, P20RR15555, P20 RR181789, 5P30GM103392]; Holden Agency and Maine Medical Center; NATIONAL CANCER INSTITUTE [R01CA091645] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015555] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065301, R01HL083151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103392, P30GM106391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Holden Agency and Maine Medical Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants CA91645 (to P. C. B.), HL65301 (to R. F.), HL083151 and P20RR15555 (to C. V.), P20 RR181789 (Bioinformatics Core to D. M. Wojchowski), and 5P30GM103392 (to R. F.) and by the Holden Agency and Maine Medical Center. P. C. B. and C. V. hold an equity interest in CryptoMedix, LLC. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adair-Kirk TL, 2008, INT J BIOCHEM CELL B, V40, P1101, DOI 10.1016/j.biocel.2007.12.005; Adler JJ, 2013, P NATL ACAD SCI USA, V110, P17368, DOI 10.1073/pnas.1308236110; Alghisi GC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004449; Atkinson SJ, 2014, BIOCHEM SOC T, V42, P1590, DOI 10.1042/BST20140206; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Brooke BS, 2003, TRENDS CELL BIOL, V13, P51, DOI 10.1016/S0962-8924(02)00007-7; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Cao YH, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003149; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Contois L, 2009, SEMIN CANCER BIOL, V19, P318, DOI 10.1016/j.semcancer.2009.05.002; Contois LW, 2015, ANGIOGENESIS, V18, P31, DOI 10.1007/s10456-014-9445-2; Contois LW, 2012, J BIOL CHEM, V287, P1779, DOI 10.1074/jbc.M111.267732; Cretu A, 2007, CLIN CANCER RES, V13, P3068, DOI 10.1158/1078-0432.CCR-06-2342; Dai XM, 2013, J BIOL CHEM, V288, P34041, DOI 10.1074/jbc.M113.518019; Danhier F, 2012, MOL PHARMACEUT, V9, P2961, DOI 10.1021/mp3002733; Davis George E, 2011, Drug Discov Today Dis Models, V8, P13; Debefve E, 2008, ANGIOGENESIS, V11, P235, DOI 10.1007/s10456-008-9106-4; Deryugina EI, 2008, METHOD ENZYMOL, V444, P21, DOI 10.1016/S0076-6879(08)02802-4; Deryugina EI, 2014, NEOPLASIA, V16, P771, DOI 10.1016/j.neo.2014.08.013; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Feng WY, 2008, J CELL BIOL, V183, P1145, DOI 10.1083/jcb.200802179; Gong HX, 2010, SCIENCE, V327, P340, DOI 10.1126/science.1174779; Gong Y, 2013, ANGIOGENESIS, V16, P861, DOI 10.1007/s10456-013-9361-x; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; GURRATH M, 1992, EUR J BIOCHEM, V210, P911, DOI 10.1111/j.1432-1033.1992.tb17495.x; Hangai M, 2002, AM J PATHOL, V161, P1429, DOI 10.1016/S0002-9440(10)64418-5; Hodivala-Dilke K, 2008, CURR OPIN CELL BIOL, V20, P514, DOI 10.1016/j.ceb.2008.06.007; Jetten N, 2014, ANGIOGENESIS, V17, P109, DOI 10.1007/s10456-013-9381-6; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Kaneko K, 2014, BIOCHEM BIOPH RES CO, V447, P352, DOI 10.1016/j.bbrc.2014.04.006; Kostidis S, 2004, J PEPT SCI, V10, P494, DOI 10.1002/psc.559; Kunicki TJ, 1997, J BIOL CHEM, V272, P4103, DOI 10.1074/jbc.272.7.4103; Legler DF, 2001, J CELL SCI, V114, P1545; Liao ZJ, 2015, BLOOD, V125, P1995, DOI 10.1182/blood-2014-09-603035; Madsen DH, 2013, J CELL BIOL, V202, P951, DOI 10.1083/jcb.201301081; Matsumoto T, 2002, J CELL BIOL, V156, P149, DOI 10.1083/jcb.200103096; McMullen M, 2004, ONCOGENE, V23, P1275, DOI 10.1038/sj.onc.1207243; Melkonian G, 2002, J EXP ZOOL, V292, P241, DOI 10.1002/jez.10014; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Miyoshi T, 2006, FASEB J, V20, P1904, DOI 10.1096/fj.05-5565fje; Mogford JE, 1996, CIRC RES, V79, P821, DOI 10.1161/01.RES.79.4.821; MONTGOMERY AMP, 1994, P NATL ACAD SCI USA, V91, P8856, DOI 10.1073/pnas.91.19.8856; Moserle L, 2014, CANCER DISCOV, V4, P31, DOI 10.1158/2159-8290.CD-13-0199; Petitclerc E, 2000, J BIOL CHEM, V275, P8051, DOI 10.1074/jbc.275.11.8051; Pickup MW, 2014, EMBO REP, V15, P1243, DOI 10.15252/embr.201439246; PIERSCHBACHER MD, 1987, J BIOL CHEM, V262, P17294; Rajashekhar G, 2011, J CELL PHYSIOL, V226, P800, DOI 10.1002/jcp.22404; Reynolds AR, 2009, NAT MED, V15, P392, DOI 10.1038/nm.1941; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Robinson SD, 2011, CURR OPIN CELL BIOL, V23, P630, DOI 10.1016/j.ceb.2011.03.014; Rousseau S, 1997, ONCOGENE, V15, P2169, DOI 10.1038/sj.onc.1201380; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Schnoor M, 2008, J IMMUNOL, V180, P5707, DOI 10.4049/jimmunol.180.8.5707; Shen B, 2012, CURR OPIN CELL BIOL, V24, P600, DOI 10.1016/j.ceb.2012.08.011; Shen ZW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117522; Skjot-Arkil H, 2010, ASSAY DRUG DEV TECHN, V8, P542, DOI 10.1089/adt.2009.0258; Somanath PR, 2009, ANGIOGENESIS, V12, P177, DOI 10.1007/s10456-009-9141-9; Steri V, 2014, CIRC RES, V114, P79, DOI 10.1161/CIRCRESAHA.114.301591; Stupp R, 2014, LANCET ONCOL, V15, P1100, DOI 10.1016/S1470-2045(14)70379-1; Sudhakar A, 2003, P NATL ACAD SCI USA, V100, P4766, DOI 10.1073/pnas.0730882100; Tang Y, 2013, DEV CELL, V25, P402, DOI 10.1016/j.devcel.2013.04.011; von Wichert G, 2003, J CELL BIOL, V161, P143, DOI 10.1083/jcb.200211061; Xu JS, 2001, J CELL BIOL, V154, P1069, DOI 10.1083/jcb.200103111; Yip KP, 1997, AM J PHYSIOL-RENAL, V273, pF768, DOI 10.1152/ajprenal.1997.273.5.F768; Yu CH, 2011, P NATL ACAD SCI USA, V108, P20585, DOI 10.1073/pnas.1109485108; Zwadlo-Klarwasser G, 2001, J MATER SCI-MATER M, V12, P195, DOI 10.1023/A:1008950713001	70	16	17	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2731	2750		10.1074/jbc.M115.669614	http://dx.doi.org/10.1074/jbc.M115.669614			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26668310	Green Published, hybrid			2022-12-26	WOS:000369626900015
J	Mourier, G; Salinas, M; Kessler, P; Stura, EA; Leblanc, M; Tepshi, L; Besson, T; Diochot, S; Baron, A; Douguet, D; Lingueglia, E; Servent, D				Mourier, Gilles; Salinas, Miguel; Kessler, Pascal; Stura, Enrico A.; Leblanc, Mathieu; Tepshi, Livia; Besson, Thomas; Diochot, Sylvie; Baron, Anne; Douguet, Dominique; Lingueglia, Eric; Servent, Denis			Mambalgin-1 Pain-relieving Peptide, Stepwise Solid-phase Synthesis, Crystal Structure, and Functional Domain for Acid-sensing Ion Channel 1a Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHEMICAL-SYNTHESIS; BINDING-SITE; TOXIN; CRYSTALLIZATION	Mambalgins are peptides isolated from mamba venom that specifically inhibit a set of acid-sensing ion channels (ASICs) to relieve pain. We show here the first full stepwise solid phase peptide synthesis of mambalgin-1 and confirm the biological activity of the synthetic toxin both in vitro and in vivo. We also report the determination of its three-dimensional crystal structure showing differences with previously described NMR structures. Finally, the functional domain by which the toxin inhibits ASICla channels was identified in its loop II and more precisely in the face containing Phe-27, Leu-32, and Leu-34 residues. Moreover, proximity between Leu-32 in mambalgin-1 and Phe-350 in rASICia was proposed from double mutant cycle analysis. These data provide information on the structure and on the pharmacophore for ASIC channel inhibition by mambalgins that could have therapeutic value against pain and probably other neurological disorders.	Commissariat Energie Atom, iBiTecS, Serv Ingn Mol Proteines, F-91191 Gif Sur Yvette, France; CNRS, Inst Pharmacol Mol & Cellulaire, F-06560 Valbonne, France; Univ Nice Sophia Antipolis, F-06560 Valbonne, France; LabEx Ion Channel Sci & Therapeut, UMR 7275, F-06560 Valbonne, France	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Cote d'Azur	Lingueglia, E (corresponding author), CNRS, Inst Pharmacol Mol & Cellulaire, UMR7275, F-06560 Valbonne, France.; Servent, D (corresponding author), CEA, iBiTecS, F-91191 Gif Sur Yvette, France.	lingueglia@ipmc.cnrs.fr; denis.servent@cea.fr	BARON, Anne/N-5691-2016; Diochot, Sylvie/ABG-5495-2020; Stura, Enrico A./A-2793-2010; SALINAS, Miguel/N-6380-2016; LINGUEGLIA, Eric/F-5509-2013; douguet, dominique/D-5644-2017	BARON, Anne/0000-0002-8026-6380; Stura, Enrico A./0000-0001-6718-2118; SALINAS, Miguel/0000-0002-7445-123X; LINGUEGLIA, Eric/0000-0003-3902-3405; Servent, Denis/0000-0002-0774-1691	CNRS; INSERM; Agence Nationale de la Recherche [ANR-13-BSV4-0009]	CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by CNRS, INSERM, and Agence Nationale de la Recherche Grant ANR-13-BSV4-0009. The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Baron A, 2015, NEUROPHARMACOLOGY, V94, P19, DOI 10.1016/j.neuropharm.2015.01.005; Baron A, 2013, TOXICON, V75, P187, DOI 10.1016/j.toxicon.2013.04.008; Chowdhury S, 2014, J GEN PHYSIOL, V144, P441, DOI 10.1085/jgp.201411184; Ciccone L, 2015, NEW BIOTECHNOL, V32, P54, DOI 10.1016/j.nbt.2014.09.002; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; Deval E, 2015, NEUROPHARMACOLOGY, V94, P49, DOI 10.1016/j.neuropharm.2015.02.009; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Diochot S, 2016, PAIN, V157, P552, DOI 10.1097/j.pain.0000000000000397; Diochot S, 2012, NATURE, V490, P552, DOI 10.1038/nature11494; Duran D., 2013, Journal of Physics: Conference Series, V425, DOI 10.1088/1742-6596/425/1/012005; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fruchart-Gaillard C, 2008, MOL PHARMACOL, V74, P1554, DOI 10.1124/mol.108.050773; Fruchart-Gaillard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039166; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; McCoy AJ, 2004, ACTA CRYSTALLOGR D, V60, P1220, DOI 10.1107/S0907444904009990; Mourier G, 2003, MOL PHARMACOL, V63, P26, DOI 10.1124/mol.63.1.26; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; MUTTER M, 1995, PEPTIDE RES, V8, P145; Newman J, 2004, ACTA CRYSTALLOGR D, V60, P610, DOI 10.1107/S0907444903029640; Noel Jacques, 2010, Expert Rev Clin Pharmacol, V3, P331, DOI 10.1586/ecp.10.13; Pan M, 2014, CHEM COMMUN, V50, P5837, DOI 10.1039/c4cc00779d; Saez NJ, 2015, BRIT J PHARMACOL, V172, P4985, DOI 10.1111/bph.13267; Saez NJ, 2011, MOL PHARMACOL, V80, P796, DOI 10.1124/mol.111.072207; Salinas M, 2014, J BIOL CHEM, V289, P13363, DOI 10.1074/jbc.M114.561076; Schroeder CI, 2014, ANGEW CHEM INT EDIT, V53, P1017, DOI 10.1002/anie.201308898; STURA EA, 1991, J CRYST GROWTH, V110, P270, DOI 10.1016/0022-0248(91)90896-D; STURA EA, 1992, J CRYST GROWTH, V122, P273, DOI 10.1016/0022-0248(92)90256-I; Terwilliger TC, 2002, ACTA CRYSTALLOGR D, V58, P1937, DOI 10.1107/S0907444902016438; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vera L, 2013, CRYST GROWTH DES, V13, P1878, DOI 10.1021/cg301537n; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; Woolf CJ, 2013, LANCET NEUROL, V12, P18, DOI 10.1016/S1474-4422(12)70287-9	37	35	36	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2616	2629		10.1074/jbc.M115.702373	http://dx.doi.org/10.1074/jbc.M115.702373			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26680001	Green Published, hybrid			2022-12-26	WOS:000369626900007
J	Guo, WT; Sun, B; Xiao, ZC; Liu, YJ; Wang, YD; Zhang, L; Wang, RW; Chen, SRW				Guo, Wenting; Sun, Bo; Xiao, Zhichao; Liu, Yingjie; Wang, Yundi; Zhang, Lin; Wang, Ruiwu; Chen, S. R. Wayne			The EF-hand Ca2+ Binding Domain Is Not Required for Cytosolic Ca2+ Activation of the Cardiac Ryanodine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RYR2 MUTATIONS; SUDDEN-DEATH; VENTRICULAR-TACHYCARDIA; SARCOPLASMIC-RETICULUM; RELEASE CHANNEL; MOLECULAR-IDENTIFICATION; TERMINATION; THRESHOLD; SENSOR; DYSFUNCTION	Activation of the cardiac ryanodine receptor (RyR2) by elevating cytosolic Ca2+ is a central step in the process of Ca2+-induced Ca2+ release, but the molecular basis of RyR2 activation by cytosolic Ca2+ is poorly defined. It has been proposed recently that the putative Ca2+ binding domain encompassing a pair of EF-hand motifs (EF1 and EF2) in the skeletal muscle ryanodine receptor (RyR1) functions as a Ca2+ sensor that regulates the gating of RyR1. Although the role of the EF-hand domain in RyR1 function has been studied extensively, little is known about the functional significance of the corresponding EF-hand domain in RyR2. Here we investigate the effect of mutations in the EF-hand motifs on the Ca2+ activation of RyR2. We found that mutations in the EF-hand motifs or deletion of the entire EF-hand domain did not affect the Ca2+-dependent activation of [H-3]ryanodine binding or the cytosolic Ca2+ activation of RyR2. On the other hand, deletion of the EF-hand domain markedly suppressed the luminal Ca2+ activation of RyR2 and spontaneous Ca2+ release in HEK293 cells during store Ca2+ overload or store overload-induced Ca2+ release (SOICR). Furthermore, mutations in the EF2 motif, but not EF1 motif, of RyR2 raised the threshold for SOICR termination, whereas deletion of the EF-hand domain of RyR2 increased both the activation and termination thresholds for SOICR. These results indicate that, although the EF-hand domain is not required for RyR2 activation by cytosolic Ca2+, it plays an important role in luminal Ca2+ activation and SOICR.	Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Physiol & Pharmacol, Calgary, AB T2N 4N1, Canada; Univ Calgary, Libin Cardiovasc Inst Alberta, Dept Biochem & Mol Biol, Calgary, AB T2N 4N1, Canada	Libin Cardiovascular Institute Of Alberta; University of Calgary; Libin Cardiovascular Institute Of Alberta; University of Calgary	Chen, SRW (corresponding author), HRIC GAC58,3330 Hosp Dr N-W, Calgary, AB, Canada.	swchen@ucalgary.ca			NIGMS/National Institutes of Health [P41-GM103311]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER; Alberta Innovates [201300501, 201500221, 201400104, 201200822] Funding Source: researchfish	NIGMS/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Alberta Innovates	Molecular graphics and analyses were performed with the University of California, San Francisco Chimera package. Chimera was developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco (supported by NIGMS/National Institutes of Health Grant P41-GM103311).	Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2014, ANNU REV PHYSIOL, V76, P107, DOI 10.1146/annurev-physiol-020911-153308; Chen SRW, 1998, J BIOL CHEM, V273, P14675, DOI 10.1074/jbc.273.24.14675; Chen WQ, 2014, NAT MED, V20, P184, DOI 10.1038/nm.3440; Efremov RG, 2015, NATURE, V517, P39, DOI 10.1038/nature13916; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; Fan GZ, 2015, NATURE, V527, P336, DOI 10.1038/nature15249; Fessenden JD, 2004, J BIOL CHEM, V279, P53028, DOI 10.1074/jbc.M411136200; Gomez AC, 2014, BIOCHEMISTRY-US, V53, P1373, DOI 10.1021/bi401586h; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HYMEL L, 1988, BIOCHEM BIOPH RES CO, V152, P308, DOI 10.1016/S0006-291X(88)80715-0; Jiang D, 2007, P NATL ACAD SCI USA, V104, P18309, DOI 10.1073/pnas.0706573104; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Jones PP, 2008, BIOCHEM J, V412, P171, DOI 10.1042/BJ20071287; Kong H, 2008, BIOCHEM J, V414, P441, DOI 10.1042/BJ20080489; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li P, 2001, J GEN PHYSIOL, V118, P33, DOI 10.1085/jgp.118.1.33; LINDSAY ARG, 1991, BIOCHIM BIOPHYS ACTA, V1064, P89, DOI 10.1016/0005-2736(91)90415-5; Liu YJ, 2015, J BIOL CHEM, V290, P7736, DOI 10.1074/jbc.M114.618827; Mi T, 2015, BIOCHEM J, V467, P177, DOI 10.1042/BJ20141263; Miyakawa T, 2001, EMBO J, V20, P1674, DOI 10.1093/emboj/20.7.1674; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Postma AV, 2005, J MED GENET, V42, P863, DOI 10.1136/jmg.2004.028993; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Sondergaard MT, 2015, J BIOL CHEM, V290, P26151, DOI 10.1074/jbc.M115.676627; Tang YJ, 2012, CIRC RES, V110, P968, DOI 10.1161/CIRCRESAHA.111.256560; Tian XX, 2013, BIOCHEM J, V455, P367, DOI 10.1042/BJ20130805; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Tu HP, 2003, BIOPHYS J, V85, P290, DOI 10.1016/S0006-3495(03)74474-9; Xiong H, 1998, BIOCHEMISTRY-US, V37, P4804, DOI 10.1021/bi971198b; Xiong LW, 2006, BIOPHYS J, V90, P173, DOI 10.1529/biophysj.105.066092; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Zalk R, 2015, NATURE, V517, P44, DOI 10.1038/nature13950; Zhao MC, 1999, J BIOL CHEM, V274, P25971, DOI 10.1074/jbc.274.37.25971; Zhou Q, 2011, NAT MED, V17, P1003, DOI 10.1038/nm.2406	38	30	31	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2150	2160		10.1074/jbc.M115.693325	http://dx.doi.org/10.1074/jbc.M115.693325			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26663082	Green Published, hybrid			2022-12-26	WOS:000369610400009
J	de Sousa, GF; Lima, MD; Custodio, DF; Freitas, VM; Monteiro, G				de Sousa, Graziele Fonseca; Lima, Maira de Assis; Custodio, Debora Fernandes; Freitas, Vanessa Morais; Monteiro, Gisele			Chemogenomic Study of Carboplatin in Saccharomyces cerevisiae: Inhibition of the NEDDylation Process Overcomes Cellular Resistance Mediated by HuR and Cullin Proteins	PLOS ONE			English	Article							EPITHELIAL OVARIAN-CARCINOMA; CANCER CELLS; EXPRESSION; PROGNOSIS; MLN4924; ERCC5; YEAST	The use of carboplatin in cancer chemotherapy is limited by the emergence of drug resistance. To understand the molecular basis for this resistance, a chemogenomic screen was performed in 53 yeast mutants that had previously presented strong sensitivity to this widely used anticancer agent. Thirty-four mutants were responsive to carboplatin, and from these, 21 genes were selected for further studies because they have human homologues. Sixty percent of these yeast genes possessed human homologues which encoded proteins that interact with cullin scaffolds of ubiquitin ligases, or whose mRNA are under the regulation of Human antigen R (HuR) protein. Both HuR and cullin proteins are regulated through NED-Dylation post-translational modification, and so our results indicate that inhibition of this process should sensitise resistant tumour cells to carboplatin. We showed that treatment of a tumour cell line with MLN4924, a NEDDylation inhibitor, overcame the resistance to carboplatin. Our data suggest that inhibition of NEDDylation may be a useful strategy to resensitise tumour cells in patients that have acquired carboplatin resistance.	[de Sousa, Graziele Fonseca; Custodio, Debora Fernandes; Monteiro, Gisele] Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Tecnol Bioquim Farmaceut, Sao Paulo, Brazil; [Lima, Maira de Assis; Freitas, Vanessa Morais] Univ Sao Paulo, Inst Ciencias Biomed, Dept Biol Celular Desenvolvimento, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo	Monteiro, G (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Tecnol Bioquim Farmaceut, Sao Paulo, Brazil.	smgisele@usp.br	Freitas, Vanessa M/D-7897-2012; Monteiro, Gisele/E-5897-2012	Freitas, Vanessa M/0000-0001-9613-8626; Monteiro, Gisele/0000-0002-3385-047X	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2011/04173-1, 2009/01303-1, 2015/07749-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by GFS received grant by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - grant number 2011/04173-1 to GFS, and by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - grant numbers 2009/01303-1 and 2015/07749-2 to GM. DFC, MAL and VMF received no specific funding for this work.	Arnoldo A, 2014, GENOME MED, V6, DOI 10.1186/gm549; Bonome T, 2008, CANCER RES, V68, P5478, DOI 10.1158/0008-5472.CAN-07-6595; Brody JR, 2011, WIRES RNA, V2, P435, DOI 10.1002/wrna.62; Chen XJ, 2014, ARCH GYNECOL OBSTET, V290, P525, DOI 10.1007/s00404-014-3216-6; Dolan ME, 2004, CANCER RES, V64, P4353, DOI 10.1158/0008-5472.CAN-04-0340; Embade N, 2012, HEPATOLOGY, V55, P1237, DOI 10.1002/hep.24795; Frede J, 2013, EUR J CANCER, V49, P2331, DOI 10.1016/j.ejca.2013.03.016; He CY, 2013, ANTI-CANCER DRUG, V24, P300, DOI 10.1097/CAD.0b013e32835bd6ce; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Huang YT, 2015, SCI REP-UK, V5, DOI 10.1038/srep12484; Jazaeri AA, 2013, MOL CANCER THER, V12, P1958, DOI 10.1158/1535-7163.MCT-12-1028; Lal S, 2014, CANCER RES, V74, P1128, DOI 10.1158/0008-5472.CAN-13-1915; Navarro FJ, 2012, CURR OPIN CELL BIOL, V24, P833, DOI 10.1016/j.ceb.2012.10.015; Nawrocki ST, 2013, CLIN CANCER RES, V19, P3577, DOI 10.1158/1078-0432.CCR-12-3212; Osterberg L, 2005, CANCER GENET CYTOGEN, V163, P144, DOI 10.1016/j.cancergencyto.2005.06.023; Osterberg L, 2009, CYTOGENET GENOME RES, V125, P8, DOI 10.1159/000218744; Peters D, 2005, MOL CANCER THER, V4, P1605, DOI 10.1158/1535-7163.MCT-04-0311; Sarikas A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-4-220; Tang YC, 2013, CELL, V152, P394, DOI 10.1016/j.cell.2012.11.043; Walsh CS, 2008, J CLIN ONCOL, V26, P2952, DOI 10.1200/JCO.2007.13.5806; Yasuno T, 1999, ANTICANCER RES, V19, P4049; Yoshihara K, 2009, CANCER SCI, V100, P1421, DOI 10.1111/j.1349-7006.2009.01204.x; Zhao YC, 2014, ANTIOXID REDOX SIGN, V21, P2383, DOI 10.1089/ars.2013.5795	23	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145377	10.1371/journal.pone.0145377	http://dx.doi.org/10.1371/journal.pone.0145377			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26692264	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092300065
J	Ito, Y; Yamanishi, M; Ikeuchi, A; Imamura, C; Matsuyama, T				Ito, Yoichiro; Yamanishi, Mamoru; Ikeuchi, Akinori; Imamura, Chie; Matsuyama, Takashi			Combinatorial Screening for Transgenic Yeasts with High Cellulase Activities in Combination with a Tunable Expression System	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; TERMINATOR REGIONS; ETHANOL-PRODUCTION; PROTEIN YIELD; PROMOTERS; HYDROLYSIS; PATHWAY; GENE; ACTIVATOR	Combinatorial screening used together with a broad library of gene expression cassettes is expected to produce a powerful tool for the optimization of the simultaneous expression of multiple enzymes. Recently, we proposed a highly tunable protein expression system that utilized multiple genome-integrated target genes to fine-tune enzyme expression in yeast cells. This tunable system included a library of expression cassettes each composed of three gene-expression control elements that in different combinations produced a wide range of protein expression levels. In this study, four gene expression cassettes with graded protein expression levels were applied to the expression of three cellulases: cellobiohydrolase 1, cellobiohydrolase 2, and endoglucanase 2. After combinatorial screening for transgenic yeasts simultaneously secreting these three cellulases, we obtained strains with higher cellulase expressions than a strain harboring three cellulase-expression constructs within one high-performance gene expression cassette. These results show that our method will be of broad use throughout the field of metabolic engineering.	[Ito, Yoichiro; Yamanishi, Mamoru; Matsuyama, Takashi] Toyota Cent Res & Dev Labs Inc, Matsuyama Res Grp, Nagakute, Aichi 48011, Japan; [Ikeuchi, Akinori; Imamura, Chie] Toyota Cent Res & Dev Labs Inc, Biotechnol Lab, Nagakute, Aichi 48011, Japan	Toyota Central R&D Labs Inc; Toyota Central R&D Labs Inc	Ito, Y (corresponding author), Technol Res Assoc Highly Efficient Gene Design, Kobe, Hyogo, Japan.	yito@dragon.kobe-u.ac.jp; e1215@mosk.tytlabs.co.jp		Matsuyama, Takashi/0000-0001-7834-9358	JSPS [15K07378]	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partially supported by a JSPS Grant-in-Aid for Scientific Research (C) (Grant Number 15K07378 (TM)). All authors were employed by TOYOTA Central Research and Development Laboratories Incorporation at the time of the study. The specific contributions of each author are listed in the Author Contributions section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajikumar PK, 2010, SCIENCE, V330, P70, DOI 10.1126/science.1191652; Alper H, 2005, P NATL ACAD SCI USA, V102, P12678, DOI 10.1073/pnas.0504604102; Blazeck J, 2013, BIOTECHNOL J, V8, P46, DOI 10.1002/biot.201200120; Borodina I, 2014, BIOTECHNOL J, V9, P609, DOI 10.1002/biot.201300445; BRENT R, 1985, CELL, V43, P729, DOI 10.1016/0092-8674(85)90246-6; Cobb RE, 2012, CURR OPIN CHEM BIOL, V16, P285, DOI 10.1016/j.cbpa.2012.05.186; Coleman DJ, 2007, ANAL BIOCHEM, V371, P146, DOI 10.1016/j.ab.2007.08.027; Da Silva NA, 2012, FEMS YEAST RES, V12, P197, DOI 10.1111/j.1567-1364.2011.00769.x; Du J, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks549; HOHMANN S, 1991, J BACTERIOL, V173, P7963, DOI 10.1128/jb.173.24.7963-7969.1991; Ilmen M, 2011, BIOTECHNOL BIOFUELS, V4, DOI 10.1186/1754-6834-4-30; Ito Y, 2013, PROTEIN ENG DES SEL, V26, P73, DOI 10.1093/protein/gzs072; Ito Y, 2015, ACS SYNTH BIOL, V4, P12, DOI 10.1021/sb500096y; Ito Y, 2013, J BIOTECHNOL, V168, P486, DOI 10.1016/j.jbiotec.2013.09.024; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kim B, 2013, APPL ENVIRON MICROB, V79, P931, DOI 10.1128/AEM.02736-12; Kim IK, 2012, FEMS YEAST RES, V12, P228, DOI 10.1111/j.1567-1364.2011.00779.x; Kitagawa T, 2011, J BIOTECHNOL, V151, P194, DOI 10.1016/j.jbiotec.2010.12.002; Kung Y, 2012, ACS SYNTH BIOL, V1, P498, DOI 10.1021/sb300074k; Liao HH, 2011, BIOTECHNOL J, V6, P1409, DOI 10.1002/biot.201100157; Lu CF, 2007, APPL ENVIRON MICROB, V73, P6072, DOI 10.1128/AEM.00955-07; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; Matsuyama T, 2011, J BIOSCI BIOENG, V111, P175, DOI 10.1016/j.jbiosc.2010.09.014; Olson DG, 2012, CURR OPIN BIOTECH, V23, P396, DOI 10.1016/j.copbio.2011.11.026; Partow S, 2010, YEAST, V27, P955, DOI 10.1002/yea.1806; SALOHEIMO M, 1988, GENE, V63, P11, DOI 10.1016/0378-1119(88)90541-0; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shao ZY, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn991; Siddiqui MS, 2012, FEMS YEAST RES, V12, P144, DOI 10.1111/j.1567-1364.2011.00774.x; Sun J, 2012, BIOTECHNOL BIOENG, V109, P2082, DOI 10.1002/bit.24481; Sun Y, 2002, BIORESOURCE TECHNOL, V83, P1, DOI 10.1016/S0960-8524(01)00212-7; Suzuki H, 2012, J BIOTECHNOL, V157, P64, DOI 10.1016/j.jbiotec.2011.11.015; TRIEZENBERG SJ, 1988, GENE DEV, V2, P718, DOI 10.1101/gad.2.6.718; Tsai SL, 2010, APPL ENVIRON MICROB, V76, P7514, DOI 10.1128/AEM.01777-10; Vogl T, 2014, ACS SYNTH BIOL, V3, P188, DOI 10.1021/sb400091p; Wen F, 2010, APPL ENVIRON MICROB, V76, P1251, DOI 10.1128/AEM.01687-09; Xu Q, 2009, CURR OPIN BIOTECH, V20, P364, DOI 10.1016/j.copbio.2009.05.006; Yamada R, 2013, BIOTECHNOL ADV, V31, P754, DOI 10.1016/j.biotechadv.2013.02.007; Yamada R, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-32; Yamanishi M, 2013, ACS SYNTH BIOL, V2, P337, DOI 10.1021/sb300116y; Yamanishi M, 2012, ACS SYNTH BIOL, V1, P172, DOI 10.1021/sb200017p; Yamanishi M, 2011, BIOSCI BIOTECH BIOCH, V75, P2234, DOI 10.1271/bbb.110246; Yanase S, 2010, BIOTECHNOL J, V5, P449, DOI 10.1002/biot.200900291; Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282	44	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144870	10.1371/journal.pone.0144870	http://dx.doi.org/10.1371/journal.pone.0144870			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26692026	Green Submitted, gold, Green Published			2022-12-26	WOS:000367092300024
J	Schrauwen, JTC; Karanasos, A; van Ditzhuijzen, NS; Aben, JP; van der Steen, AFW; Wentzel, JJ; Gijsen, FJH				Schrauwen, Jelle T. C.; Karanasos, Antonios; van Ditzhuijzen, Nienke S.; Aben, Jean-Paul; van der Steen, Antonius F. W.; Wentzel, Jolanda J.; Gijsen, Frank J. H.			Influence of the Accuracy of Angiography-Based Reconstructions on Velocity and Wall Shear Stress Computations in Coronary Bifurcations: A Phantom Study	PLOS ONE			English	Article							INTRAVASCULAR ULTRASOUND; 3-DIMENSIONAL RECONSTRUCTION; ATHEROSCLEROTIC PLAQUE; BLOOD-FLOW; ARTERIES; METHODOLOGY; VALIDATION; LESIONS; PROGRESSION; PATTERNS	Introduction Wall shear stress (WSS) plays a key role in the onset and progression of atherosclerosis in human coronary arteries. Especially sites with low and oscillating WSS near bifurcations have a higher propensity to develop atherosclerosis. WSS computations in coronary bifurcations can be performed in angiography-based 3D reconstructions. It is essential to evaluate how reconstruction errors influence WSS computations in mildly-diseased coronary bifurcations. In mildly-diseased lesions WSS could potentially provide more insight in plaque progression. Materials Methods Four Plexiglas phantom models of coronary bifurcations were imaged with bi-plane angiography. The lumens were segmented by two clinically experienced readers. Based on the segmentations 3D models were generated. This resulted in three models per phantom: one gold-standard from the phantom model itself, and one from each reader. Steady-state and transient simulations were performed with computational fluid dynamics to compute the WSS. A similarity index and a noninferiority test were used to compare the WSS in the phantoms and their reconstructions. The margin for this test was based on the resolution constraints of angiography. Results The reconstruction errors were similar to previously reported data; in seven out of eight reconstructions less than 0.10 mm. WSS in the regions proximal and far distal of the stenosis showed a good agreement. However, the low WSS areas directly distal of the stenosis showed some disagreement between the phantoms and the readers. This was due to small deviations in the reconstruction of the stenosis that caused differences in the resulting jet, and consequently the size and location of the low WSS area. Discussion This study showed that WSS can accurately be computed within angiography-based 3D reconstructions of coronary arteries with early stage atherosclerosis. Qualitatively, there was a good agreement between the phantoms and the readers. Quantitatively, the low WSS regions directly distal to the stenosis were sensitive to small reconstruction errors.	[Schrauwen, Jelle T. C.; van der Steen, Antonius F. W.; Wentzel, Jolanda J.; Gijsen, Frank J. H.] Erasmus MC, Thoraxctr, Dept Biomed Engn, Rotterdam, Netherlands; [Karanasos, Antonios; van Ditzhuijzen, Nienke S.] Erasmus MC, Thoraxctr, Dept Cardiol, Rotterdam, Netherlands; [Aben, Jean-Paul] Pie Med Imaging, Maastricht, Netherlands; [van der Steen, Antonius F. W.] Delft Univ Technol, Dept Imaging Phys, Delft, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Delft University of Technology	Gijsen, FJH (corresponding author), Erasmus MC, Thoraxctr, Dept Biomed Engn, Rotterdam, Netherlands.	f.gijsen@erasmusmc.nl	Karanasos, Antonios/AAQ-7739-2020	Karanasos, Antonios/0000-0001-8052-6739	Stichting technische wetenschappen [11635]	Stichting technische wetenschappen	This work was supported by Stichting technische wetenschappen, Grant number: 11635 and Progamme name: Cardiovascular Risk Management by Advanced Medical Image Analysis. (URLs: http://stw.nl/en/; http://www.stw.nl/nl/programmas/cardiovascular-risk-management-advanced-medical-image-analysis-carisma). The funder provided support in the form of salaries for authors JS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Bourantas CV, 2014, INT J CARDIOVAS IMAG, V30, P485, DOI 10.1007/s10554-014-0374-3; Bourantas CV, 2013, EUROINTERVENTION, V9, P582, DOI 10.4244/EIJV9I5A94; Bovendeerd PHM, 2006, ANN BIOMED ENG, V34, P1833, DOI 10.1007/s10439-006-9189-2; Caro CG, 1996, P ROY SOC A-MATH PHY, V452, P185, DOI 10.1098/rspa.1996.0011; Chen MCY, 2005, ASAIO J, V51, P313, DOI 10.1097/01.mat.0000169117.07070.fb; CHO YI, 1991, BIORHEOLOGY, V28, P241; Cicha I, 2011, STROKE, V42, P3502, DOI 10.1161/STROKEAHA.111.627265; Corban MT, 2014, ATHEROSCLEROSIS, V232, P271, DOI 10.1016/j.atherosclerosis.2013.11.049; De Santis G, 2010, MED BIOL ENG COMPUT, V48, P371, DOI 10.1007/s11517-010-0583-4; Feldman CL, 2002, AM HEART J, V143, P931, DOI 10.1067/mhj.2002.123118; Fujii K, 2006, AM J CARDIOL, V98, P429, DOI 10.1016/j.amjcard.2006.03.020; Fukumoto Y, 2008, J AM COLL CARDIOL, V51, P645, DOI 10.1016/j.jacc.2007.10.030; Gijsen F, 2013, J BIOMECH, V46, P240, DOI 10.1016/j.jbiomech.2012.11.006; Gijsen FJH, 2008, AM J PHYSIOL-HEART C, V295, pH1608, DOI 10.1152/ajpheart.01081.2007; Girasis C, 2013, EUROINTERVENTION, V8, P1451, DOI 10.4244/EIJV8I12A219; Girasis C, 2011, CATHETER CARDIO INTE, V77, P790, DOI 10.1002/ccd.22704; Goubergrits L, 2008, INT J CARDIOVAS IMAG, V24, P411, DOI 10.1007/s10554-007-9275-z; Goubergrits L, 2009, ANN BIOMED ENG, V37, P682, DOI 10.1007/s10439-009-9656-7; Grigioni M, 2005, J BIOMECH, V38, P1375, DOI 10.1016/j.jbiomech.2004.06.028; He XJ, 1996, J BIOMECH ENG-T ASME, V118, P74, DOI 10.1115/1.2795948; Johnston BM, 2006, J BIOMECH, V39, P1116, DOI 10.1016/j.jbiomech.2005.01.034; Lee SW, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3127252; Leter EM, 2004, INT J RADIAT ONCOL, V58, P278, DOI 10.1016/j.ijrobp.2003.08.017; Morbiducci U, 2009, ANN BIOMED ENG, V37, P516, DOI 10.1007/s10439-008-9609-6; Myers JG, 2001, ANN BIOMED ENG, V29, P109, DOI 10.1114/1.1349703; Nakazawa G, 2010, J AM COLL CARDIOL, V55, P1679, DOI 10.1016/j.jacc.2010.01.021; Newby DE, 2010, HEART, V96, P1247, DOI 10.1136/hrt.2009.175141; Onuma Y, 2011, EUROINTERVENTION, V7, P629, DOI 10.4244/EIJV7I5A100; Peiffer V, 2013, CARDIOVASC RES, V99, P242, DOI 10.1093/cvr/cvt044; Pijls N.H.J., 2000, CORONARY PRESSURE, V2nd; Samady H, 2011, CIRCULATION, V124, P779, DOI 10.1161/CIRCULATIONAHA.111.021824; Schrauwen JTC, 2015, ANN BIOMED ENG, V43, P59, DOI 10.1007/s10439-014-1090-9; Schrauwen JTC, 2015, J BIOMECH IN PRESS; Slager CJ, 2005, NAT CLIN PRACT CARD, V2, P401, DOI 10.1038/ncpcardio0274; Slager CJ, 2000, CIRCULATION, V102, P511; Stone PH, 2012, CIRCULATION, V126, P172, DOI 10.1161/CIRCULATIONAHA.112.096438; Tu SX, 2011, INT J CARDIOVAS IMAG, V27, P197, DOI 10.1007/s10554-011-9809-2; van der Giessen AG, 2011, J BIOMECH, V44, P1089, DOI 10.1016/j.jbiomech.2011.01.036; Van Langenhove G, 2000, Circulation, V102, pE22; Virmani R, 2000, ARTERIOSCL THROM VAS, V20, P1262, DOI 10.1161/01.ATV.20.5.1262; Walker E, 2011, J GEN INTERN MED, V26, P192, DOI 10.1007/s11606-010-1513-8; Wellnhofer E, 2009, ATHEROSCLEROSIS, V202, P483, DOI 10.1016/j.atherosclerosis.2008.05.044; Wellnhofer E, 1999, INT J CARDIAC IMAG, V15, P339, DOI 10.1023/A:1006322609072; Wellnhofer E, 2006, BIOMED ENG ONLINE, V5, DOI 10.1186/1475-925X-5-39; Wellnhofer E, 2010, ATHEROSCLEROSIS, V213, P475, DOI 10.1016/j.atherosclerosis.2010.09.007; Wentzel JJ, 2005, J BIOMECH, V38, P1551, DOI 10.1016/j.jbiomech.2004.06.022; Wentzel JJ, 2012, CARDIOVASC RES, V96, P234, DOI 10.1093/cvr/cvs217; Zeng DH, 2008, J BIOMECH ENG-T ASME, V130, DOI 10.1115/1.2937744	48	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145114	10.1371/journal.pone.0145114	http://dx.doi.org/10.1371/journal.pone.0145114			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690897	gold, Green Submitted, Green Published			2022-12-26	WOS:000367092300037
J	Arias, CA; Betancur, MCT; Pinzon, MA; Arango, DC; Taffur, CAC; Prada, EC				Arias Arias, Carolina; Tamayo Betancur, Maria Carolina; Alejandro Pinzon, Miguel; Cardona Arango, Doris; Capataz Taffur, Cesar Antonio; Correa Prada, Edgar			Differences in the Clinical Outcome of Osteomyelitis by Treating Specialty: Orthopedics or Infectology	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; INFECTIONS; MANAGEMENT; DIAGNOSIS; CONSULTATION; OXACILLIN; RIFAMPIN; ADULTS	Osteomyelitis is a heterogeneous infection with regard to etiology and treatment, and currently no single management protocol exists. Management of the condition is typically an interdisciplinary approach between orthopedics and infectious disease; however, the orthopedist is often the person who manages treatment. The aim of the study was to determine differences in the outcome of osteomyelitis according to its treating specialty and to identify factors associated with the recurrence of the disease. An ambispective cohort study of 129 patients with osteomyelitis was conducted and the proportions for qualitative variables and central tendency and dispersion measures for quantitative variables were calculated; the latter were tested for normality using the Shapiro-Wilk test. A bivariate analysis was conducted with measures of association based on the chi square test and crude relative risk. A logistic regression model was applied and statistical significance was set at p < 0.05, including the model of relevant clinical variables that fit the Hosmer-Lemeshow test. We found that 70% of patients were treated either by orthopedics or infectious disease. Patients who were treated by an orthopedist alone presented a greater risk of relapse or reinfection (RR = 4.6; 95% CI 2.3;8.9). Risk factors of osteomyelitis recurrence as determined in the regression model included the following: age of 57 years or older (RR = 1.3; 95% 0.3;5.2), long bones (RR = 1.9; 95% CI 0.5;7.1), fracture (RR = 5.0; 95% CI 0.4;51.4), monotherapy (RR = 3.0; 95% CI 0.6;14.5), receiving less than 4 weeks of antibiotics (RR = 1.5; 95% CI 0.2;10.1), inadequate treatment (RR = 3.1; 95% CI 0.4;20.1), and receiving orthopedics treatment (RR = 5.5; 95% CI 1.6;18.2). Most patients evaluated jointly by orthopedics and infectious disease received adequate treatment for osteomyelitis and had fewer relapses.	[Arias Arias, Carolina; Tamayo Betancur, Maria Carolina; Cardona Arango, Doris] Univ CES, Dept Epidemiol, Medellin, Antioquia, Colombia; [Alejandro Pinzon, Miguel] Clin Medellin, Dept Infect Dis, Medellin, Antioquia, Colombia; [Capataz Taffur, Cesar Antonio] Fdn Clin Norte, Dept Infect Dis, Bello, Antioquia, Colombia; [Correa Prada, Edgar] Nueva Clin Sagrado Corazon, Dept Orthoped, Medellin, Antioquia, Colombia		Pinzon, MA (corresponding author), Clin Medellin, Dept Infect Dis, Medellin, Antioquia, Colombia.	alejandropinzon01@yahoo.es						Conterno LO, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004439.pub3; Forsberg JA, 2011, J AM ACAD ORTHOP SUR, V19, pS8, DOI 10.5435/00124635-201102001-00003; Hassan Azza M, 2009, EGYPT J MED MICROBIO, V18, P55; Hatzenbuehler J, 2011, AM FAM PHYSICIAN, V84, P1027; Honda H, 2010, AM J MED, V123, P631, DOI 10.1016/j.amjmed.2010.01.015; Jenkins TC, 2008, CLIN INFECT DIS, V46, P1000, DOI 10.1086/529190; Jorge LS, 2010, BRAZ J INFECT DIS, V14, P310, DOI 10.1590/S1413-86702010000300020; KINDSFATER K, 1995, J ORTHOP TRAUMA, V9, P121, DOI 10.1097/00005131-199504000-00006; Lazzarini L, 2005, INT J INFECT DIS, V9, P127, DOI 10.1016/j.ijid.2004.09.009; Lew DP, 1997, NEW ENGL J MED, V336, P999, DOI 10.1056/NEJM199704033361406; MADER JT, 1992, CLIN INFECT DIS, V15, pS155, DOI 10.1093/clind/15.Supplement_1.S155; McHenry MC, 2002, CLIN INFECT DIS, V34, P1342, DOI 10.1086/340102; NORDEN CW, 1986, SOUTHERN MED J, V79, P947, DOI 10.1097/00007611-198608000-00008; NORRBY SR, 1993, J ANTIMICROB CHEMOTH, V31, P41, DOI 10.1093/jac/31.suppl_D.41; Rieg S, 2009, J INFECTION, V59, P232, DOI 10.1016/j.jinf.2009.07.015; Salvana Jose, 2005, Conn Med, V69, P195; Sanders J, 2013, ORTHOPEDICS, V36, P368, DOI 10.3928/01477447-20130426-07; Schmitt S, 2014, CLIN INFECT DIS, V58, P22, DOI 10.1093/cid/cit610; SHEFTEL TG, 1986, ANTIMICROB AGENTS CH, V29, P112, DOI 10.1128/AAC.29.1.112; Takakura S, 2006, INFECT CONT HOSP EP, V27, P964, DOI 10.1086/504934; Tice AD, 2003, J ANTIMICROB CHEMOTH, V51, P1261, DOI 10.1093/jac/dkg186; Uckay I, 2009, J INFECTION, V58, P205, DOI 10.1016/j.jinf.2009.01.012; VANDERAUWERA P, 1985, ANTIMICROB AGENTS CH, V28, P467, DOI 10.1128/AAC.28.4.467; WALDVOGEL FA, 1970, NEW ENGL J MED, V283, P822; Wieland BW, 2012, CLIN INFECT DIS, V54, P585, DOI 10.1093/cid/cir857; Zuluaga AF, 2006, ARCH INTERN MED, V166, P95, DOI 10.1001/archinte.166.1.95	26	19	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144736	10.1371/journal.pone.0144736	http://dx.doi.org/10.1371/journal.pone.0144736			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678551	Green Published, gold, Green Submitted			2022-12-26	WOS:000366723400022
J	Shen, RZ; Achenbach, J; Shen, Y; Palaia, J; Rahkola, JT; Nick, HJ; Smythies, LE; McConnell, M; Fowler, MG; Smith, PD; Janoff, EN				Shen, Ruizhong; Achenbach, Jenna; Shen, Yue; Palaia, Jana; Rahkola, Jeremy T.; Nick, Heidi J.; Smythies, Lesley E.; McConnell, Michelle; Fowler, Mary G.; Smith, Phillip D.; Janoff, Edward N.			Mother-to-Child HIV-1 Transmission Events Are Differentially Impacted by Breast Milk and Its Components from HIV-1-Infected Women	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CELL-ASSOCIATED HIV-1; TYPE-1 TRANSCYTOSIS; EPITHELIAL-CELLS; DENDRITIC CELLS; SECRETORY IGA; POSITIVE MOTHERS; FED INFANTS; R5 HIV-1; INFECTION	Breast milk is a vehicle of infection and source of protection in post-natal mother-to-child HIV-1 transmission (MTCT). Understanding the mechanism by which breast milk limits vertical transmission will provide critical insight into the design of preventive and therapeutic approaches to interrupt HIV-1 mucosal transmission. However, characterization of the inhibitory activity of breast milk in human intestinal mucosa, the portal of entry in postnatal MTCT, has been constrained by the limited availability of primary mucosal target cells and tissues to recapitulate mucosal transmission ex vivo. Here, we characterized the impact of skimmed breast milk, breast milk antibodies (Igs) and non-Ig components from HIV-1-infected Ugandan women on the major events of HIV-1 mucosal transmission using primary human intestinal cells and tissues. HIV-1-specific IgG antibodies and non-Ig components in breast milk inhibited the uptake of Ugandan HIV-1 isolates by primary human intestinal epithelial cells, viral replication in and transport of HIV-1-bearing dendritic cells through the human intestinal mucosa. Breast milk HIV-1-specific IgG and IgA, as well as innate factors, blocked the uptake and transport of HIV-1 through intestinal mucosa. Thus, breast milk components have distinct and complementary effects in reducing HIV-1 uptake, transport through and replication in the intestinal mucosa and, therefore, likely contribute to preventing postnatal HIV-1 transmission. Our data suggests that a successful preventive or therapeutic approach would require multiple immune factors acting at multiple steps in the HIV-1 mucosal transmission process.	[Shen, Ruizhong; Nick, Heidi J.; Smythies, Lesley E.; Smith, Phillip D.] Univ Alabama Birmingham, Dept Med, Div Gastroenterol, Birmingham, AL 35294 USA; [Achenbach, Jenna; Palaia, Jana; Rahkola, Jeremy T.; Janoff, Edward N.] Univ Colorado Denver, Mucosal & Vaccine Res Program Colorado MAVRC, Aurora, CO 80045 USA; [Shen, Yue] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Rahkola, Jeremy T.; Janoff, Edward N.] Denver Vet Affairs Med Ctr, Denver, CO USA; [McConnell, Michelle] Ctr Dis Control & Prevent, Atlanta, GA USA; [Fowler, Mary G.] Makerere Univ Johns Hopkins Univ Res Collaborat, Kampala, Uganda; [Smith, Phillip D.] Vet Affairs Med Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Auburn University System; Auburn University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; Centers for Disease Control & Prevention - USA; Makerere University; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Janoff, EN (corresponding author), Univ Colorado Denver, Mucosal & Vaccine Res Program Colorado MAVRC, Aurora, CO 80045 USA.	rshen@uab.edu; Edward.Janoff@ucdenver.edu		NICK, HEIDI/0000-0002-7853-6302	National Institutes of Health [AI093151, AI106395, AI083127, DK064400, AI41361, HD059527, AI083615]; UAB Center for AIDS Research (CFAR); Comprehensive Cancer Center Pilot Grant Program; amfAR; Foundation for AIDS Research [108015-49-RGRL]; Elisabeth Glaser Pediatric AIDS Foundations [MV-00-9-900-01432-0-00]; Research Service of the Veterans Administration; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD059527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI106395, R56AI093151, R21AI083615, R01AI097265] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK064400] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UAB Center for AIDS Research (CFAR); Comprehensive Cancer Center Pilot Grant Program; amfAR; Foundation for AIDS Research; Elisabeth Glaser Pediatric AIDS Foundations; Research Service of the Veterans Administration; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	National Institutes of Health grants AI093151 and AI106395 (RS), AI083127 and DK064400 (PDS), AI41361, HD059527 and AI083615 (ENJ); UAB Center for AIDS Research (CFAR) and Comprehensive Cancer Center Pilot Grant Program (RS); amfAR, the Foundation for AIDS Research 108015-49-RGRL (PDS); the Elisabeth Glaser Pediatric AIDS Foundations MV-00-9-900-01432-0-00 (ENJ); and the Research Service of the Veterans Administration (PDS and ENJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizire J, 2012, JAIDS-J ACQ IMM DEF, V60, P483, DOI 10.1097/QAI.0b013e318246bf9e; Alfsen A, 2001, J IMMUNOL, V166, P6257, DOI 10.4049/jimmunol.166.10.6257; Baroncelli S, 2008, AIDS, V22, P1515, DOI 10.1097/QAD.0b013e3282fd6e0c; Bobardt MD, 2007, J VIROL, V81, P395, DOI 10.1128/JVI.01303-06; Bomsel M, 1997, NAT MED, V3, P42, DOI 10.1038/nm0197-42; Bomsel M, 2003, NAT REV MOL CELL BIO, V4, P57, DOI 10.1038/nrm1005; Bomsel M, 1998, IMMUNITY, V9, P277, DOI 10.1016/S1074-7613(00)80610-X; Cavarelli M, 2013, EMBO MOL MED, V5, P776, DOI 10.1002/emmm.201202232; Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834; Devito C, 2000, J IMMUNOL, V165, P5170, DOI 10.4049/jimmunol.165.9.5170; DUNN DT, 1992, LANCET, V340, P585, DOI 10.1016/0140-6736(92)92115-V; Fouda GG, 2011, J VIROL, V85, P9555, DOI 10.1128/JVI.05174-11; Fowler MG, 2007, AM J OBSTET GYNECOL, V197, pS3, DOI 10.1016/j.ajog.2007.06.048; Friedman J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037648; HARMSEN MC, 1995, J INFECT DIS, V172, P380, DOI 10.1093/infdis/172.2.380; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Hocini H, 1997, AIDS RES HUM RETROV, V13, P1179, DOI 10.1089/aid.1997.13.1179; Hocini H, 2001, J VIROL, V75, P5370, DOI 10.1128/JVI.75.11.5370-5374.2001; Humphrey JH, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6580; Koulinska IN, 2006, JAIDS-J ACQ IMM DEF, V41, P93, DOI 10.1097/01.qai.0000179424.19413.24; Kuhn L, 2005, JAIDS-J ACQ IMM DEF, V39, P138; Kuhn L, 2006, J PEDIATR-US, V149, P611, DOI 10.1016/j.jpeds.2006.06.017; Leroy V, 1998, LANCET, V352, P597, DOI 10.1016/S0140-6736(98)01419-6; Lewis P, 1998, J INFECT DIS, V177, P34, DOI 10.1086/513816; Lohman BL, 2003, J INFECT DIS, V188, P1666, DOI 10.1086/379374; Lyimo MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043815; Lyimo MA, 2009, JAIDS-J ACQ IMM DEF, V51, P117, DOI 10.1097/QAI.0b013e3181a3908d; Mantis NJ, 2007, J IMMUNOL, V179, P3144, DOI 10.4049/jimmunol.179.5.3144; Matoba N, 2004, P NATL ACAD SCI USA, V101, P13584, DOI 10.1073/pnas.0405297101; Meng G, 2002, NAT MED, V8, P150, DOI 10.1038/nm0202-150; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Palaia JM, 2014, J INFECTION, V68, P264, DOI 10.1016/j.jinf.2013.11.002; Pollakis G, 2011, CURR OPIN HIV AIDS, V6, P341, DOI 10.1097/COH.0b013e3283499e11; Pollara J, 2015, J VIROL, V89, P9952, DOI 10.1128/JVI.01560-15; Rousseau CM, 2004, J INFECT DIS, V190, P1880, DOI 10.1086/425076; Saeland E, 2009, MOL IMMUNOL, V46, P2309, DOI 10.1016/j.molimm.2009.03.025; Shapiro RL, 2007, J INFECT DIS, V196, P562, DOI 10.1086/519847; Shen RZ, 2014, J VIROL, V88, P14258, DOI 10.1128/JVI.02164-14; Shen RZ, 2014, J VIROL, V88, P7683, DOI 10.1128/JVI.00766-14; Shen RZ, 2014, AM J REPROD IMMUNOL, V71, P608, DOI 10.1111/aji.12244; Shen RZ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002060; Shen RZ, 2011, AM J REPROD IMMUNOL, V65, P261, DOI 10.1111/j.1600-0897.2010.00939.x; Shen RZ, 2010, J LEUKOCYTE BIOL, V87, P663, DOI 10.1189/jlb.0909605; Shen RZ, 2010, J IMMUNOL, V184, P3648, DOI 10.4049/jimmunol.0903346; Shen R, 2009, J VIROL, V83, P3258, DOI 10.1128/JVI.01796-08; Smith MM, 2000, NUTR REV, V58, P333, DOI 10.1111/j.1753-4887.2000.tb01830.x; Tudor D, 2009, MUCOSAL IMMUNOL, V2, P412, DOI 10.1038/mi.2009.89; Van de Perre P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003327; VANDEPERRE P, 1993, LANCET, V341, P914, DOI 10.1016/0140-6736(93)91210-D; Wahl A, 2015, J VIROL, V89, P10868, DOI 10.1128/JVI.01702-15; Wahl A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002732; Walter J, 2009, J INFECT DIS, V200, P1498, DOI 10.1086/644603; Wolbank S, 2003, J VIROL, V77, P4095, DOI 10.1128/JVI.77.7.4095-4103.2003	54	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145150	10.1371/journal.pone.0145150	http://dx.doi.org/10.1371/journal.pone.0145150			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26680219	Green Published, Green Submitted, gold			2022-12-26	WOS:000366723400051
J	Taki, S; Kamada, H; Inoue, M; Nagano, K; Mukai, Y; Higashisaka, K; Yoshioka, Y; Tsutsumi, Y; Tsunoda, S				Taki, Shintaro; Kamada, Haruhiko; Inoue, Masaki; Nagano, Kazuya; Mukai, Yohei; Higashisaka, Kazuma; Yoshioka, Yasuo; Tsutsumi, Yasuo; Tsunoda, Shin-ichi			A Novel Bispecific Antibody against Human CD3 and Ephrin Receptor A10 for Breast Cancer Therapy	PLOS ONE			English	Article							SINGLE-CHAIN ANTIBODY; GROWTH-FACTOR RECEPTOR; TRASTUZUMAB RESISTANCE; LEUKEMIA; LYMPHOMA; POTENT; CELLS; INTERLEUKIN-2; BLINATUMOMAB; CYTOTOXICITY	Ephrin receptor A10 (EphA10), a transmembrane receptor that binds to ephrin, is a newly identified breast cancer marker protein that has also been detected in HER2-negative tissue. In this study, we report creation of a novel bispecific antibody (BsAb) binding both EphA10 and CD3, thereby forming a bridge between antigens expressed on both tumor and immune cells and promoting recognition of tumor cells by immune cells and redirection of cytotoxic T cells (CTL). This BsAb (EphA10/CD3) was expressed in supernatants of BsAb gene-transfected cells asmonomeric and dimeric molecules. Redirected T-cell lysis was observed when monomeric and dimeric BsAb were added to EphA10-overexpressing tumor cells in vitro. Furthermore, dimeric BsAb (EphA10/CD3) was more cytotoxic than monomeric BsAb, with efficient tumor cell lysis elicited by lower concentrations (<= 10(-1) mu g/mL) and a lower effector to target (E/T) cell ratio (E/T = 2.5). Dimeric BsAb (EphA10/CD3) also showed significant antitumor effects in human xenograft mouse models. Together, these results revealed opportunities to redirect the activity of CTL towards tumor cells that express EphA10 using the BsAb (EphA10/CD3), which could be tested in future clinical trials as a novel and potent therapeutic for breast cancer tumors.	[Taki, Shintaro; Kamada, Haruhiko; Inoue, Masaki; Tsunoda, Shin-ichi] Natl Inst Biomed Innovat Hlth & Nutr, Lab Biopharmaceut Res, Ibaraki, Osaka, Japan; [Taki, Shintaro; Nagano, Kazuya; Higashisaka, Kazuma; Yoshioka, Yasuo; Tsutsumi, Yasuo; Tsunoda, Shin-ichi] Osaka Univ, Grad Sch Pharmaceut Sci, Suita, Osaka, Japan; [Kamada, Haruhiko; Yoshioka, Yasuo; Tsutsumi, Yasuo; Tsunoda, Shin-ichi] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka, Japan; [Mukai, Yohei; Yoshioka, Yasuo; Tsutsumi, Yasuo; Tsunoda, Shin-ichi] Natl Inst Biomed Innovat Hlth & Nutr, Ctr Drug Design Res, Ibaraki, Osaka, Japan	Osaka University; Osaka University	Tsunoda, S (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr, Lab Biopharmaceut Res, 7-6-8 Saito Asagi, Ibaraki, Osaka, Japan.	tsunoda@nibio.go.jp		Tsunoda, Shin-ichi/0000-0003-3299-2182	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science (JSPS); Health Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan; Project for Development of Innovative Research on Cancer Therapeutics, the Ministry of Education, Culture, Sports, Science and Technology of Japan; JSPS; Grants-in-Aid for Scientific Research [15K12550] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan; Project for Development of Innovative Research on Cancer Therapeutics, the Ministry of Education, Culture, Sports, Science and Technology of Japan; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by a Grants-in-Aid for Scientific Research and a Project for the Development of Innovative Research on Cancer Therapeutics from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and from the Japan Society for the Promotion of Science (JSPS) (S. Taki, H. Kamada, S. Tsunoda). This study was also supported in part by Health Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan (H. Kamada, S. Tsunoda).; This study was supported in part by Grants-in-Aid for Scientific Research from the Project for Development of Innovative Research on Cancer Therapeutics, the Ministry of Education, Culture, Sports, Science and Technology of Japan, and from the JSPS. This study was also supported in part by Health Labor Sciences Research Grants from the Ministry of Health, Labor and Welfare of Japan.	Asano R, 2011, J BIOL CHEM, V286, P1812, DOI 10.1074/jbc.M110.172957; Baeuerle PA, 2009, CANCER RES, V69, P4941, DOI 10.1158/0008-5472.CAN-09-0547; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Brischwein K, 2006, MOL IMMUNOL, V43, P1129, DOI 10.1016/j.molimm.2005.07.034; Clynes RA, 2000, NAT MED, V6, P443, DOI 10.1038/74704; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Crown J, 2012, ANN ONCOL, V23, P56, DOI 10.1093/annonc/mds196; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dodelet VC, 2000, ONCOGENE, V19, P5614, DOI 10.1038/sj.onc.1203856; Dreier T, 2002, INT J CANCER, V100, P690, DOI 10.1002/ijc.10557; Flieger D, 2000, CANCER IMMUNOL IMMUN, V49, P441, DOI 10.1007/s002620000130; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Fury MG, 2008, CANCER IMMUNOL IMMUN, V57, P155, DOI 10.1007/s00262-007-0357-5; Gogineni K, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3064; Goldstein NI, 1995, CLIN CANCER RES, V1, P1311; Hammond SA, 2007, CANCER RES, V67, P3927, DOI 10.1158/0008-5472.CAN-06-2760; Hartmann F, 1997, BLOOD, V89, P2042, DOI 10.1182/blood.V89.6.2042; Hoffman LM, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00063; Imai S, 2011, BIOMATERIALS, V32, P162, DOI 10.1016/j.biomaterials.2010.09.030; Jager M, 2009, CANCER RES, V69, P4270, DOI 10.1158/0008-5472.CAN-08-2861; James ND, 2001, BRIT J CANCER, V85, P152, DOI 10.1054/bjoc.2001.1878; Kandouz M, 2012, CANCER METAST REV, V31, P353, DOI 10.1007/s10555-012-9352-1; Kipriyanov SM, 1999, J MOL BIOL, V293, P41, DOI 10.1006/jmbi.1999.3156; Klee GG, 2000, ARCH PATHOL LAB MED, V124, P921; Koene HR, 1997, BLOOD, V90, P1109, DOI 10.1182/blood.V90.3.1109.1109_1109_1114; Kondo J, 2011, P NATL ACAD SCI USA, V108, P6235, DOI 10.1073/pnas.1015938108; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Loffler A, 2000, BLOOD, V95, P2098, DOI 10.1182/blood.V95.6.2098; Maloney DG, 1997, BLOOD, V90, P2188; Nagano K, 2014, J CONTROL RELEASE, V189, P72, DOI 10.1016/j.jconrel.2014.06.010; Nagano K, 2014, BIOCHEM BIOPH RES CO, V450, P545, DOI 10.1016/j.bbrc.2014.06.007; Nagata Y, 2004, CANCER CELL, V6, P117, DOI 10.1016/j.ccr.2004.06.022; Nagorsen D, 2009, LEUKEMIA LYMPHOMA, V50, P886, DOI 10.1080/10428190902943077; Nelson AL, 2010, NAT REV DRUG DISCOV, V9, P767, DOI 10.1038/nrd3229; Niwa R, 2004, CANCER RES, V64, P2127, DOI 10.1158/0008-5472.CAN-03-2068; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Reslan L, 2009, MABS-AUSTIN, V1, P222, DOI 10.4161/mabs.1.3.8292; Reusch U, 2014, MABS-AUSTIN, V6, P727, DOI 10.4161/mabs.28591; Scott AM, 2012, NAT REV CANCER, V12, P278, DOI 10.1038/nrc3236; Seidman AD, 2008, J CLIN ONCOL, V26, P1642, DOI 10.1200/JCO.2007.11.6699; SHEPARD HM, 1991, J CLIN IMMUNOL, V11, P117, DOI 10.1007/BF00918679; Spector NL, 2009, J CLIN ONCOL, V27, P5838, DOI 10.1200/JCO.2009.22.1507; Todorovska A, 2001, J IMMUNOL METHODS, V248, P47, DOI 10.1016/S0022-1759(00)00342-2; Topp MS, 2011, J CLIN ONCOL, V29, P2493, DOI 10.1200/JCO.2010.32.7270; Xu QL, 1997, J MOL MED-JMM, V75, P576, DOI 10.1007/s001090050142; Zhang SY, 2011, NAT MED, V17, P461, DOI 10.1038/nm.2309; Zhang T, 2011, CANCER RES, V71, P2066, DOI 10.1158/0008-5472.CAN-10-3200	47	28	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144712	10.1371/journal.pone.0144712	http://dx.doi.org/10.1371/journal.pone.0144712			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678395	Green Submitted, Green Published, gold			2022-12-26	WOS:000366723400020
J	Botto-Menezes, C; dos Santos, MCS; Simplicio, JL; de Medeiros, JM; Gomes, KCB; Costa, ICD; Batista-Silva, E; do Nascimento, CT; Chagas, ECD; Sardinha, JFJ; de Santana, FS; Brock, M; Bardaj, A; Martinez-Espinosa, FE				Botto-Menezes, Camila; Silva dos Santos, Monica Caroline; Simplicio, Janiceia Lopes; de Medeiros, Jandira Menezes; Barroso Gomes, Kelly Cristina; de Carvalho Costa, Isabel Cristina; Batista-Silva, Eva; do Nascimento, Cristiana Teixeira; da Silva Chagas, Eda Cristina; Jardim Sardinha, Jose Felipe; de Santana Filho, Franklin Simoes; Brock, Marianna; Bardaj, Azucena; Martinez-Espinosa, Flor Ernestina			Plasmodium vivax Malaria in Pregnant Women in the Brazilian Amazon and the Risk Factors Associated with Prematurity and Low Birth Weight: A Descriptive Study	PLOS ONE			English	Article							EPIDEMIOLOGY; FALCIPARUM; CONSEQUENCES; INFECTIONS; OUTCOMES; BURDEN; AREA	Introduction Plasmodium vivax is the most prevalent malaria species in the American region. Brazil accounts for the higher number of the malaria cases reported in pregnant women in the Americas. This study aims to describe the characteristics of pregnant women with malaria in an endemic area of the Brazilian Amazon and the risk factors associated with prematurity and low birth weight (LBW). Methods/Principal Findings Between December 2005 and March 2008, 503 pregnant women with malaria that attended a tertiary health centre were enrolled and followed up until delivery and reported a total of 1016 malaria episodes. More than half of study women (54%) were between 20-29 years old, and almost a third were adolescents. The prevalence of anaemia at enrolment was 59%. Most women (286/503) reported more than one malaria episode and most malaria episodes (84.5%, 846/1001) were due to P. vivax infection. Among women with only P. vivax malaria, the risk of preterm birth and low birth weight decreased in multigravidae (OR, 0.36 [95% CI, 0.16-0.82]; p = 0.015 and OR 0.24 [95% CI, 0.10-0.58]; p = 0.001, respectively). The risk of preterm birth decreased with higher maternal age (OR 0.43 [95% CI, 0.19-0.95]; p = 0.037) and among those women who reported higher antenatal care (ANC) attendance (OR, 0.32 [95% CI, 0.15-0.70]; p = 0.005). Conclusion This study shows that P. vivax is the prevailing species among pregnant women with malaria in the region and shows that vivax clinical malaria may represent harmful consequences for the health of the mother and their offsprings particularly on specific groups such as adolescents, primigravidae and those women with lower ANC attendance.	[Botto-Menezes, Camila; Brock, Marianna] Univ Estado Amazonas, Programa Posgrad Med Trop, Manaus, Amazonas, Brazil; [Botto-Menezes, Camila; Silva dos Santos, Monica Caroline; Simplicio, Janiceia Lopes; de Medeiros, Jandira Menezes; Barroso Gomes, Kelly Cristina; de Carvalho Costa, Isabel Cristina; de Santana Filho, Franklin Simoes] Univ Fed Amazonas, Manaus, Amazonas, Brazil; [Batista-Silva, Eva; do Nascimento, Cristiana Teixeira; da Silva Chagas, Eda Cristina; Jardim Sardinha, Jose Felipe; de Santana Filho, Franklin Simoes; Martinez-Espinosa, Flor Ernestina] Fundacao Med Trop Dr Heitor Vieira Dourado FMT HV, Manaus, Amazonas, Brazil; [Bardaj, Azucena] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Martinez-Espinosa, Flor Ernestina] Ctr Pesquisas Leonidas & Maria Deane Fiocruz Amaz, Manaus, Amazonas, Brazil	Universidade do Estado do Amazonas; Universidade Federal de Amazonas; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Fundacao Oswaldo Cruz	Botto-Menezes, C (corresponding author), Univ Estado Amazonas, Programa Posgrad Med Trop, Manaus, Amazonas, Brazil.	camila.chabm@gmail.com	Bardají, Azucena/AAE-9145-2019; Alonso, Azucena Bardají/V-5978-2018	Alonso, Azucena Bardají/0000-0002-5135-0540	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM), Regional Scientific Development Program [DCR/2005]; European Union Seventh Framework Programme (FP7) [201588]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM), Regional Scientific Development Program; European Union Seventh Framework Programme (FP7)	The study was supported by the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) and by the Fundacao de Amparo a Pesquisa do Estado do Amazonas (FAPEAM), Regional Scientific Development Program (DCR/2005) conferred to FEME in 2005. AB received support from the European Union Seventh Framework Programme (FP7/2007-2013) under the grant agreement 201588.	Akanbi O M, 2009, East Afr J Public Health, V6, P63; [Anonymous], 2010, GUIA PRAT TRAT MAL B; [Anonymous], PORT SAUD; [Anonymous], DAT SIST INF NASC VI; [Anonymous], SIST INF VIG EP; [Anonymous], REP SIT MAL AM; [Anonymous], THESIS; [Anonymous], SIST INF NASC VIV SI; Brutus L, 2013, EMERG INFECT DIS, V19, P1605, DOI 10.3201/eid1910.130308; Clifton VL, 2010, PLACENTA, V31, pS33, DOI 10.1016/j.placenta.2009.11.010; Cottrell G, 2007, AM J TROP MED HYG, V76, P849, DOI 10.4269/ajtmh.2007.76.849; Costa Carolina Marinho da, 2009, Acta Amaz., V39, P901, DOI 10.1590/S0044-59672009000400018; Chagas ECD, 2009, REV PANAM SALUD PUBL, V26, P203, DOI 10.1590/S1020-49892009000900003; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Fernando SD, 2011, ASIAN PAC J TROP MED, V4, P330, DOI 10.1016/S1995-7645(11)60098-9; de Santana FS, 2007, EMERG INFECT DIS, V13, P1125, DOI 10.3201/eid1307.061386; Galappaththy GNL, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004389.pub3; Gama BE, 2011, MEM I OSWALDO CRUZ, V106, P159, DOI 10.1590/S0074-02762011000900020; Gomez E, 2009, INVEST CLIN, V50, P455; Karunaweera ND, 2003, TRENDS PARASITOL, V19, P188, DOI 10.1016/S1471-4922(03)00036-9; Kochar DK, 2005, EMERG INFECT DIS, V11, P132, DOI 10.3201/eid1101.040519; Lee ACC, 2013, LANCET GLOB HEALTH, V1, pE26, DOI 10.1016/S2214-109X(13)70006-8; McGready R, 2004, AM J TROP MED HYG, V70, P398, DOI 10.4269/ajtmh.2004.70.398; Nosten F, 1999, LANCET, V354, P546, DOI 10.1016/S0140-6736(98)09247-2; Okoko BJ, 2003, ACTA TROP, V87, P193, DOI 10.1016/S0001-706X(03)00097-4; Oliveira-Ferreira J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-115; Pedreira CE, 2011, AN ACAD BRAS CIENC, V83, P619, DOI 10.1590/S0001-37652011005000008; Poespoprodjo JR, 2008, CLIN INFECT DIS, V46, P1374, DOI 10.1086/586743; Price RN, 2007, AM J TROP MED HYG, V77, P79, DOI 10.4269/ajtmh.2007.77.79; Rodriguez-Morales AJ, 2006, AM J TROP MED HYG, V74, P755, DOI 10.4269/ajtmh.2006.74.755; Singh N, 1999, B WORLD HEALTH ORGAN, V77, P567; Steketee RW, 2001, AM J TROP MED HYG, V64, P28, DOI 10.4269/ajtmh.2001.64.28; Tobon-Castano A, 2011, REV SOC BRAS MED TRO, V44, P364, DOI 10.1590/S0037-86822011005000030; Umbers AJ, 2011, TRENDS PARASITOL, V27, P168, DOI 10.1016/j.pt.2011.01.007; Villegas L, 2007, TROP MED INT HEALTH, V12, P209, DOI [10.1111/j.1365-3165.2006.01778.x, 10.1111/j.1365-3156.2006.01778.x]; WHO, 2012, WORLD MALARIA REPORT 2012, P1	37	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144399	10.1371/journal.pone.0144399	http://dx.doi.org/10.1371/journal.pone.0144399			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675007	Green Published, gold, Green Submitted			2022-12-26	WOS:000366722700039
J	Kalani, R; Liotta, EM; Prabhakaran, S				Kalani, Rizwan; Liotta, Eric M.; Prabhakaran, Shyam			Diagnostic Yield of Universal Urine Toxicology Screening in an Unselected Cohort of Stroke Patients	PLOS ONE			English	Article							HEALTH-CARE PROFESSIONALS; ISCHEMIC-STROKE; ABUSE; COCAINE; VASOCONSTRICTION; HEMORRHAGE; CANNABIS	Background Illicit drug use increases the risk of cerebrovascular events by a variety of mechanisms. A recent report suggested that universal urine toxicology (UTox) screening of patients with stroke may be warranted. We aimed to evaluate the diagnostic yield of urine drug screening among unselected patients admitted with acute stroke or transient ischemic attack (TIA). Methods Using a single-center prospective study design, we evaluated consecutive patients with acute ischemic stroke, TIA, intracerebral hemorrhage (ICH), or subarachnoid hemorrhage (SAH) over one year. Urine samples were collected within 48 hours of admission and analyzed for common classes of abused drugs. Prevalence of positive UTox screening was determined. We evaluated whether baseline demographics and clinical factors were associated with UTox results. Results Of 483 eligible patients (acute ischemic stroke 66.4%; TIA 18.8%; ICH 7.7%; SAH 7.0%), 414 (85.7%) completed UTox screening. The mean (standard deviation) age was 65.1 (15.6) years, 52.7% were male, and 64.3% were Caucasian. Twenty-two (4.6%) patients had positive screening-cannabinoids were detected in 13 cases (3.1%), cocaine in 5 cases (1.2%), amphetamines in 1 case, and phencyclidine in 1 case. The highest yield (14.1%) was observed in patients < 60 years old with history of tobacco use while it was < 5% in the remaining subgroups (p<0.01). Conclusions Consistent with current guidelines, a selective approach to UTox screening should be pursued in acute stroke evaluation. The highest diagnostic yield is likely to be for cannabinoids and cocaine testing in younger patients with a history of concurrent tobacco use.	[Kalani, Rizwan] Univ Washington, Dept Neurol, Seattle, WA 98195 USA; [Liotta, Eric M.; Prabhakaran, Shyam] Northwestern Univ, Dept Neurol, Chicago, IL 60611 USA	University of Washington; University of Washington Seattle; Northwestern University	Kalani, R (corresponding author), Univ Washington, Dept Neurol, Seattle, WA 98195 USA.	rkalani517@gmail.com						Abuse S., 2013, NSDUH SER H, V46; ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Barber PA, 2013, STROKE, V44, P2327, DOI 10.1161/STROKEAHA.113.001562; BOYKO OB, 1987, J NEUROSURG, V67, P446, DOI 10.3171/jns.1987.67.3.0446; Brust JCM, 1997, NEUROL CLIN, V15, P945; Burke James F, 2014, Continuum (Minneap Minn), V20, P436, DOI 10.1212/01.CON.0000446112.05291.35; Degenhardt L, 2013, LANCET, V382, P1564, DOI 10.1016/S0140-6736(13)61530-5; Ducros A, 2007, BRAIN, V130, P3091, DOI 10.1093/brain/awm256; Gorodetzky CW, 1977, HDB EXPT PHARM, V45, P319; Ho EL, 2009, NEUROCRIT CARE, V10, P295, DOI 10.1007/s12028-008-9177-5; JACOBS IG, 1989, RADIOLOGY, V170, P223, DOI 10.1148/radiology.170.1.2909100; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; KAKU DA, 1990, ANN INTERN MED, V113, P821, DOI 10.7326/0003-4819-113-11-821; McGee SM, 2004, AM J FOREN MED PATH, V25, P334, DOI 10.1097/01.paf.0000137206.16785.2f; Petitti DB, 1998, EPIDEMIOLOGY, V9, P596, DOI 10.1097/00001648-199811000-00005; ROTHROCK JF, 1988, NEUROLOGY, V38, P589, DOI 10.1212/WNL.38.4.589; Sacco RL, 2013, STROKE, V44, P2064, DOI 10.1161/STR.0b013e318296aeca; Silver B, 2013, NEUROLOGY, V80, P1702, DOI 10.1212/WNL.0b013e318293e2fe; SLOAN MA, 1992, STROKE, V23, P427, DOI 10.1161/01.STR.23.3.427; Treadwell SD, 2007, POSTGRAD MED J, V83, P389, DOI 10.1136/pgmj.2006.055970; UNODC, WORLD DRUG REP 2013; WILSON JF, 1994, ANN CLIN BIOCHEM, V31, P335, DOI 10.1177/000456329403100405; Wolff V, 2011, STROKE, V42, P1778, DOI 10.1161/STROKEAHA.110.610915	23	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144772	10.1371/journal.pone.0144772	http://dx.doi.org/10.1371/journal.pone.0144772			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675665	gold, Green Published			2022-12-26	WOS:000366722700061
J	Lee, YT; de Vasconcellos, JF; Byrnes, C; Kaushal, M; Rabel, A; Tumburu, L; Allwardt, JM; Miller, JL				Lee, Y. Terry; de Vasconcellos, Jaira F.; Byrnes, Colleen; Kaushal, Megha; Rabel, Antoinette; Tumburu, Laxminath; Allwardt, Joshua M.; Miller, Jeffery L.			Erythroid-Specific Expression of LIN28A Is Sufficient for Robust Gamma-Globin Gene and Protein Expression in Adult Erythroblasts	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LIN-28; FETAL; DIFFERENTIATION; IDENTIFICATION; HEMOGLOBIN; EKLF/KLF1; PROMOTER; CELLS; AGE	Increasing fetal hemoglobin (HbF) levels in adult humans remains an active area in hematologic research. Here we explored erythroid-specific LIN28A expression for its effect in regulating gamma-globin gene expression and HbF levels in cultured adult erythroblasts. For this purpose, lentiviral transduction vectors were produced with LIN28A expression driven by erythroid-specific gene promoter regions of the human KLF1 or SPTA1 genes. Transgene expression of LIN28A with a linked puromycin resistance marker was restricted to the erythroid lineage as demonstrated by selective survival of erythroid colonies (greater than 95% of all colonies). Erythroblast LIN28A over-expression (LIN28A-OE) did not significantly affect proliferation or inhibit differentiation. Greater than 70% suppression of total let-7 microRNA levels was confirmed in LIN28A-OE cells. Increases in gamma-globin mRNA and protein expression with HbF levels reaching 30-40% were achieved. These data suggest that erythroblast targeting of LIN28A expression is sufficient for increasing fetal hemoglobin expression in adult human erythroblasts.	[Lee, Y. Terry; de Vasconcellos, Jaira F.; Byrnes, Colleen; Kaushal, Megha; Rabel, Antoinette; Tumburu, Laxminath; Allwardt, Joshua M.; Miller, Jeffery L.] NIDDK, Mol Genom & Therapeut Sect, Mol Med Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Miller, JL (corresponding author), NIDDK, Mol Genom & Therapeut Sect, Mol Med Branch, NIH, Bethesda, MD 20892 USA.	jm7f@nih.gov		Ferreira de Vasconcellos, Jaira/0000-0001-5011-4493	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK025101, ZIADK025100, ZIADK025098] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases supported this work.	BENNETT V, 1989, BIOCHIM BIOPHYS ACTA, V988, P107, DOI 10.1016/0304-4157(89)90006-3; Bhanu NV, 2005, BLOOD, V105, P387, DOI 10.1182/blood-2004-04-1599; Boulanger L, 2002, J BIOL CHEM, V277, P41563, DOI 10.1074/jbc.M208184200; Copley MR, 2013, NAT CELL BIOL, V15, P916, DOI 10.1038/ncb2783; Davoodian N, 2014, J PHYSIOL BIOCHEM, V70, P781, DOI 10.1007/s13105-014-0346-z; de Vasconcellos JF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106924; Goh SH, 2005, BLOOD, V106, P1466, DOI 10.1182/blood-2005-03-0948; Hanawa H, 2002, MOL THER, V5, P242, DOI 10.1006/mthe.2002.0549; He CY, 2009, NAT GENET, V41, P724, DOI 10.1038/ng.385; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Kropp J, 2015, BIOCHEM J, V466, P85, DOI 10.1042/BJ20141175; Lee YT, 2013, BLOOD, V122, P1034, DOI 10.1182/blood-2012-12-472308; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; MARCHESI V. T., 1968, SCIENCE, V159, P203, DOI 10.1126/science.159.3811.203; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Noh SJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-98; Ong KK, 2009, NAT GENET, V41, P729, DOI 10.1038/ng.382; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Siatecka M, 2011, BLOOD, V118, P2044, DOI 10.1182/blood-2011-03-331371; Sripichai O, 2009, BLOOD, V114, P2299, DOI 10.1182/blood-2009-05-219386; Stefani G, 2015, NOVEL MECH LIN 28 RE; Sulem P, 2009, NAT GENET, V41, P734, DOI 10.1038/ng.383; Tanno T, 2009, BLOOD, V114, P181, DOI 10.1182/blood-2008-12-195503; Tewari R, 1998, EMBO J, V17, P2334, DOI 10.1093/emboj/17.8.2334; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wilbert ML, 2012, MOL CELL, V48, P195, DOI 10.1016/j.molcel.2012.08.004; Wojda U, 2002, BLOOD, V99, P3005, DOI 10.1182/blood.V99.8.3005.h8003005_3005_3013; Wolgast LR, 2011, AM J CLIN PATHOL, V136, P300, DOI 10.1309/AJCPSA5RNM9IGFJF; Wolny Marcin, 2012, Postepy Biochem, V58, P245; Wong EY, 2004, J BIOL CHEM, V279, P55024, DOI 10.1074/jbc.M408886200; Yien YY, 2013, MOL CELL BIOL, V33, P4, DOI 10.1128/MCB.01058-12; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	36	8	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144977	10.1371/journal.pone.0144977	http://dx.doi.org/10.1371/journal.pone.0144977			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675483	Green Published, gold, Green Submitted			2022-12-26	WOS:000366722700079
J	Caz, V; Elvira, M; Tabernero, M; Grande, AG; Lopez-Plaza, B; de Miguel, E; Largo, C; Santamaria, M				Caz, Victor; Elvira, Marcos; Tabernero, Maria; Grande, Antonio G.; Lopez-Plaza, Bricia; de Miguel, Enrique; Largo, Carlota; Santamaria, Monica			Growth Hormone Protects the Intestine Preserving Radiotherapy Efficacy on Tumors: A Short-Term Study	PLOS ONE			English	Article							ADULT HYPOPITUITARY PATIENTS; HUMAN MAMMARY-CARCINOMA; IN-VITRO; GENE-EXPRESSION; PRIMARY CANCERS; TREFOIL FACTOR; NUDE-MICE; RADIATION; CELLS; RAT	The efficacy of radiotherapy on tumors is hampered by its devastating adverse effects on healthy tissue, particularly that of the gastrointestinal tract. These effects cause acute symptoms that are so disruptive to patients that they can lead to interruption of the radiotherapy program. These adverse effects could limit the intensity of radiation received by the patient, resulting in a sublethal dose to the tumor, thus increasing the risk of tumor resistance. The lack of an effective treatment to protect the bowel during radiation therapy to allow higher radiation doses that are lethal to the tumor has become a barrier to implementing effective therapy. In this study, we present a comparative analysis of both intestinal and tumor tissue in regard to the efficacy and the preventive impact of a short-term growth hormone (GH) treatment in tumor-bearing rats as a protective agent during radiotherapy. Our data show that the exogenous administration of GH improved intestinal recovery after radiation treatment while preserving the therapeutic effect against the tumor. GH significantly increased proliferation in the irradiated intestine but not in the irradiated tumors, as assessed by Positron Emission Tomography and the proliferative markers Ki67, cyclin D3, and Proliferating Cell Nuclear Antigen. This proliferative effect was consistent with a significant increase in irradiated intestinal villi and crypt length. Furthermore, GH significantly decreased caspase-3 activity in the intestine, whereas GH did not produce this effect in the irradiated tumors. In conclusion, short-term GH treatment protects the bowel, inducing proliferation while reducing apoptosis in healthy intestinal tissue and preserving radiotherapy efficacy on tumors.	[Caz, Victor; Elvira, Marcos; Tabernero, Maria; de Miguel, Enrique; Largo, Carlota; Santamaria, Monica] Hosp La Paz, Res Inst, Dept Expt Surg, Madrid, Spain; [Grande, Antonio G.] La Paz Univ Hosp, Dept Radiat Oncol, Madrid, Spain; [Lopez-Plaza, Bricia] Hosp La Paz, Res Inst, Dept Nutr, Madrid, Spain	Hospital Universitario La Paz; Hospital Universitario La Paz; Hospital Universitario La Paz	Largo, C (corresponding author), Hosp La Paz, Res Inst, Dept Expt Surg, Madrid, Spain.	carlota.largo@salud.madrid.org; monica.santamaria@idipaz.es	Doadrio, Ignacio/F-8448-2016	Doadrio, Ignacio/0000-0003-4863-9711; Largo, Carlota/0000-0003-3306-7925	Instituto de Salud Carlos III-Fondos Feder [FIS PI13/01990]; Instituto de Salud Carlos III, I3SNS [CES10/011]	Instituto de Salud Carlos III-Fondos Feder; Instituto de Salud Carlos III, I3SNS	This work was supported by Instituto de Salud Carlos III-Fondos Feder grant FIS PI13/01990 to MS. This work was also supported by a contract (CES10/011) from the Instituto de Salud Carlos III, I3SNS to MS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck PL, 2004, GASTROENTEROLOGY, V126, P796, DOI 10.1053/j.gastro.2003.12.004; Bennett WL, 2007, MOL CELL ENDOCRINOL, V274, P53, DOI 10.1016/j.mce.2007.05.020; Booth D, 2001, J Natl Cancer Inst Monogr, P16; Carel JC, 2012, J CLIN ENDOCR METAB, V97, P416, DOI 10.1210/jc.2011-1995; Carlo-Stella C, 2004, EXP HEMATOL, V32, P171, DOI 10.1016/j.exphem.2003.11.007; Chen BJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011056; Chen JY, 2004, WORLD J GASTROENTERO, V10, P1132; Child CJ, 2015, EUR J ENDOCRINOL, V172, P779, DOI 10.1530/EJE-14-1123; Child CJ, 2011, EUR J ENDOCRINOL, V165, P217, DOI 10.1530/EJE-11-0286; Clavijo J, 2004, EUR J GASTROEN HEPAT, V16, P75, DOI 10.1097/00042737-200401000-00012; Costoya Jose A., 2000, Molecular Cell Biology Research Communications, V4, P26, DOI 10.1006/mcbr.2000.0252; Liang DM, 2006, WORLD J GASTROENTERO, V12, P3810, DOI 10.3748/wjg.v12.i24.3810; de Segura IAG, 2004, EUR J GASTROEN HEPAT, V16, P479, DOI [10.1097/00042737-200405000-00008, 10.1097/01.meg.0000108302.52416.c4]; Denham JW, 2013, LANCET, V382, P2046, DOI 10.1016/S0140-6736(13)61946-7; DeSegura IAG, 1996, J SURG RES, V62, P5, DOI 10.1006/jsre.1996.0164; Devesa J, 2010, MED CLIN-BARCELONA, V135, P665, DOI 10.1016/j.medcli.2009.10.017; Devin JK, 2008, GROWTH HORM IGF RES, V18, P253, DOI 10.1016/j.ghir.2007.11.001; FDA Drug Safety Communication, 2011, ONG SAF REV REC HUM; Fiebig HH, 2000, ANTI-CANCER DRUG, V11, P659, DOI 10.1097/00001813-200009000-00011; Glynn N, 2012, INT J ENDOCRINOL, V2012, DOI 10.1155/2012/972617; de Segura IAG, 2010, EXP BIOL MED, V235, P463, DOI 10.1258/ebm.2009.009247; Gomez-De-Segura IA, 1998, ACTA ONCOL, V37, P179, DOI 10.1080/028418698429748; Gonzalez-Rodriguez A, 2007, J CELL PHYSIOL, V212, P76, DOI 10.1002/jcp.21004; Harb Ali H, 2014, Curr Gastroenterol Rep, V16, P383, DOI 10.1007/s11894-014-0383-3; Ibrahim YH, 2004, GROWTH HORM IGF RES, V14, P261, DOI 10.1016/j.ghir.2004.01.005; ICHIYA Y, 1991, J NUCL MED, V32, P1655; Jeay S, 2002, MOL CELL ENDOCRINOL, V188, P1, DOI 10.1016/S0303-7207(02)00014-X; Jiang J, 2011, ENDOCRINOLOGY, V152, P4777, DOI 10.1210/en.2011-1336; Kawaguchi M, 2015, CANCER SCI, V106, P1130, DOI 10.1111/cas.12725; Lee CL, 2013, TRANSL CANCER RES, V2, P412, DOI 10.3978/j.issn.2218-676X.2013.09.01; Liang D, 2014, CHIN MED, V5, P259; Liang H, 2007, WORLD J GASTROENTERO, V13, P4365, DOI 10.3748/wjg.v13.i32.4365; LOBIE PE, 1990, ENDOCRINOLOGY, V126, P299, DOI 10.1210/endo-126-1-299; Louis E, 2007, J NUCL MED, V48, P1053, DOI 10.2967/jnumed.107.040436; Morante J, 2003, DIGEST DIS SCI, V48, P2159, DOI 10.1023/B:DDAS.0000004520.71462.c9; Ning SC, 1998, INT J RADIAT ONCOL, V40, P177, DOI 10.1016/S0360-3016(97)00561-0; Ortega M, 2001, ACTA ONCOL, V40, P615, DOI 10.1080/028418601750444169; Perry JK, 2006, GROWTH HORM IGF RES, V16, P277, DOI 10.1016/j.ghir.2006.09.006; Posadas SJ, 2011, EXP BIOL MED, V236, P205, DOI 10.1258/ebm.2010.009358; POTTEN CS, 1995, GUT, V36, P864, DOI 10.1136/gut.36.6.864; POTTEN CS, 1990, INT J RADIAT BIOL, V58, P925, DOI 10.1080/09553009014552281; POTTEN CS, 1990, INT J RADIAT BIOL, V57, P185, DOI 10.1080/09553009014550431; Potten CS, 1997, COMP BIOCHEM PHYS B, V118, P473, DOI 10.1016/S0305-0491(97)00219-8; Raguso CA, 2002, CLIN NUTR, V21, P487, DOI 10.1054/clnu.2002.0579; Riccardi C, 2006, NAT PROTOC, V1, P1458, DOI 10.1038/nprot.2006.238; Santamaria M, 2013, GASTROENTEROLOGY, V144, P818, DOI 10.1053/j.gastro.2012.12.029; Shadad AK, 2013, WORLD J GASTROENTERO, V19, P199, DOI 10.3748/wjg.v19.i2.199; Shen L, 2015, NEUROL SCI, V36, P1859, DOI 10.1007/s10072-015-2269-z; Sklar CA, 2002, J CLIN ENDOCR METAB, V87, P3136, DOI 10.1210/jc.87.7.3136; Stacey R, 2014, THER ADV CHRONIC DIS, V5, P15, DOI 10.1177/2040622313510730; Tekin SB, 2006, J EUR ACAD DERMATOL, V20, P293, DOI 10.1111/j.1468-3083.2006.01454.x; TOROSIAN MH, 1993, J PEDIATR ENDOCRINOL, V6, P93; Trobec K, 2011, J CACHEXIA SARCOPENI, V2, P191, DOI 10.1007/s13539-011-0043-5; Vazquez I, 1999, DIGEST DIS SCI, V44, P2350, DOI 10.1023/A:1026637611298; Wang ZM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118213; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015; Wilton P, 2010, J PEDIATR-US, V157, P265, DOI 10.1016/j.jpeds.2010.02.028; WOLF RF, 1994, ANN SURG ONCOL, V1, P314, DOI 10.1007/BF02303570; Xu XQ, 2005, J BIOL CHEM, V280, P23987, DOI 10.1074/jbc.M503869200; Yu J, 2013, TRANSL CANCER RES, V2, P384, DOI 10.3978/j.issn.2218-676X.2013.07.03; Zhu T, 2005, CANCER RES, V65, P317; Zhu Z, 2005, ONCOGENE, V24, P3774, DOI 10.1038/sj.onc.1208541	62	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144537	10.1371/journal.pone.0144537	http://dx.doi.org/10.1371/journal.pone.0144537			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670463	gold, Green Published, Green Submitted			2022-12-26	WOS:000366719300011
J	Kolyadko, VN; Lushchekina, SV; Vuimo, TA; Surov, SS; Ovsepyan, RA; Korneeva, VA; Vorobiev, II; Orlova, NA; Minakhin, L; Kuznedelov, K; Severinov, KV; Ataullakhanov, FI; Panteleev, MA				Kolyadko, Vladimir N.; Lushchekina, Sofya V.; Vuimo, Tatiana A.; Surov, Stepan S.; Ovsepyan, Ruzanna A.; Korneeva, Vera A.; Vorobiev, Ivan I.; Orlova, Nadezhda A.; Minakhin, Leonid; Kuznedelov, Konstantin; Severinov, Konstantin V.; Ataullakhanov, Fazoil I.; Panteleev, Mikhail A.			New Infestin-4 Mutants with Increased Selectivity against Factor XIIa	PLOS ONE			English	Article							SERINE PROTEINASE-INHIBITORS; COAGULATION-FACTOR-XII; THROMBIN GENERATION; TRYPSIN-INHIBITOR; IN-VITRO; MOLECULAR-DYNAMICS; BLOOD-COAGULATION; ACTIVE-SITE; WEB SERVER; CORN	Factor XIIa (fXIIa) is a serine protease that triggers the coagulation contact pathway and plays a role in thrombosis. Because it interferes with coagulation testing, the need to inhibit fXIIa exists in many cases. Infestin-4 (Inf4) is a Kazal-type inhibitor of fXIIa. Its specificity for fXIIa can be enhanced by point mutations in the protease-binding loop. We attempted to adapt Inf4 for the selective repression of the contact pathway under various in vitro conditions, e.g., during blood collection and in 'global' assays of tissue factor (TF)-dependent coagulation. First, we designed a set of new Inf4 mutants that, in contrast to wt-Inf4, had stabilized canonical conformations during molecular dynamics simulation. Off-target activities against factor Xa (fXa), plasmin, and other coagulation proteases were either reduced or eliminated in these recombinant mutants, as demonstrated by chromogenic assays. Interactions with fXIIa and fXa were also analyzed using protein-protein docking. Next, Mutant B, one of the most potent mutants (its Ki for fXIIa is 0.7 nM) was tested in plasma. At concentrations 5-20 mu M, this mutant delayed the contact-activated generation of thrombin, as well as clotting in thromboelastography and thrombodynamics assays. In these assays, Mutant B did not affect coagulation initiated by TF, thus demonstrating sufficient selectivity and its potential practical significance as a reagent for coagulation diagnostics.	[Kolyadko, Vladimir N.; Surov, Stepan S.; Korneeva, Vera A.; Ataullakhanov, Fazoil I.; Panteleev, Mikhail A.] Russian Acad Sci, Ctr Theoret Problems Physicochem Pharmacol, Moscow, Russia; [Lushchekina, Sofya V.] Russian Acad Sci, Emanuel Inst Biochem Phys, Moscow, Russia; [Vuimo, Tatiana A.; Ovsepyan, Ruzanna A.; Ataullakhanov, Fazoil I.; Panteleev, Mikhail A.] Minist Hlth, Fed Res & Clin Ctr Pediat Hematol Oncol & Immunol, Moscow, Russia; [Vorobiev, Ivan I.; Orlova, Nadezhda A.] Russian Acad Sci, Ctr Bioengn, Moscow, Russia; [Minakhin, Leonid; Kuznedelov, Konstantin; Severinov, Konstantin V.] Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ USA; [Ataullakhanov, Fazoil I.; Panteleev, Mikhail A.] Moscow MV Lomonosov State Univ, Dept Phys, Moscow, Russia; [Ataullakhanov, Fazoil I.; Panteleev, Mikhail A.] Moscow Inst Phys & Technol, Fac Biol & Med Phys, Dolgoprudnyi, Russia; [Ataullakhanov, Fazoil I.; Panteleev, Mikhail A.] HemaCore LLC, Moscow, Russia	Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences; Russian Academy of Sciences; Russian Academy of Sciences; Emanuel Institute of Biochemical Physics; Dmitry Rogachev National Medical Research Center Of Pediatric Hematology, Oncology & Immunology; Ministry of Health of the Russian Federation; Research Center of Biotechnology RAS; Russian Academy of Sciences; Rutgers State University New Brunswick; Lomonosov Moscow State University; Moscow Institute of Physics & Technology	Panteleev, MA (corresponding author), Russian Acad Sci, Ctr Theoret Problems Physicochem Pharmacol, Moscow, Russia.	mapanteleev@yandex.ru	Severinov, Konstantin/C-8545-2016; Orlova, Nadezhda/AAE-8279-2020; Panteleev, Mikhail A/H-5491-2012; Lushchekina, Sofya/F-8469-2010; Ataullakhanov, Fazoil/J-8076-2012; Ataullakhanov, Fazoil/O-3458-2019; Vorobiev, Ivan/ABF-6809-2021; Zhivotova, Vera/E-4766-2014	Orlova, Nadezhda/0000-0001-9483-2892; Panteleev, Mikhail A/0000-0002-8128-7757; Lushchekina, Sofya/0000-0002-6922-020X; Vorobiev, Ivan/0000-0003-0064-4458; Zhivotova, Vera/0000-0003-2937-1190; Kolyadko, Vladimir/0000-0003-4008-2461	Russian Science Foundation [14-14-00195]; Dynasty Foundation Fellowship; HemaCore LLC	Russian Science Foundation(Russian Science Foundation (RSF)); Dynasty Foundation Fellowship; HemaCore LLC	The project was supported by Russian Science Foundation grant 14-14-00195 to MAP, with the exception of all molecular dynamics and docking studies that were supported by Dynasty Foundation Fellowship to SVL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. HemaCore LLC provided support in the form of salaries for authors VNK, TAV, SSS, RAO, VAK, FIA, MAP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Apostoluk W, 1998, PROTEINS, V32, P459, DOI 10.1002/(SICI)1097-0134(19980901)32:4<459::AID-PROT5>3.0.CO;2-B; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Campos ITN, 2012, ACTA CRYSTALLOGR D, V68, P695, DOI 10.1107/S0907444912009067; Campos ITN, 2004, FEBS LETT, V577, P512, DOI 10.1016/j.febslet.2004.10.052; Campos ITN, 2002, INSECT BIOCHEM MOLEC, V32, P991, DOI 10.1016/S0965-1748(02)00035-8; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Colman RW, 1997, BLOOD, V90, P3819, DOI 10.1182/blood.V90.10.3819; Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371; Dashkevich NM, 2012, BIOPHYS J, V103, P2233, DOI 10.1016/j.bpj.2012.10.011; Fadeeva OA, 2010, BIOCHEMISTRY-MOSCOW+, V75, P734, DOI 10.1134/S0006297910060088; Grzesiak A, 2000, BBA-PROTEIN STRUCT M, V1478, P318, DOI 10.1016/S0167-4838(00)00034-0; Hagedorn I, 2010, CIRCULATION, V121, P1510, DOI 10.1161/CIRCULATIONAHA.109.924761; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOJIMA Y, 1980, THROMB RES, V20, P149, DOI 10.1016/0049-3848(80)90381-3; Holmes MB, 2000, CIRCULATION, V102, P2051, DOI 10.1161/01.CIR.102.17.2051; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jimenez-Garcia B, 2013, BIOINFORMATICS, V29, P1698, DOI 10.1093/bioinformatics/btt262; Kolyadko VN, 2014, BIOCHEM MOSC SUPPL S, V8, P279, DOI 10.1134/S1990747814040059; Korneeva VA, 2014, J BIOL CHEM, V289, P14109, DOI 10.1074/jbc.M114.553735; Leung PY, 2012, TRANSL STROKE RES, V3, P381, DOI 10.1007/s12975-012-0186-5; Lipets E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087692; London N, 2011, NUCLEIC ACIDS RES, V39, pW249, DOI 10.1093/nar/gkr431; Luddington R, 2004, J THROMB HAEMOST, V2, P1954, DOI 10.1111/j.1538-7836.2004.00964.x; Panteleev MA, 2015, THROMB J, V13, DOI 10.1186/s12959-014-0032-y; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; Renne T, 2005, J EXP MED, V202, P271, DOI 10.1084/jem.20050664; Renne T, 2012, BLOOD, V120, P4296, DOI 10.1182/blood-2012-07-292094; Rimphanitchayakit V, 2010, DEV COMP IMMUNOL, V34, P377, DOI 10.1016/j.dci.2009.12.004; Sadovnichy V., 2013, LOMONOSOV SUPERCOMPU, P283; Salonen LM, 2009, ANGEW CHEM INT EDIT, V48, P811, DOI 10.1002/anie.200804695; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schmaier AH, 2008, J CLIN INVEST, V118, P3006, DOI 10.1172/JCI36617; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Schousboe I, 2008, BIOCHEM PHARMACOL, V75, P1007, DOI 10.1016/j.bcp.2007.10.003; Schrodinger LLC., 2014, PYMOL MOL GRAPHICS S; Soshitova NP, 2012, BLOOD COAGUL FIBRIN, V23, P498, DOI 10.1097/MBC.0b013e328352e90e; Spronk HMH, 2009, THROMB HAEMOSTASIS, V101, P1156, DOI 10.1160/TH08-10-0670; Sugase K, 2008, PROTEIN EXPRES PURIF, V57, P108, DOI 10.1016/j.pep.2007.10.018; Tarandovskiy ID, 2013, THROMB RES, V131, pE274, DOI 10.1016/j.thromres.2013.04.004; Thaimattam R, 2002, ACTA CRYSTALLOGR D, V58, P1448, DOI 10.1107/S0907444902011769; WIECZOREK M, 1985, BIOCHEM BIOPH RES CO, V126, P646, DOI 10.1016/0006-291X(85)90233-5; Wu Y, 2007, P NATL ACAD SCI USA, V104, P19784, DOI 10.1073/pnas.0708251104; Xu YM, 2014, THROMB HAEMOSTASIS, V111, P694, DOI 10.1160/TH13-08-0668; Yau JW, 2012, ACTA BIOMATER, V8, P4092, DOI 10.1016/j.actbio.2012.07.019	45	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144940	10.1371/journal.pone.0144940	http://dx.doi.org/10.1371/journal.pone.0144940			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670620	Green Submitted, gold, Green Published			2022-12-26	WOS:000366719300032
J	You, XP; Zou, QL; Li, JL; Zhou, JY				You, Xiao-Ping; Zou, Qi-Lei; Li, Jian-Long; Zhou, Ji-Yuan			Likelihood Ratio Test for Excess Homozygosity at Marker Loci on X Chromosome	PLOS ONE			English	Article							ASSOCIATION ANALYSIS; MAXIMUM-LIKELIHOOD; FREQUENCIES; PARENT	The assumption of Hardy-Weinberg equilibrium (HWE) is generally required for association analysis using case-control design on autosomes; otherwise, the size may be inflated. There has been an increasing interest of exploring the association between diseases and markers on X chromosome and the effect of the departure from HWE on association analysis on X chromosome. Note that there are two hypotheses of interest regarding the X chromosome: (i) the frequencies of the same allele at a locus in males and females are equal and (ii) the inbreeding coefficient in females is zero (without excess homozygosity). Thus, excess homozygosity and significantly different minor allele frequencies between males and females are used to filter X-linked variants. There are two existing methods to test for (i) and (ii), respectively. However, their size and powers have not been studied yet. Further, there is no existing method to simultaneously detect both hypotheses till now. Therefore, in this article, we propose a novel likelihood ratio test for both (i) and (ii) on X chromosome. To further investigate the underlying reason why the null hypothesis is statistically rejected, we also develop two likelihood ratio tests for detecting (i) and (ii), respectively. Moreover, we explore the effect of population stratification on the proposed tests. From our simulation study, the size of the test for (i) is close to the nominal significance level. However, the size of the excess homozygosity test and the test for both (i) and (ii) is conservative. So, we propose parametric bootstrap techniques to evaluate their validity and performance. Simulation results show that the proposed methods with bootstrap techniques control the size well under the respective null hypothesis. Power comparison demonstrates that the methods with bootstrap techniques are more powerful than those without bootstrap procedure and the existing methods. The application of the proposed methods to a rheumatoid arthritis dataset indicates their utility.	[Zhou, Ji-Yuan] Southern Med Univ, Sch Publ Hlth & Trop Med, State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China; Southern Med Univ, Sch Publ Hlth & Trop Med, Guangdong Prov Key Lab Trop Res, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Zhou, JY (corresponding author), Southern Med Univ, Sch Publ Hlth & Trop Med, State Key Lab Organ Failure Res, Guangzhou, Guangdong, Peoples R China.	zhoujiyuan5460@hotmail.com	Zhou, Ji-Yuan/AAI-4623-2020	Zhou, Ji-Yuan/0000-0003-0866-4402	National Natural Science Foundation of China [81373098]; Science and Technology Planning Project of Guangdong Province, China [2013B021800038]; National Institutes of Health [R01 GM031575, NO1-AR-2-2263, RO1-AR-44422]; National Arthritis Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [N01AR022263, R01AR044422] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031575] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Planning Project of Guangdong Province, China; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Arthritis Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Natural Science Foundation of China (81373098), Science and Technology Planning Project of Guangdong Province, China (2013B021800038) to Professor Ji-Yuan Zhou. The Genetic Analysis Workshops are supported by the National Institutes of Health grant R01 GM031575. The RA data were gathered with the support of grants from the National Institutes of Health (NO1-AR-2-2263 and RO1-AR-44422), and the National Arthritis Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos-Landgraf JM, 2006, AM J HUM GENET, V79, P493, DOI 10.1086/507565; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; Chang D, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0113684, 10.1371/journal.pone.0113596]; Chen ZX, 2017, STAT METHODS MED RES, V26, P567, DOI 10.1177/0962280214551815; Chung RH, 2007, AM J HUM GENET, V80, P59, DOI 10.1086/510630; Clayton D, 2008, BIOSTATISTICS, V9, P593, DOI 10.1093/biostatistics/kxn007; Clayton DG, 2009, GENOME MED, V1, DOI 10.1186/gm110; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Ding J, 2006, AM J HUM GENET, V79, P567, DOI 10.1086/507609; EMIGH TH, 1980, BIOMETRICS, V36, P627, DOI 10.2307/2556115; Gartler SM, 2014, J GENET, V93, P591, DOI 10.1007/s12041-014-0360-5; Gillespie J., 2010, BIOMETRICS, DOI DOI 10.2307/2533705; Hickey PF, 2011, GENET EPIDEMIOL, V35, P664, DOI 10.1002/gepi.20616; Horvath S, 2000, AM J HUM GENET, V66, P1161, DOI 10.1086/302823; Horvath S, 2001, EUR J HUM GENET, V9, P301, DOI 10.1038/sj.ejhg.5200625; Konig IR, 2014, GENET EPIDEMIOL, V38, P97, DOI 10.1002/gepi.21782; Kuk AYC, 2009, BIOINFORMATICS, V25, P379, DOI 10.1093/bioinformatics/btn623; Lenart BA, 2009, OSTEOPOROSIS INT, V20, P1353, DOI 10.1007/s00198-008-0805-x; Li CC, 1976, 1 COURS POP GEN; Mao WG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077399; Nei M., 1987, MOL EVOLUTIONARY GEN; Overall ADJ, 2001, MOL BIOL EVOL, V18, P2048, DOI 10.1093/oxfordjournals.molbev.a003746; Reich DE, 2001, GENET EPIDEMIOL, V20, P4, DOI 10.1002/1098-2272(200101)20:1<4::AID-GEPI2>3.0.CO;2-T; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schaid DJ, 1999, AM J EPIDEMIOL, V149, P706; SELF SG, 1987, J AM STAT ASSOC, V82, P605, DOI 10.2307/2289471; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wang M, 2014, BIOINFORMATICS, V30, P2611, DOI 10.1093/bioinformatics/btu347; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weir BS, 1989, COMPLETE CHARACTERIZ; Wright S, 1921, GENETICS, V6, P111; Yang Z. H., 2005, STAT METHODS MOL EVO; Zhang DW, 2003, BIOSTATISTICS, V4, P57, DOI 10.1093/biostatistics/4.1.57; Zhang H, 2014, BIOINFORMATICS, V30, P2171, DOI 10.1093/bioinformatics/btu186; Zhang L, 2008, GENET EPIDEMIOL, V32, P370, DOI 10.1002/gepi.20311; Zheng G, 2007, GENET EPIDEMIOL, V31, P834, DOI 10.1002/gepi.20244	36	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145032	10.1371/journal.pone.0145032	http://dx.doi.org/10.1371/journal.pone.0145032			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671781	Green Submitted, Green Published, gold			2022-12-26	WOS:000366719300041
J	Bowles, KR; Brooks, SP; Dunnett, SB; Jones, L				Bowles, Kathryn R.; Brooks, Simon P.; Dunnett, Stephen B.; Jones, Lesley			Huntingtin Subcellular Localisation Is Regulated by Kinase Signalling Activity in the StHdh(Q111) Model of HD	PLOS ONE			English	Article							CREB-BINDING PROTEIN; MUTANT HUNTINGTIN; EGF RECEPTOR; POLYGLUTAMINE PROTEINS; NUCLEAR-LOCALIZATION; STRIATAL NEURONS; DISEASE PROTEIN; EXPRESSION; PHOSPHORYLATION; CELLS	Huntington's disease is a neurodegenerative disorder characterised primarily by motor abnormalities, and is caused by an expanded polyglutamine repeat in the huntingtin protein. Huntingtin dynamically shuttles between subcellular compartments, and the mutant huntingtin protein is mislocalised to cell nuclei, where it may interfere with nuclear functions, such as transcription. However, the mechanism by which mislocalisation of mutant huntingtin occurs is currently unknown. An immortalised embryonic striatal cell model of HD (StHdh(Q111)) was stimulated with epidermal growth factor in order to determine whether the subcellular localisation of huntingtin is dependent on kinase signalling pathway activation. Aberrant phosphorylation of AKT and MEK signalling pathways was identified in cells carrying mutant huntingtin. Activity within these pathways was found to contribute to the regulation of huntingtin and mutant huntingtin localisation, as well as to the expression of immediate-early genes. We propose that altered kinase signalling is a phenotype of Huntington's disease that occurs prior to cell death; specifically, that altered kinase signalling may influence huntingtin localisation, which in turn may impact upon nuclear processes such as transcriptional regulation. Aiming to restore the balance of activity between kinase signalling networks may therefore prove to be an effective approach to delaying Huntington's disease symptom development and progression.	[Bowles, Kathryn R.; Jones, Lesley] Cardiff Univ, Inst Psychol Med & Clin Neurosci, MRC Ctr Neuropsychiat Genet & Genom, Sch Med, Cardiff CF24 4HQ, S Glam, Wales; [Brooks, Simon P.; Dunnett, Stephen B.] Cardiff Univ, Sch Biosci, Brain Repair Grp, Cardiff CF10 3AX, S Glam, Wales	Cardiff University; Cardiff University	Bowles, KR (corresponding author), Mt Sinai Sch Med, Friedman Brain Inst, Ronald M Loeb Ctr Alzheimers Dis, 1425 Madison Ave,Icahn 10-52, New York, NY 10029 USA.	Kathryn.bowles@mssm.edu	Dunnett, Stephen B/A-5869-2010	Dunnett, Stephen B/0000-0003-1826-1578; Brooks, Simon/0000-0001-9853-6177	Wellcome Trust [089640/Z/09/Z]; CHDI; Medical Research Council [MR/L010305/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); CHDI; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This project was funded by a Wellcome Trust Scholarship awarded to KRB, grant number 089640/Z/09/Z (www.wellcome.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Professor Marcy MacDonald for the kind gift of the StHdh<SUP>Q111</SUP> cells lines, and Dr. Sandrine Humbert for the generous gift of the S421 antibody. We also thank Yateen Patel for maintaining the Hdh<SUP>Q111</SUP> mouse colony and co-ordinating the staged pregnancies. KRB was supported by a Wellcome Trust studentship. The breeding colony is supported by CHDI.	Aiken CT, 2009, J BIOL CHEM, V284, P29427, DOI 10.1074/jbc.M109.013193; Apostol BL, 2006, HUM MOL GENET, V15, P273, DOI 10.1093/hmg/ddi443; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Atwal RS, 2011, NAT CHEM BIOL, V7, P453, DOI [10.1038/NCHEMBIO.582, 10.1038/nchembio.582]; Aylward EH, 2004, NEUROLOGY, V63, P66, DOI 10.1212/01.WNL.0000132965.14653.D1; Bae BI, 2005, NEURON, V47, P29, DOI 10.1016/j.neuron.2005.06.005; Bauer PO, 2009, J NEUROCHEM, V110, P1737, DOI 10.1111/j.1471-4159.2009.06302.x; Benn CL, 2008, J NEUROSCI, V28, P10720, DOI 10.1523/JNEUROSCI.2126-08.2008; Boutell JM, 1999, HUM MOL GENET, V8, P1647, DOI 10.1093/hmg/8.9.1647; Bowles KR, 2014, J HUNTINGTONS DIS, V3, P89, DOI 10.3233/JHD-140106; Brognard J, 2011, CURR OPIN GENET DEV, V21, P4, DOI 10.1016/j.gde.2010.10.012; Buckley NJ, 2010, NEUROBIOL DIS, V39, P28, DOI 10.1016/j.nbd.2010.02.003; Cabodi S, 2009, J CELL PHYSIOL, V218, P294, DOI 10.1002/jcp.21603; Carnemolla A, 2009, J BIOL CHEM, V284, P18167, DOI 10.1074/jbc.M109.018325; Carri AD, 2013, DEVELOPMENT, V140, P301, DOI 10.1242/dev.084608; Chong ZZ, 2005, HISTOL HISTOPATHOL, V20, P299, DOI 10.14670/HH-20.299; Ciarmiello A, 2006, J NUCL MED, V47, P215; Crook ZR, 2011, NEURON, V69, P423, DOI 10.1016/j.neuron.2010.12.035; del Toro D, 2009, MOL BIOL CELL, V20, P1478, DOI 10.1091/mbc.E08-07-0726; Desmond Carly R, 2013, Commun Integr Biol, V6, pe23318, DOI 10.4161/cib.23318; Desmond CR, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412379; Dorsman JC, 1999, PHILOS T R SOC B, V354, P1061, DOI 10.1098/rstb.1999.0459; Dunah AW, 2002, SCIENCE, V296, P2238, DOI 10.1126/science.1072613; Dunnett SB, 2000, NEUROMETH, V36, P3, DOI 10.1007/978-1-59259-690-4_1; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; Ferrigno P, 2000, NEURON, V26, P9, DOI 10.1016/S0896-6273(00)81132-0; Fossale E, 2002, HUM MOL GENET, V11, P2233, DOI 10.1093/hmg/11.19.2233; Gines S, 2003, J BIOL CHEM, V278, P50514, DOI 10.1074/jbc.M309348200; Gines S, 2010, J BIOL CHEM, V285, P21537, DOI 10.1074/jbc.M109.084202; GRAFTON ST, 1992, ARCH NEUROL-CHICAGO, V49, P1161, DOI 10.1001/archneur.1992.00530350075022; Gu XF, 2009, NEURON, V64, P828, DOI 10.1016/j.neuron.2009.11.020; Havel LS, 2011, HUM MOL GENET, V20, P1424, DOI 10.1093/hmg/ddr023; Hilditch-Maguire P, 2000, HUM MOL GENET, V9, P2789, DOI 10.1093/hmg/9.19.2789; HOOGEVEEN AT, 1993, HUM MOL GENET, V2, P2069, DOI 10.1093/hmg/2.12.2069; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Humbert S, 2003, CLIN NEUROSCI RES, V3, P149, DOI 10.1016/S1566-2772(03)00057-4; Iijima-Andot K, 2005, P NATL ACAD SCI USA, V102, P10261, DOI 10.1073/pnas.0503937102; Johnson R, 2008, NEUROBIOL DIS, V29, P438, DOI 10.1016/j.nbd.2007.11.001; Kegel KB, 2002, J BIOL CHEM, V277, P7466, DOI 10.1074/jbc.M103946200; Kim YJ, 2006, NEUROBIOL DIS, V22, P346, DOI 10.1016/j.nbd.2005.11.012; Kong PJ, 2009, NEUROL RES, V31, P77, DOI 10.1179/174313208X331572; KUWERT T, 1990, BRAIN, V113, P1405, DOI 10.1093/brain/113.5.1405; Lee JM, 2007, PLOS GENET, V3, P1397, DOI 10.1371/journal.pgen.0030135; Leng Y, 2004, DIABETES, V53, P1436, DOI 10.2337/diabetes.53.6.1436; Levine MS, 2004, TRENDS NEUROSCI, V27, P691, DOI 10.1016/j.tins.2004.08.008; Li SH, 2002, MOL CELL BIOL, V22, P1277, DOI 10.1128/MCB.22.5.1277-1287.2002; LI XJ, 1995, NATURE, V378, P398, DOI 10.1038/378398a0; Lievens JC, 2005, HUM MOL GENET, V14, P713, DOI 10.1093/hmg/ddi067; Lievens JC, 2008, HUM MOL GENET, V17, P882, DOI 10.1093/hmg/ddm360; Lin SY, 2001, NAT CELL BIOL, V3, P802, DOI 10.1038/ncb0901-802; Liu YF, 1997, J BIOL CHEM, V272, P8121, DOI 10.1074/jbc.272.13.8121; Maiuri T, 2013, HUM MOL GENET, V22, P1383, DOI 10.1093/hmg/dds554; McCampbell A, 2000, HUM MOL GENET, V9, P2197, DOI 10.1093/hmg/9.14.2197; Melone MAB, 2013, BBA-MOL BASIS DIS, V1832, P105, DOI 10.1016/j.bbadis.2012.09.001; Novak MJU, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c3109; Owada Y, 1997, J MOL NEUROSCI, V9, P27, DOI 10.1007/BF02789392; Pal A, 2006, J CELL BIOL, V172, P605, DOI 10.1083/jcb.200509091; Pennuto M, 2009, HUM MOL GENET, V18, pR40, DOI 10.1093/hmg/ddn412; Pineda JR, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-33; Rangone H, 2004, EUR J NEUROSCI, V19, P273, DOI 10.1111/j.0953-816X.2003.03131.x; Reddy PH, 1999, TRENDS NEUROSCI, V22, P248, DOI 10.1016/S0166-2236(99)01415-0; Ritch JJ, 2012, MOL CELL NEUROSCI, V50, P70, DOI 10.1016/j.mcn.2012.03.011; Ro YT, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-18; Rockabrand E, 2007, HUM MOL GENET, V16, P61, DOI 10.1093/hmg/ddl440; Rosas HD, 2008, BRAIN, V131, P1057, DOI 10.1093/brain/awn025; Saavedra A, 2010, CELL DEATH DIFFER, V17, P324, DOI 10.1038/cdd.2009.127; Saavedra A, 2011, J NEUROSCI, V31, P8150, DOI 10.1523/JNEUROSCI.3446-10.2011; Sawa A, 2005, NEUROBIOL DIS, V20, P267, DOI 10.1016/j.nbd.2005.02.013; Schilling B, 2006, J BIOL CHEM, V281, P23686, DOI 10.1074/jbc.M513507200; Seong IS, 2010, HUM MOL GENET, V19, P573, DOI 10.1093/hmg/ddp524; Shimohata T, 2000, NAT GENET, V26, P29, DOI 10.1038/79139; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Song C, 2002, J BIOL CHEM, V277, P6703, DOI 10.1074/jbc.M110338200; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Steffan JS, 2004, SCIENCE, V304, P100, DOI 10.1126/science.1092194; Sun J, 2007, J NEUROSCI RES, V85, P2306, DOI 10.1002/jnr.21369; Tao T, 2001, TRAFFIC, V2, P385, DOI 10.1034/j.1600-0854.2001.002006385.x; Taylor DM, 2013, J NEUROSCI, V33, P2313, DOI 10.1523/JNEUROSCI.4965-11.2013; Thompson LM, 2009, J CELL BIOL, V187, P1083, DOI 10.1083/jcb.200909067; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Truant R, 2003, CLIN NEUROSCI RES, V3, P157, DOI 10.1016/S1566-2772(03)00058-6; Truant R, 2007, PROG NEUROBIOL, V83, P211, DOI 10.1016/j.pneurobio.2006.11.004; Vonsattel JPG, 1998, J NEUROPATH EXP NEUR, V57, P369; Warby SC, 2005, HUM MOL GENET, V14, P1569, DOI 10.1093/hmg/ddi165; Warby SC, 2009, MOL CELL NEUROSCI, V40, P121, DOI 10.1016/j.mcn.2008.09.007; Wexler NS, 2012, ANNU REV MED, V63, P1, DOI 10.1146/annurev-med-050710-134457; Wheeler VC, 2000, HUM MOL GENET, V9, P503, DOI 10.1093/hmg/9.4.503; Wheeler VC, 2002, HUM MOL GENET, V11, P633, DOI 10.1093/hmg/11.6.633; Xia JR, 2003, HUM MOL GENET, V12, P1393, DOI 10.1093/hmg/ddg156; Zala D, 2008, HUM MOL GENET, V17, P3837, DOI 10.1093/hmg/ddn281; Zoghbi HY, 2000, ANNU REV NEUROSCI, V23, P217, DOI 10.1146/annurev.neuro.23.1.217	91	4	4	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144864	10.1371/journal.pone.0144864	http://dx.doi.org/10.1371/journal.pone.0144864			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660732	Green Published, Green Submitted, gold, Green Accepted			2022-12-26	WOS:000366715900123
J	Dias-Teixeira, KL; Calegari-Silva, TC; Dos Santos, GRRM; dos Santos, JV; Lima, C; Medina, JM; Aktas, BH; Lopes, UG				Dias-Teixeira, Karina Luiza; Calegari-Silva, Teresa Cristina; Dos Santos, Guilherme R. R. M.; dos Santos, Jose Vitorino; Lima, Carolina; Medina, Jorge Mansur; Aktas, Bertal Huseyin; Lopes, Ulisses G.			The integrated endoplasmic reticulum stress response in Leishmania amazonensis macrophage infection: the role of X-box binding protein 1 transcription factor	FASEB JOURNAL			English	Article						ER stress; XBP1; thapsigargin IRE1; IFN1-beta; oxidative stress	IFN-BETA INDUCTION; CUTANEOUS LEISHMANIASIS; SENSOR IRE1-ALPHA; ER STRESS; PARASITES; XBP1; SUBVERSION; ACTIVATION; VIRUS	Endoplasmic reticulum (ER) stress triggers the integrated ER-stress response (IERSR) that ensures cellular survival of ER stress and represents a primordial form of innate immunity. We investigated the role of IERSR during Leishmania amazonensis infection. Treatment of RAW 264.7 infected macrophages with the ER stress-inducing agent thapsigargin (TG; 1 mu M) increased L. amazonensis infectivity in an IFN1-alpha receptor (IFNAR)-dependent manner. In Western blot assays, we showed that L. amazonensis activates the inositol-requiring enzyme (IRE1)/X-box binding protein (XBP)-1-splicing arms of the IERSR in host cells. In chromatin immunoprecipitation (ChIP) assays, we showed an increased occupancy of enhancer and promoter sequences for the Ifnb gene by XBP1 in infected RAW 264.7 cells. Knocking down XBP1 expression by transducing RAW 264.7 cells with the short hairpin XBP1 lentiviral vector significantly reduced the parasite proliferation associated with impaired translocation of phosphorylated IFN regulatory transcription factor (IRF)-3 to the nucleus and a decrease in IFN1-beta expression. Knocking down XBP1 expression also increased NO concentration, as determined by Griess reaction and reduced the expression of antioxidant genes, such as heme oxygenase (HO)-1, that protect parasites from oxidative stress. We conclude that L. amazonensis activation of XBP1 plays a critical role in infection by protecting the parasites from oxidative stress and increasing IFN1-beta expression.-Dias-Teixeira, K. L., Calegari-Silva, T. C., Dos Santos, G. R. R. M., Vitorino dos Santos, J., Lima, C., Medina, J. M., Aktas, B. H., Lopes, U. G. The integrated endoplasmic reticulum stress response in Leishmania amazonensis macrophage infection: the role of X-box binding protein 1 transcription factor. FASEB J. 30, 1557-1565 (2016). www.fasebj.org	[Dias-Teixeira, Karina Luiza; Calegari-Silva, Teresa Cristina; Dos Santos, Guilherme R. R. M.; dos Santos, Jose Vitorino; Lima, Carolina; Lopes, Ulisses G.] Univ Fed Rio de Janeiro, Lab Parasitol Mol, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [Medina, Jorge Mansur] Univ Fed Rio de Janeiro, Inst Bioquim Med, Ctr Ciencias Saude, Rio De Janeiro, Brazil; [Aktas, Bertal Huseyin] Brigham & Womens Hosp, Dept Med, Hematol Lab Translat, 75 Francis St, Boston, MA 02115 USA; [Aktas, Bertal Huseyin] Harvard Univ, Sch Med, Boston, MA USA	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Lopes, UG (corresponding author), Univ Fed Rio de Janeiro, CCS, Inst Biofis Carlos Chagas Filho, Lab Parasitol Mol, Av Carlos Chagas Filho S-N, BR-21949902 Rio de Janeiro, RJ, Brazil.	lopesu@biof.ufrj.br	Dias Teixeira, Karina/J-4918-2017; Lopes, Ulisses Gazos/T-6634-2019; dos Santos, Guilherme Rodrigo Reis M/D-8868-2018	Dias Teixeira, Karina/0000-0002-6115-6768; dos Santos, Guilherme Rodrigo Reis M/0000-0001-8680-869X; Calegari Silva, Teresa Cristina/0000-0002-1656-3460				Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Calegari-Silva TC, 2009, IMMUNOL LETT, V127, P19, DOI 10.1016/j.imlet.2009.08.009; Chen T, 2011, NAT CHEM BIOL, V7, P610, DOI [10.1038/nchembio.613, 10.1038/NCHEMBIO.613]; Fros JJ, 2015, J GEN VIROL, V96, P580, DOI 10.1099/vir.0.071845-0; Fung TS, 2014, J VIROL, V88, P12752, DOI 10.1128/JVI.02138-14; Gregory DJ, 2005, PARASITOLOGY, V130, pS27, DOI 10.1017/S0031182005008139; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Inacio P, 2015, EMBO REP, V16, P955, DOI 10.15252/embr.201439979; Kaushansky A, 2015, EMBO REP, V16, P883, DOI 10.15252/embr.201540792; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; LIOU HC, 1990, SCIENCE, V247, P1581, DOI 10.1126/science.2321018; Liu Y, 2009, CELL DEATH DIFFER, V16, P847, DOI 10.1038/cdd.2009.14; Martinon F, 2010, NAT IMMUNOL, V11, P411, DOI 10.1038/ni.1857; Olivier M, 2005, CLIN MICROBIOL REV, V18, P293, DOI 10.1128/CMR.18.2.293-305.2005; Pillich H, 2012, CELL MICROBIOL, V14, P949, DOI 10.1111/j.1462-5822.2012.01769.x; Silveira FT, 2004, MEM I OSWALDO CRUZ, V99, P239, DOI 10.1590/S0074-02762004000300001; Smith JA, 2008, EUR J IMMUNOL, V38, P1194, DOI 10.1002/eji.200737882; Stafford JL, 2002, CRIT REV MICROBIOL, V28, P187, DOI 10.1080/1040-840291046731; van 't Wout EFA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004946; Vivarini AD, 2011, FASEB J, V25, P4162, DOI 10.1096/fj.11-185165; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; World Health Organization/Tropical Disease Researchers, 2015, GLOB HLTH OBS GHO DA; Xin LJ, 2010, J IMMUNOL, V184, P7047, DOI 10.4049/jimmunol.0903273; Zeng L, 2010, J IMMUNOL, V185, P2324, DOI 10.4049/jimmunol.0903052	24	19	20	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1557	1565		10.1096/fj.15-281550	http://dx.doi.org/10.1096/fj.15-281550			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26678450	Green Published			2022-12-26	WOS:000372629100017
J	Dasgupta, S; Fishman, MA; Mahallati, H; Castro, LM; Tashima, AK; Ferro, ES; Fricker, LD				Dasgupta, Sayani; Fishman, Michael A.; Mahallati, Hana; Castro, Leandro M.; Tashima, Alexandre K.; Ferro, Emer S.; Fricker, Lloyd D.			Reduced Levels of Proteasome Products in a Mouse Striatal Cell Model of Huntington's Disease	PLOS ONE			English	Article							FACTOR-KAPPA-B; INHIBITOR PS-341; QUANTITATIVE PEPTIDOMICS; INTRACELLULAR PEPTIDES; EXPANDED POLYGLUTAMINE; INCLUSION-BODIES; SYSTEM; DEGRADATION; ACTIVATION; NUCLEAR	Huntington's disease is the result of a long polyglutamine tract in the gene encoding huntingtin protein, which in turn causes a large number of cellular changes and ultimately results in neurodegeneration of striatal neurons. Although many theories have been proposed, the precise mechanism by which the polyglutamine expansion causes cellular changes is not certain. Some evidence supports the hypothesis that the long polyglutamine tract inhibits the proteasome, a multiprotein complex involved in protein degradation. However, other studies report normal proteasome function in cells expressing long polyglutamine tracts. The controversy may be due to the methods used to examine proteasome activity in each of the previous studies. In the present study, we measured proteasome function by examining levels of endogenous peptides that are products of proteasome cleavage. Peptide levels were compared among mouse striatal cell lines expressing either 7 glutamines (STHdh(Q7/Q7)) or 111 glutamines in the huntingtin protein, either heterozygous (STHdh(Q7/Q111)) or homozygous (STHdh(Q111/Q111)). Both of the cell lines expressing huntingtin with 111 glutamines showed a large reduction in nearly all of the peptides detected in the cells, relative to levels of these peptides in cells homozygous for 7 glutamines. Treatment of STHdh(Q7/Q7) cells with proteasome inhibitors epoxomicin or bortezomib also caused a large reduction in most of these peptides, suggesting that they are products of proteasome-mediated cleavage of cellular proteins. Taken together, these results support the hypothesis that proteasome function is impaired by the expression of huntingtin protein containing long polyglutamine tracts.	[Dasgupta, Sayani; Fishman, Michael A.; Mahallati, Hana; Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA; [Castro, Leandro M.] Sao Paulo State Univ UNESP, BR-11330900 Sao Vicente, SP, Brazil; [Tashima, Alexandre K.] Univ Fed Sao Paulo, Dept Biochem, Escola Paulista Med, BR-04023901 Sao Paulo, SP, Brazil; [Ferro, Emer S.] Univ Sao Paulo, Inst Biomed Sci, Dept Pharmacol, BR-05508000 Sao Paulo, SP, Brazil; [Fricker, Lloyd D.] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine; Universidade Estadual Paulista; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Yeshiva University; Albert Einstein College of Medicine	Fricker, LD (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	lloyd.fricker@einstein.yu.edu	Castro, Leandro/O-6762-2019; Tashima, Alexandre Keiji/B-8228-2015; Ferro, Emer S/D-3908-2012; Castro, Leandro/ABI-5520-2020; Castro, Leandro M/E-5654-2014	Castro, Leandro/0000-0002-7156-2006; Tashima, Alexandre Keiji/0000-0002-1332-8895; Ferro, Emer S/0000-0003-1651-9192; Castro, Leandro/0000-0002-7156-2006; Dasgupta, Sayani/0000-0003-4782-7956	US National Institutes of Health [R01-DA004494]; Financiadora de Estudos e Projetos (FINEP); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/19321-9]; Brazilian National Research Council (CNPq) [400944/2014-6, 445363/2014-2]; CNPq research fellowship [303135/2011-5]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM104547] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Financiadora de Estudos e Projetos (FINEP)(Financiadora de Inovacao e Pesquisa (Finep)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq research fellowship(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The study was primarily funded by a grant from the US National Institutes of Health R01-DA004494 to LDF. Mass spectrometry was supported by grants from Financiadora de Estudos e Projetos (FINEP) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP, 2012/19321-9 to AKT), and Brazilian National Research Council (CNPq) grants 400944/2014-6 and 445363/2014-2 to ESF. ESF is supported by a CNPq research fellowship (303135/2011-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arastu-Kapur S, 2011, CLIN CANCER RES, V17, P2734, DOI 10.1158/1078-0432.CCR-10-1950; Arkin MR, 2009, CURR OPIN CHEM BIOL, V13, P284, DOI 10.1016/j.cbpa.2009.05.125; Bence NF, 2005, METHOD ENZYMOL, V399, P481, DOI 10.1016/S0076-6879(05)99033-2; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Bennett EJ, 2007, NATURE, V448, P704, DOI 10.1038/nature06022; Churchill EN, 2009, TRENDS ENDOCRIN MET, V20, P25, DOI 10.1016/j.tem.2008.10.002; Ciechanover A, 2003, NEURON, V40, P427, DOI 10.1016/S0896-6273(03)00606-8; Crawford LJA, 2006, CANCER RES, V66, P6379, DOI 10.1158/0008-5472.CAN-06-0605; Cunha FM, 2008, J BIOL CHEM, V283, P24448, DOI 10.1074/jbc.M801252200; Cusack JC, 2001, CANCER RES, V61, P3535; Das E, 2015, DELAYED CELL CYCLE P; Dasgupta S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103604; de Araujo CB, 2014, J BIOL CHEM, V289, P16711, DOI 10.1074/jbc.M113.537118; Diaz-Hernandez M, 2003, J NEUROSCI, V23, P11653; Diaz-Hernandez M, 2006, J NEUROCHEM, V98, P1585, DOI 10.1111/j.1471-4159.2006.03968.x; Ding QX, 2002, J BIOL CHEM, V277, P13935, DOI 10.1074/jbc.M107706200; DUYAO MP, 1995, SCIENCE, V269, P407, DOI 10.1126/science.7618107; Ferro E. S., 2014, EUPA OPEN PROTEOMICS, V3, P143, DOI [10.1016/j.euprot.2014.02.009, DOI 10.1016/J.EUPROT.2014.02.009]; Fricker LD, 2006, MASS SPECTROM REV, V25, P327, DOI 10.1002/mas.20079; Fricker LD, 2012, J PROTEOME RES, V11, P1981, DOI 10.1021/pr2012076; Fricker LD, 2010, MOL BIOSYST, V6, P1355, DOI 10.1039/c003317k; Gelman JS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053263; Gelman JS, 2012, METHODS MOL BIOL, V829, P487, DOI 10.1007/978-1-61779-458-2_31; Gelman JS, 2011, J PROTEOME RES, V10, P1583, DOI 10.1021/pr100952f; Ghatak S, 2015, BIOCHEM BIOPH RES CO, V459, P509, DOI 10.1016/j.bbrc.2015.02.137; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Grisham MB, 1999, METHOD ENZYMOL, V300, P345; Groner B, 2012, BIOENGINEERED, V3, P320, DOI 10.4161/bioe.21272; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Hideshima T, 2001, CANCER RES, V61, P3071; Hipp MS, 2012, J CELL BIOL, V196, P573, DOI 10.1083/jcb.201110093; Holmberg CI, 2004, EMBO J, V23, P4307, DOI 10.1038/sj.emboj.7600426; Hunter JM, 2007, J NEUROSCI RES, V85, P1774, DOI 10.1002/jnr.21287; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Juenemann K, 2013, J BIOL CHEM, V288, P27068, DOI 10.1074/jbc.M113.486076; Kalogeris TJ, 1999, AM J PHYSIOL-CELL PH, V276, pC856, DOI 10.1152/ajpcell.1999.276.4.C856; Khan LA, 2006, J NEUROCHEM, V98, P576, DOI 10.1111/j.1471-4159.2006.03895.x; Kisselev AF, 2006, J BIOL CHEM, V281, P8582, DOI 10.1074/jbc.M509043200; Kniepert A, 2014, TRENDS BIOCHEM SCI, V39, P17, DOI 10.1016/j.tibs.2013.10.004; Kondo T, 2010, SCIENCE, V329, P336, DOI 10.1126/science.1188158; Labbadia J, 2013, TRENDS BIOCHEM SCI, V38, P378, DOI 10.1016/j.tibs.2013.05.003; Lee JM, 2012, NEUROLOGY, V78, P690, DOI 10.1212/WNL.0b013e318249f683; London N, 2013, CURR OPIN STRUC BIOL, V23, P894, DOI 10.1016/j.sbi.2013.07.006; Matsui M, 2006, BIOL CHEM, V387, P1535, DOI 10.1515/BC.2006.191; Maynard CJ, 2009, P NATL ACAD SCI USA, V106, P13986, DOI 10.1073/pnas.0906463106; Michalik A, 2004, NEUROBIOL DIS, V16, P202, DOI 10.1016/j.nbd.2003.12.020; Milner E, 2013, MOL CELL PROTEOMICS, V12, P1853, DOI 10.1074/mcp.M112.026013; Morano C, 2008, ANAL CHEM, V80, P9298, DOI 10.1021/ac801654h; Navon A, 2009, J BIOL CHEM, V284, P33713, DOI 10.1074/jbc.R109.018481; Ortega Z, 2007, CELL MOL LIFE SCI, V64, P2245, DOI 10.1007/s00018-007-7222-8; Ortega Z, 2014, FRONT MOL NEUROSCI, V7, DOI [10.3389/fnmol.2014.00077, 10.3389/fnmo1.2014.00077]; Pickering AM, 2012, PROG MOL BIOL TRANSL, V109, P227, DOI 10.1016/B978-0-12-397863-9.00006-7; Pickering AM, 2012, ARCH BIOCHEM BIOPHYS, V523, P181, DOI 10.1016/j.abb.2012.04.018; Plotkin JL, 2015, CURR OPIN NEUROBIOL, V33, P53, DOI 10.1016/j.conb.2015.01.020; Quintanilla RA, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-45; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Ross CA, 2014, NAT REV NEUROL, V10, P204, DOI 10.1038/nrneurol.2014.24; Ross CA, 2011, LANCET NEUROL, V10, P83, DOI 10.1016/S1474-4422(10)70245-3; Rousseau E, 2009, J BIOL CHEM, V284, P1917, DOI 10.1074/jbc.M806256200; Rubinstein M, 2009, BIOPOLYMERS, V91, P505, DOI 10.1002/bip.21164; Russo LC, 2012, PROTEOMICS, V12, P2641, DOI 10.1002/pmic.201200032; Schipper-Krom S, 2014, FEBS LETT, V588, P151, DOI 10.1016/j.febslet.2013.11.023; Schipper-Krom S, 2012, BIOCHEM RES INT, V2012, DOI 10.1155/2012/837015; Schrader M., 2014, EUPA OPEN PROTEOM, V3, P171, DOI [10.1016/j.euprot.2014.02.014, DOI 10.1016/J.EUPROT.2014.02.014]; Seo H, 2004, ANN NEUROL, V56, P319, DOI 10.1002/ana.20207; Sillerud LO, 2005, CURR PROTEIN PEPT SC, V6, P151, DOI 10.2174/1389203053545462; Stadtmueller BM, 2011, MOL CELL, V41, P8, DOI 10.1016/j.molcel.2010.12.020; Sunwoo JB, 2001, CLIN CANCER RES, V7, P1419; Swanson CJ, 2014, J BIOL CHEM, V289, P25460, DOI 10.1074/jbc.R114.583906; Tomko RJ, 2013, ANNU REV BIOCHEM, V82, P415, DOI 10.1146/annurev-biochem-060410-150257; Trettel F, 2000, HUM MOL GENET, V9, P2799, DOI 10.1093/hmg/9.19.2799; Venkatraman P, 2004, MOL CELL, V14, P95, DOI 10.1016/S1097-2765(04)00151-0; Waelter S, 2001, MOL BIOL CELL, V12, P1393, DOI 10.1091/mbc.12.5.1393; Wang JJ, 2008, J CELL BIOL, V180, P1177, DOI 10.1083/jcb.200709080; Wardman J, 2011, METHODS MOL BIOL, V768, P307, DOI 10.1007/978-1-61779-204-5_17; Zhang RJ, 2002, ANAL CHEM, V74, P3662, DOI 10.1021/ac025614w	77	16	16	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145333	10.1371/journal.pone.0145333	http://dx.doi.org/10.1371/journal.pone.0145333			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691307	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092300059
J	Cheatham, MA; Edge, RM; Homma, K; Leserman, EL; Dallos, P; Zheng, J				Cheatham, Mary Ann; Edge, Roxanne M.; Homma, Kazuaki; Leserman, Emily L.; Dallos, Peter; Zheng, Jing			Prestin-Dependence of Outer Hair Cell Survival and Partial Rescue of Outer Hair Cell Loss in Prestin(V499G/Y501H) Knockin Mice	PLOS ONE			English	Article							INDUCED HEARING-LOSS; DEVELOPMENTAL EXPRESSION; COCHLEAR FUNCTION; MOTOR PROTEIN; D-METHIONINE; MOUSE; ELECTROMOTILITY; THRESHOLD; OTOTOXICITY; MECHANISMS	A knockin (KI) mouse expressing mutated prestin(V499G/Y501H) (499 prestin) was created to study cochlear amplification. Recordings from isolated outer hair cells (OHC) in this mutant showed vastly reduced electromotility and, as a consequence, reduced hearing sensitivity. Although 499 prestin OHCs were normal in stiffness and longer than OHCs lacking prestin, accelerated OHC death was unexpectedly observed relative to that documented in prestin knockout (KO) mice. These observations imply an additional role of prestin in OHC maintenance besides its known requirement for mammalian cochlear amplification. In order to gain mechanistic insights into prestin-associated OHC loss, we implemented several interventions to improve survival. First, 499 prestin KI's were backcrossed to Bak KO mice, which lack the mitochondrial pro-apoptotic gene Bak. Because oxidative stress is implicated in OHC death, another group of 499 prestin KI mice was fed the antioxidant diet, Protandim. 499 KI mice were also backcrossed onto the FVB murine strain, which retains excellent high-frequency hearing well into adulthood, to reduce the compounding effect of age-related hearing loss associated with the original 499 prestin KIs. Finally, a compound heterozygous (chet) mouse expressing one copy of 499 prestin and one copy of KO prestin was also created to reduce quantities of 499 prestin protein. Results show reduction in OHC death in chets, and in 499 prestin KIs on the FVB background, but only a slight improvement in OHC survival for mice receiving Protandim. We also report that improved OHC survival in 499 prestin KIs had little effect on hearing phenotype, reaffirming the original contention about the essential role of prestin's motor function in cochlear amplification.	[Cheatham, Mary Ann; Edge, Roxanne M.; Leserman, Emily L.; Dallos, Peter] Northwestern Univ, Knowles Hearing Ctr, Roxelyn & Richard Pepper Dept Commun Sci & Disord, Evanston, IL 60208 USA; [Homma, Kazuaki; Zheng, Jing] Northwestern Univ, Feinberg Sch Med, Knowles Hearing Ctr, Dept Otolaryngol Head & Neck Surg, Chicago, IL 60611 USA; [Dallos, Peter] Northwestern Univ, Dept Neurobiol, Evanston, IL 60208 USA	Northwestern University; Northwestern University; Feinberg School of Medicine; Northwestern University	Cheatham, MA (corresponding author), Northwestern Univ, Knowles Hearing Ctr, Roxelyn & Richard Pepper Dept Commun Sci & Disord, Evanston, IL 60208 USA.	m-cheatham@northwestern.edu	Dallos, Peter/Q-9360-2019; Zheng, Jing/F-5273-2017	Dallos, Peter/0000-0002-9731-6591; Zheng, Jing/0000-0003-2790-1143	Knowles Hearing Center; NIDCD [DC000089, DC010633, DC011813]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [RC1DC010633, R01DC000089, R56DC011813, R01DC011813] Funding Source: NIH RePORTER	Knowles Hearing Center; NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by the Knowles Hearing Center, and NIDCD grants DC000089, DC010633 and DC011813. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Work supported by The Hugh Knowles Center and NIDCD grants DC000089 and DC010633 and DC011813.	Abe T, 2007, J MEMBRANE BIOL, V215, P49, DOI 10.1007/s00232-007-9004-5; Campbell KCM, 2007, HEARING RES, V226, P92, DOI 10.1016/j.heares.2006.11.012; Cheatham M, 2012, ABS ASS RES OTOLARYN, V48; Cheatham MA, 2007, AUDIOL NEURO-OTOL, V12, P378, DOI 10.1159/000106481; Cheatham MA, 2004, J PHYSIOL-LONDON, V560, P821, DOI 10.1113/jphysiol.2004.069559; Cheatham MA, 2005, J PHYSIOL-LONDON, V569, P229, DOI 10.1113/jphysiol.2005.093518; Cheatham MA, 2014, J NEUROSCI, V34, P10325, DOI 10.1523/JNEUROSCI.1256-14.2014; Coffin AB, 2013, JARO-J ASSOC RES OTO, V14, P645, DOI 10.1007/s10162-013-0404-1; Corbacella E, 2004, HEARING RES, V197, P11, DOI 10.1016/j.heares.2004.03.012; Dallos P, 2008, NEURON, V58, P333, DOI 10.1016/j.neuron.2008.02.028; Fujimoto C, 2014, OXID MED CELL LONGEV, V2014, DOI 10.1155/2014/582849; Furness DN, 2015, CELL TISSUE RES, V361, P387, DOI 10.1007/s00441-015-2113-z; Gao JG, 2007, P NATL ACAD SCI USA, V104, P12542, DOI 10.1073/pnas.0700356104; Gao SS, 2014, J NEUROPHYSIOL, V112, P1192, DOI 10.1152/jn.00306.2014; HE DZZ, 1994, HEARING RES, V78, P77, DOI 10.1016/0378-5955(94)90046-9; Henderson D, 2006, EAR HEARING, V27, P1, DOI 10.1097/01.aud.0000191942.36672.f3; Homma K, 2013, J BIOL CHEM, V288, P2452, DOI 10.1074/jbc.M112.411579; Huynh HM, 2006, ABS ASSOC RES OTOLAR, V142; KIANG NYS, 1986, HEARING RES, V22, P171; Le Prell CG, 2007, FREE RADICAL BIO MED, V42, P1454, DOI 10.1016/j.freeradbiomed.2007.02.008; Liberman MC, 2002, NATURE, V419, P300, DOI 10.1038/nature01059; Liu JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005284; Marcotti W, 1999, J PHYSIOL-LONDON, V520, P653, DOI 10.1111/j.1469-7793.1999.00653.x; Muller M, 2005, HEARING RES, V202, P63, DOI 10.1016/j.heares.2004.08.011; Oliver D, 2001, SCIENCE, V292, P2340, DOI 10.1126/science.1060939; Rabbitt RD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000444; ROBERTSON D, 1979, PFLUG ARCH EUR J PHY, V380, P7, DOI 10.1007/BF00582605; RYAN A, 1975, NATURE, V253, P44, DOI 10.1038/253044a0; Sha SH, 2000, HEARING RES, V142, P34, DOI 10.1016/S0378-5955(00)00003-4; Sodhi JS, 2004, J MOL BIOL, V342, P307, DOI 10.1016/j.jmb.2004.07.019; Someya S, 2009, P NATL ACAD SCI USA, V106, P19432, DOI 10.1073/pnas.0908786106; Souter M, 1995, HEARING RES, V91, P43, DOI 10.1016/0378-5955(95)00163-8; Viberg A, 2004, HEARING RES, V197, P1, DOI 10.1016/j.heares.2004.04.016; Weddell TD, 2011, CURR BIOL, V21, pR682, DOI 10.1016/j.cub.2011.08.001; Wei X, 2005, NEUROSCIENCE, V131, P513, DOI 10.1016/j.neuroscience.2004.11.014; Wilson T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108276; Wong ACY, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00058; Wu XD, 2004, MOL BRAIN RES, V126, P30, DOI 10.1016/j.molbrainres.2004.03.020; Yamashita T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045453; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Zheng J, 2005, J CELL SCI, V118, P2987, DOI 10.1242/jcs.02431; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	42	7	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145428	10.1371/journal.pone.0145428	http://dx.doi.org/10.1371/journal.pone.0145428			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26682723	Green Submitted, gold, Green Published			2022-12-26	WOS:000366725800075
J	Curnoe, D; Ji, XP; Liu, W; Bao, ZD; Tacon, PSC; Ren, L				Curnoe, Darren; Ji, Xueping; Liu, Wu; Bao, Zhende; Tacon, Paul S. C.; Ren, Liang			A Hominin Femur with Archaic Affinities from the Late Pleistocene of Southwest China	PLOS ONE			English	Article							MODERN HUMANS; EARLY HOMO; YUNNAN; SIZE; MORPHOLOGY; SEQUENCE; HISTORY; GENOME; SITE; BODY	The number of Late Pleistocene hominin species and the timing of their extinction are issues receiving renewed attention following genomic evidence for interbreeding between the ancestors of some living humans and archaic taxa. Yet, major gaps in the fossil record and uncertainties surrounding the age of key fossils have meant that these questions remain poorly understood. Here we describe and compare a highly unusual femur from Late Pleistocene sediments at Maludong (Yunnan), Southwest China, recovered along with cranial remains that exhibit a mixture of anatomically modern human and archaic traits. Our studies show that the Maludong femur has affinities to archaic hominins, especially Lower Pleistocene femora. However, the scarcity of later Middle and Late Pleistocene archaic remains in East Asia makes an assessment of systematically relevant character states difficult, warranting caution in assigning the specimen to a species at this time. The Maludong fossil probably samples an archaic population that survived until around 14,000 years ago in the biogeographically complex region of Southwest China.	[Curnoe, Darren] Univ New S Wales, Sch Biol Earth & Environm Sci, Palaeontol Geobiol & Earth Arch Res Ctr, Sydney, NSW, Australia; [Ji, Xueping] Yunnan Inst Cultural Rel & Archaeol, Kunming, Yunnan, Peoples R China; [Liu, Wu] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Vertebrate Evolut & Human Origins, Beijing, Peoples R China; [Bao, Zhende; Ren, Liang] Mengzi Inst Cultural Rel, Mengzi, Yunnan, Peoples R China; [Tacon, Paul S. C.] Griffith Univ, Sch Humanities, Pl Evolut & Rock Art Heritage Unit, Nathan, Qld 4111, Australia	University of New South Wales Sydney; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; Griffith University	Curnoe, D (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Palaeontol Geobiol & Earth Arch Res Ctr, Sydney, NSW, Australia.	d.curnoe@unsw.edu.au; jxpchina@foxmail.com		Curnoe, Darren/0000-0001-8622-4141; Tacon, Paul/0000-0002-0280-4366	Australian Research Council [DP0877603, FT120100168]; Yunnan Institute of Cultural Relics and Archaeology [A-201301]; University of New South Wales; Griffith University	Australian Research Council(Australian Research Council); Yunnan Institute of Cultural Relics and Archaeology; University of New South Wales; Griffith University(Griffith University)	The authors wish to thank the Australian Research Council (grants DP0877603 & FT120100168), the Yunnan Institute of Cultural Relics and Archaeology (Key Project Grant A-201301), and the University of New South Wales and Griffith University for funding this research.	Argue D, 2009, J HUM EVOL, V57, P623, DOI 10.1016/j.jhevol.2009.05.002; Barnosky AD, 2008, P NATL ACAD SCI USA, V105, P11543, DOI 10.1073/pnas.0801918105; Barton RNE, 2009, QUATERNARY SCI REV, V28, P1914, DOI 10.1016/j.quascirev.2009.03.010; Bromham L, 2007, BIOL LETTERS, V3, P398, DOI 10.1098/rsbl.2007.0113; Brown P, 2004, NATURE, V431, P1055, DOI 10.1038/nature02999; Cooper A, 2013, SCIENCE, V342, P321, DOI 10.1126/science.1244869; Curnoe D, 2015, SCI REP-UK, V5, DOI 10.1038/srep12408; Curnoe D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031918; Gordon AD, 2008, P NATL ACAD SCI USA, V105, P4650, DOI 10.1073/pnas.0710041105; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; GRINE FE, 1995, AM J PHYS ANTHROPOL, V97, P151, DOI 10.1002/ajpa.1330970207; Hammer MF, 2011, P NATL ACAD SCI USA, V108, P15123, DOI 10.1073/pnas.1109300108; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Holt BM, 2003, AM J PHYS ANTHROPOL, V122, P200, DOI 10.1002/ajpa.10256; Ji XP, 2013, CHINESE SCI BULL, V58, P4472, DOI 10.1007/s11434-013-6026-5; Jungers WL, 2009, J HUM EVOL, V57, P538, DOI 10.1016/j.jhevol.2008.08.014; KENNEDY GE, 1983, J HUM EVOL, V12, P587, DOI 10.1016/S0047-2484(83)80001-3; Krause J, 2010, NATURE, V464, P894, DOI 10.1038/nature08976; Krzywinski M, 2014, NAT METHODS, V11, P119, DOI 10.1038/nmeth.2813; Li R, 2015, SCI REP-UK, V5, DOI 10.1038/srep09396; LI XW, 1986, J BIOGEOGR, V13, P367, DOI 10.2307/2844964; Lordkipanidze D, 2007, NATURE, V449, P305, DOI 10.1038/nature06134; Lovejoy CO, 2002, AM J PHYS ANTHROPOL, V119, P97, DOI 10.1002/ajpa.10111; Martin R., 1928, LEHRBUCH ANTHR; MCHENRY HM, 1991, AM J PHYS ANTHROPOL, V85, P149, DOI 10.1002/ajpa.1330850204; McHenry HM, 2000, ANNU REV ANTHROPOL, V29, P125, DOI 10.1146/annurev.anthro.29.1.125; Meyer M, 2012, SCIENCE, V338, P222, DOI 10.1126/science.1224344; Pinhasi R, 2011, P NATL ACAD SCI USA, V108, P8611, DOI 10.1073/pnas.1018938108; Prufer K, 2014, NATURE, V505, P43, DOI 10.1038/nature12886; Reich D, 2010, NATURE, V468, P1053, DOI 10.1038/nature09710; Roberts RG, 2009, J HUM EVOL, V57, P484, DOI 10.1016/j.jhevol.2009.01.003; Ruff CB, 1999, AM J PHYS ANTHROPOL, V109, P509, DOI 10.1002/(SICI)1096-8644(199908)109:4<509::AID-AJPA7>3.0.CO;2-X; Ruff CB, 2000, J HUM EVOL, V38, P269, DOI 10.1006/jhev.1999.0322; RUFF CB, 1995, AM J PHYS ANTHROPOL, V98, P527, DOI 10.1002/ajpa.1330980412; Ruff CB, 2015, J HUM EVOL, V80, P147, DOI 10.1016/j.jhevol.2014.12.004; Shen GJ, 2014, QUAT GEOCHRONOL, V23, P56, DOI 10.1016/j.quageo.2014.06.004; Stewart JR, 2012, SCIENCE, V335, P1317, DOI 10.1126/science.1215627; Stringer C, 2002, PHILOS T R SOC B, V357, P563, DOI 10.1098/rstb.2001.1057; TRINKAUS E, 1984, AM J PHYS ANTHROPOL, V64, P137, DOI 10.1002/ajpa.1330640206; TRINKAUS E, 1976, Zeitschrift fuer Morphologie und Anthropologie, V67, P291; Trinkaus E, 2007, P NATL ACAD SCI USA, V104, P7367, DOI 10.1073/pnas.0702214104; Trinkaus E, 2006, CURR ANTHROPOL, V47, P597, DOI 10.1086/504165; Trinkaus Erik, 2012, Paleoanthropology, V2012, P13; Wall JD, 2013, GENETICS, V194, P199, DOI 10.1534/genetics.112.148213; Weston EM, 2009, NATURE, V459, P85, DOI 10.1038/nature07922; WOLPOFF MH, 1978, AM J PHYS ANTHROPOL, V48, P143, DOI 10.1002/ajpa.1330480203; Wu X.Z., 1995, HUMAN EVOLUTION CHIN; Wu XJ, 2014, P NATL ACAD SCI USA, V111, P10509, DOI 10.1073/pnas.1410735111; Wu XJ, 2014, CR PALEVOL, V13, P333, DOI 10.1016/j.crpv.2013.10.002; Wu XZ, 2004, QUATERN INT, V117, P131, DOI 10.1016/S1040-6182(03)00123-X; Xing S, 2015, AM J PHYS ANTHROPOL, V156, P224, DOI 10.1002/ajpa.22641; Zhu H, 2006, BIOTROPICA, V38, P310, DOI 10.1111/j.1744-7429.2006.00147.x	52	15	16	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0143332	10.1371/journal.pone.0143332	http://dx.doi.org/10.1371/journal.pone.0143332			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678851	gold, Green Published, Green Submitted			2022-12-26	WOS:000366723400004
J	Niu, YZ; Pan, DB; Shi, DF; Bai, QF; Liu, HX; Yao, XJ				Niu, Yuzhen; Pan, Dabo; Shi, Danfeng; Bai, Qifeng; Liu, Huanxiang; Yao, Xiaojun			Influence of Chirality of Crizotinib on Its MTH1 Protein Inhibitory Activity: Insight from Molecular Dynamics Simulations and Binding Free Energy Calculations	PLOS ONE			English	Article							COMPUTER-SIMULATIONS; RESP METHODOLOGY; FORCE-FIELD; MMGBSA; DECOMPOSITION; CONVERGENCE; COMPLEXES; MECHANICS; STRATEGY; MODEL	As a promising target for the treatment of lung cancer, the MutT Homolog 1 (MTH1) protein can be inhibited by crizotinib. A recent work shows that the inhibitory potency of (S)-crizotinib against MTH1 is about 20 times over that of (R)-crizotinib. But the detailed molecular mechanism remains unclear. In this study, molecular dynamics (MD) simulations and free energy calculations were used to elucidate the mechanism about the effect of chirality of crizotinib on the inhibitory activity against MTH1. The binding free energy of (S)-crizotinib predicted by the Molecular Mechanics/Generalized Born Surface Area (MM/GBSA) and Adaptive biasing force (ABF) methodologies is much lower than that of (R)-crizotinib, which is consistent with the experimental data. The analysis of the individual energy terms suggests that the van der Waals interactions are important for distinguishing the binding of (S)crizotinib and (R)-crizotinib. The binding free energy decomposition analysis illustrated that residues Tyr7, Phe27, Phe72 and Trp117 were important for the selective binding of (S)-crizotinib to MTH1. The adaptive biasing force (ABF) method was further employed to elucidate the unbinding process of (S)-crizotinib and (R)-crizotinib from the binding pocket of MTH1. ABF simulation results suggest that the reaction coordinates of the (S)-crizotinib from the binding pocket is different from (R)-crizotinib. The results from our study can reveal the details about the effect of chirality on the inhibition activity of crizotinib to MTH1 and provide valuable information for the design of more potent inhibitors.	[Niu, Yuzhen; Pan, Dabo; Shi, Danfeng; Bai, Qifeng; Yao, Xiaojun] Lanzhou Univ, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China; [Niu, Yuzhen; Pan, Dabo; Shi, Danfeng; Bai, Qifeng; Yao, Xiaojun] Lanzhou Univ, Dept Chem, Lanzhou 730000, Peoples R China; [Liu, Huanxiang] Lanzhou Univ, Sch Pharm, Lanzhou 730000, Peoples R China; [Yao, Xiaojun] Lanzhou Univ, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730000, Peoples R China; [Liu, Huanxiang] Separating Sci Inst Lanzhou, Lanzhou 730000, Peoples R China	Lanzhou University; Lanzhou University; Lanzhou University; Lanzhou University	Yao, XJ (corresponding author), Lanzhou Univ, State Key Lab Appl Organ Chem, Lanzhou 730000, Peoples R China.	xjyao@lzu.edu.cn	Bai, Qifeng/A-2950-2019	Bai, Qifeng/0000-0001-7296-6187; Liu, Huanxiang/0000-0002-9284-3667	National Natural Science Foundation of China [21475054]; Fundamental Research Funds for the Central Universities [lzujbky-2014-191]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (Grant No. 21475054) and the Fundamental Research Funds for the Central Universities (Grant No. lzujbky-2014-191). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Natural Science Foundation of China (Grant No. 21475054) and the Fundamental Research Funds for the Central Universities (Grant No. lzujbky-2014-191).	Arbiser JL, 2002, P NATL ACAD SCI USA, V99, P715, DOI 10.1073/pnas.022630199; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Bello M, 2014, BIOPOLYMERS, V101, P1010, DOI 10.1002/bip.22483; Case D.A., 2002, RIGIDITY THEO APP FU, P329; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CASE DA, 1994, CURR OPIN STRUC BIOL, V4, P285, DOI 10.1016/S0959-440X(94)90321-2; CIEPLAK P, 1995, J COMPUT CHEM, V16, P1357, DOI 10.1002/jcc.540161106; Cui JJ, 2011, J MED CHEM, V54, P6342, DOI 10.1021/jm2007613; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Darve E, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2829861; Deng YQ, 2009, J PHYS CHEM B, V113, P2234, DOI 10.1021/jp807701h; Duan Y, 2003, J COMPUT CHEM, V24, P1999, DOI 10.1002/jcc.10349; Faller CE, 2013, J PHYS CHEM B, V117, P518, DOI 10.1021/jp309741j; Fox T, 1998, J PHYS CHEM B, V102, P8070, DOI 10.1021/jp9717655; Frisch G. W. T. M. J., 2009, GAUSSIAN 09; Gad H, 2014, NATURE, V508, P215, DOI 10.1038/nature13181; Gaillard T, 2014, J COMPUT CHEM, V35, P1371, DOI 10.1002/jcc.23637; GEORGE P, 1976, TETRAHEDRON, V32, P317, DOI 10.1016/0040-4020(76)80043-9; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Gumbart JC, 2013, J CHEM THEORY COMPUT, V9, P794, DOI 10.1021/ct3008099; Hou TJ, 2008, J MOL BIOL, V376, P1201, DOI 10.1016/j.jmb.2007.12.054; Hou TJ, 2011, J COMPUT CHEM, V32, P866, DOI 10.1002/jcc.21666; Hou TJ, 2011, J CHEM INF MODEL, V51, P69, DOI 10.1021/ci100275a; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kennedy CH, 2003, FREE RADICAL BIO MED, V34, P1447, DOI 10.1016/S0891-5849(03)00176-X; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Martin HSC, 2014, J COMPUT CHEM, V35, P692, DOI 10.1002/jcc.23525; Mitsushita J, 2004, CANCER RES, V64, P3580, DOI 10.1158/0008-5472.CAN-03-3909; Onufriev A, 2004, PROTEINS, V55, P383, DOI 10.1002/prot.20033; Patel A, 2015, ONCOGENE, V34, P2586, DOI 10.1038/onc.2014.195; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; prime, 2008, PRIM VERS 2 0; Rai Priyamvada, 2012, Small GTPases, V3, P120, DOI 10.4161/sgtp.19556; Rodriguez-Gomez D, 2004, J CHEM PHYS, V120, P3563, DOI 10.1063/1.1642607; Romo TD, 2011, J CHEM THEORY COMPUT, V7, P2464, DOI 10.1021/ct2002754; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Srivastava HK, 2013, J BIOMOL STRUCT DYN, V31, P522, DOI 10.1080/07391102.2012.703071; Sun H., 2014, MATH PROBL ENG, V2014, P1, DOI DOI 10.1007/S00704-013-1033-7; Sun HY, 2014, PHYS CHEM CHEM PHYS, V16, P16719, DOI 10.1039/c4cp01388c; Sun HY, 2013, J CHEM INF MODEL, V53, P2376, DOI 10.1021/ci400188q; Sundberg EJ, 2003, ADV PROTEIN CHEM, V61, P119; Svensson LM, 2011, FEBS LETT, V585, P2617, DOI 10.1016/j.febslet.2011.07.017; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Weinberg F, 2010, P NATL ACAD SCI USA, V107, P8788, DOI 10.1073/pnas.1003428107; Weiser J, 1999, J COMPUT CHEM, V20, P217, DOI 10.1002/(SICI)1096-987X(19990130)20:2<217::AID-JCC4>3.0.CO;2-A; Woo HJ, 2005, P NATL ACAD SCI USA, V102, P6825, DOI 10.1073/pnas.0409005102; Ylilauri M, 2013, J CHEM INF MODEL, V53, P2626, DOI 10.1021/ci4002475	48	17	18	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145219	10.1371/journal.pone.0145219	http://dx.doi.org/10.1371/journal.pone.0145219			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26677850	gold, Green Submitted, Green Published			2022-12-26	WOS:000366723400057
J	Paris, RM; Petrovas, C; Ferrando-Martinez, S; Moysi, E; Boswell, KL; Archer, E; Yamamoto, T; Ambrozak, D; Casazza, JP; Haubrich, R; Connors, M; Ake, J; Kim, JH; Koup, RA				Paris, Robert M.; Petrovas, Constantinos; Ferrando-Martinez, Sara; Moysi, Eirini; Boswell, Kristin L.; Archer, Eva; Yamamoto, Takuya; Ambrozak, David; Casazza, Joseph P.; Haubrich, Richard; Connors, Mark; Ake, Julie; Kim, Jerome H.; Koup, Richard A.			Selective Loss of Early Differentiated, Highly Functional PD1(high) CD4 T Cells with HIV Progression	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; DISEASE PROGRESSION; SPARING REGIMENS; TELOMERE LENGTH; IN-VIVO; PD-1; EXHAUSTION; CTLA-4; LYMPHOCYTES; DYSFUNCTION	The role of PD-1 expression on CD4 T cells during HIV infection is not well understood. Here, we describe the differential expression of PD-1 in CD127(high) CD4 T cells within the early/intermediate differentiated (EI) (CD27(high)CD45RA(low)) T cell population among uninfected and HIV-infected subjects, with higher expression associated with decreased viral replication (HIV-1 viral load). A significant loss of circulating PD-1(high)CTLA-4(low) CD4 T cells was found specifically in the CD127(high)CD27(high)CD45RA(low) compartment, while initiation of antiretroviral treatment, particularly in subjects with advanced disease, reversed these dynamics. Increased HIV-1 Gag DNA was also found in PD-1(high) compared to PD-1(low) ED CD4 T cells. In line with an increased susceptibility to HIV infection, PD-1 expression in this CD4 T cell subset was associated with increased activation and expression of the HIV co-receptor, CCR5. Rather than exhaustion, this population produced more IFN-g, MIP1-a, IL-4, IL-10, and IL-17a compared to PD-1(low) EI CD4 T cells. In line with our previous findings, PD-1(high) EI CD4 T cells were also characterized by a high expression of CCR7, CXCR5 and CCR6, a phenotype associated with increased in vitro B cell help. Our data show that expression of PD-1 on early-differentiated CD4 T cells may represent a population that is highly functional, more susceptible to HIV infection and selectively lost in chronic HIV infection.	[Paris, Robert M.; Petrovas, Constantinos; Ferrando-Martinez, Sara; Moysi, Eirini; Boswell, Kristin L.; Archer, Eva; Yamamoto, Takuya; Ambrozak, David; Casazza, Joseph P.; Koup, Richard A.] NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Moysi, Eirini] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Paris, Robert M.; Ake, Julie] US Mil HIV Res Program, Silver Spring, MD USA; [Haubrich, Richard] Univ Calif San Diego, Div Infect Dis, Antiviral Res Ctr, San Diego, CA 92103 USA; [Connors, Mark] NIAID, HIV Specif Immun Sect, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA; [Kim, Jerome H.] Int Vaccine Inst, Seoul, South Korea	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Miami; Walter Reed Army Institute of Research (WRAIR); University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); International Vaccine Institute	Petrovas, C (corresponding author), NIAID, Immunol Lab, Vaccine Res Ctr, NIH, Bldg 10, Bethesda, MD 20892 USA.	petrovasc@mail.nih.gov	Yamamoto, Takuya/L-2642-2013	Yamamoto, Takuya/0000-0003-3753-1211; Moysi, Eirini/0000-0002-2070-2902	Intramural Research Program of the Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health [AI064086]; University of California San Diego Center for AIDS Research [AI36214]; San Diego AIDS Clinical Trial Group [CTU AI69432]; U.S. Army Medical Research and Material Command (USAMRMC) [Y1-AI-2642-12]; National Institutes of Allergy and Infectious Diseases [Y1-AI-2642-12]; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067]; U.S. Department of Defense (DOD) [W81XWH-07-2-0067]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K24AI064086, U01AI069432, ZIAAI001090, UM1AI069432, ZIAAI000855, N01AI002642, P30AI036214] Funding Source: NIH RePORTER	Intramural Research Program of the Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health; University of California San Diego Center for AIDS Research; San Diego AIDS Clinical Trial Group; U.S. Army Medical Research and Material Command (USAMRMC)(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); National Institutes of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DOD)(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the Intramural Research Program of the Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health (AI064086; RH), the University of California San Diego Center for AIDS Research (AI36214; RH), and the San Diego AIDS Clinical Trial Group (CTU AI69432; RH). The work was also supported in part by an Interagency Agreement Y1-AI-2642-12 between the U.S. Army Medical Research and Material Command (USAMRMC) and the National Institutes of Allergy and Infectious Diseases and by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DOD).	Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Birx DL, 2000, J INFECT DIS, V181, P881, DOI 10.1086/315308; Boswell KL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003853; Brenchley JM, 2008, BLOOD, V112, P2826, DOI 10.1182/blood-2008-05-159301; Brenchley JM, 2004, J VIROL, V78, P1160, DOI 10.1128/JVI.78.3.1160-1168.2004; Butler NS, 2012, NAT IMMUNOL, V13, P188, DOI 10.1038/ni.2180; Colle JH, 2006, JAIDS-J ACQ IMM DEF, V42, P277, DOI 10.1097/01.qai.0000214823.11034.4e; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Doria-Rose NA, 2010, J VIROL, V84, P1631, DOI 10.1128/JVI.01482-09; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Gosselin A, 2010, J IMMUNOL, V184, P1604, DOI 10.4049/jimmunol.0903058; Hathcock KS, 2003, J IMMUNOL, V170, P147, DOI 10.4049/jimmunol.170.1.147; Haubrich RH, 2009, AIDS, V23, P1109, DOI 10.1097/QAD.0b013e32832b4377; Hong JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060186; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Kinter AL, 2008, J IMMUNOL, V181, P6738, DOI 10.4049/jimmunol.181.10.6738; Klatt NR, 2010, CURR OPIN HIV AIDS, V5, P135, DOI 10.1097/COH.0b013e3283364846; Kulpa DA, 2013, SEMIN IMMUNOL, V25, P219, DOI 10.1016/j.smim.2013.02.002; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Perreau M, 2012, J EXP MED; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; Riddler SA, 2008, NEW ENGL J MED, V358, P2095, DOI 10.1056/NEJMoa074609; ROEDERER M, 1995, J CLIN INVEST, V95, P2061, DOI 10.1172/JCI117892; Salek-Ardakani S, 2013, NAT IMMUNOL, V14, P531, DOI 10.1038/ni.2619; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Utzschneider DT, 2013, NAT IMMUNOL, V14, P603, DOI 10.1038/ni.2606; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Watanabe N, 2003, NAT IMMUNOL, V4, P670, DOI 10.1038/ni944; Weng NP, 1998, IMMUNITY, V9, P151, DOI 10.1016/S1074-7613(00)80597-X; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Zaunders JJ, 2006, J VIROL, V80, P10162, DOI 10.1128/JVI.00249-06	36	11	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144767	10.1371/journal.pone.0144767	http://dx.doi.org/10.1371/journal.pone.0144767			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678998	gold, Green Published, Green Submitted			2022-12-26	WOS:000366723400025
J	Cha, S; Park, AY; Kang, C				Cha, Seongwon; Park, Ah Yeon; Kang, Changsoo			A Genome-Wide Association Study Uncovers a Genetic Locus Associated with Thoracic-to-Hip Ratio in Koreans	PLOS ONE			English	Article							RISK; CIRCUMFERENCE; VISUALIZATION; METAANALYSIS; POPULATION; GLUCOSE; NIDDM	The thoracic-to-hip circumference ratio (THR) is an anthropometric marker recently described as a predictor of type 2 diabetes. In this study, we performed a genome-wide association study (GWAS) followed by confirmatory analyses to identify genetic markers associated with THR. A total of 7,240 Korean subjects (4,988 for the discovery stage and 2,252 for the confirmatory analyses) were recruited for this study, and genome-wide single nucleotide polymorphism (SNP) genotyping of the initial 4,988 individuals was performed using Affymetrix Human SNP array 5.0. Linear regression analysis was then performed to adjust for the effects of age, sex, and current diabetes medication status on the THR of the study subjects. In the initial discovery stage, there was a statistically nominal association between minor alleles of SNP markers on chromosomes 4, 8, 10, and 12, and THR changes (p < 5.0 x 10(-6)). The subsequent confirmatory analyses of these markers, however, only detected a significant association between two SNPs in the HECTD4 gene and decreased THRs. Notably, this association was detected in male (rs11066280: p = 1.14 x 10(-2); rs2074356: p = 1.10 x 10(-2)), but not in female subjects. Meanwhile, the combined results from the two analyses (initial and confirmatory) indicated that minor alleles of these two intronic variants exhibited a significant genome-wide association with decreased THR in the male subjects (n = 3,155; rs11066280: effect size = -0.008624, p = 6.19 x 10(-9); rs2074356: effect size = -0.008762, p = 1.89 x 10(-8)). Furthermore, minor alleles of these two SNPs exhibited protective effects on patients' risks for developing type 2 diabetes. In conclusion, we have identified two genetic variations in HECTD4 that are associated with THR, particularly in men.	[Cha, Seongwon; Park, Ah Yeon] Korea Inst Oriental Med, Mibyeong Res Ctr, Daejeon 34054, South Korea; [Kang, Changsoo] Sungshin Womens Univ, Dept Biol, Seoul 01133, South Korea; [Kang, Changsoo] Sungshin Womens Univ, Res Inst Basic Sci, Coll Nat Sci, Seoul 01133, South Korea	Korea Institute of Oriental Medicine (KIOM); Sungshin Women's University; Sungshin Women's University	Kang, C (corresponding author), Sungshin Womens Univ, Dept Biol, Seoul 01133, South Korea.	ckang@sungshin.ac.kr	Cha, Seongwon/A-2377-2012	Cha, Seongwon/0000-0001-9012-8718	Korea Center for Disease Control and Prevention [4851-307, KBP-2014-16, KBP-2014-063, 4845-301, 4851-302]; Korea Institute of Oriental Medicine (KIOM) [K15090]; Bio&Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning, Republic of Korea [2006- 2005173, I-1210/002-002-03]	Korea Center for Disease Control and Prevention; Korea Institute of Oriental Medicine (KIOM); Bio&Medical Technology Development Program of the National Research Foundation (NRF) - Ministry of Science, ICT & Future Planning, Republic of Korea	This study was provided with biospecimens and data from the Korean Genome Analysis Project (4845-301), the Korean Genome and Epidemiology Study (4851-302), and Korea Biobank Project (4851-307, KBP-2014-16, KBP-2014-063) that were supported by the Korea Center for Disease Control and Prevention, and was also supported by the research program of the Korea Institute of Oriental Medicine (KIOM) (K15090) and by the Bio&Medical Technology Development Program of the National Research Foundation (NRF) funded by the Ministry of Science, ICT & Future Planning (No. 2006- 2005173, I-1210/002-002-03), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Cha SW, 2008, OBESITY, V16, P2185, DOI 10.1038/oby.2008.314; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Cho YS, 2009, NAT GENET, V41, P527, DOI 10.1038/ng.357; COLDITZ GA, 1990, AM J EPIDEMIOL, V132, P501, DOI 10.1093/oxfordjournals.aje.a115686; de Vegt F, 2001, JAMA-J AM MED ASSOC, V285, P2109, DOI 10.1001/jama.285.16.2109; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Pham DD, 2013, INTEGR MED RES, V2, P1, DOI 10.1016/j.imr.2013.01.001; Pham DD, 2014, DIABETES RES CLIN PR, V104, P273, DOI 10.1016/j.diabres.2013.12.022; Edelstein SL, 1997, DIABETES, V46, P701, DOI 10.2337/diabetes.46.4.701; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Hu FB, 2001, NEW ENGL J MED, V345, P790, DOI 10.1056/NEJMoa010492; Jeong S, 2011, J BIOTECHNOL, V154, P321, DOI 10.1016/j.jbiotec.2011.05.017; Kato N, 2011, NAT GENET, V43, P530, DOI 10.1038/ng.834; Kraja AT, 2014, MOL GENET METAB, V112, P317, DOI 10.1016/j.ymgme.2014.04.007; Li PP, 2015, NAT MED, V21, P239, DOI 10.1038/nm.3800; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Snijder MB, 2003, AM J CLIN NUTR, V77, P1192, DOI 10.1093/ajcn/77.5.1192; Stevens J, 2001, OBES RES, V9, P696, DOI 10.1038/oby.2001.94; Wang SL, 1997, DIABETOLOGIA, V40, P1431, DOI 10.1007/s001250050846; Yoo Keun-Young, 2005, Asian Pac J Cancer Prev, V6, P238; Yoon D, 2012, HUM GENET, V131, P1009, DOI 10.1007/s00439-011-1102-x	22	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145220	10.1371/journal.pone.0145220	http://dx.doi.org/10.1371/journal.pone.0145220			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675016	gold, Green Published, Green Submitted			2022-12-26	WOS:000366722700116
J	Sanchez-Sevilla, JF; Horvath, A; Botella, MA; Gaston, A; Folta, K; Kilian, A; Denoyes, B; Amaya, I				Sanchez-Sevilla, Jose F.; Horvath, Aniko; Botella, Miguel A.; Gaston, Amelia; Folta, Kevin; Kilian, Andrzej; Denoyes, Beatrice; Amaya, Iraida			Diversity Arrays Technology (DArT) Marker Platforms for Diversity Analysis and Linkage Mapping in a Complex Crop, the Octoploid Cultivated Strawberry (Fragaria x ananassa)	PLOS ONE			English	Article							GENETIC DIVERSITY; SNP DISCOVERY; POPULATION; MAP; GENOME; MICROSATELLITE; SOFTWARE; SSR; IDENTIFICATION; INFERENCE	Cultivated strawberry (Fragaria x ananassa) is a genetically complex allo-octoploid crop with 28 pairs of chromosomes (2n = 8x = 56) for which a genome sequence is not yet available. The diploid Fragaria vesca is considered the donor species of one of the octoploid subgenomes and its available genome sequence can be used as a reference for genomic studies. A wide number of strawberry cultivars are stored in ex situ germplasm collections worldwide but a number of previous studies have addressed the genetic diversity present within a limited number of these collections. Here, we report the development and application of two platforms based on the implementation of Diversity Array Technology (DArT) markers for high-throughput genotyping in strawberry. The first DArT microarray was used to evaluate the genetic diversity of 62 strawberry cultivars that represent a wide range of variation based on phenotype, geographical and temporal origin and pedigrees. A total of 603 DArT markers were used to evaluate the diversity and structure of the population and their cluster analyses revealed that these markers were highly efficient in classifying the accessions in groups based on historical, geographical and pedigree-based cues. The second DArTseq platform took benefit of the complexity reduction method optimized for strawberry and the development of next generation sequencing technologies. The strawberry DArTseq was used to generate a total of 9,386 SNP markers in the previously developed '232' x '1392' mapping population, of which, 4,242 high quality markers were further selected to saturate this map after several filtering steps. The high-throughput platforms here developed for genotyping strawberry will facilitate genome-wide characterizations of large accessions sets and complement other available options.	[Sanchez-Sevilla, Jose F.; Amaya, Iraida] Ctr Churriana, Inst Andaluz Invest & Formac Agr & Pesquera IFAPA, Malaga 29140, Spain; [Horvath, Aniko; Gaston, Amelia; Denoyes, Beatrice] INRA, UMR BFP 1332, F-33140 Villenave Dornon, France; [Horvath, Aniko; Gaston, Amelia; Denoyes, Beatrice] Univ Bordeaux, UMR NFP 1332, F-33140 Villenave Dornon, France; [Botella, Miguel A.] Univ Malaga, Dept Bioquim & Biol Mol, Inst Hortofruticultura Subtrop & Mediterranea IHS, E-29071 Malaga, Spain; [Folta, Kevin; Amaya, Iraida] Univ Florida, Dept Hort Sci, Gainesville, FL 32611 USA; [Kilian, Andrzej] Univ Canberra, Divers Arrays Technol Pty Ltd, Bruce, ACT 2617, Australia	INRAE; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Malaga; CSIC-UMA - Instituto de Hortofruticultura Subtropical y Mediterranea La Mayora (IHSM); State University System of Florida; University of Florida; University of Canberra	Amaya, I (corresponding author), Ctr Churriana, Inst Andaluz Invest & Formac Agr & Pesquera IFAPA, Malaga 29140, Spain.	iraida.amaya@juntadeandalucia.es	Botella, Miguel A/B-5734-2012; Amaya, Iraida/C-3709-2016; Sánchez Sevilla, José Federico/L-3279-2013; GASTON, AMELIA/R-8691-2016	Botella, Miguel A/0000-0002-8867-1831; Amaya, Iraida/0000-0002-4612-8902; Sánchez Sevilla, José Federico/0000-0002-6690-7196; Gaston, Amelia/0000-0001-9974-8083; Denoyes, Beatrice/0000-0002-0369-9609; Kilian, Andrzej/0000-0002-2730-7462	Spanish Ministry of Economy and Competitivity; FEDER [AGL2012-40066]; EUBerry Project (EU FP7) [KBBE-2010-4, 265942]; Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme [IOF Flavor 328052]	Spanish Ministry of Economy and Competitivity(Spanish Government); FEDER(European Commission); EUBerry Project (EU FP7); Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme	This work was supported by the Spanish Ministry of Economy and Competitivity and FEDER (grant number AGL2012-40066), the EUBerry Project (EU FP7 KBBE-2010-4 Grant Agreement number 265942) and by a Marie Curie International Outgoing Fellowship within the 7th European Community Framework Programme to IA (IOF Flavor 328052). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari M, 2006, THEOR APPL GENET, V113, P1409, DOI 10.1007/s00122-006-0365-4; Akhunov E, 2009, THEOR APPL GENET, V119, P507, DOI 10.1007/s00122-009-1059-5; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Amil-Ruiz F, 2011, PLANT CELL PHYSIOL, V52, P1873, DOI 10.1093/pcp/pcr136; ANDERSON JA, 1993, GENOME, V36, P181, DOI 10.1139/g93-024; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Bassil NV, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1310-1; Bombarely A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-503; Bringhurst R. S., 1984, Iowa State Journal of Research, V58, P371; Chambers A, 2013, MOL BREEDING, V31, P615, DOI 10.1007/s11032-012-9819-3; Courtois B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078037; Cruz VMV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064062; DALE A, 1990, HORTSCIENCE, V25, P1341, DOI 10.21273/HORTSCI.25.11.1341; Darrow GM, 1966, STRAWBERRY HIST BREE; Davik J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137746; Davis T. M., 2007, GENOME MAPPING MOL B, P189, DOI DOI 10.1007/978-3-540-34533-6_8; Debnath SC, 2008, CAN J PLANT SCI, V88, P313, DOI 10.4141/CJPS07088; Degani C, 2001, EUPHYTICA, V117, P1, DOI 10.1023/A:1004008408435; Delourme R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-120; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Durstewitz G, 2010, GENOME, V53, P948, DOI 10.1139/G10-079; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Elshire RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019379; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Galletta G. J., 1990, SMALL FRUIT CROP MAN, P83; Garcia AAF, 2013, SCI REP-UK, V3, DOI 10.1038/srep03399; Govan CL, 2008, MOL BREEDING, V22, P649, DOI 10.1007/s11032-008-9206-2; Grant OM, 2012, ENVIRON EXP BOT, V76, P7, DOI 10.1016/j.envexpbot.2011.09.013; Grant OM, 2010, ENVIRON EXP BOT, V68, P264, DOI 10.1016/j.envexpbot.2010.01.008; Hancock J.F., 1999, STRAWBERRIES, P25; Hancock JF, 2008, STRAWBERRIES, P393, DOI [10.1007/978-1-4020-6907-9_13, DOI 10.1007/978-1-4020-6907-9_13]; Heller-Uszynska K, 2011, MOL BREEDING, V28, P37, DOI 10.1007/s11032-010-9460-y; Horvath A, 2011, ANN APPL BIOL, V159, P358, DOI 10.1111/j.1744-7348.2011.00503.x; Isobe SN, 2013, DNA RES, V20, P79, DOI 10.1093/dnares/dss035; Jaccoud D, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.4.e25; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Gil-Ariza DJ, 2009, J AM SOC HORTIC SCI, V134, P337, DOI 10.21273/JASHS.134.3.337; Kilian Andrzej, 2012, Methods Mol Biol, V888, P67, DOI 10.1007/978-1-61779-870-2_5; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lerceteau-Kohler E, 2012, THEOR APPL GENET, V124, P1059, DOI 10.1007/s00122-011-1769-3; Lerceteau-Kohler E, 2003, THEOR APPL GENET, V107, P619, DOI 10.1007/s00122-003-1300-6; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Petroli CD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044684; PHYLIP J F., 2004, PHYLIP PHYLOGENY INF; Pritchard JK, 2000, GENETICS, V155, P945; Raman H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101673; Raman H, 2010, CROP PASTURE SCI, V61, P222, DOI 10.1071/CP09093; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousseau-Gueutin M, 2009, MOL PHYLOGENET EVOL, V51, P515, DOI 10.1016/j.ympev.2008.12.024; Rousseau-Gueutin M, 2008, GENETICS, V179, P2045, DOI 10.1534/genetics.107.083840; Salentijn EMJ, 2003, PHYSIOL PLANTARUM, V118, P571, DOI 10.1034/j.1399-3054.2003.00138.x; Sanchez-Sevilla JF, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-218; Sansaloni CP, 2011, BMC P S7, V5, P54, DOI [10.1186/1753-6561-5-S7-P54, DOI 10.1186/1753-6561-5-S7-P54]; Sargent DJ, 2008, GENOME, V51, P120, DOI [10.1139/G07-107, 10.1139/g07-107]; Sargent DJ, 2012, THEOR APPL GENET, V124, P1229, DOI 10.1007/s00122-011-1782-6; Sargent DJ, 2006, THEOR APPL GENET, V112, P1349, DOI 10.1007/s00122-006-0237-y; Sargent DJ, 2004, THEOR APPL GENET, V109, P1385, DOI 10.1007/s00122-004-1767-9; Sargent DJ, 2015, PLANT SCI; Schouten HJ, 2012, MOL BREEDING, V29, P645, DOI 10.1007/s11032-011-9579-5; Schwieterman ML, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088446; Shulaev V, 2011, NAT GENET, V43, P109, DOI 10.1038/ng.740; Simko I, 2012, PLANT SCI, V184, P54, DOI 10.1016/j.plantsci.2011.12.009; SJULIN TM, 1987, J AM SOC HORTIC SCI, V112, P375; Sugimoto T, 2005, PLANT BREEDING, V124, P498, DOI 10.1111/j.1439-0523.2005.01144.x; Tennessen JA, 2014, GENOME BIOL EVOL, V6, P3295, DOI 10.1093/gbe/evu261; Tinker NA, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-39; Troggio M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067407; Tyrka M, 2002, EUPHYTICA, V125, P273, DOI 10.1023/A:1015892313900; Ulrich D, 2013, J APPL BOT FOOD QUAL, V86, P37, DOI 10.5073/JABFQ.2013.086.006; Vallarino JG, 2015, NEW PHYTOL, V208, P482, DOI 10.1111/nph.13463; van Dijk T, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-55; Van Ooijen JW, 2011, GENET RES, V93, P343, DOI 10.1017/S0016672311000279; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wang SC, 2014, PLANT BIOTECHNOL J, V12, P787, DOI 10.1111/pbi.12183; Wenzl P, 2004, P NATL ACAD SCI USA, V101, P9915, DOI 10.1073/pnas.0401076101; Wenzl P, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-206; Wilhelm S, 1974, HIST STRAWBERRY ANCI; Zorrilla-Fontanesi Y, 2012, PLANT PHYSIOL, V159, P851, DOI 10.1104/pp.111.188318; Zorrilla-Fontanesi Y, 2011, THEOR APPL GENET, V123, P755, DOI 10.1007/s00122-011-1624-6; Zorrilla-Fontanesi Y, 2011, MOL BREEDING, V27, P137, DOI 10.1007/s11032-010-9417-1	82	49	52	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144960	10.1371/journal.pone.0144960	http://dx.doi.org/10.1371/journal.pone.0144960			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675207	Green Submitted, Green Published, gold			2022-12-26	WOS:000366722700078
J	Wang, J; Jian, HJ; Wei, LJ; Qu, CM; Xu, XF; Lu, K; Qian, W; Li, JN; Li, MT; Liu, LZ				Wang, Jia; Jian, Hongju; Wei, Lijuan; Qu, Cunmin; Xu, Xinfu; Lu, Kun; Qian, Wei; Li, Jiana; Li, Maoteng; Liu, Liezhao			Genome-Wide Analysis of Seed Acid Detergent Lignin (ADL) and Hull Content in Rapeseed (Brassica napus L.)	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; OILSEED RAPE; MAJOR QTL; PHENOLIC-COMPOUNDS; CROP PLANTS; SSR MARKERS; ASSOCIATION; QUALITY; GENE; COLOR	A stable yellow-seeded variety is the breeding goal for obtaining the ideal rapeseed (Brassica napus L.) plant, and the amount of acid detergent lignin (ADL) in the seeds and the hull content (HC) are often used as yellow-seeded rapeseed screening indices. In this study, a genome-wide association analysis of 520 accessions was performed using the Q + K model with a total of 31,839 single-nucleotide polymorphism (SNP) sites. As a result, three significant associations on the B. napus chromosomes A05, A09, and C05 were detected for seed ADL content. The peak SNPs were within 9.27, 14.22, and 20.86 kb of the key genes BnaA. PAL4, BnaA. CAD2/BnaA. CAD3, and BnaC. CCR1, respectively. Further analyses were performed on the major locus of A05, which was also detected in the seed HC examination. A comparison of our genome-wide association study (GWAS) results and previous linkage mappings revealed a common chromosomal region on A09, which indicates that GWAS can be used as a powerful complementary strategy for dissecting complex traits in B. napus. Genomic selection (GS) utilizing the significant SNP markers based on the GWAS results exhibited increased predictive ability, indicating that the predictive ability of a given model can be substantially improved by using GWAS and GS.	[Wang, Jia; Jian, Hongju; Wei, Lijuan; Qu, Cunmin; Xu, Xinfu; Lu, Kun; Qian, Wei; Li, Jiana; Liu, Liezhao] Southwest Univ, Coll Agron & Biotechnol, Chongqing, Peoples R China; [Li, Maoteng] Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Inst Resource Biol & Biotechnol, Wuhan 430074, Peoples R China	Southwest University - China; Huazhong University of Science & Technology	Liu, LZ (corresponding author), Southwest Univ, Coll Agron & Biotechnol, Chongqing, Peoples R China.	liezhao2003@126.com	Lu, Kun/C-2597-2008	Lu, Kun/0000-0003-1370-8633	National Natural Science Foundation of China [31171584]; National Natural Science Foundation of China (CN) [31371655]; 973 Program [2015CB150201]; Contributed reagents/analysis tools and Earmarked Fund for Modern Agro-industry Technology Research System [CARS-13]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China (CN)(National Natural Science Foundation of China (NSFC)); 973 Program(National Basic Research Program of China); Contributed reagents/analysis tools and Earmarked Fund for Modern Agro-industry Technology Research System	Funding provided by National Natural Science Foundation of China, (31171584), pr. Liezhao Liu, Conceived and designed the experiments, analyzed the data, National Natural Science Foundation of China (CN), (31371655), pr. Liezhao Liu, 973 Program, (2015CB150201), Pr. Wei Qian, Contributed reagents/analysis tools and Earmarked Fund for Modern Agro-industry Technology Research System, (CARS-13), pr. Jiana Li, Contributed reagents/materials.	Andersen JR, 2003, TRENDS PLANT SCI, V8, P554, DOI 10.1016/j.tplants.2003.09.010; Angelovici R, 2013, PLANT CELL, V25, P4827, DOI 10.1105/tpc.113.119370; Badani AG, 2006, GENOME, V49, P1499, DOI 10.1139/G06-091; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BOX GEP, 1964, J ROY STAT SOC B, V26, P211, DOI 10.1111/j.2517-6161.1964.tb00553.x; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Cai DF, 2014, THEOR APPL GENET, V127, P85, DOI 10.1007/s00122-013-2203-9; Cavanagh C, 2008, CURR OPIN PLANT BIOL, V11, P215, DOI 10.1016/j.pbi.2008.01.002; Dimov Z, 2012, PLANT BREEDING, V131, P361, DOI 10.1111/j.1439-0523.2012.01951.x; Endelman JB, 2011, PLANT GENOME-US, V4, P250, DOI 10.3835/plantgenome2011.08.0024; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Fomeju BF, 2014, BMC GENOMICS, P15; Fritsche S, 2012, FRONT PLANT SCI, P3; Fu FY, 2007, GENOME, V50, P840, DOI 10.1139/G07-068; Gebhardt C, 2004, MOL BREEDING, V13, P93, DOI 10.1023/B:MOLB.0000012878.89855.df; Hasan M, 2008, THEOR APPL GENET, V116, P1035, DOI 10.1007/s00122-008-0733-3; Honsdorf N, 2010, GENOME, V53, P899, DOI 10.1139/G10-049; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Jestin C, 2011, MOL BREEDING, V27, P271, DOI 10.1007/s11032-010-9429-x; Jin MengYang, 2007, Scientia Agricultura Sinica, V40, P677; Li F, 2014, DNA RES, V21, P355, DOI 10.1093/dnares/dsu002; Liang YL, 2002, CHINESE J OIL CROP S, V24, P13; Liu HF, 2014, AGR TECHNOLOGY, V34, P22; Liu LZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083052; Liu LZ, 2012, THEOR APPL GENET, V124, P1573, DOI 10.1007/s00122-012-1811-0; Lund M. S., 2009, BMC P S1, V3, pS1, DOI DOI 10.1186/1753-6561-3-S1-S1; McMullen MD, 2009, SCIENCE, V325, P737, DOI 10.1126/science.1174320; Nuzhdin SV, 2012, TRENDS GENET, V28, P421, DOI 10.1016/j.tig.2012.06.003; Ochodzki P, 2003, 11 INT RAP C COP 6 1, P5; Olsen HG, 2011, ANIM GENET, V42, P466, DOI 10.1111/j.1365-2052.2011.02179.x; Pauli D, 2014, PLANT GENOME, P7; Qu CM, 2013, J EXP BOT, V64, P2885, DOI 10.1093/jxb/ert148; Raman H, 2014, PLOS ONE, P9; RAMAN H, 2014, SCIENCE, V9, P16207, DOI DOI 10.1126/SCIENCE.1253435; Ravel C, 2007, EUPHYTICA, V158, P331, DOI 10.1007/s10681-006-9288-z; Rezaeizad A, 2011, EUPHYTICA, V177, P335, DOI 10.1007/s10681-010-0231-y; Sebat J, 2004, SCIENCE, V305, P525, DOI 10.1126/science.1098918; Seren U, 2012, PLANT CELL, V24, P4793, DOI 10.1105/tpc.112.108068; SIMBAYA J, 1995, J AGR FOOD CHEM, V43, P2062, DOI 10.1021/jf00056a020; Slavov GT, 2014, NEW PHYTOL, V201, P1227, DOI 10.1111/nph.12621; Snowdon RJ, 2010, GENOME, V53, P917, DOI 10.1139/G10-052; Stein A, 2013, PLANT BREEDING, V132, P382, DOI 10.1111/pbr.12073; Stracke S, 2009, THEOR APPL GENET, V118, P259, DOI 10.1007/s00122-008-0896-y; Stringam GR, 1974, P 4 INT RAP C, V2, P99; Wang NA, 2011, J EXP BOT, V62, P5641, DOI 10.1093/jxb/err249; Wang X.R., 2012, PLOS ONE, P7, DOI [DOI 10.1371/J0URNAL.P0NE.0040084, 10.1371/journal.pone.0040084]; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999; Wittkop B, 2009, EUPHYTICA, V170, P131, DOI 10.1007/s10681-009-9940-5; Xiao YJ, 2012, THEOR APPL GENET, V125, P437, DOI 10.1007/s00122-012-1843-5; Yan XY, 2009, EUPHYTICA, V170, P355, DOI 10.1007/s10681-009-0006-5; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Zhang ZW, 2010, NAT GENET, V42, P355, DOI 10.1038/ng.546; Zou J, 2010, GENOME, V53, P908, DOI 10.1139/G10-075	53	18	20	4	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145045	10.1371/journal.pone.0145045	http://dx.doi.org/10.1371/journal.pone.0145045			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673885	Green Published, gold, Green Submitted			2022-12-26	WOS:000366722700089
J	Zimik, S; Nayak, AR; Pandit, R				Zimik, Soling; Nayak, Alok Ranjan; Pandit, Rahul			A Computational Study of the Factors Influencing the PVC-Triggering Ability of a Cluster of Early Afterdepolarization-Capable Myocytes	PLOS ONE			English	Article							HUMAN VENTRICULAR TISSUE; HEART-FAILURE; CARDIAC FIBROBLASTS; CELLULAR BASIS; CANINE HEARTS; DE-POINTES; M-CELLS; ARRHYTHMIAS; FIBROSIS; FIBRILLATION	Premature ventricular complexes (PVCs), which are abnormal impulse propagations in cardiac tissue, can develop because of various reasons including early afterdepolarizations (EADs). We show how a cluster of EAD-generating cells (EAD clump) can lead to PVCs in a model of cardiac tissue, and also investigate the factors that assist such clumps in triggering PVCs. In particular, we study, through computer simulations, the effects of the following factors on the PVC-triggering ability of an EAD clump: (1) the repolarization reserve (RR) of the EAD cells; (2) the size of the EAD clump; (3) the coupling strength between the EAD cells in the clump; and (4) the presence of fibroblasts in the EAD clump. We find that, although a low value of RR is necessary to generate EADs and hence PVCs, a very low value of RR leads to low-amplitude EAD oscillations that decay with time and do not lead to PVCs. We demonstrate that a certain threshold size of the EAD clump, or a reduction in the coupling strength between the EAD cells, in the clump, is required to trigger PVCs. We illustrate how randomly distributed inexcitable obstacles, which we use to model collagen deposits, affect PVC-triggering by an EAD clump. We show that the gap-junctional coupling of fibroblasts with myocytes can either assist or impede the PVC-triggering ability of an EAD clump, depending on the resting membrane potential of the fibroblasts and the coupling strength between the myocyte and fibroblasts. We also find that the triggering of PVCs by an EAD clump depends sensitively on factors like the pacing cycle length and the distribution pattern of the fibroblasts.	[Zimik, Soling; Nayak, Alok Ranjan; Pandit, Rahul] Indian Inst Sci, Dept Phys, Ctr Condensed Matter Theory, Bangalore 560012, Karnataka, India; [Nayak, Alok Ranjan] Indian Inst Sci, Robert Bosch Ctr Cyber Phys Syst, Bangalore 560012, Karnataka, India; [Pandit, Rahul] Indian Inst Sci, Jawaharlal Nehru Ctr Adv Sci Res, Bangalore 560012, Karnataka, India	Indian Institute of Science (IISC) - Bangalore; Bosch; Indian Institute of Science (IISC) - Bangalore; Department of Science & Technology (India); Jawaharlal Nehru Center for Advanced Scientific Research (JNCASR); Indian Institute of Science (IISC) - Bangalore	Pandit, R (corresponding author), Indian Inst Sci, Dept Phys, Ctr Condensed Matter Theory, Bangalore 560012, Karnataka, India.	rahul@physics.iisc.ernet.in	Nayak, Alok/E-2979-2016; Nayak, Alok Ranjan/AAF-1119-2020	Nayak, Alok/0000-0003-0102-0778; 	Department of Science and Technology (DST), India; University Grants Commission (UGC), India; Council for Scientific and Industrial Research (CSIR), India; Robert Bosch Centre for Cyber Physical Systems	Department of Science and Technology (DST), India(Department of Science & Technology (India)); University Grants Commission (UGC), India(University Grants Commission, India); Council for Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India); Robert Bosch Centre for Cyber Physical Systems	This study was supported by research grants from the Department of Science and Technology (DST), India and the University Grants Commission (UGC), India. Soling Zimik is supported by research fellowships from the Council for Scientific and Industrial Research (CSIR), India. Alok Ranjan Nayak is supported by the Robert Bosch Centre for Cyber Physical Systems. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai X, 2005, CIRC RES, V96, P54, DOI 10.1161/01.RES.0000152325.07495.5a; Akar FG, 2002, CIRCULATION, V105, P1247, DOI 10.1161/hc1002.105231; ANTZELEVITCH C, 1991, CIRC RES, V69, P1427, DOI 10.1161/01.RES.69.6.1427; Bansch D, 2003, CIRCULATION, V108, P3011, DOI 10.1161/01.CIR.0000103701.30662.5C; Biernacka A, 2011, AGING DIS, V2, P158; Bueno-Orovio A, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2014.0352; Calvo D, 2015, CIRC-ARRHYTHMIA ELEC, V8, P1133, DOI 10.1161/CIRCEP.114.002717; de Jong S, 2011, J CARDIOVASC PHARM, V57, P630, DOI 10.1097/FJC.0b013e318207a35f; de Lange E, 2012, BIOPHYS J, V103, P365, DOI 10.1016/j.bpj.2012.06.007; Defauw A, 2014, AM J PHYSIOL-HEART C, V307, pH1456, DOI 10.1152/ajpheart.00410.2014; Elshrif MM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084401; Fast VG, 1996, CIRC RES, V79, P115, DOI 10.1161/01.RES.79.1.115; Feld Y, 2002, CIRCULATION, V105, P522, DOI 10.1161/hc0402.102661; Gaudesius G, 2003, CIRC RES, V93, P421, DOI 10.1161/01.RES.0000089258.40661.0C; GRAY RA, 1995, SCIENCE, V270, P1222, DOI 10.1126/science.270.5239.1222; Greisas A, 2012, IEEE T BIO-MED ENG, V59, P1398, DOI 10.1109/TBME.2012.2188291; Haissaguerre M, 2002, LANCET, V359, P677, DOI 10.1016/S0140-6736(02)07807-8; Jacquemet V, 2007, EUROPACE, V9, P29, DOI 10.1093/europace/eum207; JANSE MJ, 1980, CIRC RES, V47, P151, DOI 10.1161/01.RES.47.2.151; Kapur NK, 2012, CIRCULATION, V125, P2728, DOI 10.1161/CIRCULATIONAHA.111.080002; Li GR, 2002, AM J PHYSIOL-HEART C, V283, pH1031, DOI 10.1152/ajpheart.00105.2002; Li GR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007307; MacCannell KA, 2007, BIOPHYS J, V92, P4121, DOI 10.1529/biophysj.106.101410; Majumder R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045040; Miragoli M, 2007, CIRC RES, V101, P755, DOI 10.1161/CIRCRESAHA.107.160549; Morita N, 2009, AM J PHYSIOL-HEART C, V297, pH1594, DOI 10.1152/ajpheart.00579.2009; Nayak AR, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00207; Nayak AR, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.032720; Nayak AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072950; Nguyen TP, 2014, J MOL CELL CARDIOL, V70, P83, DOI 10.1016/j.yjmcc.2013.10.018; Nguyen TP, 2012, CARDIOVASC RES, V93, P242, DOI 10.1093/cvr/cvr292; Nuss HB, 1999, AM J PHYSIOL-HEART C, V277, pH80, DOI 10.1152/ajpheart.1999.277.1.H80; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Passini E, 2016, J MOL CELL CARDIOL, V96, P72, DOI 10.1016/j.yjmcc.2015.09.003; Pogwizd SM, 2004, TRENDS CARDIOVAS MED, V14, P61, DOI 10.1016/j.tcm.2003.12.002; POLLARD AE, 1992, CRIT REV BIOMED ENG, V20, P171; Qu ZL, 2013, CARDIOVASC RES, V99, P6, DOI 10.1093/cvr/cvt104; Rohr S, 2012, CIRC-ARRHYTHMIA ELEC, V5, P442, DOI 10.1161/CIRCEP.110.957647; ROOK MB, 1992, AM J PHYSIOL, V263, pC959, DOI 10.1152/ajpcell.1992.263.5.C959; Saiz J, 1999, IEEE T BIO-MED ENG, V46, P138, DOI 10.1109/10.740876; Sato D, 2009, P NATL ACAD SCI USA, V106, P2983, DOI 10.1073/pnas.0809148106; Shajahan TK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004738; Shajahan TK, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.011929; Shibukawa Y, 2005, BIOPHYS J, V88, P3924, DOI 10.1529/biophysj.104.054429; Solhjoo S, 2015, PLOS ONE, V78, P90, DOI DOI 10.1016/J.YJMCC.2014.09.024; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; Ten Tusscher KHWJ, 2007, EUROPACE, V9, P38, DOI 10.1093/europace/eum206; Tran DX, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.258103; Vandersickel N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084595; Veldkamp MW, 2001, EUR HEART J, V22, P955, DOI 10.1053/euhj.2000.2499; Volders PGA, 2000, CARDIOVASC RES, V46, P376, DOI 10.1016/S0008-6363(00)00022-5; WEBER KT, 1993, CARDIOVASC RES, V27, P341, DOI 10.1093/cvr/27.3.341; Wiegerinck RF, 2008, HEART RHYTHM, V5, P1178, DOI 10.1016/j.hrthm.2008.04.026; WINFREE AT, 1994, SCIENCE, V266, P1003, DOI 10.1126/science.7973648; Xie YF, 2010, BIOPHYS J, V99, P1408, DOI 10.1016/j.bpj.2010.06.042; Xie YF, 2009, AM J PHYSIOL-HEART C, V297, pH775, DOI 10.1152/ajpheart.00341.2009; Zhao ZH, 2012, CARDIOVASC RES, V95, P308, DOI 10.1093/cvr/cvs183; Zimik S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130632; Zlochiver S, 2008, BIOPHYS J, V95, P4469, DOI 10.1529/biophysj.108.136473	59	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144979	10.1371/journal.pone.0144979	http://dx.doi.org/10.1371/journal.pone.0144979			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675670	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000366722700080
J	Hu, LP; Huang, WQ; Hjort, EE; Bei, L; Platanias, LC; Eklund, EA				Hu, Liping; Huang, Weiqi; Hjort, Elizabeth E.; Bei, Ling; Platanias, Leonidas C.; Eklund, Elizabeth A.			The Interferon Consensus Sequence Binding Protein (Icsbp/Irf8) Is Required for Termination of Emergency Granulopoiesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						calpain; CD95 (APO-1; Fas); gene expression; hematopoiesis; innate immunity	COLONY-STIMULATING FACTOR; MYELOID PROGENITOR CELLS; BETA-CATENIN ACTIVITY; TRANSCRIPTION FACTOR; PTPN13 GENE; G-CSF; GRANULOCYTE; MICE; PU.1; EXPRESSION	Emergency granulopoiesis occurs in response to infectious or inflammatory challenge and is a component of the innate immune response. Some molecular events involved in initiating emergency granulopoiesis are known, but termination of this process is less well defined. In this study, we found that the interferon consensus sequence binding protein (Icsbp/Irf8) was required to terminate emergency granulopoiesis. Icsbp is an interferon regulatory transcription factor with leukemia suppressor activity. Expression of Icsbp is decreased in chronic myeloid leukemia, and Icsbp(-/-) mice exhibit progressive granulocytosis with evolution to blast crisis, similar to the course of human chronic myeloid leukemia. In this study, we found aberrantly sustained granulocyte production in Icsbp(-/-) mice after stimulation of an emergency granulopoiesis response. Icsbp represses transcription of the genes encoding Fas-associated phosphatase 1 (Fap1) and growth arrest-specific 2 (Gas2) and activates genes encoding Fanconi C and F. After stimulation of emergency granulopoiesis, we found increased and sustained expression of Fap1 and Gas2 in bone marrow myeloid progenitor cells from Icsbp(-/-) mice in comparison with the wild type. This was associated with resistance to Fas-induced apoptosis and increased -catenin activity in these cells. We also found that repeated episodes of emergency granulopoiesis accelerated progression to acute myeloid leukemia in Icsbp(-/-) mice. This was associated with impaired Fanconi C and F expression and increased sensitivity to DNA damage in bone marrow myeloid progenitors. Our results suggest that impaired Icsbp expression enhances leukemogenesis by deregulating processes that normally limit granulocyte expansion during the innate immune response.	[Hu, Liping; Huang, Weiqi; Hjort, Elizabeth E.; Bei, Ling; Platanias, Leonidas C.; Eklund, Elizabeth A.] Northwestern Univ, Feinberg Sch Med, 303 E Super,Lurie 5-105, Chicago, IL 60611 USA; [Platanias, Leonidas C.; Eklund, Elizabeth A.] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, 303 E Super,Lurie 5-105, Chicago, IL 60611 USA; [Huang, Weiqi; Bei, Ling; Platanias, Leonidas C.; Eklund, Elizabeth A.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	Northwestern University; Feinberg School of Medicine; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Eklund, EA (corresponding author), Northwestern Univ, Feinberg Sch Med, 303 E Super,Lurie 5-105, Chicago, IL 60611 USA.	e-eklund@northwestern.edu			National Institutes of Health [R01-DK098812, R01-CA174205, R01-CA77816, CA155566]; Veterans Affairs Grant [IBX002067]; NATIONAL CANCER INSTITUTE [R01CA077816, R01CA155566, P30CA060553, R01CA174205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098812] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002067] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Grant(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by National Institutes of Health Grants R01-DK098812 and R01-CA174205 (to E. A. E.) and R01-CA77816 and CA155566 (to L. C. P.) and Veterans Affairs Grant IBX002067 (to E. A. E.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Basu S, 2000, BLOOD, V95, P3725; Benetti R, 2005, J BIOL CHEM, V280, P22070, DOI 10.1074/jbc.M501810200; Burchert A, 2004, BLOOD, V103, P3480, DOI 10.1182/blood-2003-08-2970; Cain DW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019957; DeKoter RP, 1998, EMBO J, V17, P4456, DOI 10.1093/emboj/17.15.4456; DRIGGERS PH, 1990, P NATL ACAD SCI USA, V87, P3743, DOI 10.1073/pnas.87.10.3743; Eash KJ, 2009, BLOOD, V113, P4711, DOI 10.1182/blood-2008-09-177287; Eklund EA, 1999, J IMMUNOL, V163, P6095; Eklund EA, 1998, J BIOL CHEM, V273, P13957, DOI 10.1074/jbc.273.22.13957; Hao SX, 2000, MOL CELL BIOL, V20, P1149, DOI 10.1128/MCB.20.4.1149-1161.2000; Hirai H, 2006, NAT IMMUNOL, V7, P732, DOI 10.1038/ni1354; Holtschke T, 1996, CELL, V87, P307, DOI 10.1016/S0092-8674(00)81348-3; Hu LP, 2013, J CLIN INVEST, V123, P3952, DOI 10.1172/JCI69032; Huang WQ, 2008, J BIOL CHEM, V283, P7921, DOI 10.1074/jbc.M706710200; Huang WQ, 2006, MOL CELL BIOL, V26, P6311, DOI 10.1128/MCB.00036-06; Huang WQ, 2013, J BIOL CHEM, V288, P12766, DOI 10.1074/jbc.M112.429696; Huang WQ, 2013, LEUKEMIA LYMPHOMA, V54, P619, DOI 10.3109/10428194.2012.720979; Huang WQ, 2012, J BIOL CHEM, V287, P8110, DOI 10.1074/jbc.M111.294884; Huang WQ, 2010, MOL CELL BIOL, V30, P4575, DOI 10.1128/MCB.01595-09; Iwama A, 2002, J EXP MED, V195, P547, DOI 10.1084/jem.20011465; Kakar R, 2005, J LEUKOCYTE BIOL, V77, P120, DOI 10.1189/jlb.0704429; Kim YM, 1999, J IMMUNOL, V163, P2000; Konieczna I, 2008, J CLIN INVEST, V118, P853, DOI 10.1172/JCI33742; Kool M, 2008, J IMMUNOL, V181, P3755, DOI 10.4049/jimmunol.181.6.3755; Kreisel D, 2011, BLOOD, V118, P6172, DOI 10.1182/blood-2011-04-347823; Kurotaki D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5978; Kurotaki D, 2013, BLOOD, V121, P1839, DOI 10.1182/blood-2012-06-437863; LIESCHKE GJ, 1994, BLOOD, V84, P1737; LORD BI, 1991, BLOOD, V77, P2154; Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002; Panopoulos AD, 2006, BLOOD, V108, P3682, DOI 10.1182/blood-2006-02-003012; Radich JP, 2006, P NATL ACAD SCI USA, V103, P2794, DOI 10.1073/pnas.0510423103; Rehli M, 2000, J BIOL CHEM, V275, P9773, DOI 10.1074/jbc.275.13.9773; Saberwal G, 2009, J BIOL CHEM, V284, P33242, DOI 10.1074/jbc.M109.010231; Salto Y., 2013, EUR J IMMUNOL, V43, P1651; Scheller M, 1999, BLOOD, V94, P3764, DOI 10.1182/blood.V94.11.3764.423k03_3764_3771; Schlacher K, 2012, CANCER CELL, V22, P106, DOI 10.1016/j.ccr.2012.05.015; Stoffel R, 1996, BLOOD, V87, P567, DOI 10.1182/blood.V87.2.567.bloodjournal872567; Tamura T, 2000, IMMUNITY, V13, P155, DOI 10.1016/S1074-7613(00)00016-9; Taniguchi T, 2002, BLOOD, V100, P2414, DOI 10.1182/blood-2002-01-0278; Ueda Y, 2009, J IMMUNOL, V182, P6477, DOI 10.4049/jimmunol.0803961; Wang LC, 2008, DNA REPAIR, V7, P1973, DOI 10.1016/j.dnarep.2008.08.005; Ward AC, 1999, BLOOD, V93, P447, DOI 10.1182/blood.V93.2.447; Yanagisawa J, 1997, J BIOL CHEM, V272, P8539, DOI 10.1074/jbc.272.13.8539; Zhan YF, 1998, BLOOD, V91, P863, DOI 10.1182/blood.V91.3.863.863_863_869; Zhang DE, 1997, P NATL ACAD SCI USA, V94, P569, DOI 10.1073/pnas.94.2.569; Zheng C, 2006, LEUKEMIA, V20, P1028, DOI 10.1038/sj.leu.2404227	47	15	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4107	4120		10.1074/jbc.M115.681361	http://dx.doi.org/10.1074/jbc.M115.681361			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26683374	Green Published, hybrid			2022-12-26	WOS:000371338400035
J	Speckmann, T; Sabatini, PV; Nian, C; Smith, RG; Lynn, FC				Speckmann, Thilo; Sabatini, Paul V.; Nian, Cuilan; Smith, Riley G.; Lynn, Francis C.			Npas4 Transcription Factor Expression Is Regulated by Calcium Signaling Pathways and Prevents Tacrolimus-induced Cytotoxicity in Pancreatic Beta Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-II; INSULIN GENE-EXPRESSION; MAMMALIAN TARGET; INDUCED APOPTOSIS; GROWTH-FACTOR; RISK-FACTORS; GLUCOSE; CYCLOSPORINE; ACTIVATION; SECRETION	Cytosolic calcium influx activates signaling pathways known to support pancreatic beta cell function and survival by modulating gene expression. Impaired calcium signaling leads to decreased beta cell mass and diabetes. To appreciate the causes of these cytotoxic perturbations, a more detailed understanding of the relevant signaling pathways and their respective gene targets is required. In this study, we examined the calcium-induced expression of the cytoprotective beta cell transcription factor Npas4. Pharmacological inhibition implicated the calcineurin, Akt/protein kinase B, and Ca2+/calmodulin-dependent protein kinase signaling pathways in the regulation of Npas4 transcription and translation. Both Npas4 mRNA and protein had high turnover rates, and, at the protein level, degradation was mediated via the ubiquitin-proteasome pathway. Finally, beta cell cytotoxicity of the calcineurin inhibitor and immunosuppressant tacrolimus (FK-506) was prevented by Npas4 overexpression. These results delineate the pathways regulating Npas4 expression and stability and demonstrate its importance in clinical settings such as islet transplantation.	[Speckmann, Thilo; Sabatini, Paul V.; Nian, Cuilan; Smith, Riley G.; Lynn, Francis C.] Child & Family Res Inst, Diabet Res Program, Vancouver, BC V5Z 4H4, Canada; [Speckmann, Thilo; Sabatini, Paul V.; Nian, Cuilan; Lynn, Francis C.] Univ British Columbia, Dept Surg, Vancouver, BC V5Z 1M9, Canada; [Speckmann, Thilo; Sabatini, Paul V.; Nian, Cuilan; Lynn, Francis C.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada	Child & Family Research Institute; University of British Columbia; University of British Columbia	Lynn, FC (corresponding author), Child & Family Res Inst, Diabet Res Program, Vancouver, BC V5Z 4H4, Canada.; Lynn, FC (corresponding author), Univ British Columbia, Dept Surg, Vancouver, BC V5Z 1M9, Canada.; Lynn, FC (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V5Z 1M9, Canada.	francis.lynn@ubc.ca	Speckmann, Thilo/ABN-7893-2022	Speckmann, Thilo/0000-0001-7265-0879; Lynn, Francis/0000-0001-9318-1063; Sabatini, Paul/0000-0001-6613-566X	Canadian Institutes of Health [MOP 343144]; Canadian Institutes of Health Research-British Columbia transplantation trainee fellowship; University of British Columbia; Canadian Diabetes Association; Michael Smith Foundation for Health Research; Child and Family Research Institute	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Canadian Institutes of Health Research-British Columbia transplantation trainee fellowship(Canadian Institutes of Health Research (CIHR)); University of British Columbia; Canadian Diabetes Association; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Child and Family Research Institute	This work was supported by Canadian Institutes of Health Research Grant MOP 343144 (to F. C. L.).; Recipient of a Canadian Institutes of Health Research-British Columbia transplantation trainee fellowship.; Supported by doctoral fellowships from the University of British Columbia and the Canadian Diabetes Association.; Supported by the Michael Smith Foundation for Health Research, the Canadian Diabetes Association, and the Child and Family Research Institute.	Assmann A, 2009, PEDIATR DIABETES, V10, P14, DOI 10.1111/j.1399-5448.2008.00468.x; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bersten DC, 2014, BBA-GENE REGUL MECH, V1839, P13, DOI 10.1016/j.bbagrm.2013.11.004; Bhatt HS, 2000, BIOCHEM PHARMACOL, V60, P1655, DOI 10.1016/S0006-2952(00)00483-4; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432; Cantley J, 2009, J CLIN INVEST, V119, P125, DOI 10.1172/JCI26934; Cotovio P, 2013, TRANSPL P, V45, P1079, DOI 10.1016/j.transproceed.2013.03.009; da Silva Xavier Gabriela, 2003, Biochem J, V371, P761, DOI 10.1042/BJ20021812; Dadi PK, 2014, J BIOL CHEM, V289, P12435, DOI 10.1074/jbc.M114.562587; Demirci MS, 2010, CLIN TRANSPLANT, V24, pE170, DOI 10.1111/j.1399-0012.2010.01247.x; Dixit SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058655; Elghazi L, 2007, DIABETES OBES METAB, V9, P147, DOI 10.1111/j.1463-1326.2007.00783.x; Fred RG, 2009, MOL CELL ENDOCRINOL, V297, P28, DOI 10.1016/j.mce.2008.06.007; Fu A, 2013, MOL CELL ENDOCRINOL, V366, P127, DOI 10.1016/j.mce.2012.06.020; Gao L, 2006, BIOCHEM BIOPH RES CO, V345, P1606, DOI 10.1016/j.bbrc.2006.05.066; Gilon P, 2014, CELL CALCIUM, V56, P340, DOI 10.1016/j.ceca.2014.09.001; Hartley T, 2009, AM J PHYSIOL-ENDOC M, V296, pE1, DOI 10.1152/ajpendo.90538.2008; Hatanaka M, 2014, DIABETES, V63, P3404, DOI 10.2337/db14-0105; Heit JJ, 2006, NATURE, V443, P345, DOI 10.1038/nature05097; HIRANO Y, 1992, TRANSPLANTATION, V53, P889, DOI 10.1097/00007890-199204000-00033; Huang Y, 2014, PROG MOL BIOL TRANSL, V121, P321, DOI 10.1016/B978-0-12-800101-1.00010-7; ISHIDA A, 1995, BIOCHEM BIOPH RES CO, V212, P806, DOI 10.1006/bbrc.1995.2040; Johnson JD, 2009, CELL TRANSPLANT, V18, P833, DOI 10.3727/096368909X471198; Jung M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116972; Kim SJ, 2005, J BIOL CHEM, V280, P22297, DOI 10.1074/jbc.M500540200; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; KRENTZ AJ, 1993, DIABETES, V42, P1753, DOI 10.2337/diabetes.42.12.1753; Leclerc I, 2004, DIABETES, V53, pS67, DOI 10.2337/diabetes.53.suppl_3.S67; Leibiger IB, 2008, ANNU REV NUTR, V28, P233, DOI 10.1146/annurev.nutr.28.061807.155530; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Liu B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045711; Lopez-Avalos MD, 2006, DIABETES, V55, P1223, DOI 10.2337/db05-0450; Luciani DS, 2005, MOL CELL ENDOCRINOL, V241, P88, DOI 10.1016/j.mce.2005.06.006; Lynn FC, 2001, DIABETES, V50, P1004, DOI 10.2337/diabetes.50.5.1004; Lynn FC, 2009, TRENDS ENDOCRIN MET, V20, P452, DOI 10.1016/j.tem.2009.05.007; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mayer AD, 1997, TRANSPLANTATION, V64, P436, DOI 10.1097/00007890-199708150-00012; Means AR, 2008, MOL ENDOCRINOL, V22, P2759, DOI 10.1210/me.2008-0312; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Moser M, 2004, MOL BRAIN RES, V128, P141, DOI 10.1016/j.molbrainres.2004.06.023; Nishimura R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056799; Ooe N, 2004, MOL CELL BIOL, V24, P608, DOI 10.1128/MCB.24.2.608-616.2004; Ooe N, 2009, BIOCHEM BIOPH RES CO, V378, P761, DOI 10.1016/j.bbrc.2008.11.137; Pirsch JD, 1997, TRANSPLANTATION, V63, P977, DOI 10.1097/00007890-199704150-00013; Pore N, 2006, MOL CANCER RES, V4, P471, DOI 10.1158/1541-7786.MCR-05-0234; Qiu J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3034; Rorsman P, 2012, CELL CALCIUM, V51, P300, DOI 10.1016/j.ceca.2011.11.006; Sabatini PV, 2015, TRENDS ENDOCRIN MET, V26, P49, DOI 10.1016/j.tem.2014.11.002; Sabatini PV, 2013, DIABETES, V62, P2808, DOI 10.2337/db12-1527; Salt IP, 1998, BIOCHEM J, V335, P533, DOI 10.1042/bj3350533; Santos Gustavo Jorge Dos, 2014, Mol Metab, V3, P484, DOI 10.1016/j.molmet.2014.03.011; Shin S, 2014, MOL METAB, V3, P803, DOI 10.1016/j.molmet.2014.08.001; Soleimanpour SA, 2010, J BIOL CHEM, V285, P40050, DOI 10.1074/jbc.M110.154955; Sreenan SK, 2001, DIABETES, V50, P2013, DOI 10.2337/diabetes.50.9.2013; Srimontri P, 2014, EXP BRAIN RES, V232, P2957, DOI 10.1007/s00221-014-3977-y; Srinivasan S, 2005, DIABETES, V54, P968, DOI 10.2337/diabetes.54.4.968; Srinivasan S, 2002, AM J PHYSIOL-ENDOC M, V283, pE784, DOI 10.1152/ajpendo.00177.2002; Suefuji M, 2012, BIOCHEM BIOPH RES CO, V421, P801, DOI 10.1016/j.bbrc.2012.04.091; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Vasavada RC, 2006, INT J BIOCHEM CELL B, V38, P931, DOI 10.1016/j.biocel.2005.08.003; Vincenti F, 2007, AM J TRANSPLANT, V7, P1506, DOI 10.1111/j.1600-6143.2007.01749.x; Wang MJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0064860, 10.1371/journal.pone.0072082, 10.1371/journal.pone.0073741]; WELSH M, 1985, J BIOL CHEM, V260, P3590; Wrede CE, 2002, J BIOL CHEM, V277, P49676, DOI 10.1074/jbc.M208756200; Xavier GD, 2000, J BIOL CHEM, V275, P36269, DOI 10.1074/jbc.M006597200; Zhang SJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000604	67	22	24	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2682	2695		10.1074/jbc.M115.704098	http://dx.doi.org/10.1074/jbc.M115.704098			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26663079	Green Published, hybrid			2022-12-26	WOS:000369626900012
J	Deng, XB; Mohandass, D; Katabuchi, M; Hughes, AC; Roubik, DW				Deng, Xiaobao; Mohandass, Dharmalingam; Katabuchi, Masatoshi; Hughes, Alice C.; Roubik, David W.			Impact of Striped-Squirrel Nectar-Robbing Behaviour on Gender Fitness in Alpinia roxburghii Sweet (Zingiberaceae)	PLOS ONE			English	Article							BLEPHAROCALYX ZINGIBERACEAE; REPRODUCTIVE FITNESS; IPOMOPSIS-AGGREGATA; POLLINATOR BEHAVIOR; BUMBLE BEES; PLANT; ROBBERS; POLLEN; CONSEQUENCES; SUCCESS	Nectar-robbing has the potential to strongly affect male and female reproductive fitness of plants. One example of nectar theft is that shown by striped-squirrels (Tamiops swinhoei) on a number of ginger species, including Alpinia roxburghii and A. kwangsiensis (Zingiberaceae). In this study, we used a fluorescent dye as a pollen analogue, and measured fruit and seed output, to test the effect of squirrel nectar-robbing on A. roxburghii reproductive fitness. Pollen transfer between robbed and unrobbed flowers was assessed by comparing 60 randomly established plots containing robbed and unrobbed flowers. The frequency of squirrel robbing visits and broken styles were recorded from a number of flowers for five consecutive days. Two bee species (Bombus eximius and Apis cerana), were the primary pollinators, and their visitation frequency was recorded for six consecutive days. The results showed that fluorescent powder from unrobbed flowers was dispersed further, and to a greater number of flowers than that placed on robbed flowers. Additionally, robbing flowers caused significant damage to reproductive organs, resulting in lower fruit and seed sets in robbed than in unrobbed flowers and influencing both male and female fitness. The frequency of the primary pollinator visits (B. eximius) was significantly higher for unrobbed plants than for robbed plants. The present study clearly shows the negative impact of squirrel robbing on A. roxburghii male reproductive fitness and neutral impact on female reproductive fitness.	[Deng, Xiaobao; Mohandass, Dharmalingam; Roubik, David W.] Chinese Acad Sci, XTBG, Key Lab Trop Forest Ecol, Mengla County 666303, Yunnan, Peoples R China; [Katabuchi, Masatoshi] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Hughes, Alice C.] Chinese Acad Sci, XTBG, Ctr Integrat Conservat, Mengla County 666303, Yunnan, Peoples R China; [Roubik, David W.] Smithsonian Trop Res Inst, Balboa 03092, Ancon, Panama	Chinese Academy of Sciences; State University System of Florida; University of Florida; Chinese Academy of Sciences; Smithsonian Institution; Smithsonian Tropical Research Institute	Mohandass, D (corresponding author), Chinese Acad Sci, XTBG, Key Lab Trop Forest Ecol, Mengla County 666303, Yunnan, Peoples R China.	dmohandass997@yahoo.com	Katabuchi, Masatoshi/P-3768-2018; Mohandass, Dharmalingam/AAT-4750-2020; hughes, Alice/HCH-3838-2022	Katabuchi, Masatoshi/0000-0001-9900-9029; Mohandass, Dharmalingam/0000-0002-0949-6589; hughes, Alice/0000-0002-4899-3158	National Science Foundation of China [30470271, 31061160188-03, 31200173]; Chinese Academy of Sciences Research Fellowship for International Young Scientist Researchers [119103KP11]; Xishuangbanna Station for Tropical Rain Forest Ecosystem Studies; Caiyonghe National Park of Chinese Forestry Administration	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences Research Fellowship for International Young Scientist Researchers; Xishuangbanna Station for Tropical Rain Forest Ecosystem Studies; Caiyonghe National Park of Chinese Forestry Administration	This research was supported by the National Science Foundation of China Grant No. 30470271 and 31061160188-03, awarded to Xiao-bao Deng, who conducted the experiment in the field. The publication was also supported by the National Natural Science Foundation of China Grant. No. 31200173, awarded to D. Mohandass, who helped write this paper. The study was partially supported by Chinese Academy of Sciences Research Fellowship for International Young Scientist Researchers (119103KP11), awarded to M. Katabuchi, who performed the statistical analyses. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the Xishuangbanna Station for Tropical Rain Forest Ecosystem Studies and Caiyonghe National Park of Chinese Forestry Administration for allowing us to use their facilities and for their support of our fieldwork. We are thankful to Prof. Qing-Jun Li who provided logistic support and facilities for writing this paper. We are also thankful to two anonymous reviewers for helpful comments on the manuscript. Our sincere thanks go to Mr. Kingsly Chuo Beng and Mr. Mason J. Campbell for useful English corrections in the final version. We are also grateful to Dr. Michael Breed for his insightful suggestions pertaining to the field experiment, and for obtaining fluorescence powder from Colorado University, USA. We thank Chun Li, Donghua Zhou and Congjian Luo for their assistance in the fieldwork conducted during the flowering seasons.	Arizmendi MC, 1996, FUNCT ECOL, V10, P119, DOI 10.2307/2390270; Burkle LA, 2007, AM J BOT, V94, P1935, DOI 10.3732/ajb.94.12.1935; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Castro S, 2008, PLANT ECOL, V199, P201, DOI 10.1007/s11258-008-9424-z; Darwin C, 1877, EFFECTS CROSS SELF F; Deng XB, 2004, BIOTROPICA, V36, P633, DOI 10.1646/1603; Deng XiaoBao, 2005, Acta Phytoecologica Sinica, V29, P274; FRITZ RS, 1981, OECOLOGIA, V50, P316, DOI 10.1007/BF00344969; Galen C, 1999, OIKOS, V85, P426, DOI 10.2307/3546692; Gelman A., 2004, BAYESIAN DATA ANAL; Gonzalez-Gomez PL, 2005, BIOTROPICA, V37, P693, DOI 10.1111/j.1744-7429.2005.00088.x; HIGASHI S, 1988, ECOL ENTOMOL, V13, P411, DOI 10.1111/j.1365-2311.1988.tb00373.x; HODGES CM, 1985, ECOLOGY, V66, P179, DOI 10.2307/1941318; Huang WJ, 1995, RODENTS CHINA, P76; INOUYE DW, 1980, ECOLOGY, V61, P1251, DOI 10.2307/1936841; Irwin RE, 2000, ECOLOGY, V81, P2637, DOI 10.1890/0012-9658(2000)081[2637:CONRFR]2.0.CO;2; Irwin RE, 2006, AM J BOT, V93, P64, DOI 10.3732/ajb.93.1.64; Irwin RE, 1998, OECOLOGIA, V116, P519, DOI 10.1007/s004420050617; Irwin RE, 2010, ANNU REV ECOL EVOL S, V41, P271, DOI 10.1146/annurev.ecolsys.110308.120330; Irwin RE, 2008, ECOLOGY, V89, P3093, DOI 10.1890/08-0081.1; JENSEN TS, 1985, OIKOS, V44, P149, DOI 10.2307/3544056; Li QJ, 2001, NATURE, V410, P432, DOI 10.1038/35068635; Maloof JE, 2001, AM J BOT, V88, P1960, DOI 10.2307/3558423; Maloof JE, 2000, ECOLOGY, V81, P2651, DOI 10.1890/0012-9658(2000)081[2651:ANRCOM]2.0.CO;2; Maruyama PK, 2015, OECOLOGIA, V178, P783, DOI 10.1007/s00442-015-3275-9; Mayer C, 2014, EVOL ECOL, V28, P669, DOI 10.1007/s10682-014-9696-9; Momose K, 1998, AM J BOT, V85, P1477, DOI 10.2307/2446404; Morris WF, 1996, ECOLOGY, V77, P1451, DOI 10.2307/2265542; NEWTON SD, 1983, J APICULT RES, V22, P124, DOI 10.1080/00218839.1983.11100573; PYKE GH, 1982, ECOLOGY, V63, P555, DOI 10.2307/1938970; R Core Team, 2021, R LANGUAGE ENV STAT; REDDY TB, 1992, CURR SCI INDIA, V62, P690; Renner SS, 2001, TRENDS ECOL EVOL, V16, P595, DOI 10.1016/S0169-5347(01)02280-7; Richardson SJ, 2004, OECOLOGIA, V139, P267, DOI 10.1007/s00442-004-1501-y; ROUBIK DW, 1982, ECOLOGY, V63, P354, DOI 10.2307/1938953; ROUBIK DW, 1985, OECOLOGIA, V66, P161, DOI 10.1007/BF00379850; Spielgelhalter D, 2003, WINBUGS USER MANUAL; Stout JC, 2000, ACTA OECOL, V21, P277, DOI 10.1016/S1146-609X(00)01085-7; Sun S, 2007, ANN BOT-LONDON, V99, P661, DOI 10.1093/aob/mcl292; Tandon R, 2003, ANN BOT-LONDON, V92, P715, DOI 10.1093/aob/mcg193; Temeles EJ, 2002, INT J PLANT SCI, V163, P803, DOI 10.1086/342033; THOMSON JD, 1986, J ECOL, V74, P329, DOI 10.2307/2260258; THOMSON JD, 1980, OECOLOGIA, V46, P68, DOI 10.1007/BF00346968; Traveset A, 1998, FUNCT ECOL, V12, P459, DOI 10.1046/j.1365-2435.1998.00212.x; WASER NM, 1982, ECOLOGY, V63, P1168, DOI 10.2307/1937253; Zhang L, 2003, PLANT SYST EVOL, V241, P67, DOI 10.1007/s00606-003-0021-2; Zhang YW, 2009, J EVOLUTION BIOL, V22, P527, DOI 10.1111/j.1420-9101.2008.01669.x; Zhang YW, 2007, PLANT ECOL, V193, P1, DOI 10.1007/s11258-006-9244-y; Zhang YW, 2014, J ECOL, V102, P229, DOI 10.1111/1365-2745.12166; ZIMMERMAN M, 1985, AM MIDL NAT, V113, P84, DOI 10.2307/2425350	51	1	2	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144585	10.1371/journal.pone.0144585	http://dx.doi.org/10.1371/journal.pone.0144585			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689684	gold, Green Published			2022-12-26	WOS:000367092300010
J	Nelson, A; Wassmann, R; Sander, BO; Palao, LK				Nelson, Andrew; Wassmann, Reiner; Sander, Bjoern Ole; Palao, Leo Kris			Climate-Determined Suitability of the Water Saving Technology "Alternate Wetting and Drying" in Rice Systems: A Scalable Methodology demonstrated for a Province in the Philippines	PLOS ONE			English	Article							MANAGEMENT; IRRIGATION; TRENDS; ASIA	70% of the world's freshwater is used for irrigated agriculture and demand is expected to increase to meet future food security requirements. In Asia, rice accounts for the largest proportion of irrigated water use and reducing or conserving water in rice systems has been a long standing goal in agricultural research. The Alternate Wetting and Drying (AWD) technique has been developed to reduce water use by up to 30% compared to the continuously flooded conditions typically found in rice systems, while not impacting yield. AWD also reduces methane emissions produced by anaerobic archae and hence has applications for reducing water use and greenhouse gas emissions. Although AWD is being promoted across Asia, there have been no attempts to estimate the suitable area for this promising technology on a large scale. We present and demonstrate a spatial and temporal climate suitability assessment method for AWD that can be widely applied across rice systems in Asia. We use a simple water balance model and easily available spatial and temporal information on rice area, rice seasonality, rainfall, potential evapotranspiration and soil percolation rates to assess the suitable area per season. We apply the model to Cagayan province in the Philippines and conduct a sensitivity analysis to account for uncertainties in soil percolation and suitability classification. As expected, the entire dry season is climatically suitable for AWD for all scenarios. A further 60% of the wet season area is found suitable contradicting general perceptions that AWD would not be feasible in the wet season and showing that spatial and temporal assessments are necessary to explore the full potential of AWD.	[Nelson, Andrew] Univ Twente, Fac Geoinformat & Earth Observat ITC, NL-7500 AE Enschede, Netherlands; [Wassmann, Reiner; Sander, Bjoern Ole; Palao, Leo Kris] Int Rice Res Inst, Los Banos 4031, Philippines	University of Twente; CGIAR; International Rice Research Institute (IRRI)	Nelson, A (corresponding author), Univ Twente, Fac Geoinformat & Earth Observat ITC, NL-7500 AE Enschede, Netherlands.	a.nelson@utwente.nl	Nelson, Andy/G-3649-2012	Nelson, Andy/0000-0002-7249-3778	CGIAR Research Program on Rice: Global Rice Science Partnership (GRISP); CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS); Climate and Clean Air Coalition (CCAC)	CGIAR Research Program on Rice: Global Rice Science Partnership (GRISP)(CGIAR); CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS)(CGIAR); Climate and Clean Air Coalition (CCAC)	AN, RW, and LKP received support from The CGIAR Research Program on Rice: Global Rice Science Partnership (GRISP), http://www.grisp.net/main/summary. BOS received support from The CGIAR Research Program on Climate Change, Agriculture and Food Security (CCAFS), https://ccafs.cgiar.org/. BOS received support from Climate and Clean Air Coalition (CCAC), http://www.ccacoalition.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen R. G., 1998, FAO Irrigation and Drainage Paper; [Anonymous], 1985, REFERENCE CROP EVAPO; [Anonymous], 2006, CARBON LAND WATER GL; Aureus M, 2009, RICE TODAY, V8, P16; Bouman B. A. M., 2001, International Rice Research Notes, V26, P17; Bouman B.A.M., 2007, WATER MANAGEMENT IRR, P53; Dawe D, 2005, PLANT PROD SCI, V8, P221, DOI 10.1626/pps.8.221; Doll P, 2002, WATER RESOUR RES, V38, DOI 10.1029/2001WR000355; Food and Agriculture Organization (FAO), 2013, AQUASTAT; Frenken K., 2012, IRRIGATION WATER REQ; GRiSP (Global Rice Science Partnership). (, 2013, RICE ALMANAC, V4th edition; Hijmans R., 2012, GLOBAL ADM AREAS DAT; Humphreys E, 2005, PLANT PROD SCI, V8, P242, DOI 10.1626/pps.8.242; IRRI PhilRice, 2013, MAPP RIC PHIL; Khan S, 2006, AGR WATER MANAGE, V80, P87, DOI 10.1016/j.agwat.2005.07.006; Lampayan RM, 2015, FIELD CROP RES, V170, P95, DOI 10.1016/j.fcr.2014.10.013; Molle F., 2004, EVOLUTION IRRIGATION, P1; MONDAL MK, 1993, AGR WATER MANAGE, V23, P11, DOI 10.1016/0378-3774(93)90017-5; NOAA, 2015, GLOB SURF SUMM DAY G; PSA, 2012, 2010 CENS POP HOUS P; Richards M, 2014, ALTERNATE WETTING DR; Rosegrant MW, 2009, ANNU REV ENV RESOUR, V34, P205, DOI 10.1146/annurev.environ.030308.090351; Sakaguchi A, 2014, AGR WATER MANAGE, V137, P116, DOI [10.1016/j.agwat.2014.01.009, 10.1016/j.agwat.2014.01.099]; Sander BO, 2014, GEODERMA, V235, P355, DOI 10.1016/j.geoderma.2014.07.020; Searchinger T, 2015, WETTING DRYING REDUC; SIOPONGCO JDL, 2013, ALTERNATE WETTING DR; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; TUONG TP, 1994, SOIL SCI SOC AM J, V58, P1794, DOI 10.2136/sssaj1994.03615995005800060031x; UNFCCC, 2011, AMS 3 AU METH EM RED; UNFCCC, 2015, ASB0008 STAND BAS ME; Uprety, 2017, TECHNOLOGIES CLIMATE; Vorosmarty CJ, 2010, NATURE, V467, P555, DOI 10.1038/nature09440; Vorosmarty CJ, 2000, SCIENCE, V289, P284, DOI 10.1126/science.289.5477.284; Wada Y, 2011, HYDROL EARTH SYST SC, V15, P3785, DOI 10.5194/hess-15-3785-2011; WOPEREIS MCS, 1992, SOIL TILL RES, V24, P199, DOI 10.1016/0167-1987(92)90087-R; Xiao XM, 2006, REMOTE SENS ENVIRON, V100, P95, DOI 10.1016/j.rse.2005.10.004	36	24	24	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145268	10.1371/journal.pone.0145268	http://dx.doi.org/10.1371/journal.pone.0145268			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689778	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092300051
J	Weehuizen, TAF; Prior, JL; van der Vaart, TW; Ngugi, SA; Nepogodiev, SA; Field, RA; Kager, LM; van't Veer, C; de Vos, AF; Wiersinga, WJ				Weehuizen, Tassili A. F.; Prior, Joann L.; van der Vaart, Thomas W.; Ngugi, Sarah A.; Nepogodiev, Sergey A.; Field, Robert A.; Kager, Liesbeth M.; van't Veer, Cornelis; de Vos, Alex F.; Wiersinga, W. Joost			Differential Toll-Like Receptor-Signalling of Burkholderia pseudomallei Lipopolysaccharide in Murine and Human Models	PLOS ONE			English	Article							ANTIGENIC POLYSACCHARIDE MOIETY; SUBTRACTIVE HYBRIDIZATION; CAPSULAR POLYSACCHARIDE; HOST-DEFENSE; LIPID-A; LPS; DIVERSITY; EPIDEMIOLOGY; MELIOIDOSIS; RECOGNITION	The Gram-negative bacterium Burkholderia pseudomallei causes melioidosis and is a CDC category B bioterrorism agent. Toll-like receptor (TLR)-2 impairs host defense during pulmonary B. pseudomallei infection while TLR4 only has limited impact. We investigated the role of TLRs in B. pseudomallei-lipopolysaccharide (LPS) induced inflammation. Purified B. pseudomallei-LPS activated only TLR2-transfected-HEK-cells during short stimulation but both HEK-TLR2 and HEK-TLR4-cells after 24 h. In human blood, an additive effect of TLR2 on TLR4-mediated signalling induced by B. pseudomallei-LPS was observed. In contrast, murine peritoneal macrophages recognized B. pseudomallei-LPS solely through TLR4. Intranasal inoculation of B. pseudomallei-LPS showed that both TLR4-knockout((-/-)) and TLR2x4(-/-), but not TLR2(-/-) mice, displayed diminished cytokine responses and neutrophil influx compared to wild-type controls. These data suggest that B. pseudomallei-LPS signalling occurs solely through murine TLR4, while in human models TLR2 plays an additional role, highlighting important differences between specificity of human and murine models that may have important consequences for B. pseudomallei-LPS sensing by TLRs and subsequent susceptibility to melioidosis.	[Weehuizen, Tassili A. F.; van der Vaart, Thomas W.; Kager, Liesbeth M.; van't Veer, Cornelis; de Vos, Alex F.; Wiersinga, W. Joost] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, NL-1105 AZ Amsterdam, Netherlands; [Weehuizen, Tassili A. F.; van der Vaart, Thomas W.; Kager, Liesbeth M.; van't Veer, Cornelis; de Vos, Alex F.; Wiersinga, W. Joost] Univ Amsterdam, Acad Med Ctr, CEMM, NL-1105 AZ Amsterdam, Netherlands; [Prior, Joann L.; Ngugi, Sarah A.] Def Sci & Technol Lab, Salisbury, Wilts, England; [Nepogodiev, Sergey A.; Field, Robert A.] John Innes Ctr, Colney, Herts, England; [Wiersinga, W. Joost] Univ Amsterdam, Acad Med Ctr, Div Infect Dis, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Defence Science & Technology Laboratory; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Amsterdam; Academic Medical Center Amsterdam	Weehuizen, TAF (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun Amsterdam CINIMA, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	t.a.weehuizen@amc.uva.nl; w.j.wiersinga@amc.uva.nl	van der Vaart, Thomas/AFQ-1712-2022	van der Vaart, Thomas/0000-0002-5873-0474; Wiersinga, Willem/0000-0003-2277-1343; Field, Rob/0000-0001-8574-0275	Netherlands Organisation for Health Research and Development / ZonMW [90700424]; Netherlands Organization for Scientific Research [91610008]; BBSRC [BBS/E/J/000C0618] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0618] Funding Source: researchfish	Netherlands Organisation for Health Research and Development / ZonMW(Netherlands Organization for Health Research and Development); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Netherlands Organisation for Health Research and Development / ZonMW; grant number 90700424 and the Netherlands Organization for Scientific Research; grant number: 91610008.	Anas AA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010183; Anuntagool N, 2006, AM J TROP MED HYG, V74, P348, DOI 10.4269/ajtmh.2006.74.348; Anuntagool N, 2000, Southeast Asian J Trop Med Public Health, V31 Suppl 1, P146; Arjcharoen S, 2007, INFECT IMMUN, V75, P4298, DOI 10.1128/IAI.00285-07; Brett PJ, 2007, MOL MICROBIOL, V63, P379, DOI 10.1111/j.1365-2958.2006.05519.x; Burtnick MN, 1999, ANTIMICROB AGENTS CH, V43, P2648, DOI 10.1128/AAC.43.11.2648; Caroff M, 2002, MICROBES INFECT, V4, P915, DOI 10.1016/S1286-4579(02)01612-X; Centers for Disease Control and Prevention (CDC) Department of Health and Human Services (HHS), 2012, Fed Regist, V77, P61083; Chan JK, 2012, J CLIN INVEST, V122, P2711, DOI 10.1172/JCI62423; Chantratita N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081617; Charuchaimontri C, 1999, CLIN INFECT DIS, V29, P813, DOI 10.1086/520441; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Darveau RP, 1998, CURR OPIN MICROBIOL, V1, P36, DOI 10.1016/S1369-5274(98)80140-9; Darveau RP, 2004, INFECT IMMUN, V72, P5041, DOI 10.1128/IAI.72.9.5041-5051.2004; DeShazer D, 2004, J BACTERIOL, V186, P3938, DOI 10.1128/JB.186.12.3938-3950.2004; DeShazer D, 1998, MOL MICROBIOL, V30, P1081, DOI 10.1046/j.1365-2958.1998.01139.x; Goris MGA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018279; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Ho M, 1997, INFECT IMMUN, V65, P3648, DOI 10.1128/IAI.65.9.3648-3653.1997; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; JOHNSON KG, 1976, CAN J MICROBIOL, V22, P29, DOI 10.1139/m76-004; Lee HK, 2002, J IMMUNOL, V168, P4012, DOI 10.4049/jimmunol.168.8.4012; Lindner B, 2000, METH MOL B, V145, P311; Matsuura M, 1996, FEMS MICROBIOL LETT, V137, P79, DOI 10.1111/j.1574-6968.1996.tb08086.x; Medzhitov R, 2001, NAT REV IMMUNOL, V1, P135, DOI 10.1038/35100529; Meumann EM, 2012, CLIN INFECT DIS, V54, P362, DOI 10.1093/cid/cir808; Mulye M, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002988; Munford RS, 2008, INFECT IMMUN, V76, P454, DOI 10.1128/IAI.00939-07; Nahori MA, 2005, J IMMUNOL, V175, P6022, DOI 10.4049/jimmunol.175.9.6022; Nelson M, 2004, J MED MICROBIOL, V53, P1177, DOI 10.1099/jmm.0.45766-0; Netea MG, 2002, TRENDS IMMUNOL, V23, P135, DOI 10.1016/S1471-4906(01)02169-X; Novem V, 2009, CLIN VACCINE IMMUNOL, V16, P1420, DOI 10.1128/CVI.00472-08; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Pristovsek P, 1999, J MED CHEM, V42, P4604, DOI 10.1021/jm991031b; Reckseidler SL, 2001, INFECT IMMUN, V69, P34, DOI 10.1128/IAI.69.1.34-44.2001; Rehli M, 2002, TRENDS IMMUNOL, V23, P375, DOI 10.1016/S1471-4906(02)02259-7; Rotz LD, 2002, EMERG INFECT DIS, V8, P225, DOI 10.3201/eid0802.010164; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Seydel U, 2000, CHEM IMMUNOL, V74, P5; Simpson AJH, 2000, J INFECT DIS, V181, P1014, DOI 10.1086/315306; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; Tuanyok A, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001453; van 't Veer C, 2011, J BIOL CHEM, V286, P36603, DOI 10.1074/jbc.M110.189126; WARREN HS, 1985, ANTIMICROB AGENTS CH, V28, P107, DOI 10.1128/AAC.28.1.107; Werts C, 2001, NAT IMMUNOL, V2, P346, DOI 10.1038/86354; Weshphal O. JK, 1974, METHODS CARBOHYDRATE, V5, P83; West TE, 2012, GENES IMMUN, V13, P38, DOI 10.1038/gene.2011.49; West TE, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-46; Wiersinga WJ, 2008, J INFECT DIS, V198, P1388, DOI 10.1086/592220; Wiersinga WJ, 2007, PLOS MED, V4, P1268, DOI 10.1371/journal.pmed.0040248; Wiersinga WJ, 2007, J INFECT DIS, V196, P1707, DOI 10.1086/522141; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699; Wiersinga WJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003494; Woodman ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052276; Yu M, 2006, SHOCK, V26, P174, DOI 10.1097/01.shk.0000225404.51320.82	56	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145397	10.1371/journal.pone.0145397	http://dx.doi.org/10.1371/journal.pone.0145397			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689559	Green Submitted, Green Published, gold			2022-12-26	WOS:000367092300069
J	Alves, SP; Raundrup, K; Cabo, A; Bessa, RJB; Almeida, AM				Alves, Susana P.; Raundrup, Katrine; Cabo, Angelo; Bessa, Rui J. B.; Almeida, Andre M.			Fatty Acid Composition of Muscle, Adipose Tissue and Liver from Muskoxen (Ovibos moschatus) Living in West Greenland	PLOS ONE			English	Article							BRANCHED-CHAIN; INTRAMUSCULAR FAT; ANGUJAARTORFIUP NUNAA; NUTRITIONAL QUALITY; TRANS-18/1 ISOMERS; SEASONAL-VARIATION; BODY-COMPOSITION; BEEF; MEAT; TRIGLYCERIDES	Information about lipid content and fatty acid (FA) composition of muskoxen (Ovibos moschatos) edible tissues is very limited in comparison to other meat sources. Thus, this work aims to present the first in-depth characterization of the FA profile of meat, subcutaneous adipose tissue and liver of muskoxen living in West Greenland. Furthermore, we aim to evaluate the effect of sex in the FA composition of these edible tissues. Samples from muscle (Longissimus dorsi), subcutaneous adipose tissue and liver were collected from female and male muskoxen, which were delivered at the butchery in Kangerlussuaq (West Greenland) during the winter hunting season. The lipid content of muscle, adipose tissue and liver averaged 284, 846 and 173 mg/g of dry tissue, respectively. This large lipid contents confirms that in late winter, when forage availability is scarce, muskoxen from West Greenland still have high fat reserves, demonstrating that they are well adapted to seasonal feed restriction. A detailed characterization of FA and dimethylacetal composition of muskoxen muscle, subcutaneous adipose tissue and liver showed that there are little differences on FA composition between sexes. Nevertheless, the 18:1cis-9 was the most abundant FA in muscle and adipose tissue, reaching 43% of total FA in muscle. The high content of 18:1cis-9 suggests that it can be selectively stored in muskoxen tissues. Regarding the nutritional composition of muskoxen edible tissues, they are not a good source of polyunsaturated FA; however, they may contribute to a higher fat intake. Information about the FA composition of muskoxen meat and liver is scarce, so this work can contribute to the characterization of the nutritional fat properties of muskoxen edible tissues and can be also useful to update food composition databases.	[Alves, Susana P.; Cabo, Angelo; Bessa, Rui J. B.; Almeida, Andre M.] Univ Lisbon, FMV, CIISA, P-1699 Lisbon, Portugal; [Raundrup, Katrine] Greenland Inst Nat Resources, Nuuk, Greenland; [Almeida, Andre M.] IBET, Oeiras, Portugal	Universidade de Lisboa; Greenland Institute of Natural Resources	Alves, SP (corresponding author), Univ Lisbon, FMV, CIISA, P-1699 Lisbon, Portugal.	susanaalves@fmv.ulisboa.pt	Alves, Susana P/C-1447-2008; Almeida, Andre/I-4369-2013; Bessa, Rui J. B./B-8006-2008; Alves, Susana/Q-3889-2019	Alves, Susana P/0000-0002-3171-9566; Almeida, Andre/0000-0002-7810-3988; Bessa, Rui J. B./0000-0003-4109-3488; Alves, Susana/0000-0002-3171-9566	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BPD/76836/2011]; FCT [PTDC/CVT/120122/2010, UID/CVT/00276/2013]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	SPA was supported by Fundacao para a Ciencia e a Tecnologia (FCT) (www.fct.pt) through grant SFRH/BPD/76836/2011. The work was also supported by FCT through grants PTDC/CVT/120122/2010 and UID/CVT/00276/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMCZEWSKI JZ, 1994, CAN J ANIM SCI, V74, P305, DOI 10.4141/cjas94-042; Adamczewski JZ, 1997, J ZOOL, V241, P245, DOI 10.1111/j.1469-7998.1997.tb01956.x; Adamczewski JZ, 1995, CAN J ZOOL, V73, P2021, DOI 10.1139/z95-238; Aldai N, 2011, ANIMAL, V5, P1643, DOI 10.1017/S1751731111000607; Aldai N, 2013, EUR J LIPID SCI TECH, V115, P1378, DOI 10.1002/ejlt.201300072; Alfaia CPM, 2009, FOOD CHEM, V114, P939, DOI 10.1016/j.foodchem.2008.10.041; Alves SP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077313; Becker W, 2008, SCAND J NUTR, V48, P10, DOI [10.3402/fnr.v48i4.1633, DOI 10.3402/FNR.V48I4.1633]; Bell A W, 1979, Prog Lipid Res, V18, P117, DOI 10.1016/0163-7827(79)90013-4; Berthelot V, 2001, SMALL RUMINANT RES, V41, P29, DOI 10.1016/S0921-4488(01)00190-0; Bessa RJB, 2007, EUR J LIPID SCI TECH, V109, P868, DOI 10.1002/ejlt.200600311; Bessa RJB, 2015, EUR J LIPID SCI TECH, V117, P1325, DOI 10.1002/ejlt.201400468; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Cappelen J, 2015, 1508 DAN MET I; Costa ASH, 2012, INT J BIOL SCI, V8, P214, DOI 10.7150/ijbs.8.214; Cruz-Hernandez C, 2004, J AOAC INT, V87, P545; Cuyler C, 2009, 75 GREENL I NAT RES; Dugan MER, 2007, LIPIDS, V42, P509, DOI 10.1007/s11745-007-3051-7; DUNCAN WRH, 1978, BRIT J NUTR, V40, P29, DOI 10.1079/BJN19780092; Dyall SC, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00052; Enser M, 1998, MEAT SCI, V49, P329, DOI 10.1016/S0309-1740(97)00144-7; Enser M, 1998, MEAT SCI, V49, P321, DOI 10.1016/S0309-1740(97)00143-5; FAO, 2010, FATS FATT AC HUM NUT; FOLCH J, 1957, J BIOL CHEM, V226, P497; FORCHHAMMER MC, 1995, CAN J ZOOL, V73, P1344, DOI 10.1139/z95-158; GARTON GA, 1971, J SCI FOOD AGR, V22, P29, DOI 10.1002/jsfa.2740220110; GARTON GA, 1972, BRIT J NUTR, V28, P409, DOI 10.1079/BJN19720050; GARTON GA, 1971, CAN J ZOOLOG, V49, P1159, DOI 10.1139/z71-176; Hassan AA, 2012, INT J CIRCUMPOL HEAL, V71, DOI 10.3402/ijch.v71i0.17997; Hills Foods, 2015, WILD ARCT MUSK; Hocquette JF, 2010, ANIMAL, V4, P303, DOI 10.1017/S1751731109991091; Hocquette JF, 1999, REPROD NUTR DEV, V39, P27, DOI 10.1051/rnd:19990102; Hoffman LC, 2006, MEAT SCI, V74, P197, DOI 10.1016/j.meatsci.2006.04.005; HORNING MG, 1961, J BIOL CHEM, V236, P669; Howe P, 2006, NUTRITION, V22, P47, DOI 10.1016/j.nut.2005.05.009; Jeronimo E, 2010, ANIM FEED SCI TECH, V158, P136, DOI 10.1016/j.anifeedsci.2010.04.010; Jorgensen B. V., 2001, 0018 DAN MET I; Kelley NS, 2007, J NUTR, V137, P2599, DOI 10.1093/jn/137.12.2599; Kim SC, 2007, J ANIM SCI, V85, P706, DOI 10.2527/jas.2006-289; Kraft J, 2008, J AGR FOOD CHEM, V56, P4775, DOI 10.1021/jf8001813; Kuhnlein HV, 2002, J FOOD COMPOS ANAL, V15, P545, DOI 10.1016/S0889-1575(02)91066-5; Mapiye C, 2012, MEAT SCI, V92, P210, DOI 10.1016/j.meatsci.2012.03.016; National Health and Medical Research Council, 2006, NUTR REF VAL AUSTR N; Nellemann C, 1997, CAN J ZOOL, V75, P1129, DOI 10.1139/z97-135; Nunavut Development Corporation, 2015, NUN MUSK; Olesen Carsten Riis, 1993, Rangifer, V13, P27; Park Y, 2007, FOOD RES INT, V40, P311, DOI 10.1016/j.foodres.2006.11.002; Pedersen CB, 2000, ARCTIC, V53, P18; Pestana JM, 2012, J SCI FOOD AGR, V92, P2428, DOI 10.1002/jsfa.5648; Pestana JM, 2012, EUR FOOD RES TECHNOL, V234, P187, DOI 10.1007/s00217-011-1625-3; Pestana JM, 2012, MEAT SCI, V90, P819, DOI 10.1016/j.meatsci.2011.11.023; RACLOT T, 1993, J LIPID RES, V34, P1515; Raclot T, 2003, PROG LIPID RES, V42, P257, DOI 10.1016/S0163-7827(02)00066-8; Raghavan M, 2014, QUATERNARY SCI REV, V102, P192, DOI 10.1016/j.quascirev.2014.08.001; Ran-Ressler RR, 2011, LIPIDS, V46, P569, DOI 10.1007/s11745-011-3530-8; Robinson JG, 2006, AM J CARDIOL, V98, p39I, DOI 10.1016/j.amjcard.2005.12.026; Rosa HJD, 2014, J ANIM SCI, V92, P3701, DOI 10.2527/jas.2013-6982; Rowell JE, 2001, J ANIM SCI, V79, P1670; SCAIFE JR, 1978, BIOCHEM J, V176, P799, DOI 10.1042/bj1760799; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Simopoulos Artemis P., 1999, Annals of Nutrition and Metabolism, V43, P127, DOI 10.1159/000012777; Soppela P, 2002, COMP BIOCHEM PHYS A, V132, P403, DOI 10.1016/S1095-6433(02)00040-5; STAALAND H, 1992, Rangifer, V12, P105; STURDIVANT CA, 1992, MEAT SCI, V32, P449, DOI 10.1016/0309-1740(92)90086-J; Tajik Hossein, 2012, Vet Res Forum, V3, P275; THING H, 1987, HOLARCTIC ECOL, V10, P95; US Department of Agriculture ARS, 2014, USDA NAT NUTR DAT ST; Vlaeminck B, 2006, ANIM FEED SCI TECH, V131, P389, DOI 10.1016/j.anifeedsci.2006.06.017; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Yurawecz MP, 1998, LIPIDS, V33, P803, DOI 10.1007/s11745-998-0273-z	70	18	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145241	10.1371/journal.pone.0145241	http://dx.doi.org/10.1371/journal.pone.0145241			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678792	Green Submitted, Green Published, gold			2022-12-26	WOS:000366723400063
J	Gothard, D; Smith, EL; Kanczler, JM; Black, CR; Wells, JA; Roberts, CA; White, LJ; Qutachi, O; Peto, H; Rashidi, H; Rojo, L; Stevens, MM; El Haj, AJ; Rose, FRAJ; Shakesheff, KM; Oreffo, ROC				Gothard, David; Smith, Emma L.; Kanczler, Janos M.; Black, Cameron R.; Wells, Julia A.; Roberts, Carol A.; White, Lisa J.; Qutachi, Omar; Peto, Heather; Rashidi, Hassan; Rojo, Luis; Stevens, Molly M.; El Haj, Alicia J.; Rose, Felicity R. A. J.; Shakesheff, Kevin M.; Oreffo, Richard O. C.			In Vivo Assessment of Bone Regeneration in Alginate/Bone ECM Hydrogels with Incorporated Skeletal Stem Cells and Single Growth Factors	PLOS ONE			English	Article							FACTOR-RELEASING HYDROGELS; EXTRACELLULAR-MATRIX; CHONDROGENIC DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; MORPHOGENETIC PROTEIN-2; MECHANICAL-PROPERTIES; GRAFT SUBSTITUTES; COLLAGEN HYDROGEL; FACTOR DELIVERY; TISSUE-REPAIR	The current study has investigated the use of decellularised, demineralised bone extracellular matrix (ECM) hydrogel constructs for in vivo tissue mineralisation and bone formation. Stro-1-enriched human bone marrow stromal cells were incorporated together with select growth factors including VEGF, TGF-beta 3, BMP-2, PTHrP and VitD3, to augment bone formation, and mixed with alginate for structural support. Growth factors were delivered through fast (non-osteogenic factors) and slow (osteogenic factors) release PLGA microparticles. Constructs of 5 mm length were implanted in vivo for 28 days within mice. Dense tissue assessed by micro-CT correlated with histologically assessed mineralised bone formation in all constructs. Exogenous growth factor addition did not enhance bone formation further compared to alginate/bone ECM (ALG/ECM) hydrogels alone. UV irradiation reduced bone formation through degradation of intrinsic growth factors within the bone ECM component and possibly also ECM cross-linking. BMP-2 and VitD3 rescued osteogenic induction. ALG/ECM hydrogels appeared highly osteoinductive and delivery of angiogenic or chondrogenic growth factors led to altered bone formation. All constructs demonstrated extensive host tissue invasion and vascularisation aiding integration and implant longevity. The proposed hydrogel system functioned without the need for growth factor incorporation or an exogenous inducible cell source. Optimal growth factor concentrations and spatiotemporal release profiles require further assessment, as the bone ECM component may suffer batch variability between donor materials. In summary, ALG/ECM hydrogels provide a versatile biomaterial scaffold for utilisation within regenerative medicine which may be tailored, ultimately, to form the tissue of choice through incorporation of select growth factors.	[Gothard, David; Smith, Emma L.; Kanczler, Janos M.; Black, Cameron R.; Wells, Julia A.; Roberts, Carol A.; Oreffo, Richard O. C.] Univ Southampton, Bone & Joint Res Grp, Ctr Human Dev Stem Cells & Regenerat, Inst Dev Sci, Southampton SO16 6YD, Hants, England; [White, Lisa J.; Qutachi, Omar; Peto, Heather; Rashidi, Hassan; Rose, Felicity R. A. J.; Shakesheff, Kevin M.] Univ Nottingham, Wolfson Ctr Stem Cells Tissue Engn & Modelling, Sch Pharm, Ctr Biomol Sci, Nottingham NG7 2RD, England; [Shakesheff, Kevin M.] Locate Therapeut Ltd, MediCity, Nottingham NG90 6BH, England; [Rojo, Luis; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Royal Sch Mines, Dept Mat, London SW7 2AZ, England; [Rojo, Luis; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, London SW7 2AZ, England; [Rojo, Luis; Stevens, Molly M.] Univ London Imperial Coll Sci Technol & Med, Inst Biomed Engn, London SW7 2AZ, England; [Rojo, Luis] Guys Hosp, Biomat Biomimet Biophoton Res Div, Kings Coll London, Inst Dent, London SE1 9RT, England; [El Haj, Alicia J.] Keele Univ, Inst Sci & Technol Med, Guy Hilton Res Ctr, Keele ST4 7BQ, Staffs, England	University of Southampton; University of Nottingham; Imperial College London; Imperial College London; Imperial College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Keele University	Gothard, D (corresponding author), Univ Southampton, Bone & Joint Res Grp, Ctr Human Dev Stem Cells & Regenerat, Inst Dev Sci, Southampton SO16 6YD, Hants, England.	D.Gothard@soton.ac.uk; roco@soton.ac.uk	White, Lisa/AAM-9012-2021; Rojo, Luis/B-3073-2009; Shakesheff, Kevin/AAR-6603-2021; Shakesheff, Kevin M/O-6371-2018; Rashidi, Hassan/N-9313-2014; Qutachi, Omar/AAD-7332-2019; Oreffo, Richard/A-4615-2011	Rojo, Luis/0000-0001-6334-6736; Shakesheff, Kevin M/0000-0003-3236-2439; Rashidi, Hassan/0000-0001-8078-6688; Qutachi, Omar/0000-0002-5026-7358; Kanczler, Janos/0000-0001-7249-0414; Rose, Felicity/0000-0001-6640-8840; Wells, Julia Anne/0000-0001-8272-0236; Stevens, Molly/0000-0002-7335-266X; White, Lisa/0000-0003-0571-999X; El Haj, Alicia/0000-0003-3544-5678; Oreffo, Richard/0000-0001-5995-6726	BBSRC (sLOLA grant) [BB/G010579/1]; BBSRC [BB/G010579/1, BB/G010617/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/G010579/1, BB/G010617/1] Funding Source: researchfish	BBSRC (sLOLA grant); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the BBSRC (sLOLA grant BB/G010579/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the Mr Douglas Dunlop and colleagues at the Southampton General Hospital for provision of adult human bone marrow samples. We would also like to thank Dr Jens Madsen for his help with statistical analysis. Research funding from the BBSRC (sLOLA BB/G010579/1) is gratefully acknowledged.	Alsberg E, 2001, J DENT RES, V80, P2025, DOI 10.1177/00220345010800111501; Ambikaipalan A, 2013, CURR STEM CELL RES T, V8, P210, DOI 10.2174/1574888X11308030005; Anseth KS, 1996, BIOMATERIALS, V17, P1647, DOI 10.1016/0142-9612(96)87644-7; Augst AD, 2006, MACROMOL BIOSCI, V6, P623, DOI 10.1002/mabi.200600069; Badylak SF, 2009, ACTA BIOMATER, V5, P1, DOI 10.1016/j.actbio.2008.09.013; Baroli B, 2007, J PHARM SCI-US, V96, P2197, DOI 10.1002/jps.20873; Basmanav FB, 2008, BIOMATERIALS, V29, P4195, DOI 10.1016/j.biomaterials.2008.07.017; Bhakta G, 2013, ACTA BIOMATER, V9, P9098, DOI 10.1016/j.actbio.2013.07.008; Bhakta G, 2012, BIOMATERIALS, V33, P6113, DOI 10.1016/j.biomaterials.2012.05.030; Bonfield W, 2006, PHILOS T R SOC A, V364, P227, DOI 10.1098/rsta.2005.1692; Bosnakovski D, 2006, BIOTECHNOL BIOENG, V93, P1152, DOI 10.1002/bit.20828; BRADLEY CM, 1992, AUST NZ J SURG, V62, P39, DOI 10.1111/j.1445-2197.1992.tb05352.x; Brown BN, 2009, BIOMATERIALS, V30, P1482, DOI 10.1016/j.biomaterials.2008.11.040; Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131; Buttermann GR, 2008, SPINE J, V8, P426, DOI 10.1016/j.spinee.2006.12.006; Chan G, 2008, TRENDS BIOTECHNOL, V26, P382, DOI 10.1016/j.tibtech.2008.03.011; Chiarello E, 2013, AGING CLIN EXP RES, V25, pS101, DOI 10.1007/s40520-013-0088-8; Coyac BR, 2013, J DENT RES, V92, P648, DOI 10.1177/0022034513488599; Dadsetan M, 2008, BIOMATERIALS, V29, P2193, DOI 10.1016/j.biomaterials.2008.01.006; Dawson JI, 2008, ARCH BIOCHEM BIOPHYS, V473, P124, DOI 10.1016/j.abb.2008.03.024; Fedorovich NE, 2007, TISSUE ENG, V13, P1905, DOI 10.1089/ten.2006.0175; Flausse A, 2013, J BIOMED MATER RES A, V101, P3211, DOI 10.1002/jbm.a.34629; Geckil H, 2010, NANOMEDICINE-UK, V5, P469, DOI [10.2217/nnm.10.12, 10.2217/NNM.10.12]; Ghosh K, 2007, ADV DRUG DELIVER REV, V59, P1306, DOI 10.1016/j.addr.2007.08.014; Gothard D, 2014, J TISSUE ENG, V5, DOI 10.1177/2041731414551763; Greenwald AS, 2001, J BONE JOINT SURG AM, V83A, P98, DOI 10.2106/00004623-200100022-00007; Gruskin E, 2012, ADV DRUG DELIVER REV, V64, P1063, DOI 10.1016/j.addr.2012.06.008; He XZ, 2008, LANGMUIR, V24, P12508, DOI 10.1021/la802447v; Howard D, 2008, J ANAT, V213, P66, DOI 10.1111/j.1469-7580.2008.00878.x; Jakob F, 2013, MATURITAS, V75, P118, DOI 10.1016/j.maturitas.2013.03.004; Johnson TD, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/49/494015; Kanczler JA, 2008, BIOMATERIALS, V29, P1892, DOI 10.1016/j.biomaterials.2007.12.031; Kim BS, 1998, TRENDS BIOTECHNOL, V16, P224, DOI 10.1016/S0167-7799(98)01191-3; Kim J, 2013, J KOREAN SOC ATMOS E, V29, P1, DOI 10.5572/KOSAE.2013.29.1.001; Kirby GTS, 2011, POLYMERS-BASEL, V3, P571, DOI 10.3390/polym3010571; Kisiel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078551; Kolambkar YM, 2011, BIOMATERIALS, V32, P65, DOI 10.1016/j.biomaterials.2010.08.074; Kuhls Rainer, 2001, Cell and Tissue Banking, V2, P143, DOI 10.1023/A:1020173119669; Laschke MW, 2008, J BIOMED MATER RES A, V85A, P397, DOI 10.1002/jbm.a.31503; Lee CSD, 2010, BIOMATERIALS, V31, P4926, DOI 10.1016/j.biomaterials.2010.03.001; LEO WJ, 1990, BIOTECHNOL PROGR, V6, P51, DOI 10.1021/bp00001a008; Li ZS, 2005, BIOMATERIALS, V26, P3919, DOI 10.1016/j.biomaterials.2004.09.062; Ma K, 2012, ACTA BIOMATER, V8, P3754, DOI 10.1016/j.actbio.2012.06.028; Mano JF, 2007, J R SOC INTERFACE, V4, P999, DOI 10.1098/rsif.2007.0220; Markel DC, 2012, J INFLAMM RES, V5, P13, DOI 10.2147/JIR.S21411; Marsh D, 1998, CLIN ORTHOP RELAT R, pS22; Mladenov KV, 2010, EUR SPINE J, V19, pS135, DOI 10.1007/s00586-009-1179-2; Murphy WL, 1999, J PERIODONTAL RES, V34, P413, DOI 10.1111/j.1600-0765.1999.tb02275.x; Nakasone S, 2013, CLIN ORTHOP RELAT R, V471, P1926, DOI 10.1007/s11999-013-2833-x; Nukavarapu SP, 2013, BIOTECHNOL ADV, V31, P706, DOI 10.1016/j.biotechadv.2012.11.004; Parenteau-Bareil R, 2010, MATERIALS, V3, P1863, DOI 10.3390/ma3031863; Peterson B, 2004, J BONE JOINT SURG AM, V86A, P2243, DOI 10.2106/00004623-200410000-00016; Rabie A B, 1999, Aust Orthod J, V15, P269; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Rose FRAJ, 2002, BIOCHEM BIOPH RES CO, V292, P1, DOI 10.1006/bbrc.2002.6519; Rutledge K, 2014, TISSUE ENG PART C-ME, V20, P865, DOI [10.1089/ten.tec.2013.0411, 10.1089/ten.TEC.2013.0411]; Sawkins MJ, 2013, ACTA BIOMATER, V9, P7865, DOI 10.1016/j.actbio.2013.04.029; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schneider GB, 2004, BIOMATERIALS, V25, P3023, DOI 10.1016/j.biomaterials.2003.09.084; Silva NA, 2013, BIOCHIMIE, V95, P2314, DOI 10.1016/j.biochi.2013.08.016; Singh M, 2008, TISSUE ENG PART B-RE, V14, P341, DOI 10.1089/ten.teb.2008.0304; Smith EL, 2014, ACTA BIOMATER, V10, P4186, DOI 10.1016/j.actbio.2014.06.011; Smith EL, 2014, ACTA BIOMATER, V10, P4197, DOI 10.1016/j.actbio.2014.05.025; Stoppel WL, 2014, J BIOMED MATER RES B, V102, P877, DOI 10.1002/jbm.b.33070; Suarez-Gonzalez D, 2013, TISSUE ENG A; Tabata Y, 2003, TISSUE ENG, V9, pS5, DOI 10.1089/10763270360696941; Taghavi CE, 2010, SPINE, V35, P1144, DOI 10.1097/BRS.0b013e3181bb5203; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; TULI SM, 1978, J BONE JOINT SURG BR, V60, P116, DOI 10.1302/0301-620X.60B1.342532; Wang JC, 2007, EUR SPINE J, V16, P1233, DOI 10.1007/s00586-006-0282-x; Wenger MPE, 2007, BIOPHYS J, V93, P1255, DOI 10.1529/biophysj.106.103192; White LJ, 2013, MAT SCI ENG C-MATER, V33, P2578, DOI 10.1016/j.msec.2013.02.020; Williams EL, 2013, METHODS MOL BIOL, V1035, P67, DOI 10.1007/978-1-62703-508-8_7; Yan TQ, 2013, J SURG RES; Zhang L, 2012, J BIOMED MATER RES A, V100A, P2717, DOI 10.1002/jbm.a.34194; Zheng L, 2010, J BIOMED MATER RES A, V93A, P783, DOI 10.1002/jbm.a.32588	76	51	53	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145080	10.1371/journal.pone.0145080	http://dx.doi.org/10.1371/journal.pone.0145080			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675008	Green Published, Green Accepted, Green Submitted, gold			2022-12-26	WOS:000366722700096
J	Kim, TY; Shin, JS; Lee, J; Lee, YJ; Kim, MR; Ahn, YJ; Park, KB; Hwang, DS; Ha, IH				Kim, Tae-Yoon; Shin, Joon-Shik; Lee, Jinho; Lee, Yoon Jae; Kim, Me-Riong; Ahn, Yong-Jun; Park, Ki Byung; Hwang, Deok-Sang; Ha, In-Hyuk			Gender Difference in Associations between Chronic Temporomandibular Disorders and General Quality of Life in Koreans: A Cross-Sectional Study	PLOS ONE			English	Article							PAIN-DYSFUNCTION SYNDROME; CLINICAL PAIN; JOINT PAIN; SYMPTOMS; HEADACHE; DEPRESSION; ADOLESCENTS; PREVALENCE; CHILDREN; ANXIETY	Background Chronic temporomandibular disorder (TMD) is known to have strong correlations with psychological factors and to display gender disparity. However, while chronic TMD is known to affect quality of life, large-scale studies investigating the influence on quality of life by gender are scarce. Methods This cross-sectional study assessed the data of 17,198 participants aged >= 19 years who completed chronic TMD and EuroQol-5 Dimension sections in the 4th Korean National Health and Nutrition Examination Survey (2007-2009). We adjusted for covariates (health behavior, sociodemographic factors) in regression analysis for complex sampling design to calculate regression coefficients and 95% CIs for gender difference in the association between chronic TMD and quality of life. We also evaluated which covariates of somatic health, mental health, health behavior, and sociodemographic factors weakened the relationship between TMD and EQ-5D. Results Prevalence of chronic TMD was 1.6% (men 1.3%, women 1.8%), and chronic TMD persisted to negatively impact quality of life even after adjusting for confounding variables. Low sociodemographic factors and health behavior had a negative effect on quality of life. Somatic health and mental health were most affected by chronic TMD. As for quality of life, women were affected to a greater extent than men by TMD. Women were more affected by osteoarthritis and general mental health (stress, depressive symptoms, and thoughts of suicide), and men by employment. Conclusions These results imply that chronic diseases and psychological factors are important in chronic TMD, and that there may be physiological and pathological gender differences in TMD.	[Kim, Tae-Yoon; Shin, Joon-Shik; Lee, Jinho; Lee, Yoon Jae; Kim, Me-Riong; Ahn, Yong-Jun; Park, Ki Byung; Ha, In-Hyuk] Jaseng Med Fdn, Jaseng Spine & Joint Res Inst, Seoul, South Korea; [Hwang, Deok-Sang] Kyung Hee Univ, Dept Korean Med Obstet & Gynecol, Seoul, South Korea	Kyung Hee University	Ha, IH (corresponding author), Jaseng Med Fdn, Jaseng Spine & Joint Res Inst, Seoul, South Korea.	hanihata@gmail.com	Lee, Yoon Jae/ABA-8808-2020	Lee, Yoon Jae/0000-0002-1532-0942; Shin, Joon-Shik/0000-0001-5488-3273; HA, IN-HYUK/0000-0002-5020-6723; Lee, Jinho/0000-0003-0672-6892	Jaseng Medical Foundation	Jaseng Medical Foundation	The authors received no specific funding for this work. However, this work was supported by Jaseng Medical Foundation. Jaseng Medical Foundation had no involvement in study design, data collection, analysis and interpretation, manuscript writing, nor decision for manuscript publication. The authors thank Jaseng Medical Foundation for their support.	Aggarwal V, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008456.pub2; Ballegaard V, 2008, CEPHALALGIA, V28, P832, DOI 10.1111/j.1468-2982.2008.01597.x; BEATON RD, 1991, J PROSTHET DENT, V65, P289, DOI 10.1016/0022-3913(91)90177-X; Berkley K., 1997, BEHAV BRAIN SCI, V20, P1; Bonjardim LR, 2005, INT J PROSTHODONT, V18, P347; Christidis N, 2014, J HEADACHE PAIN, V15; Ciancaglini R, 2001, J DENT, V29, P93, DOI 10.1016/S0300-5712(00)00042-7; CLARK GT, 1987, J AM DENT ASSOC, V115, P251, DOI 10.14219/jada.archive.1987.0231; Dao TTT, 1998, J PROSTHET DENT, V79, P663, DOI 10.1016/S0022-3913(98)70073-3; De Laat A, 1998, Clin Oral Investig, V2, P54, DOI 10.1007/s007840050045; Dick B, 2007, CANADIAN J ANESTHESI, V54, P44579; DWORKIN SF, 1990, J AM DENT ASSOC, V120, P273, DOI 10.14219/jada.archive.1990.0043; DWORKIN SF, 1994, J PROSTHET DENT, V72, P29, DOI 10.1016/0022-3913(94)90213-5; Dworkin SF, 2006, TMDS EVIDENCE BASED, P203; Fillingim RB, 1999, PAIN, V83, P419, DOI 10.1016/S0304-3959(99)00128-1; GALE EN, 1989, J PROSTHET DENT, V61, P235, DOI 10.1016/0022-3913(89)90381-8; Gatchel RJ, 1996, J AM DENT ASSOC, V127, P1365, DOI 10.14219/jada.archive.1996.0450; Giannakopoulos NN, 2010, J DENT, V38, P369, DOI 10.1016/j.jdent.2010.01.003; Glaros AG, 2007, CEPHALALGIA, V27, P542, DOI 10.1111/j.1468-2982.2007.01325.x; Goncalves DAG, 2010, HEADACHE, V50, P231, DOI 10.1111/j.1526-4610.2009.01511.x; GRECO CM, 1998, FUNCTIONAL SOMATIC S, P127; Group EQ, 1990, HLTH POLICY, V16, P199, DOI DOI 10.1016/0168-8510(90)90421-9; Korszun A, 1998, ORAL SURG ORAL MED O, V86, P416, DOI 10.1016/S1079-2104(98)90366-3; LeResche L, 1997, CRIT REV ORAL BIOL M, V8, P291, DOI 10.1177/10454411970080030401; LeResche L, 1997, PAIN, V69, P153, DOI 10.1016/S0304-3959(96)03230-7; Manfredini D, 2004, J ORAL REHABIL, V31, P933, DOI 10.1111/j.1365-2842.2004.01335.x; McNeill C, 1997, J PROSTHET DENT, V77, P510, DOI 10.1016/S0022-3913(97)70145-8; Ministry of Health and Welfare, KOR CTR DIS CONTR PR; Morris S, 1997, BRIT DENT J, V182, P255, DOI 10.1038/sj.bdj.4809362; Murray Heather, 1996, Journal of Orofacial Pain, V10, P316; Naito Mariko, 2006, J Oral Sci, V48, P1, DOI 10.2334/josnusd.48.1; Nam HS., 2007, EQ 5D KOREAN VALUATI; Nilsson IM, 2006, J OROFAC PAIN, V20, P138; Ojima K, 2007, BIOPSYCHOSOC MED, V1, DOI 10.1186/1751-0759-1-3; Pinelli C, 2007, CLIN ORAL INVEST, V11, P431, DOI 10.1007/s00784-007-0133-0; Plesh O, 2011, J OROFAC PAIN, V25, P190; Rantala MAI, 2003, ACTA ODONTOL SCAND, V61, P217, DOI 10.1080/00016350310004089; Reisine S T, 1989, Community Dent Health, V6, P257; Riley JL, 1998, PAIN, V74, P181, DOI 10.1016/S0304-3959(97)00199-1; Rodrigues JH, 2012, PHYSIOTHER RES INT, V17, DOI 10.1002/pri.508; Scher AI, 2008, HEADACHE, V48, P16, DOI 10.1111/j.1526-4610.2007.00970.x; SCHNURR RF, 1991, ORAL SURG ORAL MED O, V72, P550, DOI 10.1016/0030-4220(91)90492-U; Sherman J J, 2001, Curr Pain Headache Rep, V5, P421, DOI 10.1007/s11916-001-0053-7; Sipila K, 2001, CRANIO, V19, P183, DOI 10.1080/08869634.2001.11746168; Sonmez H, 2001, J ORAL REHABIL, V28, P280, DOI 10.1111/j.1365-2842.2001.tb01678.x; Thilander B, 2002, ANGLE ORTHOD, V72, P146; Tjakkes GHE, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-46; Turp JC, 1998, J DENT RES, V77, P1465, DOI 10.1177/00220345980770061101; TVERSKY J, 1991, ORAL SURG ORAL MED O, V71, P696, DOI 10.1016/0030-4220(91)90276-I; Unruh AM, 1996, PAIN, V65, P123, DOI 10.1016/0304-3959(95)00214-6; Vanderas A P, 2002, Int J Paediatr Dent, V12, P336, DOI 10.1046/j.1365-263X.2002.00380.x; Vanderas AP, 2001, CRANIO, V19, P123, DOI 10.1080/08869634.2001.11746161; VONKORFF M, 1988, PAIN, V32, P173, DOI 10.1016/0304-3959(88)90066-8; Wanman Anders, 1995, Journal of Orofacial Pain, V9, P235; Weingarten TN, 2009, PAIN, V147, P67, DOI 10.1016/j.pain.2009.08.021; Wiesinger B, 2007, PAIN, V131, P311, DOI 10.1016/j.pain.2007.03.018; Wolfe F, 2005, J RHEUMATOL, V32, P2421; Yap AUJ, 2002, J PROSTHET DENT, V88, P479, DOI 10.1067/mpr.2002.129375; ZACH GA, 1991, J PROSTHET DENT, V66, P810, DOI 10.1016/0022-3913(91)90423-T	59	28	29	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145002	10.1371/journal.pone.0145002	http://dx.doi.org/10.1371/journal.pone.0145002			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673219	Green Published, Green Submitted, gold			2022-12-26	WOS:000366722700085
J	Linhares, MM; Affonso, RJ; Viana, LD; Silva, SRM; Denadai, MVA; de Toledo, SRC; Matos, D				Linhares, Marcelo Moura; Affonso, Renato Jose, Jr.; Viana, Luciano de Souza; Morini Silva, Sandra Regina; Araujo Denadai, Marcos Vinicius; Caminada de Toledo, Silvia Regina; Matos, Delcio			Genetic and Immunohistochemical Expression of Integrins ITGAV, ITGA6, and ITGA3 As Prognostic Factor for Colorectal Cancer: Models for Global and Disease-Free Survival	PLOS ONE			English	Article							COLON-CARCINOMA CELLS; EXTRACELLULAR-MATRIX; TUMOR PROGRESSION; OSTEOPONTIN; FIBRONECTIN; METASTASES; MIGRATION; OVEREXPRESSION; ACTIVATION; PREDICTION	Objective To evaluate the relationship between the expression profiles of 84 extracellular matrix (ECM) genes and the prognosis of patients with colorectal cancer (CRC). Methods This retrospective study included 114 patients with stage I-IV CRC who underwent primary tumour resection. Quantitative real-time PCR and immunohistochemistry assays were conducted using primary tumour samples. Kaplan-Meier survival curves were also generated to identify differences in global survival (GS) and disease-free survival (DFS) for the hypoor hyperexpression status of each marker. The log-rank test was used to verify whether the differences were significant. Stepwise Cox regression models were also used to identify the risk factors associated with GS and DFS in a multivariate mode, and then were used to score the risk of death associated with each marker, either independently or in association. Results In the univariate analyses, significant differences in GS in relation to the expression profiles of ITGAV (p = 0.001), ITGA3 (p = 0.002), ITGA6 (p = 0.001), SPARC (p = 0.036), MMP9 (p = 0.034), and MMP16 (p = 0.038) were observed. For DFS, significant differences were observed in associated with ITGAV (p = 0.004) and ITGA3 (p = 0.001). However, only the ITGAV and ITGA6 gene markers for GS (hazard ratio (HR) = 3.209, 95% confidence interval (CI) = 1.412-7.293, p = 0.005 and HR = 3.105, 95% CI = 1.367-7.055, p = 0.007, respectively), and ITGA3 for DFS (HR = 3.806, 95% CI = 1.573-9.209, p = 0.003), remained in the final Cox regression models. A scoring system was developed to evaluate the risk of patient death based on the number of markers for the components of the final GS model. Scores of 0, 1, or 2 were associated with the following mean survival rates [CI]: 47.162 [44.613-49.711], 39.717 [35.471-43.964], 30.197 [24.030-36.327], respectively. Conclusions Multivariate mathematical models demonstrated an association between hyperexpression of the ITGAV and ITGA6 integrins and GS, and also between the ITGA3 integrin and DFS, in patients with colorectal tumours. A risk scoring system based on detected hyperexpression of 0, 1, or 2 markers (e.g., ITGAV and/or ITGA6) was also found to accurately correlate with the GS curves generated for the present cohort.	[Linhares, Marcelo Moura; Affonso, Renato Jose, Jr.; Viana, Luciano de Souza; Morini Silva, Sandra Regina; Araujo Denadai, Marcos Vinicius; Matos, Delcio] Fed Univ Sao Paulo UNIFESP, Escola Paulista Med, Postgrad Program Interdisciplinary Surg Sci, Sao Paulo, Brazil; [Affonso, Renato Jose, Jr.; Viana, Luciano de Souza; Morini Silva, Sandra Regina] Hosp Canc Barretos Fundacao Pio XII, Barretos, Brazil; [Caminada de Toledo, Silvia Regina] Fed Univ Sao Paulo UNIFESP, Mol Biol Lab, EPM, GRAACC, Sao Paulo, Brazil	Universidade Federal de Sao Paulo (UNIFESP); Hospital de Cancer de Barretos; Universidade Federal de Sao Paulo (UNIFESP)	Linhares, MM (corresponding author), Fed Univ Sao Paulo UNIFESP, Escola Paulista Med, Postgrad Program Interdisciplinary Surg Sci, Sao Paulo, Brazil.	mlinhares@unifesp.br	Linhares, Marcelo Moura/Y-5137-2019; de Souza Viana, Luciano/S-8179-2019; Linhares, Marcelo Moura/Y-5137-2019	Linhares, Marcelo Moura/0000-0002-9540-5937; Linhares, Marcelo Moura/0000-0001-9562-0058	CAPES (Coordination for the Improvement of Higher Level -or Education-Personnel - Brazilian Government); Fundacao Pio XII, Barretos - Brazil	CAPES (Coordination for the Improvement of Higher Level -or Education-Personnel - Brazilian Government); Fundacao Pio XII, Barretos - Brazil	This work was supported by CAPES (Coordination for the Improvement of Higher Level -or Education-Personnel - Brazilian Government) and Fundacao Pio XII, Barretos - Brazil.	AKIYAMA SK, 1995, CANCER METAST REV, V14, P173, DOI 10.1007/BF00690290; Arnold SA, 2009, J CELL COMMUN SIGNAL, V3, P255, DOI 10.1007/s12079-009-0072-4; Bertucci F, 2004, ONCOGENE, V23, P1377, DOI 10.1038/sj.onc.1207262; Davidson B, 2003, CANCER METAST REV, V22, P103, DOI 10.1023/A:1022272204045; Denadai MVA, 2013, BMC CLIN PATHOL, V13, DOI 10.1186/1472-6890-13-16; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Devita Govindan R., 2012, DEVITA HELLMAN ROSEN; Eschrich S, 2005, J CLIN ONCOL, V23, P3526, DOI 10.1200/JCO.2005.00.695; Galamb O, 2009, CELL ONCOL, V31, P19, DOI 10.3233/CLO-2009-0458; Gardina PJ, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-325; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Ha SY, 2014, J CLIN PATHOL, V67, P576, DOI 10.1136/jclinpath-2013-202163; Instituto Nacional de Cancer, 2011, EST 2012 INC CANC BR; Karmakar S, 2003, CANCER LETT, V196, P217, DOI 10.1016/S0304-3835(03)00208-8; Kemperman H, 1997, EXP CELL RES, V234, P156, DOI 10.1006/excr.1997.3599; Koehler A, 2004, J PATHOL, V204, P65, DOI 10.1002/path.1606; Koivisto L, 2000, EXP CELL RES, V255, P10, DOI 10.1006/excr.1999.4769; Kwon HC, 2004, DIS COLON RECTUM, V47, P141, DOI 10.1007/s10350-003-0032-7; LODISH H, 2003, MOL CELL BIOL; Lustosa SA, 2014, SCI WORLD J, V4, P1; Mattila E, 2005, NAT CELL BIOL, V7, P78, DOI 10.1038/ncb1209; Meeh PF, 2009, NEOPLASIA, V11, P1074, DOI 10.1593/neo.09808; Meyerhardt J., 2007, COLORECTAL CANC; NIP J, 1992, J CLIN INVEST, V90, P1406, DOI 10.1172/JCI116007; O'Connor KL, 2000, J CELL BIOL, V148, P253, DOI 10.1083/jcb.148.2.253; Ohtaka K, 1996, BIOCHEM BIOPH RES CO, V220, P346, DOI 10.1006/bbrc.1996.0408; Rangaswami H, 2006, TRENDS CELL BIOL, V16, P79, DOI 10.1016/j.tcb.2005.12.005; Vassos N, 2014, INT J CLIN EXP PATHO, V7, P288; Viana LD, 2013, ONCOLOGY-BASEL, V84, P81, DOI 10.1159/000343436; Vonlaufen A, 2001, MODERN PATHOL, V14, P1126, DOI 10.1038/modpathol.3880447; Waisberg J, 2014, ANTICANCER RES, V34, P5599; Watanabe T, 2009, DIS COLON RECTUM, V52, P1941, DOI 10.1007/DCR.0b013e3181b53684; World Health Organization, 2011, GLOB HLTH OBS DAT RE; Yeatman TJ, 2003, CLIN EXP METASTAS, V20, P85, DOI 10.1023/A:1022502805474; Zhang CH, 2012, INT J CANCER, V130, P2685, DOI 10.1002/ijc.26301; Zutter MM, 1998, J MAMMARY GLAND BIOL, V3, P191, DOI 10.1023/A:1018798907544	36	31	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144333	10.1371/journal.pone.0144333	http://dx.doi.org/10.1371/journal.pone.0144333			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674523	Green Published, Green Submitted, gold			2022-12-26	WOS:000366722700036
J	Segnani, C; Ippolito, C; Antonioli, L; Pellegrini, C; Blandizzi, C; Dolfi, A; Bernardini, N				Segnani, Cristina; Ippolito, Chiara; Antonioli, Luca; Pellegrini, Carolina; Blandizzi, Corrado; Dolfi, Amelio; Bernardini, Nunzia			Histochemical Detection of Collagen Fibers by Sirius Red/Fast Green Is More Sensitive than van Gieson or Sirius Red Alone in Normal and Inflamed Rat Colon	PLOS ONE			English	Article							PULMONARY-FIBROSIS; IMAGE-ANALYSIS; MODEL; QUANTIFICATION; PENTOXIFYLLINE	Collagen detection in histological sections and its quantitative estimation by computer-aided image analysis represent important procedures to assess tissue localization and distribution of connective fibers. Different histochemical approaches have been proposed to detect and quantify collagen deposition in paraffin slices with different degrees of satisfaction. The present study was performed to compare the qualitative and quantitative efficiency of three histochemical methods available for collagen staining in paraffin sections of colon. van Gieson, Sirius Red and Sirius Red/Fast Green stainings were carried out for collagen detection and quantitative estimation by morphometric image analysis in colonic specimens from normal rats or animals with 2,4-dinitrobenzenesulfonic acid (DNBS) induced colitis. Haematoxylin/eosin staining was carried out to assess tissue morphology and histopathological lesions. Among the three investigated methods, Sirius Red/Fast Green staining allowed to best highlight well-defined red-stained collagen fibers and to obtain the highest quantitative results by morphometric image analysis in both normal and inflamed colon. Collagen fibers, which stood out against the green-stained non-collagen components, could be clearly appreciated, even in their thinner networks, within all layers of normal or inflamed colonic wall. The present study provides evidence that, as compared with Sirius Red alone or van Gieson staining, the Sirius Red/Fast Green method is the most sensitive, in terms of both qualitative and quantitative evaluation of collagen fibers, in paraffin sections of both normal and inflamed colon.	[Segnani, Cristina; Ippolito, Chiara; Dolfi, Amelio; Bernardini, Nunzia] Univ Pisa, Dept Clin & Expt Med, Unit Histol & Med Embryol, Pisa, Italy; [Antonioli, Luca; Pellegrini, Carolina; Blandizzi, Corrado] Univ Pisa, Div Pharmacol, Dept Clin & Expt Med, Pisa, Italy	University of Pisa; University of Pisa	Bernardini, N (corresponding author), Univ Pisa, Dept Clin & Expt Med, Unit Histol & Med Embryol, Pisa, Italy.	nunzia.bernardini@med.unipi.it	Blandizzi, Corrado/AAB-8736-2019; Bernardini, Nunzia/AAC-4602-2021; Pellegrini, Carolina/ABE-3462-2021	Pellegrini, Carolina/0000-0003-2644-5430; BERNARDINI, NUNZIA/0000-0001-9061-9402; Ippolito, Chiara/0000-0001-8671-313X; BLANDIZZI, CORRADO/0000-0001-9927-5386	Interdepartmental Center for Research in Clinical Pharmacology and Experimental Therapeutics, University of Pisa, Italy	Interdepartmental Center for Research in Clinical Pharmacology and Experimental Therapeutics, University of Pisa, Italy	This work was supported by an institutional research grant issued by the Interdepartmental Center for Research in Clinical Pharmacology and Experimental Therapeutics, University of Pisa, Italy.	Alexakis C, 2004, GUT, V53, P85, DOI 10.1136/gut.53.1.85; Antonioli L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116253; Burke JP, 2007, AM J GASTROENTEROL, V102, P439, DOI 10.1111/j.1572-0241.2006.01010.x; Caravan P, 2013, AM J RESP CELL MOL, V49, P1120, DOI 10.1165/rcmb.2013-0039OC; Encarnacion MMD, 2004, AM J TRANSPLANT, V4, P248, DOI 10.1046/j.1600-6143.2003.00311.x; Fiocchi C, 2011, AM J PHYSIOL-GASTR L, V300, pG677, DOI 10.1152/ajpgi.00104.2011; Fornai M, 2006, J PHARMACOL EXP THER, V317, P938, DOI 10.1124/jpet.105.098350; Garcia-Tsao G, 2010, HEPATOLOGY, V51, P1445, DOI 10.1002/hep.23478; Garewal H, 2003, DIGEST DIS SCI, V48, P197, DOI 10.1023/A:1021871423154; GASCONBARRE M, 1989, J HISTOCHEM CYTOCHEM, V37, P377, DOI 10.1177/37.3.2465335; Geboes KP, 2000, ACTA GASTRO-ENT BELG, V63, P371; Hadi AM, 2011, CELL ONCOL, V34, P343, DOI 10.1007/s13402-011-0035-7; Haller ST, 2014, AM J HYPERTENS, V27, P603, DOI 10.1093/ajh/hpt169; Huang Y, 2013, LIVER INT, V33, P1249, DOI 10.1111/liv.12184; Ippolito C, 2015, J CELL MOL MED, V19, P485, DOI 10.1111/jcmm.12428; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; LOPEZDELEON A, 1985, J HISTOCHEM CYTOCHEM, V33, P737, DOI 10.1177/33.8.2410480; Marlow SL, 2006, EXP MOL PATHOL, V80, P54, DOI 10.1016/j.yexmp.2005.04.006; Martinez-Galan L, 2010, ARCH BRONCONEUMOL, V46, P20, DOI 10.1016/j.arbres.2009.10.006; Pape L, 2003, TRANSPLANTATION, V76, P955, DOI 10.1097/01.TP.0000078899.62040.E5; Peterson TC, 1997, ALIMENT PHARM THERAP, V11, P575, DOI 10.1046/j.1365-2036.1997.00188.x; Peterson TC, 2011, EUR J PHARMACOL, V662, P47, DOI 10.1016/j.ejphar.2011.04.030; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Pilling D, 2007, J IMMUNOL, V179, P4035, DOI 10.4049/jimmunol.179.6.4035; PUCHTLER H, 1973, BEITR PATHOL, V150, P174, DOI 10.1016/S0005-8165(73)80016-2; Rabau MY, 1995, EXP MOL PATHOL, V62, P160, DOI 10.1006/exmp.1995.1017; Rich Lillian, 2005, Brazilian Journal of Morphological Sciences, V22, P97; San-Miguel B, 2010, J NUTR, V140, P1065, DOI 10.3945/jn.110.121525; Standish RA, 2006, GUT, V55, P569, DOI 10.1136/gut.2005.084475; Street JM, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12088; Sweat F, 1964, ARCH PATHOL, P7869; Tamiolakis D, 2002, Clin Exp Obstet Gynecol, V29, P135; Thoua NM, 2012, RHEUMATOLOGY, V51, P1989, DOI 10.1093/rheumatology/kes191; Vogel B, 2015, METHODSX, V2, P124, DOI 10.1016/j.mex.2015.02.007; WHITTAKER P, 1994, BASIC RES CARDIOL, V89, P397, DOI 10.1007/BF00788278	35	67	68	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144630	10.1371/journal.pone.0144630	http://dx.doi.org/10.1371/journal.pone.0144630			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673752	Green Published, Green Submitted, gold			2022-12-26	WOS:000366722700049
J	Deng, S; Wang, CY; Zhang, X; Wang, Q; Lin, L				Deng, Sheng; Wang, Cai-yue; Zhang, Xin; Wang, Qing; Lin, Ling			VdNUC-2, the Key Regulator of Phosphate Responsive Signaling Pathway, Is Required for Verticillium dahliae Infection	PLOS ONE			English	Article							ANKYRIN-REPEAT; NEUROSPORA-CRASSA; FUNCTIONAL-ANALYSIS; PROTEIN; KINASE; PATHOGENICITY; TRANSDUCTION; EXPRESSION; VIRULENCE; INACTIVATION	In fungal cells, a phosphate (Pi) responsive signaling and metabolism (PHO) pathway regulates Pi-homeostasis. NUC-2/PHO81 and its homologs are one of the most important components in the regulation pathway. In soil-borne phytopathogenic fungus Verticillium dahliae, we identified a Neurospora crassa nuc-2 homolog gene VdNUC-2. VdNUC-2 is composed of 1,018 amino acids, and is highly conserved in tested filamentous fungi. Under conditions of Pi-starvation, compared with the wild-type strain and ectopic complementation strains, the VdNUC-2 knocked out mutants exhibited reduced radial growth, decreased production of conidia and microsclerotia, and were more sensitive to hydrogen peroxide stress. The virulence of VdNUC-2 defective mutants was significantly compromised, and that was unable to be restored by exogenous application of extra Pi. Additionally, the deletion mutants of VdNUC-1, a key transcription factor gene positively controlled by VdNUC-2 in the PHO pathway, showed the similar cultural phenotypes as VdNUC-2 mutants when both of them grew in Pi-limited conditions. However, the virulence of VdNUC-1 mutants was comparable to the wild-type strain. These evidences indicated that the virulence reduction in VdNUC-2 mutants is not due to the interruptions in the PHO pathway or the disturbance of Pi-homeostasis in V. dahliae cytoplasm. VdNUC-2 is not only a crucial gene in the PHO pathway in V. dahliae, but also is required for the full virulence during host-infection.	[Deng, Sheng; Wang, Cai-yue; Zhang, Xin; Wang, Qing; Lin, Ling] Jiangsu Acad Agr Sci, Inst Plant Protect, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences	Lin, L (corresponding author), Jiangsu Acad Agr Sci, Inst Plant Protect, Nanjing, Jiangsu, Peoples R China.	linling@jaas.ac.cn		Deng, Sheng/0000-0002-9050-7221	National Science Foundation [31101400, 31201462, 31301625]; Special Fund for Agro-scientific Research in the Public Interest [201503109]; National Key Technology Research and Development Program [2012BAD19B05]; "333" Project of JiangSu Province [BRA2015447]	National Science Foundation(National Science Foundation (NSF)); Special Fund for Agro-scientific Research in the Public Interest; National Key Technology Research and Development Program(National Key Technology R&D Program); "333" Project of JiangSu Province(Natural Science Foundation of Jiangsu Province)	This work was supported by the National Science Foundation (31101400, 31201462 and 31301625), Special Fund for Agro-scientific Research in the Public Interest (201503109), the National Key Technology Research and Development Program during the Twelfth Five-year Plan Period (2012BAD19B05) and the "333" Project of JiangSu Province (BRA2015447).	Al-Khodor S, 2010, TRENDS MICROBIOL, V18, P132, DOI 10.1016/j.tim.2009.11.004; Becerra C, 2004, GENE, V340, P111, DOI 10.1016/j.gene.2004.06.006; Castillo-Lluva S, 2007, J CELL SCI, V120, P1584, DOI 10.1242/jcs.005314; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; de Jonge R, 2013, GENOME RES, V23, P1271, DOI 10.1101/gr.152660.112; de Jonge R, 2012, P NATL ACAD SCI USA, V109, P5110, DOI 10.1073/pnas.1119623109; Deng S, 2014, CAN J MICROBIOL, V60, P445, DOI 10.1139/cjm-2014-0081; Dick Claudia Fernanda, 2011, Enzyme Res, V2011, P103980, DOI 10.4061/2011/103980; Dub AM, 2013, EUKARYOT CELL, V12, P1609, DOI 10.1128/EC.00160-13; Fernandez J, 2014, PROTOPLASMA, V251, P37, DOI 10.1007/s00709-013-0541-8; Fradin EF, 2006, MOL PLANT PATHOL, V7, P71, DOI [10.1111/j.1364-3703.2006.00323.x, 10.1111/J.1364-3703.2006.00323.X]; Giraldo MC, 2013, NAT REV MICROBIOL, V11, P800, DOI 10.1038/nrmicro3119; Gras DE, 2007, FEMS MICROBIOL LETT, V269, P196, DOI 10.1111/j.1574-6968.2006.00613.x; Gras DE, 2013, FUNGAL GENET BIOL, V60, P140, DOI 10.1016/j.fgb.2013.05.007; Hamel LP, 2012, PLANT CELL, V24, P1327, DOI 10.1105/tpc.112.096156; Heller J, 2011, ANNU REV PHYTOPATHOL, V49, P369, DOI 10.1146/annurev-phyto-072910-095355; Hoagland D.R., 1938, The Water Culture Methods for Growing Plants without Soil, V347, P1, DOI DOI 10.1017/CBO9781107415324.004; Hoppenau CE, 2014, ENVIRON EXP BOT, V108, P14, DOI 10.1016/j.envexpbot.2013.12.015; Huang JY, 2009, PLANT MOL BIOL, V71, P207, DOI 10.1007/s11103-009-9518-6; Ip YT, 1998, CURR OPIN CELL BIOL, V10, P205, DOI 10.1016/S0955-0674(98)80143-9; KANG SC, 1990, MOL CELL BIOL, V10, P5839, DOI 10.1128/MCB.10.11.5839; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Klosterman SJ, 2009, ANNU REV PHYTOPATHOL, V47, P39, DOI 10.1146/annurev-phyto-080508-081748; Lenburg ME, 1996, TRENDS BIOCHEM SCI, V21, P383, DOI 10.1016/S0968-0004(96)90127-9; Li JN, 2006, BIOCHEMISTRY-US, V45, P15168, DOI 10.1021/bi062188q; Li L, 2007, ANNU REV MICROBIOL, V61, P423, DOI 10.1146/annurev.micro.61.080706.093432; Liu SY, 2013, GENE, V529, P307, DOI 10.1016/j.gene.2013.06.089; Liu TL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5686; Luo XM, 2014, APPL MICROBIOL BIOT, V98, P6921, DOI 10.1007/s00253-014-5863-8; METZENBERG RL, 1979, MICROBIOL REV, V43, P361, DOI 10.1128/MMBR.43.3.361-383.1979; Mou SL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059699; Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160; Paz Z, 2011, FUNGAL GENET BIOL, V48, P677, DOI 10.1016/j.fgb.2011.02.003; Peleg Y, 1996, MOL GEN GENET, V252, P709, DOI 10.1007/s004380050280; Raghothama KG, 1999, ANNU REV PLANT PHYS, V50, P665, DOI 10.1146/annurev.arplant.50.1.665; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santhanam P, 2013, MOL PLANT MICROBE IN, V26, P249, DOI 10.1094/MPMI-08-12-0198-R; SCHNEIDER KR, 1994, SCIENCE, V266, P122, DOI 10.1126/science.7939631; Secco D, 2012, FEBS LETT, V586, P289, DOI 10.1016/j.febslet.2012.01.036; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tian H, 2015, FUNGAL GENET BIOL, V74, P21, DOI 10.1016/j.fgb.2014.11.003; Timpner C, 2013, MOL PLANT MICROBE IN, V26, P1312, DOI 10.1094/MPMI-06-13-0181-R; Tomar P, 2014, J BIOSCIENCES, V39, P525, DOI 10.1007/s12038-014-9435-y; Turra D, 2014, ANNU REV PHYTOPATHOL, V52, P267, DOI 10.1146/annurev-phyto-102313-050143; Tzima AK, 2011, MOL PLANT MICROBE IN, V24, P129, DOI 10.1094/MPMI-09-09-0217; Tran VT, 2014, NEW PHYTOL, V202, P565, DOI 10.1111/nph.12671; Wolff B, 1999, ONCOGENE, V18, P2663, DOI 10.1038/sj.onc.1202617; Yang YA, 2012, PLANT PHYSIOL, V159, P1857, DOI 10.1104/pp.112.197152; Yun YZ, 2015, NEW PHYTOL, V207, P119, DOI 10.1111/nph.13374; Zhang CK, 2013, FUNGAL GENET BIOL, V61, P90, DOI 10.1016/j.fgb.2013.09.001; Zhang JR, 2015, BIOTECHNOL BIOENG, V112, P1033, DOI 10.1002/bit.25516; Zhang XC, 2010, MOL BIOL REP, V37, P653, DOI 10.1007/s11033-009-9507-5	53	9	12	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145190	10.1371/journal.pone.0145190	http://dx.doi.org/10.1371/journal.pone.0145190			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670613	Green Published, gold, Green Submitted			2022-12-26	WOS:000366719300052
J	Grosser, S; Burridge, CP; Peucker, AJ; Waters, JM				Grosser, Stefanie; Burridge, Christopher P.; Peucker, Amanda J.; Waters, Jonathan M.			Coalescent Modelling Suggests Recent Secondary-Contact of Cryptic Penguin Species	PLOS ONE			English	Article							EUDYPTULA-MINOR; POPULATION-STRUCTURE; SARCOPHILUS-HARRISII; MITOCHONDRIAL-DNA; BLUE-PENGUIN; DIVERGENCE; SOFTWARE; TIME; MARKERS; DIVERSITY	Molecular genetic analyses present powerful tools for elucidating demographic and biogeographic histories of taxa. Here we present genetic evidence showing a dynamic history for two cryptic lineages within Eudyptula, the world's smallest penguin. Specifically, we use a suite of genetic markers to reveal that two congeneric taxa ('Australia' and 'New Zealand') co-occur in southern New Zealand, with only low levels of hybridization. Coalescent modelling suggests that the Australian little penguin only recently expanded into southern New Zealand. Analyses conducted under time-dependent molecular evolutionary rates lend support to the hypothesis of recent anthropogenic turnover, consistent with shifts detected in several other New Zealand coastal vertebrate taxa. This apparent turnover event highlights the dynamic nature of the region's coastal ecosystem.	[Grosser, Stefanie; Waters, Jonathan M.] Univ Otago, Dept Zool, Allan Wilson Ctr, Dunedin, New Zealand; [Burridge, Christopher P.] Univ Tasmania, Sch Biol Sci, Hobart, Tas, Australia; [Peucker, Amanda J.] Deakin Univ, Sch Life & Environm Sci, Warrnambool, Vic, Australia	University of Otago; University of Tasmania; Deakin University	Grosser, S (corresponding author), Univ Otago, Dept Anat, Allan Wilson Ctr, Dunedin, New Zealand.	grost309@student.otago.ac.nz	Burridge, Christopher/J-2653-2012; Waters, Jon/B-4983-2009; Burridge, Chris/L-4392-2019	Burridge, Christopher/0000-0002-8185-6091; Waters, Jon/0000-0002-1514-7916; 	Allan Wilson Centre, Marsden [UoO1112]	Allan Wilson Centre, Marsden(Royal Society of New ZealandMarsden Fund (NZ))	Funding was provided by the Allan Wilson Centre, Marsden Contract UoO1112, and SG received a University of Otago Doctoral Scholarship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnew P, 2014, J ORNITHOL, V155, P101, DOI 10.1007/s10336-013-0992-x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson EC, 2002, GENETICS, V160, P1217; [Anonymous], 2012, IUCN RED LIST CAT CR, V2nd, P32; Avise J, 2004, MOL MARKERS NATURAL; Banks J, 2006, POLAR BIOL, V30, P61, DOI 10.1007/s00300-006-0160-3; Banks Jonathan C., 2002, Notornis, V49, P29; Barnes I, 2002, SCIENCE, V295, P2267, DOI 10.1126/science.1067814; Beaumont MA, 2010, ANNU REV ECOL EVOL S, V41, P379, DOI 10.1146/annurev-ecolsys-102209-144621; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bickford D, 2007, TRENDS ECOL EVOL, V22, P148, DOI 10.1016/j.tree.2006.11.004; Boessenkool S, 2009, P ROY SOC B-BIOL SCI, V276, P815, DOI 10.1098/rspb.2008.1246; Bruen TC, 2006, GENETICS, V172, P2665, DOI 10.1534/genetics.105.048975; Burridge CP, 2003, NEW ZEAL J MAR FRESH, V37, P223, DOI 10.1080/00288330.2003.9517160; Chiswell SM, 2003, MAR ECOL PROG SER, V247, P173, DOI 10.3354/meps247173; Collins CJ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0097; COLLURA RV, 1995, NATURE, V378, P485, DOI 10.1038/378485a0; Cullen JM, 2009, MAR ECOL PROG SER, V378, P269, DOI 10.3354/meps07881; Daniel TA, 2007, ANIM BEHAV, V74, P1241, DOI 10.1016/j.anbehav.2007.01.029; DANN P, 1992, EMU, V91, P263, DOI 10.1071/MU9910263; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Emerson BC, 2015, MOL ECOL, V24, P702, DOI 10.1111/mec.13070; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Feinberg JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108213; Forster JR, 1781, COMMENT PHYS SOC REG, V3, P135; GALES R, 1985, EMU, V85, P127, DOI 10.1071/MU9850127; Geller JB, 1999, CONSERV BIOL, V13, P661, DOI 10.1046/j.1523-1739.1999.97470.x; Grosser S, 2015, CONSERV GENET RESOUR; Grosser S, 2015, CONSERV GENET RESOUR, V7, P143, DOI 10.1007/s12686-014-0313-6; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hey J, 2010, MOL BIOL EVOL, V27, P905, DOI 10.1093/molbev/msp296; Ho SYW, 2011, MOL ECOL, V20, P3087, DOI 10.1111/j.1365-294X.2011.05178.x; Ho SYW, 2005, MOL BIOL EVOL, V22, P1561, DOI 10.1093/molbev/msi145; Hofreiter M, 2007, CURR BIOL, V17, pR122, DOI 10.1016/j.cub.2007.01.026; Holdaway RN, 2001, NEW ZEAL J ZOOL, V28, P119, DOI 10.1080/03014223.2001.9518262; Holder MT, 2001, SYST BIOL, V50, P978, DOI 10.1080/106351501753462911; Hrbek T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083623; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jouventin P, 2006, MOL ECOL, V15, P3413, DOI 10.1111/j.1365-294X.2006.03028.x; Kinsky F.C., 1976, Records nat Mus NZ, V1, P105; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Macey S, 2015, NZ J ZOOL, DOI [10.1080/03014223.2014.995107, DOI 10.1080/03014223.2014.995107]; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; MARCHANT S, 1990, HDB AUSTR NZ ANTARTI, V1; Mathews G. M., 1911, BIRDS AUSTR; MEREDITH MAM, 1988, HEREDITY, V60, P69, DOI 10.1038/hdy.1988.11; MICKELSON MJ, 1992, EMU, V91, P355, DOI 10.1071/MU9910355; Millar CD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000209; Miller W, 2011, P NATL ACAD SCI USA, V108, P12348, DOI 10.1073/pnas.1102838108; Miyazaki M, 2015, ACTA ETHOL, V18, P227, DOI 10.1007/s10211-014-0193-5; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Pemberton David, 2008, Papers and Proceedings of the Royal Society of Tasmania, V142, P13; Petit RJ, 2009, TRENDS ECOL EVOL, V24, P386, DOI 10.1016/j.tree.2009.02.011; Peucker AJ, 2009, AUK, V126, P397, DOI 10.1525/auk.2009.08055; Pritchard JK, 2000, GENETICS, V155, P945; Prychitko TM, 1997, MOL PHYLOGENET EVOL, V8, P193, DOI 10.1006/mpev.1997.0420; Robertson HA, 2013, NZ CLASSIFICATION SE, V4, P11; Roeder AD, 2002, CONSERV GENET, V3, P341, DOI 10.1023/A:1019982009059; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; Slack KE, 2003, GENE, V302, P43, DOI 10.1016/S0378111902010533; Slatkin M, 1996, GENET RES, V68, P259, DOI 10.1017/S0016672300034236; Smith I, 2013, J ROY SOC NEW ZEAL, V43, P1, DOI 10.1080/03036758.2011.574709; Stahel C., 1987, LITTLE PENGUIN FAIRY; Stephens JF, 1826, GENERAL ZOOL, V13, P68; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Stevenson Caryn, 2007, Marine Ornithology, V35, P71; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Tavares ES, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-81; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Waters JM, 2013, TRENDS ECOL EVOL, V28, P78, DOI 10.1016/j.tree.2012.08.024; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; Wilmshurst JM, 2008, P NATL ACAD SCI USA, V105, P7676, DOI 10.1073/pnas.0801507105; Zavodna M, 2008, EXP PARASITOL, V120, P57, DOI 10.1016/j.exppara.2008.04.021	80	37	37	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144966	10.1371/journal.pone.0144966	http://dx.doi.org/10.1371/journal.pone.0144966			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26675310	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900158
J	Gupta, SC; Singh, R; Asters, M; Liu, J; Zhang, X; Pabbidi, MR; Watabe, K; Mo, YY				Gupta, S. C.; Singh, R.; Asters, M.; Liu, J.; Zhang, X.; Pabbidi, M. R.; Watabe, K.; Mo, Y-Y			Regulation of breast tumorigenesis through acid sensors	ONCOGENE			English	Article							SENSING ION CHANNELS; NADPH-OXIDASE; CANCER GENOMICS; CALCIUM; CA2+; ACTIVATION; PH; METASTASIS; CELLS; ROS	The low extracellular pH in the microenvironment has been shown to promote tumor growth and metastasis; however, the underlying mechanism is poorly understood. Particularly, little is known how the tumor cell senses the acidic signal to activate the acidosis-mediated signaling. In this study, we show that breast cancer cells express acid-sensing ion channel 1 (ASIC1), a proton-gated cation channel primarily expressed in the nervous system. RNA interference, knockout and rescue experiments demonstrate a critical role for ASIC1 in acidosis-induced reactive oxidative species and NF-kappa B activation, two key events for tumorigenesis. Mechanistically, ASIC1 is required for acidosis-mediated signaling through calcium influx. We show that as a cytoplasmic membrane protein, ASIC1 is also associated with mitochondria, suggesting that ASIC1 may regulate mitochondrial calcium influx. Importantly, interrogation of the Cancer Genome Atlas breast invasive carcinoma data set indicates that alterations of ASIC1 alone or combined with other 4 ASIC genes are significantly correlated with poor patient survival. Furthermore, ASIC1 inhibitors cause a significant reduction of tumor growth and tumor load. Together, these results suggest that ASIC1 contributes to breast cancer pathogenesis in response to acidic tumor microenvironments, and ASIC1 may serve as a prognostic marker and a therapeutic target for breast cancer.	[Gupta, S. C.; Singh, R.; Asters, M.; Liu, J.; Mo, Y-Y] Univ Mississippi, Med Ctr, Inst Canc, 2500 N State St,Room G651, Jackson, MS 39216 USA; [Gupta, S. C.; Singh, R.] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA; [Zhang, X.] Univ Mississippi, Med Ctr, Ctr Biostat & Bioinformat, Jackson, MS 39216 USA; [Pabbidi, M. R.; Mo, Y-Y] Univ Mississippi, Med Ctr, Dept Pharmacol & Toxicol, Jackson, MS 39216 USA; [Watabe, K.] Wake Forest Univ, Sch Med, Dept Canc Biol, Winston Salem, NC 27109 USA	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center; Wake Forest University	Mo, YY (corresponding author), Univ Mississippi, Med Ctr, Inst Canc, 2500 N State St,Room G651, Jackson, MS 39216 USA.	ymo@umc.edu	Mo, Yin-Yuan/R-8255-2019; Gupta, Subash/AAF-2563-2019; Singh, Ramesh/S-4568-2017	Gupta, Subash/0000-0002-0418-1940; Singh, Ramesh/0000-0001-5052-7925	National Institutes of Health [R01 CA154989]; UMMC's Intramural Research Support Program; COBRE grant [GM103328]; NATIONAL CANCER INSTITUTE [R01CA154989] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UMMC's Intramural Research Support Program; COBRE grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Parminder J.S. Vig at UMMC for providing mouse brain tissues. This work is supported in part by a grant from the National Institutes of Health R01 CA154989 (YM) and a grant from UMMC's Intramural Research Support Program (SCG). Imaging Core of Center for Psychiatric Neuroscience at UMMC is supported by COBRE grant GM103328.	Abbey CK, 2004, P NATL ACAD SCI USA, V101, P11438, DOI 10.1073/pnas.0404396101; Banfi B, 2004, J BIOL CHEM, V279, P18583, DOI 10.1074/jbc.M310268200; Banfi B, 2001, J BIOL CHEM, V276, P37594, DOI 10.1074/jbc.M103034200; Benarroch EE, 2014, NEUROLOGY, V82, P628, DOI 10.1212/WNL.0000000000000134; Berdiev BK, 2003, J BIOL CHEM, V278, P15023, DOI 10.1074/jbc.M300991200; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Berridge MJ, 1998, NATURE, V395, P645, DOI 10.1038/27094; Bianchi L, 2002, NEURON, V34, P337, DOI 10.1016/S0896-6273(02)00687-6; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Bubien JK, 1999, AM J PHYSIOL-CELL PH, V276, pC1405, DOI 10.1152/ajpcell.1999.276.6.C1405; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen XM, 2005, J GEN PHYSIOL, V126, P71, DOI 10.1085/jgp.200509303; Chu XP, 2012, CURR DRUG TARGETS, V13, P263, DOI 10.2174/138945012799201685; Damaghi M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00370; Drago I, 2011, EMBO J, V30, P4119, DOI 10.1038/emboj.2011.337; El Jamali A, 2008, FREE RADICAL BIO MED, V44, P868, DOI 10.1016/j.freeradbiomed.2007.11.020; Estrella V, 2013, CANCER RES, V73, P1524, DOI 10.1158/0008-5472.CAN-12-2796; Feissner RF, 2009, FRONT BIOSCI-LANDMRK, V14, P1197, DOI 10.2741/3303; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Giorgio V, 2010, BBA-BIOENERGETICS, V1797, P1113, DOI 10.1016/j.bbabio.2009.12.006; Granfeldt D, 2002, J LEUKOCYTE BIOL, V71, P611; Gupta SC, 2014, ONCOTARGET, V5, P12070, DOI 10.18632/oncotarget.2514; Gupta SC, 2013, J BIOL CHEM, V288, P32343, DOI 10.1074/jbc.M113.455188; Hashim AI, 2011, NMR BIOMED, V24, P582, DOI 10.1002/nbm.1644; Ho TT, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gku1198; Huang J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.541; Jagnandan D, 2007, J BIOL CHEM, V282, P6494, DOI 10.1074/jbc.M608966200; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Pandey D, 2011, MOL PHARMACOL, V80, P407, DOI 10.1124/mol.110.070193; Peppicelli S, 2013, CLIN EXP METASTAS, V30, P957, DOI 10.1007/s10585-013-9595-4; Pinton P, 2008, ONCOGENE, V27, P6407, DOI 10.1038/onc.2008.308; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Rizzuto R, 2006, PHYSIOL REV, V86, P369, DOI 10.1152/physrev.00004.2005; Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575; Sachdeva M, 2010, CANCER RES, V70, P378, DOI 10.1158/0008-5472.CAN-09-2021; Schaefer L, 2000, FEBS LETT, V471, P205, DOI 10.1016/S0014-5793(00)01403-4; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Ugawa S, 2002, J CLIN INVEST, V110, P1185, DOI 10.1172/JCI200215709; Viola HM, 2007, CIRC RES, V100, P1036, DOI 10.1161/01.RES.0000263010.19273.48; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wang G, 2006, HYPERTENSION, V48, P482, DOI 10.1161/01.HYP.0000236647.55200.07; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Wemmie JA, 2013, NAT REV NEUROSCI, V14, P461, DOI 10.1038/nrn3529; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Xu L, 2000, CANCER RES, V60, P4610; Ye JH, 2007, BIOCHEM BIOPH RES CO, V355, P986, DOI 10.1016/j.bbrc.2007.02.061; Zha XM, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-1; Zhang A, 2013, CELL RES, V23, P340, DOI 10.1038/cr.2012.164	52	50	50	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 4	2016	35	31					4102	4111		10.1038/onc.2015.477	http://dx.doi.org/10.1038/onc.2015.477			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS8GG	26686084	Green Accepted			2022-12-26	WOS:000381020900008
J	Abedini, A; Zamberlam, G; Lapointe, E; Tourigny, C; Boyer, A; Paquet, M; Hayashi, K; Honda, H; Kikuchi, A; Price, C; Boerboom, D				Abedini, Atefeh; Zamberlam, Gustavo; Lapointe, Evelyne; Tourigny, Catherine; Boyer, Alexandre; Paquet, Marilene; Hayashi, Kanako; Honda, Hiroaki; Kikuchi, Akira; Price, Christopher; Boerboom, Derek			WNT5a is required for normal ovarian follicle development and antagonizes gonadotropin responsiveness in granulosa cells by suppressing canonical WNT signaling	FASEB JOURNAL			English	Article						female fertility; conditional gene targeting; microarray	DEPENDENT PROTEIN-KINASE; BETA-CATENIN; FEMALE FERTILITY; FRIZZLED HOMOLOGS; BINDING PROTEIN; EXPRESSION; PHOSPHORYLATION; PATHWAY; GASTRULATION; MICE	Whereas the roles of the canonical wingless type MMTV(mouse mammary tumor virus) integration site family (WNT) signaling pathway in the regulation of ovarian follicle growth and steroidogenesis are now established, noncanonical WNT signaling in the ovary has been largely overlooked. Noncanonical WNTs, including WNT5a and WNT11, are expressed in granulosa cells (GCs) and are differentially regulated throughout follicle development, but their physiologic roles remain unknown. Using conditional gene targeting, we found that GC-specific inactivation of Wnt5a (but not Wnt11) results in the female subfertility associated with increased follicular atresia and decreased rates of ovulation. Microarray analyses have revealed that WNT5a acts to down-regulate the expression of FSH-responsive genes in vitro, and corresponding increases in the expression of these genes have been found in the GCs of conditional knockout mice. Unexpectedly, we found that WNT5a regulates its target genes not by signaling via the WNT/Ca2+ or planar cell polarity pathways, but rather by inhibiting the canonical pathway, causing both beta-catenin (CTNNB1) and cAMP responsive element binding (CREB) protein levels to decrease via a glycogen synthase kinase-3 beta-dependent mechanism. We further found that WNT5a prevents follicle-stimulating hormone and luteinizing protein from up-regulating the CTNNB1 and CREB proteins and their target genes, indicating that WNT5a functions as a physiologic inhibitor of gonadotropin signaling. Together, these findings identify WNT5a as a key regulator of follicle development and gonadotropin responsiveness.-Abedini, A., Zamberlam, G., Lapointe, E., Tourigny, C., Boyer, A., Paquet, M., Hayashi, K., Honda, H., Kikuchi, A., Price, C., Boerboom, D. WNT5a is required for normal ovarian follicle development and antagonizes gonadotropin responsiveness in granulosa cells by suppressing canonical WNT signaling. FASEB J. 30, 1534-1547 (2016). www.fasebj.org	[Abedini, Atefeh; Zamberlam, Gustavo; Lapointe, Evelyne; Tourigny, Catherine; Boyer, Alexandre; Paquet, Marilene; Price, Christopher; Boerboom, Derek] Univ Montreal, Fac Med Vet, Ctr Rech Reprod Anim, St Hyacinthe, PQ J2S 7C6, Canada; [Hayashi, Kanako] So Illinois Univ, Sch Med, Dept Physiol, Carbondale, IL 62901 USA; [Honda, Hiroaki] Hiroshima Univ, Dept Dis Model, Res Inst Radiat Biol & Med, Hiroshima, Japan; [Kikuchi, Akira] Osaka Univ, Dept Mol Biol & Biochem, Grad Sch Med, Osaka, Japan	Universite de Montreal; Southern Illinois University System; Southern Illinois University; Hiroshima University; Osaka University	Boerboom, D (corresponding author), Univ Montreal, Fac Med Vet, Ctr Rech Reprod Anim, St Hyacinthe, PQ J2S 7C6, Canada.	derek.boerboom@umontreal.ca	Paquet, Marilene/L-3414-2019; Price, Christopher/A-6383-2012	Paquet, Marilene/0000-0002-3562-4636; Price, Christopher/0000-0002-6727-8280; Hayashi, Kanako/0000-0002-5028-799X; Zamberlam, Gustavo/0000-0002-0089-9955	Canadian Institutes of Health Research [MOP-102508]; Canada Research Chair in Ovarian Molecular Biology and Functional Genomics; U. S. National Institutes of Health (NIH) The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) [R03-HD058222]; NIH NICHD (SCCPRR) [U54-HD28934]; Reseau Quebecois en Reproduction; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD028934] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R03HD058222] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Ovarian Molecular Biology and Functional Genomics(Canada Research Chairs); U. S. National Institutes of Health (NIH) The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH NICHD (SCCPRR); Reseau Quebecois en Reproduction; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank Ms. M. Girard (Universite de Montreal) for assistance with mouse colony management. This work was supported by Operating Grant MOP-102508 from the Canadian Institutes of Health Research and the Canada Research Chair in Ovarian Molecular Biology and Functional Genomics (to D.B.) and U. S. National Institutes of Health (NIH) The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Grant R03-HD058222 (to K.H.). The University of Virginia Center for Research in Reproduction Ligand Assay and Analysis Core is supported by NIH NICHD (SCCPRR) Grant U54-HD28934. A.A. was supported by a graduate studentship from the Reseau Quebecois en Reproduction.	Abdul-Ghani M, 2011, MOL CELL BIOL, V31, P163, DOI 10.1128/MCB.01539-09; Abedini A, 2015, MOL CELL ENDOCRINOL, V403, P39, DOI 10.1016/j.mce.2015.01.017; Boyer A, 2010, FASEB J, V24, P3010, DOI 10.1096/fj.09-145789; Boyer A, 2010, TRENDS ENDOCRIN MET, V21, P25, DOI 10.1016/j.tem.2009.08.005; Boyer A, 2009, CARCINOGENESIS, V30, P869, DOI 10.1093/carcin/bgp051; Bryja V, 2009, MOL BIOL CELL, V20, P924, DOI 10.1091/mbc.E08-07-0711; Conti M, 2006, MOL ENDOCRINOL, V20, P715, DOI 10.1210/me.2005-0185; Edson MA, 2009, ENDOCR REV, V30, P624, DOI 10.1210/er.2009-0012; Fan HY, 2008, DEVELOPMENT, V135, P2127, DOI 10.1242/dev.020560; Fan HY, 2010, MOL ENDOCRINOL, V24, P1529, DOI 10.1210/me.2010-0141; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Finnson KW, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.096396; Gifford JAH, 2009, BIOL REPROD, V80, P1282, DOI 10.1095/biolreprod.108.072280; Habas R, 2003, GENE DEV, V17, P295, DOI 10.1101/gad.1022203; Harwood BN, 2008, DEV DYNAM, V237, P1099, DOI 10.1002/dvdy.21491; Hayashi K, 2011, BIOL REPROD, V84, P308, DOI 10.1095/biolreprod.110.088161; Hino S, 2005, MOL CELL BIOL, V25, P9063, DOI 10.1128/MCB.25.20.9063-9072.2005; Hsieh M, 2005, BIOL REPROD, V73, P1135, DOI 10.1095/biolreprod.105.042739; Hsieh M, 2002, ENDOCRINOLOGY, V143, P898, DOI 10.1210/en.143.3.898; Ishitani T, 1999, NATURE, V399, P798, DOI 10.1038/21674; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Jorgez CJ, 2004, MOL ENDOCRINOL, V18, P953, DOI 10.1210/me.2003-0301; Keller R, 2003, DIFFERENTIATION, V71, P171, DOI 10.1046/j.1432-0436.2003.710301.x; Kenigsberg S, 2009, MOL HUM REPROD, V15, P89, DOI 10.1093/molehr/gan082; Komiya Yuko, 2008, Organogenesis, V4, P68; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Lapointe E, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.112.102608; Lapointe Evelyne, 2011, Front Biosci (Schol Ed), V3, P276, DOI 10.2741/s151; Law NC, 2013, MOL ENDOCRINOL, V27, P1295, DOI 10.1210/me.2013-1025; Lee JM, 2010, MOL CELL, V37, P183, DOI 10.1016/j.molcel.2009.12.022; Li L, 1999, J BIOL CHEM, V274, P129, DOI 10.1074/jbc.274.1.129; Marlow F, 2002, CURR BIOL, V12, P876, DOI 10.1016/S0960-9822(02)00864-3; Metcalfe C, 2011, J CELL SCI, V124, P3537, DOI 10.1242/jcs.091991; Mukherjee A, 1996, ENDOCRINOLOGY, V137, P3234, DOI 10.1210/en.137.8.3234; Naillat F, 2010, HUM MOL GENET, V19, P1539, DOI 10.1093/hmg/ddq027; Parakh TN, 2006, P NATL ACAD SCI USA, V103, P12435, DOI 10.1073/pnas.0603006103; Polakis P, 2000, GENE DEV, V14, P1837; Richards JS, 2010, J CLIN INVEST, V120, P963, DOI 10.1172/JCI41350; Ricken A, 2002, ENDOCRINOLOGY, V143, P2741, DOI 10.1210/en.143.7.2741; Rico C, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115634; Roy L, 2009, ENDOCRINOLOGY, V150, P5036, DOI 10.1210/en.2009-0771; Saadeddin A, 2009, MOL CANCER RES, V7, P1189, DOI 10.1158/1541-7786.MCR-09-0027; Sanchez AM, 2014, FERTIL STERIL, V101, P1688, DOI 10.1016/j.fertnstert.2014.02.040; Saneyoshi T, 2002, NATURE, V417, P295, DOI 10.1038/417295a; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; Sheldahl LC, 1999, CURR BIOL, V9, P695, DOI 10.1016/S0960-9822(99)80310-8; Sutherland Calum, 2011, Int J Alzheimers Dis, V2011, P505607, DOI 10.4061/2011/505607; Taurin S, 2006, J BIOL CHEM, V281, P9971, DOI 10.1074/jbc.M508778200; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wang HX, 2010, BIOL REPROD, V82, P865, DOI 10.1095/biolreprod.109.080903; Weiser DC, 2007, GENE DEV, V21, P1559, DOI 10.1101/gad.1535007; Wolf D, 2002, J BIOL CHEM, V277, P25562, DOI 10.1074/jbc.M201196200; ZELEZNIK AJ, 1974, ENDOCRINOLOGY, V95, P818, DOI 10.1210/endo-95-3-818	55	41	43	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1534	1547		10.1096/fj.15-280313	http://dx.doi.org/10.1096/fj.15-280313			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26667040	Green Published			2022-12-26	WOS:000372629100015
J	Dawaliby, R; Trubbia, C; Delporte, C; Noyon, C; Ruysschaert, JM; Van Antwerpen, P; Govaerts, C				Dawaliby, Rosie; Trubbia, Cataldo; Delporte, Cedric; Noyon, Caroline; Ruysschaert, Jean-Marie; Van Antwerpen, Pierre; Govaerts, Cedric			Phosphatidylethanolamine Is a Key Regulator of Membrane Fluidity in Eukaryotic Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cholesterol; homeostasis; membrane bilayer; membrane lipid; phosphatidylethanolamine	TYPE-2 HYPERCHOLESTEROLEMIA; DROSOPHILA-MELANOGASTER; LIPID FLUIDITY; SREBP PATHWAY; CHOLESTEROL; LOVASTATIN; PHASE	Adequate membrane fluidity is required for a variety of key cellular processes and in particular for proper function of membrane proteins. In most eukaryotic cells, membrane fluidity is known to be regulated by fatty acid desaturation and cholesterol, although some cells, such as insect cells, are almost devoid of sterol synthesis. We show here that insect and mammalian cells present similar microviscosity at their respective physiological temperature. To investigate how both sterols and phospholipids control fluidity homeostasis, we quantified the lipidic composition of insect SF9 and mammalian HEK 293T cells under normal or sterol-modified condition. As expected, insect cells show minimal sterols compared with mammalian cells. A major difference is also observed in phospholipid content as the ratio of phosphatidylethanolamine (PE) to phosphatidylcholine (PC) is inverted (4 times higher in SF9 cells). In vitro studies in liposomes confirm that both cholesterol and PE can increase rigidity of the bilayer, suggesting that both can be used by cells to maintain membrane fluidity. We then show that exogenously increasing the cholesterol amount in SF9 membranes leads to a significant decrease in PE:PC ratio whereas decreasing cholesterol in HEK 293T cells using statin treatment leads to an increase in the PE:PC ratio. In all cases, the membrane fluidity is maintained, indicating that both cell types combine regulation by sterols and phospholipids to control proper membrane fluidity.	[Dawaliby, Rosie; Trubbia, Cataldo; Ruysschaert, Jean-Marie; Govaerts, Cedric] Univ Libre Bruxelles, Ctr Struct Biol & Bioinformat, Lab Struct & Funct Biol Membranes, CP 206-02,Bd Triomphe, B-1050 Brussels, Belgium; [Delporte, Cedric; Noyon, Caroline; Van Antwerpen, Pierre] Univ Libre Bruxelles, Fac Pharm, Lab Pharmaceut Chem, B-1050 Brussels, Belgium; [Delporte, Cedric; Noyon, Caroline; Van Antwerpen, Pierre] Univ Libre Bruxelles, Fac Pharm, Analyt Platform, B-1050 Brussels, Belgium; [Delporte, Cedric; Noyon, Caroline] FRS FNRS, Molenbeek St Jean, Belgium	Universite Libre de Bruxelles; Universite Libre de Bruxelles; Fonds de la Recherche Scientifique - FNRS	Govaerts, C (corresponding author), Univ Libre Bruxelles, Struct & Funct Biol Membranes, Bldg BC,Rm 1C4 203,Blvd Triomphe,Acces 2, B-1050 Brussels, Belgium.	Cedric.Govaerts@ulb.ac.be	; Delporte, Cedric/C-2228-2013	Dawaliby, Rosie/0000-0001-7476-0350; Delporte, Cedric/0000-0001-7453-7028; Noyon, Caroline/0000-0002-1505-4541; Van Antwerpen, Pierre/0000-0002-4934-8863	Fonds de la Recherche Scientifique-Fonds National de la Recherche Scientifique (FRS-FNRS) [F.4523.12, 34553.08, T.0136.13]; "Fond Extraordinaire de Recherche" of the Universite Libre de Bruxelles	Fonds de la Recherche Scientifique-Fonds National de la Recherche Scientifique (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); "Fond Extraordinaire de Recherche" of the Universite Libre de Bruxelles	This work was supported in part by Fonds de la Recherche Scientifique-Fonds National de la Recherche Scientifique (FRS-FNRS) Grants F.4523.12, 34553.08, and T.0136.13 and a grant from "Fond Extraordinaire de Recherche" 2007 of the Universite Libre de Bruxelles. The authors declare that they have no conflicts of interest with the contents of this article.	Ahn T, 1999, ARCH BIOCHEM BIOPHYS, V369, P288, DOI 10.1006/abbi.1999.1376; Allen HG, 2006, NUTRITION, V22, P1096, DOI 10.1016/j.nut.2006.07.007; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Carvalho M, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.29; CHABANEL A, 1983, BIOPHYS J, V44, P171, DOI 10.1016/S0006-3495(83)84288-X; Cooper BS, 2014, FUNCT ECOL, V28, P886, DOI 10.1111/1365-2435.12264; Cooper BS, 2012, EVOLUTION, V66, P1976, DOI 10.1111/j.1558-5646.2011.01566.x; Cybulski LE, 2004, J BIOL CHEM, V279, P39340, DOI 10.1074/jbc.M405150200; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Holthuis JCM, 2014, NATURE, V510, P48, DOI 10.1038/nature13474; Janosi J, 2004, ANTICANCER RES, V24, P1817; Kaiser RD, 1999, BIOCHEMISTRY-US, V38, P2610, DOI 10.1021/bi985065h; Koter M, 2004, INT J BIOCHEM CELL B, V36, P205, DOI 10.1016/S1357-2725(03)00195-X; Koter M, 2002, EUR J CLIN PHARMACOL, V58, P501, DOI 10.1007/s00228-002-0507-9; LEVY Y, 1992, BRIT J CLIN PHARMACO, V34, P427; Lipowsky R, 2014, BIOL CHEM, V395, P253, DOI 10.1515/hsz-2013-0244; Lockshon D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045049; Mansilla MC, 2004, J BACTERIOL, V186, P6681, DOI 10.1128/JB.186.20.6681-6688.2004; Marheineke K, 1998, FEBS LETT, V441, P49, DOI 10.1016/S0014-5793(98)01523-3; Nicolson GL, 2014, BBA-BIOMEMBRANES, V1838, P1451, DOI 10.1016/j.bbamem.2013.10.019; Pan Q, 2014, LIPIDS, V49, P715, DOI 10.1007/s11745-014-3900-0; QUARFORDT SH, 1970, J LIPID RES, V11, P528; Roy R, 1997, BBA-BIOMEMBRANES, V1323, P65, DOI 10.1016/S0005-2736(96)00176-9; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Seegmiller AC, 2002, DEV CELL, V2, P229, DOI 10.1016/S1534-5807(01)00119-8; SILVIUS JR, 1986, BIOCHIM BIOPHYS ACTA, V857, P217, DOI 10.1016/0005-2736(86)90350-0; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; vanVliet AK, 1996, BIOCHEM PHARMACOL, V52, P1387, DOI 10.1016/S0006-2952(96)00467-4; Wenk MR, 2005, NAT REV DRUG DISCOV, V4, P594, DOI 10.1038/nrd1776; YEAGLE PL, 1985, BIOCHIM BIOPHYS ACTA, V822, P267, DOI 10.1016/0304-4157(85)90011-5	31	182	186	4	57	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3658	3667		10.1074/jbc.M115.706523	http://dx.doi.org/10.1074/jbc.M115.706523			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26663081	Green Published, hybrid			2022-12-26	WOS:000370854500043
J	Sharma, N; Longjam, G; Schreiber, G				Sharma, Nanaocha; Longjam, Geeta; Schreiber, Gideon			Type I Interferon Signaling Is Decoupled from Specific Receptor Orientation through Lenient Requirements of the Transmembrane Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; interferon; mutagenesis; protein-protein interaction; transmembrane domain; cytokine receptor	RESONANCE ENERGY-TRANSFER; GROWTH-HORMONE RECEPTOR; ERYTHROPOIETIN RECEPTOR; WEB SERVER; STRUCTURAL BASIS; ALPHA RECEPTOR; IFN-BETA; LIGAND; ACTIVATION; DIMERIZATION	Type I interferons serve as the first line of defense against pathogen invasion. Binding of IFNs to its receptors, IFNAR1 and IFNAR2, is leading to activation of the IFN response. To determine whether structural perturbations observed during binding are propagated to the cytoplasmic domain, multiple mutations were introduced into the transmembrane helix and its surroundings. Insertion of one to five alanine residues near either the N or C terminus of the transmembrane domain (TMD) likely promotes a rotation of 100 degrees and a translation of 1.5 per added residue. Surprisingly, the added alanines had little effect on the binding affinity of IFN to the cell surface receptors, STAT phosphorylation, or gene induction. Similarly, substitution of the juxtamembrane residues of the TMD with alanines, or replacement of the TMD of IFNAR1 with that of IFNAR2, did not affect IFN binding or activity. Finally, only the addition of 10 serine residues (but not 2 or 4) between the extracellular domain of IFNAR1 and the TMD had some effect on signaling. Bioinformatic analysis shows a correlation between high sequence conservation of TMDs of cytokine receptors and the ability to transmit structural signals. Sequence conservation near the TMD of IFNAR1 is low, suggesting limited functional importance for this region. Our results suggest that IFN binding to the extracellular domains of IFNAR1 and IFNAR2 promotes proximity between the intracellular domains and that differential signaling is a function of duration of activation and affinity of binding rather than specific conformational changes transmitted from the outside to the inside of the cell.	[Sharma, Nanaocha; Longjam, Geeta; Schreiber, Gideon] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Schreiber, G (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	gideon.schreiber@weizmann.ac.il			United States-Israel Binational Science Foundation [2011093]; European Community [264399]	United States-Israel Binational Science Foundation(US-Israel Binational Science Foundation); European Community(European Commission)	This work was supported by United States-Israel Binational Science Foundation Grant 2011093, the European Community 7th Framework Program TRANSPOL, 264399. The authors declare that they have no conflicts of interest with the contents of this article.	Abd Halim KB, 2015, BBA-GEN SUBJECTS, V1850, P1017, DOI 10.1016/j.bbagen.2014.09.006; ABRAMOVICH C, 1994, EMBO J, V13, P5871, DOI 10.1002/j.1460-2075.1994.tb06932.x; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; Atanasova M, 2012, CRIT REV BIOCHEM MOL, V47, P502, DOI 10.3109/10409238.2012.729561; Bessman NJ, 2014, CURR OPIN STRUC BIOL, V29, P95, DOI 10.1016/j.sbi.2014.10.002; Brown RJ, 2005, NAT STRUCT MOL BIOL, V12, P814, DOI 10.1038/nsmb977; COHEN B, 1995, MOL CELL BIOL, V15, P4208; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; Damjanovich S, 1997, P NATL ACAD SCI USA, V94, P13134, DOI 10.1073/pnas.94.24.13134; de Weerd NA, 2013, NAT IMMUNOL, V14, P901, DOI 10.1038/ni.2667; de Weerd NA, 2012, IMMUNOL CELL BIOL, V90, P483, DOI 10.1038/icb.2012.9; Defour JP, 2013, P NATL ACAD SCI USA, V110, P2540, DOI 10.1073/pnas.1211560110; Dosch DD, 2010, FASEB J, V24, P32, DOI 10.1096/fj.09-132670; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Francois-Newton V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022200; Freed DM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8380; Gadd SL, 2006, MOL ENDOCRINOL, V20, P2734, DOI 10.1210/me.2006-0114; Heukers R, 2013, J CELL SCI, V126, P4900, DOI 10.1242/jcs.128611; HWANG SY, 1995, P NATL ACAD SCI USA, V92, P11284, DOI 10.1073/pnas.92.24.11284; Jaitin DA, 2006, MOL CELL BIOL, V26, P1888, DOI 10.1128/MCB.26.5.1888-1897.2006; Kalie E, 2008, J BIOL CHEM, V283, P32925, DOI 10.1074/jbc.M806019200; Kalie E, 2007, J BIOL CHEM, V282, P11602, DOI 10.1074/jbc.M610115200; Kaur S, 2008, J IMMUNOL, V181, P7316, DOI 10.4049/jimmunol.181.10.7316; Kavran JM, 2014, ELIFE, V3, DOI 10.7554/eLife.03772; Krause CD, 2006, BIOCHEM BIOPH RES CO, V340, P377, DOI 10.1016/j.bbrc.2005.11.182; Krause CD, 2002, MOL CELL PROTEOMICS, V1, P805, DOI 10.1074/mcp.M200065-MCP200; Krause CD, 2006, CELL RES, V16, P55, DOI 10.1038/sj.cr.7310008; Krause CD, 2013, CYTOKINE, V64, P286, DOI 10.1016/j.cyto.2013.06.309; Kubatzky KF, 2005, J BIOL CHEM, V280, P14844, DOI 10.1074/jbc.M411251200; Kumar KGS, 2004, J BIOL CHEM, V279, P46614, DOI 10.1074/jbc.M407082200; LEUNG S, 1995, MOL CELL BIOL, V15, P1312; Levin D, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004998; Levin D, 2011, MOL CELL BIOL, V31, P3252, DOI 10.1128/MCB.05251-11; Li E, 2012, BBA-BIOMEMBRANES, V1818, P183, DOI 10.1016/j.bbamem.2011.08.031; Lis M, 2006, BIOCHEM BIOPH RES CO, V339, P321, DOI 10.1016/j.bbrc.2005.11.022; Livnah O, 1998, NAT STRUCT BIOL, V5, P993, DOI 10.1038/2965; Livnah O, 1999, SCIENCE, V283, P987, DOI 10.1126/science.283.5404.987; Lochte S, 2014, J CELL BIOL, V207, P407, DOI 10.1083/jcb.201406032; Manni S, 2014, STRUCTURE, V22, P1077, DOI 10.1016/j.str.2014.05.010; Mendrola JM, 2002, J BIOL CHEM, V277, P4704, DOI 10.1074/jbc.M108681200; Moraga I, 2015, CELL, V160, P1196, DOI 10.1016/j.cell.2015.02.011; Moraga I, 2014, ADV IMMUNOL, V121, P1, DOI 10.1016/B978-0-12-800100-4.00001-5; Pang XD, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002427; Platanias LC, 2005, NAT REV IMMUNOL, V5, P375, DOI 10.1038/nri1604; Polyansky AA, 2014, BIOINFORMATICS, V30, P889, DOI 10.1093/bioinformatics/btt645; Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990; Russ WP, 1999, P NATL ACAD SCI USA, V96, P863, DOI 10.1073/pnas.96.3.863; Sankararaman S, 2009, NUCLEIC ACIDS RES, V37, pW390, DOI 10.1093/nar/gkp339; Schreiber G, 2015, TRENDS IMMUNOL, V36, P139, DOI 10.1016/j.it.2015.01.002; Seubert N, 2003, MOL CELL, V12, P1239, DOI 10.1016/S1097-2765(03)00389-7; SPRANG SR, 1993, CURR OPIN STRUC BIOL, V3, P815, DOI 10.1016/0959-440X(93)90144-A; Staerk J, 2011, EMBO J, V30, P4398, DOI 10.1038/emboj.2011.315; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Strunk JJ, 2008, J MOL BIOL, V377, P725, DOI 10.1016/j.jmb.2008.01.017; Strunk JJ, 2009, BIOCONJUGATE CHEM, V20, P41, DOI 10.1021/bc8002088; Stuttfeld E, 2009, IUBMB LIFE, V61, P915, DOI 10.1002/iub.234; Tenhumberg S, 2006, BIOCHEM BIOPH RES CO, V346, P649, DOI 10.1016/j.bbrc.2006.05.173; Thomas C, 2011, CELL, V146, P621, DOI 10.1016/j.cell.2011.06.048; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Verma A, 2002, J BIOL CHEM, V277, P7726, DOI 10.1074/jbc.M106640200; Wallweber HJA, 2014, NAT STRUCT MOL BIOL, V21, P443, DOI 10.1038/nsmb.2807; Wilmes S, 2015, J CELL BIOL, V209, P579, DOI 10.1083/jcb.201412049; Yan H, 1996, EMBO J, V15, P1064, DOI 10.1002/j.1460-2075.1996.tb00444.x; Zaks-Zilberman M, 2008, J BIOL CHEM, V283, P13398, DOI 10.1074/jbc.M710230200; Zhao LJ, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-157	65	12	12	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3371	3384		10.1074/jbc.M115.686071	http://dx.doi.org/10.1074/jbc.M115.686071			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26679999	Green Published, hybrid			2022-12-26	WOS:000370854500021
J	Choudhury, AR; Novic, M				Choudhury, Amrita Roy; Novic, Marjana			Pred beta TM: A Novel beta-Transmembrane Region Prediction Algorithm	PLOS ONE			English	Article							BARREL MEMBRANE-PROTEINS; DATA-BANK; IDENTIFICATION; TOPOLOGY	Predicting the transmembrane regions is an important aspect of understanding the structures and architecture of different beta-barrel membrane proteins. Despite significant efforts, currently available beta-transmembrane region predictors are still limited in terms of prediction accuracy, especially in precision. Here, we describe Pred beta TM, a transmembrane region prediction algorithm for beta-barrel proteins. Using amino acid pair frequency information in known beta-transmembrane protein sequences, we have trained a support vector machine classifier to predict beta-transmembrane segments. Position-specific amino acid preference data is incorporated in the final prediction. The predictor does not incorporate evolutionary profile information explicitly, but is based on sequence patterns generated implicitly by encoding the protein segments using amino acid adjacency matrix. With a benchmark set of 35 beta-transmembrane proteins, Pred beta TM shows a sensitivity and precision of 83.71% and 72.98%, respectively. The segment overlap score is 82.19%. In comparison with other state-of-art methods, Pred beta TM provides a higher precision and segment overlap without compromising with sensitivity. Further, we applied Pred beta TM to analyze the beta-barrel membrane proteins without defined transmembrane regions and the uncharacterized protein sequences in eight bacterial genomes and predict possible beta-transmembrane proteins. Pred beta TM can be freely accessed on the web at http://transpred.ki.si/.	[Choudhury, Amrita Roy; Novic, Marjana] Natl Inst Chem, Lab Chemometr, Ljubljana, Slovenia	National Institute of Chemistry - Slovenia	Choudhury, AR (corresponding author), Natl Inst Chem, Lab Chemometr, Ljubljana, Slovenia.	amrita.roychoudhury@ki.si			Ministry of Higher Education, Science and Technology of the Republic of Slovenia [P1-017, J1-2151]; European Regional Development Fund (Cross-border Collaboration Italy-Slovenia, TRANS2CARE strategic project)	Ministry of Higher Education, Science and Technology of the Republic of Slovenia; European Regional Development Fund (Cross-border Collaboration Italy-Slovenia, TRANS2CARE strategic project)	This work is supported by the Ministry of Higher Education, Science and Technology of the Republic of Slovenia [P1-017, J1-2151], as well as by the European Regional Development Fund (Cross-border Collaboration Italy-Slovenia 2007-2013, TRANS2CARE strategic project). Funding for open access charge: Ministry of Higher Education, Science and Technology of the Republic of Slovenia.	Bagos PG, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-7; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Gromiha MM, 2005, NUCLEIC ACIDS RES, V33, pW164, DOI 10.1093/nar/gki367; Jacoboni I, 2001, PROTEIN SCI, V10, P779, DOI 10.1110/ps.37201; Kaur G, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-28; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Lomize MA, 2006, BIOINFORMATICS, V22, P623, DOI 10.1093/bioinformatics/btk023; Lu W, 2014, J BACTERIOL, V196, P1073, DOI 10.1128/JB.01021-13; Natt NK, 2004, PROTEINS, V56, P11, DOI 10.1002/prot.20092; Pautsch A, 2000, J MOL BIOL, V298, P273, DOI 10.1006/jmbi.2000.3671; Randall A, 2008, BIOINFORMATICS, V24, P513, DOI 10.1093/bioinformatics/btm548; Randic M, 2008, SAR QSAR ENVIRON RES, V19, P339, DOI 10.1080/10629360802085082; Roy Choudhury A, 2012, INT J CHEM MODEL, V4, P205; Schulz GE, 2000, CURR OPIN STRUC BIOL, V10, P443, DOI 10.1016/S0959-440X(00)00120-2; Stewart L, 2014, PATHOG DIS, V71, P20, DOI 10.1111/2049-632X.12107; Tusnady GE, 2008, NUCLEIC ACIDS RES, V36, pD234, DOI 10.1093/nar/gkm751; Tusnady GE, 2004, BIOINFORMATICS, V20, P2964, DOI 10.1093/bioinformatics/bth340; Wimley WC, 2003, CURR OPIN STRUC BIOL, V13, P404, DOI 10.1016/S0959-440X(03)00099-X; Wimley WC, 2002, PROTEIN SCI, V11, P301, DOI 10.1110/ps.29402; Wright MS, 2014, MBIO, V5, DOI 10.1128/mBio.00963-13; Zhang W, 2014, ENVIRON MICROBIOL, V16, P963, DOI 10.1111/1462-2920.12234; Zupan J, 1997, CHEMOMETR INTELL LAB, V38, P1, DOI 10.1016/S0169-7439(97)00030-0	24	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145564	10.1371/journal.pone.0145564	http://dx.doi.org/10.1371/journal.pone.0145564			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694538	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092500057
J	Choveau, FS; Zhang, J; Bierbower, SM; Sharma, R; Shapiro, MS				Choveau, Frank S.; Zhang, Jie; Bierbower, Sonya M.; Sharma, Ramaswamy; Shapiro, Mark S.			The Role of the Carboxyl Terminus Helix C-D Linker in Regulating KCNQ3 K+ Current Amplitudes by Controlling Channel Trafficking	PLOS ONE			English	Article							SURFACE EXPRESSION; POTASSIUM CHANNELS; DETERMINANTS; DOMAIN; SIGNAL; MOTIF; IDENTIFICATION; DEACTIVATION; SENSITIVITY; SELECTIVITY	In the central and peripheral nervous system, the assembly of KCNQ3 with KCNQ2 as mostly heteromers, but also homomers, underlies "M-type" currents, a slowly-activating voltage-gated K+ current that plays a dominant role in neuronal excitability. KCNQ3 homomers yield much smaller currents compared to KCNQ2 or KCNQ4 homomers and KCNQ2/3 heteromers. This smaller current has been suggested to result either from divergent channel surface expression or from a pore that is more unstable in KCNQ3. Channel surface expression has been shown to be governed by the distal part of the C-terminus in which helices C and D are critical for channel trafficking and assembly. A sequence alignment of this region in KCNQ channels shows that KCNQ3 possesses a longer linker between helix C and D compared to the other KCNQ subunits. Here, we investigate the role of the extra residues of this linker on KCNQ channel expression. Deletion of these residues increased KCNQ3 current amplitudes. Total internal reflection fluorescence imaging and plasma membrane protein assays suggest that the increase in current is due to a higher surface expression of the channels. Conversely, introduction of the extra residues into the linker between helices C and D of KCNQ4 reduced current amplitudes by decreasing the number of KCNQ4 channels at the plasma membrane. Confocal imaging suggests a higher fraction of channels, which possess the extra residues of helix C-D linker, were retained within the endoplasmic reticulum. Such retention does not appear to lead to protein accumulation and activation of the unfolded protein response that regulates protein folding and maintains endoplasmic reticulum homeostasis. Taken together, we conclude that extra helix C-D linker residues play a role in KCNQ3 current amplitudes by controlling the exit of the channel from the endoplasmic reticulum.	[Choveau, Frank S.; Zhang, Jie; Bierbower, Sonya M.; Shapiro, Mark S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Sharma, Ramaswamy] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio	Shapiro, MS (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA.	shapirom@uthscsa.edu	Choveau, Frank/AFI-6500-2022; Choveau, Frank/AAF-3858-2022		National Institutes of Health [R01 NS150305, R56 NS153503]; UTHSCSA; NIH-NCI (CTRC at UTHSCSA) [P30 CA54174]; NIH-NIA [P01AG19316]; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS094461] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG019316] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UTHSCSA; NIH-NCI (CTRC at UTHSCSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH-NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Institutes of Health grants R01 NS150305 and R56 NS153503 to M.S.S.; We thank Drs. Nikita Gamper and James D. Lechleiter for their constructive discussions. We thank Pamela Reed for her assistance with biochemistry assays and Exing Wang for his assistance with confocal imaging. All the confocal experiments were performed at the Core Optical Imaging Facility which is supported by UTHSCSA, NIH-NCI P30 CA54174 (CTRC at UTHSCSA) and NIH-NIA P01AG19316.	Alaimo A, 2009, J BIOL CHEM, V284, P20668, DOI 10.1074/jbc.M109.019539; ALMERS W, 1980, J GEN PHYSIOL, V75, P61, DOI 10.1085/jgp.75.1.61; Axelrod D, 2003, METHOD ENZYMOL, V361, P1; Gomez-Posada JC, 2010, J NEUROSCI, V30, P9316, DOI 10.1523/JNEUROSCI.0851-10.2010; Chakrapani S, 2011, NAT STRUCT MOL BIOL, V18, P67, DOI 10.1038/nsmb.1968; Chan KW, 1996, P NATL ACAD SCI USA, V93, P14193, DOI 10.1073/pnas.93.24.14193; Choveau FS, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00397; Choveau FS, 2012, BIOPHYS J, V102, P2499, DOI 10.1016/j.bpj.2012.04.019; Choveau FS, 2012, BIOPHYS J, V102, P2489, DOI 10.1016/j.bpj.2012.04.018; Cordero-Morales JF, 2006, NAT STRUCT MOL BIOL, V13, P311, DOI 10.1038/nsmb1069; Cordero-Morales JF, 2007, NAT STRUCT MOL BIOL, V14, P1062, DOI 10.1038/nsmb1309; Cordero-Morales JF, 2011, BIOPHYS J, V100, P2387, DOI 10.1016/j.bpj.2011.01.073; Dahimene S, 2006, CIRC RES, V99, P1076, DOI 10.1161/01.RES.0000250262.12219.95; Etxeberria A, 2004, J NEUROSCI, V24, P9146, DOI 10.1523/JNEUROSCI.3194-04.2004; Etxeberria A, 2008, FASEB J, V22, P1135, DOI 10.1096/fj.07-9712com; Hadley JK, 2000, BRIT J PHARMACOL, V129, P413, DOI 10.1038/sj.bjp.0703086; Hardt B, 2003, GLYCOBIOLOGY, V13, P159, DOI 10.1093/glycob/cwg013; Hernandez CC, 2009, J GEN PHYSIOL, V134, P437, DOI 10.1085/jgp.200910313; Howard RJ, 2007, NEURON, V53, P663, DOI 10.1016/j.neuron.2007.02.010; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; Jentsch TJ, 2000, NAT REV NEUROSCI, V1, P21, DOI 10.1038/35036198; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Li Y, 2004, J NEUROSCI, V24, P5079, DOI 10.1523/JNEUROSCI.0882-04.2004; Lockless SW, 2007, PLOS BIOL, V5, P1079, DOI 10.1371/journal.pbio.0050121; London B, 1997, CIRC RES, V81, P870; Lu JL, 2001, BIOCHEMISTRY-US, V40, P10934, DOI 10.1021/bi010763e; Maljevic S, 2003, J PHYSIOL-LONDON, V548, P353, DOI 10.1113/jphysiol.2003.040980; MANDERS EMM, 1992, J CELL SCI, V103, P857; Manganas LN, 2001, P NATL ACAD SCI USA, V98, P14055, DOI 10.1073/pnas.241403898; Martinez-Marmol R, 2013, J CELL SCI, V126, P5681, DOI 10.1242/jcs.134825; Michelsen K, 2005, EMBO REP, V6, P717, DOI 10.1038/sj.embor.7400480; Misonou H, 2004, CRIT REV BIOCHEM MOL, V39, P125, DOI 10.1080/10409230490475417; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Nagaya N, 1997, J BIOL CHEM, V272, P3022, DOI 10.1074/jbc.272.5.3022; Nakajo K, 2008, J PHYSIOL-LONDON, V586, P2827, DOI 10.1113/jphysiol.2007.148601; Pahl HL, 1996, J CELL BIOL, V132, P511, DOI 10.1083/jcb.132.4.511; Pan N, 2009, CELL SIGNAL, V21, P349, DOI 10.1016/j.cellsig.2008.11.006; PELHAM HRB, 1988, EMBO J, V7, P913, DOI 10.1002/j.1460-2075.1988.tb02896.x; Phartiyal P, 2008, J BIOL CHEM, V283, P3702, DOI 10.1074/jbc.M708999200; RAE J, 1991, J NEUROSCI METH, V37, P15, DOI 10.1016/0165-0270(91)90017-T; Robbins J, 2001, PHARMACOL THERAPEUT, V90, P1, DOI 10.1016/S0163-7258(01)00116-4; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Schwake M, 2006, J NEUROSCI, V26, P3757, DOI 10.1523/JNEUROSCI.5017-05.2006; Schwake M, 2003, EMBO REP, V4, P76, DOI 10.1038/sj.embor.embor715; Seebohm G, 2005, J PHYSIOL-LONDON, V563, P359, DOI 10.1113/jphysiol.2004.080887; Shapiro MS, 2000, J NEUROSCI, V20, P1710; Shim J, 2004, MOL BIOL CELL, V15, P4818, DOI 10.1091/mbc.E04-02-0108; Valiyaveetil FI, 2006, SCIENCE, V314, P1004, DOI 10.1126/science.1133415; Viloria CG, 2000, BIOPHYS J, V79, P231, DOI 10.1016/S0006-3495(00)76286-2; Vivaudou M, 1997, J BIOL CHEM, V272, P31553, DOI 10.1074/jbc.272.50.31553; Wang JL, 1998, J GEN PHYSIOL, V112, P637, DOI 10.1085/jgp.112.5.637; Wang JM, 2002, NAT NEUROSCI, V5, P963, DOI 10.1038/nn918; Zaika O, 2008, BIOPHYS J, V95, P5121, DOI 10.1529/biophysj.108.137604; Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009; Zhu J, 2005, BIOCHEM J, V388, P355, DOI 10.1042/BJ20041447; Zhu J, 2003, J BIOL CHEM, V278, P25558, DOI 10.1074/jbc.M207984200	57	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145367	10.1371/journal.pone.0145367	http://dx.doi.org/10.1371/journal.pone.0145367			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26692086	Green Submitted, Green Published, gold			2022-12-26	WOS:000367092300064
J	Felber, K; Elks, PM; Lecca, M; Roehl, HH				Felber, Katharina; Elks, Philip M.; Lecca, Maria; Roehl, Henry H.			Expression of osterix Is Regulated by FGF and Wnt/beta-Catenin Signalling during Osteoblast Differentiation	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; MESENCHYMAL STEM-CELLS; TRANSCRIPTION FACTOR OSTERIX; BONE-FORMATION; GENE-EXPRESSION; RETINOIC ACID; MAP-KINASE; ZEBRAFISH DEVELOPMENT; ALKALINE-PHOSPHATASE; MESODERM INDUCTION	Osteoblast differentiation from mesenchymal cells is regulated by multiple signalling pathways. Here we have analysed the roles of Fibroblast Growth Factor (FGF) and canonical Wingless-type MMTV integration site (Wnt/beta-Catenin) signalling pathways on zebrafish osteogenesis. We have used transgenic and chemical interference approaches to manipulate these pathways and have found that both pathways are required for osteoblast differentiation in vivo. Our analysis of bone markers suggests that these pathways act at the same stage of differentiation to initiate expression of the osteoblast master regulatory gene osterix (osx). We use two independent approaches that suggest that osx is a direct target of these pathways. Firstly, we manipulate signalling and show that osx gene expression responds with similar kinetics to that of known transcriptional targets of the FGF and Wnt pathways. Secondly, we have performed ChIP with transcription factors for both pathways and our data suggest that a genomic region in the first intron of osx mediates transcriptional activation. Based upon these data, we propose that FGF and Wnt/beta-Catenin pathways act in part by directing transcription of osx to promote osteoblast differentiation at sites of bone formation.	[Roehl, Henry H.] Univ Sheffield, Bateson Ctr, Sheffield S10 2TN, S Yorkshire, England; Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield; University of Sheffield	Roehl, HH (corresponding author), Univ Sheffield, Bateson Ctr, Sheffield S10 2TN, S Yorkshire, England.	h.roehl@sheffield.ac.uk			Wellcome Trust UK [072346/Z/03/Z]; Cancer Research UK [C11413/A4072]; Medical Research Council UK [MR/J001457/1]; MRC [MR/J001457/1] Funding Source: UKRI; Medical Research Council [MR/J001457/1] Funding Source: researchfish	Wellcome Trust UK(Wellcome Trust); Cancer Research UK(Cancer Research UK); Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by the following grant sponsors: HHR: Wellcome Trust UK, 072346/Z/03/Z; Cancer Research UK, C11413/A4072; and Medical Research Council UK, MR/J001457/1.	Ambrosetti D, 2008, MOL CELL BIOL, V28, P4759, DOI 10.1128/MCB.01849-07; Avaron F, 2006, DEV DYNAM, V235, P478, DOI 10.1002/dvdy.20619; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Christen B, 1999, DEVELOPMENT, V126, P119; Cubbage CC, 1996, J MORPHOL, V229, P121, DOI 10.1002/(SICI)1097-4687(199608)229:2<121::AID-JMOR1>3.0.CO;2-4; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; De Boer J, 2004, TISSUE ENG, V10, P393, DOI 10.1089/107632704323061753; DeLaurier A, 2010, GENESIS, V48, P505, DOI 10.1002/dvg.20639; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; Eswarakumar VP, 2002, DEVELOPMENT, V129, P3783; Felber K, 2011, MECH DEVELOP, V128, P141, DOI 10.1016/j.mod.2010.11.006; Flores MV, 2004, GENE EXPR PATTERNS, V4, P573, DOI 10.1016/j.modgep.2004.01.016; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Gong YQ, 2001, CELL, V107, P513, DOI 10.1016/S0092-8674(01)00571-2; Hammond CL, 2009, DEVELOPMENT, V136, P3991, DOI 10.1242/dev.042150; Hartmann C, 2007, MOL CELLS, V24, P177; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Hu HL, 2005, DEVELOPMENT, V132, P49, DOI 10.1242/dev.01564; Huycke TR, 2012, DEVELOPMENT, V139, P2371, DOI 10.1242/dev.079806; Huysseune A., 2000, P307, DOI 10.1016/B978-012529650-2/50024-X; Jackson RA, 2006, GENE, V379, P79, DOI 10.1016/j.gene.2006.04.028; Jeon E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043982; Kim HJ, 2003, J BIOL CHEM, V278, P319, DOI 10.1074/jbc.M203750200; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2011, J CELL BIOCHEM, V112, P750, DOI 10.1002/jcb.22994; LABONNE C, 1995, DEVELOPMENT, V121, P1475; Lapunzina P, 2010, AM J HUM GENET, V87, P110, DOI 10.1016/j.ajhg.2010.05.016; Laue K, 2008, DEVELOPMENT, V135, P3775, DOI 10.1242/dev.021238; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Lerner UH, 2015, J INTERN MED, V277, P630, DOI 10.1111/joim.12368; Li N, 2010, DEVELOPMENT, V137, P389, DOI 10.1242/dev.044164; Li N, 2009, DEV DYNAM, V238, P459, DOI 10.1002/dvdy.21838; Liu GZ, 2009, J CELL BIOL, V185, P67, DOI 10.1083/jcb.200810137; Mansukhani A, 2000, J CELL BIOL, V149, P1297, DOI 10.1083/jcb.149.6.1297; Marie PJ, 2003, GENE, V316, P23, DOI 10.1016/S0378-1119(03)00748-0; Milat F, 2009, MOL CELL ENDOCRINOL, V310, P52, DOI 10.1016/j.mce.2009.06.002; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Nusslein-Volhard C., 2002, ZEBRAFISH PRACTICAL; Ohbayashi N, 2002, GENE DEV, V16, P870, DOI 10.1101/gad.965702; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Pinto JP, 2005, J BONE MINER RES, V20, P1440, DOI 10.1359/JBMR.050318; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; Renn J, 2009, DEV DYNAM, V238, P241, DOI 10.1002/dvdy.21836; RODAN SB, 1989, J BIOL CHEM, V264, P19934; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Roehl H, 2001, CURR BIOL, V11, P503, DOI 10.1016/S0960-9822(01)00143-9; Sawada A, 2001, DEVELOPMENT, V128, P4873; Shimizu-Sasaki K, 2001, J BIOL CHEM, V276, P5459, DOI 10.1074/jbc.M008971200; Simon MA, 2000, CELL, V103, P13, DOI 10.1016/S0092-8674(00)00100-8; Spoorendonk KM, 2008, DEVELOPMENT, V135, P3765, DOI 10.1242/dev.024034; Stein GS, 1996, PHYSIOL REV, V76, P593, DOI 10.1152/physrev.1996.76.2.593; Stevens JR, 2010, J BONE MINER RES, V25, P2138, DOI 10.1002/jbmr.118; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Su N, 2008, FRONT BIOSCI-LANDMRK, V13, P2842, DOI 10.2741/2890; Tan SH, 2014, P NATL ACAD SCI USA, V111, pE5262, DOI 10.1073/pnas.1420463111; UMBHAUER M, 1995, NATURE, V376, P58, DOI 10.1038/376058a0; van der Meulen T, 2005, BBA-GENE STRUCT EXPR, V1729, P105, DOI 10.1016/j.bbaexp.2005.03.008; Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; Witten PE, 2009, BIOL REV, V84, P315, DOI 10.1111/j.1469-185X.2009.00077.x; Xiao GZ, 2000, J BIOL CHEM, V275, P4453, DOI 10.1074/jbc.275.6.4453; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105; Zhang X, 2002, BIOCHEM BIOPH RES CO, V290, P526, DOI 10.1006/bbrc.2001.6217	66	33	37	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144982	10.1371/journal.pone.0144982	http://dx.doi.org/10.1371/journal.pone.0144982			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689368	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092300028
J	Thakore-Shah, K; Koleilat, T; Jan, M; John, A; Pyle, AD				Thakore-Shah, Kaushali; Koleilat, Tasneem; Jan, Majib; John, Alan; Pyle, April D.			REST/NRSF Knockdown Alters Survival, Lineage Differentiation and Signaling in Human Embryonic Stem Cells	PLOS ONE			English	Article							TARGET GENES; NEURONAL GENES; IN-VIVO; REST NRSF; TRANSCRIPTION; REPRESSOR; PROTEIN; PLURIPOTENCY; NEUROGENESIS; EXPRESSION	REST (RE1 silencing transcription factor), also known as NRSF (neuron-restrictive silencer factor), is a well-known transcriptional repressor of neural genes in non-neural tissues and stem cells. Dysregulation of REST activity is thought to play a role in diverse diseases including epilepsy, cancer, Down's syndrome and Huntington's disease. The role of REST/NRSF in control of human embryonic stem cell (hESC) fate has never been examined. To evaluate the role of REST in hESCs we developed an inducible REST knockdown system and examined both growth and differentiation over short and long term culture. Interestingly, we have found that altering REST levels in multiple hESC lines does not result in loss of self-renewal but instead leads to increased survival. During differentiation, REST knockdown resulted in increased MAPK/ERK and WNT signaling and increased expression of mesendoderm differentiation markers. Therefore we have uncovered a new role for REST in regulation of growth and early differentiation decisions in human embryonic stem cells.	[Thakore-Shah, Kaushali; Pyle, April D.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Koleilat, Tasneem; Jan, Majib] Calif State Univ Northridge, Northridge, CA 91325 USA; [John, Alan; Pyle, April D.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Pyle, April D.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; California State University System; California State University Northridge; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Pyle, AD (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA.	apyle@mednet.ucla.edu			California Institute for Regenerative Medicine (CIRM) Bridges to Stem Cell Research Program; UCLA Jonsson Comprehensive Cancer Center (JCCC) grant; National Institutes of Health [P01GM081621]; Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research (BSCRC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081621] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM) Bridges to Stem Cell Research Program; UCLA Jonsson Comprehensive Cancer Center (JCCC) grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research (BSCRC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	TK and MJ were supported by the California Institute for Regenerative Medicine (CIRM) Bridges to Stem Cell Research Program. This work was supported in part by the UCLA Jonsson Comprehensive Cancer Center (JCCC) grant to ADP. ADP was also supported by the National Institutes of Health through grant P01GM081621, and the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research (BSCRC).	Alva JA, 2011, STEM CELLS, V29, P1952, DOI 10.1002/stem.748; Aoki H, 2012, DEVELOPMENT, V139, P667, DOI 10.1242/dev.072272; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Bassuk AG, 2008, AM J HUM GENET, V83, P572, DOI 10.1016/j.ajhg.2008.10.003; Bingham AJ, 2007, MOL CELL BIOL, V27, P4082, DOI 10.1128/MCB.00269-07; Blauwkamp TA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2064; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bruce AW, 2009, GENOME RES, V19, P994, DOI 10.1101/gr.089086.108; Buckley NJ, 2009, NATURE, V457, pE5, DOI 10.1038/nature07784; Canzonetta C, 2008, AM J HUM GENET, V83, P388, DOI 10.1016/j.ajhg.2008.08.012; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Coulson J.M., 2005, CURR BIOL, V15, P666; Damoiseaux R, 2009, STEM CELLS, V27, P533, DOI 10.1634/stemcells.2008-0596; Duhamel S, 2012, CANCER RES, V72, P626, DOI 10.1158/0008-5472.CAN-11-2126; Fazeli A, 2011, INT J DEV BIOL, V55, P175, DOI 10.1387/ijdb.103177af; Formisano L, 2007, P NATL ACAD SCI USA, V104, P4170, DOI 10.1073/pnas.0611704104; Garriga-Canut M, 2006, NAT NEUROSCI, V9, P1382, DOI 10.1038/nn1791; Greber B, 2011, EMBO J, V30, P4874, DOI 10.1038/emboj.2011.407; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256; Jones FS, 1999, BIOESSAYS, V21, P372, DOI 10.1002/(SICI)1521-1878(199905)21:5<372::AID-BIES3>3.0.CO;2-3; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Lunyak VV, 2005, CELL, V121, P499, DOI 10.1016/j.cell.2005.05.003; Majumder S, 2006, CELL CYCLE, V5, P1929, DOI 10.4161/cc.5.17.2982; Pereira LA, 2012, STEM CELL RES, V8, P165, DOI 10.1016/j.scr.2011.09.007; Satoh J, 2013, BIOINFORM BIOL INSIG, V7, P357, DOI 10.4137/BBI.S13279; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Sebolt-Leopold JS, 2004, NAT REV CANCER, V4, P937, DOI 10.1038/nrc1503; Singh AM, 2012, CELL STEM CELL, V10, P312, DOI 10.1016/j.stem.2012.01.014; Singh S. K., 2008, NATURE; Tahiliani M, 2007, NATURE, V447, P601, DOI 10.1038/nature05823; Wagoner MP, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000979; Weissman AM, 2008, CANCER CELL, V13, P381, DOI 10.1016/j.ccr.2008.04.011; Westbrook TF, 2005, CELL, V121, P837, DOI 10.1016/j.cell.2005.03.033; Yamada Y, 2010, CELL STEM CELL, V6, P10, DOI 10.1016/j.stem.2009.12.003; Zeng XM, 2004, RESTOR NEUROL NEUROS, V22, P421; Zuccato C, 2003, NAT GENET, V35, P76, DOI 10.1038/ng1219; Zuccato C, 2007, J NEUROSCI, V27, P6972, DOI 10.1523/JNEUROSCI.4278-06.2007	41	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145280	10.1371/journal.pone.0145280	http://dx.doi.org/10.1371/journal.pone.0145280			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690059	Green Submitted, gold, Green Published			2022-12-26	WOS:000367092300053
J	Tulstrup, MVL; Christensen, EG; Carvalho, V; Linninge, C; Ahrne, S; Hojberg, O; Licht, TR; Bahl, MI				Tulstrup, Monica Vera-Lise; Christensen, Ellen Gerd; Carvalho, Vera; Linninge, Caroline; Ahrne, Siv; Hojberg, Ole; Licht, Tine Rask; Bahl, Martin Iain			Antibiotic Treatment Affects Intestinal Permeability and Gut Microbial Composition in Wistar Rats Dependent on Antibiotic Class	PLOS ONE			English	Article							EPITHELIAL BARRIER FUNCTION; ELECTRICAL-RESISTANCE; TIGHT; BUTYRATE; MODEL; MICE; BIFIDOBACTERIA; COLONIZATION; INFLAMMATION; FERMENTATION	Antibiotics are frequently administered orally to treat bacterial infections not necessarily related to the gastrointestinal system. This has adverse effects on the commensal gut microbial community, as it disrupts the intricate balance between specific bacterial groups within this ecosystem, potentially leading to dysbiosis. We hypothesized that modulation of community composition and function induced by antibiotics affects intestinal integrity depending on the antibiotic administered. To address this a total of 60 Wistar rats (housed in pairs with 6 cages per group) were dosed by oral gavage with either amoxicillin (AMX), cefotaxime (CTX), vancomycin (VAN), metronidazole (MTZ), or water (CON) daily for 10-11 days. Bacterial composition, alpha diversity and caecum short chain fatty acid levels were significantly affected by AMX, CTX and VAN, and varied among antibiotic treatments. A general decrease in diversity and an increase in the relative abundance of Proteobacteria was observed for all three antibiotics. Additionally, the relative abundance of Bifidobacteriaceae was increased in the CTX group and both Lactobacillaceae and Verrucomicrobiaceae were increased in the VAN group compared to the CON group. No changes in microbiota composition or function were observed following MTZ treatment. Intestinal permeability to 4 kDa FITC-dextran decreased after CTX and VAN treatment and increased following MTZ treatment. Plasma haptoglobin levels were increased by both AMX and CTX but no changes in expression of host tight junction genes were found in any treatment group. A strong correlation between the level of caecal succinate, the relative abundance of Clostridiaceae 1 family in the caecum, and the level of acute phase protein haptoglobin in blood plasma was observed. In conclusion, antibiotic-induced changes in microbiota may be linked to alterations in intestinal permeability, although the specific interactions remain to be elucidated as changes in permeability did not always result from major changes in microbiota and vice versa.	[Tulstrup, Monica Vera-Lise; Christensen, Ellen Gerd; Carvalho, Vera; Licht, Tine Rask; Bahl, Martin Iain] Tech Univ Denmark, Natl Food Inst, Div Diet Dis prevent & Toxicol, Soborg, Denmark; [Linninge, Caroline; Ahrne, Siv] Lund Univ, Dept Food Technol Engn & Nutr, Lund, Sweden; [Hojberg, Ole] Aarhus Univ, Dept Anim Sci, Tjele, Denmark	Technical University of Denmark; Lund University; Aarhus University	Bahl, MI (corresponding author), Tech Univ Denmark, Natl Food Inst, Div Diet Dis prevent & Toxicol, Soborg, Denmark.	mbah@food.dtu.dk		Tulstrup, Monica Vera-Lise/0000-0002-2568-3982; Bahl, Martin Iain/0000-0003-1579-8038; Licht, Tine Rask/0000-0002-6399-9574	Danish Council for Independent Research, Technology and Production Sciences [DFF-1335-00092]; Royal Physiographic Society of Lund	Danish Council for Independent Research, Technology and Production Sciences(Det Frie Forskningsrad (DFF)); Royal Physiographic Society of Lund	The present work was funded by a grant from the Danish Council for Independent Research, Technology and Production Sciences (DFF-133500092) and The Royal Physiographic Society of Lund.	Anderson RC, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-316; Antonopoulos DA, 2009, INFECT IMMUN, V77, P2367, DOI 10.1128/IAI.01520-08; Bergmann KR, 2013, AM J PATHOL, V182, P1595, DOI 10.1016/j.ajpath.2013.01.013; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Canibe N, 2007, J ANIM SCI, V85, P2959, DOI 10.2527/jas.2006-744; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cho I, 2012, NATURE, V488, P621, DOI 10.1038/nature11400; Christensen Ellen Gerd, 2014, BMC Res Notes, V7, P660, DOI 10.1186/1756-0500-7-660; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Commane DM, 2005, NUTR CANCER, V51, P102, DOI 10.1207/s15327914nc5101_14; Dubourg G, 2013, INT J ANTIMICROB AG, V41, P149, DOI 10.1016/j.ijantimicag.2012.10.012; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Perez-Cobas AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080201; Ewaschuk JB, 2008, AM J PHYSIOL-GASTR L, V295, pG1025, DOI 10.1152/ajpgi.90227.2008; Fak F, 2008, AM J PHYSIOL-GASTR L, V294, pG148, DOI 10.1152/ajpgi.00023.2007; Ferreyra JA, 2014, CELL HOST MICROBE, V16, P770, DOI 10.1016/j.chom.2014.11.003; Fujimura KE, 2010, EXPERT REV ANTI-INFE, V8, P435, DOI [10.1586/eri.10.14, 10.1586/ERI.10.14]; Hill DA, 2010, MUCOSAL IMMUNOL, V3, P148, DOI 10.1038/mi.2009.132; Hviid A, 2011, GUT, V60, P49, DOI 10.1136/gut.2010.219683; JENSEN MT, 1995, ANIM SCI, V61, P293, DOI 10.1017/S1357729800013837; Jernberg C, 2010, MICROBIOL-SGM, V156, P3216, DOI 10.1099/mic.0.040618-0; Jiang PP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044929; John LJ, 2011, ANTIOXID REDOX SIGN, V15, P1255, DOI 10.1089/ars.2011.3892; Kanauchi O, 1999, J GASTROEN HEPATOL, V14, P880, DOI 10.1046/j.1440-1746.1999.01971.x; Klingberg TD, 2005, APPL ENVIRON MICROB, V71, P7528, DOI 10.1128/AEM.71.11.7528-7530.2005; Lewis K, 2013, NAT REV DRUG DISCOV, V12, P371, DOI 10.1038/nrd3975; Lofmark S, 2010, CLIN INFECT DIS, V50, pS16, DOI 10.1086/647939; Lopez P, 2012, FOOD RES INT, V46, P99, DOI 10.1016/j.foodres.2011.11.020; Louis P, 2014, NAT REV MICROBIOL, V12, P661, DOI 10.1038/nrmicro3344; Maccaferri S, 2010, J ANTIMICROB CHEMOTH, V65, P2556, DOI 10.1093/jac/dkq345; Macfarlane S, 2014, ENVIRON MICROBIOL, V16, P919, DOI 10.1111/1462-2920.12399; Madsen K, 2001, GASTROENTEROLOGY, V121, P580, DOI 10.1053/gast.2001.27224; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Nejrup RG, 2015, BR J NUTR, P1; Panda S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095476; Pryde SE, 2002, FEMS MICROBIOL LETT, V217, P133, DOI 10.1016/S0378-1097(02)01106-0; Putaala H, 2008, RES MICROBIOL, V159, P692, DOI 10.1016/j.resmic.2008.08.002; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Schroedl W, 2014, SCAND J IMMUNOL, V79, P299, DOI 10.1111/sji.12161; Shen L, 2011, ANNU REV PHYSIOL, V73, P283, DOI 10.1146/annurev-physiol-012110-142150; Ubeda C, 2012, TRENDS IMMUNOL, V33, P459, DOI 10.1016/j.it.2012.05.003; Wang HB, 2012, DIGEST DIS SCI, V57, P3126, DOI 10.1007/s10620-012-2259-4; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; White JR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000352; Wlodarska M, 2011, INFECT IMMUN, V79, P1536, DOI 10.1128/IAI.01104-10; Zhang YC, 2014, TOXICOL APPL PHARM, V277, P138, DOI 10.1016/j.taap.2014.03.009	47	132	137	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144854	10.1371/journal.pone.0144854	http://dx.doi.org/10.1371/journal.pone.0144854			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691591	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092300021
J	Sammarco, PW; Porter, SA; Genazzio, M; Sinclair, J				Sammarco, Paul W.; Porter, Scott A.; Genazzio, Melissa; Sinclair, James			Success in Competition for Space in Two Invasive Coral Species in the western Atlantic - Tubastraea micranthus and T-coccinea	PLOS ONE			English	Article							GULF-OF-MEXICO; INTERSPECIFIC AGGRESSION; NORTHERN GULF; SPONGE/CORAL INTERACTIONS; SCLERACTINIAN CORALS; EXPANSION; OVERGROWTH; DISPERSAL; OCTOCORALLIA; COMMUNITIES	Invasion success by an alien species is dependent upon rate of reproduction, growth, mortality, physical characteristics of the environment, and successful competition for resources with native species. For sessile, epibenthic marine species, one critical resource is space. We examined competitive success in two invasive Indo-Pacific corals involved in competition for space in the northern Gulf of Mexico-Tubastraea coccinea and T. micranthus-on up to 13 offshore oil/gas platforms south of the Mississippi River. Still-capture photos of thousands of overgrowth interactions between the target corals and other sessile epibenthic fauna were analyzed from ROV videos collected at 8-183 m depth. T. micranthus was observed overgrowing >90% of all sessile epibenthic species which it encountered. Frequencies of competitive success varied significantly between platforms. T. coccinea was competitively superior to all competitors pooled, at the 60% level. There was little variability between T. coccinea populations. T. coccinea encountered the following species most frequently-the encrusting sponges Xestospongia sp. (with the commensal Parazoanthus catenularis), X. carbonaria, Dictyonella funicularis, Mycale carmigropila, Phorbas amaranthus, and Haliclona vansoesti- and was found to be, on average, competitively superior to them. Both T. micranthus and T. coccinea appear to be good competitors for space against these species in the northern Gulf of Mexico. Competitive success in T. micranthus was highest in the NE part of the study area, and lowest in the SW area near the Mississippi River plume. T. coccinea's competitive success peaked in the SW study area. This suggests that variation in competitive success both within and between populations of these species may be due to differences in local environmental factors.	[Sammarco, Paul W.; Porter, Scott A.; Genazzio, Melissa] Louisiana Univ Marine Consortium LUMCON, Chauvin, LA 70344 USA; [Sammarco, Paul W.] Louisiana State Univ, Dept Oceanog & Coastal Sci, Baton Rouge, LA 70803 USA; [Porter, Scott A.] EcoLog Environm Inc, Houma, LA 70361 USA; [Genazzio, Melissa] Univ N Carolina, Ctr Marine Sci, Wilmington, NC 28409 USA; [Sinclair, James] Bur Safety & Environm Enforcement, US Dept Interior, New Orleans, LA 70123 USA	Louisiana State University System; Louisiana State University; University of North Carolina; University of North Carolina Wilmington; United States Department of the Interior	Sammarco, PW (corresponding author), Louisiana Univ Marine Consortium LUMCON, 8124 Hwy 56, Chauvin, LA 70344 USA.	psammarco@lumcon.edu		Genazzio, Melissa A/0000-0002-0901-0331	U.S. Department of the Interior, Bureau of Ocean Energy Management (BOEM), Environmental Studies Program [M10AC20006]; US Dept. Interior, Minerals Management Service[MMS]/Bureau of Ocean Energy Management [BOEM/BSEE]; BOEM	U.S. Department of the Interior, Bureau of Ocean Energy Management (BOEM), Environmental Studies Program; US Dept. Interior, Minerals Management Service[MMS]/Bureau of Ocean Energy Management [BOEM/BSEE]; BOEM	This study was funded by the U.S. Department of the Interior, Bureau of Ocean Energy Management (BOEM), Environmental Studies Program through Interagency Agreement M10AC20006. PWS and SAP received the funding. Please note that the fourth author is a representative of the funding agency which supported this study (US Dept. Interior, Minerals Management Service[MMS]/Bureau of Ocean Energy Management [BOEM/BSEE]). This study was not part of a research "grant", but of a "cooperative research agreement" and a collaboration between my laboratory and this agency. Co-author Scott A. Porter is employed by EcoLogic Environmental, Inc. He is the proprietor and sole employee. EcoLogic Environmental, Inc. provided support in the form of salary for author SAP. SAP played a role in the study design, data collection and analysis, decision to publish and preparation of the manuscript. The specific role of this author is articulated in the 'authoor contributions' section.; We would like to express our hearty thanks to the many folks who provided us with assistance in the field and the laboratory: R/V Acadiana, LUMCON-C. Sevin, T. Widgeon, M. Wike; M/V Fling, Freeport, TX-B. Allen, K. Bush, K. Dies, M. McReynold, B. Oldham, M. Spurgeon, J. Tyler; US Air Force/NASA-D. Perrenod; ARACAR-John Blitch; LUMCON-D. Beltz (statistical analyses); Others-M. Gaskill. This study was funded by the U.S. Department of the Interior, Bureau of Ocean Energy Management (BOEM), Environmental Studies Program through Cooperative Agreement M10AC20006. We extend our thanks to BOEM for funding the study, administered through the Louisiana State University Coastal Marine Institute (CMI) program, under the direction of L. Rouse and S. Welsh.	Aerts LAM, 1998, MAR ECOL PROG SER, V175, P241, DOI 10.3354/meps175241; Aerts LAM, 1997, MAR ECOL PROG SER, V148, P125, DOI 10.3354/meps148125; Alamaru A, 2009, CORAL REEFS, V28, P865, DOI 10.1007/s00338-009-0507-7; ALINO PM, 1992, MAR ECOL PROG SER, V81, P129, DOI 10.3354/meps081129; Belote RT, 2004, NEW PHYTOL, V161, P827, DOI 10.1111/j.1469-8137.2004.00977.x; BEST MA, 1986, MAR BIOL, V93, P371, DOI 10.1007/BF00401104; BUSS LW, 1979, NATURE, V281, P475, DOI 10.1038/281475a0; Cairns Stephen D., 2000, Uitgaven Natuurwetenschappelijke Studiekring voor het Caraibisch Gebied, V143, P1; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Chadwick NE, 2011, CORAL REEFS: AN ECOSYSTEM IN TRANSITION, P347, DOI 10.1007/978-94-007-0114-4_20; Coll J. C., 1992, 3 S SUR SUBST NAT IN, P227; COLL JC, 1989, CHEM SCRIPTA, V29, P383; Collin R, 2005, CARIBB J SCI, V41, P638; de Paula AF, 2004, B MAR SCI, V74, P175; Diez JM, 2008, ECOL LETT, V11, P674, DOI 10.1111/j.1461-0248.2008.01178.x; Dussuncao C, 2009, MIT PUBLICATION, V09-32; Engelhardt K.A.M., 2011, ENCY BIOL INVASIONS, P209; Fenner D, 2004, CORAL REEFS, V23, P505, DOI 10.1007/s00338-004-0422-x; Fenner D, 2001, B MAR SCI, V69, P1175; Gallaway BJ, 1981, 10BS8287 FWS OFF BIO; Griffiths RW, 1991, J SHELLFISH RES, V10, P1; Gurevitch J, 2004, TRENDS ECOL EVOL, V19, P470, DOI 10.1016/j.tree.2004.07.005; Hennessey SM, 2014, J EXP MAR BIOL ECOL, V459, P144, DOI 10.1016/j.jembe.2014.05.021; Humann P., 2002, REEF CORAL IDENTIFIC; JACKSON JBC, 1975, P NATL ACAD SCI USA, V72, P5160, DOI 10.1073/pnas.72.12.5160; JACKSON JBC, 1977, AM NAT, V111, P743, DOI 10.1086/283203; Johnson LE, 1996, ECOLOGY, V77, P1686, DOI 10.2307/2265774; LaJeunesse TC, 2005, CORAL REEFS, V24, P157, DOI 10.1007/s00338-004-0436-4; LANG J, 1973, B MAR SCI, V23, P260; LANG J, 1971, B MAR SCI, V21, P952; Lang JC, 1973, COMMUNICATION; LEWBEL GS, 1987, MAR ENVIRON RES, V21, P199, DOI 10.1016/0141-1136(87)90066-3; MAC ARTHUR ROBERT H., 1967; MacArthur R.H., 1972, pvii; Mangla S, 2011, PLANT ECOL, V212, P531, DOI 10.1007/s11258-011-9909-z; MCINTOSH AR, 1992, J FISH BIOL, V41, P63, DOI 10.1111/j.1095-8649.1992.tb03170.x; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; PORTER JW, 1988, BIOL BULL, V175, P230, DOI 10.2307/1541563; Preston DL, 2012, ECOLOGY, V93, P1254, DOI 10.1890/11-1821.1; Qasem J.R., 2001, J CROP PRODUCTION, V4, P43; Rejmanek M, 1996, ECOL STU AN, V122, P153; Rice EL, 1984, ALLELOPATHY PHYSL EC; RICHARDSON CA, 1979, MAR BIOL, V55, P181, DOI 10.1007/BF00396816; ROHLF F. J., 1996, BIOMSTAT WINDOWS STA; Rohlf FJ, 1981, STAT TABLES; Russell-Hunter W. D., 1968, BIOL LOWER INVERTEBR; Sammarco P.W., 1983, Coral Reefs, V1, P173, DOI 10.1007/BF00571194; Sammarco Paul W., 2013, Management of Biological Invasions, V4, P291; Sammarco PW, 2014, MAR ECOL PROG SER, V495, P161, DOI 10.3354/meps10576; Sammarco PW, 2012, J EXP MAR BIOL ECOL, V436, P36, DOI 10.1016/j.jembe.2012.08.009; Sammarco PW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030144; Sammarco PW, 2010, AQUAT INVASIONS, V5, P131, DOI 10.3391/ai.2010.5.2.02; SAMMARCO PW, 1992, MAR ECOL PROG SER, V88, P93, DOI 10.3354/meps088093; SAMMARCO PW, 1980, J EXP MAR BIOL ECOL, V45, P245, DOI 10.1016/0022-0981(80)90061-1; SAMMARCO PW, 1982, J EXP MAR BIOL ECOL, V61, P31, DOI 10.1016/0022-0981(82)90020-X; Sammarco PW, 2004, MAR ECOL PROG SER, V280, P129, DOI 10.3354/meps280129; Sammarco PW, 1982, THE REEF AND MAN, V1, P525; Secord D, 2003, BIOL INVASIONS, V5, P117, DOI 10.1023/A:1024054909052; Shearer T, 2008, 2008 OC SCI M WAT GL; SHEPPARD CRC, 1979, MAR ECOL PROG SER, V1, P237, DOI 10.3354/meps001237; Silva AG, 2011, AQUAT INVASIONS, V6, pS105, DOI 10.3391/ai.2011.6.S1.024; Sokal R. R, 1981, BIOMETRY; Sokal Robert R., 1969, BIOMETRY; Sorte CJB, 2010, GLOBAL ECOL BIOGEOGR, V19, P303, DOI 10.1111/j.1466-8238.2009.00519.x; Stachowicz JJ, 2002, ECOLOGY, V83, P2575; Suchanek TH, 2002, SPONGES IMPORTANT SP; Thomsen MS, 2007, BIOL INVASIONS, V9, P499, DOI 10.1007/s10530-006-9043-3; Vila M, 2004, OIKOS, V105, P229, DOI 10.1111/j.0030-1299.2004.12682.x; WAHLE CM, 1980, SCIENCE, V209, P689, DOI 10.1126/science.209.4457.689; Wang JT, 2012, ZOOL STUD, V51, P150; Wonham MJ, 2000, MAR BIOL, V136, P1111, DOI 10.1007/s002270000303; Zea S, 2009, SPONGE GUIDE PICTURE	72	19	19	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144581	10.1371/journal.pone.0144581	http://dx.doi.org/10.1371/journal.pone.0144581			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684321	Green Published, Green Submitted, gold			2022-12-26	WOS:000366725800014
J	Thompson, AF; Crowe, ME; Lieven, CJ; Levin, LA				Thompson, Alex F.; Crowe, Megan E.; Lieven, Christopher J.; Levin, Leonard A.			Induction of Neuronal Morphology in the 661W Cone Photoreceptor Cell Line with Staurosporine	PLOS ONE			English	Article							MEDIATED DEATH; RGC-5; DIFFERENTIATION; APOPTOSIS; GLUTAMATE; TUMORS	Purpose RGC-5 cells undergo differentiation into a neuronal phenotype with low concentrations of staurosporine. Although the RGC-5 cell line was initially thought to be of retinal ganglion cell origin, recent evidence suggests that the RGC-5 line could have been the result of contamination with 661W mouse cone photoreceptor cells. This raised the possibility that a cone photoreceptor cell line could be multipotent and could be differentiated to a neuronal phenotype. Methods 661W and RGC-5 cells, non-neuronal retinal astrocytes, retinal endothelial cells, retinal pericytes, M21 melanoma cells, K562 chronic myelogenous leukemia cells, and Daudi Burkitt lymphoma cells, were differentiated with staurosporine. The resulting morphology was quantitated using NeuronJ with respect to neurite counts and topology. Results Treatment with staurosporine induced similar-appearing morphological differentiation in both 661W and RGC-5 cells. The following measures were not significantly different between 661W and RGC-5 cells: number of neurites per cell, total neurite field length, number of neurite branch points, and cell viability. Neuronal-like differentiation was not observed in the other cell lines tested. Conclusions 661W and RGC-5 cells have virtually identical and distinctive morphology when differentiated with low concentrations of staurosporine. This result demonstrates that a retinal neuronal precursor cell with cone photoreceptor lineage can be differentiated to express a neuronal morphology.	[Thompson, Alex F.; Crowe, Megan E.; Lieven, Christopher J.; Levin, Leonard A.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI 53706 USA; [Levin, Leonard A.] McGill Univ, Dept Ophthalmol, Montreal, PQ H3A 2T5, Canada	University of Wisconsin System; University of Wisconsin Madison; McGill University	Levin, LA (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Ophthalmol & Visual Sci, Madison, WI 53706 USA.	lalevin@wisc.edu		Thompson, Alex/0000-0003-4316-7532	National Eye Institute NIH [R21 EY017970, R21 EY025074, P30EY016665]; Retina Research Foundation; Research to Prevent Blindness, Inc.; NIH; NATIONAL EYE INSTITUTE [R21EY017970, R21EY025074, P30EY016665] Funding Source: NIH RePORTER	National Eye Institute NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Retina Research Foundation; Research to Prevent Blindness, Inc.(Research to Prevent Blindness (RPB)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	National Eye Institute NIH R21 EY017970, R21 EY025074, and P30EY016665 (Core Grant), Retina Research Foundation (LAL), and an unrestricted departmental grant from Research to Prevent Blindness, Inc.; NIH R21 EY017970, R21 EY025074, and P30EY016665, Retina Research Foundation, and an unrestricted departmental grant from Research to Prevent Blindness, Inc. LAL is Canada Research Chair of Ophthalmology and Visual Sciences.	Al-Ubaidi MR, 2014, EXP EYE RES, V119, P115, DOI 10.1016/j.exer.2013.10.012; ALUBAIDI MR, 1992, J CELL BIOL, V119, P1681, DOI 10.1083/jcb.119.6.1681; Boatright JH, 2013, MOL VIS, V19, P1848; BUMOL TF, 1982, P NATL ACAD SCI-BIOL, V79, P1245, DOI 10.1073/pnas.79.4.1245; Burugula B, 2011, INVEST OPHTH VIS SCI, V52, P4263, DOI 10.1167/iovs.10-7103; Fragoso MA, 2011, CELL MOL NEUROBIOL, V31, P163, DOI 10.1007/s10571-010-9603-z; Frassetto LJ, 2006, INVEST OPHTH VIS SCI, V47, P427, DOI 10.1167/iovs.05-0340; Ganapathy PS, 2010, CURR EYE RES, V35, P80, DOI 10.3109/02713680903421194; Harper MM, 2009, EXP EYE RES, V89, P538, DOI 10.1016/j.exer.2009.05.013; Kheirkhah A, 2013, INVEST OPHTH VIS SCI, V54; KLEIN E, 1968, CANCER RES, V28, P1300; Krishnamoorthy RR, 2013, INVEST OPHTH VIS SCI, V54, P5712, DOI 10.1167/iovs.13-12085; Krishnamoorthy RR, 2001, MOL BRAIN RES, V86, P1, DOI 10.1016/S0169-328X(00)00224-2; Kritis AA, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00091; Lamb TD, 2007, NAT REV NEUROSCI, V8, P960, DOI 10.1038/nrn2283; Lieven CJ, 2007, EXP EYE RES, V85, P678, DOI 10.1016/j.exer.2007.08.001; Lin S, 2009, MOL VIS, V15, P26; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; Nieto PS, 2010, NEUROCHEM INT, V57, P216, DOI 10.1016/j.neuint.2010.05.013; Rock N, 2008, EXP EYE RES, V86, P492, DOI 10.1016/j.exer.2007.12.006; Scheef E, 2005, MOL VIS, V11, P613; Scheef EA, 2009, AM J PHYSIOL-CELL PH, V296, pC724, DOI 10.1152/ajpcell.00409.2008; Schnichels S, 2012, NEUROCHEM INT, V60, P581, DOI 10.1016/j.neuint.2012.02.017; Schultheiss M, 2012, GRAEF ARCH CLIN EXP, V250, P1221, DOI 10.1007/s00417-011-1906-3; Sheedlo HJ, 2007, IN VITRO CELL DEV-AN, V43, P361, DOI 10.1007/s11626-007-9051-3; Shi H, 2015, APOPTOSIS, V20, P433, DOI 10.1007/s10495-015-1091-7; Su XJ, 2003, MOL VIS, V9, P171; Tan E, 2004, INVEST OPHTH VIS SCI, V45, P764, DOI 10.1167/iovs.03-1114; Thompson AF, 2010, NEUROCHEM INT, V56, P554, DOI 10.1016/j.neuint.2009.12.018; Tsuruma K, 2012, J PHARMACOL SCI, V118, P351, DOI 10.1254/jphs.11110FP; Van Bergen NJ, 2009, INVEST OPHTH VIS SCI, V50, P4267, DOI 10.1167/iovs.09-3484; Wood JPM, 2010, INVEST OPHTH VIS SCI, V51, P3774, DOI 10.1167/iovs.09-4305; Yang MH, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/901329	33	15	15	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145270	10.1371/journal.pone.0145270	http://dx.doi.org/10.1371/journal.pone.0145270			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684837	Green Submitted, gold, Green Published			2022-12-26	WOS:000366725800055
J	Nozhenko, Y; Asnani-Kishnani, M; Rodriguez, AM; Palou, A				Nozhenko, Yuriy; Asnani-Kishnani, Madhu; Rodriguez, Ana M.; Palou, Andreu			Milk Leptin Surge and Biological Rhythms of Leptin and Other Regulatory Proteins in Breastmilk	PLOS ONE			English	Article							GESTATIONAL CALORIE RESTRICTION; LACTATING MOTHERS; SERUM LEPTIN; FOOD-INTAKE; PLASMA ADIPONECTIN; CIRCADIAN-RHYTHM; PREVENTS OBESITY; LIPID-METABOLISM; ENERGY-BALANCE; DIURNAL RHYTHM	A significant number of chronic diseases are linked to perinatal nutrition, and prevention may be associated to naturally occurring components of breast milk. One key hormone in breast milk is leptin, related with the protection from obesity in the adulthood, thus knowing its changes through the day or lactation is crucial. We aimed to investigate the daily rhythms in the milk levels of leptin, together with other two related hormones, ghrelin and adiponectin, during lactation (days 5, 10 and 15) in rat dams, and the relation with morphometric parameters (dams and pups). Summarizing the main results, the existence of biological rhythms, but not daily and maybe circasemidian, was confirmed for the three hormones at the earliest period of lactation. The correlations performed generally showed a possible dependence of milk hormone levels on plasma levels at the early phase of lactation, while with the progression of lactation this dependence may fade and the hormone levels are suggested to be more dependent on mammary gland production/maturation. There was also a correlation between milk leptin and adiponectin levels, especially in the first half of lactation, suggesting a possible parallel regulation. Interestingly, we describe a milk leptin surge around the mid of lactation (at day 10) which may be related with pup's growth (males and females) and with the well-known (in the literature) plasma leptin surge in pups. All this knowledge may be crucial for future applications in the development of formula milk and in relation with the role of leptin surge during lactation.	[Rodriguez, Ana M.] UIB, Lab Mol Biol Nutr & Biotechnol Nutrigen, Palma De Mallorca, Balearic Island, Spain; CIBER Fisiopatol Obesidad & Nutr CIBEROBN, Palma De Mallorca, Balearic Island, Spain	Universitat de les Illes Balears; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Rodriguez, AM (corresponding author), UIB, Lab Mol Biol Nutr & Biotechnol Nutrigen, Palma De Mallorca, Balearic Island, Spain.	amrodriguez@uib.es	Palou, Andreu/K-9881-2014; Guerrero, Ana M. Rodriguez/H-6678-2015	Palou, Andreu/0000-0002-0295-4452; Guerrero, Ana M. Rodriguez/0000-0002-1559-6279	Spanish Government (project EPIMILK) [AGL2012-33692]; "Agencia Espanola de Cooperacion y Desarrollo" of the Spanish Ministry of Foreign Affairs and Cooperation; University of the Balearic Islands	Spanish Government (project EPIMILK); "Agencia Espanola de Cooperacion y Desarrollo" of the Spanish Ministry of Foreign Affairs and Cooperation; University of the Balearic Islands	This work was supported by the Spanish Government (project EPIMILK, AGL2012-33692, Principal Investigator AP). YN received a grant by "Agencia Espanola de Cooperacion y Desarrollo" of the Spanish Ministry of Foreign Affairs and Cooperation (http://www.aecid.es/es). MA received a grant by the University of the Balearic Islands (www.uib.es). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Spanish Government (project EPIMILK, AGL2012-33692, Principal Investigator AP). YN was granted by "Agencia Espanola de Cooperacion y Desarrollo" of the Spanish Ministry of Foreign Affairs and Cooperation (http://www.aecid.es/es). MA was granted by the University of the Balearic Islands (www.uib.es).	Ahima RS, 1998, J CLIN INVEST, V101, P1020, DOI 10.1172/JCI1176; Bautista CJ, 2008, PEDIATR RES, V63, P358, DOI 10.1203/01.pdr.0000304938.78998.21; Bonnet M, 2002, J ANIM SCI, V80, P723; Bronsky J, 2011, J PEDIATR GASTR NUTR, V52, P474, DOI 10.1097/MPG.0b013e3182062fcc; Butte NF, 1997, J CLIN ENDOCR METAB, V82, P585, DOI 10.1210/jc.82.2.585; Casabiell X, 1997, J CLIN ENDOCR METAB, V82, P4270, DOI 10.1210/jc.82.12.4270; Cheung WW, 2012, ISRN ENDOCRINOL, V2012, P536905, DOI [DOI 10.5402/2012/536905, 10.5402/2012/536905]; Contreras C, 2013, HORM METAB RES, V45, P935, DOI 10.1055/s-0033-1351281; CRAMER CP, 1990, DEV PSYCHOBIOL, V23, P479, DOI 10.1002/dev.420230604; Cretenet G, 2010, CELL METAB, V11, P47, DOI 10.1016/j.cmet.2009.11.002; Cripps RL, 2005, CLIN SCI, V109, P1, DOI 10.1042/CS20040367; Cubero J, 2005, NEUROENDOCRINOL LETT, V26, P657; De Vriese C, 2010, NUTRITION, V26, P579, DOI 10.1016/j.nut.2009.09.013; Devaskar SU, 1997, BIOCHEM BIOPH RES CO, V238, P44, DOI 10.1006/bbrc.1997.7237; Eilers E, 2011, EARLY HUM DEV, V87, P415, DOI 10.1016/j.earlhumdev.2011.03.004; Eriksson L, 1998, ACTA VET SCAND, V39, P301; Fernandez-Twinn DS, 2010, ANN NY ACAD SCI, V1212, P78, DOI 10.1111/j.1749-6632.2010.05798.x; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Ilcol YO, 2007, ACTA PAEDIATR, V96, P1632, DOI 10.1111/j.1651-2227.2007.00493.x; Inui A, 2001, NAT REV NEUROSCI, V2, P551, DOI 10.1038/35086018; Kierson JA, 2006, ACTA PAEDIATR, V95, P991, DOI 10.1080/08035250600669769; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Konieczna J, 2015, INT J OBESITY, V39, P959, DOI 10.1038/ijo.2015.22; Konieczna J, 2015, SCI REP-UK, V5, DOI 10.1038/srep09088; Martin LJ, 2006, AM J CLIN NUTR, V83, P1106, DOI 10.1093/ajcn/83.5.1106; Matsubara M, 2002, EUR J ENDOCRINOL, V147, P173, DOI 10.1530/eje.0.1470173; Miralles O, 2006, OBESITY, V14, P1371, DOI 10.1038/oby.2006.155; Oliver P, 2002, DEV DYNAM, V223, P148, DOI 10.1002/dvdy.1233; Ozarda Y, 2012, CLIN BIOCHEM, V45, P298, DOI 10.1016/j.clinbiochem.2011.12.022; Palou A, 2009, APPETITE, V52, P249, DOI 10.1016/j.appet.2008.09.013; Pickavance L, 1998, BIOCHEM BIOPH RES CO, V248, P196, DOI 10.1006/bbrc.1998.8934; Pico C, 2007, INT J OBESITY, V31, P1199, DOI 10.1038/sj.ijo.0803585; Priego T, 2010, INT J OBESITY, V34, P809, DOI 10.1038/ijo.2010.18; Rayner DV, 1997, AM J PHYSIOL-REG I, V273, pR446, DOI 10.1152/ajpregu.1997.273.1.R446; Refinetti R, 2007, BIOL RHYTHM RES, V38, P275, DOI 10.1080/09291010600903692; RODGERS CT, 1995, LAB ANIM, V29, P450, DOI 10.1258/002367795780739980; Ryan AS, 2003, DIABETES CARE, V26, P2383, DOI 10.2337/diacare.26.8.2383; Sanchez CL, 2009, NUTR NEUROSCI, V12, P2, DOI 10.1179/147683009X388922; Sanchez J, 2005, ENDOCRINOLOGY, V146, P2575, DOI 10.1210/en.2005-0112; Sanchez J, 2004, PFLUG ARCH EUR J PHY, V448, P500, DOI 10.1007/s00424-004-1283-4; Savino F, 2013, CELL MOL BIOL, V59, P89, DOI 10.1170/T950; Savino F, 2012, ACTA PAEDIATR, V101, P1058, DOI 10.1111/j.1651-2227.2012.02744.x; Savino F, 2010, EUR J CLIN NUTR, V64, P972, DOI 10.1038/ejcn.2010.105; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Smith-Kirwin SM, 1998, J CLIN ENDOCR METAB, V83, P1810, DOI 10.1210/jc.83.5.1810; Turer AT, 2012, DIABETOLOGIA, V55, P2319, DOI 10.1007/s00125-012-2598-x; Varela L, 2011, J MOL ENDOCRINOL, V46, pR43, DOI 10.1677/JME-10-0068; Yildiz BO, 2004, P NATL ACAD SCI USA, V101, P10434, DOI 10.1073/pnas.0403465101; Zhou YH, 2005, GENE EXPR PATTERNS, V5, P711, DOI 10.1016/j.modgep.2005.02.002	50	23	23	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145376	10.1371/journal.pone.0145376	http://dx.doi.org/10.1371/journal.pone.0145376			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26680765	Green Published, gold, Green Submitted			2022-12-26	WOS:000366723400073
J	Hommes, TJ; van Lieshout, MH; van't Veer, C; Florquin, S; Bootsma, HJ; Hermans, PW; de Vos, AF; van der Poll, T				Hommes, Tijmen J.; van Lieshout, Miriam H.; van't Veer, Cornelis; Florquin, Sandrine; Bootsma, Hester J.; Hermans, Peter W.; de Vos, Alex F.; van der Poll, Tom			Role of Nucleotide-Binding Oligomerization Domain-Containing (NOD) 2 in Host Defense during Pneumococcal Pneumonia	PLOS ONE			English	Article							STREPTOCOCCUS-PNEUMONIAE; STAPHYLOCOCCUS-AUREUS; IMMUNE-RESPONSE; INNATE; INFECTION; PEPTIDOGLYCAN; COLONIZATION; RECOGNITION; MECHANISMS; RECEPTORS	Streptococcus (S.) pneumoniae is the most common causative pathogen in community-acquired pneumonia. Nucleotide-binding oligomerization domain-containing (NOD) 2 is a pattern recognition receptor located in the cytosol of myeloid cells that is able to detect peptidoglycan fragments of S. pneumoniae. We here aimed to investigate the role of NOD2 in the host response during pneumococcal pneumonia. Phagocytosis of S. pneumoniae was studied in NOD2 deficient (Nod2(-/-)) and wild-type (Wt) alveolar macrophages and neutrophils in vitro. In subsequent in vivo experiments Nod2(-/-) and Wt mice were inoculated with serotype 2 S. pneumoniae (D39), an isogenic capsule locus deletion mutant (D39 Delta cps) or serotype 3 S. pneumoniae (6303) via the airways, and bacterial growth and dissemination and the lung inflammatory response were evaluated. Nod2(-/-) alveolar macrophages and blood neutrophils displayed a reduced capacity to internalize pneumococci in vitro. During pneumonia caused by S. pneumoniae D39 Nod2(-/-) mice were indistinguishable from Wt mice with regard to bacterial loads in lungs and distant organs, lung pathology and neutrophil recruitment. While Nod2(-/-) and Wt mice also had similar bacterial loads after infection with the more virulent S. pneumoniae 6303 strain, Nod2(-/-) mice displayed a reduced bacterial clearance of the normally avirulent unencapsulated D39 Delta cps strain. These results suggest that NOD2 does not contribute to host defense during pneumococcal pneumonia and that the pneumococcal capsule impairs recognition of S. pneumoniae by NOD2.	[Hommes, Tijmen J.; van Lieshout, Miriam H.; van't Veer, Cornelis; de Vos, Alex F.; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands; [Hommes, Tijmen J.; van Lieshout, Miriam H.; van't Veer, Cornelis; de Vos, Alex F.; van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Ctr Infect & Immun, NL-1105 AZ Amsterdam, Netherlands; [Florquin, Sandrine] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands; [Bootsma, Hester J.; Hermans, Peter W.] Radboud Univ Nijmegen, Med Ctr, Lab Pediat Infect Dis, NL-6525 ED Nijmegen, Netherlands; [van der Poll, Tom] Univ Amsterdam, Acad Med Ctr, Div Infect Dis, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam	Hommes, TJ (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	t.j.hommes@amc.nl	Hermans, Peter W.M./H-8042-2014	Florquin, Sandrine/0000-0002-9676-1722	AMC Graduate School from the University of Amsterdam	AMC Graduate School from the University of Amsterdam	This work was supported by a grant (PhD scholarship) from the AMC Graduate School from the University of Amsterdam (https://www.amc.nl/web/Onderwijs/PhD-6/AMC-Graduate-School/About-the-AMC-Graduate-School.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bender JM, 2010, PEDIATR INFECT DIS J, V29, P712, DOI 10.1097/INF.0b013e3181db03a7; Berrington WR, 2010, EUR J IMMUNOL, V40, P3519, DOI 10.1002/eji.201040518; Bootsma HJ, 2007, INFECT IMMUN, V75, P5489, DOI 10.1128/IAI.01823-06; Burgos J, 2011, CLIN INFECT DIS, V53, P254, DOI 10.1093/cid/cir354; Caruso R, 2014, IMMUNITY, V41, P898, DOI 10.1016/j.immuni.2014.12.010; Davis KM, 2011, J CLIN INVEST, V121, P3666, DOI 10.1172/JCI57761; de Vos AF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118181; Deshmukh HS, 2009, INFECT IMMUN, V77, P1376, DOI 10.1128/IAI.00940-08; Dessing MC, 2007, AM J RESP CRIT CARE, V175, P604, DOI 10.1164/rccm.200606-824OC; Divangahi M, 2008, J IMMUNOL, V181, P7157, DOI 10.4049/jimmunol.181.10.7157; Hommes TJ, 2014, J PATHOL, V233, P357, DOI 10.1002/path.4361; Hong JS, 2011, J IMMUNOL, V186, P6427, DOI 10.4049/jimmunol.1003449; Hyams C, 2010, INFECT IMMUN, V78, P704, DOI 10.1128/IAI.00881-09; Kadioglu A, 2004, TRENDS IMMUNOL, V25, P143, DOI 10.1016/j.it.2003.12.006; Kapetanovic R, 2010, MICROBES INFECT, V12, P759, DOI 10.1016/j.micinf.2010.05.003; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Knapp S, 2004, J IMMUNOL, V172, P3132, DOI 10.4049/jimmunol.172.5.3132; Koppe U, 2012, CELL MICROBIOL, V14, P460, DOI 10.1111/j.1462-5822.2011.01746.x; Lammers AJ, 2011, IMMUNOBIOLOGY, V216, P863, DOI 10.1016/j.imbio.2011.02.004; Magee AD, 2001, INFECT IMMUN, V69, P3755, DOI 10.1128/IAI.69.6.3755-3761.2001; Morona JK, 2004, J INFECT DIS, V189, P1905, DOI 10.1086/383352; Opitz B, 2004, J BIOL CHEM, V279, P36426, DOI 10.1074/jbc.M403861200; Shimada K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000379; Sorbara MT, 2011, IMMUNOL REV, V243, P40, DOI 10.1111/j.1600-065X.2011.01047.x; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; Vissers M, 2014, INFECT IMMUN, V82, P4952, DOI 10.1128/IAI.02150-14; Watanabe T, 2004, NAT IMMUNOL, V5, P800, DOI 10.1038/ni1092; Weinberger DM, 2010, CLIN INFECT DIS, V51, P692, DOI 10.1086/655828; Welte T, 2012, THORAX, V67, P71, DOI 10.1136/thx.2009.129502; Wiersinga WJ, 2007, PLOS MED, V4, P1268, DOI 10.1371/journal.pmed.0040248; Yu JG, 2011, J CLIN MICROBIOL, V49, P534, DOI 10.1128/JCM.01827-10	31	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145138	10.1371/journal.pone.0145138	http://dx.doi.org/10.1371/journal.pone.0145138			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673231	Green Submitted, gold, Green Published			2022-12-26	WOS:000366722700105
J	Jarukanont, D; Arredondo, IB; Femat, R; Garcia, ME				Jarukanont, Daungruthai; Bonifas Arredondo, Imelda; Femat, Ricardo; Garcia, Martin E.			Vesicle Motion during Sustained Exocytosis in Chromaffin Cells: Numerical Model Based on Amperometric Measurements	PLOS ONE			English	Article							SINGLE SECRETORY GRANULES; MEDIATED MEMBRANE-FUSION; DENSE-CORE VESICLES; SYNAPTIC VESICLES; NEUROTRANSMITTER RELEASE; FLUORESCENCE MICROSCOPY; REGULATED EXOCYTOSIS; PLASMA-MEMBRANE; SNARE COMPLEX; CALCIUM	Chromaffin cells release catecholamines by exocytosis, a process that includes vesicle docking, priming and fusion. Although all these steps have been intensively studied, some aspects of their mechanisms, particularly those regarding vesicle transport to the active sites situated at the membrane, are still unclear. In this work, we show that it is possible to extract information on vesicle motion in Chromaffin cells from the combination of Langevin simulations and amperometric measurements. We developed a numerical model based on Langevin simulations of vesicle motion towards the cell membrane and on the statistical analysis of vesicle arrival times. We also performed amperometric experiments in bovine-adrenal Chromaffin cells under Ba2+ stimulation to capture neurotransmitter releases during sustained exocytosis. In the sustained phase, each amperometric peak can be related to a single release from a new vesicle arriving at the active site. The amperometric signal can then be mapped into a spike-series of release events. We normalized the spike-series resulting from the current peaks using a time-rescaling transformation, thus making signals coming from different cells comparable. We discuss why the obtained spike-series may contain information about the motion of all vesicles leading to release of catecholamines. We show that the release statistics in our experiments considerably deviate from Poisson processes. Moreover, the interspike-time probability is reasonably well described by two-parameter gamma distributions. In order to interpret this result we computed the vesicles' arrival statistics from our Langevin simulations. As expected, assuming purely diffusive vesicle motion we obtain Poisson statistics. However, if we assume that all vesicles are guided toward the membrane by an attractive harmonic potential, simulations also lead to gamma distributions of the interspike-time probability, in remarkably good agreement with experiment. We also show that including the fusion-time statistics in our model does not produce any significant changes on the results. These findings indicate that the motion of the whole ensemble of vesicles towards the membrane is directed and reflected in the amperometric signals. Our results confirm the conclusions of previous imaging studies performed on single vesicles that vesicles' motion underneath plasma membranes is not purely random, but biased towards the membrane.	[Jarukanont, Daungruthai; Garcia, Martin E.] Univ Kassel, Inst Phys, D-34125 Kassel, Germany; [Jarukanont, Daungruthai; Garcia, Martin E.] Univ Kassel, Ctr Interdisciplinary Nanostruct Sci & Technol CI, D-34125 Kassel, Germany; [Bonifas Arredondo, Imelda; Femat, Ricardo] IPICYT, Div Matemat Aplicadas, San Luis Potosi, Mexico	Universitat Kassel; Universitat Kassel; Instituto Potosino Investigacion Cientifica y Tecnologica	Femat, R (corresponding author), IPICYT, Div Matemat Aplicadas, Camino Presa San Jose 2055,Lomas 4A Secc, San Luis Potosi, Mexico.	rfemat@ipicyt.edu.mx; garcia@physik.uni-kassel.de	Garcia, Martin E/D-2697-2009; Femat, Ricardo/HGF-0751-2022					Abeles M., 1982, LOCAL CORTICAL CIRCU, V6; Allersma MW, 2004, MOL BIOL CELL, V15, P4658, DOI 10.1091/mbc.E04-02-0149; Amatore C, 2003, CHEMPHYSCHEM, V4, P147, DOI 10.1002/cphc.200390024; Artalejo CR, 2002, P NATL ACAD SCI USA, V99, P6358, DOI 10.1073/pnas.082658499; Ashery U, 2000, EMBO J, V19, P3586, DOI 10.1093/emboj/19.14.3586; Augustine GJ, 2001, CURR OPIN NEUROBIOL, V11, P320, DOI 10.1016/S0959-4388(00)00214-2; Becherer U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000505; Becherer U, 2006, CELL TISSUE RES, V326, P393, DOI 10.1007/s00441-006-0243-z; Bhalla A, 2005, MOL BIOL CELL, V16, P4755, DOI 10.1091/mbc.E05-04-0277; Brown EN, 2002, NEURAL COMPUT, V14, P325, DOI 10.1162/08997660252741149; Burgoyne RD, 2003, PHYSIOL REV, V83, P581, DOI 10.1152/physrev.00031.2002; Chen YA, 2001, NAT REV MOL CELL BIO, V2, P98, DOI 10.1038/35052017; Chou T, 2014, ARXIV PREPRINT ARXIV; Chow RH, 1996, NEURON, V16, P369, DOI 10.1016/S0896-6273(00)80054-9; de Wit H, 2010, HISTOCHEM CELL BIOL, V134, P103, DOI 10.1007/s00418-010-0719-5; de Wit H, 2009, CELL, V138, P935, DOI 10.1016/j.cell.2009.07.027; Domanska MK, 2009, J BIOL CHEM, V284, P32158, DOI 10.1074/jbc.M109.047381; Draper NR, 2014, APPLIED REGRESSION A; Duncan RR, 2003, NATURE, V422, P176, DOI 10.1038/nature01389; Evanko D, 2005, NAT METHODS, V2, P650, DOI 10.1038/nmeth0905-650; Finnegan JM, 1996, J NEUROCHEM, V66, P1914; Gandasi NR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4914; Garcia AG, 2006, PHYSIOL REV, V86, P1093, DOI 10.1152/physrev.00039.2005; GERSTEIN GL, 1960, BIOPHYS J, V1, P15, DOI 10.1016/S0006-3495(60)86872-5; Graczyk A, 2013, FRONTIERS ENDOCRINOL, V4, DOI [10.3389/fendo.2013.00147, DOI 10.3389/FENDO.2013.00147]; Hammarlund M, 2007, PLOS BIOL, V5, P1695, DOI 10.1371/journal.pbio.0050198; HELDMAN E, 1989, J BIOL CHEM, V264, P7914; Henkel AW, 1996, J NEUROSCI, V16, P3960; Holt M, 2004, CURR BIOL, V14, P173, DOI 10.1016/j.cub.2003.12.053; Hosoi N, 2009, NEURON, V63, P216, DOI 10.1016/j.neuron.2009.06.010; Hugo S, 2013, J NEUROSCI, V 33, P17123, DOI 10.1523/JNEUROSCI.1589-13.2013; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Jahn R, 2012, NATURE, V490, P201, DOI 10.1038/nature11320; Johns LM, 2001, J CELL BIOL, V153, P177, DOI 10.1083/jcb.153.1.177; Jones E., 2001, SCIPY OPEN SOURCE SC; Kasai H, 2012, PHYSIOL REV, V92, P1915, DOI 10.1152/physrev.00007.2012; Kasai K, 2008, TRAFFIC, V9, P1191, DOI 10.1111/j.1600-0854.2008.00744.x; Keating DJ, 2008, HUM MOL GENET, V17, P1020, DOI 10.1093/hmg/ddm374; Kroese D. P., 2012, REV COMPUT STAT, V4, P48, DOI DOI 10.1002/WICS.194; Lee TH, 2011, SEMIN IMMUNOPATHOL, V33, P455, DOI 10.1007/s00281-011-0250-3; Liu DF, 2011, IMMUNOL CELL BIOL, V89, P728, DOI 10.1038/icb.2010.167; LIVETT BG, 1984, PHYSIOL REV, V64, P1103, DOI 10.1152/physrev.1984.64.4.1103; Maucort G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087242; Mohrmann R, 2010, SCIENCE, V330, P502, DOI 10.1126/science.1193134; Mosharov EV, 2005, NAT METHODS, V2, P651, DOI 10.1038/nmeth782; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Nofal S, 2007, J NEUROSCI, V27, P1386, DOI 10.1523/JNEUROSCI.4714-06.2007; Oheim M, 2000, EUR BIOPHYS J BIOPHY, V29, P67, DOI 10.1007/s002490050253; Pillow JW., 2009, NIPS, P1473; Plattner H, 1997, J CELL BIOL, V139, P1709, DOI 10.1083/jcb.139.7.1709; PRZYWARA DA, 1993, P NATL ACAD SCI USA, V90, P557, DOI 10.1073/pnas.90.2.557; Reichl L.E., 2009, MODERN COURSE STAT P; Rickman C, 2004, J BIOL CHEM, V279, P644, DOI 10.1074/jbc.M310879200; Rizo J, 2012, ANNU REV CELL DEV BI, V28, P279, DOI 10.1146/annurev-cellbio-101011-155818; Sagiv A, 2012, ONCOGENE, V32, P1971, DOI [10.1038/onc.2012.206, DOI 10.1038/ONC.2012.206]; Sakaba T, 2006, J NEUROSCI, V26, P5863, DOI 10.1523/JNEUROSCI.0182-06.2006; Sakaba T, 2001, NEURON, V32, P1119, DOI 10.1016/S0896-6273(01)00543-8; Schneggenburger R, 2002, TRENDS NEUROSCI, V25, P206, DOI 10.1016/S0166-2236(02)02139-2; SCOTT DW, 1979, BIOMETRIKA, V66, P605, DOI 10.1093/biomet/66.3.605; Stevens DR, 2011, FRONTIERS IN SYNAPTI, P3, DOI [10.3389/fnsyn.2011.00002, DOI 10.3389/FNSYN.2011.00002]; Steyer JA, 1999, BIOPHYS J, V76, P2262, DOI 10.1016/S0006-3495(99)77382-0; Steyer JA, 1997, NATURE, V388, P474, DOI 10.1038/41329; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412; Takahashi N, 2010, CELL METAB, V12, P19, DOI 10.1016/j.cmet.2010.05.013; Trifaro JM, 1997, NEUROCHEM RES, V22, P831, DOI 10.1023/A:1022087910902; Tukey J.W., EXPLORATORY DATA ANA; van den Bogaart G, 2010, NAT STRUCT MOL BIOL, V17, P358, DOI 10.1038/nsmb.1748; van Lengerich B, 2013, BIOPHYS J, V105, P409, DOI 10.1016/j.bpj.2013.05.056; Verhage M, 2008, TRAFFIC, V9, P1414, DOI 10.1111/j.1600-0854.2008.00759.x; Verhulst P. F., 1838, QUETELET, V10, P113; Voets T, 2001, NEURON, V31, P581, DOI 10.1016/S0896-6273(01)00391-9; WIGHTMAN RM, 1991, P NATL ACAD SCI USA, V88, P10754, DOI 10.1073/pnas.88.23.10754; WINKELMANN R, 1995, J BUS ECON STAT, V13, P467, DOI 10.2307/1392392; Zenisek D, 2000, NATURE, V406, P849, DOI 10.1038/35022500; ZHOU Z, 1995, J BIOL CHEM, V270, P3498, DOI 10.1074/jbc.270.8.3498; Zikich D, 2008, J NEUROSCI, V28, P1949, DOI 10.1523/JNEUROSCI.5096-07.2008	77	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144045	10.1371/journal.pone.0144045	http://dx.doi.org/10.1371/journal.pone.0144045			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675312	Green Published, Green Submitted, gold			2022-12-26	WOS:000366722700021
J	Kurtagic, E; Rich, CB; Buczek-Thomas, JA; Nugent, MA				Kurtagic, Elma; Rich, Celeste B.; Buczek-Thomas, Jo Ann; Nugent, Matthew A.			Neutrophil Elastase-Generated Fragment of Vascular Endothelial Growth Factor-A Stimulates Macrophage and Endothelial Progenitor Cell Migration	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; FACTOR VEGF FAMILY; MAINTENANCE PROGRAM; EMPHYSEMA; ANGIOGENESIS; LUNG; RECEPTORS; GENE; INVOLVEMENT; HOMEOSTASIS	Elastase released from neutrophils as part of the innate immune system has been implicated in chronic diseases such as emphysema and cardiovascular disease. We have previously shown that neutrophil elastase targets vascular endothelial growth factor-A (VEGF) for partial degradation to generate a fragment of VEGF (VEGFf) that has distinct activities. Namely, VEGFf binds to VEGF receptor 1 but not to VEGF receptor 2 and shows altered signaling compared to intact VEGF. In the present study we investigated the chemotactic function of VEGF and VEGFf released from cells by neutrophil elastase. We found that endothelial cells migrated in response to intact VEGF but not VEGFf whereas RAW 264.7 macrophages/monocytes and embryonic endothelial progenitor cells were stimulated to migrate by either VEGF or VEGFf. To investigate the role of elastase-mediated release of VEGF from cells/extracellular matrices, a co-culture system was established. High or low VEGF producing cells were co-cultured with macrophages, endothelial or endothelial progenitor cells and treated with neutrophil elastase. Elastase treatment stimulated macrophage and endothelial progenitor cell migration with the response being greater with the high VEGF expressing cells. However, elastase treatment led to decreased endothelial cell migration due to VEGF cleavage to VEGF fragment. These findings suggest that the tissue response to NE-mediated injury might involve the generation of diffusible VEGF fragments that stimulate inflammatory cell recruitment.	[Kurtagic, Elma; Rich, Celeste B.; Buczek-Thomas, Jo Ann; Nugent, Matthew A.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA; [Nugent, Matthew A.] Univ Massachusetts, Dept Biol Sci, Lowell, MA USA	Boston University; University of Massachusetts System; University of Massachusetts Lowell	Nugent, MA (corresponding author), Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA.	matthew_nugent@uml.edu	Nugent, Matthew/GSI-5872-2022		National Institutes of Health grant [HL088672]; BrightFocus Foundation grant [M2012014]; NIH grant [HL088672]	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BrightFocus Foundation grant(BrightFocus Foundation); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Support was provided by National Institutes of Health grant HL088672 to MAN [http://www.nih.gov/] and BrightFocus Foundation grant M2012014 to MAN [http://www.brightfocus.org/].; We thank Dr. Antonis Hatzopoulos at Vanderbilt University for providing eEPCs and advice on their use. This study was funded in part by NIH grant HL088672 (MAN), and grant M2012014 from the BrightFocus Foundation (MAN).	Ackah E, 2005, J CLIN INVEST, V115, P2119, DOI 10.1172/JCI24726; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Barbera JA, 2011, EUR RESPIR J, V37, P752, DOI 10.1183/09031936.00154610; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Belgore F, 2004, J CLIN PATHOL, V57, P266, DOI 10.1136/jcp.2003.012419; Buczek-Thomas JA, 1999, J BIOL CHEM, V274, P25167, DOI 10.1074/jbc.274.35.25167; Buczek-Thomas JA, 2002, J CELL PHYSIOL, V192, P294, DOI 10.1002/jcp.10135; Demedts IK, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-53; Dinbergs ID, 1996, J BIOL CHEM, V271, P29822, DOI 10.1074/jbc.271.47.29822; Dollery CM, 2003, CIRCULATION, V107, P2829, DOI 10.1161/01.CIR.0000072792.65250.4A; Dor Y, 2001, AM J PHYSIOL-CELL PH, V280, pC1367, DOI 10.1152/ajpcell.2001.280.6.C1367; FARIS B, 1992, MATRIX, V12, P185, DOI 10.1016/S0934-8832(11)80060-0; Foley CJ, 2014, ONCOGENE, V33, P2264, DOI 10.1038/onc.2013.157; Forsten-Williams K, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-170; Fu YN, 2011, J HISTOCHEM CYTOCHEM, V59, P463, DOI 10.1369/0022155411401748; Gillis S, 1997, SEMIN HEMATOL, V34, P336; Gooptu B, 2009, EUR RESPIR J, V34, P475, DOI 10.1183/09031936.00096508; Handsley MM, 2005, INT J CANCER, V115, P849, DOI 10.1002/ijc.20945; Hatzopoulos AK, 1998, DEVELOPMENT, V125, P1457; Holmes DIR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-209; Inoue M, 1998, CIRCULATION, V98, P2108, DOI 10.1161/01.CIR.98.20.2108; Kalka C, 2000, ANN THORAC SURG, V70, P829, DOI 10.1016/S0003-4975(00)01633-7; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; Kupatt C, 2005, FASEB J, V19, P1576, DOI 10.1096/fj.04-3282fje; Kurtagic E, 2009, AM J PHYSIOL-LUNG C, V296, pL534, DOI 10.1152/ajplung.90505.2008; Madonna R, 2015, VASC PHARMACOL, V67-69, P2, DOI 10.1016/j.vph.2015.02.018; Marino F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124565; Mobius-Winkler S, 2009, CYTOM PART A, V75A, P25, DOI 10.1002/cyto.a.20669; Pearson JD, 2010, MICROVASC RES, V79, P162, DOI 10.1016/j.mvr.2009.12.004; Peinado VI, 2006, AM J RESP CELL MOL, V34, P257, DOI 10.1165/rcmb.2005-0255OC; Peinado VI, 2008, CHEST, V134, P808, DOI 10.1378/chest.08-0820; RASCHKE WC, 1978, CELL, V15, P261, DOI 10.1016/0092-8674(78)90101-0; RISAU W, 1988, DEVELOPMENT, V102, P471; Robinson CJ, 2001, J CELL SCI, V114, P853; Shapiro SD, 2003, EUR RESPIR J, V22, p30S, DOI 10.1183/09031936.03.00000903a; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Somanath PR, 2006, CELL CYCLE, V5, P512, DOI 10.4161/cc.5.5.2538; Tang KC, 2004, J APPL PHYSIOL, V97, P1559, DOI 10.1152/japplphysiol.00221.2004; Tuder RM, 2008, CURR OPIN PHARMACOL, V8, P255, DOI 10.1016/j.coph.2008.03.003; Tuder Rubin M, 2006, Proc Am Thorac Soc, V3, P673, DOI 10.1513/pats.200605-124SF; Voelkel NF, 2006, AM J PHYSIOL-LUNG C, V290, pL209, DOI 10.1152/ajplung.00185.2005; Wei JW, 2004, CANCER CELL, V5, P477, DOI 10.1016/S1535-6108(04)00116-3; Winkler Tilo, 2011, Critical Reviews in Biomedical Engineering, V39, P263, DOI 10.1615/CritRevBiomedEng.v39.i4.20; WOLFE BL, 1993, J BIOL CHEM, V268, P12418	45	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145115	10.1371/journal.pone.0145115	http://dx.doi.org/10.1371/journal.pone.0145115			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26672607	Green Submitted, gold, Green Published			2022-12-26	WOS:000366722700101
J	Hajam, IA; Dar, PA; Appavoo, E; Kishore, S; Bhanuprakash, V; Ganesh, K				Hajam, Irshad Ahmed; Dar, Pervaiz Ahmad; Appavoo, Elamurugan; Kishore, Subodh; Bhanuprakash, Veerakyathappa; Ganesh, Kondabattula			Bacterial Ghosts of Escherichia coli Drive Efficient Maturation of Bovine Monocyte-Derived Dendritic Cells	PLOS ONE			English	Article							IMMUNE-RESPONSE; GENE-E; EXPRESSION; LYSIS; ACTIVATION; CYTOKINE; BLOOD; ANTIGEN; DIFFERENTIATION; INDUCTION	Bacterial ghosts (BGs) are empty cell envelopes derived from Gram-negative bacteria. They not only represent a potential platform for development of novel vaccines but also provide a tool for efficient adjuvant and antigen delivery system. In the present study, we investigated the interaction between BGs of Escherichia coli (E. coli) and bovine monocyte-derived dendritic cells (MoDCs). MoDCs are highly potent antigen-presenting cells and have the potential to act as a powerful tool for manipulating the immune system. We generated bovine MoDCs in vitro from blood monocytes using E. coli expressed bovine GM-CSF and IL-4 cytokines. These MoDCs displayed typical morphology and functions similar to DCs. We further investigated the E. coli BGs to induce maturation of bovine MoDCs in comparison to E. coli lipopolysaccharide (LPS). We observed the maturation marker molecules such as MHC-II, CD80 and CD86 were induced early and at higher levels in BG stimulated MoDCs as compared to the LPS stimulated MoDCs. BG mediated stimulation induced significantly higher levels of cytokine expression in bovine MoDCs than LPS. Both pro-inflammatory (IL-12 and TNF-alpha) and anti-inflammatory (IL-10) cytokines were induced in MoDCs after BGs stimulation. We further analysed the effects of BGs on the bovine MoDCs in an allogenic mixed lymphocyte reaction (MLR). We found the BG-treated bovine MoDCs had significantly (p<0.05) higher capacity to stimulate allogenic T cell proliferation in MLR as compared to the LPS. Taken together, these findings demonstrate the E. coli BGs induce a strong activation and maturation of bovine MoDCs.	[Hajam, Irshad Ahmed; Appavoo, Elamurugan; Kishore, Subodh; Bhanuprakash, Veerakyathappa; Ganesh, Kondabattula] Indian Vet Res Inst, FMD Res Ctr, Bangalore, Karnataka, India; [Dar, Pervaiz Ahmad] SKUAST Kashmir, Fac Vet Sci & Anim Husb, Div Vet Microbiol & Immunol, Srinagar, Jammu & Kashmir, India	Indian Council of Agricultural Research (ICAR); ICAR - Indian Veterinary Research Institute; Sher-e-Kashmir University of Agricultural Sciences & Technology of Kashmir (SKUAST Kashmir)	Dar, PA (corresponding author), SKUAST Kashmir, Fac Vet Sci & Anim Husb, Div Vet Microbiol & Immunol, Srinagar, Jammu & Kashmir, India.	dar.pervaiz@gmail.com; kondabattula@gmail.com	Kondabattula, Ganesh/AAT-7377-2021; Dar, Pervaiz/F-3596-2016; V, BHANUPRAKASH/AAG-6804-2019	Dar, Pervaiz/0000-0001-6718-7293; 				Akbari O, 2001, NAT IMMUNOL, V2, P725, DOI 10.1038/90667; Amara AA, 2013, SCI WORLD J, DOI 10.1155/2013/545741; Bajer AA, 2003, J LEUKOCYTE BIOL, V73, P100, DOI 10.1189/jlb.0302128; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; BAYER ME, 1968, J GEN MICROBIOL, V53, P395, DOI 10.1099/00221287-53-3-395; Benko S, 2008, BIOL CHEM, V389, P469, DOI 10.1515/BC.2008.054; BLASI U, 1989, J BIOL CHEM, V264, P4552; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chaudhari AA, 2012, VET RES, V43, DOI 10.1186/1297-9716-43-44; Dar P, 2013, VACCINE, V31, P3327, DOI 10.1016/j.vaccine.2013.05.078; Dar PA, 2015, CYTOKINE, V72, P58, DOI 10.1016/j.cyto.2014.12.011; Datta SK, 2003, J IMMUNOL, V170, P4102, DOI 10.4049/jimmunol.170.8.4102; DENHARDT DT, 1965, J MOL BIOL, V12, P641, DOI 10.1016/S0022-2836(65)80318-7; Dubois B, 2001, J LEUKOCYTE BIOL, V70, P633; Ebensen T, 2004, J IMMUNOL, V172, P6858, DOI 10.4049/jimmunol.172.11.6858; Estes DM, 1998, IMMUNOLOGY, V95, P604; Gonzalez-Cano P, 2014, DEV COMP IMMUNOL, V44, P378, DOI 10.1016/j.dci.2014.01.014; Granucci F, 2003, J INFECT DIS, V187, pS346, DOI 10.1086/374748; Haidinger W, 2003, APPL ENVIRON MICROB, V69, P6106, DOI 10.1128/AEM.69.10.6106-6113.2003; Hajam IA, 2013, VET ITAL, V49, P181, DOI 10.12834/VetIt.2013.492.187.192; HALFMANN G, 1986, J BACTERIOL, V166, P683, DOI 10.1128/jb.166.2.683-685.1986; Hamza T, 2010, INT J MOL SCI, V11, P789, DOI 10.3390/ijms11030789; Hart DNJ, 1997, BLOOD, V90, P3245, DOI 10.1182/blood.V90.9.3245; Hope JC, 2003, VET IMMUNOL IMMUNOP, V95, P21, DOI 10.1016/S0165-2427(03)00104-1; Huter V, 1999, J CONTROL RELEASE, V61, P51, DOI 10.1016/S0168-3659(99)00099-1; Joffre O, 2009, IMMUNOL REV, V227, P234, DOI 10.1111/j.1600-065X.2008.00718.x; Kaka AS, 2008, J IMMUNOTHER, V31, P359, DOI 10.1097/CJI.0b013e318165f5d2; KITAMURA T, 1989, J CELL PHYSIOL, V140, P323, DOI 10.1002/jcp.1041400219; Kudela P, 2010, VACCINE, V28, P5760, DOI 10.1016/j.vaccine.2010.06.087; Langenkamp A, 2000, NAT IMMUNOL, V1, P311, DOI 10.1038/79758; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Mauel S, 2014, IMMUNOLOGY, V177, P463; Mayr UB, 2005, ADV DRUG DELIVER REV, V57, P1381, DOI 10.1016/j.addr.2005.01.027; Menzies M, 2006, VET IMMUNOL IMMUNOP, V109, P23, DOI 10.1016/j.vetimm.2005.06.014; MOORE KW, 1993, ANNU REV IMMUNOL, V11, P165, DOI 10.1146/annurev.iy.11.040193.001121; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Pickl WF, 1996, J IMMUNOL, V157, P3850; Pinchuk LM, 2003, COMP IMMUNOL MICROB, V26, P233, DOI 10.1016/S0147-9571(02)00061-9; Price JC, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.110965; Saenz R, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-211; Sanders CJ, 2006, J IMMUNOL, V177, P2810, DOI 10.4049/jimmunol.177.5.2810; Sei JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109273; Steinbach F, 1998, RES IMMUNOL, V149, P627, DOI 10.1016/S0923-2494(99)80028-5; Werling D, 1999, J LEUKOCYTE BIOL, V66, P50, DOI 10.1002/jlb.66.1.50; WITTE A, 1990, J BACTERIOL, V172, P4109, DOI 10.1128/jb.172.7.4109-4114.1990; WITTE A, 1989, EUR J BIOCHEM, V180, P393, DOI 10.1111/j.1432-1033.1989.tb14661.x; YOUNG KD, 1982, J VIROL, V44, P993, DOI 10.1128/JVI.44.3.993-1002.1982; Zaros LG, 2007, GENET MOL BIOL, V30, P575, DOI 10.1590/S1415-47572007000400012	49	35	40	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144397	10.1371/journal.pone.0144397	http://dx.doi.org/10.1371/journal.pone.0144397			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26669936	Green Submitted, Green Published, gold			2022-12-26	WOS:000366719300007
J	Balzer, J; Heuer, K; Demir, E; Hoffmanns, MA; Baldus, S; Fuchs, PC; Awakowicz, P; Suschek, CV; Oplander, C				Balzer, Julian; Heuer, Kiara; Demir, Erhan; Hoffmanns, Martin A.; Baldus, Sabrina; Fuchs, Paul C.; Awakowicz, Peter; Suschek, Christoph V.; Oplaender, Christian			Non-Thermal Dielectric Barrier Discharge (DBD) Effects on Proliferation and Differentiation of Human Fibroblasts Are Primary Mediated by Hydrogen Peroxide	PLOS ONE			English	Article							ATMOSPHERIC-PRESSURE PLASMA; NITRIC-OXIDE; MYOFIBROBLAST DIFFERENTIATION; OXIDATIVE STRESS; HUMAN SKIN; KERATINOCYTES; TEMPERATURE; IRRADIATION; MEDICINE; ARREST	The proliferation of fibroblasts and myofibroblast differentiation are crucial in wound healing and wound closure. Impaired wound healing is often correlated with chronic bacterial contamination of the wound area. A new promising approach to overcome wound contamination, particularly infection with antibiotic-resistant pathogens, is the topical treatment with non-thermal "cold" atmospheric plasma (CAP). Dielectric barrier discharge (DBD) devices generate CAP containing active and reactive species, which have antibacterial effects but also may affect treated tissue/cells. Moreover, DBD treatment acidifies wound fluids and leads to an accumulation of hydrogen peroxide (H2O2) and nitric oxide products, such as nitrite and nitrate, in the wound. Thus, in this paper, we addressed the question of whether DBD-induced chemical changes may interfere with wound healing-relevant cell parameters such as viability, proliferation and myofibroblast differentiation of primary human fibroblasts. DBD treatment of 250 mu l buffered saline (PBS) led to a treatment time-dependent acidification (pH 6.7; 300 s) and coincidently accumulation of nitrite (similar to 300 mu M), nitrate (similar to 1 mM) and H2O2 (similar to 200 mu M). Fibroblast viability was reduced by single DBD treatments (60-300 s; similar to 77-66%) or exposure to freshly DBD-treated PBS (60-300 s; similar to 75-55%), accompanied by prolonged proliferation inhibition of the remaining cells. In addition, the total number of myofibroblasts was reduced, whereas in contrast, the myofibroblast frequency was significantly increased 12 days after DBD treatment or exposure to DBD-treated PBS. Control experiments mimicking DBD treatment indicate that plasma-generated H2O2 was mainly responsible for the decreased proliferation and differentiation, but not for DBD-induced toxicity. In conclusion, apart from antibacterial effects, DBD/CAP may mediate biological processes, for example, wound healing by accumulation of H2O2. Therefore, a clinical DBD treatment must be well-balanced in order to avoid possible unwanted side effects such as a delayed healing process.	[Balzer, Julian; Heuer, Kiara; Hoffmanns, Martin A.; Suschek, Christoph V.; Oplaender, Christian] Univ Dusseldorf, Fac Med, Dept Trauma & Hand Surg, Dusseldorf, Germany; [Demir, Erhan; Fuchs, Paul C.] Univ Witten Herdecke, Merheim Hosp Cologne, Dept Plast Surg, Hand Surg,Burn Ctr, Cologne, Germany; [Baldus, Sabrina; Awakowicz, Peter] Ruhr Univ Bochum, Inst Elect Engn & Plasma Technol, Bochum, Germany	Heinrich Heine University Dusseldorf; Witten Herdecke University; Ruhr University Bochum	Oplander, C (corresponding author), Univ Dusseldorf, Fac Med, Dept Trauma & Hand Surg, Dusseldorf, Germany.	christian.oplaender@hhu.de			German Research Foundation, Deutsche Forschungsgemeinschaft [OP 207/6-1, SU 631/4-1, AW 7/4-1]; Bundesministerium fur Wirtschaft und Energie [ZIM KF2790102]	German Research Foundation, Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Wirtschaft und Energie	This work was supported by the German Research Foundation, Deutsche Forschungsgemeinschaft, http://www.dfg.de/: OP 207/6-1 was received by CO, SU 631/4-1 was received by CVS, and AW 7/4-1 was received by PA. It also received support from Bundesministerium fur Wirtschaft und Energie, http://www.bmwi.de/. ZIM KF2790102 was received by CVS.	Baum CL, 2005, DERMATOL SURG, V31, P674; Bekeschus S, 2014, FREE RADICAL RES, V48, P542, DOI 10.3109/10715762.2014.892937; Bibinov N, 2011, J PHYS D, P44; Blackert S, 2013, J DERMATOL SCI, V70, P173, DOI 10.1016/j.jdermsci.2013.01.012; Brehmer F, 2015, J EUR ACAD DERMATOL, V29, P148, DOI 10.1111/jdv.12490; Chen LC, 2009, CHEM LETT, V38, P520, DOI 10.1246/cl.2009.520; CHEN Q, 1994, P NATL ACAD SCI USA, V91, P4130, DOI 10.1073/pnas.91.10.4130; Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X; Davis SC, 2008, WOUND REPAIR REGEN, V16, P23, DOI 10.1111/j.1524-475X.2007.00303.x; DEBONO DP, 1995, ATHEROSCLEROSIS, V114, P235, DOI 10.1016/0021-9150(94)05488-5; Desmouliere A, 2005, WOUND REPAIR REGEN, V13, P7, DOI 10.1111/j.1067-1927.2005.130102.x; DESMOULIERE A, 1995, CELL BIOL INT, V19, P471, DOI 10.1006/cbir.1995.1090; Dimitrijevic-Bussod M, 1999, CANCER RES, V59, P4843; Driessens N, 2009, ENDOCR-RELAT CANCER, V16, P845, DOI 10.1677/ERC-09-0020; Edwards R, 2004, CURR OPIN INFECT DIS, V17, P91, DOI 10.1097/00001432-200404000-00004; Feelisch M, 2002, FASEB J, V16, P1775, DOI 10.1096/fj.02-0363com; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Haertel B, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/761451; Haertel B, 2012, CELL BIOL INT, V36, P1217, DOI 10.1042/CBI20120139; Haertel B, 2012, IMMUNOBIOLOGY, V217, P628, DOI 10.1016/j.imbio.2011.10.017; Heinlin J, 2013, J EUR ACAD DERMATOL, V27, P324, DOI 10.1111/j.1468-3083.2011.04395.x; Heinlin J, 2011, J EUR ACAD DERMATOL, V25, P1, DOI 10.1111/j.1468-3083.2010.03702.x; Heinlin J, 2010, J DTSCH DERMATOL GES, V8, P968, DOI 10.1111/j.1610-0387.2010.07495.x; Heuer K, 2015, NITRIC OXIDE-BIOL CH, V44, P52, DOI 10.1016/j.niox.2014.11.015; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Isbary G, 2013, EXPERT REV MED DEVIC, V10, P367, DOI [10.1586/erd.13.4, 10.1586/ERD.13.4]; Jones Stuart G, 2004, Int J Low Extrem Wounds, V3, P201, DOI 10.1177/1534734604271810; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; Kalghatgi S, 2010, ANN BIOMED ENG, V38, P748, DOI 10.1007/s10439-009-9868-x; Kaushik NK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103349; KONG MG, 2009, NEW J PHYS, V11, DOI DOI 10.1088/1367-2630/11/11/115012; Kuo LJ, 2008, IN VIVO, V22, P305; Liebmann J, 2011, NITRIC OXIDE-BIOL CH, V24, P8, DOI 10.1016/j.niox.2010.09.005; Liebmann J, 2010, J INVEST DERMATOL, V130, P259, DOI 10.1038/jid.2009.194; Maisch T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034610; Oplander C, 2011, J PHOTOCH PHOTOBIO B, V103, P118, DOI 10.1016/j.jphotobiol.2011.02.018; PIERAGGI MT, 1985, ANN PATHOL, V5, P65; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SELLERS RM, 1980, ANALYST, V105, P950, DOI 10.1039/an9800500950; Shi XM, 2008, PLASMA PROCESS POLYM, V5, P482, DOI 10.1002/ppap.200700174; Shin DM, 2004, PLAST RECONSTR SURG, V113, P633, DOI 10.1097/01.PRS.0000101530.33096.5B; Stoffels E, 2002, PLASMA SOURCES SCI T, V11, P383, DOI 10.1088/0963-0252/11/4/304; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; Suschek CV, 2006, BIOL CHEM, V387, P499, DOI 10.1515/BC.2006.065; Suschek CV, 2005, METHOD ENZYMOL, V396, P568, DOI 10.1016/S0076-6879(05)96048-5; Toullec A, 2010, EMBO MOL MED, V2, P211, DOI 10.1002/emmm.201000073; Weltmann KD, 2009, CONTRIB PLASM PHYS, V49, P631, DOI 10.1002/ctpp.200910067; Winter J, 2014, J PHYS D, V47; Xu DH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128205; Yang F, 1997, CLIN CHEM, V43, P657	50	43	44	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144968	10.1371/journal.pone.0144968	http://dx.doi.org/10.1371/journal.pone.0144968			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26661594	gold, Green Published, Green Submitted			2022-12-26	WOS:000366715900159
J	Di Giacomo, D; De Domenico, E; Sette, C; Geremia, R; Grimaldi, P				Di Giacomo, Daniele; De Domenico, Emanuela; Sette, Claudio; Geremia, Raffaele; Grimaldi, Paola			Type 2 cannabinoid receptor contributes to the physiological regulation of spermatogenesis	FASEB JOURNAL			English	Article						endocannabinoid system; histone methylation; meiosis; retinoic acid	FOLLICLE-STIMULATING-HORMONE; RETINOIC ACID; ENDOCANNABINOID SYSTEM; MEIOTIC INITIATION; EPIGENETIC EVENTS; MESSENGER-RNA; DIFFERENTIATION; SPERMATOGONIA; IDENTIFICATION; INVOLVEMENT	Type 2 cannabinoid receptor (CB2) has been proposed to play a pivotal role in meiotic entry of male germcells, similar to retinoic acid (RA). In this study, we showed that activation of CB2 with the specific agonist JWH133 [3-(1',1'-dimethylbutyl)-1-deoxy-8-THC] (IC50 10(-6) M) mimics epigenetic events induced by RA (IC50 1027 M) in spermatogonia. Both JWH133 and RA treatments stimulate the expression of the meiotic genes c-Kit and Stra8, by up-regulating H3K4me3 and down-regulating H3K9me2 levels in genomic regions flanking the transcription start site. Moreover, both agents increase the expression of Prdm9, the gene encoding a meiosis-specific histone, H3K4me3 methyltransferase, which marks hotspots of recombination in prophase I, thus resulting in a global increase in H3K4me3. Notably, prolonged administration of JWH133 to immature 7 dpp CD-1 mice induced an acceleration of the onset of spermatogenesis, whereas the specific CB2 antagonist delayed germ cell differentiation. Thus, both hyper- and hypostimulation of CB2 disrupted the temporal dynamics of the spermatogenic cycle. These findings highlight the importance of proper CB2 signaling for the maintenance of a correct temporal progression of spermatogenesis and suggest a possible adverse effect of cannabis in deregulating this process.-Di Giacomo, D., De Domenico, E., Sette, C., Geremia, R., Grimaldi, P. Type 2 cannabinoid receptor contributes to the physiological regulation of spermatogenesis. FASEB J. 30, 1453-1463 (2016). www.fasebj.org	[Di Giacomo, Daniele; De Domenico, Emanuela; Sette, Claudio; Geremia, Raffaele; Grimaldi, Paola] Univ Roma Tor Vergata, Sect Anat, Dept Biomed & Prevent, Rome, Italy; [Sette, Claudio] Fdn Santa Lucia, Lab Neuroembryol, Rome, Italy	University of Rome Tor Vergata; IRCCS Santa Lucia	Grimaldi, P (corresponding author), Univ Roma Tor Vergata, Dept Biomed & Prevent, Via Montpellier 1, I-00133 Rome, Italy.	p.grimaldi@med.uniroma2.it	GRIMALDI, PAOLA/AAJ-7920-2020; Grimaldi, Paola/AAW-8721-2020	GRIMALDI, PAOLA/0000-0001-6724-7604; DE DOMENICO, EMANUELA/0000-0002-8937-605X	Grant PRIN from the Italian Ministry of Education; Agenzia Spaziale Italiana	Grant PRIN from the Italian Ministry of Education; Agenzia Spaziale Italiana(Agenzia Spaziale Italiana (ASI))	The authors thank Dr. M. Barchi and Dr. M. Faieta (Department of Biomedicine and Prevention, University of Rome "Tor Vergata", Italy) for suggestions with nuclear spreads preparation and analysis and Dr. F. Botti (Department of Clinical Sciences and Translational Medicine-University of Rome "Tor Vergata", Italy) for assistance with histological preparation. This work was supported in part by Grant PRIN 2011 from the Italian Ministry of Education (to R.G.) and Agenzia Spaziale Italiana. The authors declare no conflicts of interest.	Akhmetshina A, 2009, ARTHRITIS RHEUM-US, V60, P1129, DOI 10.1002/art.24395; Alves MG, 2013, CELL MOL LIFE SCI, V70, P777, DOI 10.1007/s00018-012-1079-1; Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Baker D, 2000, NATURE, V404, P84, DOI 10.1038/35003583; Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Bledau AS, 2014, DEVELOPMENT, V141, P1022, DOI 10.1242/dev.098152; Blume-Jensen P, 2000, NAT GENET, V24, P157, DOI 10.1038/72814; Busada JT, 2015, DEV BIOL, V397, P140, DOI 10.1016/j.ydbio.2014.10.020; Cacciola G, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105726; Chioccarelli T, 2010, ENDOCRINOLOGY, V151, P5017, DOI 10.1210/en.2010-0133; CLERMONT Y, 1972, PHYSIOL REV, V52, P198, DOI 10.1152/physrev.1972.52.1.198; Cobellis G, 2006, BIOL REPROD, V75, P82, DOI 10.1095/biolreprod.106.051730; de Rooij DG, 2001, REPRODUCTION, V121, P347, DOI 10.1530/rep.0.1210347; Di Marzo V, 1998, TRENDS NEUROSCI, V21, P521, DOI 10.1016/S0166-2236(98)01283-1; Glaser S, 2006, DEVELOPMENT, V133, P1423, DOI 10.1242/dev.02302; Godmann M, 2007, BIOL REPROD, P208; Grey C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001176; Grimaldi P, 2012, CELL MOL LIFE SCI, V69, P4177, DOI 10.1007/s00018-012-1074-6; Grimaldi P, 2009, P NATL ACAD SCI USA, V106, P11131, DOI 10.1073/pnas.0812789106; Griswold MD, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.096610; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lewis SEM, 2012, INT J ANDROL, V35, P731, DOI 10.1111/j.1365-2605.2012.01259.x; Maccarrone M, 2003, ENDOCRINOLOGY, V144, P20, DOI 10.1210/en.2002-220544; Meccariello R, 2006, MOL REPROD DEV, V73, P551, DOI 10.1002/mrd.20434; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Nottke A, 2009, DEVELOPMENT, V136, P879, DOI 10.1242/dev.020966; Parvanov ED, 2010, SCIENCE, V327, P835, DOI 10.1126/science.1181495; Pellegrini M, 2008, CELL CYCLE, V7, P3878, DOI 10.4161/cc.7.24.7262; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; ROSSI P, 1993, DEV BIOL, V155, P68, DOI 10.1006/dbio.1993.1007; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Smagulova F, 2011, NATURE, V472, P375, DOI 10.1038/nature09869; Tachibana M, 2007, EMBO J, V26, P3346, DOI 10.1038/sj.emboj.7601767; Van Sickle MD, 2005, SCIENCE, V310, P329, DOI 10.1126/science.1115740; Wang Y, 2007, ENDOCRINOLOGY, V148, P2233, DOI 10.1210/en.2006-1206; Wenger T, 1999, J NEUROENDOCRINOL, V11, P873; Wu H, 2013, CELL REP, V5, P13, DOI 10.1016/j.celrep.2013.08.035; Yap DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027127; Zhou Q, 2008, BIOL REPROD, V78, P537, DOI 10.1095/biolreprod.107.064337	44	24	24	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1453	1463		10.1096/fj.15-279034	http://dx.doi.org/10.1096/fj.15-279034			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26671998				2022-12-26	WOS:000372629100008
J	Hover, S; King, B; Hall, B; Loundras, EA; Taqi, H; Daly, J; Dallas, M; Peers, C; Schnettler, E; McKimmie, C; Kohl, A; Barr, JN; Mankouri, J				Hover, Samantha; King, Barnabas; Hall, Bradley; Loundras, Eleni-Anna; Taqi, Hussah; Daly, Janet; Dallas, Mark; Peers, Chris; Schnettler, Esther; McKimmie, Clive; Kohl, Alain; Barr, John N.; Mankouri, Jamel			Modulation of Potassium Channels Inhibits Bunyavirus Infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antiviral agent; ion channel; negative-strand RNA virus; pathogenesis; potassium channel	NONSTRUCTURAL PROTEIN NSS; BUNYAMWERA-VIRUS; ION CHANNELS; SCHMALLENBERG VIRUS; CELL-PROLIFERATION; GENOME REPLICATION; FEVER VIRUS; K+ CHANNEL; NEURONS; ORTHOBUNYAVIRUS	Bunyaviruses are considered to be emerging pathogens facilitated by the segmented nature of their genome that allows reassortment between different species to generate novel viruses with altered pathogenicity. Bunyaviruses are transmitted via a diverse range of arthropod vectors, as well as rodents, and have established a global disease range with massive importance in healthcare, animal welfare, and economics. There are no vaccines or anti-viral therapies available to treat human bunyavirus infections and so development of new anti-viral strategies is urgently required. Bunyamwera virus (BUNV; genus Orthobunyavirus) is the model bunyavirus, sharing aspects of its molecular and cellular biology with all Bunyaviridae family members. Here, we show for the first time that BUNV activates and requires cellular potassium (K+) channels to infect cells. Time of addition assays using K+ channel modulating agents demonstrated that K+ channel function is critical to events shortly after virus entry but prior to viral RNA synthesis/replication. A similar K+ channel dependence was identified for other bunyaviruses namely Schmallenberg virus (Orthobunyavirus) as well as the more distantly related Hazara virus (Nairovirus). Using a rational pharmacological screening regimen, two-pore domain K+ channels (K-2P) were identified as the K+ channel family mediating BUNV K+ channel dependence. As several K-2P channel modulators are currently in clinical use, our work suggests they may represent a new and safe drug class for the treatment of potentially lethal bunyavirus disease.	[Hover, Samantha; Hall, Bradley; Loundras, Eleni-Anna; Taqi, Hussah; Peers, Chris; Barr, John N.; Mankouri, Jamel] Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England; [King, Barnabas] Univ Nottingham, Sch Life Sci, Nottingham NG7 2UH, England; [Daly, Janet] Univ Nottingham, Vet Med & Sci, Nottingham NG7 2RD, England; [Dallas, Mark] Univ Reading, Sch Pharm, Reading RG6 6AP, Berks, England; [Schnettler, Esther; McKimmie, Clive; Kohl, Alain] Univ Glasgow, MRC, Ctr Virus Res, Glasgow G61 1QH, Lanark, Scotland	University of Leeds; University of Nottingham; University of Nottingham; University of Reading; University of Glasgow	Barr, JN; Mankouri, J (corresponding author), Univ Leeds, Sch Mol & Cellular Biol, Leeds LS2 9JT, W Yorkshire, England.	J.N.Barr@leeds.ac.uk; J.Mankouri@leeds.ac.uk	Daly, Janet/G-9797-2011; McKimmie, Clive/AAD-9509-2019; Schnettler, Esther/AAV-8774-2020; Dallas, Mark/Q-6117-2019	McKimmie, Clive/0000-0002-7694-9509; Dallas, Mark/0000-0002-5190-0522; Mankouri, Jamel/0000-0002-4325-3687; Peers, Chris/0000-0002-8354-346X; Daly, Janet/0000-0002-1912-4500; Hover, Samantha/0000-0001-9190-5670; Loundras, Eleni-Anna/0000-0002-3485-3111; barr, john/0000-0002-9035-2039	Royal Society [RG110306]; Medical Research Council [G1001724, MC_UU_12014/8] Funding Source: researchfish; MRC [G1001724, MC_UU_12014/8] Funding Source: UKRI	Royal Society(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We acknowledge the late Richard M. Elliott for contribution of reagents, support, and advice during this and previous studies. The confocal microscope used for imaging was funded by a Royal Society equipment grant (Grant Number RG110306).	Adams MJ, 2013, ARCH VIROL, V158, P2633, DOI 10.1007/s00705-013-1749-9; Bagal S, 2013, J MED CHEM, V56, P593, DOI 10.1021/jm3011433; Barr JN, 2003, VIROLOGY, V311, P326, DOI 10.1016/S0042-6822(03)00130-2; Barry G, 2014, J GEN VIROL, V95, P1640, DOI 10.1099/vir.0.065425-0; Baxter DF, 2002, J BIOMOL SCREEN, V7, P79, DOI 10.1177/108705710200700110; Becchetti A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00312; Bowen MD, 2001, VIROLOGY, V291, P185, DOI 10.1006/viro.2001.1201; BRAUNER T, 1984, BIOCHIM BIOPHYS ACTA, V771, P208, DOI 10.1016/0005-2736(84)90535-2; Bridgen A, 2001, P NATL ACAD SCI USA, V98, P664, DOI 10.1073/pnas.98.2.664; Briese T, 2006, J VIROL, V80, P5627, DOI 10.1128/JVI.02448-05; Briese T, 2013, VIROLOGY, V446, P207, DOI 10.1016/j.virol.2013.07.030; Buchholz UJ, 1999, J VIROL, V73, P251, DOI 10.1128/JVI.73.1.251-259.1999; Carlton-Smith C, 2012, J VIROL, V86, P11548, DOI 10.1128/JVI.01773-12; Carvalho FA, 2012, J VIROL, V86, P2096, DOI 10.1128/JVI.06796-11; Cheng E, 2011, J BIOL CHEM, V286, P11814, DOI 10.1074/jbc.M110.210179; Crotty S, 2002, J MOL MED, V80, P86, DOI 10.1007/s00109-001-0308-0; Davis BA, 2001, J MEMBRANE BIOL, V183, P25, DOI 10.1007/s00232-001-0050-0; Dong YY, 2015, SCIENCE, V347, P1256, DOI 10.1126/science.1261512; Dowall SD, 2012, J GEN VIROL, V93, P560, DOI 10.1099/vir.0.038455-0; Dwivedi R, 2005, ARTERIOSCL THROM VAS, V25, pE7, DOI 10.1161/01.ATV.0000152610.40086.31; Eleftherianos I, 2011, P NATL ACAD SCI USA, V108, P12024, DOI 10.1073/pnas.1108926108; Elliott RM, 2009, CLIN MICROBIOL INFEC, V15, P510, DOI 10.1111/j.1469-0691.2009.02849.x; Elliott RM, 2014, NAT REV MICROBIOL, V12, P673, DOI 10.1038/nrmicro3332; ELLIOTT RM, 1986, VIROLOGY, V150, P21, DOI 10.1016/0042-6822(86)90262-X; Enyedi P, 2010, PHYSIOL REV, V90, P559, DOI 10.1152/physrev.00029.2009; Evangelista S, 2004, CURR PHARM DESIGN, V10, P3561, DOI 10.2174/1381612043382972; FERON O, 1992, BRIT J PHARMACOL, V105, P480, DOI 10.1111/j.1476-5381.1992.tb14279.x; Feske S, 2012, NAT REV IMMUNOL, V12, P532, DOI 10.1038/nri3233; Fontana J, 2008, CELL MICROBIOL, V10, P2012, DOI 10.1111/j.1462-5822.2008.01184.x; FRUGULHETTI ICPP, 1989, J GEN VIROL, V70, P3493, DOI 10.1099/0022-1317-70-12-3493; Goldstein SAN, 2005, PHARMACOL REV, V57, P527, DOI 10.1124/pr.57.4.12; Goldstein SAN, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002225; Goller KV, 2012, EMERG INFECT DIS, V18, P1644, DOI 10.3201/eid1810.120835; Hoffmann B, 2012, EMERG INFECT DIS, V18, P469, DOI 10.3201/eid1803.111905; Hollidge BS, 2012, J VIROL, V86, P7988, DOI 10.1128/JVI.00140-12; Hsu K, 2004, MOL CELL, V14, P259, DOI 10.1016/S1097-2765(04)00183-2; Hu CL, 2006, NEUROPHARMACOLOGY, V51, P737, DOI 10.1016/j.neuropharm.2006.05.013; Igloi Z, 2015, J VIROL, V89, P4023, DOI 10.1128/JVI.02946-14; Irvine E, 2007, J NEUROIMMUNE PHARM, V2, P265, DOI 10.1007/s11481-007-9072-4; Jiang YX, 2000, J GEN PHYSIOL, V115, P269, DOI 10.1085/jgp.115.3.269; KAAKKOLA S, 1982, UNDERSEA BIOMED RES, V9, P233; Kainulainen M, 2014, J VIROL, V88, P3464, DOI 10.1128/JVI.02914-13; Kohl A, 2004, J VIROL, V78, P5679, DOI 10.1128/JVI.78.11.5679-5685.2004; Kudo S, 1999, CLIN PHARMACOKINET, V37, P435, DOI 10.2165/00003088-199937060-00001; Lang F, 2006, CONTRIB NEPHROL, V152, P142, DOI 10.1159/000096321; Lesage F, 2000, AM J PHYSIOL-RENAL, V279, pF793, DOI 10.1152/ajprenal.2000.279.5.F793; Nieva JL, 2012, NAT REV MICROBIOL, V10, P563, DOI 10.1038/nrmicro2820; Maltezou HC, 2010, TRAVEL MED INFECT DI, V8, P139, DOI 10.1016/j.tmaid.2010.04.008; Mankouri J, 2010, P NATL ACAD SCI USA, V107, P11549, DOI 10.1073/pnas.0912426107; Mankouri J, 2009, P NATL ACAD SCI USA, V106, P15903, DOI 10.1073/pnas.0906798106; Mathie A, 2010, J PHYSIOL-LONDON, V588, P3149, DOI 10.1113/jphysiol.2010.192344; Meier R, 2014, J VIROL, V88, P8565, DOI 10.1128/JVI.00388-14; Miller AN, 2012, SCIENCE, V335, P432, DOI 10.1126/science.1213274; MURPHY FA, 1968, J VIROL, V2, P1315, DOI 10.1128/JVI.2.11.1315-1325.1968; Musset B, 2006, J PHYSIOL-LONDON, V572, P639, DOI 10.1113/jphysiol.2006.106898; Novoa RR, 2005, J VIROL, V79, P10852, DOI 10.1128/JVI.79.17.10852-10863.2005; Peluffo RD, 2004, J GEN PHYSIOL, V123, P249, DOI 10.1085/jgp.200308872; Sakurai Y, 2015, SCIENCE, V347, P995, DOI 10.1126/science.1258758; SANCHEZ DY, 1994, J GEN PHYSIOL, V104, P173, DOI 10.1085/jgp.104.1.173; Schoen A, 2015, EUR J CELL BIOL, V94, P384, DOI 10.1016/j.ejcb.2015.06.001; Shi XH, 2004, J VIROL, V78, P10793, DOI 10.1128/JVI.78.19.10793-10802.2004; Shin HW, 2014, J ANESTH, V28, P81, DOI 10.1007/s00540-013-1661-1; Shtanko O, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004390; Tauro LB, 2015, VET J, V206, P111, DOI 10.1016/j.tvjl.2015.06.013; Walter CT, 2011, J GEN VIROL, V92, P80, DOI 10.1099/vir.0.024240-0; Weber F, 2002, J VIROL, V76, P7949, DOI 10.1128/JVI.76.16.7949-7955.2002; Wicher D, 2001, PROG NEUROBIOL, V64, P431, DOI 10.1016/S0301-0082(00)00066-6; Windley MJ, 2011, MOL PHARMACOL, V80, P1, DOI 10.1124/mol.110.070540; Wu WN, 2012, J VIROL, V86, P7777, DOI 10.1128/JVI.00460-12; Zhang AL, 2014, EXP LUNG RES, V40, P237, DOI 10.3109/01902148.2014.905655; Zhang YZ, 2012, CLIN INFECT DIS, V54, P527, DOI 10.1093/cid/cir804	71	30	30	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3411	3422		10.1074/jbc.M115.692673	http://dx.doi.org/10.1074/jbc.M115.692673			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26677217	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000370854500024
J	Jia, F; Cui, MX; Than, MT; Han, M				Jia, Fan; Cui, Mingxue; Than, Minh T.; Han, Min			Developmental Defects of Caenorhabditis elegans Lacking Branched-chain alpha-Ketoacid Dehydrogenase Are Mainly Caused by Monomethyl Branched-chain Fatty Acid Deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYRUP-URINE-DISEASE; TERM-FOLLOW-UP; AMINO-ACIDS; C-ELEGANS; LIVER-TRANSPLANTATION; 18-METHYLEICOSANOIC ACID; VERNIX CASEOSA; RAT-BRAIN; BIOSYNTHESIS; GENE	Branched-chain alpha-ketoacid dehydrogenase (BCKDH) catalyzes the critical step in the branched-chain amino acid (BCAA) catabolic pathway and has been the focus of extensive studies. Mutations in the complex disrupt many fundamental metabolic pathways and cause multiple human diseases including maple syrup urine disease (MSUD), autism, and other related neurological disorders. BCKDH may also be required for the synthesis of monomethyl branched-chain fatty acids (mmBCFAs) from BCAAs. The pathology of MSUD has been attributed mainly to BCAA accumulation, but the role of mmBCFA has not been evaluated. Here we show that disrupting BCKDH in Caenorhabditis elegans causes mmBCFA deficiency, in addition to BCAA accumulation. Worms with deficiency in BCKDH function manifest larval arrest and embryonic lethal phenotypes, and mmBCFA supplementation suppressed both without correcting BCAA levels. The majority of developmental defects caused by BCKDH deficiency may thus be attributed to lacking mmBCFAs in worms. Tissue-specific analysis shows that restoration of BCKDH function in multiple tissues can rescue the defects, but is especially effective in neurons. Taken together, we conclude that mmBCFA deficiency is largely responsible for the developmental defects in the worm and conceivably might also be a critical contributor to the pathology of human MSUD.	[Jia, Fan; Cui, Mingxue; Than, Minh T.; Han, Min] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Han, M (corresponding author), Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA.	mhan@colorado.edu			National Institutes of Health [P40OD010440]; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank M. Kniazeva for advice, A. Sewell for critical reading of the manuscript, the CGC for strains (funded by National Institutes of Health (Grant P40OD010440)), and H. Zhu, H. Tang, and other lab members for helpful discussions.	Amaral AU, 2010, BRAIN RES, V1324, P75, DOI 10.1016/j.brainres.2010.02.018; Caraballo SCG, 2014, J NUTR BIOCHEM, V25, P1263, DOI 10.1016/j.jnutbio.2014.07.005; Chuang D.T., 2001, METABOLIC MOL BASES, P1971; Cole JT, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00018; Destaillats F, 2002, LIPIDS, V37, P325, DOI 10.1007/s11745-002-0898-y; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Frank MP, 2007, J CHROMATOGR B, V852, P646, DOI 10.1016/j.jchromb.2007.01.002; GIBSON RA, 1981, AM J CLIN NUTR, V34, P252, DOI 10.1093/ajcn/34.2.252; HRADEC J, 1994, J CHROMATOGR B, V660, P386, DOI 10.1016/0378-4347(94)00292-4; Jones LN, 1997, MICRON, V28, P469, DOI 10.1016/S0968-4328(97)00039-5; KANEDA T, 1991, MICROBIOL REV, V55, P288, DOI 10.1128/MMBR.55.2.288-302.1991; Kniazeva M, 2004, PLOS BIOL, V2, P1446, DOI 10.1371/journal.pbio.0020257; Kniazeva M, 2008, GENE DEV, V22, P2102, DOI 10.1101/gad.1692008; Kniazeva M, 2015, DEV CELL, V33, P260, DOI 10.1016/j.devcel.2015.02.015; Kniazeva M, 2012, GENE DEV, V26, P554, DOI 10.1101/gad.187054.112; Labrousse AM, 1999, MOL CELL, V4, P815, DOI 10.1016/S1097-2765(00)80391-3; LAU KS, 1992, J BIOL CHEM, V267, P24090; Lu XW, 1998, CELL, V95, P981, DOI 10.1016/S0092-8674(00)81722-5; Mazariegos GV, 2012, J PEDIATR-US, V160, P116, DOI 10.1016/j.jpeds.2011.06.033; MCGHEE JD, 1990, GENETICS, V125, P505; McLaughlin PM, 2013, CLIN NEUROPSYCHOL, V27, P1199, DOI 10.1080/13854046.2013.816372; MITSUBUCHI H, 1991, J BIOL CHEM, V266, P14686; MORII H, 1982, COMP BIOCHEM PHYS B, V71, P357, DOI 10.1016/0305-0491(82)90395-9; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; NICOLAIDES N, 1974, SCIENCE, V186, P19, DOI 10.1126/science.186.4158.19; Oku H, 2000, LIPIDS, V35, P373, DOI 10.1007/s11745-000-534-x; OKU H, 1994, BBA-LIPID LIPID MET, V1214, P279; Ran-Ressler RR, 2008, PEDIATR RES, V64, P605, DOI 10.1203/PDR.0b013e318184d2e6; Ran-Ressler RR, 2014, BRIT J NUTR, V112, P565, DOI 10.1017/S0007114514001081; Rissmann R, 2006, J INVEST DERMATOL, V126, P1823, DOI 10.1038/sj.jid.5700305; Schonberger S, 2004, MOL GENET METAB, V82, P69, DOI 10.1016/j.ymgme.2004.01.016; Simon E, 2007, J INHERIT METAB DIS, V30, P264, DOI 10.1007/s10545-007-0475-4; Sitta A, 2014, CELL MOL NEUROBIOL, V34, P157, DOI 10.1007/s10571-013-0002-0; Smith JR, 2005, MICRON, V36, P261, DOI 10.1016/j.micron.2004.11.004; Strand JM, 2014, METABOLISM, V63, P1063, DOI 10.1016/j.metabol.2014.05.003; Strauss KA, 2006, AM J TRANSPLANT, V6, P557, DOI 10.1111/j.1600-6143.2005.01209.x; Strauss Kevin A., 2003, Curr Treat Options Neurol, V5, P329, DOI 10.1007/s11940-003-0039-3; Strauss KA, 2010, MOL GENET METAB, V99, P333, DOI 10.1016/j.ymgme.2009.12.007; Su X, 2015, OBESITY, V23, P329, DOI 10.1002/oby.20923; Svensk E, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003801; Tavares RG, 2000, J NEUROL SCI, V181, P44, DOI 10.1016/S0022-510X(00)00402-0; Von Stetina SE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r135; Walsh KS, 2010, CLIN NEUROPSYCHOL, V24, P689, DOI 10.1080/13854040903527279; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; YEAMAN SJ, 1989, BIOCHEM J, V257, P625, DOI 10.1042/bj2570625; ZHANG B, 1991, MOL BIOL MED, V8, P39; Zhu HH, 2013, ELIFE, V2, DOI 10.7554/eLife.00429; Zinnanti WJ, 2009, BRAIN, V132, P903, DOI 10.1093/brain/awp024	48	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2967	2973		10.1074/jbc.M115.676650	http://dx.doi.org/10.1074/jbc.M115.676650			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26683372	Green Published, hybrid			2022-12-26	WOS:000369626900033
J	Nevin, PE; Pfeiffer, J; Kibira, SPS; Lubinga, SJ; Mukose, A; Babigumira, JB				Nevin, Paul E.; Pfeiffer, James; Kibira, Simon P. S.; Lubinga, Solomon J.; Mukose, Aggrey; Babigumira, Joseph B.			Perceptions of HIV and Safe Male Circumcision in High HIV Prevalence Fishing Communities on Lake Victoria, Uganda	PLOS ONE			English	Article							MEDICAL MALE CIRCUMCISION; RISK-FACTORS; PREVENTION; BARRIERS; RAKAI; MEN; KNOWLEDGE; BEHAVIOR; KISUMU	Background In 2010, the Uganda Ministry of Health introduced its Safe Male Circumcision (SMC) strategy for HIV prevention with the goal of providing 4.2 million voluntary medical male circumcisions by 2015. Fishing communities, where HIV prevalence is approximately 3-5 times higher than the national average, have been identified as a key population needing targeted HIV prevention services by the National HIV Prevention Strategy. This study aimed to understand perceptions of HIV and identify potential barriers and facilitators to SMC in fishing communities along Lake Victoria. Methods We conducted 8 focus group discussions, stratified by sex and age, with 67 purposefully sampled participants in 4 communities in Kalangala District, Uganda. Results There was universal knowledge of the availability of SMC services, but males reported high uptake in the community while females indicated that it is low. Improved hygiene, disease prevention, and improved sexual performance and desirability were reported facilitators. Barriers included a perceived increase in SMC recipients' physiological libido, post-surgical abstinence, lost income during convalescence, and lengthier recovery due to occupational hazards. Both males and females reported concerns about spousal fidelity during post-SMC abstinence. Reported misconceptions and community-held cultural beliefs include fear that foreskins are sold after their removal, the belief that a SMC recipient's first sexual partner after the procedure should not be his spouse, and the belief that vaginal fluids aid circumcision wound healing. Conclusions Previous outreach efforts have effectively reached these remote communities, where availability and health benefits of SMC are widely understood. However, community-specific intervention strategies are needed to address the barriers identified in this study. We recommend the development of targeted counseling, outreach, and communication strategies to address barriers, misconceptions, and community-held beliefs. Interventions should also incorporate female partners into the SMC decision-making process and develop compensation strategies to address lost income during SMC recovery.	[Nevin, Paul E.; Pfeiffer, James] Univ Washington, Sch Med, Dept Global Hlth, Seattle, WA 98195 USA; [Nevin, Paul E.; Pfeiffer, James] Univ Washington, Sch Publ Hlth, Dept Global Hlth, Seattle, WA 98195 USA; [Pfeiffer, James] Hlth Alliance Int, Seattle, WA USA; [Pfeiffer, James] Univ Washington, Dept Anthropol, Seattle, WA 98195 USA; [Kibira, Simon P. S.] Makerere Univ, Sch Publ Hlth, Dept Community Hlth & Behav Sci, Kampala, Uganda; [Lubinga, Solomon J.; Babigumira, Joseph B.] Univ Washington, Sch Med, Dept Global Hlth, Global Med Program, Seattle, WA USA; [Lubinga, Solomon J.; Babigumira, Joseph B.] Univ Washington, Sch Publ Hlth, Dept Global Hlth, Global Med Program, Seattle, WA 98195 USA; [Lubinga, Solomon J.; Babigumira, Joseph B.] Univ Washington, Sch Pharm, Pharmaceut Outcomes Res & Policy Program, Seattle, WA 98195 USA; [Mukose, Aggrey] Makerere Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Kampala, Uganda	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Makerere University; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Makerere University	Nevin, PE (corresponding author), Univ Washington, Sch Med, Dept Global Hlth, Seattle, WA 98195 USA.	penevin@uw.edu	Babigumira, Joseph/T-4208-2019; Lubinga, Solomon James/AAD-6637-2019; Lubinga, Solomon James/B-6590-2018	Lubinga, Solomon James/0000-0003-0539-9156; Lubinga, Solomon James/0000-0003-0539-9156; Kibira, Simon Peter Sebina/0000-0002-7385-423X	National Institutes of Health [P30AI027757]; University of Washington School of Public Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027757] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington School of Public Health(University of Washington); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	JBB received award number P30AI027757 from the National Institutes of Health (http://www.nih.gov/). JBB also received an emerging challenges pilot grant from the University of Washington School of Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asiki G, 2011, SEX TRANSM INFECT, V87, P511, DOI 10.1136/sti.2010.046805; Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Evens E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098221; George G, 2014, AJAR-AFR J AIDS RES, V13, P179, DOI 10.2989/16085906.2014.943253; Gray R, 2012, AIDS, V26, P609, DOI 10.1097/QAD.0b013e3283504a3f; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; Herman-Roloff A, 2012, AIDS BEHAV, V16, P1173, DOI 10.1007/s10461-011-0073-1; Herman-Roloff A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019814; Hewett PC, 2012, AIDS, V26, P749, DOI 10.1097/QAD.0b013e32835097ff; Jones D, 2014, AIDS BEHAV, V18, P278, DOI 10.1007/s10461-013-0530-0; Kalichman S, 2007, PLOS MED, V4, P597, DOI 10.1371/journal.pmed.0040138; Kissling E, 2005, AIDS, V19, P1939, DOI 10.1097/01.aids.0000191925.54679.94; KITZINGER J, 1995, BRIT MED J, V311, P299, DOI 10.1136/bmj.311.7000.299; Kiwanuka N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094932; Kiwanuka N, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18621; Kong XR, 2014, AIDS BEHAV, V18, P880, DOI 10.1007/s10461-014-0740-0; Kwena ZA, 2010, INT J STD AIDS, V21, P708, DOI 10.1258/ijsa.2010.010160; Lanham M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044825; Maibvise C, 2014, AJAR-AFR J AIDS RES, V13, P281, DOI 10.2989/16085906.2014.952652; Miles M. B., 2019, SAGE, DOI DOI 10.1080/1034912X.2016.1228856; Opio A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070770; Patton M. Q., 1990, QUALITATIVE EVALUATI; Plotkin M, 2013, GLOB HEALTH-SCI PRAC, V1, P108, DOI 10.9745/GHSP-D-12-00037; Seeley JA, 2005, AIDS CARE, V17, P688, DOI 10.1080/09540120412331336698; Seeley J, 2012, SEX TRANSM DIS, V39, P433, DOI 10.1097/OLQ.0b013e318251555d; Skolnik L, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1119; Smolak A, 2014, AIDS CARE, V26, P282, DOI 10.1080/09540121.2013.824541; Ssekubugu R, 2013, QUAL HEALTH RES, V23, P795, DOI 10.1177/1049732313482189; Tumwesigye NM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1069; UBOS, 2014, NATL POPULATION HOUS; Uganda AIDS Commission, 2014, DISTR HIV AIDS SUPP; Uganda AIDS Commission, 2014, HIV AIDS UG COUNTR P; Uganda AIDS Commission, 2014, CONS MIDT REV REP NA; Uganda AIDS Commission, 2011, NAT HIV PREV STRAT 2; Uganda Ministry of Health, 2011, SAF MAL CIRC HIV PRE; Uganda Ministry of Health, 2010, SAF MAL CIRC POL; Uganda Ministry of Health, 2012, UG AIDS IND SURV 201; Uganda Ministry of Health, 2010, SAF MAL CIRC HIV PRE; Uganda Ministry of Health, 2012, UND SAF MAL CIRC; Westercamp N, 2014, AIDS BEHAV, V18, P1764, DOI 10.1007/s10461-014-0846-4	41	13	13	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145543	10.1371/journal.pone.0145543	http://dx.doi.org/10.1371/journal.pone.0145543			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CZ4SF	26689212	Green Submitted, Green Published, gold			2022-12-26	WOS:000367092300087
J	Ngwe, MFSN; Omokolo, DN; Joly, S				Ngwe, Marie Florence Sandrine Ngo; Omokolo, Denis Ndoumou; Joly, Simon			Evolution and Phylogenetic Diversity of Yam Species (Dioscorea spp.): Implication for Conservation and Agricultural Practices	PLOS ONE			English	Article							ROTUNDATA COMPLEX; BIODIVERSITY; CHLOROPLAST; PERSPECTIVE; MIGRATION	Yams (Dioscorea spp.) consist of approximately 600 species. Presently, these species are threatened by genetic erosion due to many factors such as pest attacks and farming practices. In parallel, complex taxonomic boundaries in this genus makes it more challenging to properly address the genetic diversity of yam and manage its germplasm. As a first step toward evaluating and preserving the genetic diversity yam species, we use a phylogenetic diversity (PD) approach that has the advantage to investigate phylogenetic relationships and test hypotheses of species monophyly while alleviating to the problem of ploidy variation within and among species. The Bayesian phylogenetic analysis of 62 accessions from 7 species from three regions of Cameroon showed that most Dioscorea sections were monophyletic, but species within sections were generally non-monophyletic. The wild species D. praehensilis and cultivated D. cayenensis were the species with the highest PD. At the opposite, D. esculenta has a low PD and future studies should focus on this species to properly address its conservation status. We also show that wild species show a stronger genetic structure than cultivated species, which potentially reflects the management of the yam germplasm by farmers. These findings show that phylogenetic diversity is a promising approach for an initial investigation of genetic diversity in a crop consisting of closely related species.	[Ngwe, Marie Florence Sandrine Ngo; Omokolo, Denis Ndoumou] Univ Yaounde I, Higher Teachers Training Coll, Lab Plant Physiol, Yaounde, Cameroon; [Joly, Simon] Montreal Bot Garden, Inst Rech Biol Vegetale, Montreal, PQ H1X 2B2, Canada; [Joly, Simon] Univ Montreal, Montreal, PQ H1X 2B2, Canada; [Ngwe, Marie Florence Sandrine Ngo] Inst Agr Res Development CEREFEN, Meyomessala, Cameroon	University of Yaounde I; Universite de Montreal; Universite de Montreal	Ngwe, MFSN (corresponding author), Univ Yaounde I, Higher Teachers Training Coll, Lab Plant Physiol, POB 47, Yaounde, Cameroon.	florencengongwe@yahoo.fr		Joly, Simon/0000-0002-0865-8267	L'Oreal-UNESCO	L'Oreal-UNESCO	This work was funded by the L'Oreal-UNESCO for Women in Science [grant to NNMFS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, TRACER V1 6; Asahina H, 2010, J NAT MED-TOKYO, V64, P133, DOI 10.1007/s11418-009-0379-8; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; BIRKY CW, 1989, GENETICS, V121, P613; Bivand R, 2015, TOOLS READING HANDLI; Bruvo R, 2004, MOL ECOL, V13, P2101, DOI 10.1111/j.1365-294X.2004.02209.x; Burkill IH, 1960, SOCIETY, V56, P319; Cadotte MW, 2013, P NATL ACAD SCI USA, V110, P8996, DOI 10.1073/pnas.1301685110; Couto RS, 2014, PHYTOTAXA, V163, P229, DOI 10.11646/phytotaxa.163.4.3; Croxton MD, 2011, INVAS PLANT SCI MANA, V1, P32; Dansi A., 2013, International Journal of Biological and Chemical Sciences, V7, P60; Dansi A, 2001, EUPHYTICA, V119, P301, DOI 10.1023/A:1017510402681; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond A. J., 2009, GENEIOUS V 4 7; Dumont R, 2005, COLLECTION REPERES, P119; Dumont R, 1994, IGNAMES CAMEROUN; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engler A, 1924, PFLANZENREICH, V4, P253; ENNOS RA, 1994, HEREDITY, V72, P250, DOI 10.1038/hdy.1994.35; Faith DP, 2010, CURR OPIN ENV SUST, V2, P66, DOI 10.1016/j.cosust.2010.04.002; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Faith DP, 2006, EVOL BIOINFORM ONLIN, V2, P70; FIDA, 2003, RAPP PREEV PNDRT, VI; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Gerritsen H., 2014, MAPPLOTS DATA VISUAL; Girma G, 2012, INT J CONSERV SCI, V3, P199; Girma G, 2014, THEOR APPL GENET, V127, P1783, DOI 10.1007/s00122-014-2339-2; Helmus MR, 2007, AM NAT, V169, pE68, DOI 10.1086/511334; Huber, 1998, DIOSCOREACEAE FAMILI, VIII, P216; Hughes JB, 1997, SCIENCE, V278, P689, DOI 10.1126/science.278.5338.689; Islam Md. Tariqul, 2008, Plant Tissue Culture & Biotechnology, V18, P25; IUCN (World Conservation Union), 2001, IUCN RED LIST CAT VE; Joly S, 2015, METHODS ECOL EVOL, V6, P938, DOI 10.1111/2041-210X.12343; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Koonjul PK, 1999, NUCLEIC ACIDS RES, V27, P915, DOI 10.1093/nar/27.3.915; Lee A.C., 2014, BERKELEY SCI J, V18; Levy F, 1999, HEREDITY, V82, P422, DOI 10.1038/sj.hdy.6885000; Mi XC, 2012, AM NAT, V180, pE17, DOI 10.1086/665999; Miege J., 1948, 28 ANN B 313 314 NOV, V313-314, P509; Mignouna HD, 2003, GENET RESOUR CROP EV, V50, P519, DOI 10.1023/A:1023990618128; Mignouna HD, 2002, GENET RESOUR CROP EV, V49, P21, DOI 10.1023/A:1013805813522; Mishler BD, 2009, TAXON, V58, P61, DOI 10.1002/tax.581009; MOOERS AO, 2005, PHYLOGENY CONSERVATI; Moritz CC, 2013, MOL ECOL, V22, P5969, DOI 10.1111/mec.12565; Ngo Ngwe MFS, 2014, J PLANT BREEDING GEN, V02, P87; NIXON KC, 1990, CLADISTICS, V6, P211, DOI 10.1111/j.1096-0031.1990.tb00541.x; Norman P. E., 2012, International Journal of Agronomy and Plant Production, V3, P265; OKSANEN FJ, 2013, R PACKAGE VERSION 2; Peres-Neto PR, 2006, ECOLOGY, V87, P2614, DOI 10.1890/0012-9658(2006)87[2614:VPOSDM]2.0.CO;2; Primack RB., 2012, PRIMER CONSERVATION, V5th; Purvis A, 2005, PHYLOGENY CONSERVATI; R. Core Team, 2013, R LANGUAGE ENV STAT; Ronquist F, 2010, MRBAYES 3 1 MANUEL; Sautour M, 2007, J NAT MED, V61, P91, DOI 10.1007/s11418-006-0126-3; Scarcelli N, 2006, GENET RESOUR CROP EV, V53, P121, DOI 10.1007/s10722-004-1950-5; Scarcelli N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019954; Sesay L, 2013, SKY J AGR RES, V2, P1; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Shorthouse DP, 2010, SIMPLEMAPPR ONLINE T; Sih A, 2011, EVOL APPL, V4, P367, DOI 10.1111/j.1752-4571.2010.00166.x; Siquiera VBMS, 2011, AM J BOT, P144; Srivastava DS, 2005, ANNU REV ECOL EVOL S, V36, P267, DOI 10.1146/annurev.ecolsys.36.102003.152636; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Thrall PH, 2011, EVOL APPL, V4, P200, DOI 10.1111/j.1752-4571.2010.00179.x; Ting CT, 2000, FLORA IN CHINA; Tortoe C, 2012, AFR J FOOD SCI TECHN, V3, P59; Tostain S, 2010, IGNAMES MALGACHES RE, P23; Wilkin P, 2005, SYST BOT, V30, P736, DOI 10.1600/036364405775097879; Wilkin Paul, 2008, Kew Bulletin, V63, P113, DOI 10.1007/s12225-007-9000-z; Winter M, 2009, P NATL ACAD SCI USA, V106, P21721, DOI 10.1073/pnas.0907088106; Gao X, 2008, J SYST EVOL, V46, P315, DOI 10.3724/SP.J.1002.2008.08007; Yan QQ, 2014, GENET MOL RES, V13, P1514, DOI 10.4238/2014.March.12.3; Zoundjihekpon J., 1993, THESIS	73	19	19	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145364	10.1371/journal.pone.0145364	http://dx.doi.org/10.1371/journal.pone.0145364			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691919	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092300063
J	Tian, T; McLachlan, GJ; Dieters, MJ; Basford, KE				Tian, Ting; McLachlan, Geoffrey J.; Dieters, Mark J.; Basford, Kaye E.			Application of Multiple Imputation for Missing Values in Three-Way Three-Mode Multi-Environment Trial Data	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; COMPONENT ANALYSIS; VARIETY TRIALS; GENOTYPE	It is a common occurrence in plant breeding programs to observe missing values in three-way three-mode multi-environment trial (MET) data. We proposed modifications of models for estimating missing observations for these data arrays, and developed a novel approach in terms of hierarchical clustering. Multiple imputation (MI) was used in four ways, multiple agglomerative hierarchical clustering, normal distribution model, normal regression model, and predictive mean match. The later three models used both Bayesian analysis and non-Bayesian analysis, while the first approach used a clustering procedure with randomly selected attributes and assigned real values from the nearest neighbour to the one with missing observations. Different proportions of data entries in six complete datasets were randomly selected to be missing and the MI methods were compared based on the efficiency and accuracy of estimating those values. The results indicated that the models using Bayesian analysis had slightly higher accuracy of estimation performance than those using non-Bayesian analysis but they were more time-consuming. However, the novel approach of multiple agglomerative hierarchical clustering demonstrated the overall best performances.	[Tian, Ting; Dieters, Mark J.; Basford, Kaye E.] Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld, Australia; [McLachlan, Geoffrey J.] Univ Queensland, Sch Math & Phys, Brisbane, Qld, Australia	University of Queensland; University of Queensland	Tian, T (corresponding author), Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld, Australia.	t.tian2@uq.edu.au	McLachlan, Geoffrey J/A-1491-2008; Basford, Kaye/T-9578-2019	McLachlan, Geoffrey J/0000-0002-5921-3145; Basford, Kaye/0000-0003-0955-4504	Monsanto Company	Monsanto Company	The funding for the PhD scholarship for Ms Ting Tian came from Monsanto Company, but there is no employment, patents, products in development, marketed products or any restrictions whatsoever on the research work reported in this manuscript. Unrestricted funding for a scholarship was the requirement for independent consultancy work by Professor Kaye Basford for Monsanto Company. She has no patents, products in development, or marketed products associated with that company. There are no competing interests in relation to the research being reported in this manuscript. This competing interests statement does not alter or impact on the authors' adherence to PLOS ONE policies on sharing data and materials.	[Anonymous], 2001, MISSING DATA; Basford KE, 1997, J STAT PLAN INFER, V57, P93, DOI 10.1016/S0378-3758(96)00038-9; BASFORD KE, 1990, THEOR APPL GENET, V79, P225, DOI 10.1007/BF00225956; Box G. E. P., 2011, BAYESIAN INFERENCE S; de la Vega AJ, 2002, FIELD CROP RES, V78, P165, DOI 10.1016/S0378-4290(02)00123-5; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Gelman A, 2006, BAYESIAN ANAL, V1, P515, DOI 10.1214/06-BA117A; Gilmour A., 2006, ASREML USER GUIDE RE; Kiers HAL, 2000, J CHEMOMETR, V14, P105, DOI 10.1002/1099-128X(200005/06)14:3<105::AID-CEM582>3.0.CO;2-I; Kim C.J., 1999, STATE SPACE MODELS R; Krishnan T, 1998, STAT MED, V17, P1187, DOI DOI 10.1002/(SICI)1097-0258(19980530)17:10<1187::AID-SIM849>3.0.CO;2-A; Kroonenberg PM, 2012, CURR ANAL CHEM, V8, P224; KROONENBERG PM, 1995, EUPHYTICA, V84, P31, DOI 10.1007/BF01677554; KROONENBERG PM, 1989, EUPHYTICA, V44, P109, DOI 10.1007/BF00022605; Little R. J. A., 1987, STAT ANAL; LITTLE RJA, 1988, J BUS ECON STAT, V6, P287, DOI 10.2307/1391878; Oba S, 2003, BIOINFORMATICS, V19, P2088, DOI 10.1093/bioinformatics/btg287; PATTERSON HD, 1971, BIOMETRIKA, V58, P545, DOI 10.1093/biomet/58.3.545; RUBIN DB, 1986, J BUS ECON STAT, V4, P87, DOI 10.2307/1391390; Rubin DB, 2004, MULTIPLE IMPUTATION; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schafer JL, 1997, ANAL INCOMPLETE MULT, V1st, DOI 10.1201/9781439821862; Soullier N, 2010, BMC MED RES METHODOL, V10, DOI 10.1186/1471-2288-10-79; Steele Russell J, 2010, Stat Methodol, V7, P351; TUCKER LR, 1966, PSYCHOMETRIKA, V31, P279, DOI 10.1007/BF02289464; van Buuren S., 2018, FLEXIBLE IMPUTATION, V2nd, DOI DOI 10.1201/9780429492259; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	29	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144370	10.1371/journal.pone.0144370	http://dx.doi.org/10.1371/journal.pone.0144370			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689369	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092300008
J	Shukla, SK; Cook, D; Meyer, J; Vernon, SD; Le, T; Clevidence, D; Robertson, CE; Schrodi, SJ; Yale, S; Frank, DN				Shukla, Sanjay K.; Cook, Dane; Meyer, Jacob; Vernon, Suzanne D.; Le, Thao; Clevidence, Derek; Robertson, Charles E.; Schrodi, Steven J.; Yale, Steven; Frank, Daniel N.			Changes in Gut and Plasma Microbiome following Exercise Challenge in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)	PLOS ONE			English	Article							GRAM-NEGATIVE ENTEROBACTERIA; NITROSATIVE STRESS; SYNDROME CFS; INFLAMMATORY PATHWAYS; LEAKY GUT; LPS; NORMALIZATION; TRANSLOCATION; RESPONSES; SYMPTOMS	Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a disease characterized by intense and debilitating fatigue not due to physical activity that has persisted for at least 6 months, post-exertional malaise, unrefreshing sleep, and accompanied by a number of secondary symptoms, including sore throat, memory and concentration impairment, headache, and muscle/joint pain. In patients with post-exertional malaise, significant worsening of symptoms occurs following physical exertion and exercise challenge serves as a useful method for identifying biomarkers for exertion intolerance. Evidence suggests that intestinal dysbiosis and systemic responses to gut microorganisms may play a role in the symptomology of ME/CFS. As such, we hypothesized that post-exertion worsening of ME/CFS symptoms could be due to increased bacterial translocation from the intestine into the systemic circulation. To test this hypothesis, we collected symptom reports and blood and stool samples from ten clinically characterized ME/CFS patients and ten matched healthy controls before and 15 minutes, 48 hours, and 72 hours after a maximal exercise challenge. Microbiomes of blood and stool samples were examined. Stool sample microbiomes differed between ME/CFS patients and healthy controls in the abundance of several major bacterial phyla. Following maximal exercise challenge, there was an increase in relative abundance of 6 of the 9 major bacterial phyla/genera in ME/CFS patients from baseline to 72 hours post-exercise compared to only 2 of the 9 phyla/genera in controls (p = 0.005). There was also a significant difference in clearance of specific bacterial phyla from blood following exercise with high levels of bacterial sequences maintained at 72 hours post-exercise in ME/CFS patients versus clearance in the controls. These results provide evidence for a systemic effect of an altered gut microbiome in ME/CFS patients compared to controls. Upon exercise challenge, there were significant changes in the abundance of major bacterial phyla in the gut in ME/CFS patients not observed in healthy controls. In addition, compared to controls clearance of bacteria from the blood was delayed in ME/CFS patients following exercise. These findings suggest a role for an altered gut microbiome and increased bacterial translocation following exercise in ME/CFS patients that may account for the profound post-exertional malaise experienced by ME/CFS patients.	[Shukla, Sanjay K.; Le, Thao; Schrodi, Steven J.] Marshfield Clin Res Fdn, Marshfield, WI 54449 USA; [Cook, Dane; Meyer, Jacob] William S Middleton Mem Vet Adm Med Ctr, Madison, WI USA; [Cook, Dane; Clevidence, Derek] Univ Wisconsin, Madison, WI USA; [Vernon, Suzanne D.] Bateman Horne Ctr Excellence, Salt Lake City, UT USA; [Robertson, Charles E.; Frank, Daniel N.] Univ Colorado Denver, Aurora, CO USA; [Yale, Steven] Marshfield Clin Fdn Med Res & Educ, Marshfield, WI USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); William S Middleton Memorial Veterans Hospital; University of Wisconsin System; University of Wisconsin Madison; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Marshfield Clinic	Shukla, SK (corresponding author), Marshfield Clin Res Fdn, Marshfield, WI 54449 USA.	shukla.sanjay@mcrf.mfldclin.edu	Meyer, Jacob/AAD-8057-2020; Schrodi, Steven J./O-4288-2019	Meyer, Jacob/0000-0003-3180-5728; Schrodi, Steven J./0000-0003-2304-8528; ROBERTSON, CHARLES/0000-0002-4136-4121	CFIDS Association of America; Marshfield Clinic Research Foundation	CFIDS Association of America; Marshfield Clinic Research Foundation	This study was funded from a grant from The CFIDS Association of America to SKS and donors to the Marshfield Clinic Research Foundation. The funding agency has no role in the study design or in the preparation of the manuscript.	Benitez-Paez A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057782; Centers for Disease Control and Prevention, CHRONIC FATIGUE SYND; Clarke SF, 2014, GUT, V63, P1913, DOI 10.1136/gutjnl-2013-306541; Cohen J., 1988, STAT POWER ANAL BEHA, V2nd; Cook DB, 2012, MED SCI SPORT EXER, V44, P1186, DOI 10.1249/MSS.0b013e3182417b9a; Cook DB, 2003, MED SCI SPORT EXER, V35, P563, DOI 10.1249/01.MSS.0000058360.61448.6C; Maranduba CMD, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/931574; Evans CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092193; Frank DN, 2012, JAIDS-J ACQ IMM DEF, V60, P299, DOI 10.1097/QAI.0b013e31824e4bdb; Frank DN, 2011, TRENDS MICROBIOL, V19, P427, DOI 10.1016/j.tim.2011.06.005; Frank JA, 2008, APPL ENVIRON MICROB, V74, P2461, DOI 10.1128/AEM.02272-07; Fremont M, 2013, ANAEROBE, V22, P50, DOI 10.1016/j.anaerobe.2013.06.002; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Ianiro G, 2014, CURR DRUG TARGETS, V15, P762, DOI 10.2174/1389450115666140606111402; Jason Leonard A, 2008, Dyn Med, V7, P6, DOI 10.1186/1476-5918-7-6; Krebs NF, 2013, J PEDIATR-US, V163, P416, DOI 10.1016/j.jpeds.2013.01.024; Lakhan SE, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-79; Lambert JE, 2015, APPL PHYSIOL NUTR ME, V40, P749, DOI 10.1139/apnm-2014-0452; Lee TH, 2000, GASTROINTEST ENDOSC, V52, P223, DOI 10.1067/mge.2000.107718; Li E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026284; Light AR, 2009, J PAIN, V10, P1099, DOI 10.1016/j.jpain.2009.06.003; Maes M, 2007, NEUROENDOCRINOL LETT, V28, P739; Maes M, 2007, J AFFECT DISORDERS, V99, P237, DOI 10.1016/j.jad.2006.08.021; Maes M, 2014, NEUROENDOCRINOL LETT, V35, P445; Maes M, 2013, J AFFECT DISORDERS, V150, P223, DOI 10.1016/j.jad.2013.03.029; Maes M, 2012, PSYCHIAT RES, V200, P754, DOI 10.1016/j.psychres.2012.03.031; Maes M, 2012, J AFFECT DISORDERS, V136, P909, DOI 10.1016/j.jad.2011.09.010; Maes M, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-35; Maes M, 2008, NEUROENDOCRINOL LETT, V29, P902; Maes M, 2009, CURR OPIN PSYCHIATR, V22, P75, DOI 10.1097/YCO.0b013e32831a4728; Mayer EA, 2015, J CLIN INVEST, V125, P926, DOI 10.1172/JCI76304; McNair D. M, 1992, PROFILE MOOD STATES; MELZACK R, 1987, PAIN, V30, P191, DOI 10.1016/0304-3959(87)91074-8; Meyer JD, 2013, FATIGUE, V1, P190, DOI 10.1080/21641846.2013.838444; Mika A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125889; Morris G, 2016, MOL NEUROBIOL, V53, P4638, DOI 10.1007/s12035-015-9392-y; Morris G, 2014, CURR NEUROPHARMACOL, V12, P168, DOI 10.2174/1570159X11666131120224653; Morris G, 2014, MOL NEUROBIOL, V49, P741, DOI 10.1007/s12035-013-8553-0; Morris G, 2014, METAB BRAIN DIS, V29, P19, DOI 10.1007/s11011-013-9435-x; Morris G, 2013, METAB BRAIN DIS, V28, P523, DOI 10.1007/s11011-012-9324-8; Morris G, 2013, NEUROENDOCRINOL LETT, V34, P185; Natelson BH, 2002, CLIN DIAGN LAB IMMUN, V9, P747, DOI 10.1128/CDLI.9.4.747-752.2002; Nijs J, 2014, EXERC IMMUNOL REV, V20, P94; O'Connor PJ, 2006, NUTR REV, V64, pS7, DOI 10.1111/j.1753-4887.2006.tb00256.x; O'Sullivan O, 2015, GUT MICROBES, V6, P131, DOI 10.1080/19490976.2015.1011875; Proal AD, 2013, IMMUNOL RES, V56, P398, DOI 10.1007/s12026-013-8413-z; Ramakrishnan VR, 2015, J ALLERGY CLIN IMMUN; Rao AV, 2009, GUT PATHOG, V1, DOI 10.1186/1757-4749-1-6; Reynolds Kenneth J, 2004, Cost Eff Resour Alloc, V2, P4, DOI 10.1186/1478-7547-2-4; Robertson CE, 2013, BIOINFORMATICS, V29, P3100, DOI 10.1093/bioinformatics/btt526; Shukla SK, 2015, TRENDS MOL MED; SMETS EMA, 1995, J PSYCHOSOM RES, V39, P315, DOI 10.1016/0022-3999(94)00125-O; Solomon Laura, 2003, Health Qual Life Outcomes, V1, P48, DOI 10.1186/1477-7525-1-48; Wagner BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020296; Wagner Dieter, 2005, Popul Health Metr, V3, P8, DOI 10.1186/1478-7954-3-8; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; West CE, 2015, J ALLERGY CLIN IMMUN, V135, P3, DOI 10.1016/j.jaci.2014.11.012	57	64	71	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145453	10.1371/journal.pone.0145453	http://dx.doi.org/10.1371/journal.pone.0145453			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683192	Green Submitted, Green Published, gold			2022-12-26	WOS:000366725800078
J	Zhang, YJ; Wang, W; Yang, HL; Li, Y; Kang, XY; Wang, XR; Yang, ZL				Zhang, Yuan-Jie; Wang, Wei; Yang, Hai-Ling; Li, Yue; Kang, Xiang-Yang; Wang, Xiao-Ru; Yang, Zhi-Ling			Molecular Properties and Functional Divergence of the Dehydroascorbate Reductase Gene Family in Lower and Higher Plants	PLOS ONE			English	Article							ENHANCED TOLERANCE; GLUTATHIONE; EXPRESSION; INCREASES; TRANSPORT; ASCORBATE; PROTEINS; OZONE	Dehydroascorbate reductase (DHAR), which reduces oxidized ascorbate, is important for maintaining an appropriate ascorbate redox state in plant cells. To date, genome-wide molecular characterization of DHARs has only been conducted in bryophytes (Physcomitrella patens) and eudicots (e.g. Arabidopsis thaliana). In this study, to gain a general understanding of the molecular properties and functional divergence of the DHARs in land plants, we further conducted a comprehensive analysis of DHARs from the lycophyte Selaginella moellendorffii, gymnosperm Picea abies and monocot Zea mays. DHARs were present as a small gene family in all of the land plants we examined, with gene numbers ranging from two to four. All the plants contained cytosolic and chloroplastic DHARs, indicating dehydroascorbate (DHA) can be directly reduced in the cytoplasm and chloroplast by DHARs in all the plants. A novel vacuolar DHAR was found in Z. mays, indicating DHA may also be reduced in the vacuole by DHARs in Z. mays. The DHARs within each species showed extensive functional divergence in their gene structures, subcellular localizations, and enzymatic characteristics. This study provides new insights into the molecular characteristics and functional divergence of DHARs in land plants.	[Zhang, Yuan-Jie; Wang, Wei; Yang, Hai-Ling; Li, Yue; Kang, Xiang-Yang; Wang, Xiao-Ru; Yang, Zhi-Ling] Beijing Forestry Univ, Coll Biol Sci & Technol, Natl Engn Lab Tree Breeding, Beijing, Peoples R China	Beijing Forestry University	Yang, ZL (corresponding author), Beijing Forestry Univ, Coll Biol Sci & Technol, Natl Engn Lab Tree Breeding, Beijing, Peoples R China.	yang_zhiling@yahoo.com	Wang, Xiao-Ru/H-6811-2012	Wang, Xiao-Ru/0000-0002-6150-7046	Natural Science Foundation of China (NSFC) [31270641]	Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the Natural Science Foundation of China (NSFC 31270641). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boruc J, 2010, PLANT PHYSIOL, V152, P553, DOI 10.1104/pp.109.148643; Byun SA, 2013, GENOME BIOL EVOL, V5, P2402, DOI 10.1093/gbe/evt183; Chen Z, 2004, PLANT CELL, V16, P1143, DOI 10.1105/tpc.021584; Chen Z, 2006, PLANT PHYSIOL, V142, P775, DOI 10.1104/pp.106.085506; Dixon DP, 2002, J BIOL CHEM, V277, P30859, DOI 10.1074/jbc.M202919200; Eltayeb AE, 2006, PHYSIOL PLANTARUM, V127, P57, DOI 10.1111/j.1399-3054.2006.00624.x; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Horemans N, 2000, PLANT PHYSIOL BIOCH, V38, P531, DOI 10.1016/S0981-9428(00)00782-8; KERK NM, 1995, DEVELOPMENT, V121, P2825; Kim YS, 2014, J AGRON CROP SCI, V200, P444, DOI 10.1111/jac.12078; Kim YS, 2013, PLANTA, V237, P1613, DOI 10.1007/s00425-013-1862-8; Liu YJ, 2013, PLANT PHYSIOL, V161, P773, DOI 10.1104/pp.112.205815; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; RAUTENKRANZ AAF, 1994, PLANT PHYSIOL, V106, P187, DOI 10.1104/pp.106.1.187; Takahama Umeo, 2004, Phytochemistry Reviews, V3, P207, DOI 10.1023/B:PHYT.0000047805.08470.e3; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang ZX, 2013, MOL BIOL REP, V40, P5105, DOI 10.1007/s11033-013-2612-5; Yamasaki H, 1999, PLANT CELL PHYSIOL, V40, P640, DOI 10.1093/oxfordjournals.pcp.a029587; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Yoshida S, 2006, PLANT CELL PHYSIOL, V47, P304, DOI 10.1093/pcp/pci246; Yuen WK, 2001, COMP BIOCHEM PHYS A, V129, P631, DOI 10.1016/S1095-6433(01)00327-0	21	9	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145038	10.1371/journal.pone.0145038	http://dx.doi.org/10.1371/journal.pone.0145038			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684301	Green Published, Green Submitted, gold			2022-12-26	WOS:000366725800032
J	Freyler, K; Gollhofer, A; Colin, R; Bruderlin, U; Ritzmann, R				Freyler, Kathrin; Gollhofer, Albert; Colin, Ralf; Bruederlin, Uli; Ritzmann, Ramona			Reactive Balance Control in Response to Perturbation in Unilateral Stance: Interaction Effects of Direction, Displacement and Velocity on Compensatory Neuromuscular and Kinematic Responses	PLOS ONE			English	Article							POSTURAL RESPONSES; STRETCH REFLEX; SUDDEN TORQUES; CENTRAL SET; PLATFORM; ADAPTATION; CONTRIBUTE; MOVEMENTS; INSIGHTS; MUSCLES	Unexpected sudden perturbations challenge postural equilibrium and require reactive compensation. This study aimed to assess interaction effects of the direction, displacement and velocity of perturbations on electromyographic (EMG) activity, centre of pressure (COP) displacement and joint kinematics to detect neuromuscular characteristics (phasic and segmental) and kinematic strategies of compensatory reactions in an unilateral balance paradigm. In 20 subjects, COP displacement and velocity, ankle, knee and hip joint excursions and EMG during short (SLR), medium (MLR) and long latency response (LLR) of four shank and five thigh muscles were analysed during random surface translations varying in direction (anterior-posterior (sagittal plane), medial-lateral (frontal plane)), displacement (2 vs. 3cm) and velocity (0.11 vs. 0.18m/s) of perturbation when balancing on one leg on a movable platform. Phases: SLR and MLR were scaled to increased velocity (P<0.05); LLR was scaled to increased displacement (P<0.05). Segments: phasic interrelationships were accompanied by segmental distinctions: distal muscles were used for fast compensation in SLR (P<0.05) and proximal muscles to stabilise in LLR (P<0.05). Kinematics: ankle joints compensated for both increasing displacement and velocity in all directions (P<0.05), whereas knee joint deflections were particularly sensitive to increasing displacement in the sagittal (P<0.05) and hip joint deflections to increasing velocity in the frontal plane (P<0.05). COP measures increased with increasing perturbation velocity and displacement (P<0.05). Interaction effects indicate that compensatory responses are based on complex processes, including different postural strategies characterised by phasic and segmental specifications, precisely adjusted to the type of balance disturbance. To regain balance after surface translation, muscles of the distal segment govern the quick regain of equilibrium; the muscles of the proximal limb serve as delayed stabilisers after a balance disturbance. Further, a kinematic distinction regarding the compensation for balance disturbance indicated different plane- and segment-specific sensitivities with respect to the determinants displacement and velocity.	[Freyler, Kathrin; Gollhofer, Albert; Ritzmann, Ramona] Univ Freiburg, Dept Sport & Sport Sci, D-79106 Freiburg, Germany; [Colin, Ralf; Bruederlin, Uli] Univ Appl Sci, Dept Mechatron, Esslingen, Germany	University of Freiburg	Freyler, K (corresponding author), Univ Freiburg, Dept Sport & Sport Sci, Hugstetter Str 55, D-79106 Freiburg, Germany.	kathrin.freyler@sport.uni-freiburg.de	Gollhofer, Albert/ABF-5766-2020; Albert, Gollhofer/V-3291-2019		German Aerospace Center [DLR 50WB1120]; German Ministry of Economy and Technology (ZIM Project) [KF2168712RR2]; Albert-Ludwigs-University Freiburg	German Aerospace Center(Helmholtz AssociationGerman Aerospace Centre (DLR)); German Ministry of Economy and Technology (ZIM Project); Albert-Ludwigs-University Freiburg	This study was funded by the German Aerospace Center (DLR 50WB1120) and German Ministry of Economy and Technology (ZIM Project KF2168712RR2). The article processing charge was funded by the open access publication fund of the Albert-Ludwigs-University Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Bhatt T, 2009, J NEUROPHYSIOL, V101, P948, DOI 10.1152/jn.91004.2008; BLAKE AJ, 1988, AGE AGEING, V17, P365, DOI 10.1093/ageing/17.6.365; Boeer J, 2010, SPORTVERLETZ SPORTSC, V24, P40, DOI 10.1055/s-0029-1245184; Boeer J, 2010, J GERIATR PHYS THER, V33, P10, DOI 10.1097/JPT.0b013e3181d0720e; Brown LA, 2001, GAIT POSTURE, V14, P256, DOI 10.1016/S0966-6362(01)00131-X; Chomiak Taylor, 2015, J Clin Med Res, V7, P182, DOI 10.14740/jocmr1878w; d'Avella A, 2008, J NEUROPHYSIOL, V100, P1433, DOI 10.1152/jn.01377.2007; Di Giulio I, 2013, J APPL PHYSIOL, V114, P1717, DOI 10.1152/japplphysiol.01299.2012; DIENER HC, 1985, ELECTROEN CLIN NEURO, V60, P407, DOI 10.1016/0013-4694(85)91014-4; DIENER HC, 1988, J NEUROPHYSIOL, V59, P1888, DOI 10.1152/jn.1988.59.6.1888; DIENER HC, 1984, EXP BRAIN RES, V56, P126; DIETZ V, 1988, NEUROSCI LETT, V94, P82, DOI 10.1016/0304-3940(88)90274-1; DIETZ V, 1985, EXP BRAIN RES, V57, P348; DIETZ V, 1991, NEUROSCI LETT, V126, P71, DOI 10.1016/0304-3940(91)90374-3; DIETZ V, 1992, PHYSIOL REV, V72, P33, DOI 10.1152/physrev.1992.72.1.33; DIETZ V, 1989, J NEUROPHYSIOL, V62, P680, DOI 10.1152/jn.1989.62.3.680; Giboin L, 2015, HUMAN MOVEMENT SCI, P4422; GOLLHOFER A, 1993, EUR J APPL PHYSIOL, V66, P415, DOI 10.1007/BF00599614; GOLLHOFER A, 1989, NEUROSCI LETT, V105, P73, DOI 10.1016/0304-3940(89)90014-1; GOTTLIEB GL, 1979, J NEUROPHYSIOL, V42, P91, DOI 10.1152/jn.1979.42.1.91; GOTTLIEB GL, 1981, J NEUROPHYSIOL, V46, P179, DOI 10.1152/jn.1981.46.1.179; Grey MJ, 2001, J PHYSIOL-LONDON, V534, P925, DOI 10.1111/j.1469-7793.2001.00925.x; Henry SM, 1998, J NEUROPHYSIOL, V80, P1939, DOI 10.1152/jn.1998.80.4.1939; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Honeycutt CF, 2012, J NEUROPHYSIOL, V108, P1253, DOI 10.1152/jn.00929.2011; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; HORAK FB, 1994, J NEUROPHYSIOL, V72, P479, DOI 10.1152/jn.1994.72.2.479; Horak FB, 1997, PHYS THER, V77, P517, DOI 10.1093/ptj/77.5.517; HORAK FB, 1989, J NEUROPHYSIOL, V62, P841, DOI 10.1152/jn.1989.62.4.841; HUGHES MA, 1995, CLIN BIOMECH, V10, P318, DOI 10.1016/0268-0033(94)00001-N; Jacobs JV, 2007, J NEURAL TRANSM, V114, P1339, DOI 10.1007/s00702-007-0657-0; Labanca L, 2015, EUR J APPL PHYSIOL, V115, P1441, DOI 10.1007/s00421-015-3126-8; da Costa PHL, 2013, GAIT POSTURE, V37, P419, DOI 10.1016/j.gaitpost.2012.08.015; Mergner T, 1998, BRAIN RES REV, V28, P118, DOI 10.1016/S0165-0173(98)00032-0; MOORE SP, 1988, EXP BRAIN RES, V73, P648, DOI 10.1007/BF00406624; Murnaghan CD, 2013, HUM MOVEMENT SCI, V32, P857, DOI 10.1016/j.humov.2013.07.002; NARDONE A, 1990, EXP BRAIN RES, V80, P323; NASHNER LM, 1977, EXP BRAIN RES, V30, P13; Nijhuis LBO, 2007, J NEUROPHYSIOL, V98, P3047, DOI 10.1152/jn.01303.2006; Richardson JK, 1996, ARCH PHYS MED REHAB, V77, P1152, DOI 10.1016/S0003-9993(96)90139-2; Rinalduzzi S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/434683; Ritzmann R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128400; Roelants M, 2006, J STRENGTH COND RES, V20, P124, DOI 10.1519/R-16674.1; Runge CF, 1999, GAIT POSTURE, V10, P161, DOI 10.1016/S0966-6362(99)00032-6; Strang AJ, 2011, EUR J APPL PHYSIOL, V111, P1485, DOI 10.1007/s00421-010-1770-6; Taube W, 2006, J APPL PHYSIOL, V101, P420, DOI 10.1152/japplphysiol.01447.2005; Tokuno CD, 2006, EXP BRAIN RES, V174, P19, DOI 10.1007/s00221-006-0414-x; Wiley ME, 1998, DEV MED CHILD NEUROL, V40, P100, DOI 10.1111/j.1469-8749.1998.tb15369.x; Winter D.A., 1995, GAIT POSTURE, V3, P193, DOI 10.1016/0966-6362(96)82849-9	49	25	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144529	10.1371/journal.pone.0144529	http://dx.doi.org/10.1371/journal.pone.0144529			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678061	Green Published, Green Submitted, gold			2022-12-26	WOS:000366723400018
J	Kasaie, P; Mathema, B; Kelton, WD; Azman, AS; Pennington, J; Dowdy, DW				Kasaie, Parastu; Mathema, Barun; Kelton, W. David; Azman, Andrew S.; Pennington, Jeff; Dowdy, David W.			A Novel Tool Improves Existing Estimates of Recent Tuberculosis Transmission in Settings of Sparse Data Collection	PLOS ONE			English	Article							NEW-YORK-CITY; MOLECULAR EPIDEMIOLOGY; LATENT TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; SOUTH-AFRICA; INFECTION; RISK; PROPORTION; PATTERNS; DISEASE	In any setting, a proportion of incident active tuberculosis (TB) reflects recent transmission ("recent transmission proportion"), whereas the remainder represents reactivation. Appropriately estimating the recent transmission proportion has important implications for local TB control, but existing approaches have known biases, especially where data are incomplete. We constructed a stochastic individual-based model of a TB epidemic and designed a set of simulations (derivation set) to develop two regression-based tools for estimating the recent transmission proportion from five inputs: underlying TB incidence, sampling coverage, study duration, clustered proportion of observed cases, and proportion of observed clusters in the sample. We tested these tools on a set of unrelated simulations (validation set), and compared their performance against that of the traditional 'n-1' approach. In the validation set, the regression tools reduced the absolute estimation bias (difference between estimated and true recent transmission proportion) in the 'n-1' technique by a median [interquartile range] of 60% [9%, 82%] and 69% [30%, 87%]. The bias in the 'n-1' model was highly sensitive to underlying levels of study coverage and duration, and substantially underestimated the recent transmission proportion in settings of incomplete data coverage. By contrast, the regression models' performance was more consistent across different epidemiological settings and study characteristics. We provide one of these regression models as a user-friendly, web-based tool. Novel tools can improve our ability to estimate the recent TB transmission proportion from data that are observable (or estimable) by public health practitioners with limited available molecular data.	[Kasaie, Parastu; Azman, Andrew S.; Pennington, Jeff; Dowdy, David W.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA; [Mathema, Barun] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Kelton, W. David] Univ Cincinnati, Dept Operat Business Analyt & Informat Syst, Cincinnati, OH USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Columbia University; University System of Ohio; University of Cincinnati	Dowdy, DW (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21218 USA.	ddowdy@jhsph.edu	Kasaie, Parastu/AAD-1960-2021	Mathema, Barun/0000-0003-2772-479X; Azman, Andrew/0000-0001-8662-9077	Johns Hopkins University Center for AIDS Research, an NIH [P30AI094189]; NIH; NIAID; NCI; NICHD; NHLBI; NIDA; NIMH; NIA; FIC; NIGMS; NIDDK; OAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI094189] Funding Source: NIH RePORTER	Johns Hopkins University Center for AIDS Research, an NIH; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); FIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OAR; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by B. Frank and Kathleen Polk Assistant Professorship in Epidemiology, Johns Hopkins Bloomberg School of Public Health [DWD, ASA, PK]. This research was funded in part by a 2015 developmental grant from the Johns Hopkins University Center for AIDS Research, an NIH funded program (P30AI094189), which is supported by the following NIH Co-Funding and Participating Institutes and Centers: NIAID, NCI, NICHD, NHLBI, NIDA, NIMH, NIA, FIC, NIGMS, NIDDK, and OAR. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	ALLAND D, 1994, NEW ENGL J MED, V330, P1710, DOI 10.1056/NEJM199406163302403; Anderson LF, 2014, LANCET INFECT DIS, V14, P406, DOI 10.1016/S1473-3099(14)70022-2; Andrews JR, 2012, CLIN INFECT DIS, V54, P784, DOI 10.1093/cid/cir951; Azman AS, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0216-0; Badri M, 2002, LANCET, V359, P2059, DOI 10.1016/S0140-6736(02)08904-3; Benedetti A, 2010, AM J EPIDEMIOL, V172, P318, DOI 10.1093/aje/kwq124; Bishai WR, 1998, JAMA-J AM MED ASSOC, V280, P1679, DOI 10.1001/jama.280.19.1679; Driver CR, 2007, EPIDEMIOL INFECT, V135, P634, DOI 10.1017/S0950268806007278; Fok A, 2008, INT J TUBERC LUNG D, V12, P480; GENEWEIN A, 1993, LANCET, V342, P841, DOI 10.1016/0140-6736(93)92698-S; Geng E, 2002, NEW ENGL J MED, V346, P1453, DOI 10.1056/NEJMoa012972; Glynn JR, 1999, INT J TUBERC LUNG D, V3, P1055; Glynn JR, 1999, AM J EPIDEMIOL, V149, P366, DOI 10.1093/oxfordjournals.aje.a009822; Golub JE, 2008, JAIDS-J ACQ IMM DEF, V49, P532, DOI 10.1097/QAI.0b013e31818d5c1c; Grabowski MK, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001610; Guerra-Assuncao JA, 2015, ELIFE, V4, DOI 10.7554/eLife.05166; Hollm-Delgado MG, 2009, SOC SCI MED, V69, P747, DOI 10.1016/j.socscimed.2009.06.043; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; Houben RMGJ, 2009, TROP MED INT HEALTH, V14, P892, DOI 10.1111/j.1365-3156.2009.02316.x; Houben RMGJ, 2014, AM J EPIDEMIOL; Jasmer RM, 2002, NEW ENGL J MED, V347, P1860, DOI 10.1056/NEJMcp021045; Kasaie P, 2014, BETTER N 1 MODEL EST; Kasaie P, 2014, WINT SIMUL C PROC, P1469, DOI 10.1109/WSC.2014.7020000; Kouyos RD, 2014, INT J EPIDEMIOL; Lin PL, 2010, J IMMUNOL, V185, P15, DOI 10.4049/jimmunol.0903856; Mahony AA, 2013, MED J AUSTRALIA, V198, P210, DOI 10.5694/mja12.10556; Mathema B, 2014, ANN AM THORAC SOC; Mathema B, 2006, CLIN MICROBIOL REV, V19, P658, DOI 10.1128/CMR.00061-05; MCKENNA MT, 1995, NEW ENGL J MED, V332, P1071, DOI 10.1056/NEJM199504203321606; Meissner JS, 2012, AM J RESP CRIT CARE, V185; Middelkoop K, 2015, J INFECT DIS, V211, P53, DOI 10.1093/infdis/jiu403; Moonan PK, 2012, EMERG INFECT DIS, V18, P458, DOI 10.3201/eid1803.111107; Morrison J, 2008, LANCET INFECT DIS, V8, P359, DOI 10.1016/S1473-3099(08)70071-9; Murray M, 2002, EMERG INFECT DIS, V8, P363, DOI 10.3201/eid0804.000444; Murray M, 2002, P NATL ACAD SCI USA, V99, P1538, DOI 10.1073/pnas.022618299; Murray M, 2002, AM J EPIDEMIOL, V155, P565, DOI 10.1093/aje/155.6.565; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Roetzer A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001387; Sanchez MA, 1997, AM J EPIDEMIOL, V145, P1127; Schurch AC, 2012, INFECT GENET EVOL, V12, P602, DOI 10.1016/j.meegid.2011.08.032; SMALL PM, 1994, NEW ENGL J MED, V330, P1703, DOI 10.1056/NEJM199406163302402; SUTHERLAND I, 1982, TUBERCLE, V63, P255, DOI 10.1016/S0041-3879(82)80013-5; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; van Deutekom H, 2004, AM J RESP CRIT CARE, V169, P806, DOI 10.1164/rccm.200306-856OC; van Soolingen D, 1999, J INFECT DIS, V180, P726, DOI 10.1086/314930; Verver S, 2004, LANCET, V363, P212, DOI 10.1016/S0140-6736(03)15332-9; Vynnycky E, 1997, EPIDEMIOL INFECT, V119, P183, DOI 10.1017/S0950268897007917; Vynnycky E, 2001, EPIDEMIOL INFECT, V126, P43, DOI 10.1017/S095026880100499X; World Health Organization, 2013, GLOB TB REP; World Health Organization, 2013, WHO TB BURD EST	50	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144137	10.1371/journal.pone.0144137	http://dx.doi.org/10.1371/journal.pone.0144137			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26679499	gold, Green Submitted, Green Published			2022-12-26	WOS:000366723400008
J	Broell, F; Taggart, CT				Broell, Franziska; Taggart, Christopher T.			Scaling in Free-Swimming Fish and Implications for Measuring Size-at-Time in the Wild	PLOS ONE			English	Article							SAITHE POLLACHIUS-VIRENS; ACCELERATION DATA-LOGGER; TAIL BEAT; ACIPENSER-BREVIROSTRUM; SHORTNOSE STURGEON; STROKE FREQUENCY; SPEED; OTOLITHS; KINEMATICS; BEHAVIOR	This study was motivated by the need to measure size-at-age, and thus growth rate, in fish in the wild. We postulated that this could be achieved using accelerometer tags based first on early isometric scaling models that hypothesize that similar animals should move at the same speed with a stroke frequency that scales with length-(1), and second on observations that the speed of primarily air-breathing free-swimming animals, presumably swimming 'efficiently',is independent of size, confirming that stroke frequency scales as length-(1). However, such scaling relations between size and swimming parameters for fish remain mostly theoretical. Based on free-swimming saithe and sturgeon tagged with accelerometers, we introduce a species-specific scaling relationship between dominant tail beat frequency (TBF) and fork length. Dominant TBF was proportional to length-(1) ( r(2) = 0.73, n = 40), and estimated swimming speed within species was independent of length. Similar scaling relations accrued in relation to body mass(-0.29). We demonstrate that the dominant TBF can be used to estimate size-at-time and that accelerometer tags with onboard processing may be able to provide size-at-time estimates among free-swimming fish and thus the estimation of growth rate (change in size-at-time) in the wild.	[Broell, Franziska; Taggart, Christopher T.] Dalhousie Univ, Dept Oceanog, Halifax, NS B3H 4R2, Canada	Dalhousie University	Broell, F (corresponding author), Dalhousie Univ, Dept Oceanog, 1355 Oxford St, Halifax, NS B3H 4R2, Canada.	franziskabroell@dal.ca			OTN Canada; Natural Sciences and Engineering Research Council of Canada (NSERC) [NETGP 375118 - 08]	OTN Canada; Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by OTN Canada (oceantrackingnetwork.org) - Natural Sciences and Engineering Research Council of Canada (NSERC Strategic Network Grant; NETGP 375118 - 08) funding to CTT and FB.	Aitken A. C., 1936, P ROY SOC EDINB, V55, P42, DOI [10.1017/s0370164600014346, DOI 10.1017/S0370164600014346]; [Anonymous], MATLAB R2012A NAT; BAINBRIDGE R, 1958, J EXP BIOL, V35, P109; BAINBRIDGE RICHARD, 1961, SYMPOSIA ZOOL SOC LONDON, V5, P13; Broell F, 2013, J EXP BIOL, V216, P1255, DOI 10.1242/jeb.077396; Burnham KP, 2002, J APPL STAT, V29, P245, DOI 10.1080/02664760120108755; CAMPANA SE, 1990, CAN J FISH AQUAT SCI, V47, P2219, DOI 10.1139/f90-246; CAMPANA SE, 1985, CAN J FISH AQUAT SCI, V42, P1014, DOI 10.1139/f85-127; Cargnelli LM, 1999, NMFSNE131 NOAA; Chattopadhyay S, 2006, P NATL ACAD SCI USA, V103, P13712, DOI 10.1073/pnas.0602043103; Cheng JY, 1998, PHILOS T ROY SOC B, V353, P981, DOI 10.1098/rstb.1998.0262; Christiansen P, 1999, J MORPHOL, V239, P167, DOI 10.1002/(SICI)1097-4687(199902)239:2<167::AID-JMOR5>3.3.CO;2-#; DADSWELL MJ, 1979, CAN J ZOOL, V57, P2186, DOI 10.1139/z79-287; Deslauriers D, 2012, CAN J ZOOL, V90, P345, DOI 10.1139/Z2012-004; Domenici P, 1997, J EXP BIOL, V200, P1165; Faust MD, 2013, J FISH WILDL MANAG, V4, P332, DOI 10.3996/062013-JFWM-041; Gazzola M, 2014, NAT PHYS, V10, P758, DOI 10.1038/NPHYS3078; Glazier DS, 2005, BIOL REV, V80, P611, DOI 10.1017/S1464793105006834; Gray J., 1968, ANIMAL LOCOMOTION; HESS F, 1984, J EXP BIOL, V109, P229; Hill A. V., 1950, Science Progress London, V38, P209; Kawabe R, 2003, FISHERIES SCI, V69, P959, DOI 10.1046/j.1444-2906.2003.00713.x; Kawabe R, 2003, FISHERIES SCI, V69, P3, DOI 10.1046/j.1444-2906.2003.00581.x; KEDEM B, 1986, P IEEE, V74, P1477, DOI 10.1109/PROC.1986.13663; Kohannim S, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.1073; LONG JH, 1995, ENVIRON BIOL FISH, V44, P199, DOI 10.1007/BF00005916; Motani R, 2002, NATURE, V415, P309, DOI 10.1038/415309a; Neuheimer AB, 2007, CAN J FISH AQUAT SCI, V64, P375, DOI 10.1139/F07-003; Noda T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079392; PANFILI J, 1992, J FISH BIOL, V41, P201, DOI 10.1111/j.1095-8649.1992.tb02650.x; PANNELLA G, 1971, SCIENCE, V173, P1124, DOI 10.1126/science.173.4002.1124; Pedley T.J, 1977, SCALE EFFECTS ANIMAL; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Robinson MP, 2002, J ZOOL, V256, P449, DOI 10.1017/S0952836902000493; Sardenne F, 2015, FISH RES, V163, P44, DOI 10.1016/j.fishres.2014.03.008; Sato K, 2007, P R SOC B, V274, P471, DOI 10.1098/rspb.2006.0005; Sato K, 2010, P R SOC B, V277, P707, DOI 10.1098/rspb.2009.1515; Sato K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005400; STASKO AB, 1976, J FISH RES BOARD CAN, V33, P2596, DOI 10.1139/f76-305; Stein, 2000, DIGIT SIGNAL PROCESS; Steinhausen MF, 2005, MAR BIOL, V148, P197, DOI 10.1007/s00227-005-0055-9; Taylor GK, 2014, OX ECOL EV, P1, DOI 10.1093/acprof:oso/9780198566373.001.0001; Toro E, 2003, J EXP BIOL, V206, P2641, DOI 10.1242/jeb.00473; Tsuda Y, 2006, ECOL FRESHW FISH, V15, P264, DOI 10.1111/j.1600-0633.2006.00147.x; van Ginneken V, 2005, J EXP BIOL, V208, P1329, DOI 10.1242/jeb.01524; van Leeuwen JL, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0479; Videler J.J., 1991, Reviews in Fish Biology and Fisheries, V1, P23, DOI 10.1007/BF00042660; VIDELER JJ, 1984, J EXP BIOL, V109, P209; Watanabe Y, 2008, J ZOOL, V275, P381, DOI 10.1111/j.1469-7998.2008.00451.x; Webb P.W., 1975, B FISH RES BOARD CAN, V190, P1, DOI DOI 10.1002/RRA.1371; WEBB PW, 1986, CAN J ZOOL, V64, P2137, DOI 10.1139/z86-328; Webb PW, 1976, FISH PHYSL, V7; Wu T. Y.-T., 1971, ADV APPL MECH, V11, P1	55	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144875	10.1371/journal.pone.0144875	http://dx.doi.org/10.1371/journal.pone.0144875			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673777	Green Submitted, gold, Green Published			2022-12-26	WOS:000366722700069
J	Bruggeman, DJ				Bruggeman, Douglas J.			The Value of Learning about Natural History in Biodiversity Markets	PLOS ONE			English	Article							RED-COCKADED WOODPECKER; HABITAT FRAGMENTATION; POPULATION-DYNAMICS; DISPERSAL; MODELS; RESISTANCE; INDEXES; RISK	Markets for biodiversity have generated much controversy because of the often unstated and untested assumptions included in transactions rules. Simple trading rules are favored to reduce transaction costs, but others have argued that this leads to markets that favor development and erode biodiversity. Here, I describe how embracing complexity and uncertainty within a tradable credit system for the Red-cockaded Woodpecker (Picoides borealis) creates opportunities to achieve financial and conservation goals simultaneously. Reversing the effects of habitat fragmentation is one of the main reasons for developing markets. I include uncertainty in habitat fragmentation effects by evaluating market transactions using five alternative dispersal models that were able to approximate observed patterns of occupancy and movement. Further, because dispersal habitat is often not included in market transactions, I contrast how changes in breeding versus dispersal habitat affect credit values. I use an individually-based, spatially-explicit population model for the Red-cockaded Woodpecker (Picoides borealis) to predict spatial-and temporal-influences of landscape change on species occurrence and genetic diversity. Results indicated that the probability of no net loss of abundance and genetic diversity responded differently to the transient dynamics in breeding and dispersal habitat. Trades that do not violate the abundance cap may simultaneously violate the cap for the erosion of genetic diversity. To highlight how economic incentives may help reduce uncertainty, I demonstrate tradeoffs between the value of tradable credits and the value of information needed to predict the influence of habitat trades on population viability. For the trade with the greatest uncertainty regarding the change in habitat fragmentation, I estimate that the value of using 13-years of data to reduce uncertainty in dispersal behaviors is $6.2 million. Future guidance for biodiversity markets should at least encourage the use of spatially-and temporally-explicit techniques that include population genetic estimates and the influence of uncertainty.	[Bruggeman, Douglas J.] Ecol Serv & Markets Inc, Marshall, NC 28753 USA		Bruggeman, DJ (corresponding author), Ecol Serv & Markets Inc, Marshall, NC 28753 USA.	dougbrugg@gmail.com			Ecological Services and Markets, Inc. (ESaM)	Ecological Services and Markets, Inc. (ESaM)	Ecological Services and Markets, Inc. (ESaM;esmarkets.com) funded this study. ESaM had sole responsibility for study design, analysis, decision to publish, and preparation of the manuscript.	Armsworth PR, 2006, P NATL ACAD SCI USA, V103, P5403, DOI 10.1073/pnas.0505278103; Beissinger SR, 1998, J WILDLIFE MANAGE, V62, P821, DOI 10.2307/3802534; Bouzat JL, 2000, GENETICA, V110, P109, DOI 10.1023/A:1017985522650; Bruggeman DJ, 2005, ENVIRON MANAGE, V36, P518, DOI 10.1007/s00267-004-0239-y; Bruggeman DJ, 2014, DEV ADAPTIVE MANAGEM; Bruggeman DJ, 2008, ENVIRON MANAGE, V42, P591, DOI 10.1007/s00267-008-9179-2; Bruggeman DJ, 2014, LANDSCAPE ECOL, V29, P639, DOI 10.1007/s10980-014-0011-5; Bruggeman DJ, 2010, MOL ECOL, V19, P3679, DOI 10.1111/j.1365-294X.2010.04659.x; Bruggeman DJ, 2009, LANDSCAPE ECOL, V24, P775, DOI 10.1007/s10980-009-9351-y; Clemen R.T, 2001, MAKING HARD DECISION; Cosentino BJ, 2012, P ROY SOC B-BIOL SCI, V279, P1575, DOI 10.1098/rspb.2011.1880; Cushman SA, 2012, LANDSCAPE ECOL, V27, P369, DOI 10.1007/s10980-011-9693-0; Ferraro PJ, 2006, PLOS BIOL, V4, P482, DOI 10.1371/journal.pbio.0040105; Fisher B, 2009, ECOL ECON, V68, P643, DOI 10.1016/j.ecolecon.2008.09.014; Fox J, 2005, CONSERV BIOL, V19, P996, DOI 10.1111/j.1523-1739.2005.00231.x; Goss-Custard JD, 2006, ECOL APPL, V16, P2215, DOI 10.1890/1051-0761(2006)016[2215:TOABIM]2.0.CO;2; Grantham HS, 2009, ECOL LETT, V12, P293, DOI 10.1111/j.1461-0248.2009.01287.x; Grimm V, 1999, ECOL MODEL, V115, P129, DOI 10.1016/S0304-3800(98)00188-4; Grimm V, 2010, ECOL MODEL, V221, P2760, DOI 10.1016/j.ecolmodel.2010.08.019; Horan RD, 2005, J ECON BEHAV ORGAN, V58, P1, DOI 10.1016/j.jebo.2004.03.009; Jepsen JU, 2005, ECOL MODEL, V181, P445, DOI 10.1016/j.ecolmodel.2003.11.019; Jones CA, 1997, CONTEMP ECON POLICY, V15, P111, DOI 10.1111/j.1465-7287.1997.tb00494.x; Kesler DC, 2010, BEHAV ECOL, V21, P1337, DOI 10.1093/beheco/arq158; Letcher BH, 1998, BIOL CONSERV, V86, P1, DOI 10.1016/S0006-3207(98)00019-6; Lewis DJ, 2009, AM J AGR ECON, V91, P1080, DOI 10.1111/j.1467-8276.2009.01310.x; Lindenmayer DB, 2007, TRENDS ECOL EVOL, V22, P127, DOI 10.1016/j.tree.2006.11.006; Loomis JB, 1996, ECOL ECON, V18, P197, DOI 10.1016/0921-8009(96)00029-8; Mac Nally R, 2000, BIOL CONSERV, V95, P7, DOI 10.1016/S0006-3207(00)00017-3; Madsen B., 2010, STATE BIODIVERSITY M; Manly BFJ, 1986, RANDOMIZATION BOOTST; Margules CR, 2000, NATURE, V405, P243, DOI 10.1038/35012251; Maron M, 2012, BIOL CONSERV, V155, P141, DOI 10.1016/j.biocon.2012.06.003; Meffe GK, 1996, BIODIVERSITY MANAGED; Minor ES, 2007, ECOL APPL, V17, P1771, DOI 10.1890/06-1073.1; Moilanen A, 2009, RESTOR ECOL, V17, P470, DOI 10.1111/j.1526-100X.2008.00382.x; Moritz C, 2002, SYST BIOL, V51, P238, DOI 10.1080/10635150252899752; Obama B., 2015, PRESIDENTIAL MEMORAN; Parkhurst GM, 2002, ECOL ECON, V41, P305, DOI 10.1016/S0921-8009(02)00036-8; Parkhurst GM, 2008, AM J AGR ECON, V90, P1192, DOI 10.1111/j.1467-8276.2008.01203.x; Polasky S, 2014, P NATL ACAD SCI USA, V111, P6248, DOI 10.1073/pnas.1404484111; Reed DH, 2004, ANIM CONSERV, V7, P181, DOI 10.1017/S1367943004001313; Ruckelshaus M, 1997, CONSERV BIOL, V11, P1298, DOI 10.1046/j.1523-1739.1997.96151.x; Runge CA, 2014, FRONT ECOL ENVIRON, V12, P395, DOI 10.1890/130237; Schlaifer R., 1961, APPL STAT DECISION T; Sugg DW, 1996, TRENDS ECOL EVOL, V11, P338, DOI 10.1016/0169-5347(96)20050-3; Thomas CD, 1999, J ANIM ECOL, V68, P647, DOI 10.1046/j.1365-2656.1999.00330.x; TIETENBERG T, 2004, TRADABLE PERMITS APP; Trainor AM, 2013, LANDSCAPE ECOL, V28, P755, DOI 10.1007/s10980-013-9861-5; U.S. Fish and Wildlife Service, 2003, REC PLAN RED COCK WO; Walker S, 2009, CONSERV LETT, V2, P149, DOI 10.1111/j.1755-263X.2009.00061.x; Walters C., 1986, ADAPTIVE MANAGEMENT; Walters JR, 2002, J WILDLIFE MANAGE, V66, P1064, DOI 10.2307/3802938; WALTERS JR, 1988, ETHOLOGY, V78, P275; Walters JR, 2011, DECISION SUPPORT SYS; Wennergren U, 1995, OIKOS, V74, P349, DOI 10.2307/3545979; Wiegand T, 2004, BIODIVERS CONSERV, V13, P53, DOI 10.1023/B:BIOC.0000004313.86836.ab; Wiegand T, 1999, AM NAT, V154, P605, DOI 10.1086/303272; Wilhere GF, 2002, CONSERV BIOL, V16, P20, DOI 10.1046/j.1523-1739.2002.00350.x; Williams BK, 2012, ADAPTOVE MANAGEMENT; Williams KJ, 2012, ECOL ECON, V81, P48, DOI 10.1016/j.ecolecon.2012.07.005; Winfree R, 2005, AM NAT, V165, P707, DOI 10.1086/430009; With KA, 1999, CONSERV BIOL, V13, P314, DOI 10.1046/j.1523-1739.1999.013002314.x; Yokota F, 2004, MED DECIS MAKING, V24, P287, DOI 10.1177/0272989X04263157	63	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144047	10.1371/journal.pone.0144047	http://dx.doi.org/10.1371/journal.pone.0144047			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9JH	26675488	gold, Green Submitted, Green Published			2022-12-26	WOS:000366722700022
J	Salinas, RP; Flores, RMO; Distel, JS; Aguilera, MO; Colombo, MI; Beron, W				Salinas, Romina P.; Ortiz Flores, Rodolfo M.; Distel, Jesus S.; Aguilera, Milton O.; Colombo, Maria I.; Beron, Walter			Coxiella burnetii Phagocytosis Is Regulated by GTPases of the Rho Family and the RhoA Effectors mDia1 and ROCK	PLOS ONE			English	Article							FC-GAMMA-R; RECEPTOR-MEDIATED PHAGOCYTOSIS; DIAPHANOUS-RELATED FORMINS; ARP2/3 COMPLEX; MYOSIN-II; ALPHA(V)BETA(3) INTEGRIN; SALMONELLA INVASION; DISTINCT MECHANISMS; BACTERIAL PATHOGENS; ACTIN CYTOSKELETON	The GTPases belonging to the Rho family control the actin cytoskeleton rearrangements needed for particle internalization during phagocytosis. ROCK and mDia1 are downstream effectors of RhoA, a GTPase involved in that process. Coxiella burnetii, the etiologic agent of Q fever, is internalized by the host's cells in an actin-dependent manner. Nevertheless, the molecular mechanism involved in this process has been poorly characterized. This work analyzes the role of different GTPases of the Rho family and some downstream effectors in the internalization of C. burnetii by phagocytic and non-phagocytic cells. The internalization of C. burnetii into HeLa and RAW cells was significantly inhibited when the cells were treated with Clostridium difficile Toxin B which irreversibly inactivates members of the Rho family. In addition, the internalization was reduced in HeLa cells that overexpressed the dominant negative mutants of RhoA, Rac1 or Cdc42 or that were knocked down for the Rho GTPases. The pharmacological inhibition or the knocking down of ROCK diminished bacterium internalization. Moreover, C. burnetii was less efficiently internalized in HeLa cells overexpressing mDia1-N1, a dominant negative mutant of mDia1, while the overexpression of the constitutively active mutant mDia1-Delta N3 increased bacteria uptake. Interestingly, when HeLa and RAW cells were infected, RhoA, Rac1 and mDia1 were recruited to membrane cell fractions. Our results suggest that the GTPases of the Rho family play an important role in C. burnetii phagocytosis in both HeLa and RAW cells. Additionally, we present evidence that ROCK and mDia1, which are downstream effectors of RhoA, are involved in that process.	[Salinas, Romina P.; Ortiz Flores, Rodolfo M.; Distel, Jesus S.; Aguilera, Milton O.; Colombo, Maria I.; Beron, Walter] Univ Nacl Cuyo, Inst Histol & Embriol, Fac Ciencias Med, CONICET, RA-5500 Mendoza, Argentina	University Nacional Cuyo Mendoza	Beron, W (corresponding author), Univ Nacl Cuyo, Inst Histol & Embriol, Fac Ciencias Med, CONICET, RA-5500 Mendoza, Argentina.	wberon@fcm.uncu.edu.ar	Ortiz Flores, Rodolfo Matias/ABA-5380-2021	Ortiz Flores, Rodolfo Matias/0000-0003-4509-0161; Distel, Jesus Sebastian/0000-0003-4589-5314	CONICET (Consejo Nacional de Investigacion Cientifica y Tecnica) (PIP); ANPCyT (Agencia Nacional de Promocion Cientifica y Tecnologica) [PICT-2012-2425]; SECTyP (Secretaria de Ciencia, Tecnica y Postgrado); Universidad Nacional de Cuyo	CONICET (Consejo Nacional de Investigacion Cientifica y Tecnica) (PIP); ANPCyT (Agencia Nacional de Promocion Cientifica y Tecnologica)(ANPCyT); SECTyP (Secretaria de Ciencia, Tecnica y Postgrado); Universidad Nacional de Cuyo	This work was supported by grants from CONICET (Consejo Nacional de Investigacion Cientifica y Tecnica) (PIP 2010-2012), ANPCyT (Agencia Nacional de Promocion Cientifica y Tecnologica) (PICT-2012-2425) and SECTyP (Secretaria de Ciencia, Tecnica y Postgrado) (2013-2015), Universidad Nacional de Cuyo, to WB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Aguilera M, 2009, INFECT IMMUN, V77, P4609, DOI 10.1128/IAI.00301-09; Aktories K, 2005, NAT REV MICROBIOL, V3, P397, DOI 10.1038/nrmicro1150; Alberts AS, 2001, J BIOL CHEM, V276, P2824, DOI 10.1074/jbc.M006205200; Alix E, 2011, J CELL BIOL, V195, P943, DOI 10.1083/jcb.201105019; Allen LAH, 1996, J EXP MED, V184, P627, DOI 10.1084/jem.184.2.627; Alonso A, 2004, INT MICROBIOL, V7, P181; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Amano M, 2010, CYTOSKELETON, V67, P545, DOI 10.1002/cm.20472; Aspenstrom P, 2004, BIOCHEM J, V377, P327, DOI 10.1042/BJ20031041; BACA OG, 1983, MICROBIOL REV, V47, P127, DOI 10.1128/MMBR.47.2.127-149.1983; BACA OG, 1993, ACTA VIROL, V37, P143; Benard V, 1999, J BIOL CHEM, V274, P13198, DOI 10.1074/jbc.274.19.13198; Beron W, 2002, INFECT IMMUN, V70, P5816, DOI 10.1128/IAI.70.10.5816-5821.2002; Bhadriraju K, 2007, EXP CELL RES, V313, P3616, DOI 10.1016/j.yexcr.2007.07.002; Bierne H, 2005, J CELL SCI, V118, P1537, DOI 10.1242/jcs.02285; Bierne H, 2001, J CELL BIOL, V155, P101, DOI 10.1083/jcb.200104037; Billker O, 2002, EMBO J, V21, P560, DOI 10.1093/emboj/21.4.560; Bishop AL, 2000, BIOCHEM J, V348, P241, DOI 10.1042/0264-6021:3480241; Brandt DT, 2007, J CELL BIOL, V178, P193, DOI 10.1083/jcb.200612071; Burnham CAD, 2007, FEMS MICROBIOL LETT, V272, P8, DOI 10.1111/j.1574-6968.2007.00768.x; Capo C, 1999, J IMMUNOL, V163, P6078; Carabeo RA, 2004, TRAFFIC, V5, P418, DOI 10.1111/j.1398-9219.2004.00184.x; Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717; Chi XJ, 2013, INT J MOL SCI, V14, P7089, DOI 10.3390/ijms14047089; Colucci-Guyon E, 2005, CURR BIOL, V15, P2007, DOI 10.1016/j.cub.2005.09.051; Cossart P, 2010, CURR OPIN CELL BIOL, V22, P547, DOI 10.1016/j.ceb.2010.05.006; Cougoule C, 2006, J BIOL CHEM, V281, P8756, DOI 10.1074/jbc.M513731200; Croise Pauline, 2014, Small GTPases, V5, pe29469, DOI 10.4161/sgtp.29469; Dellacasagrande J, 2000, INFECT IMMUN, V68, P5673, DOI 10.1128/IAI.68.10.5673-5678.2000; Dubois T, 2005, NAT CELL BIOL, V7, P353, DOI 10.1038/ncb1244; Duman JG, 2015, NEUROSCI LETT, V601, P4, DOI 10.1016/j.neulet.2015.05.034; Fairn GD, 2012, TRENDS IMMUNOL, V33, P397, DOI 10.1016/j.it.2012.03.003; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Fernandez-Borja M, 2005, J CELL SCI, V118, P2661, DOI 10.1242/jcs.02384; Firat-Karalar EN, 2011, CURR OPIN CELL BIOL, V23, P4, DOI 10.1016/j.ceb.2010.10.007; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Fox R, 2007, EMBO J, V26, P505, DOI 10.1038/sj.emboj.7601522; Frampton AR, 2007, J VIROL, V81, P10879, DOI 10.1128/JVI.00504-07; Gardel ML, 2010, ANNU REV CELL DEV BI, V26, P315, DOI 10.1146/annurev.cellbio.011209.122036; Genth H, 2006, FEBS LETT, V580, P3565, DOI 10.1016/j.febslet.2006.04.100; Goh WI, 2012, J BIOL CHEM, V287, P4702, DOI 10.1074/jbc.M111.305102; Gourlay CW, 2005, BIOCHEM SOC T, V33, P1260, DOI 10.1042/BST0331260; Gutierrez MG, 2005, CELL MICROBIOL, V7, P981, DOI 10.1111/j.1462-5822.2005.00527.x; Hackam DJ, 1997, J EXP MED, V186, P955, DOI 10.1084/jem.186.6.955; Hanisch J, 2011, CELL HOST MICROBE, V9, P273, DOI 10.1016/j.chom.2011.03.009; Haglund CM, 2010, NAT CELL BIOL, V12, P1057, DOI 10.1038/ncb2109; Hall AB, 2006, IMMUNITY, V24, P305, DOI 10.1016/j.immuni.2006.02.005; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Heindl JE, 2010, INFECT IMMUN, V78, P193, DOI 10.1128/IAI.00252-09; Hodgson L., 2010, CURR PROTOC CELL BIO, DOI [10.1002/0471143030.cb1411s46, DOI 10.1002/0471143030.CB1411S46]; Hoppe AD, 2004, MOL BIOL CELL, V15, P3509, DOI 10.1091/mbc.E03-11-0847; Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093; Howe D, 2000, INFECT IMMUN, V68, P3815, DOI 10.1128/IAI.68.7.3815-3821.2000; Hussain SK, 2010, FRONT MICROBIOL, V1, DOI 10.3389/fmicb.2010.00137; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940; KAPLAN G, 1977, SCAND J IMMUNOL, V6, P797, DOI 10.1111/j.1365-3083.1977.tb02153.x; Khan NA, 2003, MICROB PATHOGENESIS, V35, P35, DOI 10.1016/S0882-4010(03)00090-1; Kim JG, 2012, J BIOL CHEM, V287, P5145, DOI 10.1074/jbc.M111.257634; Ladwein M, 2008, FEBS LETT, V582, P2066, DOI 10.1016/j.febslet.2008.04.033; Lemichez E, 2013, EXP CELL RES, V319, P2329, DOI 10.1016/j.yexcr.2013.04.021; Li F, 2005, J BIOL CHEM, V280, P6986, DOI 10.1074/jbc.M411605200; Matas OB, 2005, EUR J CELL BIOL, V84, P699, DOI 10.1016/j.ejcb.2005.05.001; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; May RC, 2000, NAT CELL BIOL, V2, P246, DOI 10.1038/35008673; May RC, 2001, J CELL SCI, V114, P1061; McDonough JA, 2013, MBIO, V4, DOI 10.1128/mBio.00606-12; Meconi S, 1998, INFECT IMMUN, V66, P5527, DOI 10.1128/IAI.66.11.5527-5533.1998; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; Michaelson D, 2006, METHOD ENZYMOL, V406, P296, DOI 10.1016/S0076-6879(06)06022-8; Newton HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054566; Niedergang F, 2005, CURR TOP MICROBIOL, V291, P43; Olazabal IM, 2002, CURR BIOL, V12, P1413, DOI 10.1016/S0960-9822(02)01069-2; Patel JC, 2008, METHOD ENZYMOL, V439, P145, DOI 10.1016/S0076-6879(07)00411-9; Patel JC, 2000, METHOD ENZYMOL, V325, P462; Pertz O, 2004, J CELL SCI, V117, P1313, DOI 10.1242/jcs.01117; Pertz O, 2010, J CELL SCI, V123, P1841, DOI 10.1242/jcs.064345; Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012; Pizarro-Cerda J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a010009; Qualmann B, 2003, BIOCHEM J, V371, P233, DOI 10.1042/bj20030139; Ramalingam N, 2010, EUR J CELL BIOL, V89, P723, DOI 10.1016/j.ejcb.2010.06.001; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Roberts PJ, 2008, J BIOL CHEM, V283, P25150, DOI 10.1074/jbc.M800882200; Romano PS, 2007, CELL MICROBIOL, V9, P891, DOI 10.1111/j.1462-5822.2006.00838.x; Rosales EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039348; Schonichen A, 2010, BBA-MOL CELL RES, V1803, P152, DOI 10.1016/j.bbamcr.2010.01.014; Subtil A, 2004, J CELL SCI, V117, P3923, DOI 10.1242/jcs.01247; SWANSON JA, 1995, TRENDS CELL BIOL, V5, P89, DOI 10.1016/S0962-8924(00)88956-4; Tam VC, 2007, CELL HOST MICROBE, V1, P95, DOI 10.1016/j.chom.2007.03.005; Tierrez A, 2005, CELL MICROBIOL, V7, P901, DOI 10.1111/j.1462-5822.2005.00540.x; Tominaga T, 2000, MOL CELL, V5, P13, DOI 10.1016/S1097-2765(00)80399-8; Truong D, 2013, CELL MICROBIOL, V15, P2051, DOI 10.1111/cmi.12173; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; van Schaik EJ, 2013, NAT REV MICROBIOL, V11, P561, DOI 10.1038/nrmicro3049; Voth DE, 2007, CELL MICROBIOL, V9, P829, DOI 10.1111/j.1462-5822.2007.00901.x; Waag DM, 2007, VACCINE, V25, P7288, DOI 10.1016/j.vaccine.2007.08.002; Wallar BJ, 2007, EXP CELL RES, V313, P560, DOI 10.1016/j.yexcr.2006.10.033; Watanabe N, 1997, EMBO J, V16, P3044, DOI 10.1093/emboj/16.11.3044; Watanabe N, 1999, NAT CELL BIOL, V1, P136, DOI 10.1038/11056; Wheeler AP, 2004, EXP CELL RES, V301, P43, DOI 10.1016/j.yexcr.2004.08.012; Woldehiwet Z, 2004, RES VET SCI, V77, P93, DOI 10.1016/j.rvsc.2003.09.001; Yang C, 2007, PLOS BIOL, V5, P2624, DOI 10.1371/journal.pbio.0050317; Yoneda A, 2005, J CELL BIOL, V170, P443, DOI 10.1083/jcb.200412043	103	14	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145211	10.1371/journal.pone.0145211	http://dx.doi.org/10.1371/journal.pone.0145211			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674774	gold, Green Published, Green Submitted			2022-12-26	WOS:000366722700115
J	Senter, P; Robins, JH				Senter, Phil; Robins, James H.			Resting Orientations of Dinosaur Scapulae and Forelimbs: A Numerical Analysis, with Implications for Reconstructions and Museum Mounts	PLOS ONE			English	Article							THEROPOD DINOSAUR; STRUTHIOMIMUS; SPECIMEN; SKELETON; FURCULA; ANATOMY; POSTURE; CHINA	The inclination of the scapular blade and the resting pose of the forelimb in dinosaurs differ among reconstructions and among skeletal mounts. For most dinosaurian taxa, no attempt has previously been made to quantify the correct resting positions of these elements. Here, we used data from skeletons preserved in articulation to quantify the resting orientations of the scapula and forelimb in dinosaurs. Specimens were included in the study only if they were preserved lying on their sides; for each specimen the angle between forelimb bones at a given joint was included in the analysis only if the joint was preserved in articulation. Using correlation analyses of the angles between the long axis of the sacrum, the first dorsal centrum, and the scapular blade in theropods and Eoraptor, we found that vertebral hyperextension does not influence scapular orientation in saurischians. Among examined taxa, the long axis of the scapular blade was found to be most horizontal in bipedal saurischians, most vertical in basal ornithopods, and intermediate in hadrosauroids. We found that in bipedal dinosaurs other than theropods with semilunate carpals, the resting orientation of the elbow is close to a right angle and the resting orientation of the wrist is such that the hand exhibits only slight ulnar deviation from the antebrachium. In theropods with semilunate carpals the elbow and wrist are more flexed at rest, with the elbow at a strongly acute angle and with the wrist approximately at a right angle. The results of our study have important implications for correct orientations of bones in reconstructions and skeletal mounts. Here, we provide recommendations on bone orientations based on our results.	[Senter, Phil] Fayetteville State Univ, Dept Biol Sci, Fayetteville, NC 28301 USA; [Robins, James H.] SE Missouri State Univ, Dept Biol, Cape Girardeau, MO 63701 USA	University of North Carolina; Fayetteville State University	Senter, P (corresponding author), Fayetteville State Univ, Dept Biol Sci, Fayetteville, NC 28301 USA.	psenter@uncfsu.edu						ACHENBACH J, 2003, NATL GEOGR, V203, P2; [Anonymous], 1997, AUDUBON, V99; Bakker RT., 1987, DINOSAURS PAST PRESE, V1, P38; Bonaparte Jose F., 1995, Ameghiniana, V32, P341; Bonnan MF, 2007, SPEC PAP PALAEONTOL, P139; Brown B, 1917, B AM MUS NAT HIST, V37, P281; Brown B, 1916, B AM MUS NAT HIST, V35, P709; Brown B, 1913, AM MUS J, V8, P138; Brown B, 1937, AM MUS NOVIT, V955, P1; Carpenter Kenneth, 2002, Senckenbergiana Lethaea, V82, P59; Carpenter Kenneth, 2001, P90; Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; Chure DJ, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P283; Currie PJ, 2001, CAN J EARTH SCI, V38, P1705, DOI 10.1139/e01-050; Cutler A, 2011, J VERTEBR PALEONTOL, V31, P95; Czerkas Stephen A., 2002, Dinosaur Museum Journal, V1, P97; Dal Sasso C, 1998, NATURE, V392, P383; Dalla Vecchia FM, 2009, J VERTEBR PALEONTOL, V29, P1100, DOI 10.1671/039.029.0428; Elzanowski A, 2001, ACTA PALAEONTOL POL, V46, P519; Faux CM, 2007, PALEOBIOLOGY, V33, P201, DOI 10.1666/06015.1; Galton P.M., 1976, Postilla, VNo. 69, P1; Galton P.M., 1983, Geologica et Palaeontologica, V17, P207; Gambaryan P., 1974, HOW MAMMALS RUN; Garstka William R., 1997, P385; Gatton P. M., 1970, J. Paleont., V44, P464; Gilmore C. W., 1905, Proceedings United States Museum, Vxxix, P433; Gilmore C.W., 1915, P US NATL MUS, V49, P591, DOI DOI 10.5479/SI.00963801.49-2127.591; Gishlick AD, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P301; Glut D., 1972, DINOSAUR DICT; Glut D. F., 1997, DINOSAURS ENCY; Godefroit Pascal, 2013, Nature Communications, V4, P1; Godefroit P, 2013, NATURE, V498, P359, DOI 10.1038/nature12168; Hatcher J. B., 1907, MONOGRAPHS US GEOLOG, VXLIX, DOI DOI 10.5962/BHL.TITLE.60500; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Hwang Sunny H., 2004, Journal of Systematic Palaeontology, V2, P13, DOI 10.1017/S1477201903001081; JENKINS FA, 1983, J MORPHOL, V175, P195, DOI 10.1002/jmor.1051750207; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Ji Qiang, 2005, Dizhi Tongbao, V24, P197; JOHNSON RE, 1995, FUNCTIONAL MORPHOLOGY IN VERTEBRATE PALEONTOLOGY, P205; Kobayashi Y, 2003, ACTA PALAEONTOL POL, V48, P235; Kobayashi Y, 1999, NATURE, V402, P480, DOI 10.1038/44999; Lanzendorf J.J., 2000, DINOSAUR IMAGERY SCI; Larson P, 2005, LIFE O PAST, P247; Larson P, 2004, REX APPEAL; Lu JC, 2005, LIFE O PAST, P256; LULL RICHARD SWANN, 1933, MEM PEABODY MUS NAT HIST, V3, P1; Mallison H, 2010, ACTA PALAEONTOL POL, V55, P433, DOI 10.4202/app.2009.0075; Matthew WD, 1923, AM MUS NOVIT, V89, P1, DOI [10.5281/zenodo.4715537, DOI 10.5281/ZENODO.4715537]; Newman B. H., 1970, Biol. J. Linn. Soc., V2, P119, DOI 10.1111/j.1095-8312.1970.tb01707.x; NICHOLLS EL, 1985, PALAEONTOLOGY, V28, P643; Norell Mark A., 1999, American Museum Novitates, V3282, P1; O'Connor J, 2011, P NATL ACAD SCI USA, V108, P19662, DOI 10.1073/pnas.1117727108; OSBORN HENRY FAIRFIELD, 1933, AMER MUS NOVITATES, V654, P1; Osborn HF, 1916, B AM MUS NAT HIST, V35, P733; OSTROM J H, 1978, Zitteliana, V4, P73; PARKS WA, 1920, U TORONTO STUDIES GE, V11, P1; PARKS WA, 1922, U TORONTO STUDIES GE, V13, P1; Paul G., 1988, PREDATORY DINOSAURS; Paul GS, 2000, PALEOBIOLOGY, V26, P450, DOI 10.1666/0094-8373(2000)026<0450:FPINDI>2.0.CO;2; Paul GS, 1987, DINOSAURS PAST PRESE, V2, P4; PETERSON JA, 1984, J ZOOL, V202, P1; Peyer K, 2006, J VERTEBR PALEONTOL, V26, P879, DOI 10.1671/0272-4634(2006)26[879:AROCFT]2.0.CO;2; Rauhut OWM, 2012, P NATL ACAD SCI USA, V109, P11746, DOI 10.1073/pnas.1203238109; Senter P, 2005, PALEOBIOLOGY, V31, P373, DOI 10.1666/0094-8373(2005)031[0373:FITSFO]2.0.CO;2; Senter P, 2005, J ZOOL, V266, P307, DOI 10.1017/S0952836905006989; Senter P, 2007, J ZOOL, V273, P305, DOI 10.1111/j.1469-7998.2007.00329.x; Senter P, 2006, ACTA PALAEONTOL POL, V51, P305; Senter P, 2006, J VERTEBR PALEONTOL, V26, P897, DOI 10.1671/0272-4634(2006)26[897:COFFBD]2.0.CO;2; Senter Phil, 2006, Paleobios, V26, P7; Sereno PC., 1994, J VERTEBR PALEONTOL, V13, P425, DOI DOI 10.1080/02724634.1994.10011524; Simpson G. G., 1960, QUANTITATIVE ZOOLOGY; STERNBERG C. M., 1940, JOUR PALEONTOL, V14, P481; STERNBERG C. M., 1933, CANADIAN FIELD NATURALIST, V47, P79; Tykoski RS, 2002, J VERTEBR PALEONTOL, V22, P728, DOI 10.1671/0272-4634(2002)022[0728:AFITCT]2.0.CO;2; Vargas-Peixoto D, 2015, J S AM EARTH SCI, V61, P129, DOI 10.1016/j.jsames.2014.09.024; Varricchio DJ, 2008, ACTA PALAEONTOL POL, V53, P567, DOI 10.4202/app.2008.0402; WELLES S P, 1984, Palaeontographica Abteilung A Palaeozoologie-Stratigraphie, V185, P85; Wellnhofer P., 1974, Palaeontographica Abt A, V147, P169; Wellnhofer Peter, 1992, Natural History Museum of Los Angeles County Science Series, V36, P3; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 2006, NATURE, V439, P715, DOI 10.1038/nature04511; Xu X, 2012, NATURE, V484, P92, DOI 10.1038/nature10906; Xu X, 2010, NATURE, V464, P1338, DOI 10.1038/nature08965; Xu X, 2009, P NATL ACAD SCI USA, V106, P832, DOI 10.1073/pnas.0810055106; Zar, 2011, BIOSTAT ANAL; Zhou Z, 2000, VERTEBR PALAS, V38, P111; Zhou Zhong-He, 2000, Vertebrata Palasiatica, V38, P241	87	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144036	10.1371/journal.pone.0144036	http://dx.doi.org/10.1371/journal.pone.0144036			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675035	Green Submitted, Green Published, gold			2022-12-26	WOS:000366722700019
J	Zhang, J; Yin, BJ; Xie, YH; Li, J; Yang, ZB; Zhang, GG				Zhang, Jie; Yin, Binjie; Xie, Yuhuai; Li, Jing; Yang, Zaibin; Zhang, Guiguo			Legume-Cereal Intercropping Improves Forage Yield, Quality and Degradability	PLOS ONE			English	Article							ALFALFA STEM TISSUES; CROP-LIVESTOCK SYSTEMS; VITRO GAS-PRODUCTION; PERENNIAL RYEGRASS; RUMINAL DEGRADATION; FED DIETS; RUMEN; CORN; MIXTURES; CLOVER	Intercropping legume with cereal is an extensively applied planting pattern in crop cultivation. However, forage potential and the degradability of harvested mixtures from intercropping system remain unclear. To investigate the feasibility of applying an intercropping system as a forage supply source to ruminants, two consecutive experiments (experiments 1 and 2) involving a field cultivation trial and a subsequent in vivo degradable experiment were conducted to determine the forage production performance and the ruminally degradable characteristics of a harvested mixture from an alfalfa/corn-rye intercropping system. In experiment 1, the intercropping system was established by alternating alfalfa and corn or rye with a row ratio of 5:2. Dry matter (DM) and nutrient yields were determined. In experiment 2, forages harvested from the different treatments were used as feedstuff to identify nutrient degradation kinetics and distribution of components between the rapidly degradable (a), potentially degradable (b) and the degradation rate constant (c) of 'b' fraction by in sacco method in Small-Tail Han wether Sheep. The intercropping system of alfalfa and corn-rye provided higher forage production performance with net increases of 9.52% and 34.81% in DM yield, 42.13% and 16.74% in crude protein (CP) yield, 25.94% and 69.99% in degradable DM yield, and 16.96% and 5.50% in degradable CP yield than rotation and alfalfa sole cropping systems, respectively. In addition, the harvest mixture from intercropping system also had greater 'a' fraction, 'b' fraction, 'c' values, and effective degradability (E value) of DM and CP than corn or rye hay harvested from rotation system. After 48-h exposure to rumen microbes, intercropping harvest materials were degraded to a higher extent than separately degraded crop stems from the sole system as indicated by visual microscopic examination with more tissues disappeared. Thus, the intercropping of alfalfa and corn-rye exhibited a greater forage production potential, and could be applied as forage supply source for ruminants. The improved effective degradability of harvest mixture material could be attributed to greater degradable components involving the rapidly degradable fractions (a), potentially degradable (b) fractions, and degradable rate constant (c), than that of corn and rye hay.	[Zhang, Jie; Yin, Binjie; Xie, Yuhuai; Yang, Zaibin; Zhang, Guiguo] Shandong Agr Univ, Coll Anim Sci & Technol, Tai An 271018, Shandong, Peoples R China; [Li, Jing; Zhang, Guiguo] Peking Univ, Coll Life Sci, Dept Biochem & Mol Biol, Beijing 100871, Peoples R China	Shandong Agricultural University; Peking University	Zhang, GG (corresponding author), Shandong Agr Univ, Coll Anim Sci & Technol, Tai An 271018, Shandong, Peoples R China.	zhanggg@sdau.edu.cn	Xie, Yuhuai/ACE-2095-2022	Xie, Yuhuai/0000-0001-7280-7098	Special Fund for Agro-scientific Research in the Public Interest of China [201403047]; Awarding Fund for Outstanding Young Scientists of Shandong Province [BS2013NY007]; Shandong Province Special Fund of Native Sheep Varieties Protecting Project	Special Fund for Agro-scientific Research in the Public Interest of China; Awarding Fund for Outstanding Young Scientists of Shandong Province; Shandong Province Special Fund of Native Sheep Varieties Protecting Project	This work was supported by the Special Fund for Agro-scientific Research in the Public Interest of China (project no. 201403047), the Awarding Fund for Outstanding Young Scientists of Shandong Province (project no. BS2013NY007), and the Shandong Province Special Fund of Native Sheep Varieties Protecting Project.	Abbeddou S, 2011, SMALL RUMINANT RES, V96, P126, DOI 10.1016/j.smallrumres.2010.11.017; Anil L, 1998, GRASS FORAGE SCI, V53, P301, DOI 10.1046/j.1365-2494.1998.00144.x; Carruthers K, 2000, EUR J AGRON, V12, P103, DOI 10.1016/S1161-0301(99)00051-9; Cho AS, 2012, ANIM SCI J, V83, P650, DOI 10.1111/j.1740-0929.2011.01003.x; Da Silva Michele Simili, 2014, ANIM FEED SCI TECH, V5, P17; Dixon RM, 1999, AUST J AGR RES, V50, P757, DOI 10.1071/AR98165; EASTIN EF, 1978, ANAL BIOCHEM, V85, P591, DOI 10.1016/0003-2697(78)90259-2; Eguienta YK, 2002, CROP LIVESTOCK INTER, P221; Elgersma A, 1998, GRASS FORAGE SCI, V53, P353, DOI 10.1046/j.1365-2494.1998.00151.x; Engels FM, 2005, ANIM FEED SCI TECH, V120, P309, DOI 10.1016/j.anifeedsci.2005.03.003; Engels FM, 1998, ANN BOT-LONDON, V82, P561, DOI 10.1006/anbo.1998.0705; Erice G, 2010, J PLANT PHYSIOL, V167, P114, DOI 10.1016/j.jplph.2009.07.016; Halmemies-Beauchet-Filleau A, 2013, J DAIRY SCI, V96, P5882, DOI 10.3168/jds.2013-6872; Jiang D, 2012, RENEW SUST ENERG REV, V16, P1377, DOI 10.1016/j.rser.2011.12.012; Jung HG, 2006, CROP SCI, V46, P1801, DOI 10.2135/cropsci2006.02-0086; JUNG HG, 1995, J ANIM SCI, V73, P2774; Jung HG, 2001, NETH J AGR SCI, V49, P3, DOI 10.1016/S1573-5214(01)80012-9; King C, 2014, GRASS FORAGE SCI, V69, P64, DOI 10.1111/gfs.12032; Lauriault LM, 2004, AGRON J, V96, P352, DOI 10.2134/agronj2004.0352; Lenne JM, 2006, OUTLOOK AGR, V35, P167, DOI 10.5367/000000006778536765; Li L, 2003, NUTR CYCL AGROECOSYS, V65, P61, DOI 10.1023/A:1021885032241; Li L, 1999, PLANT SOIL, V212, P105, DOI 10.1023/A:1004656205144; Li L, 2001, FIELD CROP RES, V71, P123, DOI 10.1016/S0378-4290(01)00156-3; Lopez S, 1999, J ANIM SCI, V77, P1875; Metzler-Zebeli BU, 2012, J SCI FOOD AGR, V92, P2479, DOI 10.1002/jsfa.5656; Niderkorn V, 2011, J ANIM SCI, V89, P1138, DOI 10.2527/jas.2010-2819; Niderkorn V, 2009, ANIMAL, V3, P951, DOI 10.1017/S1751731109004261; ORSKOV ER, 1979, J AGR SCI, V92, P499, DOI 10.1017/S0021859600063048; Ross SM, 2004, AGRON J, V96, P1013, DOI 10.2134/agronj2004.1013; Russelle MP, 2007, AGRON J, V99, P325, DOI 10.2134/agronj2006.0139; Sleugh B, 2000, AGRON J, V92, P24, DOI 10.2134/agronj2000.92124x; Strydhorst SM, 2008, AGRON J, V100, P182, DOI 10.2134/agronj2007.0197; Sulc RM, 2007, AGRON J, V99, P335, DOI 10.2134/agronj2006.0086; Sun B., 2014, PLOS ONE, P1; Sun XZ, 2010, ANIM FEED SCI TECH, V155, P172, DOI 10.1016/j.anifeedsci.2009.12.004; Terramoccia S, 2000, LIVEST PROD SCI, V65, P185, DOI 10.1016/S0301-6226(99)00155-4; Zhang GG, 2012, J APPL POULTRY RES, V21, P216, DOI 10.3382/japr.2010-00288; Zhang GG, 2013, J AGR SCI, V5, P129; Zhang GG, 2011, FIELD CROP RES, V124, P66, DOI 10.1016/j.fcr.2011.06.006	39	25	28	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144813	10.1371/journal.pone.0144813	http://dx.doi.org/10.1371/journal.pone.0144813			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26672990	Green Published, gold, Green Submitted			2022-12-26	WOS:000366722700064
J	Carpenter-Thompson, JR; Schmidt, S; McAuley, E; Husain, FT				Carpenter-Thompson, Jake R.; Schmidt, Sara; McAuley, Edward; Husain, Fatima T.			Increased Frontal Response May Underlie Decreased Tinnitus Severity	PLOS ONE			English	Article							QUALITY-OF-LIFE; BECK DEPRESSION INVENTORY; PHYSICAL-ACTIVITY; OLDER-ADULTS; PSYCHIATRIC OUTPATIENTS; ANXIETY INVENTORY; FMRI; TIME; SUFFERERS; VALIDITY	Objectives The overall goal of the study was to identify functional and behavioral differences between individuals with higher tinnitus distress and individuals with lower tinnitus distress. Subsequent exploratory analyses were conducted to investigate the role physical activity may have on the observed results between high and low distress groups. The purpose of the experiment was to identify brain regions to be targeted in future intervention studies for tinnitus. Design A total of 32 individuals with varying levels of tinnitus severity were recruited from the Urbana-Champaign area. Volunteers were divided into higher tinnitus distress (HD) and lower tinnitus distress (LD) groups. Note that these groups also significantly differed based on physical activity level and were subsequently stratified into higher and lower physical activity level subgroups for exploratory analysis. While in a functional magnetic resonance imaging (fMRI) scanner, subjects listened to affective sounds classified as pleasant, neutral or unpleasant from the International Affective Digital Sounds database. Results The HD group recruited amygdala and parahippocampus to a greater extent than the LD group when listening to affective sounds. The LD group engaged frontal regions to a greater extent when listening to the affective stimuli compared to the HD group. Both higher physical activity level subgroups recruited more frontal regions, and both lower levels of physical activity subgroups recruited more limbic regions respectively. Conclusion Individuals with lower tinnitus distress may utilize frontal regions to better control their emotional response to affective sounds. Our analysis also suggests physical activity may contribute to lower tinnitus severity and greater engagement of the frontal cortices. We suggest that future intervention studies focus on changes in the function of limbic and frontal regions when evaluating the efficacy of treatment. Additionally, we recommend further investigation concerning the impact of physical activity level on tinnitus distress.	[Carpenter-Thompson, Jake R.; Schmidt, Sara; Husain, Fatima T.] Univ Illinois, Neurosci Program, Champaign, IL 61820 USA; [Carpenter-Thompson, Jake R.] Univ Illinois, Med Scholars Program, Champaign, IL USA; [Husain, Fatima T.] Univ Illinois, Dept Speech & Hearing Sci, Champaign, IL USA; [Carpenter-Thompson, Jake R.; Schmidt, Sara; McAuley, Edward; Husain, Fatima T.] Univ Illinois, Beckman Inst, Champaign, IL USA; [McAuley, Edward] Univ Illinois, Dept Kinesiol & Community Hlth, Champaign, IL USA	University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Husain, FT (corresponding author), Univ Illinois, Neurosci Program, Champaign, IL 61820 USA.	husainf@acnlab.com			American Tinnitus Association [392]; Center on Health, Aging, and Disability at University of Illinois Urbana-Champaign	American Tinnitus Association; Center on Health, Aging, and Disability at University of Illinois Urbana-Champaign	This work was supported by Grant #392 "Effects of Exercise on Tinnitus Severity" from the American Tinnitus Association, https://www.ata.org/, and by "Understanding the Role of Physical Fitness in Mitigating Tinnitus Severity: An fMRI Study" from the Center on Health, Aging, and Disability at University of Illinois Urbana-Champaign, http://chad.illinois.edu/.	AINSWORTH BE, 1992, J ADOLESCENT HEALTH, V13, P606, DOI 10.1016/1054-139X(92)90375-L; Babyak M, 2000, PSYCHOSOM MED, V62, P633, DOI 10.1097/00006842-200009000-00006; Bartels H, 2008, EAR HEARING, V29, P947, DOI 10.1097/AUD.0b013e3181888f83; Beck A.T., 1990, BECK SCALE SUICIDE I; BECK AT, 1984, J CLIN PSYCHOL, V40, P1365, DOI 10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO;2-D; Bradley M. M., 2007, B3 U FLOR; Brown SG, 2006, AM J PREV MED, V30, P131, DOI 10.1016/j.amepre.2005.10.007; Carpenter-Thompson JR, 2015, EAR HEARING; Carpenter-Thompson JR, 2015, NEURAL PLASTICITY, V2015; Carpenter-Thompson JR, 2014, BRAIN RES; Courneya K, 1996, ONCOLOGY NURSING FOR; De Ridder D, 2006, ACTA OTO-LARYNGOL, V126, P50, DOI 10.1080/03655230600895580; De Ridder D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024273; Dolcos F, 2011, J COGN PSYCHOL, V23, P669, DOI 10.1080/20445911.2011.594433; Elavsky S, 2005, ANN BEHAV MED, V30, P138, DOI 10.1207/s15324796abm3002_6; FYDRICH T, 1992, J ANXIETY DISORD, V6, P55, DOI 10.1016/0887-6185(92)90026-4; Gaab N, 2003, NEUROIMAGE, V19, P1417, DOI 10.1016/S1053-8119(03)00224-6; Gillison FB, 2006, HEALTH EDUC RES, V21, P836, DOI 10.1093/her/cyl139; Giraud AL, 1999, NEUROREPORT, V10, P1, DOI 10.1097/00001756-199901180-00001; Godin G, 1997, MED SCI SPORTS EXERC, V29, P36, DOI DOI 10.1097/00005768-199706001-00009; Golm D, 2013, HEARING RES, V295, P87, DOI 10.1016/j.heares.2012.03.003; HALFORD JBS, 1991, J PSYCHOSOM RES, V35, P383, DOI 10.1016/0022-3999(91)90033-K; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; Haller S, 2010, EUR RADIOL, V20, P696, DOI 10.1007/s00330-009-1595-z; Husain FT, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00010; Husain FT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026639; Jacques PS, 2010, NEUROBIOL AGING, V31, P315, DOI 10.1016/j.neurobiolaging.2008.03.012; Jastreboff P J, 2000, J Am Acad Audiol, V11, P162; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; Julian LJ, 2011, ARTHRIT CARE RES, V63, pS467, DOI 10.1002/acr.20561; Kraus KS, 2012, HEARING RES, V288, P34, DOI 10.1016/j.heares.2012.02.009; Kumar S, 2012, J NEUROSCI, V32, P14184, DOI 10.1523/JNEUROSCI.1759-12.2012; Kurth F, 2010, BRAIN STRUCT FUNCT, V214, P519, DOI 10.1007/s00429-010-0255-z; Langguth B, 2007, PROG BRAIN RES, V166, P221, DOI 10.1016/S0079-6123(07)66020-8; Leaver AM, 2011, NEURON, V69, P33, DOI 10.1016/j.neuron.2010.12.002; McAuley E, 2004, BRAIN BEHAV IMMUN, V18, P214, DOI 10.1016/j.bbi.2003.12.007; Meikle MB, 2012, EAR HEARING, V33, P153, DOI 10.1097/AUD.0b013e31822f67c0; Mirz F, 2000, ACTA OTO-LARYNGOL, P241; Mirz F, 2000, NEUROREPORT, V11, P633, DOI 10.1097/00001756-200002280-00039; Motl RW, 2005, PREV MED, V40, P735, DOI 10.1016/j.ypmed.2004.09.016; Newman CW, 1998, J AM ACAD AUDIOLOGY, V9; Phan KL, 2003, BIOL PSYCHIAT, V53, P211, DOI 10.1016/S0006-3223(02)01485-3; Plewnia C, 2007, HUM BRAIN MAPP, V28, P238, DOI 10.1002/hbm.20270; Rauschecker JP, 2010, NEURON, V66, P819, DOI 10.1016/j.neuron.2010.04.032; Reyes SA, 2002, HEARING RES, V171, P43, DOI 10.1016/S0378-5955(02)00346-5; Schmidt SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076488; Searchfield G, 2011, EVAL HEALTH PROF; Sindhusake D, 2003, INT J AUDIOL, V42, P289, DOI 10.3109/14992020309078348; St Jacques PL, 2009, PSYCHOL SCI, V20, P74, DOI 10.1111/j.1467-9280.2008.02258.x; STEER RA, 1993, J ANXIETY DISORD, V7, P195, DOI 10.1016/0887-6185(93)90002-3; Steer RA, 1997, PSYCHOL REP, V80, P443, DOI 10.2466/pr0.1997.80.2.443; Suh MR, 2002, RENAL FAILURE, V24, P337; TYLER RS, 1983, J SPEECH HEAR DISORD, V48, P150, DOI 10.1044/jshd.4802.150; Unterrainer Josef, 2003, Int Tinnitus J, V9, P130; Vanneste S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088253; Vanneste S, 2011, EUR J NEUROSCI, V34, P718, DOI 10.1111/j.1460-9568.2011.07793.x; Vanneste S, 2010, NEUROIMAGE, V52, P470, DOI 10.1016/j.neuroimage.2010.04.029	57	19	19	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144419	10.1371/journal.pone.0144419	http://dx.doi.org/10.1371/journal.pone.0144419			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26675290	Green Submitted, Green Published, gold			2022-12-26	WOS:000366715900047
J	Pinto, A; Mace, Y; Drouet, F; Bony, E; Boidot, R; Draoui, N; Lobysheva, I; Corbet, C; Polet, F; Martherus, R; Deraedt, Q; Rodriguez, J; Lamy, C; Schicke, O; Delvaux, D; Louis, C; Kiss, R; Kriegsheim, AV; Dessy, C; Elias, B; Quetin-Leclercq, J; Riant, O; Feron, O				Pinto, A.; Mace, Y.; Drouet, F.; Bony, E.; Boidot, R.; Draoui, N.; Lobysheva, I.; Corbet, C.; Polet, F.; Martherus, R.; Deraedt, Q.; Rodriguez, J.; Lamy, C.; Schicke, O.; Delvaux, D.; Louis, C.; Kiss, R.; Kriegsheim, A. V.; Dessy, C.; Elias, B.; Quetin-Leclercq, J.; Riant, O.; Feron, O.			A new ER-specific photosensitizer unravels O-1(2)-driven protein oxidation and inhibition of deubiquitinases as a generic mechanism for cancer PDT	ONCOGENE			English	Article							ENDOPLASMIC-RETICULUM; PHOTODYNAMIC THERAPY; MAMMALIAN TARGET; HYPOXIA; MTOR; PHOTOEXCITATION; MULTIMERIZATION; SENSITIZERS	Photosensitizers (PS) are ideally devoid of any activity in the absence of photoactivation, and rely on molecular oxygen for the formation of singlet oxygen (O-1(2)) to produce cellular damage. Off-targets and tumor hypoxia therefore represent obstacles for the use of PS for cancer photodynamic therapy. Herein, we describe the characterization of OR141, a benzophenazine compound identified through a phenotypic screening for its capacity to be strictly activated by light and to kill a large variety of tumor cells under both normoxia and hypoxia. This new class of PS unraveled an unsuspected common mechanism of action for PS that involves the combined inhibition of the mammalian target of rapamycin (mTOR) signaling pathway and proteasomal deubiquitinases (DUBs) USP14 and UCH37. Oxidation of mTOR and other endoplasmic reticulum (ER)-associated proteins drives the early formation of high molecular weight (MW) complexes of multimeric proteins, the concomitant blockade of DUBs preventing their degradation and precipitating cell death. Furthermore, we validated the antitumor effects of OR141 in vivo and documented its highly selective accumulation in the ER, further increasing the ER stress resulting from O-1(2) generation upon light activation.	[Pinto, A.; Draoui, N.; Lobysheva, I.; Corbet, C.; Polet, F.; Martherus, R.; Delvaux, D.; Louis, C.; Dessy, C.; Feron, O.] Catholic Univ Louvain, IREC, Pole Pharmacol & Therapeut FATH, Brussels, Belgium; [Mace, Y.; Drouet, F.; Boidot, R.; Deraedt, Q.; Lamy, C.; Schicke, O.; Elias, B.; Riant, O.] Catholic Univ Louvain, Inst Condensed Matter & Nanosci Mol Solids & Reac, 1 Pl Louis Pasteur,Bte 3, B-1348 Louvain La Neuve, Belgium; [Bony, E.; Quetin-Leclercq, J.] Catholic Univ Louvain, LDRI, Pharmacognosy Res Grp GNOS, Louvain La Neuve, Belgium; [Rodriguez, J.; Kriegsheim, A. V.] Conway Inst, Syst Biol Ireland, Dublin 4, Ireland; [Kiss, R.] Univ Libre Bruxelles, Fac Pharm, Lab Cancerol & Toxicol Expt, Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Universite Libre de Bruxelles	Riant, O (corresponding author), Catholic Univ Louvain, Inst Condensed Matter & Nanosci Mol Solids & Reac, 1 Pl Louis Pasteur,Bte 3, B-1348 Louvain La Neuve, Belgium.; Feron, O (corresponding author), UCLouvain, IREC, Pole Pharmacol & Therapeut FATH, 53 Ave E Mounier,B1-53-09, B-1200 Brussels, Belgium.	olivier.riant@uclouvain.be; olivier.feron@uclouvain.be	von Kriegsheim, Alex/C-2371-2016; FERON, Olivier/AAM-6395-2020; rodriguez, javier/AAB-1131-2019; riant, olivier/AAU-3567-2021	von Kriegsheim, Alex/0000-0002-4952-8573; FERON, Olivier/0000-0001-5360-0286; rodriguez, javier/0000-0001-7467-8533; Deraedt, Quentin/0000-0001-9226-2777; riant, olivier/0000-0003-4852-6469; Leclercq, Joelle/0000-0002-2278-6206	Region Bruxelles Capitale (Innoviris); Fonds national de la Recherche Scientifique (FRS-FNRS); Belgian Foundation against cancer; J Maisin Foundation; Belgian Science Policy Office (Belspo) [UP7-03]; Action de Recherche Concertee [ARC 14/19]	Region Bruxelles Capitale (Innoviris)(Innoviris); Fonds national de la Recherche Scientifique (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); Belgian Foundation against cancer; J Maisin Foundation; Belgian Science Policy Office (Belspo)(Belgian Federal Science Policy Office); Action de Recherche Concertee	This work was supported by grants from the Region Bruxelles Capitale (Innoviris), the Fonds national de la Recherche Scientifique (FRS-FNRS), the Belgian Foundation against cancer, the J Maisin Foundation, the interuniversity attraction pole (IUAP) research program #UP7-03 from the Belgian Science Policy Office (Belspo) and an Action de Recherche Concertee (ARC 14/19).	Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Altun M, 2011, CHEM BIOL, V18, P1401, DOI 10.1016/j.chembiol.2011.08.018; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Brodsky JL, 2012, CELL, V151, P1163, DOI 10.1016/j.cell.2012.11.012; Brugarolas J, 2004, GENE DEV, V18, P2893, DOI 10.1101/gad.1256804; Cao YT, 2005, CANCER RES, V65, P5498, DOI 10.1158/0008-5472.CAN-04-4553; Castano AP, 2006, NAT REV CANCER, V6, P535, DOI 10.1038/nrc1894; Clarke HJ, 2014, CANCER CELL, V25, P563, DOI 10.1016/j.ccr.2014.03.015; Corbet C, 2014, CANCER RES, V74, P5507, DOI 10.1158/0008-5472.CAN-14-0705; Davies MJ, 2004, PHOTOCH PHOTOBIO SCI, V3, P17, DOI 10.1039/b307576c; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Diao YR, 2010, P NATL ACAD SCI USA, V107, P20974, DOI 10.1073/pnas.1007225107; Donohue E, 2011, J BIOL CHEM, V286, P7290, DOI 10.1074/jbc.M110.139915; Draoui N, 2014, MOL CANCER THER, V13, P1410, DOI 10.1158/1535-7163.MCT-13-0653; Hiraoka W, 2006, ULTRASON SONOCHEM, V13, P535, DOI 10.1016/j.ultsonch.2005.10.001; Hwang JY, 2012, J CONTROL RELEASE, V163, P368, DOI 10.1016/j.jconrel.2012.09.015; Jain A, 2014, P NATL ACAD SCI USA, V111, P17833, DOI 10.1073/pnas.1419425111; Li WM, 2007, CIRC RES, V100, P79, DOI 10.1161/01.RES.0000253094.03023.3f; Liu XY, 2007, MOL BIOL CELL, V18, P1073, DOI 10.1091/mbc.E06-05-0406; Ma YJ, 2004, NAT REV CANCER, V4, P966, DOI 10.1038/nrc1505; Mroz Pawel, 2011, Cancers (Basel), V3, P2516, DOI 10.3390/cancers3022516; Nadeau PJ, 2007, MOL BIOL CELL, V18, P3903, DOI 10.1091/mbc.E07-05-0491; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Nau W., 2011, CHEMPHYSCHEM, V12, P2496; Ng WY, 2007, J CELL SCI, V120, P682, DOI 10.1242/jcs.03351; Ormond AB, 2013, MATERIALS, V6, P817, DOI 10.3390/ma6030817; Poon E, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409001173; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Seront E, 2013, BRIT J CANCER, V109, P1586, DOI 10.1038/bjc.2013.505; Sueishi Y, 2014, J CLIN BIOCHEM NUTR, V54, P67, DOI 10.3164/jcbn.13-53; Takahara T, 2006, J BIOL CHEM, V281, P28605, DOI 10.1074/jbc.M606087200; Udeshi ND, 2013, NAT PROTOC, V8, P1950, DOI 10.1038/nprot.2013.120; van der Wijk T, 2004, J BIOL CHEM, V279, P44355, DOI 10.1074/jbc.M407483200; Wilson BC, 2008, PHYS MED BIOL, V53, pR61, DOI 10.1088/0031-9155/53/9/R01; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Wouters BG, 2008, NAT REV CANCER, V8, P851, DOI 10.1038/nrc2501; Yoshii H, 2012, BIOCHEM BIOPH RES CO, V417, P640, DOI 10.1016/j.bbrc.2011.12.024	37	22	22	0	24	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JUL 28	2016	35	30					3976	3985		10.1038/onc.2015.474	http://dx.doi.org/10.1038/onc.2015.474			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS8DJ	26686091				2022-12-26	WOS:000381013100009
J	Ji, QQ; Fang, ZP; Ye, Q; Ruan, ZR; Zhou, XL; Wang, ED				Ji, Quan-Quan; Fang, Zhi-Peng; Ye, Qing; Ruan, Zhi-Rong; Zhou, Xiao-Long; Wang, En-Duo			C-terminal Domain of Leucyl-tRNA Synthetase from Pathogenic Candida albicans Recognizes both tRNA(Ser) and tRNA(Leu)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						aminoacyl-tRNA synthetase; C-terminal domain (carboxyl tail domain; CTD); Candida albicans; enzyme mechanism; transfer RNA (tRNA); recognition; tRNALeu; tRNASer	SERYL-TRANSFER-RNA; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; QUALITY-CONTROL; CUG CODON; AMINOACYLATION; BINDING; ANTICODON; IDENTITY; COMPLEX	Leucyl-tRNA synthetase (LeuRS) is a multidomain enzyme that catalyzes Leu-tRNA(Leu) formation and is classified into bacterial and archaeal/eukaryotic types with significant diversity in the C-terminal domain (CTD). CTDs of both bacterial and archaeal LeuRSs have been reported to recognize tRNA(Leu) through different modes of interaction. In the human pathogen Candida albicans, the cytoplasmic LeuRS (CaLeuRS) is distinguished by its capacity to recognize a uniquely evolved chimeric tRNA(Ser) (CatRNA(Ser)(CAG)) in addition to its cognate CatRNA(Leu), leading to CUG codon reassignment. Our previous study showed that eukaryotic but not archaeal LeuRSs recognize this peculiar tRNA(Ser), suggesting the significance of their highly divergent CTDs in tRNA(Ser) recognition. The results of this study provided the first evidence of the indispensable function of the CTD of eukaryotic LeuRS in recognizing non-cognate CatRNA(Ser) and cognate CatRNA(Leu). Three lysine residues were identified as involved in mediating enzyme-tRNA interaction in the leucylation process: mutation of all three sites totally ablated the leucylation activity. The importance of the three lysine residues was further verified by gel mobility shift assays and complementation of a yeast leuS gene knock-out strain.	[Ji, Quan-Quan; Fang, Zhi-Peng; Ye, Qing; Ruan, Zhi-Rong; Zhou, Xiao-Long; Wang, En-Duo] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China; [Wang, En-Duo] ShanghaiTech Univ, Sch Life Sci & Technol, 319 Yue Yang Rd, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; ShanghaiTech University	Zhou, XL; Wang, ED (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, State Key Lab Mol Biol, 320 Yue Yang Rd, Shanghai 200031, Peoples R China.; Wang, ED (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, 319 Yue Yang Rd, Shanghai 200031, Peoples R China.	xlzhou@sibcb.ac.cn; edwang@sibcb.ac.cn	Ruan, Zhi-Rong/GYI-8935-2022	Ruan, Zhi-Rong/0000-0002-1806-2942; Fang, Zhipeng/0000-0001-5720-1709	National Key Basic Research Foundation of China [2012CB911000]; Natural Science Foundation of China [31130064, 91440204]; Committee of Science and Technology in Shanghai [12JC1409700, 15ZR1446500]; Youth Innovation Promotion Association, Chinese Academy of Sciences	National Key Basic Research Foundation of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Committee of Science and Technology in Shanghai(Shanghai Science & Technology Committee); Youth Innovation Promotion Association, Chinese Academy of Sciences	This work was supported in part by National Key Basic Research Foundation of China Grant 2012CB911000, Natural Science Foundation of China Grants 31130064 and 91440204, and Committee of Science and Technology in Shanghai Grants 12JC1409700 and 15ZR1446500. The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the Youth Innovation Promotion Association, Chinese Academy of Sciences (to X.-L. Z.).	BOREL F, 1994, NUCLEIC ACIDS RES, V22, P2963, DOI 10.1093/nar/22.15.2963; BRENNAN T, 1976, NUCLEIC ACIDS RES, V3, P3235, DOI 10.1093/nar/3.11.3235; Chen X, 2011, NUCLEIC ACIDS RES, V39, P235, DOI 10.1093/nar/gkq763; Christian T, 2007, J MOL BIOL, V373, P623, DOI 10.1016/j.jmb.2007.08.010; Cusack S, 2000, EMBO J, V19, P2351, DOI 10.1093/emboj/19.10.2351; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Fang ZP, 2014, NUCLEIC ACIDS RES, V42, P5109, DOI 10.1093/nar/gku108; Francin M, 2002, J BIOL CHEM, V277, P1762, DOI 10.1074/jbc.M109759200; Frugier M, 2000, EMBO J, V19, P2371, DOI 10.1093/emboj/19.10.2371; Fukai S, 2003, RNA, V9, P100, DOI 10.1261/rna.2760703; Fukunaga R, 2005, NAT STRUCT MOL BIOL, V12, P915, DOI 10.1038/nsmb985; Fukunaga R, 2005, J MOL BIOL, V346, P57, DOI 10.1016/j.jmb.2004.11.060; Hsu JL, 2006, J BIOL CHEM, V281, P23075, DOI 10.1074/jbc.M601606200; Hu QH, 2013, NUCLEIC ACIDS RES, V41, P1859, DOI 10.1093/nar/gks1307; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Lincecum TL, 2003, MOL CELL, V11, P951, DOI 10.1016/S1097-2765(03)00098-4; Ling C, 2005, J BIOL CHEM, V280, P34755, DOI 10.1074/jbc.M413511200; Moura GR, 2010, FEBS LETT, V584, P334, DOI 10.1016/j.febslet.2009.11.066; O'Sullivan JM, 2001, GENE, V275, P133, DOI 10.1016/S0378-1119(01)00632-1; Perreau VM, 1999, J MOL BIOL, V293, P1039, DOI 10.1006/jmbi.1999.3209; Rocha R, 2011, P NATL ACAD SCI USA, V108, P14091, DOI 10.1073/pnas.1102835108; Rocha R, 2011, ACTA CRYSTALLOGR F, V67, P153, DOI 10.1107/S1744309110048542; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; Ruan ZR, 2015, J BIOL CHEM, V290, P1664, DOI 10.1074/jbc.M114.599886; Santos MAS, 1996, EMBO J, V15, P5060, DOI 10.1002/j.1460-2075.1996.tb00886.x; SANTOS MAS, 1993, EMBO J, V12, P607, DOI 10.1002/j.1460-2075.1993.tb05693.x; Silva RM, 2007, EMBO J, V26, P4555, DOI 10.1038/sj.emboj.7601876; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Soma A, 1996, J MOL BIOL, V263, P707, DOI 10.1006/jmbi.1996.0610; STEINBERG S, 1993, NUCLEIC ACIDS RES, V21, P3011, DOI 10.1093/nar/21.13.3011; Suzuki T, 1997, EMBO J, V16, P1122, DOI 10.1093/emboj/16.5.1122; Tukalo M, 2005, NAT STRUCT MOL BIOL, V12, P923, DOI 10.1038/nsmb986; VINCENT C, 1995, NUCLEIC ACIDS RES, V23, P1113, DOI 10.1093/nar/23.7.1113; Yan W, 1996, BIOCHEMISTRY-US, V35, P6559, DOI 10.1021/bi952889f; Yao P, 2008, J BIOL CHEM, V283, P22591, DOI 10.1074/jbc.M801181200; Zheng YG, 2004, NUCLEIC ACIDS RES, V32, P3294, DOI 10.1093/nar/gkh665; Zhou XL, 2013, NUCLEIC ACIDS RES, V41, P9825, DOI 10.1093/nar/gkt741; Zhou XL, 2013, NUCLEIC ACIDS RES, V41, P302, DOI 10.1093/nar/gks982; Zhou XL, 2011, NUCLEIC ACIDS RES, V39, P8857, DOI 10.1093/nar/gkr595; Zhou XL, 2008, J BIOL CHEM, V283, P36608, DOI 10.1074/jbc.M806745200; Zhou XL, 2013, SCI CHINA LIFE SCI, V56, P921, DOI 10.1007/s11427-013-4542-9	42	4	4	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3613	3625		10.1074/jbc.M115.699777	http://dx.doi.org/10.1074/jbc.M115.699777			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26677220	hybrid, Green Published			2022-12-26	WOS:000370854500039
J	Cho, IJ; Chang, HJ; Chung, H; Lee, SE; Shim, CY; Hong, GR; Ha, JW; Chung, N				Cho, In-Jeong; Chang, Hyuk-Jae; Chung, Hyemoon; Lee, Sang-Eun; Shim, Chi Young; Hong, Geu-Ru; Ha, Jong-Won; Chung, Namsik			Differential Impact of Constrictive Physiology after Pericardiocentesis in Malignancy Patients with Pericardial Effusion	PLOS ONE			English	Article							CARDIAC-TAMPONADE; DIAGNOSTIC-VALUE; OUTCOMES; MANAGEMENT; CANCER; ECHOCARDIOGRAPHY; DRAINAGE; DISEASE	Background Echocardiographic signs of constrictive physiology (CP) after pericardiocentesis are frequently observed in malignancy patients. The purpose of the current study was to explore whether features of CP after pericardiocentesis have prognostic impact in malignancy patients with pericardial effusion (PE). Methods We retrospectively reviewed 467 consecutive patients who underwent pericardiocentesis at our institution from January 2006 to May 2014. Among them, 205 patients with advanced malignancy who underwent comprehensive echocardiography after the procedure comprised the study population. Co-primary end points were all-cause mortality (ACM) and repeated drainage (RD) for PE. Patients were divided into four subgroups according to cytologic result for malignant cells and CP (positive cytology with negative CP, both positive, both negative, and negative cytology with positive CP). Results CP after pericardiocentesis was present in 106 patients (50%) at median 4 days after the procedure. During median follow-up of 208 days, ACM and RD occurred in 162 patients (79%) and 29 patients (14%), respectively. Cox regression analysis revealed that independent predictors for ACM were male gender and positive cytology (all, p < 0.05). For RD, predictors were positive cytology, the absence of cardiac tamponade, and negative CP after pericardiocentesis (all, p < 0.05). When the patients were divided into four subgroups, patients with negative cytology and positive CP demonstrated the most favorable survival (hazard ratio [HR]: 0.39, p = 0.005) and the lowest RD rates (HR: 0.07, p = 0.012). Conclusion CP after pericardiocentesis is common, but does not always imply poor survival or the need for RD in patients with advanced malignancies. On the contrary, the presence of CP in patients with negative cytology conferred the most favorable survival and the lowest rate of RD. Comprehensive echocardiographic evaluation for CP after pericardiocentesis would be helpful for predicting prognosis in patients with advanced malignancies.	[Cho, In-Jeong; Chang, Hyuk-Jae; Chung, Hyemoon; Lee, Sang-Eun; Shim, Chi Young; Hong, Geu-Ru; Ha, Jong-Won; Chung, Namsik] Yonsei Univ, Coll Med, Dept Internal Med, Div Cardiol,Severance Hosp, Seoul, South Korea; [Chang, Hyuk-Jae] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Chang, HJ (corresponding author), Yonsei Univ, Coll Med, Dept Internal Med, Div Cardiol,Severance Hosp, Seoul, South Korea.	hjchang@yuhs.ac	Shim, Chi Young/AAK-1057-2021	Shim, Chi Young/0000-0002-6136-0136; Lee, Sang-Eun/0000-0001-6645-4038; Chang, Hyuk-Jae/0000-0002-6139-7545; Hong, Geu-Ru/0000-0003-4981-3304; Ha, Jong-Won/0000-0002-8260-2958	Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MSIP) [2012027176]	Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) - Ministry of Science, ICT & Future Planning (MSIP)	This research was supported by Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (MSIP) (No. 2012027176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyarajah V, 2007, TEX HEART I J, V34, P347; CAMPBELL PT, 1992, CHEST, V101, P938, DOI 10.1378/chest.101.4.938; Cosyns B, 2014, EUR HEART J CARDIOVA, V23; Cullinane CA, 2004, CHEST, V125, P1328, DOI 10.1378/chest.125.4.1328; Dal-Bianco JP, 2009, J AM SOC ECHOCARDIOG, V22, P24, DOI 10.1016/j.echo.2008.11.004; Ha JW, 2002, J AM SOC ECHOCARDIOG, V15, P1468, DOI 10.1067/mje.2002.127452; HANCOCK EW, 1980, AM HEART J, V100, P917, DOI 10.1016/0002-8703(80)90074-5; Im E, 2013, J AM COLL CARDIOL, V61, P2110, DOI 10.1016/j.jacc.2013.02.033; Laham RJ, 1996, HEART, V75, P67, DOI 10.1136/hrt.75.1.67; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Merce J, 1999, AM HEART J, V138, P759, DOI 10.1016/S0002-8703(99)70193-6; Patel N, 2013, AM J CARDIOL, V112, P1235, DOI 10.1016/j.amjcard.2013.05.066; POSNER MR, 1981, AM J MED, V71, P407, DOI 10.1016/0002-9343(81)90168-6; Rafique AM, 2011, AM J CARDIOL, V108, P1820, DOI 10.1016/j.amjcard.2011.07.057; Sagrista-Sauleda J, 2004, NEW ENGL J MED, V350, P469, DOI 10.1056/NEJMoa035630; SANFILIPPO AJ, 1990, CIRCULATION, V82, P792, DOI 10.1161/01.CIR.82.3.792; Talreja DR, 2003, CIRCULATION, V108, P1852, DOI 10.1161/01.CIR.0000087606.18453.FD; Tsang TSM, 2000, MAYO CLIN PROC, V75, P248; Tsang TSM, 2002, MAYO CLIN PROC, V77, P429; VAITKUS PT, 1994, JAMA-J AM MED ASSOC, V272, P59, DOI 10.1001/jama.272.1.59; Wang HJ, 2002, CHEST, V122, P893, DOI 10.1378/chest.122.3.893; Wang ZJ, 2003, RADIOGRAPHICS, V23, pS167, DOI 10.1148/rg.23si035504; WILKES JD, 1995, CANCER, V76, P1377, DOI 10.1002/1097-0142(19951015)76:8<1377::AID-CNCR2820760813>3.0.CO;2-M	23	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145461	10.1371/journal.pone.0145461	http://dx.doi.org/10.1371/journal.pone.0145461			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691279	gold, Green Submitted, Green Published			2022-12-26	WOS:000367092300079
J	Pan, SC; Chen, YC; Wang, JY; Sheng, WH; Lin, HH; Fang, CT; Chang, SC				Pan, Sung-Ching; Chen, Yee-Chun; Wang, Jann-Yuan; Sheng, Wang-Huei; Lin, Hsien-Ho; Fang, Chi-Tai; Chang, Shan-Chwen			Tuberculosis in Healthcare Workers: A Matched Cohort Study in Taiwan	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; INCREASED RISK; TRANSMISSION; INFECTION; DIAGNOSIS; MORTALITY; DISEASES; WORKING; STAFF	Background Proportional mortality ratio data indicate that healthcare workers (HCWs) have an elevated tuberculosis (TB) mortality. Whether this is caused by an increased TB incidence, a worse TB treatment outcome, or a combination of effects, remains unclear. To elucidate the hazard components of occupational TB, we assessed TB incidence and TB treatment outcome among HCWs in Taiwan. Methods We compared the incidence of active TB among HCWs at a major medical center in Taiwan with that of Taiwan general population in 2004-2012. We also compared the TB treatment outcome of HCWs with that of age/sex-matched non-HCW patients treated at the same hospital, as well as that of nationally registered TB patients. Results The standardized TB incidence ratio of the HCWs was 1.9 (95% confidence interval [CI]: 1.2-2.9), compared with the general population. HCWs with pulmonary TB (n = 30) were less likely to have underlying diseases, delay in diagnosis, delay in treatment, or side effects of treatment, compared with age/sex-matched non-HCW TB patients (n = 120) (all Ps<0.05). The TB treatment outcome of HCWs was significantly better than that of non-HCW patients (TB-related mortality: 0.0% vs. 5.8%, P = 0.008, Mantel-Haenszel test). The standardized TB-related mortality rate was 1.08%[ 95% CI: 0.96% - 1.20%] for all of the nationally registered TB patients in Taiwan. Conclusions HCWs are at increased risk of active TB, compared with general population. To mitigate this occupational hazard, more efforts need to be directed towards the prevention of nosocomial TB transmission. Healthy worker effect, more rapid diagnosis, and less delay in treatment contribute to a lower TB-related mortality in HCWs.	[Pan, Sung-Ching; Lin, Hsien-Ho; Fang, Chi-Tai] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan; [Pan, Sung-Ching; Chen, Yee-Chun; Wang, Jann-Yuan; Sheng, Wang-Huei; Fang, Chi-Tai; Chang, Shan-Chwen] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Chen, Yee-Chun; Chang, Shan-Chwen] Natl Taiwan Univ, Coll Med, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University	Fang, CT (corresponding author), Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan.	fangct@ntu.edu.tw; hsienho@gmail.com	Fang, Chi-Tai/P-2908-2016; Chen, Yee-Chun/AGW-7535-2022	Fang, Chi-Tai/0000-0002-7380-1699; Chen, Yee-Chun/0000-0002-1816-9010; WANG, JANN-YUAN/0000-0003-3406-366X; SHENG, WANG-HUEI/0000-0002-5605-7853; PAN, SUNG-CHING/0000-0003-3154-6690; LIN, HSIEN-HO/0000-0002-7481-6016; CHANG, SHAN-CHWEN/0000-0001-6505-4139				Alonso-Echanove J, 2001, CLIN INFECT DIS, V33, P589, DOI 10.1086/321892; [Anonymous], 2007, AD TOX TABL IN PRESS; [Anonymous], STAT COMM DIS SURV R; Babus V, 1997, INT J TUBERC LUNG D, V1, P254; Bang KM, 2005, INT J TUBERC LUNG D, V9, P437; Centers for Disease Control and Prevention (CDC), 1995, MMWR Morb Mortal Wkly Rep, V44, P14; Centers for Disease Control R.O.C. (Taiwan), 2012, EP TB TAIW; Centers for Disease Control R.O.C. (Taiwan), 2013, TAIW GUID TB DIAGN T; Centers for Disease Control R. O. C. (Taiwan), 2014, TAIW TUB CONTR REP 2; Centers for Disease Control Taiwan, 2015, HIV STAT TAIP; Chan PC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057719; Chiang CY, 2005, INT J TUBERC LUNG D, V9, P1006; Chien JY, 2015, CLIN MICROBIOL INFEC, V21, P59, DOI 10.1016/j.cmi.2014.08.008; Chou M, 2004, MMWR-MORBID MORTAL W, V51, P321; Cuhadaroglu C, 2002, BMC INFECT DIS, V2, DOI 10.1186/1471-2334-2-14; Dimitrova B, 2005, INT J TUBERC LUNG D, V9, P43; El-Sadr WM, 2008, SEMIN RESP CRIT CARE, V29, P525, DOI 10.1055/s-0028-1085703; Eyob G, 2002, INT J TUBERC LUNG D, V6, P85; Harries AD, 1999, T ROY SOC TROP MED H, V93, P32, DOI 10.1016/S0035-9203(99)90170-0; Holty JEC, 2009, CURR OPIN ORGAN TRAN, V14, P613, DOI 10.1097/MOT.0b013e3283324dfc; Hosoglu S, 2005, AM J INFECT CONTROL, V33, P23, DOI 10.1016/j.ajic.2004.07.013; Jarand J, 2010, TROP MED INT HEALTH, V15, P1179, DOI 10.1111/j.1365-3156.2010.02590.x; Kawatsu Lisa, 2014, Kekkaku, V89, P547; Kilinc O, 2002, RESP MED, V96, P506, DOI 10.1053/rmed.2002.1315; Kruuner A, 2001, INT J TUBERC LUNG D, V5, P170; Lash TL, 2008, MODERN EPIDEMIOLOGY, P267; Lee CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037978; Liu YC, 2010, INT J TUBERC LUNG D, V14, P72; McKenna MT, 1996, AM J RESP CRIT CARE, V154, P587, DOI 10.1164/ajrccm.154.3.8810591; Menzies D, 2007, INT J TUBERC LUNG D, V11, P593; MENZIES D, 1995, NEW ENGL J MED, V332, P92, DOI 10.1056/NEJM199501123320206; Orenstein EW, 2009, LANCET INFECT DIS, V9, P153, DOI 10.1016/S1473-3099(09)70041-6; Pleszewski B, 1998, INT J TUBERC LUNG D, V2, P898; Rao KG, 2004, INT J TUBERC LUNG D, V8, P1392; SEPKOWITZ KA, 1995, CLIN INFECT DIS, V21, P1098, DOI 10.1093/clinids/21.5.1098; Skodric V, 2000, INT J TUBERC LUNG D, V4, P827; Statistics Do, 2014, ABR LIF TABL TAIW MI; Taki Hisashi, 2008, Kekkaku, V83, P497; vanDeutekom H, 1997, CLIN INFECT DIS, V25, P1071, DOI 10.1086/516072; Vasankari T, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-291; Virenfeldt J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-004818; Wang FD, 2006, INFECT CONT HOSP EP, V27, P510, DOI 10.1086/503639; Wilkinson D, 1998, T ROY SOC TROP MED H, V92, P500, DOI 10.1016/S0035-9203(98)90889-6; World Health Organization, 2008, WHOHTMTB2008392	44	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145047	10.1371/journal.pone.0145047	http://dx.doi.org/10.1371/journal.pone.0145047			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26679188	Green Published, Green Submitted, gold			2022-12-26	WOS:000366723400046
J	Smirni, D; Turriziani, P; Mangano, GR; Cipolotti, L; Oliveri, M				Smirni, Daniela; Turriziani, Patrizia; Mangano, Giuseppa Renata; Cipolotti, Lisa; Oliveri, Massimiliano			Modulating Memory Performance in Healthy Subjects with Transcranial Direct Current Stimulation Over the Right Dorsolateral Prefrontal Cortex	PLOS ONE			English	Article							LONG-TERM-MEMORY; NONINVASIVE BRAIN-STIMULATION; VERBAL EPISODIC MEMORY; MAGNETIC STIMULATION; RECOGNITION MEMORY; ALZHEIMERS-DISEASE; INHIBITORY CONTROL; FRONTAL-CORTEX; OLDER-ADULTS; RETRIEVAL	Objective The role of the Dorsolateral Prefrontal Cortex (DLPFC) in recognition memory has been well documented in lesion, neuroimaging and repetitive Transcranial Magnetic Stimulation (rTMS) studies. The aim of the present study was to investigate the effects of transcranial Direct Current Stimulation (tDCS) over the left and the right DLPFC during the delay interval of a non-verbal recognition memory task. Method 36 right-handed young healthy subjects participated in the study. The experimental task was an Italian version of Recognition Memory Test for unknown faces. Study included two experiments: in a first experiment, each subject underwent one session of sham tDCS and one session of left or right cathodal tDCS; in a second experiment each subject underwent one session of sham tDCS and one session of left or right anodal tDCS. Results Cathodal tDCS over the right DLPFC significantly improved non verbal recognition memory performance, while cathodal tDCS over the left DLPFC had no effect. Anodal tDCS of both the left and right DLPFC did not modify non verbal recognition memory performance. Conclusion Complementing the majority of previous studies, reporting long term memory facilitations following left prefrontal anodal tDCS, the present findings show that cathodal tDCS of the right DLPFC can also improve recognition memory in healthy subjects.	[Smirni, Daniela; Turriziani, Patrizia; Mangano, Giuseppa Renata; Cipolotti, Lisa; Oliveri, Massimiliano] Univ Palermo, Dipartimento Sci Psicol Pedag & Formaz, Palermo, Italy; [Smirni, Daniela; Turriziani, Patrizia; Mangano, Giuseppa Renata; Cipolotti, Lisa; Oliveri, Massimiliano] NeuroTeam Life & Sci, Palermo, Italy; [Cipolotti, Lisa] Natl Hosp Neurol & Neurosurg, Dept Neuropsychol, London WC1N 3BG, England; [Oliveri, Massimiliano] IRCCS Fdn SantaLucia, Rome, Italy	University of Palermo; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Smirni, D (corresponding author), Univ Palermo, Dipartimento Sci Psicol Pedag & Formaz, Palermo, Italy.	daniela.smirni@unipa.it	Smirni, Daniela/R-3445-2019; Oliveri, Massimiliano/HDO-5602-2022	Smirni, Daniela/0000-0002-4410-2047; Turriziani, Patrizia/0000-0003-4802-280X; cipolotti, lisa/0000-0001-5838-3647				Acevedo A, 2007, J GERIATR PSYCH NEUR, V20, P239, DOI 10.1177/0891988707308808; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Ball K, 2002, JAMA-J AM MED ASSOC, V288, P2271, DOI 10.1001/jama.288.18.2271; Bestmann S, 2003, NEUROIMAGE, V20, P1685, DOI 10.1016/j.neuroimage.2003.07.028; Bilek E, 2013, J NEUROSCI, V33, P7050, DOI 10.1523/JNEUROSCI.3081-12.2013; Boggio PS, 2006, J NEUROL SCI, V249, P31, DOI 10.1016/j.jns.2006.05.062; Boggio PS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004959; Boggio PS, 2012, BRAIN STIMUL, V5, P223, DOI 10.1016/j.brs.2011.06.006; Boggio PS, 2011, NEUROPSYCHOL REHABIL, V21, P703, DOI 10.1080/09602011.2011.617943; Buckner RL, 2001, NAT REV NEUROSCI, V2, P624, DOI 10.1038/35090048; Chi RP, 2010, BRAIN RES, V1353, P168, DOI 10.1016/j.brainres.2010.07.062; Cipolotti L, 2008, NEUROPSYCHOLOGIA, V46, P2745, DOI 10.1016/j.neuropsychologia.2008.05.009; Cipolotti L, 2001, NEUROPSYCHOLOGIA, V39, P151, DOI 10.1016/S0028-3932(00)00103-2; Cotelli M, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00038; De Neys W, 2008, PSYCHOL SCI, V19, P483, DOI 10.1111/j.1467-9280.2008.02113.x; Ferrucci R, 2008, NEUROLOGY, V71, P493, DOI 10.1212/01.wnl.0000317060.43722.a3; Fletcher PC, 2001, BRAIN, V124, P849, DOI 10.1093/brain/124.5.849; Floel A, 2004, CEREB CORTEX, V14, P404, DOI 10.1093/cercor/bhh002; Gandiga PC, 2006, CLIN NEUROPHYSIOL, V117, P845, DOI 10.1016/j.clinph.2005.12.003; Habib R, 2003, TRENDS COGN SCI, V7, P241, DOI 10.1016/S1364-6613(03)00110-4; Hammer A, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-72; Jacobs HIL, 2015, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00344; Jacobson TK, 2013, J NEUROPHYSIOL, V109, P1852, DOI 10.1152/jn.00409.2012; Javadi AH, 2013, BRAIN STIMUL, V6, P668, DOI 10.1016/j.brs.2012.10.007; Javadi AH, 2012, BRAIN STIMUL, V5, P468, DOI 10.1016/j.brs.2011.08.003; Javadi AH, 2012, BRAIN STIMUL, V5, P231, DOI 10.1016/j.brs.2011.06.007; Juan CH, 2012, BRAIN STIMUL, V5, P63, DOI 10.1016/j.brs.2012.03.012; Kamida T, 2011, BEHAV BRAIN RES, V217, P99, DOI 10.1016/j.bbr.2010.08.050; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kincses TZ, 2004, NEUROPSYCHOLOGIA, V42, P113, DOI 10.1016/S0028-3932(03)00124-6; Kirchhoff BA, 2000, J NEUROSCI, V20, P6173, DOI 10.1523/JNEUROSCI.20-16-06173.2000; Knoch D, 2006, J NEUROSCI, V26, P6469, DOI 10.1523/JNEUROSCI.0804-06.2006; Manenti R, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00049; Manenti R, 2012, BRAIN STIMUL, V5, P103, DOI 10.1016/j.brs.2012.03.004; McDermott KB, 1999, J COGNITIVE NEUROSCI, V11, P631, DOI 10.1162/089892999563698; MILNER B, 1991, NEUROPSYCHOLOGIA, V29, P601, DOI 10.1016/0028-3932(91)90013-X; Nitsche MA, 2001, NEUROLOGY, V57, P1899, DOI 10.1212/WNL.57.10.1899; Oliveri M, 1999, BRAIN, V122, P1731, DOI 10.1093/brain/122.9.1731; Penolazzi B, 2014, J NEUROSCI, V34, P6606, DOI 10.1523/JNEUROSCI.0349-14.2014; Penolazzi B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010623; Pisoni A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123085; Rossi S, 2001, NAT NEUROSCI, V4, P948, DOI 10.1038/nn0901-948; Rounis E, 2006, J NEUROSCI, V26, P9629, DOI 10.1523/JNEUROSCI.2657-06.2006; Sandrini M, 2003, J COGNITIVE NEUROSCI, V15, P855, DOI 10.1162/089892903322370771; Sandrini M, 2013, CURR BIOL, V23, P2181, DOI 10.1016/j.cub.2013.08.045; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Smirni D., 2010, G ITAL PSICOL, V1, P227; Spaniol J, 2009, NEUROPSYCHOLOGIA, V47, P1765, DOI 10.1016/j.neuropsychologia.2009.02.028; Squire LR, 2004, NEUROBIOL LEARN MEM, V82, P171, DOI 10.1016/j.nlm.2004.06.005; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; TULVING E, 1994, P NATL ACAD SCI USA, V91, P2016, DOI 10.1073/pnas.91.6.2016; Turriziani P, 2008, BEHAV NEUROL, V19, P23, DOI 10.1155/2008/568057; Turriziani P, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00062; Turriziani P, 2010, NEUROIMAGE, V52, P348, DOI 10.1016/j.neuroimage.2010.04.007; van Kesteren MTR, 2010, P NATL ACAD SCI USA, V107, P7550, DOI 10.1073/pnas.0914892107; Wagner AD, 1998, BRAIN, V121, P1985, DOI 10.1093/brain/121.10.1985; Warrington E.K., 1984, RECOGNITION MEMORY T; Warrington EK, 1996, CAMDEN MEMORY TEST; Wermke M, 2008, EUR J NUCL MED MOL I, V35, pS12, DOI 10.1007/s00259-007-0698-5; Williams JA, 2010, PHYS THER, V90, P398, DOI 10.2522/ptj.20090075; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805; Zwissler B, 2014, J NEUROSCI, V34, P4022, DOI 10.1523/JNEUROSCI.5407-13.2014	62	36	37	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144838	10.1371/journal.pone.0144838	http://dx.doi.org/10.1371/journal.pone.0144838			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26679936	Green Published, Green Submitted, gold			2022-12-26	WOS:000366723400030
J	Zhang, ZR; Yu, H; Jiang, SS; Liao, JM; Lu, TL; Wang, LF; Zhang, D; Yue, WH				Zhang, Zhengrong; Yu, Hao; Jiang, Sisi; Liao, Jinmin; Lu, Tianlan; Wang, Lifang; Zhang, Dai; Yue, Weihua			Evidence for Association of Cell Adhesion Molecules Pathway and NLGN1 Polymorphisms with Schizophrenia in Chinese Han Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; BIPOLAR DISORDER; NEUROLIGIN 1; HUMAN BRAIN; RISK; METAANALYSIS; IDENTIFICATION; PSYCHOSIS; SYNAPSES	Multiple risk variants of schizophrenia have been identified by Genome-wide association studies (GWAS). As a complement for GWAS, previous pathway-based analysis has indicated that cell adhesion molecules (CAMs) pathway might be involved in the pathogenesis of schizophrenia. However, less replication studies have been reported. Our objective was to investigate the association between CAMs pathway and schizophrenia in the Chinese Han population. We first performed a pathway analysis utilizing our previous GWAS data. The CAMs pathway (hsa04514) was significantly associated with schizophrenia using hybrid gene set-based test (P = 1.03x10(-10)) and hypergeometric test (P = 5.04x10(-6)). Moreover, 12 genes (HLA-A, HLA-C, HLA-DOB, HLA-DPB1, HLA-DQA2, HLA-DRB1, MPZ, CD276, NLGN1, NRCAM, CLDN1 and ICAM3) were modestly significantly associated with schizophrenia (P<0.01). Then, we selected one promising gene neuroligin 1 (NLGN1) to further investigate the association between eight significant SNPs and schizophrenia in an independent sample (1814 schizophrenia cases and 1487 healthy controls). Our study showed that seven SNPs of NLGN1 and two haplotype blocks were significantly associated with schizophrenia. This association was confirmed by the results of combined analysis. Among them, SNP rs9835385 had the most significant association with schizophrenia (P = 2.83x10(-7)). Furthermore, in silico analysis we demonstrated that NLGN1 is preferentially expressed in human brain and SNP rs1488547 was related to the expression level. We validated the association of CAMs pathway with schizophrenia in pathway-level and identified one susceptibility gene NLGN1. Further investigation of the roles of CAMs pathway in the pathogenesis of schizophrenia is warranted.	[Zhang, Zhengrong; Jiang, Sisi; Liao, Jinmin; Lu, Tianlan; Wang, Lifang; Zhang, Dai; Yue, Weihua] Peking Univ, Inst Mental Hlth, Hosp 6, Beijing 100871, Peoples R China; [Zhang, Zhengrong; Jiang, Sisi; Liao, Jinmin; Lu, Tianlan; Wang, Lifang; Zhang, Dai; Yue, Weihua] Peking Univ, Minist Hlth, Key Lab Mental Hlth, Beijing 100871, Peoples R China; [Zhang, Zhengrong; Jiang, Sisi; Liao, Jinmin; Lu, Tianlan; Wang, Lifang; Zhang, Dai; Yue, Weihua] Peking Univ, Natl Clin Res Ctr Mental Disorders, Beijing 100871, Peoples R China; [Yu, Hao] Tsinghua Univ, Sch Life Sci, Beijing 100084, Peoples R China; [Yu, Hao; Zhang, Dai] Tsinghua Univ Peking Univ Joint Ctr Life Sci, Beijing, Peoples R China; [Zhang, Dai] Peking Univ, PKU IDG McGovern Inst Brain Res, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University; Tsinghua University; Peking University	Zhang, D (corresponding author), Peking Univ, Inst Mental Hlth, Hosp 6, Beijing 100871, Peoples R China.	daizhang@bjmu.edu.cn; dryue@bjmu.edu.cn	Yu, Hao/GYD-8698-2022	Yu, Hao/0000-0002-9785-8489	National Key Technology R&D Program of China [2015BAI13B01]; National Natural Science Foundation of China [81222017, 91232305, 81361120395, 81221002]; Program for New Century Excellent Talents in University [NCET-120008]	National Key Technology R&D Program of China(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This work was supported by the National Key Technology R&D Program of China (2015BAI13B01), National Natural Science Foundation of China (81222017, 91232305, 81361120395, and 81221002), Program for New Century Excellent Talents in University (NCET-120008).; We extend our gratitude to all subjects who participated in this study. This work was supported by grants from the National Natural Science Foundation of China (81222017, 91232305, 81361120395, and 81221002), National Key Technology R&D Program of China (2015BAI13B01), and Program for New Century Excellent Talents in University (NCET-120008).	Aberg KA, 2013, JAMA PSYCHIAT, V70, P573, DOI 10.1001/jamapsychiatry.2013.288; ANDREASEN NC, 1995, LANCET, V346, P477, DOI 10.1016/S0140-6736(95)91325-4; Andreassen O. A, 2014, MOL PSYCHIAT; Askland K, 2012, HUM GENET, V131, P373, DOI 10.1007/s00439-011-1082-x; Bacanu SA, 2014, MOL PSYCHIATR, V19, P276, DOI 10.1038/mp.2013.33; Benita Y, 2010, BLOOD, V115, P5376, DOI 10.1182/blood-2010-01-263855; Benson DL, 2000, TRENDS CELL BIOL, V10, P473, DOI 10.1016/S0962-8924(00)01838-9; Blundell J, 2010, J NEUROSCI, V30, P2115, DOI 10.1523/JNEUROSCI.4517-09.2010; Bray NJ, 2008, SCHIZOPHRENIA BULL, V34, P412, DOI 10.1093/schbul/sbn013; Brown AS, 2006, SCHIZOPHRENIA BULL, V32, P200, DOI 10.1093/schbul/sbj052; Bundy H, 2011, ACTA PSYCHIAT SCAND, V123, P98, DOI 10.1111/j.1600-0447.2010.01623.x; Choi YB, 2011, NEURON, V70, P468, DOI 10.1016/j.neuron.2011.03.020; Corvin A, 2014, BIOL PSYCHIAT, V75, P276, DOI 10.1016/j.biopsych.2013.09.018; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dimas AS, 2009, SCIENCE, V325, P1246, DOI 10.1126/science.1174148; Eaton WW, 2006, AM J PSYCHIAT, V163, P521, DOI 10.1176/appi.ajp.163.3.521; Elangbam CS, 1997, VET PATHOL, V34, P61, DOI 10.1177/030098589703400113; Feinberg K, 2010, NEURON, V65, P490, DOI 10.1016/j.neuron.2010.02.004; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Giusti-Rodriguez P, 2013, J CLIN INVEST, V123, P4557, DOI 10.1172/JCI66031; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Hargreaves A, 2014, PSYCHOL MED, V44, P2177, DOI 10.1017/S0033291713002663; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Honer WG, 1997, NEUROSCIENCE, V78, P99, DOI 10.1016/S0306-4522(96)00489-7; Jia PL, 2010, SCHIZOPHR RES, V122, P38, DOI 10.1016/j.schres.2010.07.001; Kang HJ, 2011, NATURE, V478, P483, DOI 10.1038/nature10523; Lewis CM, 2010, AM J PSYCHIAT; Li MX, 2012, AM J HUM GENET, V91, P478, DOI 10.1016/j.ajhg.2012.08.004; Li MX, 2011, AM J HUM GENET, V88, P283, DOI 10.1016/j.ajhg.2011.01.019; Mighdoll MI, 2015, SCHIZOPHR RES, V161, P85, DOI 10.1016/j.schres.2014.09.040; Millson A, 2012, AM J MED GENET A, V158A, P159, DOI 10.1002/ajmg.a.34349; Mowry BJ, 2013, MOL PSYCHIATR, V18, P38, DOI 10.1038/mp.2012.34; Murphy A, 2010, HUM MOL GENET, V19, P4745, DOI 10.1093/hmg/ddq392; O'Donovan MC, 2008, NAT GENET, V40, P1053, DOI 10.1038/ng.201; O'Dushlaine C, 2011, MOL PSYCHIATR, V16, P286, DOI 10.1038/mp.2010.7; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Ramasamy A, 2014, NAT NEUROSCI, V17, P1418, DOI 10.1038/nn.3801; Reissner C, 2008, P NATL ACAD SCI USA, V105, P15124, DOI 10.1073/pnas.0801639105; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Ripke S, 2013, NAT GENET, V45, P1150, DOI 10.1038/ng.2742; Sakurai T, 2012, MOL CELL NEUROSCI, V49, P351, DOI 10.1016/j.mcn.2011.12.002; Sanes JR, 2009, ANNU REV CELL DEV BI, V25, P161, DOI 10.1146/annurev.cellbio.24.110707.175402; Singh S, 2014, GENE, V535, P97, DOI 10.1016/j.gene.2013.09.110; Song JY, 1999, P NATL ACAD SCI USA, V96, P1100, DOI 10.1073/pnas.96.3.1100; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Sullivan PF, 2003, ARCH GEN PSYCHIAT, V60, P1187, DOI 10.1001/archpsyc.60.12.1187; Sun CC, 2011, HUM MOL GENET, V20, P3042, DOI 10.1093/hmg/ddr208; Sun YV, 2012, HUM GENET, V131, P1677, DOI 10.1007/s00439-012-1198-7; van Os J, 2010, NATURE, V468, P203, DOI 10.1038/nature09563; Vawter MP, 1999, MOL PSYCHIATR, V4, P467, DOI 10.1038/sj.mp.4000547; Wang K, 2010, NAT REV GENET, V11, P843, DOI 10.1038/nrg2884; Wright JW, 2002, PEPTIDES, V23, P221, DOI 10.1016/S0196-9781(01)00599-X; Yang TP, 2010, BIOINFORMATICS, V26, P2474, DOI 10.1093/bioinformatics/btq452; Yang XF, 2014, PROTEIN CELL, V5, P420, DOI 10.1007/s13238-014-0054-z; Yu H, 2014, PROG NEURO-PSYCHOPH, V51, P140, DOI 10.1016/j.pnpbp.2014.01.006; Yue WH, 2011, NAT GENET, V43, P1228, DOI 10.1038/ng.979; Yue WH, 2011, BEHAV BRAIN FUNCT, V7, DOI 10.1186/1744-9081-7-7; Zou FG, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002707	58	19	20	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144719	10.1371/journal.pone.0144719	http://dx.doi.org/10.1371/journal.pone.0144719			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674772	Green Published, Green Submitted, gold			2022-12-26	WOS:000366722700056
J	Xie, CY; Cao, X; Chen, XB; Wang, D; Zhang, WK; Sun, Y; Hu, WB; Zhou, ZJ; Wang, Y; Huang, PB				Xie, Changyan; Cao, Xu; Chen, Xibing; Wang, Dong; Zhang, Wei Kevin; Sun, Ying; Hu, Wenbao; Zhou, Zijing; Wang, Yan; Huang, Pingbo			Mechanosensitivity of wild-type and G551D cystic fibrosis transmembrane conductance regulator (CFTR) controls regulatory volume decrease in simple epithelia	FASEB JOURNAL			English	Article						hypotonicity; ion channel; mechanosensitive; osmotic swelling	SENSITIVE CL-CHANNELS; ESSENTIAL COMPONENT; CHLORIDE CHANNELS; AIRWAY EPITHELIUM; PRIMARY CULTURES; ANION CHANNELS; CURRENTS; ACTIVATION; MUTATION; CELLS	Mutations of cysticfibrosis transmembrane conductance regulator (CFTR), an epithelial ligand-gated anion channel, are associated with the lethal genetic disease cystic fibrosis. The CFTR G551D mutation impairs ATP hydrolysis and thereby makes CFTR refractory to cAMP stimulation. Both wild-type (WT) and G551D CFTR have been implicated in regulatory volume decrease (RVD), but the underlying mechanism remains incompletely understood. Here, we show that the channel activity of both WT and G551D CFTR is directly stimulated by mechanical perturbation induced by cell swelling at the single-channel, cellular, and tissue levels. Hypotonicity activated CFTR single channels in cell-attached membrane patches and WT-CFTR-mediated short-circuit current (Isc) in Calu-3 cells, and this was independent of Ca2+ and cAMP/PKA signaling. Genetic suppression and ablation but not G551D mutation of CFTR suppressed the hypotonicity- and stretch-induced Isc in Calu-3 cells and mouse duodena. Moreover, ablation but not G551D mutation of the CFTR gene inhibited the RVD of crypts isolated from mouse intestine; more importantly, CFTR-specific blockers markedly suppressed RVD in both WT- and G551DCFTRmice, demonstrating for thefirst time that the channel activity of both WT and G551D CFTR is required for epithelial RVD. Our findings uncover a previously unrecognized mechanism underlying CFTR involvement in epithelial RVD and suggest that the mechanosensitivity of G551D CFTR might underlie the mild phenotypes resulting from this mutation.-Xie, C., Cao, X., Chen, X, Wang, D., Zhang, W. K., Sun, Y., Hu, W., Zhou, Z., Wang, Y., Huang, P. Mechanosensitivity of wild-type and G551D cystic fibrosis transmembrane conductance regulator (CFTR) controls regulatory volume decrease in simple epithelia. FASEB J. 30, 1579-1589 (2016). www.fasebj.org	[Xie, Changyan; Cao, Xu; Chen, Xibing; Wang, Dong; Zhang, Wei Kevin; Sun, Ying; Hu, Wenbao; Zhou, Zijing; Wang, Yan; Huang, Pingbo] Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China; [Huang, Pingbo] Hong Kong Univ Sci & Technol, Div Biomed Engn, Hong Kong, Hong Kong, Peoples R China; [Huang, Pingbo] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Hong Kong, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Huang, PB (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Kowloon, Hong Kong, Peoples R China.	bohuangp@ust.hk	Sun, Ying/F-9124-2019; Zhang, Wei/M-4241-2019	Zhang, Wei/0000-0003-4960-6137; Huang, Pingbo/0000-0002-4560-8760	Hong Kong Research Grants Council [GRF660913, GRF16102415]; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA035165] Funding Source: NIH RePORTER	Hong Kong Research Grants Council(Hong Kong Research Grants Council); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors are grateful to B. Wainwright (University of Queensland, Brisbane, QLD, Australia) and D. M. Bedwell (University of Alabama at Birmingham, Birmingham, AL, USA) for generating and providing G551D CFTR mice, and to T. C. Hwang (University of Missouri, Columbia, MO, USA) for providing the cDNA of G551D CFTR. The authors thank K.-L. So for technical support. This work was supported by Hong Kong Research Grants Council (Grants GRF660913 and GRF16102415 to P.H.). The authors declare no conflicts of interest.	Amlal H, 2000, AM J PHYSIOL-RENAL, V279, pF532, DOI 10.1152/ajprenal.2000.279.3.F532; Ando-Akatsuka Y, 2002, PFLUG ARCH EUR J PHY, V445, P177, DOI 10.1007/s00424-002-0920-z; Bajnath RB, 1997, PFLUG ARCH EUR J PHY, V433, P276; Barriere H, 2003, AM J PHYSIOL-RENAL, V284, pF796, DOI 10.1152/ajprenal.00237.2002; Becker D, 2005, J CELL SCI, V118, P2435, DOI 10.1242/jcs.02372; Belfodil R, 2003, AM J PHYSIOL-RENAL, V284, pF812, DOI 10.1152/ajprenal.00238.2002; Bompadre SG, 2007, J GEN PHYSIOL, V129, P285, DOI 10.1085/jgp.200609667; Bond TD, 1998, J PHYSIOL-LONDON, V511, P45, DOI 10.1111/j.1469-7793.1998.045bi.x; Braunstein Gavin M, 2004, J Cyst Fibros, V3, P99, DOI 10.1016/j.jcf.2004.01.006; CHAN HC, 1992, AM J PHYSIOL, V262, pC1273, DOI 10.1152/ajpcell.1992.262.5.C1273; CHAN HC, 1992, J BIOL CHEM, V267, P8411; Comer DM, 2009, QJM-INT J MED, V102, P793, DOI 10.1093/qjmed/hcp120; Dagenais A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074565; De Smet P, 1998, AM J PHYSIOL-CELL PH, V275, pC189, DOI 10.1152/ajpcell.1998.275.1.C189; Delaney SJ, 1996, EMBO J, V15, P955, DOI 10.1002/j.1460-2075.1996.tb00432.x; Devor DC, 1999, J GEN PHYSIOL, V113, P743, DOI 10.1085/jgp.113.5.743; Diener M, 1996, PFLUG ARCH EUR J PHY, V432, P293, DOI 10.1007/s004240050136; Duan YY, 2012, J BIOL CHEM, V287, P40547, DOI 10.1074/jbc.M112.403584; Furst J, 2002, PFLUG ARCH EUR J PHY, V444, P1, DOI 10.1007/s00424-002-0805-1; Gisolfi CV, 1998, J APPL PHYSIOL, V85, P1941, DOI 10.1152/jappl.1998.85.5.1941; Gottlieb RA, 1996, P NATL ACAD SCI USA, V93, P3587, DOI 10.1073/pnas.93.8.3587; Gray Michael A, 2010, Cellscience, V7, P1; Hamill OP, 2007, CURR TOP MEMBR, V59, P191, DOI 10.1016/S1063-5823(06)59009-X; Harron SA, 2009, CAN J PHYSIOL PHARM, V87, P337, DOI [10.1139/Y09-009, 10.1139/y09-009]; HAWS C, 1994, AM J PHYSIOL, V266, pL502, DOI 10.1152/ajplung.1994.266.5.L502; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Ichishima K, 2010, BRIT J PHARMACOL, V161, P193, DOI 10.1111/j.1476-5381.2010.00896.x; Joiner CH, 2007, BLOOD, V109, P1728, DOI 10.1182/blood-2006-04-018630; Krouse ME, 2004, AM J PHYSIOL-LUNG C, V287, pL1274, DOI 10.1152/ajplung.00036.2004; Kumar L, 2014, J EXP MED, V211, P929, DOI 10.1084/jem.20131379; Kunzelmann K, 2015, TRENDS BIOCHEM SCI, V40, P535, DOI 10.1016/j.tibs.2015.07.005; Lemoine JL, 2005, GENE THER, V12, P1275, DOI 10.1038/sj.gt.3302548; Liu Y, 1998, AM J PHYSIOL-CELL PH, V275, pC343; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Ma TH, 2002, J BIOL CHEM, V277, P37235, DOI 10.1074/jbc.M205932200; MacVinish LJ, 2007, BRIT J PHARMACOL, V150, P1055, DOI 10.1038/sj.bjp.0707175; MCCANN JD, 1989, J GEN PHYSIOL, V94, P1015, DOI 10.1085/jgp.94.6.1015; Milenkovic A, 2015, P NATL ACAD SCI USA, V112, pE2630, DOI 10.1073/pnas.1418840112; MORRIS CE, 1989, SCIENCE, V243, P807, DOI 10.1126/science.2536958; Oceandy D, 2002, HUM MOL GENET, V11, P1059, DOI 10.1093/hmg/11.9.1059; Okada Y, 2004, PFLUG ARCH EUR J PHY, V448, P287, DOI 10.1007/s00424-004-1276-3; Okada Y, 2009, J PHYSIOL-LONDON, V587, P2141, DOI 10.1113/jphysiol.2008.165076; Parad RB, 1996, J MED GENET, V33, P711, DOI 10.1136/jmg.33.8.711; Pedersen SF, 1998, J MEMBRANE BIOL, V163, P97, DOI 10.1007/s002329900374; Qiu ZZ, 2014, CELL, V157, P447, DOI 10.1016/j.cell.2014.03.024; Sachs F, 2010, PHYSIOLOGY, V25, P50, DOI 10.1152/physiol.00042.2009; Sardini A, 2003, BBA-BIOMEMBRANES, V1618, P153, DOI 10.1016/j.bbamem.2003.10.008; Sawada A, 2003, J CLIN INVEST, V112, P1707, DOI 10.1172/JCI18937; Schultz BD, 1996, AM J PHYSIOL-LUNG C, V271, pL192, DOI 10.1152/ajplung.1996.271.2.L192; Schwiebert EM, 1998, P NATL ACAD SCI USA, V95, P2674, DOI 10.1073/pnas.95.5.2674; SHEN RQ, 1994, AM J PHYSIOL, V266, pL493, DOI 10.1152/ajplung.1994.266.5.L493; SMALL DL, 1994, AM J PHYSIOL, V267, pC598, DOI 10.1152/ajpcell.1994.267.2.C598; SNOUWAERT JN, 1992, SCIENCE, V257, P1083, DOI 10.1126/science.257.5073.1083; Sun Y, 2012, J CELL SCI, V125, P4507, DOI 10.1242/jcs.105023; VALVERDE MA, 1995, P NATL ACAD SCI USA, V92, P9038, DOI 10.1073/pnas.92.20.9038; Valverde MA, 2000, CELL PHYSIOL BIOCHEM, V10, P321, DOI 10.1159/000016365; VALVERDE MA, 1993, PFLUG ARCH EUR J PHY, V425, P552, DOI 10.1007/BF00374885; VALVERDE MA, 1993, PFLUG ARCH EUR J PHY, V425, P434, DOI 10.1007/BF00374869; Vazquez E, 2001, P NATL ACAD SCI USA, V98, P5329, DOI 10.1073/pnas.091096498; Vennekens R, 1999, J PHYSIOL-LONDON, V515, P75, DOI 10.1111/j.1469-7793.1999.075ad.x; Voets T, 1999, P NATL ACAD SCI USA, V96, P5298, DOI 10.1073/pnas.96.9.5298; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Wan XD, 1999, AM J PHYSIOL-CELL PH, V276, pC318, DOI 10.1152/ajpcell.1999.276.2.C318; Wang D, 2008, AM J PHYSIOL-CELL PH, V294, pC1443, DOI 10.1152/ajpcell.00556.2007; Wang Y, 2005, AM J PHYSIOL-CELL PH, V289, pC1145, DOI 10.1152/ajpcell.00627.2004; Watt AP, 2005, THORAX, V60, P659, DOI 10.1136/thx.2004.038240; Zhang WK, 2010, NAT CELL BIOL, V12, P507, DOI 10.1038/ncb2053	67	6	6	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1579	1589		10.1096/fj.15-283002	http://dx.doi.org/10.1096/fj.15-283002			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26683699	Green Published			2022-12-26	WOS:000372629100019
J	Zhang, GH; An, YF; Lu, X; Zhong, H; Zhu, YH; Wu, YM; Ma, F; Yang, JM; Liu, YC; Zhou, ZP; Peng, Y; Chen, ZF				Zhang, Guohai; An, Yunfeng; Lu, Xing; Zhong, Hui; Zhu, Yanhong; Wu, Yiming; Ma, Feng'e; Yang, Jingmei; Liu, Yancheng; Zhou, Zuping; Peng, Yan; Chen, Zhenfeng			A Novel Naphthalimide Compound Restores p53 Function in Non-small Cell Lung Cancer by Reorganizing the Bak center dot Bcl-xl Complex and Triggering Transcriptional Regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						anticancer drug; apoptosis; cell cycle; lung cancer; p53	SER389 PHOSPHORYLATION; DNA-DAMAGE; PROTEIN; APOPTOSIS; PATHWAY; PROLIFERATION; ACCUMULATION; STATISTICS; ACTIVATION; ARREST	p53 inactivation is a hallmark in non-small-cell lung cancer (NSCLC). It is therefore highly desirable to develop tumor-specific treatment for NSCLC therapy by restoring p53 function. Herein, a novel naphthalimide compound, NA-17, was identified as a promising drug candidate in view of both its anticancer activity and mechanism of action. NA-17 exhibited strong anticancer activity on a broad range of cancer cell lines but showed low toxicity to normal cell lines, such as HL-7702 and WI-38. Moreover, NA-17 showed p53-dependent inhibition selectivity in different NSCLC cell lines due to the activation state of endogenous p53 in the background level. Further studies revealed that NA-17 caused cell cycle arrest at the G(1) phase, changed cell size, and induced apoptosis and cell death by increasing the proportion of sub-G(1) cells. Molecular mechanism studies suggested that targeted accumulation of phospho-p53 in mitochondria and nuclei induced by NA-17 resulted in activation of Bak and direct binding of phospho-p53 to the target DNA sequences, thereby evoking cell apoptosis and cell cycle arrest and eventually leading to irreversible cancer cell inhibition. This work provided new insights into the molecular interactions and anticancer mechanisms of phospho-p53-dependent naphthalimide compounds.	[Zhang, Guohai; An, Yunfeng; Lu, Xing; Zhong, Hui; Zhu, Yanhong; Wu, Yiming; Ma, Feng'e; Yang, Jingmei; Liu, Yancheng; Zhou, Zuping; Peng, Yan; Chen, Zhenfeng] Guangxi Normal Univ, Sch Pharm & Chem, State Key Lab Chem & Mol Engn Med Resources, Yucai Rd 15, Guilin 541004, Peoples R China	Guangxi Normal University	Peng, Y; Chen, ZF (corresponding author), Guangxi Normal Univ, Sch Pharm & Chem, State Key Lab Chem & Mol Engn Med Resources, Yucai Rd 15, Guilin 541004, Peoples R China.	pengyan630@gxnu.edu.cn; chenzf@gxnu.edu.cn		Lu, Xing/0000-0002-2796-4390	Natural Science Foundation of China [81401912]; Ministry of Education Innovation Team [IRT1225]; Natural Science Foundation of Guangxi Province [2013GXNS-FBA019159, 2014GXNSFAA118165, 2015GXNSFDA139010]; Guangxi Scientific Research and Technology Development Project [13349002]; Guangxi Pharmaceutical Industry Talent Small Highland Project [1309, 1312]; Foundation of State Key Laboratory Cultivation Base for the Chemistry and Molecular Engineering of Medicinal Resources; Ministry of Science and Technology of China [CMEMR2015-A09, CMEMR2013-A07]; Bagui scholar program	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education Innovation Team; Natural Science Foundation of Guangxi Province(National Natural Science Foundation of Guangxi Province); Guangxi Scientific Research and Technology Development Project; Guangxi Pharmaceutical Industry Talent Small Highland Project; Foundation of State Key Laboratory Cultivation Base for the Chemistry and Molecular Engineering of Medicinal Resources; Ministry of Science and Technology of China(Ministry of Science and Technology, China); Bagui scholar program	This work was supported by Natural Science Foundation of China Grant 81401912; The Ministry of Education Innovation Team Grant IRT1225; Natural Science Foundation of Guangxi Province Grants 2013GXNS-FBA019159, 2014GXNSFAA118165, and 2015GXNSFDA139010; Guangxi Scientific Research and Technology Development Project Grant 13349002; Guangxi Pharmaceutical Industry Talent Small Highland Project Grants 1309 and 1312; the Foundation of State Key Laboratory Cultivation Base for the Chemistry and Molecular Engineering of Medicinal Resources; Ministry of Science and Technology of China Grants CMEMR2015-A09 and CMEMR2013-A07; and the Bagui scholar program (to Z. Z.). The authors declare that they have no conflicts of interest with the contents of this article.	Abe Y, 2001, J BIOL CHEM, V276, P44003, DOI 10.1074/jbc.M105669200; Bates S, 1998, NATURE, V395, P124, DOI 10.1038/25867; Bourouba M, 2011, EUR CYTOKINE NETW, V22, P38, DOI 10.1684/ecn.2011.0270; Brady CA, 2011, CELL, V145, P571, DOI 10.1016/j.cell.2011.03.035; Bruins W, 2008, MOL CELL BIOL, V28, P1974, DOI 10.1128/MCB.01610-07; Busch SE, 2014, ONCOGENE, V33, P2665, DOI 10.1038/onc.2013.208; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Elias J, 2014, BBA-PROTEINS PROTEOM, V1844, P232, DOI 10.1016/j.bbapap.2013.09.019; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Follis AV, 2014, NAT STRUCT MOL BIOL, V21, P535, DOI 10.1038/nsmb.2829; Freeman CL, 2012, EXPERT REV HEMATOL, V5, P17, DOI [10.1586/ehm.11.68, 10.1586/EHM.11.68]; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Hao MM, 1996, J BIOL CHEM, V271, P29380, DOI 10.1074/jbc.271.46.29380; Hoogervorst EM, 2005, CANCER RES, V65, P3610, DOI 10.1158/0008-5472.CAN-04-4328; Ingrassia L, 2009, CURR MED CHEM, V16, P1192, DOI 10.2174/092986709787846659; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Li HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037657; Llambi F, 2011, MOL CELL, V44, P517, DOI 10.1016/j.molcel.2011.10.001; Marcel V, 2013, CANCER CELL, V24, P318, DOI 10.1016/j.ccr.2013.08.013; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; MIYASHITA T, 1995, CELL, V80, P293; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Mollereau B, 2014, APOPTOSIS, V19, P1421, DOI 10.1007/s10495-014-1035-7; Nieminen AI, 2013, P NATL ACAD SCI USA, V110, pE1839, DOI 10.1073/pnas.1208530110; Otera H, 2005, EMBO J, V24, P1375, DOI 10.1038/sj.emboj.7600614; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sot B, 2007, J BIOL CHEM, V282, P29193, DOI 10.1074/jbc.M705544200; Van Quaquebeke E, 2007, J MED CHEM, V50, P4122, DOI 10.1021/jm070315q; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Walls TH, 2012, BIOORGAN MED CHEM, V20, P5269, DOI 10.1016/j.bmc.2012.06.042; Wawryk-Gawda E, 2014, PROTOPLASMA, V251, P525, DOI 10.1007/s00709-013-0548-1; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Westphal D, 2011, BBA-MOL CELL RES, V1813, P521, DOI 10.1016/j.bbamcr.2010.12.019; Yao GD, 2014, ARCH BIOCHEM BIOPHYS, V558, P51, DOI 10.1016/j.abb.2014.05.029; Zhang GH, 2013, BIOCHEM PHARMACOL, V86, P1721, DOI 10.1016/j.bcp.2013.10.013; Zhang YW, 2014, INT J CANCER, V134, P1013, DOI 10.1002/ijc.28226; Zhu H, 2009, NEOPLASIA, V11, P1226, DOI 10.1593/neo.09986	44	27	28	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 19	2016	291	8					4211	4225		10.1074/jbc.M115.669978	http://dx.doi.org/10.1074/jbc.M115.669978			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF4RQ	26668309	Green Published, hybrid			2022-12-26	WOS:000371338400044
J	Chang, CW; Chiang, CW; Gaffaney, JD; Chapman, ER; Jackson, MB				Chang, Che-Wei; Chiang, Chung-Wei; Gaffaney, Jon D.; Chapman, Edwin R.; Jackson, Meyer B.			Lipid-anchored Synaptobrevin Provides Little or No Support for Exocytosis or Liposome Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED MEMBRANE-FUSION; CA2+-TRIGGERED EXOCYTOSIS; VESICLE FUSION; SNARE COMPLEX; TRANSMEMBRANE-DOMAIN; C-TERMINUS; PORES; SYNAPTOTAGMIN; FORCE; SUFFICIENT	SNARE proteins catalyze many forms of biological membrane fusion, including Ca2+-triggered exocytosis. Although fusion mediated by SNAREs generally involves proteins anchored to each fusing membrane by a transmembrane domain (TMD), the role of TMDs remains unclear, and previous studies diverge on whether SNAREs can drive fusion without a TMD. This issue is important because it relates to the question of the structure and composition of the initial fusion pore, as well as the question of whether SNAREs mediate fusion solely by creating close proximity between two membranes versus a more active role in transmitting force to the membrane to deform and reorganize lipid bilayer structure. To test the role of membrane attachment, we generated four variants of the synaptic v-SNARE synaptobrevin-2 (syb2) anchored to the membrane by lipid instead of protein. These constructs were tested for functional efficacy in three different systems as follows: Ca2+-triggered dense core vesicle exocytosis, spontaneous synaptic vesicle exocytosis, and Ca2+-synaptotagmin-enhanced SNARE-mediated liposome fusion. Lipid-anchoring motifs harboring one or two lipid acylation sites completely failed to support fusion in any of these assays. Only the lipid-anchoring motif from cysteine string protein-alpha, which harbors many lipid acylation sites, provided support for fusion but at levels well below that achieved with wild type syb2. Thus, lipid-anchored syb2 provides little or no support for exocytosis, and anchoring syb2 to a membrane by a TMD greatly improves its function. The low activity seen with syb2-cysteine string protein-alpha may reflect a slower alternative mode of SNARE-mediated membrane fusion.	[Chang, Che-Wei; Jackson, Meyer B.] Univ Wisconsin, Physiol PhD Grad Training Program, Madison, WI 53705 USA; [Chiang, Chung-Wei; Chapman, Edwin R.; Jackson, Meyer B.] Univ Wisconsin, Biophys PhD Program, Madison, WI 53705 USA; [Gaffaney, Jon D.; Chapman, Edwin R.] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53705 USA; [Chapman, Edwin R.; Jackson, Meyer B.] Univ Wisconsin, Dept Neurosci, 1111 Highland Ave, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Jackson, MB (corresponding author), Univ Wisconsin, Dept Neurosci, 1111 Highland Ave, Madison, WI 53705 USA.	mbjackso@wisc.edu		Chiang, Chung-Wei/0000-0002-9443-914X; Chapman, Edwin/0000-0001-9787-8140	National Institutes of Health [NS44057, MH061876]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH061876] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044057] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grants NS44057 (to M. B. J.) and MH061876 (to E. R. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Borisovska M, 2005, EMBO J, V24, P2114, DOI 10.1038/sj.emboj.7600696; Borisovska M, 2012, J NEUROSCI, V32, P15983, DOI 10.1523/JNEUROSCI.6282-11.2012; Chang CW, 2015, BIOPHYS J, V109, P76, DOI 10.1016/j.bpj.2015.05.021; Chang CW, 2015, J NEUROSCI, V35, P5772, DOI 10.1523/JNEUROSCI.3983-14.2015; Chicka MC, 2008, NAT STRUCT MOL BIOL, V15, P827, DOI 10.1038/nsmb.1463; Fang QH, 2008, P NATL ACAD SCI USA, V105, P15388, DOI 10.1073/pnas.0805377105; Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036; Fdez E, 2010, J CELL SCI, V123, P2473, DOI 10.1242/jcs.061325; Gao Y, 2012, SCIENCE, V337, P1340, DOI 10.1126/science.1224492; Gascon S, 2008, J NEUROSCI METH, V168, P104, DOI 10.1016/j.jneumeth.2007.09.023; Grote E, 2000, J CELL BIOL, V151, P453, DOI 10.1083/jcb.151.2.453; Guzman RE, 2010, J NEUROSCI, V30, P10272, DOI 10.1523/JNEUROSCI.1551-10.2010; Han X, 2004, SCIENCE, V304, P289, DOI 10.1126/science.1095801; Han X, 2005, BIOPHYS J, V88, pL20, DOI 10.1529/biophysj.104.056739; Hui EF, 2011, NAT STRUCT MOL BIOL, V18, P813, DOI 10.1038/nsmb.2075; Jackson MB, 2008, NAT STRUCT MOL BIOL, V15, P684, DOI 10.1038/nsmb.1449; Jackson MB, 2006, ANNU REV BIOPH BIOM, V35, P135, DOI 10.1146/annurev.biophys.35.040405.101958; Jackson MB, 2011, CURR TOP MEMBR, V68, P185, DOI 10.1016/B978-0-12-385891-7.00008-8; Jackson MB, 2010, J MEMBRANE BIOL, V235, P89, DOI 10.1007/s00232-010-9258-1; Jahn R, 1999, ANNU REV BIOCHEM, V68, P863, DOI 10.1146/annurev.biochem.68.1.863; Kesavan J, 2007, CELL, V131, P351, DOI 10.1016/j.cell.2007.09.025; Kweon DH, 2003, NAT STRUCT BIOL, V10, P440, DOI 10.1038/nsb928; Lin RC, 2000, ANNU REV CELL DEV BI, V16, P19, DOI 10.1146/annurev.cellbio.16.1.19; LINDAU M, 1995, CURR OPIN CELL BIOL, V7, P509, DOI 10.1016/0955-0674(95)80007-7; Lindau M, 2012, BIOPHYS J, V103, P959, DOI 10.1016/j.bpj.2012.08.007; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; McNew JA, 1999, MOL CELL, V4, P415, DOI 10.1016/S1097-2765(00)80343-3; Mohrmann R, 2010, SCIENCE, V330, P502, DOI 10.1126/science.1193134; Ngatchou AN, 2010, P NATL ACAD SCI USA, V107, P18463, DOI 10.1073/pnas.1006727107; Pieren M, 2015, J BIOL CHEM, V290, P12821, DOI 10.1074/jbc.M115.647776; Poirier MA, 1998, J BIOL CHEM, V273, P11370, DOI 10.1074/jbc.273.18.11370; Ramirez Denise M O, 2012, Cell Logist, V2, P20; Ramirez DMO, 2012, NEURON, V73, P121, DOI 10.1016/j.neuron.2011.10.034; Risselada HJ, 2011, CHEMBIOCHEM, V12, P1049, DOI 10.1002/cbic.201100020; Sinha R, 2011, P NATL ACAD SCI USA, V108, P14318, DOI 10.1073/pnas.1101818108; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Sudhof TC, 2009, SCIENCE, V323, P474, DOI 10.1126/science.1161748; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; van den Bogaart G, 2010, NAT STRUCT MOL BIOL, V17, P358, DOI 10.1038/nsmb.1748; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimbs T, 1998, TRENDS CELL BIOL, V8, P260, DOI 10.1016/S0962-8924(98)01285-9; Xu H, 2011, P NATL ACAD SCI USA, V108, P17325, DOI 10.1073/pnas.1113888108; Xu YB, 2005, NAT STRUCT MOL BIOL, V12, P417, DOI 10.1038/nsmb921; Zhang Z, 2010, BIOPHYS J, V98, P2524, DOI 10.1016/j.bpj.2010.02.043; Zhang ZJ, 2010, BIOPHYS J, V98, P968, DOI 10.1016/j.bpj.2009.11.024; Zhou P, 2013, NEURON, V80, P470, DOI 10.1016/j.neuron.2013.09.010	47	26	26	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					2848	2857		10.1074/jbc.M115.701169	http://dx.doi.org/10.1074/jbc.M115.701169			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26663078	hybrid, Green Published			2022-12-26	WOS:000369626900024
J	Gu, CG; Xu, JS; Rohling, J; Yang, HJ; Liu, ZH				Gu, Changgui; Xu, Jinshan; Rohling, Jos; Yang, Huijie; Liu, Zonghua			Noise Induces Oscillation and Synchronization of the Circadian Neurons	PLOS ONE			English	Article							SUPRACHIASMATIC NUCLEUS; DIM LIGHT; CLOCK; RHYTHMS; MECHANISM; ILLUMINATION; NETWORK; PERIOD; NIGHT; CYCLE	The principle clock of mammals, named suprachiasmatic nucleus (SCN), coordinates the circadian rhythms of behavioral and physiological activity to the external 24 h light-dark cycle. In the absence of the daily cycle, the SCN acts as an endogenous clock that regulates the similar to 24h rhythm of activity. Experimental and theoretical studies usually take the light-dark cycle as a main external influence, and often ignore light pollution as an external influence. However, in modern society, the light pollution such as induced by electrical lighting influences the circadian clock. In the present study, we examined the effect of external noise (light pollution) on the collective behavior of coupled circadian oscillators under constant darkness using a Goodwin model. We found that the external noise plays distinct roles in the network behavior of neurons for weak or strong coupling between the neurons. In the case of strong coupling, the noise reduces the synchronization and the period of the SCN network. Interestingly, in the case of weak coupling, the noise induces a circadian rhythm in the SCN network which is absent in noise-free condition. In addition, the noise increases the synchronization and decreases the period of the SCN network. Our findings may shed new light on the impact of the external noise on the collective behavior of SCN neurons.	[Gu, Changgui; Yang, Huijie] Univ Shanghai Sci & Technol, Sch Business, Shanghai, Peoples R China; [Xu, Jinshan] Zhejiang Univ Technol, Coll Comp Sci & Technol, Hangzhou, Zhejiang, Peoples R China; [Rohling, Jos] Leiden Univ, Med Ctr, Neurophysiol Lab, Dept Mol Cell Biol, Leiden, Netherlands; [Liu, Zonghua] E China Normal Univ, Dept Phys, Shanghai 200062, Peoples R China	University of Shanghai for Science & Technology; Zhejiang University of Technology; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; East China Normal University	Gu, CG (corresponding author), Univ Shanghai Sci & Technol, Sch Business, Shanghai, Peoples R China.	gu_changgui@163.com	Rohling, Jos/AAC-3516-2022	Rohling, Jos H T/0000-0001-5721-2715	Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning [QD2015016]; National Science Foundation of China [11505114, 11405145]; Natural Science Foundation of Zhejiang Province [LQ14A050002]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, National Science Foundation of China [10975099]; innovation Program of Shanghai Municipal Education Commission [13YZ072]	Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Zhejiang Province(Natural Science Foundation of Zhejiang Province); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning, National Science Foundation of China; innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission)	CG is supported by The Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning (QD2015016) [http://www.shmec.gov.cn/] and National Science Foundation of China (11505114) [http://www.nsfc.gov.cn/]. JX is supported by Natural Science Foundation of Zhejiang Province (LQ14A050002) [http://www.zjnsf.gov.cn/] and National Science Foundation of China (11405145) [http://www.nsfc.gov.cn/]. HY is supported by The Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning [http://www.shmec.gov.cn/], National Science Foundation of China (10975099) [http://www.nsfc.gov.cn/] and the innovation Program of Shanghai Municipal Education Commission under Grant No. 13YZ072.	Abraham U, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.92; Albus H, 2005, CURR BIOL, V15, P886, DOI 10.1016/j.cub.2005.03.051; Bernard S, 2007, PLOS COMPUT BIOL, V3, P667, DOI 10.1371/journal.pcbi.0030068; CAMPBELL SS, 1993, SLEEP, V16, P638; Czeisler CA, 1999, SCIENCE, V284, P2177, DOI 10.1126/science.284.5423.2177; DORRSCHEIDT GJ, 1975, J MATH BIOL, V2, P107; Evans JA, 2009, CURR BIOL, V19, pR156, DOI 10.1016/j.cub.2009.01.023; Farajnia S, 2012, J NEUROSCI, V32, P5891, DOI 10.1523/JNEUROSCI.0469-12.2012; Fonken LK, 2013, J BIOL RHYTHM, V28, P262, DOI 10.1177/0748730413493862; Gorman MR, 2006, CHRONOBIOL INT, V23, P245, DOI 10.1080/07420520500521905; Gu CG, 2014, J BIOL RHYTHM, V29, P16, DOI 10.1177/0748730413516752; Gu CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036900; Gu CG, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.046224; Gu CG, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.030904; Guckenheimer J., 1983, NONLINEAR OSCILLATOR; Halberg F., 1990, CYCLES NATURE INTRO; HERZEL H, 1995, PHYS REV E, V52, P3238, DOI 10.1103/PhysRevE.52.3238; Hirota T, 2004, ZOOL SCI, V21, P359, DOI 10.2108/zsj.21.359; Honma S, 2004, NEUROSCI LETT, V358, P173, DOI 10.1016/j.neulet.2004.01.022; Kloeden P. E., 1992, APPL MATH NEW YORK, V23, DOI [10.1007/978-3-662-12616-5, DOI 10.1007/978-3-662-12616-5]; Ko CH, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000513; Liang XM, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.031916; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Locke JCW, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-22; Middleton B, 1996, J SLEEP RES, V5, P69, DOI 10.1046/j.1365-2869.1996.d01-67.x; Ruoff P, 1999, J BIOL RHYTHM, V14, P469, DOI 10.1177/074873099129001037; Ueda HR, 2002, J THEOR BIOL, V216, P501, DOI 10.1006/jtbi.2002.3000; Ullner E, 2009, BIOPHYS J, V96, P3573, DOI 10.1016/j.bpj.2009.02.031; Vansteensel MJ, 2003, CURR BIOL, V13, P1538, DOI 10.1016/S0960-9822(03)00560-8; Welsh DK, 2010, ANNU REV PHYSIOL, V72, P551, DOI 10.1146/annurev-physiol-021909-135919; Xu JS, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.041903; Yamaguchi S, 2003, SCIENCE, V302, P1408, DOI 10.1126/science.1089287; Yi M, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.012902	34	17	17	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145360	10.1371/journal.pone.0145360	http://dx.doi.org/10.1371/journal.pone.0145360			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691765	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092300062
J	Mahmood, A; Pulakat, L				Mahmood, Abuzar; Pulakat, Lakshmi			Differential Effects of beta-Blockers, Angiotensin II Receptor Blockers, and a Novel AT2R Agonist NP-6A4 on Stress Response of Nutrient-Starved Cardiovascular Cells	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; REAL-TIME; CARDIOMYOCYTE APOPTOSIS; MYOCARDIAL-INFARCTION; LABEL-FREE; HEART; MECHANISMS; INHIBITION; NEBIVOLOL; AUTOPHAGY	In order to determine differences in cardiovascular cell response during nutrient stress to different cardiovascular protective drugs, we investigated cell responses of serum starved mouse cardiomyocyte HL-1 cells and primary cultures of human coronary artery vascular smooth muscles (hCAVSMCs) to treatment with beta-blockers (atenolol, metoprolol, carvedilol, nebivolol, 3 mu M each), AT1R blocker losartan (1 mu M) and AT2R agonists (CGP42112A and novel agonist NP-6A4, 300nM each). Treatment with nebivolol, carvedilol, metoprolol and atenolol suppressed Cell Index (CI) of serum-starved HL-1 cells (<= 17%, <= 8%, <= 15% and <= 15% respectively) as measured by the Xcelligence Real-Time Cell Analyzer (RTCA). Conversely, CI was increased by Ang II (>= 9.6%), CGP42112A (>= 14%), and NP-6A4 (>= 25%) respectively and this effect was blocked by AT2R antagonist PD123319, but not by AT1R antagonist losartan. Thus, the CI signature for each drug could be unique. MTS cell proliferation assay showed that NP-6A4, but not other drugs, increased viability (>= 20%) of HL-1 and hCAVSMCs. Wheat Germ Agglutinin (WGA) staining showed that nebivolol was most effective in reducing cell sizes of HL-1 and hCAVSMCs. Myeloid Cell Leukemia 1 (MCL-1) is a protein critical for cardiovascular cell survival and implicated in cell adhesion. beta-blockers significantly suppressed and NP-6A4 increased MCL-1 expression in HL-1 and hCAVSMCs as determined by immunofluorescence. Thus, reduction in cell size and/or MCL-1 expression might underlie beta-blocker-induced reduction in CI of HL-1. Conversely, increase in cell viability and MCL-1 expression by NP-6A4 through AT2R could have resulted in NP-6A4 mediated increase in CI of HL-1. These data show for the first time that activation of the AT2R-MCL-1 axis by NP-6A4 in nutrient-stressed mouse and human cardiovascular cells (mouse HL-1 cells and primary cultures of hCAVSMCs) might underlie improved survival of cells treated by NP-6A4 compared to other drugs tested in this study.	[Mahmood, Abuzar; Pulakat, Lakshmi] Univ Missouri, Dept Med, Columbia, MO 65211 USA; [Pulakat, Lakshmi] Univ Missouri, Dept Nutr & Exercise Physiol, Columbia, MO USA; [Mahmood, Abuzar; Pulakat, Lakshmi] Harry S Truman Mem Vet Affairs Hosp, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harry S. Truman Memorial Veterans' Hospital	Pulakat, L (corresponding author), Univ Missouri, Dept Med, Columbia, MO 65211 USA.	pulakatl@health.missouri.edu			Life Science Mission Enhancement Fund from UM-Columbia; NIH NHLBI [1R01HL118376-01]; Novopyxis; Missouri Foundation for Veteran's Medical Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118376] Funding Source: NIH RePORTER	Life Science Mission Enhancement Fund from UM-Columbia; NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Novopyxis; Missouri Foundation for Veteran's Medical Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in part, by the Life Science Mission Enhancement Fund from UM-Columbia (LP), as well as research grants from NIH NHLBI 1R01HL118376-01 (LP), Novopyxis (LP) and Missouri Foundation for Veteran's Medical Research (LP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akazawa H, 2013, CARDIOVASC DRUG THER, V27, P155, DOI 10.1007/s10557-012-6392-2; Altarche-Xifro W, 2009, STEM CELLS, V27, P2488, DOI 10.1002/stem.171; Amann U, 2014, CLIN RES CARDIOL, V103, P655, DOI 10.1007/s00392-014-0688-0; [Anonymous], 2015, LEAD CAUS DEATH; Arnold N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103284; Badalzadeh R, 2015, J PHYSIOL SCI, V65, P201, DOI 10.1007/s12576-015-0365-8; Blessberger H, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004476.pub2, 10.1002/14651858.CD004476.pub3]; Brunt KR, 2009, EXP BIOL MED, V234, P582, DOI 10.3181/0810-RM-312; Erickson CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071980; Falcon BL, 2005, HYPERTENSION, V45, P692, DOI 10.1161/01.HYP.0000154254.89733.29; Gatica D, 2015, CIRC RES, V116, P456, DOI 10.1161/CIRCRESAHA.114.303788; Grimm Christine, 2010, GMS Health Technol Assess, V6, pDoc03, DOI 10.3205/hta000081; Gul R, 2015, OBESITY, V23, P2251, DOI 10.1002/oby.21227; Gul R, 2012, CARDIORENAL MED, V2, P268, DOI 10.1159/000343456; Gul R, 2012, CARDIORENAL MED, V2, P225, DOI 10.1159/000339565; Gupta S, 2008, CARDIOVASC THER, V26, P189, DOI 10.1111/j.1755-5922.2008.00054.x; Hashem SI, 2015, STEM CELLS, V33, P2343, DOI 10.1002/stem.2015; Ibe JCF, 2013, AM J RESP CELL MOL, V49, P609, DOI 10.1165/rcmb.2012-0446OC; Kajstura J, 1997, J MOL CELL CARDIOL, V29, P859, DOI 10.1006/jmcc.1996.0333; Ke N, 2015, METHODS MOL BIOL, V1272, P215, DOI 10.1007/978-1-4939-2336-6_15; Ke N, 2011, METHODS MOL BIOL, V740, P33, DOI 10.1007/978-1-61779-108-6_6; Keating GM, 2003, DRUGS, V63, P1697, DOI 10.2165/00003495-200363160-00006; Knowle D, 2001, PEPTIDES, V22, P2145, DOI 10.1016/S0196-9781(01)00553-8; Kumar V, 2002, FEBS LETT, V532, P379, DOI 10.1016/S0014-5793(02)03713-4; Ladage D, 2010, J CARDIOVASC PHARM, V56, P275, DOI 10.1097/FJC.0b013e3181eb4ff2; Ludwig M, 2012, CAN J PHYSIOL PHARM, V90, P287, DOI [10.1139/Y11-108, 10.1139/y11-108]; Ma XC, 2012, CIRCULATION, V125, P3170, DOI 10.1161/CIRCULATIONAHA.111.041814; Mangat R, 2006, AM J PHYSIOL-HEART C, V291, pH854, DOI 10.1152/ajpheart.01205.2005; Ong SB, 2015, J MOL CELL CARDIOL, V78, P23, DOI 10.1016/j.yjmcc.2014.11.005; Parenti A, 2000, J PHARMACOL EXP THER, V292, P698; Perciavalle RM, 2012, NAT CELL BIOL, V14, P575, DOI 10.1038/ncb2488; Pulakat L, 2002, FEBS LETT, V524, P73, DOI 10.1016/S0014-5793(02)03005-3; Ramis G, 2013, BIOMED MICRODEVICES, V15, P985, DOI 10.1007/s10544-013-9790-8; Rinkenberger JL, 2000, GENE DEV, V14, P23; Sato M, 2000, CIRCULATION, V102, P346; Solaini G, 2010, BBA-BIOENERGETICS, V1797, P1171, DOI 10.1016/j.bbabio.2010.02.011; Strauss MH, 2006, CIRCULATION, V114, P838, DOI 10.1161/CIRCULATIONAHA.105.594986; Su Q, 2013, EXP CLIN CARDIOL, V18, P161; Sugino H, 2001, HYPERTENSION, V37, P1394, DOI 10.1161/01.HYP.37.6.1394; Thomas RL, 2013, GENE DEV, V27, P1365, DOI 10.1101/gad.215871.113; Thompson PL, 2013, CURR OPIN CARDIOL, V28, P399, DOI 10.1097/HCO.0b013e328361e97a; Troncoso R, 2012, CARDIOVASC RES, V93, P320, DOI 10.1093/cvr/cvr321; Vardeny O, 2011, AM J CARDIOL, V107, P1705, DOI 10.1016/j.amjcard.2011.01.064; Wang X, 2013, GENE DEV, V27, P1351, DOI 10.1101/gad.215855.113; Wang YY, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0820-1; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; World Health Organization, 2014, TOP 10 CAUS DEATH; Xiao L, 2013, AM J PHYSIOL-CELL PH, V304, pC1073, DOI 10.1152/ajpcell.00364.2012; Yang CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085785; Zhang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098179	50	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144824	10.1371/journal.pone.0144824	http://dx.doi.org/10.1371/journal.pone.0144824			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691397	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092300020
J	Sisler, JD; Morgan, M; Raje, V; Grande, RC; Derecka, M; Meier, J; Cantwell, M; Szczepanek, K; Korzun, WJ; Lesnefsky, EJ; Harris, TE; Croniger, CM; Larner, AC				Sisler, Jennifer D.; Morgan, Magdalena; Raje, Vidisha; Grande, Rebecca C.; Derecka, Marta; Meier, Jeremy; Cantwell, Marc; Szczepanek, Karol; Korzun, William J.; Lesnefsky, Edward J.; Harris, Thurl E.; Croniger, Colleen M.; Larner, Andrew C.			The Signal Transducer and Activator of Transcription 1 (STAT1) Inhibits Mitochondrial Biogenesis in Liver and Fatty Acid Oxidation in Adipocytes	PLOS ONE			English	Article							EXPRESSION; RESISTANCE; GLUCOSE; GAMMA	The transcription factor STAT1 plays a central role in orchestrating responses to various pathogens by activating the transcription of nuclear-encoded genes that mediate the antiviral, the antigrowth, and immune surveillance effects of interferons and other cytokines. In addition to regulating gene expression, we report that STAT1(-/-) mice display increased energy expenditure and paradoxically decreased release of triglycerides from white adipose tissue (WAT). Liver mitochondria from STAT1(-/-) mice show both defects in coupling of the electron transport chain (ETC) and increased numbers of mitochondria. Consistent with elevated numbers of mitochondria, STAT1(-/-) mice expressed increased amounts of PGC1 alpha, a master regulator of mitochondrial biogenesis. STAT1 binds to the PGC1 alpha promoter in fed mice but not in fasted animals, suggesting that STAT1 inhibited transcription of PGC1 alpha. Since STAT1(-/-) mice utilized more lipids we examined white adipose tissue (WAT) stores. Contrary to expectations, fasted STAT1(-/-) mice did not lose lipid from WAT. beta-adrenergic stimulation of glycerol release from isolated STAT1(-/-) WAT was decreased, while activation of hormone sensitive lipase was not changed. These findings suggest that STAT1(-/-) adipose tissue does not release glycerol and that free fatty acids (FFA) re-esterify back to triglycerides, thus maintaining fat mass in fasted STAT1(-/-) mice.	[Sisler, Jennifer D.; Morgan, Magdalena; Raje, Vidisha; Derecka, Marta; Meier, Jeremy; Cantwell, Marc; Szczepanek, Karol; Lesnefsky, Edward J.; Larner, Andrew C.] Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Sisler, Jennifer D.; Morgan, Magdalena; Raje, Vidisha; Derecka, Marta; Meier, Jeremy; Cantwell, Marc; Szczepanek, Karol; Lesnefsky, Edward J.; Larner, Andrew C.] Virginia Commonwealth Univ, Massey Canc Ctr, Richmond, VA 23298 USA; [Grande, Rebecca C.; Harris, Thurl E.] Univ Virginia, Sch Med, Dept Pharmacol, Charlottesville, VA 22908 USA; [Szczepanek, Karol; Lesnefsky, Edward J.] McGuire Dept Vet Affairs Med Ctr, Med Serv, Richmond, VA 23249 USA; [Korzun, William J.] Virginia Commonwealth Univ, Dept Clin Chem, Richmond, VA 23298 USA; [Croniger, Colleen M.] Case Western Reserve Univ, Sch Med, Dept Nutr, Cleveland, OH 44106 USA; [Lesnefsky, Edward J.] Virginia Commonwealth Univ, Dept Internal Med, Div Cardiol, Richmond, VA 23298 USA; [Lesnefsky, Edward J.] Virginia Commonwealth Univ, Pauley Heart Ctr, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University; University of Virginia; Hunter Holmes McGuire Veterinary Affairs Medical Center; Virginia Commonwealth University; Case Western Reserve University; Virginia Commonwealth University; Virginia Commonwealth University	Larner, AC (corresponding author), Virginia Commonwealth Univ, Dept Biochem & Mol Biol, Med Coll Virginia Campus, Richmond, VA 23298 USA.	alarner@vcu.edu		Derecka, Marta/0000-0001-6265-9781; Raje, Vidisha/0000-0003-1808-6511	NIH [1R01 DK099732, 1R01GM101677-01A1]; NIH NINDS Center [5P30NS047463]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099732, R01DK101946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM101677] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047463] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NINDS Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants 1R01 DK099732 and 1R01GM101677-01A1 to Andrew Larner. Microscopy was performed at the VCU Dept. of Anatomy and Neurobiology Microscopy Facility, supported, in part, with funding from NIH NINDS Center core grant 5P30NS047463.	Bederman IR, 2009, J BIOL CHEM, V284, P6101, DOI 10.1074/jbc.M808668200; Bell EL, 2005, MITOCHONDRION, V5, P322, DOI 10.1016/j.mito.2005.06.005; Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Brunelle JK, 2005, CELL METAB, V1, P409, DOI 10.1016/j.cmet.2005.05.002; Cheon H, 2013, EMBO J, V32, P2751, DOI 10.1038/emboj.2013.203; Demaria M, 2010, AGING-US, V2, P823, DOI 10.18632/aging.100232; Dominy J.E., 2013, COLD SPRING HARBOR P, V5; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Kenwood BM, 2014, MOL METAB, V3, P114, DOI 10.1016/j.molmet.2013.11.005; Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200; Kumar A, 1997, SCIENCE, V278, P1630, DOI 10.1126/science.278.5343.1630; Kumar A, 2010, DIABETES, V59, P1397, DOI 10.2337/db09-1061; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; LOWRY OH, 1951, J BIOL CHEM, V193, P265; McPherson PAC, 2012, J PHYSIOL BIOCHEM, V68, P141, DOI 10.1007/s13105-011-0112-4; Meier JA, 2014, SEMIN IMMUNOL, V26, P20, DOI 10.1016/j.smim.2013.12.005; Millward CA, 2009, MAMM GENOME, V20, P71, DOI 10.1007/s00335-008-9165-2; Nakae J, 2008, DIABETES, V57, P563, DOI 10.2337/db07-0698; Palikaras K, 2014, EXP GERONTOL, V56, P182, DOI 10.1016/j.exger.2014.01.021; Pitroda SP, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-68; Reshef L, 2003, J BIOL CHEM, V278, P30413, DOI 10.1074/jbc.R300017200; Sawada T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014006; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stephens JM, 1996, J BIOL CHEM, V271, P10441, DOI 10.1074/jbc.271.18.10441; Tinsley FC, 2004, OBES RES, V12, P150, DOI 10.1038/oby.2004.20; Todoric J, 2011, DIABETES, V60, P1668, DOI 10.2337/db10-1628; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Yang JB, 2008, CELL RES, V18, P443, DOI 10.1038/cr.2008.41	28	18	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144444	10.1371/journal.pone.0144444	http://dx.doi.org/10.1371/journal.pone.0144444			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689548	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092300009
J	Thirumurthy, H; Hayashi, K; Linnemayr, S; Vreeman, RC; Levin, IP; Bangsberg, DR; Brewer, NT				Thirumurthy, Harsha; Hayashi, Kami; Linnemayr, Sebastian; Vreeman, Rachel C.; Levin, Irwin P.; Bangsberg, David R.; Brewer, Noel T.			Time Preferences Predict Mortality among HIV-Infected Adults Receiving Antiretroviral Therapy in Kenya	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; CIGARETTE SMOKERS; ALCOHOL; ADHERENCE; FUTURE	Background Identifying characteristics of HIV-infected adults likely to have poor treatment outcomes can be useful for targeting interventions efficiently. Research in economics and psychology suggests that individuals' intertemporal time preferences, which indicate the extent to which they trade-off immediate vs. future cost and benefits, can influence various health behaviors. While there is empirical support for the association between time preferences and various non-HIV health behaviors and outcomes, the extent to which time preferences predict outcomes of those receiving antiretroviral therapy (ART) has not been examined previously. Methods HIV-infected adults initiating ART were enrolled at a health facility in Kenya. Participants' time preferences were measured at enrollment and used to classify them as having either a low or high discount rate for future benefits. At 48 weeks, we assessed mortality and ART adherence, as measured by Medication Event Monitoring System (MEMS). Logistic regression models adjusting for socio-economic characteristics and risk factors were used to determine the association between time preferences and mortality as well as MEMS adherence >= 90%. Results Overall, 44% (96/220) of participants were classified as having high discount rates. Participants with high discount rates had significantly higher 48-week mortality than participants with low discount rates (9.3% vs. 3.1%; adjusted odds ratio 3.84; 95% CI 1.03, 14.50). MEMS adherence >= 90% was similar for participants with high vs. low discount rates (42.3% vs. 49.6%, AOR 0.70; 95% CI 0.40, 1.25). Conclusion High discount rates were associated with significantly higher risk of mortality among HIV-infected patients initiating ART. Greater use of time preference measures may improve identification of patients at risk of poor clinical outcomes. More research is needed to further identify mechanisms of action and also to build upon and test the generalizability of this finding.	[Thirumurthy, Harsha] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Policy & Management, Chapel Hill, NC USA; [Thirumurthy, Harsha] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA; [Hayashi, Kami; Brewer, Noel T.] Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Behav, Chapel Hill, NC USA; [Linnemayr, Sebastian] RAND Corp, Santa Monica, CA USA; [Vreeman, Rachel C.] Indiana Univ Sch Med, Dept Pediat, Indianapolis, IN 46202 USA; [Vreeman, Rachel C.] Acad Model Providing Access Healthcare, Eldoret, Kenya; [Levin, Irwin P.] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA; [Bangsberg, David R.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Global Hlth, Boston, MA USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; RAND Corporation; Indiana University System; Indiana University Bloomington; University of Iowa; Harvard University; Harvard Medical School; Massachusetts General Hospital	Thirumurthy, H (corresponding author), Univ N Carolina, Gillings Sch Global Publ Hlth, Dept Hlth Policy & Management, Chapel Hill, NC USA.	harsha@unc.edu	Brewer, Noel T/C-4375-2008	Brewer, Noel T/0000-0003-2241-7002; Thirumurthy, Harsha/0000-0002-3308-7603	World Bank Research Group - Bank Netherlands Partnership Program (BNPP) [7142349, 7144565]; United States Agency for International Development, President's Emergency Plan for AIDS Relief (PEPFAR); National Institute of Child Health & Human Development [K01HD061605]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K01HD061605, P2CHD050924] Funding Source: NIH RePORTER	World Bank Research Group - Bank Netherlands Partnership Program (BNPP); United States Agency for International Development, President's Emergency Plan for AIDS Relief (PEPFAR)(United States Agency for International Development (USAID)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Institute of Child Health & Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The World Bank Research Group provided financial support for this project under contracts 7142349 and 7144565 funded by the Bank Netherlands Partnership Program (BNPP). This research was also supported in part by a grant to the USAID-Academic Model Providing Access to Healthcare Partnership from the United States Agency for International Development as part of the President's Emergency Plan for AIDS Relief (PEPFAR). H. Thirumurthy received support from the National Institute of Child Health & Human Development (K01HD061605).	Axon RN, 2009, J AM SOC HYPERTENS, V3, P35, DOI 10.1016/j.jash.2008.08.005; Barnighausen T, 2011, LANCET INFECT DIS, V11, P942, DOI 10.1016/S1473-3099(11)70181-5; Baker F, 2003, J ABNORM PSYCHOL, V112, P382, DOI 10.1037/0021-843X.112.3.382; Bickel WK, 2008, DRUG ALCOHOL DEPEN, V96, P256, DOI 10.1016/j.drugalcdep.2008.03.009; Boulle A, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001718; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Brandt S, 2013, PEDIATRICS, V131, pE1204, DOI 10.1542/peds.2011-2982; Chapman GB, 2005, HEALTH PSYCHOL, V24, pS41, DOI 10.1037/0278-6133.24.4.S41; Chapman GB, 2001, J EXP PSYCHOL-APPL, V7, P235, DOI 10.1037//1076-898X.7.3.235; Frederick S, 2002, J ECON LIT, V40, P351, DOI 10.1257/002205102320161311; Galarraga O, 2013, AIDS BEHAV, V17, P2283, DOI 10.1007/s10461-013-0415-2; Gyrd-Hansen Dorte, 2002, Eur J Health Econ, V3, P10, DOI 10.1007/s10198-002-0098-5; Loewenstein G, 2007, JAMA-J AM MED ASSOC, V298, P2415, DOI 10.1001/jama.298.20.2415; MacKillop J, 2015, AIDS BEHAV, V19, P450, DOI 10.1007/s10461-014-0909-6; MacKillop J, 2011, PSYCHOPHARMACOLOGY, V216, P305, DOI 10.1007/s00213-011-2229-0; MacKillop J, 2010, J ABNORM PSYCHOL, V119, P106, DOI 10.1037/a0017513; May M, 2010, LANCET, V376, P449, DOI 10.1016/S0140-6736(10)60666-6; Mills EJ, 2006, PLOS MED, V3, P2039, DOI 10.1371/journal.pmed.0030438; O'Donoghue T, 1999, AM ECON REV, V89, P103, DOI 10.1257/aer.89.1.103; Odum Amy L, 2002, Nicotine Tob Res, V4, P295, DOI 10.1080/14622200210141257; Petry NM, 2001, PSYCHOPHARMACOLOGY, V154, P243, DOI 10.1007/s002130000638; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Siedner MJ, 2013, AIDS, V27, P1503, DOI 10.1097/QAD.0b013e32835fd873; Smith PK, 2005, ECON HUM BIOL, V3, P259, DOI 10.1016/j.ehb.2005.05.001; Ware NC, 2009, PLOS MED, V6, P39, DOI 10.1371/journal.pmed.1000011; Wools-Kaloustian K, 2006, AIDS, V20, P41, DOI 10.1097/01.aids.0000196177.65551.ea	26	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145245	10.1371/journal.pone.0145245	http://dx.doi.org/10.1371/journal.pone.0145245			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684298	Green Published, gold			2022-12-26	WOS:000366725800050
J	Jiang, XX; Fei, XW; Zhao, L; Ye, XL; Xin, LB; Qu, Y; Xu, KH; Wu, RJ; Lin, J				Jiang, Xiu Xiu; Fei, Xiang Wei; Zhao, Li; Ye, Xiao Lei; Xin, Liao Bin; Qu, Yang; Xu, Kai Hong; Wu, Rui Jin; Lin, Jun			Aquaporin 5 Plays a Role in Estrogen-Induced Ectopic Implantation of Endometrial Stromal Cells in Endometriosis	PLOS ONE			English	Article							WATER CHANNEL DISEASES; MOLECULAR-MECHANISMS; DRUG DEVELOPMENT; BREAST-CANCER; LUNG-CANCER; EXPRESSION; AQP5; PROLIFERATION; IDENTIFICATION; ACTIVATION	Aquaporin 5 (AQP5) participates in the migration of endometrial cells. Elucidation of the molecular mechanisms associated with AQP5-mediated, migration of endometrial cells may contribute to a better understanding of endometriosis. Our objectives included identifying the estrogen-response element (ERE) in the promoter region of the AQP5 gene, and, investigating the effects of AQP5 on ectopic implantation of endometrial cells. Luciferase reporter assays and electrophoretic mobility shift assay (EMSA) identified the ERE-like motif in the promoter region of the AQP5 gene. After blocking and up-regulating estradiol (E-2) levels, we analysed the expression of AQP5 in endometrial stromal (ES) cells. After blocking E-2/or phosphatidylinositol 3 kinase(PI3K), we analysed the role of AQP5 in signaling pathways. We constructed an AQP5, shRNA, lentiviral vector to knock out the AQP5 gene in ES cells. After knock-out of the AQP5 gene, we studied the role of AQP5 in cell invasion, proliferation, and the formation of ectopic endometrial implants in female mice. We identified an estrogen-response element in the promoter region of the AQP5 gene. Estradiol (E-2) increased AQP5 expression in a dose-dependent fashion, that was blocked by ICI182,780(an estrogen receptor inhibitor). E-2 activated PI3K/protein kinase B(AKT) pathway (PI3K/AKT), that, in turn, increased AQP5 expression. LY294002(PI3K inhibitor) attenuated estrogen-enhanced, AQP5 expression. Knock-out of the AQP5 gene with AQP5 shRNA lentiviral vector significantly inhibited E-2-enhanced invasion, proliferation of ES cells and formation of ectopic implants. Estrogen induces AQP5 expression by activating ERE in the promoter region of the AQP5gene, activates the PI3K/AKT pathway, and, promotes endometrial cell invasion and proliferation. These results provide new insights into some of the mechanisms that may underpin the development of deposits of ectopic endometrium.	[Jiang, Xiu Xiu; Zhao, Li; Xu, Kai Hong; Wu, Rui Jin; Lin, Jun] Zhejiang Univ, Sch Med, Womens Hosp, Dept Gynecol, Hangzhou 310006, Zhejiang, Peoples R China; [Fei, Xiang Wei; Qu, Yang] Zhejiang Univ, Sch Med, Womens Hosp, Dept Lab, Hangzhou 310006, Zhejiang, Peoples R China; [Ye, Xiao Lei] Ningbo Univ, Sch Med, Dept Lab, Ningbo 315000, Zhejiang, Peoples R China; [Xin, Liao Bin] Zhejiang Univ, Sch Med, Sir Run Run Shaw Hosp, Dept Gynecol, Hangzhou 310006, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Ningbo University; Zhejiang University	Xu, KH (corresponding author), Zhejiang Univ, Sch Med, Womens Hosp, Dept Gynecol, Hangzhou 310006, Zhejiang, Peoples R China.	xukh@zju.edu.cn; wurj@zju.edu.cn; janet418@sina.com.cn			Zhejiang Province Natural Science Foundation of China [LY12H04009]; National Natural Science Foundation of China [81170546, 81401179]	Zhejiang Province Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by: 1. The Zhejiang Province Natural Science Foundation of China (grant number: LY12H04009). Xiu xiu Jiang received the funding; http://www.zjnsf.gov.cn. 2. The National Natural Science Foundation of China (grant numbers: 81170546). Jun Lin received the funding, http://www.nsfc.gov.cn. 3. The National Natural Science Foundation of China (grant number: 81401179). Xiu Xiu Jiang received the funding, http://www.nsfc.gov.cn. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chae YK, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002162; Chen FL, 2014, PLASMID, V76, P24, DOI 10.1016/j.plasmid.2014.08.004; Gresz V, 2001, AM J PHYSIOL-GASTR L, V281, pG247, DOI 10.1152/ajpgi.2001.281.1.G247; Huang YH, 2013, TUMOR BIOL, V34, P1743, DOI 10.1007/s13277-013-0712-4; Jiang XX, 2012, ONCOL LETT, V4, P257, DOI 10.3892/ol.2012.738; Jiang XX, 2010, FERTIL STERIL, V94, P1229, DOI 10.1016/j.fertnstert.2009.08.053; Kim SO, 2012, WORLD J UROL, V30, P207, DOI 10.1007/s00345-011-0674-3; King LS, 1996, ANNU REV PHYSIOL, V58, P619, DOI 10.1146/annurev.ph.58.030196.003155; Kobayashi M, 2006, GENES CELLS, V11, P1133, DOI 10.1111/j.1365-2443.2006.01009.x; Lee SJ, 2014, ANN SURG ONCOL, V21, P375, DOI 10.1245/s10434-013-3317-7; Li JP, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-284; Li X, 2012, ZHONGGUO ZHONG YAO Z, V37, P1640; Lindsay LA, 2006, REPRODUCTION, V131, P369, DOI 10.1530/rep.1.00914; Lonetti A, 2014, LEUKEMIA, V28, P1196, DOI 10.1038/leu.2013.369; Morishita Y, 2004, J PHARMACOL SCI, V96, P276, DOI 10.1254/jphs.FMJ04004X7; Noda Y, 2004, J PHARMACOL SCI, V96, P249, DOI 10.1254/jphs.FMJ04004X2; O'Brien JE, 2006, J BIOL CHEM, V281, P26683, DOI 10.1074/jbc.M601522200; PRESTON GM, 1991, P NATL ACAD SCI USA, V88, P11110, DOI 10.1073/pnas.88.24.11110; RAINA S, 1995, J BIOL CHEM, V270, P1908, DOI 10.1074/jbc.270.4.1908; Saglam O, 2007, CLIN COLORECTAL CANC, V6, P652, DOI 10.3816/CCC.2007.n.034; Sakamoto Y, 2014, BIOCHEM BIOPH RES CO, V448, P355, DOI 10.1016/j.bbrc.2014.04.047; Shan T, 2014, ONCOL REP, V32, P1564, DOI 10.3892/or.2014.3377; Shi XM, 2014, TUMOR BIOL, V35, P7035, DOI 10.1007/s13277-014-1956-3; Shi ZH, 2012, J SURG ONCOL, V106, P267, DOI 10.1002/jso.22155; Skowronski MT, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-109; Woo J, 2008, CANCER LETT, V264, P54, DOI 10.1016/j.canlet.2008.01.029; Xin Liao-bing, 2015, Zhejiang Da Xue Xue Bao Yi Xue Ban, V44, P285; Yan CX, 2014, J OVARIAN RES, V7, DOI 10.1186/s13048-014-0078-2; Zhang ZQ, 2010, J PATHOL, V221, P210, DOI 10.1002/path.2702; Zou LB, 2011, J CLIN ENDOCR METAB, V96, pE1399, DOI 10.1210/jc.2011-0426	30	18	19	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145290	10.1371/journal.pone.0145290	http://dx.doi.org/10.1371/journal.pone.0145290			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26679484	Green Published, gold, Green Submitted			2022-12-26	WOS:000366723400067
J	Sepulveda, AJ; Tercek, MT; Al-Chokhachy, R; Ray, AM; Thoma, DP; Hossack, BR; Pederson, GT; Rodman, AW; Olliff, T				Sepulveda, Adam J.; Tercek, Michael T.; Al-Chokhachy, Robert; Ray, Andrew M.; Thoma, David P.; Hossack, Blake R.; Pederson, Gregory T.; Rodman, Ann W.; Olliff, Tom			The Shifting Climate Portfolio of the Greater Yellowstone Area	PLOS ONE			English	Article							CONSERVATION; MANAGEMENT; VULNERABILITY; SNOWPACK; TRENDS; VARIABILITY; ADAPTATION; EXTREMES; IMPACTS	Knowledge of climatic variability at small spatial extents (< 50 km) is needed to assess vulnerabilities of biological reserves to climate change. We used empirical and modeled weather station data to test if climate change has increased the synchrony of surface air temperatures among 50 sites within the Greater Yellowstone Area (GYA) of the interior western United States. This important biological reserve is the largest protected area in the Lower 48 states and provides critical habitat for some of the world's most iconic wildlife. We focused our analyses on temporal shifts and shape changes in the annual distributions of seasonal minimum and maximum air temperatures among valley-bottom and higher elevation sites from 1948-2012. We documented consistent patterns of warming since 1948 at all 50 sites, with the most pronounced changes occurring during the Winter and Summer when minimum and maximum temperature distributions increased. These shifts indicate more hot temperatures and less cold temperatures would be expected across the GYA. Though the shifting statistical distributions indicate warming, little change in the shape of the temperature distributions across sites since 1948 suggest the GYA has maintained a diverse portfolio of temperatures within a year. Spatial heterogeneity in temperatures is likely maintained by the GYA's physiographic complexity and its large size, which encompasses multiple climate zones that respond differently to synoptic drivers. Having a diverse portfolio of temperatures may help biological reserves spread the extinction risk posed by climate change.	[Sepulveda, Adam J.; Al-Chokhachy, Robert; Pederson, Gregory T.] US Geol Survey, Northern Rocky Mt Sci Ctr, Bozeman, MT 59715 USA; [Tercek, Michael T.] Walking Shadow Ecol, Gardiner, MT 59030 USA; [Ray, Andrew M.; Thoma, David P.] Natl Pk Serv, Greater Yellowstone Inventory & Monitory Network, Bozeman, MT 59715 USA; [Hossack, Blake R.] US Geol Survey, Aldo Leopold Wilderness Res Inst, Missoula, MT 59801 USA; [Rodman, Ann W.] Natl Pk Serv, Yellowstone Ctr Resources, Yellowstone Np, WY 82190 USA; [Olliff, Tom] Natl Pk Serv, Intermountain Reg Landscape Conservat & Climate C, Bozeman, MT 59715 USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Department of the Interior	Sepulveda, AJ (corresponding author), US Geol Survey, Northern Rocky Mt Sci Ctr, 2327 Univ Way,Suite 2, Bozeman, MT 59715 USA.	asepulveda@usgs.gov			U.S. Geological Survey's National Park Monitoring Project program; Walking Shadow Ecology	U.S. Geological Survey's National Park Monitoring Project program; Walking Shadow Ecology	Funding for this research was provided by the U.S. Geological Survey's National Park Monitoring Project program. Walking Shadow Ecology provided support in the form of salary for author MTT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the 'author contributions' section.	Abatzoglou JT, 2011, INT J CLIMATOL, V31, P1135, DOI 10.1002/joc.2137; Ackerly DD, 2010, DIVERS DISTRIB, V16, P476, DOI 10.1111/j.1472-4642.2010.00654.x; Al-Chokhachy R, 2013, GLOBAL CHANGE BIOL, V19, DOI 10.1111/gcb.12262; Barnett TP, 2005, NATURE, V438, P303, DOI 10.1038/nature04141; Bell J, 2012, J HYDROL ENG, V17, P521, DOI 10.1061/(ASCE)HE.1943-5584.0000469; Case MJ, 2015, BIOL CONSERV, V187, P127, DOI 10.1016/j.biocon.2015.04.013; Cliff A. D., 1981, SPATIAL PROCESSES MO; Daly C, 2006, INT J CLIMATOL, V26, P707, DOI 10.1002/joc.1322; Den Boer P. J., 1968, Acta Biotheoretica, V18, P165; Diffenbaugh NS, 2005, P NATL ACAD SCI USA, V102, P15774, DOI 10.1073/pnas.0506042102; Dobrowski SZ, 2011, GLOBAL CHANGE BIOL, V17, P1022, DOI 10.1111/j.1365-2486.2010.02263.x; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Field C, 2012, MANAGING RISKS EXTRE; Figge F, 2004, BIODIVERS CONSERV, V13, P827, DOI 10.1023/B:BIOC.0000011729.93889.34; Grimm NB, 2013, FRONT ECOL ENVIRON, V11, P474, DOI 10.1890/120282; Hamlet AF, 2007, EFFECTS 20 CENTURY W, P43; Hansen J, 2012, P NATL ACAD SCI USA, V109, pE2415, DOI 10.1073/pnas.1205276109; Hartmann D., 2013, CLIMATE CHANGE 2013; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Hobbs RJ, 2010, FRONT ECOL ENVIRON, V8, P483, DOI 10.1890/090089; Intergovernmental Panel on Climate Change (IPCC), 2014, CLIMATE CHANGE 201 A; Isaac V, 2012, J CLIMATE, V25, P3599, DOI 10.1175/JCLI-D-11-00003.1; Kapnick S, 2012, CLIM DYNAM, V38, P1885, DOI 10.1007/s00382-011-1089-y; Keiter R. B., 1994, GREATER YELLOWSTONE; Knowles N, 2006, J CLIMATE, V19, P4545, DOI 10.1175/JCLI3850.1; Lambeck RJ, 1997, CONSERV BIOL, V11, P849, DOI 10.1046/j.1523-1739.1997.96319.x; Lawler JJ, 2009, ANN NY ACAD SCI, V1162, P79, DOI 10.1111/j.1749-6632.2009.04147.x; Leadley P., 2010, BIODIVERSITY SCENARI; Liebhold A, 2004, ANNU REV ECOL EVOL S, V35, P467, DOI 10.1146/annurev.ecolsys.34.011802.132516; Liu XD, 2000, INT J CLIMATOL, V20, P1729, DOI [10.1002/1097-0088(20001130)20:14<1729::AID-JOC556>3.0.CO;2-Y, 10.1002/1097-0088(20001130)20:14&lt;1729::AID-JOC556&gt;3.0.CO;2-Y]; Logan JA, 2010, ECOL APPL, V20, P895, DOI 10.1890/09-0655.1; Losos JB, 2000, NATURE, V408, P847, DOI 10.1038/35048558; Lundquist JD, 2007, J GEOPHYS RES-ATMOS, P112; Markowitz H, 1952, J FINANC, V7, P77, DOI 10.1111/j.1540-6261.1952.tb01525.x; McGuire CR, 2012, ELEVATION DEPENDENT; Menne MJ, 2009, J CLIMATE, V22, P1700, DOI 10.1175/2008JCLI2263.1; Noss RF, 2002, CONSERV BIOL, V16, P895, DOI 10.1046/j.1523-1739.2002.01405.x; Oyler JW, 2015, INT J CLIMATOL, V35, P2258, DOI 10.1002/joc.4127; Oyler JW, 2015, GEOPHYS RES LETT, V42, P153, DOI 10.1002/2014GL062803; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parmesan C, 2013, ECOL LETT, V16, P58, DOI 10.1111/ele.12098; Parry M. L., 2007, CLIMATE CHANGE 2007; Pederson GT, 2013, GEOPHYS RES LETT, V40, P1811, DOI 10.1002/grl.50424; Pederson GT, 2011, SCIENCE, V333, P332, DOI 10.1126/science.1201570; Pederson GT, 2011, J CLIMATE, V24, P1666, DOI 10.1175/2010JCLI3729.1; Pederson GT, 2010, CLIMATIC CHANGE, V98, P133, DOI 10.1007/s10584-009-9642-y; Raimondo S, 2004, ECOL ENTOMOL, V29, P96, DOI 10.1111/j.0307-6946.2004.00579.x; Regonda SK, 2005, J CLIMATE, V18, P372, DOI 10.1175/JCLI-3272.1; ROMME WH, 1989, BIOSCIENCE, V39, P695, DOI 10.2307/1311000; Schindler DE, 2015, FRONT ECOL ENVIRON, V13, P257, DOI 10.1890/140275; Schindler DE, 2010, NATURE, V465, P609, DOI 10.1038/nature09060; SEN PK, 1968, J AM STAT ASSOC, V63, P1379; Shafer SL, 2005, UNDERSTANDING SPATIL, P21; Shinker JJ, 2010, EARTH INTERACT, V14, DOI 10.1175/2010EI323.1; Sitas N, 2009, ANIM CONSERV, V12, P231, DOI 10.1111/j.1469-1795.2009.00244.x; Smith B, 2000, CLIMATIC CHANGE, V45, P223, DOI 10.1023/A:1005661622966; Thibault KM, 2008, P NATL ACAD SCI USA, V105, P3410, DOI 10.1073/pnas.0712282105; Thompson RM, 2013, ECOL LETT, V16, P799, DOI 10.1111/ele.12095; Thornton PK, 2014, GLOBAL CHANGE BIOL, V20, P3313, DOI 10.1111/gcb.12581; Viviroli D, 2011, HYDROL EARTH SYST SC, V15, P471, DOI 10.5194/hess-15-471-2011; Watters JV, 2003, BIOL CONSERV, V112, P435, DOI 10.1016/S0006-3207(02)00343-9; Westerling AL, 2011, P NATL ACAD SCI USA, V108, P13165, DOI 10.1073/pnas.1110199108; WHITLOCK C, 1993, QUATERNARY RES, V39, P231, DOI 10.1006/qres.1993.1026; You QL, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032669; Yue S, 2002, J HYDROL, V259, P254, DOI 10.1016/S0022-1694(01)00594-7	65	25	25	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145060	10.1371/journal.pone.0145060	http://dx.doi.org/10.1371/journal.pone.0145060			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674185	Green Published, Green Submitted, gold			2022-12-26	WOS:000366722700091
J	Wang, K; Guo, WX; Li, N; Gao, CF; Shi, J; Tang, YF; Shen, F; Wu, MC; Liu, SR; Cheng, SQ				Wang, Kang; Guo, Wei Xing; Li, Nan; Gao, Chun Fang; Shi, Jie; Tang, Yu Fu; Shen, Feng; Wu, Meng Chao; Liu, Shan Rong; Cheng, Shu Qun			Serum LncRNAs Profiles Serve as Novel Potential Biomarkers for the Diagnosis of HBV-Positive Hepatocellular Carcinoma	PLOS ONE			English	Article							LONG NONCODING RNA; OPERATING CHARACTERISTIC CURVES; ALPHA-FETOPROTEIN; HEPATITIS-B; PROSTATE-CANCER; HIGH EXPRESSION; NUCLEIC-ACIDS; URINE TEST; CELL; METASTASIS	Background Hepatocellular carcinoma (HCC) is a common malignancy that has a poor prognosis because there is lack of methods for early diagnosis. We aimed to utilize two serum long non-coding RNAs (lncRNAs), uc001ncr and AX800134, to diagnose hepatitis B virus (HBV)-positive HCC. Methods lncRNA microarrays were utilized to measure the differential expression of lncRNAs between tumor tissues and corresponding non-tumor tissues in HBV-positive hapatocellular carcinoma. uc001ncr and AX800134 were selected as candidate lncRNAs and detected in three independent cohorts containing a total of 684 participants (healthy individuals and chronic HBV patients and HBV-positive HCC patients) who were recruited between March 2011 and December 2012. A logistic regression model was constructed using a training cohort (n = 353) and validated using an independent cohort (n = 181). The area under the receiver operating characteristic curve (AUC) was utilized to evaluate the diagnostic accuracy. Results We determined that a panel based on the expression of uc001ncr and AX800134 accurately diagnosed HBV-positive HCC (AUC values of 0.9494 and 0.9491 for the training and validation cohorts, respectively). The diagnostic performance of the panel remained high in patients with AFP <= 400 ng/ml (AUC values of 0.9371 and 0.9527 for the training and validation cohorts, respectively). The panel also diagnosed early HCC (AUC values of 0.9450 and 0.9564 for the training and validation cohorts, respectively). Conclusion Our results indicated that the serum expression of uc001ncr and AX800134 has potential as novel potential biomarker for the diagnosis of HCC, especially in patients with AFP <= 400 ng/ml or early-stage disease (BCLC 0+A).	[Wang, Kang; Guo, Wei Xing; Li, Nan; Gao, Chun Fang; Shi, Jie; Tang, Yu Fu; Shen, Feng; Wu, Meng Chao; Cheng, Shu Qun] Second Mil Med Univ, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China; [Liu, Shan Rong] Second Mil Med Univ, Changhai Hosp, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Liu, SR (corresponding author), Second Mil Med Univ, Changhai Hosp, Shanghai, Peoples R China.	liushanrong@hotmail.com; chengshuqun@aliyun.com	SHI, JIE/GXG-3394-2022; Shen, Feng/GSD-2508-2022; cheng, sq/GPT-4112-2022		grants of the Science Fund for Creative Research Groups [81221061]; Chang Jiang Scholars Program; Shanghai Science and Technology Committee [134119a0200, 10JC1417600]; State Key Project on Infections Diseases of China [2012zx10002016016003]; China National Funds for Distinguished Young Scientists [81125018]; New Excellent Talents Program of Shanghai Municipal Health Bureau [XBR2011025]; New Excellent Talents Program of Shanghai Science and Technology Committee [10XD1405800]; National Natural Science Foundation [81101831]; Excellent Young Scholar Program of SMMU [20111010B]; Natural Science Foundation of Shanghai, China [12ZR1439600]	grants of the Science Fund for Creative Research Groups; Chang Jiang Scholars Program(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); State Key Project on Infections Diseases of China; China National Funds for Distinguished Young Scientists(National Natural Science Foundation of China (NSFC)); New Excellent Talents Program of Shanghai Municipal Health Bureau; New Excellent Talents Program of Shanghai Science and Technology Committee; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Excellent Young Scholar Program of SMMU; Natural Science Foundation of Shanghai, China(Natural Science Foundation of Shanghai)	This work was supported by the grants of the Science Fund for Creative Research Groups (No. 81221061); Chang Jiang Scholars Program (2012); Shanghai Science and Technology Committee (No. 134119a0200); The State Key Project on Infections Diseases of China (2012zx10002016016003); The China National Funds for Distinguished Young Scientists (No. 81125018); The New Excellent Talents Program of Shanghai Municipal Health Bureau (No. XBR2011025); The New Excellent Talents Program of Shanghai Science and Technology Committee (No. 10XD1405800); Shanghai Science and Technology Committee (No. 10JC1417600); The National Natural Science Foundation (No. 81101831); Excellent Young Scholar Program of SMMU (No. 20111010B); and Project supported by the Natural Science Foundation of Shanghai, China (No. 12ZR1439600).	AKEYAMA T, 1972, NEW ENGL J MED, V287, P989; Cocucci E, 2009, TRENDS CELL BIOL, V19, P43, DOI 10.1016/j.tcb.2008.11.003; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; DIBISCEGLIE AM, 1989, CANCER, V64, P2117, DOI 10.1002/1097-0142(19891115)64:10<2117::AID-CNCR2820641024>3.0.CO;2-7; Dong L, 2015, INT J CANCER, V137, P1128, DOI 10.1002/ijc.29484; El-Serag HB, 2008, GASTROENTEROLOGY, V134, P1752, DOI 10.1053/j.gastro.2008.02.090; Farinati F, 2006, AM J GASTROENTEROL, V101, P524, DOI 10.1111/j.1572-0241.2006.00443.x; Fradet YF, 2004, UROLOGY, V64, P311, DOI 10.1016/j.urology.2004.03.052; Fu WM, 2015, J HEPATOL, V26; Guo S, 2015, INT J CLIN EXP PATHO, V8, P5395; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; HANLEY JA, 1983, RADIOLOGY, V148, P839, DOI 10.1148/radiology.148.3.6878708; Hu XD, 2016, TUMOR BIOL, V37, P3497, DOI 10.1007/s13277-015-4023-9; Huang JF, 2013, HEPATOLOGY, V57, P1882, DOI 10.1002/hep.26195; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Johnson P J, 2001, Clin Liver Dis, V5, P145, DOI 10.1016/S1089-3261(05)70158-6; Kapranov P, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-149; LEANDRO G, 1989, ONCOLOGY-BASEL, V46, P381; Lee GL, 2011, NAT REV UROL, V8, P123, DOI 10.1038/nrurol.2011.10; Li LM, 2010, CANCER RES, V70, P9798, DOI 10.1158/0008-5472.CAN-10-1001; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Matouk IJ, 2009, EUR J GASTROEN HEPAT, V21, P688, DOI 10.1097/MEG.0b013e328306a3a2; Orozco AF, 2010, CYTOM PART A, V77A, P502, DOI 10.1002/cyto.a.20886; Panzitt K, 2007, GASTROENTEROLOGY, V132, P330, DOI 10.1053/j.gastro.2006.08.026; Poon Ronnie Tung-Ping, 2004, Liver Transpl, V10, pS39, DOI 10.1002/lt.20040; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Reis Eduardo M., 2012, Frontiers in Genetics, V3, P32, DOI 10.3389/fgene.2012.00032; Schwarzenbach H, 2011, NAT REV CANCER, V11, P426, DOI 10.1038/nrc3066; Shappell Scott B, 2008, Rev Urol, V10, P44; SIMONETTI RG, 1991, DIGEST DIS SCI, V36, P962, DOI 10.1007/BF01297149; Takahashi K, 2014, HEPATOLOGY, V60, P744, DOI 10.1002/hep.27043; TAKETA K, 1990, HEPATOLOGY, V12, P1420, DOI 10.1002/hep.1840120625; Tantai JC, 2015, INT J CLIN EXP PATHO, V8, P7887; Tinzl M, 2004, EUR UROL, V46, P182, DOI 10.1016/j.eururo.2004.06.004; Tong YK, 2006, CLIN CHIM ACTA, V363, P187, DOI 10.1016/j.cccn.2005.05.048; Trevisani F, 2001, J HEPATOL, V34, P570, DOI 10.1016/S0168-8278(00)00053-2; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Wang KC, 2011, MOL CELL, V43, P904, DOI 10.1016/j.molcel.2011.08.018; Wang T, 2015, ONCOTARGET, DOI 10.18632/oncotarget.6304; Xu N, 2015, TUMOR BIOL, V36, P7659, DOI 10.1007/s13277-015-3469-0; Yang F, 2011, HEPATOLOGY, V54, P1679, DOI 10.1002/hep.24563; Yang Z, 2011, ANN SURG ONCOL, V18, P1243, DOI 10.1245/s10434-011-1581-y; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0; Zhou J, 2011, J CLIN ONCOL, V29, P4781, DOI 10.1200/JCO.2011.38.2697	47	42	46	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144934	10.1371/journal.pone.0144934	http://dx.doi.org/10.1371/journal.pone.0144934			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674525	gold, Green Published, Green Submitted			2022-12-26	WOS:000366722700074
J	Andrews, CS; Miyata, M; Susuki-Miyata, S; Lee, BC; Komatsu, K; Li, JD				Andrews, Carla S.; Miyata, Masanori; Susuki-Miyata, Seiko; Lee, Byung-Cheol; Komatsu, Kensei; Li, Jian-Dong			nil Nontypeable Haemophilus influenzae-Induced MyD88 Short Expression Is Regulated by Positive IKK beta and CREB Pathways and Negative ERK1/2 Pathway	PLOS ONE			English	Article							NF-KAPPA-B; OBSTRUCTIVE PULMONARY-DISEASE; DEPENDENT UP-REGULATION; STREPTOCOCCUS-PNEUMONIAE; EPITHELIAL-CELLS; INFLAMMATION; ACTIVATION; INNATE; CYLD; INTERLEUKIN-8	Airway diseases such as asthma and chronic obstructive pulmonary disease (COPD) are characterized by excessive inflammation and are exacerbated by nontypeable Haemophilus influenzae (NTHi). Airway epithelial cells mount the initial innate immune responses to invading pathogens and thus modulate inflammation. While inflammation is necessary to eliminate a pathogen, excessive inflammation can cause damage to the host tissue. Therefore, the inflammatory response must be tightly regulated and deciphering the signaling pathways involved in this response will enhance our understanding of the regulation of the host inflammatory response. NTHi binds to TLR2 and signal propagation requires the adaptor molecule myeloid differentiation factor 88 (MyD88). An alternative spliced form of MyD88 is called MyD88 short (MyD88s) and has been identified in macrophages and embryonic cell lines as a negative regulator of inflammation. However, the role of MyD88s in NTHi-induced inflammation in airway epithelial cells remains unknown. Here we show that NTHi induces MyD88s expression and MyD88s is a negative regulator of inflammation in airway epithelial cells. We further demonstrate that MyD88s is positively regulated by IKK beta and CREB and negatively regulated by ERK1/2 signaling pathways. Taken together these data indicate that airway inflammation is controlled in a negative feedback manner involving MyD88s and suggest that airway epithelial cells are essential to maintain immune homeostasis.	[Andrews, Carla S.; Miyata, Masanori; Susuki-Miyata, Seiko; Lee, Byung-Cheol; Komatsu, Kensei; Li, Jian-Dong] Georgia State Univ, Inst Biomed Sci, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA	University System of Georgia; Georgia State University	Li, JD (corresponding author), Georgia State Univ, Inst Biomed Sci, Ctr Inflammat Immun & Infect, Atlanta, GA 30303 USA.	jdli@gsu.edu	Komatsu, Kensei/AAO-6492-2021	Komatsu, Kensei/0000-0001-7418-3805; Li, Jian-Dong/0000-0002-5593-050X	National Institutes of Health [DC005843, DC004562, DC013833, GM107529]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107529] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005843, R01DC004562, R01DC013833] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by grants from National Institutes of Health (http://www.nih.gov) DC005843, DC004562, DC013833 and GM107529 to JDL. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adib-Conquy M, 2006, CRIT CARE MED, V34, P2377, DOI 10.1097/01.CCM.0000233875.93866.88; Alikhan MM, 2014, CURR OPIN PULM MED, V20, P159, DOI 10.1097/MCP.0000000000000023; Barbu C, 2011, ROM J MORPHOL EMBRYO, V52, P21; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Cohen P, 2014, J CELL SCI, V127, P2383, DOI 10.1242/jcs.149831; Foxwell AR, 1998, MICROBIOL MOL BIOL R, V62, P294, DOI 10.1128/MMBR.62.2.294-308.1998; Ha U, 2007, J IMMUNOL, V178, P1736, DOI 10.4049/jimmunol.178.3.1736; Hallstrand TS, 2014, CLIN IMMUNOL, V151, P1, DOI 10.1016/j.clim.2013.12.003; Ito M, 2010, INT J PEDIATR OTORHI, V74, P901, DOI 10.1016/j.ijporl.2010.05.008; Janssens S, 2003, FEBS LETT, V548, P103, DOI 10.1016/S0014-5793(03)00747-6; Janssens S, 2002, CURR BIOL, V12, P467, DOI 10.1016/S0960-9822(02)00712-1; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Jono H, 2004, J BIOL CHEM, V279, P36171, DOI 10.1074/jbc.M406638200; Jundi K, 2015, BIOMOLECULES, V5, P1386, DOI 10.3390/biom5031386; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Knight DA, 2012, RESPIROLOGY, V17, P563, DOI 10.1111/j.1440-1843.2012.02126.x; Komatsu K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2674; Lee J, 2012, J BIOL CHEM, V287, P22799, DOI 10.1074/jbc.M111.337378; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Lim JH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001032; Lugade AA, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00010; Miyata M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7062; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Newton K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a006049; Oeckinghaus A, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000034; Proud D, 2011, IMMUNOL REV, V242, P186, DOI 10.1111/j.1600-065X.2011.01033.x; Rubinstein AL, 2011, BMC PULM MED, V11, DOI 10.1186/1471-2466-11-34; Sanin DE, 2015, J IMMUNOL, V195, P1218, DOI 10.4049/jimmunol.1500146; Schumacher SK, 2012, PEDIATR INFECT DIS J, V31, P145, DOI 10.1097/INF.0b013e31823aaeb3; Shuto T, 2001, P NATL ACAD SCI USA, V98, P8774, DOI 10.1073/pnas.151236098; Susuki-Miyata S, 2015, P NATL ACAD SCI USA, V112, pE1800, DOI 10.1073/pnas.1418716112; Wang BN, 2003, INFECT IMMUN, V71, P5523, DOI 10.1128/IAI.71.10.5523-5530.2003; Wang WJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0083908, 10.1371/journal.pone.0084654]	34	3	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144840	10.1371/journal.pone.0144840	http://dx.doi.org/10.1371/journal.pone.0144840			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26669856	Green Published, gold, Green Submitted			2022-12-26	WOS:000366719300026
J	Lu, ZY; Zeng, YQ; Lu, FH; Liu, XS; Zou, CA				Lu, Zhaoyu; Zeng, Yuqun; Lu, Fuhua; Liu, Xusheng; Zou, Chuan			Rhubarb Enema Attenuates Renal Tubulointerstitial Fibrosis in 5/6 Nephrectomized Rats by Alleviating Indoxyl Sulfate Overload	PLOS ONE			English	Article							BOUND UREMIC SOLUTES; TOXINS; KIDNEY	Aim To investigate the effects of rhubarb enema treatment using a 5/6 nephrectomized rat model and study its mechanisms. Methods Twenty-eight Sprague Dawley rats were divided into three groups: sham operation group (n = 8), 5/6 nephrectomized (5/6Nx) (n = 10), and 5/6Nx with rhubarb enema treatment (n = 10). The rhubarb enema was continuous for 1.0month. Serum creatinine, serum indoxyl sulfate (IS) level, renal pathology, tubulointerstitial fibrosis, and renal oxidative stress were assessed. Results 5/6Nx rats showed increasing levels of serum creatinine and severe pathological lesions. Their serum creatinine levels obviously decreased after rhubarb enema treatment (P < 0.05 vs 5/6Nx group). The administration of rhubarb enema attenuated the histopathological changes in 5/6Nx rats. In addition, 5/6Nx rats showed an enhanced extent of tubulointerstitial fibrosis compared with sham rats, and administration of rhubarb enema to 5/6Nx rats ameliorated tubulointerstitial fibrosis. 5/6Nx rats showed increased serum levels of IS, renal oxidative stress, and NF-kappa B compared with sham rats, whereas administration of rhubarb enema to 5/6Nx rats decreased serum levels of IS, renal oxidative stress, and NF-kappa B levels. Conclusion Rhubarb enema treatment ameliorates tubulointerstitial fibrosis in the kidneys of 5/6Nx rats, most likely by alleviating IS overload and reducing kidney oxidative stress and inflammatory injury.	[Lu, Zhaoyu; Zeng, Yuqun; Lu, Fuhua; Liu, Xusheng; Zou, Chuan] Guangzhou Univ Chinese Med, Affiliated Hosp 2, Natl Key Unit Clin Res TCM Chron Kidney Dis, Key Unit Kidney Dis,Guangdong Prov Hosp TCM, Guangzhou 510120, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine	Zou, CA (corresponding author), Guangzhou Univ Chinese Med, Affiliated Hosp 2, Natl Key Unit Clin Res TCM Chron Kidney Dis, Key Unit Kidney Dis,Guangdong Prov Hosp TCM, Guangzhou 510120, Guangdong, Peoples R China.	doctorzc541888@126.com			National Natural Science Foundation of China [81202819]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (Nos. 81202819).	Aronov PA, 2011, J AM SOC NEPHROL, V22, P1769, DOI 10.1681/ASN.2010121220; Chiu Cheng-An, 2010, Rev Diabet Stud, V7, P275, DOI 10.1900/RDS.2010.7.275; Evenepoel P, 2009, KIDNEY INT, V76, pS12, DOI 10.1038/ki.2009.402; Fagugli RM, 2002, AM J KIDNEY DIS, V40, P339, DOI 10.1053/ajkd.2002.34518; Friedman EA, 2009, CURR MED RES OPIN, V25, P1913, DOI 10.1185/03007990903069173; Guo Jun, 2011, Clinical Focus, V26, P1595; He PX, 2014, ACTA PHARMACOL SIN, V35, P1546, DOI 10.1038/aps.2014.105; Jiang J, 2011, J MED RES CHIN, V40, P20; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Li A, 2013, MICROCIRCULATION, V20, P617, DOI 10.1111/micc.12061; Liabeuf S, 2011, TOXINS, V3, P911, DOI 10.3390/toxins3070911; Lin B., 2011, J NEW CHIN MED CHIN, V43, P38; Lin CJ, 2010, NEPHROL DIAL TRANSPL, V25, P3693, DOI 10.1093/ndt/gfq251; McCullough PA, 2010, AM J KIDNEY DIS, V55, pS1, DOI 10.1053/j.ajkd.2009.12.017; Meert N, 2009, NEPHROL DIAL TRANSPL, V24, P562, DOI 10.1093/ndt/gfn522; Meijers BKI, 2009, CLIN J AM SOC NEPHRO, V4, P1932, DOI 10.2215/CJN.02940509; Meijers BKI, 2011, NEPHROL DIAL TRANSPL, V26, P759, DOI 10.1093/ndt/gfq818; Shu ZJ, 2011, EXPERT OPIN THER TAR, V15, P1147, DOI 10.1517/14728222.2011.614234; Torres-Gonzalez M, 2014, AM J PHYSIOL-CELL PH, V306, pC221, DOI 10.1152/ajpcell.00140.2013; Tumur Z, 2009, AM J NEPHROL, V29, P551, DOI 10.1159/000191468; Vanholder R, 2008, BLOOD PURIFICAT, V26, P77, DOI 10.1159/000110570; Vanholder R, 2008, J AM SOC NEPHROL, V19, P863, DOI 10.1681/ASN.2007121377; Wang GF, 2009, RAPID COMMUN MASS SP, V23, P2061, DOI 10.1002/rcm.4111; Watanabe H, 2011, J PHARM SCI-US, V100, P3682, DOI 10.1002/jps.22592; Zhang BD, 2009, CHIN J TRADIT CHIN M, V50, P261; Zhang LX, 2012, LANCET, V379, P815, DOI 10.1016/S0140-6736(12)60033-6; Zhao C, 2011, CLIN FOCUS CHIN, V26, P1310; Zheng H., 2008, LIAONING J TRADITION, V35, P1650; Zhou QG, 2009, ACTA PHARMACOL SIN, V30, P98, DOI 10.1038/aps.2008.11; Zhu Wei, 2005, Zhongguo Zhong Xi Yi Jie He Za Zhi, V25, P471	30	19	24	3	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144726	10.1371/journal.pone.0144726	http://dx.doi.org/10.1371/journal.pone.0144726			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671452	Green Submitted, Green Published, gold			2022-12-26	WOS:000366719300018
J	Sueoka, H; Aoki, M; Tsukimura, T; Togawa, T; Sakuraba, H				Sueoka, Hideaki; Aoki, Mikio; Tsukimura, Takahiro; Togawa, Tadayasu; Sakuraba, Hitoshi			Distributions of Globotriaosylceramide Isoforms, and Globotriaosylsphingosine and Its Analogues in an alpha-Galactosidase A Knockout Mouse, a Model of Fabry Disease	PLOS ONE			English	Article							MASS-SPECTROMETRY; ENDOTHELIAL DYSFUNCTION; MICE; NEPHROPATHY; K(CA)3.1; PLASMA	Fabry disease is caused by deficient activity of alpha-galactosidase A (GLA) and characterized by systemic accumulation of glycosphingolipids, substrates of the enzyme. To gain insight into the pathogenesis of Fabry disease based on accumulated substrates, we examined the tissue and plasma distributions of globotriaosylceramide (Gb3) isoforms, and globotriao-sylsphingosine (lyso-Gb3) and its analogues in a GLA knockout mouse, a model of Fabry disease, by means of liquid chromatography-mass spectrometry and nano-liquid chromatography-tandem mass spectrometry, respectively. The results revealed that the contents of these substrates in the liver, kidneys, heart, and plasma of GLA knockout mice were apparently higher than in those of wild-type ones, and organ specificity in the accumulation of Gb3 isoforms was found. Especially in the kidneys, accumulation of a large amount of Gb3 isoforms including hydroxylated residues was found. In the GLA knockout mice, the proportion of hydrophobic Gb3 isoforms was apparently higher than that in the wild-type mice. On the other hand, hydrophilic residues were abundant in plasma. Unlike that of Gb3, the concentration of lyso-Gb3 was high in the liver, and the lyso-Gb3/Gb3 ratio in plasma was significantly higher than those in the organs. The concentration of lyso-Gb3 was apparently higher than those of its analogues in the organs and plasma from both the GLA knockout and wild-type mice. This information will be useful for elucidating the basis of Fabry disease.	[Sueoka, Hideaki; Aoki, Mikio] Sumitomo Dainippon Pharma Co Ltd, Genom Sci Labs, Konohana Ku, Osaka, Japan; [Tsukimura, Takahiro; Togawa, Tadayasu] Meiji Pharmaceut Univ, Dept Funct Bioanal, Tokyo, Japan; [Sakuraba, Hitoshi] Meiji Pharmaceut Univ, Dept Clin Genet, Tokyo, Japan	Dainippon Sumitomo Pharmaceutical Company; Meiji Pharmaceutical University; Meiji Pharmaceutical University	Sakuraba, H (corresponding author), Meiji Pharmaceut Univ, Dept Clin Genet, Tokyo, Japan.	sakuraba@my-pharm.ac.jp			Japan Society for Promotion of Science [15K0960]; Sumitomo Dainippon Pharma Co., Ltd.; Sumitomo Dainippon Pharma Co., Ltd	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Sumitomo Dainippon Pharma Co., Ltd.; Sumitomo Dainippon Pharma Co., Ltd	This work was supported by the Japan Society for Promotion of Science (ID: 15K0960, HSa), and Sumitomo Dainippon Pharma Co., Ltd. Sumitomo Dainippon Pharma Co., Ltd provided research tools and support in the form of salaries for two authors [H. Sueoka and M. Aoki], but did not play any additional role in the study design, data collection or analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are given in the 'author contributions' section.; We wish to thank A.B Kulkarni and T. Oshima (National Institutes of Health) for the GLA knockout mice. This work was supported by the Japan Society for Promotion of Science (ID: 15K0960, H Sa). We also wish to thank the members of Sumitomo Dainippon Pharma Co., Ltd., especially Tetsuya Nishide, for the experimental assistance.	Aerts JM, 2008, P NATL ACAD SCI USA, V105, P2812, DOI 10.1073/pnas.0712309105; [Anonymous], 2014, METABOLIC MOL BASES; Auray-Blais C, 2012, ANAL CHEM, V84, P2745, DOI 10.1021/ac203433e; Bangari DS, 2015, AM J PATHOL, V185, P651, DOI 10.1016/j.ajpath.2014.11.004; Choi L, 2015, NEUROSCI LETT, V594, P163, DOI 10.1016/j.neulet.2015.01.084; Choi S, 2014, ARTERIOSCL THROM VAS, V34, P81, DOI 10.1161/ATVBAHA.113.302200; Germain DP, 2010, ORPHANET J RARE DIS, V5, DOI 10.1186/1750-1172-5-30; Gold H, 2013, CLIN CHEM, V59, P547, DOI 10.1373/clinchem.2012.192138; Ikeda K, 2010, RAPID COMMUN MASS SP, V24, P2957, DOI 10.1002/rcm.4716; Khanna R, 2010, MOL THER, V18, P23, DOI 10.1038/mt.2009.220; Kuchar L, 2015, ANAL BIOANAL CHEM, V407, P2283, DOI 10.1007/s00216-014-8402-7; Lee MH, 2012, INT J MOL MED, V30, P1275, DOI 10.3892/ijmm.2012.1139; Marshall J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015033; Ohshima T, 1999, P NATL ACAD SCI USA, V96, P6423, DOI 10.1073/pnas.96.11.6423; Ohshima T, 1997, P NATL ACAD SCI USA, V94, P2540, DOI 10.1073/pnas.94.6.2540; Park S, 2011, CARDIOVASC RES, V89, P290, DOI 10.1093/cvr/cvq333; Rodrigues LG, 2009, NEUROBIOL DIS, V33, P48, DOI 10.1016/j.nbd.2008.09.001; Rombach SM, 2010, BBA-MOL BASIS DIS, V1802, P741, DOI 10.1016/j.bbadis.2010.05.003; Sanchez-Nino MD, 2011, NEPHROL DIAL TRANSPL, V26, P1797, DOI 10.1093/ndt/gfq306; Satoh K, 2014, ARTERIOSCL THROM VAS, V34, P2, DOI 10.1161/ATVBAHA.113.302744; Sueoka H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127048; Tajima Y, 2009, AM J HUM GENET, V85, P569, DOI 10.1016/j.ajhg.2009.09.016; Takenaka T, 2000, P NATL ACAD SCI USA, V97, P7515, DOI 10.1073/pnas.120177997; Togawa T, 2010, MOL GENET METAB, V100, P257, DOI 10.1016/j.ymgme.2010.03.020; van Breemen MJ, 2011, BBA-MOL BASIS DIS, V1812, P70, DOI 10.1016/j.bbadis.2010.09.007; Wang A. M., 1996, American Journal of Human Genetics, V59, pA208; Yamada T, 2013, J CHROMATOGR A, V1292, P211, DOI 10.1016/j.chroma.2013.01.078	27	16	16	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144958	10.1371/journal.pone.0144958	http://dx.doi.org/10.1371/journal.pone.0144958			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26661087	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900156
J	Yeh, JH; Hung, CH; Wang, JH; Chen, CH; Kee, KM; Kuo, CM; Yen, YH; Cheng, YF; Chen, YY; Hsu, HC; Lu, SN				Yeh, Jen-Hao; Hung, Chao-Hung; Wang, Jing-Houng; Chen, Chien-Hung; Kee, Kwong-Ming; Kuo, Chung-Mou; Yen, Yi-Hao; Cheng, Yu-Fan; Chen, Yen-Yang; Hsu, Hsuan-Chi; Lu, Sheng-Nan			Modifiable Prognostic Factors of Hepatocellular Carcinoma in Patients with Non-Surgical Treatment	PLOS ONE			English	Article							HEPATITIS-C VIRUS; RADIOFREQUENCY ABLATION; LIVER RESECTION; SURGICAL RESECTION; ANTIVIRAL THERAPY; TUMOR ABLATION; SURVIVAL; RECURRENCE; CIRRHOSIS; TRANSPLANTATION	Background & aims Current hepatocellular carcinoma (HCC) staging systems only use baseline characteristics to predict outcome. We aimed to explore modifiable factors of the prognosis in HCC cases had undergone non-surgical treatment. Methods All HCC cases in Kaohsiung Chang Gung Memorial hospital in southern Taiwan from 2002 to 2012 must met all below criteria: (1) met international diagnostic guidelines, (2) underwent the initial treatments in our hospital (3) treated by non-surgical treatment modalities and (4) survived more than two years, with follow-up time longer than five years. Results A total 698 patients were enrolled: 451 (24.6%, group A) survivied between 2 to 5 years, and 247 (13.5%, group B) had survived > 5 years. Aside from liver function reserve and BCLC stages, four interventional factors: initial treatment modality, outcomes of 1st or 2nd treatment, and anti-viral therapy to chronic viral hepatitis were associated with prognosis. After propensity score matching, multiple logistic regression of 223 well-matched pairs showed that recurrence within one year after 1st treatment (OR: 2.17, 95% CI: 1.35-3.48), incomplete 2nd treatment (2.01, 1.27-3.17) and absence of anti-viral agents (1.68, 1.09-2.59) were independent poor prognostic factors. Conclusion Complete treatment and anti-viral agents to chronic hepatitis were both independent modifiable prognostic factors of HCC patients had undergone non-surgical treatment. Based on these findings, timely treatment to achieve maximal locoregional control and anti-viral treatment should be provided as possible.	[Yeh, Jen-Hao; Hung, Chao-Hung; Wang, Jing-Houng; Chen, Chien-Hung; Kee, Kwong-Ming; Kuo, Chung-Mou; Yen, Yi-Hao; Lu, Sheng-Nan] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan; [Yeh, Jen-Hao; Hung, Chao-Hung; Wang, Jing-Houng; Chen, Chien-Hung; Kee, Kwong-Ming; Kuo, Chung-Mou; Yen, Yi-Hao; Lu, Sheng-Nan] Chang Gung Univ, Coll Med, Kaohsiung, Taiwan; [Cheng, Yu-Fan] Kaohsiung Chang Gung Mem Hosp, Dept Diagnost Radiol, Kaohsiung, Taiwan; [Chen, Yen-Yang] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hematol Oncol, Kaohsiung, Taiwan; [Hsu, Hsuan-Chi] Kaohsiung Chang Gung Mem Hosp, Dept Radiat Oncol, Kaohsiung, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital	Lu, SN (corresponding author), Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan.	juten@ms17.hinet.net			Kaohsiung Chang-Gung Memorial hospital [CMRPG8B1413]	Kaohsiung Chang-Gung Memorial hospital(Chang Gung Memorial Hospital)	This study was supported by the CMRPG8B1413 project of Kaohsiung Chang-Gung Memorial hospital to Dr. Sheng-Nan Lu. The funder had no role in this study design, data collection and analysis, decision to publish or preparation of the manuscript. https://www.cgmh.org.tw/eng2002/index.asp.	Bharat A, 2006, J AM COLL SURGEONS, V203, P411, DOI 10.1016/j.jamcollsurg.2006.06.016; Bruix J, 2011, HEPATOLOGY, V53, P1020, DOI 10.1002/hep.24199; Chan KM, 2011, ANN SURG ONCOL, V18, P2638, DOI 10.1245/s10434-011-1779-z; Changchien CS, 2008, J GASTROENTEROL, V43, P159, DOI 10.1007/s00535-007-2134-9; Cho YK, 2011, J GASTROEN HEPATOL, V26, P1354, DOI 10.1111/j.1440-1746.2011.06812.x; Clavien PA, 2012, LANCET ONCOL, V13, pE11, DOI 10.1016/S1470-2045(11)70175-9; European Association for the study of the liver and European Organisation for Research and Treatment of Cancer, 2012, EUR J CANCER, V48, P599, DOI DOI 10.1016/J.EJCA.2011.12.021; Goldberg SN, 2005, RADIOLOGY, V235, P728, DOI 10.1148/radiol.2353042205; Huang YJ, 2009, INT J RADIAT ONCOL, V73, P1155, DOI 10.1016/j.ijrobp.2008.06.1486; Hung CH, 2005, J GASTROEN HEPATOL, V20, P1553, DOI 10.1111/j.1440-1746.2005.03925.x; Ishikawa T, 2012, HEPATO-GASTROENTEROL, V59, P529, DOI 10.5754/hge10867; Johnson PJ, 2015, J CLIN ONCOL, V33, P550, DOI 10.1200/JCO.2014.57.9151; Kuo YH, 2010, EUR J CANCER, V46, P744, DOI 10.1016/j.ejca.2009.12.018; Lee DH, 2014, RADIOLOGY, V270, P900, DOI 10.1148/radiol.13130940; Lencioni RA, 2003, RADIOLOGY, V228, P235, DOI 10.1148/radiol.2281020718; Livraghi T, 2008, HEPATOLOGY, V47, P82, DOI 10.1002/hep.21933; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; Lok ASF, 2012, JAMA-J AM MED ASSOC, V308, P1922, DOI 10.1001/jama.2012.12971; Mazzaferro V, 2006, HEPATOLOGY, V44, P1543, DOI 10.1002/hep.21415; OKUDA K, 1985, CANCER, V56, P918, DOI 10.1002/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E; Park JW, 2012, J HEPATOL, V56, P1336, DOI 10.1016/j.jhep.2012.01.006; Portolani N, 2006, ANN SURG, V243, P229, DOI 10.1097/01.sla.0000197706.21803.a1; Shah SA, 2006, J AM COLL SURGEONS, V202, P275, DOI 10.1016/j.jamcollsurg.2005.10.005; Su CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066457; The Cancer of the Liver Italian Program (CLIP), 1998, HEPATOLOGY, V28, P751, DOI DOI 10.1002/HEP.510280322; Tiong L, 2011, BRIT J SURG, V98, P1210, DOI 10.1002/bjs.7669; Tseng PL, 2010, J GASTROEN HEPATOL, V25, P1426, DOI 10.1111/j.1440-1746.2010.06285.x; Vauthey JN, 2007, J AM COLL SURGEONS, V204, P1016, DOI 10.1016/j.jamcollsurg.2006.12.043; Vauthey JN, 2010, HPB, V12, P289, DOI 10.1111/j.1477-2574.2010.00181.x; Wang JH, 2008, EUR J CANCER, V44, P1000, DOI 10.1016/j.ejca.2008.02.018; Wang JH, 2015, J GASTROEN HEPATOL, V30, P358, DOI 10.1111/jgh.12686; Wang JH, 2013, AM J GASTROENTEROL, V108, P416, DOI 10.1038/ajg.2012.445; Wang JH, 2012, J HEPATOL, V56, P412, DOI 10.1016/j.jhep.2011.05.020; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975	34	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144893	10.1371/journal.pone.0144893	http://dx.doi.org/10.1371/journal.pone.0144893			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26661388	Green Published, Green Submitted, gold			2022-12-26	WOS:000366715900138
J	Wang, XG; Sun, J; Hu, JH				Wang, Xuguo; Sun, Jun; Hu, JinHong			IMQ Induced K14-VEGF Mouse: A Stable and Long-Term Mouse Model of Psoriasis-Like Inflammation	PLOS ONE			English	Article							DENDRITIC CELLS; SKIN INFLAMMATION; PLAQUE-FORMATION; T-CELLS; VEGF; IDENTIFICATION; LYMPHOCYTES; RECEPTOR; DENSITY; IL-23	An imiquimod (IMQ) induced wild type (WT) mouse can mimic some features of psoriasis, such as thickened skin, abnormal keratinocyte-related proteins, infiltration of inflammatory cells and pro-inflammatory cytokines. This model is a prevalent model that is widely used in the study of psoriasis. However, skin inflammation decreases during the eighth day when IMQ is given to WT mice, which may result in false results when evaluating the pharmacodynamics effects of a drug. To extend the timeliness and inherit the advantages of this model, we applied IMQ to the skin of 8-week-old homozygous K14-VEGF mice to investigate whether IMQ can prolong mice ear inflammation. In our experiments, we found that, compared to the IMQ induced WT mice model, the IMQ induced K14-VEGF mice have serious skin inflammation, even on the fourteenth day. We also evaluated the stability of skin inflammation at days 8, 10, and 13, and the inflammatory situation remained stable in the skin. This research intends to improve the existing model, and we hypothesize that the IMQ induced K14-VEGF mouse will become a practical mouse model in psoriasis research.	[Wang, Xuguo; Hu, JinHong] Second Mil Med Univ, Changhai Hosp, Dept Pharm, Shanghai, Peoples R China; [Sun, Jun] Jinan Mil Area, Gen Hosp, Dept Pharm, Jinan, Shandong, Peoples R China	Naval Medical University	Hu, JH (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Pharm, Shanghai, Peoples R China.	wxh201309@126.com						Beutner KR, 1998, J AM ACAD DERMATOL, V38, P230, DOI 10.1016/S0190-9622(98)70243-9; Brenner D, 2007, BLOOD, V110, P3968, DOI 10.1182/blood-2007-01-071167; Detmar M, 1998, J INVEST DERMATOL, V111, P1, DOI 10.1046/j.1523-1747.1998.00262.x; Di Cesare A, 2009, J INVEST DERMATOL, V129, P1339, DOI 10.1038/jid.2009.59; El Malki K, 2013, J INVEST DERMATOL, V133, P441, DOI 10.1038/jid.2012.318; Griffiths CEM, 2007, LANCET, V370, P263, DOI 10.1016/S0140-6736(07)61128-3; Hedrick MN, 2009, J CLIN INVEST, V119, P2317, DOI 10.1172/JCI37378; Kim TG, 2014, J INVEST DERMATOL, V134, P1462, DOI 10.1038/jid.2013.534; Lindroos J, 2011, J INVEST DERMATOL, V131, P1110, DOI 10.1038/jid.2010.432; Micali G, 2010, INT J DERMATOL, V49, P249, DOI 10.1111/j.1365-4632.2009.04287.x; Moniaga CS, 2011, J DERMATOL SCI, V61, P79, DOI 10.1016/j.jdermsci.2010.11.005; Nair RP, 2009, NAT GENET, V41, P199, DOI 10.1038/ng.311; Nordlind K, 2008, EXP DERMATOL, V17, P301, DOI 10.1111/j.1600-0625.2007.00670.x; Palamara F, 2004, J IMMUNOL, V173, P3051, DOI 10.4049/jimmunol.173.5.3051; Pantelyushin S, 2012, J CLIN INVEST, V122, P2252, DOI 10.1172/JCI61862; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Steinmann A, 2000, J AM ACAD DERMATOL, V43, P555, DOI 10.1067/mjd.2000.107954; Sun J.-P., 2013, ELECT J DIFFERENTIAL, V2013, P1, DOI DOI 10.1371/J0URNAL.P0NE.0067078; Suzuki T, 2014, J DERMATOL SCI, V74, P116, DOI 10.1016/j.jdermsci.2013.12.013; Taneda K, 2011, BRIT J DERMATOL, V165, P277, DOI 10.1111/j.1365-2133.2011.10347.x; Tortola L, 2012, J CLIN INVEST, V122, P3965, DOI 10.1172/JCI63451; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; Uribe-Herranz M, 2013, J INVEST DERMATOL, V133, P1541, DOI 10.1038/jid.2012.512; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Wagner EF, 2010, NAT REV RHEUMATOL, V6, P704, DOI 10.1038/nrrheum.2010.157; Walter A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2566; Wary Kishore K, 2003, Mol Cancer, V2, P25, DOI 10.1186/1476-4598-2-25; Witte E, 2014, J INVEST DERMATOL, V134, P2757, DOI 10.1038/jid.2014.308; Wohn C, 2013, P NATL ACAD SCI USA, V110, P10723, DOI 10.1073/pnas.1307569110; Wolk K, 2003, J BIOL CHEM, V278, P18030, DOI 10.1074/jbc.M207714200; Wu Jason K, 2004, Australas J Dermatol, V45, P47, DOI 10.1111/j.1440-0960.2004.00030.x; Xia YP, 2003, BLOOD, V102, P161, DOI 10.1182/blood-2002-12-3793; Zaba LC, 2009, J INVEST DERMATOL, V129, P302, DOI 10.1038/jid.2008.225	33	11	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145498	10.1371/journal.pone.0145498	http://dx.doi.org/10.1371/journal.pone.0145498			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691862	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092300083
J	Lacour, G; Chanaud, L; L'Ambert, G; Hance, T				Lacour, Guillaume; Chanaud, Lionel; L'Ambert, Gregory; Hance, Thierry			Seasonal Synchronization of Diapause Phases in Aedes albopictus (Diptera: Culicidae)	PLOS ONE			English	Article							CHIKUNGUNYA VIRUS; RANGE EXPANSION; TEMPERATURE; POPULATIONS; DENGUE; EVOLUTION; MOSQUITO; SKUSE; OVIPOSITION; PHOTOPERIOD	In temperate areas, population dynamics of the invasive Asian tiger mosquito Aedes albopictus are strongly affected by winter. The work we present here analyzes the adaptive synchronization of the diapause process in the wintry generation of A. albopictus, where the egg stage is exposed to adverse winter conditions. The seasonal pattern of egg laying activity of a French Mediterranean population of the Asian tiger mosquito was monitored weekly for 2 years with ovitraps. The field diapause incidence and the critical photoperiod (CPP, i.e. the maternal day length inducing diapause in 50% of the eggs), were determined by hatching experiments on the collected eggs. The period of diapause termination was estimated by a field survey of the first hatchings for both years. The CPP is equal to 13.5 hours of light and occurs in the field on the 25th of August. Thus, it is on September 11th, 17 days after the CPP, that 50% of the eggs are in a prediapause stage in the field. The egg diapause rate increases rapidly during September, whereas the mean number of eggs laid decreases sharply after mid-September. Surprisingly, after having reached a peak of 95% at the end of September, from mid-October the diapause incidence declined and stayed below 50%. Indeed, both years the diapause initiates before the rapid decrease of the environmental temperature. This leaves a sufficient period of time to the complete development of one generation of A. albopictus with effective induction of diapause in the laid eggs. The very first larvae hatched were sampled both years in the first half of March. With 20 to 26 weeks in the egg stage and about 7 weeks in the larval stages, the first annual generation spends a long time in immature stages. On a practical point of view, this long development time represents a wide window for eggs and larvae control in early spring.	[Lacour, Guillaume; Chanaud, Lionel; L'Ambert, Gregory] EID Mediterranee, Montpellier, France; [Lacour, Guillaume; Hance, Thierry] Catholic Univ Louvain, Earth & Life Inst, Ctr Rech Biodiversite, Louvain, Belgium	Universite Catholique Louvain	Lacour, G (corresponding author), EID Mediterranee, Montpellier, France.	glacour@eid-med.org	Lacour, Guillaume/AAQ-5935-2021	Lacour, Guillaume/0000-0002-9588-6064	EID Mediterranee; French ministry in charge of health, Direction Generale de la Sante (DGS)	EID Mediterranee; French ministry in charge of health, Direction Generale de la Sante (DGS)	This work was supported by EID Mediterranee and the French ministry in charge of health, Direction Generale de la Sante (DGS).r The authors are grateful to the EID Mediterranee (EID) staff for helping to provide mosquito egg samples, Myriam Cros for the map and Nathalie Barras for English revision. This work was supported by EID Mediterranee and the French ministry in charge of health, Direction Generale de la Sante (DGS). This paper is number BRC343 of the Biodiversity Research Centre.	Adhami J, 1998, J AM MOSQUITO CONTR, V14, P340; Andreadis TG, 2010, J AM MOSQUITO CONTR, V26, P257, DOI 10.2987/10-6004.1; [Anonymous], 2015, EURO SURVEILL; Bean DW, 2012, EVOL APPL, V5, P511, DOI 10.1111/j.1752-4571.2012.00262.x; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338; Bueno-Mari R, 2015, J VECTOR DIS, V52, P175; Caminade C, 2012, J R SOC INTERFACE; Claeys C, 2013, INT REV SOC RES, V3, P151, DOI DOI 10.1515/IRSR-2013-0015; Collantes Francisco, 2014, Anales de Biologia, V36, P71, DOI 10.6018/analesbio.36.12; Delatte H, 2009, J MED ENTOMOL, V46, P33, DOI 10.1603/033.046.0105; Delaunay P, 2007, Med Trop (Mars), V67, P310; Denlinger DL, 2014, ANNU REV ENTOMOL, V59, P73, DOI 10.1146/annurev-ento-011613-162023; Dieng H, 2012, INT J BIOMETEOROL, V56, P113, DOI 10.1007/s00484-011-0402-0; European Center for Disease Control and Prevention, 2013, ENV RISK MAPP AED AL; Fonseca DM, 2015, J MED ENTOMOL, V52, P705, DOI 10.1093/jme/tjv060; Fontenille D, 2007, ECOL CONT VECTOR-BOR, V1, P169; Giatropoulos A, 2012, J MED ENTOMOL, V49, P262, DOI 10.1603/ME11096; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Giron S., 2015, Bulletin Epidemiologique Hebdomadaire, P217; Gjenero-Margan I, 2011, EUROSURVEILLANCE, V16, P2; Grandadam M, 2011, EMERG INFECT DIS, V17, P910, DOI 10.3201/eid1705.101873; Halstead S. B., 2008, Dengue; Kobayashi M, 2002, J MED ENTOMOL, V39, P4, DOI 10.1603/0022-2585-39.1.4; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Kuno G, 2012, J MED ENTOMOL, V49, P1163, DOI 10.1603/ME12022; La Ruche G, 2010, EUROSURVEILLANCE, V15, P2; Lacour G, 2014, J INSECT PHYSIOL, V71, P87, DOI 10.1016/j.jinsphys.2014.10.008; Lounibos LP, 2011, J AM MOSQUITO CONTR, V27, P433, DOI 10.2987/11-6164.1; Lounibos LP, 2003, ANN ENTOMOL SOC AM, V96, P512, DOI 10.1603/0013-8746(2003)096[0512:AEOPDI]2.0.CO;2; Marchand E, 2013, EUROSURVEILLANCE, V18, P3, DOI 10.2807/1560-7917.ES2013.18.50.20661; MCNAMARA JM, 1994, J THEOR BIOL, V168, P201, DOI 10.1006/jtbi.1994.1099; Medlock JM, 2006, J VECTOR ECOL, V31, P292, DOI 10.3376/1081-1710(2006)31[292:AOTPFS]2.0.CO;2; MITCHELL CJ, 1995, J VECTOR ECOL, V20, P44; Mogi M, 2012, J MED ENTOMOL, V49, P1233, DOI 10.1603/ME12104; Musolin DL, 2012, ENTOMOL REV, V92, P715, DOI DOI 10.1134/S0013873812070019; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; POZZA GLD, 1994, J AM MOSQUITO CONTR, V10, P589; PUMPUNI CB, 1992, J AM MOSQUITO CONTR, V8, P223; Pumpuni CB, 1989, FACTORS INFLUENCING; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rezza G, 2007, LANCET, V370, P1840, DOI 10.1016/S0140-6736(07)61779-6; Roiz D, 2010, VECTOR-BORNE ZOONOT, V10, P811, DOI 10.1089/vbz.2009.0098; Romi R, 2006, J AM MOSQUITO CONTR, V22, P149, DOI 10.2987/8756-971X(2006)22[149:CAAOOF]2.0.CO;2; Sinegre G, 1974, THESIS, P280; Tauber M.J., 1986, SEASONAL ADAPTATIONS, P411; Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100; Toma L, 2003, J AM MOSQUITO CONTR, V19, P19; Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698; TRPIS M, 1970, CAN J ZOOLOG, V48, P892, DOI 10.1139/z70-158; Urbanelli S, 2000, HEREDITY, V84, P331, DOI 10.1046/j.1365-2540.2000.00676.x; Urbanski J, 2012, AM NAT, V179, P490, DOI 10.1086/664709; Velo E, 2012, 18 E SOVE C 2012 OCT; Vinogradova E.B., 2007, DIAPAUSE AQUATIC INV, P83, DOI DOI 10.1007/978-1-4020-5680-2_5; Waldock J, 2013, PATHOG GLOB HEALTH, V107, P224, DOI 10.1179/2047773213Y.0000000100; [No title captured]	56	29	30	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145311	10.1371/journal.pone.0145311	http://dx.doi.org/10.1371/journal.pone.0145311			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683460	Green Submitted, Green Published, gold			2022-12-26	WOS:000366725800062
J	Xing, JY; Song, GP; Deng, JP; Jiang, LZ; Xiong, P; Yang, BJ; Liu, SS				Xing, Jie-yu; Song, Gao-peng; Deng, Jun-peng; Jiang, Ling-zhi; Xiong, Ping; Yang, Bin-jie; Liu, Shan-shan			Antitumor Effects and Mechanism of Novel Emodin Rhamnoside Derivatives against Human Cancer Cells In Vitro	PLOS ONE			English	Article							INDUCED APOPTOSIS; DOWN-REGULATION; GENE-EXPRESSION; SCC-4 CELLS; INHIBITION; GEMCITABINE; GLYCOSIDES; MIGRATION; INVASION; DEATH	A series of novel anthracene L-rhamnopyranosides compounds were designed and synthesized and their anti-proliferative activities on cancer cell lines were investigated. We found that one derivative S-8 (EM-d-Rha) strongly inhibited cell proliferation of a panel of different human cancer cell lines including A549, HepG2, OVCAR-3, HeLa and K562 and SGC-790 cell lines, and displayed IC50 values in low micro-molar ranges, which are ten folds more effective than emodin. In addition, we found EM-d-Rha (3-(2 '',3 ''-Di-O-acetyl-alpha-L-rhamnopyranosyl-(1 -> 4)-2',3'-di-O-acetyl-alpha-L-rhamnopyranosyl)-emodin) substantially induced cellular apoptosis of HepG2 and OVCAR-3 cells in the early growth stage. Furthermore, EM-d-Rha led to the decrease of mitochondrial transmembrane potential, and up-regulated the express of cells apoptosis factors in a concentration-and time-dependent manner. The results indicated the EM-d-Rha may inhibit the growth and proliferation of HepG2 cells through the pathway of apoptosis induction, and the possible molecular mechanism may due to the activation of intrinsic apoptotic signal pathway.	[Xing, Jie-yu; Song, Gao-peng; Xiong, Ping; Yang, Bin-jie; Liu, Shan-shan] South China Agr Univ, Dept Pharmaceut Engn, Guangzhou, Guangdong, Peoples R China; [Deng, Jun-peng] Oklahoma State Univ, Dept Biochem & Mol Biol, Stillwater, OK 74078 USA; [Jiang, Ling-zhi] Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Microbial Genet Engn, Shenzhen, Guangdong, Peoples R China	South China Agricultural University; Oklahoma State University System; Oklahoma State University - Stillwater; Shenzhen University	Jiang, LZ (corresponding author), Shenzhen Univ, Coll Life Sci, Shenzhen Key Lab Microbial Genet Engn, Shenzhen, Guangdong, Peoples R China.	jlz2004@szu.edu.cn; xp0000542003@scau.edu.cn			Major Program of Science and Technology Program of Guangzhou, China [11C32100704]; Reserch Project of Chinese Medicine Administration of Guangdong province, China [2010276]; Natural Science Foundation for Youths, China [B020602]	Major Program of Science and Technology Program of Guangzhou, China; Reserch Project of Chinese Medicine Administration of Guangdong province, China; Natural Science Foundation for Youths, China	This work was supported by the Major Program of Science and Technology Program of Guangzhou (PX, 11C32100704), China, Reserch Project of Chinese Medicine Administration of Guangdong province(px, 2010276), China and the Natural Science Foundation for Youths (GPS & PX, B020602), China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carter GT, 2011, NAT PROD REP, V28, P1783, DOI 10.1039/c1np00033k; Cha TL, 2005, CANCER RES, V65, P2287, DOI 10.1158/0008-5472.CAN-04-3250; Chen H, 2011, ONCOL REP, V25, P1253, DOI 10.3892/or.2011.1174; Chen YY, 2010, INT J ONCOL, V36, P1113; Chun-Guang W, 2010, EUR J PHARMACOL, V627, P33, DOI 10.1016/j.ejphar.2009.10.035; Damodharan U, 2011, APPL BIOCHEM BIOTECH, V165, P1245, DOI 10.1007/s12010-011-9342-8; Han YM, 2012, BIOORG MED CHEM LETT, V22, P323, DOI 10.1016/j.bmcl.2011.11.008; [何林 He Lin], 2011, [第三军医大学学报, Acta Academiae Medicinae Militaris Tertiae], V33, P2370; Hsu CM, 2010, BIOCHEM BIOPH RES CO, V392, P473, DOI 10.1016/j.bbrc.2009.10.153; Huang ZW, 2008, ARCH PHARM RES, V31, P742, DOI 10.1007/s12272-001-1221-6; Huang ZW, 2009, CANCER DETECT PREV, V32, P286, DOI 10.1016/j.cdp.2008.12.003; Kaneshiro T, 2006, EUR J PHARMACOL, V553, P46, DOI 10.1016/j.ejphar.2006.09.026; Kim R, 2002, CANCER CHEMOTH PHARM, V50, P343, DOI 10.1007/s00280-002-0522-7; Ko JC, 2010, LUNG CANCER, V69, P155, DOI 10.1016/j.lungcan.2009.10.013; Ko JC, 2010, BIOCHEM PHARMACOL, V79, P655, DOI 10.1016/j.bcp.2009.09.024; Lai JM, 2009, EUR J PHARMACOL, V623, P1, DOI 10.1016/j.ejphar.2009.08.031; Li J, 2015, J CANCER RES CLIN, V141, P283, DOI 10.1007/s00432-014-1820-2; Li P., 2004, CELL, V116, pS59; Li XX, 2013, STEM CELLS DEV, V22, P554, DOI 10.1089/scd.2011.0709; Li XX, 2012, BIOCHEM BIOPH RES CO, V419, P728, DOI 10.1016/j.bbrc.2012.02.090; LIN CN, 1991, PHYTOCHEMISTRY, V30, P3103, DOI 10.1016/S0031-9422(00)98262-1; LIN CN, 1990, PHYTOCHEMISTRY, V29, P3903, DOI 10.1016/0031-9422(90)85356-K; Lin SY, 2009, ANTICANCER RES, V29, P327; Liu A, 2011, ONCOL REP, V26, P81, DOI 10.3892/or.2011.1257; Liu DL, 2012, INT J ONCOL, V40, P1049, DOI 10.3892/ijo.2011.1285; Liu JX, 2012, ONCOL REP, V28, P1991, DOI 10.3892/or.2012.2042; Ma YS, 2012, FOOD CHEM TOXICOL, V50, P1271, DOI 10.1016/j.fct.2012.01.033; Mai LP, 2001, J NAT PROD, V64, P1162, DOI 10.1021/np010030v; Manu KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057015; Muto A, 2007, MOL CANCER THER, V6, P987, DOI 10.1158/1535-7163.MCT-06-0605; Ok S, 2012, IMMUNOPHARM IMMUNOT, V34, P768, DOI 10.3109/08923973.2012.654494; RAO JUM, 1986, J NAT PROD, V49, P343, DOI 10.1021/np50044a028; Ricci JE, 2003, CELL DEATH DIFFER, V10, P488, DOI 10.1038/sj.cdd.4401225; Song GP, 2010, BIOORGAN MED CHEM, V18, P5183, DOI 10.1016/j.bmc.2010.05.064; Su YT, 2005, BIOCHEM PHARMACOL, V70, P229, DOI 10.1016/j.bcp.2005.04.026; Subramaniam A, 2013, APOPTOSIS, V18, P1175, DOI 10.1007/s10495-013-0851-5; Teich L, 2004, BIOORGAN MED CHEM, V12, P5961, DOI 10.1016/j.bmc.2004.08.024; WAGNER H, 1974, Z NATURFORSCH C, VC 29, P204; Wang SP, 2012, INT J PHARMACEUT, V430, P238, DOI 10.1016/j.ijpharm.2012.03.027; Wang W, 2010, BIOCHEM PHARMACOL, V79, P1134, DOI 10.1016/j.bcp.2009.12.006; Wang WF, 2013, MED CHEM, V9, P545, DOI 10.2174/1573406411309040008; Wang XD, 2007, BIOL PHARM BULL, V30, P1113, DOI 10.1248/bpb.30.1113; Wang Xin-hua, 2004, Yaoxue Xuebao, V39, P254; Wang YX, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-71; Xie QC, 2014, BMC COMPLEM ALTERN M, V14, DOI 10.1186/1472-6882-14-377; Yan YY, 2014, J BUON, V19, P650; Yan YY, 2008, MOL CANCER THER, V7, P1688, DOI 10.1158/1535-7163.MCT-07-2362; Yi J, 2008, NEOPLASIA, V10, P41, DOI 10.1593/neo.07754; Yim H, 1999, PLANTA MED, V65, P9, DOI 10.1055/s-1999-13953; Zhang W, 2013, INT J ONCOL, V42, P1189, DOI 10.3892/ijo.2013.1839	50	22	23	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144781	10.1371/journal.pone.0144781	http://dx.doi.org/10.1371/journal.pone.0144781			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26682731	Green Published, Green Submitted, gold			2022-12-26	WOS:000366725800021
J	Kim, TH; Joung, JY; Kang, M; Choi, SK; Kim, K; Jang, JY; Cho, YY; Min, YK; Chung, JH; Kim, SW				Kim, Tae Hyuk; Joung, Ji Young; Kang, Mira; Choi, Sun Kyu; Kim, Kyunga; Jang, Ju Young; Cho, Yoon Young; Min, Yong-Ki; Chung, Jae Hoon; Kim, Sun Wook			A Modest Protective Effect of Thyrotropin against Bone Loss Is Associated with Plasma Triiodothyronine Levels	PLOS ONE			English	Article							SUBCLINICAL THYROID-DYSFUNCTION; TYPE-2 IODOTHYRONINE DEIODINASE; MINERAL DENSITY; POSTMENOPAUSAL WOMEN; INCREASED RISK; HIP FRACTURE; NORMAL RANGE; TSH; HYPERTHYROIDISM; METAANALYSIS	Background The independent skeletal effect of thyrotropin (thyroid stimulating hormone, TSH) has been suggested in animal studies. However, clinical data on the association between bone loss and variations in TSH levels is inconsistent. This study aimed to investigate the relationship between TSH levels and bone mineral density (BMD). Methods We conducted a cross-sectional study with 37,431 subjects (33,052 cases with euthyroidism and 4,379 cases with subclinical thyroid dysfunction) aged over 35 years. We performed thyroid function tests and measured BMD at the lumbar spine, femur neck, and total hip. Results Levels of TSH and T3 were positively correlated in women (r = 0.076, P = 0.001) and uncorrelated in men. In both men and women, TSH levels correlated positively and T3 levels correlated negatively with BMD at all skeletal sites in age and body mass index adjusted analyses. BMD increased steadily with TSH levels from the subclinical hyperthyroid to subclinical hypothyroid range in subjects with T3 levels in the highest tertile (119.5-200.0 ng/dL), but was no longer significant in subjects with lower plasma T3 levels. Conclusions The variations in TSH levels within the euthyroid and subclinical range were positively correlated with BMD in healthy men and women. The negative effect of T3 on BMD appears to be compensated for by increased TSH in subjects with plasma T3 levels in the upper normal range.	[Kim, Tae Hyuk; Joung, Ji Young; Jang, Ju Young; Cho, Yoon Young; Min, Yong-Ki; Chung, Jae Hoon; Kim, Sun Wook] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Med, Seoul, South Korea; [Kang, Mira] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Hlth Promot, Seoul, South Korea; [Choi, Sun Kyu; Kim, Kyunga] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Biostat & Clin Epidemiol Ctr,Res Inst Future Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Kim, SW (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Endocrinol & Metab,Dept Med, Seoul, South Korea.	swkimmd@skku.edu	Kim, Tae Hyuk/B-9921-2013; KIM, SUN WOOK/I-9389-2017	Kim, Tae Hyuk/0000-0002-7975-2437; choe, seongyu/0000-0001-8827-7060	Samsung Medical Center grant [CRP1500078]	Samsung Medical Center grant(Samsung)	This study was supported by Samsung Medical Center grant [#CRP1500078]. All authors are employed by a not-for-profit organization, Samsung Medical Center, Seoul, Korea. The organization provided support in the form of salaries for authors, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla SM, 2014, CLIN ENDOCRINOL, V81, P633, DOI 10.1111/cen.12538; Abe E, 2003, CELL, V115, P151, DOI 10.1016/S0092-8674(03)00771-2; Asvold BO, 2007, ARCH INTERN MED, V167, P1428, DOI 10.1001/archinte.167.13.1428; Baliram R, 2012, J CLIN INVEST, V122, P3737, DOI 10.1172/JCI63948; Bassett JHD, 2010, P NATL ACAD SCI USA, V107, P7604, DOI 10.1073/pnas.0911346107; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Bianco AC, 2006, J CLIN INVEST, V116, P2571, DOI 10.1172/JCI29812; Blum MR, 2015, JAMA-J AM MED ASSOC, V313, P2055, DOI 10.1001/jama.2015.5161; Brennan SL, 2009, J BONE MINER RES, V24, P809, DOI [10.1359/JBMR.081243, 10.1359/jbmr.081243]; de Lloyd A, 2010, J ENDOCRINOL, V204, P13, DOI 10.1677/JOE-09-0262; Faber J, 1998, CLIN ENDOCRINOL, V48, P285; FABER J, 1994, EUR J ENDOCRINOL, V130, P350, DOI 10.1530/eje.0.1300350; Garin MC, 2014, J CLIN ENDOCR METAB, V99, P2657, DOI 10.1210/jc.2014-1051; Grimnes G, 2008, THYROID, V18, P1147, DOI 10.1089/thy.2008.0158; Kim KM, 2014, J CLIN ENDOCR METAB, V99, P2409, DOI 10.1210/jc.2014-1006; Kim TH, 2013, J CLIN ENDOCR METAB, V98, P3420, DOI 10.1210/jc.2013-1607; Law MR, 1997, BMJ-BRIT MED J, V315, P841, DOI 10.1136/bmj.315.7112.841; Leader A, 2014, J CLIN ENDOCR METAB, V99, P2665, DOI 10.1210/jc.2013-2474; LEE MS, 1990, J CLIN ENDOCR METAB, V70, P766, DOI 10.1210/jcem-70-3-766; Lin JD, 2011, ENDOCR RES, V36, P1, DOI 10.3109/07435800.2010.514877; Morimura T, 2005, ENDOCRINOLOGY, V146, P2077, DOI 10.1210/en.2004-1432; MOSEKILDE L, 1990, ENDOCRIN METAB CLIN, V19, P35, DOI 10.1016/S0889-8529(18)30338-4; MOSEKILDE L, 1978, ACTA ENDOCRINOL-COP, V87, P751, DOI 10.1530/acta.0.0870751; MUDDE AH, 1994, CLIN ENDOCRINOL, V41, P421, DOI 10.1111/j.1365-2265.1994.tb02571.x; Murphy E, 2010, J CLIN ENDOCR METAB, V95, P3173, DOI 10.1210/jc.2009-2630; Sampath TK, 2007, J BONE MINER RES, V22, P849, DOI 10.1359/JBMR.070302; Sun L, 2008, P NATL ACAD SCI USA, V105, P4289, DOI 10.1073/pnas.0712395105; Wirth CD, 2014, ANN INTERN MED, V161, P189, DOI 10.7326/M14-0125	28	6	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145292	10.1371/journal.pone.0145292	http://dx.doi.org/10.1371/journal.pone.0145292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26679692	Green Published, Green Submitted, gold			2022-12-26	WOS:000366723400068
J	Garcia, N; Feranec, RS; Passey, BH; Cerling, TE; Arsuaga, JL				Garcia, Nuria; Feranec, Robert S.; Passey, Benjamin H.; Cerling, Thure E.; Luis Arsuaga, Juan			Exploring the Potential of Laser Ablation Carbon Isotope Analysis for Examining Ecology during the Ontogeny of Middle Pleistocene Hominins from Sima de los Huesos (Northern Spain)	PLOS ONE			English	Article							INTRA-TOOTH VARIATION; STABLE CARBON; DIETARY HABITS; FOSSIL MAMMALS; ENAMEL; ATAPUERCA; COLLAGEN; BONE; DISCRIMINATION; SEQUENCE	Laser ablation of tooth enamel was used to analyze stable carbon isotope compositions of teeth of hominins, red deer, and bears from middle Pleistocene sites in the Sierra de Atapuerca in northern Spain, to investigate the possibility that this technique could be used as an additional tool to identify periods of physiological change that are not detectable as changes in tooth morphology. Most of the specimens were found to have minimal intratooth variation in carbon isotopes (< 2.3 parts per thousand), suggesting isotopically uniform diets through time and revealing no obvious periods of physiological change. However, one of the two sampled hominin teeth displayed a temporal carbon isotope shift (3.2 parts per thousand) that was significantly greater than observed for co-occurring specimens. The delta C-13 value of this individual averaged about -16 parts per thousand early in life, and -13 parts per thousand later in life. This isotopic change occurred on the canine crown about 4.2 mm from the root, which corresponds to an approximate age of two to four years old in modern humans. Our dataset is perforce small owing to the precious nature of hominid teeth, but it demonstrates the potential utility of the intra-tooth isotope profile method for extracting ontogenetic histories of human ancestors.	[Garcia, Nuria; Luis Arsuaga, Juan] Univ Complutense Madrid, Fac Ciencias Geol, Dept Paleontol, E-28040 Madrid, Spain; [Garcia, Nuria; Luis Arsuaga, Juan] Ctr Mixto UCM ISCIII Evoluc & Comportamiento Huma, Madrid 28029, Spain; [Feranec, Robert S.] New York State Museum & Sci Serv, Res & Collect Div, Cultural Educ Ctr 3140, Albany, NY 12230 USA; [Passey, Benjamin H.] Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA; [Cerling, Thure E.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA	Complutense University of Madrid; Complutense University of Madrid; UCM-ISCIII Center for Human Evolution & Behavior; Johns Hopkins University; Utah System of Higher Education; University of Utah	Arsuaga, JL (corresponding author), Univ Complutense Madrid, Fac Ciencias Geol, Dept Paleontol, Ciudad Univ, E-28040 Madrid, Spain.	jlarsuaga@isciii.es		Cerling, Thure/0000-0002-3590-294X; Arsuaga, Juan Luis/0000-0001-5361-2295	Ministerio de Ciencia e Innovacion [CGL2009-12703-C03-03]; Programa (convocatoria) de Estancias de Doctores y Tecnologos Extranjeros en la Universidad Complutense-Grupo Santander (Madrid, Spain); NY State Museum	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Programa (convocatoria) de Estancias de Doctores y Tecnologos Extranjeros en la Universidad Complutense-Grupo Santander (Madrid, Spain); NY State Museum	Funding for this project was provided by the Ministerio de Ciencia e Innovacion (CGL2009-12703-C03-03), Programa (convocatoria 2010) de Estancias de Doctores y Tecnologos Extranjeros en la Universidad Complutense-Grupo Santander (Madrid, Spain), and the NY State Museum. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Kelley Feranec for help with figures, Rebeca Garcia (Laboratory of Human Evolution, University of Burgos) for SEM microscope pictures, and Rolf Quam and two anonymous reviewers for helpful comments and criticisms that improved this manuscript. Funding for this project was provided by the Ministerio de Ciencia e Innovacion (CGL2009-12703-C03-03), Programa (convocatoria 2010) de Estancias de Doctores y Tecnologos Extranjeros en la Universidad Complutense-Grupo Santander (Madrid, Spain), and the NY State Museum.	Anderson D L, 1976, J Forensic Sci, V21, P191; Arsuaga JL, 2014, SCIENCE, V344, P1358, DOI 10.1126/science.1253958; Balaisse M, 2001, J ARCHAEOL SCI, V28, P235, DOI 10.1006/jasc.1999.0535; Balasse M, 2002, J ARCHAEOL SCI, V29, P853, DOI 10.1006/jasc.2001.0725; Bescos GC, 2001, ANTHROPOLOGIE, V105, P115; Bischoff JL, 2007, J ARCHAEOL SCI, V34, P763, DOI 10.1016/j.jas.2006.08.003; Bischoff JL, 1997, J HUM EVOL, V33, P129, DOI 10.1006/jhev.1997.0130; Bocherens H, 1997, QUATERNARY RES, V48, P370, DOI 10.1006/qres.1997.1927; BOCHERENS H, 1994, PALAEOGEOGR PALAEOCL, V107, P213, DOI 10.1016/0031-0182(94)90095-7; Bocherens H., 1991, Bulletin du Musee d'Anthropologie Prehistorique de Monaco, V34, P29; Bocherens H, 2001, J HUM EVOL, V40, P497, DOI 10.1006/jhev.2000.0452; BOCHERENS H, 1991, J HUM EVOL, V20, P481, DOI 10.1016/0047-2484(91)90021-M; Bocherens Herve, 2003, Deinsea, V9, P57; Cerling TE, 1999, OECOLOGIA, V120, P347, DOI 10.1007/s004420050868; Cerling TE, 1996, PALAEOGEOGR PALAEOCL, V126, P173, DOI 10.1016/S0031-0182(96)00078-8; Cerling TE, 2004, OECOLOGIA, V138, P5, DOI 10.1007/s00442-003-1375-4; Codron J, 2005, J ARCHAEOL SCI, V32, P1757, DOI 10.1016/j.jas.2005.06.006; COLLINS RP, 1985, VEGETATIO, V64, P121; CONSTANDSEWESTERMANN TS, 1984, P K NED AKAD B PHYS, V87, P139; Cuenca-Bescos G, 2010, QUATERN INT, V212, P109, DOI 10.1016/j.quaint.2009.06.007; CuencaBescos G, 1997, J HUM EVOL, V33, P175, DOI 10.1006/jhev.1997.0153; Cunha E, 2004, AM J PHYS ANTHROPOL, V125, P220, DOI 10.1002/ajpa.10402; Dabney J, 2013, P NATL ACAD SCI USA, V110, P15758, DOI 10.1073/pnas.1314445110; Darimont CT, 2002, CAN J ZOOL, V80, P1638, DOI 10.1139/Z02-149; DECASTRO JMB, 1995, AM J PHYS ANTHROPOL, V96, P301, DOI 10.1002/ajpa.1330960307; Demuro M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110169; DENIRO MJ, 1978, GEOCHIM COSMOCHIM AC, V42, P495, DOI 10.1016/0016-7037(78)90199-0; DeSantis LRG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005750; Dettwyler Katherine A., 1995, BREASTFEEDING, P39, DOI [10.4324/9781315081984-2, DOI 10.4324/9781315081984-2]; Drucker D, 2003, PALAEOGEOGR PALAEOCL, V195, P375, DOI 10.1016/S0031-0182(03)00366-3; EHLERINGER JR, 1993, ANNU REV ECOL SYST, V24, P411, DOI 10.1146/annurev.es.24.110193.002211; EHLERINGER JR, 1991, TRENDS ECOL EVOL, V6, P95, DOI 10.1016/0169-5347(91)90183-X; Falgueres C, 1999, J HUM EVOL, V37, P343, DOI 10.1006/jhev.1999.0326; FARQUHAR GD, 1989, ANNU REV PLANT PHYS, V40, P503, DOI 10.1146/annurev.pp.40.060189.002443; Feranec R, 2010, PALAEOGEOGR PALAEOCL, V297, P263, DOI 10.1016/j.palaeo.2010.08.006; Feranec RS, 2007, PALAEOGEOGR PALAEOCL, V252, P575, DOI 10.1016/j.palaeo.2007.05.012; Feranec RS, 2009, PALAEOGEOGR PALAEOCL, V271, P153, DOI 10.1016/j.palaeo.2008.10.005; Feranec RS, 2006, PALEOBIOLOGY, V32, P191, DOI 10.1666/05006.1; Fricke HC, 1996, PALAEOGEOGR PALAEOCL, V126, P91, DOI 10.1016/S0031-0182(96)00072-7; Fuller BT, 2006, AM J PHYS ANTHROPOL, V129, P279, DOI 10.1002/ajpa.20249; Garcia Garcia N, 2003, OSOS OTROS CARNIVORO; Garcia N, 1997, J HUM EVOL, V33, P155, DOI 10.1006/jhev.1997.0154; Garcia NG, 2009, J ARCHAEOL SCI, V36, P1142, DOI 10.1016/j.jas.2008.12.018; Garcia N, 2011, QUATERNARY SCI REV, V30, P1413, DOI 10.1016/j.quascirev.2010.11.008; GARTEN CT, 1992, OECOLOGIA, V90, P1, DOI 10.1007/BF00317801; Harris EF, 2002, DENT ANTHR J, V16, P15, DOI 10.26575/daj.v16i1.165; Heaton THE, 1999, J ARCHAEOL SCI, V26, P637, DOI 10.1006/jasc.1998.0381; Henry AG, 2012, NATURE, V487, P90, DOI 10.1038/nature11185; Iacumin P, 2000, PALAEOGEOGR PALAEOCL, V163, P33, DOI 10.1016/S0031-0182(00)00141-3; Koch PL, 1997, J ARCHAEOL SCI, V24, P417, DOI 10.1006/jasc.1996.0126; Kohn MJ, 2004, GEOCHIM COSMOCHIM AC, V68, P403, DOI 10.1016/S0016-7037(03)00443-5; KRUEGER HW, 1991, J ARCHAEOL SCI, V18, P355, DOI 10.1016/0305-4403(91)90071-V; Lee-Thorp J, 2003, J ANTHROPOL ARCHAEOL, V22, P208, DOI 10.1016/S0278-4165(03)00035-7; Arsuaga JL, 2010, P NATL ACAD SCI USA, V107, P8910, DOI 10.1073/pnas.0914614107; Macfadden BJ, 1996, J VERTEBR PALEONTOL, V16, P103, DOI 10.1080/02724634.1996.10011288; Meyer M, 2014, NATURE, V505, P403, DOI 10.1038/nature12788; MOLE S, 1994, OECOLOGIA, V97, P316, DOI 10.1007/BF00317320; Monson R.K., 1999, C4 PLANT BIOL, P339; MOORREES COENRAAD F.A., 1963, JOUR DENT RES, V42, P1490, DOI 10.1177/00220345630420062701; OLEARY MH, 1988, BIOSCIENCE, V38, P328, DOI 10.2307/1310735; Palmqvist P, 2003, PALEOBIOLOGY, V29, P205, DOI 10.1666/0094-8373(2003)029<0205:PROALP>2.0.CO;2; Passey BH, 2006, CHEM GEOL, V235, P238, DOI 10.1016/j.chemgeo.2006.07.002; Passey BH, 2005, J ARCHAEOL SCI, V32, P1459, DOI 10.1016/j.jas.2005.03.015; Passey BH, 2002, GEOCHIM COSMOCHIM AC, V66, P3225, DOI 10.1016/S0016-7037(02)00933-X; Pettitt PB, 2000, WORLD ARCHAEOL, V31, P351, DOI 10.1080/713781494; Richards MP, 2008, P NATL ACAD SCI USA, V105, P600, DOI 10.1073/pnas.0711063105; Richards MP, 2000, P NATL ACAD SCI USA, V97, P7663, DOI 10.1073/pnas.120178997; Richards MP, 2002, AM J PHYS ANTHROPOL, V119, P205, DOI 10.1002/ajpa.10124; Rozzi FVR, 2004, NATURE, V428, P936, DOI 10.1038/nature02428; SCHOENINGER MJ, 1982, NATURE, V297, P577, DOI 10.1038/297577a0; Sellen DW, 2001, HUM NATURE-INT BIOS, V12, P47, DOI 10.1007/s12110-001-1013-y; Sellen DW, 2001, J NUTR, V131, P2707, DOI 10.1093/jn/131.10.2707; TIESZEN LL, 1979, OECOLOGIA, V37, P351, DOI 10.1007/BF00347911; VANDERMERWE NJ, 1991, J ARCHAEOL SCI, V18, P249, DOI 10.1016/0305-4403(91)90064-V; VOGEL JC, 1978, S AFR J SCI, V74, P298; WANG Y, 1994, PALAEOGEOGR PALAEOCL, V107, P281, DOI 10.1016/0031-0182(94)90100-7; Williams JS, 2005, AM J PHYS ANTHROPOL, V128, P781, DOI 10.1002/ajpa.20229; WOOD JW, 1992, CURR ANTHROPOL, V33, P343, DOI 10.1086/204084; Wright LE, 1998, AM J PHYS ANTHROPOL, V106, P1; Zazzo A, 2005, GEOCHIM COSMOCHIM AC, V69, P3631, DOI 10.1016/j.gca.2005.02.031; Zazzo A, 2004, GEOCHIM COSMOCHIM AC, V68, P1, DOI 10.1016/S0016-7037(03)00278-3	81	11	11	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0142895	10.1371/journal.pone.0142895	http://dx.doi.org/10.1371/journal.pone.0142895			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673156	Green Published, gold, Green Submitted			2022-12-26	WOS:000366722700007
J	Smyslova, P; Popa, I; Lycka, A; Tejral, G; Hlavac, J				Smyslova, Petra; Popa, Igor; Lycka, Antonin; Tejral, Gracian; Hlavac, Jan			Non-Catalyzed Click Reactions of ADIBO Derivatives with 5-Methyluridine Azides and Conformational Study of the Resulting Triazoles	PLOS ONE			English	Article							COPPER-FREE CLICK; ALKYNE CYCLOADDITION; CHEMISTRY; NANOPARTICLES; NUCLEOSIDES; PROTEIN	Copper-free click reactions between a dibenzoazocine derivative and azides derived from 5-methyluridine were investigated. The non-catalyzed reaction yielded both regioisomers in an approximately equivalent ratio. The NMR spectra of each regioisomer revealed conformational isomery. The ratio of isomers was dependent on the type of regioisomer and the type of solvent. The synthesis of various analogs, a detailed NMR study and computational modeling provided evidence that the isomery was dependent on the interaction of the azocine and pyrimidine parts.	[Smyslova, Petra; Popa, Igor; Hlavac, Jan] Inst Mol & Translat Med, Olomouc, Czech Republic; [Smyslova, Petra; Hlavac, Jan] Palacky Univ, Fac Sci, Dept Organ Chem, CR-77147 Olomouc, Czech Republic; [Lycka, Antonin] Univ Hradec Kralove, Fac Sci, Hradec Kralove, Czech Republic; [Tejral, Gracian] Charles Univ Prague, Inst Biophys, Fac Med 2, Prague 5, Czech Republic; [Tejral, Gracian] Acad Sci Czech Republic, Inst Expt Med, Lab Tissue Engn, Prague 4, Czech Republic	Palacky University Olomouc; University of Hradec Kralove; Charles University Prague; Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences	Hlavac, J (corresponding author), Inst Mol & Translat Med, Olomouc, Czech Republic.	hlavac@orgchem.upol.cz		Lycka, Antonin/0000-0002-8911-5044	Ministry of Education, Youth and Sport of the Czech Republic [IGA_PrF_2015_007]; Technological Agency CR [TE01020028]; European Social Fund [CZ.1.07/2.3.00/20.0009]; National Program of sustainability [LO1304]; MetaCentrum [LM2010005]	Ministry of Education, Youth and Sport of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Technological Agency CR; European Social Fund(European Social Fund (ESF)); National Program of sustainability; MetaCentrum	The research in this project was supported by the Ministry of Education, Youth and Sport of the Czech Republic (project IGA_PrF_2015_007), Technological Agency CR (project TE01020028) and by the European Social Fund (CZ.1.07/2.3.00/20.0009). The infrastructure of this project (Institute of Molecular and Translation Medicine) was supported by the National Program of sustainability (project LO1304). Computational resources were provided by the MetaCentrum under the program LM2010005 and the CERIT-SC under the program Centre CERIT Scientific Cloud, part of the Operational Program Research and Development for Innovations, Reg. no. CZ.1.05/3.2.00/08.0144.	Agard NJ, 2004, J AM CHEM SOC, V126, P15046, DOI 10.1021/ja044996f; Arumugam S, 2014, J ORG CHEM, V79, P2702, DOI 10.1021/jo500143v; Baskin JM, 2010, ALDRICHIM ACTA, V43, P15; Bostic HE, 2012, CHEM COMMUN, V48, P1431, DOI 10.1039/c1cc14415d; Carpenter RD, 2011, ACS MED CHEM LETT, V2, P885, DOI 10.1021/ml200187j; Carroll L, 2013, ORG BIOMOL CHEM, V11, P5772, DOI 10.1039/c3ob40897c; Cheng ZL, 2011, BIOCONJUGATE CHEM, V22, P2021, DOI 10.1021/bc200214g; Chiacchio U, 2003, TETRAHEDRON, V59, P4733, DOI 10.1016/S0040-4020(03)00689-6; Debets MF, 2010, CHEM COMMUN, V46, P97, DOI 10.1039/b917797c; Frisch G. W., 2013, GAUSSIAN 09; Garland W, 2009, WO patent, Patent No. 2009114325; Hausner SH, 2013, NUCL MED BIOL, V40, P233, DOI 10.1016/j.nucmedbio.2012.10.007; Holstein JM, 2014, CHEM COMMUN, V50, P4478, DOI 10.1039/c4cc01549e; Jang S, 2012, BIOCONJUGATE CHEM, V23, P2256, DOI 10.1021/bc300364z; Jewett JC, 2010, CHEM SOC REV, V39, P1272, DOI 10.1039/b901970g; Kim HL, 2015, ACS MED CHEM LETT, V6, P402, DOI 10.1021/ml500464f; Lee S B, 2013, ANGEW CHEM INT ED, V52; Lee S, 2014, BIOCONJUGATE CHEM, V25, P601, DOI 10.1021/bc500020g; Li GQ, 2014, MOL PHARMACEUT, V11, P3938, DOI 10.1021/mp500354x; Prim D, 2013, MOLECULES, V18, P9833, DOI 10.3390/molecules18089833; Rajaganesh R, 2011, CARBOHYD RES, V346, P2327, DOI 10.1016/j.carres.2011.07.024; Reschke ML, 2014, BBA-PROTEINS PROTEOM, V1844, P2182, DOI 10.1016/j.bbapap.2014.07.017; Satpati D, 2014, J RADIOANAL NUCL CH, V302, P765, DOI 10.1007/s10967-014-3197-8; Smyslova P., 2012, PREPARATION REACTIVI; Soerensen R S, 2013, ENZYMATIC LIGATION O, V7, P8098, DOI [10.1021/nn403386f, DOI 10.1021/NN403386F]; Starke F, 2010, ARKIVOC, P350, DOI 10.3998/ark.5550190.0011.b28; Wang CF, 2015, BIOMATERIALS, V48, P108, DOI 10.1016/j.biomaterials.2015.01.008; Wang XX, 2014, RSC ADV, V4, P43087, DOI 10.1039/c4ra07574a; WITTIG G, 1961, CHEM BER-RECL, V94, P3260, DOI 10.1002/cber.19610941213; Wittmann JG, 2008, STRUCTURE, V16, P82, DOI 10.1016/j.str.2007.10.020; Zayas J, 2015, BIOCONJUGATE CHEM, V26, P1519, DOI 10.1021/acs.bioconjchem.5b00300; Zhao MX, 2014, J AM CHEM SOC, V136, P15319, DOI 10.1021/ja508083g; Zhou QH, 2013, J AM CHEM SOC, V135, P12994, DOI 10.1021/ja407739y	33	6	6	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144613	10.1371/journal.pone.0144613	http://dx.doi.org/10.1371/journal.pone.0144613			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673606	Green Published, gold, Green Submitted			2022-12-26	WOS:000366722700048
J	Zere, TR; Vakulskas, CA; Leng, YY; Pannuri, A; Potts, AH; Dias, R; Tang, DJ; Kolaczkowski, B; Georgellis, D; Ahmer, BMM; Romeo, T				Zere, Tesfalem R.; Vakulskas, Christopher A.; Leng, Yuanyuan; Pannuri, Archana; Potts, Anastasia H.; Dias, Raquel; Tang, Dongjie; Kolaczkowski, Bryan; Georgellis, Dimitris; Ahmer, Brian M. M.; Romeo, Tony			Genomic Targets and Features of BarA-UvrY (-SirA) Signal Transduction Systems	PLOS ONE			English	Article							PROTEIN-DNA INTERACTIONS; ESCHERICHIA-COLI; TRANSCRIPTION INITIATION; GENE-EXPRESSION; TRANSLATIONAL REPRESSION; REGULATORY SYSTEM; CHROMOSOMAL GENES; FLHDC EXPRESSION; CSRA; RNA	The two-component signal transduction system BarA-UvrY of Escherichia coli and its orthologs globally regulate metabolism, motility, biofilm formation, stress resistance, virulence of pathogens and quorum sensing by activating the transcription of genes for regulatory sRNAs, e.g. CsrB and CsrC in E. coli. These sRNAs act by sequestering the RNA binding protein CsrA (RsmA) away from lower affinity mRNA targets. In this study, we used ChIP-exo to identify, at single nucleotide resolution, genomic sites for UvrY (SirA) binding in E. coli and Salmonella enterica. The csrB and csrC genes were the strongest targets of cross-linking, which required UvrY phosphorylation by the BarA sensor kinase. Crosslinking occurred at two sites, an inverted repeat sequence far upstream of the promoter and a site near the -35 sequence. DNAse I footprinting revealed specific binding of UvrY in vitro only to the upstream site, indicative of additional binding requirements and/or indirect binding to the downstream site. Additional genes, including cspA, encoding the cold-shock RNA-binding protein CspA, showed weaker crosslinking and modest or negligible regulation by UvrY. We conclude that the global effects of UvrY/SirA on gene expression are primarily mediated by activating csrB and csrC transcription. We also used in vivo crosslinking and other experimental approaches to reveal new features of csrB/csrC regulation by the DeaD and SrmB RNA helicases, IHF, ppGpp and DksA. Finally, the phylogenetic distribution of BarA-UvrY was analyzed and found to be uniquely characteristic of gamma-Proteobacteria and strongly anti-correlated with fliW, which encodes a protein that binds to CsrA and antagonizes its activity in Bacillus subtilis. We propose that BarA-UvrY and orthologous TCS transcribe sRNA antagonists of CsrA throughout the gamma-Proteobacteria, but rarely or never perform this function in other species.	[Zere, Tesfalem R.; Vakulskas, Christopher A.; Leng, Yuanyuan; Pannuri, Archana; Potts, Anastasia H.; Dias, Raquel; Tang, Dongjie; Kolaczkowski, Bryan; Romeo, Tony] Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Georgellis, Dimitris] Univ Nacl Autonoma Mexico, Dept Genet Mol, Inst Fisiol Celular, Mexico City 04510, DF, Mexico; [Ahmer, Brian M. M.] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA	State University System of Florida; University of Florida; Universidad Nacional Autonoma de Mexico; University System of Ohio; Ohio State University	Romeo, T (corresponding author), Univ Florida, Inst Food & Agr Sci, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.	tromeo@ufl.edu	Ahmer, Brian M. M./F-2228-2010; Georgellis, Dimitris/U-2517-2017	Ahmer, Brian M. M./0000-0002-4267-7322; Georgellis, Dimitris/0000-0002-6114-795X; Vakulskas, Christopher/0000-0001-8510-4332	National Institute of General Medical Sciences [R01GM059969]; National Institute of Allergy and Infectious Diseases; University of Florida Foundation, Inc.; Guangxi Scholarship Fund of Guangxi Education Department; Consejo Nacional de Ciencia y Tecnologia [178033]; Direccion General Asuntos del Personal Academico; Universidad Nacional Autonoma de Mexico [IN209215]; National Institute of Allergy and Infectious Diseases [F32AI100322, R01AI097116]; National Institutes of Health [R01GM059969, F32AI100322, R01AI097116]; DGAPA-UNAM [IN209215]; University of Florida Alumni Graduate Fellowship; Guangxi Scholarship Fund of Guangxi Education Department, PR China; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097116, F32AI100322] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059969] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Florida Foundation, Inc.(University of Florida); Guangxi Scholarship Fund of Guangxi Education Department; Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Direccion General Asuntos del Personal Academico; Universidad Nacional Autonoma de Mexico(Universidad Nacional Autonoma de Mexico); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DGAPA-UNAM(Universidad Nacional Autonoma de Mexico); University of Florida Alumni Graduate Fellowship(University of Florida); Guangxi Scholarship Fund of Guangxi Education Department, PR China; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences, Award Number: R01GM059969 to TR, the National Institute of Allergy and Infectious Diseases to TR, the University of Florida Foundation, Inc., Award Number: Alumni Graduate Fellowships Fund to TRZ, Guangxi Scholarship Fund of Guangxi Education Department to DT, the Consejo Nacional de Ciencia y Tecnologia, Award Number: 178033 to DG, the Direccion General Asuntos del Personal Academico, Universidad Nacional Autonoma de Mexico, Award Number: IN209215 to DG, the National Institute of Allergy and Infectious Diseases Award Number: F32AI100322 to CAV, and the National Institute of Allergy and Infectious Diseases Award Number: R01AI097116 to BMMA and TR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; These studies were supported in part by the National Institutes of Health (R01AI097116, R01GM059969, F32AI100322), the Consejo Nacional de Ciencia y Tecnologia (178033), the DGAPA-UNAM (IN209215), a University of Florida Alumni Graduate Fellowship (T.Z.) and the Guangxi Scholarship Fund of Guangxi Education Department, PR China (D.T.).	Albert I, 2008, BIOINFORMATICS, V24, P1305, DOI 10.1093/bioinformatics/btn119; Altier C, 2000, MOL MICROBIOL, V35, P635, DOI 10.1046/j.1365-2958.2000.01734.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Angiuoli SV, 2008, OMICS, V12, P137, DOI 10.1089/omi.2008.0017; Babitzke P, 2007, CURR OPIN MICROBIOL, V10, P156, DOI 10.1016/j.mib.2007.03.007; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barker MM, 2001, J MOL BIOL, V305, P689, DOI 10.1006/jmbi.2000.4328; Brencic A, 2009, MOL MICROBIOL, V73, P434, DOI 10.1111/j.1365-2958.2009.06782.x; Broberg M, 2014, APPL ENVIRON MICROB, V80, P1972, DOI 10.1128/AEM.03829-13; Camacho MI, 2015, J BACTERIOL, V197, P983, DOI 10.1128/JB.02325-14; CHASHEL M, 1969, NATURE, V221, P838, DOI 10.1038/221838a0; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dessimoz C, 2012, BIOINFORMATICS, V28, P900, DOI 10.1093/bioinformatics/bts050; Dias R, 2014, J BIOINF COMPUT BIOL, V12, DOI 10.1142/S0219720014500139; Edwards AN, 2011, MOL MICROBIOL, V80, P1561, DOI 10.1111/j.1365-2958.2011.07663.x; Federhen S, 2012, NUCLEIC ACIDS RES, V40, pD136, DOI 10.1093/nar/gkr1178; Chavez RG, 2010, J BACTERIOL, V192, P2009, DOI 10.1128/JB.01685-09; Goodier RI, 2001, J BACTERIOL, V183, P2249, DOI 10.1128/JB.183.7.2249-2258.2001; GOOSEN N, 1995, MOL MICROBIOL, V16, P1, DOI 10.1111/j.1365-2958.1995.tb02386.x; Hammer BK, 2002, MOL MICROBIOL, V44, P107, DOI 10.1046/j.1365-2958.2002.02884.x; Huang Y, 2008, J BACTERIOL, V190, P4233, DOI 10.1128/JB.00205-08; Humair B, 2010, APPL ENVIRON MICROB, V76, P1497, DOI 10.1128/AEM.02014-09; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Krin E, 2008, ENVIRON MICROBIOL, V10, P1118, DOI 10.1111/j.1462-2920.2007.01528.x; Lawhon SD, 2002, MOL MICROBIOL, V46, P1451, DOI 10.1046/j.1365-2958.2002.03268.x; Lee DJ, 2012, ANNU REV MICROBIOL, V66, P125, DOI 10.1146/annurev-micro-092611-150012; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Liu MY, 1997, J BIOL CHEM, V272, P17502, DOI 10.1074/jbc.272.28.17502; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Martinez LC, 2014, J BACTERIOL, V196, P325, DOI 10.1128/JB.00806-13; Martinez LC, 2011, MOL MICROBIOL, V80, P1637, DOI 10.1111/j.1365-2958.2011.07674.x; Mercante J, 2006, J BIOL CHEM, V281, P31832, DOI 10.1074/jbc.M606057200; Mercante J, 2009, J MOL BIOL, V392, P511, DOI 10.1016/j.jmb.2009.07.034; Mrazek J, 2008, BIOINFORMATICS, V24, P1041, DOI 10.1093/bioinformatics/btn077; Mukherjee S, 2011, MOL MICROBIOL, V82, P447, DOI 10.1111/j.1365-2958.2011.07822.x; Oshima T, 2002, MOL MICROBIOL, V46, P281, DOI 10.1046/j.1365-2958.2002.03170.x; Pannuri A, 2012, J BACTERIOL, V194, P79, DOI 10.1128/JB.06209-11; Paul BJ, 2005, P NATL ACAD SCI USA, V102, P7823, DOI 10.1073/pnas.0501170102; Paul BJ, 2004, CELL, V118, P311, DOI 10.1016/j.cell.2004.07.009; Pernestig AK, 2001, J BIOL CHEM, V276, P225, DOI 10.1074/jbc.M001550200; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Prieto AI, 2012, NUCLEIC ACIDS RES, V40, P3524, DOI 10.1093/nar/gkr1236; Reimmann C, 1997, MOL MICROBIOL, V24, P309, DOI 10.1046/j.1365-2958.1997.3291701.x; Rhee HS, 2011, CELL, V147, P1408, DOI 10.1016/j.cell.2011.11.013; Rice PA, 1996, CELL, V87, P1295, DOI 10.1016/S0092-8674(00)81824-3; RICHET E, 1991, CELL, V66, P1185, DOI 10.1016/0092-8674(91)90041-V; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; ROMEO T, 1993, J BACTERIOL, V175, P4744, DOI 10.1128/JB.175.15.4744-4755.1993; Romeo T, 2013, ENVIRON MICROBIOL, V15, P313, DOI 10.1111/j.1462-2920.2012.02794.x; Sahu SN, 2003, MOL CELL BIOCHEM, V253, P167, DOI 10.1023/A:1026028930203; SCHRODER I, 1993, J BIOL CHEM, V268, P771; Suzuki K, 2002, J BACTERIOL, V184, P5130, DOI 10.1128/JB.184.18.5130-5140.2002; Suzuki K, 2006, GENE DEV, V20, P2605, DOI 10.1101/gad.1461606; Teif VB, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/41/414105; Teplitski M, 2003, J BACTERIOL, V185, P7257, DOI 10.1128/JB.185.24.7257-7265.2003; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198; Vakulskas CA, 2015, MICROBIOL MOL BIOL R, V79, P193, DOI 10.1128/MMBR.00052-14; Vakulskas CA, 2014, MOL MICROBIOL, V92, P945, DOI 10.1111/mmi.12606; Wade JT, 2007, MOL MICROBIOL, V65, P21, DOI 10.1111/j.1365-2958.2007.05781.x; Wade JT, 2005, GENE DEV, V19, P2619, DOI 10.1101/gad.1355605; Wei BDL, 2001, MOL MICROBIOL, V40, P245, DOI 10.1046/j.1365-2958.2001.02380.x; Weilbacher T, 2003, MOL MICROBIOL, V48, P657, DOI 10.1046/j.1365-2958.2003.03459.x; Wong SM, 1998, INFECT IMMUN, V66, P5854, DOI 10.1128/IAI.66.12.5854-5861.1998; Yakhnin AV, 2013, MOL MICROBIOL, V87, P851, DOI 10.1111/mmi.12136; Yakhnin H, 2007, MOL MICROBIOL, V64, P1605, DOI 10.1111/j.1365-2958.2007.05765.x; Yakhnin H, 2011, J BACTERIOL, V193, P6162, DOI 10.1128/JB.05975-11; Yakhnin H, 2011, MOL MICROBIOL, V81, P689, DOI 10.1111/j.1365-2958.2011.07723.x	68	59	60	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145035	10.1371/journal.pone.0145035	http://dx.doi.org/10.1371/journal.pone.0145035			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673755	Green Published, Green Submitted, gold			2022-12-26	WOS:000366722700088
J	Liu, L; Yang, YL; Wang, ZY; Wu, H; Wang, Y; Wang, L				Liu, Li; Yang, Yi-Long; Wang, Zi-Yue; Wu, Hui; Wang, Yang; Wang, Lie			Prevalence and Positive Correlates of Posttraumatic Stress Disorder Symptoms among Chinese Patients with Hematological Malignancies: A Cross-Sectional Study	PLOS ONE			English	Article							QUALITY-OF-LIFE; BONE-MARROW-TRANSPLANTATION; BREAST-CANCER PATIENTS; NON-HODGKINS-LYMPHOMA; SOCIAL SUPPORT; GENDER-DIFFERENCES; CIVILIAN VERSION; PTSD CHECKLIST; SELF-EFFICACY; SURVIVORS	Purpose Positive psychological constructs have been given increasing attention in research on the coping resources of cancer-related distresses. However, little research is available on post-traumatic stress disorder (PTSD) in patients with hematological malignancies. The purposes of this study were to assess the prevalence of PTSD symptoms and to explore the associations of perceived social support (PSS), hope, optimism and resilience with PTSD symptoms among Chinese patients with hematological malignancies. Methods A cross-sectional study was conducted during the period from July 2013 through April 2014. A total of 225 inpatients with hematological malignancies, which were eligible for the study, completed the Post-traumatic Stress Checklist-Civilian Version, Multidimensional Scale of Perceived Social Support, Adult Hope Scale, Life Orientation Scale-Revised, and Resilience Scale. Hierarchical regression analysis was performed to explore the correlates of PTSD symptoms. Results Overall, the prevalence of PTSD symptoms was 10.7%. Initially, PSS was negatively associated with PTSD symptoms (beta = -0.248, P < 0.01). However, when positive psychological variables were added, optimism was negatively associated with PTSD symptoms (beta = -0.452, P < 0.01), and gender had a significant effect on PTSD symptoms. Women were more vulnerable to these symptoms than men (beta = 0.123, P < 0.05). When the analysis was performed separately by gender, only optimism showed a significantly negative association with PTSD symptoms in both men (beta = -0.389, P < 0.01) and women (beta = -0.493, P < 0.01). Conclusions Some patients with hematological malignancies suffer from PTSD symptoms. The positive effects of PSS and optimism on PTSD symptoms suggest that an integrated approach to psychosocial intervention from both external and internal perspectives could have practical significance. Gender difference should be considered in developing potential interventions in reducing cancer-related PTSD symptoms.	[Liu, Li; Yang, Yi-Long; Wang, Zi-Yue; Wu, Hui; Wang, Yang; Wang, Lie] China Med Univ, Dept Social Med, Sch Publ Hlth, Shenyang 110001, Liaoning, Peoples R China	China Medical University	Wang, L (corresponding author), China Med Univ, Dept Social Med, Sch Publ Hlth, Shenyang 110001, Liaoning, Peoples R China.	liewang@mail.cmu.edu.cn						Abbey G, 2015, PSYCHO-ONCOLOGY, V24, P371, DOI 10.1002/pon.3654; American Psychiatric Association, 1994, DIAGNOSTIC AND STATI; Andreasen Nancy C, 2011, Dialogues Clin Neurosci, V13, P240; Andrykowski MA, 2000, PSYCHO-ONCOLOGY, V9, P69; Andrykowski MA, 1998, J CONSULT CLIN PSYCH, V66, P586, DOI 10.1037/0022-006X.66.3.586; Bendall LJ, 2010, CURR DRUG TARGETS, V11, P767; Black EK, 2005, PSYCHO-ONCOL, V14, P510, DOI 10.1002/pon.894; Bonanno GA, 2007, J CONSULT CLIN PSYCH, V75, P671, DOI 10.1037/0022-006X.75.5.671; Carver CS, 2014, TRENDS COGN SCI, V18, P293, DOI 10.1016/j.tics.2014.02.003; Casellas-Grau A, 2014, PSYCHO-ONCOLOGY, V23, P9, DOI 10.1002/pon.3353; Charuvastra A, 2008, ANNU REV PSYCHOL, V59, P301, DOI 10.1146/annurev.psych.58.110405.085650; [陈露露 Chen Lulu], 2012, [第三军医大学学报, Journal of Third Military Medical University], V34, P1097; Clarke SA, 2006, CANCER NURS, V29, P66, DOI 10.1097/00002820-200601000-00012; Cordova MJ, 2007, J CLIN PSYCHOL MED S, V14, P308, DOI 10.1007/s10880-007-9083-6; CORDOVA MJ, 1995, J CONSULT CLIN PSYCH, V63, P981, DOI 10.1037/0022-006X.63.6.981; Cordova MJ, 2000, J TRAUMA STRESS, V13, P301, DOI 10.1023/A:1007762812848; Else-Quest NM, 2012, PSYCHOL BULL, V138, P947, DOI 10.1037/a0027930; Freedman SA, 2002, J TRAUMA STRESS, V15, P407, DOI 10.1023/A:1020189425935; Geffen DB, 2003, LEUKEMIA LYMPHOMA, V44, P1925, DOI 10.1080/1042819031000123573; Gottlieb BH, 2010, J PSYCHOSOM RES, V69, P511, DOI 10.1016/j.jpsychores.2009.10.001; Hahn EE, 2015, PSYCHO-ONCOLOGY, V24, P643, DOI 10.1002/pon.3623; Hirsch JK, 2006, SUICIDE LIFE-THREAT, V36, P661, DOI 10.1521/suli.2006.36.6.661; Ho S, 2011, ORAL ONCOL, V47, P121, DOI 10.1016/j.oraloncology.2010.11.015; Hou WL, 2014, AIDS CARE, V26, P996, DOI 10.1080/09540121.2013.873764; Jacobsen PB, 1998, PSYCHOSOM MED, V60, P366, DOI 10.1097/00006842-199805000-00026; Jacobsen PB, 2002, J CONSULT CLIN PSYCH, V70, P235, DOI 10.1037//0022-006X.70.1.235; Kornblith AB, 2003, CANCER-AM CANCER SOC, V98, P679, DOI 10.1002/cncr.11531; Kornblith AB, 2007, PSYCHO-ONCOLOGY, V16, P895, DOI 10.1002/pon.1146; Lai JCL, 1998, INT J PSYCHOL, V33, P45, DOI 10.1080/002075998400600; Lee V, 2006, SOC SCI MED, V62, P3133, DOI 10.1016/j.socscimed.2005.11.041; Magaletta PR, 1999, J CLIN PSYCHOL, V55, P539, DOI 10.1002/(SICI)1097-4679(199905)55:5<539::AID-JCLP2>3.3.CO;2-7; Mehnert A, 2007, PSYCHO-ONCOLOGY, V16, P181, DOI 10.1002/pon.1057; Morrill EF, 2008, PSYCHO-ONCOLOGY, V17, P948, DOI 10.1002/pon.1313; Norberg AL, 2006, PSYCHO-ONCOLOGY, V15, P335, DOI 10.1002/pon.960; Ong AD, 2006, PERS INDIV DIFFER, V41, P1263, DOI 10.1016/j.paid.2006.03.028; Oniszczenko W, 2014, ARCH MED SCI, V10, P110, DOI 10.5114/aoms.2013.33069; Perez S, 2014, J TRAUMA STRESS, V27, P224, DOI 10.1002/jts.21901; Pratchett LC, 2010, PSYCHIAT CLIN N AM, V33, P465, DOI 10.1016/j.psc.2010.01.010; Rajandram Rama K, 2011, BMC Res Notes, V4, P519, DOI 10.1186/1756-0500-4-519; Rodin G, 2013, PSYCHO-ONCOLOGY, V22, P299, DOI 10.1002/pon.2092; Rourke MT, 2007, PEDIATR BLOOD CANCER, V49, P177, DOI 10.1002/pbc.20942; Rustad JK, 2012, PALLIAT SUPPORT CARE, V10, P213, DOI 10.1017/S1478951511000897; Santos FRM, 2006, J PSYCHOSOM RES, V60, P505, DOI 10.1016/j.jpsychores.2005.08.017; SCHEIER MF, 1985, HEALTH PSYCHOL, V4, P219, DOI 10.1037/0278-6133.4.3.219; Sharpley CF, 2014, EUR J CANCER CARE, V23, P545, DOI 10.1111/ecc.12170; Shelby RA, 2005, J TRAUMA STRESS, V18, P347, DOI 10.1002/jts.20033; Shu XL, 2012, SOC SCI RES, V41, P1100, DOI 10.1016/j.ssresearch.2012.05.004; Smith SK, 2008, J CLIN ONCOL, V26, P934, DOI 10.1200/JCO.2007.12.3414; SNYDER CR, 1991, J PERS SOC PSYCHOL, V60, P570, DOI 10.1037/0022-3514.60.4.570; Snyder CR, 2002, PSYCHOL INQ, V13, P249, DOI 10.1207/S15327965PLI1304_01; Tian J, 2013, SUPPORT CARE CANCER, V21, P1497, DOI 10.1007/s00520-012-1699-x; Tolin DF, 2006, PSYCHOL BULL, V132, P959, DOI 10.1037/0033-2909.132.6.959; Trunzo JJ, 2003, J CONSULT CLIN PSYCH, V71, P805, DOI 10.1037/0022-006X.71.4.805; Varela VS, 2013, PSYCHO-ONCOLOGY, V22, P434, DOI 10.1002/pon.2109; Wagnild G., 2009, RESILIENCE SCALE USE; Wang Q., 2013, MED INFORM, V26, P62; Wang YP, 2015, PSYCHO-ONCOLOGY, V24, P533, DOI 10.1002/pon.3685; Weathers F. W., 1993, ANN M INT SOC TRAUM, DOI [10.1037/t02622-000, DOI 10.1037/T02622-000]; Widows MR, 2000, PSYCHOSOM MED, V62, P873, DOI 10.1097/00006842-200011000-00018; Wu G, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00010; Xiao YC, 2012, ASIA PAC J HUM RESOU, V50, P6, DOI 10.1111/j.1744-7941.2011.00005.x; Yang YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094804; Zenger M, 2010, PSYCHO-ONCOLOGY, V19, P879, DOI 10.1002/pon.1635; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2	64	24	27	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145103	10.1371/journal.pone.0145103	http://dx.doi.org/10.1371/journal.pone.0145103			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9HZ	26669841	Green Published, gold, Green Submitted			2022-12-26	WOS:000366719300046
J	Dietz, PM; Van Handel, M; Wang, HS; Peters, PJ; Zhang, J; Viall, A; Branson, BM				Dietz, Patricia M.; Van Handel, Michelle; Wang, Huisheng; Peters, Philip J.; Zhang, Jun; Viall, Abigail; Branson, Bernard M.			HIV Testing among Outpatients with Medicaid and Commercial Insurance	PLOS ONE			English	Article							SELF-REPORT	Objective To assess HIV testing and factors associated with receipt of testing among persons with Medicaid and commercial insurance during 2012. Methods Outpatient and laboratory claims were analyzed from two databases: all Medicaid claims from six states and all claims from Medicaid health plans from four other states and a large national convenience sample of patients with commercial insurance in the United States. We excluded those aged < 13 years and > 64 years, enrolled < 9 of the 12 months, pregnant females, and previously diagnosed with HIV. We identified patients with new HIV diagnoses that followed (did not precede) the HIV test, using HIV ICD-9 codes. HIV testing percentages were assessed by patient demographics and other tests or diagnoses that occurred during the same visit. Results During 2012, 89,242 of 2,069,536 patients (4.3%) with Medicaid had at least one HIV test, and 850 (1.0%) of those tested received a new HIV diagnosis. Among 27,206,804 patients with commercial insurance, 757,646 (2.8%) had at least one HIV test, and 5,884 (0.8%) of those tested received a new HIV diagnosis. During visits that included an HIV test, 80.2% of Medicaid and 83.0% of commercial insurance claims also included a test or diagnosis for a sexually transmitted infection (STI), and/or Hepatitis B or C virus at the same visit. Conclusions HIV testing primarily took place concurrently with screening or diagnoses for STIs or Hepatitis B or C. We found little evidence to suggest routine screening for HIV infection was widespread.	[Dietz, Patricia M.; Van Handel, Michelle; Wang, Huisheng; Peters, Philip J.; Zhang, Jun; Viall, Abigail; Branson, Bernard M.] Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Dietz, PM (corresponding author), Ctr Dis Control & Prevent, Div HIV AIDS Prevent, Atlanta, GA 30333 USA.	pad8@cdc.gov						[Anonymous], 2006, MMWR MORB MORTAL WKL; [Anonymous], 2015, FIN UPD SUMM HUM IMM; Arya Monisha, 2014, J Int Assoc Provid AIDS Care, V13, P296, DOI 10.1177/2325957413517140; Centers for Disease Control and Prevention, 2013, HIV SURV REP, V25; Centers for Disease Control and Prevention, 2013, HIV TEST TRENDS US 2, P2000; Centers for Disease Control and Prevention, 2015, HIV SURV REP, V20; Chandra A, 2012, NATL HLTH STAT REPOR; Czamogorski M, 2009, AM J PUBLIC HEALTH, V103, pe40, DOI 10.; Huang YLA, 2015, HEALTH AFFAIR, V34, P1657, DOI 10.1377/hlthaff.2015.0249; Lin X, 2014, MMWR-MORBID MORTAL W, V63, P537; Meyers D, 2008, AM FAM PHYSICIAN, V77, P819; Mohajer Mayar Al, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P101, DOI 10.1177/1545109711430165; OCampo P, 1997, J CLIN EPIDEMIOL, V50, P57, DOI 10.1016/S0895-4356(96)00301-0; Sanders GD, 2005, NEW ENGL J MED, V352, P570, DOI 10.1056/NEJMsa042657; SAS Institute Inc, 2012, SAS VERS 9 3 WIND; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; The Kaiser Family Foundation, QUICK TAK UPD ACA HI; Yudin MH, 2006, J OBSTET GYNAECOL CA, V28, P867, DOI 10.1016/S1701-2163(16)32286-1	18	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144965	10.1371/journal.pone.0144965	http://dx.doi.org/10.1371/journal.pone.0144965			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26661399	Green Published, gold			2022-12-26	WOS:000366715900157
J	Sabesan, R; Hofer, H; Roorda, A				Sabesan, Ramkumar; Hofer, Heidi; Roorda, Austin			Characterizing the Human Cone Photoreceptor Mosaic via Dynamic Photopigment Densitometry	PLOS ONE			English	Article							SCANNING LASER OPHTHALMOSCOPE; WAVELENGTH-SENSITIVE CONES; LIVING HUMAN EYE; ADAPTIVE OPTICS; RETINAL DENSITOMETRY; COLOR-BLINDNESS; GENE-THERAPY; DENSITY; FOVEA; ARRANGEMENT	Densitometry is a powerful tool for the biophysical assessment of the retina. Until recently, this was restricted to bulk spatial scales in living humans. The application of adaptive optics (AO) to the conventional fundus camera and scanning laser ophthalmoscope (SLO) has begun to translate these studies to cellular scales. Here, we employ an AOSLO to perform dynamic photopigment densitometry in order to characterize the optical properties and spectral types of the human cone photoreceptor mosaic. Cone-resolved estimates of optical density and photosensitivity agree well with bulk estimates, although show smaller variability than previously reported. Photopigment kinetics of individual cones derived from their selective bleaching allowed efficient mapping of cone sub-types in human retina. Estimated uncertainty in identifying a cone as long vs middle wavelength was less than 5%, and the total time taken per subject ranged from 3-9 hours. Short wavelength cones were delineated in every subject with high fidelity. The lack of a third cone-type was confirmed in a protanopic subject. In one color normal subject, cone assignments showed 91% correspondence against a previously reported cone-typing method from more than a decade ago. Combined with cone-targeted stimulation, this brings us closer in studying the visual percept arising from a specific cone type and its implication for color vision circuitry.	[Sabesan, Ramkumar; Roorda, Austin] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Hofer, Heidi] Univ Houston, Coll Optometry, Houston, TX USA	University of California System; University of California Berkeley; University of Houston System; University of Houston	Sabesan, R (corresponding author), Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.	rsabesan@uw.edu			National Eye Institute Bioengineering Research [R01EY023591]; National Eye Insitute grant [R21EY021642]; Fight for Sight Postdoctoral award; Burroughs Wellcome Fund; NATIONAL EYE INSTITUTE [R21EY021642, R01EY023591] Funding Source: NIH RePORTER	National Eye Institute Bioengineering Research; National Eye Insitute grant; Fight for Sight Postdoctoral award; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Eye Institute Bioengineering Research Partnership grant R01EY023591, National Eye Insitute grant R21EY021642 and a Fight for Sight Postdoctoral award (https://www.fightforsight.org/Grants/ResearchAward-Types/). Ramkumar Sabesan holds a Career Award at the Scientific Interfaces from the Burroughs Wellcome Fund (http://www.bwfund.org/grantprograms/interfaces-science/career-awards-scientificinterface).	Arathorn DW, 2007, OPT EXPRESS, V15, P13731, DOI 10.1364/OE.15.013731; Atchison DA, 2005, J OPT SOC AM A, V22, P29, DOI 10.1364/JOSAA.22.000029; Bedggood P, 2012, INVEST OPHTH VIS SCI, V53, P3673, DOI 10.1167/iovs.11-8796; Berendschot TTJM, 1996, J PHYSIOL-LONDON, V492, P307, DOI 10.1113/jphysiol.1996.sp021310; Boye SE, 2013, MOL THER, V21, P509, DOI 10.1038/mt.2012.280; Bruce KS, 2015, INVEST OPHTH VIS SCI, V56, P4431, DOI 10.1167/iovs.15-16547; Carroll J, 2004, P NATL ACAD SCI USA, V101, P8461, DOI 10.1073/pnas.0401440101; Carroll Joseph, 2002, J Vis, V2, P531, DOI 10.1167/2.8.1; Christou JC, 2004, J OPT SOC AM A, V21, P1393, DOI 10.1364/JOSAA.21.001393; CICERONE CM, 1989, VISION RES, V29, P115, DOI 10.1016/0042-6989(89)90178-8; Cooper RF, 2011, BIOMED OPT EXPRESS, V2, P2577, DOI 10.1364/BOE.2.002577; CURCIO CA, 1991, J COMP NEUROL, V312, P610, DOI 10.1002/cne.903120411; Delori F. o. C., 2007, J OPT SOC AM A, V24, P1250; Dubra A, 2011, BIOMED OPT EXPRESS, V2, P1757, DOI 10.1364/BOE.2.001757; ELSNER AE, 1993, J OPT SOC AM A, V10, P52, DOI 10.1364/JOSAA.10.000052; Field GD, 2010, NATURE, V467, P673, DOI 10.1038/nature09424; Fraley C, 2002, J AM STAT ASSOC, V97, P611, DOI 10.1198/016214502760047131; Grieve K, 2008, INVEST OPHTH VIS SCI, V49, P713, DOI 10.1167/iovs.07-0837; Harmening WM, 2014, J NEUROSCI, V34, P5667, DOI 10.1523/JNEUROSCI.5191-13.2014; Hofer H, 2005, J NEUROSCI, V25, P9669, DOI 10.1523/JNEUROSCI.2414-05.2005; Jonnal RS, 2007, OPT EXPRESS, V15, P16141, DOI 10.1364/OE.15.016141; Kremers J, 2000, J OPT SOC AM A, V17, P517, DOI 10.1364/JOSAA.17.000517; Liang JZ, 1997, J OPT SOC AM A, V14, P2884, DOI 10.1364/JOSAA.14.002884; Mancuso K, 2009, NATURE, V461, P784, DOI 10.1038/nature08401; Masella BD, 2014, INVEST OPHTH VIS SCI, V55, P7525, DOI 10.1167/iovs.13-13795; MOLLON JD, 1992, NATURE, V360, P677, DOI 10.1038/360677a0; Packer OS, 1996, J NEUROSCI, V16, P2251; Pallikaris A, 2003, INVEST OPHTH VIS SCI, V44, P4580, DOI 10.1167/iovs.03-0094; Renner AB, 2004, VISUAL NEUROSCI, V21, P827, DOI 10.1017/S0952523804216030; Roorda A, 2002, OPT EXPRESS, V10, P405, DOI 10.1364/OE.10.000405; Roorda A, 2001, VISION RES, V41, P1291, DOI 10.1016/S0042-6989(01)00043-8; Roorda A, 1999, NATURE, V397, P520, DOI 10.1038/17383; Roorda A, 2010, OPTOMETRY VISION SCI, V87, P260, DOI 10.1097/OPX.0b013e3181d39479; RUSHTON WAH, 1968, VISION RES, V8, P617, DOI 10.1016/0042-6989(68)90040-0; Sincich LC, 2009, NAT NEUROSCI, V12, P967, DOI 10.1038/nn.2352; SMITH VC, 1973, VISION RES, V13, P1199, DOI 10.1016/0042-6989(73)90156-9; Stockman A, 2000, VISION RES, V40, P1711, DOI 10.1016/S0042-6989(00)00021-3; Tuten WS, 2012, OPTOMETRY VISION SCI, V89, P563, DOI 10.1097/OPX.0b013e3182512b98; VANNORREN D, 1989, VISION RES, V29, P369, DOI 10.1016/0042-6989(89)90085-0; WALD G, 1967, J OPT SOC AM, V57, P1289, DOI 10.1364/JOSA.57.001289; WEBB RH, 1987, APPL OPTICS, V26, P1492, DOI 10.1364/AO.26.001492; Williams DR, 2011, VISION RES, V51, P1379, DOI 10.1016/j.visres.2011.05.002; WILLIAMS DR, 1981, VISION RES, V21, P1341, DOI 10.1016/0042-6989(81)90241-8; WILLIAMS DR, 1981, VISION RES, V21, P1357, DOI 10.1016/0042-6989(81)90242-X	44	34	35	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144891	10.1371/journal.pone.0144891	http://dx.doi.org/10.1371/journal.pone.0144891			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26660894	Green Published, gold, Green Submitted			2022-12-26	WOS:000366715900137
J	Farnsworth, NL; Walter, RL; Hemmati, A; Westacott, MJ; Benninger, RKP				Farnsworth, Nikki L.; Walter, Rachelle L.; Hemmati, Alireza; Westacott, Matthew J.; Benninger, Richard K. P.			Low Level Pro-inflammatory Cytokines Decrease Connexin36 Gap Junction Coupling in Mouse and Human Islets through Nitric Oxide-mediated Protein Kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cytokine; diabetes; gap junction; islet; nitric oxide; PKC-; connexin36	PANCREATIC BETA-CELLS; K-ATP CHANNELS; INSULIN-SECRETION; DIABETES-MELLITUS; PKC-DELTA; INTRACELLULAR CA2+; LANGERHANS; GLUCOSE; TYPE-1; PHOSPHORYLATION	Pro-inflammatory cytokines contribute to the decline in islet function during the development of diabetes. Cytokines can disrupt insulin secretion and calcium dynamics; however, the mechanisms underlying this are poorly understood. Connexin36 gap junctions coordinate glucose-induced calcium oscillations and pulsatile insulin secretion across the islet. Loss of gap junction coupling disrupts these dynamics, similar to that observed during the development of diabetes. This study investigates the mechanisms by which pro-inflammatory cytokines mediate gap junction coupling. Specifically, as cytokine-induced NO can activate PKC, we aimed to understand the role of PKC in modulating cytokine-induced changes in gap junction coupling. Isolated mouse and human islets were treated with varying levels of a cytokine mixture containing TNF-, IL-1, and IFN-. Islet dysfunction was measured by insulin secretion, calcium dynamics, and gap junction coupling. Modulators of PKC and NO were applied to determine their respective roles in modulating gap junction coupling. High levels of cytokines caused cell death and decreased insulin secretion. Low levels of cytokine treatment disrupted calcium dynamics and decreased gap junction coupling, in the absence of disruptions to insulin secretion. Decreases in gap junction coupling were dependent on NO-regulated PKC, and altered membrane organization of connexin36. This study defines several mechanisms underlying the disruption to gap junction coupling under conditions associated with the development of diabetes. These mechanisms will allow for greater understanding of islet dysfunction and suggest ways to ameliorate this dysfunction during the development of diabetes.	[Farnsworth, Nikki L.; Benninger, Richard K. P.] Univ Colorado, Anschutz Med Campus, Barbara Davis Ctr Childhood Diabet, Aurora, CO 80045 USA; [Farnsworth, Nikki L.; Walter, Rachelle L.; Hemmati, Alireza; Westacott, Matthew J.; Benninger, Richard K. P.] Univ Colorado, Anschutz Med Campus, Dept Bioengn, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Benninger, RKP (corresponding author), Univ Colorado, Anschutz Med Campus, 1775 Aurora Ct,M20-4306D,Mail Stop B140, Aurora, CO 80045 USA.	richard.benninger@ucdenver.edu		benninger, richard/0000-0002-5063-6096; Farnsworth, Nikki/0000-0002-9834-9168	National Institutes of Health [R00 DK085145, R01 DK102950, R01 DK106412, F32 DK102276, UL1 TR001082, P30 NS048154]; Juvenile Diabetes Research Foundation [5-CDA-2014-198-A-N]; Blum-Kovler Scholarship; University of Colorado; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK102276, R01DK106412, R01DK102950, P30DK057516, R00DK085145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS048154] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Blum-Kovler Scholarship; University of Colorado; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants R00 DK085145, R01 DK102950, and R01 DK106412, and Juvenile Diabetes Research Foundation Grant 5-CDA-2014-198-A-N (to R. K. P. B.), National Institutes of Health Grant F32 DK102276 and a Blum-Kovler Scholarship (to N. L. F.), and University of Colorado internal funds. Imaging experiments performed in the University of Colorado Anschutz Medical Campus Advance Light Microscopy Core were supported in part by National Institutes of Health Grants UL1 TR001082 and P30 NS048154. Islet isolation performed in the Barbara Davis Center Islet Core was supported in part by P30 DK057516. Authors declare no conflict of interest.	Akash MSH, 2013, J CELL BIOCHEM, V114, P525, DOI 10.1002/jcb.24402; Alexandraki K, 2006, ANN NY ACAD SCI, V1084, P89, DOI 10.1196/annals.1372.039; Allagnat F, 2013, CELL DEATH DIFFER, V20, P1742, DOI 10.1038/cdd.2013.134; Allagnat F, 2008, J BIOL CHEM, V283, P5226, DOI 10.1074/jbc.M708181200; Benninger RKP, 2008, BIOPHYS J, V95, P5048, DOI 10.1529/biophysj.108.140863; Boni-Schnetzler M, 2009, ENDOCRINOLOGY, V150, P5218, DOI 10.1210/en.2009-0543; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Cantley J, 2011, DIABETOLOGIA, V54, P380, DOI 10.1007/s00125-010-1962-y; Carpenter L, 2001, J BIOL CHEM, V276, P5368, DOI 10.1074/jbc.M010036200; Carvalho CPF, 2012, AM J PHYSIOL-ENDOC M, V303, pE144, DOI 10.1152/ajpendo.00489.2011; CERASI E, 1967, ACTA ENDOCRINOL-COP, V55, P278, DOI 10.1530/acta.0.0550278; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; CORBETT JA, 1993, P NATL ACAD SCI USA, V90, P1731, DOI 10.1073/pnas.90.5.1731; CORBETT JA, 1992, J CLIN INVEST, V90, P2384, DOI 10.1172/JCI116129; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Dula SB, 2010, CELL CALCIUM, V48, P133, DOI 10.1016/j.ceca.2010.07.007; Eckersten D, 2012, REGUL PEPTIDES, V174, P32, DOI 10.1016/j.regpep.2011.11.006; EIZIRIK DL, 1994, J CLIN INVEST, V93, P1968, DOI 10.1172/JCI117188; Farnsworth NL, 2014, J PHYSIOL-LONDON, V592, P4431, DOI 10.1113/jphysiol.2014.276733; Farnsworth NL, 2014, FEBS LETT, V588, P1278, DOI 10.1016/j.febslet.2014.02.035; Grapengiesser E, 2001, PANCREAS, V23, P387, DOI 10.1097/00006676-200111000-00009; Haefliger JA, 2013, J MOL ENDOCRINOL, V51, P49, DOI 10.1530/JME-13-0054; Harada N, 2004, J CARDIOVASC PHARM, V44, P35, DOI 10.1097/00005344-200407000-00005; Head WS, 2012, DIABETES, V61, P1700, DOI 10.2337/db11-1312; Heitmeier MR, 1997, J BIOL CHEM, V272, P13697, DOI 10.1074/jbc.272.21.13697; Hendey B, 2002, J LEUKOCYTE BIOL, V71, P863; Henquin JC, 2002, DIABETES, V51, pS60, DOI 10.2337/diabetes.51.2007.S60; Hodson DJ, 2013, J CLIN INVEST, V123, P4182, DOI 10.1172/JCI68459; Hraha TH, 2014, BIOPHYS J, V106, P299, DOI 10.1016/j.bpj.2013.11.026; Imai Y, 2013, TRENDS ENDOCRIN MET, V24, P351, DOI 10.1016/j.tem.2013.01.007; Ize-Ludlow D, 2011, DIABETES, V60, P2086, DOI 10.2337/db11-0373; KANATSUKA A, 1988, METABOLISM, V37, P878, DOI 10.1016/0026-0495(88)90123-0; KANETO H, 1995, DIABETES, V44, P733, DOI 10.2337/diabetes.44.7.733; KAWAHARA DJ, 1991, CYTOKINE, V3, P117, DOI 10.1016/1043-4666(91)90031-8; Klee P, 2011, J CLIN INVEST, V121, P4870, DOI 10.1172/JCI40509; Kono T, 2012, MOL ENDOCRINOL, V26, P257, DOI 10.1210/me.2011-1181; Koster JC, 2002, P NATL ACAD SCI USA, V99, P16992, DOI 10.1073/pnas.012479199; Kothmann WW, 2007, VISUAL NEUROSCI, V24, P363, DOI 10.1017/S095252380707037X; Lampe PD, 2000, J CELL BIOL, V149, P1503, DOI 10.1083/jcb.149.7.1503; Lampe PD, 2000, ARCH BIOCHEM BIOPHYS, V384, P205, DOI 10.1006/abbi.2000.2131; LO SSS, 1992, DIABETOLOGIA, V35, P277, DOI 10.1007/BF00400930; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Matveyenko AV, 2012, DIABETES, V61, P2269, DOI 10.2337/db11-1462; MISCHAK H, 1993, J BIOL CHEM, V268, P20110; Molina AJA, 2009, DIABETES, V58, P2303, DOI 10.2337/db07-1781; Niger C, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-14; ORAHILLY S, 1988, NEW ENGL J MED, V318, P1225, DOI 10.1056/NEJM198805123181902; Padgett LE, 2013, ANN NY ACAD SCI, V1281, P16, DOI 10.1111/j.1749-6632.2012.06826.x; PANAGIOTIDIS G, 1992, EUR J PHARMACOL, V229, P277, DOI 10.1016/0014-2999(92)90568-O; Perkins G, 1997, BIOPHYS J, V72, P533, DOI 10.1016/S0006-3495(97)78693-4; Ramadan JW, 2011, CELL CALCIUM, V50, P481, DOI 10.1016/j.ceca.2011.08.005; Ravier MA, 2005, DIABETES, V54, P1798, DOI 10.2337/diabetes.54.6.1798; Ravier MA, 2002, DIABETOLOGIA, V45, P1154, DOI 10.1007/s00125-002-0883-9; Robertson RP, 2009, TRENDS ENDOCRIN MET, V20, P388, DOI 10.1016/j.tem.2009.05.004; Rocheleau JV, 2006, PLOS BIOL, V4, P221, DOI 10.1371/journal.pbio.0040026; ROE MW, 1994, J BIOL CHEM, V269, P18279; SCHARP DW, 1973, TRANSPLANTATION, V16, P686, DOI 10.1097/00007890-197312000-00028; Soltoff SP, 2007, TRENDS PHARMACOL SCI, V28, P453, DOI 10.1016/j.tips.2007.07.003; Thomas HE, 2002, DIABETES, V51, P311, DOI 10.2337/diabetes.51.2.311; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; Tsuboi T, 2003, BIOCHEM J, V369, P287, DOI 10.1042/BJ20021288; Urschel S, 2006, J BIOL CHEM, V281, P33163, DOI 10.1074/jbc.M606396200; Verrilli G. M., 2011, FASEB J, V25, P1063; Wikstrom JD, 2007, DIABETES, V56, P2569, DOI 10.2337/db06-0757; WILLMOTT NJ, 1995, FEBS LETT, V371, P99, DOI 10.1016/0014-5793(95)00848-4; Yoshida K, 1999, BBA-MOL BASIS DIS, V1453, P230, DOI 10.1016/S0925-4439(98)00105-7	66	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3184	3196		10.1074/jbc.M115.679506	http://dx.doi.org/10.1074/jbc.M115.679506			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26668311	hybrid, Green Published			2022-12-26	WOS:000370854500007
J	Montaville, P; Kuhn, S; Compper, C; Carlier, MF				Montaville, Pierre; Kuehn, Sonja; Compper, Christel; Carlier, Marie-France			Role of the C-terminal Extension of Formin 2 in Its Activation by Spire Protein and Processive Assembly of Actin Filaments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						actin; fluorescence anisotropy; fluorescence correlation spectroscopy (FCS); formin; processivity; profilin	MOUSE OOCYTES; DROSOPHILA OOCYTE; HOMOLOGY-2 DOMAIN; WH2 DOMAINS; BARBED ENDS; NUCLEATION; DYNAMICS; CAPPUCCINO; SEQUENCE; SPINDLE	Formin 2 (Fmn2), a member of the FMN family of formins, plays an important role in early development. This formin cooperates with profilin and Spire, a WASP homology domain 2 (WH2) repeat protein, to stimulate assembly of a dynamic cytoplasmic actin meshwork that facilitates translocation of the meiotic spindle in asymmetric division of mouse oocytes. The kinase-like non-catalytic domain (KIND) of Spire directly interacts with the C-terminal extension of the formin homology domain 2 (FH2) domain of Fmn2, called FSI. This direct interaction is required for the synergy between the two proteins in actin assembly. We have recently demonstrated how Spire, which caps barbed ends via its WH2 domains, activates Fmn2. Fmn2 by itself associates very poorly to filament barbed ends but is rapidly recruited to Spire-capped barbed ends via the KIND domain, and it subsequently displaces Spire from the barbed end to elicit rapid processive assembly from profilinactin. Here, we address the mechanism by which Spire and Fmn2 compete at barbed ends and the role of FSI in orchestrating this competition as well as in the processivity of Fmn2. We have combined microcalorimetric, fluorescence, and hydrodynamic binding assays, as well as bulk solution and single filament measurements of actin assembly, to show that removal of FSI converts Fmn2 into a Capping Protein. This activity is mimicked by association of KIND to Fmn2. In addition, FSI binds actin at filament barbed ends as a weak capper and plays a role in displacing the WH2 domains of Spire from actin, thus allowing the association of actin-binding regions of FH2 to the barbed end.	[Montaville, Pierre; Kuehn, Sonja; Compper, Christel; Carlier, Marie-France] CNRS, Inst Biol Integrat Cellule, Cytoskeleton Dynam & Motil, F-91198 Gif Sur Yvette, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Carlier, MF (corresponding author), CNRS, Inst Biol Integrat Cellule, Cytoskeleton Dynam & Motil, F-91198 Gif Sur Yvette, France.	marie-france.carlier@i2bc.paris-saclay.fr		montaville, Pierre/0000-0002-9931-3482	European Research Council [249982, 241548]	European Research Council(European Research Council (ERC)European Commission)	This work was supported by European Research Council Advanced Grant 249982 "Forcefulactin" and FP7 Program 241548 "MitoSys" (to M. F. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Almonacid M, 2015, NAT CELL BIOL, V17, P470, DOI 10.1038/ncb3131; Anthis NJ, 2013, PROTEIN SCI, V22, P851, DOI 10.1002/pro.2253; Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044; Baker JL, 2015, STRUCTURE, V23, P68, DOI 10.1016/j.str.2014.10.014; Bosch M, 2007, MOL CELL, V28, P555, DOI 10.1016/j.molcel.2007.09.018; Carlier MF, 2015, CELL MOL LIFE SCI, V72, P3051, DOI 10.1007/s00018-015-1914-2; Carlier MF, 2014, METHOD ENZYMOL, V540, P3, DOI 10.1016/B978-0-12-397924-7.00001-7; Carlier MF, 2013, CYTOSKELETON, V70, P540, DOI 10.1002/cm.21124; Chhabra ES, 2006, J BIOL CHEM, V281, P26754, DOI 10.1074/jbc.M604666200; Dahlgaard K, 2007, DEV CELL, V13, P539, DOI 10.1016/j.devcel.2007.09.003; De La Cruz EM, 2000, BIOPHYS J, V78, P2516, DOI 10.1016/S0006-3495(00)76797-X; Didry D, 2012, EMBO J, V31, P1000, DOI 10.1038/emboj.2011.461; EMMONS S, 1995, GENE DEV, V9, P2482, DOI 10.1101/gad.9.20.2482; Goode BL, 2007, ANNU REV BIOCHEM, V76, P593, DOI 10.1146/annurev.biochem.75.103004.142647; Gould CJ, 2011, CURR BIOL, V21, P384, DOI 10.1016/j.cub.2011.01.047; Heimsath EG, 2012, J BIOL CHEM, V287, P3087, DOI 10.1074/jbc.M111.312207; Holubcova Z, 2013, NAT CELL BIOL, V15, P937, DOI 10.1038/ncb2802; Ito T, 2011, J MOL BIOL, V408, P18, DOI 10.1016/j.jmb.2010.12.045; Jegou A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001161; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Manseau L, 1996, DEVELOPMENT, V122, P2109; Montaville P, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001795; Otomo T, 2005, NATURE, V433, P488, DOI 10.1038/nature03251; Park E, 2015, STRUCTURE, V23, P1492, DOI 10.1016/j.str.2015.05.015; Pechlivanis M, 2009, J BIOL CHEM, V284, P25324, DOI 10.1074/jbc.M109.030320; Pernier J, 2013, NAT STRUCT MOL BIOL, V20, P1069, DOI 10.1038/nsmb.2639; Pfender S, 2011, CURR BIOL, V21, P955, DOI 10.1016/j.cub.2011.04.029; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; Quinlan ME, 2007, J CELL BIOL, V179, P117, DOI 10.1083/jcb.200706196; Rosales-Nieves AE, 2006, NAT CELL BIOL, V8, P367, DOI 10.1038/ncb1385; Shekhar S, 2016, MOL BIOL CELL, V27, P1, DOI 10.1091/mbc.E15-06-0352; Shekhar S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9730; Tu DQ, 2012, P NATL ACAD SCI USA, V109, pE3424, DOI 10.1073/pnas.1203035109; Vizcarra CL, 2014, J BIOL CHEM, V289, P30602, DOI 10.1074/jbc.M114.588368; Vizcarra CL, 2011, P NATL ACAD SCI USA, V108, P11884, DOI 10.1073/pnas.1105703108; Wellington A, 1999, DEVELOPMENT, V126, P5267; Xu YW, 2004, CELL, V116, P711, DOI 10.1016/S0092-8674(04)00210-7; Zeth K, 2011, J BIOL CHEM, V286, P30732, DOI 10.1074/jbc.M111.257782	38	6	6	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3302	3318		10.1074/jbc.M115.681379	http://dx.doi.org/10.1074/jbc.M115.681379			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26668326	Green Published, hybrid			2022-12-26	WOS:000370854500016
J	Kikuchi, K; Mochizuki, O				Kikuchi, Kenji; Mochizuki, Osamu			Diffusive Promotion by Velocity Gradient of Cytoplasmic Streaming (CPS) in Nitella Internodal Cells	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; MOTIVE FORCE; ACTIN; MYOSIN; MECHANISM; ALGA	Cytoplasmic streaming (CPS) is well known to assist the movement of nutrients, organelles and genetic material by transporting all of the cytoplasmic contents of a cell. CPS is generated by motility organelles that are driven by motor proteins near a membrane surface, where the CPS has been found to have a flat velocity profile in the flow field according to the sliding theory. There is a consistent mixing of contents inside the cell by CPS if the velocity gradient profile is flattened, which is not assisted by advection diffusion but is only supported by Brownian diffusion. Although the precise flow structure of the cytoplasm has an important role for cellular metabolism, the hydrodynamic mechanism of its convection has not been clarified. We conducted an experiment to visualise the flow of cytoplasm in Nitella cells by injecting tracer fluorescent nanoparticles and using a flow visualisation system in order to understand how the flow profile affects their metabolic system. We determined that the velocity field in the cytosol has an obvious velocity gradient, not a flattened gradient, which suggests that the gradient assists cytosolic mixing by Taylor-Aris dispersion more than by Brownian diffusion.	[Kikuchi, Kenji] Tohoku Univ, Grad Sch Engn, Depertment Bioengn & Robot, Sendai, Miyagi 980, Japan; [Mochizuki, Osamu] Toyo Univ, Depertment Biomed Engn, Kawagoe, Saitama, Japan	Tohoku University; Toyo University	Kikuchi, K (corresponding author), Tohoku Univ, Grad Sch Engn, Depertment Bioengn & Robot, Sendai, Miyagi 980, Japan.	kenji@pfsl.mech.tohoku.ac.jp	Kikuchi, Kenji/T-3160-2019		JSPS KAKENHI [25000008, 25630056]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number, 25000008, 25630056.	ALLEN NS, 1974, J CELL BIOL, V63, P270, DOI 10.1083/jcb.63.1.270; ALLEN NS, 1978, ANNU REV BIOPHYS BIO, V7, P497, DOI 10.1146/annurev.bb.07.060178.002433; Aris R, 1956, DISPERSION SOLUTE FL; Core RW, 2011, NATURE PROTCOLS, V6, P1929; Corti B., 1774, OSSERVAZIONI MICROSC; Ewart AJ, 1903, COMMUNICATION; Goldstein RE, 2015, INTERFACE FOCUS, V5, DOI 10.1098/rsfs.2015.0030; Hayashi Y, 1980, THEORETICAL STUDY MO, V85, P469; KACHAR B, 1988, J CELL BIOL, V106, P1545, DOI 10.1083/jcb.106.5.1545; KAMIYA N, 1981, ANNU REV PLANT PHYS, V32, P205, DOI 10.1146/annurev.pp.32.060181.001225; Kamiya N., 1956, BOT MAG TOKYO, V69, P544, DOI [10.15281/jplantres1887.69.544, DOI 10.15281/JPLANTRES1887.69.544]; Kaneko T, 2005, PLANT CELL PHYSIOL, V46, P130, DOI 10.1093/pcp/pci004; KATO T, 1977, J BIOCHEM-TOKYO, V82, P777, DOI 10.1093/oxfordjournals.jbchem.a131754; MA YZ, 1989, PLANT PHYSIOL, V89, P586, DOI 10.1104/pp.89.2.586; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; MUSTACICH RV, 1974, PHYS REV LETT, V33, P617, DOI 10.1103/PhysRevLett.33.617; PALEVITZ BA, 1974, P NATL ACAD SCI USA, V71, P363, DOI 10.1073/pnas.71.2.363; Park JS, 2004, EXPT FLUIDS, P37105; Pieuchot L, 2015, DEV CELL, V34, P410, DOI 10.1016/j.devcel.2015.07.017; Shimmen T, 2004, CURR OPIN CELL BIOL, V16, P68, DOI 10.1016/j.ceb.2003.11.009; Shimmen T, 1996, PLANT CELL PHYSIOL, V37, P591, DOI 10.1093/oxfordjournals.pcp.a028986; Shimmen T, 2007, J PLANT RES, V120, P31, DOI 10.1007/s10265-006-0061-0; STAIGER CJ, 1987, PROTOPLASMA, V141, P1, DOI 10.1007/BF01276783; TAZAWA M, 1968, PROTOPLASMA, V65, P207, DOI 10.1007/BF01666379; TSUCHIYA Y, 1991, BIOPHYS J, V59, P249, DOI 10.1016/S0006-3495(91)82215-9; Ueda H, 2010, P NATL ACAD SCI USA, V107, P6894, DOI 10.1073/pnas.0911482107; van de Meent JW, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.178102; van de Meent JW, 2010, J FLUID MECH, V642, P5, DOI 10.1017/S0022112009992187; Vedel S, 2014, J FLUID MECH, V752, P107, DOI 10.1017/jfm.2014.324; WILLIAMSON RE, 1974, NATURE, V248, P801, DOI 10.1038/248801a0; Wolff K, 2012, J R SOC INTERFACE, V9, P1398, DOI 10.1098/rsif.2011.0868	31	4	4	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0144938	10.1371/journal.pone.0144938	http://dx.doi.org/10.1371/journal.pone.0144938			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694322	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092500016
J	Chapman, DC; Stocki, P; Williams, DB				Chapman, Daniel C.; Stocki, Pawel; Williams, David B.			Cyclophilin C Participates in the US2-Mediated Degradation of Major Histocompatibility Complex Class I Molecules	PLOS ONE			English	Article							SIGNAL PEPTIDE PEPTIDASE; ENDOPLASMIC-RETICULUM CHAPERONES; PROTEIN DISULFIDE-ISOMERASE; MEMBRANE-PROTEIN; ANTIGEN PRESENTATION; MONOCLONAL-ANTIBODIES; MISFOLDED PROTEINS; MASS-SPECTROMETRY; STRUCTURAL BASIS; RIBOPHORIN I	Human cytomegalovirus uses a variety of mechanisms to evade immune recognition through major histocompatibility complex class I molecules. One mechanism mediated by the immunoevasin protein US2 causes rapid disposal of newly synthesized class I molecules by the endoplasmic reticulum-associated degradation pathway. Although several components of this degradation pathway have been identified, there are still questions concerning how US2 targets class I molecules for degradation. In this study we identify cyclophilin C, a peptidyl prolyl isomerase of the endoplasmic reticulum, as a component of US2-mediated immune evasion. Cyclophilin C could be co-isolated with US2 and with the class I molecule HLA-A2. Furthermore, it was required at a particular expression level since depletion or overexpression of cyclophilin C impaired the degradation of class I molecules. To better characterize the involvement of cyclophilin C in class I degradation, we used LC-MS/MS to detect US2-interacting proteins that were influenced by cyclophilin C expression levels. We identified malectin, PDIA6, and TMEM33 as proteins that increased in association with US2 upon cyclophilin C knockdown. In subsequent validation all were shown to play a functional role in US2 degradation of class I molecules. This was specific to US2 rather than general ER-associated degradation since depletion of these proteins did not impede the degradation of a misfolded substrate, the null Hong Kong variant of alpha(1)-antitrypsin.	[Chapman, Daniel C.; Williams, David B.] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Stocki, Pawel; Williams, David B.] Univ Toronto, Dept Biochem, Toronto, ON, Canada	University of Toronto; University of Toronto	Williams, DB (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	david.williams@utoronto.ca			Canadian Cancer Society [018157]; Canadian Institutes of Health Research [MOP-123226]	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grant 018157 from the Canadian Cancer Society to DBW (http://www.cancer.ca) and grant MOP-123226 from the Canadian Institutes of Health Research to DBW (http://www.cihr-irsc.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn K, 1997, IMMUNITY, V6, P613, DOI 10.1016/S1074-7613(00)80349-0; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Bantscheff M, 2012, ANAL BIOANAL CHEM, V404, P939, DOI 10.1007/s00216-012-6203-4; Barik S, 2006, CELL MOL LIFE SCI, V63, P2889, DOI 10.1007/s00018-006-6215-3; BARNSTABLE CJ, 1978, CELL, V14, P9, DOI 10.1016/0092-8674(78)90296-9; Bergeron MJ, 2011, J BIOL CHEM, V286, P11242, DOI 10.1074/jbc.M110.171728; Bernasconi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013008; Blom D, 2004, EMBO J, V23, P650, DOI 10.1038/sj.emboj.7600090; Boname JM, 2014, J CELL BIOL, V205, P847, DOI 10.1083/jcb.201312009; Carpentier M, 1999, J BIOL CHEM, V274, P10990, DOI 10.1074/jbc.274.16.10990; Chapman DC, 2010, SEMIN CELL DEV BIOL, V21, P512, DOI 10.1016/j.semcdb.2009.12.013; Chen Y, 2011, MOL BIOL CELL, V22, P3559, DOI 10.1091/mbc.E11-03-0201; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Danilczyk UG, 2001, J BIOL CHEM, V276, P25532, DOI 10.1074/jbc.M100270200; Dong M, 2008, MOL BIOL CELL, V19, P2620, DOI 10.1091/mbc.E07-07-0674; Feige MJ, 2009, MOL CELL, V34, P569, DOI 10.1016/j.molcel.2009.04.028; FRIEDMAN J, 1991, CELL, V66, P799, DOI 10.1016/0092-8674(91)90123-G; Furman MH, 2002, J VIROL, V76, P11753, DOI 10.1128/JVI.76.22.11753-11756.2002; Galli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016304; Gewurz BE, 2001, P NATL ACAD SCI USA, V98, P6794, DOI 10.1073/pnas.121172898; Hansen TH, 2009, NAT REV IMMUNOL, V9, P503, DOI 10.1038/nri2575; Hassink GC, 2009, EMBO REP, V10, P755, DOI 10.1038/embor.2009.69; Hegde NR, 2006, J BIOL CHEM, V281, P20910, DOI 10.1074/jbc.M602989200; Hengel H, 1997, IMMUNITY, V6, P623, DOI 10.1016/S1074-7613(00)80350-7; Hsu JL, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004811; Jansen G, 2012, MOL CELL PROTEOMICS, V11, P710, DOI 10.1074/mcp.M111.016550; Jessop CE, 2009, J CELL SCI, V122, P4287, DOI 10.1242/jcs.059154; JONES TR, 1995, J VIROL, V69, P4830, DOI 10.1128/JVI.69.8.4830-4841.1995; Jones TR, 1996, P NATL ACAD SCI USA, V93, P11327, DOI 10.1073/pnas.93.21.11327; Kim E, 2009, J IMMUNOL, V183, P7379, DOI 10.4049/jimmunol.0901489; Kozlov G, 2010, J BIOL CHEM, V285, P35551, DOI 10.1074/jbc.M110.160101; Kumar P, 2009, J BIOL CHEM, V284, P29784, DOI 10.1074/jbc.M109.038497; Lee SO, 2010, EMBO J, V29, P363, DOI 10.1038/emboj.2009.359; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Loureiro J, 2006, NATURE, V441, P894, DOI 10.1038/nature04830; Ma B, 2003, RAPID COMMUN MASS SP, V17, P2337, DOI 10.1002/rcm.1196; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Niu L, 2013, MOL IMMUNOL, V55, P381, DOI 10.1016/j.molimm.2013.03.015; Noriega V, 2012, IMMUNOL RES, V54, P140, DOI 10.1007/s12026-012-8304-8; Oresic K, 2008, J GEN VIROL, V89, P1122, DOI 10.1099/vir.0.83516-0; Oresic K, 2009, J BIOL CHEM, V284, P5905, DOI 10.1074/jbc.M807568200; Park B, 2010, J EXP MED, V207, P2033, DOI 10.1084/jem.20091793; Qin SY, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.394288; Ruggiano A, 2014, J CELL BIOL, V204, P868, DOI 10.1083/jcb.201312042; Rutkevich LA, 2010, MOL BIOL CELL, V21, P3093, DOI 10.1091/mbc.E10-04-0356; Sakabe I, 2015, BREAST CANCER RES TR, V153, P285, DOI 10.1007/s10549-015-3536-7; SAPER MA, 1991, J MOL BIOL, V219, P277, DOI 10.1016/0022-2836(91)90567-P; Schallus T, 2008, MOL BIOL CELL, V19, P3404, DOI 10.1091/mbc.E08-04-0354; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Seitz C, 1998, MOL IMMUNOL, V35, P819, DOI 10.1016/S0161-5890(98)00077-7; Soetandyo N, 2010, J BIOL CHEM, V285, P32352, DOI 10.1074/jbc.M110.131649; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Stagg HR, 2009, J CELL BIOL, V186, P685, DOI 10.1083/jcb.200906110; STAM NJ, 1986, J IMMUNOL, V137, P2299; Stocki P, 2014, J BIOL CHEM, V289, P23086, DOI 10.1074/jbc.M114.570911; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Takeda K, 2014, BIOCHEM BIOPH RES CO, V454, P436, DOI 10.1016/j.bbrc.2014.10.102; Tortorella D, 2000, ANNU REV IMMUNOL, V18, P861, DOI 10.1146/annurev.immunol.18.1.861; Tortorella D, 1998, J CELL BIOL, V142, P365, DOI 10.1083/jcb.142.2.365; Urade Takeshi, 2014, Kobe J Med Sci, V60, pE57; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; van de Weijer ML, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4832; van den Boomen DJH, 2015, MOL IMMUNOL, V68, P106, DOI 10.1016/j.molimm.2015.07.005; van den Boomen DJH, 2014, P NATL ACAD SCI USA, V111, P11425, DOI 10.1073/pnas.1409099111; Vembar SS, 2008, NAT REV MOL CELL BIO, V9, P944, DOI 10.1038/nrm2546; Wang GH, 2006, J PROTEOME RES, V5, P1214, DOI 10.1021/pr050406g; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Wiertz EJHJ, 1996, CELL, V84, P769, DOI 10.1016/S0092-8674(00)81054-5; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wu Y, 2003, P NATL ACAD SCI USA, V100, P8229, DOI 10.1073/pnas.1430537100; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Yu CC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056667, 10.1371/journal.pone.0054627]	79	6	6	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145458	10.1371/journal.pone.0145458	http://dx.doi.org/10.1371/journal.pone.0145458			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691022	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092300078
J	Fogliata, A; Nicolini, G; Bourgier, C; Clivio, A; De Rose, F; Fenoglietto, P; Lobefalo, F; Mancosu, P; Tomatis, S; Vanetti, E; Scorsetti, M; Cozzi, L				Fogliata, Antonella; Nicolini, Giorgia; Bourgier, Celine; Clivio, Alessandro; De Rose, Fiorenza; Fenoglietto, Pascal; Lobefalo, Francesca; Mancosu, Pietro; Tomatis, Stefano; Vanetti, Eugenio; Scorsetti, Marta; Cozzi, Luca			Performance of a Knowledge-Based Model for Optimization of Volumetric Modulated Arc Therapy Plans for Single and Bilateral Breast Irradiation	PLOS ONE			English	Article							RADIATION-THERAPY; PROSTATE-CANCER; AT-RISK; IMRT; RADIOTHERAPY; QUALITY; ENGINE; ORGANS; BEAMS	Purpose To evaluate the performance of a model-based optimisation process for volumetric modulated arc therapy, VMAT, applied to whole breast irradiation. Methods and Materials A set of 150 VMAT dose plans with simultaneous integrated boost were selected to train a model for the prediction of dose-volume constraints. The dosimetric validation was done on different groups of patients from three institutes for single (50 cases) and bilateral breast (20 cases). Results Quantitative improvements were observed between the model-based and the reference plans, particularly for heart dose. Of 460 analysed dose-volume objectives, 13% of the clinical plans failed to meet the constraints while the respective model-based plans succeeded. Only in 5 cases did the reference plans pass while the respective model-based failed the criteria. For the bilateral breast analysis, the model-based plans resulted in superior or equivalent dose distributions to the reference plans in 96% of the cases. Conclusions Plans optimised using a knowledge-based model to determine the dose-volume constraints showed dosimetric improvements when compared to earlier approved clinical plans. The model was applicable to patients from different centres for both single and bilateral breast irradiation. The data suggests that the dose-volume constraint optimisation can be effectively automated with the new engine and could encourage its application to clinical practice.	[Fogliata, Antonella; De Rose, Fiorenza; Lobefalo, Francesca; Mancosu, Pietro; Tomatis, Stefano; Scorsetti, Marta; Cozzi, Luca] Humanitas Clin & Res Ctr, Radiotherapy & Radiosurg Dept, Milan, Italy; [Nicolini, Giorgia; Clivio, Alessandro; Vanetti, Eugenio] Oncol Inst Southern Switzerland, Bellinzona, Switzerland; [Bourgier, Celine; Fenoglietto, Pascal] ICM Val dAurelle, Dept Radiotherapy, Montpellier, France	Institute of Oncology Research (IOR); UNICANCER; Universite de Montpellier; Institut Regional du Cancer Montpellier / Val d'Aurelle (ICM)	Fogliata, A (corresponding author), Humanitas Clin & Res Ctr, Radiotherapy & Radiosurg Dept, Milan, Italy.	antonella.fogliata@humanitas.it	De Rose, Fiorenza/AAC-6414-2022; Mancosu, Pietro/AAB-9807-2019; Mancosu, Pietro/HBQ-0722-2022; Scorsetti, Marta/AAB-7024-2019; Bourgier, Celine/Y-8679-2019; Tomatis, Stefano/AAA-6002-2021; nicolini, giorgia/AAZ-3810-2021; cozzi, luca/GZL-4895-2022; nicolini, giorgia/AAA-2633-2019; clivio, alessandro/AAG-5660-2021	De Rose, Fiorenza/0000-0001-7994-495X; Mancosu, Pietro/0000-0002-0165-7931; Mancosu, Pietro/0000-0002-0165-7931; cozzi, luca/0000-0001-7862-898X; nicolini, giorgia/0000-0002-8130-8861; LOBEFALO, FRANCESCA/0000-0003-3634-2582; Scorsetti, Marta/0000-0003-0320-559X; Fogliata, Antonella/0000-0002-2282-9894; Tomatis, Stefano/0000-0002-4791-0373	Varian Medical Systems; Wellcome Trust; National Council of Science, Technology and Innovation (NACOSTI); Kilifi [084538]	Varian Medical Systems; Wellcome Trust(Wellcome TrustEuropean Commission); National Council of Science, Technology and Innovation (NACOSTI); Kilifi	The funder Varian Medical Systems provided support in the form of salaries for author LC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.; We would like to acknowledge financial support from Wellcome Trust programme, Kilifi (strategic award, 084538) and the National Council of Science, Technology and Innovation (NACOSTI). The children of Mukuru/Mbagathi and their parents/guardians who participated in the study. Special thanks to the entire field, clinical and laboratory staff of the Kenya Medical Research Institute, Mukuru clinics and Mbagathi District hospital, involved in collection of all the data used in this project. This article is published with permission from the Director, KEMRI.	Appenzoller LM, 2012, MED PHYS, V39, P7446, DOI 10.1118/1.4761864; Chanyavanich V, 2011, MED PHYS, V38, P2515, DOI 10.1118/1.3574874; Fogliata A, 2014, RADIOTHER ONCOL, V113, P385, DOI 10.1016/j.radonc.2014.11.009; Fogliata A, 2014, RADIAT ONCOL, V9, DOI 10.1186/s13014-014-0236-0; Good D, 2013, INT J RADIAT ONCOL, V87, P176, DOI 10.1016/j.ijrobp.2013.03.015; Hastie T., 2009, UNSUPERVISED LEARNIN; Johansen S, 2009, ACTA ONCOL, V48, P495, DOI 10.1080/02841860802657227; Lian J, 2013, MED PHYS, V40, DOI 10.1118/1.4828788; Moore KL, 2011, INT J RADIAT ONCOL, V81, P545, DOI 10.1016/j.ijrobp.2010.11.030; Nichols GP, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-66; Nicolini G, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-27; Popescu CC, 2010, INT J RADIAT ONCOL, V76, P287, DOI 10.1016/j.ijrobp.2009.05.038; Qiu JJ, 2010, INT J RADIAT ONCOL, V78, P288, DOI 10.1016/j.ijrobp.2009.10.036; Scorsetti M, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-145; Spruijt KH, 2013, INT J RADIAT ONCOL, V85, P506, DOI 10.1016/j.ijrobp.2012.03.040; Subramaniam S, 2012, STRAHLENTHER ONKOL, V188, P484, DOI 10.1007/s00066-012-0075-6; Tol JP, 2015, INT J RADIAT ONCOL, V91, P612, DOI 10.1016/j.ijrobp.2014.11.014; Toscas JI, 2010, RADIOTHER ONCOL, V96, P192, DOI 10.1016/j.radonc.2010.05.007; Varian Medical Systems, 2014, ECL PHOT EL INSTR US, P183; Yin Y, 2012, MED DOSIM, V37, P287, DOI 10.1016/j.meddos.2011.11.001; Yuan LL, 2012, MED PHYS, V39, P6868, DOI 10.1118/1.4757927; Zhu XF, 2011, MED PHYS, V38, P719, DOI 10.1118/1.3539749	22	54	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145137	10.1371/journal.pone.0145137	http://dx.doi.org/10.1371/journal.pone.0145137			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691687	gold, Green Published, Green Submitted			2022-12-26	WOS:000367092300042
J	Gutierrez-Bedmar, M; Maritnez, EV; Garcia-Rodriguez, A; Munoz-Bravo, C; Mariscal, A				Gutierrez-Bedmar, Mario; Villalobos Maritnez, Elena; Garcia-Rodriguez, Antonio; Munoz-Bravo, Carlos; Mariscal, Alberto			Psychiatric Status across Body Mass Index in a Mediterranean Spanish Population	PLOS ONE			English	Article							NATIONAL EPIDEMIOLOGIC SURVEY; PERSONALITY-DISORDERS; MENTAL-HEALTH; PSYCHOLOGICAL DISTRESS; DIETARY PATTERN; WEIGHT-LOSS; OBESITY; DEPRESSION; ASSOCIATIONS; PREVALENCE	Background Mental and body weight disorders are among the major global health challenges, and their comorbidity may play an important role in treatment and prevention of both pathologies. A growing number of studies have examined the relationship between psychiatric status and body weight, but our knowledge is still limited. Objective The present study aims to investigate the cross-sectional relationships of psychiatric status and body mass index (BMI) in Malaga, a Mediterranean city in the South of Spain. Materials and Methods A total of 563 participants were recruited from those who came to his primary care physician, using a systematic random sampling, non-proportional stratified by BMI categories. Structured clinical interviews were used to assess current Axes-I and II mental disorders according to the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR). BMI was calculated as weight (Kg) divided by square of height in meters (m(2)). Logistic regression was used to investigate the association between BMI and the presence of any mental disorder. BMI was introduced in the models using restricted cubic splines. Results We found that high BMI values were directly associated with mood and adjustment disorders, and low BMI values were directly associated with avoidant and dependent personality disorders (PDs). We observed an inverse relationship between low BMI values and cluster A PDs. There were not significant relationships between anxiety or substance-related disorders and BMI. Conclusion Psychiatric status and BMI are related in a Mediterranean Spanish population. A multidisciplinary approach to both pathologies becomes increasingly more necessary.	[Gutierrez-Bedmar, Mario; Garcia-Rodriguez, Antonio; Munoz-Bravo, Carlos; Mariscal, Alberto] Univ Malaga, Dept Publ Hlth & Psychiat, E-29071 Malaga, Spain; [Villalobos Maritnez, Elena] Univ Hosp Virgen Victoria, Community Mental Hlth Serv, Malaga, Spain	Universidad de Malaga	Gutierrez-Bedmar, M (corresponding author), Univ Malaga, Dept Publ Hlth & Psychiat, E-29071 Malaga, Spain.	bedmar@uma.es	Mariscal, Alberto/ABH-5409-2020; Gutierrez-Bedmar, Mario/F-2364-2018	Mariscal, Alberto/0000-0002-4684-2161; Gutierrez-Bedmar, Mario/0000-0003-0898-8212; Garcia Rodriguez, Antonio/0000-0002-7672-3024				American Psychiatric Association, 2000, DIAGN STAT MAN MENT; AssociationAP, 2000, DSM 4 APATF DIAGN ST; Atlantis E, 2008, INT J OBESITY, V32, P881, DOI 10.1038/ijo.2008.54; Barry D, 2008, ANN EPIDEMIOL, V18, P458, DOI 10.1016/j.annepidem.2007.12.009; Berkowitz RI, 2011, PSYCHIAT CLIN N AM, V34, P747, DOI 10.1016/j.psc.2011.08.007; Bornstein RF, 2001, J PSYCHOPATHOL BEHAV, V23, P151, DOI 10.1023/A:1010913203679; Bruffaerts R, 2008, CAN J PSYCHIAT, V53, P679, DOI 10.1177/070674370805301007; Casey P, 2011, WORLD PSYCHIATRY, V10, P11; Collins PY, 2011, NATURE, V475, P27, DOI 10.1038/475027a; de Wit L, 2010, PSYCHIAT RES, V178, P230, DOI 10.1016/j.psychres.2009.04.015; de Wit LM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-14; Esposito K, 2011, METAB SYNDR RELAT D, V9, P1, DOI 10.1089/met.2010.0031; Fabricatore AN, 2011, INT J OBESITY, V35, P1363, DOI 10.1038/ijo.2011.2; Faith MS, 2011, OBES REV, V12, pe438, DOI 10.1111/j.1467-789X.2010.00843.x; Goldney RD, 2009, AUST NZ J PSYCHIAT, V43, P652, DOI 10.1080/00048670902970825; Hach I, 2007, EUR J PUBLIC HEALTH, V17, P297, DOI 10.1093/eurpub/ckl227; Harding JL, 2014, OBESITY, V22, P277, DOI 10.1002/oby.20423; Harrell FE, 2001, REGRESSION MODELING; Henriksen CA, 2014, J NERV MENT DIS, V202, P379, DOI 10.1097/NMD.0000000000000135; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; Hudson JI, 2007, BIOL PSYCHIAT, V61, P348, DOI 10.1016/j.biopsych.2006.03.040; Beunza JJ, 2010, AM J CLIN NUTR, V92, P1484, DOI 10.3945/ajcn.2010.29764; Kelly SJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-765; Kessler RC, 2013, BIOL PSYCHIAT, V73, P904, DOI 10.1016/j.biopsych.2012.11.020; Lenzenweger MF, 2007, BIOL PSYCHIAT, V62, P553, DOI 10.1016/j.biopsych.2006.09.019; Lopresti AL, 2013, PROG NEURO-PSYCHOPH, V45, P92, DOI 10.1016/j.pnpbp.2013.05.005; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Maclean JC, 2014, ECON HUM BIOL, V12, P153, DOI 10.1016/j.ehb.2013.10.002; Marcus MD, 2014, CURR OPIN PSYCHIATR, V27, P443, DOI 10.1097/YCO.0000000000000103; Marek RJ, 2014, OBES SURG, V24, P631, DOI 10.1007/s11695-013-1149-y; Mather AA, 2009, J PSYCHOSOM RES, V66, P277, DOI 10.1016/j.jpsychores.2008.09.008; Mather AA, 2008, PSYCHOSOM MED, V70, P1012, DOI 10.1097/PSY.0b013e318189a930; McCrea R, 2012, INT J OBESITY, V36, P414, DOI 10.1038/ijo.2011.65; McElroy SL, 2004, J CLIN PSYCHIAT, V65, P634; McLaren L, 2008, SOC PSYCH PSYCH EPID, V43, P63, DOI 10.1007/s00127-007-0269-x; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Orsini N, 2009, 3 NORD BALT COUNTR S; Pan A, 2012, INT J OBESITY, V36, P595, DOI 10.1038/ijo.2011.111; PETRY NM, 2008, OVERWEIGHT OBESITY A, V70, P288, DOI DOI 10.1097/PSY.0B013E3181651651; Pickering RP, 2007, J CLIN PSYCHIAT, V68, P998, DOI 10.4088/JCP.v68n0704; Pickering RP, 2011, J CLIN PSYCHIAT, V72, P1494, DOI 10.4088/JCP.10m06077gry; Revah-Levy A, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-649; Rienks J, 2013, EUR J CLIN NUTR, V67, P75, DOI 10.1038/ejcn.2012.193; Roberts RE, 2003, INT J OBESITY, V27, P514, DOI 10.1038/sj.ijo.0802204; Rosmond R, 1999, J ENDOCRINOL INVEST, V22, P279, DOI 10.1007/BF03343557; Rosmond R, 2001, J ENDOCRINOL INVEST, V24, P159, DOI 10.1007/BF03343836; Sanchez-Villegas A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-208; Schneider N, 2009, EAT WEIGHT DISORD-ST, V14, pE205, DOI 10.1007/BF03325118; Scott KM, 2008, INT J OBESITY, V32, P192, DOI 10.1038/sj.ijo.0803701; Scott KA, 2008, J PSYCHOSOM RES, V64, P97, DOI 10.1016/j.jpsychores.2007.09.006; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Stanley SH, 2013, SOC PSYCH PSYCH EPID, V48, P487, DOI 10.1007/s00127-012-0546-1; Martinez EV, 2014, NUTRIENTS, V6, P1662, DOI 10.3390/nu6041662; Vos T, 2015, LANCET, V386, P743, DOI 10.1016/S0140-6736(15)60692-4; Wittchen HU, 2011, EUR NEUROPSYCHOPHARM, V21, P655, DOI 10.1016/j.euroneuro.2011.07.018; World Health Organization, 1995, WHO TECH REP SER; Zhao G, 2009, INT J OBESITY, V33, P257, DOI 10.1038/ijo.2008.268	57	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145414	10.1371/journal.pone.0145414	http://dx.doi.org/10.1371/journal.pone.0145414			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9KM	26684876	Green Published, gold, Green Submitted			2022-12-26	WOS:000366725800073
J	Jongbloets, BC; van Gassen, KLI; Kan, AA; Engberink, AHOO; de Wit, M; Wolterink-Donselaar, IG; Koerkamp, MJAG; van Nieuwenhuizen, O; Holstege, FCP; de Graan, PNE				Jongbloets, Bart C.; van Gassen, Koen L. I.; Kan, Anne A.; Engberink, Anneke H. O. Olde; de Wit, Marina; Wolterink-Donselaar, Inge G.; Koerkamp, Marian J. A. Groot; van Nieuwenhuizen, Onno; Holstege, Frank C. P.; de Graan, Pierre N. E.			Expression Profiling after Prolonged Experimental Febrile Seizures in Mice Suggests Structural Remodeling in the Hippocampus	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; IMMATURE RAT MODEL; LARGE GENE LISTS; LONG-TERM; STATUS EPILEPTICUS; GLUTAMINE-SYNTHETASE; MICROARRAY DATA; CHANNELS; CELLS; BRAIN	Febrile seizures are the most prevalent type of seizures among children up to 5 years of age (2-4% ofWestern-European children). Complex febrile seizures are associated with an increased risk to develop temporal lobe epilepsy. To investigate short-and long-term effects of experimental febrile seizures (eFS), we induced eFS in highly febrile convulsion-susceptible C57BL/6J mice at post-natal day 10 by exposure to hyperthermia (HT) and compared them to normotherm-exposed (NT) mice. We detected structural re-organization in the hippocampus 14 days after eFS. To identify molecular candidates, which entrain this structural re-organization, we investigated temporal changes in mRNA expression profiles eFS 1 hour to 56 days after eFS. We identified 931 regulated genes and profiled several candidates using in situ hybridization and histology at 3 and 14 days after eFS. This is the first study to report genome-wide transcriptome analysis after eFS in mice. We identify temporal regulation of multiple processes, such as stress-, immune-and inflammatory responses, glia activation, glutamate-glutamine cycle and myelination. Identification of the short-and long-term changes after eFS is important to elucidate the mechanisms contributing to epileptogenesis.	[Jongbloets, Bart C.; van Gassen, Koen L. I.; Kan, Anne A.; Engberink, Anneke H. O. Olde; de Wit, Marina; Wolterink-Donselaar, Inge G.; de Graan, Pierre N. E.] Univ Med Ctr Utrecht, Dept Translat Neurosci, Brain Ctr Rudolf Magnus, Utrecht, Netherlands; [Koerkamp, Marian J. A. Groot; Holstege, Frank C. P.] Univ Med Ctr Utrecht, Div Biomed Genet, Mol Canc Res, Utrecht, Netherlands; [van Nieuwenhuizen, Onno] Univ Med Ctr Utrecht, Dept Pediat Neurol, Brain Ctr Rudolf Magnus, Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center	de Graan, PNE (corresponding author), Univ Med Ctr Utrecht, Dept Translat Neurosci, Brain Ctr Rudolf Magnus, Utrecht, Netherlands.	P.N.E.deGraan@umcutrecht.nl	Holstege, Frank/AAM-9944-2021	van Gassen, Koen/0000-0001-7934-0662; Groot Koerkamp, Marian JA/0000-0002-0867-0821; Olde Engberink, Anneke/0000-0002-0100-4770	National Epilepsy Fund of the Netherlands [NEF 10-17, 03-12]; Epilepsies of Childhood Foundation	National Epilepsy Fund of the Netherlands; Epilepsies of Childhood Foundation	This work was supported by the National Epilepsy Fund of the Netherlands, grant number: NEF 10-17 and 03-12, (https://www.epilepsie.nl), and the Epilepsies of Childhood Foundation, grant number: N/A, website: N/A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronica E, 2007, NEUROBIOL DIS, V26, P497, DOI 10.1016/j.nbd.2007.01.015; BABB TL, 1984, EPILEPSIA, V25, P729, DOI 10.1111/j.1528-1157.1984.tb03484.x; Baram TZ, 1997, DEV BRAIN RES, V98, P265, DOI 10.1016/S0165-3806(96)00190-3; Barnes G, 2003, HIPPOCAMPUS, V13, P1, DOI 10.1002/hipo.10041; Binder DK, 2006, GLIA, V53, P631, DOI 10.1002/glia.20318; BLACKSTAD T, 1961, J COMP NEUROL, V117, P133, DOI 10.1002/cne.901170202; Boender AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094159; Brewster A, 2002, J NEUROSCI, V22, P4591, DOI 10.1523/JNEUROSCI.22-11-04591.2002; Chui R, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-1; Cross JH, 2012, EPILEPSIA, V53, P3, DOI 10.1111/j.1528-1167.2012.03608.x; de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Drojdahl N, 2010, GLIA, V58, P29, DOI 10.1002/glia.20897; Dube C, 2005, ANN NEUROL, V57, P152, DOI 10.1002/ana.20358; Dube C, 2006, BRAIN, V129, P911, DOI 10.1093/brain/awl018; Dube C, 2000, ANN NEUROL, V47, P336, DOI 10.1002/1531-8249(200003)47:3<336::AID-ANA9>3.0.CO;2-W; Dube CM, 2009, BRAIN DEV-JPN, V31, P366, DOI 10.1016/j.braindev.2008.11.010; Eckhaus J, 2013, EPILEPSY RES, V105, P103, DOI 10.1016/j.eplepsyres.2013.02.011; Edgar JM, 2009, GLIA, V57, P1815, DOI 10.1002/glia.20893; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eid T, 2004, LANCET, V363, P28, DOI 10.1016/S0140-6736(03)15166-5; Engel J, 2001, NEUROSCIENTIST, V7, P340, DOI 10.1177/107385840100700410; Fang M, 2010, BRAIN RES, V1324, P14, DOI 10.1016/j.brainres.2010.02.007; FRENCH JA, 1993, ANN NEUROL, V34, P774, DOI 10.1002/ana.410340604; Gatti S, 2002, MECH FEVER FEBRILE S; Gonzalez P, 2009, J NEUROPATH EXP NEUR, V68, P391, DOI 10.1097/NEN.0b013e31819dca30; Gorter JA, 2006, J NEUROSCI, V26, P11083, DOI 10.1523/JNEUROSCI.2766-06.2006; Greenwood J, 2011, NEUROPATH APPL NEURO, V37, P24, DOI 10.1111/j.1365-2990.2010.01140.x; Hamelin S, 2014, NEUROBIOL DIS, V69, P156, DOI 10.1016/j.nbd.2014.05.025; HAUSER WA, 1994, EPILEPSIA, V35, pS1, DOI 10.1111/j.1528-1157.1994.tb05932.x; Hessel EVS, 2009, GENES BRAIN BEHAV, V8, P248, DOI 10.1111/j.1601-183X.2008.00466.x; Hessel EVS, 2014, ANN CLIN TRANSL NEUR, V1, P239, DOI 10.1002/acn3.48; Holtmaat AJGD, 2003, EXP NEUROL, V182, P142, DOI 10.1016/S0014-4886(03)00035-9; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ishizaki Y, 2009, EPILEPSIA, V50, P761, DOI 10.1111/j.1528-1167.2008.01861.x; Jansen JFA, 2008, NEUROBIOL DIS, V32, P293, DOI 10.1016/j.nbd.2008.07.010; Jung KH, 2011, EPILEPSIA, V52, P541, DOI 10.1111/j.1528-1167.2010.02916.x; Kamal A, 2006, EUR J NEUROSCI, V23, P2230, DOI 10.1111/j.1460-9568.2006.04732.x; Kan AA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-207; Kohara K, 2014, NAT NEUROSCI, V17, P269, DOI 10.1038/nn.3614; Koyama R, 2012, NAT MED, V18, P1271, DOI 10.1038/nm.2850; Kuijpers M, 2010, J NEUROIMMUNOL, V229, P73, DOI 10.1016/j.jneuroim.2010.07.004; Kwak SE, 2008, BRAIN RES, V1216, P1, DOI 10.1016/j.brainres.2008.04.026; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Levin S G, 2007, Neurosci Behav Physiol, V37, P467, DOI 10.1007/s11055-007-0036-1; Lewis DV, 2014, ANN NEUROL, V75, P178, DOI 10.1002/ana.24081; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Louboutin JP, 2011, FASEB J, V25, P737, DOI 10.1096/fj.10-161851; Malik AR, 2013, J BIOL CHEM, V288, P8544, DOI 10.1074/jbc.M112.411629; Margaritis T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.21; Myllykoski M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032336; Mylvaganam S, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00172; Nagelhus EA, 2004, NEUROSCIENCE, V129, P905, DOI 10.1016/j.neuroscience.2004.08.053; Neligan A, 2012, NEUROLOGY, V78, P1166, DOI 10.1212/WNL.0b013e31824f807a; Niisato E, 2012, DEV NEUROBIOL, V72, P1447, DOI 10.1002/dneu.22007; Notenboom RGE, 2010, EUR J NEUROSCI, V32, P749, DOI 10.1111/j.1460-9568.2010.07321.x; Otte WM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039078; Parent JM, 2006, HIPPOCAMPUS, V16, P321, DOI 10.1002/hipo.20166; Pernot F, 2010, J NEUROSCI RES, V88, P1000, DOI 10.1002/jnr.22282; Proper EA, 2000, BRAIN, V123, P19, DOI 10.1093/brain/123.1.19; Richichi C, 2008, NEUROBIOL DIS, V29, P297, DOI 10.1016/j.nbd.2007.09.003; Richter F, 2009, J COMP NEUROL, V515, P538, DOI 10.1002/cne.22062; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schuchmann S, 2006, NAT MED, V12, P817, DOI 10.1038/nm1422; Sharma AK, 2009, TOXICOL PATHOL, V37, P776, DOI 10.1177/0192623309344202; Shinnar S, 2012, NEUROLOGY, V79, P871, DOI 10.1212/WNL.0b013e318266fcc5; Steinhauser C, 2012, GLIA, V60, P1192, DOI 10.1002/glia.22313; Swijsen A, 2012, EPILEPSIA, V53, P1968, DOI 10.1111/j.1528-1167.2012.03694.x; Takahashi H, 2011, NEURON, V69, P287, DOI 10.1016/j.neuron.2010.12.024; Theodore WH, 1999, NEUROLOGY, V52, P132, DOI 10.1212/WNL.52.1.132; Toth Z, 1998, J NEUROSCI, V18, P4285; Uetani N, 2000, EMBO J, V19, P2775, DOI 10.1093/emboj/19.12.2775; van Campen JS, 2014, EPILEPSY BEHAV, V38, P160, DOI 10.1016/j.yebeh.2013.09.029; van der Hel WS, 2005, NEUROLOGY, V64, P326, DOI 10.1212/01.WNL.0000149636.44660.99; van Gassen KLI, 2008, GENES BRAIN BEHAV, V7, P578, DOI 10.1111/j.1601-183X.2008.00393.x; van Gassen KLI, 2009, GENES BRAIN BEHAV, V8, P290, DOI 10.1111/j.1601-183X.2008.00471.x; van Gassen KLI, 2008, EPILEPSIA, V49, P1055, DOI 10.1111/j.1528-1167.2007.01470.x; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Wang ZC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095237; Wu H., 2003, ANAL GENE EXPRESSION, P313, DOI DOI 10.1007/0-387-21679-0_14; Xiong Y, 2014, BRAIN RES; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Zhou Y, 2011, J NEUROCHEM, V116, P406, DOI 10.1111/j.1471-4159.2010.07121.x	84	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145247	10.1371/journal.pone.0145247	http://dx.doi.org/10.1371/journal.pone.0145247			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684451	gold, Green Published, Green Submitted			2022-12-26	WOS:000366725800051
J	Magni, S; Christofides, N; Johnson, S; Weiner, R				Magni, Sarah; Christofides, Nicola; Johnson, Saul; Weiner, Renay			Alcohol Use and Transactional Sex among Women in South Africa: Results from a Nationally Representative Survey	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED INFECTIONS; DAR-ES-SALAAM; HIV-INFECTION; CAPE-TOWN; BINGE DRINKING; HIV/AIDS RISK; YOUNG-PEOPLE; UNSAFE SEX; CONDOM USE; MEN	Background Transactional sex is a risk factor for HIV infection. Alcohol use may increase the risk of transactional sex. No nationally-representative studies have examined the relationship between multiple dimensions of alcohol use and transactional sex in women in South Africa. The aim of the study was to examine the relationship between alcohol dependence, binge drinking and frequency of drinking in the past month and transactional sex in adult women in South Africa. Methods A cross-sectional study using multi-stage, cluster sampling collected data from a nationally representative sample of 5,969 women aged 16-55 years in 2012. The analysis conducted for this paper was restricted to women reporting sexual activity in the past 12 months (n = 3,594). Transactional sex was defined as having received money/gifts in exchange for sex with any sex partner in the past year. Alcohol use measures included: alcohol dependence (>= 2 positive responses to the CAGE questionnaire); binge drinking (>= 4 drinks for women on one occasion); and drinking frequency in the previous month. Logistic regression models were built to test the hypotheses that each dimension of alcohol use was associated with transactional sex. Results About 6.3% (n = 225) of sexually active women reported transactional sex. Almost a third (30.6%) of sexually active women had ever drunk alcohol, and 19.2% were current (past month) drinkers. Among lifetime drinkers, 28.0% were alcohol dependent and 56.6% were binge drinkers. Alcohol dependent women were twice as likely to report transactional sex (AOR 2.0, 95% CI 1.1-4.3, p<0.05) than those not alcohol dependent. Binge drinkers were 3.1 times more likely to have had transactional sex (95% CI 1.5-6.6, p<0.01) than non-binge drinkers. There was no significant relationship between frequency of drinking in the past month and transactional sex. Conclusion Alcohol dependency and binge drinking are significantly associated with transactional sex in South African women. HIV prevention programmes need to target these women, and address both their alcohol use, as well as the HIV risks associated with transactional sex.	[Magni, Sarah; Christofides, Nicola; Weiner, Renay] Univ Witwatersrand, Johannesburg, South Africa; [Magni, Sarah; Johnson, Saul] Anansi Hlth Consulting, Johannesburg, South Africa; [Weiner, Renay] Soul City Inst Hlth & Dev Commun, Johannesburg, South Africa	University of Witwatersrand	Magni, S (corresponding author), Univ Witwatersrand, Johannesburg, South Africa.	sarah.e.magni@gmail.com			Anansi Health Consulting	Anansi Health Consulting	The authors received no specific funding for this work. Anansi Health Consulting provided support in the form of salaries for authors SM and SJ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	[Anonymous], 2012, UNAIDS REPORT ON THE; [Anonymous], 2011, NAT STRAT PLAN HIV S; [Anonymous], 1998, S AFR DEM HLTH SURV; Baliunas D, 2010, INT J PUBLIC HEALTH, V55, P159, DOI 10.1007/s00038-009-0095-x; Bonita R., 2006, BASIC EPIDEMIOLOGY, V2nd ed.; Braithwaite RS, 2014, ALCOHOL CLIN EXP RES, V38, P1059, DOI 10.1111/acer.12332; Carrasco MA, 2016, AIDS BEHAV, V20, P484, DOI 10.1007/s10461-015-1233-5; Chatterji M, 2005, SOC BIOL, V52, P56; Chavez PR, 2011, AM J PREV MED, V40, P468, DOI 10.1016/j.amepre.2010.12.008; Chersich MF, 2007, INT J STD AIDS, V18, P764, DOI 10.1258/095646207782212342; Chersich MF, 2010, INT J STD AIDS, V21, P2, DOI 10.1258/ijsa.2000.009432; Claassen JN, 1999, S AFR MED J, V89, P976; CLELAND J, 1987, POP STUD-J DEMOG, V41, P5, DOI 10.1080/0032472031000142516; Coldiron ME, 2008, AIDS BEHAV, V12, P594, DOI 10.1007/s10461-007-9304-x; Cook RL, 2005, SEX TRANSM DIS, V32, P156, DOI 10.1097/01.olq.0000151418.03899.97; Courtney KE, 2009, PSYCHOL BULL, V135, P142, DOI 10.1037/a0014414; Dhalla S, 2007, CLIN INVEST MED, V30, P33, DOI 10.25011/cim.v30i1.447; Dunkle KL, 2004, SOC SCI MED, V59, P1581, DOI 10.1016/j.socscimed.2004.02.003; Dunkle KL, 2007, SOC SCI MED, V65, P1235, DOI 10.1016/j.socscimed.2007.04.029; European Centre for Monitoring Alcohol Marketing, 2008, WOM NEW MARK TRENDS; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Fiellin DA, 2000, ARCH INTERN MED, V160, P1977, DOI 10.1001/archinte.160.13.1977; Fisher JC, 2008, SEX TRANSM DIS, V35, P537, DOI 10.1097/OLQ.0b013e3181677547; Fisher JC, 2007, SEX TRANSM DIS, V34, P856, DOI 10.1097/OLQ.0b013e318067b4fd; Fritz K, 2009, PREVENTION ALCOHOL R; Fritz K, 2013, MEASURING ALCOHOL RE; Fritz K. E., 2002, AIDS BEHAV, V6, P221, DOI DOI 10.1023/A:1019887707474; Ghebremichael M, 2009, SEX TRANSM DIS, V36, P102, DOI 10.1097/OLQ.0b013e31818b20e6; Gregson S, 2002, LANCET, V359, P1896, DOI 10.1016/S0140-6736(02)08780-9; Hargreaves JR, 2002, TROP MED INT HEALTH, V7, P793, DOI 10.1046/j.1365-3156.2002.00943.x; Harrison L, 1997, NIDA Res Monogr, V167, P1; Hunter Mark., 2002, AFR STUD-UK, V61, P99, DOI [DOI 10.1080/00020180220140091, 10.1080/00020180220140091]; Jernigan DH, 2015, ADDICTION, V110, P551, DOI 10.1111/add.12468; Jewkes R., 2012, Journal of AIDS and Clinical Research, V3, P158; Jewkes R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-325; Johnson S, 2013, 3 NATL HIV COMMUNICA; Kalichman SC, 2007, JAIDS-J ACQ IMM DEF, V44, P594, DOI 10.1097/QAI.0b013e3180415e07; Kalichman SC, 2013, SEX TRANSM INFECT, V89, P231, DOI 10.1136/sextrans-2012-050569; Kapiga SH, 1998, AIDS, V12, P75, DOI 10.1097/00002030-199801000-00009; Kincaid DL, 2000, COMMUN RES, V27, P723, DOI 10.1177/009365000027006003; Lane T, 2008, AIDS BEHAV, V12, pS78, DOI 10.1007/s10461-008-9389-x; LeBeau D, 2009, ALCOHOL CONSUMPTION; Leclerc-Madlala S, 2003, SOC DYNAMICS, V29, P213, DOI 10.1080/02533950308628681; Lewis JJC, 2005, SEX TRANSM DIS, V32, P364, DOI 10.1097/01.olq.0000154506.84492.61; Luke N, 2003, STUD FAMILY PLANN, V34, P67, DOI 10.1111/j.1728-4465.2003.00067.x; MacPhail C, 2001, SOC SCI MED, V52, P1613, DOI 10.1016/S0277-9536(00)00272-0; Maganja RK, 2007, AIDS CARE, V19, P974, DOI 10.1080/09540120701294286; Matasha E, 1998, AIDS CARE, V10, P571, DOI 10.1080/09540129848433; Mbulaiteye SM, 2000, INT J EPIDEMIOL, V29, P911, DOI 10.1093/ije/29.5.911; Morojele NK, 2006, SOC SCI MED, V62, P217, DOI 10.1016/j.socscimed.2005.05.031; Myer L, 2007, EPIDEMIOLOGY RES MAN, P155; Ojo OA, 2010, SAMJ S AFR MED J, V100, P180, DOI 10.7196/SAMJ.3767; Parry CDH, 2005, ADDICTION, V100, P426, DOI 10.1111/j.1360-0443.2005.01015.x; Peltzer K, 2011, AFR J PSYCHIATRY, V14, P30; Pettifor AE, 2004, EMERG INFECT DIS, V10, P1996, DOI 10.3201/eid1011.040252; Pitpitan EV, 2014, PREV SCI, V15, P296, DOI 10.1007/s11121-013-0381-y; Republic of South Africa, 2019, HLTH ACT 61 2003; Shisana O, 2014, S AFRICAN NATL HIV P; Shuper PA, 2010, ALCOHOL ALCOHOLISM, V45, P159, DOI 10.1093/alcalc/agp091; Stoebenau K, 2015, CLARIFYING MEANING T; Townsend L, 2011, QUAL HEALTH RES, V21, P41, DOI 10.1177/1049732310378296; Townsend L, 2011, AIDS BEHAV, V15, P132, DOI 10.1007/s10461-010-9680-5; Wamoyi J, 2010, REPROD HEALTH, V7, DOI 10.1186/1742-4755-7-2; Watt MH, 2012, SOC SCI MED, V74, P1005, DOI 10.1016/j.socscimed.2011.12.022; Weiser SD, 2006, PLOS MED, V3, P1940, DOI 10.1371/journal.pmed.0030392; WHO, 2011, PREV HIV SEX WORK SE; Wojcicki JM, 2001, SOC SCI MED, V53, P99, DOI 10.1016/S0277-9536(00)00315-4; Wolff B, 2006, ADDICTION, V101, P1277, DOI 10.1111/j.1360-0443.2006.01516.x; Zablotska IB, 2006, AIDS, V20, P1191, DOI 10.1097/01.aids.0000226960.25589.72; Zembe YZ, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-28	70	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145326	10.1371/journal.pone.0145326	http://dx.doi.org/10.1371/journal.pone.0145326			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9KM	26683812	gold, Green Published			2022-12-26	WOS:000366725800065
J	Marton, G; Orban, G; Kiss, M; Fiath, R; Pongracz, A; Ulbert, I				Marton, Gergely; Orban, Gabor; Kiss, Marcell; Fiath, Richard; Pongracz, Anita; Ulbert, Istvan			A Multimodal, SU-8-Platinum - Polyimide Microelectrode Array for Chronic In Vivo Neurophysiology	PLOS ONE			English	Article							DRUG-DELIVERY; BRAIN-TISSUE; ELECTROCORTICOGRAPHY; OSCILLATIONS; FABRICATION; INTERFACE; DESIGN; SYSTEM; SLEEP; VITRO	Utilization of polymers as insulator and bulk materials of microelectrode arrays (MEAs) makes the realization of flexible, biocompatible sensors possible, which are suitable for various neurophysiological experiments such as in vivo detection of local field potential changes on the surface of the neocortex or unit activities within the brain tissue. In this paper the microfabrication of a novel, all-flexible, polymer-based MEA is presented. The device consists of a three dimensional sensor configuration with an implantable depth electrode array and brain surface electrodes, allowing the recording of electrocorticographic (ECoG) signals with laminar ones, simultaneously. In vivo recordings were performed in anesthetized rat brain to test the functionality of the device under both acute and chronic conditions. The ECoG electrodes recorded slow-wave thalamocortical oscillations, while the implanted component provided high quality depth recordings. The implants remained viable for detecting action potentials of individual neurons for at least 15 weeks.	[Marton, Gergely; Fiath, Richard; Ulbert, Istvan] Hungarian Acad Sci, Res Ctr Nat Sci, Inst Cognit Neurosci & Psychol, H-1117 Budapest, Hungary; [Marton, Gergely; Kiss, Marcell; Pongracz, Anita] Hungarian Acad Sci, Energy Res Ctr, Inst Tech Phys & Mat Sci, Dept Microtechnol, H-1121 Budapest, Hungary; [Marton, Gergely] Semmelweis Univ, Sch PhD Studies, H-1085 Budapest, Hungary; [Orban, Gabor; Kiss, Marcell] Budapest Univ Technol & Econ, Dept Electron Devices, H-1117 Budapest, Hungary; [Fiath, Richard; Ulbert, Istvan] Pazmany Peter Catholic Univ, Fac Informat Technol & Bion, H-1083 Budapest, Hungary	Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Research Centre for Natural Sciences; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Centre for Energy Research; Hungarian Research Centre for Natural Sciences; Semmelweis University; Budapest University of Technology & Economics	Marton, G (corresponding author), Hungarian Acad Sci, Res Ctr Nat Sci, Inst Cognit Neurosci & Psychol, Magyar Tudosok Korutja 2,Bldg Q2, H-1117 Budapest, Hungary.	marton.gergely@ttk.mta.hu	Ulbert, Istvan/F-2213-2010; Fiath, Richard/V-4360-2019	Fiath, Richard/0000-0001-8732-2691; Kiss, Marcell/0000-0001-5930-1367	Bolyai Janos Grant of the HAS; KTIA [NAP 13-2-2015-0004]; OTKA [K81354]; ANR-TET Multisca; EU FP7 NeuroSeeker grants [600925];  [KTIA_13_NAP-A-IV/1-2-3-6];  [TAMOP-4.2.1.B-11/2/KMR-2011-0002]	Bolyai Janos Grant of the HAS; KTIA; OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); ANR-TET Multisca(French National Research Agency (ANR)); EU FP7 NeuroSeeker grants; ; 	This work was funded by the Bolyai Janos Grant of the HAS and KTIA NAP 13-2-2015-0004 to Anita Pongracz, and OTKA K81354, KTIA_13_NAP-A-IV/1-2-3-6, ANR-TET Multisca, TAMOP-4.2.1.B-11/2/KMR-2011-0002, EU FP7 Grant No. 600925 NeuroSeeker grants to Istvan Ulbert. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Mrs. Karolyne Payer, Mr. Robert Hodovan and Mr. Andras Lorincz for their support in microfabrication. We also wish to thank Attila Nagy for his help with packaging and Richard Fiath for useful discussions on in vivo measurements. This work was funded by the Bolyai Janos Grant of the HAS and KTIA NAP 13-2-2015-0004 to Anita Pongracz and OTKA K81354, KTIA_13_NAP-A-IV/1-2-3-6, ANR-TET Multisca, TAMOP-4.2.1.B-11/2/KMR-2011-0002, EU FP7 Grant No. 600925 NeuroSeeker grants to Istvan Ulbert. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altuna A, 2013, LAB CHIP, V13, P1422, DOI 10.1039/c3lc41364k; Boretius T, 2010, BIOSENS BIOELECTRON, V26, P62, DOI 10.1016/j.bios.2010.05.010; Cash SS, 2009, SCIENCE, V324, P1084, DOI 10.1126/science.1169626; Chader GJ, 2009, PROG BRAIN RES, V175, P317, DOI 10.1016/S0079-6123(09)17522-2; Chang CW, 2013, SENSORS-BASEL, V13, P4624, DOI 10.3390/s130404624; Chang TY, 2007, LANGMUIR, V23, P11718, DOI 10.1021/la7017049; Chauvette S, 2011, J NEUROSCI, V31, P14998, DOI 10.1523/JNEUROSCI.2339-11.2011; Chauvette S, 2010, CEREB CORTEX, V20, P2660, DOI 10.1093/cercor/bhq009; Chen YY, 2009, J NEUROSCI METH, V182, P6, DOI 10.1016/j.jneumeth.2009.05.010; Cheung KC, 2007, BIOMED MICRODEVICES, V9, P923, DOI 10.1007/s10544-006-9045-z; Crunelli V, 2010, NAT NEUROSCI, V13, P10, DOI 10.1038/nn.2445; Csercsa R, 2010, BRAIN, V133, P2814, DOI 10.1093/brain/awq169; Dombovari B., 2013, BIOMED TECH, P1; DYMOND AM, 1970, J NEUROSURG, V33, P574, DOI 10.3171/jns.1970.33.5.0574; Ereifej ES, 2013, BIOMED MICRODEVICES, V15, P917, DOI 10.1007/s10544-013-9780-x; Fontanini A, 2003, J NEUROSCI, V23, P7993; Hashiguchi K, 2007, SEIZURE-EUR J EPILEP, V16, P238, DOI 10.1016/j.seizure.2006.12.010; Hassler C, 2011, J POLYM SCI POL PHYS, V49, P18, DOI 10.1002/polb.22169; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Jones MS, 1999, J NEUROPHYSIOL, V82, P1599, DOI 10.1152/jn.1999.82.3.1599; Kelly RC, 2007, J NEUROSCI, V27, P261, DOI 10.1523/JNEUROSCI.4906-06.2007; Kim BJ, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/4/045002; Kotzar G, 2002, BIOMATERIALS, V23, P2737, DOI 10.1016/S0142-9612(02)00007-8; Laszlo G, 2011, SENSOR ACTUAT A-PHYS, V166, P14, DOI 10.1016/j.sna.2010.12.019; Marton G, 2015, MICROSYST TECHNOL, V21, P619, DOI 10.1007/s00542-014-2203-y; Marton G, 2014, J MATER SCI-MATER M, V25, P931, DOI 10.1007/s10856-013-5114-z; Marton G, 2013, IEEE SENS J, V13, P3263, DOI 10.1109/JSEN.2013.2260325; Matsuo T, 2013, NEUROSURGERY, V73, P146, DOI 10.1227/01.neu.0000430327.48387.e1; McKhann GM, 2000, J NEUROSURG, V93, P44, DOI 10.3171/jns.2000.93.1.0044; Mercanzini A, 2008, SENSOR ACTUAT A-PHYS, V143, P90, DOI 10.1016/j.sna.2007.07.027; Metz S, 2004, BIOSENS BIOELECTRON, V19, P1309, DOI 10.1016/j.bios.2003.11.021; Myllymaa S, 2009, BIOSENS BIOELECTRON, V24, P3067, DOI 10.1016/j.bios.2009.03.028; Nemani KV, 2013, MAT SCI ENG C-MATER, V33, P4453, DOI 10.1016/j.msec.2013.07.001; Ochoa M, 2013, BIOMED MICRODEVICES, V15, P437, DOI 10.1007/s10544-013-9743-2; Paxinos G, 2009, RAT BRIAN STEREOTAXI; Polikov VS, 2005, J NEUROSCI METH, V148, P1, DOI 10.1016/j.jneumeth.2005.08.015; Poppendieck W, 2014, BIOMED MICRODEVICES, V16, P837, DOI 10.1007/s10544-014-9887-8; Seymour JP, 2011, BIOMED MICRODEVICES, V13, P441, DOI 10.1007/s10544-011-9512-z; SPENCER DD, 1984, NEUROLOGY, V34, P432, DOI 10.1212/WNL.34.4.432; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Stieglitz T, 2002, BIOSENS BIOELECTRON, V17, P685, DOI 10.1016/S0956-5663(02)00019-2; Stieglitz T, 2000, BIOMED MICRODEVICES, V2, P283, DOI 10.1023/A:1009955222114; Sugano H, 2007, SEIZURE-EUR J EPILEP, V16, P120, DOI 10.1016/j.seizure.2006.10.010; Toda H, 2011, NEUROIMAGE, V54, P203, DOI 10.1016/j.neuroimage.2010.08.003; Ulbert I, 2001, J NEUROSCI METH, V106, P69, DOI 10.1016/S0165-0270(01)00330-2; Ulbert T, 2004, EPILEPSIA, V45, P48, DOI 10.1111/j.0013-9580.2004.04011.x; von Metzen RP, 2013, BIOMED MICRODEVICES, V15, P727, DOI 10.1007/s10544-013-9758-8; Ward MP, 2009, BRAIN RES, V1282, P183, DOI 10.1016/j.brainres.2009.05.052; WISE KD, 1970, IEEE T BIO-MED ENG, VBM17, P238, DOI 10.1109/TBME.1970.4502738; Wise KD, 2007, SENSOR ACTUAT A-PHYS, V136, P39, DOI 10.1016/j.sna.2007.02.013	50	24	24	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145307	10.1371/journal.pone.0145307	http://dx.doi.org/10.1371/journal.pone.0145307			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683306	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000366725800061
J	Mullapudi, N; Ye, B; Suzuki, M; Fazzari, M; Han, W; Shi, MK; Marquardt, G; Lin, J; Wang, T; Keller, S; Zhu, CC; Locker, JD; Spivack, SD				Mullapudi, Nandita; Ye, Bin; Suzuki, Masako; Fazzari, Melissa; Han, Weiguo; Shi, Miao K.; Marquardt, Gaby; Lin, Juan; Wang, Tao; Keller, Steven; Zhu, Changcheng; Locker, Joseph D.; Spivack, Simon D.			Genome Wide Methylome Alterations in Lung Cancer	PLOS ONE			English	Article							METHYLATION-SPECIFIC PCR; DNA METHYLATION; PROMOTER METHYLATION; GENE-EXPRESSION; CPG ISLANDS; ADENOCARCINOMA; ASSOCIATION; BIOMARKERS; PHENOTYPE; DIAGNOSIS	Aberrant cytosine 5-methylation underlies many deregulated elements of cancer. Among paired non-small cell lung cancers (NSCLC), we sought to profile DNA 5-methyl-cytosine features which may underlie genome-wide deregulation. In one of the more dense interrogations of the methylome, we sampled 1.2 million CpG sites from twenty-four NSCLC tumor (T)-non-tumor (NT) pairs using a methylation-sensitive restriction enzyme-based HELP-microarray assay. We found 225,350 differentially methylated (DM) sites in adenocarcinomas versus adjacent non-tumor tissue that vary in frequency across genomic compartment, particularly notable in gene bodies (GB; p<2.2E-16). Further, when DM was coupled to differential transcriptome (DE) in the same samples, 37,056 differential loci in adenocarcinoma emerged. Approximately 90% of the DM-DE relationships were non-canonical; for example, promoter DM associated with DE in the same direction. Of the canonical changes noted, promoter (PR) DM loci with reciprocal changes in expression in adenocarcinomas included HBEGF, AGER, PTPRM, DPT, CST1, MELK; DM GB loci with concordant changes in expression included FOXM1, FERMT1, SLC7A5, and FAP genes. IPA analyses showed adenocarcinoma- specific promoter DMxDE overlay identified familiar lung cancer nodes [tP53, Akt] as well as less familiar nodes [HBEGF, NQO1, GRK5, VWF, HPGD, CDH5, CTNNAL1, PTPN13, DACH1, SMAD6, LAMA3, AR]. The unique findings from this study include the discovery of numerous candidate The unique findings from this study include the discovery of numerous candidate methylation sites in both PR and GB regions not previously identified in NSCLC, and many non-canonical relationships to gene expression. These DNA methylation features could potentially be developed as risk or diagnostic biomarkers, or as candidate targets for newer methylation locus-targeted preventive or therapeutic agents.	[Mullapudi, Nandita; Han, Weiguo; Shi, Miao K.; Marquardt, Gaby; Spivack, Simon D.] Albert Einstein Coll Med, Dept Med Pulm, Bronx, NY 10467 USA; [Ye, Bin] Albert Einstein Coll Med, Dept Bioinformat, Bronx, NY 10467 USA; [Suzuki, Masako; Fazzari, Melissa; Spivack, Simon D.] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Lin, Juan] Albert Einstein Coll Med, Div Biostat, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Wang, Tao; Spivack, Simon D.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Keller, Steven] Montefiore Med Ctr, Dept Cardiovasc & Thorac Surg, Bronx, NY 10467 USA; [Zhu, Changcheng; Locker, Joseph D.] Montefiore Med Ctr, Dept Pathol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Spivack, SD (corresponding author), Albert Einstein Coll Med, Dept Med Pulm, Bronx, NY 10467 USA.	simon.spivack@einstein.yu.edu	Suzuki, Masako/ABF-6497-2020	Suzuki, Masako/0000-0003-0605-9225; Fazzari, Melissa/0000-0002-5674-3589	NCI [1RC1 CA145422-01, 1K24-CA139054-01]; Stony-Wold Herbert Foundation [1R01-CA180126-01, P30 CA013330]; NATIONAL CANCER INSTITUTE [K24CA139054, P30CA013330, R01CA180126, RC1CA145422] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Stony-Wold Herbert Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by NCI 1RC1 CA145422-01 (SDS); 1K24-CA139054-01 (SDS); Stony-Wold Herbert Foundation (NM); 1R01-CA180126-01 (SDS Co-PI); P30 CA013330 (Albert Einstein Cancer Center core grant).	Alberg AJ, 2013, CHEST, P143; American Cancer Society, 2014, CANC FACTS FIG; Anglim PP, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-81; Belinsky SA, 1998, P NATL ACAD SCI USA, V95, P11891, DOI 10.1073/pnas.95.20.11891; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Black JD, 2000, FRONT BIOSCI-LANDMRK, V5, pD406, DOI 10.2741/Black; Brenet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014524; Burk U, 2008, EMBO REP, V9, P582, DOI 10.1038/embor.2008.74; Cao X, 2015, SCI REP; Carvalho RH, 2012, EPIGENET CHROMATIN, V5, DOI 10.1186/1756-8935-5-9; Chen K, 2013, CANCER RES, V73, P3262, DOI 10.1158/0008-5472.CAN-12-3191; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Ehrlich M, 2002, ONCOGENE, V21, P5400, DOI 10.1038/sj.onc.1205651; Fang ZY, 2013, J BIOL CHEM, V288, P7918, DOI 10.1074/jbc.M112.416842; Fazzari MJ, 2004, NAT REV GENET, V5, P446, DOI 10.1038/nrg1349; Fu Y, DNA METHYLATION MEDI, P5; Ganguly R, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-014-0045-y; Gray D, 2005, CANCER RES, V65, P9751, DOI 10.1158/0008-5472.CAN-04-4531; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Han WG, 2006, ANAL BIOCHEM, V355, P50, DOI 10.1016/j.ab.2006.05.010; Han WG, 2013, EPIGENETICS-US, V8, P1176, DOI 10.4161/epi.26195; Han WG, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-86; Hatada I, 2006, ONCOGENE, V25, P3059, DOI 10.1038/sj.onc.1209331; Heller G, 2013, CARCINOGENESIS, V34, P513, DOI 10.1093/carcin/bgs363; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Hurteau GJ, 2007, CANCER RES, V67, P7972, DOI 10.1158/0008-5472.CAN-07-1058; Jones PA, 2012, FUNCTIONS DNA METHYL, V13, DOI [10.1038/nrg3230, DOI 10.1038/NRG3230]; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Khulan B, 2006, COMP ISOSCHIZOMER PR, P1046; Kim YW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040960; Laird PW, 2010, NAT REV GENET, V11, P191, DOI 10.1038/nrg2732; Lin J, 2014, AM J PATHOL, V184, P2868, DOI 10.1016/j.ajpath.2014.06.028; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Lokk K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039813; Maunakea AK, 2013, CELL RES, V23, P1256, DOI 10.1038/cr.2013.110; Micke P, 2014, INT J CANCER, V135, P2206, DOI 10.1002/ijc.28857; Moravcikova E, 2012, INT J ONCOL, V40, P2111, DOI 10.3892/ijo.2012.1397; Nikolaidis G, 2012, CANCER RES, V72, P5692, DOI 10.1158/0008-5472.CAN-12-2309; Oh JE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.130; Ostrow KL, 2010, CLIN CANCER RES, V16, P3463, DOI 10.1158/1078-0432.CCR-09-3304; Palmisano WA, 2000, ADV BRIEF PREDICTING, V1, P5954; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Sandoval J, 2013, J CLIN ONCOL, V31, P4140, DOI 10.1200/JCO.2012.48.5516; Selamat SA, 2012, GENOME RES, V22, P1197, DOI 10.1101/gr.132662.111; Shames DS, 2006, PLOS MED, V3, P2244, DOI 10.1371/journal.pmed.0030486; Shinjo K, 2012, SCI TECHNOLOGY; Tan XL, 2009, CLIN CANCER RES, V15, P7562, DOI 10.1158/1078-0432.CCR-09-1694; Tanaka M, 2011, J HISTOCHEM CYTOCHEM, V59, P942, DOI 10.1369/0022155411420569; Thompson RF, 2008, BIOINFORMATICS, V24, P1161, DOI 10.1093/bioinformatics/btn096; Toyooka S, 2003, INT J CANCER, V103, P153, DOI 10.1002/ijc.10787; Travis WD, 2011, J THORAC ONCOL, V6, P244, DOI 10.1097/JTO.0b013e318206a221; Tsou JA, 2002, ONCOGENE, V21, P5450, DOI 10.1038/sj.onc.1205605; Varley KE, 2013, DYNAMIC DNA METHYLAT, P555; Wan J, 2013, NUCLEIC ACIDS RES, V41, P8503, DOI 10.1093/nar/gkt652; Wang HB, 2014, J BIOL CHEM, V289, P19823, DOI 10.1074/jbc.M114.548446; Wang YL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-59; Wessa P, 2014, OFFIC RES DEV ED, V1, P23; Woenckhaus M, 2006, J PATHOL, V210, P192, DOI 10.1002/path.2039; Yamatoji M, 2012, INT J CANCER, V130, P2903, DOI 10.1002/ijc.26328; Yauch RL, 2005, CLIN CANCER RES, V11, P8686, DOI 10.1158/1078-0432.CCR-05-1492	62	26	26	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0143826	10.1371/journal.pone.0143826	http://dx.doi.org/10.1371/journal.pone.0143826			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683690	Green Published, Green Submitted, gold			2022-12-26	WOS:000366725800010
J	Simoneau-Buessinger, E; Leteneur, S; Toumi, A; Dessurne, A; Gabrielli, F; Barbier, F; Jakobi, JM				Simoneau-Buessinger, Emilie; Leteneur, Sebastien; Toumi, Anis; Dessurne, Alexandra; Gabrielli, Franois; Barbier, Franck; Jakobi, Jennifer M.			Bilateral Strength Deficit Is Not Neural in Origin; Rather Due to Dynamometer Mechanical Configuration	PLOS ONE			English	Article							ISOKINETIC DYNAMOMETER; POSTURAL ADJUSTMENTS; MUSCLE ACTIVATION; CORTICAL ACTIVITY; CROSS-EDUCATION; FLEXOR MUSCLES; LEG PRESS; CONTRACTIONS; HUMANS; TORQUE	During maximal contractions, the sum of forces exerted by homonymous muscles unilaterally is typically higher than the sum of forces exerted by the same muscles bilaterally. However, the underlying mechanism(s) of this phenomenon, which is known as the bilateral strength deficit, remain equivocal. One potential factor that has received minimal attention is the contribution of body adjustments to bilateral and unilateral force production. The purpose of this study was to evaluate the plantar-flexors in an innovative dynamometer that permitted the influence of torque from body adjustments to be adapted. Participants were identically positioned between two setup configurations where torques generated from body adjustments were included within the net ankle torque (locked-unit) or independent of the ankle (open-unit). Twenty healthy adult males performed unilateral and bilateral maximal voluntary isometric plantar-flexion contractions using the dynamometer in the open and locked-unit mechanical configurations. While there was a significant bilateral strength deficit in the locked-unit (p = 0.01), it was not evident in the open-unit (p = 0.07). In the locked-unit, unilateral torque was greater than in the open-unit (p<0.001) and this was due to an additional torque from the body since the electromyographic activity of the agonist muscles did not differ between the two setups (p>0.05). This study revealed that the mechanical configuration of the dynamometer and then the body adjustments caused the observation of a bilateral strength deficit.	[Simoneau-Buessinger, Emilie; Leteneur, Sebastien; Toumi, Anis; Gabrielli, Franois; Barbier, Franck] UVHC, Lab Automat Mecan & Informat Ind & Humaines LAMIH, CNRS, UMR 8201, Valenciennes, France; [Dessurne, Alexandra] HEPH Condorcet, Lab Effort & Mouvement, Tournai, Belgium; [Jakobi, Jennifer M.] Univ British Columbia Okanagan, Sch Hlth & Exercise Sci, Kelowna, BC, Canada	Centre National de la Recherche Scientifique (CNRS); Universite Polytechnique Hauts-de-France; University of British Columbia; University of British Columbia Okanagan	Simoneau-Buessinger, E (corresponding author), UVHC, Lab Automat Mecan & Informat Ind & Humaines LAMIH, CNRS, UMR 8201, Valenciennes, France.	emilie.simoneau@univ-valenciennes.fr	Simoneau, Emilie/ABA-6405-2020	SIMONEAU-BUESSINGER, Emilie/0000-0003-2059-884X; Gabrielli, Francois/0000-0001-5019-1261				Barry BK, 2008, EXP BRAIN RES, V190, P347, DOI 10.1007/s00221-008-1479-5; Buckthorpe MW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057549; CHAPMAN JP, 1987, NEUROPSYCHOLOGIA, V25, P579, DOI 10.1016/0028-3932(87)90082-0; Cresswell AG, 2002, J SPORT MED PHYS FIT, V42, P19; Devanne H, 2002, J NEUROPHYSIOL, V87, P3006, DOI 10.1152/jn.2002.87.6.3006; Drouin JM, 2004, EUR J APPL PHYSIOL, V91, P22, DOI 10.1007/s00421-003-0933-0; Ebben WP, 2006, J STRENGTH COND RES, V20, P985; Ebben WP, 2008, MED SCI SPORT EXER, V40, P1805, DOI 10.1249/MSS.0b013e31817dc4ad; Enoka RM, 1997, J BIOMECH, V30, P447, DOI 10.1016/S0021-9290(96)00170-4; Farthing JP, 2007, BRAIN TOPOGR, V20, P77, DOI 10.1007/s10548-007-0033-2; Farthing JP, 2009, EXERC SPORT SCI REV, V37, P179, DOI 10.1097/JES.0b013e3181b7e882; FORSSBERG H, 1994, EXP BRAIN RES, V97, P515; FRIEDLI WG, 1984, J NEUROL NEUROSUR PS, V47, P611, DOI 10.1136/jnnp.47.6.611; Hakkinen K, 1996, J GERONTOL A-BIOL, V51, pB21, DOI 10.1093/gerona/51A.1.B21; Hakkinen K, 1997, Electromyogr Clin Neurophysiol, V37, P131; Hasan Z, 2005, J MOTOR BEHAV, V37, P484, DOI 10.3200/JMBR.37.6.484-493; Hay D, 2006, HUM MOVEMENT SCI, V25, P181, DOI 10.1016/j.humov.2005.11.007; HENRY FM, 1961, RES QUART, V32, P42, DOI 10.1080/10671188.1961.10762069; Herbert RD, 1996, J APPL PHYSIOL, V80, P1351, DOI 10.1152/jappl.1996.80.4.1351; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; HERZOG W, 1988, J BIOMECH, V21, P5, DOI 10.1016/0021-9290(88)90185-6; HOWARD JD, 1991, J APPL PHYSIOL, V70, P306, DOI 10.1152/jappl.1991.70.1.306; Jakobi JM, 2001, CAN J APPL PHYSIOL, V26, P12, DOI 10.1139/h01-002; Jakobi JM, 1998, J APPL PHYSIOL, V84, P200, DOI 10.1152/jappl.1998.84.1.200; Janzen CL, 2006, EUR J APPL PHYSIOL, V97, P253, DOI 10.1007/s00421-006-0165-1; Katz R, 1999, PROG NEUROBIOL, V57, P325, DOI 10.1016/S0301-0082(98)00056-2; KAUFMAN KR, 1995, J BIOMECH, V28, P1243, DOI 10.1016/0021-9290(94)00176-5; Kawakami Y, 1998, EUR J APPL PHYSIOL O, V77, P212, DOI 10.1007/s004210050324; Kuruganti U, 2005, EUR J APPL PHYSIOL, V94, P175, DOI 10.1007/s00421-004-1313-0; Lan N., 2002, IEEE T NEUR SYS REH, V10, P59; LeBozec S, 1997, CR ACAD SCI III-VIE, V320, P715, DOI 10.1016/S0764-4469(97)84819-6; MacDonald MM, 2014, APPL PHYSL NUTR META; Maffiuletti NA, 2002, J APPL PHYSIOL, V92, P1383, DOI 10.1152/japplphysiol.00884.2001; Magnus CRA, 2008, APPL PHYSIOL NUTR ME, V33, P1132, DOI 10.1139/H08-101; Massion J, 2004, PROG BRAIN RES, V143, P13, DOI 10.1016/S0079-6123(03)43002-1; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; Mottram CJ, 2005, J NEUROPHYSIOL, V93, P1381, DOI 10.1152/jn.00837.2004; ODA S, 1994, EUR J APPL PHYSIOL O, V69, P240, DOI 10.1007/BF01094795; OHTSUKI T, 1983, BEHAV BRAIN RES, V7, P165, DOI 10.1016/0166-4328(83)90190-0; Post M, 2007, NEUROIMAGE, V35, P16, DOI 10.1016/j.neuroimage.2006.11.050; Simoneau E, 2007, EUR J APPL PHYSIOL, V100, P507, DOI 10.1007/s00421-006-0254-1; SOECHTING JF, 1989, EXP BRAIN RES, V74, P535; Taniguchi Y, 2001, EXP BRAIN RES, V137, P259; Toumi A, 2015, EUR J APPL PHYSIOL, V115, P2303, DOI 10.1007/s00421-015-3210-0; van der Fits IBM, 1998, EXP BRAIN RES, V120, P202, DOI 10.1007/s002210050394; Van Dieen JH, 2003, MED SCI SPORT EXER, V35, P111, DOI 10.1097/00005768-200301000-00018; Webber SC, 2010, PHYS THER, V90, P1165, DOI 10.2522/ptj.20090394	47	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145077	10.1371/journal.pone.0145077	http://dx.doi.org/10.1371/journal.pone.0145077			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684828	Green Published, Green Submitted, gold			2022-12-26	WOS:000366725800036
J	Zhang, DH; Jasieniecka-Gazarkiewicz, K; Wan, X; Luo, L; Zhang, YB; Banas, A; Jiang, ML; Gong, YM				Zhang, Donghui; Jasieniecka-Gazarkiewicz, Katarzyna; Wan, Xia; Luo, Ling; Zhang, Yinbo; Banas, Antoni; Jiang, Mulan; Gong, Yangmin			Molecular Characterization of Two Lysophospholipid:acyl-CoA Acyltransferases Belonging to the MBOAT Family in Nicotiana benthamiana	PLOS ONE			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); POLYUNSATURATED FATTY-ACIDS; ACYL-COA; LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE; LANDS CYCLE; YEAST; IDENTIFICATION; BIOSYNTHESIS; PHOSPHATIDYLCHOLINE; METABOLISM	In the remodeling pathway for the synthesis of phosphatidylcholine (PC), acyl-CoA-dependent lysophosphatidylcholine (lysoPC) acyltransferase (LPCAT) catalyzes the reacylation of lysoPC. A number of genes encoding LPCATs have been cloned and characterized from several plants in recent years. Using Arabidopsis and other plant LPCAT sequences to screen the genome database of Nicotiana benthamiana, we identified two cDNAs encoding the putative tobacco LPCATs (NbLPCAT1 and NbLPCAT2). Both of them were predicted to encode a protein of 463 amino acids with high similarity to LPCATs from other plants. Protein sequence features such as the presence of at least eight putative transmembrane regions, four highly conserved signature motifs and several invariant residues indicate that NbLPCATs belong to the membrane bound O-acyltransferase family. Lysophospholipid acyltransferase activity of NbLPCATs was confirmed by testing lysoplatelet-activating factor (lysoPAF) sensitivity through heterologous expression of each full-length cDNA in a yeast mutant Y02431 (lca1 Delta) disrupted in endogenous LPCAT enzyme activity. Analysis of fatty acid profiles of phospholipids from the NbLPCAT-expressing yeast mutant Y02431 cultures supplemented with polyunsaturated fatty acids suggested more incorporation of linoleic acid (18: 2n6, LA) and alpha-linolenic acid (18: 3n3, ALA) into PC compared to yeast mutant harbouring empty vector. In vitro enzymatic assay demonstrated that NbLPCAT1 had high lysoPC acyltransferase activity with a clear preference for alpha-linolenoyl-CoA (18: 3), while NbLPCAT2 showed a high lysophosphatidic acid (lysoPA) acyltransferase activity towards alpha-linolenoyl-CoA and a weak lysoPC acyltransferase activity. Tissue-specific expression analysis showed a ubiquitous expression of NbLPCAT1 and NbLPCAT2 in roots, stems, leaves, flowers and seeds, and a strong expression in developing flowers. This is the first report on the cloning and characterization of lysophospholipid acyltransferases from N. benthamiana.	[Zhang, Donghui; Wan, Xia; Luo, Ling; Zhang, Yinbo; Jiang, Mulan; Gong, Yangmin] Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan 430062, Peoples R China; [Jasieniecka-Gazarkiewicz, Katarzyna; Banas, Antoni] Univ Gdansk, Intercollegiate Fac Biotechnol, PL-80822 Gdansk, Poland; [Jasieniecka-Gazarkiewicz, Katarzyna; Banas, Antoni] Med Univ Gdansk, PL-80822 Gdansk, Poland	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Fahrenheit Universities; University of Gdansk; Fahrenheit Universities; Medical University Gdansk	Jiang, ML (corresponding author), Chinese Acad Agr Sci, Oil Crops Res Inst, Minist Agr, Key Lab Biol & Genet Improvement Oil Crops, Wuhan 430062, Peoples R China.	mljiang@oilcrops.cn; gongyangmin@caas.cn		Jasieniecka-Gazarkiewicz, Katarzyna/0000-0002-7682-188X; Banas, Antoni/0000-0001-9397-7627	National Natural Science Foundation of China [31270346]; National Hi-Tech Program of China [2011AA100904]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Hi-Tech Program of China	This research was supported by grants from the National Natural Science Foundation of China (31270346) and National Hi-Tech Program of China (2011AA100904).	Abbadi A, 2004, PLANT CELL, V16, P2734, DOI 10.1105/tpc.104.026070; Bao XM, 1998, PLANT PHYSIOL, V118, P183, DOI 10.1104/pp.118.1.183; Cahoon EB, 2007, CURR OPIN PLANT BIOL, V10, P236, DOI 10.1016/j.pbi.2007.04.005; Chen QL, 2007, FEBS LETT, V581, P5511, DOI 10.1016/j.febslet.2007.10.061; Dahlqvist A, 2000, P NATL ACAD SCI USA, V97, P6487, DOI 10.1073/pnas.120067297; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Gu ZM, 2004, MOL MICROBIOL, V51, P149, DOI 10.1046/j.1365-2958.2003.03802.x; Harayama T, 2008, J BIOL CHEM, V283, P11097, DOI 10.1074/jbc.M708909200; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Hoffmann M, 2008, J BIOL CHEM, V283, P22352, DOI 10.1074/jbc.M802377200; Kazachkov M, 2008, LIPIDS, V43, P895, DOI 10.1007/s11745-008-3233-y; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Lager I, 2013, J BIOL CHEM, V288, P36902, DOI 10.1074/jbc.M113.521815; LANDS WEM, 1960, J BIOL CHEM, V235, P2233; LANDS WEM, 1982, J BIOL CHEM, V257, P4968; LANDS WEM, 1965, ANNU REV BIOCHEM, V34, P313, DOI 10.1146/annurev.bi.34.070165.001525; Arroyo-Caro JM, 2013, LIPIDS, V48, P663, DOI 10.1007/s11745-013-3797-z; MYHER JJ, 1989, LIPIDS, V24, P396, DOI 10.1007/BF02535147; Nakanishi H, 2006, J BIOL CHEM, V281, P20140, DOI 10.1074/jbc.M600225200; Petrie JR, 2010, METAB ENG, V12, P233, DOI 10.1016/j.ymben.2009.12.001; Shimizu T, 2006, IUBMB LIFE, V58, P328, DOI 10.1080/15216540600702289; Shindou H, 2000, BIOCHEM BIOPH RES CO, V271, P812, DOI 10.1006/bbrc.2000.2723; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Shindou H, 2009, BIOCHEM BIOPH RES CO, V383, P320, DOI 10.1016/j.bbrc.2009.04.013; Shindou H, 2009, J LIPID RES, V50, pS46, DOI 10.1194/jlr.R800035-JLR200; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; STYMNE S, 1984, BIOCHEM J, V223, P305, DOI 10.1042/bj2230305; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Wang LP, 2012, PLANT CELL, V24, P4652, DOI 10.1105/tpc.112.104604; Zaremberg V, 2002, J BIOL CHEM, V277, P39035, DOI 10.1074/jbc.M207753200; Zhao Y, 2008, J BIOL CHEM, V283, P8258, DOI 10.1074/jbc.M710422200; Zheng Q, 2012, PHYTOCHEMISTRY, V75, P21, DOI 10.1016/j.phytochem.2011.11.022	34	8	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144653	10.1371/journal.pone.0144653	http://dx.doi.org/10.1371/journal.pone.0144653			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684752	Green Published, Green Submitted, gold			2022-12-26	WOS:000366725800017
J	Jiao, B; Liu, XY; Zhou, L; Wang, MH; Zhou, YF; Xiao, TT; Zhang, WW; Sun, R; Waye, MMY; Tang, BS; Shen, L				Jiao, Bin; Liu, Xiaoyan; Zhou, Lin; Wang, Maggie Haitian; Zhou, Yafang; Xiao, Tingting; Zhang, Weiwei; Sun, Rui; Waye, Mary Miu Yee; Tang, Beisha; Shen, Lu			Polygenic Analysis of Late-Onset Alzheimer's Disease from Mainland China	PLOS ONE			English	Article							APOLIPOPROTEIN-E GENOTYPE; GENOME-WIDE ASSOCIATION; IDENTIFIES VARIANTS; SUSCEPTIBILITY LOCI; COMMON VARIANTS; CLU; POLYMORPHISM; MUTATION; CD2AP; EPHA1	Recently, a number of single nucleotide polymorphisms (SNPs) were identified to be associated with late-onset Alzheimer disease (LOAD) through genome-wide association study data. Identification of SNP-SNP interaction played an important role in better understanding genetic basis of LOAD. In this study, fifty-eight SNPs were screened in a cohort of 229 LOAD cases and 318 controls from mainland China, and their interaction was evaluated by a series of analysis methods. Seven risk SNPs and six protective SNPs were identified to be associated with LOAD. Risk SNPs included rs9331888 (CLU), rs6691117 (CR1), rs4938933 (MS4A), rs9349407 (CD2AP), rs1160985 (TOMM40), rs4945261 (GAB2) and rs5984894 (PCDH11X); Protective SNPs consisted of rs744373 (BIN1), rs1562990 (MS4A), rs597668 (EXOC3L2), rs9271192 (HLA-DRB5/DRB1), rs157581 and rs11556505 (TOMM40). Among positive SNPs presented above, we found the interaction between rs4938933 (risk) and rs1562990 (protective) in MS4A weakened their each effect for LOAD; for three significant SNPs in TOMM40, their cumulative interaction induced the two protective SNPs effects lost and made the risk SNP effect aggravate for LOAD. Finally, we found rs6656401-rs3865444 (CR1-CD33) pairs were significantly associated with decreasing LOAD risk, while rs28834970-rs6656401 (PTK2B-CR1), and rs28834970-rs6656401 (PTK2B-CD33) were associated with increasing LOAD risk. In a word, our study indicates that SNP-SNP interaction existed in the same gene or cross different genes, which could weaken or aggravate their initial single effects for LOAD.	[Jiao, Bin; Liu, Xiaoyan; Zhou, Lin; Zhou, Yafang; Xiao, Tingting; Zhang, Weiwei; Tang, Beisha; Shen, Lu] Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China; [Tang, Beisha; Shen, Lu] State Key Lab Med Genet, Changsha, Hunan, Peoples R China; [Zhou, Lin; Zhou, Yafang; Tang, Beisha; Shen, Lu] Cent S Univ, Key Lab Hunan Prov Neurodegenerat Disorders, Changsha, Hunan, Peoples R China; [Wang, Maggie Haitian; Sun, Rui] Chinese Univ Hong Kong, Sch Publ Hlth & Primary Care, Div Biostat, Shatin, Hong Kong, Peoples R China; [Waye, Mary Miu Yee] Chinese Univ Hong Kong, Sch Biomed Sci, Shatin, Hong Kong, Peoples R China	Central South University; Central South University; Chinese University of Hong Kong; Chinese University of Hong Kong	Shen, L (corresponding author), Cent S Univ, Xiangya Hosp, Dept Neurol, Changsha, Hunan, Peoples R China.	shenlu2505@126.com	Wang, Maggie Haitian/F-5954-2017; Jiao, Bin/HHZ-6629-2022; 韋妙宜教授, Mary Miu Yee Waye/A-9674-2008	Wang, Maggie Haitian/0000-0003-1223-4595; 韋妙宜教授, Mary Miu Yee Waye/0000-0002-2582-4917	National Natural Science Foundation of China [81471295]; Natural Science Foundation of Hunan Province [14jj7011]; Hunan Provincial Innovation Foundation For Postgraduate [CX2014B113]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); Hunan Provincial Innovation Foundation For Postgraduate	! This study was supported by the National Natural Science Foundation of China (No. 81471295, sponsored by LS, http://npd.nsfc.gov.cn/); the Natural Science Foundation of Hunan Province (No.14jj7011, sponsored by LZ, http://www.hnst.gov.cn/zxgz/zkjj/); Hunan Provincial Innovation Foundation For Postgraduate (No. CX2014B113, sponsored by BJ, http://wenku.baidu.com/link?url=J1uokswv7ZGiIQ ? boCUWwU8GV9hJTic2aGOP2S3rTW9uT3_fGaFF1neXBII2-l9xLhZFMOBhqD-kBAT3hSMF91WE2bi2OyKU_shtFYDKbtJq).	Balasa M, 2011, NEUROLOGY, V76, P1720, DOI 10.1212/WNL.0b013e31821a44dd; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Beck Tim N, 2014, Oncoscience, V1, P486; BERTRAND P, 1995, MOL BRAIN RES, V33, P174, DOI 10.1016/0169-328X(95)00097-C; Chen H, 2015, MOL NEUROBIOL; Crehan H, 2012, IMMUNOBIOLOGY, V217, P244, DOI 10.1016/j.imbio.2011.07.017; Cruchaga C, 2014, NATURE, V505, P550, DOI 10.1038/nature12825; De Jager P, 2012, ALZHEIMERS DEMENT, V8, P232; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Jiao B, 2014, NEUROBIOL AGING, V35, pe1951, DOI DOI 10.1016/J.NEUR0BI0LAGING.2014.02.014; Jiao B, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.10.001; Jonsson T, 2012, NATURE, V488, P96, DOI 10.1038/nature11283; Jun G, 2015, MOL PSYCHIAT; Jun G, 2012, ARCH NEUROL-CHICAGO, V69, P1270, DOI 10.1001/archneurol.2012.2052; Kullo IJ, 2011, AM J HUM GENET, V89, P131, DOI 10.1016/j.ajhg.2011.05.019; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lockhart R, 2014, ANN STAT, V42, P413, DOI 10.1214/13-AOS1175; Ma J, 2014, MOL NEUROBIOL; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Reiman EM, 2007, NEURON, V54, P713, DOI 10.1016/j.neuron.2007.05.022; Salakhov R R, 2014, Genetika, V50, P222; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Shuai P, 2015, NEUROSCI LETT, V591, P160, DOI 10.1016/j.neulet.2015.02.040; Shulman JM, 2013, JAMA NEUROL, V70, P1150, DOI 10.1001/jamaneurol.2013.2815; Tanzi RE, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006296; Wang MH, 2014, META GENE, V2, P384, DOI 10.1016/j.mgene.2014.04.010; Wetzel-Smith MK, 2014, NAT MED, V20, P1452, DOI 10.1038/nm.3736	34	52	53	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144898	10.1371/journal.pone.0144898	http://dx.doi.org/10.1371/journal.pone.0144898			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26680604	Green Published, gold, Green Submitted			2022-12-26	WOS:000366723400033
J	Zhang, B; Yu, W; Zhou, LQ; He, ZS; Shen, C; He, Q; Li, J; Liu, LB; Wang, C; Chen, XY; Fan, Y; Hu, S; Zhang, L; Han, WK; Jin, J				Zhang, Bo; Yu, Wei; Zhou, Li-Qun; He, Zhi-Song; Shen, Cheng; He, Qun; Li, Jun; Liu, Li-Bo; Wang, Cong; Chen, Xiao-Yu; Fan, Yu; Hu, Shuai; Zhang, Lei; Han, Wen-Ke; Jin, Jie			Prognostic Significance of Preoperative Albumin-Globulin Ratio in Patients with Upper Tract Urothelial Carcinoma	PLOS ONE			English	Article							UPPER URINARY-TRACT; SYSTEMIC INFLAMMATORY RESPONSE; LONG-TERM MORTALITY; C-REACTIVE PROTEIN; CANCER-PATIENTS; RADICAL NEPHROURETERECTOMY; CLINICAL-SIGNIFICANCE; ARISTOLOCHIC ACID; PREDICT SURVIVAL; LYMPHOCYTE RATIO	Background Preoperative albumin-globulin ratio (AGR) reflects both malnutrition and systemic inflammation in cancer patients. In particular, systemic inflammation has been reported to contribute to tumor progression and poor oncological outcome in various malignancies. However, the prognostic value of preoperative AGR in upper tract urothelial carcinoma (UTUC) has not been examined. Methods We retrospectively reviewed medical data of 187 operable UTUC patients in a Chinese cohort with a high incidence of chronic kidney disease (CKD). AGR was calculated as [AGR = albumin/(serum total protein-albumin)]. The associations of preoperative AGR with clinicopathologic characteristics and prognosis were assessed. Multivariate analyses using Cox regression models were performed to determine the independent prognostic factors. Results The median (IQR) preoperative AGR was 1.50 (1.30-1.70), and the optimal cutoff value was determined to be 1.45 according to the receiver operating curve analysis. Low AGR was significantly associated with female gender, high CKD stage and tumor grade (P < 0.05). Eighty-three patients died before the follow-up endpoint. Kaplan-Meier analysis showed that an AGR < 1.45 predicted significantly poorer overall and cancer-specific survivals compared to an AGR >= 1.45 (P < 0.001 and P = 0.008, respectively). Multivariate analyses showed that an AGR < 1.45 was an independent risk factor for poorer overall and cancer-specific survivals (P = 0.002 and P = 0.015, respectively). Conclusions Preoperative AGR can act as an effective biomarker with easy accessibility for evaluating the prognosis of patients with UTUC. AGR should be applied in UTUC patients for risk stratification and determination of optimal therapeutic regimens.	[Zhang, Bo; Yu, Wei; Zhou, Li-Qun; He, Zhi-Song; Shen, Cheng; He, Qun; Li, Jun; Liu, Li-Bo; Fan, Yu; Hu, Shuai; Zhang, Lei; Han, Wen-Ke; Jin, Jie] Peking Univ, Hosp 1, Dept Urol, Beijing 100871, Peoples R China; [Zhang, Bo; Yu, Wei; Zhou, Li-Qun; He, Zhi-Song; Shen, Cheng; He, Qun; Li, Jun; Liu, Li-Bo; Fan, Yu; Hu, Shuai; Zhang, Lei; Han, Wen-Ke; Jin, Jie] Peking Univ, Inst Urol, Beijing 100871, Peoples R China; [Zhang, Bo; Yu, Wei; Zhou, Li-Qun; He, Zhi-Song; Shen, Cheng; He, Qun; Li, Jun; Liu, Li-Bo; Fan, Yu; Hu, Shuai; Zhang, Lei; Han, Wen-Ke; Jin, Jie] Natl Urol Canc Ctr, Beijing, Peoples R China; [Wang, Cong; Chen, Xiao-Yu] Peking Univ, Hlth Sci Ctr, Beijing 100871, Peoples R China	Peking University; Peking University; Peking University	Han, WK (corresponding author), Peking Univ, Hosp 1, Dept Urol, Beijing 100871, Peoples R China.	hanwenke@medmail.com.cn; jinjie@vip.163.com	Zhou, Li/GSE-4531-2022		National Natural Science Foundation of China [81200548]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Natural Science Foundation of China to Wei Yu (http://www.nsfc.gov.cn/publish/portal1/) (Grant No. 81200548). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Absenger G, 2013, BRIT J CANCER, V109, P395, DOI 10.1038/bjc.2013.346; Al-Shaiba R, 2004, BRIT J CANCER, V91, P205, DOI 10.1038/sj.bjc.6601886; Azab B, 2013, INT J COLORECTAL DIS, V28, P1629, DOI 10.1007/s00384-013-1748-z; Azab BN, 2013, AM J SURG, V206, P764, DOI 10.1016/j.amjsurg.2013.03.007; Barber MD, 1999, NUTR CANCER, V35, P106, DOI 10.1207/S15327914NC352_2; CAZADOR AC, 1989, REV ESP ENFERM APAR, V75, P143; Chandra RK, 1999, P NUTR SOC, V58, P681, DOI 10.1017/S0029665199000890; Chen CY, 2007, J FORMOS MED ASSOC, V106, P992, DOI 10.1016/S0929-6646(08)60074-1; COHEN MH, 1981, CANCER TREAT REP, V65, P187; Colin P, 2009, BJU INT, V104, P1436, DOI 10.1111/j.1464-410X.2009.08838.x; DEWYS WD, 1980, AM J MED, V69, P491, DOI 10.1016/S0149-2918(05)80001-3; Ding YJ, 2012, TOXICOL APPL PHARM, V261, P59, DOI 10.1016/j.taap.2012.03.011; Du XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094473; Duran AO, 2014, ASIAN PAC J CANCER P, V15, P6449, DOI 10.7314/APJCP.2014.15.15.6449; Elinav E, 2013, NAT REV CANCER, V13, P759, DOI 10.1038/nrc3611; Fox P, 2013, BRIT J CANCER, V109, P147, DOI 10.1038/bjc.2013.300; Gupta D, 2010, NUTR J, V9, DOI 10.1186/1475-2891-9-69; Hashimoto T, 2013, WORLD J UROL, V31, P953, DOI 10.1007/s00345-012-0942-x; Huang CC, 2007, TOXICOL SCI, V100, P486, DOI 10.1093/toxsci/kfm235; Kaysen GA, 2003, KIDNEY INT, V64, pS92, DOI 10.1046/j.1523-1755.64.s87.14.x; Kaysen GA, 2001, J AM SOC NEPHROL, V12, P1549, DOI 10.1681/ASN.V1271549; Ku JH, 2014, INT BRAZ J UROL, V40, P753, DOI 10.1590/S1677-5538.IBJU.2014.06.06; LAURSEN I, 1990, ANTICANCER RES, V10, P343; Lehmann J, 2007, EUR UROL, V51, P1281, DOI 10.1016/j.eururo.2006.11.021; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Lughezzani G, 2012, EUR UROL, V62, P100, DOI 10.1016/j.eururo.2012.02.030; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; McMillan DC, 2001, NUTR CANCER, V39, P210, DOI 10.1207/S15327914nc392_8; McMillan DC, 2009, CURR OPIN CLIN NUTR, V12, P223, DOI 10.1097/MCO.0b013e32832a7902; Muliawati Yanti, 2012, Acta Med Indones, V44, P154; Obata J, 2013, UROL ONCOL-SEMIN ORI, V31, P1725, DOI 10.1016/j.urolonc.2012.05.008; Qayyum Tahir, 2013, Curr Urol, V6, P189, DOI 10.1159/000343537; Raman JD, 2011, BJU INT, V107, P1059, DOI 10.1111/j.1464-410X.2010.09675.x; Saito K, 2007, BJU INT, V100, P269, DOI 10.1111/j.1464-410X.2007.06934.x; Sakano S, 2013, ANN SURG ONCOL, V20, P4389, DOI 10.1245/s10434-013-3259-0; Seaton K, 2001, J NATL MED ASSOC, V93, P490; Sung HH, 2015, BJU INT, V115, P587, DOI 10.1111/bju.12846; Yang MH, 2002, UROLOGY, V59, P681, DOI 10.1016/S0090-4295(02)01529-7; Yeun J Y, 1998, Am J Kidney Dis, V32, pS118, DOI 10.1016/S0272-6386(98)70174-X	39	36	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144961	10.1371/journal.pone.0144961	http://dx.doi.org/10.1371/journal.pone.0144961			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26681341	Green Published, Green Submitted, gold			2022-12-26	WOS:000366723400036
J	He, MZ; Yang, Z; Abdellatif, M; Sayed, D				He, Minzhen; Yang, Zhi; Abdellatif, Maha; Sayed, Danish			GTPase Activating Protein (Sh3 Domain) Binding Protein 1 Regulates the Processing of MicroRNA-1 during Cardiac Hypertrophy	PLOS ONE			English	Article							POSTTRANSCRIPTIONAL GENE-REGULATION; ENDORIBONUCLEASE G3BP; MESSENGER-RNA; EXPRESSION; INITIATION; GROWTH; BIOGENESIS; PROMOTES; TARGETS; MUSCLE	Background MicroRNAs (miR) are small, posttranscriptional regulators, expressed as part of a longer primary transcript, following which they undergo nuclear and cytoplasmic processing by Drosha and Dicer, respectively, to form the functional mature similar to 20mer that gets incorporated into the silencing complex. Others and we have shown that mature miR-1 levels decrease with pressure-induced cardiac hypertrophy, however, there is little or no change in the primary transcript encompassing miR-1 stem-loop, suggesting critical regulatory step in microRNA processing. The objective of this study was to investigate the underlying mechanisms regulating miR-1 expression in cardiomyocytes. Results Here we report that GTPase-activating protein (SH3 domain) binding protein 1 (G3bp1), an endoribonuclease regulates miR-1 processing in cardiomyocytes. G3bp1 is upregulated during cardiac hypertrophy and restricts miR-1 processing by binding to its consensus sequence in the pre-miR-1-2 stem-loop. In accordance, exogenous G3bp1 is sufficient to reduce miR-1 levels, along with derepression of miR-1 targets; General transcription factor IIB (Gtf2b), cyclin dependent factor 9 (Cdk9) and eukaryotic initiation factor 4E (Eif4e). While Cdk9 and Gtf2b are essential for transcription, Eif4e is required for translation. Thus, downregulation of miR-1 is necessary for increase in these molecules. Similar to miR-1 knockdown, G3bp1 overexpression is not sufficient for development of cardiac hypertrophy. Conversely, knockdown of G3bp1 in hypertrophying cardiomyocytes inhibited downregulation of miR-1 and upregulation of its targets along with restricted hypertrophy, suggesting that G3bp1 is necessary for development of cardiac hypertrophy. These results indicate that G3bp1-mediated inhibition of miR-1 processing with growth stimulation results in decrease in mature miR-1 and, thereby, an increase of its targets, which play fundamental roles in the development of hypertrophy. Conclusion G3bp1 posttranscriptionally regulates miRNA-1 processing in the heart, and G3bp1 mediated downregulation of mature miRNA-1 levels is required for the derepression of its targets and increase in gene expression during cardiac hypertrophy.	[He, Minzhen; Yang, Zhi; Abdellatif, Maha; Sayed, Danish] Rutgers New Jersey Med Sch, Cardiovasc Res Inst, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Sayed, D (corresponding author), Rutgers New Jersey Med Sch, Cardiovasc Res Inst, Dept Cell Biol & Mol Med, Newark, NJ 07103 USA.	sayeddh@njms.rutgers.edu			American Heart Association [12SDG8820011]; National Heart Lung Blood Institute [1R01 HL-081381-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128799, R01HL081381] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Heart Lung Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	DS was funded by 12SDG8820011, American Heart Association, http://www.heart.org/HEARTORG/. MA was funded by 1R01 HL-081381-01A1, National Heart Lung Blood Institute, http://www.nhlbi.nih.gov/.	Backs J, 2006, CIRC RES, V98, P15, DOI 10.1161/01.RES.0000197782.21444.8f; Briata P, 2013, BIOCH BIOPHYS ACTA, V22; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chang SH, 2014, CURR OPIN HEMATOL, V21, P235, DOI 10.1097/MOH.0000000000000040; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; CHIEN KR, 1991, FASEB J, V5, P3037, DOI 10.1096/fasebj.5.15.1835945; Creighton CJ, 2008, RNA, V14, P2290, DOI 10.1261/rna.1188208; CUTILLETTA AF, 1978, J MOL CELL CARDIOL, V10, P677, DOI 10.1016/0022-2828(78)90403-0; CUTILLETTA AF, 1979, TEX REP BIOL MED, V39, P95; CUTILLETTA AF, 1980, J MOL CELL CARDIOL, V12, P827, DOI 10.1016/0022-2828(80)90083-8; Elia L, 2009, CIRCULATION, V120, P2377, DOI 10.1161/CIRCULATIONAHA.109.879429; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gallouzi IE, 1998, MOL CELL BIOL, V18, P3956, DOI 10.1128/MCB.18.7.3956; Giudice J, 2014, ADV EXP MED BIOL, V825, P389, DOI 10.1007/978-1-4939-1221-6_11; Graham F L, 1991, Methods Mol Biol, V7, P109, DOI 10.1385/0-89603-178-0:109; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Ho JJD, 2014, WIRES RNA, V5, P69, DOI 10.1002/wrna.1197; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Ikeda S, 2009, MOL CELL BIOL, V29, P2193, DOI 10.1128/MCB.01222-08; Kennedy D, 1996, Biomed Pept Proteins Nucleic Acids, V2, P93; Kennedy Derek, 2001, Journal of Cellular Biochemistry, V84, P173; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; King IN, 2014, J BIOL CHEM, V289, P14263, DOI 10.1074/jbc.M114.561902; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li Q, 2010, J CELL SCI, V123, P2444, DOI 10.1242/jcs.067165; Liu Q, 2008, NUCLEIC ACIDS RES, V36, P5391, DOI 10.1093/nar/gkn522; Lypowy J, 2005, J BIOL CHEM, V280, P25717, DOI 10.1074/jbc.M414266200; Mahmoud SA, 2013, J PATHOL, V231, P147, DOI 10.1002/path.4234; Makhlouf AA, 1998, AM J PHYSIOL-HEART C, V274, pH2133, DOI 10.1152/ajpheart.1998.274.6.H2133; Martin S, 2013, J NEUROCHEM, V4, P12189; Matsuki H, 2013, GENES CELLS, V18, P135, DOI 10.1111/gtc.12023; MEERSON FZ, 1974, BASIC RES CARDIOL, V69, P484, DOI 10.1007/BF01906981; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Ortega AD, 2010, J CELL SCI, V123, P2685, DOI 10.1242/jcs.065920; Parker F, 1996, MOL CELL BIOL, V16, P2561; Pikkarainen S, 2004, CARDIOVASC RES, V63, P196, DOI 10.1016/j.cardiores.2004.03.025; Rao PK, 2009, CIRC RES, V105, P585, DOI 10.1161/CIRCRESAHA.109.200451; Rau F, 2011, NAT STRUCT MOL BIOL, V18, P840, DOI 10.1038/nsmb.2067; Sayed D, 2008, MOL BIOL CELL, V19, P3272, DOI 10.1091/mbc.E08-02-0159; Sayed D, 2007, CIRC RES, V100, P416, DOI 10.1161/01.RES.0000257913.42552.23; Sayed D, 2015, CIRC-HEART FAIL, V8, P138, DOI 10.1161/CIRCHEARTFAILURE.114.001660; Sayed D, 2013, J BIOL CHEM, V288, P2546, DOI 10.1074/jbc.M112.429449; Sayed D, 2011, PHYSIOL REV, V91, P827, DOI 10.1152/physrev.00006.2010; SCHEPER GC, 1992, J BIOL CHEM, V267, P7269; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sonenberg N, 1998, CURR OPIN CELL BIOL, V10, P268, DOI 10.1016/S0955-0674(98)80150-6; Tatsuguchi M, 2007, J MOL CELL CARDIOL, V42, P1137, DOI 10.1016/j.yjmcc.2007.04.004; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tourriere H, 2001, MOL CELL BIOL, V21, P7747, DOI 10.1128/MCB.21.22.7747-7760.2001; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Wada H, 1996, J BIOL CHEM, V271, P8359, DOI 10.1074/jbc.271.14.8359; Winslow S, 2013, MOL CANCER, V12, P1476; Yoon JH, 2013, J MOL BIOL, V425, P3723, DOI 10.1016/j.jmb.2012.11.024; Zekri L, 2005, MOL CELL BIOL, V25, P8703, DOI 10.1128/MCB.25.19.8703-8716.2005	60	19	24	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145112	10.1371/journal.pone.0145112	http://dx.doi.org/10.1371/journal.pone.0145112			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675618	Green Published, gold, Green Submitted			2022-12-26	WOS:000366722700100
J	Santulli-Marotto, S; Gervais, A; Fisher, J; Strake, B; Ogden, CA; Riveley, C; Giles-Komar, J				Santulli-Marotto, Sandra; Gervais, Alexis; Fisher, Jamie; Strake, Brandy; Ogden, Carol Anne; Riveley, Chelsea; Giles-Komar, Jill			Discovering Molecules That Regulate Efferocytosis Using Primary Human Macrophages and High Content Imaging	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; RECEPTOR TYROSINE KINASES; APOPTOTIC CELL CLEARANCE; ALPHA SIRP-ALPHA; IMPAIRED CLEARANCE; IN-VITRO; FC-GAMMA; PHAGOCYTOSIS; ACTIVATION; INFLAMMATION	Defective clearance of apoptotic cells can result in sustained inflammation and subsequent autoimmunity. Macrophages, the "professional phagocyte" of the body, are responsible for efficient, non-phlogistic, apoptotic cell clearance. Controlling phagocytosis of apoptotic cells by macrophages is an attractive therapeutic opportunity to ameliorate inflammation. Using high content imaging, we have developed a system for evaluating the effects of antibody treatment on apoptotic cell uptake in primary human macrophages by comparing the Phagocytic Index (PI) for each antibody. Herein we demonstrate the feasibility of evaluating a panel of antibodies of unknown specificities obtained by immunization of mice with primary human macrophages and show that they can be distinguished based on individual PI measurements. In this study similar to 50% of antibodies obtained enhance phagocytosis of apoptotic cells while approximately 5% of the antibodies in the panel exhibit some inhibition. Though the specificities of the majority of antibodies are unknown, two of the antibodies that improved apoptotic cell uptake recognize recombinant MerTK; a receptor known to function in this capacity in vivo. The agonistic impact of these antibodies on efferocytosis could be demonstrated without addition of either of the MerTK ligands, Gas6 or ProS. These results validate applying the mechanism of this fundamental biological process as a means for identification of modulators that could potentially serve as therapeutics. This strategy for interrogating macrophages to discover molecules regulating apoptotic cell uptake is not limited by access to purified protein thereby increasing the possibility of finding novel apoptotic cell uptake pathways.	[Santulli-Marotto, Sandra; Gervais, Alexis; Fisher, Jamie; Strake, Brandy; Ogden, Carol Anne; Giles-Komar, Jill] Janssen Res & Dev LLC, Spring House, PA 19477 USA; [Riveley, Chelsea] FlowMetric Inc, Doylestown, PA 18902 USA	Johnson & Johnson; Johnson & Johnson USA; Janssen Biotech Inc	Santulli-Marotto, S (corresponding author), Janssen Res & Dev LLC, 1400 Welsh & McKean Rds, Spring House, PA 19477 USA.	ssantull@its.jnj.com						A-Gonzalez N, 2009, IMMUNITY, V31, P245, DOI 10.1016/j.immuni.2009.06.018; Barclay AN, 2014, ANNU REV IMMUNOL, V32, P25, DOI 10.1146/annurev-immunol-032713-120142; Baumann I, 2002, ARTHRITIS RHEUM-US, V46, P191, DOI 10.1002/1529-0131(200201)46:1<191::AID-ART10027>3.0.CO;2-K; Blazar BR, 2001, J EXP MED, V194, P541, DOI 10.1084/jem.194.4.541; Bottcher A, 2006, ARTHRITIS RHEUM-US, V54, P927, DOI 10.1002/art.21660; Cocco RE, 2001, MOL BIOL CELL, V12, P919, DOI 10.1091/mbc.12.4.919; Cohen HB, 2013, J LEUKOCYTE BIOL, V94, P913, DOI 10.1189/jlb.0413236; Cook RS, 2013, J CLIN INVEST, V123, P3231, DOI 10.1172/JCI67655; Cvetanovic M, 2004, J IMMUNOL, V172, P880, DOI 10.4049/jimmunol.172.2.880; DESTGROTH SF, 1980, J IMMUNOL METHODS, V35, P1, DOI 10.1016/0022-1759(80)90146-5; Dialynas DP, 1997, IMMUNOLOGY, V90, P470, DOI 10.1046/j.1365-2567.1997.00185.x; Dialynas DP, 1997, CELL IMMUNOL, V177, P182, DOI 10.1006/cimm.1997.1112; Erwig LP, 2008, CELL DEATH DIFFER, V15, P243, DOI 10.1038/sj.cdd.4402184; Fadok VA, 1998, J CLIN INVEST, V101, P890, DOI 10.1172/JCI1112; Fadok VA, 2001, J IMMUNOL, V166, P6847, DOI 10.4049/jimmunol.166.11.6847; Gaipl US, 2007, J AUTOIMMUN, V28, P114, DOI 10.1016/j.jaut.2007.02.005; Gaipl US, 2005, AUTOIMMUN REV, V4, P189, DOI 10.1016/j.autrev.2004.10.007; Gardai SJ, 2006, J LEUKOCYTE BIOL, V79, P896, DOI 10.1189/jlb.1005550; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; Graham DK, 2006, CLIN CANCER RES, V12, P2662, DOI 10.1158/1078-0432.CCR-05-2208; Graham DK, 2014, NAT REV CANCER, V14, P769, DOI 10.1038/nrc3847; Hanayama R, 2002, NATURE, V417, P182, DOI 10.1038/417182a; Hanayama R, 2004, SCIENCE, V304, P1147, DOI 10.1126/science.1094359; HARRIS P, 1985, J LEUKOCYTE BIOL, V37, P407, DOI 10.1002/jlb.37.4.407; Hart SP, 1997, J IMMUNOL, V159, P919; Herrmann M, 1998, ARTHRITIS RHEUM-US, V41, P1241, DOI 10.1002/1529-0131(199807)41:7<1241::AID-ART15>3.0.CO;2-H; Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992; Huynh MLN, 2002, J CLIN INVEST, V109, P41, DOI 10.1172/JCI200211638; Jaguin M, 2013, CELL IMMUNOL, V281, P51, DOI 10.1016/j.cellimm.2013.01.010; Nguyen KQ, 2013, AUTOIMMUNITY, V46, P294, DOI 10.3109/08916934.2013.794515; Khanna S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009539; Kim S, 2005, CELL CYCLE, V4, P231; Korns D, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00057; Krysko O, 2010, APOPTOSIS, V15, P1137, DOI 10.1007/s10495-010-0504-x; Lu QX, 2001, SCIENCE, V293, P306, DOI 10.1126/science.1061663; Mantovani A, 2014, CURR OPIN PHARMACOL, V17, P38, DOI 10.1016/j.coph.2014.07.004; McCubbrey AL, 2012, J IMMUNOL, V189, P112, DOI 10.4049/jimmunol.1200984; McGrath MS, 1999, PATHOBIOLOGY, V67, P277, DOI 10.1159/000028079; Mikolajczyk TP, 2009, IMMUNOLOGY, V128, P103, DOI 10.1111/j.1365-2567.2009.03087.x; Miksa M, 2009, J IMMUNOL METHODS, V342, P71, DOI 10.1016/j.jim.2008.11.019; Mor Gil, 2003, Reprod Biol Endocrinol, V1, P119, DOI 10.1186/1477-7827-1-119; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Munoz LE, 2005, RHEUMATOLOGY, V44, P1101, DOI 10.1093/rheumatology/keh693; Munoz LE, 2010, AUTOIMMUN REV, V10, P38, DOI 10.1016/j.autrev.2010.08.015; Munoz LE, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00139; Nagata S, 2010, CELL, V140, P619, DOI 10.1016/j.cell.2010.02.014; Oldenborg PA, 2001, J EXP MED, V193, P855, DOI 10.1084/jem.193.7.855; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Park D, 2007, NATURE, V450, P430, DOI 10.1038/nature06329; Poon IKH, 2014, NAT REV IMMUNOL, V14, P166, DOI 10.1038/nri3607; Porcheray F, 2005, CLIN EXP IMMUNOL, V142, P481, DOI 10.1111/j.1365-2249.2005.02934.x; Pradhan D, 1997, MOL BIOL CELL, V8, P767, DOI 10.1091/mbc.8.5.767; Reddy SM, 2002, J IMMUNOL, V169, P702, DOI 10.4049/jimmunol.169.2.702; Rey-Giraud F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042656; Richens TR, 2009, AM J RESP CRIT CARE, V179, P1011, DOI 10.1164/rccm.200807-1148OC; Rycyzyn MA, 2008, HYBRIDOMA, V27, P25, DOI 10.1089/hyb.2007.0537; Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592; Scarlett JL, 2000, FEBS LETT, V475, P267, DOI 10.1016/S0014-5793(00)01681-1; Scott RS, 2001, NATURE, V411, P207, DOI 10.1038/35075603; Shao WH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3206; Sheriff A, 2004, RHEUM DIS CLIN N AM, V30, P505, DOI 10.1016/j.rdc.2004.04.006; Stanford JC, 2014, J CLIN INVEST, V124, P4737, DOI 10.1172/JCI76375; Stepczynska A, 2001, ONCOGENE, V20, P1193, DOI 10.1038/sj.onc.1204221; Tominaga T, 1998, TOHOKU J EXP MED, V186, P99, DOI 10.1620/tjem.186.99; TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208; van den Brand BT, 2013, ARTHRITIS RHEUM-US, V65, P671, DOI 10.1002/art.37786; van der Goes A, 2000, J LEUKOCYTE BIOL, V67, P801, DOI 10.1002/jlb.67.6.801; Vandivier RW, 2006, CHEST, V129, P1673, DOI 10.1378/chest.129.6.1673; Vandivier RW, 2002, CHEST, V121, p89S, DOI 10.1378/chest.121.3_suppl.89S; Voll RE, 1997, NATURE, V390, P350, DOI 10.1038/37022; Xu W, 2006, BLOOD, V107, P4930, DOI 10.1182/blood-2005-10-4144; Zagorska A, 2014, NAT IMMUNOL, V15, P920, DOI 10.1038/ni.2986; Zizzo G, 2012, J IMMUNOL, V189, P3508, DOI 10.4049/jimmunol.1200662	73	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145078	10.1371/journal.pone.0145078	http://dx.doi.org/10.1371/journal.pone.0145078			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674639	gold, Green Published, Green Submitted			2022-12-26	WOS:000366722700094
J	Shaughnessy, RG; Farrell, D; Riepema, K; Bakker, D; Gordon, SV				Shaughnessy, Ronan G.; Farrell, Damien; Riepema, Karel; Bakker, Douwe; Gordon, Stephen V.			Analysis of Biobanked Serum from a Mycobacterium avium subsp paratuberculosis Bovine Infection Model Confirms the Remarkable Stability of Circulating miRNA Profiles and Defines a Bovine Serum miRNA Repertoire	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; LIPID-METABOLISM; WHOLE-BLOOD; SMALL RNA; EXPRESSION; MICRORNA; BIOMARKERS; DIAGNOSIS; CANCER; DISEASES	Johne's Disease (JD) is a chronic enteritis of ruminants caused by Mycobacterium avium subspecies paratuberculosis (MAP). Current disease control strategies are hampered by the lack of sensitive and specific diagnostic modalities. Therefore, novel diagnostic and prognostic tools are needed, and circulating microRNAs (miRNAs) may hold potential in this area. The aims of this study were twofold: (i) to address the stability of miRNA in bovine sera from biobanked samples, and (ii) to assess the potential of miRNAs as biomarkers for JD disease progression. To address these aims we used bovine sera from an experimental MAP infection model that had been stored at -20 degrees C for over a decade, allowing us to also assess the stability of miRNA profiles in biobanked serum samples through comparison with fresh sera. Approximately 100-200 intact miRNAs were identified in each sample with 83 of these being consistently detected across all 57 samples. The miRNA profile of the biobanked sera stored at -20 degrees C for over 10 years was highly similar to the profile of < 1 year-old sera stored at -80 degrees C, with an overlap of 73 shared miRNAs. IsomiR analysis also indicated a distinct bovine serum-specific isomiR profile as compared to previously reported bovine macrophage miRNA profiles. To explore the prognostic potential of miRNA profiles cattle defined as seropositive for anti-MAP antibodies (n = 5) were compared against seronegative cattle (n = 7). No significant differential expressed miRNAs were detected at either the early (6 months) or late (43, 46 and 49 months) intervals (FDR <= 0.05, fold-change >= 1.5) across seropositive or seronegative animals. However, comparing pre-infection sera to the early and late time-points identified increased miR-29a and miR-92b abundance (2-fold) that may be due to blood-cell population changes over time (P<0.001). In conclusion our study has demonstrated that bovine circulating miRNAs retain their integrity under long-term sub-optimal storage temperatures opening the way for increased miRNA analyses from biobanked samples for a range of infectious and non-infectious diseases.	[Shaughnessy, Ronan G.; Farrell, Damien; Gordon, Stephen V.] Univ Coll Dublin, UCD Sch Vet Med, Dublin 4, Ireland; [Riepema, Karel] Wageningen Univ, Dept Bacteriol, NL-8200 AB Lelystad, Netherlands; [Riepema, Karel] Wageningen Univ, TSEs, Cent Vet Inst, NL-8200 AB Lelystad, Netherlands; [Gordon, Stephen V.] Univ Coll Dublin, UCD Sch Med, Dublin 4, Ireland; [Gordon, Stephen V.] Univ Coll Dublin, UCD Sch Biomol & Biomed Sci, Dublin 4, Ireland; [Gordon, Stephen V.] Univ Coll Dublin, UCD Conway Inst Biomol & Biomed Sci, Dublin 4, Ireland	University College Dublin; Wageningen University & Research; Wageningen University & Research; University College Dublin; University College Dublin; University College Dublin	Gordon, SV (corresponding author), Univ Coll Dublin, UCD Sch Vet Med, Dublin 4, Ireland.	stephen.gordon@ucd.ie		Farrell, Damien/0000-0003-3020-7945; Gordon, Stephen/0000-0002-4833-5542; Shaughnessy, Ronan/0000-0002-9164-3583	Irish Department of Agriculture Food and the Marine [RSF11/S/141, ERA_NET 11/RD/EMIDA/1]; Irish Research Council Postdoctoral Fellowship [GOIPD/2015/475]; Dutch Department of Economic Affairs	Irish Department of Agriculture Food and the Marine; Irish Research Council Postdoctoral Fellowship(Irish Research Council for Science, Engineering and Technology); Dutch Department of Economic Affairs	This work was supported by the Irish Department of Agriculture Food and the Marine grants RSF11/S/141 (ICONMAP) and ERA_NET 11/RD/EMIDA/1 (MycobactDiagnosis). DF is funded by an Irish Research Council Postdoctoral Fellowship (GOIPD/2015/475). The cattle infections were funded by the Dutch Department of Agriculture, Nature and Fisheries, currently known as the Dutch Department of Economic Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Irish Department of Agriculture Food and the Marine grants RSF11/S/141 (ICONMAP) and ERA_NET 11/RD/EMIDA/1 (MycobactDiagnosis). DF is funded by an Irish Research Council Postdoctoral Fellowship (GOIPD/2015/475). The cattle infections were funded by the Dutch Department of Agriculture, Nature and Fisheries, currently known as the Dutch Department of Economic Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We thank Dr Jim O'Mahony (Cork Institute of Technology, Ireland) for the gift of M. avium subspecies paratuberculosis CIT003, Dr John Browne (UCD) for advice on RNA-seq library preparation and Dr Kevin Carr (Michigan State University, USA) for advice on small RNA sequencing.	Abd-El-Fattah AA, 2013, CELL BIOCHEM BIOPHYS, V67, P875, DOI 10.1007/s12013-013-9575-y; Afum-Adjei Awuah A, 2014, INT IMMUNOLOGY; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Burgos K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094839; Chan YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058169; Chase CCL, 2008, VET CLIN N AM-FOOD A, V24, P87, DOI 10.1016/j.cvfa.2007.11.001; Chen JD, 2014, PEDIATR RES, V75, P595, DOI 10.1038/pr.2014.18; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng HH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064795; Chevillet JR, 2014, P NATL ACAD SCI USA, V111, P14888, DOI 10.1073/pnas.1408301111; Coussens Paul M., 2001, Animal Health Research Reviews, V2, P141; Creemers EE, 2012, CIRC RES, V110, P483, DOI 10.1161/CIRCRESAHA.111.247452; David J, 2014, VET RES, V45, DOI 10.1186/s13567-014-0096-5; David J, 2014, VET IMMUNOL IMMUNOP, V160, P107, DOI 10.1016/j.vetimm.2014.04.006; De Guire V, 2013, CLIN BIOCHEM, V46, P846, DOI 10.1016/j.clinbiochem.2013.03.015; Dhahbi JM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-298; Duttagupta R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020769; Farrell D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134310; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Fu YR, 2011, J CLIN MICROBIOL, V49, P4246, DOI 10.1128/JCM.05459-11; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Ge QY, 2014, MOLECULES, V19, P1568, DOI 10.3390/molecules19021568; Guo L, 2014, GENE, V544, P1, DOI 10.1016/j.gene.2014.04.039; Guo L, 2012, MOL BIOL REP, V39, P6699, DOI 10.1007/s11033-012-1493-3; Hackenberg M, 2011, NUCLEIC ACIDS RES, V39, pW132, DOI 10.1093/nar/gkr247; Herthnek D, 2006, J APPL MICROBIOL, V100, P1095, DOI 10.1111/j.1365-2672.2006.02924.x; Hines ME, 2007, VET MICROBIOL, V122, P197, DOI 10.1016/j.vetmic.2007.03.009; JORGENSEN JB, 1982, ACTA VET SCAND, V23, P325; Jutila Mark A., 2008, Animal Health Research Reviews, V9, P47, DOI 10.1017/S1466252307001363; Katoh T, 2009, GENE DEV, V23, P433, DOI 10.1101/gad.1761509; Kim SJ, 2007, CLIN CHEM, V53, P1038, DOI 10.1373/clinchem.2006.078436; Leinonen R, 2011, NUCLEIC ACIDS RES, V39, pD19, DOI 10.1093/nar/gkq1019; Llorens F, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-104; Loher P, 2014, ONCOTARGET, V5, P8790, DOI 10.18632/oncotarget.2405; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; McGahon MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065809; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Muskens J, 2000, VET MICROBIOL, V77, P253, DOI 10.1016/S0378-1135(00)00310-2; Neilsen CT, 2012, TRENDS GENET, V28, P544, DOI 10.1016/j.tig.2012.07.005; Noren Hooten N, 2013, AGING-US, V5, P725, DOI 10.18632/aging.100603; Olsen I, 2002, VET QUART, V24, P12, DOI 10.1080/01652176.2002.9695120; Pritchard CC, 2012, NAT REV GENET, V13, P358, DOI 10.1038/nrg3198; Qi YH, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-384; REDDI KK, 1976, P NATL ACAD SCI USA, V73, P2308, DOI 10.1073/pnas.73.7.2308; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Russo F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047786; Sharbati J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020258; Shin MK, 2015, J MICROBIOL BIOTECHN, V25, P255, DOI 10.4014/jmb.1408.08059; Siddle KJ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005064; Starega-Roslan J, 2011, NUCLEIC ACIDS RES, V39, P257, DOI 10.1093/nar/gkq727; Thirunavukkarasu S, 2014, VET IMMUNOL IMMUNOP, V160, P147, DOI 10.1016/j.vetimm.2014.04.002; Tiberio P, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/731479; Timms VJ, 2011, J MICROBIOL METH, V85, P1, DOI 10.1016/j.mimet.2011.01.026; Turchinovich A, 2012, TRENDS BIOCHEM SCI, V37, P460, DOI 10.1016/j.tibs.2012.08.003; Vegh P, 2013, VET IMMUNOL IMMUNOP, V155, P238, DOI 10.1016/j.vetimm.2013.08.004; Williams Z, 2013, P NATL ACAD SCI USA, V110, P4255, DOI 10.1073/pnas.1214046110; Wyman SK, 2011, GENOME RES, V21, P1450, DOI 10.1101/gr.118059.110; Zhang HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088909; Zhang J, 2015, GENOM PROTEOM BIOINF, V13, P17, DOI 10.1016/j.gpb.2015.02.001; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081076	60	24	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145089	10.1371/journal.pone.0145089	http://dx.doi.org/10.1371/journal.pone.0145089			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675426	Green Published, gold, Green Submitted			2022-12-26	WOS:000366722700099
J	Arcanjo, DDR; Vasconcelos, AG; Comerma-Steffensen, SG; Jesus, JR; Silva, LP; Pires, OR; Costa-Neto, CM; Oliveira, EB; Migliolo, L; Franco, OL; Restini, CBA; Paulo, M; Bendhack, LM; Bemquerer, MP; Oliveira, AP; Simonsen, U; Leite, JRDD				Rufino Arcanjo, Daniel Dias; Vasconcelos, Andreanne Gomes; Comerma-Steffensen, Simon Gabriel; Jesus, Joilson Ramos; Silva, Luciano Paulino; Pires Junior, Osmindo Rodrigues; Costa-Neto, Claudio Miguel; Oliveira, Eduardo Brandt; Migliolo, Ludovico; Franco, Octavio Luiz; Araujo Restini, Carolina Baraldi; Paulo, Michele; Bendhack, Lusiane Maria; Bemquerer, Marcelo Porto; Oliveira, Aldeidia Pereira; Simonsen, Ulf; de Souza de Almeida Leite, Jose Roberto			A Novel Vasoactive Proline-Rich Oligopeptide from the Skin Secretion of the Frog Brachycephalus ephippium	PLOS ONE			English	Article							BRADYKININ-POTENTIATING PEPTIDES; ANGIOTENSIN-CONVERTING-ENZYME; ATLANTIC RAIN-FOREST; NITRIC-OXIDE; BOTHROPS-JARARACA; NATRIURETIC PEPTIDE; MASS-SPECTROMETRY; RELAXING FACTOR; SCORPION-VENOM; SMOOTH-MUSCLE	Proline-rich oligopeptides (PROs) are a large family which comprises the bradykinin-potentiating peptides (BPPs). They inhibit the activity of the angiotensin I-converting enzyme (ACE) and have a typical pyroglutamyl (Pyr)/proline-rich structure at the N- and C-terminus, respectively. Furthermore, PROs decrease blood pressure in animals. In the present study, the isolation and biological characterization of a novel vasoactive BPP isolated from the skin secretion of the frog Brachycephalus ephippium is described. This new PRO, termed BPP-Brachy, has the primary structure WPPPKVSP and the amidated form termed BPP-BrachyNH(2) inhibits efficiently ACE in rat serum. In silico molecular modeling and docking studies suggest that BPP-BrachyNH(2) is capable of forming a hydrogen bond network as well as multiple van der Waals interactions with the rat ACE, which blocks the access of the substrate to the C-domain active site. Moreover, in rat thoracic aorta BPP-BrachyNH(2) induces potent endothelium-dependent vasodilatation with similar magnitude as captopril. In DAF-FM DA-loaded aortic cross sections examined by confocal microscopy, BPP-BrachyNH(2) was found to increase the release of nitric oxide (NO). Moreover, BPP-BrachyNH(2) was devoid of toxicity in endothelial and smooth muscle cell cultures. In conclusion, the peptide BPP-BrachyNH(2) has a novel sequence being the first BPP isolated from the skin secretion of the Brachycephalidae family. This opens for exploring amphibians as a source of new biomolecules. The BPP-BrachyNH(2) is devoid of cytotoxicity and elicits endothelium-dependent vasodilatation mediated by NO. These findings open for the possibility of potential application of these peptides in the treatment of endothelial dysfunction and cardiovascular diseases.	[Rufino Arcanjo, Daniel Dias; Vasconcelos, Andreanne Gomes; Jesus, Joilson Ramos; de Souza de Almeida Leite, Jose Roberto] Univ Fed Piaui UFPI, Nucleo Pesquisa Biodiversidade & Biotecnol BIOTEC, Parnaiba, PI, Brazil; [Rufino Arcanjo, Daniel Dias; Oliveira, Aldeidia Pereira] Univ Fed Piaui UFPI, NPPM, LFC, Teresina, PI, Brazil; [Comerma-Steffensen, Simon Gabriel; Simonsen, Ulf] Aarhus Univ, Dept Biomed, Pulm & Cardiovasc Pharmacol, Aarhus, Denmark; [Silva, Luciano Paulino; Bemquerer, Marcelo Porto] EMBRAPA Recursos Genet & Biotecnol, Lab Espectrometria Massa, Brasilia, DF, Brazil; [Pires Junior, Osmindo Rodrigues] Univ Brasilia UnB, ICB, Lab Toxinol, Brasilia, DF, Brazil; [Costa-Neto, Claudio Miguel; Oliveira, Eduardo Brandt] Univ Sao Paulo, FMRP, Dept Bioquim & Imunol, BR-14049 Ribeirao Preto, SP, Brazil; [Migliolo, Ludovico; Franco, Octavio Luiz] Univ Catolica Brasilia, CAPB, Brasilia, DF, Brazil; [Araujo Restini, Carolina Baraldi] Univ Ribeirao Preto UNAERP, Curso Med, Ribeirao Preto, SP, Brazil; [Paulo, Michele; Bendhack, Lusiane Maria] Univ Sao Paulo, FCFRP, Dept Fis & Quim, BR-14049 Ribeirao Preto, SP, Brazil	Universidade Federal do Piaui; Universidade Federal do Piaui; Aarhus University; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade de Brasilia; Universidade de Sao Paulo; Universidade Catolica de Brasilia; Universidade de Ribeirao Preto; Universidade de Sao Paulo	Leite, JRDD (corresponding author), Univ Fed Piaui UFPI, Nucleo Pesquisa Biodiversidade & Biotecnol BIOTEC, Campus Minist Reis Velloso CMRV, Parnaiba, PI, Brazil.	jrsaleite@gmail.com	Franco, Octavio L/T-3020-2017; Comerma-Steffensen, Simon Gabriel/H-9631-2019; MIGLIOLO, LUDOVICO/AAV-6913-2021; Bemquerer, Marcelo Porto/A-9688-2013; Arcanjo, Daniel Dias Rufino/D-8851-2012; Silva, Luciano Paulino/G-4915-2012; Pires, O.r./ABC-8410-2020; Costa-Neto, Claudio/K-7291-2015; Rodrigues Pires Junior, Osmindo/Q-8384-2016	Comerma-Steffensen, Simon Gabriel/0000-0001-6516-694X; MIGLIOLO, LUDOVICO/0000-0002-6606-2189; Bemquerer, Marcelo Porto/0000-0002-9740-5818; Arcanjo, Daniel Dias Rufino/0000-0001-7021-2744; Silva, Luciano Paulino/0000-0001-9075-7725; Franco, Octavio/0000-0001-9546-0525; Oliveira, Aldeidia/0000-0003-3286-4295; Costa-Neto, Claudio/0000-0002-7256-6412; Gomes Vasconcelos, Andreanne/0000-0002-9651-1598; Rodrigues Pires Junior, Osmindo/0000-0002-9875-9407	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [552676/2011-0]; Fundacao de Amparo a Pesquisa do Piaui (FAPEPI); CAPES Foundation (Bolsista CAPES-PDSE) [BEX 2883/15-5]; CDCH-UCV; Aarhus University	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Piaui (FAPEPI); CAPES Foundation (Bolsista CAPES-PDSE)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CDCH-UCV; Aarhus University	The authors would like to thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, 552676/2011-0 process number), Fundacao de Amparo a Pesquisa do Piaui (FAPEPI, payment of scholarships to students) for the financial support and Genetic Resources and Biotechnology (EMBRAPA) for the facilities, structure mass spectrometry and peptide synthesis. Daniel D. R. Arcanjo acknowledges the CAPES Foundation (Bolsista CAPES-PDSE - Processo no BEX 2883/15-5) for the financial support. S. Comerma-Steffensen acknowledges the CDCH-UCV and the Aarhus University for their support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to FMRP-USP (Faculdade de Medicina de Ribeirao Preto, Universidade de Sao Paulo, Brazil) for the facility of laser confocal microscopy, and to LEM (Laboratorio de Espectrometria de Massa) at EMBRAPA Genetic Resources and Biotechnology for the facilities, structure mass spectrometry and peptide synthesis. Daniel D. R. Arcanjo acknowledges the CAPES Foundation (Bolsista CAPES-PDSE-Processo no BEX 2883/15-5) for the financial support. S. Comerma-Steffensen acknowledges the CDCH-UCV and the Aarhus University for their support. There is no conflict of interest.	Akif M, 2011, FEBS J, V278, P3644, DOI 10.1111/j.1742-4658.2011.08276.x; ARAUJO RL, 1976, GEN PHARMACOL, V7, P123, DOI 10.1016/0306-3623(76)90047-1; BAGNARA JT, 1979, SCIENCE, V203, P410, DOI 10.1126/science.760198; Biedermannova L, 2008, PHYS CHEM CHEM PHYS, V10, P6350, DOI 10.1039/b805087b; Camargo ACM, 2012, TOXICON, V59, P516, DOI 10.1016/j.toxicon.2011.07.013; Capellini VK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062887; Conceicao K, 2007, PEPTIDES, V28, P515, DOI 10.1016/j.peptides.2006.10.002; Conlon JM, 1999, REGUL PEPTIDES, V79, P71, DOI 10.1016/S0167-0115(98)00160-8; Coutinho-Neto A, 2013, TOXINS, V5, P327, DOI 10.3390/toxins5020327; Cushman DW, 1999, NAT MED, V5, P1110, DOI 10.1038/13423; Dourado FS, 2007, TOXICON, V50, P572, DOI 10.1016/j.toxicon.2007.04.027; Ferreira LAF, 1996, TOXICON, V34, P599, DOI 10.1016/0041-0101(96)00010-4; Ferreira LAF, 1998, J PROTEIN CHEM, V17, P285, DOI 10.1023/A:1022545020764; FERREIRA SH, 1970, BIOCHEMISTRY-US, V9, P2583, DOI 10.1021/bi00815a005; FERREIRA SH, 1965, BRIT J PHARM CHEMOTH, V24, P163, DOI 10.1111/j.1476-5381.1965.tb02091.x; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; GAVRAS H, 1974, NEW ENGL J MED, V291, P817, DOI 10.1056/NEJM197410172911603; GAVRAS H, 1978, NEW ENGL J MED, V298, P991, DOI 10.1056/NEJM197805042981803; Gomes CL, 2007, BIOCHEM PHARMACOL, V74, P1350, DOI 10.1016/j.bcp.2007.07.014; Guerreiro JR, 2009, J BIOL CHEM, V284, P20022, DOI 10.1074/jbc.M109.021089; Hayashi MAF, 2003, J NEUROCHEM, V85, P969, DOI 10.1046/j.1471-4159.2003.01743.x; Ianzer D, 2004, PEPTIDES, V25, P1085, DOI 10.1016/j.peptides.2004.04.006; Ianzer D, 2007, J PHARMACOL EXP THER, V322, P795, DOI 10.1124/jpet.107.120873; Ianzer Danielle, 2011, Ther Adv Cardiovasc Dis, V5, P281, DOI 10.1177/1753944711427318; IGNARRO LJ, 1988, J PHARMACOL EXP THER, V244, P181; Jitonnom J, 2012, J MOL GRAPH MODEL, V38, P298, DOI 10.1016/j.jmgm.2012.09.002; KATO H, 1971, BIOCHEMISTRY-US, V10, P972, DOI 10.1021/bi00782a007; Kojima H, 1998, CHEM PHARM BULL, V46, P373; Lameu C, 2013, INTEGRATED VIEW MOL, P119, DOI [10.5772/3429, DOI 10.5772/3429]; Leite JRSA, 2005, PEPTIDES, V26, P565, DOI 10.1016/j.peptides.2004.11.002; Lewis RJ, 2003, NAT REV DRUG DISCOV, V2, P790, DOI 10.1038/nrd1197; Machado RJA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063571; Masuyer G, 2012, SCI REP-UK, V2, DOI 10.1038/srep00717; MEKI ARMA, 1995, PEPTIDES, V16, P1359, DOI 10.1016/0196-9781(95)02036-5; Menin L, 2008, TOXICON, V51, P1288, DOI 10.1016/j.toxicon.2008.02.019; Morais KLP, 2011, BIOCHEM PHARMACOL, V81, P736, DOI 10.1016/j.bcp.2010.12.016; Morais KLP, 2013, PEPTIDES, V48, P124, DOI 10.1016/j.peptides.2013.07.016; Murayama N, 1997, P NATL ACAD SCI USA, V94, P1189, DOI 10.1073/pnas.94.4.1189; Nagano T, 2002, CHEM REV, V102, P1235, DOI 10.1021/cr010152s; ONDETTI MA, 1971, BIOCHEMISTRY-US, V10, P4033, DOI 10.1021/bi00798a004; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; Paulo M, 2012, EUR J PHARM SCI, V45, P344, DOI 10.1016/j.ejps.2011.12.002; Petriz BD, 2013, CURR PROTEIN PEPT SC, V14, P459, DOI 10.2174/13892037113149990063; Pie MR, 2013, ECOL MODEL, V250, P165, DOI 10.1016/j.ecolmodel.2012.10.019; Pires OR, 2005, TOXICON, V45, P73, DOI 10.1016/j.toxicon.2004.09.016; Pires OR, 2003, TOXICON, V42, P563, DOI 10.1016/S0041-0101(03)00235-6; Pires OR, 2002, TOXICON, V40, P761, DOI 10.1016/S0041-0101(01)00279-3; Pombal JP, 1998, J HERPETOL, V32, P70, DOI 10.2307/1565481; REES DD, 1990, BRIT J PHARMACOL, V101, P746, DOI 10.1111/j.1476-5381.1990.tb14151.x; Rioli V, 2008, FEBS J, V275, P2442, DOI 10.1111/j.1742-4658.2008.06389.x; SANTOS RAS, 1985, HYPERTENSION, V7, P244, DOI 10.1161/01.HYP.7.2.244; Schmaier AH, 2002, J CLIN INVEST, V109, P1007, DOI 10.1172/JCI200215490; Schonbrunn E, 2013, J MED CHEM, V56, P3768, DOI 10.1021/jm301234k; Silva-Filho JC, 2012, BASIC CLIN PHARMACOL, V110, P171, DOI 10.1111/j.1742-7843.2011.00784.x; Soares MR, 2005, TOXICON, V46, P31, DOI 10.1016/j.toxicon.2005.03.006; Verano-Braga T, 2008, BIOCHEM BIOPH RES CO, V371, P515, DOI 10.1016/j.bbrc.2008.04.104; Verano-Braga T, 2010, TOXICON, V56, P1162, DOI 10.1016/j.toxicon.2010.04.006; YANG HYT, 1972, J NEUROCHEM, V19, P2443, DOI 10.1111/j.1471-4159.1972.tb01298.x; [No title captured]	59	14	15	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0145071	10.1371/journal.pone.0145071	http://dx.doi.org/10.1371/journal.pone.0145071			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9GR	26661890	gold, Green Published, Green Submitted			2022-12-26	WOS:000366715900180
J	Smeriglio, P; Alonso-Martin, S; Masciarelli, S; Madaro, L; Iosue, I; Marrocco, V; Relaix, F; Fazi, F; Marazzi, G; Sassoon, DA; Bouche, M				Smeriglio, Piera; Alonso-Martin, Sonia; Masciarelli, Silvia; Madaro, Luca; Iosue, Ilaria; Marrocco, Valeria; Relaix, Frederic; Fazi, Francesco; Marazzi, Giovanna; Sassoon, David A.; Bouche, Marina			Phosphotyrosine phosphatase inhibitor bisperoxovanadium endows myogenic cells with enhanced muscle stem cell functions via epigenetic modulation of Sca-1 and Pw1 promoters	FASEB JOURNAL			English	Article						cell reprogramming; muscle regeneration; PW1 interstitial cells; muscle cell fate; cell stemness	SKELETAL-MUSCLE; SATELLITE CELLS; SELF-RENEWAL; PROGENITOR CELLS; REGENERATION; EXPANSION; DIFFERENTIATION; MICE; TRANSPLANTATION; PLURIPOTENCY	Understanding the regulation of the stem cell fate is fundamental for designing novel regenerative medicine strategies. Previous studies have suggested that pharmacological treatments with small molecules provide a robust and reversible regulation of the stem cell program. Previously, we showed that treatment with a vanadium compound influences muscle cell fate in vitro. In this study, we demonstrate that treatment with the phosphotyrosine phosphatase inhibitor bisperoxovanadium (BpV) drives primary muscle cells to a poised stem cell stage, with enhanced function in muscle regeneration in vivo following transplantation into injured muscles. Importantly, BpV-treated cells displayed increased self-renewal potential in vivo and replenished the niche in both satellite and interstitial cell compartments. Moreover, we found that BpV treatment induces specific activating chromatin modifications at the promoter regions of genes associated with stem cell fate, including Sca-1 and Pw1. Thus, our findings indicate that BpV resets the cell fate program by specific epigenetic regulations, such that the committed myogenic cell fate is redirected to an earlier progenitor cell fate stage, which leads to an enhanced regenerative stem cell potential.-Smeriglio, P., Alonso-Martin, S., Masciarelli, S., Madaro, L., Iosue, I., Marrocco, V., Relaix, F., Fazi, F., Marazzi, G., Sassoon, D. A., Bouche, M. Phosphotyrosine phosphatase inhibitor bisperoxovanadium endows myogenic cells with enhanced muscle stem cell functions via epigenetic modulation of Sca-1 and Pw1 promoters. FASEB J. 30, 1404-1415 (2016). www.fasebj.org	[Smeriglio, Piera; Marazzi, Giovanna; Sassoon, David A.] Univ Paris 06, Stem Cells & Regenerat Med, Inst Cardiometab & Nutr, Unite Mixte Rech Sante 1166,INSERM,Sorbonne Univ, Paris, France; [Smeriglio, Piera; Masciarelli, Silvia; Madaro, Luca; Iosue, Ilaria; Marrocco, Valeria; Fazi, Francesco; Bouche, Marina] Univ Roma La Sapienza, Dept Anat Histol Forens Med & Orthoped, Unit Histol, Piazzale Aldo Moro 5, I-00185 Rome, Italy; [Alonso-Martin, Sonia; Relaix, Frederic] Inst Mondor Rech Biomed, INSERM, U955, Creteil, France; [Alonso-Martin, Sonia; Relaix, Frederic] Univ Paris Est Creteil, Fac Med, Creteil, France; [Relaix, Frederic] Univ Paris 06, Sorbonne Univ, INSERM, Unite Mixte Rech Sante 974,CNRS,FRE3617,Ctr Res M, Paris, France; [Relaix, Frederic] Etab Francais Sang, Creteil, France; [Relaix, Frederic] Univ Paris Est, Ecole Natl Vet Alfort, Maison Alfort, France; [Smeriglio, Piera] Stanford Univ, Dept Orthoped Surg, Stanford, CA 94305 USA; [Madaro, Luca] IRCCS Fdn Santa Lucia, Dept Epigenet & Pharmacol, Rome, Italy	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Sapienza University Rome; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Ecole Nationale Veterinaire d'Alfort (ENVA); Stanford University; IRCCS Santa Lucia	Sassoon, DA (corresponding author), Univ Paris 06, Stem Cells & Regenerat Med, Inst Cardiometab & Nutr, Unite Mixte Rech Sante 1166,INSERM,Sorbonne Univ, Paris, France.; Bouche, M (corresponding author), Univ Roma La Sapienza, DAHFMO, Unit Histol, Via A Scarpa 14, I-00161 Rome, Italy.; Sassoon, DA (corresponding author), Univ Paris 06, INSERM, Sorbonne Univ, Stem Cells & Regenerat Med,ICAN,UMRS 1166, F-75634 Paris, France.	david.a.sassoon@gmail.com; marina.bouche@uniroma1.it	Smeriglio, Piera/AAK-9870-2021; Alonso-Martin, Sonia/L-2751-2019; Alonso-Martin, Sonia/F-3021-2013; Madaro, Luca/ABE-4683-2021; Madaro, Luca/K-4629-2016; Fazi, Francesco/K-5304-2018; SASSOON, David A/G-2502-2013	Alonso-Martin, Sonia/0000-0002-3254-0365; Alonso-Martin, Sonia/0000-0002-3254-0365; Madaro, Luca/0000-0003-0839-5724; Madaro, Luca/0000-0003-0839-5724; Fazi, Francesco/0000-0003-2910-7912; SASSOON, David A/0000-0001-6074-048X; MASCIARELLI, SILVIA/0000-0002-6738-6281; Relaix, Frederic/0000-0003-1270-1472; Bouche, Marina/0000-0002-0938-5360; Smeriglio, Piera/0000-0002-3430-6839; Marazzi, giovanna/0000-0002-5388-1038	French Ministry of Research "Chaired Excellence"; Muscular Dystrophy Association of America; European Community [Health-F5-2009-223098]; ENDOSTEM (Activation of Vasculature Associated Stem Cells for the Repair and Maintenance of Muscle Tissue) [241440]; Agence Nationale de la Recherche (Laboratoire d'Excellence Revive, Investissement d'Avenir) [ANR-10-LABX-73]; IHU-ICAN projects; Italian Ministry for University and Research; Sapienza University of Rome; French Association against Myopathies (AFM); Telethon Italy; Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome; Duchenne Parent Project (Amsterdam, The Netherlands)	French Ministry of Research "Chaired Excellence"; Muscular Dystrophy Association of America(Muscular Dystrophy Association); European Community(European Commission); ENDOSTEM (Activation of Vasculature Associated Stem Cells for the Repair and Maintenance of Muscle Tissue); Agence Nationale de la Recherche (Laboratoire d'Excellence Revive, Investissement d'Avenir)(French National Research Agency (ANR)); IHU-ICAN projects; Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR)); Sapienza University of Rome; French Association against Myopathies (AFM)(Association Francaise contre les Myopathies); Telethon Italy(Fondazione Telethon); Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Duchenne Parent Project (Amsterdam, The Netherlands)(Netherlands Government)	The authors thank Edgar Gomes (Myology Institute, Paris, France) for his generous gift of GFP-H1-C2cell line; Antonio Musaro (Department of Anatomy, Histology, Forensic Medicine, and Orthopedics, Sapienza University of Rome, Italy) for his guidance and input in this project; Andrew Ho (Baxter Laboratory for Stem Cell Biology, Stanford University, Stanford, CA, USA); and Biliana Lozanoska-Ochser and Mario Molinaro (Department of Anatomy, Histology, Forensic Medicine, and Orthopedics, Sapienza University of Rome, Italy) for critical reading and editing of this manuscript. The authors also thank C. Blanc and B. Hoareau (Flow Cytometry Core CyPS, Pierre and Marie Curie University, Pitie-Salpetriere Hospital, Paris, France) for their assistance and help in sorting strategies. This work was supported by the French Ministry of Research "Chaired Excellence" and the Muscular Dystrophy Association of America to D.A.S. and the European Community Seventh Framework Program projects OPTISTEM (Optimization of Stem Cell Therapy for Degenerative Epithelial and Muscle Diseases contract number Health-F5-2009-223098) and ENDOSTEM (Activation of Vasculature Associated Stem Cells for the Repair and Maintenance of Muscle Tissue-agreement number 241440). D.A.S. acknowledges support from the Agence Nationale de la Recherche (Laboratoire d'Excellence Revive, Investissement d'Avenir; ANR-10-LABX-73) and the IHU-ICAN projects. M.B. acknowledges support from the Italian Ministry for University and Research, the Sapienza University of Rome, the French Association against Myopathies (AFM), and the Telethon Italy. Piera Smeriglio was supported by a doctoral fellowship from Istituto Pasteur-Fondazione Cenci Bolognetti, Sapienza University of Rome; Luca Madaro was recipient of a postdoctoral fellowship from Duchenne Parent Project (Amsterdam, The Netherlands). The authors declare no conflicts of interest.	Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Bernet JD, 2014, NAT MED, V20, P265, DOI 10.1038/nm.3465; Besson V, 2011, P NATL ACAD SCI USA, V108, P11470, DOI 10.1073/pnas.1103873108; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; BISCHOFF R, 1994, DEV DYNAM, V201, P41, DOI 10.1002/aja.1002010105; BISCHOFF R, 1986, DEV BIOL, V115, P140, DOI 10.1016/0012-1606(86)90235-6; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Bonfanti C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7364; Cadot B, 2012, EMBO REP, V13, P741, DOI 10.1038/embor.2012.89; Castaldi L, 2007, FASEB J, V21, P3573, DOI 10.1096/fj.06-7454com; Chakkalakal JV, 2012, NATURE, V490, P355, DOI 10.1038/nature11438; Chen SB, 2007, P NATL ACAD SCI USA, V104, P10482, DOI 10.1073/pnas.0704360104; Choi MC, 2014, EMBO REP, V15, P1175, DOI 10.15252/embr.201439195; Collins CA, 2005, CELL CYCLE, V4, P1338, DOI 10.4161/cc.4.10.2114; Cosgrove BD, 2014, NAT MED, V20, P255, DOI 10.1038/nm.3464; De Carvalho DD, 2010, TRENDS CELL BIOL, V20, P609, DOI 10.1016/j.tcb.2010.08.003; Deasy BM, 2002, STEM CELLS, V20, P50, DOI 10.1634/stemcells.20-1-50; Di Agostino S, 2006, CANCER CELL, V10, P191, DOI 10.1016/j.ccr.2006.08.013; GIBSON MC, 1983, MUSCLE NERVE, V6, P574, DOI 10.1002/mus.880060807; Grounds MD, 1998, ANN NY ACAD SCI, V854, P78, DOI 10.1111/j.1749-6632.1998.tb09894.x; Gussoni E, 1997, NAT MED, V3, P970, DOI 10.1038/nm0997-970; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Kim WH, 2012, ACS CHEM BIOL, V7, P732, DOI 10.1021/cb200532v; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Liadaki K, 2012, J HISTOCHEM CYTOCHEM, V60, P31, DOI 10.1369/0022155411428991; MCGEACHIE JK, 1987, CELL TISSUE RES, V248, P125, DOI 10.1007/BF01239972; Mitchell KJ, 2010, NAT CELL BIOL, V12, P257, DOI 10.1038/ncb2025; Mitchell PO, 2005, DEV BIOL, V283, P240, DOI 10.1016/j.ydbio.2005.04.016; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Montarras D, 2000, BIOL CELL, V92, P565, DOI 10.1016/S0248-4900(00)01110-2; Motohashi N, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00001; Mu XD, 2011, AM J PATHOL, V179, P931, DOI 10.1016/j.ajpath.2011.05.004; Ono Y, 2010, DEV BIOL, V337, P29, DOI 10.1016/j.ydbio.2009.10.005; Pajcini KV, 2010, CELL STEM CELL, V7, P198, DOI 10.1016/j.stem.2010.05.022; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Paliwal P, 2011, CHEM BIOL, V18, P1153, DOI 10.1016/j.chembiol.2011.07.012; Pannerec A, 2013, DEVELOPMENT, V140, P2879, DOI 10.1242/dev.089326; Peault B, 2007, MOL THER, V15, P867, DOI 10.1038/mt.sj.6300145; Relaix F, 1996, DEV BIOL, V177, P383, DOI 10.1006/dbio.1996.0172; Rocheteau P, 2012, CELL, V148, P112, DOI 10.1016/j.cell.2011.11.049; Rosania GR, 2000, NAT BIOTECHNOL, V18, P304, DOI 10.1038/73753; ROSENBLATT JD, 1995, IN VITRO CELL DEV-AN, V31, P773; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sajko S, 2004, J HISTOCHEM CYTOCHEM, V52, P179, DOI 10.1177/002215540405200205; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schwarzkopf M, 2006, GENE DEV, V20, P3440, DOI 10.1101/gad.412606; Segales J, 2015, FEBS J, V282, P1571, DOI 10.1111/febs.13065; Serra C, 2007, MOL CELL, V28, P200, DOI 10.1016/j.molcel.2007.08.021; Sousa-Victor P, 2011, TOXICOL MECH METHOD, V21, P334, DOI 10.3109/15376516.2011.557873; Tanaka EM, 1997, J CELL BIOL, V136, P155, DOI 10.1083/jcb.136.1.155; Tierney MT, 2014, NAT MED, V20, P1182, DOI 10.1038/nm.3656; Torrente Y, 2001, J CELL BIOL, V152, P335, DOI 10.1083/jcb.152.2.335; Wu J, 2014, NATURE, V516, P172, DOI 10.1038/516172a; Xu Y, 2008, NATURE, V453, P338, DOI 10.1038/nature07042; Yoshida N, 1998, J CELL SCI, V111, P769; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Zammit PS, 2001, DIFFERENTIATION, V68, P193, DOI 10.1046/j.1432-0436.2001.680407.x; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	62	4	4	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2016	30	4					1404	1415		10.1096/fj.15-275420	http://dx.doi.org/10.1096/fj.15-275420			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DH2PR	26672000				2022-12-26	WOS:000372629100004
J	Korneeva, NL; Song, AR; Gram, H; Edens, MA; Rhoads, RE				Korneeva, Nadejda L.; Song, Anren; Gram, Hermann; Edens, Mary Ann; Rhoads, Robert E.			Inhibition of Mitogen-activated Protein Kinase (MAPK)-interacting Kinase (MNK) Preferentially Affects Translation of mRNAs Containing Both a 5-Terminal Cap and Hairpin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						eukaryotic translation initiation; eukaryotic translation initiation factor 4E (eIF4E); eukaryotic translation initiation factor 4G (eIF4G); mRNA; phosphorylation	INITIATION-FACTOR 4E; FACTOR 4G EIF4G; CELL-CYCLE PROGRESSION; ENTRY SITE; ENCEPHALOMYOCARDITIS VIRUS; DEPENDENT TRANSLATION; PHOSPHORYLATED EIF4E; SECONDARY STRUCTURE; BINDING PROTEIN; FACTOR EIF-4E	The MAPK-interacting kinases 1 and 2 (MNK1 and MNK2) are activated by extracellular signal-regulated kinases 1 and 2 (ERK1/2) or p38 in response to cellular stress and extracellular stimuli that include growth factors, cytokines, and hormones. Modulation of MNK activity affects translation of mRNAs involved in the cell cycle, cancer progression, and cell survival. However, the mechanism by which MNK selectively affects translation of these mRNAs is not understood. MNK binds eukaryotic translation initiation factor 4G (eIF4G) and phosphorylates the cap-binding protein eIF4E. Using a cell-free translation system from rabbit reticulocytes programmed with mRNAs containing different 5-ends, we show that an MNK inhibitor, CGP57380, affects translation of only those mRNAs that contain both a cap and a hairpin in the 5-UTR. Similarly, a C-terminal fragment of human eIF4G-1, eIF4G(1357-1600), which prevents binding of MNK to intact eIF4G, reduces eIF4E phosphorylation and inhibits translation of only capped and hairpin-containing mRNAs. Analysis of proteins bound to m(7)GTP-Sepharose reveals that both CGP and eIF4G(1357-1600) decrease binding of eIF4E to eIF4G. These data suggest that MNK stimulates translation only of mRNAs containing both a cap and 5-terminal RNA duplex via eIF4E phosphorylation, thereby enhancing the coupled cap-binding and RNA-unwinding activities of eIF4F.	[Korneeva, Nadejda L.; Edens, Mary Ann] Louisiana State Univ, Dept Emergency Med, Hlth Sci Ctr, Shreveport, LA 71130 USA; [Korneeva, Nadejda L.; Song, Anren; Rhoads, Robert E.] Louisiana State Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, Shreveport, LA 71130 USA; [Gram, Hermann] Novartis Inst Biomed Res, Forum 1, CH-4002 Basel, Switzerland; [Song, Anren] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Novartis; University of Texas System; University of Texas Health Science Center Houston	Korneeva, NL (corresponding author), BRI, F5-23 1501 Kings Hwy, Shreveport, LA 71130 USA.	nkorne@lsuhsc.edu			NIGMS, National Institutes of Health [2R01GM20818]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM020818] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIGMS, National Institutes of Health, Grant 2R01GM20818 (to R. E. R.). Hermann Gram is an employee and shareholder of Novartis AG. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABRAMSON RD, 1987, J BIOL CHEM, V262, P3826; Adesso L, 2013, ONCOGENE, V32, P2848, DOI 10.1038/onc.2012.306; Altman JK, 2013, BLOOD, V121, P3675, DOI 10.1182/blood-2013-01-477216; Astanehe A, 2012, ONCOGENE, V31, P4434, DOI 10.1038/onc.2011.617; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bianchini A, 2008, CARCINOGENESIS, V29, P2279, DOI 10.1093/carcin/bgn221; Bradley CA, 2002, J BIOL CHEM, V277, P12559, DOI 10.1074/jbc.M111134200; Brown MC, 2014, J VIROL, V88, P13149, DOI 10.1128/JVI.01884-14; Brown MA, 2014, CURR CLIN IMAG, P88; Buxade M, 2005, IMMUNITY, V23, P177, DOI 10.1016/j.immuni.2005.06.009; Buxade M, 2008, FRONT BIOSCI-LANDMRK, V13, P5359, DOI 10.2741/3086; Byrd MP, 2002, MOL CELL BIOL, V22, P4499, DOI 10.1128/MCB.22.13.4499-4511.2002; Carroll M, 2013, J INTERF CYTOK RES, V33, P227, DOI 10.1089/jir.2012.0142; Chen YJ, 2010, NUCLEIC ACIDS RES, V38, P764, DOI 10.1093/nar/gkp1034; Chrestensen CA, 2007, GENES CELLS, V12, P1133, DOI 10.1111/j.1365-2443.2007.01122.x; Chrestensen CA, 2007, J BIOL CHEM, V282, P4243, DOI 10.1074/jbc.M607368200; Cobbold LC, 2008, MOL CELL BIOL, V28, P40, DOI 10.1128/MCB.01298-07; Cuesta R, 2004, J VIROL, V78, P7707, DOI 10.1128/JVI.78.14.7707-7716.2004; Das F, 2013, J CELL PHYSIOL, V228, P1617, DOI 10.1002/jcp.24327; De Gregorio E, 1998, RNA, V4, P828, DOI 10.1017/S1355838298980372; Dobrikov M, 2011, MOL CELL BIOL, V31, P2947, DOI 10.1128/MCB.05589-11; Dobrikov MI, 2014, MOL CELL BIOL, V34, P439, DOI 10.1128/MCB.01046-13; Dyer J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074085; ELROYSTEIN O, 1989, P NATL ACAD SCI USA, V86, P6126, DOI 10.1073/pnas.86.16.6126; Ferrandiz-Pulido C, 2013, J UROLOGY, V190, P2288, DOI 10.1016/j.juro.2013.06.015; FLYNN A, 1995, J BIOL CHEM, V270, P21684, DOI 10.1074/jbc.270.37.21684; Flynn A, 1996, EUR J BIOCHEM, V236, P40, DOI 10.1111/j.1432-1033.1996.00040.x; Fukunaga R, 1997, EMBO J, V16, P1921, DOI 10.1093/emboj/16.8.1921; Furic L, 2010, P NATL ACAD SCI USA, V107, P14134, DOI 10.1073/pnas.1005320107; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Grudzien E, 2006, J BIOL CHEM, V281, P1857, DOI 10.1074/jbc.M509121200; Grzmil M, 2014, J CLIN INVEST, V124, P742, DOI 10.1172/JCI70198; Hinnebusch AG, 2014, ANNU REV BIOCHEM, V83, P779, DOI 10.1146/annurev-biochem-060713-035802; Imataka H, 1997, MOL CELL BIOL, V17, P6940, DOI 10.1128/MCB.17.12.6940; JACKSON RJ, 1991, EUR J BIOCHEM, V200, P285, DOI 10.1111/j.1432-1033.1991.tb16184.x; Jemielity J, 2003, RNA, V9, P1108, DOI 10.1261/rna.5430403; Jo OD, 2008, J BIOL CHEM, V283, P23274, DOI 10.1074/jbc.M801185200; JOSHI B, 1995, J BIOL CHEM, V270, P14597, DOI 10.1074/jbc.270.24.14597; Joshi Sonali, 2014, World J Biol Chem, V5, P321, DOI 10.4331/wjbc.v5.i3.321; Joshi S, 2011, J BIOL CHEM, V286, P6017, DOI 10.1074/jbc.M110.197921; Kevil CG, 1996, INT J CANCER, V65, P785, DOI 10.1002/(SICI)1097-0215(19960315)65:6<785::AID-IJC14>3.0.CO;2-3; Knauf U, 2001, MOL CELL BIOL, V21, P5500, DOI 10.1128/MCB.21.16.5500-5511.2001; Konicek BW, 2011, CANCER RES, V71, P1849, DOI 10.1158/0008-5472.CAN-10-3298; Korneeva NL, 2010, MOL CANCER RES, V8, P1571, DOI 10.1158/1541-7786.MCR-10-0091; Korneeva NL, 2005, J BIOL CHEM, V280, P1872, DOI 10.1074/jbc.M406168200; Korneeva NL, 2001, J BIOL CHEM, V276, P2872, DOI 10.1074/jbc.M006345200; LAMPHEAR BJ, 1993, J BIOL CHEM, V268, P19200; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; Landon AL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6413; Lawson SK, 2013, MOL CELL BIOL, V33, P127, DOI 10.1128/MCB.00695-12; Li YK, 2010, NEOPLASIA, V12, P848, DOI 10.1593/neo.10704; Lim S, 2013, P NATL ACAD SCI USA, V110, pE2298, DOI 10.1073/pnas.1301838110; Lomakin IB, 2000, MOL CELL BIOL, V20, P6019, DOI 10.1128/MCB.20.16.6019-6029.2000; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Marcotrigiano J, 1999, MOL CELL, V3, P707, DOI 10.1016/S1097-2765(01)80003-4; Marzec M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024849; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; McKendrick L, 2001, EUR J BIOCHEM, V268, P5375, DOI 10.1046/j.0014-2956.2001.02478.x; Niedzwiecka A, 2002, J MOL BIOL, V319, P615, DOI 10.1016/S0022-2836(02)00328-5; Nikolcheva T, 2002, J CLIN INVEST, V110, P119, DOI 10.1172/JCI200215336; Noubade R, 2011, BLOOD, V118, P3290, DOI 10.1182/blood-2011-02-336552; Orton KC, 2004, J BIOL CHEM, V279, P38649, DOI 10.1074/jbc.M407337200; Paix A, 2011, DEV BIOL, V357, P211, DOI 10.1016/j.ydbio.2011.06.019; Panja D, 2014, CELL REP, V9, P1430, DOI 10.1016/j.celrep.2014.10.016; Panja D, 2009, J BIOL CHEM, V284, P31498, DOI 10.1074/jbc.M109.056077; Parra JL, 2005, J BIOL CHEM, V280, P37623, DOI 10.1074/jbc.M508356200; Patursky-Polischuk I, 2009, MOL CELL BIOL, V29, P640, DOI 10.1128/MCB.00980-08; PAUSE A, 1994, EMBO J, V13, P1205, DOI 10.1002/j.1460-2075.1994.tb06370.x; PELLETIER J, 1987, BIOCHEM CELL BIOL, V65, P576, DOI 10.1139/o87-074; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pisareva VP, 2008, CELL, V135, P1237, DOI 10.1016/j.cell.2008.10.037; Pons B, 2011, INT J ONCOL, V39, P1337, DOI 10.3892/ijo.2011.1118; Proud CG, 2015, BBA-GENE REGUL MECH, V1849, P766, DOI 10.1016/j.bbagrm.2014.10.003; Pyronnet S, 1999, EMBO J, V18, P270, DOI 10.1093/emboj/18.1.270; Ramalingam S, 2014, ONCOTARGET, V5, P530, DOI 10.18632/oncotarget.1528; RAY BK, 1985, J BIOL CHEM, V260, P7651; Ross G, 2006, J NEUROCHEM, V97, P79, DOI 10.1111/j.1471-4159.2006.03704.x; Rousseau D, 1996, P NATL ACAD SCI USA, V93, P1065, DOI 10.1073/pnas.93.3.1065; Ryman KD, 2005, J VIROL, V79, P1487, DOI 10.1128/JVI.79.3.1487-1499.2005; Scheper GC, 2002, J BIOL CHEM, V277, P3303, DOI 10.1074/jbc.M103607200; Scheper GC, 2001, MOL CELL BIOL, V21, P743, DOI 10.1128/MCB.21.3.743-754.2001; Shi Y, 2013, ONCOGENE, V32, P190, DOI 10.1038/onc.2012.43; Shi YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094011; Shveygert M, 2010, MOL CELL BIOL, V30, P5160, DOI 10.1128/MCB.00448-10; Slepenkov SV, 2006, J BIOL CHEM, V281, P14927, DOI 10.1074/jbc.M601653200; Smart FM, 2003, P NATL ACAD SCI USA, V100, P14403, DOI 10.1073/pnas.2436349100; SONENBERG N, 1978, P NATL ACAD SCI USA, V75, P4843, DOI 10.1073/pnas.75.10.4843; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stepinski J, 2001, RNA, V7, P1486; Svitkin YV, 2001, RNA, V7, P1743; Teo T, 2015, CANCER LETT, V357, P612, DOI 10.1016/j.canlet.2014.12.029; Topisirovic I, 2011, WIRES RNA, V2, P277, DOI 10.1002/wrna.52; Tschopp C., 2000, Molecular Cell Biology Research Communications, V3, P205, DOI 10.1006/mcbr.2000.0217; Tuxworth WJ, 2004, BIOCHEM J, V378, P73, DOI 10.1042/BJ20031027; TZAREVA NV, 1994, FEBS LETT, V337, P189, DOI 10.1016/0014-5793(94)80271-8; Ueda T, 2004, MOL CELL BIOL, V24, P6539, DOI 10.1128/MCB.24.15.6539-6549.2004; Ueda T, 2010, P NATL ACAD SCI USA, V107, P13984, DOI 10.1073/pnas.1008136107; Waskiewicz AJ, 1999, MOL CELL BIOL, V19, P1871; Waskiewicz AJ, 1997, EMBO J, V16, P1909, DOI 10.1093/emboj/16.8.1909; Wendel HG, 2007, GENE DEV, V21, P3232, DOI 10.1101/gad.1604407; YAN RQ, 1992, J BIOL CHEM, V267, P23226; Yoon SO, 2006, CANCER RES, V66, P2732, DOI 10.1158/0008-5472.CAN-05-2941; Zhang M, 2008, MOL CELL BIOL, V28, P6496, DOI 10.1128/MCB.00477-08; Zhang Y, 2008, BIOCHEM BIOPH RES CO, V367, P54, DOI 10.1016/j.bbrc.2007.12.118; Zhao XH, 2003, J BIOL CHEM, V278, P4449, DOI 10.1074/jbc.M212393200; Zheng J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089220	106	24	26	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3455	3467		10.1074/jbc.M115.694190	http://dx.doi.org/10.1074/jbc.M115.694190			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26668315	hybrid, Green Published			2022-12-26	WOS:000370854500027
J	Kempa, M; Budrejko, S; Piepiorka-Broniecka, M; Rogowski, J; Kozlowski, D; Raczak, G				Kempa, Maciej; Budrejko, Szymon; Piepiorka-Broniecka, Marta; Rogowski, Jan; Kozlowski, Dariusz; Raczak, Grzegorz			One-Year Follow-Up of Patients Undergoing Transvenous Extraction of Pacemaker and Defibrillator Leads	PLOS ONE			English	Article							EXPERIENCE; MORTALITY	Introduction The number of pacemaker and ICD implantations has increased substantially in the recent years. Therefore, complications are also observed in a greater number. In many cases, transvenous extraction of the previously implanted device (pacemaker or ICD) is the only solution. One may find in the literature information about the efficacy and safety of that procedure, but data concerning the results of long-term follow up are still limited. Aim The aim of the study was to assess the one-year mortality in the cohort of patients undergoing transvenous lead extraction procedures in our centre. Methods Records of the patients undergoing transvenous lead removal in the Department of Cardiology and Electrotherapy of the Medical University of Gdansk were analyzed. We collected detailed information about 192 patients that had undergone the procedure from January 2003 until June 2012. Data were collected from medical and surgical records. We analyzed concomitant diseases, indications, and possible complications. Long-term follow-up data were gathered in the follow-up ambulatory records and over-the-phone interviews with patients or families. In several cases, we consulted the database of the Polish National Health Fund. Results During the early post-operative period 5 patients died, although none of those deaths was associated with the procedure itself. No other major complications were observed. During one-year follow-up other 5 patients died, which gave the overall one-year survival rate of 92.7%. Heart failure, renal failure and an infective indication showed significant association with increased mortality. Conclusion Results of transvenous lead extraction, a relatively safe procedure, should be assessed over time extending beyond the sole perioperative period. Some complications may be delayed in their nature, and may be observed only during the long-term follow up.	[Kempa, Maciej; Budrejko, Szymon; Kozlowski, Dariusz; Raczak, Grzegorz] Med Univ Gdansk, Dept Cardiol & Electrotherapy, Gdansk, Poland; [Piepiorka-Broniecka, Marta] St Vincent Paulo Hosp, Dept Cardiol, Gdynia, Poland; [Rogowski, Jan] Med Univ Gdansk, Dept Cardiac Surg, Gdansk, Poland	Fahrenheit Universities; Medical University Gdansk; Fahrenheit Universities; Medical University Gdansk	Kozlowski, D (corresponding author), Med Univ Gdansk, Dept Cardiol & Electrotherapy, Gdansk, Poland.	dkozl@gumed.edu.pl						Byrd CL, 2002, PACE, V25, P804, DOI 10.1046/j.1460-9592.2002.t01-1-00804.x; Hamid S, 2010, PACE, V33, P209, DOI 10.1111/j.1540-8159.2009.02601.x; Hendrikson C, 2011, PACE, V34, P32, DOI [10.1111/j.1540-8159.2010.02941.x, DOI 10.1111/J.1540-8159.2010.02941.X]; Kutarski A, 2010, KARDIOL POL, V68, P736; Kutarski A, 2009, KARDIOL POL, V67, P149; Maytin M, 2012, CIRC-ARRHYTHMIA ELEC, V5, P252, DOI 10.1161/CIRCEP.111.965277; Maytin M, 2010, CIRC-ARRHYTHMIA ELEC, V3, P413, DOI 10.1161/CIRCEP.110.954107; Nielsen JC, 2015, EUR HEART J, V36, P2484, DOI 10.1093/eurheartj/ehv060; SMITH HJ, 1994, PACE, V17, P2016, DOI 10.1111/j.1540-8159.1994.tb03792.x; Wazni O, 2010, J AM COLL CARDIOL, V55, P579, DOI 10.1016/j.jacc.2009.08.070; Wilkoff BL, 2009, HEART RHYTHM, V6, P1085, DOI 10.1016/j.hrthm.2009.05.020	11	5	5	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0144915	10.1371/journal.pone.0144915	http://dx.doi.org/10.1371/journal.pone.0144915			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694032	Green Submitted, Green Published, gold			2022-12-26	WOS:000367092500014
J	Alves, JM; Carneiro, M; Afonso, S; Lopes, S; Garreau, H; Boucher, S; Allain, D; Queney, G; Esteves, PJ; Bolet, G; Ferrand, N				Alves, Joel M.; Carneiro, Miguel; Afonso, Sandra; Lopes, Susana; Garreau, Herve; Boucher, Samuel; Allain, Daniel; Queney, Guillaume; Esteves, Pedro J.; Bolet, Gerard; Ferrand, Nuno			Levels and Patterns of Genetic Diversity and Population Structure in Domestic Rabbits	PLOS ONE			English	Article							GENOME-WIDE SURVEY; ORYCTOLAGUS-CUNICULUS; NUCLEOTIDE DIVERSITY; LINKAGE DISEQUILIBRIUM; PRINCIPAL-COMPONENTS; MICROSATELLITE LOCI; CATTLE BREEDS; REVEALS; WILD; PROGRAM	Over thousands of years humans changed the genetic and phenotypic composition of several organisms and in the process transformed wild species into domesticated forms. From this close association, domestic animals emerged as important models in biomedical and fundamental research, in addition to their intrinsic economical and cultural value. The domestic rabbit is no exception but few studies have investigated the impact of domestication on its genetic variability. In order to study patterns of genetic structure in domestic rabbits and to quantify the genetic diversity lost with the domestication process, we genotyped 45 microsatellites for 471 individuals belonging to 16 breeds and 13 wild localities. We found that both the initial domestication and the subsequent process of breed formation, when averaged across breeds, culminated in losses of similar to 20% of genetic diversity present in the ancestral wild population and domestic rabbits as a whole, respectively. Despite the short time elapsed since breed diversification we uncovered a well-defined structure in domestic rabbits where the FST between breeds was 22%. However, we failed to detect deeper levels of structure, probably consequence of a recent and single geographic origin of domestication together with a non-bifurcating process of breed formation, which were often derived from crosses between two or more breeds. Finally, we found evidence for intrabreed stratification that is associated with demographic and selective causes such as formation of strains, colour morphs within the same breed, or country/breeder of origin. These additional layers of population structure within breeds should be taken into account in future mapping studies.	[Alves, Joel M.; Carneiro, Miguel; Afonso, Sandra; Lopes, Susana; Esteves, Pedro J.; Ferrand, Nuno] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO, Vairao, Portugal; [Alves, Joel M.] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England; [Alves, Joel M.; Carneiro, Miguel; Ferrand, Nuno] Univ Porto, Fac Ciencias, Dept Biol, P-4100 Oporto, Portugal; [Garreau, Herve; Allain, Daniel; Bolet, Gerard] INRA, Genet Physiol & Syst Elevage UMR1388, F-31326 Castanet Tolosan, France; [Boucher, Samuel] Labovet Conseil Reseau Cristal, Les Herbiers, France; [Queney, Guillaume] ANTAGENE, Wildlife Genet Lab, Lyon, France; [Esteves, Pedro J.] CESPU, IPSN, CITS, Gandra, Portugal	Universidade do Porto; University of Cambridge; Universidade do Porto; INRAE	Alves, JM (corresponding author), Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO, Campus Agr Vairao, Vairao, Portugal.	j.alves@gen.cam.ac.uk	Afonso, Sandra/AAV-9350-2021; Ferrand, Nuno/E-6085-2014; Allain, Daniel/AAT-6658-2020; QUENEY, Guillaume/C-5723-2009; afonso, sandra/M-5702-2013; Carneiro, Miguel/L-7864-2013; Alves, Joel/L-8007-2013; Esteves, Pedro/A-7537-2010	Afonso, Sandra/0000-0001-7212-991X; Ferrand, Nuno/0000-0002-2408-4195; QUENEY, Guillaume/0000-0002-6071-5169; afonso, sandra/0000-0001-7212-991X; Carneiro, Miguel/0000-0001-9882-7775; Alves, Joel/0000-0001-6138-9134; Esteves, Pedro/0000-0002-6055-8298	FEDER funds through the COMPETE program; Portuguese national funds through the FCT Fundacao para a Ciencia e a Tecnologia [POCI/CVT/61590/2004, PTDC/BIA-BDE/72304/2006, PTDC/BIA-BDE/72277/2006, PTDC/CVT/122943/2010]; POPH-QREN funds from the European Social Fund and Portuguese MCTES [IF/00283/2014, SFRH/BPD/72343/2010, SFRH/BD/72381/2010]; Project "Genomics Applied To Genetic Resources"; North Portugal Regional Operational Programme (ON.2 - O Novo Norte), under the National Strategic Reference Framework (NSRF), through the European Regional Development Fund (ERDF); Labovet Conseil; ANTAGENE	FEDER funds through the COMPETE program; Portuguese national funds through the FCT Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); POPH-QREN funds from the European Social Fund and Portuguese MCTES; Project "Genomics Applied To Genetic Resources"; North Portugal Regional Operational Programme (ON.2 - O Novo Norte), under the National Strategic Reference Framework (NSRF), through the European Regional Development Fund (ERDF); Labovet Conseil; ANTAGENE	This work was partially funded by FEDER funds through the COMPETE program and Portuguese national funds through the FCT Fundacao para a Ciencia e a Tecnologia - (POCI/CVT/61590/2004; PTDC/BIA-BDE/72304/2006; PTDC/BIA-BDE/72277/2006; PTDC/CVT/122943/2010 research projects to N.F. and Wessel van der Loo) and by POPH-QREN funds from the European Social Fund and Portuguese MCTES (FCT Investigator grant to M.C. (IF/00283/2014); FCT, SFRH/BPD/72343/2010 post-doc grant to M.C.; FCT SFRH/BD/72381/2010 PhD grant to J.M.A.) and through the Project "Genomics Applied To Genetic Resources" co-financed by North Portugal Regional Operational Programme 2007/2013 (ON.2 - O Novo Norte), under the National Strategic Reference Framework (NSRF), through the European Regional Development Fund (ERDF). FCT website: http://www.fct.pt/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Labovet Conseil and ANTAGENE provided support in the form of salaries for authors S.B. and G.Q. respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bjornstad G, 2000, J ANIM BREED GENET, V117, P307, DOI 10.1046/j.1439-0388.2000.00264.x; Bolet G, 1999, EVALUATION CONSERVAT, P281; BOWCOCK AM, 1994, NATURE, V368, P455, DOI 10.1038/368455a0; Bradley DG, 1996, P NATL ACAD SCI USA, V93, P5131, DOI 10.1073/pnas.93.10.5131; Branco M, 2000, HEREDITY, V85, P307, DOI 10.1046/j.1365-2540.2000.00756.x; Bruford MW, 2003, NAT REV GENET, V4, P900, DOI 10.1038/nrg1203; Callou C, 2003, GARENNE CLAPIER ETUD; Canon J, 2006, ANIM GENET, V37, P327, DOI 10.1111/j.1365-2052.2006.01461.x; Canon J, 2000, ANIM GENET, V31, P39, DOI 10.1046/j.1365-2052.2000.00591.x; Canon J, 2001, GENET SEL EVOL, V33, P311, DOI 10.1051/gse:2001121; Carneiro M, 2007, GENET SEL EVOL, V39, P341, DOI 10.1051/gse:2007007; Carneiro M, 2014, SCIENCE, V345, P1074, DOI 10.1126/science.1253714; Carneiro M, 2011, MOL BIOL EVOL, V28, P1801, DOI 10.1093/molbev/msr003; CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616; Chang ML, 2009, J HERED, V100, pS28, DOI 10.1093/jhered/esp012; Chantry-Darmon C, 2003, CYTOGENET GENOME RES, V103, P192, DOI 10.1159/000076310; Chapman JA, 2008, LAGOMORPH BIOL; Clutton-Brock J, 1999, NATURAL HIST DOMESTI; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Dobney K, 2006, J ZOOL, V269, P261, DOI 10.1111/j.1469-7998.2006.00042.x; Donard E., 1982, RECHERCHES LEPORINES; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Ferrand N, 2007, PHYLOGEOGRAPHY OF SOUTHERN EUROPEAN REFUGIA, P207, DOI 10.1007/1-4020-4904-8_7; FITCH WM, 1967, SCIENCE, V155, P279, DOI 10.1126/science.155.3760.279; FLUX JEC, 1992, MAMMAL REV, V22, P151, DOI 10.1111/j.1365-2907.1992.tb00129.x; Gao LZ, 2008, GENETICS, V179, P965, DOI 10.1534/genetics.106.068072; Geraldes A, 2005, ANIM GENET, V36, P349, DOI 10.1111/j.1365-2052.2005.01300.x; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; Granevitze Z, 2009, ANIM GENET, V40, P686, DOI 10.1111/j.1365-2052.2009.01902.x; Gray MM, 2009, GENETICS, V181, P1493, DOI 10.1534/genetics.108.098830; Handley LJL, 2007, HEREDITY, V99, P620, DOI 10.1038/sj.hdy.6801039; HARDY C, 1995, J MOL EVOL, V40, P227, DOI 10.1007/BF00163228; Haudry A, 2007, MOL BIOL EVOL, V24, P1506, DOI 10.1093/molbev/msm077; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kijas JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004668; Langella O., 1999, POPULATIONS 1 2 32; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Laval G, 2000, GENET SEL EVOL, V32, P187, DOI 10.1051/gse:2000113; Lebas F., 1997, FAO ANIMAL PRODUCTIO, V21; Liu AZ, 2006, GENETICS, V173, P321, DOI 10.1534/genetics.105.051110; Long JR, 2003, ANIM GENET, V34, P82, DOI 10.1046/j.1365-2052.2003.00945.x; Lopez-Martinez N., 1989, REVISION SISTEMATICA; Luetkemeier ES, 2010, MOL PHYLOGENET EVOL, V54, P680, DOI 10.1016/j.ympev.2009.11.004; MacHugh DE, 1998, ANIM GENET, V29, P333, DOI 10.1046/j.1365-2052.1998.295330.x; MONNEROT M, 1994, GENET SEL EVOL, V26, pS167, DOI 10.1051/gse:19940712; Mougel F, 1997, ANIM GENET, V28, P58, DOI 10.1111/j.1365-2052.1997.00047.x; PAETKAU D, 1995, MOL ECOL, V4, P347, DOI 10.1111/j.1365-294X.1995.tb00227.x; Parker HG, 2004, SCIENCE, V304, P1160, DOI 10.1126/science.1097406; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Queney G, 2002, J HERED, V93, P205, DOI 10.1093/jhered/93.3.205; Queney G, 2001, MOL BIOL EVOL, V18, P2169, DOI 10.1093/oxfordjournals.molbev.a003763; R Core Team, 2013, R LANG ENV STAT COMP; Rogel-Gaillard Claire, 2009, V3, P165, DOI 10.1007/978-3-540-73835-0_7; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rubin CJ, 2010, NATURE, V464, P587, DOI 10.1038/nature08832; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Shiomi Masashi, 2009, P49, DOI 10.1007/978-90-481-2227-1_7; Tapio M, 2010, BMC GENET, V11, DOI 10.1186/1471-2156-11-76; Vallone PM, 2004, BIOTECHNIQUES, V37, P226, DOI 10.2144/04372ST03; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vigouroux Y, 2005, GENETICS, V169, P1617, DOI 10.1534/genetics.104.032086; Vila C, 2005, TRENDS GENET, V21, P214, DOI 10.1016/j.tig.2005.02.004; vonHoldt BM, 2010, NATURE, V464, P898, DOI 10.1038/nature08837; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitman B.D., 2004, DOMESTIC RABBITS THE	76	27	27	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144687	10.1371/journal.pone.0144687	http://dx.doi.org/10.1371/journal.pone.0144687			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689909	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092300012
J	Brouard, MJ; Coulson, T; Newman, C; Macdonald, DW; Buesching, CD				Brouard, Marc J.; Coulson, Tim; Newman, Chris; Macdonald, David W.; Buesching, Christina D.			Analysis on Population Level Reveals Trappability of Wild Rodents Is Determined by Previous Trap Occupant	PLOS ONE			English	Article							SHORT-TAILED VOLE; APODEMUS-SYLVATICUS; MICROTUS-AGRESTIS; PEROMYSCUS-MANICULATUS; CONSPECIFIC ODORS; WOODLAND RODENTS; MUS-MUSCULUS; HOUSE MICE; CAPTURE; GLAREOLUS	Live trapping is central to the study of small mammals. Thus, any bias needs to be understood and accounted for in subsequent analyses to ensure accurate population estimates. One rarely considered bias is the behavioural response of individuals to the trap, in particular the olfactory cues left behind by previous occupants (PO). We used a data set of 8,115 trap nights spanning 17 separate trapping sessions between August 2002 and November 2013 in Wytham Woods, Oxfordshire, UK to examine if the decision to enter a trap was affected by the PO, if this was detectable in traditional Capture-Mark-Recapture trapping data (i.e., individuals not uniquely marked), and if it was possible for this effect to bias the population estimates obtained. Data were collected on Apodemus sylvaticus, Myodes glareolus, and Microtus agrestis. Three Generalised Linear Models revealed a significant tendency for the three species to enter traps with same-species PO. With, for example, A. sylvaticus 9.1 times more likely to enter a same species PO trap compared to one that contained a M. agrestis in the grassland during the nocturnal period. Simulation highlighted that, when all other factors are equal, the species with the highest PO effect will have the highest capture rate and therefore return more accurate population estimates. Despite the large dataset, certain species-, sex-, and/or age-combinations were under-represented, and thus no effects of any additional individual-specific characteristics could be evaluated. Uniquely marking individuals would allow for the PO effect to be disentangled from other biases such as trap-shyness and spatial heterogeneity, but may not be possible in all cases and will depend on the aims of the study and the resources available.	[Brouard, Marc J.; Coulson, Tim] Univ Oxford, Dept Zool, Ecol & Evolutionary Dynam E2D, Oxford, Oxon, England; [Newman, Chris; Macdonald, David W.; Buesching, Christina D.] Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Tubney, Oxon, England	University of Oxford; University of Oxford	Buesching, CD (corresponding author), Univ Oxford, Dept Zool, Wildlife Conservat Res Unit, Tubney, Oxon, England.	christina.buesching@zoo.ox.ac	Coulson, Tim/AAL-8148-2021	Coulson, Tim/0000-0001-9371-9003; Brouard, Marc/0000-0002-6758-2194	Earthwatch Institute Europe; People's Trust for Endangered Species; ERC; Natural Environment Research Council [NE/K014218/1] Funding Source: researchfish; NERC [NE/K014218/1] Funding Source: UKRI	Earthwatch Institute Europe; People's Trust for Endangered Species; ERC(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The different studies which contributed to this data set were made possible by field grants from the Earthwatch Institute Europe and the People's Trust for Endangered Species. Tim Coulson acknowledges support from an ERC grant that has funded data collection from small rodents in Wytham Woods since 2013.	Bailey NT, 1952, THE JOURNAL OF ANIMA, P120, DOI [10.2307/1913, DOI 10.2307/1913]; BAILEY NTJ, 1951, BIOMETRIKA, V38, P293, DOI 10.2307/2332575; BOONSTRA R, 1976, J ZOOL, V180, P467; Buesching CD, 2008, MAMM BIOL, V73, P318, DOI 10.1016/j.mambio.2007.09.009; Choquet R, 2009, ENVIRON ECOL STAT SE, V3, P845, DOI 10.1007/978-0-387-78151-8_39; Coulson T, 2012, OIKOS, V121, P1337, DOI 10.1111/j.1600-0706.2012.00035.x; Crawley MJ, 2013, R BOOK, P557; Cubaynes S, 2010, CONSERV BIOL, V24, P621, DOI 10.1111/j.1523-1739.2009.01431.x; DALY M, 1980, BEHAV ECOL SOCIOBIOL, V6, P323, DOI 10.1007/BF00292775; DALY M, 1978, BEHAV BIOL, V23, P254, DOI 10.1016/S0091-6773(78)91926-0; DRICKAMER LC, 1995, J CHEM ECOL, V21, P541, DOI 10.1007/BF02033700; Edalgo JA, 2007, J WILDLIFE MANAGE, V71, P246, DOI 10.2193/2006-344; Fisher N, 2010, WYTHAM WOODS: OXFORD'S ECOLOGICAL LABORATORY, P197; Gipps J. H. W., 1985, S ZOOLOGICAL SOC LON, V55, P61; GURNELL J, 1992, ANIM BEHAV, V43, P623, DOI 10.1016/0003-3472(92)90084-M; GURNELL J, 1983, J ZOOL, V200, P289; Gurnell J., 2006, LIVE TRAPPING SMALL, VFourth edition, revised ed.; Hayes RA, 2006, ANIM BEHAV, V71, P1307, DOI 10.1016/j.anbehav.2005.08.017; Herman CS, 2000, OIKOS, V91, P139, DOI 10.1034/j.1600-0706.2000.910113.x; Heth G, 1996, CHEMOECOLOGY, V7, P107, DOI 10.1007/BF01239487; Huggins R, 1991, BIOMETRICS, P725, DOI [10.2307/2532158, DOI 10.2307/2532158]; HUGGINS RM, 1989, BIOMETRIKA, V76, P133, DOI 10.1093/biomet/76.1.133; JENSEN TS, 1975, OIKOS, V26, P196, DOI 10.2307/3543709; Jolly G, 1965, BIOMETRIKA, P225, DOI [10.2307/2333826, DOI 10.2307/2333826]; Kikkawa J, 1964, THE JOURNAL OF ANIMA, P259, DOI [10.2307/2631, DOI 10.2307/2631]; Krebs CJ, 2006, ECOLOGICAL CENSUS TECHNIQUES: A HANDBOOK, 2ND EDITION, P351, DOI 10.1017/CBO9780511790508.011; KREBS CJ, 1984, CAN J ZOOL, V62, P2440, DOI 10.1139/z84-360; KREBS CJ, 1966, ECOL MONOGR, V36, P240, DOI 10.2307/1942418; Lincoln F. C., 1930, CALCULATING WATERFOW; Macdonald DW, 1998, PROPOSALS FOR FUTURE; MAZDZER E, 1976, J MAMMAL, V57, P607, DOI 10.2307/1379317; MONTGOMERY WI, 1979, ACTA THERIOL, V24, P35, DOI 10.4098/AT.arch.79-4; MYLLYMAKI A, 1977, OIKOS, V29, P553, DOI 10.2307/3543594; Oracle, 2015, TREEMAP JAVA PLATFOR; Peterson C.G.J, 1896, REPORT DANISH BIOL S, V6, P1; R Core Team, 2014, R A LANGUAGE AND ENV; ROWE FP, 1970, J ZOOL, V162, P517; SHILLITO ELIZABETH E., 1963, BEHAVIOUR, V21, P145, DOI 10.1163/156853963X00149; Simeonovska-Nikolova DM, 2007, J ETHOL, V25, P41, DOI 10.1007/s10164-006-0203-9; SMITH MH, 1968, J MAMMAL, V49, P455, DOI 10.2307/1378203; Stoddart D, 1985, S ZOOL SOC LOND, V55, P117; STODDART DM, 1982, ANIM BEHAV, V30, P293, DOI 10.1016/S0003-3472(82)80266-2; STODDART DM, 1982, J ANIM ECOL, V51, P375, DOI 10.2307/3971; STODDART DM, 1976, OECOLOGIA, V22, P439, DOI 10.1007/BF00345320; STODDART DM, 1986, OIKOS, V46, P194, DOI 10.2307/3565467; Stoddart DM, 1983, CHEM SIGNALS VERTEBR, V3, P223; STODDART DM, 1980, CHEM SIGNALS VERTEBR, P1; Strachan R, 1995, MAMMAL DETECTIVE; SUMMERLIN CT, 1973, ECOLOGY, V54, P1156, DOI 10.2307/1935584; TEW TE, 1994, J MAMMAL, V75, P750, DOI 10.2307/1382526; Villette P, 2015, J MAMMAL; White GC, 1999, BIRD STUDY, V46, P120, DOI 10.1080/00063659909477239; Wolton R.J., 1985, S ZOOL SOC LONDON, V55, P249; WUENSCH KL, 1982, J MAMMAL, V63, P312, DOI 10.2307/1380645; Yalden DW, 2008, MAMMALS OF THE BRITI; Yunger JA, 1999, J MAMMAL, V80, P1336, DOI 10.2307/1383184	56	5	6	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145006	10.1371/journal.pone.0145006	http://dx.doi.org/10.1371/journal.pone.0145006			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689683	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092300030
J	Walter, BM; Cartman, ST; Minton, NP; Butala, M; Rupnik, M				Walter, Beata M.; Cartman, Stephen T.; Minton, Nigel P.; Butala, Matej; Rupnik, Maja			The SOS Response Master Regulator LexA Is Associated with Sporulation, Motility and Biofilm Formation in Clostridium difficile	PLOS ONE			English	Article							BACILLUS-SUBTILIS; TOXIN PRODUCTION; GENE-EXPRESSION; CELL-DIVISION; PCR RIBOTYPES; CHEO BOX; RESISTANCE; RECA; METRONIDAZOLE; PROTEIN	The LexA regulated SOS network is a bacterial response to DNA damage of metabolic or environmental origin. In Clostridium difficile, a nosocomial pathogen causing a range of intestinal diseases, the in-silico deduced LexA network included the core SOS genes involved in the DNA repair and genes involved in various other biological functions that vary among different ribotypes. Here we describe the construction and characterization of a lexA Clos Tron mutant in C. difficile R20291 strain. The mutation of lexA caused inhibition of cell division resulting in a filamentous phenotype. The lexA mutant also showed decreased sporulation, a reduction in swimming motility, greater sensitivity to metronidazole, and increased biofilm formation. Changes in the regulation of toxin A, but not toxin B, were observed in the lexA mutant in the presence of sub-inhibitory concentrations of levofloxacin. C. difficile LexA is, therefore, not only a regulator of DNA damage but also controls many biological functions associated with virulence.	[Walter, Beata M.; Rupnik, Maja] NLZOH, Natl Lab Hlth Environm & Food, Maribor, Slovenia; [Cartman, Stephen T.; Minton, Nigel P.] Univ Nottingham, Clostridia Res Grp, BBSRC EPSRC Synthet Biol Res Ctr, Sch Life Sci,Ctr Biomol Sci, Nottingham NG7 2RD, England; [Butala, Matej] Univ Ljubljana, Biotechn Fac, Dept Biol, Ljubljana, Slovenia; [Rupnik, Maja] Univ Maribor, Fac Med, SLO-2000 Maribor, Slovenia; [Rupnik, Maja] Ctr Excellence Integrated Approaches Chem & Biol, Ljubljana, Slovenia	UK Research & Innovation (UKRI); Engineering & Physical Sciences Research Council (EPSRC); University of Nottingham; University of Ljubljana; University of Maribor	Butala, M (corresponding author), Univ Ljubljana, Biotechn Fac, Dept Biol, Ljubljana, Slovenia.	matej.butala@bf.uni-lj.si	Walter, Beata/AAF-7927-2019	Walter, Beata/0000-0002-7597-9431; Minton, Nigel/0000-0002-9277-1261	European Community's Seventh Framework Programme FP7 [237942]; Javna Agencija za Raziskovalno Dejavnost RS [P1-0207]; MRC [G0601176] Funding Source: UKRI; Medical Research Council [G0601176] Funding Source: researchfish	European Community's Seventh Framework Programme FP7; Javna Agencija za Raziskovalno Dejavnost RS; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by European Community's Seventh Framework Programme FP7/2007-2013 (Grant agreement: 237942; Recipients: BMW, STC, NPM, and MR; http://ec.europa.eu/research/fp7/index_en.cfm); and Javna Agencija za Raziskovalno Dejavnost RS (SI), (Award Number: P1-0207; Recipient: MB; https://www.arrs.gov.si/en/novo.asp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldape MJ, 2013, J MED MICROBIOL, V62, P741, DOI 10.1099/jmm.0.056218-0; Au N, 2005, J BACTERIOL, V187, P7655, DOI 10.1128/JB.187.22.7655-7666.2005; Baharoglu Z, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003421; Bouillaut Laurent, 2011, Curr Protoc Microbiol, VChapter 9, DOI 10.1002/9780471729259.mc09a02s20; Buchholz M, 2013, MICROBIOL-SGM, V159, P1564, DOI 10.1099/mic.0.064766-0; Burns DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024894; Burns DA, 2010, J BACTERIOL, V192, P657, DOI 10.1128/JB.01209-09; Butala M, 2009, CELL MOL LIFE SCI, V66, P82, DOI 10.1007/s00018-008-8378-6; Cartman ST, 2012, APPL ENVIRON MICROB, V78, P4683, DOI 10.1128/AEM.00249-12; Chellappa ST, 2013, RES MICROBIOL, V164, P1019, DOI 10.1016/j.resmic.2013.10.001; Chong PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082622; Cowan AE, 2003, P NATL ACAD SCI USA, V100, P4209, DOI 10.1073/pnas.0636762100; Cox MM, 2007, CRIT REV BIOCHEM MOL, V42, P41, DOI 10.1080/10409230701260258; Da Re S, 2009, EMBO REP, V10, P929, DOI 10.1038/embor.2009.99; Dapa T, 2013, J BACTERIOL, V195, P545, DOI 10.1128/JB.01980-12; Deneve C, 2008, J MED MICROBIOL, V57, P732, DOI 10.1099/jmm.0.47676-0; Drummond LJ, 2003, J MED MICROBIOL, V52, P1033, DOI 10.1099/jmm.0.05387-0; Dupuy B, 1998, MOL MICROBIOL, V27, P107, DOI 10.1046/j.1365-2958.1998.00663.x; Edwards AN, 2014, FEMS MICROBIOL LETT, V358, P110, DOI 10.1111/1574-6968.12499; Erill I, 2007, FEMS MICROBIOL REV, V31, P637, DOI 10.1111/j.1574-6976.2007.00082.x; Fang AQ, 2009, P NATL ACAD SCI USA, V106, P13225, DOI 10.1073/pnas.0906425106; Godoy V. G, 2004, ENCY BIOL CHEM, P546; Gotoh H, 2010, Biofouling, V26, P603, DOI 10.1080/08927014.2010.501895; Gullberg E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002158; Heap JT, 2007, J MICROBIOL METH, V70, P452, DOI 10.1016/j.mimet.2007.05.021; Heap JT, 2010, J MICROBIOL METH, V80, P49, DOI 10.1016/j.mimet.2009.10.018; Heap JT, 2009, J MICROBIOL METH, V78, P79, DOI 10.1016/j.mimet.2009.05.004; Hocquet D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002778; Jerman B, 2005, ANTIMICROB AGENTS CH, V49, P3087, DOI 10.1128/AAC.49.7.3087-3090.2005; Johnston JL, 1997, MICROBIOL-UK, V143, P885, DOI 10.1099/00221287-143-3-885; Kawai Y, 2003, MOL MICROBIOL, V47, P1113, DOI 10.1046/j.1365-2958.2003.03360.x; Keessen EC, 2013, ANTIMICROB RESIST IN, V2, DOI 10.1186/2047-2994-2-14; Lachowicz D, 2015, ANAEROBE, V31, P37, DOI 10.1016/j.anaerobe.2014.09.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lynch T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053757; Mani N, 2001, P NATL ACAD SCI USA, V98, P5844, DOI 10.1073/pnas.101126598; Mathur H, 2013, ANTIMICROB AGENTS CH, V57, P2882, DOI 10.1128/AAC.00261-13; Metcalf D, 2010, ANAEROBE, V16, P439, DOI 10.1016/j.anaerobe.2010.06.007; Moura I, 2013, J ANTIMICROB CHEMOTH, V68, P362, DOI 10.1093/jac/dks420; Nuyts S, 2001, APPL ENVIRON MICROB, V67, P4464, DOI 10.1128/AEM.67.10.4464-4470.2001; Pelaez T, 2008, J CLIN MICROBIOL, V46, P3028, DOI 10.1128/JCM.00524-08; Pettit LJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-160; Pultz NJ, 2005, ANTIMICROB AGENTS CH, V49, P3529, DOI 10.1128/AAC.49.8.3529-3532.2005; Quinones M, 2005, MOL CELL, V17, P291, DOI 10.1016/j.molcel.2004.11.046; Redgrave LS, 2014, TRENDS MICROBIOL, V22, P438, DOI 10.1016/j.tim.2014.04.007; Roth V, 2006, DOUBLING TIME ONLINE; Rowland SL, 2004, MOL CELL, V13, P689, DOI 10.1016/S1097-2765(04)00084-X; Rupnik M, 2009, NAT REV MICROBIOL, V7, P526, DOI 10.1038/nrmicro2164; Sagar S., 2014, INT J PHARM SCI REV, V25, P102; Singh R, 2010, ANTIMICROB AGENTS CH, V54, P4262, DOI 10.1128/AAC.00168-10; Spigaglia P, 2008, J MED MICROBIOL, V57, P784, DOI 10.1099/jmm.0.47738-0; Spigaglia P, 2009, ANTIMICROB AGENTS CH, V53, P2463, DOI 10.1128/AAC.01252-08; Tenover FC, 2012, ANTIMICROB AGENTS CH, V56, P2929, DOI 10.1128/AAC.00220-12; The European Committee on Antimicrobial Susceptibility Testing, 2015, BREAKP TABL INT MICS; Vlasic I, 2014, NUCLEIC ACIDS RES, V42, P2295, DOI 10.1093/nar/gkt1194; Walter BM, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-88; Zgur-Bertok D, 2012, BIOCHEM SOC T, V40, P1507, DOI 10.1042/BST20120184; Zidaric V, 2012, APPL ENVIRON MICROB, V78, P8515, DOI 10.1128/AEM.02185-12	58	38	39	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144763	10.1371/journal.pone.0144763	http://dx.doi.org/10.1371/journal.pone.0144763			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26682547	gold, Green Published, Green Submitted			2022-12-26	WOS:000366725800020
J	Janmaat, CJ; de Rooij, KE; Locher, H; de Groot, SC; de Groot, JCMJ; Frijns, JHM; Huisman, MA				Janmaat, C. J.; de Rooij, K. E.; Locher, H.; de Groot, S. C.; de Groot, J. C. M. J.; Frijns, J. H. M.; Huisman, M. A.			Human Dermal Fibroblasts Demonstrate Positive Immunostaining for Neuron- and Glia-Specific Proteins	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; III BETA-TUBULIN; STEM-CELLS; EXPRESSION; MARKERS; IDENTITY; DISEASE; ENOLASE; MODEL; SOX9	In stem cell cultures from adult human tissue, undesirable contamination with fibroblasts is frequently present. The presence of fibroblasts obscures the actual number of stem cells and may result in extracellular matrix production after transplantation. Identification of fibroblasts is difficult because of the lack of specific fibroblast markers. In our laboratory, we isolate and expand neural-crest-derived stem cells from human hair follicle bulges and investigate their potential to differentiate into neural cells. To establish cellular identities, we perform immunohistochemistry with antibodies specific for glial and neuronal markers, and use fibroblasts as negative control. We frequently observe that human adult dermal fibroblasts also express some glial and neuronal markers. In this study, we have sought to determine whether our observations represent actual expression of these markers or result from cross-reactivity. Immunohistochemistry was performed on human adult dermal fibroblasts using acknowledged glial and neuronal antibodies followed by verification of the data using RT-qPCR. Human adult dermal fibroblasts showed expression of the glia-specific markers SOX9, glial fibrillary acidic protein and EGR2 (KROX20) as well as for the neuron-specific marker class III beta-tubulin, both at the protein and mRNA level. Furthermore, human adult dermal fibroblasts showed false-positive immunostaining for S100 beta and GAP43 and to a lower extent for OCT6. Our results indicate that immunophenotyping as a tool to determine cellular identity is not as reliable as generally assumed, especially since human adult dermal fibroblasts may be mistaken for neural cells, indicating that the ultimate proof of glial or neuronal identity can only be provided by their functionality.	[Janmaat, C. J.; Locher, H.; de Groot, S. C.; de Groot, J. C. M. J.; Frijns, J. H. M.; Huisman, M. A.] Leiden Univ, Med Ctr, Dept Otorhinolaryngol & Head & Neck Surg, Leiden, Netherlands; [de Rooij, K. E.] Percuros BV, Enschede, Netherlands; [de Rooij, K. E.] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Janmaat, CJ (corresponding author), Leiden Univ, Med Ctr, Dept Otorhinolaryngol & Head & Neck Surg, Leiden, Netherlands.	C.J.Janmaat@lumc.nl	Locher, Heiko/C-8481-2013; Frijns, Johan H.M./H-6249-2011	Locher, Heiko/0000-0002-4174-0270; Frijns, Johan H.M./0000-0002-1180-3314	Stichting Het Heinsius-Houbolt Fonds	Stichting Het Heinsius-Houbolt Fonds	We thank T. Schomann, C. van der Ploeg and C. Out for technical support. H. Locher was supported by Stichting Het Heinsius-Houbolt Fonds.	Azzimonti B, 2009, VIROLOGY, V388, P260, DOI 10.1016/j.virol.2009.03.033; Bainbridge P, 2013, J WOUND CARE, V22, P407; Bianco P, 2013, EMBO J, V32, P1489, DOI 10.1038/emboj.2013.114; CACCAMO DV, 1989, ACTA NEUROPATHOL, V79, P248, DOI 10.1007/BF00294658; Chakravarty G, 2011, EXP BIOL MED, V236, P145, DOI 10.1258/ebm.2010.010086; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Dupin E, 2012, DEV BIOL, V366, P83, DOI 10.1016/j.ydbio.2012.02.035; Fanjul M, 2010, J HISTOCHEM CYTOCHEM, V58, P807, DOI 10.1369/jhc.2010.955807; Gasca S, 2002, P NATL ACAD SCI USA, V99, P11199, DOI 10.1073/pnas.172383099; Goodpaster T, 2008, J HISTOCHEM CYTOCHEM, V56, P347, DOI 10.1369/jhc.7A7287.2007; Grigoriadis N, 2011, EXP NEUROL, V230, P78, DOI 10.1016/j.expneurol.2011.02.021; HAYNES BF, 1984, J EXP MED, V159, P1149, DOI 10.1084/jem.159.4.1149; Hematti P, 2012, CYTOTHERAPY, V14, P516, DOI 10.3109/14653249.2012.677822; Jessen KR, 2002, J ANAT, V200, P367, DOI 10.1046/j.1469-7580.2002.00046.x; Jouhilahti EM, 2008, J HISTOCHEM CYTOCHEM, V56, P1113, DOI 10.1369/jhc.2008.952002; Kendall RT, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00123; Kisselbach L, 2009, CYTOTECHNOLOGY, V59, P31, DOI 10.1007/s10616-009-9190-3; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Locher H, 2013, DIFFERENTIATION, V85, P173, DOI 10.1016/j.diff.2013.05.003; Mladinic M, 2014, STEM CELL RES, V12, P815, DOI 10.1016/j.scr.2014.03.006; Nakatani K, 2006, ARCH HISTOL CYTOL, V69, P61, DOI 10.1679/aohc.69.61; Ng Tsz Kin, 2014, World J Stem Cells, V6, P111, DOI 10.4252/wjsc.v6.i2.111; Pereira MCL, 2011, STEM CELL REV REP, V7, P1006, DOI 10.1007/s12015-011-9256-4; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Plotnikov SV, 2013, CURR OPIN CELL BIOL, V25, P619, DOI 10.1016/j.ceb.2013.06.003; Rehberg S, 2002, MOL CELL BIOL, V22, P5826, DOI 10.1128/MCB.22.16.5826-5834.2002; Savagner P, 2010, ANN ONCOL, V21, P89, DOI 10.1093/annonc/mdq292; Sensenbrenner M, 1997, J MOL MED-JMM, V75, P653, DOI 10.1007/s001090050149; Shiras A, 2001, IN VITRO CELL DEV-AN, V37, P172; Sieber-Blum Maya, 2004, Birth Defects Res C Embryo Today, V72, P162, DOI 10.1002/bdrc.20008; Steiner J, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-2; Stoll SW, 2012, J INVEST DERMATOL, V132, P2148, DOI 10.1038/jid.2012.78; Takenouchi T, 2010, CELL BIOL INT REP, V17; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Vento P, 1999, J HISTOCHEM CYTOCHEM, V47, P1405, DOI 10.1177/002215549904701107; Zhang CC, 2005, BLOOD, V105, P4314, DOI 10.1182/blood-2004-11-4418; Zimmermann T, 2001, ARTHRITIS RES, V3, P72, DOI 10.1186/ar142	38	6	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145235	10.1371/journal.pone.0145235	http://dx.doi.org/10.1371/journal.pone.0145235			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678612	Green Published, gold, Green Submitted			2022-12-26	WOS:000366723400062
J	Sloka, S; Zhornitsky, S; Silva, C; Metz, LM; Yong, VW				Sloka, Scott; Zhornitsky, Simon; Silva, Claudia; Metz, Luanne M.; Yong, V. Wee			1,25-Dihydroxyvitamin D-3 Protects against Immune-Mediated Killing of Neurons in Culture and in Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							VITAMIN-D HORMONE; MULTIPLE-SCLEROSIS; IN-VIVO; ENVIRONMENTAL-FACTORS; GLATIRAMER ACETATE; RISK-FACTORS; BRAIN; MODEL; MS; NEUROPROTECTION	Several studies have reported that low vitamin D levels are associated with an increased risk of developing multiple sclerosis (MS). As MS is an inflammatory disorder with degeneration of axons and neurons, we examined whether the biologically active form of vitamin D, 1,25-dihydroxyvitamin D3 (1,25D3), could protect against the T cell-mediated killing of human neurons in culture, and the axonal loss seen in mice with experimental autoimmune encephalomyelitis (EAE). Human neurons were exposed to activated human T lymphocytes and the loss of neurons was documented 24 hours later by counting the number of microtubule-associated protein-2 positive cells. Mice with EAE were harvested for counts of axonal profiles in the spinal cord. 1,25D3 was exposed to T cells in culture or administered to mice from peak EAE clinical severity when axonal loss was already evolving. Activated T lymphocytes killed human neurons prominently within 24 hours but toxicity was significantly attenuated when T cells were exposed to 1,25D3 prior to the co-culture. In EAE, 1,25D3 treatment initiated from peak clinical severity reduced the extent of clinical disability and mitigated the progressive loss of axons. The reduction of axonal and neuronal loss by 1,25D3 in the context of an inflammatory assault to the central nervous system is a potential contributor to the putative benefits of vitamin D in MS.	[Sloka, Scott] Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; Univ Calgary, Cumming Sch Med, Dept Clin Neurosci, Calgary, AB, Canada	University of Calgary; University of Calgary	Yong, VW (corresponding author), Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada.	vyong@ucalgary.ca		Yong, V. Wee/0000-0002-2600-3563	NeuroScience Canada Brain Repair program; Multiple Sclerosis Scientific Research Foundation; Canadian Institutes of Health Research; Alberta Innovates [201300669] Funding Source: researchfish	NeuroScience Canada Brain Repair program; Multiple Sclerosis Scientific Research Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates	This work was funded by operating grants from the NeuroScience Canada Brain Repair program, the Multiple Sclerosis Scientific Research Foundation, and the Canadian Institutes of Health Research (VWY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was funded by operating grants from the NeuroScience Canada Brain Repair program, the Multiple Sclerosis Scientific Research Foundation, and the Canadian Institutes of Health Research.	ACHESON E. D., 1960, ACTA PSYCHIATR ET NEUROL SCAND SUPPL, V35, P132, DOI 10.1111/j.1600-0447.1960.tb08674.x; Ascherio A, 2008, SEMIN NEUROL, V28, P17, DOI 10.1055/s-2007-1019126; Atif F, 2013, NEUROPHARMACOLOGY, V67, P78, DOI 10.1016/j.neuropharm.2012.10.004; Beretich BD, 2009, MULT SCLER J, V15, P891, DOI 10.1177/1352458509105579; Brewer LD, 2001, J NEUROSCI, V21, P98, DOI 10.1523/JNEUROSCI.21-01-00098.2001; Cantorna MT, 1996, P NATL ACAD SCI USA, V93, P7861, DOI 10.1073/pnas.93.15.7861; Duan SR, 2014, NEUROSCI LETT, V570, P108, DOI 10.1016/j.neulet.2014.04.021; Ebers GC, 2008, LANCET NEUROL, V7, P268, DOI 10.1016/S1474-4422(08)70042-5; Farias AS, 2013, CNS NEUROSCI THER, V19, P269, DOI 10.1111/cns.12071; GASCONBARRE M, 1983, AM J PHYSIOL, V244, pE266, DOI 10.1152/ajpendo.1983.244.3.E266; Geurts JJG, 2008, LANCET NEUROL, V7, P841, DOI 10.1016/S1474-4422(08)70191-1; Girolamo F, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0084-z; Giuliani F, 2005, J NEUROIMMUNOL, V158, P213, DOI 10.1016/j.jneuroim.2004.09.006; Giuliani F, 2003, J IMMUNOL, V171, P368, DOI 10.4049/jimmunol.171.1.368; Jang W, 2014, BIOCHEM BIOPH RES CO, V451, P142, DOI 10.1016/j.bbrc.2014.07.081; Koch MW, 2013, J NEUROL SCI, V324, P10, DOI 10.1016/j.jns.2012.10.021; LEMIRE JM, 1991, J CLIN INVEST, V87, P1103, DOI 10.1172/JCI115072; Makar TK, 2008, J NEUROL SCI, V270, P70, DOI 10.1016/j.jns.2008.02.011; Marrie RA, 2004, LANCET NEUROL, V3, P709, DOI 10.1016/S1474-4422(04)00933-0; Methner A, 2013, NAT REV NEUROL, V9, P72, DOI 10.1038/nrneurol.2012.277; Mishra MK, 2014, ANN CLIN TRANSL NEUR, V1, P409, DOI 10.1002/acn3.67; Nystad AE, 2014, APMIS, V122, P1178, DOI 10.1111/apm.12281; PARDRIDGE WM, 1985, J NEUROCHEM, V44, P1138, DOI 10.1111/j.1471-4159.1985.tb08735.x; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Shirazi HA, 2015, EXP MOL PATHOL, V98, P240, DOI 10.1016/j.yexmp.2015.02.004; Siffrin V, 2010, IMMUNITY, V33, P424, DOI 10.1016/j.immuni.2010.08.018; Skihar V, 2009, P NATL ACAD SCI USA, V106, P17992, DOI 10.1073/pnas.0909607106; Sloka S, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-56; Sloka S, 2011, CAN J NEUROL SCI, V38, P98, DOI 10.1017/S0317167100011124; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Vecil GG, 2000, J NEUROSCI RES, V61, P212, DOI 10.1002/1097-4547(20000715)61:2<212::AID-JNR12>3.0.CO;2-9; Weaver A, 2005, FASEB J, V19, P1668, DOI 10.1096/fj.04-2030fje; Wergeland S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026262	33	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144084	10.1371/journal.pone.0144084	http://dx.doi.org/10.1371/journal.pone.0144084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26679341	Green Submitted, Green Published, gold			2022-12-26	WOS:000366723400007
J	Martens, J; Daly, D; Deschamps, K; Fernandes, RJP; Staes, F				Martens, Jonas; Daly, Daniel; Deschamps, Kevin; Pinto Fernandes, Ricardo Jorge; Staes, Filip			Intra-Individual Variability of Surface Electromyography in Front Crawl Swimming	PLOS ONE			English	Article							INTERINDIVIDUAL VARIABILITY; NORMALIZATION METHODS; EMG; GAIT; PERFORMANCE; REPEATABILITY; MOVEMENTS; SHOULDER; PATTERNS; CHILDREN	The variability of electromyographic (EMG) recordings between and within participants is a complex problem, rarely studied in swimming. The importance of signal normalization has long been recognized, but the method used might influence variability. The aims of this study were to: (i) assess the intra-individual variability of the EMG signal in highly skilled front crawl swimmers, (ii) determine the influence of two methods of both amplitude and time normalization of the EMG signal on intra-individual variability and of time normalization on muscle activity level and (iii) describe the muscle activity, normalized using MVIC, in relation to upper limb crawl stroke movements. Muscle activity of rectus abdominis and deltoideus medialis was recorded using wireless surface EMG in 15 adult male competitive swimmers during three trials of 12.5 m front crawl at maximal speed without breathing. Two full upper limb cycles were analyzed from each of the swimming trials, resulting in six full cycles used for the intra-individual variability assessment, quantified with the coefficient of variation (CV), coefficient of quartile variation (CQV) and the variance ratio (VR). The results of this study support previous findings on EMG patterns of deltoideus medialis and rectus abdominis as prime mover during the recovery (45% activity relative to MVIC), and stabilizer of the trunk during the pull (14.5% activity) respectively. The intra-individual variability was lower (VR of 0.34-0.47) when compared to other cyclic movements. No meaningful differences were found between variability measures CV or VR when applying either of the amplitude or the time normalization methods. In addition to reporting the mean amplitude and standard deviation, future EMG studies in swimming should also report the intra-individual variability, preferably using VR as it is independent of peak amplitude, provides a good measure of repeatability and is insensitive to mean EMG amplitude and the degree of smoothing applied.	[Martens, Jonas; Daly, Daniel] Katholieke Univ Leuven, Dept Kinesiol, Leuven, Belgium; [Deschamps, Kevin; Staes, Filip] Katholieke Univ Leuven, Dept Rehabil Sci, Leuven, Belgium; [Pinto Fernandes, Ricardo Jorge] Univ Porto, Ctr Res Educ Innovat & Intervent Sport, Fac Sport, P-4100 Oporto, Portugal	KU Leuven; KU Leuven; Universidade do Porto	Martens, J (corresponding author), Katholieke Univ Leuven, Dept Kinesiol, Leuven, Belgium.	Jonas.Martens@faber.kuleuven.be	Fernandes, Ricardo J./A-1040-2012	Fernandes, Ricardo J./0000-0002-5811-0443; Staes, Filip/0000-0002-1569-6333				Albertus-Kajee Y, 2010, J ELECTROMYOGR KINES, V20, P1036, DOI 10.1016/j.jelekin.2010.07.011; Ball N, 2013, J APPL BIOMECH, V29, P600, DOI 10.1123/jab.29.5.600; Barthels KM, 1971, 1 INT S BIOM SWIMM W, P105; Ben Kibler W, 2006, SPORTS MED, V36, P189, DOI 10.2165/00007256-200636030-00001; Bolgla LA, 2007, J ELECTROMYOGR KINES, V17, P102, DOI 10.1016/j.jelekin.2005.11.007; Bonett DG, 2006, BIOMETRICAL J, V48, P144, DOI 10.1002/bimj.200410148; Burden A, 2010, J ELECTROMYOGR KINES, V20, P1023, DOI 10.1016/j.jelekin.2010.07.004; Burden AM, 2003, J ELECTROMYOGR KINES, V13, P519, DOI 10.1016/S1050-6411(03)00082-8; Clarys Jan Pieter, 1993, Journal of Sports Sciences, V11, P379, DOI 10.1080/02640419308730010; CLARYS JP, 1985, APPL ERGON, V16, P11, DOI 10.1016/0003-6870(85)90143-7; Clarys JP, 2000, ERGONOMICS, V43, P1750, DOI 10.1080/001401300750004159; Clarys JP, 2011, WORLD BOOK SWIMMING, P43; Cram J, 1998, INTRO SURFACE ELECTR; GABEL RH, 1994, ELECTROEN CLIN NEURO, V93, P188, DOI 10.1016/0168-5597(94)90040-X; Granata KP, 2005, GAIT POSTURE, V22, P346, DOI 10.1016/j.gaitpost.2004.11.014; Guidetti L, 1996, J ELECTROMYOGR KINES, V6, P37, DOI 10.1016/1050-6411(95)00015-1; Hermens H.J.M.R.F.B., 1999, SENIAM EUROPEAN RECO; HERSHLER C, 1978, IEEE T BIO-MED ENG, V25, P413, DOI 10.1109/TBME.1978.326338; Hibbs AE, 2008, SPORTS MED, V38, P995, DOI 10.2165/00007256-200838120-00004; Hislop H.J., 2007, DANIELS WORTHINGHAMS; Hug F, 2008, EUR J APPL PHYSIOL, V104, P667, DOI 10.1007/s00421-008-0810-y; Hug F, 2009, J ELECTROMYOGR KINES, V19, P182, DOI 10.1016/j.jelekin.2007.10.010; KADABA MP, 1985, J ORTHOPAED RES, V3, P350, DOI 10.1002/jor.1100030312; Kamen G, 2010, ESSENTIALS ELECTROMY; KNUTSON LM, 1994, J ELECTROMYOGR KINES, V4, P47, DOI 10.1016/1050-6411(94)90026-4; Lewillie L., 1976, P 5 INT C BIOM, P230; Lewillie L, 1974, BIOMECHANICS, P203; Martens J, 2014, OPEN SLEEP J, V7, P1; Martens J, 2015, J ELECTROMYOGR KINES, V25, P273, DOI 10.1016/j.jelekin.2014.12.003; McLeod I., 2010, SWIMMING ANATOMY; Monteil KM, 1992, SWIMMING SCI, VVI, P99; Persyn U, 1974, TECHNISCH HYDRODYNAM; Piette G., 1979, SWIMMING, P153; PINK M, 1991, AM J SPORT MED, V19, P569, DOI 10.1177/036354659101900603; ROUARD AH, 1995, J ELECTROMYOGR KINES, V5, P177, DOI 10.1016/1050-6411(95)00008-N; ROUARD AH, 1990, INT J SPORTS MED, V11, P150, DOI 10.1055/s-2007-1024781; Rouffet DM, 2008, J ELECTROMYOGR KINES, V18, P866, DOI 10.1016/j.jelekin.2007.03.008; Tirosh O, 2013, J ELECTROMYOGR KINES, V23, P1451, DOI 10.1016/j.jelekin.2013.06.002; Winter D., 2009, BIOMECHANICS MOTOR C, V4th	39	25	25	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144998	10.1371/journal.pone.0144998	http://dx.doi.org/10.1371/journal.pone.0144998			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673163	gold, Green Submitted, Green Published			2022-12-26	WOS:000366722700084
J	Perpetuo, IP; Raposeiro, R; Caetano-Lopes, J; Vieira-Sousa, E; Campanilho-Marques, R; Ponte, C; Canhao, H; Ainola, M; Fonseca, JE				Perpetuo, Ines P.; Raposeiro, Rita; Caetano-Lopes, Joana; Vieira-Sousa, Elsa; Campanilho-Marques, Raquel; Ponte, Cristina; Canhao, Helena; Ainola, Mari; Fonseca, Joao E.			Effect of Tumor Necrosis Factor Inhibitor Therapy on Osteoclasts Precursors in Ankylosing Spondylitis	PLOS ONE			English	Article							BONE-MINERAL DENSITY; RHEUMATOID-ARTHRITIS; L-SELECTIN; RADIOGRAPHIC PROGRESSION; RECEPTOR ACTIVATOR; UP-REGULATION; DIFFERENTIATION; INFLAMMATION; NEUTROPHIL; BIOMARKERS	Introduction Ankylosing Spondylitis (AS) is characterized by excessive local bone formation and concomitant systemic bone loss. Tumor necrosis factor (TNF) plays a central role in the inflammation of axial skeleton and enthesis of AS patients. Despite reduction of inflammation and systemic bone loss, AS patients treated with TNF inhibitors (TNFi) have ongoing local bone formation. The aim of this study was to assess the effect of TNFi in the differentiation and activity of osteoclasts (OC) in AS patients. Methods 13 AS patients treated with TNFi were analyzed at baseline and after a minimum follow-up period of 6 months. 25 healthy donors were recruited as controls. Blood samples were collected to assess receptor activator of nuclear factor kappa-B ligand (RANKL) surface expression on circulating leukocytes and frequency and phenotype of monocyte subpopulations. Quantification of serum levels of bone turnover markers and cytokines, in vitro OC differentiation assay and qRT-PCR for OC specific genes were performed. Results RANKL(+) circulating lymphocytes (B and T cells) and IL-17A, IL-23 and TGF-beta levels were decreased after TNFi treatment. We found no differences in the frequency of the different monocyte subpopulations, however, we found decreased expression of CCR2 and increased expression of CD62L after TNFi treatment. OC number was reduced in patients at baseline when compared to controls. OC specific gene expression was reduced in circulating OC precursors after TNFi treatment. However, when cultured in OC differentiating conditions, OC precursors from AS TNFi-treated patients showed increased activity as compared to baseline. Conclusion In AS patients, TNFi treatment reduces systemic pro osteoclastogenic stimuli. However, OC precursors from AS patients exposed to TNFi therapy have increased in vitro activity in response to osteoclastogenic stimuli.	[Perpetuo, Ines P.; Raposeiro, Rita; Caetano-Lopes, Joana; Vieira-Sousa, Elsa; Campanilho-Marques, Raquel; Ponte, Cristina; Canhao, Helena; Fonseca, Joao E.] Univ Lisbon, Lisbon Acad Med Ctr, Inst Med Mol, Rheumatol Res Unit,Fac Med, P-1699 Lisbon, Portugal; [Vieira-Sousa, Elsa; Campanilho-Marques, Raquel; Ponte, Cristina; Canhao, Helena; Fonseca, Joao E.] Ctr Hosp Lisboa Norte, Rheumatol & Bone Metab Dis Dept, Lisbon Acad Med Ctr, Hosp Santa Maria,EPE, Lisbon, Portugal; [Ainola, Mari] Univ Helsinki, Musculoskeletal Dis & Inflammat Res Grp, Biomedicum Helsinki, Fac Med,Inst Clin Med, Helsinki, Finland	Universidade de Lisboa; Universidade de Lisboa; Hospital Santa Maria; University of Helsinki	Perpetuo, IP (corresponding author), Univ Lisbon, Lisbon Acad Med Ctr, Inst Med Mol, Rheumatol Res Unit,Fac Med, P-1699 Lisbon, Portugal.	ines.perpetuo@gmail.com	Ponte, Cristina/AEU-0624-2022; Caetano-Lopes, Joana/J-9345-2012; IP, Perpétuo/F-3643-2011; Canhao, Helena/C-9611-2018; Ainola, Mari-Mia/T-8035-2017	Ponte, Cristina/0000-0002-3989-1192; Caetano-Lopes, Joana/0000-0003-0310-4641; IP, Perpétuo/0000-0001-7671-2539; Canhao, Helena/0000-0003-1894-4870; Ainola, Mari-Mia/0000-0003-2853-5851; Vieira de Sousa, Elsa Cristina/0000-0002-7170-8802	Fundacao para a Ciencia e Tecnologia [SFRH/BD/70533/2010]; Investigator-Initiated Studies Program of Merck Sharp Dohme Corp	Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); Investigator-Initiated Studies Program of Merck Sharp Dohme Corp	This work was supported by Fundacao para a Ciencia e Tecnologia (http://www.fct.pt/index.phtml.en) PhD grant (SFRH/BD/70533/2010) and in part by a research grant from Investigator-Initiated Studies Program of Merck Sharp & Dohme Corp (http://www.merck.com/index.html-Merck_P08574). The opinions expressed in this paper are those of the authors and do not necessarily represent those of Merck Sharp & Dohme Corp. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai-Aql ZS, 2008, J DENT RES, V87, P107, DOI 10.1177/154405910808700215; Appel H, 2009, CLIN EXP RHEUMATOL, V27, pS15; ARNETT TR, 1987, ENDOCRINOLOGY, V120, P602, DOI 10.1210/endo-120-2-602; BARBIERI P, 1990, ANN RHEUM DIS, V49, P396, DOI 10.1136/ard.49.6.396; BIASI D, 1995, CLIN EXP RHEUMATOL, V13, P623; Boissy P, 2002, ENDOCRINOLOGY, V143, P1913, DOI 10.1210/en.143.5.1913; Caetano-Lopes J, 2014, CLIN REV ALLERG IMMU, V47, P38, DOI 10.1007/s12016-013-8366-y; CALIN A, 1994, J RHEUMATOL, V21, P2281; Carmona-Fernandes D, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3500; Cascao R, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3168; Chen CH, 2010, CLIN RHEUMATOL, V29, P1155, DOI 10.1007/s10067-010-1543-y; Corr M, 2014, CLIN RHEUMATOL, V33, P759, DOI 10.1007/s10067-014-2663-6; El Maghraoui A, 2004, JOINT BONE SPINE, V71, P291, DOI 10.1016/j.jbspin.2003.06.002; Faccio R, 2003, J CLIN INVEST, V111, P749, DOI 10.1172/JCI200316924; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Haroon NN, 2014, SEMIN ARTHRITIS RHEU, V44, P155, DOI 10.1016/j.semarthrit.2014.05.008; Husheem M, 2005, CALCIFIED TISSUE INT, V76, P222, DOI 10.1007/s00223-004-0123-z; Hwang ST, 1996, J EXP MED, V184, P1343, DOI 10.1084/jem.184.4.1343; Jung YK, 2012, J BONE MINER RES, V27, P2024, DOI 10.1002/jbmr.1632; Kang KY, 2013, RHEUMATOLOGY, V52, P718, DOI 10.1093/rheumatology/kes364; Kim MS, 2005, J BIOL CHEM, V280, P16163, DOI 10.1074/jbc.M412713200; Klingberg E, 2014, J RHEUMATOL, V41, P1349, DOI 10.3899/jrheum.131199; Kobayashi K, 2000, J EXP MED, V191, P275, DOI 10.1084/jem.191.2.275; KURIHARA N, 1989, BLOOD, V74, P1295; Lees RL, 1999, J BONE MINER RES, V14, P937, DOI 10.1359/jbmr.1999.14.6.937; Limon-Camacho L, 2012, J RHEUMATOL, V39, P830, DOI 10.3899/jrheum.110862; Machado P, 2011, ANN RHEUM DIS, V70, P47, DOI 10.1136/ard.2010.138594; Mader TL, 2014, CALCIFIED TISSUE INT, V95, P457, DOI 10.1007/s00223-014-9914-z; Maksymowych WP, 2015, ANN RHEUM DIS, V74, P123, DOI 10.1136/annrheumdis-2015-eular.6285; Maxwell LJ, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005468.pub2; Mei Y, 2011, CLIN RHEUMATOL, V30, P269, DOI 10.1007/s10067-010-1647-4; Nicholson MW, 1998, J BIOL CHEM, V273, P763, DOI 10.1074/jbc.273.2.763; OSIER LK, 1987, BONE MINER, V3, P35; Pedersen SJ, 2011, J RHEUMATOL, V38, P1349, DOI 10.3899/jrheum.100925; Pedersen SJ, 2011, ARTHRITIS RHEUM-US, V63, P3789, DOI 10.1002/art.30627; PIPER K, 1992, ANAT EMBRYOL, V186, P291; Schett G, 2005, NAT CLIN PRACT RHEUM, V1, P47, DOI 10.1038/ncprheum0036; SIMON SI, 1995, J IMMUNOL, V155, P1502; Singh HJ, 2013, J CLIN DIAGN RES, V7, P2832, DOI 10.7860/JCDR/2013/6779.3770; Siu S, 2014, ARTHRITIS CARE RES; Stupphann D, 2008, RHEUMATOL INT, V28, P987, DOI 10.1007/s00296-008-0567-y; Surdacki A, 2014, J RHEUMATOL, V41, P481, DOI 10.3899/jrheum.130803; Taylan A, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-191; Ustun N, 2014, ACTA REUMATOL PORT, V39, P146; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Wong KL, 2012, IMMUNOL RES, V53, P41, DOI 10.1007/s12026-012-8297-3; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Wright C, 2009, ANN RHEUM DIS, V68, P1626, DOI 10.1136/ard.2008.097204; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134	49	11	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144655	10.1371/journal.pone.0144655	http://dx.doi.org/10.1371/journal.pone.0144655			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674064	Green Published, Green Submitted, gold			2022-12-26	WOS:000366722700051
J	Petersen, JE; Frantz, CM; Shammin, MR; Yanisch, TM; Tincknell, E; Myers, N				Petersen, John E.; Frantz, Cynthia M.; Shammin, Md. Rumi; Yanisch, Tess M.; Tincknell, Evan; Myers, Noel			Electricity and Water Conservation on College and University Campuses in Response to National Competitions among Dormitories: Quantifying Relationships between Behavior, Conservation Strategies and Psychological Metrics	PLOS ONE			English	Article							ENERGY; CONSUMPTION; FEEDBACK; IMPACT; INFORMATION	"Campus Conservation Nationals" (CCN) is a recurring, nation-wide electricity and wateruse reduction competition among dormitories on college campuses. We conducted a two year empirical study of the competition's effects on resource consumption and the relationship between conservation, use of web technology and various psychological measures. Significant reductions in electricity and water use occurred during the two CCN competitions examined (n = 105,000 and 197,000 participating dorm residents respectively). In 2010, overall reductions during the competition were 4% for electricity and 6% for water. The top 10% of dorms achieved 28% and 36% reductions in electricity and water respectively. Participation was larger in 2012 and reductions were slightly smaller (i.e. 3% electricity). The fact that no seasonal pattern in electricity use was evident during non-competition periods suggests that results are attributable to the competition. Post competition resource use data collected in 2012 indicates that conservation behavior was sustained beyond the competition. Surveys were used to assess psychological and behavioral responses (n = 2,900 and 2,600 in 2010 and 2012 respectively). Electricity reductions were significantly correlated with: web visitation, specific conservation behaviors, awareness of the competition, motivation and sense of empowerment. However, participants were significantly more motivated than empowered. Perceived benefits of conservation were skewed towards global and future concerns while perceived barriers tended to be local. Results also suggest that competitionsmay be useful for "preaching beyond the choir"-engaging those who might lack prior intrinsic or political motivation. Although college life is distinct, certain conclusions related to competitions, self-efficacy, and motivation and social norms likely extend to other residential settings.	[Petersen, John E.; Shammin, Md. Rumi; Myers, Noel] Oberlin Coll, Environm Studies Program, Oberlin, OH 44074 USA; [Frantz, Cynthia M.; Tincknell, Evan] Oberlin Coll, Dept Psychol, Oberlin, OH 44074 USA; [Yanisch, Tess M.] New York Univ Steinhardt, Dept Appl Psychol, New York, NY USA	Oberlin College; Oberlin College; New York University	Petersen, JE (corresponding author), Oberlin Coll, Environm Studies Program, Oberlin, OH 44074 USA.	john.petersen@oberlin.edu			Great Lakes Protection Fund [901]; U.S. Environmental Protection Agency P3 Program [SU832466]	Great Lakes Protection Fund; U.S. Environmental Protection Agency P3 Program	Funding was provided by Great Lakes Protection Fund (www.glpf.org/), Grant #901, to JEP, CMF, and MRS. Funding was also provided by U.S. Environmental Protection Agency P3 Program (http://www.epa.gov/p3/), Grant #SU832466, to JEP and CMF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamse W, 2005, J ENVIRON PSYCHOL, V25, P273, DOI 10.1016/j.jenvp.2005.08.002; Abrahamse W, 2007, J ENVIRON PSYCHOL, V27, P265, DOI 10.1016/j.jenvp.2007.08.002; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; Ardoin N., 2013, INFLUENCING CONSERVA; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; BECKER LJ, 1978, J APPL PSYCHOL, V63, P428, DOI 10.1037/0021-9010.63.4.428; Carrico AR, 2011, J ENVIRON PSYCHOL, V31, P1, DOI 10.1016/j.jenvp.2010.11.004; Cialdini R.B., 2009, INFLUENCE SCI PRACTI, V5th ed.; Delmas MA, 2013, ENERG POLICY, V61, P729, DOI 10.1016/j.enpol.2013.05.109; Diamond R, 1987, ENERGY EFFICIENCY PE; Dietz T, 2009, P NATL ACAD SCI USA, V106, P18452, DOI 10.1073/pnas.0908738106; DOE, 2012, BUILD EN DAT BOOK; Ehrhardt-Martinez K., 2010, ADV METERING INITIAT; Evans GW, 1998, J ENVIRON PSYCHOL, V18, P85, DOI 10.1006/jevp.1998.0089; Froehlich J, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1999; Gardner G.T., 1996, ENV PROBLEMS HUMAN B; Goldstein NJ, 2008, J CONSUM RES, V35, P472, DOI 10.1086/586910; Haas R, 1998, ENERG BUILDINGS, V27, P195, DOI 10.1016/S0378-7788(97)00034-0; Hagan C, 2008, ORG RESIDENCE HALL C, P32; HARKINS SG, 1989, J PERS SOC PSYCHOL, V56, P934, DOI 10.1037/0022-3514.56.6.934; Heede R, 2002, OBERLIN CLIMATE NEUT; Hodge C, 2011, DORM ENERGY COMPETIT; Jain RK, 2012, ENERG BUILDINGS, V48, P8, DOI 10.1016/j.enbuild.2011.12.033; Jones CM, 2015, REV ENERGY REDUCTION; KATZEV RD, 1983, J ECON PSYCHOL, V3, P267, DOI 10.1016/0167-4870(83)90006-5; Maniates M.F., 2001, GLOBAL ENVIRON POLIT, V1, P31, DOI [10.1162/152638001316881395, DOI 10.1162/152638001316881395, https://doi.org/10.1162/152638001316881395]; Markowitz E, 2014, CONNECTING CLIMATE C; Mayer FS, 2004, J ENVIRON PSYCHOL, V24, P503, DOI 10.1016/j.jenvp.2004.10.001; McKenzie-Mohr D., 1999, FOSTERING SUSTAINABL; Nolan JM, 2008, PERS SOC PSYCHOL B, V34, P913, DOI 10.1177/0146167208316691; O'Connor RE, 1999, RISK ANAL, V19, P461, DOI 10.1111/j.1539-6924.1999.tb00421.x; PALLAK MS, 1976, PERS SOC PSYCHOL B, V2, P27, DOI 10.1177/014616727600200105; Peschiera G, 2012, ENERG BUILDINGS, V49, P584, DOI 10.1016/j.enbuild.2012.03.011; Peschiera G, 2010, ENERG BUILDINGS, V42, P1329, DOI 10.1016/j.enbuild.2010.03.001; Peters J., 2009, P INT S ROB RES ISRR, P1; Petersen J.E., 2007, INT J SUSTAINABILITY, V8, P16, DOI DOI 10.1108/14676370710717562; Petersen JE, 2014, SOLUTIONS, V5, P79; Raudenbush S., 2000, HLM 6 HIERARCHICAL L; Siero FW, 1996, J ENVIRON PSYCHOL, V16, P235, DOI 10.1006/jevp.1996.0019; Steg L, 2009, J ENVIRON PSYCHOL, V29, P309, DOI 10.1016/j.jenvp.2008.10.004; Wilson A, 2001, ENV BUILDING NEWS, V10	41	20	20	1	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144070	10.1371/journal.pone.0144070	http://dx.doi.org/10.1371/journal.pone.0144070			41	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9JH	26672599	gold, Green Submitted, Green Published			2022-12-26	WOS:000366722700024
J	Tveitaras, MK; Skogstrand, T; Leh, S; Helle, F; Iversen, BM; Chatziantoniou, C; Reed, RK; Hultstrom, M				Tveitaras, Maria K.; Skogstrand, Trude; Leh, Sabine; Helle, Frank; Iversen, Bjarne M.; Chatziantoniou, Christos; Reed, Rolf K.; Hultstrom, Michael			Matrix Metalloproteinase-2 Knockout and Heterozygote Mice Are Protected from Hydronephrosis and Kidney Fibrosis after Unilateral Ureteral Obstruction	PLOS ONE			English	Article							RENAL INTERSTITIAL FIBROSIS; GROWTH; STAGE; INJURY; MATRIX-METALLOPROTEINASE-9; INHIBITION; SECRETION; ISCHEMIA; CLEAVAGE; PROTEIN	Matrix Metalloproteinase-2 (Mmp2) is a collagenase known to be important in the development of renal fibrosis. In unilateral ureteral obstruction (UUO) the obstructed kidney (OK) develops fibrosis, while the contralateral (CL) does not. In this study we investigated the effect of UUO on gene expression, fibrosis and pelvic remodeling in the kidneys of Mmp2 deficient mice (Mmp2-/-), heterozygous animals (Mmp2+/-) and wild-type mice (Mmp2+/+). Sham operated animals served as controls (Cntrl). UUO was prepared under isoflurane anaesthesia, and the animals were sacrificed after one week. UUO caused hydronephrosis, dilation of renal tubules, loss of parenchymal thickness, and fibrosis. Damage was most severe in Mmp2+/+ mice, while both Mmp2-/- and Mmp2+/- groups showed considerably milder hydronephrosis, no tubular necrosis, and less tubular dilation. Picrosirius red quantification of fibrous collagen showed 1.63 +/- 0.25% positivity in OK and 0.29 +/- 0.11% in CL (p<0.05) of Mmp2+/+, Mmp2-/- OK and Mmp2-/- CL exhibited only 0.49 +/- 0.09% and 0.23 +/- 0.04% (p<0.05) positivity, respectively. Mmp2+/- OK and Mmp2+/- CL showed 0.43 +/- 0.09% and 0.22 +/- 0.06% (p<0.05) positivity, respectively. Transcriptomic analysis showed that 26 genes (out of 48 examined) were differentially expressed by ANOVA (p<0.05). 25 genes were upregulated in Mmp2+/+ OK compared to Mmp2+/+ CL: Adamts1, -2, Col1a1, -2, -3a1, -4a1, -5a1, -5a2, Dcn, Fbln1, -5, Fmod, Fn1, Itga2, Loxl1, Mgp, Mmp2, -3, Nid1, Pdgfb, Spp1, Tgfb1, Timp2, Trf, Vim. In Mmp2-/- and Mmp2+/- 18 and 12 genes were expressed differentially between OK and CL, respectively. Only Mmp2 was differentially regulated when comparing Mmp2-/- OK and Mmp2+/- OK. Under stress, it appears that Mmp2+/- OK responds with less Mmp2 upregulation than Mmp2+/+ OK, suggesting that there is a threshold level of Mmp2 necessary for damage and fibrosis to occur. In	[Tveitaras, Maria K.; Skogstrand, Trude; Reed, Rolf K.; Hultstrom, Michael] Univ Bergen, Dept Biomed, Bergen, Norway; [Tveitaras, Maria K.; Skogstrand, Trude; Leh, Sabine; Helle, Frank; Iversen, Bjarne M.; Hultstrom, Michael] Univ Bergen, Dept Clin Med, Bergen, Norway; [Skogstrand, Trude] Haukeland Hosp, Dept Med, N-5021 Bergen, Norway; [Leh, Sabine] Haukeland Hosp, Dept Pathol, N-5021 Bergen, Norway; [Chatziantoniou, Christos] Univ Paris 06, INSERM, UMR 702, Paris, France; [Reed, Rolf K.] Univ Bergen, Ctr Canc Biomarkers, CCBIO, Bergen, Norway; [Hultstrom, Michael] Uppsala Univ, Dept Med Cellbiol, Uppsala, Sweden; [Hultstrom, Michael] Uppsala Univ, Dept Surg Sci, Anaesthesiol & Intens Care Med, Uppsala, Sweden	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; University of Bergen; Uppsala University; Uppsala University	Hultstrom, M (corresponding author), Univ Bergen, Dept Biomed, Bergen, Norway.	michael.hultstrom@mcb.uu.se	Leh, Sabine/E-6053-2011; Hultström, Michael/H-3642-2019; Reed, Rolf K./B-9422-2017; Chatziantoniou, Christos/L-2501-2016	Leh, Sabine/0000-0002-0764-2941; Hultström, Michael/0000-0003-4675-1099; Reed, Rolf K./0000-0002-2633-6595; 	Western Health Authority of Norway (Helse Vest) [911685]; Swedish Society For Medical Research (SSMF); Western Health Authority of Norway (Helse Vest)	Western Health Authority of Norway (Helse Vest); Swedish Society For Medical Research (SSMF); Western Health Authority of Norway (Helse Vest)	The study was supported by the Western Health Authority of Norway (Helse Vest) (project no: 911685) www.helsevest.no, and the Swedish Society For Medical Research (SSMF) www.ssmf.se. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was supported by the Western Health Authority of Norway (Helse Vest), and the Swedish Society for Medical Research (SSMF).	AIMES RT, 1995, J BIOL CHEM, V270, P5872, DOI 10.1074/jbc.270.11.5872; Catania JM, 2007, AM J PHYSIOL-RENAL, V292, pF905, DOI 10.1152/ajprenal.00421.2006; Chade Alejandro R, 2012, F1000 Med Rep, V4, P1, DOI 10.3410/M4-1; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Du TY, 2013, PLOS ONE, V8; Du XY, 2012, LAB INVEST, V92, P1149, DOI 10.1038/labinvest.2012.68; Eitner F, 2008, J AM SOC NEPHROL, V19, P281, DOI 10.1681/ASN.2007030290; Fernandez-Patron C, 1999, CIRC RES, V85, P906; Flamant M, 2007, HYPERTENSION, V50, P212, DOI 10.1161/HYPERTENSIONAHA.107.089631; Goulter AB, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-34; Hamdi A, 2012, BJU INT, V110, pE1027, DOI 10.1111/j.1464-410X.2012.11193.x; Heikkila J, 2011, J UROLOGY, V186, P2392, DOI 10.1016/j.juro.2011.07.109; Henderson NC, 2008, AM J PATHOL, V172, P288, DOI 10.2353/ajpath.2008.070726; Hultstrom M, 2008, NEPHROL DIAL TRANSPL, V23, P896, DOI 10.1093/ndt/gfm710; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Kaneko T, 2012, NEPHRON EXP NEPHROL, V122, P23, DOI 10.1159/000346569; Kim HS, 2001, J AM SOC NEPHROL, V12, P736, DOI 10.1681/ASN.V124736; Kishioka H, 2001, AM J HYPERTENS, V14, P439, DOI 10.1016/S0895-7061(00)01290-5; Kunugi S, 2011, LAB INVEST, V91, P170, DOI 10.1038/labinvest.2010.174; LeBleu VS, 2013, NAT MED, V19, P227, DOI 10.1038/nm.2989; Ledbetter S, 2000, KIDNEY INT, V58, P2367, DOI 10.1046/j.1523-1755.2000.00420.x; Martin IV, 2013, AM J PATHOL, V182, P107, DOI 10.1016/j.ajpath.2012.09.006; Martinez A, 2004, BIOCHEM J, V383, P413, DOI 10.1042/BJ20040920; Nangaku M, 2004, INTERNAL MED, V43, P9, DOI 10.2169/internalmedicine.43.9; Nishida M, 2007, BIOCHEM BIOPH RES CO, V354, P133, DOI 10.1016/j.bbrc.2006.12.165; Ohno-Matsui K, 2003, INVEST OPHTH VIS SCI, V44, P5370, DOI 10.1167/iovs.03-0249; Ostendorf T, 2014, KIDNEY INT SUPPL, V4, P65, DOI 10.1038/kisup.2014.12; Schaefer L, 2002, AM J PATHOL, V160, P1181, DOI 10.1016/S0002-9440(10)64937-1; Skogstrand T, 2013, J HYPERTENS, V31, P152, DOI 10.1097/HJH.0b013e32835a5d4e; Suofu Y, 2012, NEUROSCIENCE, V212, P180, DOI 10.1016/j.neuroscience.2012.03.036; Takamiya Y, 2013, NEPHROL DIAL TRANSPL, V28, P55, DOI 10.1093/ndt/gfs387; Tan TK, 2013, LAB INVEST, V93, P434, DOI 10.1038/labinvest.2013.3; Tang WW, 1996, AM J PATHOL, V148, P1169; Tveitaras MK S T, 2012, FASEB J, V26, p[868, 812]; Vesey DA, 2002, J LAB CLIN MED, V140, P342, DOI 10.1067/mlc.2002.128468; Wang XH, 2010, AM J PHYSIOL-RENAL, V299, pF973, DOI 10.1152/ajprenal.00216.2010; Wang ZC, 2014, KIDNEY INT, V85, P82, DOI 10.1038/ki.2013.225; Zeisberg M, 2006, PLOS MED, V3, P535, DOI 10.1371/journal.pmed.0030100	39	22	23	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0143390	10.1371/journal.pone.0143390	http://dx.doi.org/10.1371/journal.pone.0143390			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673451	Green Published, Green Submitted, gold			2022-12-26	WOS:000366722700009
J	Birlie, A; Tesfaw, G; Dejene, T; Woldemichael, K				Birlie, Abayneh; Tesfaw, Getnet; Dejene, Tariku; Woldemichael, Kifle			Time to Death and Associated Factors among Tuberculosis Patients in Dangila Woreda, Northwest Ethiopia	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; MORTALITY	Background Tuberculosis (TB) is among the leading causes of morbidity and mortality worldwide. More than 70% of the deaths of TB patients occur during the first two months of TB treatment. The major risk factors that increase early death of TB patients are being positive for human immunodeficiency virus (HIV), being of old age, being underweight or undergoing re-treatment. Objective To assess the time of reported deaths and associated factors in a cohort of patients with TB during TB treatment. Methods An institution-based retrospective cohort study was analyzed in Dangila Woreda, Northwest Ethiopia from March 1st through March 30, 2014. All TB patients registered in the direct observed treatment (DOTs) clinic from 2008-2012 were included in the study. Data were entered into EpiData and exported to SPSS for analysis. The survival probability was analyzed by the Kaplan Meier method and Cox regression analysis was applied to investigate factors associated with death during TB treatment. Results From a total of 872 cases registered in TB registry log book, 810 were used for the analysis of which 60 (7.4%) died during the treatment. The overall mortality rate was 12.8/1000 person months of observation. A majority of TB deaths 34 (56.7%) occurred during the intensive phase of the treatment, and the median time of death was at two months of the treatment. Age, HIV status and baseline body weight were independent predictors of death during TB treatment. Conclusions Most deaths occurred in the first two months of TB treatment. Old age, TB/HIV co-infection and a baseline body weight of <35 kg increased the mortality during TB treatment. Therefore, a special follow up of TB patients during the intensive phase, of older patients and of TB/HIV co-infected cases, as well as nutritionally supplementing for underweight patients may be important to consider as interventions to reduce deaths during TB treatment.	[Birlie, Abayneh] Addis Ababa City Adm Hlth Bur, Dept Monitoring & Evaluat, Addis Ababa, Ethiopia; [Tesfaw, Getnet] Jimma Univ, Dept Med Lab Sci & Pathol, Coll Hlth Sci, Jimma, Ethiopia; [Dejene, Tariku] Univ Addis Ababa, Dept Stat, Coll Nat Sci, Addis Ababa, Ethiopia; [Woldemichael, Kifle] Jimma Univ, Dept Epidemiol, Coll Hlth Sci, Jimma, Ethiopia	Jimma University; Addis Ababa University; Jimma University	Birlie, A (corresponding author), Addis Ababa City Adm Hlth Bur, Dept Monitoring & Evaluat, Addis Ababa, Ethiopia.	abaybrl@gmail.com			Jimma University Postgraduate Coordination Office	Jimma University Postgraduate Coordination Office	This work was funded by Jimma University Postgraduate Coordination Office, www.ju.edu.et. The funding was received by AB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis Z, 2013, IJBAR, V4, P7; Alavi SM, 2008, PAK J MED SCI, V24, P4; Albuquerque Maria de Fátima Pessoa Militão de, 2009, Rev. bras. epidemiol., V12, P513, DOI 10.1590/S1415-790X2009000400001; Babatunde OA, 2013, J MED MED SCI, V4, P10; Bao QS, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-344; Berhe G, 2012, BMC PUBLIC HEALTH, P12; Beza M.G., 2013, J INFECT DIS THER, V1, P101, DOI [10.4172/2332-0877.1000101, DOI 10.4172/2332-0877.1000101]; Biadglegne F., 2013, INT J MED MED SCI, V5, P85, DOI DOI 10.5897/IJMMS12.142; Cayla JA, 2004, INT J TUBERC LUNG D, V8, P458; Farah MG, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-14; Federal Ministry of Health, 2011, ETH NAT TB PREV SURV; Federal Ministry of Health, 2013, GUID CLIN PROGR MAN; Federal Ministry of Health, 2008, TUB LEPR TB HIV PREV, V4th; Getahun B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-127; Harries AD, 2001, INT J TUBERC LUNG D, V5, P1000; Jonnalagada S, 2011, BMC PUBLIC HEALTH, V11, P7; Moolphate S, 2011, INT J GEN MED, V4, P181, DOI 10.2147/IJGM.S16486; Mugusi FM, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-409; Naing NN, 2001, SE ASIAN J TROP MED, V32, P14; Pardeshi Geeta, 2009, Indian J Med Sci, V63, P180, DOI 10.4103/0019-5359.53163; Shaweno D, 2012, BMC RES NOTES, P5; Shen X, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-95; Sileshi B, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-297; Tessema B, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-371; Vasantha M, 2008, Indian J Tuberc, V55, P64; World Health Organization, 2004, TB HIV CLIN MAN, V2nd; World Health Organization, 2021, 10 THREATS GLOB HLTH; World Health Organization, 2013, TUB FACT SHEET	28	35	36	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144244	10.1371/journal.pone.0144244	http://dx.doi.org/10.1371/journal.pone.0144244			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26669737	Green Published, Green Submitted, gold			2022-12-26	WOS:000366719300005
J	Kim, K; Kim, T; Yoon, T; Lee, C				Kim, Kayeon; Kim, Taekjun; Yoon, Taehwan; Lee, Choongkil			Covariation between Spike and LFP Modulations Revealed with Focal and Asynchronous Stimulation of Receptive Field Surround in Monkey Primary Visual Cortex	PLOS ONE			English	Article							MACAQUE V1 NEURONS; AREA MT; FUNCTIONAL CONNECTIVITY; EXPRESS-SACCADES; TRAVELING-WAVES; STRIATE CORTEX; CAT CORTEX; TIME; SUPPRESSION; RESPONSES	A focal visual stimulus outside the classical receptive field (RF) of a V1 neuron does not evoke a spike response by itself, and yet evokes robust changes in the local field potential (LFP). This subthreshold LFP provides a unique opportunity to investigate how changes induced by surround stimulation leads to modulation of spike activity. In the current study, two identical Gabor stimuli were sequentially presented with a variable stimulus onset asynchrony (SOA) ranging from 0 to 100 ms: the first (S1) outside the RF and the second (S2) over the RF of primary visual cortex neurons, while trained monkeys performed a fixation task. This focal and asynchronous stimulation of the RF surround enabled us to analyze the modulation of S2-evoked spike activity and covariation between spike and LFP modulation across SOA. In this condition, the modulation of S2-evoked spike response was dominantly facilitative and was correlated with the change in LFP amplitude, which was pronounced for the cells recorded in the upper cortical layers. The time course of covariation between the SOA-dependent spike modulation and LFP amplitude suggested that the subthreshold LFP evoked by the S1 can predict the magnitude of upcoming spike modulation.	[Kim, Kayeon; Kim, Taekjun; Lee, Choongkil] Seoul Natl Univ, Dept Psychol, Seoul, South Korea; [Yoon, Taehwan; Lee, Choongkil] Seoul Natl Univ, Program Cognit Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Lee, C (corresponding author), Seoul Natl Univ, Dept Psychol, Seoul, South Korea.	cklee@snu.ac.kr		Kim, Taekjun/0000-0002-8376-8861; Kim, Kayeon/0000-0002-4565-9429	Cognitive Neuroscience Research Program Grant of the National Research Foundation of Korea [NRF-20062005108]; Next Generation Grant of the Seoul National University	Cognitive Neuroscience Research Program Grant of the National Research Foundation of Korea(National Research Foundation of Korea); Next Generation Grant of the Seoul National University	This work was supported by the Cognitive Neuroscience Research Program Grant of the National Research Foundation of Korea (NRF-20062005108, http://nrf.re.kr) to CL, and by the Next Generation Grant of the Seoul National University to KK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLMAN J, 1985, ANNU REV NEUROSCI, V8, P407, DOI 10.1146/annurev.ne.08.030185.002203; ALLMAN J, 1985, PERCEPTION, V14, P105, DOI 10.1068/p140105; Angelucci A, 2002, J NEUROSCI, V22, P8633; Angelucci A, 2006, PROG BRAIN RES, V154, P93, DOI 10.1016/S0079-6123(06)54005-1; Bair W, 2002, J NEUROSCI, V22, P3189, DOI 10.1523/JNEUROSCI.22-08-03189.2002; Bair W, 2003, J NEUROSCI, V23, P7690; Benucci A, 2007, NEURON, V55, P103, DOI 10.1016/j.neuron.2007.06.017; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; Bringuier V, 1999, SCIENCE, V283, P695, DOI 10.1126/science.283.5402.695; BURT P, 1981, PSYCHOL REV, V88, P171, DOI 10.1037/0033-295X.88.2.171; Buzsaki G, 2012, NAT REV NEUROSCI, V13, P407, DOI 10.1038/nrn3241; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2547, DOI 10.1152/jn.00693.2001; Cavanaugh JR, 2002, J NEUROPHYSIOL, V88, P2530, DOI 10.1152/jn.00692.2001; DAS A, 1995, NATURE, V375, P780, DOI 10.1038/375780a0; FISCHER B, 1984, EXP BRAIN RES, V55, P232; Fitzpatrick D, 2000, CURR OPIN NEUROBIOL, V10, P438, DOI 10.1016/S0959-4388(00)00113-6; Freeman RD, 2001, PROG BRAIN RES, V134, P157; Fregnac Y, 2009, B ACAD NAT MED PARIS, V193, P851, DOI 10.1016/S0001-4079(19)32526-9; GILBERT CD, 1989, J NEUROSCI, V9, P2432; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; GRINVALD A, 1994, J NEUROSCI, V14, P2545; Guo K, 2007, EUR J NEUROSCI, V26, P1045, DOI 10.1111/j.1460-9568.2007.05712.x; Hafed ZM, 2011, J NEUROSCI, V31, P15219, DOI 10.1523/JNEUROSCI.3106-11.2011; Haider B, 2013, NATURE, V493, P97, DOI 10.1038/nature11665; Haider B, 2010, NEURON, V65, P107, DOI 10.1016/j.neuron.2009.12.005; Haslinger R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039699; Henry CA, 2013, J NEUROSCI, V33, P6230, DOI 10.1523/JNEUROSCI.4155-12.2013; HORTON JC, 1991, ARCH OPHTHALMOL-CHIC, V109, P816, DOI 10.1001/archopht.1991.01080060080030; Ichida JM, 2007, J NEUROPHYSIOL, V98, P2168, DOI 10.1152/jn.00298.2007; Jancke D, 2004, NATURE, V428, P423, DOI 10.1038/nature02396; Jones HE, 2001, J NEUROPHYSIOL, V86, P2011, DOI 10.1152/jn.2001.86.4.2011; JUDGE SJ, 1980, VISION RES, V20, P535, DOI 10.1016/0042-6989(80)90128-5; Kajikawa Y, 2011, NEURON, V72, P847, DOI 10.1016/j.neuron.2011.09.029; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; Katzner S, 2009, NEURON, V61, P35, DOI 10.1016/j.neuron.2008.11.016; Kim T, 2014, NEUROSCIENCE, V274, P170, DOI 10.1016/j.neuroscience.2014.05.041; Kim T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047543; KRAUT MA, 1985, ELECTROEN CLIN NEURO, V62, P300, DOI 10.1016/0168-5597(85)90007-3; Lee J, 2010, J NEUROPHYSIOL, V104, P2556, DOI 10.1152/jn.01040.2009; Levitt JB, 2002, VISUAL NEUROSCI, V19, P439, DOI 10.1017/S0952523802194065; Liu J, 2006, J NEUROSCI, V26, P7779, DOI 10.1523/JNEUROSCI.5052-05.2006; Liu YJ, 2011, J NEUROPHYSIOL, V105, P1306, DOI 10.1152/jn.00692.2010; Logothetis NK, 2007, NEURON, V55, P809, DOI 10.1016/j.neuron.2007.07.027; Maier A, 2011, J NEUROSCI, V31, P1971, DOI 10.1523/JNEUROSCI.5300-09.2011; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; MITZDORF U, 1987, INT J NEUROSCI, V33, P33, DOI 10.3109/00207458708985928; Nauhaus I, 2012, J NEUROSCI, V32, P3088, DOI 10.1523/JNEUROSCI.5827-11.2012; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Okun M, 2010, J NEUROSCI, V30, P4440, DOI 10.1523/JNEUROSCI.5062-09.2010; Pelli DG, 1997, SPATIAL VISION, V10, P437, DOI 10.1163/156856897X00366; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; Rasch MJ, 2008, J NEUROPHYSIOL, V99, P1461, DOI 10.1152/jn.00919.2007; Ray S, 2011, J NEUROSCI, V31, P12674, DOI 10.1523/JNEUROSCI.1856-11.2011; RODMAN HR, 1987, VISION RES, V27, P2035, DOI 10.1016/0042-6989(87)90118-0; ROHRER WH, 1993, VISION RES, V33, P2447, DOI 10.1016/0042-6989(93)90125-G; Rudolph M, 2007, J NEUROSCI, V27, P5280, DOI 10.1523/JNEUROSCI.4652-06.2007; Sceniak MP, 1999, NAT NEUROSCI, V2, P733, DOI 10.1038/11197; Sceniak MP, 2001, J NEUROPHYSIOL, V85, P1873, DOI 10.1152/jn.2001.85.5.1873; SCHROEDER CE, 1991, VISION RES, V31, P1143, DOI 10.1016/0042-6989(91)90040-C; Series P, 2003, J PHYSIOL-PARIS, V97, P453, DOI 10.1016/j.jphysparis.2004.01.023; Smith FW, 2010, P NATL ACAD SCI USA, V107, P20099, DOI 10.1073/pnas.1000233107; Thompson KG, 1996, J NEUROPHYSIOL, V76, P4040, DOI 10.1152/jn.1996.76.6.4040; Vinje WE, 2002, J NEUROSCI, V22, P2904, DOI 10.1523/JNEUROSCI.22-07-02904.2002; Walker GA, 1999, J NEUROSCI, V19, P10536; Walker GA, 2000, VISUAL NEUROSCI, V17, P369, DOI 10.1017/S0952523800173055; Xing DJ, 2012, P NATL ACAD SCI USA, V109, P13871, DOI 10.1073/pnas.1201478109; Xing DJ, 2009, J NEUROSCI, V29, P11540, DOI 10.1523/JNEUROSCI.2573-09.2009	67	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144929	10.1371/journal.pone.0144929	http://dx.doi.org/10.1371/journal.pone.0144929			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670337	Green Published, gold, Green Submitted			2022-12-26	WOS:000366719300030
J	Tribelli, PM; Venero, ECS; Ricardi, MM; Gomez-Lozano, M; Iustman, LJR; Molin, S; Lopez, NI				Tribelli, Paula M.; Solar Venero, Esmeralda C.; Ricardi, Martiniano M.; Gomez-Lozano, Maria; Raiger Iustman, Laura J.; Molin, Soren; Lopez, Nancy I.			Novel Essential Role of Ethanol Oxidation Genes at Low Temperature Revealed by Transcriptome Analysis in the Antarctic Bacterium Pseudomonas extremaustralis	PLOS ONE			English	Article							2-COMPONENT REGULATORY SYSTEM; ALCOHOL-DEHYDROGENASE; IRON ACQUISITION; GLOBAL REGULATOR; REDOX STATE; SMALL RNAS; STRESS; AERUGINOSA; GENOME; COLD	Temperature is one of the most important factors for bacterial growth and development. Cold environments are widely distributed on earth, and psychrotolerant and psychrophilic microorganisms have developed different adaptation strategies to cope with the stress derived from low temperatures. Pseudomonas extremaustralis is an Antarctic bacterium able to grow under low temperatures and to produce high amounts of polyhydroxyalkanoates (PHAs). In this work, we analyzed the genome-wide transcriptome by RNA deep-sequencing technology of early exponential cultures of P. extremaustralis growing in LB (Luria Broth) supplemented with sodium octanoate to favor PHA accumulation at 8 degrees C and 30 degrees C. We found that genes involved in primary metabolism, including tricarboxylic acid cycle (TCA) related genes, as well as cytochromes and amino acid metabolism coding genes, were repressed at low temperature. Among up-regulated genes, those coding for transcriptional regulatory and signal transduction proteins were over-represented at cold conditions. Remarkably, we found that genes involved in ethanol oxidation, exaA, exaB and exaC, encoding a pyrroloquinoline quinone (PQQ)-dependent ethanol dehydrogenase, the cytochrome c550 and an aldehyde dehydrogenase respectively, were up-regulated. Along with RNA-seq experiments, analysis of mutant strains for pqqB (PQQ biosynthesis protein B) and exaA were carried out. We found that the exaA and pqqB genes are essential for growth under low temperature in LB supplemented with sodium octanoate. Additionally, prosaniline assay measurements showed the presence of alcohol dehydrogenase activity at both 8 degrees C and 30 degrees C, while the activity was abolished in a pqqB mutant strain. These results together with the detection of ethanol by gas chromatography in P. extremaustralis cultures grown at 8 degrees C support the conclusion that this pathway is important under cold conditions. The obtained results have led to the identification of novel components involved in cold adaptation mechanisms in this bacterium, suggesting for the first time a role of the ethanol oxidation pathway for bacterial growth at low temperatures.	[Tribelli, Paula M.; Raiger Iustman, Laura J.; Lopez, Nancy I.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina; [Tribelli, Paula M.; Solar Venero, Esmeralda C.; Raiger Iustman, Laura J.; Lopez, Nancy I.] Consejo Nacl Invest Cient & Tecn, IQUIBICEN, RA-1033 Buenos Aires, DF, Argentina; [Ricardi, Martiniano M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, CONICET, Inst Fisiol Biol Mol & Neurociencias IFIBYNE, Buenos Aires, DF, Argentina; [Gomez-Lozano, Maria; Molin, Soren] Tech Univ Denmark, Novo Nordisk Fdn, Ctr Biosustainabil, Horsholm, Denmark	University of Buenos Aires; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; Novo Nordisk Foundation; Technical University of Denmark	Lopez, NI (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Intendente Guiraldes 2160,C1428EGA, Buenos Aires, DF, Argentina.	nan@qb.fcen.uba.ar	Gomez-Lozano, PhD, Maria/ABA-2244-2021	Gomez-Lozano, PhD, Maria/0000-0002-7078-4141; Ricardi, Martiniano/0000-0002-7904-6305; Molin, Soren/0000-0002-7973-2639; Solar Venero, Esmeralda/0000-0003-3516-8535; Raiger Iustman, Laura J./0000-0002-8541-3204; Tribelli, Paula Maria/0000-0001-9558-6275	Universidad de Buenos Aires [20020130100451BA]; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [0338]; Agencia Nacional de Promocion Cientifica (ANPCyT), Argentina [2259]; CONICET; short term EMBO fellowship	Universidad de Buenos Aires(University of Buenos Aires); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica (ANPCyT), Argentina(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); short term EMBO fellowship	This work was supported by grants from Universidad de Buenos Aires 2014-2017, Proyecto No 20020130100451BA, Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, PIP 2011, No 0338), and Agencia Nacional de Promocion Cientifica (ANPCyT: PICT 2013, No 2259), Argentina. PMT, LJRI, and NIL are career investigators from Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina). ESV has a graduate student fellowship from CONICET. MMR has a postdoctoral fellowship from CONICET. RNA-seq experiments were performed by PMTat Dr. Molin's Lab supported by a short term EMBO fellowship.	Ayub ND, 2009, EXTREMOPHILES, V13, P59, DOI 10.1007/s00792-008-0197-z; Balasubramanian D, 2014, NUCLEIC ACIDS RES, V42, P979, DOI 10.1093/nar/gkt942; Barbier M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089941; Barria C, 2013, MICROBIOL-SGM, V159, P2437, DOI 10.1099/mic.0.052209-0; Bignucolo A, 2013, J BIOTECHNOL, V167, P309, DOI 10.1016/j.jbiotec.2013.07.002; Casey A, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00068; Catone MV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098873; Chattopadhyay MK, 2011, CURR MICROBIOL, V62, P544, DOI 10.1007/s00284-010-9742-y; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CONWAY T, 1987, J BACTERIOL, V169, P2591, DOI 10.1128/jb.169.6.2591-2597.1987; Conway T, 2014, MBIO, V5, DOI 10.1128/mBio.01442-14; DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990; Filipiak W, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-113; Fonseca P, 2011, ENV MICROBIOL REP, V3, P329, DOI 10.1111/j.1758-2229.2010.00229.x; Gomez-Lozano M, 2015, ENV MICROBIOL REP, V7, P227, DOI 10.1111/1758-2229.12233; Gomez-Lozano M, 2014, METHODS MOL BIOL, V1149, P433, DOI 10.1007/978-1-4939-0473-0_34; Gomez-Lozano M, 2012, ENVIRON MICROBIOL, V14, P2006, DOI 10.1111/j.1462-2920.2012.02759.x; Hempel N, 2013, J BACTERIOL, V195, P3925, DOI 10.1128/JB.00531-13; Jung IL, 2003, ARCH BIOCHEM BIOPHYS, V418, P125, DOI 10.1016/j.abb.2003.08.003; Karpinets TV, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-30; LAGEVEEN RG, 1988, APPL ENVIRON MICROB, V54, P2924, DOI 10.1128/AEM.54.12.2924-2932.1988; Larionov A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-62; Lee SH, 2005, APPL ENVIRON MICROB, V71, P8581, DOI 10.1128/AEM.71.12.8581-8586.2005; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Lopez NI, 2009, CURR MICROBIOL, V59, P514, DOI 10.1007/s00284-009-9469-9; Martinez-Antonio A, 2003, CURR OPIN MICROBIOL, V6, P482, DOI 10.1016/j.mib.2003.09.002; McClure R, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt444; McPhee JB, 2003, MOL MICROBIOL, V50, P205, DOI 10.1046/j.1365-2958.2003.03673.x; Mern DS, 2010, MICROBIOL-SGM, V156, P1505, DOI 10.1099/mic.0.032847-0; Miller SH, 2010, ENV MICROBIOL REP, V2, P403, DOI 10.1111/j.1758-2229.2009.00105.x; Mykytczuk NCS, 2013, ISME J, V7, P1211, DOI 10.1038/ismej.2013.8; Nikel PI, 2014, NEW BIOTECHNOL, V31, P562, DOI 10.1016/j.nbt.2014.02.006; Nikel PI, 2006, APPL ENVIRON MICROB, V72, P2614, DOI 10.1128/AEM.72.4.2614-2620.2006; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; Piette F, 2011, APPL ENVIRON MICROB, V77, P3881, DOI 10.1128/AEM.02757-10; Iustman LJR, 2015, EXTREMOPHILES, V19, P207, DOI 10.1007/s00792-014-0700-7; Rodrigues DF, 2008, APPL ENVIRON MICROB, V74, P1677, DOI 10.1128/AEM.02000-07; Sabra W, 2002, MICROBIOL-SGM, V148, P3195, DOI 10.1099/00221287-148-10-3195; Schmidtke C, 2012, NUCLEIC ACIDS RES, V40, P2020, DOI 10.1093/nar/gkr904; Schobert M, 2001, MICROBIOL-SGM, V147, P363, DOI 10.1099/00221287-147-2-363; Schreiber K, 2006, J BACTERIOL, V188, P659, DOI 10.1128/JB.188.2.659-668.2006; Sharma CM, 2010, NATURE, V464, P250, DOI 10.1038/nature08756; Subashchandrabose S, 2014, P NATL ACAD SCI USA, V111, P18327, DOI 10.1073/pnas.1415959112; Toyama H, 2004, ARCH BIOCHEM BIOPHYS, V428, P10, DOI 10.1016/j.abb.2004.03.037; Tribelli PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076685; Tribelli PM, 2013, MICROBIOL-SGM, V159, P259, DOI 10.1099/mic.0.061085-0; Tribelli PM, 2011, EXTREMOPHILES, V15, P541, DOI 10.1007/s00792-011-0384-1; Tribelli PM, 2010, J MOL MICROB BIOTECH, V19, P180, DOI 10.1159/000320261; Vasil ML, 2007, BIOMETALS, V20, P587, DOI 10.1007/s10534-006-9067-2; Vrionis HA, 2002, APPL MICROBIOL BIOT, V58, P469, DOI 10.1007/s00253-001-0912-5; Wang DP, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-618; WOZNIAK DJ, 1994, J BACTERIOL, V176, P6007, DOI 10.1128/jb.176.19.6007-6014.1994	52	24	25	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145353	10.1371/journal.pone.0145353	http://dx.doi.org/10.1371/journal.pone.0145353			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671564	gold, Green Published, Green Submitted			2022-12-26	WOS:000366719300059
J	Kim, JE; Roh, E; Lee, MH; Yu, DH; Kim, DJ; Lim, TG; Jung, SK; Peng, C; Cho, YY; Dickinson, S; Alberts, D; Bowden, GT; Einspahr, J; Stratton, SP; Curiel-Lewandrowski, C; Bode, AM; Lee, KW; Dong, Z				Kim, J-E; Roh, E.; Lee, M. H.; Yu, D. H.; Kim, D. J.; Lim, T-G; Jung, S. K.; Peng, C.; Cho, Y-Y; Dickinson, S.; Alberts, D.; Bowden, G. T.; Einspahr, J.; Stratton, S. P.; Curiel-Lewandrowski, C.; Bode, A. M.; Lee, K. W.; Dong, Z.			Fyn is a redox sensor involved in solar ultraviolet light-induced signal transduction in skin carcinogenesis	ONCOGENE			English	Article							SRC-FAMILY KINASES; TYROSINE PHOSPHORYLATION; PKC-DELTA; C-DELTA; APOPTOSIS; CANCER; ACTIVATION; RADIATION; STRESS; TARGET	Solar ultraviolet (UV) light is a major etiological factor in skin carcinogenesis, with solar UV-stimulated signal transduction inducing pathological changes and skin damage. The primary sensor of solar UV-induced cellular signaling has not been identified. We use an experimental system of solar simulated light (SSL) to mimic solar UV and we demonstrate that Fyn is a primary redox sensor involved in SSL-induced signal transduction. Reactive oxygen species (ROS) generated by SSL exposure directly oxidize Cys488 of Fyn, resulting in increased Fyn kinase activity. Fyn oxidation was increased in mouse skin after SSL exposure and Fyn-knockout mice formed larger and more tumors compared with Fyn wild-type mice when exposed to SSL for an extended period of time. Murine embryonic fibroblasts (MEFs) lacking Fyn and cells in which Fyn expression was knocked down were resistant to SSL-induced apoptosis. Furthermore, cells expressing mutant Fyn (C448A) were resistant to SSL-induced apoptosis. These findings suggest that Fyn acts as a regulatory nexus between solar UV, ROS and signal transduction during skin carcinogenesis.	[Kim, J-E; Roh, E.; Lee, M. H.; Yu, D. H.; Kim, D. J.; Lim, T-G; Jung, S. K.; Peng, C.; Cho, Y-Y; Bode, A. M.; Dong, Z.] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA; [Kim, J-E; Lim, T-G; Jung, S. K.; Lee, K. W.] Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea; [Kim, J-E; Lim, T-G; Lee, K. W.] Seoul Natl Univ, Adv Inst Convergence Technol, Suwon, Gyeonggi Do, South Korea; [Lee, M. H.] China US Hormel Canc Inst, Zhenzhou, Henan, Peoples R China; [Lim, T-G; Jung, S. K.] Korea Food Res Inst, Div Strateg Food Res, Songnam, Gyeonggi Do, South Korea; [Cho, Y-Y] Catholic Univ Korea, Coll Pharm, Bucheon Si, Gyeonggi Do, South Korea; [Dickinson, S.; Alberts, D.; Bowden, G. T.; Einspahr, J.; Stratton, S. P.; Curiel-Lewandrowski, C.] Univ Arizona, Ctr Canc, Tucson, AZ USA	University of Minnesota System; Seoul National University (SNU); Seoul National University (SNU); Korea Food Research Institute (KFRI); Catholic University of Korea; University of Arizona	Dong, Z (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.; Lee, KW (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul 151921, South Korea.	kiwon@snu.ac.kr; zgdong@hi.umn.edu	Lee, Ki Won/M-4114-2018; kim, jong-eun/B-3550-2017; Lim, Tae-Gyu/AAO-8475-2020; Cho, Yong-Yeon/AAD-4263-2020	kim, jong-eun/0000-0002-5030-6126; Lim, Tae-Gyu/0000-0001-6930-9565; Cho, Yong-Yeon/0000-0003-1107-2651	National Institutes of Health [CA077646, CA027502, CA166011, CA172457, R37CA081064]; Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [F00044]; Leap Research Program through the National Research Foundation, Ministry of Science, ICT and Future Planning, Republic of Korea [2015R1A2A1A10053567]; Hormel Foundation; NATIONAL CANCER INSTITUTE [P01CA027502, R37CA081064, R01CA077646, R21CA172457, R01CA166011] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Leap Research Program through the National Research Foundation, Ministry of Science, ICT and Future Planning, Republic of Korea; Hormel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by The Hormel Foundation and National Institutes of Health grants to ZD (CA077646, CA027502, CA166011, CA172457 and R37CA081064), the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (F00044) and the Leap Research Program through the National Research Foundation, Ministry of Science, ICT and Future Planning, Republic of Korea (2015R1A2A1A10053567).	Abdel-Malek ZA, 2010, PIGM CELL MELANOMA R, V23, P171, DOI 10.1111/j.1755-148X.2010.00679.x; Aleshin A, 2010, NEOPLASIA, V12, P599, DOI 10.1593/neo.10328; Basu A, 2010, THESCIENTIFICWORLDJO, V10, P2272, DOI 10.1100/tsw.2010.214; Benes C, 2001, AM J PHYSIOL-CELL PH, V280, pC1498, DOI 10.1152/ajpcell.2001.280.6.C1498; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Breitkreutz D, 2007, J CANCER RES CLIN, V133, P793, DOI 10.1007/s00432-007-0280-3; Byun S, 2013, CARCINOGENESIS, V34, P397, DOI 10.1093/carcin/bgs358; Byun S, 2010, CANCER RES, V70, P2415, DOI 10.1158/0008-5472.CAN-09-4093; Chan CB, 2010, DIABETES, V59, P883, DOI 10.2337/db09-1404; Chen ZY, 2011, CARCINOGENESIS, V32, P1419, DOI 10.1093/carcin/bgr088; Fukunaga M, 2001, BIOCHEM BIOPH RES CO, V289, P573, DOI 10.1006/bbrc.2001.6025; Giannoni E, 2005, MOL CELL BIOL, V25, P6391, DOI 10.1128/MCB.25.15.6391-6403.2005; Giannoni E, 2010, FREE RADICAL BIO MED, V49, P516, DOI 10.1016/j.freeradbiomed.2010.04.025; Hanson KM, 2002, PHOTOCHEM PHOTOBIOL, V76, P57, DOI 10.1562/0031-8655(2002)076<0057:OAQOUI>2.0.CO;2; Humphries MJ, 2008, ONCOGENE, V27, P3045, DOI 10.1038/sj.onc.1210967; Joseloff E, 2002, J BIOL CHEM, V277, P12318, DOI 10.1074/jbc.M111618200; Jung SK, 2008, CANCER RES, V68, P6021, DOI 10.1158/0008-5472.CAN-08-0899; Krutmann J, 2010, TXB AGING SKIN, P101; Kulms D, 2002, J INVEST DERM SYMP P, V7, P46, DOI 10.1046/j.1523-1747.2002.19638.x; Lee KM, 2010, BIOCHEM PHARMACOL, V80, P2042, DOI 10.1016/j.bcp.2010.06.042; Lee KM, 2010, CANCER PREV RES, V3, P454, DOI 10.1158/1940-6207.CAPR-09-0137; Li JX, 2012, CANCER RES, V72, P260, DOI 10.1158/0008-5472.CAN-11-2596; Li WJ, 2007, J BIOL CHEM, V282, P1161, DOI 10.1074/jbc.M606583200; Lippens S, 2009, APOPTOSIS, V14, P549, DOI 10.1007/s10495-009-0324-z; Liu KD, 2013, CANCER RES, V73, P2181, DOI 10.1158/0008-5472.CAN-12-3408; Loesch M, 2008, FRONT BIOSCI-LANDMRK, V13, P3581, DOI 10.2741/2951; Madan V, 2010, LANCET, V375, P673, DOI 10.1016/S0140-6736(09)61196-X; Narayanan DL, 2010, INT J DERMATOL, V49, P978, DOI 10.1111/j.1365-4632.2010.04474.x; Oi N, 2012, CANCER PREV RES, V5, P1103, DOI 10.1158/1940-6207.CAPR-11-0397; Parkin DM, 2011, BRIT J CANCER, V105, pS66, DOI 10.1038/bjc.2011.486; Parsons SJ, 2004, ONCOGENE, V23, P7906, DOI 10.1038/sj.onc.1208160; Raj D, 2006, J INVEST DERMATOL, V126, P243, DOI 10.1038/sj.jid.5700008; Saito YD, 2010, CANCER-AM CANCER SOC, V116, P1629, DOI 10.1002/cncr.24879; Shim JH, 2010, CANCER PREV RES, V3, P670, DOI 10.1158/1940-6207.CAPR-09-0185; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Sui XB, 2014, CANCER LETT, V344, P174, DOI 10.1016/j.canlet.2013.11.019; Tang X, 2007, CELL DEATH DIFFER, V14, P368, DOI 10.1038/sj.cdd.4402011; Vasant C, 2003, FREE RADICAL BIO MED, V35, P1082, DOI 10.1016/S0891-5849(03)00471-4; Wagener FADTG, 2013, INT J MOL SCI, V14, P9126, DOI 10.3390/ijms14059126; Xu YR, 2005, J DERMATOL SCI, pS1, DOI 10.1016/j.descs.2005.06.002; Yoo SK, 2011, NATURE, V480, P109, DOI 10.1038/nature10632; Zhao L, 2009, CANCER RES, V69, P9439, DOI 10.1158/0008-5472.CAN-09-2976	42	21	21	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 4	2016	35	31					4091	4101		10.1038/onc.2015.471	http://dx.doi.org/10.1038/onc.2015.471			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS8GG	26686094	Green Accepted			2022-12-26	WOS:000381020900007
J	Dunne, M; Leicht, S; Krichel, B; Mertens, HDT; Thompson, A; Krijgsveld, J; Svergun, DI; Gomez-Torres, N; Garde, S; Uetrecht, C; Narbad, A; Mayer, MJ; Meijers, R				Dunne, Matthew; Leicht, Stefan; Krichel, Boris; Mertens, Haydyn D. T.; Thompson, Andrew; Krijgsveld, Jeroen; Svergun, Dmitri I.; Gomez-Torres, Natalia; Garde, Sonia; Uetrecht, Charlotte; Narbad, Arjan; Mayer, Melinda J.; Meijers, Rob			Crystal Structure of the CTP1L Endolysin Reveals How Its Activity Is Regulated by a Secondary Translation Product	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bacteriophage; enzyme catalysis; mass spectrometry (MS); oligomerization; protein structure; Clostridia; antimicrobial; endolysin; native mass spectrometry; secondary translation	SMALL-ANGLE SCATTERING; OF-FLIGHT INSTRUMENT; BIOLOGICAL MACROMOLECULES; BACTERIOPHAGE ENDOLYSINS; CLOSTRIDIUM-PERFRINGENS; PROTEIN ASSEMBLIES; MASS-SPECTROMETRY; OVERLAPPING GENES; GENOMIC SEQUENCE; PHAGE	Bacteriophages produce endolysins, which lyse the bacterial host cell to release newly produced virions. The timing of lysis is regulated and is thought to involve the activation of a molecular switch. We present a crystal structure of the activated endolysin CTP1L that targets Clostridium tyrobutyricum, consisting of a complex between the full-length protein and an N-terminally truncated C-terminal cell wall binding domain (CBD). The truncated CBD is produced through an internal translation start site within the endolysin gene. Mutants affecting the internal translation site change the oligomeric state of the endolysin and reduce lytic activity. The activity can be modulated by reconstitution of the full-length endolysin-CBD complex with free CBD. The same oligomerization mechanism applies to the CD27L endolysin that targets Clostridium difficile and the CS74L endolysin that targets Clostridium sporogenes. When the CTP1L endolysin gene is introduced into the commensal bacterium Lactococcus lactis, the truncated CBD is also produced, showing that the alternative start codon can be used in other bacterial species. The identification of a translational switch affecting oligomerization presented here has implications for the design of effective endolysins for the treatment of bacterial infections.	[Dunne, Matthew; Mertens, Haydyn D. T.; Svergun, Dmitri I.; Meijers, Rob] European Mol Biol Lab, Notkestr 85, D-22607 Hamburg, Germany; [Leicht, Stefan; Krijgsveld, Jeroen] European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany; [Krichel, Boris; Uetrecht, Charlotte] Leibniz Inst Expt Virol, Heinrich Pette Inst, Martinistr 52, D-20251 Hamburg, Germany; [Thompson, Andrew] Synchrotron Soleil, BP 48, F-91192 Gif Sur Yvette, France; [Gomez-Torres, Natalia; Garde, Sonia] Inst Nacl Invest & Tecnol Agr & Alimentaria, Dept Tecnol Alimentos, Carretera La Coruna Km 7, Madrid 28040, Spain; [Uetrecht, Charlotte] European XFEL GmbH, Notkestr 85, D-22607 Hamburg, Germany; [Narbad, Arjan; Mayer, Melinda J.] Inst Food Res, Norwich NR4 7UA, Norfolk, England	European Molecular Biology Laboratory (EMBL); European Molecular Biology Laboratory (EMBL); Heinrich Pette Institute; SOLEIL Synchrotron; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); European XFEL; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia	Meijers, R (corresponding author), European Mol Biol Lab, Notkestr 85, D-22607 Hamburg, Germany.; Mayer, MJ (corresponding author), Inst Food Res, Norwich NR4 7UA, Norfolk, England.	melinda.mayer@ifr.ac.uk; r.meijers@embl-hamburg.de	Uetrecht, Charlotte/D-1883-2010; Dunne, Matthew/J-4751-2019; Krichel, Boris/GXH-3060-2022; Garde, Sonia/J-7994-2014	Uetrecht, Charlotte/0000-0002-1991-7922; Dunne, Matthew/0000-0002-2329-8183; Krichel, Boris/0000-0001-9667-0719; Gomez-Torres, Natalia/0000-0003-4279-2977; Meijers, Rob/0000-0003-2872-6279; Krijgsveld, Jeroen/0000-0001-7549-9326; Svergun, Dmitri/0000-0003-0830-5696; Garde, Sonia/0000-0002-5180-766X; Mertens, Haydyn/0000-0002-5664-744X	Spanish Ministry of Economy and Competitiveness Project [RTA 2011-00024-C02-01]; Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria grant; Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant [BB/J004529/1]; Leibniz Association Grant [SAW-2014-HPI-4]; EU FP7 e-Infrastructures Program, Grant WeNMR [261572]; BBSRC [BBS/E/F/00044453] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/F/00044453] Funding Source: researchfish	Spanish Ministry of Economy and Competitiveness Project(Spanish Government); Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria grant; Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Leibniz Association Grant; EU FP7 e-Infrastructures Program, Grant WeNMR; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Spanish Ministry of Economy and Competitiveness Project RTA 2011-00024-C02-01 (to S. G.), an Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria grant (to N. G. T.), Biotechnology and Biological Sciences Research Council Institute Strategic Programme Grant BB/J004529/1 (to M. M. and A. N.), and Leibniz Association Grant SAW-2014-HPI-4 (to B. K. and C. U.). The authors declare that they have no conflicts of interest with the contents of this article.; Supported by the EU FP7 e-Infrastructures Program, Grant WeNMR, Contract 261572.	Abaev I, 2013, APPL MICROBIOL BIOT, V97, P3449, DOI 10.1007/s00253-012-4252-4; Benesch JLP, 2007, CHEM REV, V107, P3544, DOI 10.1021/cr068289b; Brettschneider C, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.44; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cohen SX, 2008, ACTA CRYSTALLOGR D, V64, P49, DOI 10.1107/S0907444907047580; Cowtan K, 2012, ACTA CRYSTALLOGR D, V68, P328, DOI 10.1107/S0907444911039655; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Dunne M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004228; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2011, ACTA CRYSTALLOGR D, V67, P282, DOI 10.1107/S090744491003982X; Fernandez A, 2009, APPL ENVIRON MICROB, V75, P869, DOI 10.1128/AEM.01728-08; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gervasi T, 2014, APPL MICROBIOL BIOT, V98, P2495, DOI 10.1007/s00253-013-5128-y; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Kuty GF, 2010, J BACTERIOL, V192, P5682, DOI 10.1128/JB.00674-10; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; Lorenzen K, 2007, INT J MASS SPECTROM, V268, P198, DOI 10.1016/j.ijms.2007.06.012; Mayer MJ, 2008, J BACTERIOL, V190, P6734, DOI 10.1128/JB.00686-08; Mayer MJ, 2012, APPL ENVIRON MICROB, V78, P3685, DOI 10.1128/AEM.07884-11; Mayer MJ, 2011, J BACTERIOL, V193, P5477, DOI 10.1128/JB.00439-11; Mayer MJ, 2010, APPL ENVIRON MICROB, V76, P5415, DOI 10.1128/AEM.00989-10; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGowan S, 2012, P NATL ACAD SCI USA, V109, P12752, DOI 10.1073/pnas.1208424109; Morgner N, 2012, ANAL CHEM, V84, P2939, DOI 10.1021/ac300056a; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nascimento JG, 2008, J BACTERIOL, V190, P457, DOI 10.1128/JB.01195-07; Nelson D, 2006, P NATL ACAD SCI USA, V103, P10765, DOI 10.1073/pnas.0604521103; Parreira R, 1999, GENE, V226, P83, DOI 10.1016/S0378-1119(98)00554-X; Polonio-Vallon T, 2014, CELL CYCLE, V13, P115, DOI 10.4161/cc.26857; Proenca D, 2015, MOL MICROBIOL, V95, P739, DOI 10.1111/mmi.12857; Rau A, 2001, J BIOL CHEM, V276, P31994, DOI 10.1074/jbc.M102591200; Read RJ, 2011, ACTA CRYSTALLOGR D, V67, P338, DOI 10.1107/S0907444910051371; Resch G, 2011, INT J ANTIMICROB AG, V38, P516, DOI 10.1016/j.ijantimicag.2011.08.009; Scherbakov DV, 2000, MOL BIOL+, V34, P485, DOI 10.1007/BF02759558; Schmelcher M, 2012, FUTURE MICROBIOL, V7, P1147, DOI [10.2217/fmb.12.97, 10.2217/FMB.12.97]; SHEARMAN CA, 1994, APPL ENVIRON MICROB, V60, P3063, DOI 10.1128/AEM.60.9.3063-3073.1994; Sun QG, 2009, NAT STRUCT MOL BIOL, V16, P1192, DOI 10.1038/nsmb.1681; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Tahallah N, 2001, RAPID COMMUN MASS SP, V15, P596, DOI 10.1002/rcm.275; Tamai E, 2014, MOL MICROBIOL, V92, P326, DOI 10.1111/mmi.12559; Uetrecht C, 2011, ANGEW CHEM INT EDIT, V50, P8248, DOI 10.1002/anie.201008120; van den Heuvel RHH, 2006, ANAL CHEM, V78, P7473, DOI 10.1021/ac061039a; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; Xu M, 2005, SCIENCE, V307, P113, DOI 10.1126/science.1105143; Young R, 2013, CURR OPIN MICROBIOL, V16, P790, DOI 10.1016/j.mib.2013.08.008	49	28	28	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAR 4	2016	291	10					4882	4893		10.1074/jbc.M115.671172	http://dx.doi.org/10.1074/jbc.M115.671172			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DF8WF	26683375	Green Published, hybrid			2022-12-26	WOS:000371640600004
J	Mangan, MSJ; Bird, CH; Kaiserman, D; Matthews, AY; Hitchen, C; Steer, DL; Thompson, PE; Bird, PI				Mangan, Matthew S. J.; Bird, Catherina H.; Kaiserman, Dion; Matthews, Anthony Y.; Hitchen, Corinne; Steer, David L.; Thompson, Philip E.; Bird, Phillip I.			A Novel Serpin Regulatory Mechanism: SerpinB9 IS REVERSIBLY INHIBITED BY VICINAL DISULFIDE BOND FORMATION IN THE REACTIVE CENTER LOOP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						immunotherapy; lysosome; natural killer cells (NK cells); protease; reactive oxygen species (ROS); serpin; T cell; SerpinB9; granzyme B; lysosomal membrane permeabilization	GRANZYME-B INHIBITOR; CELL-RECEPTOR STIMULATION; NEUTROPHIL EXTRACELLULAR TRAPS; T-CELL; PROTEASE INHIBITOR-9; SELECTIVE REGULATION; MEDIATED APOPTOSIS; CYTOTOXIC PATHWAYS; HYDROGEN-PEROXIDE; OXYGEN	The intracellular protease inhibitor Sb9 (SerpinB9) is a regulator of the cytotoxic lymphocyte protease GzmB (granzyme B). Although GzmB is primarily involved in the destruction of compromised cells, recent evidence suggests that it is also involved in lysosome-mediated death of the cytotoxic lymphocyte itself. Sb9 protects the cell from GzmB released from lysosomes into the cytosol. Here we show that reactive oxygen species (ROS) generated within cytotoxic lymphocytes by receptor stimulation are required for lyososomal permeabilization and release of GzmB into the cytosol. Importantly, ROS also inactivate Sb9 by oxidizing a highly conserved cysteine pair (P1-P1 in rodents and P1-P2 in other mammals) in the reactive center loop to form a vicinal disulfide bond. Replacement of the P4-P3 reactive center loop residues of the prototype serpin, SERPINA1, with the P4-P5 residues of Sb9 containing the cysteine pair is sufficient to convert SERPINA1 into a ROS-sensitive GzmB inhibitor. Conversion of the cysteine pair to serines in either human or mouse Sb9 results in a functional serpin that inhibits GzmB and resists ROS inactivation. We conclude that ROS sensitivity of Sb9 allows the threshold for GzmB-mediated suicide to be lowered, as part of a conserved post-translational homeostatic mechanism regulating lymphocyte numbers or activity. It follows, for example, that antioxidants may improve NK cell viability in adoptive immunotherapy applications by stabilizing Sb9.	[Mangan, Matthew S. J.; Bird, Catherina H.; Kaiserman, Dion; Matthews, Anthony Y.; Hitchen, Corinne; Steer, David L.; Bird, Phillip I.] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Thompson, Philip E.] Monash Univ, Monash Inst Pharmaceut Sci, Dept Med Chem, Parkville, Vic 3052, Australia	Monash University; Monash University	Bird, PI (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Wellington Rd, Clayton, Vic 3800, Australia.	phil.bird@monash.edu		Bird, Phillip/0000-0002-6695-606X; Thompson, Philip/0000-0002-5910-7625	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia. The authors declare that they have no conflicts of interest with the contents of this article.	Afonina IS, 2010, IMMUNOL REV, V235, P105, DOI 10.1111/j.0105-2896.2010.00908.x; Aits S, 2013, J CELL SCI, V126, P1905, DOI 10.1242/jcs.091181; Ansari AW, 2010, J IMMUNOL, V185, P877, DOI 10.4049/jimmunol.1000651; Azzi J, 2013, J IMMUNOL, V191, P2319, DOI 10.4049/jimmunol.1300851; Bajor-Dattilo EB, 2013, BEST PRACT RES CL HA, V26, P75, DOI 10.1016/j.beha.2013.04.007; Benarafa C, 2005, P NATL ACAD SCI USA, V102, P11367, DOI 10.1073/pnas.0502934102; Bird CH, 2014, CELL DEATH DIFFER, V21, P876, DOI 10.1038/cdd.2014.7; Bird CH, 2010, BIOL CHEM, V391, P999, DOI 10.1515/BC.2010.099; Bird CH, 1998, MOL CELL BIOL, V18, P6387, DOI 10.1128/MCB.18.11.6387; Bladergroen BA, 2002, BLOOD, V99, P232, DOI 10.1182/blood.V99.1.232; Bots M, 2005, BLOOD, V105, P1153, DOI 10.1182/blood-2004-03-0791; BRIGGS RT, 1975, J CELL BIOL, V64, P254, DOI 10.1083/jcb.64.1.254; Brinkmann V, 2004, SCIENCE, V303, P1532, DOI 10.1126/science.1092385; Buzza MS, 2001, CELL IMMUNOL, V210, P21, DOI 10.1006/cimm.2001.1806; Cairns RA, 2011, NAT REV CANCER, V11, P85, DOI 10.1038/nrc2981; Classen CF, 2006, CLIN EXP IMMUNOL, V143, P534, DOI 10.1111/j.1365-2249.2006.03006.x; Classen CF, 2004, HAEMATOLOGICA, V89, P1314; Cooley J, 2001, BIOCHEMISTRY-US, V40, P15762, DOI 10.1021/bi0113925; Devadas S, 2002, J EXP MED, V195, P59, DOI 10.1084/jem.20010659; Devadas S, 2006, IMMUNITY, V25, P237, DOI 10.1016/j.immuni.2006.06.011; Fialkow L, 2007, FREE RADICAL BIO MED, V42, P153, DOI 10.1016/j.freeradbiomed.2006.09.030; Gelderman KA, 2007, J CLIN INVEST, V117, P3020, DOI 10.1172/JCI31935; Godal R, 2006, BLOOD, V107, P3205, DOI 10.1182/blood-2005-07-2880; Hansson M, 1996, J IMMUNOL, V156, P42; Hildeman DA, 2004, FREE RADICAL BIO MED, V36, P1496, DOI 10.1016/j.freeradbiomed.2004.03.023; Hill BG, 2012, J MOL CELL CARDIOL, V52, P559, DOI 10.1016/j.yjmcc.2011.07.009; Hirst CE, 2003, J IMMUNOL, V170, P805, DOI 10.4049/jimmunol.170.2.805; Horvath AJ, 2011, METHOD ENZYMOL, V501, P223, DOI 10.1016/B978-0-12-385950-1.00011-0; Hughes K, 2012, HORM MOL BIOL CLIN I, V10, P211, DOI 10.1515/hmbci-2012-0008; Ida H, 2003, EUR J IMMUNOL, V33, P3284, DOI 10.1002/eji.200324376; Jackson SH, 2004, NAT IMMUNOL, V5, P818, DOI 10.1038/ni1096; Kaiserman D, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-167; Kaiserman D, 2006, J CELL BIOL, V175, P619, DOI 10.1083/jcb.200606073; Kaiserman D, 2011, METHOD ENZYMOL, V501, P1, DOI 10.1016/B978-0-12-385950-1.00001-8; Kobayashi CI, 2012, J CELL PHYSIOL, V227, P421, DOI 10.1002/jcp.22764; Laforge M, 2006, J IMMUNOL, V176, P3966, DOI 10.4049/jimmunol.176.7.3966; Lapteva Natalia, 2014, Critical Reviews in Oncogenesis, V19, P121; Loebbermann J, 2012, MUCOSAL IMMUNOL, V5, P161, DOI 10.1038/mi.2011.62; Medema JP, 2001, P NATL ACAD SCI USA, V98, P11515, DOI 10.1073/pnas.201398198; Michalek RD, 2007, J IMMUNOL, V179, P6456, DOI 10.4049/jimmunol.179.10.6456; Miki H, 2012, J BIOCHEM, V151, P255, DOI 10.1093/jb/mvs006; Morris EC, 2003, BIOCHEM J, V371, P165, DOI 10.1042/BJ20021567; Muris JJF, 2004, LEUKEMIA, V18, P589, DOI 10.1038/sj.leu.2403240; Northfield SE, 2010, INT J PEPT RES THER, V16, P159, DOI 10.1007/s10989-010-9220-1; OWEN MC, 1983, NEW ENGL J MED, V309, P694, DOI 10.1056/NEJM198309223091203; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; de Hooge ASK, 2007, CLIN CANCER RES, V13, P206, DOI 10.1158/1078-0432.CCR-06-1457; Salti SM, 2011, J IMMUNOL, V187, P6301, DOI 10.4049/jimmunol.1100891; Schick C, 1998, P NATL ACAD SCI USA, V95, P13465, DOI 10.1073/pnas.95.23.13465; Scott FL, 1999, BLOOD, V93, P2089, DOI 10.1182/blood.V93.6.2089.406k10_2089_2097; Sena LA, 2013, IMMUNITY, V38, P225, DOI 10.1016/j.immuni.2012.10.020; Silverman GA, 2010, J BIOL CHEM, V285, P24299, DOI 10.1074/jbc.R110.112771; Sun J, 2001, J BIOL CHEM, V276, P15177, DOI 10.1074/jbc.M006645200; Sun JR, 1999, BIOCHEM BIOPH RES CO, V261, P251, DOI 10.1006/bbrc.1999.0989; Sun JR, 1997, J BIOL CHEM, V272, P15434, DOI 10.1074/jbc.272.24.15434; Sun JR, 1996, J BIOL CHEM, V271, P27802, DOI 10.1074/jbc.271.44.27802; Taggart C, 2000, J BIOL CHEM, V275, P27258; Tatla S, 1999, FREE RADICAL BIO MED, V26, P14, DOI 10.1016/S0891-5849(98)00133-6; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; TRAPANI JA, 1993, BIOCHEM BIOPH RES CO, V195, P910, DOI 10.1006/bbrc.1993.2131; Whisstock JC, 2010, J BIOL CHEM, V285, P24307, DOI 10.1074/jbc.R110.141408; Williams MS, 2004, FREE RADICAL BIO MED, V37, P1144, DOI 10.1016/j.freeradbiomed.2004.05.029; Willoughby CA, 2002, BIOORG MED CHEM LETT, V12, P2197, DOI 10.1016/S0960-894X(02)00363-3; Zhang ML, 2006, IMMUNITY, V24, P451, DOI 10.1016/j.immuni.2006.02.002	64	12	13	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3626	3638		10.1074/jbc.M115.699298	http://dx.doi.org/10.1074/jbc.M115.699298			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26670609	hybrid, Green Published			2022-12-26	WOS:000370854500040
J	AlSudais, H; Aabed, K; Nicola, W; Dixon, K; Chen, JH; Li, Q				AlSudais, Hamood; Aabed, Kawther; Nicola, William; Dixon, Katherine; Chen, Jihong; Li, Qiao			Retinoid X Receptor-selective Signaling in the Regulation of Akt/Protein Kinase B Isoform-specific Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER CACHEXIA; SKELETAL-MUSCLE; RXR-ALPHA; MICE LACKING; MUTANT MICE; MYOD; DIFFERENTIATION; AKT; PATHWAYS; ACETYLTRANSFERASE	The differentiation and fusion of myoblasts into mature myotubes are complex processes responding to multiple signaling pathways. The function of Akt/PKB is critical for myogenesis, but less is clear as to the regulation of its isoform-specific expression. Bexarotene is a drug already used clinically to treat cancer, and it has the ability to enhance the commitment of embryonic stem cells into skeletal muscle lineage. Whereas bexarotene regulates fundamental biological processes through retinoid X receptor (RXR)-mediated gene expression, molecular pathways underlying its positive effects on myogenesis remain unclear. In this study, we have examined the signaling pathways that transmit bexarotene action in the context of myoblast differentiation. We show that bexarotene promotes myoblast differentiation and fusion through the activation of RXR and the regulation of Akt/PKB isoform-specific expression. Interestingly, bexarotene signaling appears to correlate with residuespecific histone acetylation and is able to counteract the detrimental effects of cachectic factors on myogenic differentiation. We also signify an isoform-specific role for Akt/PKB in RXR-selective signaling to promote and to retain myoblast differentiation. Taken together, our findings establish the viability of applying bexarotene in the prevention and treatment of muscle-wasting disorders, particularly given the lack of drugs that promote myogenic differentiation available for potential clinical applications. Furthermore, the model of bexarotene-enhanced myogenic differentiation will provide an important avenue to identify additional genetic targets and specific molecular interactions that we can study and apply for the development of potential therapeutics in muscle regeneration and repair.	[AlSudais, Hamood; Nicola, William; Dixon, Katherine; Li, Qiao] Univ Ottawa, Dept Cellular & Mol Med, Fac Med, 451 Smyth Rd,Rm 2537, Ottawa, ON K1H 8M5, Canada; [Aabed, Kawther; Chen, Jihong; Li, Qiao] Univ Ottawa, Dept Pathol & Lab Med, Fac Med, 451 Smyth Rd,Rm 2537, Ottawa, ON K1H 8M5, Canada	University of Ottawa; University of Ottawa	Li, Q (corresponding author), Univ Ottawa, Dept Cellular & Mol Med, Fac Med, 451 Smyth Rd,Rm 2537, Ottawa, ON K1H 8M5, Canada.; Li, Q (corresponding author), Univ Ottawa, Dept Pathol & Lab Med, Fac Med, 451 Smyth Rd,Rm 2537, Ottawa, ON K1H 8M5, Canada.	qiao.li@uottawa.ca	AlSudais, Hamood/AGI-7624-2022; Aabed, Kawther/AAD-8205-2020	AlSudais, Hamood/0000-0001-8228-1392; Aabed, Kawther/0000-0002-9927-5308; Li, Qiao/0000-0002-5941-1985; Dixon, Katherine/0000-0002-7334-888X; Chen, Jihong/0000-0001-7336-8808	operating grant from Natural Sciences and Engineering Research Council of Canada	operating grant from Natural Sciences and Engineering Research Council of Canada	This work was supported in part by an operating grant from Natural Sciences and Engineering Research Council of Canada (to Q. L.). The authors declare that they have no conflicts of interest with the contents of this article.	Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Acharyya S, 2007, CLIN CANCER RES, V13, P1356, DOI 10.1158/1078-0432.CCR-06-2307; Asp P, 2011, P NATL ACAD SCI USA, V108, pE149, DOI 10.1073/pnas.1102223108; Barbosa-Morais NL, 2012, SCIENCE, V338, P1587, DOI 10.1126/science.1230612; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Blum R, 2012, GENE DEV, V26, P2763, DOI 10.1101/gad.200113.112; Boergesen M, 2012, MOL CELL BIOL, V32, P852, DOI 10.1128/MCB.06175-11; Chambon P, 2005, MOL ENDOCRINOL, V19, P1418, DOI 10.1210/me.2005-0125; Chen J, 2004, CELL MOL LIFE SCI, V61, P1675, DOI 10.1007/s00018-004-4103-9; Chen JH, 2005, MOL CELL BIOL, V25, P525, DOI 10.1128/MCB.25.2.525-532.2005; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Daniel B, 2014, GENE DEV, V28, P1562, DOI 10.1101/gad.242685.114; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dodson S, 2011, ANNU REV MED, V62, P265, DOI 10.1146/annurev-med-061509-131248; Fanzani A, 2012, J CACHEXIA SARCOPENI, V3, P163, DOI 10.1007/s13539-012-0074-6; Folkers GE, 1998, J BIOL CHEM, V273, P32200, DOI 10.1074/jbc.273.48.32200; Fujio Y, 1999, MOL CELL BIOL, V19, P5073; Gampe RT, 2000, GENE DEV, V14, P2229, DOI 10.1101/gad.802300; Gardner S, 2012, AM J PHYSIOL-CELL PH, V303, pC1292, DOI 10.1152/ajpcell.00259.2012; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Gniadecki R, 2007, BRIT J DERMATOL, V157, P433, DOI 10.1111/j.1365-2133.2007.07975.x; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Hamed M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02390; Higazi A, 2011, EPIGENETICS-US, V6, P202, DOI 10.4161/epi.6.2.13658; Huang WC, 2005, MOL CELL BIOL, V25, P6592, DOI 10.1128/MCB.25.15.6592-6602.2005; Jiang ZL, 2006, FASEB J, V20, P2570, DOI 10.1096/fj.06-6347fje; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Kandel ES, 1999, EXP CELL RES, V253, P210, DOI 10.1006/excr.1999.4690; Kaneko S, 2002, J BIOL CHEM, V277, P23230, DOI 10.1074/jbc.M201733200; Kaplan R, 2002, J LIPID RES, V43, P952; KASTNER P, 1994, CELL, V78, P987, DOI 10.1016/0092-8674(94)90274-7; Krezel W, 1996, P NATL ACAD SCI USA, V93, P9010, DOI 10.1073/pnas.93.17.9010; Langen RCJ, 2004, FASEB J, V18, P227, DOI 10.1096/fj.03-0251com; Le May M, 2011, J BIOL CHEM, V286, P26806, DOI 10.1074/jbc.M111.227058; LEID M, 1992, TRENDS BIOCHEM SCI, V17, P427, DOI 10.1016/0968-0004(92)90014-Z; Lokireddy S, 2012, BIOCHEM J, V446, P23, DOI 10.1042/BJ20112024; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173; Nagy L, 2012, PHYSIOL REV, V92, P739, DOI 10.1152/physrev.00004.2011; Nahoum V, 2007, P NATL ACAD SCI USA, V104, P17323, DOI 10.1073/pnas.0705356104; Nielsen R, 2008, GENE DEV, V22, P2953, DOI 10.1101/gad.501108; Rajagopal N, 2014, G3-GENES GENOM GENET, V4, P2051, DOI 10.1534/g3.114.013565; Sapin V, 1997, DEV BIOL, V191, P29, DOI 10.1006/dbio.1997.8687; Schultze Simon M., 2011, Archives of Physiology and Biochemistry, V117, P70, DOI 10.3109/13813455.2010.539236; SILBERSTEIN L, 1986, CELL, V46, P1075, DOI 10.1016/0092-8674(86)90707-5; SUCOV HM, 1994, GENE DEV, V8, P1007, DOI 10.1101/gad.8.9.1007; Sykes SM, 2011, CELL, V146, P697, DOI 10.1016/j.cell.2011.07.032; Szalay K, 1997, EUR J CELL BIOL, V74, P391; Tajbakhsh S, 1997, CELL, V89, P127, DOI 10.1016/S0092-8674(00)80189-0; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; Wu K, 2002, CANCER EPIDEM BIOMAR, V11, P467; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	55	10	11	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 5	2016	291	6					3090	3099		10.1074/jbc.M115.692707	http://dx.doi.org/10.1074/jbc.M115.692707			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0RK	26668312	hybrid, Green Published			2022-12-26	WOS:000369626900044
J	Chandrasekara, CHWMRB; Wijesundera, WSS; Perera, HN; Chong, SS; Rajan-Babu, IS				Chandrasekara, C. H. W. M. R. Bhagya; Wijesundera, W. S. Sulochana; Perera, Hemamali N.; Chong, Samuel S.; Rajan-Babu, Indhu-Shree			Cascade Screening for Fragile X Syndrome/CGG Repeat Expansions in Children Attending Special Education in Sri Lanka	PLOS ONE			English	Article							CGG REPEAT; FMR1 GENE; MENTAL-RETARDATION; HIGH-RISK; DIAGNOSIS; METHYLATION; MUTATION; DNA; PREVALENCE; FREQUENCY	Fragile X syndrome (FXS) is the commonest cause of inherited mental retardation and clinically presents with learning, emotional and behaviour problems. FXS is caused by expansion of cytosine-guanine-guanine (CGG) repeats present in the 5' untranslated region of the FMR1 gene. The aim of this study was to screen children attending special education institutions in Sri Lanka to estimate the prevalence of CGG repeat expansions. The study population comprised a representative national sample of 850 children (540 males, 310 females) with 5 to 18 years of age from moderate to severe mental retardation of wide ranging aetiology. Screening for CGG repeat expansion was carried out on DNA extracted from buccal cells using 3' direct triplet primed PCR followed by melting curve analysis. To identify the expanded status of screened positive samples, capillary electrophoresis, methylation specific PCR and Southern hybridization were carried out using venous blood samples. Prevalence of CGG repeat expansions was 2.2%. Further classification of the positive samples into FXS full mutation, pre-mutation and grey zone gave prevalence of 1.3%, 0.8% and 0.1% respectively. All positive cases were male. No females with FXS were detected in our study may have been due to the small sample size.	[Chandrasekara, C. H. W. M. R. Bhagya; Wijesundera, W. S. Sulochana] Univ Colombo, Fac Med, Dept Biochem & Mol Biol, Colombo 08, Sri Lanka; [Perera, Hemamali N.] Univ Colombo, Fac Med, Dept Psychol Med, Colombo 08, Sri Lanka; [Chong, Samuel S.; Rajan-Babu, Indhu-Shree] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pediat, Singapore 119074, Singapore; [Chong, Samuel S.] Natl Univ Hlth Syst, Childrens Med Inst, Khoo Teck Puat Natl Univ, Singapore 119228, Singapore; [Chong, Samuel S.] Natl Univ Singapore Hosp, Dept Lab Med, Singapore 119074, Singapore	University of Colombo; University of Colombo; National University of Singapore; National University of Singapore; National University of Singapore	Chandrasekara, CHWMRB (corresponding author), Univ Colombo, Fac Med, Dept Biochem & Mol Biol, Kynsey Rd, Colombo 08, Sri Lanka.	chmbhagya@gmail.com	Chong, Samuel S./D-8098-2015	Chong, Samuel S./0000-0002-1872-5937; Rajan Babu, Indhu Shree/0000-0002-5614-5212	National Research Council Sri Lanka [12-068]; University of Colombo Sri Lanka [AP/3/2012/CG/11]	National Research Council Sri Lanka; University of Colombo Sri Lanka	This work was supported by the National Research Council Sri Lanka, 12-068, www.nrc.gov.lk/; and the University of Colombo Sri Lanka AP/3/2012/CG/11, www.cmb.ac.lk/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkhalaf M, 2001, MED PRIN PRACT, V10, P73, DOI 10.1159/000050344; Behery AK, 2008, J EGYPT PUBLIC HEAL, V83, P273; Bhagya C H W M R Chandrasekara, 2013, Indian J Hum Genet, V19, P78, DOI 10.4103/0971-6866.112898; Bilgen T, 2005, Indian J Med Sci, V59, P150; Chandrasekara B, 2016, SLJCH IN PRESS, V45; Crawford DC, 1999, AM J HUM GENET, V64, P495, DOI 10.1086/302260; Demirhan O, 2003, YONSEI MED J, V44, P583, DOI 10.3349/ymj.2003.44.4.583; DEVYS D, 1992, AM J MED GENET, V43, P208, DOI 10.1002/ajmg.1320430134; FalikZaccai TC, 1997, AM J HUM GENET, V60, P103; Fatima T, 2014, AM J MED GENET A, V164, P1151, DOI 10.1002/ajmg.a.36423; Fernandez-Carvajal I, 2009, J MOL DIAGN, V11, P306, DOI 10.2353/jmoldx.2009.080174; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Godler DE, 2013, HUM MOL GENET, V22, P1516, DOI 10.1093/hmg/ddt002; Godler DE, 2010, HUM MOL GENET, V19, P1618, DOI 10.1093/hmg/ddq037; Grasso M, 2014, J MOL DIAGN, V16, P23, DOI 10.1016/j.jmoldx.2013.09.004; Greydanus Donald E., 2005, Indian Journal of Pediatrics, V72, P859, DOI 10.1007/BF02731116; Hagerman R, 2011, J NEURODEV DISORD, V3, P211, DOI 10.1007/s11689-011-9084-5; Hagerman RJ, 2008, CLIN INTERV AGING, V3, P251, DOI 10.2147/CIA.S1794; HAGERMAN RJ, 1994, AM J MED GENET, V51, P474, DOI 10.1002/ajmg.1320510436; HAGERMAN RJ, 1994, AM J MED GENET, V51, P298, DOI 10.1002/ajmg.1320510404; Handel CM, 2006, WILDLIFE SOC B, V34, P1094, DOI 10.2193/0091-7648(2006)34[1094:UOBSFS]2.0.CO;2; HOFSTEE Y, 1994, AM J MED GENET, V51, P466, DOI 10.1002/ajmg.1320510434; Iqbal MA, 2000, ANN SAUDI MED, V20, P214, DOI 10.5144/0256-4947.2000.214; Kanwal M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122213; Lim GXY, 2015, J MOL DIAGN, V17, P302, DOI 10.1016/j.jmoldx.2014.12.005; Lyons JI, 2015, J MOL DIAGN, V17, P463, DOI 10.1016/j.jmoldx.2015.04.006; Maddalena Anne, 2001, Genetics in Medicine, V3, P200, DOI 10.1097/00125817-200105000-00010; Major T, 2003, J NEUROGENET, V17, P223, DOI 10.1080/714049415; MAVROU A, 1988, AM J MED GENET, V31, P735, DOI 10.1002/ajmg.1320310403; McConkie-Rosell Allyn, 2005, J Genet Couns, V14, P249, DOI 10.1007/s10897-005-4802-x; Merenstein SA, 1996, AM J MED GENET, V64, P388, DOI 10.1002/(SICI)1096-8628(19960809)64:2<388::AID-AJMG31>3.3.CO;2-S; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Monaghan KG, 2013, GENET MED, V15, P575, DOI 10.1038/gim.2013.61; NANBA E, 1995, BRAIN DEV-JPN, V17, P317, DOI 10.1016/0387-7604(95)00031-6; Paul R, 2010, NEUROTOXICOLOGY, V31, P399, DOI 10.1016/j.neuro.2010.04.002; Pietrobono R, 2005, HUM MOL GENET, V14, P267, DOI 10.1093/hmg/ddi024; ROUSSEAU F, 1991, NEW ENGL J MED, V325, P1673, DOI 10.1056/NEJM199112123252401; Seltzer MM, 2012, AM J MED GENET B, V159B, P589, DOI 10.1002/ajmg.b.32065; Sharma D, 2001, GENET EPIDEMIOL, V20, P129, DOI 10.1002/1098-2272(200101)20:1<129::AID-GEPI11>3.0.CO;2-2; Sofocleous C, 2008, IN VIVO, V22, P451; Sullivan SD, 2011, SEMIN REPROD MED, V29, P299, DOI 10.1055/s-0031-1280915; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Teo CRL, 2012, CLIN CHEM, V58, P568, DOI 10.1373/clinchem.2011.174615; Tuncbilek E, 1999, AM J MED GENET, V84, P202, DOI 10.1002/(SICI)1096-8628(19990528)84:3<202::AID-AJMG6>3.0.CO;2-O; Winarni TI, 2012, GENET TEST MOL BIOMA, V16, P162, DOI 10.1089/gtmb.2011.0089; Youings SA, 2000, J MED GENET, V37, P415, DOI 10.1136/jmg.37.6.415; Zhou Y, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.012716; Zhou YY, 2006, CLIN CHEM, V52, P1492, DOI 10.1373/clinchem.2006.068593	48	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145537	10.1371/journal.pone.0145537	http://dx.doi.org/10.1371/journal.pone.0145537			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26694146	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092500055
J	Kuessel, L; Husslein, H; Marschalek, J; Brunner, J; Ristl, R; Popow-Kraupp, T; Kiss, H				Kuessel, Lorenz; Husslein, Heinrich; Marschalek, Julian; Brunner, Julia; Ristl, Robin; Popow-Kraupp, Theresia; Kiss, Herbert			Prediction of Maternal Cytomegalovirus Serostatus in Early Pregnancy: A Retrospective Analysis in Western Europe	PLOS ONE			English	Article							TO-MOTHER TRANSMISSION; CONGENITAL-CYTOMEGALOVIRUS; SEXUAL-ACTIVITY; UNITED-STATES; RISK-FACTORS; INFECTION; SEROPREVALENCE; PREVENTION; BIRTH; WOMEN	Background Cytomegalovirus (CMV) is the most prevalent congenital viral infection and thus places an enormous disease burden on newborn infants. Seroprevalence of maternal antibodies to CMV due to CMV exposure prior to pregnancy is currently the most important protective factor against congenital CMV disease. The aim of this study was to identify potential predictors, and to develop and evaluate a risk-predicting model for the maternal CMV serostatus in early pregnancy. Methods Maternal and paternal background information, as well as maternal CMV serostatus in early pregnancy from 882 pregnant women were analyzed. Women were divided into two groups based on their CMV serostatus, and were compared using univariate analysis. To predict serostatus based on epidemiological baseline characteristics, a multiple logistic regression model was calculated using stepwise model selection. Sensitivity and specificity were analyzed using ROC curves. A nomogram based on the model was developed. Results 646 women were CMV seropositive (73.2%), and 236 were seronegative (26.8%). The groups differed significantly with respect to maternal age (p = 0.006), gravidity (p<0.001), parity (p<0.001), use of assisted reproduction techniques (p = 0.018), maternal and paternal migration background (p<0.001), and maternal and paternal education level (p<0.001). ROC evaluation of the selected prediction model revealed an area under the curve of 0.83 (95% CI: 0.8-0.86), yielding sensitivity and specificity values of 0.69 and 0.86, respectively. Conclusion We identified predictors of maternal CMV serostatus in early pregnancy and developed a risk-predicting model based on baseline epidemiological characteristics. Our findings provide easy accessible information that can influence the counseling of pregnant woman in terms of their CMV-associated risk.	[Kuessel, Lorenz; Husslein, Heinrich; Marschalek, Julian; Brunner, Julia; Kiss, Herbert] Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria; [Ristl, Robin] Med Univ Vienna, Sect Med Stat, Ctr Med Stat Informat & Intelligent Syst, Vienna, Austria; [Popow-Kraupp, Theresia] Med Univ Vienna, Dept Virol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna	Kiss, H (corresponding author), Med Univ Vienna, Dept Obstet & Gynecol, Vienna, Austria.	herbert.kiss@meduniwien.ac.at		Husslein, Heinrich/0000-0003-0585-7444; Ristl, Robin/0000-0002-4163-9236				Adler SP, 1996, PEDIATR INFECT DIS J, V15, P240, DOI 10.1097/00006454-199603000-00013; Adler SP, 2005, PEDIATR INFECT DIS J, V24, P1105, DOI 10.1097/00006454-200512000-00016; Adler SP, 2004, J PEDIATR-US, V145, P485, DOI 10.1016/j.jpeds.2004.05.041; Adler SP, 2013, CLIN INFECT DIS, V57, pS189, DOI 10.1093/cid/cit585; Bodeus M, 2010, J CLIN VIROL, V47, P201, DOI 10.1016/j.jcv.2009.11.009; Boppana SB, 1999, PEDIATRICS, V104, P55, DOI 10.1542/peds.104.1.55; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Cannon MJ, 2010, REV MED VIROL, V20, P202, DOI 10.1002/rmv.655; DEMMLER GJ, 1991, REV INFECT DIS, V13, P315, DOI 10.1093/clinids/13.2.315; Feigin RD., 2009, FEIGIN CHERRYS TXB P, V6th ed.; Fisher S, 2000, J VIROL, V74, P6808, DOI 10.1128/JVI.74.15.6808-6820.2000; Fowler KB, 2006, PEDIATRICS, V118, pE286, DOI 10.1542/peds.2005-1142; Fowler KB, 2003, JAMA-J AM MED ASSOC, V289, P1008, DOI 10.1001/jama.289.8.1008; Fowler KB, 1992, NEW ENGL J MED, V327, P495; Gandhi MK, 2004, LANCET INFECT DIS, V4, P725, DOI 10.1016/S1473-3099(04)01202-2; Gratacap-Cavallier B, 1998, EUR J EPIDEMIOL, V14, P147, DOI 10.1023/A:1007450729633; Hecker M, 2004, VOX SANG, V86, P41, DOI 10.1111/j.0042-9007.2004.00388.x; ISTAS AS, 1995, CLIN INFECT DIS, V20, P665, DOI 10.1093/clinids/20.3.665; Kadambari S, 2011, EARLY HUM DEV, V87, P723, DOI 10.1016/j.earlhumdev.2011.08.021; Kenneson A, 2007, REV MED VIROL, V17, P253, DOI 10.1002/rmv.535; Manicklal S, 2013, CLIN MICROBIOL REV, V26, P86, DOI 10.1128/CMR.00062-12; Mussi-Pinhata MM, 2009, CLIN INFECT DIS, V49, P522, DOI 10.1086/600882; Nigro G, 2005, NEW ENGL J MED, V353, P1350, DOI 10.1056/NEJMoa043337; Ornoy A, 2006, REPROD TOXICOL, V21, P399, DOI 10.1016/j.reprotox.2005.02.002; Pembrey L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081881; Plosa EJ, 2012, AM ACAD PEDIAT, V33, P156, DOI [10.1542/pir.33-4-156, DOI 10.1542/PIR.33-4-156]; Revello MG, 2014, NEW ENGL J MED, V370, P1316, DOI 10.1056/NEJMoa1310214; Sheffield JS, 2015, CYTOMEGALOVIRUS INFE; Staras SAS, 2008, SEX TRANSM DIS, V35, P472, DOI 10.1097/OLQ.0b013e3181644b70; Staras SAS, 2008, J CLIN VIROL, V43, P266, DOI 10.1016/j.jcv.2008.07.012; Townsend CL, 2013, CLIN INFECT DIS, V56, P1232, DOI 10.1093/cid/cit018; van der Sande MAB, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000492; Vauloup-Fellous C, 2009, J CLIN VIROL, V46, pS49, DOI 10.1016/j.jcv.2009.09.003	33	3	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145470	10.1371/journal.pone.0145470	http://dx.doi.org/10.1371/journal.pone.0145470			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26693714	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092500052
J	Schuldt, NJ; Auger, JL; Hogquist, KA; Binstadt, BA				Schuldt, Nathaniel J.; Auger, Jennifer L.; Hogquist, Kristin A.; Binstadt, Bryce A.			Bi-Allelic TCR alpha or beta Recombination Enhances T Cell Development but Is Dispensable for Antigen Responses and Experimental Autoimmune Encephalomyelitis	PLOS ONE			English	Article							EXPRESSION; MICE; REPERTOIRE; EXCLUSION; SELECTION; ACTIVATION; FREQUENCY; DELETION; CHAINS; LOCUS	Dual TCR alpha-expressing T cells outnumber dual TCR beta-expressing cells by similar to 10:1. As a result, efforts to understand how dual TCR T cells impact immunity have focused on dual TCR alpha expression; dual TCR beta expression remains understudied. We recently demonstrated, however, that dual TCR beta expression accelerated disease in a TCR transgenic model of autoimmune arthritis through enhanced positive selection efficiency, indicating that dual TCR beta expression, though rare, can impact thymic selection. Here we generated mice hemizygous for TCR alpha, TCR beta, or both on the C57BL/6 background to investigate the impact bi-allelic TCR chain recombination has on T cell development, repertoire diversity, and autoimmunity. Lack of bi-allelic TCR alpha or TCR beta recombination reduced alpha beta thymocyte development efficiency, and the absence of bi-allelic TCR beta recombination promotedd T cell development. However, we observed no differences in the numbers of naive and expanded antigen-specific T cells between TCR alpha(+/-)beta(+/-) and wildtype mice, and TCR repertoire analysis revealed only subtle differences in V beta gene usage. Finally, the absence of dual TCR T cells did not impact induced experimental autoimmune encephalomyelitis pathogenesis. Thus, despite more stringent allelic exclusion of TCR beta relative to TCR alpha, bi-allelic TCR beta expression can measurably impact thymocyte development and is necessary for maintaining normal alpha beta/gamma delta T cell proportions.	[Schuldt, Nathaniel J.; Auger, Jennifer L.; Hogquist, Kristin A.; Binstadt, Bryce A.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Hogquist, Kristin A.] Univ Minnesota, Lab Med & Pathol, Minneapolis, MN 55455 USA; [Schuldt, Nathaniel J.; Auger, Jennifer L.; Hogquist, Kristin A.; Binstadt, Bryce A.] Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Binstadt, BA (corresponding author), Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA.	binstadt@umn.edu	Binstadt, Bryce/N-1305-2013	Binstadt, Bryce/0000-0003-3127-3856; Schuldt, Nathan/0000-0001-7692-4814	National Institutes of Health/National Institute of Allergy and Infectious Diseases; American Association of Immunologists; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI035296, R21AI101540] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Association of Immunologists; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health/National Institute of Allergy and Infectious Diseases (http://www.niaid.nih.gov) and American Association of Immunologists (aai.org).	Akue AD, 2012, J IMMUNOL, V188, P2516, DOI 10.4049/jimmunol.1102213; Auger JL, 2012, EUR J IMMUNOL, V42, P2354, DOI 10.1002/eji.201242520; Blink SE, 2009, CURR MOL MED, V9, P15, DOI 10.2174/156652409787314516; Bolotin DA, 2012, EUR J IMMUNOL, V42, P3073, DOI 10.1002/eji.201242517; Brady BL, 2010, J IMMUNOL, V185, P3801, DOI 10.4049/jimmunol.1001158; Burnet F., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; Corthay A, 2001, J AUTOIMMUN, V16, P423, DOI 10.1006/jaut.2001.0504; Delarasse C, 2003, J CLIN INVEST, V112, P544, DOI 10.1172/JCI200315861; Delovitch TL, 1997, IMMUNITY, V7, P727, DOI 10.1016/S1074-7613(00)80392-1; ELLIOTT JI, 1995, J EXP MED, V182, P953, DOI 10.1084/jem.182.4.953; Elliott JI, 1996, EUR J IMMUNOL, V26, P953, DOI 10.1002/eji.1830260436; Enouz S, 2012, J EXP MED, V209, P1769, DOI 10.1084/jem.20120905; Frommer F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015372; Gartner F, 1999, IMMUNITY, V10, P537, DOI 10.1016/S1074-7613(00)80053-9; He X, 2002, NAT IMMUNOL, V3, P127, DOI 10.1038/ni751; Jenkins MK, 2012, J IMMUNOL, V188, P4135, DOI 10.4049/jimmunol.1102661; Ji QY, 2010, NAT IMMUNOL, V11, P628, DOI 10.1038/ni.1888; Mendel I, 1996, EUR J IMMUNOL, V26, P2470, DOI 10.1002/eji.1830261030; MENDEL I, 1995, EUR J IMMUNOL, V25, P1951, DOI 10.1002/eji.1830250723; Mills SY, 2007, COMPLEMENT THER MED, V15, P1, DOI [10.1002/0471142735.im1501s77, 10.1002/0471142735.im1501s88]; MOMBAERTS P, 1992, NATURE, V360, P225, DOI 10.1038/360225a0; MOMBAERTS P, 1991, P NATL ACAD SCI USA, V88, P3084, DOI 10.1073/pnas.88.8.3084; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Moon JJ, 2011, P NATL ACAD SCI USA, V108, P14602, DOI 10.1073/pnas.1109806108; Moon JJ, 2009, NAT PROTOC, V4, P565, DOI 10.1038/nprot.2009.9; Morris GP, 2009, J IMMUNOL, V182, P6639, DOI 10.4049/jimmunol.0900638; Ni PP, 2014, J IMMUNOL, V193, P1778, DOI 10.4049/jimmunol.1400532; PADOVAN E, 1993, SCIENCE, V262, P422, DOI 10.1126/science.8211163; Sarukhan A, 1998, IMMUNITY, V8, P563, DOI 10.1016/S1074-7613(00)80561-0; Spahn TW, 1999, EUR J IMMUNOL, V29, P4060, DOI 10.1002/(SICI)1521-4141(199912)29:12<4060::AID-IMMU4060>3.0.CO;2-S; Su DL, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/985753; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Zal T, 1996, P NATL ACAD SCI USA, V93, P9102, DOI 10.1073/pnas.93.17.9102; Zehn D, 2009, NATURE, V458, P211, DOI 10.1038/nature07657	34	3	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145762	10.1371/journal.pone.0145762	http://dx.doi.org/10.1371/journal.pone.0145762			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26693713	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092500072
J	Westbom, C; Thompson, JK; Leggett, A; MacPherson, M; Beuschel, S; Pass, H; Vacek, P; Shukla, A				Westbom, Catherine; Thompson, Joyce K.; Leggett, Alan; MacPherson, Maximilian; Beuschel, Stacie; Pass, Harvey; Vacek, Pamela; Shukla, Arti			Inflammasome Modulation by Chemotherapeutics in Malignant Mesothelioma	PLOS ONE			English	Article							NLRP3 INFLAMMASOME; PROSTATE-CANCER; CELLS; CASPASE-1; PROMOTES; IL-1-BETA; RELEASE; GROWTH; DOXORUBICIN; RESISTANCE	Malignant mesothelioma (MM) is a fatal disease in dire need of therapy. The role of inflammasomes in cancer is not very well studied, however, literature supports both pro- and antitumorigenic effects of inflammasomes on cancer depending upon the type of cancer. Asbestos is a causative agent for MM and we have shown before that it causes inflammasome priming and activation in mesothelial cells. MM tumor cells/tissues showed decreased levels of inflammasome components like NLRP3 and caspase-1 as compared to human mesothelial cells or normal tissue counterpart of tumor. Based on our preliminary findings we hypothesized that treatment of MMs with chemotherapeutic drugs may elevate the levels of NLRP3 and caspase-1 resulting in increased cell death by pyroptosis while increasing the levels of IL-1 beta and other pro-inflammatory molecules. Therefore, a combined strategy of chemotherapeutic drug and IL-1R antagonist may play a beneficial role in MM therapy. To test our hypothesis we used two human MM tumor cell lines (Hmeso, H2373) and two chemotherapeutic drugs (doxorubicin, cisplatin). Through a series of experiments we showed that both chemotherapeutic drugs caused increases in NLRP3 levels, caspase-1 activation, pyroptosis and pro-inflammatory molecules released from MM cells. In vivo studies using SCID mice and Hmeso cells showed that tumors were smaller in combined treatment group of cisplatin and IL-1R antagonist (Anakinra) as compared to cisplatin alone or untreated control groups. Taken together our study suggests that chemotherapeutic drugs in combination with IL-1R antagonist may have a beneficial role in MM treatment.	[Westbom, Catherine; Thompson, Joyce K.; Leggett, Alan; MacPherson, Maximilian; Beuschel, Stacie; Shukla, Arti] Univ Vermont, Coll Med, Dept Pathol & Lab Med, Burlington, VT 05405 USA; [Vacek, Pamela] Univ Vermont, Coll Med, Dept Med Biostat, Burlington, VT USA; [Pass, Harvey] NYU, Hosp Joint Dis, Dept Cardiothorac Surg, New York, NY USA	University of Vermont; University of Vermont; New York University; NYU Langone Medical Center; Hospital for Joint Disease NYULMC	Shukla, A (corresponding author), Univ Vermont, Coll Med, Dept Pathol & Lab Med, Burlington, VT 05405 USA.	Arti.Shukla@med.uvm.edu		Thompson, Joyce/0000-0001-7898-0078; Pass, Harvey/0000-0003-3222-3471	NIH [RO1 ES021110]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021110] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This study was supported by NIH RO1 ES021110.	Allen IC, 2010, J EXP MED, V207, P1045, DOI 10.1084/jem.20100050; Antonopoulos C, 2015, J BIOL CHEM, V290, P20167, DOI 10.1074/jbc.M115.652321; Antonopoulos C, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.27499; Antonopoulos C, 2013, J IMMUNOL, V191, P4789, DOI 10.4049/jimmunol.1300645; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; Bruchard M, 2014, B CANCER, V101, P605, DOI 10.1684/bdc.2014.1936; Bruchard M, 2013, NAT MED, V19, P57, DOI 10.1038/nm.2999; Creagh EM, 2014, TRENDS IMMUNOL, V35, P631, DOI 10.1016/j.it.2014.10.004; Dickson MA, 2000, MOL CELL BIOL, V20, P1436, DOI 10.1128/MCB.20.4.1436-1447.2000; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Hillegass JM, 2013, PART FIBRE TOXICOL, V10, DOI 10.1186/1743-8977-10-39; Hillegass JM, 2011, INT J CANCER, V129, P233, DOI 10.1002/ijc.25666; Hillegass JM, 2010, ANN NY ACAD SCI, V1203, P7, DOI 10.1111/j.1749-6632.2010.05554.x; Hillegass JM, 2010, WIRES NANOMED NANOBI, V2, P219, DOI 10.1002/wnan.54; Huang J, 2012, CANCER RES, V72, P230, DOI 10.1158/0008-5472.CAN-11-2001; Idris Adi, 2015, Biomark Cancer, V7, P25, DOI 10.4137/BIC.S25375; Krelin Y, 2007, CANCER RES, V67, P1062, DOI 10.1158/0008-5472.CAN-06-2956; Lamkanfi M, 2008, MOL CELL PROTEOMICS, V7, P2350, DOI 10.1074/mcp.M800132-MCP200; Lee DW, 2015, RENAL FAILURE, V37, P144, DOI 10.3109/0886022X.2014.970194; Newick K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039404; Palomo J, 2015, CYTOKINE, V76, P25, DOI 10.1016/j.cyto.2015.06.017; Pan BZ, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-165; Park MS, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134858; PASS HI, 1995, ANN THORAC SURG, V59, P835, DOI 10.1016/0003-4975(95)00045-M; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; REALE FR, 1987, CANCER RES, V47, P3199; Schwarznau A, 2009, J CELL PHYSIOL, V220, P341, DOI 10.1002/jcp.21770; Shukla A, 2006, FASEB J, V20, P997, DOI 10.1096/fj.05-4554fje; Shukla A, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-314; Shukla A, 2013, CLIN CANCER RES, V19, P2071, DOI 10.1158/1078-0432.CCR-12-3202; Shukla A, 2011, INT J CANCER, V129, P1075, DOI 10.1002/ijc.25763; Shukla A, 2009, AM J PATHOL, V175, P2197, DOI 10.2353/ajpath.2009.090400; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Smythe W Roy, 2002, Curr Oncol Rep, V4, P305, DOI 10.1007/s11912-002-0006-2; Wang YH, 2004, INT J ONCOL, V25, P173; Westbom CM, 2014, AM J PATHOL, V184, P2816, DOI 10.1016/j.ajpath.2014.06.008; Winter RN, 2004, ANTICANCER RES, V24, P1377; Winter RN, 2001, CANCER RES, V61, P1227; Wong J, 2014, CANCER BIOL THER, V15, P1395, DOI 10.4161/cbt.29922; Zaki MH, 2011, CANCER CELL, V20, P649, DOI 10.1016/j.ccr.2011.10.022; Zhang YY, 2014, TOXICOL APPL PHARM, V281, P1, DOI 10.1016/j.taap.2014.09.016	41	24	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145404	10.1371/journal.pone.0145404	http://dx.doi.org/10.1371/journal.pone.0145404			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689911	Green Submitted, Green Published, gold			2022-12-26	WOS:000367092300072
J	Wibberg, D; Rupp, O; Blom, J; Jelonek, L; Krober, M; Verwaaijen, B; Goesmann, A; Albaum, S; Grosch, R; Puhler, A; Schluter, A				Wibberg, Daniel; Rupp, Oliver; Blom, Jochen; Jelonek, Lukas; Kroeber, Magdalena; Verwaaijen, Bart; Goesmann, Alexander; Albaum, Stefan; Grosch, Rita; Puehler, Alfred; Schlueter, Andreas			Development of a Rhizoctonia solani AG1-IB Specific Gene Model Enables Comparative Genome Analyses between Phytopathogenic R-solani AG1-IA, AG1-IB, AG3 and AG8 Isolates	PLOS ONE			English	Article							SOFTWARE; SEQUENCE; INSIGHTS; FUNGUS; ANNOTATION; PREDICTION; EVOLUTION; ALIGNMENT; RNA	Rhizoctonia solani, a soil-born plant pathogenic basidiomycetous fungus, affects various economically important agricultural and horticultural crops. The draft genome sequence for the R. solani AG1-IB isolate 7/3/14 as well as a corresponding transcriptome dataset (Expressed Sequence Tags-ESTs) were established previously. Development of a specific R. solani AG1-IB gene model based on GMAP transcript mapping within the eukaryotic gene prediction platform AUGUSTUS allowed detection of new genes and provided insights into the gene structure of this fungus. In total, 12,616 genes were recognized in the genome of the AG1-IB isolate. Analysis of predicted genes by means of different bioinformatics tools revealed new genes whose products potentially are involved in degradation of plant cell wall components, melanin formation and synthesis of secondary metabolites. Comparative genome analyses between members of different R. solani anastomosis groups, namely AG1-IA, AG3 and AG8 and the newly annotated R. solani AG1-IB genome were performed within the comparative genomics platform EDGAR. It appeared that only 21 to 28% of all genes encoded in the draft genomes of the different strains were identified as core genes. Based on Average Nucleotide Identity (ANI) and Average Amino-acid Identity (AAI) analyses, considerable sequence differences between isolates representing different anastomosis groups were identified. However, R. solani isolates form a distinct cluster in relation to other fungi of the phylum Basidiomycota. The isolate representing AG1-IB encodes significant more genes featuring predictable functions in secondary metabolite production compared to other completely sequenced R. solani strains. The newly established R. solani AG1-IB 7/3/14 gene layout now provides a reliable basis for post-genomics studies.	[Wibberg, Daniel; Jelonek, Lukas; Kroeber, Magdalena; Verwaaijen, Bart; Albaum, Stefan; Puehler, Alfred; Schlueter, Andreas] Univ Bielefeld, CeBiTec, Inst Genome Res & Syst Biol, D-33615 Bielefeld, Germany; [Rupp, Oliver; Blom, Jochen; Jelonek, Lukas; Goesmann, Alexander] Univ Giessen, Bioinformat & Syst Biol, D-35390 Giessen, Germany; [Grosch, Rita] Leibniz Inst Vegetables & Ornamental Crops, Grossbeeren, Germany	University of Bielefeld; Justus Liebig University Giessen; Leibniz Institut fur Gemuse- und Zierpflanzenbau (IGZ)	Schluter, A (corresponding author), Univ Bielefeld, CeBiTec, Inst Genome Res & Syst Biol, D-33615 Bielefeld, Germany.	aschluet@CeBiTec.Uni-Bielefeld.de	Grosch, Rita/HHM-5490-2022	Goesmann, Alexander/0000-0002-7086-2568; Rupp, Oliver/0000-0003-2755-6458; Puhler, Alfred/0000-0003-4723-2960; Schluter, Andreas/0000-0003-4830-310X; Jelonek, Lukas/0000-0002-9973-0374; Grosch, Rita/0000-0002-7179-5715	Federal Ministry of Education and Research (Germany) [0315654B, 031A533, 031A560D]; CLIB Graduate Cluster Industrial Biotechnology at Bielefeld University (Germany) - Federal Ministry of Innovation, Science and Research (MIWF) of the federal state North Rhine-Westphalia, Germany; Article Processing Charge by the Deutsche Forschungsgemeinschaft; Open Access Publication Fund of Bielefeld University	Federal Ministry of Education and Research (Germany)(Federal Ministry of Education & Research (BMBF)); CLIB Graduate Cluster Industrial Biotechnology at Bielefeld University (Germany) - Federal Ministry of Innovation, Science and Research (MIWF) of the federal state North Rhine-Westphalia, Germany; Article Processing Charge by the Deutsche Forschungsgemeinschaft; Open Access Publication Fund of Bielefeld University	The work was funded by the Federal Ministry of Education and Research (Germany): Grant numbers: 0315654B, 031A533 and 031A560D. LJ and BV acknowledge their scholarships from the CLIB Graduate Cluster Industrial Biotechnology at Bielefeld University (Germany) granted by the Federal Ministry of Innovation, Science and Research (MIWF) of the federal state North Rhine-Westphalia, Germany. Moreover, the authors acknowledge support for the Article Processing Charge by the Deutsche Forschungsgemeinschaft and the Open Access Publication Fund of Bielefeld University.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bekel T, 2009, J BIOTECHNOL, V140, P3, DOI 10.1016/j.jbiotec.2009.01.006; Besemer J, 2005, NUCLEIC ACIDS RES, V33, pW451, DOI 10.1093/nar/gki487; Blom J, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-154; Carling DE, 2002, PHYTOPATHOLOGY, V92, P893, DOI 10.1094/PHYTO.2002.92.8.893; Cubeta MA, 2014, GENOME ANNOUNC, V2; Ellinghaus D, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-18; Felsenstein J., 2004, PHYLIP PHYLOGENY INF; Foissac S, 2007, NUCLEIC ACIDS RES, V35, pW297, DOI 10.1093/nar/gkm311; Ghosh S, 2014, CURR GENET, V60, P327, DOI 10.1007/s00294-014-0438-x; Garcia VG, 2006, SPAN J AGRIC RES, V4, P55; Goris J, 2007, INT J SYST EVOL MICR, V57, P81, DOI 10.1099/ijs.0.64483-0; Hane JK, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004281; Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Losada L, 2014, FEMS MICROBIOL LETT, V352, P165, DOI 10.1111/1574-6968.12387; Martin F, 2008, NATURE, V452, P88, DOI 10.1038/nature06556; McGuire AM, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r50; Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312; Morgenstern B, 2005, NUCL ACIDS RES, V33; Muszewska A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029425; Reid I, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-229; Rupp O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085568; Satou Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r152; Schaefer Wilhelm, 1993, Trends in Microbiology, V1, P69, DOI 10.1016/0966-842X(93)90037-R; Stajich JE, 2010, P NATL ACAD SCI USA, V107, P11889, DOI 10.1073/pnas.1003391107; Stanke M, 2006, NUCLEIC ACIDS RES, V34, pW435, DOI 10.1093/nar/gkl200; Steinbiss S, 2009, NUCLEIC ACIDS RES, V37, P7002, DOI 10.1093/nar/gkp759; Wibberg D, 2015, J BIOTECHNOL, V203, P19, DOI 10.1016/j.jbiotec.2015.03.005; Wibberg D, 2014, FUNGAL BIOL-UK, V118, P800, DOI 10.1016/j.funbio.2014.06.007; Wibberg D, 2013, J BIOTECHNOL, V167, P142, DOI 10.1016/j.jbiotec.2012.12.010; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310; Yeh RF, 2001, GENOME RES, V11, P803, DOI 10.1101/gr.175701; Zheng AP, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2427; Zuccaro A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002290	36	26	27	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144769	10.1371/journal.pone.0144769	http://dx.doi.org/10.1371/journal.pone.0144769			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690577	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092300015
J	Xu, XJ; Xie, SP; Shi, XM; Lv, J; Tang, XW; Wang, XL; Lu, SP; Wang, MZ; Zhang, XB; Sun, J; Yao, H				Xu, Xijia; Xie, Shiping; Shi, Xiaomeng; Lv, Jie; Tang, Xiaowei; Wang, Xiaolan; Lu, Shuiping; Wang, Mingzhong; Zhang, Xiaobing; Sun, Jing; Yao, Hui			Hexanucleotide Repeat Expansion in C9ORF72 Is Not Detected in the Treatment-Resistant Schizophrenia Patients of Chinese Han	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; GENE; ALS	Hexanucleotide (GGGGCC) repeat expansion in C9ORF72 (HRE) causes frontotemporal lobar degeneration, frontotemporal dementia-amyotrophic lateral sclerosis, and amyotrophic lateral sclerosis. HRE was also seen in the genomes of patients suffering from several other degenerative diseases. However, whether it is present in the treatment-resistant schizophrenia patients remains unknown. Genotyping 386 patients suffering from treatment-resistant schizophrenia using the method of Repeat-Primed PCR, we reported here that no HRE was detected in the patients of Chinese Han.	[Xu, Xijia; Xie, Shiping; Shi, Xiaomeng; Wang, Xiaolan; Lu, Shuiping; Sun, Jing; Yao, Hui] Nanjing Med Univ, Affiliated Nanjing Brain Hosp, Dept Psychiat, Nanjing 210029, Jiangsu, Peoples R China; [Xu, Xijia; Xie, Shiping] Nanjing Univ, Nanjing Brain Hosp, Sch Med, Nanjing 210093, Jiangsu, Peoples R China; [Lv, Jie; Wang, Mingzhong] Nanjing Qinglongshan Mental Hosp, Dept Psychiat, Nanjing 211123, Jiangsu, Peoples R China; [Tang, Xiaowei; Zhang, Xiaobing] Yangzhou Univ, Coll Med, Affiliated Wutaishan Hosp, Dept Psychiat, Yangzhou 225003, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing University; Yangzhou University	Xie, SP (corresponding author), Nanjing Med Univ, Affiliated Nanjing Brain Hosp, Dept Psychiat, Nanjing 210029, Jiangsu, Peoples R China.	xieshiping@medmail.com.cn			Nanjing Medical Science and Technique Development Foundation, Nanjing Commission of Health and Family Planning [QRX11121, ZKX08034]; Jiangsu Provincial Commission of Health and Family Planning [H200875]; National Health and Family Planning Commission of the People's Republic of China [2011-873]; Jiangsu Provincial Commission of Health and Family Planning	Nanjing Medical Science and Technique Development Foundation, Nanjing Commission of Health and Family Planning; Jiangsu Provincial Commission of Health and Family Planning; National Health and Family Planning Commission of the People's Republic of China; Jiangsu Provincial Commission of Health and Family Planning	This work was funded by Nanjing Medical Science and Technique Development Foundation, Nanjing Commission of Health and Family Planning (grant numbers: QRX11121, ZKX08034; http://www.njjsw.gov.cn/; recipient: XX); Jiangsu Provincial Commission of Health and Family Planning (grant number: H200875; http://www.jswst.gov.cn; recipient: XX); National Health and Family Planning Commission of the People's Republic of China (grant number: State Key Clinical Specialty [Psychiatry, 2011-873]; http://www.nhfpc.gov.cn/; recipients: XX SX); and Jiangsu Provincial Commission of Health and Family Planning (grant number: Provincial Medical Key Discipline [Psychiatry, 2011-12]; http://www.jswst.gov.cn; recipients: XX SX). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck J, 2013, AM J HUM GENET, V92, P345, DOI 10.1016/j.ajhg.2013.01.011; Bieniek KF, 2014, JAMA NEUROL, V71, P775, DOI 10.1001/jamaneurol.2013.6368; Daoud H, 2014, CAN J NEUROL SCI, V41, P759, DOI 10.1017/cjn.2014.39; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Frank J, 2015, MOL PSYCHIATR, V20, P150, DOI 10.1038/mp.2014.56; Galimberti D, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.12.004; Galimberti D, 2013, BIOL PSYCHIAT, V74, P384, DOI 10.1016/j.biopsych.2013.01.031; Garcia-Redondo A, 2013, HUM MUTAT, V34, P79, DOI 10.1002/humu.22211; Gijselinck I, 2012, LANCET NEUROL, V11, P54, DOI 10.1016/S1474-4422(11)70261-7; Goldman JS, 2014, JAMA NEUROL, V71, P771, DOI 10.1001/jamaneurol.2013.5762; He J, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2015.06.002; Kohli MA, 2013, NEUROBIOL AGING, V34, DOI 10.1016/j.neurobiolaging.2012.10.003; Koutsis G, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2014.08.020; Liu R, 2013, AMYOTROPH LAT SCL FR, V14, P630, DOI 10.3109/21678421.2013.817588; Mori K, 2013, SCIENCE, V339, P1335, DOI 10.1126/science.1232927; Ogaki K, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.05.011; Pliner HA, 2014, ACTA NEUROPATHOL, V127, P391, DOI 10.1007/s00401-014-1250-x; Rademakers R, 2012, LANCET NEUROL, V11, P297, DOI 10.1016/S1474-4422(12)70046-7; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Yoshino Y, 2015, J NEURAL TRANSM, V122, P731, DOI 10.1007/s00702-014-1295-y	21	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145347	10.1371/journal.pone.0145347	http://dx.doi.org/10.1371/journal.pone.0145347			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691640	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092300061
J	Houle, D; Paquette, A; Cote, B; Logan, T; Power, H; Charron, I; Duchesne, L				Houle, Daniel; Paquette, Alain; Cote, Benoit; Logan, Travis; Power, Hugues; Charron, Isabelle; Duchesne, Louis			Impacts of Climate Change on the Timing of the Production Season of Maple Syrup in Eastern Canada	PLOS ONE			English	Article							SAP; FLOW	Maple syrup production is an important economic activity in north-eastern North-America. The beginning and length of the production season is linked to daily variation in temperature. There are increasing concerns about the potential impact of climatic change on this industry. Here, we used weekly data of syrup yield for the 1999-2011 period from 121 maple stands in 11 regions of Quebec (Canada) to predict how the period of production may be impacted by climate warming. The date at which the production begins is highly variable between years with an average range of 36 days among the regions. However, the average start date for a given region, which ranged from Julian day 65 to 83, was highly predictable (r(2) = 0.88) using the average temperature from January to April (TJ-A). A logistic model predicting the weekly presence or absence of production was also developed. Using the inputs of 77 future climate scenarios issued from global models, projections of future production timing were made based on average TJ-A and on the logistic model. The projections of both approaches were in very good agreement and suggest that the sap season will be displaced to occur 15-19 days earlier on average in the 2080-2100 period. The data also show that the displacement in time will not be accompanied by a greater between years variability in the beginning of the season. However, in the southern part of Quebec, very short periods of syrup production due to unfavourable conditions in the spring will occur more frequently in the future although their absolute frequencies will remain low.	[Houle, Daniel; Power, Hugues; Duchesne, Louis] Minist Forets Faune & Parcs Quebec, Direct Rech Forestiere, Quebec City, PQ G1P 3W8, Canada; [Houle, Daniel; Logan, Travis; Charron, Isabelle] Consortium Climatol Reg & Adaptat Changements Cli, Montreal, PQ H3A 1B9, Canada; [Paquette, Alain] Univ Quebec, Ctr Forest Res, Ctr Ville Stn, Montreal, PQ H3C 3P8, Canada; [Cote, Benoit] McGill Univ, Dep Nat Resource Sci, Ste Anne De Bellevue, PQ H9X 3V9, Canada	Ouranos Consortium; University of Quebec; University of Quebec Montreal; McGill University	Houle, D (corresponding author), Minist Forets Faune & Parcs Quebec, Direct Rech Forestiere, 2700 Einstein, Quebec City, PQ G1P 3W8, Canada.	daniel.houle@mffp.gouv.qc.ca		Duchesne, Louis/0000-0001-6784-445X	Ministere des Forets, de la Faune et des Parcs du Quebec; Le Fond Vert du Ministere du Developpement Durable, Environnement, et Parc du Quebec; Natural Resources Canada	Ministere des Forets, de la Faune et des Parcs du Quebec; Le Fond Vert du Ministere du Developpement Durable, Environnement, et Parc du Quebec; Natural Resources Canada(Natural Resources CanadaCanadian Forest Service)	The costs associated with this research were covered by the "Ministere des Forets, de la Faune et des Parcs du Quebec" (DH) and "Le Fond Vert du Ministere du Developpement Durable, Environnement, et Parc du Quebec" within the framework of the Action Plan 2006-2012 on climate change in association with Natural Resources Canada (DH and BC) (http://www.mffp.gouv.qc.ca/accueil.jsp), (http://www.mddelcc.gouv.qc.ca/ministere/fonds-vert/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; [Anonymous], 2000, SPECIAL REPORT EMISS; Bradley E, 1983, AM STAT, V37, P36; Duchesne L, 2014, PEERJ, V2, DOI 10.7717/peerj.428; Duchesne L, 2009, FOREST ECOL MANAG, V258, P2683, DOI 10.1016/j.foreco.2009.09.035; Gabriel WJ, 1972, PHENOTYPIC SELECTION; Hawkins E, 2009, B AM METEOROL SOC, V90, P1095, DOI 10.1175/2009BAMS2607.1; Hopkinson RF, 2011, J APPL METEOROL CLIM, V50, P1654, DOI 10.1175/2011JAMC2684.1; Hutchinson MF, 2009, J APPL METEOROL CLIM, V48, P725, DOI 10.1175/2008JAMC1979.1; KIM YT, 1985, FOREST CHRON, V61, P303, DOI 10.5558/tfc61303-4; Logan T, 2011, ATLAS SCENARIOS CLIM; MARVIN JW, 1956, PLANT PHYSIOL, V31, P57, DOI 10.1104/pp.31.1.57; Marvin JW, 1957, INVESTIGATION SUGAR; Marvin JW, 1958, PHYSL MAPLE SAPFLOW; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Menzel A, 2006, GLOBAL CHANGE BIOL, V12, P1969, DOI 10.1111/j.1365-2486.2006.01193.x; Mpelasoka FS, 2009, J HYDROMETEOROL, V10, P1168, DOI 10.1175/2009JHM1045.1; Murphy BL, 2012, J RURAL COMMUNITY D, V7, P42; Norby RJ, 2003, GLOBAL CHANGE BIOL, V9, P1792, DOI 10.1111/j.1365-2486.2003.00714.x; Perkins TD, 2009, ADV FOOD NUTR RES, V56, P101, DOI 10.1016/S1043-4526(08)00604-9; PLAMONDON A P, 1977, Naturaliste Canadien (Quebec), V104, P127; PLAMONDON AP, 1980, CAN J FOREST RES, V10, P152, DOI 10.1139/x80-027; POTHIER D, 1995, CAN J FOREST RES, V25, P1815, DOI 10.1139/x95-196; Skinner CB, 2010, CLIMATIC CHANGE, V100, P685, DOI 10.1007/s10584-009-9685-0; Tyminski WPJ, 2011, UTILITY USING SUGAR; USDA NASS, 2012, MAPL SYR 2012 2012 M	26	18	19	2	104	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144844	10.1371/journal.pone.0144844	http://dx.doi.org/10.1371/journal.pone.0144844			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26682889	Green Published, Green Submitted, gold			2022-12-26	WOS:000366725800022
J	Morita, C; Tsuji, H; Hata, T; Gondo, M; Takakura, S; Kawai, K; Yoshihara, K; Ogata, K; Nomoto, K; Miyazaki, K; Sudo, N				Morita, Chihiro; Tsuji, Hirokazu; Hata, Tomokazu; Gondo, Motoharu; Takakura, Shu; Kawai, Keisuke; Yoshihara, Kazufumi; Ogata, Kiyohito; Nomoto, Koji; Miyazaki, Kouji; Sudo, Nobuyuki			Gut Dysbiosis in Patients with Anorexia Nervosa	PLOS ONE			English	Article							CLOSTRIDIUM-DIFFICILE; MICROBIOTA; INCREASE; DIARRHEA; SYSTEM; RISK; ENVIRONMENT; INFECTION; COMMUNITY; OUTBREAK	Anorexia nervosa (AN) is a psychological illness with devastating physical consequences; however, its pathophysiological mechanism remains unclear. Because numerous reports have indicated the importance of gut microbiota in the regulation of weight gain, it is reasonable to speculate that AN patients might have a microbial imbalance, i.e. dysbiosis, in their gut. In this study, we compared the fecal microbiota of female patients with AN (n = 25), including restrictive (ANR, n = 14) and binge-eating (ANBP, n = 11) subtypes, with those of age-matched healthy female controls (n = 21) using the Yakult Intestinal Flora-SCAN based on 16S or 23S rRNA-targeted RT-quantitative PCR technology. AN patients had significantly lower amounts of total bacteria and obligate anaerobes including those from the Clostridium coccoides group, Clostridium leptum subgroup, and Bacteroides fragilis group than the age-matched healthy women. Lower numbers of Streptococcus were also found in the AN group than in the control group. In the analysis based on AN subtypes, the counts of the Bacteroides fragilis group in the ANR and ANBP groups and the counts of the Clostridium coccoides group in the ANR group were significantly lower than those in the control group. The detection rate of the Lactobacillus plantarum subgroup was significantly lower in the AN group than in the control group. The AN group had significantly lower acetic and propionic acid concentrations in the feces than the control group. Moreover, the subtype analysis showed that the fecal concentrations of acetic acid were lower in the ANR group than in the control group. Principal component analysis confirmed a clear difference in the bacterial components between the AN patients and healthy women. Collectively, these results clearly indicate the existence of dysbiosis in the gut of AN patients.	[Morita, Chihiro; Hata, Tomokazu; Gondo, Motoharu; Takakura, Shu; Kawai, Keisuke; Yoshihara, Kazufumi; Sudo, Nobuyuki] Kyushu Univ, Grad Sch Med Sci, Dept Psychosomat Med, Fukuoka 812, Japan; [Tsuji, Hirokazu; Ogata, Kiyohito; Nomoto, Koji; Miyazaki, Kouji] Yakult Cent Inst, Tokyo, Japan	Kyushu University; Yakult Honsha Company, Limited	Sudo, N (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Psychosomat Med, Fukuoka 812, Japan.	nobuyuki@med.kyushu-u.ac.jp		Sudo, Nobuyuki/0000-0002-7935-878X; Hirokazu, Tsuji/0000-0003-2856-6447	Ministry of Education, Culture, Sports, Science, and Technology in Japan [22659144, 25293167]	Ministry of Education, Culture, Sports, Science, and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was partially supported by Grants-in-Aid for General Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology in Japan (22659144, https://kaken.nii.ac.jp/d/p/22659144.ja.html; 25293167, https://kaken.nii.ac.jp/d/p/25293167.ja.html: NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armougom F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007125; Clarke G, 2013, MOL PSYCHIATR, V18, P666, DOI 10.1038/mp.2012.77; COATES ME, 1963, BRIT J NUTR, V17, P141, DOI 10.1079/BJN19630015; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Corder GW, 2009, COMP 2 UNRELATED SAM, P57; DEMPSEY DT, 1984, AM J CLIN NUTR, V39, P236, DOI 10.1093/ajcn/39.2.236; Dial S, 2005, JAMA-J AM MED ASSOC, V294, P2989, DOI 10.1001/jama.294.23.2989; Dial S, 2004, CAN MED ASSOC J, V171, P33, DOI 10.1503/cmaj.1040876; Dibner JJ, 2005, POULTRY SCI, V84, P634, DOI 10.1093/ps/84.4.634; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Gareau MG, 2011, GUT, V60, P307, DOI 10.1136/gut.2009.202515; Goodrich JK, 2014, CELL, V159, P789, DOI 10.1016/j.cell.2014.09.053; Guarner F, 2003, LANCET, V361, P512, DOI 10.1016/S0140-6736(03)12489-0; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; KAYE WH, 1988, AM J CLIN NUTR, V47, P989, DOI 10.1093/ajcn/47.6.989; Kurakawa T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126226; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Marzola E, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-290; Matsuda K, 2007, APPL ENVIRON MICROB, V73, P32, DOI 10.1128/AEM.01224-06; Matsuda K, 2009, APPL ENVIRON MICROB, V75, P1961, DOI 10.1128/AEM.01843-08; MOORE PR, 1946, J BIOL CHEM, V165, P437; Moukaddem M, 1997, AM J CLIN NUTR, V66, P133; Muto CA, 2005, INFECT CONT HOSP EP, V26, P273, DOI 10.1086/502539; Neufeld KM, 2011, NEUROGASTROENT MOTIL, V23, DOI 10.1111/j.1365-2982.2010.01620.x; Nishino R, 2013, NEUROGASTROENT MOTIL, V25, DOI 10.1111/nmo.12110; Ohigashi S, 2013, DIGEST DIS SCI, V58, P1717, DOI 10.1007/s10620-012-2526-4; Pepin J, 2005, CLIN INFECT DIS, V40, P1591, DOI 10.1086/430315; Sakaguchi S, 2010, J CLIN MICROBIOL, V48, P1624, DOI 10.1128/JCM.01724-09; Sato J, 2014, DIABETES CARE, V37, P2343, DOI 10.2337/dc13-2817; Shah S, 2000, QJM-MON J ASSOC PHYS, V93, P175, DOI 10.1093/qjmed/93.3.175; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Sudo N, 1997, J IMMUNOL, V159, P1739; Treasure J, 2010, LANCET, V375, P583, DOI 10.1016/S0140-6736(09)61748-7; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Van Wymelbeke V, 2004, AM J CLIN NUTR, V80, P1469, DOI 10.1093/ajcn/80.6.1469	37	115	119	3	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145274	10.1371/journal.pone.0145274	http://dx.doi.org/10.1371/journal.pone.0145274			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26682545	gold, Green Published, Green Submitted			2022-12-26	WOS:000366725800056
J	Lima-Costa, MF; Macinko, J; Mambrini, JVD; Cesar, CC; Peixoto, SV; Magalhaes, WCS; Horta, BL; Barreto, M; Castro-Costa, E; Firmo, JOA; Proietti, FA; Leal, TP; Rodrigues, MR; Pereira, A; Tarazona-Santos, E				Lima-Costa, M. Fernanda; Macinko, James; de Melo Mambrini, Juliana Vaz; Cesar, Cibele C.; Peixoto, Sergio V.; Magalhaes, Wagner C. S.; Horta, Bernardo L.; Barreto, Mauricio; Castro-Costa, Erico; Firmo, Joselia O. A.; Proietti, Fernando A.; Leal, Thiago Peixoto; Rodrigues, Maira R.; Pereira, Alexandre; Tarazona-Santos, Eduardo			Genomic Ancestry, Self-Rated Health and Its Association with Mortality in an Admixed Population: 10 Year Follow-Up of the Bambui-Epigen (Brazil) Cohort Study of Ageing	PLOS ONE			English	Article							OLDER-ADULTS; SOCIOECONOMIC-STATUS; LATIN-AMERICA; COMMUNITY; COLOR; SURVIVAL; POSITION; MODELS; US	Background Self-rated health (SRH) has strong predictive value for mortality in different contexts and cultures, but there is inconsistent evidence on ethnoracial disparities in SRH in Latin America, possibly due to the complexity surrounding ethnoracial self-classification. Materials/Methods We used 370,539 Single Nucleotide Polymorphisms (SNPs) to examine the association between individual genomic proportions of African, European and Native American ancestry, and ethnoracial self-classification, with baseline and 10-year SRH trajectories in 1,311 community dwelling older Brazilians. We also examined whether genomic ancestry and ethnoracial self-classification affect the predictive value of SRH for subsequent mortality. Results European ancestry predominated among participants, followed by African and Native American (median = 84.0%, 9.6% and 5.3%, respectively); the prevalence of Non-White (Mixed and Black) was 39.8%. Persons at higher levels of African and Native American genomic ancestry, and those self-identified as Non-White, were more likely to report poor health than other groups, even after controlling for socioeconomic conditions and an array of self-reported and objective physical health measures. Increased risks for mortality associated with worse SRH trajectories were strong and remarkably similar (hazard ratio similar to 3) across all genomic ancestry and ethno-racial groups. Conclusions Our results demonstrated for the first time that higher levels of African and Native American genomic ancestry-and the inverse for European ancestry-were strongly correlated with worse SRH in a Latin American admixed population. Both genomic ancestry and ethnoracial self-classification did not modify the strong association between baseline SRH or SRH trajectory, and subsequent mortality.	[Lima-Costa, M. Fernanda; de Melo Mambrini, Juliana Vaz; Peixoto, Sergio V.; Castro-Costa, Erico; Firmo, Joselia O. A.; Proietti, Fernando A.] Fundacao Oswaldo Cruz, Inst Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Macinko, James] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Hlth Policy & Management, Los Angeles, CA USA; [Macinko, James] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Dept Community Hlth Sci, Los Angeles, CA USA; [Cesar, Cibele C.] Univ Fed Minas Gerais, Dept Estat, Belo Horizonte, MG, Brazil; [Magalhaes, Wagner C. S.; Leal, Thiago Peixoto; Rodrigues, Maira R.; Tarazona-Santos, Eduardo] Univ Fed Minas Gerais, Dept Biol Geral, Belo Horizonte, MG, Brazil; [Horta, Bernardo L.] Univ Fed Pelotas, Dept Social Med, Pelotas, RS, Brazil; [Barreto, Mauricio] Fundacao Oswaldo Cruz, Inst Pesquisas Goncalo Muniz, Salvador, BA, Brazil; [Pereira, Alexandre] Univ Sao Paulo, Inst Coracao, Sao Paulo, Brazil	Fundacao Oswaldo Cruz; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Pelotas; Fundacao Oswaldo Cruz; Universidade de Sao Paulo	Lima-Costa, MF (corresponding author), Fundacao Oswaldo Cruz, Inst Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.	lima-costa@cpqrr.fiocruz.br	de Melo Mambrini, Juliana Vaz/AAO-9462-2021; Pereira, Alexandre/HHN-1038-2022; Firmo, Josélia Oliveira Araújo/AAD-6553-2022; Peixoto, SÃ©rgio/AAK-7335-2021; Tarazona-Santos, Eduardo/AAF-1110-2019; Horta, Bernardo/A-7604-2008; Costa, Maria Fernanda Furtado de Lima e/ABE-3779-2021; Magalhaes, Wagner CS/D-8822-2015; Barreto, Mauricio L/B-1752-2008; Peixoto, Sergio/K-3230-2016; de Castro e Costa, Erico/G-1684-2014	Firmo, Josélia Oliveira Araújo/0000-0001-5330-476X; Horta, Bernardo/0000-0001-9843-412X; Costa, Maria Fernanda Furtado de Lima e/0000-0002-3474-2980; Barreto, Mauricio L/0000-0002-0215-4930; Tarazona, Eduardo/0000-0003-3508-3160; Peixoto, Sergio/0000-0001-9431-2280; Macinko, James/0000-0001-8055-5441; Peixoto Leal, Thiago/0000-0002-5829-6452; de Castro e Costa, Erico/0000-0003-0792-5439	Department of Science and Technology (DECIT, Ministry of Health); National Fund for Scientific and Technological Development (FNDCT, Ministry of Science and Technology); Funding of Studies and Projects (FINEP, Ministry of Science and Technology, Brazil); Coordination of Improvement of Higher Education Personnel (CAPES, Ministry of Education, Brazil)	Department of Science and Technology (DECIT, Ministry of Health); National Fund for Scientific and Technological Development (FNDCT, Ministry of Science and Technology); Funding of Studies and Projects (FINEP, Ministry of Science and Technology, Brazil); Coordination of Improvement of Higher Education Personnel (CAPES, Ministry of Education, Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by the Department of Science and Technology (DECIT, Ministry of Health) and National Fund for Scientific and Technological Development (FNDCT, Ministry of Science and Technology), Funding of Studies and Projects (FINEP, Ministry of Science and Technology, Brazil), Coordination of Improvement of Higher Education Personnel (CAPES, Ministry of Education, Brazil). MFLC, SVP, JOAF, FAP, CCC and ETS are fellow researchers of the National Council for Research and Technological Development (CNPq).	Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Beleigoli AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075809; Beleigoli AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052111; Benyamini Y, 2003, GERONTOLOGIST, V43, P396, DOI 10.1093/geront/43.3.396; de Oliveira BLCA, 2014, CAD SAUDE PUBLICA, V30, P1438, DOI 10.1590/0102-311X00071413; Chor D, 2004, INT J EPIDEMIOL, V33, P100, DOI 10.1093/ije/dyg277; Costa E, 2006, INT PSYCHOGERIATR, V18, P493, DOI 10.1017/S1041610205002954; COX DR, 1972, J R STAT SOC B, V34, P187; DeSalvo KB, 2006, J GEN INTERN MED, V21, P267, DOI 10.1111/j.1525-1497.2005.00291.x; Diggle P. J., 2002, ANALYSIS OF LONGITUD; Lima-Costa MF, 2012, ANN EPIDEMIOL, V22, P644, DOI 10.1016/j.annepidem.2012.06.101; Fernandes F., 1972, NEGRO MUNDO BRANCOS; Fitzmaurice GM, 2011, APPLIED LONGITUDINAL; Franks P, 2003, SOC SCI MED, V56, P2505, DOI 10.1016/S0277-9536(02)00281-2; Idler EL, 1997, J HEALTH SOC BEHAV, V38, P21, DOI 10.2307/2955359; Instituto Brasileiro de Geografia e Estatistica-IBGE, 2013, ATLAS DO CENSO DEMOG; Ismail K, 2008, EVID-BASED MENT HEAL, V11, P99, DOI 10.1136/ebmh.11.4.99; Jurges H, 2007, HEALTH ECON, V16, P163, DOI 10.1002/hec.1134; Jylha M, 2009, SOC SCI MED, V69, P307, DOI 10.1016/j.socscimed.2009.05.013; Kwate NOA, 2014, SOC SCI MED, V116, P150, DOI 10.1016/j.socscimed.2014.05.041; Lee SJ, 2007, J AM GERIATR SOC, V55, P1624, DOI 10.1111/j.1532-5415.2007.01360.x; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Lima-Costa MF, 2015, SCI REP-UK, V5, DOI 10.1038/srep09812; Lima-Costa MF, 2012, AM J EPIDEMIOL, V175, P228, DOI 10.1093/aje/kwr290; Lima-Costa MF, 2011, INT J EPIDEMIOL, V40, P862, DOI 10.1093/ije/dyq143; Lima-Costa MF, 2010, STROKE, V41, P2477, DOI 10.1161/STROKEAHA.110.588061; Lima-Costa MF, 2010, AM J EPIDEMIOL, V172, P190, DOI 10.1093/aje/kwq106; Lopez R, 2004, SOC SCI MED, V59, P2409, DOI 10.1016/j.socscimed.2004.03.033; Meyer OL, 2014, AM J PUBLIC HEALTH, V104, P1734, DOI 10.2105/AJPH.2014.302003; Montenegro RA, 2006, LANCET, V367, P1859, DOI 10.1016/S0140-6736(06)68808-9; Perreira KM, 2014, SOC SCI MED, V116, P241, DOI 10.1016/j.socscimed.2014.05.054; Prefeitura Municipal de Bambui, 2015, HISTORIA DA CIDADE; Royston P, 2006, STATA J, V6, P83, DOI 10.1177/1536867X0600600105; Ruiz-Linares A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004572; Silva Clarice Lima Alvares da, 2013, Cad Saude Publica, V29, P2241; Telles E. E., 2004, RACE IN ANOTHER AMER; Telles E, 2013, HAHR-HISP AM HIST R, V93, P411, DOI 10.1215/00182168-2210858; Thornton T, 2012, AM J HUM GENET, V91, P122, DOI 10.1016/j.ajhg.2012.05.024; Travassos C, 2011, INT J EQUITY HEALTH, V10, DOI 10.1186/1475-9276-10-35; Viruell-Fuentes EA, 2011, AM J PUBLIC HEALTH, V101, P1306, DOI 10.2105/AJPH.2009.175455	41	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0144456	10.1371/journal.pone.0144456	http://dx.doi.org/10.1371/journal.pone.0144456			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26680774	gold, Green Submitted, Green Published			2022-12-26	WOS:000366723400014
J	Ayo, CM; Camargo, AVD; Frederico, FB; Siqueira, RC; Previato, M; Murata, FHA; Silveira-Carvalho, AP; Barbosa, AP; de Mattos, CDB; de Mattos, LC				Ayo, Christiane Maria; da Silveira Camargo, Ana Vitoria; Frederico, Fabio Batista; Siqueira, Rubens Camargo; Previato, Mariana; Antunes Murata, Fernando Henrique; Silveira-Carvalho, Aparecida Perpetuo; Barbosa, Amanda Pires; Brandao de Mattos, Cinara de Cassia; de Mattos, Luiz Carlos			MHC Class I Chain-Related Gene A Polymorphisms and Linkage Disequilibrium with HLA-B and HLA-C Alleles in Ocular Toxoplasmosis	PLOS ONE			English	Article							CONGENITAL TOXOPLASMOSIS; NK CELLS; GLOBAL REASSESSMENT; MICA POLYMORPHISM; MEMORIAL-LECTURE; SOUTHERN BRAZIL; EYE LESIONS; T-CELLS; GONDII; DISEASE	This study investigated whether polymorphisms of the MICA (major histocompatibility complex class I chain-related gene A) gene are associated with eye lesions due to Toxoplasma gondii infection in a group of immunocompetent patients from southeastern Brazil. The study enrolled 297 patients with serological diagnosis of toxoplasmosis. Participants were classified into two distinct groups after conducting fundoscopic exams according to the presence (n = 148) or absence (n = 149) of ocular scars/lesions due to toxoplasmosis. The group of patients with scars/lesions was further subdivided into two groups according to the type of the ocular manifestation observed: primary (n = 120) or recurrent (n = 28). Genotyping of the MICA and HLA alleles was performed by the polymerase chain reaction-sequence specific oligonucleotide technique (PCR-SSO; One Lambda (R)) and the MICA-129 polymorphism (rs1051792) was identified by nested polymerase chain reaction (PCR-RFLP). Significant associations involving MICA polymorphisms were not found. Although the MICA*002 similar to HLA-B*35 haplotype was associated with increased risk of developing ocular toxoplasmosis (P-value = 0.04; OR = 2.20; 95% CI = 1.05-4.60), and the MICA*008 similar to HLA-C*07 haplotype was associated with protection against the development of manifestations of ocular toxoplasmosis (P-value = 0.009; OR: 0.44; 95% CI: 0.22-0.76), these associations were not statistically significant after adjusting for multiple comparisons. MICA polymorphisms do not appear to influence the development of ocular lesions in patients diagnosed with toxoplasmosis in this study population.	[Ayo, Christiane Maria; da Silveira Camargo, Ana Vitoria; Siqueira, Rubens Camargo; Previato, Mariana; Antunes Murata, Fernando Henrique; Silveira-Carvalho, Aparecida Perpetuo; Brandao de Mattos, Cinara de Cassia; de Mattos, Luiz Carlos] Fac Med Sao Jose Rio Preto Sao Jose Rio Preto, Dept Mol Biol, Immunogenet Lab, Sao Jose Do Rio Preto, SP, Brazil; [Frederico, Fabio Batista; Barbosa, Amanda Pires] Hosp Base Sao Jose Rio Preto, Ophthalmol Outpatient Clin, Fundacao Fac Reg Med Sao Jose Rio Preto, Sao Jose Do Rio Preto, SP, Brazil; [Ayo, Christiane Maria; da Silveira Camargo, Ana Vitoria; Frederico, Fabio Batista; Previato, Mariana; Antunes Murata, Fernando Henrique; Barbosa, Amanda Pires; Brandao de Mattos, Cinara de Cassia; de Mattos, Luiz Carlos] Fundacao Fac Reg Med Sao Jose Do Rio Preto, FAMERP Toxoplasma Res Grp, Sao Jose Do Rio Preto, SP, Brazil	Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP); Universidade de Sao Paulo; Faculdade de Medicina de Sao Jose do Rio Preto (FAMERP)	de Mattos, LC (corresponding author), Fac Med Sao Jose Rio Preto Sao Jose Rio Preto, Dept Mol Biol, Immunogenet Lab, Sao Jose Do Rio Preto, SP, Brazil.	luiz.demattos@outlook.com	Frederico, Fábio Batista/AAE-2118-2019; BRANDÃO, CINARA/B-3650-2008; Murata, Fernando/AFV-2409-2022; ayo, christiane/B-5448-2017; Ayo, Christiane/AAE-2356-2019; PREVIATO, MARIANA/O-6122-2018; Murata, Fernando Henrique Antunes/AAD-5840-2020; de Mattos, Luiz Carlos/P-3574-2019; DE MATTOS, LUIZ CARLOS/F-6739-2010; de Mattos, Luiz Carlos/P-4005-2019	Frederico, Fábio Batista/0000-0002-0993-7938; BRANDÃO, CINARA/0000-0002-4836-3113; Ayo, Christiane/0000-0003-3983-0119; Murata, Fernando Henrique Antunes/0000-0002-4642-9553; DE MATTOS, LUIZ CARLOS/0000-0002-8572-8177; de Mattos, Luiz Carlos/0000-0002-8572-8177; Siqueira, Rubens/0000-0003-4563-1570	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/06580-9, 2013/10050-5, 2013/15879-8, 2015/13723-6, 2013/25650-8, 2009/17540-2]; Fundacao de Apoio a Pesquisa e Extensao de Sao Jose do Rio Preto (FAPERP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Faculdade de Medicina de Sao Jose do Rio Preto (BAP-FAMERP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [473579/2009-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Fundacao de Apoio a Pesquisa e Extensao de Sao Jose do Rio Preto (FAPERP); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Faculdade de Medicina de Sao Jose do Rio Preto (BAP-FAMERP); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (grants: 2013/06580-9 to CMA; 2013/10050-5 to MP; 2013/15879-8 to FHAM; 2015/13723-6 to CCBM; 2013/25650-8 and 2009/17540-2 to LCM); by Fundacao de Apoio a Pesquisa e Extensao de Sao Jose do Rio Preto (FAPERP) to FHAM. AVSC was supported by scholarship from Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES). CCBM was supported by grant from Faculdade de Medicina de Sao Jose do Rio Preto (BAP-FAMERP). LCM was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (grant: 473579/2009-0). FBF RCS APB APSC were not supported by grants. The opinions, assumptions, and conclusions or recommendations expressed in this material are the responsibility of the authors and do not necessarily reflect the views of FAPESP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour Y, 2014, INT J IMMUNOGENET, V41, P486, DOI 10.1111/iji.12146; Carneiro ACAV, 2013, J CLIN MICROBIOL, V51, P901, DOI 10.1128/JCM.02502-12; Amroun H, 2005, HUM IMMUNOL, V66, P1057, DOI 10.1016/j.humimm.2005.09.004; Andrade GMQ, 2009, J PEDIAT, V86, P85; Arantes TEF, 2015, AM J OPHTHALMOL, V159, P1002, DOI 10.1016/j.ajo.2015.02.015; Aspinall TV, 2003, INT J PARASITOL, V33, P97, DOI 10.1016/S0020-7519(02)00230-8; Ayo CM, 2015, CLIN INFECT DIS; BAHRAM S, 1994, P NATL ACAD SCI USA, V91, P6259, DOI 10.1073/pnas.91.14.6259; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Berrebi A, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.002; Boothroyd JC, 2002, CURR OPIN MICROBIOL, V5, P438, DOI 10.1016/S1369-5274(02)00349-1; Bosch-Driessen LEH, 2002, OPHTHALMOLOGY, V109, P869, DOI 10.1016/S0161-6420(02)00990-9; Bustillo JL, 2015, BRIT J OPHTHALMOL, V99, P382, DOI 10.1136/bjophthalmol-2014-305843; Caspi RR, 2006, IMMUNOL REV, V213, P23, DOI 10.1111/j.1600-065X.2006.00439.x; Collins RWM, 2004, EUR J IMMUNOGENET, V31, P105, DOI 10.1111/j.1365-2370.2004.00457.x; Combe CL, 2005, INFECT IMMUN, V73, P4913, DOI 10.1128/IAI.73.8.4913-4921.2005; Crane IJ, 2008, SEMIN IMMUNOPATHOL, V30, P165, DOI 10.1007/s00281-008-0106-7; de-la-Torre A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002541; DEBOER JH, 1994, INVEST OPHTH VIS SCI, V35, P3702; del Puerto F, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001587; DESMONTS G, 1974, NEW ENGL J MED, V290, P1110, DOI 10.1056/NEJM197405162902003; Dubey JP, 2012, PARASITOLOGY, V139, P1375, DOI 10.1017/S0031182012000765; Dutra MS, 2013, J INFECT DIS, V207, P152, DOI 10.1093/infdis/jis640; EXCOFFIER L, 1995, MOL BIOL EVOL, V12, P921; Ferreira AIC, 2014, EPIDEMIOL INFECT, V142, P142, DOI 10.1017/S0950268813000526; Furtado JM, 2013, CLIN EXP OPHTHALMOL, V41, P82, DOI 10.1111/j.1442-9071.2012.02821.x; Garcia G, 2011, HUM IMMUNOL, V72, P904, DOI 10.1016/j.humimm.2011.06.010; GAZZINELLI RT, 1994, EXP PARASITOL, V78, P217, DOI 10.1006/expr.1994.1022; Gilbert RE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000277; Gong Z, 2012, BRAZ J MED BIOL RES, V45, P222, DOI 10.1590/S0100-879X2012007500024; Grigg ME, 2015, AM J OPHTHALMOL, V159, P999, DOI 10.1016/j.ajo.2015.04.005; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Holland GN, 2004, AM J OPHTHALMOL, V137, P1, DOI 10.1016/j.ajo.2003.10.032; Holland GN, 2003, AM J OPHTHALMOL, V136, P973, DOI 10.1016/j.ajo.2003.09.040; Hong JX, 2012, BMC OPHTHALMOL, V12, DOI 10.1186/1471-2415-12-6; Hunter CA, 1996, CURR TOP MICROBIOL, V219, P113; Imanish T, 1992, HLA 1991, V1, P1065; Jones JL, 2014, AM J TROP MED HYG, V90, P794, DOI 10.4269/ajtmh.13-0722; Khan A, 2006, EMERG INFECT DIS, V12, P942, DOI 10.3201/eid1206.060025; Klaren VNA, 2001, J IMMUNOL, V167, P6263, DOI 10.4049/jimmunol.167.11.6263; Lemaitre C, 2001, INVEST OPHTH VIS SCI, V42, P2022; Lopez-Hernandez R, 2010, HUM IMMUNOL, V71, P512, DOI 10.1016/j.humimm.2010.02.003; Lu FL, 2004, INFECT IMMUN, V72, P4966, DOI 10.1128/IAI.72.9.4966-4972.2004; Maenz M, 2014, PROG RETIN EYE RES, V39, P77, DOI 10.1016/j.preteyeres.2013.12.005; Marin MLC, 2004, EUR J IMMUNOGENET, V31, P63, DOI 10.1111/j.1365-2370.2004.00446.x; Meerburg BG, 2009, PARASITOL RES, V105, P17, DOI 10.1007/s00436-009-1447-4; Mendes NHD, 2014, T ROY SOC TROP MED H, V108, P656, DOI 10.1093/trstmh/tru113; Miller CM, 2009, INT J PARASITOL, V39, P23, DOI 10.1016/j.ijpara.2008.08.002; Nagineni CN, 2002, CLIN EXP IMMUNOL, V128, P372, DOI 10.1046/j.1365-2249.2002.01815.x; Pardoll DM, 2001, SCIENCE, V294, P534, DOI 10.1126/science.1066284; Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100; PATZ A, 1985, ARCH OPHTHALMOL-CHIC, V103, P1796, DOI 10.1001/archopht.1985.01050120030015; Phan L, 2008, AM J OPHTHALMOL, V146, P375, DOI 10.1016/j.ajo.2008.04.033; Phan L, 2008, OPHTHALMOLOGY, V115, P553, DOI 10.1016/j.ophtha.2007.06.022; Pleyer U, 2014, OPHTHALMIC RES, V52, P116, DOI 10.1159/000363141; Pollock RA, 2013, TISSUE ANTIGENS, V82, P43, DOI 10.1111/tan.12126; Ribas F, 2008, TISSUE ANTIGENS, V72, P532, DOI 10.1111/j.1399-0039.2008.01142.x; Ferreira IMR, 2011, EXP PARASITOL, V129, P190, DOI 10.1016/j.exppara.2011.06.002; Roberts F, 1999, PARASITOL TODAY, V15, P51, DOI 10.1016/S0169-4758(98)01377-5; Rosenberg EA, 2008, AM FAM PHYSICIAN, V77, P1431; Rothova Aniki, 2003, Curr Opin Ophthalmol, V14, P384, DOI 10.1097/00055735-200312000-00011; Sáfadi Marco A. P., 2003, Braz J Infect Dis, V7, P325, DOI 10.1590/S1413-86702003000500007; Sauer A, 2012, J INFECT DIS, V206, P1319, DOI 10.1093/infdis/jis486; do Sacramento WS, 2012, INT J IMMUNOGENET, V39, P210, DOI 10.1111/j.1744-313X.2011.01074.x; Solana R, 2012, SEMIN IMMUNOL, V24, P331, DOI 10.1016/j.smim.2012.04.008; Souza CF, 2012, TISSUE ANTIGENS, V79, P58, DOI 10.1111/j.1399-0039.2011.01789.x; Steinle A, 2001, IMMUNOGENETICS, V53, P279, DOI 10.1007/s002510100325; Stephens HAF, 2001, TRENDS IMMUNOL, V22, P378, DOI 10.1016/S1471-4906(01)01960-3; Streilein JW, 1999, PROG RETIN EYE RES, V18, P357, DOI 10.1016/S1350-9462(98)00022-6; Vasconcelos-Santos DV, 2012, CURR OPIN OPHTHALMOL, V23, P543, DOI 10.1097/ICU.0b013e328358bae5; Yoshida K, 2011, ARTHRITIS RHEUM-US, V63, P3058, DOI 10.1002/art.30501; Zwirner NW, 2006, INMUNOLOGIA, V25, P25	72	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144534	10.1371/journal.pone.0144534	http://dx.doi.org/10.1371/journal.pone.0144534			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26672749	Green Submitted, Green Published, gold			2022-12-26	WOS:000366722700043
J	Chen, YM; Hou, YS; Guo, ZX; Wang, WQ; Zhong, CR; Zhou, RC; Shi, SH				Chen, Yongmei; Hou, Yansong; Guo, Zixiao; Wang, Wenqing; Zhong, Cairong; Zhou, Renchao; Shi, Suhua			Applications of Multiple Nuclear Genes to the Molecular Phylogeny, Population Genetics and Hybrid Identification in the Mangrove Genus Rhizophora	PLOS ONE			English	Article							ADAPTIVE INTROGRESSION; NATURAL HYBRIDIZATION; CHLOROPLAST DNA; RIBOSOMAL DNA; R. MUCRONATA; SOFTWARE; PATTERNS; TRAITS	The genus Rhizophora is one of the most important components of mangrove forests. It is an ideal system for studying biogeography, molecular evolution, population genetics, hybridization and conservation genetics of mangroves. However, there are no sufficient molecular markers to address these topics. Here, we developed 77 pairs of nuclear gene primers, which showed successful PCR amplifications across all five Rhizophora species and sequencing in R. apiculata. Here, we present three tentative applications using a subset of the developed nuclear genes to (I) reconstruct the phylogeny, (II) examine the genetic structure and (III) identify natural hybridization in Rhizophora. Phylogenetic analyses support the hypothesis that Rhizophora had disappeared in the Atlantic-East Pacific (AEP) region and was re-colonized from the IWP region approximately 12.7 Mya. Population genetics analyses in four natural populations of R. apiculata in Hainan, China, revealed extremely low genetic diversity, strong population differentiation and extensive admixture, suggesting that the Pleistocene glaciations, particularly the last glacial maximum, greatly influenced the population dynamics of R. apiculata in Hainan. We also verified the hybrid status of a morphologically intermediate individual between R. apiculata and R. stylosa in Hainan. Based on the sequences of five nuclear genes and one chloroplast intergenic spacer, this individual is likely to be an F1 hybrid, with R. stylosa as its maternal parent. The nuclear gene markers developed in this study should be of great value for characterizing the hybridization and introgression patterns in other cases of this genus and testing the role of natural selection using population genomics approaches.	[Chen, Yongmei; Hou, Yansong; Guo, Zixiao; Zhou, Renchao; Shi, Suhua] Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Chen, Yongmei; Hou, Yansong; Guo, Zixiao; Zhou, Renchao; Shi, Suhua] Sun Yat Sen Univ, Guangdong Prov Key Lab Plant Resources, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China; [Wang, Wenqing] Xiamen Univ, Sch Life Sci, Xiamen, Fujian, Peoples R China; [Zhong, Cairong] Hainan Dongzhai Harbor Natl Nat Reserve, Haikou, Hainan, Peoples R China; [Chen, Yongmei] Univ Sichuan Sci & Engn, Sch Chem & Pharmaceut Engn, Zigong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Xiamen University	Zhou, RC (corresponding author), Sun Yat Sen Univ, State Key Lab Biocontrol, Sch Life Sci, Guangzhou 510275, Guangdong, Peoples R China.	zhrench@mail.sysu.edu.cn; lssssh@mail.sysu.edu.cn		Guo, Zixiao/0000-0003-4820-4056	National Natural Science Foundation of China [41130208, 91331202, 31170213, 91231106]; State Key Laboratory of Biocontrol [SKLBC14A03]; Chang Hungta Science Foundation of Sun Yat-sen University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Biocontrol; Chang Hungta Science Foundation of Sun Yat-sen University	This project was supported by grants from the National Natural Science Foundation of China (http://npd.nsfc.gov.cn/fundingProjectSearchAction.action, Nos. 41130208 and 91331202 (SS received the funding), 31170213 and 91231106 (RZ received the funding)), the State Key Laboratory of Biocontrol (http://sklbc.sysu.edu.cn/Ky_work/Project/index.aspx?typeid=273, Nos. SKLBC14A03 (SS received the funding)) and the Chang Hungta Science Foundation of Sun Yat-sen University. All funders supported the study design. The data collection and analysis were supported by grants from the National Natural Science Foundation of China (Nos. 41130208 and 91331202) and the State Key Laboratory of Biocontrol (Nos. SKLBC14A03). The preparation of the manuscript and decision to publish were supported by grants from the National Natural Science Foundation of China (Nos. 31170213 and 91231106).	Arnold Michael L., 2009, Journal of Biology (London), V8, P82, DOI 10.1186/jbiol176; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Cannon CH, 2009, P NATL ACAD SCI USA, V106, P11188, DOI 10.1073/pnas.0809865106; CARNEY SE, 1994, AM J BOT, V81, P1169, DOI 10.2307/2445479; Ceron-Souza I, 2010, AM J BOT, V97, P945, DOI 10.3732/ajb.0900172; Dassanayake M, 2009, NEW PHYTOL, V183, P764, DOI 10.1111/j.1469-8137.2009.02913.x; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Drexler Judy Z., 2001, Pacific Science, V55, P17, DOI 10.1353/psc.2001.0004; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duke NC, 2010, BLUMEA, V55, P171, DOI 10.3767/000651910X527293; Duke NC, 1998, GLOBAL ECOL BIOGEOGR, V7, P27, DOI 10.2307/2997695; Duke NC, 2002, TREES-STRUCT FUNCT, V16, P65, DOI 10.1007/s00468-001-0141-7; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Graham A, 2006, ANN MO BOT GARD, V93, P325, DOI 10.3417/0026-6493(2006)93[325:PEAMDI]2.0.CO;2; Guo MM, 2011, AQUAT BOT, V95, P59, DOI 10.1016/j.aquabot.2011.03.001; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Inomata N, 2009, GENES GENET SYST, V84, P277, DOI 10.1266/ggs.84.277; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lo EYY, 2010, J EVOLUTION BIOL, V23, P2249, DOI 10.1111/j.1420-9101.2010.02087.x; Lo EYY, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-83; Miller KG, 2005, SCIENCE, V310, P1293, DOI 10.1126/science.1116412; Miyama M, 2006, PLANT SCI, V171, P234, DOI 10.1016/j.plantsci.2006.03.015; Ng W, 2015, CONSERV GENET, V16, P137, DOI 10.1007/s10592-014-0647-3; Ng WL, 2015, AQUAT BOT, V120, P222, DOI 10.1016/j.aquabot.2014.07.006; Ng WL, 2013, TREE GENET GENOMES, V9, P1151, DOI 10.1007/s11295-013-0619-7; Park KR, 2003, BOT B ACAD SINICA, P44; Parks DH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069885; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; RABINOWITZ D, 1978, J BIOGEOGR, V5, P113, DOI 10.2307/3038167; Rambaut A., 2003, TRACER; Ricklefs RE, 2006, AM NAT, V168, P805, DOI 10.1086/508711; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Sandoval-Castro E, 2012, AQUAT BOT, V99, P20, DOI 10.1016/j.aquabot.2012.01.002; Schwarzbach AE, 2000, AM J BOT, V87, P547, DOI 10.2307/2656599; Schwarzbach Andrea E., 2001, Wetlands Ecology and Management, V9, P195, DOI 10.1023/A:1011104706251; Shi SH, 2002, BIOCHEM SYST ECOL, V30, P309, DOI 10.1016/S0305-1978(01)00102-8; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tomlinson PB, 1986, THE BOTANY OF MANGRO; Triest L, 2008, AQUAT BOT, V89, P138, DOI 10.1016/j.aquabot.2007.12.013; Vaillancourt RE, 2000, THEOR APPL GENET, V101, P473, DOI 10.1007/s001220051505; Vergeer P, 2013, NEW PHYTOL, V197, P989, DOI 10.1111/nph.12060; Wee AKS, 2014, J BIOGEOGR, V41, P954, DOI 10.1111/jbi.12263; Whitney KD, 2006, AM NAT, V167, P794, DOI 10.1086/504606; Whitney KD, 2010, NEW PHYTOL, V187, P230, DOI 10.1111/j.1469-8137.2010.03234.x; Woodruff DS, 2010, BIODIVERS CONSERV, V19, P919, DOI 10.1007/s10531-010-9783-3; Zhang RS, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-74; Zhou RC, 2005, MOL PHYLOGENET EVOL, V35, P595, DOI 10.1016/j.ympev.2005.03.012; Zhou RC, 2011, MOL BIOL EVOL, V28, P2833, DOI 10.1093/molbev/msr102	51	10	10	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145058	10.1371/journal.pone.0145058	http://dx.doi.org/10.1371/journal.pone.0145058			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674070	gold, Green Published, Green Submitted			2022-12-26	WOS:000366722700090
J	Yamada, T; Yamada, M; Tsukagoshi, M				Yamada, Toshihiro; Yamada, Mariko; Tsukagoshi, Minoru			Taxonomic Revision of Pinus fujiii (Yasui) Miki (Pinaceae) and Its Implications for the Phytogeography of the Section Trifoliae in East Asia	PLOS ONE			English	Article							FOSSIL; MIOCENE; WASHINGTON; PHYLOGENY; JAPAN; CONES; MA	Pinus trifolia Miki 1939 (Pinaceae) was originally proposed based on seed cones from the upper Miocene of Aichi and Gifu Prefectures, central Japan. However, before the publication of P. trifolia, a different name (Pinus fujiii (Yasui) Miki) was given to a female cone with the same morphology. On the other hand, P. fujiii auct. non (Yasui) Miki has been used for seed cones with different morphologies from Yasui's holotype, i.e., apophyses arranged in 5:8 parastichies and a perexcentromucronate slightly-pointed umbo. As a result of re-examination on the Miki and Yasui specimens, we concluded that P. trifolia was a synonym for P. fujiii and proposed here Pinus mikii sp. nov. for cones assigned to P. fujiii auct. non (Yasui) Miki. We also emended the diagnosis of P. fujiii based on these specimens. Pinus fujiii is characterized by a large female cone in which the apophyses with a centromucronate prickle-like umbo are arranged in 8:13 parastichies, and deciduous seed wings. These characters suggest that P. fujiii belongs to the section Trifoliae of the subgenus Pinus, which is now restricted to North and Central America and the Caribbean islands. Fossil data suggest that the P. fujiii lineage firstly appeared in Japan around the Eocene/Oligocene boundary. We speculate that the P. fujiii lineage might have moved southward to Japan from a refugium located elsewhere in high-latitude areas in response to the late Eocene cooling event, as occurred with other Trifoliae species in North America.	[Yamada, Toshihiro; Yamada, Mariko] Kanazawa Univ, Coll Sci & Engn, Sch Nat Syst, Kanazawa, Ishikawa, Japan; [Tsukagoshi, Minoru] Osaka Museum Nat Hist, Osaka, Japan	Kanazawa University	Yamada, T (corresponding author), Kanazawa Univ, Coll Sci & Engn, Sch Nat Syst, Kanazawa, Ishikawa, Japan.	ptilo@mb.infoweb.ne.jp	Yamada, Mariko/GQY-4891-2022; Yamada, Toshihiro/L-3594-2015	Yamada, Toshihiro/0000-0002-9064-7048	Ministry of Education, Culture, Sports, Science and Technology [26304010]	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by KAKENHI (Grant-in-Aid for Scientific Research) 26304010 from the Ministry of Education, Culture, Sports, Science and Technology (http://www.mext.go.jp) to TY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando Y, 1999, B GIFU PREF MUS, V20, P17; AXELROD D., 1967, P S BIOL CALIFORNIA, P93; AXELROD D I, 1984, Transactions of the San Diego Society of Natural History, V20, P277; AXELROD DI, 1986, ANN MO BOT GARD, V73, P565, DOI 10.2307/2399194; Axelrod DI, 1937, PUBL CARNEGIE I WASH, V476, P125; Axelrod DI, 1950, PUBL CARNEGIE I WASH, V590, P119; Condit C, 1944, PUBL CARNEGIE I WASH, V553, P57; Debreczy Z, 2011, CONIFERS WORLD, V2; Debreczy Z, 2011, CONIFERS WORLD, V1-2; Dorf E., 1930, PUBL CARNEGIE I WASH, V412, P1; Duhamel du Monceau M., 1755, TRAITE ARBRES ARBUST, V2; Eckert AJ, 2006, MOL PHYLOGENET EVOL, V40, P166, DOI 10.1016/j.ympev.2006.03.009; FARJON A, 1997, FLORA NEOTROPICA MON, V75; Gernandt DS, 2005, TAXON, V54, P29, DOI 10.2307/25065300; Gorozhankin I.N., 1904, LEKCII MORFOLOGII SI; Hernandez-Leon S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070501; Ina H, 1981, MONOGRAPH MIZUNAMI F, V2, P1; Kimura T., 1981, T P PALAEONOLOGICAL, V122, P87; Kvacek Z, 2014, PALAEONTOGR ABT B, V291, P131; Lindley J, 1832, FOSSIL FLORA GREAT B, V1; Linnaeus C., 1753, SPECIES PLANTARUM, P1000; Little EL, 1969, USDA FOREST SERVICE, V1144; Loudon JC, 1838, ARBORETUM FRUCTICETU, V4, P2152; Maarten JM, 2011, PHYTOTAXA, V19, P55; MAI D H, 1986, Feddes Repertorium, V97, P571; Maruyama S, 1997, ISL ARC, V6, P121, DOI 10.1111/j.1440-1738.1997.tb00043.x; MATSUO H., 1963, TERTIARY FLORAS JAPA, P219; Miki S, 1972, GEOGR REP KUMAMOTO U, V2, P72; MIKI S, 1948, MINERAL GEOL, V2, P105; MIKI SHIGERU, 1941, JAPANESE JOUR BOT, V11, P237; MIKI SHIGERU, 1939, BOT MAG [TOKYO], V53, P239; Mili S., 1957, Journal of the Institute of Polytechnics, Osaka City University, Osaka Ser. D., P221; Millar Constance L., 1998, P69; MILLER CN, 1992, AM J BOT, V79, P754, DOI 10.2307/2444940; MILLER CN, 1978, B TORREY BOT CLUB, V105, P93, DOI 10.2307/2484425; Mirov N. T., 1967, GENUS PINUS; Muller K, 2004, MOL PHYLOGENET EVOL, V31, P780, DOI 10.1016/j.ympev.2003.12.006; Nakayama K, 1989, EARTH SCI, V43, P40; Nakayama K, 1999, EARTH SCI, V53, P173; Nirei T, 2011, B SAITAMA MUS NAT HI, V5, P101; Oga Y, 1960, J SOC EARTHSCIENTIST, V11, P228; Omori M, 1965, J GEOL SOC JAPAN, V842, P467; Ozaki Masanori, 1996, Journal of the Geological Society of Japan, V102, P73; Pilger R., 1926, NATURL PFLANZ, VXIII, P331; Price Robert A., 1998, P49; Rossler R, 2014, TAXON, V63, P177, DOI 10.12705/631.7; Saneyoshi M, 2000, EARTH SCI, V54, P127; Sawada K, 2013, INT J COAL GEOL, V107, P78, DOI 10.1016/j.coal.2012.10.013; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tanai T., 1961, J FS HOKKAIDO U, V11, P119; Teodoridis V, 2008, NEUES JAHRB GEOL P-A, V250, P287, DOI 10.1127/0077-7749/2008/0250-0287; Thiers B., INDEX HERBARIORUM GL; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P73, DOI 10.5962/bhl.part.13179; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P243, DOI 10.5962/bhl.part.13183; TSUKAGOSHI M, 1998, J GEOL SOC JAPAN, V104, P495; UNDERWOOD JC, 1980, AM J BOT, V67, P1132, DOI 10.2307/2442205; WIGGINS IL, 1951, AM J BOT, V38, P211, DOI 10.2307/2438071; Willyard A, 2007, MOL BIOL EVOL, V24, P620, DOI 10.1093/molbev/msl207; Yamada M., 2014, J PHYTOGEOGRAPHY TAX, V62, P29; Yamada T, 2014, J PLANT RES, V127, P193, DOI 10.1007/s10265-013-0621-z; Yasui K., 1928, J FS IMPERIAL U TOKY, V1, P381; Zachos J, 2001, SCIENCE, V292, P686, DOI 10.1126/science.1059412	62	5	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0143512	10.1371/journal.pone.0143512	http://dx.doi.org/10.1371/journal.pone.0143512			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673795	Green Published, gold			2022-12-26	WOS:000366722700011
J	Zhou, XX; Wang, Q; Zhang, XL; Chen, YS; Peng, XC; Mao, YQ; Yang, Y; Fu, BG; Wang, XH; Tang, TT				Zhou, Xiaoxiao; Wang, Qi; Zhang, Xianlong; Chen, Yunsu; Peng, Xiaochun; Mao, Yuanqing; Yang, Yang; Fu, Beigang; Wang, Xiuhui; Tang, Tingting			Severe Pelvic Obliquity Affects Femoral Offset in Patients with Total Hip Arthroplasty but Not Leg-Length Inequality	PLOS ONE			English	Article							DISCREPANCY; MOTION; GAIT	Leg-length inequality is an extensively studied complication of total hip arthroplasty in normal patients. However, few studies have focused on the pelvic obliquity of coronal pelvic malrotation. We hypothesized that pelvic obliquity with a fixed abduction/adduction contracture deformity of the hip may intraoperatively affect the release of soft tissues, ultimately resulting in a leg-length inequality. This study also investigated whether the femoral and vertical offsets of total hip arthroplasty were correlated with pelvic obliquity. This prospective study divided 98 patients into six groups based on the inclination of pelvic obliquity before total hip arthroplasty. Leg-length inequality, variation of pelvic obliquity, offset, and vertical offset were measured after total hip arthroplasty. Leg-length inequality and vertical offset were not significantly different among groups, whereas the variation of pelvic obliquity was significantly higher in type IIC pelvic obliquity than in other groups. Type IC pelvic obliquity had a significantly shorter offset than did the other groups, which may have been an important factor leading to type IC pelvic obliquity. Pelvic obliquity exhibited no significant effect on leg-length inequality in patients with total hip arthroplasty. A shorter offset may be caused by the higher tension of the abductor in the operated hip, which may result in the formation of type IC pelvic obliquity. Releasing the abductor contracture and restoring femoral offset are important for increasing hip stability and maintaining pelvic balance following total hip arthroplasty.	[Zhou, Xiaoxiao; Fu, Beigang; Wang, Xiuhui] Shanghai Univ Med & Hlth Sci, Dept Orthoped, Zhoupu Hosp Pudong Dist, Shanghai, Peoples R China; [Wang, Qi; Zhang, Xianlong; Chen, Yunsu; Peng, Xiaochun] Shanghai Jiao Tong Univ, Dept Orthopaed, Shanghai Peoples Hosp 6, Shanghai 200030, Peoples R China; [Mao, Yuanqing; Tang, Tingting] Shanghai Jiao Tong Univ, Dept Orthopaed, Peoples Hosp 9, Shanghai 200030, Peoples R China; [Yang, Yang] Wenzhou Med Univ, Wenzhou, Zhejiang, Peoples R China	Shanghai University of Medicine & Health Sciences; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Wenzhou Medical University	Wang, Q (corresponding author), Shanghai Univ Med & Hlth Sci, Dept Orthoped, Zhoupu Hosp Pudong Dist, Shanghai, Peoples R China.	wongqi2010@126.com	Tang, Tingting/B-1361-2013; zhang, xian/GYA-0290-2022	Tang, Tingting/0000-0002-1670-7452; 				Bouffard V, 2011, REHABIL RES PRACT, V2011, DOI 10.1155/2011/586412; Brinckmann P, 2002, MUSCULOSKELETAL BIOM, P69; Charnley J., 1979, LOW FRICTION ARTHROP, P3; Dastane M, 2011, CLIN ORTHOP RELAT R, V469, P429, DOI 10.1007/s11999-010-1554-7; Dolhain P, 2002, Acta Orthop Belg, V68, P490; DUBOUSSET J, 1990, ORTHOPADE, V19, P300; FACKLER CD, 1980, CLIN ORTHOP RELAT R, P169; Feng Zongquan, 2000, CHIN J ORTHOP, V20, P649; Free SA, 1996, J ORTHOP RES, V14, P245, DOI 10.1002/jor.1100140212; GOODMAN SB, 1988, CLIN ORTHOP RELAT R, P199; Jasty M, 1996, CLIN ORTHOP RELAT R, P165; JOHNSTON RC, 1979, J BONE JOINT SURG AM, V61, P639, DOI 10.2106/00004623-197961050-00001; Kakushima M, 2003, SPINE, V28, P2472, DOI 10.1097/01.BRS.0000090829.82231.4A; Laupacis A, 2002, J BONE JOINT SURG AM, V84A, P1823, DOI 10.2106/00004623-200210000-00013; Lee DY, 1997, J BONE JOINT SURG BR, V79B, P190, DOI 10.1302/0301-620X.79B2.7052; Little NJ, 2009, CLIN ORTHOP RELAT R, V467, P2895, DOI 10.1007/s11999-009-0845-3; LOIZEAU J, 1995, ARCH PHYS MED REHAB, V76, P552, DOI 10.1016/S0003-9993(95)80510-9; Madsen MS, 2004, J ORTHOP RES, V22, P44, DOI 10.1016/S0736-0266(03)00151-7; Maloney WJ, 2004, J ARTHROPLASTY, V19, P108, DOI 10.1016/j.arth.2004.02.018; MCGRORY BJ, 1995, J BONE JOINT SURG BR, V77B, P865, DOI 10.1302/0301-620X.77B6.7593096; Nordin M, 2001, BASIC BIOMECHANICS M, P203; Polkowski GG, 2010, SPORTS MED ARTHROSC, V18, P56, DOI 10.1097/JSA.0b013e3181dc5774; Ranawat CS, 2001, J ARTHROPLASTY, V16, P715, DOI 10.1054/arth.2001.24442; Ranawat CS, 1997, J ARTHROPLASTY, V12, P359, DOI 10.1016/S0883-5403(97)90190-X; Restrepo C, 2011, CLIN ORTHOP RELAT R, V469, P476, DOI 10.1007/s11999-010-1561-8; Sathappan SS, 2008, J ARTHROPLASTY, V23, P203, DOI 10.1016/j.arth.2007.01.022; VASAVADA AN, 1994, CLIN ORTHOP RELAT R, P121; Visuri T, 1993, Ital J Orthop Traumatol, V19, P107; Zhao Hongwu, 2013, J PRACTICAL ORTHOPAE, V19, P1023; Zhou XX, 2012, J ARTHROPLASTY, V27, P299, DOI 10.1016/j.arth.2011.09.022	30	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144863	10.1371/journal.pone.0144863	http://dx.doi.org/10.1371/journal.pone.0144863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673427	Green Submitted, Green Published, gold			2022-12-26	WOS:000366722700067
J	Paco, S; Casserras, T; Rodriguez, MA; Jou, C; Puigdelloses, M; Ortez, CI; Diaz-Manera, J; Gallardo, E; Colomer, J; Nascimento, A; Kalko, SG; Jimenez-Mallebrera, C				Paco, Sonia; Casserras, Teresa; Angels Rodriguez, Maria; Jou, Cristina; Puigdelloses, Montserrat; Ortez, Carlos I.; Diaz-Manera, Jordi; Gallardo, Eduardo; Colomer, Jaume; Nascimento, Andres; Kalko, Susana G.; Jimenez-Mallebrera, Cecilia			Transcriptome Analysis of Ullrich Congenital Muscular Dystrophy Fibroblasts Reveals a Disease Extracellular Matrix Signature and Key Molecular Regulators	PLOS ONE			English	Article							ASCORBIC-ACID TREATMENT; COLLAGEN-VI DEFICIENCY; TENASCIN-X; VITAMIN-C; EXPRESSION; MUSCLE; SKIN; INTEGRIN; MYOPATHIES; GENES	Background Collagen VI related myopathies encompass a range of phenotypes with involvement of skeletal muscle, skin and other connective tissues. They represent a severe and relatively common form of congenital disease for which there is no treatment. Collagen VI in skeletal muscle and skin is produced by fibroblasts. Aims & Methods In order to gain insight into the consequences of collagen VI mutations and identify key disease pathways we performed global gene expression analysis of dermal fibroblasts from patients with Ullrich Congenital Muscular Dystrophy with and without vitamin C treatment. The expression data were integrated using a range of systems biology tools. Results were validated by real-time PCR, western blotting and functional assays. Findings We found significant changes in the expression levels of almost 600 genes between collagen VI deficient and control fibroblasts. Highly regulated genes included extracellular matrix components and surface receptors, including integrins, indicating a shift in the interaction between the cell and its environment. This was accompanied by a significant increase in fibroblasts adhesion to laminin. The observed changes in gene expression profiling may be under the control of two miRNAs, miR-30c and miR-181a, which we found elevated in tissue and serum from patients and which could represent novel biomarkers for muscular dystrophy. Finally, the response to vitamin C of collagen VI mutated fibroblasts significantly differed from healthy fibroblasts. Vitamin C treatment was able to revert the expression of some key genes to levels found in control cells raising the possibility of a beneficial effect of vitamin C as a modulator of some of the pathological aspects of collagen VI related diseases.	[Paco, Sonia; Angels Rodriguez, Maria; Puigdelloses, Montserrat; Ortez, Carlos I.; Colomer, Jaume; Nascimento, Andres; Jimenez-Mallebrera, Cecilia] Fdn St Joan de Deu, Hosp St Joan de Deu, Neuropaediat Dept, Neuromuscular Unit, Barcelona, Spain; [Casserras, Teresa; Kalko, Susana G.] Hosp Clin Barcelona, Bioinformat Core Facil, IDIBAPS, Barcelona, Spain; [Jou, Cristina] Hosp St Joan de Deu, Dept Pathol, Barcelona, Spain; [Diaz-Manera, Jordi; Gallardo, Eduardo] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Dept Neurol, Neuromuscular Dis Unit, E-08193 Barcelona, Spain; [Nascimento, Andres; Jimenez-Mallebrera, Cecilia] Inst Salud Carlos III, Ctr Biomed Res Rare Dis CIBERER, Madrid, Spain	University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Barcelona; Autonomous University of Barcelona; Hospital of Santa Creu i Sant Pau; CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III	Jimenez-Mallebrera, C (corresponding author), Fdn St Joan de Deu, Hosp St Joan de Deu, Neuropaediat Dept, Neuromuscular Unit, Barcelona, Spain.	cjimenezm@hsjdbcn.org	Jiménez-Mallebrera, Cecilia/F-5030-2016	Jiménez-Mallebrera, Cecilia/0000-0001-8203-7103; Gallardo, Eduard/0000-0002-3942-3436; Diaz-Manera, Jordi/0000-0003-2941-7988; Kalko, Susana/0000-0002-6701-0233; Ortez Gonzalez, Carlos Ignacio/0000-0001-8187-8103; Puigdelloses, Montserrat/0000-0001-6011-1755	Plan Nacional de I+D+I and Instituto de Salud Carlos III-Subdireccion General de Evaluacion y Fomento de la Investigacion Sanitaria [PI10/00177, PI13/00837, PI15/01822]; European Regional Development Fund (FEDER); Hospital Sant Joan de Deu Reserch Grants; Instituto de Salud Carlos III grant [CP09/00011]	Plan Nacional de I+D+I and Instituto de Salud Carlos III-Subdireccion General de Evaluacion y Fomento de la Investigacion Sanitaria; European Regional Development Fund (FEDER)(European Commission); Hospital Sant Joan de Deu Reserch Grants; Instituto de Salud Carlos III grant(Instituto de Salud Carlos III)	This work was funded by the "Plan Nacional de I+D+I and Instituto de Salud Carlos III-Subdireccion General de Evaluacion y Fomento de la Investigacion Sanitaria, http://www.isciii.es/", projects PI10/00177 (CJM), and PI13/00837 (CJM) and PI15/01822 (JDM), and the European Regional Development Fund (FEDER) (CJM). MAR is sponsored by the Hospital Sant Joan de Deu Reserch Grants. CJM is funded by the Instituto de Salud Carlos III grant CP09/00011.	Abonnenc M, 2013, CIRC RES, V113, P1138, DOI 10.1161/CIRCRESAHA.113.302400; Accorsi Anthony, 2015, J Neuromuscul Dis, V2, P51; Alexander Matthew S, 2015, J Neuromuscul Dis, V2, P1; Allamand V, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-30; Atkinson JC, 1996, EXP CELL RES, V228, P283, DOI 10.1006/excr.1996.0328; Bonnemann CG, 2011, NAT REV NEUROL, V7, P379, DOI 10.1038/nrneurol.2011.81; Borza CM, 2006, J BIOL CHEM, V281, P20932, DOI 10.1074/jbc.M601147200; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Burg MA, 1996, J BIOL CHEM, V271, P26110, DOI 10.1074/jbc.271.42.26110; Collins J, 2010, CURR NEUROL NEUROSCI, V10, P83, DOI 10.1007/s11910-010-0092-8; Duarte TL, 2009, FREE RADICAL BIO MED, V46, P78, DOI 10.1016/j.freeradbiomed.2008.09.028; Eisenberg I, 2009, J CELL MOL MED, V13, P2, DOI 10.1111/j.1582-4934.2008.00524.x; Ferreira LM, 2009, AN ACAD BRAS CIENC, V81, P623, DOI 10.1590/S0001-37652009000300024; Guo S, 2010, J DENT RES, V89, P219, DOI 10.1177/0022034509359125; Higashi K, 2006, MUSCLE NERVE, V33, P120, DOI 10.1002/mus.20449; Hodges BL, 1997, J CELL SCI, V110, P2873; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jimenez-Mallebrera C, 2006, NEUROMUSCULAR DISORD, V16, P571, DOI 10.1016/j.nmd.2006.07.015; Juneja SC, 2013, ARTHRITIS, DOI 10.1155/2013/154812; Kawahara G, 2007, NEUROLOGY, V69, P1043, DOI 10.1212/01.wnl.0000271386.89878.22; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Kirschner J, 2005, AM J MED GENET A, V132A, P296, DOI 10.1002/ajmg.a.30443; Kuo HJ, 1997, J BIOL CHEM, V272, P26522, DOI 10.1074/jbc.272.42.26522; Lettmann S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105686; Lewis RA, 2013, JAMA NEUROL, V70, P981, DOI 10.1001/jamaneurol.2013.3178; Lowell CA, 2011, METHODS MOL BIOL, V757, P369, DOI 10.1007/978-1-61779-166-6_22; MacDonald EM, 2012, CURR OPIN RHEUMATOL, V24, P628, DOI 10.1097/BOR.0b013e328358df34; Minamitani T, 2004, EXP CELL RES, V298, P305, DOI 10.1016/j.yexcr.2004.04.030; Minamitani T, 2004, EXP CELL RES, V297, P49, DOI 10.1016/j.yexcr.2004.03.002; OONO T, 1993, J INVEST DERMATOL, V100, P329, DOI 10.1111/1523-1747.ep12470022; Paco S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077430; Paco S, 2012, J NEUROPATH EXP NEUR, V71, P894, DOI 10.1097/NEN.0b013e31826c6f7b; Pan TC, 2013, J BIOL CHEM, V288, P14320, DOI 10.1074/jbc.M112.433078; Park HJ, 2010, EXP DERMATOL, V19, pE258, DOI 10.1111/j.1600-0625.2010.01070.x; Park NY, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-80; Passage E, 2004, NAT MED, V10, P396, DOI 10.1038/nm1023; PELTONEN J, 1990, ARTHRITIS RHEUM-US, V33, P1829, DOI 10.1002/art.1780331211; PFAFF M, 1993, EXP CELL RES, V206, P167, DOI 10.1006/excr.1993.1134; Ruhl M, 1999, J BIOL CHEM, V274, P34361, DOI 10.1074/jbc.274.48.34361; Sabatelli P, 2001, MATRIX BIOL, V20, P475, DOI 10.1016/S0945-053X(01)00160-3; Sarkar P, 2012, MOL CELL PROTEOMICS, V11, P1829, DOI 10.1074/mcp.M112.020503; Schmidt S, 2010, CELL TISSUE RES, V339, P83, DOI 10.1007/s00441-009-0892-9; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sinno Hani, 2013, Plast Surg Int, V2013, P146764, DOI 10.1155/2013/146764; Smith AN, 2010, EXP CELL RES, V316, P48, DOI 10.1016/j.yexcr.2009.08.001; Taylor CJ, 2012, EXP DIABETES RES, DOI 10.1155/2012/168368; Valero T, 2014, CURR PHARM DESIGN, V20, P5507, DOI 10.2174/138161282035140911142118; Villoslada P, 2009, ANN NEUROL, V65, P124, DOI 10.1002/ana.21634; Zaharieva IT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080263	50	18	18	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145107	10.1371/journal.pone.0145107	http://dx.doi.org/10.1371/journal.pone.0145107			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670220	gold, Green Submitted, Green Published			2022-12-26	WOS:000366719300049
J	Rikiishi, K; Matsuura, T; Ikeda, Y; Maekawa, M				Rikiishi, Kazuhide; Matsuura, Takakazu; Ikeda, Yoko; Maekawa, Masahiko			Light Inhibition of Shoot Regeneration Is Regulated by Endogenous Abscisic Acid Level in Calli Derived from Immature Barley Embryos	PLOS ONE			English	Article							TISSUE-CULTURE TRAITS; SOMATIC EMBRYOGENESIS; PLANT-REGENERATION; GENETIC-TRANSFORMATION; ANTHER CULTURE; HORMONE-LEVELS; LEAF EXPLANTS; SATIVA L.; ARABIDOPSIS; RICE	Shoot regeneration in calli derived from immature barley embryos is regulated by light conditions during the callus-induction period. Barley cultivars Kanto Nijo-5 (KN5) and K-3 (K3) showed lower efficiency of shoot regeneration in a 16-h photoperiod during callus-induction than those in continuous darkness, whereas shoot regeneration was enhanced in cultures under a 16-h photoperiod in Golden Promise (GP) and Lenins (LN). These cultivars were classified as photo-inhibition type (KN5 and K3) or photo-induction type (GP and LN) according to their response to light. Contents of endogenous plant hormones were determined in calli cultured under a 16-h photoperiod and continuous darkness. In photo-inhibition type, higher accumulation of abscisic acid (ABA) was detected in calli cultured under a 16-h photoperiod, whereas calli showed lower levels of endogenous ABA in continuous darkness. However, cultivars of photo-induction type showed lower levels of ABA in calli cultured under both light conditions, similarly to photo-inhibition type in continuous darkness. Exogenous ABA inhibited the callus growth and shoot regeneration independent of light conditions in all cultivars. In photo-inhibition type, lower levels of endogenous ABA induced by ABA biosynthesis inhibitor, fluridone, reduced the photo-inhibition of shoot regeneration. Expression of ABA biosynthesis gene, HvNCED1, in calli was regulated by the light conditions. Higher expression was observed in calli cultured under a 16-h photoperiod. These results indicate that ABA biosynthesis could be activated through the higher expression of HvNCED1 in a 16-h photoperiod and that the higher accumulations of ABA inhibit shoot regeneration in the photo-inhibition type cultivars.	[Rikiishi, Kazuhide; Matsuura, Takakazu; Ikeda, Yoko; Maekawa, Masahiko] Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan	Okayama University	Rikiishi, K (corresponding author), Okayama Univ, Inst Plant Sci & Resources, Kurashiki, Okayama, Japan.	riki@rib.okayama-u.ac.jp		Ikeda, Yoko/0000-0002-3150-8902	Ohara Foundation for Agricultural Research	Ohara Foundation for Agricultural Research	This work was supported by a grant from the Ohara Foundation for Agricultural Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARCELO P, 1994, PLANT J, V5, P583, DOI 10.1046/j.1365-313X.1994.5040583.x; Ben AIM, 1997, THEOR APPL GENET, V94, P1047; Berrios EF, 2000, THEOR APPL GENET, V101, P1299, DOI 10.1007/s001220051610; BROWN C, 1989, J PLANT PHYSIOL, V133, P727, DOI 10.1016/S0176-1617(89)80080-X; CARMAN JG, 1988, PLANTA, V175, P417, DOI 10.1007/BF00396349; Cary AJ, 2002, PLANT J, V32, P867, DOI 10.1046/j.1365-313X.2002.01479.x; Charriere F, 1998, PLANT SCI, V137, P63, DOI 10.1016/S0168-9452(98)00128-9; Che P, 2002, PLANT CELL, V14, P2771, DOI 10.1105/tpc.006668; Che P, 2007, PLANTA, V226, P1183, DOI 10.1007/s00425-007-0565-4; Che P, 2006, PLANT PHYSIOL, V141, P620, DOI 10.1104/pp.106.081240; ETIENNE H, 1993, PLANT SCI, V88, P91, DOI 10.1016/0168-9452(93)90113-E; Fernando SC, 2000, PLANT SCI, V151, P193, DOI 10.1016/S0168-9452(99)00218-6; Finkelstein Ruth R., 2002, Plant Cell, V14, pS15; Goggin DE, 2015, ANN BOT-LONDON, V115, P293, DOI 10.1093/aob/mcu231; Guzman M, 2000, PLANT SCI, V151, P107, DOI 10.1016/S0168-9452(99)00204-6; Han SY, 2004, BIOORG MED CHEM LETT, V14, P3033, DOI 10.1016/j.bmcl.2004.04.035; Hiei Y, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00628; Himmelbach A, 2003, CURR OPIN PLANT BIOL, V6, P470, DOI 10.1016/S1369-5266(03)00090-6; Hoang TG, 2012, RUSS J PLANT PHYSL+, V59, P406, DOI 10.1134/S1021443712030089; Hoekstra S, 1997, PLANT SCI, V126, P211, DOI 10.1016/S0168-9452(97)00096-4; Holme IB, 2004, THEOR APPL GENET, V108, P1513, DOI 10.1007/s00122-003-1570-z; Huang WL, 2012, PLANT CELL TISS ORG, V108, P257, DOI 10.1007/s11240-011-0038-0; INOUE M, 1981, JPN J CROP SCI, V50, P318, DOI 10.1626/jcs.50.318; IVANOVA A, 1994, PHYSIOL PLANTARUM, V92, P85, DOI 10.1111/j.1399-3054.1994.tb06658.x; Jimenez VM, 2001, PHYSIOL PLANTARUM, V111, P389, DOI 10.1034/j.1399-3054.2001.1110317.x; Jimenez VM, 2001, PLANT SCI, V160, P247, DOI 10.1016/S0168-9452(00)00382-4; Kamal GB, 2007, AFR J BIOTECHNOL, V6, P861; KOORNEEF M, 1993, PLANT J, V3, P131, DOI 10.1111/j.1365-313X.1993.tb00016.x; KRAEPIEL Y, 1995, PLANTA, V197, P142, DOI 10.1007/BF00239950; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; Kwon YS, 2001, MOL CELLS, V11, P64; Lema-Ruminska J, 2013, SCI WORLD J, DOI 10.1155/2013/513985; MAGGON R, 1995, SCI HORTIC-AMSTERDAM, V63, P123, DOI 10.1016/0304-4238(95)00780-W; Mano Y, 2002, THEOR APPL GENET, V105, P708, DOI 10.1007/s00122-002-0992-3; Mano Y, 1996, BREEDING SCI, V46, P137; Millar AA, 2006, PLANT J, V45, P942, DOI 10.1111/j.1365-313X.2006.02659.x; Motte H, 2014, P NATL ACAD SCI USA, V111, P8305, DOI 10.1073/pnas.1404978111; Nakagawa H, 2001, SCI HORTIC-AMSTERDAM, V90, P85, DOI 10.1016/S0304-4238(00)00259-4; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Nambara E, 2003, TRENDS PLANT SCI, V8, P213, DOI 10.1016/S1360-1385(03)00060-8; Nishimura A, 2005, P NATL ACAD SCI USA, V102, P11940, DOI 10.1073/pnas.0504220102; Obert B, 2008, BIOTECHNOL LETT, V30, P945, DOI 10.1007/s10529-007-9618-9; Oritani T, 2003, NAT PROD REP, V20, P414, DOI 10.1039/b109859b; Perez-Jimenez M, 2014, J PLANT PHYSIOL, V171, P619, DOI 10.1016/j.jplph.2014.01.006; Popova LP, 1998, PLANT PHYSIOL BIOCH, V36, P313, DOI 10.1016/S0981-9428(98)80045-4; QURESHI JA, 1989, PLANT CELL TISS ORG, V18, P55, DOI 10.1007/BF00033465; RAJASEKARAN K, 1987, PLANT PHYSIOL, V84, P47, DOI 10.1104/pp.84.1.47; Rikiishi K, 2003, PLANT BREEDING, V122, P99, DOI 10.1046/j.1439-0523.2003.00822.x; Rikiishi K, 2003, PLANT BREEDING, V122, P105, DOI 10.1046/j.1439-0523.2003.00823.x; Rikiishi K, 2008, BREEDING SCI, V58, P129, DOI 10.1270/jsbbs.58.129; Rikiishi K, 2010, J CEREAL SCI, V51, P292, DOI 10.1016/j.jcs.2010.01.003; Saito S, 2004, PLANT PHYSIOL, V134, P1439, DOI 10.1104/pp.103.037614; TaguchiShiobara F, 1997, THEOR APPL GENET, V95, P828, DOI 10.1007/s001220050632; Takeuchi Y, 2000, CROP SCI, V40, P245, DOI 10.2135/cropsci2000.401245x; Thompson AJ, 2000, PLANT MOL BIOL, V42, P833, DOI 10.1023/A:1006448428401; Tingay S, 1997, PLANT J, V11, P1369, DOI 10.1046/j.1365-313X.1997.11061369.x; TORRIZO LB, 1986, PLANT CELL REP, V5, P136, DOI 10.1007/BF00269253; Trujillo-Moya C, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-140; Tsukahara K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123308; Tuan PA, 2013, FOOD CHEM, V141, P3803, DOI 10.1016/j.foodchem.2013.06.085; Tyagi N, 2010, CROP SCI, V50, P1697, DOI 10.2135/cropsci2009.10.0624; van Bergen S, 1999, J PLANT GROWTH REGUL, V18, P135, DOI 10.1007/PL00007061; WAN YC, 1994, PLANT PHYSIOL, V104, P37, DOI 10.1104/pp.104.1.37; Wu SH, 2014, ANNU REV PLANT BIOL, V65, P311, DOI 10.1146/annurev-arplant-050213-040337; Zhang S, 1999, PLANT CELL REP, V18, P959, DOI 10.1007/s002990050691; Zhang SG, 2010, BIOCHEM BIOPH RES CO, V398, P355, DOI 10.1016/j.bbrc.2010.06.056	66	5	5	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145242	10.1371/journal.pone.0145242	http://dx.doi.org/10.1371/journal.pone.0145242			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670930	Green Submitted, gold, Green Published			2022-12-26	WOS:000366719300055
J	Wang, Y; Xu, J; Gao, G; Li, J; Huang, H; Jin, H; Zhu, J; Che, X; Huang, C				Wang, Y.; Xu, J.; Gao, G.; Li, J.; Huang, H.; Jin, H.; Zhu, J.; Che, X.; Huang, C.			Tumor-suppressor NF kappa B2 p100 interacts with ERK2 and stabilizes PTEN mRNA via inhibition of miR-494	ONCOGENE			English	Article							KAPPA-B PATHWAY; MAP KINASE; CELL PROLIFERATION; SIGNALING PATHWAY; DOWN-REGULATION; PEA-15 REVEALS; PROTEIN; CANCER; EXPRESSION; APOPTOSIS	Emerging evidence from The Cancer Genome Atlas has revealed that nuclear factor kappa B2 (nf kappa b2) gene encoding p100 is genetically deleted or mutated in human cancers, implicating NF kappa B2 as a potential tumor suppressor. However, the molecular mechanism underlying the antitumorigenic action of p100 remains poorly understood. Here we report that p100 inhibits cancer cell anchorageindependent growth, a hallmark of cellular malignancy, by stabilizing the tumor-suppressor phosphatase and tensin homolog (PTEN) mRNA via a mechanism that is independent of p100' s inhibitory role in NF kappa B activation. We further demonstrate that the regulatory effect of p100 on PTEN expression is mediated by its downregulation of miR-494 as a result of the inactivation of extracellular signal-regulated kinase 2 (ERK2), in turn leading to inhibition of c-Jun/ activator protein-1-dependent transcriptional activity. Furthermore, we identify that p100 specifically interacts with non-phosphorylated ERK2 and prevents ERK2 phosphorylation and nuclear translocation. Moreover, the death domain at C-terminal of p100 is identified as being crucial and sufficient for its interaction with ERK2. Taken together, our findings provide novel mechanistic insights into the understanding of the tumor-suppressive role for NF kappa B2 p100.	[Wang, Y.; Xu, J.; Gao, G.; Li, J.; Huang, H.; Jin, H.; Zhu, J.; Che, X.; Huang, C.] NYU, Sch Med, Nelson Inst Environm Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA	New York University	Huang, C (corresponding author), NYU, Sch Med, Nelson Inst Environm Med, 57 Old Forge Rd, Tuxedo Pk, NY 10987 USA.	chuanshu.huang@nyumc.org		Huang, Chuanshu/0000-0003-4133-5096; Wang, Yulei/0000-0002-6495-3391	 [NIH/NCI CA165980];  [CA177665];  [CA112557];  [NIH/NIEHS ES000260]; NATIONAL CANCER INSTITUTE [P01CA165980, R01CA177665, R01CA112557] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES000260] Funding Source: NIH RePORTER	; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We greatly appreciate Dr Han-Fei Ding for his generous gifts about constructs expressing p100 and various deletion mutants of p100. We also appreciate Dr Shao-Cong Sun from the Department of Immunology, University of Texas MD Anderson Cancer Center for the gift of constructs expressing p100Ser866/870Ala or p100 Delta DD. This work was supported partially by grants from NIH/NCI CA165980, CA177665 and CA112557, as well as NIH/NIEHS ES000260.	Alimonti A, 2010, NAT GENET, V42, P454, DOI 10.1038/ng.556; Arabi A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1975; Arroyo JD, 2005, ONCOGENE, V24, P7746, DOI 10.1038/sj.onc.1209038; Basak S, 2007, CELL, V128, P369, DOI 10.1016/j.cell.2006.12.033; Busino L, 2012, NAT CELL BIOL, V14, P375, DOI 10.1038/ncb2463; Caamano JH, 1998, J EXP MED, V187, P185, DOI 10.1084/jem.187.2.185; Chen K, 2013, AM J HUM GENET, V93, P812, DOI 10.1016/j.ajhg.2013.09.009; Courtois G, 2006, ONCOGENE, V25, P6831, DOI 10.1038/sj.onc.1209939; Dioletis E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070095; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; Fukushima H, 2012, CELL REP, V1, P434, DOI 10.1016/j.celrep.2012.04.002; Fusco AJ, 2008, J BIOL CHEM, V283, P12324, DOI 10.1074/jbc.M707898200; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hettinger K, 2007, CELL DEATH DIFFER, V14, P218, DOI 10.1038/sj.cdd.4401946; Hill JM, 2002, EMBO J, V21, P6494, DOI 10.1093/emboj/cdf641; Ishikawa H, 1997, J EXP MED, V186, P999, DOI 10.1084/jem.186.7.999; Kim WK, 2011, CLIN CANCER RES, V17, P7584, DOI 10.1158/1078-0432.CCR-11-0166; Li J, 1998, CANCER RES, V58, P5667; Li JL, 2004, HYBRIDOMA HYBRIDOM, V23, P1, DOI 10.1089/153685904322771962; Li JX, 2004, J CELL BIOL, V165, P77, DOI 10.1083/jcb.200401004; Liu LH, 2010, LIFE SCI, V86, P192, DOI 10.1016/j.lfs.2009.12.002; Mace PD, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2687; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Montagut C, 2009, CANCER LETT, V283, P125, DOI 10.1016/j.canlet.2009.01.022; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Romagnoli M, 2012, CANCER RES, V72, P6268, DOI 10.1158/0008-5472.CAN-12-2270; Romano G, 2012, P NATL ACAD SCI USA, V109, P16570, DOI 10.1073/pnas.1207917109; Shaulian E, 2010, CELL SIGNAL, V22, P894, DOI 10.1016/j.cellsig.2009.12.008; Shi YJ, 2012, J CELL SCI, V125, P4687, DOI 10.1242/jcs.093765; Skeen JE, 2006, CANCER CELL, V10, P269, DOI 10.1016/j.ccr.2006.08.022; Song L, 2007, MOL CELL BIOL, V27, P2713, DOI 10.1128/MCB.00657-06; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Vasudevan KM, 2004, MOL CELL BIOL, V24, P1007, DOI 10.1128/MCB.24.3.1007-1021.2004; Virolle T, 2001, NAT CELL BIOL, V3, P1124, DOI 10.1038/ncb1201-1124; Wang XH, 2010, CIRCULATION, V122, P1308, DOI 10.1161/CIRCULATIONAHA.110.964684; Wang YQ, 2002, NAT CELL BIOL, V4, P888, DOI 10.1038/ncb872; Wang Z, 2008, J BIOL CHEM, V283, P10698, DOI 10.1074/jbc.M800806200; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4; Whitmarsh AJ, 1996, J MOL MED-JMM, V74, P589, DOI 10.1007/s001090050063; Xia DR, 2007, J BIOL CHEM, V282, P3507, DOI 10.1074/jbc.M610141200; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Yilmaz ZB, 2014, CELL REP, V9, P1756, DOI 10.1016/j.celrep.2014.11.014; Yu HS, 2013, INT J MOL SCI, V14, P13329, DOI 10.3390/ijms140713329; Yu Y, 2014, ONCOGENE, V33, P996, DOI 10.1038/onc.2013.8; Zhang DY, 2014, J CELL SCI, V127, P2920, DOI 10.1242/jcs.148130; Zhang RW, 2014, J BIOL CHEM, V289, P6394, DOI 10.1074/jbc.M113.513960	50	24	25	2	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 4	2016	35	31					4080	4090		10.1038/onc.2015.470	http://dx.doi.org/10.1038/onc.2015.470			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	DS8GG	26686085	Green Accepted			2022-12-26	WOS:000381020900006
J	Jia, H; Shao, MQ; He, YJ; Guan, RZ; Chu, P; Jiang, HD				Jia, Huan; Shao, Mingquan; He, Yongjun; Guan, Rongzhan; Chu, Pu; Jiang, Haidong			Proteome Dynamics and Physiological Responses to Short-Term Salt Stress in Brassica napus Leaves	PLOS ONE			English	Article							CINNAMYL ALCOHOL-DEHYDROGENASE; QUANTITATIVE PROTEOMICS; ARABIDOPSIS-THALIANA; PLANT; PHOTOSYNTHESIS; EXPRESSION; PROTEINS; SALINITY; WHEAT; MECHANISMS	Salt stress limits plant growth and crop productivity and is an increasing threat to agriculture worldwide. In this study, proteomic and physiological responses of Brassica napus leaves under salt stress were investigated. Seedlings under salt treatment showed growth inhibition and photosynthesis reduction. A comparative proteomic analysis of seedling leaves exposed to 200 mM NaCl for 24 h, 48 h and 72 h was conducted. Forty-four protein spots were differentially accumulated upon NaCl treatment and 42 of them were identified, including several novel salt-responsive proteins. To determine the functional roles of these proteins in salt adaptation, their dynamic changes in abundance were analyzed. The results suggested that the up-accumulated proteins, which were associated with protein metabolism, damage repair and defense response, might contribute to the alleviation of the deleterious effect of salt stress on chlorophyll biosynthesis, photosynthesis, energy synthesis and respiration in Brassica napus leaves. This study will lead to a better understanding of the molecular basis of salt stress adaptation in Brassica napus and provides a basis for genetic engineering of plants with improved salt tolerance in the future.	[Jia, Huan; Shao, Mingquan; He, Yongjun; Guan, Rongzhan; Chu, Pu; Jiang, Haidong] Nanjing Agr Univ, Coll Agr, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China; [Guan, Rongzhan] Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Chu, P (corresponding author), Nanjing Agr Univ, Coll Agr, State Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China.	chupu@njau.edu.cn; hdjiang@njau.edu.cn		Guan, Rongzhan/0000-0001-9177-6610	National Natural Science Foundation of China [31270386, 31301352]; Fundamental Research Funds for the Central Universities of China [KYZ201202-7, KJQN201423]; National Basic Research Program of China (973 Program) [2011CB109300]; Jiangsu Agricultural Science and Technology Innovation Fund (JASTIF) [CX (14) 2003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities of China(Fundamental Research Funds for the Central Universities); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Jiangsu Agricultural Science and Technology Innovation Fund (JASTIF)	This work was supported by the National Natural Science Foundation of China (No. 31270386 and 31301352), the Fundamental Research Funds for the Central Universities of China (KYZ201202-7 and KJQN201423), the National Basic Research Program of China (973 Program) (No. 2011CB109300), and the Jiangsu Agricultural Science and Technology Innovation Fund (JASTIF) (CX (14) 2003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed NU, 2012, PLANT PHYSIOL BIOCH, V58, P106, DOI 10.1016/j.plaphy.2012.06.015; Ashraf M, 2013, PHOTOSYNTHETICA, V51, P163, DOI 10.1007/s11099-013-0021-6; Bandehagh A., 2013, Annals of Biological Research, V4, P212; Bandehagh A, 2011, PROTEOMICS, V11, P1965, DOI 10.1002/pmic.201000564; Barkla BJ, 2013, PROTEOMICS, V13, P1885, DOI 10.1002/pmic.201200399; BECKMANN RP, 1990, SCIENCE, V248, P850, DOI 10.1126/science.2188360; BOLLER T, 1983, PLANTA, V157, P22, DOI 10.1007/BF00394536; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; de Abreu CEB, 2014, PLANT CELL REP, V33, P1289, DOI 10.1007/s00299-014-1616-5; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Chen AP, 2007, J PLANT RES, V120, P337, DOI 10.1007/s10265-006-0058-8; Chu P, 2015, J PROTEOMICS, V113, P244, DOI 10.1016/j.jprot.2014.10.005; Deng WW, 2013, J PLANT PHYSIOL, V170, P272, DOI 10.1016/j.jplph.2012.10.010; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; El-Shintinawy F, 2001, BIOL PLANTARUM, V44, P541, DOI 10.1023/A:1013738603020; Fatehi F, 2012, MOL BIOL REP, V39, P6387, DOI 10.1007/s11033-012-1460-z; Fernandez-Garcia N, 2011, PLANT CELL ENVIRON, V34, P821, DOI 10.1111/j.1365-3040.2011.02285.x; Gao L, 2011, PHYTOCHEMISTRY, V72, P1180, DOI 10.1016/j.phytochem.2010.12.008; Golldack D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00151; GRIMM B, 1990, P NATL ACAD SCI USA, V87, P4169, DOI 10.1073/pnas.87.11.4169; Hartel H, 1997, PLANT PHYSIOL, V113, P1113, DOI 10.1104/pp.113.4.1113; Ismail A, 2014, J EXP BOT, V65, P2963, DOI 10.1093/jxb/eru159; Li B, 2013, PLANT PHYSIOL BIOCH, V67, P7, DOI 10.1016/j.plaphy.2013.02.016; Liu CW, 2014, PROTEOMICS, V14, P1759, DOI 10.1002/pmic.201300276; Lyon BR, 2011, PLANT PHYSIOL, V157, P1926, DOI 10.1104/pp.111.185025; Ma HY, 2012, J PROTEOMICS, V75, P1529, DOI 10.1016/j.jprot.2011.11.026; Machado CR, 1997, J MOL BIOL, V273, P114, DOI 10.1006/jmbi.1997.1302; Machado CR, 1996, PLANT MOL BIOL, V31, P585, DOI 10.1007/BF00042231; Manaa A, 2014, COMPARATIVE PROTEOMI, V15, P21803; McCarty RE, 2005, J BIOENERG BIOMEMBR, V37, P289, DOI 10.1007/s10863-005-8640-7; Moradi F, 2007, ANN BOT-LONDON, V99, P1161, DOI 10.1093/aob/mcm052; Munns R, 2006, J EXP BOT, V57, P1025, DOI 10.1093/jxb/erj100; Parker R, 2006, J EXP BOT, V57, P1109, DOI 10.1093/jxb/erj134; Podda A, 2013, J PLANT PHYSIOL, V170, P1101, DOI 10.1016/j.jplph.2013.03.006; Purty Ram Singh, 2008, Physiology and Molecular Biology of Plants, V14, P39, DOI 10.1007/s12298-008-0004-4; Qureshi MI, 2007, J PLANT PHYSIOL, V164, P1239, DOI 10.1016/j.jplph.2007.01.013; Rai S, 2014, J PROTEOMICS, V98, P254, DOI 10.1016/j.jprot.2013.12.020; Razavizadeh R, 2009, PEPTIDES, V30, P1651, DOI 10.1016/j.peptides.2009.06.023; Ribeiro DT, 2005, J EXP BOT, V56, P1797, DOI 10.1093/jxb/eri168; Rossignol M, 2006, PROTEOMICS, V6, P5529, DOI 10.1002/pmic.200600260; Saha P, 2012, PLANT PHYSIOL BIOCH, V60, P214, DOI 10.1016/j.plaphy.2012.08.008; Sanchez-Aguayo I, 2004, PLANTA, V220, P278, DOI 10.1007/s00425-004-1350-2; Shavrukov Y, 2013, J EXP BOT, V64, P119, DOI 10.1093/jxb/ers316; Shi SS, 2011, PROTEOMICS, V11, P4712, DOI 10.1002/pmic.201100042; Sobhanian H, 2011, J PROTEOMICS, V74, P1323, DOI 10.1016/j.jprot.2011.03.018; Sobhanian H, 2010, PROTEOME SCI, V8, DOI 10.1186/1477-5956-8-19; Stepien P, 2009, PLANT PHYSIOL, V149, P1154, DOI 10.1104/pp.108.132407; Steppuhn H, 2001, CROP SCI, V41, P1827, DOI 10.2135/cropsci2001.1827; Subramanian B, 2005, J AGR FOOD CHEM, V53, P313, DOI 10.1021/jf048922z; Sudhir P, 2004, PHOTOSYNTHETICA, V42, P481, DOI 10.1007/S11099-005-0001-6; Tahir, 2013, SALT STRESS PLANTS S, P47; Tang XL, 2015, CRIT REV BIOTECHNOL, V35, P425, DOI 10.3109/07388551.2014.889080; TAUSSKY HH, 1953, J BIOL CHEM, V202, P675; Tsang EWT, 2003, PLANT MOL BIOL, V51, P191, DOI 10.1023/A:1021102118801; Turan S, 2015, PHYSIOL PLANTARUM, V153, P477, DOI 10.1111/ppl.12250; Wang HL, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-6; Wang JC, 2015, PLANT CELL ENVIRON, V38, P655, DOI 10.1111/pce.12428; Wang L., 2014, DISCRETE DYN NAT SOC, V2014, P1, DOI DOI 10.1002/ASL2.454; Wang MY, 2011, METHOD ENZYMOL, V489, P319, DOI 10.1016/B978-0-12-385116-1.00018-2; Wang ZM, 2013, INT J MOL SCI, V14, P20299, DOI 10.3390/ijms141020299; Xu CP, 2010, PLANT CELL REP, V29, P595, DOI 10.1007/s00299-010-0847-3; Yadav S, 2011, J ENVIRON BIOL, V32, P667; Yan SP, 2005, PROTEOMICS, V5, P235, DOI 10.1002/pmic.200400853; Yang L, 2012, J PLANT PHYSIOL, V169, P839, DOI 10.1016/j.jplph.2012.01.023; Yi XP, 2014, J PROTEOMICS, V99, P84, DOI 10.1016/j.jprot.2014.01.017; Zhang H, 2012, J PROTEOME RES, V11, P49, DOI 10.1021/pr200861w; Zhang X, 2008, J EXP BOT, V59, P839, DOI 10.1093/jxb/erm364; Zhao Q, 2013, P NATL ACAD SCI USA, V110, P13660, DOI 10.1073/pnas.1312234110; Zhou YL, 2012, PLANTA, V235, P523, DOI 10.1007/s00425-011-1527-4; Zou J, 2011, PLANT CELL REP, V30, P2155, DOI 10.1007/s00299-011-1122-y	70	24	25	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144808	10.1371/journal.pone.0144808	http://dx.doi.org/10.1371/journal.pone.0144808			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691228	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092300019
J	Kondo, K; Kubo, T; Kunieda, T				Kondo, Koyuki; Kubo, Takeo; Kunieda, Takekazu			Suggested Involvement of PP1/PP2A Activity and De Novo Gene Expression in Anhydrobiotic Survival in a Tardigrade, Hypsibius dujardini, by Chemical Genetic Approach	PLOS ONE			English	Article							OXIDATIVE STRESS; WATER-LOSS; PROTEIN; DESICCATION; INHIBITION; TREHALOSE; TRANSCRIPTION; SUBUNIT; PHOSPHORYLATION; DEHYDRATION	Upon desiccation, some tardigrades enter an ametabolic dehydrated state called anhydrobiosis and can survive a desiccated environment in this state. For successful transition to anhydrobiosis, some anhydrobiotic tardigrades require pre-incubation under high humidity conditions, a process called preconditioning, prior to exposure to severe desiccation. Although tardigrades are thought to prepare for transition to anhydrobiosis during preconditioning, the molecular mechanisms governing such processes remain unknown. In this study, we used chemical genetic approaches to elucidate the regulatory mechanisms of anhydrobiosis in the anhydrobiotic tardigrade, Hypsibius dujardini. We first demonstrated that inhibition of transcription or translation drastically impaired anhydrobiotic survival, suggesting that de novo gene expression is required for successful transition to anhydrobiosis in this tardigrade. We then screened 81 chemicals and identified 5 chemicals that significantly impaired anhydrobiotic survival after severe desiccation, in contrast to little or no effect on survival after high humidity exposure only. In particular, cantharidic acid, a selective inhibitor of protein phosphatase (PP) 1 and PP2A, exhibited the most profound inhibitory effects. Another PP1/PP2A inhibitor, okadaic acid, also significantly and specifically impaired anhydrobiotic survival, suggesting that PP1/PP2A activity plays an important role for anhydrobiosis in this species. This is, to our knowledge, the first report of the required activities of signaling molecules for desiccation tolerance in tardigrades. The identified inhibitory chemicals could provide novel clues to elucidate the regulatory mechanisms underlying anhydrobiosis in tardigrades.	[Kondo, Koyuki; Kubo, Takeo; Kunieda, Takekazu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo 1130033, Japan	University of Tokyo	Kunieda, T (corresponding author), Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Hongo 7-3-1, Tokyo 1130033, Japan.	kunieda@bs.s.u-tokyo.ac.jp	Kunieda, Takekazu/G-4946-2014; KUBO, TAKEO/G-4951-2014	Kubo, Takeo/0000-0002-5914-5269; Kunieda, Takekazu/0000-0002-6256-1335	Japan Society for the Promotion of Science [26660288, 25281016, 15J11297]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid for challenging Exploratory Research (No. 26660288) and Grants-in-Aid for Scientific Research (No. 25281016) from the Japan Society for the Promotion of Science. KK received a Grant-in-Aid for JSPS Fellows (No. 15J11297) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe J, 1997, J BIOL CHEM, V272, P20389, DOI 10.1074/jbc.272.33.20389; AHN HS, 1989, BIOCHEM PHARMACOL, V38, P3331; Ambrogini E, 2010, CELL METAB, V11, P136, DOI 10.1016/j.cmet.2009.12.009; Banton MC, 2012, J EXP BIOL, V215, P4288, DOI 10.1242/jeb.074799; Bensaude O, 2011, TRANSCR-AUSTIN, V2, P103, DOI 10.4161/trns.2.3.16172; Bootman MD, 2002, FASEB J, V16, DOI 10.1096/fj.02-0037rev; Browne J, 2002, NATURE, V416, P38, DOI 10.1038/416038a; Contreras-Porcia L, 2011, J EXP BOT, V62, P1815, DOI 10.1093/jxb/erq364; Cowan KJ, 2003, J EXP BIOL, V206, P1107, DOI 10.1242/jeb.00220; CROWE J H, 1975, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V32, P37; Crowe LM, 2002, COMP BIOCHEM PHYS A, V131, P505, DOI 10.1016/S1095-6433(01)00503-7; Degma P, 2015, ACTUAL CHECKLIST TAR, P40; DeSilva DR, 1998, J IMMUNOL, V160, P4175; Ding JY, 2000, J BIOL CHEM, V275, P30873, DOI 10.1074/jbc.M004813200; Dingle H., 1996, BIOL LIFE MOVE, P474; Erkut C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082473; Erkut C, 2011, CURR BIOL, V21, P1331, DOI 10.1016/j.cub.2011.06.064; Gabriel WN, 2007, DEV BIOL, V312, P545, DOI 10.1016/j.ydbio.2007.09.055; Gusev O, 2011, CELL STRESS CHAPERON, V16, P81, DOI 10.1007/s12192-010-0223-9; Halberg KA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085091; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; Harper JL, 2003, BIOCHEM PHARMACOL, V65, P329, DOI 10.1016/S0006-2952(02)01488-0; HASHIMOTO Y, 1991, BIOCHEM BIOPH RES CO, V181, P423, DOI 10.1016/S0006-291X(05)81436-6; HAYSTEAD TAJ, 1989, NATURE, V337, P78, DOI 10.1038/337078a0; HIGA LM, 1993, J EXP ZOOL, V267, P120, DOI 10.1002/jez.1402670205; Ito S, 2004, EUR J PHARMACOL, V486, P325, DOI 10.1016/j.ejphar.2004.01.013; Janssens V, 2001, BIOCHEM J, V353, P417, DOI 10.1042/0264-6021:3530417; Johnson CG, 1940, ANN APPL BIOL, V27, P295, DOI 10.1111/j.1744-7348.1940.tb07499.x; Jonsson KI, 2007, COMP BIOCHEM PHYS B, V146, P456, DOI 10.1016/j.cbpb.2006.10.111; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Lapinski J, 2003, FEBS LETT, V553, P387, DOI 10.1016/S0014-5793(03)01062-7; Leuenroth JS, 2007, PNAS, V104, P4389, DOI [10.1073/pnas.0700499104, DOI 10.1073/PNAS.0700499104]; LI YM, 1993, BIOCHEM PHARMACOL, V46, P1435, DOI 10.1016/0006-2952(93)90109-A; LINDELL TJ, 1970, SCIENCE, V170, P447, DOI 10.1126/science.170.3956.447; Liu QY, 2011, INT IMMUNOPHARMACOL, V11, P377, DOI 10.1016/j.intimp.2011.01.012; MACHIN J, 1967, J ZOOL, V152, P55; MACNEIL S, 1988, BIOCHEM PHARMACOL, V37, P1717, DOI 10.1016/0006-2952(88)90434-0; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; McCallum C, 2007, IMMUNOBIOLOGY, V212, P549, DOI 10.1016/j.imbio.2007.02.002; Mobjerg N, 2011, ACTA PHYSIOL, V202, P409, DOI 10.1111/j.1748-1716.2011.02252.x; Narasimhan SD, 2009, CELL CYCLE, V8, P3878, DOI 10.4161/cc.8.23.10072; Padmanabhan S, 2009, CELL, V136, P939, DOI 10.1016/j.cell.2009.01.025; Pal R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5425; Pereira ED, 2003, CELL STRESS CHAPERON, V8, P120; Qin SF, 1997, J BIOL CHEM, V272, P17994, DOI 10.1074/jbc.272.29.17994; Raman CS, 2001, BIOCHEMISTRY-US, V40, P13448, DOI 10.1021/bi010957u; Reiter W, 2013, MOL CELL BIOL, V33, P1057, DOI 10.1128/MCB.00834-12; Schneider-Poetsch T, 2010, NAT CHEM BIOL, V6, P209, DOI 10.1038/NCHEMBIO.304; Shannon AJ, 2005, J EXP BIOL, V208, P2433, DOI 10.1242/jeb.01629; Shi YG, 2009, CELL, V139, P468, DOI 10.1016/j.cell.2009.10.006; Singh A, 2010, MOL BIOL CELL, V21, P1140, DOI 10.1091/mbc.E09-09-0795; Soundararajan R, 2009, CANCER BIOL THER, V8, P2054, DOI 10.4161/cbt.8.21.9803; Stateva SR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128783; Tanaka S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118272; Tenlen JR, 2013, DEV GENES EVOL, V223, P171, DOI 10.1007/s00427-012-0432-6; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; van der Horst A, 2007, NAT REV MOL CELL BIO, V8, P440, DOI 10.1038/nrm2190; Vereshchagina N, 2008, J CELL SCI, V121, P3383, DOI 10.1242/jcs.035220; Wang WY, 2006, MOL PHARMACOL, V70, P1380, DOI 10.1124/mol.106.023986; Watanabe M, 2006, APPL ENTOMOL ZOOL, V41, P15, DOI 10.1303/aez.2006.15; Watanabe M, 2002, J EXP BIOL, V205, P2799; Waters V, 2005, AM J RESP CELL MOL, V33, P138, DOI 10.1165/rcmb.2005-0005OC; WESTH P, 1991, J EXP ZOOL, V258, P303, DOI 10.1002/jez.1402580305; White RJ, 2011, NAT REV GENET, V12, P459, DOI 10.1038/nrg3001; WINSTON PW, 1960, ECOLOGY, V41, P232, DOI 10.2307/1931961; WRIGHT JC, 1989, J EXP BIOL, V142, P267; Yamaguchi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044209; Yan L, 2008, J BIOL CHEM, V283, P7411, DOI 10.1074/jbc.M708083200	68	26	26	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0144803	10.1371/journal.pone.0144803	http://dx.doi.org/10.1371/journal.pone.0144803			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26690982	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092300018
J	Macreadie, PI; Rolph, TC; Boyd, R; Schroder-Adams, CJ; Skilbeck, CG				Macreadie, Peter I.; Rolph, Timothy C.; Boyd, Ron; Schroeder-Adams, Claudia J.; Skilbeck, Charles G.			Do ENSO and Coastal Development Enhance Coastal Burial of Terrestrial Carbon?	PLOS ONE			English	Article							EL-NINO; MARINE-SEDIMENTS; ORGANIC-MATTER; PRECIPITATION; ACCUMULATION; EVOLUTION	Carbon cycling on the east coast of Australia has the potential to be strongly affected by El Nino-Southern Oscillation (ENSO) intensification and coastal development (industrialization and urbanization). We performed paleoreconstructions of estuarine sediments from a seagrass-dominated estuary on the east coast of Australia (Tuggerah Lake, New South Wales) to test the hypothesis that millennial-scale ENSO intensification and European settlement in Australia have increased the transfer of organic carbon from land into coastal waters. Our data show that carbon accumulation rates within coastal sediments increased significantly during periods of maximum millennial-scale ENSO intensity ("super-ENSO") and coastal development. We suggest that ENSO and coastal development destabilize and liberate terrestrial soil carbon, which, during rainfall events (e.g., La Nina), washes into estuaries and becomes trapped and buried by coastal vegetation (seagrass in this case). Indeed, periods of high carbon burial were generally characterized as having rapid sedimentation rates, higher content of fine-grained sediments, and increased content of wood and charcoal fragments. These results, though preliminary, suggest that coastal development and ENSO intensification-both of which are predicted to increase over the coming century-can enhance capture and burial of terrestrial carbon by coastal ecosystems. These findings have important relevance for current efforts to build an understanding of terrestrial-marine carbon connectivity into global carbon budgets.	[Macreadie, Peter I.] Univ Technol Sydney, Plant Funct Biol & Climate Change Cluster, Broadway, NSW 2007, Australia; [Macreadie, Peter I.] Deakin Univ, Sch Life & Environm Sci, Ctr Integrat Ecol, Burwood, Vic 3125, Australia; [Rolph, Timothy C.; Boyd, Ron] Univ Newcastle, Sch Geosci, Callaghan, NSW 2308, Australia; [Schroeder-Adams, Claudia J.] Carleton Univ, Dept Earth Sci, Ottawa, ON K1S 5B6, Canada; [Skilbeck, Charles G.] Univ Technol Sydney, Sch Environm, Broadway, NSW 2007, Australia	University of Technology Sydney; Deakin University; University of Newcastle; Carleton University; University of Technology Sydney	Macreadie, PI (corresponding author), Univ Technol Sydney, Plant Funct Biol & Climate Change Cluster, Broadway, NSW 2007, Australia.	petermacreadie@gmail.com		Schroder-Adams, Claudia/0000-0002-0245-2559; Boyd, Ronald/0000-0002-2374-7567	Australian Research Council DECRA [DE130101084]; Australian Institute of Nuclear Science and Engineering AINSE [ALNGRA 14031, 04-140]; ARC [DP0209388]; NSERC	Australian Research Council DECRA(Australian Research Council); Australian Institute of Nuclear Science and Engineering AINSE; ARC(Australian Research Council); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding was provided by an Australian Research Council DECRA Fellowship (DE130101084 to P.I.M.), an Australian Institute of Nuclear Science and Engineering AINSE Grants (ALNGRA 14031 and 04-140 to P.I.M., T.C.R.and C.G.S.), an ARC Discovery Project DP0209388 (to T.C.R., C.G.S., and R.B.), and a NSERC Discovery Grant (to C.J.S.A.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalto R, 2003, NATURE, V425, P493, DOI 10.1038/nature02002; Bauer JE, 2013, NATURE, V504, P61, DOI 10.1038/nature12857; Berkeley A, 2007, EARTH-SCI REV, V83, P205, DOI 10.1016/j.earscirev.2007.04.003; Bianchi TS, 2013, GEOPHYS RES LETT, V40, P116, DOI 10.1029/2012GL054145; Burdige DJ, 2007, CHEM REV, V107, P467, DOI 10.1021/cr050347q; Cai WJ, 2014, NAT CLIM CHANGE, V4, P111, DOI [10.1038/NCLIMATE2100, 10.1038/nclimate2100]; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Cane MA, 2005, EARTH PLANET SC LETT, V230, P227, DOI 10.1016/j.epsl.2004.12.003; Eusterhues K, 2003, ORG GEOCHEM, V34, P1591, DOI 10.1016/j.orggeochem.2003.08.007; Fissore C, 2010, FRONT ECOL ENVIRON, V8, P409, DOI 10.1890/090059; FOLEY JA, 2002, GLOBAL BIOGEOCHEM CY, V16, P1, DOI DOI 10.1029/2002GB001872; Gagan MK, 2004, QUATERN INT, V118, P127, DOI 10.1016/S1040-6182(03)00134-4; Hilton RG, 2008, NAT GEOSCI, V1, P759, DOI 10.1038/ngeo333; Kennedy H, 2010, GLOBAL BIOGEOCHEM CY, V24, DOI 10.1029/2010GB003848; Kirwan ML, 2011, GEOLOGY, V39, P507, DOI 10.1130/G31789.1; Lynch AH, 2007, ANNU REV EARTH PL SC, V35, P215, DOI 10.1146/annurev.earth.35.092006.145055; Macreadie P. I., 2015, GEORESJ, V5, P57, DOI DOI 10.1016/J.GRJ.2015.01.002; Macreadie PI, 2012, GLOBAL CHANGE BIOL, V18, P891, DOI 10.1111/j.1365-2486.2011.02582.x; Mcleod E, 2011, FRONT ECOL ENVIRON, V9, P552, DOI 10.1890/110004; Micevski T, 2006, J HYDROL, V327, P219, DOI 10.1016/j.jhydrol.2005.11.017; NADELHOFFER KF, 1988, SOIL SCI SOC AM J, V52, P1633, DOI 10.2136/sssaj1988.03615995005200060024x; Nyberg J, 2001, QUATERNARY RES, V56, P87, DOI 10.1006/qres.2001.2249; Page SE, 2002, NATURE, V420, P61, DOI 10.1038/nature01131; Pendleton L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043542; Power S, 2013, NATURE, V502, P541, DOI 10.1038/nature12580; Regnier P, 2013, NAT GEOSCI, V6, P597, DOI [10.1038/ngeo1830, 10.1038/NGEO1830]; ROY PS, 1981, J GEOL SOC AUST, V28, P471, DOI 10.1080/00167618108729182; Saintilan N, 2013, ESTUAR COAST SHELF S, V128, P84, DOI 10.1016/j.ecss.2013.05.010; Schroder-Adams CJ, 2014, ESTUAR COAST SHELF S, V139, P78, DOI 10.1016/j.ecss.2013.12.006	29	10	10	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145136	10.1371/journal.pone.0145136	http://dx.doi.org/10.1371/journal.pone.0145136			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691557	Green Published, gold			2022-12-26	WOS:000367092300041
J	Bonsang-Kitzis, H; Chaltier, L; Belin, L; Savignoni, A; Rouzier, R; Sablin, MP; Lerebours, F; Bidard, FC; Cottu, P; Sastre-Garau, X; Lae, M; Pierga, JY; Reyal, F				Bonsang-Kitzis, Helene; Chaltier, Leonor; Belin, Lisa; Savignoni, Alexia; Rouzier, Roman; Sablin, Marie-Paule; Lerebours, Florence; Bidard, Francois-Clement; Cottu, Paul; Sastre-Garau, Xavier; Lae, Marick; Pierga, Jean-Yves; Reyal, Fabien			Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy	PLOS ONE			English	Article							PROGESTERONE-RECEPTOR; ESTROGEN-RECEPTOR; PREOPERATIVE CHEMOTHERAPY; ADJUVANT CHEMOTHERAPY; MOLECULAR SUBTYPES; DOSE INTENSITY; OBESE-PATIENTS; TUMOR SIZE; EXPRESSION; SURVIVAL	Background Triple-negative breast cancers (TNBC) are a specific subtype of breast cancers with a particularly poor prognosis. However, it is a very heterogeneous subgroup in terms of clinical behavior and sensitivity to systemic treatments. Thus, the identification of risk factors specifically associated with those tumors still represents a major challenge. A therapeutic strategy increasingly used for TNBC patients is neoadjuvant chemotherapy (NAC). Only a subset of patients achieves a pathologic complete response (pCR) after NAC and have a better outcome than patients with residual disease. Purpose The aim of this study is to identify clinical factors associated with the metastatic-free survival in TNBC patients who received NAC. Methods We analyzed 326 cT1-3N1-3M0 patients with ductal infiltrating TNBC treated by NAC. The survival analysis was performed using a Cox proportional hazard model to determine clinical features associated with prognosis on the whole TNBC dataset. In addition, we built a recursive partitioning tree in order to identify additional clinical features associated with prognosis in specific subgroups of TNBC patients. Results We identified the lymph node involvement after NAC as the only clinical feature significantly associated with a poor prognosis using a Cox multivariate model (HR = 3.89 [2.42-6.25], p<0.0001). Using our recursive partitioning tree, we were able to distinguish 5 subgroups of TNBC patients with different prognosis. For patients without lymph node involvement after NAC, obesity was significantly associated with a poor prognosis (HR = 2.64 [1.28-5.55]). As for patients with lymph node involvement after NAC, the pre-menopausal status in grade III tumors was associated with poor prognosis (HR = 9.68 [5.71-18.31]). Conclusion This study demonstrates that axillary lymph node status after NAC is the major prognostic factor for triple-negative breast cancers. Moreover, we identified body mass index and menopausal status as two other promising prognostic factors in this breast cancer subgroup. Using these clinical factors, we were able to classify TNBC patients in 5 subgroups, for which pre-menopausal patients with grade III tumors and lymph node involvement after NAC have the worse prognosis.	[Bonsang-Kitzis, Helene; Rouzier, Roman; Reyal, Fabien] Inst Curie, Dept Surg, Paris, France; [Chaltier, Leonor; Belin, Lisa; Savignoni, Alexia] Inst Curie, Dept Biostat, Paris, France; [Sablin, Marie-Paule; Lerebours, Florence; Bidard, Francois-Clement; Cottu, Paul; Pierga, Jean-Yves] Inst Curie, Dept Med Oncol, Paris, France; [Sastre-Garau, Xavier; Lae, Marick] Inst Curie, Dept Tumor Biol, Paris, France; [Pierga, Jean-Yves] Paris Descartes Univ, Paris, France; [Bonsang-Kitzis, Helene; Reyal, Fabien] Inst Curie, Translat Res Dept, Residual Tumor & Response Treatment Lab, Paris, France; [Bonsang-Kitzis, Helene; Reyal, Fabien] INSERM, Immun & Canc UMR932, Paris, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Reyal, F (corresponding author), Inst Curie, Dept Surg, Paris, France.	fabien.reyal@curie.fr	Cottu, Paul/ABC-8595-2020; Rouzier, Roman/G-2953-2018	Sastre-Garau, Xavier/0000-0001-5992-2083; Rouzier, Roman/0000-0002-8167-6808; Belin, Lisa/0000-0002-7628-6629; Bidard, Francois-Clement/0000-0001-5932-8949				Aurilio G, 2014, EUR J CANCER, V50, P277, DOI 10.1016/j.ejca.2013.10.004; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Blows FM, 2010, SUBTYPING BREAST CAN, P7, DOI [10.1371/journal.pmed.1000279, DOI 10.1371/JOURNAL.PMED.1000279]; BRENTANI MM, 1986, INT J CANCER, V38, P637, DOI 10.1002/ijc.2910380504; Buchholz TA, 2008, J CLIN ONCOL, V26, P791, DOI 10.1200/JCO.2007.15.0326; Budman DR, 1998, J NATL CANCER I, V90, P1205, DOI 10.1093/jnci/90.16.1205; Bulun SE, 2012, TRENDS ENDOCRIN MET, V23, P83, DOI 10.1016/j.tem.2011.10.003; Carey LA, 2011, ONCOLOGIST, V16, P71, DOI 10.1634/theoncologist.2011-S1-71; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dent R, 2009, CANCER-AM CANCER SOC, V115, P4917, DOI 10.1002/cncr.24573; Federico A, 2007, INT J CANCER, V121, P2381, DOI 10.1002/ijc.23192; Fisher CS, 2012, ANN SURG ONCOL, V19, P253, DOI 10.1245/s10434-011-1877-y; Foulkes WD, 2010, NEW ENGL J MED, V363, P1938, DOI 10.1056/NEJMra1001389; Foulkes WD, 2009, BREAST CANCER RES TR, V117, P199, DOI 10.1007/s10549-008-0102-6; FREIREICH EMIL J., 1966, CANCER CHEMOTHERAP REP, V50, P219; Fulford LG, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1636; Gaudet MM, 2011, BREAST CANCER RES TR, V130, P587, DOI 10.1007/s10549-011-1616-x; Greenman CG, 2008, CANCER-AM CANCER SOC, V112, P2159, DOI 10.1002/cncr.23416; Griggs JJ, 2005, ARCH INTERN MED, V165, P1267, DOI 10.1001/archinte.165.11.1267; He JH, 2012, MED ONCOL, V29, P406, DOI 10.1007/s12032-011-9832-0; Liedtke C, 2008, J CLIN ONCOL, V26, P1275, DOI 10.1200/JCO.2007.14.4147; Loibl S, 2011, BREAST CANCER RES TR, V130, P477, DOI 10.1007/s10549-011-1715-8; Lorincz AM, 2006, ENDOCR-RELAT CANCER, V13, P279, DOI 10.1677/erc.1.00729; Lyman GH, 2011, J ONCOL PRACT, V7, P17, DOI 10.1200/JOP.2010.000200; Lyman GH, 2009, J NATL COMPR CANC NE, V7, P99, DOI 10.6004/jnccn.2009.0009; Millikan RC, 2008, BREAST CANCER RES TR, V109, P123, DOI 10.1007/s10549-007-9632-6; Phipps AI, 2011, CANCER EPIDEM BIOMAR, V20, P454, DOI 10.1158/1055-9965.EPI-10-0974; Pierga JY, 2000, BRIT J CANCER, V83, P1480, DOI 10.1054/bjoc.2000.1461; Rakha EA, 2006, PROGNOSTIC MARKERS T, V2, P4, DOI [10.1002/cncr.22381, DOI 10.1002/CNCR.22381]; Rakha EA, 2007, CANCER-AM CANCER SOC, V109, P25, DOI 10.1002/cncr.22381; Rastogi P, 2008, J CLIN ONCOL, V26, P778, DOI 10.1200/JCO.2007.15.0235; Rodriguez-Pinilla SM, 2006, CLIN CANCER RES, V12, P1533, DOI 10.1158/1078-0432.CCR-05-2281; Rouzier R, 2005, CLIN CANCER RES, V11, P5678, DOI 10.1158/1078-0432.CCR-04-2421; Sorlie Therese, 2007, Methods Mol Biol, V360, P91; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Stephenson GD, 2003, NUTR CANCER, V45, P1, DOI 10.1207/S15327914NC4501_1; Symmans WF, 2007, J CLIN ONCOL, V25, P4414, DOI 10.1200/JCO.2007.10.6823; Tang DB, 2012, MED ONCOL, V29, P526, DOI 10.1007/s12032-011-9948-2; Tischkowitz M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-134; Tutt ANJ, 2008, TRIPLE NEGATIVE TUMO, P108, DOI [10.1111/j.1365-2559.2007.02889.x, DOI 10.1111/J.1365-2559.2007.02889.X]; Wolff AC, 2007, J CLIN ONCOL, V25, P118, DOI 10.1200/JCO.2006.09.2775; Yang XR, 2007, CANCER EPIDEM BIOMAR, V16, P439, DOI 10.1158/1055-9965.EPI-06-0806	42	23	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144359	10.1371/journal.pone.0144359	http://dx.doi.org/10.1371/journal.pone.0144359			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684197	gold, Green Published, Green Submitted			2022-12-26	WOS:000366725800013
J	Denecke, S; Nowell, CJ; Fournier-Level, A; Perry, T; Batterham, P				Denecke, Shane; Nowell, Cameron J.; Fournier-Level, Alexandre; Perry, Trent; Batterham, Phil			The Wiggle Index: An Open Source Bioassay to Assess Sub-Lethal Insecticide Response in Drosophila melanogaster	PLOS ONE			English	Article							TARGET-SITE RESISTANCE; NEONICOTINOID INSECTICIDES; ENVIRONMENTAL FATE; DEGRADATION; PESTICIDES; SPINOSAD; STRAIN; METABOLISM; RESOURCE; ACID	Toxicological assays measuring mortality are routinely used to describe insecticide response, but sub-lethal exposures to insecticides can select for resistance and yield additional biological information describing the ways in which an insecticide impacts the insect. Here we present the Wiggle Index (WI), a high-throughput method to quantify insecticide response by measuring the reduction in motility during sub-lethal exposures in larvae of the vinegar fly Drosophila melanogaster. A susceptible wild type strain was exposed to the insecticides chlorantraniliprole, imidacloprid, spinosad, and ivermectin. Each insecticide reduced larval motility, but response times and profiles differed among insecticides. Two sets of target site mutants previously identified in mortality studies on the basis of imidacloprid or spinosad resistance phenotypes were tested. In each case the resistant mutant responded significantly less than the control. The WI was also able to detect a spinosad response in the absence of the primary spinosad target site. This response was not detected in mortality assays suggesting that spinosad, like many other insecticides, may have secondary targets affecting behaviour. The ability of the WI to detect changes in insecticide metabolism was confirmed by overexpressing the imidacloprid metabolizing Cyp6g1 gene in digestive tissues or the central nervous system. The data presented here validate the WI as an inexpensive, generic, sub-lethal assay that can complement information gained from mortality assays, extending our understanding of the genetic basis of insecticide response in D. melanogaster.	[Denecke, Shane; Fournier-Level, Alexandre; Perry, Trent; Batterham, Phil] Univ Melbourne, Sch BioSci, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia; [Nowell, Cameron J.] Monash Univ, Fac Pharm & Pharmaceut Sci, Parkville, Vic 3052, Australia	University of Melbourne; Monash University	Batterham, P (corresponding author), Univ Melbourne, Sch BioSci, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia.	p.batterham@unimelb.edu.au	Denecke, Shane/AAO-6540-2020; Perry, Trent/ABB-9462-2021; Batterham, Philip/G-5914-2012; Perry, Trent/A-7206-2012	Denecke, Shane/0000-0002-7291-1394; Perry, Trent/0000-0002-8045-0487; Batterham, Philip/0000-0001-9840-9119; Perry, Trent/0000-0002-8045-0487; Nowell, Cameron/0000-0002-8662-9840; FOURNIER-LEVEL, ALEXANDRE/0000-0002-6047-7164	Australian Research Council [DP130102414]	Australian Research Council(Australian Research Council)	This research was supported by the Australian Research Council (Discovery Project Grant DP130102414), http://www.arc.gov.au/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The authors would like to thank the Basler lab, the Bloomington stock centre and the Drosophila Genome Resource Center for the provision of D. melanogaster stocks and the Australian Drosophila Biomedical Research Support Facility for handling the quarantine of imported flies. This research was supported by funding from the Australian Research Council (Discovery Project Grant DP130102414) awarded to PB.	Bai D, 1991, ACTIONS IMIDACLOPRID, P197; Banks WA, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-S1-S3; Bass C, 2013, P NATL ACAD SCI USA, V110, P19460, DOI 10.1073/pnas.1314122110; Bass C, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-51; Baxter SW, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000802; Begley DJ, 2004, CURR PHARM DESIGN, V10, P1295, DOI 10.2174/1381612043384844; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bloomquist J, 1992, REDUCED NEURONAL SEN, V25, P17; Bonmatin JM, 2015, ENVIRON SCI POLLUT R, V22, P35, DOI 10.1007/s11356-014-3332-7; Cameron R, 2013, J ECON ENTOMOL, V106, P597, DOI 10.1603/EC12370; Cleveland CB, 2002, J AGR FOOD CHEM, V50, P3244, DOI 10.1021/jf011663i; Cresswell JE, 2012, PEST MANAG SCI, V68, P819, DOI 10.1002/ps.3290; Daborn PJ, 2007, INSECT BIOCHEM MOLEC, V37, P512, DOI 10.1016/j.ibmb.2007.02.008; Daborn PJ, 2012, INSECT BIOCHEM MOLEC, V42, P918, DOI 10.1016/j.ibmb.2012.09.003; Daborn PJ, 2002, SCIENCE, V297, P2253, DOI 10.1126/science.1074170; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Fairbrother A, 2014, ENVIRON TOXICOL CHEM, V33, P719, DOI 10.1002/etc.2527; Feyereisen R, 2015, PESTIC BIOCHEM PHYS, V121, P61, DOI 10.1016/j.pestbp.2015.01.004; Ffrench-Constant RH, 2013, GENETICS, V194, P807, DOI 10.1534/genetics.112.141895; Flood J, 2010, FOOD SECUR, V2, P215, DOI 10.1007/s12571-010-0072-5; Gao JR, 2007, INSECT MOL BIOL, V16, P325, DOI 10.1111/j.1365-2583.2007.00730.x; Garlapow ME, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138129; Guedes RNC, 2016, ANNU REV ENTOMOL, V61, P43, DOI 10.1146/annurev-ento-010715-023646; Hellou J, 2011, ENVIRON SCI POLLUT R, V18, P1, DOI 10.1007/s11356-010-0367-2; Hoi KK, 2014, ANAL CHEM, V86, P3525, DOI 10.1021/ac404188g; Hsu JC, 2012, INSECT BIOCHEM MOLEC, V42, P806, DOI 10.1016/j.ibmb.2012.07.010; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; IRAC [Insecticide Resistance Action Committee], 2015, TEST METH; Ivanov DK, 2015, J GERONTOL A-BIOL, V70, P1470, DOI 10.1093/gerona/glv047; Joussen N, 2008, METABOLISM IMIDACLOP, V73, P65, DOI [10.1002/ps, DOI 10.1002/PS]; Kane NS, 2000, P NATL ACAD SCI USA, V97, P13949, DOI 10.1073/pnas.240464697; King EG, 2012, GENETICS, V191, P935, DOI 10.1534/genetics.112.138537; Lahm GP, 2009, BIOORGAN MED CHEM, V17, P4127, DOI 10.1016/j.bmc.2009.01.018; Li XC, 2007, ANNU REV ENTOMOL, V52, P231, DOI 10.1146/annurev.ento.51.110104.151104; Liu ZH, 2011, PEST MANAG SCI, V67, P1245, DOI 10.1002/ps.2174; Liu ZW, 2005, P NATL ACAD SCI USA, V102, P8420, DOI 10.1073/pnas.0502901102; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Marriage TN, 2014, GENETICS, V198, P45, DOI 10.1534/genetics.114.162107; McKenzie J a, 1994, GENETICA, P9; McKenzie JA, 1998, PREDICTING INSECTICI, P1729; Nichols CD, 2012, JOVE-J VIS EXP, DOI 10.3791/3795; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; Perry T, 2008, INSECT BIOCHEM MOLEC, V38, P520, DOI 10.1016/j.ibmb.2007.12.007; Perry T, 2007, INSECT BIOCHEM MOLEC, V37, P184, DOI 10.1016/j.ibmb.2006.11.009; Perry T, 2015, INSECT BIOCHEM MOLEC, V64, P106, DOI 10.1016/j.ibmb.2015.01.017; Perry T, 2012, PESTIC BIOCHEM PHYS, V102, P56, DOI 10.1016/j.pestbp.2011.10.010; Preston S, 2015, INT J PARASITOL, V45, P333, DOI 10.1016/j.ijpara.2015.01.007; Puinean AM, 2013, J NEUROCHEM, V124, P590, DOI 10.1111/jnc.12029; Remucal CK, 2014, ENVIRON SCI-PROC IMP, V16, P628, DOI 10.1039/c3em00549f; Roote J, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-3-149, 10.1186/gb4010]; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schmidt JM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000998; Strycharz JP, 2013, PESTIC BIOCHEM PHYS, V107, P207, DOI 10.1016/j.pestbp.2013.06.010; Tome HW, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-195; Tooming E, 2014, PEST MANAG SCI, V70, P959, DOI 10.1002/ps.3636; Venken KJT, 2011, NAT METHODS, V8, P737, DOI 10.1038/nmeth.1662; Watson GB, 2001, PESTIC BIOCHEM PHYS, V71, P20, DOI 10.1006/pest.2001.2559; Watson GB, 2010, INSECT BIOCHEM MOLEC, V40, P376, DOI 10.1016/j.ibmb.2009.11.004; Wei H, 2010, AGR SCI CHINA, V9, P1612, DOI 10.1016/S1671-2927(09)60258-3; Wolf FW, 2002, J NEUROSCI, V22, P11035; Zhu F, 2010, P NATL ACAD SCI USA, V107, P8557, DOI 10.1073/pnas.1000059107	62	15	15	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145051	10.1371/journal.pone.0145051	http://dx.doi.org/10.1371/journal.pone.0145051			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684454	Green Published, gold			2022-12-26	WOS:000366725800033
J	Mettler, R; Segelbacher, G; Schaefer, HM				Mettler, Raeann; Segelbacher, Gernot; Schaefer, H. Martin			Interactions between a Candidate Gene for Migration (ADCYAP1), Morphology and Sex Predict Spring Arrival in Blackcap Populations	PLOS ONE			English	Article							SYLVIA-ATRICAPILLA; BIRD POPULATION; MIGRANT BIRDS; WING-LENGTH; CLOCK GENES; BEHAVIOR; HETEROZYGOSITY; ADAPTATIONS; EVOLUTION; COMMON	Avian research has begun to reveal associations between candidate genes and migratory behaviors of captive birds, yet few studies utilize genotypic, morphometric, and phenological data from wild individuals. Previous studies have identified an association between ADCYAP1 polymorphism and autumn migratory behavior (restlessness, or zugunruhe), but little is known about the relationship between ADCYAP1 and spring migratory behavior. The timing of spring migration and arrival to the breeding ground are phenological traits which could be particularly favorable for establishing territories and acquiring mates, thus important to fitness and reproductive success. Here, we investigated how individual genotypic ADCYAP1 variation and phenotypic variation (wing length and shape) of blackcaps (Sylvia atricapilla) affect spring arrival date across nine natural populations in Europe. We hypothesized that longer alleles should be associated with earlier spring arrival dates and expected the effect on arrival date to be stronger for males as they arrive earlier. However, we found that longer wings were associated with earlier spring arrival to the breeding grounds for females, but not for males. Another female-specific effect indicated an interaction between ADCYAP1 allele size and wing pointedness on the response of spring arrival: greater allele size had a positive effect on spring arrival date for females with rounder wings, while a negative effect was apparent for females with more pointed wings. Also, female heterozygotes with pointed wing tips arrived significantly earlier than both homozygotes with pointed wings and heterozygotes with round wings. Stable isotope ratios (delta H-2) of a subset of blackcaps captured in Freiburg in 2011 allowed us also to assign individuals to their main overwintering areas in northwest (NW) and southwest (SW) Europe. NW males arrived significantly earlier to the Freiburg breeding site than both SW males and females in 2011. NW females had more pointed wing tips compared to SW females, but no difference in ADCYAP1 allele size was found between the different migration routes.	[Mettler, Raeann; Schaefer, H. Martin] Univ Freiburg, Dept Evolutionary Biol & Anim Ecol, D-79106 Freiburg, Germany; [Mettler, Raeann; Schaefer, H. Martin] Black Hills State Univ, Sch Nat Sci, Spearfish, SD 57799 USA; [Segelbacher, Gernot] Univ Freiburg, Wildlife Ecol & Management, D-79106 Freiburg, Germany	University of Freiburg; Black Hills State University; University of Freiburg	Mettler, R (corresponding author), Black Hills State Univ, Sch Nat Sci, Spearfish, SD 57799 USA.	raeann.mettler@gmail.com	Segelbacher, Gernot/F-3633-2011	Segelbacher, Gernot/0000-0002-8024-7008	Deutsche Forschungsgemeinschaft (DE) grant [Scha 1008/6-1]; Deutsche Forschungsgemeinschaft (DFG) [Scha 1008/6-1]	Deutsche Forschungsgemeinschaft (DE) grant; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	RM, HMS, and GS were funded through a Deutsche Forschungsgemeinschaft (DE) grant (Scha 1008/6-1).; The authors thank Heidi Kurz, Hans Winkler, Diego Santiago-Alarcon, Gregor Rolshausen, Michael W. Stracco, and several students at Universitat Freiburg for field assistance and analysis advice. We also thank the staff at Universitat Freiburg Institute fur Rechtsmedizin for technical laboratory assistance and the Universitat Freiburg Open-Access-Publikationsfonds for publication assistance. This research was funded by a grant (Scha 1008/6-1) of the Deutsche Forschungsgemeinschaft (DFG).	Alho JS, 2010, MOL ECOL RESOUR, V10, P720, DOI 10.1111/j.1755-0998.2010.02830.x; [Anonymous], 1992, HDB BIRDS EUROPE MID; Baldwin MW, 2010, J EVOLUTION BIOL, V23, P1050, DOI 10.1111/j.1420-9101.2010.01975.x; Bearhop S, 2005, SCIENCE, V310, P502, DOI 10.1126/science.1115661; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERTHOLD P, 1992, NATURE, V360, P668, DOI 10.1038/360668a0; Bourret A, 2015, ECOL EVOL, V5, P3628, DOI 10.1002/ece3.1630; Caro SP, 2009, FUNCT ECOL, V23, P172, DOI 10.1111/j.1365-2435.2008.01486.x; Cassone VM, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00032; Chakarov N, 2013, MOL ECOL, V22, P5430, DOI 10.1111/mec.12493; Coppack T, 2011, J ORNITHOL, V152, P67, DOI 10.1007/s10336-011-0708-z; Delmore KE, 2015, MOL ECOL, V24, P1873, DOI 10.1111/mec.13150; Desrochers A, 2010, ECOLOGY, V91, P1577, DOI 10.1890/09-2202.1; Dierschke V, 2005, BEHAV ECOL SOCIOBIOL, V57, P470, DOI 10.1007/s00265-004-0872-8; Dingle H, 2006, J ORNITHOL, V147, P212, DOI 10.1007/s10336-005-0052-2; Fiedler W, 2005, ANN NY ACAD SCI, V1046, P253, DOI 10.1196/annals.1343.022; Forschler MI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018732; Forstmeier W, 2012, MOL ECOL, V21, P3237, DOI 10.1111/j.1365-294X.2012.05593.x; Fox John, 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i15, DOI 10.18637/JSS.V008.I15]; HELBIG AJ, 1991, BEHAV ECOL SOCIOBIOL, V28, P9; Hermes C, PLOS ONE IN PRESS; JENNI L, 1989, BIRD STUDY, V36, P1, DOI 10.1080/00063658909476996; Johnsen A, 2007, MOL ECOL, V16, P4867, DOI 10.1111/j.1365-294X.2007.03552.x; Kopiec K, 2012, ORNIS FENNICA, V89, P254; Kwak E, 2006, J BIOL CHEM, V281, P19100, DOI 10.1074/jbc.M511927200; Liedvogel M, 2011, TRENDS ECOL EVOL, V26, P561, DOI 10.1016/j.tree.2011.07.009; Liedvogel M, 2009, MOL ECOL, V18, P2444, DOI 10.1111/j.1365-294X.2009.04204.x; Lo Valvo F, 1998, RINGING MIGR, V9, P51; Lockwood R, 1998, J AVIAN BIOL, V29, P273, DOI 10.2307/3677110; Matschiner M, 2009, BIOINFORMATICS, V25, P1982, DOI 10.1093/bioinformatics/btp303; Mettler R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081365; Miller JM, 2014, HEREDITY, V112, P240, DOI 10.1038/hdy.2013.99; MONKKONEN M, 1995, EVOL ECOL, V9, P520, DOI 10.1007/BF01237833; Mueller JC, 2013, MOL ECOL, V22, P3629, DOI 10.1111/mec.12288; Mueller JC, 2011, P ROY SOC B-BIOL SCI, V278, P2848, DOI 10.1098/rspb.2010.2567; Nagy AD, 2007, PEPTIDES, V28, P1767, DOI 10.1016/j.peptides.2007.07.013; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; Nosil P, 2012, OX ECOL EV, P3; Nowak JZ, 2003, CURR PHARM DESIGN, V9, P467, DOI 10.2174/1381612033391586; Petering M.E.H., 2013, FLEX SERV MANUF J, P1, DOI 10.12688/f1000research.2-115.v1; Piersma T, 2005, ANN NY ACAD SCI, V1046, P282, DOI 10.1196/annals.1343.026; Pulido F, 2003, AVIAN MIGRATION, P53; Pulido F, 2001, P ROY SOC B-BIOL SCI, V268, P953, DOI 10.1098/rspb.2001.1602; Pulido F, 2007, BIOSCIENCE, V57, P165, DOI 10.1641/B570211; Pulido F, 2010, P NATL ACAD SCI USA, V107, P7341, DOI 10.1073/pnas.0910361107; R Core Team, 2013, R LANG ENV STAT COMP; Rappole J., 2013, AVIAN MIGRANT BIOL B; Rolshausen G, 2013, ECOL EVOL, V3, P4278, DOI 10.1002/ece3.825; Rolshausen G, 2009, CURR BIOL, V19, P2097, DOI 10.1016/j.cub.2009.10.061; Rolshausen G, 2010, OECOLOGIA, V162, P175, DOI 10.1007/s00442-009-1445-3; Ruegg K, 2014, MOL ECOL, V23, P4757, DOI 10.1111/mec.12842; Saino N, 2015, MOL ECOL, V24, P1758, DOI 10.1111/mec.13159; Santiago-Alarcon D, 2013, J AVIAN BIOL, V44, P521, DOI 10.1111/j.1600-048X.2013.00181.x; Schwartz C, 2013, CURR TOP DEV BIOL, V105, P247, DOI 10.1016/B978-0-12-396968-2.00009-9; Steinmeyer C, 2009, GENETICA, V136, P109, DOI 10.1007/s10709-008-9318-y; Tarka M, 2014, AM NAT, V183, P62, DOI 10.1086/674072; Vaudry D, 2009, PHARMACOL REV, V61, P283, DOI 10.1124/pr.109.001370; Venables WN., 2002, MODERN APPL STAT S 4; Wang G, 2012, J BIOL RHYTHM, V27, P145, DOI 10.1177/0748730411435965; WINKLER H, 1992, IBIS, V134, P21	60	10	10	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144587	10.1371/journal.pone.0144587	http://dx.doi.org/10.1371/journal.pone.0144587			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684459	Green Published, gold, Green Submitted			2022-12-26	WOS:000366725800015
J	Wang, Y; Li, GH; Yang, SY; Gu, XY; Li, XY; Liu, MY; Wu, XJ; Guan, Y; Press, R; Zhu, J; Zhang, HL				Wang, Ying; Li, Guihong; Yang, Siyu; Gu, Xiaoyi; Li, Xinyu; Liu, Mingyang; Wu, Xiujuan; Guan, Yun; Press, Rayomand; Zhu, Jie; Zhang, Hong-Liang			Fasting Glucose Levels Correlate with Disease Severity of Guillain-Barre Syndrome	PLOS ONE			English	Article							DIABETIC-NEUROPATHY	Objective A potential association between diabetes and Guillain-Barre syndrome (GBS) has been indicated by a few case studies. We retrospectively analyzed the clinical features of a large cohort of GBS patients to explore the relationship between the level of fasting plasma glucose (FPG) obtained in the acute phase at admission and the severity of GBS. Methods Three hundred and four GBS patients were divided into two groups, one with normal FPG and the other with high FPG levels according to the international standards of FPG. Results The GBS disability scale score was positively, the Medical Research Council (MRC) sum score was negatively correlated to the level of FPG, but not to blood HBA1c or CSF glucose concentrations. A relatively higher FPG level was observed in older and younger GBS patients, and more often in those with cranial nerve involvement, autonomic deficit, dyspnea and ventilator dependence than in patients without these clinical characteristics. Importantly, higher levels of FPG at admission were associated with poorer short-term prognosis measured by the MRC sum score and the GBS disability scale at discharge. Conclusions Our data demonstrates that FPG in the acute phase of GBS correlates with the severity of GBS and may predict the short-term prognosis of GBS.	[Wang, Ying; Wu, Xiujuan; Zhu, Jie; Zhang, Hong-Liang] Jilin Univ, Hosp 1, Dept Neurol, Changchun 130023, Peoples R China; [Li, Guihong; Yang, Siyu; Gu, Xiaoyi; Li, Xinyu; Liu, Mingyang] Jilin Univ, Norman Bethune Hlth Sci Ctr, Changchun 130023, Peoples R China; [Guan, Yun] Fudan Univ, Shanghai Med Coll, Shanghai 200433, Peoples R China; [Press, Rayomand] Karolinska Inst, Div Neurol, Dept Clin Neurosci, Stockholm, Sweden; [Zhu, Jie; Zhang, Hong-Liang] Karolinska Inst, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden	Jilin University; Jilin University; Fudan University; Karolinska Institutet; Karolinska Institutet	Zhang, HL (corresponding author), Jilin Univ, Hosp 1, Dept Neurol, Changchun 130023, Peoples R China.	drzhl@hotmail.com	Zhang, Hongliang/AAN-3077-2020; Press, Rayomand/AAW-8142-2020; Li, Lambert LL/F-7146-2015; li, xin/HHS-9461-2022; Li, Guihong/GSI-5154-2022	Zhang, Hongliang/0000-0001-9205-5559; liu, mingyang/0000-0003-4101-716X				Chamberlain JL, 2010, J AUTOIMMUN, V34, P469, DOI 10.1016/j.jaut.2009.12.004; Donath MY, 2013, CELL METAB, V17, P860, DOI 10.1016/j.cmet.2013.05.001; FLAX H, 1990, DIABETES RES CLIN EX, V14, P47; HUGHES RAC, 1978, LANCET, V2, P750, DOI 10.1016/s0140-6736(78)92644-2; Kanemasa Y, 2011, INTERNAL MED, V50, P2201, DOI 10.2169/internalmedicine.50.5553; KLEYWEG RP, 1991, MUSCLE NERVE, V14, P1103, DOI 10.1002/mus.880141111; Lu MO, 2011, J NEUROL, V258, P533, DOI 10.1007/s00415-010-5836-5; MASER RE, 1989, DIABETES, V38, P1456, DOI 10.2337/diabetes.38.11.1456; Misasi R, 1997, DIABETES METAB REV, V13, P163, DOI 10.1002/(SICI)1099-0895(199709)13:3<163::AID-DMR189>3.0.CO;2-Z; Roodbol J, 2011, NEUROLOGY, V76, P807, DOI 10.1212/WNL.0b013e31820e7b62; Rouanet-Larriviere M, 2000, J PERIPHER NERV SYST, V5, P27, DOI 10.1046/j.1529-8027.2000.00122.x; Tishler M, 2004, ISR MED ASSOC J, V6, P430; Vaishnavi C, 2014, INDIAN J PATHOL MICR, V57, P51, DOI 10.4103/0377-4929.130897; Zhang HL, 2014, EXPERT OPIN THER TAR, V18, P355, DOI 10.1517/14728222.2014.882899; Zhang HL, 2013, CYTOKINE GROWTH F R, V24, P443, DOI 10.1016/j.cytogfr.2013.05.005; Zychowska M, 2013, PHARMACOL REP, V65, P1601, DOI 10.1016/S1734-1140(13)71521-4	16	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145075	10.1371/journal.pone.0145075	http://dx.doi.org/10.1371/journal.pone.0145075			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684748	gold, Green Published, Green Submitted			2022-12-26	WOS:000366725800035
J	White, ME; Hayward, JJ; Stokol, T; Boyko, AR				White, Michelle E.; Hayward, Jessica J.; Stokol, Tracy; Boyko, Adam R.			Genetic Mapping of Novel Loci Affecting Canine Blood Phenotypes	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; DOG DOMESTICATION; ACTIVATION; MONOCYTES; REVEALS; DISEASE; TRAITS; BIM	Since the publication of the dog genome and the construction of high-quality genome-wide SNP arrays, thousands of dogs have been genotyped for disease studies. For many of these dogs, additional clinical phenotypes are available, such as hematological and clinical chemistry results collected during routine veterinary care. Little is known about the genetic basis of variation in blood phenotypes, but this variation may play an important role in the etiology and progression of many diseases. From a cohort of dogs that had been previously genotyped on a semi-custom Illumina CanineHD array for various genome-wide association studies (GWAS) at Cornell University Hospital for Animals, we chose 353 clinically healthy, adult dogs for our analysis of clinical pathologic test results (14 hematological tests and 25 clinical chemistry tests). After correcting for age, body weight and sex, genetic associations were identified for amylase, segmented neutrophils, urea nitrogen, glucose, and mean corpuscular hemoglobin. Additionally, a strong genetic association (P = 8.1x10(-13)) was evident between a region of canine chromosome 13 (CFA13) and alanine aminotransferase (ALT), explaining 23% of the variation in ALT levels. This region of CFA13 encompasses the GPT gene that encodes the transferase. Dogs homozygous for the derived allele exhibit lower ALT activity, making increased ALT activity a less useful marker of hepatic injury in these individuals. Overall, these associations provide a roadmap for identifying causal variants that could improve interpretation of clinical blood tests and understanding of genetic risk factors associated with diseases such as canine diabetes and anemia, and demonstrate the utility of holistic phenotyping of dogs genotyped for disease mapping studies.	[White, Michelle E.; Hayward, Jessica J.; Boyko, Adam R.] Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA; [Stokol, Tracy] Cornell Univ, Coll Vet Med, Dept Populat Med & Diagnost Sci, Ithaca, NY 14853 USA	Cornell University; Cornell University	White, ME (corresponding author), Cornell Univ, Coll Vet Med, Dept Biomed Sci, Ithaca, NY 14853 USA.	mew248@cornell.edu; boyko@cornell.edu	Hayward, Jessica/AGW-0493-2022	White, Michelle E./0000-0002-9079-0880	Zoetis Animal Health; Cornell University Center for Advanced Technology in Life Science Enterprise; NIH [R24 GM082910-A1, R24 GM082910-S1, R01 12-PAF-04410]; Office Of the Director, National Institutes Of Health of the National Institutions of Health [T32ODO011000]; Stanton Foundation Next Generation Canine Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM103961, R24GM082910] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD011000] Funding Source: NIH RePORTER	Zoetis Animal Health; Cornell University Center for Advanced Technology in Life Science Enterprise; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office Of the Director, National Institutes Of Health of the National Institutions of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanton Foundation Next Generation Canine Research Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was made possible by funding support from Zoetis Animal Health (ARB), the Cornell University Center for Advanced Technology in Life Science Enterprise (ARB), NIH R24 GM082910-A1 (ARB), R24 GM082910-S1 (ARB), and R01 12-PAF-04410 (ARB). https://www.zoetis.com/, https://smallbizdev.cornell.edu/organizations/cat, http://grants.nih.gov/grants/oer.htm. MEW was supported by the Office Of the Director, National Institutes Of Health of the National Institutions of Health under Award Number T32ODO011000, http://grants.nih.gov/grants/oer.htm. JJH was supported by a Stanton Foundation Next Generation Canine Research Fellowship. http://thestantonfoundation.org/canine/next-gen-research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andina N, 2009, CELL DEATH DIFFER, V16, P1248, DOI 10.1038/cdd.2009.50; Arendt M, 2014, ANIM GENET, V45, P716, DOI 10.1111/age.12179; Axelsson E, 2013, NATURE, V495, P360, DOI 10.1038/nature11837; Bates D., 2015, LINEAR MIXED EFFECTS; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Behrend EN, 1997, VET CLIN N AM-SMALL, V27, P187, DOI 10.1016/S0195-5616(97)50027-1; Castelhano MGP, 2009, JAVMA-J AM VET MED A, V234, P75, DOI 10.2460/javma.234.1.75; Center SA, 2007, VET CLIN N AM-SMALL, V37, P297, DOI 10.1016/j.cvsm.2006.11.009; Conklin KA, 2000, NUTR CANCER, V37, P1, DOI 10.1207/S15327914NC3701_1; D'Alessandro A, 2010, J PROTEOME RES, V9, P144, DOI 10.1021/pr900831f; Davis RC, 2013, MAMM GENOME, V24, P105, DOI 10.1007/s00335-013-9448-0; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; DEVRIES JE, 1979, J IMMUNOL, V122, P1099; Faldyna M, 2001, VET IMMUNOL IMMUNOP, V82, P23, DOI 10.1016/S0165-2427(01)00337-3; Gabriele L, 2004, BLOOD, V103, P980, DOI 10.1182/blood-2003-03-0981; Hayward J, NAT COMMUN IN PRESS; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Kettunen J, 2012, NAT GENET, V44, P269, DOI 10.1038/ng.1073; Lavoue R, 2014, VET CLIN PATH, V43, P352, DOI 10.1111/vcp.12151; Lawrence J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081288; Lidell ME, 2011, DIABETES, V60, P427, DOI 10.2337/db10-0409; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Nakajima Kei, 2011, BMC Res Notes, V4, P419, DOI 10.1186/1756-0500-4-419; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Puthalakath H, 1999, MOL CELL, V3, P287, DOI 10.1016/S1097-2765(00)80456-6; Raviv Z, 2013, CANCER CHEMOTH PHARM, V71, P275, DOI 10.1007/s00280-012-2039-z; Schoenebeck JJ, 2014, ANNU REV CELL DEV BI, V30, P535, DOI 10.1146/annurev-cellbio-100913-012927; Shannon LM, 2015, P NATL ACAD SCI USA, V112, P13639, DOI 10.1073/pnas.1516215112; Suhre K, 2011, NATURE, V477, P54, DOI 10.1038/nature10354; Takemoto Y, 1999, INT IMMUNOL, V11, P1957, DOI 10.1093/intimm/11.12.1957; Teslovich TM, 2010, NATURE, V466, P707, DOI 10.1038/nature09270; van der Harst P, 2012, NATURE, V492, P369, DOI 10.1038/nature11677; Zhou X, 2012, NAT GENET, V44, P821, DOI 10.1038/ng.2310; Ziegler A, 2012, HUM GENET, V131, P1627, DOI 10.1007/s00439-012-1188-9	35	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145199	10.1371/journal.pone.0145199	http://dx.doi.org/10.1371/journal.pone.0145199			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683458	gold, Green Submitted, Green Published			2022-12-26	WOS:000366725800044
J	Ding, XD; Jiang, W; Zhou, PP; Liu, LL; Wan, XL; Yuan, XJ; Wang, XZ; Chen, M; Chen, J; Yang, J; Kong, C; Li, B; Peng, C; Wong, CCL; Hou, FJ; Zhang, Y				Ding, Xiaodan; Jiang, Wei; Zhou, Peipei; Liu, Lulu; Wan, Xiaoling; Yuan, Xiujie; Wang, Xizi; Chen, Miao; Chen, Jun; Yang, Jing; Kong, Chao; Li, Bin; Peng, Chao; Wong, Catherine C. L.; Hou, Fajian; Zhang, Yan			Mixed Lineage Leukemia 5 (MLL5) Protein Stability Is Cooperatively Regulated by O-GlcNac Transferase (OGT) and Ubiquitin Specific Protease 7 (USP7)	PLOS ONE			English	Article							N-ACETYLGLUCOSAMINE TRANSFERASE; CELL-CYCLE PROGRESSION; PROSTATE-CANCER CELLS; EMBRYONIC STEM-CELLS; BREAST-CANCER; SUBSTRATE-SPECIFICITY; GENOMIC STABILITY; MYELOID-LEUKEMIA; X-CHROMOSOME; KAPPA-B	Mixed lineage leukemia 5 (MLL5) protein is a trithorax family histone 3 lysine 4 (H3K4) methyltransferase that regulates diverse biological processes, including cell cycle progression, hematopoiesis and cancer. The mechanisms by which MLL5 protein stability is regulated have remained unclear to date. Here, we showed that MLL5 protein stability is cooperatively regulated by O-GlcNAc transferase (OGT) and ubiquitin-specific protease 7 (USP7). Depletion of OGT in cells led to a decrease in the MLL5 protein level through ubiquitin/proteasome-dependent proteolytic degradation, whereas ectopic expression of OGT protein suppressed MLL5 ubiquitylation. We further identified deubiquitinase USP7 as a novel MLL5-associated protein using mass spectrometry. USP7 stabilized the MLL5 protein through direct binding and deubiquitylation. Loss of USP7 induced degradation of MLL5 protein. Conversely, overexpression of USP7, but not a catalytically inactive USP7 mutant, led to decreased ubiquitylation and increased MLL5 stability. Co-immunoprecipitation and co-immunostaining assays revealed that MLL5, OGT and USP7 interact with each other to form a stable ternary complex that is predominantly located in the nucleus. In addition, upregulation of MLL5 expression was correlated with increased expression of OGT and USP7 in human primary cervical adenocarcinomas. Our results collectively reveal a novel molecular mechanism underlying regulation of MLL5 protein stability and provide new insights into the functional interplay among O-GlcNAc transferase, deubiquitinase and histone methyltransferase.	[Ding, Xiaodan] Nanjing Med Univ, Dept Immunol, Nanjing, Jiangsu, Peoples R China; [Ding, Xiaodan; Zhou, Peipei; Liu, Lulu; Wan, Xiaoling; Yuan, Xiujie; Chen, Miao; Yang, Jing; Kong, Chao; Li, Bin; Zhang, Yan] Chinese Acad Sci, Inst Pasteur Shanghai, Key Lab Mol Virol & Immunol, Shanghai, Peoples R China; [Jiang, Wei] Fudan Univ, Shanghai Red House Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China; [Liu, Lulu] Soochow Univ, Inst Biol & Med Sci, Suzhou, Jiangsu, Peoples R China; [Wang, Xizi] Sun Yet Sen Univ, Coll Life Sci, Guangzhou, Guangdong, Peoples R China; [Chen, Miao; Chen, Jun] Shanghai Normal Univ, Coll Life Sci, Shanghai, Peoples R China; [Peng, Chao; Wong, Catherine C. L.; Hou, Fajian] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Biochem & Cell Biol, Natl Ctr Prot Sci Shanghai, Shanghai, Peoples R China	Nanjing Medical University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Fudan University; Soochow University - China; Sun Yat Sen University; Shanghai Normal University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Jiang, W (corresponding author), Fudan Univ, Shanghai Red House Obstet & Gynecol Hosp, Shanghai 200433, Peoples R China.	jw52317@126.com; yan_zhang@sibs.ac.cn	Wan, Xiaoling/T-1813-2019; lI, Bin/AAR-4966-2021	lI, Bin/0000-0002-7640-8884; Wong, Catherine CL/0000-0001-7270-980X	National Basic Research Program of China [2015CB964901]; National Natural Science Foundation of China [31471207, 81270618]; Medicine Guide Project of the Science and Technology Commission of Shanghai Municipality [114119a233]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Medicine Guide Project of the Science and Technology Commission of Shanghai Municipality	This work is supported by National Basic Research Program of China Grants (2015CB964901, http://www.most.gov.cn), National Natural Science Foundation of China Grants (31471207 and 81270618, http://www.nsfc.gov.cn) to YZ, and the Medicine Guide Project of the Science and Technology Commission of Shanghai Municipality (114119a233, http://www.stcsm.gov.cn/) to WJ.	Baychelier F, 2013, BLOOD, V122, P2935, DOI 10.1182/blood-2013-03-489054; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Champattanachai V, 2013, PROTEOMICS, V13, P2088, DOI 10.1002/pmic.201200126; Chang F, 2008, INT J BIOCHEM CELL B, V40, P2472, DOI 10.1016/j.biocel.2008.04.012; Cheon KW, 2006, INT J ONCOL, V28, P1209; Colleran A, 2013, P NATL ACAD SCI USA, V110, P618, DOI 10.1073/pnas.1208446110; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; de Bie P, 2010, BIOCHEM BIOPH RES CO, V400, P389, DOI 10.1016/j.bbrc.2010.08.082; Deng LW, 2004, P NATL ACAD SCI USA, V101, P757, DOI 10.1073/pnas.2036345100; Ding F, 2013, AMINO ACIDS, V45, P339, DOI 10.1007/s00726-013-1504-2; Dong S, 2014, CELL REP, V9, P16, DOI 10.1016/j.celrep.2014.08.068; Emerling BM, 2002, ONCOGENE, V21, P4849, DOI 10.1038/sj.onc.1205615; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Faesen AC, 2012, BIOCHEM SOC T, V40, P539, DOI 10.1042/BST20120004; Ferrer CM, 2014, MOL CELL, V54, P820, DOI 10.1016/j.molcel.2014.04.026; Fujiki R, 2011, NATURE, V480, P557, DOI 10.1038/nature10656; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Giovinazzi S, 2014, ONCOTARGET, V5, P3728, DOI 10.18632/oncotarget.1989; Golks A, 2007, EMBO J, V26, P4368, DOI 10.1038/sj.emboj.7601845; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; He JS, 2014, J BIOL CHEM, V289, P27278, DOI 10.1074/jbc.M114.589812; Heuser M, 2009, BLOOD, V113, P1432, DOI [10.1182/blood-2008-02-162263, 10.1182/blood-2008-06-162263]; Huang X, 2013, J BIOL CHEM, V288, P36418, DOI 10.1074/jbc.M113.495713; Huang Z, 2011, NAT CELL BIOL, V13, P142, DOI 10.1038/ncb2153; Itkonen HM, 2013, CANCER RES, V73, P5277, DOI 10.1158/0008-5472.CAN-13-0549; Jagannathan M, 2014, MOL CELL BIOL, V34, P132, DOI 10.1128/MCB.00639-13; Jin FZ, 2013, EXP CELL RES, V319, P1482, DOI 10.1016/j.yexcr.2013.03.013; Kamigaito T, 2014, PROSTATE CANCER P D, V17, P18, DOI 10.1038/pcan.2013.56; Keembiyehetty C, 2015, J BIOL CHEM; Khoronenkova SV, 2011, NUCLEIC ACIDS RES, V39, P2604, DOI 10.1093/nar/gkq1210; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kumar A, 2014, J BIOL CHEM, V289, P13543, DOI 10.1074/jbc.M114.553321; Lazarus MB, 2013, SCIENCE, V342, P1235, DOI 10.1126/science.1243990; Lazarus MB, 2011, NATURE, V469, P564, DOI 10.1038/nature09638; Li MD, 2013, CELL METAB, V17, P303, DOI 10.1016/j.cmet.2012.12.015; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Love Dona C, 2005, Sci STKE, V2005, pre13, DOI 10.1126/stke.3122005re13; Lucena-Araujo AR, 2014, BRIT J HAEMATOL, V166, P540, DOI 10.1111/bjh.12921; Lynch TP, 2012, J BIOL CHEM, V287, P11070, DOI 10.1074/jbc.M111.302547; Ma JF, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-8; Ma ZY, 2014, J BIOL CHEM, V289, P34457, DOI 10.1074/jbc.R114.577718; Ma ZY, 2013, J BIOL CHEM, V288, P15121, DOI 10.1074/jbc.M113.470047; Madan V, 2009, BLOOD, V113, P1444, DOI 10.1182/blood-2008-02-142638; Maertens GN, 2010, EMBO J, V29, P2553, DOI 10.1038/emboj.2010.129; Marz P, 2006, J BIOL CHEM, V281, P20263, DOI 10.1074/jbc.M601563200; Milne TA, 2014, HAEMATOLOGICA, V99, P1405, DOI 10.3324/haematol.2014.113357; Myers SA, 2011, P NATL ACAD SCI USA, V108, P9490, DOI 10.1073/pnas.1019289108; Nagel AK, 2014, AMINO ACIDS, V46, P2305, DOI 10.1007/s00726-014-1827-7; Nicholson B, 2011, CELL BIOCHEM BIOPHYS, V60, P61, DOI 10.1007/s12013-011-9185-5; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Park JJ, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.32; Peng C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012658; Qian J., 2014, ONCOGENE; Qiao Z, 2012, J BIOMED RES, V26, P268, DOI 10.7555/JBR.26.20110121; Qin WH, 2011, J CELL BIOCHEM, V112, P439, DOI 10.1002/jcb.22998; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Sakabe K, 2010, P NATL ACAD SCI USA, V107, P19915, DOI 10.1073/pnas.1009023107; Schuettengruber B, 2011, NAT REV MOL CELL BIO, V12, P799, DOI 10.1038/nrm3230; Schwertman P, 2012, NAT GENET, V44, P598, DOI 10.1038/ng.2230; Shafi R, 2000, P NATL ACAD SCI USA, V97, P5735, DOI 10.1073/pnas.100471497; Shi DD, 2010, CANCER BIOL THER, V10, P737, DOI 10.4161/cbt.10.8.13417; Sodi VL, 2015, MOL CANC RES; Starska K, 2014, CLIN EXP MED; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Tan EP, 2014, J BIOL CHEM, V289, P14719, DOI 10.1074/jbc.M113.525790; van Loosdregt J, 2013, IMMUNITY, V39, P259, DOI 10.1016/j.immuni.2013.05.018; Vocadlo DJ, 2012, CURR OPIN CHEM BIOL, V16, P488, DOI 10.1016/j.cbpa.2012.10.021; Wan XL, 2014, STEM CELL REV REP, V10, P643, DOI 10.1007/s12015-014-9527-y; Yang WH, 2006, NAT CELL BIOL, V8, P1074, DOI 10.1038/ncb1470; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang YR, 2012, AGING CELL, V11, P439, DOI 10.1111/j.1474-9726.2012.00801.x; Yap DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027127; Yew CW, 2011, CANCER RES, V71, P6696, DOI 10.1158/0008-5472.CAN-11-1271; Yun HY, 2014, HAEMATOLOGICA, V99, P1456, DOI 10.3324/haematol.2013.101386; Zeidan Q, 2010, MOL BIOL CELL, V21, P1922, DOI 10.1091/mbc.E09-11-0941; Zhang Y, 2009, BLOOD, V113, P1455, DOI 10.1182/blood-2008-05-159905; Zhou PP, 2013, J BIOL CHEM, V288, P17532, DOI 10.1074/jbc.M112.439729	78	39	42	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145023	10.1371/journal.pone.0145023	http://dx.doi.org/10.1371/journal.pone.0145023			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678539	Green Published, Green Submitted, gold			2022-12-26	WOS:000366723400042
J	Curry, CJ; White, PA; Derr, JN				Curry, Caitlin J.; White, Paula A.; Derr, James N.			Mitochondrial Haplotype Diversity in Zambian Lions: Bridging a Gap in the Biogeography of an Iconic Species	PLOS ONE			English	Article							PANTHERA-LEO; CONSERVATION; POPULATION; INFERENCE; EVOLUTION; SOUTHERN; MRBAYES; HISTORY; EASTERN; PARK	Analysis of DNA sequence diversity at the 12S to 16S mitochondrial genes of 165 African lions (Panthera leo) from five main areas in Zambia has uncovered haplotypes which link Southern Africa with East Africa. Phylogenetic analysis suggests Zambia may serve as a bridge connecting the lion populations in southern Africa to eastern Africa, supporting earlier hypotheses that eastern-southern Africa may represent the evolutionary cradle for the species. Overall gene diversity throughout the Zambian lion population was 0.7319 +/-0.0174 with eight haplotypes found; three haplotypes previously described and the remaining five novel. The addition of these five novel haplotypes, so far only found within Zambia, nearly doubles the number of haplotypes previously reported for any given geographic location of wild lions. However, based on an AMOVA analysis of these haplotypes, there is little to no matrilineal gene flow (FST = 0.47) when the eastern and western regions of Zambia are considered as two regional sub-populations. Crossover haplotypes (H9, H11, and Z1) appear in both populations as rare in one but common in the other. This pattern is a possible result of the lion mating system in which predominately males disperse, as all individuals with crossover haplotypes were male. The determination and characterization of lion sub-populations, such as done in this study for Zambia, represent a higher-resolution of knowledge regarding both the genetic health and connectivity of lion populations, which can serve to inform conservation and management of this iconic species.	[Curry, Caitlin J.; Derr, James N.] Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, Interdisciplinary Program Genet, College Stn, TX 77845 USA; [White, Paula A.] Univ Calif Los Angeles, Ctr Trop Res, Inst Environm & Sustainabil, Los Angeles, CA USA	Texas A&M University System; Texas A&M University College Station; University of California System; University of California Los Angeles	Derr, JN (corresponding author), Texas A&M Univ, Coll Vet Med & Biomed Sci, Dept Vet Pathobiol, Interdisciplinary Program Genet, College Stn, TX 77845 USA.	jderr@cvm.tamu.edu		Curry, Caitlin/0000-0002-3853-7191	Zambia Wildlife Authority; Professional Hunters Association of Zambia; Safari Hunters and Outfitters Association of Zambia; Boore Family Foundation; Dallas Safari Club; Safari Club International Foundation; Texas AM Foundation	Zambia Wildlife Authority; Professional Hunters Association of Zambia; Safari Hunters and Outfitters Association of Zambia; Boore Family Foundation; Dallas Safari Club; Safari Club International Foundation; Texas AM Foundation	This research has been funded in part by the Zambia Wildlife Authority, Professional Hunters Association of Zambia (www.phazambia.com), Safari Hunters and Outfitters Association of Zambia, the Boore Family Foundation, Dallas Safari Club (biggame.org), Safari Club International Foundation (www.safariclub.org) and the Texas A&M Foundation (txamfoundation.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], AFR LION PANTH LEO S; [Anonymous], SEQ VERS 5 3 SEQ AN; [Anonymous], AS LION PANTH LEO PE; Antunes A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000251; Arif I. A., 2009, Animal Biodiversity and Conservation, V32, P9; Avise JC, 1995, MITOCHONDRIAL DNA PO, V9, P686; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barnett R, 2006, P ROY SOC B-BIOL SCI, V273, P2119, DOI 10.1098/rspb.2006.3555; Barnett R, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-70; Bauer H, 2004, ORYX, V38, P26, DOI 10.1017/S0030605304000055; Bauer H, 2012, PANTHERA LEO IUCN RE; Becker MS, 2013, J WILDLIFE MANAGE, V77, P128, DOI 10.1002/jwmg.446; Bertola LD, 2011, J BIOGEOGR, V38, P1356, DOI 10.1111/j.1365-2699.2011.02500.x; Bertola LD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137975; Bertola LD, 2012, GENETIC DIVERSITY NE, P61; Dolrenry S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088081; Dubach J, 2005, CONSERV GENET, V6, P15, DOI 10.1007/s10592-004-7729-6; Dubach JM, 2013, CONSERV GENET, V14, P741, DOI 10.1007/s10592-013-0453-3; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; IUCN, 2006, CONS STRAT LION PATH; Kim JH, 2006, GENE, V366, P292, DOI 10.1016/j.gene.2005.08.023; Midlane N, 2014, BIOL CONSERV, V172, P101, DOI 10.1016/j.biocon.2014.02.006; Midlane N, 2015, BIODIVERS CONSERV; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Nowell K., 1996, WILD CATS STATUS SUR; PUSEY AE, 1987, BEHAVIOUR, V101, P275, DOI 10.1163/156853987X00026; Rambaut A, 2009, FIGTREE V1 3 1; Rambaut A, TRACER V1 2014; Riggio J, 2013, BIODIVERS CONSERV, V22, P17, DOI 10.1007/s10531-012-0381-4; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rosenblatt E, 2014, BIOL CONSERV, V180, P176, DOI 10.1016/j.biocon.2014.10.006; Spong G, 2002, J EVOLUTION BIOL, V15, P945, DOI 10.1046/j.1420-9101.2002.00473.x; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Tende T, 2014, ECOL EVOL, V4, P2668, DOI 10.1002/ece3.1116; Tende T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084288; Triant DA, 2011, ANIM BEHAV, V82, P601, DOI 10.1016/j.anbehav.2011.06.011; Trinkel M, 2008, ANIM CONSERV, V11, P138, DOI 10.1111/j.1469-1795.2008.00163.x; Wan QH, 2004, ELECTROPHORESIS, V25, P2165, DOI 10.1002/elps.200305922; Zwickl DJ, 2006, PHILOSOPHY	42	6	6	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0143827	10.1371/journal.pone.0143827	http://dx.doi.org/10.1371/journal.pone.0143827			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674533	Green Published, Green Submitted, gold			2022-12-26	WOS:000366722700016
J	Kim, WS; Kim, JS; Bin Cha, S; Han, SJ; Kim, H; Kwon, KW; Kim, SJ; Eum, SY; Cho, SN; Shin, SJ				Kim, Woo Sik; Kim, Jong-Seok; Bin Cha, Seung; Han, Seung Jung; Kim, HongMin; Kwon, Kee Woong; Kim, So Jeong; Eum, Seok-Yong; Cho, Sang-Nae; Shin, Sung Jae			Virulence-Dependent Alterations in the Kinetics of Immune Cells during Pulmonary Infection by Mycobacterium tuberculosis	PLOS ONE			English	Article							DENDRITIC CELLS; T-CELLS; STRAIN; HOST; TH1; MICE; PATHOGENESIS; MACROPHAGES; VACCINATION; NECROSIS	A better understanding of the kinetics of accumulated immune cells that are involved in pathophysiology during Mycobacterium tuberculosis (Mtb) infection may help to facilitate the development of vaccines and immunological interventions. However, the kinetics of innate and adaptive cells that are associated with pathogenesis during Mtb infection and their relationship to Mtb virulence are not clearly understood. In this study, we used a mouse model to compare the bacterial burden, inflammation and kinetics of immune cells during aerogenic infection in the lung between laboratory-adapted strains (Mtb H37Rv and H37Ra) and Mtb K strain, a hyper-virulent W-Beijing lineage strain. The Mtb K strain multiplied more than 10- and 3.54-fold more rapidly than H37Ra and H37Rv, respectively, during the early stage of infection (at 28 days post-infection) and resulted in exacerbated lung pathology at 56 to 112 days post-infection. Similar numbers of innate immune cells had infiltrated, regardless of the strain, by 14 days post-infection. High, time-dependent frequencies of F4/80(-)CD11c(+)CD11b(-)Siglec-H(+)PDCA-1(+) plasmacytoid DCs and CD11c(-)CD11b(+)Gr-1(int) cells were observed in the lungs of mice that were infected with the Mtb K strain. Regarding adaptive immunity, Th1 and Th17 T cells that express T-bet and ROR gamma t, respectively, significantly increased in the lungs that were infected with the laboratory-adapted strains, and the population of CD4(+)CD25(+)Foxp3(+) regulatory T cells was remarkably increased at 112 days post-infection in the lungs of mice that were infected with the K strain. Collectively, our findings indicate that the highly virulent Mtb K strain may trigger the accumulation of pDCs and Gr1(int)CD11b(+) cells with the concomitant down-regulation of the Th1 response and the maintenance of an up-regulated Th2 response without inducing a Th17 response during chronic infection. These results will help to determine which immune system components must be considered for the development of tuberculosis (TB) vaccines and immunological interventions.	[Kim, Woo Sik; Kim, Jong-Seok; Bin Cha, Seung; Han, Seung Jung; Kim, HongMin; Kwon, Kee Woong; Kim, So Jeong; Cho, Sang-Nae; Shin, Sung Jae] Yonsei Univ, Dept Microbiol, Inst Immunol & Immunol Dis, Coll Med, Seoul 120749, South Korea; [Kim, HongMin; Kwon, Kee Woong; Kim, So Jeong; Cho, Sang-Nae; Shin, Sung Jae] Yonsei Univ, Coll Med, Brain Korea PLUS Project Med Sci 21, Seoul, South Korea; [Eum, Seok-Yong] Int TB Res Ctr, Div Immunopathol & Cellular Immunol, Chang Won, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Shin, SJ (corresponding author), Yonsei Univ, Dept Microbiol, Inst Immunol & Immunol Dis, Coll Med, Seoul 120749, South Korea.	sjshin@yuhs.ac		Shin, Sung Jae/0000-0003-0854-4582	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of the Ministry of science, ICT & Future Planning [NRF-2013R1A2A1A01009932]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of the Ministry of science, ICT & Future Planning	This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of the Ministry of science, ICT & Future Planning (NRF-2013R1A2A1A01009932). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/814943; Ali A., 2014, JOURNAL OF MICROBIOL, V4, P25, DOI [10.5923/s.microbiology.201401.04, DOI 10.5923/S.MICROBIOLOGY.201401.04]; Amaral EP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004188; Ancelet LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045888; Antonelli LRV, 2010, J CLIN INVEST, V120, P1674, DOI 10.1172/JCI40817; Beamer GL, 2008, J IMMUNOL, V181, P5545, DOI 10.4049/jimmunol.181.8.5545; Beisiegel M, 2009, EUR J IMMUNOL, V39, P3369, DOI 10.1002/eji.200939615; Buu TN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042323; Byun EH, 2012, FASEB J, V26, P2695, DOI 10.1096/fj.11-199588; Carlsson F, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000895; Chakraborty P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062966; Ehlers S, 2003, ANN RHEUM DIS, V62, P37, DOI 10.1136/ard.62.suppl_2.ii37; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gideon HP, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004603; Green AM, 2013, J IMMUNOL, V190, P270, DOI 10.4049/jimmunol.1200061; Guidry TV, 2007, MICROBIOL-SGM, V153, P3360, DOI 10.1099/mic.0.2007/010850-0; Gupta V, 2010, HUM IMMUNOL, V71, P682, DOI 10.1016/j.humimm.2010.03.010; Hanekom M, 2007, J CLIN MICROBIOL, V45, P1483, DOI 10.1128/JCM.02191-06; Hunter RL, 2014, ANN CLIN LAB SCI, V44, P365; Jeon BY, 2012, J MED MICROBIOL, V61, P1373, DOI 10.1099/jmm.0.047027-0; Kamath AB, 2003, INFECT IMMUN, V71, P4112, DOI 10.1128/IAI.71.7.4112-4118.2003; Kim SJ, 2001, INT J TUBERC LUNG D, V5, P824; Kipnis A, 2005, INFECT IMMUN, V73, P7759, DOI 10.1128/IAI.73.11.7759-7764.2005; Lee JS, 2008, CELL HOST MICROBE, V3, P97, DOI 10.1016/j.chom.2008.01.002; Leung AN, 1999, RADIOLOGY, V210, P307, DOI 10.1148/radiology.210.2.r99ja34307; Manca C, 2001, P NATL ACAD SCI USA, V98, P5752, DOI 10.1073/pnas.091096998; Mayer-Barber KD, 2014, NATURE, V511, P99, DOI 10.1038/nature13489; McKenna K, 2005, J VIROL, V79, P17, DOI 10.1128/JVI.79.1.17-27.2005; Meraviglia S, 2011, CLIN DEV IMMUNOL, DOI 10.1155/2011/587315; Mihret A, 2012, VIRULENCE, V3, P654, DOI 10.4161/viru.22586; Obregon-Henao A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080669; Ordway D, 2007, J IMMUNOL, V179, P522, DOI 10.4049/jimmunol.179.1.522; Palanisamy GS, 2008, TUBERCULOSIS, V88, P295, DOI 10.1016/j.tube.2007.12.003; Peters W, 2001, P NATL ACAD SCI USA, V98, P7958, DOI 10.1073/pnas.131207398; Reiling N, 2013, MBIO, V4, DOI 10.1128/mBio.00250-13; Romagnoli A, 2012, AUTOPHAGY, V8, P1357, DOI 10.4161/auto.20881; Satchidanandam V, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004176; Semple PL, 2013, AM J RESP CRIT CARE, V187, P1249, DOI 10.1164/rccm.201210-1934OC; Shin AR, 2008, CLIN VACCINE IMMUNOL, V15, P1788, DOI 10.1128/CVI.00231-08; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Sreejit G, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004446; Tsiganov EN, 2014, J IMMUNOL, V192, P4718, DOI 10.4049/jimmunol.1301365; Tundup S, 2014, FEBS OPEN BIO, V4, P822, DOI 10.1016/j.fob.2014.09.001; van Crevel R, 2002, CLIN MICROBIOL REV, V15, P294, DOI 10.1128/CMR.15.2.294-309.2002; Verwaerde C, 2014, VACCINE, V32, P6240, DOI 10.1016/j.vaccine.2014.09.024; Vilaplana C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100830; Weiser JN, 2015, J INFECT DIS, V212, P1677, DOI 10.1093/infdis/jiv262; WHO, 2014, GLOBAL TUBERCULOSIS; Zhang L, 2012, DNA CELL BIOL, V31, P171, DOI 10.1089/dna.2011.1290	49	22	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145234	10.1371/journal.pone.0145234	http://dx.doi.org/10.1371/journal.pone.0145234			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675186	Green Submitted, Green Published, gold			2022-12-26	WOS:000366722700117
J	Zhang, Y; Feng, YM; Ahmad, M; Ming, X; Zhou, L; Deng, J				Zhang, Ying; Feng, Yuanming; Ahmad, Munir; Ming, Xin; Zhou, Li; Deng, Jun			Intermediate Megavoltage Photon Beams for Improved Lung Cancer Treatments	PLOS ONE			English	Article							BODY RADIATION-THERAPY; DOSE CALCULATION TOOL; BREAST-CANCER; RADIOTHERAPY; ENERGY; MV; TARGETS; PLANAR; IMRT	The goal of this study is to evaluate the effects of intermediate megavoltage (3-MV) photon beams on SBRT lung cancer treatments. To start with, a 3-MV virtual beam was commissioned on a commercial treatment planning system based on Monte Carlo simulations. Three optimized plans (6-MV, 3-MV and dual energy of 3-and 6-MV) were generated for 31 lung cancer patients with identical beam configuration and optimization constraints for each patient. Dosimetric metrics were evaluated and compared among the three plans. Overall, planned dose conformity was comparable among three plans for all 31 patients. For 21 thin patients with average short effective path length (< 10 cm), the 3-MV plans showed better target coverage and homogeneity with dose spillage index R-50% = 4.68 +/- 0.83 and homogeneity index = 1.26 +/- 0.06, as compared to 4.95 +/- 1.01 and 1.31 +/- 0.08 in the 6-MV plans (p < 0.001). Correspondingly, the average/maximum reductions of lung volumes receiving 20 Gy (V-20Gy), 5 Gy (V-5Gy), and mean lung dose (MLD) were 7%/20%, 9%/30% and 5%/10%, respectively in the 3-MV plans (p < 0.05). The doses to 5% volumes of the cord, esophagus, trachea and heart were reduced by 9.0%, 10.6%, 11.4% and 7.4%, respectively (p < 0.05). For 10 thick patients, dual energy plans can bring dosimetric benefits with comparable target coverage, integral dose and reduced dose to the critical structures, as compared to the 6-MV plans. In conclusion, our study indicated that 3-MV photon beams have potential dosimetric benefits in treating lung tumors in terms of improved tumor coverage and reduced doses to the adjacent critical structures, in comparison to 6-MV photon beams. Intermediate megavoltage photon beams (< 6-MV) may be considered and added into current treatment approaches to reduce the adjacent normal tissue doses while maintaining sufficient tumor dose coverage in lung cancer radiotherapy.	[Zhang, Ying; Feng, Yuanming; Ming, Xin] Tianjin Univ, Dept Biomed Engn, Tianjin 300072, Peoples R China; [Zhang, Ying; Ming, Xin; Deng, Jun] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA; [Ahmad, Munir] William W Backus Hosp, Dept Radiat Oncol, Norwich, CT USA; [Zhou, Li] Sichuan Univ, West China Hosp, Ctr Radiat Phys & Technol, Ctr Canc, Chengdu 610064, Peoples R China	Tianjin University; Yale University; Sichuan University	Deng, J (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06510 USA.	jun.deng@yale.edu			China Scholarship Council [201206250087]	China Scholarship Council(China Scholarship Council)	YZ was supported by China Scholarship Council (no. 201206250087). There was no other funding support for YZ or any co-author of this work. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHNESJO A, 1989, MED PHYS, V16, P577, DOI 10.1118/1.596360; Benedict SH, 2010, MED PHYS, V37, P4078, DOI 10.1118/1.3438081; Bjorn Hardemark A L, 2004, P3IMRT DIRECT MACHIN; Darby SC, 2005, LANCET ONCOL, V6, P557, DOI 10.1016/S1470-2045(05)70251-5; Deng J, 2000, PHYS MED BIOL, V45, P411, DOI 10.1088/0031-9155/45/2/311; Dong P, 2014, MED PHYS, V41, DOI [10.1118/1.4868464, 10.1118/1.4888003]; Doyle JJ, 2007, INT J RADIAT ONCOL, V68, P82, DOI 10.1016/j.ijrobp.2006.12.019; Fox C, 2008, PHYS MED BIOL, V53, P3175, DOI 10.1088/0031-9155/53/12/007; Gong YL, 2008, RADIAT ONCOL, V3, DOI 10.1186/1748-717X-3-11; Guckenberger M, 2007, RADIOTHER ONCOL, V85, P435, DOI 10.1016/j.radonc.2007.10.044; HALPERIN E, 2005, PEDIAT RAD ONCOLOGY; Kataria T, 2012, J MED PHYS, V37, P207, DOI 10.4103/0971-6203.103606; Keller BM, 2007, MED PHYS, V34, P3996, DOI 10.1118/1.2775666; Li JS, 2000, PHYS MED BIOL, V45, P2969, DOI 10.1088/0031-9155/45/10/316; Lu XQ, 2000, FEASIBILITY STUDY US, V441, P449; Ma C.-M., 1995, 509D NRC PIRS; Ma CM, 1998, RADIAT PHYS CHEM, V53, P329, DOI 10.1016/S0969-806X(98)00113-3; Ma CM, 2002, PHYS MED BIOL, V47, P1671, DOI 10.1088/0031-9155/47/10/305; Madani I, 2007, RADIOTHER ONCOL, V82, P63, DOI 10.1016/j.radonc.2006.11.016; Meeks SL, 2005, MED PHYS, V32, P2673, DOI 10.1118/1.1990289; Nelson W. R., 1985, EGS4 CODE SYSTEM; Organization W.H., 2014, GLOBOCAN 2012 EST CA; Park JM, 2012, MED PHYS, V39, P1265, DOI 10.1118/1.3682172; Park JM, 2011, J APPL CLIN MED PHYS, V12, P147, DOI 10.1120/jacmp.v12i4.3563; Parsons D, 2012, MED PHYS, V39, P4568, DOI 10.1118/1.4730503; Robar JL, 2009, MED PHYS, V36, P3955, DOI 10.1118/1.3183499; ROGERS DWO, 1995, MED PHYS, V22, P503, DOI 10.1118/1.597552; Seco J, 2013, MONTE CARLO TECHNIQU; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; St-Hilaire J, 2009, J APPL CLIN MED PHYS, V10, P36, DOI 10.1120/jacmp.v10i4.3012; Stevens SW, 2011, PHYS MED BIOL, V56, P3809, DOI 10.1088/0031-9155/56/13/005; Timmerman RD, 2005, CURRENT PROBLEMS CAN; Timmerman R, 2010, JAMA-J AM MED ASSOC, V303, P1070, DOI 10.1001/jama.2010.261; Yartsev S, 2007, Biomed Imaging Interv J, V3, pe17, DOI 10.2349/biij.3.1.e17; Zhang Ying, 2015, British Journal of Medicine and Medical Research, V6, P661, DOI 10.9734/BJMMR/2015/15040	35	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145117	10.1371/journal.pone.0145117	http://dx.doi.org/10.1371/journal.pone.0145117			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26672752	Green Published, Green Submitted, gold			2022-12-26	WOS:000366722700102
J	Carter, EL; Gupta, N; Ragsdale, SW				Carter, Eric L.; Gupta, Nirupama; Ragsdale, Stephen W.			High Affinity Heme Binding to a Heme Regulatory Motif on the Nuclear Receptor Rev-erb beta Leads to Its Degradation and Indirectly Regulates Its Interaction with Nuclear Receptor Corepressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT DEGRADATION; HORMONE RECEPTORS; MOLECULAR-CLONING; GENE-EXPRESSION; HIGH-THROUGHPUT; NITRIC-OXIDE; ALPHA; PROTEIN; DOMAIN; IDENTIFICATION	Rev-erb beta and Rev-erb beta are heme-binding nuclear receptors (NR) that repress the transcription of genes involved in regulating metabolism, inflammation, and the circadian clock. Previous gene expression and co-immunoprecipitation studies led to a model in which heme binding to Rev-erb beta recruits nuclear receptor corepressor 1 (NCoR1) into an active repressor complex. However, in contradiction, biochemical and crystallographic studies have shown that heme decreases the affinity of the ligand-binding domain of Rev-erb NRs for NCoR1 peptides. One explanation for this discrepancy is that the ligand-binding domain and NCoR1 peptides used for in vitro studies cannot replicate the key features of the full-length proteins used in cellular studies. However, the combined in vitro and cellular results described here demonstrate that heme does not directly promote interactions between full-length Rev-erb beta (FLRev-erb beta) and an NCoR1 construct encompassing all three NR interaction domains. NCoR1 tightly binds both apo- and heme-replete FLRev-erb beta.DNA complexes; furthermore, heme, at high concentrations, destabilizes the FLRev-erb beta-NCoR1 complex. The interaction between FLRev-erb beta and NCoR1 as well as Rev-erb beta repression at the Bmal1 promoter appear to be modulated by another cellular factor(s), at least one of which is related to the ubiquitin-proteasome pathway. Our studies suggest that heme is involved in regulating the degradation of Rev-erb beta in a manner consistent with its role in circadian rhythm maintenance. Finally, the very slow rate constant (10(-6) s(-1)) of heme dissociation from Rev-erb beta rules out a prior proposal that Rev-erb beta acts as an intracellular heme sensor.	[Carter, Eric L.; Gupta, Nirupama; Ragsdale, Stephen W.] Univ Michigan, Dept Biol Chem, 1150 W Med Ctr Dr,5301 MSRB 3, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Ragsdale, SW (corresponding author), Univ Michigan, Dept Biol Chem, 1150 W Med Ctr Dr,5301 MSRB 3, Ann Arbor, MI 48109 USA.	sragsdal@umich.edu		Carter, Eric/0000-0003-2877-3411	National Institutes of Health [5R01-HL-102662, 1F32HL114150]; NIEHS [T32ES007062]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102662, F32HL114150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007062, P30ES017885] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health Grants 5R01-HL-102662 (to S. W. R.) and 1F32HL114150 (to E. L. C.) and by Grant T32ES007062 from the NIEHS (to E. L. C.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adelmant G, 1996, P NATL ACAD SCI USA, V93, P3553, DOI 10.1073/pnas.93.8.3553; Airola MV, 2010, BIOCHEMISTRY-US, V49, P4327, DOI 10.1021/bi901945w; Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; Aranda A, 2001, PHYSIOL REV, V81, P1269, DOI 10.1152/physrev.2001.81.3.1269; Bagai I, 2015, BIOCHEMISTRY-US, V54, P2693, DOI 10.1021/bi501489r; Bain DL, 2007, ANNU REV PHYSIOL, V69, P201, DOI 10.1146/annurev.physiol.69.031905.160308; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Bergen JM, 2008, BIOCONJUGATE CHEM, V19, P377, DOI 10.1021/bc700315v; BONNELYE E, 1994, CELL GROWTH DIFFER, V5, P1357; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Burris TP, 2013, PHARMACOL REV, V65, P710, DOI 10.1124/pr.112.006833; Caceres L, 2011, GENE DEV, V25, P1476, DOI 10.1101/gad.2064111; Carter EL, 2014, J INORG BIOCHEM, V133, P92, DOI 10.1016/j.jinorgbio.2014.01.005; Chandra V, 2013, J BIOL CHEM, V288, P10692, DOI 10.1074/jbc.M113.455915; Chen Y, 2010, MOL ENDOCRINOL, V24, P1650, DOI 10.1210/me.2010-0129; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Chopin-Delannoy S, 2003, J MOL ENDOCRINOL, V30, P197, DOI 10.1677/jme.0.0300197; Cohen RN, 1998, MOL ENDOCRINOL, V12, P1567, DOI 10.1210/me.12.10.1567; Cohen RN, 2001, MOL ENDOCRINOL, V15, P1049, DOI 10.1210/me.15.7.1049; Copeland R. A., 2002, ENZYMES, P76; Coste H, 2002, J BIOL CHEM, V277, P27120, DOI 10.1074/jbc.M203421200; Crumbley C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017290; Dawson R. M. C., 1991, DATA BIOCH RES, V3rd, P363; Dioum EM, 2002, SCIENCE, V298, P2385, DOI 10.1126/science.1078456; DUMAS B, 1994, MOL ENDOCRINOL, V8, P996, DOI 10.1210/me.8.8.996; ENMARK E, 1994, BIOCHEM BIOPH RES CO, V204, P49, DOI 10.1006/bbrc.1994.2424; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Estall JL, 2009, P NATL ACAD SCI USA, V106, P22510, DOI 10.1073/pnas.0912533106; Fleischhacker AS, 2015, BIOCHEMISTRY-US, V54, P2709, DOI 10.1021/acs.biochem.5b00266; Fontaine C, 2003, J BIOL CHEM, V278, P37672, DOI 10.1074/jbc.M304664200; Garrick MD, 1999, BBA-MOL CELL RES, V1449, P125, DOI 10.1016/S0167-4889(99)00006-3; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Guenthner CJ, 2009, NEUROSCIENCE, V164, P832, DOI 10.1016/j.neuroscience.2009.08.022; Gupta N, 2011, J BIOL CHEM, V286, P4392, DOI 10.1074/jbc.M110.193466; Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040; HARDING HP, 1995, MOL CELL BIOL, V15, P4791; HARGROVE MS, 1994, J BIOL CHEM, V269, P4207; Hargrove MS, 1996, BIOCHEMISTRY-US, V35, P11293, DOI 10.1021/bi960371l; Hen T, 2000, BIOCHEM BIOPH RES CO, V273, P584, DOI 10.1006/bbrc.2000.2995; Hogan KA, 2013, CYTOKINE, V64, P652, DOI 10.1016/j.cyto.2013.09.004; Igarashi J, 2004, J BIOL CHEM, V279, P15752, DOI 10.1074/jbc.M310273200; Igarashi J, 2008, J BIOL CHEM, V283, P18782, DOI 10.1074/jbc.M801400200; Ishikawa H, 2005, MOL CELL, V19, P171, DOI 10.1016/j.molcel.2005.05.027; Jin LH, 2010, ADV DRUG DELIVER REV, V62, P1218, DOI 10.1016/j.addr.2010.08.007; Kaasik K, 2004, NATURE, V430, P467, DOI 10.1038/nature02724; Kim JY, 2010, J MOL BIOL, V396, P747, DOI 10.1016/j.jmb.2009.12.008; Kuhl T, 2013, ACS CHEM BIOL, V8, P1785, DOI 10.1021/cb400317x; Kumar N, 2010, ENDOCRINOLOGY, V151, P3015, DOI 10.1210/en.2009-0800; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAZAR MA, 1989, MOL CELL BIOL, V9, P1128, DOI 10.1128/MCB.9.3.1128; Liu AC, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000023; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; LIU SC, 1988, BLOOD, V71, P1755; Lukat-Rodgers GS, 2010, INORG CHEM, V49, P6349, DOI 10.1021/ic902388q; Marvin KA, 2009, BIOCHEMISTRY-US, V48, P7056, DOI 10.1021/bi900697c; Miksanova M, 2006, BIOCHEMISTRY-US, V45, P9894, DOI 10.1021/bi060556k; Mitkova AV, 2003, J BIOL CHEM, V278, P52253, DOI 10.1074/jbc.M308956200; MIYAJIMA N, 1989, CELL, V57, P31, DOI 10.1016/0092-8674(89)90169-4; MIYAJIMA N, 1988, NUCLEIC ACIDS RES, V16, P11057, DOI 10.1093/nar/16.23.11057; MORRISON GR, 1965, ANAL CHEM, V37, P1124, DOI 10.1021/ac60228a014; Mottis A, 2013, GENE DEV, V27, P819, DOI 10.1101/gad.214023.113; Munakata H, 2004, J BIOCHEM, V136, P233, DOI 10.1093/jb/mvh112; Ojha S, 2000, BIOCHEMISTRY-US, V39, P10542, DOI 10.1021/bi000831h; OMURA T, 1984, J BIOCHEM-TOKYO, V96, P1491, DOI 10.1093/oxfordjournals.jbchem.a134978; Owens CP, 2012, BIOCHEMISTRY-US, V51, P1518, DOI 10.1021/bi2018305; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Pardee KI, 2009, PLOS BIOL, V7, P384, DOI 10.1371/journal.pbio.1000043; PenadeOrtiz S, 1997, J NEUROBIOL, V32, P341, DOI 10.1002/(SICI)1097-4695(199703)32:3<341::AID-NEU7>3.0.CO;2-7; Phelan CA, 2010, NAT STRUCT MOL BIOL, V17, P808, DOI 10.1038/nsmb.1860; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Qi ZH, 1999, P NATL ACAD SCI USA, V96, P13056, DOI 10.1073/pnas.96.23.13056; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Ramakrishnan SN, 2009, BIOCHEM BIOPH RES CO, V388, P654, DOI 10.1016/j.bbrc.2009.08.045; Ramakrishnan SN, 2005, J BIOL CHEM, V280, P8651, DOI 10.1074/jbc.M413949200; Raspe E, 2002, J LIPID RES, V43, P2172, DOI 10.1194/jlr.M200386-JLR200; Reinking J, 2005, CELL, V122, P195, DOI 10.1016/j.cell.2005.07.005; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; RETNAKARAN R, 1994, MOL ENDOCRINOL, V8, P1234, DOI 10.1210/me.8.9.1234; Rial DV, 2002, PROTEIN EXPRES PURIF, V25, P503, DOI 10.1016/S1046-5928(02)00024-4; Rish KR, 2007, BBA-BIOENERGETICS, V1767, P1107, DOI 10.1016/j.bbabio.2007.06.003; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Simcox JA, 2015, DIABETES, V64, P1108, DOI 10.2337/db14-0646; Spencer ALM, 2014, J BIOL CHEM, V289, P29836, DOI 10.1074/jbc.M114.582783; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Strausberg RL, 2002, P NATL ACAD SCI USA, V99, P16899, DOI 10.1073/pnas.242603899; SUZUKI H, 1989, J BIOL CHEM, V264, P920; Terenzi H, 1996, PROTEIN EXPRES PURIF, V8, P313, DOI 10.1006/prep.1996.0106; Torra IP, 2000, ENDOCRINOLOGY, V141, P3799, DOI 10.1210/en.141.10.3799; Uchida T, 2012, J INORG BIOCHEM, V108, P188, DOI 10.1016/j.jinorgbio.2011.12.005; Virshup DM, 2007, COLD SPRING HARB SYM, V72, P413, DOI 10.1101/sqb.2007.72.048; VOZ ML, 1991, J BIOL CHEM, V266, P13397; Wang JD, 2008, BBA-MOL CELL RES, V1783, P224, DOI 10.1016/j.bbamcr.2007.09.004; Wang JD, 2007, FEBS J, V274, P5370, DOI 10.1111/j.1742-4658.2007.06062.x; Wang J, 2008, MOL CELL BIOL, V28, P2213, DOI 10.1128/MCB.01608-07; Watson PJ, 2012, MOL CELL ENDOCRINOL, V348, P440, DOI 10.1016/j.mce.2011.08.033; Woo EJ, 2007, J MOL BIOL, V373, P735, DOI 10.1016/j.jmb.2007.08.037; Wu N, 2009, GENE DEV, V23, P2201, DOI 10.1101/gad.1825809; Wu YF, 2001, J BIOL CHEM, V276, P3929, DOI 10.1074/jbc.M006743200; Yang JH, 2008, MOL CELL BIOL, V28, P4697, DOI 10.1128/MCB.00236-08; Yin L, 2006, SCIENCE, V311, P1002, DOI 10.1126/science.1121613; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Yin L, 2010, P NATL ACAD SCI USA, V107, P11614, DOI 10.1073/pnas.1000438107; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06; ZHANG L, 1995, EMBO J, V14, P313, DOI 10.1002/j.1460-2075.1995.tb07005.x; Zhao Q, 1998, MOL CELL, V1, P849, DOI 10.1016/S1097-2765(00)80084-2; Zhou P, 2010, J BIOMOL NMR, V46, P23, DOI 10.1007/s10858-009-9371-6; Zvonic S, 2006, DIABETES, V55, P962, DOI 10.2337/diabetes.55.04.06.db05-0873	110	35	35	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2196	2222		10.1074/jbc.M115.670281	http://dx.doi.org/10.1074/jbc.M115.670281			27	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26670607	hybrid, Green Published			2022-12-26	WOS:000369610400013
J	Florek, M; Schneidawind, D; Pierini, A; Baker, J; Armstrong, R; Pan, YQ; Leveson-Gower, D; Negrin, R; Meyer, E				Florek, Mareike; Schneidawind, Dominik; Pierini, Antonio; Baker, Jeanette; Armstrong, Randall; Pan, Yuqiong; Leveson-Gower, Dennis; Negrin, Robert; Meyer, Everett			Freeze and Thaw of CD4(+) CD25(+) Foxp3(+) Regulatory T Cells Results in Loss of CD62L Expression and a Reduced Capacity to Protect against Graft-versus-Host Disease	PLOS ONE			English	Article							L-SELECTIN EXPRESSION; CD34(+) CELLS; BONE-MARROW; CRYOPRESERVATION; IMPACT; TRANSPLANTATION; ENGRAFTMENT; RECOVERY; GVHD	The adoptive transfer of CD4(+) CD25(+) Foxp3(+) regulatory T cells (Tregs) in murine models of allogeneic hematopoietic cell transplantation (HCT) has been shown to protect recipient mice from lethal acute graft-versus-host disease (GVHD) and this approach is being actively investigated in human clinical trials. Here, we examined the effects of cryopreservation on Tregs. We found that freeze and thaw of murine and human Tregs is associated with reduced expression of L-selectin (CD62L), which was previously established to be an important factor that contributes to the in vivo protective effects of Tregs. Frozen and thawed murine Tregs showed a reduced capacity to bind to the CD62L binding partner MADCAM1 in vitro as well as an impaired homing to secondary lymphoid organs in vivo. Upon adoptive transfer frozen and thawed Tregs failed to protect against lethal GVHD compared with fresh Tregs in a murine model of allogeneic HCT across major histocompatibility barriers. In summary, the direct administration of adoptively transferred frozen and thawed Tregs adversely affects their immunosuppressive potential which is an important factor to consider in the clinical implementation of Treg immunotherapies.	[Florek, Mareike; Schneidawind, Dominik; Pierini, Antonio; Baker, Jeanette; Armstrong, Randall; Pan, Yuqiong; Leveson-Gower, Dennis; Negrin, Robert; Meyer, Everett] Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA; [Schneidawind, Dominik] Univ Tubingen, Dept Med 2, Tubingen, Germany; [Pierini, Antonio] Univ Perugia, Dept Med, Hematol & Clin Immunol, I-06100 Perugia, Italy	Stanford University; Eberhard Karls University of Tubingen; University of Perugia	Schneidawind, D (corresponding author), Stanford Univ, Dept Med, Sch Med, Div Blood & Marrow Transplantat, Stanford, CA 94305 USA.	dominik.schneidawind@med.uni-tuebingen.de	Pierini, Antonio/K-6650-2016; Schneidawind, Dominik/AAR-4509-2020		SPARK program at Stanford University; Dr. Mildred Scheel Postdoctoral Fellowship from the German Cancer Aid; Stanford Institute for Immunity, Transplantation and Infection; American Society for Blood and Marrow Transplantation; Fondazione Italiana per la Ricerca sul Cancro (FIRC); Societa Italiana di Ematologia Sperimentale (SIES); Associazione Italiana contro le Leucemie-Linfomi e Mieloma (AIL); New Investigator Award from the American Society for Blood and Marrow Transplantation; Amy Manesevit Award from the National Marrow Donor Program; NIH [5 K08 HL119590]; NATIONAL CANCER INSTITUTE [R01CA231582, P01CA049605] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL119590, R01HL114591] Funding Source: NIH RePORTER; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	SPARK program at Stanford University; Dr. Mildred Scheel Postdoctoral Fellowship from the German Cancer Aid; Stanford Institute for Immunity, Transplantation and Infection; American Society for Blood and Marrow Transplantation; Fondazione Italiana per la Ricerca sul Cancro (FIRC)(Fondazione AIRC per la ricerca sul cancro); Societa Italiana di Ematologia Sperimentale (SIES); Associazione Italiana contro le Leucemie-Linfomi e Mieloma (AIL); New Investigator Award from the American Society for Blood and Marrow Transplantation; Amy Manesevit Award from the National Marrow Donor Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This study was supported by the SPARK program at Stanford University. DS was supported by a Dr. Mildred Scheel Postdoctoral Fellowship from the German Cancer Aid, a Young Investigator Award from the Stanford Institute for Immunity, Transplantation and Infection, and a New Investigator Award from the American Society for Blood and Marrow Transplantation. AP was supported by Fondazione Italiana per la Ricerca sul Cancro (FIRC), Societa Italiana di Ematologia Sperimentale (SIES), Associazione Italiana contro le Leucemie-Linfomi e Mieloma (AIL) and a New Investigator Award from the American Society for Blood and Marrow Transplantation. EM was supported by the Amy Manesevit Award from the National Marrow Donor Program and NIH Grant Number 5 K08 HL119590.	Brunstein CG, 2011, BLOOD, V117, P1061, DOI 10.1182/blood-2010-07-293795; Connor EM, 1999, J LEUKOCYTE BIOL, V65, P349, DOI 10.1002/jlb.65.3.349; De Boer F, 1998, BONE MARROW TRANSPL, V22, P1103, DOI 10.1038/sj.bmt.1701495; Deneys V, 1999, J IMMUNOL METHODS, V228, P13, DOI 10.1016/S0022-1759(99)00089-7; Di Ianni M, 2011, BLOOD, V117, P3921, DOI 10.1182/blood-2010-10-311894; Edinger M, 2003, BLOOD, V101, P640, DOI 10.1182/blood-2002-06-1751; Ermann J, 2005, BLOOD, V105, P2220, DOI 10.1182/blood-2004-05-2044; Fu S, 2004, AM J TRANSPLANT, V4, P65, DOI 10.1046/j.1600-6143.2003.00293.x; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; Hattori Y, 2001, EXP HEMATOL, V29, P114, DOI 10.1016/S0301-472X(00)00615-9; Koenigsmann MP, 1998, BONE MARROW TRANSPL, V22, P1077, DOI 10.1038/sj.bmt.1701484; KORBLING M, 1995, BLOOD, V86, P2842; LASKY LA, 1992, CELL, V69, P927, DOI 10.1016/0092-8674(92)90612-G; Medd P, 2013, BONE MARROW TRANSPL, V48, P243, DOI 10.1038/bmt.2012.118; Nguyen VH, 2007, BLOOD, V109, P2649, DOI 10.1182/blood-2006-08-044529; Ochando JC, 2005, J IMMUNOL, V174, P6993, DOI 10.4049/jimmunol.174.11.6993; Oelschlaegel U, 2007, ANN HEMATOL, V86, P569, DOI 10.1007/s00277-007-0286-6; Parody R, 2013, EUR J HAEMATOL, V91, P448, DOI 10.1111/ejh.12140; Peters JH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003161; ROSILLO MC, 1995, VOX SANG, V68, P210, DOI 10.1111/j.1423-0410.1995.tb02574.x; ROWLEY SD, 1994, BLOOD, V83, P2731; Sattui S, 2012, CYTOM PART B-CLIN CY, V82B, P54, DOI 10.1002/cyto.b.20621; Schneidawind D, 2015, BLOOD, V125, P3491, DOI 10.1182/blood-2014-11-612762; SIEGELMAN MH, 1989, SCIENCE, V243, P1165, DOI 10.1126/science.2646713; Taylor PA, 2004, BLOOD, V104, P3804, DOI 10.1182/blood-2004-05-1850; Timeus F, 2003, HAEMATOLOGICA, V88, P74; Zeiser R, 2008, BLOOD, V111, P453, DOI 10.1182/blood-2007-06-094482; Zhao XY, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0507-z	28	21	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145763	10.1371/journal.pone.0145763	http://dx.doi.org/10.1371/journal.pone.0145763			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26693907	Green Published, gold, Green Submitted			2022-12-26	WOS:000367092500073
J	Mitsi, M; Schulz, MMP; Gousopoulos, E; Ochsenbein, AM; Detmar, M; Vogel, V				Mitsi, Maria; Schulz, Martin Michael Peter; Gousopoulos, Epameinondas; Ochsenbein, Alexandra Michaela; Detmar, Michael; Vogel, Viola			Walking the Line: A Fibronectin Fiber-Guided Assay to Probe Early Steps of (Lymph) angiogenesis	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; VASCULAR LUMEN FORMATION; VEGF-A; EXTRACELLULAR-MATRIX; CELL-MIGRATION; MECHANICAL FORCES; NETWORK FORMATION; VESSEL FORMATION; LYMPHANGIOGENESIS; DISEASE	Angiogenesis and lymphangiogenesis are highly complex morphogenetic processes, central to many physiological and pathological conditions, including development, cancer metastasis, inflammation and wound healing. While it is described that extracellular matrix (ECM) fibers are involved in the spatiotemporal regulation of angiogenesis, current angiogenesis assays are not specifically designed to dissect and quantify the underlying molecular mechanisms of how the fibrillar nature of ECM regulates vessel sprouting. Even less is known about the role of the fibrillar ECM during the early stages of lymphangiogenesis. To address such questions, we introduced here an in vitro (lymph) angiogenesis assay, where we used microbeads coated with endothelial cells as simple sprouting sources and deposited them on single Fn fibers used as substrates to mimic fibrillar ECM. The fibers were deposited on a transparent substrate, suitable for live microscopic observation of the ensuing cell outgrowth events at the single cell level. Our proof-of-concept studies revealed that fibrillar Fn, compared to Fn-coated surfaces, provides far stronger sprouting and guidance cues to endothelial cells, independent of the tested mechanical strains of the Fn fibers. Additionally, we found that VEGF-A, but not VEGF-C, stimulates the collective outgrowth of lymphatic endothelial cells (LEC), while the collective outgrowth of blood vascular endothelial cells (HUVEC) was prominent even in the absence of these angiogenic factors. In addition to the findings presented here, the modularity of our assay allows for the use of different ECM or synthetic fibers as substrates, as well as of other cell types, thus expanding the range of applications in vascular biology and beyond.	[Mitsi, Maria; Vogel, Viola] ETH, Lab Appl Mech, Zurich, Switzerland; [Schulz, Martin Michael Peter; Gousopoulos, Epameinondas; Ochsenbein, Alexandra Michaela; Detmar, Michael] ETH, Inst Pharmaceut Sci, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Vogel, V (corresponding author), ETH, Lab Appl Mech, Zurich, Switzerland.	viola.vogel@hest.ethz.ch	Vogel, Viola/O-8025-2015; Mitsi, Maria/S-2519-2017	Vogel, Viola/0000-0003-2898-7671; Mitsi, Maria/0000-0001-8983-1983	European Research Council [233157, 268968]; National Institute of Health [CA69184]; Swiss National Science Foundation [31003A-130627, 310030B-147087]; Competence Centre for Materials Science and Technology; Oncosuisse and Krebsliga Zurich; NATIONAL CANCER INSTITUTE [R01CA069184] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Competence Centre for Materials Science and Technology; Oncosuisse and Krebsliga Zurich; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors gratefully acknowledge financial support from the European Research Council: 233157, VV and 268968, MD (http://erc.europa.eu/advanced-grants); National Institute of Health: CA69184, MD (http://grants.nih.gov/grants/oer.htm); Swiss National Science Foundation: 31003A-130627 and 310030B-147087, both to MD; Competence Centre for Materials Science and Technology: Grant title: 'Fibroblast growth factor-2 delivery for tissue repair: from natural concepts to engineered systems' to both VV and MD (http://www.ccmx.ch/academia/benefits-for-academia/funding-of-projects/); Oncosuisse and Krebsliga Zurich (both to MD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arima S, 2011, DEVELOPMENT, V138, P4763, DOI 10.1242/dev.068023; Astrof S, 2009, ANGIOGENESIS, V12, P165, DOI 10.1007/s10456-009-9136-6; Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Axnick J, 2012, CURR OPIN HEMATOL, V19, P192, DOI 10.1097/MOH.0b013e3283523ebc; Baneyx G, 2002, P NATL ACAD SCI USA, V99, P5139, DOI 10.1073/pnas.072650799; Benest AV, 2008, CARDIOVASC RES, V78, P315, DOI 10.1093/cvr/cvm094; Bentley K, 2014, NAT CELL BIOL, V16, P309, DOI 10.1038/ncb2926; BROWN RA, 1994, BIOMATERIALS, V15, P457, DOI 10.1016/0142-9612(94)90225-9; Bruce D, 2011, CELL COMMUN ADHES, V18, P85, DOI 10.3109/15419061.2011.619673; Caussinus E, 2008, CURR BIOL, V18, P1727, DOI 10.1016/j.cub.2008.10.062; Chabria M, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1135; Chen Daniel, 2015, DEV BIOL, P1; Chen L, 2011, J SURG ONCOL, V103, P475, DOI 10.1002/jso.21794; Childs S, 2002, DEVELOPMENT, V129, P973; Chiu CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043040; CLARK RAF, 1982, J INVEST DERMATOL, V79, P269, DOI 10.1111/1523-1747.ep12500076; CLARK RAF, 1982, J INVEST DERMATOL, V79, P264, DOI 10.1111/1523-1747.ep12500075; CLARK RAF, 1982, J EXP MED, V156, P646, DOI 10.1084/jem.156.2.646; Cueni Leah N., 2008, Lymphatic Research and Biology, V6, P109, DOI 10.1089/lrb.2008.1008; EJIM OS, 1993, BIOMATERIALS, V14, P743, DOI 10.1016/0142-9612(93)90038-4; Farhadian F, 1996, CARDIOVASC RES, V32, P433, DOI 10.1016/S0008-6363(96)00119-8; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2009, EUR CYTOKINE NETW, V20, P158, DOI 10.1684/ecn.2009.0170; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Friedl P, 2009, NAT REV MOL CELL BIO, V10, P445, DOI 10.1038/nrm2720; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047; Geudens I, 2011, DEVELOPMENT, V138, P4569, DOI 10.1242/dev.062323; Hagerling R, 2013, EMBO J, V32, P629, DOI 10.1038/emboj.2012.340; Halin C, 2007, BLOOD, V110, P3158, DOI 10.1182/blood-2007-01-066811; Hamada K, 2000, BLOOD, V96, P3793, DOI 10.1182/blood.V96.12.3793.h8003793_3793_3800; Hirakawa S, 2005, J EXP MED, V201, P1089, DOI 10.1084/jem.20041896; Hirakawa S, 2003, AM J PATHOL, V162, P575, DOI 10.1016/S0002-9440(10)63851-5; Hong YK, 2004, FASEB J, V18, P1111, DOI 10.1096/fj.03-1179fje; Hynes RO, 2007, J THROMB HAEMOST, V5, P32, DOI 10.1111/j.1538-7836.2007.02569.x; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733; Jakobsson L, 2010, NAT CELL BIOL, V12, P943, DOI 10.1038/ncb2103; Jansen KA, 2013, BIOPHYS J, V105, P2240, DOI 10.1016/j.bpj.2013.10.008; Korff T, 1999, J CELL SCI, V112, P3249; Kubow KE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9026; Kubow KE, 2009, INTEGR BIOL-UK, V1, P635, DOI 10.1039/b914996a; Li J, 2003, MICROSC RES TECHNIQ, V60, P107, DOI 10.1002/jemt.10249; Little WC, 2008, MATRIX BIOL, V27, P451, DOI 10.1016/j.matbio.2008.02.003; Little WC, 2009, NANO LETT, V9, P4158, DOI 10.1021/nl902365z; Malinda Katherine M., 2009, V467, P287, DOI 10.1007/978-1-59745-241-0_17; Mallory BP, 2006, MICROVASC RES, V72, P62, DOI 10.1016/j.mvr.2006.05.002; Mancuso MR, 2006, J CLIN INVEST, V116, P2610, DOI 10.1172/JCI24612; Maruthamuthu V, 2011, P NATL ACAD SCI USA, V108, P4708, DOI 10.1073/pnas.1011123108; NEHLS V, 1995, MICROVASC RES, V50, P311, DOI 10.1006/mvre.1995.1061; Oh SJ, 1997, DEV BIOL, V188, P96, DOI 10.1006/dbio.1997.8639; Planas-Paz L, 2013, CELL MOL LIFE SCI, V70, P4341, DOI 10.1007/s00018-013-1358-5; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Sacharidou A, 2012, CELLS TISSUES ORGANS, V195, P122, DOI 10.1159/000331410; SANDERS EJ, 1994, INT J DEV BIOL, V38, P701; Schulz MMP, 2012, P NATL ACAD SCI USA, V109, pE2665, DOI 10.1073/pnas.1206036109; Schwarzbauer JE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005041; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Smith ML, 2007, PLOS BIOL, V5, P2243, DOI 10.1371/journal.pbio.0050268; Stenzel D, 2011, DEVELOPMENT, V138, P4451, DOI 10.1242/dev.071381; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Van Obberghen-Schilling E, 2011, INT J DEV BIOL, V55, P511, DOI 10.1387/ijdb.103243eo; Vogel V, 2006, ANNU REV BIOPH BIOM, V35, P459, DOI 10.1146/annurev.biophys.35.040405.102013; Wuest TR, 2010, J EXP MED, V207, P101, DOI 10.1084/jem.20091385; Yang L, 2013, J THEOR BIOL, V332, P228, DOI 10.1016/j.jtbi.2013.03.013; Zamir E, 2000, NAT CELL BIOL, V2, P191, DOI 10.1038/35008607; Zheng W, 2011, BLOOD, V118, P1154, DOI 10.1182/blood-2010-11-317800; Zhou XM, 2008, GENE DEV, V22, P1231, DOI 10.1101/gad.1643308	68	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145210	10.1371/journal.pone.0145210	http://dx.doi.org/10.1371/journal.pone.0145210			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26689200	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092300047
J	Daianu, M; Jacobs, RE; Weitz, TM; Town, TC; Thompson, PM				Daianu, Madelaine; Jacobs, Russell E.; Weitz, Tara M.; Town, Terrence C.; Thompson, Paul M.			Multi-Shell Hybrid Diffusion Imaging (HYDI) at 7 Tesla in TgF344-AD Transgenic Alzheimer Rats	PLOS ONE			English	Article							MRI TRACTOGRAPHY; AXON DIAMETER; BRAIN; DENSITY; DISEASE; HARDI	Diffusion weighted imaging (DWI) is widely used to study microstructural characteristics of the brain. Diffusion tensor imaging (DTI) and high-angular resolution imaging (HARDI) are frequently used in radiology and neuroscience research but can be limited in describing the signal behavior in composite nerve fiber structures. Here, we developed and assessed the benefit of a comprehensive diffusion encoding scheme, known as hybrid diffusion imaging (HYDI), composed of 300 DWI volumes acquired at 7-Tesla with diffusion weightings at b = 1000, 3000, 4000, 8000 and 12000 s/mm(2) and applied it in transgenic Alzheimer rats (line TgF344-AD) that model the full clinico-pathological spectrum of the human disease. We studied and visualized the effects of the multiple concentric "shells" when computing three distinct anisotropy maps-fractional anisotropy (FA), generalized fractional anisotropy (GFA) and normalized quantitative anisotropy (NQA). We tested the added value of the multi-shell q-space sampling scheme, when reconstructing neural pathways using mathematical frameworks from DTI and q-ball imaging (QBI). We show a range of properties of HYDI, including lower apparent anisotropy when using high b-value shells in DTI-based reconstructions, and increases in apparent anisotropy in QBI-based reconstructions. Regardless of the reconstruction scheme, HYDI improves FA-, GFA- and NQA-aided tractography. HYDI may be valuable in human connectome projects and clinical research, as well as magnetic resonance research in experimental animals.	[Daianu, Madelaine; Thompson, Paul M.] Univ So Calif, Mark & Mary Stevens Neuroimaging & Informat Inst, Imaging Genet Ctr, Marina Del Rey, CA 90292 USA; [Daianu, Madelaine; Thompson, Paul M.] Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90024 USA; [Jacobs, Russell E.] CALTECH, Beckman Inst, Div Biol & Biol Engn, Pasadena, CA 91125 USA; [Weitz, Tara M.; Town, Terrence C.] Univ So Calif, Zilkha Neurogenet Inst, Dept Physiol & Biophys, Los Angeles, CA USA; [Thompson, Paul M.] Univ So Calif, Dept Neurol, Los Angeles, CA USA; [Thompson, Paul M.] Univ So Calif, Dept Psychiat, Los Angeles, CA USA; [Thompson, Paul M.] Univ So Calif, Dept Radiol, Los Angeles, CA USA; [Thompson, Paul M.] Univ So Calif, Dept Engn, Los Angeles, CA USA; [Thompson, Paul M.] Univ So Calif, Dept Pediat, Los Angeles, CA 90089 USA; [Thompson, Paul M.] Univ So Calif, Dept Ophthalmol, Los Angeles, CA 90089 USA	University of Southern California; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; California Institute of Technology; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California; University of Southern California	Thompson, PM (corresponding author), Univ So Calif, Mark & Mary Stevens Neuroimaging & Informat Inst, Imaging Genet Ctr, Marina Del Rey, CA 90292 USA.	pthomp@usc.edu	Thompson, Paul M/C-4194-2018; Jacobs, Russell/H-1087-2011	Thompson, Paul M/0000-0002-4720-8867; Jacobs, Russell/0000-0002-1382-8486	NIBIB [R01 EB008281, R01 EB008432]; NIA; National Library of Medicine [AG016570, AG040060, EB01651, MH097268, LM05639]; NINDS [R01 NS076794]; NIH [R01 AG034499-05]; NIH Institutes [R01 EB008432, U54 EB020403]; NIH/NINDS [5R01NS076794-05]; NIMH; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000993, U54EB020403, R01EB008281, P41EB015922, R01EB008432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH097268] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG016570, R01AG040060, RF1AG041915, R01AG034499] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [R01LM005639] Funding Source: NIH RePORTER	NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Institutes(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Algorithm development and image analysis for this study were funded, in part, by grants to PT from the NIBIB (R01 EB008281, R01 EB008432) and by the NIA, NIBIB, NIMH, and the National Library of Medicine (AG016570, AG040060, EB01651, MH097268, LM05639 to PT) and by an NINDS grant to TT (R01 NS076794). Data collection and sharing for this project was funded by NIH Grant R01 AG034499-05. NIBIB & the Beckman Institute at Caltech provided essential support for the scanner & personnel (NIBIB EB000993). This work was also supported in part by a Consortium grant (U54 EB020403) from the NIH Institutes contributing to the Big Data to Knowledge (BD2K) Initiative and R01 EB008432. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Algorithm development and image analysis for this study were funded, in part, by grants to PT from the NIBIB (R01 EB008281, R01 EB008432) and by the NIA, NIBIB, NIMH, and the National Library of Medicine (AG016570, AG040060, EB01651, MH097268, LM05639 to PT) and by an NINDS grant to TT (R01 NS076794). Data collection and sharing for this project was funded by NIH Grant R01 AG034499-05. NIBIB & the Beckman Institute at Caltech provided essential support for the scanner & personnel (NIBIB EB000993). TT and TMW were supported by an NIH/NINDS grant (5R01NS076794-05). This work was also supported in part by a Consortium grant (U54 EB020403) from the NIH Institutes contributing to the Big Data to Knowledge (BD2K) Initiative and R01 EB008432.	Aganj I, 2011, MED IMAGE ANAL, V15, P414, DOI 10.1016/j.media.2011.01.003; Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Alomair OI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130133; Barazany D, 2009, BRAIN, V132, P1210, DOI 10.1093/brain/awp042; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benveniste H, 2000, NEUROIMAGE, V11, P601, DOI 10.1006/nimg.2000.0567; Caruyer Emmanuel, 2013, Magn Reson Med, V69, P1534, DOI 10.1002/mrm.24736; Cohen RM, 2013, J NEUROSCI, V33, P6245, DOI 10.1523/JNEUROSCI.3672-12.2013; Daianu M, 2016, INT SOC OPT IN PRESS; Daianu M., 2015, LECT NOTES IN PRESS; Daianu M, 2015, INT SOC OPTICS PHOTO, V9413; Daianu M., 2015, BRAIN IMAGI IN PRESS; Daianu M, 2015, HUM BRAIN MAPP, V36, P3087, DOI 10.1002/hbm.22830; Daianu M, 2013, BRAIN CONNECT, V3, P407, DOI 10.1089/brain.2012.0137; Davoodi-Bojd E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095921; DeLano MC, 2000, AM J NEURORADIOL, V21, P1830; Descoteaux M, 2007, MAGN RESON MED, V58, P497, DOI 10.1002/mrm.21277; Descoteaux M, 2011, MED IMAGE ANAL, V15, P603, DOI 10.1016/j.media.2010.07.001; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; Duarte-Carvajalino JM, 2014, MAGN RESON MED, V72, P1471, DOI 10.1002/mrm.25046; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Khachaturian MH, 2007, MAGN RESON MED, V57, P289, DOI 10.1002/mrm.21090; Leow A, 2005, LECT NOTES COMPUT SC, V3565, P493; Nir T. M., 2015, MED IMAGE C IN PRESS; Nir TM, 2013, NEUROIMAGE-CLIN, V3, P180, DOI 10.1016/j.nicl.2013.07.006; Setsompop K, 2013, NEUROIMAGE, V80, P220, DOI 10.1016/j.neuroimage.2013.05.078; Thomas C, 2014, P NATL ACAD SCI USA, V111, P16574, DOI 10.1073/pnas.1405672111; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Tuch DS, 2004, MAGN RESON MED, V52, P1358, DOI 10.1002/mrm.20279; Van Essen DC, 2012, NEUROIMAGE, V62, P2222, DOI 10.1016/j.neuroimage.2012.02.018; Van Hecke W, 2010, HUM BRAIN MAPP, V31, P98, DOI 10.1002/hbm.20848; Villalon-Reina JE, 2015, MED IMAGE C IN PRESS; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Wedeen VJ, 2012, SCIENCE, V335, P1628, DOI 10.1126/science.1215280; Weiner HL, 2002, NATURE, V420, P879, DOI 10.1038/nature01325; Wu YC, 2008, IEEE T MED IMAGING, V27, P858, DOI 10.1109/TMI.2008.922696; Wu YC, 2007, NEUROIMAGE, V36, P617, DOI 10.1016/j.neuroimage.2007.02.050; Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713; Yeh FC, 2011, NEUROIMAGE, V55, P1054, DOI 10.1016/j.neuroimage.2010.11.087; Zhan L, 2011, I S BIOMED IMAGING, P305, DOI 10.1109/ISBI.2011.5872411	41	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145205	10.1371/journal.pone.0145205	http://dx.doi.org/10.1371/journal.pone.0145205			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683657	gold, Green Published, Green Accepted, Green Submitted			2022-12-26	WOS:000366725800046
J	Griffin, RH; Yapuncich, GS				Griffin, Randi H.; Yapuncich, Gabriel S.			The Independent Evolution Method Is Not a Viable Phylogenetic Comparative Method	PLOS ONE			English	Article							ORNSTEIN-UHLENBECK MODELS; STABILIZING SELECTION; ADAPTIVE EVOLUTION; PLANUM TEMPORALE; SIZE DIMORPHISM; FOOD HABITS; ASYMMETRY; TREES; CHARACTERS; MORPHOLOGY	Phylogenetic comparative methods (PCMs) use data on species traits and phylogenetic relationships to shed light on evolutionary questions. Recently, Smaers and Vinicius suggested a new PCM, Independent Evolution (IE), which purportedly employs a novel model of evolution based on Felsenstein's Adaptive Peak Model. The authors found that IE improves upon previous PCMs by producing more accurate estimates of ancestral states, as well as separate estimates of evolutionary rates for each branch of a phylogenetic tree. Here, we document substantial theoretical and computational issues with IE. When data are simulated under a simple Brownian motion model of evolution, IE produces severely biased estimates of ancestral states and changes along individual branches. We show that these branch-specific changes are essentially ancestor-descendant or "directional" contrasts, and draw parallels between IE and previous PCMs such as "minimum evolution". Additionally, while comparisons of branch-specific changes between variables have been interpreted as reflecting the relative strength of selection on those traits, we demonstrate through simulations that regressing IE estimated branch-specific changes against one another gives a biased estimate of the scaling relationship between these variables, and provides no advantages or insights beyond established PCMs such as phylogenetically independent contrasts. In light of our findings, we discuss the results of previous papers that employed IE. We conclude that Independent Evolution is not a viable PCM, and should not be used in comparative analyses.	[Griffin, Randi H.; Yapuncich, Gabriel S.] Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA	Duke University	Griffin, RH (corresponding author), Duke Univ, Dept Evolutionary Anthropol, Durham, NC 27708 USA.	randi.griffin@duke.edu; gabriel.yapuncich@duke.edu	Yapuncich, Gabriel/AAC-8197-2019	Yapuncich, Gabriel/0000-0001-7371-5857				[Anonymous], 2014, R LANG ENV STAT COMP; Arnold C, 2010, EVOL ANTHROPOL, V19, P114, DOI 10.1002/evan.20251; Beaulieu JM, 2012, EVOLUTION, V66, P2369, DOI 10.1111/j.1558-5646.2012.01619.x; BURTON AM, 1994, J ZOOL, V232, P525, DOI 10.1111/j.1469-7998.1994.tb00001.x; Butler MA, 2004, AM NAT, V164, P683, DOI 10.1086/426002; Carrano MT, 2000, PALEOBIOLOGY, V26, P489, DOI 10.1666/0094-8373(2000)026<0489:HATEOD>2.0.CO;2; Cavalli-Sforza LL, 1964, EVOLUTION, V22, P550; EARHART CM, 1970, CONDOR, V72, P251, DOI 10.2307/1366002; Eastman JM, 2011, EVOLUTION, V65, P3578, DOI 10.1111/j.1558-5646.2011.01401.x; FARRIS JS, 1970, SYST ZOOL, V19, P83, DOI 10.2307/2412028; FARRIS JS, 1972, AM NAT, V106, P645, DOI 10.1086/282802; FELSENSTEIN J, 1988, ANNU REV ECOL SYST, V19, P445, DOI 10.1146/annurev.es.19.110188.002305; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; GALABURDA AM, 1987, NEUROPSYCHOLOGIA, V25, P853, DOI 10.1016/0028-3932(87)90091-1; Garamszegi, 2014, MODERN PHYLOGENETIC, P553; Garland T, 2005, J EXP BIOL, V208, P3015, DOI 10.1242/jeb.01745; GARLAND T, 1992, SYST BIOL, V41, P18, DOI 10.2307/2992503; GARLAND T, 1991, EVOLUTION, V45, P1969, DOI 10.1111/j.1558-5646.1991.tb02703.x; Gingerich PD, 2000, J THEOR BIOL, V204, P201, DOI 10.1006/jtbi.2000.2008; Goswami A, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0254; GOULD SJ, 1971, AM NAT, V105, P113, DOI 10.1086/282710; GOULD SJ, 1966, BIOL REV, V41, P587, DOI 10.1111/j.1469-185X.1966.tb01624.x; Griffin RH, 2015, EVALUATING LEGITIMAC; Hansen TF, 1997, EVOLUTION, V51, P1341, DOI 10.1111/j.1558-5646.1997.tb01457.x; Hansen TF, 2008, EVOLUTION, V62, P1965, DOI 10.1111/j.1558-5646.2008.00412.x; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Ho LST, 2014, METHODS ECOL EVOL, V5, P1133, DOI 10.1111/2041-210X.12285; HUEY RB, 1987, EVOLUTION, V41, P1098, DOI 10.1111/j.1558-5646.1987.tb05879.x; Ingram T, 2013, METHODS ECOL EVOL, V4, P416, DOI 10.1111/2041-210X.12034; Jombart T., 2008, ADEPHYLO EXPLORATORY; Jones KE, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0285-5; Kivell TL, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-229; Laurin M, 2010, SYST BIOL, V59, P689, DOI 10.1093/sysbio/syq059; LOSOS JB, 1990, ANIM BEHAV, V39, P879, DOI 10.1016/S0003-3472(05)80952-2; MADDISON WP, 1991, SYST ZOOL, V40, P304, DOI 10.2307/2992324; MARTINS EP, 1991, EVOLUTION, V45, P534, DOI [10.2307/2409910, 10.1111/j.1558-5646.1991.tb04328.x]; Mays S, 1999, INT J OSTEOARCHAEOL, V9, P18, DOI 10.1002/(SICI)1099-1212(199901/02)9:1<18::AID-OA455>3.0.CO;2-A; Nunn C. L., 2011, COMP APPROACH EVOLUT; O'Meara BC, 2012, ANNU REV ECOL EVOL S, V43, P267, DOI 10.1146/annurev-ecolsys-110411-160331; Pagel M, 1997, ZOOL SCR, V26, P331, DOI 10.1111/j.1463-6409.1997.tb00423.x; PAGEL M, 1993, J THEOR BIOL, V164, P191, DOI 10.1006/jtbi.1993.1148; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Plochocki JH, 2002, INT J OSTEOARCHAEOL, V12, P349, DOI 10.1002/oa.633; Portner HO, 2008, SCIENCE, V322, P690, DOI 10.1126/science.1163156; Rabosky DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089543; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Rezende EL, 2012, COMPR PHYSIOL, V2, P639, DOI 10.1002/cphy.c100079; Royer-Carenzi M, 2013, MATH BIOSCI, V242, P95, DOI 10.1016/j.mbs.2012.12.003; Smaers JB, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0269; Smaers JB, 2013, ANN NY ACAD SCI, V1822, P59; Smaers JB, 2015, EVOMAP R PACKAGE EVO; Smaers JB, 2012, P NATL ACAD SCI USA, V109, P18006, DOI 10.1073/pnas.1212181109; Smaers JB, 2011, ANN NY ACAD SCI, V1225, P176, DOI 10.1111/j.1749-6632.2011.06003.x; Smaers JB, 2009, EVOL ECOL RES, V11, P991; Smith RJ, 1999, J HUM EVOL, V36, P423, DOI 10.1006/jhev.1998.0281; Sokal RR, 1995, BIOMETRY; Steinmetz H, 1996, NEUROSCI BIOBEHAV R, V20, P587, DOI 10.1016/0149-7634(95)00071-2; STORER RW, 1966, AUK, V83, P423, DOI 10.2307/4083053; Thomas G.H., 2014, BIAS MEASUREMENT ERR, DOI [10.1101/004036, DOI 10.1101/004036]; Thomas GH, 2012, METHODS ECOL EVOL, V3, P145, DOI 10.1111/j.2041-210X.2011.00132.x; Tsegai ZJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078781; Uyeda JC, 2014, SYST BIOL, V63, P902, DOI 10.1093/sysbio/syu057; VANVALEN L, 1962, EVOLUTION, V16, P125; Webster AJ, 2004, J EVOLUTION BIOL, V17, P396, DOI 10.1046/j.1420-9101.2003.00664.x; WHEELER WC, 1993, MOL BIOL EVOL, V10, P707; Yapuncich GS, 2015, AM J PHYS ANTHROPOL, V157, P472, DOI 10.1002/ajpa.22735	66	2	2	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144147	10.1371/journal.pone.0144147	http://dx.doi.org/10.1371/journal.pone.0144147			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683838	Green Published, Green Submitted, gold			2022-12-26	WOS:000366725800011
J	Wallrabenstein, I; Singer, M; Panten, J; Hatt, H; Gisselmann, G				Wallrabenstein, Ivonne; Singer, Marco; Panten, Johannes; Hatt, Hanns; Gisselmann, Guenter			Timberol (R) Inhibits TAAR5-Mediated Responses to Trimethylamine and Influences the Olfactory Threshold in Humans	PLOS ONE			English	Article							AMINE-ASSOCIATED RECEPTORS; MAMMALIAN ODORANT RECEPTORS; FUNCTIONAL EXPRESSION; GENETIC-VARIATION; MENSTRUATION; ACTIVATION; SUBSYSTEM; CELLS	In mice, trace amine-associated receptors (TAARs) are interspersed in the olfactory epithelium and constitute a chemosensory subsystem that is highly specific for detecting volatile amines. Humans possess six putative functional TAAR genes. Human TAAR5 (hTAAR5) is highly expressed in the olfactory mucosa and was shown to be specifically activated by trimethylamine. In this study, we were challenged to uncover an effective blocker substance for trimethylamine-induced hTAAR5 activation. To monitor blocking effects, we recombinantly expressed hTAAR5 and employed a commonly used Cre-luciferase reporter gene assay. Among all tested potential blocker substances, Timberol (R), an amber-woody fragrance, is able to inhibit the trimethylamine-induced hTAAR5 activation up to 96%. Moreover, human psychophysical data showed that the presence of Timberol (R) increases the olfactory detection threshold for the characteristic fishy odor of trimethylamine by almost one order of magnitude. In conclusion, our results show that among tested receptors Timberol (R) is a specific and potent antagonist for the hTAAR5-mediated response to trimethylamine in a heterologous system. Furthermore, our data concerning the observed shift of the olfactory detection threshold in vivo implicate that hTAAR5 or other receptors that may be inhibited by Timberol (R) could be involved in the high affinity olfactory perception of trimethylamine in humans.	[Wallrabenstein, Ivonne; Hatt, Hanns; Gisselmann, Guenter] Ruhr Univ Bochum, Dept Cell Physiol, Bochum, Germany; [Singer, Marco; Panten, Johannes] Symrise AG, Holzminden, Germany	Ruhr University Bochum; Symrise	Gisselmann, G (corresponding author), Ruhr Univ Bochum, Dept Cell Physiol, Univ Str 150, Bochum, Germany.	Guenter.Gisselmann@rub.de			Deutsche Forschungsgemeinschaft [SFB642, SPP1932]; Symrise AG	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Symrise AG	Supported by the grants SFB642 and SPP1932 by Deutsche Forschungsgemeinschaft (www.dfg.de). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Symrise AG provided support in the form of salaries for authors MS and JP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Amoore JE, 1976, J CHEM ECOL, V2, P49, DOI 10.1007/BF00988023; Carnicelli V, 2010, CHEMOSENS PERCEPT, V3, P99, DOI 10.1007/s12078-010-9075-z; Ferrero DM, 2012, ACS CHEM BIOL, V7, P1184, DOI 10.1021/cb300111e; Gram L, 2002, CURR OPIN BIOTECH, V13, P262, DOI 10.1016/S0958-1669(02)00309-9; Horowitz LF, 2014, J NEUROSCI, V34, P12241, DOI 10.1523/JNEUROSCI.1779-14.2014; Hukkanen J, 2005, BRIT J CLIN PHARMACO, V60, P224, DOI 10.1111/j.1365-2125.2005.02406.x; Jacquier V, 2006, J NEUROCHEM, V97, P537, DOI 10.1111/j.1471-4159.2006.03771.x; Jaeger SR, 2013, CURR BIOL, V23, P1601, DOI 10.1016/j.cub.2013.07.030; Johnson MA, 2012, P NATL ACAD SCI USA, V109, P13410, DOI 10.1073/pnas.1206724109; Keller A, 2007, NATURE, V449, P468, DOI 10.1038/nature06162; Li Q, 2013, CURR BIOL, V23, P11, DOI 10.1016/j.cub.2012.10.047; Li YR, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001230; Liberles SD, 2006, NATURE, V442, P645, DOI 10.1038/nature05066; Liberles SD, 2009, ANN NY ACAD SCI, V1170, P168, DOI 10.1111/j.1749-6632.2009.04014.x; Lindemann L, 2005, GENOMICS, V85, P372, DOI 10.1016/j.ygeno.2004.11.010; Malnic B, 1999, CELL, V96, P713, DOI 10.1016/S0092-8674(00)80581-4; Mcrae JF, 2012, CHEM SENSES, V37, P585, DOI 10.1093/chemse/bjs049; Menashe I, 2007, PLOS BIOL, V5, P2462, DOI 10.1371/journal.pbio.0050284; Mitchell SC, 2001, DRUG METAB DISPOS, V29, P517; Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096; Oka Y, 2004, EMBO J, V23, P120, DOI 10.1038/sj.emboj.7600032; Pacifico R, 2012, CELL REP, V2, P76, DOI 10.1016/j.celrep.2012.06.006; Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021; Shimizu M, 2007, BMC MED GENET, V8, DOI 10.1186/1471-2350-8-2; Shirasu M, 2011, J BIOCHEM, V150, P257, DOI 10.1093/jb/mvr090; Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376; Treacy EP, 1998, HUM MOL GENET, V7, P839, DOI 10.1093/hmg/7.5.839; Vallender EJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-51; Wallrabenstein I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054950; Wolrath H, 2002, APMIS, V110, P819, DOI 10.1034/j.1600-0463.2002.1101108.x; Zhang AQ, 1996, LANCET, V348, P1740, DOI 10.1016/S0140-6736(05)65872-2; Zhang JJ, 2013, J NEUROSCI, V33, P3228, DOI 10.1523/JNEUROSCI.4299-12.2013; Zhuang H, 2008, NAT PROTOC, V3, P1402, DOI 10.1038/nprot.2008.120; Zhuang HY, 2007, J BIOL CHEM, V282, P15284, DOI 10.1074/jbc.M700386200; Zschocke J, 1999, LANCET, V354, P834	35	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144704	10.1371/journal.pone.0144704	http://dx.doi.org/10.1371/journal.pone.0144704			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684881	Green Published, Green Submitted, gold			2022-12-26	WOS:000366725800019
J	Moreno, E; Perez-Gonzalez, J; Carranza, J; Moya-Larano, J				Moreno, Eulalia; Perez-Gonzalez, Javier; Carranza, Juan; Moya-Larano, Jordi			Better Fitness in Captive Cuvier's Gazelle despite Inbreeding Increase: Evidence of Purging?	PLOS ONE			English	Article							GENETIC LOAD; DELETERIOUS MUTATIONS; SPECIES CONSERVATION; ENDANGERED UNGULATE; DEPRESSION; MICROSATELLITES; POPULATIONS; SIZE; PROGRAMS; SURVIVAL	Captive breeding of endangered species often aims at preserving genetic diversity and to avoid the harmful effects of inbreeding. However, deleterious alleles causing inbreeding depression can be purged when inbreeding persists over several generations. Despite its great importance both for evolutionary biology and for captive breeding programmes, few studies have addressed whether and to which extent purging may occur. Here we undertake a longitudinal study with the largest captive population of Cuvier's gazelle managed under a European Endangered Species Programme since 1975. Previous results in this population have shown that highly inbred mothers tend to produce more daughters, and this fact was used in 2006 to reach a more appropriate sex-ratio in this polygynous species by changing the pairing strategy (i.e., pairing some inbred females instead of keeping them as surplus individuals in the population). Here, by using studbook data we explore whether purging has occurred in the population by investigating whether after the change in pairing strategy a) inbreeding and homozygosity increased at the population level, b) fitness (survival) increased, and c) the relationship between inbreeding and juvenile survival, was positive. Consistent with the existence of purging, we found an increase in inbreeding coefficients, homozygosity and juvenile survival. In addition, we showed that in the course of the breeding programme the relationship between inbreeding and juvenile survival was not uniform but rather changed over time: it was negative in the early years, flat in the middle years and positive after the change in pairing strategy. We highlight that by allowing inbred individuals to mate in captive stocks we may favour sex-ratio bias towards females, a desirable managing strategy to reduce the surplus of males that force most zoos to use ethical culling and euthanizing management tools. We discuss these possibilities but also acknowledge that many other effects should be considered before implementing inbreeding and purging as elements in management decisions.	[Moreno, Eulalia; Moya-Larano, Jordi] Estn Expt Zonas Aridas CSIC, Dept Ecol Func & Evolut, Ctra Sacramento S-N, E-04120 La Canada De San Urbano, Almeria, Spain; [Perez-Gonzalez, Javier; Carranza, Juan] Univ Cordoba, Ungulate Res Unit, Catedra Recursos Cineget & Piscicolas, E-14071 Cordoba, Spain; [Perez-Gonzalez, Javier] Mancomunidad Integral Municipios Ctr, Guarderia Rural, E-06810 Badajoz, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental de Zonas Aridas (EEZA); Universidad de Cordoba	Moreno, E (corresponding author), Estn Expt Zonas Aridas CSIC, Dept Ecol Func & Evolut, Ctra Sacramento S-N, E-04120 La Canada De San Urbano, Almeria, Spain.	emoreno@eeza.csic.es	Moreno, Eulalia/D-4230-2014; Carranza, Juan/E-4472-2010; Pérez-González, Javier/AAF-6106-2020; Moya-Laraño, Jordi/K-8596-2014	Moreno, Eulalia/0000-0002-7197-5679; Moya-Laraño, Jordi/0000-0001-7141-3206; Perez-Gonzalez, Javier/0000-0003-0624-835X	Spanish Ministry of Science and Innovation [GCL 2008-00562/BOS, CGL2010-17163]; European Regional Development Fund	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund(European Commission)	This work was partly funded by the Spanish Ministry of Science and Innovation under Projects GCL 2008-00562/BOS to EM and CGL2010-17163 to JC, and by the European Regional Development Fund.	ALADOS CL, 1991, J ZOOL, V223, P307, DOI 10.1111/j.1469-7998.1991.tb04767.x; BARRETT SCH, 1991, NATURE, V352, P522, DOI 10.1038/352522a0; Belkhir K, 2004, GENETIX 4 05 LOGICIE; Beudels RC, 2005, SAHELO SAHARAN ANTEL, P57; Bijlsma R, 1999, J EVOLUTION BIOL, V12, P1125, DOI 10.1046/j.1420-9101.1999.00113.x; BISHOP MD, 1994, GENETICS, V136, P619; Boakes EH, 2007, HEREDITY, V98, P172, DOI 10.1038/sj.hdy.6800923; Buchanan F. C., 1993, Animal Genetics, V24, P145, DOI 10.1111/j.1365-2052.1993.tb00269.x; Cassinello J, 2005, BIOL CONSERV, V122, P453, DOI 10.1016/j.biocon.2004.09.006; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.es.18.110187.001321; CHARLESWORTH D, 1990, EVOLUTION, V44, P1469, DOI 10.1111/j.1558-5646.1990.tb03839.x; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; Coulson TN, 1998, P ROY SOC B-BIOL SCI, V265, P489, DOI 10.1098/rspb.1998.0321; Crnokrak P, 2002, EVOLUTION, V56, P2347, DOI 10.1111/j.0014-3820.2002.tb00160.x; Crnokrak P, 1999, HEREDITY, V83, P260, DOI 10.1038/sj.hdy.6885530; Crow James F., 1993, Oxford Surveys in Evolutionary Biology, V9, P3; Darwin CR, 1876, EFFECTS CROSS SELF F; EDE AJ, 1995, ANIM GENET, V26, P129, DOI 10.1111/j.1365-2052.1995.tb02655.x; Espeso G, 2012, INT CUVIERS GAZELLE; Fair MD, 2012, S AFR J ANIM SCI, V42, P114, DOI 10.4314/sajas.v42i2.3; Falconer D. S., 1996, INTRO QUANTITATIVE G; Fox CW, 2008, EVOLUTION, V62, P2236, DOI 10.1111/j.1558-5646.2008.00441.x; Fox CW, 2011, EVOLUTION, V65, P246, DOI 10.1111/j.1558-5646.2010.01108.x; Fox John, 2003, J STAT SOFTW, V8, P1, DOI [10.18637/jss.v008.i15, DOI 10.18637/JSS.V008.I15]; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Frankham R, 2008, MOL ECOL, V17, P325, DOI 10.1111/j.1365-294X.2007.03399.x; Fredrickson R, 2002, ANIM CONSERV, V5, P39, DOI 10.1017/S1367943002001051; Glemin S, 2003, EVOLUTION, V57, P2678; Gonzalez-Recio O, 2007, J DAIRY SCI, V90, P5744, DOI 10.3168/jds.2007-0203; GROSSE WM, 1995, ANIM GENET, V26, P126, DOI 10.1111/j.1365-2052.1995.tb02652.x; Gutierrez JP, 2008, GENET SEL EVOL, V40, P359, DOI 10.1051/gse:2008008; Hedrick PW, 2002, EVOLUTION, V56, P654; Hedrick PW, 1997, ZOO BIOL, V16, P47, DOI 10.1002/(SICI)1098-2361(1997)16:1<47::AID-ZOO7>3.0.CO;2-B; HEDRICK PW, 1994, HEREDITY, V73, P363, DOI 10.1038/hdy.1994.183; Ibanez B, 2013, ANIM CONSERV, V16, P108, DOI 10.1111/j.1469-1795.2012.00580.x; Ibanez B, 2014, ECOL EVOL, V4, P4117, DOI 10.1002/ece3.1280; Ibanez B, 2011, MAMM BIOL, V76, P748, DOI 10.1016/j.mambio.2011.04.002; ISIS, 2004, INT SPEC INF SYST SP; Jamieson IG, 2006, CONSERV BIOL, V20, P38, DOI 10.1111/j.1523-1739.2005.00282.x; Johnstone-Yellin TL, 2009, J MAMMAL, V90, P453, DOI 10.1644/08-MAMM-A-030.1; Joron M, 2003, NATURE, V424, P191, DOI 10.1038/nature01713; Ruiz-Lopez MJ, 2010, P ROY SOC B-BIOL SCI, V277, P2541, DOI 10.1098/rspb.2010.0333; Kalinowski ST, 1999, CONSERV BIOL, V13, P1371, DOI 10.1046/j.1523-1739.1999.98346.x; Lacy Robert, 1995, P187; Lacy RC, 2012, METHODS ECOL EVOL, V3, P433, DOI 10.1111/j.2041-210X.2011.00148.x; Larsen LK, 2011, J EVOLUTION BIOL, V24, P823, DOI 10.1111/j.1420-9101.2010.02224.x; Leberg PL, 2008, MOL ECOL, V17, P334, DOI 10.1111/j.1365-294X.2007.03433.x; Legendre P., 2012, NUMERICAL ECOLOGY; MITTON JB, 1993, HEREDITY, V71, P59, DOI 10.1038/hdy.1993.107; MOMMENS G, 1994, ANIM GENET, V25, P368, DOI 10.1111/j.1365-2052.1994.tb00381.x; MOORE SS, 1994, MAMM GENOME, V5, P84, DOI 10.1007/BF00292333; Moreno E, 2006, P 23 EAZA ANN C MADR; Moreno E, 2008, INT STUDBOOK CUVIER; Moreno E, 2011, J NAT CONSERV, V19, P148, DOI 10.1016/j.jnc.2010.10.004; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Ogilby WM, 1841, P ZOOL SOC, V1836-1840, P34; OHTA T, 1974, GENET RES, V23, P191, DOI 10.1017/S0016672300014816; Pekkala N, 2012, ECOL EVOL, V2, P1791, DOI 10.1002/ece3.293; Pelletier F, 2009, TRENDS ECOL EVOL, V24, P263, DOI 10.1016/j.tree.2008.11.013; Penfold LM, 2014, ZOO BIOL, V33, P20, DOI 10.1002/zoo.21104; R Core Team, 2013, R LANG ENV STAT COMP; Ralls K, 1983, GENETICS CONSERVATIO, P164; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reed DH, 2000, ANIM CONSERV, V3, P7, DOI 10.1017/S136794300000069X; Reid JM, 2006, AM NAT, V168, P1, DOI 10.1086/504852; Robert A, 2009, BIOL CONSERV, V142, P2915, DOI 10.1016/j.biocon.2009.07.016; Robertson BC, 2006, BIOL LETTERS, V2, P229, DOI 10.1098/rsbl.2005.0430; Roff DA, 2002, EVOLUTION, V56, P768, DOI 10.1111/j.0014-3820.2002.tb01387.x; Roldan ERS, 1998, P ROY SOC B-BIOL SCI, V265, P243, DOI 10.1098/rspb.1998.0288; Steck B, 2014, LESSER KUDU EUROPEAN; STEFFEN P, 1993, ANIM GENET, V24, P121, DOI 10.1111/j.1365-2052.1993.tb00252.x; Tella JL, 2001, TRENDS ECOL EVOL, V16, P76, DOI 10.1016/S0169-5347(00)02075-9; TEMPLETON AR, 1984, ZOO BIOL, V3, P177, DOI 10.1002/zoo.1430030302; TEMPLETON AR, 1987, ZOO BIOL, V6, P305, DOI 10.1002/zoo.1430060405; Templeton AR, 1983, GENETICS CONSERVATIO, P241; van Oosterhout C, 2003, J EVOLUTION BIOL, V16, P273, DOI 10.1046/j.1420-9101.2003.00511.x; Wang JL, 2000, GENET RES, V76, P75, DOI 10.1017/S0016672399004450; Wilcken J, 1998, MANAGING ZOO POPULAT; Wright S., 1969, THEORY GENE FREQUENC, V2, P520; Xue YL, 2015, SCIENCE, V348, P242, DOI 10.1126/science.aaa3952; Zschokke S, 2002, CAN J ZOOL, V80, P2014, DOI [10.1139/z02-183, 10.1139/Z02-183]	82	13	13	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145111	10.1371/journal.pone.0145111	http://dx.doi.org/10.1371/journal.pone.0145111			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26679703	Green Submitted, Green Published, gold			2022-12-26	WOS:000366723400049
J	Nusinovici, S; Madouasse, A; Hoch, T; Guatteo, R; Beaudeau, F				Nusinovici, Simon; Madouasse, Aurelien; Hoch, Thierry; Guatteo, Raphael; Beaudeau, Francois			Evaluation of Two PCR Tests for Coxiella burnetii Detection in Dairy Cattle Farms Using Latent Class Analysis	PLOS ONE			English	Article							Q-FEVER; CONDITIONAL DEPENDENCE; BAYESIAN-ANALYSIS; GOAT FARMS; ABSENCE; SAMPLES	Different tests performed on bulk tank milk samples (BTM) are available to determine the C. burnetii status of herds. However, these tests, which are based on the detection of either antibodies directed against C. burnetii (ELISA) or bacterial DNA (PCR), have limitations. A currently disease-free herd infected in the past may continue to test positive with ELISA due to the persistence of antibodies in animals that were infected and that subsequently cleared the infection. Infectious herds can also be misclassified using PCR because of the absence of bacteria in the BTM when the test is performed. Recently, PCR has been used for bacterial DNA detection in the farm environment, which constitutes the main reservoir of C. burnetii. The objectives of this study were to assess and compare the sensitivities and specificities of one commonly used PCR test in BTM (PCR BTM) and of a PCR applied to environmental samples (PCR DUST) in dairy cattle farms. BTM and dust samples were collected (using environmental swabs) in 95 herds. The evaluation of the performance of the 2 tests was conducted using latent class models accounting for within herd disease dynamics. Parameter estimation was carried out using MCMC, within a Bayesian framework. Two types of priors were used for the specificity of PCR DUST. A model with a uniform prior on 0-1 fitted the data better than a model with a uniform prior on 0.95-1. With the best model PCR DUST had a lower sensitivity than PCR BTM (0.75 versus 0.83) and a specificity of 0.72. The moderately low value for the specificity of PCR DUST suggests that the presence of bacteria on farm is not always associated with persistent infections and shedding of bacteria in milk.	[Nusinovici, Simon; Madouasse, Aurelien; Hoch, Thierry; Guatteo, Raphael; Beaudeau, Francois] INRA, Biol Epidemiol & Risk Anal Anim Hlth UMR1300, CS 40706, F-44307 Nantes, France; [Nusinovici, Simon; Madouasse, Aurelien; Hoch, Thierry; Guatteo, Raphael; Beaudeau, Francois] LUNAM Univ, Oniris, UMR BioEpAR, CS 40706, F-44307 Nantes, France	INRAE; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique	Madouasse, A (corresponding author), INRA, Biol Epidemiol & Risk Anal Anim Hlth UMR1300, CS 40706, F-44307 Nantes, France.	aurelien.madouasse@oniris-nantes.fr	Hoch, Thierry/P-6980-2019; Hoch, Thierry/ACK-3000-2022; Madouasse, Aurélien/AAC-2814-2019	Madouasse, Aurélien/0000-0002-9254-5707; Hoch, Thierry/0000-0002-7916-1936	French Research Agency, program Investments for the future [ANR-10-BINF-07 (MIHMES)]; European fund for the regional development FEDER; Groupement de Defense Sanitaire de Bretagne	French Research Agency, program Investments for the future(French National Research Agency (ANR)); European fund for the regional development FEDER; Groupement de Defense Sanitaire de Bretagne	This work was supported by the French Research Agency, program Investments for the future, project ANR-10-BINF-07 (MIHMES), by the European fund for the regional development FEDER, and by the Groupement de Defense Sanitaire de Bretagne.; This work was supported by the French Research Agency, program Investments for the future, project ANR-10-BINF-07 (MIHMES), by the European fund for the regional development FEDER, and by the Groupement de Defense Sanitaire de Bretagne. The authors thank Jean-Yves Audiart for his outstanding contribution to the data collection process.	Agerholm JS, 2013, ACTA VET SCAND, V55, DOI 10.1186/1751-0147-55-13; Arricau-Bouvery N, 2005, VET RES, V36, P327, DOI 10.1051/vetres:2005010; Berri M, 2000, VET MICROBIOL, V72, P285, DOI 10.1016/S0378-1135(99)00178-9; Botner A, 2010, EFSA J, V8, DOI 10.2903/j.efsa.2010.1595; Collins J, 2014, STAT MED, V33, P4141, DOI 10.1002/sim.6218; de Bruin A, 2011, APPL ENVIRON MICROB, V77, P6516, DOI 10.1128/AEM.05097-11; Dendukuri N, 2001, BIOMETRICS, V57, P158, DOI 10.1111/j.0006-341X.2001.00158.x; Engel B, 2010, J AGR BIOL ENVIR ST, V15, P83, DOI 10.1007/s13253-009-0013-y; Gelman A, 2004, BIOMETRICS, V60, P407, DOI 10.1111/j.0006-341X.2004.00185.x; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; Guatteo R, 2007, VET RES, V38, P849, DOI 10.1051/vetres:2007038; Guatteo R, 2006, VET RES, V37, P827, DOI 10.1051/vetres:2006038; Hogerwerf L, 2012, APPL ENVIRON MICROB, V78, P5410, DOI 10.1128/AEM.00677-12; HUI SL, 1980, BIOMETRICS, V36, P167, DOI 10.2307/2530508; Jones G, 2010, BIOMETRICS, V66, P855, DOI 10.1111/j.1541-0420.2009.01330.x; Kersh GJ, 2013, APPL ENVIRON MICROB, V79, P1697, DOI 10.1128/AEM.03472-12; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Norris M, 2009, STAT INTERFACE, V2, P171; Raoult D, 2005, LANCET INFECT DIS, V5, P219, DOI 10.1016/S1473-3099(05)70052-9; Toft N, 2007, VET MICROBIOL, V120, P77, DOI 10.1016/j.vetmic.2006.10.025; VACEK PM, 1985, BIOMETRICS, V41, P959, DOI 10.2307/2530967; Wang C, 2011, J DAIRY SCI, V94, P2320, DOI 10.3168/jds.2010-3675	22	4	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144608	10.1371/journal.pone.0144608	http://dx.doi.org/10.1371/journal.pone.0144608			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673419	Green Published, gold, Green Submitted			2022-12-26	WOS:000366722700047
J	Apicella, A; Heunemann, P; Bolisetty, S; Marascio, M; Graf, AG; Garamszegi, L; Mezzenga, R; Fischer, P; Plummer, CJ; Manson, JA				Apicella, Alessandra; Heunemann, Peggy; Bolisetty, Sreenath; Marascio, Matteo; Graf, Anja Gemperli; Garamszegi, Laszlo; Mezzenga, Raffaele; Fischer, Peter; Plummer, Christopher J.; Manson, Jan-Anders			The Influence of Arginine on the Response of Enamel Matrix Derivative (EMD) Proteins to Thermal Stress: Towards Improving the Stability of EMD-Based Products	PLOS ONE			English	Article							HUMAN SERUM-ALBUMIN; IN-VITRO; AGGREGATION; AMELOGENIN; PH; SOLUBILIZATION; PURIFICATION; EQUILIBRIUM; PREVENTION	In a current procedure for periodontal tissue regeneration, enamel matrix derivative (EMD), which is the active component, is mixed with a propylene glycol alginate (PGA) gel carrier and applied directly to the periodontal defect. Exposure of EMD to physiological conditions then causes it to precipitate. However, environmental changes during manufacture and storage may result in modifications to the conformation of the EMD proteins, and eventually premature phase separation of the gel and a loss in therapeutic effectiveness. The present work relates to efforts to improve the stability of EMD-based formulations such as Emdogain (TM) through the incorporation of arginine, a well-known protein stabilizer, but one that to our knowledge has not so far been considered for this purpose. Representative EMD-buffer solutions with and without arginine were analyzed by 3D-dynamic light scattering, UV-Vis spectroscopy, transmission electron microscopy and Fourier transform infrared spectroscopy at different acidic pH and temperatures, T, in order to simulate the effect of pH variations and thermal stress during manufacture and storage. The results provided evidence that arginine may indeed stabilize EMD against irreversible aggregation with respect to variations in pH and T under these conditions. Moreover, stopped-flow transmittance measurements indicated arginine addition not to suppress precipitation of EMD from either the buffers or the PGA gel carrier when the pH was raised to 7, a fundamental requirement for dental applications.	[Apicella, Alessandra; Marascio, Matteo; Plummer, Christopher J.; Manson, Jan-Anders] Ecole Polytech Fed Lausanne, Lab Technol Composites & Polymeres LTC, CH-1015 Lausanne, Switzerland; [Heunemann, Peggy; Fischer, Peter] ETH, Inst Food Nutr & Hlth, Food Proc Engn, CH-8092 Zurich, Switzerland; [Bolisetty, Sreenath; Mezzenga, Raffaele] ETH, Inst Food Nutr & Hlth, Food & Soft Mat Sci, CH-8092 Zurich, Switzerland; [Graf, Anja Gemperli; Garamszegi, Laszlo] Inst Straumann AG, CH-4052 Basel, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Institut Straumann AG	Fischer, P (corresponding author), ETH, Inst Food Nutr & Hlth, Food Proc Engn, CH-8092 Zurich, Switzerland.	peter.fischer@hest.ethz.ch; christopher.plummer@epfl.ch	plummer, christopher JG/B-1599-2014; Fischer, Peter/A-8740-2011	Fischer, Peter/0000-0002-2992-5037	Competence Center of Materials Science and Technology; Institut Straumann AG	Competence Center of Materials Science and Technology; Institut Straumann AG	Financial support for the academic partners was provided by the Competence Center of Materials Science and Technology (http://www.ccmx.ch/home/). The funding body had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Institut Straumann AG provided support in the form of salaries for authors AGG and LG, and materials costs, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are given in the 'author contributions' section.	Aichmayer B, 2010, BIOMACROMOLECULES, V11, P369, DOI 10.1021/bm900983b; Apicella A, 2013, MRS SPRING M EXH SAN; Arakawa T, 2003, BIOCHEM BIOPH RES CO, V304, P148, DOI 10.1016/S0006-291X(03)00578-3; Baldwin RL, 1996, BIOPHYS J, V71, P2056, DOI 10.1016/S0006-3495(96)79404-3; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Barth A, 2010, TENSIDE SURFACT DET, V47, P300, DOI 10.3139/113.110081; Baynes BM, 2005, BIOCHEMISTRY-US, V44, P4919, DOI 10.1021/bi047528r; Beniash E, 2012, J DENT RES, V91, P967, DOI 10.1177/0022034512457371; Block ID, 2010, REV SCI INSTRUM, V81, DOI 10.1063/1.3518961; Bondos SE, 2003, ANAL BIOCHEM, V316, P223, DOI 10.1016/S0003-2697(03)00059-9; Cairo F, 2008, J CLIN PERIODONTOL, V35, P136, DOI 10.1111/j.1600-051X.2008.01267.x; Chiti Fabrizio, 2006, PROTEIN MISFOLDING A, P43; Clem DS, 2011, INSIDE DENT, V7; Creighton T. E., 1993, PROTEINS STRUCTURES; Daneshegar P, 2012, J BRAZIL CHEM SOC, V23, P315, DOI 10.1590/S0103-50532012000200018; Dar TA, 2007, BIOPHYS CHEM, V127, P140, DOI 10.1016/j.bpc.2007.01.006; Das U, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001176; Fang PA, 2011, P NATL ACAD SCI USA, V108, P14097, DOI 10.1073/pnas.1106228108; Fang PA, 2011, CELLS TISSUES ORGANS, V194, P166, DOI 10.1159/000324250; Farruggia B, 1997, INT J BIOL MACROMOL, V20, P43, DOI 10.1016/S0141-8130(96)01150-6; FINCHAM AG, 1994, J STRUCT BIOL, V112, P103, DOI 10.1006/jsbi.1994.1011; Garamszegi L, 2012, Straumann Holding AG, Patent No. [WO2012049324 A2 (CA2801332A1, EP2566504A2, WO2012049324A3), 201204934]; Garamszegi L, 2013, Straumann Holding, Patent No. [US 20130210735 A1, 20130210735]; Gokarn YR, 2006, EXCIPIENT DEV PHARM, P291; Gorza FDS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/872701; Hofmann A, 2014, METHODS OF MOLECULAR ANALYSIS IN THE LIFE SCIENCES, P1, DOI 10.1017/CBO9781107045224; Kim W, 2006, P NATL ACAD SCI USA, V103, P15824, DOI 10.1073/pnas.0605629103; Lee SH, 2006, PROTEIN SCI, V15, P304, DOI 10.1110/ps.051813506; Lossdorfer S, 2007, J DENT RES, V86, P980, DOI 10.1177/154405910708601012; Maciel RRG, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/461365; Margolis HC, 2006, J DENT RES, V85, P775, DOI 10.1177/154405910608500902; Melo A, 1999, J MOL STRUC-THEOCHEM, V463, P81, DOI 10.1016/S0166-1280(98)00396-0; Melo EP, 1997, J BIOCHEM BIOPH METH, V34, P45; Mezzenga R, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/4/046601; Moradian-Oldak J, 2000, J STRUCT BIOL, V131, P27, DOI 10.1006/jsbi.2000.4237; Moradian-Oldak J, 2001, MATRIX BIOL, V20, P293, DOI 10.1016/S0945-053X(01)00154-8; Nakakido M, 2009, CURR PHARM BIOTECHNO, V10, P415, DOI 10.2174/138920109788488824; Petrou Irene, 2009, J Clin Dent, V20, P23; Poklar N, 2000, J CHEM EDUC, V77, P380, DOI 10.1021/ed077p380; RENUGOPALAKRISHNAN V, 1986, BIOCHEMISTRY-US, V25, P4879, DOI 10.1021/bi00365a023; Shah D, 2011, BIOTECHNOL PROGR, V27, P513, DOI 10.1002/btpr.563; Shiraki K, 2002, J BIOCHEM, V132, P591, DOI 10.1093/oxfordjournals.jbchem.a003261; Stout BM, 2014, J PERIODONTOL, V85, pE9, DOI 10.1902/jop.2013.130264; Thomas B, 2004, DUNN SCH PATHOLOGY C; Trombelli L, 2008, J CLIN PERIODONTOL, V35, P117, DOI 10.1111/j.1600-051X.2008.01265.x; Tsumoto K, 2004, BIOTECHNOL PROGR, V20, P1301, DOI 10.1021/bp0498793; Venezia E, 2004, CRIT REV ORAL BIOL M, V15, P382, DOI 10.1177/154411130401500605; Wennstrom JL, 2002, J CLIN PERIODONTOL, V29, P9, DOI 10.1034/j.1600-051x.2002.290102.x; Wiedemann-Bidlack FB, 2007, J STRUCT BIOL, V160, P57, DOI 10.1016/j.jsb.2007.06.007	49	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144641	10.1371/journal.pone.0144641	http://dx.doi.org/10.1371/journal.pone.0144641			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670810	Green Published, Green Submitted, gold			2022-12-26	WOS:000366719300014
J	Grimaldi, A; Parada, C; Chai, Y				Grimaldi, Alexandre; Parada, Carolina; Chai, Yang			A Comprehensive Study of Soft Palate Development in Mice	PLOS ONE			English	Article							CRANIAL NEURAL CREST; LEVATOR VELI-PALATINI; CLEFT-PALATE; SUPERIOR CONSTRICTOR; MUSCLE DEVELOPMENT; PROGENITOR CELLS; INNERVATION; MECHANISMS; MYOGENESIS; GROWTH	Cleft palate is one of the most common congenital birth defects. Tremendous efforts have been made over the last decades towards understanding hard palate development. However, little is known about soft palate morphogenesis and myogenesis. Finding an appropriate surgical repair to restore physiological functions of the soft palate in patients with cleft palate is a major challenge for surgeons, and complete restoration is not always achievable. Here, we first analyzed the morphology, orientation and attachments of the four muscles of the murine soft palate and found that they are very similar to their counterparts in humans, validating the use of mus musculus as a model for future studies. Our data suggests that muscle differentiation extends from the lateral region to the midline following palatal fusion. We also detected an epithelial seam in the fusing soft palatal shelves, consistent with the process of fusion of the posterior palatal shelves, followed by degradation of the epithelial remnants. Innervation and vascularization are present mainly in the oral side of the soft palate, complementing the differentiated muscles. Cell lineage tracing using Wnt1-Cre; Zsgreen(fl/fl) mice indicated that all the tendons and mesenchyme embedding the soft palate muscles are neural crest-derived. We propose that the posterior attachment of the soft palate to the pharyngeal wall is an interface between the neural crest-and mesoderm-derived mesenchyme in the craniofacial region, and thus can serve as a potential model for the study of boundaries during development. Taken together, our study provides a comprehensive view of the development and morphology of the murine soft palate and serves as a reference for further molecular analyses.	[Grimaldi, Alexandre; Parada, Carolina; Chai, Yang] Univ So Calif, Ctr Craniofacial Mol Biol, Herman Ostrow Sch Dent, Los Angeles, CA 90033 USA	University of Southern California	Chai, Y (corresponding author), Univ So Calif, Ctr Craniofacial Mol Biol, Herman Ostrow Sch Dent, 2250 Alcazar St, Los Angeles, CA 90033 USA.	ychai@usc.edu		Parada Borja, Carolina/0000-0003-2176-6729; GRIMALDI, Alexandre/0000-0002-5978-2057	National Institute of Dental and Craniofacial Research, NIH [R37 DE012711, U01 DE024421]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE012711, U01DE024421] Funding Source: NIH RePORTER	National Institute of Dental and Craniofacial Research, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This study was supported by a grant from the National Institute of Dental and Craniofacial Research (http://www.nidcr.nih.gov/), NIH R37 DE012711; U01 DE024421, to Yang Chai. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Julie Mayo and Bridget Samuels for critical reading of the manuscript, and Pedro Sanchez-Lara for discussing the clinical aspects of this work. This study was supported by grants from the National Institute of Dental and Craniofacial Research, NIH R37 DE012711; U01 DE024421, to Yang Chai.	Baggiolini A, 2015, CELL STEM CELL, V16, P314, DOI 10.1016/j.stem.2015.02.017; BURDI AR, 1967, AM J ANAT, V120, P149, DOI 10.1002/aja.1001200112; Bush JO, 2012, DEVELOPMENT, V139, P231, DOI 10.1242/dev.067082; Chai Y, 2000, DEVELOPMENT, V127, P1671; Chai Y, 2006, DEV DYNAM, V235, P2353, DOI 10.1002/dvdy.20833; Cho JH, 2013, LARYNGOSCOPE, V123, P2900, DOI 10.1002/lary.24067; COHEN SR, 1993, CLEFT PALATE-CRAN J, V30, P441, DOI 10.1597/1545-1569(1993)030<0441:SPMADF>2.3.CO;2; COHEN SR, 1994, CLEFT PALATE-CRAN J, V31, P345, DOI 10.1597/1545-1569(1994)031<0345:POAMIH>2.3.CO;2; COLEMAN RD, 1965, ANAT REC, V151, P107, DOI 10.1002/ar.1091510202; De la Cuadra Blanco Crotida, 2012, Cells Tissues Organs, V195, P392, DOI 10.1159/000329253; Eppig J, B6 CG TG WNT1 CRE 11; FERGUSON MWJ, 1988, DEVELOPMENT, V103, P41; FURUSAWA K, 1991, BRAIN RES BULL, V26, P599, DOI 10.1016/0361-9230(91)90101-O; Gart MS, 2014, CLIN PLAST SURG, V41, P253, DOI 10.1016/j.cps.2013.12.010; Han A, 2014, MOL CELL BIOL, V34, P3120, DOI 10.1128/MCB.00623-14; Hilliard SA, 2005, J ANAT, V207, P655, DOI 10.1111/j.1469-7580.2005.00474.x; Hosokawa R, 2010, DEV BIOL, V341, P186, DOI 10.1016/j.ydbio.2010.02.030; Iwata J, 2014, DEVELOPMENT, V141, P909, DOI 10.1242/dev.103093; Kalcheim C, 1998, NEURAL CREST; KELLER JT, 1983, BRAIN RES, V270, P209, DOI 10.1016/0006-8993(83)90594-2; Knox SM, 2010, SCIENCE, V329, P1645, DOI 10.1126/science.1192046; Knox SM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2493; Liao YF, 2004, CLEFT PALATE-CRAN J, V41, P152, DOI 10.1597/02-162; Marrinan EM, 1998, CLEFT PALATE-CRAN J, V35, P95, DOI 10.1597/1545-1569(1998)035<0095:VFINCP>2.3.CO;2; Martinez-Alvarez C, 2000, DEV BIOL, V220, P343, DOI 10.1006/dbio.2000.9644; Monroy PLC, 2012, TISSUE ENG PART B-RE, V18, P468, DOI [10.1089/ten.TEB.2012.0049, 10.1089/ten.teb.2012.0049]; Oka K, 2012, J HISTOCHEM CYTOCHEM, V60, P57, DOI 10.1369/0022155411427059; Rinon A, 2007, DEVELOPMENT, V134, P3065, DOI 10.1242/dev.002501; Sakamoto Y, 2015, SURG RADIOL ANAT, V37, P649, DOI 10.1007/s00276-015-1444-5; Shimokawa T, 2004, SURG RADIOL ANAT, V26, P100, DOI 10.1007/s00276-003-0183-1; SMILEY GR, 1975, ARCH ORAL BIOL, V20, P297, DOI 10.1016/0003-9969(75)90127-2; Smith TM, 2013, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00488; Snider TN, 2014, BIRTH DEFECTS RES C, V102, P324, DOI 10.1002/bdrc.21075; Vacher C, 1997, CLEFT PALATE-CRAN J, V34, P189, DOI 10.1597/1545-1569(1997)034<0189:MOTSPC>2.3.CO;2; van der Sloot Paul G, 2003, Curr Opin Otolaryngol Head Neck Surg, V11, P225, DOI 10.1097/00020840-200308000-00001; VELASCO JRM, 1990, ARCH BIOL, V101, P447; Zhao H, 2014, CELL STEM CELL, V14, P160, DOI 10.1016/j.stem.2013.12.013	37	17	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145018	10.1371/journal.pone.0145018	http://dx.doi.org/10.1371/journal.pone.0145018			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671681	Green Published, Green Submitted, gold			2022-12-26	WOS:000366719300040
J	Tun, S; Ithoi, I; Mahmud, R; Samsudin, NI; Heng, CK; Ling, LY				Tun, Sandee; Ithoi, Init; Mahmud, Rohela; Samsudin, Nur Izyan; Heng, Chua Kek; Ling, Lau Yee			Detection of Helminth Eggs and Identification of Hookworm Species in Stray Cats, Dogs and Soil from Klang Valley, Malaysia	PLOS ONE			English	Article							GASTROINTESTINAL PARASITES; ANCYLOSTOMA-CEYLANICUM; INTESTINAL PARASITES; TOXOCARA-MALAYSIENSIS; PREVALENCE; COMMUNITIES; INFECTIONS; URBAN; TRANSMISSION; POPULATIONS	The present study was conducted to determine the prevalence of helminth eggs excreted in the faeces of stray cats, dogs and in soil samples. A total of 505 fresh samples of faeces (from 227 dogs and 152 cats) and soil were collected. The egg stage was detected via microscopy after the application of formalin-ether concentration technique. Genomic DNA was extracted from the samples containing hookworm eggs and used for further identification to the species level using real-time polymerase chain reaction coupled with high resolution melting analysis. Microscopic observation showed that the overall prevalence of helminth eggs among stray cats and dogs was 75.7% (95% CI = 71.2%-79.9%), in which 87.7% of dogs and 57.9% of cats were infected with at least one parasite genus. Five genera of heliminth eggs were detected in the faecal samples, including hookworms (46.4%), Toxocara (11.1%), Trichuris (8.4%), Spirometra (7.4%) and Ascaris (2.4%). The prevalence of helminth infections among stray dogs was significantly higher than that among stray cats (p < 0.001). Only three genera of helminths were detected in soil samples with the prevalence of 23% (95% CI = 15.1%-31%), consisting of hookworms (16.6%), Ascaris (4%) and Toxocara (2.4%). The molecular identification of hookworm species revealed that Ancylostoma ceylanicum was dominant in both faecal and soil samples. The dog hookworm, Ancylostoma caninum, was also detected among cats, which is the first such occurrence reported in Malaysia till date. This finding indicated that there was a cross-infection of A. caninum between stray cats and dogs because of their coexistent within human communities. Taken together, these data suggest the potential role of stray cats and dogs as being the main sources of environmental contamination as well as for human infections.	[Tun, Sandee; Ithoi, Init; Mahmud, Rohela; Samsudin, Nur Izyan; Ling, Lau Yee] Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia; [Heng, Chua Kek] Univ Malaya, Fac Med, Dept Biomed Sci, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Ithoi, I (corresponding author), Univ Malaya, Fac Med, Dept Parasitol, Kuala Lumpur, Malaysia.	init@um.edu.my	Lau, Yee Ling/C-6996-2009; Ithoi, Init/B-8660-2010; CHUA, KEK HENG/B-5261-2010	Lau, Yee Ling/0000-0002-2037-2165; Ithoi, Init/0000-0001-8698-4546; CHUA, KEK HENG/0000-0002-0452-9994	University of Malaya High Impact Research Grant HIR-MOHE [UM.C/625/1/HIR/MOHE/MED/18]	University of Malaya High Impact Research Grant HIR-MOHE	This study was supported by University of Malaya High Impact Research Grant HIR-MOHE (project UM.C/625/1/HIR/MOHE/MED/18). The funder had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abu-Madi MA, 2010, VET PARASITOL, V168, P284, DOI 10.1016/j.vetpar.2009.11.027; Azian M. Y. Noor, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P205; Bahgat M, 1998, J EGYPTIAN SOC PARAS, V29, P873; BAKER MK, 1989, J S AFR VET ASSOC, V60, P139; Barutzki Dieter, 2011, Parasitol Res, V109 Suppl 1, pS45, DOI 10.1007/s00436-011-2402-8; Beiromvand M, 2013, PREV VET MED, V109, P162, DOI 10.1016/j.prevetmed.2012.09.009; Bethony J, 2006, LANCET, V367, P1521, DOI 10.1016/S0140-6736(06)68653-4; Bowman DD, 2010, TRENDS PARASITOL, V26, P162, DOI 10.1016/j.pt.2010.01.005; Bridger KE, 2009, VET PARASITOL, V162, P167, DOI 10.1016/j.vetpar.2009.02.016; Brooker S, 1999, T ROY SOC TROP MED H, V93, P240, DOI 10.1016/S0035-9203(99)90007-X; Calvete C, 1998, VET PARASITOL, V75, P235, DOI 10.1016/S0304-4017(97)00182-9; CHAN MS, 1994, PARASITOLOGY, V109, P373, DOI 10.1017/S0031182000078410; Choo J, 2000, T ROY SOC TROP MED H, V94, P21, DOI 10.1016/S0035-9203(00)90425-5; Costa AFDV, 2008, VET PARASITOL, V153, P277, DOI 10.1016/j.vetpar.2008.02.005; Deplazes P, 2011, VET PARASITOL, V182, P41, DOI 10.1016/j.vetpar.2011.07.014; DOS, 2006, BAS POP CHAR ADM DIS; ENGBAEK K, 1984, Z PARASITENKD, V70, P87, DOI 10.1007/BF00929578; Fisher M, 2003, TRENDS PARASITOL, V19, P167, DOI 10.1016/S1471-4922(03)00027-8; Gasser RB, 1998, MOL BIOCHEM PARASIT, V92, P303, DOI 10.1016/S0166-6851(98)00008-5; GHADIRIAN E, 1976, CAN J PUBLIC HEALTH, V67, P495; Giacometti A, 2000, EUR J EPIDEMIOL, V16, P1023, DOI 10.1023/A:1010853124085; Gibbons LM, 2001, J PARASITOL, V87, P660, DOI 10.1645/0022-3395(2001)087[0660:TMNSNA]2.0.CO;2; Hajipour N, 2015, J PARASITIC DIS, P1; Hsu YC, 2012, NEW ENGL J MED, V366, pE20, DOI 10.1056/NEJMicm1101717; Hu M, 2002, ELECTROPHORESIS, V23, P27, DOI [10.1002/1522-2683(200201)23:1<27::AID-ELPS27>3.0.CO;2-7, 10.1002/1522-2683(200201)23:1&lt;27::AID-ELPS27&gt;3.0.CO;2-7]; Inpankaew Tawin, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P247; Inpankaew T, 2014, EMERG INFECT DIS, V20, P976, DOI 10.3201/eid2006.131770; Jittapalapong S, 2007, KASETSART J NAT SCI, V41, P69; Khalafalla RE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020283; KHOSHOO V, 1995, J PEDIATR GASTR NUTR, V21, P481, DOI 10.1097/00005176-199511000-00022; Krecek RC, 2010, VET PARASITOL, V172, P147, DOI 10.1016/j.vetpar.2010.04.033; Labarthe N, 2004, VET PARASITOL, V123, P133, DOI 10.1016/j.vetpar.2004.06.002; Landmann JK, 2003, MED J AUSTRALIA, V178, P69, DOI 10.5694/j.1326-5377.2003.tb05066.x; Lefkaditis MA, 2014, HELMINTHOLOGIA, V51, P73, DOI 10.2478/s11687-014-0211-1; Li MW, 2006, PARASITOL RES, V99, P554, DOI 10.1007/s00436-006-0194-z; Liu Y, 2013, BIOMED RES INT, P2013; Lorenzini G., 2007, Brazilian Journal of Veterinary Research and Animal Science, V44, P137; Lucio-Forster A, 2011, J FELINE MED SURG, V13, P300, DOI 10.1016/j.jfms.2010.12.013; Mahdy MAK, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-88; Martinez-Moreno FJ, 2007, VET PARASITOL, V143, P7, DOI 10.1016/j.vetpar.2006.08.004; Mizgajska H, 2001, J HELMINTHOL, V75, P147; Ngui R, 2014, ACTA PARASITOL, V59, P737, DOI 10.2478/s11686-014-0306-3; Ngui R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041996; Ngui R, 2012, AM J TROP MED HYG, V86, P837, DOI 10.4269/ajtmh.2012.11-0446; Ngui R, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001522; Oge S, 2000, DEUT TIERARZTL WOCH, V107, P72; Oliveira-Sequeira TCG, 2002, VET PARASITOL, V103, P19, DOI 10.1016/S0304-4017(01)00575-1; Olsen A, 1998, T ROY SOC TROP MED H, V92, P643, DOI 10.1016/S0035-9203(98)90795-7; Palmer CS, 2008, VET PARASITOL, V151, P181, DOI 10.1016/j.vetpar.2007.10.015; Palmer CS, 2007, VET PARASITOL, V145, P304, DOI 10.1016/j.vetpar.2006.12.018; Prociv P, 1996, ACTA TROP, V62, P23, DOI 10.1016/S0001-706X(96)00016-2; Ramirez-Barrios RA, 2004, VET PARASITOL, V121, P11, DOI 10.1016/j.vetpar.2004.02.024; RITCHIE LAWRENCE S., 1948, BULL U S ARMY MED DEPT, V8, P326; Scorza AV, 2011, VET PARASITOL, V183, P178, DOI 10.1016/j.vetpar.2011.06.025; SETASUBAN P, 1976, Southeast Asian Journal of Tropical Medicine and Public Health, V7, P534; Shalaby HA, 2010, PARASITOL RES, V106, P1021, DOI 10.1007/s00436-010-1755-8; Stoltzfus RJ, 1997, AM J CLIN NUTR, V65, P153, DOI 10.1093/ajcn/65.1.153; Traub RJ, 2008, VET PARASITOL, V155, P67, DOI 10.1016/j.vetpar.2008.05.001; Traub RJ, 2014, VET PARASITOL, V205, P233, DOI 10.1016/j.vetpar.2014.06.037; Traub RJ, 2013, INT J PARASITOL, V43, P1009, DOI 10.1016/j.ijpara.2013.07.006; Traub RJ, 2004, VET PARASITOL, V123, P245, DOI 10.1016/j.vetpar.2004.05.026; Traub RJ, 2003, PARASITOL RES, V90, pS156, DOI 10.1007/s00436-003-0925-3; Ulukanligil M, 2001, MEM I OSWALDO CRUZ, V96, P903, DOI 10.1590/S0074-02762001000700004; Waap H, 2014, J HELMINTHOL, V88, P389, DOI 10.1017/S0022149X1300031X; Yamamoto Norishige, 2009, Kansenshogaku Zasshi, V83, P223; YOSHIDA Y, 1968, AM J TROP MED HYG, V17, P378, DOI 10.4269/ajtmh.1968.17.378; Zain SNM, 2013, VET PARASITOL, V196, P469, DOI 10.1016/j.vetpar.2013.03.030; Zibaei M, 2007, TROP BIOMED, V24, P39	68	25	26	2	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0142231	10.1371/journal.pone.0142231	http://dx.doi.org/10.1371/journal.pone.0142231			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671680	Green Submitted, Green Published, gold			2022-12-26	WOS:000366719300001
J	Chen, Q; Lu, MJ; Monks, BR; Birnbaum, MJ				Chen, Qing; Lu, Mingjian; Monks, Bobby R.; Birnbaum, Morris J.			Insulin Is Required to Maintain Albumin Expression by Inhibiting Forkhead Box O1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED RECEPTOR-GAMMA; TRANSCRIPTION FACTOR FKHR; TREATED DIABETIC-RATS; MTOR COMPLEX 1; GENE-EXPRESSION; PRIMARY CULTURES; MESSENGER-RNA; NUCLEAR EXCLUSION; LIPID-METABOLISM; SERUM-ALBUMIN	Diabetes is accompanied by dysregulation of glucose, lipid, and protein metabolism. In recent years, much effort has been spent on understanding how insulin regulates glucose and lipid metabolism, whereas the effect of insulin on protein metabolism has received less attention. In diabetes, hepatic production of serum albumin decreases, and it has been long established that insulin positively controls albumin gene expression. In this study, we used a genetic approach in mice to identify the mechanism by which insulin regulates albumin gene transcription. Albumin expression was decreased significantly in livers with insulin signaling disrupted by ablation of the insulin receptor or Akt. Concomitant deletion of Forkhead Box O1 (Foxo1) in these livers rescued the decreased albumin secretion. Furthermore, activation of Foxo1 in the liver is sufficient to suppress albumin expression. These results suggest that Foxo1 acts as a repressor of albumin expression.	[Chen, Qing; Lu, Mingjian; Monks, Bobby R.; Birnbaum, Morris J.] Univ Penn, Inst Diabet Obes & Metab, Perelman Sch Med, Philadelphia, PA 19104 USA; [Chen, Qing; Birnbaum, Morris J.] Univ Penn, Dept Biochem & Biophys, Perelman Sch Med, Philadelphia, PA 19104 USA; [Chen, Qing; Birnbaum, Morris J.] Univ Penn, Perelman Sch Med, Grad Grp Biochem & Mol Biophys, Philadelphia, PA 19104 USA; [Birnbaum, Morris J.] Pfizer Inc, Cardiovasc & Metab Dis Res Unit, Cambridge, MA 02140 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Pfizer	Birnbaum, MJ (corresponding author), Pfizer Inc, Cardiovasc & Metab Dis Res Unit, Cambridge, MA 02140 USA.	birnbaum@mail.med.upenn.edu	Lu, Mingjian/AGK-0751-2022; Lu, Mingjian/AAO-6179-2021	Lu, Mingjian/0000-0001-9328-4935; Birnbaum, Morris/0000-0001-9972-8680	National Institutes of Health [RO1 DK56886]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056886] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant RO1 DK56886. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brown MS, 2008, CELL METAB, V7, P95, DOI 10.1016/j.cmet.2007.12.009; Centers for Disease Control, 2020, NATL DIABETES STAT R; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; DEFEO P, 1991, J CLIN INVEST, V88, P833, DOI 10.1172/JCI115384; Deng X, 2012, J BIOL CHEM, V287, P20132, DOI 10.1074/jbc.M112.347211; Dowell P, 2003, J BIOL CHEM, V278, P45485, DOI 10.1074/jbc.M309069200; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Everett LJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-337; Fan WQ, 2009, J BIOL CHEM, V284, P12188, DOI 10.1074/jbc.M808915200; Fanali G, 2012, MOL ASPECTS MED, V33, P209, DOI 10.1016/j.mam.2011.12.002; FLAIM KE, 1985, AM J PHYSIOL, V249, pE447, DOI 10.1152/ajpendo.1985.249.5.E447; FRIEDMAN AD, 1989, GENE DEV, V3, P1314, DOI 10.1101/gad.3.9.1314; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Hirota K, 2003, J BIOL CHEM, V278, P13056, DOI 10.1074/jbc.C200553200; Hirota K, 2008, J BIOL CHEM, V283, P32432, DOI 10.1074/jbc.M806179200; HUTSON SM, 1987, AM J PHYSIOL, V252, pE291, DOI 10.1152/ajpendo.1987.252.3.E291; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; JEFFERSON LS, 1983, J BIOL CHEM, V258, P1369; Kim JJ, 2009, DIABETES, V58, P1275, DOI 10.2337/db08-1001; KIMBALL SR, 1995, AM J PHYSIOL-ENDOC M, V268, pE6, DOI 10.1152/ajpendo.1995.268.1.E6; Laplante M, 2010, P NATL ACAD SCI USA, V107, P3281, DOI 10.1073/pnas.1000323107; Leavens KF, 2011, CRIT REV BIOCHEM MOL, V46, P200, DOI 10.3109/10409238.2011.562481; Li SJ, 2010, P NATL ACAD SCI USA, V107, P3441, DOI 10.1073/pnas.0914798107; LLOYD CE, 1987, AM J PHYSIOL, V252, pC205, DOI 10.1152/ajpcell.1987.252.2.C205; Lu MJ, 2012, NAT MED, V18, P388, DOI 10.1038/nm.2686; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Michael MD, 2000, MOL CELL, V6, P87, DOI 10.1016/S1097-2765(00)00010-1; Miller RA, 2013, NATURE, V494, P256, DOI 10.1038/nature11808; Murphy CT, 2003, NATURE, V424, P277, DOI 10.1038/nature01789; Nakae J, 1999, J BIOL CHEM, V274, P15982, DOI 10.1074/jbc.274.23.15982; PEAVY DE, 1978, P NATL ACAD SCI USA, V75, P5879, DOI 10.1073/pnas.75.12.5879; PEAVY DE, 1985, AM J PHYSIOL, V248, pE656, DOI 10.1152/ajpendo.1985.248.6.E656; PIETRANGELO A, 1992, J CLIN INVEST, V89, P1755, DOI 10.1172/JCI115778; Qiao LP, 2006, J BIOL CHEM, V281, P39915, DOI 10.1074/jbc.M607215200; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Rena G, 2002, EMBO J, V21, P2263, DOI 10.1093/emboj/21.9.2263; SAKUMA K, 1987, J NUTR, V117, P1141, DOI 10.1093/jn/117.6.1141; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; Schuster E, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.54; Sekine K, 2007, EMBO J, V26, P3607, DOI 10.1038/sj.emboj.7601784; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Tepper RG, 2013, CELL, V154, P676, DOI 10.1016/j.cell.2013.07.006; Thoreen CC, 2012, NATURE, V485, P109, DOI 10.1038/nature11083; Tuteja G, 2008, NUCLEIC ACIDS RES, V36, P4149, DOI 10.1093/nar/gkn366; Wang XM, 2006, PHYSIOLOGY, V21, P362, DOI 10.1152/physiol.00024.2006; Xiong XW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074340; Zhang WW, 2006, J BIOL CHEM, V281, P10105, DOI 10.1074/jbc.M600272200	49	18	20	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 29	2016	291	5					2371	2378		10.1074/jbc.M115.677351	http://dx.doi.org/10.1074/jbc.M115.677351			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DD0LB	26668316	Green Published, hybrid			2022-12-26	WOS:000369610400026
J	Kerherve, HA; Millet, GY; Solomon, C				Kerherve, Hugo A.; Millet, Guillaume Y.; Solomon, Colin			The Dynamics of Speed Selection and Psycho-Physiological Load during a Mountain Ultramarathon	PLOS ONE			English	Article							ULTRA-MARATHON RACE; ENERGY-COST; PACING STRATEGIES; PERCEIVED EXERTION; EXERCISE; PERFORMANCE; WALKING; UPHILL; LEVEL; MODEL	Background Exercise intensity during ultramarathons (UM) is expected to be regulated as a result of the development of psycho-physiological strain and in anticipation of perceived difficulties (duration, topography). The aim of this study was to investigate the dynamics of speed, heart rate and perceived exertion during a long trail UM in a mountainous setting. Methods Fifteen participants were recruited from competitors in a 106 km trail mountain UM with a total elevation gain and loss of 5870 m. Speed and gradient, heart rate (HR) and ratings of perceived exertion (dissociated between the general [RPEGEN] and knee extensor fatigue [RPEKE] and collected using a voice recorder) were measured during the UM. Self-selected speed at three gradients (level, negative, positive), HR, RPEGEN and RPEKE were determined for each 10% section of total event duration (TED). Results The participants completed the event in 18.3 +/- 3.0 h, for a total calculated distance of 105.6 +/- 1.8 km. Speed at all gradients decreased, and HR at all gradients significantly decreased from 10% to 70%, 80% and 90%, but not 100% of TED. RPEGEN and RPEKE increased throughout the event. Speed increased from 90% to 100% of TED at all gradients. Average speed was significantly correlated with total time stopped (r = -.772; p = .001; 95% confidence interval [CI] = -1.15, -0.39) and the magnitude of speed loss (r = .540; p = .038; 95% CI = -1.04, -0.03), but not with the variability of speed (r = -.475; p = .073; 95% CI = -1.00, 0.05). Conclusions Participants in a mountain UM event combined positive pacing strategies (speed decreased until 70-90% of TED), an increased speed in the last 10% of the event, a decrease in HR at 70-90% of TED, and an increase in RPEGEN and RPEKE in the last 30% of the event. A greater speed loss and less total time stopped were the factors associated with increased total performance. These results could be explained by theoretical perspectives of a complex regulatory system modulating motor drive in anticipation of perceived difficulties such as elevation changes.	[Kerherve, Hugo A.; Solomon, Colin] Univ Sunshine Coast, Sch Hlth & Sport Sci, Sippy Downs, Qld 4556, Australia; [Kerherve, Hugo A.] Univ Savoie Mt Blanc, Lab Physiol Exercice, EA 4338, Le Bourget Du Lac, France; [Millet, Guillaume Y.] Univ Calgary, Human Performance Lab, Calgary, AB, Canada; [Millet, Guillaume Y.] Univ Lyon, Lab Physiol Exercice, F-42023 St Etienne, France	University of the Sunshine Coast; University of Calgary	Kerherve, HA (corresponding author), Univ Sunshine Coast, Sch Hlth & Sport Sci, Sippy Downs, Qld 4556, Australia.	hugo-alain.kerherve@univ-smb.fr	Millet, Guillaume/AAO-6520-2020	Millet, Guillaume/0000-0002-6395-0762	USC; Queensland Education and Training	USC; Queensland Education and Training	No specific funding was used for this study. The first author was supported by university research funds and scholarship (USC and Queensland Education and Training).	Abbiss CR, 2008, SPORTS MED, V38, P239, DOI 10.2165/00007256-200838030-00004; Achten J, 2003, SPORTS MED, V33, P517, DOI 10.2165/00007256-200333070-00004; Angus SD, 2011, MED SCI SPORT EXER, V43, P2405, DOI 10.1249/MSS.0b013e3182245367; Ansley L, 2004, MED SCI SPORT EXER, V36, P1819, DOI 10.1249/01.MSS.0000142409.70181.9D; Ansley L, 2004, MED SCI SPORT EXER, V36, P309, DOI 10.1249/01.MSS.0000113474.31529.C6; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; CAVAGNA GA, 1976, J PHYSIOL-LONDON, V262, P639, DOI 10.1113/jphysiol.1976.sp011613; DAVIES CTM, 1986, J APPL PHYSIOL, V61, P611, DOI 10.1152/jappl.1986.61.2.611; de Koning JJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015863; Gimenez P, 2013, MED SCI SPORT EXER, V45, P1807, DOI 10.1249/MSS.0b013e318292c0ec; Hoffman MD, 2014, INT J SPORT PHYSIOL, V9, P1054, DOI 10.1123/ijspp.2013-0556; Clemente-Suarez VJ, 2015, APPL PHYSIOL NUTR ME, V40, P269, DOI 10.1139/apnm-2014-0263; Knechtle B, 2012, CHINESE J PHYSIOL, V55, P125, DOI [10.4077/CJP.2012.BAA022, 10.4077/CJP.2011.AMM050]; Lambert MI, 2004, J SPORT SCI MED, V3, P167; Martin V, 2005, J SPORT MED PHYS FIT, V45, P143; Martin V, 2010, J APPL PHYSIOL, V108, P1224, DOI 10.1152/japplphysiol.01202.2009; Micklewright D, 2009, S AFRICAN J SPORTS M, V21; Millet GY, 2011, SPORTS MED, V41, P489, DOI 10.2165/11588760-000000000-00000; Millet GY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017059; MINETTI AE, 1994, J EXP BIOL, V195, P211; Minetti AE, 2002, J APPL PHYSIOL, V93, P1039, DOI 10.1152/japplphysiol.01177.2001; Morin JB, 2011, J BIOMECH, V44, P1104, DOI 10.1016/j.jbiomech.2011.01.028; Morin JB, 2011, MED SCI SPORT EXER, V43, P829, DOI 10.1249/MSS.0b013e3181fec518; Noakes TD, 2009, BRIT J SPORT MED, V43, P760, DOI 10.1136/bjsm.2008.046763; Noakes TD, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00082; Swart J, 2009, BRIT J SPORT MED, V43, P782, DOI 10.1136/bjsm.2008.055889; Townshend AD, 2008, MED SCI SPORT EXER, V40, P124, DOI 10.1249/mss.0b013e3181590bc2; Townshend AD, 2010, MED SCI SPORT EXER, V42, P160, DOI 10.1249/MSS.0b013e3181af21e2; Tucker R, 2009, BRIT J SPORT MED, V43, P392, DOI 10.1136/bjsm.2008.050799; Tucker R, 2009, BRIT J SPORT MED, V43, DOI 10.1136/bjsm.2009.057562; Utter AC, 2003, PERCEPT MOTOR SKILL, V97, P175, DOI 10.2466/PMS.97.5.175-184; Vernillo G, 2015, J SPORT SCI, V33, P1998, DOI 10.1080/02640414.2015.1022870; Vincenty T., 1975, SURVEY REV, V23, P88, DOI [10.1179/sre.1975.23.176.88, DOI 10.1179/SRE.1975.23.176.88]; Waldron M, 2011, J SPORT SCI, V29, P1613, DOI 10.1080/02640414.2011.608703	34	15	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 21	2015	10	12							e0145482	10.1371/journal.pone.0145482	http://dx.doi.org/10.1371/journal.pone.0145482			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SF	26691599	Green Published, Green Submitted, gold			2022-12-26	WOS:000367092300081
J	Hyun, SH; Lee, KH; Choi, JY; Kim, BT; Kim, J; Zo, JI; Kim, H; Kwon, OJ; Ahn, HK				Hyun, Seung Hyup; Lee, Kyung-Han; Choi, Joon Young; Kim, Byung-Tae; Kim, Jhingook; Zo, Jae Ill; Kim, Hojoong; Kwon, O. Jung; Ahn, Hee Kyung			Influence of Body Mass Index on the Prognostic Value of Tumor F-18-FDG Uptake in Stage I Non-Small Cell Lung Cancer	PLOS ONE			English	Article							POSITRON-EMISSION-TOMOGRAPHY; METABOLIC SYNDROME; OBESITY; SURVIVAL; MORTALITY; ASSOCIATION; COHORT; RISK	Background The impact of host energy balance status on outcome of lung cancer has not been fully explored. It is also unknown if there is a potential modifying effect of body mass index (BMI) on tumor cell behavior in patients with early-stage non-small cell lung cancer (NSCLC). We therefore investigated the interactive effects of tumor [F-18]-fluorodeoxyglucose (FDG) avidity and BMI. Methods We investigated 1,197 patients with stage I NSCLC who underwent preoperative FDG positron emission tomography followed by curative resection. The primary outcome measure was disease-free survival (DFS). A multivariable Cox proportional hazards model was used to assess the potential independent effects of the prognostic variables. A stratified Cox regression analysis was also performed to assess the potential modifying effects of BMI on the relationship between tumor FDG uptake and patient survival. Results There were 145 tumor recurrences and 19 deaths during a median follow-up of 30 months. Tumor-related variables, including tumor size, maximum standardized uptake value (SUVmax), histologic cell type, differentiation, lymphovascular invasion, and visceral pleural invasion, did not differ significantly according to BMI status. In multivariable Cox regression analysis, overweight or obesity [hazard ratio (HR), 0.59; 95% CI, 0.43-0.81; P = 0.001] and tumor SUVmax (HR, 1.72; 95% CI, 1.43-2.07; P < 0.001) were significantly associated with DFS. There was a significant modifying effect of BMI (P for interaction < 0.001 in multivariable analysis). High tumor SUVmax was more strongly associated with worse DFS in normal weight patients (HR, 4.72; 95% CI, 2.77-8.06; P < 0.001) than in overweight or obese patients (HR, 2.61; 95% CI, 1.58-4.31; P < 0.001). Conclusions Tumor FDG avidity is an independent predictor of DFS in patients with early-stage NSCLC and this prognostic value was strengthened in normal weight patients than in overweight or obese patients. These results suggest that the host-tumor interaction between host energy balance status and tumor glucose metabolism plays an important role in the outcome of early-stage NSCLC.	[Hyun, Seung Hyup; Lee, Kyung-Han; Choi, Joon Young; Kim, Byung-Tae] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Nucl Med, Seoul, South Korea; [Kim, Jhingook; Zo, Jae Ill] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac Surg, Seoul, South Korea; [Kim, Hojoong; Kwon, O. Jung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Pulm & Crit Care Med,Dept Med, Seoul, South Korea; [Ahn, Hee Kyung] Gachon Univ, Div Hematol Oncol, Dept Internal Med, Gil Med Ctr, Incheon, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Gachon University	Lee, KH (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Nucl Med, Seoul, South Korea.	khnm.lee@samsung.com	Choi, Joon Young/D-6140-2017		Samsung Medical Center	Samsung Medical Center(Samsung)	The authors received no specific funding for this work. Co-authors Seung Hyup Hyun, Kyung-Han Lee, Joon Young Choi, Byung-Tae Kim, Jhingook Kim, Jae Ill Zo, Hojoong Kim, and O Jung Kwon are employed by Samsung Medical Center, which is administratively separate from the Samsung Corporation. Samsung Medical Center provided support in the form of salaries for authors SHH, K-HL, JYC, B-TK, JK, JIZ, HK and OJK, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Attaran S, 2012, EUR J CARDIO-THORAC, V42, P653, DOI 10.1093/ejcts/ezs135; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Braun S, 2011, INT J BIOL SCI, V7, P1003, DOI 10.7150/ijbs.7.1003; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Cavazos DA, 2014, NUTR CANCER, V66, P1179, DOI 10.1080/01635581.2014.951738; Choi Y, 2013, INT J CANCER, V132, P625, DOI 10.1002/ijc.27639; Dahlberg SE, 2013, J THORAC ONCOL, V8, P1121, DOI 10.1097/JTO.0b013e31829cf942; Dooms C, 2009, J THORAC ONCOL, V4, P822, DOI 10.1097/JTO.0b013e3181a97df7; Downey RJ, 2004, J CLIN ONCOL, V22, P3255, DOI 10.1200/JCO.2004.11.109; Ettinger DS, 2010, J NATL COMPR CANC NE, V8, P740, DOI 10.6004/jnccn.2010.0056; Graham MM, 2000, NUCL MED BIOL, V27, P647, DOI 10.1016/S0969-8051(00)00143-8; Hakimi AA, 2013, JNCI-J NATL CANCER I, V105, P1862, DOI 10.1093/jnci/djt310; Hursting SD, 2012, ARTERIOSCL THROM VAS, V32, P1766, DOI 10.1161/ATVBAHA.111.241927; Kollarova H, 2008, NEOPLASMA, V55, P71; LAUSEN B, 1992, BIOMETRICS, V48, P73, DOI 10.2307/2532740; Leung CC, 2011, INT J EPIDEMIOL, V40, P174, DOI 10.1093/ije/dyq134; Lynam-Lennon N, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-907; Paesmans M, 2010, J THORAC ONCOL, V5, P612, DOI 10.1097/JTO.0b013e3181d0a4f5; Park SY, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-151; Parr CL, 2010, LANCET ONCOL, V11, P741, DOI 10.1016/S1470-2045(10)70141-8; Vesselle H, 2008, J THORAC ONCOL, V3, P971, DOI 10.1097/JTO.0b013e31818307a7; Vucenik I, 2012, ANN NY ACAD SCI, V1271, P37, DOI 10.1111/j.1749-6632.2012.06750.x; Yang L, 2009, INT J CANCER, V125, P2136, DOI 10.1002/ijc.24527; Yang Y, 2013, INT J CANCER, V132, P1162, DOI 10.1002/ijc.27719; Yoon HH, 2011, J CLIN ONCOL, V29, P4561, DOI 10.1200/JCO.2011.37.1260; Yu H, 2000, JNCI-J NATL CANCER I, V92, P1472, DOI 10.1093/jnci/92.18.1472; Yu H, 1999, JNCI-J NATL CANCER I, V91, P151, DOI 10.1093/jnci/91.2.151	27	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145020	10.1371/journal.pone.0145020	http://dx.doi.org/10.1371/journal.pone.0145020			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684001	Green Submitted, gold, Green Published			2022-12-26	WOS:000366725800030
J	Izac, M; Garnier, D; Speck, D; Lindley, ND				Izac, Marie; Garnier, Dominique; Speck, Denis; Lindley, Nic D.			A Functional Tricarboxylic Acid Cycle Operates during Growth of Bordetella pertussis on Amino Acid Mixtures as Sole Carbon Substrates	PLOS ONE			English	Article							ESCHERICHIA-COLI; LACTOCOCCUS-LACTIS; TOXIN PRODUCTION; GENOMIC CONTENT; FERMENTATION; CULTIVATION; METABOLISM; PROTEIN	It has been claimed that citrate synthase, aconitase and isocitrate dehydrogenase activities are non-functional in Bordetella pertussis and that this might explain why this bacterium's growth is sometimes associated with accumulation of polyhydroxybutyrate (PHB) and/or free fatty acids. However, the sequenced genome includes the entire citric acid pathway genes. Furthermore, these genes were expressed and the corresponding enzyme activities detected at high levels for the pathway when grown on a defined medium imitating the amino acid content of complex media often used for growth of this pathogenic micro-organism. In addition, no significant PHB or fatty acids could be detected. Analysis of the carbon balance and stoichiometric flux analysis based on specific rates of amino acid consumption, and estimated biomass requirements coherent with the observed growth rate, clearly indicate that a fully functional tricarboxylic acid cycle operates in contrast to previous reports.	[Izac, Marie; Lindley, Nic D.] Univ Toulouse, INSA, UPSr, INP,LISBP, Toulouse, France; [Izac, Marie; Lindley, Nic D.] INRA, Ingn Syst Biol & Proc UMR792, F-31931 Toulouse, France; [Izac, Marie; Lindley, Nic D.] CNRS, UMR5504, Toulouse, France; [Garnier, Dominique; Speck, Denis] Sanofi Pasteur, Marcy Letoile, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Institut National Polytechnique de Toulouse; INRAE; Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite de Toulouse; Universite Federale Toulouse Midi-Pyrenees (ComUE); Institut National des Sciences Appliquees de Toulouse	Lindley, ND (corresponding author), Univ Toulouse, INSA, UPSr, INP,LISBP, Toulouse, France.	lindley@insa-toulouse.fr		Lindley, Nic D/0000-0002-9538-1306	Sanofi-Pasteur	Sanofi-Pasteur	This project was funded by a direct grant (MI) from Sanofi-Pasteur who were involved in the study design and the decision to publish the data.; The authors would like to thank Sanofi-Pasteur for financial support and the GeT platform (http://get.genotoul.fr/) for help in qPCR experiments and primer design.	Ampe F, 1997, APPL ENVIRON MICROB, V63, P2765, DOI 10.1128/AEM.63.7.2765-2770.1997; [Anonymous], 2013, VACCINES 6; Antoine R, 2005, J MOL BIOL, V351, P799, DOI 10.1016/j.jmb.2005.05.071; Antoine R, 2003, J BACTERIOL, V185, P1470, DOI 10.1128/JB.185.4.1470-1474.2003; Bart MJ, 2014, MBIO, V5, DOI 10.1128/mBio.01074-14; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; Bogdan JA, 2001, INFECT IMMUN, V69, P6823, DOI 10.1128/IAI.69.11.6823-6830.2001; Bouchez V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002437; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Budman H, 2013, BIOTECHNOL PROGR, V29, P520, DOI 10.1002/btpr.1675; Cherry JD, 2012, NEW ENGL J MED, V367, P785, DOI 10.1056/NEJMp1209051; Esquerre T, 2014, NUCLEIC ACIDS RES, V42, P2460, DOI 10.1093/nar/gkt1150; Frohlich BT, 1996, J BIOTECHNOL, V45, P137, DOI 10.1016/0168-1656(95)00155-7; FROHLICH BT, 1995, J BIOTECHNOL, V39, P205, DOI 10.1016/0168-1656(95)00013-G; He QS, 2008, FUTURE MICROBIOL, V3, P329, DOI 10.2217/17460913.3.3.329; HOZBOR D, 1994, FEMS IMMUNOL MED MIC, V9, P117; IMAIZUMI A, 1983, J CLIN MICROBIOL, V17, P781, DOI 10.1128/JCM.17.5.781-786.1983; JEBB WHH, 1951, J GEN MICROBIOL, V5, P951, DOI 10.1099/00221287-5-5-951; King AJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-64; Lambert LC, 2014, J INFECT DIS, V209, pS4, DOI 10.1093/infdis/jit592; Lapujade P, 1998, APPL ENVIRON MICROB, V64, P2485; Maharjan RP, 2008, RES MICROBIOL, V159, P602, DOI 10.1016/j.resmic.2008.08.004; NIKOLAJEWSKI HE, 1990, BIOLOGICALS, V18, P305, DOI 10.1016/1045-1056(90)90034-W; Nouaille S, 2009, APPL ENVIRON MICROB, V75, P4473, DOI 10.1128/AEM.02653-08; Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227; ROWATT E, 1957, J GEN MICROBIOL, V17, P297, DOI 10.1099/00221287-17-2-297; Scheu PD, 2012, J BACTERIOL, V194, P636, DOI 10.1128/JB.06345-11; STAINER DW, 1970, J GEN MICROBIOL, V63, P211, DOI 10.1099/00221287-63-2-211; Thalen M, 1999, J BIOTECHNOL, V75, P147, DOI 10.1016/S0168-1656(99)00155-8; Thalen M, 2006, BIOLOGICALS, V34, P289, DOI 10.1016/j.biologicals.2005.12.001; Ulloa-Gutierrez R, 2009, EXPERT REV VACCINES, V8, P153, DOI 10.1586/14760584.8.2.153; Weitzman PDJ., 1969, METHOD ENZYMOL, P22; Yamamoto K, 2009, BIOSCI BIOTECH BIOCH, V73, P346, DOI 10.1271/bbb.80586	33	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145251	10.1371/journal.pone.0145251	http://dx.doi.org/10.1371/journal.pone.0145251			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684737	Green Submitted, gold, Green Published			2022-12-26	WOS:000366725800053
J	Kristmundsson, A; Erlingsdottir, A; Freeman, MA				Kristmundsson, Arni; Erlingsdottir, Asthildur; Freeman, Mark A.			Is an Apicomplexan Parasite Responsible for the Collapse of the Iceland Scallop (Chlamys islandica) Stock?	PLOS ONE			English	Article							PECTEN-MAXIMUS L; PLACOPECTEN-MAGELLANICUS; PROTOTHACA-STAMINEA; MASS MORTALITY; SEA SCALLOP; MULLER; INFECTION; POPULATIONS; ATLANTIC; WATERS	Due to the total and unexpected collapse of the Iceland scallop, Chlamys islandica, stocks around Iceland during the 2000s, a commercial fishing ban has been imposed on this valuable resource since 2003. Following the initial identification of an apicomplexan parasite in the scallops, a long-term surveillance program was established to evaluate the effect of the parasite on the population. The infections were highly prevalent in all shell sizes throughout the study. However, the parasite only impacts mature scallops where they cause severe macroscopic changes, characterized by an extensively diminished and abnormally coloured adductor muscle. A highly significant relationship was observed between infection intensity and gonad and adductor muscle indices. The first four years of the study, were characterized by high infection intensity and very poor condition of the adductor muscle and gonads, whilst during subsequent years, infections gradually decreased and the condition of the scallops improved. Histopathological changes were restricted to the presence of apicomplexan zoites which were widely distributed, causing varying degrees of pathology in all organs. In heavy infections, muscular and connective tissues were totally necrotized, destroying significant parts of numerous organs, especially the adductor muscle, digestive gland and gonads. The progression of the disease was in good synchrony with the mortality rates and the subsequent decline observed in the scallop stock and recruitment indices. Our findings strongly suggest that the apicomplexan parasite played a major role in the collapse of the Iceland scallop stock in Breidafjordur. In addition to causing mortality, the infections significantly impact gonad development which contributes further to the collapse of the stock in the form of lower larval recruitment. Furthermore, compelling evidence exists that this apicomplexan pathogen is causing serious disease outbreaks in other scallop populations. Similar abnormal adductor muscles and the parasite itself have been identified or observed in association with other mass mortality events in several different scallop species and commercial stocks in the northern hemisphere.	[Kristmundsson, Arni; Erlingsdottir, Asthildur; Freeman, Mark A.] Univ Iceland, Fish Dis Lab, Inst Expt Pathol Keldur, Reykjavik, Iceland; [Freeman, Mark A.] Univ Malaya, Inst Ocean & Earth Sci, Kuala Lumpur, Malaysia; [Freeman, Mark A.] Ross Univ, Sch Vet Med, Basseterre, St Kitts & Nevi	University of Iceland; Universiti Malaya	Kristmundsson, A (corresponding author), Univ Iceland, Fish Dis Lab, Inst Expt Pathol Keldur, Reykjavik, Iceland.	arnik@hi.is	Freeman, Mark A/B-7777-2010	Kristmundsson, Arni/0000-0001-7387-8584	Ministry of Industries and Innovation in Iceland [IEP-H.diskur-69935]; University of Malaya, Malaysia [RP001L-13SUS]	Ministry of Industries and Innovation in Iceland; University of Malaya, Malaysia(Universiti Malaya)	This work was supported by the Ministry of Industries and Innovation in Iceland; http://eng.atvinnuvegaruduneyti.is [grant no. IEP-H.diskur-69935] and University of Malaya, Malaysia [grant number RP001L-13SUS]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnfinnsson J, 2015, 20 INT PECT WORKSH G, P7; Brenner K, 2012, J SHELLFISH RES, V31, P1123, DOI 10.2983/035.031.0423; Brokordt KB, 2004, J SHELLFISH RES, V23, P25; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Carballal MJ, 2001, J INVERTEBR PATHOL, V78, P87, DOI 10.1006/jipa.2001.5049; Desser SS, 1997, FOLIA PARASIT, V44, P241; DICKIE LM, 1963, J FISH RES BOARD CAN, V20, P451, DOI 10.1139/f63-035; Eiriksson H, 1986, HAFRANNSOKNIR, V35, P5; Eiriksson H, 2000, ICES ANN SCI C NANT; Freeman MA, 2008, J FISH DIS, V31, P921, DOI 10.1111/j.1365-2761.2008.00965.x; Garcia EG, 2006, ADV MAR BIOL, V51, P1, DOI 10.1016/S0065-2881(06)51001-6; Giguere M., 1995, CAN TECH REP FISH AQ, V2033, P26; Gudfinnsson HG, 2001, SJOR SJAVARNYTJAR HE, P20; GULKA G, 1983, J FISH DIS, V6, P355, DOI 10.1111/j.1365-2761.1983.tb00087.x; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Haynes E. B., 1966, Research Bulletin International Commission NW Atlantic Fisheries, V3, P32; Hine PM, 2002, DIS AQUAT ORGAN, V51, P49, DOI 10.3354/dao051049; Howard DW, 2004, 5 NOAA NOS NCCOS; ICES, 2006, CM2006MCC01 ICES ACF; Inglis S, 2015, 20 INT PECT WORKSH G, P96; Jonasson JP, 2007, ICES J MAR SCI, V64, P298, DOI 10.1093/icesjms/fsl028; Jonasson JP, 2004, AQUAC RES, V35, P1405, DOI 10.1111/j.1365-2109.2004.01159.x; Karlsson JD, 1991, WORLD AQUACULTURE WO, V1, P180; Kristmundsson A, 2014, P 7 INT S AQ AN HLTH, P155; Kristmundsson A, 2005, P 12 INT C EUR ASS F; Kristmundsson A, 2011, J INVERTEBR PATHOL, V108, P147, DOI 10.1016/j.jip.2011.08.003; Kristmundsson A, 2011, J INVERTEBR PATHOL, V108, P139, DOI 10.1016/j.jip.2011.08.001; Leibovitz L., 1984, Journal of the World Mariculture Society, V15, P269; LESTER RJG, 1984, HELGOLANDER MEERESUN, V37, P53, DOI 10.1007/BF01989295; MASON J, 1958, J MAR BIOL ASSOC UK, V37, P653, DOI 10.1017/S0025315400005701; Mayo-Hernandez E, 2013, J SEA RES, V83, P195, DOI 10.1016/j.seares.2013.04.001; MCDONALD V, 1987, J PARASITOL, V73, P617, DOI 10.2307/3282145; Medcof J. C., 1965, Studies from the Stations of the Fisheries Research Board of Canada, P33; Medcof J.C., 1949, PROG REP ATLANTIC CO, V45, P3; MORADO JF, 1984, J INVERTEBR PATHOL, V43, P207, DOI 10.1016/0022-2011(84)90139-3; MRI, 2007, STAT MAR STOCKS IC W; MRI, 2002, STAT MAR STOCKS IC W; MRI, 2009, STAT MAR STOCKS IC W; MRI, 2015, 2015 STAT MAR STOCKS; MRI, 2003, STAT MAR STOCKS IC W; Naidu K.S., 1987, J NW ATL FISH SCI, V7, P131, DOI [10.2960/J.v7.a15, DOI 10.2960/J.V7.A15]; Rubach S, 1987, RESSURSKARTLEGGING A; Samuelsen OB, 2006, DIS AQUAT ORGAN, V71, P239, DOI 10.3354/dao071239; Steinhagen D, 1998, FOLIA PARASIT, V45, P326; Stevenson, 1936, THESIS; Stokesbury KDE, 2007, MAR ECOL PROG SER, V349, P151, DOI 10.3354/meps07113; Sundet JH, ARE THERE POTE UNPUB, V43, P12; TAYLOR AC, 1978, J MAR BIOL ASSOC UK, V58, P687, DOI 10.1017/S0025315400041333; THORARINSDOTTIR GG, 1993, AQUACULTURE, V110, P87, DOI 10.1016/0044-8486(93)90436-3; VAHL O, 1981, J EXP MAR BIOL ECOL, V53, P281, DOI 10.1016/0022-0981(81)90026-5; Webb S, 2008, 1334 CAWTHR, P28; WHYTE SK, 1994, DIS AQUAT ORGAN, V18, P53, DOI 10.3354/dao018053; WIBORG KRISTIAN FREDRIK, 1963, FISKERIDIREKT SKRIFTER SER HAVUNDERS, V13, P38; [No title captured]	54	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144685	10.1371/journal.pone.0144685	http://dx.doi.org/10.1371/journal.pone.0144685			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684810	Green Published, Green Submitted, gold			2022-12-26	WOS:000366725800018
J	Salzberger, W; Garcia-Beltran, WF; Dugan, H; Gubbala, S; Simoneau, C; Gressens, SB; Jost, S; Altfeld, M				Salzberger, Wilhelm; Garcia-Beltran, Wilfredo F.; Dugan, Haley; Gubbala, Supreetha; Simoneau, Camille; Gressens, Simon B.; Jost, Stephanie; Altfeld, Marcus			Influence of Glycosylation Inhibition on the Binding of KIR3DL1 to HLA-B*57:01	PLOS ONE			English	Article							CELL-SURFACE EXPRESSION; LINKED OLIGOSACCHARIDES; RECOGNITION; MOLECULES; LYMPHOCYTES; ACTIVATION; PATTERNS; SITE	Viral infections can affect the glycosylation pattern of glycoproteins involved in antiviral immunity. Given the importance of protein glycosylation for immune function, we investigated the effect that modulation of the highly conserved HLA class I N-glycan has on KIR: HLA interactions and NK cell function. We focused on HLA-B*57:01 and its interaction with KIR3DL1, which has been shown to play a critical role in determining the progression of a number of human diseases, including human immunodeficiency virus-1 infection. 721.221 cells stably expressing HLA-B*57:01 were treated with a panel of glycosylation enzyme inhibitors, and HLA class I expression and KIR3DL1 binding was quantified. In addition, the functional outcomes of HLA-B*57:01 N-glycan disruption/modulation on KIR3DL1 zeta(+) Jurkat reporter cells and primary human KIR3DL1+NK cells was assessed. Different glycosylation enzyme inhibitors had varying effects on HLA-B*57:01 expression and KIR3DL1-Fc binding. Themost remarkable effect was that of tunicamycin, an inhibitor of the first step of N-glycosylation, which resulted in significantly reduced KIR3DL1-Fc binding despite sustained expression of HLA-B*57:01 on 721.221 cells. This effect was paralleled by decreased activation of KIR3DL1 zeta(+) Jurkat reporter cells, as well as increased degranulation of primary human KIR3DL1(+) NK cell clones when encountering HLA-B*57:01-expressing 721.221 cells that were pre-treated with tunicamycin. Overall, these results demonstrate that N-glycosylation of HLA class I is important for KIR:HLA binding and has an impact on NK cell function.	[Salzberger, Wilhelm; Altfeld, Marcus] Leibniz Inst Expt Virol, Heinrich Pette Inst, Dept Virus Immunol, Hamburg, Germany; [Garcia-Beltran, Wilfredo F.; Dugan, Haley; Gubbala, Supreetha; Simoneau, Camille; Gressens, Simon B.; Jost, Stephanie; Altfeld, Marcus] Ragon Inst MGH MIT & Harvard, Cambridge, MA USA	Heinrich Pette Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Altfeld, M (corresponding author), Leibniz Inst Expt Virol, Heinrich Pette Inst, Dept Virus Immunol, Hamburg, Germany.	marcus.altfeld@hpi.uni-hamburg.de	Altfeld, Marcus/AAE-7306-2019	Altfeld, Marcus/0000-0001-5972-2997	Deutsche Gesellschaft fur Infektiologische Forschung (WFS); Heinrich-Pette-Institut (WFS); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [F31AI116366] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	Deutsche Gesellschaft fur Infektiologische Forschung (WFS); Heinrich-Pette-Institut (WFS); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the Deutsche Gesellschaft fur Infektiologische Forschung (WFS), http://www.dzif.de/, and the Heinrich-Pette-Institut (WFS), http://www.hpi-hamburg.de. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerman ME, 2013, J CLIN INVEST, V123, P2183, DOI 10.1172/JCI65708; Alter G, 2011, NATURE, V476, P96, DOI 10.1038/nature10237; Alter G, 2009, J VIROL, V83, P6798, DOI 10.1128/JVI.00256-09; Altfeld M, 2015, NAT IMMUNOL, V16, P554, DOI 10.1038/ni.3157; Bagriacik EU, 1996, GLYCOBIOLOGY, V6, P413, DOI 10.1093/glycob/6.4.413; Barber LD, 1996, J IMMUNOL, V156, P3275; BARBOSA JA, 1987, J EXP MED, V166, P1329, DOI 10.1084/jem.166.5.1329; Bashirova AA, 2006, ANNU REV GENOM HUM G, V7, P277, DOI 10.1146/annurev.genom.7.080505.115726; Bieberich Erhard, 2014, Adv Neurobiol, V9, P47, DOI 10.1007/978-1-4939-1154-7_3; Braud VM, 1998, NATURE, V391, P795, DOI 10.1038/35869; Campbell KS, 2013, J ALLERGY CLIN IMMUN, V132, P536, DOI 10.1016/j.jaci.2013.07.006; Cella M, 2000, METH MOL B, V121, P1; Chung AW, 2014, AIDS, V28, P2523, DOI 10.1097/QAD.0000000000000444; Esko JD, 2009, CHEM TOOLS INHIBITIN; Fadda L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002805; Fadda L, 2011, J VIROL, V85, P5970, DOI 10.1128/JVI.00412-11; GLASSY MC, 1981, AM J PATHOL, V103, P1; GOLDSTEIN SAN, 1985, J EXP MED, V162, P1381, DOI 10.1084/jem.162.4.1381; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; HART GW, 1982, J BIOL CHEM, V257, P151; Kamya P, 2011, J VIROL, V85, P5949, DOI 10.1128/JVI.02652-10; Korner C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00326; Lanteri M, 2003, GLYCOBIOLOGY, V13, P909, DOI 10.1093/glycob/cwg110; Long EO, 2013, ANNU REV IMMUNOL, V31, P227, DOI 10.1146/annurev-immunol-020711-075005; MIYAZAKI J, 1986, J EXP MED, V163, P856, DOI 10.1084/jem.163.4.856; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Nagae M, 2012, INT J MOL SCI, V13, P8398, DOI 10.3390/ijms13078398; Orange JS, 2006, CURR OPIN ALLERGY CL, V6, P399, DOI 10.1097/ACI.0b013e3280106b65; PAABO S, 1986, P NATL ACAD SCI USA, V83, P9665, DOI 10.1073/pnas.83.24.9665; PARHAM P, 1977, J BIOL CHEM, V252, P7555; PLOEGH HL, 1981, J IMMUNOL, V126, P270; Raska M, 2010, J BIOL CHEM, V285, P20860, DOI 10.1074/jbc.M109.085472; Robinson J, 2015, NUCLEIC ACIDS RES, V43, pD423, DOI 10.1093/nar/gku1161; Schonthal AH, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/857516; STORKUS WJ, 1989, J IMMUNOL, V143, P3853; Tardif KD, 2003, J VIROL, V77, P11644, DOI 10.1128/JVI.77.21.11644-11650.2003; van Teijlingen NH, 2014, AIDS, V28, P1399, DOI 10.1097/QAD.0000000000000284; VANKEMENADE FJ, 1994, J LEUKOCYTE BIOL, V56, P159, DOI 10.1002/jlb.56.2.159; Vestrheim AC, 2014, IMMUN INFLAMM DIS, V2, P76, DOI 10.1002/iid3.22; Vivian JP, 2011, NATURE, V479, P401, DOI 10.1038/nature10517; Wu J, 2003, ADV CANCER RES, V90, P127, DOI 10.1016/S0065-230X(03)90004-2	41	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145324	10.1371/journal.pone.0145324	http://dx.doi.org/10.1371/journal.pone.0145324			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26680341	gold, Green Published, Green Submitted			2022-12-26	WOS:000366723400071
J	Tehrani, F; Reiner, L; Bavarian, B				Tehrani, Farshad; Reiner, Lisa; Bavarian, Behzad			Rapid Prototyping of a High Sensitivity Graphene Based Glucose Sensor Strip	PLOS ONE			English	Article							COPPER; NANOWIRES; HYBRID; NANOPARTICLES; NANOCUBES; SHEETS	A rapid prototyping of an inexpensive, disposable graphene and copper nanocomposite sensor strip using polymeric flexible substrate for highly sensitive and selective nonenzymatic glucose detection has been developed and tested for direct oxidization of glucose. The CuNPs were electrochemically deposited on to the graphene sheets to improve electron transfer rates and to enhance electrocatalytic activity toward glucose. The graphene based electrode with CuNPs demonstrated a high degree of sensitivity (1101.3 +/- 56 mu A/mM. cm(2)), excellent selectivity (without an interference with Ascorbic Acid, Uric Acid, Dopamine, and Acetaminophen), good stability with a linear response to glucose ranging from 0.1 mM to 0.6 mM concentration, and detection limits of 0.025 mM to 0.9 mM. Characterization of the electrodes was performed by scanning electron microscopy (FESEM and SEM). The electrochemical properties of the modified graphene electrodes were inspected by cyclic voltammetry (CV), electrochemical impedance spectroscopy (EIS), and amperometry.	[Tehrani, Farshad; Reiner, Lisa; Bavarian, Behzad] Calif State Univ Northridge, Mfg Syst Engn & Management, Kecks Adv Mat Lab, Northridge, CA 91330 USA; [Tehrani, Farshad; Reiner, Lisa; Bavarian, Behzad] Calif State Univ Northridge, Mfg Syst Engn & Management, Corros Res Lab, Northridge, CA 91330 USA	California State University System; California State University Northridge; California State University System; California State University Northridge	Tehrani, F (corresponding author), Calif State Univ Northridge, Mfg Syst Engn & Management, Kecks Adv Mat Lab, Northridge, CA 91330 USA.	farshad.tehrani.703@my.csun.edu						Claussen JC, 2012, ADV FUNCT MATER, V22, P3399, DOI 10.1002/adfm.201200551; Fan ZJ, 2013, ELECTROCHIM ACTA, V109, P602, DOI 10.1016/j.electacta.2013.07.153; Gan T, 2011, MICROCHIM ACTA, V175, P1, DOI 10.1007/s00604-011-0639-7; Gao HC, 2011, ACS APPL MATER INTER, V3, P3049, DOI 10.1021/am200563f; Grujicic D, 2002, ELECTROCHIM ACTA, V47, P2901, DOI 10.1016/S0013-4686(02)00161-5; He P, 2012, ANAL CHIM ACTA, V739, P25, DOI 10.1016/j.aca.2012.06.004; Hecht DS, 2011, ADV MATER, V23, P1482, DOI 10.1002/adma.201003188; Huang JW, 2013, SENSOR ACTUAT B-CHEM, V182, P618, DOI 10.1016/j.snb.2013.03.065; Kang XH, 2007, ANAL BIOCHEM, V363, P143, DOI 10.1016/j.ab.2007.01.003; Kang XH, 2009, BIOSENS BIOELECTRON, V25, P901, DOI 10.1016/j.bios.2009.09.004; Luo J, 2012, ANAL CHIM ACTA, V709, P47, DOI 10.1016/j.aca.2011.10.025; Luo LQ, 2012, BIOELECTROCHEMISTRY, V88, P156, DOI 10.1016/j.bioelechem.2012.03.006; Mallesha M, 2012, J SOLID STATE ELECTR, V16, P2675, DOI 10.1007/s10008-012-1674-y; Novoselov KS, 2012, NATURE, V490, P192, DOI 10.1038/nature11458; Pumera M., 2010, TRENDS ANAL CHEM, V29; Shao YY, 2010, ELECTROANAL, V22, P1027, DOI 10.1002/elan.200900571; Song HY, 2013, ANAL CHIM ACTA, V788, P24, DOI 10.1016/j.aca.2013.06.016; Stankovich S, 2006, NATURE, V442, P282, DOI 10.1038/nature04969; Wang J, 2011, ELECTROCHIM ACTA, V56, P7510, DOI 10.1016/j.electacta.2011.06.102; Wang LS, 2013, SENSOR ACTUAT B-CHEM, V176, P9, DOI 10.1016/j.snb.2012.08.077; Wu HX, 2010, ELECTROCHIM ACTA, V55, P3734, DOI 10.1016/j.electacta.2010.02.017; Yang JA, 2010, BIOSENS BIOELECTRON, V26, P279, DOI 10.1016/j.bios.2010.06.014; Zhang S, 2011, CHEM MATER, V23, P1079, DOI 10.1021/cm101568z; Zhang YC, 2012, BIOSENS BIOELECTRON, V31, P426, DOI 10.1016/j.bios.2011.11.006; Zhao Y, 2012, COLLOID SURFACE A, V409, P105, DOI 10.1016/j.colsurfa.2012.05.045; Zhu Z, 2012, SENSORS, P12	26	18	18	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 17	2015	10	12							e0145036	10.1371/journal.pone.0145036	http://dx.doi.org/10.1371/journal.pone.0145036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JO	26678700	Green Submitted, Green Published, gold			2022-12-26	WOS:000366723400043
J	Brahma, B; Patra, MC; Karri, S; Chopra, M; Mishra, P; De, BC; Kumar, S; Mahanty, S; Thakur, K; Poluri, KM; Datta, TK; De, S				Brahma, Biswajit; Patra, Mahesh Chandra; Karri, Satyanagalakshmi; Chopra, Meenu; Mishra, Purusottam; De, Bidhan Chandra; Kumar, Sushil; Mahanty, Sourav; Thakur, Kiran; Poluri, Krishna Mohan; Datta, Tirtha Kumar; De, Sachinandan			Diversity, Antimicrobial Action and Structure-Activity Relationship of Buffalo Cathelicidins	PLOS ONE			English	Article							BUBALUS-BUBALIS; MEMBRANE CURVATURE; OUTER-MEMBRANE; PEPTIDES; RESISTANCE; PROTEINS; CELLS; INDOLICIDIN; DEFENSINS; GEOMETRY	Cathelicidins are an ancient class of antimicrobial peptides (AMPs) with broad spectrum bactericidal activities. In this study, we investigated the diversity and biological activity of cathelicidins of buffalo, a species known for its disease resistance. A series of new homologs of cathelicidin4 (CATHL4), which were structurally diverse in their antimicrobial domain, was identified in buffalo. AMPs of newly identified buffalo CATHL4s (buCATHL4s) displayed potent antimicrobial activity against selected Gram positive (G+) and Gram negative (G-) bacteria. These peptides were prompt to disrupt the membrane integrity of bacteria and induced specific changes such as blebing, budding, and pore like structure formation on bacterial membrane. The peptides assumed different secondary structure conformations in aqueous and membrane-mimicking environments. Simulation studies suggested that the amphipathic design of buCATHL4 was crucial for water permeation following membrane disruption. A great diversity, broad-spectrum antimicrobial action, and ability to induce an inflammatory response indicated the pleiotropic role of cathelicidins in innate immunity of buffalo. This study suggests short buffalo cathelicidin peptides with potent bactericidal properties and low cytotoxicity have potential translational applications for the development of novel antibiotics and antimicrobial peptidomimetics.	[Brahma, Biswajit; Patra, Mahesh Chandra; Karri, Satyanagalakshmi; Chopra, Meenu; Mishra, Purusottam; De, Bidhan Chandra; Kumar, Sushil; Mahanty, Sourav; Thakur, Kiran; Datta, Tirtha Kumar; De, Sachinandan] Natl Dairy Res Inst, Anim Biotechnol Ctr, Anim Genom Lab, Karnal 132001, Haryana, India; [Poluri, Krishna Mohan] Indian Inst Technol, Dept Biotechnol, Roorkee, Uttarakhand, India	Indian Council of Agricultural Research (ICAR); ICAR - National Dairy Research Institute; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Roorkee	De, S (corresponding author), Natl Dairy Res Inst, Anim Biotechnol Ctr, Anim Genom Lab, Karnal 132001, Haryana, India.	sachinandan@ndri.res.in	Poluri, Krishna Mohan/H-6083-2013; Patra, Mahesh/I-9746-2014	Poluri, Krishna Mohan/0000-0003-3801-7134; De, Sachinandan/0000-0002-3182-0904; Brahma, Biswajit/0000-0003-0052-5029; Patra, Mahesh/0000-0003-0471-6236; De, Bidhan Chandra/0000-0002-9379-8909	Department of Biotechnology, Govt. of India [BT/PR3111/AAQ/1/474/2011]; IYBA fellowship from DBT, Govt. of India	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India); IYBA fellowship from DBT, Govt. of India	The study was supported by funding from Department of Biotechnology, Govt. of India (Grant No.: BT/PR3111/AAQ/1/474/2011). KMP acknowledge the support of IYBA fellowship from DBT, Govt. of India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We express our sincere thanks to Dr Jasvir Singh (IARI, New Delhi) for taking TEM images. We thank Dr SK Tomar, and Mr. Babbar (NDRI, India) for their help in SEM analysis. We are thankful to Dr AK Srivastava (Director, NDRI) for providing research facilities and his valuable comments on this study. The study was supported by funding from Department of Biotechnology (DBT), Govt. of India (Grant No.: BT/PR3111/AAQ/1/474/2011). KMP acknowledges the support of IYBA fellowship from DBT, Govt. of India. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen HK, 2010, NAT REV MICROBIOL, V8, P251, DOI 10.1038/nrmicro2312; BARBER J, 1989, NATURE, V340, P601, DOI 10.1038/340601a0; BASSAM BJ, 1993, APPL BIOCHEM BIOTECH, V42, P181, DOI 10.1007/BF02788051; Berney M, 2007, APPL ENVIRON MICROB, V73, P3283, DOI 10.1128/AEM.02750-06; Bickhart DM, 2012, GENOME RES, V22, P778, DOI 10.1101/gr.133967.111; Bjarnsholt T, 2013, NAT REV DRUG DISCOV, V12, P791, DOI 10.1038/nrd4000; Borriello G, 2006, INFECT IMMUN, V74, P2115, DOI 10.1128/IAI.74.4.2115-2120.2006; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; D'haene B, 2010, METHODS, V50, P262, DOI 10.1016/j.ymeth.2009.12.007; Das H, 2008, DNA SEQUENCE, V19, P347, DOI 10.1080/10425170701606219; Das H, 2006, DNA SEQUENCE, V17, P407, DOI 10.1080/10425170600760125; FAO, 2000, WAT BUFF ASS UND, P1; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Hancock REW, 1997, TRENDS MICROBIOL, V5, P37, DOI 10.1016/S0966-842X(97)81773-8; HEIN WR, 1991, IMMUNOL TODAY, V12, P30, DOI 10.1016/0167-5699(91)90109-7; Hilchie AL, 2013, NAT CHEM BIOL, V9, P761, DOI [10.1038/NCHEMBIO.1393, 10.1038/nchembio.1393]; Hsu CH, 2005, NUCLEIC ACIDS RES, V33, P4053, DOI 10.1093/nar/gki725; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Limia A, 2001, FEMS MICROBIOL LETT, V197, P151, DOI 10.1111/j.1574-6968.2001.tb10597.x; Liu GY, 2009, PEDIATR RES, V65, p71R, DOI 10.1203/PDR.0b013e31819dc44d; Moser B, 2011, CELL MOL LIFE SCI, V68, P2443, DOI 10.1007/s00018-011-0706-6; Mukherjee A, 2013, J ANIM SCI BIOTECHNO, V4, DOI 10.1186/2049-1891-4-15; Nagpal S, 1999, J BIOL CHEM, V274, P23296, DOI 10.1074/jbc.274.33.23296; NRC, 1981, WAT BUFF NEW PROSP U; Panicker VP, 2013, INDIAN J BIOCHEM BIO, V50, P273; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Pulido D, 2012, ANTIMICROB AGENTS CH, V56, P2378, DOI 10.1128/AAC.06107-11; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; Schmidt NW, 2013, CURR OPIN SOLID ST M, V17, P151, DOI 10.1016/j.cossms.2013.09.004; Schmidt NW, 2013, J AM CHEM SOC, V135, P13710, DOI 10.1021/ja400146z; Schmidt NW, 2012, J BIOL CHEM, V287, P21866, DOI 10.1074/jbc.M112.358721; Schmidt NW, 2011, J AM CHEM SOC, V133, P6720, DOI 10.1021/ja200079a; Siegel DP, 2004, BIOPHYS J, V87, P366, DOI 10.1529/biophysj.104.040782; Singh MK., 2013, J TEXT, V2013, P1, DOI [10.1155/2013/579129, DOI 10.1155/2013/579129]; Srinivas N, 2010, SCIENCE, V327, P1010, DOI 10.1126/science.1182749; Subbalakshmi C, 1998, FEMS MICROBIOL LETT, V160, P91, DOI 10.1016/S0378-1097(98)00008-1; Tomasinsig L, 2005, CURR PROTEIN PEPT SC, V6, P23, DOI 10.2174/1389203053027520; Torrent M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003005; Walsh AG, 2000, MOL MICROBIOL, V35, P718, DOI 10.1046/j.1365-2958.2000.01741.x; Wang JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024030; Whelan JA, 2003, J IMMUNOL METHODS, V278, P261, DOI 10.1016/S0022-1759(03)00223-0; Wiegand I, 2008, NAT PROTOC, V3, P163, DOI 10.1038/nprot.2007.521; Wildman KAH, 2003, BIOCHEMISTRY-US, V42, P6545, DOI 10.1021/bi0273563; Zanetti M, 2004, J LEUKOCYTE BIOL, V75, P39, DOI 10.1189/jlb.0403147; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhu SY, 2012, P NATL ACAD SCI USA, V109, P8495, DOI 10.1073/pnas.1201263109; Zimmerberg J, 2006, NAT REV MOL CELL BIO, V7, P9, DOI 10.1038/nrm1784	51	20	21	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144741	10.1371/journal.pone.0144741	http://dx.doi.org/10.1371/journal.pone.0144741			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675301	Green Submitted, Green Published, gold			2022-12-26	WOS:000366722700059
J	Hopkinson, RJ; Leung, IKH; Smart, TJ; Rose, NR; Henry, L; Claridge, TDW; Schofield, CJ				Hopkinson, Richard J.; Leung, Ivanhoe K. H.; Smart, Tristan J.; Rose, Nathan R.; Henry, Luc; Claridge, Timothy D. W.; Schofield, Christopher J.			Studies on the Glutathione-Dependent Formaldehyde-Activating Enzyme from Paracoccus denitrificans	PLOS ONE			English	Article							NMR-SPECTROSCOPY; ESCHERICHIA-COLI; HISTONE DEMETHYLASES; 2-DIMENSIONAL NMR; EXCHANGE; REPAIR; DNA; METABOLISM; PATHWAY; BINDING	Formaldehyde is a toxin and carcinogen that is both an environmental pollutant and an endogenous metabolite. Formaldehyde metabolism, which is probably essential for all aerobic cells, likely proceeds via multiple mechanisms, including via a glutathione-dependent pathway that is widely conserved in bacteria, plants and animals. However, it is unclear whether the first step in the glutathione-dependent pathway (i.e. formation of S-hydroxymethylglutathione (HMG)) is enzyme-catalysed. We report studies on glutathione-dependent formaldehyde-activating enzyme (GFA) from Paracoccus denitrificans, which has been proposed to catalyse HMG formation from glutathione and formaldehyde on the basis of studies using NMR exchange spectroscopy (EXSY). Although we were able to replicate the EXSY results, time course experiments unexpectedly imply that GFA does not catalyse HMG formation under standard conditions. However, GFA was observed to bind glutathione using NMR and mass spectrometry. Overall, the results reveal that GFA binds glutathione but does not directly catalyse HMG formation under standard conditions. Thus, it is possible that GFA acts as a glutathione carrier that acts to co-localise glutathione and formaldehyde in a cellular context.	[Hopkinson, Richard J.; Leung, Ivanhoe K. H.; Smart, Tristan J.; Rose, Nathan R.; Henry, Luc; Claridge, Timothy D. W.; Schofield, Christopher J.] Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England; [Leung, Ivanhoe K. H.] Univ Auckland, Sch Chem Sci, Auckland, New Zealand	University of Oxford; University of Auckland	Hopkinson, RJ (corresponding author), Univ Oxford, Dept Chem, Chem Res Lab, Oxford OX1 3TA, England.	richard.hopkinson@chem.ox.ac.uk; christopher.schofield@chem.ox.ac.uk	Hopkinson, Richard J/K-8372-2013; Leung, Ivanhoe/G-6168-2010; Claridge, Tim/A-8324-2018	Hopkinson, Richard J/0000-0001-7610-8163; Leung, Ivanhoe/0000-0003-0633-6771; Claridge, Tim/0000-0001-5583-6460; Schofield, Christopher/0000-0002-0290-6565; Henry, Luc/0000-0001-9653-7299	Wellcome Trust [086482/Z/08/Z]; British Heart Foundation [PG/12/33/29546]; University of Auckland [FRDF/3708277]; Biotechnology and Biological Sciences Research Council [BB/E527620/1]; St. Edmund Hall, University of Oxford; St. John's College, University of Oxford	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); University of Auckland; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); St. Edmund Hall, University of Oxford; St. John's College, University of Oxford	The authors thank the Wellcome Trust (086482/Z/08/Z, www.wellcome.ac.uk), the British Heart Foundation (PG/12/33/29546, www.bhf.org.uk), the University of Auckland (IKHL, FRDF/3708277, www.auckland.ac.nz) and the Biotechnology and Biological Sciences Research Council (studentship to RJH, BB/E527620/1, www.bbsrc.ac.uk) for funding the work. RJH acknowledges a William R. Miller Junior Research Fellowship from St. Edmund Hall, University of Oxford. LH acknowledges a Berrow Foundation Scholarship, Lincoln College, University of Oxford. NRR acknowledges a Commonwealth Scholarship and a Junior Research Fellowship from St. John's College, University of Oxford. The funders had no role in study design, data collection and analysis, decision to publish, or publication of the manuscript.	Agger K, 2008, CURR OPIN GENET DEV, V18, P159, DOI 10.1016/j.gde.2007.12.003; Bachand AM, 2010, CRIT REV TOXICOL, V40, P85, DOI 10.3109/10408440903341696; Bateman R, 2007, ORG BIOMOL CHEM, V5, P3363, DOI 10.1039/b707602a; Bosetti C, 2008, ANN ONCOL, V19, P29, DOI 10.1093/annonc/mdm202; Dalvit C, 2000, J BIOMOL NMR, V18, P65, DOI 10.1023/A:1008354229396; Dalvit C, 2001, J BIOMOL NMR, V21, P349, DOI 10.1023/A:1013302231549; ELBING K, 2001, CURRENT PROTOCOLS MO; Goenrich M, 2002, J BIOL CHEM, V277, P3069, DOI 10.1074/jbc.C100579200; Gutheil WG, 1997, BIOCHEM BIOPH RES CO, V238, P693, DOI 10.1016/S0006-291X(00)90000-7; Harms N, 1996, J BACTERIOL, V178, P6296, DOI 10.1128/jb.178.21.6296-6299.1996; Hopkinson RJ, 2010, ORG BIOMOL CHEM, V8, P4915, DOI 10.1039/c0ob00208a; Hopkinson RJ, 2010, CHEMBIOCHEM, V11, P506, DOI 10.1002/cbic.200900713; HUNTER BK, 1984, BIOCHEMISTRY-US, V23, P508, DOI 10.1021/bi00298a017; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Kong XQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025444; Leung IKH, 2010, CHEM BIOL, V17, P1316, DOI 10.1016/j.chembiol.2010.09.016; MASON RP, 1986, BIOCHEMISTRY-US, V25, P4504, DOI 10.1021/bi00364a008; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; NAYLOR S, 1988, BIOCHEM J, V249, P573, DOI 10.1042/bj2490573; Neculai AM, 2005, J BIOL CHEM, V280, P2826, DOI 10.1074/jbc.C400517200; PAIK WK, 1973, BIOCHEM BIOPH RES CO, V51, P781, DOI 10.1016/0006-291X(73)91383-1; PERRIN CL, 1990, CHEM REV, V90, P935, DOI 10.1021/cr00104a002; Pontel Lucas B, 2015, MOL CELL, V60, P177, DOI [10.1016/j.molcel.2015.08.020, DOI 10.1016/J.MOLCEL.2015.08.020]; Rosado IV, 2011, NAT STRUCT MOL BIOL, V18, P1432, DOI 10.1038/nsmb.2173; Sanchez-Pedregal VM, 2005, ANGEW CHEM INT EDIT, V44, P4172, DOI 10.1002/anie.200500503; Sedgwick B, 2007, DNA REPAIR, V6, P429, DOI 10.1016/j.dnarep.2006.10.005; Seidman CE, 2001, CURRENT PROTOCOLS MO; Tabor S., 2001, CURRENT PROTOCOLS MO; Tadeu AMB, 2008, EMBO J, V27, P2510, DOI 10.1038/emboj.2008.175; Walport LJ, 2014, J BIOL CHEM, V289, P18302, DOI 10.1074/jbc.M114.555052; Walport LJ, 2012, CURR OPIN CHEM BIOL, V16, P525, DOI 10.1016/j.cbpa.2012.09.015; Yi CQ, 2010, NATURE, V468, P330, DOI 10.1038/nature09497	33	6	6	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145085	10.1371/journal.pone.0145085	http://dx.doi.org/10.1371/journal.pone.0145085			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675168	Green Published, gold			2022-12-26	WOS:000366722700097
J	Johnson, TW; Mumford, AD; Scott, LJ; Mundell, S; Butler, M; Strange, JW; Rogers, CA; Reeves, BC; Baumbach, A				Johnson, Thomas W.; Mumford, Andrew D.; Scott, Lauren J.; Mundell, Stuart; Butler, Mark; Strange, Julian W.; Rogers, Chris A.; Reeves, Barnaby C.; Baumbach, Andreas			A Study of Platelet Inhibition, Using a 'Point of Care' Platelet Function Test, following Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction [PINPOINT-PPCI]	PLOS ONE			English	Article							CLOPIDOGREL; PRASUGREL; BIVALIRUDIN; REACTIVITY; TICAGRELOR; HEPARIN; PCI; AGGREGATION; STANDARD; THERAPY	Background Rapid coronary recanalization following ST-elevation myocardial infarction (STEMI) requires effective anti-platelet and anti-thrombotic therapies. This study tested the impact of door to end of procedure ('door-to-end') time and baseline platelet activity on platelet inhibition within 24hours post-STEMI. Methods and Findings 108 patients, treated with prasugrel and procedural bivalirudin, underwent Multiplate (R) platelet function testing at baseline, 0, 1, 2 and 24hours post-procedure. Major adverse cardiac events (MACE), bleeding and stent thrombosis (ST) were recorded. Baseline ADP activity was high (88.3U [71.8-109.0]), procedural time and consequently bivalirudin infusion duration were short (median door-to-end time 55minutes [40-70] and infusion duration 30minutes [ 20-42]). Baseline ADP was observed to influence all subsequent measurements of ADP activity, whereas door-to-end time only influenced ADP immediately post-procedure. High residual platelet reactivity (HRPR ADP>46.8U) was observed in 75% of patients immediately post-procedure and persisted in 24% of patients at 2hours. Five patients suffered in-hospital MACE (4.6%). Acute ST occurred in 4 patients, all were <120mins post-procedure and had HRPR. No significant bleeding was observed. In a post-hoc analysis, pre-procedural morphine use was associated with significantly higher ADP activity following intervention. Conclusions Baseline platelet function, time to STEMI treatment and opiate use all significantly influence immediate post-procedural platelet activity.	[Johnson, Thomas W.; Strange, Julian W.; Baumbach, Andreas] Bristol Heart Inst, Bristol, Avon, England; [Mumford, Andrew D.; Scott, Lauren J.; Mundell, Stuart; Butler, Mark; Rogers, Chris A.; Reeves, Barnaby C.] Univ Bristol, Bristol, Avon, England	University of Bristol; University of Bristol	Johnson, TW (corresponding author), Bristol Heart Inst, Bristol, Avon, England.	tom.johnson@uhbristol.nhs.uk		Strange, Julian/0000-0003-0476-0886; Mundell, Stuart/0000-0001-7754-3271; mumford, andrew/0000-0002-5523-511X; Reeves, Barnaby/0000-0002-5101-9487; Johnson, Thomas/0000-0003-4638-601X	local charitable trust (Above Beyond); Medicines Company; National Institute for Health Research (NIHR) Bristol Biomedical Research Unit in Cardiovascular Disease; British Heart Foundation [FS/09/031/27599, FS/11/49/28751] Funding Source: researchfish	local charitable trust (Above Beyond); Medicines Company; National Institute for Health Research (NIHR) Bristol Biomedical Research Unit in Cardiovascular Disease(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation)	This study was supported by a local charitable trust (Above & Beyond), The Medicines Company, and a grant from the National Institute for Health Research (NIHR) Bristol Biomedical Research Unit in Cardiovascular Disease. This paper represents independent research. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the UK Department of Health. None of the funders had any involvement in the study design; in the collection, analysis and interpretation of the data; in the writing of the report; and in the decision to submit the paper for publication.	Alexopoulos D, 2014, CIRC-CARDIOVASC INTE, V7, P233, DOI 10.1161/CIRCINTERVENTIONS.113.001118; Bhatt DL, 2013, NEW ENGL J MED, V368, P1303, DOI 10.1056/NEJMoa1300815; Bonello L, 2011, J AM COLL CARDIOL, V58, P467, DOI 10.1016/j.jacc.2011.04.017; Brandt JT, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2006.10.010; Collet JP, 2012, NEW ENGL J MED, V367, P2100, DOI 10.1056/NEJMoa1209979; Heestermans AACM, 2008, THROMB RES, V122, P776, DOI 10.1016/j.thromres.2008.01.021; Hobl EL, 2014, J AM COLL CARDIOL, V63, P630, DOI 10.1016/j.jacc.2013.10.068; Jernberg T, 2006, EUR HEART J, V27, P1166, DOI 10.1093/eurheartj/ehi877; Johnson TW, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-44; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Montalescot G, 2014, NEW ENGL J MED, V371, P1016, DOI 10.1056/NEJMoa1407024; Montalescot G, 2014, CIRCULATION, V129, P2136, DOI 10.1161/CIRCULATIONAHA.113.007524; Parodi G, 2014, EUR HEART J, V35, P1030; Parodi G, 2015, CIRC-CARDIOVASC INTE, V8, DOI 10.1161/CIRCINTERVENTIONS.114.001593; Parodi G, 2013, J AM COLL CARDIOL, V61, P1601, DOI 10.1016/j.jacc.2013.01.024; Price MJ, 2011, JAMA-J AM MED ASSOC, V305, P1097, DOI 10.1001/jama.2011.290; RAO AK, 1988, J AM COLL CARDIOL, V11, P1; Robson R, 2000, J INVASIVE CARDIOL, P1042; Schulz KF, 2005, LANCET, V365, P1591, DOI 10.1016/S0140-6736(05)66461-6; Schulz S, 2014, EUR HEART J, V35, P2285, DOI 10.1093/eurheartj/ehu182; Schulz S, 2014, CLIN CARDIOL, V37, P270, DOI 10.1002/clc.22268; Shahzad A, 2014, LANCET, V384, P1849, DOI 10.1016/S0140-6736(14)60924-7; Sibbing D, 2008, EUR HEART J, V29, P1504, DOI 10.1093/eurheartj/ehn195; Sibbing D, 2009, J AM COLL CARDIOL, V53, P849, DOI 10.1016/j.jacc.2008.11.030; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Stone GW, 2008, NEW ENGL J MED, V358, P2218, DOI 10.1056/NEJMoa0708191; Trenk D, 2012, J AM COLL CARDIOL, V59, P2159, DOI 10.1016/j.jacc.2012.02.026	27	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144984	10.1371/journal.pone.0144984	http://dx.doi.org/10.1371/journal.pone.0144984			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26672598	Green Published, gold, Green Submitted			2022-12-26	WOS:000366722700081
J	Zhang, XY; Crippen, TL; Coates, CJ; Wood, TK; Tomberlin, JK				Zhang, Xinyang; Crippen, Tawni L.; Coates, Craig J.; Wood, Thomas K.; Tomberlin, Jeffery K.			Effect of Quorum Sensing by Staphylococcus epidermidis on the Attraction Response of Female Adult Yellow Fever Mosquitoes, Aedes aegypti aegypti (Linnaeus) (Diptera: Culicidae), to a Blood-Feeding Source	PLOS ONE			English	Article							TO-CELL COMMUNICATION; HUMAN SKIN; MALARIA MOSQUITO; CARBON-DIOXIDE; HOST-SEEKING; MICROBIOTA; BACTERIA; CALLIPHORIDAE; ODOR; IDENTIFICATION	Aedes aegypti, the principal vector of yellow fever and dengue fever, is responsible for more than 30,000 deaths annually. Compounds such as carbon dioxide, amino acids, fatty acids and other volatile organic compounds (VOCs) have been widely studied for their role in attracting Ae. aegypti to hosts. Many VOCs from humans are produced by associated skin microbiota. Staphyloccocus epidermidis, although not the most abundant bacteria according to surveys of relative 16S ribosomal RNA abundance, commonly occurs on human skin. Bacteria demonstrate population level decision-making through quorum sensing. Many quorum sensing molecules, such as indole, volatilize and become part of the host odor plum. To date, no one has directly demonstrated the link between quorum sensing (i.e., decision-making) by bacteria associated with a host as a factor regulating arthropod vector attraction. This study examined this specific question with regards to S. epidermidis and Ae. aegypti. Pairwise tests were conducted to examine the response of female Ae. aegypti to combinations of tryptic soy broth (TSB) and S. epidermidis wildtype and agr-strains. The agr gene expresses an accessory gene regulator for quorum sensing; therefore, removing this gene inhibits quorum sensing of the bacteria. Differential attractiveness of mosquitoes to the wildtype and agr-strains was observed. Both wildtype and the agr-strain of S. epidermidis with TSB were marginally more attractive to Ae. aegypti than the TSB alone. Most interestingly, the blood-feeder treated with wildtype S. epidermidis/TSB attracted 74% of Ae. aegypti compared to the agr-strain of S. epidermidis/TSB (P <= 0.0001). This study is the first to suggest a role for interkingdom communication between host symbiotic bacteria and mosquitoes. This may have implications for mosquito decision-making with regards to host detection, location and acceptance. We speculate that mosquitoes "eavesdrop" on the chemical discussions occurring between host-associated microbes to determine suitability for blood feeding. We believe these data suggest that manipulating quorum sensing by bacteria could serve as a novel approach for reducing mosquito attraction to hosts, or possibly enhancing the trapping of adults at favored oviposition sites.	[Zhang, Xinyang; Coates, Craig J.; Tomberlin, Jeffery K.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Zhang, Xinyang] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Crippen, Tawni L.] Texas A&M Univ, USDA ARS, Southern Plains Agr Res Ctr, College Stn, TX 77843 USA; [Wood, Thomas K.] Penn State Univ, Dept Chem Engn, State Coll, PA 16802 USA	Texas A&M University System; Texas A&M University College Station; University of Cambridge; Texas A&M University System; Texas A&M University College Station; United States Department of Agriculture (USDA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Zhang, XY (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	zxy1385@gmail.com; jktomberlin@tamu.edu	Wood, Thomas/GWZ-2481-2022	Wood, Thomas/0000-0001-8962-8571; Crippen, Tawni/0000-0001-5129-2371	Department of Entomology and AgriLife Research, Texas AM University	Department of Entomology and AgriLife Research, Texas AM University	The authors wish to thank the support from Department of Entomology and AgriLife Research, Texas A&M University for this research. This work was completed in partial fulfillment of a MS degree to XZ.	Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Bernier UR, 2000, ANAL CHEM, V72, P747, DOI 10.1021/ac990963k; Carey AF, 2010, NATURE, V464, P66, DOI 10.1038/nature08834; Chaudhury MF, 2010, J MED ENTOMOL, V47, P349, DOI 10.1603/ME09235; Chaudhury MF, 2002, J MED ENTOMOL, V39, P130, DOI 10.1603/0022-2585-39.1.130; Clements A, 1995, AM J TROP MED HYG, V52, P579; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Cork A, 1996, OLF MOSQ HOST INT CI; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DAVIS EE, 1975, J COMP PHYSIOL, V96, P223, DOI 10.1007/BF00612696; De Jong R, 1996, CIB FUND S; DEJONG R, 1995, EXPERIENTIA, V51, P80, DOI 10.1007/BF01964925; Dekker T, 2001, PHYSIOL ENTOMOL, V26, P124, DOI 10.1046/j.1365-3032.2001.00225.x; Eldridge B.F., 2003, MED ENTOMOLOGY TXB P; Eldridge BF, 2000, MEDICAL ENTOMOLOGY, P1; Fredricks DN, 2001, J INVEST DERM SYMP P, V6, P167, DOI 10.1046/j.0022-202x.2001.00039.x; Geier M, 1999, CHEM SENSES, V24, P647, DOI 10.1093/chemse/24.6.647; GILLIES MT, 1980, B ENTOMOL RES, V70, P525, DOI 10.1017/S0007485300007811; Heijtza RD, 2011, P NATL ACAD SCI USA, V108, P3047, DOI 10.1073/pnas.1010529108; Hentzer M, 2003, EMBO J, V22, P3803, DOI 10.1093/emboj/cdg366; Hughes DT, 2008, NAT REV MICROBIOL, V6, P111, DOI 10.1038/nrmicro1836; James A G, 2004, Int J Cosmet Sci, V26, P149, DOI 10.1111/j.1467-2494.2004.00214.x; Joint I, 2002, SCIENCE, V298, P1207, DOI 10.1126/science.1077075; KLOOS WE, 1975, APPL MICROBIOL, V30, P381, DOI 10.1128/AEM.30.3.381-395.1975; KLOWDEN MJ, 1988, J AM MOSQUITO CONTR, V4, P73; Kong KF, 2006, INT J MED MICROBIOL, V296, P133, DOI 10.1016/j.ijmm.2006.01.042; Lee J, 2008, ISME J, V2, P1007, DOI 10.1038/ismej.2008.54; Lee YK, 2011, P NATL ACAD SCI USA, V108, P4615, DOI 10.1073/pnas.1000082107; LEYDEN JJ, 1987, J INVEST DERMATOL, V88, pS65, DOI 10.1111/1523-1747.ep12468965; Lowery CA, 2008, CHEM SOC REV, V37, P1337, DOI 10.1039/b702781h; Ma Q, 2012, ISME J, V6, P1356, DOI 10.1038/ismej.2011.210; Mayer EA, 2011, NAT REV NEUROSCI, V12, P453, DOI 10.1038/nrn3071; McCLELLAND G. A. H., 1959, BULL ENT RES, V50, P227, DOI 10.1017/S0007485300054547; Microbiology ASF., 2008, HUM HAV 10 TIM MOR B; Moreira CG, 2012, INFECT IMMUN, V80, P4344, DOI 10.1128/IAI.00803-12; Morris MC, 2005, NEW ZEAL J AGR RES, V48, P151, DOI 10.1080/00288233.2005.9513645; Ponnusamy L, 2008, P NATL ACAD SCI USA, V105, P9262, DOI 10.1073/pnas.0802505105; PRICE GD, 1979, J CHEM ECOL, V5, P383, DOI 10.1007/BF00987924; Qiu YT, 2004, MED VET ENTOMOL, V18, P429, DOI 10.1111/j.0269-283X.2004.00534.x; Qiu YT, 2006, CHEM SENSES, V31, P845, DOI 10.1093/chemse/bjl027; SCHLEIFER KH, 1975, INT J SYST BACTERIOL, V25, P50, DOI 10.1099/00207713-25-1-50; SHELLEY WB, 1953, AMA ARCH DERM SYPH, V68, P430, DOI 10.1001/archderm.1953.01540100070012; Shin SC, 2011, SCIENCE, V334, P670, DOI 10.1126/science.1212782; Smallegange RC, 2011, TRENDS PARASITOL, V27, P143, DOI 10.1016/j.pt.2010.12.009; Sturgill G, 2004, MOL MICROBIOL, V51, P437, DOI 10.1046/j.1365-2958.2003.03835.x; Sumba Leunita A., 2004, International Journal of Tropical Insect Science, V24, P260, DOI 10.1079/IJT200433; Syed Z, 2008, P NATL ACAD SCI USA, V105, P13598, DOI 10.1073/pnas.0805312105; Syed Z, 2009, P NATL ACAD SCI USA, V106, P18803, DOI 10.1073/pnas.0906932106; Takken W, 1999, ANNU REV ENTOMOL, V44, P131, DOI 10.1146/annurev.ento.44.1.131; TAKKEN W, 1991, INSECT SCI APPL, V12, P287, DOI 10.1017/S1742758400020816; THOMAS DL, 1990, J WILDLIFE MANAGE, V54, P322, DOI 10.2307/3809050; Turnbaugh PJ, 2007, NATURE, V449, P804, DOI 10.1038/nature06244; Verhulst NO, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015829; Verhulst NO, 2010, FEMS MICROBIOL ECOL, V74, P1, DOI 10.1111/j.1574-6941.2010.00908.x; Verhulst NO, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-302; Vuong C, 2000, INFECT IMMUN, V68, P1048, DOI 10.1128/IAI.68.3.1048-1053.2000; Wang YL, 2010, P NATL ACAD SCI USA, V107, P8375, DOI 10.1073/pnas.1003571107; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Wu LC, 2005, SCIENCE, V309, P774, DOI 10.1126/science.1112422; YASUNO M, 1970, B WORLD HEALTH ORGAN, V43, P319	61	11	11	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0143950	10.1371/journal.pone.0143950	http://dx.doi.org/10.1371/journal.pone.0143950			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674802	Green Published, gold, Green Submitted			2022-12-26	WOS:000366722700018
J	Ma, HL; Wang, Y; Wu, JH; Wang, BX; Guo, SC; Luo, P; Han, BX				Ma, Hailin; Wang, Yan; Wu, Jianhui; Wang, Baoxi; Guo, Shichun; Luo, Ping; Han, Buxin			Long-Term Exposure to High Altitude Affects Conflict Control in the Conflict-Resolving Stage	PLOS ONE			English	Article							DECISION-MAKING; P300; ADAPTATION; BRAIN; COMPONENTS; RESIDENCE; HYPOXIA; N200; TASK	The neurocognitive basis of the effect of long-term high altitude exposure on conflict control is unclear. Event related potentials (ERPs) were recorded in a flanker task to investigate the influence of high altitude on conflict control in the high-altitude group (who had lived at high altitude for three years but were born at low altitude) and the low-altitude group (living in low altitude only). Although altitude effect was not significant at the behavioral level, ERPs showed cognitive conflict modulation. The interaction between group and trial type was significant: P3 amplitude was greater in the low-altitude group than in the high-altitude group in the incongruent trial. This result suggests that long-term exposure to high altitude affects conflict control in the conflict-resolving stage, and that attentional resources are decreased to resist the conflict control in the high-altitude group.	[Ma, Hailin; Wang, Yan; Han, Buxin] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China; [Ma, Hailin] Univ Chinese Acad Sci, Beijing, Peoples R China; [Ma, Hailin; Luo, Ping] Tibet Univ, Inst Educ & Psychol, Tibet, Peoples R China; [Wu, Jianhui] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Wang, Baoxi] Jiangxi Normal Univ, Sch Psychol, Key Lab Jiangxi Prov Psychol & Cognit Sci, Nanchang, Peoples R China; [Guo, Shichun] Tsinghua Univ, Dept Psychol, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Tibet University; Chinese Academy of Sciences; Institute of Psychology, CAS; Jiangxi Normal University; Tsinghua University	Wang, Y (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Beijing 100101, Peoples R China.	wangyan@psych.ac.cn			National Natural Science Foundation of China [Y2JJ081004]; Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences(Chinese Academy of Sciences)	This research was supported by the National Natural Science Foundation of China (Y2JJ081004) and Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences.; This research was supported by the National Natural Science Foundation of China (Y2JJ081004) and Key Laboratory of Mental Health, Institute of Psychology, Chinese Academy of Sciences.	Beall CM, 2000, HUM BIOL, V72, P201; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Brydges CR, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00080; Clayson PE, 2011, NEUROPSYCHOLOGIA, V49, P1953, DOI 10.1016/j.neuropsychologia.2011.03.023; COLES MGH, 1995, OX PSYCH S, P86; Di Russo F, 2002, HUM BRAIN MAPP, V15, P95, DOI 10.1002/hbm.10010; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Fan J, 2003, NEUROIMAGE, V18, P42, DOI 10.1006/nimg.2002.1319; Hayashi R, 2005, CLIN NEUROPHYSIOL, V116, P1471, DOI 10.1016/j.clinph.2005.02.020; Heil M, 2000, J PSYCHOPHYSIOL, V14, P218, DOI 10.1027//0269-8803.14.4.218; HOCHACHKA PW, 1994, J CEREBR BLOOD F MET, V14, P671, DOI 10.1038/jcbfm.1994.84; Johnstone SJ, 2009, INT J PSYCHOPHYSIOL, V72, P145, DOI 10.1016/j.ijpsycho.2008.11.007; Kok A, 2001, PSYCHOPHYSIOLOGY, V38, P557, DOI 10.1017/S0048577201990559; Kopp B, 1996, PSYCHOPHYSIOLOGY, V33, P282, DOI 10.1111/j.1469-8986.1996.tb00425.x; Larson MJ, 2014, INT J PSYCHOPHYSIOL, V93, P283, DOI 10.1016/j.ijpsycho.2014.06.007; Luck SJ, 2014, INTRODUCTION TO THE EVENT-RELATED POTENTIAL TECHNIQUE, 2ND EDITION, P1; Luck SJ, 2012, OXFORD HDB EVENT REL; Ma HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep11524; Mennes M, 2008, PSYCHOPHYSIOLOGY, V45, P714, DOI 10.1111/j.1469-8986.2008.00678.x; Miller J, 1998, PSYCHOPHYSIOLOGY, V35, P99, DOI 10.1111/1469-8986.3510099; Nieuwenhuis S, 2005, PSYCHOL BULL, V131, P510, DOI 10.1037/0033-2909.131.4.510; Okumura A, 2003, HIGH ALT MED BIOL, V4, P349, DOI 10.1089/152702903769192304; Pascual-Marqui R.D., 2002, JPN J CLIN NEUROPHYS, V30, P81; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Richardson C, 2011, CLIN NEUROPHYSIOL, V122, P1726, DOI 10.1016/j.clinph.2011.02.001; Rueda MR, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-39; SEMLITSCH HV, 1986, PSYCHOPHYSIOLOGY, V23, P695, DOI 10.1111/j.1469-8986.1986.tb00696.x; Singh SB, 2004, INDIAN J MED RES, V120, P94; Thakur L, 2011, INDIAN J MED RES, V134, P113; Tillman CM, 2011, PSYCHOPHYSIOLOGY, V48, P1405, DOI 10.1111/j.1469-8986.2011.01203.x; Tulek B, 2013, J SLEEP RES, V22, P422, DOI 10.1111/jsr.12038; Ulrich R, 2001, PSYCHOPHYSIOLOGY, V38, P816, DOI 10.1111/1469-8986.3850816; van Veen V, 2002, PHYSIOL BEHAV, V77, P477, DOI 10.1016/S0031-9384(02)00930-7; Virues-Ortega J, 2011, DEVELOPMENTAL SCI, V14, P1185, DOI 10.1111/j.1467-7687.2011.01064.x; Wang BX, 2013, BRAIN RES, V1490, P161, DOI 10.1016/j.brainres.2012.10.053; Wang YQ, 2014, SCI REP-UK, V4, DOI 10.1038/srep05459; Wesensten NJ, 1993, AVIAT SPACE ENV MED; Wu TY, 2006, HIGH ALT MED BIOL, V7, P193, DOI 10.1089/ham.2006.7.193; Yan XD, 2011, BRAIN COGNITION, V77, P53, DOI 10.1016/j.bandc.2011.06.002; Yan XD, 2010, BRAIN RES, V1348, P21, DOI 10.1016/j.brainres.2010.06.024; Zubieta-Calleja G., 2010, HUMAN ADAPTATION HIG	42	11	16	5	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145246	10.1371/journal.pone.0145246	http://dx.doi.org/10.1371/journal.pone.0145246			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671280	gold, Green Published, Green Submitted			2022-12-26	WOS:000366719300057
J	Olsson, E; Winter, C; George, A; Chen, YL; Torngren, T; Bendahl, PO; Borg, A; Gruvberger-Saal, SK; Saal, LH				Olsson, Eleonor; Winter, Christof; George, Anthony; Chen, Yilun; Torngren, Therese; Bendahl, Par-Ola; Borg, Ake; Gruvberger-Saal, Sofia K.; Saal, Lao H.			Mutation Screening of 1,237 Cancer Genes across Six Model Cell Lines of Basal-Like Breast Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; DNA-SEQUENCING DATA; MOLECULAR PORTRAITS; COLORECTAL CANCERS; TUMOR-SUPPRESSOR; CARCINOMAS; PHENOTYPE; FRAMEWORK; PATTERNS; GENOMES	Basal-like breast cancer is an aggressive subtype generally characterized as poor prognosis and lacking the expression of the three most important clinical biomarkers, estrogen receptor, progesterone receptor, and HER2. Cell lines serve as useful model systems to study cancer biology in vitro and in vivo. We performed mutational profiling of six basal-like breast cancer cell lines (HCC38, HCC1143, HCC1187, HCC1395, HCC1954, and HCC1937) and their matched normal lymphocyte DNA using targeted capture and next-generation sequencing of 1,237 cancer-associated genes, including all exons, UTRs and upstream flanking regions. In total, 658 somatic variants were identified, of which 378 were non-silent (average 63 per cell line, range 37-146) and 315 were novel (not present in the Catalogue of Somatic Mutations in Cancer database; COSMIC). 125 novel mutations were confirmed by Sanger sequencing (59 exonic, 48 3'UTR and 10 5'UTR, 1 splicing), with a validation rate of 94% of high confidence variants. Of 36 mutations previously reported for these cell lines but not detected in our exome data, 36% could not be detected by Sanger sequencing. The base replacements C/G>A/T, C/G>G/C, C/G>T/A and A/T>G/C were significantly more frequent in the coding regions compared to the non-coding regions (OR 3.2, 95% CI 2.0-5.3, P<0.0001; OR 4.3, 95% CI 2.9-6.6, P<0.0001; OR 2.4, 95% CI 1.8-3.1, P<0.0001; OR 1.8, 95% CI 1.2-2.7, P = 0.024, respectively). The single nucleotide variants within the context of T[C] T/A[G] A and T[C] A/T[G] A were more frequent in the coding than in the non-coding regions (OR 3.7, 95% CI 2.2-6.1, P<0.0001; OR 3.8, 95% CI 2.0-7.2, P = 0.001, respectively). Copy number estimations were derived from the targeted regions and correlated well to Affymetrix SNP array copy number data (Pearson correlation 0.82 to 0.96 for all compared cell lines; P<0.0001). These mutation calls across 1,237 cancer-associated genes and identification of novel variants will aid in the design and interpretation of biological experiments using these six basal-like breast cancer cell lines.	[Olsson, Eleonor; Winter, Christof; George, Anthony; Chen, Yilun; Torngren, Therese; Bendahl, Par-Ola; Borg, Ake; Gruvberger-Saal, Sofia K.; Saal, Lao H.] Lund Univ, Dept Clin Sci, Div Oncol & Pathol, Lund, Sweden; [Olsson, Eleonor; Winter, Christof; George, Anthony; Chen, Yilun; Torngren, Therese; Borg, Ake; Gruvberger-Saal, Sofia K.; Saal, Lao H.] Lund Univ, Ctr Canc, Lund, Sweden; [Borg, Ake; Saal, Lao H.] Lund Univ, CREATE Hlth Strateg Ctr Translat Canc Res, Lund, Sweden	Lund University; Lund University; Lund University	Saal, LH (corresponding author), Lund Univ, Dept Clin Sci, Div Oncol & Pathol, Lund, Sweden.	lao.saal@med.lu.se	Winter, Christof/A-1887-2011; Olsson, Eleonor/AAF-1733-2020; Saal, Lao H/A-2919-2011; Winter, Christof/AAF-1860-2020	Winter, Christof/0000-0002-0253-9056; Saal, Lao H/0000-0002-0815-1896; Winter, Christof/0000-0002-0253-9056	Swedish Research Council; Swedish Cancer Society; Governmental Funding of Clinical Research within National Health Service; Crafoord Foundation; Mrs. Berta Kamprad Foundation; Lund University Medical Faculty; Gunnar Nilsson Cancer Foundation; Skane University Hospital Foundation; BioCARE Research Program; King Gustav Vth Jubilee Foundation; Krapperup Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Governmental Funding of Clinical Research within National Health Service; Crafoord Foundation; Mrs. Berta Kamprad Foundation; Lund University Medical Faculty; Gunnar Nilsson Cancer Foundation; Skane University Hospital Foundation; BioCARE Research Program; King Gustav Vth Jubilee Foundation; Krapperup Foundation	This study was funded by the Swedish Research Council, Swedish Cancer Society, Governmental Funding of Clinical Research within National Health Service, Crafoord Foundation, Mrs. Berta Kamprad Foundation, Lund University Medical Faculty, Gunnar Nilsson Cancer Foundation, Skane University Hospital Foundation, BioCARE Research Program, King Gustav Vth Jubilee Foundation, and the Krapperup Foundation. The funders had no role in study design, data gathering, data analysis, data interpretation, decision to publish, or writing of the report.	Abaan OD, 2013, CANCER RES, V73, P4372, DOI 10.1158/0008-5472.CAN-12-3342; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Antoniou AC, 2014, NEW ENGL J MED, V371, P497, DOI [10.1056/NEJMoa1400382, 10.1056/NEJMc1410673]; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Da Silva L, 2007, J CLIN PATHOL, V60, P1328, DOI 10.1136/jcp.2006.041731; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ferlay J, 2012, INT J CANC; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Friebel TM, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju091; FUTREAL PA, 1994, SCIENCE, V266, P120, DOI 10.1126/science.7939630; Galante PAF, 2011, NUCLEIC ACIDS RES, V39, P6056, DOI 10.1093/nar/gkr221; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hakansson S, 1997, AM J HUM GENET, V60, P1068; Han JX, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2875; Hollestelle A, 2010, BREAST CANCER RES TR, V121, P53, DOI 10.1007/s10549-009-0460-8; Hu Z, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2487; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Kanehisa M, 2014, NUCLEIC ACIDS RES, V42, pD199, DOI 10.1093/nar/gkt1076; Kao J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006146; Kircher M, 2014, NAT GENET, V46, P310, DOI 10.1038/ng.2892; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Landrum MJ, 2014, NUCLEIC ACIDS RES, V42, pD980, DOI 10.1093/nar/gkt1113; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2012, BIOINFORMATICS, V28, P1307, DOI 10.1093/bioinformatics/bts146; Li ST, 2013, GENOME RES, V23, P195, DOI 10.1101/gr.132480.111; Liu XM, 2013, HUM MUTAT, V34, pE2393, DOI 10.1002/humu.22376; Lobry C, 2014, BLOOD, V123, P2451, DOI 10.1182/blood-2013-08-355818; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McPherson K, 2000, BMJ-BRIT MED J, V321, P624, DOI 10.1136/bmj.321.7261.624; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Reva B, 2011, NUCLEIC ACIDS RES, V39, pE118, DOI 10.1093/nar/gkr407; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Saal LH, 2008, NAT GENET, V40, P102, DOI 10.1038/ng.2007.39; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shah SP, 2009, NATURE, V461, P809, DOI 10.1038/nature08489; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Stephens PJ, 2009, NATURE, V462, P1005, DOI 10.1038/nature08645; Turner NC, 2006, ONCOGENE, V25, P5846, DOI 10.1038/sj.onc.1209876; Wang K, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq603; Wistuba II, 1998, CLIN CANCER RES, V4, P2931; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; WOOSTER R, 1994, SCIENCE, V265, P2088, DOI 10.1126/science.8091231	54	5	5	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144528	10.1371/journal.pone.0144528	http://dx.doi.org/10.1371/journal.pone.0144528			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26670335	Green Published, Green Submitted, gold			2022-12-26	WOS:000366719300010
J	Sujkowski, A; Rainier, S; Fink, JK; Wessells, RJ				Sujkowski, Alyson; Rainier, Shirley; Fink, John K.; Wessells, Robert J.			Delayed Induction of Human NTE (PNPLA6) Rescues Neurodegeneration and Mobility Defects of Drosophila swiss cheese (sws) Mutants	PLOS ONE			English	Article							NEUROPATHY TARGET ESTERASE; MUTATIONS; PHOSPHATIDYLCHOLINE; DEGENERATION; FAILURE; DECLINE; FORMS	Human PNPLA6 gene encodes Neuropathy Target Esterase protein (NTE). PNPLA6 gene mutations cause hereditary spastic paraplegia (SPG39 HSP), Gordon-Holmes syndrome, Boucher-Neuhauser syndromes, Laurence-Moon syndrome, and Oliver-McFarlane syndrome. Mutations in the Drosophila NTE homolog swiss cheese (sws) cause early-onset, progressive behavioral defects and neurodegeneration characterized by vacuole formation. We investigated sws(5) flies and show for the first time that this allele causes progressive vacuolar formation in the brain and progressive deterioration of negative geotaxis speed and endurance. We demonstrate that inducible, neuron-specific expression of full-length human wildtype NTE reduces vacuole formation and substantially rescues mobility. Indeed, neuron-specific expression of wildtype human NTE is capable of rescuing mobility defects after 10 days of adult life at 29 degrees C, when significant degeneration has already occurred, and significantly extends longevity of mutants at 25 degrees C. These results raise the exciting possibility that late induction of NTE function may reduce or ameliorate neurodegeneration in humans even after symptoms begin. In addition, these results highlight the utility of negative geotaxis endurance as a new assay for longitudinal tracking of degenerative phenotypes in Drosophila.	[Sujkowski, Alyson; Wessells, Robert J.] Wayne State Univ, Sch Med, Dept Physiol, Detroit, MI 48201 USA; [Rainier, Shirley; Fink, John K.] Univ Michigan, Dept Neurol, Sch Med, Ann Arbor, MI 48109 USA; [Fink, John K.] Ann Arbor Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, Ann Arbor, MI USA	Wayne State University; University of Michigan System; University of Michigan; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System	Fink, JK (corresponding author), Univ Michigan, Dept Neurol, Sch Med, Ann Arbor, MI 48109 USA.	jkfink@umich.edu; rwessell@med.wayne.edu	Wessells, Robert/AAG-3406-2020	Sujkowski, Alyson/0000-0002-9909-9279; Wessells, Robert/0000-0002-4516-3183	National Institutes of Health [R01 NS069700]; Department of Veterans Affairs (Merit Review Award); Spastic Paraplegia Foundation; Geriatric Research, Education, and Clinical Center; Ann Arbor Veterans Affairs Medical Center; Wayne State Department of Physiology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS069700] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs (Merit Review Award)(US Department of Veterans Affairs); Spastic Paraplegia Foundation; Geriatric Research, Education, and Clinical Center; Ann Arbor Veterans Affairs Medical Center; Wayne State Department of Physiology; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This investigation was supported by grants (to JKF) from the National Institutes of Health (R01 NS069700), Department of Veterans Affairs (Merit Review Award), the Spastic Paraplegia Foundation; the Geriatric Research, Education, and Clinical Center, Ann Arbor Veterans Affairs Medical Center, the Paul and Lois Katzman Family, and the generous contributions of private individuals and families and by support (to RJW) from the Wayne State Department of Physiology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akassoglou K, 2004, P NATL ACAD SCI USA, V101, P5075, DOI 10.1073/pnas.0401030101; Barone MC, 2013, JOVE-J VIS EXP, DOI 10.3791/50339; Bazzell B, 2013, J EXP BIOL, V216, P859, DOI 10.1242/jeb.078758; da Cruz AB, 2008, J NEUROSCI, V28, P10885, DOI 10.1523/JNEUROSCI.3015-08.2008; Fink JK, 2002, NEUROL CLIN, V20, P711, DOI 10.1016/S0733-8619(02)00007-5; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; Hein ND, 2010, TOXICOL LETT, V199, P1, DOI 10.1016/j.toxlet.2010.06.020; Hufnagel RB, 2015, J MED GENET, V52, P85, DOI 10.1136/jmedgenet-2014-102856; Kim M, 2013, AUTOPHAGY, V9, P1201, DOI 10.4161/auto.24811; Kmoch S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6614; Kretzschmar D, 1997, J NEUROSCI, V17, P7425; Kretzschmar Doris, 2005, Invertebrate Neuroscience, V5, P97, DOI 10.1007/s10158-005-0005-8; Makhaeva GF, 2010, CHEM-BIOL INTERACT, V187, P177, DOI 10.1016/j.cbi.2009.12.018; Makhaeva GF, 2014, J APPL TOXICOL, V34, P1426, DOI 10.1002/jat.2977; Moser M, 2004, MOL CELL BIOL, V24, P1667, DOI 10.1128/MCB.24.4.1667-1679.2004; Muhlig-Versen M, 2005, J NEUROSCI, V25, P2865, DOI 10.1523/JNEUROSCI.5097-04.2005; Petersen AJ, 2012, P NATL ACAD SCI USA, V109, pE656, DOI 10.1073/pnas.1110470109; Piazza N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005886; Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Synofzik M, 2014, BRAIN, V137, P69, DOI 10.1093/brain/awt326; Tinkerhess MJ, 2012, JOVE-J VIS EXP, DOI 10.3791/3786; Tinkerhess MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031633; Topaloglu AK, 2014, J CLIN ENDOCR METAB, V99, pE2067, DOI 10.1210/jc.2014-1836; Tsou WL, 2015, NEUROBIOL DIS, V82, P12, DOI 10.1016/j.nbd.2015.05.010; VILANOVA E, 1993, CHEM-BIOL INTERACT, V87, P369, DOI 10.1016/0009-2797(93)90065-7; Wentzell JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087526; Zaccheo O, 2004, J BIOL CHEM, V279, P24024, DOI 10.1074/jbc.M400830200; Zhang S, 2009, DIS MODEL MECH, V2, P247, DOI 10.1242/dmm.000653	29	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0145356	10.1371/journal.pone.0145356	http://dx.doi.org/10.1371/journal.pone.0145356			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671664	gold, Green Submitted, Green Published			2022-12-26	WOS:000366719300060
J	Colchero, MA; Salgado, JC; Unar-Munguia, M; Molina, M; Ng, SW; Rivera-Dommarco, JA				Arantxa Colchero, M.; Carlos Salgado, Juan; Unar-Munguia, Mishel; Molina, Mariana; Ng, Shuwen; Angel Rivera-Dommarco, Juan			Changes in Prices After an Excise Tax to Sweetened Sugar Beverages Was Implemented in Mexico: Evidence from Urban Areas	PLOS ONE			English	Article								In 2014 an excise tax to non-alcoholic sweetened beverages (SSB) was implemented in Mexico. The objective of this paper is to study whether and to what degree these taxes passed-through onto SSB prices in urban areas overall and by region, type of beverage and package size. Prices were obtained from the National Institute of Statistics and Geography from 2011 to 2014. We applied a pre-post quasi-experimental approach using fixed effects models. In sensitivity analysis we applied other model specifications to test the robustness of the findings and we also present weighted estimations based on household purchases. The dependent variables are real prices of a specific beverage category; the main independent variables are dummies for each month of 2014, and the models adjust for time trends and seasonality. Results suggest that the SSB tax passed along to consumers for all SSBs and we found overshifting for the carbonated SSBs. A greater effect is seen among the small package sizes, and we see heterogeneous effects by region. Estimating the effect of the tax on prices is important to understand the potential effect on consumption.	[Arantxa Colchero, M.; Carlos Salgado, Juan; Molina, Mariana] Inst Nacl Salud Publ, Ctr Hlth Syst Res CISS, Cuernavaca, Morelos, Mexico; [Unar-Munguia, Mishel; Angel Rivera-Dommarco, Juan] Inst Nacl Salud Publ, Nutr & Hlth Res Ctr CINyS, Cuernavaca, Morelos, Mexico; [Ng, Shuwen] Univ N Carolina, Dept Nutr, Chapel Hill, NC USA; [Ng, Shuwen] Univ N Carolina, Carolina Populat Ctr, Chapel Hill, NC USA	Instituto Nacional de Salud Publica; Instituto Nacional de Salud Publica; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Colchero, MA (corresponding author), Inst Nacl Salud Publ, Ctr Hlth Syst Res CISS, Cuernavaca, Morelos, Mexico.	acolchero@insp.mx	Munguia, Mishel Unar/P-7134-2019	Munguia, Mishel Unar/0000-0002-1156-9337	Bloomberg Foundation	Bloomberg Foundation	Funded by Bloomberg Foundation, project "Fighting obesity in Mexico: Supporting the design and evaluation of effective social actions and public policies". The sponsor did not have any role in the study design, analysis, and preparation of the manuscript or decision to publish.	Barquera S, 2013, SALUD PUBLICA MEXICO, V55, pS151, DOI 10.21149/spm.v55s2.5111; Berardi N., 2012, IMPACT SODA TAX PRIC, DOI 10.2139/ssrn.2192470; Bergman UM, 2012, ARE EXCISE TAXES BEV; Besley T, 1998, 6667 NAT BUR EC RES; Besley TJ, 1999, NATL TAX J, V52, P157; Bonnet C, 2013, J PUBLIC ECON, V106, P77, DOI 10.1016/j.jpubeco.2013.06.010; Cahuana H L, 2012, OBSEIDAD MEXICO RECO, P331; Colchero MA, 2015, ECON HUM BIOL, V19, P129, DOI 10.1016/j.ehb.2015.08.007; Consejo Nacional de Poblacion, 2012, PROYECC POBL NAC 201; Delipalla S, 1999, ESTIMATING TAX INCID, V9901; Euromonitor, 2011, EUR INT PASS GLOB MA; Harris J, 1987, TAX POLICY EC; Hernandez-Avila M, 2013, SALUD PUBLICA MEXICO, V55, pS129, DOI 10.21149/spm.v55s2.5108; Instituto Nacional de Estadistica y Geografia, 2013, MONTHL SURV MAN IND; Instituto Nacional de Estadistica y Geografia, 2011, SIST CUENT NAC MEX; Instituto Nacional de Estadistica y Geografia, 2013, IND NAC PREC CONS DO; Instituto Nacional de Estadustica y Geografia, 2014, IND PREC; Instituto Nacional de Salud Publica, 2012, EST NUTR AN SEQ AL P; Kenkel D, 2005, AM EC REV, V95; Konrad KA, 2014, CAN J ECON, V47, P173, DOI 10.1111/caje.12067; Ma ZQ, 2013, PREV CHRONIC DIS, V10, DOI [10.5888/pcd10.120268, 10.5888/pcd10.130143]; Malik VS, 2006, AM J CLIN NUTR, V84, P274; Malik VS, 2010, DIABETES CARE, V33, P2477, DOI 10.2337/dc10-1079; Mccorriston S, 2005, INT TAX PUBLIC FINAN, V12, P627, DOI 10.1007/s10797-005-0476-x; Morenga LT, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7492; OECD, 2011, HLTH GLANC 2011 IND; Roodman D, 2009, STATA J, V9, P86, DOI 10.1177/1536867X0900900106; Sanchez-Pimienta T, 2015, 16 C INV SAL PUBL; Seade J, 1985, 260 U WARW DEP EC WA; Secretaria de Salud, 2013, ESTR NAC PREV CONTR; Stata Corp, 2014, STATA STAT SOFTW REL; Vartanian LR, 2007, AM J PUBLIC HEALTH, V97, P667, DOI 10.2105/AJPH.2005.083782; Willett WC, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e8077; Young DJ, 2002, NATL TAX J, V55, P57, DOI 10.17310/ntj.2002.1.04	34	110	113	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 14	2015	10	12							e0144408	10.1371/journal.pone.0144408	http://dx.doi.org/10.1371/journal.pone.0144408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CY9GR	26675166	Green Published, gold, Green Submitted			2022-12-26	WOS:000366715900044
J	Ruscica, M; Ricci, C; Macchi, C; Magni, P; Cristofani, R; Liu, JW; Corsini, A; Ferri, N				Ruscica, Massimiliano; Ricci, Chiara; Macchi, Chiara; Magni, Paolo; Cristofani, Riccardo; Liu, Jingwen; Corsini, Alberto; Ferri, Nicola			Suppressor of Cytokine Signaling-3 (SOCS-3) Induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Expression in Hepatic HepG2 Cell Line	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						hepatocyte; insulin; proprotein convertase subtilisin; kexin type 9 (PCSK9); suppressor of cytokine signaling 3 (SOCS3); tumor necrosis factor (TNF); HepG2; stat-3	SMOOTH-MUSCLE-CELLS; HUMAN ENDOTHELIAL-CELLS; NECROSIS-FACTOR-ALPHA; PLASMA PCSK9; INSULIN-RESISTANCE; APOLIPOPROTEIN-B; PROTEIN; CHOLESTEROL; ACTIVATION; MUTATIONS	The suppressor of cytokine signaling (SOCS) proteins are negative regulators of the JAK/STAT pathway activated by proinflammatory cytokines, including the tumor necrosis factor- (TNF-). SOCS3 is also implicated in hypertriglyceridemia associated to insulin resistance. Proprotein convertase subtilisin kexin type 9 (PCSK9) levels are frequently found to be positively correlated to insulin resistance and plasma very low density lipoprotein (VLDL) triglycerides concentrations. The present study aimed to investigate the possible role of TNF- and JAK/STAT pathway on de novo lipogenesis and PCSK9 expression in HepG2 cells. TNF- induced both SOCS3 and PCSK9 in a concentration-dependent manner. This effect was inhibited by transfection with siRNA anti-STAT3, suggesting the involvement of the JAK/STAT pathway. Retroviral overexpression of SOCS3 in HepG2 cells (HepG2(SOCS3)) strongly inhibited STAT3 phosphorylation and induced PCSK9 mRNA and protein, with no effect on its promoter activity and mRNA stability. Consistently, siRNA anti-SOCS3 reduced PCSK9 mRNA levels, whereas an opposite effect was observed with siRNA anti-STAT3. In addition, HepG2(SOCS3) express higher mRNA levels of key enzymes involved in the de novo lipogenesis, such as fattyacid synthase, stearoyl-CoA desaturase (SCD)-1, and apoB. These responses were associated with a significant increase of SCD-1 protein, activation of sterol regulatory element-binding protein-1c (SREBP-1), accumulation of cellular triglycerides, and secretion of apoB. HepG2(SOCS3) show lower phosphorylation levels of insulin receptor substrate 1 (IRS-1) Tyr(896) and Akt Ser(473) in response to insulin. Finally, insulin stimulation produced an additive effect with SOCS3 overexpression, further inducing PCSK9, SREBP-1, fatty acid synthase, and apoB mRNA. In conclusion, our data candidate PCSK9 as a gene involved in lipid metabolism regulated by proinflammatory cytokine TNF- in a SOCS3-dependent manner.	[Ruscica, Massimiliano; Ricci, Chiara; Macchi, Chiara; Magni, Paolo; Cristofani, Riccardo; Corsini, Alberto] Univ Milan, Dipartimento Sci Farmacol & Biomol, I-20133 Milan, Italy; [Liu, Jingwen] Palo Alto Hlth Care Syst, Dept Vet Affairs, Palo Alto, CA 94304 USA; [Corsini, Alberto] Multimed IRCCS, I-20099 Milan, Italy; [Magni, Paolo] Univ Milan, Ctr Studio Malattie Dismetab & Iperlipemie Enrica, I-20162 Milan, Italy; [Cristofani, Riccardo] Univ Milan, Ctr Eccellenza Malattie Neurodegenerat, Milan, Italy; [Ferri, Nicola] Univ Padua, Dipartimento Sci Farm, I-35131 Padua, Italy	University of Milan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; IRCCS Multimedica; University of Milan; University of Milan; University of Padua	Ferri, N (corresponding author), Dipartimento Sci Farm, Largo Meneghetti 2, I-35131 Padua, Italy.	nicola.ferri@unipd.it	Ruscica, Massimiliano/K-7133-2012; Ruscica, Massimiliano/AAP-8672-2020; ferri, nicola/K-7085-2019; Macchi, Chiara/AAH-5753-2020; Cristofani, Riccardo/P-1245-2014	Ruscica, Massimiliano/0000-0002-0195-7061; Ruscica, Massimiliano/0000-0002-0195-7061; ferri, nicola/0000-0001-8898-7441; Macchi, Chiara/0000-0002-5919-989X; Cristofani, Riccardo/0000-0003-2719-846X; MAGNI, PAOLO/0000-0002-2254-8881	Fondazione Cariplo [2012-0549]; Piano di Sviluppo Universita degli Studi di Milano	Fondazione Cariplo(Fondazione Cariplo); Piano di Sviluppo Universita degli Studi di Milano	This work was supported by Fondazione Cariplo Grant Rif. 2012-0549 (to A. C. and N. F.) and Piano di Sviluppo Universita degli Studi di Milano 2014 linea B (to N. F. and M. R.). All the authors declare that they have no conflicts of interest with the contents of this article.	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Adorni MP, 2011, ATHEROSCLEROSIS, V215, P70, DOI 10.1016/j.atherosclerosis.2010.12.004; Alborn WE, 2007, CLIN CHEM, V53, P1814, DOI 10.1373/clinchem.2007.091280; Baass A, 2009, CLIN CHEM, V55, P1637, DOI 10.1373/clinchem.2009.126987; Benjannet S, 2006, J BIOL CHEM, V281, P30561, DOI 10.1074/jbc.M606495200; Bjorbaek C, 1999, J BIOL CHEM, V274, P30059, DOI 10.1074/jbc.274.42.30059; Cao AQ, 2011, J LIPID RES, V52, P518, DOI 10.1194/jlr.M010603; Careskey HE, 2008, J LIPID RES, V49, P394, DOI 10.1194/jlr.M700437-JLR200; Cariou B, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-4; Chorba JS, 2014, J BIOL CHEM, V289, P29030, DOI 10.1074/jbc.M114.594861; CORSINI A, 1995, ARTERIOSCL THROM VAS, V15, P420, DOI 10.1161/01.ATV.15.3.420; Costet P, 2006, J BIOL CHEM, V281, P6211, DOI 10.1074/jbc.M508582200; Cui YX, 2004, MOL CELL BIOL, V24, P258, DOI 10.1128/MCB.24.1.258-269.2004; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Dubuc G, 2010, J LIPID RES, V51, P140, DOI 10.1194/jlr.M900273-JLR200; Elam MB, 2010, METABOLISM, V59, P587, DOI 10.1016/j.metabol.2009.09.001; Emanuelli B, 2000, J BIOL CHEM, V275, P15985, DOI 10.1074/jbc.275.21.15985; Emanuelli B, 2001, J BIOL CHEM, V276, P47944, DOI 10.1074/jbc.M104602200; Ferri N, 2003, J BIOL CHEM, V278, P19757, DOI 10.1074/jbc.M212714200; Ferri N, 2007, ARTERIOSCL THROM VAS, V27, P1043, DOI 10.1161/ATVBAHA.107.139881; Ferri N, 2016, TRANSL RES, V173, P19, DOI 10.1016/j.trsl.2015.10.004; Ferri N, 2012, ATHEROSCLEROSIS, V220, P381, DOI 10.1016/j.atherosclerosis.2011.11.026; Galic S, 2014, BIOCHEM J, V461, P177, DOI 10.1042/BJ20140143; Garton KJ, 2002, BIOTECHNIQUES, V32, P830, DOI 10.2144/02324rr01; Giunzioni I, 2016, J PATHOL, V238, P52, DOI 10.1002/path.4630; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Greco CM, 2012, CARDIOVASC RES, V95, P366, DOI 10.1093/cvr/cvs204; Guo YL, 2013, CLIN DRUG INVEST, V33, P877, DOI 10.1007/s40261-013-0129-2; Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Huijgen R, 2012, J AM COLL CARDIOL, V59, P1778, DOI 10.1016/j.jacc.2011.12.043; Jeong HJ, 2008, J LIPID RES, V49, P399, DOI 10.1194/jlr.M700443-JLR200; Kamisuki S, 2009, CHEM BIOL, V16, P882, DOI 10.1016/j.chembiol.2009.07.007; Lakoski SG, 2009, J CLIN ENDOCR METAB, V94, P2537, DOI 10.1210/jc.2009-0141; Li H, 2009, J BIOL CHEM, V284, P28885, DOI 10.1074/jbc.M109.052407; Masciocchi D, 2012, MEDCHEMCOMM, V3, P592, DOI 10.1039/c2md20018j; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; McNutt MC, 2007, J BIOL CHEM, V282, P20799, DOI 10.1074/jbc.C700095200; Melone M, 2012, J AM COLL CARDIOL, V59, P1697, DOI 10.1016/j.jacc.2011.11.064; Naka T, 1997, NATURE, V387, P924, DOI 10.1038/43219; Norata GD, 2004, BRIT J HAEMATOL, V127, P97, DOI 10.1111/j.1365-2141.2004.05163.x; Ouguerram K, 2004, ARTERIOSCL THROM VAS, V24, P1448, DOI 10.1161/01.ATV.0000133684.77013.88; Pellegrino S, 2009, BIOORG MED CHEM LETT, V19, P6298, DOI 10.1016/j.bmcl.2009.09.105; Pirvulescu M, 2012, BIOCHEM BIOPH RES CO, V422, P321, DOI 10.1016/j.bbrc.2012.04.159; Rashid S, 2014, CIRCULATION, V130, P431, DOI 10.1161/CIRCULATIONAHA.113.006720; Roubtsova A, 2011, ARTERIOSCL THROM VAS, V31, P785, DOI 10.1161/ATVBAHA.110.220988; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Shende VR, 2015, J LIPID RES, V56, P801, DOI 10.1194/jlr.M052969; Steppan CM, 2005, MOL CELL BIOL, V25, P1569, DOI 10.1128/MCB.25.4.1569-1575.2005; Sun H, 2012, ARTERIOSCL THROM VAS, V32, P1585, DOI 10.1161/ATVBAHA.112.250043; Torisu T, 2007, GENES CELLS, V12, P143, DOI 10.1111/j.1365-2443.2007.01044.x; Ueki K, 2004, MOL CELL BIOL, V24, P5434, DOI 10.1128/MCB.24.12.5434-5446.2004; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101	54	77	81	3	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3508	3519		10.1074/jbc.M115.664706	http://dx.doi.org/10.1074/jbc.M115.664706			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	26668321	Green Published, hybrid			2022-12-26	WOS:000370854500031
J	Michoux, N; Guillet, A; Rommel, D; Mazzamuto, G; Sindic, C; Duprez, T				Michoux, Nicolas; Guillet, Alain; Rommel, Denis; Mazzamuto, Giosue; Sindic, Christian; Duprez, Thierry			Texture Analysis of T2-Weighted MR Images to Assess Acute Inflammation in Brain MS Lesions	PLOS ONE			English	Article							MULTIPLE-SCLEROSIS; DIFFUSION; CLASSIFICATION; HETEROGENEITY; PATTERNS	Brain blood barrier breakdown as assessed by contrast-enhanced (CE) T1-weighted MR imaging is currently the standard radiological marker of inflammatory activity in multiple sclerosis (MS) patients. Our objective was to evaluate the performance of an alternative model assessing the inflammatory activity of MS lesions by texture analysis of T2-weighted MR images. Twenty-one patients with definite MS were examined on the same 3.0T MR system by T2-weighted, FLAIR, diffusion-weighted and CE-T1 sequences. Lesions and mirrored contralateral areas within the normal appearing white matter (NAWM) were characterized by texture parameters computed from the gray level co-occurrence and run length matrices, and by the apparent diffusion coefficient (ADC). Statistical differences between MS lesions and NAWM were analyzed. ROC analysis and leave-one-out cross-validation were performed to evaluate the performance of individual parameters, and multi-parametric models using linear discriminant analysis (LDA), partial least squares (PLS) and logistic regression (LR) in the identification of CE lesions. ADC and all but one texture parameter were significantly different within white matter lesions compared to within NAWM(p < 0.0167). Using LDA, an 8-texture parameter model identified CE lesions with a sensitivity Se = 70% and a specificity Sp = 76%. Using LR, a 10-texture parameter model performed better with Se = 86%/Sp = 84%. Using PLS, a 6-texture parameter model achieved the highest accuracy with Se = 88%/Sp = 81%. Texture parameter from T2-weighted images can assess brain inflammatory activity with sufficient accuracy to be considered as a potential alternative to enhancement on CE T1-weighted images.	[Michoux, Nicolas] Catholic Univ Louvain, IREC Inst Expt & Clin Res, B-1200 Brussels, Belgium; [Guillet, Alain] Catholic Univ Louvain, Dept Stat, B-1200 Brussels, Belgium; [Rommel, Denis; Mazzamuto, Giosue; Duprez, Thierry] Catholic Univ Louvain, Dept Radiol, Clin Univ St Luc, B-1200 Brussels, Belgium; [Sindic, Christian] Catholic Univ Louvain, Dept Neurol, Clin Univ St Luc, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc; Universite Libre de Bruxelles; Vrije Universiteit Brussel; Universite Catholique Louvain; Cliniques Universitaires Saint-Luc	Michoux, N (corresponding author), Catholic Univ Louvain, IREC Inst Expt & Clin Res, B-1200 Brussels, Belgium.	nicolas.michoux@uclouvain.be		Duprez, Thierry/0000-0002-1579-0100; Guillet, Alain/0000-0002-2938-1498				Anik Y, 2011, CLIN NEURORADIOL, V21, P207, DOI 10.1007/s00062-011-0091-4; Bammer R, 2000, MAGNET RESON MED, V44, P583, DOI 10.1002/1522-2594(200010)44:4<583::AID-MRM12>3.0.CO;2-O; Baumann K, 2003, TRAC-TREND ANAL CHEM, V22, P395, DOI 10.1016/S0165-9936(03)00607-1; Bonzano L, 2009, MULT SCLER J, V15, P1043, DOI 10.1177/1352458509106610; Collewet G, 2004, MAGN RESON IMAGING, V22, P81, DOI 10.1016/j.mri.2003.09.001; CROSS GR, 1983, IEEE T PATTERN ANAL, V5, P25, DOI 10.1109/TPAMI.1983.4767341; Depeursinge A, 2012, LECT NOTES COMPUTER; Drabycz S, 2008, INT J COMPUT ASS RAD, V3, P465, DOI 10.1007/s11548-008-0219-4; Farber RS, 2009, J MAGN RESON IMAGING, V30, P732, DOI 10.1002/jmri.21922; Faro A, P MEDICON IFMBE 2010, V20, P272; Filippi M, 2000, ARCH NEUROL-CHICAGO, V57, P1017, DOI 10.1001/archneur.57.7.1017; Filippi M, 2011, ARCH NEUROL-CHICAGO, V68, P1514, DOI 10.1001/archneurol.2011.914; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; GARTHWAITE PH, 1994, J AM STAT ASSOC, V89, P122, DOI 10.2307/2291207; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Harrison LCV, 2010, ACAD RADIOL, V17, P696, DOI 10.1016/j.acra.2010.01.005; Henning J, 2011, HIGH FIELD MR IMAGIN, P81; Inglese M, 2010, NMR BIOMED, V23, P865, DOI 10.1002/nbm.1515; Karimaghaloo Z, 2013, LECT NOTES COMPUT SC, V8151, P543, DOI 10.1007/978-3-642-40760-4_68; Loizou CP, 2011, IEEE T INF TECHNOL B, V15, P119, DOI 10.1109/TITB.2010.2091279; Loizou CP, 2011, IFIP ADV INF COMM TE, V364, P400; Loizou CP, 2014, J NEURORADIOL, V23; Niall A, 2004, METHODS MODELS STAT; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Pagani E, 2007, AM J NEURORADIOL, V28, P411; Pampel F, 2000, SAGE U PAPERS SERIES, P07; Plumat J, 2009, INSIGHT J; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Poonawalla AH, 2008, RADIOLOGY, V246, P880, DOI 10.1148/radiol.2463070486; Savio S, 2014, ACTA RADIOL, V14; Tang XO, 1998, IEEE T IMAGE PROCESS, V7, P1602, DOI 10.1109/83.725367; Theocharakis P, 2009, MAGN RESON IMAGING, V27, P417, DOI 10.1016/j.mri.2008.07.014; Tozer DJ, 2009, J MAGN RESON IMAGING, V30, P506, DOI 10.1002/jmri.21885; Verma RK, 2013, PLOS ONE, V16; Yu O, 2004, MAGN RESON IMAGING, V22, P1139, DOI 10.1016/j.mri.2004.08.017; Yu O, 1999, MAGN RESON IMAGING, V17, P1261, DOI 10.1016/S0730-725X(99)00062-4; Yurtsever I, 2008, EUR J RADIOL, V65, P421, DOI 10.1016/j.ejrad.2007.05.002; Zhang J, 2008, MAGN RESON IMAGING, V26, P1160, DOI 10.1016/j.mri.2008.01.016; Zhang YY, 2014, MAGN RESON IMAGING, V32, P168, DOI 10.1016/j.mri.2013.10.006; Zhang YY, 2013, ANN NEUROL, V74, P91, DOI 10.1002/ana.23867; Zhang YY, 2009, NEUROIMAGE, V47, P107, DOI 10.1016/j.neuroimage.2009.03.075; Zhu H, 2003, P 11 INT SOC MAGN RE, P277	42	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 22	2015	10	12							e0145497	10.1371/journal.pone.0145497	http://dx.doi.org/10.1371/journal.pone.0145497			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ4SH	26693908	Green Submitted, gold, Green Published			2022-12-26	WOS:000367092500053
J	Forbi, JC; Layden, JE; Phillips, RO; Mora, N; Xia, GL; Campo, DS; Purdy, MA; Dimitrova, ZE; Owusu, DO; Punkova, LT; Skums, P; Owusu-Ofori, S; Sarfo, FS; Vaughan, G; Roh, H; Opare-Sem, OK; Cooper, RS; Khudyakov, YE				Forbi, Joseph C.; Layden, Jennifer E.; Phillips, Richard O.; Mora, Nallely; Xia, Guo-liang; Campo, David S.; Purdy, Michael A.; Dimitrova, Zoya E.; Owusu, Dorcas O.; Punkova, Lili T.; Skums, Pavel; Owusu-Ofori, Shirley; Sarfo, Fred Stephen; Vaughan, Gilberto; Roh, Hajung; Opare-Sem, Ohene K.; Cooper, Richard S.; Khudyakov, Yury E.			Next-Generation Sequencing Reveals Frequent Opportunities for Exposure to Hepatitis C Virus in Ghana	PLOS ONE			English	Article							BLOOD-DONORS; WEST-AFRICA; INFECTION; EPIDEMIOLOGY; POPULATION; GENOTYPE; EFFICACY; PREVALENCE; SOFOSBUVIR; EVOLUTION	Globally, hepatitis C Virus (HCV) infection is responsible for a large proportion of persons with liver disease, including cancer. The infection is highly prevalent in sub-Saharan Africa. West Africa was identified as a geographic origin of two HCV genotypes. However, little is known about the genetic composition of HCV populations in many countries of the region. Using conventional and next-generation sequencing (NGS), we identified and genetically characterized 65 HCV strains circulating among HCV-positive blood donors in Kumasi, Ghana. Phylogenetic analysis using consensus sequences derived from 3 genomic regions of the HCV genome, 5'-untranslated region, hypervariable region 1 (HVR1) and NS5B gene, consistently classified the HCV variants (n = 65) into genotypes 1 (HCV-1, 15%) and genotype 2 (HCV-2, 85%). The Ghanaian and West African HCV-2 NS5B sequences were found completely intermixed in the phylogenetic tree, indicating a substantial genetic heterogeneity of HCV-2 in Ghana. Analysis of HVR1 sequences from intra-host HCV variants obtained by NGS showed that three donors were infected with >1 HCV strain, including infections with 2 genotypes. Two other donors share an HCV strain, indicating HCV transmission between them. The HCV-2 strain sampled from one donor was replaced with another HCV-2 strain after only 2 months of observation, indicating rapid strain switching. Bayesian analysis estimated that the HCV-2 strains in Ghana were expanding since the 16th century. The blood donors in Kumasi, Ghana, are infected with a very heterogeneous HCV population of HCV-1 and HCV-2, with HCV-2 being prevalent. The detection of three cases of co- or super-infections and transmission linkage between 2 cases suggests frequent opportunities for HCV exposure among the blood donors and is consistent with the reported high HCV prevalence. The conditions for effective HCV-2 transmission existed for similar to 3-4 centuries, indicating a long epidemic history of HCV-2 in Ghana.	[Forbi, Joseph C.; Xia, Guo-liang; Campo, David S.; Purdy, Michael A.; Dimitrova, Zoya E.; Punkova, Lili T.; Skums, Pavel; Vaughan, Gilberto; Roh, Hajung; Khudyakov, Yury E.] Ctr Dis Control & Prevent, Mol Epidemiol & Bioinformat Lab, Div Viral Hepatitis, Atlanta, GA 30333 USA; [Layden, Jennifer E.; Mora, Nallely; Cooper, Richard S.] Loyola Univ Chicago, Dept Publ Hlth Sci, Maywood, IL USA; [Layden, Jennifer E.] Loyola Univ Chicago, Stritch Sch Med, Dept Med, Maywood, IL USA; [Phillips, Richard O.; Owusu, Dorcas O.; Owusu-Ofori, Shirley; Sarfo, Fred Stephen; Opare-Sem, Ohene K.] Komfo Anokye Teaching Hosp, Kumasi, Ghana; [Phillips, Richard O.; Sarfo, Fred Stephen] Kwame Nkrumah Univ Sci & Technol, Kumasi, Ghana	Centers for Disease Control & Prevention - USA; Loyola University Chicago; Loyola University Chicago; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology	Forbi, JC (corresponding author), Ctr Dis Control & Prevent, Mol Epidemiol & Bioinformat Lab, Div Viral Hepatitis, Atlanta, GA 30333 USA.	JForbi@cdc.gov	OWUSU, Dorcas Ohui/O-9491-2014; Phillips, Richard Odame/ABD-5394-2021; Roh, Ha-Jung/N-1365-2016	OWUSU, Dorcas Ohui/0000-0003-4299-5870; Phillips, Richard Odame/0000-0001-8992-0222; Roh, Ha-Jung/0000-0003-1523-6844	Loyola University, Chicago, USA; Laboratory Branch, Division of Viral Hepatitis, CDC, Atlanta, USA; MRC [MR/J01477X/1] Funding Source: UKRI	Loyola University, Chicago, USA; Laboratory Branch, Division of Viral Hepatitis, CDC, Atlanta, USA; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Internal funding was provided to JEL by Loyola University, Chicago, USA. This work was supported by the Laboratory Branch, Division of Viral Hepatitis, CDC, Atlanta, USA.	Alfonso V, 2005, J GEN VIROL, V86, P2781, DOI 10.1099/vir.0.81084-0; Allain JP, 2009, TRANSFUSION, V49, P669, DOI 10.1111/j.1537-2995.2008.02055.x; Ampofo W, 2002, J CLIN MICROBIOL, V40, P3523, DOI 10.1128/JCM.40.9.3523-3525.2002; [Anonymous], 1999, J Hepatol, V31 Suppl 1, P3; Averhoff FM, 2012, CLIN INFECT DIS, V55, pS10, DOI 10.1093/cid/cis361; BUKH J, 1995, SEMIN LIVER DIS, V15, P41, DOI 10.1055/s-2007-1007262; Campo D. S., 2015, J INFECT DIS; Campo DS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00267; Candotti D, 2003, J VIROL, V77, P7914, DOI 10.1128/JVI.77.14.7914-7923.2003; Chen CM, 2004, P NATL ACAD SCI USA, V101, P5303, DOI 10.1073/pnas.0307513100; Cuevas JM, 2009, J VIROL, V83, P5760, DOI 10.1128/JVI.00201-09; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Farci P, 2000, SCIENCE, V288, P339, DOI 10.1126/science.288.5464.339; Farci P, 2011, SEMIN LIVER DIS, V31, P356, DOI 10.1055/s-0031-1297925; Fischer W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012303; Forbi JC, 2014, J MED VIROL, V86, P765, DOI 10.1002/jmv.23897; Forbi JC, 2012, J GEN VIROL, V93, P1410, DOI 10.1099/vir.0.042184-0; Forbi JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011615; Ghana-HealthNest, 2013, GHAN NEEDS 250000 UN; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Itskowitz Marc S., 2007, Comprehensive Therapy, V33, P87, DOI 10.1007/s12019-007-8005-8; Koff RS, 2014, ALIMENT PHARM THER, V39, P478, DOI 10.1111/apt.12601; Layden JE, 2014, CLIN INFECT DIS; Layden JE, 2015, CLIN INFECT DIS, V60, P1033, DOI 10.1093/cid/ciu965; Li H S, 2010, ACTA ECOLOGICA SINIC, V1, P1, DOI DOI 10.1371/J0URNAL.PPAT.1000890; Li H, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002880; Madhava V, 2002, LANCET INFECT DIS, V2, P293, DOI 10.1016/S1473-3099(02)00264-5; MARTELL M, 1992, J VIROL, V66, P3225, DOI 10.1128/JVI.66.5.3225-3229.1992; Mathworks, 2010, MATLAB; Neumann AU, 1998, SCIENCE, V282, P103, DOI 10.1126/science.282.5386.103; Nkrumah B, 2011, Ghana Med J, V45, P97; Owusu-Ofori S, 2005, TRANSFUSION, V45, P133, DOI 10.1111/j.1537-2995.2004.04279.x; Pouillot R, 2008, INFECT GENET EVOL, V8, P676, DOI 10.1016/j.meegid.2008.06.001; Purdy MA, 2015, J GEN VIROL; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Ramachandran S, 2011, J VIROL, V85, P6369, DOI 10.1128/JVI.02204-10; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Schmidt-Martin D, 2015, J GEN VIROL; Schvaneveldt R. W., 1989, PSYCHOL LEARN MOTIV, V24, P249, DOI DOI 10.1016/S0079-7421(08)60539-3; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Skums P, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S6; Sulkowski MS, 2014, NEW ENGL J MED, V370, P211, DOI 10.1056/NEJMoa1306218; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tejada-Strop A, 2015, J VIROL METHODS, V212, P66, DOI 10.1016/j.jviromet.2014.10.018; Wansbrough-Jones MH, 1998, T ROY SOC TROP MED H, V92, P496, DOI 10.1016/S0035-9203(98)90887-2; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Yusim K, 2010, J GEN VIROL, V91, P1194, DOI 10.1099/vir.0.017491-0	48	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0145530	10.1371/journal.pone.0145530	http://dx.doi.org/10.1371/journal.pone.0145530			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683463	Green Published, Green Submitted, gold			2022-12-26	WOS:000366725800080
J	Forman, OP; Pettitt, L; Komaromy, AM; Bedford, P; Mellersh, C				Forman, Oliver P.; Pettitt, Louise; Komaromy, Andrs M.; Bedford, Peter; Mellersh, Cathryn			A Novel Genome-Wide Association Study Approach Using Genotyping by Exome Sequencing Leads to the Identification of a Primary Open Angle Glaucoma Associated Inversion Disrupting ADAMTS17	PLOS ONE			English	Article							NEURONAL CEROID-LIPOFUSCINOSIS; PRIMARY LENS LUXATION; MUTATION; BREEDS; DOG; DELETION; LINKAGE	Closed breeding populations in the dog in conjunction with advances in gene mapping and sequencing techniques facilitate mapping of autosomal recessive diseases and identification of novel disease-causing variants, often using unorthodox experimental designs. In our investigation we demonstrate successful mapping of the locus for primary open angle glaucoma in the Petit Basset Griffon Venden dog breed with 12 cases and 12 controls, using a novel genotyping by exome sequencing approach. The resulting genome-wide association signal was followed up by genome sequencing of an individual case, leading to the identification of an inversion with a breakpoint disrupting the ADAMTS17 gene. Genotyping of additional controls and expression analysis provide strong evidence that the inversion is disease causing. Evidence of cryptic splicing resulting in novel exon transcription as a consequence of the inversion in ADAMTS17 is identified through RNAseq experiments. This investigation demonstrates how a novel genotyping by exome sequencing approach can be used to map an autosomal recessive disorder in the dog, with the use of genome sequencing to facilitate identification of a disease-associated variant.	[Forman, Oliver P.; Pettitt, Louise; Mellersh, Cathryn] Anim Hlth Trust, Kennel Club Genet Ctr, Newmarket Suffolk CB8 7UU, England; [Bedford, Peter] Univ London, Univ London Royal Vet Coll, Dept Clin Sci & Serv, Hatfield AL9 7TA, Herts, England; [Komaromy, Andrs M.] Michigan State Univ, Ctr Vet Med, Coll Vet Med, Dept Small Anim Clin Sci, E Lansing, MI 48824 USA	Animal Health Trust; University of London; University of London Royal Veterinary College; Michigan State University	Forman, OP (corresponding author), Anim Hlth Trust, Kennel Club Genet Ctr, Newmarket Suffolk CB8 7UU, England.	oliver.forman@aht.org.uk			Waltham Foundation	Waltham Foundation	The study into primary open angle glaucoma was funded by the Waltham Foundation (www.waltham.com/waltham-research/funding-opportunities/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahonen SJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111941; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; Farias FHG, 2010, INVEST OPHTH VIS SCI, V51, P4716, DOI 10.1167/iovs.09-5142; Gilliam D, 2014, J VET INTERN MED, V28, P871, DOI 10.1111/jvim.12355; Gould D, 2011, VET OPHTHALMOL, V14, P378, DOI 10.1111/j.1463-5224.2011.00892.x; Guo JY, 2015, BMC VET RES, V10, DOI 10.1186/s12917-014-0181-z; Guo J, 2014, MOL GENET METAB, V112, P302, DOI 10.1016/j.ymgme.2014.05.014; Hubmacher D, 2011, CELL MOL LIFE SCI, V68, P3137, DOI 10.1007/s00018-011-0780-9; Kang HM, 2010, NAT GENET, V42, P348, DOI 10.1038/ng.548; Kuchtey J, 2014, J OCUL PHARMACOL TH, V30, P170, DOI 10.1089/jop.2013.0184; Kuchtey J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001306; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lim G, 2011, LEUKEMIA RES, V35, pE106, DOI 10.1016/j.leukres.2011.03.020; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Morales J, 2009, AM J HUM GENET, V85, P558, DOI 10.1016/j.ajhg.2009.09.011; Mosyak L, 2008, PROTEIN SCI, V17, P16, DOI 10.1110/ps.073287008; Parker HG, 2007, GENOME RES, V17, P1562, DOI 10.1101/gr.6772807; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Safra N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003646; Siva N, 2015, LANCET, V385, P103, DOI 10.1016/S0140-6736(14)62453-3	22	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0143546	10.1371/journal.pone.0143546	http://dx.doi.org/10.1371/journal.pone.0143546			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26683476	Green Submitted, Green Published, gold			2022-12-26	WOS:000366725800008
J	Gueguen, N; Desquiret-Dumas, V; Leman, G; Chupin, S; Baron, S; Nivet-Antoine, V; Vessieres, E; Ayer, A; Henrion, D; Lenaers, G; Reynier, P; Procaccio, V				Gueguen, Naig; Desquiret-Dumas, Valerie; Leman, Geraldine; Chupin, Stephanie; Baron, Stephanie; Nivet-Antoine, Valerie; Vessieres, Emilie; Ayer, Audrey; Henrion, Daniel; Lenaers, Guy; Reynier, Pascal; Procaccio, Vincent			Resveratrol Directly Binds to Mitochondrial Complex I and Increases Oxidative Stress in Brain Mitochondria of Aged Mice	PLOS ONE			English	Article							NADH-UBIQUINONE OXIDOREDUCTASE; RESPIRATORY-CHAIN; CYTOCHROME-C; DIETARY RESVERATROL; YARROWIA-LIPOLYTICA; TRANS-RESVERATROL; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; RAT-LIVER	Resveratrol is often described as a promising therapeutic molecule for numerous diseases, especially in metabolic and neurodegenerative disorders. While the mechanism of action is still debated, an increasing literature reports that resveratrol regulates the mitochondrial respiratory chain function. In a recent study we have identified mitochondrial complex I as a direct target of this molecule. Nevertheless, the mechanisms and consequences of such an interaction still require further investigation. In this study, we identified in silico by docking study a binding site for resveratrol at the nucleotide pocket of complex I. In vitro, using solubilized complex I, we demonstrated a competition between NAD+ and resveratrol. At low doses (<5 mu M), resveratrol stimulated complex I activity, whereas at high dose (50 mu M) it rather decreased it. In vivo, in brain mitochondria from resveratrol treated young mice, we showed that complex I activity was increased, whereas the respiration rate was not improved. Moreover, in old mice with low antioxidant defenses, we demonstrated that complex I activation by resveratrol led to oxidative stress. These results bring new insights into the mechanism of action of resveratrol on mitochondria and highlight the importance of the balance between pro- and antioxidant effects of resveratrol depending on its dose and age. These parameters should be taken into account when clinical trials using resveratrol or analogues have to be designed.	[Gueguen, Naig; Desquiret-Dumas, Valerie; Leman, Geraldine; Chupin, Stephanie; Vessieres, Emilie; Ayer, Audrey; Henrion, Daniel; Lenaers, Guy; Reynier, Pascal; Procaccio, Vincent] Univ Angers, F-49000 Angers, France; [Gueguen, Naig; Desquiret-Dumas, Valerie; Chupin, Stephanie; Reynier, Pascal; Procaccio, Vincent] CHU Angers, Dept Biochim & Genet, F-49000 Angers, France; [Gueguen, Naig; Desquiret-Dumas, Valerie; Leman, Geraldine; Chupin, Stephanie; Vessieres, Emilie; Ayer, Audrey; Henrion, Daniel; Lenaers, Guy; Reynier, Pascal; Procaccio, Vincent] CNRS, INSERM, U1083, UMR 6214, F-49000 Angers, France; [Baron, Stephanie; Nivet-Antoine, Valerie] Univ Paris 05, Fac Pharm, EA 4466, F-75270 Paris, France	Universite d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; UDICE-French Research Universities; Universite Paris Cite	Gueguen, N (corresponding author), Univ Angers, F-49000 Angers, France.	NaGueguen@chu-angers.fr	Henrion, Daniel/N-7023-2015; Baron, Stephanie/AAY-5703-2020; Lenaers, guy/X-4727-2019; Nivet-Antoine, Valerie/R-1981-2017; Henrion, Daniel/J-8141-2015; Henrion, Daniel/AAK-1995-2021; Naig, Gueguen/K-2699-2015; lenaers, guy/K-2421-2015	Henrion, Daniel/0000-0003-1094-0285; Baron, Stephanie/0000-0002-0375-6968; Nivet-Antoine, Valerie/0000-0003-2490-0428; Henrion, Daniel/0000-0003-1094-0285; Henrion, Daniel/0000-0003-1094-0285; Naig, Gueguen/0000-0002-3094-8121; procaccio, Vincent/0000-0002-1537-4684; Reynier, Pascal/0000-0003-0802-4608; lenaers, guy/0000-0003-2736-3349; Desquiret-Dumas, Valerie/0000-0001-9551-9400	Region Pays de la Loire; Fondation pour la Recherche Medicale [DRM20101220457]; Union Nationale des Aveugles et Deficients Visuels; Retina France; Ouvrir les Yeux; Association contre les Maladies Mitochondriales	Region Pays de la Loire(Region Pays de la Loire); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Union Nationale des Aveugles et Deficients Visuels; Retina France; Ouvrir les Yeux; Association contre les Maladies Mitochondriales	Funding provided by Region Pays de la Loire (VP, PR), Fondation pour la Recherche Medicale (VP) grant no DRM20101220457, Union Nationale des Aveugles et Deficients Visuels www.unadev.com (VP, PR), Retina France www.retina.fr (PR), Ouvrir les Yeux www.ouvrirlesyeux.org (PR) and Association contre les Maladies Mitochondriales www.association-ammi.org (VP, PR).	Agarwal B, 2013, INT J CARDIOL, V166, P246, DOI 10.1016/j.ijcard.2012.09.027; de la Lastral CA, 2007, BIOCHEM SOC T, V35, P1156, DOI 10.1042/BST0351156; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Baron S, 2014, J GERONTOL A-BIOL, V69, P260, DOI 10.1093/gerona/glt081; Bastin J, 2011, HUM MOL GENET, V20, P2048, DOI 10.1093/hmg/ddr089; Batandier C, 2006, J BIOENERG BIOMEMBR, V38, P33, DOI 10.1007/s10863-006-9003-8; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; BENZI G, 1992, NEUROBIOL AGING, V13, P361, DOI 10.1016/0197-4580(92)90109-B; Bhatt JK, 2012, NUTR RES, V32, P537, DOI 10.1016/j.nutres.2012.06.003; Bikadi Z, 2009, J CHEMINFORMATICS, V1, DOI 10.1186/1758-2946-1-15; Birrell JA, 2013, BIOCHEM J, V456, P139, DOI 10.1042/BJ20130606; Birrell JA, 2011, FEBS LETT, V585, P2318, DOI 10.1016/j.febslet.2011.05.065; Bosutti A, 2015, SCI REP-UK, V5, DOI 10.1038/srep08093; Boveris A, 2008, IUBMB LIFE, V60, P308, DOI 10.1002/iub.46; Boyer JZ, 2012, J PHOTOCH PHOTOBIO B, V113, P42, DOI 10.1016/j.jphotobiol.2012.04.013; Calabrese EJ, 2010, HUM EXP TOXICOL, V29, P1034, DOI 10.1177/0960327110383641; Chakrabarti S, 2011, AGING DIS, V2, P242; Chan SHH, 2009, HYPERTENSION, V53, P217, DOI 10.1161/HYPERTENSIONAHA.108.116905; Chen CZ, 2013, FOOD CHEM TOXICOL, V59, P8, DOI 10.1016/j.fct.2013.05.030; Crowell JA, 2004, TOXICOL SCI, V82, P614, DOI 10.1093/toxsci/kfh263; Csiszar A, 2009, AM J PHYSIOL-HEART C, V297, pH13, DOI 10.1152/ajpheart.00368.2009; Desquiret-Dumas V, 2013, J BIOL CHEM, V288, P36662, DOI 10.1074/jbc.M113.466490; Djafarzadeh R, 2000, BBA-BIOENERGETICS, V1459, P230, DOI 10.1016/S0005-2728(00)00154-7; Flamment M, 2009, AM J PHYSIOL-ENDOC M, V297, pE1162, DOI 10.1152/ajpendo.00169.2009; Friedman J, 2011, OXID STRESS APPL BAS, P19, DOI 10.1007/978-1-60327-514-9_2; Fu S, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00022; Fukuhara K, 2006, BIOORGAN MED CHEM, V14, P1437, DOI 10.1016/j.bmc.2005.09.070; Fukui M, 2010, FREE RADICAL BIO MED, V49, P800, DOI 10.1016/j.freeradbiomed.2010.06.002; Fusser M, 2011, CARCINOGENESIS, V32, P80, DOI 10.1093/carcin/bgq196; Galati G, 2002, TOXICOLOGY, V177, P91, DOI 10.1016/S0300-483X(02)00198-1; Galkin A, 2005, J BIOL CHEM, V280, P30129, DOI 10.1074/jbc.M504709200; Gertz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049761; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P13632, DOI 10.1073/pnas.0706290104; Gliemann L, 2013, J PHYSIOL-LONDON, V591, P5047, DOI 10.1113/jphysiol.2013.258061; Guillet V, 2011, FASEB J, V25, P1618, DOI 10.1096/fj.10-173609; Guillet V, 2010, MITOCHONDRION, V10, P115, DOI 10.1016/j.mito.2009.11.004; Hadi SM, 2007, SEMIN CANCER BIOL, V17, P370, DOI 10.1016/j.semcancer.2007.04.002; Han YS, 2004, BRIT J PHARMACOL, V141, P997, DOI 10.1038/sj.bjp.0705688; Heiss EH, 2007, J BIOL CHEM, V282, P26759, DOI 10.1074/jbc.M703229200; Hirst J, 2008, BIOCHEM SOC T, V36, P976, DOI 10.1042/BST0360976; Hunte C, 2010, SCIENCE, V329, P448, DOI 10.1126/science.1191046; Jackson JR, 2011, J GERONTOL A-BIOL, V66, P751, DOI 10.1093/gerona/glr047; Kaeberlein M, 2005, J BIOL CHEM, V280, P17038, DOI 10.1074/jbc.M500655200; Kipp JL, 2001, ENDOCRINE, V15, P165, DOI 10.1385/ENDO:15:2:165; Kitada M, 2011, DIABETES, V60, P634, DOI 10.2337/db10-0386; Kudin AP, 2008, BBA-BIOENERGETICS, V1777, P689, DOI 10.1016/j.bbabio.2008.05.010; Kudin AP, 2004, J BIOL CHEM, V279, P4127, DOI 10.1074/jbc.M310341200; Kussmaul L, 2006, P NATL ACAD SCI USA, V103, P7607, DOI 10.1073/pnas.0510977103; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Leifert WR, 2008, NUTR RES, V28, P729, DOI 10.1016/j.nutres.2008.09.001; Lelfert WR, 2008, NUTR RES, V28, P842, DOI 10.1016/j.nutres.2008.09.001; LEQUOC D, 1976, BIOCHEM BIOPH RES CO, V68, P106, DOI 10.1016/0006-291X(76)90016-4; Lu KT, 2006, J AGR FOOD CHEM, V54, P3126, DOI [10.1021/jf053011q, 10.1021/JF053011Q]; Manczak M, 2005, J NEUROCHEM, V92, P494, DOI 10.1111/j.1471-4159.2004.02884.x; Lopez-Nicolas JM, 2008, J AGR FOOD CHEM, V56, P7600, DOI 10.1021/jf800843e; Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001; Menet MC, 2013, ANAL CHIM ACTA, V761, P128, DOI 10.1016/j.aca.2012.11.048; Moreira AC, 2013, FOOD CHEM TOXICOL, V53, P18, DOI 10.1016/j.fct.2012.11.031; Mourier A, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001129; Nemekaite-Ceniene A, 2005, ARCH BIOCHEM BIOPHYS, V441, P182, DOI 10.1016/j.abb.2005.07.002; Nulton-Persson AC, 2004, J CARDIOVASC PHARM, V44, P591, DOI 10.1097/00005344-200411000-00012; Paulsen CE, 2010, ACS CHEM BIOL, V5, P47, DOI 10.1021/cb900258z; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Pereverzev MO, 2003, BIOCHEM SOC T, V31, P1312; Pshenichnyuk Stanislav A, 2015, Methods Mol Biol, V1265, P285, DOI 10.1007/978-1-4939-2288-8_20; Ray PS, 1999, FREE RADICAL BIO MED, V27, P160, DOI 10.1016/S0891-5849(99)00063-5; Ristow M, 2014, DOSE-RESPONSE, V12, P288, DOI 10.2203/dose-response.13-035.Ristow; Robb EL, 2008, BIOCHEM BIOPH RES CO, V372, P254, DOI 10.1016/j.bbrc.2008.05.028; Robb EL, 2010, MOLECULES, V15, P1196, DOI 10.3390/molecules15031196; Rocha KKR, 2009, FOOD CHEM TOXICOL, V47, P1362, DOI 10.1016/j.fct.2009.03.010; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Sakai K, 2014, SUBCELL BIOCHEM, V77, P61, DOI 10.1007/978-94-007-7920-4_5; Salvador Gabriela A, 2010, Int J Alzheimers Dis, V2011, P720658, DOI 10.4061/2011/720658; Santidrian AF, 2013, J CLIN INVEST, V123, P1068, DOI 10.1172/JCI64264; Sassi N, 2014, BBA-BIOENERGETICS, V1837, P1781, DOI 10.1016/j.bbabio.2014.06.010; Sassi N, 2014, CURR PHARM DESIGN, V20, P172, DOI 10.2174/13816128113199990034; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Schirmer H, 2012, MOL BIOL REP, V39, P3281, DOI 10.1007/s11033-011-1096-4; Srividhya R, 2009, INT J DEV NEUROSCI, V27, P223, DOI 10.1016/j.ijdevneu.2009.01.003; Stojanovic S, 2001, ARCH BIOCHEM BIOPHYS, V391, P79, DOI 10.1006/abbi.2001.2388; Tan GY, 2010, POULTRY SCI, V89, P115, DOI 10.3382/ps.2009-00318; Vingtdeux V, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-S2-S6; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; Wilson T, 1996, LIFE SCI, V59, pPL15, DOI 10.1016/0024-3205(96)00260-3; Yoshino J, 2012, CELL METAB, V16, P658, DOI 10.1016/j.cmet.2012.09.015; Zhao YG, 2003, J BIOL CHEM, V278, P2356, DOI 10.1074/jbc.M209681200; Zheng JB, 2000, BRIT J PHARMACOL, V130, P1115, DOI 10.1038/sj.bjp.0703397; Zhou X, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.530; Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859; Zini R, 1999, DRUG EXP CLIN RES, V25, P87	90	55	58	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 18	2015	10	12							e0144290	10.1371/journal.pone.0144290	http://dx.doi.org/10.1371/journal.pone.0144290			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9KM	26684010	gold, Green Submitted, Green Published			2022-12-26	WOS:000366725800012
J	Brun, J; Lutz, KA; Neumayer, KMH; Klein, G; Seeger, T; Uynuk-Ool, T; Worgotter, K; Schmid, S; Kraushaar, U; Guenther, E; Rolauffs, B; Aicher, WK; Hart, ML				Brun, Juliane; Lutz, Katrin A.; Neumayer, Katharina M. H.; Klein, Gerd; Seeger, Tanja; Uynuk-Ool, Tatiana; Woergoetter, Katharina; Schmid, Sandra; Kraushaar, Udo; Guenther, Elke; Rolauffs, Bernd; Aicher, Wilhelm K.; Hart, Melanie L.			Smooth Muscle-Like Cells Generated from Human Mesenchymal Stromal Cells Display Marker Gene Expression and Electrophysiological Competence Comparable to Bladder Smooth Muscle Cells	PLOS ONE			English	Article							STRESS URINARY-INCONTINENCE; GATED SODIUM-CHANNELS; STEM-CELLS; T-TYPE; CA2+ CHANNELS; PERIURETHRAL INJECTION; PHENOTYPIC MODULATION; MOLECULAR REGULATION; REGENERATIVE CELLS; VASCULAR-DISEASE	The use of mesenchymal stromal cells (MSCs) differentiated toward a smooth muscle cell (SMC) phenotype may provide an alternative for investigators interested in regenerating urinary tract organs such as the bladder where autologous smooth muscle cells cannot be used or are unavailable. In this study we measured the effects of good manufacturing practice (GMP)-compliant expansion followed by myogenic differentiation of human MSCs on the expression of a range of contractile (from early to late) myogenic markers in relation to the electrophysiological parameters to assess the functional role of the differentiated MSCs and found that differentiation of MSCs associated with electrophysiological competence comparable to bladder SMCs. Within 1-2 weeks of myogenic differentiation, differentiating MSCs significantly expressed alpha smooth muscle actin (alpha SMA; ACTA2), transgelin (TAGLN), calponin (CNN1), and smooth muscle myosin heavy chain (SM-MHC; MYH11) according to qRT-PCR and/or immunofluorescence and Western blot. Voltage-gated Na+ current levels also increased within the same time period following myogenic differentiation. In contrast to undifferentiated MSCs, differentiated MSCs and bladder SMCs exhibited elevated cytosolic Ca2+ transients in response to K+-induced depolarization and contracted in response to K+ indicating functional maturation of differentiated MSCs. Depolarization was suppressed by Cd2+, an inhibitor of voltage-gated Ca2+-channels. The expression of Na+-channels was pharmacologically identified as the Na(v)1.4 subtype, while the K+ and Ca2+ ion channels were identified by gene expression of KCNMA1, CACNA1C and CACNA1H which encode for the large conductance Ca2+-activated K+ channel BKCa channels, Cav1.2 L-type Ca2+ channels and Cav3.2 T-type Ca2+ channels, respectively. This protocol may be used to differentiate adult MSCs into smooth muscle-like cells with an intermediate-to-late SMC contractile phenotype exhibiting voltage-gated ion channel activity comparable to bladder SMCs which may be important for urological regenerative medicine applications.	[Brun, Juliane; Lutz, Katrin A.; Neumayer, Katharina M. H.; Aicher, Wilhelm K.; Hart, Melanie L.] Univ Tubingen, Dept Urol, Clin Res Grp KFO 273, Tubingen, Germany; [Klein, Gerd; Seeger, Tanja] Univ Tubingen, Med Res Ctr, Univ Med Clin, Dept 2, Tubingen, Germany; [Uynuk-Ool, Tatiana; Woergoetter, Katharina; Rolauffs, Bernd; Hart, Melanie L.] Univ Tubingen, Siegfried Weller Inst Trauma Res, Lab Mol Biomech, Tubingen, Germany; [Schmid, Sandra; Kraushaar, Udo; Guenther, Elke] Univ Tubingen, NMI Nat & Med Sci Inst, Dept Electrophysiol, Reutlingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Hart, ML (corresponding author), Univ Tubingen, Dept Urol, Clin Res Grp KFO 273, Tubingen, Germany.	melaniehar@gmail.com	Klein, Gerd/C-8499-2013	Kraushaar, Udo/0000-0002-4660-1093; Rolauffs, Bernd/0000-0002-3275-8196; Brun, Juliane/0000-0002-0964-3681; Aicher, Wilhelm K/0000-0003-2210-6773; Dr. Guenther, Elke/0000-0002-8758-1607	German Research Foundation (DFG); Kathe und Josef Klinz-Stiftung	German Research Foundation (DFG)(German Research Foundation (DFG)); Kathe und Josef Klinz-Stiftung	This study was funded by the German Research Foundation (DFG) for the KFO 273 (http://www.kfo273.org), the Kathe und Josef Klinz-Stiftung and institutional funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors thank Tanja Abruzzese and Jan Maerz for their excellent technical support and expert training of the students involved in this project. We would also like to thank Dr. Hans-Jorg Buhring and Dr. Kavitha Sivasubramanian for helping with the flow cytometry experiments, as well as Sandra Buckenmaier for helping with the patch clamp data. This study was funded by the German Research Foundation (DFG) for the KFO 273 (http://www.kfo273.org), the Kathe und Josef Klinz-Stiftung and institutional funding.	Andersson KE, 2004, PHYSIOL REV, V84, P935, DOI 10.1152/physrev.00038.2003; Antoon R, 2012, J BIOMED MATER RES A, V100A, P72, DOI 10.1002/jbm.a.33230; Archer SL, 1996, CIRC RES, V78, P431, DOI 10.1161/01.RES.78.3.431; Assinder SJ, 2009, INT J BIOCHEM CELL B, V41, P482, DOI 10.1016/j.biocel.2008.02.011; Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Babu GJ, 2000, MICROSC RES TECHNIQ, V50, P532, DOI 10.1002/1097-0029(20000915)50:6<532::AID-JEMT10>3.0.CO;2-E; Bajpai VK, 2012, STEM CELL RES, V8, P74, DOI 10.1016/j.scr.2011.07.003; Beamish JA, 2010, TISSUE ENG PART B-RE, V16, P467, DOI [10.1089/ten.teb.2009.0630, 10.1089/ten.TEB.2009.0630]; Bharadwaj S, 2011, TISSUE ENG PT A, V17, P2123, DOI [10.1089/ten.TEA.2010.0637, 10.1089/ten.tea.2010.0637]; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Bieback K, 2013, TRANSFUS MED HEMOTH, V40, P326, DOI 10.1159/000354061; Buhring HJ, 2007, ANN NY ACAD SCI, V1106, P262, DOI 10.1196/annals.1392.000; Caione P, 2012, PEDIATR SURG INT, V28, P421, DOI 10.1007/s00383-012-3063-0; Campbell JH, 2012, ARTERIOSCL THROM VAS, V32, P1784, DOI 10.1161/ATVBAHA.111.243212; Cheong A, 2006, CELL CYCLE, V5, P129, DOI 10.4161/cc.5.2.2310; Cox RH, 1998, J VASC RES, V35, P310, DOI 10.1159/000025600; Doughty D., 2005, URINARY FECAL INCONT, V3rd; Felka T, 2010, CYTOTHERAPY, V12, P143, DOI 10.3109/14653240903470647; Frenette PS, 2013, ANNU REV IMMUNOL, V31, P285, DOI 10.1146/annurev-immunol-032712-095919; Fry CH, 2006, CELL CALCIUM, V40, P231, DOI 10.1016/j.ceca.2006.04.027; Fry CH, 2014, PFLUG ARCH EUR J PHY, V466, P781, DOI 10.1007/s00424-014-1446-x; Gong Z, 2009, TISSUE ENG PT A, V15, P319, DOI 10.1089/ten.tea.2008.0161; Gotoh M, 2014, INT J UROL, V21, P294, DOI 10.1111/iju.12266; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Harris LJ, 2011, J SURG RES, V168, P306, DOI 10.1016/j.jss.2009.08.001; Hart ML, 2015, TISSUE ENG PART B-RE, V21, P365, DOI [10.1089/ten.teb.2014.0627, 10.1089/ten.TEB.2014.0627]; Hart ML, 2015, TISSUE EN B IN PRESS; Herman IM, 1993, CURR OPIN CELL BIOL, V5, P48, DOI 10.1016/S0955-0674(05)80007-9; Herrera GM, 2001, AM J PHYSIOL-CELL PH, V280, pC481, DOI 10.1152/ajpcell.2001.280.3.C481; Herrera-Imbroda B, 2015, ADV DRUG DELIVER REV, V82-83, P106, DOI 10.1016/j.addr.2014.10.018; Hill-Eubanks DC, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004549; Hollywood MA, 2003, J PHYSIOL-LONDON, V550, P753, DOI 10.1113/jphysiol.2003.043695; House SJ, 2008, PFLUG ARCH EUR J PHY, V456, P769, DOI 10.1007/s00424-008-0491-8; Jack GS, 2009, BIOMATERIALS, V30, P3259, DOI 10.1016/j.biomaterials.2009.02.035; Kajioka S, 2002, EUR J PHARMACOL, V443, P19, DOI 10.1016/S0014-2999(02)01593-5; Kanematsu A, 2005, AM J PATHOL, V166, P565, DOI 10.1016/S0002-9440(10)62278-X; Kim JH, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/930713; Klein G, 2015, ADV DRUG DELIVER REV, V82-83, P123, DOI 10.1016/j.addr.2014.10.026; Kurpinski K, 2010, STEM CELLS, V28, P734, DOI 10.1002/stem.319; Lee CN, 2010, J KOREAN MED SCI, V25, P813, DOI 10.3346/jkms.2010.25.6.813; MURAKI K, 1991, J PHYSIOL-LONDON, V442, P351, DOI 10.1113/jphysiol.1991.sp018797; Narita Y, 2008, CELL TISSUE RES, V333, P449, DOI 10.1007/s00441-008-0654-0; Neylon CB, 1999, CIRC RES, V85, pE33, DOI 10.1161/01.RES.85.9.e33; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Park WS, 2013, AM J PHYSIOL-CELL PH, V305, pC377, DOI 10.1152/ajpcell.00404.2012; Petkov GV, 2014, AM J PHYSIOL-REG I, V307, pR571, DOI 10.1152/ajpregu.00142.2014; Pilz GA, 2011, STEM CELLS DEV, V20, P635, DOI 10.1089/scd.2010.0308; Platoshyn O, 2004, AM J PHYSIOL-LUNG C, V287, pL226, DOI 10.1152/ajplung.00438.2003; Raghavan AM, 2009, KIDNEY INT, V76, P236, DOI 10.1038/ki.2009.81; Ratz PH, 2005, AM J PHYSIOL-CELL PH, V288, pC769, DOI 10.1152/ajpcell.00529.2004; Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963; Rodman DM, 2005, CIRC RES, V96, P864, DOI 10.1161/01.RES.0000163066.07472.ff; Saleh S, 2005, J PHYSIOL-LONDON, V568, P155, DOI 10.1113/jphysiol.2005.090951; Schmalhofer WA, 2008, MOL PHARMACOL, V74, P1476, DOI 10.1124/mol.108.047670; Seeger T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137419; SHINJOH M, 1991, EUR J PHARMACOL, V205, P199; Sobue K, 1999, MOL CELL BIOCHEM, V190, P105, DOI 10.1023/A:1006941621170; Sui GP, 2004, PROSTATE, V59, P275, DOI 10.1002/pros.20007; Sui GP, 2003, BJU INT, V92, P476, DOI 10.1046/j.1464-410X.2003.04356.x; Tian H, 2010, BIOMATERIALS, V31, P870, DOI 10.1016/j.biomaterials.2009.10.001; Ulrich C, 2015, STEM CELLS DEV, V24, P1558, DOI 10.1089/scd.2014.0465; Ulrich C, 2013, STEM CELLS DEV, V22, P2859, DOI 10.1089/scd.2012.0693; Wang GK, 2008, MOL PHARMACOL, V73, P940, DOI 10.1124/mol.107.041541; Wegener JW, 2004, FASEB J, V18, P1159, DOI 10.1096/fj.04-1516fje; Williams C, 2012, TISSUE ENG PT A, V18, P986, DOI [10.1089/ten.tea.2011.0172, 10.1089/ten.TEA.2011.0172]; WINDER SJ, 1993, CELL SIGNAL, V5, P677, DOI 10.1016/0898-6568(93)90029-L; Yamamoto T, 2012, INT J UROL, V19, P652, DOI 10.1111/j.1442-2042.2012.02999.x	67	19	19	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0145153	10.1371/journal.pone.0145153	http://dx.doi.org/10.1371/journal.pone.0145153			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26673782	Green Published, gold, Green Submitted			2022-12-26	WOS:000366722700108
J	Evans, BJ; Carter, TF; Greenbaum, E; Gvozdik, V; Kelley, DB; McLaughlin, PJ; Pauwels, OSG; Portik, DM; Stanley, EL; Tinsley, RC; Tobias, ML; Blackburn, DC				Evans, Ben J.; Carter, Timothy F.; Greenbaum, Eli; Gvozdik, Vaclav; Kelley, Darcy B.; McLaughlin, Patrick J.; Pauwels, Olivier S. G.; Portik, Daniel M.; Stanley, Edward L.; Tinsley, Richard C.; Tobias, Martha L.; Blackburn, David C.			Genetics, Morphology, Advertisement Calls, and Historical Records Distinguish Six New Polyploid Species of African Clawed Frog (Xenopus, Pipidae) from West and Central Africa	PLOS ONE			English	Article							HOST-DEFENSE PEPTIDES; LAEVIS-LAEVIS ANURA; GENUS XENOPUS; SKIN SECRETIONS; CAPE PROVINCE; EVOLUTION; PHYLOGENY; GENOME; SOUTH; GILLI	African clawed frogs, genus Xenopus, are extraordinary among vertebrates in the diversity of their polyploid species and the high number of independent polyploidization events that occurred during their diversification. Here we update current understanding of the evolutionary history of this group and describe six new species from west and central sub-Saharan Africa, including four tetraploids and two dodecaploids. We provide information on molecular variation, morphology, karyotypes, vocalizations, and estimated geographic ranges, which support the distinctiveness of these new species. We resurrect Xenopus calcaratus from synonymy of Xenopus tropicalis and refer populations from Bioko Island and coastal Cameroon (near Mt. Cameroon) to this species. To facilitate comparisons to the new species, we also provide comments on the type specimens, morphology, and distributions of X. epitropicalis, X. tropicalis, and X. fraseri. This includes significantly restricted application of the names X. fraseri and X. epitropicalis, the first of which we argue is known definitively only from type specimens and possibly one other specimen. Inferring the evolutionary histories of these new species allows refinement of species groups within Xenopus and leads to our recognition of two subgenera (Xenopus and Silurana) and three species groups within the subgenus Xenopus (amieti, laevis, and muelleri species groups).	[Evans, Ben J.] McMaster Univ, Dept Biol, Hamilton, ON, Canada; [Carter, Timothy F.] Univ Guelph, Ontario Vet Coll, Biomed Sci, Guelph, ON N1G 2W1, Canada; [Greenbaum, Eli] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA; [Gvozdik, Vaclav] Acad Sci Czech Republ, Inst Vertebrate Biol, Brno, Czech Republic; [Gvozdik, Vaclav; Tobias, Martha L.] Natl Museum, Dept Zool, Prague, Czech Republic; [Kelley, Darcy B.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [McLaughlin, Patrick J.] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Pauwels, Olivier S. G.] Inst Royal Sci Nat Belgique, Dept Vertebres Recents, B-1040 Brussels, Belgium; [Portik, Daniel M.] Univ Calif Berkeley, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Stanley, Edward L.; Blackburn, David C.] Calif Acad Sci, San Francisco, CA 94118 USA; [Tinsley, Richard C.] Univ Bristol, Sch Biol Sci, Bristol, Avon, England	McMaster University; University of Guelph; University of Texas System; University of Texas El Paso; Czech Academy of Sciences; Institute of Vertebrate Biology of the Czech Academy of Sciences; National Museum; Columbia University; Drexel University; University of California System; University of California Berkeley; California Academy of Sciences; University of Bristol	Evans, BJ (corresponding author), McMaster Univ, Dept Biol, Life Sci Bldg,Room 328, Hamilton, ON, Canada.	evansb@mcmaster.ca	Gvozdik, Vaclav/E-4043-2010; Blackburn, David/L-3812-2019	Blackburn, David/0000-0002-1810-9886; Evans, Ben/0000-0002-9512-8845	NSERC [RGPIN/283102-2012]; NSF [DEB1202609]; Museum of Comparative Zoology; Czech Science Foundation (GACR) [15-13415Y]; IVB institutional support [RVO: 68081766]; Ministry of Culture of the Czech Republic [DKRVO 2015/15, 00023272]; Centre National de la Recherche Scientifique et Technologique (CENAREST); Direct For Biological Sciences [1145459] Funding Source: National Science Foundation; Division Of Environmental Biology [1560667] Funding Source: National Science Foundation	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSF(National Science Foundation (NSF)); Museum of Comparative Zoology; Czech Science Foundation (GACR)(Grant Agency of the Czech Republic); IVB institutional support; Ministry of Culture of the Czech Republic; Centre National de la Recherche Scientifique et Technologique (CENAREST)(Centre National de la Recherche Scientifique (CNRS)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Financial support for components of this work come from NSERC RGPIN/283102-2012 BJE), NSF DEB1202609 (DCB), and the Museum of Comparative Zoology. VG was supported by the Czech Science Foundation (GACR, project number 15-13415Y), IVB institutional support (RVO: 68081766), and Ministry of Culture of the Czech Republic (DKRVO 2015/15, National Museum, 00023272). The material collected in Gabon was supported by a National Geographic Young Explorer's Grant with permission from the Centre National de la Recherche Scientifique et Technologique (CENAREST) and logistical support of the Wildlife Conservation Society, Gabon Program.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; AmphibiaWeb, 2015, INF AMPH BIOL CONS; Bauer Aaron M., 1996, Mitteilungen aus dem Zoologischen Museum in Berlin, V72, P259; Bewick AJ, 2013, GENOME BIOL EVOL, V5, P1087, DOI 10.1093/gbe/evt073; Bewick AJ, 2012, SYST BIOL, V61, P913, DOI 10.1093/sysbio/sys039; Bewick AJ, 2011, EVOLUTION, V65, P698, DOI 10.1111/j.1558-5646.2010.01163.x; Blackburn DC, 2011, ZOOTAXA, P57, DOI 10.11646/zootaxa.3035.1.2; Boulenger G.A., 1882, CATALOGUE BATRACHIA, VSecond; Boulenger GA, 1905, P ZOOL SOC LOND, V1905, P248; Bowes JB, 2008, NUCLEIC ACIDS RES, V36, pD761, DOI 10.1093/nar/gkm826; Brown R.W., 1956, COMPOSITION SCI WORD; Cannatella D, 2015, CYTOGENET GENOME RES, V145, P283, DOI 10.1159/000438910; CANNATELLA DC, 1993, SYST BIOL, V42, P476, DOI 10.2307/2992485; CANNATELLA DC, 1988, ZOOL J LINN SOC-LOND, V94, P1, DOI 10.1111/j.1096-3642.1988.tb00880.x; Conlon JM, 2015, PEPTIDES, V63, P118, DOI 10.1016/j.peptides.2014.11.005; Conlon JM, 2014, COMP BIOCHEM PHYS D, V12, P45, DOI 10.1016/j.cbd.2014.10.001; Conlon JM, 2012, PEPTIDES, V37, P113, DOI 10.1016/j.peptides.2012.07.005; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Oliveira FB, 2006, S AM PRIMATES COMP P, P55; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Du Preez LH, 2009, AQUAT TOXICOL, V95, P10, DOI 10.1016/j.aquatox.2009.07.018; Dupont LM, 2000, PALAEOGEOGR PALAEOCL, V155, P95, DOI 10.1016/S0031-0182(99)00095-4; Ernst R, 2015, SALAMANDRA, V51, P147; ESTES R, 1977, Annals of the South African Museum, V73, P49; Evans BJ, 2011, J ZOOL, V283, P276, DOI 10.1111/j.1469-7998.2010.00769.x; Evans B. J., 2012, POLYPLOIDY GENOME EV, P385, DOI DOI 10.1007/978-3-642-31442-1_18; Evans BJ, 2008, FRONT BIOSCI-LANDMRK, V13, P4687, DOI 10.2741/3033; Evans BJ, 2008, ZOOTAXA, P55; Evans BJ, 2007, GENETICS, V176, P1119, DOI 10.1534/genetics.106.069690; Evans BJ, 2011, MOL ECOL, V20, P4216, DOI 10.1111/j.1365-294X.2011.05262.x; Evans BJ, 2005, MOL BIOL EVOL, V22, P1193, DOI 10.1093/molbev/msi104; Evans BJ, 2004, MOL PHYLOGENET EVOL, V33, P197, DOI 10.1016/j.ympev.2004.04.018; Evans BJ, 1998, COPEIA, P504; Evans BJ, 1997, MOL ECOL, V6, P333, DOI 10.1046/j.1365-294X.1997.00198.x; Fischberg M., 1982, Alytes (Paris), V1, P53; Fischer WJ, 2000, J ZOOL, V252, P99, DOI 10.1017/S0952836900009110; Fisher CT, 2013, OXFORD DICT NATL BIO; FLAJNIK MF, 1993, EMBO J, V12, P4385, DOI 10.1002/j.1460-2075.1993.tb06123.x; Fogell DJ, 2013, PEERJ, V1, DOI 10.7717/peerj.166; Furman BLS, 2015, MOL ECOL, V24, P909, DOI 10.1111/mec.13076; GRAF JD, 1986, BIOCHEM GENET, V24, P821, DOI 10.1007/BF00554522; Gray J.E., 1864, ANN MAG NAT HIST, V14, P315; GREENBAUM E, 2010, HERPETOLOGICAL REV, V41, P376; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Gunther A, 1858, CATALOGUE BATRACHIA; Haramoto Y, 2015, MITOCHONDRI IN PRESS; Harland RM, 2011, TRENDS GENET, V27, P507, DOI 10.1016/j.tig.2011.08.003; Hedtke SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067908; Hellsten U, 2010, SCIENCE, V328, P633, DOI 10.1126/science.1183670; Henrici AC, 2001, J PALEONTOL, V75, P870, DOI 10.1666/0022-3360(2001)075<0870:FOOXAP>2.0.CO;2; Herrmann H.-J., 1989, Veroeffentlichungen Naturhistorisches Museum Schloss Bertholdsburg Schleusingen, V4, P13; Herrmann H-J, 1994, AMPHIBIEN AQUARIUM; Irisarri I, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-114; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jackson JA, 2006, INT J PARASITOL, V36, P1341, DOI 10.1016/j.ijpara.2006.07.003; Jackson JA, 2003, INT J PARASITOL, V33, P137, DOI 10.1016/S0020-7519(02)00255-2; JACKSON JA, 1995, SYST PARASITOL, V32, P1, DOI 10.1007/BF00009463; Jackson JA, 2001, J ZOOL, V254, P405, DOI 10.1017/S0952836901000905; Jackson JA, 1998, INT J PARASITOL, V28, P1195, DOI 10.1016/S0020-7519(98)00065-4; Jackson K, 2010, HERPETOL CONSERV BIO, V5, P414; Kobel H.R., 1996, Symposia of the Zoological Society of London, V68, P9; KOBEL HR, 1981, J ZOOL, V194, P317, DOI 10.1111/j.1469-7998.1981.tb04584.x; Kobel HR, 1998, HERPETOL J, V8, P13; Lillo F, 2013, ITAL J ZOOL, V80, P566, DOI 10.1080/11250003.2013.847502; Mable BK, 2011, J ZOOL, V284, P151, DOI 10.1111/j.1469-7998.2011.00829.x; Maley J, 1996, P ROYAL SOC EDINBURG, V104B, P31, DOI 10.1017/S0269727000006114; Mechkarska M, 2011, PEPTIDES, V32, P1502, DOI 10.1016/j.peptides.2011.05.025; Mechkarska M, 2011, COMP BIOCHEM PHYS D, V6, P206, DOI 10.1016/j.cbd.2011.03.003; Mohneke M., 2010, Traffic Bulletin, V22, P117; MULLER L, 1910, ABHANDLUNGEN KONI MP, V24, P544; Nichol JE, 1999, GEOGR J, V165, P79, DOI 10.2307/3060512; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; Ouidah Law R., 2004, SOCIAL HIST W AFRICA; Peters W.C.H., 1875, MONATSBERICHTE KONIG, V1875, P196; Picker M. D., 1996, BIOL XENOPUS, P61; Pokorna M, 2014, CYTOGENET GENOME RES, V142, P190, DOI 10.1159/000358847; Rambaut A., 2007, TRACER V1 5; Roelants K, 2007, P NATL ACAD SCI USA, V104, P887, DOI 10.1073/pnas.0608378104; Rungger D, 2002, INT J DEV BIOL, V46, P49; Sabaj Perez M. H., 2014, STANDARD SYMBOLIC CO; Salamone L, 2006, HERMINE B SOC ZOOLOG, V147, P2; Salamone L, 2006, BIOL C 16 17 FEBR 20, P11; SATO K, 1993, J IMMUNOL, V150, P2831; Schmid M, 2015, CYTOGENET GENOME RES, V145, P315, DOI 10.1159/000431388; Schmid M, 2015, CYTOGENET GENOME RES, V145, P201, DOI 10.1159/000433481; Shapiro HA, 1934, NATURE, V133, P762, DOI 10.1038/133762a0; SHELTON PMJ, 1970, J EMBRYOL EXP MORPH, V24, P511; SHUM BP, 1993, J IMMUNOL, V151, P5376; Tinsley R.C., 1996, Symposia of the Zoological Society of London, V68, P35; Tinsley R.C., 1996, Symposia of the Zoological Society of London, V68, P403; Tinsley R.C., 1996, Symposia of the Zoological Society of London, V68, P233; Tinsley R. C., 1995, Amphibia-Reptilia, V16, P375, DOI 10.1163/156853895X00451; Tinsley RC, 1998, INT J PARASITOL, V28, P1573, DOI 10.1016/S0020-7519(98)00085-X; Tinsley RC, 1998, SYST PARASITOL, V40, P93, DOI 10.1023/B:SYPA.0000004047.41228.a6; TINSLEY RC, 1973, J ZOOL, V169, P1, DOI 10.1111/j.1469-7998.1973.tb04650.x; TINSLEY RC, 1979, J ZOOL, V188, P69; Tobias ML, 2014, BEHAVIOUR, V151, P1313, DOI 10.1163/1568539X-00003186; Tobias ML, 2011, BEHAVIOUR, V148, P519, DOI 10.1163/000579511X569435; Trueb Linda, 1996, Symposia of the Zoological Society of London, V68, P349; Tymowska J., 1991, P259; VIGNY C, 1979, REV SUISSE ZOOL, V86, P877, DOI 10.5962/bhl.part.82345; Wagler J., 1827, ISIS OKEN, V20, P726; Wagner P, 2013, SALAMANDRA, V49, P206; Yager David D., 1996, Symposia of the Zoological Society of London, V68, P121; Zhang P, 2013, MOL BIOL EVOL, V30, P1899, DOI 10.1093/molbev/mst091; Zimkus BM, 2013, ZOOL SCR, V42, P591, DOI 10.1111/zsc.12029; Zimkus Breda M., 2012, Herpetological Review, V43, P99	107	42	44	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0142823	10.1371/journal.pone.0142823	http://dx.doi.org/10.1371/journal.pone.0142823			51	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26672747	gold, Green Published, Green Submitted			2022-12-26	WOS:000366722700005
J	Fusco, N; Guerini-Rocco, E; Del Gobbo, A; Franco, R; Zito-Marino, F; Vaira, V; Bulfamante, G; Ercoli, G; Nosotti, M; Palleschi, A; Bosari, S; Ferrero, S				Fusco, Nicola; Guerini-Rocco, Elena; Del Gobbo, Alessandro; Franco, Renato; Zito-Marino, Federica; Vaira, Valentina; Bulfamante, Gaetano; Ercoli, Giulia; Nosotti, Mario; Palleschi, Alessandro; Bosari, Silvano; Ferrero, Stefano			The Contrasting Role of p16(Ink4A) Patterns of Expression in Neuroendocrine and Non-Neuroendocrine Lung Tumors: A Comprehensive Analysis with Clinicopathologic and Molecular Correlations	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; PROGNOSTIC IMPLICATIONS; CANCER PATIENTS; IMAGE-ANALYSIS; P16; P53; IMMUNOHISTOCHEMISTRY; ADENOCARCINOMAS; LOCALIZATION; INHIBITORS	Lung cancer encompasses a constellation of malignancies with no validated prognostic markers. p16(Ink4A) expression has been reported in different subtypes of lung cancers; however, its prognostic value is controversial. Here, we sought to investigate the clinical significance of p16(Ink4A) immunoexpression according to specific staining patterns and its operational implications. A total of 502 tumors, including 277 adenocarcinomas, 84 squamous cell carcinomas, 22 large cell carcinomas, 47 typical carcinoids, 12 atypical carcinoids, 28 large cell neuroendocrine carcinomas, and 32 small cell carcinomas were reviewed and subjected to immunohistochemical analysis for p16Ink4A and Ki67. The spectrum of p16Ink4A expression was annotated for each case as negative, sporadic, focal, or diffuse. Expression at immunohistochemical level showed intra-tumor homogeneity, regardless tumor histo-type. Enrichments in cells expressing p16(Ink4A) were observed from lower- to higher-grade neuroendocrine malignancies, whereas a decrease was seen in poorly and undifferentiated non-neuroendocrine carcinomas. Tumor proliferation indices were higher in neuroendocrine tumors expressing p16(Ink4A) while non-neuroendocrine malignancies immunoreactive for p16(Ink4A) showed a decrease in Ki67-positive cells. Quantitative statistical analyses including each histotype and the p16(Ink4A) status confirmed the independent prognostic role of p16(Ink4A) expression, being a high-risk indicator in neuroendocrine tumors and a marker of good prognosis in non-neuroendocrine lung malignancies. In this study, we provide circumstantial evidence to suggest that the routinary assessment of p16(Ink4A) expression using a three-tiered scoring algorithm, even in a small biopsy, may constitute a reliable, reproducible, and cost-effective substrate for a more accurate risk stratification of each individual patient.	[Fusco, Nicola; Guerini-Rocco, Elena; Del Gobbo, Alessandro; Ercoli, Giulia; Bosari, Silvano; Ferrero, Stefano] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Div Pathol, Milan, Italy; [Franco, Renato; Zito-Marino, Federica] IRCCS Fdn Pascale, Ist Nazl Tumori, Dept Pathol, Naples, Italy; [Vaira, Valentina] Ist Nazl Genet Mol Romeo & Enrica Invernizzi, Milan, Italy; [Vaira, Valentina; Bosari, Silvano] Univ Milan, Dept Pathophysiol & Organ Transplantat, Milan, Italy; [Bulfamante, Gaetano] Univ Milan, Div Pathol, San Paolo Hosp, Dept Hlth Sci, Milan, Italy; [Nosotti, Mario; Palleschi, Alessandro] Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Div Thorac Surg, Milan, Italy; [Ferrero, Stefano] Univ Milan, Dept Biomed Surg & Dent Sci, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; Fondazione IRCCS Istituto Nazionale Tumori Milan; IRCCS Fondazione Pascale; University of Milan; San Paolo-Polo Universitaria Hospital; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Ferrero, S (corresponding author), Osped Maggiore Policlin, Fdn IRCCS Ca Granda, Div Pathol, Milan, Italy.	stefano.ferrero@unimi.it	Palleschi, Alessandro/J-6416-2015; Marino, Federica ZMF Zito/K-8634-2016; Nosotti, Mario/K-7389-2016; Fusco, Nicola/D-6264-2016; Vaira, Valentina/K-6499-2016; Nosotti, Mario/AAA-5976-2022; Bosari, Silvano/K-7744-2016	Palleschi, Alessandro/0000-0003-4510-5167; Nosotti, Mario/0000-0002-8571-121X; Fusco, Nicola/0000-0002-9101-9131; Vaira, Valentina/0000-0003-4416-6216; Nosotti, Mario/0000-0002-8571-121X; Franco, Renato/0000-0002-8340-3184; Bosari, Silvano/0000-0002-9744-6951; GUERINI ROCCO, ELENA/0000-0003-2001-7582				[Anonymous], 2015, SURV EP END RES STAT; Arcaro A, 2015, CRIT REV ONCOL HEMAT, V95, P154, DOI 10.1016/j.critrevonc.2015.03.001; Cortes AA, 2015, TRANSL LUNG CANCER R, V4, P191, DOI 10.3978/j.issn.2218-6751.2014.06.01; Beasley MB, 2003, HUM PATHOL, V34, P136, DOI 10.1053/hupa.2003.8; Bian CA, 2015, WORLD J SURG ONCOL, V13, DOI 10.1186/s12957-015-0502-0; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chan JKC, 2013, INT J SURG PATHOL, V21, P455, DOI 10.1177/1066896913502529; Chen LY, 2015, BREAST CANCER RES TR, V149, P631, DOI 10.1007/s10549-015-3288-4; Chen M, 2010, INT J ONCOL, V37, P963, DOI 10.3892/ijo_00000747; Cheng YL, 2003, EUR J CARDIO-THORAC, V23, P221, DOI 10.1016/S1010-7940(02)00749-2; Compton C. C., 2012, AJCC CANC STAGING AT; de Bruin EC, 2014, SCIENCE, V346, P251, DOI 10.1126/science.1253462; Derenzini M, 2009, J PATHOL, V219, P373, DOI 10.1002/path.2612; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; Evangelou K, 2004, BIOTECH HISTOCHEM, V79, P5, DOI 10.1080/10520290310001659466; Fan XH, 2015, TUMOR BIOL, V36, P3043, DOI 10.1007/s13277-014-2940-7; Fusco N, 2016, HISTOPATHOLOGY, V68, P262, DOI 10.1111/his.12735; Fusco N, 2013, MODERN PATHOL, V26, P816, DOI 10.1038/modpathol.2012.228; Gazzeri S, 1998, ONCOGENE, V16, P497, DOI 10.1038/sj.onc.1201559; Georgiadou D, 2014, APMIS, V122, P1230, DOI 10.1111/apm.12289; Gessner C, 2002, EUR RESPIR J, V19, P134, DOI 10.1183/09031936.02.00219402; Han CP, 2009, MODERN PATHOL, V22, P797, DOI 10.1038/modpathol.2009.31; Inoue R, 2004, GENE THER, V11, P1195, DOI 10.1038/sj.gt.3302284; Kawahara A, 2012, LUNG CANCER, V78, P39, DOI 10.1016/j.lungcan.2012.07.002; Klaes R, 2001, INT J CANCER, V92, P276, DOI 10.1002/ijc.1174; Lade-Keller J, 2014, J CLIN PATHOL, V67, P520, DOI 10.1136/jclinpath-2013-202127; Lindeman NI, 2013, J MOL DIAGN, V15, P415, DOI 10.1016/j.jmoldx.2013.03.001; Lou-Qian Zhang, 2013, PLoS One, V8, pe54970, DOI 10.1371/journal.pone.0054970; Marchetti A, 2014, J THORAC ONCOL, V9, P1470, DOI 10.1097/JTO.0000000000000280; McCalmont TH, 2012, J CUTAN PATHOL, V39, P1060, DOI 10.1111/cup.12059; Nilsson K, 2006, INT J CANCER, V118, P1120, DOI 10.1002/ijc.21466; Pan QL, 2005, J MOL DIAGN, V7, P396, DOI 10.1016/S1525-1578(10)60569-7; Piscuoglio S, 2015, HISTOPATHOLOGY, V67, P719, DOI 10.1111/his.12712; Remo A, 2016, APPL IMMUNOHISTO M M, V24, P201, DOI 10.1097/PAI.0000000000000171; SERRANO M, 1993, NATURE, V366, P704, DOI 10.1038/366704a0; Shoushtari A, 2010, CANCER-AM CANCER SOC, V116, P2645, DOI 10.1002/cncr.25040; Singhal S, 2005, CLIN CANCER RES, V11, P3974, DOI 10.1158/1078-0432.CCR-04-2661; Souza-Rodrigues E, 2007, PROTEOMICS, V7, P4102, DOI 10.1002/pmic.200700133; Subhawong AP, 2009, AM J SURG PATHOL, V33, P163, DOI 10.1097/PAS.0b013e31817f9790; Tong JL, 2011, LUNG CANCER, V74, P155, DOI 10.1016/j.lungcan.2011.04.019; Travis WDBE., 2015, WHO CLASSIFICATION T, V4; Vaira V, 2015, LIVER INT, V35, P1077, DOI 10.1111/liv.12636; Zhu CQ, 2006, J CLIN PATHOL, V59, P790, DOI 10.1136/jcp.2005.031351; Zhu CQ, 2014, TRANSL LUNG CANCER R, V3, P149, DOI 10.3978/j.issn.2218-6751.2014.06.09	44	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144923	10.1371/journal.pone.0144923	http://dx.doi.org/10.1371/journal.pone.0144923			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674347	Green Submitted, Green Published, gold			2022-12-26	WOS:000366722700073
J	Liu, Q; Ren, J; Song, JN; Li, JY				Liu, Qian; Ren, Jing; Song, Jiangning; Li, Jinyan			Co-Occurring Atomic Contacts for the Characterization of Protein Binding Hot Spots	PLOS ONE			English	Article							FREE-ENERGY; PREDICTION; INTERFACES; AFFINITY; DATABASE; IDENTIFICATION; MUTATIONS; SERVER; MODEL	A binding hot spot is a small area at a protein-protein interface that can make significant contribution to binding free energy. This work investigates the substantial contribution made by some special co-occurring atomic contacts at a binding hot spot. A co-occurring atomic contact is a pair of atomic contacts that are close to each other with no more than three covalent-bond steps. We found that two kinds of co-occurring atomic contacts can play an important part in the accurate prediction of binding hot spot residues. One is the co-occurrence of two nearby hydrogen bonds. For example, mutations of any residue in a hydrogen bond network consisting of multiple co-occurring hydrogen bonds could disrupt the interaction considerably. The other kind of co-occurring atomic contact is the co-occurrence of a hydrophobic carbon contact and a contact between a hydrophobic carbon atom and a pi ring. In fact, this co-occurrence signifies the collective effect of hydrophobic contacts. We also found that the B-factor measurements of several specific groups of amino acids are useful for the prediction of hot spots. Taking the B-factor, individual atomic contacts and the co-occurring contacts as features, we developed a new prediction method and thoroughly assessed its performance via cross-validation and independent dataset test. The results show that our method achieves higher prediction performance than well-known methods such as Robetta, FoldX and Hotpoint. We conclude that these contact descriptors, in particular the novel co-occurring atomic contacts, can be used to facilitate accurate and interpretable characterization of protein binding hot spots.	[Liu, Qian; Ren, Jing; Li, Jinyan] Univ Technol Sydney, Adv Analyt Inst, Broadway, NSW 2007, Australia; [Song, Jiangning] Monash Univ, Fac Med, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia; [Song, Jiangning] Monash Univ, Fac Informat Technol, Ctr Res Intelligent Syst, Melbourne, Vic 3800, Australia; [Li, Jinyan] Univ Technol Sydney, Ctr Hlth Technol, Broadway, NSW 2007, Australia	University of Technology Sydney; Monash University; Monash University; University of Technology Sydney	Li, JY (corresponding author), Univ Technol Sydney, Adv Analyt Inst, Broadway, NSW 2007, Australia.	jinyan.li@uts.edu.au	Song, Jiangning/F-9787-2010	Song, Jiangning/0000-0001-8031-9086; Li, Jinyan/0000-0003-1833-7413	Australian Research Council Discovery Project grant [ARC DP130102124]	Australian Research Council Discovery Project grant(Australian Research Council)	This work was partly supported by an Australian Research Council Discovery Project grant (ARC DP130102124). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was partly supported by an Australian Research Council Discovery Project grant (ARC DP130102124). We thank Professors Geoffrey I. Webb and Robert Pike for their comments and proofreading work on some parts of this manuscript.	Assi SA, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1158; Benedix A, 2009, NAT METHODS, V6, P3, DOI 10.1038/nmeth0109-3; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen P, 2013, PROTEINS, V81, P1351, DOI 10.1002/prot.24278; Cho KI, 2009, NUCLEIC ACIDS RES, V37, P2672, DOI 10.1093/nar/gkp132; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Darnell SJ, 2008, NUCLEIC ACIDS RES, V36, pW265, DOI 10.1093/nar/gkn346; Dehouck Y, 2013, NUCLEIC ACIDS RES, V41, pW333, DOI 10.1093/nar/gkt450; Fischer TB, 2003, BIOINFORMATICS, V19, P1453, DOI 10.1093/bioinformatics/btg163; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Guney E, 2008, NUCLEIC ACIDS RES, V36, pD662, DOI 10.1093/nar/gkm813; Halperin I, 2004, STRUCTURE, V12, P1027, DOI 10.1016/j.str.2004.04.009; Hubbard SJ, 1993, NACCESS COMPUTER PRO; Huo S, 2002, J COMPUT CHEM, V23, P15, DOI 10.1002/jcc.1153; Kastritis PL, 2014, J MOL BIOL, V426, P2632, DOI 10.1016/j.jmb.2014.04.017; Keskin O, 2005, J MOL BIOL, V345, P1281, DOI 10.1016/j.jmb.2004.10.077; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kortemme T, 2004, SCI STKE, V2004; Lei Deng, 2013, Research in Computational Molecular Biology. 17th Annual International Conference (RECOMB 2013). Proceedings, P333, DOI 10.1007/978-3-642-37195-0_32; Liu Q, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-57; Liu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059737; Liu QY, 2013, ANAL CHEM, V85, P9630, DOI 10.1021/ac401921z; Moretti R, 2013, PROTEINS, V81, P1980, DOI 10.1002/prot.24356; Ofran Y, 2007, PLOS COMPUT BIOL, V3, P1169, DOI 10.1371/journal.pcbi.0030119; Pallara C, 2013, PROTEINS, V81, P2192, DOI 10.1002/prot.24387; Parthasarathy S, 1997, PROTEIN SCI, V6, P2561, DOI 10.1002/pro.5560061208; Schymkowitz J, 2005, NUCL ACIDS RES, V33; Shingate P, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-303; Thorn KS, 2001, BIOINFORMATICS, V17, P284, DOI 10.1093/bioinformatics/17.3.284; Tuncbag N, 2010, NUCLEIC ACIDS RES, V38, pW402, DOI 10.1093/nar/gkq323; Tuncbag N, 2009, BIOINFORMATICS, V25, P1513, DOI 10.1093/bioinformatics/btp240; von Kries JP, 2000, NAT STRUCT BIOL, V7, P800; Wang L, 2012, PROTEIN ENG DES SEL, V25, P119, DOI 10.1093/protein/gzr066; WELLS JA, 1991, METHOD ENZYMOL, V202, P390; Xia JF, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-174; Yuan Z, 2005, PROTEINS, V58, P905, DOI 10.1002/prot.20375; Yuan Z, 2003, PROTEIN ENG, V16, P109, DOI 10.1093/proeng/gzg014; Zhu XL, 2013, PROTEINS, V81, P2221, DOI 10.1002/prot.24405	40	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144486	10.1371/journal.pone.0144486	http://dx.doi.org/10.1371/journal.pone.0144486			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26675422	Green Published, Green Submitted, gold			2022-12-26	WOS:000366722700040
J	Chu, TLH; Guan, QN; Nguan, CYC; Du, CG				Chu, Tony L. H.; Guan, Qiunong; Nguan, Christopher Y. C.; Du, Caigan			Halofuginone Synergistically Enhances Anti-Proliferation of Rapamycin in T Cells and Reduces Cytotoxicity of Cyclosporine in Cultured Renal Tubular Epithelial Cells	PLOS ONE			English	Article							HUMAN CANCER-CELLS; COMBINATION THERAPY; CALCINEURIN; CYCLOPHILIN; MTOR; INHIBITOR; APOPTOSIS; EFFICACY; IMMUNOSUPPRESSION; IDENTIFICATION	Both rapamycin (RAPA) and cyclosporin A (CsA) are commonly used for immunosuppression, however their adverse side effects limit their application. Thus, it is of interest to develop novel means to enhance or preserve the immunosuppressive activity of RAPA or CsA while reducing their toxicity. Halofuginone (HF) has been recently tested as a potential immunosuppressant. This study investigated the interaction of HF with RAPA or with CsA in cell cultures. Cell proliferation in cultures was determined using methylthiazol tetrazolium assay, and cell apoptosis assessed by flow cytometric analysis and Western blot. The drug-drug interaction was determined according to Loewe's equation or Bliss independence. Here, we showed that addition of HF to anti-CD 3 antibody-stimulated splenocyte cultures induced synergistic suppression of T cell proliferation in the presence of RAPA, indicated by an interaction index (gamma) value of < 1.0 between HF and RAPA, but not in those with CsA. The synergistic interaction of RAPA with HF in the suppression of T cell proliferation was also seen in a mixed lymphocyte reaction and Jurkat T cell growth, and was positively correlated with an increase in cell apoptosis, but not with proline depletion. In cultured kidney tubular epithelial cells, HF attenuated the cytotoxicity of CsA. In conclusion, these data indicate that HF synergistically enhances anti-T cell proliferation of RAPA and reduces the nephrotoxicity of CsA in vitro, suggesting the potential use of HF for enhancing anti-T cell proliferation of RAPA and reducing CsA-mediated nephrotoxicity.	[Chu, Tony L. H.; Guan, Qiunong; Nguan, Christopher Y. C.; Du, Caigan] Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada; [Du, Caigan] Vancouver Coastal Hlth Res Inst, Immun & Infect Res Ctr, Vancouver, BC, Canada	University of British Columbia; Vancouver Coastal Health Research Institute	Du, CG (corresponding author), Univ British Columbia, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada.	caigan@mail.ubc.ca			Kidney Foundation of Canada; CIHR for Health Research Strategic Training Program in Transplantation Research; BC Proteomics Network Training programs	Kidney Foundation of Canada; CIHR for Health Research Strategic Training Program in Transplantation Research(Canadian Institutes of Health Research (CIHR)); BC Proteomics Network Training programs	This study was supported by a grant from the Kidney Foundation of Canada. TLHC received training awards from the CIHR for Health Research Strategic Training Program in Transplantation Research, and the BC Proteomics Network Training programs.; This study was supported by a grant from the Kidney Foundation of Canada. TLHC received training awards from the CIHR for Health Research Strategic Training Program in Transplantation Research, and the BC Proteomics Network Training programs. The authors are grateful to Mr. Jeffrey Helm (IIRC Research Manager, Vancouver, Canada) and Mr. Wayne H. Zhao for editorial assistance.	Abraham RT, 1996, ANNU REV IMMUNOL, V14, P483, DOI 10.1146/annurev.immunol.14.1.483; Augustine JJ, 2007, CURR OPIN NEPHROL HY, V16, P535, DOI 10.1097/MNH.0b013e3282f0b319; CABEL MC, 1991, POULTRY SCI, V70, P289, DOI 10.3382/ps.0700289; Caramelo C, 2004, NEPHROL DIAL TRANSPL, V19, P285, DOI 10.1093/ndt/gfg516; Cardenas M E, 1995, Curr Opin Nephrol Hypertens, V4, P472, DOI 10.1097/00041552-199511000-00002; Carlson TJ, 2014, J IMMUNOL, V192, P2167, DOI 10.4049/jimmunol.1302316; Cebrian C, 2001, J BIOL CHEM, V276, P29410, DOI 10.1074/jbc.M102916200; Chen YH, 2005, ONCOGENE, V24, P672, DOI 10.1038/sj.onc.1208099; Chen YH, 2003, ONCOGENE, V22, P3937, DOI 10.1038/sj.onc.1206565; Chi Eun Young, 2013, Obstet Gynecol Sci, V56, P84, DOI 10.5468/OGS.2013.56.2.84; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; Chu TLH, 2013, INT IMMUNOPHARMACOL, V16, P414, DOI 10.1016/j.intimp.2013.04.031; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; de Figueiredo-Pontes LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026713; De Waele V, 2010, PREV VET MED, V96, P143, DOI 10.1016/j.prevetmed.2010.06.017; Derici U, 2001, ACTA NEUROL BELG, V101, P124; Dong LH, 2013, J HEMATOL ONCOL, V6, DOI 10.1186/1756-8722-6-53; Du CG, 2006, AM J PHYSIOL-RENAL, V290, pF1044, DOI 10.1152/ajprenal.00341.2005; Du CG, 2001, EXP BIOL MED, V226, P1051, DOI 10.1177/153537020122601113; Ernst RA, 1996, POULTRY SCI, V75, P1493, DOI 10.3382/ps.0751493; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; FOXWELL BMJ, 1988, BIOCHIM BIOPHYS ACTA, V938, P447, DOI 10.1016/0005-2736(88)90142-3; FRUMAN DA, 1992, P NATL ACAD SCI USA, V89, P3686, DOI 10.1073/pnas.89.9.3686; Gadir N, 2008, ONCOGENE, V27, P1055, DOI 10.1038/sj.onc.1210721; GRECO WR, 1995, PHARMACOL REV, V47, P331; Greco WR, 1996, J NATL CANCER I, V88, P699, DOI 10.1093/jnci/88.11.699; HEEG K, 1985, J IMMUNOL METHODS, V77, P237, DOI 10.1016/0022-1759(85)90036-5; Issa N, 2013, AM J NEPHROL, V37, P602, DOI 10.1159/000351648; JANG CS, 1948, NATURE, V161, P400, DOI 10.1038/161400b0; Jennings P, 2009, TOXICOL IN VITRO, V23, P486, DOI 10.1016/j.tiv.2008.12.023; Kaczmarek I, 2013, J HEART LUNG TRANSPL, V32, P277, DOI 10.1016/j.healun.2012.11.028; Kahan BD, 2009, TRANSPL P, V41, P1423, DOI 10.1016/j.transproceed.2009.05.001; Keller TL, 2012, NAT CHEM BIOL, V8, P311, DOI [10.1038/NCHEMBIO.790, 10.1038/nchembio.790]; Klein P, 2008, VET J, V177, P429, DOI 10.1016/j.tvjl.2007.05.007; Leiba M, 2006, J LEUKOCYTE BIOL, V80, P399, DOI 10.1189/jlb.0705409; Loewe S, 1926, N-S ARCH EX PATH PH, V114, P313; Malaekeh-Nikouei B, 2008, COLLOID SURFACE B, V67, P238, DOI 10.1016/j.colsurfb.2008.09.001; Marionnet AV, 1997, CELL BIOL TOXICOL, V13, P115, DOI 10.1023/B:CBTO.0000010396.88482.54; MARKS WH, 1991, TRANSPLANTATION, V52, P340, DOI 10.1097/00007890-199108000-00030; Nikoletopoulou V, 2013, BBA-MOL CELL RES, V1833, P3448, DOI 10.1016/j.bbamcr.2013.06.001; Peddi VR, 2013, TRANSPLANT REV-ORLAN, V27, P97, DOI 10.1016/j.trre.2013.06.001; QUESNIAUX VFJ, 1987, EUR J IMMUNOL, V17, P1359, DOI 10.1002/eji.1830170921; Ravikumar B, 2006, HUM MOL GENET, V15, P1209, DOI 10.1093/hmg/ddl036; Rush D, 2013, TRANSPLANT REV-ORLAN, V27, P93, DOI 10.1016/j.trre.2013.04.003; Schonder KS, 2011, CRIT CARE NURS CLIN, V23, P405, DOI 10.1016/j.ccell.2011.06.001; Sundrud MS, 2009, SCIENCE, V324, P1334, DOI 10.1126/science.1172638; Tedesco D, 2012, J TRANSPLANT, V2012, DOI 10.1155/2012/230386; Trotz-Williams LA, 2011, VET REC, V168, DOI 10.1136/vr.d1492; Wang BB, 2012, TRANSPL IMMUNOL, V26, P50, DOI 10.1016/j.trim.2011.10.004; Williams A, 2006, CURR TOP DEV BIOL, V76, P89, DOI 10.1016/S0070-2153(06)76003-3; Yellen P, 2011, CELL CYCLE, V10, P3948, DOI 10.4161/cc.10.22.18124; Zhao Liang, 2010, Front Biosci (Elite Ed), V2, P241, DOI 10.2741/e86	52	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 15	2015	10	12							e0144735	10.1371/journal.pone.0144735	http://dx.doi.org/10.1371/journal.pone.0144735			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9HZ	26671563	Green Published, Green Submitted, gold			2022-12-26	WOS:000366719300019
J	Hasebe, Y; Yamamoto, H; Fukuda, K; Nishimiya, K; Hanawa, K; Shindo, T; Kondo, M; Nakano, M; Wakayama, Y; Takayama, K; Shimokawa, H				Hasebe, Yuhi; Yamamoto, Hiroaki; Fukuda, Koji; Nishimiya, Kensuke; Hanawa, Kenichiro; Shindo, Tomohiko; Kondo, Masateru; Nakano, Makoto; Wakayama, Yuji; Takayama, Kazuyoshi; Shimokawa, Hiroaki			Development of a Novel Shock Wave Catheter Ablation System - The First Feasibility Study in Pigs	PLOS ONE			English	Article							RECURRENT VENTRICULAR-TACHYCARDIA; RADIOFREQUENCY ABLATION; ATRIAL-FIBRILLATION; NONISCHEMIC CARDIOMYOPATHY; LESION FORMATION; THERAPY; RISK; DEFIBRILLATOR; COMPLICATIONS; TEMPERATURE	Introduction Radio-frequency catheter ablation (RFCA) using Joule heat has two fundamental weaknesses: the limited depth of treatment and the risk of thrombus formation. In contrast, focused shock wave (SW) therapy could damage tissues at arbitrary depths without heat generation. Thus, we aimed to develop a SWcatheter ablation (SWCA) system that could compensate for the weaknesses of RFCA therapy. Methods and Results We developed a SWCA system where the SW generated by a Q-switched Holmium: yttrium aluminum garnet (YAG) laser beam was reflected by a reflector attached to 14-Fr catheter tip and then was converged onto the focus. We examined the feasibility of our system on pigs in vivo. When applied using the epicardial approach, the SWCA caused persistent spheroidal lesions with mild superficial injury than the RFCA. The lesions were created to a depth based on the focal length (2.0 mm) [2.36 +/- 0.45 (SD) mm immediately after procedure, n = 16]. When applied to the atrioventricular (AV) node using the endocardial approach, the SWCA caused junctional escape rhythms in 2 pigs and AV block in 12 pigs (complete AV block in 9) in acute phase (n = 14). Nine of the 14 pigs survived with pacemakers for the long-term study, and the AV block persisted for 12.6 +/- 3.9 (SD) days in all surviving pigs. Histological examination showed AV nodal cell body atrophy in the acute phase and fibrotic lesions in the chronic phase. Importantly, no acute or chronic fatal complications were noted. Conclusions Our novel SWCA system could be a promising modality as a non-thermal ablation method to compensate for the weaknesses of RFCA therapy. However, further research and development will be necessary as the current prototype still exhibited the presence of micro-thrombus formation in the animal studies.	[Hasebe, Yuhi; Fukuda, Koji; Nishimiya, Kensuke; Hanawa, Kenichiro; Shindo, Tomohiko; Kondo, Masateru; Nakano, Makoto; Wakayama, Yuji; Takayama, Kazuyoshi; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan; [Yamamoto, Hiroaki; Shimokawa, Hiroaki] Tohoku Univ, Grad Sch Med, Dept Adv Cardiovasc Med, Sendai, Miyagi 980, Japan	Tohoku University; Tohoku University	Shimokawa, H (corresponding author), Tohoku Univ, Grad Sch Med, Dept Cardiovasc Med, Sendai, Miyagi 980, Japan.	shimo@cardio.med.tohoku.ac.jp	Santos-Gomes, G/J-2367-2019; Lago, Joao/W-5238-2019; Fukuda, Koji/AAP-5927-2021; Passero, Luiz Felipe D/B-9549-2012; Laurenti, Marcia Dalastra/C-4734-2012; Santos-Gomes, Gabriela/I-2391-2012; Levy, Debora/G-8208-2014	Lago, Joao/0000-0002-1193-8374; Passero, Luiz Felipe D/0000-0002-5986-6381; FUKUDA, KOJI/0000-0001-7209-8420; Levy, Debora/0000-0001-7492-997X; Santos-Gomes, Gabriela/0000-0001-9264-3887; Yamamoto, Eduardo/0000-0003-2375-6081; Kallas, Esper/0000-0003-2026-6925; Shimokawa, Hiroaki/0000-0001-7534-4826; Rafael-Fernandes, Mariana/0000-0002-5214-7667; Silva, Marcelo/0000-0002-1000-0149; Laurenti, Marcia Dalastra/0000-0002-1080-2440	Japanese Ministry of Health, Labour and Welfare, Tokyo, Japan; Japan Science and Technology Agency, Tokyo, Japan [AS2313010F]	Japanese Ministry of Health, Labour and Welfare, Tokyo, Japan(Ministry of Health, Labour and Welfare, Japan); Japan Science and Technology Agency, Tokyo, Japan(Japan Science & Technology Agency (JST))	The authors had no disclosure for this work. This work was supported in part by the grants-in- aid for Medical Equipment Development and Promotion Research Project (H20-Activity-General-002) from the Japanese Ministry of Health, Labour and Welfare, Tokyo, Japan and the grants- in- aid for Adaptable and Seamless Technology transfer Program (A- STEP) through target-driven R& D (AS2313010F) from Japan Science and Technology Agency, Tokyo, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; DELIUS M, 1987, ULTRASOUND MED BIOL, V13, P61, DOI 10.1016/0301-5629(87)90075-5; Dukkipati SR, 2011, CIRC-ARRHYTHMIA ELEC, V4, P185, DOI 10.1161/CIRCEP.110.957290; EVAN AP, 1991, AM J KIDNEY DIS, V17, P445, DOI 10.1016/S0272-6386(12)80639-1; Evan AP, 1998, NEPHRON, V78, P1, DOI 10.1159/000044874; Fenelon G, 2006, J INTERV CARD ELECTR, V15, P57, DOI 10.1007/s10840-006-7620-0; Gaita F, 2010, CIRCULATION, V122, P1667, DOI 10.1161/CIRCULATIONAHA.110.937953; Haqqani HM, 2011, HEART RHYTHM, V8, P1169, DOI 10.1016/j.hrthm.2011.03.008; Hohnloser SH, 2006, EUR HEART J, V27, P3027, DOI 10.1093/eurheartj/ehl276; Hsia HH, 2003, CIRCULATION, V108, P704, DOI 10.1161/01.CIR.0000083725.72693.EA; JACKMAN WM, 1992, NEW ENGL J MED, V327, P313, DOI 10.1056/NEJM199207303270504; Kato K, 2007, J NEUROSURG, V106, P667, DOI 10.3171/jns.2007.106.4.667; Keane D, 2005, J CARDIOVASC ELECTR, V16, P1025, DOI 10.1111/j.1540-8167.2005.00270.x; Khairy P, 2003, CIRCULATION, V107, P2045, DOI 10.1161/01.CIR.0000058706.82623.A1; Kikuchi Y, 2010, CIRC J, V74, P589, DOI 10.1253/circj.CJ-09-1028; Koruth JS, 2012, HEART RHYTHM, V9, P1932, DOI 10.1016/j.hrthm.2012.08.001; KUWAHARA MA, 1987, J UROLOGY, V137, P837, DOI 10.1016/S0022-5347(17)44268-6; Matlaga BR, 2008, J ENDOUROL, V22, P121, DOI 10.1089/end.2007.9852; MAYER R, 1990, J UROLOGY, V144, P1505, DOI 10.1016/S0022-5347(17)39787-2; Moss AJ, 1996, NEW ENGL J MED, V335, P1933, DOI 10.1056/NEJM199612263352601; NAKAGAWA H, 1995, CIRCULATION, V91, P2264, DOI 10.1161/01.CIR.91.8.2264; Nakahara S, 2010, J AM COLL CARDIOL, V55, P2355, DOI 10.1016/j.jacc.2010.01.041; NATH S, 1995, PROG CARDIOVASC DIS, V37, P185, DOI 10.1016/S0033-0620(05)80006-4; Nishida T, 2004, CIRCULATION, V110, P3055, DOI 10.1161/01.CIR.0000148849.51177.97; Rassweiler JJ, 2011, EUR UROL, V59, P784, DOI 10.1016/j.eururo.2011.02.033; Raum K, 1997, IEEE T ULTRASON FERR, V44, P810, DOI 10.1109/58.655196; Sacher F, 2010, J AM COLL CARDIOL, V55, P2366, DOI 10.1016/j.jacc.2009.10.084; Sinelnikov YD, 2009, ACOUST PHYS+, V55, P647, DOI 10.1134/S1063771009040216; Soejima K, 2001, CIRCULATION, V103, P1858; Sosa E, 2000, J AM COLL CARDIOL, V35, P1442, DOI 10.1016/S0735-1097(00)00606-9; STRICKBERGER SA, 1995, AM HEART J, V130, P1026, DOI 10.1016/0002-8703(95)90204-X; TAKAYAMA K, 1989, P INT WORKSH SHOCK W, P217; TANNO K, 1994, JPN CIRC J, V58, P123, DOI 10.1253/jcj.58.123; Tokuda M, 2011, CIRC-ARRHYTHMIA ELEC, V4, P889, DOI 10.1161/CIRCEP.111.966283; Zhou L, 1999, J CARDIOVASC ELECTR, V10, P611, DOI 10.1111/j.1540-8167.1999.tb00719.x	35	50	50	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 29	2015	10	1							e0116017	10.1371/journal.pone.0116017	http://dx.doi.org/10.1371/journal.pone.0116017			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CA0LR	26674781	Green Published, Green Submitted, gold			2022-12-26	WOS:000348609800005
J	He, Q; Wang, F; Liu, SH; Zhu, DY; Cong, HJ; Gao, F; Li, BQ; Wang, HW; Lin, Z; Liao, J; Gu, LC				He, Qing; Wang, Feng; Liu, Shiheng; Zhu, Deyu; Cong, Hengjiang; Gao, Fei; Li, Bingqing; Wang, Hongwei; Lin, Zong; Liao, Jun; Gu, Lichuan			Structural and biochemical insight into the mechanism of Rv2837c from Mycobacterium tuberculosis as a c-di-NMP phosphodiesterase (vol 291, pg 3668, 2016)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Correction													Cong, Hengjiang/ABA-2924-2020; Cong, Hengjiang/ABA-2928-2020	Cong, Hengjiang/0000-0002-9225-0095; Liao, Jun/0000-0001-7487-5545				He Q, 2016, J BIOL CHEM, V291, P14386, DOI [10.1074/jbc.A115.699801, 10.1074/jbc.M115.699801]	1	40	43	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 1	2016	291	27					14386	14387		10.1074/jbc.A115.699801	http://dx.doi.org/10.1074/jbc.A115.699801			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DR5XG	27371563	Green Published, hybrid			2022-12-26	WOS:000379975100041
J	Yamamoto, ES; Campos, BLS; Jesus, JA; Laurenti, MD; Ribeiro, SP; Kallas, EG; Rafael-Fernandes, M; Santos-Gomes, G; Silva, MS; Sessa, DP; Lago, JHG; Levy, D; Passero, LFD				Yamamoto, Eduardo S.; Campos, Bruno L. S.; Jesus, Jessica A.; Laurenti, Marcia D.; Ribeiro, Susan P.; Kallas, Esper G.; Rafael-Fernandes, Mariana; Santos-Gomes, Gabriela; Silva, Marcelo S.; Sessa, Deborah P.; Lago, Joao H. G.; Levy, Debora; Passero, Luiz F. D.			The Effect of Ursolic Acid on Leishmania (Leishmania) amazonensis Is Related to Programed Cell Death and Presents Therapeutic Potential in Experimental Cutaneous Leishmaniasis	PLOS ONE			English	Article							OLEANOLIC ACID; AMPHOTERICIN-B; IN-VITRO; ANTILEISHMANIAL ACTIVITY; VISCERAL LEISHMANIASIS; SECONDARY METABOLITES; TRADITIONAL MEDICINE; APOPTOSIS; DONOVANI; MECHANISM	Among neglected tropical diseases, leishmaniasis is one of the most important ones, affecting more than 12 million people worldwide. The available treatments are not well tolerated, and present diverse side effects, justifying the search for new therapeutic compounds. In the present study, the activity of ursolic acid (UA) and oleanolic acid (OA) were assayed in experimental cutaneous leishmaniasis (in vitro and in vivo). Promastigote forms of L. amazonensis were incubated with OA and UA for 24h, and effective concentration 50% (EC50) was estimated. Ultraestructural alterations in Leishmania amazonensis promastigotes after UA treatment were evaluated by transmission electron microscopy, and the possible mode of action was assayed through Annexin V and propidium iodide staining, caspase 3/7 activity, DNA fragmentation and transmembrane mitochondrial potential. The UA potential was evaluated in intracellular amastigotes, and its therapeutic potential was evaluated in L. amazonensis infected BALB/c mice. UA eliminated L. amazonensis promastigotes with an EC50 of 6.4 mu g/mL, comparable with miltefosine, while OA presented only a marginal effect on promastigote forms at 100 mu g/mL. The possible mechanism by which promastigotes were eliminated by UA was programmed cell death, independent of caspase 3/7, but it was highly dependent on mitochondria activity. UA was not toxic for peritoneal macrophages from BALB/c mice, and it was able to eliminate intracellular amastigotes, associated with nitric oxide (NO) production. OA did not eliminate amastigotes nor trigger NO. L. amazonensis infected BALB/c mice submitted to UA treatment presented lesser lesion size and parasitism compared to control. This study showed, for the first time, that UA eliminate promastigote forms through a mechanism associated with programed cell death, and importantly, was effective in vivo. Therefore, UA can be considered an interesting candidate for future tests as a prototype drug for the treatment of cutaneous leishmaniasis.	[Yamamoto, Eduardo S.; Campos, Bruno L. S.; Jesus, Jessica A.; Laurenti, Marcia D.; Passero, Luiz F. D.] Univ Sao Paulo, Lab Pathol Infect Dis LIM50, Dept Pathol, Sch Med, BR-01246903 Sao Paulo, SP, Brazil; [Ribeiro, Susan P.; Kallas, Esper G.] Univ Sao Paulo, Lab Clin Immunol & Allergy LIM60, Sch Med, BR-01246903 Sao Paulo, SP, Brazil; [Rafael-Fernandes, Mariana; Santos-Gomes, Gabriela; Silva, Marcelo S.] Univ Nova Lisboa, Global Hlth & Trop Med, IHMT, P-1349008 Lisbon, Portugal; [Sessa, Deborah P.; Lago, Joao H. G.] Univ Fed Sao Paulo, Inst Environm Chem & Pharmaceut Sci, BR-09920000 Diadema, SP, Brazil; [Levy, Debora] Univ Sao Paulo, Lab Genet & Mol Hematol LIM31, Sch Med, BR-01246903 Sao Paulo, SP, Brazil; [Ribeiro, Susan P.] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Nova de Lisboa; Institute of Hygiene & Tropical Medicine - UNL; Universidade Federal de Sao Paulo (UNIFESP); Universidade de Sao Paulo; Case Western Reserve University	Passero, LFD (corresponding author), Univ Sao Paulo, Lab Pathol Infect Dis LIM50, Dept Pathol, Sch Med, Ave Dr Arnaldo 455, BR-01246903 Sao Paulo, SP, Brazil.	felipepassero@yahoo.com.br	Santos-Gomes, G/J-2367-2019; Lago, Joao/W-5238-2019; Fukuda, Koji/AAP-5927-2021; Passero, Luiz Felipe D/B-9549-2012; Laurenti, Marcia Dalastra/C-4734-2012; Santos-Gomes, Gabriela/I-2391-2012; Levy, Debora/G-8208-2014	Lago, Joao/0000-0002-1193-8374; Passero, Luiz Felipe D/0000-0002-5986-6381; FUKUDA, KOJI/0000-0001-7209-8420; Levy, Debora/0000-0001-7492-997X; Santos-Gomes, Gabriela/0000-0001-9264-3887; Yamamoto, Eduardo/0000-0003-2375-6081; Kallas, Esper/0000-0003-2026-6925; Shimokawa, Hiroaki/0000-0001-7534-4826; Rafael-Fernandes, Mariana/0000-0002-5214-7667; Silva, Marcelo/0000-0002-1000-0149; Laurenti, Marcia Dalastra/0000-0002-1080-2440	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2012/03903-9, 2013/16297-2]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo, grants: 2012/03903-9 and 2013/16297-2. URL: http://fapesp.br/en/.	Alvarado HL, 2015, COLLOID SURFACE B, V130, P40, DOI 10.1016/j.colsurfb.2015.03.062; Ashutosh, 2007, J MED MICROBIOL, V56, P143, DOI 10.1099/jmm.0.46841-0; Bacellar O, 2002, INFECT IMMUN, V70, P6734, DOI 10.1128/IAI.70.12.6734-6740.2002; Begum S, 2014, CHEM BIODIVERS, V11, P709, DOI 10.1002/cbdv.201300151; BENNETT RN, 1994, NEW PHYTOL, V127, P617, DOI 10.1111/j.1469-8137.1994.tb02968.x; Bero J, 2011, J ETHNOPHARMACOL, V137, P998, DOI 10.1016/j.jep.2011.07.022; Both DM, 2002, ARCH DERMATOL RES, V293, P569, DOI 10.1007/s00403-001-0272-0; Camargos HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104429; Campos BLS, 2015, PARASITE IMMUNOL, V37, P407, DOI 10.1111/pim.12206; Carneiro MB, 2015, IFN GAMMA DEPENDENT; Chattopadhyay A, 2011, BIOCHEM BIOPH RES CO, V416, P7, DOI 10.1016/j.bbrc.2011.11.023; da Luz RAI, 2011, J ANTIMICROB CHEMOTH, V66, P350, DOI 10.1093/jac/dkq444; da Silva AA, 2009, FITOTERAPIA, V80, P478, DOI 10.1016/j.fitote.2009.06.007; Das M, 2001, J CELL SCI, V114, P2461; Das R, 2008, APOPTOSIS, V13, P867, DOI 10.1007/s10495-008-0224-7; Decuypere S, 2005, ANTIMICROB AGENTS CH, V49, P4616, DOI 10.1128/AAC.49.11.4616-4621.2005; Demicheli C, 2008, CHEM COMMUN, P4828, DOI 10.1039/b809186b; Passero LFD, 2014, CURR CLIN PHARMACOL, V9, P187, DOI 10.2174/1574884709999140606161413; Passero LFD, 2010, APMIS, V118, P973, DOI 10.1111/j.1600-0463.2010.02679.x; Dutta A, 2007, J MED MICROBIOL, V56, P1196, DOI 10.1099/jmm.0.47114-0; Serna ME, 2015, PARASITOL INT, V64, P295, DOI 10.1016/j.parint.2015.03.005; Franca F, 1996, Rev Soc Bras Med Trop, V29, P229, DOI 10.1590/S0037-86821996000300002; Freitas-Junior LH, 2012, INT J PARASITOL-DRUG, V2, P11, DOI 10.1016/j.ijpddr.2012.01.003; Gachet MS, 2010, J ETHNOPHARMACOL, V128, P184, DOI 10.1016/j.jep.2010.01.007; Germonprez N, 2005, J MED CHEM, V48, P32, DOI 10.1021/jm031150y; Giovannini C, 2002, FEBS LETT, V523, P200, DOI 10.1016/S0014-5793(02)02972-1; Gnoatto SCB, 2008, J ENZYM INHIB MED CH, V23, P604, DOI [10.1080/14756360802204870, 10.1080/14756360802204870 ]; Hill RA, 2012, NAT PROD REP, V29, P780, DOI 10.1039/c2np20027a; Jesus JA, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/620472; Johann S, 2012, MED MYCOL, V50, P843, DOI 10.3109/13693786.2012.678903; Kontogianni VG, 2009, ANAL CHIM ACTA, V635, P188, DOI 10.1016/j.aca.2009.01.021; Laniado-Laborin R, 2009, REV IBEROAM MICOL, V26, P223, DOI 10.1016/j.riam.2009.06.003; Laurenti MD, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/134236; Lin XR, 2014, FOOD FUNCT, V5, P1175, DOI 10.1039/c3fo60720h; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; Machado M, 2012, EXP PARASITOL, V130, P223, DOI 10.1016/j.exppara.2011.12.012; Maes L, 2004, ANTIMICROB AGENTS CH, V48, P2056, DOI 10.1128/AAC.48.6.2056-2060.2004; Mehta A, 2004, J BIOL CHEM, V279, P11798, DOI 10.1074/jbc.M309341200; Neto RLM, 2011, EXP PARASITOL, V127, P215, DOI 10.1016/j.exppara.2010.07.020; Nam H, 2013, FOOD CHEM TOXICOL, V62, P579, DOI 10.1016/j.fct.2013.09.024; Oldfield E, 2012, ANGEW CHEM INT EDIT, V51, P1124, DOI 10.1002/anie.201103110; Ovesna Z, 2006, MUTAT RES-FUND MOL M, V600, P131, DOI 10.1016/j.mrfmmm.2006.03.008; Passero LFD, 2015, PARASITOL INT, V64, P32, DOI 10.1016/j.parint.2015.01.006; Passero LFD, 2011, PARASITOL RES, V108, P529, DOI 10.1007/s00436-010-2091-8; Rath S, 2003, QUIM NOVA, V26, P550, DOI 10.1590/S0100-40422003000400018; Rego FD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122038; Rittig MG, 2000, PARASITOL TODAY, V16, P292, DOI 10.1016/S0169-4758(00)01692-6; Salvioli S, 1997, FEBS LETT, V411, P77, DOI 10.1016/S0014-5793(97)00669-8; Santos DO, 2008, PARASITOL RES, V103, P1, DOI 10.1007/s00436-008-0943-2; Saraste A, 2000, CARDIOVASC RES, V45, P528, DOI 10.1016/S0008-6363(99)00384-3; Seebacher W, 2003, MAGN RESON CHEM, V41, P636, DOI 10.1002/mrc.1214; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Sundar S, 2000, CLIN INFECT DIS, V31, P1104, DOI 10.1086/318121; Tan N, 2002, PHYTOCHEMISTRY, V61, P881, DOI 10.1016/S0031-9422(02)00361-8; Thakur CP, 1999, T ROY SOC TROP MED H, V93, P319, DOI 10.1016/S0035-9203(99)90037-8; Torrado JJ, 2008, J PHARM SCI-US, V97, P2405, DOI 10.1002/jps.21179; Torres-Santos EC, 2004, PHYTOMEDICINE, V11, P114, DOI 10.1078/0944-7113-00381; Wang X, 2013, CARCINOGENESIS, V34, P1323, DOI 10.1093/carcin/bgt058; Yamamoto ES, 2014, PARASITOL RES, V113, P333, DOI 10.1007/s00436-013-3659-x; Yang L, 2010, CANCER LETT, V298, P128, DOI 10.1016/j.canlet.2010.06.010; You HJ, 2001, FEBS LETT, V509, P156, DOI 10.1016/S0014-5793(01)03161-1; Zeng JW, 2015, MOL MED REP, V12, P1997, DOI 10.3892/mmr.2015.3666	62	50	50	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 16	2015	10	12							e0144946	10.1371/journal.pone.0144946	http://dx.doi.org/10.1371/journal.pone.0144946			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY9JH	26674781	Green Submitted, gold, Green Published			2022-12-26	WOS:000366722700076
J	He, Q; Wang, F; Liu, SH; Zhu, DY; Cong, HJ; Gao, F; Li, BQ; Wang, HW; Lin, Z; Liao, J; Gu, LC				He, Qing; Wang, Feng; Liu, Shiheng; Zhu, Deyu; Cong, Hengjiang; Gao, Fei; Li, Bingqing; Wang, Hongwei; Lin, Zong; Liao, Jun; Gu, Lichuan			Structural and Biochemical Insight into the Mechanism of Rv2837c from Mycobacterium tuberculosis as a c-di-NMP Phosphodiesterase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cyclic diadenosine monophosphate (c-di-AMP); enzyme degradation; Mycobacterium tuberculosis; phosphodiesterases; structure-function	AFFECT BACTERIAL-GROWTH; LONG-TERM SURVIVAL; AMP PHOSPHODIESTERASE; GMP; IDENTIFICATION; SPORULATION; RESOLUTION; REVEALS; PROTEIN; LEADS	The intracellular infections of Mycobacterium tuberculosis, which is the causative agent of tuberculosis, are regulated by many cyclic dinucleotide signaling. Rv2837c from M. tuberculosis is a soluble, stand-alone DHH-DHHA1 domain phosphodiesterase that down-regulates c-di-AMP through catalytic degradation and plays an important role in M. tuberculosis infections. Here, we report the crystal structure of Rv2837c (2.0 angstrom), and its complex with hydrolysis intermediate 5-pApA (2.35 angstrom). Our structures indicate that both DHH and DHHA1 domains are essential for c-di-AMP degradation. Further structural analysis shows that Rv2837c does not distinguish adenine from guanine, which explains why Rv2837c hydrolyzes all linear dinucleotides with almost the same efficiency. We observed that Rv2837c degraded other c-di-NMPs at a lower rate than it did on c-di-AMP. Nevertheless, our data also showed that Rv2837c significantly decreases concentrations of both c-di-AMP and c-di-GMP in vivo. Our results suggest that beside its major role in c-di-AMP degradation Rv2837c could also regulate c-di-GMP signaling pathways in bacterial cell.	[He, Qing; Wang, Feng; Liu, Shiheng; Zhu, Deyu; Cong, Hengjiang; Gao, Fei; Li, Bingqing; Wang, Hongwei; Gu, Lichuan] Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China; [Lin, Zong] Tsinghua Univ, Yangtze Delta Reg Inst, Dept Biotechnol & Biomed, Jiaxing 314006, Zhejiang, Peoples R China; [Liao, Jun] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 200031, Peoples R China	Shandong University; Tsinghua University; ShanghaiTech University	Gu, LC (corresponding author), Shandong Univ, Sch Life Sci, State Key Lab Microbial Technol, Jinan 250100, Shandong, Peoples R China.	lcgu@sdu.edu.cn	Cong, Hengjiang/ABA-2924-2020; Cong, Hengjiang/ABA-2928-2020	Cong, Hengjiang/0000-0002-9225-0095; Liao, Jun/0000-0001-7487-5545	National Natural Science Foundation of China [31470732]; Shandong Provincial Funds for Distinguished Young Scientists Grant [JQ201307]; Zhejiang Natural Science Foundation [LR12C05001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Funds for Distinguished Young Scientists Grant; Zhejiang Natural Science Foundation(Natural Science Foundation of Zhejiang Province)	This work was supported by National Natural Science Foundation of China Grant 31470732 (to L.G.) and Shandong Provincial Funds for Distinguished Young Scientists Grant JQ201307 (to L.G.), This work was also supported by Zhejiang Natural Science Foundation Grant LR12C05001 (to Z.L.). The authors declare that they have no conflicts of interest with the contents of this article.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bai YL, 2013, J BACTERIOL, V195, P5123, DOI 10.1128/JB.00769-13; Bejerano-Sagie M, 2006, CELL, V125, P679, DOI 10.1016/j.cell.2006.03.039; Bharati BK, 2012, MICROBIOL-SGM, V158, P1415, DOI 10.1099/mic.0.053892-0; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Burhenne Heike, 2013, Methods Mol Biol, V1016, P27, DOI 10.1007/978-1-62703-441-8_3; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Dey B, 2015, NAT MED, V21, P401, DOI 10.1038/nm.3813; Dey B, 2014, SEMIN IMMUNOL, V26, P486, DOI 10.1016/j.smim.2014.09.002; EGLI M, 1990, P NATL ACAD SCI USA, V87, P3235, DOI 10.1073/pnas.87.8.3235; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gao J, 2015, CELL RES, V25, P539, DOI 10.1038/cr.2015.40; Gentner M, 2012, J AM CHEM SOC, V134, P1019, DOI 10.1021/ja207742q; Gomelsky M, 2011, MOL MICROBIOL, V79, P562, DOI 10.1111/j.1365-2958.2010.07514.x; GUAN Y, 1993, J BIOMOL STRUCT DYN, V11, P253, DOI 10.1080/07391102.1993.10508725; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huynh TN, 2015, P NATL ACAD SCI USA, V112, pE747, DOI 10.1073/pnas.1416485112; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Kumar M, 2008, MICROBIOL-SGM, V154, P2942, DOI 10.1099/mic.0.2008/017806-0; Manikandan K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086096; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Postic G, 2012, RNA, V18, P155, DOI 10.1261/rna.029132.111; Rao F, 2010, J BIOL CHEM, V285, P473, DOI 10.1074/jbc.M109.040238; Romling U, 2005, MOL MICROBIOL, V57, P629, DOI 10.1111/j.1365-2958.2005.04697.x; Romling U, 2006, CURR OPIN MICROBIOL, V9, P218, DOI 10.1016/j.mib.2006.02.010; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Srivastav R, 2014, NUCLEIC ACIDS RES, V42, P7894, DOI 10.1093/nar/gku425; Sultan SZ, 2011, INFECT IMMUN, V79, P3273, DOI 10.1128/IAI.05153-11; Tang Q, 2015, INT J BIOL SCI, V11, P813, DOI 10.7150/ijbs.11797; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Witte CE, 2013, MBIO, V4, DOI 10.1128/mBio.00282-13; Yang J, 2014, MOL MICROBIOL, V93, P65, DOI 10.1111/mmi.12641; Ye MP, 2014, INFECT IMMUN, V82, P1840, DOI 10.1128/IAI.00030-14; Zhang L, 2013, J BIOL CHEM, V288, P3085, DOI 10.1074/jbc.M112.428110; Zhu DY, 2014, MOL CELL, V55, P931, DOI 10.1016/j.molcel.2014.08.001; Zumla A, 2015, LANCET GLOB HEALTH, V3, pE10, DOI 10.1016/S2214-109X(14)70361-4	41	40	43	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 12	2016	291	7					3668	3681		10.1074/jbc.M115.699801	http://dx.doi.org/10.1074/jbc.M115.699801			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DE7ZB	27371563	Green Published, hybrid			2022-12-26	WOS:000370854500044
